Citrus Sinensis ID: 005586

---

Local Sequence Feature Prediction

Residue Number Marker
--------10--------20--------30--------40--------50--------60--------70--------80--------90-------100-------110-------120-------130-------140-------150-------160-------170-------180-------190-------200-------210-------220-------230-------240-------250-------260-------270-------280-------290-------300-------310-------320-------330-------340-------350-------360-------370-------380-------390-------400-------410-------420-------430-------440-------450-------460-------470-------480-------490-------500-------510-------520-------530-------540-------550-------560-------570-------580-------590-------600-------610-------620-------630-------640-------650-------660-------670-------680-------69
Protein Sequence
MGISHVLIPLLVLITSSLTGLVCGNTELRALLDLKASLDPENKLLQSWTENGDPCSGSFEGIACNEHRKVANISLQGKGLTGKLSPSLSGLKCLSGLYLHYNSLSGEIPKEIRNLTELTDLYLDVNNLSGNIPPEIGSMASLQVLQLCCNQLTGNIPAQIGSLKSLSVLTLQHNRLNGGIPDSLGNLGKLKRLDLSFNSLFGTIPESLANNAELLFLDVQNNTLSGIVPSALKRLNGGFQFQNNPGLCGDGIASLRACTVYDNTQINPVKPFGSHSNDTTPIDISEPSGFKEHCNQSQCSNSSKFPQIAVLAAVTSVTVILAGTGILIFFRYRRHKQKIGNTSESSDWQLSTDLTLAKDFNRNGASPLVSLEYCHGWDPLGDYLNGTGFSREHLNSFRLNLEEVESATQCFSEVNLLGKGNFSSVYKGTLRDGTLVAIRSINVTSCKSEEAEFVKGLYLLTSLRHENIIRLRGFCCSRGRGECFLIYDFAPKGKLSKYLDQEEGSSNVLDWSTRVSIIIGIAKGIGYLHSSEVNKPAIVHRNLSVEKVLIDQQFNPLIADCGLHKLLADDIVFSVLKTSAAMGYLAPEYVTTGRFTERSDIFAFGVIILQILTGSLVLTSSMRLAAESATFENFIDRNLKGKFSESEAAKLGKMALVCTHEDPENRPTMEAVIEELTVAAPVMATFLFS
Secondary Structure (PSIPRED)
cccHHHHHHHHHHHHHHcccccccHHHHHHHHHHHHccccccccccccccccccccccccEEEccccccEEEEEEcccccEEcccccccccccccEEEccccccEEcccccccccccccEEEcccccccccccccccccccccEEEcccccccccccccccccccccEEEccccccEEccccccccccccccEEcccccccccccHHHHccccccEEEccccccccccccHHHHcccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccEEEEEHHHHHHHHHHHHHHHEEEEEEcccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccHHHHHHHHcccccccEEccccccEEEEEEEccccEEEEEEEcccccccHHHHHHHHHHHHccccccccccccEEEEEccccEEEEEEcccccccHHHHHcccccccccccHHHHHHHHHHHHHHHHHcccccccccccEEcccccccccccccccEEEcccccccccccccccEEEcccccccccccccccccccccccccccHHHHHHHHHHccccHHHHHHHHHHHccccEEEcccccccccHHHHHHHHHHHHHcccccccccccHHHHHHHHHcccccccccccc
Secondary Structure Prediction (SSPRO)
cccccEEccHHHHccccccEEEccccccccccccccccccccccccEEEccccccccccccccccccccEEEEEEccccccccccHHHcccccccEEEcccccccccccccccccccccEEEcccccccEEccccccccccccEEEcccccccEEccccccccccccEEEccccccccccHHHHcccccccEEEccccccccccHHHHcccccccEEEccccccEEEccHHHHcccccEEEEccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHcccccccccccccccccHHHHHHHHcccccccccccccccccccccccccccccccccccccccHHHHHHHHccccHHHEEEcccccEEEEEEcccccEEEEEEcccccccccHHHHHHHHHHHHHccccccHEEEEEEEccccccEEEEEEccccccHHHHHcccccccccccHHHHHHHHHHHHHHHHHHHccccccccEEEEccccccEEEcccccHHHHHccHHHHcccccccEEHEHccccccccccHcEEEEEcccccHHHHHHHHHHHHccccccHHHHHHHHHcccHHHHccHHHcccccHHHHHHHHHHHHHHccccccccccHHHHHHHHHHHcccccccccc
Coil and Loop (DISEMBL)
MGISHVLIPLLVLITSSltglvcgnTELRALLDLKASLDPENKLLQswtengdpcsgsfegiacneHRKVANIslqgkgltgklspslsglkclSGLYLHYnslsgeipKEIRNLTELTDLYLDVnnlsgnippeigsMASLQVLQLCCNQltgnipaqigslkSLSVLTLQHnrlnggipdslgnlgklkrldlsfnslfgtipeslANNAELLFLDVQnntlsgivpsalkrlnggfqfqnnpglcgdgiaslractvydntqinpvkpfgshsndttpidisepsgfkehcnqsqcsnsskfpQIAVLAAVTSVTVILAGTGILIFFRYRRhkqkigntsessdwqlsTDLTLakdfnrngasplvsleychgwdplgdylngtgfsrEHLNSFRLNLEEVESATQCfsevnllgkgnfssvykgtlrdgTLVAIRSINVTSCKSEEAEFVKGLYLLTSLRHENIIRLRGFccsrgrgecfliydfapkgklskyldqeegssnvldwsTRVSIIIGIAKGIgylhssevnkpaivhRNLSVEKVLIDqqfnpliadcgLHKLLADDIVFSVLKTSaamgylapeyvttgrftersdifAFGVIILQILTGSLVLTSSMRLAAESATFENFIDrnlkgkfseseAAKLGKMALVCthedpenrptMEAVIEELTVAAPVMATFLFS
Flexible Loop (DISEMBL)
MGISHVLIPLLVLITSSLTGLVCGNTELRALLDLKASLDPENKLLQSWTENGDPCSGSFEGIACNEHRKVANISLQGKGLTGKLSPSLSGLKCLSGLYLHYNSLSGEIPKEIRNLTELTDLYLDVNNLSGNIPPEIGSMASLQVLQLCCNQLTGNIPAQIGSLKSLSVLTLQHNRLNGGIPDSLGNLGKLKRLDLSFNSLFGTIPESLANNAELLFLDVQNNTLSGIVPSALKRLNGGFQFQNNPGLCGDGIASLRACTVYDNTQINPVKPFGSHSNDTTPIDISEPSGFKEHCNQSQCSNSSKFPQIAVLAAVTSVTVILAGTGILIFFRYRRHKQKigntsessdwqlSTDLTLAKDFNRNGASPLVSLEYCHGWDPLGDYLNGTGFSREHLNSFRLNLEEVESATQCFSevnllgkgnfSSVYKGTLRDGTLVAIRSInvtsckseeaeFVKGLYLLTSLRHENIIRLRGFCCSRGRGECFLIYDFAPKGKLSKYLDQEEgssnvldwstRVSIIIGIAKGIGYLHSSEVNKPAIVHRNLSVEKVLIDQQFNPLIADCGLHKLLADDIVFSVLKTSAAMGYLAPEYVTTGRFTERSDIFAFGVIILQILTGSLVLTSSMRLAAESATFENFIDRNLKGKFSESEAAKLGKMALVCTHEDPENRPTMEAVIEELTVAAPVMATFLFS
Low Complexity Region (SEG)
MGISHVLIPLLVLITSSLTGLVCGNTELRALLDLKASLDPENKLLQSWTENGDPCSGSFEGIACNEHRKVANISLQGKGLTGKLSPSLSGLKCLSGLYLHYNSLSGEIPKEIRNLTELTDLYLDVNNLSGNIPPEIGSMASLQVLQLCCNQLTGNIPAQIGSLKSLSVLTLQHNRLNGGIPDSLGNLGKLKRLDLSFNSLFGTIPESLANNAELLFLDVQNNTLSGIVPSALKRLNGGFQFQNNPGLCGDGIASLRACTVYDNTQINPVKPFGSHSNDTTPIDISEPSGFKEHCNQSQCSNSSKFPQIAVLAAVTSVTVILAGTGILIFFRYRRHKQKIGNTSESSDWQLSTDLTLAKDFNRNGASPLVSLEYCHGWDPLGDYLNGTGFSREHLNSFRLNLEEVESATQCFSEVNLLGKGNFSSVYKGTLRDGTLVAIRSINVTSCKSEEAEFVKGLYLLTSLRHENIIRLRGFCCSRGRGECFLIYDFAPKGKLSKYLDQEEGSSNVLDWSTRVSIIIGIAKGIGYLHSSEVNKPAIVHRNLSVEKVLIDQQFNPLIADCGLHKLLADDIVFSVLKTSAAMGYLAPEYVTTGRFTERSDIFAFGVIILQILTGSLVLTSSMRLAAESATFENFIDRNLKGKFSESEAAKLGKMALVCTHEDPENRPTMEAVIEELTVAAPVMATFLFS
Disordered region (IsUnstruct)
***SHVLIPLLVLITSSLTGLVCGNTELRALLDLKASLDPENKLLQSWTENGDPCSGSFEGIACNEHRKVANISLQGKGLTGKLSPSLSGLKCLSGLYLHYNSLSGEIPKEIRNLTELTDLYLDVNNLSGNIPPEIGSMASLQVLQLCCNQLTGNIPAQIGSLKSLSVLTLQHNRLNGGIPDSLGNLGKLKRLDLSFNSLFGTIPESLANNAELLFLDVQNNTLSGIVPSALKRLNGGFQFQNNPGLCGDGIASLRACTVYDNTQINPV***********************************FPQIAVLAAVTSVTVILAGTGILIFFRYRRHKQKI********WQLSTDLTLAKDFNRNGASPLVSLEYCHGWDPLGDYLNGTGFSREHLNSFRLNLEEVESATQCFSEVNLLGKGNFSSVYKGTLRDGTLVAIRSINVTSCKSEEAEFVKGLYLLTSLRHENIIRLRGFCCSRGRGECFLIYDFAPKGKLSKYLDQEEGSSNVLDWSTRVSIIIGIAKGIGYLHSSEVNKPAIVHRNLSVEKVLIDQQFNPLIADCGLHKLLADDIVFSVLKTSAAMGYLAPEYVTTGRFTERSDIFAFGVIILQILTGSLVLTSSMRLAAESATFENFIDRNLKG*********LGKMALVCT***********AVIEELTVAAPVMATFL**
Disordered Region (DISOPRED)
*GISHVLIPLLVLITSSLTGLVCGNTELRALLDLKASLDPENKLLQSWTENGDPCSGSFEGIACNEHRKVANISLQGKGLTGKLSPSLSGLKCLSGLYLHYNSLSGEIPKEIRNLTELTDLYLDVNNLSGNIPPEIGSMASLQVLQLCCNQLTGNIPAQIGSLKSLSVLTLQHNRLNGGIPDSLGNLGKLKRLDLSFNSLFGTIPESLANNAELLFLDVQNNTLSGIVPSALKRLNGGFQFQNNPGLCGDGIA*****TVYDNTQINPVKPFG***********************************AVLAAVTSVTVILAGTGILIFFRYR*********************************************************REHLNSFRLNLEEVESATQCFSEVNLLGKGNFSSVYKGTLRDGTLVAIRSI*************KGLYLLTSLRHENIIRLRGFCCSRGRGECFLIYDFAPKGKLSKYLDQEEGSSNVLDWSTRVSIIIGIAKGIGYLHSSEVNKPAIVHRNLSVEKVLIDQQFNPLIADCGLHKLLADDIVFSVLKTSAAMGYLAPEYVTTGRFTERSDIFAFGVIILQILTGSLVLTSSMRLAAESATFENFIDRNLKGKFSESEAAKLGKMALVCTHEDPENRPTMEAVIEELTVAAPV***F***
Disordered Region (DISEMBL)
MGISHVLIPLLVLITSSLTGLVCGNTELRALLDLKASLDPENKLLQSWTENGDPCSGSFEGIACNEHRKVANISLQGKGLTGKLSPSLSGLKCLSGLYLHYNSLSGEIPKEIRNLTELTDLYLDVNNLSGNIPPEIGSMASLQVLQLCCNQLTGNIPAQIGSLKSLSVLTLQHNRLNGGIPDSLGNLGKLKRLDLSFNSLFGTIPESLANNAELLFLDVQNNTLSGIVPSALKRLNGGFQFQNNPGLCGDGIASLRACTVYDNTQINPVKPFGSHSNDTTPIDISEPSGF************SKFPQIAVLAAVTSVTVILAGTGILIFFRYRRHKQ**********WQLSTDLTLAKDFNRNGASPLVSLEYCHGWDPLGDYLNGTGFSREHLNSFRLNLEEVESATQCFSEVNLLGKGNFSSVYKGTLRDGTLVAIRSINVTSCKSEEAEFVKGLYLLTSLRHENIIRLRGFCCSRGRGECFLIYDFAPKGKLSKYLDQEEGSSNVLDWSTRVSIIIGIAKGIGYLHSSEVNKPAIVHRNLSVEKVLIDQQFNPLIADCGLHKLLADDIVFSVLKTSAAMGYLAPEYVTTGRFTERSDIFAFGVIILQILTGSLVLTSSMRLAAESATFENFIDRNLKGKFSESEAAKLGKMALVCTHEDPENRPTMEAVIEELTVAAPVMATFLFS
Disordered Region (DISPRO)
*GISHVLIPLLVLITSSLTGLVCGNTELRALLDLKASLDPENKLLQSWTENGDPCSGSFEGIACNEHRKVANISLQGKGLTGKLSPSLSGLKCLSGLYLHYNSLSGEIPKEIRNLTELTDLYLDVNNLSGNIPPEIGSMASLQVLQLCCNQLTGNIPAQIGSLKSLSVLTLQHNRLNGGIPDSLGNLGKLKRLDLSFNSLFGTIPESLANNAELLFLDVQNNTLSGIVPSALKRLNGGFQFQNNPGLCGDGIASLRACTVYDNTQINPVKPFGSHSNDTTPIDISEPSGFKEHCNQSQCSNSSKFPQIAVLAAVTSVTVILAGTGILIFFRYRRHKQ***********QLSTDLTLAKDFNR**ASPLVS*****************GFSREHLNSFRLNLEEVESATQCFSEVNLLGKGNFSSVYKGTLRDGTLVAIRSINVTSCKSEEAEFVKGLYLLTSLRHENIIRLRGFCCSRGRGECFLIYDFAPKGKLSKYLDQEEGSSNVLDWSTRVSIIIGIAKGIGYLHSSEVNKPAIVHRNLSVEKVLIDQQFNPLIADCGLHKLLADDIVFSVLKTSAAMGYLAPEYVTTGRFTERSDIFAFGVIILQILTGSLVLTSSMRLAAESATFENFIDRNLKGKFSESEAAKLGKMALVCTHEDPENRPTMEAVIEELTVAAPV*******
Transmembrane Helix (TMHMM)
oooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooHHHHHHHHHHHHHHHHHHHHHHHiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiHHHHHHHHHHHHHHHHHHHHooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooo
Transmembrane Helix (HMMTOP)
oooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooHHHHHHHHHHHHHHHHHHHHiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiHHHHHHHHHHHHHHHHHHHHooooooooooooooHHHHHHHHHHHHHHHHHHHHiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiii
Transmembrane Helix (MEMSAT)
ooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooHHHHHHHHHHHHHHHHHHHHHHHHiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiii
TM Helix, Signal Peptide (MEMSAT_SVM)
SSSSSSSSSSSSSSSSSiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiHHHHHHHHHHHHHHHHHHHHHHHHoooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooo
TM Helix, Signal Peptide (Phobius)
SSSSSSSSSSSSSSSSSSSSSSSSoooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooHHHHHHHHHHHHHHHHHHHHHHHiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiHHHHHHHHHHHHHHHHHHooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooo
Signal Peptide (SignalP HMM Mode)
SSSSSSSSSSSSSSSSSSSSooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooo
Signal Peptide (SignalP NN Mode)
xxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxx
Coiled Coils (COILS)
MGISHVLIPLLVLITSSLTGLVCGNTELRALLDLKASLDPENKLLQSWTENGDPCSGSFEGIACNEHRKVANISLQGKGLTGKLSPSLSGLKCLSGLYLHYNSLSGEIPKEIRNLTELTDLYLDVNNLSGNIPPEIGSMASLQVLQLCCNQLTGNIPAQIGSLKSLSVLTLQHNRLNGGIPDSLGNLGKLKRLDLSFNSLFGTIPESLANNAELLFLDVQNNTLSGIVPSALKRLNGGFQFQNNPGLCGDGIASLRACTVYDNTQINPVKPFGSHSNDTTPIDISEPSGFKEHCNQSQCSNSSKFPQIAVLAAVTSVTVILAGTGILIFFRYRRHKQKIGNTSESSDWQLSTDLTLAKDFNRNGASPLVSLEYCHGWDPLGDYLNGTGFSREHLNSFRLNLEEVESATQCFSEVNLLGKGNFSSVYKGTLRDGTLVAIRSINVTSCKSEEAEFVKGLYLLTSLRHENIIRLRGFCCSRGRGECFLIYDFAPKGKLSKYLDQEEGSSNVLDWSTRVSIIIGIAKGIGYLHSSEVNKPAIVHRNLSVEKVLIDQQFNPLIADCGLHKLLADDIVFSVLKTSAAMGYLAPEYVTTGRFTERSDIFAFGVIILQILTGSLVLTSSMRLAAESATFENFIDRNLKGKFSESEAAKLGKMALVCTHEDPENRPTMEAVIEELTVAAPVMATFLFS
Positional Conservation
no confident homologs detected

---

Close Homologs for Annotation Transfer

Close Homologs in SWISS-PROT Database Detected by BLAST

Original result of BLAST against SWISS-PROT Database

ID	Length	Definition	RBH(Q2H)	RBH(H2Q)	Q cover	H cover	Identity	E-value
Query	689	2.2.26 [Sep-21-2011]
Q8RY65	635	Protein NSP-INTERACTING K	no	no	0.689	0.748	0.315	5e-67
Q6R2J8	703	Protein STRUBBELIG-RECEPT	no	no	0.927	0.908	0.281	9e-63
C0LGU5	614	Probable LRR receptor-lik	no	no	0.757	0.850	0.283	5e-62
C0LGQ5	1249	LRR receptor-like serine/	no	no	0.814	0.449	0.287	5e-62
Q93ZS4	632	Protein NSP-INTERACTING K	no	no	0.777	0.848	0.288	1e-61
Q9LFS4	638	Protein NSP-INTERACTING K	no	no	0.786	0.849	0.279	1e-61
O49318	1124	Probable leucine-rich rep	no	no	0.806	0.494	0.287	2e-60
Q8VZG8	1045	Probable LRR receptor-lik	no	no	0.751	0.495	0.288	4e-60
Q9FIZ3	1252	LRR receptor-like serine/	no	no	0.808	0.444	0.291	9e-59
Q0WVM4	634	Probable LRR receptor-lik	no	no	0.789	0.858	0.281	9e-58

>sp|Q8RY65|NIK2_ARATH Protein NSP-INTERACTING KINASE 2 OS=Arabidopsis thaliana GN=NIK2 PE=1 SV=1

 Score =  256 bits (654), Expect = 5e-67,   Method: Compositional matrix adjust.
 Identities = 178/565 (31%), Positives = 276/565 (48%), Gaps = 90/565 (15%)

Query: 127 NLSGNIPPEIGSMASLQVLQLCCNQLTGNIPAQIGSLKSLSVLTLQHNRLNGGIPDSLGN 186
           NLSG +   IG++ +LQ + L  N +TGNIP +IG L  L  L L  N   G IP +L  
Sbjct: 92  NLSGTLSSSIGNLTNLQTVLLQNNYITGNIPHEIGKLMKLKTLDLSTNNFTGQIPFTLSY 151

Query: 187 LGKLKRLDLSFNSLFGTIPESLANNAELLFLDVQNNTLSGIVPSALKRLNGGFQFQNNPG 246
              L+ L ++ NSL GTIP SLAN  +L FLD+  N LSG VP +L +    F    N  
Sbjct: 152 SKNLQYLRVNNNSLTGTIPSSLANMTQLTFLDLSYNNLSGPVPRSLAKT---FNVMGNSQ 208

Query: 247 LCGDGIASLRACTVYDNTQINPVKPFGSHSNDTTPIDISEPSGFKEHCNQSQCSNS-SKF 305
           +C  G    + C                  N T P    +P     + +Q++ S+  +K 
Sbjct: 209 ICPTGTE--KDC------------------NGTQP----KPMSITLNSSQNKSSDGGTKN 244

Query: 306 PQIAVLAAV--TSVTVILAGTGILIFFRYRRHKQKIGNTSESSDWQLSTDLTLAKDFNRN 363
            +IAV+  V  T V +++ G G L+++R R +KQ                  L  D N  
Sbjct: 245 RKIAVVFGVSLTCVCLLIIGFGFLLWWRRRHNKQ-----------------VLFFDINEQ 287

Query: 364 GASPLVSLEYCHGWDPLGDYLNGTGFSREHLNSFRLNLEEVESATQCFSEVNLLGKGNFS 423
                   E C G                  N  R N +E++SAT  FS  NL+GKG F 
Sbjct: 288 NKE-----EMCLG------------------NLRRFNFKELQSATSNFSSKNLVGKGGFG 324

Query: 424 SVYKGTLRDGTLVAIRSINVTSCKSEEAEFVKGLYLLTSLRHENIIRLRGFCCSRGRGEC 483
           +VYKG L DG+++A++ +   +    E +F   L +++   H N++RL GFC +    E 
Sbjct: 325 NVYKGCLHDGSIIAVKRLKDINNGGGEVQFQTELEMISLAVHRNLLRLYGFCTTSS--ER 382

Query: 484 FLIYDFAPKGKLSKYLDQEEGSSNVLDWSTRVSIIIGIAKGIGYLHSSEVNKPAIVHRNL 543
            L+Y +   G ++  L  +     VLDW TR  I +G  +G+ YLH  E   P I+HR++
Sbjct: 383 LLVYPYMSNGSVASRLKAKP----VLDWGTRKRIALGAGRGLLYLH--EQCDPKIIHRDV 436

Query: 544 SVEKVLIDQQFNPLIADCGLHKLLADDIVFSVLKTSAAMGYLAPEYVTTGRFTERSDIFA 603
               +L+D  F  ++ D GL KLL  +           +G++APEY++TG+ +E++D+F 
Sbjct: 437 KAANILLDDYFEAVVGDFGLAKLLDHEESHVTTAVRGTVGHIAPEYLSTGQSSEKTDVFG 496

Query: 604 FGVIILQILTGSLVL----TSSMRLA--------AESATFENFIDRNLKGKFSESEAAKL 651
           FG+++L+++TG   L     ++ R A         +    E  +D++LK  +   E  ++
Sbjct: 497 FGILLLELITGLRALEFGKAANQRGAILDWVKKLQQEKKLEQIVDKDLKSNYDRIEVEEM 556

Query: 652 GKMALVCTHEDPENRPTMEAVIEEL 676
            ++AL+CT   P +RP M  V+  L
Sbjct: 557 VQVALLCTQYLPIHRPKMSEVVRML 581

Involved in defense response to geminivirus infection (By similarity). Phosphorylates RPL10A in vitro.
Arabidopsis thaliana (taxid: 3702)
EC: 2EC: .EC: 7EC: .EC: 1EC: 1EC: .EC: 1

>sp|Q6R2J8|SRF8_ARATH Protein STRUBBELIG-RECEPTOR FAMILY 8 OS=Arabidopsis thaliana GN=SRF8 PE=2 SV=1

 Score =  242 bits (617), Expect = 9e-63,   Method: Compositional matrix adjust.
 Identities = 196/697 (28%), Positives = 328/697 (47%), Gaps = 58/697 (8%)

Query: 5   HVLIPLLVLITSSLTGL-----VCGNTELRALLDLKASLDPENKLLQSWTENGDPCSGSF 59
             +  +L+L  +S++G      V   ++++AL  L  SL+  ++L       GDPC  S+
Sbjct: 6   RAMFTVLLLFIASISGFSVVRCVTDPSDVQALQVLYTSLNSPSQLTNWKNGGGDPCGESW 65

Query: 60  EGIACNEHRKVANISLQGKGLTGKLSPSLSGLKCLSGLYLHYNSLSGEIPKEIRNLTELT 119
           +GI C E   V  I +   G++G L   LS LK L  L +  NS+   +P ++     LT
Sbjct: 66  KGITC-EGSAVVTIDISDLGVSGTLGYLLSDLKSLRKLDVSGNSIHDTLPYQLP--PNLT 122

Query: 120 DLYLDVNNLSGNIPPEIGSMASLQVLQLCCNQLTGNIPAQIGSLKSLSVLTLQHNRLNGG 179
            L L  NNLSGN+P  I +M SL  + +  N LT +I       KSL+ L L HN  +G 
Sbjct: 123 SLNLARNNLSGNLPYSISAMGSLSYMNVSGNSLTMSIGDIFADHKSLATLDLSHNNFSGD 182

Query: 180 IPDSLGNLGKLKRLDLSFNSLFGTIPESLANNAELLFLDVQNNTLSGIVPSALKRLNGGF 239
           +P SL  +  L  L +  N L G+I   + +   L  L+V NN  +G +P  L  +    
Sbjct: 183 LPSSLSTVSTLSVLYVQNNQLTGSI--DVLSGLPLKTLNVANNHFNGSIPKELSSIQ--- 237

Query: 240 QFQNNPGLCGDGIASLRACTVYDNTQINPVKPFGSHSNDTTPIDISEPSGFKEH--CNQS 297
                  L  DG         +DN   +P +P      +T       PSG K+    ++ 
Sbjct: 238 ------TLIYDG-------NSFDNVPASP-QPERPGKKET-------PSGSKKPKIGSEE 276

Query: 298 QCSNSSKFPQIAVLAAVTSVTVILAG-TGILIFFRYRRHKQKIGNTSESSDWQLSTDLTL 356
           + S+S K     V+  +   ++ +AG   ++++    + K+K+  ++ +S   L    T 
Sbjct: 277 KSSDSGKGLSGGVVTGIVFGSLFVAGIIALVLYLCLHKKKRKVRGSTRASQRSLPLSGTP 336

Query: 357 AKDFNR-NGASPLVSLEYCHGWDPLGDYLNGTG---FSREHLNSFRLNLEEVESATQCFS 412
                R    + +  L+         D +   G     R  + + +  +  ++ AT  FS
Sbjct: 337 EVQEQRVKSVASVADLKSSPAEKVTVDRVMKNGSISRIRSPITASQYTVSSLQVATNSFS 396

Query: 413 EVNLLGKGNFSSVYKGTLRDGTLVAIRSI-NVTSCKSEEAEFVKGLYLLTSLRHENIIRL 471
           + N++G+G+   VY+    +G ++AI+ I N      EE  F++ +  ++ LRH NI+ L
Sbjct: 397 QENIIGEGSLGRVYRAEFPNGKIMAIKKIDNAALSLQEEDNFLEAVSNMSRLRHPNIVPL 456

Query: 472 RGFCCSRGRGECFLIYDFAPKGKLSKYLDQEEGSSNVLDWSTRVSIIIGIAKGIGYLHSS 531
            G+C     G+  L+Y++   G L   L   +  S  L W+ RV + +G AK + YLH  
Sbjct: 457 AGYCTE--HGQRLLVYEYVGNGNLDDTLHTNDDRSMNLTWNARVKVALGTAKALEYLH-- 512

Query: 532 EVNKPAIVHRNLSVEKVLIDQQFNPLIADCGLHKLLADDIVFSVLKTSAAMGYLAPEYVT 591
           EV  P+IVHRN     +L+D++ NP ++D GL  L  +       +   + GY APE+  
Sbjct: 513 EVCLPSIVHRNFKSANILLDEELNPHLSDSGLAALTPNTERQVSTQVVGSFGYSAPEFAL 572

Query: 592 TGRFTERSDIFAFGVIILQILTGSLVLTSSMRLAAES------------ATFENFIDRNL 639
           +G +T +SD++ FGV++L++LTG   L SS   A +S                  +D +L
Sbjct: 573 SGIYTVKSDVYTFGVVMLELLTGRKPLDSSRTRAEQSLVRWATPQLHDIDALSKMVDPSL 632

Query: 640 KGKFSESEAAKLGKMALVCTHEDPENRPTMEAVIEEL 676
            G +     ++   +  +C   +PE RP M  V+++L
Sbjct: 633 NGMYPAKSLSRFADIIALCIQPEPEFRPPMSEVVQQL 669

Arabidopsis thaliana (taxid: 3702)

>sp|C0LGU5|Y5457_ARATH Probable LRR receptor-like serine/threonine-protein kinase At5g45780 OS=Arabidopsis thaliana GN=At5g45780 PE=2 SV=1

 Score =  239 bits (610), Expect = 5e-62,   Method: Compositional matrix adjust.
 Identities = 189/666 (28%), Positives = 293/666 (43%), Gaps = 144/666 (21%)

Query: 25  NTELRALLDLKASLDPENKLLQSWTENG-DPCSGSFEGIACNEHRKVANISLQGKGLTGK 83
           N E+ AL+ +K  +  E ++L  W  N  DPC+ +  G  C+    V ++ +  KGL   
Sbjct: 37  NYEVAALMSVKNKMKDEKEVLSGWDINSVDPCTWNMVG--CSSEGFVVSLEMASKGL--- 91

Query: 84  LSPSLSGLKCLSGLYLHYNSLSGEIPKEIRNLTELTDLYLDVNNLSGNIPPEIGSMASLQ 143
                                                        SG +   IG +  L 
Sbjct: 92  ---------------------------------------------SGILSTSIGELTHLH 106

Query: 144 VLQLCCNQLTGNIPAQIGSLKSLSVLTLQHNRLNGGIPDSLGNLGKLKRLDLSFNSLFGT 203
            L L  NQLTG IP+++G L  L  L L  NR +G IP SLG L  L  L LS N L G 
Sbjct: 107 TLLLQNNQLTGPIPSELGQLSELETLDLSGNRFSGEIPASLGFLTHLNYLRLSRNLLSGQ 166

Query: 204 IPESLANNAELLFLDVQNNTLSGIVPSALKRLNGGFQFQNNPGLCGDGIASLRACTVYDN 263
           +P  +A  + L FLD+  N LSG  P+   +    ++   N  LCG   AS   C+    
Sbjct: 167 VPHLVAGLSGLSFLDLSFNNLSGPTPNISAK---DYRIVGNAFLCGP--ASQELCS---- 217

Query: 264 TQINPVKPFGSHSNDTTPIDISEPSGFKEHCNQSQCSNSSKFPQIAVLAAVTSVTVILAG 323
                         D TP+     +G  E  N    S    F    V+A + S+      
Sbjct: 218 --------------DATPV--RNATGLSEKDNSKHHSLVLSFAFGIVVAFIISL------ 255

Query: 324 TGILIFFRYRRHKQKIGNTSESSDWQLSTDLTLAKDFNRNGASPLVSLEYCHGWDPLGDY 383
             + +FF    H+ ++  +    D++                                  
Sbjct: 256 --MFLFFWVLWHRSRLSRSHVQQDYE---------------------------------- 279

Query: 384 LNGTGFSREHLNSFRLNLEEVESATQCFSEVNLLGKGNFSSVYKGTLRDGTLVAIRSINV 443
                F   HL   R +  E+++AT  FS  N+LG+G F  VYKG L +GT+VA++ +  
Sbjct: 280 -----FEIGHLK--RFSFREIQTATSNFSPKNILGQGGFGMVYKGYLPNGTVVAVKRLK- 331

Query: 444 TSCKSEEAEFVKGLYLLTSLRHENIIRLRGFCCSRGRGECFLIYDFAPKGKLSKYLDQEE 503
               + E +F   + ++    H N++RL GFC +    E  L+Y + P G ++  L    
Sbjct: 332 DPIYTGEVQFQTEVEMIGLAVHRNLLRLFGFCMTPE--ERMLVYPYMPNGSVADRLRDNY 389

Query: 504 GSSNVLDWSTRVSIIIGIAKGIGYLHSSEVNKPAIVHRNLSVEKVLIDQQFNPLIADCGL 563
           G    LDW+ R+SI +G A+G+ YLH  E   P I+HR++    +L+D+ F  ++ D GL
Sbjct: 390 GEKPSLDWNRRISIALGAARGLVYLH--EQCNPKIIHRDVKAANILLDESFEAIVGDFGL 447

Query: 564 HKLLADDIVFSVLKTSAAMGYLAPEYVTTGRFTERSDIFAFGVIILQILTG--------- 614
            KLL              +G++APEY++TG+ +E++D+F FGV+IL+++TG         
Sbjct: 448 AKLLDQRDSHVTTAVRGTIGHIAPEYLSTGQSSEKTDVFGFGVLILELITGHKMIDQGNG 507

Query: 615 ----SLVLTSSMRLAAESATFENFIDRNLKGKFSESEAAKLGKMALVCTHEDPENRPTME 670
                ++L+    L AE   F   +DR+LKG+F +    ++ ++AL+CT   P  RP M 
Sbjct: 508 QVRKGMILSWVRTLKAEK-RFAEMVDRDLKGEFDDLVLEEVVELALLCTQPHPNLRPRMS 566

Query: 671 AVIEEL 676
            V++ L
Sbjct: 567 QVLKVL 572

Arabidopsis thaliana (taxid: 3702)

EC: 2

EC: .

EC: 7

EC: .

EC: 1

EC: 1

EC: .

EC: 1

>sp|C0LGQ5|GSO1_ARATH LRR receptor-like serine/threonine-protein kinase GSO1 OS=Arabidopsis thaliana GN=GSO1 PE=2 SV=1

 Score =  239 bits (610), Expect = 5e-62,   Method: Compositional matrix adjust.
 Identities = 183/637 (28%), Positives = 297/637 (46%), Gaps = 76/637 (11%)

Query: 68   RKVANISLQGKGLTGKLSPSLSGLKCLSGLYLHYNSLSGEIPKEIRNLTELTDLYLDVNN 127
            +K+ +I L    L+G + P L  L  L  L L  N     +P E+ N T+L  L LD N+
Sbjct: 647  KKLTHIDLNNNFLSGPIPPWLGKLSQLGELKLSSNQFVESLPTELFNCTKLLVLSLDGNS 706

Query: 128  LSGNIPPEIGSMASLQVLQLCCNQLTGNIPAQIGSLKSLSVLTLQHNRLNGGIPDSLGNL 187
            L+G+IP EIG++ +L VL L  NQ +G++P  +G L  L  L L  N L G IP  +G L
Sbjct: 707  LNGSIPQEIGNLGALNVLNLDKNQFSGSLPQAMGKLSKLYELRLSRNSLTGEIPVEIGQL 766

Query: 188  GKLKR-LDLSFNSLFGTIPESLANNAELLFLDVQNNTLSGIVPSALKRLNGGFQFQNNPG 246
              L+  LDLS+N+  G IP ++   ++L  LD+ +N L+G VP                G
Sbjct: 767  QDLQSALDLSYNNFTGDIPSTIGTLSKLETLDLSHNQLTGEVP----------------G 810

Query: 247  LCGDGIASLRACTV-YDNTQINPVKPFGSHSNDTTPIDISEPSGFKEHCNQSQCSNSSK- 304
              GD + SL    V ++N      K F     D+   +          CN+ + +N  + 
Sbjct: 811  SVGD-MKSLGYLNVSFNNLGGKLKKQFSRWPADSFLGNTGLCGSPLSRCNRVRSNNKQQG 869

Query: 305  --FPQIAVLAAVTSVTVILAGTGILIFFRYRRHK--QKIGNTSESSDWQLSTDLTLAKDF 360
                 + +++A++++T I     ++  F  +RH   +K+G+ S +     S+     K  
Sbjct: 870  LSARSVVIISAISALTAIGLMILVIALFFKQRHDFFKKVGHGSTAYTSSSSSSQATHKPL 929

Query: 361  NRNGASPLVSLEYCHGWDPLGDYLNGTGFSREHLNSFRLNLEEVESATQCFSEVNLLGKG 420
             RNGAS                                +  E++  AT   SE  ++G G
Sbjct: 930  FRNGAS-----------------------------KSDIRWEDIMEATHNLSEEFMIGSG 960

Query: 421  NFSSVYKGTLRDGTLVAIRSINVTSCKSEEAEFVKGLYLLTSLRHENIIRLRGFCCSRGR 480
                VYK  L +G  VA++ I           F + +  L  +RH ++++L G+C S+  
Sbjct: 961  GSGKVYKAELENGETVAVKKILWKDDLMSNKSFSREVKTLGRIRHRHLVKLMGYCSSKSE 1020

Query: 481  GECFLIYDFAPKGKLSKYLDQE----EGSSNVLDWSTRVSIIIGIAKGIGYLHSSEVNKP 536
            G   LIY++   G +  +L ++    E    +LDW  R+ I +G+A+G+ YLH   V  P
Sbjct: 1021 GLNLLIYEYMKNGSIWDWLHEDKPVLEKKKKLLDWEARLRIAVGLAQGVEYLHHDCV--P 1078

Query: 537  AIVHRNLSVEKVLIDQQFNPLIADCGLHKLLA---DDIVFSVLKTSAAMGYLAPEYVTTG 593
             IVHR++    VL+D      + D GL K+L    D    S    + + GY+APEY  + 
Sbjct: 1079 PIVHRDIKSSNVLLDSNMEAHLGDFGLAKVLTENCDTNTDSNTWFACSYGYIAPEYAYSL 1138

Query: 594  RFTERSDIFAFGVIILQILTGSL----VLTSSM--------RLAAESATFENFIDRNLKG 641
            + TE+SD+++ G+++++I+TG +    V  + M         L    +  +  ID  LK 
Sbjct: 1139 KATEKSDVYSMGIVLMEIVTGKMPTDSVFGAEMDMVRWVETHLEVAGSARDKLIDPKLKP 1198

Query: 642  --KFSESEAAKLGKMALVCTHEDPENRPTMEAVIEEL 676
               F E  A ++ ++AL CT   P+ RP+     + L
Sbjct: 1199 LLPFEEDAACQVLEIALQCTKTSPQERPSSRQACDSL 1235

Together with GSO2, receptor-like serine/threonine-kinase required during the development of the epidermal surface in embryos and cotyledons.

Arabidopsis thaliana (taxid: 3702)

EC: 2

EC: .

EC: 7

EC: .

EC: 1

EC: 1

EC: .

EC: 1

>sp|Q93ZS4|NIK3_ARATH Protein NSP-INTERACTING KINASE 3 OS=Arabidopsis thaliana GN=NIK3 PE=1 SV=1

 Score =  238 bits (607), Expect = 1e-61,   Method: Compositional matrix adjust.
 Identities = 195/675 (28%), Positives = 303/675 (44%), Gaps = 139/675 (20%)

Query: 15  TSSLTGLVCGNTELRALLDLKASLDPENKLLQSWTENG-DPCSGSFEGIACNEHRKVANI 73
           T S TG+   N E+ AL+ +K  L+   K+L++W  N  DPCS                 
Sbjct: 26  TLSPTGV---NYEVTALVAVKNELNDPYKVLENWDVNSVDPCSWRM-------------- 68

Query: 74  SLQGKGLTGKLSPSLSGLKCLSGLYLHYNSLSGEIPKEIRNLTELTDLYLDVNNLSGNIP 133
                            + C  G                     ++ L L   +LSG + 
Sbjct: 69  -----------------VSCTDGY--------------------VSSLDLPSQSLSGTLS 91

Query: 134 PEIGSMASLQVLQLCCNQLTGNIPAQIGSLKSLSVLTLQHNRLNGGIPDSLGNLGKLKRL 193
           P IG++  LQ + L  N +TG IP  IG L+ L  L L +N   G IP SLG L  L  L
Sbjct: 92  PRIGNLTYLQSVVLQNNAITGPIPETIGRLEKLQSLDLSNNSFTGEIPASLGELKNLNYL 151

Query: 194 DLSFNSLFGTIPESLANNAELLFLDVQNNTLSGIVPSALKRLNGGFQFQNNPGLCGDGIA 253
            L+ NSL GT PESL+    L  +D+  N LSG +P    R    F+   N  +CG    
Sbjct: 152 RLNNNSLIGTCPESLSKIEGLTLVDISYNNLSGSLPKVSART---FKVIGNALICGPKAV 208

Query: 254 SLRACTVYDNTQINPVKPFGSHSNDTTPIDISEPSGFKEHCNQSQCSNSSKFPQIAVLAA 313
           S        N    P +P       T P D  + SG + + +    + +         A+
Sbjct: 209 S--------NCSAVP-EPL------TLPQDGPDESGTRTNGHHVALAFA---------AS 244

Query: 314 VTSVTVILAGTGILIFFRYRRHKQKIGNTSESSDWQLSTDLTLAKDFNRNGASPLVSLEY 373
            ++   +   +G+ +++RYRR+KQ   + +E  D                   P VSL  
Sbjct: 245 FSAAFFVFFTSGMFLWWRYRRNKQIFFDVNEQYD-------------------PEVSLG- 284

Query: 374 CHGWDPLGDYLNGTGFSREHLNSFRLNLEEVESATQCFSEVNLLGKGNFSSVYKGTLRDG 433
                              HL   R   +E+ SAT  F+  N+LG+G +  VYKG L DG
Sbjct: 285 -------------------HLK--RYTFKELRSATNHFNSKNILGRGGYGIVYKGHLNDG 323

Query: 434 TLVAIRSINVTSCKSEEAEFVKGLYLLTSLRHENIIRLRGFCCSRGRGECFLIYDFAPKG 493
           TLVA++ +   +    E +F   +  ++   H N++RLRGFC S    E  L+Y + P G
Sbjct: 324 TLVAVKRLKDCNIAGGEVQFQTEVETISLALHRNLLRLRGFCSS--NQERILVYPYMPNG 381

Query: 494 KLSKYLDQEEGSSNVLDWSTRVSIIIGIAKGIGYLHSSEVNKPAIVHRNLSVEKVLIDQQ 553
            ++  L         LDWS R  I +G A+G+ YLH  E   P I+HR++    +L+D+ 
Sbjct: 382 SVASRLKDNIRGEPALDWSRRKKIAVGTARGLVYLH--EQCDPKIIHRDVKAANILLDED 439

Query: 554 FNPLIADCGLHKLLADDIVFSVLKTSAAMGYLAPEYVTTGRFTERSDIFAFGVIILQILT 613
           F  ++ D GL KLL              +G++APEY++TG+ +E++D+F FG+++L+++T
Sbjct: 440 FEAVVGDFGLAKLLDHRDSHVTTAVRGTVGHIAPEYLSTGQSSEKTDVFGFGILLLELIT 499

Query: 614 GSL------------VLTSSMRLAAESATFENFIDRNLKGKFSESEAAKLGKMALVCTHE 661
           G              V+   ++   +    +  ID++L  KF   E  ++ ++AL+CT  
Sbjct: 500 GQKALDFGRSAHQKGVMLDWVKKLHQEGKLKQLIDKDLNDKFDRVELEEIVQVALLCTQF 559

Query: 662 DPENRPTMEAVIEEL 676
           +P +RP M  V++ L
Sbjct: 560 NPSHRPKMSEVMKML 574

Involved in defense response to geminivirus infection.

Arabidopsis thaliana (taxid: 3702)

EC: 2

EC: .

EC: 7

EC: .

EC: 1

EC: 1

EC: .

EC: 1

>sp|Q9LFS4|NIK1_ARATH Protein NSP-INTERACTING KINASE 1 OS=Arabidopsis thaliana GN=NIK1 PE=1 SV=1

 Score =  238 bits (606), Expect = 1e-61,   Method: Compositional matrix adjust.
 Identities = 192/688 (27%), Positives = 308/688 (44%), Gaps = 146/688 (21%)

Query: 10  LLVLITSSLTGLVCG---NTELRALLDLKASLDPENKLLQSWTENG-DPCSGSFEGIACN 65
            L L+ SS+ GL+     N E++AL+D+KASL   + +L +W  +  DPCS +   + C+
Sbjct: 21  FLCLLCSSVHGLLSPKGVNFEVQALMDIKASLHDPHGVLDNWDRDAVDPCSWTM--VTCS 78

Query: 66  EHRKVANISLQGKGLTGKLSPSLSGLKCLSGLYLHYNSLSGEIPKEIRNLTELTDLYLDV 125
               V  +           +PS                                      
Sbjct: 79  SENFVIGLG----------TPS-------------------------------------- 90

Query: 126 NNLSGNIPPEIGSMASLQVLQLCCNQLTGNIPAQIGSLKSLSVLTLQHNRLNGGIPDSLG 185
            NLSG + P I ++ +L+++ L  N + G IPA+IG L  L  L L  N  +G IP S+G
Sbjct: 91  QNLSGTLSPSITNLTNLRIVLLQNNNIKGKIPAEIGRLTRLETLDLSDNFFHGEIPFSVG 150

Query: 186 NLGKLKRLDLSFNSLFGTIPESLANNAELLFLDVQNNTLSGIVPSALKRLNGGFQFQNNP 245
            L  L+ L L+ NSL G  P SL+N  +L FLD+  N LSG VP    +    F    NP
Sbjct: 151 YLQSLQYLRLNNNSLSGVFPLSLSNMTQLAFLDLSYNNLSGPVPRFAAKT---FSIVGNP 207

Query: 246 GLCGDGIASLRACTVYDNTQINPVKPFGSHSNDTTPIDIS---EPSGFKEHCNQSQCSNS 302
            +C  G                  +P     N TT I +S     +G   +   S+    
Sbjct: 208 LICPTG-----------------TEP---DCNGTTLIPMSMNLNQTGVPLYAGGSRNHKM 247

Query: 303 SKFPQIAVLAAVTSVTVILAGTGILIFFRYRRHKQKIGNTSESSDWQLSTDLTLAKDFNR 362
           +    IAV ++V +V++I    G+ +++R R ++    +                KD N 
Sbjct: 248 A----IAVGSSVGTVSLIFIAVGLFLWWRQRHNQNTFFD---------------VKDGNH 288

Query: 363 NGASPLVSLEYCHGWDPLGDYLNGTGFSREHLNSFRLNLEEVESATQCFSEVNLLGKGNF 422
           +    L +L                          R    E++ AT  FS  NLLGKG +
Sbjct: 289 HEEVSLGNLR-------------------------RFGFRELQIATNNFSSKNLLGKGGY 323

Query: 423 SSVYKGTLRDGTLVAIRSINVTSCKSEEAEFVKGLYLLTSLRHENIIRLRGFCCSRGRGE 482
            +VYKG L D T+VA++ +        E +F   + +++   H N++RL GFC ++   E
Sbjct: 324 GNVYKGILGDSTVVAVKRLKDGGALGGEIQFQTEVEMISLAVHRNLLRLYGFCITQT--E 381

Query: 483 CFLIYDFAPKGKLSKYLDQEEGSSNVLDWSTRVSIIIGIAKGIGYLHSSEVNKPAIVHRN 542
             L+Y +   G ++  +  +     VLDWS R  I IG A+G+ YLH  E   P I+HR+
Sbjct: 382 KLLVYPYMSNGSVASRMKAKP----VLDWSIRKRIAIGAARGLVYLH--EQCDPKIIHRD 435

Query: 543 LSVEKVLIDQQFNPLIADCGLHKLLADDIVFSVLKTSAAMGYLAPEYVTTGRFTERSDIF 602
           +    +L+D     ++ D GL KLL              +G++APEY++TG+ +E++D+F
Sbjct: 436 VKAANILLDDYCEAVVGDFGLAKLLDHQDSHVTTAVRGTVGHIAPEYLSTGQSSEKTDVF 495

Query: 603 AFGVIILQILTGSL------------VLTSSMRLAAESATFENFIDRNL--KGKFSESEA 648
            FG+++L+++TG              V+   ++   +    E  +D+ L  K  + E E 
Sbjct: 496 GFGILLLELVTGQRAFEFGKAANQKGVMLDWVKKIHQEKKLELLVDKELLKKKSYDEIEL 555

Query: 649 AKLGKMALVCTHEDPENRPTMEAVIEEL 676
            ++ ++AL+CT   P +RP M  V+  L
Sbjct: 556 DEMVRVALLCTQYLPGHRPKMSEVVRML 583

Involved in defense response to geminivirus infection via regulation of the nuclear trafficking of RPL10A. Phosphorylates RPL10A in vitro.

Arabidopsis thaliana (taxid: 3702)

EC: 2

EC: .

EC: 7

EC: .

EC: 1

EC: 1

EC: .

EC: 1

>sp|O49318|Y2317_ARATH Probable leucine-rich repeat receptor-like protein kinase At2g33170 OS=Arabidopsis thaliana GN=At2g33170 PE=2 SV=1

 Score =  234 bits (596), Expect = 2e-60,   Method: Compositional matrix adjust.
 Identities = 181/630 (28%), Positives = 296/630 (46%), Gaps = 74/630 (11%)

Query: 68   RKVANISLQGKGLTGKLSPSLSGLKCLSGLYLHYNSLSGEIPKEIRNLTELTDLYLDVNN 127
            +K+  + L     +  L   +S L  L    +  NSL+G IP EI N   L  L L  N+
Sbjct: 517  QKLQRLHLAANQFSSNLPNEISKLSNLVTFNVSSNSLTGPIPSEIANCKMLQRLDLSRNS 576

Query: 128  LSGNIPPEIGSMASLQVLQLCCNQLTGNIPAQIGSLKSLSVLTLQHNRLNGGIPDSLGNL 187
              G++PPE+GS+  L++L+L  N+ +GNIP  IG+L  L+ L +  N  +G IP  LG L
Sbjct: 577  FIGSLPPELGSLHQLEILRLSENRFSGNIPFTIGNLTHLTELQMGGNLFSGSIPPQLGLL 636

Query: 188  GKLK-RLDLSFNSLFGTIPESLANNAELLFLDVQNNTLSGIVPSALKRLNGGFQFQNNPG 246
              L+  ++LS+N   G IP  + N   L++L + NN LSG +P+          F+N   
Sbjct: 637  SSLQIAMNLSYNDFSGEIPPEIGNLHLLMYLSLNNNHLSGEIPTT---------FEN--- 684

Query: 247  LCGDGIASLRACTVYDNTQINPVKPFGSHSNDTTPIDISEPSGFKEHC--NQSQCSNS-S 303
                 ++SL  C    N     +     H+     + ++   G K  C  +   C  S S
Sbjct: 685  -----LSSLLGCNFSYNNLTGQLP----HTQIFQNMTLTSFLGNKGLCGGHLRSCDPSHS 735

Query: 304  KFPQIAVLAAVTSVTVILAGTGILIFFRYRRHKQKIGNTSESSDWQLSTDLTLAKDFNRN 363
             +P I+ L A ++                RR +  I  +S      L   + +   F RN
Sbjct: 736  SWPHISSLKAGSA----------------RRGRIIIIVSSVIGGISLLL-IAIVVHFLRN 778

Query: 364  GASPLVSLEYCHGWDPLGDYLNGTGFSREHLNSFRLNLEEVESATQCFSEVNLLGKGNFS 423
               P  +  Y H  +P     +     +E     R  ++++  AT+ F +  ++G+G   
Sbjct: 779  PVEP--TAPYVHDKEPFFQESDIYFVPKE-----RFTVKDILEATKGFHDSYIVGRGACG 831

Query: 424  SVYKGTLRDGTLVAIRSINVTSCKSEEAE------FVKGLYLLTSLRHENIIRLRGFCCS 477
            +VYK  +  G  +A++ +      +          F   +  L  +RH NI+RL  FC  
Sbjct: 832  TVYKAVMPSGKTIAVKKLESNREGNNNNSNNTDNSFRAEILTLGKIRHRNIVRLYSFCYH 891

Query: 478  RGRGECFLIYDFAPKGKLSKYLDQEEGSSNVLDWSTRVSIIIGIAKGIGYLHSSEVNKPA 537
            +G     L+Y++  +G L + L    G S+ +DW TR +I +G A+G+ YLH     KP 
Sbjct: 892  QGSNSNLLLYEYMSRGSLGELL--HGGKSHSMDWPTRFAIALGAAEGLAYLHHD--CKPR 947

Query: 538  IVHRNLSVEKVLIDQQFNPLIADCGLHKLLADDIVFSVLKTSAAMGYLAPEYVTTGRFTE 597
            I+HR++    +LID+ F   + D GL K++   +  SV   + + GY+APEY  T + TE
Sbjct: 948  IIHRDIKSNNILIDENFEAHVGDFGLAKVIDMPLSKSVSAVAGSYGYIAPEYAYTMKVTE 1007

Query: 598  RSDIFAFGVIILQILTGSLVLTSSMRLAAESATF-ENFI-DRNLKGKFSESEAAK----- 650
            + DI++FGV++L++LTG       +    + AT+  N I D +L  +  +    K     
Sbjct: 1008 KCDIYSFGVVLLELLTGK-APVQPLEQGGDLATWTRNHIRDHSLTSEILDPYLTKVEDDV 1066

Query: 651  -------LGKMALVCTHEDPENRPTMEAVI 673
                   + K+A++CT   P +RPTM  V+
Sbjct: 1067 ILNHMITVTKIAVLCTKSSPSDRPTMREVV 1096

Arabidopsis thaliana (taxid: 3702)

EC: 2

EC: .

EC: 7

EC: .

EC: 1

EC: 1

EC: .

EC: 1

>sp|Q8VZG8|Y4885_ARATH Probable LRR receptor-like serine/threonine-protein kinase At4g08850 OS=Arabidopsis thaliana GN=At4g08850 PE=1 SV=3

 Score =  233 bits (594), Expect = 4e-60,   Method: Compositional matrix adjust.
 Identities = 180/624 (28%), Positives = 287/624 (45%), Gaps = 106/624 (16%)

Query: 69   KVANISLQGKGLTGKLSPSLSGLKCLSGLYLHYNSLSGEIPKEIRNLTELTDLYLDVNNL 128
            +++ + L    +TG+L  S+S +  +S L L+ N LSG+IP  IR LT L  L L  N  
Sbjct: 503  QLSQLDLSSNRITGELPESISNINRISKLQLNGNRLSGKIPSGIRLLTNLEYLDLSSNRF 562

Query: 129  SGNIPPEIGSMASLQVLQLCCNQLTGNIPAQIGSLKSLSVLTLQHNRLNGGIPDSLGNLG 188
            S  IPP + ++  L  + L  N L   IP  +  L  L +L L +N+L+G I     +L 
Sbjct: 563  SSEIPPTLNNLPRLYYMNLSRNDLDQTIPEGLTKLSQLQMLDLSYNQLDGEISSQFRSLQ 622

Query: 189  KLKRLDLSFNSLFGTIPESLANNAELLFLDVQNNTLSGIVPSALKRLNGGFQ------FQ 242
             L+RLDLS N+L G IP S  +   L  +DV +N L G +P      N  F+      F+
Sbjct: 623  NLERLDLSHNNLSGQIPPSFKDMLALTHVDVSHNNLQGPIPD-----NAAFRNAPPDAFE 677

Query: 243  NNPGLCG--DGIASLRACTVYDNTQINPVKPFGSHSNDTTPIDISEPSGFKEHCNQSQCS 300
             N  LCG  +    L+ C++                           S  K H +++   
Sbjct: 678  GNKDLCGSVNTTQGLKPCSIT--------------------------SSKKSHKDRNLI- 710

Query: 301  NSSKFPQIAVLAAVTSVTVILA-GTGILIFFRYRRHKQKIGNTSESSDWQLSTDLTLAKD 359
                   I +L  +    +IL+   GI I FR R  + +    SES    LS        
Sbjct: 711  -------IYILVPIIGAIIILSVCAGIFICFRKRTKQIEEHTDSESGGETLSI------- 756

Query: 360  FNRNGASPLVSLEYCHGWDPLGDYLNGTGFSREHLNSFRLNLEEVESATQCFSEVNLLGK 419
            F+ +G                                 ++  +E+  AT  F    L+G 
Sbjct: 757  FSFDG---------------------------------KVRYQEIIKATGEFDPKYLIGT 783

Query: 420  GNFSSVYKGTLRDGTLVAIRSINVT-----SCKSEEAEFVKGLYLLTSLRHENIIRLRGF 474
            G    VYK  L +  ++A++ +N T     S  S + EF+  +  LT +RH N+++L GF
Sbjct: 784  GGHGKVYKAKLPNA-IMAVKKLNETTDSSISNPSTKQEFLNEIRALTEIRHRNVVKLFGF 842

Query: 475  CCSRGRGECFLIYDFAPKGKLSKYLDQEEGSSNVLDWSTRVSIIIGIAKGIGYLHSSEVN 534
            C  R     FL+Y++  +G L K L+ ++ +   LDW  R++++ G+A  + Y+H     
Sbjct: 843  CSHRRN--TFLVYEYMERGSLRKVLENDDEAKK-LDWGKRINVVKGVAHALSYMHHDR-- 897

Query: 535  KPAIVHRNLSVEKVLIDQQFNPLIADCGLHKLLADDIVFSVLKTSAAMGYLAPEYVTTGR 594
             PAIVHR++S   +L+ + +   I+D G  KLL  D   +    +   GY+APE     +
Sbjct: 898  SPAIVHRDISSGNILLGEDYEAKISDFGTAKLLKPD-SSNWSAVAGTYGYVAPELAYAMK 956

Query: 595  FTERSDIFAFGVIILQILT----GSLVLTSSMRLAAESATFENFIDRNLKGKFSE--SEA 648
             TE+ D+++FGV+ L+++     G LV T S      + + ++  D  L     E   E 
Sbjct: 957  VTEKCDVYSFGVLTLEVIKGEHPGDLVSTLSSSPPDATLSLKSISDHRLPEPTPEIKEEV 1016

Query: 649  AKLGKMALVCTHEDPENRPTMEAV 672
             ++ K+AL+C H DP+ RPTM ++
Sbjct: 1017 LEILKVALLCLHSDPQARPTMLSI 1040

Arabidopsis thaliana (taxid: 3702)

EC: 2

EC: .

EC: 7

EC: .

EC: 1

EC: 1

EC: .

EC: 1

>sp|Q9FIZ3|GSO2_ARATH LRR receptor-like serine/threonine-protein kinase GSO2 OS=Arabidopsis thaliana GN=GSO2 PE=2 SV=2

 Score =  228 bits (582), Expect = 9e-59,   Method: Compositional matrix adjust.
 Identities = 186/637 (29%), Positives = 296/637 (46%), Gaps = 80/637 (12%)

Query: 68   RKVANISLQGKGLTGKLSPSLSGLKCLSGLYLHYNSLSGEIPKEIRNLTELTDLYLDVNN 127
            +K+ +I L    L+G +   L  L  L  L L  N   G +P EI +LT +  L+LD N+
Sbjct: 648  KKLTHIDLNNNYLSGVIPTWLGKLPLLGELKLSSNKFVGSLPTEIFSLTNILTLFLDGNS 707

Query: 128  LSGNIPPEIGSMASLQVLQLCCNQLTGNIPAQIGSLKSLSVLTLQHNRLNGGIPDSLGNL 187
            L+G+IP EIG++ +L  L L  NQL+G +P+ IG L  L  L L  N L G IP  +G L
Sbjct: 708  LNGSIPQEIGNLQALNALNLEENQLSGPLPSTIGKLSKLFELRLSRNALTGEIPVEIGQL 767

Query: 188  GKLKR-LDLSFNSLFGTIPESLANNAELLFLDVQNNTLSGIVPSALKRLNGGFQFQNNPG 246
              L+  LDLS+N+  G IP +++   +L  LD+ +N L G V                PG
Sbjct: 768  QDLQSALDLSYNNFTGRIPSTISTLPKLESLDLSHNQLVGEV----------------PG 811

Query: 247  LCGDGIASLRACTV-YDNTQINPVKPFGSHSNDTTPIDISEPSGFKEHCNQSQCSNSSKF 305
              GD + SL    + Y+N +    K F     D    +         HCN++   N    
Sbjct: 812  QIGD-MKSLGYLNLSYNNLEGKLKKQFSRWQADAFVGNAGLCGSPLSHCNRAGSKNQRSL 870

Query: 306  -PQ-IAVLAAVTSVTVILAGTGILIFFRYRRH---KQKIGNTSESSDWQLSTDLTLAKDF 360
             P+ + +++A++S+  I     ++I F  + H   K+  G  S  S    S+   L   F
Sbjct: 871  SPKTVVIISAISSLAAIALMVLVIILFFKQNHDLFKKVRGGNSAFSSNSSSSQAPL---F 927

Query: 361  NRNGASPLVSLEYCHGWDPLGDYLNGTGFSREHLNSFRLNLEEVESATQCFSEVNLLGKG 420
            +  GA   +       WD                        ++  AT   +E  ++G G
Sbjct: 928  SNGGAKSDIK------WD------------------------DIMEATHYLNEEFMIGSG 957

Query: 421  NFSSVYKGTLRDGTLVAIRSINVTSCKSEEAEFVKGLYLLTSLRHENIIRLRGFCCSRGR 480
                VYK  L++G  +A++ I           F + +  L ++RH ++++L G+C S+  
Sbjct: 958  GSGKVYKAELKNGETIAVKKILWKDDLMSNKSFNREVKTLGTIRHRHLVKLMGYCSSKAD 1017

Query: 481  GECFLIYDFAPKGKLSKYLDQEEGSSN--VLDWSTRVSIIIGIAKGIGYLHSSEVNKPAI 538
            G   LIY++   G +  +L   E +    VL W TR+ I +G+A+G+ YLH   V  P I
Sbjct: 1018 GLNLLIYEYMANGSVWDWLHANENTKKKEVLGWETRLKIALGLAQGVEYLHYDCV--PPI 1075

Query: 539  VHRNLSVEKVLIDQQFNPLIADCGLHKLLA---DDIVFSVLKTSAAMGYLAPEYVTTGRF 595
            VHR++    VL+D      + D GL K+L    D    S    + + GY+APEY  + + 
Sbjct: 1076 VHRDIKSSNVLLDSNIEAHLGDFGLAKILTGNYDTNTESNTMFAGSYGYIAPEYAYSLKA 1135

Query: 596  TERSDIFAFGVIILQILTGSL--------------VLTSSMRLAAESATFENFIDRNLKG 641
            TE+SD+++ G+++++I+TG +               + + +     S   E  ID  LK 
Sbjct: 1136 TEKSDVYSMGIVLMEIVTGKMPTEAMFDEETDMVRWVETVLDTPPGSEAREKLIDSELKS 1195

Query: 642  KFS-ESEAA-KLGKMALVCTHEDPENRPTMEAVIEEL 676
                E EAA ++ ++AL CT   P+ RP+     E L
Sbjct: 1196 LLPCEEEAAYQVLEIALQCTKSYPQERPSSRQASEYL 1232

Together with GSO1, receptor-like serine/threonine-kinase required during the development of the epidermal surface in embryos and cotyledons. Involved in the nuclear division phase of megagametogenesis.

Arabidopsis thaliana (taxid: 3702)

EC: 2

EC: .

EC: 7

EC: .

EC: 1

EC: 1

EC: .

EC: 1

>sp|Q0WVM4|Y2239_ARATH Probable LRR receptor-like serine/threonine-protein kinase At2g23950 OS=Arabidopsis thaliana GN=At2g23950 PE=2 SV=1

 Score =  225 bits (574), Expect = 9e-58,   Method: Compositional matrix adjust.
 Identities = 195/692 (28%), Positives = 310/692 (44%), Gaps = 148/692 (21%)

Query: 1   MGISHVLIPLLVLITSSLTGLVCGNTELRALLDLKASLDPENKLLQSWTE-NGDPCSGSF 59
           M I  VL+ L   +T SL+     N E+ AL+++K  L   + + ++W E + DPCS + 
Sbjct: 9   MKIFSVLLLLCFFVTCSLSS-EPRNPEVEALINIKNELHDPHGVFKNWDEFSVDPCSWTM 67

Query: 60  EGIACNEHRKVANISLQGKGLTGKLSPSLSGLKCLSGLYLHYNSLSGEIPKEIRNLTELT 119
             I+C+    V  +           +PS               SLSG +   I NLT L 
Sbjct: 68  --ISCSSDNLVIGLG----------APS--------------QSLSGTLSGSIGNLTNLR 101

Query: 120 DLYLDVNNLSGNIPPEIGSMASLQVLQLCCNQLTGNIPAQIGSLKSLSVLTLQHNRLNGG 179
            + L  NN+SG                         IP +I SL  L  L L +NR +G 
Sbjct: 102 QVSLQNNNISGK------------------------IPPEICSLPKLQTLDLSNNRFSGE 137

Query: 180 IPDSLGNLGKLKRLDLSFNSLFGTIPESLANNAELLFLDVQNNTLSGIVPSALKRLNGGF 239
           IP S+  L  L+ L L+ NSL G  P SL+    L FLD+  N L G VP    R    F
Sbjct: 138 IPGSVNQLSNLQYLRLNNNSLSGPFPASLSQIPHLSFLDLSYNNLRGPVPKFPART---F 194

Query: 240 QFQNNPGLCGDGIASLRACTVYDNTQINPVKPFGSHSNDTTPIDISEPSGFKEHCNQSQC 299
               NP +C + +  +  C+             GS S     + +   SG + +      
Sbjct: 195 NVAGNPLICKNSLPEI--CS-------------GSISASPLSVSLRSSSGRRTNI----- 234

Query: 300 SNSSKFPQIAVLAAVT---SVTVILAGTGILIFFRYRRHKQKIGNTSESSDWQLSTDLTL 356
                   +AV   V+   +V+VIL+    L F  YR+ +++               LT+
Sbjct: 235 --------LAVALGVSLGFAVSVILS----LGFIWYRKKQRR---------------LTM 267

Query: 357 AKDFNRNGASPLVSLEYCHGWDPLGDYLNGTGFSREHLNSFRLNLEEVESATQCFSEVNL 416
            +          +S +   G   LG+           L SF     E+  AT  FS  ++
Sbjct: 268 LR----------ISDKQEEGLLGLGN-----------LRSF--TFRELHVATDGFSSKSI 304

Query: 417 LGKGNFSSVYKGTLRDGTLVAIRSINVTSCKSEEAEFVKGLYLLTSLRHENIIRLRGFCC 476
           LG G F +VY+G   DGT+VA++ +   +  S  ++F   L +++   H N++RL G+C 
Sbjct: 305 LGAGGFGNVYRGKFGDGTVVAVKRLKDVNGTSGNSQFRTELEMISLAVHRNLLRLIGYCA 364

Query: 477 SRGRGECFLIYDFAPKGKLSKYLDQEEGSSNVLDWSTRVSIIIGIAKGIGYLHSSEVNKP 536
           S    E  L+Y +   G ++  L  +      LDW+TR  I IG A+G+ YLH  E   P
Sbjct: 365 SSS--ERLLVYPYMSNGSVASRLKAKPA----LDWNTRKKIAIGAARGLFYLH--EQCDP 416

Query: 537 AIVHRNLSVEKVLIDQQFNPLIADCGLHKLLADDIVFSVLKTSAAMGYLAPEYVTTGRFT 596
            I+HR++    +L+D+ F  ++ D GL KLL  +           +G++APEY++TG+ +
Sbjct: 417 KIIHRDVKAANILLDEYFEAVVGDFGLAKLLNHEDSHVTTAVRGTVGHIAPEYLSTGQSS 476

Query: 597 ERSDIFAFGVIILQILTGSLVLTSSMRLAAESATF------------ENFIDRNLKGKFS 644
           E++D+F FG+++L+++TG   L     ++ + A              E  +DR L   + 
Sbjct: 477 EKTDVFGFGILLLELITGMRALEFGKSVSQKGAMLEWVRKLHKEMKVEELVDRELGTTYD 536

Query: 645 ESEAAKLGKMALVCTHEDPENRPTMEAVIEEL 676
             E  ++ ++AL+CT   P +RP M  V++ L
Sbjct: 537 RIEVGEMLQVALLCTQFLPAHRPKMSEVVQML 568

Arabidopsis thaliana (taxid: 3702)

EC: 2

EC: .

EC: 7

EC: .

EC: 1

EC: 1

EC: .

EC: 1

Close Homologs in the Non-Redundant Database Detected by BLAST

Original result of BLAST against Nonredundant Database

GI	Length	Definition	Q cover	H cover	Identity	E-value
Query	689
255537079	693	leucine rich repeat receptor kinase, put	0.947	0.942	0.709	0.0
224125098	682	predicted protein [Populus trichocarpa]	0.947	0.957	0.702	0.0
224071591	646	predicted protein [Populus trichocarpa]	0.928	0.990	0.684	0.0
296082849	680	unnamed protein product [Vitis vinifera]	0.950	0.963	0.679	0.0
359474325	813	PREDICTED: probable LRR receptor-like se	0.947	0.803	0.676	0.0
297803850	687	hypothetical protein ARALYDRAFT_492596 [	0.972	0.975	0.634	0.0
225455531	681	PREDICTED: leucine-rich repeat receptor-	0.978	0.989	0.631	0.0
449460425	683	PREDICTED: LRR receptor-like serine/thre	0.969	0.978	0.622	0.0
15235780	688	leucine-rich repeat protein kinase-like	0.943	0.944	0.642	0.0
356497165	689	PREDICTED: probable LRR receptor-like se	0.949	0.949	0.633	0.0

>gi|255537079|ref|XP_002509606.1| leucine rich repeat receptor kinase, putative [Ricinus communis] gi|223549505|gb|EEF50993.1| leucine rich repeat receptor kinase, putative [Ricinus communis]

 Score =  961 bits (2485), Expect = 0.0,   Method: Compositional matrix adjust.
 Identities = 465/655 (70%), Positives = 551/655 (84%), Gaps = 2/655 (0%)

Query: 22  VCGNTELRALLDLKASLDPENKLLQSWTENGDPCSGSFEGIACNEHRKVANISLQGKGLT 81
           VCGNTELRAL++LK++LDP NK LQSW  +GDPCSGSFEG+ACNEHRKVANISLQG+GL+
Sbjct: 38  VCGNTELRALIELKSALDPTNKFLQSWAADGDPCSGSFEGVACNEHRKVANISLQGRGLS 97

Query: 82  GKLSPSLSGLKCLSGLYLHYNSLSGEIPKEIRNLTELTDLYLDVNNLSGNIPPEIGSMAS 141
           G +SP+++ LKCLSGLYLHYNSLSGEIPKE+ NLTEL+D+YL+VNNLSG+IPPEIG MAS
Sbjct: 98  GSISPAVAKLKCLSGLYLHYNSLSGEIPKELANLTELSDVYLNVNNLSGSIPPEIGGMAS 157

Query: 142 LQVLQLCCNQLTGNIPAQIGSLKSLSVLTLQHNRLNGGIPDSLGNLGKLKRLDLSFNSLF 201
           LQVL+LCCNQLTG+IP ++ SLK L+V+ LQ+NRL   IP  LGNLG L+RLDL FN+L 
Sbjct: 158 LQVLELCCNQLTGSIPREMDSLKRLTVVALQYNRLTDQIPAGLGNLGMLRRLDLGFNNLS 217

Query: 202 GTIPESLANNAELLFLDVQNNTLSGIVPSALKRLNGGFQFQNNPGLCGDGIASLRACTVY 261
           G IP +LAN  +L  LDV+NN+LSG+VPSAL++LNGGFQF+NN GLCG G   LRACT +
Sbjct: 218 GPIPITLANAPQLQVLDVRNNSLSGMVPSALQKLNGGFQFENNKGLCGAGFPELRACTAF 277

Query: 262 DNTQINPVKPFGSHSNDTTPIDISEPSGFKEHCNQSQCSNSSKFPQIAVLAAVTSVTVIL 321
           DN  IN V+P GS +N TT  +I   +  +  C+Q++CSNSSKFPQ+A+++ VT+ T+IL
Sbjct: 278 DNMNINQVEPSGSITNTTTSKNIPVSAILQAPCDQTKCSNSSKFPQVAIISGVTTATIIL 337

Query: 322 AGTGILIFFRYRRHKQKIGNTSESSDWQLSTDLTLAKDFNRNGASPLVSLEYCHGWDPLG 381
            G   LI F YRR KQKIGN SESS+ +LSTD   AK+F+R GASPLVSLEY +GWDP  
Sbjct: 338 IGVAFLIIFFYRRQKQKIGNISESSEGRLSTDK--AKEFHRAGASPLVSLEYSNGWDPFR 395

Query: 382 DYLNGTGFSREHLNSFRLNLEEVESATQCFSEVNLLGKGNFSSVYKGTLRDGTLVAIRSI 441
              NG G S   LN+FR NLEEVESATQCFSEVNLLGK +FSSVYKG LR G+LVA+RSI
Sbjct: 396 GCRNGVGISEPSLNNFRFNLEEVESATQCFSEVNLLGKSSFSSVYKGILRGGSLVAVRSI 455

Query: 442 NVTSCKSEEAEFVKGLYLLTSLRHENIIRLRGFCCSRGRGECFLIYDFAPKGKLSKYLDQ 501
           N+TSCKSEE EFVKGL LLTSLRH+N++RLRGFCCS+GRGECFLIYDFAP G LS+YLD 
Sbjct: 456 NITSCKSEEDEFVKGLNLLTSLRHDNLVRLRGFCCSKGRGECFLIYDFAPMGNLSRYLDL 515

Query: 502 EEGSSNVLDWSTRVSIIIGIAKGIGYLHSSEVNKPAIVHRNLSVEKVLIDQQFNPLIADC 561
           E+GSS++L+WSTRVSII GIAKGI YLH  EVNKPAI+HR +S+EKVL+DQ+F PL+AD 
Sbjct: 516 EDGSSHILEWSTRVSIINGIAKGIEYLHRREVNKPAIIHRRVSIEKVLLDQEFKPLMADS 575

Query: 562 GLHKLLADDIVFSVLKTSAAMGYLAPEYVTTGRFTERSDIFAFGVIILQILTGSLVLTSS 621
           GLHKLLADDIVFS LKTSAAMGYLAPEYVTTG FTE+SDI+AFGVIILQIL+G  +L++ 
Sbjct: 576 GLHKLLADDIVFSGLKTSAAMGYLAPEYVTTGHFTEKSDIYAFGVIILQILSGQHMLSNL 635

Query: 622 MRLAAESATFENFIDRNLKGKFSESEAAKLGKMALVCTHEDPENRPTMEAVIEEL 676
           MRLAA S+ +E+FID NLKG FSESEAA L K+AL CT E PE RPTMEAVI+E+
Sbjct: 636 MRLAAASSRYEDFIDTNLKGNFSESEAAMLSKIALDCTQELPEQRPTMEAVIQEM 690

Source: Ricinus communis

Species: Ricinus communis

Genus: Ricinus

Family: Euphorbiaceae

Order: Malpighiales

Phylum: Streptophyta

Superkingdom: Eukaryota

>gi|224125098|ref|XP_002329893.1| predicted protein [Populus trichocarpa] gi|222871130|gb|EEF08261.1| predicted protein [Populus trichocarpa]

 Score =  918 bits (2372), Expect = 0.0,   Method: Compositional matrix adjust.
 Identities = 460/655 (70%), Positives = 535/655 (81%), Gaps = 2/655 (0%)

Query: 25  NTELRALLDLKASLDPENKLLQSWTENGDPCSGSFEGIACNEHRKVANISLQGKGLTGKL 84
           NTEL AL+ LK +LDP NK LQSWT +GDPCSG FEG+ACNEH +VANISLQGKGL+G +
Sbjct: 26  NTELEALVKLKFALDPNNKYLQSWTSDGDPCSGLFEGVACNEHGQVANISLQGKGLSGTI 85

Query: 85  SPSLSGLKCLSGLYLHYNSLSGEIPKEIRNLTELTDLYLDVNNLSGNIPPEIGSMASLQV 144
           SP+++ LK LSGLYLHYNSLSGEIPKEI NL  L+DLYL+VNNLSG+IPPEIGSMASLQV
Sbjct: 86  SPAVAELKSLSGLYLHYNSLSGEIPKEIVNLVGLSDLYLNVNNLSGSIPPEIGSMASLQV 145

Query: 145 LQLCCNQLTGNIPAQIGSLKSLSVLTLQHNRLNGGIPDSLGNLGKLKRLDLSFNSLFGTI 204
           L+LCCNQL G IP ++GSLK LSVL LQ+NRL G IP SLG LG LKRLD+SFN L GTI
Sbjct: 146 LELCCNQLAGYIPTEMGSLKRLSVLALQYNRLVGQIPASLGTLGMLKRLDMSFNYLSGTI 205

Query: 205 PESLANNAELLFLDVQNNTLSGIVPSALKRLNGGFQFQNNPGLCGDGIASLRACTVYDNT 264
           P+ +AN   L  LDV+NN+LSG VP ALKRLNGGFQF+NN GLCG G   LRAC+ +DN 
Sbjct: 206 PQGIANIPRLEVLDVRNNSLSGTVPFALKRLNGGFQFENNQGLCGTGFHPLRACSAFDNM 265

Query: 265 QINPVKPFGSHSNDTTPIDISEPSGFKEHCNQSQCSNSSKFPQIAVLAAVTSVTVILAGT 324
            IN V   G  +N++      + +  + HCNQ+ CSNSSK PQ A++A V  VT+ L G 
Sbjct: 266 NINQVGSLGPIANNSAKKVTPQSAILQAHCNQTHCSNSSKLPQAAIVAGVIIVTITLMGA 325

Query: 325 GILIFFRYRRHKQKIGNTSESSDWQLSTDLTLAKDFNRNGASPLVSLEYCHGWDPLGDYL 384
           G LI F YRR KQKIGNTS+SSD +LSTD   AK+F+R GASPL SLEY +GWDPLGD  
Sbjct: 326 GFLIIFCYRRKKQKIGNTSDSSDGRLSTDQ--AKEFHRAGASPLASLEYSNGWDPLGDSR 383

Query: 385 NGTGFSREHLNSFRLNLEEVESATQCFSEVNLLGKGNFSSVYKGTLRDGTLVAIRSINVT 444
           NG  FS EHLN+FR NLEE+ESATQCFSEVN+LGK +FS+VYKG LRDG++VAI+SINVT
Sbjct: 384 NGIEFSVEHLNNFRFNLEEIESATQCFSEVNVLGKSSFSTVYKGVLRDGSIVAIKSINVT 443

Query: 445 SCKSEEAEFVKGLYLLTSLRHENIIRLRGFCCSRGRGECFLIYDFAPKGKLSKYLDQEEG 504
           SCK EEAEFVKGL LLTSLRH+N+ RLRGFCCSRGRGECFLIYDFAPKG LS+YLD E+G
Sbjct: 444 SCKPEEAEFVKGLNLLTSLRHDNLTRLRGFCCSRGRGECFLIYDFAPKGDLSRYLDLEDG 503

Query: 505 SSNVLDWSTRVSIIIGIAKGIGYLHSSEVNKPAIVHRNLSVEKVLIDQQFNPLIADCGLH 564
           S+ VLDWSTRVSII GIAKGI YLHS E  KPAI+HR +SVEKVL+DQQ NPLIAD GL 
Sbjct: 504 SNQVLDWSTRVSIINGIAKGIRYLHSIEEKKPAIIHRRISVEKVLLDQQVNPLIADSGLA 563

Query: 565 KLLADDIVFSVLKTSAAMGYLAPEYVTTGRFTERSDIFAFGVIILQILTGSLVLTSSMRL 624
           KLLADDIVFS +K SAAMGYLAPEYVTTG FTE+SDI++FGVIILQIL+G  +L++SMRL
Sbjct: 564 KLLADDIVFSTIKISAAMGYLAPEYVTTGLFTEKSDIYSFGVIILQILSGKQLLSNSMRL 623

Query: 625 AAESATFENFIDRNLKGKFSESEAAKLGKMALVCTHEDPENRPTMEAVIEELTVA 679
           AA    + +FID +L+G FSESEAAKL K+AL CT + P+ RPTM+ VI+EL ++
Sbjct: 624 AAACCRYNDFIDTSLRGNFSESEAAKLAKIALACTDDLPDQRPTMKEVIQELNLS 678

Source: Populus trichocarpa

Species: Populus trichocarpa

Genus: Populus

Family: Salicaceae

Order: Malpighiales

Phylum: Streptophyta

Superkingdom: Eukaryota

>gi|224071591|ref|XP_002303531.1| predicted protein [Populus trichocarpa] gi|222840963|gb|EEE78510.1| predicted protein [Populus trichocarpa]

 Score =  892 bits (2304), Expect = 0.0,   Method: Compositional matrix adjust.
 Identities = 445/650 (68%), Positives = 528/650 (81%), Gaps = 10/650 (1%)

Query: 32  LDLKASLDPENKLLQSWTENGDPCSGSFEGIACNEHRKVANISLQGKGLTGKLSPSLSGL 91
           ++LK++LDP NK L+SW  +GDPCSG FEG+ACNEH  VANISLQGKGL+G LSP+++ L
Sbjct: 1   MELKSALDPTNKYLKSWASDGDPCSGLFEGVACNEHGNVANISLQGKGLSGTLSPAVAEL 60

Query: 92  KCLSGLYLHYNSLSGEIPKEIRNLTELTDLYLDVNNLSGNIPPEIGSMASLQVLQLCCNQ 151
           K LSGLYLHYNSLSGEIPKEI +LTEL+DLYL+VNN+SG+IPPE+G+MASLQVL+LCCNQ
Sbjct: 61  KSLSGLYLHYNSLSGEIPKEIADLTELSDLYLNVNNISGSIPPEMGNMASLQVLELCCNQ 120

Query: 152 LTGNIPAQIGSLKSLSVLTLQHNRLNGGIPDSLGNLGKLKRLDLSFNSLFGTIPESLANN 211
           L+GNIP ++GSLK LSVL LQ+NRL   IP SLG LG LK L +SFN L G+IP+ +AN 
Sbjct: 121 LSGNIPPEMGSLKRLSVLALQYNRLTDQIPASLGTLGMLKMLYMSFNHLSGSIPQGIANI 180

Query: 212 AELLFLDVQNNTLSGIVPSALKRLNGGFQFQNNPGLCGDGIASLRAC-TVYDNTQINPVK 270
            ++  LDV+NN+LSGIVPSALKRLNGGFQF+NNPGLCG G   LRAC  V+D   IN V 
Sbjct: 181 PQMEVLDVRNNSLSGIVPSALKRLNGGFQFENNPGLCGTGFPLLRACNAVFD---INQVG 237

Query: 271 PFGSHSNDTTPIDISEPSGFKEHCNQSQCSNSSKFPQIAVLAAVTSVTVILAGTGILIFF 330
           P G  +N+T    I +    + HCN + CSNSSK PQ A++A V +VTV L G G LI F
Sbjct: 238 PLGPIANNTAQKVIPQSEILQAHCNLTHCSNSSKLPQAAIVAGVITVTVTLMGAGFLIIF 297

Query: 331 RYRRHKQKIGNTSESSDWQLSTDLTLAKDFNRNGASPLVSLEYCHGWDPLGDYLNGTGFS 390
            YRR KQKIGNTS  S+ +LST    AK+F+R GASPLVSLEY +GWDPLGD  NG   S
Sbjct: 298 LYRRKKQKIGNTSAFSEGRLSTHQ--AKEFHRAGASPLVSLEYSNGWDPLGDSRNGIEIS 355

Query: 391 REHLNSFRLNLEEVESATQCFSEVNLLGKGNFSSVYKGTLRDGTLVAIRSINVTSCKSEE 450
            EHLN+FR NLEE+ESAT+CFSEVN+LGK +FS+VYKG LRDG+LVAIRSIN+TSCK EE
Sbjct: 356 GEHLNNFRFNLEEIESATRCFSEVNVLGKSSFSTVYKGILRDGSLVAIRSINLTSCKPEE 415

Query: 451 AEFVKGLYLLTSLRHENIIRLRGFCCSRGRGECFLIYDFAPKGKLSKYLDQEEGSSNVLD 510
           AEFVKGL LLTSLRH N+ RLRGFCCSRGRGECFLIYDFAP+G LS+YLD E+GS+ VLD
Sbjct: 416 AEFVKGLDLLTSLRHNNLTRLRGFCCSRGRGECFLIYDFAPRGDLSRYLDLEDGSNQVLD 475

Query: 511 WSTRVSIIIGIAKGIGYLHSSEVNKPAIVHRNLSVEKVLIDQQFNPLIADCGLHKLLADD 570
           WS RV II GIAKGI YLHSSE NKP ++HR +SVEKVL+DQQFNPLIAD GL KLLADD
Sbjct: 476 WSARVYIINGIAKGIRYLHSSEENKPVMIHRRISVEKVLLDQQFNPLIADSGLAKLLADD 535

Query: 571 IVFSVLKTSAAMGYLAPEYVTTGRFTERSDIFAFGVIILQILTGSLVLTS-SMRLAAESA 629
           +VFS +K SAAMGYL+PEYVTTG FTE+SDI+AFGVIILQIL+G  +L S SMRLAA   
Sbjct: 536 VVFSTIKISAAMGYLSPEYVTTGLFTEKSDIYAFGVIILQILSGKQMLYSKSMRLAAACC 595

Query: 630 TFENFIDRNLKGKFSESEAAKLGKMALVCTHEDPENRPTMEAVIEELTVA 679
            +++F+D +L+G FSESEAAKL K+AL      P++RPTM+ VI+EL ++
Sbjct: 596 MYDDFVDTSLQGNFSESEAAKLAKIALT---RLPDHRPTMKEVIQELNLS 642

Source: Populus trichocarpa

Species: Populus trichocarpa

Genus: Populus

Family: Salicaceae

Order: Malpighiales

Phylum: Streptophyta

Superkingdom: Eukaryota

>gi|296082849|emb|CBI22150.3| unnamed protein product [Vitis vinifera]

 Score =  887 bits (2293), Expect = 0.0,   Method: Compositional matrix adjust.
 Identities = 447/658 (67%), Positives = 533/658 (81%), Gaps = 3/658 (0%)

Query: 22  VCGNTELRALLDLKASLDPENKLLQSWTENGDPCSGSFEGIACNEHRKVANISLQGKGLT 81
           V GN+ELRAL+++KASLDP N+ L SWT + DPCSGSFEG+ CNEHRKVANI+LQGKGL+
Sbjct: 25  VWGNSELRALMEMKASLDPVNRFLSSWTSDADPCSGSFEGVHCNEHRKVANITLQGKGLS 84

Query: 82  GKLSPSLSGLKCLSGLYLHYNSLSGEIPKEIRNLTELTDLYLDVNNLSGNIPPEIGSMAS 141
           GK+ P+++GLKCLSGLYLHYNSLSGEIP+EI +LTEL+DLYLD NNLSG IPPEIG+MAS
Sbjct: 85  GKVPPAVAGLKCLSGLYLHYNSLSGEIPREISSLTELSDLYLDFNNLSGAIPPEIGNMAS 144

Query: 142 LQVLQLCCNQLTGNIPAQIGSLKSLSVLTLQHNRLNGGIPDSLGNLGKLKRLDLSFNSLF 201
           LQVLQLC NQLTG IP++IG LK LSV++LQ N L G IP SLGNLG L+ L+LSFN L 
Sbjct: 145 LQVLQLCSNQLTGAIPSEIGFLKKLSVVSLQKNNLTGKIPPSLGNLGMLRMLNLSFNRLS 204

Query: 202 GTIPESLANNAELLFLDVQNNTLSGIVPSALKRLNGGFQFQNN-PGLCGDGIASLRACTV 260
           GTIP +LA    L FLDV+NN+L GIVPS LK+L  GFQ  NN  GLCG G +SLR C+ 
Sbjct: 205 GTIPANLAQAPALEFLDVRNNSLWGIVPSGLKKLKEGFQHANNSAGLCGVGFSSLRVCSY 264

Query: 261 YDNTQINPVKPFGSHSNDTTPIDISEPSGFKEHCNQSQCSNSSKFPQIAVLAAVTSVTVI 320
           +D   IN  + F + + D TP      S F+ HCNQ+ C N SKFP+I +++ VT+VTV 
Sbjct: 265 WDGMNINQSETFPATNTDFTPTIYPVSSNFRPHCNQTHCPNVSKFPRIVLVSGVTTVTVT 324

Query: 321 LAGTGILIFFRYRRHKQKIGNTSESSDWQLSTDLTLAKDFNRNGASPLVSLEYCHGWDPL 380
           L+  G+L F  YRR KQKIG++ ++S+ QLSTD ++  D +R  ASPLVSLEY  GWDPL
Sbjct: 325 LSAVGLLTFLCYRRRKQKIGSSFDTSECQLSTDRSI--DCHRKIASPLVSLEYSTGWDPL 382

Query: 381 GDYLNGTGFSREHLNSFRLNLEEVESATQCFSEVNLLGKGNFSSVYKGTLRDGTLVAIRS 440
            D  NG  FS+E   + R NL+E+ESATQ FSEVNLLGK  F SVYKG LRDG+LVAIRS
Sbjct: 383 ADGRNGNVFSQEFCQNPRFNLDEIESATQYFSEVNLLGKSKFWSVYKGILRDGSLVAIRS 442

Query: 441 INVTSCKSEEAEFVKGLYLLTSLRHENIIRLRGFCCSRGRGECFLIYDFAPKGKLSKYLD 500
           I+ TSCKSEEA+F+KGL LL+SLRHEN++RLRGFCCS+GRGEC+LI+DF P G LS+YLD
Sbjct: 443 ISATSCKSEEADFLKGLNLLSSLRHENLVRLRGFCCSKGRGECYLIHDFVPNGSLSRYLD 502

Query: 501 QEEGSSNVLDWSTRVSIIIGIAKGIGYLHSSEVNKPAIVHRNLSVEKVLIDQQFNPLIAD 560
            EEGSS VL+WSTRVSII GIAKGIGYLHSSE NKP++VHR++S +KVLIDQ+FNPLI+D
Sbjct: 503 LEEGSSQVLNWSTRVSIIHGIAKGIGYLHSSEENKPSLVHRSISADKVLIDQRFNPLISD 562

Query: 561 CGLHKLLADDIVFSVLKTSAAMGYLAPEYVTTGRFTERSDIFAFGVIILQILTGSLVLTS 620
            GL KLLADDIVFS LKTSAA+GYLAPEY+TTG FTE+SDI+AFGVIILQIL+G   LT+
Sbjct: 563 SGLPKLLADDIVFSALKTSAALGYLAPEYITTGSFTEKSDIYAFGVIILQILSGKQQLTN 622

Query: 621 SMRLAAESATFENFIDRNLKGKFSESEAAKLGKMALVCTHEDPENRPTMEAVIEELTV 678
           SMRLAAES  F +F+D NLKG+FSESEAAKL K+ L CTHE P+NRP ME VI+EL+ 
Sbjct: 623 SMRLAAESCRFADFVDTNLKGEFSESEAAKLAKIGLACTHELPDNRPIMETVIQELST 680

Source: Vitis vinifera

Species: Vitis vinifera

Genus: Vitis

Family: Vitaceae

Order: Vitales

Phylum: Streptophyta

Superkingdom: Eukaryota

>gi|359474325|ref|XP_002266682.2| PREDICTED: probable LRR receptor-like serine/threonine-protein kinase At4g36180 [Vitis vinifera]

 Score =  879 bits (2272), Expect = 0.0,   Method: Compositional matrix adjust.
 Identities = 444/656 (67%), Positives = 531/656 (80%), Gaps = 3/656 (0%)

Query: 22  VCGNTELRALLDLKASLDPENKLLQSWTENGDPCSGSFEGIACNEHRKVANISLQGKGLT 81
           V GN+ELRAL+++KASLDP N+ L SWT + DPCSGSFEG+ CNEHRKVANI+LQGKGL+
Sbjct: 25  VWGNSELRALMEMKASLDPVNRFLSSWTSDADPCSGSFEGVHCNEHRKVANITLQGKGLS 84

Query: 82  GKLSPSLSGLKCLSGLYLHYNSLSGEIPKEIRNLTELTDLYLDVNNLSGNIPPEIGSMAS 141
           GK+ P+++GLKCLSGLYLHYNSLSGEIP+EI +LTEL+DLYLD NNLSG IPPEIG+MAS
Sbjct: 85  GKVPPAVAGLKCLSGLYLHYNSLSGEIPREISSLTELSDLYLDFNNLSGAIPPEIGNMAS 144

Query: 142 LQVLQLCCNQLTGNIPAQIGSLKSLSVLTLQHNRLNGGIPDSLGNLGKLKRLDLSFNSLF 201
           LQVLQLC NQLTG IP++IG LK LSV++LQ N L G IP SLGNLG L+ L+LSFN L 
Sbjct: 145 LQVLQLCSNQLTGAIPSEIGFLKKLSVVSLQKNNLTGKIPPSLGNLGMLRMLNLSFNRLS 204

Query: 202 GTIPESLANNAELLFLDVQNNTLSGIVPSALKRLNGGFQFQNN-PGLCGDGIASLRACTV 260
           GTIP +LA    L FLDV+NN+L GIVPS LK+L  GFQ  NN  GLCG G +SLR C+ 
Sbjct: 205 GTIPANLAQAPALEFLDVRNNSLWGIVPSGLKKLKEGFQHANNSAGLCGVGFSSLRVCSY 264

Query: 261 YDNTQINPVKPFGSHSNDTTPIDISEPSGFKEHCNQSQCSNSSKFPQIAVLAAVTSVTVI 320
           +D   IN  + F + + D TP      S F+ HCNQ+ C N SKFP+I +++ VT+VTV 
Sbjct: 265 WDGMNINQSETFPATNTDFTPTIYPVSSNFRPHCNQTHCPNVSKFPRIVLVSGVTTVTVT 324

Query: 321 LAGTGILIFFRYRRHKQKIGNTSESSDWQLSTDLTLAKDFNRNGASPLVSLEYCHGWDPL 380
           L+  G+L F  YRR KQKIG++ ++S+ QLSTD ++  D +R  ASPLVSLEY  GWDPL
Sbjct: 325 LSAVGLLTFLCYRRRKQKIGSSFDTSECQLSTDRSI--DCHRKIASPLVSLEYSTGWDPL 382

Query: 381 GDYLNGTGFSREHLNSFRLNLEEVESATQCFSEVNLLGKGNFSSVYKGTLRDGTLVAIRS 440
            D  NG  FS+E   + R NL+E+ESATQ FSEVNLLGK  F SVYKG LRDG+LVAIRS
Sbjct: 383 ADGRNGNVFSQEFCQNPRFNLDEIESATQYFSEVNLLGKSKFWSVYKGILRDGSLVAIRS 442

Query: 441 INVTSCKSEEAEFVKGLYLLTSLRHENIIRLRGFCCSRGRGECFLIYDFAPKGKLSKYLD 500
           I+ TSCKSEEA+F+KGL LL+SLRHEN++RLRGFCCS+GRGEC+LI+DF P G LS+YLD
Sbjct: 443 ISATSCKSEEADFLKGLNLLSSLRHENLVRLRGFCCSKGRGECYLIHDFVPNGSLSRYLD 502

Query: 501 QEEGSSNVLDWSTRVSIIIGIAKGIGYLHSSEVNKPAIVHRNLSVEKVLIDQQFNPLIAD 560
            EEGSS VL+WSTRVSII GIAKGIGYLHSSE NKP++VHR++S +KVLIDQ+FNPLI+D
Sbjct: 503 LEEGSSQVLNWSTRVSIIHGIAKGIGYLHSSEENKPSLVHRSISADKVLIDQRFNPLISD 562

Query: 561 CGLHKLLADDIVFSVLKTSAAMGYLAPEYVTTGRFTERSDIFAFGVIILQILTGSLVLTS 620
            GL KLLADDIVFS LKTSAA+GYLAPEY+TTG FTE+SDI+AFGVIILQIL+G   LT+
Sbjct: 563 SGLPKLLADDIVFSALKTSAALGYLAPEYITTGSFTEKSDIYAFGVIILQILSGKQQLTN 622

Query: 621 SMRLAAESATFENFIDRNLKGKFSESEAAKLGKMALVCTHEDPENRPTMEAVIEEL 676
           SMRLAAES  F +F+D NLKG+FSESEAAKL K+ L CTHE P+NRP ME  +++L
Sbjct: 623 SMRLAAESCRFADFVDTNLKGEFSESEAAKLAKIGLACTHELPDNRPIMETTLKKL 678

Source: Vitis vinifera

Species: Vitis vinifera

Genus: Vitis

Family: Vitaceae

Order: Vitales

Phylum: Streptophyta

Superkingdom: Eukaryota

>gi|297803850|ref|XP_002869809.1| hypothetical protein ARALYDRAFT_492596 [Arabidopsis lyrata subsp. lyrata] gi|297315645|gb|EFH46068.1| hypothetical protein ARALYDRAFT_492596 [Arabidopsis lyrata subsp. lyrata]

 Score =  863 bits (2231), Expect = 0.0,   Method: Compositional matrix adjust.
 Identities = 435/686 (63%), Positives = 535/686 (77%), Gaps = 16/686 (2%)

Query: 1   MGISHVLIPLLVLITSSLTGLVCGNTELRALLDLKASLDPENKLLQSWTENGDPCSGSFE 60
           + +S  L+ LL +  S+ +  V GN EL+AL++LK+SLDPENKLL+SWT NGDPC GSFE
Sbjct: 2   VSLSATLLILLSIFFSTPSN-VRGNAELKALMELKSSLDPENKLLRSWTFNGDPCDGSFE 60

Query: 61  GIACNEHRKVANISLQGKGLTGKLSPSLSGLKCLSGLYLHYNSLSGEIPKEIRNLTELTD 120
           GIACN+H KVANISLQGK L GKLSP+++ LKCLSGLYLHYNSLSGEIP+EI NLTEL+D
Sbjct: 61  GIACNQHLKVANISLQGKRLAGKLSPAVAELKCLSGLYLHYNSLSGEIPQEITNLTELSD 120

Query: 121 LYLDVNNLSGNIPPEIGSMASLQVLQLCCNQLTGNIPAQIGSLKSLSVLTLQHNRLNGGI 180
           LYL+VNN SG IP +IGSM  LQV+ LCCN LTG IP  IG+LK L+VL+LQHN+L G +
Sbjct: 121 LYLNVNNFSGEIPADIGSMDGLQVMDLCCNSLTGKIPKNIGTLKKLNVLSLQHNQLTGEV 180

Query: 181 PDSLGNLGKLKRLDLSFNSLFGTIPESLANNAELLFLDVQNNTLSGIVPSALKRLNGGFQ 240
           P SLGNL  L R+DLSFN+L G IP++LAN  +L  LD++NNTLSG VPS LK+LNG FQ
Sbjct: 181 PWSLGNLSMLSRIDLSFNNLLGLIPKTLANIPQLETLDLRNNTLSGFVPSGLKKLNGSFQ 240

Query: 241 FQNNPGLCGDGIASLRACTVYDNTQINPVK-PFGSHSNDTTPI-DISEPSGFKEHCNQSQ 298
           F+NN GLCG    SLRAC+ +DN  I   K P G    D + + +ISE    ++HCN++Q
Sbjct: 241 FENNTGLCGMDFPSLRACSAFDNANIEQFKQPPGEIDTDKSALHNISESVYLQKHCNKTQ 300

Query: 299 C-SNSSKFPQIAVLAAVTSVTVILAGTGILIFFRYRRHKQKIGNTSESSDWQLSTDLTLA 357
           C  +SSK PQ+A++++V +VT+ L G GIL FFRYRR KQKI NT E S+ +LSTD  L 
Sbjct: 301 CKKSSSKLPQVALISSVITVTITLLGAGILTFFRYRRRKQKISNTPEFSEGRLSTD--LQ 358

Query: 358 KDFNRNGASPLVSLEYCHGWDPLGDYLNGTGFSRE-HL----NSFRLNLEEVESATQCFS 412
           KDF    ASPLVSL Y   WDPLGD  NG  FS+E HL    +SFR NLE++ESATQCFS
Sbjct: 359 KDFR---ASPLVSLAYTKEWDPLGDSRNGAEFSQEPHLFVVNSSFRFNLEDIESATQCFS 415

Query: 413 EVNLLGKGNFSSVYKGTLRDGTLVAIRSINVTSCKSEEAEFVKGLYLLTSLRHENIIRLR 472
           E NLL + +F+SV+KG LRDG+ VAIRSIN++SCK+EE EF+ GL LL+SL HEN+++LR
Sbjct: 416 EANLLSRNSFTSVFKGVLRDGSPVAIRSINISSCKNEEVEFMNGLKLLSSLSHENLMKLR 475

Query: 473 GFCCSRGRGECFLIYDFAPKGKLSKYLD-QEEGSSNVLDWSTRVSIIIGIAKGIGYLH-S 530
           GFCCSRGRGECFLIYDFA KGKLS +LD QE  ++ VLDW  R+SII GIAKGI YLH S
Sbjct: 476 GFCCSRGRGECFLIYDFASKGKLSNFLDIQEHETNQVLDWPARISIIKGIAKGIAYLHGS 535

Query: 531 SEVNKPAIVHRNLSVEKVLIDQQFNPLIADCGLHKLLADDIVFSVLKTSAAMGYLAPEYV 590
            +  KP IVHRN+SVEK+L+D+QFNPLIAD GLH LLADD+VFS LKTSAAMGYLAPEYV
Sbjct: 536 DQQKKPTIVHRNISVEKILLDEQFNPLIADSGLHNLLADDMVFSALKTSAAMGYLAPEYV 595

Query: 591 TTGRFTERSDIFAFGVIILQILTGSLVLTSSMRLAAESATFENFIDRNLKGKFSESEAAK 650
           TTG+FTE++DIFAFGVIILQIL+G L+LTSS+R+AAE+     FID  L+ +F + EA  
Sbjct: 596 TTGKFTEKTDIFAFGVIILQILSGKLMLTSSLRIAAENGEHSGFIDEYLREEFDKPEAIA 655

Query: 651 LGKMALVCTHEDPENRPTMEAVIEEL 676
           + ++ + CT E P NRP +E ++E++
Sbjct: 656 MARIGISCTQEIPNNRPNIETLLEDI 681

Source: Arabidopsis lyrata subsp. lyrata

Species: Arabidopsis lyrata

Genus: Arabidopsis

Family: Brassicaceae

Order: Brassicales

Phylum: Streptophyta

Superkingdom: Eukaryota

>gi|225455531|ref|XP_002267632.1| PREDICTED: leucine-rich repeat receptor-like serine/threonine-protein kinase At1g17230 [Vitis vinifera]

 Score =  861 bits (2225), Expect = 0.0,   Method: Compositional matrix adjust.
 Identities = 427/676 (63%), Positives = 520/676 (76%), Gaps = 2/676 (0%)

Query: 1   MGISHVLIPLLVLITSSLTGLVCGNTELRALLDLKASLDPENKLLQSWTENGDPCSGSFE 60
           M IS  +  L +  T  +  LV G +ELR+L+ +K++LDP N  L SWT NGDPC GSFE
Sbjct: 1   MAISAFVSTLFIFFTLQVPLLVHGTSELRSLMVIKSTLDPHNLFLSSWTINGDPCDGSFE 60

Query: 61  GIACNEHRKVANISLQGKGLTGKLSPSLSGLKCLSGLYLHYNSLSGEIPKEIRNLTELTD 120
           G+ACNE  +VANISLQGKGLTGKLSP+++GLK L+GLYLHYNSL GEIP EI NLT+L+D
Sbjct: 61  GVACNERGQVANISLQGKGLTGKLSPAIAGLKHLTGLYLHYNSLYGEIPVEIANLTQLSD 120

Query: 121 LYLDVNNLSGNIPPEIGSMASLQVLQLCCNQLTGNIPAQIGSLKSLSVLTLQHNRLNGGI 180
           LYL+VNNLSG IP E+G MA+LQVLQLC NQLTG+IP Q+GSLK LSVL LQ N+L G I
Sbjct: 121 LYLNVNNLSGTIPAELGKMATLQVLQLCYNQLTGSIPTQLGSLKKLSVLALQSNQLTGAI 180

Query: 181 PDSLGNLGKLKRLDLSFNSLFGTIPESLANNAELLFLDVQNNTLSGIVPSALKRLNGGFQ 240
           P SLG+LG L RLDLSFN LFG+IP  LA+   L  LD++NNTLSG +P ALKRLNGGFQ
Sbjct: 181 PASLGDLGMLVRLDLSFNRLFGSIPRRLADVVSLEVLDIRNNTLSGKIPPALKRLNGGFQ 240

Query: 241 FQNNPGLCGDGIASLRACTVYDNTQINPVKPFGSHSNDTTPIDISEPSGFKEHCNQSQCS 300
           ++NN  LCGDG + L+ C   D T  +  +P+G+ SN  +  DI E +  + HC+++ CS
Sbjct: 241 YKNNARLCGDGFSYLKVCNSLDLTNQSRPEPYGAGSNTQSTGDIPETANVQLHCDKAHCS 300

Query: 301 NSSKFPQIAVLAAVTSVTVILAGTGILIFFRYRRHKQKIGNTSESSDWQLSTDLTLAKDF 360
           N SK     V+  +  VT+ L+  GIL F +YRR KQK+G++ + SD +LSTD    K+ 
Sbjct: 301 NPSKSSHAPVVVGMVVVTIALSAIGILSFAQYRRRKQKLGSSFDISDSRLSTDQ--GKEV 358

Query: 361 NRNGASPLVSLEYCHGWDPLGDYLNGTGFSREHLNSFRLNLEEVESATQCFSEVNLLGKG 420
            R   SPLVSLEY +GWDPL D  N  GF +E   SFR NLEEVESATQ FSEVNLLGK 
Sbjct: 359 YRKNGSPLVSLEYSNGWDPLADGRNYGGFPQEVFQSFRFNLEEVESATQHFSEVNLLGKS 418

Query: 421 NFSSVYKGTLRDGTLVAIRSINVTSCKSEEAEFVKGLYLLTSLRHENIIRLRGFCCSRGR 480
           NFS++YKG LRDG+LVAI+SIN TSCKSE+AEF+KGL +LTSLRHEN++RLRG CCS+GR
Sbjct: 419 NFSAIYKGILRDGSLVAIKSINKTSCKSEDAEFLKGLNILTSLRHENLVRLRGLCCSKGR 478

Query: 481 GECFLIYDFAPKGKLSKYLDQEEGSSNVLDWSTRVSIIIGIAKGIGYLHSSEVNKPAIVH 540
           GECFLIYDF P G L  YLD ++G S VL+WSTRVS+I GIAKGI YLH  ++NKPA+VH
Sbjct: 479 GECFLIYDFIPNGNLLSYLDLKDGDSKVLEWSTRVSMISGIAKGIEYLHGYKLNKPALVH 538

Query: 541 RNLSVEKVLIDQQFNPLIADCGLHKLLADDIVFSVLKTSAAMGYLAPEYVTTGRFTERSD 600
           +N+S EKVLIDQ+ NPL++D GLHKLL DDIVFS LK SAAMGYLAPEY TTGRFTE+SD
Sbjct: 539 QNISAEKVLIDQRLNPLLSDSGLHKLLTDDIVFSALKASAAMGYLAPEYTTTGRFTEKSD 598

Query: 601 IFAFGVIILQILTGSLVLTSSMRLAAESATFENFIDRNLKGKFSESEAAKLGKMALVCTH 660
           ++AFGV++ QIL+G    TSS+ L AE+  F++FID NL G+FSE EAAKL ++AL+CTH
Sbjct: 599 LYAFGVLVFQILSGKRKFTSSIHLGAETCRFQDFIDANLHGRFSEYEAAKLARIALMCTH 658

Query: 661 EDPENRPTMEAVIEEL 676
           E P  RP+ME VI EL
Sbjct: 659 ESPIERPSMETVIHEL 674

Source: Vitis vinifera

Species: Vitis vinifera

Genus: Vitis

Family: Vitaceae

Order: Vitales

Phylum: Streptophyta

Superkingdom: Eukaryota

>gi|449460425|ref|XP_004147946.1| PREDICTED: LRR receptor-like serine/threonine-protein kinase GSO2-like [Cucumis sativus] gi|449494315|ref|XP_004159511.1| PREDICTED: LRR receptor-like serine/threonine-protein kinase GSO2-like [Cucumis sativus]

 Score =  850 bits (2197), Expect = 0.0,   Method: Compositional matrix adjust.
 Identities = 421/676 (62%), Positives = 527/676 (77%), Gaps = 8/676 (1%)

Query: 6   VLIPLLVLITSSLTGLVCGNTELRALLDLKASLDPENKLLQSWTENGDPCSGSFEGIACN 65
           + +   +  + S + LV GN+E++AL++LK SLDPEN++L+SWT +GDPC G F G+ACN
Sbjct: 8   IFMVYFIAFSLSFSYLVYGNSEVKALMELKVSLDPENRVLRSWTIDGDPCGGKFVGVACN 67

Query: 66  EHRKVANISLQGKGLTGKLSPSLSGLKCLSGLYLHYNSLSGEIPKEIRNLTELTDLYLDV 125
           EHRKVANISLQG+GL+GK+SP+++ LKCLSGLYLHYN+LSGEIP+EI +L EL DLYLDV
Sbjct: 68  EHRKVANISLQGRGLSGKVSPAVAELKCLSGLYLHYNNLSGEIPREISSLNELADLYLDV 127

Query: 126 NNLSGNIPPEIGSMASLQVLQLCCNQLTGNIPAQIGSLKSLSVLTLQHNRLNGGIPDSLG 185
           N+L+G+IP EIG+M+SLQVLQ+CCNQL+G IP QIGSL+ L+VL LQHNRL+G IP SLG
Sbjct: 128 NSLTGDIPEEIGNMSSLQVLQICCNQLSGKIPTQIGSLRKLTVLALQHNRLSGEIPTSLG 187

Query: 186 NLGKLKRLDLSFNSLFGTIPESLANNAELLFLDVQNNTLSGIVPSALKRLNGGFQFQNNP 245
           +L  LKRL LSFN+  G IP +LA   +L  +DV+NN+  G VPS L++LN GFQ +NNP
Sbjct: 188 SLEMLKRLYLSFNNFSGRIPFNLATIPQLEVVDVRNNSFFGHVPSGLRKLNEGFQGENNP 247

Query: 246 GLCGDGIASLRACTVYDNTQI--NPVKPFGSHSNDTTPIDISEPSG---FKEHCNQSQCS 300
           GLCG G  ++R CTV+DN  I  +  +PF S  N+T     + P     +  +CNQ  CS
Sbjct: 248 GLCGVGFVTVRKCTVFDNENIKGDGFQPFLSEPNNTATTQKNIPQSADFYNANCNQLHCS 307

Query: 301 NSSKFPQIAVLAAVTSVTVILAGTGILIFFRYRRHKQKIGNTSESSDWQLSTDLTLAKDF 360
            S++ P+IAV++AV  V+VIL  + IL  F YRR KQKIGN+S S D +LSTD   A++ 
Sbjct: 308 KSTRVPKIAVVSAVLIVSVILMVSMILTVFWYRRRKQKIGNSSLSCDDRLSTDQ--AREL 365

Query: 361 NRNGASPLVSLEYCHGWDPLGDYLNGTGFSREHLNSFRLNLEEVESATQCFSEVNLLGKG 420
               ASPLV LEY HGWD L D + G G S ++L  F  N+EEVESATQ FSE NLLG+ 
Sbjct: 366 YSKSASPLVCLEYSHGWDSLADGIKGLGLS-QYLGKFIFNVEEVESATQYFSEANLLGRS 424

Query: 421 NFSSVYKGTLRDGTLVAIRSINVTSCKSEEAEFVKGLYLLTSLRHENIIRLRGFCCSRGR 480
           +FS VYKG L+DG+ VAIRSIN+TSCKSEEAEF++GL LL+SLRHEN++ LRGFCCSRGR
Sbjct: 425 SFSMVYKGVLKDGSCVAIRSINMTSCKSEEAEFLRGLNLLSSLRHENLVTLRGFCCSRGR 484

Query: 481 GECFLIYDFAPKGKLSKYLDQEEGSSNVLDWSTRVSIIIGIAKGIGYLHSSEVNKPAIVH 540
           GE FL+YDF  +G LS+YLD E+GSS+VL+WS RVSII GIAKGI YLH  E NKPA+VH
Sbjct: 485 GEFFLVYDFVSRGSLSQYLDVEDGSSHVLEWSKRVSIINGIAKGIAYLHHEEANKPAMVH 544

Query: 541 RNLSVEKVLIDQQFNPLIADCGLHKLLADDIVFSVLKTSAAMGYLAPEYVTTGRFTERSD 600
           +++S+EK+LID QFN LI+D GL KLLADDI+FS LK+SAAMGYLAPEY+T GRFTE+SD
Sbjct: 545 KSISIEKILIDHQFNALISDSGLSKLLADDIIFSSLKSSAAMGYLAPEYITIGRFTEKSD 604

Query: 601 IFAFGVIILQILTGSLVLTSSMRLAAESATFENFIDRNLKGKFSESEAAKLGKMALVCTH 660
           I+AFGVII QIL+G+  L +S+ L AE   FE+FIDRNLKG FSES+A KL  +AL CT+
Sbjct: 605 IYAFGVIIFQILSGTRRLANSLLLQAEVCKFEDFIDRNLKGNFSESQATKLANLALSCTN 664

Query: 661 EDPENRPTMEAVIEEL 676
           E P NRPT+E +IEEL
Sbjct: 665 ELPINRPTIEDLIEEL 680

Source: Cucumis sativus

Species: Cucumis sativus

Genus: Cucumis

Family: Cucurbitaceae

Order: Cucurbitales

Phylum: Streptophyta

Superkingdom: Eukaryota

>gi|15235780|ref|NP_194004.1| leucine-rich repeat protein kinase-like protein [Arabidopsis thaliana] gi|2827550|emb|CAA16558.1| leucine rich repeat receptor kinase-like protein [Arabidopsis thaliana] gi|7269119|emb|CAB79228.1| leucine rich repeat receptor kinase-like protein [Arabidopsis thaliana] gi|38564276|gb|AAR23717.1| At4g22730 [Arabidopsis thaliana] gi|51971929|dbj|BAD44629.1| leucine rich repeat receptor kinase-like protein [Arabidopsis thaliana] gi|224589626|gb|ACN59346.1| leucine-rich repeat receptor-like protein kinase [Arabidopsis thaliana] gi|332659245|gb|AEE84645.1| leucine-rich repeat protein kinase-like protein [Arabidopsis thaliana]

 Score =  849 bits (2194), Expect = 0.0,   Method: Compositional matrix adjust.
 Identities = 428/666 (64%), Positives = 520/666 (78%), Gaps = 16/666 (2%)

Query: 22  VCGNTELRALLDLKASLDPENKLLQSWTENGDPCSGSFEGIACNEHRKVANISLQGKGLT 81
           V GN EL+AL++LK+SLDPENKLL+SWT NGDPC GSFEGIACN+H KVANISLQGK L 
Sbjct: 22  VRGNAELKALMELKSSLDPENKLLRSWTFNGDPCDGSFEGIACNQHLKVANISLQGKRLV 81

Query: 82  GKLSPSLSGLKCLSGLYLHYNSLSGEIPKEIRNLTELTDLYLDVNNLSGNIPPEIGSMAS 141
           GKLSP+++ LKCLSGLYLHYNSLSGEIP+EI NLTEL+DLYL+VNN SG IP +IGSMA 
Sbjct: 82  GKLSPAVAELKCLSGLYLHYNSLSGEIPQEITNLTELSDLYLNVNNFSGEIPADIGSMAG 141

Query: 142 LQVLQLCCNQLTGNIPAQIGSLKSLSVLTLQHNRLNGGIPDSLGNLGKLKRLDLSFNSLF 201
           LQV+ LCCN LTG IP  IGSLK L+VL+LQHN+L G +P +LGNL  L RLDLSFN+L 
Sbjct: 142 LQVMDLCCNSLTGKIPKNIGSLKKLNVLSLQHNKLTGEVPWTLGNLSMLSRLDLSFNNLL 201

Query: 202 GTIPESLANNAELLFLDVQNNTLSGIVPSALKRLNGGFQFQNNPGLCGDGIASLRACTVY 261
           G IP++LAN  +L  LD++NNTLSG VP  LK+LNG FQF+NN GLCG    SLRAC+ +
Sbjct: 202 GLIPKTLANIPQLDTLDLRNNTLSGFVPPGLKKLNGSFQFENNTGLCGIDFPSLRACSAF 261

Query: 262 DNT-QINPVK-PFGSHSNDTTPI-DISEPSGFKEHCNQSQC-SNSSKFPQIAVLAAVTSV 317
           DN   I   K P G    D + + +I E    ++HCNQ+ C  +SSK PQ+A++++V +V
Sbjct: 262 DNANNIEQFKQPPGEIDTDKSALHNIPESVYLQKHCNQTHCKKSSSKLPQVALISSVITV 321

Query: 318 TVILAGTGILIFFRYRRHKQKIGNTSESSDWQLSTDLTLAKDFNRNGASPLVSLEYCHGW 377
           T+ L G GIL FFRYRR KQKI NT E S+ +LSTD    K+F    ASPLVSL Y   W
Sbjct: 322 TITLIGAGILTFFRYRRRKQKISNTPEFSEGRLSTD--QQKEFR---ASPLVSLAYTKEW 376

Query: 378 DPLGDYLNGTGFSRE-HL----NSFRLNLEEVESATQCFSEVNLLGKGNFSSVYKGTLRD 432
           DPLGD  NG  FS+E HL    +SFR NLE++ESATQCFSE NLL + +F+SV+KG LRD
Sbjct: 377 DPLGDSRNGAEFSQEPHLFVVNSSFRFNLEDIESATQCFSEANLLSRNSFTSVFKGVLRD 436

Query: 433 GTLVAIRSINVTSCKSEEAEFVKGLYLLTSLRHENIIRLRGFCCSRGRGECFLIYDFAPK 492
           G+ VAIRSIN++SCK+EE EF+ GL LL+SL HEN+++LRGFCCSRGRGECFLIYDFA K
Sbjct: 437 GSPVAIRSINISSCKNEEVEFMNGLKLLSSLSHENLVKLRGFCCSRGRGECFLIYDFASK 496

Query: 493 GKLSKYLDQEEGSSN-VLDWSTRVSIIIGIAKGIGYLH-SSEVNKPAIVHRNLSVEKVLI 550
           GKLS +LD +E  +N VL WS R+SII GIAKGI YLH S +  KP IVHRN+SVEK+L+
Sbjct: 497 GKLSNFLDLQERETNLVLAWSARISIIKGIAKGIAYLHGSDQQKKPTIVHRNISVEKILL 556

Query: 551 DQQFNPLIADCGLHKLLADDIVFSVLKTSAAMGYLAPEYVTTGRFTERSDIFAFGVIILQ 610
           D+QFNPLIAD GLH LLADD+VFS LKTSAAMGYLAPEYVTTG+FTE++DIFAFGVIILQ
Sbjct: 557 DEQFNPLIADSGLHNLLADDMVFSALKTSAAMGYLAPEYVTTGKFTEKTDIFAFGVIILQ 616

Query: 611 ILTGSLVLTSSMRLAAESATFENFIDRNLKGKFSESEAAKLGKMALVCTHEDPENRPTME 670
           IL+G L+LTSS+R AAE+     FID +L+ +F + EA  + ++ + CT E P NRP +E
Sbjct: 617 ILSGKLMLTSSLRNAAENGEHNGFIDEDLREEFDKPEATAMARIGISCTQEIPNNRPNIE 676

Query: 671 AVIEEL 676
            ++E +
Sbjct: 677 TLLENI 682

Source: Arabidopsis thaliana

Species: Arabidopsis thaliana

Genus: Arabidopsis

Family: Brassicaceae

Order: Brassicales

Phylum: Streptophyta

Superkingdom: Eukaryota

>gi|356497165|ref|XP_003517433.1| PREDICTED: probable LRR receptor-like serine/threonine-protein kinase At4g36180-like [Glycine max]

 Score =  831 bits (2147), Expect = 0.0,   Method: Compositional matrix adjust.
 Identities = 424/669 (63%), Positives = 504/669 (75%), Gaps = 15/669 (2%)

Query: 21  LVCGNTELRALLDLKASLDPENKLLQSWTENGDPCSGSFEGIACNEHRKVANISLQGKGL 80
           +V G  ELRAL++LK+SLDPE K+L SW  +GDPCSG FEG+ACNEHRKVANISLQGKGL
Sbjct: 24  MVVGTVELRALMELKSSLDPEGKILGSWISDGDPCSGFFEGVACNEHRKVANISLQGKGL 83

Query: 81  TGKLSPSLSGLKCLSGLYLHYNSLSGEIPKEIRNLTELTDLYLDVNNLSGNIPPEIGSMA 140
           +G LSP+L+ LKCLSGLYLHYN+LSGEIP  I NLTEL DLYLDVN+LSG IPPEI +MA
Sbjct: 84  SGWLSPALAELKCLSGLYLHYNNLSGEIPPRISNLTELVDLYLDVNSLSGAIPPEISNMA 143

Query: 141 SLQVLQLCCNQLTGNIPAQIGSLKSLSVLTLQHNRLNGGIPDSLGNLGKLKRLDLSFNSL 200
           SLQVLQL  NQL GNIP Q+GSLK LS L LQ+N+L G IP SLGNL KL RL+LSFN+ 
Sbjct: 144 SLQVLQLGDNQLVGNIPTQMGSLKHLSTLALQYNKLTGQIPLSLGNLEKLSRLNLSFNNF 203

Query: 201 FGTIPESLANNAELLFLDVQNNTLSGIVPSALKRLNGGFQFQNNPGLCGDGIASLRACTV 260
            GT+P +LA+   L  LD+QNN LSGIVPSALKRL   FQ  NNPGLCG G ++LRAC  
Sbjct: 204 SGTVPATLAHIEHLEVLDIQNNYLSGIVPSALKRLGERFQGANNPGLCGVGFSTLRACNK 263

Query: 261 YDNTQINPV------KPFGSHSNDTTPIDISEPSGFKEHCNQSQCSNSSKFPQIAVLAAV 314
             +  +N +      +P  S S+   P    EP+  + HC Q+ CS S +FP   + A V
Sbjct: 264 DQDLNVNHIDTSDGDQPENSDSSKALP----EPAYVQSHCGQTHCSKSRRFPHTVITAGV 319

Query: 315 TSVTVILAGTGILIFFRYRRHKQKIGNTSESS-DWQLSTDLTLAKDFNRNGASPLVSLEY 373
             V +     G L FFRYRR KQ+I NTS SS + ++S D    K+F     S LV++EY
Sbjct: 320 IIVALAFICAGFLTFFRYRRQKQRISNTSSSSSEGKVSPDQ--PKEFYTKSPSALVNIEY 377

Query: 374 CHGWDPLGDYLNGT--GFSREHLNSFRLNLEEVESATQCFSEVNLLGKGNFSSVYKGTLR 431
             GWDPL +  N    G   E+LN FR N++EVESATQ  SE NLLGK  FS+VYKG LR
Sbjct: 378 YSGWDPLSNGQNADVGGLCNEYLNQFRFNVDEVESATQYLSETNLLGKSKFSAVYKGVLR 437

Query: 432 DGTLVAIRSINVTSCKSEEAEFVKGLYLLTSLRHENIIRLRGFCCSRGRGECFLIYDFAP 491
           DG+LVAIRSI+VT CK+EEAEFVKGL LLTSL HEN++RLRGFCCSR RGECFLIYDFA 
Sbjct: 438 DGSLVAIRSISVTCCKTEEAEFVKGLNLLTSLTHENLVRLRGFCCSRSRGECFLIYDFAT 497

Query: 492 KGKLSKYLDQEEGSSNVLDWSTRVSIIIGIAKGIGYLHSSEVNKPAIVHRNLSVEKVLID 551
            G LS+YLD E+GS +VL+WS RVSII GIAKGI YLHS E +KP IVH+N+SVE VL+D
Sbjct: 498 MGNLSQYLDIEDGSGHVLEWSKRVSIIKGIAKGIEYLHSKEESKPTIVHQNISVENVLLD 557

Query: 552 QQFNPLIADCGLHKLLADDIVFSVLKTSAAMGYLAPEYVTTGRFTERSDIFAFGVIILQI 611
            QFNPLI D GL KLLADD+VFS LK SAAMGYLAPEY+TTGRFTE+SDI+AFGVIILQ+
Sbjct: 558 HQFNPLIMDAGLPKLLADDVVFSALKVSAAMGYLAPEYITTGRFTEKSDIYAFGVIILQV 617

Query: 612 LTGSLVLTSSMRLAAESATFENFIDRNLKGKFSESEAAKLGKMALVCTHEDPENRPTMEA 671
           L+G   + SS+R A ES  F+  +D NLKG++S+SEAA L K+A+ CTHE P+ RPTM  
Sbjct: 618 LSGKTTIGSSIRTAVESFRFDESVDTNLKGRYSKSEAATLSKLAIQCTHELPDQRPTMVD 677

Query: 672 VIEELTVAA 680
           VI+EL+V++
Sbjct: 678 VIQELSVSS 686

Source: Glycine max

Species: Glycine max

Genus: Glycine

Family: Fabaceae

Order: Fabales

Phylum: Streptophyta

Superkingdom: Eukaryota

---

Prediction of Gene Ontology (GO) Terms

---

Prediction of Enzyme Commission (EC) Number

EC Number Prediction by Annotation Transfer from SWISS-PROT Entries

Original result of BLAST against SWISS-PROT

No confident hit for EC number transfering in SWISSPROT detected by BLAST

EC Number Prediction by Ezypred Server

Original result from Ezypred Server

Fail to connect to Ezypred Server

EC Number Prediction by EFICAz Software

No EC number assignment, probably not an enzyme!

---

Prediction of Functionally Associated Proteins

Functionally Associated Proteins Detected by STRING

Original result from the STRING server

Your Input: fgenesh4_pm.C_scaffold_127000014 hypothetical protein (682 aa) (Populus trichocarpa)

Predicted Functional Partners:

Sorry, there are no predicted associations at the current settings.

---

Conserved Domains and Related Protein Families

Conserved Domains Detected by RPS-BLAST

Original result of RPS-BLAST against CDD database part I

ID	Length	Definition	E-value
Query	689
cd00192	262	cd00192, PTKc, Catalytic domain of Protein Tyrosin	8e-40
smart00221	258	smart00221, STYKc, Protein kinase; unclassified sp	1e-39
smart00219	257	smart00219, TyrKc, Tyrosine kinase, catalytic doma	2e-39
cd00180	215	cd00180, PKc, Catalytic domain of Protein Kinases	1e-35
PLN00113	968	PLN00113, PLN00113, leucine-rich repeat receptor-l	2e-33
pfam07714	258	pfam07714, Pkinase_Tyr, Protein tyrosine kinase	4e-32
pfam00069	260	pfam00069, Pkinase, Protein kinase domain	1e-30
PLN00113	968	PLN00113, PLN00113, leucine-rich repeat receptor-l	1e-29
PLN00113	968	PLN00113, PLN00113, leucine-rich repeat receptor-l	2e-29
cd05038	284	cd05038, PTKc_Jak_rpt2, Catalytic (repeat 2) domai	5e-28
PLN00113	968	PLN00113, PLN00113, leucine-rich repeat receptor-l	1e-27
smart00220	254	smart00220, S_TKc, Serine/Threonine protein kinase	1e-27
cd05041	251	cd05041, PTKc_Fes_like, Catalytic domain of Fes-li	9e-27
PLN00113	968	PLN00113, PLN00113, leucine-rich repeat receptor-l	3e-26
cd05034	261	cd05034, PTKc_Src_like, Catalytic domain of Src ki	1e-25
PLN00113	968	PLN00113, PLN00113, leucine-rich repeat receptor-l	3e-25
cd05148	261	cd05148, PTKc_Srm_Brk, Catalytic domain of the Pro	3e-25
cd05081	284	cd05081, PTKc_Jak2_Jak3_rpt2, Catalytic (repeat 2)	1e-24
cd06606	260	cd06606, STKc_MAPKKK, Catalytic domain of the Prot	4e-24
PLN00113	968	PLN00113, PLN00113, leucine-rich repeat receptor-l	2e-23
cd05057	279	cd05057, PTKc_EGFR_like, Catalytic domain of Epide	3e-23
cd05073	260	cd05073, PTKc_Hck, Catalytic domain of the Protein	2e-22
PLN00113	968	PLN00113, PLN00113, leucine-rich repeat receptor-l	5e-22
cd05056	270	cd05056, PTKc_FAK, Catalytic domain of the Protein	1e-21
cd05068	261	cd05068, PTKc_Frk_like, Catalytic domain of Fyn-re	1e-21
cd05085	250	cd05085, PTKc_Fer, Catalytic domain of the Protein	3e-21
PLN03150	623	PLN03150, PLN03150, hypothetical protein; Provisio	4e-21
cd08529	256	cd08529, STKc_FA2-like, Catalytic domain of the Pr	5e-21
cd05059	256	cd05059, PTKc_Tec_like, Catalytic domain of Tec-li	1e-20
cd05069	260	cd05069, PTKc_Yes, Catalytic domain of the Protein	1e-20
cd05072	261	cd05072, PTKc_Lyn, Catalytic domain of the Protein	3e-20
cd05070	260	cd05070, PTKc_Fyn_Yrk, Catalytic domain of the Pro	3e-20
cd05067	260	cd05067, PTKc_Lck_Blk, Catalytic domain of the Pro	4e-20
cd05071	262	cd05071, PTKc_Src, Catalytic domain of the Protein	4e-20
cd05063	268	cd05063, PTKc_EphR_A2, Catalytic domain of the Pro	5e-20
cd05079	284	cd05079, PTKc_Jak1_rpt2, Catalytic (repeat 2) doma	6e-20
PLN00113	968	PLN00113, PLN00113, leucine-rich repeat receptor-l	8e-20
cd05046	275	cd05046, PTK_CCK4, Pseudokinase domain of the Prot	8e-20
cd05048	283	cd05048, PTKc_Ror, Catalytic Domain of the Protein	9e-20
cd05032	277	cd05032, PTKc_InsR_like, Catalytic domain of Insul	1e-19
cd05112	256	cd05112, PTKc_Itk, Catalytic domain of the Protein	1e-19
cd05111	279	cd05111, PTK_HER3, Pseudokinase domain of the Prot	3e-19
cd05058	262	cd05058, PTKc_Met_Ron, Catalytic domain of the Pro	4e-19
PLN00113	968	PLN00113, PLN00113, leucine-rich repeat receptor-l	5e-19
cd05044	269	cd05044, PTKc_c-ros, Catalytic domain of the Prote	8e-19
cd05049	280	cd05049, PTKc_Trk, Catalytic domain of the Protein	8e-19
cd05033	266	cd05033, PTKc_EphR, Catalytic domain of Ephrin Rec	8e-19
cd05084	252	cd05084, PTKc_Fes, Catalytic domain of the Protein	1e-18
cd05060	257	cd05060, PTKc_Syk_like, Catalytic domain of Spleen	1e-18
cd08215	258	cd08215, STKc_Nek, Catalytic domain of the Protein	1e-18
cd05039	256	cd05039, PTKc_Csk_like, Catalytic domain of C-term	3e-18
cd05114	256	cd05114, PTKc_Tec_Rlk, Catalytic domain of the Pro	3e-18
cd05110	303	cd05110, PTKc_HER4, Catalytic domain of the Protei	3e-18
COG0515	384	COG0515, SPS1, Serine/threonine protein kinase [Ge	6e-18
cd08530	256	cd08530, STKc_CNK2-like, Catalytic domain of the P	8e-18
cd05080	283	cd05080, PTKc_Tyk2_rpt2, Catalytic (repeat 2) doma	3e-17
cd05051	296	cd05051, PTKc_DDR, Catalytic domain of the Protein	3e-17
cd05035	273	cd05035, PTKc_Axl_like, Catalytic Domain of Axl-li	4e-17
cd05065	269	cd05065, PTKc_EphR_B, Catalytic domain of the Prot	4e-17
cd05123	250	cd05123, STKc_AGC, Catalytic domain of AGC family	6e-17
cd05040	257	cd05040, PTKc_Ack_like, Catalytic domain of the Pr	1e-16
PLN00113	968	PLN00113, PLN00113, leucine-rich repeat receptor-l	2e-16
cd05108	316	cd05108, PTKc_EGFR, Catalytic domain of the Protei	2e-16
cd05053	293	cd05053, PTKc_FGFR, Catalytic domain of the Protei	2e-16
cd05581	280	cd05581, STKc_PDK1, Catalytic domain of the Protei	4e-16
cd05122	253	cd05122, PKc_STE, Catalytic domain of STE family P	5e-16
cd05109	279	cd05109, PTKc_HER2, Catalytic domain of the Protei	6e-16
cd05090	283	cd05090, PTKc_Ror1, Catalytic domain of the Protei	8e-16
cd05052	263	cd05052, PTKc_Abl, Catalytic domain of the Protein	9e-16
cd05113	256	cd05113, PTKc_Btk_Bmx, Catalytic domain of the Pro	1e-15
cd05115	257	cd05115, PTKc_Zap-70, Catalytic domain of the Prot	2e-15
cd06632	258	cd06632, STKc_MEKK1_plant, Catalytic domain of the	3e-15
cd05116	257	cd05116, PTKc_Syk, Catalytic domain of the Protein	1e-14
cd06627	254	cd06627, STKc_Cdc7_like, Catalytic domain of Cell	1e-14
cd05066	267	cd05066, PTKc_EphR_A, Catalytic domain of the Prot	1e-14
cd05082	256	cd05082, PTKc_Csk, Catalytic domain of the Protein	1e-14
cd05092	280	cd05092, PTKc_TrkA, Catalytic domain of the Protei	2e-14
cd05074	273	cd05074, PTKc_Tyro3, Catalytic domain of the Prote	2e-14
cd05062	277	cd05062, PTKc_IGF-1R, Catalytic domain of the Prot	2e-14
cd07840	287	cd07840, STKc_CDK9_like, Catalytic domain of Cycli	2e-14
PLN00113	968	PLN00113, PLN00113, leucine-rich repeat receptor-l	3e-14
cd05089	297	cd05089, PTKc_Tie1, Catalytic domain of the Protei	3e-14
cd05047	270	cd05047, PTKc_Tie, Catalytic domain of Tie Protein	5e-14
cd05096	304	cd05096, PTKc_DDR1, Catalytic domain of the Protei	7e-14
cd05097	295	cd05097, PTKc_DDR_like, Catalytic domain of Discoi	8e-14
cd05101	304	cd05101, PTKc_FGFR2, Catalytic domain of the Prote	9e-14
cd05088	303	cd05088, PTKc_Tie2, Catalytic domain of the Protei	9e-14
cd05064	266	cd05064, PTKc_EphR_A10, Catalytic domain of the Pr	9e-14
cd05075	272	cd05075, PTKc_Axl, Catalytic domain of the Protein	1e-13
PHA02988	283	PHA02988, PHA02988, hypothetical protein; Provisio	1e-13
cd05045	290	cd05045, PTKc_RET, Catalytic domain of the Protein	1e-13
cd05099	314	cd05099, PTKc_FGFR4, Catalytic domain of the Prote	2e-13
cd05050	288	cd05050, PTKc_Musk, Catalytic domain of the Protei	3e-13
cd06610	267	cd06610, STKc_OSR1_SPAK, Catalytic domain of the P	3e-13
cd08221	256	cd08221, STKc_Nek9, Catalytic domain of the Protei	3e-13
cd06623	264	cd06623, PKc_MAPKK_plant_like, Catalytic domain of	3e-13
cd05094	291	cd05094, PTKc_TrkC, Catalytic domain of the Protei	3e-13
cd05083	254	cd05083, PTKc_Chk, Catalytic domain of the Protein	6e-13
cd06628	267	cd06628, STKc_MAPKKK_Byr2_like, Catalytic domain o	7e-13
cd06605	265	cd06605, PKc_MAPKK, Catalytic domain of the dual-s	7e-13
cd05091	283	cd05091, PTKc_Ror2, Catalytic domain of the Protei	8e-13
cd05061	288	cd05061, PTKc_InsR, Catalytic domain of the Protei	1e-12
cd06631	265	cd06631, STKc_YSK4, Catalytic domain of the Protei	2e-12
cd05095	296	cd05095, PTKc_DDR2, Catalytic domain of the Protei	2e-12
cd07836	284	cd07836, STKc_Pho85, Catalytic domain of the Serin	2e-12
cd08217	265	cd08217, STKc_Nek2, Catalytic domain of the Protei	3e-12
cd06630	268	cd06630, STKc_MEKK1, Catalytic domain of the Prote	3e-12
cd05578	258	cd05578, STKc_Yank1, Catalytic domain of the Prote	4e-12
cd05093	288	cd05093, PTKc_TrkB, Catalytic domain of the Protei	4e-12
cd05098	307	cd05098, PTKc_FGFR1, Catalytic domain of the Prote	4e-12
cd08223	257	cd08223, STKc_Nek4, Catalytic domain of the Protei	4e-12
cd05043	280	cd05043, PTK_Ryk, Pseudokinase domain of Ryk (Rece	6e-12
cd05055	302	cd05055, PTKc_PDGFR, Catalytic domain of the Prote	9e-12
cd06917	277	cd06917, STKc_NAK1_like, Catalytic domain of Funga	9e-12
cd08220	256	cd08220, STKc_Nek8, Catalytic domain of the Protei	1e-11
cd08229	267	cd08229, STKc_Nek7, Catalytic domain of the Protei	2e-11
cd08224	267	cd08224, STKc_Nek6_Nek7, Catalytic domain of the P	2e-11
cd06621	287	cd06621, PKc_MAPKK_Pek1_like, Catalytic domain of	3e-11
cd05042	269	cd05042, PTKc_Aatyk, Catalytic domain of the Prote	3e-11
cd07861	285	cd07861, STKc_CDK1_euk, Catalytic domain of the Se	5e-11
cd05612	291	cd05612, STKc_PRKX_like, Catalytic domain of PRKX-	8e-11
cd05036	277	cd05036, PTKc_ALK_LTK, Catalytic domain of the Pro	1e-10
cd06640	277	cd06640, STKc_MST4, Catalytic domain of the Protei	1e-10
cd07838	287	cd07838, STKc_CDK4_6_like, Catalytic domain of Cyc	2e-10
cd05100	334	cd05100, PTKc_FGFR3, Catalytic domain of the Prote	2e-10
cd05579	265	cd05579, STKc_MAST_like, Catalytic domain of Micro	2e-10
cd07833	288	cd07833, STKc_CDKL, Catalytic domain of Cyclin-Dep	2e-10
cd06612	256	cd06612, STKc_MST1_2, Catalytic domain of the Prot	2e-10
cd07846	286	cd07846, STKc_CDKL2_3, Catalytic domain of the Ser	4e-10
cd06642	277	cd06642, STKc_STK25-YSK1, Catalytic domain of the	5e-10
cd06624	268	cd06624, STKc_ASK, Catalytic domain of the Protein	5e-10
cd06625	263	cd06625, STKc_MEKK3_like, Catalytic domain of MAP/	5e-10
cd06641	277	cd06641, STKc_MST3, Catalytic domain of the Protei	9e-10
cd08228	267	cd08228, STKc_Nek6, Catalytic domain of the Protei	1e-09
cd05589	324	cd05589, STKc_PKN, Catalytic domain of the Protein	2e-09
cd08218	256	cd08218, STKc_Nek1, Catalytic domain of the Protei	3e-09
cd05118	283	cd05118, STKc_CMGC, Catalytic domain of CMGC famil	4e-09
cd07860	284	cd07860, STKc_CDK2_3, Catalytic domain of the Seri	4e-09
cd06609	274	cd06609, STKc_MST3_like, Catalytic domain of Mamma	5e-09
cd06620	284	cd06620, PKc_MAPKK_Byr1_like, Catalytic domain of	5e-09
cd06651	266	cd06651, STKc_MEKK3, Catalytic domain of the Prote	6e-09
cd06629	272	cd06629, STKc_MAPKKK_Bck1_like, Catalytic domain o	9e-09
cd08528	269	cd08528, STKc_Nek10, Catalytic domain of the Prote	1e-08
cd06626	264	cd06626, STKc_MEKK4, Catalytic domain of the Prote	1e-08
cd07829	282	cd07829, STKc_CDK_like, Catalytic domain of Cyclin	1e-08
cd06636	282	cd06636, STKc_MAP4K4_6, Catalytic domain of the Pr	2e-08
cd07835	283	cd07835, STKc_CDK1_like, Catalytic domain of Cycli	2e-08
cd07845	309	cd07845, STKc_CDK10, Catalytic domain of the Serin	2e-08
COG4886	394	COG4886, COG4886, Leucine-rich repeat (LRR) protei	3e-08
COG4886	394	COG4886, COG4886, Leucine-rich repeat (LRR) protei	5e-08
cd05582	318	cd05582, STKc_RSK_N, N-terminal catalytic domain o	5e-08
cd06637	272	cd06637, STKc_TNIK, Catalytic domain of the Protei	6e-08
cd06635	317	cd06635, STKc_TAO1, Catalytic domain of the Protei	7e-08
cd08225	257	cd08225, STKc_Nek5, Catalytic domain of the Protei	9e-08
cd07867	317	cd07867, STKc_CDC2L6, Catalytic domain of Serine/T	1e-07
cd06652	265	cd06652, STKc_MEKK2, Catalytic domain of the Prote	1e-07
cd07868	317	cd07868, STKc_CDK8, Catalytic domain of the Serine	2e-07
cd06639	291	cd06639, STKc_myosinIIIB, Catalytic domain of the	2e-07
cd07842	316	cd07842, STKc_CDK8_like, Catalytic domain of Cycli	2e-07
PLN00034	353	PLN00034, PLN00034, mitogen-activated protein kina	2e-07
TIGR03903	1266	TIGR03903, TOMM_kin_cyc, TOMM system kinase/cyclas	3e-07
cd05570	318	cd05570, STKc_PKC, Catalytic domain of the Protein	3e-07
cd07862	290	cd07862, STKc_CDK6, Catalytic domain of the Serine	3e-07
cd07841	298	cd07841, STKc_CDK7, Catalytic domain of the Serine	3e-07
pfam13855	60	pfam13855, LRR_8, Leucine rich repeat	4e-07
cd05102	338	cd05102, PTKc_VEGFR3, Catalytic domain of the Prot	4e-07
cd05078	258	cd05078, PTK_Jak2_Jak3_rpt1, Pseudokinase (repeat	4e-07
cd05619	316	cd05619, STKc_nPKC_theta, Catalytic domain of the	5e-07
cd07873	301	cd07873, STKc_PCTAIRE1, Catalytic domain of the Se	5e-07
cd05103	343	cd05103, PTKc_VEGFR2, Catalytic domain of the Prot	5e-07
cd07848	287	cd07848, STKc_CDKL5, Catalytic domain of the Serin	6e-07
cd06653	264	cd06653, STKc_MEKK3_like_1, Catalytic domain of MA	6e-07
COG4886	394	COG4886, COG4886, Leucine-rich repeat (LRR) protei	7e-07
cd06614	286	cd06614, STKc_PAK, Catalytic domain of the Protein	7e-07
PTZ00024	335	PTZ00024, PTZ00024, cyclin-dependent protein kinas	8e-07
cd05105	400	cd05105, PTKc_PDGFR_alpha, Catalytic domain of the	9e-07
PLN00009	294	PLN00009, PLN00009, cyclin-dependent kinase A; Pro	9e-07
cd05620	316	cd05620, STKc_nPKC_delta, Catalytic domain of the	1e-06
cd07839	284	cd07839, STKc_CDK5, Catalytic domain of the Serine	1e-06
cd07866	311	cd07866, STKc_BUR1, Catalytic domain of the Serine	1e-06
cd06611	280	cd06611, STKc_SLK_like, Catalytic domain of Ste20-	1e-06
cd06634	308	cd06634, STKc_TAO2, Catalytic domain of the Protei	1e-06
cd07869	303	cd07869, STKc_PFTAIRE1, Catalytic domain of the Se	2e-06
PHA03209	357	PHA03209, PHA03209, serine/threonine kinase US3; P	2e-06
cd07872	309	cd07872, STKc_PCTAIRE2, Catalytic domain of the Se	2e-06
cd07837	295	cd07837, STKc_CdkB_plant, Catalytic domain of the	3e-06
cd05613	290	cd05613, STKc_MSK1_N, N-terminal catalytic domain	3e-06
cd07870	291	cd07870, STKc_PFTAIRE2, Catalytic domain of the Se	3e-06
cd07830	283	cd07830, STKc_MAK_like, Catalytic domain of Male g	3e-06
pfam08263	42	pfam08263, LRRNT_2, Leucine rich repeat N-terminal	4e-06
cd05086	268	cd05086, PTKc_Aatyk2, Catalytic domain of the Prot	4e-06
cd06617	283	cd06617, PKc_MKK3_6, Catalytic domain of the dual-	4e-06
cd08219	255	cd08219, STKc_Nek3, Catalytic domain of the Protei	5e-06
cd05585	312	cd05585, STKc_YPK1_like, Catalytic domain of Yeast	5e-06
cd07871	288	cd07871, STKc_PCTAIRE3, Catalytic domain of the Se	6e-06
cd05054	337	cd05054, PTKc_VEGFR, Catalytic domain of the Prote	7e-06
cd05571	323	cd05571, STKc_PKB, Catalytic domain of the Protein	7e-06
cd07879	342	cd07879, STKc_p38delta_MAPK13, Catalytic domain of	9e-06
cd05603	321	cd05603, STKc_SGK2, Catalytic domain of the Protei	1e-05
cd05087	269	cd05087, PTKc_Aatyk1_Aatyk3, Catalytic domain of t	1e-05
cd05580	290	cd05580, STKc_PKA, Catalytic domain of the Protein	1e-05
cd05604	325	cd05604, STKc_SGK3, Catalytic domain of the Protei	1e-05
cd07832	286	cd07832, STKc_CCRK, Catalytic domain of the Serine	1e-05
cd05611	260	cd05611, STKc_Rim15_like, Catalytic domain of fung	2e-05
cd06613	262	cd06613, STKc_MAP4K3_like, Catalytic domain of Mit	2e-05
cd07851	343	cd07851, STKc_p38, Catalytic domain of the Serine/	3e-05
cd05104	375	cd05104, PTKc_Kit, Catalytic domain of the Protein	3e-05
cd05577	277	cd05577, STKc_GRK, Catalytic domain of the Protein	3e-05
cd05583	288	cd05583, STKc_MSK_N, N-terminal catalytic domain o	3e-05
cd05605	285	cd05605, STKc_GRK4_like, Catalytic domain of G pro	4e-05
cd07876	359	cd07876, STKc_JNK2, Catalytic domain of the Serine	4e-05
cd05632	285	cd05632, STKc_GRK5, Catalytic domain of the Protei	5e-05
cd05595	323	cd05595, STKc_PKB_beta, Catalytic domain of the Pr	5e-05
cd05593	328	cd05593, STKc_PKB_gamma, Catalytic domain of the P	5e-05
cd05587	324	cd05587, STKc_cPKC, Catalytic domain of the Protei	8e-05
cd07856	328	cd07856, STKc_Sty1_Hog1, Catalytic domain of the S	8e-05
PRK13184	932	PRK13184, pknD, serine/threonine-protein kinase; R	8e-05
cd05607	277	cd05607, STKc_GRK7, Catalytic domain of the Protei	8e-05
cd05572	262	cd05572, STKc_cGK_PKG, Catalytic domain of the Pro	1e-04
cd06649	331	cd06649, PKc_MEK2, Catalytic domain of the dual-sp	1e-04
cd06650	333	cd06650, PKc_MEK1, Catalytic domain of the dual-sp	1e-04
cd07863	288	cd07863, STKc_CDK4, Catalytic domain of the Serine	1e-04
cd05631	285	cd05631, STKc_GRK4, Catalytic domain of the Protei	1e-04
cd06655	296	cd06655, STKc_PAK2, Catalytic domain of the Protei	1e-04
cd05616	323	cd05616, STKc_cPKC_beta, Catalytic domain of the P	1e-04
PLN00113	968	PLN00113, PLN00113, leucine-rich repeat receptor-l	2e-04
cd05590	320	cd05590, STKc_nPKC_eta, Catalytic domain of the Pr	2e-04
cd05107	401	cd05107, PTKc_PDGFR_beta, Catalytic domain of the	2e-04
cd05630	285	cd05630, STKc_GRK6, Catalytic domain of the Protei	2e-04
cd05592	316	cd05592, STKc_nPKC_theta_delta, Catalytic domain o	2e-04
cd06644	292	cd06644, STKc_STK10_LOK, Catalytic domain of the P	2e-04
cd07880	343	cd07880, STKc_p38gamma_MAPK12, Catalytic domain of	3e-04
cd07865	310	cd07865, STKc_CDK9, Catalytic domain of the Serine	3e-04
cd05575	323	cd05575, STKc_SGK, Catalytic domain of the Protein	3e-04
cd06622	286	cd06622, PKc_MAPKK_PBS2_like, Catalytic domain of	3e-04
cd05602	325	cd05602, STKc_SGK1, Catalytic domain of the Protei	3e-04
cd00116	319	cd00116, LRR_RI, Leucine-rich repeats (LRRs), ribo	3e-04
cd05037	259	cd05037, PTK_Jak_rpt1, Pseudokinase (repeat 1) dom	4e-04
cd05594	325	cd05594, STKc_PKB_alpha, Catalytic domain of the P	5e-04
cd07877	345	cd07877, STKc_p38alpha_MAPK14, Catalytic domain of	5e-04
PTZ00263	329	PTZ00263, PTZ00263, protein kinase A catalytic sub	7e-04
cd05584	323	cd05584, STKc_p70S6K, Catalytic domain of the Prot	9e-04
cd06615	308	cd06615, PKc_MEK, Catalytic domain of the dual-spe	0.001
cd06608	275	cd06608, STKc_myosinIII_like, Catalytic domain of	0.001
cd06657	292	cd06657, STKc_PAK4, Catalytic domain of the Protei	0.001
cd06619	279	cd06619, PKc_MKK5, Catalytic domain of the dual-sp	0.001
cd07859	338	cd07859, STKc_TDY_MAPK_plant, Catalytic domain of	0.001
pfam13855	60	pfam13855, LRR_8, Leucine rich repeat	0.002
cd05615	323	cd05615, STKc_cPKC_alpha, Catalytic domain of the	0.002
cd05614	332	cd05614, STKc_MSK2_N, N-terminal catalytic domain	0.002
PTZ00266	1021	PTZ00266, PTZ00266, NIMA-related protein kinase; P	0.003
cd08226	328	cd08226, PK_STRAD_beta, Pseudokinase domain of STE	0.003
cd07844	291	cd07844, STKc_PCTAIRE_like, Catalytic domain of PC	0.004
cd05633	279	cd05633, STKc_GRK3, Catalytic domain of the Protei	0.004
cd07878	343	cd07878, STKc_p38beta_MAPK11, Catalytic domain of	0.004

>gnl|CDD|173624 cd00192, PTKc, Catalytic domain of Protein Tyrosine Kinases

 Score =  146 bits (372), Expect = 8e-40
 Identities = 81/280 (28%), Positives = 130/280 (46%), Gaps = 35/280 (12%)

Query: 415 NLLGKGNFSSVYKGTLRDG----TLVAIRSINVTSCKSEEAEFVKGLYLLTSLRHENIIR 470
             LG+G F  VYKG L+      T VA++++   + + E  +F+K   ++  L H N++R
Sbjct: 1   KKLGEGAFGEVYKGKLKGKDGKTTEVAVKTLKEDASEEERKDFLKEARVMKKLGHPNVVR 60

Query: 471 LRGFCCSRGRGECFLIYDFAPKGKLSKYL-----DQEEGSSNVLDWSTRVSIIIGIAKGI 525
           L G C        +L+ ++   G L  YL            + L     +S  I IAKG+
Sbjct: 61  LLGVC--TEEEPLYLVLEYMEGGDLLDYLRKSRPVFPSPEKSTLSLKDLLSFAIQIAKGM 118

Query: 526 GYLHSSEVNKPAIVHRNLSVEKVLIDQQFNPLIADCGLHKLLADDIVFSVLKTSAAM--G 583
            YL S    K   VHR+L+    L+ +     I+D GL + + DD  +   KT   +   
Sbjct: 119 EYLAS---KK--FVHRDLAARNCLVGEDLVVKISDFGLSRDVYDDDYY-RKKTGGKLPIR 172

Query: 584 YLAPEYVTTGRFTERSDIFAFGVIILQILTGSLVLTSSMRLAAE---SATFENFIDRNLK 640
           ++APE +  G FT +SD+++FGV++ +I T          L A      + E  ++   K
Sbjct: 173 WMAPESLKDGIFTSKSDVWSFGVLLWEIFT----------LGATPYPGLSNEEVLEYLRK 222

Query: 641 G---KFSESEAAKLGKMALVCTHEDPENRPTMEAVIEELT 677
           G      E    +L ++ L C   DPE+RPT   ++E L 
Sbjct: 223 GYRLPKPEYCPDELYELMLSCWQLDPEDRPTFSELVERLE 262

Protein Tyrosine Kinase (PTK) family, catalytic domain. This PTKc family is part of a larger superfamily that includes the catalytic domains of protein serine/threonine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. They can be classified into receptor and non-receptor tyr kinases. PTKs play important roles in many cellular processes including, lymphocyte activation, epithelium growth and maintenance, metabolism control, organogenesis regulation, survival, proliferation, differentiation, migration, adhesion, motility, and morphogenesis. Receptor tyr kinases (RTKs) are integral membrane proteins which contain an extracellular ligand-binding region, a transmembrane segment, and an intracellular tyr kinase domain. RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain, leading to intracellular signaling. Some RTKs are orphan receptors with no known ligands. Non-receptor (or cytoplasmic) tyr kinases are distributed in different intracellular compartments and are usually multi-domain proteins containing a catalytic tyr kinase domain as well as various regulatory domains such as SH3 and SH2. PTKs are usually autoinhibited and require a mechanism for activation. In many PTKs, the phosphorylation of tyr residues in the activation loop is essential for optimal activity. Aberrant expression of PTKs is associated with many development abnormalities and cancers. Length = 262

>gnl|CDD|214568 smart00221, STYKc, Protein kinase; unclassified specificity

 Score =  146 bits (370), Expect = 1e-39
 Identities = 76/265 (28%), Positives = 131/265 (49%), Gaps = 18/265 (6%)

Query: 417 LGKGNFSSVYKGTLRDG-----TLVAIRSINVTSCKSEEAEFVKGLYLLTSLRHENIIRL 471
           LG+G F  VYKGTL+         VA++++   + + +  EF++   ++  L H NI++L
Sbjct: 7   LGEGAFGEVYKGTLKGKGDGKEVEVAVKTLKEDASEQQIEEFLREARIMRKLDHPNIVKL 66

Query: 472 RGFCCSRGRGECFLIYDFAPKGKLSKYLDQEEGSSNVLDWSTRVSIIIGIAKGIGYLHSS 531
            G C         ++ ++ P G L  YL +       L  S  +S  + IA+G+ YL S 
Sbjct: 67  LGVCTEEEPL--MIVMEYMPGGDLLDYLRKNRP--KELSLSDLLSFALQIARGMEYLES- 121

Query: 532 EVNKPAIVHRNLSVEKVLIDQQFNPLIADCGLHKLLADDIVFSVLKTSAAMGYLAPEYVT 591
              K   +HR+L+    L+ +     I+D GL + L DD  + V      + ++APE + 
Sbjct: 122 ---KN-FIHRDLAARNCLVGENLVVKISDFGLSRDLYDDDYYKVKGGKLPIRWMAPESLK 177

Query: 592 TGRFTERSDIFAFGVIILQILTGSLVLTSSMRLAAESATFENFIDRNLKGKFSESEAAKL 651
            G+FT +SD+++FGV++ +I T        M     +A    ++ +  +     +   +L
Sbjct: 178 EGKFTSKSDVWSFGVLLWEIFTLGEEPYPGM----SNAEVLEYLKKGYRLPKPPNCPPEL 233

Query: 652 GKMALVCTHEDPENRPTMEAVIEEL 676
            K+ L C  EDPE+RPT   ++E L
Sbjct: 234 YKLMLQCWAEDPEDRPTFSELVEIL 258

Phosphotransferases. The specificity of this class of kinases can not be predicted. Possible dual-specificity Ser/Thr/Tyr kinase. Length = 258

>gnl|CDD|197581 smart00219, TyrKc, Tyrosine kinase, catalytic domain

 Score =  145 bits (369), Expect = 2e-39
 Identities = 72/268 (26%), Positives = 126/268 (47%), Gaps = 25/268 (9%)

Query: 417 LGKGNFSSVYKGTLRD-----GTLVAIRSINVTSCKSEEAEFVKGLYLLTSLRHENIIRL 471
           LG+G F  VYKG L+         VA++++   + + +  EF++   ++  L H N+++L
Sbjct: 7   LGEGAFGEVYKGKLKGKGGKKKVEVAVKTLKEDASEQQIEEFLREARIMRKLDHPNVVKL 66

Query: 472 RGFCCSRGRGECFLIYDFAPKGKLSKYLDQEEGSSNVLDWSTRVSIIIGIAKGIGYLHSS 531
            G C        +++ ++   G L  YL     +   L  S  +S  + IA+G+ YL S 
Sbjct: 67  LGVCTEEEPL--YIVMEYMEGGDLLSYL---RKNRPKLSLSDLLSFALQIARGMEYLES- 120

Query: 532 EVNKPAIVHRNLSVEKVLIDQQFNPLIADCGLHKLLADDIVFSVLKTSAAMGYLAPEYVT 591
              K   +HR+L+    L+ +     I+D GL + L DD  +        + ++APE + 
Sbjct: 121 ---KN-FIHRDLAARNCLVGENLVVKISDFGLSRDLYDDDYYRKRGGKLPIRWMAPESLK 176

Query: 592 TGRFTERSDIFAFGVIILQILTGSLVLTSSMRLAAESATFENFIDRNLKGKFSESEA--- 648
            G+FT +SD+++FGV++ +I T        M       + E  ++    G          
Sbjct: 177 EGKFTSKSDVWSFGVLLWEIFTLGEQPYPGM-------SNEEVLEYLKNGYRLPQPPNCP 229

Query: 649 AKLGKMALVCTHEDPENRPTMEAVIEEL 676
            +L  + L C  EDPE+RPT   ++E L
Sbjct: 230 PELYDLMLQCWAEDPEDRPTFSELVEIL 257

Phosphotransferases. Tyrosine-specific kinase subfamily. Length = 257

>gnl|CDD|173623 cd00180, PKc, Catalytic domain of Protein Kinases

 Score =  133 bits (337), Expect = 1e-35
 Identities = 69/263 (26%), Positives = 113/263 (42%), Gaps = 51/263 (19%)

Query: 417 LGKGNFSSVYKGTLR-DGTLVAIRSINVTSCKSEEAEFVKGLYLLTSLRHENIIRLRGFC 475
           LG+G F +VY    +  G  VAI+ I      S   E ++ + +L  L H NI++L G  
Sbjct: 1   LGEGGFGTVYLARDKKTGKKVAIKIIKKEDSSSLLEELLREIEILKKLNHPNIVKLYGVF 60

Query: 476 CSRGRGECFLIYDFAPKGKLSKYLDQEEGSSNVLDWSTRVSIIIGIAKGIGYLHSSEVNK 535
                   +L+ ++   G L   L + EG    L     + I++ I +G+ YLHS+    
Sbjct: 61  --EDENHLYLVMEYCEGGSLKDLLKENEG---KLSEDEILRILLQILEGLEYLHSNG--- 112

Query: 536 PAIVHRNLSVEKVLIDQ-QFNPLIADCGLHKLLADDIVFSVLKTSAAMGYLAPE-YVTTG 593
             I+HR+L  E +L+D       +AD GL KLL  D             Y+APE  +  G
Sbjct: 113 --IIHRDLKPENILLDSDNGKVKLADFGLSKLLTSDKSLLK-TIVGTPAYMAPEVLLGKG 169

Query: 594 RFTERSDIFAFGVIILQILTGSLVLTSSMRLAAESATFENFIDRNLKGKFSESEAAKLGK 653
            ++E+SDI++ GVI+ ++                    ++ I +                
Sbjct: 170 YYSEKSDIWSLGVILYEL-----------------PELKDLIRK---------------- 196

Query: 654 MALVCTHEDPENRPTMEAVIEEL 676
                  +DPE RP+ + ++E L
Sbjct: 197 ----MLQKDPEKRPSAKEILEHL 215

Protein Kinases (PKs), catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The PK family is part of a larger superfamily that includes the catalytic domains of RIO kinases, aminoglycoside phosphotransferase, choline kinase, phosphoinositide 3-kinase (PI3K), and actin-fragmin kinase. PKs make up a large family of serine/threonine kinases, protein tyrosine kinases (PTKs), and dual-specificity PKs that phosphorylate both serine/threonine and tyrosine residues of target proteins. Majority of protein phosphorylation, about 95%, occurs on serine residues while only 1% occurs on tyrosine residues. Protein phosphorylation is a mechanism by which a wide variety of cellular proteins, such as enzymes and membrane channels, are reversibly regulated in response to certain stimuli. PKs often function as components of signal transduction pathways in which one kinase activates a second kinase, which in turn, may act on other kinases; this sequential action transmits a signal from the cell surface to target proteins, which results in cellular responses. The PK family is one of the largest known protein families with more than 100 homologous yeast enzymes and 550 human proteins. A fraction of PK family members are pseudokinases that lack crucial residues for catalytic activity. The mutiplicity of kinases allows for specific regulation according to substrate, tissue distribution, and cellular localization. PKs regulate many cellular processes including proliferation, division, differentiation, motility, survival, metabolism, cell-cycle progression, cytoskeletal rearrangement, immunity, and neuronal functions. Many kinases are implicated in the development of various human diseases including different types of cancer. Length = 215

>gnl|CDD|215061 PLN00113, PLN00113, leucine-rich repeat receptor-like protein kinase; Provisional

 Score =  137 bits (347), Expect = 2e-33
 Identities = 91/243 (37%), Positives = 128/243 (52%), Gaps = 28/243 (11%)

Query: 27  ELRALLDLKASLDPENKLLQSWTENGDPCSGSFEGIACNEHRKVANISLQGKGLTGKLSP 86
           EL  LL  K+S++   K L +W  + D C   ++GI CN   +V +I L GK ++GK+S 
Sbjct: 30  ELELLLSFKSSINDPLKYLSNWNSSADVCL--WQGITCNNSSRVVSIDLSGKNISGKISS 87

Query: 87  SLSGLKCLSGLYLHYNSLSGEIPKEI--------------RNLT------ELTDLY-LDV 125
           ++  L  +  + L  N LSG IP +I               N T       + +L  LD+
Sbjct: 88  AIFRLPYIQTINLSNNQLSGPIPDDIFTTSSSLRYLNLSNNNFTGSIPRGSIPNLETLDL 147

Query: 126 NN--LSGNIPPEIGSMASLQVLQLCCNQLTGNIPAQIGSLKSLSVLTLQHNRLNGGIPDS 183
           +N  LSG IP +IGS +SL+VL L  N L G IP  + +L SL  LTL  N+L G IP  
Sbjct: 148 SNNMLSGEIPNDIGSFSSLKVLDLGGNVLVGKIPNSLTNLTSLEFLTLASNQLVGQIPRE 207

Query: 184 LGNLGKLKRLDLSFNSLFGTIPESLANNAELLFLDVQNNTLSGIVPSA---LKRLNGGFQ 240
           LG +  LK + L +N+L G IP  +     L  LD+  N L+G +PS+   LK L   F 
Sbjct: 208 LGQMKSLKWIYLGYNNLSGEIPYEIGGLTSLNHLDLVYNNLTGPIPSSLGNLKNLQYLFL 267

Query: 241 FQN 243
           +QN
Sbjct: 268 YQN 270

Length = 968

>gnl|CDD|219530 pfam07714, Pkinase_Tyr, Protein tyrosine kinase

 Score =  124 bits (315), Expect = 4e-32
 Identities = 75/271 (27%), Positives = 128/271 (47%), Gaps = 30/271 (11%)

Query: 417 LGKGNFSSVYKGTLRD-----GTLVAIRSINVTSCKSEEAEFVKGLYLLTSLRHENIIRL 471
           LG+G F  VYKGTL+       T VA++++   + + E  EF++   ++  L H NI+RL
Sbjct: 7   LGEGAFGEVYKGTLKGDGEGTETKVAVKTLKEGASEEEREEFLEEASIMKKLSHPNIVRL 66

Query: 472 RGFCCSRGRGECFLIYDFAPKGKLSKYLDQEEGSSNVLDWSTRVSIIIGIAKGIGYLHSS 531
            G C        +++ ++ P G L  +L +       L     + + + IAKG+ YL S 
Sbjct: 67  LGVC--TQGEPLYIVTEYMPGGDLLDFLRKHGEK---LTLKDLLQMALQIAKGMEYLES- 120

Query: 532 EVNKPAIVHRNLSVEKVLIDQQFNPLIADCGLHKLLADDIVFSVLKTSAAMGYL-----A 586
              K   VHR+L+    L+ +     I+D GL + + +D  +         G L     A
Sbjct: 121 ---KN-FVHRDLAARNCLVTENLVVKISDFGLSRDIYEDDYY----RKRGGGKLPIKWMA 172

Query: 587 PEYVTTGRFTERSDIFAFGVIILQILTGSLVLTSSMRLAAESAT-FENFIDRNLKGKFSE 645
           PE +  G+FT +SD+++FGV++ +I T              S       ++   +    E
Sbjct: 173 PESLKDGKFTSKSDVWSFGVLLWEIFTL-----GEQPYPGMSNEEVLELLEDGYRLPRPE 227

Query: 646 SEAAKLGKMALVCTHEDPENRPTMEAVIEEL 676
           +   +L ++ L C   DPE+RPT   ++E+L
Sbjct: 228 NCPDELYELMLQCWAYDPEDRPTFSELVEDL 258

Length = 258

>gnl|CDD|215690 pfam00069, Pkinase, Protein kinase domain

 Score =  120 bits (304), Expect = 1e-30
 Identities = 73/275 (26%), Positives = 122/275 (44%), Gaps = 30/275 (10%)

Query: 411 FSEVNLLGKGNFSSVYKGTLR-DGTLVAIRSINVTSCKSEEAEFVKG-LYLLTSLRHENI 468
           +  +  LG G+F +VYK   +  G +VA++ +   S KS++ +  +  + +L  L H NI
Sbjct: 1   YELLRKLGSGSFGTVYKAKHKGTGKIVAVKILKKRSEKSKKDQTARREIRILRRLSHPNI 60

Query: 469 IRLRGFCCSRGRGECFLIYDFAPKGKLSKYLDQEEGSSNVLDWSTRVSIIIGIAKGIGYL 528
           +RL      +     +L+ ++   G L  YL +       L       I + I +G+ YL
Sbjct: 61  VRLIDAFEDKDH--LYLVMEYCEGGDLFDYLSRG----GPLSEDEAKKIALQILRGLEYL 114

Query: 529 HSSEVNKPAIVHRNLSVEKVLIDQQFNPLIADCGLHKLLADDIVFSVLKTS--AAMGYLA 586
           HS+      I+HR+L  E +L+D+     IAD GL K L   +  S   T+      Y+A
Sbjct: 115 HSN-----GIIHRDLKPENILLDENGVVKIADFGLAKKL---LKSSSSLTTFVGTPWYMA 166

Query: 587 PEYVTTGR-FTERSDIFAFGVIILQILTGSLVLTSSMRLAAESATFENFIDRNLKGKFSE 645
           PE +  G  +  + D+++ GVI+ ++LTG    +    L          I R L      
Sbjct: 167 PEVLLGGNGYGPKVDVWSLGVILYELLTGKPPFSGENILDQLQ-----LIRRILGPPLEF 221

Query: 646 SEAAKLGKMALV------CTHEDPENRPTMEAVIE 674
            E                C ++DP  RPT E +++
Sbjct: 222 DEPKWSSGSEEAKDLIKKCLNKDPSKRPTAEEILQ 256

Length = 260

>gnl|CDD|215061 PLN00113, PLN00113, leucine-rich repeat receptor-like protein kinase; Provisional

 Score =  125 bits (315), Expect = 1e-29
 Identities = 66/153 (43%), Positives = 89/153 (58%)

Query: 80  LTGKLSPSLSGLKCLSGLYLHYNSLSGEIPKEIRNLTELTDLYLDVNNLSGNIPPEIGSM 139
           LTG +  SL  LK L  L+L+ N LSG IP  I +L +L  L L  N+LSG IP  +  +
Sbjct: 248 LTGPIPSSLGNLKNLQYLFLYQNKLSGPIPPSIFSLQKLISLDLSDNSLSGEIPELVIQL 307

Query: 140 ASLQVLQLCCNQLTGNIPAQIGSLKSLSVLTLQHNRLNGGIPDSLGNLGKLKRLDLSFNS 199
            +L++L L  N  TG IP  + SL  L VL L  N+ +G IP +LG    L  LDLS N+
Sbjct: 308 QNLEILHLFSNNFTGKIPVALTSLPRLQVLQLWSNKFSGEIPKNLGKHNNLTVLDLSTNN 367

Query: 200 LFGTIPESLANNAELLFLDVQNNTLSGIVPSAL 232
           L G IPE L ++  L  L + +N+L G +P +L
Sbjct: 368 LTGEIPEGLCSSGNLFKLILFSNSLEGEIPKSL 400

Length = 968

>gnl|CDD|215061 PLN00113, PLN00113, leucine-rich repeat receptor-like protein kinase; Provisional

 Score =  124 bits (313), Expect = 2e-29
 Identities = 74/163 (45%), Positives = 96/163 (58%)

Query: 73  ISLQGKGLTGKLSPSLSGLKCLSGLYLHYNSLSGEIPKEIRNLTELTDLYLDVNNLSGNI 132
           + L G  L GK+  SL+ L  L  L L  N L G+IP+E+  +  L  +YL  NNLSG I
Sbjct: 169 LDLGGNVLVGKIPNSLTNLTSLEFLTLASNQLVGQIPRELGQMKSLKWIYLGYNNLSGEI 228

Query: 133 PPEIGSMASLQVLQLCCNQLTGNIPAQIGSLKSLSVLTLQHNRLNGGIPDSLGNLGKLKR 192
           P EIG + SL  L L  N LTG IP+ +G+LK+L  L L  N+L+G IP S+ +L KL  
Sbjct: 229 PYEIGGLTSLNHLDLVYNNLTGPIPSSLGNLKNLQYLFLYQNKLSGPIPPSIFSLQKLIS 288

Query: 193 LDLSFNSLFGTIPESLANNAELLFLDVQNNTLSGIVPSALKRL 235
           LDLS NSL G IPE +     L  L + +N  +G +P AL  L
Sbjct: 289 LDLSDNSLSGEIPELVIQLQNLEILHLFSNNFTGKIPVALTSL 331

Length = 968

>gnl|CDD|173628 cd05038, PTKc_Jak_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases

 Score =  113 bits (285), Expect = 5e-28
 Identities = 60/208 (28%), Positives = 106/208 (50%), Gaps = 17/208 (8%)

Query: 414 VNLLGKGNFSSVYKGT---LRDGT--LVAIRSINVTSCKSEEAEFVKGLYLLTSLRHENI 468
           +  LG+G+F  V       L D T   VA++S+N +  +   ++F + + +L +L HENI
Sbjct: 9   IKQLGEGHFGKVELCRYDPLGDNTGEQVAVKSLNHSGEEQHRSDFEREIEILRTLDHENI 68

Query: 469 IRLRGFCCSRGRGECFLIYDFAPKGKLSKYLDQEEGSSNVLDWSTRVSIIIGIAKGIGYL 528
           ++ +G C   G     LI ++ P G L  YL   +   + ++    +     I KG+ YL
Sbjct: 69  VKYKGVCEKPGGRSLRLIMEYLPSGSLRDYL---QRHRDQINLKRLLLFSSQICKGMDYL 125

Query: 529 HSSEVNKPAIVHRNLSVEKVLIDQQFNPLIADCGLHKLLADDIVFSVLKT---SAAMGYL 585
            S        +HR+L+   +L++ +    I+D GL K+L +D  +  +K    S    Y 
Sbjct: 126 GSQRY-----IHRDLAARNILVESEDLVKISDFGLAKVLPEDKDYYYVKEPGESPIFWY- 179

Query: 586 APEYVTTGRFTERSDIFAFGVIILQILT 613
           APE + T +F+  SD+++FGV + ++ T
Sbjct: 180 APECLRTSKFSSASDVWSFGVTLYELFT 207

Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; catalytic (c) domain (repeat 2). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Most Jaks are expressed in a wide variety of tissues, except for Jak3, which is expressed only in hematopoietic cells. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jaks are also involved in regulating the surface expression of some cytokine receptors. The Jak-STAT pathway is involved in many biological processes including hematopoiesis, immunoregulation, host defense, fertility, lactation, growth, and embryogenesis. Length = 284

>gnl|CDD|215061 PLN00113, PLN00113, leucine-rich repeat receptor-like protein kinase; Provisional

 Score =  119 bits (299), Expect = 1e-27
 Identities = 67/156 (42%), Positives = 92/156 (58%)

Query: 80  LTGKLSPSLSGLKCLSGLYLHYNSLSGEIPKEIRNLTELTDLYLDVNNLSGNIPPEIGSM 139
           L+G + PS+  L+ L  L L  NSLSGEIP+ +  L  L  L+L  NN +G IP  + S+
Sbjct: 272 LSGPIPPSIFSLQKLISLDLSDNSLSGEIPELVIQLQNLEILHLFSNNFTGKIPVALTSL 331

Query: 140 ASLQVLQLCCNQLTGNIPAQIGSLKSLSVLTLQHNRLNGGIPDSLGNLGKLKRLDLSFNS 199
             LQVLQL  N+ +G IP  +G   +L+VL L  N L G IP+ L + G L +L L  NS
Sbjct: 332 PRLQVLQLWSNKFSGEIPKNLGKHNNLTVLDLSTNNLTGEIPEGLCSSGNLFKLILFSNS 391

Query: 200 LFGTIPESLANNAELLFLDVQNNTLSGIVPSALKRL 235
           L G IP+SL     L  + +Q+N+ SG +PS   +L
Sbjct: 392 LEGEIPKSLGACRSLRRVRLQDNSFSGELPSEFTKL 427

Length = 968

>gnl|CDD|214567 smart00220, S_TKc, Serine/Threonine protein kinases, catalytic domain

 Score =  112 bits (282), Expect = 1e-27
 Identities = 72/271 (26%), Positives = 116/271 (42%), Gaps = 28/271 (10%)

Query: 411 FSEVNLLGKGNFSSVYKGT-LRDGTLVAIRSINVTSCKSEEAEFVKGLYLLTSLRHENII 469
           +  +  LG+G+F  VY     + G LVAI+ I     K +    ++ + +L  L+H NI+
Sbjct: 1   YEILEKLGEGSFGKVYLARDKKTGKLVAIKVIKKKKIKKDRERILREIKILKKLKHPNIV 60

Query: 470 RLRGFCCSRGRGECFLIYDFAPKGKLSKYLDQEEGSSNVLDWSTRVSIIIGIAKGIGYLH 529
           RL          + +L+ ++   G L   L +       L        +  I   + YLH
Sbjct: 61  RLYDVFEDED--KLYLVMEYCEGGDLFDLLKKRGR----LSEDEARFYLRQILSALEYLH 114

Query: 530 SSEVNKPAIVHRNLSVEKVLIDQQFNPLIADCGLHKLLADDIVFSVLKTSAA-MGYLAPE 588
           S       IVHR+L  E +L+D+  +  +AD GL + L        L T      Y+APE
Sbjct: 115 S---KG--IVHRDLKPENILLDEDGHVKLADFGLARQLDPG---EKLTTFVGTPEYMAPE 166

Query: 589 YVTTGRFTERSDIFAFGVIILQILTGSLVLTSSMRLAAESATFENFIDRNLKGKFSE--- 645
            +    + +  DI++ GVI+ ++LTG        +L      F+            E   
Sbjct: 167 VLLGKGYGKAVDIWSLGVILYELLTGKPPFPGDDQL---LELFKKIGKPKPPFPPPEWDI 223

Query: 646 SEAAK--LGKMALVCTHEDPENRPTMEAVIE 674
           S  AK  + K+ LV   +DPE R T E  ++
Sbjct: 224 SPEAKDLIRKL-LV---KDPEKRLTAEEALQ 250

Phosphotransferases. Serine or threonine-specific kinase subfamily. Length = 254

>gnl|CDD|173629 cd05041, PTKc_Fes_like, Catalytic domain of Fes-like Protein Tyrosine Kinases

 Score =  109 bits (274), Expect = 9e-27
 Identities = 65/267 (24%), Positives = 122/267 (45%), Gaps = 23/267 (8%)

Query: 416 LLGKGNFSSVYKGTLRDGTLVAIRSINVTSCKSEEAEFVKGLYLLTSLRHENIIRLRGFC 475
            +GKGNF  VYKG L+  T VA+++   T     + +F++   +L    H NI++L G C
Sbjct: 2   KIGKGNFGDVYKGVLKGNTEVAVKTCRSTLPPDLKRKFLQEAEILKQYDHPNIVKLIGVC 61

Query: 476 CSRGRGECFLIYDFAPKGKLSKYLDQEEGSSNVLDWSTRVSIIIGIAKGIGYLHSSEVNK 535
               +   +++ +  P G L  +L       N L     + + +  A G+ YL S     
Sbjct: 62  VQ--KQPIYIVMELVPGGSLLTFL---RKKKNRLTVKKLLQMSLDAAAGMEYLESKNC-- 114

Query: 536 PAIVHRNLSVEKVLIDQQFNPLIADCGLHKLLADDIVFSVLKTSAAMG-----YLAPEYV 590
              +HR+L+    L+ +     I+D G+ +   +  +++V   S  +      + APE +
Sbjct: 115 ---IHRDLAARNCLVGENNVLKISDFGMSR-EEEGGIYTV---SDGLKQIPIKWTAPEAL 167

Query: 591 TTGRFTERSDIFAFGVIILQILTGSLVLTSSMRLAAESATFENFIDRNLKGKFSESEAAK 650
             GR+T  SD++++G+++ +  +        M   +   T E  I+   +    +    +
Sbjct: 168 NYGRYTSESDVWSYGILLWETFSLGDTPYPGM---SNQQTRE-RIESGYRMPAPQLCPEE 223

Query: 651 LGKMALVCTHEDPENRPTMEAVIEELT 677
           + ++ L C   DPENRP+   +  EL 
Sbjct: 224 IYRLMLQCWAYDPENRPSFSEIYNELQ 250

Protein Tyrosine Kinase (PTK) family; Fes subfamily; catalytic (c) domain. Fes subfamily members include Fes (or Fps), Fer, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr kinase activity. Fes and Fer kinases play roles in haematopoiesis, inflammation and immunity, growth factor signaling, cytoskeletal regulation, cell migration and adhesion, and the regulation of cell-cell interactions. Fes and Fer show redundancy in their biological functions. Length = 251

>gnl|CDD|215061 PLN00113, PLN00113, leucine-rich repeat receptor-like protein kinase; Provisional

 Score =  114 bits (288), Expect = 3e-26
 Identities = 67/164 (40%), Positives = 93/164 (56%)

Query: 73  ISLQGKGLTGKLSPSLSGLKCLSGLYLHYNSLSGEIPKEIRNLTELTDLYLDVNNLSGNI 132
           ++L    L G++   L  +K L  +YL YN+LSGEIP EI  LT L  L L  NNL+G I
Sbjct: 193 LTLASNQLVGQIPRELGQMKSLKWIYLGYNNLSGEIPYEIGGLTSLNHLDLVYNNLTGPI 252

Query: 133 PPEIGSMASLQVLQLCCNQLTGNIPAQIGSLKSLSVLTLQHNRLNGGIPDSLGNLGKLKR 192
           P  +G++ +LQ L L  N+L+G IP  I SL+ L  L L  N L+G IP+ +  L  L+ 
Sbjct: 253 PSSLGNLKNLQYLFLYQNKLSGPIPPSIFSLQKLISLDLSDNSLSGEIPELVIQLQNLEI 312

Query: 193 LDLSFNSLFGTIPESLANNAELLFLDVQNNTLSGIVPSALKRLN 236
           L L  N+  G IP +L +   L  L + +N  SG +P  L + N
Sbjct: 313 LHLFSNNFTGKIPVALTSLPRLQVLQLWSNKFSGEIPKNLGKHN 356

Length = 968

>gnl|CDD|173626 cd05034, PTKc_Src_like, Catalytic domain of Src kinase-like Protein Tyrosine Kinases

 Score =  106 bits (267), Expect = 1e-25
 Identities = 71/255 (27%), Positives = 121/255 (47%), Gaps = 17/255 (6%)

Query: 417 LGKGNFSSVYKGTLRDGTLVAIRSINVTSCKSEEAEFVKGLYLLTSLRHENIIRLRGFCC 476
           LG G F  V+ GT    T VA++++   +   E   F++   ++  LRH+ +++L   C 
Sbjct: 14  LGAGQFGEVWMGTWNGTTKVAVKTLKPGTMSPEA--FLQEAQIMKKLRHDKLVQLYAVC- 70

Query: 477 SRGRGE-CFLIYDFAPKGKLSKYLDQEEGSSNVLDWSTRVSIIIGIAKGIGYLHSSEVNK 535
                E  +++ ++  KG L  +L   EG    L     V +   IA+G+ YL S     
Sbjct: 71  --SEEEPIYIVTEYMSKGSLLDFLKSGEGKK--LRLPQLVDMAAQIAEGMAYLESRNY-- 124

Query: 536 PAIVHRNLSVEKVLIDQQFNPLIADCGLHKLLADDIVFSVLKTSAAMGYLAPEYVTTGRF 595
              +HR+L+   +L+ +     IAD GL +L+ DD   +       + + APE    GRF
Sbjct: 125 ---IHRDLAARNILVGENLVCKIADFGLARLIEDDEYTAREGAKFPIKWTAPEAANYGRF 181

Query: 596 TERSDIFAFGVIILQILTGSLVLTSSMRLAAESATFENFIDRNLKGKFSESEAAKLGKMA 655
           T +SD+++FG+++ +I+T   V    M         E  ++R  +     +   +L  + 
Sbjct: 182 TIKSDVWSFGILLTEIVTYGRVPYPGM---TNREVLEQ-VERGYRMPRPPNCPEELYDLM 237

Query: 656 LVCTHEDPENRPTME 670
           L C  +DPE RPT E
Sbjct: 238 LQCWDKDPEERPTFE 252

Protein Tyrosine Kinase (PTK) family; Src kinase subfamily; catalytic (c) domain. Src subfamily members include Src, Lck, Hck, Blk, Lyn, Fgr, Fyn, Yrk, and Yes. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) proteins are cytoplasmic (or non-receptor) tyr kinases which are anchored to the plasma membrane. They contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. They were identified as the first proto-oncogene products, and they regulate cell adhesion, invasion, and motility in cancer cells and tumor vasculature, contributing to cancer progression and metastasis. Src kinases are overexpressed in a variety of human cancers, making them attractive targets for therapy. They are also implicated in acute inflammatory responses and osteoclast function. Src, Fyn, Yes, and Yrk are widely expressed, while Blk, Lck, Hck, Fgr, and Lyn show a limited expression pattern. Length = 261

>gnl|CDD|215061 PLN00113, PLN00113, leucine-rich repeat receptor-like protein kinase; Provisional

 Score =  111 bits (279), Expect = 3e-25
 Identities = 67/156 (42%), Positives = 91/156 (58%)

Query: 80  LTGKLSPSLSGLKCLSGLYLHYNSLSGEIPKEIRNLTELTDLYLDVNNLSGNIPPEIGSM 139
           L+G++   +     L  L L  N L G+IP  + NLT L  L L  N L G IP E+G M
Sbjct: 152 LSGEIPNDIGSFSSLKVLDLGGNVLVGKIPNSLTNLTSLEFLTLASNQLVGQIPRELGQM 211

Query: 140 ASLQVLQLCCNQLTGNIPAQIGSLKSLSVLTLQHNRLNGGIPDSLGNLGKLKRLDLSFNS 199
            SL+ + L  N L+G IP +IG L SL+ L L +N L G IP SLGNL  L+ L L  N 
Sbjct: 212 KSLKWIYLGYNNLSGEIPYEIGGLTSLNHLDLVYNNLTGPIPSSLGNLKNLQYLFLYQNK 271

Query: 200 LFGTIPESLANNAELLFLDVQNNTLSGIVPSALKRL 235
           L G IP S+ +  +L+ LD+ +N+LSG +P  + +L
Sbjct: 272 LSGPIPPSIFSLQKLISLDLSDNSLSGEIPELVIQL 307

Length = 968

>gnl|CDD|133248 cd05148, PTKc_Srm_Brk, Catalytic domain of the Protein Tyrosine Kinases, Srm and Brk

 Score =  105 bits (263), Expect = 3e-25
 Identities = 70/268 (26%), Positives = 128/268 (47%), Gaps = 19/268 (7%)

Query: 411 FSEVNLLGKGNFSSVYKGTLRDGTLVAIRSINVTSCKSEEAEFVKGLYLLTSLRHENIIR 470
           F+    LG G F  V++G  ++   VAI+ +       ++ +F K +  L  LRH+++I 
Sbjct: 8   FTLERKLGSGYFGEVWEGLWKNRVRVAIKILKSDD-LLKQQDFQKEVQALKRLRHKHLIS 66

Query: 471 LRGFCCSRGRGECFLIYDFAPKGKLSKYLDQEEGSSNVLDWSTRVSIIIGIAKGIGYLHS 530
           L   C S G    ++I +   KG L  +L   EG   VL  ++ + +   +A+G+ YL  
Sbjct: 67  LFAVC-SVGE-PVYIITELMEKGSLLAFLRSPEG--QVLPVASLIDMACQVAEGMAYLEE 122

Query: 531 SEVNKPAIVHRNLSVEKVLIDQQFNPLIADCGLHKLLADDIVFSVLKTSAAMGYLAPEYV 590
                   +HR+L+   +L+ +     +AD GL +L+ +D V+          + APE  
Sbjct: 123 QN-----SIHRDLAARNILVGEDLVCKVADFGLARLIKED-VYLSSDKKIPYKWTAPEAA 176

Query: 591 TTGRFTERSDIFAFGVIILQILTGSLVLTSSMRLAAESATFENF--IDRNLKGKFSESEA 648
           + G F+ +SD+++FG+++ ++ T   V    M         E +  I    +        
Sbjct: 177 SHGTFSTKSDVWSFGILLYEMFTYGQVPYPGM------NNHEVYDQITAGYRMPCPAKCP 230

Query: 649 AKLGKMALVCTHEDPENRPTMEAVIEEL 676
            ++ K+ L C   +PE+RP+ +A+ EEL
Sbjct: 231 QEIYKIMLECWAAEPEDRPSFKALREEL 258

Protein Tyrosine Kinase (PTK) family; Src-related kinase lacking C-terminal regulatory tyrosine and N-terminal myristylation sites (Srm) and breast tumor kinase (Brk, also called protein tyrosine kinase 6); catalytic (c) domains. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Srm and Brk are a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases in general contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr; they are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Srm and Brk however, lack the N-terminal myristylation sites. Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Brk has been found to be overexpressed in a majority of breast tumors. Length = 261

>gnl|CDD|133212 cd05081, PTKc_Jak2_Jak3_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3

 Score =  104 bits (260), Expect = 1e-24
 Identities = 63/209 (30%), Positives = 109/209 (52%), Gaps = 16/209 (7%)

Query: 414 VNLLGKGNFSSVYK---GTLRDGT--LVAIRSINVTSCKSEEAEFVKGLYLLTSLRHENI 468
           +  LGKGNF SV       L+D T  +VA++ +  ++      +F + + +L SL+H+NI
Sbjct: 9   IQQLGKGNFGSVELCRYDPLQDNTGEVVAVKKLQHST-AEHLRDFEREIEILKSLQHDNI 67

Query: 469 IRLRGFCCSRGRGECFLIYDFAPKGKLSKYLDQEEGSSNVLDWSTRVSIIIGIAKGIGYL 528
           ++ +G C S GR    L+ ++ P G L  YL +       LD    +     I KG+ YL
Sbjct: 68  VKYKGVCYSAGRRNLRLVMEYLPYGSLRDYLQKHRER---LDHRKLLLYASQICKGMEYL 124

Query: 529 HSSEVNKPAIVHRNLSVEKVLIDQQFNPLIADCGLHKLLADDIVFSVLKT--SAAMGYLA 586
            S        VHR+L+   +L++ +    I D GL K+L  D  +  ++    + + + A
Sbjct: 125 GSKRY-----VHRDLATRNILVESENRVKIGDFGLTKVLPQDKEYYKVREPGESPIFWYA 179

Query: 587 PEYVTTGRFTERSDIFAFGVIILQILTGS 615
           PE +T  +F+  SD+++FGV++ ++ T S
Sbjct: 180 PESLTESKFSVASDVWSFGVVLYELFTYS 208

Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jak2 is widely expressed in many tissues while Jak3 is expressed only in hematopoietic cells. Jak2 is essential for the signaling of hormone-like cytokines such as growth hormone, erythropoietin, thrombopoietin, and prolactin, as well as some IFNs and cytokines that signal through the IL-3 and gp130 receptors. Jak3 binds the shared receptor subunit common gamma chain and thus, is essential in the signaling of cytokines that use it such as IL-2, IL-4, IL-7, IL-9, IL-15, and IL-21. Disruption of Jak2 in mice results in an embryonic lethal phenotype with multiple defects including erythropoietic and cardiac abnormalities. It is the only Jak gene that results in a lethal phenotype when disrupted in mice. A mutation in the pseudokinase domain of Jak2, V617F, is present in many myeloproliferative diseases, including almost all patients with polycythemia vera, and 50% of patients with essential thrombocytosis and myelofibrosis. Jak3 is important in lymphoid development and myeloid cell differentiation. Inactivating mutations in Jak3 have been reported in humans with severe combined immunodeficiency (SCID). Length = 284

>gnl|CDD|173724 cd06606, STKc_MAPKKK, Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-Activated Protein Kinase Kinase Kinase

 Score =  101 bits (255), Expect = 4e-24
 Identities = 57/210 (27%), Positives = 101/210 (48%), Gaps = 24/210 (11%)

Query: 414 VNLLGKGNFSSVYKGTLRD-GTLVAIRSINVTSCKSEEAEFVKG-LYLLTSLRHENIIRL 471
             LLG+G+F SVY    +D G L+A++S+ ++    EE E ++  + +L+SL+H NI+R 
Sbjct: 5   GELLGRGSFGSVYLALDKDTGELMAVKSVELSGDSEEELEALEREIRILSSLQHPNIVRY 64

Query: 472 RGFCCSRGRGECFLIYDFAPKGKLSKYLDQ----EEGSSNVLDWSTRVSIIIGIAKGIGY 527
            G      +    +  ++   G LS  L +     E    +  ++ +      I +G+ Y
Sbjct: 65  YGSERDEEKNTLNIFLEYVSGGSLSSLLKKFGKLPE--PVIRKYTRQ------ILEGLAY 116

Query: 528 LHSSEVNKPAIVHRNLSVEKVLIDQQFNPLIADCGLHKLLADDIVFSVLKTSAAMG---Y 584
           LHS   N   IVHR++    +L+D      +AD G  K L D        +    G   +
Sbjct: 117 LHS---NG--IVHRDIKGANILVDSDGVVKLADFGCAKRLGDIETGEGTGSVR--GTPYW 169

Query: 585 LAPEYVTTGRFTERSDIFAFGVIILQILTG 614
           +APE +    +   +DI++ G  ++++ TG
Sbjct: 170 MAPEVIRGEEYGRAADIWSLGCTVIEMATG 199

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKKKs (MKKKs or MAP3Ks) are also called MAP/ERK kinase kinases (MEKKs) in some cases. They phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. This subfamily is composed of the Apoptosis Signal-regulating Kinases ASK1 (or MAPKKK5) and ASK2 (or MAPKKK6), MEKK1, MEKK2, MEKK3, MEKK4, as well as plant and fungal MAPKKKs. Also included in this subfamily are the cell division control proteins Schizosaccharomyces pombe Cdc7 and Saccharomyces cerevisiae Cdc15. Length = 260

>gnl|CDD|215061 PLN00113, PLN00113, leucine-rich repeat receptor-like protein kinase; Provisional

 Score =  105 bits (264), Expect = 2e-23
 Identities = 63/160 (39%), Positives = 88/160 (55%)

Query: 73  ISLQGKGLTGKLSPSLSGLKCLSGLYLHYNSLSGEIPKEIRNLTELTDLYLDVNNLSGNI 132
           I L    L+G++   + GL  L+ L L YN+L+G IP  + NL  L  L+L  N LSG I
Sbjct: 217 IYLGYNNLSGEIPYEIGGLTSLNHLDLVYNNLTGPIPSSLGNLKNLQYLFLYQNKLSGPI 276

Query: 133 PPEIGSMASLQVLQLCCNQLTGNIPAQIGSLKSLSVLTLQHNRLNGGIPDSLGNLGKLKR 192
           PP I S+  L  L L  N L+G IP  +  L++L +L L  N   G IP +L +L +L+ 
Sbjct: 277 PPSIFSLQKLISLDLSDNSLSGEIPELVIQLQNLEILHLFSNNFTGKIPVALTSLPRLQV 336

Query: 193 LDLSFNSLFGTIPESLANNAELLFLDVQNNTLSGIVPSAL 232
           L L  N   G IP++L  +  L  LD+  N L+G +P  L
Sbjct: 337 LQLWSNKFSGEIPKNLGKHNNLTVLDLSTNNLTGEIPEGL 376

Length = 968

>gnl|CDD|173636 cd05057, PTKc_EGFR_like, Catalytic domain of Epidermal Growth Factor Receptor-like Protein Tyrosine Kinases

 Score = 99.8 bits (249), Expect = 3e-23
 Identities = 72/280 (25%), Positives = 120/280 (42%), Gaps = 35/280 (12%)

Query: 414 VNLLGKGNFSSVYKGTLR-DGTL----VAIRSINVTSCKSEEAEFVKGLYLLTSLRHENI 468
           + +LG G F +VYKG    +G      VAI+ +   +      E +   Y++ S+ H ++
Sbjct: 12  IKVLGSGAFGTVYKGVWIPEGEKVKIPVAIKVLREETSPKANKEILDEAYVMASVDHPHV 71

Query: 469 IRLRGFCCSRGRGECFLIYDFAPKGKLSKYLDQEE---GSSNVLDWSTRVSIIIGIAKGI 525
           +RL G C S    +  LI    P G L  Y+   +   GS  +L+W  +      IAKG+
Sbjct: 72  VRLLGICLSS---QVQLITQLMPLGCLLDYVRNHKDNIGSQYLLNWCVQ------IAKGM 122

Query: 526 GYLHSSEVNKPAIVHRNLSVEKVLIDQQFNPLIADCGLHKLLADDIVFSVLKTSAAM--- 582
            YL         +VHR+L+   VL+    +  I D GL KLL  D+              
Sbjct: 123 SYLEEKR-----LVHRDLAARNVLVKTPQHVKITDFGLAKLL--DVDEKEYHAEGGKVPI 175

Query: 583 GYLAPEYVTTGRFTERSDIFAFGVIILQILTGSLVLTSSMRLAAESATFENFIDRNLKGK 642
            ++A E +    +T +SD++++GV + +++T        +         E         +
Sbjct: 176 KWMALESILHRIYTHKSDVWSYGVTVWELMTFGAKPYEGIPAVEIPDLLEK------GER 229

Query: 643 FSESEAAKLG-KMALV-CTHEDPENRPTMEAVIEELTVAA 680
             +     +   M LV C   D E+RPT + +I E +  A
Sbjct: 230 LPQPPICTIDVYMVLVKCWMIDAESRPTFKELINEFSKMA 269

Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR) subfamily; catalytic (c) domain. EGFR (HER, ErbB) subfamily members include EGFR (HER1, ErbB1), HER2 (ErbB2), HER3 (ErbB3), HER4 (ErbB4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The EGFR proteins are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, resulting in the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. Collectively, they can recognize a variety of ligands including EGF, TGFalpha, and neuregulins, among others. All four subfamily members can form homo- or heterodimers. HER3 contains an impaired kinase domain and depends on its heterodimerization partner for activation. EGFR subfamily members are involved in signaling pathways leading to a broad range of cellular responses including cell proliferation, differentiation, migration, growth inhibition, and apoptosis. Gain of function alterations, through their overexpression, deletions, or point mutations in their kinase domains, have been implicated in various cancers. These receptors are targets of many small molecule inhibitors and monoclonal antibodies used in cancer therapy. Length = 279

>gnl|CDD|133204 cd05073, PTKc_Hck, Catalytic domain of the Protein Tyrosine Kinase, Hematopoietic cell kinase

 Score = 96.6 bits (240), Expect = 2e-22
 Identities = 62/267 (23%), Positives = 128/267 (47%), Gaps = 27/267 (10%)

Query: 417 LGKGNFSSVYKGTLRDGTLVAIRSINVTSCKSEEAEFVKGLYLLTSLRHENIIRLRGFCC 476
           LG G F  V+  T    T VA++++   S   E   F+    ++ +L+H+ +++L     
Sbjct: 14  LGAGQFGEVWMATYNKHTKVAVKTMKPGSMSVEA--FLAEANVMKTLQHDKLVKLHAVVT 71

Query: 477 SRGRGECFLIYDFAPKGKLSKYLDQEEGSS----NVLDWSTRVSIIIGIAKGIGYLHSSE 532
              +   ++I +F  KG L  +L  +EGS      ++D+S +      IA+G+ +     
Sbjct: 72  ---KEPIYIITEFMAKGSLLDFLKSDEGSKQPLPKLIDFSAQ------IAEGMAF----- 117

Query: 533 VNKPAIVHRNLSVEKVLIDQQFNPLIADCGLHKLLADDIVFSVLKTSAAMGYLAPEYVTT 592
           + +   +HR+L    +L+       IAD GL +++ D+   +       + + APE +  
Sbjct: 118 IEQRNYIHRDLRAANILVSASLVCKIADFGLARVIEDNEYTAREGAKFPIKWTAPEAINF 177

Query: 593 GRFTERSDIFAFGVIILQILTGSLVLTSSMRLAAESATFENFIDRNLKGKFSESEAAKLG 652
           G FT +SD+++FG+++++I+T   +    M     +      ++R  +    E+   +L 
Sbjct: 178 GSFTIKSDVWSFGILLMEIVTYGRIPYPGM----SNPEVIRALERGYRMPRPENCPEELY 233

Query: 653 KMALVCTHEDPENRPT---MEAVIEEL 676
            + + C    PE RPT   +++V+++ 
Sbjct: 234 NIMMRCWKNRPEERPTFEYIQSVLDDF 260

Protein Tyrosine Kinase (PTK) family; Hematopoietic cell kinase (Hck); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Hck is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Hck is present in myeloid and lymphoid cells that play a role in the development of cancer. It may be important in the oncogenic signaling of the protein Tel-Abl, which induces a chronic myelogenous leukemia (CML)-like disease. Hck also acts as a negative regulator of granulocyte colony-stimulating factor (G-CSF)-induced proliferation of granulocytic precursors, suggesting a possible role in the development of acute myeloid leukemia (AML). In addition, Hck is essential in regulating the degranulation of polymorphonuclear leukocytes (PMNs). Genetic polymorphisms affect the expression level of Hck, which affects PMN mediator release and influences the development of chronic obstructive pulmonary disease (COPD). Length = 260

>gnl|CDD|215061 PLN00113, PLN00113, leucine-rich repeat receptor-like protein kinase; Provisional

 Score =  101 bits (253), Expect = 5e-22
 Identities = 66/195 (33%), Positives = 97/195 (49%), Gaps = 9/195 (4%)

Query: 40  PENKLLQSWTENGDPCSGSFEGIACN--EHRKVANISLQGKGLTGKLSPSLSGLKCLSGL 97
           P  ++LQ W+      SG    I  N  +H  +  + L    LTG++   L     L  L
Sbjct: 332 PRLQVLQLWSNK---FSG---EIPKNLGKHNNLTVLDLSTNNLTGEIPEGLCSSGNLFKL 385

Query: 98  YLHYNSLSGEIPKEIRNLTELTDLYLDVNNLSGNIPPEIGSMASLQVLQLCCNQLTGNIP 157
            L  NSL GEIPK +     L  + L  N+ SG +P E   +  +  L +  N L G I 
Sbjct: 386 ILFSNSLEGEIPKSLGACRSLRRVRLQDNSFSGELPSEFTKLPLVYFLDISNNNLQGRIN 445

Query: 158 AQIGSLKSLSVLTLQHNRLNGGIPDSLGNLGKLKRLDLSFNSLFGTIPESLANNAELLFL 217
           ++   + SL +L+L  N+  GG+PDS G+  +L+ LDLS N   G +P  L + +EL+ L
Sbjct: 446 SRKWDMPSLQMLSLARNKFFGGLPDSFGS-KRLENLDLSRNQFSGAVPRKLGSLSELMQL 504

Query: 218 DVQNNTLSGIVPSAL 232
            +  N LSG +P  L
Sbjct: 505 KLSENKLSGEIPDEL 519

Length = 968

>gnl|CDD|133187 cd05056, PTKc_FAK, Catalytic domain of the Protein Tyrosine Kinase, Focal Adhesion Kinase

 Score = 95.2 bits (237), Expect = 1e-21
 Identities = 51/202 (25%), Positives = 94/202 (46%), Gaps = 17/202 (8%)

Query: 416 LLGKGNFSSVYKGTLRDGTLVAIRSINVTSCKSEEA-----EFVKGLYLLTSLRHENIIR 470
            +G+G F  VY+G         I ++ V +CK+  +     +F++  Y++    H +I++
Sbjct: 13  CIGEGQFGDVYQGVYMSPENEKI-AVAVKTCKNCTSPSVREKFLQEAYIMRQFDHPHIVK 71

Query: 471 LRGFCCSRGRGECFLIYDFAPKGKLSKYLDQEEGSSNVLDWSTRVSIIIGIAKGIGYLHS 530
           L G          +++ + AP G+L  YL         LD ++ +     ++  + YL S
Sbjct: 72  LIGVITEN---PVWIVMELAPLGELRSYLQVN---KYSLDLASLILYSYQLSTALAYLES 125

Query: 531 SEVNKPAIVHRNLSVEKVLIDQQFNPLIADCGLHKLLADDIVFSVLKTSAAMGYLAPEYV 590
                   VHR+++   VL+       + D GL + L D+  +   K    + ++APE +
Sbjct: 126 KR-----FVHRDIAARNVLVSSPDCVKLGDFGLSRYLEDESYYKASKGKLPIKWMAPESI 180

Query: 591 TTGRFTERSDIFAFGVIILQIL 612
              RFT  SD++ FGV + +IL
Sbjct: 181 NFRRFTSASDVWMFGVCMWEIL 202

Protein Tyrosine Kinase (PTK) family; Focal Adhesion Kinase (FAK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FAK is a cytoplasmic (or nonreceptor) tyr kinase that contains an autophosphorylation site and a FERM domain at the N-terminus, a central tyr kinase domain, proline-rich regions, and a C-terminal FAT (focal adhesion targeting) domain. FAK activity is dependent on integrin-mediated cell adhesion, which facilitates N-terminal autophosphorylation. Full activation is achieved by the phosphorylation of its two adjacent A-loop tyrosines. FAK is important in mediating signaling initiated at sites of cell adhesions and at growth factor receptors. Through diverse molecular interactions, FAK functions as a biosensor or integrator to control cell motility. It is a key regulator of cell survival, proliferation, migration and invasion, and thus plays an important role in the development and progression of cancer. Src binds to autophosphorylated FAK forming the FAK-Src dual kinase complex, which is activated in a wide variety of tumor cells and generates signals promoting growth and metastasis. FAK is being developed as a target for cancer therapy. Length = 270

>gnl|CDD|133199 cd05068, PTKc_Frk_like, Catalytic domain of Fyn-related kinase-like Protein Tyrosine Kinases

 Score = 94.8 bits (236), Expect = 1e-21
 Identities = 62/256 (24%), Positives = 120/256 (46%), Gaps = 17/256 (6%)

Query: 417 LGKGNFSSVYKGTLRDGTLVAIRSINVTSCKSEEAEFVKGLYLLTSLRHENIIRLRGFCC 476
           LG G F  V++G   + T VA++++   +   +  +F+    ++  LRH  +I+L   C 
Sbjct: 14  LGAGQFGEVWEGLWNNTTPVAVKTLKPGT--MDPKDFLAEAQIMKKLRHPKLIQLYAVCT 71

Query: 477 SRGRGE-CFLIYDFAPKGKLSKYLDQEEGSSNVLDWSTRVSIIIGIAKGIGYLHSSEVNK 535
                E  +++ +    G L +YL    G +  L     + +   +A G+ YL +     
Sbjct: 72  ---LEEPIYIVTELMKYGSLLEYLQGGAGRA--LKLPQLIDMAAQVASGMAYLEAQN--- 123

Query: 536 PAIVHRNLSVEKVLIDQQFNPLIADCGLHKLLADDIVFSVLKTSAAMGYLAPEYVTTGRF 595
              +HR+L+   VL+ +     +AD GL +++ +DI  +       + + APE     RF
Sbjct: 124 --YIHRDLAARNVLVGENNICKVADFGLARVIKEDIYEAREGAKFPIKWTAPEAALYNRF 181

Query: 596 TERSDIFAFGVIILQILTGSLVLTSSMRLAAESATFENFIDRNLKGKFSESEAAKLGKMA 655
           + +SD+++FG+++ +I+T   +    M     +A     +D+  +         +L  + 
Sbjct: 182 SIKSDVWSFGILLTEIVTYGRMPYPGM----TNAEVLQQVDQGYRMPCPPGCPKELYDIM 237

Query: 656 LVCTHEDPENRPTMEA 671
           L C  EDP++RPT E 
Sbjct: 238 LDCWKEDPDDRPTFET 253

Protein Tyrosine Kinase (PTK) family; Human Fyn-related kinase (Frk) and similar proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Frk and Srk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Frk, also known as Rak, is specifically expressed in liver, lung, kidney, intestine, mammary glands, and the islets of Langerhans. Rodent homologs were previously referred to as GTK (gastrointestinal tyr kinase), BSK (beta-cell Src-like kinase), or IYK (intestinal tyr kinase). Studies in mice reveal that Frk is not essential for viability. It plays a role in the signaling that leads to cytokine-induced beta-cell death in Type I diabetes. It also regulates beta-cell number during embryogenesis and early in life. Length = 261

>gnl|CDD|133216 cd05085, PTKc_Fer, Catalytic domain of the Protein Tyrosine Kinase, Fer

 Score = 93.1 bits (231), Expect = 3e-21
 Identities = 66/263 (25%), Positives = 123/263 (46%), Gaps = 14/263 (5%)

Query: 416 LLGKGNFSSVYKGTLRDGTLVAIRSINVTSCKSEEAEFVKGLYLLTSLRHENIIRLRGFC 475
           LLGKGNF  V+KGTL+D T VA+++      +  + +F+    +L    H NI++L G C
Sbjct: 2   LLGKGNFGEVFKGTLKDKTPVAVKTCKEDLPQELKIKFLSEARILKQYDHPNIVKLIGVC 61

Query: 476 CSRGRGECFLIYDFAPKGKLSKYLDQEEGSSNVLDWSTRVSIIIGIAKGIGYLHSSEVNK 535
               R   +++ +  P G    +L +++   + L     V   +  A G+ YL S     
Sbjct: 62  TQ--RQPIYIVMELVPGGDFLSFLRKKK---DELKTKQLVKFALDAAAGMAYLESKNC-- 114

Query: 536 PAIVHRNLSVEKVLIDQQFNPLIADCGLHKLLADDIVFSVLKTSAAMGYLAPEYVTTGRF 595
              +HR+L+    L+ +     I+D G+ +   D I  S       + + APE +  GR+
Sbjct: 115 ---IHRDLAARNCLVGENNVLKISDFGMSRQEDDGIYSSSGLKQIPIKWTAPEALNYGRY 171

Query: 596 TERSDIFAFGVIILQILTGSLVLTSSMRLAAESATFENFIDRNLKGKFSESEAAKLGKMA 655
           +  SD++++G+++ +  T SL +     +  + A  +  +++  +    +     + K+ 
Sbjct: 172 SSESDVWSYGILLWE--TFSLGVCPYPGMTNQQAREQ--VEKGYRMSCPQKCPDDVYKVM 227

Query: 656 LVCTHEDPENRPTMEAVIEELTV 678
             C    PENRP    + +EL  
Sbjct: 228 QRCWDYKPENRPKFSELQKELAA 250

Protein Tyrosine Kinase (PTK) family; Fer kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fer kinase is a member of the Fes subfamily of proteins which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. Fer kinase is expressed in a wide variety of tissues, and is found to reside in both the cytoplasm and the nucleus. It plays important roles in neuronal polarization and neurite development, cytoskeletal reorganization, cell migration, growth factor signaling, and the regulation of cell-cell interactions mediated by adherens junctions and focal adhesions. Fer kinase also regulates cell cycle progression in malignant cells. Length = 250

>gnl|CDD|178695 PLN03150, PLN03150, hypothetical protein; Provisional

 Score = 97.6 bits (243), Expect = 4e-21
 Identities = 74/238 (31%), Positives = 95/238 (39%), Gaps = 79/238 (33%)

Query: 27  ELRALLDLKASLDPENKLLQSWTENGDPCSGS---FEGIACNEHRKVANISLQGKGLTGK 83
           E+ AL  LK+SL    +    W  NGDPC      + G  C                   
Sbjct: 373 EVSALQTLKSSLGLPLRF--GW--NGDPCVPQQHPWSGADCQFDST-------------- 414

Query: 84  LSPSLSGLKCLSGLYLHYNSLSGEIPKEIRNLTELTDLYLDVNNLSGNIPPEIGSMASLQ 143
                 G   + GL L    L G IP +I  L  L  + L  N++ GNIPP +GS+ SL+
Sbjct: 415 -----KGKWFIDGLGLDNQGLRGFIPNDISKLRHLQSINLSGNSIRGNIPPSLGSITSLE 469

Query: 144 VLQLCCNQLTGNIPAQIGSLKSLSVLTLQHNRLNGGIPDSLGNLGKLKRLDLSFNSLFGT 203
           VL L                         +N  NG IP+SLG L  L+ L+L+ NS    
Sbjct: 470 VLDL------------------------SYNSFNGSIPESLGQLTSLRILNLNGNS---- 501

Query: 204 IPESLANNAELLFLDVQNNTLSGIVPSAL--KRLNGG-FQFQNNPGLCGDGIASLRAC 258
                               LSG VP+AL  + L+   F F +N GLC  GI  LRAC
Sbjct: 502 --------------------LSGRVPAALGGRLLHRASFNFTDNAGLC--GIPGLRAC 537

Length = 623

>gnl|CDD|173771 cd08529, STKc_FA2-like, Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii FA2 and similar domains

 Score = 92.6 bits (230), Expect = 5e-21
 Identities = 68/266 (25%), Positives = 127/266 (47%), Gaps = 31/266 (11%)

Query: 411 FSEVNLLGKGNFSSVYKGTLR-DGTLVAIRSINVTSC-KSEEAEFVKGLYLLTSLRHENI 468
           F  +N +GKG+F  V+K   + D  + A++ I+++   + E  E +    +L  L    I
Sbjct: 2   FEILNKIGKGSFGVVFKVVRKADKRVYAMKQIDLSKMNRREREEAIDEARVLAKLDSSYI 61

Query: 469 IRLRGFCCSRGRGECFLIYDFAPKGKLSKYLDQEEGS--SNVLDWSTRVSIIIGIAKGIG 526
           IR   +     +G+  ++ ++A  G L K L  + G        W   + I++G+A    
Sbjct: 62  IRY--YESFLDKGKLNIVMEYAENGDLHKLLKMQRGRPLPEDQVWRFFIQILLGLA---- 115

Query: 527 YLHSSEVNKPAIVHRNLSVEKVLIDQQFNPLIADCGLHKLLADDIVF--SVLKTSAAMGY 584
           +LHS +     I+HR++    + +D   N  I D G+ KLL+D+  F  +++ T     Y
Sbjct: 116 HLHSKK-----ILHRDIKSLNLFLDAYDNVKIGDLGVAKLLSDNTNFANTIVGTPY---Y 167

Query: 585 LAPEYVTTGRFTERSDIFAFGVIILQILTGSLVLTSSMRLAAESATFENFIDRNLKGKF- 643
           L+PE      + E+SD++A GV++ +  TG     ++ + A         I + ++G F 
Sbjct: 168 LSPELCEDKPYNEKSDVWALGVVLYECCTGKHPFDANNQGA--------LILKIIRGVFP 219

Query: 644 --SESEAAKLGKMALVCTHEDPENRP 667
             S+  + +L ++   C  +D   RP
Sbjct: 220 PVSQMYSQQLAQLIDQCLTKDYRQRP 245

Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii FA2-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii FA2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes FA2 and CNK4. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii FA2 was discovered in a genetic screen for deflagellation-defective mutants. It is essential for basal-body/centriole-associated microtubule severing, and plays a role in cell cycle progression. No cellular function has yet been ascribed to CNK4. Length = 256

>gnl|CDD|173637 cd05059, PTKc_Tec_like, Catalytic domain of Tec-like Protein Tyrosine Kinases

 Score = 91.7 bits (228), Expect = 1e-20
 Identities = 66/271 (24%), Positives = 121/271 (44%), Gaps = 36/271 (13%)

Query: 417 LGKGNFSSVYKGTLRDGTLVAIRSINVTSCKSEEAEFVKGLYLLTSLRHENIIRLRGFCC 476
           LG G F  V+ G  R    VAI+ I   +  SE+ +F++   ++  L H N+++L G C 
Sbjct: 12  LGSGQFGVVHLGKWRGKIDVAIKMIREGAM-SED-DFIEEAKVMMKLSHPNLVQLYGVCT 69

Query: 477 SRGRGECFLIYDFAPKGKLSKYLDQEEGSSNVLDWSTRVSIIIGIAKGIGYLHSSEVNKP 536
            +     F++ ++   G L  YL + +G    L     + +   + + + YL S+     
Sbjct: 70  KQR--PIFIVTEYMANGCLLNYLRERKG---KLGTEWLLDMCSDVCEAMEYLESNGF--- 121

Query: 537 AIVHRNLSVEKVLIDQQFNPLIADCGLHKLLADDIVFSVLKTSAAMGYLAPEYVTTGRFT 596
             +HR+L+    L+ +     ++D GL + + DD   S   T   + +  PE     RF+
Sbjct: 122 --IHRDLAARNCLVGEDNVVKVSDFGLARYVLDDQYTSSQGTKFPVKWAPPEVFDYSRFS 179

Query: 597 ERSDIFAFGVIILQILTGSLVLTSSMRLAAESATFENFIDRNLKGKFSESEAAKLGKMAL 656
            +SD+++FGV++ ++ +                 +E F   N +   S S   +L +  L
Sbjct: 180 SKSDVWSFGVLMWEVFSEG------------KMPYERF--SNSEVVESVSAGYRLYRPKL 225

Query: 657 V----------CTHEDPENRPTMEAVIEELT 677
                      C HE PE+RP  + ++ +LT
Sbjct: 226 APTEVYTIMYSCWHEKPEDRPAFKKLLSQLT 256

Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) subfamily; catalytic (c) domain. The Tec subfamily is composed of Tec, Btk, Bmx (Etk), Itk (Tsk, Emt), Rlk (Txk), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec kinases are cytoplasmic (or nonreceptor) tyr kinases (nRTKs) with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. In addition, some members contain the Tec homology (TH) domain, which contains proline-rich and zinc-binding regions. Tec kinases form the second largest subfamily of nRTKs and are expressed mainly by haematopoietic cells, although Tec and Bmx are also found in endothelial cells. B-cells express Btk and Tec, while T-cells express Itk, Txk, and Tec. Collectively, Tec kinases are expressed in a variety of myeloid cells such as mast cells, platelets, macrophages, and dendritic cells. Each Tec kinase shows a distinct cell-type pattern of expression. The function of Tec kinases in lymphoid cells have been studied extensively. They play important roles in the development, differentiation, maturation, regulation, survival, and function of B-cells and T-cells. Mutations in Btk cause the severe B-cell immunodeficiency, X-linked agammaglobulinaemia (XLA). Length = 256

>gnl|CDD|133200 cd05069, PTKc_Yes, Catalytic domain of the Protein Tyrosine Kinase, Yes

 Score = 91.7 bits (227), Expect = 1e-20
 Identities = 65/256 (25%), Positives = 118/256 (46%), Gaps = 16/256 (6%)

Query: 417 LGKGNFSSVYKGTLRDGTLVAIRSINVTSCKSEEAEFVKGLYLLTSLRHENIIRLRGFCC 476
           LG+G F  V+ GT    T VAI+++   +   E   F++   ++  LRH+ ++ L     
Sbjct: 14  LGQGCFGEVWMGTWNGTTKVAIKTLKPGTMMPEA--FLQEAQIMKKLRHDKLVPLYAVVS 71

Query: 477 SRGRGECFLIYDFAPKGKLSKYLDQEEGSSNVLDWSTRVSIIIGIAKGIGYLHSSEVNKP 536
                  +++ +F  KG L  +L  +EG    L     V +   IA G+ Y     + + 
Sbjct: 72  EE---PIYIVTEFMGKGSLLDFL--KEGDGKYLKLPQLVDMAAQIADGMAY-----IERM 121

Query: 537 AIVHRNLSVEKVLIDQQFNPLIADCGLHKLLADDIVFSVLKTSAAMGYLAPEYVTTGRFT 596
             +HR+L    +L+       IAD GL +L+ D+   +       + + APE    GRFT
Sbjct: 122 NYIHRDLRAANILVGDNLVCKIADFGLARLIEDNEYTARQGAKFPIKWTAPEAALYGRFT 181

Query: 597 ERSDIFAFGVIILQILTGSLVLTSSMRLAAESATFENFIDRNLKGKFSESEAAKLGKMAL 656
            +SD+++FG+++ +++T   V    M         E  ++R  +    +     L ++  
Sbjct: 182 IKSDVWSFGILLTELVTKGRVPYPGM---VNREVLEQ-VERGYRMPCPQGCPESLHELMK 237

Query: 657 VCTHEDPENRPTMEAV 672
           +C  +DP+ RPT E +
Sbjct: 238 LCWKKDPDERPTFEYI 253

Protein Tyrosine Kinase (PTK) family; Yes kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Yes (or c-Yes) is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. c-Yes kinase is the cellular homolog of the oncogenic protein (v-Yes) encoded by the Yamaguchi 73 and Esh sarcoma viruses. It displays functional overlap with other Src subfamily members, particularly Src. It also shows some unique functions such as binding to occludins, transmembrane proteins that regulate extracellular interactions in tight junctions. Yes also associates with a number of proteins in different cell types that Src does not interact with, like JAK2 and gp130 in pre-adipocytes, and Pyk2 in treated pulmonary vein endothelial cells. Although the biological function of Yes remains unclear, it appears to have a role in regulating cell-cell interactions and vesicle trafficking in polarized cells. Length = 260

>gnl|CDD|173641 cd05072, PTKc_Lyn, Catalytic domain of the Protein Tyrosine Kinase, Lyn

 Score = 90.5 bits (224), Expect = 3e-20
 Identities = 63/261 (24%), Positives = 124/261 (47%), Gaps = 23/261 (8%)

Query: 414 VNLLGKGNFSSVYKGTLRDGTLVAIRSINVTSCKSEEAEFVKGLYLLTSLRHENIIRLRG 473
           V  LG G F  V+ G   + T VA++++   +   +   F++   L+ +L+H+ ++RL  
Sbjct: 11  VKKLGAGQFGEVWMGYYNNSTKVAVKTLKPGTMSVQA--FLEEANLMKTLQHDKLVRL-- 66

Query: 474 FCCSRGRGECFLIYDFAPKGKLSKYLDQEEGSSNVL----DWSTRVSIIIGIAKGIGYLH 529
           +         ++I ++  KG L  +L  +EG   +L    D+S +      IA+G+ Y  
Sbjct: 67  YAVVTKEEPIYIITEYMAKGSLLDFLKSDEGGKVLLPKLIDFSAQ------IAEGMAY-- 118

Query: 530 SSEVNKPAIVHRNLSVEKVLIDQQFNPLIADCGLHKLLADDIVFSVLKTSAAMGYLAPEY 589
              + +   +HR+L    VL+ +     IAD GL +++ D+   +       + + APE 
Sbjct: 119 ---IERKNYIHRDLRAANVLVSESLMCKIADFGLARVIEDNEYTAREGAKFPIKWTAPEA 175

Query: 590 VTTGRFTERSDIFAFGVIILQILTGSLVLTSSMRLAAESATFENFIDRNLKGKFSESEAA 649
           +  G FT +SD+++FG+++ +I+T   +    M     ++   + + R  +    E+   
Sbjct: 176 INFGSFTIKSDVWSFGILLYEIVTYGKIPYPGM----SNSDVMSALQRGYRMPRMENCPD 231

Query: 650 KLGKMALVCTHEDPENRPTME 670
           +L  +   C  E  E RPT +
Sbjct: 232 ELYDIMKTCWKEKAEERPTFD 252

Protein Tyrosine Kinase (PTK) family; Lyn kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lyn is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Lyn is expressed in B lymphocytes and myeloid cells. It exhibits both positive and negative regulatory roles in B cell receptor (BCR) signaling. Lyn, as well as Fyn and Blk, promotes B cell activation by phosphorylating ITAMs (immunoreceptor tyr activation motifs) in CD19 and in Ig components of BCR. It negatively regulates signaling by its unique ability to phosphorylate ITIMs (immunoreceptor tyr inhibition motifs) in cell surface receptors like CD22 and CD5. Lyn also plays an important role in G-CSF receptor signaling by phosphorylating a variety of adaptor molecules. Length = 261

>gnl|CDD|133201 cd05070, PTKc_Fyn_Yrk, Catalytic domain of the Protein Tyrosine Kinases, Fyn and Yrk

 Score = 90.4 bits (224), Expect = 3e-20
 Identities = 64/254 (25%), Positives = 117/254 (46%), Gaps = 16/254 (6%)

Query: 417 LGKGNFSSVYKGTLRDGTLVAIRSINVTSCKSEEAEFVKGLYLLTSLRHENIIRLRGFCC 476
           LG G F  V+ GT    T VA++++   +   E   F++   ++  LRH+ +++L     
Sbjct: 14  LGNGQFGEVWMGTWNGNTKVAVKTLKPGTMSPES--FLEEAQIMKKLRHDKLVQLYAVVS 71

Query: 477 SRGRGECFLIYDFAPKGKLSKYLDQEEGSSNVLDWSTRVSIIIGIAKGIGYLHSSEVNKP 536
                  +++ ++  KG L  +L   EG +  L     V +   +A G+ Y     + + 
Sbjct: 72  EE---PIYIVTEYMSKGSLLDFLKDGEGRA--LKLPNLVDMAAQVAAGMAY-----IERM 121

Query: 537 AIVHRNLSVEKVLIDQQFNPLIADCGLHKLLADDIVFSVLKTSAAMGYLAPEYVTTGRFT 596
             +HR+L    +L+       IAD GL +L+ D+   +       + + APE    GRFT
Sbjct: 122 NYIHRDLRSANILVGDGLVCKIADFGLARLIEDNEYTARQGAKFPIKWTAPEAALYGRFT 181

Query: 597 ERSDIFAFGVIILQILTGSLVLTSSMRLAAESATFENFIDRNLKGKFSESEAAKLGKMAL 656
            +SD+++FG+++ +++T   V    M         E  ++R  +    +     L ++ L
Sbjct: 182 IKSDVWSFGILLTELVTKGRVPYPGMN---NREVLEQ-VERGYRMPCPQDCPISLHELML 237

Query: 657 VCTHEDPENRPTME 670
            C  +DPE RPT E
Sbjct: 238 QCWKKDPEERPTFE 251

Protein Tyrosine Kinase (PTK) family; Fyn and Yrk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fyn and Yrk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Fyn, together with Lck, plays a critical role in T-cell signal transduction by phosphorylating ITAM (immunoreceptor tyr activation motif) sequences on T-cell receptors, ultimately leading to the proliferation and differentiation of T-cells. In addition, Fyn is involved in the myelination of neurons, and is implicated in Alzheimer's and Parkinson's diseases. Yrk has been detected only in chickens. It is primarily found in neuronal and epithelial cells and in macrophages. It may play a role in inflammation and in response to injury. Length = 260

>gnl|CDD|173640 cd05067, PTKc_Lck_Blk, Catalytic domain of the Protein Tyrosine Kinases, Lymphocyte-specific kinase and Blk

 Score = 90.3 bits (224), Expect = 4e-20
 Identities = 64/257 (24%), Positives = 117/257 (45%), Gaps = 16/257 (6%)

Query: 414 VNLLGKGNFSSVYKGTLRDGTLVAIRSINVTSCKSEEAEFVKGLYLLTSLRHENIIRLRG 473
           V  LG G F  V+ G     T VAI+S+   S       F+    L+  L+H  ++RL  
Sbjct: 11  VKKLGAGQFGEVWMGYYNGHTKVAIKSLKQGSM--SPEAFLAEANLMKQLQHPRLVRLYA 68

Query: 474 FCCSRGRGECFLIYDFAPKGKLSKYLDQEEGSSNVLDWSTRVSIIIGIAKGIGYLHSSEV 533
                 +   ++I ++   G L  +L   EG    L  +  + +   IA+G+ ++     
Sbjct: 69  VVT---QEPIYIITEYMENGSLVDFLKTPEGIK--LTINKLIDMAAQIAEGMAFIERKNY 123

Query: 534 NKPAIVHRNLSVEKVLIDQQFNPLIADCGLHKLLADDIVFSVLKTSAAMGYLAPEYVTTG 593
                +HR+L    +L+ +     IAD GL +L+ D+   +       + + APE +  G
Sbjct: 124 -----IHRDLRAANILVSETLCCKIADFGLARLIEDNEYTAREGAKFPIKWTAPEAINYG 178

Query: 594 RFTERSDIFAFGVIILQILTGSLVLTSSMRLAAESATFENFIDRNLKGKFSESEAAKLGK 653
            FT +SD+++FG+++ +I+T   +    M         +N ++R  +    ++   +L +
Sbjct: 179 TFTIKSDVWSFGILLTEIVTYGRIPYPGMT---NPEVIQN-LERGYRMPRPDNCPEELYE 234

Query: 654 MALVCTHEDPENRPTME 670
           +  +C  E PE RPT E
Sbjct: 235 LMRLCWKEKPEERPTFE 251

Protein Tyrosine Kinase (PTK) family; Lck and Blk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lck (lymphocyte-specific kinase) and Blk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Lck is expressed in T-cells and natural killer (NK) cells. It plays a critical role in T-cell maturation, activation, and T-cell receptor (TCR) signaling. Lck phosphorylates ITAM (immunoreceptor tyr activation motif) sequences on several subunits of TCRs, leading to the activation of different second messenger cascades. Phosphorylated ITAMs serve as binding sites for other signaling factor such as Syk and ZAP-70, leading to their activation and propagation of downstream events. In addition, Lck regulates drug-induced apoptosis by interfering with the mitochondrial death pathway. The apototic role of Lck is independent of its primary function in T-cell signaling. Blk is expressed specifically in B-cells. It is involved in pre-BCR (B-cell receptor) signaling. Length = 260

>gnl|CDD|133202 cd05071, PTKc_Src, Catalytic domain of the Protein Tyrosine Kinase, Src

 Score = 90.5 bits (224), Expect = 4e-20
 Identities = 65/254 (25%), Positives = 115/254 (45%), Gaps = 16/254 (6%)

Query: 417 LGKGNFSSVYKGTLRDGTLVAIRSINVTSCKSEEAEFVKGLYLLTSLRHENIIRLRGFCC 476
           LG+G F  V+ GT    T VAI+++   +   E   F++   ++  LRHE +++L     
Sbjct: 14  LGQGCFGEVWMGTWNGTTRVAIKTLKPGTMSPEA--FLQEAQVMKKLRHEKLVQLYAVVS 71

Query: 477 SRGRGECFLIYDFAPKGKLSKYLDQEEGSSNVLDWSTRVSIIIGIAKGIGYLHSSEVNKP 536
                  +++ ++  KG L  +L  E G    L     V +   IA G+ Y     V + 
Sbjct: 72  EE---PIYIVTEYMSKGSLLDFLKGEMGK--YLRLPQLVDMAAQIASGMAY-----VERM 121

Query: 537 AIVHRNLSVEKVLIDQQFNPLIADCGLHKLLADDIVFSVLKTSAAMGYLAPEYVTTGRFT 596
             VHR+L    +L+ +     +AD GL +L+ D+   +       + + APE    GRFT
Sbjct: 122 NYVHRDLRAANILVGENLVCKVADFGLARLIEDNEYTARQGAKFPIKWTAPEAALYGRFT 181

Query: 597 ERSDIFAFGVIILQILTGSLVLTSSMRLAAESATFENFIDRNLKGKFSESEAAKLGKMAL 656
            +SD+++FG+++ ++ T   V    M     +    + ++R  +          L  +  
Sbjct: 182 IKSDVWSFGILLTELTTKGRVPYPGM----VNREVLDQVERGYRMPCPPECPESLHDLMC 237

Query: 657 VCTHEDPENRPTME 670
            C  ++PE RPT E
Sbjct: 238 QCWRKEPEERPTFE 251

Protein Tyrosine Kinase (PTK) family; Src kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) is a cytoplasmic (or non-receptor) tyr kinase, containing an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region with a conserved tyr. It is activated by autophosphorylation at the tyr kinase domain, and is negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). c-Src is the vertebrate homolog of the oncogenic protein (v-Src) from Rous sarcoma virus. Together with other Src subfamily proteins, it is involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Src also play a role in regulating cell adhesion, invasion, and motility in cancer cells and tumor vasculature, contributing to cancer progression and metastasis. Elevated levels of Src kinase activity have been reported in a variety of human cancers. Several inhibitors of Src have been developed as anti-cancer drugs. Src is also implicated in acute inflammatory responses and osteoclast function. Length = 262

>gnl|CDD|133194 cd05063, PTKc_EphR_A2, Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A2

 Score = 90.0 bits (223), Expect = 5e-20
 Identities = 54/210 (25%), Positives = 104/210 (49%), Gaps = 16/210 (7%)

Query: 410 CFSEVNLLGKGNFSSVYKGTL----RDGTLVAIRSINVTSCKSEEAEFVKGLYLLTSLRH 465
             ++  ++G G F  V++G L    R    VAI+++     + +  +F+    ++    H
Sbjct: 6   HITKQKVIGAGEFGEVFRGILKMPGRKEVAVAIKTLKPGYTEKQRQDFLSEASIMGQFSH 65

Query: 466 ENIIRLRGFCCSRGRGECFLIYDFAPKGKLSKYLDQEEGSSNVLDWSTRVSIIIGIAKGI 525
            NIIRL G           +I ++   G L KYL   +G  +       V ++ GIA G+
Sbjct: 66  HNIIRLEGVVTKFK--PAMIITEYMENGALDKYLRDHDGEFSSYQL---VGMLRGIAAGM 120

Query: 526 GYLHSSEVNKPAIVHRNLSVEKVLIDQQFNPLIADCGLHKLLADD--IVFSVLKTSAAMG 583
            YL  S++N    VHR+L+   +L++      ++D GL ++L DD    ++       + 
Sbjct: 121 KYL--SDMN---YVHRDLAARNILVNSNLECKVSDFGLSRVLEDDPEGTYTTSGGKIPIR 175

Query: 584 YLAPEYVTTGRFTERSDIFAFGVIILQILT 613
           + APE +   +FT  SD+++FG+++ ++++
Sbjct: 176 WTAPEAIAYRKFTSASDVWSFGIVMWEVMS 205

Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA2 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). Ephrin/EphR interaction mainly results in cell-cell repulsion or adhesion, making it important in neural development and plasticity, cell morphogenesis, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. The EphA2 receptor is overexpressed in tumor cells and tumor blood vessels in a variety of cancers including breast, prostate, lung, and colon. As a result, it is an attractive target for drug design since its inhibition could affect several aspects of tumor progression. Length = 268

>gnl|CDD|173644 cd05079, PTKc_Jak1_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Janus kinase 1

 Score = 90.4 bits (224), Expect = 6e-20
 Identities = 61/205 (29%), Positives = 105/205 (51%), Gaps = 17/205 (8%)

Query: 417 LGKGNFSSVY------KGTLRDGTLVAIRSINVTSCKSEEAEFVKGLYLLTSLRHENIIR 470
           LG+G+F  V       +G    G  VA++S+   S  +  A+  K + +L +L HENI++
Sbjct: 12  LGEGHFGKVELCRYDPEGD-NTGEQVAVKSLKPESGGNHIADLKKEIEILRNLYHENIVK 70

Query: 471 LRGFCCSRGRGECFLIYDFAPKGKLSKYLDQEEGSSNVLDWSTRVSIIIGIAKGIGYLHS 530
            +G C   G     LI +F P G L +YL +   + N ++   ++   + I KG+ YL S
Sbjct: 71  YKGICTEDGGNGIKLIMEFLPSGSLKEYLPR---NKNKINLKQQLKYAVQICKGMDYLGS 127

Query: 531 SEVNKPAIVHRNLSVEKVLIDQQFNPLIADCGLHKLLADDIVFSVLKT--SAAMGYLAPE 588
            +      VHR+L+   VL++ +    I D GL K +  D  +  +K    + + + APE
Sbjct: 128 RQY-----VHRDLAARNVLVESEHQVKIGDFGLTKAIETDKEYYTVKDDLDSPVFWYAPE 182

Query: 589 YVTTGRFTERSDIFAFGVIILQILT 613
            +   +F   SD+++FGV + ++LT
Sbjct: 183 CLIQSKFYIASDVWSFGVTLYELLT 207

Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jak1 is widely expressed in many tissues. Many cytokines are dependent on Jak1 for signaling, including those that use the shared receptor subunits common gamma chain (IL-2, IL-4, IL-7, IL-9, IL-15, IL-21) and gp130 (IL-6, IL-11, oncostatin M, G-CSF, and IFNs, among others). The many varied interactions of Jak1 and its ubiquitous expression suggest many biological roles. Jak1 is important in neurological development, as well as in lymphoid development and function. It also plays a role in the pathophysiology of cardiac hypertrophy and heart failure. A mutation in the ATP-binding site of Jak1 was identified in a human uterine leiomyosarcoma cell line, resulting in defective cytokine induction and antigen presentation, thus allowing the tumor to evade the immune system. Length = 284

>gnl|CDD|215061 PLN00113, PLN00113, leucine-rich repeat receptor-like protein kinase; Provisional

 Score = 94.1 bits (234), Expect = 8e-20
 Identities = 63/180 (35%), Positives = 87/180 (48%), Gaps = 24/180 (13%)

Query: 86  PSLSGLKCLSGLYLHYNSLSGEIPKEIRNLTELTDLYLDVNNLSGNIPPEIGSMASLQVL 145
           P   G K L  L L  N  SG +P+++ +L+EL  L L  N LSG IP E+ S   L  L
Sbjct: 469 PDSFGSKRLENLDLSRNQFSGAVPRKLGSLSELMQLKLSENKLSGEIPDELSSCKKLVSL 528

Query: 146 QLCCNQLTGNIPAQIGSLKSLSVLTLQHNRLNGGIPDSLGNLGKLKRLDLSFNSLFGTIP 205
            L  NQL+G IPA    +  LS L L  N+L+G IP +LGN+  L ++++S N L G++P
Sbjct: 529 DLSHNQLSGQIPASFSEMPVLSQLDLSQNQLSGEIPKNLGNVESLVQVNISHNHLHGSLP 588

Query: 206 ESLANNAELLFLDVQNNTLSGIVPSALKRLNGGFQFQNNPGLCGDGIAS-LRACTVYDNT 264
            + A      FL +  + ++G                 N  LCG    S L  C     T
Sbjct: 589 STGA------FLAINASAVAG-----------------NIDLCGGDTTSGLPPCKRVRKT 625

Length = 968

>gnl|CDD|133178 cd05046, PTK_CCK4, Pseudokinase domain of the Protein Tyrosine Kinase, Colon Carcinoma Kinase 4

 Score = 89.8 bits (223), Expect = 8e-20
 Identities = 64/280 (22%), Positives = 128/280 (45%), Gaps = 29/280 (10%)

Query: 412 SEVNLLGKGNFSSVYKGTLR------DGTLVAIRSINVTSCKSEEAEFVKGLYLLTSLRH 465
            E+  LG+G F  V+    +        TLV ++++  T  ++ ++EF + L +   L H
Sbjct: 8   QEITTLGRGEFGEVFLAKAKGIEEEGGETLVLVKALQKTKDENLQSEFRRELDMFRKLSH 67

Query: 466 ENIIRLRGFCCSRGRGECFLIYDFAPKGKLSKYL-----DQEEGSSNVLDWSTRVSIIIG 520
           +N++RL G C  R     ++I ++   G L ++L       E+     L    +V++   
Sbjct: 68  KNVVRLLGLC--REAEPHYMILEYTDLGDLKQFLRATKSKDEKLKPPPLSTKQKVALCTQ 125

Query: 521 IAKGIGYLHSSEVNKPAIVHRNLSVEKVLIDQQFNPLIADCGLHKLLADDIVFSVLKTSA 580
           IA G+ +L ++       VHR+L+    L+  Q    ++   L K + +   + +     
Sbjct: 126 IALGMDHLSNAR-----FVHRDLAARNCLVSSQREVKVSLLSLSKDVYNSEYYKLRNALI 180

Query: 581 AMGYLAPEYVTTGRFTERSDIFAFGVIILQILTGSLVLTSSMRLAAESATFENFIDR--- 637
            + +LAPE V    F+ +SD+++FGV++ ++ T          L     + E  ++R   
Sbjct: 181 PLRWLAPEAVQEDDFSTKSDVWSFGVLMWEVFT-------QGELPFYGLSDEEVLNRLQA 233

Query: 638 -NLKGKFSESEAAKLGKMALVCTHEDPENRPTMEAVIEEL 676
             L+    E   ++L K+   C   +P++RP+   ++  L
Sbjct: 234 GKLELPVPEGCPSRLYKLMTRCWAVNPKDRPSFSELVSAL 273

Protein Tyrosine Kinase (PTK) family; Colon Carcinoma Kinase 4 (CCK4); pseudokinase domain. The PTKc (catalytic domain) family, to which this subfamily belongs, includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CCK4, also called protein tyrosine kinase 7 (PTK7), is an orphan receptor tyr kinase (RTK) containing an extracellular region with seven immunoglobulin domains, a transmembrane segment, and an intracellular inactive pseudokinase domain. Studies in mice reveal that CCK4 is essential for neural development. Mouse embryos containing a truncated CCK4 die perinatally and display craniorachischisis, a severe form of neural tube defect. The mechanism of action of the CCK4 pseudokinase is still unknown. Other pseudokinases such as HER3 rely on the activity of partner RTKs. Length = 275

>gnl|CDD|133179 cd05048, PTKc_Ror, Catalytic Domain of the Protein Tyrosine Kinases, Receptor tyrosine kinase-like Orphan Receptors

 Score = 89.8 bits (223), Expect = 9e-20
 Identities = 63/214 (29%), Positives = 104/214 (48%), Gaps = 26/214 (12%)

Query: 417 LGKGNFSSVYKGTL------RDGTLVAIRSINVTSCKSEEAEFVKGLYLLTSLRHENIIR 470
           LG+G F  VYKG L         T VAI+++   +    + EF +   L++ L+H NI+ 
Sbjct: 13  LGEGAFGKVYKGELTGPNERLSATSVAIKTLKENAEPKVQQEFRQEAELMSDLQHPNIVC 72

Query: 471 LRGFCCSRGRGECFLIYDFAPKGKLSKYL------------DQEEGSSNVLDWSTRVSII 518
           L G C ++ +  C L +++   G L ++L              +E   + LD S  + I 
Sbjct: 73  LLGVC-TKEQPTCML-FEYLAHGDLHEFLVRNSPHSDVGAESGDETVKSSLDCSDFLHIA 130

Query: 519 IGIAKGIGYLHSSEVNKPAIVHRNLSVEKVLIDQQFNPLIADCGLHKLLADDIVFSVLKT 578
           I IA G+ YL S        VHR+L+    L+ +     I+D GL + +     + V   
Sbjct: 131 IQIAAGMEYLSSHH-----FVHRDLAARNCLVGEGLTVKISDFGLSRDIYSADYYRVQSK 185

Query: 579 SA-AMGYLAPEYVTTGRFTERSDIFAFGVIILQI 611
           S   + ++ PE +  G+FT  SDI++FGV++ +I
Sbjct: 186 SLLPVRWMPPEAILYGKFTTESDIWSFGVVLWEI 219

Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor (Ror) subfamily; catalytic (c) domain. The Ror subfamily consists of Ror1, Ror2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. Ror kinases are expressed in many tissues during development. They play important roles in bone and heart formation. Mutations in human Ror2 result in two different bone development genetic disorders, recessive Robinow syndrome and brachydactyly type B. Drosophila Ror is expressed only in the developing nervous system during neurite outgrowth and neuronal differentiation, suggesting a role for Drosophila Ror in neural development. More recently, mouse Ror1 and Ror2 have also been found to play an important role in regulating neurite growth in central neurons. Ror1 and Ror2 are believed to have some overlapping and redundant functions. Length = 283

>gnl|CDD|173625 cd05032, PTKc_InsR_like, Catalytic domain of Insulin Receptor-like Protein Tyrosine Kinases

 Score = 89.3 bits (222), Expect = 1e-19
 Identities = 69/277 (24%), Positives = 121/277 (43%), Gaps = 32/277 (11%)

Query: 417 LGKGNFSSVYKGTLRD------GTLVAIRSINVTSCKSEEAEFVKGLYLLTSLRHENIIR 470
           LG+G+F  VY+G  +        T VAI+++N  +   E  EF+    ++      +++R
Sbjct: 14  LGQGSFGMVYEGLAKGVVKGEPETRVAIKTVNENASMRERIEFLNEASVMKEFNCHHVVR 73

Query: 471 LRGFCCSRGRGECFLIYDFAPKGKLSKYLDQ---EEGSSNVLDWSTRVSII---IGIAKG 524
           L G   S G+    ++ +   KG L  YL     E  ++  L   T    I     IA G
Sbjct: 74  LLGVV-STGQ-PTLVVMELMAKGDLKSYLRSRRPEAENNPGLGPPTLQKFIQMAAEIADG 131

Query: 525 IGYLHSSEVNKPAIVHRNLSVEKVLIDQQFNPLIADCGLHKLLADDIVFS--VLKTSAAM 582
           + YL + +      VHR+L+    ++ +     I D G+      DI  +    K    +
Sbjct: 132 MAYLAAKK-----FVHRDLAARNCMVAEDLTVKIGDFGM----TRDIYETDYYRKGGKGL 182

Query: 583 ---GYLAPEYVTTGRFTERSDIFAFGVIILQILTGSLVLTSSMRLAAESATFENFIDRNL 639
               ++APE +  G FT +SD+++FGV++ ++ T  L       L+ E      F+    
Sbjct: 183 LPVRWMAPESLKDGVFTTKSDVWSFGVVLWEMAT--LAEQPYQGLSNEEVL--KFVIDGG 238

Query: 640 KGKFSESEAAKLGKMALVCTHEDPENRPTMEAVIEEL 676
                E+   KL ++  +C   +P+ RPT   ++  L
Sbjct: 239 HLDLPENCPDKLLELMRMCWQYNPKMRPTFLEIVSSL 275

Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The InsR subfamily is composed of InsR, Insulin-like Growth Factor-1 Receptor (IGF-1R), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR and IGF-1R are receptor tyr kinases (RTKs) composed of two alphabeta heterodimers. Binding of the ligand (insulin, IGF-1, or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological function. InsR and IGF-1R, which share 84% sequence identity in their kinase domains, display physiologically distinct yet overlapping functions in cell growth, differentiation, and metabolism. InsR activation leads primarily to metabolic effects while IGF-1R activation stimulates mitogenic pathways. In cells expressing both receptors, InsR/IGF-1R hybrids are found together with classical receptors. Both receptors can interact with common adaptor molecules such as IRS-1 and IRS-2. Length = 277

>gnl|CDD|133243 cd05112, PTKc_Itk, Catalytic domain of the Protein Tyrosine Kinase, Interleukin-2-inducible T-cell Kinase

 Score = 88.5 bits (219), Expect = 1e-19
 Identities = 66/275 (24%), Positives = 129/275 (46%), Gaps = 31/275 (11%)

Query: 412 SEVNL---LGKGNFSSVYKGTLRDGTLVAIRSINVTSCKSEEAEFVKGLYLLTSLRHENI 468
           SE+ L   +G G F  V+ G   +   VAI++I      SEE +F++   ++  L H  +
Sbjct: 4   SELTLVQEIGSGQFGLVWLGYWLEKRKVAIKTIR-EGAMSEE-DFIEEAQVMMKLSHPKL 61

Query: 469 IRLRGFCCSRGRGECFLIYDFAPKGKLSKYLDQEEGSSNVLDWSTRVSIIIGIAKGIGYL 528
           ++L G C  R      L+++F   G LS YL  + G        T + + + + +G+ YL
Sbjct: 62  VQLYGVCTERS--PICLVFEFMEHGCLSDYLRAQRGK---FSQETLLGMCLDVCEGMAYL 116

Query: 529 HSSEVNKPAIVHRNLSVEKVLIDQQFNPLIADCGLHKLLADDIVFSVLKTSAAMGYLAPE 588
            SS V     +HR+L+    L+ +     ++D G+ + + DD   S   T   + + +PE
Sbjct: 117 ESSNV-----IHRDLAARNCLVGENQVVKVSDFGMTRFVLDDQYTSSTGTKFPVKWSSPE 171

Query: 589 YVTTGRFTERSDIFAFGVIILQILTGSLVLTSSMRLAAESATFENFID------RNLKGK 642
             +  +++ +SD+++FGV++ ++        S  +   E+ +    ++      R  K +
Sbjct: 172 VFSFSKYSSKSDVWSFGVLMWEVF-------SEGKTPYENRSNSEVVETINAGFRLYKPR 224

Query: 643 FSESEAAKLGKMALVCTHEDPENRPTMEAVIEELT 677
            +     +L +    C  E PE+RP+   ++ +L 
Sbjct: 225 LASQSVYELMQH---CWKERPEDRPSFSLLLHQLA 256

Protein Tyrosine Kinase (PTK) family; Interleukin-2 (IL-2)-inducible T-cell kinase (Itk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Itk (also known as Tsk or Emt) is a member of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. In addition, Itk contains the Tec homology (TH) domain containing one proline-rich region and a zinc-binding region. Tec kinases are expressed mainly by haematopoietic cells. Itk is expressed in T-cells and mast cells, and is important in their development and differentiation. Of the three Tec kinases expressed in T-cells, Itk plays the predominant role in T-cell receptor (TCR) signaling. It is activated by phosphorylation upon TCR crosslinking and is involved in the pathway resulting in phospholipase C-gamma1 activation and actin polymerization. It also plays a role in the downstream signaling of the T-cell costimulatory receptor CD28, the T-cell surface receptor CD2, and the chemokine receptor CXCR4. In addition, Itk is crucial for the development of T-helper(Th)2 effector responses. Length = 256

>gnl|CDD|173656 cd05111, PTK_HER3, Pseudokinase domain of the Protein Tyrosine Kinase, HER3

 Score = 88.1 bits (218), Expect = 3e-19
 Identities = 77/287 (26%), Positives = 128/287 (44%), Gaps = 37/287 (12%)

Query: 408 TQCFSEVNLLGKGNFSSVYKGT-LRDGTL----VAIRSINVTSCKSEEAEFVKGLYLLTS 462
                ++ LLG G F +V+KG  + +G      VAI++I   S +    E    +  + S
Sbjct: 6   ETELRKLKLLGSGVFGTVHKGIWIPEGDSIKIPVAIKTIQDRSGRQTFQEITDHMLAMGS 65

Query: 463 LRHENIIRLRGFCCSRGRGECFLIYDFAPKGKLSKYLDQEEGSSN---VLDWSTRVSIII 519
           L H  I+RL G C         L+   +P G L  ++ Q   S +   +L+W  +     
Sbjct: 66  LDHAYIVRLLGICPG---ASLQLVTQLSPLGSLLDHVRQHRDSLDPQRLLNWCVQ----- 117

Query: 520 GIAKGIGYLHSSEVNKPAIVHRNLSVEKVLIDQQFNPLIADCGLHKLLADD---IVFSVL 576
            IAKG+ YL         +VHRNL+   +L+       IAD G+  LL  D     +S  
Sbjct: 118 -IAKGMYYLEEH-----RMVHRNLAARNILLKSDSIVQIADFGVADLLYPDDKKYFYSEH 171

Query: 577 KTSAAMGYLAPEYVTTGRFTERSDIFAFGVIILQILTGSLVLTSSMRLAAESATFENFID 636
           KT   + ++A E +  GR+T +SD++++GV + ++++      + MR        E    
Sbjct: 172 KTP--IKWMALESILFGRYTHQSDVWSYGVTVWEMMSYGAEPYAGMRPHEVPDLLE---- 225

Query: 637 RNLKG-KFSESEAAKLG-KMALV-CTHEDPENRPTMEAVIEELTVAA 680
              KG + ++ +   +   M +V C   D   RPT + +  E T  A
Sbjct: 226 ---KGERLAQPQICTIDVYMVMVKCWMIDENVRPTFKELANEFTRMA 269

Protein Tyrosine Kinase (PTK) family; HER3 (ErbB3); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER3 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. HER3 binds the neuregulin ligands, NRG1 and NRG2. HER3 contains an impaired tyr kinase domain and relies on its heterodimerization partners for activity following ligand binding. The HER2-HER3 heterodimer constitutes a high affinity co-receptor capable of potent mitogenic signaling. HER3 participates in a signaling pathway involved in the proliferation, survival, adhesion, and motility of tumor cells. Length = 279

>gnl|CDD|133189 cd05058, PTKc_Met_Ron, Catalytic domain of the Protein Tyrosine Kinases, Met and Ron

 Score = 87.1 bits (216), Expect = 4e-19
 Identities = 71/274 (25%), Positives = 129/274 (47%), Gaps = 30/274 (10%)

Query: 415 NLLGKGNFSSVYKGTLRDG----TLVAIRSINVTSCKSEEAEFVKGLYLLTSLRHENIIR 470
            ++GKG+F  VY GTL D        A++S+N  +   E  +F+K   ++    H N++ 
Sbjct: 1   RVIGKGHFGCVYHGTLIDSDGQKIHCAVKSLNRITDLEEVEQFLKEGIIMKDFSHPNVLS 60

Query: 471 LRGFCCSRGRGECFLIYDFAPKGKLSKYLDQEEGSSNVLDWSTRVSIIIGIAKGIGYLHS 530
           L G C     G   ++  +   G L  ++  E  +  V D    +   + +AKG+ YL S
Sbjct: 61  LLGICL-PSEGSPLVVLPYMKHGDLRNFIRSETHNPTVKDL---IGFGLQVAKGMEYLAS 116

Query: 531 SEVNKPAIVHRNLSVEKVLIDQQFNPLIADCGLHKLLADDIVFSVLKTSAA---MGYLAP 587
            +      VHR+L+    ++D+ F   +AD GL + + D   +SV   + A   + ++A 
Sbjct: 117 KK-----FVHRDLAARNCMLDESFTVKVADFGLARDIYDKEYYSVHNHTGAKLPVKWMAL 171

Query: 588 EYVTTGRFTERSDIFAFGVIILQILTGSLVLTSSMRLA-----AESATFENFIDRNLKGK 642
           E + T +FT +SD+++FGV++ +++T         R A      +S     ++ +  +  
Sbjct: 172 ESLQTQKFTTKSDVWSFGVLLWELMT---------RGAPPYPDVDSFDITVYLLQGRRLL 222

Query: 643 FSESEAAKLGKMALVCTHEDPENRPTMEAVIEEL 676
             E     L ++ L C H  PE RPT   ++  +
Sbjct: 223 QPEYCPDPLYEVMLSCWHPKPEMRPTFSELVSRI 256

Protein Tyrosine Kinase (PTK) family; Met and Ron; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Met and Ron are receptor tyr kinases (RTKs) composed of an alpha-beta heterodimer. The extracellular alpha chain is disulfide linked to the beta chain, which contains an extracellular ligand-binding region with a sema domain, a PSI domain and four IPT repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Met binds to the ligand, hepatocyte growth factor/scatter factor (HGF/SF), and is also called the HGF receptor. HGF/Met signaling plays a role in growth, transformation, cell motility, invasion, metastasis, angiogenesis, wound healing, and tissue regeneration. Aberrant expression of Met through mutations or gene amplification is associated with many human cancers including hereditary papillary renal and gastric carcinomas. The ligand for Ron is macrophage stimulating protein (MSP). Ron signaling is important in regulating cell motility, adhesion, proliferation, and apoptosis. Aberrant Ron expression is implicated in tumorigenesis and metastasis. Length = 262

>gnl|CDD|215061 PLN00113, PLN00113, leucine-rich repeat receptor-like protein kinase; Provisional

 Score = 91.4 bits (227), Expect = 5e-19
 Identities = 90/281 (32%), Positives = 138/281 (49%), Gaps = 43/281 (15%)

Query: 413 EVNLLGKGNFSSVYKG-TLRDGTLVAIRSIN-VTSCKSEE-AEFVKGLYLLTSLRHENII 469
           E N++ +G   + YKG ++++G    ++ IN V S  S E A+  K       L+H NI+
Sbjct: 694 EENVISRGKKGASYKGKSIKNGMQFVVKEINDVNSIPSSEIADMGK-------LQHPNIV 746

Query: 470 RLRGFCCSRGRGECFLIYDFAPKGKLSKYLDQEEGSSNVLDWSTRVSIIIGIAKGIGYLH 529
           +L G C  R     +LI+++     LS+ L         L W  R  I IGIAK + +LH
Sbjct: 747 KLIGLC--RSEKGAYLIHEYIEGKNLSEVL-------RNLSWERRRKIAIGIAKALRFLH 797

Query: 530 SSEVNKPAIVHRNLSVEKVLIDQQFNPLIADCGLHKLLADDIVFSVLKTSAAMGYLAPEY 589
                 PA+V  NLS EK++ID +  P +    L  LL  D       +SA   Y+APE 
Sbjct: 798 CR--CSPAVVVGNLSPEKIIIDGKDEPHLR-LSLPGLLCTD--TKCFISSA---YVAPET 849

Query: 590 VTTGRFTERSDIFAFGVIILQILTG------------SLVLTSSMRLAAESATFENFIDR 637
             T   TE+SDI+ FG+I++++LTG            S+V     R        + +ID 
Sbjct: 850 RETKDITEKSDIYGFGLILIELLTGKSPADAEFGVHGSIV--EWARYCYSDCHLDMWIDP 907

Query: 638 NLKGKFS--ESEAAKLGKMALVCTHEDPENRPTMEAVIEEL 676
           +++G  S  ++E  ++  +AL CT  DP  RP    V++ L
Sbjct: 908 SIRGDVSVNQNEIVEVMNLALHCTATDPTARPCANDVLKTL 948

Length = 968

>gnl|CDD|173630 cd05044, PTKc_c-ros, Catalytic domain of the Protein Tyrosine Kinase, C-ros

 Score = 86.4 bits (214), Expect = 8e-19
 Identities = 76/282 (26%), Positives = 127/282 (45%), Gaps = 35/282 (12%)

Query: 415 NLLGKGNFSSVYKGTLRD----GT---LVAIRSINVTSCKSEEAEFVKGLYLLTSLRHEN 467
           N LG G F  VY+GT  D    G+    VA++++   +   E+ EF+K  +L+++  H N
Sbjct: 1   NFLGSGAFGEVYEGTATDILGPGSGPIRVAVKTLRKGATDQEKKEFLKEAHLMSNFNHPN 60

Query: 468 IIRLRGFCCSRGRGECFLIYDFAPKGKLSKYL---DQEEGSSNVLDWSTRVSIIIGIAKG 524
           I++L G C        ++I +    G L  YL     E     +L     + I + +AKG
Sbjct: 61  IVKLLGVCLLNE--PQYIIMELMEGGDLLSYLRDARVERFGPPLLTLKELLDICLDVAKG 118

Query: 525 IGYLHSSEVNKPAIVHRNLSVEKVLIDQQFNPL-----IADCGLHKLLADDIVFSVLKTS 579
             YL      +   +HR+L+    L+ ++         I D GL    A DI  S     
Sbjct: 119 CVYLE-----QMHFIHRDLAARNCLVSEKGYDADRVVKIGDFGL----ARDIYKSDYYRK 169

Query: 580 AAMG-----YLAPEYVTTGRFTERSDIFAFGVIILQILTGSLVLTSSMRLAAESATFENF 634
              G     ++APE +  G+FT +SD+++FGV++ +ILT    L      A  +      
Sbjct: 170 EGEGLLPVRWMAPESLLDGKFTTQSDVWSFGVLMWEILT----LGQQPYPALNNQEVLQH 225

Query: 635 IDRNLKGKFSESEAAKLGKMALVCTHEDPENRPTMEAVIEEL 676
           +    + +  E+   K+ ++   C  +DP  RPT + + E L
Sbjct: 226 VTAGGRLQKPENCPDKIYQLMTNCWAQDPSERPTFDRIQEIL 267

Protein Tyrosine Kinases (PTK) family; C-ros and Drosophila Sevenless proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The proto-oncogene c-ros encodes an orphan receptor tyr kinase (RTK) with an unknown ligand. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. C-ros is expressed in embryonic cells of the kidney, intestine and lung, but disappears soon after birth. It persists only in the adult epididymis. Male mice bearing inactive mutations of c-ros lack the initial segment of the epididymis and are infertile. The Drosophila protein, Sevenless, is required for the specification of the R7 photoreceptor cell during eye development. Length = 269

>gnl|CDD|133180 cd05049, PTKc_Trk, Catalytic domain of the Protein Tyrosine Kinases, Tropomyosin Related Kinases

 Score = 86.7 bits (215), Expect = 8e-19
 Identities = 58/218 (26%), Positives = 100/218 (45%), Gaps = 32/218 (14%)

Query: 417 LGKGNFSSVYKGTLR------DGTLVAIRSINVTSCKSEEAEFVKGLYLLTSLRHENIIR 470
           LG+G F  V+ G         D  LVA++++  T+      +F +   LLT+ +HENI++
Sbjct: 13  LGEGAFGKVFLGECYHLEPENDKELVAVKTLKETASNDARKDFEREAELLTNFQHENIVK 72

Query: 471 LRGFCCSRGRGEC-FLIYDFAPKGKLSKYL-------------DQEEGSSNVLDWSTRVS 516
             G C     G+   +++++   G L+K+L             D   G    L  S  + 
Sbjct: 73  FYGVC---TEGDPPIMVFEYMEHGDLNKFLRSHGPDAAFLKSPDSPMGE---LTLSQLLQ 126

Query: 517 IIIGIAKGIGYLHSSEVNKPAIVHRNLSVEKVLIDQQFNPLIADCGLHKLLADDIVFSVL 576
           I + IA G+ YL S        VHR+L+    L+       I D G+ + +     + V 
Sbjct: 127 IAVQIASGMVYLASQH-----FVHRDLATRNCLVGYDLVVKIGDFGMSRDVYTTDYYRVG 181

Query: 577 -KTSAAMGYLAPEYVTTGRFTERSDIFAFGVIILQILT 613
             T   + ++ PE +   +FT  SD+++FGV++ +I T
Sbjct: 182 GHTMLPIRWMPPESIMYRKFTTESDVWSFGVVLWEIFT 219

Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase (Trk) subfamily; catalytic (c) domain. The Trk subfamily consists of TrkA, TrkB, TrkC, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Trk subfamily members are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, the nerve growth factor (NGF) family of neutrotrophins, leads to Trk receptor oligomerization and activation of the catalytic domain. Trk receptors are mainly expressed in the peripheral and central nervous systems. They play important roles in cell fate determination, neuronal survival and differentiation, as well as in the regulation of synaptic plasticity. Altered expression of Trk receptors is associated with many human diseases. Length = 280

>gnl|CDD|133165 cd05033, PTKc_EphR, Catalytic domain of Ephrin Receptor Protein Tyrosine Kinases

 Score = 86.6 bits (215), Expect = 8e-19
 Identities = 53/210 (25%), Positives = 102/210 (48%), Gaps = 17/210 (8%)

Query: 410 CFSEVNLLGKGNFSSVYKGTL----RDGTLVAIRSINVTSCKSEEAEFVKGLYLLTSLRH 465
             +   ++G G F  V +G L    +    VAI+++   S   +  +F+    ++    H
Sbjct: 5   YVTIEKVIGGGEFGEVCRGRLKLPGKKEIDVAIKTLKAGSSDKQRLDFLTEASIMGQFDH 64

Query: 466 ENIIRLRGFCCSRGRGECFLIY-DFAPKGKLSKYLDQEEGSSNVLDWSTRVSIIIGIAKG 524
            NIIRL G      +    +I  ++   G L K+L + +G          V ++ GIA G
Sbjct: 65  PNIIRLEGVVT---KSRPVMIITEYMENGSLDKFLRENDGK---FTVGQLVGMLRGIASG 118

Query: 525 IGYLHSSEVNKPAIVHRNLSVEKVLIDQQFNPLIADCGLHKLLAD-DIVFSVLKTSAAMG 583
           + YL  SE+N    VHR+L+   +L++      ++D GL + L D +  ++       + 
Sbjct: 119 MKYL--SEMN---YVHRDLAARNILVNSNLVCKVSDFGLSRRLEDSEATYTTKGGKIPIR 173

Query: 584 YLAPEYVTTGRFTERSDIFAFGVIILQILT 613
           + APE +   +FT  SD+++FG+++ ++++
Sbjct: 174 WTAPEAIAYRKFTSASDVWSFGIVMWEVMS 203

Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). They can be classified into two classes (EphA and EphB), according to their extracellular sequences, which largely correspond to binding preferences for either GPI-anchored ephrin-A ligands or transmembrane ephrin-B ligands. Vertebrates have ten EphA and six EhpB receptors, which display promiscuous ligand interactions within each class. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. This allows ephrin/EphR dimers to form, leading to the activation of the intracellular tyr kinase domain. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). The main effect of ephrin/EphR interaction is cell-cell repulsion or adhesion. Ephrin/EphR signaling is important in neural development and plasticity, cell morphogenesis and proliferation, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. Length = 266

>gnl|CDD|173645 cd05084, PTKc_Fes, Catalytic domain of the Protein Tyrosine Kinase, Fes

 Score = 85.8 bits (212), Expect = 1e-18
 Identities = 64/263 (24%), Positives = 121/263 (46%), Gaps = 18/263 (6%)

Query: 417 LGKGNFSSVYKGTLR-DGTLVAIRSINVTSCKSEEAEFVKGLYLLTSLRHENIIRLRGFC 475
           +G+GNF  V+ G LR D T VA++S   T     +A+F++   +L    H NI+RL G C
Sbjct: 3   IGRGNFGEVFSGRLRADNTPVAVKSCRETLPPDLKAKFLQEARILKQYSHPNIVRLIGVC 62

Query: 476 CSRGRGECFLIYDFAPKGKLSKYLDQEEGSSNVLDWSTRVSIIIGIAKGIGYLHSSEVNK 535
               +   +++ +    G    +L + EG    L     + ++   A G+ YL S     
Sbjct: 63  TQ--KQPIYIVMELVQGGDFLTFL-RTEGPR--LKVKELIQMVENAAAGMEYLESKHC-- 115

Query: 536 PAIVHRNLSVEKVLIDQQFNPLIADCGLHKLLADDIVFSV--LKTSAAMGYLAPEYVTTG 593
              +HR+L+    L+ ++    I+D G+ +   D +  S   +K    + + APE +  G
Sbjct: 116 ---IHRDLAARNCLVTEKNVLKISDFGMSREEEDGVYASTGGMK-QIPVKWTAPEALNYG 171

Query: 594 RFTERSDIFAFGVIILQILTGSLVLTSSMRLAAESATFENFIDRNLKGKFSESEAAKLGK 653
           R++  SD+++FG+++ +  +    L +       +      I++ ++    E     + +
Sbjct: 172 RYSSESDVWSFGILLWEAFS----LGAVPYANLSNQQTREAIEQGVRLPCPELCPDAVYR 227

Query: 654 MALVCTHEDPENRPTMEAVIEEL 676
           +   C   DP  RP+   V +EL
Sbjct: 228 LMERCWEYDPGQRPSFSTVHQEL 250

Protein Tyrosine Kinase (PTK) family; Fes (or Fps) kinase subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr kinase activity. Fes kinase is expressed in myeloid, vascular endothelial, epithelial, and neuronal cells. It plays important roles in cell growth and differentiation, angiogenesis, inflammation and immunity, and cytoskeletal regulation. A recent study implicates Fes kinase as a tumor suppressor in colorectal cancer. Length = 252

>gnl|CDD|133191 cd05060, PTKc_Syk_like, Catalytic domain of Spleen Tyrosine Kinase-like Protein Tyrosine Kinases

 Score = 85.9 bits (213), Expect = 1e-18
 Identities = 69/275 (25%), Positives = 122/275 (44%), Gaps = 48/275 (17%)

Query: 417 LGKGNFSSVYKGTLR--DGTL--VAIRSINVTSCKSEEAEFVKGLYLLTSLRHENIIRLR 472
           LG GNF SV KG      G    VA++++      + + EF++   ++  L H  I+RL 
Sbjct: 3   LGHGNFGSVVKGVYLMKSGKEVEVAVKTLKQEHIAAGKKEFLREASVMAQLDHPCIVRLI 62

Query: 473 GFCCSRGRGECF-LIYDFAPKGKLSKYL--DQEEGSSNVLDWSTRVSIIIGIAKGIGYLH 529
           G C    +GE   L+ + AP G L KYL   +E   S++ + + +V      A G+ YL 
Sbjct: 63  GVC----KGEPLMLVMELAPLGPLLKYLKKRREIPVSDLKELAHQV------AMGMAYLE 112

Query: 530 SSEVNKPAIVHRNLSVEKVLIDQQFNPLIADCGLHKLLADDIVFSVLKTSA--AMGYLAP 587
           S        VHR+L+   VL+  +    I+D G+ + L     +    T+    + + AP
Sbjct: 113 SKH-----FVHRDLAARNVLLVNRHQAKISDFGMSRALGAGSDYYRATTAGRWPLKWYAP 167

Query: 588 EYVTTGRFTERSDIFAFGVIILQI----------LTGSLVLTSSMRLAAESATFENFIDR 637
           E +  G+F+ +SD++++GV + +           + G+ V+                ++ 
Sbjct: 168 ECINYGKFSSKSDVWSYGVTLWEAFSYGAKPYGEMKGAEVIA--------------MLES 213

Query: 638 NLKGKFSESEAAKLGKMALVCTHEDPENRPTMEAV 672
             +    E    ++  + L C    PE+RPT   +
Sbjct: 214 GERLPRPEECPQEIYSIMLSCWKYRPEDRPTFSEL 248

Protein Tyrosine Kinase (PTK) family; Spleen Tyrosine Kinase (Syk) subfamily; catalytic (c) domain. The Syk subfamily is composed of Syk, ZAP-70, Shark, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. They are involved in the signaling downstream of activated receptors (including B-cell, T-cell, and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferation, differentiation, survival, adhesion, migration, and phagocytosis. Syk is important in B-cell receptor (BCR) signaling, while Zap-70 is primarily expressed in T-cells and NK cells, and is a crucial component in T-cell receptor (TCR) signaling. Syk also plays a central role in Fc receptor-mediated phagocytosis in the adaptive immune system. Shark is exclusively expressed in ectodermally derived epithelia, and is localized preferentially to the apical surface of the epithelial cells, it may play a role in a signaling pathway for epithelial cell polarity. Length = 257

>gnl|CDD|173755 cd08215, STKc_Nek, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase

 Score = 85.6 bits (213), Expect = 1e-18
 Identities = 63/285 (22%), Positives = 123/285 (43%), Gaps = 53/285 (18%)

Query: 411 FSEVNLLGKGNFSSVYKGT-LRDGTLVAIRSINVTSCKSEEAEFVKG-LYLLTSLRHENI 468
           +  +  +GKG+F  VY      DG L  ++ I++++   +E E     + +L  L H NI
Sbjct: 2   YEIIKQIGKGSFGKVYLVRRKSDGKLYVLKEIDLSNMSEKEREDALNEVKILKKLNHPNI 61

Query: 469 IRLRGFCCSRGRGECFL-------IYDFAPKGKLSKYLDQ--EEGSS----NVLDWSTRV 515
           I+           E F        + ++A  G LS+ + +  +EG       +LDW  + 
Sbjct: 62  IKYY---------ESFEEKGKLCIVMEYADGGDLSQKIKKQKKEGKPFPEEQILDWFVQ- 111

Query: 516 SIIIGIAKGIGYLHSSEVNKPAIVHRNLSVEKVLIDQQFNPLIADCGLHKLLADDIVFSV 575
                +   + YLHS    K  I+HR++  + + +       + D G+ K+L+      +
Sbjct: 112 -----LCLALKYLHS---RK--ILHRDIKPQNIFLTSNGLVKLGDFGISKVLSST--VDL 159

Query: 576 LKTSAAMG---YLAPEYVTTGRFTERSDIFAFGVIILQILTGSLVLTSSMRLAAESATFE 632
            KT    G   YL+PE      +  +SDI++ G ++ ++ T        ++   E     
Sbjct: 160 AKTVV--GTPYYLSPELCQNKPYNYKSDIWSLGCVLYELCT--------LKHPFEGENLL 209

Query: 633 NFIDRNLKGKF---SESEAAKLGKMALVCTHEDPENRPTMEAVIE 674
               + LKG++       +++L  +      +DPE RP++  +++
Sbjct: 210 ELALKILKGQYPPIPSQYSSELRNLVSSLLQKDPEERPSIAQILQ 254

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase (Nek) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek family is composed of 11 different mammalian members (Nek1-11) with similarity to the catalytic domain of Aspergillus nidulans NIMA kinase, the founding member of the Nek family which was identified in a screen for cell cycle mutants that were prevented from entering mitosis. Neks contain a conserved N-terminal catalytic domain and a more divergent C-terminal regulatory region of various sizes and structures. They are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. Length = 258

>gnl|CDD|133171 cd05039, PTKc_Csk_like, Catalytic domain of C-terminal Src kinase-like Protein Tyrosine Kinases

 Score = 84.8 bits (210), Expect = 3e-18
 Identities = 61/268 (22%), Positives = 117/268 (43%), Gaps = 28/268 (10%)

Query: 416 LLGKGNFSSVYKGTLRDGTLVAIRSI--NVTSCKS--EEAEFVKGLYLLTSLRHENIIRL 471
            +GKG F  V  G  R G  VA++ +  + T+ ++   EA        +T+LRH N+++L
Sbjct: 13  TIGKGEFGDVMLGDYR-GQKVAVKCLKDDSTAAQAFLAEASV------MTTLRHPNLVQL 65

Query: 472 RGFCCSRGRGECFLIYDFAPKGKLSKYLDQEEGSSNVLDWSTRVSIIIGIAKGIGYLHSS 531
            G          +++ ++  KG L  YL     +   L    ++   + + +G+ YL   
Sbjct: 66  LGVVLQGN--PLYIVTEYMAKGSLVDYLRSRGRAVITLA--QQLGFALDVCEGMEYLEEK 121

Query: 532 EVNKPAIVHRNLSVEKVLIDQQFNPLIADCGLHKLLADDIVFSVLKTSAAMGYLAPEYVT 591
                  VHR+L+   VL+ +     ++D GL    A +           + + APE + 
Sbjct: 122 N-----FVHRDLAARNVLVSEDLVAKVSDFGL----AKEASQGQDSGKLPVKWTAPEALR 172

Query: 592 TGRFTERSDIFAFGVIILQILTGSLVLTSSMRLAAESATFENFIDRNLKGKFSESEAAKL 651
             +F+ +SD+++FG+++ +I +   V    + L       E       + +  E    ++
Sbjct: 173 EKKFSTKSDVWSFGILLWEIYSFGRVPYPRIPLKDVVPHVEK----GYRMEAPEGCPPEV 228

Query: 652 GKMALVCTHEDPENRPTMEAVIEELTVA 679
            K+   C   DP  RPT + + E+L + 
Sbjct: 229 YKVMKDCWELDPAKRPTFKQLREQLALI 256

Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk) subfamily; catalytic (c) domain. The Csk subfamily is composed of Csk, Chk, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk and Chk are translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk catalyzes the tyr phosphorylation of the regulatory C-terminal tail of Src kinases, resulting in their inactivation. Chk inhibit Src kinases using a noncatalytic mechanism by simply binding to them. As negative regulators of Src kinases, Csk and Chk play important roles in cell proliferation, survival, and differentiation, and consequently, in cancer development and progression. Length = 256

>gnl|CDD|173658 cd05114, PTKc_Tec_Rlk, Catalytic domain of the Protein Tyrosine Kinases, Tyrosine kinase expressed in hepatocellular carcinoma and Resting lymphocyte kinase

 Score = 84.9 bits (210), Expect = 3e-18
 Identities = 64/264 (24%), Positives = 122/264 (46%), Gaps = 22/264 (8%)

Query: 417 LGKGNFSSVYKGTLRDGTLVAIRSINVTSCKSEEAEFVKGLYLLTSLRHENIIRLRGFCC 476
           LG G F  V+ G  R    VAI++IN     SEE +F++   ++  L H  +++L G C 
Sbjct: 12  LGSGQFGVVHLGKWRAQIKVAIKAIN-EGAMSEE-DFIEEAKVMMKLSHPKLVQLYGVCT 69

Query: 477 SRGRGECFLIYDFAPKGKLSKYLDQEEG--SSNVLDWSTRVSIIIGIAKGIGYLHSSEVN 534
            +     +++ +F   G L  YL Q +G  S ++L     +S+   + +G+ YL  +   
Sbjct: 70  QQK--PLYIVTEFMENGCLLNYLRQRQGKLSKDML-----LSMCQDVCEGMEYLERN--- 119

Query: 535 KPAIVHRNLSVEKVLIDQQFNPLIADCGLHKLLADDIVFSVLKTSAAMGYLAPEYVTTGR 594
             + +HR+L+    L+       ++D G+ + + DD   S       + +  PE     +
Sbjct: 120 --SFIHRDLAARNCLVSSTGVVKVSDFGMTRYVLDDEYTSSSGAKFPVKWSPPEVFNFSK 177

Query: 595 FTERSDIFAFGVIILQILT-GSLVLTSSMRLAAESATFENFIDRNLKGKFSESEAAKLGK 653
           ++ +SD+++FGV++ ++ T G +                 F  R  + K +   +  + +
Sbjct: 178 YSSKSDVWSFGVLMWEVFTEGKMPFEKKSNYEVVEMISRGF--RLYRPKLA---SMTVYE 232

Query: 654 MALVCTHEDPENRPTMEAVIEELT 677
           +   C HE PE RPT   ++  +T
Sbjct: 233 VMYSCWHEKPEGRPTFAELLRAIT 256

Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) and Resting lymphocyte kinase (Rlk); catalytic (c) domain. The PTKc family is part of a larger superfamily, that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec and Rlk (also named Txk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. Instead of PH, Rlk contains an N-terminal cysteine-rich region. In addition to PH, Tec also contains the Tec homology (TH) domain with proline-rich and zinc-binding regions. Tec kinases are expressed mainly by haematopoietic cells. Tec is more widely-expressed than other Tec subfamily kinases. It is found in endothelial cells, both B- and T-cells, and a variety of myeloid cells including mast cells, erythroid cells, platelets, macrophages and neutrophils. Rlk is expressed in T-cells and mast cell lines. Tec and Rlk are both key components of T-cell receptor (TCR) signaling. They are important in TCR-stimulated proliferation, IL-2 production and phopholipase C-gamma1 activation. Length = 256

>gnl|CDD|173655 cd05110, PTKc_HER4, Catalytic domain of the Protein Tyrosine Kinase, HER4

 Score = 85.9 bits (212), Expect = 3e-18
 Identities = 62/212 (29%), Positives = 106/212 (50%), Gaps = 23/212 (10%)

Query: 411 FSEVNLLGKGNFSSVYKGT-LRDGTLV----AIRSINVTSCKSEEAEFVKGLYLLTSLRH 465
              V +LG G F +VYKG  + +G  V    AI+ +N T+      EF+    ++ S+ H
Sbjct: 9   LKRVKVLGSGAFGTVYKGIWVPEGETVKIPVAIKILNETTGPKANVEFMDEALIMASMDH 68

Query: 466 ENIIRLRGFCCSRGRGECFLIYDFAPKGKLSKYLDQEE---GSSNVLDWSTRVSIIIGIA 522
            +++RL G C S       L+    P G L  Y+ + +   GS  +L+W  +      IA
Sbjct: 69  PHLVRLLGVCLSP---TIQLVTQLMPHGCLLDYVHEHKDNIGSQLLLNWCVQ------IA 119

Query: 523 KGIGYLHSSEVNKPAIVHRNLSVEKVLIDQQFNPLIADCGLHKLL-ADDIVFSVLKTSAA 581
           KG+ YL         +VHR+L+   VL+    +  I D GL +LL  D+  ++       
Sbjct: 120 KGMMYLEERR-----LVHRDLAARNVLVKSPNHVKITDFGLARLLEGDEKEYNADGGKMP 174

Query: 582 MGYLAPEYVTTGRFTERSDIFAFGVIILQILT 613
           + ++A E +   +FT +SD++++GV I +++T
Sbjct: 175 IKWMALECIHYRKFTHQSDVWSYGVTIWELMT 206

Protein Tyrosine Kinase (PTK) family; HER4 (ErbB4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER4 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. Ligands that bind HER4 fall into two groups, the neuregulins (or heregulins) and some EGFR (HER1) ligands including betacellulin, HBEGF, and epiregulin. All four neuregulins (NRG1-4) interact with HER4. Upon ligand binding, HER4 forms homo- or heterodimers with other HER proteins. HER4 is essential in embryonic development. It is implicated in mammary gland, cardiac, and neural development. As a postsynaptic receptor of NRG1, HER4 plays an important role in synaptic plasticity and maturation. The impairment of NRG1/HER4 signaling may contribute to schizophrenia. Length = 303

>gnl|CDD|223589 COG0515, SPS1, Serine/threonine protein kinase [General function prediction only / Signal transduction mechanisms / Transcription / DNA replication, recombination, and repair]

 Score = 85.9 bits (211), Expect = 6e-18
 Identities = 71/280 (25%), Positives = 121/280 (43%), Gaps = 29/280 (10%)

Query: 414 VNLLGKGNFSSVYKGTLRDGTLVAIR--SINVTSCKSEEAEFVKGLYLLTSLRHE-NIIR 470
           +  LG+G+F  VY    RD  LVA++  +  + S   E   F++ + +L SL H  NI++
Sbjct: 5   LRKLGEGSFGEVYLA--RDRKLVALKVLAKKLESKSKEVERFLREIQILASLNHPPNIVK 62

Query: 471 LRGFCCSRGRGECFLIYDFAPKGKLSKYLDQEEGSSNVLDWSTRVSIIIGIAKGIGYLHS 530
           L  F   +  G  +L+ ++   G L   L  + G    L  S  + I+  I   + YLHS
Sbjct: 63  LYDFF--QDEGSLYLVMEYVDGGSLEDLLK-KIGRKGPLSESEALFILAQILSALEYLHS 119

Query: 531 SEVNKPAIVHRNLSVEKVLIDQQ-FNPLIADCGLHKLLADDIVFSVLKTSAA-----MGY 584
                  I+HR++  E +L+D+      + D GL KLL D    S +    +      GY
Sbjct: 120 K-----GIIHRDIKPENILLDRDGRVVKLIDFGLAKLLPDPGSTSSIPALPSTSVGTPGY 174

Query: 585 LAPEYVT---TGRFTERSDIFAFGVIILQILTGSLVLTSSMRLAAESATFENF------- 634
           +APE +        +  SDI++ G+ + ++LTG          +A S T +         
Sbjct: 175 MAPEVLLGLSLAYASSSSDIWSLGITLYELLTGLPPFEGEKNSSATSQTLKIILELPTPS 234

Query: 635 IDRNLKGKFSESEAAKLGKMALVCTHEDPENRPTMEAVIE 674
           +   L     E  +     +      +DP+NR +  + + 
Sbjct: 235 LASPLSPSNPELISKAASDLLKKLLAKDPKNRLSSSSDLS 274

Length = 384

>gnl|CDD|173772 cd08530, STKc_CNK2-like, Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii CNK2, and similar domains

 Score = 83.3 bits (206), Expect = 8e-18
 Identities = 65/276 (23%), Positives = 123/276 (44%), Gaps = 39/276 (14%)

Query: 411 FSEVNLLGKGNFSSVYK-GTLRDGTLVAIRSINVTS-CKSEEAEFVKGLYLLTSLRHENI 468
           F  +  LGKG++ SVYK   L D    A++ +++ S  + E  + V  + +L S+ H NI
Sbjct: 2   FKVLKKLGKGSYGSVYKVKRLSDNQFYALKEVDLGSMSQKEREDAVNEIRILASVNHPNI 61

Query: 469 IRLRGFCCSRGRGECFL-------IYDFAPKGKLSKYLDQEEGSSNVLDWSTRVSIIIGI 521
           I  +         E FL       + ++AP G LSK + + +    ++       I I +
Sbjct: 62  ISYK---------EAFLDGNKLCIVMEYAPFGDLSKAISKRKKKRKLIPEQEIWRIFIQL 112

Query: 522 AKGIGYLHSSEVNKPAIVHRNLSVEKVLIDQQFNPLIADCGLHKLLADDIVFSVLKTSAA 581
            +G+  LH  +     I+HR+L    +L+       I D G+ K+L  ++  + + T   
Sbjct: 113 LRGLQALHEQK-----ILHRDLKSANILLVANDLVKIGDLGISKVLKKNMAKTQIGTPH- 166

Query: 582 MGYLAPEYVTTGR-FTERSDIFAFGVIILQILTGSLVLTSSMRLAAESATFENFIDRNLK 640
             Y+APE V  GR ++ +SDI++ G ++ ++ T             E+ + ++   +  +
Sbjct: 167 --YMAPE-VWKGRPYSYKSDIWSLGCLLYEMATF--------APPFEARSMQDLRYKVQR 215

Query: 641 GKF---SESEAAKLGKMALVCTHEDPENRPTMEAVI 673
           GK+       +  L           P+ RP  + ++
Sbjct: 216 GKYPPIPPIYSQDLQNFIRSMLQVKPKLRPNCDKIL 251

Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii Never In Mitosis gene A (NIMA)-related kinase 1 (CNK2)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii CNK2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes CNK1, and -2. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii CNK2 has both cilliary and cell cycle functions. It influences flagellar length through promoting flagellar disassembly, and it regulates cell size, through influencing the size threshold at which cells commit to mitosis. Length = 256

>gnl|CDD|133211 cd05080, PTKc_Tyk2_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2

 Score = 82.3 bits (203), Expect = 3e-17
 Identities = 58/207 (28%), Positives = 107/207 (51%), Gaps = 23/207 (11%)

Query: 417 LGKGNFSSV----YKGTLRDGT--LVAIRSINVTSCKSEEAEFVKGLYLLTSLRHENIIR 470
           LG+G+F  V    Y     DGT  +VA++++     +   + + K + +L +L HENI++
Sbjct: 12  LGEGHFGKVSLYCYDPA-NDGTGEMVAVKTLKRECGQQNTSGWKKEINILKTLYHENIVK 70

Query: 471 LRGFCCSRGRGECF-LIYDFAPKGKLSKYLDQEE-GSSNVLDWSTRVSIIIGIAKGIGYL 528
            +G CCS   G+   LI ++ P G L  YL + +   + +L ++ +      I +G+ YL
Sbjct: 71  YKG-CCSEQGGKGLQLIMEYVPLGSLRDYLPKHKLNLAQLLLFAQQ------ICEGMAYL 123

Query: 529 HSSEVNKPAIVHRNLSVEKVLIDQQFNPLIADCGLHKLLADDIVFSVLKTS--AAMGYLA 586
           HS        +HR+L+   VL+D      I D GL K + +   +  ++    + + + A
Sbjct: 124 HSQHY-----IHRDLAARNVLLDNDRLVKIGDFGLAKAVPEGHEYYRVREDGDSPVFWYA 178

Query: 587 PEYVTTGRFTERSDIFAFGVIILQILT 613
            E +   +F+  SD+++FGV + ++LT
Sbjct: 179 VECLKENKFSYASDVWSFGVTLYELLT 205

Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Tyk2 is widely expressed in many tissues. It is involved in signaling via the cytokine receptors IFN-alphabeta, IL-6, IL-10, IL-12, IL-13, and IL-23. It mediates cell surface urokinase receptor (uPAR) signaling and plays a role in modulating vascular smooth muscle cell (VSMC) functional behavior in response to injury. Tyk2 is also important in dendritic cell function and T helper (Th)1 cell differentiation. A homozygous mutation of Tyk2 was found in a patient with hyper-IgE syndrome (HIES), a primary immunodeficiency characterized by recurrent skin abscesses, pneumonia, and elevated serum IgE. This suggests that Tyk2 may play important roles in multiple cytokine signaling involved in innate and adaptive immunity. Length = 283

>gnl|CDD|173632 cd05051, PTKc_DDR, Catalytic domain of the Protein Tyrosine Kinases, Discoidin Domain Receptors

 Score = 82.4 bits (204), Expect = 3e-17
 Identities = 75/304 (24%), Positives = 128/304 (42%), Gaps = 39/304 (12%)

Query: 389 FSREHLNSFRLNLEEVESATQCFSEV-NLLGKGNFSSVYKGTLRDGTLVAIRSINVTSCK 447
           F R+ LN F   L E +       E   L      +           LVA++ +   +  
Sbjct: 2   FPRQPLN-FVEKLGEGQFGEVHLCEADGLQDFSEKAFAENDNADAPVLVAVKVLRPDASD 60

Query: 448 SEEAEFVKGLYLLTSLRHENIIRLRGFCCSRGRGECFLIYDFAPKGKLSKYLDQEEG--- 504
           +   +F+K + +L+ L   NI RL G C         +I ++   G L+++L +      
Sbjct: 61  NAREDFLKEVKILSRLSDPNIARLLGVC--TVDPPLCMIMEYMENGDLNQFLQKHVAETS 118

Query: 505 ----SSNVLDWSTRVSIIIGIAKGIGYLHSSEVNKPAIVHRNLSVEKVLIDQQFNPLIAD 560
               +S  L +ST + +   IA G+ YL    +N    VHR+L+    L+ + +   IAD
Sbjct: 119 GLACNSKSLSFSTLLYMATQIASGMRYL--ESLN---FVHRDLATRNCLVGKNYTIKIAD 173

Query: 561 CGLHK-LLADDIVFSVLKTSAAMG--YLAPEYVTTGRFTERSDIFAFGVIILQILTGSLV 617
            G+ + L + D  +  ++  A +   ++A E V  G+FT +SD++AFGV + +I      
Sbjct: 174 FGMSRNLYSSD--YYRVQGRAPLPIRWMAWESVLLGKFTTKSDVWAFGVTLWEI------ 225

Query: 618 LTSSMRLAAESATFENFIDRNLKGKFSESE-----------AAKLGKMALVCTHEDPENR 666
           LT       E  T +  I+ N    F +                + ++ L C   D E+R
Sbjct: 226 LTLCREQPYEHLTDQQVIE-NAGHFFRDDGRQIYLPRPPNCPKDIYELMLECWRRDEEDR 284

Query: 667 PTME 670
           PT  
Sbjct: 285 PTFR 288

Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR) subfamily; catalytic (c) domain. The DDR subfamily consists of homologs of mammalian DDR1, DDR2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR subfamily members are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linked to a variety of human cancers including breast, colon, ovarian, brain, and lung. There is no evidence showing that DDRs act as transforming oncogenes. They are more likely to play a role in the regulation of tumor growth and metastasis. Length = 296

>gnl|CDD|133167 cd05035, PTKc_Axl_like, Catalytic Domain of Axl-like Protein Tyrosine Kinases

 Score = 81.8 bits (202), Expect = 4e-17
 Identities = 65/273 (23%), Positives = 118/273 (43%), Gaps = 21/273 (7%)

Query: 416 LLGKGNFSSVYKGTLR--DGTL--VAIRSINVTSCKSEEAE-FVKGLYLLTSLRHENIIR 470
           +LG+G F SV +G L   DG+   VA++++ +      E E F+     +    H N+++
Sbjct: 6   ILGEGEFGSVMEGQLSQDDGSQLKVAVKTMKLDIHTYSEIEEFLSEAACMKDFDHPNVMK 65

Query: 471 LRGFCCSRGRGECF----LIYDFAPKGKLSKYL--DQEEGSSNVLDWSTRVSIIIGIAKG 524
           L G C      +      +I  F   G L  +L   +  G    L   T +  ++ IA G
Sbjct: 66  LIGVCFEASSLQKIPKPMVILPFMKHGDLHSFLLYSRLGGLPEKLPLQTLLKFMVDIALG 125

Query: 525 IGYLHSSEVNKPAIVHRNLSVEKVLIDQQFNPLIADCGL-HKLLADDIVFSVLKTSAAMG 583
           + YL +        +HR+L+    ++ +     +AD GL  K+ + D           + 
Sbjct: 126 MEYLSNRN-----FIHRDLAARNCMLREDMTVCVADFGLSKKIYSGDYYRQGRIAKMPVK 180

Query: 584 YLAPEYVTTGRFTERSDIFAFGVIILQILTGSLVLTSSMRLAAESATFENFIDRNLKGKF 643
           ++A E +    +T +SD++AFGV + +I T       +     E+    +++    + K 
Sbjct: 181 WIAIESLADRVYTSKSDVWAFGVTMWEIAT----RGQTPYPGVENHEIYDYLRHGNRLKQ 236

Query: 644 SESEAAKLGKMALVCTHEDPENRPTMEAVIEEL 676
            E    +L  +   C   DP++RPT   + E L
Sbjct: 237 PEDCLDELYDLMYSCWRADPKDRPTFTKLREVL 269

Protein Tyrosine Kinase (PTK) family; Axl subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The Axl subfamily consists of Axl, Tyro3 (or Sky), Mer (or Mertk), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl subfamily members are implicated in a variety of cellular effects including survival, proliferation, migration, and phagocytosis. They are also associated with several types of cancer as well as inflammatory, autoimmune, vascular, and kidney diseases. Mer is named after its original reported expression pattern (monocytes, epithelial, and reproductive tissues). It is required for the ingestion of apoptotic cells by phagocytes such as macrophages, retinal pigment epithelial cells, and dendritic cells. Mer is also important in maintaining immune homeostasis. Length = 273

>gnl|CDD|173638 cd05065, PTKc_EphR_B, Catalytic domain of the Protein Tyrosine Kinases, Class EphB Ephrin Receptors

 Score = 81.5 bits (201), Expect = 4e-17
 Identities = 56/206 (27%), Positives = 103/206 (50%), Gaps = 18/206 (8%)

Query: 416 LLGKGNFSSVYKGTL----RDGTLVAIRSINVTSCKSEEAEFVKGLYLLTSLRHENIIRL 471
           ++G G F  V +G L    +    VAI+++     + +  +F+    ++    H NII L
Sbjct: 11  VIGAGEFGEVCRGRLKLPGKREIFVAIKTLKSGYTEKQRRDFLSEASIMGQFDHPNIIHL 70

Query: 472 RGFCCSRGRGECFLIYDFAPKGKLSKYLDQEEGSSNVLDWSTRVSIIIGIAKGIGYLHSS 531
            G   ++ R    +I +F   G L  +L Q +G   V+     V ++ GIA G+ YL  S
Sbjct: 71  EGVV-TKSR-PVMIITEFMENGALDSFLRQNDGQFTVIQL---VGMLRGIAAGMKYL--S 123

Query: 532 EVNKPAIVHRNLSVEKVLIDQQFNPLIADCGLHKLLADD----IVFSVLKTSAAMGYLAP 587
           E+N    VHR+L+   +L++      ++D GL + L DD       S L     + + AP
Sbjct: 124 EMN---YVHRDLAARNILVNSNLVCKVSDFGLSRFLEDDTSDPTYTSSLGGKIPIRWTAP 180

Query: 588 EYVTTGRFTERSDIFAFGVIILQILT 613
           E +   +FT  SD++++G+++ ++++
Sbjct: 181 EAIAYRKFTSASDVWSYGIVMWEVMS 206

Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; class EphB receptors; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). Class EphB receptors bind to transmembrane ephrin-B ligands. There are six vertebrate EhpB receptors (EphB1-6), which display promiscuous interactions with three ephrin-B ligands. One exception is EphB2, which also interacts with ephrin A5. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). Ephrin/EphR interaction mainly results in cell-cell repulsion or adhesion. EphBRs play important roles in synapse formation and plasticity, spine morphogenesis, axon guidance, and angiogenesis. In the intestinal epithelium, EphBRs are Wnt signaling target genes that control cell compartmentalization. They function as suppressors of color cancer progression. Length = 269

>gnl|CDD|173660 cd05123, STKc_AGC, Catalytic domain of AGC family Protein Serine/Threonine Kinases

 Score = 80.6 bits (200), Expect = 6e-17
 Identities = 58/241 (24%), Positives = 103/241 (42%), Gaps = 27/241 (11%)

Query: 417 LGKGNFSSVYKGTLRD-GTLVAIRSINVTSCKSE-EAEFVKG-LYLLTSLRHENIIRLRG 473
           LGKG+F  V     +D G L A++ +         E E       +L+ + H  I++L  
Sbjct: 1   LGKGSFGKVLLVRKKDTGKLYAMKVLKKKKIIKRKEVEHTLTERNILSRINHPFIVKL-- 58

Query: 474 FCCSRGRGECFLIYDFAPKGKLSKYLDQEEGSSNVLDWSTRVSIIIG-IAKGIGYLHSSE 532
               +   + +L+ ++AP G+L  +L +E           R       I   + YLHS  
Sbjct: 59  HYAFQTEEKLYLVLEYAPGGELFSHLSKE----GRFS-EERARFYAAEIVLALEYLHSLG 113

Query: 533 VNKPAIVHRNLSVEKVLIDQQFNPLIADCGLHKLLADDIVFSVLKTSAAMG---YLAPEY 589
                I++R+L  E +L+D   +  + D GL K L+ +      +T+   G   YLAPE 
Sbjct: 114 -----IIYRDLKPENILLDADGHIKLTDFGLAKELSSEGS----RTNTFCGTPEYLAPEV 164

Query: 590 VTTGRFTERSDIFAFGVIILQILTGSLVLTSSMRLAAESATFENFIDRNLKGKFSESEAA 649
           +    + +  D ++ GV++ ++LTG     +  R       +E  +   L+     S  A
Sbjct: 165 LLGKGYGKAVDWWSLGVLLYEMLTGKPPFYAEDR----KEIYEKILKDPLRFPEFLSPEA 220

Query: 650 K 650
           +
Sbjct: 221 R 221

Serine/Threonine Kinases (STKs), AGC (Protein Kinases A, G and C) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The AGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and Phosphoinositide 3-Kinase (PI3K). Members of this family include cAMP-dependent Protein Kinase (PKA), cGMP-dependent Protein Kinase (PKG), Protein Kinase C (PKC), Protein Kinase B (PKB), G protein-coupled Receptor Kinase (GRK), Serum- and Glucocorticoid-induced Kinase (SGK), and 70 kDa ribosomal Protein S6 Kinase (p70S6K or S6K), among others. AGC kinases share an activation mechanism based on the phosphorylation of up to three sites: the activation loop (A-loop), the hydrophobic motif (HM) and the turn motif. Phosphorylation at the A-loop is required of most AGC kinases, which results in a disorder-to-order transition of the A-loop. The ordered conformation results in the access of substrates and ATP to the active site. A subset of AGC kinases with C-terminal extensions containing the HM also requires phosphorylation at this site. Phosphorylation at the HM allows the C-terminal extension to form an ordered structure that packs into the hydrophobic pocket of the catalytic domain, which then reconfigures the kinase into an active bi-lobed state. In addition, growth factor-activated AGC kinases such as PKB, p70S6K, RSK, MSK, PKC, and SGK, require phosphorylation at the turn motif (also called tail or zipper site), located N-terminal to the HM at the C-terminal extension. AGC kinases regulate many cellular processes including division, growth, survival, metabolism, motility, and differentiation. Many are implicated in the development of various human diseases. Length = 250

>gnl|CDD|133172 cd05040, PTKc_Ack_like, Catalytic domain of the Protein Tyrosine Kinase, Activated Cdc42-associated kinase

 Score = 80.1 bits (198), Expect = 1e-16
 Identities = 71/286 (24%), Positives = 119/286 (41%), Gaps = 57/286 (19%)

Query: 416 LLGKGNFSSVYKGTLRD--GTL--VAI---RSINVTSCKSEEAEFVKGLYLLTSLRHENI 468
            LG G+F  V +G      G +  VA+   +S  ++    +   F+K   ++ SL HEN+
Sbjct: 2   KLGDGSFGVVRRGEWSTSGGKVIPVAVKCLKSDKLSDIMDD---FLKEAAIMHSLDHENL 58

Query: 469 IRLRGFCCSRGRGECFLIYDFAPKGKLSKYLDQEEGS----SNVLDWSTRVSIIIGIAKG 524
           IRL G   +       ++ + AP G L   L ++       S + D++ +      IA G
Sbjct: 59  IRLYGVVLTH---PLMMVTELAPLGSLLDRLRKDALGHFLISTLCDYAVQ------IANG 109

Query: 525 IGYLHSSEVNKPAIVHRNLSVEKVLIDQQFNPLIADCGLHKLL--ADDIVFSVLKTSAAM 582
           + YL S        +HR+L+   +L+       I D GL + L   +D            
Sbjct: 110 MRYLESKR-----FIHRDLAARNILLASDDKVKIGDFGLMRALPQNEDHYVMEEHLKVPF 164

Query: 583 GYLAPEYVTTGRFTERSDIFAFGVIILQI----------LTGSLVLTSSMRLAAESATFE 632
            + APE + T  F+  SD++ FGV + ++          L+GS +L              
Sbjct: 165 AWCAPESLRTRTFSHASDVWMFGVTLWEMFTYGEEPWAGLSGSQILKK------------ 212

Query: 633 NFIDRNLKGKFSESEAA--KLGKMALVCTHEDPENRPTMEAVIEEL 676
             ID+  + +    EA    +  + L C   +P +RPT  A+ E L
Sbjct: 213 --IDKEGE-RLERPEACPQDIYNVMLQCWAHNPADRPTFAALREFL 255

Protein Tyrosine Kinase (PTK) family; Activated Cdc42-associated kinase (Ack) subfamily; catalytic (c) domain. Ack subfamily members include Ack1, thirty-eight-negative kinase 1 (Tnk1), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ack subfamily members are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal catalytic domain, an SH3 domain, a Cdc42-binding CRIB domain, and a proline-rich region. They are mainly expressed in brain and skeletal tissues and are involved in the regulation of cell adhesion and growth, receptor degradation, and axonal guidance. Ack1 is also associated with androgen-independent prostate cancer progression. Tnk1 regulates TNFalpha signaling and may play an important role in cell death. Length = 257

>gnl|CDD|215061 PLN00113, PLN00113, leucine-rich repeat receptor-like protein kinase; Provisional

 Score = 83.4 bits (206), Expect = 2e-16
 Identities = 61/180 (33%), Positives = 81/180 (45%), Gaps = 25/180 (13%)

Query: 80  LTGKLSPSLSGLKCLSGLYLHYNSLSGEIPKEIRNLTELTDLYLDVNNLSGNIPPEIGSM 139
            TGK+  +L+ L  L  L L  N  SGEIPK +     LT L L  NNL+G IP  + S 
Sbjct: 320 FTGKIPVALTSLPRLQVLQLWSNKFSGEIPKNLGKHNNLTVLDLSTNNLTGEIPEGLCSS 379

Query: 140 ASLQVLQLCCNQLTGNIPAQIGSLKSLSVLTLQHNRLNGGIPDS---------------- 183
            +L  L L  N L G IP  +G+ +SL  + LQ N  +G +P                  
Sbjct: 380 GNLFKLILFSNSLEGEIPKSLGACRSLRRVRLQDNSFSGELPSEFTKLPLVYFLDISNNN 439

Query: 184 -LGNLG-------KLKRLDLSFNSLFGTIPESLANNAELLFLDVQNNTLSGIVPSALKRL 235
             G +         L+ L L+ N  FG +P+S  +   L  LD+  N  SG VP  L  L
Sbjct: 440 LQGRINSRKWDMPSLQMLSLARNKFFGGLPDSFGSK-RLENLDLSRNQFSGAVPRKLGSL 498

Length = 968

>gnl|CDD|173654 cd05108, PTKc_EGFR, Catalytic domain of the Protein Tyrosine Kinase, Epidermal Growth Factor Receptor

 Score = 80.8 bits (199), Expect = 2e-16
 Identities = 62/222 (27%), Positives = 108/222 (48%), Gaps = 28/222 (12%)

Query: 401 LEEVESATQCFSEVNLLGKGNFSSVYKGT-LRDG----TLVAIRSINVTSCKSEEAEFVK 455
           L+E E     F ++ +LG G F +VYKG  + +G      VAI+ +   +      E + 
Sbjct: 4   LKETE-----FKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILD 58

Query: 456 GLYLLTSLRHENIIRLRGFCCSRGRGECFLIYDFAPKGKLSKYLDQEE---GSSNVLDWS 512
             Y++ S+ + ++ RL G C +       LI    P G L  Y+ + +   GS  +L+W 
Sbjct: 59  EAYVMASVDNPHVCRLLGICLT---STVQLITQLMPFGCLLDYVREHKDNIGSQYLLNWC 115

Query: 513 TRVSIIIGIAKGIGYLHSSEVNKPAIVHRNLSVEKVLIDQQFNPLIADCGLHKLL-ADDI 571
            +      IAKG+ YL         +VHR+L+   VL+    +  I D GL KLL AD+ 
Sbjct: 116 VQ------IAKGMNYLEERR-----LVHRDLAARNVLVKTPQHVKITDFGLAKLLGADEK 164

Query: 572 VFSVLKTSAAMGYLAPEYVTTGRFTERSDIFAFGVIILQILT 613
            +        + ++A E +    +T +SD++++GV + +++T
Sbjct: 165 EYHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMT 206

Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EGFR (HER1, ErbB1) is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. Ligands for EGFR include EGF, heparin binding EGF-like growth factor (HBEGF), epiregulin, amphiregulin, TGFalpha, and betacellulin. Upon ligand binding, EGFR can form homo- or heterodimers with other EGFR subfamily members. The EGFR signaling pathway is one of the most important pathways regulating cell proliferation, differentiation, survival, and growth. Overexpression and mutation in the kinase domain of EGFR have been implicated in the development and progression of a variety of cancers. A number of monoclonal antibodies and small molecule inhibitors have been developed that target EGFR, including the antibodies Cetuximab and Panitumumab, which are used in combination with other therapies for the treatment of colorectal cancer and non-small cell lung carcinoma (NSCLC). The small molecule inhibitors Gefitinib (Iressa) and Erlotinib (Tarceva), already used for NSCLC, are undergoing clinical trials for other types of cancer including gastrointestinal, breast, head and neck, and bladder. Length = 316

>gnl|CDD|173634 cd05053, PTKc_FGFR, Catalytic domain of the Protein Tyrosine Kinases, Fibroblast Growth Factor Receptors

 Score = 80.2 bits (198), Expect = 2e-16
 Identities = 72/293 (24%), Positives = 127/293 (43%), Gaps = 51/293 (17%)

Query: 414 VNLLGKGNFSSVYKGTLRD------GTLVAIRSINVTSCKSEEAEFVKGLYLLTSL-RHE 466
              LG+G F  V K            + VA++ +   + + + ++ V  + ++  + +H+
Sbjct: 17  GKPLGEGAFGQVVKAEAVGLDNPNETSTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHK 76

Query: 467 NIIRLRGFCCSRGRGECFLIYDFAPKGKLSKYLD----QEEGSSNVLDWSTR-------- 514
           NII L G  C+   G  +++ ++A  G L  +L       E +S                
Sbjct: 77  NIINLLG-VCT-QEGPLYVVVEYAAHGNLRDFLRARRPPGEYASPDDPRPPEETLTQKDL 134

Query: 515 VSIIIGIAKGIGYLHSSEVNKPAIVHRNLSVEKVLIDQQFNPLIADCGLHKLLADDI--V 572
           VS    +A+G+ +L S +      +HR+L+   VL+ +     IAD GL    A DI  +
Sbjct: 135 VSFAYQVARGMEFLASKK-----CIHRDLAARNVLVTEDHVMKIADFGL----ARDIHHI 185

Query: 573 FSVLKTSAA---MGYLAPEYVTTGRFTERSDIFAFGVIILQILT--GSLVLTSSMRLAAE 627
               KT+     + ++APE +    +T +SD+++FGV++ +I T  GS      +     
Sbjct: 186 DYYRKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLLWEIFTLGGSPYPGIPV----- 240

Query: 628 SATFENFIDRNLK-GKFSESEA---AKLGKMALVCTHEDPENRPTMEAVIEEL 676
               E      LK G   E       +L  +   C HE P  RPT + ++E+L
Sbjct: 241 ----EELFK-LLKEGYRMEKPQNCTQELYHLMRDCWHEVPSQRPTFKQLVEDL 288

Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor (FGFR) subfamily; catalytic (c) domain. The FGFR subfamily consists of FGFR1, FGFR2, FGFR3, FGFR4, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K).PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, and to heparin/heparan sulfate (HS) results in the formation of a ternary complex, which leads to receptor dimerization and activation, and intracellular signaling. There are at least 23 FGFs and four types of FGFRs. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. FGF/FGFR signaling is important in the regulation of embryonic development, homeostasis, and regenerative processes. Depending on the cell type and stage, FGFR signaling produces diverse cellular responses including proliferation, growth arrest, differentiation, and apoptosis. Aberrant signaling leads to many human diseases such as skeletal, olfactory, and metabolic disorders, as well as cancer. Length = 293

>gnl|CDD|173672 cd05581, STKc_PDK1, Catalytic domain of the Protein Serine/Threonine Kinase, Phosphoinositide-dependent kinase 1

 Score = 78.8 bits (195), Expect = 4e-16
 Identities = 69/287 (24%), Positives = 118/287 (41%), Gaps = 46/287 (16%)

Query: 416 LLGKGNFSSVYKGTLR-DGTLVAIRSIN---VTSCKSEEAEFVKGLYLLTSLRHENIIRL 471
           ++G+G+FS+V     +      AI+ ++   +   K  +   ++   L     H  II+L
Sbjct: 8   IIGEGSFSTVVLAKEKETNKEYAIKILDKRQLIKEKKVKYVKIEKEVLTRLNGHPGIIKL 67

Query: 472 RGFCCSRGRGECFLIYDFAPKGKLSKYLDQEEGSSNVLDWSTRVSIIIGIAKGIGYLHSS 531
             +   +     + + ++AP G+L +Y+ ++ GS   LD          I   + YLHS 
Sbjct: 68  --YYTFQDEENLYFVLEYAPNGELLQYI-RKYGS---LDEKCTRFYAAEILLALEYLHSK 121

Query: 532 EVNKPAIVHRNLSVEKVLIDQQFNPLIADCGLHKLLADDIVFSVLKTSAAMG-------- 583
                 I+HR+L  E +L+D+  +  I D G  K+L  +      K  A           
Sbjct: 122 -----GIIHRDLKPENILLDKDMHIKITDFGTAKVLDPNSSPESNKGDATNIDSQIEKNR 176

Query: 584 -----------YLAPEYVTTGRFTERSDIFAFGVIILQILTGSLVLTSSMRLAAESATFE 632
                      Y++PE +      + SD++A G II Q+LTG        R + E  TF+
Sbjct: 177 RRFASFVGTAEYVSPELLNEKPAGKSSDLWALGCIIYQMLTG----KPPFRGSNEYLTFQ 232

Query: 633 NFIDRNLKGKFSE--SEAAK-LGKMALVCTHEDPENRPTMEAVIEEL 676
             +       F       AK L +  LV    DP++R  +    +EL
Sbjct: 233 KILKLEY--SFPPNFPPDAKDLIEKLLV---LDPQDRLGVNEGYDEL 274

Serine/Threonine Kinases (STKs), Phosphoinositide-dependent kinase 1 (PDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PDK1 carries an N-terminal catalytic domain and a C-terminal pleckstrin homology (PH) domain that binds phosphoinositides. It phosphorylates the activation loop of AGC kinases that are regulated by PI3K such as PKB, SGK, and PKC, among others, and is crucial for their activation. Thus, it contributes in regulating many processes including metabolism, growth, proliferation, and survival. PDK1 also has the ability to autophosphorylate and is constitutively active in mammalian cells. PDK1 is essential for normal embryo development and is important in regulating cell volume. Length = 280

>gnl|CDD|173659 cd05122, PKc_STE, Catalytic domain of STE family Protein Kinases

 Score = 78.0 bits (193), Expect = 5e-16
 Identities = 64/264 (24%), Positives = 116/264 (43%), Gaps = 21/264 (7%)

Query: 410 CFSEVNLLGKGNFSSVYKGT-LRDGTLVAIRSINVTSCKSEEAEFVKGLYLLTSLRHENI 468
            F  +  +GKG F  VYK    R G  VAI+ I + S + +E + +  + +L   +H NI
Sbjct: 1   LFEILEKIGKGGFGEVYKARHKRTGKEVAIKVIKLESKEKKE-KIINEIQILKKCKHPNI 59

Query: 469 IRLRGFCCSRGRGECFLIYDFAPKGKLSKYLDQEEGSSNVLDWSTRVSIIIGIAKGIGYL 528
           ++   +     + E +++ +F   G L   L     ++  L  S    +   + KG+ YL
Sbjct: 60  VKY--YGSYLKKDELWIVMEFCSGGSLKDLLK---STNQTLTESQIAYVCKELLKGLEYL 114

Query: 529 HSSEVNKPAIVHRNLSVEKVLIDQQFNPLIADCGLHKLLADDIVFSVLKTSAAMGYLAPE 588
           HS   N   I+HR++    +L+       + D GL   L+D    +         ++APE
Sbjct: 115 HS---NG--IIHRDIKAANILLTSDGEVKLIDFGLSAQLSDTKARN--TMVGTPYWMAPE 167

Query: 589 YVTTGRFTERSDIFAFGVIILQILTGSLVLTSSMRLAA--ESATFENFIDRNLKGKFSES 646
            +    +  ++DI++ G+  +++  G    +    + A  + AT      RN + K+S+ 
Sbjct: 168 VINGKPYDYKADIWSLGITAIELAEGKPPYSELPPMKALFKIATNGPPGLRNPE-KWSDE 226

Query: 647 EAAKLGKMALVCTHEDPENRPTME 670
                      C  ++PE RPT E
Sbjct: 227 ----FKDFLKKCLQKNPEKRPTAE 246

Protein Kinases (PKs), STE family, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The STE family is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases (STKs), protein tyrosine kinases (PTKs), RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This family is composed of STKs, and some dual-specificity PKs that phosphorylate both threonine and tyrosine residues of target proteins. Most members are kinases involved in mitogen-activated protein kinase (MAPK) signaling cascades, acting as MAPK kinases (MAPKKs), MAPK kinase kinases (MAPKKKs), or MAPK kinase kinase kinases (MAP4Ks). The MAPK signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAPK, which is phosphorylated and activated by a MAPKK, which itself is phosphorylated and activated by a MAPKKK. Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAPKKK to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. Other STE family members include p21-activated kinases (PAKs) and class III myosins, among others. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain, which can phosphorylate several cytoskeletal proteins, conventional myosin regulatory light chains, as well as autophosphorylate the C-terminal motor domain. They play an important role in maintaining the structural integrity of photoreceptor cell microvilli. Length = 253

>gnl|CDD|133240 cd05109, PTKc_HER2, Catalytic domain of the Protein Tyrosine Kinase, HER2

 Score = 78.5 bits (193), Expect = 6e-16
 Identities = 74/297 (24%), Positives = 128/297 (43%), Gaps = 48/297 (16%)

Query: 401 LEEVESATQCFSEVNLLGKGNFSSVYKGT-LRDG----TLVAIRSINVTSCKSEEAEFVK 455
           L+E E       +V +LG G F +VYKG  + DG      VAI+ +   +      E + 
Sbjct: 4   LKETE-----LKKVKVLGSGAFGTVYKGIWIPDGENVKIPVAIKVLRENTSPKANKEILD 58

Query: 456 GLYLLTSLRHENIIRLRGFCCSRGRGECFLIYDFAPKGKLSKYLDQEE---GSSNVLDWS 512
             Y++  +    + RL G C +       L+    P G L  Y+ + +   GS ++L+W 
Sbjct: 59  EAYVMAGVGSPYVCRLLGICLT---STVQLVTQLMPYGCLLDYVRENKDRIGSQDLLNWC 115

Query: 513 TRVSIIIGIAKGIGYLHSSEVNKPAIVHRNLSVEKVLIDQQFNPLIADCGLHKLL-ADDI 571
            +      IAKG+ YL   EV    +VHR+L+   VL+    +  I D GL +LL  D+ 
Sbjct: 116 VQ------IAKGMSYLE--EVR---LVHRDLAARNVLVKSPNHVKITDFGLARLLDIDET 164

Query: 572 VFSVLKTSAAMGYLAPEYVTTGRFTERSDIFAFGVIILQILTGSLVLTSSMRLAAESATF 631
            +        + ++A E +   RFT +SD++++GV + +++T              +  +
Sbjct: 165 EYHADGGKVPIKWMALESILHRRFTHQSDVWSYGVTVWELMTFG------------AKPY 212

Query: 632 ENFIDRNLKGKFSESE-------AAKLGKMALV-CTHEDPENRPTMEAVIEELTVAA 680
           +    R +     + E             M +V C   D E RP    +++E +  A
Sbjct: 213 DGIPAREIPDLLEKGERLPQPPICTIDVYMIMVKCWMIDSECRPRFRELVDEFSRMA 269

Protein Tyrosine Kinase (PTK) family; HER2 (ErbB2, HER2/neu); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER2 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. HER2 does not bind to any known EGFR subfamily ligands, but contributes to the kinase activity of all possible heterodimers. It acts as the preferred partner with other ligand-bound EGFR proteins and functions as a signal amplifier, with the HER2-HER3 heterodimer being the most potent pair in mitogenic signaling. HER2 plays an important role in cell development, proliferation, survival and motility. Overexpression of HER2 results in its activation and downstream signaling, even in the absence of ligand. HER2 overexpression, mainly due to gene amplification, has been shown in a variety of human cancers. Its role in breast cancer is especially well-documented. HER2 is up-regulated in about 25% of breast tumors and is associated with increases in tumor aggressiveness, recurrence and mortality. HER2 is a target for monoclonal antibodies and small molecule inhibitors, which are being developed as treatments for cancer. The first humanized antibody approved for clinical use is Trastuzumab (Herceptin), which is being used in combination with other therapies to improve the survival rates of patients with HER2-overexpressing breast cancer. Length = 279

>gnl|CDD|133221 cd05090, PTKc_Ror1, Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 1

 Score = 78.1 bits (192), Expect = 8e-16
 Identities = 60/219 (27%), Positives = 107/219 (48%), Gaps = 26/219 (11%)

Query: 417 LGKGNFSSVYKGTL-----RDGTLVAIRSINVTSCKSEEAEFVKGLYLLTSLRHENIIRL 471
           LG+  F  +YKG L         LVAI+++   +   +  EF +   L+  L H NI+ L
Sbjct: 13  LGECAFGKIYKGHLYLPGMDHAQLVAIKTLKDINNPQQWGEFQQEASLMAELHHPNIVCL 72

Query: 472 RGFCCSRGRGECFLIYDFAPKGKLSKYL-------------DQEEGSSNVLDWSTRVSII 518
            G   ++ +  C L +++  +G L ++L             D++    + LD    + I 
Sbjct: 73  LG-VVTQEQPVCML-FEYLNQGDLHEFLIMRSPHSDVGCSSDEDGTVKSSLDHGDFLHIA 130

Query: 519 IGIAKGIGYLHSSEVNKPAIVHRNLSVEKVLIDQQFNPLIADCGLHKLLADDIVFSVL-K 577
           I IA G+ YL S        VH++L+   +LI +Q +  I+D GL + +     + V  K
Sbjct: 131 IQIAAGMEYLSSH-----FFVHKDLAARNILIGEQLHVKISDLGLSREIYSADYYRVQPK 185

Query: 578 TSAAMGYLAPEYVTTGRFTERSDIFAFGVIILQILTGSL 616
           +   + ++ PE +  G+F+  SDI++FGV++ +I +  L
Sbjct: 186 SLLPIRWMPPEAIMYGKFSSDSDIWSFGVVLWEIFSFGL 224

Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 1 (Ror1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. Ror kinases are expressed in many tissues during development. Avian Ror1 was found to be involved in late limb development. Studies in mice reveal that Ror1 is important in the regulation of neurite growth in central neurons, as well as in respiratory development. Loss of Ror1 also enhances the heart and skeletal abnormalities found in Ror2-deficient mice. Length = 283

>gnl|CDD|173633 cd05052, PTKc_Abl, Catalytic domain of the Protein Tyrosine Kinase, Abelson kinase

 Score = 77.6 bits (191), Expect = 9e-16
 Identities = 56/263 (21%), Positives = 120/263 (45%), Gaps = 16/263 (6%)

Query: 415 NLLGKGNFSSVYKGTL-RDGTLVAIRSINVTSCKSEEAEFVKGLYLLTSLRHENIIRLRG 473
           + LG G +  VY+G   +    VA++++   + + EE  F+K   ++  ++H N+++L G
Sbjct: 12  HKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVEE--FLKEAAVMKEIKHPNLVQLLG 69

Query: 474 FCCSRGRGECFLIYDFAPKGKLSKYLDQEEGSSNVLDWSTRVSIIIGIAKGIGYLHSSEV 533
            C        ++I +F   G L  YL   E +   ++    + +   I+  + YL     
Sbjct: 70  VCTREP--PFYIITEFMTYGNLLDYL--RECNRQEVNAVVLLYMATQISSAMEYLEKKN- 124

Query: 534 NKPAIVHRNLSVEKVLIDQQFNPLIADCGLHKLLADDIVFSVLKTSAAMGYLAPEYVTTG 593
                +HR+L+    L+ +     +AD GL +L+  D   +       + + APE +   
Sbjct: 125 ----FIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHAGAKFPIKWTAPESLAYN 180

Query: 594 RFTERSDIFAFGVIILQILTGSLVLTSSMRLAAESATFENFIDRNLKGKFSESEAAKLGK 653
           +F+ +SD++AFGV++ +I T  +    S     + +     +++  + +  E    K+ +
Sbjct: 181 KFSIKSDVWAFGVLLWEIATYGM----SPYPGIDLSQVYELLEKGYRMERPEGCPPKVYE 236

Query: 654 MALVCTHEDPENRPTMEAVIEEL 676
           +   C   +P +RP+   + +  
Sbjct: 237 LMRACWQWNPSDRPSFAEIHQAF 259

Protein Tyrosine Kinase (PTK) family; Abelson (Abl) kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Abl (or c-Abl) is a ubiquitously-expressed cytoplasmic (or nonreceptor) tyr kinase that contains SH3, SH2, and tyr kinase domains in its N-terminal region, as well as nuclear localization motifs, a putative DNA-binding domain, and F- and G-actin binding domains in its C-terminal tail. It also contains a short autoinhibitory cap region in its N-terminus. Abl is normally inactive and requires phosphorylation and myristoylation for activation. Abl function depends on its subcellular localization. In the cytoplasm, Abl plays a role in cell proliferation and survival. In response to DNA damage or oxidative stress, Abl is transported to the nucleus where it induces apoptosis. In chronic myelogenous leukemia (CML) patients, an aberrant translocation results in the replacement of the first exon of Abl with the BCR (breakpoint cluster region) gene. The resulting BCR-Abl fusion protein is constitutively active and associates into tetramers, resulting in a hyperactive kinase sending a continuous signal. This leads to uncontrolled proliferation, morphological transformation and anti-apoptotic effects. BCR-Abl is the target of selective inhibitors, such as imatinib (Gleevec), used in the treatment of CML. Abl2, also known as ARG (Abelson-related gene), is thought to play a cooperative role with Abl in the proper development of the nervous system. The Tel-ARG fusion protein, resulting from reciprocal translocation between chromosomes 1 and 12, is associated with acute myeloid leukemia (AML). The TEL gene is a frequent fusion partner of other tyr kinase oncogenes, including Tel/Abl, Tel/PDGFRbeta, and Tel/Jak2, found in patients with leukemia and myeloproliferative disorders. Length = 263

>gnl|CDD|173657 cd05113, PTKc_Btk_Bmx, Catalytic domain of the Protein Tyrosine Kinases, Bruton's tyrosine kinase and Bone marrow kinase on the X chromosome

 Score = 77.2 bits (190), Expect = 1e-15
 Identities = 69/259 (26%), Positives = 120/259 (46%), Gaps = 20/259 (7%)

Query: 417 LGKGNFSSVYKGTLRDGTLVAIRSINVTSCKSEEAEFVKGLYLLTSLRHENIIRLRGFCC 476
           LG G F  V  G  R    VAI+ I   S    E EF++   ++  L HE +++L G  C
Sbjct: 12  LGTGQFGVVKYGKWRGQYDVAIKMIKEGSM--SEDEFIEEAKVMMKLSHEKLVQLYG-VC 68

Query: 477 SRGRGECFLIYDFAPKGKLSKYLDQEEGSSNVLDWSTRVSIIIGIAKGIGYLHSSEVNKP 536
           ++ R   +++ ++   G L  YL +E G       S  + +   + +G+ YL S +    
Sbjct: 69  TKQR-PIYIVTEYMSNGCLLNYL-REHGKR--FQPSQLLEMCKDVCEGMAYLESKQ---- 120

Query: 537 AIVHRNLSVEKVLIDQQFNPLIADCGLHKLLADDIVFSVLKTSAAMGYLAPEYVTTGRFT 596
             +HR+L+    L+D Q    ++D GL + + DD   S + +   + +  PE +   +F+
Sbjct: 121 -FIHRDLAARNCLVDDQGCVKVSDFGLSRYVLDDEYTSSVGSKFPVRWSPPEVLLYSKFS 179

Query: 597 ERSDIFAFGVIILQILT-GSLVLTSSMRLAAESATFENFID-RNLKGKFSESEAAKLGKM 654
            +SD++AFGV++ ++ + G +           S T E       L      SE  K+  +
Sbjct: 180 SKSDVWAFGVLMWEVYSLGKM----PYERFNNSETVEKVSQGLRLYRPHLASE--KVYAI 233

Query: 655 ALVCTHEDPENRPTMEAVI 673
              C HE  E RPT + ++
Sbjct: 234 MYSCWHEKAEERPTFQQLL 252

Protein Tyrosine Kinase (PTK) family; Bruton's tyrosine kinase (Btk) and Bone marrow kinase on the X chromosome (Bmx); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Btk and Bmx (also named Etk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. In addition, Btk contains the Tec homology (TH) domain with proline-rich and zinc-binding regions. Tec kinases are expressed mainly by haematopoietic cells. Btk is expressed in B-cells, and a variety of myeloid cells including mast cells, platelets, neutrophils, and dendrictic cells. It interacts with a variety of partners, from cytosolic proteins to nuclear transcription factors, suggesting a diversity of functions. Stimulation of a diverse array of cell surface receptors, including antigen engagement of the B-cell receptor (BCR), leads to PH-mediated membrane translocation of Btk and subsequent phosphorylation by Src kinase and activation. Btk plays an important role in the life cycle of B-cells including their development, differentiation, proliferation, survival, and apoptosis. Mutations in Btk cause the primary immunodeficiency disease, X-linked agammaglobulinaemia (XLA) in humans. Bmx is primarily expressed in bone marrow and the arterial endothelium, and plays an important role in ischemia-induced angiogenesis. It facilitates arterial growth, capillary formation, vessel maturation, and bone marrow-derived endothelial progenitor cell mobilization. Length = 256

>gnl|CDD|133246 cd05115, PTKc_Zap-70, Catalytic domain of the Protein Tyrosine Kinase, Zeta-chain-associated protein of 70kDa

 Score = 76.5 bits (188), Expect = 2e-15
 Identities = 57/205 (27%), Positives = 100/205 (48%), Gaps = 22/205 (10%)

Query: 417 LGKGNFSSVYKGT--LRDGTL-VAIRSINVTSCKSEEAEFVKGLYLLTSLRHENIIRLRG 473
           LG GNF  V KG   +R   + VAI+ +   + KS   E ++   ++  L +  I+R+ G
Sbjct: 3   LGSGNFGCVKKGVYKMRKKQIDVAIKVLKNENEKSVRDEMMREAEIMHQLDNPYIVRMIG 62

Query: 474 FCCSRGRGECFLIYDFAPKGKLSKYL---DQEEGSSNVLDWSTRVSIIIGIAKGIGYLHS 530
            C +       L+ + A  G L+K+L     E   SNV++   +VS+      G+ YL  
Sbjct: 63  VCEAEA---LMLVMEMASGGPLNKFLSGKKDEITVSNVVELMHQVSM------GMKYLEG 113

Query: 531 SEVNKPAIVHRNLSVEKVLIDQQFNPLIADCGLHKLLADDIVFSVLKTSAA--MGYLAPE 588
                   VHR+L+   VL+  Q    I+D GL K L  D  +   +++    + + APE
Sbjct: 114 KN-----FVHRDLAARNVLLVNQHYAKISDFGLSKALGADDSYYKARSAGKWPLKWYAPE 168

Query: 589 YVTTGRFTERSDIFAFGVIILQILT 613
            +   +F+ RSD++++G+ + +  +
Sbjct: 169 CINFRKFSSRSDVWSYGITMWEAFS 193

Protein Tyrosine Kinase (PTK) family; Zeta-chain-associated protein of 70kDa (Zap-70); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Zap-70 is a member of the Syk subfamily of kinases, which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Zap-70 is primarily expressed in T-cells and NK cells, and is a crucial component in T-cell receptor (TCR) signaling. Zap-70 binds the phosphorylated ITAM (immunoreceptor tyr activation motif) sequences of the activated TCR zeta-chain through its SH2 domains, leading to its phosphorylation and activation. It then phosphorylates target proteins, which propagate the signals to downstream pathways. Zap-70 is hardly detected in normal peripheral B-cells, but is present in some B-cell malignancies. It is used as a diagnostic marker for chronic lymphocytic leukemia (CLL) as it is associated with the more aggressive subtype of the disease. Length = 257

>gnl|CDD|132963 cd06632, STKc_MEKK1_plant, Catalytic domain of the Protein Serine/Threonine Kinase, Plant MAP/ERK kinase kinase 1

 Score = 75.9 bits (187), Expect = 3e-15
 Identities = 62/207 (29%), Positives = 97/207 (46%), Gaps = 23/207 (11%)

Query: 416 LLGKGNFSSVYKG-TLRDGTLVAIRSINVTSCKSEEAEFVKGLY----LLTSLRHENIIR 470
           LLG G+F SVY+G  L DG   A++ +++        E VK L     LL+ L+H NI++
Sbjct: 7   LLGSGSFGSVYEGLNLDDGDFFAVKEVSLADDGQTGQEAVKQLEQEIALLSKLQHPNIVQ 66

Query: 471 LRGFCCSRGRGECFLIYDFAPKGKLSKYLDQEEGS--SNVLDWSTRVSIIIGIAKGIGYL 528
             G          FL  +  P G L+K L ++ GS    V+   TR      I  G+ YL
Sbjct: 67  YLGTEREEDNLYIFL--ELVPGGSLAKLL-KKYGSFPEPVIRLYTR-----QILLGLEYL 118

Query: 529 HSSEVNKPAIVHRNLSVEKVLIDQQFNPLIADCGLHKLLADDIVFSVLKTSAAMGYLAPE 588
           H         VHR++    +L+D      +AD G+ K + +       K S    ++APE
Sbjct: 119 HDRN-----TVHRDIKGANILVDTNGVVKLADFGMAKQVVEFSFAKSFKGSPY--WMAPE 171

Query: 589 YV-TTGRFTERSDIFAFGVIILQILTG 614
            +   G +   +DI++ G  +L++ TG
Sbjct: 172 VIAQQGGYGLAADIWSLGCTVLEMATG 198

Serine/threonine kinases (STKs), plant MAP/ERK kinase kinase 1 (MEKK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The plant MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of plant mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) including Arabidopsis thaliana MEKK1 and MAPKKK3. MEKK1 is a MAPKKK that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Arabidopsis thaliana MEKK1 activates MPK4, a MAPK that regulates systemic acquired resistance. MEKK1 also participates in the regulation of temperature-sensitive and tissue-specific cell death. Length = 258

>gnl|CDD|133247 cd05116, PTKc_Syk, Catalytic domain of the Protein Tyrosine Kinase, Spleen tyrosine kinase

 Score = 74.2 bits (182), Expect = 1e-14
 Identities = 63/268 (23%), Positives = 119/268 (44%), Gaps = 34/268 (12%)

Query: 417 LGKGNFSSVYKG---TLRDGTLVAIRSI-NVTSCKSEEAEFVKGLYLLTSLRHENIIRLR 472
           LG GNF +V KG     +    VA++ + N  +  + + E ++   ++  L +  I+R+ 
Sbjct: 3   LGSGNFGTVKKGMYKMKKSEKTVAVKILKNDNNDPALKDELLREANVMQQLDNPYIVRMI 62

Query: 473 GFCCSRGRGECF-LIYDFAPKGKLSKYLDQEEGSS--NVLDWSTRVSIIIGIAKGIGYLH 529
           G C      E + L+ + A  G L+K+L + +  +  N+ +   +VS+      G+ YL 
Sbjct: 63  GIC----EAESWMLVMELAELGPLNKFLQKNKHVTEKNITELVHQVSM------GMKYLE 112

Query: 530 SSEVNKPAIVHRNLSVEKVLIDQQFNPLIADCGLHKLLADDIVFSVLKTSAA--MGYLAP 587
            +       VHR+L+   VL+  Q    I+D GL K L  D  +   KT     + + AP
Sbjct: 113 ETN-----FVHRDLAARNVLLVTQHYAKISDFGLSKALGADENYYKAKTHGKWPVKWYAP 167

Query: 588 EYVTTGRFTERSDIFAFGVIILQILTGSLVLTSSMRLAAESATFENFIDRNLKGKFSESE 647
           E +   +F+ +SD+++FGV++ +  +        M+    +   E+       G+  E  
Sbjct: 168 ECMNYYKFSSKSDVWSFGVLMWEAFSYGQKPYKGMKGNEVTQMIES-------GERMECP 220

Query: 648 AA---KLGKMALVCTHEDPENRPTMEAV 672
                ++  +  +C     + RP    V
Sbjct: 221 QRCPPEMYDLMKLCWTYGVDERPGFAVV 248

Protein Tyrosine Kinase (PTK) family; Spleen tyrosine kinase (Syk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk, together with Zap-70, form the Syk subfamily of kinases which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Syk was first cloned from the spleen, and its function in hematopoietic cells is well-established. Syk is involved in the signaling downstream of activated receptors (including B-cell and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferation, differentiation, survival, adhesion, migration, and phagocytosis. More recently, Syk expression has been detected in other cell types (including epithelial cells, vascular endothelial cells, neurons, hepatocytes, and melanocytes), suggesting a variety of biological functions in non-immune cells. Syk plays a critical role in maintaining vascular integrity and in wound healing during embryogenesis. It also regulates Vav3, which is important in osteoclast function including bone development. In breast epithelial cells, where Syk acts as a negative regulator for epidermal growth factor receptor (EGFR) signaling, loss of Syk expression is associated with abnormal proliferation during cancer development suggesting a potential role as a tumor suppressor. In mice, Syk has been shown to inhibit malignant transformation of mammary epithelial cells induced with murine mammary tumor virus (MMTV). Length = 257

>gnl|CDD|173731 cd06627, STKc_Cdc7_like, Catalytic domain of Cell division control protein 7-like Protein Serine/Threonine Kinases

 Score = 74.2 bits (183), Expect = 1e-14
 Identities = 55/205 (26%), Positives = 98/205 (47%), Gaps = 20/205 (9%)

Query: 415 NLLGKGNFSSVYKG-TLRDGTLVAIRSINVTSCKSEEAEFVKG-LYLLTSLRHENIIRLR 472
           +L+G+G F  VYKG  L  G  VAI+ I++   K E  + +   + LL +L+H NI++  
Sbjct: 6   DLIGRGAFGVVYKGLNLETGDFVAIKQISLEKIKEEALKSIMQEIDLLKNLKHPNIVKYI 65

Query: 473 GFCCSRGRGECFLIYDFAPKGKLSKYLDQEEGSSNVLDWSTRVSI-IIGIAKGIGYLHSS 531
           G          ++I ++A  G L + + +       L     V++ +  + +G+ YLH  
Sbjct: 66  GS--IETSDSLYIILEYAENGSLRQIIKKFGPFPESL-----VAVYVYQVLQGLAYLHEQ 118

Query: 532 EVNKPAIVHRNLSVEKVLIDQQFNPLIADCGLHKLLADD--IVFSVLKTSAAMGYLAPEY 589
                 ++HR++    +L  +     +AD G+   L D      SV+ T   M   APE 
Sbjct: 119 -----GVIHRDIKAANILTTKDGVVKLADFGVATKLNDVSKDDASVVGTPYWM---APEV 170

Query: 590 VTTGRFTERSDIFAFGVIILQILTG 614
           +     +  SDI++ G  ++++LTG
Sbjct: 171 IEMSGASTASDIWSLGCTVIELLTG 195

Serine/threonine kinases (STKs), (Cdc7)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Cdc7-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include Schizosaccharomyces pombe Cdc7, Saccharomyces cerevisiae Cdc15, Arabidopsis thaliana mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) epsilon, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Fission yeast Cdc7 is essential for cell division by playing a key role in the initiation of septum formation and cytokinesis. Budding yeast Cdc15 functions to coordinate mitotic exit with cytokinesis. Arabidopsis MAPKKK epsilon is required for pollen development in the plasma membrane. Length = 254

>gnl|CDD|173639 cd05066, PTKc_EphR_A, Catalytic domain of the Protein Tyrosine Kinases, Class EphA Ephrin Receptors

 Score = 74.2 bits (182), Expect = 1e-14
 Identities = 48/210 (22%), Positives = 100/210 (47%), Gaps = 16/210 (7%)

Query: 410 CFSEVNLLGKGNFSSVYKGTLR----DGTLVAIRSINVTSCKSEEAEFVKGLYLLTSLRH 465
           C     ++G G F  V  G L+        VAI+++     + +  +F+    ++    H
Sbjct: 5   CIKIEKVIGAGEFGEVCSGRLKLPGKREIPVAIKTLKAGYTEKQRRDFLSEASIMGQFDH 64

Query: 466 ENIIRLRGFCCSRGRGECFLIYDFAPKGKLSKYLDQEEGSSNVLDWSTRVSIIIGIAKGI 525
            NII L G   ++ +    ++ ++   G L  +L + +G   V+     V ++ GIA G+
Sbjct: 65  PNIIHLEG-VVTKSK-PVMIVTEYMENGSLDAFLRKHDGQFTVIQL---VGMLRGIASGM 119

Query: 526 GYLHSSEVNKPAIVHRNLSVEKVLIDQQFNPLIADCGLHKLLADD--IVFSVLKTSAAMG 583
            YL          VHR+L+   +L++      ++D GL ++L DD    ++       + 
Sbjct: 120 KYLSDM-----GYVHRDLAARNILVNSNLVCKVSDFGLSRVLEDDPEAAYTTRGGKIPIR 174

Query: 584 YLAPEYVTTGRFTERSDIFAFGVIILQILT 613
           + APE +   +FT  SD++++G+++ ++++
Sbjct: 175 WTAPEAIAYRKFTSASDVWSYGIVMWEVMS 204

Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; most class EphA receptors including EphA3, EphA4, EphA5, and EphA7, but excluding EphA1, EphA2 and EphA10; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. One exception is EphA4, which also binds ephrins-B2/B3. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). Ephrin/EphR interaction mainly results in cell-cell repulsion or adhesion, making it important in neural development and plasticity, cell morphogenesis, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. EphARs and ephrin-A ligands are expressed in multiple areas of the developing brain, especially in the retina and tectum. They are part of a system controlling retinotectal mapping. Length = 267

>gnl|CDD|133213 cd05082, PTKc_Csk, Catalytic domain of the Protein Tyrosine Kinase, C-terminal Src kinase

 Score = 73.9 bits (181), Expect = 1e-14
 Identities = 65/264 (24%), Positives = 119/264 (45%), Gaps = 28/264 (10%)

Query: 417 LGKGNFSSVYKGTLRDGTLVAIRSINVTSCKSEEAEFVKGLYLLTSLRHENIIRLRGFCC 476
           +GKG F  V  G  R G  VA++ I   +       F+    ++T LRH N+++L G   
Sbjct: 14  IGKGEFGDVMLGDYR-GNKVAVKCIKNDATAQA---FLAEASVMTQLRHSNLVQLLGVIV 69

Query: 477 SRGRGECFLIYDFAPKGKLSKYLDQEEGSSNVLDWSTRVSIIIGIAKGIGYLHSSEVNKP 536
              +G  +++ ++  KG L  YL +  G S VL     +   + + + + YL ++     
Sbjct: 70  EE-KGGLYIVTEYMAKGSLVDYL-RSRGRS-VLGGDCLLKFSLDVCEAMEYLEANN---- 122

Query: 537 AIVHRNLSVEKVLIDQQFNPLIADCGLHKLLADDIVFSVLKTSA-AMGYLAPEYVTTGRF 595
             VHR+L+   VL+ +     ++D GL K  +     S   T    + + APE +   +F
Sbjct: 123 -FVHRDLAARNVLVSEDNVAKVSDFGLTKEAS-----STQDTGKLPVKWTAPEALREKKF 176

Query: 596 TERSDIFAFGVIILQILTGSLVLTSSMRLAAESATFENFIDRNLKG-KFSESEAAKLGKM 654
           + +SD+++FG+++ +I        S  R+       ++ + R  KG K    +       
Sbjct: 177 STKSDVWSFGILLWEIY-------SFGRVPYPRIPLKDVVPRVEKGYKMDAPDGCPPVVY 229

Query: 655 ALV--CTHEDPENRPTMEAVIEEL 676
            ++  C H D   RP+   + E+L
Sbjct: 230 DVMKQCWHLDAATRPSFLQLREQL 253

Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk catalyzes the tyr phosphorylation of the regulatory C-terminal tail of Src kinases, resulting in their inactivation. Csk is expressed in a wide variety of tissues. As a negative regulator of Src, Csk plays a role in cell proliferation, survival, and differentiation, and consequently, in cancer development and progression. In addition, Csk also shows Src-independent functions. It is a critical component in G-protein signaling, and plays a role in cytoskeletal reorganization and cell migration. Length = 256

>gnl|CDD|173648 cd05092, PTKc_TrkA, Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase A

 Score = 74.3 bits (182), Expect = 2e-14
 Identities = 58/215 (26%), Positives = 103/215 (47%), Gaps = 26/215 (12%)

Query: 417 LGKGNFSSVYKGTL------RDGTLVAIRSINVTSCKSEEAEFVKGLYLLTSLRHENIIR 470
           LG+G F  V+          +D  LVA++++   S +S   +F +   LLT L+H++I+R
Sbjct: 13  LGEGAFGKVFLAECHNLLPEQDKMLVAVKALKEAS-ESARQDFQREAELLTVLQHQHIVR 71

Query: 471 LRGFCCSRGRGECFLIYDFAPKGKLSKYLDQEEGSSNVLDWSTRVS-----------III 519
             G  C+ GR    +++++   G L+++L      + +L     V+           I  
Sbjct: 72  FYG-VCTEGR-PLLMVFEYMRHGDLNRFLRSHGPDAKILAGGEDVAPGQLTLGQMLAIAS 129

Query: 520 GIAKGIGYLHSSEVNKPAIVHRNLSVEKVLIDQQFNPLIADCGLHKLLADDIVFSVL-KT 578
            IA G+ YL S        VHR+L+    L+ Q     I D G+ + +     + V  +T
Sbjct: 130 QIASGMVYLASLH-----FVHRDLATRNCLVGQGLVVKIGDFGMSRDIYSTDYYRVGGRT 184

Query: 579 SAAMGYLAPEYVTTGRFTERSDIFAFGVIILQILT 613
              + ++ PE +   +FT  SDI++FGV++ +I T
Sbjct: 185 MLPIRWMPPESILYRKFTTESDIWSFGVVLWEIFT 219

Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase A (TrkA); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkA is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkA to its ligand, nerve growth factor (NGF), results in receptor oligomerization and activation of the catalytic domain. TrkA is expressed mainly in neural-crest-derived sensory and sympathetic neurons of the peripheral nervous system, and in basal forebrain cholinergic neurons of the central nervous system. It is critical for neuronal growth, differentiation and survival. Alternative TrkA splicing has been implicated as a pivotal regulator of neuroblastoma (NB) behavior. Normal TrkA expression is associated with better NB prognosis, while the hypoxia-regulated TrkAIII splice variant promotes NB pathogenesis and progression. Aberrant TrkA expression has also been demonstrated in non-neural tumors including prostate, breast, lung, and pancreatic cancers. Length = 280

>gnl|CDD|133205 cd05074, PTKc_Tyro3, Catalytic domain of the Protein Tyrosine Kinase, Tyro3

 Score = 73.8 bits (181), Expect = 2e-14
 Identities = 67/273 (24%), Positives = 122/273 (44%), Gaps = 21/273 (7%)

Query: 416 LLGKGNFSSVYKGTLR--DGTL--VAIRSINV-TSCKSEEAEFVKGLYLLTSLRHENIIR 470
           +LGKG F SV +  L+  DG+   VA++ +       S+  EF++    +    H N+I+
Sbjct: 6   MLGKGEFGSVREAQLKSEDGSFQKVAVKMLKADIFSSSDIEEFLREAACMKEFDHPNVIK 65

Query: 471 LRGFCC-SRGRGEC---FLIYDFAPKGKLSKYLDQEEGSSN--VLDWSTRVSIIIGIAKG 524
           L G    SR +G      +I  F   G L  +L           L   T V  +I IA G
Sbjct: 66  LIGVSLRSRAKGRLPIPMVILPFMKHGDLHTFLLMSRIGEEPFTLPLQTLVRFMIDIASG 125

Query: 525 IGYLHSSEVNKPAIVHRNLSVEKVLIDQQFNPLIADCGL-HKLLADDIVFSVLKTSAAMG 583
           + YL S        +HR+L+    ++++     +AD GL  K+ + D       +   + 
Sbjct: 126 MEYLSSKN-----FIHRDLAARNCMLNENMTVCVADFGLSKKIYSGDYYRQGCASKLPVK 180

Query: 584 YLAPEYVTTGRFTERSDIFAFGVIILQILTGSLVLTSSMRLAAESATFENFIDRNLKGKF 643
           +LA E +    +T  SD++AFGV + +I+T       +     E++   N++ +  + K 
Sbjct: 181 WLALESLADNVYTTHSDVWAFGVTMWEIMT----RGQTPYAGVENSEIYNYLIKGNRLKQ 236

Query: 644 SESEAAKLGKMALVCTHEDPENRPTMEAVIEEL 676
                  + ++   C   +P+ RP+ + + ++L
Sbjct: 237 PPDCLEDVYELMCQCWSPEPKCRPSFQHLRDQL 269

Protein Tyrosine Kinase (PTK) family; Tyro3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyro3 (or Sky) is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Tyro3 is predominantly expressed in the central nervous system and the brain, and functions as a neurotrophic factor. It is also expressed in osteoclasts and has a role in bone resorption. Length = 273

>gnl|CDD|133193 cd05062, PTKc_IGF-1R, Catalytic domain of the Protein Tyrosine Kinase, Insulin-like Growth Factor-1 Receptor

 Score = 73.5 bits (180), Expect = 2e-14
 Identities = 56/210 (26%), Positives = 103/210 (49%), Gaps = 20/210 (9%)

Query: 417 LGKGNFSSVY----KGTLRDG--TLVAIRSINVTSCKSEEAEFVKGLYLLTSLRHENIIR 470
           LG+G+F  VY    KG ++D   T VAI+++N  +   E  EF+    ++      +++R
Sbjct: 14  LGQGSFGMVYEGIAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKEFNCHHVVR 73

Query: 471 LRGFCCSRGRGECFLIYDFAPKGKLSKYL-----DQEEGSSNVLDWSTRVSIIIG-IAKG 524
           L G   S+G+    +I +   +G L  YL     + E           ++  + G IA G
Sbjct: 74  LLG-VVSQGQ-PTLVIMELMTRGDLKSYLRSLRPEMENNPVQAPPSLKKMIQMAGEIADG 131

Query: 525 IGYLHSSEVNKPAIVHRNLSVEKVLIDQQFNPLIADCGLHK-LLADDIVFSVLKTSAAMG 583
           + YL++++      VHR+L+    ++ + F   I D G+ + +   D      K    + 
Sbjct: 132 MAYLNANK-----FVHRDLAARNCMVAEDFTVKIGDFGMTRDIYETDYYRKGGKGLLPVR 186

Query: 584 YLAPEYVTTGRFTERSDIFAFGVIILQILT 613
           +++PE +  G FT  SD+++FGV++ +I T
Sbjct: 187 WMSPESLKDGVFTTYSDVWSFGVVLWEIAT 216

Protein Tyrosine Kinase (PTK) family; Insulin-like Growth Factor-1 Receptor (IGF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. IGF-1R is a receptor tyr kinases (RTK) that is composed of two alphabeta heterodimers. Binding of the ligand (IGF-1 or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, which stimulates downstream kinase activities and biological function. IGF-1R signaling is important in the differentiation, growth, and survival of normal cells. In cancer cells, where it is frequently overexpressed, IGF-1R is implicated in proliferation, the suppression of apoptosis, invasion, and metastasis. IGF-1R is being developed as a therapeutic target in cancer treatment. Length = 277

>gnl|CDD|143345 cd07840, STKc_CDK9_like, Catalytic domain of Cyclin-Dependent protein Kinase 9-like Serine/Threonine Kinases

 Score = 73.7 bits (182), Expect = 2e-14
 Identities = 44/155 (28%), Positives = 77/155 (49%), Gaps = 23/155 (14%)

Query: 417 LGKGNFSSVYKG-TLRDGTLVAIRSINVTSCKSEEAEF-------VKGLYLLTSLRHENI 468
           +G+G +  VYK    + G LVA++ I +   ++E+  F       +K   LL  LRH NI
Sbjct: 7   IGEGTYGQVYKARNKKTGELVALKKIRM---ENEKEGFPITAIREIK---LLQKLRHPNI 60

Query: 469 IRLRGFCCSRGRGECFLIYDFAPKGKLSKYLDQEEGSSNVLDWSTRVSIIIGIAKGIGYL 528
           +RL+    S+G+G  ++++++     L+  LD  E        S     +  + +G+ YL
Sbjct: 61  VRLKEIVTSKGKGSIYMVFEYMDH-DLTGLLDSPEVK---FTESQIKCYMKQLLEGLQYL 116

Query: 529 HSSEVNKPAIVHRNLSVEKVLIDQQFNPLIADCGL 563
           HS+      I+HR++    +LI+      +AD GL
Sbjct: 117 HSN-----GILHRDIKGSNILINNDGVLKLADFGL 146

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK9 and CDK12 from higher eukaryotes, yeast BUR1, C-type plant CDKs (CdkC), and similar proteins. CDK9, BUR1, and CdkC are functionally equivalent. They act as a kinase for the C-terminal domain of RNA polymerase II and participate in regulating mutliple steps of gene expression including transcription elongation and RNA processing. CDK9 and CdkC associate with T-type cyclins while BUR1 associates with the cyclin BUR2. CDK12 is a unique CDK that contains an arginine/serine-rich (RS) domain, which is predominantly found in splicing factors. CDK12 interacts with cyclins L1 and L2, and participates in regulating transcription and alternative splicing. Length = 287

>gnl|CDD|215061 PLN00113, PLN00113, leucine-rich repeat receptor-like protein kinase; Provisional

 Score = 76.0 bits (187), Expect = 3e-14
 Identities = 43/113 (38%), Positives = 60/113 (53%)

Query: 69  KVANISLQGKGLTGKLSPSLSGLKCLSGLYLHYNSLSGEIPKEIRNLTELTDLYLDVNNL 128
           ++ N+ L     +G +   L  L  L  L L  N LSGEIP E+ +  +L  L L  N L
Sbjct: 476 RLENLDLSRNQFSGAVPRKLGSLSELMQLKLSENKLSGEIPDELSSCKKLVSLDLSHNQL 535

Query: 129 SGNIPPEIGSMASLQVLQLCCNQLTGNIPAQIGSLKSLSVLTLQHNRLNGGIP 181
           SG IP     M  L  L L  NQL+G IP  +G+++SL  + + HN L+G +P
Sbjct: 536 SGQIPASFSEMPVLSQLDLSQNQLSGEIPKNLGNVESLVQVNISHNHLHGSLP 588

Length = 968

>gnl|CDD|133220 cd05089, PTKc_Tie1, Catalytic domain of the Protein Tyrosine Kinase, Tie1

 Score = 73.9 bits (181), Expect = 3e-14
 Identities = 53/215 (24%), Positives = 105/215 (48%), Gaps = 25/215 (11%)

Query: 415 NLLGKGNFSSVYKGTLR-DGTLV--AIRSINVTSCKSEEAEFVKGLYLLTSL-RHENIIR 470
           +++G+GNF  V +  ++ DG  +  AI+ +   + +++  +F   L +L  L  H NII 
Sbjct: 8   DVIGEGNFGQVIRAMIKKDGLKMNAAIKMLKEFASENDHRDFAGELEVLCKLGHHPNIIN 67

Query: 471 LRGFCCSRGRGECFLIYDFAPKGKLSKYLDQ------------EEGSSNVLDWSTRVSII 518
           L G C    RG  ++  ++AP G L  +L +            E G+++ L     +   
Sbjct: 68  LLGAC--ENRGYLYIAIEYAPYGNLLDFLRKSRVLETDPAFAKEHGTASTLTSQQLLQFA 125

Query: 519 IGIAKGIGYLHSSEVNKPAIVHRNLSVEKVLIDQQFNPLIADCGLHKLLADDIVFSVLKT 578
             +A G+ YL   +      +HR+L+   VL+ +     IAD GL +   +++       
Sbjct: 126 SDVATGMQYLSEKQ-----FIHRDLAARNVLVGENLASKIADFGLSR--GEEVYVKKTMG 178

Query: 579 SAAMGYLAPEYVTTGRFTERSDIFAFGVIILQILT 613
              + ++A E +    +T +SD+++FGV++ +I++
Sbjct: 179 RLPVRWMAIESLNYSVYTTKSDVWSFGVLLWEIVS 213

Protein Tyrosine Kinase (PTK) family; Tie1; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie1 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. No specific ligand has been identified for Tie1, although the angiopoietin, Ang-1, binds to Tie1 through integrins at high concentrations. In vivo studies of Tie1 show that it is critical in vascular development. Length = 297

>gnl|CDD|88330 cd05047, PTKc_Tie, Catalytic domain of Tie Protein Tyrosine Kinases

 Score = 72.4 bits (177), Expect = 5e-14
 Identities = 51/215 (23%), Positives = 100/215 (46%), Gaps = 25/215 (11%)

Query: 415 NLLGKGNFSSVYKGTLRDGTL---VAIRSINVTSCKSEEAEFVKGLYLLTSL-RHENIIR 470
           +++G+GNF  V K  ++   L    AI+ +   + K +  +F   L +L  L  H NII 
Sbjct: 1   DVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIIN 60

Query: 471 LRGFCCSRGRGECFLIYDFAPKGKLSKYLDQ------------EEGSSNVLDWSTRVSII 518
           L G C    RG  +L  ++AP G L  +L +               +++ L     +   
Sbjct: 61  LLGAC--EHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFA 118

Query: 519 IGIAKGIGYLHSSEVNKPAIVHRNLSVEKVLIDQQFNPLIADCGLHKLLADDIVFSVLKT 578
             +A+G+ YL   +      +HR+L+   +L+ + +   IAD GL +    ++       
Sbjct: 119 ADVARGMDYLSQKQ-----FIHRDLAARNILVGENYVAKIADFGLSR--GQEVYVKKTMG 171

Query: 579 SAAMGYLAPEYVTTGRFTERSDIFAFGVIILQILT 613
              + ++A E +    +T  SD++++GV++ +I++
Sbjct: 172 RLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVS 206

Protein Tyrosine Kinase (PTK) family; Tie subfamily; catalytic (c) domain. The Tie subfamily consists of Tie1 and Tie2. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie proteins are receptor tyr kinases (RTKs) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2, while no specific ligand has been identified for Tie1. The binding of Ang-1 to Tie2 leads to receptor autophosphorylation and activation, promoting cell migration and survival. In contrast, Ang-2 binding to Tie2 does not result in the same response, suggesting that Ang-2 may function as an antagonist. In vivo studies of Tie1 show that it is critical in vascular development. Length = 270

>gnl|CDD|133227 cd05096, PTKc_DDR1, Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 1

 Score = 72.7 bits (178), Expect = 7e-14
 Identities = 55/194 (28%), Positives = 98/194 (50%), Gaps = 23/194 (11%)

Query: 435 LVAIRSINVTSCKSEEAEFVKGLYLLTSLRHENIIRLRGFCCSRGRGECFLIYDFAPKGK 494
           LVA++ +   + K+   +F+K + +L+ L+  NIIRL G C         +I ++   G 
Sbjct: 48  LVAVKILRPDANKNARNDFLKEVKILSRLKDPNIIRLLGVCVD--EDPLCMITEYMENGD 105

Query: 495 LSKY-----LDQEEGSSN----------VLDWSTRVSIIIGIAKGIGYLHSSEVNKPAIV 539
           L+++     LD +E + N           + +S+ + + + IA G+ YL  S +N    V
Sbjct: 106 LNQFLSSHHLDDKEENGNDAVPPAHCLPAISYSSLLHVALQIASGMKYL--SSLN---FV 160

Query: 540 HRNLSVEKVLIDQQFNPLIADCGLHK-LLADDIVFSVLKTSAAMGYLAPEYVTTGRFTER 598
           HR+L+    L+ +     IAD G+ + L A D      +    + ++A E +  G+FT  
Sbjct: 161 HRDLATRNCLVGENLTIKIADFGMSRNLYAGDYYRIQGRAVLPIRWMAWECILMGKFTTA 220

Query: 599 SDIFAFGVIILQIL 612
           SD++AFGV + +IL
Sbjct: 221 SDVWAFGVTLWEIL 234

Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 1 (DDR1) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR1 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR1 binds to all collagens tested to date (types I-IV). It is widely expressed in many tissues. It is abundant in the brain and is also found in keratinocytes, colonic mucosa epithelium, lung epithelium, thyroid follicles, and the islets of Langerhans. During embryonic development, it is found in the developing neuroectoderm. DDR1 is a key regulator of cell morphogenesis, differentiation and proliferation. It is important in the development of the mammary gland, the vasculator and the kidney. DDR1 is also found in human leukocytes, where it facilitates cell adhesion, migration, maturation, and cytokine production. Length = 304

>gnl|CDD|133228 cd05097, PTKc_DDR_like, Catalytic domain of Discoidin Domain Receptor-like Protein Tyrosine Kinases

 Score = 72.3 bits (177), Expect = 8e-14
 Identities = 62/253 (24%), Positives = 119/253 (47%), Gaps = 24/253 (9%)

Query: 435 LVAIRSINVTSCKSEEAEFVKGLYLLTSLRHENIIRLRGFCCSRGRGECFLIYDFAPKGK 494
           LVA++ +     K+   +F+K + +++ L++ NIIRL G C S       +I ++   G 
Sbjct: 46  LVAVKMLRADVTKTARNDFLKEIKIMSRLKNPNIIRLLGVCVS--DDPLCMITEYMENGD 103

Query: 495 LSKYLDQEEGSSNV--------LDWSTRVSIIIGIAKGIGYLHSSEVNKPAIVHRNLSVE 546
           L+++L Q E  S          +  +  + + + IA G+ YL S        VHR+L+  
Sbjct: 104 LNQFLSQREIESTFTHANNIPSVSIANLLYMAVQIASGMKYLASLN-----FVHRDLATR 158

Query: 547 KVLIDQQFNPLIADCGLHKLLADDIVFSVL-KTSAAMGYLAPEYVTTGRFTERSDIFAFG 605
             L+   +   IAD G+ + L     + +  +    + ++A E +  G+FT  SD++AFG
Sbjct: 159 NCLVGNHYTIKIADFGMSRNLYSGDYYRIQGRAVLPIRWMAWESILLGKFTTASDVWAFG 218

Query: 606 VIILQILTGSLVLTSSMRLAAESATFEN----FIDRNLKGKFSESE--AAKLGKMALVCT 659
           V + ++ T  L       L ++    EN    F ++  +   S++    + + K+ + C 
Sbjct: 219 VTLWEMFT--LCKEQPYSLLSDEQVIENTGEFFRNQGRQIYLSQTPLCPSPVFKLMMRCW 276

Query: 660 HEDPENRPTMEAV 672
             D ++RPT   +
Sbjct: 277 SRDIKDRPTFNKI 289

Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR)-like proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR-like proteins are members of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linked to a variety of human cancers including breast, colon, ovarian, brain, and lung. There is no evidence showing that DDRs act as transforming oncogenes. They are more likely to play a role in the regulation of tumor growth and metastasis. Length = 295

>gnl|CDD|133232 cd05101, PTKc_FGFR2, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 2

 Score = 72.4 bits (177), Expect = 9e-14
 Identities = 66/282 (23%), Positives = 125/282 (44%), Gaps = 33/282 (11%)

Query: 417 LGKGNFSSVY--------KGTLRDGTLVAIRSINVTSCKSEEAEFVKGLYLLTSL-RHEN 467
           LG+G F  V         K   ++   VA++ +   + + + ++ V  + ++  + +H+N
Sbjct: 23  LGEGCFGQVVMAEALGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKN 82

Query: 468 IIRLRGFCCSRGRGECFLIYDFAPKGKLSKYL------------DQEEGSSNVLDWSTRV 515
           II L G  C++  G  ++I ++A KG L +YL            D        + +   V
Sbjct: 83  IINLLG-ACTQD-GPLYVIVEYASKGNLREYLRARRPPGMEYSYDIARVPDEQMTFKDLV 140

Query: 516 SIIIGIAKGIGYLHSSEVNKPAIVHRNLSVEKVLIDQQFNPLIADCGLHKLLAD-DIVFS 574
           S    +A+G+ YL S +      +HR+L+   VL+ +     IAD GL + + + D    
Sbjct: 141 SCTYQVARGMEYLASQKC-----IHRDLAARNVLVTENNVMKIADFGLARDVNNIDYYKK 195

Query: 575 VLKTSAAMGYLAPEYVTTGRFTERSDIFAFGVIILQILTGSLVLTSSMRLAAESATFENF 634
                  + ++APE +    +T +SD+++FGV++ +I T    L  S             
Sbjct: 196 TTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFT----LGGSPYPGIPVEELFKL 251

Query: 635 IDRNLKGKFSESEAAKLGKMALVCTHEDPENRPTMEAVIEEL 676
           +    +     +   +L  M   C H  P +RPT + ++E+L
Sbjct: 252 LKEGHRMDKPANCTNELYMMMRDCWHAIPSHRPTFKQLVEDL 293

Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 2 (FGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR2 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. There are many splice variants of FGFR2 which show differential expression and binding to FGF ligands. Disruption of either FGFR2 or FGFR2b is lethal in mice, due to defects in the placenta or severe impairment of tissue development including lung, limb, and thyroid, respectively. Disruption of FGFR2c in mice results in defective bone and skull development. Genetic alterations of FGFR2 are associated with many human skeletal disorders including Apert syndrome, Crouzon syndrome, Jackson-Weiss syndrome, and Pfeiffer syndrome. Length = 304

>gnl|CDD|133219 cd05088, PTKc_Tie2, Catalytic domain of the Protein Tyrosine Kinase, Tie2

 Score = 72.3 bits (177), Expect = 9e-14
 Identities = 51/215 (23%), Positives = 100/215 (46%), Gaps = 25/215 (11%)

Query: 415 NLLGKGNFSSVYKGTLRDGTL---VAIRSINVTSCKSEEAEFVKGLYLLTSL-RHENIIR 470
           +++G+GNF  V K  ++   L    AI+ +   + K +  +F   L +L  L  H NII 
Sbjct: 13  DVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIIN 72

Query: 471 LRGFCCSRGRGECFLIYDFAPKGKLSKYLDQEE------------GSSNVLDWSTRVSII 518
           L G C    RG  +L  ++AP G L  +L +               +++ L     +   
Sbjct: 73  LLGAC--EHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFA 130

Query: 519 IGIAKGIGYLHSSEVNKPAIVHRNLSVEKVLIDQQFNPLIADCGLHKLLADDIVFSVLKT 578
             +A+G+ YL   +      +HR+L+   +L+ + +   IAD GL +    ++       
Sbjct: 131 ADVARGMDYLSQKQ-----FIHRDLAARNILVGENYVAKIADFGLSR--GQEVYVKKTMG 183

Query: 579 SAAMGYLAPEYVTTGRFTERSDIFAFGVIILQILT 613
              + ++A E +    +T  SD++++GV++ +I++
Sbjct: 184 RLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVS 218

Protein Tyrosine Kinase (PTK) family; Tie2; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie2 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie2 is expressed mainly in endothelial cells and hematopoietic stem cells. It is also found in a subset of tumor-associated monocytes and eosinophils. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2. The binding of Ang-1 to Tie2 leads to receptor autophosphorylation and activation, promoting cell migration and survival. In contrast, Ang-2 binding to Tie2 does not result in the same response, suggesting that Ang-2 may function as an antagonist. Tie2 signaling plays key regulatory roles in vascular integrity and quiescence, and in inflammation. Length = 303

>gnl|CDD|133195 cd05064, PTKc_EphR_A10, Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A10

 Score = 71.5 bits (175), Expect = 9e-14
 Identities = 51/205 (24%), Positives = 96/205 (46%), Gaps = 20/205 (9%)

Query: 416 LLGKGNFSSVYKGTL----RDGTLVAIRSINVTSCKSEEAEFVKGLYLLTSLRHENIIRL 471
           +LG G F  + +G L    +    VAI ++       +   F+     L    H NI+RL
Sbjct: 12  ILGTGRFGELCRGCLKLPSKRELPVAIHTLRAGCSDKQRRGFLAEALTLGQFDHSNIVRL 71

Query: 472 RGFCCSRGRGECFLIY-DFAPKGKLSKYLDQEEGSSNVLDWSTRVSIIIGIAKGIGYLHS 530
            G      RG   +I  ++   G L  +L + EG    L     + ++ G+A G+ YL  
Sbjct: 72  EGVIT---RGNTMMIVTEYMSNGALDSFLRKHEGQ---LVAGQLMGMLPGLASGMKYL-- 123

Query: 531 SEVNKPAIVHRNLSVEKVLIDQQFNPLIADCGLHKLLADDI--VFSVLKTSAAMGYLAPE 588
           SE+     VH+ L+  KVL++      I+  G  +L  D    +++ +   + + + APE
Sbjct: 124 SEM---GYVHKGLAAHKVLVNSDLVCKIS--GFRRLQEDKSEAIYTTMSGKSPVLWAAPE 178

Query: 589 YVTTGRFTERSDIFAFGVIILQILT 613
            +    F+  SD+++FG+++ ++++
Sbjct: 179 AIQYHHFSSASDVWSFGIVMWEVMS 203

Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA10 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). EphA10, which contains an inactive tyr kinase domain, may function to attenuate signals of co-clustered active receptors. EphA10 is mainly expressed in the testis. Ephrin/EphR interaction results in cell-cell repulsion or adhesion, making it important in neural development and plasticity, cell morphogenesis, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. Length = 266

>gnl|CDD|173642 cd05075, PTKc_Axl, Catalytic domain of the Protein Tyrosine Kinase, Axl

 Score = 71.6 bits (175), Expect = 1e-13
 Identities = 65/271 (23%), Positives = 122/271 (45%), Gaps = 20/271 (7%)

Query: 417 LGKGNFSSVYKGTLR--DGTL-VAIRSINVTSC-KSEEAEFVKGLYLLTSLRHENIIRLR 472
           LG+G F SV +G L   D  L VA++++ +  C +SE  +F+     +    H N++RL 
Sbjct: 7   LGEGEFGSVMEGQLNQDDSILKVAVKTMKIAICTRSEMEDFLSEAVCMKEFDHPNVMRLI 66

Query: 473 GFCCSRGRGECF----LIYDFAPKGKLSKYL--DQEEGSSNVLDWSTRVSIIIGIAKGIG 526
           G C      E +    +I  F   G L  +L   +       L     V  +  IA G+ 
Sbjct: 67  GVCLQTVESEGYPSPVVILPFMKHGDLHSFLLYSRLGDCPQYLPTQMLVKFMTDIASGME 126

Query: 527 YLHSSEVNKPAIVHRNLSVEKVLIDQQFNPLIADCGLHKLLADDIVFSVLKTSA-AMGYL 585
           YL S        +HR+L+    ++++  N  +AD GL K + +   +   + +   + ++
Sbjct: 127 YLSSKS-----FIHRDLAARNCMLNENMNVCVADFGLSKKIYNGDYYRQGRIAKMPVKWI 181

Query: 586 APEYVTTGRFTERSDIFAFGVIILQILTGSLVLTSSMRLAAESATFENFIDRNLKGKFSE 645
           A E +    +T +SD+++FGV + +I T       +     E++   +++ +  + K   
Sbjct: 182 AIESLADRVYTTKSDVWSFGVTMWEIATRG----QTPYPGVENSEIYDYLRQGNRLKQPP 237

Query: 646 SEAAKLGKMALVCTHEDPENRPTMEAVIEEL 676
                L  +   C   +P++RP+ E +  EL
Sbjct: 238 DCLDGLYSLMSSCWLLNPKDRPSFETLRCEL 268

Protein Tyrosine Kinase (PTK) family; Axl; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl is widely expressed in a variety of organs and cells including epithelial, mesenchymal, hematopoietic, as well as non-transformed cells. Axl signaling is important in many cellular functions such as survival, anti-apoptosis, proliferation, migration, and adhesion. Axl was originally isolated from patients with chronic myelogenous leukemia and a chronic myeloproliferative disorder. Axl is overexpressed in many human cancers including colon, squamous cell, thyroid, breast, and lung carcinomas. Length = 272

>gnl|CDD|165291 PHA02988, PHA02988, hypothetical protein; Provisional

 Score = 71.7 bits (176), Expect = 1e-13
 Identities = 57/259 (22%), Positives = 108/259 (41%), Gaps = 23/259 (8%)

Query: 424 SVYKGTLRDGTLVAIRSINV--TSCKSEEAEFVKGLYLLTSLRHENIIRLRGFCCSRGRG 481
           S+YKG   +   V IR+        K         +  L  +   NI+++ GF       
Sbjct: 35  SIYKGIF-NNKEVIIRTFKKFHKGHKVLIDITENEIKNLRRIDSNNILKIYGFIIDIVDD 93

Query: 482 ECF--LIYDFAPKGKLSKYLDQEEGSSNVLDWSTRVSIIIGIAKGIGYLHSSEVNKPAIV 539
                LI ++  +G L + LD+E+     L + T++ + I   KG+  L+    NKP   
Sbjct: 94  LPRLSLILEYCTRGYLREVLDKEKD----LSFKTKLDMAIDCCKGLYNLYKY-TNKP--- 145

Query: 540 HRNLSVEKVLIDQQFNPLIADCGLHKLLADDIVFSVLKTSAAMGYLAPEYVTT--GRFTE 597
           ++NL+    L+ + +   I   GL K+L+        K    M Y + + +      +T 
Sbjct: 146 YKNLTSVSFLVTENYKLKIICHGLEKILSS----PPFKNVNFMVYFSYKMLNDIFSEYTI 201

Query: 598 RSDIFAFGVIILQILTGSLVLTSSMRLAAESATFENFIDRNLKGKFSESEAAKLGKMALV 657
           + DI++ GV++ +I TG +   +          ++  I++N   K       ++  +   
Sbjct: 202 KDDIYSLGVVLWEIFTGKIPFEN----LTTKEIYDLIINKNNSLKLPLDCPLEIKCIVEA 257

Query: 658 CTHEDPENRPTMEAVIEEL 676
           CT  D   RP ++ ++  L
Sbjct: 258 CTSHDSIKRPNIKEILYNL 276

Length = 283

>gnl|CDD|173631 cd05045, PTKc_RET, Catalytic domain of the Protein Tyrosine Kinase, REarranged during Transfection protein

 Score = 71.5 bits (175), Expect = 1e-13
 Identities = 70/287 (24%), Positives = 128/287 (44%), Gaps = 38/287 (13%)

Query: 417 LGKGNFSSVYKGTL-----RDG-TLVAIRSINVTSCKSEEAEFVKGLYLLTSLRHENIIR 470
           LG+G F  V K T      R G T VA++ +   +  SE  + +    LL  + H ++I+
Sbjct: 8   LGEGEFGKVVKATAFRLKGRAGYTTVAVKMLKENASSSELRDLLSEFNLLKQVNHPHVIK 67

Query: 471 LRGFCCSRGRGECFLIYDFAPKGKLSKYLDQEE--GSSNVLDWSTR-------------- 514
           L G C   G     LI ++A  G L  +L +    G S +     R              
Sbjct: 68  LYGACSQDG--PLLLIVEYAKYGSLRSFLRESRKVGPSYLGSDGNRNSSYLDNPDERALT 125

Query: 515 ----VSIIIGIAKGIGYLHSSEVNKPAIVHRNLSVEKVLIDQQFNPLIADCGLHK-LLAD 569
               +S    I++G+ YL  +E+    +VHR+L+   VL+ +     I+D GL + +  +
Sbjct: 126 MGDLISFAWQISRGMQYL--AEMK---LVHRDLAARNVLVAEGRKMKISDFGLSRDVYEE 180

Query: 570 DIVFSVLKTSAAMGYLAPEYVTTGRFTERSDIFAFGVIILQILTGSLVLTSSMRLAAESA 629
           D      K    + ++A E +    +T +SD+++FGV++ +I+T    L  +        
Sbjct: 181 DSYVKRSKGRIPVKWMAIESLFDHIYTTQSDVWSFGVLLWEIVT----LGGNPYPGIAPE 236

Query: 630 TFENFIDRNLKGKFSESEAAKLGKMALVCTHEDPENRPTMEAVIEEL 676
              N +    + +  E+ + ++  + L C  ++P+ RPT   + +EL
Sbjct: 237 RLFNLLKTGYRMERPENCSEEMYNLMLTCWKQEPDKRPTFADISKEL 283

Protein Tyrosine Kinase (PTK) family; RET (REarranged during Transfection) protein; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. RET is a receptor tyr kinase (RTK) containing an extracellular region with four cadherin-like repeats, a calcium-binding site, and a cysteine-rich domain, a transmembrane segment, and an intracellular catalytic domain. It is part of a multisubunit complex that binds glial-derived neurotropic factor (GDNF) family ligands (GFLs) including GDNF, neurturin, artemin, and persephin. GFLs bind RET along with four GPI-anchored coreceptors, bringing two RET molecules together, leading to autophosphorylation, activation, and intracellular signaling. RET is essential for the development of the sympathetic, parasympathetic and enteric nervous systems, and the kidney. RET disruption by germline mutations causes diseases in humans including congenital aganglionosis of the gastrointestinal tract (Hirschsprung's disease) and three related inherited cancers: multiple endocrine neoplasia type 2A (MEN2A), MEN2B, and familial medullary thyroid carcinoma (FMTC). Length = 290

>gnl|CDD|133230 cd05099, PTKc_FGFR4, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 4

 Score = 71.5 bits (175), Expect = 2e-13
 Identities = 72/290 (24%), Positives = 126/290 (43%), Gaps = 49/290 (16%)

Query: 417 LGKGNFSSVYK----GTLRD----GTLVAIRSINVTSCKSEEAEFVKGLYLLTSL-RHEN 467
           LG+G F  V +    G  +        VA++ +   +   + A+ +  + L+  + +H+N
Sbjct: 20  LGEGCFGQVVRAEAYGIDKSRPDQTVTVAVKMLKDNATDKDLADLISEMELMKLIGKHKN 79

Query: 468 IIRLRGFCCSRGRGECFLIYDFAPKGKLSKYL------------DQEEGSSNVLDWSTRV 515
           II L G C   G    ++I ++A KG L ++L            D  +     L +   V
Sbjct: 80  IINLLGVCTQEG--PLYVIVEYAAKGNLREFLRARRPPGPDYTFDITKVPEEQLSFKDLV 137

Query: 516 SIIIGIAKGIGYLHSSEVNKPAIVHRNLSVEKVLIDQQFNPLIADCGLHKLLADDIVFSV 575
           S    +A+G+ YL S        +HR+L+   VL+ +     IAD GL + + D   +  
Sbjct: 138 SCAYQVARGMEYLESRRC-----IHRDLAARNVLVTEDNVMKIADFGLARGVHDIDYYK- 191

Query: 576 LKTSAA---MGYLAPEYVTTGRFTERSDIFAFGVIILQILT--GS----LVLTSSMRLAA 626
            KTS     + ++APE +    +T +SD+++FG+++ +I T  GS    + +    +L  
Sbjct: 192 -KTSNGRLPVKWMAPEALFDRVYTHQSDVWSFGILMWEIFTLGGSPYPGIPVEELFKLLR 250

Query: 627 ESATFENFIDRNLKGKFSESEAAKLGKMALVCTHEDPENRPTMEAVIEEL 676
           E    +         K S         M   C H  P  RPT + ++E L
Sbjct: 251 EGHRMD---------KPSNCTHELYMLMR-ECWHAVPTQRPTFKQLVEAL 290

Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 4 (FGFR4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR4 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. Unlike other FGFRs, there is only one splice form of FGFR4. It binds FGF1, FGF2, FGF6, FGF19, and FGF23. FGF19 is a selective ligand for FGFR4. Although disruption of FGFR4 in mice causes no obvious phenotype, in vivo inhibition of FGFR4 in cultured skeletal muscle cells resulted in an arrest of muscle progenitor differentiation. FGF6 and FGFR4 are uniquely expressed in myofibers and satellite cells. FGF6/FGFR4 signaling appears to play a key role in the regulation of muscle regeneration. A polymorphism in FGFR4 is found in head and neck squamous cell carcinoma. Length = 314

>gnl|CDD|133181 cd05050, PTKc_Musk, Catalytic domain of the Protein Tyrosine Kinase, Muscle-specific kinase

 Score = 70.6 bits (173), Expect = 3e-13
 Identities = 56/222 (25%), Positives = 104/222 (46%), Gaps = 32/222 (14%)

Query: 417 LGKGNFSSVYKGTL------RDGTLVAIRSINVTSCKSEEAEFVKGLYLLTSLRHENIIR 470
           +G+G F  V++            T+VA++ +   +    +A+F +   L+    H NI++
Sbjct: 13  IGQGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASADMQADFQREAALMAEFDHPNIVK 72

Query: 471 LRGFCCSRGRGECFLIYDFAPKGKLSKYL------DQEEGSS----------NVLDWST- 513
           L G  C+ G+  C L++++   G L+++L       Q   S           N L  S  
Sbjct: 73  LLG-VCAVGKPMC-LLFEYMAYGDLNEFLRHRSPRAQCSLSHSTSSARKCGLNPLPLSCT 130

Query: 514 -RVSIIIGIAKGIGYLHSSEVNKPAIVHRNLSVEKVLIDQQFNPLIADCGL-HKLLADDI 571
            ++ I   +A G+ YL  SE  K   VHR+L+    L+ +     IAD GL   + + D 
Sbjct: 131 EQLCIAKQVAAGMAYL--SE-RK--FVHRDLATRNCLVGENMVVKIADFGLSRNIYSADY 185

Query: 572 VFSVLKTSAAMGYLAPEYVTTGRFTERSDIFAFGVIILQILT 613
             +    +  + ++ PE +   R+T  SD++A+GV++ +I +
Sbjct: 186 YKASENDAIPIRWMPPESIFYNRYTTESDVWAYGVVLWEIFS 227

Protein Tyrosine Kinase (PTK) family; Muscle-specific kinase (Musk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Musk is a receptor tyr kinase (RTK) containing an extracellular region with four immunoglobulin-like domains and a cysteine-rich cluster, a transmembrane segment, and an intracellular catalytic domain. Musk is expressed and concentrated in the postsynaptic membrane in skeletal muscle. It is essential for the establishment of the neuromuscular junction (NMJ), a peripheral synapse that conveys signals from motor neurons to muscle cells. Agrin, a large proteoglycan released from motor neurons, stimulates Musk autophosphorylation and activation, leading to the clustering of acetylcholine receptors (AChRs). To date, there is no evidence to suggest that agrin binds directly to Musk. Mutations in AChR, Musk and other partners are responsible for diseases of the NMJ, such as the autoimmune syndrome myasthenia gravis. Length = 288

>gnl|CDD|173726 cd06610, STKc_OSR1_SPAK, Catalytic domain of the Protein Serine/Threonine Kinases, Oxidative stress response kinase and Ste20-related proline alanine-rich kinase

 Score = 70.5 bits (173), Expect = 3e-13
 Identities = 67/280 (23%), Positives = 124/280 (44%), Gaps = 47/280 (16%)

Query: 417 LGKGNFSSVYKG-TLRDGTLVAIRSINVTSCKSEEAEFVKGLYLLTSLRHENIIRLRGFC 475
           +G G  + VY    L +   VAI+ I++  C++   E  K +  ++   H N++    + 
Sbjct: 9   IGVGATAVVYAAICLPNNEKVAIKRIDLEKCQTSVDELRKEVQAMSQCNHPNVV---KYY 65

Query: 476 CSRGRGEC-FLIYDFAPKGKL-----SKYLDQEEGSSNVLDWSTRVSIIIGIAKGIGYLH 529
            S   G+  +L+  +   G L     S Y          LD +   +++  + KG+ YLH
Sbjct: 66  TSFVVGDELWLVMPYLSGGSLLDIMKSSY------PRGGLDEAIIATVLKEVLKGLEYLH 119

Query: 530 SSEVNKPAIVHRNLSVEKVLIDQQFNPLIADCGLHKLLADDIVFSVLKTSAAMG---YLA 586
           S+       +HR++    +L+ +  +  IAD G+   LAD    +       +G   ++A
Sbjct: 120 SN-----GQIHRDIKAGNILLGEDGSVKIADFGVSASLADGGDRTRKVRKTFVGTPCWMA 174

Query: 587 PEYVTTGR-FTERSDIFAFGVIILQILTG-----------SLVLTSSMRLAAESATFENF 634
           PE +     +  ++DI++FG+  +++ TG            L+LT    L  +  + E  
Sbjct: 175 PEVMEQVHGYDFKADIWSFGITAIELATGAAPYSKYPPMKVLMLT----LQNDPPSLETG 230

Query: 635 IDRNLKGKFSESEAAKLGKMALVCTHEDPENRPTMEAVIE 674
            D     K+S+S      KM  +C  +DP  RPT E +++
Sbjct: 231 AD---YKKYSKS----FRKMISLCLQKDPSKRPTAEELLK 263

Serine/threonine kinases (STKs), oxidative stress response kinase (OSR1) and Ste20-related proline alanine-rich kinase (SPAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The OSR1 and SPAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SPAK is also referred to as STK39 or PASK (proline-alanine-rich STE20-related kinase). OSR1 and SPAK regulate the activity of cation-chloride cotransporters through direct interaction and phosphorylation. They are also implicated in cytoskeletal rearrangement, cell differentiation, transformation and proliferation. OSR1 and SPAK contain a conserved C-terminal (CCT) domain, which recognizes a unique motif ([RK]FX[VI]) present in their activating kinases (WNK1/WNK4) and their substrates. Length = 267

>gnl|CDD|173761 cd08221, STKc_Nek9, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 9

 Score = 70.2 bits (172), Expect = 3e-13
 Identities = 57/270 (21%), Positives = 123/270 (45%), Gaps = 31/270 (11%)

Query: 414 VNLLGKGNFSS--VYKGTLRDGTLVAIRSINVTSCKSEEAEFVKG-LYLLTSLRHENIIR 470
           + +LGKG F    +Y+ T  D +LV  + +N+T    +E       + +L+ L+H NII 
Sbjct: 5   IRVLGKGAFGEATLYRRT-EDDSLVVWKEVNLTRLSEKERRDALNEIVILSLLQHPNIIA 63

Query: 471 -LRGFCCSRGRGECFLIYDFAPKGKLSKYLDQEEGSSNVLDWSTRVSIIIGIAKGIGYLH 529
               F          +  ++A  G L   + +++G   + +    +  +  I   + Y+H
Sbjct: 64  YYNHFMDD---NTLLIEMEYANGGTLYDKIVRQKG--QLFEEEMVLWYLFQIVSAVSYIH 118

Query: 530 SSEVNKPAIVHRNLSVEKVLIDQQFNPLIADCGLHKLLADDIVF--SVLKTSAAMGYLAP 587
                K  I+HR++    + + +     + D G+ K+L  +     +V+ T     Y++P
Sbjct: 119 -----KAGILHRDIKTLNIFLTKAGLIKLGDFGISKILGSEYSMAETVVGTPY---YMSP 170

Query: 588 EYVTTGRFTERSDIFAFGVIILQILTGSLVLTSSMRLAAESATFENFIDRNLKGKFS--- 644
           E     ++  +SDI+A G ++ ++LT        ++   ++    N + + ++G ++   
Sbjct: 171 ELCQGVKYNFKSDIWALGCVLYELLT--------LKRTFDATNPLNLVVKIVQGNYTPVV 222

Query: 645 ESEAAKLGKMALVCTHEDPENRPTMEAVIE 674
              +++L  +      +DPE RPT + V++
Sbjct: 223 SVYSSELISLVHSLLQQDPEKRPTADEVLD 252

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 9 (Nek9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek9 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek9, also called Nercc1, is primarily a cytoplasmic protein but can also localize in the nucleus. It is involved in modulating chromosome alignment and splitting during mitosis. It interacts with the gamma-tubulin ring complex and the Ran GTPase, and is implicated in microtubule organization. Nek9 associates with FACT (FAcilitates Chromatin Transcription) and modulates interphase progression. It also interacts with Nek6, and Nek7, during mitosis, resulting in their activation. Length = 256

>gnl|CDD|132954 cd06623, PKc_MAPKK_plant_like, Catalytic domain of Plant dual-specificity MAP kinase kinases and similar proteins

 Score = 69.9 bits (172), Expect = 3e-13
 Identities = 62/279 (22%), Positives = 112/279 (40%), Gaps = 59/279 (21%)

Query: 414 VNLLGKGNFSSVYKGTLR-DGTLVAIRSINVTSCKSEEAEFVKGLYLLTSLRHENIIRLR 472
           V +LG+G+   VYK   +  G + A++ I+V   +    + ++ L  L S     +++  
Sbjct: 6   VKVLGQGSSGVVYKVRHKPTGKIYALKKIHVDGDEEFRKQLLRELKTLRSCESPYVVKCY 65

Query: 473 GFCCSRGRGECFLIYDFAPKGKLSKYLDQEEGSSNVLDWSTRV--SIIIGIAKGIGYLHS 530
           G       GE  ++ ++   G L+  L +             V   I   I KG+ YLH 
Sbjct: 66  GAFYK--EGEISIVLEYMDGGSLADLLKKVGK------IPEPVLAYIARQILKGLDYLH- 116

Query: 531 SEVNKPAIVHRNLSVEKVLIDQQFNPLIADCGLHKLLAD--DIVFSVLKTSAAMGYLAPE 588
               K  I+HR++    +LI+ +    IAD G+ K+L +  D   + + T     Y++PE
Sbjct: 117 ---TKRHIIHRDIKPSNLLINSKGEVKIADFGISKVLENTLDQCNTFVGTVT---YMSPE 170

Query: 589 YVTTGRFTERSDIFAFGVIILQILTG-----------------SLVLTSSMRLAAE--SA 629
            +    ++  +DI++ G+ +L+   G                 ++       L AE  S 
Sbjct: 171 RIQGESYSYAADIWSLGLTLLECALGKFPFLPPGQPSFFELMQAICDGPPPSLPAEEFSP 230

Query: 630 TFENFIDRNLKGKFSESEAAKLGKMALVCTHEDPENRPT 668
            F +FI                      C  +DP+ RP+
Sbjct: 231 EFRDFISA--------------------CLQKDPKKRPS 249

Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, Plant MAPKKs and similar proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include MAPKKs from plants, kinetoplastids, alveolates, and mycetozoa. The MAPKK, LmxPK4, from Leishmania mexicana, is important in differentiation and virulence. Dictyostelium discoideum MEK1 is required for proper chemotaxis. MEK1 null mutants display severe defects in cell polarization and directional movement. Plants contain multiple MAPKKs like other eukaryotes. The Arabidopsis genome encodes for 10 MAPKKs while poplar and rice contain 13 MAPKKs each. The functions of these proteins have not been fully elucidated. There is evidence to suggest that MAPK cascades are involved in plant stress responses. In Arabidopsis, MKK3 plays a role in pathogen signaling, MKK2 is involved in cold and salt stress signaling, MKK4/MKK5 participates in innate immunity, and MKK7 regulates basal and systemic acquired resistance. Length = 264

>gnl|CDD|173650 cd05094, PTKc_TrkC, Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase C

 Score = 70.4 bits (172), Expect = 3e-13
 Identities = 57/217 (26%), Positives = 102/217 (47%), Gaps = 29/217 (13%)

Query: 417 LGKGNFSSVYKGT------LRDGTLVAIRSINVTSCKSEEAEFVKGLYLLTSLRHENIIR 470
           LG+G F  V+          +D  LVA++++   +  + + +F +   LLT+L+HE+I++
Sbjct: 13  LGEGAFGKVFLAECYNLSPTKDKMLVAVKALKDPTLAARK-DFQREAELLTNLQHEHIVK 71

Query: 471 LRGFCCSRGRGE-CFLIYDFAPKGKLSKYL------------DQEEGSSNVLDWSTRVSI 517
             G C   G G+   +++++   G L+K+L             Q   +   L  S  + I
Sbjct: 72  FYGVC---GDGDPLIMVFEYMKHGDLNKFLRAHGPDAMILVDGQPRQAKGELGLSQMLHI 128

Query: 518 IIGIAKGIGYLHSSEVNKPAIVHRNLSVEKVLIDQQFNPLIADCGLHKLLADDIVFSVL- 576
              IA G+ YL S        VHR+L+    L+       I D G+ + +     + V  
Sbjct: 129 ASQIASGMVYLASQH-----FVHRDLATRNCLVGANLLVKIGDFGMSRDVYSTDYYRVGG 183

Query: 577 KTSAAMGYLAPEYVTTGRFTERSDIFAFGVIILQILT 613
            T   + ++ PE +   +FT  SD+++FGVI+ +I T
Sbjct: 184 HTMLPIRWMPPESIMYRKFTTESDVWSFGVILWEIFT 220

Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase C (TrkC); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkC is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkC to its ligand, neurotrophin 3 (NT3), results in receptor oligomerization and activation of the catalytic domain. TrkC is broadly expressed in the nervous system and in some non-neural tissues including the developing heart. NT3/TrkC signaling plays an important role in the innervation of the cardiac conducting system and the development of smooth muscle cells. Mice deficient with NT3 and TrkC have multiple heart defects. NT3/TrkC signaling is also critical for the development and maintenance of enteric neurons that are important for the control of gut peristalsis. Length = 291

>gnl|CDD|133214 cd05083, PTKc_Chk, Catalytic domain of the Protein Tyrosine Kinase, Csk homologous kinase

 Score = 68.8 bits (168), Expect = 6e-13
 Identities = 48/197 (24%), Positives = 101/197 (51%), Gaps = 18/197 (9%)

Query: 417 LGKGNFSSVYKGTLRDGTLVAIRSINVTSCKSEEAEFVKGLYLLTSLRHENIIRLRGFCC 476
           +G+G F +V +G    G  VA+++I    C      F++   ++T L H+N++RL G   
Sbjct: 14  IGEGEFGAVLQGEYT-GQKVAVKNIK---CDVTAQAFLEETAVMTKLHHKNLVRLLGVIL 69

Query: 477 SRGRGECFLIYDFAPKGKLSKYLDQEEGSSNVLDWSTRVSIIIGIAKGIGYLHSSEVNKP 536
             G    +++ +   KG L  +L +  G + V      +   + +A+G+ YL S +    
Sbjct: 70  HNG---LYIVMELMSKGNLVNFL-RTRGRALV-SVIQLLQFSLDVAEGMEYLESKK---- 120

Query: 537 AIVHRNLSVEKVLIDQQFNPLIADCGLHKLLADDIVFSVLKTSAAMGYLAPEYVTTGRFT 596
            +VHR+L+   +L+ +     ++D GL ++ +  +  S L       + APE +   +F+
Sbjct: 121 -LVHRDLAARNILVSEDGVAKVSDFGLARVGSMGVDNSKLPVK----WTAPEALKHKKFS 175

Query: 597 ERSDIFAFGVIILQILT 613
            +SD++++GV++ ++ +
Sbjct: 176 SKSDVWSYGVLLWEVFS 192

Protein Tyrosine Kinase (PTK) family; Csk homologous kinase (Chk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. Chk is also referred to as megakaryocyte-associated tyrosine kinase (Matk). To inhibit Src kinases, Chk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Chk inhibit Src kinases using a noncatalytic mechanism by simply binding to them. As a negative regulator of Src kinases, Chk may play important roles in cell proliferation, survival, and differentiation, and consequently, in cancer development and progression. Chk is expressed in brain and hematopoietic cells. Studies in mice reveal that Chk is not functionally redundant with Csk and that it plays an important role as a regulator of immune responses. Chk also plays a role in neural differentiation in a manner independent of Src by enhancing Mapk activation via Ras-mediated signaling. Length = 254

>gnl|CDD|173732 cd06628, STKc_MAPKKK_Byr2_like, Catalytic domain of fungal Byr2-like MAP Kinase Kinase Kinases

 Score = 69.1 bits (169), Expect = 7e-13
 Identities = 54/214 (25%), Positives = 105/214 (49%), Gaps = 25/214 (11%)

Query: 416 LLGKGNFSSVYKG-TLRDGTLVAIR-----SINVTSCKSEEA--EFVKG-LYLLTSLRHE 466
           L+G G+F SVY G     G L+A++     S++ +S   + +  + +   + LL  L+HE
Sbjct: 7   LIGSGSFGSVYLGMNASSGELMAVKQVELPSVSASSKDRKRSMLDALAREIALLKELQHE 66

Query: 467 NIIRLRGFCCSRGRGECFLIYDFAPKGKLSKYLDQEEGSSNVLDWSTRVSIIIGIAKGIG 526
           NI++  G          FL Y   P G ++  L+         + +   + +  I KG+ 
Sbjct: 67  NIVQYLGSSLDADHLNIFLEY--VPGGSVAALLNN----YGAFEETLVRNFVRQILKGLN 120

Query: 527 YLHSSEVNKPAIVHRNLSVEKVLIDQQFNPLIADCGLHKLLADDIVFSVLKTS-----AA 581
           YLH+       I+HR++    +L+D +    I+D G+ K L  + + +    +      +
Sbjct: 121 YLHNRG-----IIHRDIKGANILVDNKGGIKISDFGISKKLEANSLSTKTNGARPSLQGS 175

Query: 582 MGYLAPEYVTTGRFTERSDIFAFGVIILQILTGS 615
           + ++APE V    +T ++DI++ G +++++LTG 
Sbjct: 176 VFWMAPEVVKQTSYTRKADIWSLGCLVVEMLTGK 209

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Byr2-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Schizosaccharomyces pombe Byr2, Saccharomyces cerevisiae and Cryptococcus neoformans Ste11, and related proteins. They contain an N-terminal SAM (sterile alpha-motif) domain, which mediates protein-protein interaction, and a C-terminal catalytic domain. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Fission yeast Byr2 is regulated by Ras1. It responds to pheromone signaling and controls mating through the MAPK pathway. Budding yeast Ste11 functions in MAPK cascades that regulate mating, high osmolarity glycerol, and filamentous growth responses. Length = 267

>gnl|CDD|173723 cd06605, PKc_MAPKK, Catalytic domain of the dual-specificity Protein Kinase, Mitogen-Activated Protein Kinase Kinase

 Score = 68.9 bits (169), Expect = 7e-13
 Identities = 46/202 (22%), Positives = 98/202 (48%), Gaps = 13/202 (6%)

Query: 414 VNLLGKGNFSSVYKGTLR-DGTLVAIRSINVTSCKSEEAEFVKGLYLLTSLRHENIIRLR 472
           +  LG GN   V K   R  G ++A+++I +   ++ + + ++ L +L       I+   
Sbjct: 6   LGELGAGNSGVVSKVLHRPTGKIMAVKTIRLEINEAIQKQILRELDILHKCNSPYIVGFY 65

Query: 473 GFCCSRGRGECFLIYDFAPKGKLSKYLDQEEGSSNVLDWSTRVSIIIGIAKGIGYLHSSE 532
           G   + G  +  +  ++   G L K L + +G    +       I + + KG+ YLH   
Sbjct: 66  GAFYNNG--DISICMEYMDGGSLDKILKEVQG---RIPERILGKIAVAVLKGLTYLHE-- 118

Query: 533 VNKPAIVHRNLSVEKVLIDQQFNPLIADCGLHKLLADDIVFSVLKTSAAMGYLAPEYVTT 592
             K  I+HR++    +L++ +    + D G+   L + +  + + TS+   Y+APE +  
Sbjct: 119 --KHKIIHRDVKPSNILVNSRGQIKLCDFGVSGQLVNSLAKTFVGTSS---YMAPERIQG 173

Query: 593 GRFTERSDIFAFGVIILQILTG 614
             ++ +SDI++ G+ ++++ TG
Sbjct: 174 NDYSVKSDIWSLGLSLIELATG 195

Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK or MAP2K), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK or MAP3K). MAPKKs are dual-specificity PKs that phosphorylate their downstream targets, MAPKs, at specific threonine and tyrosine residues. There are three MAPK subfamilies: extracellular signal-regulated kinase (ERK), c-Jun N-terminal kinase (JNK), and p38. In mammalian cells, there are seven MAPKKs (named MKK1-7) and 20 MAPKKKs. Each MAPK subfamily can be activated by at least two cognate MAPKKs and by multiple MAPKKKs. Length = 265

>gnl|CDD|173647 cd05091, PTKc_Ror2, Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 2

 Score = 69.3 bits (169), Expect = 8e-13
 Identities = 57/233 (24%), Positives = 107/233 (45%), Gaps = 28/233 (12%)

Query: 403 EVESATQCFSEVNLLGKGNFSSVYKGTL------RDGTLVAIRSINVTSCKSEEAEFVKG 456
           E+  +T  F E   LG+  F  VYKG L           VAI+++   +      EF   
Sbjct: 1   EINLSTVRFMEE--LGEDRFGKVYKGHLFGTAPGEQTQAVAIKTLKDKAEGPLREEFKHE 58

Query: 457 LYLLTSLRHENIIRLRGFCCSRGRGECFLIYDFAPKGKLSKYL------------DQEEG 504
             + + L+H NI+ L G           +I+ +     L ++L            D ++ 
Sbjct: 59  AMMRSRLQHPNIVCLLGVVTKEQ--PLSMIFSYCSHSDLHEFLVMRSPHSDVGSTDDDKT 116

Query: 505 SSNVLDWSTRVSIIIGIAKGIGYLHSSEVNKPAIVHRNLSVEKVLIDQQFNPLIADCGLH 564
             + L+ +  V I+  IA G+ +L S  V     VH++L+   VL+  + N  I+D GL 
Sbjct: 117 VKSTLEPADFVHIVTQIAAGMEFLSSHHV-----VHKDLATRNVLVFDKLNVKISDLGLF 171

Query: 565 KLLADDIVFSVLKTSA-AMGYLAPEYVTTGRFTERSDIFAFGVIILQILTGSL 616
           + +     + ++  S   + +++PE +  G+F+  SDI+++GV++ ++ +  L
Sbjct: 172 REVYAADYYKLMGNSLLPIRWMSPEAIMYGKFSIDSDIWSYGVVLWEVFSYGL 224

Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 2 (Ror2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. Ror2 plays important roles in skeletal and heart formation. Ror2-deficient mice show widespread bone abnormalities, ventricular defects in the heart, and respiratory dysfunction. Mutations in human Ror2 result in two different bone development genetic disorders, recessive Robinow syndrome and brachydactyly type B. Ror2 is also implicated in neural development. Length = 283

>gnl|CDD|133192 cd05061, PTKc_InsR, Catalytic domain of the Protein Tyrosine Kinase, Insulin Receptor

 Score = 68.8 bits (168), Expect = 1e-12
 Identities = 64/276 (23%), Positives = 120/276 (43%), Gaps = 30/276 (10%)

Query: 417 LGKGNFSSVYKGTLRD------GTLVAIRSINVTSCKSEEAEFVKGLYLLTSLRHENIIR 470
           LG+G+F  VY+G  RD       T VA++++N ++   E  EF+    ++      +++R
Sbjct: 14  LGQGSFGMVYEGNARDIIKGEAETRVAVKTVNESASLRERIEFLNEASVMKGFTCHHVVR 73

Query: 471 LRGFCCSRGRGECFLIYDFAPKGKLSKYL-----DQEEGSSNVL-DWSTRVSIIIGIAKG 524
           L G   S+G+    ++ +    G L  YL     + E             + +   IA G
Sbjct: 74  LLG-VVSKGQ-PTLVVMELMAHGDLKSYLRSLRPEAENNPGRPPPTLQEMIQMAAEIADG 131

Query: 525 IGYLHSSEVNKPAIVHRNLSVEKVLIDQQFNPLIADCGLHK-LLADDIVFSVLKTSAAMG 583
           + YL     N    VHR+L+    ++   F   I D G+ + +   D      K    + 
Sbjct: 132 MAYL-----NAKKFVHRDLAARNCMVAHDFTVKIGDFGMTRDIYETDYYRKGGKGLLPVR 186

Query: 584 YLAPEYVTTGRFTERSDIFAFGVIILQILTGSLVLTSSMRLAAESATFENFIDRNLKGKF 643
           ++APE +  G FT  SD+++FGV++ +I       TS      +  + E  +   + G +
Sbjct: 187 WMAPESLKDGVFTTSSDMWSFGVVLWEI-------TSLAEQPYQGLSNEQVLKFVMDGGY 239

Query: 644 ---SESEAAKLGKMALVCTHEDPENRPTMEAVIEEL 676
               ++   ++  +  +C   +P+ RPT   ++  L
Sbjct: 240 LDQPDNCPERVTDLMRMCWQFNPKMRPTFLEIVNLL 275

Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR is a receptor tyr kinase (RTK) that is composed of two alphabeta heterodimers. Binding of the insulin ligand to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological function. InsR signaling plays an important role in many cellular processes including glucose homeostasis, glycogen synthesis, lipid and protein metabolism, ion and amino acid transport, cell cycle and proliferation, cell differentiation, gene transcription, and nitric oxide synthesis. Insulin resistance, caused by abnormalities in InsR signaling, has been described in diabetes, hypertension, cardiovascular disease, metabolic syndrome, heart failure, and female infertility. Length = 288

>gnl|CDD|132962 cd06631, STKc_YSK4, Catalytic domain of the Protein Serine/Threonine Kinase, Yeast Sps1/Ste20-related kinase 4

 Score = 68.0 bits (166), Expect = 2e-12
 Identities = 74/270 (27%), Positives = 118/270 (43%), Gaps = 36/270 (13%)

Query: 415 NLLGKGNFSSVYKGTLRDGTLVAIRSI-----NVTSCKSEEAEFVKGLYLLTSLRHENII 469
            +LGKG + +VY G    G L+A++ +     NV + + E  +  + + LL SL+H NI+
Sbjct: 6   EVLGKGAYGTVYCGLTNQGQLIAVKQVELDTSNVLAAEKEYEKLQEEVDLLKSLKHVNIV 65

Query: 470 RLRGFCCSRGRGECFLIYDFAPKGKLSKYLDQEEG-SSNVLDWSTRVSIIIGIAKGIGYL 528
           +  G C        F+  +F P G +S  L++       V    T+      I  G+ YL
Sbjct: 66  QYLGTCLDDNTISIFM--EFVPGGSISSILNRFGPLPEPVFCKYTK-----QILDGVAYL 118

Query: 529 HSSEVNKPAIVHRNLSVEKV---------LIDQQFNPLIADCGLHKLLADDIVFSVLKTS 579
           H++ V     VHR++    V         LID      +A  GLH   ++     +LK+ 
Sbjct: 119 HNNCV-----VHRDIKGNNVMLMPNGIIKLIDFGCARRLAWVGLHGTHSN-----MLKSM 168

Query: 580 AAMGY-LAPEYVTTGRFTERSDIFAFGVIILQILTGSLVLTSSMRLAAESATFENFIDRN 638
               Y +APE +    +  +SDI++ G  + ++ TG   L S  RLA   A F     R 
Sbjct: 169 HGTPYWMAPEVINESGYGRKSDIWSIGCTVFEMATGKPPLASMDRLA---AMFYIGAHRG 225

Query: 639 LKGKFSESEAAKLGKMALVCTHEDPENRPT 668
           L  +  +S +A        C   D   RP+
Sbjct: 226 LMPRLPDSFSAAAIDFVTSCLTRDQHERPS 255

Serine/threonine kinases (STKs), yeast Sps1/Ste20-related kinase 4 (YSK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YSK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. YSK4 is a putative MAPKKK, whose mammalian gene has been isolated. MAPKKKs (MKKKs or MAP3Ks) phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Length = 265

>gnl|CDD|173651 cd05095, PTKc_DDR2, Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 2

 Score = 68.4 bits (167), Expect = 2e-12
 Identities = 50/187 (26%), Positives = 96/187 (51%), Gaps = 15/187 (8%)

Query: 435 LVAIRSINVTSCKSEEAEFVKGLYLLTSLRHENIIRLRGFCCSRGRGECFLIYDFAPKGK 494
           LVA++ +   + K+   +F+K + +++ L+  NIIRL   C +       +I ++   G 
Sbjct: 48  LVAVKMLREDANKNARNDFLKEIKIMSRLKDPNIIRLLAVCITSD--PLCMITEYMENGD 105

Query: 495 LSKYL-------DQEEGSSNVLDWSTRVSIIIGIAKGIGYLHSSEVNKPAIVHRNLSVEK 547
           L+++L         E+     + +ST + +   IA G+ YL  S +N    VHR+L+   
Sbjct: 106 LNQFLSRHEPQEAAEKADVVTISYSTLIFMATQIASGMKYL--SSLN---FVHRDLATRN 160

Query: 548 VLIDQQFNPLIADCGLHKLLADDIVFSVL-KTSAAMGYLAPEYVTTGRFTERSDIFAFGV 606
            L+ + +   IAD G+ + L     + +  +    + +++ E +  G+FT  SD++AFGV
Sbjct: 161 CLVGKNYTIKIADFGMSRNLYSGDYYRIQGRAVLPIRWMSWESILLGKFTTASDVWAFGV 220

Query: 607 IILQILT 613
            + +ILT
Sbjct: 221 TLWEILT 227

Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 2 (DDR2) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR2 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR2 binds mostly to fibrillar collagens. More recently, it has been reported to also bind collagen X. DDR2 is widely expressed in many tissues with the highest levels found in skeletal muscle, skin, kidney and lung. It is important in cell proliferation and development. Mice, with a deletion of DDR2, suffer from dwarfism and delayed healing of epidermal wounds. DDR2 also contributes to collagen (type I) regulation by inhibiting fibrillogenesis and altering the morphology of collagen fibers. It is also expressed in immature dendritic cells (DCs), where it plays a role in DC activation and function. Length = 296

>gnl|CDD|143341 cd07836, STKc_Pho85, Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Pho85

 Score = 67.9 bits (166), Expect = 2e-12
 Identities = 58/208 (27%), Positives = 110/208 (52%), Gaps = 14/208 (6%)

Query: 411 FSEVNLLGKGNFSSVYKGTLR-DGTLVAIRSINVTSCKSEEAEFVKGLYLLTSLRHENII 469
           F ++  LG+G +++VYKG  R  G +VA++ I++ + +   +  ++ + L+  L+HENI+
Sbjct: 2   FKQLEKLGEGTYATVYKGRNRTTGEIVALKEIHLDAEEGTPSTAIREISLMKELKHENIV 61

Query: 470 RLRGFCCSRGRGECFLIYDFAPKGKLSKYLDQEEGSSNVLDWSTRVSIIIGIAKGIGYLH 529
           RL     +  +    L++++  K  L KY+D   G    LD +T  S    + KGI + H
Sbjct: 62  RLHDVIHTENK--LMLVFEYMDK-DLKKYMDT-HGVRGALDPNTVKSFTYQLLKGIAFCH 117

Query: 530 SSEVNKPAIVHRNLSVEKVLIDQQFNPLIADCGLHKLLADDI-VFSVLKTSAAMGYLAPE 588
            + V     +HR+L  + +LI+++    +AD GL +     +  FS       + Y AP+
Sbjct: 118 ENRV-----LHRDLKPQNLLINKRGELKLADFGLARAFGIPVNTFS--NEVVTLWYRAPD 170

Query: 589 YVTTGR-FTERSDIFAFGVIILQILTGS 615
            +   R ++   DI++ G I+ +++TG 
Sbjct: 171 VLLGSRTYSTSIDIWSVGCIMAEMITGR 198

Serine/Threonine Kinases (STKs), Pho85 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Pho85 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Pho85 is a multifunctional Cyclin-Dependent protein Kinase (CDK) in yeast. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Pho85 is regulated by 10 different cyclins (Pcls) and plays a role in G1 progression, cell polarity, phosphate and glycogen metabolism, gene expression, and in signaling changes in the environment. It is not essential for yeast viability and is the functional homolog of mammalian CDK5, which plays a role in central nervous system development. Length = 284

>gnl|CDD|173757 cd08217, STKc_Nek2, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 2

 Score = 67.3 bits (165), Expect = 3e-12
 Identities = 45/210 (21%), Positives = 95/210 (45%), Gaps = 9/210 (4%)

Query: 411 FSEVNLLGKGNFSSVYKGT-LRDGTLVAIRSINVTSCKSEEAE-FVKGLYLLTSLRHENI 468
           +  +  +GKG+F +V K     DG ++  + I+  +   +E +  V  + +L  L+H NI
Sbjct: 2   YEVLETIGKGSFGTVRKVRRKSDGKILVWKEIDYGNMTEKEKQQLVSEVNILRELKHPNI 61

Query: 469 IRLRGFCCSRGRGECFLIYDFAPKGKLSKYLDQEEGSSNVLDWSTRVSIIIGIAKGIGYL 528
           +R       R     +++ ++   G L++ + + +     ++      I+  +   +   
Sbjct: 62  VRYYDRIIDRSNQTLYIVMEYCEGGDLAQLIQKCKKERKYIEEEFIWRILTQLLLALYEC 121

Query: 529 HSSEVNKPAIVHRNLSVEKVLIDQQFNPLIADCGLHKLLADDIVFSVLKTSAAMG---YL 585
           H+       ++HR+L    + +D   N  + D GL K+L  D  F        +G   Y+
Sbjct: 122 HNRSDPGNTVLHRDLKPANIFLDANNNVKLGDFGLAKILGHDSSF----AKTYVGTPYYM 177

Query: 586 APEYVTTGRFTERSDIFAFGVIILQILTGS 615
           +PE +    + E+SDI++ G +I ++   S
Sbjct: 178 SPEQLNHMSYDEKSDIWSLGCLIYELCALS 207

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 2 (Nek2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek2 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek2 subfamily includes Aspergillus nidulans NIMA kinase, the founding member of the Nek family, which was identified in a screen for cell cycle mutants prevented from entering mitosis. NIMA is essential for mitotic entry and progression through mitosis, and its degradation is essential for mitotic exit. NIMA is involved in nuclear membrane fission. Vertebrate Nek2 is a cell cycle-regulated STK, localized in centrosomes and kinetochores, that regulates centrosome splitting at the G2/M phase. It also interacts with other mitotic kinases such as Polo-like kinase 1 and may play a role in spindle checkpoint. An increase in the expression of the human NEK2 gene is strongly associated with the progression of non-Hodgkin lymphoma. Length = 265

>gnl|CDD|132961 cd06630, STKc_MEKK1, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 1

 Score = 67.2 bits (164), Expect = 3e-12
 Identities = 55/213 (25%), Positives = 95/213 (44%), Gaps = 25/213 (11%)

Query: 416 LLGKGNFSSVYKGTLRD---GTLVAIRSINVTSCKSEEAEFV-----KGLYLLTSLRHEN 467
            LG G FSS Y+   RD   GTL+A++ +      S E E V     K + L+  L H +
Sbjct: 7   QLGTGAFSSCYQA--RDVKTGTLMAVKQVTYVRNTSSEQEEVVEALRKEIRLMARLNHPH 64

Query: 468 IIRLRGFCCSRGRGECFLIYDFAPKGKLSKYLDQEEGSSNVLDWSTRVSIIIGIAKGIGY 527
           IIR+ G  C       F+  ++   G +S  L +          +  ++    + +G+ Y
Sbjct: 65  IIRMLGATCEDSHFNLFV--EWMAGGSVSHLLSKYGAFKE----AVIINYTEQLLRGLSY 118

Query: 528 LHSSEVNKPAIVHRNLSVEKVLIDQQFNPL-IADCGLHKLLADDIVFSVLKTSAAMG--- 583
           LH ++     I+HR++    +LID     L IAD G    LA     +       +G   
Sbjct: 119 LHENQ-----IIHRDVKGANLLIDSTGQRLRIADFGAAARLAAKGTGAGEFQGQLLGTIA 173

Query: 584 YLAPEYVTTGRFTERSDIFAFGVIILQILTGSL 616
           ++APE +   ++    D+++ G +I+++ T   
Sbjct: 174 FMAPEVLRGEQYGRSCDVWSVGCVIIEMATAKP 206

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 1 (MEKK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK1 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK1 activates the extracellular signal-regulated kinase 1/2 (ERK1/2) and c-Jun N-terminal kinase (JNK) pathways by activating their respective MAPKKs, MEK1/2 and MKK4/MKK7, respectively. MEKK1 is important in regulating cell survival and apoptosis. MEKK1 also plays a role in cell migration, tissue maintenance and homeostasis, and wound healing. Length = 268

>gnl|CDD|173669 cd05578, STKc_Yank1, Catalytic domain of the Protein Serine/Threonine Kinase, Yank1

 Score = 66.6 bits (163), Expect = 4e-12
 Identities = 52/209 (24%), Positives = 87/209 (41%), Gaps = 20/209 (9%)

Query: 411 FSEVNLLGKGNFSSVYKGTLRD-GTLVAIRSINVTSC--KSEEAEFVKGLYLLTSLRHEN 467
           F  + ++GKG F  V     RD   + A++ +N   C  K      +    +L  L H  
Sbjct: 2   FELLRVIGKGAFGKVCIVQKRDTKKMFAMKYMNKQKCVEKGSVRNVLNERRILQELNHPF 61

Query: 468 IIRLR-GFCCSRGRGECFLIYDFAPKGKLSKYLDQEEGSSNVLDWSTRVSIIIG-IAKGI 525
           ++ L   F         +L+ D    G L  +L Q+   S       +V   I  I   +
Sbjct: 62  LVNLWYSFQ---DEENMYLVVDLLLGGDLRYHLSQKVKFS-----EEQVKFWICEIVLAL 113

Query: 526 GYLHSSEVNKPAIVHRNLSVEKVLIDQQFNPLIADCGLHKLLADDIVFSVLKTSAAMGYL 585
            YLHS       I+HR++  + +L+D+Q +  I D  +   +  D +     TS   GY+
Sbjct: 114 EYLHSK-----GIIHRDIKPDNILLDEQGHVHITDFNIATKVTPDTL--TTSTSGTPGYM 166

Query: 586 APEYVTTGRFTERSDIFAFGVIILQILTG 614
           APE +    ++   D ++ GV   + L G
Sbjct: 167 APEVLCRQGYSVAVDWWSLGVTAYECLRG 195

Serine/Threonine Kinases (STKs), Yank1 or STK32A subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Yank1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily contains uncharacterized STKs with similarity to the human protein designated Yank1 or STK32A. Length = 258

>gnl|CDD|173649 cd05093, PTKc_TrkB, Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase B

 Score = 67.0 bits (163), Expect = 4e-12
 Identities = 55/214 (25%), Positives = 99/214 (46%), Gaps = 26/214 (12%)

Query: 417 LGKGNFSSVYKGTL------RDGTLVAIRSINVTSCKSEEAEFVKGLYLLTSLRHENIIR 470
           LG+G F  V+          +D  LVA++++   S  +   +F +   LLT+L+HE+I++
Sbjct: 13  LGEGAFGKVFLAECYNLCPEQDKILVAVKTLKDAS-DNARKDFHREAELLTNLQHEHIVK 71

Query: 471 LRGFCCSRGRGE-CFLIYDFAPKGKLSKYLDQ---------EEGSSNVLDWSTRVSIIIG 520
             G C     G+   +++++   G L+K+L           E      L  S  + I   
Sbjct: 72  FYGVCV---EGDPLIMVFEYMKHGDLNKFLRAHGPDAVLMAEGNRPAELTQSQMLHIAQQ 128

Query: 521 IAKGIGYLHSSEVNKPAIVHRNLSVEKVLIDQQFNPLIADCGLHKLLADDIVFSVL-KTS 579
           IA G+ YL S        VHR+L+    L+ +     I D G+ + +     + V   T 
Sbjct: 129 IAAGMVYLASQH-----FVHRDLATRNCLVGENLLVKIGDFGMSRDVYSTDYYRVGGHTM 183

Query: 580 AAMGYLAPEYVTTGRFTERSDIFAFGVIILQILT 613
             + ++ PE +   +FT  SD+++ GV++ +I T
Sbjct: 184 LPIRWMPPESIMYRKFTTESDVWSLGVVLWEIFT 217

Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase B (TrkB); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkB is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkB to its ligands, brain-derived neurotrophic factor (BDNF) or neurotrophin 4 (NT4), results in receptor oligomerization and activation of the catalytic domain. TrkB is broadly expressed in the nervous system and in some non-neural tissues. It plays important roles in cell proliferation, differentiation, and survival. BDNF/Trk signaling plays a key role in regulating activity-dependent synaptic plasticity. TrkB also contributes to protection against gp120-induced neuronal cell death. TrkB overexpression is associated with poor prognosis in neuroblastoma (NB) and other human cancers. It acts as a suppressor of anoikis (detachment-induced apoptosis) and contributes to tumor metastasis. Length = 288

>gnl|CDD|133229 cd05098, PTKc_FGFR1, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 1

 Score = 67.3 bits (164), Expect = 4e-12
 Identities = 64/261 (24%), Positives = 118/261 (45%), Gaps = 33/261 (12%)

Query: 434 TLVAIRSINVTSCKSEEAEFVKGLYLLTSL-RHENIIRLRGFCCSRGRGECFLIYDFAPK 492
           T VA++ +   + + + ++ +  + ++  + +H+NII L G C   G    ++I ++A K
Sbjct: 51  TKVAVKMLKSDATEKDLSDLISEMEMMKMIGKHKNIINLLGACTQDG--PLYVIVEYASK 108

Query: 493 GKLSKYL------------DQEEGSSNVLDWSTRVSIIIGIAKGIGYLHSSEVNKPAIVH 540
           G L +YL            +  +     L +   VS    +A+G+ YL S +      +H
Sbjct: 109 GNLREYLRARRPPGMEYCYNPTQVPEEQLSFKDLVSCAYQVARGMEYLASKKC-----IH 163

Query: 541 RNLSVEKVLIDQQFNPLIADCGLHKLLADDI--VFSVLKTSAA---MGYLAPEYVTTGRF 595
           R+L+   VL+ +     IAD GL    A DI  +    KT+     + ++APE +    +
Sbjct: 164 RDLAARNVLVTEDNVMKIADFGL----ARDIHHIDYYKKTTNGRLPVKWMAPEALFDRIY 219

Query: 596 TERSDIFAFGVIILQILTGSLVLTSSMRLAAESATFENFIDRNLKGKFSESEAAKLGKMA 655
           T +SD+++FGV++ +I T    L  S             +    +     +   +L  M 
Sbjct: 220 THQSDVWSFGVLLWEIFT----LGGSPYPGVPVEELFKLLKEGHRMDKPSNCTNELYMMM 275

Query: 656 LVCTHEDPENRPTMEAVIEEL 676
             C H  P  RPT + ++E+L
Sbjct: 276 RDCWHAVPSQRPTFKQLVEDL 296

Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 1 (FGFR1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR1 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. Alternative splicing of FGFR1 transcripts produces a variety of isoforms, which are differentially expressed in cells. FGFR1 binds the ligands, FGF1 and FGF2, with high affinity and has also been reported to bind FGF4, FGF6, and FGF9. FGFR1 signaling is critical in the control of cell migration during embryo development. It promotes cell proliferation in fibroblasts. Nuclear FGFR1 plays a role in the regulation of transcription. Mutations, insertions or deletions of FGFR1 have been identified in patients with Kallman's syndrome (KS), an inherited disorder characterized by hypogonadotropic hypogonadism and loss of olfaction. Aberrant FGFR1 expression has been found in some human cancers including 8P11 myeloproliferative syndrome (EMS), breast cancer, and pancreatic adenocarcinoma. Length = 307

>gnl|CDD|173763 cd08223, STKc_Nek4, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 4

 Score = 66.5 bits (162), Expect = 4e-12
 Identities = 63/282 (22%), Positives = 131/282 (46%), Gaps = 46/282 (16%)

Query: 410 CFSEVNLLGKGNFSSVYKGTL----RDGTLVAIRSINVTSCKSEE---AEFVKGLYLLTS 462
           CF  V ++GKG++  V   +L     DG    I+ +N+ +    E   AE  +   LL+ 
Sbjct: 3   CF--VRVVGKGSYGEV---SLVRHRTDGKQYVIKKLNLRNASRRERKAAE--QEAQLLSQ 55

Query: 463 LRHENIIRLRGFCCSRGRGECFLIYDFAPKGKLSKYLDQEEG----SSNVLDWSTRVSII 518
           L+H NI+  R        G  +++  F   G L   L +++G     + V++W       
Sbjct: 56  LKHPNIVAYRE-SWEGEDGLLYIVMGFCEGGDLYHKLKEQKGKLLPENQVVEW------F 108

Query: 519 IGIAKGIGYLHSSEVNKPAIVHRNLSVEKVLIDQQFNPLIADCGLHKLLAD--DIVFSVL 576
           + IA  + YLH        I+HR+L  + V + +     + D G+ ++L +  D+  +++
Sbjct: 109 VQIAMALQYLHEKH-----ILHRDLKTQNVFLTRTNIIKVGDLGIARVLENQCDMASTLI 163

Query: 577 KTSAAMGYLAPEYVTTGRFTERSDIFAFGVIILQILTGSLVLTSSMRLAAESATFENFID 636
            T     Y++PE  +   +  +SD++A G  + ++ T        ++ A  +    + + 
Sbjct: 164 GTPY---YMSPELFSNKPYNYKSDVWALGCCVYEMAT--------LKHAFNAKDMNSLVY 212

Query: 637 RNLKGKF---SESEAAKLGKMALVCTHEDPENRPTMEAVIEE 675
           R ++GK     +  + +LG++      + PE RP++++++ +
Sbjct: 213 RIIEGKLPPMPKDYSPELGELIATMLSKRPEKRPSVKSILRQ 254

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 4 (Nek4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek4 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. Nek4 is highly abundant in the testis. Its specific function is unknown. Length = 257

>gnl|CDD|133175 cd05043, PTK_Ryk, Pseudokinase domain of Ryk (Receptor related to tyrosine kinase)

 Score = 66.3 bits (162), Expect = 6e-12
 Identities = 53/213 (24%), Positives = 98/213 (46%), Gaps = 24/213 (11%)

Query: 415 NLLGKGNFSSVYKGTLRDGTLVAIRSINVTSCKSEEAE-----FVKGLYLLTSLRHENII 469
           +LL +G F  ++ G L D        + V + K   +E      ++   LL  L H+NI+
Sbjct: 12  DLLQEGTFGRIFYGILIDEKPGKEEEVFVKTVKDHASEIQVTLLLQESCLLYGLSHQNIL 71

Query: 470 RLRGFCCSRGRGECFLIYDFAPKGKLSKYLDQ----EEGSSNVLDWSTR--VSIIIGIAK 523
            +    C       F++Y +   G L  +L Q    E  +   L  ST+  V + I IA 
Sbjct: 72  PILH-VCIEDGEPPFVLYPYMNWGNLKLFLQQCRLGEANNPQAL--STQQLVHMAIQIAC 128

Query: 524 GIGYLHSSEVNKPAIVHRNLSVEKVLIDQQFNPLIADCGLHK-LLADDIVFSVL--KTSA 580
           G+ YLH   V     +H++++    +ID++    I D  L + L   D  +  L    + 
Sbjct: 129 GMSYLHKRGV-----IHKDIAARNCVIDEELQVKITDNALSRDLFPMD--YHCLGDNENR 181

Query: 581 AMGYLAPEYVTTGRFTERSDIFAFGVIILQILT 613
            + ++A E +    ++  SD+++FGV++ +++T
Sbjct: 182 PVKWMALESLVNKEYSSASDVWSFGVLLWELMT 214

Protein Tyrosine Kinase (PTK) family; Receptor related to tyrosine kinase (Ryk); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ryk is a receptor tyr kinase (RTK) containing an extracellular region with two leucine-rich motifs, a transmembrane segment, and an intracellular inactive pseudokinase domain. The extracellular region of Ryk shows homology to the N-terminal domain of Wnt inhibitory factor-1 (WIF) and serves as the ligand (Wnt) binding domain of Ryk. Ryk is expressed in many different tissues both during development and in adults, suggesting a widespread function. It acts as a chemorepulsive axon guidance receptor of Wnt glycoproteins and is responsible for the establishment of axon tracts during the development of the central nervous system. In addition, studies in mice reveal that Ryk is essential in skeletal, craniofacial, and cardiac development. Thus, it appears Ryk is involved in signal transduction despite its lack of kinase activity. Ryk may function as an accessory protein that modulates the signals coming from catalytically active partner RTKs such as the Eph receptors. Length = 280

>gnl|CDD|133186 cd05055, PTKc_PDGFR, Catalytic domain of the Protein Tyrosine Kinases, Platelet Derived Growth Factor Receptors

 Score = 66.4 bits (162), Expect = 9e-12
 Identities = 69/261 (26%), Positives = 120/261 (45%), Gaps = 22/261 (8%)

Query: 417 LGKGNFSSVYKGTL-----RDGTL-VAIRSINVTSCKSEEAEFVKGLYLLTSL-RHENII 469
           LG G F  V + T       D  + VA++ +  T+  SE    +  L +++ L  HENI+
Sbjct: 43  LGAGAFGKVVEATAYGLSKSDAVMKVAVKMLKPTAHSSEREALMSELKIMSHLGNHENIV 102

Query: 470 RLRGFCCSRGRGECFLIYDFAPKGKLSKYLDQEEGSSNVLDWSTRVSIIIGIAKGIGYLH 529
            L G  C+ G G   +I ++   G L  +L ++  S   L     +S    +AKG+ +L 
Sbjct: 103 NLLG-ACTIG-GPILVITEYCCYGDLLNFLRRKRES--FLTLEDLLSFSYQVAKGMAFLA 158

Query: 530 SSEVNKPAIVHRNLSVEKVLIDQQFNPLIADCGLHKLLADDIVFSVLKTSAAM--GYLAP 587
           S        +HR+L+   VL+       I D GL + + +D  + V+K +A +   ++AP
Sbjct: 159 SKNC-----IHRDLAARNVLLTHGKIVKICDFGLARDIMNDSNY-VVKGNARLPVKWMAP 212

Query: 588 EYVTTGRFTERSDIFAFGVIILQILTGSLVLTSSMRLAAESATFENFIDRNLKGKFSESE 647
           E +    +T  SD++++G+++ +I   SL       +  +S  F   I    +    E  
Sbjct: 213 ESIFNCVYTFESDVWSYGILLWEIF--SLGSNPYPGMPVDS-KFYKLIKEGYRMAQPEHA 269

Query: 648 AAKLGKMALVCTHEDPENRPT 668
            A++  +   C   DP  RPT
Sbjct: 270 PAEIYDIMKTCWDADPLKRPT 290

Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) subfamily; catalytic (c) domain. The PDGFR subfamily consists of PDGFR alpha, PDGFR beta, KIT, CSF-1R, the mammalian FLT3, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. PDGFR kinase domains are autoinhibited by their juxtamembrane regions containing tyr residues. The binding to their ligands leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR subfamily receptors are important in the development of a variety of cells. PDGFRs are expressed in a many cells including fibroblasts, neurons, endometrial cells, mammary epithelial cells, and vascular smooth muscle cells. PDGFR signaling is critical in normal embryonic development, angiogenesis, and wound healing. PDGFRs transduce mitogenic signals for connective tissue cells and are important for cell shape and motility. Kit is important in the development of melanocytes, germ cells, mast cells, hematopoietic stem cells, the interstitial cells of Cajal, and the pacemaker cells of the GI tract. CSF-1R signaling is critical in the regulation of macrophages and osteoclasts. Mammalian FLT3 plays an important role in the survival, proliferation, and differentiation of stem cells. Length = 302

>gnl|CDD|132991 cd06917, STKc_NAK1_like, Catalytic domain of Fungal Nak1-like Protein Serine/Threonine Kinases

 Score = 65.9 bits (161), Expect = 9e-12
 Identities = 52/216 (24%), Positives = 104/216 (48%), Gaps = 30/216 (13%)

Query: 411 FSEVNLLGKGNFSSVYKGT-LRDGTLVAIRSINVTSCKSEEAEFVKGLYLLTSLRH---E 466
           +  + L+G+G + +VY+G  +  G +VA++ IN+ +   + ++  + + LL+ LR     
Sbjct: 3   YQRLELIGRGAYGAVYRGKHVPTGRVVALKIINLDTPDDDVSDIQREVALLSQLRQSQPP 62

Query: 467 NIIRLRGFCCSRGRGECFLIYDFAPKGK---LSKYLDQEEGSSNVLDWSTRVSIIIGIAK 523
           NI +  G    +G    ++I ++A  G    L K     E   +V        II  +  
Sbjct: 63  NITKYYG-SYLKGP-RLWIIMEYAEGGSVRTLMKAGPIAEKYISV--------IIREVLV 112

Query: 524 GIGYLHSSEVNKPAIVHRNLSVEKVLIDQQFNPLIADCGLHKLLADDIVFSVLKTSAAMG 583
            + Y+H        ++HR++    +L+    N  + D G+  LL      +  K S  +G
Sbjct: 113 ALKYIHKV-----GVIHRDIKAANILVTNTGNVKLCDFGVAALLNQ----NSSKRSTFVG 163

Query: 584 ---YLAPEYVTTGR-FTERSDIFAFGVIILQILTGS 615
              ++APE +T G+ +  ++DI++ G+ I ++ TG+
Sbjct: 164 TPYWMAPEVITEGKYYDTKADIWSLGITIYEMATGN 199

Serine/threonine kinases (STKs), Nak1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nak1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of Schizosaccharomyces pombe Nak1, Saccharomyces cerevisiae Kic1p (kinase that interacts with Cdc31p) and related proteins. Nak1 (also known as N-rich kinase 1), is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Kic1p is required by budding yeast for cell integrity and morphogenesis. Kic1p interacts with Cdc31p, the yeast homologue of centrin, and phosphorylates substrates in a Cdc31p-dependent manner. Length = 277

>gnl|CDD|173760 cd08220, STKc_Nek8, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 8

 Score = 65.3 bits (159), Expect = 1e-11
 Identities = 65/273 (23%), Positives = 126/273 (46%), Gaps = 33/273 (12%)

Query: 411 FSEVNLLGKGNFSSVYKGTLR-DGTLVAIRSINVTS-CKSEEAEFVKGLYLLTSLRHENI 468
           + ++ ++G+G F  V+    + D  LV I+ I V    K E         +L  L H NI
Sbjct: 2   YEKIRVVGRGAFGIVHLCRRKADQKLVIIKQIPVEQMTKDERLAAQNECQVLKLLSHPNI 61

Query: 469 IR-LRGFCCSRGRGECFLIYDFAPKGKLSKYLDQEEGSSNVLDWSTRVSIIIGIAKGIGY 527
           I     F   +      ++ ++AP G L++Y+ +   S  +LD  T +   + I   + +
Sbjct: 62  IEYYENFLEDKALM---IVMEYAPGGTLAEYIQKRCNS--LLDEDTILHFFVQILLALHH 116

Query: 528 LHSSEVNKPAIVHRNLSVEKVLIDQQFNPL-IADCGLHKLLADDIVFSVLKTSAAMG--- 583
           +H+       I+HR+L  + +L+D+    + I D G+ K+L+     S  K    +G   
Sbjct: 117 VHTKL-----ILHRDLKTQNILLDKHKMVVKIGDFGISKILS-----SKSKAYTVVGTPC 166

Query: 584 YLAPEYVTTGRFTERSDIFAFGVIILQILTGSLVLTSSMRLAAESATFENFIDRNLKGKF 643
           Y++PE      + ++SDI+A G ++ ++         S++ A E+A     + + + G F
Sbjct: 167 YISPELCEGKPYNQKSDIWALGCVLYELA--------SLKRAFEAANLPALVLKIMSGTF 218

Query: 644 ---SESEAAKLGKMALVCTHEDPENRPTMEAVI 673
              S+  +  L ++ L   + DP  RP +  ++
Sbjct: 219 APISDRYSPDLRQLILSMLNLDPSKRPQLSQIM 251

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 8 (Nek8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek8 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek8 contains an N-terminal kinase catalytic domain and a C-terminal RCC1 (regulator of chromosome condensation) domain. A double point mutation in Nek8 causes cystic kidney disease in mice that genetically resembles human autosomal recessive polycystic kidney disease (ARPKD). Nek8 is also associated with a rare form of juvenile renal cystic disease, nephronophthisis type 9. It has been suggested that a defect in the ciliary localization of Nek8 contributes to the development of cysts manifested by these diseases. Length = 256

>gnl|CDD|173769 cd08229, STKc_Nek7, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 7

 Score = 65.0 bits (158), Expect = 2e-11
 Identities = 60/266 (22%), Positives = 114/266 (42%), Gaps = 27/266 (10%)

Query: 417 LGKGNFSSVYKGT-LRDGTLVAIRSINVTSCKSEEA--EFVKGLYLLTSLRHENIIRLRG 473
           +G+G FS VY+ T L DG  VA++ + +      +A  + +K + LL  L H N+I+   
Sbjct: 10  IGRGQFSEVYRATCLLDGVPVALKKVQIFDLMDAKARADCIKEIDLLKQLNHPNVIKYYA 69

Query: 474 FCCSRGRGECFLIYDFAPKGKLSKYLDQEEGSSNVLDWSTRVSIIIGIAKGIGYLHSSEV 533
                   E  ++ + A  G LS+ +   +    ++   T     + +   + ++HS   
Sbjct: 70  SFIEDN--ELNIVLELADAGDLSRMIKHFKKQKRLIPEKTVWKYFVQLCSALEHMHSRR- 126

Query: 534 NKPAIVHRNLSVEKVLIDQQFNPLIADCGLHKLLADDIVFSVLKTSAAMG------YLAP 587
               ++HR++    V I       + D GL +  +        KT+AA        Y++P
Sbjct: 127 ----VMHRDIKPANVFITATGVVKLGDLGLGRFFSS-------KTTAAHSLVGTPYYMSP 175

Query: 588 EYVTTGRFTERSDIFAFGVIILQILT-GSLVLTSSMRLAAESATFENFIDRNLKGKFSES 646
           E +    +  +SDI++ G ++ ++    S      M L +     E      L    S+ 
Sbjct: 176 ERIHENGYNFKSDIWSLGCLLYEMAALQSPFYGDKMNLYSLCKKIEQCDYPPLP---SDH 232

Query: 647 EAAKLGKMALVCTHEDPENRPTMEAV 672
            + +L ++  +C + DPE RP +  V
Sbjct: 233 YSEELRQLVNMCINPDPEKRPDITYV 258

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 7 (Nek7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek7 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek7 is required for mitotic spindle formation and cytokinesis. It is enriched in the centrosome and is critical for microtubule nucleation. Nek7 is activated by Nek9 during mitosis, and may regulate the p70 ribosomal S6 kinase. Length = 267

>gnl|CDD|173764 cd08224, STKc_Nek6_Nek7, Catalytic domain of the Protein Serine/Threonine Kinases, Never In Mitosis gene A-related kinase 6 and 7

 Score = 64.8 bits (158), Expect = 2e-11
 Identities = 64/281 (22%), Positives = 118/281 (41%), Gaps = 53/281 (18%)

Query: 417 LGKGNFSSVYKGT-LRDGTLVAIRSINV--TSCKSEEAEFVKGLYLLTSLRHENIIR-LR 472
           +GKG FS VYK   L DG +VA++ + +          + +K + LL  L H N+I+ L 
Sbjct: 10  IGKGQFSVVYKAICLLDGRVVALKKVQIFEMMDAKARQDCLKEIDLLKQLDHPNVIKYLA 69

Query: 473 GFCCSRGRGECFLIYDFAPKGKLSKYLDQEEGSSNVLDWSTRVSIIIGIAKGIGYLHSSE 532
            F       E  ++ + A  G LS+ +   +    ++   T     + +   + ++HS  
Sbjct: 70  SFI---ENNELNIVLELADAGDLSRMIKHFKKQKRLIPERTIWKYFVQLCSALEHMHSKR 126

Query: 533 VNKPAIVHRNLSVEKVLIDQQFNPLIADCGLHKLLADDIVFSVLKTSAAMG------YLA 586
                I+HR++    V I       + D GL +  +        KT+AA        Y++
Sbjct: 127 -----IMHRDIKPANVFITATGVVKLGDLGLGRFFSS-------KTTAAHSLVGTPYYMS 174

Query: 587 PEYVTTGRFTERSDIFAFGVIILQILTGSLVLTSSMRLAAESATFENFIDR-NL------ 639
           PE +    +  +SDI++ G ++ +             +AA  + F    D+ NL      
Sbjct: 175 PERIHENGYNFKSDIWSLGCLLYE-------------MAALQSPFYG--DKMNLYSLCKK 219

Query: 640 --KGKF----SESEAAKLGKMALVCTHEDPENRPTMEAVIE 674
             K  +    ++  + +L  +   C + DPE RP +  V++
Sbjct: 220 IEKCDYPPLPADHYSEELRDLVSRCINPDPEKRPDISYVLQ 260

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) and Nek7 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6/7 subfamily is part of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 and Nek7 are the shortest Neks, consisting only of the catalytic domain and a very short N-terminal extension. They show distinct expression patterns and both appear to be downstream substrates of Nek9. They are required for mitotic spindle formation and cytokinesis. They may also be regulators of the p70 ribosomal S6 kinase. Length = 267

>gnl|CDD|132952 cd06621, PKc_MAPKK_Pek1_like, Catalytic domain of fungal Pek1-like dual-specificity MAP kinase kinases

 Score = 64.8 bits (158), Expect = 3e-11
 Identities = 43/209 (20%), Positives = 90/209 (43%), Gaps = 21/209 (10%)

Query: 410 CFSEVNLLGKGNFSSVYKGTLRD-GTLVAIRSINVTSCKSEEAEFVKGLYLLTSLRHENI 468
              E++ LG+G   SV K  L++ G + A+++I        + + ++ L +  S +   I
Sbjct: 2   KIVELSRLGEGAGGSVTKCRLKNTGMIFALKTITTDPNPDLQKQILRELEINKSCKSPYI 61

Query: 469 IRLRGFCCSRGRGECFLIYDFAPKGKLSKYLDQEEGSSNVLDWSTRVS------IIIGIA 522
           ++  G           +  ++   G L            V     R+       I   + 
Sbjct: 62  VKYYGAFLDESSSSIGIAMEYCEGGSLDSIY------KKVKKRGGRIGEKVLGKIAESVL 115

Query: 523 KGIGYLHSSEVNKPAIVHRNLSVEKVLIDQQFNPLIADCGLHKLLADDIVFSVLKTSAAM 582
           KG+ YLHS +     I+HR++    +L+ ++    + D G+   L + +  +   TS   
Sbjct: 116 KGLSYLHSRK-----IIHRDIKPSNILLTRKGQVKLCDFGVSGELVNSLAGTFTGTSF-- 168

Query: 583 GYLAPEYVTTGRFTERSDIFAFGVIILQI 611
            Y+APE +    ++  SD+++ G+ +L++
Sbjct: 169 -YMAPERIQGKPYSITSDVWSLGLTLLEV 196

Protein kinases (PKs), MAP kinase kinase(MAPKK) subfamily, fungal Pek1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include the MAPKKs Pek1/Skh1 from Schizosaccharomyces pombe and MKK2 from Saccharomyces cerevisiae, and related proteins. Both fission yeast Pek1 and baker's yeast MKK2 are components of the cell integrity MAPK pathway. In fission yeast, Pek1 phosphorylates and activates the MAPK Pmk1/Spm1 and is regulated by the MAPKKK Mkh1. In baker's yeast, the pathway involves the MAPK Slt2, the MAPKKs MKK1 and MKK2, and the MAPKKK Bck1. The cell integrity MAPK cascade is activated by multiple stress conditions, and is essential in cell wall construction, morphogenesis, cytokinesis, and ion homeostasis. Length = 287

>gnl|CDD|133174 cd05042, PTKc_Aatyk, Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases

 Score = 64.1 bits (156), Expect = 3e-11
 Identities = 61/285 (21%), Positives = 109/285 (38%), Gaps = 43/285 (15%)

Query: 417 LGKGNFSSVYKGTLRDGTLVA---IRSINVTSCKSEEAEFVKGLYLLTSLRHENIIRLRG 473
           +G G F  V  G    G   A   ++ +  ++   E+  F++ +     L H N+++  G
Sbjct: 3   IGNGWFGKVLLGEAHRGMSKARVVVKELRASATPDEQLLFLQEVQPYRELNHPNVLQCLG 62

Query: 474 FCCSRGRGECFLIYDFAPKGKLSKYLDQEEGS-SNVLDWSTRVSIIIGIAKGIGYLHSSE 532
            C         L+ +F P G L  YL    G  + +        +   +A G+ +LH   
Sbjct: 63  QCIE--SIPYLLVLEFCPLGDLKNYLRSNRGMVAQMAQKDVLQRMACEVASGLLWLH--- 117

Query: 533 VNKPAIVHRNLSVEKVLIDQQFNPLIADCGL-HKLLADDIVFSVLKTSAAMGYLAPEYVT 591
             +   +H +L++    +    +  I D GL  +   +D   +    +  + +LAPE V 
Sbjct: 118 --QADFIHSDLALRNCQLTADLSVKIGDYGLALEQYPEDYYITKDCHAVPLRWLAPELVE 175

Query: 592 -------TGRFTERSDIFAFGVIILQILTGSLVLTSSMRLAAESATFENFIDRNLKGKFS 644
                      T++S+I++ GV + ++ T            A    + +  D  +  +  
Sbjct: 176 IRGQDLLPKDQTKKSNIWSLGVTMWELFT------------AADQPYPDLSDEQVLKQVV 223

Query: 645 ESEAAKLGKMALVCTHED------------PENRPTMEAVIEELT 677
             +  KL K  L   + D            PE RPT E V E LT
Sbjct: 224 REQDIKLPKPQLDLKYSDRWYEVMQFCWLDPETRPTAEEVHELLT 268

Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase (Aatyk) subfamily; catalytic (c) domain. The Aatyk subfamily is also referred to as the lemur tyrosine kinase (Lmtk) subfamily. It consists of Aatyk1 (Lmtk1), Aatyk2 (Lmtk2, Brek), Aatyk3 (Lmtk3), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk proteins are mostly receptor tyr kinases (RTKs) containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 does not contain a transmembrane segment and is a cytoplasmic (or nonreceptor) kinase. Aatyk proteins are classified as tyr kinases based on overall sequence similarity and the phylogenetic tree. However, analysis of catalytic residues suggests that Aatyk proteins may be multispecific kinases, functioning also as serine/threonine kinases. They are involved in neural differentiation, nerve growth factor (NGF) signaling, apoptosis, and spermatogenesis. Length = 269

>gnl|CDD|173752 cd07861, STKc_CDK1_euk, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 1 from higher eukaryotes-like

 Score = 63.6 bits (155), Expect = 5e-11
 Identities = 62/211 (29%), Positives = 103/211 (48%), Gaps = 23/211 (10%)

Query: 411 FSEVNLLGKGNFSSVYKG-TLRDGTLVAIRSINVTSCKSEE----AEFVKGLYLLTSLRH 465
           ++++  +G+G +  VYKG   + G +VA++ I +   +SEE    +  ++ + LL  L+H
Sbjct: 2   YTKIEKIGEGTYGVVYKGRNKKTGQIVAMKKIRL---ESEEEGVPSTAIREISLLKELQH 58

Query: 466 ENIIRLRGFCCSRGRGECFLIYDFAPKGKLSKYLDQEEGSSNVLDWSTRVSIIIGIAKGI 525
            NI+ L+       R   +LI++F     L KYLD        +D     S +  I +GI
Sbjct: 59  PNIVCLQDVLMQESR--LYLIFEFLSM-DLKKYLDSL-PKGQYMDAELVKSYLYQILQGI 114

Query: 526 GYLHSSEVNKPAIVHRNLSVEKVLIDQQFNPLIADCGLHKLLADDIVFSVLKTSA-AMGY 584
            + HS  V     +HR+L  + +LID +    +AD GL +  A  I   V       + Y
Sbjct: 115 LFCHSRRV-----LHRDLKPQNLLIDNKGVIKLADFGLAR--AFGIPVRVYTHEVVTLWY 167

Query: 585 LAPEYVTTG--RFTERSDIFAFGVIILQILT 613
            APE V  G  R++   DI++ G I  ++ T
Sbjct: 168 RAPE-VLLGSPRYSTPVDIWSIGTIFAEMAT 197

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyclin A complex controls G2 phase entry and progression. CDK1/cyclin A2 has also been implicated as an important regulator of S phase events. The CDK1/cyclin B complex is critical for G2 to M phase transition. It induces mitosis by activating nuclear enzymes that regulate chromatin condensation, nuclear membrane degradation, mitosis-specific microtubule and cytoskeletal reorganization. CDK1 also associates with cyclin E and plays a role in the entry into S phase. CDK1 transcription is stable throughout the cell cycle but is modulated in some pathological conditions. It may play a role in regulating apoptosis under these conditions. In breast cancer cells, HER2 can mediate apoptosis by inactivating CDK1. Activation of CDK1 may contribute to HIV-1 induced apoptosis and neuronal apoptosis in neurodegenerative diseases. Length = 285

>gnl|CDD|173703 cd05612, STKc_PRKX_like, Catalytic domain of PRKX-like Protein Serine/Threonine Kinases

 Score = 63.2 bits (154), Expect = 8e-11
 Identities = 54/210 (25%), Positives = 93/210 (44%), Gaps = 24/210 (11%)

Query: 411 FSEVNLLGKGNFSSVYKGTLR-DGTLVAIRSINVTSC-KSEEAEFVKG-LYLLTSLRHEN 467
              +  +G G F  V+    R      A++ + +    + ++ + V     +L  + H  
Sbjct: 3   LERIKTVGTGTFGRVHLVRDRISEHYYALKVMAIPEVIRLKQEQHVHNEKRVLKEVSHPF 62

Query: 468 IIRLRGFCCSRGRGECFLIYDFAPKGKLSKYLDQEEGSSNVLDWSTRVSIIIGIAKGIGY 527
           IIRL  F     +   +++ ++ P G+L  YL      SN    ST +     I   + Y
Sbjct: 63  IIRL--FWTEHDQRFLYMLMEYVPGGELFSYLRNSGRFSN----STGLFYASEIVCALEY 116

Query: 528 LHSSEVNKPAIVHRNLSVEKVLIDQQFNPLIADCGLHKLLADDIVFSVLKTSAAMG---Y 584
           LHS E     IV+R+L  E +L+D++ +  + D G  K L D       +T    G   Y
Sbjct: 117 LHSKE-----IVYRDLKPENILLDKEGHIKLTDFGFAKKLRD-------RTWTLCGTPEY 164

Query: 585 LAPEYVTTGRFTERSDIFAFGVIILQILTG 614
           LAPE + +    +  D +A G++I ++L G
Sbjct: 165 LAPEVIQSKGHNKAVDWWALGILIYEMLVG 194

Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, PRKX-like kinases, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include human PRKX (X chromosome-encoded protein kinase), Drosophila DC2, and similar proteins. PRKX is present in many tissues including fetal and adult brain, kidney, and lung. The PRKX gene is located in the Xp22.3 subregion and has a homolog called PRKY on the Y chromosome. An abnormal interchange between PRKX aand PRKY leads to the sex reversal disorder of XX males and XY females. PRKX is implicated in granulocyte/macrophage lineage differentiation, renal cell epithelial migration, and tubular morphogenesis in the developing kidney. Length = 291

>gnl|CDD|133168 cd05036, PTKc_ALK_LTK, Catalytic domain of the Protein Tyrosine Kinases, Anaplastic Lymphoma Kinase and Leukocyte Tyrosine Kinase

 Score = 62.5 bits (152), Expect = 1e-10
 Identities = 56/227 (24%), Positives = 102/227 (44%), Gaps = 30/227 (13%)

Query: 405 ESATQCFSEVNLLGKGNFSSVYKGTL--RDGTL----VAIRSINVTSCKSEEAEFVKGLY 458
           E      + +  LG G F  VY+G    RDG      VA++++  +  + +E++F+    
Sbjct: 2   EVPRDSITLLRALGHGAFGEVYEGLYRGRDGDAVELQVAVKTLPESCSEQDESDFLMEAL 61

Query: 459 LLTSLRHENIIRLRGFCCSRGRGECFLIYDFAPKGKLSKYLDQEE---GSSNVLDWSTRV 515
           +++   H+NI+RL G      R   F++ +    G L  +L +        + L     +
Sbjct: 62  IMSKFNHQNIVRLIGVSFE--RLPRFILLELMAGGDLKSFLRENRPRPERPSSLTMKDLL 119

Query: 516 SIIIGIAKGIGYLHSSEVNKPAIVHRNLSVEKVLIDQQFNP----LIADCGLHKLLADDI 571
                +AKG  YL  +       +HR+++    L+  +  P     IAD G    +A DI
Sbjct: 120 FCARDVAKGCKYLEENH-----FIHRDIAARNCLLTCK-GPGRVAKIADFG----MARDI 169

Query: 572 VFS--VLKTSAAM---GYLAPEYVTTGRFTERSDIFAFGVIILQILT 613
             +    K   AM    ++ PE    G FT ++D+++FGV++ +I +
Sbjct: 170 YRASYYRKGGRAMLPIKWMPPEAFLDGIFTSKTDVWSFGVLLWEIFS 216

Protein Tyrosine Kinase (PTK) family; Anaplastic Lymphoma Kinase (ALK) and Leukocyte Tyrosine (tyr) Kinase (LTK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyr residues in protein substrates. ALK and LTK are orphan receptor tyr kinases (RTKs) whose ligands are not yet well-defined. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. They are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. ALK appears to play an important role in mammalian neural development as well as visceral muscle differentiation in Drosophila. ALK is aberrantly expressed as fusion proteins, due to chromosomal translocations, in about 60% of anaplastic large cell lymphomas (ALCLs). ALK fusion proteins are also found in rare cases of diffuse large B cell lymphomas (DLBCLs). LTK is mainly expressed in B lymphocytes and neuronal tissues. It is important in cell proliferation and survival. Transgenic mice expressing TLK display retarded growth and high mortality rate. In addition, a polymorphism in mouse and human LTK is implicated in the pathogenesis of systemic lupus erythematosus. Length = 277

>gnl|CDD|132971 cd06640, STKc_MST4, Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 4

 Score = 62.4 bits (151), Expect = 1e-10
 Identities = 60/271 (22%), Positives = 124/271 (45%), Gaps = 27/271 (9%)

Query: 409 QCFSEVNLLGKGNFSSVYKGT-LRDGTLVAIRSINVTSCKSEEAEFVKGLYLLTSLRHEN 467
           + F+++  +GKG+F  V+KG   R   +VAI+ I++   + E  +  + + +L+      
Sbjct: 4   ELFTKLERIGKGSFGEVFKGIDNRTQQVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPY 63

Query: 468 IIRLRGFCCSRGRG-ECFLIYDFAPKGKLSKYLDQEEGSSNVLDWSTRVSIIIGIAKGIG 526
           + +  G   S  +G + ++I ++   G     L      +   D     +++  I KG+ 
Sbjct: 64  VTKYYG---SYLKGTKLWIIMEYLGGGSALDLL-----RAGPFDEFQIATMLKEILKGLD 115

Query: 527 YLHSSEVNKPAIVHRNLSVEKVLIDQQFNPLIADCGLHKLLADDIVFSVLKTSAAMG--- 583
           YLHS +      +HR++    VL+ +Q +  +AD G+   L D    + +K +  +G   
Sbjct: 116 YLHSEKK-----IHRDIKAANVLLSEQGDVKLADFGVAGQLTD----TQIKRNTFVGTPF 166

Query: 584 YLAPEYVTTGRFTERSDIFAFGVIILQILTGSLVLTSSMRLAAESATFENFIDRNLKGKF 643
           ++APE +    +  ++DI++ G+  +++  G     S M                L G+F
Sbjct: 167 WMAPEVIQQSAYDSKADIWSLGITAIELAKGE-PPNSDMHPMRVLFLIPKNNPPTLTGEF 225

Query: 644 SESEAAKLGKMALVCTHEDPENRPTMEAVIE 674
           S+       +    C ++DP  RPT + +++
Sbjct: 226 SKP----FKEFIDACLNKDPSFRPTAKELLK 252

Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 4 (MST4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST4 is sometimes referred to as MASK (MST3 and SOK1-related kinase). It plays a role in mitogen-activated protein kinase (MAPK) signaling during cytoskeletal rearrangement, morphogenesis, and apoptosis. It influences cell growth and transformation by modulating the extracellular signal-regulated kinase (ERK) pathway. MST4 may also play a role in tumor formation and progression. It localizes in the Golgi apparatus by interacting with the Golgi matrix protein GM130 and may play a role in cell migration. Length = 277

>gnl|CDD|173739 cd07838, STKc_CDK4_6_like, Catalytic domain of Cyclin-Dependent protein Kinase 4 and 6-like Serine/Threonine Kinases

 Score = 62.3 bits (152), Expect = 2e-10
 Identities = 58/216 (26%), Positives = 96/216 (44%), Gaps = 38/216 (17%)

Query: 411 FSEVNLLGKGNFSSVYKGT-LRDGTLVAIRSINVTSCKSEEA-------EFVKGLYLLTS 462
           + E+  +G+G + +VYK   L  G  VA++ + V    SEE        E +  L  L S
Sbjct: 1   YEELAEIGEGAYGTVYKARDLNTGRFVALKKVRV--PLSEEGIPLSTLRE-IALLKQLES 57

Query: 463 LRHENIIRLRGFC--CSRGRG-ECFLIYDFAPKGKLSKYLDQEEGSSNVLDWSTRVSIII 519
             H NI+RL   C      R  +  L+++   +  L+ YL +       L   T   ++ 
Sbjct: 58  FEHPNIVRLLDVCHGPRTDRELKLTLVFEHVDQ-DLATYLSK--CPKPGLPPETIKDLMR 114

Query: 520 GIAKGIGYLHSSEVNKPAIVHRNLSVEKVLIDQQFNPLIADCGLHKLLADDIVF-SVLKT 578
            + +G+ +LHS       IVHR+L  + +L+       IAD GL ++ + ++   SV+ T
Sbjct: 115 QLLRGVDFLHSH-----RIVHRDLKPQNILVTSDGQVKIADFGLARIYSFEMALTSVVVT 169

Query: 579 SAAMGYLAPE------YVTTGRFTERSDIFAFGVII 608
              + Y APE      Y T        D+++ G I 
Sbjct: 170 ---LWYRAPEVLLQSSYATP------VDMWSVGCIF 196

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) and CDK6-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4/6-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 and CDK6 partner with D-type cyclins to regulate the early G1 phase of the cell cycle. They are the first kinase activated by mitogenic signals to release cells from the G0 arrested state. CDK4 and CDK6 are both expressed ubiquitously, associate with all three D cyclins (D1, D2 and D3), and phosphorylate the retinoblastoma (pRb) protein. They are also regulated by the INK4 family of inhibitors which associate with either the CDK alone or the CDK/cyclin complex. CDK4 and CDK6 show differences in subcellular localization, sensitivity to some inhibitors, timing in activation, tumor selectivity, and possibly substrate profiles. Although CDK4 and CDK6 seem to show some redundancy, they also have discrete, nonoverlapping functions. CDK6 plays an important role in cell differentiation. Length = 287

>gnl|CDD|173652 cd05100, PTKc_FGFR3, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 3

 Score = 62.7 bits (152), Expect = 2e-10
 Identities = 67/291 (23%), Positives = 125/291 (42%), Gaps = 33/291 (11%)

Query: 417 LGKGNFSSVY--------KGTLRDGTLVAIRSINVTSCKSEEAEFVKGLYLLTSL-RHEN 467
           LG+G F  V         K        VA++ +   +   + ++ V  + ++  + +H+N
Sbjct: 20  LGEGCFGQVVMAEAIGIDKDKPNKPVTVAVKMLKDDATDKDLSDLVSEMEMMKMIGKHKN 79

Query: 468 IIRLRGFCCSRGRGECFLIYDFAPKGKLSKYL------------DQEEGSSNVLDWSTRV 515
           II L G  C++  G  +++ ++A KG L +YL            D  +     L +   V
Sbjct: 80  IINLLG-ACTQD-GPLYVLVEYASKGNLREYLRARRPPGMDYSFDTCKLPEEQLTFKDLV 137

Query: 516 SIIIGIAKGIGYLHSSEVNKPAIVHRNLSVEKVLIDQQFNPLIADCGLHKLLAD-DIVFS 574
           S    +A+G+ YL S +      +HR+L+   VL+ +     IAD GL + + + D    
Sbjct: 138 SCAYQVARGMEYLASQKC-----IHRDLAARNVLVTEDNVMKIADFGLARDVHNIDYYKK 192

Query: 575 VLKTSAAMGYLAPEYVTTGRFTERSDIFAFGVIILQILTGSLVLTSSMRLAAESATFENF 634
                  + ++APE +    +T +SD+++FGV++ +I T    L  S             
Sbjct: 193 TTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLLWEIFT----LGGSPYPGIPVEELFKL 248

Query: 635 IDRNLKGKFSESEAAKLGKMALVCTHEDPENRPTMEAVIEELTVAAPVMAT 685
           +    +     +   +L  +   C H  P  RPT + ++E+L     V +T
Sbjct: 249 LKEGHRMDKPANCTHELYMIMRECWHAVPSQRPTFKQLVEDLDRVLTVTST 299

Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 3 (FGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR3 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. Many FGFR3 splice variants have been reported with the IIIb and IIIc isoforms being the predominant forms. FGFR3 IIIc is the isoform expressed in chondrocytes, the cells affected in dwarfism, while IIIb is expressed in epithelial cells. FGFR3 ligands include FGF1, FGF2, FGF4, FGF8, FGF9, and FGF23. It is a negative regulator of long bone growth. In the cochlear duct and in the lens, FGFR3 is involved in differentiation while it appears to have a role in cell proliferation in epithelial cells. Germline mutations in FGFR3 are associated with skeletal disorders including several forms of dwarfism. Some missense mutations are associated with multiple myeloma and carcinomas of the bladder and cervix. Overexpression of FGFR3 is found in thyroid carcinoma. Length = 334

>gnl|CDD|173670 cd05579, STKc_MAST_like, Catalytic domain of Microtubule-associated serine/threonine kinase-like proteins

 Score = 61.9 bits (151), Expect = 2e-10
 Identities = 47/217 (21%), Positives = 88/217 (40%), Gaps = 39/217 (17%)

Query: 417 LGKGNFSSVY---KGTLRDGTLVAIRSIN---------VTSCKSEEAEFVKGLYLLTSLR 464
           + KG +  V+   K +  D  + AI+ I          V    +E         +L+  +
Sbjct: 1   ISKGAYGRVFLAKKKSTGD--IYAIKVIKKADMIRKNQVDQVLTERD-------ILSQAQ 51

Query: 465 HENIIRLRGFCCSRGRGECFLIYDFAPKGKLSKYLDQEEGSSNVLDWSTRVSIIIGIAKG 524
              +++L  +   +G+   +L+ ++ P G L+  L+        LD       I  I   
Sbjct: 52  SPYVVKL--YYSFQGKKNLYLVMEYLPGGDLASLLENV----GSLDEDVARIYIAEIVLA 105

Query: 525 IGYLHSSEVNKPAIVHRNLSVEKVLIDQQFNPLIADCGLHK-------LLADDIVFSVLK 577
           + YLHS+      I+HR+L  + +LID   +  + D GL K       +  +D      +
Sbjct: 106 LEYLHSN-----GIIHRDLKPDNILIDSNGHLKLTDFGLSKVGLVRRQINLNDDEKEDKR 160

Query: 578 TSAAMGYLAPEYVTTGRFTERSDIFAFGVIILQILTG 614
                 Y+APE +     ++  D ++ G I+ + L G
Sbjct: 161 IVGTPDYIAPEVILGQGHSKTVDWWSLGCILYEFLVG 197

Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MAST kinase subfamily includes MAST kinases, MAST-like (MASTL) kinases, and fungal kinases with similarity to Saccharomyces cerevisiae Rim15 and Schizosaccharomyces pombe cek1. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. MASTL kinases carry only a catalytic domain which contains a long insert relative to other kinases. The fungal kinases in this subfamily harbor other domains in addition to a central catalytic domain, which also contains an insert relative to MAST kinases like MASTL. Rim15 contains a C-terminal signal receiver (REC) domain while cek1 contains an N-terminal PAS domain. MAST kinases are cytoskeletal associated kinases of unknown function that are also expressed at neuromuscular junctions and postsynaptic densities. The fungal proteins Rim15 and cek1 are involved in the regulation of meiosis and mitosis, respectively. Length = 265

>gnl|CDD|143338 cd07833, STKc_CDKL, Catalytic domain of Cyclin-Dependent protein Kinase Like Serine/Threonine Kinases

 Score = 62.0 bits (151), Expect = 2e-10
 Identities = 55/208 (26%), Positives = 93/208 (44%), Gaps = 22/208 (10%)

Query: 414 VNLLGKGNFSSVYKGTLRD-GTLVAIRSINVTSCKSEEAEFVKGLYL-----LTSLRHEN 467
           + ++G+G +  V K   +  G +VAI+       +SE+ E VK   L     L  LRHEN
Sbjct: 6   LGVVGEGAYGVVLKCRNKATGEIVAIKKFK----ESEDDEDVKKTALREVKVLRQLRHEN 61

Query: 468 IIRLRGFCCSRGRGECFLIYDFAPKGKLSKYLDQEEGSSNVLDWSTRVSIIIGIAKGIGY 527
           I+ L+     +GR   +L++++  +      L+  E S   L      S I  + + I Y
Sbjct: 62  IVNLKEAFRRKGR--LYLVFEYVER----TLLELLEASPGGLPPDAVRSYIWQLLQAIAY 115

Query: 528 LHSSEVNKPAIVHRNLSVEKVLIDQQFNPLIADCGLHKLLADDIVFSVLKTSAAMGYLAP 587
            HS       I+HR++  E +L+ +     + D G  + L       +    A   Y AP
Sbjct: 116 CHSHN-----IIHRDIKPENILVSESGVLKLCDFGFARALRARPASPLTDYVATRWYRAP 170

Query: 588 E-YVTTGRFTERSDIFAFGVIILQILTG 614
           E  V    + +  D++A G I+ ++L G
Sbjct: 171 ELLVGDTNYGKPVDVWAIGCIMAELLDG 198

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like (CDKL) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDKL1-5 and similar proteins. Some CDKLs, like CDKL1 and CDKL3, may be implicated in transformation and others, like CDKL3 and CDKL5, are associated with mental retardation when impaired. CDKL2 plays a role in learning and memory. Length = 288

>gnl|CDD|132943 cd06612, STKc_MST1_2, Catalytic domain of the Protein Serine/Threonine Kinases, Mammalian Ste20-like protein kinase 1 and 2

 Score = 61.5 bits (150), Expect = 2e-10
 Identities = 48/217 (22%), Positives = 104/217 (47%), Gaps = 35/217 (16%)

Query: 409 QCFSEVNLLGKGNFSSVYKGTLRD-GTLVAIRSINVTSCKSEEAEFVKGLYLLTSLRHEN 467
           + F  +  LG+G++ SVYK   ++ G +VAI+ + V     +  E +K + +L       
Sbjct: 3   EVFDILEKLGEGSYGSVYKAIHKETGQVVAIKVVPVE---EDLQEIIKEISILKQCDSPY 59

Query: 468 IIRLRGFCCSRGRGECFLIYDFAPKGKLS-------KYLDQEEGSSNVLDWSTRVSIIIG 520
           I++  G        + +++ ++   G +S       K L +EE +          +I+  
Sbjct: 60  IVKYYG--SYFKNTDLWIVMEYCGAGSVSDIMKITNKTLTEEEIA----------AILYQ 107

Query: 521 IAKGIGYLHSSEVNKPAIVHRNLSVEKVLIDQQFNPLIADCGLHKLLADDIVFSVLKTSA 580
             KG+ YLHS++      +HR++    +L++++    +AD G+   L D    ++ K + 
Sbjct: 108 TLKGLEYLHSNK-----KIHRDIKAGNILLNEEGQAKLADFGVSGQLTD----TMAKRNT 158

Query: 581 AMG---YLAPEYVTTGRFTERSDIFAFGVIILQILTG 614
            +G   ++APE +    +  ++DI++ G+  +++  G
Sbjct: 159 VIGTPFWMAPEVIQEIGYNNKADIWSLGITAIEMAEG 195

Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 1 (MST1) and MST2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST1/2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST1, MST2, and related proteins including Drosophila Hippo and Dictyostelium discoideum Krs1 (kinase responsive to stress 1). MST1/2 and Hippo are involved in a conserved pathway that governs cell contact inhibition, organ size control, and tumor development. MST1 activates the mitogen-activated protein kinases (MAPKs) p38 and c-Jun N-terminal kinase (JNK) through MKK7 (a MAPK kinase) and MEKK1 (a MAPK kinase kinase) by acting as a MAPK kinase kinase kinase (MAPKKKK). Activation of JNK by MST1 leads to caspase activation and apoptosis. MST1 has also been implicated in cell proliferation and differentiation. Krs1 may regulate cell growth arrest and apoptosis in response to cellular stress. Length = 256

>gnl|CDD|173743 cd07846, STKc_CDKL2_3, Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 2 and 3

 Score = 60.9 bits (148), Expect = 4e-10
 Identities = 70/292 (23%), Positives = 116/292 (39%), Gaps = 62/292 (21%)

Query: 416 LLGKGNFSSVYKGTLRD-GTLVAIRSINVTSCKSEEAEFVKGL-----YLLTSLRHENII 469
           L+G+G++  V K   ++ G +VAI+       +SE+ + VK +      +L  LRHEN++
Sbjct: 8   LVGEGSYGMVMKCKHKETGQIVAIKKF----LESEDDKMVKKIAMREIRMLKQLRHENLV 63

Query: 470 RLRGFCCSRGRGECFLIYDFAPKGKLSKYLDQEEGSSNVLDWSTRVSIIIGIAKGIGYLH 529
            L      R +   +L+++F         LD  E   N LD S     +  I +GI + H
Sbjct: 64  NLIEVF--RRKKRLYLVFEFVDH----TVLDDLEKYPNGLDESRVRKYLFQILRGIEFCH 117

Query: 530 SSEVNKPAIVHRNLSVEKVLIDQQFNPLIADCGLHKLLA------DDIVFSVLKTSAAMG 583
           S       I+HR++  E +L+ Q     + D G  + LA       D V       A   
Sbjct: 118 SHN-----IIHRDIKPENILVSQSGVVKLCDFGFARTLAAPGEVYTDYV-------ATRW 165

Query: 584 YLAPEY-VTTGRFTERSDIFAFGVIILQILTGSLVLTSS----------MRLAAESATFE 632
           Y APE  V   ++    DI+A G ++ ++LTG  +                L       +
Sbjct: 166 YRAPELLVGDTKYGRAVDIWAVGCLVTEMLTGEPLFPGDSDIDQLYHIIKCLGNLIPRHQ 225

Query: 633 NFIDRN----------------LKGKFSESEAAKLGKMALVCTHEDPENRPT 668
               +N                L+ +F +     L      C   DP++RP+
Sbjct: 226 EIFQKNPLFAGMRLPEVKEIEPLEKRFPKLSGLVLDLAKQ-CLRIDPDDRPS 276

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 2 (CDKL2) and CDKL3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL2 and CDKL3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL2, also called p56 KKIAMRE, is expressed in testis, kidney, lung, and brain. It functions mainly in mature neurons and plays an important role in learning and memory. Inactivation of CDKL3, also called NKIAMRE (NKIATRE in rat), by translocation is associated with mild mental retardation. It has been reported that CDKL3 is lost in leukemic cells having a chromosome arm 5q deletion, and may contribute to the transformed phenotype. Length = 286

>gnl|CDD|132973 cd06642, STKc_STK25-YSK1, Catalytic domain of the Protein Serine/Threonine Kinase, STK25 or Yeast Sps1/Ste20-related kinase 1

 Score = 60.8 bits (147), Expect = 5e-10
 Identities = 62/271 (22%), Positives = 123/271 (45%), Gaps = 27/271 (9%)

Query: 409 QCFSEVNLLGKGNFSSVYKGTL-RDGTLVAIRSINVTSCKSEEAEFVKGLYLLTSLRHEN 467
           + F+++  +GKG+F  VYKG   R   +VAI+ I++   + E  +  + + +L+      
Sbjct: 4   ELFTKLERIGKGSFGEVYKGIDNRTKEVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPY 63

Query: 468 IIRLRGFCCSRGRG-ECFLIYDFAPKGKLSKYLDQEEGSSNVLDWSTRVSIIIGIAKGIG 526
           I R  G   S  +G + ++I ++   G     L         L+ +   +I+  I KG+ 
Sbjct: 64  ITRYYG---SYLKGTKLWIIMEYLGGGSALDLL-----KPGPLEETYIATILREILKGLD 115

Query: 527 YLHSSEVNKPAIVHRNLSVEKVLIDQQFNPLIADCGLHKLLADDIVFSVLKTSAAMG--- 583
           YLHS        +HR++    VL+ +Q +  +AD G+   L D    + +K +  +G   
Sbjct: 116 YLHSERK-----IHRDIKAANVLLSEQGDVKLADFGVAGQLTD----TQIKRNTFVGTPF 166

Query: 584 YLAPEYVTTGRFTERSDIFAFGVIILQILTGSLVLTSSMRLAAESATFENFIDRNLKGKF 643
           ++APE +    +  ++DI++ G+  +++  G      +  L      F   I +N     
Sbjct: 167 WMAPEVIKQSAYDFKADIWSLGITAIELAKGE---PPNSDLHPMRVLF--LIPKNSPPTL 221

Query: 644 SESEAAKLGKMALVCTHEDPENRPTMEAVIE 674
               +    +    C ++DP  RPT + +++
Sbjct: 222 EGQYSKPFKEFVEACLNKDPRFRPTAKELLK 252

Serine/threonine kinases (STKs), STK25 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK25 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. STK25 is also called Ste20/oxidant stress response kinase 1 (SOK1) or yeast Sps1/Ste20-related kinase 1 (YSK1). STK25 is localized in the Golgi apparatus through its interaction with the Golgi matrix protein GM130. It may play a role in the regulation of cell migration and polarization. STK25 binds and phosphorylates CCM3 (cerebral cavernous malformation 3), also called PCD10 (programmed cell death 10), and may play a role in apoptosis. Human STK25 is a candidate gene responsible for pseudopseudohypoparathyroidism (PPHP), a disease that shares features with the Albright hereditary osteodystrophy (AHO) phenotype. Length = 277

>gnl|CDD|173730 cd06624, STKc_ASK, Catalytic domain of the Protein Serine/Threonine Kinase, Apoptosis signal-regulating kinase

 Score = 60.6 bits (147), Expect = 5e-10
 Identities = 57/213 (26%), Positives = 101/213 (47%), Gaps = 34/213 (15%)

Query: 416 LLGKGNFSSVYKG-TLRDGTLVAIRSINVTSCKSEEAEFVKGLY----LLTSLRHENIIR 470
           +LGKG +  VY    L     +AI+ I        ++ +V+ L+    L + L+H NI++
Sbjct: 15  VLGKGTYGIVYAARDLSTQVRIAIKEIPER-----DSRYVQPLHEEIALHSYLKHRNIVQ 69

Query: 471 LRGFCCSRGRGECFLIY-DFAPKGKLSKYLDQEEG----SSNVLDWSTRVSIIIGIAKGI 525
             G   S      F I+ +  P G LS  L  + G    +   + + T+      I +G+
Sbjct: 70  YLG-SDS--ENGFFKIFMEQVPGGSLSALLRSKWGPLKDNEQTIIFYTK-----QILEGL 121

Query: 526 GYLHSSEVNKPAIVHRNLSVEKVLIDQQFNPL-IADCGLHKLLADDIVFSVLKT-SAAMG 583
            YLH ++     IVHR++  + VL++     + I+D G  K LA   +    +T +  + 
Sbjct: 122 KYLHDNQ-----IVHRDIKGDNVLVNTYSGVVKISDFGTSKRLAG--INPCTETFTGTLQ 174

Query: 584 YLAPEYVTTGR--FTERSDIFAFGVIILQILTG 614
           Y+APE +  G   +   +DI++ G  I+++ TG
Sbjct: 175 YMAPEVIDKGPRGYGAPADIWSLGCTIVEMATG 207

Serine/threonine kinases (STKs), Apoptosis signal-regulating kinase (ASK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ASK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Subfamily members are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) and include ASK1, ASK2, and MAPKKK15. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. ASK1 (also called MAPKKK5) functions in the c-Jun N-terminal kinase (JNK) and p38 MAPK signaling pathways by directly activating their respective MAPKKs, MKK4/MKK7 and MKK3/MKK6. It plays important roles in cytokine and stress responses, as well as in reactive oxygen species (ROS)-mediated cellular responses. ASK1 is implicated in various diseases mediated by oxidative stress including inschemic heart disease, hypertension, vessel injury, brain ischemia, Fanconi anemia, asthma, and pulmonary edema, among others. ASK2 (also called MAPKKK6) functions only in a heteromeric complex with ASK1, and can activate ASK1 by direct phosphorylation. The function of MAPKKK15 is still unknown. Length = 268

>gnl|CDD|132956 cd06625, STKc_MEKK3_like, Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases

 Score = 60.2 bits (146), Expect = 5e-10
 Identities = 54/207 (26%), Positives = 92/207 (44%), Gaps = 22/207 (10%)

Query: 416 LLGKGNFSSVYKGTLRD-GTLVAIRSINVTSCKSEEAEFVKGL----YLLTSLRHENIIR 470
           LLG+G F  VY     D G  +A++ +       E  + V  L     LL +L+HE I++
Sbjct: 9   LLGQGAFGRVYLCYDVDTGRELAVKQVPFDPDSPETKKEVNALECEIQLLKNLQHERIVQ 68

Query: 471 LRGFCCSRGRGECFLIYDFAPKGKLSKYLDQEEG-SSNVLDWSTRVSIIIGIAKGIGYLH 529
             G  C R      +  ++ P G +   L      +  V    TR      I +G+ YLH
Sbjct: 69  YYG--CLRDDETLSIFMEYMPGGSVKDQLKAYGALTETVTRKYTR-----QILEGVEYLH 121

Query: 530 SSEVNKPAIVHRNLSVEKVLIDQQFNPLIADCGLHKLLADDIVFSVLKTSAAMG---YLA 586
           S+      IVHR++    +L D   N  + D G  K L   I  S     +  G   +++
Sbjct: 122 SNM-----IVHRDIKGANILRDSAGNVKLGDFGASKRL-QTICSSGTGMKSVTGTPYWMS 175

Query: 587 PEYVTTGRFTERSDIFAFGVIILQILT 613
           PE ++   +  ++D+++ G  ++++LT
Sbjct: 176 PEVISGEGYGRKADVWSVGCTVVEMLT 202

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK2 and MEKK3 activate MEK5 (also called MKK5), which activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development. MEKK2 and MEKK3 can also activate the MAPKs, c-Jun N-terminal kinase (JNK) and p38, through their respective MAPKKs. Length = 263

>gnl|CDD|132972 cd06641, STKc_MST3, Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 3

 Score = 59.7 bits (144), Expect = 9e-10
 Identities = 62/274 (22%), Positives = 126/274 (45%), Gaps = 33/274 (12%)

Query: 409 QCFSEVNLLGKGNFSSVYKGT-LRDGTLVAIRSINVTSCKSEEAEFVKGLYLLTSLRHEN 467
           + F+++  +GKG+F  V+KG   R   +VAI+ I++   + E  +  + + +L+      
Sbjct: 4   ELFTKLEKIGKGSFGEVFKGIDNRTQKVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPY 63

Query: 468 IIRLRGFCCSRGRGECFLIYDFAPKGKLSKYLDQEEGSSNVLDWSTRVSIIIGIAKGIGY 527
           + +  G      +   ++I ++   G     L  E G    LD +   +I+  I KG+ Y
Sbjct: 64  VTKYYGSYLKDTK--LWIIMEYLGGGSALDLL--EPGP---LDETQIATILREILKGLDY 116

Query: 528 LHSSEVNKPAIVHRNLSVEKVLIDQQFNPLIADCGLHKLLADDIVFSVLKTSAAMG---Y 584
           LHS +      +HR++    VL+ +     +AD G+   L D    + +K +  +G   +
Sbjct: 117 LHSEKK-----IHRDIKAANVLLSEHGEVKLADFGVAGQLTD----TQIKRNTFVGTPFW 167

Query: 585 LAPEYVTTGRFTERSDIFAFGVIILQILTGSLVLTSSMRLAAESATFENFIDRN----LK 640
           +APE +    +  ++DI++ G+  +++  G         L      F   I +N    L+
Sbjct: 168 MAPEVIKQSAYDSKADIWSLGITAIELAKGE---PPHSELHPMKVLF--LIPKNNPPTLE 222

Query: 641 GKFSESEAAKLGKMALVCTHEDPENRPTMEAVIE 674
           G +S+     L +    C +++P  RPT + +++
Sbjct: 223 GNYSKP----LKEFVEACLNKEPSFRPTAKELLK 252

Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST3 phosphorylates the STK NDR and may play a role in cell cycle progression and cell morphology. It may also regulate paxillin and consequently, cell migration. MST3 is present in human placenta, where it plays an essential role in the oxidative stress-induced apoptosis of trophoblasts in normal spontaneous delivery. Dysregulation of trophoblast apoptosis may result in pregnancy complications such as preeclampsia and intrauterine growth retardation. Length = 277

>gnl|CDD|173768 cd08228, STKc_Nek6, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 6

 Score = 59.7 bits (144), Expect = 1e-09
 Identities = 63/269 (23%), Positives = 115/269 (42%), Gaps = 29/269 (10%)

Query: 417 LGKGNFSSVYKGT-LRDGTLVAIRSINVTSCKSEEA--EFVKGLYLLTSLRHENIIR-LR 472
           +G+G FS VY+ T L D   VA++ + +      +A  + VK + LL  L H N+I+ L 
Sbjct: 10  IGRGQFSEVYRATCLLDRKPVALKKVQIFEMMDAKARQDCVKEIDLLKQLNHPNVIKYLD 69

Query: 473 GFCCSRGRGECFLIYDFAPKGKLSKYLDQEEGSSNVLDWSTRVSIIIGIAKGIGYLHSSE 532
            F       E  ++ + A  G LS+ +   +    ++   T     + +   + ++HS  
Sbjct: 70  SFIED---NELNIVLELADAGDLSQMIKYFKKQKRLIPERTVWKYFVQLCSAVEHMHSRR 126

Query: 533 VNKPAIVHRNLSVEKVLIDQQFNPLIADCGLHKLLADDIVFSVLKTSAAMG------YLA 586
           V     +HR++    V I       + D GL +  +        KT+AA        Y++
Sbjct: 127 V-----MHRDIKPANVFITATGVVKLGDLGLGRFFSS-------KTTAAHSLVGTPYYMS 174

Query: 587 PEYVTTGRFTERSDIFAFGVIILQILT-GSLVLTSSMRLAAESATFENFIDRNLKGKFSE 645
           PE +    +  +SDI++ G ++ ++    S      M L +     E      L     E
Sbjct: 175 PERIHENGYNFKSDIWSLGCLLYEMAALQSPFYGDKMNLFSLCQKIEQCDYPPLPT---E 231

Query: 646 SEAAKLGKMALVCTHEDPENRPTMEAVIE 674
             + KL ++  +C + DP+ RP +  V +
Sbjct: 232 HYSEKLRELVSMCIYPDPDQRPDIGYVHQ 260

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 is required for the transition from metaphase to anaphase. It also plays important roles in mitotic spindle formation and cytokinesis. Activated by Nek9 during mitosis, Nek6 phosphorylates Eg5, a kinesin that is important for spindle bipolarity. Nek6 localizes to spindle microtubules during metaphase and anaphase, and to the midbody during cytokinesis. Length = 267

>gnl|CDD|173680 cd05589, STKc_PKN, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase N

 Score = 58.9 bits (143), Expect = 2e-09
 Identities = 62/220 (28%), Positives = 98/220 (44%), Gaps = 39/220 (17%)

Query: 411 FSEVNLLGKGNFSSV----YKGTLRDGTLVAIRSIN---------VTSCKSEEAEFVKGL 457
           F  + +LG+G+F  V    YK T   G L AI+++          V S   E+  F    
Sbjct: 1   FRCLAVLGRGHFGKVLLAEYKKT---GELYAIKALKKGDIIARDEVESLMCEKRIFE--- 54

Query: 458 YLLTSLRHENIIRLRGFCCSRGRGECFLIYDFAPKGKLSKYLDQEEGSSNVLDWSTRVSI 517
               S RH  ++ L  F C +       + ++A  G L  ++  +     V      V  
Sbjct: 55  -TANSERHPFLVNL--FACFQTEDHVCFVMEYAAGGDLMMHIHTD-----VFSEPRAVFY 106

Query: 518 IIGIAKGIGYLHSSEVNKPAIVHRNLSVEKVLIDQQFNPLIADCGLHKLLADDIVFSVLK 577
              +  G+ YLH    NK  IV+R+L ++ +L+D +    IAD GL K   + + F   +
Sbjct: 107 AACVVLGLQYLHE---NK--IVYRDLKLDNLLLDTEGFVKIADFGLCK---EGMGFGD-R 157

Query: 578 TSAAMG---YLAPEYVTTGRFTERSDIFAFGVIILQILTG 614
           TS   G   +LAPE +T   +T   D +  GV+I ++L G
Sbjct: 158 TSTFCGTPEFLAPEVLTETSYTRAVDWWGLGVLIYEMLVG 197

Serine/Threonine Kinases (STKs), Protein Kinase N (PKN) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKN subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKN has a C-terminal catalytic domain that is highly homologous to PKCs. Its unique N-terminal regulatory region contains antiparallel coiled-coil (ACC) domains. In mammals, there are three PKN isoforms from different genes (designated PKN-alpha, beta, and gamma), which show different enzymatic properties, tissue distribution, and varied functions. PKN can be activated by the small GTPase Rho, and by fatty acids such as arachidonic and linoleic acids. It is involved in many biological processes including cytokeletal regulation, cell adhesion, vesicle transport, glucose transport, regulation of meiotic maturation and embryonic cell cycles, signaling to the nucleus, and tumorigenesis. Length = 324

>gnl|CDD|173758 cd08218, STKc_Nek1, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 1

 Score = 58.3 bits (141), Expect = 3e-09
 Identities = 56/278 (20%), Positives = 130/278 (46%), Gaps = 39/278 (14%)

Query: 411 FSEVNLLGKGNF-SSVYKGTLRDGTLVAIRSINVTSCKSEE-AEFVKGLYLLTSLRHENI 468
           + +V  +G+G+F  ++   +  DG    I+ IN++    +E  E  K + +L++++H NI
Sbjct: 2   YVKVKKIGEGSFGKAILVKSKEDGKQYVIKEINISKMSPKEREESRKEVAVLSNMKHPNI 61

Query: 469 IRLR-GFCCSRGRGECFLIYDFAPKGKLSKYLDQEEGS----SNVLDWSTRVSIIIGIAK 523
           ++ +  F      G  +++ D+   G L K ++ + G       +LDW       + I  
Sbjct: 62  VQYQESF---EENGNLYIVMDYCEGGDLYKKINAQRGVLFPEDQILDW------FVQICL 112

Query: 524 GIGYLHSSEVNKPAIVHRNLSVEKVLIDQQFNPLIADCGLHKLLADDIVFSVLKTSAAMG 583
            + ++H  +     I+HR++  + + + +     + D G+ ++L      +V      +G
Sbjct: 113 ALKHVHDRK-----ILHRDIKSQNIFLTKDGTIKLGDFGIARVLNS----TVELARTCIG 163

Query: 584 ---YLAPEYVTTGRFTERSDIFAFGVIILQILTGSLVLTSSMRLAAESATFENFIDRNLK 640
              YL+PE      +  +SDI+A G ++ ++ T        ++ A E+   +N + + ++
Sbjct: 164 TPYYLSPEICENRPYNNKSDIWALGCVLYEMCT--------LKHAFEAGNMKNLVLKIIR 215

Query: 641 GKF---SESEAAKLGKMALVCTHEDPENRPTMEAVIEE 675
           G +   S   +  L  +       +P +RP++ +++E+
Sbjct: 216 GSYPPVSSHYSYDLRNLVSQLFKRNPRDRPSVNSILEK 253

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 1 (Nek1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek1 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek1 is associated with centrosomes throughout the cell cycle. It is involved in the formation of primary cilium and in the maintenance of centrosomes. It cycles through the nucleus and may be capable of relaying signals between the cilium and the nucleus. Nek1 is implicated in the development of polycystic kidney disease, which is characterized by benign polycystic tumors formed by abnormal overgrowth of renal epithelial cells. It appears also to be involved in DNA damage response, and may be important for both correct DNA damage checkpoint activation and DNA repair. Length = 256

>gnl|CDD|143333 cd05118, STKc_CMGC, Catalytic domain of CMGC family Serine/Threonine Kinases

 Score = 58.1 bits (141), Expect = 4e-09
 Identities = 52/206 (25%), Positives = 88/206 (42%), Gaps = 23/206 (11%)

Query: 417 LGKGNFSSVYKG-TLRDGTLVAIRSI-----NVTSCKSEEAEFVKGLYLLTSLRHENIIR 470
           +G+G +  VYK      G +VAI+ I     +    K+   E      LL  L H NII+
Sbjct: 7   IGEGTYGVVYKARDKLTGEIVAIKKIKLRFESEGIPKTALREIK----LLKELNHPNIIK 62

Query: 471 LRGFCCSRGRGECFLIYDFAPKGKLSKYLDQEEGSSNVLDWSTRVSIIIGIAKGIGYLHS 530
           L      R +G+ +L+++F     L K +         L  S   S +  + +G+ + HS
Sbjct: 63  LLDVF--RHKGDLYLVFEFM-DTDLYKLIK---DRQRGLPESLIKSYLYQLLQGLAFCHS 116

Query: 531 SEVNKPAIVHRNLSVEKVLIDQQFNPLIADCGLHKLLADDIVFSVLKTSAAMGYLAPE-Y 589
                  I+HR+L  E +LI+ +    +AD GL +     +            Y APE  
Sbjct: 117 H-----GILHRDLKPENLLINTEGVLKLADFGLARSFGSPVRP-YTHYVVTRWYRAPELL 170

Query: 590 VTTGRFTERSDIFAFGVIILQILTGS 615
           +    ++   DI++ G I  ++L+  
Sbjct: 171 LGDKGYSTPVDIWSVGCIFAELLSRR 196

Serine/Threonine Kinases (STKs), CMGC family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CMGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The CMGC family consists of Cyclin-Dependent protein Kinases (CDKs), Mitogen-activated protein kinases (MAPKs) such as Extracellular signal-regulated kinase (ERKs), c-Jun N-terminal kinases (JNKs), and p38, and similar proteins. CDKs belong to a large subfamily of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. MAPKs serve as important mediators of cellular responses to extracellular signals. They control critical cellular functions including differentiation, proliferation, migration, and apoptosis. They are also implicated in the pathogenesis of many diseases including multiple types of cancer, stroke, diabetes, and chronic inflammation. Length = 283

>gnl|CDD|173751 cd07860, STKc_CDK2_3, Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase 2 and 3

 Score = 57.9 bits (140), Expect = 4e-09
 Identities = 51/211 (24%), Positives = 101/211 (47%), Gaps = 24/211 (11%)

Query: 411 FSEVNLLGKGNFSSVYKG-TLRDGTLVAIRSINV-TSCKSEEAEFVKGLYLLTSLRHENI 468
           F +V  +G+G +  VYK      G +VA++ I + T  +   +  ++ + LL  L H NI
Sbjct: 2   FQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNI 61

Query: 469 IRLRGFCCSRGRGECFLIYDFAPKGKLSKYLDQEEGSSNVLDWSTRVSIIIGIAKGIGYL 528
           ++L     +  +   +L+++F  +  L K++D    S   +      S +  + +G+ + 
Sbjct: 62  VKLLDVIHTENK--LYLVFEFLHQ-DLKKFMDASPLSG--IPLPLIKSYLFQLLQGLAFC 116

Query: 529 HSSEVNKPAIVHRNLSVEKVLIDQQFNPLIADCGLHKLLADDIVFSV-LKT----SAAMG 583
           HS  V     +HR+L  + +LI+ +    +AD GL +       F V ++T       + 
Sbjct: 117 HSHRV-----LHRDLKPQNLLINTEGAIKLADFGLAR------AFGVPVRTYTHEVVTLW 165

Query: 584 YLAPEYVTTGRF-TERSDIFAFGVIILQILT 613
           Y APE +   ++ +   DI++ G I  +++T
Sbjct: 166 YRAPEILLGCKYYSTAVDIWSLGCIFAEMVT 196

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 2 (CDK2) and CDK3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK2/3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK2 is regulated by cyclin E or cyclin A. Upon activation by cyclin E, it phosphorylates the retinoblastoma (pRb) protein which activates E2F mediated transcription and allows cells to move into S phase. The CDK2/cyclin A complex plays a role in regulating DNA replication. CDK2, together with CDK4, also regulates embryonic cell proliferation. Despite these important roles, mice deleted for the cdk2 gene are viable and normal except for being sterile. This may be due to compensation provided by CDK1 (also called Cdc2), which can also bind cyclin E and drive the G1 to S phase transition. CDK3 is regulated by cyclin C and it phosphorylates pRB specifically during the G0/G1 transition. This phosphorylation is required for cells to exit G0 efficiently and enter the G1 phase. Length = 284

>gnl|CDD|132940 cd06609, STKc_MST3_like, Catalytic domain of Mammalian Ste20-like protein kinase 3-like Protein Serine/Threonine Kinases

 Score = 57.6 bits (140), Expect = 5e-09
 Identities = 66/278 (23%), Positives = 120/278 (43%), Gaps = 56/278 (20%)

Query: 411 FSEVNLLGKGNFSSVYKGT-LRDGTLVAIRSINVTSCKSEEAEFVKGLYLLTSLRHENII 469
           F+ +  +GKG+F  VYK    R   +VAI+ I++   + E  +  + +  L+  R   I 
Sbjct: 3   FTLLECIGKGSFGEVYKAIDKRTNQVVAIKVIDLEEAEDEIEDIQQEIQFLSQCRSPYIT 62

Query: 470 RLRGFCCSRGRGECFLIYDFAPKG-KL---SKYLDQEEGS------SNVLDWSTRVSIII 519
           +  G          FL      KG KL    +Y     GS         LD +    I+ 
Sbjct: 63  KYYG---------SFL------KGSKLWIIMEYCGG--GSCLDLLKPGKLDETYIAFILR 105

Query: 520 GIAKGIGYLHSSEVNKPAIVHRNLSVEKVLIDQQFNPLIADCGLHKLLADDIVFSVLKTS 579
            +  G+ YLH     K   +HR++    +L+ ++ +  +AD G    ++  +  ++ K +
Sbjct: 106 EVLLGLEYLHEE--GK---IHRDIKAANILLSEEGDVKLADFG----VSGQLTSTMSKRN 156

Query: 580 AAMG---YLAPEYVTTGRFTERSDIFAFGVIILQILTGSLVLTS--SMRLAAESATFE-- 632
             +G   ++APE +    + E++DI++ G+  +++  G   L+    MR       F   
Sbjct: 157 TFVGTPFWMAPEVIKQSGYDEKADIWSLGITAIELAKGEPPLSDLHPMR-----VLFLIP 211

Query: 633 -NFIDRNLKGKFSESEAAKLGKMAL-VCTHEDPENRPT 668
            N        KFS     K  K  + +C ++DP+ RP+
Sbjct: 212 KNNPPSLEGNKFS-----KPFKDFVSLCLNKDPKERPS 244

Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST3, MST4, STK25, Schizosaccharomyces pombe Nak1 and Sid1, Saccharomyces cerevisiae sporulation-specific protein 1 (SPS1), and related proteins. Nak1 is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Sid1 is a component in the septation initiation network (SIN) signaling pathway, and plays a role in cytokinesis. SPS1 plays a role in regulating proteins required for spore wall formation. MST4 plays a role in mitogen-activated protein kinase (MAPK) signaling during cytoskeletal rearrangement, morphogenesis, and apoptosis. MST3 phosphorylates the STK NDR and may play a role in cell cycle progression and cell morphology. STK25 may play a role in the regulation of cell migration and polarization. Length = 274

>gnl|CDD|132951 cd06620, PKc_MAPKK_Byr1_like, Catalytic domain of fungal Byr1-like dual-specificity MAP kinase kinases

 Score = 57.5 bits (139), Expect = 5e-09
 Identities = 57/266 (21%), Positives = 109/266 (40%), Gaps = 33/266 (12%)

Query: 417 LGKGNFSSVYK-GTLRDGTLVAIRSINVTSCKSEEAEFVKGLYLLTSLRHENIIRLRGFC 475
           LG GN  SV K   +  GT++A + +++ +  S   + ++ L ++   R   I+   G  
Sbjct: 13  LGAGNGGSVSKVKHIPTGTVMAKKVVHIGAKSSVRKQILRELQIMHECRSPYIVSFYG-- 70

Query: 476 CSRGRGECFLIYDFAPKGKLSKYLDQEEG--SSNVLDWSTRVSIIIGIAKGIGYLHSSEV 533
                    +  +F   G L +   ++ G     +L       I + + +G+ YL+    
Sbjct: 71  AFLNENNICMCMEFMDCGSLDRIY-KKGGPIPVEILG-----KIAVAVVEGLTYLY---- 120

Query: 534 NKPAIVHRNLSVEKVLIDQQFNPLIADCGLHKLLADDIVFSVLKTSAAMGYLAPEYVTTG 593
           N   I+HR++    +L++ +    + D G+   L + I  + + TS    Y++PE +  G
Sbjct: 121 NVHRIMHRDIKPSNILVNSRGQIKLCDFGVSGELINSIADTFVGTST---YMSPERIQGG 177

Query: 594 RFTERSDIFAFGVIILQILTGSLVLTSSMRLAAESATFENFID-----------RNLKGK 642
           ++T +SD+++ G+ I+++  G      S             +D           R     
Sbjct: 178 KYTVKSDVWSLGISIIELALGKFPFAFSNIDDDGQDDPMGILDLLQQIVQEPPPRLPSSD 237

Query: 643 FSESEAAKLGKMALVCTHEDPENRPT 668
           F E     L      C  +DP  RPT
Sbjct: 238 FPED----LRDFVDACLLKDPTERPT 259

Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal Byr1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include the MAPKKs Byr1 from Schizosaccharomyces pombe, FUZ7 from Ustilago maydis, and related proteins. Byr1 phosphorylates its downstream target, the MAPK Spk1, and is regulated by the MAPKKK Byr2. The Spk1 cascade is pheromone-responsive and is essential for sporulation and sexual differentiation in fission yeast. FUZ7 phosphorylates and activates its target, the MAPK Crk1, which is required in mating and virulence in U. maydis. Length = 284

>gnl|CDD|132982 cd06651, STKc_MEKK3, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 3

 Score = 57.4 bits (138), Expect = 6e-09
 Identities = 57/208 (27%), Positives = 96/208 (46%), Gaps = 22/208 (10%)

Query: 416 LLGKGNFSSVYKGTLRD-GTLVAIRSINVTSCKSEEAEFVKGL----YLLTSLRHENIIR 470
           LLG+G F  VY     D G  +A + +       E ++ V  L     LL +L+HE I++
Sbjct: 9   LLGQGAFGRVYLCYDVDTGRELAAKQVQFDPESPETSKEVSALECEIQLLKNLQHERIVQ 68

Query: 471 LRGFCCSRGRGECFL--IYDFAPKGKLSKYLDQEEGSSNVLDWSTRVSIIIGIAKGIGYL 528
             G  C R R E  L    ++ P G +    DQ +    + +  TR      I +G+ YL
Sbjct: 69  YYG--CLRDRAEKTLTIFMEYMPGGSVK---DQLKAYGALTESVTR-KYTRQILEGMSYL 122

Query: 529 HSSEVNKPAIVHRNLSVEKVLIDQQFNPLIADCGLHKLLADDIVFSVLKTSAAMG---YL 585
           HS+      IVHR++    +L D   N  + D G  K L   I  S     +  G   ++
Sbjct: 123 HSN-----MIVHRDIKGANILRDSAGNVKLGDFGASKRL-QTICMSGTGIRSVTGTPYWM 176

Query: 586 APEYVTTGRFTERSDIFAFGVIILQILT 613
           +PE ++   +  ++D+++ G  ++++LT
Sbjct: 177 SPEVISGEGYGRKADVWSLGCTVVEMLT 204

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK3 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development. In addition, MEKK3 is involved in interleukin-1 receptor and Toll-like receptor 4 signaling. It is also a specific regulator of the proinflammatory cytokines IL-6 and GM-CSF in some immune cells. MEKK3 also regulates calcineurin, which plays a critical role in T cell activation, apoptosis, skeletal myocyte differentiation, and cardiac hypertrophy. Length = 266

>gnl|CDD|132960 cd06629, STKc_MAPKKK_Bck1_like, Catalytic domain of fungal Bck1-like MAP Kinase Kinase Kinases

 Score = 56.7 bits (137), Expect = 9e-09
 Identities = 68/281 (24%), Positives = 121/281 (43%), Gaps = 42/281 (14%)

Query: 416 LLGKGNFSSVYKG-TLRDGTLVAIRSINVTSC-----KSEEAEFVKGLY----LLTSLRH 465
           L+GKG +  VY    +  G ++A++ + + +       S + + VK L      L  L H
Sbjct: 8   LIGKGTYGRVYLALNVTTGEMMAVKQVELPATIAGRHDSRQKDMVKALRSEIETLKDLDH 67

Query: 466 ENIIRLRGFCCSRGRGECFLIYDFAPKGK----LSKYLDQEEGSSNVLDWSTRVSIIIGI 521
            NI++  GF  +      FL Y   P G     L  Y   EE                 +
Sbjct: 68  LNIVQYLGFETTEEYLSIFLEY--VPGGSIGSCLRTYGRFEE--------QLVRFFTEQV 117

Query: 522 AKGIGYLHSSEVNKPAIVHRNLSVEKVLIDQQFNPLIADCGLHKLLADDIVFSVLKTS-- 579
            +G+ YLHS       I+HR+L  + +L+D      I+D G+ K  +DDI  +    S  
Sbjct: 118 LEGLAYLHSK-----GILHRDLKADNLLVDADGICKISDFGISK-KSDDIYDNDQNMSMQ 171

Query: 580 AAMGYLAPEYVTTGR--FTERSDIFAFGVIILQILTGSLVLTSSMRLAAESATFENFIDR 637
            ++ ++APE + +    ++ + DI++ G ++L++  G    +      A +A F+    R
Sbjct: 172 GSVFWMAPEVIHSYSQGYSAKVDIWSLGCVVLEMFAGRRPWS---DEEAIAAMFKLGNKR 228

Query: 638 NLKGKFSESEAAKLGKMAL----VCTHEDPENRPTMEAVIE 674
           +         +  L  +AL     C   +P+NRPT   +++
Sbjct: 229 S-APPIPPDVSMNLSPVALDFLNACFTINPDNRPTARELLQ 268

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Bck1-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Saccharomyces cerevisiae Bck1 and Schizosaccharomyces pombe Mkh1, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Budding yeast Bck1 is part of the cell integrity MAPK pathway, which is activated by stresses and aggressions to the cell wall. The MAPKKK Bck1, MAPKKs Mkk1 and Mkk2, and the MAPK Slt2 make up the cascade that is important in the maintenance of cell wall homeostasis. Fission yeast Mkh1 is involved in MAPK cascades regulating cell morphology, cell wall integrity, salt resistance, and filamentous growth in response to stress. Length = 272

>gnl|CDD|173770 cd08528, STKc_Nek10, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 10

 Score = 56.4 bits (136), Expect = 1e-08
 Identities = 66/271 (24%), Positives = 115/271 (42%), Gaps = 38/271 (14%)

Query: 416 LLGKGNFSSVYKGTLRDG--TLVAIRSINVTS-----CKSEEAEFVKGL-----YLLTSL 463
            LG G F  VYK   ++    L+A++ INV +      K E  + +  +      +   L
Sbjct: 7   HLGSGAFGCVYKVRKKNNGQNLLALKEINVHNPAFGKDKRERDKSIGDIVSEVTIIKEQL 66

Query: 464 RHENIIRLRGFCCSRGRGECFLIYDF---APKGKLSKYLDQEEGS-SNVLDWSTRVSIII 519
           RH NI+R         R   +++ D    AP G+    L +++   +    W+    I +
Sbjct: 67  RHPNIVRYYKTFLENDR--LYIVMDLIEGAPLGEHFNSLKEKKQRFTEERIWN----IFV 120

Query: 520 GIAKGIGYLHSSEVNKPAIVHRNLSVEKVLIDQQFNPLIADCGLHKLLADDIVFSVLKTS 579
            +   + YLH  +     IVHR+L+   +++ +     I D GL K    +      K +
Sbjct: 121 QMVLALRYLHKEK----RIVHRDLTPNNIMLGEDDKVTITDFGLAKQKQPE-----SKLT 171

Query: 580 AAMG---YLAPEYVTTGRFTERSDIFAFGVIILQILTGSLVLTSSMRLAAESATFENFID 636
           + +G   Y  PE V    + E++D++AFG I+ Q+ T      S+  L+  +   E   +
Sbjct: 172 SVVGTILYSCPEIVKNEPYGEKADVWAFGCILYQMCTLQPPFYSTNMLSLATKIVEAVYE 231

Query: 637 RNLKGKFSESEAAKLGKMALVCTHEDPENRP 667
              +G +SE     +  +   C   D E RP
Sbjct: 232 PLPEGMYSE----DVTDVITSCLTPDAEARP 258

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 10 (Nek10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek10 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. No function has yet been ascribed to Nek10. The gene encoding Nek10 is a putative causative gene for breast cancer; it is located within a breast cancer susceptibility loci on chromosome 3p24. Length = 269

>gnl|CDD|132957 cd06626, STKc_MEKK4, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 4

 Score = 56.2 bits (136), Expect = 1e-08
 Identities = 54/213 (25%), Positives = 97/213 (45%), Gaps = 27/213 (12%)

Query: 415 NLLGKGNFSSVYKG-TLRDGTLVAIRSINVTSCKSEEAEFVKG-LYLLTSLRHENIIRLR 472
           N +G G F  VY    L  G L+A++ I +     +  + +   + +L  L+H N+++  
Sbjct: 6   NKIGGGTFGKVYTAVNLDTGELMAVKEIRIQDNDPKTIKEIADEMKVLELLKHPNLVKYY 65

Query: 473 GFCCSRGRGECFLIY-DFAPKGKLSKYLDQEEGSSNVLDWSTRVSIIIGIAKGIGYLHSS 531
           G    R   E   I+ ++   G L + L  E G   +LD        + + +G+ YLHS 
Sbjct: 66  GVEVHR---EKVYIFMEYCSGGTLEELL--EHG--RILDEHVIRVYTLQLLEGLAYLHSH 118

Query: 532 EVNKPAIVHRNLSVEKVLIDQQFNPLI--ADCGLHKLLAD--DIVFSVLKTSA--AMGYL 585
                 IVHR++    + +D   N +I   D G    L +    +   +++ A     Y+
Sbjct: 119 -----GIVHRDIKPANIFLD--HNGVIKLGDFGCAVKLKNNTTTMGEEVQSLAGTPA-YM 170

Query: 586 APEYVTTGRFTER---SDIFAFGVIILQILTGS 615
           APE +T G+       +DI++ G ++L++ TG 
Sbjct: 171 APEVITGGKGKGHGRAADIWSLGCVVLEMATGK 203

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 4 (MEKK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK4 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK4 activates the c-Jun N-terminal kinase (JNK) and p38 MAPK signaling pathways by directly activating their respective MAPKKs, MKK4/MKK7 and MKK3/MKK6. JNK and p38 are collectively known as stress-activated MAPKs, as they are activated in response to a variety of environmental stresses and pro-inflammatory cytokines. MEKK4 also plays roles in the re-polarization of the actin cytoskeleton in response to osmotic stress, in the proper closure of the neural tube, in cardiovascular development, and in immune responses. Length = 264

>gnl|CDD|173733 cd07829, STKc_CDK_like, Catalytic domain of Cyclin-Dependent protein Kinase-like Serine/Threonine Kinases

 Score = 56.3 bits (137), Expect = 1e-08
 Identities = 43/157 (27%), Positives = 82/157 (52%), Gaps = 17/157 (10%)

Query: 411 FSEVNLLGKGNFSSVYKGT-LRDGTLVAIRSINVTSCKSEE---AEFVKGLYLLTSLRHE 466
           + ++  LG+G +  VYK    + G +VA++ I +     EE   +  ++ + LL  L+H 
Sbjct: 1   YEKLEKLGEGTYGVVYKARDKKTGEIVALKKIRL--DNEEEGIPSTALREISLLKELKHP 58

Query: 467 NIIRLRGFCCSRGRGECFLIYDFAPKGKLSKYLDQEEGSSNVLDWSTRVSIIIGIAKGIG 526
           NI++L     +  +   +L++++     L KYLD+  G    L  +   SI+  + +G+ 
Sbjct: 59  NIVKLLDVIHTERK--LYLVFEYCDM-DLKKYLDKRPG---PLSPNLIKSIMYQLLRGLA 112

Query: 527 YLHSSEVNKPAIVHRNLSVEKVLIDQQFNPLIADCGL 563
           Y HS   ++  I+HR+L  + +LI++     +AD GL
Sbjct: 113 YCHS---HR--ILHRDLKPQNILINRDGVLKLADFGL 144

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase (CDK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKs are partly regulated by their subcellular localization, which defines substrate phosphorylation and the resulting specific function. CDK1, CDK2, CDK4, and CDK6 have well-defined functions in the cell cycle, such as the regulation of the early G1 phase by CDK4 or CDK6, the G1/S phase transition by CDK2, or the entry of mitosis by CDK1. They also exhibit overlapping cyclin specificity and functions in certain conditions. Knockout mice with a single CDK deleted remain viable with specific phenotypes, showing that some CDKs can compensate for each other. For example, CDK4 can compensate for the loss of CDK6, however, double knockout mice with both CDK4 and CDK6 deleted die in utero. CDK8 and CDK9 are mainly involved in transcription while CDK5 is implicated in neuronal function. CDK7 plays essential roles in both the cell cycle as a CDK-Activating Kinase (CAK) and in transcription as a component of the general transcription factor TFIIH. Length = 282

>gnl|CDD|132967 cd06636, STKc_MAP4K4_6, Catalytic domain of the Protein Serine/Threonine Kinases, Mitogen-Activated Protein Kinase Kinase Kinase Kinase 4 and 6

 Score = 55.8 bits (134), Expect = 2e-08
 Identities = 69/293 (23%), Positives = 131/293 (44%), Gaps = 37/293 (12%)

Query: 399 LNLEEVESATQCFSEVNLLGKGNFSSVYKGT-LRDGTLVAIRSINVTSCKSEEAEFVKGL 457
           ++L  +      F  V ++G G +  VYKG  ++ G L AI+ ++VT  + EE E    +
Sbjct: 6   IDLSALRDPAGIFELVEVVGNGTYGQVYKGRHVKTGQLAAIKVMDVT--EDEEEEIKLEI 63

Query: 458 YLLTSL-RHENIIRLRG-FCCSRGRG---ECFLIYDFAPKGKLSKYLDQEEGSSNVLDWS 512
            +L     H NI    G F      G   + +L+ +F   G ++  +   +G++   DW 
Sbjct: 64  NMLKKYSHHRNIATYYGAFIKKSPPGHDDQLWLVMEFCGAGSVTDLVKNTKGNALKEDWI 123

Query: 513 TRVSIIIGIAKGIGYLHSSEVNKPAIVHRNLSVEKVLIDQQFNPLIADCGLHKLLADDIV 572
             +     I +G+ +LH+ +V     +HR++  + VL+ +     + D G+   L     
Sbjct: 124 AYIC--REILRGLAHLHAHKV-----IHRDIKGQNVLLTENAEVKLVDFGVSAQLDR--- 173

Query: 573 FSVLKTSAAMG---YLAPEYVTT-----GRFTERSDIFAFGVIILQILTGS--LVLTSSM 622
            +V + +  +G   ++APE +         +  RSDI++ G+  +++  G+  L     M
Sbjct: 174 -TVGRRNTFIGTPYWMAPEVIACDENPDATYDYRSDIWSLGITAIEMAEGAPPLCDMHPM 232

Query: 623 RLAAESATFENFIDRNLKGKF-SESEAAKLGKMALVCTHEDPENRPTMEAVIE 674
           R     A F   I RN   K  S+  + K       C  ++  +RP+ E +++
Sbjct: 233 R-----ALF--LIPRNPPPKLKSKKWSKKFIDFIEGCLVKNYLSRPSTEQLLK 278

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 4 (MAPKKKK4 or MAP4K4) and MAPKKKK6 (or MAP4K6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K4/MAP4K6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain. MAP4Ks (or MAPKKKKs) are involved in MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K4 is also called Nck Interacting kinase (NIK). It facilitates the activation of the MAPKs, extracellular signal-regulated kinase (ERK) 1, ERK2, and c-Jun N-terminal kinase (JNK), by phosphorylating and activating MEKK1. MAP4K4 plays a role in tumor necrosis factor (TNF) alpha-induced insulin resistance. MAP4K4 silencing in skeletal muscle cells from type II diabetic patients restores insulin-mediated glucose uptake. MAP4K4, through JNK, also plays a broad role in cell motility, which impacts inflammation, homeostasis, as well as the invasion and spread of cancer. MAP4K4 is found to be highly expressed in most tumor cell lines relative to normal tissue. MAP4K6 (also called MINK for Misshapen/NIKs-related kinase) is activated after Ras induction and mediates activation of p38 MAPK. MAP4K6 plays a role in cell cycle arrest, cytoskeleton organization, cell adhesion, and cell motility. Length = 282

>gnl|CDD|173738 cd07835, STKc_CDK1_like, Catalytic domain of Cyclin-Dependent protein Kinase 1-like Serine/Threonine Kinases

 Score = 55.4 bits (134), Expect = 2e-08
 Identities = 46/159 (28%), Positives = 76/159 (47%), Gaps = 20/159 (12%)

Query: 411 FSEVNLLGKGNFSSVYKG-TLRDGTLVAIRSINVTSCKSEEAEFV-----KGLYLLTSLR 464
           + +V  +G+G +  VYK      G +VA++ I + +    E E V     + + LL  L 
Sbjct: 1   YQKVEKIGEGTYGVVYKARDKLTGEIVALKKIRLET----EDEGVPSTAIREISLLKELN 56

Query: 465 HENIIRLRGFCCSRGRGECFLIYDFAPKGKLSKYLDQEEGSSNVLDWSTRVSIIIGIAKG 524
           H NI+RL     S  +   +L+++F     L KY+D        LD     S +  + +G
Sbjct: 57  HPNIVRLLDVVHSENK--LYLVFEFLDL-DLKKYMDSS--PLTGLDPPLIKSYLYQLLQG 111

Query: 525 IGYLHSSEVNKPAIVHRNLSVEKVLIDQQFNPLIADCGL 563
           I Y HS       ++HR+L  + +LID++    +AD GL
Sbjct: 112 IAYCHSHR-----VLHRDLKPQNLLIDREGALKLADFGL 145

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes, plants, and yeasts, as well as CDK2 and CDK3. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyclin A complex controls G2 phase entry and progression while the CDK1/cyclin B complex is critical for G2 to M phase transition. CDK2 is regulated by cyclin E or cyclin A. Upon activation by cyclin E, it phosphorylates the retinoblastoma (pRb) protein which activates E2F mediated transcription and allows cells to move into S phase. The CDK2/cyclin A complex plays a role in regulating DNA replication. Studies in knockout mice revealed that CDK1 can compensate for the loss of the cdk2 gene as it can also bind cyclin E and drive G1 to S phase transition. CDK3 is regulated by cyclin C and it phosphorylates pRB specifically during the G0/G1 transition. This phosphorylation is required for cells to exit G0 efficiently and enter the G1 phase. Length = 283

>gnl|CDD|173742 cd07845, STKc_CDK10, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 10

 Score = 55.8 bits (135), Expect = 2e-08
 Identities = 68/303 (22%), Positives = 121/303 (39%), Gaps = 61/303 (20%)

Query: 411 FSEVNLLGKGNFSSVYKGTLRD---GTLVAIRSINVTSCKSEEAEFVKGL---YLLTSLR 464
           F ++N +G+G +  VY+   RD   G +VA++ + +      +   +  L    LL +LR
Sbjct: 9   FEKLNRIGEGTYGIVYRA--RDTTSGEIVALKKVRMD--NERDGIPISSLREITLLLNLR 64

Query: 465 HENIIRLRGFCCSRGRGECFLIYDFAPKGKLSKYLDQEEGSSNVLDWSTRV-------SI 517
           H NI+ L+     +     FL+ +         Y +Q+  S  +LD             +
Sbjct: 65  HPNIVELKEVVVGKHLDSIFLVME---------YCEQDLAS--LLDNMPTPFSESQVKCL 113

Query: 518 IIGIAKGIGYLHSSEVNKPAIVHRNLSVEKVLIDQQFNPLIADCGLHKLLADDIVFSVLK 577
           ++ + +G+ YLH +      I+HR+L V  +L+  +    IAD GL +         +  
Sbjct: 114 MLQLLRGLQYLHEN-----FIIHRDLKVSNLLLTDKGCLKIADFGLARTYG-LPAKPMTP 167

Query: 578 TSAAMGYLAPEYVT-TGRFTERSDIFAFGVIILQILTGSLVLTSSMRLAA---------- 626
               + Y APE +     +T   D++A G I+ ++L    +L     +            
Sbjct: 168 KVVTLWYRAPELLLGCTTYTTAIDMWAVGCILAELLAHKPLLPGKSEIEQLDLIIQLLGT 227

Query: 627 -ESATFENFID--------------RNLKGKFSESEAAKLGKMALVCTHEDPENRPTMEA 671
              + +  F D               NLK KF     A L  +  +  + DP+ R T E 
Sbjct: 228 PNESIWPGFSDLPLVGKFTLPKQPYNNLKHKFPWLSEAGLRLLNFLLMY-DPKKRATAEE 286

Query: 672 VIE 674
            +E
Sbjct: 287 ALE 289

Serine/Threonine Kinases (STKs), Cyclin-dependent protein Kinase 10 (CDK10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK10, also called PISSLRE, is essential for cell growth and proliferation, and acts through the G2/M phase of the cell cycle. CDK10 has also been identified as an important factor in endocrine therapy resistance in breast cancer. CDK10 silencing increases the transcription of c-RAF and the activation of the p42/p44 MAPK pathway, which leads to antiestrogen resistance. Patients who express low levels of CDK10 relapse early on tamoxifen. Length = 309

>gnl|CDD|227223 COG4886, COG4886, Leucine-rich repeat (LRR) protein [Function unknown]

 Score = 56.1 bits (135), Expect = 3e-08
 Identities = 46/132 (34%), Positives = 74/132 (56%), Gaps = 5/132 (3%)

Query: 94  LSGLYLHYNSLSGEIPKEIRNLTELTDLYLDVNNLSGNIPPEIGSMASLQVLQLCCNQLT 153
           L  L L  N +   +P  +RNL  L +L L  N+LS ++P  + ++++L  L L  N+++
Sbjct: 142 LKELDLSDNKIE-SLPSPLRNLPNLKNLDLSFNDLS-DLPKLLSNLSNLNNLDLSGNKIS 199

Query: 154 GNIPAQIGSLKSLSVLTLQHNRLNGGIPDSLGNLGKLKRLDLSFNSLFGTIPESLANNAE 213
            ++P +I  L +L  L L +N +   +  SL NL  L  L+LS N L   +PES+ N + 
Sbjct: 200 -DLPPEIELLSALEELDLSNNSIIE-LLSSLSNLKNLSGLELSNNKLE-DLPESIGNLSN 256

Query: 214 LLFLDVQNNTLS 225
           L  LD+ NN +S
Sbjct: 257 LETLDLSNNQIS 268

Length = 394

>gnl|CDD|227223 COG4886, COG4886, Leucine-rich repeat (LRR) protein [Function unknown]

 Score = 55.4 bits (133), Expect = 5e-08
 Identities = 51/138 (36%), Positives = 74/138 (53%), Gaps = 10/138 (7%)

Query: 105 SGEIPKEIRNLTELTDLYLDVNNLSGNIPPEIGSMASLQVLQLCCNQLTGNIPAQIGSLK 164
           S +  + + NL  L  L L++N L  NI   +  + +L  L L  N +T +IP  IG LK
Sbjct: 82  SLDGSENLLNLLPLPSLDLNLNRLRSNISE-LLELTNLTSLDLDNNNIT-DIPPLIGLLK 139

Query: 165 S-LSVLTLQHNRLNGGIPDSLGNLGKLKRLDLSFNSLFGTIPESLANNAELLFLDVQNNT 223
           S L  L L  N++   +P  L NL  LK LDLSFN L   +P+ L+N + L  LD+  N 
Sbjct: 140 SNLKELDLSDNKI-ESLPSPLRNLPNLKNLDLSFNDLS-DLPKLLSNLSNLNNLDLSGNK 197

Query: 224 LSGI-----VPSALKRLN 236
           +S +     + SAL+ L+
Sbjct: 198 ISDLPPEIELLSALEELD 215

Length = 394

>gnl|CDD|173673 cd05582, STKc_RSK_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, 90 kDa ribosomal protein S6 kinase

 Score = 54.8 bits (132), Expect = 5e-08
 Identities = 61/210 (29%), Positives = 103/210 (49%), Gaps = 25/210 (11%)

Query: 416 LLGKGNFSSVY---KGTLRD-GTLVAIRSINVTSCKSEEAEFVKGLY-LLTSLRHENIIR 470
           +LG+G+F  V+   K T  D G L A++ +   + K  +    K    +L  + H  I++
Sbjct: 3   VLGQGSFGKVFLVRKITGPDAGQLYAMKVLKKATLKVRDRVRTKMERDILAEVNHPFIVK 62

Query: 471 LR-GFCCSRGRGECFLIYDFAPKGKLSKYLDQEEGSSNVLDWSTRVSIIIG-IAKGIGYL 528
           L   F   +  G+ +LI DF   G L   L +E     V+     V   +  +A  + +L
Sbjct: 63  LHYAF---QTEGKLYLILDFLRGGDLFTRLSKE-----VMFTEEDVKFYLAELALALDHL 114

Query: 529 HSSEVNKPAIVHRNLSVEKVLIDQQFNPLIADCGLHKLLADDI--VFSVLKTSAAMGYLA 586
           HS       I++R+L  E +L+D++ +  + D GL K   D     +S   T   + Y+A
Sbjct: 115 HSL-----GIIYRDLKPENILLDEEGHIKLTDFGLSKESIDHEKKAYSFCGT---VEYMA 166

Query: 587 PEYVTTGRFTERSDIFAFGVIILQILTGSL 616
           PE V     T+ +D ++FGV++ ++LTGSL
Sbjct: 167 PEVVNRRGHTQSADWWSFGVLMFEMLTGSL 196

Serine/Threonine Kinases (STKs), 90 kDa ribosomal protein S6 kinase (RSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. RSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family. They are activated by signaling inputs from extracellular regulated kinase (ERK) and phosphoinositide dependent kinase 1 (PDK1). ERK phosphorylates and activates the CTD of RSK, serving as a docking site for PDK1, which phosphorylates and activates the NTD, which in turn phosphorylates all known RSK substrates. RSKs act as downstream effectors of mitogen-activated protein kinase (MAPK) and play key roles in mitogen-activated cell growth, differentiation, and survival. Mammals possess four RSK isoforms (RSK1-4) from distinct genes. RSK proteins are also referred to as MAP kinase-activated protein kinases (MAPKAPKs), p90-RSKs, or p90S6Ks. Length = 318

>gnl|CDD|132968 cd06637, STKc_TNIK, Catalytic domain of the Protein Serine/Threonine Kinase, Traf2- and Nck-interacting kinase

 Score = 54.3 bits (130), Expect = 6e-08
 Identities = 65/281 (23%), Positives = 124/281 (44%), Gaps = 37/281 (13%)

Query: 411 FSEVNLLGKGNFSSVYKGT-LRDGTLVAIRSINVTSCKSEEAEFVKGLYLLTSL-RHENI 468
           F  V L+G G +  VYKG  ++ G L AI+ ++VT    EE E  + + +L     H NI
Sbjct: 8   FELVELVGNGTYGQVYKGRHVKTGQLAAIKVMDVTG--DEEEEIKQEINMLKKYSHHRNI 65

Query: 469 IRLRGFCCSRG----RGECFLIYDFAPKGKLSKYLDQEEGSSNVLDWSTRVSIIIGIAKG 524
               G    +       + +L+ +F   G ++  +   +G++   +W     I   I +G
Sbjct: 66  ATYYGAFIKKNPPGMDDQLWLVMEFCGAGSVTDLIKNTKGNTLKEEWIA--YICREILRG 123

Query: 525 IGYLHSSEVNKPAIVHRNLSVEKVLIDQQFNPLIADCGLHKLLADDIVFSVLKTSAAMG- 583
           + +LH  +V     +HR++  + VL+ +     + D G+   L      +V + +  +G 
Sbjct: 124 LSHLHQHKV-----IHRDIKGQNVLLTENAEVKLVDFGVSAQLDR----TVGRRNTFIGT 174

Query: 584 --YLAPEYVTT-----GRFTERSDIFAFGVIILQILTGS--LVLTSSMRLAAESATFENF 634
             ++APE +         +  +SD+++ G+  +++  G+  L     MR     A F   
Sbjct: 175 PYWMAPEVIACDENPDATYDFKSDLWSLGITAIEMAEGAPPLCDMHPMR-----ALF--L 227

Query: 635 IDRNLKGKF-SESEAAKLGKMALVCTHEDPENRPTMEAVIE 674
           I RN   +  S+  + K       C  ++   RPT E +++
Sbjct: 228 IPRNPAPRLKSKKWSKKFQSFIESCLVKNHSQRPTTEQLMK 268

Serine/threonine kinases (STKs), Traf2- and Nck-interacting kinase (TNIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TNIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to mitogen-activated protein kinase (MAPK), kinase kinase kinase 4 (MAP4K4), and MAP4K6. MAP4Ks participate in some MAPK signaling pathways by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). TNIK is an effector of Rap2, a small GTP-binding protein from the Ras family. TNIK specifically activates the c-Jun N-terminal kinase (JNK) pathway and plays a role in regulating the actin cytoskeleton. Length = 272

>gnl|CDD|132966 cd06635, STKc_TAO1, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 1

 Score = 54.3 bits (130), Expect = 7e-08
 Identities = 61/296 (20%), Positives = 122/296 (41%), Gaps = 58/296 (19%)

Query: 405 ESATQCFSEVNLLGKGNFSSVY-KGTLRDGTLVAIRSINVTSCKSEEA--EFVKGLYLLT 461
           E   + F+++  +G G+F +VY    +R   +VAI+ ++ +  +S E   + +K +  L 
Sbjct: 21  EDPEKLFTDLREIGHGSFGAVYFARDVRTNEVVAIKKMSYSGKQSNEKWQDIIKEVKFLQ 80

Query: 462 SLRHENIIRLRGFCCSRGRGECFLIYDFAPKGKLSKYLDQEEGSSNVLDWSTRVSIIIGI 521
            ++H N I  +G  C       +L+ ++     L    D  E     L      +I  G 
Sbjct: 81  RIKHPNSIEYKG--CYLREHTAWLVMEYC----LGSASDLLEVHKKPLQEVEIAAITHGA 134

Query: 522 AKGIGYLHSSEVNKPAIVHRNLSVEKVLIDQQFNPLIADCGLHKLLADDIVFSVLKTSAA 581
            +G+ YLHS       ++HR++    +L+ +     +AD G   + +    F        
Sbjct: 135 LQGLAYLHSHN-----MIHRDIKAGNILLTEPGQVKLADFGSASIASPANSFV-----GT 184

Query: 582 MGYLAPEYVTT---GRFTERSDIFAFGVIILQILTGSLVLTSSMRLAA-------ESAT- 630
             ++APE +     G++  + D+++ G+  +++      L +   ++A       ES T 
Sbjct: 185 PYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSALYHIAQNESPTL 244

Query: 631 --------FENFIDRNLKGKFSESEAAKLGKMALVCTHEDPENRPTMEAVIEELTV 678
                   F NF+D                     C  + P++RPT E +++ + V
Sbjct: 245 QSNEWSDYFRNFVDS--------------------CLQKIPQDRPTSEELLKHMFV 280

Serine/threonine kinases (STKs), thousand-and-one amino acids 1 (TAO1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO1 is sometimes referred to as prostate-derived sterile 20-like kinase 2 (PSK2). TAO1 activates the p38 MAPK through direct interaction with and activation of MEK3. TAO1 is highly expressed in the brain and may play a role in neuronal apoptosis. TAO1 interacts with the checkpoint proteins BubR1 and Mad2, and plays an important role in regulating mitotic progression, which is required for both chromosome congression and checkpoint-induced anaphase delay. TAO1 may play a role in protecting genomic stability. Length = 317

>gnl|CDD|173765 cd08225, STKc_Nek5, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 5

 Score = 53.4 bits (128), Expect = 9e-08
 Identities = 46/213 (21%), Positives = 101/213 (47%), Gaps = 27/213 (12%)

Query: 411 FSEVNLLGKGNFSSVYKGTLR-DGTLVAIRSINVTSCKSEEAEFVKG-LYLLTSLRHENI 468
           +  +  +G+G+F  +Y    + D     I+ I++T    +E E  K  + LL  ++H NI
Sbjct: 2   YEIIKKIGEGSFGKIYLAKAKSDSEHCVIKEIDLTKMPVKEKEASKKEVILLAKMKHPNI 61

Query: 469 IRLRGFCCSRGRGECFLIYDFAPKGKLSKYLDQEEG----SSNVLDWSTRVSIIIGIAKG 524
           +    F   +  G  F++ ++   G L K ++++ G       +L W  ++S+      G
Sbjct: 62  VTF--FASFQENGRLFIVMEYCDGGDLMKRINRQRGVLFSEDQILSWFVQISL------G 113

Query: 525 IGYLHSSEVNKPAIVHRNLSVEKVLIDQQFNPLIA---DCGLHKLLADDIVFSVLKTSAA 581
           + ++H  +     I+HR++  + + + +  N ++A   D G+ + L D +  +   T   
Sbjct: 114 LKHIHDRK-----ILHRDIKSQNIFLSK--NGMVAKLGDFGIARQLNDSMELA--YTCVG 164

Query: 582 MGY-LAPEYVTTGRFTERSDIFAFGVIILQILT 613
             Y L+PE      +  ++DI++ G ++ ++ T
Sbjct: 165 TPYYLSPEICQNRPYNNKTDIWSLGCVLYELCT 197

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 5 (Nek5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek5 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. The specific function of Nek5 is unknown. Length = 257

>gnl|CDD|143372 cd07867, STKc_CDC2L6, Catalytic domain of Serine/Threonine Kinase, Cell Division Cycle 2-like 6

 Score = 53.9 bits (129), Expect = 1e-07
 Identities = 58/221 (26%), Positives = 99/221 (44%), Gaps = 42/221 (19%)

Query: 417 LGKGNFSSVYKGTLRDG------TLVAIRS--INVTSCKSEEAEFVKGLYLLTSLRHENI 468
           +G+G +  VYK   +DG       L  I    I++++C+         + LL  L+H N+
Sbjct: 9   VGRGTYGHVYKAKRKDGKDEKEYALKQIEGTGISMSACRE--------IALLRELKHPNV 60

Query: 469 IRLRGFCCSRGRGECFLIYDFAPKG--KLSKYLDQEEGSSNVLDW--STRVSIIIGIAKG 524
           I L+    S    + +L++D+A      + K+    + +   +    S   S++  I  G
Sbjct: 61  IALQKVFLSHSDRKVWLLFDYAEHDLWHIIKFHRASKANKKPMQLPRSMVKSLLYQILDG 120

Query: 525 IGYLHSSEVNKPAIVHRNLSVEKVLI----DQQFNPLIADCGLHKLLADDIVFSVLKTSA 580
           I YLH++ V     +HR+L    +L+     ++    IAD G  +L       S LK  A
Sbjct: 121 IHYLHANWV-----LHRDLKPANILVMGEGPERGRVKIADMGFARLFN-----SPLKPLA 170

Query: 581 AMG-------YLAPEYVTTGR-FTERSDIFAFGVIILQILT 613
            +        Y APE +   R +T+  DI+A G I  ++LT
Sbjct: 171 DLDPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLT 211

Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 6 (CDC2L6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L6 is also called CDK8-like and was previously referred to as CDK11. However, this is a confusing nomenclature as CDC2L6 is distinct from CDC2L1, which is represented by the two protein products from its gene, called CDK11(p110) and CDK11(p58), as well as the caspase-processed CDK11(p46). CDK11(p110), CDK11(p58), and CDK11(p46)do not belong to this subfamily. CDC2L6 is an associated protein of Mediator, a multiprotein complex that provides a platform to connect transcriptional and chromatin regulators and cofactors, in order to activate and mediate RNA polymerase II transcription. CDC2L6 is localized mainly in the nucleus amd exerts an opposing effect to CDK8 in VP16-dependent transcriptional activation by being a negative regulator. Length = 317

>gnl|CDD|132983 cd06652, STKc_MEKK2, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 2

 Score = 53.1 bits (127), Expect = 1e-07
 Identities = 54/207 (26%), Positives = 90/207 (43%), Gaps = 20/207 (9%)

Query: 416 LLGKGNFSSVYKGTLRD-GTLVAIRSINVTSCKSEEAEFVKGL----YLLTSLRHENIIR 470
           LLG+G F  VY     D G  +A++ +       E ++ V  L     LL +L HE I++
Sbjct: 9   LLGQGAFGRVYLCYDADTGRELAVKQVQFDPESPETSKEVNALECEIQLLKNLLHERIVQ 68

Query: 471 LRGFCCSRGRGECFLIYDFAPKGKLSKYLDQEEG-SSNVLDWSTRVSIIIGIAKGIGYLH 529
             G           +  +  P G +   L      + NV    TR      I +G+ YLH
Sbjct: 69  YYGCLRDPMERTLSIFMEHMPGGSIKDQLKSYGALTENVTRKYTR-----QILEGVSYLH 123

Query: 530 SSEVNKPAIVHRNLSVEKVLIDQQFNPLIADCGLHKLLADDIVFSVLKTSAAMG---YLA 586
           S+      IVHR++    +L D   N  + D G  K L   I  S     +  G   +++
Sbjct: 124 SN-----MIVHRDIKGANILRDSVGNVKLGDFGASKRL-QTICLSGTGMKSVTGTPYWMS 177

Query: 587 PEYVTTGRFTERSDIFAFGVIILQILT 613
           PE ++   +  ++DI++ G  ++++LT
Sbjct: 178 PEVISGEGYGRKADIWSVGCTVVEMLT 204

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 2 (MEKK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK2 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK2 also activates ERK1/2, c-Jun N-terminal kinase (JNK) and p38 through their respective MAPKKs MEK1/2, JNK-activating kinase 2 (JNKK2), and MKK3/6. MEKK2 plays roles in T cell receptor signaling, immune synapse formation, cytokine gene expression, as well as in EGF and FGF receptor signaling. Length = 265

>gnl|CDD|143373 cd07868, STKc_CDK8, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 8

 Score = 53.1 bits (127), Expect = 2e-07
 Identities = 57/221 (25%), Positives = 99/221 (44%), Gaps = 42/221 (19%)

Query: 417 LGKGNFSSVYKGTLRDG------TLVAIRS--INVTSCKSEEAEFVKGLYLLTSLRHENI 468
           +G+G +  VYK   +DG       L  I    I++++C+         + LL  L+H N+
Sbjct: 9   VGRGTYGHVYKAKRKDGKDDRDYALKQIEGTGISMSACRE--------IALLRELKHPNV 60

Query: 469 IRLRGFCCSRGRGECFLIYDFAPKG--KLSKYLDQEEGSSNVLDWSTRV--SIIIGIAKG 524
           I L+    S    + +L++D+A      + K+    + +   +     +  S++  I  G
Sbjct: 61  ISLQKVFLSHADRKVWLLFDYAEHDLWHIIKFHRASKANKKPVQLPRGMVKSLLYQILDG 120

Query: 525 IGYLHSSEVNKPAIVHRNLSVEKVLI----DQQFNPLIADCGLHKLLADDIVFSVLKTSA 580
           I YLH++ V     +HR+L    +L+     ++    IAD G  +L       S LK  A
Sbjct: 121 IHYLHANWV-----LHRDLKPANILVMGEGPERGRVKIADMGFARLFN-----SPLKPLA 170

Query: 581 AMG-------YLAPEYVTTGR-FTERSDIFAFGVIILQILT 613
            +        Y APE +   R +T+  DI+A G I  ++LT
Sbjct: 171 DLDPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLT 211

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK8 can act as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the multi-subunit core Mediator complex, a cofactor that is involved in regulating RNA polymerase II (RNAP II)-dependent transcription. CDK8 phosphorylates cyclin H, a subunit of the general transcription factor TFIIH, which results in the inhibition of TFIIH-dependent phosphorylation of the C-terminal domain (CTD) of RNAP II, facilitating the inhibition of transcription. It has also been shown to promote transcription by a mechanism that is likely to involve RNAP II phosphorylation. CDK8 also functions as a stimulus-specific positive coregulator of p53 transcriptional responses. Length = 317

>gnl|CDD|132970 cd06639, STKc_myosinIIIB, Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIB myosin

 Score = 53.1 bits (127), Expect = 2e-07
 Identities = 53/235 (22%), Positives = 108/235 (45%), Gaps = 24/235 (10%)

Query: 393 HLNSFRLNLEEVESATQCFSEVNLLGKGNFSSVYKGT-LRDGTLVAIRSINVTSCKSEEA 451
             NS  L LE +   T  +  +  +GKG +  VYK T  +DG+L A++ ++  S   EE 
Sbjct: 6   PYNSSMLGLESLGDPTDTWEIIETIGKGTYGKVYKVTNKKDGSLAAVKILDPISDVDEEI 65

Query: 452 EFVKGLYLLTSL-RHENIIRLRGFCCSRGR---GECFLIYDFAPKGKLSKYLDQEEGSSN 507
           E      +L SL  H N+++  G      +   G+ +L+ +    G +++ +        
Sbjct: 66  E--AEYNILQSLPNHPNVVKFYGMFYKADKLVGGQLWLVLELCNGGSVTELVKGLLICGQ 123

Query: 508 VLDWSTRVSIIIGIAKGIGYLHSSEVNKPAIVHRNLSVEKVLIDQQFNPLIADCGLHKLL 567
            LD +    I+ G   G+ +LH++      I+HR++    +L+  +    + D G+   L
Sbjct: 124 RLDEAMISYILYGALLGLQHLHNNR-----IIHRDVKGNNILLTTEGGVKLVDFGVSAQL 178

Query: 568 ADDIVFSVLKTSAAMG---YLAPEYVTTGR-----FTERSDIFAFGVIILQILTG 614
                 + L+ + ++G   ++APE +   +     +  R D+++ G+  +++  G
Sbjct: 179 TS----TRLRRNTSVGTPFWMAPEVIACEQQYDYSYDARCDVWSLGITAIELGDG 229

Serine/threonine kinases (STKs), class IIIB myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. They may also function as cargo carriers during light-dependent translocation, in photoreceptor cells, of proteins such as transducin and arrestin. Class IIIB myosin is expressed highly in retina. It is also present in the brain and testis. The human class IIIB myosin gene maps to a region that overlaps the locus for Bardet-Biedl syndrome, which is characterized by dysmorphic extremities, retinal dystrophy, obesity, male hypogenitalism, and renal abnormalities. Length = 291

>gnl|CDD|173740 cd07842, STKc_CDK8_like, Catalytic domain of Cyclin-Dependent protein Kinase 8-like Serine/Threonine Kinases

 Score = 53.1 bits (128), Expect = 2e-07
 Identities = 53/222 (23%), Positives = 98/222 (44%), Gaps = 31/222 (13%)

Query: 411 FSEVNLLGKGNFSSVYKG---TLRDGTLVAIRSINVTSCKSEEAEF-------VKGLYLL 460
           +     +G+G +  VYK      +DG   AI+       K ++ ++        + + LL
Sbjct: 2   YEIEGCIGRGTYGRVYKAKRKNGKDGKEYAIKKF-----KGDKEQYTGISQSACREIALL 56

Query: 461 TSLRHENIIRLRGFCCSRGRGECFLIYDFAPK--GKLSKYLDQEEGSSNVLDWSTRVSII 518
             L+HEN++ L            +L++D+A     ++ K+  Q +  S  +  S   S++
Sbjct: 57  RELKHENVVSLVEVFLEHADKSVYLLFDYAEHDLWQIIKFHRQAKRVS--IPPSMVKSLL 114

Query: 519 IGIAKGIGYLHSSEVNKPAIVHRNLSVEKVLI----DQQFNPLIADCGLHKLLADDIV-- 572
             I  G+ YLHS+      ++HR+L    +L+     ++    I D GL +L    +   
Sbjct: 115 WQILNGVHYLHSN-----WVLHRDLKPANILVMGEGPERGVVKIGDLGLARLFNAPLKPL 169

Query: 573 FSVLKTSAAMGYLAPEYVTTGR-FTERSDIFAFGVIILQILT 613
             +      + Y APE +   R +T+  DI+A G I  ++LT
Sbjct: 170 ADLDPVVVTIWYRAPELLLGARHYTKAIDIWAIGCIFAELLT 211

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK8, CDC2L6, and similar proteins. CDK8 functions as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the multi-subunit core Mediator complex, a cofactor that is involved in regulating RNA polymerase II (RNAP II)-dependent transcription. CDC2L6 also associates with Mediator in complexes lacking CDK8. In VP16-dependent transcriptional activation, CDK8 and CDC2L6 exerts opposing effects by positive and negative regulation, respectively, in similar conditions. Length = 316

>gnl|CDD|215036 PLN00034, PLN00034, mitogen-activated protein kinase kinase; Provisional

 Score = 53.3 bits (128), Expect = 2e-07
 Identities = 73/306 (23%), Positives = 119/306 (38%), Gaps = 69/306 (22%)

Query: 406 SATQCFSE---VNLLGKGNFSSVYKGTLR-DGTLVAIRSINVTSCKSEEAEFVKGLYLLT 461
           SA +  SE   VN +G G   +VYK   R  G L A++ I      +   +  + + +L 
Sbjct: 68  SAAKSLSELERVNRIGSGAGGTVYKVIHRPTGRLYALKVIYGNHEDTVRRQICREIEILR 127

Query: 462 SLRHENIIRLRGFCCSRGRGECFLIYDFAPKGKLS-KYLDQEEGSSNVLDWSTRVSIIIG 520
            + H N+++          GE  ++ +F   G L   ++  E+  ++V     R      
Sbjct: 128 DVNHPNVVKCHDM--FDHNGEIQVLLEFMDGGSLEGTHIADEQFLADV----AR-----Q 176

Query: 521 IAKGIGYLHSSEVNKPAIVHRNLSVEKVLIDQQFNPLIADCGLHKLLAD--DIVFSVLKT 578
           I  GI YLH        IVHR++    +LI+   N  IAD G+ ++LA   D   S + T
Sbjct: 177 ILSGIAYLHRRH-----IVHRDIKPSNLLINSAKNVKIADFGVSRILAQTMDPCNSSVGT 231

Query: 579 SAAMGYLAPEYVTT----GRFTERS-DIFAFGVIILQILTG-------------SLVLTS 620
            A   Y++PE + T    G +   + DI++ GV IL+   G             SL+   
Sbjct: 232 IA---YMSPERINTDLNHGAYDGYAGDIWSLGVSILEFYLGRFPFGVGRQGDWASLMCAI 288

Query: 621 SMRLAAE-----SATFENFIDRNLKGKFSESEAAKLGKMALVCTHEDPENRPTMEAVIEE 675
            M    E     S  F +FI                      C   +P  R +   +++ 
Sbjct: 289 CMSQPPEAPATASREFRHFISC--------------------CLQREPAKRWSAMQLLQH 328

Query: 676 LTVAAP 681
             +   
Sbjct: 329 PFILRA 334

Length = 353

>gnl|CDD|234389 TIGR03903, TOMM_kin_cyc, TOMM system kinase/cyclase fusion protein

 Score = 53.7 bits (129), Expect = 3e-07
 Identities = 45/182 (24%), Positives = 81/182 (44%), Gaps = 23/182 (12%)

Query: 449 EEAEFVKGLYLLTSLRHENIIRL--RGFCCSRGRGECFLIYDFAPKGKLSKYLDQEEGSS 506
           + A F +   L   L H NI+ L   G       G  F ++++ P   L + L   +G  
Sbjct: 21  QRARFRRETALCARLYHPNIVALLDSGEA---PPGLLFAVFEYVPGRTLREVL-AADG-- 74

Query: 507 NVLDWSTRVSIIIGIAKGIGYLHSSEVNKPAIVHRNLSVEKVLI---DQQFNPLIADCGL 563
             L       +++ +   +   H+       IVHR+L  + +++     + +  + D G+
Sbjct: 75  -ALPAGETGRLMLQVLDALACAHNQ-----GIVHRDLKPQNIMVSQTGVRPHAKVLDFGI 128

Query: 564 HKLLA---DDIVFSVLKTSAAMG---YLAPEYVTTGRFTERSDIFAFGVIILQILTGSLV 617
             LL    D  V ++ +T+  +G   Y APE +     T  SD++A+G+I L+ LTG  V
Sbjct: 129 GTLLPGVRDADVATLTRTTEVLGTPTYCAPEQLRGEPVTPNSDLYAWGLIFLECLTGQRV 188

Query: 618 LT 619
           + 
Sbjct: 189 VQ 190

This model represents proteins of 1350 in length, in multiple species of Burkholderia, in Acidovorax avenae subsp. citrulli AAC00-1 and Delftia acidovorans SPH-1, and in multiple copies in Sorangium cellulosum, in genomic neighborhoods that include a cyclodehydratase/docking scaffold fusion protein (TIGR03882) and a member of the thiazole/oxazole modified metabolite (TOMM) precursor family TIGR03795. It has a kinase domain in the N-terminal 300 amino acids, followed by a cyclase homology domain, followed by regions without named domain definitions. It is a probable bacteriocin-like metabolite biosynthesis protein [Cellular processes, Toxin production and resistance]. Length = 1266

>gnl|CDD|173661 cd05570, STKc_PKC, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase C

 Score = 52.8 bits (127), Expect = 3e-07
 Identities = 63/282 (22%), Positives = 111/282 (39%), Gaps = 54/282 (19%)

Query: 416 LLGKGNFSSV----YKGT--------LRDGTLVAIRSINVTSCKSEEAEFVKGLYLLTSL 463
           +LGKG+F  V     KGT        L+   ++    +  T  +            LT L
Sbjct: 2   VLGKGSFGKVLLAELKGTDELYAVKVLKKDVILQDDDVECTMTEKRVLALAGKHPFLTQL 61

Query: 464 RHENIIRLRGFCCSRGRGECFLIYDFAPKGKLSKYLDQEEGSSNVLDWSTRVSIIIGIAK 523
                       C + +   F + ++   G L  ++ +    S   D          I  
Sbjct: 62  ----------HSCFQTKDRLFFVMEYVNGGDLMFHIQR----SGRFDEPRARFYAAEIVL 107

Query: 524 GIGYLHSSEVNKPAIVHRNLSVEKVLIDQQFNPLIADCGLHK--LLADDIVFSVLKTSAA 581
           G+ +LH        I++R+L ++ VL+D + +  IAD G+ K  +L          TS  
Sbjct: 108 GLQFLHER-----GIIYRDLKLDNVLLDSEGHIKIADFGMCKEGILGGV------TTSTF 156

Query: 582 MG---YLAPEYVTTGRFTERSDIFAFGVIILQILTGSLVLTSSMRLAAESATFENFIDRN 638
            G   Y+APE ++   +    D +A GV++ ++L G     S      E   F++ ++  
Sbjct: 157 CGTPDYIAPEILSYQPYGPAVDWWALGVLLYEMLAGQ----SPFEGDDEDELFQSILEDE 212

Query: 639 LK-GKFSESEAAKLGKMALVCTHEDPENR----PTMEAVIEE 675
           ++  ++   EA  + K  L    ++PE R    PT E  I+ 
Sbjct: 213 VRYPRWLSKEAKSILKSFLT---KNPEKRLGCLPTGEQDIKG 251

Serine/Threonine Kinases (STKs), Protein Kinase C (PKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, classical PKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. Novel PKCs are calcium-independent, but require DAG and PS for activity, while atypical PKCs only require PS. PKCs phosphorylate and modify the activities of a wide variety of cellular proteins including receptors, enzymes, cytoskeletal proteins, transcription factors, and other kinases. They play a central role in signal transduction pathways that regulate cell migration and polarity, proliferation, differentiation, and apoptosis. Also included in this subfamily are the PKC-like proteins, called PKNs. Length = 318

>gnl|CDD|143367 cd07862, STKc_CDK6, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 6

 Score = 52.3 bits (125), Expect = 3e-07
 Identities = 55/218 (25%), Positives = 96/218 (44%), Gaps = 29/218 (13%)

Query: 409 QCFSEVNLLGKGNFSSVYKGTLRD----GTLVAIRSINVTSCKSEEA------EFVKGLY 458
           Q +  V  +G+G +  V+K   RD    G  VA++ + V +   EE         V  L 
Sbjct: 1   QQYECVAEIGEGAYGKVFKA--RDLKNGGRFVALKRVRVQT--GEEGMPLSTIREVAVLR 56

Query: 459 LLTSLRHENIIRLRGFC-CSRGRGECFLIYDFAPKGK-LSKYLDQ--EEGSSNVLDWSTR 514
            L +  H N++RL   C  SR   E  L   F    + L+ YLD+  E G        T 
Sbjct: 57  HLETFEHPNVVRLFDVCTVSRTDRETKLTLVFEHVDQDLTTYLDKVPEPGVPT----ETI 112

Query: 515 VSIIIGIAKGIGYLHSSEVNKPAIVHRNLSVEKVLIDQQFNPLIADCGLHKLLADDIVFS 574
             ++  + +G+ +LHS  V     VHR+L  + +L+       +AD GL ++ +  +  +
Sbjct: 113 KDMMFQLLRGLDFLHSHRV-----VHRDLKPQNILVTSSGQIKLADFGLARIYSFQMALT 167

Query: 575 VLKTSAAMGYLAPEYVTTGRFTERSDIFAFGVIILQIL 612
            +  +  + Y APE +    +    D+++ G I  ++ 
Sbjct: 168 SVVVT--LWYRAPEVLLQSSYATPVDLWSVGCIFAEMF 203

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 6 (CDK6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK6 is regulated by D-type cyclins and INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein, implicating it to function in regulating the early G1 phase of the cell cycle. It is expressed ubiquitously and is localized in the cytoplasm. It is also present in the ruffling edge of spreading fibroblasts and may play a role in cell spreading. It binds to the p21 inhibitor without any effect on its own activity and it is overexpressed in squamous cell carcinomas and neuroblastomas. CDK6 has also been shown to inhibit cell differentiation in many cell types. Length = 290

>gnl|CDD|143346 cd07841, STKc_CDK7, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 7

 Score = 52.2 bits (126), Expect = 3e-07
 Identities = 45/159 (28%), Positives = 68/159 (42%), Gaps = 24/159 (15%)

Query: 414 VNLLGKGNFSSVYKGT-LRDGTLVAIRSINVTSCKSEEAEFVKGLY--------LLTSLR 464
              LG+G ++ VYK      G +VAI+ I +     E  E   G+         LL  L+
Sbjct: 5   GKKLGEGTYAVVYKARDKETGRIVAIKKIKL----GERKEAKDGINFTALREIKLLQELK 60

Query: 465 HENIIRLRGFCCSRGRGECFLIYDFAPKGKLSKYLDQEEGSSNVLDWSTRVSIIIGIAKG 524
           H NII L      +      L+++F     L K +      S VL  +   S ++   +G
Sbjct: 61  HPNIIGLLDVFGHKSN--INLVFEFME-TDLEKVIKD---KSIVLTPADIKSYMLMTLRG 114

Query: 525 IGYLHSSEVNKPAIVHRNLSVEKVLIDQQFNPLIADCGL 563
           + YLHS+      I+HR+L    +LI       +AD GL
Sbjct: 115 LEYLHSN-----WILHRDLKPNNLLIASDGVLKLADFGL 148

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 7 (CDK7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK7 plays essential roles in the cell cycle and in transcription. It associates with cyclin H and MAT1 and acts as a CDK-Activating Kinase (CAK) by phosphorylating and activating cell cycle CDKs (CDK1/2/4/6). In the brain, it activates CDK5. CDK7 is also a component of the general transcription factor TFIIH, which phosphorylates the C-terminal domain (CTD) of RNA polymerase II when it is bound with unphosphorylated DNA, as present in the pre-initiation complex. Following phosphorylation, the CTD dissociates from the DNA which allows transcription initiation. Length = 298

>gnl|CDD|206026 pfam13855, LRR_8, Leucine rich repeat

 Score = 47.2 bits (113), Expect = 4e-07
 Identities = 22/60 (36%), Positives = 30/60 (50%)

Query: 141 SLQVLQLCCNQLTGNIPAQIGSLKSLSVLTLQHNRLNGGIPDSLGNLGKLKRLDLSFNSL 200
           +L+ L L  N+LT         L +L VL L  N L    P++   L  L+ LDLS N+L
Sbjct: 1   NLKSLDLSNNRLTVIPDGAFKGLPNLKVLDLSGNNLTSISPEAFSGLPSLRSLDLSGNNL 60

Length = 60

>gnl|CDD|133233 cd05102, PTKc_VEGFR3, Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 3

 Score = 52.3 bits (125), Expect = 4e-07
 Identities = 44/161 (27%), Positives = 82/161 (50%), Gaps = 17/161 (10%)

Query: 521 IAKGIGYLHSSEVNKPAIVHRNLSVEKVLIDQQFNPLIADCGLHKLLADDIVFSVLKTSA 580
           +A+G+ +L S +      +HR+L+   +L+ +     I D GL + +  D  + V K SA
Sbjct: 183 VARGMEFLASRKC-----IHRDLAARNILLSENNVVKICDFGLARDIYKDPDY-VRKGSA 236

Query: 581 --AMGYLAPEYVTTGRFTERSDIFAFGVIILQILTGSLVLTSSMRLAAESATFENFIDRN 638
              + ++APE +    +T +SD+++FGV++ +I +    L +S     +    E F  R 
Sbjct: 237 RLPLKWMAPESIFDKVYTTQSDVWSFGVLLWEIFS----LGASPYPGVQ--INEEFCQRL 290

Query: 639 LKG---KFSESEAAKLGKMALVCTHEDPENRPTMEAVIEEL 676
             G   +  E+   ++ ++ L C   DP+ RPT  A++E L
Sbjct: 291 KDGTRMRAPENATPEIYRIMLACWQGDPKERPTFSALVEIL 331

Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 3 (VEGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR3 (or Flt4) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. VEGFR3 preferentially binds the ligands VEGFC and VEGFD. VEGFR3 is essential for lymphatic endothelial cell (EC) development and function. It has been shown to regulate adaptive immunity during corneal transplantation. VEGFR3 is upregulated on blood vascular ECs in pathological conditions such as vascular tumors and the periphery of solid tumors. It plays a role in cancer progression and lymph node metastasis. Missense mutations in the VEGFR3 gene are associated with primary human lymphedema. Length = 338

>gnl|CDD|133209 cd05078, PTK_Jak2_Jak3_rpt1, Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3

 Score = 51.4 bits (123), Expect = 4e-07
 Identities = 60/279 (21%), Positives = 117/279 (41%), Gaps = 43/279 (15%)

Query: 417 LGKGNFSSVYKGTLRD-GTLVAIRSINV------TSCKSEEAEFVKGLYLLTSLRHENII 469
           LG+G F+ ++KG  R+ G    +    V       S ++    F +   +++ L H++++
Sbjct: 3   LGQGTFTKIFKGIRREVGDYGELHKTEVLLKVLDKSHRNYSESFFEAASMMSQLSHKHLV 62

Query: 470 RLRGFCCSRGRGECFLIYDFAPKGKLSKYLDQEEGSSNVLDWSTRVSIIIGIAKGIGY-L 528
              G C      E  ++ ++   G L  YL + +   N+  W   V      AK + + L
Sbjct: 63  LNYGVCV--CGDESIMVQEYVKFGSLDTYLKKNKNLINIS-WKLEV------AKQLAWAL 113

Query: 529 HSSEVNKPAIVHRNLSVEKVLIDQQFNPLIADCGLHKLLADDIVFSVLKTS---AAMGYL 585
           H  E     + H N+  + VL+ ++ +    +    KL    I  +VL        + ++
Sbjct: 114 HFLEDKG--LTHGNVCAKNVLLIREEDRKTGNPPFIKLSDPGISITVLPKEILLERIPWV 171

Query: 586 APEYVTTGR-FTERSDIFAFGVIILQILTGSLVLTSSMRLAAESATFENFIDRNLKGKFS 644
            PE +   +  +  +D ++FG  + +I +G         L+A        +D   K +F 
Sbjct: 172 PPECIENPQNLSLAADKWSFGTTLWEIFSG-----GDKPLSA--------LDSQKKLQFY 218

Query: 645 ESE----AAKLGKMALV---CTHEDPENRPTMEAVIEEL 676
           E      A K  ++A +   C   +P+ RP+  A+I +L
Sbjct: 219 EDRHQLPAPKWTELANLINQCMDYEPDFRPSFRAIIRDL 257

Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jak2 is widely expressed in many tissues while Jak3 is expressed only in hematopoietic cells. Jak2 is essential for the signaling of hormone-like cytokines such as growth hormone, erythropoietin, thrombopoietin, and prolactin, as well as some IFNs and cytokines that signal through the IL-3 and gp130 receptors. Jak3 binds the shared receptor subunit common gamma chain and thus, is essential in the signaling of cytokines that use it such as IL-2, IL-4, IL-7, IL-9, IL-15, and IL-21. Disruption of Jak2 in mice results in an embryonic lethal phenotype with multiple defects including erythropoietic and cardiac abnormalities. It is the only Jak gene that results in a lethal phenotype when disrupted in mice. A mutation in the pseudokinase domain of Jak2, V617F, is present in many myeloproliferative diseases, including almost all patients with polycythemia vera, and 50% of patients with essential thrombocytosis and myelofibrosis. Jak3 is important in lymphoid development and myeloid cell differentiation. Inactivating mutations in Jak3 have been reported in humans with severe combined immunodeficiency (SCID). Length = 258

>gnl|CDD|173709 cd05619, STKc_nPKC_theta, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C theta

 Score = 51.9 bits (124), Expect = 5e-07
 Identities = 62/261 (23%), Positives = 109/261 (41%), Gaps = 34/261 (13%)

Query: 416 LLGKGNFSSVYKGTLR-DGTLVAIRSIN---VTSCKSEEAEFVKGLYLLTSLRHENIIRL 471
           +LGKG+F  V+   L+      AI+++    V      E   V+   L  +  H  +  L
Sbjct: 2   MLGKGSFGKVFLAELKGTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEHPFLTHL 61

Query: 472 RGFCCSRGRGECFLIYDFAPKGKLSKYLDQEEGSSNVLDWSTRVSIIIGIAKGIGYLHSS 531
             +C  + +   F + ++   G L  ++     S +  D          I  G+ +LHS 
Sbjct: 62  --YCTFQTKENLFFVMEYLNGGDLMFHIQ----SCHKFDLPRATFYAAEIICGLQFLHSK 115

Query: 532 EVNKPAIVHRNLSVEKVLIDQQFNPLIADCGLHK--LLADDIVFSVLKTSAAMG---YLA 586
                 IV+R+L ++ +L+D   +  IAD G+ K  +L D       KT    G   Y+A
Sbjct: 116 -----GIVYRDLKLDNILLDTDGHIKIADFGMCKENMLGD------AKTCTFCGTPDYIA 164

Query: 587 PEYVTTGRFTERSDIFAFGVIILQILTGSLVLTSSMRLAAESATFENF-IDRNLKGKFSE 645
           PE +   ++    D ++FGV++ ++L G     S      E   F++  +D     ++  
Sbjct: 165 PEILLGQKYNTSVDWWSFGVLLYEMLIGQ----SPFHGHDEEELFQSIRMDNPCYPRWLT 220

Query: 646 SEAAKLGKMALVCTHEDPENR 666
            EA  +     V    +PE R
Sbjct: 221 REAKDILVKLFV---REPERR 238

Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an important and non-redundant role in several aspects of T-cell biology. Although T-cells also express other PKC isoforms, PKC-theta is unique in that upon antigen stimulation, it is translocated to the plasma membrane at the immunological synapse, where it mediates signals essential for T-cell activation. It is essential for TCR-induced proliferation, cytokine production, T-cell survival, and the differentiation and effector function of T-helper (Th) cells, particularly Th2 and Th17. PKC-theta is being developed as a therapeutic target for Th2-mediated allergic inflammation and Th17-mediated autoimmune diseases. Length = 316

>gnl|CDD|143378 cd07873, STKc_PCTAIRE1, Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-1 kinase

 Score = 51.5 bits (123), Expect = 5e-07
 Identities = 47/209 (22%), Positives = 97/209 (46%), Gaps = 16/209 (7%)

Query: 409 QCFSEVNLLGKGNFSSVYKGTLR-DGTLVAIRSINVTSCKSEEAEFVKGLYLLTSLRHEN 467
           + + +++ LG+G +++VYKG  +    LVA++ I +   +      ++ + LL  L+H N
Sbjct: 6   ETYIKLDKLGEGTYATVYKGRSKLTDNLVALKEIRLEHEEGAPCTAIREVSLLKDLKHAN 65

Query: 468 IIRLRGFCCSRGRGECFLIYDFAPKGKLSKYLDQEEGSSNVLDWSTRVSIIIGIAKGIGY 527
           I+ L     +       L++++  K  L +YLD      N ++       +  + +G+ Y
Sbjct: 66  IVTLHDIIHT--EKSLTLVFEYLDK-DLKQYLDD---CGNSINMHNVKLFLFQLLRGLNY 119

Query: 528 LHSSEVNKPAIVHRNLSVEKVLIDQQFNPLIADCGLHKLLADDIVFSVLKTSAAMGYLAP 587
            H  +V     +HR+L  + +LI+++    +AD GL +  A  I            +  P
Sbjct: 120 CHRRKV-----LHRDLKPQNLLINERGELKLADFGLAR--AKSIPTKTYSNEVVTLWYRP 172

Query: 588 EYVTTGR--FTERSDIFAFGVIILQILTG 614
             +  G   ++ + D++  G I  ++ TG
Sbjct: 173 PDILLGSTDYSTQIDMWGVGCIFYEMSTG 201

Serine/Threonine Kinases (STKs), PCTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-1 is expressed ubiquitously and is localized in the cytoplasm. Its kinase activity is cell cycle dependent and peaks at the S and G2 phases. PCTAIRE-1 is highly expressed in the brain and may play a role in regulating neurite outgrowth. It can also associate with Trap (Tudor repeat associator with PCTAIRE-2), a physiological partner of PCTAIRE-2; with p11, a small dimeric protein with similarity to S100; and with 14-3-3 proteins, mediators of phosphorylation-dependent interactions in many different proteins. Length = 301

>gnl|CDD|133234 cd05103, PTKc_VEGFR2, Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 2

 Score = 52.0 bits (124), Expect = 5e-07
 Identities = 44/194 (22%), Positives = 87/194 (44%), Gaps = 15/194 (7%)

Query: 489 FAPKGKLSKYLDQEEGSS----NVLDWSTRVSIIIGIAKGIGYLHSSEVNKPAIVHRNLS 544
           F  +  LS   ++E         VL     +     +AKG+ +L S +      +HR+L+
Sbjct: 152 FVEEKSLSDVEEEEAEQEDLYKKVLTLEDLICYSFQVAKGMEFLASRKC-----IHRDLA 206

Query: 545 VEKVLIDQQFNPLIADCGLHKLLADDIVFSVLKTSA--AMGYLAPEYVTTGRFTERSDIF 602
              +L+ +     I D GL + +  D  + V K  A   + ++APE +    +T +SD++
Sbjct: 207 ARNILLSENNVVKICDFGLARDIYKDPDY-VRKGDARLPLKWMAPETIFDRVYTIQSDVW 265

Query: 603 AFGVIILQILTGSLVLTSSMRLAAESATFENFIDRNLKGKFSESEAAKLGKMALVCTHED 662
           +FGV++ +I +        +++  E   F   +    + +  +    ++ +  L C H +
Sbjct: 266 SFGVLLWEIFSLGASPYPGVKIDEE---FCRRLKEGTRMRAPDYTTPEMYQTMLDCWHGE 322

Query: 663 PENRPTMEAVIEEL 676
           P  RPT   ++E L
Sbjct: 323 PSQRPTFSELVEHL 336

Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 2 (VEGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR2 (or Flk1) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. The carboxyl terminus of VEGFR2 plays an important role in its autophosphorylation and activation. VEGFR2 binds the ligands VEGFA, VEGFC, VEGFD and VEGFE. VEGFR2 signaling is implicated in all aspects of normal and pathological vascular endothelial cell biology. It induces a variety of cellular effects including migration, survival, and proliferation. It is critical in regulating embryonic vascular development and angiogenesis. VEGFR2 is the major signal transducer in pathological angiogenesis including cancer and diabetic retinopathy, and is a target for inhibition in cancer therapy. Length = 343

>gnl|CDD|173745 cd07848, STKc_CDKL5, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase Like 5

 Score = 51.5 bits (123), Expect = 6e-07
 Identities = 54/210 (25%), Positives = 98/210 (46%), Gaps = 21/210 (10%)

Query: 411 FSEVNLLGKGNFSSVYKGTLRD-GTLVAIRSINVTSCKSEEAEFVKG-----LYLLTSLR 464
           F  + ++G+G +  V K   ++   +VAI+        SEE E VK      L +L +L+
Sbjct: 3   FEVLGVVGEGAYGVVLKCRHKETKEIVAIKKFK----DSEENEEVKETTLRELKMLRTLK 58

Query: 465 HENIIRLRGFCCSRGRGECFLIYDFAPKGKLSKYLDQEEGSSNVLDWSTRVSIIIGIAKG 524
            ENI+ L+     R RG+ +L++++  K  L      EE  + V     R S I  + K 
Sbjct: 59  QENIVELKE--AFRRRGKLYLVFEYVEKNMLELL---EEMPNGVPPEKVR-SYIYQLIKA 112

Query: 525 IGYLHSSEVNKPAIVHRNLSVEKVLIDQQFNPLIADCGLHKLLADDIVFSVLKTSAAMGY 584
           I + H ++     IVHR++  E +LI       + D G  + L++    +  +  A   Y
Sbjct: 113 IHWCHKND-----IVHRDIKPENLLISHNDVLKLCDFGFARNLSEGSNANYTEYVATRWY 167

Query: 585 LAPEYVTTGRFTERSDIFAFGVIILQILTG 614
            +PE +    + +  D+++ G I+ ++  G
Sbjct: 168 RSPELLLGAPYGKAVDMWSVGCILGELSDG 197

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 5 (CDKL5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Mutations in the gene encoding CDKL5, previously called STK9, are associated with early onset epilepsy and severe mental retardation [X-linked infantile spasm syndrome (ISSX) or West syndrome]. In addition, CDKL5 mutations also sometimes cause a phenotype similar to Rett syndrome (RTT), a progressive neurodevelopmental disorder. These pathogenic mutations are located in the N-terminal portion of the protein within the kinase domain. Length = 287

>gnl|CDD|132984 cd06653, STKc_MEKK3_like_1, Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases

 Score = 51.2 bits (122), Expect = 6e-07
 Identities = 55/209 (26%), Positives = 94/209 (44%), Gaps = 24/209 (11%)

Query: 416 LLGKGNFSSVYKGTLRD-GTLVAIRSINVTSCKSEEAEFVKGL----YLLTSLRHENIIR 470
           LLG+G F  VY     D G  +A++ +       E ++ V  L     LL +LRH+ I++
Sbjct: 9   LLGRGAFGEVYLCYDADTGRELAVKQVPFDPDSQETSKEVNALECEIQLLKNLRHDRIVQ 68

Query: 471 LRGFCCSRGRGECFL--IYDFAPKGKLSKYLDQEEG-SSNVLDWSTRVSIIIGIAKGIGY 527
             G  C R   E  L    ++ P G +   L      + NV    TR      I +G+ Y
Sbjct: 69  YYG--CLRDPEEKKLSIFVEYMPGGSIKDQLKAYGALTENVTRRYTR-----QILQGVSY 121

Query: 528 LHSSEVNKPAIVHRNLSVEKVLIDQQFNPLIADCGLHKLLADDIVFSVLKTSAAMG---Y 584
           LHS+      IVHR++    +L D   N  + D G  K +   I  S     +  G   +
Sbjct: 122 LHSN-----MIVHRDIKGANILRDSAGNVKLGDFGASKRI-QTICMSGTGIKSVTGTPYW 175

Query: 585 LAPEYVTTGRFTERSDIFAFGVIILQILT 613
           ++PE ++   +  ++D+++    ++++LT
Sbjct: 176 MSPEVISGEGYGRKADVWSVACTVVEMLT 204

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain, functionally uncharacterized subgroup 1. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MEKK3-like subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK2 and MEKK3 activate MEK5 (also called MKK5), which activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development. MEKK2 and MEKK3 can also activate the MAPKs, c-Jun N-terminal kinase (JNK) and p38, through their respective MAPKKs. Length = 264

>gnl|CDD|227223 COG4886, COG4886, Leucine-rich repeat (LRR) protein [Function unknown]

 Score = 51.9 bits (124), Expect = 7e-07
 Identities = 47/144 (32%), Positives = 72/144 (50%), Gaps = 7/144 (4%)

Query: 83  KLSPSLSGLKCLSGLYLHYNSLSGEIPKEIRNLTELTDLYLDVNNLSGNIPPEIGSMASL 142
            L   LS L  L+ L L  N +S ++P EI  L+ L +L L  NN    +   + ++ +L
Sbjct: 177 DLPKLLSNLSNLNNLDLSGNKIS-DLPPEIELLSALEELDL-SNNSIIELLSSLSNLKNL 234

Query: 143 QVLQLCCNQLTGNIPAQIGSLKSLSVLTLQHNRLNGGIPDSLGNLGKLKRLDLSFNSLFG 202
             L+L  N+L  ++P  IG+L +L  L L +N+++     SLG+L  L+ LDLS NSL  
Sbjct: 235 SGLELSNNKLE-DLPESIGNLSNLETLDLSNNQIS--SISSLGSLTNLRELDLSGNSLSN 291

Query: 203 TIPESLA--NNAELLFLDVQNNTL 224
            +P         ELL   +     
Sbjct: 292 ALPLIALLLLLLELLLNLLLTLKA 315

Length = 394

>gnl|CDD|173728 cd06614, STKc_PAK, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase

 Score = 51.1 bits (123), Expect = 7e-07
 Identities = 56/281 (19%), Positives = 119/281 (42%), Gaps = 57/281 (20%)

Query: 411 FSEVNLLGKGNFSSVYKGTLR-DGTLVAIRSINVTSCKSEEAEFVKGLYLLTSLRHENII 469
           +  +  +G+G    VYK T R  G  VAI+ + +   +++E   +  + ++   +H NI+
Sbjct: 21  YKNLEKIGEGASGEVYKATDRATGKEVAIKKMRLR-KQNKEL-IINEILIMKDCKHPNIV 78

Query: 470 RLRGFCCSRGRGECFLIYDFAPKGKLSKYLDQEEGSSNVLDWSTRVSIIIG-IAKGIGYL 528
                       E +++ ++   G L+  + Q     N      +++ +   + +G+ YL
Sbjct: 79  DYYD--SYLVGDELWVVMEYMDGGSLTDIITQNFVRMN----EPQIAYVCREVLQGLEYL 132

Query: 529 HSSEVNKPAIVHRNLSVEKVLIDQQFNPLIADCGLHKLL--ADDIVFSVLKTSAAMGYLA 586
           HS  V     +HR++  + +L+ +  +  +AD G    L        SV+ T   M   A
Sbjct: 133 HSQNV-----IHRDIKSDNILLSKDGSVKLADFGFAAQLTKEKSKRNSVVGTPYWM---A 184

Query: 587 PEYVTTGRFTERSDIFAFGVIILQILTG-----------SLVLTSS-----MRLAAE-SA 629
           PE +    +  + DI++ G++ +++  G           +L L ++     ++   + S 
Sbjct: 185 PEVIKRKDYGPKVDIWSLGIMCIEMAEGEPPYLREPPLRALFLITTKGIPPLKNPEKWSP 244

Query: 630 TFENFIDRNLKGKFSESEAAKLGKMALVCTHEDPENRPTME 670
            F++F+++                    C  +DPE RP+ E
Sbjct: 245 EFKDFLNK--------------------CLVKDPEKRPSAE 265

Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAK deregulation is associated with tumor development. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). Group II PAKs contain a PBD and a catalytic domain, but lack other motifs found in group I PAKs. Since group II PAKs do not contain an obvious AID, they may be regulated differently from group I PAKs. Group I PAKs interact with the SH3 containing proteins Nck, Grb2 and PIX; no such binding has been demonstrated for group II PAKs. Length = 286

>gnl|CDD|240233 PTZ00024, PTZ00024, cyclin-dependent protein kinase; Provisional

 Score = 51.3 bits (123), Expect = 8e-07
 Identities = 48/235 (20%), Positives = 86/235 (36%), Gaps = 44/235 (18%)

Query: 415 NLLGKGNFSSVYKG-TLRDGTLVAIRSINVTSCKSEEAEF-------------VKGLYLL 460
             LG+G +  V K      G +VAI+ + +    ++  +              ++ L ++
Sbjct: 15  AHLGEGTYGKVEKAYDTLTGKIVAIKKVKIIEISNDVTKDRQLVGMCGIHFTTLRELKIM 74

Query: 461 TSLRHENIIRLRGFCCSRGRGECF--LIYDFAPKGKLSKYLDQEEGSSNVLDWSTRVSII 518
             ++HENI+ L            F  L+ D      L K +D        L  S    I+
Sbjct: 75  NEIKHENIMGLVDVYVEGD----FINLVMDIM-ASDLKKVVD----RKIRLTESQVKCIL 125

Query: 519 IGIAKGIGYLHSSEVNKPAIVHRNLSVEKVLIDQQFNPLIADCGLHKLLADDIVF---SV 575
           + I  G+  LH         +HR+LS   + I+ +    IAD GL +           S 
Sbjct: 126 LQILNGLNVLHKW-----YFMHRDLSPANIFINSKGICKIADFGLARRYGYPPYSDTLSK 180

Query: 576 LKTSAAMGYLAPEYVT-----------TGRFTERSDIFAFGVIILQILTGSLVLT 619
            +T      +  + VT             ++    D+++ G I  ++LTG  +  
Sbjct: 181 DETMQRREEMTSKVVTLWYRAPELLMGAEKYHFAVDMWSVGCIFAELLTGKPLFP 235

Length = 335

>gnl|CDD|173653 cd05105, PTKc_PDGFR_alpha, Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor alpha

 Score = 51.6 bits (123), Expect = 9e-07
 Identities = 46/196 (23%), Positives = 89/196 (45%), Gaps = 18/196 (9%)

Query: 487 YDFAPKGKLSKYL--DQEEGSSNVLDWSTRVSIIIGIAKGIGYLHSSEVNKPAIVHRNLS 544
           Y  +   ++   L  D  EG +  LD    +S    +A+G+ +L S        VHR+L+
Sbjct: 214 YKGSNDSEVKNLLSDDGSEGLT-TLDL---LSFTYQVARGMEFLASKNC-----VHRDLA 264

Query: 545 VEKVLIDQQFNPLIADCGLHK-LLADDIVFSVLKTSAAMGYLAPEYVTTGRFTERSDIFA 603
              VL+ Q     I D GL + ++ D    S   T   + ++APE +    +T  SD+++
Sbjct: 265 ARNVLLAQGKIVKICDFGLARDIMHDSNYVSKGSTFLPVKWMAPESIFDNLYTTLSDVWS 324

Query: 604 FGVIILQILTGSLVLTSSMRLAAESATFENFIDRNLKGKFSESEAAKLGKMALVCTHEDP 663
           +G+++ +I +        M +    +TF N I    +    +    ++  + + C + +P
Sbjct: 325 YGILLWEIFSLGGTPYPGMIV---DSTFYNKIKSGYRMAKPDHATQEVYDIMVKCWNSEP 381

Query: 664 ENRPT---MEAVIEEL 676
           E RP+   +  ++E L
Sbjct: 382 EKRPSFLHLSDIVESL 397

Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) alpha; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR alpha is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR alpha forms homodimers or heterodimers with PDGFR beta, depending on the nature of the PDGF ligand. PDGF-AA, PDGF-AB, and PDGF-CC induce PDGFR alpha homodimerization. PDGFR signaling plays many roles in normal embryonic development and adult physiology. PDGFR alpha signaling is important in the formation of lung alveoli, intestinal villi, mesenchymal dermis, and hair follicles, as well as in the development of oligodendrocytes, retinal astrocytes, neural crest cells, and testicular cells. Aberrant PDGFR alpha expression is associated with some human cancers. Mutations in PDGFR alpha have been found within a subset of gastrointestinal stromal tumors (GISTs). An active fusion protein FIP1L1-PDGFR alpha, derived from interstitial deletion, is associated with idiopathic hypereosinophilic syndrome (HES) and chronic eosinophilic leukemia (CEL). Length = 400

>gnl|CDD|177649 PLN00009, PLN00009, cyclin-dependent kinase A; Provisional

 Score = 51.0 bits (122), Expect = 9e-07
 Identities = 59/214 (27%), Positives = 105/214 (49%), Gaps = 29/214 (13%)

Query: 411 FSEVNLLGKGNFSSVYKGTLR-DGTLVAIRSINVTSCKSEEAEFV-----KGLYLLTSLR 464
           + +V  +G+G +  VYK   R     +A++ I +     +E E V     + + LL  ++
Sbjct: 4   YEKVEKIGEGTYGVVYKARDRVTNETIALKKIRL----EQEDEGVPSTAIREISLLKEMQ 59

Query: 465 HENIIRLRGFCCSRGRGECFLIYDFAPKGKLSKYLDQEEGSSNVLDWSTRV--SIIIGIA 522
           H NI+RL+    S  R   +L++++     L K++D    SS     + R+  + +  I 
Sbjct: 60  HGNIVRLQDVVHSEKR--LYLVFEYLDL-DLKKHMD----SSPDFAKNPRLIKTYLYQIL 112

Query: 523 KGIGYLHSSEVNKPAIVHRNLSVEKVLIDQQFNPL-IADCGLHKLLADDI-VFSVLKTSA 580
           +GI Y HS  V     +HR+L  + +LID++ N L +AD GL +  A  I V +      
Sbjct: 113 RGIAYCHSHRV-----LHRDLKPQNLLIDRRTNALKLADFGLAR--AFGIPVRTFTHEVV 165

Query: 581 AMGYLAPEYVTTGR-FTERSDIFAFGVIILQILT 613
            + Y APE +   R ++   DI++ G I  +++ 
Sbjct: 166 TLWYRAPEILLGSRHYSTPVDIWSVGCIFAEMVN 199

Length = 294

>gnl|CDD|173710 cd05620, STKc_nPKC_delta, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C delta

 Score = 50.7 bits (121), Expect = 1e-06
 Identities = 53/206 (25%), Positives = 100/206 (48%), Gaps = 22/206 (10%)

Query: 416 LLGKGNFSSVYKGTLR-DGTLVAIRSIN---VTSCKSEEAEFVKGLYLLTSLRHENIIRL 471
           +LGKG+F  V    L+  G   A++++    V      E   V+   L  +L  EN    
Sbjct: 2   VLGKGSFGKVLLAELKGKGEYFAVKALKKDVVLIDDDVECTMVEKRVL--ALAWENPFLT 59

Query: 472 RGFCCSRGRGECFLIYDFAPKGKLSKYLDQEEGSSNVLDWSTRVSIIIGIAKGIGYLHSS 531
             +C  + +   F + +F   G L  ++ Q++G  ++   +   + I+    G+ +LHS 
Sbjct: 60  HLYCTFQTKEHLFFVMEFLNGGDLMFHI-QDKGRFDLYRATFYAAEIVC---GLQFLHSK 115

Query: 532 EVNKPAIVHRNLSVEKVLIDQQFNPLIADCGLHKLLADDIVFSVLKTSAAMG---YLAPE 588
                 I++R+L ++ V++D+  +  IAD G+ K    + VF   + S   G   Y+APE
Sbjct: 116 -----GIIYRDLKLDNVMLDRDGHIKIADFGMCK----ENVFGDNRASTFCGTPDYIAPE 166

Query: 589 YVTTGRFTERSDIFAFGVIILQILTG 614
            +   ++T   D ++FGV++ ++L G
Sbjct: 167 ILQGLKYTFSVDWWSFGVLLYEMLIG 192

Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), delta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-delta plays a role in cell cycle regulation and programmed cell death in many cell types. It slows down cell proliferation, inducing cell cycle arrest and enhancing cell differentiation. PKC-delta is also involved in the regulation of transcription as well as immune and inflammatory responses. It plays a central role in the genotoxic stress response that leads to DNA damaged-induced apoptosis. Length = 316

>gnl|CDD|143344 cd07839, STKc_CDK5, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 5

 Score = 50.5 bits (121), Expect = 1e-06
 Identities = 39/153 (25%), Positives = 76/153 (49%), Gaps = 21/153 (13%)

Query: 417 LGKGNFSSVYKGTLRD-GTLVAIRSINVTSCKSEEAEFV-----KGLYLLTSLRHENIIR 470
           +G+G + +V+K   R+   +VA++ + +     ++ E V     + + LL  L+H+NI+R
Sbjct: 8   IGEGTYGTVFKAKNRETHEIVALKRVRL----DDDDEGVPSSALREICLLKELKHKNIVR 63

Query: 471 LRGFCCSRGRGECFLIYDFAPKGKLSKYLDQEEGSSNVLDWSTRVSIIIGIAKGIGYLHS 530
           L  +       +  L++++  +  L KY D   G    +D     S +  + KG+ + HS
Sbjct: 64  L--YDVLHSDKKLTLVFEYCDQ-DLKKYFDSCNGD---IDPEIVKSFMFQLLKGLAFCHS 117

Query: 531 SEVNKPAIVHRNLSVEKVLIDQQFNPLIADCGL 563
             V     +HR+L  + +LI++     +AD GL
Sbjct: 118 HNV-----LHRDLKPQNLLINKNGELKLADFGL 145

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 5 (CDK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK5 is unusual in that it is regulated by non-cyclin proteins, p35 and p39. It is highly expressed in the nervous system and is critical in normal neural development and function. It plays a role in neuronal migration and differentiation, and is also important in synaptic plasticity and learning. CDK5 also participates in protecting against cell death and promoting angiogenesis. Impaired CDK5 activity is implicated in Alzheimer's disease, amyotrophic lateral sclerosis, Parkinson's disease, Huntington's disease and acute neuronal injury. Length = 284

>gnl|CDD|143371 cd07866, STKc_BUR1, Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Bypass UAS Requirement 1 and similar proteins

 Score = 50.8 bits (122), Expect = 1e-06
 Identities = 57/231 (24%), Positives = 96/231 (41%), Gaps = 48/231 (20%)

Query: 417 LGKGNFSSVYKG-TLRDGTLVAIRSINVTSCKSEEAEF----VKGLYLLTSLRHENIIRL 471
           LG+G F  VYK   ++ G +VA++ I +    +E+  F    ++ + +L  L+H N++ L
Sbjct: 16  LGEGTFGEVYKARQIKTGRVVALKKILM---HNEKDGFPITALREIKILKKLKHPNVVPL 72

Query: 472 ------RGFCCSRGRGECFLIYDFAPKGKLSKYLDQE-----EGSSNVLDWSTRVSIIIG 520
                 R     R RG  +++         + Y+D +     E  S  L  S     ++ 
Sbjct: 73  IDMAVERPDKSKRKRGSVYMV---------TPYMDHDLSGLLENPSVKLTESQIKCYMLQ 123

Query: 521 IAKGIGYLHSSEVNKPAIVHRNLSVEKVLIDQQFNPLIADCGLHKLLADDIVFSVLKTSA 580
           + +GI YLH +      I+HR++    +LID Q    IAD GL +           K   
Sbjct: 124 LLEGINYLHENH-----ILHRDIKAANILIDNQGILKIADFGLARPYDGPP--PNPKGGG 176

Query: 581 AMG------------YLAPEYVTTGR-FTERSDIFAFGVIILQILTGSLVL 618
             G            Y  PE +   R +T   DI+  G +  ++ T   +L
Sbjct: 177 GGGTRKYTNLVVTRWYRPPELLLGERRYTTAVDIWGIGCVFAEMFTRRPIL 227

Serine/Threonine Kinases (STKs), Bypass UAS Requirement 1 (BUR1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The BUR1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. BUR1, also called SGV1, is a yeast Cyclin-Dependent protein Kinase (CDK) that is functionally equivalent to mammalian CDK9. It associates with the cyclin BUR2. BUR genes were orginally identified in a genetic screen as factors involved in general transcription. The BUR1/BUR2 complex phosphorylates the C-terminal domain of RNA polymerase II. In addition, this complex regulates histone modification by phosporylating Rad6 and mediating the association of the Paf1 complex with chromatin. Length = 311

>gnl|CDD|132942 cd06611, STKc_SLK_like, Catalytic domain of Ste20-like kinase-like Protein Serine/Threonine Kinases

 Score = 50.5 bits (121), Expect = 1e-06
 Identities = 61/275 (22%), Positives = 116/275 (42%), Gaps = 43/275 (15%)

Query: 417 LGKGNFSSVYKGTLRD-GTLVAIRSINVTSCKSEEAE-FVKGLYLLTSLRHENIIRLRGF 474
           LG G F  VYK   ++ G   A + I + S   EE E F+  + +L+  +H NI+ L  +
Sbjct: 13  LGDGAFGKVYKAQHKETGLFAAAKIIQIES--EEELEDFMVEIDILSECKHPNIVGL--Y 68

Query: 475 CCSRGRGECFLIYDFAPKGKLSKYLDQEEGSSNVLDWSTRVSIIIGIAKGIGYLHSSEVN 534
                  + +++ +F   G L   + + E     L       +   + + + +LHS +V 
Sbjct: 69  EAYFYENKLWILIEFCDGGALDSIMLELE---RGLTEPQIRYVCRQMLEALNFLHSHKV- 124

Query: 535 KPAIVHRNLSVEKVLIDQQFNPLIADCGLHKLLADDIVFSVLKTSAAMG---YLAPEYVT 591
               +HR+L    +L+    +  +AD G+       +     K    +G   ++APE V 
Sbjct: 125 ----IHRDLKAGNILLTLDGDVKLADFGVSAKNKSTL----QKRDTFIGTPYWMAPEVVA 176

Query: 592 TGRFTE-----RSDIFAFGVIILQILTGSL--VLTSSMR-----LAAESATFENFIDRNL 639
              F +     ++DI++ G+ ++++          + MR     L +E  T +       
Sbjct: 177 CETFKDNPYDYKADIWSLGITLIELAQMEPPHHELNPMRVLLKILKSEPPTLDQ------ 230

Query: 640 KGKFSESEAAKLGKMALVCTHEDPENRPTMEAVIE 674
             K+S S    L      C  +DP++RPT   +++
Sbjct: 231 PSKWSSSFNDFLKS----CLVKDPDDRPTAAELLK 261

Serine/threonine kinases (STKs), Ste20-like kinase (SLK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of the subfamily include SLK, STK10 (also called LOK for lymphocyte-oriented kinase), SmSLK (Schistosoma mansoni SLK), and related proteins. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It also plays a role in mediating actin reorganization. STK10 is responsible in regulating the CD28 responsive element in T cells, as well as leukocyte function associated antigen (LFA-1)-mediated lymphocyte adhesion. SmSLK is capable of activating the MAPK Jun N-terminal kinase (JNK) pathway in human embryonic kidney (HEK) cells as well as in Xenopus oocytes. It may participate in regulating MAPK cascades during host-parasite interactions. Length = 280

>gnl|CDD|132965 cd06634, STKc_TAO2, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 2

 Score = 50.4 bits (120), Expect = 1e-06
 Identities = 47/207 (22%), Positives = 95/207 (45%), Gaps = 22/207 (10%)

Query: 411 FSEVNLLGKGNFSSVYKG-TLRDGTLVAIRSINVTSCKSEEA--EFVKGLYLLTSLRHEN 467
           FS++  +G G+F +VY    +R+  +VAI+ ++ +  +S E   + +K +  L  LRH N
Sbjct: 17  FSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPN 76

Query: 468 IIRLRGFCCSRGRGECFLIYDFAPKGKLSKYLDQEEGSSNVLDWSTRVSIIIGIAKGIGY 527
            I+ RG  C       +L+ ++     L    D  E     L      ++  G  +G+ Y
Sbjct: 77  TIQYRG--CYLREHTAWLVMEYC----LGSASDLLEVHKKPLQEVEIAAVTHGALQGLAY 130

Query: 528 LHSSEVNKPAIVHRNLSVEKVLIDQQFNPLIADCGLHKLLADDIVFSVLKTSAAMGYLAP 587
           LHS       ++HR++    +L+ +     + D G   ++A    F          ++AP
Sbjct: 131 LHSHN-----MIHRDVKAGNILLSEPGLVKLGDFGSASIMAPANXF-----VGTPYWMAP 180

Query: 588 EYVTT---GRFTERSDIFAFGVIILQI 611
           E +     G++  + D+++ G+  +++
Sbjct: 181 EVILAMDEGQYDGKVDVWSLGITCIEL 207

Serine/threonine kinases (STKs), thousand-and-one amino acids 2 (TAO2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Human TAO2 is also known as prostate-derived Ste20-like kinase (PSK) and was identified in a screen for overexpressed RNAs in prostate cancer. TAO2 activates both p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activating the respective MAP/ERK kinases (MEKs, also known as MKKs or MAPKKs), MEK3/MEK6 and MKK4/MKK7. TAO2 contains a long C-terminal extension with autoinhibitory segments. It is activated by the release of this inhibition and the phosphorylation of its activation loop serine. TAO2 functions as a regulator of actin cytoskeletal and microtubule organization. In addition, it regulates the transforming growth factor-activated kinase 1 (TAK1), which is a MAPKKK that plays an essential role in the signaling pathways of tumor necrosis factor (TNF), interleukin 1 (IL-1), and Toll-like receptor (TLR). Length = 308

>gnl|CDD|143374 cd07869, STKc_PFTAIRE1, Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-1 kinase

 Score = 50.1 bits (119), Expect = 2e-06
 Identities = 49/208 (23%), Positives = 96/208 (46%), Gaps = 18/208 (8%)

Query: 411 FSEVNLLGKGNFSSVYKGTLR-DGTLVAIRSINVTSCKSEEAEFVKGLYLLTSLRHENII 469
           + ++  LG+G++++VYKG  + +G LVA++ I +   +      ++   LL  L+H NI+
Sbjct: 7   YEKLEKLGEGSYATVYKGKSKVNGKLVALKVIRLQEEEGTPFTAIREASLLKGLKHANIV 66

Query: 470 RLRGFCCSRGRGECFLIYDFAPKGKLSKYLDQEEGSSNVLDWSTRVSIIIGIAKGIGYLH 529
            L     +  +    L++++     L +Y+D+  G    L        +  + +G+ Y+H
Sbjct: 67  LLHDIIHT--KETLTLVFEYV-HTDLCQYMDKHPGG---LHPENVKLFLFQLLRGLSYIH 120

Query: 530 SSEVNKPAIVHRNLSVEKVLIDQQFNPLIADCGLHKLLADDIVFSVLKTSAAMGYLAPEY 589
                +  I+HR+L  + +LI       +AD GL +  A  +            +  P  
Sbjct: 121 -----QRYILHRDLKPQNLLISDTGELKLADFGLAR--AKSVPSHTYSNEVVTLWYRPPD 173

Query: 590 VTTGRFTERS---DIFAFGVIILQILTG 614
           V  G  TE S   D++  G I ++++ G
Sbjct: 174 VLLGS-TEYSTCLDMWGVGCIFVEMIQG 200

Serine/Threonine Kinases (STKs), PFTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-1 is widely expressed except in the spleen and thymus. It is highly expressed in the brain, heart, pancreas, testis, and ovary, and is localized in the cytoplasm. It is regulated by cyclin D3 and is inhibited by the p21 cell cycle inhibitor. It has also been shown to interact with the membrane-associated cyclin Y, which recruits the protein to the plasma membrane. Length = 303

>gnl|CDD|177557 PHA03209, PHA03209, serine/threonine kinase US3; Provisional

 Score = 50.3 bits (120), Expect = 2e-06
 Identities = 34/154 (22%), Positives = 68/154 (44%), Gaps = 13/154 (8%)

Query: 459 LLTSLRHENIIRLRGFCCSRGRGECFLIYDFAPKGKLSKYLDQEEGSSNVLDWSTRVSII 518
           LL ++ H ++IR++      G   C ++  +     L  YL +       L     + I 
Sbjct: 110 LLQNVNHPSVIRMKD-TLVSGAITCMVLPHY--SSDLYTYLTKRSRP---LPIDQALIIE 163

Query: 519 IGIAKGIGYLHSSEVNKPAIVHRNLSVEKVLIDQQFNPLIADCGLHKLLADDIVFSVLKT 578
             I +G+ YLH+       I+HR++  E + I+      I D G  +       F  L  
Sbjct: 164 KQILEGLRYLHAQR-----IIHRDVKTENIFINDVDQVCIGDLGAAQFPVVAPAF--LGL 216

Query: 579 SAAMGYLAPEYVTTGRFTERSDIFAFGVIILQIL 612
           +  +   APE +   ++  ++DI++ G+++ ++L
Sbjct: 217 AGTVETNAPEVLARDKYNSKADIWSAGIVLFEML 250

Length = 357

>gnl|CDD|143377 cd07872, STKc_PCTAIRE2, Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-2 kinase

 Score = 50.0 bits (119), Expect = 2e-06
 Identities = 45/209 (21%), Positives = 96/209 (45%), Gaps = 16/209 (7%)

Query: 409 QCFSEVNLLGKGNFSSVYKGTLR-DGTLVAIRSINVTSCKSEEAEFVKGLYLLTSLRHEN 467
           + + ++  LG+G +++V+KG  +    LVA++ I +   +      ++ + LL  L+H N
Sbjct: 6   ETYIKLEKLGEGTYATVFKGRSKLTENLVALKEIRLEHEEGAPCTAIREVSLLKDLKHAN 65

Query: 468 IIRLRGFCCSRGRGECFLIYDFAPKGKLSKYLDQEEGSSNVLDWSTRVSIIIGIAKGIGY 527
           I+ L     +       L++++  K  L +Y+D      N++        +  I +G+ Y
Sbjct: 66  IVTLHDIVHT--DKSLTLVFEYLDK-DLKQYMDD---CGNIMSMHNVKIFLYQILRGLAY 119

Query: 528 LHSSEVNKPAIVHRNLSVEKVLIDQQFNPLIADCGLHKLLADDIVFSVLKTSAAMGYLAP 587
            H  +V     +HR+L  + +LI+++    +AD GL +  A  +            +  P
Sbjct: 120 CHRRKV-----LHRDLKPQNLLINERGELKLADFGLAR--AKSVPTKTYSNEVVTLWYRP 172

Query: 588 EYVTTG--RFTERSDIFAFGVIILQILTG 614
             V  G   ++ + D++  G I  ++ +G
Sbjct: 173 PDVLLGSSEYSTQIDMWGVGCIFFEMASG 201

Serine/Threonine Kinases (STKs), PCTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-2 is specifically expressed in neurons in the central nervous system, mainly in terminally differentiated neurons. It associates with Trap (Tudor repeat associator with PCTAIRE-2) and could play a role in regulating mitochondrial function in neurons. Length = 309

>gnl|CDD|143342 cd07837, STKc_CdkB_plant, Catalytic domain of the Serine/Threonine Kinase, Plant B-type Cyclin-Dependent protein Kinase

 Score = 49.4 bits (118), Expect = 3e-06
 Identities = 53/217 (24%), Positives = 93/217 (42%), Gaps = 36/217 (16%)

Query: 417 LGKGNFSSVYKG-TLRDGTLVAIRSINVTSCKSEE----AEFVKGLYLLTSLRHEN-IIR 470
           +G+G +  VYK      G LVA++    T  + +E       ++ + LL  L     I+R
Sbjct: 9   IGEGTYGKVYKARDKNTGKLVALKK---TRLEMDEEGIPPTALREISLLQMLSESIYIVR 65

Query: 471 LRGFCC-----SRGRGECFLIYDFAPKGKLSKYLDQE-EGSSNVLDWSTRVSIIIGIAKG 524
           L            G+   +L++++     L K++D    G    L   T  S +  + KG
Sbjct: 66  L--LDVEHVEEKNGKPSLYLVFEYLDS-DLKKFMDSNGRGPGRPLPAKTIKSFMYQLLKG 122

Query: 525 IGYLHSSEVNKPAIVHRNLSVEKVLIDQQFNPL-IADCGLHKLLADDIVFSVLKTS---- 579
           + + H     K  ++HR+L  + +L+D+Q   L IAD GL +       FS+   S    
Sbjct: 123 VAHCH-----KHGVMHRDLKPQNLLVDKQKGLLKIADLGLGR------AFSIPVKSYTHE 171

Query: 580 -AAMGYLAPEYVTTGR-FTERSDIFAFGVIILQILTG 614
              + Y APE +     ++   DI++ G I  ++   
Sbjct: 172 IVTLWYRAPEVLLGSTHYSTPVDIWSVGCIFAEMSRK 208

Serine/Threonine Kinases (STKs), Plant B-type Cyclin-Dependent protein Kinase (CdkB) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CdkB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. The plant-specific B-type CDKs are expressed from the late S to the M phase of the cell cycle. They are characterized by the cyclin binding motif PPT[A/T]LRE. They play a role in controlling mitosis and integrating developmental pathways, such as stomata and leaf development. CdkB has been shown to associate with both cyclin B, which controls G2/M transition, and cyclin D, which acts as a mediator in linking extracellular signals to the cell cycle. Length = 295

>gnl|CDD|173704 cd05613, STKc_MSK1_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 1

 Score = 49.2 bits (117), Expect = 3e-06
 Identities = 38/138 (27%), Positives = 65/138 (47%), Gaps = 13/138 (9%)

Query: 485 LIYDFAPKGKLSKYLDQEEGSSNVLDWSTRVSIIIG-IAKGIGYLHSSEVNKPAIVHRNL 543
           LI D+   G+L  +L Q E           V I  G I   + +LH     K  I++R++
Sbjct: 82  LILDYINGGELFTHLSQRERFK-----EQEVQIYSGEIVLALEHLH-----KLGIIYRDI 131

Query: 544 SVEKVLIDQQFNPLIADCGLHKLLADDIVFSVLKTSAAMGYLAPEYVTTGR--FTERSDI 601
            +E +L+D   + ++ D GL K   +D V         + Y+AP+ V  G     +  D 
Sbjct: 132 KLENILLDSNGHVVLTDFGLSKEFHEDEVERAYSFCGTIEYMAPDIVRGGDGGHDKAVDW 191

Query: 602 FAFGVIILQILTGSLVLT 619
           ++ GV++ ++LTG+   T
Sbjct: 192 WSMGVLMYELLTGASPFT 209

Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK1, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydrophobic motif (HM) of NTD, which facilitates the phosphorylation of the A-loop and activates the NTD, which in turn phosphorylates downstream targets. MSK1 plays a role in the regulation of translational control and transcriptional activation. It phosphorylates the transcription factors, CREB and NFkappaB. It also phosphorylates the nucleosomal proteins H3 and HMG-14. Increased phosphorylation of MEK1 is associated with the development of cerebral ischemic/hypoxic preconditioning. Length = 290

>gnl|CDD|143375 cd07870, STKc_PFTAIRE2, Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-2 kinase

 Score = 49.2 bits (117), Expect = 3e-06
 Identities = 58/215 (26%), Positives = 96/215 (44%), Gaps = 30/215 (13%)

Query: 412 SEVNL--LGKGNFSSVYKGTLR-DGTLVAIRSINVTSCKSEEA---EFVKGLYLLTSLRH 465
           S +NL  LG+G++++VYKG  R +G LVA++   V S K+EE      ++   LL  L+H
Sbjct: 6   SYLNLEKLGEGSYATVYKGISRINGQLVALK---VISMKTEEGVPFTAIREASLLKGLKH 62

Query: 466 ENIIRLRGFCCSRGRGECFLIYDFAPKGKLSKYLDQEEG---SSNVLDWSTRVSIIIGIA 522
            NI+ L     ++        Y       L++Y+ Q  G     NV         +  + 
Sbjct: 63  ANIVLLHDIIHTKETLTFVFEY---MHTDLAQYMIQHPGGLHPYNVR------LFMFQLL 113

Query: 523 KGIGYLHSSEVNKPAIVHRNLSVEKVLIDQQFNPLIADCGLHKLLADDIVFSVLKTSAAM 582
           +G+ Y+H        I+HR+L  + +LI       +AD GL +  A  I      +    
Sbjct: 114 RGLAYIHGQH-----ILHRDLKPQNLLISYLGELKLADFGLAR--AKSIPSQTYSSEVVT 166

Query: 583 GYLAPEYVTTG--RFTERSDIFAFGVIILQILTGS 615
            +  P  V  G   ++   DI+  G I +++L G 
Sbjct: 167 LWYRPPDVLLGATDYSSALDIWGAGCIFIEMLQGQ 201

Serine/Threonine Kinases (STKs), PFTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-2 is also referred to as ALS2CR7 (amyotrophic lateral sclerosis 2 (juvenile) chromosome region candidate 7). It may be associated with amyotrophic lateral sclerosis 2 (ALS2), an autosomal recessive form of juvenile ALS. The function of PFTAIRE-2 is not yet known. Length = 291

>gnl|CDD|173734 cd07830, STKc_MAK_like, Catalytic domain of Male germ cell-Associated Kinase-like Serine/Threonine Kinases

 Score = 49.1 bits (118), Expect = 3e-06
 Identities = 60/215 (27%), Positives = 93/215 (43%), Gaps = 45/215 (20%)

Query: 417 LGKGNFSSVYKGTLRD-GTLVAIRSINVTSCKSEEA----EFVKGLYLLTSLRHENIIRL 471
           LG G F SVY    ++ G LVAI+ +       EE     E VK L  L    H NI++L
Sbjct: 7   LGDGTFGSVYLARNKETGELVAIKKMKKKFYSWEECMNLRE-VKSLRKLNE--HPNIVKL 63

Query: 472 RG-FCCSRGRGECFLIYDFAPKGKLSKYLDQEEGSSNVLDWSTRVSIIIGIAKGIGYLHS 530
           +  F   R   E + ++++  +G L + +   +G       S   SII  I +G+ ++H 
Sbjct: 64  KEVF---RENDELYFVFEYM-EGNLYQLMKDRKGK--PFSESVIRSIIYQILQGLAHIH- 116

Query: 531 SEVNKPAIVHRNLSVEKVLIDQQFNPLIADCGLHKLLADDIVFSVLKTSAAMGYLAPEYV 590
               K    HR+L  E +L+       IAD GL + +     ++             +YV
Sbjct: 117 ----KHGFFHRDLKPENLLVSGPEVVKIADFGLAREIRSRPPYT-------------DYV 159

Query: 591 TTG--RFTE---RS-------DIFAFGVIILQILT 613
           +T   R  E   RS       DI+A G I+ ++ T
Sbjct: 160 STRWYRAPEILLRSTSYSSPVDIWALGCIMAELYT 194

Serine/Threonine Kinases (STKs), Male germ cell-Associated Kinase (MAK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of human MAK and MAK-related kinase (MRK), Saccharomyces cerevisiae Ime2p, Schizosaccharomyces pombe Mei4-dependent protein 3 (Mde3) and Pit1, Caenorhabditis elegans dyf-5, Arabidopsis thaliana MHK, and similar proteins. These proteins play important roles during meiosis. MAK is highly expressed in testicular cells specifically in the meiotic phase, but is not essential for spermatogenesis and fertility. It functions as a coactivator of the androgen receptor in prostate cells. MRK, also called Intestinal Cell Kinase (ICK), is expressed ubiquitously, with highest expression in the ovary and uterus. A missense mutation in MRK causes endocrine-cerebro-osteodysplasia (ECO), suggesting that this protein plays an important role in the development of many organs. MAK and MRK may be involved in regulating cell cycle and cell fate. Ime2p is a meiosis-specific kinase that is important during meiotic initiation and during the later stages of meiosis. Mde3 functions downstream of the transcription factor Mei-4 which is essential for meiotic prophase I. Length = 283

>gnl|CDD|219766 pfam08263, LRRNT_2, Leucine rich repeat N-terminal domain

 Score = 43.9 bits (104), Expect = 4e-06
 Identities = 16/43 (37%), Positives = 23/43 (53%), Gaps = 4/43 (9%)

Query: 25 NTELRALLDLKASL-DPENKLLQSWTEN-GDPCSGSFEGIACN 65
          N +  ALL  K+SL    +  L SW  +  DPC  S+ G+ C+
Sbjct: 2  NDDRDALLAFKSSLNGDPSGALSSWNPSSSDPC--SWTGVTCD 42

Leucine Rich Repeats pfam00560 are short sequence motifs present in a number of proteins with diverse functions and cellular locations. Leucine Rich Repeats are often flanked by cysteine rich domains. This domain is often found at the N-terminus of tandem leucine rich repeats. Length = 42

>gnl|CDD|133217 cd05086, PTKc_Aatyk2, Catalytic domain of the Protein Tyrosine Kinase, Apoptosis-associated tyrosine kinase 2

 Score = 48.7 bits (116), Expect = 4e-06
 Identities = 62/287 (21%), Positives = 112/287 (39%), Gaps = 48/287 (16%)

Query: 417 LGKGNFSSVYKGTLRDGTLVA---IRSINVTSCKSEEAEFVKGLYLLTSLRHENIIRLRG 473
           +G G F  V    +   T VA   ++ +   +   E+ EF++       L+H NI++  G
Sbjct: 3   IGNGWFGKVLLSEIYTDTGVARVVVKELKANASSKEQNEFLQQGDPYRILQHPNILQCLG 62

Query: 474 FCCSRGRGECFLIYDFAPKGKLSKYLDQEE---GSSNVLDWSTRVSIIIGIAKGIGYLHS 530
            C         L++++   G L  YL QE+    +S +L       +   IA G+ ++H 
Sbjct: 63  QCVEAI--PYLLVFEYCELGDLKSYLSQEQWHRRNSQLLLLQ---RMACEIAAGVTHMH- 116

Query: 531 SEVNKPAIVHRNLSVEKVLIDQQFNPLIADCGL-HKLLADDIVFSVLKTSAAMGYLAPEY 589
               K   +H +L++    +       + D G+      +D + +       + +LAPE 
Sbjct: 117 ----KHNFLHSDLALRNCFLTSDLTVKVGDYGIGPSRYKEDYIETEDDKCVPLRWLAPEL 172

Query: 590 VT-------TGRFTERSDIFAFGVIILQILTGSLVLTSSMRLAAESATFENFIDRNLKGK 642
           V        T   T+ S+++A GV + ++             AA+   + +  DR +   
Sbjct: 173 VGEFHGGLITAEQTKPSNVWALGVTLWELFEN----------AAQP--YSHLSDREVLNH 220

Query: 643 FSESEAAKLGKMALVCTHED------------PENRPTMEAVIEELT 677
             + +  KL K  L   + +            PE R T E V   LT
Sbjct: 221 VIKDQQVKLFKPQLELPYSERWYEVLQFCWLSPEKRATAEEVHRLLT 267

Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 2 (Aatyk2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk2 is a member of the Aatyk subfamily of proteins, which are receptor kinases containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk2 is also called lemur tyrosine kinase 2 (Lmtk2) or brain-enriched kinase (Brek). It is expressed at high levels in early postnatal brain, and has been shown to play a role in nerve growth factor (NGF) signaling. Studies with knockout mice reveal that Aatyk2 is essential for late stage spermatogenesis. Although it is classified as a tyr kinase based on sequence similarity and the phylogenetic tree, Aatyk2 has been characterized as a serine/threonine kinase. Length = 268

>gnl|CDD|173729 cd06617, PKc_MKK3_6, Catalytic domain of the dual-specificity Protein Kinases, MAP kinase kinases 3 and 6

 Score = 48.6 bits (116), Expect = 4e-06
 Identities = 42/152 (27%), Positives = 73/152 (48%), Gaps = 31/152 (20%)

Query: 517 IIIGIAKGIGYLHSSEVNKPAIVHRNLSVEKVLIDQQFNPLIADCGLHKLLADDIVFSVL 576
           I + I K + YLHS    K +++HR++    VLI++     + D G+   L D    SV 
Sbjct: 108 IAVSIVKALEYLHS----KLSVIHRDVKPSNVLINRNGQVKLCDFGISGYLVD----SVA 159

Query: 577 KTSAA--MGYLAPEYVTTGR----FTERSDIFAFGVIILQILTGS--------------- 615
           KT  A    Y+APE +        +  +SD+++ G+ ++++ TG                
Sbjct: 160 KTIDAGCKPYMAPERINPELNQKGYDVKSDVWSLGITMIELATGRFPYDSWKTPFQQLKQ 219

Query: 616 LVLTSSMRLAAE--SATFENFIDRNLKGKFSE 645
           +V   S +L AE  S  F++F+++ LK  + E
Sbjct: 220 VVEEPSPQLPAEKFSPEFQDFVNKCLKKNYKE 251

Protein kinases (PKs), MAP kinase kinase 3 (MKK3) and MKK6 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK3 and MKK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK3 and MKK6 are dual-specificity PKs that phosphorylate and activate their downstream target, p38 MAPK, on specific threonine and tyrosine residues. MKK3/6 plays roles in the regulation of cell cycle progression, cytokine- and stress-induced apoptosis, oncogenic transformation, and adult tissue regeneration. In addition, MKK6 plays a critical role in osteoclast survival in inflammatory disease while MKK3 is associated with tumor invasion, progression, and poor patient survival in glioma. Length = 283

>gnl|CDD|173759 cd08219, STKc_Nek3, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 3

 Score = 48.0 bits (114), Expect = 5e-06
 Identities = 41/245 (16%), Positives = 101/245 (41%), Gaps = 31/245 (12%)

Query: 437 AIRSINVTSCKSEEAEFVKGLYLLTSLRHENIIRLR-GFCCSRGRGECFLIYDFAPKGKL 495
           A++ I +    S   +  K   LL  ++H NI+  +  F      G  +++ ++   G L
Sbjct: 29  AMKEIRLPKSSSAVEDSRKEAVLLAKMKHPNIVAFKESF---EADGHLYIVMEYCDGGDL 85

Query: 496 SKYLDQEEG----SSNVLDWSTRVSIIIGIAKGIGYLHSSEVNKPAIVHRNLSVEKVLID 551
            + +  + G       +L W  ++ +      G+ ++H   V     +HR++  + + + 
Sbjct: 86  MQKIKLQRGKLFPEDTILQWFVQMCL------GVQHIHEKRV-----LHRDIKSKNIFLT 134

Query: 552 QQFNPLIADCGLHKLLADDIVFSVLKTSAAMGYLAPEYVTTGRFTERSDIFAFGVIILQI 611
           Q     + D G  +LL     ++         Y+ PE      +  +SDI++ G I+ ++
Sbjct: 135 QNGKVKLGDFGSARLLTSPGAYACTYVGTPY-YVPPEIWENMPYNNKSDIWSLGCILYEL 193

Query: 612 LTGSLVLTSSMRLAAESATFENFIDRNLKGKFSESEAAKLGKMALVCTH---EDPENRPT 668
            T        ++   ++ +++N I +  +G +    +    ++  +       +P +RP+
Sbjct: 194 CT--------LKHPFQANSWKNLILKVCQGSYKPLPSHYSYELRSLIKQMFKRNPRSRPS 245

Query: 669 MEAVI 673
              ++
Sbjct: 246 ATTIL 250

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 3 (Nek3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek3 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek3 is primarily localized in the cytoplasm and shows no cell cycle-dependent changes in its activity. It is present in the axons of neurons and affects morphogenesis and polarity through its regulation of microtubule acetylation. Nek3 modulates the signaling of the prolactin receptor through its activation of Vav2 and contributes to prolactin-mediated motility of breast cancer cells. Length = 255

>gnl|CDD|173676 cd05585, STKc_YPK1_like, Catalytic domain of Yeast Protein Kinase 1-like Protein Serine/Threonine Kinases

 Score = 48.4 bits (115), Expect = 5e-06
 Identities = 57/208 (27%), Positives = 95/208 (45%), Gaps = 29/208 (13%)

Query: 417 LGKGNFSSVY----KGTLRDGTLVAIRSINVTSCKSEEAEFVKGLYLLTSLRHENIIRLR 472
           +GKG+F  V     + T R   L  IR  ++ S +SE    +    +L  +    I+ L+
Sbjct: 1   IGKGSFGKVMQVRKRDTQRIYALKTIRKAHIVS-RSEVTHTLAERTVLAQVNCPFIVPLK 59

Query: 473 -GFCCSRGRGECFLIYDFAPKGKLSKYLDQEEGSSNVLDWSTRVSIIIG-IAKGIGYLHS 530
             F   +   + +L+  F   G+L  +L Q EG  +     +R       +   +  LH 
Sbjct: 60  FSF---QSPEKLYLVLAFINGGELFHHL-QREGRFD----LSRARFYTAELLCALENLHK 111

Query: 531 SEVNKPAIVHRNLSVEKVLIDQQFNPLIADCGLHKL-LADDIVFSVLKTSAAMG---YLA 586
             V     ++R+L  E +L+D Q +  + D GL KL + DD      KT+   G   YLA
Sbjct: 112 FNV-----IYRDLKPENILLDYQGHIALCDFGLCKLNMKDDD-----KTNTFCGTPEYLA 161

Query: 587 PEYVTTGRFTERSDIFAFGVIILQILTG 614
           PE +    +T+  D +  GV++ ++LTG
Sbjct: 162 PELLLGHGYTKAVDWWTLGVLLYEMLTG 189

Serine/Threonine Kinases (STKs), Yeast protein kinase 1 (YPK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YPK1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the AGC STKs, Saccharomyces cerevisiae YPK1 and Schizosaccharomyces pombe Gad8p. YPK1 is required for cell growth and acts as a downstream kinase in the sphingolipid-mediated signaling pathway of yeast. It also plays a role in efficient endocytosis and in the maintenance of cell wall integrity. Gad8p is a downstream target of Tor1p, the fission yeast homolog of mTOR. It plays a role in cell growth and sexual development. Length = 312

>gnl|CDD|143376 cd07871, STKc_PCTAIRE3, Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-3 kinase

 Score = 48.5 bits (115), Expect = 6e-06
 Identities = 50/211 (23%), Positives = 99/211 (46%), Gaps = 20/211 (9%)

Query: 409 QCFSEVNLLGKGNFSSVYKGTLR-DGTLVAIRSINVTSCKSEEAEFVKGLYLLTSLRHEN 467
           + + +++ LG+G +++V+KG  +    LVA++ I +   +      ++ + LL +L+H N
Sbjct: 5   ETYVKLDKLGEGTYATVFKGRSKLTENLVALKEIRLEHEEGAPCTAIREVSLLKNLKHAN 64

Query: 468 IIRLRGFCCSRGRGECF-LIYDFAPKGKLSKYLDQEEGSSNVLDWSTRVSIIIGIAKGIG 526
           I+ L     +     C  L++++     L +YLD      N++        +  + +G+ 
Sbjct: 65  IVTLHDIIHTE---RCLTLVFEYL-DSDLKQYLDN---CGNLMSMHNVKIFMFQLLRGLS 117

Query: 527 YLHSSEVNKPAIVHRNLSVEKVLIDQQFNPLIADCGLHKLLADDIVFSVLKTSAAMGYLA 586
           Y H     K  I+HR+L  + +LI+++    +AD GL +  A  +            +  
Sbjct: 118 YCH-----KRKILHRDLKPQNLLINEKGELKLADFGLAR--AKSVPTKTYSNEVVTLWYR 170

Query: 587 PEYVTTGRFTERS---DIFAFGVIILQILTG 614
           P  V  G  TE S   D++  G I+ ++ TG
Sbjct: 171 PPDVLLGS-TEYSTPIDMWGVGCILYEMATG 200

Serine/Threonine Kinases (STKs), PCTAIRE-3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-3 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-3 shows a restricted pattern of expression and is present in brain, kidney, and intestine. It is elevated in Alzheimer's disease (AD) and has been shown to associate with paired helical filaments (PHFs) and stimulate Tau phosphorylation. As AD progresses, phosphorylated Tau aggregates and forms PHFs, which leads to the formation of neurofibrillary tangles (NFTs). In human glioma cells, PCTAIRE-3 induces cell cycle arrest and cell death. Length = 288

>gnl|CDD|173635 cd05054, PTKc_VEGFR, Catalytic domain of the Protein Tyrosine Kinases, Vascular Endothelial Growth Factor Receptors

 Score = 48.3 bits (115), Expect = 7e-06
 Identities = 39/158 (24%), Positives = 79/158 (50%), Gaps = 11/158 (6%)

Query: 521 IAKGIGYLHSSEVNKPAIVHRNLSVEKVLIDQQFNPLIADCGLHKLLADDIVFSVLKTSA 580
           +A+G+ +L S +      +HR+L+   +L+ +     I D GL + +  D  + V K  A
Sbjct: 182 VARGMEFLASRKC-----IHRDLAARNILLSENNVVKICDFGLARDIYKDPDY-VRKGDA 235

Query: 581 --AMGYLAPEYVTTGRFTERSDIFAFGVIILQILTGSLVLTSSMRLAAESATFENFIDRN 638
              + ++APE +    +T +SD+++FGV++ +I +        +++  E   F   +   
Sbjct: 236 RLPLKWMAPESIFDKVYTTQSDVWSFGVLLWEIFSLGASPYPGVQIDEE---FCRRLKEG 292

Query: 639 LKGKFSESEAAKLGKMALVCTHEDPENRPTMEAVIEEL 676
            + +  E    ++  + L C H +PE+RPT   ++E L
Sbjct: 293 TRMRAPEYATPEIYSIMLDCWHNNPEDRPTFSELVEIL 330

Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor (VEGFR) subfamily; catalytic (c) domain. The VEGFR subfamily consists of VEGFR1 (Flt1), VEGFR2 (Flk1), VEGFR3 (Flt4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. There are five VEGF ligands in mammals, which bind, in an overlapping pattern to the three VEGFRs, which can form homo or heterodimers. VEGFRs regulate the cardiovascular system. They are critical for vascular development during embryogenesis and blood vessel formation in adults. They induce cellular functions common to other growth factor receptors such as cell migration, survival, and proliferation. VEGFR1 binds VEGFA, VEGFB, and placenta growth factor (PLGF). It regulates monocyte and macrophage migration, vascular permeability, haematopoiesis, and the recruitment of haematopietic progenitor cells from the bone marrow. Length = 337

>gnl|CDD|173662 cd05571, STKc_PKB, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B

 Score = 48.3 bits (115), Expect = 7e-06
 Identities = 58/212 (27%), Positives = 95/212 (44%), Gaps = 31/212 (14%)

Query: 416 LLGKGNFSSVY----KGTLRDGTLVAIRSI--NVTSCKSEEAEFVKGLYLLTSLRHENII 469
           LLGKG F  V     K T   G   A++ +   V   K E A  +    +L + RH  + 
Sbjct: 2   LLGKGTFGKVILVREKAT---GKYYAMKILKKEVIIAKDEVAHTLTESRVLQNTRHPFLT 58

Query: 470 RLRGFCCSRGRGECFLIYDFAPKGKLSKYLDQEEGSSNVLDWSTRVSIIIG--IAKGIGY 527
            L+    +  R  CF++ ++A  G+L  +L +E   S   +   R     G  I   +GY
Sbjct: 59  ALKYSFQTHDR-LCFVM-EYANGGELFFHLSRERVFS---EDRAR---FYGAEIVSALGY 110

Query: 528 LHSSEVNKPAIVHRNLSVEKVLIDQQFNPLIADCGLHKLLADDIVFSVLKTSAAMG---Y 584
           LHS +     +V+R+L +E +++D+  +  I D GL K   + I           G   Y
Sbjct: 111 LHSCD-----VVYRDLKLENLMLDKDGHIKITDFGLCK---EGISDGA-TMKTFCGTPEY 161

Query: 585 LAPEYVTTGRFTERSDIFAFGVIILQILTGSL 616
           LAPE +    +    D +  GV++ +++ G L
Sbjct: 162 LAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRL 193

Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. It is activated downstream of PI3K and plays important roles in diverse cellular functions including cell survival, growth, proliferation, angiogenesis, motility, and migration. PKB also has a central role in a variety of human cancers, having been implicated in tumor initiation, progression, and metastasis. Length = 323

>gnl|CDD|143384 cd07879, STKc_p38delta_MAPK13, Catalytic domain of the Serine/Threonine Kinase, p38delta Mitogen-Activated Protein Kinase

 Score = 48.0 bits (114), Expect = 9e-06
 Identities = 59/238 (24%), Positives = 100/238 (42%), Gaps = 39/238 (16%)

Query: 389 FSREHLNSFRLNLEEVESATQCFSEVNLLGKGNFSSVYKGT-LRDGTLVAIRSINVTSCK 447
           F RE +N     L E       ++ +  +G G + SV      R G  VAI+ +     +
Sbjct: 1   FYREEVNKTVWELPER------YTSLKQVGSGAYGSVCSAIDKRTGEKVAIKKL----SR 50

Query: 448 SEEAE-FVKGLY----LLTSLRHENIIRLRGFCCSRGRGECFLIYDF---AP--KGKLSK 497
             ++E F K  Y    LL  ++HEN+I L     S   G+ F   DF    P  +  L K
Sbjct: 51  PFQSEIFAKRAYRELTLLKHMQHENVIGLLDVFTSAVSGDEF--QDFYLVMPYMQTDLQK 108

Query: 498 YLDQEEGSSNVLDWSTRVSIIIGIAKGIGYLHSSEVNKPAIVHRNLSVEKVLIDQQFNPL 557
            +        V        ++  +  G+ Y+HS+      I+HR+L    + +++     
Sbjct: 109 IMGHPLSEDKVQ------YLVYQMLCGLKYIHSA-----GIIHRDLKPGNLAVNEDCELK 157

Query: 558 IADCGLHKLLADDIVFSVLKTSAAMGYLAPEYVTTG-RFTERSDIFAFGVIILQILTG 614
           I D GL +    ++   V+       Y APE +     + +  DI++ G I+ ++LTG
Sbjct: 158 ILDFGLARHADAEMTGYVV----TRWYRAPEVILNWMHYNQTVDIWSVGCIMAEMLTG 211

Serine/Threonine Kinases (STKs), p38delta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38delta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38delta, also called MAPK13, is found in skeletal muscle, heart, lung, testis, pancreas, and small intestine. It regulates microtubule function by phosphorylating Tau. It activates the c-jun promoter and plays a role in G2 cell cycle arrest. It also controls the degration of c-Myb, which is associated with myeloid leukemia and poor prognosis in colorectal cancer. p38delta is the main isoform involved in regulating the differentiation and apoptosis of keratinocytes. Length = 342

>gnl|CDD|173694 cd05603, STKc_SGK2, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 2

 Score = 47.7 bits (113), Expect = 1e-05
 Identities = 53/208 (25%), Positives = 94/208 (45%), Gaps = 26/208 (12%)

Query: 416 LLGKGNFSSVYKGTLR-DGTLVAIRSINVTSC--KSEEAEFV-KGLYLLTSLRHENIIRL 471
           ++GKG+F  V     + DG+  A++ +   +   K E+   + +   LL +L+H  ++ L
Sbjct: 2   VIGKGSFGKVLLAKRKSDGSFYAVKVLQKKTILKKKEQNHIMAERNVLLKNLKHPFLVGL 61

Query: 472 R-GFCCSRGRGECFLIYDFAPKGKLSKYLDQEEGSSNVLDWSTRVSIIIG-IAKGIGYLH 529
              F  +    + + + D+   G+L  +L +E           R       +A  IGYLH
Sbjct: 62  HYSFQTAE---KLYFVLDYVNGGELFFHLQRERCFL-----EPRARFYAAEVASAIGYLH 113

Query: 530 SSEVNKPAIVHRNLSVEKVLIDQQFNPLIADCGLHKLLADDIVFSVLKTSAAMG---YLA 586
           S       I++R+L  E +L+D Q + ++ D GL K    + V     TS   G   YLA
Sbjct: 114 SLN-----IIYRDLKPENILLDSQGHVVLTDFGLCK----EGVEPEETTSTFCGTPEYLA 164

Query: 587 PEYVTTGRFTERSDIFAFGVIILQILTG 614
           PE +    +    D +  G ++ ++L G
Sbjct: 165 PEVLRKEPYDRTVDWWCLGAVLYEMLYG 192

Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK2 shows a more restricted distribution that SGK1 and is most abundantly expressed in epithelial tissues including kidney, liver, pancreas, and the choroid plexus of the brain. In vitro cellular assays show that SGK2 can stimulate the activity of ion channels, the glutamate transporter EEAT4, and the glutamate receptors, GluR6 and GLUR1. Length = 321

>gnl|CDD|173646 cd05087, PTKc_Aatyk1_Aatyk3, Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases 1 and 3

 Score = 47.2 bits (112), Expect = 1e-05
 Identities = 64/285 (22%), Positives = 111/285 (38%), Gaps = 43/285 (15%)

Query: 417 LGKGNFSSVYKGTLRDG---TLVAIRSINVTSCKSEEAEFVKGLYLLTSLRHENIIRLRG 473
           +G G F  V  G +  G     V ++ + V++   E+ +F++      SL+H N+++  G
Sbjct: 3   IGNGWFGKVILGEVNSGYTPAQVVVKELRVSASVQEQMKFLEEAQPYRSLQHSNLLQCLG 62

Query: 474 FCCSRGRGECFLIYDFAPKGKLSKYLDQEEGSSNVL-DWSTRVSIIIGIAKGIGYLHSSE 532
            C         L+ +F P G L  YL     +  +  D +T   +   IA G+ +LH   
Sbjct: 63  QCTE--VTPYLLVMEFCPLGDLKGYLRSCRKAELMTPDPTTLQRMACEIALGLLHLH--- 117

Query: 533 VNKPAIVHRNLSVEKVLIDQQFNPLIADCGL-HKLLADDIVFSVLKTSAAMGYLAPEYV- 590
             K   +H +L++   L+       I D GL H    +D   +  +    + ++APE V 
Sbjct: 118 --KNNFIHSDLALRNCLLTADLTVKIGDYGLSHNKYKEDYYVTPDQLWVPLRWIAPELVD 175

Query: 591 -TTGRF-----TERSDIFAFGVIILQILTGSLVLTSSMRLAAESATFENFIDRNLKGKFS 644
              G       T+ S++++ GV I ++                S  + +  D  +     
Sbjct: 176 EVHGNLLVVDQTKESNVWSLGVTIWELFELG------------SQPYRHLSDEQVLTYTV 223

Query: 645 ESEAAKLGKMALVCTHED------------PENRPTMEAVIEELT 677
             +  KL K  L     D            PE RP+ E V   L+
Sbjct: 224 REQQLKLPKPRLKLPLSDRWYEVMQFCWLQPEQRPSAEEVHLLLS 268

Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 1 (Aatyk1) and Aatyk3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk1 and Aatyk3 are members of the Aatyk subfamily of proteins. Aatyk3 is a receptor kinase containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 has a similar domain arrangement but without the transmembrane segment and is thus, a cytoplasmic (or nonreceptor) kinase. The expression of Aatyk1 (also referred simply as Aatyk) is upregulated during growth arrest and apoptosis in myeloid cells. Aatyk1 has been implicated in neural differentiation, and is a regulator of the Na-K-2Cl cotransporter, a membrane protein involved in cell proliferation and survival, epithelial transport, and blood pressure control. The function of Aatyk3 is still unknown. Length = 269

>gnl|CDD|173671 cd05580, STKc_PKA, Catalytic domain of the Protein Serine/Threonine Kinase, cAMP-dependent protein kinase

 Score = 47.5 bits (114), Expect = 1e-05
 Identities = 41/159 (25%), Positives = 72/159 (45%), Gaps = 23/159 (14%)

Query: 460 LTSLRHENIIRLRG-FCCSRGRGECFLIYDFAPKGKLSKYLDQEEGSSNVLDWSTRVSII 518
           L S+RH  ++ L G F         +L+ ++ P G+L  +L +          +   +  
Sbjct: 55  LQSIRHPFLVNLYGSFQDDS---NLYLVMEYVPGGELFSHLRKSGRFPE--PVARFYAAQ 109

Query: 519 IGIAKGIGYLHSSEVNKPAIVHRNLSVEKVLIDQQFNPLIADCGLHKLLADDIVFSVLKT 578
           + +A  + YLHS +     IV+R+L  E +L+D      I D G  K +         +T
Sbjct: 110 VVLA--LEYLHSLD-----IVYRDLKPENLLLDSDGYIKITDFGFAKRVKG-------RT 155

Query: 579 SAAMG---YLAPEYVTTGRFTERSDIFAFGVIILQILTG 614
               G   YLAPE + +  + +  D +A G++I ++L G
Sbjct: 156 YTLCGTPEYLAPEIILSKGYGKAVDWWALGILIYEMLAG 194

Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This subfamily is composed of the cAMP-dependent proteins kinases, PKA and PRKX. The inactive PKA holoenzyme is a heterotetramer composed of two phosphorylated and active catalytic (C) subunits with a dimer of regulatory (R) subunits. Activation is achieved through the binding of the important second messenger cAMP to the R subunits, which leads to the dissociation of PKA into the R dimer and two active C subunits. PKA is present ubiquitously in cells and interacts with many different downstream targets. It plays a role in the regulation of diverse processes such as growth, development, memory, metabolism, gene expression, immunity, and lipolysis. Length = 290

>gnl|CDD|173695 cd05604, STKc_SGK3, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 3

 Score = 47.7 bits (113), Expect = 1e-05
 Identities = 53/207 (25%), Positives = 92/207 (44%), Gaps = 24/207 (11%)

Query: 416 LLGKGNFSSVYKGTL-RDGTLVAIRSIN---VTSCKSEEAEFVKGLYLLTSLRHENIIRL 471
           ++GKG+F  V       DG   A++ +    V + K ++    +   LL +++H  ++ L
Sbjct: 2   VIGKGSFGKVLLAKRKLDGKCYAVKVLQKKIVLNRKEQKHIMAERNVLLKNVKHPFLVGL 61

Query: 472 R-GFCCSRGRGECFLIYDFAPKGKLSKYLDQEEGSSNVLDWSTRVSIIIG-IAKGIGYLH 529
              F  +    + + + DF   G+L  +L +E           R       IA  +GYLH
Sbjct: 62  HYSFQTTE---KLYFVLDFVNGGELFFHLQRERSFP-----EPRARFYAAEIASALGYLH 113

Query: 530 SSEVNKPAIVHRNLSVEKVLIDQQFNPLIADCGLHKLLADDIVFSVLKTS--AAMGYLAP 587
           S       IV+R+L  E +L+D Q + ++ D GL K   + I  S   T+      YLAP
Sbjct: 114 SIN-----IVYRDLKPENILLDSQGHVVLTDFGLCK---EGIAQSDTTTTFCGTPEYLAP 165

Query: 588 EYVTTGRFTERSDIFAFGVIILQILTG 614
           E +    +    D +  G ++ ++L G
Sbjct: 166 EVIRKQPYDNTVDWWCLGAVLYEMLYG 192

Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGK3 is expressed in most tissues and is most abundant in the embryo and adult heart and spleen. It was originally discovered in a screen for antiapoptotic genes. It phosphorylates and inhibits the proapoptotic proteins, Bad and FKHRL1. SGK3 also regulates many transporters, ion channels, and receptors. It plays a critical role in hair follicle morphogenesis and hair cycling. Length = 325

>gnl|CDD|173736 cd07832, STKc_CCRK, Catalytic domain of the Serine/Threonine Kinase, Cell Cycle-Related Kinase

 Score = 47.3 bits (113), Expect = 1e-05
 Identities = 53/206 (25%), Positives = 95/206 (46%), Gaps = 22/206 (10%)

Query: 417 LGKGNFSSVYKGTLRD-GTLVAIRSINVTSCKSEEA---EFVKGLYLLTSLRHENIIRLR 472
           +G+G    V+K   R+ G  VA++ + +   + E     + ++ +  L + +H  +++L 
Sbjct: 8   IGEGAHGIVFKAKDRETGETVALKKVALR--RLEGGIPNQALREIKALQACQHPYVVKLL 65

Query: 473 G-FCCSRGRGECF-LIYDFAPKGKLSKYLDQEEGSSNVLDWSTRVSIIIGIAKGIGYLHS 530
             F      G  F L+ ++ P   LS+ L  EE     L  +   S +  + KG+ Y+H+
Sbjct: 66  DVFPH----GSGFVLVMEYMPSD-LSEVLRDEE---RPLPEAQVKSYMRMLLKGVAYMHA 117

Query: 531 SEVNKPAIVHRNLSVEKVLIDQQFNPLIADCGLHKLLADDIVFSVLKTSAAMGYLAPEYV 590
           +      I+HR+L    +LI       IAD GL +L +++         A   Y APE +
Sbjct: 118 N-----GIMHRDLKPANLLISADGVLKIADFGLARLFSEEEPRLYSHQVATRWYRAPELL 172

Query: 591 TTGR-FTERSDIFAFGVIILQILTGS 615
              R +    D++A G I  ++L GS
Sbjct: 173 YGARKYDPGVDLWAVGCIFAELLNGS 198

Serine/Threonine Kinases (STKs), Cell Cycle-Related Kinase (CCRK) p42 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CCRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CCRK was previously called p42. It is a Cyclin-Dependent Kinase (CDK)-Activating Kinase (CAK) which is essential for the activation of CDK2. It is indispensable for cell growth and has been implicated in the progression of glioblastoma multiforme. In the heart, a splice variant of CCRK with a different C-terminal half is expressed, this variant promotes cardiac cell growth and survival and is significantly down-regulated during the development of heart failure. Length = 286

>gnl|CDD|173702 cd05611, STKc_Rim15_like, Catalytic domain of fungal Rim15-like Protein Serine/Threonine Kinases

 Score = 46.3 bits (110), Expect = 2e-05
 Identities = 26/91 (28%), Positives = 41/91 (45%), Gaps = 10/91 (10%)

Query: 524 GIGYLHSSEVNKPAIVHRNLSVEKVLIDQQFNPLIADCGLHKLLADDIVFSVLKTSAAMG 583
           G+  LH     +  I+HR++  E +LIDQ  +  + D GL +           K      
Sbjct: 109 GVEDLH-----QRGIIHRDIKPENLLIDQTGHLKLTDFGLSR-----NGLENKKFVGTPD 158

Query: 584 YLAPEYVTTGRFTERSDIFAFGVIILQILTG 614
           YLAPE +      + SD ++ G +I + L G
Sbjct: 159 YLAPETILGVGDDKMSDWWSLGCVIFEFLFG 189

Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, fungal Rim15-like kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include Saccharomyces cerevisiae Rim15, Schizosaccharomyces pombe cek1, and similar fungal proteins. They contain a central catalytic domain, which contains an insert relative to MAST kinases. In addition, Rim15 contains a C-terminal signal receiver (REC) domain while cek1 contains an N-terminal PAS domain. Rim15 (or Rim15p) functions as a regulator of meiosis. It acts as a downstream effector of PKA and regulates entry into stationary phase (G0). Thus, it plays a crucial role in regulating yeast proliferation, differentiation, and aging. Cek1 may facilitate progression of mitotic anaphase. Length = 260

>gnl|CDD|173727 cd06613, STKc_MAP4K3_like, Catalytic domain of Mitogen-activated protein kinase kinase kinase kinase-like Protein Serine/Threonine Kinases

 Score = 46.5 bits (111), Expect = 2e-05
 Identities = 44/205 (21%), Positives = 89/205 (43%), Gaps = 26/205 (12%)

Query: 411 FSEVNLLGKGNFSSVYKG-TLRDGTLVAIRSINVTSCKSEEAEFVKGLYLLTSLRHENII 469
           +  +  +G G +  VYK   +  G LVAI+ I +     +     + + +L   RH NI+
Sbjct: 5   YELIQRIGSGTYGDVYKARDIATGELVAIKVIKLEP-GDDFEIIQQEISMLKECRHPNIV 63

Query: 470 RLRGFCCSRGRGECFLIYDFAPKGKLSKYLDQEEG--SSNVLDWSTRVSIIIGIAKGIGY 527
              G      R + +++ ++   G L        G  S   + +  R ++     KG+ Y
Sbjct: 64  AYFG--SYLRRDKLWIVMEYCGGGSLQDIYQVTRGPLSELQIAYVCRETL-----KGLAY 116

Query: 528 LHSSEVNKPAIVHRNLSVEKVLIDQQFNPLIADCGLHKLLADDIVFSVLKTSAAMG---Y 584
           LH +       +HR++    +L+ +  +  +AD G    ++  +  ++ K  + +G   +
Sbjct: 117 LHETGK-----IHRDIKGANILLTEDGDVKLADFG----VSAQLTATIAKRKSFIGTPYW 167

Query: 585 LAPEYV---TTGRFTERSDIFAFGV 606
           +APE       G +  + DI+A G+
Sbjct: 168 MAPEVAAVERKGGYDGKCDIWALGI 192

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily includes MAP4K3, MAP4K1, MAP4K2, MAP4K5, and related proteins. Vertebrate members contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K1, also called haematopoietic progenitor kinase 1 (HPK1), is a hematopoietic-specific STK involved in many cellular signaling cascades including MAPK, antigen receptor, apoptosis, growth factor, and cytokine signaling. It participates in the regulation of T cell receptor signaling and T cell-mediated immune responses. MAP4K2 was referred to as germinal center (GC) kinase because of its preferred location in GC B cells. MAP4K3 plays a role in the nutrient-responsive pathway of mTOR (mammalian target of rapamycin) signaling. It is required in the activation of S6 kinase by amino acids and for the phosphorylation of the mTOR-regulated inhibitor of eukaryotic initiation factor 4E. MAP4K5, also called germinal center kinase-related enzyme (GCKR), has been shown to activate the MAPK c-Jun N-terminal kinase (JNK). Length = 262

>gnl|CDD|143356 cd07851, STKc_p38, Catalytic domain of the Serine/Threonine Kinase, p38 Mitogen-Activated Protein Kinase

 Score = 46.5 bits (111), Expect = 3e-05
 Identities = 49/213 (23%), Positives = 92/213 (43%), Gaps = 26/213 (12%)

Query: 411 FSEVNLLGKGNFSSVYKGTLRD-GTLVAIRSINVTSCKSEEAEFVKGLY----LLTSLRH 465
           +  ++ +G G +  V        G  VAI+ +   S   + A   K  Y    LL  + H
Sbjct: 17  YQNLSPVGSGAYGQVCSAFDTKTGRKVAIKKL---SRPFQSAIHAKRTYRELRLLKHMDH 73

Query: 466 ENIIRLRG-FCCSRGRGECFLIYDFAP--KGKLSKYLDQEEGSSNVLDWSTRVSIIIGIA 522
           EN+I L   F  +    +   +Y         L+  +  ++ S + + +     ++  I 
Sbjct: 74  ENVIGLLDVFTPASSLEDFQDVYLVTHLMGADLNNIVKCQKLSDDHIQF-----LVYQIL 128

Query: 523 KGIGYLHSSEVNKPAIVHRNLSVEKVLIDQQFNPLIADCGLHKLLADDIVFSVLKTSAAM 582
           +G+ Y+HS+      I+HR+L    + +++     I D GL +   D++   V    A  
Sbjct: 129 RGLKYIHSA-----GIIHRDLKPSNIAVNEDCELKILDFGLARHTDDEMTGYV----ATR 179

Query: 583 GYLAPEYVTT-GRFTERSDIFAFGVIILQILTG 614
            Y APE +     + +  DI++ G I+ ++LTG
Sbjct: 180 WYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTG 212

Serine/Threonine Kinases (STKs), p38 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They function in the regulation of the cell cycle, cell development, cell differentiation, senescence, tumorigenesis, apoptosis, pain development and pain progression, and immune responses. p38 kinases are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. p38 substrates include other protein kinases and factors that regulate transcription, nuclear export, mRNA stability and translation. p38 kinases are drug targets for the inflammatory diseases psoriasis, rheumatoid arthritis, and chronic pulmonary disease. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta, which show varying substrate specificity and expression patterns. p38alpha and p38beta are ubiquitously expressed, p38gamma is predominantly found in skeletal muscle, and p38delta is found in the heart, lung, testis, pancreas, and small intestine. Length = 343

>gnl|CDD|133235 cd05104, PTKc_Kit, Catalytic domain of the Protein Tyrosine Kinase, Kit

 Score = 46.4 bits (110), Expect = 3e-05
 Identities = 46/191 (24%), Positives = 90/191 (47%), Gaps = 21/191 (10%)

Query: 494 KLSKYLDQE------EGSSNVLDWSTRVSIIIGIAKGIGYLHSSEVNKPAIVHRNLSVEK 547
           +   Y+DQ+      E     LD    +S    +AKG+ +L S        +HR+L+   
Sbjct: 190 RSGSYIDQDVTSEILEEDELALDTEDLLSFSYQVAKGMSFLASKNC-----IHRDLAARN 244

Query: 548 VLIDQQFNPLIADCGLHKLLADDIVFSVLKTSAAM--GYLAPEYVTTGRFTERSDIFAFG 605
           +L+       I D GL + + +D  + V+K +A +   ++APE +    +T  SD++++G
Sbjct: 245 ILLTHGRITKICDFGLARDIRNDSNY-VVKGNARLPVKWMAPESIFNCVYTFESDVWSYG 303

Query: 606 VIILQILTGSLVLTSSMRLAAESATFENFID--RNLKGKFSESEAAKLGKMALVCTHEDP 663
           +++ +I   SL  +    +  +S  ++   +  R L  + + SE   + K    C   DP
Sbjct: 304 ILLWEIF--SLGSSPYPGMPVDSKFYKMIKEGYRMLSPECAPSEMYDIMK---SCWDADP 358

Query: 664 ENRPTMEAVIE 674
             RPT + +++
Sbjct: 359 LKRPTFKQIVQ 369

Protein Tyrosine Kinase (PTK) family; Kit (or c-Kit); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Kit is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of Kit to its ligand, the stem-cell factor (SCF), leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. Kit is important in the development of melanocytes, germ cells, mast cells, hematopoietic stem cells, the interstitial cells of Cajal, and the pacemaker cells of the GI tract. Kit signaling is involved in major cellular functions including cell survival, proliferation, differentiation, adhesion, and chemotaxis. Mutations in Kit, which result in constitutive ligand-independent activation, are found in human cancers such as gastrointestinal stromal tumor (GIST) and testicular germ cell tumor (TGCT). The aberrant expression of Kit and/or SCF is associated with other tumor types such as systemic mastocytosis and cancers of the breast, neurons, lung, prostate, colon, and rectum. Although the structure of the human Kit catalytic domain is known, it is excluded from this specific alignment model because it contains a deletion in its sequence. Length = 375

>gnl|CDD|173668 cd05577, STKc_GRK, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase

 Score = 46.0 bits (109), Expect = 3e-05
 Identities = 30/95 (31%), Positives = 44/95 (46%), Gaps = 9/95 (9%)

Query: 521 IAKGIGYLHSSEVNKPAIVHRNLSVEKVLIDQQFNPLIADCGLHKLLADDIVFSVLKTSA 580
           I  G+ +LH        IV+R+L  E VL+D   N  I+D GL   L        +K  A
Sbjct: 104 IICGLEHLHQRR-----IVYRDLKPENVLLDDHGNVRISDLGLAVELKGG---KKIKGRA 155

Query: 581 AM-GYLAPEYVTTGRFTERSDIFAFGVIILQILTG 614
              GY+APE +    +    D FA G  + +++ G
Sbjct: 156 GTPGYMAPEVLQGEVYDFSVDWFALGCTLYEMIAG 190

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. GRKs contain a central catalytic domain, flanked by N- and C-terminal extensions. The N-terminus contains an RGS (regulator of G protein signaling) homology (RH) domain and several motifs. The C-terminus diverges among different groups of GRKs. There are seven types of GRKs, named GRK1 to GRK7. They are subdivided into three main groups: visual (GRK1/7); beta-adrenergic receptor kinases (GRK2/3); and GRK4-like (GRK4/5/6). Expression of GRK2/3/5/6 is widespread while GRK1/4/7 show a limited tissue distribution. The substrate spectrum of the widely expressed GRKs partially overlaps. GRKs play important roles in the cardiovascular, immune, respiratory, skeletal, and nervous systems. Length = 277

>gnl|CDD|173674 cd05583, STKc_MSK_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase

 Score = 45.9 bits (109), Expect = 3e-05
 Identities = 33/134 (24%), Positives = 64/134 (47%), Gaps = 13/134 (9%)

Query: 485 LIYDFAPKGKLSKYLDQEEGSSNVLDWSTRVSIIIG-IAKGIGYLHSSEVNKPAIVHRNL 543
           LI D+   G+L  +L Q E  +      + V + I  I   + +LH     +  I++R++
Sbjct: 82  LILDYVNGGELFTHLYQREHFT-----ESEVRVYIAEIVLALDHLH-----QLGIIYRDI 131

Query: 544 SVEKVLIDQQFNPLIADCGLHKLLADDIVFSVLKTSAAMGYLAPEYVTTGR--FTERSDI 601
            +E +L+D + + ++ D GL K    +           + Y+APE +  G     +  D 
Sbjct: 132 KLENILLDSEGHVVLTDFGLSKEFLAEEEERAYSFCGTIEYMAPEVIRGGSGGHDKAVDW 191

Query: 602 FAFGVIILQILTGS 615
           ++ GV+  ++LTG+
Sbjct: 192 WSLGVLTFELLTGA 205

Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, in response to various stimuli such as growth factors, hormones, neurotransmitters, cellular stress, and pro-inflammatory cytokines. This triggers phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydrophobic motif (HM) in the C-terminal extension of NTD, which facilitates the phosphorylation of the A-loop and activates the NTD, which in turn phosphorylates downstream targets. MSKs are predominantly nuclear proteins. They are widely expressed in many tissues including heart, brain, lung, liver, kidney, and pancreas. There are two isoforms of MSK, called MSK1 and MSK2. Length = 288

>gnl|CDD|173696 cd05605, STKc_GRK4_like, Catalytic domain of G protein-coupled Receptor Kinase 4-like Protein Serine/Threonine Kinases

 Score = 46.0 bits (109), Expect = 4e-05
 Identities = 43/154 (27%), Positives = 69/154 (44%), Gaps = 25/154 (16%)

Query: 521 IAKGIGYLHSSEVNKPAIVHRNLSVEKVLIDQQFNPLIADCGLH-KLLADDIVFSVLKTS 579
           I  G+  LH        IV+R+L  E +L+D   +  I+D GL  ++   + +   + T 
Sbjct: 111 ITCGLEDLHRER-----IVYRDLKPENILLDDYGHIRISDLGLAVEIPEGETIRGRVGT- 164

Query: 580 AAMGYLAPEYVTTGRFTERSDIFAFGVIILQILTGSLVLTSSMRLAAESATFENFIDRNL 639
             +GY+APE V   R+T   D +  G +I +++ G     S  R   E    E  ++R +
Sbjct: 165 --VGYMAPEVVKNERYTFSPDWWGLGCLIYEMIEGK----SPFRQRKEKVKREE-VERRV 217

Query: 640 K-------GKFSESEAAKLGKMALVCTHEDPENR 666
           K        KFSE  A  + +  L    +DP  R
Sbjct: 218 KEDQEEYSEKFSE-AARSICRQLL---TKDPGFR 247

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4-like group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. Members of the GRK4-like group include GRK4, GRK5, GRK6, and similar GRKs. GRKs in this group contain an N-terminal RGS homology (RH) domain and a catalytic domain, but lack a G protein betagamma-subunit binding domain. They are localized to the plasma membrane through post-translational lipid modification or direct binding to PIP2. Length = 285

>gnl|CDD|143381 cd07876, STKc_JNK2, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 2

 Score = 46.2 bits (109), Expect = 4e-05
 Identities = 49/205 (23%), Positives = 83/205 (40%), Gaps = 41/205 (20%)

Query: 433 GTLVAIRSI-----NVTSCKSEEAEFVKGLYLLTSLRHENIIRLRGFCCSRGRGECFLIY 487
           G  VA++ +     N T  K    E V    LL  + H+NII L              + 
Sbjct: 46  GINVAVKKLSRPFQNQTHAKRAYRELV----LLKCVNHKNIISL--------------LN 87

Query: 488 DFAPKGKLSK----YLDQEEGSSNV-------LDWSTRVSIIIGIAKGIGYLHSSEVNKP 536
            F P+  L +    YL  E   +N+       LD      ++  +  GI +LHS+     
Sbjct: 88  VFTPQKSLEEFQDVYLVMELMDANLCQVIHMELDHERMSYLLYQMLCGIKHLHSA----- 142

Query: 537 AIVHRNLSVEKVLIDQQFNPLIADCGLHKLLADDIVFSVLKTSAAMGYLAPEYVTTGRFT 596
            I+HR+L    +++       I D GL +    +  F +        Y APE +    + 
Sbjct: 143 GIIHRDLKPSNIVVKSDCTLKILDFGLARTACTN--FMMTPYVVTRYYRAPEVILGMGYK 200

Query: 597 ERSDIFAFGVIILQILTGSLVLTSS 621
           E  DI++ G I+ +++ GS++   +
Sbjct: 201 ENVDIWSVGCIMGELVKGSVIFQGT 225

Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 2 (JNK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jnk1 or Jnk2) could survive but disruption of both genes resulted in lethality. However, recent studies have shown that JNK1 and JNK2 perform distinct functions through specific binding partners and substrates. JNK2 is specifically translocated to the mitochondria during dopaminergic cell death. Specific substrates include the microtubule-associated proteins DCX and Tau, as well as TIF-IA which is involved in ribosomal RNA synthesis regulation. Mice deficient in Jnk2 show protection against arthritis, type 1 diabetes, atherosclerosis, abdominal aortic aneurysm, cardiac cell death, TNF-induced liver damage, and tumor growth, indicating that JNK2 may play roles in the pathogenesis of these diseases. Length = 359

>gnl|CDD|173721 cd05632, STKc_GRK5, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 5

 Score = 45.3 bits (107), Expect = 5e-05
 Identities = 45/153 (29%), Positives = 70/153 (45%), Gaps = 23/153 (15%)

Query: 521 IAKGIGYLHSSEVNKPAIVHRNLSVEKVLIDQQFNPLIADCGLH-KLLADDIVFSVLKTS 579
           I  G+  LH     +   V+R+L  E +L+D   +  I+D GL  K+   + +   + T 
Sbjct: 111 ILCGLEDLH-----RENTVYRDLKPENILLDDYGHIRISDLGLAVKIPEGESIRGRVGT- 164

Query: 580 AAMGYLAPEYVTTGRFTERSDIFAFGVIILQILTGSLVLTSSMRLAAESATFENFIDRNL 639
             +GY+APE +   R+T   D +  G +I +++ G     S  R   E    E    R L
Sbjct: 165 --VGYMAPEVLNNQRYTLSPDYWGLGCLIYEMIEGQ----SPFRGRKEKVKREEVDRRVL 218

Query: 640 K------GKFSESEAAKLGKMALVCTHEDPENR 666
           +       KFSE EA  + KM L    +DP+ R
Sbjct: 219 ETEEVYSAKFSE-EAKSICKMLLT---KDPKQR 247

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK5 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK5 is widely expressed in many tissues. It associates with the membrane though an N-terminal PIP2 binding domain and also binds phospholipids via its C-terminus. GRK5 deficiency is associated with early Alzheimer's disease in humans and mouse models. GRK5 also plays a crucial role in the pathogenesis of sporadic Parkinson's disease. It participates in the regulation and desensitization of PDGFRbeta, a receptor tyrosine kinase involved in a variety of downstream cellular effects including cell growth, chemotaxis, apoptosis, and angiogenesis. GRK5 also regulates Toll-like receptor 4, which is involved in innate and adaptive immunity. Length = 285

>gnl|CDD|173686 cd05595, STKc_PKB_beta, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B beta

 Score = 45.8 bits (108), Expect = 5e-05
 Identities = 57/208 (27%), Positives = 95/208 (45%), Gaps = 23/208 (11%)

Query: 416 LLGKGNFSSVY----KGTLRDGTLVAIRSINVTSCKSEEAEFVKGLYLLTSLRHENIIRL 471
           LLGKG F  V     K T R   +  +R   V   K E A  V    +L + RH  +  L
Sbjct: 2   LLGKGTFGKVILVREKATGRYYAMKILRK-EVIIAKDEVAHTVTESRVLQNTRHPFLTAL 60

Query: 472 RGFCCSRGRGECFLIYDFAPKGKLSKYLDQEEGSSNVLDWSTRVSIIIG--IAKGIGYLH 529
           +    +  R  CF++ ++A  G+L  +L +E        ++   +   G  I   + YLH
Sbjct: 61  KYAFQTHDR-LCFVM-EYANGGELFFHLSRERV------FTEERARFYGAEIVSALEYLH 112

Query: 530 SSEVNKPAIVHRNLSVEKVLIDQQFNPLIADCGLHKLLADDIVFSVLKT-SAAMGYLAPE 588
           S +V     V+R++ +E +++D+  +  I D GL K    D   + +KT      YLAPE
Sbjct: 113 SRDV-----VYRDIKLENLMLDKDGHIKITDFGLCKEGISD--GATMKTFCGTPEYLAPE 165

Query: 589 YVTTGRFTERSDIFAFGVIILQILTGSL 616
            +    +    D +  GV++ +++ G L
Sbjct: 166 VLEDNDYGRAVDWWGLGVVMYEMMCGRL 193

Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, beta (or Akt2) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-beta is the predominant PKB isoform expressed in insulin-responsive tissues. It plays a critical role in the regulation of glucose homeostasis. It is also implicated in muscle cell differentiation. Mice deficient in PKB-beta display normal growth weights but exhibit severe insulin resistance and diabetes, accompanied by lipoatrophy and B-cell failure. Length = 323

>gnl|CDD|173684 cd05593, STKc_PKB_gamma, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B gamma

 Score = 45.5 bits (107), Expect = 5e-05
 Identities = 57/207 (27%), Positives = 97/207 (46%), Gaps = 21/207 (10%)

Query: 416 LLGKGNFSSVYKGTLRD---GTLVAIRSIN--VTSCKSEEAEFVKGLYLLTSLRHENIIR 470
           LLGKG F  V    +R+   G   A++ +   V   K E A  +    +L + RH  +  
Sbjct: 2   LLGKGTFGKVI--LVREKASGKYYAMKILKKEVIIAKDEVAHTLTESRVLKNTRHPFLTS 59

Query: 471 LRGFCCSRGRGECFLIYDFAPKGKLSKYLDQEEGSSNVLDWSTRVSIIIGIAKGIGYLHS 530
           L+    ++ R  CF++ ++   G+L  +L +E   S   +  TR      I   + YLHS
Sbjct: 60  LKYSFQTKDR-LCFVM-EYVNGGELFFHLSRERVFS---EDRTRF-YGAEIVSALDYLHS 113

Query: 531 SEVNKPAIVHRNLSVEKVLIDQQFNPLIADCGLHKLLADDIVFSVLKT-SAAMGYLAPEY 589
            +     IV+R+L +E +++D+  +  I D GL K    D   + +KT      YLAPE 
Sbjct: 114 GK-----IVYRDLKLENLMLDKDGHIKITDFGLCKEGITDA--ATMKTFCGTPEYLAPEV 166

Query: 590 VTTGRFTERSDIFAFGVIILQILTGSL 616
           +    +    D +  GV++ +++ G L
Sbjct: 167 LEDNDYGRAVDWWGLGVVMYEMMCGRL 193

Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, gamma (or Akt3) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-gamma is predominantly expressed in neuronal tissues. Mice deficient in PKB-gamma show a reduction in brain weight due to the decreases in cell size and cell number. PKB-gamma has also been shown to be upregulated in estrogen-deficient breast cancer cells, androgen-independent prostate cancer cells, and primary ovarian tumors. It acts as a key mediator in the genesis of ovarian cancer. Length = 328

>gnl|CDD|173678 cd05587, STKc_cPKC, Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C

 Score = 45.2 bits (107), Expect = 8e-05
 Identities = 30/97 (30%), Positives = 53/97 (54%), Gaps = 12/97 (12%)

Query: 521 IAKGIGYLHSSEVNKPAIVHRNLSVEKVLIDQQFNPLIADCGLHKLLADDIVFSVLKTSA 580
           IA G+ +LHS       I++R+L ++ V++D + +  IAD G+ K    + +F    T  
Sbjct: 110 IAIGLFFLHSK-----GIIYRDLKLDNVMLDAEGHIKIADFGMCK----ENIFGGKTTRT 160

Query: 581 AMG---YLAPEYVTTGRFTERSDIFAFGVIILQILTG 614
             G   Y+APE +    + +  D +AFGV++ ++L G
Sbjct: 161 FCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAG 197

Serine/Threonine Kinases (STKs), Classical (or Conventional) Protein Kinase C (cPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. cPKCs contain a calcium-binding C2 region in their regulatory domain. There are four cPKC isoforms, named alpha, betaI, betaII, and gamma. cPKCs are potent kinases for histones, myelin basic protein, and protamine. PKC-gamma is mainly expressed in neuronal tissues. It plays a role in protection from ischemia. Length = 324

>gnl|CDD|143361 cd07856, STKc_Sty1_Hog1, Catalytic domain of the Serine/Threonine Kinases, Fungal Mitogen-Activated Protein Kinases Sty1 and Hog1

 Score = 45.2 bits (107), Expect = 8e-05
 Identities = 54/211 (25%), Positives = 89/211 (42%), Gaps = 21/211 (9%)

Query: 408 TQCFSEVNLLGKGNFSSV--YKGTLRDGTLVAIRSI-NVTSCKSEEAEFVKGLYLLTSLR 464
           T  + ++  +G G F  V   +  L  G  VAI+ I    S         + L LL  LR
Sbjct: 9   TNRYVDLQPVGMGAFGLVCSARDQLT-GQNVAIKKIMKPFSTPVLAKRTYRELKLLKHLR 67

Query: 465 HENIIRLRGFCCSRGRGECFLIYDFAPKGKLSKYLDQEEGSSNVLDWSTRVSIIIGIAKG 524
           HENII L     S    + + + +      L + L         + +      +  I +G
Sbjct: 68  HENIISLSDIFISP-LEDIYFVTELLGT-DLHRLLTSRPLEKQFIQY-----FLYQILRG 120

Query: 525 IGYLHSSEVNKPAIVHRNLSVEKVLIDQQFNPLIADCGLHKLLADDIVFSVLKTSAAMGY 584
           + Y+HS+ V     VHR+L    +LI++  +  I D GL ++    +   V    +   Y
Sbjct: 121 LKYVHSAGV-----VHRDLKPSNILINENCDLKICDFGLARIQDPQMTGYV----STRYY 171

Query: 585 LAPEYVTT-GRFTERSDIFAFGVIILQILTG 614
            APE + T  ++    DI++ G I  ++L G
Sbjct: 172 RAPEIMLTWQKYDVEVDIWSAGCIFAEMLEG 202

Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) Sty1/Hog1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sty1/Hog1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs Sty1 from Schizosaccharomyces pombe, Hog1 from Saccharomyces cerevisiae, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. Sty1 and Hog1 are stress-activated MAPKs that partipate in transcriptional regulation in response to stress. Sty1 is activated in response to oxidative stress, osmotic stress, and UV radiation. Sty1 is regulated by the MAP2K Wis1, which is activated by the MAP3Ks Wis4 and Win1, which receive signals of the stress condition from membrane-spanning histidine kinases Mak1-3. Activated Sty1 stabilizes the Atf1 transcription factor and induces transcription of Atf1-dependent genes of the core environmetal stress response (CESR). Hog1 is the key element in the high osmolarity glycerol (HOG) pathway and is activated upon hyperosmotic stress. Activated Hog1 accumulates in the nucleus and regulates stress-induced transcription. The HOG pathway is mediated by two transmembrane osmosensors, Sln1 and Sho1. Length = 328

>gnl|CDD|183880 PRK13184, pknD, serine/threonine-protein kinase; Reviewed

 Score = 45.5 bits (108), Expect = 8e-05
 Identities = 39/136 (28%), Positives = 59/136 (43%), Gaps = 28/136 (20%)

Query: 495 LSKYLDQEEGSSNVLDWSTRVSIIIGIAKGIGYLHSSEVNKPAIVHRNLSVEKVLIDQQF 554
           LSK  +  E +S        +SI   I   I Y+HS       ++HR+L  + +L+    
Sbjct: 102 LSK--ELAEKTS----VGAFLSIFHKICATIEYVHSK-----GVLHRDLKPDNILLGLFG 150

Query: 555 NPLIADCGLHK--------LLADD-----IVFSVL----KTSAAMGYLAPEYVTTGRFTE 597
             +I D G           LL  D     I +S +    K      Y+APE +     +E
Sbjct: 151 EVVILDWGAAIFKKLEEEDLLDIDVDERNICYSSMTIPGKIVGTPDYMAPERLLGVPASE 210

Query: 598 RSDIFAFGVIILQILT 613
            +DI+A GVI+ Q+LT
Sbjct: 211 STDIYALGVILYQMLT 226

Length = 932

>gnl|CDD|173698 cd05607, STKc_GRK7, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 7

 Score = 44.6 bits (105), Expect = 8e-05
 Identities = 31/94 (32%), Positives = 50/94 (53%), Gaps = 7/94 (7%)

Query: 521 IAKGIGYLHSSEVNKPAIVHRNLSVEKVLIDQQFNPLIADCGLHKLLADDIVFSVLKTSA 580
           I  GI +LHS +     IV+R++  E VL+D Q N  ++D GL   L D    ++ + + 
Sbjct: 104 ITCGILHLHSMD-----IVYRDMKPENVLLDDQGNCRLSDLGLAVELKDGK--TITQRAG 156

Query: 581 AMGYLAPEYVTTGRFTERSDIFAFGVIILQILTG 614
             GY+APE +    ++   D FA G  I +++ G
Sbjct: 157 TNGYMAPEILKEEPYSYPVDWFAMGCSIYEMVAG 190

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK7 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK7, also called iodopsin kinase, belongs to the visual group of GRKs. It is primarily found in the retina and plays a role in the regulation of opsin light receptors. GRK7 is located in retinal cone outer segments and plays an important role in regulating photoresponse of the cones. Length = 277

>gnl|CDD|173663 cd05572, STKc_cGK_PKG, Catalytic domain of the Protein Serine/Threonine Kinase, cGMP-dependent protein kinase

 Score = 44.1 bits (105), Expect = 1e-04
 Identities = 46/213 (21%), Positives = 85/213 (39%), Gaps = 26/213 (12%)

Query: 417 LGKGNFSSVYKGTL-RDGTLVAIRSIN---VTSCKSEEAEFVKGLYLLTSLRHENIIRL- 471
           LG G F  V    +       A++ +    +     +E  F +   +L    H  I++L 
Sbjct: 1   LGVGGFGRVELVKVKSKNRTFALKCVKKRHIVETGQQEHIFSEKE-ILEECNHPFIVKLY 59

Query: 472 RGFCCSRGRGECFLIYDFAPKGKLSKYLDQEEGSSNVLDWSTRVSIIIGIAKGIGYLHSS 531
           R F   + +   +++ ++   G+L   L ++ G     D  T    I  +     YLH+ 
Sbjct: 60  RTF---KDKKYIYMLMEYCLGGELWTIL-RDRGL---FDEYTARFYIACVVLAFEYLHNR 112

Query: 532 EVNKPAIVHRNLSVEKVLIDQQFNPLIADCGLHKLLADDIVFSVLKTSAAMG---YLAPE 588
                 I++R+L  E +L+D      + D G  K      + S  KT    G   Y+APE
Sbjct: 113 G-----IIYRDLKPENLLLDSNGYVKLVDFGFAK-----KLKSGQKTWTFCGTPEYVAPE 162

Query: 589 YVTTGRFTERSDIFAFGVIILQILTGSLVLTSS 621
            +    +    D ++ G+++ ++LTG       
Sbjct: 163 IILNKGYDFSVDYWSLGILLYELLTGRPPFGED 195

Serine/Threonine Kinases (STKs), cGMP-dependent protein kinase (cGK or PKG) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mammals have two cGK isoforms from different genes, cGKI and cGKII. cGKI exists as two splice variants, cGKI-alpha and cGKI-beta. cGK consists of an N-terminal regulatory domain containing a dimerization and an autoinhibitory pseudosubstrate region, two cGMP-binding domains, and a C-terminal catalytic domain. Binding of cGMP to both binding sites releases the inhibition of the catalytic center by the pseudosubstrate region, allowing autophosphorylation and activation of the kinase. cGKI is a soluble protein expressed in all smooth muscles, platelets, cerebellum, and kidney. It is also expressed at lower concentrations in other tissues. cGKII is a membrane-bound protein that is most abundantly expressed in the intestine. It is also present in the brain nuclei, adrenal cortex, kidney, lung, and prostate. cGKI is involved in the regulation of smooth muscle tone, smooth cell proliferation, and platelet activation. cGKII plays a role in the regulation of secretion, such as renin secretion by the kidney and aldosterone secretion by the adrenal. It also regulates bone growth and the circadian rhythm. Length = 262

>gnl|CDD|132980 cd06649, PKc_MEK2, Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 2

 Score = 44.7 bits (105), Expect = 1e-04
 Identities = 45/213 (21%), Positives = 93/213 (43%), Gaps = 30/213 (14%)

Query: 411 FSEVNLLGKGNFSSVYKGTLRDGTLVAIRS-INVTSCKSEEAEFVKGLYLLTSLRHENII 469
           F  ++ LG GN   V K   +   L+  R  I++    +   + ++ L +L       I+
Sbjct: 7   FERISELGAGNGGVVTKVQHKPSGLIMARKLIHLEIKPAIRNQIIRELQVLHECNSPYIV 66

Query: 470 RLRGFCCSRGRGECFLIYDFAPKGKLSKYLDQEEGSS--NVLDWSTRV------SIIIGI 521
              G               F   G++S  ++  +G S   VL  + R+       + I +
Sbjct: 67  GFYG--------------AFYSDGEISICMEHMDGGSLDQVLKEAKRIPEEILGKVSIAV 112

Query: 522 AKGIGYLHSSEVNKPAIVHRNLSVEKVLIDQQFNPLIADCGLHKLLADDIVFSVLKTSAA 581
            +G+ YL      K  I+HR++    +L++ +    + D G+   L D +  S + T + 
Sbjct: 113 LRGLAYLRE----KHQIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDSMANSFVGTRS- 167

Query: 582 MGYLAPEYVTTGRFTERSDIFAFGVIILQILTG 614
             Y++PE +    ++ +SDI++ G+ ++++  G
Sbjct: 168 --YMSPERLQGTHYSVQSDIWSMGLSLVELAIG 198

Protein kinases (PKs), MAP/ERK Kinase (MEK) 2 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK2 is a dual-specificity PK that phosphorylates and activates the downstream targets, extracellular signal-regulated kinase (ERK) 1 and ERK2, on specific threonine and tyrosine residues. The ERK cascade starts with extracellular signals including growth factors, hormones, and neurotransmitters, which act through receptors and ion channels to initiate intracellular signaling that leads to the activation at the MAPKKK (Raf-1 or MOS) level, which leads to the transmission of signals to MEK2, and finally to ERK1/2. The ERK cascade plays an important role in cell proliferation, differentiation, oncogenic transformation, and cell cycle control, as well as in apoptosis and cell survival under certain conditions. Gain-of-function mutations in genes encoding ERK cascade proteins, including MEK2, cause cardiofaciocutaneous (CFC) syndrome, a condition leading to multiple congenital anomalies and mental retardation in patients. Length = 331

>gnl|CDD|132981 cd06650, PKc_MEK1, Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 1

 Score = 44.6 bits (105), Expect = 1e-04
 Identities = 46/213 (21%), Positives = 96/213 (45%), Gaps = 30/213 (14%)

Query: 411 FSEVNLLGKGNFSSVYKGTLRDGTLVAIRS-INVTSCKSEEAEFVKGLYLLTSLRHENII 469
           F +++ LG GN   V+K + +   L+  R  I++    +   + ++ L +L       I+
Sbjct: 7   FEKISELGAGNGGVVFKVSHKPSGLIMARKLIHLEIKPAIRNQIIRELQVLHECNSPYIV 66

Query: 470 RLRGFCCSRGRGECFLIYDFAPKGKLSKYLDQEEGSS--NVLDWSTRV------SIIIGI 521
              G               F   G++S  ++  +G S   VL  + R+       + I +
Sbjct: 67  GFYG--------------AFYSDGEISICMEHMDGGSLDQVLKKAGRIPEQILGKVSIAV 112

Query: 522 AKGIGYLHSSEVNKPAIVHRNLSVEKVLIDQQFNPLIADCGLHKLLADDIVFSVLKTSAA 581
            KG+ YL      K  I+HR++    +L++ +    + D G+   L D +  S + T + 
Sbjct: 113 IKGLTYLRE----KHKIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDSMANSFVGTRS- 167

Query: 582 MGYLAPEYVTTGRFTERSDIFAFGVIILQILTG 614
             Y++PE +    ++ +SDI++ G+ ++++  G
Sbjct: 168 --YMSPERLQGTHYSVQSDIWSMGLSLVEMAIG 198

Protein kinases (PKs), MAP/ERK kinase (MEK) 1 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 is a dual-specificity PK that phosphorylates and activates the downstream targets, extracellular signal-regulated kinase (ERK) 1 and ERK2, on specific threonine and tyrosine residues. The ERK cascade starts with extracellular signals including growth factors, hormones, and neurotransmitters, which act through receptors and ion channels to initiate intracellular signaling that leads to the activation at the MAPKKK (Raf-1 or MOS) level, which leads to the transmission of signals to MEK1, and finally to ERK1/2. The ERK cascade plays an important role in cell proliferation, differentiation, oncogenic transformation, and cell cycle control, as well as in apoptosis and cell survival under certain conditions. Gain-of-function mutations in genes encoding ERK cascade proteins, including MEK1, cause cardiofaciocutaneous (CFC) syndrome, a condition leading to multiple congenital anomalies and mental retardation in patients. MEK1 also plays a role in cell cycle control. Length = 333

>gnl|CDD|143368 cd07863, STKc_CDK4, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 4

 Score = 44.2 bits (104), Expect = 1e-04
 Identities = 51/212 (24%), Positives = 97/212 (45%), Gaps = 22/212 (10%)

Query: 411 FSEVNLLGKGNFSSVYKGTLRD-GTLVAIRSINVTSCKSEEA---EFVKGLYLLTSLR-- 464
           +  V  +G G + +VYK      G  VA++S+ V +  +E+      V+ + LL  L   
Sbjct: 2   YEPVAEIGVGAYGTVYKARDPHSGHFVALKSVRVQT--NEDGLPLSTVREVALLKRLEAF 59

Query: 465 -HENIIRLRGFCCS-RGRGE--CFLIYDFAPKGKLSKYLDQEEGSSNVLDWSTRVSIIIG 520
            H NI+RL   C + R   E    L+++   +  L  YLD+        +  T   ++  
Sbjct: 60  DHPNIVRLMDVCATSRTDRETKVTLVFEHVDQ-DLRTYLDKVPPPGLPAE--TIKDLMRQ 116

Query: 521 IAKGIGYLHSSEVNKPAIVHRNLSVEKVLIDQQFNPLIADCGLHKLLADDIVFSVLKTSA 580
             +G+ +LH++      IVHR+L  E +L+       +AD GL ++ +  +  + +  + 
Sbjct: 117 FLRGLDFLHAN-----CIVHRDLKPENILVTSGGQVKLADFGLARIYSCQMALTPVVVT- 170

Query: 581 AMGYLAPEYVTTGRFTERSDIFAFGVIILQIL 612
            + Y APE +    +    D+++ G I  ++ 
Sbjct: 171 -LWYRAPEVLLQSTYATPVDMWSVGCIFAEMF 201

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 partners with all three D-type cyclins (D1, D2, and D3) and is also regulated by INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein and plays a role in regulating the early G1 phase of the cell cycle. It is expressed ubiquitously and is localized in the nucleus. CDK4 also shows kinase activity towards Smad3, a signal transducer of transforming growth factor (TGF)-beta signaling which modulates transcription and plays a role in cell proliferation and apoptosis. CDK4 is inhibited by the p21 inhibitor and is specifically mutated in human melanoma. Length = 288

>gnl|CDD|173720 cd05631, STKc_GRK4, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 4

 Score = 44.2 bits (104), Expect = 1e-04
 Identities = 38/142 (26%), Positives = 69/142 (48%), Gaps = 18/142 (12%)

Query: 532 EVNKPAIVHRNLSVEKVLIDQQFNPLIADCGLHKLLADDIVFSVLKTSAAMGYLAPEYVT 591
           ++ +  IV+R+L  E +L+D + +  I+D GL   + +    +V      +GY+APE + 
Sbjct: 117 DLQRERIVYRDLKPENILLDDRGHIRISDLGLAVQIPEGE--TVRGRVGTVGYMAPEVIN 174

Query: 592 TGRFTERSDIFAFGVIILQILTGSLVLTSSMRLAAESATFENFIDRNLKG-------KFS 644
             ++T   D +  G +I +++ G     S  R   E    E  +DR +K        KFS
Sbjct: 175 NEKYTFSPDWWGLGCLIYEMIQGQ----SPFRKRKERVKREE-VDRRVKEDQEEYSEKFS 229

Query: 645 ESEAAKLGKMALVCTHEDPENR 666
           E +A  + +M L    ++P+ R
Sbjct: 230 E-DAKSICRMLLT---KNPKER 247

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK4 has a limited tissue distribution. It is mainly found in the testis, but is also present in the cerebellum and kidney. It is expressed as multiple splice variants with different domain architectures. It is post-translationally palmitoylated and localized in the membrane. GRK4 polymorphisms are associated with hypertension and salt sensitivity, as they cause hyperphosphorylation, desensitization, and internalization of the dopamine 1 (D1) receptor while increasing the expression of the angiotensin II type 1 receptor. GRK4 plays a crucial role in the D1 receptor regulation of sodium excretion and blood pressure. Length = 285

>gnl|CDD|132986 cd06655, STKc_PAK2, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 2

 Score = 44.3 bits (104), Expect = 1e-04
 Identities = 43/209 (20%), Positives = 97/209 (46%), Gaps = 23/209 (11%)

Query: 411 FSEVNLLGKGNFSSVYKGT-LRDGTLVAIRSINVTSCKSEEAEFVKGLYLLTSLRHENII 469
           ++    +G+G   +V+    +  G  VAI+ IN+     +E   +  + ++  L++ NI+
Sbjct: 21  YTRYEKIGQGASGTVFTAIDVATGQEVAIKQINLQKQPKKEL-IINEILVMKELKNPNIV 79

Query: 470 RLRGFCCSRGRG-ECFLIYDFAPKGKLSKYLDQEEGSSNVLDWSTRVSIIIGIAKGIGYL 528
               F  S   G E F++ ++   G L+  +     +   +D +   ++     + + +L
Sbjct: 80  ---NFLDSFLVGDELFVVMEYLAGGSLTDVV-----TETCMDEAQIAAVCRECLQALEFL 131

Query: 529 HSSEVNKPAIVHRNLSVEKVLIDQQFNPLIADCGLHKLLADDIVFSVLKTSAAMG---YL 585
           H+++V     +HR++  + VL+    +  + D G        I     K S  +G   ++
Sbjct: 132 HANQV-----IHRDIKSDNVLLGMDGSVKLTDFGF----CAQITPEQSKRSTMVGTPYWM 182

Query: 586 APEYVTTGRFTERSDIFAFGVIILQILTG 614
           APE VT   +  + DI++ G++ ++++ G
Sbjct: 183 APEVVTRKAYGPKVDIWSLGIMAIEMVEG 211

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 2, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK2 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). PAK2 plays a role in pro-apoptotic signaling. It is cleaved and activated by caspases leading to morphological changes during apoptosis. PAK2 is also activated in response to a variety of stresses including DNA damage, hyperosmolarity, serum starvation, and contact inhibition, and may play a role in coordinating the stress response. PAK2 also contributes to cancer cell invasion through a mechanism distinct from that of PAK1. Length = 296

>gnl|CDD|173707 cd05616, STKc_cPKC_beta, Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C beta

 Score = 44.2 bits (104), Expect = 1e-04
 Identities = 29/97 (29%), Positives = 54/97 (55%), Gaps = 12/97 (12%)

Query: 521 IAKGIGYLHSSEVNKPAIVHRNLSVEKVLIDQQFNPLIADCGLHKLLADDIVFSVLKTSA 580
           IA G+ +LHS       I++R+L ++ V++D + +  IAD G+ K    + ++  + T  
Sbjct: 110 IAIGLFFLHSK-----GIIYRDLKLDNVMLDSEGHIKIADFGMCK----ENMWDGVTTKT 160

Query: 581 AMG---YLAPEYVTTGRFTERSDIFAFGVIILQILTG 614
             G   Y+APE +    + +  D +AFGV++ ++L G
Sbjct: 161 FCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAG 197

Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, beta isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, and gamma. The PKC beta isoforms (I and II), generated by alternative splicing of a single gene, are preferentially activated by hyperglycemia-induced DAG in retinal tissues. This is implicated in diabetic microangiopathy such as ischemia, neovascularization, and abnormal vasodilator function. PKC-beta also plays an important role in VEGF signaling. In addition, glucose regulates proliferation in retinal endothelial cells via PKC-betaI. PKC-beta is also being explored as a therapeutic target in cancer. It contributes to tumor formation and is involved in the tumor host mechanisms of inflammation and angiogenesis. Length = 323

>gnl|CDD|215061 PLN00113, PLN00113, leucine-rich repeat receptor-like protein kinase; Provisional

 Score = 44.5 bits (105), Expect = 2e-04
 Identities = 24/67 (35%), Positives = 39/67 (58%)

Query: 68  RKVANISLQGKGLTGKLSPSLSGLKCLSGLYLHYNSLSGEIPKEIRNLTELTDLYLDVNN 127
           +K+ ++ L    L+G++  S S +  LS L L  N LSGEIPK + N+  L  + +  N+
Sbjct: 523 KKLVSLDLSHNQLSGQIPASFSEMPVLSQLDLSQNQLSGEIPKNLGNVESLVQVNISHNH 582

Query: 128 LSGNIPP 134
           L G++P 
Sbjct: 583 LHGSLPS 589

Length = 968

>gnl|CDD|173681 cd05590, STKc_nPKC_eta, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C eta

 Score = 44.1 bits (104), Expect = 2e-04
 Identities = 48/204 (23%), Positives = 91/204 (44%), Gaps = 18/204 (8%)

Query: 416 LLGKGNFSSVYKGTLR-DGTLVAIRSINV-TSCKSEEAEFVKGLYLLTSLRHENIIRLRG 473
           +LGKG+F  V    L+  G L A++ +      + ++ E       + SL   +    + 
Sbjct: 2   VLGKGSFGKVMLARLKESGRLYAVKVLKKDVILQDDDVECTMTEKRILSLARNHPFLTQL 61

Query: 474 FCCSRGRGECFLIYDFAPKGKLSKYLDQEEGSSNVLDWSTRVSIIIGIAKGIGYLHSSEV 533
           +CC +     F + +F   G L  ++ +    S   D +        I   + +LH    
Sbjct: 62  YCCFQTPDRLFFVMEFVNGGDLMFHIQK----SRRFDEARARFYAAEITSALMFLHDK-- 115

Query: 534 NKPAIVHRNLSVEKVLIDQQFNPLIADCGLHKLLADDIVFSVLKTSAAMG---YLAPEYV 590
               I++R+L ++ VL+D + +  +AD G+ K    + +F+   TS   G   Y+APE +
Sbjct: 116 ---GIIYRDLKLDNVLLDHEGHCKLADFGMCK----EGIFNGKTTSTFCGTPDYIAPEIL 168

Query: 591 TTGRFTERSDIFAFGVIILQILTG 614
               +    D +A GV++ ++L G
Sbjct: 169 QEMLYGPSVDWWAMGVLLYEMLCG 192

Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), eta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-eta is predominantly expressed in squamous epithelia, where it plays a crucial role in the signaling of cell-type specific differentiation. It is also expressed in pro-B cells and early-stage thymocytes, and acts as a key regulator in early B-cell development. PKC-eta increases glioblastoma multiforme (GBM) proliferation and resistance to radiation, and is being developed as a therapeutic target for the management of GBM. Length = 320

>gnl|CDD|133238 cd05107, PTKc_PDGFR_beta, Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor beta

 Score = 43.8 bits (103), Expect = 2e-04
 Identities = 31/109 (28%), Positives = 53/109 (48%), Gaps = 6/109 (5%)

Query: 506 SNVLDWSTRVSIIIGIAKGIGYLHSSEVNKPAIVHRNLSVEKVLIDQQFNPLIADCGLHK 565
           S  L +   V     +A G+ +L S        VHR+L+   VLI +     I D GL +
Sbjct: 233 SPALSYMDLVGFSYQVANGMEFLASKNC-----VHRDLAARNVLICEGKLVKICDFGLAR 287

Query: 566 -LLADDIVFSVLKTSAAMGYLAPEYVTTGRFTERSDIFAFGVIILQILT 613
            ++ D    S   T   + ++APE +    +T  SD+++FG+++ +I T
Sbjct: 288 DIMRDSNYISKGSTFLPLKWMAPESIFNNLYTTLSDVWSFGILLWEIFT 336

Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) beta; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR beta is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR beta forms homodimers or heterodimers with PDGFR alpha, depending on the nature of the PDGF ligand. PDGF-BB and PDGF-DD induce PDGFR beta homodimerization. PDGFR signaling plays many roles in normal embryonic development and adult physiology. PDGFR beta signaling leads to a variety of cellular effects including the stimulation of cell growth and chemotaxis, as well as the inhibition of apoptosis and GAP junctional communication. It is critical in normal angiogenesis as it is involved in the recruitment of pericytes and smooth muscle cells essential for vessel stability. Aberrant PDGFR beta expression is associated with some human cancers. The continuously-active fusion proteins of PDGFR beta with COL1A1 and TEL are associated with dermatofibrosarcoma protuberans (DFSP) and a subset of chronic myelomonocytic leukemia (CMML), respectively. Length = 401

>gnl|CDD|173719 cd05630, STKc_GRK6, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 6

 Score = 43.5 bits (102), Expect = 2e-04
 Identities = 23/83 (27%), Positives = 46/83 (55%), Gaps = 2/83 (2%)

Query: 532 EVNKPAIVHRNLSVEKVLIDQQFNPLIADCGLHKLLADDIVFSVLKTSAAMGYLAPEYVT 591
           ++++  IV+R+L  E +L+D   +  I+D GL   + +    ++      +GY+APE V 
Sbjct: 117 DLHQERIVYRDLKPENILLDDHGHIRISDLGLAVHVPEGQ--TIKGRVGTVGYMAPEVVK 174

Query: 592 TGRFTERSDIFAFGVIILQILTG 614
             R+T   D +A G ++ +++ G
Sbjct: 175 NERYTFSPDWWALGCLLYEMIAG 197

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK6 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK6 is widely expressed in many tissues. t is expressed as multiple splice variants with different domain architectures. It is post-translationally palmitoylated and localized in the membrane. GRK6 plays important roles in the regulation of dopamine, M3 muscarinic, opioid, and chemokine receptor signaling. It also plays maladaptive roles in addiction and Parkinson's disease. GRK6-deficient mice exhibit altered dopamine receptor regulation, decreased lymphocyte chemotaxis, and increased acute inflammation and neutrophil chemotaxis. Length = 285

>gnl|CDD|173683 cd05592, STKc_nPKC_theta_delta, Catalytic domain of the Protein Serine/Threonine Kinases, Novel Protein Kinase C theta and delta

 Score = 43.2 bits (102), Expect = 2e-04
 Identities = 51/206 (24%), Positives = 90/206 (43%), Gaps = 22/206 (10%)

Query: 416 LLGKGNFSSVYKGTLRDGT-LVAIRSIN---VTSCKSEEAEFVKGLYLLTSLRHENIIRL 471
           +LGKG+F  V    L+      AI+++    V      E   V+   L  +  H  +  L
Sbjct: 2   VLGKGSFGKVMLAELKGTNEFFAIKALKKDVVLEDDDVECTMVERRVLALAWEHPFLTHL 61

Query: 472 RGFCCSRGRGECFLIYDFAPKGKLSKYLDQEEGSSNVLDWSTRVSIIIGIAKGIGYLHSS 531
             FC  + +   F + ++   G L  ++      S   D +        I  G+ +LH  
Sbjct: 62  --FCTFQTKEHLFFVMEYLNGGDLMFHIQS----SGRFDEARARFYAAEIICGLQFLHKK 115

Query: 532 EVNKPAIVHRNLSVEKVLIDQQFNPLIADCGLHKLLADDIVFSVLKTSAAMG---YLAPE 588
                 I++R+L ++ VL+D+  +  IAD G+ K      +    K S   G   Y+APE
Sbjct: 116 -----GIIYRDLKLDNVLLDKDGHIKIADFGMCKEN----MNGEGKASTFCGTPDYIAPE 166

Query: 589 YVTTGRFTERSDIFAFGVIILQILTG 614
            +   ++ E  D ++FGV++ ++L G
Sbjct: 167 ILKGQKYNESVDWWSFGVLLYEMLIG 192

Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta and delta-like isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an important and non-redundant role in several aspects of T-cell biology. PKC-delta plays a role in cell cycle regulation and programmed cell death in many cell types. Length = 316

>gnl|CDD|132975 cd06644, STKc_STK10_LOK, Catalytic domain of the Protein Serine/Threonine Kinase, STK10 or Lymphocyte-oriented kinase

 Score = 43.1 bits (101), Expect = 2e-04
 Identities = 48/205 (23%), Positives = 100/205 (48%), Gaps = 26/205 (12%)

Query: 417 LGKGNFSSVYKGTLRD-GTLVAIRSINVTSCKSEEAEFVKGLYLLTSLRHENIIRLRGFC 475
           LG G F  VYK   ++ G L A + I  T  + E  +++  + +L +  H  I++L G  
Sbjct: 20  LGDGAFGKVYKAKNKETGALAAAKVIE-TKSEEELEDYMVEIEILATCNHPYIVKLLG-- 76

Query: 476 CSRGRGECFLIYDFAPKGKL-SKYLDQEEGSSNVLDWSTRVSIIIGIAKGIGYLHSSEVN 534
                G+ +++ +F P G + +  L+ + G   + +   +V I   + + + YLHS +  
Sbjct: 77  AFYWDGKLWIMIEFCPGGAVDAIMLELDRG---LTEPQIQV-ICRQMLEALQYLHSMK-- 130

Query: 535 KPAIVHRNLSVEKVLIDQQFNPLIADCGLHKLLADDIVFSVLKTSAAMG---YLAPEYVT 591
              I+HR+L    VL+    +  +AD G    ++   V ++ +  + +G   ++APE V 
Sbjct: 131 ---IIHRDLKAGNVLLTLDGDIKLADFG----VSAKNVKTLQRRDSFIGTPYWMAPEVVM 183

Query: 592 TGRFTE-----RSDIFAFGVIILQI 611
                +     ++DI++ G+ ++++
Sbjct: 184 CETMKDTPYDYKADIWSLGITLIEM 208

Serine/threonine kinases (STKs), STK10 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Other names for STK10 include lymphocyte-oriented kinase (LOK) and Xenopus polo-like kinase kinase 1 (xPlkk1). STK10 is highly expressed in lymphocytes and is responsible in regulating leukocyte function associated antigen (LFA-1)-mediated lymphocyte adhesion. It plays a role in regulating the CD28 responsive element in T cells, and may also function as a regulator of polo-like kinase 1 (Plk1), a protein which is overexpressed in multiple tumor types. Length = 292

>gnl|CDD|143385 cd07880, STKc_p38gamma_MAPK12, Catalytic domain of the Serine/Threonine Kinase, p38gamma Mitogen-Activated Protein Kinase

 Score = 43.4 bits (102), Expect = 3e-04
 Identities = 51/215 (23%), Positives = 97/215 (45%), Gaps = 30/215 (13%)

Query: 411 FSEVNLLGKGNFSSV-YKGTLRDGTLVAIRSINVTSCKSEEAE-FVKGLY----LLTSLR 464
           + ++  +G G + +V      R G  VAI+ +     +  ++E F K  Y    LL  ++
Sbjct: 17  YRDLKQVGSGAYGTVCSALDRRTGAKVAIKKLY----RPFQSELFAKRAYRELRLLKHMK 72

Query: 465 HENIIRLRGFCCSRGRGECF----LIYDFAPKGKLSKYLDQEEGSSNVLDWSTRVSIIIG 520
           HEN+I L          + F    L+  F     L K +  E+ S + + +     ++  
Sbjct: 73  HENVIGLLDVFTPDLSLDRFHDFYLVMPFMGT-DLGKLMKHEKLSEDRIQF-----LVYQ 126

Query: 521 IAKGIGYLHSSEVNKPAIVHRNLSVEKVLIDQQFNPLIADCGLHKLLADDIVFSVLKTSA 580
           + KG+ Y+H++      I+HR+L    + +++     I D GL +    ++   V+    
Sbjct: 127 MLKGLKYIHAA-----GIIHRDLKPGNLAVNEDCELKILDFGLARQTDSEMTGYVV---- 177

Query: 581 AMGYLAPEYVTTG-RFTERSDIFAFGVIILQILTG 614
              Y APE +     +T+  DI++ G I+ ++LTG
Sbjct: 178 TRWYRAPEVILNWMHYTQTVDIWSVGCIMAEMLTG 212

Serine/Threonine Kinases (STKs), p38gamma subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38gamma subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38gamma, also called MAPK12, is predominantly expressed in skeletal muscle. Unlike p38alpha and p38beta, p38gamma is insensitive to pyridinylimidazoles. It displays an antagonizing function compared to p38alpha. p38gamma inhibits, while p38alpha stimulates, c-Jun phosphorylation and AP-1 mediated transcription. p38gamma also plays a role in the signaling between Ras and the estrogen receptor and has been implicated to increase cell invasion and breast cancer progression. In Xenopus, p38gamma is critical in the meiotic maturation of oocytes. Length = 343

>gnl|CDD|173754 cd07865, STKc_CDK9, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 9

 Score = 43.1 bits (102), Expect = 3e-04
 Identities = 39/162 (24%), Positives = 77/162 (47%), Gaps = 25/162 (15%)

Query: 414 VNLLGKGNFSSVYKGTLR-DGTLVAIRSINVTSCKSEEAEF----VKGLYLLTSLRHENI 468
           +  +G+G F  V+K   +    +VA++ + +   ++E+  F    ++ + +L  L+HEN+
Sbjct: 17  LAKIGQGTFGEVFKARHKKTKQIVALKKVLM---ENEKEGFPITALREIKILQLLKHENV 73

Query: 469 IRLRGFC------CSRGRGECFLIYDFAPKGKLSKYLDQEEGSSNV-LDWSTRVSIIIGI 521
           + L   C       +R +G  +L+++F     L+  L       NV    S    ++  +
Sbjct: 74  VNLIEICRTKATPYNRYKGSFYLVFEFCEH-DLAGLLSN----KNVKFTLSEIKKVMKML 128

Query: 522 AKGIGYLHSSEVNKPAIVHRNLSVEKVLIDQQFNPLIADCGL 563
             G+ Y+H    NK  I+HR++    +LI +     +AD GL
Sbjct: 129 LNGLYYIHR---NK--ILHRDMKAANILITKDGILKLADFGL 165

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK9 together with a cyclin partner (cyclin T1, T2a, T2b, or K) is the main component of distinct positive transcription elongation factors (P-TEFb), which function as Ser2 C-terminal domain kinases of RNA polymerase II. P-TEFb participates in multiple steps of gene expression including transcription elongation, mRNA synthesis, processing, export, and translation. It also plays a role in mediating cytokine induced transcription networks such as IL6-induced STAT3 signaling. In addition, the CDK9/cyclin T2a complex promotes muscle differentiation and enhances the function of some myogenic regulatory factors. Length = 310

>gnl|CDD|173666 cd05575, STKc_SGK, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase

 Score = 43.2 bits (102), Expect = 3e-04
 Identities = 53/207 (25%), Positives = 93/207 (44%), Gaps = 26/207 (12%)

Query: 417 LGKGNFSSVYKGTLR-DGTLVAIRSINVTSC-KSEEAEFVKGL--YLLTSLRHENIIRLR 472
           +GKG+F  V     + DG   A++ +   +  K +E + +      LL +++H  ++ L 
Sbjct: 3   IGKGSFGKVLLAKHKADGKFYAVKVLQKKAILKKKEQKHIMAERNVLLKNVKHPFLVGLH 62

Query: 473 -GFCCSRGRGECFLIYDFAPKGKLSKYLDQEEGSSNVLDWSTRVSIIIG-IAKGIGYLHS 530
             F   +   + + + D+   G+L  +L +E           R       IA  +GYLHS
Sbjct: 63  YSF---QTADKLYFVLDYVNGGELFFHLQRERSFPEP-----RARFYAAEIASALGYLHS 114

Query: 531 SEVNKPAIVHRNLSVEKVLIDQQFNPLIADCGLHKLLADDIVFSVLKTSAAMG---YLAP 587
                  I++R+L  E +L+D Q + ++ D GL K   + I  S   TS   G   YLAP
Sbjct: 115 LN-----IIYRDLKPENILLDSQGHVVLTDFGLCK---EGIEHSK-TTSTFCGTPEYLAP 165

Query: 588 EYVTTGRFTERSDIFAFGVIILQILTG 614
           E +    +    D +  G ++ ++L G
Sbjct: 166 EVLRKQPYDRTVDWWCLGAVLYEMLYG 192

Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGKs are activated by insulin and growth factors via phosphoinositide 3-kinase and PDK1. They activate ion channels, ion carriers, and the Na-K-ATPase, as well as regulate the activity of enzymes and transcription factors. SGKs play important roles in transport, hormone release, neuroexcitability, cell proliferation, and apoptosis. Length = 323

>gnl|CDD|132953 cd06622, PKc_MAPKK_PBS2_like, Catalytic domain of fungal PBS2-like dual-specificity MAP kinase kinases

 Score = 42.9 bits (101), Expect = 3e-04
 Identities = 66/270 (24%), Positives = 118/270 (43%), Gaps = 29/270 (10%)

Query: 417 LGKGNFSSVYKGTLR-DGTLVAIRSINVTSCKSEEAEFVKGLYLLTSLRHENIIRLRG-F 474
           LGKGN+ SVYK   R  G  +A++ I +   +S+  + +  L +L       I+   G F
Sbjct: 9   LGKGNYGSVYKVLHRPTGVTMAMKEIRLELDESKFNQIIMELDILHKAVSPYIVDFYGAF 68

Query: 475 CCSRGRGECFLIYDFAPKGKLSKYLDQEEGSSNVLDWSTRVSIIIGIAKGIGYLHSSEVN 534
                 G  ++  ++   G L K L     ++  +       I   + KG+ +L   E N
Sbjct: 69  FI---EGAVYMCMEYMDAGSLDK-LYAGGVATEGIPEDVLRRITYAVVKGLKFL-KEEHN 123

Query: 535 KPAIVHRNLSVEKVLIDQQFNPLIADCGLHKLLADDIVFSVLKTS-AAMGYLAPEYVTTG 593
              I+HR++    VL++      + D G    ++ ++V S+ KT+     Y+APE + +G
Sbjct: 124 ---IIHRDVKPTNVLVNGNGQVKLCDFG----VSGNLVASLAKTNIGCQSYMAPERIKSG 176

Query: 594 ------RFTERSDIFAFGVIILQILTGSLVL---TSSMRLAAESATFENFIDRNLKGKFS 644
                  +T +SD+++ G+ IL++  G       T +   A  SA  +      L   +S
Sbjct: 177 GPNQNPTYTVQSDVWSLGLSILEMALGRYPYPPETYANIFAQLSAIVDGDPPT-LPSGYS 235

Query: 645 ESEAAKLGKMALVCTHEDPENRPTMEAVIE 674
             +A         C ++ P  RPT   ++E
Sbjct: 236 -DDAQDFVAK---CLNKIPNRRPTYAQLLE 261

Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal PBS2-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include the MAPKKs Polymyxin B resistance protein 2 (PBS2) from Saccharomyces cerevisiae, Wis1 from Schizosaccharomyces pombe, and related proteins. PBS2 and Wis1 are components of stress-activated MAPK cascades in budding and fission yeast, respectively. PBS2 is the specific activator of the MAPK Hog1, which plays a central role in the response of budding yeast to stress including exposure to arsenite and hyperosmotic environments. Wis1 phosphorylates and activates the MAPK Sty1 (also called Spc1 or Phh1), which stimulates a transcriptional response to a wide range of cellular insults through the bZip transcription factors Atf1, Pcr1, and Pap1. Length = 286

>gnl|CDD|173693 cd05602, STKc_SGK1, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 1

 Score = 43.1 bits (101), Expect = 3e-04
 Identities = 39/133 (29%), Positives = 66/133 (49%), Gaps = 16/133 (12%)

Query: 521 IAKGIGYLHSSEVNKPAIVHRNLSVEKVLIDQQFNPLIADCGLHKLLADDIVFSVLKTSA 580
           IA  +GYLHS       IV+R+L  E +L+D Q + ++ D GL K    + +     TS 
Sbjct: 105 IASALGYLHSLN-----IVYRDLKPENILLDSQGHIVLTDFGLCK----ENIEHNGTTST 155

Query: 581 AMG---YLAPEYVTTGRFTERSDIFAFGVIILQILTGSLVLTSSMRLAAESATFENFIDR 637
             G   YLAPE +    +    D +  G ++ ++L G     S  R  AE   ++N +++
Sbjct: 156 FCGTPEYLAPEVLHKQPYDRTVDWWCLGAVLYEMLYGLPPFYS--RNTAE--MYDNILNK 211

Query: 638 NLKGKFSESEAAK 650
            L+ K + + +A+
Sbjct: 212 PLQLKPNITNSAR 224

Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK1 is ubiquitously expressed and is under transcriptional control of numerous stimuli including cell stress (cell shrinkage), serum, hormones (gluco- and mineralocorticoids), gonadotropins, growth factors, interleukin-6, and other cytokines. It plays roles in sodium retention and potassium elimination in the kidney, nutrient transport, salt sensitivity, memory consolidation, and cardiac repolarization. A common SGK1 variant is associated with increased blood pressure and body weight. SGK1 may also contribute to tumor growth, neurodegeneration, fibrosing disease, and ischemia. Length = 325

>gnl|CDD|238064 cd00116, LRR_RI, Leucine-rich repeats (LRRs), ribonuclease inhibitor (RI)-like subfamily

 Score = 42.7 bits (101), Expect = 3e-04
 Identities = 51/182 (28%), Positives = 71/182 (39%), Gaps = 23/182 (12%)

Query: 66  EHRKVANISLQGKGLTGKLSPSLSGLKC-LSGLYLHYNSLSGE----IPKEIRNLTELTD 120
           +  K+ N  L G      L+  L  L   L  L L  N L G     + K +R   +L +
Sbjct: 111 QELKLNNNGL-GDRGLRLLAKGLKDLPPALEKLVLGRNRLEGASCEALAKALRANRDLKE 169

Query: 121 LYLDVNNLSGN----IPPEIGSMASLQVLQLCCNQLT----GNIPAQIGSLKSLSVLTLQ 172
           L L  N +       +   + +  +L+VL L  N LT      +   + SLKSL VL L 
Sbjct: 170 LNLANNGIGDAGIRALAEGLKANCNLEVLDLNNNGLTDEGASALAETLASLKSLEVLNLG 229

Query: 173 HNRL-NGGI----PDSLGNLGKLKRLDLSFNSL----FGTIPESLANNAELLFLDVQNNT 223
            N L + G        L     L  L LS N +       + E LA    LL LD++ N 
Sbjct: 230 DNNLTDAGAAALASALLSPNISLLTLSLSCNDITDDGAKDLAEVLAEKESLLELDLRGNK 289

Query: 224 LS 225
             
Sbjct: 290 FG 291

LRRs are 20-29 residue sequence motifs present in many proteins that participate in protein-protein interactions and have different functions and cellular locations. LRRs correspond to structural units consisting of a beta strand (LxxLxLxxN/CxL conserved pattern) and an alpha helix. This alignment contains 12 strands corresponding to 11 full repeats, consistent with the extent observed in the subfamily acting as Ran GTPase Activating Proteins (RanGAP1). Length = 319

>gnl|CDD|173627 cd05037, PTK_Jak_rpt1, Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases

 Score = 42.5 bits (100), Expect = 4e-04
 Identities = 62/280 (22%), Positives = 130/280 (46%), Gaps = 42/280 (15%)

Query: 417 LGKGNFSSVYKGTLRDGTLVAIRS----INVT-----SCKSEEAEFVKGLYLLTSLRHEN 467
           LG+G F+++YKG LR  + + I      ++V      S   +   F +   L++ L H++
Sbjct: 3   LGQGTFTNIYKGVLRVQSDLDIVGPGQEVSVVLKVLGSDHRDSLAFFETASLMSQLSHKH 62

Query: 468 IIRLRGFCCSRGRGECFLIYDFAPKGKLSKYLDQEEGSSNVLDWSTRVSIIIGIAKGIGY 527
           +++L G C    R E  ++ ++   G L  +L +E+ + ++  W  ++ +   +A  + Y
Sbjct: 63  LVKLYGVCV---RDENIMVEEYVKFGPLDVFLHREKNNVSLH-W--KLDVAKQLASALHY 116

Query: 528 LHSSEVNKPAIVH-----RNLSVEKVLIDQQFNPLIADCGLHKLLADDIVFSVLKTSAAM 582
           L   E  K  +VH     +N+ V +  +++ + P I      KL    I  +VL     +
Sbjct: 117 L---EDKK--LVHGNVCGKNILVARYGLNEGYVPFI------KLSDPGIPITVLSREERV 165

Query: 583 G---YLAPEYVTTGR--FTERSDIFAFGVIILQILTGSLVLTSSMRLAAESATFENFIDR 637
               ++APE +  G+   T  +D ++FG  +L+I +      S++  + +   +++    
Sbjct: 166 ERIPWIAPECIRNGQASLTIAADKWSFGTTLLEICSNGEEPLSTLSSSEKERFYQD---- 221

Query: 638 NLKGKFSESEAAKLGKMALVCTHEDPENRPTMEAVIEELT 677
             + +    + A+L  +   C   DP  RP+  A++ +L 
Sbjct: 222 --QHRLPMPDCAELANLINQCWTYDPTKRPSFRAILRDLN 259

Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; pseudokinase domain (repeat1). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic domain. Most Jaks are expressed in a wide variety of tissues, except for Jak3, which is expressed only in hematopoietic cells. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jaks are also involved in regulating the surface expression of some cytokine receptors. The Jak-STAT pathway is involved in many biological processes including hematopoiesis, immunoregulation, host defense, fertility, lactation, growth, and embryogenesis. Length = 259

>gnl|CDD|173685 cd05594, STKc_PKB_alpha, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B alpha

 Score = 42.7 bits (100), Expect = 5e-04
 Identities = 56/208 (26%), Positives = 95/208 (45%), Gaps = 22/208 (10%)

Query: 416 LLGKGNFSSVY----KGTLRDGTLVAIRSINVTSCKSEEAEFVKGLYLLTSLRHENIIRL 471
           LLGKG F  V     K T R   +  ++   V   K E A  +    +L + RH  +  L
Sbjct: 2   LLGKGTFGKVILVKEKATGRYYAMKILKK-EVIVAKDEVAHTLTENRVLQNSRHPFLTAL 60

Query: 472 RGFCCSRGRGECFLIYDFAPKGKLSKYLDQEEGSSNVLDWSTRVSIIIG--IAKGIGYLH 529
           +    +  R  CF++ ++A  G+L  +L +E        +S   +   G  I   + YLH
Sbjct: 61  KYSFQTHDR-LCFVM-EYANGGELFFHLSRERV------FSEDRARFYGAEIVSALDYLH 112

Query: 530 SSEVNKPAIVHRNLSVEKVLIDQQFNPLIADCGLHKLLADDIVFSVLKT-SAAMGYLAPE 588
           S +     +V+R+L +E +++D+  +  I D GL K    D   + +KT      YLAPE
Sbjct: 113 SEK----NVVYRDLKLENLMLDKDGHIKITDFGLCKEGIKD--GATMKTFCGTPEYLAPE 166

Query: 589 YVTTGRFTERSDIFAFGVIILQILTGSL 616
            +    +    D +  GV++ +++ G L
Sbjct: 167 VLEDNDYGRAVDWWGLGVVMYEMMCGRL 194

Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, alpha (or Akt1) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-alpha is predominantly expressed in endothelial cells. It is critical for the regulation of angiogenesis and the maintenance of vascular integrity. It also plays a role in adipocyte differentiation. Mice deficient in PKB-alpha exhibit perinatal morbidity, growth retardation, reduction in body weight accompanied by reduced sizes of multiple organs, and enhanced apoptosis in some cell types. PKB-alpha activity has been reported to be frequently elevated in breast and prostate cancers. In some cancer cells, PKB-alpha may act as a suppressor of metastasis. Length = 325

>gnl|CDD|143382 cd07877, STKc_p38alpha_MAPK14, Catalytic domain of the Serine/Threonine Kinase, p38alpha Mitogen-Activated Protein Kinase

 Score = 42.7 bits (100), Expect = 5e-04
 Identities = 59/245 (24%), Positives = 99/245 (40%), Gaps = 52/245 (21%)

Query: 389 FSREHLNSFRLNLEEVESATQCFSEVNLLGKGNFSSVYKG-TLRDGTLVAIRSIN----- 442
           F R+ LN     + EV    Q  S V   G G + SV      + G  VA++ ++     
Sbjct: 3   FYRQELNK---TIWEVPERYQNLSPV---GSGAYGSVCAAFDTKTGLRVAVKKLSRPFQS 56

Query: 443 VTSCKSEEAEFVKGLYLLTSLRHENIIRLRGFCCSRGRGECFLIYDFAPKGKLSKYLD-- 500
           +   K    E    L LL  ++HEN+I L                 F P   L ++ D  
Sbjct: 57  IIHAKRTYRE----LRLLKHMKHENVIGLLDV--------------FTPARSLEEFNDVY 98

Query: 501 -----QEEGSSNVLDWSTRVS-----IIIGIAKGIGYLHSSEVNKPAIVHRNLSVEKVLI 550
                     +N++            +I  I +G+ Y+HS++     I+HR+L    + +
Sbjct: 99  LVTHLMGADLNNIVKCQKLTDDHVQFLIYQILRGLKYIHSAD-----IIHRDLKPSNLAV 153

Query: 551 DQQFNPLIADCGLHKLLADDIVFSVLKTSAAMGYLAPEYVTTG-RFTERSDIFAFGVIIL 609
           ++     I D GL +   D++   V    A   Y APE +     + +  DI++ G I+ 
Sbjct: 154 NEDCELKILDFGLARHTDDEMTGYV----ATRWYRAPEIMLNWMHYNQTVDIWSVGCIMA 209

Query: 610 QILTG 614
           ++LTG
Sbjct: 210 ELLTG 214

Serine/Threonine Kinases (STKs), p38alpha subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38alpha subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38alpha, also called MAPK14, is expressed in most tissues and is the major isoform involved in the immune and inflammatory response. It is the central p38 MAPK involved in myogenesis. It plays a role in regulating cell cycle check-point transition and promoting cell differentiation. p38alpha also regulates cell proliferation and death through crosstalk with the JNK pathway. Its substrates include MAPK activated protein kinase 2 (MK2), MK5, and the transcription factors ATF2 and Mitf. Length = 345

>gnl|CDD|140289 PTZ00263, PTZ00263, protein kinase A catalytic subunit; Provisional

 Score = 42.1 bits (99), Expect = 7e-04
 Identities = 25/88 (28%), Positives = 45/88 (51%), Gaps = 9/88 (10%)

Query: 527 YLHSSEVNKPAIVHRNLSVEKVLIDQQFNPLIADCGLHKLLADDIVFSVLKTSAAMGYLA 586
           YLHS +     I++R+L  E +L+D + +  + D G  K + D   F++  T     YLA
Sbjct: 133 YLHSKD-----IIYRDLKPENLLLDNKGHVKVTDFGFAKKVPDR-TFTLCGTPE---YLA 183

Query: 587 PEYVTTGRFTERSDIFAFGVIILQILTG 614
           PE + +    +  D +  GV++ + + G
Sbjct: 184 PEVIQSKGHGKAVDWWTMGVLLYEFIAG 211

Length = 329

>gnl|CDD|173675 cd05584, STKc_p70S6K, Catalytic domain of the Protein Serine/Threonine Kinase, 70 kDa ribosomal protein S6 kinase

 Score = 41.7 bits (98), Expect = 9e-04
 Identities = 41/167 (24%), Positives = 77/167 (46%), Gaps = 24/167 (14%)

Query: 481 GECFLIYDFAPKGKLSKYLDQEEGSSNVLDWSTRVSIIIGIAKGIGYLHSSEVNKPAIVH 540
           G+ +LI ++   G+L  +L++E     +    T    +  I+  + +LH     +  I++
Sbjct: 73  GKLYLILEYLSGGELFMHLERE----GIFMEDTACFYLSEISLALEHLH-----QQGIIY 123

Query: 541 RNLSVEKVLIDQQFNPLIADCGLHKLLADDIVFSVLKTSAAMG---YLAPEYVTTGRFTE 597
           R+L  E +L+D Q +  + D GL K    + +     T    G   Y+APE +      +
Sbjct: 124 RDLKPENILLDAQGHVKLTDFGLCK----ESIHEGTVTHTFCGTIEYMAPEILMRSGHGK 179

Query: 598 RSDIFAFGVIILQILTGSLVLTSSMRLAAESATFENFIDRNLKGKFS 644
             D ++ G ++  +LTG+   T+  R        +  ID+ LKGK +
Sbjct: 180 AVDWWSLGALMYDMLTGAPPFTAENR--------KKTIDKILKGKLN 218

Serine/Threonine Kinases (STKs), 70 kDa ribosomal protein S6 kinase (p70S6K) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p70S6K subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p70S6K (or S6K) contains only one catalytic kinase domain, unlike p90 ribosomal S6 kinases (RSKs). It acts as a downstream effector of the STK mTOR (mammalian Target of Rapamycin) and plays a role in the regulation of the translation machinery during protein synthesis. p70S6K also plays a pivotal role in regulating cell size and glucose homeostasis. Its targets include S6, the translation initiation factor eIF3, and the insulin receptor substrate IRS-1, among others. Mammals contain two isoforms of p70S6K, named S6K1 and S6K2 (or S6K-beta). Length = 323

>gnl|CDD|132946 cd06615, PKc_MEK, Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase

 Score = 41.3 bits (97), Expect = 0.001
 Identities = 25/98 (25%), Positives = 52/98 (53%), Gaps = 7/98 (7%)

Query: 517 IIIGIAKGIGYLHSSEVNKPAIVHRNLSVEKVLIDQQFNPLIADCGLHKLLADDIVFSVL 576
           I I + +G+ YL      K  I+HR++    +L++ +    + D G+   L D +  S +
Sbjct: 104 ISIAVLRGLTYLR----EKHKIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDSMANSFV 159

Query: 577 KTSAAMGYLAPEYVTTGRFTERSDIFAFGVIILQILTG 614
            T +   Y++PE +    +T +SDI++ G+ ++++  G
Sbjct: 160 GTRS---YMSPERLQGTHYTVQSDIWSLGLSLVEMAIG 194

Protein kinases (PKs), MAP/ERK kinase (MEK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 and MEK2 are dual-specificity PKs that phosphorylate and activate the downstream targets, ERK(extracellular signal-regulated kinase) 1 and ERK2, on specific threonine and tyrosine residues. The ERK cascade starts with extracellular signals including growth factors, hormones, and neurotransmitters, which act through receptors and ion channels to initiate intracellular signaling that leads to the activation at the MAPKKK (Raf-1 or MOS) level, which leads to the transmission of signals to MEK1/2, and finally to ERK1/2. The ERK cascade plays an important role in cell proliferation, differentiation, oncogenic transformation, and cell cycle control, as well as in apoptosis and cell survival under certain conditions. This cascade has also been implicated in synaptic plasticity, migration, morphological determination, and stress response immunological reactions. Gain-of-function mutations in genes encoding ERK cascade proteins, including MEK1/2, cause cardiofaciocutaneous (CFC) syndrome, a condition leading to multiple congenital anomalies and mental retardation in patients. Length = 308

>gnl|CDD|173725 cd06608, STKc_myosinIII_like, Catalytic domain of Class III myosin-like Protein Serine/Threonine Kinases

 Score = 41.1 bits (97), Expect = 0.001
 Identities = 63/291 (21%), Positives = 119/291 (40%), Gaps = 54/291 (18%)

Query: 411 FSEVNLLGKGNFSSVYKGT-LRDGTLVAIRSINVTSCKSEEAEFVKGLYLLTSLR----H 465
           F  V ++G+G +  VYK    + G LVAI+ +++   + EE +          LR    H
Sbjct: 8   FELVEVIGEGTYGKVYKARHKKTGQLVAIKIMDIIEDEEEEIKEE-----YNILRKYSNH 62

Query: 466 ENIIRLRG-FCCSRGRG---ECFLIYDFAPKGKLSKYLDQEEGSSNVLDWSTRVS----- 516
            NI    G F      G   + +L+ +    G ++  +        +     R+      
Sbjct: 63  PNIATFYGAFIKKNPPGNDDQLWLVMELCGGGSVTDLV------KGLRKKGKRLKEEWIA 116

Query: 517 -IIIGIAKGIGYLHSSEVNKPAIVHRNLSVEKVLIDQQFNPLIADCGLHKLLADDIVFSV 575
            I+    +G+ YLH ++V     +HR++  + +L+ +     + D G+   L      ++
Sbjct: 117 YILRETLRGLAYLHENKV-----IHRDIKGQNILLTKNAEVKLVDFGVSAQLDS----TL 167

Query: 576 LKTSAAMG---YLAPEYVT-----TGRFTERSDIFAFGVIILQILTGSLVLTS--SMRLA 625
            + +  +G   ++APE +         +  RSD+++ G+  +++  G   L     MR  
Sbjct: 168 GRRNTFIGTPYWMAPEVIACDEQPDASYDARSDVWSLGITAIELADGKPPLCDMHPMR-- 225

Query: 626 AESATFENFIDRNLKGKFSESE--AAKLGKMALVCTHEDPENRPTMEAVIE 674
              A F+  I RN        E  + K       C  ++ E RP ME ++E
Sbjct: 226 ---ALFK--IPRNPPPTLKSPENWSKKFNDFISECLIKNYEQRPFMEELLE 271

Serine/threonine kinases (STKs), Class III myosin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins with an N-terminal kinase catalytic domain and a C-terminal actin-binding motor domain. Class III myosins are present in the photoreceptors of invertebrates and vertebrates and in the auditory hair cells of mammals. The kinase domain of myosin III can phosphorylate several cytoskeletal proteins, conventional myosin regulatory light chains, and can autophosphorylate the C-terminal motor domain. Myosin III may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. It may also function as a cargo carrier during light-dependent translocation, in photoreceptor cells, of proteins such as transducin and arrestin. The Drosophila class III myosin, called NinaC (Neither inactivation nor afterpotential protein C), is critical in normal adaptation and termination of photoresponse. Vertebrates contain two isoforms of class III myosin, IIIA and IIIB. This subfamily also includes mammalian NIK-like embryo-specific kinase (NESK), Traf2- and Nck-interacting kinase (TNIK), mitogen-activated protein kinase (MAPK) kinase kinase kinase 4 (MAPKKKK4 or MAP4K4) and MAPKKKK6 (or MAP4K6). MAP4Ks are involved in some MAPK signaling pathways by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Length = 275

>gnl|CDD|132988 cd06657, STKc_PAK4, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 4

 Score = 41.2 bits (96), Expect = 0.001
 Identities = 50/273 (18%), Positives = 122/273 (44%), Gaps = 30/273 (10%)

Query: 417 LGKGNFSSVYKGTLRD-GTLVAIRSINVTSCKSEEAEFVKGLYLLTSLRHENIIRLRGFC 475
           +G+G+   V   T++  G LVA++ +++   +  E  F + + ++   +HEN++ +  + 
Sbjct: 28  IGEGSTGIVCIATVKSSGKLVAVKKMDLRKQQRRELLFNE-VVIMRDYQHENVVEM--YN 84

Query: 476 CSRGRGECFLIYDFAPKGKLSKYLDQEEGSSNVLDWSTRVSIIIGIAKGIGYLHSSEVNK 535
                 E +++ +F   G L+  +     +   +      ++ + + K +  LH+     
Sbjct: 85  SYLVGDELWVVMEFLEGGALTDIVTHTRMNEEQI-----AAVCLAVLKALSVLHAQ---- 135

Query: 536 PAIVHRNLSVEKVLIDQQFNPLIADCGLHKLLADDIVFSVLKTSAAMG---YLAPEYVTT 592
             ++HR++  + +L+       ++D G    ++ +    V +  + +G   ++APE ++ 
Sbjct: 136 -GVIHRDIKSDSILLTHDGRVKLSDFGFCAQVSKE----VPRRKSLVGTPYWMAPELISR 190

Query: 593 GRFTERSDIFAFGVIILQILTGSLVLTSSMRLAAESATFENFIDR--NLKGKFSESEAAK 650
             +    DI++ G+++++++ G     +   L A     +N   +  NL  K S S    
Sbjct: 191 LPYGPEVDIWSLGIMVIEMVDGEPPYFNEPPLKAMKMIRDNLPPKLKNLH-KVSPSLKGF 249

Query: 651 LGKMALVCTHEDPENRPTMEAVIEE--LTVAAP 681
           L ++ +     DP  R T   +++   L  A P
Sbjct: 250 LDRLLV----RDPAQRATAAELLKHPFLAKAGP 278

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 4, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK4 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK4 regulates cell morphology and cytoskeletal organization. It is essential for embryonic viability and proper neural development. Mice lacking PAK4 die due to defects in the fetal heart. In addition, their spinal cord motor neurons showed failure to differentiate and migrate. PAK4 also plays a role in cell survival and tumorigenesis. It is overexpressed in many primary tumors including colon, esophageal, and mammary tumors. PAK4 has also been implicated in viral and bacterial infection pathways. Length = 292

>gnl|CDD|132950 cd06619, PKc_MKK5, Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 5

 Score = 41.0 bits (96), Expect = 0.001
 Identities = 47/201 (23%), Positives = 89/201 (44%), Gaps = 19/201 (9%)

Query: 417 LGKGNFSSVYKGT-LRDGTLVAIRSINVTSCKSEEAEFVKGLYLLTSLRHENIIRLRGFC 475
           LG GN  +VYK   L    ++A++ I +      + + +  L +L       II   G  
Sbjct: 9   LGHGNGGTVYKAYHLLTRRILAVKVIPLDITVELQKQIMSELEILYKCDSPYIIGFYGAF 68

Query: 476 CSRGRGECFLIYDFAPKGKLSKYLDQEEGSSNVLDWSTRVSIIIGIAKGIGYLHSSEVNK 535
               R    +  +F   G L  Y    E   +VL       I + + KG+ YL S +   
Sbjct: 69  FVENR--ISICTEFMDGGSLDVYRKIPE---HVLG-----RIAVAVVKGLTYLWSLK--- 115

Query: 536 PAIVHRNLSVEKVLIDQQFNPLIADCGLHKLLADDIVFSVLKTSAAMGYLAPEYVTTGRF 595
             I+HR++    +L++ +    + D G+   L + I  + + T+A   Y+APE ++  ++
Sbjct: 116 --ILHRDVKPSNMLVNTRGQVKLCDFGVSTQLVNSIAKTYVGTNA---YMAPERISGEQY 170

Query: 596 TERSDIFAFGVIILQILTGSL 616
              SD+++ G+  +++  G  
Sbjct: 171 GIHSDVWSLGISFMELALGRF 191

Protein kinases (PKs), MAP kinase kinase 5 (MKK5) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK5, also referred to as MEK5, is a dual-specificity PK that phosphorylates its downstream target, extracellular signal-regulated kinase 5 (ERK5), on specific threonine and tyrosine residues. MKK5 is activated by MEKK2 and MEKK3 in response to mitogenic and stress stimuli. The ERK5 cascade promotes cell proliferation, differentiation, neuronal survival, and neuroprotection. This cascade plays an essential role in heart development. Mice deficient in either ERK5 or MKK5 die around embryonic day 10 due to cardiovascular defects including underdevelopment of the myocardium. In addition, MKK5 is associated with metastasis and unfavorable prognosis in prostate cancer. Length = 279

>gnl|CDD|143364 cd07859, STKc_TDY_MAPK_plant, Catalytic domain of the Serine/Threonine Kinases, TDY Mitogen-Activated Protein Kinases from Plants

 Score = 40.9 bits (96), Expect = 0.001
 Identities = 48/208 (23%), Positives = 94/208 (45%), Gaps = 19/208 (9%)

Query: 416 LLGKGNFSSVYKGT-LRDGTLVAIRSI-NVTSCKSEEAEFVKGLYLLTSLRHENIIRLRG 473
           ++GKG++  V        G  VAI+ I +V    S+    ++ + LL  LRH +I+ ++ 
Sbjct: 7   VIGKGSYGVVCSAIDTHTGEKVAIKKINDVFEHVSDATRILREIKLLRLLRHPDIVEIKH 66

Query: 474 FCCSRGRGE---CFLIYDFAPKGKLSKYLDQEEGSSNVLDWSTRVSIIIGIAKGIGYLHS 530
                 R E    +++++      +   L Q   +++ L        +  + + + Y+H+
Sbjct: 67  IMLPPSRREFKDIYVVFEL-----MESDLHQVIKANDDLTPEHHQFFLYQLLRALKYIHT 121

Query: 531 SEVNKPAIVHRNLSVEKVLIDQQFNPLIADCGLHKLLADDIVFSVLKTS--AAMGYLAPE 588
           + V      HR+L  + +L +      I D GL ++  +D   ++  T   A   Y APE
Sbjct: 122 ANV-----FHRDLKPKNILANADCKLKICDFGLARVAFNDTPTAIFWTDYVATRWYRAPE 176

Query: 589 YVTT--GRFTERSDIFAFGVIILQILTG 614
              +   ++T   DI++ G I  ++LTG
Sbjct: 177 LCGSFFSKYTPAIDIWSIGCIFAEVLTG 204

Serine/Threonine Kinases (STKs), Plant TDY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TDY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. Oryza sativa contains at least 17 MAPKs. There are two subtypes of plant MAPKs based on the conserved phosphorylation motif present in the activation loop, TEY and TDY. Arabidopsis thaliana contains more TEY-type MAPKs than TDY-type, whereas the reverse is true for Oryza sativa. This subfamily represents the TDY subtype and is composed of Group D plant MAPKs including Arabidopsis thaliana MPK18 (AtMPK18), Oryza sativa Blast- and Wound-induced MAPK1 (OsBWMK1), OsWJUMK1 (Wound- and JA-Uninducible MAPK1), Zea mays MPK6, and the Medicago sativa TDY1 gene product. OsBWMK1 enhances resistance to pathogenic infections. It mediates stress-activated defense responses by activating a transcription factor that affects the expression of stress-related genes. AtMPK18 is involved in microtubule-related functions. Length = 338

>gnl|CDD|206026 pfam13855, LRR_8, Leucine rich repeat

 Score = 36.8 bits (86), Expect = 0.002
 Identities = 22/60 (36%), Positives = 26/60 (43%), Gaps = 2/60 (3%)

Query: 118 LTDLYLDVNNLSGNIPPEI-GSMASLQVLQLCCNQLTGNIPAQIGSLKSLSVLTLQHNRL 176
           L  L L  N L+  IP      + +L+VL L  N LT   P     L SL  L L  N L
Sbjct: 2   LKSLDLSNNRLT-VIPDGAFKGLPNLKVLDLSGNNLTSISPEAFSGLPSLRSLDLSGNNL 60

Length = 60

>gnl|CDD|173706 cd05615, STKc_cPKC_alpha, Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C alpha

 Score = 40.8 bits (95), Expect = 0.002
 Identities = 26/97 (26%), Positives = 53/97 (54%), Gaps = 12/97 (12%)

Query: 521 IAKGIGYLHSSEVNKPAIVHRNLSVEKVLIDQQFNPLIADCGLHKLLADDIVFSVLKTSA 580
           I+ G+ +LH     +  I++R+L ++ V++D + +  IAD G+ K    + +   + T  
Sbjct: 110 ISVGLFFLH-----RRGIIYRDLKLDNVMLDSEGHIKIADFGMCK----EHMVDGVTTRT 160

Query: 581 AMG---YLAPEYVTTGRFTERSDIFAFGVIILQILTG 614
             G   Y+APE +    + +  D +A+GV++ ++L G
Sbjct: 161 FCGTPDYIAPEIIAYQPYGKSVDWWAYGVLLYEMLAG 197

Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, and gamma. PKC-alpha is expressed in many tissues and is associated with cell proliferation, apoptosis, and cell motility. It plays a role in the signaling of the growth factors PDGF, VEGF, EGF, and FGF. Abnormal levels of PKC-alpha have been detected in many transformed cell lines and several human tumors. In addition, PKC-alpha is required for HER2 dependent breast cancer invasion. Length = 323

>gnl|CDD|173705 cd05614, STKc_MSK2_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 2

 Score = 40.3 bits (94), Expect = 0.002
 Identities = 34/133 (25%), Positives = 63/133 (47%), Gaps = 12/133 (9%)

Query: 485 LIYDFAPKGKLSKYLDQEEGSSNVLDWSTRVSIIIG-IAKGIGYLHSSEVNKPAIVHRNL 543
           LI D+   G++  +L Q +  S        V    G I   + +LH     K  IV+R++
Sbjct: 82  LILDYVSGGEMFTHLYQRDNFS-----EDEVRFYSGEIILALEHLH-----KLGIVYRDI 131

Query: 544 SVEKVLIDQQFNPLIADCGLHKLLADDIVFSVLKTSAAMGYLAPEYV-TTGRFTERSDIF 602
            +E +L+D + + ++ D GL K    +           + Y+APE +   G   +  D +
Sbjct: 132 KLENILLDSEGHVVLTDFGLSKEFLSEEKERTYSFCGTIEYMAPEIIRGKGGHGKAVDWW 191

Query: 603 AFGVIILQILTGS 615
           + G++I ++LTG+
Sbjct: 192 SLGILIFELLTGA 204

Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK2, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydrophobic motif (HM) of NTD, which facilitates the phosphorylation of the A-loop and activates the NTD, which in turn phosphorylates downstream targets. MSK2 and MSK1 play nonredundant roles in activating histone H3 kinases, which play pivotal roles in compaction of the chromatin fiber. MSK2 is the required H3 kinase in response to stress stimuli and activation of the p38 MAPK pathway. MSK2 also plays a role in the pathogenesis of psoriasis. Length = 332

>gnl|CDD|173502 PTZ00266, PTZ00266, NIMA-related protein kinase; Provisional

 Score = 40.9 bits (95), Expect = 0.003
 Identities = 55/265 (20%), Positives = 111/265 (41%), Gaps = 27/265 (10%)

Query: 405 ESATQCFSEVNLLGKGNFSSVY-KGTLRDGTLVAIRSINVTSCKS-EEAEFVKGLYLLTS 462
           ES    +  +  +G G F  V+     R       ++I+    K  E+++ V  + ++  
Sbjct: 9   ESRLNEYEVIKKIGNGRFGEVFLVKHKRTQEFFCWKAISYRGLKEREKSQLVIEVNVMRE 68

Query: 463 LRHENIIRLRGFCCSRGRGECFLIYDFAPKGKLSKYLDQEEGSSNVLDWSTRVSIIIGIA 522
           L+H+NI+R      ++   + +++ +F   G LS+ + +       ++    V I   + 
Sbjct: 69  LKHKNIVRYIDRFLNKANQKLYILMEFCDAGDLSRNIQKCYKMFGKIEEHAIVDITRQLL 128

Query: 523 KGIGYLHSSE--VNKPAIVHRNLSVEKVL----------IDQQFNPL-------IADCGL 563
             + Y H+ +   N   ++HR+L  + +           I  Q N L       I D GL
Sbjct: 129 HALAYCHNLKDGPNGERVLHRDLKPQNIFLSTGIRHIGKITAQANNLNGRPIAKIGDFGL 188

Query: 564 HKLLA-DDIVFSVLKTSAAMGYLAPEYV--TTGRFTERSDIFAFGVIILQILTGSLVLTS 620
            K +  + +  S + T     Y +PE +   T  + ++SD++A G II ++ +G      
Sbjct: 189 SKNIGIESMAHSCVGTPY---YWSPELLLHETKSYDDKSDMWALGCIIYELCSGKTPFHK 245

Query: 621 SMRLAAESATFENFIDRNLKGKFSE 645
           +   +   +  +   D  +KGK  E
Sbjct: 246 ANNFSQLISELKRGPDLPIKGKSKE 270

Length = 1021

>gnl|CDD|173766 cd08226, PK_STRAD_beta, Pseudokinase domain of STE20-related kinase adapter protein beta

 Score = 40.3 bits (94), Expect = 0.003
 Identities = 53/218 (24%), Positives = 96/218 (44%), Gaps = 37/218 (16%)

Query: 417 LGKG--NFSSVYKGT-LRDGTLVAIRSINVTSCKSEEAEFVKGLYLLTS-LRHENIIRLR 472
           +G+G  N +SVY       GTLV +R  ++ +C  E  + ++   +L+   RH NI+   
Sbjct: 6   IGRGFCNLTSVYLARHTPTGTLVTVRITDLENCTEEHLKALQNEVVLSHFFRHPNIMTS- 64

Query: 473 GFCCSRGRGECFLIYDFAPKGKLSKYLDQ--EEGSSNVLDWSTRVSIIIGIAKGIGYLHS 530
            +         ++I  F   G  +  L     EG S  L      +I+ G  +G+ YLH 
Sbjct: 65  -WTVFTTGSWLWVISPFMAYGSANSLLKTYFPEGMSEALIG----NILFGALRGLNYLHQ 119

Query: 531 SEVNKPAIVHRNLSVEKVLIDQQFNPLIADCGL------------HKLLADDIVFSVLKT 578
           +       +HRN+    +LI    + L++  GL             K++ D   FS    
Sbjct: 120 N-----GYIHRNIKASHILISG--DGLVSLSGLSHLYSLVRNGQKAKVVYDFPQFS---- 168

Query: 579 SAAMGYLAPEYVTTGR--FTERSDIFAFGVIILQILTG 614
           ++ + +L+PE +      +  +SDI++ G+   ++ TG
Sbjct: 169 TSVLPWLSPELLRQDLYGYNVKSDIYSVGITACELATG 206

Protein Kinase family, STE20-related kinase adapter protein (STRAD) beta subfamily, pseudokinase domain. The STRAD-beta subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpigmentation of the buccal mucosa. There are two forms of STRAD, alpha and beta, that complex with LKB1 and MO25. STRAD-beta is also referred to as ALS2CR2 (Amyotrophic lateral sclerosis 2 chromosomal region candidate gene 2 protein), since the human gene encoding it is located within the juvenile ALS2 critical region on chromosome 2q33-q34. It is not linked to the development of ALS2. Length = 328

>gnl|CDD|143349 cd07844, STKc_PCTAIRE_like, Catalytic domain of PCTAIRE-like Serine/Threonine Kinases

 Score = 39.7 bits (93), Expect = 0.004
 Identities = 39/150 (26%), Positives = 71/150 (47%), Gaps = 16/150 (10%)

Query: 417 LGKGNFSSVYKGTLR-DGTLVAIRSINVTSCKSEEAEF--VKGLYLLTSLRHENIIRLRG 473
           LG+G++++VYKG  +  G LVA++ I +     E A F  ++   LL  L+H NI+ L  
Sbjct: 13  LGEGSYATVYKGRSKLTGQLVALKEIRLE--HEEGAPFTAIREASLLKDLKHANIVTLHD 70

Query: 474 FCCSRGRGECFLIYDFAPKGKLSKYLDQEEGSSNVLDWSTRVSIIIGIAKGIGYLHSSEV 533
                 +    L++++     L +Y+D        L        +  + +G+ Y H    
Sbjct: 71  II--HTKKTLTLVFEYLDT-DLKQYMDD---CGGGLSMHNVRLFLFQLLRGLAYCHQRR- 123

Query: 534 NKPAIVHRNLSVEKVLIDQQFNPLIADCGL 563
               ++HR+L  + +LI ++    +AD GL
Sbjct: 124 ----VLHRDLKPQNLLISERGELKLADFGL 149

Serine/Threonine Kinases (STKs), PCTAIRE-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily share sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. The association of PCTAIRE-like proteins with cyclins has not been widely studied, although PFTAIRE-1 has been shown to function as a CDK which is regulated by cyclin D3 as well as the membrane-associated cyclin Y. PCTAIRE-like proteins show unusual expression patterns with high levels in post-mitotic tissues, suggesting that they may be involved in regulating post-mitotic cellular events. Length = 291

>gnl|CDD|173722 cd05633, STKc_GRK3, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 3

 Score = 39.6 bits (92), Expect = 0.004
 Identities = 53/208 (25%), Positives = 91/208 (43%), Gaps = 25/208 (12%)

Query: 416 LLGKGNFSSVYKGTLRD-GTLVAIRSINVTSCKSEEAEFV----KGLYLLTSLRHENIIR 470
           ++G+G F  VY     D G + A++ ++    K ++ E +    + +  L S      I 
Sbjct: 1   IIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIV 60

Query: 471 LRGFCCSRGRGECFLIYDFAPKGKLSKYLDQEEGSSNVLDWSTRVSIIIGIAKGIGYLHS 530
              +        CF I D    G L  +L Q    S          II+G+     ++H+
Sbjct: 61  CMTYAFHTPDKLCF-ILDLMNGGDLHYHLSQHGVFSEKEMRFYATEIILGLE----HMHN 115

Query: 531 SEVNKPAIVHRNLSVEKVLIDQQFNPLIADCGLHKLLADDIVFSVLKTSAAM---GYLAP 587
             V     V+R+L    +L+D+  +  I+D G    LA D  FS  K  A++   GY+AP
Sbjct: 116 RFV-----VYRDLKPANILLDEHGHVRISDLG----LACD--FSKKKPHASVGTHGYMAP 164

Query: 588 EYVTTGR-FTERSDIFAFGVIILQILTG 614
           E +  G  +   +D F+ G ++ ++L G
Sbjct: 165 EVLQKGTAYDSSADWFSLGCMLFKLLRG 192

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK3 (also known as beta-adrenergic receptor kinase 2) is widely expressed in many tissues. GRK3-deficient mice show a lack of olfactory receptor desensitization and altered regulation of the M2 muscarinic airway. GRK3 is involved in modulating the cholinergic response of airway smooth muscles. It also plays a role in dopamine receptor regulation. GRK3 promoter polymorphisms may be associated with bipolar disorder. Length = 279

>gnl|CDD|143383 cd07878, STKc_p38beta_MAPK11, Catalytic domain of the Serine/Threonine Kinase, p38beta Mitogen-Activated Protein Kinase

 Score = 39.6 bits (92), Expect = 0.004
 Identities = 56/231 (24%), Positives = 95/231 (41%), Gaps = 24/231 (10%)

Query: 389 FSREHLNSFRLNLEEVESATQCFSEVNLLGKGNFSSVYKGTLRDGTLVAIRSINVTSCKS 448
           F R+ LN     + EV    Q  + V     G+  S Y   LR    V   S    S   
Sbjct: 1   FYRQELNK---TVWEVPERYQNLTPVGSGAYGSVCSAYDTRLRQKVAVKKLSRPFQSLIH 57

Query: 449 EEAEFVKGLYLLTSLRHENIIRLRGFCCSRGRGECF----LIYDFAPKGKLSKYLDQEEG 504
               + + L LL  ++HEN+I L          E F    L+ +      L+  +  ++ 
Sbjct: 58  ARRTY-RELRLLKHMKHENVIGLLDVFTPATSIENFNEVYLVTNLM-GADLNNIVKCQKL 115

Query: 505 SSNVLDWSTRVSIIIGIAKGIGYLHSSEVNKPAIVHRNLSVEKVLIDQQFNPLIADCGLH 564
           S   + +     +I  + +G+ Y+HS+      I+HR+L    V +++     I D GL 
Sbjct: 116 SDEHVQF-----LIYQLLRGLKYIHSA-----GIIHRDLKPSNVAVNEDCELRILDFGLA 165

Query: 565 KLLADDIVFSVLKTSAAMGYLAPEYVTTG-RFTERSDIFAFGVIILQILTG 614
           +   D++   V    A   Y APE +     + +  DI++ G I+ ++L G
Sbjct: 166 RQADDEMTGYV----ATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLKG 212

Serine/Threonine Kinases (STKs), p38beta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38beta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38beta, also called MAPK11, is widely expressed in tissues and shows more similarity with p38alpha than with the other isoforms. Both are sensitive to pyridinylimidazoles and share some common substrates such as MAPK activated protein kinase 2 (MK2) and the transcription factors ATF2, c-Fos and, ELK-1. p38beta is involved in regulating the activation of the cyclooxygenase-2 promoter and the expression of TGFbeta-induced alpha-smooth muscle cell actin. Length = 343

Conserved Domains Detected by HHsearch

Original result of HHsearch against CDD database

ID	Length	Definition	Probability
Query	689
PLN00113	968	leucine-rich repeat receptor-like protein kinase;	100.0
KOG1187	361	consensus Serine/threonine protein kinase [Signal	100.0
KOG0192	362	consensus Tyrosine kinase specific for activated (	100.0
KOG0197	468	consensus Tyrosine kinases [Signal transduction me	100.0
KOG0581	364	consensus Mitogen-activated protein kinase kinase	100.0
KOG1026	774	consensus Nerve growth factor receptor TRKA and re	100.0
KOG0196	996	consensus Tyrosine kinase, EPH (ephrin) receptor f	100.0
KOG0595	429	consensus Serine/threonine-protein kinase involved	100.0
KOG1094	807	consensus Discoidin domain receptor DDR1 [Signal t	100.0
KOG0591	375	consensus NIMA (never in mitosis)-related G2-speci	100.0
KOG1095	1025	consensus Protein tyrosine kinase [Signal transduc	100.0
KOG0575	592	consensus Polo-like serine/threonine protein kinas	100.0
KOG0615	475	consensus Serine/threonine protein kinase Chk2 and	100.0
KOG4721	904	consensus Serine/threonine protein kinase, contain	100.0
KOG0193	678	consensus Serine/threonine protein kinase RAF [Sig	100.0
cd05102	338	PTKc_VEGFR3 Catalytic domain of the Protein Tyrosi	100.0
KOG0194	474	consensus Protein tyrosine kinase [Signal transduc	100.0
KOG0198	313	consensus MEKK and related serine/threonine protei	100.0
KOG0598	357	consensus Ribosomal protein S6 kinase and related	100.0
KOG0600	560	consensus Cdc2-related protein kinase [Cell cycle	100.0
PHA02988	283	hypothetical protein; Provisional	100.0
KOG0593	396	consensus Predicted protein kinase KKIAMRE [Genera	100.0
KOG4278	1157	consensus Protein tyrosine kinase [Signal transduc	100.0
KOG0582	516	consensus Ste20-like serine/threonine protein kina	100.0
cd05064	266	PTKc_EphR_A10 Catalytic domain of the Protein Tyro	100.0
cd05096	304	PTKc_DDR1 Catalytic domain of the Protein Tyrosine	100.0
cd05104	375	PTKc_Kit Catalytic domain of the Protein Tyrosine	100.0
KOG0659	318	consensus Cdk activating kinase (CAK)/RNA polymera	100.0
cd05106	374	PTKc_CSF-1R Catalytic domain of the Protein Tyrosi	100.0
cd05108	316	PTKc_EGFR Catalytic domain of the Protein Tyrosine	100.0
cd05111	279	PTK_HER3 Pseudokinase domain of the Protein Tyrosi	100.0
PF07714	259	Pkinase_Tyr: Protein tyrosine kinase Protein kinas	100.0
cd05114	256	PTKc_Tec_Rlk Catalytic domain of the Protein Tyros	100.0
KOG0578	550	consensus p21-activated serine/threonine protein k	100.0
cd05033	266	PTKc_EphR Catalytic domain of Ephrin Receptor Prot	100.0
cd05631	285	STKc_GRK4 Catalytic domain of the Protein Serine/T	100.0
KOG3653	534	consensus Transforming growth factor beta/activin	100.0
cd05048	283	PTKc_Ror Catalytic Domain of the Protein Tyrosine	100.0
cd05072	261	PTKc_Lyn Catalytic domain of the Protein Tyrosine	100.0
cd06649	331	PKc_MEK2 Catalytic domain of the dual-specificity	100.0
KOG0661	538	consensus MAPK related serine/threonine protein ki	100.0
cd05105	400	PTKc_PDGFR_alpha Catalytic domain of the Protein T	100.0
cd05052	263	PTKc_Abl Catalytic domain of the Protein Tyrosine	100.0
cd05068	261	PTKc_Frk_like Catalytic domain of Fyn-related kina	100.0
KOG0663	419	consensus Protein kinase PITSLRE and related kinas	100.0
cd05054	337	PTKc_VEGFR Catalytic domain of the Protein Tyrosin	100.0
KOG0592	604	consensus 3-phosphoinositide-dependent protein kin	100.0
cd05113	256	PTKc_Btk_Bmx Catalytic domain of the Protein Tyros	100.0
cd05062	277	PTKc_IGF-1R Catalytic domain of the Protein Tyrosi	100.0
cd05080	283	PTKc_Tyk2_rpt2 Catalytic (repeat 2) domain of the	100.0
KOG0597	808	consensus Serine-threonine protein kinase FUSED [G	100.0
cd05094	291	PTKc_TrkC Catalytic domain of the Protein Tyrosine	100.0
KOG0616	355	consensus cAMP-dependent protein kinase catalytic	100.0
cd05059	256	PTKc_Tec_like Catalytic domain of Tec-like Protein	100.0
cd05109	279	PTKc_HER2 Catalytic domain of the Protein Tyrosine	100.0
cd05081	284	PTKc_Jak2_Jak3_rpt2 Catalytic (repeat 2) domain of	100.0
cd05148	261	PTKc_Srm_Brk Catalytic domain of the Protein Tyros	100.0
cd05085	250	PTKc_Fer Catalytic domain of the Protein Tyrosine	100.0
cd05084	252	PTKc_Fes Catalytic domain of the Protein Tyrosine	100.0
cd05053	293	PTKc_FGFR Catalytic domain of the Protein Tyrosine	100.0
cd05612	291	STKc_PRKX_like Catalytic domain of PRKX-like Prote	100.0
cd05043	280	PTK_Ryk Pseudokinase domain of Ryk (Receptor relat	100.0
KOG4257	974	consensus Focal adhesion tyrosine kinase FAK, cont	100.0
cd05571	323	STKc_PKB Catalytic domain of the Protein Serine/Th	100.0
cd05049	280	PTKc_Trk Catalytic domain of the Protein Tyrosine	100.0
PLN00034	353	mitogen-activated protein kinase kinase; Provision	100.0
cd07848	287	STKc_CDKL5 Catalytic domain of the Serine/Threonin	100.0
cd05093	288	PTKc_TrkB Catalytic domain of the Protein Tyrosine	100.0
cd05036	277	PTKc_ALK_LTK Catalytic domain of the Protein Tyros	100.0
PTZ00263	329	protein kinase A catalytic subunit; Provisional	100.0
cd05090	283	PTKc_Ror1 Catalytic domain of the Protein Tyrosine	100.0
cd05600	333	STKc_Sid2p_Dbf2p Catalytic domain of Fungal Sid2p-	100.0
KOG0583	370	consensus Serine/threonine protein kinase [Signal	100.0
cd05070	260	PTKc_Fyn_Yrk Catalytic domain of the Protein Tyros	100.0
cd05045	290	PTKc_RET Catalytic domain of the Protein Tyrosine	100.0
cd05115	257	PTKc_Zap-70 Catalytic domain of the Protein Tyrosi	100.0
KOG0201	467	consensus Serine/threonine protein kinase [Signal	100.0
cd05608	280	STKc_GRK1 Catalytic domain of the Protein Serine/T	100.0
KOG0585	576	consensus Ca2+/calmodulin-dependent protein kinase	100.0
cd07869	303	STKc_PFTAIRE1 Catalytic domain of the Serine/Threo	100.0
cd05067	260	PTKc_Lck_Blk Catalytic domain of the Protein Tyros	100.0
KOG0605	550	consensus NDR and related serine/threonine kinases	100.0
cd06650	333	PKc_MEK1 Catalytic domain of the dual-specificity	100.0
cd05107	401	PTKc_PDGFR_beta Catalytic domain of the Protein Ty	100.0
cd05063	268	PTKc_EphR_A2 Catalytic domain of the Protein Tyros	100.0
cd05071	262	PTKc_Src Catalytic domain of the Protein Tyrosine	100.0
cd05091	283	PTKc_Ror2 Catalytic domain of the Protein Tyrosine	100.0
cd08228	267	STKc_Nek6 Catalytic domain of the Protein Serine/T	100.0
cd05585	312	STKc_YPK1_like Catalytic domain of Yeast Protein K	100.0
cd05088	303	PTKc_Tie2 Catalytic domain of the Protein Tyrosine	100.0
cd05089	297	PTKc_Tie1 Catalytic domain of the Protein Tyrosine	100.0
cd05069	260	PTKc_Yes Catalytic domain of the Protein Tyrosine	100.0
KOG1025	1177	consensus Epidermal growth factor receptor EGFR an	100.0
cd05079	284	PTKc_Jak1_rpt2 Catalytic (repeat 2) domain of the	100.0
cd05595	323	STKc_PKB_beta Catalytic domain of the Protein Seri	100.0
cd05087	269	PTKc_Aatyk1_Aatyk3 Catalytic domain of the Protein	100.0
cd07862	290	STKc_CDK6 Catalytic domain of the Serine/Threonine	100.0
cd05116	257	PTKc_Syk Catalytic domain of the Protein Tyrosine	100.0
cd05098	307	PTKc_FGFR1 Catalytic domain of the Protein Tyrosin	100.0
PTZ00426	340	cAMP-dependent protein kinase catalytic subunit; P	100.0
PTZ00283	496	serine/threonine protein kinase; Provisional	100.0
PTZ00267	478	NIMA-related protein kinase; Provisional	100.0
cd07871	288	STKc_PCTAIRE3 Catalytic domain of the Serine/Threo	100.0
cd05593	328	STKc_PKB_gamma Catalytic domain of the Protein Ser	100.0
cd05035	273	PTKc_Axl_like Catalytic Domain of Axl-like Protein	100.0
cd05075	272	PTKc_Axl Catalytic domain of the Protein Tyrosine	100.0
cd05061	288	PTKc_InsR Catalytic domain of the Protein Tyrosine	100.0
cd05103	343	PTKc_VEGFR2 Catalytic domain of the Protein Tyrosi	100.0
cd05032	277	PTKc_InsR_like Catalytic domain of Insulin Recepto	100.0
KOG0658	364	consensus Glycogen synthase kinase-3 [Carbohydrate	100.0
KOG0580	281	consensus Serine/threonine protein kinase [Cell cy	100.0
cd05066	267	PTKc_EphR_A Catalytic domain of the Protein Tyrosi	100.0
cd05101	304	PTKc_FGFR2 Catalytic domain of the Protein Tyrosin	100.0
cd08224	267	STKc_Nek6_Nek7 Catalytic domain of the Protein Ser	100.0
cd05038	284	PTKc_Jak_rpt2 Catalytic (repeat 2) domain of the P	100.0
cd05055	302	PTKc_PDGFR Catalytic domain of the Protein Tyrosin	100.0
cd05097	295	PTKc_DDR_like Catalytic domain of Discoidin Domain	100.0
cd05614	332	STKc_MSK2_N N-terminal catalytic domain of the Pro	100.0
cd05051	296	PTKc_DDR Catalytic domain of the Protein Tyrosine	100.0
cd05605	285	STKc_GRK4_like Catalytic domain of G protein-coupl	100.0
cd05596	370	STKc_ROCK Catalytic domain of the Protein Serine/T	100.0
cd05058	262	PTKc_Met_Ron Catalytic domain of the Protein Tyros	100.0
cd05047	270	PTKc_Tie Catalytic domain of Tie Protein Tyrosine	100.0
cd05607	277	STKc_GRK7 Catalytic domain of the Protein Serine/T	100.0
cd05095	296	PTKc_DDR2 Catalytic domain of the Protein Tyrosine	100.0
KOG1024	563	consensus Receptor-like protein tyrosine kinase RY	100.0
cd05065	269	PTKc_EphR_B Catalytic domain of the Protein Tyrosi	100.0
cd05621	370	STKc_ROCK2 Catalytic domain of the Protein Serine/	100.0
cd05112	256	PTKc_Itk Catalytic domain of the Protein Tyrosine	100.0
cd08529	256	STKc_FA2-like Catalytic domain of the Protein Seri	100.0
cd05060	257	PTKc_Syk_like Catalytic domain of Spleen Tyrosine	100.0
cd07859	338	STKc_TDY_MAPK_plant Catalytic domain of the Serine	100.0
cd05573	350	STKc_ROCK_NDR_like Catalytic domain of ROCK- and N	100.0
KOG0588	786	consensus Serine/threonine protein kinase [Cell cy	100.0
cd05099	314	PTKc_FGFR4 Catalytic domain of the Protein Tyrosin	100.0
cd05584	323	STKc_p70S6K Catalytic domain of the Protein Serine	100.0
cd05050	288	PTKc_Musk Catalytic domain of the Protein Tyrosine	100.0
cd05601	330	STKc_CRIK Catalytic domain of the Protein Serine/T	100.0
cd05034	261	PTKc_Src_like Catalytic domain of Src kinase-like	100.0
cd05082	256	PTKc_Csk Catalytic domain of the Protein Tyrosine	100.0
cd05042	269	PTKc_Aatyk Catalytic domain of the Protein Tyrosin	100.0
cd05057	279	PTKc_EGFR_like Catalytic domain of Epidermal Growt	100.0
cd08229	267	STKc_Nek7 Catalytic domain of the Protein Serine/T	100.0
KOG0589	426	consensus Serine/threonine protein kinase [General	100.0
cd05056	270	PTKc_FAK Catalytic domain of the Protein Tyrosine	100.0
cd05073	260	PTKc_Hck Catalytic domain of the Protein Tyrosine	100.0
cd05086	268	PTKc_Aatyk2 Catalytic domain of the Protein Tyrosi	100.0
cd05594	325	STKc_PKB_alpha Catalytic domain of the Protein Ser	100.0
cd05110	303	PTKc_HER4 Catalytic domain of the Protein Tyrosine	100.0
cd06625	263	STKc_MEKK3_like Catalytic domain of MAP/ERK kinase	100.0
cd05626	381	STKc_LATS2 Catalytic domain of the Protein Serine/	100.0
cd05039	256	PTKc_Csk_like Catalytic domain of C-terminal Src k	100.0
cd05628	363	STKc_NDR1 Catalytic domain of the Protein Serine/T	100.0
cd06637	272	STKc_TNIK Catalytic domain of the Protein Serine/T	100.0
PTZ00036	440	glycogen synthase kinase; Provisional	100.0
PHA03212	391	serine/threonine kinase US3; Provisional	100.0
cd05092	280	PTKc_TrkA Catalytic domain of the Protein Tyrosine	100.0
cd05589	324	STKc_PKN Catalytic domain of the Protein Serine/Th	100.0
cd06619	279	PKc_MKK5 Catalytic domain of the dual-specificity	100.0
cd05592	316	STKc_nPKC_theta_delta Catalytic domain of the Prot	100.0
cd05100	334	PTKc_FGFR3 Catalytic domain of the Protein Tyrosin	100.0
cd05618	329	STKc_aPKC_iota Catalytic domain of the Protein Ser	100.0
cd06615	308	PKc_MEK Catalytic domain of the dual-specificity P	100.0
cd05599	364	STKc_NDR_like Catalytic domain of Nuclear Dbf2-Rel	100.0
cd07853	372	STKc_NLK Catalytic domain of the Serine/Threonine	100.0
cd05044	269	PTKc_c-ros Catalytic domain of the Protein Tyrosin	100.0
cd05040	257	PTKc_Ack_like Catalytic domain of the Protein Tyro	100.0
cd05590	320	STKc_nPKC_eta Catalytic domain of the Protein Seri	100.0
cd05041	251	PTKc_Fes_like Catalytic domain of Fes-like Protein	100.0
cd06642	277	STKc_STK25-YSK1 Catalytic domain of the Protein Se	100.0
cd05591	321	STKc_nPKC_epsilon Catalytic domain of the Protein	100.0
cd06621	287	PKc_MAPKK_Pek1_like Catalytic domain of fungal Pek	100.0
cd06646	267	STKc_MAP4K5 Catalytic domain of the Protein Serine	100.0
cd05587	324	STKc_cPKC Catalytic domain of the Protein Serine/T	100.0
cd06620	284	PKc_MAPKK_Byr1_like Catalytic domain of fungal Byr	100.0
cd05588	329	STKc_aPKC Catalytic domain of the Protein Serine/T	100.0
cd06654	296	STKc_PAK1 Catalytic domain of the Protein Serine/T	100.0
cd06638	286	STKc_myosinIIIA Catalytic domain of the Protein Se	100.0
cd05616	323	STKc_cPKC_beta Catalytic domain of the Protein Ser	100.0
cd08217	265	STKc_Nek2 Catalytic domain of the Protein Serine/T	100.0
cd05619	316	STKc_nPKC_theta Catalytic domain of the Protein Se	100.0
cd05622	371	STKc_ROCK1 Catalytic domain of the Protein Serine/	100.0
cd00192	262	PTKc Catalytic domain of Protein Tyrosine Kinases.	100.0
KOG2052	513	consensus Activin A type IB receptor, serine/threo	100.0
cd06624	268	STKc_ASK Catalytic domain of the Protein Serine/Th	100.0
cd06651	266	STKc_MEKK3 Catalytic domain of the Protein Serine/	100.0
cd05629	377	STKc_NDR_like_fungal Catalytic domain of Fungal Nu	100.0
KOG2345	302	consensus Serine/threonine protein kinase/TGF-beta	100.0
cd05046	275	PTK_CCK4 Pseudokinase domain of the Protein Tyrosi	100.0
cd05620	316	STKc_nPKC_delta Catalytic domain of the Protein Se	100.0
cd05570	318	STKc_PKC Catalytic domain of the Protein Serine/Th	100.0
KOG0694	694	consensus Serine/threonine protein kinase [Signal	100.0
cd05582	318	STKc_RSK_N N-terminal catalytic domain of the Prot	100.0
PRK13184	932	pknD serine/threonine-protein kinase; Reviewed	100.0
KOG1989	738	consensus ARK protein kinase family [Signal transd	100.0
cd07876	359	STKc_JNK2 Catalytic domain of the Serine/Threonine	100.0
KOG0199	1039	consensus ACK and related non-receptor tyrosine ki	100.0
KOG0594	323	consensus Protein kinase PCTAIRE and related kinas	100.0
cd08219	255	STKc_Nek3 Catalytic domain of the Protein Serine/T	100.0
cd05632	285	STKc_GRK5 Catalytic domain of the Protein Serine/T	100.0
cd06639	291	STKc_myosinIIIB Catalytic domain of the Protein Se	100.0
cd06609	274	STKc_MST3_like Catalytic domain of Mammalian Ste20	100.0
cd08528	269	STKc_Nek10 Catalytic domain of the Protein Serine/	100.0
cd05630	285	STKc_GRK6 Catalytic domain of the Protein Serine/T	100.0
PTZ00266	1021	NIMA-related protein kinase; Provisional	100.0
cd05625	382	STKc_LATS1 Catalytic domain of the Protein Serine/	100.0
cd07874	355	STKc_JNK3 Catalytic domain of the Serine/Threonine	100.0
cd06640	277	STKc_MST4 Catalytic domain of the Protein Serine/T	100.0
cd05597	331	STKc_DMPK_like Catalytic domain of Myotonic Dystro	100.0
cd05575	323	STKc_SGK Catalytic domain of the Protein Serine/Th	100.0
cd05076	274	PTK_Tyk2_rpt1 Pseudokinase (repeat 1) domain of th	100.0
cd07872	309	STKc_PCTAIRE2 Catalytic domain of the Serine/Threo	100.0
cd05077	262	PTK_Jak1_rpt1 Pseudokinase (repeat 1) domain of th	100.0
KOG0584	632	consensus Serine/threonine protein kinase [General	100.0
cd05615	323	STKc_cPKC_alpha Catalytic domain of the Protein Se	100.0
KOG0611	668	consensus Predicted serine/threonine protein kinas	100.0
cd06612	256	STKc_MST1_2 Catalytic domain of the Protein Serine	100.0
cd05083	254	PTKc_Chk Catalytic domain of the Protein Tyrosine	100.0
cd05603	321	STKc_SGK2 Catalytic domain of the Protein Serine/T	100.0
KOG0660	359	consensus Mitogen-activated protein kinase [Signal	100.0
cd05624	331	STKc_MRCK_beta Catalytic domain of the Protein Ser	100.0
cd05598	376	STKc_LATS Catalytic domain of the Protein Serine/T	100.0
smart00219	258	TyrKc Tyrosine kinase, catalytic domain. Phosphotr	100.0
cd05623	332	STKc_MRCK_alpha Catalytic domain of the Protein Se	100.0
KOG0200	609	consensus Fibroblast/platelet-derived growth facto	100.0
cd06605	265	PKc_MAPKK Catalytic domain of the dual-specificity	100.0
cd06643	282	STKc_SLK Catalytic domain of the Protein Serine/Th	100.0
cd05602	325	STKc_SGK1 Catalytic domain of the Protein Serine/T	100.0
cd06652	265	STKc_MEKK2 Catalytic domain of the Protein Serine/	100.0
cd05617	327	STKc_aPKC_zeta Catalytic domain of the Protein Ser	100.0
cd06617	283	PKc_MKK3_6 Catalytic domain of the dual-specificit	100.0
cd07875	364	STKc_JNK1 Catalytic domain of the Serine/Threonine	100.0
cd08223	257	STKc_Nek4 Catalytic domain of the Protein Serine/T	100.0
cd08221	256	STKc_Nek9 Catalytic domain of the Protein Serine/T	100.0
cd06629	272	STKc_MAPKKK_Bck1_like Catalytic domain of fungal B	100.0
cd05604	325	STKc_SGK3 Catalytic domain of the Protein Serine/T	100.0
cd05074	273	PTKc_Tyro3 Catalytic domain of the Protein Tyrosin	100.0
cd06655	296	STKc_PAK2 Catalytic domain of the Protein Serine/T	100.0
cd07863	288	STKc_CDK4 Catalytic domain of the Serine/Threonine	100.0
cd05078	258	PTK_Jak2_Jak3_rpt1 Pseudokinase (repeat 1) domain	100.0
cd05627	360	STKc_NDR2 Catalytic domain of the Protein Serine/T	100.0
KOG0033	355	consensus Ca2+/calmodulin-dependent protein kinase	100.0
cd08218	256	STKc_Nek1 Catalytic domain of the Protein Serine/T	100.0
cd06628	267	STKc_MAPKKK_Byr2_like Catalytic domain of fungal B	100.0
cd06610	267	STKc_OSR1_SPAK Catalytic domain of the Protein Ser	100.0
cd06631	265	STKc_YSK4 Catalytic domain of the Protein Serine/T	100.0
cd06632	258	STKc_MEKK1_plant Catalytic domain of the Protein S	100.0
PF00069	260	Pkinase: Protein kinase domain Protein kinase; unc	100.0
cd06613	262	STKc_MAP4K3_like Catalytic domain of Mitogen-activ	100.0
cd08227	327	PK_STRAD_alpha Pseudokinase domain of STE20-relate	100.0
cd06656	297	STKc_PAK3 Catalytic domain of the Protein Serine/T	100.0
cd06622	286	PKc_MAPKK_PBS2_like Catalytic domain of fungal PBS	100.0
cd07868	317	STKc_CDK8 Catalytic domain of the Serine/Threonine	100.0
cd06641	277	STKc_MST3 Catalytic domain of the Protein Serine/T	100.0
cd05037	259	PTK_Jak_rpt1 Pseudokinase (repeat 1) domain of the	100.0
cd06645	267	STKc_MAP4K3 Catalytic domain of the Protein Serine	100.0
cd06636	282	STKc_MAP4K4_6 Catalytic domain of the Protein Seri	100.0
cd07873	301	STKc_PCTAIRE1 Catalytic domain of the Serine/Threo	100.0
cd06608	275	STKc_myosinIII_like Catalytic domain of Class III	100.0
PHA03211	461	serine/threonine kinase US3; Provisional	100.0
KOG4279	1226	consensus Serine/threonine protein kinase [Signal	100.0
cd06611	280	STKc_SLK_like Catalytic domain of Ste20-like kinas	100.0
cd06644	292	STKc_STK10_LOK Catalytic domain of the Protein Ser	100.0
cd07867	317	STKc_CDC2L6 Catalytic domain of Serine/Threonine K	100.0
cd06658	292	STKc_PAK5 Catalytic domain of the Protein Serine/T	100.0
cd07844	291	STKc_PCTAIRE_like Catalytic domain of PCTAIRE-like	100.0
cd07846	286	STKc_CDKL2_3 Catalytic domain of the Serine/Threon	100.0
cd07861	285	STKc_CDK1_euk Catalytic domain of the Serine/Threo	100.0
cd06626	264	STKc_MEKK4 Catalytic domain of the Protein Serine/	100.0
cd06623	264	PKc_MAPKK_plant_like Catalytic domain of Plant dua	100.0
PTZ00284	467	protein kinase; Provisional	100.0
cd06917	277	STKc_NAK1_like Catalytic domain of Fungal Nak1-lik	100.0
cd08220	256	STKc_Nek8 Catalytic domain of the Protein Serine/T	100.0
cd07870	291	STKc_PFTAIRE2 Catalytic domain of the Serine/Threo	100.0
KOG0032	382	consensus Ca2+/calmodulin-dependent protein kinase	100.0
cd06607	307	STKc_TAO Catalytic domain of the Protein Serine/Th	100.0
cd07878	343	STKc_p38beta_MAPK11 Catalytic domain of the Serine	100.0
cd06616	288	PKc_MKK4 Catalytic domain of the dual-specificity	100.0
cd07847	286	STKc_CDKL1_4 Catalytic domain of the Serine/Threon	100.0
cd07832	286	STKc_CCRK Catalytic domain of the Serine/Threonine	100.0
cd06659	297	STKc_PAK6 Catalytic domain of the Protein Serine/T	100.0
cd06648	285	STKc_PAK_II Catalytic domain of the Protein Serine	100.0
KOG0599	411	consensus Phosphorylase kinase gamma subunit [Carb	100.0
cd05609	305	STKc_MAST Catalytic domain of the Protein Serine/T	100.0
PHA03209	357	serine/threonine kinase US3; Provisional	100.0
cd05574	316	STKc_phototropin_like Catalytic domain of Phototro	100.0
KOG0577	948	consensus Serine/threonine protein kinase [Signal	100.0
cd05586	330	STKc_Sck1_like Catalytic domain of Suppressor of l	100.0
cd07839	284	STKc_CDK5 Catalytic domain of the Serine/Threonine	100.0
cd07833	288	STKc_CDKL Catalytic domain of Cyclin-Dependent pro	100.0
cd06630	268	STKc_MEKK1 Catalytic domain of the Protein Serine/	100.0
PHA03207	392	serine/threonine kinase US3; Provisional	100.0
cd06635	317	STKc_TAO1 Catalytic domain of the Protein Serine/T	100.0
cd07843	293	STKc_CDC2L1 Catalytic domain of the Serine/Threoni	100.0
KOG0574	502	consensus STE20-like serine/threonine kinase MST [	100.0
cd05580	290	STKc_PKA Catalytic domain of the Protein Serine/Th	100.0
cd07860	284	STKc_CDK2_3 Catalytic domain of the Serine/Threoni	100.0
cd06647	293	STKc_PAK_I Catalytic domain of the Protein Serine/	100.0
cd07841	298	STKc_CDK7 Catalytic domain of the Serine/Threonine	100.0
cd08530	256	STKc_CNK2-like Catalytic domain of the Protein Ser	100.0
cd08225	257	STKc_Nek5 Catalytic domain of the Protein Serine/T	100.0
cd05572	262	STKc_cGK_PKG Catalytic domain of the Protein Serin	100.0
cd06653	264	STKc_MEKK3_like_1 Catalytic domain of MAP/ERK kina	100.0
cd07831	282	STKc_MOK Catalytic domain of the Serine/Threonine	100.0
KOG0610	459	consensus Putative serine/threonine protein kinase	100.0
cd07840	287	STKc_CDK9_like Catalytic domain of Cyclin-Dependen	100.0
cd06614	286	STKc_PAK Catalytic domain of the Protein Serine/Th	100.0
cd05578	258	STKc_Yank1 Catalytic domain of the Protein Serine/	100.0
cd07836	284	STKc_Pho85 Catalytic domain of the Serine/Threonin	100.0
cd07852	337	STKc_MAPK15 Catalytic domain of the Serine/Threoni	100.0
cd06606	260	STKc_MAPKKK Catalytic domain of the Protein Serine	100.0
cd07845	309	STKc_CDK10 Catalytic domain of the Serine/Threonin	100.0
cd07837	295	STKc_CdkB_plant Catalytic domain of the Serine/Thr	100.0
cd07835	283	STKc_CDK1_like Catalytic domain of Cyclin-Dependen	100.0
cd07849	336	STKc_ERK1_2_like Catalytic domain of Extracellular	100.0
cd06618	296	PKc_MKK7 Catalytic domain of the dual-specificity	100.0
cd05122	253	PKc_STE Catalytic domain of STE family Protein Kin	100.0
cd07842	316	STKc_CDK8_like Catalytic domain of Cyclin-Dependen	100.0
KOG0986	591	consensus G protein-coupled receptor kinase [Signa	100.0
cd05633	279	STKc_GRK3 Catalytic domain of the Protein Serine/T	100.0
cd07850	353	STKc_JNK Catalytic domain of the Serine/Threonine	100.0
cd05577	277	STKc_GRK Catalytic domain of the Protein Serine/Th	100.0
cd07864	302	STKc_CDK12 Catalytic domain of the Serine/Threonin	100.0
cd08215	258	STKc_Nek Catalytic domain of the Protein Serine/Th	100.0
cd08226	328	PK_STRAD_beta Pseudokinase domain of STE20-related	100.0
cd05613	290	STKc_MSK1_N N-terminal catalytic domain of the Pro	100.0
cd06634	308	STKc_TAO2 Catalytic domain of the Protein Serine/T	100.0
PHA02882	294	putative serine/threonine kinase; Provisional	100.0
PLN00009	294	cyclin-dependent kinase A; Provisional	100.0
PHA03390	267	pk1 serine/threonine-protein kinase 1; Provisional	100.0
cd05583	288	STKc_MSK_N N-terminal catalytic domain of the Prot	100.0
cd06657	292	STKc_PAK4 Catalytic domain of the Protein Serine/T	100.0
cd06627	254	STKc_Cdc7_like Catalytic domain of Cell division c	100.0
KOG0667	586	consensus Dual-specificity tyrosine-phosphorylatio	100.0
cd05118	283	STKc_CMGC Catalytic domain of CMGC family Serine/T	100.0
cd07830	283	STKc_MAK_like Catalytic domain of Male germ cell-A	100.0
cd05579	265	STKc_MAST_like Catalytic domain of Microtubule-ass	100.0
cd07838	287	STKc_CDK4_6_like Catalytic domain of Cyclin-Depend	100.0
cd07879	342	STKc_p38delta_MAPK13 Catalytic domain of the Serin	100.0
cd05611	260	STKc_Rim15_like Catalytic domain of fungal Rim15-l	100.0
cd08222	260	STKc_Nek11 Catalytic domain of the Protein Serine/	100.0
cd07855	334	STKc_ERK5 Catalytic domain of the Serine/Threonine	100.0
KOG1035	1351	consensus eIF-2alpha kinase GCN2 [Translation, rib	100.0
KOG0596	677	consensus Dual specificity; serine/threonine and t	100.0
KOG0983	391	consensus Mitogen-activated protein kinase (MAPK)	100.0
cd08216	314	PK_STRAD Pseudokinase domain of STE20-related kina	100.0
KOG4717	864	consensus Serine/threonine protein kinase [Signal	100.0
cd05606	278	STKc_beta_ARK Catalytic domain of the Protein Seri	100.0
cd07865	310	STKc_CDK9 Catalytic domain of the Serine/Threonine	100.0
cd07858	337	STKc_TEY_MAPK_plant Catalytic domain of the Serine	100.0
PHA03210	501	serine/threonine kinase US3; Provisional	100.0
cd06633	313	STKc_TAO3 Catalytic domain of the Protein Serine/T	100.0
cd05581	280	STKc_PDK1 Catalytic domain of the Protein Serine/T	100.0
cd07877	345	STKc_p38alpha_MAPK14 Catalytic domain of the Serin	100.0
cd07856	328	STKc_Sty1_Hog1 Catalytic domain of the Serine/Thre	100.0
cd07834	330	STKc_MAPK Catalytic domain of the Serine/Threonine	100.0
cd07866	311	STKc_BUR1 Catalytic domain of the Serine/Threonine	100.0
cd07829	282	STKc_CDK_like Catalytic domain of Cyclin-Dependent	100.0
cd07880	343	STKc_p38gamma_MAPK12 Catalytic domain of the Serin	100.0
PTZ00024	335	cyclin-dependent protein kinase; Provisional	100.0
KOG1006	361	consensus Mitogen-activated protein kinase (MAPK)	100.0
cd07854	342	STKc_MAPK4_6 Catalytic domain of the Serine/Threon	100.0
KOG4250	732	consensus TANK binding protein kinase TBK1 [Signal	100.0
cd05123	250	STKc_AGC Catalytic domain of AGC family Protein Se	100.0
KOG0579	1187	consensus Ste20-like serine/threonine protein kina	100.0
cd07857	332	STKc_MPK1 Catalytic domain of the Serine/Threonine	100.0
KOG0586	596	consensus Serine/threonine protein kinase [General	100.0
cd07851	343	STKc_p38 Catalytic domain of the Serine/Threonine	100.0
KOG0666	438	consensus Cyclin C-dependent kinase CDK8 [Transcri	100.0
PLN03224	507	probable serine/threonine protein kinase; Provisio	100.0
KOG0612	1317	consensus Rho-associated, coiled-coil containing p	100.0
KOG4645	1509	consensus MAPKKK (MAP kinase kinase kinase) SSK2 a	100.0
cd05610	669	STKc_MASTL Catalytic domain of the Protein Serine/	100.0
cd05576	237	STKc_RPK118_like Catalytic domain of the Protein S	100.0
KOG1151	775	consensus Tousled-like protein kinase [Signal tran	100.0
KOG0690	516	consensus Serine/threonine protein kinase [Signal	100.0
KOG0603	612	consensus Ribosomal protein S6 kinase [Signal tran	99.98
KOG0604	400	consensus MAP kinase-activated protein kinase 2 [S	99.98
KOG0587	953	consensus Traf2- and Nck-interacting kinase and re	99.98
smart00220	244	S_TKc Serine/Threonine protein kinases, catalytic	99.97
PLN03225	566	Serine/threonine-protein kinase SNT7; Provisional	99.97
KOG0662	292	consensus Cyclin-dependent kinase CDK5 [Intracellu	99.97
KOG0607	463	consensus MAP kinase-interacting kinase and relate	99.97
KOG4236	888	consensus Serine/threonine protein kinase PKC mu/P	99.97
KOG0669	376	consensus Cyclin T-dependent kinase CDK9 [Cell cyc	99.97
KOG0696	683	consensus Serine/threonine protein kinase [Signal	99.97
KOG0671	415	consensus LAMMER dual specificity kinases [Signal	99.97
KOG0984	282	consensus Mitogen-activated protein kinase (MAPK)	99.97
KOG1027	903	consensus Serine/threonine protein kinase and endo	99.97
KOG0608	1034	consensus Warts/lats-like serine threonine kinases	99.96
KOG0614	732	consensus cGMP-dependent protein kinase [Signal tr	99.96
cd00180	215	PKc Catalytic domain of Protein Kinases. Protein K	99.96
PLN00113	968	leucine-rich repeat receptor-like protein kinase;	99.96
KOG0695	593	consensus Serine/threonine protein kinase [Signal	99.95
KOG0668	338	consensus Casein kinase II, alpha subunit [Signal	99.95
KOG0664	449	consensus Nemo-like MAPK-related serine/threonine	99.95
KOG0665	369	consensus Jun-N-terminal kinase (JNK) [Signal tran	99.95
smart00221	225	STYKc Protein kinase; unclassified specificity. Ph	99.95
KOG1152	772	consensus Signal transduction serine/threonine kin	99.94
KOG1290	590	consensus Serine/threonine protein kinase [Signal	99.94
KOG1345	378	consensus Serine/threonine kinase [Signal transduc	99.93
KOG0195	448	consensus Integrin-linked kinase [Signal transduct	99.93
smart00750	176	KIND kinase non-catalytic C-lobe domain. It is an	99.93
PLN00181	793	protein SPA1-RELATED; Provisional	99.93
KOG0576	829	consensus Mitogen-activated protein kinase kinase	99.93
KOG0670	752	consensus U4/U6-associated splicing factor PRP4 [R	99.93
KOG1167	418	consensus Serine/threonine protein kinase of the C	99.91
PRK09188	365	serine/threonine protein kinase; Provisional	99.9
COG0515	384	SPS1 Serine/threonine protein kinase [General func	99.87
KOG1164	322	consensus Casein kinase (serine/threonine/tyrosine	99.87
KOG0590	601	consensus Checkpoint kinase and related serine/thr	99.83
cd05147	190	RIO1_euk RIO kinase family; eukaryotic RIO1, catal	99.82
KOG1240	1431	consensus Protein kinase containing WD40 repeats [	99.82
KOG1163	341	consensus Casein kinase (serine/threonine/tyrosine	99.82
PRK10359	232	lipopolysaccharide core biosynthesis protein; Prov	99.82
KOG1023	484	consensus Natriuretic peptide receptor, guanylate	99.82
PLN03150	623	hypothetical protein; Provisional	99.81
cd05145	190	RIO1_like RIO kinase family; RIO1, RIO3 and simila	99.81
KOG0617	264	consensus Ras suppressor protein (contains leucine	99.8
KOG1165	449	consensus Casein kinase (serine/threonine/tyrosine	99.79
KOG4158	598	consensus BRPK/PTEN-induced protein kinase [Signal	99.79
PRK12274	218	serine/threonine protein kinase; Provisional	99.79
KOG0603	612	consensus Ribosomal protein S6 kinase [Signal tran	99.78
PRK10345	210	hypothetical protein; Provisional	99.76
KOG4194	873	consensus Membrane glycoprotein LIG-1 [Signal tran	99.76
PF14531	288	Kinase-like: Kinase-like; PDB: 3DZO_A 2W1Z_A 3BYV_	99.74
cd05144	198	RIO2_C RIO kinase family; RIO2, C-terminal catalyt	99.71
PRK14879	211	serine/threonine protein kinase; Provisional	99.7
PRK09605	535	bifunctional UGMP family protein/serine/threonine	99.69
smart00090	237	RIO RIO-like kinase.	99.69
KOG4237	498	consensus Extracellular matrix protein slit, conta	99.69
KOG1033	516	consensus eIF-2alpha kinase PEK/EIF2AK3 [Translati	99.68
TIGR03724	199	arch_bud32 Kae1-associated kinase Bud32. Members o	99.68
KOG1166	974	consensus Mitotic checkpoint serine/threonine prot	99.66
KOG0444	1255	consensus Cytoskeletal regulator Flightless-I (con	99.65
KOG4194	873	consensus Membrane glycoprotein LIG-1 [Signal tran	99.63
KOG0617	264	consensus Ras suppressor protein (contains leucine	99.62
KOG0606	1205	consensus Microtubule-associated serine/threonine	99.59
KOG0444	1255	consensus Cytoskeletal regulator Flightless-I (con	99.59
cd05119	187	RIO RIO kinase family, catalytic domain. The RIO k	99.58
cd05120	155	APH_ChoK_like Aminoglycoside 3'-phosphotransferase	99.58
PRK01723	239	3-deoxy-D-manno-octulosonic-acid kinase; Reviewed	99.56
KOG1266	458	consensus Protein kinase [Signal transduction mech	99.51
KOG0472	565	consensus Leucine-rich repeat protein [Function un	99.51
KOG0472	565	consensus Leucine-rich repeat protein [Function un	99.5
KOG0532	722	consensus Leucine-rich repeat (LRR) protein, conta	99.47
TIGR01982	437	UbiB 2-polyprenylphenol 6-hydroxylase. This model	99.45
KOG0590	601	consensus Checkpoint kinase and related serine/thr	99.45
PRK15387	788	E3 ubiquitin-protein ligase SspH2; Provisional	99.45
PRK15370	754	E3 ubiquitin-protein ligase SlrP; Provisional	99.38
KOG0532	722	consensus Leucine-rich repeat (LRR) protein, conta	99.37
PRK15370	754	E3 ubiquitin-protein ligase SlrP; Provisional	99.36
KOG0618	1081	consensus Serine/threonine phosphatase 2C containi	99.36
PRK15387	788	E3 ubiquitin-protein ligase SspH2; Provisional	99.35
cd00116	319	LRR_RI Leucine-rich repeats (LRRs), ribonuclease i	99.31
KOG0618	1081	consensus Serine/threonine phosphatase 2C containi	99.31
PLN03150	623	hypothetical protein; Provisional	99.3
cd05151	170	ChoK Choline Kinase (ChoK). The ChoK subfamily is	99.27
PRK04750	537	ubiB putative ubiquinone biosynthesis protein UbiB	99.27
PLN03210	1153	Resistant to P. syringae 6; Provisional	99.27
cd00116	319	LRR_RI Leucine-rich repeats (LRRs), ribonuclease i	99.27
KOG0601	524	consensus Cyclin-dependent kinase WEE1 [Cell cycle	99.26
PLN03210	1153	Resistant to P. syringae 6; Provisional	99.26
KOG0601	524	consensus Cyclin-dependent kinase WEE1 [Cell cycle	99.2
KOG1259	490	consensus Nischarin, modulator of integrin alpha5	99.16
PF14580	175	LRR_9: Leucine-rich repeat; PDB: 2JE1_D 2JE0_A 2JQ	99.15
COG4886	394	Leucine-rich repeat (LRR) protein [Function unknow	99.14
cd05154	223	ACAD10_11_like Acyl-CoA dehydrogenase (ACAD) 10 an	99.13
KOG1243	690	consensus Protein kinase [General function predict	99.12
COG4886	394	Leucine-rich repeat (LRR) protein [Function unknow	99.1
cd05146	197	RIO3_euk RIO kinase family; eukaryotic RIO3, catal	99.07
KOG4237	498	consensus Extracellular matrix protein slit, conta	99.0
KOG1259	490	consensus Nischarin, modulator of integrin alpha5	98.98
PF14580	175	LRR_9: Leucine-rich repeat; PDB: 2JE1_D 2JE0_A 2JQ	98.97
COG3642	204	Mn2+-dependent serine/threonine protein kinase [Si	98.95
KOG3087	229	consensus Serine/threonine protein kinase [General	98.94
KOG3741	655	consensus Poly(A) ribonuclease subunit [RNA proces	98.89
PF13855	61	LRR_8: Leucine rich repeat; PDB: 2O6S_A 3A79_B 3RF	98.89
PF13855	61	LRR_8: Leucine rich repeat; PDB: 2O6S_A 3A79_B 3RF	98.82
KOG0606	1205	consensus Microtubule-associated serine/threonine	98.82
PRK15123	268	lipopolysaccharide core heptose(I) kinase RfaP; Pr	98.82
PF01163	188	RIO1: RIO1 family; InterPro: IPR018934 Protein pho	98.75
KOG4579	177	consensus Leucine-rich repeat (LRR) protein associ	98.66
KOG3207	505	consensus Beta-tubulin folding cofactor E [Posttra	98.63
PF08263	43	LRRNT_2: Leucine rich repeat N-terminal domain; In	98.62
KOG2137	700	consensus Protein kinase [Signal transduction mech	98.6
KOG4579	177	consensus Leucine-rich repeat (LRR) protein associ	98.54
KOG1859	1096	consensus Leucine-rich repeat proteins [General fu	98.48
PF06293	206	Kdo: Lipopolysaccharide kinase (Kdo/WaaP) family;	98.47
KOG3207	505	consensus Beta-tubulin folding cofactor E [Posttra	98.46
PRK09902	216	hypothetical protein; Provisional	98.43
KOG1859	1096	consensus Leucine-rich repeat proteins [General fu	98.38
KOG0531	414	consensus Protein phosphatase 1, regulatory subuni	98.37
COG0478	304	RIO-like serine/threonine protein kinase fused to	98.34
KOG0531	414	consensus Protein phosphatase 1, regulatory subuni	98.32
COG4248	637	Uncharacterized protein with protein kinase and he	98.23
COG0661	517	AarF Predicted unusual protein kinase [General fun	98.23
TIGR02172	226	Fb_sc_TIGR02172 Fibrobacter succinogenes paralogou	98.21
KOG4658	889	consensus Apoptotic ATPase [Signal transduction me	98.19
KOG1909	382	consensus Ran GTPase-activating protein [RNA proce	98.16

>PLN00113 leucine-rich repeat receptor-like protein kinase; Provisional

Probab=100.00  E-value=1.7e-63  Score=600.16  Aligned_cols=534  Identities=28%  Similarity=0.434  Sum_probs=320.1

Q ss_pred             EEEEEcCCCCcccccCcCcCCCCCCCEEEccCCcccccCCccccCCCCCcEEEecccCCCCCCCccccCCccccEEeeec
Q 005586           70 VANISLQGKGLTGKLSPSLSGLKCLSGLYLHYNSLSGEIPKEIRNLTELTDLYLDVNNLSGNIPPEIGSMASLQVLQLCC  149 (689)
Q Consensus        70 v~~l~L~~~~l~g~~~~~~~~l~~L~~L~L~~N~l~g~~p~~~~~l~~L~~L~Ls~N~l~g~~p~~~~~l~~L~~L~Ls~  149 (689)
                      ++.|+|++|.++|.+|..|.++++|+.|+|++|.++|.+|..+..+++|+.|+|++|++.|.+|..+ .+++|+.|+|++
T Consensus       406 L~~L~L~~n~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~n~~~~~~p~~~-~~~~L~~L~ls~  484 (968)
T PLN00113        406 LRRVRLQDNSFSGELPSEFTKLPLVYFLDISNNNLQGRINSRKWDMPSLQMLSLARNKFFGGLPDSF-GSKRLENLDLSR  484 (968)
T ss_pred             CCEEECcCCEeeeECChhHhcCCCCCEEECcCCcccCccChhhccCCCCcEEECcCceeeeecCccc-ccccceEEECcC
Confidence            3344444444444444444444444444444444444444444444444444444444444444333 234555666666


Q ss_pred             ccCCCCCchhcCCCCCCCEEeccCCcCCCCCCcccCCCCCCCeeeccCCcCCCCchhhhhCCCCCcEEecccCcCCcccc
Q 005586          150 NQLTGNIPAQIGSLKSLSVLTLQHNRLNGGIPDSLGNLGKLKRLDLSFNSLFGTIPESLANNAELLFLDVQNNTLSGIVP  229 (689)
Q Consensus       150 N~l~g~~p~~~~~l~~L~~L~l~~N~l~~~~p~~~~~l~~L~~L~ls~N~l~g~~p~~l~~~~~L~~l~l~~N~l~~~~p  229 (689)
                      |++++.+|..+.++++|+.|+|++|++++.+|..++++++|+.|+|++|+++|.+|..+..+++|+.|+|++|+++|.+|
T Consensus       485 n~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p  564 (968)
T PLN00113        485 NQFSGAVPRKLGSLSELMQLKLSENKLSGEIPDELSSCKKLVSLDLSHNQLSGQIPASFSEMPVLSQLDLSQNQLSGEIP  564 (968)
T ss_pred             CccCCccChhhhhhhccCEEECcCCcceeeCChHHcCccCCCEEECCCCcccccCChhHhCcccCCEEECCCCcccccCC
Confidence            66666666666666677777777777776777777777777777777777777777777777777777777777777777


Q ss_pred             hhHHhccC--ccccccCCCCCCCCCCCCcccccCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCccccCCCCCCCCCCCCc
Q 005586          230 SALKRLNG--GFQFQNNPGLCGDGIASLRACTVYDNTQINPVKPFGSHSNDTTPIDISEPSGFKEHCNQSQCSNSSKFPQ  307 (689)
Q Consensus       230 ~~~~~~~~--~~~~~~n~~~c~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ss~~~~  307 (689)
                      ..+..+..  .+.+.+|+..+..+.  .........      ..+  ..+.......+  ......|...   . .....
T Consensus       565 ~~l~~l~~L~~l~ls~N~l~~~~p~--~~~~~~~~~------~~~--~~n~~lc~~~~--~~~~~~c~~~---~-~~~~~  628 (968)
T PLN00113        565 KNLGNVESLVQVNISHNHLHGSLPS--TGAFLAINA------SAV--AGNIDLCGGDT--TSGLPPCKRV---R-KTPSW  628 (968)
T ss_pred             hhHhcCcccCEEeccCCcceeeCCC--cchhcccCh------hhh--cCCccccCCcc--ccCCCCCccc---c-cccee
Confidence            66655432  344555553332110  000000000      000  00000000000  0000011110   0 11111


Q ss_pred             chhhhHHHHHHHHHHHHHHHHHHHHHHhhcccCCCCCCCCccccchhhhhccccCCCCCCcccccccCCCCCCCCCCCCC
Q 005586          308 IAVLAAVTSVTVILAGTGILIFFRYRRHKQKIGNTSESSDWQLSTDLTLAKDFNRNGASPLVSLEYCHGWDPLGDYLNGT  387 (689)
Q Consensus       308 ~~ii~~v~~~~~ll~~~~~~~~~~~rr~k~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  387 (689)
                      ..++++++++++++++++++++++++|++.+.+ ..+...                           ..|+..       
T Consensus       629 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~---------------------------~~~~~~-------  673 (968)
T PLN00113        629 WFYITCTLGAFLVLALVAFGFVFIRGRNNLELK-RVENED---------------------------GTWELQ-------  673 (968)
T ss_pred             eeehhHHHHHHHHHHHHHHHHHHHHhhhccccc-cccccc---------------------------cccccc-------
Confidence            222222222222222222222222222211110 000000                           001000       


Q ss_pred             CCccccccccccCHHHHHHHhccCCcccccccCCcceEEEEEe-cCCcEEEEEEecccCCchHHHHHHHHHHHHhccCCC
Q 005586          388 GFSREHLNSFRLNLEEVESATQCFSEVNLLGKGNFSSVYKGTL-RDGTLVAIRSINVTSCKSEEAEFVKGLYLLTSLRHE  466 (689)
Q Consensus       388 ~~~~~~~~~~~~~~~~l~~at~~f~~~~~lg~G~~g~Vy~~~~-~~g~~vavK~l~~~~~~~~~~~f~~e~~~l~~l~H~  466 (689)
                      .+...  ....++++++.   ..|...+.||+|+||.||+|+. .+|..||||++.....     ...+|++.+++++||
T Consensus       674 ~~~~~--~~~~~~~~~~~---~~~~~~~~ig~G~~g~Vy~~~~~~~~~~vavK~~~~~~~-----~~~~~~~~l~~l~Hp  743 (968)
T PLN00113        674 FFDSK--VSKSITINDIL---SSLKEENVISRGKKGASYKGKSIKNGMQFVVKEINDVNS-----IPSSEIADMGKLQHP  743 (968)
T ss_pred             ccccc--cchhhhHHHHH---hhCCcccEEccCCCeeEEEEEECCCCcEEEEEEccCCcc-----ccHHHHHHHhhCCCC
Confidence            00000  00123444443   4577888999999999999997 4799999999875432     122458889999999


Q ss_pred             cceeEeeEEEcCCCCeEEEEEEcCCCCCHHHHhhhcCCCCCCCCHHHHHHHHHHHHHHHhhhhCCCCCCCceeecCCCCC
Q 005586          467 NIIRLRGFCCSRGRGECFLIYDFAPKGKLSKYLDQEEGSSNVLDWSTRVSIIIGIAKGIGYLHSSEVNKPAIVHRNLSVE  546 (689)
Q Consensus       467 niv~l~g~~~~~~~~~~~lV~e~~~~gsL~~~L~~~~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~~~ivH~dlk~~  546 (689)
                      |||+++|+|..  .+..++||||+++|+|.++++.       ++|.++.+|+.|+|+||+|||+.+  .++|+||||||+
T Consensus       744 nIv~~~~~~~~--~~~~~lv~Ey~~~g~L~~~l~~-------l~~~~~~~i~~~ia~~L~yLH~~~--~~~iiH~dlkp~  812 (968)
T PLN00113        744 NIVKLIGLCRS--EKGAYLIHEYIEGKNLSEVLRN-------LSWERRRKIAIGIAKALRFLHCRC--SPAVVVGNLSPE  812 (968)
T ss_pred             CcceEEEEEEc--CCCCEEEEeCCCCCcHHHHHhc-------CCHHHHHHHHHHHHHHHHHhccCC--CCCeecCCCCHH
Confidence            99999999954  4678999999999999999962       899999999999999999999653  466999999999


Q ss_pred             ceeecCCCCeEEecccccccccCCceeeeecCCCCCCCCCccccccCCCCCcccchhHHHHHHHHHhCCCCcchhHH---
Q 005586          547 KVLIDQQFNPLIADCGLHKLLADDIVFSVLKTSAAMGYLAPEYVTTGRFTERSDIFAFGVIILQILTGSLVLTSSMR---  623 (689)
Q Consensus       547 NiLl~~~~~~kl~DfGla~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~ksDV~sfGvvl~elltG~~p~~~~~~---  623 (689)
                      ||+++.++.+++. ||.......+     ....++.+|||||++.+..++.|+|||||||++|||+||+.|+.....   
T Consensus       813 Nil~~~~~~~~~~-~~~~~~~~~~-----~~~~~t~~y~aPE~~~~~~~~~~sDv~S~Gvvl~el~tg~~p~~~~~~~~~  886 (968)
T PLN00113        813 KIIIDGKDEPHLR-LSLPGLLCTD-----TKCFISSAYVAPETRETKDITEKSDIYGFGLILIELLTGKSPADAEFGVHG  886 (968)
T ss_pred             hEEECCCCceEEE-eccccccccC-----CCccccccccCcccccCCCCCcccchhhHHHHHHHHHhCCCCCCcccCCCC
Confidence            9999999998876 6665433221     123467889999999999999999999999999999999999853211   


Q ss_pred             -HHHh------hhhhhHhhccccCC--CCCHHHHHHHHHHHHHhccCCCCCCCCHHHHHHHHHhhCCc
Q 005586          624 -LAAE------SATFENFIDRNLKG--KFSESEAAKLGKMALVCTHEDPENRPTMEAVIEELTVAAPV  682 (689)
Q Consensus       624 -~~~~------~~~~~~~~~~~~~~--~~~~~~~~~l~~l~~~Cl~~dp~~RPs~~evl~~L~~~~p~  682 (689)
                       ...+      ......++|+.+..  ....++..++.+++.+||+.||++||+|+||+++|+.+...
T Consensus       887 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~Cl~~~P~~RPt~~evl~~L~~~~~~  954 (968)
T PLN00113        887 SIVEWARYCYSDCHLDMWIDPSIRGDVSVNQNEIVEVMNLALHCTATDPTARPCANDVLKTLESASRS  954 (968)
T ss_pred             cHHHHHHHhcCccchhheeCccccCCCCccHHHHHHHHHHHHhhCcCCchhCcCHHHHHHHHHHhhcc
Confidence             0001      11223344554433  23456778899999999999999999999999999988654

>KOG1187 consensus Serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=1.9e-58  Score=486.17  Aligned_cols=278  Identities=39%  Similarity=0.761  Sum_probs=240.4

Q ss_pred             cccCHHHHHHHhccCCcccccccCCcceEEEEEecCCcEEEEEEecccCCchHHHHHHHHHHHHhccCCCcceeEeeEEE
Q 005586          397 FRLNLEEVESATQCFSEVNLLGKGNFSSVYKGTLRDGTLVAIRSINVTSCKSEEAEFVKGLYLLTSLRHENIIRLRGFCC  476 (689)
Q Consensus       397 ~~~~~~~l~~at~~f~~~~~lg~G~~g~Vy~~~~~~g~~vavK~l~~~~~~~~~~~f~~e~~~l~~l~H~niv~l~g~~~  476 (689)
                      ..|+++++..||++|+..+.||+|+||.||+|.+++|+.||||++....... .++|.+|++++++++|||+|+|+|||.
T Consensus        63 ~~fs~~el~~AT~~Fs~~~~ig~Ggfg~VYkG~l~~~~~vAVK~~~~~~~~~-~~eF~~Ei~~ls~l~H~Nlv~LlGyC~  141 (361)
T KOG1187|consen   63 RSFSYDELRKATNNFSESNLIGEGGFGTVYKGVLSDGTVVAVKRLSSNSGQG-EREFLNEVEILSRLRHPNLVKLLGYCL  141 (361)
T ss_pred             ceeeHHHHHHHHhCCchhcceecCCCeEEEEEEECCCCEEEEEEecCCCCcc-hhHHHHHHHHHhcCCCcCcccEEEEEe
Confidence            4699999999999999999999999999999999999999999888765433 567999999999999999999999997


Q ss_pred             cCCCCeEEEEEEcCCCCCHHHHhhhcCCCCCCCCHHHHHHHHHHHHHHHhhhhCCCCCCCceeecCCCCCceeecCCCCe
Q 005586          477 SRGRGECFLIYDFAPKGKLSKYLDQEEGSSNVLDWSTRVSIIIGIAKGIGYLHSSEVNKPAIVHRNLSVEKVLIDQQFNP  556 (689)
Q Consensus       477 ~~~~~~~~lV~e~~~~gsL~~~L~~~~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~~~ivH~dlk~~NiLl~~~~~~  556 (689)
                      +.+. +.+||||||+||+|.++|+.....  +++|.+|++||.++|+||+|||+..  .|+||||||||+|||||+++++
T Consensus       142 e~~~-~~~LVYEym~nGsL~d~L~~~~~~--~L~W~~R~kIa~g~A~gL~yLH~~~--~~~iiHrDiKssNILLD~~~~a  216 (361)
T KOG1187|consen  142 EGGE-HRLLVYEYMPNGSLEDHLHGKKGE--PLDWETRLKIALGAARGLAYLHEGC--PPPIIHRDIKSSNILLDEDFNA  216 (361)
T ss_pred             cCCc-eEEEEEEccCCCCHHHHhCCCCCC--CCCHHHHHHHHHHHHHHHHHHccCC--CCCEecCCCCHHHeeECCCCCE
Confidence            6432 699999999999999999986543  6999999999999999999999864  7899999999999999999999


Q ss_pred             EEecccccccccC-CceeeeecCCCCCCCCCccccccCCCCCcccchhHHHHHHHHHhCCCCcchhH--------H---H
Q 005586          557 LIADCGLHKLLAD-DIVFSVLKTSAAMGYLAPEYVTTGRFTERSDIFAFGVIILQILTGSLVLTSSM--------R---L  624 (689)
Q Consensus       557 kl~DfGla~~~~~-~~~~~~~~~~~~~~y~aPE~~~~~~~~~ksDV~sfGvvl~elltG~~p~~~~~--------~---~  624 (689)
                      ||+|||+|+.... ........ .||.+|+||||+..+..++|+|||||||||+||+||+.+.+...        .   .
T Consensus       217 KlsDFGLa~~~~~~~~~~~~~~-~gt~gY~~PEy~~~g~lt~KsDVySFGVvllElitgr~~~d~~~~~~~~~l~~w~~~  295 (361)
T KOG1187|consen  217 KLSDFGLAKLGPEGDTSVSTTV-MGTFGYLAPEYASTGKLTEKSDVYSFGVVLLELITGRKAVDQSRPRGELSLVEWAKP  295 (361)
T ss_pred             EccCccCcccCCccccceeeec-CCCCccCChhhhccCCcCcccccccchHHHHHHHhCCcccCCCCCcccccHHHHHHH
Confidence            9999999987765 32211111 78999999999999999999999999999999999998876321        1   1


Q ss_pred             HHhhhhhhHhhccccC-CCCCH-HHHHHHHHHHHHhccCCCCCCCCHHHHHHHHHhhCC
Q 005586          625 AAESATFENFIDRNLK-GKFSE-SEAAKLGKMALVCTHEDPENRPTMEAVIEELTVAAP  681 (689)
Q Consensus       625 ~~~~~~~~~~~~~~~~-~~~~~-~~~~~l~~l~~~Cl~~dp~~RPs~~evl~~L~~~~p  681 (689)
                      ......+.+++|+.+. +.++. .++.++.+++.+|++.+|++||+|.||+++|+....
T Consensus       296 ~~~~~~~~eiiD~~l~~~~~~~~~~~~~~~~~a~~C~~~~~~~RP~m~~Vv~~L~~~~~  354 (361)
T KOG1187|consen  296 LLEEGKLREIVDPRLKEGEYPDEKEVKKLAELALRCLRPDPKERPTMSQVVKELEGILS  354 (361)
T ss_pred             HHHCcchhheeCCCccCCCCChHHHHHHHHHHHHHHcCcCCCcCcCHHHHHHHHHhhcc
Confidence            1222367889999987 66665 689999999999999999999999999999966543

>KOG0192 consensus Tyrosine kinase specific for activated (GTP-bound) p21cdc42Hs [Signal transduction mechanisms]

Probab=100.00  E-value=1.9e-49  Score=414.69  Aligned_cols=254  Identities=28%  Similarity=0.528  Sum_probs=213.1

Q ss_pred             ccccccCCcceEEEEEecCCcEEEEEEecccCCc-hHHHHHHHHHHHHhccCCCcceeEeeEEEcCCCCeEEEEEEcCCC
Q 005586          414 VNLLGKGNFSSVYKGTLRDGTLVAIRSINVTSCK-SEEAEFVKGLYLLTSLRHENIIRLRGFCCSRGRGECFLIYDFAPK  492 (689)
Q Consensus       414 ~~~lg~G~~g~Vy~~~~~~g~~vavK~l~~~~~~-~~~~~f~~e~~~l~~l~H~niv~l~g~~~~~~~~~~~lV~e~~~~  492 (689)
                      .+.||+|+||+||+|.++....||||++...... ...++|.+|+.+|.+++|||||+++|+|.+. ....++|||||++
T Consensus        46 ~~~iG~G~~g~V~~~~~~g~~~vavK~~~~~~~~~~~~~~f~~E~~il~~l~HpNIV~f~G~~~~~-~~~~~iVtEy~~~  124 (362)
T KOG0192|consen   46 EEVLGSGSFGTVYKGKWRGTDVVAVKIISDPDFDDESRKAFRREASLLSRLRHPNIVQFYGACTSP-PGSLCIVTEYMPG  124 (362)
T ss_pred             hhhcccCCceeEEEEEeCCceeEEEEEecchhcChHHHHHHHHHHHHHHhCCCCCeeeEEEEEcCC-CCceEEEEEeCCC
Confidence            3569999999999999985445999999865432 2257999999999999999999999999543 1268999999999


Q ss_pred             CCHHHHhhhcCCCCCCCCHHHHHHHHHHHHHHHhhhhCCCCCCCceeecCCCCCceeecCCC-CeEEecccccccccCCc
Q 005586          493 GKLSKYLDQEEGSSNVLDWSTRVSIIIGIAKGIGYLHSSEVNKPAIVHRNLSVEKVLIDQQF-NPLIADCGLHKLLADDI  571 (689)
Q Consensus       493 gsL~~~L~~~~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~~~ivH~dlk~~NiLl~~~~-~~kl~DfGla~~~~~~~  571 (689)
                      |+|.++|+..  ....++|..+++||.|||+||.|||+.+   | ||||||||+|||++.++ ++||+|||+++......
T Consensus       125 GsL~~~l~~~--~~~~l~~~~~l~~aldiArGm~YLH~~~---~-iIHrDLK~~NiLv~~~~~~~KI~DFGlsr~~~~~~  198 (362)
T KOG0192|consen  125 GSLSVLLHKK--RKRKLPLKVRLRIALDIARGMEYLHSEG---P-IIHRDLKSDNILVDLKGKTLKIADFGLSREKVISK  198 (362)
T ss_pred             CcHHHHHhhc--ccCCCCHHHHHHHHHHHHHHHHHHhcCC---C-eeecccChhhEEEcCCCCEEEECCCccceeecccc
Confidence            9999999885  2245999999999999999999999865   3 99999999999999997 99999999998776532


Q ss_pred             eeeeecCCCCCCCCCccccc--cCCCCCcccchhHHHHHHHHHhCCCCcchhHHHHHhhhhhhHhhccccCCCCCHHHHH
Q 005586          572 VFSVLKTSAAMGYLAPEYVT--TGRFTERSDIFAFGVIILQILTGSLVLTSSMRLAAESATFENFIDRNLKGKFSESEAA  649 (689)
Q Consensus       572 ~~~~~~~~~~~~y~aPE~~~--~~~~~~ksDV~sfGvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  649 (689)
                       .......||..|||||++.  ...|+.|+|||||||+||||+||+.||.......    ....+.....+..++..+..
T Consensus       199 -~~~~~~~GT~~wMAPEv~~~~~~~~~~K~DvySFgIvlWEl~t~~~Pf~~~~~~~----~~~~v~~~~~Rp~~p~~~~~  273 (362)
T KOG0192|consen  199 -TSMTSVAGTYRWMAPEVLRGEKSPYTEKSDVYSFGIVLWELLTGEIPFEDLAPVQ----VASAVVVGGLRPPIPKECPP  273 (362)
T ss_pred             -ccccCCCCCccccChhhhcCCCCcCCccchhhhHHHHHHHHHHCCCCCCCCCHHH----HHHHHHhcCCCCCCCccCCH
Confidence             1233367899999999999  5689999999999999999999999997653311    22333344556666777888


Q ss_pred             HHHHHHHHhccCCCCCCCCHHHHHHHHHhh
Q 005586          650 KLGKMALVCTHEDPENRPTMEAVIEELTVA  679 (689)
Q Consensus       650 ~l~~l~~~Cl~~dp~~RPs~~evl~~L~~~  679 (689)
                      .+..++.+||+.||++||++.|++..|+.+
T Consensus       274 ~l~~l~~~CW~~dp~~RP~f~ei~~~l~~~  303 (362)
T KOG0192|consen  274 HLSSLMERCWLVDPSRRPSFLEIVSRLESI  303 (362)
T ss_pred             HHHHHHHHhCCCCCCcCCCHHHHHHHHHHH
Confidence            999999999999999999999999999855

>KOG0197 consensus Tyrosine kinases [Signal transduction mechanisms]

Probab=100.00  E-value=7e-49  Score=407.99  Aligned_cols=262  Identities=28%  Similarity=0.549  Sum_probs=225.7

Q ss_pred             ccccCHHHHHHHhccCCcccccccCCcceEEEEEecCCcEEEEEEecccCCchHHHHHHHHHHHHhccCCCcceeEeeEE
Q 005586          396 SFRLNLEEVESATQCFSEVNLLGKGNFSSVYKGTLRDGTLVAIRSINVTSCKSEEAEFVKGLYLLTSLRHENIIRLRGFC  475 (689)
Q Consensus       396 ~~~~~~~~l~~at~~f~~~~~lg~G~~g~Vy~~~~~~g~~vavK~l~~~~~~~~~~~f~~e~~~l~~l~H~niv~l~g~~  475 (689)
                      .+.++.+++..       .+.||+|-||.||.|.++....||+|.++...  ....+|.+|+++|.+++|+|||+++|+|
T Consensus       200 ~wei~r~~l~l-------~~~LG~G~FG~V~~g~~~~~~~vavk~ik~~~--m~~~~f~~Ea~iMk~L~H~~lV~l~gV~  270 (468)
T KOG0197|consen  200 PWEIPREELKL-------IRELGSGQFGEVWLGKWNGSTKVAVKTIKEGS--MSPEAFLREAQIMKKLRHEKLVKLYGVC  270 (468)
T ss_pred             CeeecHHHHHH-------HHHhcCCccceEEEEEEcCCCcccceEEeccc--cChhHHHHHHHHHHhCcccCeEEEEEEE
Confidence            34566666654       46899999999999999988899999998763  3446899999999999999999999999


Q ss_pred             EcCCCCeEEEEEEcCCCCCHHHHhhhcCCCCCCCCHHHHHHHHHHHHHHHhhhhCCCCCCCceeecCCCCCceeecCCCC
Q 005586          476 CSRGRGECFLIYDFAPKGKLSKYLDQEEGSSNVLDWSTRVSIIIGIAKGIGYLHSSEVNKPAIVHRNLSVEKVLIDQQFN  555 (689)
Q Consensus       476 ~~~~~~~~~lV~e~~~~gsL~~~L~~~~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~~~ivH~dlk~~NiLl~~~~~  555 (689)
                      ..  .+..+||||||++|+|.+||+...+  ..+...+.+.+|.|||+||+||++++     +|||||.++||||+++..
T Consensus       271 ~~--~~piyIVtE~m~~GsLl~yLr~~~~--~~l~~~~Ll~~a~qIaeGM~YLes~~-----~IHRDLAARNiLV~~~~~  341 (468)
T KOG0197|consen  271 TK--QEPIYIVTEYMPKGSLLDYLRTREG--GLLNLPQLLDFAAQIAEGMAYLESKN-----YIHRDLAARNILVDEDLV  341 (468)
T ss_pred             ec--CCceEEEEEecccCcHHHHhhhcCC--CccchHHHHHHHHHHHHHHHHHHhCC-----ccchhhhhhheeeccCce
Confidence            54  3579999999999999999997433  34888999999999999999999988     999999999999999999


Q ss_pred             eEEecccccccccCCceeeeecCCCCCCCCCccccccCCCCCcccchhHHHHHHHHHh-CCCCcchhHHHHHhhhhhhHh
Q 005586          556 PLIADCGLHKLLADDIVFSVLKTSAAMGYLAPEYVTTGRFTERSDIFAFGVIILQILT-GSLVLTSSMRLAAESATFENF  634 (689)
Q Consensus       556 ~kl~DfGla~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~ksDV~sfGvvl~ellt-G~~p~~~~~~~~~~~~~~~~~  634 (689)
                      +||+||||||...++.+.......-++.|.|||.+..++++.|||||||||+||||+| |+.|+.....     ..+.+.
T Consensus       342 vKIsDFGLAr~~~d~~Y~~~~~~kfPIkWtAPEa~~~~~FS~kSDVWSFGVlL~E~fT~G~~py~~msn-----~ev~~~  416 (468)
T KOG0197|consen  342 VKISDFGLARLIGDDEYTASEGGKFPIKWTAPEALNYGKFSSKSDVWSFGVLLWELFTYGRVPYPGMSN-----EEVLEL  416 (468)
T ss_pred             EEEcccccccccCCCceeecCCCCCCceecCHHHHhhCCcccccceeehhhhHHHHhccCCCCCCCCCH-----HHHHHH
Confidence            9999999999777776655555566788999999999999999999999999999999 7778755422     234455


Q ss_pred             hccccCCCCCHHHHHHHHHHHHHhccCCCCCCCCHHHHHHHHHhhC
Q 005586          635 IDRNLKGKFSESEAAKLGKMALVCTHEDPENRPTMEAVIEELTVAA  680 (689)
Q Consensus       635 ~~~~~~~~~~~~~~~~l~~l~~~Cl~~dp~~RPs~~evl~~L~~~~  680 (689)
                      +++..+-..|+.++..+.+||..||+.+|++|||++.+...|+...
T Consensus       417 le~GyRlp~P~~CP~~vY~lM~~CW~~~P~~RPtF~~L~~~l~~~~  462 (468)
T KOG0197|consen  417 LERGYRLPRPEGCPDEVYELMKSCWHEDPEDRPTFETLREVLEDFF  462 (468)
T ss_pred             HhccCcCCCCCCCCHHHHHHHHHHhhCCcccCCCHHHHHHHHHHhh
Confidence            6777777788899999999999999999999999999988887653

>KOG0581 consensus Mitogen-activated protein kinase kinase (MAP2K) [Signal transduction mechanisms]

Probab=100.00  E-value=2.7e-48  Score=385.80  Aligned_cols=261  Identities=20%  Similarity=0.387  Sum_probs=218.1

Q ss_pred             ccCHHHHHHHhccCCcccccccCCcceEEEEEec-CCcEEEEEEecccCCchHHHHHHHHHHHHhccCCCcceeEeeEEE
Q 005586          398 RLNLEEVESATQCFSEVNLLGKGNFSSVYKGTLR-DGTLVAIRSINVTSCKSEEAEFVKGLYLLTSLRHENIIRLRGFCC  476 (689)
Q Consensus       398 ~~~~~~l~~at~~f~~~~~lg~G~~g~Vy~~~~~-~g~~vavK~l~~~~~~~~~~~f~~e~~~l~~l~H~niv~l~g~~~  476 (689)
                      .+++.|++.       .+.||+|..|+|||+.++ +++.+|+|.+........++++.+|++++.+.+||+||.++|.|+
T Consensus        75 ~i~~~dle~-------~~~lG~G~gG~V~kv~Hk~t~~i~AlK~I~~~~~~~~~~Qi~rEl~il~~~~spyIV~~ygaF~  147 (364)
T KOG0581|consen   75 GISLSDLER-------LGVLGSGNGGTVYKVRHKPTGKIYALKVILLNIDPALQKQILRELEILRSCQSPYIVGFYGAFY  147 (364)
T ss_pred             ccCHHHhhh-------hhhcccCCCcEEEEEEEcCCCeEEEEEeecccCCHHHHHHHHHHHHHHhhCCCCCeeeEeEEEE
Confidence            356666654       578999999999999987 799999999977666667789999999999999999999999997


Q ss_pred             cCCCCeEEEEEEcCCCCCHHHHhhhcCCCCCCCCHHHHHHHHHHHHHHHhhhhC-CCCCCCceeecCCCCCceeecCCCC
Q 005586          477 SRGRGECFLIYDFAPKGKLSKYLDQEEGSSNVLDWSTRVSIIIGIAKGIGYLHS-SEVNKPAIVHRNLSVEKVLIDQQFN  555 (689)
Q Consensus       477 ~~~~~~~~lV~e~~~~gsL~~~L~~~~~~~~~l~~~~~~~ia~~ia~gL~yLH~-~~~~~~~ivH~dlk~~NiLl~~~~~  555 (689)
                      .... +..++||||++|||++++...+    .+++...-+||.+|++||.|||+ .+     ||||||||+|||++..|+
T Consensus       148 ~~~~-~isI~mEYMDgGSLd~~~k~~g----~i~E~~L~~ia~~VL~GL~YLh~~~~-----IIHRDIKPsNlLvNskGe  217 (364)
T KOG0581|consen  148 SNGE-EISICMEYMDGGSLDDILKRVG----RIPEPVLGKIARAVLRGLSYLHEERK-----IIHRDIKPSNLLVNSKGE  217 (364)
T ss_pred             eCCc-eEEeehhhcCCCCHHHHHhhcC----CCCHHHHHHHHHHHHHHHHHHhhccC-----eeeccCCHHHeeeccCCC
Confidence            7643 7999999999999999998653    38889999999999999999996 44     999999999999999999


Q ss_pred             eEEecccccccccCCceeeeecCCCCCCCCCccccccCCCCCcccchhHHHHHHHHHhCCCCcchhHH-HHHhhhhhhHh
Q 005586          556 PLIADCGLHKLLADDIVFSVLKTSAAMGYLAPEYVTTGRFTERSDIFAFGVIILQILTGSLVLTSSMR-LAAESATFENF  634 (689)
Q Consensus       556 ~kl~DfGla~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~ksDV~sfGvvl~elltG~~p~~~~~~-~~~~~~~~~~~  634 (689)
                      +||+|||.++.+.+.   ......||..|||||.+.+..|+.++||||||+.++|+.+|+.|+..... ...+...+..+
T Consensus       218 VKicDFGVS~~lvnS---~a~tfvGT~~YMsPERi~g~~Ys~~sDIWSLGLsllE~a~GrfP~~~~~~~~~~~~~Ll~~I  294 (364)
T KOG0581|consen  218 VKICDFGVSGILVNS---IANTFVGTSAYMSPERISGESYSVKSDIWSLGLSLLELAIGRFPYPPPNPPYLDIFELLCAI  294 (364)
T ss_pred             EEeccccccHHhhhh---hcccccccccccChhhhcCCcCCcccceecccHHHHHHhhCCCCCCCcCCCCCCHHHHHHHH
Confidence            999999999988765   23345688899999999999999999999999999999999999965411 11111222333


Q ss_pred             hccccCCCCCHH-HHHHHHHHHHHhccCCCCCCCCHHHHHHHHHhh
Q 005586          635 IDRNLKGKFSES-EAAKLGKMALVCTHEDPENRPTMEAVIEELTVA  679 (689)
Q Consensus       635 ~~~~~~~~~~~~-~~~~l~~l~~~Cl~~dp~~RPs~~evl~~L~~~  679 (689)
                      .+ .-....|.+ .+.++..++..|+++||.+||+++|+++|-+..
T Consensus       295 v~-~ppP~lP~~~fS~ef~~FV~~CL~Kdp~~R~s~~qLl~Hpfi~  339 (364)
T KOG0581|consen  295 VD-EPPPRLPEGEFSPEFRSFVSCCLRKDPSERPSAKQLLQHPFIK  339 (364)
T ss_pred             hc-CCCCCCCcccCCHHHHHHHHHHhcCCcccCCCHHHHhcCHHHh
Confidence            33 222334444 788999999999999999999999999886544

>KOG1026 consensus Nerve growth factor receptor TRKA and related tyrosine kinases [Signal transduction mechanisms; Intracellular trafficking, secretion, and vesicular transport]

Probab=100.00  E-value=7.8e-48  Score=418.76  Aligned_cols=261  Identities=25%  Similarity=0.441  Sum_probs=221.2

Q ss_pred             CcccccccCCcceEEEEEec------CCcEEEEEEecccCCchHHHHHHHHHHHHhccCCCcceeEeeEEEcCCCCeEEE
Q 005586          412 SEVNLLGKGNFSSVYKGTLR------DGTLVAIRSINVTSCKSEEAEFVKGLYLLTSLRHENIIRLRGFCCSRGRGECFL  485 (689)
Q Consensus       412 ~~~~~lg~G~~g~Vy~~~~~------~g~~vavK~l~~~~~~~~~~~f~~e~~~l~~l~H~niv~l~g~~~~~~~~~~~l  485 (689)
                      ...+.||+|+||+||+|+..      +.+.||||.++.....+.+++|.+|+++++.++|||||+|+|.|.+  ++..++
T Consensus       489 ~~~~eLGegaFGkVf~a~~~~l~p~~~~~lVAVK~LKd~a~~~~~~dF~REaeLla~l~H~nIVrLlGVC~~--~~P~~M  566 (774)
T KOG1026|consen  489 VFKEELGEGAFGKVFLAEAYGLLPGQDEQLVAVKALKDKAENQARQDFRREAELLAELQHPNIVRLLGVCRE--GDPLCM  566 (774)
T ss_pred             eehhhhcCchhhhhhhhhccCCCCCccceehhHhhhcccccHHHHHHHHHHHHHHHhccCCCeEEEEEEEcc--CCeeEE
Confidence            34578999999999999853      4578999999998877788999999999999999999999999954  578999


Q ss_pred             EEEcCCCCCHHHHhhhcCCC----------CCCCCHHHHHHHHHHHHHHHhhhhCCCCCCCceeecCCCCCceeecCCCC
Q 005586          486 IYDFAPKGKLSKYLDQEEGS----------SNVLDWSTRVSIIIGIAKGIGYLHSSEVNKPAIVHRNLSVEKVLIDQQFN  555 (689)
Q Consensus       486 V~e~~~~gsL~~~L~~~~~~----------~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~~~ivH~dlk~~NiLl~~~~~  555 (689)
                      |+|||..|||.+||......          ..+|+-.+.+.||.|||.||+||-+..     +|||||.++|+||.++..
T Consensus       567 vFEYm~~GDL~eFLra~sP~a~~~~~g~~~~~~L~~~q~L~iA~QIAaGM~YLs~~~-----FVHRDLATRNCLVge~l~  641 (774)
T KOG1026|consen  567 VFEYMDHGDLHEFLRARSPKADKLASGQDTPPPLSTSQFLHIATQIAAGMEYLSSHH-----FVHRDLATRNCLVGENLV  641 (774)
T ss_pred             EEEecccccHHHHHHhhCCccccccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCc-----ccccchhhhhceeccceE
Confidence            99999999999999754321          223889999999999999999999887     999999999999999999


Q ss_pred             eEEecccccccccCCceeeee-cCCCCCCCCCccccccCCCCCcccchhHHHHHHHHHh-CCCCcchhHHHHHhhhhhhH
Q 005586          556 PLIADCGLHKLLADDIVFSVL-KTSAAMGYLAPEYVTTGRFTERSDIFAFGVIILQILT-GSLVLTSSMRLAAESATFEN  633 (689)
Q Consensus       556 ~kl~DfGla~~~~~~~~~~~~-~~~~~~~y~aPE~~~~~~~~~ksDV~sfGvvl~ellt-G~~p~~~~~~~~~~~~~~~~  633 (689)
                      +||+||||+|......+++.. ...-+++|||||.|..++||++||||||||||||++| |+.|+.......+    ++.
T Consensus       642 VKIsDfGLsRdiYssDYYk~~~~t~lPIRWMppEsIly~kFTteSDVWs~GVvLWEIFsyG~QPy~glSn~EV----Ie~  717 (774)
T KOG1026|consen  642 VKISDFGLSRDIYSSDYYKVRGNTLLPIRWMPPESILYGKFTTESDVWSFGVVLWEIFSYGKQPYYGLSNQEV----IEC  717 (774)
T ss_pred             EEecccccchhhhhhhhhcccCCceeeeecCCHHHhhcCcccchhhhhhhhhhhhhhhccccCcccccchHHH----HHH
Confidence            999999999977665555544 4445679999999999999999999999999999998 8889876543322    222


Q ss_pred             hhccccCCCCCHHHHHHHHHHHHHhccCCCCCCCCHHHHHHHHHhhCCccc
Q 005586          634 FIDRNLKGKFSESEAAKLGKMALVCTHEDPENRPTMEAVIEELTVAAPVMA  684 (689)
Q Consensus       634 ~~~~~~~~~~~~~~~~~l~~l~~~Cl~~dp~~RPs~~evl~~L~~~~p~~~  684 (689)
                      +-+..+ ...|+.++.+++.||..||+..|++||+++||-..|+......+
T Consensus       718 i~~g~l-L~~Pe~CP~~vY~LM~~CW~~~P~~RPsF~eI~~~L~~~~~~s~  767 (774)
T KOG1026|consen  718 IRAGQL-LSCPENCPTEVYSLMLECWNENPKRRPSFKEIHSRLQAWAQASP  767 (774)
T ss_pred             HHcCCc-ccCCCCCCHHHHHHHHHHhhcCcccCCCHHHHHHHHHHHHhcCc
Confidence            223333 56788999999999999999999999999999999987765443

>KOG0196 consensus Tyrosine kinase, EPH (ephrin) receptor family [Signal transduction mechanisms]

Probab=100.00  E-value=3.2e-46  Score=397.44  Aligned_cols=257  Identities=23%  Similarity=0.454  Sum_probs=224.4

Q ss_pred             CCcccccccCCcceEEEEEec----CCcEEEEEEecccCCchHHHHHHHHHHHHhccCCCcceeEeeEEEcCCCCeEEEE
Q 005586          411 FSEVNLLGKGNFSSVYKGTLR----DGTLVAIRSINVTSCKSEEAEFVKGLYLLTSLRHENIIRLRGFCCSRGRGECFLI  486 (689)
Q Consensus       411 f~~~~~lg~G~~g~Vy~~~~~----~g~~vavK~l~~~~~~~~~~~f~~e~~~l~~l~H~niv~l~g~~~~~~~~~~~lV  486 (689)
                      ..+.++||.|.||.||+|+++    ....||||.++.....+.+.+|+.|..+|+++.||||++|.|+.  ......+||
T Consensus       631 i~Ie~VIGaGEFGEVc~GrLk~pgkre~~VAIKTLK~GytekqrrdFL~EAsIMGQFdHPNIIrLEGVV--Tks~PvMIi  708 (996)
T KOG0196|consen  631 VKIEKVIGAGEFGEVCSGRLKLPGKREITVAIKTLKAGYTEKQRRDFLSEASIMGQFDHPNIIRLEGVV--TKSKPVMII  708 (996)
T ss_pred             eEEEEEEecccccceecccccCCCCcceeEEEeeeccCccHHHHhhhhhhhhhcccCCCCcEEEEEEEE--ecCceeEEE
Confidence            345689999999999999986    34679999999988888889999999999999999999999998  445789999


Q ss_pred             EEcCCCCCHHHHhhhcCCCCCCCCHHHHHHHHHHHHHHHhhhhCCCCCCCceeecCCCCCceeecCCCCeEEeccccccc
Q 005586          487 YDFAPKGKLSKYLDQEEGSSNVLDWSTRVSIIIGIAKGIGYLHSSEVNKPAIVHRNLSVEKVLIDQQFNPLIADCGLHKL  566 (689)
Q Consensus       487 ~e~~~~gsL~~~L~~~~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~~~ivH~dlk~~NiLl~~~~~~kl~DfGla~~  566 (689)
                      .|||+||+|+.||+.+.+.   ++|.+...+.++||.||.||-.++     +|||||.++|||++.+..+||+|||++|.
T Consensus       709 TEyMENGsLDsFLR~~DGq---ftviQLVgMLrGIAsGMkYLsdm~-----YVHRDLAARNILVNsnLvCKVsDFGLSRv  780 (996)
T KOG0196|consen  709 TEYMENGSLDSFLRQNDGQ---FTVIQLVGMLRGIASGMKYLSDMN-----YVHRDLAARNILVNSNLVCKVSDFGLSRV  780 (996)
T ss_pred             hhhhhCCcHHHHHhhcCCc---eEeehHHHHHHHHHHHhHHHhhcC-----chhhhhhhhheeeccceEEEeccccceee
Confidence            9999999999999988764   899999999999999999999988     89999999999999999999999999998


Q ss_pred             ccCCce--eeeecCCCCCCCCCccccccCCCCCcccchhHHHHHHHHHh-CCCCcchhHHHHHhhhhhhHhhccccCCCC
Q 005586          567 LADDIV--FSVLKTSAAMGYLAPEYVTTGRFTERSDIFAFGVIILQILT-GSLVLTSSMRLAAESATFENFIDRNLKGKF  643 (689)
Q Consensus       567 ~~~~~~--~~~~~~~~~~~y~aPE~~~~~~~~~ksDV~sfGvvl~ellt-G~~p~~~~~~~~~~~~~~~~~~~~~~~~~~  643 (689)
                      +.++..  +...+..-+++|.|||.+..+++|.+||||||||||||.++ |.+|+-+...+.     ....+....+...
T Consensus       781 ledd~~~~ytt~GGKIPiRWTAPEAIa~RKFTsASDVWSyGIVmWEVmSyGERPYWdmSNQd-----VIkaIe~gyRLPp  855 (996)
T KOG0196|consen  781 LEDDPEAAYTTLGGKIPIRWTAPEAIAYRKFTSASDVWSYGIVMWEVMSYGERPYWDMSNQD-----VIKAIEQGYRLPP  855 (996)
T ss_pred             cccCCCccccccCCccceeecChhHhhhcccCchhhccccceEEEEecccCCCcccccchHH-----HHHHHHhccCCCC
Confidence            866542  22233334578999999999999999999999999999986 899986654433     3445566777778


Q ss_pred             CHHHHHHHHHHHHHhccCCCCCCCCHHHHHHHHHhhCCc
Q 005586          644 SESEAAKLGKMALVCTHEDPENRPTMEAVIEELTVAAPV  682 (689)
Q Consensus       644 ~~~~~~~l~~l~~~Cl~~dp~~RPs~~evl~~L~~~~p~  682 (689)
                      |.+++..+.+||+.||++|-.+||++.|++..|.....-
T Consensus       856 PmDCP~aL~qLMldCWqkdR~~RP~F~qiV~~lDklIrn  894 (996)
T KOG0196|consen  856 PMDCPAALYQLMLDCWQKDRNRRPKFAQIVSTLDKLIRN  894 (996)
T ss_pred             CCCCcHHHHHHHHHHHHHHhhcCCCHHHHHHHHHHHhcC
Confidence            889999999999999999999999999999999776443

>KOG0595 consensus Serine/threonine-protein kinase involved in autophagy [Posttranslational modification, protein turnover, chaperones; Intracellular trafficking, secretion, and vesicular transport; Signal transduction mechanisms]

Probab=100.00  E-value=2e-44  Score=360.83  Aligned_cols=248  Identities=23%  Similarity=0.385  Sum_probs=194.5

Q ss_pred             ccCCcccccccCCcceEEEEEec-CCcEEEEEEecccC-CchHHHHHHHHHHHHhccCCCcceeEeeEEEcCCCCeEEEE
Q 005586          409 QCFSEVNLLGKGNFSSVYKGTLR-DGTLVAIRSINVTS-CKSEEAEFVKGLYLLTSLRHENIIRLRGFCCSRGRGECFLI  486 (689)
Q Consensus       409 ~~f~~~~~lg~G~~g~Vy~~~~~-~g~~vavK~l~~~~-~~~~~~~f~~e~~~l~~l~H~niv~l~g~~~~~~~~~~~lV  486 (689)
                      .+|...+.||+|+|++||+|+++ ++..||||.+.... .++..+....|+++|++++|||||.|++++.  .++..++|
T Consensus        10 ~~y~~~~~iG~GsfavVykg~h~~~~~~VAIK~i~~~~l~~k~~e~L~~Ei~iLkel~H~nIV~l~d~~~--~~~~i~lV   87 (429)
T KOG0595|consen   10 GDYELSREIGSGSFAVVYKGRHKKSGTEVAIKCIAKKKLNKKLVELLLSEIKILKELKHPNIVRLLDCIE--DDDFIYLV   87 (429)
T ss_pred             ccceehhhccCcceEEEEEeEeccCCceEEeeeehhhccCHHHHHHHHHHHHHHHhcCCcceeeEEEEEe--cCCeEEEE
Confidence            35666778999999999999986 68999999998775 3455667899999999999999999999984  45799999


Q ss_pred             EEcCCCCCHHHHhhhcCCCCCCCCHHHHHHHHHHHHHHHhhhhCCCCCCCceeecCCCCCceeecCC------CCeEEec
Q 005586          487 YDFAPKGKLSKYLDQEEGSSNVLDWSTRVSIIIGIAKGIGYLHSSEVNKPAIVHRNLSVEKVLIDQQ------FNPLIAD  560 (689)
Q Consensus       487 ~e~~~~gsL~~~L~~~~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~~~ivH~dlk~~NiLl~~~------~~~kl~D  560 (689)
                      ||||.+|||.+|++..+    .+++.+...++.|+|.||++||+++     ||||||||.||||+..      -.+||+|
T Consensus        88 MEyC~gGDLs~yi~~~~----~l~e~t~r~Fm~QLA~alq~L~~~~-----IiHRDLKPQNiLLs~~~~~~~~~~LKIAD  158 (429)
T KOG0595|consen   88 MEYCNGGDLSDYIRRRG----RLPEATARHFMQQLASALQFLHENN-----IIHRDLKPQNILLSTTARNDTSPVLKIAD  158 (429)
T ss_pred             EEeCCCCCHHHHHHHcC----CCCHHHHHHHHHHHHHHHHHHHHCC-----eeeccCCcceEEeccCCCCCCCceEEecc
Confidence            99999999999999875    3899999999999999999999998     9999999999999865      4579999


Q ss_pred             ccccccccCCceeeeecCCCCCCCCCccccccCCCCCcccchhHHHHHHHHHhCCCCcchhHHHHHhhhhhhHhhccccC
Q 005586          561 CGLHKLLADDIVFSVLKTSAAMGYLAPEYVTTGRFTERSDIFAFGVIILQILTGSLVLTSSMRLAAESATFENFIDRNLK  640 (689)
Q Consensus       561 fGla~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~ksDV~sfGvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~  640 (689)
                      ||+||.+......  ....|++-|||||++..++|+.|+|+||.|++|||+++|+.||.......... .++  .+....
T Consensus       159 FGfAR~L~~~~~a--~tlcGSplYMAPEV~~~~~YdAKADLWSiG~Ilyq~l~g~~Pf~a~t~~eL~~-~~~--k~~~~~  233 (429)
T KOG0595|consen  159 FGFARFLQPGSMA--ETLCGSPLYMAPEVIMSQQYDAKADLWSIGTILYQCLTGKPPFDAETPKELLL-YIK--KGNEIV  233 (429)
T ss_pred             cchhhhCCchhHH--HHhhCCccccCHHHHHhccccchhhHHHHHHHHHHHHhCCCCccccCHHHHHH-HHh--cccccc
Confidence            9999998765432  23468889999999999999999999999999999999999997543221110 000  011112


Q ss_pred             CCCCHHHHHHHHHHHHHhccCCCCCCCCHHHH
Q 005586          641 GKFSESEAAKLGKMALVCTHEDPENRPTMEAV  672 (689)
Q Consensus       641 ~~~~~~~~~~l~~l~~~Cl~~dp~~RPs~~ev  672 (689)
                      ...+........++...-++.+|.+|-++.+-
T Consensus       234 ~~~~~~~s~~~~~Ll~~ll~~~~~~~~~~~~~  265 (429)
T KOG0595|consen  234 PVLPAELSNPLRELLISLLQRNPKDRISFEDF  265 (429)
T ss_pred             CchhhhccCchhhhhhHHHhcCccccCchHHh
Confidence            22222333344455555556666666544443

>KOG1094 consensus Discoidin domain receptor DDR1 [Signal transduction mechanisms]

Probab=100.00  E-value=1.5e-43  Score=366.00  Aligned_cols=264  Identities=25%  Similarity=0.400  Sum_probs=218.2

Q ss_pred             HhccCCcccccccCCcceEEEEEecCCcEEEEEEecccCCchHHHHHHHHHHHHhccCCCcceeEeeEEEcCCCCeEEEE
Q 005586          407 ATQCFSEVNLLGKGNFSSVYKGTLRDGTLVAIRSINVTSCKSEEAEFVKGLYLLTSLRHENIIRLRGFCCSRGRGECFLI  486 (689)
Q Consensus       407 at~~f~~~~~lg~G~~g~Vy~~~~~~g~~vavK~l~~~~~~~~~~~f~~e~~~l~~l~H~niv~l~g~~~~~~~~~~~lV  486 (689)
                      +.......++||+|-||.|..+....+..||||.++....+..+.+|.+|+++|++++|||||+|+|.|..+  +..++|
T Consensus       536 PRs~L~~~ekiGeGqFGEVhLCeveg~lkVAVK~Lr~~a~~~~r~~F~kEIkiLsqLkhPNIveLvGVC~~D--ePicmI  613 (807)
T KOG1094|consen  536 PRSRLRFKEKIGEGQFGEVHLCEVEGPLKVAVKILRPDATKNARNDFLKEIKILSRLKHPNIVELLGVCVQD--DPLCMI  613 (807)
T ss_pred             chhheehhhhhcCcccceeEEEEecCceEEEEeecCcccchhHHHHHHHHHHHHhccCCCCeeEEEeeeecC--CchHHH
Confidence            344555678999999999999999888999999999998888889999999999999999999999999764  678999


Q ss_pred             EEcCCCCCHHHHhhhcCCCCCCCCHHHHHHHHHHHHHHHhhhhCCCCCCCceeecCCCCCceeecCCCCeEEeccccccc
Q 005586          487 YDFAPKGKLSKYLDQEEGSSNVLDWSTRVSIIIGIAKGIGYLHSSEVNKPAIVHRNLSVEKVLIDQQFNPLIADCGLHKL  566 (689)
Q Consensus       487 ~e~~~~gsL~~~L~~~~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~~~ivH~dlk~~NiLl~~~~~~kl~DfGla~~  566 (689)
                      +|||++|+|.+|+..+....  ++-..-..|+.|||.||+||.+.+     +|||||.++|+|+|.++++||+|||++|.
T Consensus       614 ~EYmEnGDLnqFl~aheapt--~~t~~~vsi~tqiasgmaYLes~n-----fVHrd~a~rNcLv~~e~~iKiadfgmsR~  686 (807)
T KOG1094|consen  614 TEYMENGDLNQFLSAHELPT--AETAPGVSICTQIASGMAYLESLN-----FVHRDLATRNCLVDGEFTIKIADFGMSRN  686 (807)
T ss_pred             HHHHhcCcHHHHHHhccCcc--cccchhHHHHHHHHHHHHHHHhhc-----hhhccccccceeecCcccEEecCcccccc
Confidence            99999999999998875422  344556779999999999999987     99999999999999999999999999997


Q ss_pred             ccCCceeeee-cCCCCCCCCCccccccCCCCCcccchhHHHHHHHHHh--CCCCcchhHHHHHhhhhhhHhhccccC---
Q 005586          567 LADDIVFSVL-KTSAAMGYLAPEYVTTGRFTERSDIFAFGVIILQILT--GSLVLTSSMRLAAESATFENFIDRNLK---  640 (689)
Q Consensus       567 ~~~~~~~~~~-~~~~~~~y~aPE~~~~~~~~~ksDV~sfGvvl~ellt--G~~p~~~~~~~~~~~~~~~~~~~~~~~---  640 (689)
                      +....++... +..-+++|||||.+..+++|.+||||+|||.|||+++  ...|+.+..+... .+...++++..-.   
T Consensus       687 lysg~yy~vqgr~vlpiRwmawEsillgkFttaSDvWafgvTlwE~~~~C~e~Py~~lt~e~v-ven~~~~~~~~~~~~~  765 (807)
T KOG1094|consen  687 LYSGDYYRVQGRAVLPIRWMAWESILLGKFTTASDVWAFGVTLWEVFMLCREQPYSQLTDEQV-VENAGEFFRDQGRQVV  765 (807)
T ss_pred             cccCCceeeecceeeeeeehhHHHHHhccccchhhhhhhHHHHHHHHHHHhhCchhhhhHHHH-HHhhhhhcCCCCccee
Confidence            7655544433 3445689999999999999999999999999999976  5678765433222 1222233332222   


Q ss_pred             CCCCHHHHHHHHHHHHHhccCCCCCCCCHHHHHHHHHhhC
Q 005586          641 GKFSESEAAKLGKMALVCTHEDPENRPTMEAVIEELTVAA  680 (689)
Q Consensus       641 ~~~~~~~~~~l~~l~~~Cl~~dp~~RPs~~evl~~L~~~~  680 (689)
                      ...|.-++.++.+++.+||..|-++||+++++...|++.+
T Consensus       766 l~~P~~cp~~lyelml~Cw~~es~~RPsFe~lh~~lq~~~  805 (807)
T KOG1094|consen  766 LSRPPACPQGLYELMLRCWRRESEQRPSFEQLHLFLQEDA  805 (807)
T ss_pred             ccCCCcCcHHHHHHHHHHhchhhhcCCCHHHHHHHHHHhc
Confidence            2346678889999999999999999999999999988643

>KOG0591 consensus NIMA (never in mitosis)-related G2-specific serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning]

Probab=100.00  E-value=3.2e-45  Score=348.31  Aligned_cols=262  Identities=19%  Similarity=0.343  Sum_probs=213.5

Q ss_pred             cCCcccccccCCcceEEEEEe-cCCcEEEEEEecccCC-chHHHHHHHHHHHHhccCCCcceeEeeEEEcCCCCeEEEEE
Q 005586          410 CFSEVNLLGKGNFSSVYKGTL-RDGTLVAIRSINVTSC-KSEEAEFVKGLYLLTSLRHENIIRLRGFCCSRGRGECFLIY  487 (689)
Q Consensus       410 ~f~~~~~lg~G~~g~Vy~~~~-~~g~~vavK~l~~~~~-~~~~~~f~~e~~~l~~l~H~niv~l~g~~~~~~~~~~~lV~  487 (689)
                      +|.+.++||+|.||+|||+.. .+|..||.|.++-... .+..++..+|+.+|++++|||||+++++-..++....+|||
T Consensus        20 ~y~Il~~IG~GsFg~vykv~~~~~g~l~a~K~i~f~~md~k~rq~~v~Ei~lLkQL~HpNIVqYy~~~f~~~~evlnivm   99 (375)
T KOG0591|consen   20 DYQILKKIGRGSFGEVYKVQCLLDGKLVALKKIQFGMMDAKARQDCVKEISLLKQLNHPNIVQYYAHSFIEDNEVLNIVM   99 (375)
T ss_pred             HHHHHHHHcCCcchheEEeeeccCcchhhhhhcchhhccHHHHHHHHHHHHHHHhcCCchHHHHHHHhhhccchhhHHHH
Confidence            355668999999999999974 5899999999974432 45567899999999999999999999965555555589999


Q ss_pred             EcCCCCCHHHHhhhcCCCCCCCCHHHHHHHHHHHHHHHhhhhCCCCCCCceeecCCCCCceeecCCCCeEEecccccccc
Q 005586          488 DFAPKGKLSKYLDQEEGSSNVLDWSTRVSIIIGIAKGIGYLHSSEVNKPAIVHRNLSVEKVLIDQQFNPLIADCGLHKLL  567 (689)
Q Consensus       488 e~~~~gsL~~~L~~~~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~~~ivH~dlk~~NiLl~~~~~~kl~DfGla~~~  567 (689)
                      ||+..|||...++........+++.+++++..|+++||.++|+.- .+..|+||||||.||+|+.+|.+|++||||+|.+
T Consensus       100 E~c~~GDLsqmIk~~K~qkr~ipE~~Vwk~f~QL~~AL~~cH~~~-~r~~VmHRDIKPaNIFl~~~gvvKLGDfGL~r~l  178 (375)
T KOG0591|consen  100 ELCDAGDLSQMIKHFKKQKRLIPEKTVWKYFVQLCRALYHCHSKI-PRGTVMHRDIKPANIFLTANGVVKLGDFGLGRFL  178 (375)
T ss_pred             HhhcccCHHHHHHHHHhccccCchHHHHHHHHHHHHHHHHHhccc-cccceeeccCcchheEEcCCCceeeccchhHhHh
Confidence            999999999999866555667999999999999999999999843 1234999999999999999999999999999998


Q ss_pred             cCCceeeeecCCCCCCCCCccccccCCCCCcccchhHHHHHHHHHhCCCCcchhHHHHHhhhhhhHhhccccCCCCC-HH
Q 005586          568 ADDIVFSVLKTSAAMGYLAPEYVTTGRFTERSDIFAFGVIILQILTGSLVLTSSMRLAAESATFENFIDRNLKGKFS-ES  646 (689)
Q Consensus       568 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~ksDV~sfGvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~  646 (689)
                      ...... .....||+.||+||.+.+..|+.||||||+||++|||+.-+.||.+.... .....+.    ..-....| +-
T Consensus       179 ~s~~tf-A~S~VGTPyYMSPE~i~~~~Y~~kSDiWslGCllyEMcaL~~PF~g~n~~-~L~~KI~----qgd~~~~p~~~  252 (375)
T KOG0591|consen  179 SSKTTF-AHSLVGTPYYMSPERIHESGYNFKSDIWSLGCLLYEMCALQSPFYGDNLL-SLCKKIE----QGDYPPLPDEH  252 (375)
T ss_pred             cchhHH-HHhhcCCCcccCHHHHhcCCCCcchhHHHHHHHHHHHHhcCCCcccccHH-HHHHHHH----cCCCCCCcHHH
Confidence            765432 23457999999999999999999999999999999999999999765221 1111111    11111233 55


Q ss_pred             HHHHHHHHHHHhccCCCCCCCCHHHHHHHHHh
Q 005586          647 EAAKLGKMALVCTHEDPENRPTMEAVIEELTV  678 (689)
Q Consensus       647 ~~~~l~~l~~~Cl~~dp~~RPs~~evl~~L~~  678 (689)
                      .+.++.+|+..|+..||+.||+...++++++.
T Consensus       253 YS~~l~~li~~ci~vd~~~RP~t~~~v~di~~  284 (375)
T KOG0591|consen  253 YSTDLRELINMCIAVDPEQRPDTVPYVQDIQS  284 (375)
T ss_pred             hhhHHHHHHHHHccCCcccCCCcchHHHHHHH
Confidence            68899999999999999999997666666654

>KOG1095 consensus Protein tyrosine kinase [Signal transduction mechanisms]

Probab=100.00  E-value=2.8e-44  Score=404.89  Aligned_cols=265  Identities=27%  Similarity=0.513  Sum_probs=220.5

Q ss_pred             CcccccccCCcceEEEEEecC--Cc----EEEEEEecccCCchHHHHHHHHHHHHhccCCCcceeEeeEEEcCCCCeEEE
Q 005586          412 SEVNLLGKGNFSSVYKGTLRD--GT----LVAIRSINVTSCKSEEAEFVKGLYLLTSLRHENIIRLRGFCCSRGRGECFL  485 (689)
Q Consensus       412 ~~~~~lg~G~~g~Vy~~~~~~--g~----~vavK~l~~~~~~~~~~~f~~e~~~l~~l~H~niv~l~g~~~~~~~~~~~l  485 (689)
                      +..+.||+|+||.||+|.+.+  |.    .||||.++.....++..+|.+|..+|++++|||||+++|+|.+  ....+|
T Consensus       695 ~l~~~lG~G~FG~VY~g~~~~~~~~~~~~~vaiK~l~~~~~~~~~~~Fl~Ea~~m~~f~HpNiv~liGv~l~--~~~~~i  772 (1025)
T KOG1095|consen  695 TLLRVLGKGAFGEVYEGTYSDVPGSVSPIQVAVKSLKRLSSEQEVSDFLKEALLMSKFDHPNIVSLIGVCLD--SGPPLI  772 (1025)
T ss_pred             EeeeeeccccccceEEEEEecCCCCccceEEEEEeccccCCHHHHHHHHHHHHHHhcCCCcceeeEEEeecC--CCCcEE
Confidence            346789999999999999753  43    4999999988777888999999999999999999999999976  467899


Q ss_pred             EEEcCCCCCHHHHhhhcCC---CCCCCCHHHHHHHHHHHHHHHhhhhCCCCCCCceeecCCCCCceeecCCCCeEEeccc
Q 005586          486 IYDFAPKGKLSKYLDQEEG---SSNVLDWSTRVSIIIGIAKGIGYLHSSEVNKPAIVHRNLSVEKVLIDQQFNPLIADCG  562 (689)
Q Consensus       486 V~e~~~~gsL~~~L~~~~~---~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~~~ivH~dlk~~NiLl~~~~~~kl~DfG  562 (689)
                      ++|||++|||..||++.+.   ....+...+.+.||.|||+|+.||++++     +|||||.++|+||++...+||+|||
T Consensus       773 ~leyM~gGDL~sflr~~r~~~~~~~~L~~~dLl~~a~dvA~G~~YLe~~~-----fvHRDLAaRNCLL~~~r~VKIaDFG  847 (1025)
T KOG1095|consen  773 LLEYMEGGDLLSFLRESRPAPFQPSNLSMRDLLAFALDVAKGMNYLESKH-----FVHRDLAARNCLLDERRVVKIADFG  847 (1025)
T ss_pred             EehhcccCcHHHHHHhcccccCCCCCCCHHHHHHHHHHHhhhhHHHHhCC-----CcCcchhhhheeecccCcEEEcccc
Confidence            9999999999999997633   1345899999999999999999999988     8999999999999999999999999


Q ss_pred             ccccccCCceeeeecC-CCCCCCCCccccccCCCCCcccchhHHHHHHHHHh-CCCCcchhHHHHHhhhhhhHhhccccC
Q 005586          563 LHKLLADDIVFSVLKT-SAAMGYLAPEYVTTGRFTERSDIFAFGVIILQILT-GSLVLTSSMRLAAESATFENFIDRNLK  640 (689)
Q Consensus       563 la~~~~~~~~~~~~~~-~~~~~y~aPE~~~~~~~~~ksDV~sfGvvl~ellt-G~~p~~~~~~~~~~~~~~~~~~~~~~~  640 (689)
                      +||...+..++..... .-+.+|||||.+..+.++.|+|||||||+|||++| |..||.+......    +..+.. .-+
T Consensus       848 lArDiy~~~yyr~~~~a~lPvkWm~PEsl~d~iFtskSDvWsFGVllWEifslG~~PY~~~~n~~v----~~~~~~-ggR  922 (1025)
T KOG1095|consen  848 LARDIYDKDYYRKHGEAMLPVKWMPPESLKDGIFTSKSDVWSFGVLLWEIFSLGATPYPSRSNFEV----LLDVLE-GGR  922 (1025)
T ss_pred             hhHhhhhchheeccCccccceecCCHHHHhhcccccccchhhhHHHHHHHHhCCCCCCCCcchHHH----HHHHHh-CCc
Confidence            9995544444333222 34568999999999999999999999999999999 7788865433221    111222 225


Q ss_pred             CCCCHHHHHHHHHHHHHhccCCCCCCCCHHHHHHHHHhhCCccccccc
Q 005586          641 GKFSESEAAKLGKMALVCTHEDPENRPTMEAVIEELTVAAPVMATFLF  688 (689)
Q Consensus       641 ~~~~~~~~~~l~~l~~~Cl~~dp~~RPs~~evl~~L~~~~p~~~~~~~  688 (689)
                      ...|..+++.+.++|..||+.+|++||++..+++++..+....-.-+|
T Consensus       923 L~~P~~CP~~ly~lM~~CW~~~pe~RP~F~~i~~q~~~i~~~~~~~~~  970 (1025)
T KOG1095|consen  923 LDPPSYCPEKLYQLMLQCWKHDPEDRPSFRTIVEQDPAISNAALGTIY  970 (1025)
T ss_pred             cCCCCCCChHHHHHHHHHccCChhhCccHHHHHhhhhhhhhhhccCcc
Confidence            667888999999999999999999999999999988777665444443

>KOG0575 consensus Polo-like serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning]

Probab=100.00  E-value=2.7e-43  Score=369.49  Aligned_cols=254  Identities=20%  Similarity=0.384  Sum_probs=214.4

Q ss_pred             ccCCcccccccCCcceEEEEEe-cCCcEEEEEEecccCC--chHHHHHHHHHHHHhccCCCcceeEeeEEEcCCCCeEEE
Q 005586          409 QCFSEVNLLGKGNFSSVYKGTL-RDGTLVAIRSINVTSC--KSEEAEFVKGLYLLTSLRHENIIRLRGFCCSRGRGECFL  485 (689)
Q Consensus       409 ~~f~~~~~lg~G~~g~Vy~~~~-~~g~~vavK~l~~~~~--~~~~~~f~~e~~~l~~l~H~niv~l~g~~~~~~~~~~~l  485 (689)
                      .+|...++||+|||..+|.++. ..|..||+|++.+...  ........+||++.++++|||||++++||  ++.+.+|+
T Consensus        18 ~~Y~~g~~LGkGgFA~cYe~~~~~tge~~A~KvVpk~~l~k~~~reKv~~EIeIHr~L~HpnIV~f~~~F--EDs~nVYi   95 (592)
T KOG0575|consen   18 KRYKRGRFLGKGGFARCYEARDLDTGEVVAVKVVPKKLLKKPKQREKVLNEIEIHRSLKHPNIVQFYHFF--EDSNNVYI   95 (592)
T ss_pred             ceeeeeeeeccCcceEEEEEEEcCCCcEEEEEEeehHHhcCcchHHHHHHHHHHHHhcCCCcEEeeeeEe--ecCCceEE
Confidence            4678889999999999999997 7899999999987542  33456788999999999999999999999  56789999


Q ss_pred             EEEcCCCCCHHHHhhhcCCCCCCCCHHHHHHHHHHHHHHHhhhhCCCCCCCceeecCCCCCceeecCCCCeEEecccccc
Q 005586          486 IYDFAPKGKLSKYLDQEEGSSNVLDWSTRVSIIIGIAKGIGYLHSSEVNKPAIVHRNLSVEKVLIDQQFNPLIADCGLHK  565 (689)
Q Consensus       486 V~e~~~~gsL~~~L~~~~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~~~ivH~dlk~~NiLl~~~~~~kl~DfGla~  565 (689)
                      |.|+|++|+|.++++..    .++++.++..+..||+.||.|||+.+     |+|||||-.|++|++++++||+|||||.
T Consensus        96 vLELC~~~sL~el~Krr----k~ltEpEary~l~QIv~GlkYLH~~~-----IiHRDLKLGNlfL~~~~~VKIgDFGLAt  166 (592)
T KOG0575|consen   96 VLELCHRGSLMELLKRR----KPLTEPEARYFLRQIVEGLKYLHSLG-----IIHRDLKLGNLFLNENMNVKIGDFGLAT  166 (592)
T ss_pred             EEEecCCccHHHHHHhc----CCCCcHHHHHHHHHHHHHHHHHHhcC-----ceecccchhheeecCcCcEEecccceee
Confidence            99999999999999843    35999999999999999999999988     9999999999999999999999999999


Q ss_pred             cccCCceeeeecCCCCCCCCCccccccCCCCCcccchhHHHHHHHHHhCCCCcchhHHHHHhhhhhhHhhccccCCCCCH
Q 005586          566 LLADDIVFSVLKTSAAMGYLAPEYVTTGRFTERSDIFAFGVIILQILTGSLVLTSSMRLAAESATFENFIDRNLKGKFSE  645 (689)
Q Consensus       566 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~ksDV~sfGvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~  645 (689)
                      .+..+.. ......||+-|+|||++.....+..+||||+|||||-|++|++||....-...    +..+....  -.+|.
T Consensus       167 ~le~~~E-rk~TlCGTPNYIAPEVl~k~gHsfEvDiWSlGcvmYtLL~G~PPFetk~vket----y~~Ik~~~--Y~~P~  239 (592)
T KOG0575|consen  167 QLEYDGE-RKKTLCGTPNYIAPEVLNKSGHSFEVDIWSLGCVMYTLLVGRPPFETKTVKET----YNKIKLNE--YSMPS  239 (592)
T ss_pred             eecCccc-ccceecCCCcccChhHhccCCCCCchhhhhhhhHHHhhhhCCCCcccchHHHH----HHHHHhcC--ccccc
Confidence            8875432 22345699999999999988999999999999999999999999976422111    11111111  12455


Q ss_pred             HHHHHHHHHHHHhccCCCCCCCCHHHHHHHHHhhC
Q 005586          646 SEAAKLGKMALVCTHEDPENRPTMEAVIEELTVAA  680 (689)
Q Consensus       646 ~~~~~l~~l~~~Cl~~dp~~RPs~~evl~~L~~~~  680 (689)
                      ..+.+..+|+...++++|.+|||.++|+.+-....
T Consensus       240 ~ls~~A~dLI~~lL~~~P~~Rpsl~~vL~h~Ff~~  274 (592)
T KOG0575|consen  240 HLSAEAKDLIRKLLRPNPSERPSLDEVLDHPFFKS  274 (592)
T ss_pred             ccCHHHHHHHHHHhcCCcccCCCHHHHhcCHhhhC
Confidence            66788999999999999999999999998876643

>KOG0615 consensus Serine/threonine protein kinase Chk2 and related proteins [Cell cycle control, cell division, chromosome partitioning]

Probab=100.00  E-value=5.6e-44  Score=356.87  Aligned_cols=255  Identities=20%  Similarity=0.324  Sum_probs=205.1

Q ss_pred             ccCCcccccccCCcceEEEEEec-CCcEEEEEEecccCCch------HHHHHHHHHHHHhccCCCcceeEeeEEEcCCCC
Q 005586          409 QCFSEVNLLGKGNFSSVYKGTLR-DGTLVAIRSINVTSCKS------EEAEFVKGLYLLTSLRHENIIRLRGFCCSRGRG  481 (689)
Q Consensus       409 ~~f~~~~~lg~G~~g~Vy~~~~~-~g~~vavK~l~~~~~~~------~~~~f~~e~~~l~~l~H~niv~l~g~~~~~~~~  481 (689)
                      +.|-..+.||+|+||.|-+|..+ +|+.||||++++.....      ......+|+++|++++|||||++++++  +..+
T Consensus       172 d~yii~~~LGsGafg~Vkla~e~~tgk~vAiKIi~krk~~~~s~~~~~~~~v~~EieILkkL~HP~IV~~~d~f--~~~d  249 (475)
T KOG0615|consen  172 DYYIISKTLGSGAFGLVKLAYEKKTGKQVAIKIINKRKSTGCSRAIAKTRDVQNEIEILKKLSHPNIVRIKDFF--EVPD  249 (475)
T ss_pred             ceeEeeeeecCCceeEEEEEEEcccCcEEEeeeeehhhcccccccccchhhhHHHHHHHHhcCCCCEEEEeeee--ecCC
Confidence            34556789999999999999865 79999999998664322      223456999999999999999999999  4457


Q ss_pred             eEEEEEEcCCCCCHHHHhhhcCCCCCCCCHHHHHHHHHHHHHHHhhhhCCCCCCCceeecCCCCCceeecCC---CCeEE
Q 005586          482 ECFLIYDFAPKGKLSKYLDQEEGSSNVLDWSTRVSIIIGIAKGIGYLHSSEVNKPAIVHRNLSVEKVLIDQQ---FNPLI  558 (689)
Q Consensus       482 ~~~lV~e~~~~gsL~~~L~~~~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~~~ivH~dlk~~NiLl~~~---~~~kl  558 (689)
                      +.|+|+|||++|+|.+.+-.+..    +.+..-..++.|++.|+.|||+.|     |+||||||+|||+..+   ..+||
T Consensus       250 s~YmVlE~v~GGeLfd~vv~nk~----l~ed~~K~~f~Qll~avkYLH~~G-----I~HRDiKPeNILl~~~~e~~llKI  320 (475)
T KOG0615|consen  250 SSYMVLEYVEGGELFDKVVANKY----LREDLGKLLFKQLLTAVKYLHSQG-----IIHRDIKPENILLSNDAEDCLLKI  320 (475)
T ss_pred             ceEEEEEEecCccHHHHHHhccc----cccchhHHHHHHHHHHHHHHHHcC-----cccccCCcceEEeccCCcceEEEe
Confidence            88999999999999999976643    667777889999999999999998     9999999999999866   77999


Q ss_pred             ecccccccccCCceeeeecCCCCCCCCCccccccCCC---CCcccchhHHHHHHHHHhCCCCcchhHHHHHhhhhhhHhh
Q 005586          559 ADCGLHKLLADDIVFSVLKTSAAMGYLAPEYVTTGRF---TERSDIFAFGVIILQILTGSLVLTSSMRLAAESATFENFI  635 (689)
Q Consensus       559 ~DfGla~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~---~~ksDV~sfGvvl~elltG~~p~~~~~~~~~~~~~~~~~~  635 (689)
                      +|||+|+..+....  .....||+.|.|||++.+..+   ..|+|+||+|||||-+++|.+||.+......   -.+++.
T Consensus       321 tDFGlAK~~g~~sf--m~TlCGTpsYvAPEVl~~kg~~~~~~kVDiWSlGcvLfvcLsG~pPFS~~~~~~s---l~eQI~  395 (475)
T KOG0615|consen  321 TDFGLAKVSGEGSF--MKTLCGTPSYVAPEVLASKGVEYYPSKVDIWSLGCVLFVCLSGYPPFSEEYTDPS---LKEQIL  395 (475)
T ss_pred             cccchhhcccccee--hhhhcCCccccChhheecCCeecccchheeeeccceEEEEeccCCCcccccCCcc---HHHHHh
Confidence            99999998875432  233568999999999987643   3488999999999999999999975422110   111221


Q ss_pred             cccc--CCCCCHHHHHHHHHHHHHhccCCCCCCCCHHHHHHHHHhh
Q 005586          636 DRNL--KGKFSESEAAKLGKMALVCTHEDPENRPTMEAVIEELTVA  679 (689)
Q Consensus       636 ~~~~--~~~~~~~~~~~l~~l~~~Cl~~dp~~RPs~~evl~~L~~~  679 (689)
                      ...+  ......+.+++..+++.+++..||++||+..|++++.|.-
T Consensus       396 ~G~y~f~p~~w~~Iseea~dlI~~mL~VdP~~R~s~~eaL~hpW~~  441 (475)
T KOG0615|consen  396 KGRYAFGPLQWDRISEEALDLINWMLVVDPENRPSADEALNHPWFK  441 (475)
T ss_pred             cCcccccChhhhhhhHHHHHHHHHhhEeCcccCcCHHHHhcChhhh
Confidence            1111  1123456788999999999999999999999999988765

>KOG4721 consensus Serine/threonine protein kinase, contains leucine zipper domain [Signal transduction mechanisms]

Probab=100.00  E-value=4e-44  Score=368.56  Aligned_cols=254  Identities=26%  Similarity=0.455  Sum_probs=215.8

Q ss_pred             ccccCHHHHHHHhccCCcccccccCCcceEEEEEecCCcEEEEEEecccCCchHHHHHHHHHHHHhccCCCcceeEeeEE
Q 005586          396 SFRLNLEEVESATQCFSEVNLLGKGNFSSVYKGTLRDGTLVAIRSINVTSCKSEEAEFVKGLYLLTSLRHENIIRLRGFC  475 (689)
Q Consensus       396 ~~~~~~~~l~~at~~f~~~~~lg~G~~g~Vy~~~~~~g~~vavK~l~~~~~~~~~~~f~~e~~~l~~l~H~niv~l~g~~  475 (689)
                      .|.++++++..       .+-||.|+.|.||+|+++ ++.||||+++.-.        ..+|+.|++++||||+.+.|+|
T Consensus       118 ~WeiPFe~IsE-------LeWlGSGaQGAVF~Grl~-netVAVKKV~elk--------ETdIKHLRkLkH~NII~FkGVC  181 (904)
T KOG4721|consen  118 LWEIPFEEISE-------LEWLGSGAQGAVFLGRLH-NETVAVKKVRELK--------ETDIKHLRKLKHPNIITFKGVC  181 (904)
T ss_pred             hccCCHHHhhh-------hhhhccCcccceeeeecc-CceehhHHHhhhh--------hhhHHHHHhccCcceeeEeeee
Confidence            35677777654       577999999999999997 6889999876432        2568899999999999999999


Q ss_pred             EcCCCCeEEEEEEcCCCCCHHHHhhhcCCCCCCCCHHHHHHHHHHHHHHHhhhhCCCCCCCceeecCCCCCceeecCCCC
Q 005586          476 CSRGRGECFLIYDFAPKGKLSKYLDQEEGSSNVLDWSTRVSIIIGIAKGIGYLHSSEVNKPAIVHRNLSVEKVLIDQQFN  555 (689)
Q Consensus       476 ~~~~~~~~~lV~e~~~~gsL~~~L~~~~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~~~ivH~dlk~~NiLl~~~~~  555 (689)
                      ..  ...++|||||++.|-|...|+...    ++.-.....+..+||.||.|||...     |||||||+-||||..+..
T Consensus       182 tq--sPcyCIiMEfCa~GqL~~VLka~~----~itp~llv~Wsk~IA~GM~YLH~hK-----IIHRDLKSPNiLIs~~d~  250 (904)
T KOG4721|consen  182 TQ--SPCYCIIMEFCAQGQLYEVLKAGR----PITPSLLVDWSKGIAGGMNYLHLHK-----IIHRDLKSPNILISYDDV  250 (904)
T ss_pred             cC--CceeEEeeeccccccHHHHHhccC----ccCHHHHHHHHHHhhhhhHHHHHhh-----HhhhccCCCceEeeccce
Confidence            43  467899999999999999998654    4777778899999999999999987     999999999999999999


Q ss_pred             eEEecccccccccCCceeeeecCCCCCCCCCccccccCCCCCcccchhHHHHHHHHHhCCCCcchhHHHHHhhhhhhHhh
Q 005586          556 PLIADCGLHKLLADDIVFSVLKTSAAMGYLAPEYVTTGRFTERSDIFAFGVIILQILTGSLVLTSSMRLAAESATFENFI  635 (689)
Q Consensus       556 ~kl~DfGla~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~ksDV~sfGvvl~elltG~~p~~~~~~~~~~~~~~~~~~  635 (689)
                      +||+|||-++...+.  ...+...||..|||||++.+.++++|+||||||||||||+||..||.+...    ..++..+-
T Consensus       251 VKIsDFGTS~e~~~~--STkMSFaGTVaWMAPEvIrnePcsEKVDIwSfGVVLWEmLT~EiPYkdVds----sAIIwGVG  324 (904)
T KOG4721|consen  251 VKISDFGTSKELSDK--STKMSFAGTVAWMAPEVIRNEPCSEKVDIWSFGVVLWEMLTGEIPYKDVDS----SAIIWGVG  324 (904)
T ss_pred             EEeccccchHhhhhh--hhhhhhhhhHhhhCHHHhhcCCcccccceehhHHHHHHHHhcCCCccccch----heeEEecc
Confidence            999999999877654  233456789999999999999999999999999999999999999964321    12233333


Q ss_pred             ccccCCCCCHHHHHHHHHHHHHhccCCCCCCCCHHHHHHHHHhhCCc
Q 005586          636 DRNLKGKFSESEAAKLGKMALVCTHEDPENRPTMEAVIEELTVAAPV  682 (689)
Q Consensus       636 ~~~~~~~~~~~~~~~l~~l~~~Cl~~dp~~RPs~~evl~~L~~~~p~  682 (689)
                      ...+....|..+++.+.-|++.||+..|..||++++++.+|..+.|.
T Consensus       325 sNsL~LpvPstcP~GfklL~Kqcw~sKpRNRPSFrqil~HldIa~pe  371 (904)
T KOG4721|consen  325 SNSLHLPVPSTCPDGFKLLLKQCWNSKPRNRPSFRQILLHLDIASPE  371 (904)
T ss_pred             CCcccccCcccCchHHHHHHHHHHhcCCCCCccHHHHHHHHhhcCHH
Confidence            44556677889999999999999999999999999999999998876

>KOG0193 consensus Serine/threonine protein kinase RAF [Signal transduction mechanisms]

Probab=100.00  E-value=1.2e-43  Score=370.06  Aligned_cols=259  Identities=24%  Similarity=0.395  Sum_probs=205.9

Q ss_pred             HhccCCcccccccCCcceEEEEEecCCcEEEEEEecccCCc-hHHHHHHHHHHHHhccCCCcceeEeeEEEcCCCCeEEE
Q 005586          407 ATQCFSEVNLLGKGNFSSVYKGTLRDGTLVAIRSINVTSCK-SEEAEFVKGLYLLTSLRHENIIRLRGFCCSRGRGECFL  485 (689)
Q Consensus       407 at~~f~~~~~lg~G~~g~Vy~~~~~~g~~vavK~l~~~~~~-~~~~~f~~e~~~l~~l~H~niv~l~g~~~~~~~~~~~l  485 (689)
                      ..+.+...+.||+|.||+||+|+|..  .||||.++..... ...+.|++|+..+++-+|.||+-+.|||..   ...+|
T Consensus       390 p~~ev~l~~rIGsGsFGtV~Rg~whG--dVAVK~Lnv~~pt~~qlqaFKnEVa~lkkTRH~NIlLFMG~~~~---p~~AI  464 (678)
T KOG0193|consen  390 PPEEVLLGERIGSGSFGTVYRGRWHG--DVAVKLLNVDDPTPEQLQAFKNEVAVLKKTRHENILLFMGACMN---PPLAI  464 (678)
T ss_pred             CHHHhhccceeccccccceeeccccc--ceEEEEEecCCCCHHHHHHHHHHHHHHhhcchhhheeeehhhcC---Cceee
Confidence            33334456889999999999999973  5999999987643 355799999999999999999999999954   34599


Q ss_pred             EEEcCCCCCHHHHhhhcCCCCCCCCHHHHHHHHHHHHHHHhhhhCCCCCCCceeecCCCCCceeecCCCCeEEecccccc
Q 005586          486 IYDFAPKGKLSKYLDQEEGSSNVLDWSTRVSIIIGIAKGIGYLHSSEVNKPAIVHRNLSVEKVLIDQQFNPLIADCGLHK  565 (689)
Q Consensus       486 V~e~~~~gsL~~~L~~~~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~~~ivH~dlk~~NiLl~~~~~~kl~DfGla~  565 (689)
                      |+.++++-+|..+||..+   ..++..+.+.||.|||.||.|||.++     |||||||+.||+|.++++|||+||||+.
T Consensus       465 iTqwCeGsSLY~hlHv~e---tkfdm~~~idIAqQiaqGM~YLHAK~-----IIHrDLKSnNIFl~~~~kVkIgDFGLat  536 (678)
T KOG0193|consen  465 ITQWCEGSSLYTHLHVQE---TKFDMNTTIDIAQQIAQGMDYLHAKN-----IIHRDLKSNNIFLHEDLKVKIGDFGLAT  536 (678)
T ss_pred             eehhccCchhhhhccchh---hhhhHHHHHHHHHHHHHhhhhhhhhh-----hhhhhccccceEEccCCcEEEeccccee
Confidence            999999999999999865   35999999999999999999999988     9999999999999999999999999986


Q ss_pred             cccCC-ceeeeecCCCCCCCCCcccccc---CCCCCcccchhHHHHHHHHHhCCCCcchhHHHHHhhhhhhHhhccccC-
Q 005586          566 LLADD-IVFSVLKTSAAMGYLAPEYVTT---GRFTERSDIFAFGVIILQILTGSLVLTSSMRLAAESATFENFIDRNLK-  640 (689)
Q Consensus       566 ~~~~~-~~~~~~~~~~~~~y~aPE~~~~---~~~~~ksDV~sfGvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~-  640 (689)
                      .-..- .........+.+.|||||++..   .+|++.+||||||+|+|||+||..||....+..    ++-.+-...+. 
T Consensus       537 vk~~w~g~~q~~qp~gsilwmAPEvIRmqd~nPfS~qSDVYaFGiV~YELltg~lPysi~~~dq----IifmVGrG~l~p  612 (678)
T KOG0193|consen  537 VKTRWSGEQQLEQPHGSLLWMAPEVIRMQDDNPFSFQSDVYAFGIVWYELLTGELPYSIQNRDQ----IIFMVGRGYLMP  612 (678)
T ss_pred             eeeeeccccccCCCccchhhhcHHHHhhcccCCCCcccchhhhhHHHHHHHhCcCCcCCCChhh----eEEEecccccCc
Confidence            43210 0111222345677999999864   468999999999999999999999996322110    00000000001 


Q ss_pred             --CCCCHHHHHHHHHHHHHhccCCCCCCCCHHHHHHHHHhhCCc
Q 005586          641 --GKFSESEAAKLGKMALVCTHEDPENRPTMEAVIEELTVAAPV  682 (689)
Q Consensus       641 --~~~~~~~~~~l~~l~~~Cl~~dp~~RPs~~evl~~L~~~~p~  682 (689)
                        ......+.+++.+|+..||..++++||.+.+|+..|+...|.
T Consensus       613 d~s~~~s~~pk~mk~Ll~~C~~~~~~eRP~F~~il~~l~~l~~~  656 (678)
T KOG0193|consen  613 DLSKIRSNCPKAMKRLLSDCWKFDREERPLFPQLLSKLEELLPS  656 (678)
T ss_pred             cchhhhccCHHHHHHHHHHHHhcCcccCccHHHHHHHHHHhhhc
Confidence              122356788999999999999999999999999988888763

>cd05102 PTKc_VEGFR3 Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 3

Probab=100.00  E-value=2.2e-42  Score=367.40  Aligned_cols=264  Identities=23%  Similarity=0.412  Sum_probs=208.0

Q ss_pred             hccCCcccccccCCcceEEEEEe------cCCcEEEEEEecccCCchHHHHHHHHHHHHhcc-CCCcceeEeeEEEcCCC
Q 005586          408 TQCFSEVNLLGKGNFSSVYKGTL------RDGTLVAIRSINVTSCKSEEAEFVKGLYLLTSL-RHENIIRLRGFCCSRGR  480 (689)
Q Consensus       408 t~~f~~~~~lg~G~~g~Vy~~~~------~~g~~vavK~l~~~~~~~~~~~f~~e~~~l~~l-~H~niv~l~g~~~~~~~  480 (689)
                      .++|...+.||+|+||.||+|..      .+++.||||+++..........+.+|+.++.++ +||||++++++|... .
T Consensus         6 ~~~~~~~~~lG~G~fg~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~~~~~~~~~-~   84 (338)
T cd05102           6 RDRLRLGKVLGHGAFGKVVEASAFGIDKKSSCNTVAVKMLKEGATASEHKALMSELKILIHIGNHLNVVNLLGACTKP-N   84 (338)
T ss_pred             hhHceeeeEeccCCcceEEEEEEeccCCcccchhhheeccccccchHHHHHHHHHHHHHHHhccCcceeeEEeEecCC-C
Confidence            45678889999999999999974      235789999998654444556899999999999 899999999988543 4


Q ss_pred             CeEEEEEEcCCCCCHHHHhhhcCCC-------------------------------------------------------
Q 005586          481 GECFLIYDFAPKGKLSKYLDQEEGS-------------------------------------------------------  505 (689)
Q Consensus       481 ~~~~lV~e~~~~gsL~~~L~~~~~~-------------------------------------------------------  505 (689)
                      ...++||||+++|+|.+++......                                                       
T Consensus        85 ~~~~lv~ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  164 (338)
T cd05102          85 GPLMVIVEFCKYGNLSNFLRAKREFFSPYREKSPKQRGRFRAMVEQSRVDRRIEAGQASVLFSRFQPSTSGSTNPPQETD  164 (338)
T ss_pred             CceEEEEecCCCCcHHHHHHhcchhcccccccchhhhhhhhhhhhhhccccccccccCCccccccccccCcccccchhcc
Confidence            5689999999999999999753210                                                       


Q ss_pred             ---CCCCCHHHHHHHHHHHHHHHhhhhCCCCCCCceeecCCCCCceeecCCCCeEEecccccccccCCcee-eeecCCCC
Q 005586          506 ---SNVLDWSTRVSIIIGIAKGIGYLHSSEVNKPAIVHRNLSVEKVLIDQQFNPLIADCGLHKLLADDIVF-SVLKTSAA  581 (689)
Q Consensus       506 ---~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~~~ivH~dlk~~NiLl~~~~~~kl~DfGla~~~~~~~~~-~~~~~~~~  581 (689)
                         ...+++.+++.++.|+++||+|||+.+     |+||||||+|||+++++.+||+|||+++........ ......++
T Consensus       165 ~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~-----ivHrDiKp~Nil~~~~~~~kl~DfG~a~~~~~~~~~~~~~~~~~~  239 (338)
T cd05102         165 DLWKSPLTMEDLICYSFQVARGMEFLASRK-----CIHRDLAARNILLSENNVVKICDFGLARDIYKDPDYVRKGSARLP  239 (338)
T ss_pred             ccccCCCCHHHHHHHHHHHHHHHHHHHHCC-----EECCCCccceEEEcCCCcEEEeecccccccccCcchhcccCCCCC
Confidence               134888999999999999999999987     999999999999999999999999999866433211 11223345


Q ss_pred             CCCCCccccccCCCCCcccchhHHHHHHHHHh-CCCCcchhHHHHHhhhhhhHhhccccCCCCCHHHHHHHHHHHHHhcc
Q 005586          582 MGYLAPEYVTTGRFTERSDIFAFGVIILQILT-GSLVLTSSMRLAAESATFENFIDRNLKGKFSESEAAKLGKMALVCTH  660 (689)
Q Consensus       582 ~~y~aPE~~~~~~~~~ksDV~sfGvvl~ellt-G~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~Cl~  660 (689)
                      ..|+|||++.+..++.++|||||||++|||+| |+.||.......    .+...+........+...+..+.+++.+||+
T Consensus       240 ~~y~aPE~~~~~~~~~~sDiwslG~il~el~~~g~~pf~~~~~~~----~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~  315 (338)
T cd05102         240 LKWMAPESIFDKVYTTQSDVWSFGVLLWEIFSLGASPYPGVQINE----EFCQRLKDGTRMRAPENATPEIYRIMLACWQ  315 (338)
T ss_pred             ccccCcHHhhcCCCCcccCHHHHHHHHHHHHhCCCCCCCCCCccH----HHHHHHhcCCCCCCCCCCCHHHHHHHHHHcc
Confidence            78999999998899999999999999999997 999986432111    1111111111122334456679999999999


Q ss_pred             CCCCCCCCHHHHHHHHHhhCC
Q 005586          661 EDPENRPTMEAVIEELTVAAP  681 (689)
Q Consensus       661 ~dp~~RPs~~evl~~L~~~~p  681 (689)
                      .||++||++.|+++.|+....
T Consensus       316 ~dp~~RPs~~el~~~l~~~~~  336 (338)
T cd05102         316 GDPKERPTFSALVEILGDLLQ  336 (338)
T ss_pred             CChhhCcCHHHHHHHHHHHHh
Confidence            999999999999999987643

Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 3 (VEGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR3 (or Flt4) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. V

>KOG0194 consensus Protein tyrosine kinase [Signal transduction mechanisms]

Probab=100.00  E-value=1.2e-42  Score=367.63  Aligned_cols=254  Identities=25%  Similarity=0.472  Sum_probs=208.9

Q ss_pred             ccccccCCcceEEEEEecC--C--cE-EEEEEeccc--CCchHHHHHHHHHHHHhccCCCcceeEeeEEEcCCCCeEEEE
Q 005586          414 VNLLGKGNFSSVYKGTLRD--G--TL-VAIRSINVT--SCKSEEAEFVKGLYLLTSLRHENIIRLRGFCCSRGRGECFLI  486 (689)
Q Consensus       414 ~~~lg~G~~g~Vy~~~~~~--g--~~-vavK~l~~~--~~~~~~~~f~~e~~~l~~l~H~niv~l~g~~~~~~~~~~~lV  486 (689)
                      .++||+|+||.||+|.++.  +  .. ||||..+..  .......+|++|.++|.+++|||||+++|++..  ....++|
T Consensus       162 ~kkLGeGaFGeV~~G~l~~~~~~~~~~VAvK~~k~~~~~~~~~~~e~m~EArvMr~l~H~NVVr~yGVa~~--~~Pl~iv  239 (474)
T KOG0194|consen  162 GKKLGEGAFGEVFKGKLKLKNGFKVVPVAVKTTKGSSELTKEQIKEFMKEARVMRQLNHPNVVRFYGVAVL--EEPLMLV  239 (474)
T ss_pred             cceeecccccEEEEEEEEecCCceeeeeEEEeecccccccHHHHHHHHHHHHHHHhCCCCCEEEEEEEEcC--CCccEEE
Confidence            4799999999999999763  3  23 899998852  334566899999999999999999999999965  4789999


Q ss_pred             EEcCCCCCHHHHhhhcCCCCCCCCHHHHHHHHHHHHHHHhhhhCCCCCCCceeecCCCCCceeecCCCCeEEeccccccc
Q 005586          487 YDFAPKGKLSKYLDQEEGSSNVLDWSTRVSIIIGIAKGIGYLHSSEVNKPAIVHRNLSVEKVLIDQQFNPLIADCGLHKL  566 (689)
Q Consensus       487 ~e~~~~gsL~~~L~~~~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~~~ivH~dlk~~NiLl~~~~~~kl~DfGla~~  566 (689)
                      ||+|+||+|.++|+....   .++..+++.++.++|+||+|||+.+     +|||||.++|+|++.++.+||+|||+++.
T Consensus       240 mEl~~gGsL~~~L~k~~~---~v~~~ek~~~~~~AA~Gl~YLh~k~-----~IHRDIAARNcL~~~~~~vKISDFGLs~~  311 (474)
T KOG0194|consen  240 MELCNGGSLDDYLKKNKK---SLPTLEKLRFCYDAARGLEYLHSKN-----CIHRDIAARNCLYSKKGVVKISDFGLSRA  311 (474)
T ss_pred             EEecCCCcHHHHHHhCCC---CCCHHHHHHHHHHHHhHHHHHHHCC-----CcchhHhHHHheecCCCeEEeCccccccC
Confidence            999999999999998754   4899999999999999999999988     89999999999999999999999999886


Q ss_pred             ccCCceeeeecCCCCCCCCCccccccCCCCCcccchhHHHHHHHHHh-CCCCcchhHHHHHhhhhhhHhhccccCCCCCH
Q 005586          567 LADDIVFSVLKTSAAMGYLAPEYVTTGRFTERSDIFAFGVIILQILT-GSLVLTSSMRLAAESATFENFIDRNLKGKFSE  645 (689)
Q Consensus       567 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~ksDV~sfGvvl~ellt-G~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~  645 (689)
                      -..-.. .......++.|+|||.+..+.|++++|||||||++||+++ |..|+.........    ..+.....+-..+.
T Consensus       312 ~~~~~~-~~~~~klPirWLAPEtl~~~~~s~kTDV~sfGV~~~Eif~~g~~Py~g~~~~~v~----~kI~~~~~r~~~~~  386 (474)
T KOG0194|consen  312 GSQYVM-KKFLKKLPIRWLAPETLNTGIFSFKTDVWSFGVLLWEIFENGAEPYPGMKNYEVK----AKIVKNGYRMPIPS  386 (474)
T ss_pred             Ccceee-ccccccCcceecChhhhccCccccccchhheeeeEEeeeccCCCCCCCCCHHHHH----HHHHhcCccCCCCC
Confidence            542111 1111235678999999999999999999999999999998 88888765332221    12223334444556


Q ss_pred             HHHHHHHHHHHHhccCCCCCCCCHHHHHHHHHhhCCc
Q 005586          646 SEAAKLGKMALVCTHEDPENRPTMEAVIEELTVAAPV  682 (689)
Q Consensus       646 ~~~~~l~~l~~~Cl~~dp~~RPs~~evl~~L~~~~p~  682 (689)
                      ..+.++..++..||..+|++||+|.++.+.++.....
T Consensus       387 ~~p~~~~~~~~~c~~~~p~~R~tm~~i~~~l~~~~~~  423 (474)
T KOG0194|consen  387 KTPKELAKVMKQCWKKDPEDRPTMSTIKKKLEALEKK  423 (474)
T ss_pred             CCHHHHHHHHHHhccCChhhccCHHHHHHHHHHHHhc
Confidence            6778889999999999999999999999999887544

>KOG0198 consensus MEKK and related serine/threonine protein kinases [Signal transduction mechanisms]

Probab=100.00  E-value=2.2e-42  Score=350.49  Aligned_cols=258  Identities=28%  Similarity=0.444  Sum_probs=207.1

Q ss_pred             CCcccccccCCcceEEEEEec-CCcEEEEEEecccCCchHHHHHHHHHHHHhccCCCcceeEeeEEEcCCCCeEEEEEEc
Q 005586          411 FSEVNLLGKGNFSSVYKGTLR-DGTLVAIRSINVTSCKSEEAEFVKGLYLLTSLRHENIIRLRGFCCSRGRGECFLIYDF  489 (689)
Q Consensus       411 f~~~~~lg~G~~g~Vy~~~~~-~g~~vavK~l~~~~~~~~~~~f~~e~~~l~~l~H~niv~l~g~~~~~~~~~~~lV~e~  489 (689)
                      +...+.||+|+||.||++... +|...|||......... .+.+.+|+++|.+++|||||+.+|.........+++.|||
T Consensus        19 ~~~~~~lG~Gs~G~V~l~~~~~~g~~~AvK~v~~~~~~~-~~~l~~Ei~iL~~l~~p~IV~~~G~~~~~~~~~~~i~mEy   97 (313)
T KOG0198|consen   19 WSKGKLLGRGSFGSVYLATNKKTGELMAVKSVELEDSPT-SESLEREIRILSRLNHPNIVQYYGSSSSRENDEYNIFMEY   97 (313)
T ss_pred             hhhhccccCccceEEEEEEecCCCcceeeeeeecccchh-HHHHHHHHHHHHhCCCCCEEeeCCccccccCeeeEeeeec
Confidence            445689999999999999976 49999999987664222 5678999999999999999999997533322368999999


Q ss_pred             CCCCCHHHHhhhcCCCCCCCCHHHHHHHHHHHHHHHhhhhCCCCCCCceeecCCCCCceeecC-CCCeEEeccccccccc
Q 005586          490 APKGKLSKYLDQEEGSSNVLDWSTRVSIIIGIAKGIGYLHSSEVNKPAIVHRNLSVEKVLIDQ-QFNPLIADCGLHKLLA  568 (689)
Q Consensus       490 ~~~gsL~~~L~~~~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~~~ivH~dlk~~NiLl~~-~~~~kl~DfGla~~~~  568 (689)
                      +++|+|.+++...++   .+++.....++.||++||+|||+.+     ||||||||+|||++. ++.+||+|||+++...
T Consensus        98 ~~~GsL~~~~~~~g~---~l~E~~v~~ytr~iL~GL~ylHs~g-----~vH~DiK~~NiLl~~~~~~~KlaDFG~a~~~~  169 (313)
T KOG0198|consen   98 APGGSLSDLIKRYGG---KLPEPLVRRYTRQILEGLAYLHSKG-----IVHCDIKPANILLDPSNGDVKLADFGLAKKLE  169 (313)
T ss_pred             cCCCcHHHHHHHcCC---CCCHHHHHHHHHHHHHHHHHHHhCC-----EeccCcccceEEEeCCCCeEEeccCccccccc
Confidence            999999999987654   3999999999999999999999988     999999999999999 7999999999998776


Q ss_pred             C--CceeeeecCCCCCCCCCccccccCC-CCCcccchhHHHHHHHHHhCCCCcchhHHHHHhhhhhhHhhccccCCCCCH
Q 005586          569 D--DIVFSVLKTSAAMGYLAPEYVTTGR-FTERSDIFAFGVIILQILTGSLVLTSSMRLAAESATFENFIDRNLKGKFSE  645 (689)
Q Consensus       569 ~--~~~~~~~~~~~~~~y~aPE~~~~~~-~~~ksDV~sfGvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~  645 (689)
                      .  ..........||+.|||||++..+. ...++||||+||++.||+||+.|+......   ...+-.+......+.++.
T Consensus       170 ~~~~~~~~~~~~~Gtp~~maPEvi~~g~~~~~~sDiWSlGCtVvEM~Tg~~PW~~~~~~---~~~~~~ig~~~~~P~ip~  246 (313)
T KOG0198|consen  170 SKGTKSDSELSVQGTPNYMAPEVIRNGEVARRESDIWSLGCTVVEMLTGKPPWSEFFEE---AEALLLIGREDSLPEIPD  246 (313)
T ss_pred             cccccccccccccCCccccCchhhcCCCcCCccchhhhcCCEEEeccCCCCcchhhcch---HHHHHHHhccCCCCCCCc
Confidence            3  2222233467899999999998643 335999999999999999999998653110   011111111112235666


Q ss_pred             HHHHHHHHHHHHhccCCCCCCCCHHHHHHHHHhhC
Q 005586          646 SEAAKLGKMALVCTHEDPENRPTMEAVIEELTVAA  680 (689)
Q Consensus       646 ~~~~~l~~l~~~Cl~~dp~~RPs~~evl~~L~~~~  680 (689)
                      ..+.+..+++..|+..||++|||+.+++++.....
T Consensus       247 ~ls~~a~~Fl~~C~~~~p~~Rpta~eLL~hpf~~~  281 (313)
T KOG0198|consen  247 SLSDEAKDFLRKCFKRDPEKRPTAEELLEHPFLKQ  281 (313)
T ss_pred             ccCHHHHHHHHHHhhcCcccCcCHHHHhhChhhhc
Confidence            77888999999999999999999999999876654

>KOG0598 consensus Ribosomal protein S6 kinase and related proteins [General function prediction only; Signal transduction mechanisms]

Probab=100.00  E-value=2.7e-42  Score=343.05  Aligned_cols=242  Identities=21%  Similarity=0.303  Sum_probs=200.3

Q ss_pred             ccCCcccccccCCcceEEEEEec-CCcEEEEEEecccCC--chHHHHHHHHHHHHhccCCCcceeEeeEEEcCCCCeEEE
Q 005586          409 QCFSEVNLLGKGNFSSVYKGTLR-DGTLVAIRSINVTSC--KSEEAEFVKGLYLLTSLRHENIIRLRGFCCSRGRGECFL  485 (689)
Q Consensus       409 ~~f~~~~~lg~G~~g~Vy~~~~~-~g~~vavK~l~~~~~--~~~~~~f~~e~~~l~~l~H~niv~l~g~~~~~~~~~~~l  485 (689)
                      ++|+..++||+|+||+||.++.+ +++.+|+|++++...  ..+.+....|..+|.+++||.||++.--+  ++.+.+|+
T Consensus        25 ~dF~~lkviGkG~fGkV~~Vrk~dt~kiYAmKvl~K~~iv~~~e~~~~~~Er~IL~~v~hPFiv~l~ysF--Qt~~kLyl  102 (357)
T KOG0598|consen   25 DDFEILKVIGKGSFGKVFQVRKKDTGKIYAMKVLKKKKIVEKKEVRHTKAERNILSKIKHPFIVKLIYSF--QTEEKLYL  102 (357)
T ss_pred             hheeeeeeeeccCCceEEEEEEcccCceeehhhhhhhHhhhhhhHHHHHHHHHHHHhCCCCcEeeeEEec--ccCCeEEE
Confidence            57888999999999999999876 599999999987764  23467888999999999999999997655  56788999


Q ss_pred             EEEcCCCCCHHHHhhhcCCCCCCCCHHHHHHHHHHHHHHHhhhhCCCCCCCceeecCCCCCceeecCCCCeEEecccccc
Q 005586          486 IYDFAPKGKLSKYLDQEEGSSNVLDWSTRVSIIIGIAKGIGYLHSSEVNKPAIVHRNLSVEKVLIDQQFNPLIADCGLHK  565 (689)
Q Consensus       486 V~e~~~~gsL~~~L~~~~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~~~ivH~dlk~~NiLl~~~~~~kl~DfGla~  565 (689)
                      |+||+.||.|..+|...+    .+++.....++.+|+.||.|||+.+     ||||||||+|||||++|+++|+||||++
T Consensus       103 Vld~~~GGeLf~hL~~eg----~F~E~~arfYlaEi~lAL~~LH~~g-----IiyRDlKPENILLd~~GHi~LtDFgL~k  173 (357)
T KOG0598|consen  103 VLDYLNGGELFYHLQREG----RFSEDRARFYLAEIVLALGYLHSKG-----IIYRDLKPENILLDEQGHIKLTDFGLCK  173 (357)
T ss_pred             EEeccCCccHHHHHHhcC----CcchhHHHHHHHHHHHHHHHHHhCC-----eeeccCCHHHeeecCCCcEEEeccccch
Confidence            999999999999998654    3888989999999999999999998     9999999999999999999999999999


Q ss_pred             cccCCceeeeecCCCCCCCCCccccccCCCCCcccchhHHHHHHHHHhCCCCcchhHHHHHhhhhhhHhhccccCCCCCH
Q 005586          566 LLADDIVFSVLKTSAAMGYLAPEYVTTGRFTERSDIFAFGVIILQILTGSLVLTSSMRLAAESATFENFIDRNLKGKFSE  645 (689)
Q Consensus       566 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~ksDV~sfGvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~  645 (689)
                      ..-.+.. ......||+.|||||++.+..|+..+|+||+||++|||+||.+||..........    .+.... ....+.
T Consensus       174 ~~~~~~~-~t~tfcGT~eYmAPEil~~~gy~~~vDWWsLGillYeML~G~pPF~~~~~~~~~~----~I~~~k-~~~~p~  247 (357)
T KOG0598|consen  174 EDLKDGD-ATRTFCGTPEYMAPEILLGKGYDKAVDWWSLGILLYEMLTGKPPFYAEDVKKMYD----KILKGK-LPLPPG  247 (357)
T ss_pred             hcccCCC-ccccccCCccccChHHHhcCCCCcccchHhHHHHHHHHhhCCCCCcCccHHHHHH----HHhcCc-CCCCCc
Confidence            5433221 2223578999999999999999999999999999999999999997654322211    111111 112233


Q ss_pred             HHHHHHHHHHHHhccCCCCCCC
Q 005586          646 SEAAKLGKMALVCTHEDPENRP  667 (689)
Q Consensus       646 ~~~~~l~~l~~~Cl~~dp~~RP  667 (689)
                      -.+.+..+++...+..||++|-
T Consensus       248 ~ls~~ardll~~LL~rdp~~RL  269 (357)
T KOG0598|consen  248 YLSEEARDLLKKLLKRDPRQRL  269 (357)
T ss_pred             cCCHHHHHHHHHHhccCHHHhc
Confidence            3566788999999999999995

>KOG0600 consensus Cdc2-related protein kinase [Cell cycle control, cell division, chromosome partitioning]

Probab=100.00  E-value=3.1e-42  Score=352.63  Aligned_cols=261  Identities=20%  Similarity=0.340  Sum_probs=210.3

Q ss_pred             ccCCcccccccCCcceEEEEEe-cCCcEEEEEEecccCCch-HHHHHHHHHHHHhccCCCcceeEeeEEEcCCCCeEEEE
Q 005586          409 QCFSEVNLLGKGNFSSVYKGTL-RDGTLVAIRSINVTSCKS-EEAEFVKGLYLLTSLRHENIIRLRGFCCSRGRGECFLI  486 (689)
Q Consensus       409 ~~f~~~~~lg~G~~g~Vy~~~~-~~g~~vavK~l~~~~~~~-~~~~f~~e~~~l~~l~H~niv~l~g~~~~~~~~~~~lV  486 (689)
                      +.|...++||+|.||.||+|+. .+|+.||+|++.....+. ...-..+||.+|++++||||++|.+...+......|+|
T Consensus       117 ~~feki~kIGeGTyg~VYkAr~~~tgkivALKKvr~d~~~~~~~~t~~REI~ILr~l~HpNIikL~eivt~~~~~siYlV  196 (560)
T KOG0600|consen  117 DSFEKIEKIGEGTYGQVYKARDLETGKIVALKKVRFDNEKEGFPITAIREIKILRRLDHPNIIKLEEIVTSKLSGSIYLV  196 (560)
T ss_pred             HHHHHHHHhcCcchhheeEeeecccCcEEEEEEeecccCCCcchHHHHHHHHHHHhcCCCcccceeeEEEecCCceEEEE
Confidence            3466678999999999999985 579999999998665332 33456799999999999999999999988767899999


Q ss_pred             EEcCCCCCHHHHhhhcCCCCCCCCHHHHHHHHHHHHHHHhhhhCCCCCCCceeecCCCCCceeecCCCCeEEeccccccc
Q 005586          487 YDFAPKGKLSKYLDQEEGSSNVLDWSTRVSIIIGIAKGIGYLHSSEVNKPAIVHRNLSVEKVLIDQQFNPLIADCGLHKL  566 (689)
Q Consensus       487 ~e~~~~gsL~~~L~~~~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~~~ivH~dlk~~NiLl~~~~~~kl~DfGla~~  566 (689)
                      +|||+. ||..++....-   .++..++..++.|++.||+|+|+.+     |+|||||.+|||||.+|.+||+|||||++
T Consensus       197 FeYMdh-DL~GLl~~p~v---kft~~qIKc~mkQLl~Gl~~cH~~g-----vlHRDIK~SNiLidn~G~LKiaDFGLAr~  267 (560)
T KOG0600|consen  197 FEYMDH-DLSGLLSSPGV---KFTEPQIKCYMKQLLEGLEYCHSRG-----VLHRDIKGSNILIDNNGVLKIADFGLARF  267 (560)
T ss_pred             Eecccc-hhhhhhcCCCc---ccChHHHHHHHHHHHHHHHHHhhcC-----eeeccccccceEEcCCCCEEeccccceee
Confidence            999976 89998876432   4899999999999999999999998     99999999999999999999999999998


Q ss_pred             ccCCceeeeecCCCCCCCCCccccccC-CCCCcccchhHHHHHHHHHhCCCCcchhHHHHHhhhhhhHhhcc--------
Q 005586          567 LADDIVFSVLKTSAAMGYLAPEYVTTG-RFTERSDIFAFGVIILQILTGSLVLTSSMRLAAESATFENFIDR--------  637 (689)
Q Consensus       567 ~~~~~~~~~~~~~~~~~y~aPE~~~~~-~~~~ksDV~sfGvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~--------  637 (689)
                      +........+....|.+|+|||.+.+. .|+.++|+||.||||.||++|++.+.+.....+...+++-.-.+        
T Consensus       268 y~~~~~~~~T~rVvTLWYRpPELLLG~t~Yg~aVDlWS~GCIl~El~~gkPI~~G~tEveQl~kIfklcGSP~e~~W~~~  347 (560)
T KOG0600|consen  268 YTPSGSAPYTSRVVTLWYRPPELLLGATSYGTAVDLWSVGCILAELFLGKPILQGRTEVEQLHKIFKLCGSPTEDYWPVS  347 (560)
T ss_pred             ccCCCCcccccceEEeeccChHHhcCCcccccceeehhhhHHHHHHHcCCCCcCCccHHHHHHHHHHHhCCCChhccccc
Confidence            876655455566778999999998875 69999999999999999999999987665444333322211000        


Q ss_pred             ------ccCC--CCC-------HHHHHHHHHHHHHhccCCCCCCCCHHHHHHHHHh
Q 005586          638 ------NLKG--KFS-------ESEAAKLGKMALVCTHEDPENRPTMEAVIEELTV  678 (689)
Q Consensus       638 ------~~~~--~~~-------~~~~~~l~~l~~~Cl~~dp~~RPs~~evl~~L~~  678 (689)
                            .++.  .+.       ..-+...++|+..+|..||.+|.|+.++++.=..
T Consensus       348 kLP~~~~~kp~~~y~r~l~E~~~~~~~~~l~Ll~~lL~ldP~kR~tA~~aL~seyF  403 (560)
T KOG0600|consen  348 KLPHATIFKPQQPYKRRLRETFKDFPASALDLLEKLLSLDPDKRGTASSALQSEYF  403 (560)
T ss_pred             cCCcccccCCCCcccchHHHHhccCCHHHHHHHHHHhccCccccccHHHHhcCccc
Confidence                  0010  111       1124567889999999999999999999976544

>PHA02988 hypothetical protein; Provisional

Probab=100.00  E-value=3.9e-41  Score=348.33  Aligned_cols=249  Identities=22%  Similarity=0.362  Sum_probs=203.8

Q ss_pred             ccccccCCcceEEEEEecCCcEEEEEEecccCCch--HHHHHHHHHHHHhccCCCcceeEeeEEEc--CCCCeEEEEEEc
Q 005586          414 VNLLGKGNFSSVYKGTLRDGTLVAIRSINVTSCKS--EEAEFVKGLYLLTSLRHENIIRLRGFCCS--RGRGECFLIYDF  489 (689)
Q Consensus       414 ~~~lg~G~~g~Vy~~~~~~g~~vavK~l~~~~~~~--~~~~f~~e~~~l~~l~H~niv~l~g~~~~--~~~~~~~lV~e~  489 (689)
                      ...||+|++|.||+|.+ +|+.||||+++......  ..+.|.+|+.+|.+++|||||+++|++.+  ......++||||
T Consensus        25 ~~~i~~g~~~~v~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~~~g~~~~~~~~~~~~~lv~Ey  103 (283)
T PHA02988         25 SVLIKENDQNSIYKGIF-NNKEVIIRTFKKFHKGHKVLIDITENEIKNLRRIDSNNILKIYGFIIDIVDDLPRLSLILEY  103 (283)
T ss_pred             CeEEeeCCceEEEEEEE-CCEEEEEEeccccccccHHHHHHHHHHHHHHHhcCCCCEEEEeeeEEecccCCCceEEEEEe
Confidence            46899999999999998 58999999997653222  24678899999999999999999999866  444578999999


Q ss_pred             CCCCCHHHHhhhcCCCCCCCCHHHHHHHHHHHHHHHhhhhCC-CCCCCceeecCCCCCceeecCCCCeEEeccccccccc
Q 005586          490 APKGKLSKYLDQEEGSSNVLDWSTRVSIIIGIAKGIGYLHSS-EVNKPAIVHRNLSVEKVLIDQQFNPLIADCGLHKLLA  568 (689)
Q Consensus       490 ~~~gsL~~~L~~~~~~~~~l~~~~~~~ia~~ia~gL~yLH~~-~~~~~~ivH~dlk~~NiLl~~~~~~kl~DfGla~~~~  568 (689)
                      +++|+|.++++...    .++|..++.++.+++.||+|||+. +     ++||||||+|||+++++.+||+|||+++.+.
T Consensus       104 ~~~g~L~~~l~~~~----~~~~~~~~~i~~~i~~~l~~lH~~~~-----~~Hrdlkp~nill~~~~~~kl~dfg~~~~~~  174 (283)
T PHA02988        104 CTRGYLREVLDKEK----DLSFKTKLDMAIDCCKGLYNLYKYTN-----KPYKNLTSVSFLVTENYKLKIICHGLEKILS  174 (283)
T ss_pred             CCCCcHHHHHhhCC----CCChhHHHHHHHHHHHHHHHHHhcCC-----CCCCcCChhhEEECCCCcEEEcccchHhhhc
Confidence            99999999997643    489999999999999999999974 4     7799999999999999999999999998764


Q ss_pred             CCceeeeecCCCCCCCCCcccccc--CCCCCcccchhHHHHHHHHHhCCCCcchhHHHHHhhhhhhHhhccccCCCCCHH
Q 005586          569 DDIVFSVLKTSAAMGYLAPEYVTT--GRFTERSDIFAFGVIILQILTGSLVLTSSMRLAAESATFENFIDRNLKGKFSES  646 (689)
Q Consensus       569 ~~~~~~~~~~~~~~~y~aPE~~~~--~~~~~ksDV~sfGvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  646 (689)
                      ...    ....++..|+|||.+.+  ..++.++|||||||++|||+||+.||.......    ....+.....+...+..
T Consensus       175 ~~~----~~~~~~~~y~aPE~~~~~~~~~~~k~Di~SlGvil~el~~g~~Pf~~~~~~~----~~~~i~~~~~~~~~~~~  246 (283)
T PHA02988        175 SPP----FKNVNFMVYFSYKMLNDIFSEYTIKDDIYSLGVVLWEIFTGKIPFENLTTKE----IYDLIINKNNSLKLPLD  246 (283)
T ss_pred             ccc----ccccCcccccCHHHhhhccccccchhhhhHHHHHHHHHHHCCCCCCCCCHHH----HHHHHHhcCCCCCCCCc
Confidence            422    23456788999999876  689999999999999999999999997542211    11222222223334445


Q ss_pred             HHHHHHHHHHHhccCCCCCCCCHHHHHHHHHhhC
Q 005586          647 EAAKLGKMALVCTHEDPENRPTMEAVIEELTVAA  680 (689)
Q Consensus       647 ~~~~l~~l~~~Cl~~dp~~RPs~~evl~~L~~~~  680 (689)
                      .+..+.+++.+||+.||++||++.|+++.|+...
T Consensus       247 ~~~~l~~li~~cl~~dp~~Rps~~ell~~l~~~~  280 (283)
T PHA02988        247 CPLEIKCIVEACTSHDSIKRPNIKEILYNLSLYK  280 (283)
T ss_pred             CcHHHHHHHHHHhcCCcccCcCHHHHHHHHHHHH
Confidence            6778999999999999999999999999998653

>KOG0593 consensus Predicted protein kinase KKIAMRE [General function prediction only]

Probab=100.00  E-value=2.5e-42  Score=331.80  Aligned_cols=254  Identities=20%  Similarity=0.329  Sum_probs=197.4

Q ss_pred             cCCcccccccCCcceEEEEEec-CCcEEEEEEecccCCchHH-HHHHHHHHHHhccCCCcceeEeeEEEcCCCCeEEEEE
Q 005586          410 CFSEVNLLGKGNFSSVYKGTLR-DGTLVAIRSINVTSCKSEE-AEFVKGLYLLTSLRHENIIRLRGFCCSRGRGECFLIY  487 (689)
Q Consensus       410 ~f~~~~~lg~G~~g~Vy~~~~~-~g~~vavK~l~~~~~~~~~-~~f~~e~~~l~~l~H~niv~l~g~~~~~~~~~~~lV~  487 (689)
                      .|+...++|+|+||.|||++.+ +|+.||||++......... +-.++||++|++++|+|+|.|+.+|  +.....++|+
T Consensus         3 kYE~LgkvGEGSYGvV~KCrnk~TgqIVAIKkF~Esedd~~VkKIAlREIrmLKqLkH~NLVnLiEVF--rrkrklhLVF   80 (396)
T KOG0593|consen    3 KYEKLGKVGEGSYGVVMKCRNKDTGQIVAIKKFVESEDDPVVKKIALREIRMLKQLKHENLVNLIEVF--RRKRKLHLVF   80 (396)
T ss_pred             HHhhhhccccCcceEEEEeccCCcccEEEEEeeccCCccHHHHHHHHHHHHHHHhcccchHHHHHHHH--HhcceeEEEe
Confidence            4666788999999999999987 5999999999877643333 4568999999999999999999998  4457899999


Q ss_pred             EcCCCCCHHHHhhhcCCCCCCCCHHHHHHHHHHHHHHHhhhhCCCCCCCceeecCCCCCceeecCCCCeEEecccccccc
Q 005586          488 DFAPKGKLSKYLDQEEGSSNVLDWSTRVSIIIGIAKGIGYLHSSEVNKPAIVHRNLSVEKVLIDQQFNPLIADCGLHKLL  567 (689)
Q Consensus       488 e~~~~gsL~~~L~~~~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~~~ivH~dlk~~NiLl~~~~~~kl~DfGla~~~  567 (689)
                      ||++.--|. -|....   ..++.....+++.|+++|+.|+|+.+     +|||||||+|||++.++.+||+|||+||.+
T Consensus        81 E~~dhTvL~-eLe~~p---~G~~~~~vk~~l~Q~l~ai~~cHk~n-----~IHRDIKPENILit~~gvvKLCDFGFAR~L  151 (396)
T KOG0593|consen   81 EYCDHTVLH-ELERYP---NGVPSELVKKYLYQLLKAIHFCHKNN-----CIHRDIKPENILITQNGVVKLCDFGFARTL  151 (396)
T ss_pred             eecchHHHH-HHHhcc---CCCCHHHHHHHHHHHHHHhhhhhhcC-----eecccCChhheEEecCCcEEeccchhhHhh
Confidence            999764444 343322   23888999999999999999999988     999999999999999999999999999988


Q ss_pred             cCCceeeeecCCCCCCCCCcccccc-CCCCCcccchhHHHHHHHHHhCCCCcchhHHHHHhhhh----------hhHhhc
Q 005586          568 ADDIVFSVLKTSAAMGYLAPEYVTT-GRFTERSDIFAFGVIILQILTGSLVLTSSMRLAAESAT----------FENFID  636 (689)
Q Consensus       568 ~~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~ksDV~sfGvvl~elltG~~p~~~~~~~~~~~~~----------~~~~~~  636 (689)
                      ..... ..+....|.+|+|||.+.+ .+|...+||||.||++.||+||.+-|.+.........+          ..+++.
T Consensus       152 ~~pgd-~YTDYVATRWYRaPELLvGDtqYG~pVDiWAiGCv~aEl~~G~pL~PG~SDiDQLy~I~ktLG~L~prhq~iF~  230 (396)
T KOG0593|consen  152 SAPGD-NYTDYVATRWYRAPELLVGDTQYGKPVDIWAIGCVFAELLTGEPLWPGRSDIDQLYLIRKTLGNLIPRHQSIFS  230 (396)
T ss_pred             cCCcc-hhhhhhhhhhccChhhhcccCcCCCcccchhhhHHHHHHhcCCcCCCCcchHHHHHHHHHHHcccCHHHHHHhc
Confidence            63211 2233457888999999887 68999999999999999999999887654322211110          111111


Q ss_pred             c--ccC--------------CCCCHHHHHHHHHHHHHhccCCCCCCCCHHHHHHHH
Q 005586          637 R--NLK--------------GKFSESEAAKLGKMALVCTHEDPENRPTMEAVIEEL  676 (689)
Q Consensus       637 ~--~~~--------------~~~~~~~~~~l~~l~~~Cl~~dp~~RPs~~evl~~L  676 (689)
                      .  .+.              .++ +..+.-+.+++..|++.||++|++.+|++.+-
T Consensus       231 ~N~~F~Gv~lP~~~~~epLe~k~-p~~s~~~ld~~k~cL~~dP~~R~sc~qll~H~  285 (396)
T KOG0593|consen  231 SNPFFHGVRLPEPEHPEPLERKY-PKISNVLLDLLKKCLKMDPDDRLSCEQLLHHP  285 (396)
T ss_pred             cCCceeeeecCCCCCccchhhhc-ccchHHHHHHHHHHhcCCccccccHHHHhcCh
Confidence            1  000              011 12345688999999999999999999998653

>KOG4278 consensus Protein tyrosine kinase [Signal transduction mechanisms]

Probab=100.00  E-value=4.9e-42  Score=355.71  Aligned_cols=260  Identities=22%  Similarity=0.407  Sum_probs=223.2

Q ss_pred             HHHHhccCCcccccccCCcceEEEEEec-CCcEEEEEEecccCCchHHHHHHHHHHHHhccCCCcceeEeeEEEcCCCCe
Q 005586          404 VESATQCFSEVNLLGKGNFSSVYKGTLR-DGTLVAIRSINVTSCKSEEAEFVKGLYLLTSLRHENIIRLRGFCCSRGRGE  482 (689)
Q Consensus       404 l~~at~~f~~~~~lg~G~~g~Vy~~~~~-~g~~vavK~l~~~~~~~~~~~f~~e~~~l~~l~H~niv~l~g~~~~~~~~~  482 (689)
                      ++....+....++||-|-||.||.|.|+ -...||||.++.+  ..+..+|++|..+|+.++|||+|+|+|+|..  ...
T Consensus       262 WEmeRtdItMkhKLGGGQYGeVYeGvWKkyslTvAVKtLKED--tMeveEFLkEAAvMKeikHpNLVqLLGVCT~--EpP  337 (1157)
T KOG4278|consen  262 WEMERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKED--TMEVEEFLKEAAVMKEIKHPNLVQLLGVCTH--EPP  337 (1157)
T ss_pred             hhccchheeeeeccCCCcccceeeeeeeccceeeehhhhhhc--chhHHHHHHHHHHHHhhcCccHHHHhhhhcc--CCC
Confidence            3333344556789999999999999997 4678999999876  4567899999999999999999999999954  467


Q ss_pred             EEEEEEcCCCCCHHHHhhhcCCCCCCCCHHHHHHHHHHHHHHHhhhhCCCCCCCceeecCCCCCceeecCCCCeEEeccc
Q 005586          483 CFLIYDFAPKGKLSKYLDQEEGSSNVLDWSTRVSIIIGIAKGIGYLHSSEVNKPAIVHRNLSVEKVLIDQQFNPLIADCG  562 (689)
Q Consensus       483 ~~lV~e~~~~gsL~~~L~~~~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~~~ivH~dlk~~NiLl~~~~~~kl~DfG  562 (689)
                      .|||+|||.+|+|.+||++...  +.++-...+.+|.||+.||+||...+     +|||||.++|+|+.++..+||+|||
T Consensus       338 FYIiTEfM~yGNLLdYLRecnr--~ev~avvLlyMAtQIsSaMeYLEkkn-----FIHRDLAARNCLVgEnhiVKvADFG  410 (1157)
T KOG4278|consen  338 FYIITEFMCYGNLLDYLRECNR--SEVPAVVLLYMATQISSAMEYLEKKN-----FIHRDLAARNCLVGENHIVKVADFG  410 (1157)
T ss_pred             eEEEEecccCccHHHHHHHhch--hhcchhHHHHHHHHHHHHHHHHHHhh-----hhhhhhhhhhccccccceEEeeccc
Confidence            8999999999999999998754  34777788999999999999999877     9999999999999999999999999


Q ss_pred             ccccccCCceeeeecCCCCCCCCCccccccCCCCCcccchhHHHHHHHHHh-CCCCcchhHHHHHhhhhhhHhhccccCC
Q 005586          563 LHKLLADDIVFSVLKTSAAMGYLAPEYVTTGRFTERSDIFAFGVIILQILT-GSLVLTSSMRLAAESATFENFIDRNLKG  641 (689)
Q Consensus       563 la~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~ksDV~sfGvvl~ellt-G~~p~~~~~~~~~~~~~~~~~~~~~~~~  641 (689)
                      |+|+|..+.+....+..-++.|.|||.+....++.|+|||+|||+||||.| |-.|+..-     +...+.+++....+-
T Consensus       411 LsRlMtgDTYTAHAGAKFPIKWTAPEsLAyNtFSiKSDVWAFGVLLWEIATYGMsPYPGi-----dlSqVY~LLEkgyRM  485 (1157)
T KOG4278|consen  411 LSRLMTGDTYTAHAGAKFPIKWTAPESLAYNTFSIKSDVWAFGVLLWEIATYGMSPYPGI-----DLSQVYGLLEKGYRM  485 (1157)
T ss_pred             hhhhhcCCceecccCccCcccccCcccccccccccchhhHHHHHHHHHHHhcCCCCCCCc-----cHHHHHHHHhccccc
Confidence            999998887665555555678999999999999999999999999999998 66677542     223345566677777


Q ss_pred             CCCHHHHHHHHHHHHHhccCCCCCCCCHHHHHHHHHhh
Q 005586          642 KFSESEAAKLGKMALVCTHEDPENRPTMEAVIEELTVA  679 (689)
Q Consensus       642 ~~~~~~~~~l~~l~~~Cl~~dp~~RPs~~evl~~L~~~  679 (689)
                      +.++.|+..+++||+.||++.|.+||++.|+-+.++..
T Consensus       486 ~~PeGCPpkVYeLMraCW~WsPsDRPsFaeiHqafEtm  523 (1157)
T KOG4278|consen  486 DGPEGCPPKVYELMRACWNWSPSDRPSFAEIHQAFETM  523 (1157)
T ss_pred             cCCCCCCHHHHHHHHHHhcCCcccCccHHHHHHHHHHH
Confidence            78899999999999999999999999999999888654

>KOG0582 consensus Ste20-like serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=1.2e-40  Score=336.20  Aligned_cols=261  Identities=20%  Similarity=0.329  Sum_probs=208.8

Q ss_pred             ccCCcccccccCCcceEEEEEe-cCCcEEEEEEecccCCchHHHHHHHHHHHHhccCCCcceeEeeEEEcCCCCeEEEEE
Q 005586          409 QCFSEVNLLGKGNFSSVYKGTL-RDGTLVAIRSINVTSCKSEEAEFVKGLYLLTSLRHENIIRLRGFCCSRGRGECFLIY  487 (689)
Q Consensus       409 ~~f~~~~~lg~G~~g~Vy~~~~-~~g~~vavK~l~~~~~~~~~~~f~~e~~~l~~l~H~niv~l~g~~~~~~~~~~~lV~  487 (689)
                      ++|...+.||.|..++||+|+. +.+..||||++..+.+....+.+.+|+..|+.++||||++++..|..  +.+.++||
T Consensus        26 ~~YeL~e~IG~G~sa~V~~A~c~p~~e~VAIK~inLEkc~~~ld~l~kE~~~msl~~HPNIv~~~~sFvv--~~~LWvVm  103 (516)
T KOG0582|consen   26 KDYELQEVIGVGASAVVYLARCIPTNEVVAIKIINLEKCNNDLDALRKEVQTMSLIDHPNIVTYHCSFVV--DSELWVVM  103 (516)
T ss_pred             cceeEEEEEeccceeEeeeeeecccCCEEEEEEeehhhhhhhHHHHHHHHHHhhhcCCCCcceEEEEEEe--cceeEEee
Confidence            4577788999999999999985 46899999999999888788899999999999999999999887754  57899999


Q ss_pred             EcCCCCCHHHHhhhcCCCCCCCCHHHHHHHHHHHHHHHhhhhCCCCCCCceeecCCCCCceeecCCCCeEEecccccccc
Q 005586          488 DFAPKGKLSKYLDQEEGSSNVLDWSTRVSIIIGIAKGIGYLHSSEVNKPAIVHRNLSVEKVLIDQQFNPLIADCGLHKLL  567 (689)
Q Consensus       488 e~~~~gsL~~~L~~~~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~~~ivH~dlk~~NiLl~~~~~~kl~DfGla~~~  567 (689)
                      .||.+||+.+.+...-..  .+++..+..|.+++++||.|||++|     .||||||+.||||+.+|.+||+|||.+..+
T Consensus       104 pfMa~GS~ldIik~~~~~--Gl~E~~Ia~iLre~LkaL~YLH~~G-----~IHRdvKAgnILi~~dG~VkLadFgvsa~l  176 (516)
T KOG0582|consen  104 PFMAGGSLLDIIKTYYPD--GLEEASIATILREVLKALDYLHQNG-----HIHRDVKAGNILIDSDGTVKLADFGVSASL  176 (516)
T ss_pred             hhhcCCcHHHHHHHHccc--cccHHHHHHHHHHHHHHHHHHHhcC-----ceecccccccEEEcCCCcEEEcCceeeeee
Confidence            999999999999875432  3899999999999999999999998     799999999999999999999999998766


Q ss_pred             cCCc---eeeeecCCCCCCCCCcccccc--CCCCCcccchhHHHHHHHHHhCCCCcchhHHHHHhhhhhhHhhccccCCC
Q 005586          568 ADDI---VFSVLKTSAAMGYLAPEYVTT--GRFTERSDIFAFGVIILQILTGSLVLTSSMRLAAESATFENFIDRNLKGK  642 (689)
Q Consensus       568 ~~~~---~~~~~~~~~~~~y~aPE~~~~--~~~~~ksDV~sfGvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~  642 (689)
                      .+..   ........+++.|||||++..  ..|+.|+||||||+...||.+|..||.......+.-..+..-...-....
T Consensus       177 ~~~G~R~~~rf~tfvgtp~wmAPEvl~q~~~GYdfKaDIwSfGITA~ELA~G~aPf~k~pPmkvLl~tLqn~pp~~~t~~  256 (516)
T KOG0582|consen  177 FDSGDRQVTRFNTFVGTPCWMAPEVLMQQLHGYDFKADIWSFGITACELAHGHAPFSKYPPMKVLLLTLQNDPPTLLTSG  256 (516)
T ss_pred             cccCceeeEeeccccCcccccChHHhhhcccCccchhhhhhhhHHHHHHhcCCCCcccCChHHHHHHHhcCCCCCccccc
Confidence            4432   122234568899999999543  46999999999999999999999999654322111111110000000111


Q ss_pred             CCH----HHHHHHHHHHHHhccCCCCCCCCHHHHHHHHHh
Q 005586          643 FSE----SEAAKLGKMALVCTHEDPENRPTMEAVIEELTV  678 (689)
Q Consensus       643 ~~~----~~~~~l~~l~~~Cl~~dp~~RPs~~evl~~L~~  678 (689)
                      .+.    .....+.+++..|+++||++|||+++++++-..
T Consensus       257 ~~~d~~k~~~ksf~e~i~~CL~kDP~kRptAskLlkh~FF  296 (516)
T KOG0582|consen  257 LDKDEDKKFSKSFREMIALCLVKDPSKRPTASKLLKHAFF  296 (516)
T ss_pred             CChHHhhhhcHHHHHHHHHHhhcCcccCCCHHHHhccHHH
Confidence            111    234578999999999999999999999987543

>cd05064 PTKc_EphR_A10 Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A10

Probab=100.00  E-value=1.2e-40  Score=341.75  Aligned_cols=255  Identities=19%  Similarity=0.386  Sum_probs=206.0

Q ss_pred             ccCCcccccccCCcceEEEEEec----CCcEEEEEEecccCCchHHHHHHHHHHHHhccCCCcceeEeeEEEcCCCCeEE
Q 005586          409 QCFSEVNLLGKGNFSSVYKGTLR----DGTLVAIRSINVTSCKSEEAEFVKGLYLLTSLRHENIIRLRGFCCSRGRGECF  484 (689)
Q Consensus       409 ~~f~~~~~lg~G~~g~Vy~~~~~----~g~~vavK~l~~~~~~~~~~~f~~e~~~l~~l~H~niv~l~g~~~~~~~~~~~  484 (689)
                      ++|+..+.||+|+||.||+|.++    .+..||+|.++..........|.+|+..+.+++||||++++|++..  .+..+
T Consensus         5 ~~~~~~~~ig~G~fg~V~~~~~~~~~~~~~~vaik~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~--~~~~~   82 (266)
T cd05064           5 KSIKIERILGTGRFGELCRGCLKLPSKRELPVAIHTLRAGCSDKQRRGFLAEALTLGQFDHSNIVRLEGVITR--GNTMM   82 (266)
T ss_pred             HHeEEeeeecccCCCeEEEEEEecCCCceeeEEEEecCCCCCHHHHHHHHHHHHHHhcCCCCCcCeEEEEEec--CCCcE
Confidence            45777899999999999999864    3678999999876544555789999999999999999999999854  57899


Q ss_pred             EEEEcCCCCCHHHHhhhcCCCCCCCCHHHHHHHHHHHHHHHhhhhCCCCCCCceeecCCCCCceeecCCCCeEEeccccc
Q 005586          485 LIYDFAPKGKLSKYLDQEEGSSNVLDWSTRVSIIIGIAKGIGYLHSSEVNKPAIVHRNLSVEKVLIDQQFNPLIADCGLH  564 (689)
Q Consensus       485 lV~e~~~~gsL~~~L~~~~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~~~ivH~dlk~~NiLl~~~~~~kl~DfGla  564 (689)
                      +||||+++|+|.+++....   ..++|..++.++.|++.||+|||+.+     ++||||||+||++++++.+|++|||.+
T Consensus        83 lv~e~~~~~~L~~~l~~~~---~~l~~~~~~~~~~~i~~al~~lH~~~-----iiH~dikp~nili~~~~~~~l~dfg~~  154 (266)
T cd05064          83 IVTEYMSNGALDSFLRKHE---GQLVAGQLMGMLPGLASGMKYLSEMG-----YVHKGLAAHKVLVNSDLVCKISGFRRL  154 (266)
T ss_pred             EEEEeCCCCcHHHHHHhCC---CCCCHHHHHHHHHHHHHHHHHHHHCC-----EeeccccHhhEEEcCCCcEEECCCccc
Confidence            9999999999999997643   24899999999999999999999887     999999999999999999999999987


Q ss_pred             ccccCCceeeeecCCCCCCCCCccccccCCCCCcccchhHHHHHHHHHh-CCCCcchhHHHHHhhhhhhHhhccccCCCC
Q 005586          565 KLLADDIVFSVLKTSAAMGYLAPEYVTTGRFTERSDIFAFGVIILQILT-GSLVLTSSMRLAAESATFENFIDRNLKGKF  643 (689)
Q Consensus       565 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~ksDV~sfGvvl~ellt-G~~p~~~~~~~~~~~~~~~~~~~~~~~~~~  643 (689)
                      ...............++..|+|||.+.+..++.++|||||||++||+++ |+.||........    .. .+........
T Consensus       155 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~ell~~g~~p~~~~~~~~~----~~-~~~~~~~~~~  229 (266)
T cd05064         155 QEDKSEAIYTTMSGKSPVLWAAPEAIQYHHFSSASDVWSFGIVMWEVMSYGERPYWDMSGQDV----IK-AVEDGFRLPA  229 (266)
T ss_pred             ccccccchhcccCCCCceeecCHHHHhhCCccchhHHHHHHHHHHHHhcCCCCCcCcCCHHHH----HH-HHHCCCCCCC
Confidence            6543322222222334567999999999999999999999999999875 9999864322111    11 1111222233


Q ss_pred             CHHHHHHHHHHHHHhccCCCCCCCCHHHHHHHHHh
Q 005586          644 SESEAAKLGKMALVCTHEDPENRPTMEAVIEELTV  678 (689)
Q Consensus       644 ~~~~~~~l~~l~~~Cl~~dp~~RPs~~evl~~L~~  678 (689)
                      +...+..+.+++..||+.+|++||++.|+.+.|..
T Consensus       230 ~~~~~~~~~~li~~c~~~~p~~RP~~~~i~~~l~~  264 (266)
T cd05064         230 PRNCPNLLHQLMLDCWQKERGERPRFSQIHSILSK  264 (266)
T ss_pred             CCCCCHHHHHHHHHHcCCCchhCCCHHHHHHHHHh
Confidence            44566789999999999999999999999998865

Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA10 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchor

>cd05096 PTKc_DDR1 Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 1

Probab=100.00  E-value=2e-40  Score=346.99  Aligned_cols=262  Identities=24%  Similarity=0.379  Sum_probs=203.0

Q ss_pred             ccCCcccccccCCcceEEEEEecC-----------------CcEEEEEEecccCCchHHHHHHHHHHHHhccCCCcceeE
Q 005586          409 QCFSEVNLLGKGNFSSVYKGTLRD-----------------GTLVAIRSINVTSCKSEEAEFVKGLYLLTSLRHENIIRL  471 (689)
Q Consensus       409 ~~f~~~~~lg~G~~g~Vy~~~~~~-----------------g~~vavK~l~~~~~~~~~~~f~~e~~~l~~l~H~niv~l  471 (689)
                      ++|...+.||+|+||.||+|.+++                 +..||+|.+..........+|.+|++++.+++||||+++
T Consensus         5 ~~~~~~~~lg~G~fg~V~~~~~~~~~~~~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~   84 (304)
T cd05096           5 GHLLFKEKLGEGQFGEVHLCEVVNPQDLPTLQFPFNVRKGRPLLVAVKILRPDANKNARNDFLKEVKILSRLKDPNIIRL   84 (304)
T ss_pred             hhCeeeeEecccCCeEEEEEEeccCcccccccccccccCCcceEEEEEEecCCCCHHHHHHHHHHHHHHhhcCCCCeeEE
Confidence            467778899999999999998642                 347999999866544556789999999999999999999


Q ss_pred             eeEEEcCCCCeEEEEEEcCCCCCHHHHhhhcCC---------------CCCCCCHHHHHHHHHHHHHHHhhhhCCCCCCC
Q 005586          472 RGFCCSRGRGECFLIYDFAPKGKLSKYLDQEEG---------------SSNVLDWSTRVSIIIGIAKGIGYLHSSEVNKP  536 (689)
Q Consensus       472 ~g~~~~~~~~~~~lV~e~~~~gsL~~~L~~~~~---------------~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~~  536 (689)
                      ++++..  .+..++||||+++|+|.+++.....               ....++|..+++|+.|++.||+|||+.+    
T Consensus        85 ~~~~~~--~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH~~~----  158 (304)
T cd05096          85 LGVCVD--EDPLCMITEYMENGDLNQFLSSHHLDDKEENGNDAVPPAHCLPAISYSSLLHVALQIASGMKYLSSLN----  158 (304)
T ss_pred             EEEEec--CCceEEEEecCCCCcHHHHHHhccccccccccccccccccccccccHHHHHHHHHHHHHHHHHHHHCC----
Confidence            999954  4678999999999999999865321               1134789999999999999999999987    


Q ss_pred             ceeecCCCCCceeecCCCCeEEecccccccccCCceee-eecCCCCCCCCCccccccCCCCCcccchhHHHHHHHHHh--
Q 005586          537 AIVHRNLSVEKVLIDQQFNPLIADCGLHKLLADDIVFS-VLKTSAAMGYLAPEYVTTGRFTERSDIFAFGVIILQILT--  613 (689)
Q Consensus       537 ~ivH~dlk~~NiLl~~~~~~kl~DfGla~~~~~~~~~~-~~~~~~~~~y~aPE~~~~~~~~~ksDV~sfGvvl~ellt--  613 (689)
                       |+||||||+|||+++++.+||+|||+++.+....... .....++..|+|||++..+.++.++|||||||++|||++  
T Consensus       159 -ivH~dlkp~Nill~~~~~~kl~DfG~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~~~~  237 (304)
T cd05096         159 -FVHRDLATRNCLVGENLTIKIADFGMSRNLYAGDYYRIQGRAVLPIRWMAWECILMGKFTTASDVWAFGVTLWEILMLC  237 (304)
T ss_pred             -ccccCcchhheEEcCCccEEECCCccceecccCceeEecCcCCCCccccCHHHHhcCCCCchhhhHHHHHHHHHHHHcc
Confidence             9999999999999999999999999998664432221 122334678999999988899999999999999999987  


Q ss_pred             CCCCcchhHHHHHhhhhhhHhhccc---cCCCCCHHHHHHHHHHHHHhccCCCCCCCCHHHHHHHHHh
Q 005586          614 GSLVLTSSMRLAAESATFENFIDRN---LKGKFSESEAAKLGKMALVCTHEDPENRPTMEAVIEELTV  678 (689)
Q Consensus       614 G~~p~~~~~~~~~~~~~~~~~~~~~---~~~~~~~~~~~~l~~l~~~Cl~~dp~~RPs~~evl~~L~~  678 (689)
                      +..|+.......... ...+.....   .....+..++..+.+++.+||+.||++||+|.||.+.|++
T Consensus       238 ~~~p~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~RPs~~~i~~~l~~  304 (304)
T cd05096         238 KEQPYGELTDEQVIE-NAGEFFRDQGRQVYLFRPPPCPQGLYELMLQCWSRDCRERPSFSDIHAFLTE  304 (304)
T ss_pred             CCCCCCcCCHHHHHH-HHHHHhhhccccccccCCCCCCHHHHHHHHHHccCCchhCcCHHHHHHHHhC
Confidence            556665432111111 111111111   1111233456789999999999999999999999998863

Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 1 (DDR1) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR1 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR1 binds to all collagens tested to date (types I-IV). It is widely expressed in many tissues. It is abundant in the brain and is also found in k

>cd05104 PTKc_Kit Catalytic domain of the Protein Tyrosine Kinase, Kit

Probab=100.00  E-value=1.2e-40  Score=358.37  Aligned_cols=260  Identities=23%  Similarity=0.408  Sum_probs=205.5

Q ss_pred             hccCCcccccccCCcceEEEEEe------cCCcEEEEEEecccCCchHHHHHHHHHHHHhcc-CCCcceeEeeEEEcCCC
Q 005586          408 TQCFSEVNLLGKGNFSSVYKGTL------RDGTLVAIRSINVTSCKSEEAEFVKGLYLLTSL-RHENIIRLRGFCCSRGR  480 (689)
Q Consensus       408 t~~f~~~~~lg~G~~g~Vy~~~~------~~g~~vavK~l~~~~~~~~~~~f~~e~~~l~~l-~H~niv~l~g~~~~~~~  480 (689)
                      .++|...+.||+|+||.||+|..      .++..||||+++..........+.+|++++..+ +|||||+++++|..  .
T Consensus        34 ~~~~~~~~~LG~G~fG~V~~~~~~~~~~~~~~~~vavK~l~~~~~~~~~~~~~~Ei~il~~l~~HpnIv~l~~~~~~--~  111 (375)
T cd05104          34 RNRLSFGKTLGAGAFGKVVEATAYGLFKSDAAMTVAVKMLKPSAHLTEREALMSELKVLSYLGNHINIVNLLGACTV--G  111 (375)
T ss_pred             hHHeehhheecCCccceEEEEEEeccccCccceeEEEEeccCCcCcHHHHHHHHHHHHHHHhcCCcceeeeeeeecc--C
Confidence            34677789999999999999974      246689999997655445556789999999999 89999999999944  5


Q ss_pred             CeEEEEEEcCCCCCHHHHhhhcCC--------------------------------------------------------
Q 005586          481 GECFLIYDFAPKGKLSKYLDQEEG--------------------------------------------------------  504 (689)
Q Consensus       481 ~~~~lV~e~~~~gsL~~~L~~~~~--------------------------------------------------------  504 (689)
                      +..++||||+++|+|.++++....                                                        
T Consensus       112 ~~~~lv~E~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~  191 (375)
T cd05104         112 GPTLVITEYCCYGDLLNFLRRKRDSFICPKHEDHAEAALYKNLLHQREMSCDSLNEYMDMKPGVSYVVPTKADKRRSVRS  191 (375)
T ss_pred             CcceeeehhccCCcHHHHHHhcccccccccccchhhhHHHHhhhhhhcccchhhhhhhhcCCCccccccccccccccccc
Confidence            778999999999999999975321                                                        


Q ss_pred             ---------------CCCCCCHHHHHHHHHHHHHHHhhhhCCCCCCCceeecCCCCCceeecCCCCeEEecccccccccC
Q 005586          505 ---------------SSNVLDWSTRVSIIIGIAKGIGYLHSSEVNKPAIVHRNLSVEKVLIDQQFNPLIADCGLHKLLAD  569 (689)
Q Consensus       505 ---------------~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~~~ivH~dlk~~NiLl~~~~~~kl~DfGla~~~~~  569 (689)
                                     ....++|..+++++.||++||+|||+.+     |+||||||+|||+++++.+||+|||+++....
T Consensus       192 ~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~~l~~lH~~~-----ivH~Dlkp~Nill~~~~~~kl~DfG~a~~~~~  266 (375)
T cd05104         192 GSYIDQDVTSEILEEDELALDTEDLLSFSYQVAKGMSFLASKN-----CIHRDLAARNILLTHGRITKICDFGLARDIRN  266 (375)
T ss_pred             ceecccccHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHCC-----eeccCCchhhEEEECCCcEEEecCccceeccC
Confidence                           0124789999999999999999999987     99999999999999999999999999987654


Q ss_pred             Cceeeee-cCCCCCCCCCccccccCCCCCcccchhHHHHHHHHHh-CCCCcchhHHHHHhhhhhhHhhccccCCCCCHHH
Q 005586          570 DIVFSVL-KTSAAMGYLAPEYVTTGRFTERSDIFAFGVIILQILT-GSLVLTSSMRLAAESATFENFIDRNLKGKFSESE  647 (689)
Q Consensus       570 ~~~~~~~-~~~~~~~y~aPE~~~~~~~~~ksDV~sfGvvl~ellt-G~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  647 (689)
                      ....... ...++..|+|||.+.+..++.++|||||||++|||+| |..|+.......    .+.+.+........+...
T Consensus       267 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDi~slG~~l~ellt~g~~p~~~~~~~~----~~~~~~~~~~~~~~~~~~  342 (375)
T cd05104         267 DSNYVVKGNARLPVKWMAPESIFNCVYTFESDVWSYGILLWEIFSLGSSPYPGMPVDS----KFYKMIKEGYRMLSPECA  342 (375)
T ss_pred             cccccccCCCCCCcceeChhHhcCCCCCCCCCHHHHHHHHHHHHhcCCCCCCCCCchH----HHHHHHHhCccCCCCCCC
Confidence            3221111 1234567999999999999999999999999999998 888885432111    111222222222223334


Q ss_pred             HHHHHHHHHHhccCCCCCCCCHHHHHHHHHh
Q 005586          648 AAKLGKMALVCTHEDPENRPTMEAVIEELTV  678 (689)
Q Consensus       648 ~~~l~~l~~~Cl~~dp~~RPs~~evl~~L~~  678 (689)
                      +.++.+++..||+.||++||+|.||+++|+.
T Consensus       343 ~~~l~~li~~cl~~dP~~RPs~~eil~~l~~  373 (375)
T cd05104         343 PSEMYDIMKSCWDADPLKRPTFKQIVQLIEQ  373 (375)
T ss_pred             CHHHHHHHHHHccCChhHCcCHHHHHHHHHh
Confidence            5679999999999999999999999999985

Protein Tyrosine Kinase (PTK) family; Kit (or c-Kit); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Kit is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of Kit to its ligand, the stem-cell factor (SCF), leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. Kit is important in the development of melanocytes, germ cells, mast cells, hematopoietic stem ce

>KOG0659 consensus Cdk activating kinase (CAK)/RNA polymerase II transcription initiation/nucleotide excision repair factor TFIIH/TFIIK, kinase subunit CDK7 [Cell cycle control, cell division, chromosome partitioning; Transcription; Replication, recombination and repair]

Probab=100.00  E-value=1e-40  Score=315.84  Aligned_cols=261  Identities=22%  Similarity=0.339  Sum_probs=207.4

Q ss_pred             ccCCcccccccCCcceEEEEEec-CCcEEEEEEecccCCchH-HHHHHHHHHHHhccCCCcceeEeeEEEcCCCCeEEEE
Q 005586          409 QCFSEVNLLGKGNFSSVYKGTLR-DGTLVAIRSINVTSCKSE-EAEFVKGLYLLTSLRHENIIRLRGFCCSRGRGECFLI  486 (689)
Q Consensus       409 ~~f~~~~~lg~G~~g~Vy~~~~~-~g~~vavK~l~~~~~~~~-~~~f~~e~~~l~~l~H~niv~l~g~~~~~~~~~~~lV  486 (689)
                      .+|...+.+|+|.||.||+|+.. +|+.||||+++....++. .....+||+.|+.++|+||+.+++.+.  ..+...+|
T Consensus         2 ~rY~~~~~lGEG~~gvVyka~d~~t~~~VAIKKIkl~~~kdGi~~talREIK~Lqel~h~nIi~LiD~F~--~~~~l~lV   79 (318)
T KOG0659|consen    2 DRYEKLEKLGEGTYGVVYKARDTETGKRVAIKKIKLGNAKDGINRTALREIKLLQELKHPNIIELIDVFP--HKSNLSLV   79 (318)
T ss_pred             chhhhhhhhcCcceEEEEEEEecCCCcEEEEEEeeccccccCccHHHHHHHHHHHHccCcchhhhhhhcc--CCCceEEE
Confidence            35667789999999999999864 799999999987754332 357889999999999999999999984  45778999


Q ss_pred             EEcCCCCCHHHHhhhcCCCCCCCCHHHHHHHHHHHHHHHhhhhCCCCCCCceeecCCCCCceeecCCCCeEEeccccccc
Q 005586          487 YDFAPKGKLSKYLDQEEGSSNVLDWSTRVSIIIGIAKGIGYLHSSEVNKPAIVHRNLSVEKVLIDQQFNPLIADCGLHKL  566 (689)
Q Consensus       487 ~e~~~~gsL~~~L~~~~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~~~ivH~dlk~~NiLl~~~~~~kl~DfGla~~  566 (689)
                      +|||+. +|+..++++.   ..++-.+...++.++++|++|||+..     |+||||||.|+|++.++.+||+|||+++.
T Consensus        80 fEfm~t-dLe~vIkd~~---i~l~pa~iK~y~~m~LkGl~y~H~~~-----IlHRDlKPnNLLis~~g~lKiADFGLAr~  150 (318)
T KOG0659|consen   80 FEFMPT-DLEVVIKDKN---IILSPADIKSYMLMTLKGLAYCHSKW-----ILHRDLKPNNLLISSDGQLKIADFGLARF  150 (318)
T ss_pred             EEeccc-cHHHHhcccc---cccCHHHHHHHHHHHHHHHHHHHhhh-----hhcccCCccceEEcCCCcEEeecccchhc
Confidence            999965 9999998754   35888999999999999999999988     99999999999999999999999999998


Q ss_pred             ccCCceeeeecCCCCCCCCCcccccc-CCCCCcccchhHHHHHHHHHhCCCCcchhHHHHHhhhhhh-------------
Q 005586          567 LADDIVFSVLKTSAAMGYLAPEYVTT-GRFTERSDIFAFGVIILQILTGSLVLTSSMRLAAESATFE-------------  632 (689)
Q Consensus       567 ~~~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~ksDV~sfGvvl~elltG~~p~~~~~~~~~~~~~~~-------------  632 (689)
                      +........ ....|.+|+|||.+.+ +.|+..+||||.||++.||+-|.+-|.+.....+....+.             
T Consensus       151 f~~p~~~~~-~~V~TRWYRAPELLfGsr~Yg~~VDmWavGCI~AELllr~P~fpG~sDidQL~~If~~LGTP~~~~WP~~  229 (318)
T KOG0659|consen  151 FGSPNRIQT-HQVVTRWYRAPELLFGSRQYGTGVDMWAVGCIFAELLLRVPFFPGDSDIDQLSKIFRALGTPTPDQWPEM  229 (318)
T ss_pred             cCCCCcccc-cceeeeeccChHHhccchhcCCcchhhhHHHHHHHHHccCCCCCCCchHHHHHHHHHHcCCCCcccCccc
Confidence            865433222 2256778999998876 5699999999999999999999877755433222211111             


Q ss_pred             -Hhhc--------cccCCCCCHHHHHHHHHHHHHhccCCCCCCCCHHHHHHHHHhhCC
Q 005586          633 -NFID--------RNLKGKFSESEAAKLGKMALVCTHEDPENRPTMEAVIEELTVAAP  681 (689)
Q Consensus       633 -~~~~--------~~~~~~~~~~~~~~l~~l~~~Cl~~dp~~RPs~~evl~~L~~~~p  681 (689)
                       .+.|        ..........+..++.+++..++..+|.+|++++|++++-....-
T Consensus       230 ~~lpdY~~~~~~P~~~~~~lf~aas~d~ldLl~~m~~ynP~~Rita~qaL~~~yf~~~  287 (318)
T KOG0659|consen  230 TSLPDYVKIQQFPKPPLNNLFPAASSDALDLLSKMLTYNPKKRITASQALKHPYFKSL  287 (318)
T ss_pred             cccccHHHHhcCCCCccccccccccHHHHHHHHhhhccCchhcccHHHHhcchhhhcC
Confidence             0000        001111233456677999999999999999999999998766643

>cd05106 PTKc_CSF-1R Catalytic domain of the Protein Tyrosine Kinase, Colony-Stimulating Factor-1 Receptor

Probab=100.00  E-value=2.2e-40  Score=356.15  Aligned_cols=261  Identities=21%  Similarity=0.405  Sum_probs=206.6

Q ss_pred             hccCCcccccccCCcceEEEEEec------CCcEEEEEEecccCCchHHHHHHHHHHHHhcc-CCCcceeEeeEEEcCCC
Q 005586          408 TQCFSEVNLLGKGNFSSVYKGTLR------DGTLVAIRSINVTSCKSEEAEFVKGLYLLTSL-RHENIIRLRGFCCSRGR  480 (689)
Q Consensus       408 t~~f~~~~~lg~G~~g~Vy~~~~~------~g~~vavK~l~~~~~~~~~~~f~~e~~~l~~l-~H~niv~l~g~~~~~~~  480 (689)
                      .++|...+.||+|+||.||+|...      ++..||+|+++..........+.+|+++++.+ +|+|||+++++|..  .
T Consensus        37 ~~~~~~~~~LG~G~fg~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~il~~l~~h~nIv~~~~~~~~--~  114 (374)
T cd05106          37 RDNLQFGKTLGAGAFGKVVEATAFGLGKEDNVLRVAVKMLKASAHTDEREALMSELKILSHLGQHKNIVNLLGACTH--G  114 (374)
T ss_pred             HHHceehheecCCCcccEEEEEEecCCcccccceeEEEeccCCCCHHHHHHHHHHHHHHHhhccCCceeeEeeEecC--C
Confidence            346778899999999999999742      34579999998665444556789999999999 89999999999844  5


Q ss_pred             CeEEEEEEcCCCCCHHHHhhhcCC--------------------------------------------------------
Q 005586          481 GECFLIYDFAPKGKLSKYLDQEEG--------------------------------------------------------  504 (689)
Q Consensus       481 ~~~~lV~e~~~~gsL~~~L~~~~~--------------------------------------------------------  504 (689)
                      +..++||||+++|+|.++++....                                                        
T Consensus       115 ~~~~lv~ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  194 (374)
T cd05106         115 GPVLVITEYCCYGDLLNFLRKKAETFLNFVMALPEISETSSDYKNITLEKKYIRSDSGFSSQGSDTYVEMRPVSSSSSQS  194 (374)
T ss_pred             CCeEEeHhhccCCcHHHHHHhhhhhhccccccccccccccccccccchhcccccccccccccccccccccCCcccccccc
Confidence            689999999999999999864321                                                        


Q ss_pred             ----------CCCCCCHHHHHHHHHHHHHHHhhhhCCCCCCCceeecCCCCCceeecCCCCeEEecccccccccCCceee
Q 005586          505 ----------SSNVLDWSTRVSIIIGIAKGIGYLHSSEVNKPAIVHRNLSVEKVLIDQQFNPLIADCGLHKLLADDIVFS  574 (689)
Q Consensus       505 ----------~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~~~ivH~dlk~~NiLl~~~~~~kl~DfGla~~~~~~~~~~  574 (689)
                                ....+++.+.++|+.||++||+|||+.+     |+||||||+|||+++++.+||+|||+++.........
T Consensus       195 ~~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~g-----iiHrDLkp~Nil~~~~~~~kL~DfGla~~~~~~~~~~  269 (374)
T cd05106         195 SDSKDEEDTEDSWPLDLDDLLRFSSQVAQGMDFLASKN-----CIHRDVAARNVLLTDGRVAKICDFGLARDIMNDSNYV  269 (374)
T ss_pred             ccccchhccCCCCCcCHHHHHHHHHHHHHHHHHHHHCC-----EEeccCchheEEEeCCCeEEEeeceeeeeccCCccee
Confidence                      0124788999999999999999999987     9999999999999999999999999998664432221


Q ss_pred             ee-cCCCCCCCCCccccccCCCCCcccchhHHHHHHHHHh-CCCCcchhHHHHHhhhhhhHhhccccCCCCCHHHHHHHH
Q 005586          575 VL-KTSAAMGYLAPEYVTTGRFTERSDIFAFGVIILQILT-GSLVLTSSMRLAAESATFENFIDRNLKGKFSESEAAKLG  652 (689)
Q Consensus       575 ~~-~~~~~~~y~aPE~~~~~~~~~ksDV~sfGvvl~ellt-G~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~  652 (689)
                      .. ...++..|||||++.+..++.++|||||||++|||++ |+.||......    ..+...+........+...+.++.
T Consensus       270 ~~~~~~~~~~y~aPE~~~~~~~~~~~DvwSlGvil~ellt~G~~Pf~~~~~~----~~~~~~~~~~~~~~~~~~~~~~l~  345 (374)
T cd05106         270 VKGNARLPVKWMAPESIFDCVYTVQSDVWSYGILLWEIFSLGKSPYPGILVN----SKFYKMVKRGYQMSRPDFAPPEIY  345 (374)
T ss_pred             eccCCCCccceeCHHHhcCCCCCccccHHHHHHHHHHHHhCCCCCCcccccc----HHHHHHHHcccCccCCCCCCHHHH
Confidence            11 2234567999999988899999999999999999997 99998653211    112222222222222233356799


Q ss_pred             HHHHHhccCCCCCCCCHHHHHHHHHhh
Q 005586          653 KMALVCTHEDPENRPTMEAVIEELTVA  679 (689)
Q Consensus       653 ~l~~~Cl~~dp~~RPs~~evl~~L~~~  679 (689)
                      +++.+||+.||++||++.+|+++|+.+
T Consensus       346 ~li~~cl~~dp~~RPs~~~l~~~l~~~  372 (374)
T cd05106         346 SIMKMCWNLEPTERPTFSQISQLIQRQ  372 (374)
T ss_pred             HHHHHHcCCChhhCcCHHHHHHHHHHH
Confidence            999999999999999999999999874

Protein Tyrosine Kinase (PTK) family; Colony-Stimulating Factor-1 Receptor (CSF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CSF-1R, also called c-Fms, is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of CSF-1R to its ligand, CSF-1, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. CSF-1R signaling is criti

>cd05108 PTKc_EGFR Catalytic domain of the Protein Tyrosine Kinase, Epidermal Growth Factor Receptor

Probab=100.00  E-value=2.7e-40  Score=347.94  Aligned_cols=260  Identities=24%  Similarity=0.429  Sum_probs=208.8

Q ss_pred             ccCCcccccccCCcceEEEEEec-CCc----EEEEEEecccCCchHHHHHHHHHHHHhccCCCcceeEeeEEEcCCCCeE
Q 005586          409 QCFSEVNLLGKGNFSSVYKGTLR-DGT----LVAIRSINVTSCKSEEAEFVKGLYLLTSLRHENIIRLRGFCCSRGRGEC  483 (689)
Q Consensus       409 ~~f~~~~~lg~G~~g~Vy~~~~~-~g~----~vavK~l~~~~~~~~~~~f~~e~~~l~~l~H~niv~l~g~~~~~~~~~~  483 (689)
                      .+|+..+.||+|+||.||+|++. +|.    .||+|.++........++|.+|+.+++.++||||++++|+|..   ...
T Consensus         7 ~~f~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~g~~~~---~~~   83 (316)
T cd05108           7 TEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRLLGICLT---STV   83 (316)
T ss_pred             hhceeeeeeecCCCceEEEEEEecCCCccceeEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEcC---CCc
Confidence            45888899999999999999864 343    4899998765444556789999999999999999999999854   356


Q ss_pred             EEEEEcCCCCCHHHHhhhcCCCCCCCCHHHHHHHHHHHHHHHhhhhCCCCCCCceeecCCCCCceeecCCCCeEEecccc
Q 005586          484 FLIYDFAPKGKLSKYLDQEEGSSNVLDWSTRVSIIIGIAKGIGYLHSSEVNKPAIVHRNLSVEKVLIDQQFNPLIADCGL  563 (689)
Q Consensus       484 ~lV~e~~~~gsL~~~L~~~~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~~~ivH~dlk~~NiLl~~~~~~kl~DfGl  563 (689)
                      ++|+||+++|+|.+++....   ..+++...+.++.||+.||+|||+.+     |+||||||+|||+++++.+||+|||+
T Consensus        84 ~~v~e~~~~g~l~~~l~~~~---~~~~~~~~~~~~~qi~~~L~~LH~~~-----iiH~dlkp~Nill~~~~~~kl~DfG~  155 (316)
T cd05108          84 QLITQLMPFGCLLDYVREHK---DNIGSQYLLNWCVQIAKGMNYLEERR-----LVHRDLAARNVLVKTPQHVKITDFGL  155 (316)
T ss_pred             eeeeecCCCCCHHHHHHhcc---ccCCHHHHHHHHHHHHHHHHHHHhcC-----eeccccchhheEecCCCcEEEccccc
Confidence            79999999999999998653   24889999999999999999999987     99999999999999999999999999


Q ss_pred             cccccCCce-eeeecCCCCCCCCCccccccCCCCCcccchhHHHHHHHHHh-CCCCcchhHHHHHhhhhhhHhhccccCC
Q 005586          564 HKLLADDIV-FSVLKTSAAMGYLAPEYVTTGRFTERSDIFAFGVIILQILT-GSLVLTSSMRLAAESATFENFIDRNLKG  641 (689)
Q Consensus       564 a~~~~~~~~-~~~~~~~~~~~y~aPE~~~~~~~~~ksDV~sfGvvl~ellt-G~~p~~~~~~~~~~~~~~~~~~~~~~~~  641 (689)
                      ++.+..... ........+..|+|||++.+..++.++|||||||++|||+| |+.|+.......     +...+......
T Consensus       156 a~~~~~~~~~~~~~~~~~~~~y~apE~~~~~~~~~~~Di~slGv~l~el~t~g~~p~~~~~~~~-----~~~~~~~~~~~  230 (316)
T cd05108         156 AKLLGADEKEYHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASE-----ISSILEKGERL  230 (316)
T ss_pred             cccccCCCcceeccCCccceeecChHHhccCCCCchhhhHHHHHHHHHHHcCCCCCCCCCCHHH-----HHHHHhCCCCC
Confidence            987754322 12222334567999999999999999999999999999998 999986532111     12222222222


Q ss_pred             CCCHHHHHHHHHHHHHhccCCCCCCCCHHHHHHHHHhhCCccc
Q 005586          642 KFSESEAAKLGKMALVCTHEDPENRPTMEAVIEELTVAAPVMA  684 (689)
Q Consensus       642 ~~~~~~~~~l~~l~~~Cl~~dp~~RPs~~evl~~L~~~~p~~~  684 (689)
                      ..+..+..++.+++..||+.+|++||++.+++.++........
T Consensus       231 ~~~~~~~~~~~~li~~cl~~~p~~Rps~~~l~~~l~~~~~~~~  273 (316)
T cd05108         231 PQPPICTIDVYMIMVKCWMIDADSRPKFRELIIEFSKMARDPQ  273 (316)
T ss_pred             CCCCCCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHcCCc
Confidence            2333455678999999999999999999999999987765443

Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EGFR (HER1, ErbB1) is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphor

>cd05111 PTK_HER3 Pseudokinase domain of the Protein Tyrosine Kinase, HER3

Probab=100.00  E-value=4.1e-40  Score=340.18  Aligned_cols=262  Identities=26%  Similarity=0.407  Sum_probs=209.0

Q ss_pred             cCCcccccccCCcceEEEEEec-CCc----EEEEEEecccCCchHHHHHHHHHHHHhccCCCcceeEeeEEEcCCCCeEE
Q 005586          410 CFSEVNLLGKGNFSSVYKGTLR-DGT----LVAIRSINVTSCKSEEAEFVKGLYLLTSLRHENIIRLRGFCCSRGRGECF  484 (689)
Q Consensus       410 ~f~~~~~lg~G~~g~Vy~~~~~-~g~----~vavK~l~~~~~~~~~~~f~~e~~~l~~l~H~niv~l~g~~~~~~~~~~~  484 (689)
                      +|...+.||+|+||.||+|.+. +|.    .+++|.+..........++..|+..+++++||||+++++++..   ...+
T Consensus         8 ~~~~~~~lg~G~~~~vy~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~~~l~~l~h~~iv~~~~~~~~---~~~~   84 (279)
T cd05111           8 ELRKLKLLGSGVFGTVHKGIWIPEGDSIKIPVAIKTIQDRSGRQTFQEITDHMLAMGSLDHAYIVRLLGICPG---ASLQ   84 (279)
T ss_pred             hceeccccCccCCcceEEEEEcCCCCceeeEEEEeecccccchHHHHHHHHHHHHHhcCCCCCcceEEEEECC---CccE
Confidence            5667789999999999999874 444    4788887654433445678889999999999999999998732   4578


Q ss_pred             EEEEcCCCCCHHHHhhhcCCCCCCCCHHHHHHHHHHHHHHHhhhhCCCCCCCceeecCCCCCceeecCCCCeEEeccccc
Q 005586          485 LIYDFAPKGKLSKYLDQEEGSSNVLDWSTRVSIIIGIAKGIGYLHSSEVNKPAIVHRNLSVEKVLIDQQFNPLIADCGLH  564 (689)
Q Consensus       485 lV~e~~~~gsL~~~L~~~~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~~~ivH~dlk~~NiLl~~~~~~kl~DfGla  564 (689)
                      +++||+++|+|.+++.....   .++|..++.|+.|++.||+|||+.+     ++||||||+||++++++.+||+|||++
T Consensus        85 ~i~e~~~~gsL~~~l~~~~~---~~~~~~~~~i~~qi~~~l~~lH~~~-----iiH~dlkp~nili~~~~~~kl~Dfg~~  156 (279)
T cd05111          85 LVTQLSPLGSLLDHVRQHRD---SLDPQRLLNWCVQIAKGMYYLEEHR-----MVHRNLAARNILLKSDSIVQIADFGVA  156 (279)
T ss_pred             EEEEeCCCCcHHHHHHhccc---CCCHHHHHHHHHHHHHHHHHHHHCC-----EeccccCcceEEEcCCCcEEEcCCccc
Confidence            99999999999999976432   4899999999999999999999887     999999999999999999999999999


Q ss_pred             ccccCCce-eeeecCCCCCCCCCccccccCCCCCcccchhHHHHHHHHHh-CCCCcchhHHHHHhhhhhhHhhccccCCC
Q 005586          565 KLLADDIV-FSVLKTSAAMGYLAPEYVTTGRFTERSDIFAFGVIILQILT-GSLVLTSSMRLAAESATFENFIDRNLKGK  642 (689)
Q Consensus       565 ~~~~~~~~-~~~~~~~~~~~y~aPE~~~~~~~~~ksDV~sfGvvl~ellt-G~~p~~~~~~~~~~~~~~~~~~~~~~~~~  642 (689)
                      +....... .......++..|+|||++.++.++.++|||||||++||++| |+.|+.......     ..+.+.......
T Consensus       157 ~~~~~~~~~~~~~~~~~~~~y~~pE~~~~~~~~~~~Dv~slG~il~el~t~g~~p~~~~~~~~-----~~~~~~~~~~~~  231 (279)
T cd05111         157 DLLYPDDKKYFYSEHKTPIKWMALESILFGRYTHQSDVWSYGVTVWEMMSYGAEPYAGMRPHE-----VPDLLEKGERLA  231 (279)
T ss_pred             eeccCCCcccccCCCCCcccccCHHHhccCCcCchhhHHHHHHHHHHHHcCCCCCCCCCCHHH-----HHHHHHCCCcCC
Confidence            87643321 12223345678999999988899999999999999999998 999986532211     112222211111


Q ss_pred             CCHHHHHHHHHHHHHhccCCCCCCCCHHHHHHHHHhhCCcccccc
Q 005586          643 FSESEAAKLGKMALVCTHEDPENRPTMEAVIEELTVAAPVMATFL  687 (689)
Q Consensus       643 ~~~~~~~~l~~l~~~Cl~~dp~~RPs~~evl~~L~~~~p~~~~~~  687 (689)
                      .+..+...+.+++.+||..+|++||++.|+++.|.......+.|+
T Consensus       232 ~~~~~~~~~~~li~~c~~~~p~~Rps~~el~~~l~~~~~~~~~~~  276 (279)
T cd05111         232 QPQICTIDVYMVMVKCWMIDENVRPTFKELANEFTRMARDPPRYL  276 (279)
T ss_pred             CCCCCCHHHHHHHHHHcCCCcccCcCHHHHHHHHHHHHhCCccee
Confidence            222344567889999999999999999999999999988888886

Protein Tyrosine Kinase (PTK) family; HER3 (ErbB3); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER3 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr r

>PF07714 Pkinase_Tyr: Protein tyrosine kinase Protein kinase; unclassified specificity

Probab=100.00  E-value=5.7e-41  Score=342.60  Aligned_cols=249  Identities=30%  Similarity=0.598  Sum_probs=195.4

Q ss_pred             ccccccCCcceEEEEEec-----CCcEEEEEEecccCCchHHHHHHHHHHHHhccCCCcceeEeeEEEcCCCCeEEEEEE
Q 005586          414 VNLLGKGNFSSVYKGTLR-----DGTLVAIRSINVTSCKSEEAEFVKGLYLLTSLRHENIIRLRGFCCSRGRGECFLIYD  488 (689)
Q Consensus       414 ~~~lg~G~~g~Vy~~~~~-----~g~~vavK~l~~~~~~~~~~~f~~e~~~l~~l~H~niv~l~g~~~~~~~~~~~lV~e  488 (689)
                      .+.||.|.||.||+|.+.     .+..|+||.++.........+|.+|++.+.+++||||++++|+|..  .+..++|||
T Consensus         4 ~~~ig~G~fg~v~~~~~~~~~~~~~~~V~vk~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~g~~~~--~~~~~lv~e   81 (259)
T PF07714_consen    4 IKQIGEGSFGKVYRAEWKQKDNDKNQPVAVKILKPSSSEEEEEEFLNEIQILRKLRHPNIVKLYGFCIE--NEPLFLVME   81 (259)
T ss_dssp             EEEEEEESSEEEEEEEEESTTTSSEEEEEEEEESTTSSHHHHHHHHHHHHHHHTHSBTTBE-EEEEEES--SSSEEEEEE
T ss_pred             eeEEccCCCcEEEEEEEEcccCCCCEEEEEEEeccccccccceeeeecccccccccccccccccccccc--ccccccccc
Confidence            468999999999999987     3678999999765544557899999999999999999999999973  456899999


Q ss_pred             cCCCCCHHHHhhhcCCCCCCCCHHHHHHHHHHHHHHHhhhhCCCCCCCceeecCCCCCceeecCCCCeEEeccccccccc
Q 005586          489 FAPKGKLSKYLDQEEGSSNVLDWSTRVSIIIGIAKGIGYLHSSEVNKPAIVHRNLSVEKVLIDQQFNPLIADCGLHKLLA  568 (689)
Q Consensus       489 ~~~~gsL~~~L~~~~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~~~ivH~dlk~~NiLl~~~~~~kl~DfGla~~~~  568 (689)
                      |+++|+|.++|+...  ...+++..+..|+.|||+||+|||+.+     ++|+||+++||++++++.+||+|||+++...
T Consensus        82 ~~~~g~L~~~L~~~~--~~~~~~~~~~~i~~~i~~~l~~Lh~~~-----iiH~~l~~~nill~~~~~~Kl~~f~~~~~~~  154 (259)
T PF07714_consen   82 YCPGGSLDDYLKSKN--KEPLSEQQRLSIAIQIAEALSYLHSNN-----IIHGNLSPSNILLDSNGQVKLSDFGLSRPIS  154 (259)
T ss_dssp             --TTEBHHHHHHHTC--TTTSBHHHHHHHHHHHHHHHHHHHHTT-----EEEST-SGGGEEEETTTEEEEESTTTGEETT
T ss_pred             ccccccccccccccc--ccccccccccccccccccccccccccc-----ccccccccccccccccccccccccccccccc
Confidence            999999999998862  235899999999999999999999987     9999999999999999999999999998763


Q ss_pred             CCc-eeeeecCCCCCCCCCccccccCCCCCcccchhHHHHHHHHHh-CCCCcchhHHHHHhhhhhhHhhccccCCCCCHH
Q 005586          569 DDI-VFSVLKTSAAMGYLAPEYVTTGRFTERSDIFAFGVIILQILT-GSLVLTSSMRLAAESATFENFIDRNLKGKFSES  646 (689)
Q Consensus       569 ~~~-~~~~~~~~~~~~y~aPE~~~~~~~~~ksDV~sfGvvl~ellt-G~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  646 (689)
                      ... ............|+|||.+....++.++||||||+++|||+| |+.|+.......    ....+ ....+...+..
T Consensus       155 ~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~ksDVysfG~~l~ei~~~~~~p~~~~~~~~----~~~~~-~~~~~~~~~~~  229 (259)
T PF07714_consen  155 EKSKYKNDSSQQLPLRYLAPEVLKDGEYTKKSDVYSFGMLLYEILTLGKFPFSDYDNEE----IIEKL-KQGQRLPIPDN  229 (259)
T ss_dssp             TSSSEEESTTSESGGGGS-HHHHHHSEESHHHHHHHHHHHHHHHHTTSSGTTTTSCHHH----HHHHH-HTTEETTSBTT
T ss_pred             ccccccccccccccccccccccccccccccccccccccccccccccccccccccccccc----ccccc-cccccceeccc
Confidence            222 112222335567999999999889999999999999999999 678875432111    11122 22222233445


Q ss_pred             HHHHHHHHHHHhccCCCCCCCCHHHHHHHH
Q 005586          647 EAAKLGKMALVCTHEDPENRPTMEAVIEEL  676 (689)
Q Consensus       647 ~~~~l~~l~~~Cl~~dp~~RPs~~evl~~L  676 (689)
                      .+..+.+++..||+.+|++||+|+++++.|
T Consensus       230 ~~~~~~~li~~C~~~~p~~RPs~~~i~~~L  259 (259)
T PF07714_consen  230 CPKDIYSLIQQCWSHDPEKRPSFQEILQEL  259 (259)
T ss_dssp             SBHHHHHHHHHHT-SSGGGS--HHHHHHHH
T ss_pred             hhHHHHHHHHHHcCCChhhCcCHHHHHhcC
Confidence            577899999999999999999999999886

Tyrosine kinase, catalytic domain; InterPro: IPR001245 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases. Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. Tyrosine-protein kinases can transfer a phosphate group from ATP to a tyrosine residue in a protein. These enzymes can be divided into two main groups []: Receptor tyrosine kinases (RTK), which are transmembrane proteins involved in signal transduction; they play key roles in growth, differentiation, metabolism, adhesion, motility, death and oncogenesis []. RTKs are composed of 3 domains: an extracellular domain (binds ligand), a transmembrane (TM) domain, and an intracellular catalytic domain (phosphorylates substrate). The TM domain plays an important role in the dimerisation process necessary for signal transduction []. Cytoplasmic / non-receptor tyrosine kinases, which act as regulatory proteins, playing key roles in cell differentiation, motility, proliferation, and survival. For example, the Src-family of protein-tyrosine kinases []. ; GO: 0004672 protein kinase activity, 0006468 protein phosphorylation; PDB: 2HYY_C 1OPL_A 2V7A_A 2G2H_B 2G1T_A 3PYY_A 3CS9_D 2HZI_A 2E2B_A 2HIW_A ....

>cd05114 PTKc_Tec_Rlk Catalytic domain of the Protein Tyrosine Kinases, Tyrosine kinase expressed in hepatocellular carcinoma and Resting lymphocyte kinase

Probab=100.00  E-value=5.1e-40  Score=334.96  Aligned_cols=251  Identities=23%  Similarity=0.453  Sum_probs=203.3

Q ss_pred             ccCCcccccccCCcceEEEEEecCCcEEEEEEecccCCchHHHHHHHHHHHHhccCCCcceeEeeEEEcCCCCeEEEEEE
Q 005586          409 QCFSEVNLLGKGNFSSVYKGTLRDGTLVAIRSINVTSCKSEEAEFVKGLYLLTSLRHENIIRLRGFCCSRGRGECFLIYD  488 (689)
Q Consensus       409 ~~f~~~~~lg~G~~g~Vy~~~~~~g~~vavK~l~~~~~~~~~~~f~~e~~~l~~l~H~niv~l~g~~~~~~~~~~~lV~e  488 (689)
                      ++|+..+.||+|+||.||++.++++..+|+|.+....  ....+|.+|++++++++||||+++++++..  .+..++|||
T Consensus         4 ~~~~~~~~lg~G~~~~vy~~~~~~~~~~a~K~~~~~~--~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~--~~~~~iv~e   79 (256)
T cd05114           4 SELTFMKELGSGQFGVVHLGKWRAQIKVAIKAINEGA--MSEEDFIEEAKVMMKLSHPKLVQLYGVCTQ--QKPLYIVTE   79 (256)
T ss_pred             HHcEEeeEecCCcCceEEEEEeccCceEEEEecccCC--ccHHHHHHHHHHHHHCCCCCceeEEEEEcc--CCCEEEEEE
Confidence            3567778999999999999999888899999887543  234679999999999999999999999843  567899999


Q ss_pred             cCCCCCHHHHhhhcCCCCCCCCHHHHHHHHHHHHHHHhhhhCCCCCCCceeecCCCCCceeecCCCCeEEeccccccccc
Q 005586          489 FAPKGKLSKYLDQEEGSSNVLDWSTRVSIIIGIAKGIGYLHSSEVNKPAIVHRNLSVEKVLIDQQFNPLIADCGLHKLLA  568 (689)
Q Consensus       489 ~~~~gsL~~~L~~~~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~~~ivH~dlk~~NiLl~~~~~~kl~DfGla~~~~  568 (689)
                      |+++|+|.++++...+   .++|..++.++.|++.||+|||+.+     |+||||||+||++++++.+||+|||+++...
T Consensus        80 ~~~~~~L~~~~~~~~~---~~~~~~~~~~~~~i~~~l~~lH~~~-----i~H~dl~p~ni~i~~~~~~kl~d~g~~~~~~  151 (256)
T cd05114          80 FMENGCLLNYLRQRQG---KLSKDMLLSMCQDVCEGMEYLERNS-----FIHRDLAARNCLVSSTGVVKVSDFGMTRYVL  151 (256)
T ss_pred             cCCCCcHHHHHHhCcc---CCCHHHHHHHHHHHHHHHHHHHHCC-----ccccccCcceEEEcCCCeEEECCCCCccccC
Confidence            9999999999976432   4899999999999999999999887     9999999999999999999999999998765


Q ss_pred             CCceeeeecCCCCCCCCCccccccCCCCCcccchhHHHHHHHHHh-CCCCcchhHHHHHhhhhhhHhhccccCCCCCHHH
Q 005586          569 DDIVFSVLKTSAAMGYLAPEYVTTGRFTERSDIFAFGVIILQILT-GSLVLTSSMRLAAESATFENFIDRNLKGKFSESE  647 (689)
Q Consensus       569 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~ksDV~sfGvvl~ellt-G~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  647 (689)
                      ...........++..|+|||++.+..++.++||||||+++|||++ |+.|+........    ...+.. ......+...
T Consensus       152 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~s~G~~l~el~~~g~~p~~~~~~~~~----~~~i~~-~~~~~~~~~~  226 (256)
T cd05114         152 DDEYTSSSGAKFPVKWSPPEVFNFSKYSSKSDVWSFGVLMWEVFTEGKMPFEKKSNYEV----VEMISR-GFRLYRPKLA  226 (256)
T ss_pred             CCceeccCCCCCchhhCChhhcccCccchhhhhHHHHHHHHHHHcCCCCCCCCCCHHHH----HHHHHC-CCCCCCCCCC
Confidence            433322223345567999999988889999999999999999999 8999864322111    111111 1111123334


Q ss_pred             HHHHHHHHHHhccCCCCCCCCHHHHHHHH
Q 005586          648 AAKLGKMALVCTHEDPENRPTMEAVIEEL  676 (689)
Q Consensus       648 ~~~l~~l~~~Cl~~dp~~RPs~~evl~~L  676 (689)
                      +.++.+++.+||+.+|++||+|.|+++.|
T Consensus       227 ~~~~~~li~~c~~~~p~~Rps~~~l~~~l  255 (256)
T cd05114         227 SMTVYEVMYSCWHEKPEGRPTFAELLRAI  255 (256)
T ss_pred             CHHHHHHHHHHccCCcccCcCHHHHHHhh
Confidence            56789999999999999999999999886

Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) and Resting lymphocyte kinase (Rlk); catalytic (c) domain. The PTKc family is part of a larger superfamily, that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec and Rlk (also named Txk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin h

>KOG0578 consensus p21-activated serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=6.9e-41  Score=348.71  Aligned_cols=251  Identities=18%  Similarity=0.340  Sum_probs=211.5

Q ss_pred             hccCCcccccccCCcceEEEEEe-cCCcEEEEEEecccCCchHHHHHHHHHHHHhccCCCcceeEeeEEEcCCCCeEEEE
Q 005586          408 TQCFSEVNLLGKGNFSSVYKGTL-RDGTLVAIRSINVTSCKSEEAEFVKGLYLLTSLRHENIIRLRGFCCSRGRGECFLI  486 (689)
Q Consensus       408 t~~f~~~~~lg~G~~g~Vy~~~~-~~g~~vavK~l~~~~~~~~~~~f~~e~~~l~~l~H~niv~l~g~~~~~~~~~~~lV  486 (689)
                      ...|.....||+|+.|.||.|.. .+++.||||++.... +...+-..+|+.+|...+|+|||.++.-|...  ++.++|
T Consensus       272 ~~~y~~~~kigqgaSG~vy~A~~~~~~~~VaiK~m~l~~-Q~~keLilnEi~Vm~~~~H~NiVnfl~Sylv~--deLWVV  348 (550)
T KOG0578|consen  272 RSKYTDFKKIGQGATGGVYVARKISTKQEVAIKRMDLRK-QPKKELLLNEILVMRDLHHPNIVNFLDSYLVG--DELWVV  348 (550)
T ss_pred             hhhhcchhhhccccccceeeeeeccCCceEEEEEEEecc-CCchhhhHHHHHHHHhccchHHHHHHHHhccc--ceeEEE
Confidence            35677778999999999999975 478999999998775 33445678999999999999999999877543  789999


Q ss_pred             EEcCCCCCHHHHhhhcCCCCCCCCHHHHHHHHHHHHHHHhhhhCCCCCCCceeecCCCCCceeecCCCCeEEeccccccc
Q 005586          487 YDFAPKGKLSKYLDQEEGSSNVLDWSTRVSIIIGIAKGIGYLHSSEVNKPAIVHRNLSVEKVLIDQQFNPLIADCGLHKL  566 (689)
Q Consensus       487 ~e~~~~gsL~~~L~~~~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~~~ivH~dlk~~NiLl~~~~~~kl~DfGla~~  566 (689)
                      ||||++|+|.+.+....     +++.+.-.|+.+++.||+|||..+     |+|||||++|||++.++.+||+|||++..
T Consensus       349 MEym~ggsLTDvVt~~~-----~~E~qIA~Icre~l~aL~fLH~~g-----IiHrDIKSDnILL~~~g~vKltDFGFcaq  418 (550)
T KOG0578|consen  349 MEYMEGGSLTDVVTKTR-----MTEGQIAAICREILQGLKFLHARG-----IIHRDIKSDNILLTMDGSVKLTDFGFCAQ  418 (550)
T ss_pred             EeecCCCchhhhhhccc-----ccHHHHHHHHHHHHHHHHHHHhcc-----eeeeccccceeEeccCCcEEEeeeeeeec
Confidence            99999999999997643     899999999999999999999988     99999999999999999999999999988


Q ss_pred             ccCCceeeeecCCCCCCCCCccccccCCCCCcccchhHHHHHHHHHhCCCCcchhHHHHHhhhhhhHhh-ccccCCCCCH
Q 005586          567 LADDIVFSVLKTSAAMGYLAPEYVTTGRFTERSDIFAFGVIILQILTGSLVLTSSMRLAAESATFENFI-DRNLKGKFSE  645 (689)
Q Consensus       567 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~ksDV~sfGvvl~elltG~~p~~~~~~~~~~~~~~~~~~-~~~~~~~~~~  645 (689)
                      +..... ......||+.|||||++....|++|+||||+|++++||+-|.+||-.......    +..+. ........++
T Consensus       419 i~~~~~-KR~TmVGTPYWMAPEVvtrk~YG~KVDIWSLGIMaIEMveGEPPYlnE~PlrA----lyLIa~ng~P~lk~~~  493 (550)
T KOG0578|consen  419 ISEEQS-KRSTMVGTPYWMAPEVVTRKPYGPKVDIWSLGIMAIEMVEGEPPYLNENPLRA----LYLIATNGTPKLKNPE  493 (550)
T ss_pred             cccccC-ccccccCCCCccchhhhhhcccCccccchhhhhHHHHHhcCCCCccCCChHHH----HHHHhhcCCCCcCCcc
Confidence            766543 33456799999999999999999999999999999999999999964322111    11111 1223334566


Q ss_pred             HHHHHHHHHHHHhccCCCCCCCCHHHHHHHH
Q 005586          646 SEAAKLGKMALVCTHEDPENRPTMEAVIEEL  676 (689)
Q Consensus       646 ~~~~~l~~l~~~Cl~~dp~~RPs~~evl~~L  676 (689)
                      ..+..+.++..+|++.|+++||++.|+|++-
T Consensus       494 klS~~~kdFL~~cL~~dv~~RasA~eLL~Hp  524 (550)
T KOG0578|consen  494 KLSPELKDFLDRCLVVDVEQRASAKELLEHP  524 (550)
T ss_pred             ccCHHHHHHHHHHhhcchhcCCCHHHHhcCh
Confidence            7788999999999999999999999999873

>cd05033 PTKc_EphR Catalytic domain of Ephrin Receptor Protein Tyrosine Kinases

Probab=100.00  E-value=1.3e-39  Score=334.04  Aligned_cols=256  Identities=23%  Similarity=0.462  Sum_probs=208.4

Q ss_pred             ccCCcccccccCCcceEEEEEec----CCcEEEEEEecccCCchHHHHHHHHHHHHhccCCCcceeEeeEEEcCCCCeEE
Q 005586          409 QCFSEVNLLGKGNFSSVYKGTLR----DGTLVAIRSINVTSCKSEEAEFVKGLYLLTSLRHENIIRLRGFCCSRGRGECF  484 (689)
Q Consensus       409 ~~f~~~~~lg~G~~g~Vy~~~~~----~g~~vavK~l~~~~~~~~~~~f~~e~~~l~~l~H~niv~l~g~~~~~~~~~~~  484 (689)
                      ++|+..+.||+|+||.||+|.++    +...||||.+..........+|.+|+.++.+++||||+++++++..  .+..+
T Consensus         4 ~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~vaik~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~--~~~~~   81 (266)
T cd05033           4 SYVTIEKVIGGGEFGEVCRGRLKLPGKKEIDVAIKTLKAGSSDKQRLDFLTEASIMGQFDHPNIIRLEGVVTK--SRPVM   81 (266)
T ss_pred             HHceeeeEecCCccceEEEEEEccCCCCcceEEEEEcCCCCChHHHHHHHHHHHHHHhCCCCCcceEeEEEec--CCceE
Confidence            46788899999999999999875    2468999998866545556789999999999999999999998844  46789


Q ss_pred             EEEEcCCCCCHHHHhhhcCCCCCCCCHHHHHHHHHHHHHHHhhhhCCCCCCCceeecCCCCCceeecCCCCeEEeccccc
Q 005586          485 LIYDFAPKGKLSKYLDQEEGSSNVLDWSTRVSIIIGIAKGIGYLHSSEVNKPAIVHRNLSVEKVLIDQQFNPLIADCGLH  564 (689)
Q Consensus       485 lV~e~~~~gsL~~~L~~~~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~~~ivH~dlk~~NiLl~~~~~~kl~DfGla  564 (689)
                      +||||+++|+|.+++....+   .++|..++.++.|++.||+|||+.+     |+||||||+||++++++.+||+|||++
T Consensus        82 iv~e~~~~~~L~~~~~~~~~---~~~~~~~~~~~~~l~~~l~~Lh~~~-----i~H~di~p~nili~~~~~~~l~dfg~~  153 (266)
T cd05033          82 IITEYMENGSLDKFLRENDG---KFTVGQLVGMLRGIASGMKYLSEMN-----YVHRDLAARNILVNSNLVCKVSDFGLS  153 (266)
T ss_pred             EEEEcCCCCCHHHHHHhccC---CCCHHHHHHHHHHHHHHHHHHHhCC-----cccCCCCcceEEEcCCCCEEECccchh
Confidence            99999999999999976543   4899999999999999999999987     999999999999999999999999999


Q ss_pred             ccccC-CceeeeecCCCCCCCCCccccccCCCCCcccchhHHHHHHHHHh-CCCCcchhHHHHHhhhhhhHhhccccCCC
Q 005586          565 KLLAD-DIVFSVLKTSAAMGYLAPEYVTTGRFTERSDIFAFGVIILQILT-GSLVLTSSMRLAAESATFENFIDRNLKGK  642 (689)
Q Consensus       565 ~~~~~-~~~~~~~~~~~~~~y~aPE~~~~~~~~~ksDV~sfGvvl~ellt-G~~p~~~~~~~~~~~~~~~~~~~~~~~~~  642 (689)
                      +.... ..........++..|+|||.+.+..++.++||||||+++|||++ |..|+........     .+.+.......
T Consensus       154 ~~~~~~~~~~~~~~~~~~~~y~~Pe~~~~~~~~~~~Dv~slG~~l~~l~~~g~~p~~~~~~~~~-----~~~~~~~~~~~  228 (266)
T cd05033         154 RRLEDSEATYTTKGGKIPIRWTAPEAIAYRKFTSASDVWSFGIVMWEVMSYGERPYWDMSNQDV-----IKAVEDGYRLP  228 (266)
T ss_pred             hcccccccceeccCCCCCccccChhhhccCCCccccchHHHHHHHHHHHccCCCCCCCCCHHHH-----HHHHHcCCCCC
Confidence            87752 22222222344568999999998899999999999999999998 9999854322111     11111111222


Q ss_pred             CCHHHHHHHHHHHHHhccCCCCCCCCHHHHHHHHHhh
Q 005586          643 FSESEAAKLGKMALVCTHEDPENRPTMEAVIEELTVA  679 (689)
Q Consensus       643 ~~~~~~~~l~~l~~~Cl~~dp~~RPs~~evl~~L~~~  679 (689)
                      .+...+..+.+++.+|++.+|++||++.||+++|...
T Consensus       229 ~~~~~~~~l~~li~~cl~~~p~~Rp~~~ei~~~l~~~  265 (266)
T cd05033         229 PPMDCPSALYQLMLDCWQKDRNERPTFSQIVSTLDKM  265 (266)
T ss_pred             CCCCCCHHHHHHHHHHcCCCcccCcCHHHHHHHHHhh
Confidence            3344567899999999999999999999999999864

Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). They can be classified into two classes (EphA and EphB), according to their extracellular sequences, which largely correspond to binding preferences for either GPI-anchored ephrin-A ligands or transmembrane ephrin-B ligands. Vertebrates have ten EphA and six EhpB receptors, which display promiscuous ligand interactions within each class. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment

>cd05631 STKc_GRK4 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 4

Probab=100.00  E-value=5.7e-40  Score=340.24  Aligned_cols=254  Identities=19%  Similarity=0.297  Sum_probs=202.8

Q ss_pred             CCcccccccCCcceEEEEEec-CCcEEEEEEecccCCc--hHHHHHHHHHHHHhccCCCcceeEeeEEEcCCCCeEEEEE
Q 005586          411 FSEVNLLGKGNFSSVYKGTLR-DGTLVAIRSINVTSCK--SEEAEFVKGLYLLTSLRHENIIRLRGFCCSRGRGECFLIY  487 (689)
Q Consensus       411 f~~~~~lg~G~~g~Vy~~~~~-~g~~vavK~l~~~~~~--~~~~~f~~e~~~l~~l~H~niv~l~g~~~~~~~~~~~lV~  487 (689)
                      |...+.||+|+||.||+|... +|+.||+|.+......  .....+.+|++++.+++|+||+++.+++..  .+..++||
T Consensus         2 f~~~~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~~~~iv~~~~~~~~--~~~~~lv~   79 (285)
T cd05631           2 FRHYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKRILEKVNSRFVVSLAYAYET--KDALCLVL   79 (285)
T ss_pred             ceEEEEEecCCCEEEEEEEEecCCceEEEEEeeHhhhhhhhhHHHHHHHHHHHHhcCCCcEEEEEEEEcc--CCeEEEEE
Confidence            666789999999999999874 7999999998754322  234568899999999999999999998843  46899999


Q ss_pred             EcCCCCCHHHHhhhcCCCCCCCCHHHHHHHHHHHHHHHhhhhCCCCCCCceeecCCCCCceeecCCCCeEEecccccccc
Q 005586          488 DFAPKGKLSKYLDQEEGSSNVLDWSTRVSIIIGIAKGIGYLHSSEVNKPAIVHRNLSVEKVLIDQQFNPLIADCGLHKLL  567 (689)
Q Consensus       488 e~~~~gsL~~~L~~~~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~~~ivH~dlk~~NiLl~~~~~~kl~DfGla~~~  567 (689)
                      ||+++|+|..++.....  ..+++..+..++.|++.||+|||+.+     |+||||||+|||+++++.+||+|||+++..
T Consensus        80 e~~~~g~L~~~~~~~~~--~~~~~~~~~~~~~qi~~~l~~lH~~~-----iiH~dikp~Nill~~~~~~kl~Dfg~~~~~  152 (285)
T cd05631          80 TIMNGGDLKFHIYNMGN--PGFDEQRAIFYAAELCCGLEDLQRER-----IVYRDLKPENILLDDRGHIRISDLGLAVQI  152 (285)
T ss_pred             EecCCCcHHHHHHhhCC--CCCCHHHHHHHHHHHHHHHHHHHhCC-----EEeCCCCHHHEEECCCCCEEEeeCCCcEEc
Confidence            99999999988865332  34899999999999999999999987     999999999999999999999999999876


Q ss_pred             cCCceeeeecCCCCCCCCCccccccCCCCCcccchhHHHHHHHHHhCCCCcchhHHHHHhhhhhhHhhccccCCCCCHHH
Q 005586          568 ADDIVFSVLKTSAAMGYLAPEYVTTGRFTERSDIFAFGVIILQILTGSLVLTSSMRLAAESATFENFIDRNLKGKFSESE  647 (689)
Q Consensus       568 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~ksDV~sfGvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  647 (689)
                      .....  .....++..|+|||++.+..++.++|||||||++|||++|+.||.......... .+...+ ......++...
T Consensus       153 ~~~~~--~~~~~g~~~y~aPE~~~~~~~~~~~DvwslGvil~el~~g~~pf~~~~~~~~~~-~~~~~~-~~~~~~~~~~~  228 (285)
T cd05631         153 PEGET--VRGRVGTVGYMAPEVINNEKYTFSPDWWGLGCLIYEMIQGQSPFRKRKERVKRE-EVDRRV-KEDQEEYSEKF  228 (285)
T ss_pred             CCCCe--ecCCCCCCCccCHhhhcCCCCCcccCchhHHHHHHHHHhCCCCCCCCCcchhHH-HHHHHh-hcccccCCccC
Confidence            44321  223457889999999999999999999999999999999999996532211111 111111 11112234445


Q ss_pred             HHHHHHHHHHhccCCCCCCCC-----HHHHHHHHH
Q 005586          648 AAKLGKMALVCTHEDPENRPT-----MEAVIEELT  677 (689)
Q Consensus       648 ~~~l~~l~~~Cl~~dp~~RPs-----~~evl~~L~  677 (689)
                      +.++.+++..||+.||++||+     +++++++-+
T Consensus       229 s~~~~~li~~~l~~~P~~R~~~~~~~~~~~~~h~~  263 (285)
T cd05631         229 SEDAKSICRMLLTKNPKERLGCRGNGAAGVKQHPI  263 (285)
T ss_pred             CHHHHHHHHHHhhcCHHHhcCCCCCCHHHHhcCHh
Confidence            667899999999999999997     899988754

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK4 has a limited tissue distribution. It is mainly found i

>KOG3653 consensus Transforming growth factor beta/activin receptor subfamily of serine/threonine kinases [Signal transduction mechanisms]

Probab=100.00  E-value=2.7e-39  Score=328.43  Aligned_cols=258  Identities=26%  Similarity=0.438  Sum_probs=197.3

Q ss_pred             ccccccCCcceEEEEEecCCcEEEEEEecccCCchHHHHHHHHHHHHh--ccCCCcceeEeeEEEcCC--CCeEEEEEEc
Q 005586          414 VNLLGKGNFSSVYKGTLRDGTLVAIRSINVTSCKSEEAEFVKGLYLLT--SLRHENIIRLRGFCCSRG--RGECFLIYDF  489 (689)
Q Consensus       414 ~~~lg~G~~g~Vy~~~~~~g~~vavK~l~~~~~~~~~~~f~~e~~~l~--~l~H~niv~l~g~~~~~~--~~~~~lV~e~  489 (689)
                      .++||+|+||.||||.+. ++.||||++...    +.+.|.+|-++.+  .++|+||++++++-....  .-+++||+||
T Consensus       215 ~eli~~Grfg~V~KaqL~-~~~VAVKifp~~----~kqs~~~Ek~Iy~lp~m~h~nIl~Fi~~ekr~t~~~~eywLVt~f  289 (534)
T KOG3653|consen  215 LELIGRGRFGCVWKAQLD-NRLVAVKIFPEQ----EKQSFQNEKNIYSLPGMKHENILQFIGAEKRGTADRMEYWLVTEF  289 (534)
T ss_pred             HHHhhcCccceeehhhcc-CceeEEEecCHH----HHHHHHhHHHHHhccCccchhHHHhhchhccCCccccceeEEeee
Confidence            367999999999999997 589999999743    4567888877766  568999999998652211  3379999999


Q ss_pred             CCCCCHHHHhhhcCCCCCCCCHHHHHHHHHHHHHHHhhhhCC----CCCCCceeecCCCCCceeecCCCCeEEecccccc
Q 005586          490 APKGKLSKYLDQEEGSSNVLDWSTRVSIIIGIAKGIGYLHSS----EVNKPAIVHRNLSVEKVLIDQQFNPLIADCGLHK  565 (689)
Q Consensus       490 ~~~gsL~~~L~~~~~~~~~l~~~~~~~ia~~ia~gL~yLH~~----~~~~~~ivH~dlk~~NiLl~~~~~~kl~DfGla~  565 (689)
                      -++|+|.+||..+.     ++|....+||..+++||+|||+.    +.-+|+|+|||||++||||.+|+++.|+|||||.
T Consensus       290 h~kGsL~dyL~~nt-----isw~~~cria~SmarGLa~LHee~p~~d~~Kp~IaHRDlkSkNVLvK~DlTccIaDFGLAl  364 (534)
T KOG3653|consen  290 HPKGSLCDYLKANT-----ISWNSLCRIAESMARGLAHLHEELPRGDHHKPPIAHRDLKSKNVLVKNDLTCCIADFGLAL  364 (534)
T ss_pred             ccCCcHHHHHHhcc-----ccHHHHHHHHHHHHHHHHHhcccCCcCCCCCCccccccccccceEEccCCcEEeeccceeE
Confidence            99999999998753     89999999999999999999974    3357999999999999999999999999999998


Q ss_pred             cccCCce-eeeecCCCCCCCCCccccccCC-CC-----CcccchhHHHHHHHHHhCCCCcc--------hhHHHHHh---
Q 005586          566 LLADDIV-FSVLKTSAAMGYLAPEYVTTGR-FT-----ERSDIFAFGVIILQILTGSLVLT--------SSMRLAAE---  627 (689)
Q Consensus       566 ~~~~~~~-~~~~~~~~~~~y~aPE~~~~~~-~~-----~ksDV~sfGvvl~elltG~~p~~--------~~~~~~~~---  627 (689)
                      .+..+.. .......||.+|||||++.+.- +.     .+.||||+|.|||||++.-.-..        -.+.....   
T Consensus       365 ~~~p~~~~~d~~~qVGT~RYMAPEvLEgainl~d~~Afkr~DvYamgLVLWEi~SRC~~~~~~~vp~Yqlpfe~evG~hP  444 (534)
T KOG3653|consen  365 RLEPGKPQGDTHGQVGTRRYMAPEVLEGAINLQDRDAFKRIDVYAMGLVLWEIASRCTDADPGPVPEYQLPFEAEVGNHP  444 (534)
T ss_pred             EecCCCCCcchhhhhhhhhhcCHHHHhhhcccccHHHHHHHHHHHHHHHHHHHHhhcccccCCCCCcccCchhHHhcCCC
Confidence            8764432 2334578999999999986632 22     46899999999999998533221        11111111   


Q ss_pred             -hhhhhH-hhccccCCCCCH-----HHHHHHHHHHHHhccCCCCCCCCHHHHHHHHHhhCC
Q 005586          628 -SATFEN-FIDRNLKGKFSE-----SEAAKLGKMALVCTHEDPENRPTMEAVIEELTVAAP  681 (689)
Q Consensus       628 -~~~~~~-~~~~~~~~~~~~-----~~~~~l~~l~~~Cl~~dp~~RPs~~evl~~L~~~~p  681 (689)
                       ...+.+ ++....++.++.     ..+..+.+.+..||..||+.|.|+.=|-+++++..-
T Consensus       445 t~e~mq~~VV~kK~RP~~p~~W~~h~~~~~l~et~EeCWDhDaeARLTA~Cv~eR~~~l~~  505 (534)
T KOG3653|consen  445 TLEEMQELVVRKKQRPKIPDAWRKHAGMAVLCETIEECWDHDAEARLTAGCVEERMAELMM  505 (534)
T ss_pred             CHHHHHHHHHhhccCCCChhhhhcCccHHHHHHHHHHHcCCchhhhhhhHHHHHHHHHHhc
Confidence             111222 223333444433     347789999999999999999999999888876643

>cd05048 PTKc_Ror Catalytic Domain of the Protein Tyrosine Kinases, Receptor tyrosine kinase-like Orphan Receptors

Probab=100.00  E-value=1.1e-39  Score=337.54  Aligned_cols=258  Identities=27%  Similarity=0.446  Sum_probs=207.9

Q ss_pred             ccCCcccccccCCcceEEEEEecC------CcEEEEEEecccCCchHHHHHHHHHHHHhccCCCcceeEeeEEEcCCCCe
Q 005586          409 QCFSEVNLLGKGNFSSVYKGTLRD------GTLVAIRSINVTSCKSEEAEFVKGLYLLTSLRHENIIRLRGFCCSRGRGE  482 (689)
Q Consensus       409 ~~f~~~~~lg~G~~g~Vy~~~~~~------g~~vavK~l~~~~~~~~~~~f~~e~~~l~~l~H~niv~l~g~~~~~~~~~  482 (689)
                      ++|+..+.||+|+||.||+|....      ...||+|.+..........+|.+|++++.+++||||+++++++..  .+.
T Consensus         5 ~~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~v~~K~~~~~~~~~~~~~~~~ei~~l~~l~h~~i~~~~~~~~~--~~~   82 (283)
T cd05048           5 SAVRFLEELGEGAFGKVYKGELTGPNERLSATSVAIKTLKENAEPKVQQEFRQEAELMSDLQHPNIVCLLGVCTK--EQP   82 (283)
T ss_pred             HHcchhhcccCccCCcEEEEEEecCCCCcceeeEEEEecccCCCHHHHHHHHHHHHHHHhcCCcccceEEEEEcC--CCc
Confidence            357778899999999999998642      257999999765544455689999999999999999999999843  467


Q ss_pred             EEEEEEcCCCCCHHHHhhhcCCC------------CCCCCHHHHHHHHHHHHHHHhhhhCCCCCCCceeecCCCCCceee
Q 005586          483 CFLIYDFAPKGKLSKYLDQEEGS------------SNVLDWSTRVSIIIGIAKGIGYLHSSEVNKPAIVHRNLSVEKVLI  550 (689)
Q Consensus       483 ~~lV~e~~~~gsL~~~L~~~~~~------------~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~~~ivH~dlk~~NiLl  550 (689)
                      .+++|||+++|+|.+++......            ...+++.+.+.++.|++.||+|||+.+     ++||||||+||++
T Consensus        83 ~~~~~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~al~~lH~~~-----i~H~dlkp~Nil~  157 (283)
T cd05048          83 TCMLFEYLAHGDLHEFLVRNSPHSDVGAESGDETVKSSLDCSDFLHIAIQIAAGMEYLSSHH-----FVHRDLAARNCLV  157 (283)
T ss_pred             eEEEEecCCCCcHHHHHHhcCCCcccccccccccccCCCCHHHHHHHHHHHHHHHHHHHhCC-----eeccccccceEEE
Confidence            89999999999999999764221            135889999999999999999999987     9999999999999


Q ss_pred             cCCCCeEEecccccccccCCce-eeeecCCCCCCCCCccccccCCCCCcccchhHHHHHHHHHh-CCCCcchhHHHHHhh
Q 005586          551 DQQFNPLIADCGLHKLLADDIV-FSVLKTSAAMGYLAPEYVTTGRFTERSDIFAFGVIILQILT-GSLVLTSSMRLAAES  628 (689)
Q Consensus       551 ~~~~~~kl~DfGla~~~~~~~~-~~~~~~~~~~~y~aPE~~~~~~~~~ksDV~sfGvvl~ellt-G~~p~~~~~~~~~~~  628 (689)
                      ++++.+||+|||+++....... .......++..|+|||++.+..++.++|||||||++|||+| |..||.......   
T Consensus       158 ~~~~~~~L~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDv~slG~il~el~~~g~~p~~~~~~~~---  234 (283)
T cd05048         158 GEGLTVKISDFGLSRDIYSADYYRVQSKSLLPVRWMPPEAILYGKFTTESDIWSFGVVLWEIFSYGLQPYYGFSNQE---  234 (283)
T ss_pred             cCCCcEEECCCcceeeccccccccccCCCcccccccCHHHhccCcCchhhhHHHHHHHHHHHHcCCCCCCCCCCHHH---
Confidence            9999999999999986543321 11222345678999999988899999999999999999998 999986432211   


Q ss_pred             hhhhHhhccccCCCCCHHHHHHHHHHHHHhccCCCCCCCCHHHHHHHHHh
Q 005586          629 ATFENFIDRNLKGKFSESEAAKLGKMALVCTHEDPENRPTMEAVIEELTV  678 (689)
Q Consensus       629 ~~~~~~~~~~~~~~~~~~~~~~l~~l~~~Cl~~dp~~RPs~~evl~~L~~  678 (689)
                        ..+.+........+...+.++.+++..||+.||++||+++||+++|+.
T Consensus       235 --~~~~i~~~~~~~~~~~~~~~~~~l~~~c~~~~p~~Rp~~~~i~~~l~~  282 (283)
T cd05048         235 --VIEMIRSRQLLPCPEDCPARVYALMIECWNEIPARRPRFKDIHTRLRS  282 (283)
T ss_pred             --HHHHHHcCCcCCCcccCCHHHHHHHHHHccCChhhCcCHHHHHHHHhc
Confidence              112222222223455667889999999999999999999999999975

Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor (Ror) subfamily; catalytic (c) domain. The Ror subfamily consists of Ror1, Ror2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimer

>cd05072 PTKc_Lyn Catalytic domain of the Protein Tyrosine Kinase, Lyn

Probab=100.00  E-value=1.2e-39  Score=333.28  Aligned_cols=254  Identities=24%  Similarity=0.446  Sum_probs=206.3

Q ss_pred             ccCCcccccccCCcceEEEEEecCCcEEEEEEecccCCchHHHHHHHHHHHHhccCCCcceeEeeEEEcCCCCeEEEEEE
Q 005586          409 QCFSEVNLLGKGNFSSVYKGTLRDGTLVAIRSINVTSCKSEEAEFVKGLYLLTSLRHENIIRLRGFCCSRGRGECFLIYD  488 (689)
Q Consensus       409 ~~f~~~~~lg~G~~g~Vy~~~~~~g~~vavK~l~~~~~~~~~~~f~~e~~~l~~l~H~niv~l~g~~~~~~~~~~~lV~e  488 (689)
                      ++|+..+.||+|+||.||+|...++..||+|.+....  ...+.|.+|+.++++++|+||+++++++.  ..+..++|||
T Consensus         6 ~~~~~~~~lg~g~~g~v~~~~~~~~~~v~iK~~~~~~--~~~~~~~~e~~~l~~l~h~~i~~~~~~~~--~~~~~~lv~e   81 (261)
T cd05072           6 ESIKLVKKLGAGQFGEVWMGYYNNSTKVAVKTLKPGT--MSVQAFLEEANLMKTLQHDKLVRLYAVVT--KEEPIYIITE   81 (261)
T ss_pred             HHeEEeeecCCcCCceEEEEEecCCceEEEEEccCCc--hhHHHHHHHHHHHHhCCCCCeeeEEEEEc--CCCCcEEEEe
Confidence            4677889999999999999998888899999987543  23568999999999999999999999884  4567899999


Q ss_pred             cCCCCCHHHHhhhcCCCCCCCCHHHHHHHHHHHHHHHhhhhCCCCCCCceeecCCCCCceeecCCCCeEEeccccccccc
Q 005586          489 FAPKGKLSKYLDQEEGSSNVLDWSTRVSIIIGIAKGIGYLHSSEVNKPAIVHRNLSVEKVLIDQQFNPLIADCGLHKLLA  568 (689)
Q Consensus       489 ~~~~gsL~~~L~~~~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~~~ivH~dlk~~NiLl~~~~~~kl~DfGla~~~~  568 (689)
                      |+++|+|.++++....  ..+++.+++.++.|+++||+|||+.+     ++||||||+||++++++.+||+|||+++...
T Consensus        82 ~~~~~~L~~~l~~~~~--~~~~~~~~~~~~~~l~~~l~~LH~~~-----i~H~dl~p~nili~~~~~~~l~dfg~~~~~~  154 (261)
T cd05072          82 YMAKGSLLDFLKSDEG--GKVLLPKLIDFSAQIAEGMAYIERKN-----YIHRDLRAANVLVSESLMCKIADFGLARVIE  154 (261)
T ss_pred             cCCCCcHHHHHHHhcC--CCCCHHHHHHHHHHHHHHHHHHHHCC-----eeccccchhhEEecCCCcEEECCCccceecC
Confidence            9999999999976432  34889999999999999999999887     9999999999999999999999999998775


Q ss_pred             CCceeeeecCCCCCCCCCccccccCCCCCcccchhHHHHHHHHHh-CCCCcchhHHHHHhhhhhhHhhccccCCCCCHHH
Q 005586          569 DDIVFSVLKTSAAMGYLAPEYVTTGRFTERSDIFAFGVIILQILT-GSLVLTSSMRLAAESATFENFIDRNLKGKFSESE  647 (689)
Q Consensus       569 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~ksDV~sfGvvl~ellt-G~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  647 (689)
                      ...........++..|+|||++....++.++|||||||++|||+| |+.|+.........     ..+............
T Consensus       155 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~t~g~~p~~~~~~~~~~-----~~~~~~~~~~~~~~~  229 (261)
T cd05072         155 DNEYTAREGAKFPIKWTAPEAINFGSFTIKSDVWSFGILLYEIVTYGKIPYPGMSNSDVM-----SALQRGYRMPRMENC  229 (261)
T ss_pred             CCceeccCCCccceecCCHHHhccCCCChhhhhhhhHHHHHHHHccCCCCCCCCCHHHHH-----HHHHcCCCCCCCCCC
Confidence            543222223335567999999988889999999999999999999 99998643221111     111111111222334


Q ss_pred             HHHHHHHHHHhccCCCCCCCCHHHHHHHHHh
Q 005586          648 AAKLGKMALVCTHEDPENRPTMEAVIEELTV  678 (689)
Q Consensus       648 ~~~l~~l~~~Cl~~dp~~RPs~~evl~~L~~  678 (689)
                      +.++.+++.+|++.+|++||+++++.+.|+.
T Consensus       230 ~~~~~~li~~~l~~~p~~Rp~~~~i~~~l~~  260 (261)
T cd05072         230 PDELYDIMKTCWKEKAEERPTFDYLQSVLDD  260 (261)
T ss_pred             CHHHHHHHHHHccCCcccCcCHHHHHHHHhc
Confidence            5678999999999999999999999999874

Protein Tyrosine Kinase (PTK) family; Lyn kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lyn is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth fa

>cd06649 PKc_MEK2 Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 2

Probab=100.00  E-value=1.3e-39  Score=344.82  Aligned_cols=261  Identities=18%  Similarity=0.317  Sum_probs=206.4

Q ss_pred             ccCCcccccccCCcceEEEEEec-CCcEEEEEEecccCCchHHHHHHHHHHHHhccCCCcceeEeeEEEcCCCCeEEEEE
Q 005586          409 QCFSEVNLLGKGNFSSVYKGTLR-DGTLVAIRSINVTSCKSEEAEFVKGLYLLTSLRHENIIRLRGFCCSRGRGECFLIY  487 (689)
Q Consensus       409 ~~f~~~~~lg~G~~g~Vy~~~~~-~g~~vavK~l~~~~~~~~~~~f~~e~~~l~~l~H~niv~l~g~~~~~~~~~~~lV~  487 (689)
                      ++|+..+.||+|+||.||+++.+ +|..||+|.+...........|.+|++++.+++||||+++++++..  .+..++||
T Consensus         5 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~--~~~~~lv~   82 (331)
T cd06649           5 DDFERISELGAGNGGVVTKVQHKPSGLIMARKLIHLEIKPAIRNQIIRELQVLHECNSPYIVGFYGAFYS--DGEISICM   82 (331)
T ss_pred             ccceEEEeecCCCCEEEEEEEECCCCcEEEEEEeecccCHHHHHHHHHHHHHHHHCCCCCCCeEEEEEEE--CCEEEEEe
Confidence            57888899999999999999976 6889999998865433445689999999999999999999999854  46899999


Q ss_pred             EcCCCCCHHHHhhhcCCCCCCCCHHHHHHHHHHHHHHHhhhhCCCCCCCceeecCCCCCceeecCCCCeEEecccccccc
Q 005586          488 DFAPKGKLSKYLDQEEGSSNVLDWSTRVSIIIGIAKGIGYLHSSEVNKPAIVHRNLSVEKVLIDQQFNPLIADCGLHKLL  567 (689)
Q Consensus       488 e~~~~gsL~~~L~~~~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~~~ivH~dlk~~NiLl~~~~~~kl~DfGla~~~  567 (689)
                      ||+++|+|.+++....    .+++..+..++.|++.||.|||+.+.    |+||||||+|||+++++.+||+|||+++..
T Consensus        83 e~~~~~~L~~~l~~~~----~~~~~~~~~~~~~i~~~l~~lH~~~~----ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~  154 (331)
T cd06649          83 EHMDGGSLDQVLKEAK----RIPEEILGKVSIAVLRGLAYLREKHQ----IMHRDVKPSNILVNSRGEIKLCDFGVSGQL  154 (331)
T ss_pred             ecCCCCcHHHHHHHcC----CCCHHHHHHHHHHHHHHHHHHhhcCC----EEcCCCChhhEEEcCCCcEEEccCcccccc
Confidence            9999999999997643    38899999999999999999997532    999999999999999999999999999866


Q ss_pred             cCCceeeeecCCCCCCCCCccccccCCCCCcccchhHHHHHHHHHhCCCCcchhHHHHHhhhh-----------------
Q 005586          568 ADDIVFSVLKTSAAMGYLAPEYVTTGRFTERSDIFAFGVIILQILTGSLVLTSSMRLAAESAT-----------------  630 (689)
Q Consensus       568 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~ksDV~sfGvvl~elltG~~p~~~~~~~~~~~~~-----------------  630 (689)
                      ....   .....++..|+|||++.+..++.++|||||||++|||+||+.||............                 
T Consensus       155 ~~~~---~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~il~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  231 (331)
T cd06649         155 IDSM---ANSFVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVELAIGRYPIPPPDAKELEAIFGRPVVDGEEGEPHSISP  231 (331)
T ss_pred             cccc---cccCCCCcCcCCHhHhcCCCCCchHhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHhcccccccccCCccccCc
Confidence            4332   12335788899999999889999999999999999999999998532111000000                 


Q ss_pred             ---------------------hhHhhc---cccCCCC-CHHHHHHHHHHHHHhccCCCCCCCCHHHHHHHHHhhCCc
Q 005586          631 ---------------------FENFID---RNLKGKF-SESEAAKLGKMALVCTHEDPENRPTMEAVIEELTVAAPV  682 (689)
Q Consensus       631 ---------------------~~~~~~---~~~~~~~-~~~~~~~l~~l~~~Cl~~dp~~RPs~~evl~~L~~~~p~  682 (689)
                                           ..+..+   ....... ......++.+++.+||+.||++||++.|++++.+.....
T Consensus       232 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~~P~~Rpt~~ell~h~~~~~~~  308 (331)
T cd06649         232 RPRPPGRPVSGHGMDSRPAMAIFELLDYIVNEPPPKLPNGVFTPDFQEFVNKCLIKNPAERADLKMLMNHTFIKRSE  308 (331)
T ss_pred             ccccccccccccccccccchhHHHHHHHHHhCCCcCCCCccccHHHHHHHHHHccCCcccCCCHHHHhcChHHhhcc
Confidence                                 000000   0000000 112356789999999999999999999999998765443

Protein kinases (PKs), MAP/ERK Kinase (MEK) 2 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK2 is a dual-specificity PK that phosphorylates and activates the downst

>KOG0661 consensus MAPK related serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=4.2e-41  Score=341.88  Aligned_cols=257  Identities=21%  Similarity=0.344  Sum_probs=206.7

Q ss_pred             hccCCcccccccCCcceEEEEEe-cCCcEEEEEEecccCCchHHHHHHHHHHHHhccC-CCcceeEeeEEEcCCCCeEEE
Q 005586          408 TQCFSEVNLLGKGNFSSVYKGTL-RDGTLVAIRSINVTSCKSEEAEFVKGLYLLTSLR-HENIIRLRGFCCSRGRGECFL  485 (689)
Q Consensus       408 t~~f~~~~~lg~G~~g~Vy~~~~-~~g~~vavK~l~~~~~~~~~~~f~~e~~~l~~l~-H~niv~l~g~~~~~~~~~~~l  485 (689)
                      .++|...+.||.|.||.||+|+- .+|..||||+++.....-++..=.+|++.|.+++ |||||++...+.+.++ ..++
T Consensus         9 m~RY~~i~klGDGTfGsV~la~~~~~~~~VAIK~MK~Kf~s~ee~~nLREvksL~kln~hpniikL~Evi~d~~~-~L~f   87 (538)
T KOG0661|consen    9 MDRYTVIRKLGDGTFGSVYLAKSKETGELVAIKKMKKKFYSWEECMNLREVKSLRKLNPHPNIIKLKEVIRDNDR-ILYF   87 (538)
T ss_pred             HHHHHHHHHhcCCcceeEEEeeecCCCceeeHHHHHhhhccHHHHHHHHHHHHHHhcCCCCcchhhHHHhhccCc-eEee
Confidence            35777889999999999999985 4799999999987765555556689999999998 9999999999866533 8999


Q ss_pred             EEEcCCCCCHHHHhhhcCCCCCCCCHHHHHHHHHHHHHHHhhhhCCCCCCCceeecCCCCCceeecCCCCeEEecccccc
Q 005586          486 IYDFAPKGKLSKYLDQEEGSSNVLDWSTRVSIIIGIAKGIGYLHSSEVNKPAIVHRNLSVEKVLIDQQFNPLIADCGLHK  565 (689)
Q Consensus       486 V~e~~~~gsL~~~L~~~~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~~~ivH~dlk~~NiLl~~~~~~kl~DfGla~  565 (689)
                      |||||+ .+|.++++.++   ..+++.....|+.||..||+|+|.+|     +.|||+||+|||+.....+||+|||+||
T Consensus        88 VfE~Md-~NLYqLmK~R~---r~fse~~irnim~QilqGL~hiHk~G-----fFHRDlKPENiLi~~~~~iKiaDFGLAR  158 (538)
T KOG0661|consen   88 VFEFMD-CNLYQLMKDRN---RLFSESDIRNIMYQILQGLAHIHKHG-----FFHRDLKPENILISGNDVIKIADFGLAR  158 (538)
T ss_pred             eHHhhh-hhHHHHHhhcC---CcCCHHHHHHHHHHHHHHHHHHHhcC-----cccccCChhheEecccceeEeccccccc
Confidence            999995 59999998763   46999999999999999999999998     9999999999999999999999999999


Q ss_pred             cccCCceeeeecCCCCCCCCCccccc-cCCCCCcccchhHHHHHHHHHhCCCCcchhHHHHHhhh---------------
Q 005586          566 LLADDIVFSVLKTSAAMGYLAPEYVT-TGRFTERSDIFAFGVIILQILTGSLVLTSSMRLAAESA---------------  629 (689)
Q Consensus       566 ~~~~~~~~~~~~~~~~~~y~aPE~~~-~~~~~~ksDV~sfGvvl~elltG~~p~~~~~~~~~~~~---------------  629 (689)
                      .......  .+....|.+|+|||++. .+-|+.+.||||+|||++|+.+-++.|.+.....+...               
T Consensus       159 ev~SkpP--YTeYVSTRWYRAPEvLLrs~~Ys~pvD~wA~GcI~aEl~sLrPLFPG~sE~Dqi~KIc~VLGtP~~~~~~e  236 (538)
T KOG0661|consen  159 EVRSKPP--YTEYVSTRWYRAPEVLLRSGYYSSPVDMWAVGCIMAELYSLRPLFPGASEIDQIYKICEVLGTPDKDSWPE  236 (538)
T ss_pred             ccccCCC--cchhhhcccccchHHhhhccccCCchHHHHHHHHHHHHHHhcccCCCCcHHHHHHHHHHHhCCCccccchh
Confidence            8765432  33445678899999975 56789999999999999999999988865432221111               


Q ss_pred             --hhhHhhccccC---C----CCCHHHHHHHHHHHHHhccCCCCCCCCHHHHHHHH
Q 005586          630 --TFENFIDRNLK---G----KFSESEAAKLGKMALVCTHEDPENRPTMEAVIEEL  676 (689)
Q Consensus       630 --~~~~~~~~~~~---~----~~~~~~~~~l~~l~~~Cl~~dp~~RPs~~evl~~L  676 (689)
                        .+...+.-.+.   +    ..-..++.++.+++.+|+++||.+|||++|.+++.
T Consensus       237 g~~La~~mnf~~P~~~~~~l~~L~p~~s~~~~~li~~ll~WDP~kRpTA~~al~~p  292 (538)
T KOG0661|consen  237 GYNLASAMNFRFPQVKPSPLKDLLPNASSEAASLIERLLAWDPDKRPTASQALQHP  292 (538)
T ss_pred             HHHHHHHhccCCCcCCCCChHHhCcccCHHHHHHHHHHhcCCCccCccHHHHhcCc
Confidence              01111111111   0    01123678899999999999999999999999875

>cd05105 PTKc_PDGFR_alpha Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor alpha

Probab=100.00  E-value=1.3e-39  Score=351.73  Aligned_cols=263  Identities=25%  Similarity=0.414  Sum_probs=208.5

Q ss_pred             hccCCcccccccCCcceEEEEEec------CCcEEEEEEecccCCchHHHHHHHHHHHHhccC-CCcceeEeeEEEcCCC
Q 005586          408 TQCFSEVNLLGKGNFSSVYKGTLR------DGTLVAIRSINVTSCKSEEAEFVKGLYLLTSLR-HENIIRLRGFCCSRGR  480 (689)
Q Consensus       408 t~~f~~~~~lg~G~~g~Vy~~~~~------~g~~vavK~l~~~~~~~~~~~f~~e~~~l~~l~-H~niv~l~g~~~~~~~  480 (689)
                      .++|...+.||+|+||.||+|...      .+..||||++.........+.|.+|+++++++. |||||+++++|.  ..
T Consensus        36 ~~~~~~~~~LG~G~fG~Vy~~~~~~~~~~~~~~~vavK~l~~~~~~~~~~~~~~Ei~~l~~l~~HpnIv~l~~~~~--~~  113 (400)
T cd05105          36 RDGLVLGRILGSGAFGKVVEGTAYGLSRSQPVMKVAVKMLKPTARSSEKQALMSELKIMTHLGPHLNIVNLLGACT--KS  113 (400)
T ss_pred             ccceehhheecCCCCceEEEEEEcccCCCCCceEEEEEecCCCCChHHHHHHHHHHHHHHhcCCCCCeeeEEEEEc--cC
Confidence            456778899999999999999853      235799999976554445578999999999996 999999999994  35


Q ss_pred             CeEEEEEEcCCCCCHHHHhhhcCC--------------------------------------------------------
Q 005586          481 GECFLIYDFAPKGKLSKYLDQEEG--------------------------------------------------------  504 (689)
Q Consensus       481 ~~~~lV~e~~~~gsL~~~L~~~~~--------------------------------------------------------  504 (689)
                      ...++||||+++|+|.++|+....                                                        
T Consensus       114 ~~~~lv~Ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  193 (400)
T cd05105         114 GPIYIITEYCFYGDLVNYLHKNRDNFLSRHPEKPKKDLDIFGINPADESTRSYVILSFENKGDYMDMKQADTTQYVPMLE  193 (400)
T ss_pred             CceEEEEEecCCCcHHHHHHHhhhhhhccccccccccccccCCCcccccccchhhhhhcccccccccccccccccchhhh
Confidence            789999999999999999875321                                                        


Q ss_pred             ------------------------------------CCCCCCHHHHHHHHHHHHHHHhhhhCCCCCCCceeecCCCCCce
Q 005586          505 ------------------------------------SSNVLDWSTRVSIIIGIAKGIGYLHSSEVNKPAIVHRNLSVEKV  548 (689)
Q Consensus       505 ------------------------------------~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~~~ivH~dlk~~Ni  548 (689)
                                                          ....++|..++.++.|+++||+|||+.+     |+||||||+||
T Consensus       194 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~-----ivH~dikp~Ni  268 (400)
T cd05105         194 IKEASKYSDIQRSNYDRPASYKGSNDSEVKNLLSDDGSEGLTTLDLLSFTYQVARGMEFLASKN-----CVHRDLAARNV  268 (400)
T ss_pred             hhhhhhhhhcccCcccccccccCcchhhHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHhCC-----eeCCCCChHhE
Confidence                                                0124788999999999999999999987     99999999999


Q ss_pred             eecCCCCeEEecccccccccCCcee-eeecCCCCCCCCCccccccCCCCCcccchhHHHHHHHHHh-CCCCcchhHHHHH
Q 005586          549 LIDQQFNPLIADCGLHKLLADDIVF-SVLKTSAAMGYLAPEYVTTGRFTERSDIFAFGVIILQILT-GSLVLTSSMRLAA  626 (689)
Q Consensus       549 Ll~~~~~~kl~DfGla~~~~~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~ksDV~sfGvvl~ellt-G~~p~~~~~~~~~  626 (689)
                      |+++++.+||+|||+++........ ......++..|+|||.+.+..++.++|||||||++|||++ |+.|+....... 
T Consensus       269 ll~~~~~~kL~DfGla~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwSlGvil~ellt~g~~P~~~~~~~~-  347 (400)
T cd05105         269 LLAQGKIVKICDFGLARDIMHDSNYVSKGSTFLPVKWMAPESIFDNLYTTLSDVWSYGILLWEIFSLGGTPYPGMIVDS-  347 (400)
T ss_pred             EEeCCCEEEEEeCCcceeccccccccccCCcCCCcceEChhhhcCCCCCchhhHHHHHHHHHHHHHCCCCCCcccchhH-
Confidence            9999999999999999866433221 1122335677999999988899999999999999999997 888886432111 


Q ss_pred             hhhhhhHhhccccCCCCCHHHHHHHHHHHHHhccCCCCCCCCHHHHHHHHHhhCC
Q 005586          627 ESATFENFIDRNLKGKFSESEAAKLGKMALVCTHEDPENRPTMEAVIEELTVAAP  681 (689)
Q Consensus       627 ~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~Cl~~dp~~RPs~~evl~~L~~~~p  681 (689)
                         .+...+........+...+..+.+++.+||+.||++||++.+|+++|+...|
T Consensus       348 ---~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~~l~~~l~~l~~  399 (400)
T cd05105         348 ---TFYNKIKSGYRMAKPDHATQEVYDIMVKCWNSEPEKRPSFLHLSDIVESLLP  399 (400)
T ss_pred             ---HHHHHHhcCCCCCCCccCCHHHHHHHHHHCccCHhHCcCHHHHHHHHHHHcC
Confidence               1111112222222344556789999999999999999999999999998765

Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) alpha; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR alpha is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR alpha forms homodimers or heterodimers with PDGFR beta, depending on the nature of the PDGF ligand. PDGF-AA, PDGF-

>cd05052 PTKc_Abl Catalytic domain of the Protein Tyrosine Kinase, Abelson kinase

Probab=100.00  E-value=1.8e-39  Score=332.32  Aligned_cols=254  Identities=22%  Similarity=0.423  Sum_probs=207.0

Q ss_pred             cCCcccccccCCcceEEEEEec-CCcEEEEEEecccCCchHHHHHHHHHHHHhccCCCcceeEeeEEEcCCCCeEEEEEE
Q 005586          410 CFSEVNLLGKGNFSSVYKGTLR-DGTLVAIRSINVTSCKSEEAEFVKGLYLLTSLRHENIIRLRGFCCSRGRGECFLIYD  488 (689)
Q Consensus       410 ~f~~~~~lg~G~~g~Vy~~~~~-~g~~vavK~l~~~~~~~~~~~f~~e~~~l~~l~H~niv~l~g~~~~~~~~~~~lV~e  488 (689)
                      +|...+.||+|+||.||+|..+ .++.||+|++...  .....+|.+|++++.+++|+||+++++++..  ....++|||
T Consensus         7 ~~~~~~~ig~g~~~~v~~~~~~~~~~~~~~K~~~~~--~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~--~~~~~lv~e   82 (263)
T cd05052           7 DITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKED--TMEVEEFLKEAAVMKEIKHPNLVQLLGVCTR--EPPFYIITE   82 (263)
T ss_pred             HeEEeeecCCcccceEEEEEEecCCceEEEEEecCC--chHHHHHHHHHHHHHhCCCCChhheEEEEcC--CCCcEEEEE
Confidence            4666789999999999999976 5889999998754  3345679999999999999999999999854  467899999


Q ss_pred             cCCCCCHHHHhhhcCCCCCCCCHHHHHHHHHHHHHHHhhhhCCCCCCCceeecCCCCCceeecCCCCeEEeccccccccc
Q 005586          489 FAPKGKLSKYLDQEEGSSNVLDWSTRVSIIIGIAKGIGYLHSSEVNKPAIVHRNLSVEKVLIDQQFNPLIADCGLHKLLA  568 (689)
Q Consensus       489 ~~~~gsL~~~L~~~~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~~~ivH~dlk~~NiLl~~~~~~kl~DfGla~~~~  568 (689)
                      |+++++|.+++.....  ..+++..++.++.|+++||+|||+.+     ++||||||+||++++++.+||+|||+++...
T Consensus        83 ~~~~~~L~~~~~~~~~--~~l~~~~~~~~~~ql~~~l~~lH~~~-----i~H~dlkp~nil~~~~~~~kl~df~~~~~~~  155 (263)
T cd05052          83 FMTYGNLLDYLRECNR--QEVNAVVLLYMATQISSAMEYLEKKN-----FIHRDLAARNCLVGENHLVKVADFGLSRLMT  155 (263)
T ss_pred             eCCCCcHHHHHHhCCC--CCCCHHHHHHHHHHHHHHHHHHHhCC-----EeecccCcceEEEcCCCcEEeCCCccccccc
Confidence            9999999999976432  34899999999999999999999987     9999999999999999999999999998776


Q ss_pred             CCceeeeecCCCCCCCCCccccccCCCCCcccchhHHHHHHHHHh-CCCCcchhHHHHHhhhhhhHhhccccCCCCCHHH
Q 005586          569 DDIVFSVLKTSAAMGYLAPEYVTTGRFTERSDIFAFGVIILQILT-GSLVLTSSMRLAAESATFENFIDRNLKGKFSESE  647 (689)
Q Consensus       569 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~ksDV~sfGvvl~ellt-G~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  647 (689)
                      ............+.+|+|||++.+..++.++|||||||++|||+| |..|+.......     ..+.+........+...
T Consensus       156 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~t~g~~p~~~~~~~~-----~~~~~~~~~~~~~~~~~  230 (263)
T cd05052         156 GDTYTAHAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQ-----VYELLEKGYRMERPEGC  230 (263)
T ss_pred             cceeeccCCCCCccccCCHHHhccCCCCchhHHHHHHHHHHHHHcCCCCCCCCCCHHH-----HHHHHHCCCCCCCCCCC
Confidence            543322222334567999999998899999999999999999998 888886432211     11112222233344455


Q ss_pred             HHHHHHHHHHhccCCCCCCCCHHHHHHHHHhh
Q 005586          648 AAKLGKMALVCTHEDPENRPTMEAVIEELTVA  679 (689)
Q Consensus       648 ~~~l~~l~~~Cl~~dp~~RPs~~evl~~L~~~  679 (689)
                      +.++.+++.+||+.+|++||++.|++++|+..
T Consensus       231 ~~~~~~li~~cl~~~p~~Rp~~~~l~~~l~~~  262 (263)
T cd05052         231 PPKVYELMRACWQWNPSDRPSFAEIHQAFETM  262 (263)
T ss_pred             CHHHHHHHHHHccCCcccCCCHHHHHHHHHhh
Confidence            67899999999999999999999999999763

Protein Tyrosine Kinase (PTK) family; Abelson (Abl) kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Abl (or c-Abl) is a ubiquitously-expressed cytoplasmic (or nonreceptor) tyr kinase that contains SH3, SH2, and tyr kinase domains in its N-terminal region, as well as nuclear localization motifs, a putative DNA-binding domain, and F- and G-actin binding domains in its C-terminal tail. It also contains a short autoinhibitory cap region in its N-terminus. Abl is normally inactive and requires phosphorylation and myristoylation for activation. Abl function depends on its subcellular localization. In the cytoplasm, Abl plays

>cd05068 PTKc_Frk_like Catalytic domain of Fyn-related kinase-like Protein Tyrosine Kinases

Probab=100.00  E-value=1.7e-39  Score=332.02  Aligned_cols=255  Identities=24%  Similarity=0.454  Sum_probs=208.4

Q ss_pred             hccCCcccccccCCcceEEEEEecCCcEEEEEEecccCCchHHHHHHHHHHHHhccCCCcceeEeeEEEcCCCCeEEEEE
Q 005586          408 TQCFSEVNLLGKGNFSSVYKGTLRDGTLVAIRSINVTSCKSEEAEFVKGLYLLTSLRHENIIRLRGFCCSRGRGECFLIY  487 (689)
Q Consensus       408 t~~f~~~~~lg~G~~g~Vy~~~~~~g~~vavK~l~~~~~~~~~~~f~~e~~~l~~l~H~niv~l~g~~~~~~~~~~~lV~  487 (689)
                      .++|...+.||+|+||.||+|...+++.||+|.++...  ...++|.+|++++++++||||+++++++..  .+..++||
T Consensus         5 ~~~~~~~~~lg~g~~~~v~~~~~~~~~~v~iK~~~~~~--~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~--~~~~~lv~   80 (261)
T cd05068           5 RTSIQLLRKLGAGQFGEVWEGLWNNTTPVAVKTLKPGT--MDPKDFLAEAQIMKKLRHPKLIQLYAVCTL--EEPIYIVT   80 (261)
T ss_pred             hhheeeEEEecccCCccEEEEEecCCeEEEEEeeCCCc--ccHHHHHHHHHHHHHCCCCCccceeEEEec--CCCeeeee
Confidence            35677889999999999999998888899999987653  235679999999999999999999998844  46789999


Q ss_pred             EcCCCCCHHHHhhhcCCCCCCCCHHHHHHHHHHHHHHHhhhhCCCCCCCceeecCCCCCceeecCCCCeEEecccccccc
Q 005586          488 DFAPKGKLSKYLDQEEGSSNVLDWSTRVSIIIGIAKGIGYLHSSEVNKPAIVHRNLSVEKVLIDQQFNPLIADCGLHKLL  567 (689)
Q Consensus       488 e~~~~gsL~~~L~~~~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~~~ivH~dlk~~NiLl~~~~~~kl~DfGla~~~  567 (689)
                      ||+++++|.+++....  ...++|..+..++.|++.||.|||+.+     |+||||||+||++++++.+||+|||+++..
T Consensus        81 e~~~~~~L~~~~~~~~--~~~~~~~~~~~~~~~i~~~l~~lH~~~-----i~H~dl~p~Nil~~~~~~~~l~dfg~~~~~  153 (261)
T cd05068          81 ELMKYGSLLEYLQGGA--GRALKLPQLIDMAAQVASGMAYLEAQN-----YIHRDLAARNVLVGENNICKVADFGLARVI  153 (261)
T ss_pred             ecccCCcHHHHHhccC--CCCCCHHHHHHHHHHHHHHHHHHHhCC-----eeeccCCcceEEEcCCCCEEECCcceEEEc
Confidence            9999999999997654  235899999999999999999999987     999999999999999999999999999877


Q ss_pred             cCCceeeeecCCCCCCCCCccccccCCCCCcccchhHHHHHHHHHh-CCCCcchhHHHHHhhhhhhHhhccccCCCCCHH
Q 005586          568 ADDIVFSVLKTSAAMGYLAPEYVTTGRFTERSDIFAFGVIILQILT-GSLVLTSSMRLAAESATFENFIDRNLKGKFSES  646 (689)
Q Consensus       568 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~ksDV~sfGvvl~ellt-G~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  646 (689)
                      .............+..|+|||++.+..++.++||||||+++|||+| |+.|+........     ...++.......+..
T Consensus       154 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~~~~-----~~~~~~~~~~~~~~~  228 (261)
T cd05068         154 KEDIYEAREGAKFPIKWTAPEAALYNRFSIKSDVWSFGILLTEIVTYGRMPYPGMTNAEV-----LQQVDQGYRMPCPPG  228 (261)
T ss_pred             cCCcccccCCCcCceeccCccccccCCCCchhhHHHHHHHHHHHHhcCCCCCCCCCHHHH-----HHHHHcCCCCCCCCc
Confidence            5432222222223457999999998899999999999999999999 9988865322111     111222222233445


Q ss_pred             HHHHHHHHHHHhccCCCCCCCCHHHHHHHHHh
Q 005586          647 EAAKLGKMALVCTHEDPENRPTMEAVIEELTV  678 (689)
Q Consensus       647 ~~~~l~~l~~~Cl~~dp~~RPs~~evl~~L~~  678 (689)
                      .+..+.+++.+|++.+|++||++.++++.|++
T Consensus       229 ~~~~~~~li~~~l~~~P~~Rp~~~~l~~~l~~  260 (261)
T cd05068         229 CPKELYDIMLDCWKEDPDDRPTFETLQWKLED  260 (261)
T ss_pred             CCHHHHHHHHHHhhcCcccCCCHHHHHHHHhc
Confidence            56789999999999999999999999999975

Protein Tyrosine Kinase (PTK) family; Human Fyn-related kinase (Frk) and similar proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Frk and Srk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins a

>KOG0663 consensus Protein kinase PITSLRE and related kinases [General function prediction only]

Probab=100.00  E-value=3e-40  Score=321.60  Aligned_cols=260  Identities=18%  Similarity=0.312  Sum_probs=209.0

Q ss_pred             cCCcccccccCCcceEEEEEec-CCcEEEEEEecccCCchH-HHHHHHHHHHHhccCCCcceeEeeEEEcCCCCeEEEEE
Q 005586          410 CFSEVNLLGKGNFSSVYKGTLR-DGTLVAIRSINVTSCKSE-EAEFVKGLYLLTSLRHENIIRLRGFCCSRGRGECFLIY  487 (689)
Q Consensus       410 ~f~~~~~lg~G~~g~Vy~~~~~-~g~~vavK~l~~~~~~~~-~~~f~~e~~~l~~l~H~niv~l~g~~~~~~~~~~~lV~  487 (689)
                      .|+..+.|++|.||.||+|+.+ ++..||+|+++....+.. .-.-.+||.+|.+++|||||.+..+.....-+..|+||
T Consensus        77 efe~lnrI~EGtyGiVYRakdk~t~eIVALKr~kmekek~GFPItsLREIniLl~~~H~NIV~vkEVVvG~~~d~iy~VM  156 (419)
T KOG0663|consen   77 EFEKLNRIEEGTYGVVYRAKDKKTDEIVALKRLKMEKEKEGFPITSLREINILLKARHPNIVEVKEVVVGSNMDKIYIVM  156 (419)
T ss_pred             HHHHHhhcccCcceeEEEeccCCcceeEEeeecccccccCCCcchhHHHHHHHHhcCCCCeeeeEEEEeccccceeeeeH
Confidence            4666789999999999999976 789999999987653322 24568999999999999999999999888888999999


Q ss_pred             EcCCCCCHHHHhhhcCCCCCCCCHHHHHHHHHHHHHHHhhhhCCCCCCCceeecCCCCCceeecCCCCeEEecccccccc
Q 005586          488 DFAPKGKLSKYLDQEEGSSNVLDWSTRVSIIIGIAKGIGYLHSSEVNKPAIVHRNLSVEKVLIDQQFNPLIADCGLHKLL  567 (689)
Q Consensus       488 e~~~~gsL~~~L~~~~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~~~ivH~dlk~~NiLl~~~~~~kl~DfGla~~~  567 (689)
                      |||+. ||...++...   +++...++..++.|+++|++|||...     |+|||||++|+|+++.|.+||+|||+||.+
T Consensus       157 e~~Eh-DLksl~d~m~---q~F~~~evK~L~~QlL~glk~lH~~w-----ilHRDLK~SNLLm~~~G~lKiaDFGLAR~y  227 (419)
T KOG0663|consen  157 EYVEH-DLKSLMETMK---QPFLPGEVKTLMLQLLRGLKHLHDNW-----ILHRDLKTSNLLLSHKGILKIADFGLAREY  227 (419)
T ss_pred             HHHHh-hHHHHHHhcc---CCCchHHHHHHHHHHHHHHHHHhhce-----eEecccchhheeeccCCcEEecccchhhhh
Confidence            99975 9999998754   45888999999999999999999988     999999999999999999999999999988


Q ss_pred             cCCceeeeecCCCCCCCCCccccccC-CCCCcccchhHHHHHHHHHhCCCCcchhHHHHHhhhhhhHh------hcc---
Q 005586          568 ADDIVFSVLKTSAAMGYLAPEYVTTG-RFTERSDIFAFGVIILQILTGSLVLTSSMRLAAESATFENF------IDR---  637 (689)
Q Consensus       568 ~~~~~~~~~~~~~~~~y~aPE~~~~~-~~~~ksDV~sfGvvl~elltG~~p~~~~~~~~~~~~~~~~~------~~~---  637 (689)
                      .... .+.+....|.+|+|||.+.+. .|++..|+||+|||+.||+++++.|.+.....+...++..+      +-+   
T Consensus       228 gsp~-k~~T~lVVTLWYRaPELLLG~~tyst~iDMWSvGCI~aE~l~~kPlf~G~sE~dQl~~If~llGtPte~iwpg~~  306 (419)
T KOG0663|consen  228 GSPL-KPYTPLVVTLWYRAPELLLGAKTYSTAVDMWSVGCIFAELLTQKPLFPGKSEIDQLDKIFKLLGTPSEAIWPGYS  306 (419)
T ss_pred             cCCc-ccCcceEEEeeecCHHHhcCCcccCcchhhhhHHHHHHHHHhcCCCCCCCchHHHHHHHHHHhCCCccccCCCcc
Confidence            7642 234455678899999998775 58999999999999999999998886554333322222111      000   


Q ss_pred             ----------------ccCCCCCHH-HHHHHHHHHHHhccCCCCCCCCHHHHHHHHHhh
Q 005586          638 ----------------NLKGKFSES-EAAKLGKMALVCTHEDPENRPTMEAVIEELTVA  679 (689)
Q Consensus       638 ----------------~~~~~~~~~-~~~~l~~l~~~Cl~~dp~~RPs~~evl~~L~~~  679 (689)
                                      .++..+... .++.-.+++...+..||++|-|+.|.+++=+..
T Consensus       307 ~lp~~k~~~f~~~pyn~lr~kF~~~~lse~g~~Lln~llt~dP~kR~tA~~~L~h~~F~  365 (419)
T KOG0663|consen  307 ELPAVKKMTFSEHPYNNLRKKFGALSLSEQGFDLLNKLLTYDPGKRITAEDGLKHEYFR  365 (419)
T ss_pred             ccchhhccccCCCCchhhhhhccccccchhHHHHHHHHhccCccccccHHHhhcccccc
Confidence                            011111111 346778899999999999999999999886554

>cd05054 PTKc_VEGFR Catalytic domain of the Protein Tyrosine Kinases, Vascular Endothelial Growth Factor Receptors

Probab=100.00  E-value=1.3e-39  Score=345.27  Aligned_cols=263  Identities=23%  Similarity=0.405  Sum_probs=207.4

Q ss_pred             ccCCcccccccCCcceEEEEEec------CCcEEEEEEecccCCchHHHHHHHHHHHHhcc-CCCcceeEeeEEEcCCCC
Q 005586          409 QCFSEVNLLGKGNFSSVYKGTLR------DGTLVAIRSINVTSCKSEEAEFVKGLYLLTSL-RHENIIRLRGFCCSRGRG  481 (689)
Q Consensus       409 ~~f~~~~~lg~G~~g~Vy~~~~~------~g~~vavK~l~~~~~~~~~~~f~~e~~~l~~l-~H~niv~l~g~~~~~~~~  481 (689)
                      ++|...+.||+|+||.||+|...      +++.||+|+++..........+.+|+.++.++ +|+||++++++|... ..
T Consensus         7 ~~~~i~~~lG~G~fg~Vy~a~~~~~~~~~~~~~va~K~~~~~~~~~~~~~~~~E~~~~~~l~~h~niv~~~~~~~~~-~~   85 (337)
T cd05054           7 DRLKLGKPLGRGAFGKVIQASAFGIEKSASCRTVAVKMLKEGATASEYKALMTELKILIHIGHHLNVVNLLGACTKP-GG   85 (337)
T ss_pred             HHhhhhcccccCcCceEEeccccccccccccceeeeeeccCCCCHHHHHHHHHHHHHHHhhccCcchhheeeeEecC-CC
Confidence            46778899999999999999742      35789999997654344456788999999999 899999999988643 45


Q ss_pred             eEEEEEEcCCCCCHHHHhhhcCCC--------------------------------------------------------
Q 005586          482 ECFLIYDFAPKGKLSKYLDQEEGS--------------------------------------------------------  505 (689)
Q Consensus       482 ~~~lV~e~~~~gsL~~~L~~~~~~--------------------------------------------------------  505 (689)
                      ..+++|||+++|+|.+++......                                                        
T Consensus        86 ~~~~v~ey~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  165 (337)
T cd05054          86 PLMVIVEYCKFGNLSNYLRSKRECFSPYRNKSTRKREMKQKEGKKQRLDSVSSSQSSASSGFIEDKSLSDVEEDEEGDEL  165 (337)
T ss_pred             CEEEEEecCCCCCHHHHHHhccccccccccccccccccccccccccccccCCccccccccccccCcchhhcccchhhhHH
Confidence            788999999999999998643210                                                        


Q ss_pred             -CCCCCHHHHHHHHHHHHHHHhhhhCCCCCCCceeecCCCCCceeecCCCCeEEecccccccccCCcee-eeecCCCCCC
Q 005586          506 -SNVLDWSTRVSIIIGIAKGIGYLHSSEVNKPAIVHRNLSVEKVLIDQQFNPLIADCGLHKLLADDIVF-SVLKTSAAMG  583 (689)
Q Consensus       506 -~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~~~ivH~dlk~~NiLl~~~~~~kl~DfGla~~~~~~~~~-~~~~~~~~~~  583 (689)
                       ...++|..+.+++.||+.||+|||+.+     |+||||||+|||+++++.+||+|||+++.+...... ......++..
T Consensus       166 ~~~~l~~~~~~~~~~qi~~aL~~lH~~~-----ivHrDikp~Nill~~~~~vkL~DfG~a~~~~~~~~~~~~~~~~~~~~  240 (337)
T cd05054         166 YKEPLTLEDLISYSFQVARGMEFLASRK-----CIHRDLAARNILLSENNVVKICDFGLARDIYKDPDYVRKGDARLPLK  240 (337)
T ss_pred             hhcCCCHHHHHHHHHHHHHHHHHHHhCC-----eecCCCCcceEEEeCCCcEEEeccccchhcccCcchhhccCCCCCcc
Confidence             125899999999999999999999987     999999999999999999999999999876433211 1122334567


Q ss_pred             CCCccccccCCCCCcccchhHHHHHHHHHh-CCCCcchhHHHHHhhhhhhHhhccccCCCCCHHHHHHHHHHHHHhccCC
Q 005586          584 YLAPEYVTTGRFTERSDIFAFGVIILQILT-GSLVLTSSMRLAAESATFENFIDRNLKGKFSESEAAKLGKMALVCTHED  662 (689)
Q Consensus       584 y~aPE~~~~~~~~~ksDV~sfGvvl~ellt-G~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~Cl~~d  662 (689)
                      |+|||++.+..++.++|||||||++|||++ |+.||......    ..+...+........+.....++.+++.+||+.+
T Consensus       241 y~aPE~~~~~~~~~~~Di~SlGv~l~el~t~g~~p~~~~~~~----~~~~~~~~~~~~~~~~~~~~~~~~~l~~~cl~~~  316 (337)
T cd05054         241 WMAPESIFDKVYTTQSDVWSFGVLLWEIFSLGASPYPGVQID----EEFCRRLKEGTRMRAPEYATPEIYSIMLDCWHNN  316 (337)
T ss_pred             ccCcHHhcCCCCCccccHHHHHHHHHHHHHcCCCCCCCCCcc----HHHHHHHhccCCCCCCccCCHHHHHHHHHHccCC
Confidence            999999999999999999999999999998 99998542111    1111222222222233445667999999999999


Q ss_pred             CCCCCCHHHHHHHHHhhCC
Q 005586          663 PENRPTMEAVIEELTVAAP  681 (689)
Q Consensus       663 p~~RPs~~evl~~L~~~~p  681 (689)
                      |++||++.||+++|+.+.+
T Consensus       317 p~~RPs~~ell~~l~~~~~  335 (337)
T cd05054         317 PEDRPTFSELVEILGDLLQ  335 (337)
T ss_pred             hhhCcCHHHHHHHHHHHHh
Confidence            9999999999999988654

Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor (VEGFR) subfamily; catalytic (c) domain. The VEGFR subfamily consists of VEGFR1 (Flt1), VEGFR2 (Flk1), VEGFR3 (Flt4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to recepto

>KOG0592 consensus 3-phosphoinositide-dependent protein kinase (PDK1) [Signal transduction mechanisms]

Probab=100.00  E-value=3.8e-40  Score=339.95  Aligned_cols=253  Identities=22%  Similarity=0.335  Sum_probs=208.6

Q ss_pred             HhccCCcccccccCCcceEEEEEec-CCcEEEEEEecccCC--chHHHHHHHHHHHHhcc-CCCcceeEeeEEEcCCCCe
Q 005586          407 ATQCFSEVNLLGKGNFSSVYKGTLR-DGTLVAIRSINVTSC--KSEEAEFVKGLYLLTSL-RHENIIRLRGFCCSRGRGE  482 (689)
Q Consensus       407 at~~f~~~~~lg~G~~g~Vy~~~~~-~g~~vavK~l~~~~~--~~~~~~f~~e~~~l~~l-~H~niv~l~g~~~~~~~~~  482 (689)
                      .-++|...+.||+|+|++|++|+.+ .+++||||++.+.-.  +...+-...|-.+|.+| .||.|++|+--|  .+...
T Consensus        71 ~~~DF~Fg~~lGeGSYStV~~A~~~~t~keYAiKVl~K~~Iike~KvkYV~~Ek~~l~~L~~hPgivkLy~TF--QD~~s  148 (604)
T KOG0592|consen   71 TPNDFKFGKILGEGSYSTVVLAREKATGKEYAIKVLDKRYIIKEKKVKYVTREKEALTQLSGHPGIVKLYFTF--QDEES  148 (604)
T ss_pred             ChhhcchhheeccccceeEEEeeecCCCceeeHhhhhHHHHHhhcccchhhHHHHHHHHhhCCCCeEEEEEEe--ecccc
Confidence            3467888999999999999999865 699999999976542  22334566788889999 899999998777  44578


Q ss_pred             EEEEEEcCCCCCHHHHhhhcCCCCCCCCHHHHHHHHHHHHHHHhhhhCCCCCCCceeecCCCCCceeecCCCCeEEeccc
Q 005586          483 CFLIYDFAPKGKLSKYLDQEEGSSNVLDWSTRVSIIIGIAKGIGYLHSSEVNKPAIVHRNLSVEKVLIDQQFNPLIADCG  562 (689)
Q Consensus       483 ~~lV~e~~~~gsL~~~L~~~~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~~~ivH~dlk~~NiLl~~~~~~kl~DfG  562 (689)
                      +|+|+||.+||+|.++++..+    .+++.....+|.+|+.||+|||+.|     ||||||||+|||||+|+++||+|||
T Consensus       149 LYFvLe~A~nGdll~~i~K~G----sfde~caR~YAAeIldAleylH~~G-----IIHRDlKPENILLd~dmhikITDFG  219 (604)
T KOG0592|consen  149 LYFVLEYAPNGDLLDLIKKYG----SFDETCARFYAAEILDALEYLHSNG-----IIHRDLKPENILLDKDGHIKITDFG  219 (604)
T ss_pred             eEEEEEecCCCcHHHHHHHhC----cchHHHHHHHHHHHHHHHHHHHhcC-----ceeccCChhheeEcCCCcEEEeecc
Confidence            999999999999999999875    3899999999999999999999998     9999999999999999999999999


Q ss_pred             ccccccCCcee----------ee--ecCCCCCCCCCccccccCCCCCcccchhHHHHHHHHHhCCCCcchhHHHHHhhhh
Q 005586          563 LHKLLADDIVF----------SV--LKTSAAMGYLAPEYVTTGRFTERSDIFAFGVIILQILTGSLVLTSSMRLAAESAT  630 (689)
Q Consensus       563 la~~~~~~~~~----------~~--~~~~~~~~y~aPE~~~~~~~~~ksDV~sfGvvl~elltG~~p~~~~~~~~~~~~~  630 (689)
                      -|+.+.+....          ..  ....||..|.+||++.....+..+|+|+|||+||.|+.|++||......    ..
T Consensus       220 sAK~l~~~~~~~~~~~~~~~a~s~~~SFVGTAeYVSPElL~~~~~~~~sDiWAlGCilyQmlaG~PPFra~Ney----li  295 (604)
T KOG0592|consen  220 SAKILSPSQKSQENPVDPNQASSRRSSFVGTAEYVSPELLNDSPAGPSSDLWALGCILYQMLAGQPPFRAANEY----LI  295 (604)
T ss_pred             ccccCChhhccccCccCcccccCcccceeeeecccCHHHhcCCCCCcccchHHHHHHHHHHhcCCCCCccccHH----HH
Confidence            99988643211          11  2245888999999999999999999999999999999999999765443    33


Q ss_pred             hhHhhccccCCCCCHHHHHHHHHHHHHhccCCCCCCCCHHHHHHHH
Q 005586          631 FENFIDRNLKGKFSESEAAKLGKMALVCTHEDPENRPTMEAVIEEL  676 (689)
Q Consensus       631 ~~~~~~~~~~~~~~~~~~~~l~~l~~~Cl~~dp~~RPs~~evl~~L  676 (689)
                      +.++++-..  .+++.-++.+.+|+.+-+..||.+|++.+|+-+|.
T Consensus       296 FqkI~~l~y--~fp~~fp~~a~dLv~KLLv~dp~~Rlt~~qIk~Hp  339 (604)
T KOG0592|consen  296 FQKIQALDY--EFPEGFPEDARDLIKKLLVRDPSDRLTSQQIKAHP  339 (604)
T ss_pred             HHHHHHhcc--cCCCCCCHHHHHHHHHHHccCccccccHHHHhhCc
Confidence            444443322  23444456788899999999999999999997664

>cd05113 PTKc_Btk_Bmx Catalytic domain of the Protein Tyrosine Kinases, Bruton's tyrosine kinase and Bone marrow kinase on the X chromosome

Probab=100.00  E-value=2.8e-39  Score=329.56  Aligned_cols=251  Identities=25%  Similarity=0.449  Sum_probs=203.5

Q ss_pred             cCCcccccccCCcceEEEEEecCCcEEEEEEecccCCchHHHHHHHHHHHHhccCCCcceeEeeEEEcCCCCeEEEEEEc
Q 005586          410 CFSEVNLLGKGNFSSVYKGTLRDGTLVAIRSINVTSCKSEEAEFVKGLYLLTSLRHENIIRLRGFCCSRGRGECFLIYDF  489 (689)
Q Consensus       410 ~f~~~~~lg~G~~g~Vy~~~~~~g~~vavK~l~~~~~~~~~~~f~~e~~~l~~l~H~niv~l~g~~~~~~~~~~~lV~e~  489 (689)
                      +|...+.||+|+||.||+|...++..+|+|.+....  ....+|.+|+.++.+++||||+++++++..  .+..++||||
T Consensus         5 ~~~~~~~lg~G~~~~vy~~~~~~~~~~aik~~~~~~--~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~--~~~~~lv~e~   80 (256)
T cd05113           5 DLTFLKELGTGQFGVVKYGKWRGQYDVAIKMIKEGS--MSEDEFIEEAKVMMKLSHEKLVQLYGVCTK--QRPIYIVTEY   80 (256)
T ss_pred             HeEEeeEecCcccceEEEEEecCCCcEEEEEcCCCc--ccHHHHHHHHHHHhcCCCCCeeeEEEEEcc--CCCcEEEEEc
Confidence            466778999999999999998877789999987543  234679999999999999999999999843  4678999999


Q ss_pred             CCCCCHHHHhhhcCCCCCCCCHHHHHHHHHHHHHHHhhhhCCCCCCCceeecCCCCCceeecCCCCeEEecccccccccC
Q 005586          490 APKGKLSKYLDQEEGSSNVLDWSTRVSIIIGIAKGIGYLHSSEVNKPAIVHRNLSVEKVLIDQQFNPLIADCGLHKLLAD  569 (689)
Q Consensus       490 ~~~gsL~~~L~~~~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~~~ivH~dlk~~NiLl~~~~~~kl~DfGla~~~~~  569 (689)
                      +++|+|.+++.....   .++|..++.++.|++.||+|||+.+     ++|+||||+||++++++.+||+|||.++....
T Consensus        81 ~~~~~l~~~i~~~~~---~~~~~~~~~~~~~i~~~l~~lH~~~-----i~H~dl~p~nili~~~~~~kl~d~g~~~~~~~  152 (256)
T cd05113          81 MSNGCLLNYLREHGK---RFQPSQLLEMCKDVCEGMAYLESKQ-----FIHRDLAARNCLVDDQGCVKVSDFGLSRYVLD  152 (256)
T ss_pred             CCCCcHHHHHHhcCC---CCCHHHHHHHHHHHHHHHHHHHhCC-----eeccccCcceEEEcCCCCEEECCCccceecCC
Confidence            999999999976432   4899999999999999999999987     99999999999999999999999999987654


Q ss_pred             CceeeeecCCCCCCCCCccccccCCCCCcccchhHHHHHHHHHh-CCCCcchhHHHHHhhhhhhHhhccccCCCCCHHHH
Q 005586          570 DIVFSVLKTSAAMGYLAPEYVTTGRFTERSDIFAFGVIILQILT-GSLVLTSSMRLAAESATFENFIDRNLKGKFSESEA  648 (689)
Q Consensus       570 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~ksDV~sfGvvl~ellt-G~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  648 (689)
                      ..........++..|+|||...+..++.++|||||||++|||+| |+.|+........    ...+. ...+...+...+
T Consensus       153 ~~~~~~~~~~~~~~y~~pe~~~~~~~~~~~Di~slG~~l~~l~~~g~~p~~~~~~~~~----~~~~~-~~~~~~~~~~~~  227 (256)
T cd05113         153 DEYTSSVGSKFPVRWSPPEVLLYSKFSSKSDVWAFGVLMWEVYSLGKMPYERFNNSET----VEKVS-QGLRLYRPHLAS  227 (256)
T ss_pred             CceeecCCCccChhhCCHHHHhcCcccchhHHHHHHHHHHHHhcCCCCCcCcCCHHHH----HHHHh-cCCCCCCCCCCC
Confidence            43323333345667999999988889999999999999999999 9999854322111    11111 111112233346


Q ss_pred             HHHHHHHHHhccCCCCCCCCHHHHHHHHH
Q 005586          649 AKLGKMALVCTHEDPENRPTMEAVIEELT  677 (689)
Q Consensus       649 ~~l~~l~~~Cl~~dp~~RPs~~evl~~L~  677 (689)
                      ..+.+++.+||+.+|++||++.++++.|+
T Consensus       228 ~~~~~li~~cl~~~p~~Rp~~~~ll~~~~  256 (256)
T cd05113         228 EKVYAIMYSCWHEKAEERPTFQQLLSSIE  256 (256)
T ss_pred             HHHHHHHHHHcCCCcccCCCHHHHHHhhC
Confidence            78999999999999999999999998874

Protein Tyrosine Kinase (PTK) family; Bruton's tyrosine kinase (Btk) and Bone marrow kinase on the X chromosome (Bmx); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Btk and Bmx (also named Etk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds

>cd05062 PTKc_IGF-1R Catalytic domain of the Protein Tyrosine Kinase, Insulin-like Growth Factor-1 Receptor

Probab=100.00  E-value=2.8e-39  Score=333.58  Aligned_cols=260  Identities=22%  Similarity=0.387  Sum_probs=205.9

Q ss_pred             HhccCCcccccccCCcceEEEEEec------CCcEEEEEEecccCCchHHHHHHHHHHHHhccCCCcceeEeeEEEcCCC
Q 005586          407 ATQCFSEVNLLGKGNFSSVYKGTLR------DGTLVAIRSINVTSCKSEEAEFVKGLYLLTSLRHENIIRLRGFCCSRGR  480 (689)
Q Consensus       407 at~~f~~~~~lg~G~~g~Vy~~~~~------~g~~vavK~l~~~~~~~~~~~f~~e~~~l~~l~H~niv~l~g~~~~~~~  480 (689)
                      ++++|+..+.||+|+||.||+|..+      .+..||+|++..........+|.+|+.++++++||||+++++++.  ..
T Consensus         4 ~~~~~~~~~~ig~G~~g~v~~~~~~~~~~~~~~~~~aik~~~~~~~~~~~~~~~~e~~~l~~l~~~~iv~~~~~~~--~~   81 (277)
T cd05062           4 AREKITMSRELGQGSFGMVYEGIAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKEFNCHHVVRLLGVVS--QG   81 (277)
T ss_pred             cHHHceeeeeeccccCCeEEEEEeccCCCCCceeEEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCeeeEEEEEc--CC
Confidence            4567888999999999999999753      356799999875543445567999999999999999999999984  35


Q ss_pred             CeEEEEEEcCCCCCHHHHhhhcCCC------CCCCCHHHHHHHHHHHHHHHhhhhCCCCCCCceeecCCCCCceeecCCC
Q 005586          481 GECFLIYDFAPKGKLSKYLDQEEGS------SNVLDWSTRVSIIIGIAKGIGYLHSSEVNKPAIVHRNLSVEKVLIDQQF  554 (689)
Q Consensus       481 ~~~~lV~e~~~~gsL~~~L~~~~~~------~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~~~ivH~dlk~~NiLl~~~~  554 (689)
                      ...++||||+++|+|.++++.....      ...++|..++.++.|++.||+|||+.+     ++||||||+||++++++
T Consensus        82 ~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~-----~vH~dlkp~Nil~~~~~  156 (277)
T cd05062          82 QPTLVIMELMTRGDLKSYLRSLRPEMENNPVQAPPSLKKMIQMAGEIADGMAYLNANK-----FVHRDLAARNCMVAEDF  156 (277)
T ss_pred             CCeEEEEecCCCCCHHHHHHHcCccccccccccCCCHHHHHHHHHHHHHHHHHHHHCC-----cccCCcchheEEEcCCC
Confidence            6789999999999999999753321      234788999999999999999999877     99999999999999999


Q ss_pred             CeEEecccccccccCCceee-eecCCCCCCCCCccccccCCCCCcccchhHHHHHHHHHh-CCCCcchhHHHHHhhhhhh
Q 005586          555 NPLIADCGLHKLLADDIVFS-VLKTSAAMGYLAPEYVTTGRFTERSDIFAFGVIILQILT-GSLVLTSSMRLAAESATFE  632 (689)
Q Consensus       555 ~~kl~DfGla~~~~~~~~~~-~~~~~~~~~y~aPE~~~~~~~~~ksDV~sfGvvl~ellt-G~~p~~~~~~~~~~~~~~~  632 (689)
                      .+||+|||+++......... .....++..|+|||++.+..++.++|||||||++|||++ |..|+........    ..
T Consensus       157 ~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~~~~p~~~~~~~~~----~~  232 (277)
T cd05062         157 TVKIGDFGMTRDIYETDYYRKGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIATLAEQPYQGMSNEQV----LR  232 (277)
T ss_pred             CEEECCCCCccccCCcceeecCCCCccCHhhcChhHhhcCCcCchhHHHHHHHHHHHHHcCCCCCCCCCCHHHH----HH
Confidence            99999999998664432211 112234667999999998889999999999999999999 6888754322111    11


Q ss_pred             HhhccccCCCCCHHHHHHHHHHHHHhccCCCCCCCCHHHHHHHHHh
Q 005586          633 NFIDRNLKGKFSESEAAKLGKMALVCTHEDPENRPTMEAVIEELTV  678 (689)
Q Consensus       633 ~~~~~~~~~~~~~~~~~~l~~l~~~Cl~~dp~~RPs~~evl~~L~~  678 (689)
                      .... ......+...+..+.+++.+|++.+|++||++.|++++|++
T Consensus       233 ~~~~-~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~e~l~~l~~  277 (277)
T cd05062         233 FVME-GGLLDKPDNCPDMLFELMRMCWQYNPKMRPSFLEIISSIKE  277 (277)
T ss_pred             HHHc-CCcCCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHhhC
Confidence            1111 11112334456689999999999999999999999999863

Protein Tyrosine Kinase (PTK) family; Insulin-like Growth Factor-1 Receptor (IGF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. IGF-1R is a receptor tyr kinases (RTK) that is composed of two alphabeta heterodimers. Binding of the ligand (IGF-1 or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, which stimulates downstream kinase activities and biological function. IGF-1R signaling is important in the differentiation, growth, and survival of normal cells. In cancer cells, wh

>cd05080 PTKc_Tyk2_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2

Probab=100.00  E-value=4.2e-39  Score=333.33  Aligned_cols=259  Identities=24%  Similarity=0.424  Sum_probs=205.7

Q ss_pred             CcccccccCCcceEEEEEe-----cCCcEEEEEEecccCCchHHHHHHHHHHHHhccCCCcceeEeeEEEcCCCCeEEEE
Q 005586          412 SEVNLLGKGNFSSVYKGTL-----RDGTLVAIRSINVTSCKSEEAEFVKGLYLLTSLRHENIIRLRGFCCSRGRGECFLI  486 (689)
Q Consensus       412 ~~~~~lg~G~~g~Vy~~~~-----~~g~~vavK~l~~~~~~~~~~~f~~e~~~l~~l~H~niv~l~g~~~~~~~~~~~lV  486 (689)
                      ...+.||+|+||.||++..     .++..||+|.+...........|.+|++++++++||||+++++++........++|
T Consensus         7 ~~~~~lg~g~~g~v~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~lv   86 (283)
T cd05080           7 KKIRVLGEGHFGKVSLYCYDPANDGTGEMVAVKTLKRECGQQNTSGWKKEINILKTLYHENIVKYKGCCSEQGGKGLQLI   86 (283)
T ss_pred             eeceecccCCCcEEEEeeEccccCCCCceEEEEEeccccChHHHHHHHHHHHHHHhCCCCCEeeEEEEEecCCCceEEEE
Confidence            6778999999999988653     36789999999765433455788999999999999999999999876555678999


Q ss_pred             EEcCCCCCHHHHhhhcCCCCCCCCHHHHHHHHHHHHHHHhhhhCCCCCCCceeecCCCCCceeecCCCCeEEeccccccc
Q 005586          487 YDFAPKGKLSKYLDQEEGSSNVLDWSTRVSIIIGIAKGIGYLHSSEVNKPAIVHRNLSVEKVLIDQQFNPLIADCGLHKL  566 (689)
Q Consensus       487 ~e~~~~gsL~~~L~~~~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~~~ivH~dlk~~NiLl~~~~~~kl~DfGla~~  566 (689)
                      |||+++|+|.+++...     .++|..+..++.|++.||+|||+.+     |+||||||+||++++++.+||+|||+++.
T Consensus        87 ~e~~~~~~l~~~~~~~-----~l~~~~~~~i~~~l~~~l~~lH~~~-----i~H~dlkp~Nili~~~~~~~l~dfg~~~~  156 (283)
T cd05080          87 MEYVPLGSLRDYLPKH-----KLNLAQLLLFAQQICEGMAYLHSQH-----YIHRDLAARNVLLDNDRLVKIGDFGLAKA  156 (283)
T ss_pred             ecCCCCCCHHHHHHHc-----CCCHHHHHHHHHHHHHHHHHHHHCC-----eeccccChheEEEcCCCcEEEeecccccc
Confidence            9999999999999753     3899999999999999999999987     99999999999999999999999999987


Q ss_pred             ccCCceee--eecCCCCCCCCCccccccCCCCCcccchhHHHHHHHHHhCCCCcchhHHHHH----------hhhhhhHh
Q 005586          567 LADDIVFS--VLKTSAAMGYLAPEYVTTGRFTERSDIFAFGVIILQILTGSLVLTSSMRLAA----------ESATFENF  634 (689)
Q Consensus       567 ~~~~~~~~--~~~~~~~~~y~aPE~~~~~~~~~ksDV~sfGvvl~elltG~~p~~~~~~~~~----------~~~~~~~~  634 (689)
                      ........  .....++..|+|||.+.+..++.++||||||+++|||+||+.|+........          ......+.
T Consensus       157 ~~~~~~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~Di~slG~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~  236 (283)
T cd05080         157 VPEGHEYYRVREDGDSPVFWYAVECLKENKFSYASDVWSFGVTLYELLTHCDSKQSPPKKFEEMIGPKQGQMTVVRLIEL  236 (283)
T ss_pred             cCCcchhhccCCCCCCCceeeCHhHhcccCCCcccccHHHHHHHHHHHhCCCCCCCCcchhhhhhcccccccchhhhhhh
Confidence            65432111  1112344569999999888899999999999999999999999753211100          00111222


Q ss_pred             hccccCCCCCHHHHHHHHHHHHHhccCCCCCCCCHHHHHHHHHhhC
Q 005586          635 IDRNLKGKFSESEAAKLGKMALVCTHEDPENRPTMEAVIEELTVAA  680 (689)
Q Consensus       635 ~~~~~~~~~~~~~~~~l~~l~~~Cl~~dp~~RPs~~evl~~L~~~~  680 (689)
                      ++.......+...+.++.+++..||+.+|++||++++|++.|+.+.
T Consensus       237 ~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rps~~~i~~~l~~~~  282 (283)
T cd05080         237 LERGMRLPCPKNCPQEVYILMKNCWETEAKFRPTFRSLIPILKEMH  282 (283)
T ss_pred             hhcCCCCCCCCCCCHHHHHHHHHHhccChhhCCCHHHHHHHHHHhh
Confidence            2222222233445678999999999999999999999999998763

Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of sign

>KOG0597 consensus Serine-threonine protein kinase FUSED [General function prediction only]

Probab=100.00  E-value=5.3e-40  Score=338.60  Aligned_cols=249  Identities=20%  Similarity=0.350  Sum_probs=210.6

Q ss_pred             ccCCcccccccCCcceEEEEEec-CCcEEEEEEecccCC-chHHHHHHHHHHHHhccCCCcceeEeeEEEcCCCCeEEEE
Q 005586          409 QCFSEVNLLGKGNFSSVYKGTLR-DGTLVAIRSINVTSC-KSEEAEFVKGLYLLTSLRHENIIRLRGFCCSRGRGECFLI  486 (689)
Q Consensus       409 ~~f~~~~~lg~G~~g~Vy~~~~~-~g~~vavK~l~~~~~-~~~~~~f~~e~~~l~~l~H~niv~l~g~~~~~~~~~~~lV  486 (689)
                      ++|...+.||+|.||.||||+-+ +.+.||+|.+.+... +++.+...+|++++++++|||||.++++|  +...+.++|
T Consensus         2 e~yhv~e~iG~Gsfg~VYKgrrK~t~~~vAik~i~K~gr~~k~l~~l~~ev~i~r~lkHpniv~m~esf--Et~~~~~vV   79 (808)
T KOG0597|consen    2 EQYHVYEMIGEGSFGRVYKGRRKYTIQVVAIKFIDKSGRNEKELKNLRQEVRILRSLKHPNIVEMLESF--ETSAHLWVV   79 (808)
T ss_pred             cchhHHHHhcCCccceeeecccccceeEEEEEEehhcCCchHHHHHHHHHHHHHHhcCCcchhhHHHhh--cccceEEEE
Confidence            46777889999999999999876 689999999977653 44567899999999999999999999998  566899999


Q ss_pred             EEcCCCCCHHHHhhhcCCCCCCCCHHHHHHHHHHHHHHHhhhhCCCCCCCceeecCCCCCceeecCCCCeEEeccccccc
Q 005586          487 YDFAPKGKLSKYLDQEEGSSNVLDWSTRVSIIIGIAKGIGYLHSSEVNKPAIVHRNLSVEKVLIDQQFNPLIADCGLHKL  566 (689)
Q Consensus       487 ~e~~~~gsL~~~L~~~~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~~~ivH~dlk~~NiLl~~~~~~kl~DfGla~~  566 (689)
                      .||+.+ +|..+|....    .+++..+..|+.++..||.|||+.+     |+|||+||.|||+++.+.+|++|||+||.
T Consensus        80 te~a~g-~L~~il~~d~----~lpEe~v~~~a~~LVsaL~yLhs~r-----ilhrd~kPqniLl~~~~~~KlcdFg~Ar~  149 (808)
T KOG0597|consen   80 TEYAVG-DLFTILEQDG----KLPEEQVRAIAYDLVSALYYLHSNR-----ILHRDMKPQNILLEKGGTLKLCDFGLARA  149 (808)
T ss_pred             ehhhhh-hHHHHHHhcc----CCCHHHHHHHHHHHHHHHHHHHhcC-----cccccCCcceeeecCCCceeechhhhhhh
Confidence            999976 9999998764    3999999999999999999999987     99999999999999999999999999998


Q ss_pred             ccCCceeeeecCCCCCCCCCccccccCCCCCcccchhHHHHHHHHHhCCCCcchhHHHHHhhhhhhHhhccccCCCCCHH
Q 005586          567 LADDIVFSVLKTSAAMGYLAPEYVTTGRFTERSDIFAFGVIILQILTGSLVLTSSMRLAAESATFENFIDRNLKGKFSES  646 (689)
Q Consensus       567 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~ksDV~sfGvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  646 (689)
                      +..+.. -.....||+-|||||.+.++.|+..+|.||+||++||+++|++||....-...    .+.+....  ...+..
T Consensus       150 m~~~t~-vltsikGtPlYmAPElv~e~pyd~~sDlWslGcilYE~~~G~PPF~a~si~~L----v~~I~~d~--v~~p~~  222 (808)
T KOG0597|consen  150 MSTNTS-VLTSIKGTPLYMAPELVEEQPYDHTSDLWSLGCILYELYVGQPPFYARSITQL----VKSILKDP--VKPPST  222 (808)
T ss_pred             cccCce-eeeeccCcccccCHHHHcCCCccchhhHHHHHHHHHHHhcCCCCchHHHHHHH----HHHHhcCC--CCCccc
Confidence            876543 33456799999999999999999999999999999999999999965321111    11111111  123456


Q ss_pred             HHHHHHHHHHHhccCCCCCCCCHHHHHHHH
Q 005586          647 EAAKLGKMALVCTHEDPENRPTMEAVIEEL  676 (689)
Q Consensus       647 ~~~~l~~l~~~Cl~~dp~~RPs~~evl~~L  676 (689)
                      .+..+..+...-+.+||.+|.+-.+++++-
T Consensus       223 ~S~~f~nfl~gLL~kdP~~RltW~~Ll~Hp  252 (808)
T KOG0597|consen  223 ASSSFVNFLQGLLIKDPAQRLTWTDLLGHP  252 (808)
T ss_pred             ccHHHHHHHHHHhhcChhhcccHHHHhcCh
Confidence            677899999999999999999999998764

>cd05094 PTKc_TrkC Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase C

Probab=100.00  E-value=4.6e-39  Score=334.46  Aligned_cols=265  Identities=23%  Similarity=0.395  Sum_probs=211.0

Q ss_pred             cCCcccccccCCcceEEEEEec------CCcEEEEEEecccCCchHHHHHHHHHHHHhccCCCcceeEeeEEEcCCCCeE
Q 005586          410 CFSEVNLLGKGNFSSVYKGTLR------DGTLVAIRSINVTSCKSEEAEFVKGLYLLTSLRHENIIRLRGFCCSRGRGEC  483 (689)
Q Consensus       410 ~f~~~~~lg~G~~g~Vy~~~~~------~g~~vavK~l~~~~~~~~~~~f~~e~~~l~~l~H~niv~l~g~~~~~~~~~~  483 (689)
                      +|...+.||+|+||.||+|...      ++..+++|.+.... ....+.|.+|++.+++++|+||+++++++..  .+..
T Consensus         6 ~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~~~~k~~~~~~-~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~--~~~~   82 (291)
T cd05094           6 DIVLKRELGEGAFGKVFLAECYNLSPTKDKMLVAVKALKDPT-LAARKDFQREAELLTNLQHEHIVKFYGVCGD--GDPL   82 (291)
T ss_pred             HeEEeeeecccCCCeEEEeEeeccCCCCcceeeEEEecCCcc-HHHHHHHHHHHHHHhcCCCCCcceEEEEEcc--CCce
Confidence            4666789999999999999753      35678999886544 3344679999999999999999999999844  5678


Q ss_pred             EEEEEcCCCCCHHHHhhhcCC------------CCCCCCHHHHHHHHHHHHHHHhhhhCCCCCCCceeecCCCCCceeec
Q 005586          484 FLIYDFAPKGKLSKYLDQEEG------------SSNVLDWSTRVSIIIGIAKGIGYLHSSEVNKPAIVHRNLSVEKVLID  551 (689)
Q Consensus       484 ~lV~e~~~~gsL~~~L~~~~~------------~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~~~ivH~dlk~~NiLl~  551 (689)
                      ++||||+++++|.+++.....            ....++|..+++++.|++.||+|||+.+     |+||||||+||+++
T Consensus        83 ~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH~~~-----i~H~dlkp~Nil~~  157 (291)
T cd05094          83 IMVFEYMKHGDLNKFLRAHGPDAMILVDGQPRQAKGELGLSQMLHIASQIASGMVYLASQH-----FVHRDLATRNCLVG  157 (291)
T ss_pred             EEEEecCCCCcHHHHHHhcCcccccccccccccCcCCCCHHHHHHHHHHHHHHHHHHHhCC-----eeecccCcceEEEc
Confidence            999999999999999975431            1234899999999999999999999987     99999999999999


Q ss_pred             CCCCeEEecccccccccCCceee-eecCCCCCCCCCccccccCCCCCcccchhHHHHHHHHHh-CCCCcchhHHHHHhhh
Q 005586          552 QQFNPLIADCGLHKLLADDIVFS-VLKTSAAMGYLAPEYVTTGRFTERSDIFAFGVIILQILT-GSLVLTSSMRLAAESA  629 (689)
Q Consensus       552 ~~~~~kl~DfGla~~~~~~~~~~-~~~~~~~~~y~aPE~~~~~~~~~ksDV~sfGvvl~ellt-G~~p~~~~~~~~~~~~  629 (689)
                      +++.+||+|||+++......... .....++..|+|||++.+..++.++|||||||++|||+| |+.|+........   
T Consensus       158 ~~~~~~l~dfg~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~g~~p~~~~~~~~~---  234 (291)
T cd05094         158 ANLLVKIGDFGMSRDVYSTDYYRVGGHTMLPIRWMPPESIMYRKFTTESDVWSFGVILWEIFTYGKQPWFQLSNTEV---  234 (291)
T ss_pred             cCCcEEECCCCcccccCCCceeecCCCCCcceeecChHHhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCHHHH---
Confidence            99999999999998664432211 122334677999999998899999999999999999999 9999854322111   


Q ss_pred             hhhHhhccccCCCCCHHHHHHHHHHHHHhccCCCCCCCCHHHHHHHHHhhCCcccccc
Q 005586          630 TFENFIDRNLKGKFSESEAAKLGKMALVCTHEDPENRPTMEAVIEELTVAAPVMATFL  687 (689)
Q Consensus       630 ~~~~~~~~~~~~~~~~~~~~~l~~l~~~Cl~~dp~~RPs~~evl~~L~~~~p~~~~~~  687 (689)
                        .+.+........+...+..+.+++.+||+.+|++||++.+|+++|+......+.|+
T Consensus       235 --~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~v~~~l~~~~~~~~~~~  290 (291)
T cd05094         235 --IECITQGRVLERPRVCPKEVYDIMLGCWQREPQQRLNIKEIYKILHALGKATPIYL  290 (291)
T ss_pred             --HHHHhCCCCCCCCccCCHHHHHHHHHHcccChhhCcCHHHHHHHHHHHHhhcCccc
Confidence              11111221222233456789999999999999999999999999999987777653

Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase C (TrkC); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkC is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkC to its ligand, neurotrophin 3 (NT3), results in receptor oligomerization and activation of the catalytic domain. TrkC is broadly expressed in the nervous system and in some n

>KOG0616 consensus cAMP-dependent protein kinase catalytic subunit (PKA) [Signal transduction mechanisms]

Probab=100.00  E-value=1e-39  Score=313.45  Aligned_cols=237  Identities=22%  Similarity=0.370  Sum_probs=201.5

Q ss_pred             ccCCcccccccCCcceEEEEEec-CCcEEEEEEecccCCc--hHHHHHHHHHHHHhccCCCcceeEeeEEEcCCCCeEEE
Q 005586          409 QCFSEVNLLGKGNFSSVYKGTLR-DGTLVAIRSINVTSCK--SEEAEFVKGLYLLTSLRHENIIRLRGFCCSRGRGECFL  485 (689)
Q Consensus       409 ~~f~~~~~lg~G~~g~Vy~~~~~-~g~~vavK~l~~~~~~--~~~~~f~~e~~~l~~l~H~niv~l~g~~~~~~~~~~~l  485 (689)
                      ++|+..+.||.|+||.|.+++.+ +|..+|+|++.+....  +..+.-.+|..+|+.+.||+++++++-+  .+.+..++
T Consensus        44 ~dfe~~~tlGtGSFGrV~LVr~k~~g~yYAmKvL~k~~vVklKQveH~~nEk~vL~~v~~PFlv~l~~t~--~d~~~lym  121 (355)
T KOG0616|consen   44 QDFERLKTLGTGSFGRVHLVREKHSGNYYAMKVLDKQKVVKLKQVEHTHNEKRVLKAVSHPFLVKLYGTF--KDNSNLYM  121 (355)
T ss_pred             hhhhheeeeccCccceEEEEEEccCCceeehhhcCHHHHHHHHHHHHHhhHHHHHhhccCceeEEEEEee--ccCCeEEE
Confidence            35667789999999999999986 6899999999876532  2345678899999999999999999888  55689999


Q ss_pred             EEEcCCCCCHHHHhhhcCCCCCCCCHHHHHHHHHHHHHHHhhhhCCCCCCCceeecCCCCCceeecCCCCeEEecccccc
Q 005586          486 IYDFAPKGKLSKYLDQEEGSSNVLDWSTRVSIIIGIAKGIGYLHSSEVNKPAIVHRNLSVEKVLIDQQFNPLIADCGLHK  565 (689)
Q Consensus       486 V~e~~~~gsL~~~L~~~~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~~~ivH~dlk~~NiLl~~~~~~kl~DfGla~  565 (689)
                      ||||+++|-|..+|+..+    .++......+|.||+.||+|||+.+     |++|||||+|||||.+|.+||+|||+|+
T Consensus       122 vmeyv~GGElFS~Lrk~~----rF~e~~arFYAAeivlAleylH~~~-----iiYRDLKPENiLlD~~G~iKitDFGFAK  192 (355)
T KOG0616|consen  122 VMEYVPGGELFSYLRKSG----RFSEPHARFYAAEIVLALEYLHSLD-----IIYRDLKPENLLLDQNGHIKITDFGFAK  192 (355)
T ss_pred             EEeccCCccHHHHHHhcC----CCCchhHHHHHHHHHHHHHHHHhcC-----eeeccCChHHeeeccCCcEEEEeccceE
Confidence            999999999999999765    3889999999999999999999998     9999999999999999999999999999


Q ss_pred             cccCCceeeeecCCCCCCCCCccccccCCCCCcccchhHHHHHHHHHhCCCCcchhHHHHHhhhhhhHhhccccCCCCCH
Q 005586          566 LLADDIVFSVLKTSAAMGYLAPEYVTTGRFTERSDIFAFGVIILQILTGSLVLTSSMRLAAESATFENFIDRNLKGKFSE  645 (689)
Q Consensus       566 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~ksDV~sfGvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~  645 (689)
                      .+...    .....||+.|+|||.+.+..+..++|.|||||++|||+.|.+||.++....    .++.++...+  .+|.
T Consensus       193 ~v~~r----T~TlCGTPeYLAPEii~sk~ynkavDWWalGVLIYEMlaG~pPF~~~~~~~----iY~KI~~~~v--~fP~  262 (355)
T KOG0616|consen  193 RVSGR----TWTLCGTPEYLAPEIIQSKGYNKAVDWWALGVLIYEMLAGYPPFYDDNPIQ----IYEKILEGKV--KFPS  262 (355)
T ss_pred             EecCc----EEEecCCccccChHHhhcCCCCcchhHHHHHHHHHHHHcCCCCCcCCChHH----HHHHHHhCcc--cCCc
Confidence            88764    334568999999999999999999999999999999999999998775532    3333433332  3555


Q ss_pred             HHHHHHHHHHHHhccCCCCCC
Q 005586          646 SEAAKLGKMALVCTHEDPENR  666 (689)
Q Consensus       646 ~~~~~l~~l~~~Cl~~dp~~R  666 (689)
                      --..++.+|+..-++.|-.+|
T Consensus       263 ~fs~~~kdLl~~LL~vD~t~R  283 (355)
T KOG0616|consen  263 YFSSDAKDLLKKLLQVDLTKR  283 (355)
T ss_pred             ccCHHHHHHHHHHHhhhhHhh
Confidence            556677888888888888888

>cd05059 PTKc_Tec_like Catalytic domain of Tec-like Protein Tyrosine Kinases

Probab=100.00  E-value=3.7e-39  Score=328.61  Aligned_cols=250  Identities=23%  Similarity=0.444  Sum_probs=202.4

Q ss_pred             cCCcccccccCCcceEEEEEecCCcEEEEEEecccCCchHHHHHHHHHHHHhccCCCcceeEeeEEEcCCCCeEEEEEEc
Q 005586          410 CFSEVNLLGKGNFSSVYKGTLRDGTLVAIRSINVTSCKSEEAEFVKGLYLLTSLRHENIIRLRGFCCSRGRGECFLIYDF  489 (689)
Q Consensus       410 ~f~~~~~lg~G~~g~Vy~~~~~~g~~vavK~l~~~~~~~~~~~f~~e~~~l~~l~H~niv~l~g~~~~~~~~~~~lV~e~  489 (689)
                      +|+..+.||+|+||.||+|..+++..+|+|.+....  ....+|.+|++++++++||||+++++++.  ..+..++||||
T Consensus         5 ~~~~~~~lg~G~~~~v~~~~~~~~~~~~iK~~~~~~--~~~~~~~~e~~~l~~l~~~~i~~~~~~~~--~~~~~~lv~e~   80 (256)
T cd05059           5 ELTFLKELGSGQFGVVHLGKWRGKIDVAIKMIREGA--MSEDDFIEEAKVMMKLSHPNLVQLYGVCT--KQRPIFIVTEY   80 (256)
T ss_pred             HcchhhhhccCCCceEEEeEecCCccEEEEEeccCC--CCHHHHHHHHHHHHhCCCCCEEEEEEEEc--CCCceEEEEec
Confidence            466678999999999999998877889999986543  23357889999999999999999999884  34678999999


Q ss_pred             CCCCCHHHHhhhcCCCCCCCCHHHHHHHHHHHHHHHhhhhCCCCCCCceeecCCCCCceeecCCCCeEEecccccccccC
Q 005586          490 APKGKLSKYLDQEEGSSNVLDWSTRVSIIIGIAKGIGYLHSSEVNKPAIVHRNLSVEKVLIDQQFNPLIADCGLHKLLAD  569 (689)
Q Consensus       490 ~~~gsL~~~L~~~~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~~~ivH~dlk~~NiLl~~~~~~kl~DfGla~~~~~  569 (689)
                      +++++|.++++....   .++|..++.|+.|++.||+|||+.+     |+||||||+||++++++.+||+|||+++...+
T Consensus        81 ~~~~~L~~~l~~~~~---~~~~~~~~~i~~qi~~~l~~lH~~~-----i~H~dl~p~ni~i~~~~~~kl~dfg~~~~~~~  152 (256)
T cd05059          81 MANGCLLNYLRERKG---KLGTEWLLDMCSDVCEAMEYLESNG-----FIHRDLAARNCLVGEDNVVKVSDFGLARYVLD  152 (256)
T ss_pred             CCCCCHHHHHHhccc---CCCHHHHHHHHHHHHHHHHHHHHCC-----cccccccHhhEEECCCCcEEECCcccceeccc
Confidence            999999999976432   4899999999999999999999987     99999999999999999999999999987654


Q ss_pred             CceeeeecCCCCCCCCCccccccCCCCCcccchhHHHHHHHHHh-CCCCcchhHHHHHhhhhhhHhhccccCCCCCHHHH
Q 005586          570 DIVFSVLKTSAAMGYLAPEYVTTGRFTERSDIFAFGVIILQILT-GSLVLTSSMRLAAESATFENFIDRNLKGKFSESEA  648 (689)
Q Consensus       570 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~ksDV~sfGvvl~ellt-G~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  648 (689)
                      ...........+..|+|||++.+..++.++|||||||++|||+| |+.|+........    . +.+........+...+
T Consensus       153 ~~~~~~~~~~~~~~y~~Pe~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~~~----~-~~~~~~~~~~~~~~~~  227 (256)
T cd05059         153 DQYTSSQGTKFPVKWAPPEVFDYSRFSSKSDVWSFGVLMWEVFSEGKMPYERFSNSEV----V-ESVSAGYRLYRPKLAP  227 (256)
T ss_pred             ccccccCCCCCCccccCHHHhccCCCCchhhHHHHHHHHHHHhccCCCCCCCCCHHHH----H-HHHHcCCcCCCCCCCC
Confidence            33222222334457999999998899999999999999999999 7888854322111    1 1111122222333456


Q ss_pred             HHHHHHHHHhccCCCCCCCCHHHHHHHH
Q 005586          649 AKLGKMALVCTHEDPENRPTMEAVIEEL  676 (689)
Q Consensus       649 ~~l~~l~~~Cl~~dp~~RPs~~evl~~L  676 (689)
                      .++.+++.+||+.+|++||+|.|++++|
T Consensus       228 ~~~~~li~~cl~~~p~~Rpt~~~~l~~l  255 (256)
T cd05059         228 TEVYTIMYSCWHEKPEDRPAFKKLLSQL  255 (256)
T ss_pred             HHHHHHHHHHhcCChhhCcCHHHHHHHh
Confidence            7899999999999999999999999987

Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) subfamily; catalytic (c) domain. The Tec subfamily is composed of Tec, Btk, Bmx (Etk), Itk (Tsk, Emt), Rlk (Txk), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec kinases are cytoplasmic (or nonreceptor) tyr kinases (nRTKs) with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows

>cd05109 PTKc_HER2 Catalytic domain of the Protein Tyrosine Kinase, HER2

Probab=100.00  E-value=5.7e-39  Score=331.63  Aligned_cols=262  Identities=24%  Similarity=0.423  Sum_probs=210.1

Q ss_pred             ccCCcccccccCCcceEEEEEec-CCc----EEEEEEecccCCchHHHHHHHHHHHHhccCCCcceeEeeEEEcCCCCeE
Q 005586          409 QCFSEVNLLGKGNFSSVYKGTLR-DGT----LVAIRSINVTSCKSEEAEFVKGLYLLTSLRHENIIRLRGFCCSRGRGEC  483 (689)
Q Consensus       409 ~~f~~~~~lg~G~~g~Vy~~~~~-~g~----~vavK~l~~~~~~~~~~~f~~e~~~l~~l~H~niv~l~g~~~~~~~~~~  483 (689)
                      ++|...+.||+|+||.||+|.+. +|.    .||+|.+..........++.+|+.++..++||||+++++++..   ...
T Consensus         7 ~~~~~~~~lg~G~~g~vy~~~~~~~~~~~~~~va~K~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~---~~~   83 (279)
T cd05109           7 TELKKVKVLGSGAFGTVYKGIWIPDGENVKIPVAIKVLRENTSPKANKEILDEAYVMAGVGSPYVCRLLGICLT---STV   83 (279)
T ss_pred             hheeeeeecCCCCCceEEEEEEecCCCccceEEEEEEecCCCCHHHHHHHHHHHHHHHhcCCCCCceEEEEEcC---CCc
Confidence            46777899999999999999864 444    4899998766545556789999999999999999999999853   457


Q ss_pred             EEEEEcCCCCCHHHHhhhcCCCCCCCCHHHHHHHHHHHHHHHhhhhCCCCCCCceeecCCCCCceeecCCCCeEEecccc
Q 005586          484 FLIYDFAPKGKLSKYLDQEEGSSNVLDWSTRVSIIIGIAKGIGYLHSSEVNKPAIVHRNLSVEKVLIDQQFNPLIADCGL  563 (689)
Q Consensus       484 ~lV~e~~~~gsL~~~L~~~~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~~~ivH~dlk~~NiLl~~~~~~kl~DfGl  563 (689)
                      ++++||+++|+|.++++...   ..+++..++.++.|++.||+|||+.+     |+||||||+|||+++++.+||+|||+
T Consensus        84 ~l~~~~~~~g~l~~~l~~~~---~~~~~~~~~~~~~qi~~~L~~lH~~~-----iiH~dlkp~Nil~~~~~~~kL~dfG~  155 (279)
T cd05109          84 QLVTQLMPYGCLLDYVRENK---DRIGSQDLLNWCVQIAKGMSYLEEVR-----LVHRDLAARNVLVKSPNHVKITDFGL  155 (279)
T ss_pred             EEEEEcCCCCCHHHHHhhcc---CCCCHHHHHHHHHHHHHHHHHHHHCC-----eeccccccceEEEcCCCcEEECCCCc
Confidence            89999999999999997643   24899999999999999999999987     99999999999999999999999999


Q ss_pred             cccccCCcee-eeecCCCCCCCCCccccccCCCCCcccchhHHHHHHHHHh-CCCCcchhHHHHHhhhhhhHhhccccCC
Q 005586          564 HKLLADDIVF-SVLKTSAAMGYLAPEYVTTGRFTERSDIFAFGVIILQILT-GSLVLTSSMRLAAESATFENFIDRNLKG  641 (689)
Q Consensus       564 a~~~~~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~ksDV~sfGvvl~ellt-G~~p~~~~~~~~~~~~~~~~~~~~~~~~  641 (689)
                      ++.+...... ......++..|+|||...+..++.++|||||||++|||+| |+.|+.......     ....+......
T Consensus       156 ~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~~~-----~~~~~~~~~~~  230 (279)
T cd05109         156 ARLLDIDETEYHADGGKVPIKWMALESILHRRFTHQSDVWSYGVTVWELMTFGAKPYDGIPARE-----IPDLLEKGERL  230 (279)
T ss_pred             eeecccccceeecCCCccchhhCCHHHhccCCCCchhHHHHHHHHHHHHHcCCCCCCCCCCHHH-----HHHHHHCCCcC
Confidence            9876533221 1222334567999999988899999999999999999998 888886432211     11222222222


Q ss_pred             CCCHHHHHHHHHHHHHhccCCCCCCCCHHHHHHHHHhhCCccccc
Q 005586          642 KFSESEAAKLGKMALVCTHEDPENRPTMEAVIEELTVAAPVMATF  686 (689)
Q Consensus       642 ~~~~~~~~~l~~l~~~Cl~~dp~~RPs~~evl~~L~~~~p~~~~~  686 (689)
                      ..+...+.++.+++..||+.||++||++.|+++.|+..+.....|
T Consensus       231 ~~~~~~~~~~~~li~~~l~~dp~~Rp~~~~l~~~l~~~~~~~~~~  275 (279)
T cd05109         231 PQPPICTIDVYMIMVKCWMIDSECRPRFRELVDEFSRMARDPSRF  275 (279)
T ss_pred             CCCccCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHhhcCCcCe
Confidence            223445678899999999999999999999999999887766554

Protein Tyrosine Kinase (PTK) family; HER2 (ErbB2, HER2/neu); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER2 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve

>cd05081 PTKc_Jak2_Jak3_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3

Probab=100.00  E-value=6.7e-39  Score=331.96  Aligned_cols=262  Identities=26%  Similarity=0.453  Sum_probs=205.5

Q ss_pred             ccCCcccccccCCcceEEEEEec-----CCcEEEEEEecccCCchHHHHHHHHHHHHhccCCCcceeEeeEEEcCCCCeE
Q 005586          409 QCFSEVNLLGKGNFSSVYKGTLR-----DGTLVAIRSINVTSCKSEEAEFVKGLYLLTSLRHENIIRLRGFCCSRGRGEC  483 (689)
Q Consensus       409 ~~f~~~~~lg~G~~g~Vy~~~~~-----~g~~vavK~l~~~~~~~~~~~f~~e~~~l~~l~H~niv~l~g~~~~~~~~~~  483 (689)
                      ++|...+.||+|+||.||+|..+     ++..||+|++.... ....+.|.+|++++++++||||+++++++...+....
T Consensus         4 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~v~iK~~~~~~-~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~   82 (284)
T cd05081           4 RHLKFIQQLGKGNFGSVELCRYDPLQDNTGEVVAVKKLQHST-AEHLRDFEREIEILKSLQHDNIVKYKGVCYSAGRRNL   82 (284)
T ss_pred             ccceeeeeccCCCCceEEEEEecCCcCCCCcEEEEEEeccCC-HHHHHHHHHHHHHHHhCCCCCeeEEEEEEccCCCCce
Confidence            46777899999999999999753     58899999987654 3445689999999999999999999998866555678


Q ss_pred             EEEEEcCCCCCHHHHhhhcCCCCCCCCHHHHHHHHHHHHHHHhhhhCCCCCCCceeecCCCCCceeecCCCCeEEecccc
Q 005586          484 FLIYDFAPKGKLSKYLDQEEGSSNVLDWSTRVSIIIGIAKGIGYLHSSEVNKPAIVHRNLSVEKVLIDQQFNPLIADCGL  563 (689)
Q Consensus       484 ~lV~e~~~~gsL~~~L~~~~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~~~ivH~dlk~~NiLl~~~~~~kl~DfGl  563 (689)
                      ++||||+++|+|.+++....   ..++|..+..++.|++.||+|||+.+     |+||||||+||++++++.+||+|||+
T Consensus        83 ~lv~e~~~~~~L~~~l~~~~---~~l~~~~~~~~~~~l~~aL~~LH~~~-----i~H~dlkp~nili~~~~~~~l~dfg~  154 (284)
T cd05081          83 RLVMEYLPYGSLRDYLQKHR---ERLDHRKLLLYASQICKGMEYLGSKR-----YVHRDLATRNILVESENRVKIGDFGL  154 (284)
T ss_pred             EEEEEecCCCCHHHHHHhcC---cCCCHHHHHHHHHHHHHHHHHHHHCC-----ceeccCCHhhEEECCCCeEEECCCcc
Confidence            99999999999999997543   24899999999999999999999987     99999999999999999999999999


Q ss_pred             cccccCCceeeee--cCCCCCCCCCccccccCCCCCcccchhHHHHHHHHHhCCCCcchhHHHHHh-----------hhh
Q 005586          564 HKLLADDIVFSVL--KTSAAMGYLAPEYVTTGRFTERSDIFAFGVIILQILTGSLVLTSSMRLAAE-----------SAT  630 (689)
Q Consensus       564 a~~~~~~~~~~~~--~~~~~~~y~aPE~~~~~~~~~ksDV~sfGvvl~elltG~~p~~~~~~~~~~-----------~~~  630 (689)
                      ++.+.........  ...++..|+|||++.+..++.++|||||||++|||++|..+..........           ...
T Consensus       155 ~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  234 (284)
T cd05081         155 TKVLPQDKEYYKVREPGESPIFWYAPESLTESKFSVASDVWSFGVVLYELFTYSDKSCSPPAEFMRMMGNDKQGQMIVYH  234 (284)
T ss_pred             cccccCCCcceeecCCCCCceEeeCHHHhccCCcChHHHHHHHHHHHHHHhhcCCcCCCcchhhhhhcccccccccchHH
Confidence            9876543221111  112334599999998888999999999999999999987765332111000           001


Q ss_pred             hhHhhccccCCCCCHHHHHHHHHHHHHhccCCCCCCCCHHHHHHHHHhh
Q 005586          631 FENFIDRNLKGKFSESEAAKLGKMALVCTHEDPENRPTMEAVIEELTVA  679 (689)
Q Consensus       631 ~~~~~~~~~~~~~~~~~~~~l~~l~~~Cl~~dp~~RPs~~evl~~L~~~  679 (689)
                      +.+.+........+...+.++.+++.+||+.+|++|||+.||++.|+.+
T Consensus       235 ~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rpt~~ei~~~l~~~  283 (284)
T cd05081         235 LIELLKNNGRLPAPPGCPAEIYAIMKECWNNDPSQRPSFSELALQVEAI  283 (284)
T ss_pred             HHHHHhcCCcCCCCCCCCHHHHHHHHHHccCChhhCCCHHHHHHHHHhc
Confidence            1122222222222334466899999999999999999999999999865

Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as th

>cd05148 PTKc_Srm_Brk Catalytic domain of the Protein Tyrosine Kinases, Srm and Brk

Probab=100.00  E-value=2.2e-39  Score=331.07  Aligned_cols=256  Identities=25%  Similarity=0.509  Sum_probs=210.7

Q ss_pred             HhccCCcccccccCCcceEEEEEecCCcEEEEEEecccCCchHHHHHHHHHHHHhccCCCcceeEeeEEEcCCCCeEEEE
Q 005586          407 ATQCFSEVNLLGKGNFSSVYKGTLRDGTLVAIRSINVTSCKSEEAEFVKGLYLLTSLRHENIIRLRGFCCSRGRGECFLI  486 (689)
Q Consensus       407 at~~f~~~~~lg~G~~g~Vy~~~~~~g~~vavK~l~~~~~~~~~~~f~~e~~~l~~l~H~niv~l~g~~~~~~~~~~~lV  486 (689)
                      +.++|+..+.||+|+||.||+|..+++..+|+|.+.... .....++..|+.++.+++|+||+++++++..  ....++|
T Consensus         4 ~~~~y~~~~~ig~g~~~~vy~~~~~~~~~~~~k~~~~~~-~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~--~~~~~lv   80 (261)
T cd05148           4 PREEFTLERKLGSGYFGEVWEGLWKNRVRVAIKILKSDD-LLKQQDFQKEVQALKRLRHKHLISLFAVCSV--GEPVYII   80 (261)
T ss_pred             cHHHHHHhhhhccCCCccEEEeEecCCCcEEEEeccccc-hhhHHHHHHHHHHHhcCCCcchhheeeeEec--CCCeEEE
Confidence            345677889999999999999999889999999987654 3345678999999999999999999999854  4678999


Q ss_pred             EEcCCCCCHHHHhhhcCCCCCCCCHHHHHHHHHHHHHHHhhhhCCCCCCCceeecCCCCCceeecCCCCeEEeccccccc
Q 005586          487 YDFAPKGKLSKYLDQEEGSSNVLDWSTRVSIIIGIAKGIGYLHSSEVNKPAIVHRNLSVEKVLIDQQFNPLIADCGLHKL  566 (689)
Q Consensus       487 ~e~~~~gsL~~~L~~~~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~~~ivH~dlk~~NiLl~~~~~~kl~DfGla~~  566 (689)
                      |||+++|+|.++++...+  ..+++..+..++.|++.||+|||+.+     |+||||||+||++++++.+||+|||++..
T Consensus        81 ~e~~~~~~L~~~~~~~~~--~~~~~~~~~~~~~~i~~al~~lH~~~-----i~h~dl~~~nilv~~~~~~kl~d~g~~~~  153 (261)
T cd05148          81 TELMEKGSLLAFLRSPEG--QVLPVASLIDMACQVAEGMAYLEEQN-----SIHRDLAARNILVGEDLVCKVADFGLARL  153 (261)
T ss_pred             EeecccCCHHHHHhcCCC--CCCCHHHHHHHHHHHHHHHHHHHHCC-----eeccccCcceEEEcCCceEEEccccchhh
Confidence            999999999999986543  35899999999999999999999887     99999999999999999999999999987


Q ss_pred             ccCCceeeeecCCCCCCCCCccccccCCCCCcccchhHHHHHHHHHh-CCCCcchhHHHHHhhhhhhHhhccccCCCCCH
Q 005586          567 LADDIVFSVLKTSAAMGYLAPEYVTTGRFTERSDIFAFGVIILQILT-GSLVLTSSMRLAAESATFENFIDRNLKGKFSE  645 (689)
Q Consensus       567 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~ksDV~sfGvvl~ellt-G~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~  645 (689)
                      ....... .....++..|+|||.+.+..++.++||||||+++|||++ |+.|+.......    .+.. +....+...+.
T Consensus       154 ~~~~~~~-~~~~~~~~~~~~PE~~~~~~~~~~~DiwslG~~l~~l~~~g~~p~~~~~~~~----~~~~-~~~~~~~~~~~  227 (261)
T cd05148         154 IKEDVYL-SSDKKIPYKWTAPEAASHGTFSTKSDVWSFGILLYEMFTYGQVPYPGMNNHE----VYDQ-ITAGYRMPCPA  227 (261)
T ss_pred             cCCcccc-ccCCCCceEecCHHHHccCCCCchhhHHHHHHHHHHHHcCCCCCCCcCCHHH----HHHH-HHhCCcCCCCC
Confidence            6543322 223345667999999988899999999999999999998 888885432111    1111 12222333445


Q ss_pred             HHHHHHHHHHHHhccCCCCCCCCHHHHHHHHHh
Q 005586          646 SEAAKLGKMALVCTHEDPENRPTMEAVIEELTV  678 (689)
Q Consensus       646 ~~~~~l~~l~~~Cl~~dp~~RPs~~evl~~L~~  678 (689)
                      ..+..+.+++.+||+.||++||+++++++.|+.
T Consensus       228 ~~~~~~~~~i~~~l~~~p~~Rpt~~~l~~~L~~  260 (261)
T cd05148         228 KCPQEIYKIMLECWAAEPEDRPSFKALREELDN  260 (261)
T ss_pred             CCCHHHHHHHHHHcCCCchhCcCHHHHHHHHhc
Confidence            566789999999999999999999999999975

Protein Tyrosine Kinase (PTK) family; Src-related kinase lacking C-terminal regulatory tyrosine and N-terminal myristylation sites (Srm) and breast tumor kinase (Brk, also called protein tyrosine kinase 6); catalytic (c) domains. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Srm and Brk are a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases in general contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr; they are activated by autophosphorylation at the tyr kinase dom

>cd05085 PTKc_Fer Catalytic domain of the Protein Tyrosine Kinase, Fer

Probab=100.00  E-value=7.4e-39  Score=325.04  Aligned_cols=248  Identities=26%  Similarity=0.484  Sum_probs=201.4

Q ss_pred             cccccCCcceEEEEEecCCcEEEEEEecccCCchHHHHHHHHHHHHhccCCCcceeEeeEEEcCCCCeEEEEEEcCCCCC
Q 005586          415 NLLGKGNFSSVYKGTLRDGTLVAIRSINVTSCKSEEAEFVKGLYLLTSLRHENIIRLRGFCCSRGRGECFLIYDFAPKGK  494 (689)
Q Consensus       415 ~~lg~G~~g~Vy~~~~~~g~~vavK~l~~~~~~~~~~~f~~e~~~l~~l~H~niv~l~g~~~~~~~~~~~lV~e~~~~gs  494 (689)
                      ++||+|+||.||+|..+++..||+|++...........|.+|++++++++||||+++++++..  .+..++||||+++|+
T Consensus         1 ~~ig~g~~g~vy~~~~~~~~~~a~K~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~--~~~~~lv~e~~~~~~   78 (250)
T cd05085           1 ELLGKGNFGEVFKGTLKDKTPVAVKTCKEDLPQELKIKFLSEARILKQYDHPNIVKLIGVCTQ--RQPIYIVMELVPGGD   78 (250)
T ss_pred             CccCCCCCceEEEEEecCCcEEEEEecCCcCCHHHHHHHHHHHHHHHhCCCCCcCeEEEEEec--CCccEEEEECCCCCc
Confidence            369999999999999888999999998765544445679999999999999999999999854  467899999999999


Q ss_pred             HHHHhhhcCCCCCCCCHHHHHHHHHHHHHHHhhhhCCCCCCCceeecCCCCCceeecCCCCeEEecccccccccCCceee
Q 005586          495 LSKYLDQEEGSSNVLDWSTRVSIIIGIAKGIGYLHSSEVNKPAIVHRNLSVEKVLIDQQFNPLIADCGLHKLLADDIVFS  574 (689)
Q Consensus       495 L~~~L~~~~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~~~ivH~dlk~~NiLl~~~~~~kl~DfGla~~~~~~~~~~  574 (689)
                      |.+++.....   .++|..++.++.|++.||.|+|+.+     ++||||||+||++++++.+||+|||+++.........
T Consensus        79 L~~~~~~~~~---~~~~~~~~~~~~~i~~~l~~lH~~~-----~~H~dl~p~nili~~~~~~~l~d~g~~~~~~~~~~~~  150 (250)
T cd05085          79 FLSFLRKKKD---ELKTKQLVKFALDAAAGMAYLESKN-----CIHRDLAARNCLVGENNVLKISDFGMSRQEDDGIYSS  150 (250)
T ss_pred             HHHHHHhcCC---CCCHHHHHHHHHHHHHHHHHHHhCC-----eeecccChheEEEcCCCeEEECCCccceecccccccc
Confidence            9999875432   4889999999999999999999887     9999999999999999999999999987654332211


Q ss_pred             eecCCCCCCCCCccccccCCCCCcccchhHHHHHHHHHh-CCCCcchhHHHHHhhhhhhHhhccccCCCCCHHHHHHHHH
Q 005586          575 VLKTSAAMGYLAPEYVTTGRFTERSDIFAFGVIILQILT-GSLVLTSSMRLAAESATFENFIDRNLKGKFSESEAAKLGK  653 (689)
Q Consensus       575 ~~~~~~~~~y~aPE~~~~~~~~~ksDV~sfGvvl~ellt-G~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~  653 (689)
                      ......+..|+|||++.+..++.++||||||+++||+++ |..||........     ...+........+...+.++.+
T Consensus       151 ~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~ll~~~~~~g~~p~~~~~~~~~-----~~~~~~~~~~~~~~~~~~~~~~  225 (250)
T cd05085         151 SGLKQIPIKWTAPEALNYGRYSSESDVWSYGILLWETFSLGVCPYPGMTNQQA-----REQVEKGYRMSCPQKCPDDVYK  225 (250)
T ss_pred             CCCCCCcccccCHHHhccCCCCchhHHHHHHHHHHHHhcCCCCCCCCCCHHHH-----HHHHHcCCCCCCCCCCCHHHHH
Confidence            112233567999999998899999999999999999998 9989864322211     1111122222334445678999


Q ss_pred             HHHHhccCCCCCCCCHHHHHHHHH
Q 005586          654 MALVCTHEDPENRPTMEAVIEELT  677 (689)
Q Consensus       654 l~~~Cl~~dp~~RPs~~evl~~L~  677 (689)
                      ++.+|++.+|++||++.|++++|.
T Consensus       226 li~~~l~~~p~~Rp~~~~l~~~l~  249 (250)
T cd05085         226 VMQRCWDYKPENRPKFSELQKELA  249 (250)
T ss_pred             HHHHHcccCcccCCCHHHHHHHhc
Confidence            999999999999999999999875

Protein Tyrosine Kinase (PTK) family; Fer kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fer kinase is a member of the Fes subfamily of proteins which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. Fer kinase is expressed in a wide variety of tissues, and is found to reside in both the cytoplasm and the nucleus. It plays important roles in neuronal polarization and neurite development, cytoskeletal reorganization, cell migration, growth factor signaling, and the regulation of cell-c

>cd05084 PTKc_Fes Catalytic domain of the Protein Tyrosine Kinase, Fes

Probab=100.00  E-value=7e-39  Score=325.67  Aligned_cols=249  Identities=25%  Similarity=0.461  Sum_probs=200.2

Q ss_pred             cccccCCcceEEEEEec-CCcEEEEEEecccCCchHHHHHHHHHHHHhccCCCcceeEeeEEEcCCCCeEEEEEEcCCCC
Q 005586          415 NLLGKGNFSSVYKGTLR-DGTLVAIRSINVTSCKSEEAEFVKGLYLLTSLRHENIIRLRGFCCSRGRGECFLIYDFAPKG  493 (689)
Q Consensus       415 ~~lg~G~~g~Vy~~~~~-~g~~vavK~l~~~~~~~~~~~f~~e~~~l~~l~H~niv~l~g~~~~~~~~~~~lV~e~~~~g  493 (689)
                      +.||+|+||.||+|..+ +++.||+|.+...........|.+|++++++++||||++++++|..  ....++||||++++
T Consensus         1 ~~lg~g~~g~vy~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~--~~~~~lv~e~~~~~   78 (252)
T cd05084           1 ERIGRGNFGEVFSGRLRADNTPVAVKSCRETLPPDLKAKFLQEARILKQYSHPNIVRLIGVCTQ--KQPIYIVMELVQGG   78 (252)
T ss_pred             CccCcccCccEEEEEEecCCceEEEEecCccCCHHHHHHHHHHHHHHHhCCCCCcceEEEEEcC--CCCeEEEEeeccCC
Confidence            36999999999999975 7899999988755434455689999999999999999999999854  46789999999999


Q ss_pred             CHHHHhhhcCCCCCCCCHHHHHHHHHHHHHHHhhhhCCCCCCCceeecCCCCCceeecCCCCeEEecccccccccCCcee
Q 005586          494 KLSKYLDQEEGSSNVLDWSTRVSIIIGIAKGIGYLHSSEVNKPAIVHRNLSVEKVLIDQQFNPLIADCGLHKLLADDIVF  573 (689)
Q Consensus       494 sL~~~L~~~~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~~~ivH~dlk~~NiLl~~~~~~kl~DfGla~~~~~~~~~  573 (689)
                      +|.++++...   ..++|.+++.++.|++.||+|||+.+     |+||||||+||++++++.+||+|||+++........
T Consensus        79 ~L~~~~~~~~---~~~~~~~~~~~~~qi~~~L~~lH~~~-----i~H~dl~p~nil~~~~~~~kl~dfg~~~~~~~~~~~  150 (252)
T cd05084          79 DFLTFLRTEG---PRLKVKELIQMVENAAAGMEYLESKH-----CIHRDLAARNCLVTEKNVLKISDFGMSREEEDGVYA  150 (252)
T ss_pred             cHHHHHHhCC---CCCCHHHHHHHHHHHHHHHHHHHhCC-----ccccccchheEEEcCCCcEEECccccCccccccccc
Confidence            9999997543   24899999999999999999999887     999999999999999999999999999865433211


Q ss_pred             eee-cCCCCCCCCCccccccCCCCCcccchhHHHHHHHHHh-CCCCcchhHHHHHhhhhhhHhhccccCCCCCHHHHHHH
Q 005586          574 SVL-KTSAAMGYLAPEYVTTGRFTERSDIFAFGVIILQILT-GSLVLTSSMRLAAESATFENFIDRNLKGKFSESEAAKL  651 (689)
Q Consensus       574 ~~~-~~~~~~~y~aPE~~~~~~~~~ksDV~sfGvvl~ellt-G~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l  651 (689)
                      ... ....+..|+|||.+.++.++.++|||||||++|||++ |..|+......     .....+........+...+.++
T Consensus       151 ~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~e~~~~~~~p~~~~~~~-----~~~~~~~~~~~~~~~~~~~~~~  225 (252)
T cd05084         151 STGGMKQIPVKWTAPEALNYGRYSSESDVWSFGILLWEAFSLGAVPYANLSNQ-----QTREAIEQGVRLPCPELCPDAV  225 (252)
T ss_pred             ccCCCCCCceeecCchhhcCCCCChHHHHHHHHHHHHHHHhCCCCCccccCHH-----HHHHHHHcCCCCCCcccCCHHH
Confidence            111 1122356999999998899999999999999999998 88888543211     1122222222333444556789


Q ss_pred             HHHHHHhccCCCCCCCCHHHHHHHHHh
Q 005586          652 GKMALVCTHEDPENRPTMEAVIEELTV  678 (689)
Q Consensus       652 ~~l~~~Cl~~dp~~RPs~~evl~~L~~  678 (689)
                      .+++.+|++.+|++||++.||+++|+.
T Consensus       226 ~~li~~~l~~~p~~Rps~~~~~~~l~~  252 (252)
T cd05084         226 YRLMERCWEYDPGQRPSFSTVHQELQS  252 (252)
T ss_pred             HHHHHHHcCCChhhCcCHHHHHHHHhC
Confidence            999999999999999999999999863

Protein Tyrosine Kinase (PTK) family; Fes (or Fps) kinase subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr kinase activity. Fes kinase is expressed in myeloid, vascular

>cd05053 PTKc_FGFR Catalytic domain of the Protein Tyrosine Kinases, Fibroblast Growth Factor Receptors

Probab=100.00  E-value=5.6e-39  Score=334.10  Aligned_cols=261  Identities=23%  Similarity=0.430  Sum_probs=209.2

Q ss_pred             HhccCCcccccccCCcceEEEEEec------CCcEEEEEEecccCCchHHHHHHHHHHHHhcc-CCCcceeEeeEEEcCC
Q 005586          407 ATQCFSEVNLLGKGNFSSVYKGTLR------DGTLVAIRSINVTSCKSEEAEFVKGLYLLTSL-RHENIIRLRGFCCSRG  479 (689)
Q Consensus       407 at~~f~~~~~lg~G~~g~Vy~~~~~------~g~~vavK~l~~~~~~~~~~~f~~e~~~l~~l-~H~niv~l~g~~~~~~  479 (689)
                      ..++|+..+.||+|+||.||++...      ....+|+|.+..........++.+|++++.++ +|+||+++++++..  
T Consensus        10 ~~~~~~~~~~ig~g~~g~v~~~~~~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~E~~~l~~l~~h~~i~~~~~~~~~--   87 (293)
T cd05053          10 PRDRLTLGKPLGEGAFGQVVKAEAVGLDNPNETSTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKNIINLLGVCTQ--   87 (293)
T ss_pred             CHhHeEEeeEecccccccEEEEEEecCCCCCCceeEEEEEccCCCCHHHHHHHHHHHHHHHhhcCCCCeeeEEEEEcC--
Confidence            3456778899999999999999864      23689999998655445556799999999999 89999999999844  


Q ss_pred             CCeEEEEEEcCCCCCHHHHhhhcC------------CCCCCCCHHHHHHHHHHHHHHHhhhhCCCCCCCceeecCCCCCc
Q 005586          480 RGECFLIYDFAPKGKLSKYLDQEE------------GSSNVLDWSTRVSIIIGIAKGIGYLHSSEVNKPAIVHRNLSVEK  547 (689)
Q Consensus       480 ~~~~~lV~e~~~~gsL~~~L~~~~------------~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~~~ivH~dlk~~N  547 (689)
                      .+..++||||+++|+|.++++...            .....++|..+++++.|++.||+|||+.+     |+||||||+|
T Consensus        88 ~~~~~li~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~-----ivH~dlkp~N  162 (293)
T cd05053          88 EGPLYVVVEYAAHGNLRDFLRARRPPGEYASPDDPRPPEETLTQKDLVSFAYQVARGMEFLASKK-----CIHRDLAARN  162 (293)
T ss_pred             CCCeEEEEEeCCCCcHHHHHHhcCCCccccccccccccccccCHHHHHHHHHHHHHHHHHHHHCC-----ccccccceee
Confidence            567899999999999999997532            12345899999999999999999999887     9999999999


Q ss_pred             eeecCCCCeEEecccccccccCCceee-eecCCCCCCCCCccccccCCCCCcccchhHHHHHHHHHh-CCCCcchhHHHH
Q 005586          548 VLIDQQFNPLIADCGLHKLLADDIVFS-VLKTSAAMGYLAPEYVTTGRFTERSDIFAFGVIILQILT-GSLVLTSSMRLA  625 (689)
Q Consensus       548 iLl~~~~~~kl~DfGla~~~~~~~~~~-~~~~~~~~~y~aPE~~~~~~~~~ksDV~sfGvvl~ellt-G~~p~~~~~~~~  625 (689)
                      |++++++.+||+|||+++.+....... .....++..|+|||++.+..++.++|||||||++|||++ |..|+.......
T Consensus       163 il~~~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~~~~  242 (293)
T cd05053         163 VLVTEDHVMKIADFGLARDIHHIDYYRKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLLWEIFTLGGSPYPGIPVEE  242 (293)
T ss_pred             EEEcCCCeEEeCccccccccccccceeccCCCCCCccccCHHHhccCCcCcccceeehhhHHHHHhcCCCCCCCCCCHHH
Confidence            999999999999999998765433211 122234567999999988899999999999999999998 888885432111


Q ss_pred             HhhhhhhHhhccccCCCCCHHHHHHHHHHHHHhccCCCCCCCCHHHHHHHHHhh
Q 005586          626 AESATFENFIDRNLKGKFSESEAAKLGKMALVCTHEDPENRPTMEAVIEELTVA  679 (689)
Q Consensus       626 ~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~Cl~~dp~~RPs~~evl~~L~~~  679 (689)
                           ..+.+........+......+.+++.+|+..+|++|||+.|++++|+..
T Consensus       243 -----~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~eil~~l~~~  291 (293)
T cd05053         243 -----LFKLLKEGYRMEKPQNCTQELYHLMRDCWHEVPSQRPTFKQLVEDLDRM  291 (293)
T ss_pred             -----HHHHHHcCCcCCCCCCCCHHHHHHHHHHcccCcccCcCHHHHHHHHHHh
Confidence                 1122222222234445567899999999999999999999999999875

Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor (FGFR) subfamily; catalytic (c) domain. The FGFR subfamily consists of FGFR1, FGFR2, FGFR3, FGFR4, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K).PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, and to heparin/heparan sulfate (HS) results in the formation of a ternary complex, which leads to receptor dimerization and activation,

>cd05612 STKc_PRKX_like Catalytic domain of PRKX-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=1.2e-39  Score=338.70  Aligned_cols=248  Identities=22%  Similarity=0.299  Sum_probs=203.6

Q ss_pred             cCCcccccccCCcceEEEEEec-CCcEEEEEEecccCC--chHHHHHHHHHHHHhccCCCcceeEeeEEEcCCCCeEEEE
Q 005586          410 CFSEVNLLGKGNFSSVYKGTLR-DGTLVAIRSINVTSC--KSEEAEFVKGLYLLTSLRHENIIRLRGFCCSRGRGECFLI  486 (689)
Q Consensus       410 ~f~~~~~lg~G~~g~Vy~~~~~-~g~~vavK~l~~~~~--~~~~~~f~~e~~~l~~l~H~niv~l~g~~~~~~~~~~~lV  486 (689)
                      +|...+.||+|+||.||+|..+ +|+.||+|++.....  ......+.+|++++.+++||||+++++++.  +....++|
T Consensus         2 ~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~--~~~~~~lv   79 (291)
T cd05612           2 DLERIKTVGTGTFGRVHLVRDRISEHYYALKVMAIPEVIRLKQEQHVHNEKRVLKEVSHPFIIRLFWTEH--DQRFLYML   79 (291)
T ss_pred             CceeeeeeecCCCeEEEEEEEcCCCCEEEEEEEEHHHHhhhHHHHHHHHHHHHHHhCCCCcHhhhHhhhc--cCCeEEEE
Confidence            6778899999999999999976 689999999875431  223457889999999999999999998874  45789999


Q ss_pred             EEcCCCCCHHHHhhhcCCCCCCCCHHHHHHHHHHHHHHHhhhhCCCCCCCceeecCCCCCceeecCCCCeEEeccccccc
Q 005586          487 YDFAPKGKLSKYLDQEEGSSNVLDWSTRVSIIIGIAKGIGYLHSSEVNKPAIVHRNLSVEKVLIDQQFNPLIADCGLHKL  566 (689)
Q Consensus       487 ~e~~~~gsL~~~L~~~~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~~~ivH~dlk~~NiLl~~~~~~kl~DfGla~~  566 (689)
                      |||+++|+|.+++....    .+++.....++.|++.||+|||+.+     |+||||||+|||+++++.+||+|||+++.
T Consensus        80 ~e~~~~~~L~~~~~~~~----~~~~~~~~~~~~qi~~~l~~lH~~~-----i~H~dlkp~NIli~~~~~~kl~Dfg~~~~  150 (291)
T cd05612          80 MEYVPGGELFSYLRNSG----RFSNSTGLFYASEIVCALEYLHSKE-----IVYRDLKPENILLDKEGHIKLTDFGFAKK  150 (291)
T ss_pred             EeCCCCCCHHHHHHHcC----CCCHHHHHHHHHHHHHHHHHHHHCC-----eeecCCCHHHeEECCCCCEEEEecCcchh
Confidence            99999999999997643    4889999999999999999999987     99999999999999999999999999987


Q ss_pred             ccCCceeeeecCCCCCCCCCccccccCCCCCcccchhHHHHHHHHHhCCCCcchhHHHHHhhhhhhHhhccccCCCCCHH
Q 005586          567 LADDIVFSVLKTSAAMGYLAPEYVTTGRFTERSDIFAFGVIILQILTGSLVLTSSMRLAAESATFENFIDRNLKGKFSES  646 (689)
Q Consensus       567 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~ksDV~sfGvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  646 (689)
                      .....    ....++..|+|||++.+..++.++|||||||++|||+||+.||.......    ....+....  ..++..
T Consensus       151 ~~~~~----~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~~l~~g~~pf~~~~~~~----~~~~i~~~~--~~~~~~  220 (291)
T cd05612         151 LRDRT----WTLCGTPEYLAPEVIQSKGHNKAVDWWALGILIYEMLVGYPPFFDDNPFG----IYEKILAGK--LEFPRH  220 (291)
T ss_pred             ccCCc----ccccCChhhcCHHHHcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHH----HHHHHHhCC--cCCCcc
Confidence            65422    12357888999999998889999999999999999999999996542211    112222111  123334


Q ss_pred             HHHHHHHHHHHhccCCCCCCCC-----HHHHHHHHHh
Q 005586          647 EAAKLGKMALVCTHEDPENRPT-----MEAVIEELTV  678 (689)
Q Consensus       647 ~~~~l~~l~~~Cl~~dp~~RPs-----~~evl~~L~~  678 (689)
                      ....+.+++.+|++.||.+||+     +.|++++.+.
T Consensus       221 ~~~~~~~li~~~l~~dp~~R~~~~~~~~~~~l~h~~~  257 (291)
T cd05612         221 LDLYAKDLIKKLLVVDRTRRLGNMKNGADDVKNHRWF  257 (291)
T ss_pred             CCHHHHHHHHHHcCCCHHHccCCccCCHHHHhcCccc
Confidence            4567899999999999999995     9999888654

Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, PRKX-like kinases, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include human PRKX (X chromosome-encoded protein kinase), Drosophila DC2, and similar proteins. PRKX is present in many tissues including fetal and adult brain, kidney, and lung. The PRKX gene is located in the Xp22.3 subregion and has a homolog called PRKY on the Y chromosome. An abnormal interchange between PRKX aand PRKY leads to the sex reversal disorder of XX males and XY females. PRKX is implicated in granulocyt

>cd05043 PTK_Ryk Pseudokinase domain of Ryk (Receptor related to tyrosine kinase)

Probab=100.00  E-value=7.9e-39  Score=330.69  Aligned_cols=262  Identities=21%  Similarity=0.365  Sum_probs=211.1

Q ss_pred             hccCCcccccccCCcceEEEEEecC-----CcEEEEEEecccCCchHHHHHHHHHHHHhccCCCcceeEeeEEEcCCCCe
Q 005586          408 TQCFSEVNLLGKGNFSSVYKGTLRD-----GTLVAIRSINVTSCKSEEAEFVKGLYLLTSLRHENIIRLRGFCCSRGRGE  482 (689)
Q Consensus       408 t~~f~~~~~lg~G~~g~Vy~~~~~~-----g~~vavK~l~~~~~~~~~~~f~~e~~~l~~l~H~niv~l~g~~~~~~~~~  482 (689)
                      .++|...+.||+|+||.||+|...+     +..|++|++...........+.+|+.++.+++|+||+++++++... ...
T Consensus         5 ~~~~~~~~~i~~g~~g~V~~~~~~~~~~~~~~~v~~k~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~-~~~   83 (280)
T cd05043           5 RDRVTLSDLLQEGTFGRIFYGILIDEKPGKEEEVFVKTVKDHASEIQVTLLLQESCLLYGLSHQNILPILHVCIED-GEP   83 (280)
T ss_pred             hhheEEeeeecccCCceEEEEEEecCCCCceeEEEEEEccCCCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEecC-CCC
Confidence            4567788999999999999999865     7889999987655445567899999999999999999999998653 467


Q ss_pred             EEEEEEcCCCCCHHHHhhhcCCC----CCCCCHHHHHHHHHHHHHHHhhhhCCCCCCCceeecCCCCCceeecCCCCeEE
Q 005586          483 CFLIYDFAPKGKLSKYLDQEEGS----SNVLDWSTRVSIIIGIAKGIGYLHSSEVNKPAIVHRNLSVEKVLIDQQFNPLI  558 (689)
Q Consensus       483 ~~lV~e~~~~gsL~~~L~~~~~~----~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~~~ivH~dlk~~NiLl~~~~~~kl  558 (689)
                      .++++||+++|+|.+++......    ...+++.+++.++.|++.||+|||+.+     ++||||||+||++++++.+||
T Consensus        84 ~~~~~~~~~~~~L~~~l~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~-----i~H~di~p~nil~~~~~~~kl  158 (280)
T cd05043          84 PFVLYPYMNWGNLKLFLQQCRLGEANNPQALSTQQLVHMAIQIACGMSYLHKRG-----VIHKDIAARNCVIDEELQVKI  158 (280)
T ss_pred             CEEEEEcCCCCcHHHHHHhccccccccccCCCHHHHHHHHHHHHHHHHHHHHCC-----EeecccCHhhEEEcCCCcEEE
Confidence            89999999999999999764322    145899999999999999999999887     999999999999999999999


Q ss_pred             ecccccccccCCceee-eecCCCCCCCCCccccccCCCCCcccchhHHHHHHHHHh-CCCCcchhHHHHHhhhhhhHhhc
Q 005586          559 ADCGLHKLLADDIVFS-VLKTSAAMGYLAPEYVTTGRFTERSDIFAFGVIILQILT-GSLVLTSSMRLAAESATFENFID  636 (689)
Q Consensus       559 ~DfGla~~~~~~~~~~-~~~~~~~~~y~aPE~~~~~~~~~ksDV~sfGvvl~ellt-G~~p~~~~~~~~~~~~~~~~~~~  636 (689)
                      +|||+++.+....... .....++..|+|||++.+..++.++|||||||++||+++ |+.|+.......     +...+.
T Consensus       159 ~d~g~~~~~~~~~~~~~~~~~~~~~~y~apE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~~-----~~~~~~  233 (280)
T cd05043         159 TDNALSRDLFPMDYHCLGDNENRPVKWMALESLVNKEYSSASDVWSFGVLLWELMTLGQTPYVEIDPFE-----MAAYLK  233 (280)
T ss_pred             CCCCCcccccCCceEEeCCCCCcchhccCHHHHhcCCCCchhhHHHhHHHHHHHhcCCCCCcCcCCHHH-----HHHHHH
Confidence            9999998764432211 122345667999999988889999999999999999999 999986532211     111111


Q ss_pred             cccCCCCCHHHHHHHHHHHHHhccCCCCCCCCHHHHHHHHHhhC
Q 005586          637 RNLKGKFSESEAAKLGKMALVCTHEDPENRPTMEAVIEELTVAA  680 (689)
Q Consensus       637 ~~~~~~~~~~~~~~l~~l~~~Cl~~dp~~RPs~~evl~~L~~~~  680 (689)
                      .......+...+.++.+++.+||+.||++||++.||++.|+...
T Consensus       234 ~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~~~~~l~~~~  277 (280)
T cd05043         234 DGYRLAQPINCPDELFAVMACCWALDPEERPSFSQLVQCLTDFH  277 (280)
T ss_pred             cCCCCCCCCcCCHHHHHHHHHHcCCChhhCCCHHHHHHHHHHHH
Confidence            12222223334567899999999999999999999999998764

Protein Tyrosine Kinase (PTK) family; Receptor related to tyrosine kinase (Ryk); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ryk is a receptor tyr kinase (RTK) containing an extracellular region with two leucine-rich motifs, a transmembrane segment, and an intracellular inactive pseudokinase domain. The extracellular region of Ryk shows homology to the N-terminal domain of Wnt inhibitory factor-1 (WIF) and serves as the ligand (Wnt) binding domain of Ryk. Ryk is expressed in many different tissues both during development and in adults, suggesting a widespread function. It

>KOG4257 consensus Focal adhesion tyrosine kinase FAK, contains FERM domain [Signal transduction mechanisms]

Probab=100.00  E-value=6.6e-40  Score=340.71  Aligned_cols=254  Identities=25%  Similarity=0.465  Sum_probs=219.0

Q ss_pred             cCCcccccccCCcceEEEEEecC-----CcEEEEEEecccCCchHHHHHHHHHHHHhccCCCcceeEeeEEEcCCCCeEE
Q 005586          410 CFSEVNLLGKGNFSSVYKGTLRD-----GTLVAIRSINVTSCKSEEAEFVKGLYLLTSLRHENIIRLRGFCCSRGRGECF  484 (689)
Q Consensus       410 ~f~~~~~lg~G~~g~Vy~~~~~~-----g~~vavK~l~~~~~~~~~~~f~~e~~~l~~l~H~niv~l~g~~~~~~~~~~~  484 (689)
                      .....++||.|-||.||+|.+.+     .-.||||.-+.+......+.|+.|..+|++++|||||+|+|+|.+   ...+
T Consensus       390 ~Itl~r~iG~GqFGdVy~gvYt~~~kge~iaVAvKtCK~d~t~d~tekflqEa~iMrnfdHphIikLIGv~~e---~P~W  466 (974)
T KOG4257|consen  390 LITLKRLIGEGQFGDVYKGVYTDPEKGERIAVAVKTCKTDCTPDDTEKFLQEASIMRNFDHPHIIKLIGVCVE---QPMW  466 (974)
T ss_pred             hccHHHhhcCCcccceeeeEecccccCcceeeeeehhccCCChhhHHHHHHHHHHHHhCCCcchhheeeeeec---ccee
Confidence            33446799999999999998642     345899998887666677899999999999999999999999965   5789


Q ss_pred             EEEEcCCCCCHHHHhhhcCCCCCCCCHHHHHHHHHHHHHHHhhhhCCCCCCCceeecCCCCCceeecCCCCeEEeccccc
Q 005586          485 LIYDFAPKGKLSKYLDQEEGSSNVLDWSTRVSIIIGIAKGIGYLHSSEVNKPAIVHRNLSVEKVLIDQQFNPLIADCGLH  564 (689)
Q Consensus       485 lV~e~~~~gsL~~~L~~~~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~~~ivH~dlk~~NiLl~~~~~~kl~DfGla  564 (689)
                      +|||..+-|-|..||+.+..   .|+..+...++.||..||+|||+..     +|||||.++|||+.....+|++|||++
T Consensus       467 ivmEL~~~GELr~yLq~nk~---sL~l~tL~ly~~Qi~talaYLeSkr-----fVHRDIAaRNiLVsSp~CVKLaDFGLS  538 (974)
T KOG4257|consen  467 IVMELAPLGELREYLQQNKD---SLPLRTLTLYCYQICTALAYLESKR-----FVHRDIAARNILVSSPQCVKLADFGLS  538 (974)
T ss_pred             EEEecccchhHHHHHHhccc---cchHHHHHHHHHHHHHHHHHHHhhc-----hhhhhhhhhheeecCcceeeecccchh
Confidence            99999999999999987653   4888899999999999999999987     899999999999999999999999999


Q ss_pred             ccccCCceeeeecCCCCCCCCCccccccCCCCCcccchhHHHHHHHHHh-CCCCcchhHHHHHhhhhhhHhhccccCCCC
Q 005586          565 KLLADDIVFSVLKTSAAMGYLAPEYVTTGRFTERSDIFAFGVIILQILT-GSLVLTSSMRLAAESATFENFIDRNLKGKF  643 (689)
Q Consensus       565 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~ksDV~sfGvvl~ellt-G~~p~~~~~~~~~~~~~~~~~~~~~~~~~~  643 (689)
                      |.+.++.+++.....-++.|||||.+.-++++.+||||-|||++||+++ |..||.....     .+.-..+...-+...
T Consensus       539 R~~ed~~yYkaS~~kLPIKWmaPESINfRrFTtASDVWMFgVCmWEIl~lGvkPfqgvkN-----sDVI~~iEnGeRlP~  613 (974)
T KOG4257|consen  539 RYLEDDAYYKASRGKLPIKWMAPESINFRRFTTASDVWMFGVCMWEILSLGVKPFQGVKN-----SDVIGHIENGERLPC  613 (974)
T ss_pred             hhccccchhhccccccceeecCccccchhcccchhhHHHHHHHHHHHHHhcCCccccccc-----cceEEEecCCCCCCC
Confidence            9999988888777777889999999999999999999999999999986 8899965322     112222333445567


Q ss_pred             CHHHHHHHHHHHHHhccCCCCCCCCHHHHHHHHHhh
Q 005586          644 SESEAAKLGKMALVCTHEDPENRPTMEAVIEELTVA  679 (689)
Q Consensus       644 ~~~~~~~l~~l~~~Cl~~dp~~RPs~~evl~~L~~~  679 (689)
                      |+.|+..+..++.+||+.||.+||.+.|+...|..+
T Consensus       614 P~nCPp~LYslmskcWayeP~kRPrftei~~~lsdv  649 (974)
T KOG4257|consen  614 PPNCPPALYSLMSKCWAYEPSKRPRFTEIKAILSDV  649 (974)
T ss_pred             CCCCChHHHHHHHHHhccCcccCCcHHHHHHHHHHH
Confidence            888999999999999999999999999998877654

>cd05571 STKc_PKB Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B

Probab=100.00  E-value=2.6e-39  Score=341.37  Aligned_cols=245  Identities=23%  Similarity=0.332  Sum_probs=198.0

Q ss_pred             cccccCCcceEEEEEec-CCcEEEEEEecccCC--chHHHHHHHHHHHHhccCCCcceeEeeEEEcCCCCeEEEEEEcCC
Q 005586          415 NLLGKGNFSSVYKGTLR-DGTLVAIRSINVTSC--KSEEAEFVKGLYLLTSLRHENIIRLRGFCCSRGRGECFLIYDFAP  491 (689)
Q Consensus       415 ~~lg~G~~g~Vy~~~~~-~g~~vavK~l~~~~~--~~~~~~f~~e~~~l~~l~H~niv~l~g~~~~~~~~~~~lV~e~~~  491 (689)
                      +.||+|+||.||+|+.+ +|+.||+|+++....  ......+.+|++++++++||||+++++++..  .+..++||||++
T Consensus         1 ~~lG~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~l~hp~i~~~~~~~~~--~~~~~lv~e~~~   78 (323)
T cd05571           1 KLLGKGTFGKVILVREKATGKYYAMKILKKEVIIAKDEVAHTLTESRVLQNTRHPFLTALKYSFQT--HDRLCFVMEYAN   78 (323)
T ss_pred             CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhHHHHHHHHHHHHHHhCCCCCCCCEEEEEEc--CCEEEEEEeCCC
Confidence            36999999999999875 789999999975432  2334578899999999999999999998844  578999999999


Q ss_pred             CCCHHHHhhhcCCCCCCCCHHHHHHHHHHHHHHHhhhhCCCCCCCceeecCCCCCceeecCCCCeEEecccccccccCCc
Q 005586          492 KGKLSKYLDQEEGSSNVLDWSTRVSIIIGIAKGIGYLHSSEVNKPAIVHRNLSVEKVLIDQQFNPLIADCGLHKLLADDI  571 (689)
Q Consensus       492 ~gsL~~~L~~~~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~~~ivH~dlk~~NiLl~~~~~~kl~DfGla~~~~~~~  571 (689)
                      +|+|.+++....    .+++.....++.||+.||+|||+.+     |+||||||+|||++.++.+||+|||+++......
T Consensus        79 ~~~L~~~l~~~~----~~~~~~~~~~~~qi~~~L~~lH~~~-----ivHrDlkp~NIll~~~~~~kl~DfG~a~~~~~~~  149 (323)
T cd05571          79 GGELFFHLSRER----VFSEDRARFYGAEIVSALGYLHSCD-----VVYRDLKLENLMLDKDGHIKITDFGLCKEGISDG  149 (323)
T ss_pred             CCcHHHHHHHcC----CCCHHHHHHHHHHHHHHHHHHHhCC-----eEeCCCCHHHEEECCCCCEEEeeCCCCcccccCC
Confidence            999999997643    4889999999999999999999988     9999999999999999999999999987542211


Q ss_pred             eeeeecCCCCCCCCCccccccCCCCCcccchhHHHHHHHHHhCCCCcchhHHHHHhhhhhhHhhccccCCCCCHHHHHHH
Q 005586          572 VFSVLKTSAAMGYLAPEYVTTGRFTERSDIFAFGVIILQILTGSLVLTSSMRLAAESATFENFIDRNLKGKFSESEAAKL  651 (689)
Q Consensus       572 ~~~~~~~~~~~~y~aPE~~~~~~~~~ksDV~sfGvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l  651 (689)
                      . ......++..|+|||.+.+..++.++|||||||++|||+||+.||........    ...+...  ...++.....++
T Consensus       150 ~-~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~Pf~~~~~~~~----~~~~~~~--~~~~p~~~~~~~  222 (323)
T cd05571         150 A-TMKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHEKL----FELILME--EIRFPRTLSPEA  222 (323)
T ss_pred             C-cccceecCccccChhhhcCCCCCccccCcccchhhhhhhcCCCCCCCCCHHHH----HHHHHcC--CCCCCCCCCHHH
Confidence            1 11223578899999999998999999999999999999999999965322111    1111111  112344456678


Q ss_pred             HHHHHHhccCCCCCCC-----CHHHHHHHHH
Q 005586          652 GKMALVCTHEDPENRP-----TMEAVIEELT  677 (689)
Q Consensus       652 ~~l~~~Cl~~dp~~RP-----s~~evl~~L~  677 (689)
                      .+++.+|++.||++||     ++.+++++-+
T Consensus       223 ~~li~~~L~~dP~~R~~~~~~~~~~ll~h~~  253 (323)
T cd05571         223 KSLLAGLLKKDPKQRLGGGPEDAKEIMEHRF  253 (323)
T ss_pred             HHHHHHHccCCHHHcCCCCCCCHHHHHcCCC
Confidence            9999999999999999     8999987643

Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. It is activated downstream of PI3K and plays important roles in diverse cellular functions including cell survival, growth, proliferation, angiogenesis, motility, and migration. PKB also has a central role in a variety of human cancers, having be

>cd05049 PTKc_Trk Catalytic domain of the Protein Tyrosine Kinases, Tropomyosin Related Kinases

Probab=100.00  E-value=7.7e-39  Score=330.65  Aligned_cols=257  Identities=24%  Similarity=0.424  Sum_probs=206.2

Q ss_pred             ccCCcccccccCCcceEEEEEecC------CcEEEEEEecccCCchHHHHHHHHHHHHhccCCCcceeEeeEEEcCCCCe
Q 005586          409 QCFSEVNLLGKGNFSSVYKGTLRD------GTLVAIRSINVTSCKSEEAEFVKGLYLLTSLRHENIIRLRGFCCSRGRGE  482 (689)
Q Consensus       409 ~~f~~~~~lg~G~~g~Vy~~~~~~------g~~vavK~l~~~~~~~~~~~f~~e~~~l~~l~H~niv~l~g~~~~~~~~~  482 (689)
                      ++|...+.||+|+||.||+|...+      +..||+|.++..........|.+|++++.+++|+||+++++++..  ...
T Consensus         5 ~~~~~~~~lg~g~~~~v~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~--~~~   82 (280)
T cd05049           5 DTIVLKRELGEGAFGKVFLGECYHLEPENDKELVAVKTLKETASNDARKDFEREAELLTNFQHENIVKFYGVCTE--GDP   82 (280)
T ss_pred             HHhhHHhhccccCCceEeeeeeccccCcCCcceEEEEeecccCCHHHHHHHHHHHHHHHhcCCCCchheeeEEec--CCC
Confidence            356777899999999999998643      478999999876544456789999999999999999999999854  477


Q ss_pred             EEEEEEcCCCCCHHHHhhhcCC----------CCCCCCHHHHHHHHHHHHHHHhhhhCCCCCCCceeecCCCCCceeecC
Q 005586          483 CFLIYDFAPKGKLSKYLDQEEG----------SSNVLDWSTRVSIIIGIAKGIGYLHSSEVNKPAIVHRNLSVEKVLIDQ  552 (689)
Q Consensus       483 ~~lV~e~~~~gsL~~~L~~~~~----------~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~~~ivH~dlk~~NiLl~~  552 (689)
                      .++||||+++|+|.+++.....          ....+++.....++.|++.|++|||+.+     ++||||||+||+++.
T Consensus        83 ~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~~-----i~h~dlkp~nili~~  157 (280)
T cd05049          83 PIMVFEYMEHGDLNKFLRSHGPDAAFLKSPDSPMGELTLSQLLQIAVQIASGMVYLASQH-----FVHRDLATRNCLVGY  157 (280)
T ss_pred             eEEEEecCCCCCHHHHHHhcCCchhhhcccccccccccHHHHHHHHHHHHHHHHHHhhCC-----eeccccccceEEEcC
Confidence            9999999999999999976432          2245889999999999999999999987     999999999999999


Q ss_pred             CCCeEEecccccccccCCceee-eecCCCCCCCCCccccccCCCCCcccchhHHHHHHHHHh-CCCCcchhHHHHHhhhh
Q 005586          553 QFNPLIADCGLHKLLADDIVFS-VLKTSAAMGYLAPEYVTTGRFTERSDIFAFGVIILQILT-GSLVLTSSMRLAAESAT  630 (689)
Q Consensus       553 ~~~~kl~DfGla~~~~~~~~~~-~~~~~~~~~y~aPE~~~~~~~~~ksDV~sfGvvl~ellt-G~~p~~~~~~~~~~~~~  630 (689)
                      ++.+||+|||+++......... .....++..|+|||++.+..++.++|||||||++|||++ |+.||.......     
T Consensus       158 ~~~~kl~d~g~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~e~~~~g~~p~~~~~~~~-----  232 (280)
T cd05049         158 DLVVKIGDFGMSRDVYTTDYYRVGGHTMLPIRWMPPESIMYRKFTTESDVWSFGVVLWEIFTYGKQPWYGLSNEE-----  232 (280)
T ss_pred             CCeEEECCcccceecccCcceecCCCCcccceecChhhhccCCcchhhhHHHHHHHHHHHHhcCCCCCCCCCHHH-----
Confidence            9999999999998654322211 122334577999999999999999999999999999999 999985432111     


Q ss_pred             hhHhhccccCCCCCHHHHHHHHHHHHHhccCCCCCCCCHHHHHHHHH
Q 005586          631 FENFIDRNLKGKFSESEAAKLGKMALVCTHEDPENRPTMEAVIEELT  677 (689)
Q Consensus       631 ~~~~~~~~~~~~~~~~~~~~l~~l~~~Cl~~dp~~RPs~~evl~~L~  677 (689)
                      ..+.+........+...+..+.+++..||+.||++||++.||++.|+
T Consensus       233 ~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~eil~~l~  279 (280)
T cd05049         233 VIECITQGRLLQRPRTCPSEVYDIMLGCWKRDPQQRINIKDIHERLQ  279 (280)
T ss_pred             HHHHHHcCCcCCCCCCCCHHHHHHHHHHcCCCcccCCCHHHHHHHhh
Confidence            11111111122223445678999999999999999999999999885

Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase (Trk) subfamily; catalytic (c) domain. The Trk subfamily consists of TrkA, TrkB, TrkC, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Trk subfamily members are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, the nerve growth factor (NGF) family of neutrotrophins, leads to Trk receptor oligomerization and activation of the catalyt

>PLN00034 mitogen-activated protein kinase kinase; Provisional

Probab=100.00  E-value=3.2e-39  Score=345.05  Aligned_cols=252  Identities=22%  Similarity=0.349  Sum_probs=196.0

Q ss_pred             CCcccccccCCcceEEEEEec-CCcEEEEEEecccCCchHHHHHHHHHHHHhccCCCcceeEeeEEEcCCCCeEEEEEEc
Q 005586          411 FSEVNLLGKGNFSSVYKGTLR-DGTLVAIRSINVTSCKSEEAEFVKGLYLLTSLRHENIIRLRGFCCSRGRGECFLIYDF  489 (689)
Q Consensus       411 f~~~~~lg~G~~g~Vy~~~~~-~g~~vavK~l~~~~~~~~~~~f~~e~~~l~~l~H~niv~l~g~~~~~~~~~~~lV~e~  489 (689)
                      |...+.||+|+||.||+|... +|+.||||++...........|.+|++++++++|+||+++++++.  ..+..++||||
T Consensus        76 ~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~--~~~~~~lv~e~  153 (353)
T PLN00034         76 LERVNRIGSGAGGTVYKVIHRPTGRLYALKVIYGNHEDTVRRQICREIEILRDVNHPNVVKCHDMFD--HNGEIQVLLEF  153 (353)
T ss_pred             HhhhhhccCCCCeEEEEEEECCCCCEEEEEEEecCCcHHHHHHHHHHHHHHHhCCCCCcceeeeEec--cCCeEEEEEec
Confidence            344678999999999999875 689999999976554445578999999999999999999999984  45789999999


Q ss_pred             CCCCCHHHHhhhcCCCCCCCCHHHHHHHHHHHHHHHhhhhCCCCCCCceeecCCCCCceeecCCCCeEEecccccccccC
Q 005586          490 APKGKLSKYLDQEEGSSNVLDWSTRVSIIIGIAKGIGYLHSSEVNKPAIVHRNLSVEKVLIDQQFNPLIADCGLHKLLAD  569 (689)
Q Consensus       490 ~~~gsL~~~L~~~~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~~~ivH~dlk~~NiLl~~~~~~kl~DfGla~~~~~  569 (689)
                      +++|+|.+..        ..++.....|+.||+.||+|||+.+     |+||||||+|||+++++.+||+|||+++....
T Consensus       154 ~~~~~L~~~~--------~~~~~~~~~i~~qi~~aL~~LH~~~-----ivHrDlkp~NIll~~~~~~kL~DfG~~~~~~~  220 (353)
T PLN00034        154 MDGGSLEGTH--------IADEQFLADVARQILSGIAYLHRRH-----IVHRDIKPSNLLINSAKNVKIADFGVSRILAQ  220 (353)
T ss_pred             CCCCcccccc--------cCCHHHHHHHHHHHHHHHHHHHHCC-----EeecCCCHHHEEEcCCCCEEEcccccceeccc
Confidence            9999986532        2466778899999999999999987     99999999999999999999999999987643


Q ss_pred             CceeeeecCCCCCCCCCcccccc-----CCCCCcccchhHHHHHHHHHhCCCCcchhHHHHHhhhhhhHhhccccCCCCC
Q 005586          570 DIVFSVLKTSAAMGYLAPEYVTT-----GRFTERSDIFAFGVIILQILTGSLVLTSSMRLAAESATFENFIDRNLKGKFS  644 (689)
Q Consensus       570 ~~~~~~~~~~~~~~y~aPE~~~~-----~~~~~ksDV~sfGvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~  644 (689)
                      ... ......++..|+|||++..     ...+.++|||||||++|||++|+.||...... .+...... +........+
T Consensus       221 ~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DvwslGvil~el~~g~~pf~~~~~~-~~~~~~~~-~~~~~~~~~~  297 (353)
T PLN00034        221 TMD-PCNSSVGTIAYMSPERINTDLNHGAYDGYAGDIWSLGVSILEFYLGRFPFGVGRQG-DWASLMCA-ICMSQPPEAP  297 (353)
T ss_pred             ccc-cccccccCccccCccccccccccCcCCCcchhHHHHHHHHHHHHhCCCCCCCCCCc-cHHHHHHH-HhccCCCCCC
Confidence            321 1223457889999998743     22356899999999999999999999632110 00011111 1111112233


Q ss_pred             HHHHHHHHHHHHHhccCCCCCCCCHHHHHHHHHhhC
Q 005586          645 ESEAAKLGKMALVCTHEDPENRPTMEAVIEELTVAA  680 (689)
Q Consensus       645 ~~~~~~l~~l~~~Cl~~dp~~RPs~~evl~~L~~~~  680 (689)
                      .....++.+++.+||+.||++||++.|++++-+...
T Consensus       298 ~~~~~~l~~li~~~l~~~P~~Rpt~~ell~hp~~~~  333 (353)
T PLN00034        298 ATASREFRHFISCCLQREPAKRWSAMQLLQHPFILR  333 (353)
T ss_pred             CccCHHHHHHHHHHccCChhhCcCHHHHhcCccccc
Confidence            445678999999999999999999999999865543

>cd07848 STKc_CDKL5 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase Like 5

Probab=100.00  E-value=3.8e-39  Score=334.36  Aligned_cols=256  Identities=19%  Similarity=0.312  Sum_probs=199.3

Q ss_pred             ccCCcccccccCCcceEEEEEec-CCcEEEEEEecccCC-chHHHHHHHHHHHHhccCCCcceeEeeEEEcCCCCeEEEE
Q 005586          409 QCFSEVNLLGKGNFSSVYKGTLR-DGTLVAIRSINVTSC-KSEEAEFVKGLYLLTSLRHENIIRLRGFCCSRGRGECFLI  486 (689)
Q Consensus       409 ~~f~~~~~lg~G~~g~Vy~~~~~-~g~~vavK~l~~~~~-~~~~~~f~~e~~~l~~l~H~niv~l~g~~~~~~~~~~~lV  486 (689)
                      ++|...+.||+|+||.||+|+.+ +++.||+|++..... ......+.+|++++.+++||||+++++++..  .+..++|
T Consensus         1 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~--~~~~~lv   78 (287)
T cd07848           1 NKFEVLGVVGEGAYGVVLKCRHKETKEIVAIKKFKDSEENEEVKETTLRELKMLRTLKQENIVELKEAFRR--RGKLYLV   78 (287)
T ss_pred             CCceEEEEecccCCEEEEEEEECCCCcEEEEEEEecccccccchhhHHHHHHHHHhCCCccccchhhhEec--CCEEEEE
Confidence            36788899999999999999986 688999999976532 2334578899999999999999999998843  5789999


Q ss_pred             EEcCCCCCHHHHhhhcCCCCCCCCHHHHHHHHHHHHHHHhhhhCCCCCCCceeecCCCCCceeecCCCCeEEeccccccc
Q 005586          487 YDFAPKGKLSKYLDQEEGSSNVLDWSTRVSIIIGIAKGIGYLHSSEVNKPAIVHRNLSVEKVLIDQQFNPLIADCGLHKL  566 (689)
Q Consensus       487 ~e~~~~gsL~~~L~~~~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~~~ivH~dlk~~NiLl~~~~~~kl~DfGla~~  566 (689)
                      |||++++.+..+....    ..+++..+..++.|++.||+|||+.+     |+||||||+||+++.++.+||+|||+++.
T Consensus        79 ~e~~~~~~l~~~~~~~----~~~~~~~~~~~~~qi~~~L~~lH~~~-----i~H~dlkp~Nill~~~~~~kl~Dfg~~~~  149 (287)
T cd07848          79 FEYVEKNMLELLEEMP----NGVPPEKVRSYIYQLIKAIHWCHKND-----IVHRDIKPENLLISHNDVLKLCDFGFARN  149 (287)
T ss_pred             EecCCCCHHHHHHhcC----CCCCHHHHHHHHHHHHHHHHHHHHCC-----eecCCCCHHHEEEcCCCcEEEeeccCccc
Confidence            9999988776554322    24889999999999999999999887     99999999999999999999999999987


Q ss_pred             ccCCceeeeecCCCCCCCCCccccccCCCCCcccchhHHHHHHHHHhCCCCcchhHHHHHhhhhhhHh------------
Q 005586          567 LADDIVFSVLKTSAAMGYLAPEYVTTGRFTERSDIFAFGVIILQILTGSLVLTSSMRLAAESATFENF------------  634 (689)
Q Consensus       567 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~ksDV~sfGvvl~elltG~~p~~~~~~~~~~~~~~~~~------------  634 (689)
                      .............++..|+|||++.+..++.++|||||||++|||++|+.||.......... .+.+.            
T Consensus       150 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslGvil~el~~g~~pf~~~~~~~~~~-~~~~~~~~~~~~~~~~~  228 (287)
T cd07848         150 LSEGSNANYTEYVATRWYRSPELLLGAPYGKAVDMWSVGCILGELSDGQPLFPGESEIDQLF-TIQKVLGPLPAEQMKLF  228 (287)
T ss_pred             ccccccccccccccccccCCcHHHcCCCCCCchhHHhHHHHHHHHHhCCCCCCCCCHHHHHH-HHHHhhCCCCHHHHHhh
Confidence            65433222233457888999999998889999999999999999999999996432111000 00000            


Q ss_pred             -hcccc--------CC------CCCHHHHHHHHHHHHHhccCCCCCCCCHHHHHHHH
Q 005586          635 -IDRNL--------KG------KFSESEAAKLGKMALVCTHEDPENRPTMEAVIEEL  676 (689)
Q Consensus       635 -~~~~~--------~~------~~~~~~~~~l~~l~~~Cl~~dp~~RPs~~evl~~L  676 (689)
                       .++..        ..      ......+..+.+++.+|++.||++|||++|++++-
T Consensus       229 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dll~~~L~~~P~~R~s~~~~l~hp  285 (287)
T cd07848         229 YSNPRFHGLRFPAVNHPQSLERRYLGILSGVLLDLMKNLLKLNPTDRYLTEQCLNHP  285 (287)
T ss_pred             hccchhcccccCcccCcccHHHhhhcccCHHHHHHHHHHccCCcccCCCHHHHhcCC
Confidence             00000        00      00112355799999999999999999999999763

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 5 (CDKL5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Mutations in the gene encoding CDKL5, previously called STK9, are associated with early onset epilepsy and severe mental retardation [X-linked infantile spasm syndrome (ISSX) or West syndrome]. In addition, CDKL5 mutations also sometimes

>cd05093 PTKc_TrkB Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase B

Probab=100.00  E-value=1e-38  Score=331.32  Aligned_cols=266  Identities=23%  Similarity=0.387  Sum_probs=210.1

Q ss_pred             ccCCcccccccCCcceEEEEEec------CCcEEEEEEecccCCchHHHHHHHHHHHHhccCCCcceeEeeEEEcCCCCe
Q 005586          409 QCFSEVNLLGKGNFSSVYKGTLR------DGTLVAIRSINVTSCKSEEAEFVKGLYLLTSLRHENIIRLRGFCCSRGRGE  482 (689)
Q Consensus       409 ~~f~~~~~lg~G~~g~Vy~~~~~------~g~~vavK~l~~~~~~~~~~~f~~e~~~l~~l~H~niv~l~g~~~~~~~~~  482 (689)
                      ++|...+.||+|+||.||++...      ++..+|+|.+.... ......|.+|++++.+++||||+++++++..  .+.
T Consensus         5 ~~~~~~~~lg~G~~~~v~~~~~~~~~~~~~~~~~~ik~~~~~~-~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~--~~~   81 (288)
T cd05093           5 HNIVLKRELGEGAFGKVFLAECYNLCPEQDKILVAVKTLKDAS-DNARKDFHREAELLTNLQHEHIVKFYGVCVE--GDP   81 (288)
T ss_pred             HHeeeccccCCcCCeeEEeeEeccCCCCCcceEEEEEecCCcC-HHHHHHHHHHHHHHHhCCCCCcceEEEEEec--CCc
Confidence            46777899999999999999852      35678999887554 3445679999999999999999999999854  467


Q ss_pred             EEEEEEcCCCCCHHHHhhhcCC---------CCCCCCHHHHHHHHHHHHHHHhhhhCCCCCCCceeecCCCCCceeecCC
Q 005586          483 CFLIYDFAPKGKLSKYLDQEEG---------SSNVLDWSTRVSIIIGIAKGIGYLHSSEVNKPAIVHRNLSVEKVLIDQQ  553 (689)
Q Consensus       483 ~~lV~e~~~~gsL~~~L~~~~~---------~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~~~ivH~dlk~~NiLl~~~  553 (689)
                      .++||||+++++|.+++.....         ....++|..++.++.|++.||+|||+.+     ++||||||+||+++++
T Consensus        82 ~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~l~~~~~~~~~~ql~~aL~~lH~~~-----i~H~dlkp~Nili~~~  156 (288)
T cd05093          82 LIMVFEYMKHGDLNKFLRAHGPDAVLMAEGNRPAELTQSQMLHIAQQIAAGMVYLASQH-----FVHRDLATRNCLVGEN  156 (288)
T ss_pred             cEEEEEcCCCCCHHHHHHHcCCccccccccCCCCCCCHHHHHHHHHHHHHHHHHHHhCC-----eeecccCcceEEEccC
Confidence            8999999999999999975431         1234899999999999999999999987     9999999999999999


Q ss_pred             CCeEEecccccccccCCcee-eeecCCCCCCCCCccccccCCCCCcccchhHHHHHHHHHh-CCCCcchhHHHHHhhhhh
Q 005586          554 FNPLIADCGLHKLLADDIVF-SVLKTSAAMGYLAPEYVTTGRFTERSDIFAFGVIILQILT-GSLVLTSSMRLAAESATF  631 (689)
Q Consensus       554 ~~~kl~DfGla~~~~~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~ksDV~sfGvvl~ellt-G~~p~~~~~~~~~~~~~~  631 (689)
                      +.+||+|||+++........ ......++..|+|||++.+..++.++|||||||++|||+| |+.|+........    .
T Consensus       157 ~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDiwslG~il~~l~t~g~~p~~~~~~~~~----~  232 (288)
T cd05093         157 LLVKIGDFGMSRDVYSTDYYRVGGHTMLPIRWMPPESIMYRKFTTESDVWSLGVVLWEIFTYGKQPWYQLSNNEV----I  232 (288)
T ss_pred             CcEEeccCCccccccCCceeecCCCCCccccccCHHHhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCHHHH----H
Confidence            99999999999866433221 1122334668999999988889999999999999999999 8888864322111    1


Q ss_pred             hHhhccccCCCCCHHHHHHHHHHHHHhccCCCCCCCCHHHHHHHHHhhCCcccccc
Q 005586          632 ENFIDRNLKGKFSESEAAKLGKMALVCTHEDPENRPTMEAVIEELTVAAPVMATFL  687 (689)
Q Consensus       632 ~~~~~~~~~~~~~~~~~~~l~~l~~~Cl~~dp~~RPs~~evl~~L~~~~p~~~~~~  687 (689)
                      ..+. .......+...+.++.+++.+||+.+|.+||++.||++.|+......+.|+
T Consensus       233 ~~i~-~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~v~~~l~~~~~~~~~~~  287 (288)
T cd05093         233 ECIT-QGRVLQRPRTCPKEVYDLMLGCWQREPHMRLNIKEIHSLLQNLAKASPVYL  287 (288)
T ss_pred             HHHH-cCCcCCCCCCCCHHHHHHHHHHccCChhhCCCHHHHHHHHHHHHHhccccc
Confidence            1111 111111222345679999999999999999999999999998876666553

Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase B (TrkB); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkB is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkB to its ligands, brain-derived neurotrophic factor (BDNF) or neurotrophin 4 (NT4), results in receptor oligomerization and activation of the catalytic domain. TrkB is broadly

>cd05036 PTKc_ALK_LTK Catalytic domain of the Protein Tyrosine Kinases, Anaplastic Lymphoma Kinase and Leukocyte Tyrosine Kinase

Probab=100.00  E-value=9.6e-39  Score=329.59  Aligned_cols=258  Identities=21%  Similarity=0.437  Sum_probs=206.1

Q ss_pred             hccCCcccccccCCcceEEEEEecC------CcEEEEEEecccCCchHHHHHHHHHHHHhccCCCcceeEeeEEEcCCCC
Q 005586          408 TQCFSEVNLLGKGNFSSVYKGTLRD------GTLVAIRSINVTSCKSEEAEFVKGLYLLTSLRHENIIRLRGFCCSRGRG  481 (689)
Q Consensus       408 t~~f~~~~~lg~G~~g~Vy~~~~~~------g~~vavK~l~~~~~~~~~~~f~~e~~~l~~l~H~niv~l~g~~~~~~~~  481 (689)
                      +++|...+.||+|+||.||+|.+.+      +..||+|.+...........|.+|+.++++++|+||+++++++.+  ..
T Consensus         5 ~~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~--~~   82 (277)
T cd05036           5 RDSITLLRALGHGAFGEVYEGLYRGRDGDAVELQVAVKTLPESCSEQDESDFLMEALIMSKFNHQNIVRLIGVSFE--RL   82 (277)
T ss_pred             HHHcEeeeECCCCCCCcEEEEEEecCCCCCCceeEEEEEcCCCCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEcc--CC
Confidence            4668888999999999999998753      578999988765544556689999999999999999999998854  45


Q ss_pred             eEEEEEEcCCCCCHHHHhhhcCCC---CCCCCHHHHHHHHHHHHHHHhhhhCCCCCCCceeecCCCCCceeecCCC---C
Q 005586          482 ECFLIYDFAPKGKLSKYLDQEEGS---SNVLDWSTRVSIIIGIAKGIGYLHSSEVNKPAIVHRNLSVEKVLIDQQF---N  555 (689)
Q Consensus       482 ~~~lV~e~~~~gsL~~~L~~~~~~---~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~~~ivH~dlk~~NiLl~~~~---~  555 (689)
                      ..++||||+++|+|.++++.....   ...++|..++.++.||+.||+|||+.+     ++||||||+||+++.++   .
T Consensus        83 ~~~lv~e~~~g~~L~~~i~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~-----ivH~dlkp~nil~~~~~~~~~  157 (277)
T cd05036          83 PRFILLELMAGGDLKSFLRENRPRPERPSSLTMKDLLFCARDVAKGCKYLEENH-----FIHRDIAARNCLLTCKGPGRV  157 (277)
T ss_pred             CcEEEEecCCCCCHHHHHHHhCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHHCC-----EeecccchheEEEeccCCCcc
Confidence            678999999999999999765321   235899999999999999999999987     99999999999998754   5


Q ss_pred             eEEecccccccccCCceeee-ecCCCCCCCCCccccccCCCCCcccchhHHHHHHHHHh-CCCCcchhHHHHHhhhhhhH
Q 005586          556 PLIADCGLHKLLADDIVFSV-LKTSAAMGYLAPEYVTTGRFTERSDIFAFGVIILQILT-GSLVLTSSMRLAAESATFEN  633 (689)
Q Consensus       556 ~kl~DfGla~~~~~~~~~~~-~~~~~~~~y~aPE~~~~~~~~~ksDV~sfGvvl~ellt-G~~p~~~~~~~~~~~~~~~~  633 (689)
                      +||+|||+++.......... .....+..|+|||++.+..++.++|||||||++|||++ |+.||.......     ..+
T Consensus       158 ~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~el~~~g~~pf~~~~~~~-----~~~  232 (277)
T cd05036         158 AKIADFGMARDIYRASYYRKGGRAMLPIKWMPPEAFLDGIFTSKTDVWSFGVLLWEIFSLGYMPYPGRTNQE-----VME  232 (277)
T ss_pred             eEeccCccccccCCccceecCCCCCccHhhCCHHHHhcCCcCchhHHHHHHHHHHHHHcCCCCCCCCCCHHH-----HHH
Confidence            89999999987643322111 11223457999999998899999999999999999997 999986532211     122


Q ss_pred             hhccccCCCCCHHHHHHHHHHHHHhccCCCCCCCCHHHHHHHHH
Q 005586          634 FIDRNLKGKFSESEAAKLGKMALVCTHEDPENRPTMEAVIEELT  677 (689)
Q Consensus       634 ~~~~~~~~~~~~~~~~~l~~l~~~Cl~~dp~~RPs~~evl~~L~  677 (689)
                      .+........+...+..+.+++.+|++.+|++||++.+|+++|+
T Consensus       233 ~~~~~~~~~~~~~~~~~~~~~i~~cl~~~p~~Rps~~~vl~~l~  276 (277)
T cd05036         233 FVTGGGRLDPPKGCPGPVYRIMTDCWQHTPEDRPNFATILERIQ  276 (277)
T ss_pred             HHHcCCcCCCCCCCCHHHHHHHHHHcCCCcccCcCHHHHHHHhh
Confidence            22222233334455678999999999999999999999999986

Protein Tyrosine Kinase (PTK) family; Anaplastic Lymphoma Kinase (ALK) and Leukocyte Tyrosine (tyr) Kinase (LTK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyr residues in protein substrates. ALK and LTK are orphan receptor tyr kinases (RTKs) whose ligands are not yet well-defined. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. They are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. ALK appears to play an important role in mammalian neural development as well

>PTZ00263 protein kinase A catalytic subunit; Provisional

Probab=100.00  E-value=2.3e-39  Score=342.68  Aligned_cols=248  Identities=19%  Similarity=0.278  Sum_probs=202.9

Q ss_pred             ccCCcccccccCCcceEEEEEec-CCcEEEEEEecccCC--chHHHHHHHHHHHHhccCCCcceeEeeEEEcCCCCeEEE
Q 005586          409 QCFSEVNLLGKGNFSSVYKGTLR-DGTLVAIRSINVTSC--KSEEAEFVKGLYLLTSLRHENIIRLRGFCCSRGRGECFL  485 (689)
Q Consensus       409 ~~f~~~~~lg~G~~g~Vy~~~~~-~g~~vavK~l~~~~~--~~~~~~f~~e~~~l~~l~H~niv~l~g~~~~~~~~~~~l  485 (689)
                      ++|...+.||+|+||.||+|+.+ +|+.||+|++.....  ......+.+|++++.+++||||+++++++..  .+..++
T Consensus        18 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~--~~~~~l   95 (329)
T PTZ00263         18 SDFEMGETLGTGSFGRVRIAKHKGTGEYYAIKCLKKREILKMKQVQHVAQEKSILMELSHPFIVNMMCSFQD--ENRVYF   95 (329)
T ss_pred             hheEEEEEEEecCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhhHHHHHHHHHHHHhCCCCCCCcEEEEEEc--CCEEEE
Confidence            45777899999999999999986 689999999975431  2334678999999999999999999998854  578999


Q ss_pred             EEEcCCCCCHHHHhhhcCCCCCCCCHHHHHHHHHHHHHHHhhhhCCCCCCCceeecCCCCCceeecCCCCeEEecccccc
Q 005586          486 IYDFAPKGKLSKYLDQEEGSSNVLDWSTRVSIIIGIAKGIGYLHSSEVNKPAIVHRNLSVEKVLIDQQFNPLIADCGLHK  565 (689)
Q Consensus       486 V~e~~~~gsL~~~L~~~~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~~~ivH~dlk~~NiLl~~~~~~kl~DfGla~  565 (689)
                      ||||+++|+|.+++....    .+++.....++.|++.||+|||+.+     |+||||||+|||+++++.+||+|||+++
T Consensus        96 v~e~~~~~~L~~~l~~~~----~~~~~~~~~~~~qi~~aL~~LH~~~-----ivH~dlkp~NIll~~~~~~kl~Dfg~~~  166 (329)
T PTZ00263         96 LLEFVVGGELFTHLRKAG----RFPNDVAKFYHAELVLAFEYLHSKD-----IIYRDLKPENLLLDNKGHVKVTDFGFAK  166 (329)
T ss_pred             EEcCCCCChHHHHHHHcC----CCCHHHHHHHHHHHHHHHHHHHHCC-----eeecCCCHHHEEECCCCCEEEeeccCce
Confidence            999999999999997643    3788889999999999999999987     9999999999999999999999999998


Q ss_pred             cccCCceeeeecCCCCCCCCCccccccCCCCCcccchhHHHHHHHHHhCCCCcchhHHHHHhhhhhhHhhccccCCCCCH
Q 005586          566 LLADDIVFSVLKTSAAMGYLAPEYVTTGRFTERSDIFAFGVIILQILTGSLVLTSSMRLAAESATFENFIDRNLKGKFSE  645 (689)
Q Consensus       566 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~ksDV~sfGvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~  645 (689)
                      .......    ...++..|+|||++.+..++.++|||||||++|||+||+.||........    ...+....  ..++.
T Consensus       167 ~~~~~~~----~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~----~~~i~~~~--~~~p~  236 (329)
T PTZ00263        167 KVPDRTF----TLCGTPEYLAPEVIQSKGHGKAVDWWTMGVLLYEFIAGYPPFFDDTPFRI----YEKILAGR--LKFPN  236 (329)
T ss_pred             EcCCCcc----eecCChhhcCHHHHcCCCCCCcceeechHHHHHHHHcCCCCCCCCCHHHH----HHHHhcCC--cCCCC
Confidence            7654321    23578889999999998999999999999999999999999965422111    11222111  12233


Q ss_pred             HHHHHHHHHHHHhccCCCCCCCC-----HHHHHHHHH
Q 005586          646 SEAAKLGKMALVCTHEDPENRPT-----MEAVIEELT  677 (689)
Q Consensus       646 ~~~~~l~~l~~~Cl~~dp~~RPs-----~~evl~~L~  677 (689)
                      ....++.+++..||+.||++||+     +.+++.+.+
T Consensus       237 ~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~ll~hp~  273 (329)
T PTZ00263        237 WFDGRARDLVKGLLQTDHTKRLGTLKGGVADVKNHPY  273 (329)
T ss_pred             CCCHHHHHHHHHHhhcCHHHcCCCCCCCHHHHhcCCc
Confidence            34567889999999999999996     788887754

>cd05090 PTKc_Ror1 Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 1

Probab=100.00  E-value=1.1e-38  Score=330.26  Aligned_cols=257  Identities=25%  Similarity=0.431  Sum_probs=203.8

Q ss_pred             cCCcccccccCCcceEEEEEe-----cCCcEEEEEEecccCCchHHHHHHHHHHHHhccCCCcceeEeeEEEcCCCCeEE
Q 005586          410 CFSEVNLLGKGNFSSVYKGTL-----RDGTLVAIRSINVTSCKSEEAEFVKGLYLLTSLRHENIIRLRGFCCSRGRGECF  484 (689)
Q Consensus       410 ~f~~~~~lg~G~~g~Vy~~~~-----~~g~~vavK~l~~~~~~~~~~~f~~e~~~l~~l~H~niv~l~g~~~~~~~~~~~  484 (689)
                      +|+..+.||+|+||.||+|..     .++..||+|.+..........+|.+|++++++++||||+++++++..  ....+
T Consensus         6 ~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~--~~~~~   83 (283)
T cd05090           6 AVRFMEELGECAFGKIYKGHLYLPGMDHAQLVAIKTLKDINNPQQWGEFQQEASLMAELHHPNIVCLLGVVTQ--EQPVC   83 (283)
T ss_pred             hceeeeeccccCCcceEEEEEecCCCCCcceEEEEeccCCCCHHHHHHHHHHHHHHhhCCCCCeeeEEEEEec--CCceE
Confidence            466778999999999999985     25688999999865444455689999999999999999999999844  46789


Q ss_pred             EEEEcCCCCCHHHHhhhcCC-------------CCCCCCHHHHHHHHHHHHHHHhhhhCCCCCCCceeecCCCCCceeec
Q 005586          485 LIYDFAPKGKLSKYLDQEEG-------------SSNVLDWSTRVSIIIGIAKGIGYLHSSEVNKPAIVHRNLSVEKVLID  551 (689)
Q Consensus       485 lV~e~~~~gsL~~~L~~~~~-------------~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~~~ivH~dlk~~NiLl~  551 (689)
                      +||||+++|+|.+++.....             ....+++.+.+.++.|++.||+|||+.+     |+||||||+|||++
T Consensus        84 lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH~~~-----i~H~dlkp~nili~  158 (283)
T cd05090          84 MLFEYLNQGDLHEFLIMRSPHSDVGCSSDEDGTVKSSLDHGDFLHIAIQIAAGMEYLSSHF-----FVHKDLAARNILIG  158 (283)
T ss_pred             EEEEcCCCCcHHHHHHhcCCCCccccccccccccccccCHHHHHHHHHHHHHHHHHHHhcC-----eehhccccceEEEc
Confidence            99999999999999964321             1234889999999999999999999987     99999999999999


Q ss_pred             CCCCeEEecccccccccCCcee-eeecCCCCCCCCCccccccCCCCCcccchhHHHHHHHHHh-CCCCcchhHHHHHhhh
Q 005586          552 QQFNPLIADCGLHKLLADDIVF-SVLKTSAAMGYLAPEYVTTGRFTERSDIFAFGVIILQILT-GSLVLTSSMRLAAESA  629 (689)
Q Consensus       552 ~~~~~kl~DfGla~~~~~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~ksDV~sfGvvl~ellt-G~~p~~~~~~~~~~~~  629 (689)
                      +++.+||+|||+++........ ......++..|+|||++.+..++.++|||||||++|||++ |..|+......     
T Consensus       159 ~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~~~g~~p~~~~~~~-----  233 (283)
T cd05090         159 EQLHVKISDLGLSREIYSADYYRVQPKSLLPIRWMPPEAIMYGKFSSDSDIWSFGVVLWEIFSFGLQPYYGFSNQ-----  233 (283)
T ss_pred             CCCcEEeccccccccccCCcceecccCCCccceecChHHhccCCCCchhhhHHHHHHHHHHHcCCCCCCCCCCHH-----
Confidence            9999999999999876433211 1122234567999999988889999999999999999999 88888543221     


Q ss_pred             hhhHhhccccCCCCCHHHHHHHHHHHHHhccCCCCCCCCHHHHHHHHHh
Q 005586          630 TFENFIDRNLKGKFSESEAAKLGKMALVCTHEDPENRPTMEAVIEELTV  678 (689)
Q Consensus       630 ~~~~~~~~~~~~~~~~~~~~~l~~l~~~Cl~~dp~~RPs~~evl~~L~~  678 (689)
                      ...+.++.......+...+.++.+++.+|++.||++||++.+|.++|+.
T Consensus       234 ~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rp~~~~i~~~l~~  282 (283)
T cd05090         234 EVIEMVRKRQLLPCSEDCPPRMYSLMTECWQEGPSRRPRFKDIHTRLRS  282 (283)
T ss_pred             HHHHHHHcCCcCCCCCCCCHHHHHHHHHHcccCcccCcCHHHHHHHhhc
Confidence            1111222221122334456678999999999999999999999999863

Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 1 (Ror1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase cataly

>cd05600 STKc_Sid2p_Dbf2p Catalytic domain of Fungal Sid2p- and Dbf2p-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=4.2e-39  Score=341.45  Aligned_cols=254  Identities=17%  Similarity=0.246  Sum_probs=203.7

Q ss_pred             cCCcccccccCCcceEEEEEec-CCcEEEEEEecccCC--chHHHHHHHHHHHHhccCCCcceeEeeEEEcCCCCeEEEE
Q 005586          410 CFSEVNLLGKGNFSSVYKGTLR-DGTLVAIRSINVTSC--KSEEAEFVKGLYLLTSLRHENIIRLRGFCCSRGRGECFLI  486 (689)
Q Consensus       410 ~f~~~~~lg~G~~g~Vy~~~~~-~g~~vavK~l~~~~~--~~~~~~f~~e~~~l~~l~H~niv~l~g~~~~~~~~~~~lV  486 (689)
                      +|...+.||+|+||.||+|+.. +|+.||+|++.....  ......+.+|++++.+++||||+++++++.  ..+..++|
T Consensus         2 ~y~~~~~ig~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~iv~~~~~~~--~~~~~~lv   79 (333)
T cd05600           2 DFQILTQVGQGGYGQVFLAKKKDTGEIVALKRMKKSLLFKLNEVRHVLTERDILTTTKSEWLVKLLYAFQ--DDEYLYLA   79 (333)
T ss_pred             CcEEEEEEeecCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhHHHHHHHHHHHHHhCCCCCCccEEEEEE--cCCEEEEE
Confidence            5788899999999999999986 589999999975432  234467889999999999999999999884  35789999


Q ss_pred             EEcCCCCCHHHHhhhcCCCCCCCCHHHHHHHHHHHHHHHhhhhCCCCCCCceeecCCCCCceeecCCCCeEEeccccccc
Q 005586          487 YDFAPKGKLSKYLDQEEGSSNVLDWSTRVSIIIGIAKGIGYLHSSEVNKPAIVHRNLSVEKVLIDQQFNPLIADCGLHKL  566 (689)
Q Consensus       487 ~e~~~~gsL~~~L~~~~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~~~ivH~dlk~~NiLl~~~~~~kl~DfGla~~  566 (689)
                      |||+++|+|.+++....    .+++.....++.|++.||+|||+.+     |+||||||+|||+++++.+||+|||+++.
T Consensus        80 ~e~~~g~~L~~~l~~~~----~l~~~~~~~~~~qi~~~l~~lH~~~-----ivH~dlkp~Nil~~~~~~~kL~Dfg~a~~  150 (333)
T cd05600          80 MEYVPGGDFRTLLNNLG----VLSEDHARFYMAEMFEAVDALHELG-----YIHRDLKPENFLIDASGHIKLTDFGLSKG  150 (333)
T ss_pred             EeCCCCCCHHHHHHHcC----CCCHHHHHHHHHHHHHHHHHHHHCC-----ccccCCCHHHEEECCCCCEEEEeCcCCcc
Confidence            99999999999997543    3889999999999999999999987     99999999999999999999999999986


Q ss_pred             ccCCceeeeecCCCCCCCCCccccccCCCCCcccchhHHHHHHHHHhCCCCcchhHHHHHhhhh--hhHhhccccCCCCC
Q 005586          567 LADDIVFSVLKTSAAMGYLAPEYVTTGRFTERSDIFAFGVIILQILTGSLVLTSSMRLAAESAT--FENFIDRNLKGKFS  644 (689)
Q Consensus       567 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~ksDV~sfGvvl~elltG~~p~~~~~~~~~~~~~--~~~~~~~~~~~~~~  644 (689)
                      ...    ......++..|+|||++.+..++.++|||||||++|||++|+.||............  ....+.........
T Consensus       151 ~~~----~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~  226 (333)
T cd05600         151 IVT----YANSVVGSPDYMAPEVLRGKGYDFTVDYWSLGCMLYEFLCGFPPFSGSTPNETWENLKYWKETLQRPVYDDPR  226 (333)
T ss_pred             ccc----ccCCcccCccccChhHhcCCCCCCccceecchHHHhhhhhCCCCCCCCCHHHHHHHHHhccccccCCCCCccc
Confidence            543    122345788999999999989999999999999999999999999653221111100  00111111000001


Q ss_pred             HHHHHHHHHHHHHhccCCCCCCCCHHHHHHHHHh
Q 005586          645 ESEAAKLGKMALVCTHEDPENRPTMEAVIEELTV  678 (689)
Q Consensus       645 ~~~~~~l~~l~~~Cl~~dp~~RPs~~evl~~L~~  678 (689)
                      ...+.++.+++..|+..+|++||++.|++++.+.
T Consensus       227 ~~~s~~~~~li~~~l~~~~~rr~s~~~ll~h~~~  260 (333)
T cd05600         227 FNLSDEAWDLITKLINDPSRRFGSLEDIKNHPFF  260 (333)
T ss_pred             cccCHHHHHHHHHHhhChhhhcCCHHHHHhCccc
Confidence            1346678899999999999999999999987543

Serine/Threonine Kinases (STKs), ROCK- and NDR-like subfamily, fungal Sid2p- and Dbf2p-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sid2p- and Dbf2p-like group is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group contains fungal kinases including Schizosaccharomyces pombe Sid2p and Saccharomyces cerevisiae Dbf2p. Group members show similarity to NDR kinases in that they contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Sid2p plays a crucial role in the septum initiation network (SIN) and in the initiation of cytokinesis.

>KOG0583 consensus Serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=8.1e-39  Score=337.94  Aligned_cols=254  Identities=23%  Similarity=0.337  Sum_probs=207.6

Q ss_pred             hccCCcccccccCCcceEEEEEec-CCcEEEEEEecccCCc----hHHHHHHHHHHHHhccC-CCcceeEeeEEEcCCCC
Q 005586          408 TQCFSEVNLLGKGNFSSVYKGTLR-DGTLVAIRSINVTSCK----SEEAEFVKGLYLLTSLR-HENIIRLRGFCCSRGRG  481 (689)
Q Consensus       408 t~~f~~~~~lg~G~~g~Vy~~~~~-~g~~vavK~l~~~~~~----~~~~~f~~e~~~l~~l~-H~niv~l~g~~~~~~~~  481 (689)
                      .+.|...+.||+|.||+|+.|... +|..||+|.+......    ...+...+|+.++++++ ||||++++.++..  ..
T Consensus        16 ~g~y~~~~~lG~GsfgkV~~a~~~~t~~~vAiKii~~~~~~~~~~~~~~~i~rEi~~~~~~~~HpnI~~l~ev~~t--~~   93 (370)
T KOG0583|consen   16 IGKYELGRTLGSGSFGKVKLAKHRLTGEKVAIKIIDRKKVSSKSQKLDELIKREISILRRLRSHPNIIRLLEVFAT--PT   93 (370)
T ss_pred             cCceeeeeeecCCCCeeEEEeeeccCCCeEEEEEechhcccccccccchhhHHHHHHHHHhccCCCEeEEEEEEec--CC
Confidence            356777899999999999999865 7899999977654211    23445668999999999 9999999999954  46


Q ss_pred             eEEEEEEcCCCCCHHHHhhhcCCCCCCCCHHHHHHHHHHHHHHHhhhhCCCCCCCceeecCCCCCceeecCC-CCeEEec
Q 005586          482 ECFLIYDFAPKGKLSKYLDQEEGSSNVLDWSTRVSIIIGIAKGIGYLHSSEVNKPAIVHRNLSVEKVLIDQQ-FNPLIAD  560 (689)
Q Consensus       482 ~~~lV~e~~~~gsL~~~L~~~~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~~~ivH~dlk~~NiLl~~~-~~~kl~D  560 (689)
                      ..++||||+.+|+|.+++....    .+.+.+..++..|++.|++|+|+.+     |+||||||+|||+|++ +.+||+|
T Consensus        94 ~~~ivmEy~~gGdL~~~i~~~g----~l~E~~ar~~F~Qlisav~y~H~~g-----i~HRDLK~ENilld~~~~~~Kl~D  164 (370)
T KOG0583|consen   94 KIYIVMEYCSGGDLFDYIVNKG----RLKEDEARKYFRQLISAVAYCHSRG-----IVHRDLKPENILLDGNEGNLKLSD  164 (370)
T ss_pred             eEEEEEEecCCccHHHHHHHcC----CCChHHHHHHHHHHHHHHHHHHhCC-----EeeCCCCHHHEEecCCCCCEEEec
Confidence            6999999999999999998833    3788899999999999999999988     9999999999999999 9999999


Q ss_pred             cccccccc-CCceeeeecCCCCCCCCCccccccCC-CC-CcccchhHHHHHHHHHhCCCCcchhHHHHHhhhhhhHhhcc
Q 005586          561 CGLHKLLA-DDIVFSVLKTSAAMGYLAPEYVTTGR-FT-ERSDIFAFGVIILQILTGSLVLTSSMRLAAESATFENFIDR  637 (689)
Q Consensus       561 fGla~~~~-~~~~~~~~~~~~~~~y~aPE~~~~~~-~~-~ksDV~sfGvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~  637 (689)
                      ||++.... .+.  ......|++.|+|||++.+.. |+ .++||||+||+||-|++|+.||.+.......    ..+...
T Consensus       165 FG~s~~~~~~~~--~l~t~cGsp~Y~aPEvl~~~~~Y~g~~aDvWS~GViLy~ml~G~~PF~d~~~~~l~----~ki~~~  238 (370)
T KOG0583|consen  165 FGLSAISPGEDG--LLKTFCGSPAYAAPEVLSGKGTYSGKAADVWSLGVILYVLLCGRLPFDDSNVPNLY----RKIRKG  238 (370)
T ss_pred             cccccccCCCCC--cccCCCCCcccCCHHHhCCCCCcCCchhhhhhhHHHHHHHHhCCCCCCCccHHHHH----HHHhcC
Confidence            99999883 322  334456899999999999977 86 7899999999999999999999874322211    111111


Q ss_pred             ccCCCCCHHH-HHHHHHHHHHhccCCCCCCCCHHHHHHHHHhhC
Q 005586          638 NLKGKFSESE-AAKLGKMALVCTHEDPENRPTMEAVIEELTVAA  680 (689)
Q Consensus       638 ~~~~~~~~~~-~~~l~~l~~~Cl~~dp~~RPs~~evl~~L~~~~  680 (689)
                      .  -.++... +.++..++.+|+..+|.+|+++.+++.+-|...
T Consensus       239 ~--~~~p~~~~S~~~~~Li~~mL~~~P~~R~t~~~i~~h~w~~~  280 (370)
T KOG0583|consen  239 E--FKIPSYLLSPEARSLIEKMLVPDPSTRITLLEILEHPWFQK  280 (370)
T ss_pred             C--ccCCCCcCCHHHHHHHHHHcCCCcccCCCHHHHhhChhhcc
Confidence            1  1233334 788999999999999999999999998877664

>cd05070 PTKc_Fyn_Yrk Catalytic domain of the Protein Tyrosine Kinases, Fyn and Yrk

Probab=100.00  E-value=1.3e-38  Score=325.38  Aligned_cols=253  Identities=25%  Similarity=0.476  Sum_probs=205.5

Q ss_pred             ccCCcccccccCCcceEEEEEecCCcEEEEEEecccCCchHHHHHHHHHHHHhccCCCcceeEeeEEEcCCCCeEEEEEE
Q 005586          409 QCFSEVNLLGKGNFSSVYKGTLRDGTLVAIRSINVTSCKSEEAEFVKGLYLLTSLRHENIIRLRGFCCSRGRGECFLIYD  488 (689)
Q Consensus       409 ~~f~~~~~lg~G~~g~Vy~~~~~~g~~vavK~l~~~~~~~~~~~f~~e~~~l~~l~H~niv~l~g~~~~~~~~~~~lV~e  488 (689)
                      ++|+..+.||+|+||.||+|..+++..||+|.+.....  ...+|.+|+.++++++|+|++++++++.   ....++|||
T Consensus         6 ~~~~~~~~ig~g~~~~v~~~~~~~~~~~~~k~~~~~~~--~~~~~~~E~~~l~~l~~~~i~~~~~~~~---~~~~~lv~e   80 (260)
T cd05070           6 ESLQLIKKLGNGQFGEVWMGTWNGNTKVAVKTLKPGTM--SPESFLEEAQIMKKLRHDKLVQLYAVVS---EEPIYIVTE   80 (260)
T ss_pred             HHhhhhheeccccCceEEEEEecCCceeEEEEecCCCC--CHHHHHHHHHHHHhcCCCceEEEEeEEC---CCCcEEEEE
Confidence            35677789999999999999988888999999876542  3457999999999999999999999873   245789999


Q ss_pred             cCCCCCHHHHhhhcCCCCCCCCHHHHHHHHHHHHHHHhhhhCCCCCCCceeecCCCCCceeecCCCCeEEeccccccccc
Q 005586          489 FAPKGKLSKYLDQEEGSSNVLDWSTRVSIIIGIAKGIGYLHSSEVNKPAIVHRNLSVEKVLIDQQFNPLIADCGLHKLLA  568 (689)
Q Consensus       489 ~~~~gsL~~~L~~~~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~~~ivH~dlk~~NiLl~~~~~~kl~DfGla~~~~  568 (689)
                      |+++++|.++++....  ..+++.+++.++.+++.||+|||+.+     |+||||||+||++++++.+||+|||+++.+.
T Consensus        81 ~~~~~~L~~~~~~~~~--~~~~~~~~~~~~~~l~~al~~lH~~~-----i~H~di~p~Nili~~~~~~~l~dfg~~~~~~  153 (260)
T cd05070          81 YMSKGSLLDFLKDGEG--RALKLPNLVDMAAQVAAGMAYIERMN-----YIHRDLRSANILVGDGLVCKIADFGLARLIE  153 (260)
T ss_pred             ecCCCcHHHHHHhcCC--CCCCHHHHHHHHHHHHHHHHHHHHCC-----cccCCCccceEEEeCCceEEeCCceeeeecc
Confidence            9999999999976432  34899999999999999999999987     9999999999999999999999999998765


Q ss_pred             CCceeeeecCCCCCCCCCccccccCCCCCcccchhHHHHHHHHHh-CCCCcchhHHHHHhhhhhhHhhccccCCCCCHHH
Q 005586          569 DDIVFSVLKTSAAMGYLAPEYVTTGRFTERSDIFAFGVIILQILT-GSLVLTSSMRLAAESATFENFIDRNLKGKFSESE  647 (689)
Q Consensus       569 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~ksDV~sfGvvl~ellt-G~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  647 (689)
                      ...........++..|+|||++.+..++.++||||||+++|||++ |+.||......     ...+.+........+...
T Consensus       154 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~~g~~p~~~~~~~-----~~~~~~~~~~~~~~~~~~  228 (260)
T cd05070         154 DNEYTARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELVTKGRVPYPGMNNR-----EVLEQVERGYRMPCPQDC  228 (260)
T ss_pred             CcccccccCCCCCccccChHHHhcCCCcchhhhHHHHHHHHHHHhcCCCCCCCCCHH-----HHHHHHHcCCCCCCCCcC
Confidence            433222222334567999999988889999999999999999999 88888543211     111122222222334455


Q ss_pred             HHHHHHHHHHhccCCCCCCCCHHHHHHHHHh
Q 005586          648 AAKLGKMALVCTHEDPENRPTMEAVIEELTV  678 (689)
Q Consensus       648 ~~~l~~l~~~Cl~~dp~~RPs~~evl~~L~~  678 (689)
                      +..+.+++.+|+..+|++||++.++++.|+.
T Consensus       229 ~~~~~~li~~~l~~~p~~Rpt~~~l~~~l~~  259 (260)
T cd05070         229 PISLHELMLQCWKKDPEERPTFEYLQSFLED  259 (260)
T ss_pred             CHHHHHHHHHHcccCcccCcCHHHHHHHHhc
Confidence            6789999999999999999999999998874

Protein Tyrosine Kinase (PTK) family; Fyn and Yrk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fyn and Yrk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that r

>cd05045 PTKc_RET Catalytic domain of the Protein Tyrosine Kinase, REarranged during Transfection protein

Probab=100.00  E-value=1.3e-38  Score=330.90  Aligned_cols=259  Identities=25%  Similarity=0.419  Sum_probs=206.6

Q ss_pred             CCcccccccCCcceEEEEEec------CCcEEEEEEecccCCchHHHHHHHHHHHHhccCCCcceeEeeEEEcCCCCeEE
Q 005586          411 FSEVNLLGKGNFSSVYKGTLR------DGTLVAIRSINVTSCKSEEAEFVKGLYLLTSLRHENIIRLRGFCCSRGRGECF  484 (689)
Q Consensus       411 f~~~~~lg~G~~g~Vy~~~~~------~g~~vavK~l~~~~~~~~~~~f~~e~~~l~~l~H~niv~l~g~~~~~~~~~~~  484 (689)
                      |...+.||+|+||.||+|...      ....+++|.+..........++.+|+.++++++||||+++++.+..  .+..+
T Consensus         2 ~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~--~~~~~   79 (290)
T cd05045           2 LVLGKTLGEGEFGKVVKATAFRLKGRAGYTTVAVKMLKENASSSELRDLLSEFNLLKQVNHPHVIKLYGACSQ--DGPLL   79 (290)
T ss_pred             ccccccccCcCCcceEEEEEecCCCCCcceeEEEEecCCCCCHHHHHHHHHHHHHHhhCCCCCEeeEEEEEec--CCCcE
Confidence            566789999999999999853      2357899988766544456789999999999999999999999844  46789


Q ss_pred             EEEEcCCCCCHHHHhhhcCC--------------------CCCCCCHHHHHHHHHHHHHHHhhhhCCCCCCCceeecCCC
Q 005586          485 LIYDFAPKGKLSKYLDQEEG--------------------SSNVLDWSTRVSIIIGIAKGIGYLHSSEVNKPAIVHRNLS  544 (689)
Q Consensus       485 lV~e~~~~gsL~~~L~~~~~--------------------~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~~~ivH~dlk  544 (689)
                      +|+||+++|+|.+++.....                    ....++|.+++.++.|++.||+|||+.+     |+|||||
T Consensus        80 lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~-----ivH~dik  154 (290)
T cd05045          80 LIVEYAKYGSLRSFLRESRKVGPSYLGSDGNRNSSYLDNPDERALTMGDLISFAWQISRGMQYLAEMK-----LVHRDLA  154 (290)
T ss_pred             EEEEecCCCCHHHHHHhcCCccccccccccccccccccCccccccCHHHHHHHHHHHHHHHHHHHHCC-----eehhhhh
Confidence            99999999999999864321                    1135889999999999999999999887     9999999


Q ss_pred             CCceeecCCCCeEEecccccccccCCce-eeeecCCCCCCCCCccccccCCCCCcccchhHHHHHHHHHh-CCCCcchhH
Q 005586          545 VEKVLIDQQFNPLIADCGLHKLLADDIV-FSVLKTSAAMGYLAPEYVTTGRFTERSDIFAFGVIILQILT-GSLVLTSSM  622 (689)
Q Consensus       545 ~~NiLl~~~~~~kl~DfGla~~~~~~~~-~~~~~~~~~~~y~aPE~~~~~~~~~ksDV~sfGvvl~ellt-G~~p~~~~~  622 (689)
                      |+|||+++++.+||+|||+++....... .......++..|+|||.+.+..++.++||||||+++|||+| |+.|+....
T Consensus       155 p~nill~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~apE~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~  234 (290)
T cd05045         155 ARNVLVAEGRKMKISDFGLSRDVYEEDSYVKRSKGRIPVKWMAIESLFDHIYTTQSDVWSFGVLLWEIVTLGGNPYPGIA  234 (290)
T ss_pred             hheEEEcCCCcEEeccccccccccCccchhcccCCCCCccccCHHHHccCCcchHhHHHHHHHHHHHHHhcCCCCCCCCC
Confidence            9999999999999999999986533221 11122334567999999988889999999999999999999 998886432


Q ss_pred             HHHHhhhhhhHhhccccCCCCCHHHHHHHHHHHHHhccCCCCCCCCHHHHHHHHHhhCC
Q 005586          623 RLAAESATFENFIDRNLKGKFSESEAAKLGKMALVCTHEDPENRPTMEAVIEELTVAAP  681 (689)
Q Consensus       623 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~Cl~~dp~~RPs~~evl~~L~~~~p  681 (689)
                      ...     +.+.+........+.....++.+++..|++.+|++||++.|+++.|+....
T Consensus       235 ~~~-----~~~~~~~~~~~~~~~~~~~~~~~~i~~cl~~~P~~Rp~~~~i~~~l~~~~~  288 (290)
T cd05045         235 PER-----LFNLLKTGYRMERPENCSEEMYNLMLTCWKQEPDKRPTFADISKELEKMMV  288 (290)
T ss_pred             HHH-----HHHHHhCCCCCCCCCCCCHHHHHHHHHHccCCcccCCCHHHHHHHHHHHHh
Confidence            211     122222323333344556789999999999999999999999999988643

Protein Tyrosine Kinase (PTK) family; RET (REarranged during Transfection) protein; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. RET is a receptor tyr kinase (RTK) containing an extracellular region with four cadherin-like repeats, a calcium-binding site, and a cysteine-rich domain, a transmembrane segment, and an intracellular catalytic domain. It is part of a multisubunit complex that binds glial-derived neurotropic factor (GDNF) family ligands (GFLs) including GDNF, neurturin, artemin, and persephin. GFLs bind RET along with four GPI-anchored coreceptors, bringing two RET molecules together, leadi

>cd05115 PTKc_Zap-70 Catalytic domain of the Protein Tyrosine Kinase, Zeta-chain-associated protein of 70kDa

Probab=100.00  E-value=2.1e-38  Score=323.30  Aligned_cols=248  Identities=25%  Similarity=0.411  Sum_probs=199.8

Q ss_pred             ccccCCcceEEEEEec---CCcEEEEEEecccCCchHHHHHHHHHHHHhccCCCcceeEeeEEEcCCCCeEEEEEEcCCC
Q 005586          416 LLGKGNFSSVYKGTLR---DGTLVAIRSINVTSCKSEEAEFVKGLYLLTSLRHENIIRLRGFCCSRGRGECFLIYDFAPK  492 (689)
Q Consensus       416 ~lg~G~~g~Vy~~~~~---~g~~vavK~l~~~~~~~~~~~f~~e~~~l~~l~H~niv~l~g~~~~~~~~~~~lV~e~~~~  492 (689)
                      .||+|+||.||+|.++   ++..||+|++.........++|.+|+.++++++||||+++++++.   .+..++||||+++
T Consensus         2 ~ig~G~~g~v~~~~~~~~~~~~~vavk~~~~~~~~~~~~~~~~E~~~l~~l~h~~ii~~~~~~~---~~~~~lv~e~~~~   78 (257)
T cd05115           2 ELGSGNFGCVKKGVYKMRKKQIDVAIKVLKNENEKSVRDEMMREAEIMHQLDNPYIVRMIGVCE---AEALMLVMEMASG   78 (257)
T ss_pred             ccCCCCcccEEEEEEecCCCceeEEEEEcccccChHHHHHHHHHHHHHHhcCCCCeEEEEEEEc---CCCeEEEEEeCCC
Confidence            3899999999999864   456799999976654444567999999999999999999999873   2468999999999


Q ss_pred             CCHHHHhhhcCCCCCCCCHHHHHHHHHHHHHHHhhhhCCCCCCCceeecCCCCCceeecCCCCeEEecccccccccCCce
Q 005586          493 GKLSKYLDQEEGSSNVLDWSTRVSIIIGIAKGIGYLHSSEVNKPAIVHRNLSVEKVLIDQQFNPLIADCGLHKLLADDIV  572 (689)
Q Consensus       493 gsL~~~L~~~~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~~~ivH~dlk~~NiLl~~~~~~kl~DfGla~~~~~~~~  572 (689)
                      |+|.+++....   ..+++.++++++.|++.||+|||+.+     ++||||||+||++++++.+||+|||+++.......
T Consensus        79 ~~L~~~l~~~~---~~~~~~~~~~~~~~i~~~l~~lH~~~-----i~H~dlkp~nil~~~~~~~kl~dfg~~~~~~~~~~  150 (257)
T cd05115          79 GPLNKFLSGKK---DEITVSNVVELMHQVSMGMKYLEGKN-----FVHRDLAARNVLLVNQHYAKISDFGLSKALGADDS  150 (257)
T ss_pred             CCHHHHHHhCC---CCCCHHHHHHHHHHHHHHHHHHHhcC-----eeecccchheEEEcCCCcEEeccCCccccccCCcc
Confidence            99999997543   24899999999999999999999987     99999999999999999999999999986644322


Q ss_pred             ee--eecCCCCCCCCCccccccCCCCCcccchhHHHHHHHHHh-CCCCcchhHHHHHhhhhhhHhhccccCCCCCHHHHH
Q 005586          573 FS--VLKTSAAMGYLAPEYVTTGRFTERSDIFAFGVIILQILT-GSLVLTSSMRLAAESATFENFIDRNLKGKFSESEAA  649 (689)
Q Consensus       573 ~~--~~~~~~~~~y~aPE~~~~~~~~~ksDV~sfGvvl~ellt-G~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  649 (689)
                      ..  .....++..|+|||.+....++.++|||||||++||+++ |+.|+.......     ....+........+..+..
T Consensus       151 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~~-----~~~~~~~~~~~~~~~~~~~  225 (257)
T cd05115         151 YYKARSAGKWPLKWYAPECINFRKFSSRSDVWSYGITMWEAFSYGQKPYKKMKGPE-----VMSFIEQGKRLDCPAECPP  225 (257)
T ss_pred             ceeccCCCCCCcccCCHHHHccCCCCchhhHHHHHHHHHHHhcCCCCCcCcCCHHH-----HHHHHHCCCCCCCCCCCCH
Confidence            11  111223467999999988889999999999999999996 999986542221     1122222222334445577


Q ss_pred             HHHHHHHHhccCCCCCCCCHHHHHHHHHhh
Q 005586          650 KLGKMALVCTHEDPENRPTMEAVIEELTVA  679 (689)
Q Consensus       650 ~l~~l~~~Cl~~dp~~RPs~~evl~~L~~~  679 (689)
                      ++.+++..||+.+|++||++.+|.+.|+..
T Consensus       226 ~l~~li~~c~~~~~~~Rp~~~~i~~~l~~~  255 (257)
T cd05115         226 EMYALMKDCWIYKWEDRPNFAKVEERMRTY  255 (257)
T ss_pred             HHHHHHHHHcCCChhhCcCHHHHHHHHhhh
Confidence            899999999999999999999999998763

Protein Tyrosine Kinase (PTK) family; Zeta-chain-associated protein of 70kDa (Zap-70); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Zap-70 is a member of the Syk subfamily of kinases, which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Zap-70 is primarily expressed in T-cells and NK cells, and is a crucial component in T-cell receptor (TCR) signaling. Zap-70 binds the phosphorylated ITAM (immunoreceptor tyr activation motif) sequences of the activated TCR zeta-chain through its SH2 domains, leading to its pho

>KOG0201 consensus Serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=1.9e-40  Score=334.75  Aligned_cols=249  Identities=19%  Similarity=0.393  Sum_probs=209.1

Q ss_pred             cCCcccccccCCcceEEEEEec-CCcEEEEEEecccCCchHHHHHHHHHHHHhccCCCcceeEeeEEEcCCCCeEEEEEE
Q 005586          410 CFSEVNLLGKGNFSSVYKGTLR-DGTLVAIRSINVTSCKSEEAEFVKGLYLLTSLRHENIIRLRGFCCSRGRGECFLIYD  488 (689)
Q Consensus       410 ~f~~~~~lg~G~~g~Vy~~~~~-~g~~vavK~l~~~~~~~~~~~f~~e~~~l~~l~H~niv~l~g~~~~~~~~~~~lV~e  488 (689)
                      .|+..+.||+|.||.||||... .++.||+|++..+..+.+..+..+|+.++++++|+||.+++|.+..  +..++++||
T Consensus        14 ~~~~~~~IgrGsfG~Vyk~~d~~t~k~vAiKii~Le~~~deIediqqei~~Ls~~~~~~it~yygsyl~--g~~LwiiMe   91 (467)
T KOG0201|consen   14 LYTKLELIGRGSFGEVYKAIDNKTKKVVAIKIIDLEEAEDEIEDIQQEISVLSQCDSPNITEYYGSYLK--GTKLWIIME   91 (467)
T ss_pred             ccccchhccccccceeeeeeeccccceEEEEEechhhcchhhHHHHHHHHHHHhcCcchHHhhhhheee--cccHHHHHH
Confidence            4666789999999999999975 6899999999988877777889999999999999999999997754  367899999


Q ss_pred             cCCCCCHHHHhhhcCCCCCCCCHHHHHHHHHHHHHHHhhhhCCCCCCCceeecCCCCCceeecCCCCeEEeccccccccc
Q 005586          489 FAPKGKLSKYLDQEEGSSNVLDWSTRVSIIIGIAKGIGYLHSSEVNKPAIVHRNLSVEKVLIDQQFNPLIADCGLHKLLA  568 (689)
Q Consensus       489 ~~~~gsL~~~L~~~~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~~~ivH~dlk~~NiLl~~~~~~kl~DfGla~~~~  568 (689)
                      ||.+|++.+.|....    .+++....-|++++..||.|||+.+     .+|||||+.|||+..+|.+|++|||++..+.
T Consensus        92 y~~gGsv~~lL~~~~----~~~E~~i~~ilre~l~~l~ylH~~~-----kiHrDIKaanil~s~~g~vkl~DfgVa~ql~  162 (467)
T KOG0201|consen   92 YCGGGSVLDLLKSGN----ILDEFEIAVILREVLKGLDYLHSEK-----KIHRDIKAANILLSESGDVKLADFGVAGQLT  162 (467)
T ss_pred             HhcCcchhhhhccCC----CCccceeeeehHHHHHHhhhhhhcc-----eecccccccceeEeccCcEEEEecceeeeee
Confidence            999999999997653    2467777789999999999999987     8999999999999999999999999999887


Q ss_pred             CCceeeeecCCCCCCCCCccccccCCCCCcccchhHHHHHHHHHhCCCCcchhHHHHHhhhhhhHhhccccCCCCCHHHH
Q 005586          569 DDIVFSVLKTSAAMGYLAPEYVTTGRFTERSDIFAFGVIILQILTGSLVLTSSMRLAAESATFENFIDRNLKGKFSESEA  648 (689)
Q Consensus       569 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~ksDV~sfGvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  648 (689)
                      ...... ....||+.|||||++....|+.|+||||+|++.+||.+|.+|+.......     ..-.+.+...+......+
T Consensus       163 ~~~~rr-~tfvGTPfwMAPEVI~~~~Y~~KADIWSLGITaiEla~GePP~s~~hPmr-----vlflIpk~~PP~L~~~~S  236 (467)
T KOG0201|consen  163 NTVKRR-KTFVGTPFWMAPEVIKQSGYDTKADIWSLGITAIELAKGEPPHSKLHPMR-----VLFLIPKSAPPRLDGDFS  236 (467)
T ss_pred             chhhcc-ccccccccccchhhhccccccchhhhhhhhHHHHHHhcCCCCCcccCcce-----EEEeccCCCCCccccccC
Confidence            665443 55679999999999998899999999999999999999999986432210     111122222222233456


Q ss_pred             HHHHHHHHHhccCCCCCCCCHHHHHHH
Q 005586          649 AKLGKMALVCTHEDPENRPTMEAVIEE  675 (689)
Q Consensus       649 ~~l~~l~~~Cl~~dp~~RPs~~evl~~  675 (689)
                      ..+.+++..|+.++|+.||++.+++++
T Consensus       237 ~~~kEFV~~CL~k~P~~RpsA~~LLKh  263 (467)
T KOG0201|consen  237 PPFKEFVEACLDKNPEFRPSAKELLKH  263 (467)
T ss_pred             HHHHHHHHHHhhcCcccCcCHHHHhhh
Confidence            679999999999999999999999987

>cd05608 STKc_GRK1 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 1

Probab=100.00  E-value=8.3e-39  Score=330.63  Aligned_cols=250  Identities=20%  Similarity=0.258  Sum_probs=198.2

Q ss_pred             cccCCcceEEEEEec-CCcEEEEEEecccCCc--hHHHHHHHHHHHHhccCCCcceeEeeEEEcCCCCeEEEEEEcCCCC
Q 005586          417 LGKGNFSSVYKGTLR-DGTLVAIRSINVTSCK--SEEAEFVKGLYLLTSLRHENIIRLRGFCCSRGRGECFLIYDFAPKG  493 (689)
Q Consensus       417 lg~G~~g~Vy~~~~~-~g~~vavK~l~~~~~~--~~~~~f~~e~~~l~~l~H~niv~l~g~~~~~~~~~~~lV~e~~~~g  493 (689)
                      ||+|+||+||++..+ +|+.||+|++......  .....+..|++++++++|+||+++.+++.  .....++||||+++|
T Consensus         1 lg~G~~g~Vy~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~~~~i~~~~~~~~--~~~~~~lv~e~~~~g   78 (280)
T cd05608           1 LGKGGFGEVSACQMRATGKLYACKKLNKKRLKKRKGYEGAMVEKRILAKVHSRFIVSLAYAFQ--TKTDLCLVMTIMNGG   78 (280)
T ss_pred             CCCCCceeEEEEEEccCCcEEEEEeeeHHHHhhhHHHHHHHHHHHHHHhCCCCcEeeeeEEEc--CCCeEEEEEeCCCCC
Confidence            799999999999875 7899999998754322  23356788999999999999999998874  357799999999999


Q ss_pred             CHHHHhhhcCCCCCCCCHHHHHHHHHHHHHHHhhhhCCCCCCCceeecCCCCCceeecCCCCeEEecccccccccCCcee
Q 005586          494 KLSKYLDQEEGSSNVLDWSTRVSIIIGIAKGIGYLHSSEVNKPAIVHRNLSVEKVLIDQQFNPLIADCGLHKLLADDIVF  573 (689)
Q Consensus       494 sL~~~L~~~~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~~~ivH~dlk~~NiLl~~~~~~kl~DfGla~~~~~~~~~  573 (689)
                      +|..++.........+++..++.++.|++.||+|||+.+     |+||||||+||++++++.+||+|||+++....... 
T Consensus        79 ~L~~~~~~~~~~~~~l~~~~~~~~~~qi~~~l~~lH~~~-----i~H~dlkp~Nili~~~~~~~l~dfg~~~~~~~~~~-  152 (280)
T cd05608          79 DLRYHIYNVDEENPGFPEPRACFYTAQIISGLEHLHQRR-----IIYRDLKPENVLLDNDGNVRISDLGLAVELKDGQS-  152 (280)
T ss_pred             CHHHHHHhccccCCCCCHHHHHHHHHHHHHHHHHHHHCC-----cccCCCCHHHEEECCCCCEEEeeCccceecCCCCc-
Confidence            999988654333346899999999999999999999987     99999999999999999999999999976644321 


Q ss_pred             eeecCCCCCCCCCccccccCCCCCcccchhHHHHHHHHHhCCCCcchhHHHHHhhhhhhHhhccccCCCCCHHHHHHHHH
Q 005586          574 SVLKTSAAMGYLAPEYVTTGRFTERSDIFAFGVIILQILTGSLVLTSSMRLAAESATFENFIDRNLKGKFSESEAAKLGK  653 (689)
Q Consensus       574 ~~~~~~~~~~y~aPE~~~~~~~~~ksDV~sfGvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~  653 (689)
                      ......++..|+|||++.+..++.++|||||||++|||++|+.||....................  ..++...+..+.+
T Consensus       153 ~~~~~~g~~~y~aPE~~~~~~~~~~~DvwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~~~~  230 (280)
T cd05608         153 KTKGYAGTPGFMAPELLQGEEYDFSVDYFALGVTLYEMIAARGPFRARGEKVENKELKQRILNDS--VTYPDKFSPASKS  230 (280)
T ss_pred             cccccCCCcCccCHHHhcCCCCCccccHHHHHHHHHHHHhCCCCCCCCCcchhHHHHHHhhcccC--CCCcccCCHHHHH
Confidence            12234578889999999999999999999999999999999999964321111111111111111  1233445677899


Q ss_pred             HHHHhccCCCCCCC-----CHHHHHHHH
Q 005586          654 MALVCTHEDPENRP-----TMEAVIEEL  676 (689)
Q Consensus       654 l~~~Cl~~dp~~RP-----s~~evl~~L  676 (689)
                      ++..|++.||++||     ++++++++-
T Consensus       231 li~~~l~~~P~~R~~~~~~~~~~~l~h~  258 (280)
T cd05608         231 FCEALLAKDPEKRLGFRDGNCDGLRTHP  258 (280)
T ss_pred             HHHHHhcCCHHHhcCCCCCCHHHHhcCh
Confidence            99999999999999     788888764

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK1, also called rhodopsin kinase, belongs to the visual g

>KOG0585 consensus Ca2+/calmodulin-dependent protein kinase kinase beta and related serine/threonine protein kinases [Signal transduction mechanisms]

Probab=100.00  E-value=3.5e-39  Score=327.38  Aligned_cols=263  Identities=19%  Similarity=0.300  Sum_probs=213.0

Q ss_pred             HhccCCcccccccCCcceEEEEEec-CCcEEEEEEecccCCc-------------hHHHHHHHHHHHHhccCCCcceeEe
Q 005586          407 ATQCFSEVNLLGKGNFSSVYKGTLR-DGTLVAIRSINVTSCK-------------SEEAEFVKGLYLLTSLRHENIIRLR  472 (689)
Q Consensus       407 at~~f~~~~~lg~G~~g~Vy~~~~~-~g~~vavK~l~~~~~~-------------~~~~~f~~e~~~l~~l~H~niv~l~  472 (689)
                      ..++|...+.||+|.||.|-+|+.. +++.||||++.+....             ...+...+||.+|++++|||||+|+
T Consensus        95 ~lNqy~l~~eiG~G~yGkVkLar~~~~~~l~AiKil~K~~~~~~~~~~~~~a~~~~~~ekv~~EIailKkl~H~nVV~Li  174 (576)
T KOG0585|consen   95 QLNQYELIKEIGSGQYGKVKLARDEVDGKLYAIKILPKKELRRQYGFPRQPAMKLMPIEKVRREIAILKKLHHPNVVKLI  174 (576)
T ss_pred             ehhheehhhhhcCCccceEEEEeecCCCcEEEEEeechhhhhhhcccccccccccCcHHHHHHHHHHHHhcCCcCeeEEE
Confidence            4467888899999999999999865 7999999999654211             1124788999999999999999999


Q ss_pred             eEEEcCCCCeEEEEEEcCCCCCHHHHhhhcCCCCCCCCHHHHHHHHHHHHHHHhhhhCCCCCCCceeecCCCCCceeecC
Q 005586          473 GFCCSRGRGECFLIYDFAPKGKLSKYLDQEEGSSNVLDWSTRVSIIIGIAKGIGYLHSSEVNKPAIVHRNLSVEKVLIDQ  552 (689)
Q Consensus       473 g~~~~~~~~~~~lV~e~~~~gsL~~~L~~~~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~~~ivH~dlk~~NiLl~~  552 (689)
                      .+..+...+..|+|+|||..|.+...=..    ...++..+.+++.+++..||+|||.++     ||||||||+|+||++
T Consensus       175 EvLDDP~s~~~YlVley~s~G~v~w~p~d----~~els~~~Ar~ylrDvv~GLEYLH~Qg-----iiHRDIKPsNLLl~~  245 (576)
T KOG0585|consen  175 EVLDDPESDKLYLVLEYCSKGEVKWCPPD----KPELSEQQARKYLRDVVLGLEYLHYQG-----IIHRDIKPSNLLLSS  245 (576)
T ss_pred             EeecCcccCceEEEEEeccCCccccCCCC----cccccHHHHHHHHHHHHHHHHHHHhcC-----eeccccchhheEEcC
Confidence            99988778899999999998876533211    122899999999999999999999988     999999999999999


Q ss_pred             CCCeEEecccccccccCC----ceeeeecCCCCCCCCCccccccCC----CCCcccchhHHHHHHHHHhCCCCcchhHHH
Q 005586          553 QFNPLIADCGLHKLLADD----IVFSVLKTSAAMGYLAPEYVTTGR----FTERSDIFAFGVIILQILTGSLVLTSSMRL  624 (689)
Q Consensus       553 ~~~~kl~DfGla~~~~~~----~~~~~~~~~~~~~y~aPE~~~~~~----~~~ksDV~sfGvvl~elltG~~p~~~~~~~  624 (689)
                      ++++||+|||.+......    .........||+.|||||...++.    .+.+.||||+||.||.|+.|+.||.+....
T Consensus       246 ~g~VKIsDFGVs~~~~~~~~~~~d~~L~~tvGTPAF~APE~c~~~~~~~~~g~a~DiWalGVTLYCllfG~~PF~~~~~~  325 (576)
T KOG0585|consen  246 DGTVKISDFGVSNEFPQGSDEGSDDQLSRTVGTPAFFAPELCSGGNSFSYSGFALDIWALGVTLYCLLFGQLPFFDDFEL  325 (576)
T ss_pred             CCcEEeeccceeeecccCCccccHHHHhhcCCCccccchHhhcCCCCccccchhhhhhhhhhhHHHhhhccCCcccchHH
Confidence            999999999999866322    111233478999999999987733    257889999999999999999999776543


Q ss_pred             HHhhhhhhHhhccccCCCCCHHHHHHHHHHHHHhccCCCCCCCCHHHHHHHHHhhCCc
Q 005586          625 AAESATFENFIDRNLKGKFSESEAAKLGKMALVCTHEDPENRPTMEAVIEELTVAAPV  682 (689)
Q Consensus       625 ~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~Cl~~dp~~RPs~~evl~~L~~~~p~  682 (689)
                      .    .+..++...+.-...+++...+.+|+.+++.+||++|.+..+|..+.+...+.
T Consensus       326 ~----l~~KIvn~pL~fP~~pe~~e~~kDli~~lL~KdP~~Ri~l~~ik~Hpwvt~~g  379 (576)
T KOG0585|consen  326 E----LFDKIVNDPLEFPENPEINEDLKDLIKRLLEKDPEQRITLPDIKLHPWVTRDG  379 (576)
T ss_pred             H----HHHHHhcCcccCCCcccccHHHHHHHHHHhhcChhheeehhhheecceeccCC
Confidence            3    34444554444333345688899999999999999999999999999877663

>cd07869 STKc_PFTAIRE1 Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-1 kinase

Probab=100.00  E-value=1.1e-38  Score=333.60  Aligned_cols=260  Identities=19%  Similarity=0.354  Sum_probs=199.3

Q ss_pred             ccCCcccccccCCcceEEEEEec-CCcEEEEEEecccCCchHHHHHHHHHHHHhccCCCcceeEeeEEEcCCCCeEEEEE
Q 005586          409 QCFSEVNLLGKGNFSSVYKGTLR-DGTLVAIRSINVTSCKSEEAEFVKGLYLLTSLRHENIIRLRGFCCSRGRGECFLIY  487 (689)
Q Consensus       409 ~~f~~~~~lg~G~~g~Vy~~~~~-~g~~vavK~l~~~~~~~~~~~f~~e~~~l~~l~H~niv~l~g~~~~~~~~~~~lV~  487 (689)
                      ++|...+.||+|+||.||+|+.+ +|+.||+|++...........+.+|++++++++||||+++++++..  ....++||
T Consensus         5 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~--~~~~~lv~   82 (303)
T cd07869           5 DSYEKLEKLGEGSYATVYKGKSKVNGKLVALKVIRLQEEEGTPFTAIREASLLKGLKHANIVLLHDIIHT--KETLTLVF   82 (303)
T ss_pred             ccceEeeeEEecCCEEEEEEEECCCCCEEEEEEeccccccccchhHHHHHHHHhhCCCCCcCeEEEEEec--CCeEEEEE
Confidence            57888899999999999999986 6899999999765433444567899999999999999999999854  47899999


Q ss_pred             EcCCCCCHHHHhhhcCCCCCCCCHHHHHHHHHHHHHHHhhhhCCCCCCCceeecCCCCCceeecCCCCeEEecccccccc
Q 005586          488 DFAPKGKLSKYLDQEEGSSNVLDWSTRVSIIIGIAKGIGYLHSSEVNKPAIVHRNLSVEKVLIDQQFNPLIADCGLHKLL  567 (689)
Q Consensus       488 e~~~~gsL~~~L~~~~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~~~ivH~dlk~~NiLl~~~~~~kl~DfGla~~~  567 (689)
                      ||++ ++|.+++....+   .+++..+..++.|++.||+|||+.+     |+||||||+|||+++++.+||+|||+++..
T Consensus        83 e~~~-~~l~~~~~~~~~---~~~~~~~~~~~~qi~~al~~lH~~~-----ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~  153 (303)
T cd07869          83 EYVH-TDLCQYMDKHPG---GLHPENVKLFLFQLLRGLSYIHQRY-----ILHRDLKPQNLLISDTGELKLADFGLARAK  153 (303)
T ss_pred             ECCC-cCHHHHHHhCCC---CCCHHHHHHHHHHHHHHHHHHHHCC-----eecCCCCHHHEEECCCCCEEECCCCcceec
Confidence            9995 688888865432   3788999999999999999999987     999999999999999999999999998754


Q ss_pred             cCCceeeeecCCCCCCCCCcccccc-CCCCCcccchhHHHHHHHHHhCCCCcchhHHHHHhhhhhhHhh-----------
Q 005586          568 ADDIVFSVLKTSAAMGYLAPEYVTT-GRFTERSDIFAFGVIILQILTGSLVLTSSMRLAAESATFENFI-----------  635 (689)
Q Consensus       568 ~~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~ksDV~sfGvvl~elltG~~p~~~~~~~~~~~~~~~~~~-----------  635 (689)
                      ..... ......++..|+|||.+.+ ..++.++||||+||++|||+||+.||............+....           
T Consensus       154 ~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~  232 (303)
T cd07869         154 SVPSH-TYSNEVVTLWYRPPDVLLGSTEYSTCLDMWGVGCIFVEMIQGVAAFPGMKDIQDQLERIFLVLGTPNEDTWPGV  232 (303)
T ss_pred             cCCCc-cCCCCcccCCCCChHHHcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCccHHHHHHHHHHHhCCCChhhccch
Confidence            32211 1223456788999998765 4578999999999999999999999964321111000000000           


Q ss_pred             ------cc-ccCCCCCH---------HHHHHHHHHHHHhccCCCCCCCCHHHHHHHHHhhC
Q 005586          636 ------DR-NLKGKFSE---------SEAAKLGKMALVCTHEDPENRPTMEAVIEELTVAA  680 (689)
Q Consensus       636 ------~~-~~~~~~~~---------~~~~~l~~l~~~Cl~~dp~~RPs~~evl~~L~~~~  680 (689)
                            ++ ......+.         .....+.+++..|++.||++|||+.|++++-+...
T Consensus       233 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dli~~mL~~dp~~R~s~~~~l~h~~f~~  293 (303)
T cd07869         233 HSLPHFKPERFTLYSPKNLRQAWNKLSYVNHAEDLASKLLQCFPKNRLSAQAALSHEYFSD  293 (303)
T ss_pred             hhccccccccccccCCccHHHHhhccCCChHHHHHHHHHhccCchhccCHHHHhcCccccc
Confidence                  00 00000000         01246789999999999999999999998866543

Serine/Threonine Kinases (STKs), PFTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-1 is widely expressed except in the spleen and thymus. It is highly expressed in the brain, heart, pancreas, testis, and ovary, and is localized in the cytoplasm. It is regulated by cyclin D3 an

>cd05067 PTKc_Lck_Blk Catalytic domain of the Protein Tyrosine Kinases, Lymphocyte-specific kinase and Blk

Probab=100.00  E-value=2e-38  Score=323.96  Aligned_cols=253  Identities=25%  Similarity=0.456  Sum_probs=206.0

Q ss_pred             ccCCcccccccCCcceEEEEEecCCcEEEEEEecccCCchHHHHHHHHHHHHhccCCCcceeEeeEEEcCCCCeEEEEEE
Q 005586          409 QCFSEVNLLGKGNFSSVYKGTLRDGTLVAIRSINVTSCKSEEAEFVKGLYLLTSLRHENIIRLRGFCCSRGRGECFLIYD  488 (689)
Q Consensus       409 ~~f~~~~~lg~G~~g~Vy~~~~~~g~~vavK~l~~~~~~~~~~~f~~e~~~l~~l~H~niv~l~g~~~~~~~~~~~lV~e  488 (689)
                      ++|...++||+|+||.||+|..++++.||+|.+....  ....+|.+|+.++++++|+||+++++++.   .+..++|||
T Consensus         6 ~~~~~~~~ig~G~~g~v~~~~~~~~~~~a~K~~~~~~--~~~~~~~~E~~~l~~l~h~~i~~~~~~~~---~~~~~~v~e   80 (260)
T cd05067           6 ETLKLVKKLGAGQFGEVWMGYYNGHTKVAIKSLKQGS--MSPEAFLAEANLMKQLQHPRLVRLYAVVT---QEPIYIITE   80 (260)
T ss_pred             HHceeeeeeccCccceEEeeecCCCceEEEEEecCCC--CcHHHHHHHHHHHHhcCCcCeeeEEEEEc---cCCcEEEEE
Confidence            4677789999999999999999899999999987654  23457999999999999999999999863   356899999


Q ss_pred             cCCCCCHHHHhhhcCCCCCCCCHHHHHHHHHHHHHHHhhhhCCCCCCCceeecCCCCCceeecCCCCeEEeccccccccc
Q 005586          489 FAPKGKLSKYLDQEEGSSNVLDWSTRVSIIIGIAKGIGYLHSSEVNKPAIVHRNLSVEKVLIDQQFNPLIADCGLHKLLA  568 (689)
Q Consensus       489 ~~~~gsL~~~L~~~~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~~~ivH~dlk~~NiLl~~~~~~kl~DfGla~~~~  568 (689)
                      |+++|+|.+++....+  ..+++.++..++.|++.||+|||+.+     ++||||||+||++++++.++|+|||+++...
T Consensus        81 ~~~~~~L~~~~~~~~~--~~~~~~~~~~i~~~i~~al~~LH~~~-----i~H~dl~p~ni~i~~~~~~~l~dfg~~~~~~  153 (260)
T cd05067          81 YMENGSLVDFLKTPEG--IKLTINKLIDMAAQIAEGMAFIERKN-----YIHRDLRAANILVSETLCCKIADFGLARLIE  153 (260)
T ss_pred             cCCCCCHHHHHHhcCC--CCCCHHHHHHHHHHHHHHHHHHhcCC-----eecccccHHhEEEcCCCCEEEccCcceeecC
Confidence            9999999999876543  35899999999999999999999987     9999999999999999999999999998765


Q ss_pred             CCceeeeecCCCCCCCCCccccccCCCCCcccchhHHHHHHHHHh-CCCCcchhHHHHHhhhhhhHhhccccCCCCCHHH
Q 005586          569 DDIVFSVLKTSAAMGYLAPEYVTTGRFTERSDIFAFGVIILQILT-GSLVLTSSMRLAAESATFENFIDRNLKGKFSESE  647 (689)
Q Consensus       569 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~ksDV~sfGvvl~ellt-G~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  647 (689)
                      ...........++..|+|||++....++.++||||||+++|||++ |+.|+........     .+.+........+...
T Consensus       154 ~~~~~~~~~~~~~~~y~~pe~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~~~-----~~~~~~~~~~~~~~~~  228 (260)
T cd05067         154 DNEYTAREGAKFPIKWTAPEAINYGTFTIKSDVWSFGILLTEIVTYGRIPYPGMTNPEV-----IQNLERGYRMPRPDNC  228 (260)
T ss_pred             CCCcccccCCcccccccCHHHhccCCcCcccchHHHHHHHHHHHhCCCCCCCCCChHHH-----HHHHHcCCCCCCCCCC
Confidence            332222222334568999999988889999999999999999999 9999864322111     1111222222233344


Q ss_pred             HHHHHHHHHHhccCCCCCCCCHHHHHHHHHh
Q 005586          648 AAKLGKMALVCTHEDPENRPTMEAVIEELTV  678 (689)
Q Consensus       648 ~~~l~~l~~~Cl~~dp~~RPs~~evl~~L~~  678 (689)
                      +.++.+++.+|++.+|++||++++++..|+.
T Consensus       229 ~~~~~~li~~~l~~~p~~Rp~~~~l~~~l~~  259 (260)
T cd05067         229 PEELYELMRLCWKEKPEERPTFEYLRSVLED  259 (260)
T ss_pred             CHHHHHHHHHHccCChhhCCCHHHHHHHhhc
Confidence            5679999999999999999999999998864

Protein Tyrosine Kinase (PTK) family; Lck and Blk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lck (lymphocyte-specific kinase) and Blk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Sr

>KOG0605 consensus NDR and related serine/threonine kinases [General function prediction only]

Probab=100.00  E-value=5.4e-39  Score=331.96  Aligned_cols=256  Identities=19%  Similarity=0.266  Sum_probs=207.7

Q ss_pred             HhccCCcccccccCCcceEEEEEec-CCcEEEEEEecccCC--chHHHHHHHHHHHHhccCCCcceeEeeEEEcCCCCeE
Q 005586          407 ATQCFSEVNLLGKGNFSSVYKGTLR-DGTLVAIRSINVTSC--KSEEAEFVKGLYLLTSLRHENIIRLRGFCCSRGRGEC  483 (689)
Q Consensus       407 at~~f~~~~~lg~G~~g~Vy~~~~~-~g~~vavK~l~~~~~--~~~~~~f~~e~~~l~~l~H~niv~l~g~~~~~~~~~~  483 (689)
                      ..++|.....||+|+||.||+|+-+ +|..+|+|++++..-  ..+......|-.+|....+|+||+|+-.|  .+.+.+
T Consensus       139 ~~~DFe~Lk~IgkGAfGeVrLarKk~Tg~iyAmK~LkKS~M~~~~Qv~hV~aERdiL~~~ds~~vVKLyYsF--QD~~~L  216 (550)
T KOG0605|consen  139 SLDDFELLKVIGKGAFGEVRLARKKDTGEIYAMKILKKSEMLKKNQVEHVRAERDILAEVDSPWVVKLYYSF--QDKEYL  216 (550)
T ss_pred             CcccchhheeeccccceeEEEEEEccCCcEEeeecccHHHHHhhhhHHHHHHHHHHhhhcCCCcEEEEEEEe--cCCCee
Confidence            4467888999999999999999976 699999999987642  34456788899999999999999998666  567899


Q ss_pred             EEEEEcCCCCCHHHHhhhcCCCCCCCCHHHHHHHHHHHHHHHhhhhCCCCCCCceeecCCCCCceeecCCCCeEEecccc
Q 005586          484 FLIYDFAPKGKLSKYLDQEEGSSNVLDWSTRVSIIIGIAKGIGYLHSSEVNKPAIVHRNLSVEKVLIDQQFNPLIADCGL  563 (689)
Q Consensus       484 ~lV~e~~~~gsL~~~L~~~~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~~~ivH~dlk~~NiLl~~~~~~kl~DfGl  563 (689)
                      ||||||+||||+..+|....    .|+......++.+++.|++-+|+.|     +|||||||+|+|||..|++||+||||
T Consensus       217 YLiMEylPGGD~mTLL~~~~----~L~e~~arfYiaE~vlAI~~iH~~g-----yIHRDIKPdNlLiD~~GHiKLSDFGL  287 (550)
T KOG0605|consen  217 YLIMEYLPGGDMMTLLMRKD----TLTEDWARFYIAETVLAIESIHQLG-----YIHRDIKPDNLLIDAKGHIKLSDFGL  287 (550)
T ss_pred             EEEEEecCCccHHHHHHhcC----cCchHHHHHHHHHHHHHHHHHHHcC-----cccccCChhheeecCCCCEeeccccc
Confidence            99999999999999998765    4888888999999999999999998     99999999999999999999999999


Q ss_pred             cccccCC-----------------------ce-----ee------------------eecCCCCCCCCCccccccCCCCC
Q 005586          564 HKLLADD-----------------------IV-----FS------------------VLKTSAAMGYLAPEYVTTGRFTE  597 (689)
Q Consensus       564 a~~~~~~-----------------------~~-----~~------------------~~~~~~~~~y~aPE~~~~~~~~~  597 (689)
                      +.-+...                       ..     ..                  .....||+.|||||++.+..|+.
T Consensus       288 s~gl~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~w~~nrr~~a~StVGTPDYiAPEVll~kgY~~  367 (550)
T KOG0605|consen  288 STGLDKKHRIESYRLDEQMQINLSEAKPSDFPKFNTPRSTMSRREQLQTWKRNRRQLAYSTVGTPDYIAPEVLLGKGYGK  367 (550)
T ss_pred             cchhhhhhhhhhhcchhhhhhhhccCCCccccccccccchhhHHHHHHHHHhhhhhhhhcccCCccccchHHHhcCCCCc
Confidence            8543210                       00     00                  01246889999999999999999


Q ss_pred             cccchhHHHHHHHHHhCCCCcchhHHHHHhhhhhhHhhccccCCCCCHHHHHHHHHHHHHhccCCCCCCC---CHHHHHH
Q 005586          598 RSDIFAFGVIILQILTGSLVLTSSMRLAAESATFENFIDRNLKGKFSESEAAKLGKMALVCTHEDPENRP---TMEAVIE  674 (689)
Q Consensus       598 ksDV~sfGvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~Cl~~dp~~RP---s~~evl~  674 (689)
                      .+|+||+|||+|||+.|-+||.+......+...+.-  ...+...-......+..+++.+|+. ||++|-   .++||-+
T Consensus       368 ~cDwWSLG~ImyEmLvGyPPF~s~tp~~T~rkI~nw--r~~l~fP~~~~~s~eA~DLI~rll~-d~~~RLG~~G~~EIK~  444 (550)
T KOG0605|consen  368 ECDWWSLGCIMYEMLVGYPPFCSETPQETYRKIVNW--RETLKFPEEVDLSDEAKDLITRLLC-DPENRLGSKGAEEIKK  444 (550)
T ss_pred             cccHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHH--hhhccCCCcCcccHHHHHHHHHHhc-CHHHhcCcccHHHHhc
Confidence            999999999999999999999887666555433221  1112222223345789999999999 999996   5777776


Q ss_pred             HH
Q 005586          675 EL  676 (689)
Q Consensus       675 ~L  676 (689)
                      |.
T Consensus       445 HP  446 (550)
T KOG0605|consen  445 HP  446 (550)
T ss_pred             CC
Confidence            64

>cd06650 PKc_MEK1 Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 1

Probab=100.00  E-value=1.9e-38  Score=336.18  Aligned_cols=259  Identities=19%  Similarity=0.328  Sum_probs=203.5

Q ss_pred             ccCCcccccccCCcceEEEEEec-CCcEEEEEEecccCCchHHHHHHHHHHHHhccCCCcceeEeeEEEcCCCCeEEEEE
Q 005586          409 QCFSEVNLLGKGNFSSVYKGTLR-DGTLVAIRSINVTSCKSEEAEFVKGLYLLTSLRHENIIRLRGFCCSRGRGECFLIY  487 (689)
Q Consensus       409 ~~f~~~~~lg~G~~g~Vy~~~~~-~g~~vavK~l~~~~~~~~~~~f~~e~~~l~~l~H~niv~l~g~~~~~~~~~~~lV~  487 (689)
                      ++|+..+.||+|+||.||++..+ +|..+|+|.+...........|.+|++++++++||||++++++|..  .+..++||
T Consensus         5 ~~y~~~~~lg~g~~g~V~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~--~~~~~lv~   82 (333)
T cd06650           5 DDFEKISELGAGNGGVVFKVSHKPSGLIMARKLIHLEIKPAIRNQIIRELQVLHECNSPYIVGFYGAFYS--DGEISICM   82 (333)
T ss_pred             hhhheeccccCCCCEEEEEEEECCCCcEEEEEEeecccCHHHHHHHHHHHHHHHHCCCCcccceeEEEEE--CCEEEEEE
Confidence            57888899999999999999986 6889999998765434445679999999999999999999999965  47899999


Q ss_pred             EcCCCCCHHHHhhhcCCCCCCCCHHHHHHHHHHHHHHHhhhhCCCCCCCceeecCCCCCceeecCCCCeEEecccccccc
Q 005586          488 DFAPKGKLSKYLDQEEGSSNVLDWSTRVSIIIGIAKGIGYLHSSEVNKPAIVHRNLSVEKVLIDQQFNPLIADCGLHKLL  567 (689)
Q Consensus       488 e~~~~gsL~~~L~~~~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~~~ivH~dlk~~NiLl~~~~~~kl~DfGla~~~  567 (689)
                      ||+++|+|.+++....    .+++.....++.+++.||+|||+.+    .|+||||||+|||+++++.+||+|||+++..
T Consensus        83 e~~~~~~L~~~l~~~~----~~~~~~~~~~~~~l~~~l~~lH~~~----~ivH~dlkp~Nili~~~~~~kL~Dfg~~~~~  154 (333)
T cd06650          83 EHMDGGSLDQVLKKAG----RIPEQILGKVSIAVIKGLTYLREKH----KIMHRDVKPSNILVNSRGEIKLCDFGVSGQL  154 (333)
T ss_pred             ecCCCCcHHHHHHHcC----CCCHHHHHHHHHHHHHHHHHHHhcC----CEEecCCChhhEEEcCCCCEEEeeCCcchhh
Confidence            9999999999997643    3788999999999999999999742    2999999999999999999999999999765


Q ss_pred             cCCceeeeecCCCCCCCCCccccccCCCCCcccchhHHHHHHHHHhCCCCcchhHHHHHhh-------hh----------
Q 005586          568 ADDIVFSVLKTSAAMGYLAPEYVTTGRFTERSDIFAFGVIILQILTGSLVLTSSMRLAAES-------AT----------  630 (689)
Q Consensus       568 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~ksDV~sfGvvl~elltG~~p~~~~~~~~~~~-------~~----------  630 (689)
                      ....   .....++..|+|||.+.+..++.++|||||||++|||++|+.||..........       ..          
T Consensus       155 ~~~~---~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  231 (333)
T cd06650         155 IDSM---ANSFVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVEMAIGRYPIPPPDAKELELMFGCPVEGDPAESETSPRP  231 (333)
T ss_pred             hhhc---cccCCCCccccCHHHhcCCCCCcHHHHHHHHHHHHHHHHCCCCCCCcchhHHHHHhcCcccCCccccccCccc
Confidence            4321   122357788999999988889999999999999999999999986422110000       00          


Q ss_pred             -------------------hhHhhcccc---CCCCC-HHHHHHHHHHHHHhccCCCCCCCCHHHHHHHHHhhC
Q 005586          631 -------------------FENFIDRNL---KGKFS-ESEAAKLGKMALVCTHEDPENRPTMEAVIEELTVAA  680 (689)
Q Consensus       631 -------------------~~~~~~~~~---~~~~~-~~~~~~l~~l~~~Cl~~dp~~RPs~~evl~~L~~~~  680 (689)
                                         .....+...   ....+ .....++.+++.+||+.||++||++.|++++-+...
T Consensus       232 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~~P~~Rpt~~ell~h~~~~~  304 (333)
T cd06650         232 RPPGRPLSSYGPDSRPPMAIFELLDYIVNEPPPKLPSGVFGAEFQDFVNKCLIKNPAERADLKQLMVHAFIKR  304 (333)
T ss_pred             CCccchhhhhcccccccccHHHHHHHHhcCCCccCCCCCcCHHHHHHHHHhccCCcccCcCHHHHhhCHHHhc
Confidence                               000000000   00000 012456889999999999999999999998866543

Protein kinases (PKs), MAP/ERK kinase (MEK) 1 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 is a dual-specificity PK that phosphorylates and activates the downst

>cd05107 PTKc_PDGFR_beta Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor beta

Probab=100.00  E-value=1e-38  Score=344.52  Aligned_cols=260  Identities=25%  Similarity=0.388  Sum_probs=205.9

Q ss_pred             ccCCcccccccCCcceEEEEEec------CCcEEEEEEecccCCchHHHHHHHHHHHHhccC-CCcceeEeeEEEcCCCC
Q 005586          409 QCFSEVNLLGKGNFSSVYKGTLR------DGTLVAIRSINVTSCKSEEAEFVKGLYLLTSLR-HENIIRLRGFCCSRGRG  481 (689)
Q Consensus       409 ~~f~~~~~lg~G~~g~Vy~~~~~------~g~~vavK~l~~~~~~~~~~~f~~e~~~l~~l~-H~niv~l~g~~~~~~~~  481 (689)
                      ++|...+.||+|+||.||+|+++      .+..||+|+++........+.+.+|++++.++. |||||+++++|..  .+
T Consensus        37 ~~~~~~~~lG~G~fG~Vy~~~~~~~~~~~~~~~vavK~l~~~~~~~~~~~~~~E~~~l~~l~~H~niv~~~~~~~~--~~  114 (401)
T cd05107          37 DNLVLGRTLGSGAFGRVVEATAHGLSHSQSTMKVAVKMLKSTARSSEKQALMSELKIMSHLGPHLNIVNLLGACTK--GG  114 (401)
T ss_pred             HHeehhhhccCCCceeEEEEEEcCCCCCCCceEEEEEecCCCCChhHHHHHHHHHHHHHhcCCCCCeEEEEEEEcc--CC
Confidence            45666789999999999999864      346899999986543444567999999999997 9999999999854  46


Q ss_pred             eEEEEEEcCCCCCHHHHhhhcCC---------------------------------------------------------
Q 005586          482 ECFLIYDFAPKGKLSKYLDQEEG---------------------------------------------------------  504 (689)
Q Consensus       482 ~~~lV~e~~~~gsL~~~L~~~~~---------------------------------------------------------  504 (689)
                      ..++|+||+++|+|.++++....                                                         
T Consensus       115 ~~~iv~E~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  194 (401)
T cd05107         115 PIYIITEYCRYGDLVDYLHRNKHTFLQYYLDKNRDDGSLISGGSTPLSQRKSHVSLGSESDGGYMDMSKDESADYVPMQD  194 (401)
T ss_pred             CcEEEEeccCCCcHHHHHHhccccchhhhcccccccccccccccccccccccchhhhhccCccccccCCccccCccchhc
Confidence            78999999999999999975321                                                         


Q ss_pred             -------------------------------------CCCCCCHHHHHHHHHHHHHHHhhhhCCCCCCCceeecCCCCCc
Q 005586          505 -------------------------------------SSNVLDWSTRVSIIIGIAKGIGYLHSSEVNKPAIVHRNLSVEK  547 (689)
Q Consensus       505 -------------------------------------~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~~~ivH~dlk~~N  547 (689)
                                                           ....++|...++|+.|++.||+|||+.+     |+||||||+|
T Consensus       195 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~-----ivHrdlkp~N  269 (401)
T cd05107         195 MKGTVKYADIESSNYESPYDQYLPSAPERTRRDTLINESPALSYMDLVGFSYQVANGMEFLASKN-----CVHRDLAARN  269 (401)
T ss_pred             chhhhhhhhhhccCcCCchhhhhcccCCCcchhhhhcCCCCCCHHHHHHHHHHHHHHHHHHhcCC-----cCcccCCcce
Confidence                                                 1124788889999999999999999876     9999999999


Q ss_pred             eeecCCCCeEEecccccccccCCce-eeeecCCCCCCCCCccccccCCCCCcccchhHHHHHHHHHh-CCCCcchhHHHH
Q 005586          548 VLIDQQFNPLIADCGLHKLLADDIV-FSVLKTSAAMGYLAPEYVTTGRFTERSDIFAFGVIILQILT-GSLVLTSSMRLA  625 (689)
Q Consensus       548 iLl~~~~~~kl~DfGla~~~~~~~~-~~~~~~~~~~~y~aPE~~~~~~~~~ksDV~sfGvvl~ellt-G~~p~~~~~~~~  625 (689)
                      ||+++++.+||+|||+++....... .......++..|+|||.+.+..++.++|||||||++|||++ |+.|+.......
T Consensus       270 iLl~~~~~~kL~DfGla~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslGvil~e~l~~g~~P~~~~~~~~  349 (401)
T cd05107         270 VLICEGKLVKICDFGLARDIMRDSNYISKGSTFLPLKWMAPESIFNNLYTTLSDVWSFGILLWEIFTLGGTPYPELPMNE  349 (401)
T ss_pred             EEEeCCCEEEEEecCcceecccccccccCCCcCCCCceeChHHhcCCCCCcHhHHHHHHHHHHHHHHcCCCCCCCCCchH
Confidence            9999999999999999986533221 11112345678999999988889999999999999999998 888885432111


Q ss_pred             HhhhhhhHhhccccCCCCCHHHHHHHHHHHHHhccCCCCCCCCHHHHHHHHHhh
Q 005586          626 AESATFENFIDRNLKGKFSESEAAKLGKMALVCTHEDPENRPTMEAVIEELTVA  679 (689)
Q Consensus       626 ~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~Cl~~dp~~RPs~~evl~~L~~~  679 (689)
                          ...+.+....+...+.....++.+++..||+.+|++||+++||++.|+..
T Consensus       350 ----~~~~~~~~~~~~~~p~~~~~~l~~li~~cl~~~P~~RPs~~ell~~L~~~  399 (401)
T cd05107         350 ----QFYNAIKRGYRMAKPAHASDEIYEIMQKCWEEKFEIRPDFSQLVHLVGDL  399 (401)
T ss_pred             ----HHHHHHHcCCCCCCCCCCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHHH
Confidence                11222233333333444567899999999999999999999999999865

Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) beta; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR beta is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR beta forms homodimers or heterodimers with PDGFR alpha, depending on the nature of the PDGF ligand. PDGF-BB and PDGF-D

>cd05063 PTKc_EphR_A2 Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A2

Probab=100.00  E-value=2.5e-38  Score=324.74  Aligned_cols=256  Identities=23%  Similarity=0.463  Sum_probs=205.2

Q ss_pred             ccCCcccccccCCcceEEEEEec-CC---cEEEEEEecccCCchHHHHHHHHHHHHhccCCCcceeEeeEEEcCCCCeEE
Q 005586          409 QCFSEVNLLGKGNFSSVYKGTLR-DG---TLVAIRSINVTSCKSEEAEFVKGLYLLTSLRHENIIRLRGFCCSRGRGECF  484 (689)
Q Consensus       409 ~~f~~~~~lg~G~~g~Vy~~~~~-~g---~~vavK~l~~~~~~~~~~~f~~e~~~l~~l~H~niv~l~g~~~~~~~~~~~  484 (689)
                      ++|+..+.||+|+||.||+|..+ ++   ..+|+|.+.........++|..|++++.+++|||++++.+++..  .+..+
T Consensus         5 ~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~--~~~~~   82 (268)
T cd05063           5 SHITKQKVIGAGEFGEVFRGILKMPGRKEVAVAIKTLKPGYTEKQRQDFLSEASIMGQFSHHNIIRLEGVVTK--FKPAM   82 (268)
T ss_pred             HHceEeeEecCCCCccEEEEEEecCCCCceEEEEEeccccCCHHHHHHHHHHHHHHhcCCCCCeeEEEEEEcc--CCCcE
Confidence            46777899999999999999975 33   37999998765444456789999999999999999999999844  46789


Q ss_pred             EEEEcCCCCCHHHHhhhcCCCCCCCCHHHHHHHHHHHHHHHhhhhCCCCCCCceeecCCCCCceeecCCCCeEEeccccc
Q 005586          485 LIYDFAPKGKLSKYLDQEEGSSNVLDWSTRVSIIIGIAKGIGYLHSSEVNKPAIVHRNLSVEKVLIDQQFNPLIADCGLH  564 (689)
Q Consensus       485 lV~e~~~~gsL~~~L~~~~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~~~ivH~dlk~~NiLl~~~~~~kl~DfGla  564 (689)
                      +||||+++++|.++++...+   .++|.++..++.|++.||+|||+.+     ++||||||+||++++++.+||+|||++
T Consensus        83 lv~e~~~~~~L~~~~~~~~~---~~~~~~~~~~~~~l~~al~~lH~~~-----i~H~dlkp~Nili~~~~~~kl~dfg~~  154 (268)
T cd05063          83 IITEYMENGALDKYLRDHDG---EFSSYQLVGMLRGIAAGMKYLSDMN-----YVHRDLAARNILVNSNLECKVSDFGLS  154 (268)
T ss_pred             EEEEcCCCCCHHHHHHhcCC---CCCHHHHHHHHHHHHHHHHHHHHCC-----eeccccchhhEEEcCCCcEEECCCccc
Confidence            99999999999999976432   4899999999999999999999987     999999999999999999999999999


Q ss_pred             ccccCCceeee--ecCCCCCCCCCccccccCCCCCcccchhHHHHHHHHHh-CCCCcchhHHHHHhhhhhhHhhccccCC
Q 005586          565 KLLADDIVFSV--LKTSAAMGYLAPEYVTTGRFTERSDIFAFGVIILQILT-GSLVLTSSMRLAAESATFENFIDRNLKG  641 (689)
Q Consensus       565 ~~~~~~~~~~~--~~~~~~~~y~aPE~~~~~~~~~ksDV~sfGvvl~ellt-G~~p~~~~~~~~~~~~~~~~~~~~~~~~  641 (689)
                      +..........  .....+..|+|||++....++.++|||||||++|||+| |+.|+.......     ....+......
T Consensus       155 ~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~Dv~slG~il~ell~~g~~p~~~~~~~~-----~~~~i~~~~~~  229 (268)
T cd05063         155 RVLEDDPEGTYTTSGGKIPIRWTAPEAIAYRKFTSASDVWSFGIVMWEVMSFGERPYWDMSNHE-----VMKAINDGFRL  229 (268)
T ss_pred             eecccccccceeccCCCcCceecCHHHhhcCCcChHhHHHHHHHHHHHHHhCCCCCCCcCCHHH-----HHHHHhcCCCC
Confidence            86643321111  11223457999999988889999999999999999998 999985432211     11111112222


Q ss_pred             CCCHHHHHHHHHHHHHhccCCCCCCCCHHHHHHHHHhh
Q 005586          642 KFSESEAAKLGKMALVCTHEDPENRPTMEAVIEELTVA  679 (689)
Q Consensus       642 ~~~~~~~~~l~~l~~~Cl~~dp~~RPs~~evl~~L~~~  679 (689)
                      ..+.....++.+++.+|++.+|++||+|.+|++.|+.+
T Consensus       230 ~~~~~~~~~~~~li~~c~~~~p~~Rp~~~~i~~~l~~~  267 (268)
T cd05063         230 PAPMDCPSAVYQLMLQCWQQDRARRPRFVDIVNLLDKL  267 (268)
T ss_pred             CCCCCCCHHHHHHHHHHcCCCcccCcCHHHHHHHHHhh
Confidence            22334567789999999999999999999999999764

Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA2 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored

>cd05071 PTKc_Src Catalytic domain of the Protein Tyrosine Kinase, Src

Probab=100.00  E-value=2.2e-38  Score=324.17  Aligned_cols=254  Identities=25%  Similarity=0.455  Sum_probs=205.0

Q ss_pred             ccCCcccccccCCcceEEEEEecCCcEEEEEEecccCCchHHHHHHHHHHHHhccCCCcceeEeeEEEcCCCCeEEEEEE
Q 005586          409 QCFSEVNLLGKGNFSSVYKGTLRDGTLVAIRSINVTSCKSEEAEFVKGLYLLTSLRHENIIRLRGFCCSRGRGECFLIYD  488 (689)
Q Consensus       409 ~~f~~~~~lg~G~~g~Vy~~~~~~g~~vavK~l~~~~~~~~~~~f~~e~~~l~~l~H~niv~l~g~~~~~~~~~~~lV~e  488 (689)
                      ++|...+.||+|+||.||+|...+...||+|++.....  ...+|.+|++++++++||||+++++++.+   ...++|||
T Consensus         6 ~~~~~~~~lg~g~~~~v~~~~~~~~~~valK~~~~~~~--~~~~~~~E~~~l~~l~~~~i~~~~~~~~~---~~~~lv~e   80 (262)
T cd05071           6 ESLRLEVKLGQGCFGEVWMGTWNGTTRVAIKTLKPGTM--SPEAFLQEAQVMKKLRHEKLVQLYAVVSE---EPIYIVTE   80 (262)
T ss_pred             HHeeEeeecCCCCCCcEEEEEecCCceEEEEecccCcc--CHHHHHHHHHHHHhCCCCCcceEEEEECC---CCcEEEEE
Confidence            46778899999999999999987777899999975432  34578999999999999999999998732   45789999


Q ss_pred             cCCCCCHHHHhhhcCCCCCCCCHHHHHHHHHHHHHHHhhhhCCCCCCCceeecCCCCCceeecCCCCeEEeccccccccc
Q 005586          489 FAPKGKLSKYLDQEEGSSNVLDWSTRVSIIIGIAKGIGYLHSSEVNKPAIVHRNLSVEKVLIDQQFNPLIADCGLHKLLA  568 (689)
Q Consensus       489 ~~~~gsL~~~L~~~~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~~~ivH~dlk~~NiLl~~~~~~kl~DfGla~~~~  568 (689)
                      |+++|+|.++++...+  ..++|..++.++.|+++||+|||+.+     |+||||||+||++++++.+||+|||.++.+.
T Consensus        81 ~~~~~~L~~~~~~~~~--~~~~~~~~~~~~~~l~~aL~~lH~~~-----i~H~dl~p~Nill~~~~~~~L~dfg~~~~~~  153 (262)
T cd05071          81 YMSKGSLLDFLKGEMG--KYLRLPQLVDMAAQIASGMAYVERMN-----YVHRDLRAANILVGENLVCKVADFGLARLIE  153 (262)
T ss_pred             cCCCCcHHHHHhhccc--cCCCHHHHHHHHHHHHHHHHHHHHCC-----ccccccCcccEEEcCCCcEEeccCCceeecc
Confidence            9999999999976432  34789999999999999999999987     9999999999999999999999999998765


Q ss_pred             CCceeeeecCCCCCCCCCccccccCCCCCcccchhHHHHHHHHHh-CCCCcchhHHHHHhhhhhhHhhccccCCCCCHHH
Q 005586          569 DDIVFSVLKTSAAMGYLAPEYVTTGRFTERSDIFAFGVIILQILT-GSLVLTSSMRLAAESATFENFIDRNLKGKFSESE  647 (689)
Q Consensus       569 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~ksDV~sfGvvl~ellt-G~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  647 (689)
                      ...........++..|+|||+..+..++.++||||||+++|||+| |+.|+........    ... +........+...
T Consensus       154 ~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~DvwslG~~l~ellt~g~~p~~~~~~~~~----~~~-~~~~~~~~~~~~~  228 (262)
T cd05071         154 DNEYTARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPYPGMVNREV----LDQ-VERGYRMPCPPEC  228 (262)
T ss_pred             ccccccccCCcccceecCHhHhccCCCCchhhHHHHHHHHHHHHcCCCCCCCCCChHHH----HHH-HhcCCCCCCcccc
Confidence            433222223345667999999988899999999999999999999 7888854322111    111 1111112234456


Q ss_pred             HHHHHHHHHHhccCCCCCCCCHHHHHHHHHhh
Q 005586          648 AAKLGKMALVCTHEDPENRPTMEAVIEELTVA  679 (689)
Q Consensus       648 ~~~l~~l~~~Cl~~dp~~RPs~~evl~~L~~~  679 (689)
                      +..+.+++.+|++.+|++||++.++++.|+..
T Consensus       229 ~~~l~~li~~~l~~~p~~Rp~~~~~~~~l~~~  260 (262)
T cd05071         229 PESLHDLMCQCWRKEPEERPTFEYLQAFLEDY  260 (262)
T ss_pred             CHHHHHHHHHHccCCcccCCCHHHHHHHHHHh
Confidence            67899999999999999999999999998763

Protein Tyrosine Kinase (PTK) family; Src kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) is a cytoplasmic (or non-receptor) tyr kinase, containing an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region with a conserved tyr. It is activated by autophosphorylation at the tyr kinase domain, and is negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). c-Src is the vertebrate homolog of the oncogenic protein (v-Src) from Rous sarcoma virus. Together with other Src subfamily proteins, it is invo

>cd05091 PTKc_Ror2 Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 2

Probab=100.00  E-value=1.6e-38  Score=329.02  Aligned_cols=255  Identities=24%  Similarity=0.396  Sum_probs=202.5

Q ss_pred             CCcccccccCCcceEEEEEec------CCcEEEEEEecccCCchHHHHHHHHHHHHhccCCCcceeEeeEEEcCCCCeEE
Q 005586          411 FSEVNLLGKGNFSSVYKGTLR------DGTLVAIRSINVTSCKSEEAEFVKGLYLLTSLRHENIIRLRGFCCSRGRGECF  484 (689)
Q Consensus       411 f~~~~~lg~G~~g~Vy~~~~~------~g~~vavK~l~~~~~~~~~~~f~~e~~~l~~l~H~niv~l~g~~~~~~~~~~~  484 (689)
                      |...+.||+|+||.||+|...      ++..||+|++...........|.+|+.++.+++||||+++++++..  .+..+
T Consensus         7 ~~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~l~h~~iv~~~~~~~~--~~~~~   84 (283)
T cd05091           7 VRFMEELGEDRFGKVYKGHLFGTAPGEQTQAVAIKTLKDKAEGPLREEFKHEAMMRSRLQHPNIVCLLGVVTK--EQPLS   84 (283)
T ss_pred             HHHHHHhCCCCCCeEEEEEEecCCCCCceeEEEEEEccCCCCHHHHHHHHHHHHHHhcCCCCCcCeEEEEEcC--CCceE
Confidence            455678999999999999864      3578999999865433345678999999999999999999999854  46789


Q ss_pred             EEEEcCCCCCHHHHhhhcCC------------CCCCCCHHHHHHHHHHHHHHHhhhhCCCCCCCceeecCCCCCceeecC
Q 005586          485 LIYDFAPKGKLSKYLDQEEG------------SSNVLDWSTRVSIIIGIAKGIGYLHSSEVNKPAIVHRNLSVEKVLIDQ  552 (689)
Q Consensus       485 lV~e~~~~gsL~~~L~~~~~------------~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~~~ivH~dlk~~NiLl~~  552 (689)
                      +++||+++++|.+++.....            ....+++..++.++.|++.||+|||+.+     |+||||||+||++++
T Consensus        85 ~~~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ql~~aL~~lH~~g-----i~H~dlkp~Nil~~~  159 (283)
T cd05091          85 MIFSYCSHSDLHEFLVMRSPHSDVGSTDDDKTVKSTLEPADFVHIVTQIAAGMEFLSSHH-----VVHKDLATRNVLVFD  159 (283)
T ss_pred             EEEEcCCCCcHHHHHHhcCCCccccccccccccccccCHHHHHHHHHHHHHHHHHHHHcC-----ccccccchhheEecC
Confidence            99999999999999863211            1235889999999999999999999987     999999999999999


Q ss_pred             CCCeEEecccccccccCCceee-eecCCCCCCCCCccccccCCCCCcccchhHHHHHHHHHh-CCCCcchhHHHHHhhhh
Q 005586          553 QFNPLIADCGLHKLLADDIVFS-VLKTSAAMGYLAPEYVTTGRFTERSDIFAFGVIILQILT-GSLVLTSSMRLAAESAT  630 (689)
Q Consensus       553 ~~~~kl~DfGla~~~~~~~~~~-~~~~~~~~~y~aPE~~~~~~~~~ksDV~sfGvvl~ellt-G~~p~~~~~~~~~~~~~  630 (689)
                      ++.+||+|||+++.+....... .....+++.|+|||.+.++.++.++|||||||++|||+| |..|+......    ..
T Consensus       160 ~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~~~g~~p~~~~~~~----~~  235 (283)
T cd05091         160 KLNVKISDLGLFREVYAADYYKLMGNSLLPIRWMSPEAIMYGKFSIDSDIWSYGVVLWEVFSYGLQPYCGYSNQ----DV  235 (283)
T ss_pred             CCceEecccccccccccchheeeccCccCCccccCHHHHhcCCCCcchhHHHHHHHHHHHHcCCCCCCCCCCHH----HH
Confidence            9999999999998764432211 222334678999999988889999999999999999998 77787543221    11


Q ss_pred             hhHhhccccCCCCCHHHHHHHHHHHHHhccCCCCCCCCHHHHHHHHH
Q 005586          631 FENFIDRNLKGKFSESEAAKLGKMALVCTHEDPENRPTMEAVIEELT  677 (689)
Q Consensus       631 ~~~~~~~~~~~~~~~~~~~~l~~l~~~Cl~~dp~~RPs~~evl~~L~  677 (689)
                      ...+.+.. ....+...+..+.+++..||+.+|++||++.||++.|+
T Consensus       236 ~~~i~~~~-~~~~~~~~~~~~~~li~~cl~~~p~~RP~~~~i~~~l~  281 (283)
T cd05091         236 IEMIRNRQ-VLPCPDDCPAWVYTLMLECWNEFPSRRPRFKDIHSRLR  281 (283)
T ss_pred             HHHHHcCC-cCCCCCCCCHHHHHHHHHHhCCCcccCCCHHHHHHHhh
Confidence            22222221 22334556777999999999999999999999999986

Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 2 (Ror2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase cataly

>cd08228 STKc_Nek6 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 6

Probab=100.00  E-value=2.4e-38  Score=324.62  Aligned_cols=261  Identities=20%  Similarity=0.321  Sum_probs=208.0

Q ss_pred             ccCCcccccccCCcceEEEEEec-CCcEEEEEEecccC--CchHHHHHHHHHHHHhccCCCcceeEeeEEEcCCCCeEEE
Q 005586          409 QCFSEVNLLGKGNFSSVYKGTLR-DGTLVAIRSINVTS--CKSEEAEFVKGLYLLTSLRHENIIRLRGFCCSRGRGECFL  485 (689)
Q Consensus       409 ~~f~~~~~lg~G~~g~Vy~~~~~-~g~~vavK~l~~~~--~~~~~~~f~~e~~~l~~l~H~niv~l~g~~~~~~~~~~~l  485 (689)
                      ++|...+.||+|+||.||+|+.. +++.||||.+....  .......|.+|++++++++||||+++++++..  .+..++
T Consensus         2 ~~~~i~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~--~~~~~~   79 (267)
T cd08228           2 ANFQIEKKIGRGQFSEVYRATCLLDRKPVALKKVQIFEMMDAKARQDCVKEIDLLKQLNHPNVIKYLDSFIE--DNELNI   79 (267)
T ss_pred             cceeeeeeeccCCCeeEEEEEEeCCCCEEEEEEeeccccCCHHHHHHHHHHHHHHHhCCCcceeeeeeeEEE--CCeEEE
Confidence            46778899999999999999875 78999999886532  23344678999999999999999999998854  468899


Q ss_pred             EEEcCCCCCHHHHhhhcCCCCCCCCHHHHHHHHHHHHHHHhhhhCCCCCCCceeecCCCCCceeecCCCCeEEecccccc
Q 005586          486 IYDFAPKGKLSKYLDQEEGSSNVLDWSTRVSIIIGIAKGIGYLHSSEVNKPAIVHRNLSVEKVLIDQQFNPLIADCGLHK  565 (689)
Q Consensus       486 V~e~~~~gsL~~~L~~~~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~~~ivH~dlk~~NiLl~~~~~~kl~DfGla~  565 (689)
                      |+||+++|+|.+++.........+++...+.++.|+++||+|||+.+     ++||||||+||+++.++.++|+|||++.
T Consensus        80 v~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~-----i~H~dl~~~nil~~~~~~~~l~d~g~~~  154 (267)
T cd08228          80 VLELADAGDLSQMIKYFKKQKRLIPERTVWKYFVQLCSAVEHMHSRR-----VMHRDIKPANVFITATGVVKLGDLGLGR  154 (267)
T ss_pred             EEEecCCCcHHHHHHHhhhccCCCCHHHHHHHHHHHHHHHHHHhhCC-----eeCCCCCHHHEEEcCCCCEEECccccce
Confidence            99999999999998654333345888999999999999999999987     9999999999999999999999999988


Q ss_pred             cccCCceeeeecCCCCCCCCCccccccCCCCCcccchhHHHHHHHHHhCCCCcchhHHHHHhhhhhhHhhcc-ccCCCCC
Q 005586          566 LLADDIVFSVLKTSAAMGYLAPEYVTTGRFTERSDIFAFGVIILQILTGSLVLTSSMRLAAESATFENFIDR-NLKGKFS  644 (689)
Q Consensus       566 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~ksDV~sfGvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~-~~~~~~~  644 (689)
                      ....... ......++..|+|||.+.+..++.++||||||+++|||+||+.|+.......   ..+.+.+.. .......
T Consensus       155 ~~~~~~~-~~~~~~~~~~~~aPE~~~~~~~~~~~Di~slG~~l~el~~g~~p~~~~~~~~---~~~~~~~~~~~~~~~~~  230 (267)
T cd08228         155 FFSSKTT-AAHSLVGTPYYMSPERIHENGYNFKSDIWSLGCLLYEMAALQSPFYGDKMNL---FSLCQKIEQCDYPPLPT  230 (267)
T ss_pred             eccchhH-HHhcCCCCccccChhhhccCCCCchhhHHHHHHHHHHHhcCCCCCccccccH---HHHHHHHhcCCCCCCCh
Confidence            7654321 1122346778999999988889999999999999999999999985432111   011111111 1111122


Q ss_pred             HHHHHHHHHHHHHhccCCCCCCCCHHHHHHHHHhhC
Q 005586          645 ESEAAKLGKMALVCTHEDPENRPTMEAVIEELTVAA  680 (689)
Q Consensus       645 ~~~~~~l~~l~~~Cl~~dp~~RPs~~evl~~L~~~~  680 (689)
                      ......+.+++.+||+.+|++||++.||++.++...
T Consensus       231 ~~~~~~~~~li~~cl~~~p~~Rp~~~~vl~~~~~~~  266 (267)
T cd08228         231 EHYSEKLRELVSMCIYPDPDQRPDIGYVHQIAKQMH  266 (267)
T ss_pred             hhcCHHHHHHHHHHCCCCcccCcCHHHHHHHHHHhc
Confidence            345678999999999999999999999999998753

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 is required for the transition from metaphase to anaphase. It also plays important roles in mitotic spindle formation and cytokinesis. Activated by Nek9 during mitosis, Nek6 phosphorylates Eg5, a kinesin that is important for spindle bipolarity. Nek6 localizes to spindle microtubules during metaphase

>cd05585 STKc_YPK1_like Catalytic domain of Yeast Protein Kinase 1-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=8.8e-39  Score=335.73  Aligned_cols=242  Identities=21%  Similarity=0.294  Sum_probs=195.6

Q ss_pred             cccCCcceEEEEEec-CCcEEEEEEecccC--CchHHHHHHHHHHHHhccCCCcceeEeeEEEcCCCCeEEEEEEcCCCC
Q 005586          417 LGKGNFSSVYKGTLR-DGTLVAIRSINVTS--CKSEEAEFVKGLYLLTSLRHENIIRLRGFCCSRGRGECFLIYDFAPKG  493 (689)
Q Consensus       417 lg~G~~g~Vy~~~~~-~g~~vavK~l~~~~--~~~~~~~f~~e~~~l~~l~H~niv~l~g~~~~~~~~~~~lV~e~~~~g  493 (689)
                      ||+|+||.||+|... +++.||+|++....  .......+.+|++++.+++||||+++++++..  .+..++||||+++|
T Consensus         1 lg~G~~g~Vy~~~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~--~~~~~lv~e~~~~g   78 (312)
T cd05585           1 IGKGSFGKVMQVRKRDTQRIYALKTIRKAHIVSRSEVTHTLAERTVLAQVNCPFIVPLKFSFQS--PEKLYLVLAFINGG   78 (312)
T ss_pred             CCcCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCcEeceeeEEec--CCeEEEEEcCCCCC
Confidence            799999999999976 58899999987542  13344678899999999999999999998843  57899999999999


Q ss_pred             CHHHHhhhcCCCCCCCCHHHHHHHHHHHHHHHhhhhCCCCCCCceeecCCCCCceeecCCCCeEEecccccccccCCcee
Q 005586          494 KLSKYLDQEEGSSNVLDWSTRVSIIIGIAKGIGYLHSSEVNKPAIVHRNLSVEKVLIDQQFNPLIADCGLHKLLADDIVF  573 (689)
Q Consensus       494 sL~~~L~~~~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~~~ivH~dlk~~NiLl~~~~~~kl~DfGla~~~~~~~~~  573 (689)
                      +|.+++....    .+++..+..++.|+++||+|||+.+     |+||||||+|||+++++.+||+|||+++....... 
T Consensus        79 ~L~~~l~~~~----~~~~~~~~~~~~qi~~~l~~lH~~~-----i~HrDlkp~Nili~~~~~~kl~Dfg~~~~~~~~~~-  148 (312)
T cd05585          79 ELFHHLQREG----RFDLSRARFYTAELLCALENLHKFN-----VIYRDLKPENILLDYQGHIALCDFGLCKLNMKDDD-  148 (312)
T ss_pred             cHHHHHHhcC----CCCHHHHHHHHHHHHHHHHHHHhCC-----eEeCCCCHHHeEECCCCcEEEEECcccccCccCCC-
Confidence            9999997643    3899999999999999999999987     99999999999999999999999999986433221 


Q ss_pred             eeecCCCCCCCCCccccccCCCCCcccchhHHHHHHHHHhCCCCcchhHHHHHhhhhhhHhhccccCCCCCHHHHHHHHH
Q 005586          574 SVLKTSAAMGYLAPEYVTTGRFTERSDIFAFGVIILQILTGSLVLTSSMRLAAESATFENFIDRNLKGKFSESEAAKLGK  653 (689)
Q Consensus       574 ~~~~~~~~~~y~aPE~~~~~~~~~ksDV~sfGvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~  653 (689)
                      ......+|..|+|||.+.+..++.++|||||||++|||+||+.||.......    ....+....  ..++.....++.+
T Consensus       149 ~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGvil~el~tg~~pf~~~~~~~----~~~~~~~~~--~~~~~~~~~~~~~  222 (312)
T cd05585         149 KTNTFCGTPEYLAPELLLGHGYTKAVDWWTLGVLLYEMLTGLPPFYDENVNE----MYRKILQEP--LRFPDGFDRDAKD  222 (312)
T ss_pred             ccccccCCcccCCHHHHcCCCCCCccceechhHHHHHHHhCCCCcCCCCHHH----HHHHHHcCC--CCCCCcCCHHHHH
Confidence            1223457889999999999999999999999999999999999996532211    111222111  1234445667899


Q ss_pred             HHHHhccCCCCCCC---CHHHHHHHH
Q 005586          654 MALVCTHEDPENRP---TMEAVIEEL  676 (689)
Q Consensus       654 l~~~Cl~~dp~~RP---s~~evl~~L  676 (689)
                      ++..||+.||++||   ++.|++.+.
T Consensus       223 li~~~L~~dp~~R~~~~~~~e~l~hp  248 (312)
T cd05585         223 LLIGLLSRDPTRRLGYNGAQEIKNHP  248 (312)
T ss_pred             HHHHHcCCCHHHcCCCCCHHHHHcCC
Confidence            99999999999997   467777664

Serine/Threonine Kinases (STKs), Yeast protein kinase 1 (YPK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YPK1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the AGC STKs, Saccharomyces cerevisiae YPK1 and Schizosaccharomyces pombe Gad8p. YPK1 is required for cell growth and acts as a downstream kinase in the sphingolipid-mediated signaling pathway of yeast. It also plays a role in efficient endocytosis and in the maintenance of cell wall integrity. Gad8p is a downstream target of Tor1p, the fission yeast homolog of mTOR. It pl

>cd05088 PTKc_Tie2 Catalytic domain of the Protein Tyrosine Kinase, Tie2

Probab=100.00  E-value=1.5e-38  Score=332.48  Aligned_cols=264  Identities=23%  Similarity=0.418  Sum_probs=204.9

Q ss_pred             ccCCcccccccCCcceEEEEEec-CCc--EEEEEEecccCCchHHHHHHHHHHHHhcc-CCCcceeEeeEEEcCCCCeEE
Q 005586          409 QCFSEVNLLGKGNFSSVYKGTLR-DGT--LVAIRSINVTSCKSEEAEFVKGLYLLTSL-RHENIIRLRGFCCSRGRGECF  484 (689)
Q Consensus       409 ~~f~~~~~lg~G~~g~Vy~~~~~-~g~--~vavK~l~~~~~~~~~~~f~~e~~~l~~l-~H~niv~l~g~~~~~~~~~~~  484 (689)
                      ++|+..+.||+|+||.||+|..+ +|.  .+|+|+++.........+|.+|++++.++ +||||+++++++.  ..+..+
T Consensus         7 ~~~~~~~~lg~G~~g~V~~a~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~Ei~~l~~l~~h~~iv~~~~~~~--~~~~~~   84 (303)
T cd05088           7 NDIKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIINLLGACE--HRGYLY   84 (303)
T ss_pred             hhceeeeeecCCCCceEEEEEEccCCceeeEEEEEecccCCHHHHHHHHHHHHHHHHhcCCCCcceEEEEEC--CCCCce
Confidence            45777889999999999999975 454  46888776544344557899999999999 8999999999984  356799


Q ss_pred             EEEEcCCCCCHHHHhhhcCC------------CCCCCCHHHHHHHHHHHHHHHhhhhCCCCCCCceeecCCCCCceeecC
Q 005586          485 LIYDFAPKGKLSKYLDQEEG------------SSNVLDWSTRVSIIIGIAKGIGYLHSSEVNKPAIVHRNLSVEKVLIDQ  552 (689)
Q Consensus       485 lV~e~~~~gsL~~~L~~~~~------------~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~~~ivH~dlk~~NiLl~~  552 (689)
                      +|+||+++|+|.++++....            ....+++.+++.++.|++.||+|||+.+     |+||||||+|||+++
T Consensus        85 lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~~LH~~g-----i~H~dlkp~Nili~~  159 (303)
T cd05088          85 LAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQKQ-----FIHRDLAARNILVGE  159 (303)
T ss_pred             EEEEeCCCCcHHHHHHhcccccccccccccccccCcCCHHHHHHHHHHHHHHHHHHHhCC-----ccccccchheEEecC
Confidence            99999999999999976431            1135889999999999999999999987     999999999999999


Q ss_pred             CCCeEEecccccccccCCceeeeecCCCCCCCCCccccccCCCCCcccchhHHHHHHHHHh-CCCCcchhHHHHHhhhhh
Q 005586          553 QFNPLIADCGLHKLLADDIVFSVLKTSAAMGYLAPEYVTTGRFTERSDIFAFGVIILQILT-GSLVLTSSMRLAAESATF  631 (689)
Q Consensus       553 ~~~~kl~DfGla~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~ksDV~sfGvvl~ellt-G~~p~~~~~~~~~~~~~~  631 (689)
                      ++.+||+|||+++......  .......+..|+|||++.+..++.++|||||||++|||+| |..||.......     .
T Consensus       160 ~~~~kl~dfg~~~~~~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~~~-----~  232 (303)
T cd05088         160 NYVAKIADFGLSRGQEVYV--KKTMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPYCGMTCAE-----L  232 (303)
T ss_pred             CCcEEeCccccCcccchhh--hcccCCCcccccCHHHHhccCCcccccchhhhhHHHHHHhcCCCCcccCChHH-----H
Confidence            9999999999986432111  1111223567999999988889999999999999999998 999985432111     1


Q ss_pred             hHhhccccCCCCCHHHHHHHHHHHHHhccCCCCCCCCHHHHHHHHHhhCCccccc
Q 005586          632 ENFIDRNLKGKFSESEAAKLGKMALVCTHEDPENRPTMEAVIEELTVAAPVMATF  686 (689)
Q Consensus       632 ~~~~~~~~~~~~~~~~~~~l~~l~~~Cl~~dp~~RPs~~evl~~L~~~~p~~~~~  686 (689)
                      .+.+........+...+..+.+++.+|++.+|++||++.+++++|..+-.....|
T Consensus       233 ~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~~l~~~~~~~~~~  287 (303)
T cd05088         233 YEKLPQGYRLEKPLNCDDEVYDLMRQCWREKPYERPSFAQILVSLNRMLEERKTY  287 (303)
T ss_pred             HHHHhcCCcCCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHHhhhhh
Confidence            1111111122223334567899999999999999999999999998765554433

Protein Tyrosine Kinase (PTK) family; Tie2; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie2 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie2 is expressed mainly in endothelial cells and hematopoietic stem cells. It is also found in a subset of tumor-associated monocytes and eosinophils. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2. The binding of A

>cd05089 PTKc_Tie1 Catalytic domain of the Protein Tyrosine Kinase, Tie1

Probab=100.00  E-value=2e-38  Score=330.62  Aligned_cols=259  Identities=22%  Similarity=0.408  Sum_probs=203.9

Q ss_pred             ccCCcccccccCCcceEEEEEec-CCc--EEEEEEecccCCchHHHHHHHHHHHHhcc-CCCcceeEeeEEEcCCCCeEE
Q 005586          409 QCFSEVNLLGKGNFSSVYKGTLR-DGT--LVAIRSINVTSCKSEEAEFVKGLYLLTSL-RHENIIRLRGFCCSRGRGECF  484 (689)
Q Consensus       409 ~~f~~~~~lg~G~~g~Vy~~~~~-~g~--~vavK~l~~~~~~~~~~~f~~e~~~l~~l-~H~niv~l~g~~~~~~~~~~~  484 (689)
                      ++|+..+.||+|+||.||+|..+ ++.  .+++|.++........+.|.+|++++.++ +||||+++++++..  .+..+
T Consensus         2 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~--~~~~~   79 (297)
T cd05089           2 EDIKFEDVIGEGNFGQVIRAMIKKDGLKMNAAIKMLKEFASENDHRDFAGELEVLCKLGHHPNIINLLGACEN--RGYLY   79 (297)
T ss_pred             ccceeeeeecCCCcceEEEEEecCCCCcceeEEEEccccCCHHHHHHHHHHHHHHHhhcCCCchhheEEEEcc--CCcce
Confidence            46778899999999999999875 343  47888887544344556899999999999 79999999999844  46789


Q ss_pred             EEEEcCCCCCHHHHhhhcCC------------CCCCCCHHHHHHHHHHHHHHHhhhhCCCCCCCceeecCCCCCceeecC
Q 005586          485 LIYDFAPKGKLSKYLDQEEG------------SSNVLDWSTRVSIIIGIAKGIGYLHSSEVNKPAIVHRNLSVEKVLIDQ  552 (689)
Q Consensus       485 lV~e~~~~gsL~~~L~~~~~------------~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~~~ivH~dlk~~NiLl~~  552 (689)
                      +|+||+++|+|.++++....            ....+++..++.|+.|++.||+|||+.+     |+||||||+|||+++
T Consensus        80 lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~lH~~~-----ivH~dlkp~Nill~~  154 (297)
T cd05089          80 IAIEYAPYGNLLDFLRKSRVLETDPAFAKEHGTASTLTSQQLLQFASDVATGMQYLSEKQ-----FIHRDLAARNVLVGE  154 (297)
T ss_pred             EEEEecCCCcHHHHHHhccccccccccccccCccCCCCHHHHHHHHHHHHHHHHHHHHCC-----cccCcCCcceEEECC
Confidence            99999999999999975421            1134889999999999999999999987     999999999999999


Q ss_pred             CCCeEEecccccccccCCceeeeecCCCCCCCCCccccccCCCCCcccchhHHHHHHHHHh-CCCCcchhHHHHHhhhhh
Q 005586          553 QFNPLIADCGLHKLLADDIVFSVLKTSAAMGYLAPEYVTTGRFTERSDIFAFGVIILQILT-GSLVLTSSMRLAAESATF  631 (689)
Q Consensus       553 ~~~~kl~DfGla~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~ksDV~sfGvvl~ellt-G~~p~~~~~~~~~~~~~~  631 (689)
                      ++.+||+|||++.......  .......+..|+|||++.+..++.++|||||||++|||+| |+.||........     
T Consensus       155 ~~~~kl~dfg~~~~~~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~DvwSlG~il~el~t~g~~pf~~~~~~~~-----  227 (297)
T cd05089         155 NLASKIADFGLSRGEEVYV--KKTMGRLPVRWMAIESLNYSVYTTKSDVWSFGVLLWEIVSLGGTPYCGMTCAEL-----  227 (297)
T ss_pred             CCeEEECCcCCCcccccee--ccCCCCcCccccCchhhccCCCCchhhHHHHHHHHHHHHcCCCCCCCCCCHHHH-----
Confidence            9999999999986432211  1111223457999999988889999999999999999998 9999864322111     


Q ss_pred             hHhhccccCCCCCHHHHHHHHHHHHHhccCCCCCCCCHHHHHHHHHhhCC
Q 005586          632 ENFIDRNLKGKFSESEAAKLGKMALVCTHEDPENRPTMEAVIEELTVAAP  681 (689)
Q Consensus       632 ~~~~~~~~~~~~~~~~~~~l~~l~~~Cl~~dp~~RPs~~evl~~L~~~~p  681 (689)
                      .+.+........+...+..+.+++.+||+.+|.+||++.+++++|..+..
T Consensus       228 ~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~i~~~l~~~~~  277 (297)
T cd05089         228 YEKLPQGYRMEKPRNCDDEVYELMRQCWRDRPYERPPFAQISVQLSRMLE  277 (297)
T ss_pred             HHHHhcCCCCCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHH
Confidence            11122222222334456778999999999999999999999999877644

Protein Tyrosine Kinase (PTK) family; Tie1; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie1 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. No specific ligand has been identified for Tie1, although the angiopoietin, Ang-1, binds to Tie1 through integrins at high concentrations.

>cd05069 PTKc_Yes Catalytic domain of the Protein Tyrosine Kinase, Yes

Probab=100.00  E-value=2.9e-38  Score=322.79  Aligned_cols=253  Identities=25%  Similarity=0.469  Sum_probs=204.5

Q ss_pred             ccCCcccccccCCcceEEEEEecCCcEEEEEEecccCCchHHHHHHHHHHHHhccCCCcceeEeeEEEcCCCCeEEEEEE
Q 005586          409 QCFSEVNLLGKGNFSSVYKGTLRDGTLVAIRSINVTSCKSEEAEFVKGLYLLTSLRHENIIRLRGFCCSRGRGECFLIYD  488 (689)
Q Consensus       409 ~~f~~~~~lg~G~~g~Vy~~~~~~g~~vavK~l~~~~~~~~~~~f~~e~~~l~~l~H~niv~l~g~~~~~~~~~~~lV~e  488 (689)
                      ++|...+.||+|+||.||+|...++..||+|++....  ...+.|.+|++++++++|+|++++++++.   .+..++|||
T Consensus         6 ~~~~~~~~ig~g~~~~v~~~~~~~~~~~~lK~~~~~~--~~~~~~~~E~~~l~~l~h~~i~~~~~~~~---~~~~~~v~e   80 (260)
T cd05069           6 ESLRLDVKLGQGCFGEVWMGTWNGTTKVAIKTLKPGT--MMPEAFLQEAQIMKKLRHDKLVPLYAVVS---EEPIYIVTE   80 (260)
T ss_pred             HHeeeeeeecCcCCCeEEEEEEcCCceEEEEEcccCC--ccHHHHHHHHHHHHhCCCCCeeeEEEEEc---CCCcEEEEE
Confidence            3566778999999999999998877789999887543  23457899999999999999999999873   245789999


Q ss_pred             cCCCCCHHHHhhhcCCCCCCCCHHHHHHHHHHHHHHHhhhhCCCCCCCceeecCCCCCceeecCCCCeEEeccccccccc
Q 005586          489 FAPKGKLSKYLDQEEGSSNVLDWSTRVSIIIGIAKGIGYLHSSEVNKPAIVHRNLSVEKVLIDQQFNPLIADCGLHKLLA  568 (689)
Q Consensus       489 ~~~~gsL~~~L~~~~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~~~ivH~dlk~~NiLl~~~~~~kl~DfGla~~~~  568 (689)
                      |+++|+|.++++....  ..++|..+..++.|++.||+|||+.+     ++||||||+||++++++.+||+|||+++...
T Consensus        81 ~~~~~~L~~~~~~~~~--~~~~~~~~~~~~~~l~~al~~lH~~~-----i~H~dl~~~Nill~~~~~~~l~dfg~~~~~~  153 (260)
T cd05069          81 FMGKGSLLDFLKEGDG--KYLKLPQLVDMAAQIADGMAYIERMN-----YIHRDLRAANILVGDNLVCKIADFGLARLIE  153 (260)
T ss_pred             cCCCCCHHHHHhhCCC--CCCCHHHHHHHHHHHHHHHHHHHhCC-----EeecccCcceEEEcCCCeEEECCCccceEcc
Confidence            9999999999976432  34899999999999999999999887     9999999999999999999999999998765


Q ss_pred             CCceeeeecCCCCCCCCCccccccCCCCCcccchhHHHHHHHHHh-CCCCcchhHHHHHhhhhhhHhhccccCCCCCHHH
Q 005586          569 DDIVFSVLKTSAAMGYLAPEYVTTGRFTERSDIFAFGVIILQILT-GSLVLTSSMRLAAESATFENFIDRNLKGKFSESE  647 (689)
Q Consensus       569 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~ksDV~sfGvvl~ellt-G~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  647 (689)
                      ...........++..|+|||+..+..++.++|||||||++|||+| |+.|+.........    .. +........+...
T Consensus       154 ~~~~~~~~~~~~~~~y~~Pe~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~~~~~----~~-~~~~~~~~~~~~~  228 (260)
T cd05069         154 DNEYTARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELVTKGRVPYPGMVNREVL----EQ-VERGYRMPCPQGC  228 (260)
T ss_pred             CCcccccCCCccchhhCCHHHhccCCcChHHHHHHHHHHHHHHHhCCCCCCCCCCHHHHH----HH-HHcCCCCCCCccc
Confidence            432222222345667999999988899999999999999999999 89898654322111    11 1112222334455


Q ss_pred             HHHHHHHHHHhccCCCCCCCCHHHHHHHHHh
Q 005586          648 AAKLGKMALVCTHEDPENRPTMEAVIEELTV  678 (689)
Q Consensus       648 ~~~l~~l~~~Cl~~dp~~RPs~~evl~~L~~  678 (689)
                      +..+.+++.+||+.+|++||++++|++.|+.
T Consensus       229 ~~~~~~li~~~l~~~p~~Rp~~~~i~~~l~~  259 (260)
T cd05069         229 PESLHELMKLCWKKDPDERPTFEYIQSFLED  259 (260)
T ss_pred             CHHHHHHHHHHccCCcccCcCHHHHHHHHhc
Confidence            6789999999999999999999999999875

Protein Tyrosine Kinase (PTK) family; Yes kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Yes (or c-Yes) is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine an

>KOG1025 consensus Epidermal growth factor receptor EGFR and related tyrosine kinases [Signal transduction mechanisms]

Probab=100.00  E-value=1.7e-39  Score=347.21  Aligned_cols=259  Identities=26%  Similarity=0.438  Sum_probs=220.5

Q ss_pred             cccccccCCcceEEEEEe-cCC----cEEEEEEecccCCchHHHHHHHHHHHHhccCCCcceeEeeEEEcCCCCeEEEEE
Q 005586          413 EVNLLGKGNFSSVYKGTL-RDG----TLVAIRSINVTSCKSEEAEFVKGLYLLTSLRHENIIRLRGFCCSRGRGECFLIY  487 (689)
Q Consensus       413 ~~~~lg~G~~g~Vy~~~~-~~g----~~vavK~l~~~~~~~~~~~f~~e~~~l~~l~H~niv~l~g~~~~~~~~~~~lV~  487 (689)
                      ..++||+|+||+||||.+ ++|    .+||+|++......+...+|.+|+-.|++++|||+++|+|+|...   ...||+
T Consensus       700 k~kvLGsgAfGtV~kGiw~Pege~vKipVaiKvl~~~t~~~~s~e~LdeAl~masldHpnl~RLLgvc~~s---~~qlvt  776 (1177)
T KOG1025|consen  700 KDKVLGSGAFGTVYKGIWIPEGENVKIPVAIKVLIEFTSPKASIELLDEALRMASLDHPNLLRLLGVCMLS---TLQLVT  776 (1177)
T ss_pred             hhceeccccceeEEeeeEecCCceecceeEEEEeeccCCchhhHHHHHHHHHHhcCCCchHHHHhhhcccc---hHHHHH
Confidence            357999999999999986 333    579999998877677778999999999999999999999999653   478999


Q ss_pred             EcCCCCCHHHHhhhcCCCCCCCCHHHHHHHHHHHHHHHhhhhCCCCCCCceeecCCCCCceeecCCCCeEEecccccccc
Q 005586          488 DFAPKGKLSKYLDQEEGSSNVLDWSTRVSIIIGIAKGIGYLHSSEVNKPAIVHRNLSVEKVLIDQQFNPLIADCGLHKLL  567 (689)
Q Consensus       488 e~~~~gsL~~~L~~~~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~~~ivH~dlk~~NiLl~~~~~~kl~DfGla~~~  567 (689)
                      +|||.|+|.+|++.++.   .+.-+..+.|..|||+||.|||..+     +|||||.++|||+.+-..+||.|||+++.+
T Consensus       777 q~mP~G~LlDyvr~hr~---~igsq~lLnw~~QIAkgM~YLe~qr-----lVHrdLaaRNVLVksP~hvkitdfgla~ll  848 (1177)
T KOG1025|consen  777 QLMPLGCLLDYVREHRD---NIGSQDLLNWCYQIAKGMKYLEEQR-----LVHRDLAARNVLVKSPNHVKITDFGLAKLL  848 (1177)
T ss_pred             HhcccchHHHHHHHhhc---cccHHHHHHHHHHHHHHHHHHHhcc-----hhhhhhhhhheeecCCCeEEEEecchhhcc
Confidence            99999999999998764   3777889999999999999999876     999999999999999999999999999988


Q ss_pred             cCCc-eeeeecCCCCCCCCCccccccCCCCCcccchhHHHHHHHHHh-CCCCcchhHHHHHhhhhhhHhhccccCCCCCH
Q 005586          568 ADDI-VFSVLKTSAAMGYLAPEYVTTGRFTERSDIFAFGVIILQILT-GSLVLTSSMRLAAESATFENFIDRNLKGKFSE  645 (689)
Q Consensus       568 ~~~~-~~~~~~~~~~~~y~aPE~~~~~~~~~ksDV~sfGvvl~ellt-G~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~  645 (689)
                      ..+. .+......-.+.|||-|.+....|+.++|||||||.+||++| |..|+...     ....+.+++....+...|+
T Consensus       849 ~~d~~ey~~~~gK~pikwmale~i~~~~~thqSDVWsfGVtiWElmTFGa~Py~gi-----~~~eI~dlle~geRLsqPp  923 (1177)
T KOG1025|consen  849 APDEKEYSAPGGKVPIKWMALESIRIRKYTHQSDVWSFGVTIWELMTFGAKPYDGI-----PAEEIPDLLEKGERLSQPP  923 (1177)
T ss_pred             CcccccccccccccCcHHHHHHHhhccCCCchhhhhhhhhhHHHHHhcCCCccCCC-----CHHHhhHHHhccccCCCCC
Confidence            6543 333333444567999999999999999999999999999998 78887543     2234555666666667788


Q ss_pred             HHHHHHHHHHHHhccCCCCCCCCHHHHHHHHHhhCCcccccc
Q 005586          646 SEAAKLGKMALVCTHEDPENRPTMEAVIEELTVAAPVMATFL  687 (689)
Q Consensus       646 ~~~~~l~~l~~~Cl~~dp~~RPs~~evl~~L~~~~p~~~~~~  687 (689)
                      .+..++..++.+||..|+..||+++++...+.+.+.+..-|+
T Consensus       924 iCtiDVy~~mvkCwmid~~~rp~fkel~~~fs~~ardpqryl  965 (1177)
T KOG1025|consen  924 ICTIDVYMVMVKCWMIDADSRPTFKELAEEFSRMARDPQRYL  965 (1177)
T ss_pred             CccHHHHHHHHHHhccCcccCccHHHHHHHHHHHhcCcceEe
Confidence            899999999999999999999999999999998887765543

>cd05079 PTKc_Jak1_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Janus kinase 1

Probab=100.00  E-value=2.9e-38  Score=327.27  Aligned_cols=262  Identities=26%  Similarity=0.444  Sum_probs=205.9

Q ss_pred             cCCcccccccCCcceEEEEEe-----cCCcEEEEEEecccCCchHHHHHHHHHHHHhccCCCcceeEeeEEEcCCCCeEE
Q 005586          410 CFSEVNLLGKGNFSSVYKGTL-----RDGTLVAIRSINVTSCKSEEAEFVKGLYLLTSLRHENIIRLRGFCCSRGRGECF  484 (689)
Q Consensus       410 ~f~~~~~lg~G~~g~Vy~~~~-----~~g~~vavK~l~~~~~~~~~~~f~~e~~~l~~l~H~niv~l~g~~~~~~~~~~~  484 (689)
                      .|+..+.||+|+||.||++.+     .++..||+|.+...........|.+|++++++++|||++++++++...+....+
T Consensus         5 ~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~va~K~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~   84 (284)
T cd05079           5 FLKRIRDLGEGHFGKVELCRYDPEGDNTGEQVAVKSLKPESGGNHIADLKKEIEILRNLYHENIVKYKGICTEDGGNGIK   84 (284)
T ss_pred             hhhhceecCCCCceeEEEEEEccCCCCccceEEEEEcCccccHHHHHHHHHHHHHHHhCCCCCeeeeeeEEecCCCCceE
Confidence            466788999999999999974     257899999987665444556899999999999999999999998665456789


Q ss_pred             EEEEcCCCCCHHHHhhhcCCCCCCCCHHHHHHHHHHHHHHHhhhhCCCCCCCceeecCCCCCceeecCCCCeEEeccccc
Q 005586          485 LIYDFAPKGKLSKYLDQEEGSSNVLDWSTRVSIIIGIAKGIGYLHSSEVNKPAIVHRNLSVEKVLIDQQFNPLIADCGLH  564 (689)
Q Consensus       485 lV~e~~~~gsL~~~L~~~~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~~~ivH~dlk~~NiLl~~~~~~kl~DfGla  564 (689)
                      +||||+++++|.+++....   ..++|.+++.++.|++.||+|||+.+     |+||||||+||++++++.+||+|||++
T Consensus        85 lv~e~~~g~~L~~~l~~~~---~~~~~~~~~~i~~~i~~aL~~lH~~g-----i~H~dlkp~Nil~~~~~~~~l~dfg~~  156 (284)
T cd05079          85 LIMEFLPSGSLKEYLPRNK---NKINLKQQLKYAVQICKGMDYLGSRQ-----YVHRDLAARNVLVESEHQVKIGDFGLT  156 (284)
T ss_pred             EEEEccCCCCHHHHHHhcc---CCCCHHHHHHHHHHHHHHHHHHHHCC-----eeecccchheEEEcCCCCEEECCCccc
Confidence            9999999999999996543   24899999999999999999999987     999999999999999999999999999


Q ss_pred             ccccCCcee--eeecCCCCCCCCCccccccCCCCCcccchhHHHHHHHHHhCCCCcchhHHHHHh----------hhhhh
Q 005586          565 KLLADDIVF--SVLKTSAAMGYLAPEYVTTGRFTERSDIFAFGVIILQILTGSLVLTSSMRLAAE----------SATFE  632 (689)
Q Consensus       565 ~~~~~~~~~--~~~~~~~~~~y~aPE~~~~~~~~~ksDV~sfGvvl~elltG~~p~~~~~~~~~~----------~~~~~  632 (689)
                      +........  ......++..|+|||++.+..++.++|||||||++|||+|++.|..........          .....
T Consensus       157 ~~~~~~~~~~~~~~~~~~~~~y~apE~~~~~~~~~~~Di~slG~il~ellt~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  236 (284)
T cd05079         157 KAIETDKEYYTVKDDLDSPVFWYAPECLIQSKFYIASDVWSFGVTLYELLTYCDSESSPMTLFLKMIGPTHGQMTVTRLV  236 (284)
T ss_pred             cccccCccceeecCCCCCCccccCHHHhccCCCCccccchhhhhhhhhhhcCCCCCccccchhhhhcccccccccHHHHH
Confidence            876443211  111233556799999998888999999999999999999987765322110000          00011


Q ss_pred             HhhccccCCCCCHHHHHHHHHHHHHhccCCCCCCCCHHHHHHHHHhh
Q 005586          633 NFIDRNLKGKFSESEAAKLGKMALVCTHEDPENRPTMEAVIEELTVA  679 (689)
Q Consensus       633 ~~~~~~~~~~~~~~~~~~l~~l~~~Cl~~dp~~RPs~~evl~~L~~~  679 (689)
                      +.+........+...+..+.+++.+|++.+|++||++.++++.|+.+
T Consensus       237 ~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~il~~l~~~  283 (284)
T cd05079         237 RVLEEGKRLPRPPNCPEEVYQLMRKCWEFQPSKRTTFQNLIEGFEAI  283 (284)
T ss_pred             HHHHcCccCCCCCCCCHHHHHHHHHHccCCcccCcCHHHHHHHHHhh
Confidence            11111112222344567899999999999999999999999999865

Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers a

>cd05595 STKc_PKB_beta Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B beta

Probab=100.00  E-value=8.1e-39  Score=337.56  Aligned_cols=244  Identities=23%  Similarity=0.335  Sum_probs=197.2

Q ss_pred             cccccCCcceEEEEEec-CCcEEEEEEecccCC--chHHHHHHHHHHHHhccCCCcceeEeeEEEcCCCCeEEEEEEcCC
Q 005586          415 NLLGKGNFSSVYKGTLR-DGTLVAIRSINVTSC--KSEEAEFVKGLYLLTSLRHENIIRLRGFCCSRGRGECFLIYDFAP  491 (689)
Q Consensus       415 ~~lg~G~~g~Vy~~~~~-~g~~vavK~l~~~~~--~~~~~~f~~e~~~l~~l~H~niv~l~g~~~~~~~~~~~lV~e~~~  491 (689)
                      +.||+|+||.||+++.+ +|..||+|++.....  ......+.+|++++.+++||||+++++++..  .+..++||||++
T Consensus         1 ~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~i~~~~~~~~~--~~~~~lv~E~~~   78 (323)
T cd05595           1 KLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHPFLTALKYAFQT--HDRLCFVMEYAN   78 (323)
T ss_pred             CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhHHHHHHHHHHHHHHhCCCCCCcceeeEEec--CCEEEEEEeCCC
Confidence            36999999999999875 689999999975431  2344578889999999999999999998844  478999999999


Q ss_pred             CCCHHHHhhhcCCCCCCCCHHHHHHHHHHHHHHHhhhhCCCCCCCceeecCCCCCceeecCCCCeEEecccccccccCCc
Q 005586          492 KGKLSKYLDQEEGSSNVLDWSTRVSIIIGIAKGIGYLHSSEVNKPAIVHRNLSVEKVLIDQQFNPLIADCGLHKLLADDI  571 (689)
Q Consensus       492 ~gsL~~~L~~~~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~~~ivH~dlk~~NiLl~~~~~~kl~DfGla~~~~~~~  571 (689)
                      +|+|..++....    .+++..+..++.|++.||+|||+.+     |+||||||+|||+++++.+||+|||+++......
T Consensus        79 ~~~L~~~l~~~~----~~~~~~~~~~~~qi~~aL~~LH~~~-----ivH~Dlkp~NIll~~~~~~kL~Dfg~~~~~~~~~  149 (323)
T cd05595          79 GGELFFHLSRER----VFTEERARFYGAEIVSALEYLHSRD-----VVYRDIKLENLMLDKDGHIKITDFGLCKEGISDG  149 (323)
T ss_pred             CCcHHHHHHHcC----CCCHHHHHHHHHHHHHHHHHHHHCC-----eEecCCCHHHEEEcCCCCEEecccHHhccccCCC
Confidence            999999887543    4899999999999999999999987     9999999999999999999999999987542221


Q ss_pred             eeeeecCCCCCCCCCccccccCCCCCcccchhHHHHHHHHHhCCCCcchhHHHHHhhhhhhHhhccccCCCCCHHHHHHH
Q 005586          572 VFSVLKTSAAMGYLAPEYVTTGRFTERSDIFAFGVIILQILTGSLVLTSSMRLAAESATFENFIDRNLKGKFSESEAAKL  651 (689)
Q Consensus       572 ~~~~~~~~~~~~y~aPE~~~~~~~~~ksDV~sfGvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l  651 (689)
                      . ......++..|+|||++.+..++.++|||||||++|||++|+.||........    ...+.....  .++.....++
T Consensus       150 ~-~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~ell~g~~Pf~~~~~~~~----~~~~~~~~~--~~p~~~~~~~  222 (323)
T cd05595         150 A-TMKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHERL----FELILMEEI--RFPRTLSPEA  222 (323)
T ss_pred             C-ccccccCCcCcCCcccccCCCCCchhchhhhHHHHHHHHhCCCCCCCCCHHHH----HHHHhcCCC--CCCCCCCHHH
Confidence            1 12234578899999999988999999999999999999999999965322111    111111111  2334446678


Q ss_pred             HHHHHHhccCCCCCCC-----CHHHHHHHH
Q 005586          652 GKMALVCTHEDPENRP-----TMEAVIEEL  676 (689)
Q Consensus       652 ~~l~~~Cl~~dp~~RP-----s~~evl~~L  676 (689)
                      .+++..|++.||++||     ++.+++++-
T Consensus       223 ~~li~~~L~~dP~~R~~~~~~~~~~~l~h~  252 (323)
T cd05595         223 KSLLAGLLKKDPKQRLGGGPSDAKEVMEHR  252 (323)
T ss_pred             HHHHHHHccCCHHHhCCCCCCCHHHHHcCC
Confidence            9999999999999998     899998764

Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, beta (or Akt2) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-beta is the predominant PKB isoform expressed in insulin-responsive tissues. It plays a critical role in the regulation of glucose homeostasis. It is also implicated in muscle cell differentiation. Mice deficient in

>cd05087 PTKc_Aatyk1_Aatyk3 Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases 1 and 3

Probab=100.00  E-value=4.2e-38  Score=323.35  Aligned_cols=254  Identities=22%  Similarity=0.334  Sum_probs=192.3

Q ss_pred             ccccCCcceEEEEEecC---CcEEEEEEecccCCchHHHHHHHHHHHHhccCCCcceeEeeEEEcCCCCeEEEEEEcCCC
Q 005586          416 LLGKGNFSSVYKGTLRD---GTLVAIRSINVTSCKSEEAEFVKGLYLLTSLRHENIIRLRGFCCSRGRGECFLIYDFAPK  492 (689)
Q Consensus       416 ~lg~G~~g~Vy~~~~~~---g~~vavK~l~~~~~~~~~~~f~~e~~~l~~l~H~niv~l~g~~~~~~~~~~~lV~e~~~~  492 (689)
                      .||+|+||.||+|.+.+   +..+|+|.++..........|.+|+.++++++||||+++++++.+  ....++||||+++
T Consensus         2 ~lg~G~~g~Vy~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~--~~~~~lv~e~~~~   79 (269)
T cd05087           2 EIGNGWFGKVILGEVNSGYTPAQVVVKELRVSASVQEQMKFLEEAQPYRSLQHSNLLQCLGQCTE--VTPYLLVMEFCPL   79 (269)
T ss_pred             cccccCCceEEEEEEcCCCCceEEEEEecCCCCChHHHHHHHHHHHHHHhCCCCCEeeEEEEEcC--CCCcEEEEECCCC
Confidence            59999999999998653   467999998766544455689999999999999999999999843  4678999999999


Q ss_pred             CCHHHHhhhcCCC-CCCCCHHHHHHHHHHHHHHHhhhhCCCCCCCceeecCCCCCceeecCCCCeEEecccccccccCCc
Q 005586          493 GKLSKYLDQEEGS-SNVLDWSTRVSIIIGIAKGIGYLHSSEVNKPAIVHRNLSVEKVLIDQQFNPLIADCGLHKLLADDI  571 (689)
Q Consensus       493 gsL~~~L~~~~~~-~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~~~ivH~dlk~~NiLl~~~~~~kl~DfGla~~~~~~~  571 (689)
                      |+|.++++..... ....++..+..++.|+++||+|||+.+     ++||||||+||++++++.+||+|||+++......
T Consensus        80 g~L~~~l~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~-----i~H~dlkp~nil~~~~~~~kL~dfg~~~~~~~~~  154 (269)
T cd05087          80 GDLKGYLRSCRKAELMTPDPTTLQRMACEIALGLLHLHKNN-----FIHSDLALRNCLLTADLTVKIGDYGLSHNKYKED  154 (269)
T ss_pred             CcHHHHHHHhhhcccccccHHHHHHHHHHHHHHHHHHHHCC-----EeccccCcceEEEcCCCcEEECCccccccccCcc
Confidence            9999999764321 234678888899999999999999987     9999999999999999999999999997654332


Q ss_pred             eee-eecCCCCCCCCCccccccC-------CCCCcccchhHHHHHHHHHh-CCCCcchhHHHHHhhhhhhHhhccccCCC
Q 005586          572 VFS-VLKTSAAMGYLAPEYVTTG-------RFTERSDIFAFGVIILQILT-GSLVLTSSMRLAAESATFENFIDRNLKGK  642 (689)
Q Consensus       572 ~~~-~~~~~~~~~y~aPE~~~~~-------~~~~ksDV~sfGvvl~ellt-G~~p~~~~~~~~~~~~~~~~~~~~~~~~~  642 (689)
                      ... .....++..|+|||++...       .++.++||||||+++|||++ |+.||..............+...+.....
T Consensus       155 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~~l~el~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~  234 (269)
T cd05087         155 YYVTPDQLWVPLRWIAPELVDEVHGNLLVVDQTKESNVWSLGVTIWELFELGSQPYRHLSDEQVLTYTVREQQLKLPKPR  234 (269)
T ss_pred             eeecCCCcCCcccccCHhHhccccccccccCCCccchhHHHHHHHHHHHhCCCCCCCCCChHHHHHHHhhcccCCCCCCc
Confidence            211 1123456779999988542       35789999999999999996 99998643222111111111000001111


Q ss_pred             CCHHHHHHHHHHHHHhccCCCCCCCCHHHHHHHHH
Q 005586          643 FSESEAAKLGKMALVCTHEDPENRPTMEAVIEELT  677 (689)
Q Consensus       643 ~~~~~~~~l~~l~~~Cl~~dp~~RPs~~evl~~L~  677 (689)
                      ........+.+++..|+ .+|++||+++||++.|+
T Consensus       235 ~~~~~~~~~~~l~~~c~-~~P~~Rpt~~~l~~~l~  268 (269)
T cd05087         235 LKLPLSDRWYEVMQFCW-LQPEQRPSAEEVHLLLS  268 (269)
T ss_pred             cCCCCChHHHHHHHHHh-cCcccCCCHHHHHHHhc
Confidence            11223456888999999 58999999999998875

Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 1 (Aatyk1) and Aatyk3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk1 and Aatyk3 are members of the Aatyk subfamily of proteins. Aatyk3 is a receptor kinase containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 has a similar domain arrangement but without the transmembrane segment and is thus, a cytoplasmic (or nonreceptor) kinase. The expression of Aatyk1 (also referred simply as Aatyk) is upregulated during growth arrest and apoptosis in myeloid cells

>cd07862 STKc_CDK6 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 6

Probab=100.00  E-value=2.1e-38  Score=329.28  Aligned_cols=257  Identities=19%  Similarity=0.363  Sum_probs=195.0

Q ss_pred             cCCcccccccCCcceEEEEEec--CCcEEEEEEecccCCc-hHHHHHHHHHHHHhcc---CCCcceeEeeEEEc---CCC
Q 005586          410 CFSEVNLLGKGNFSSVYKGTLR--DGTLVAIRSINVTSCK-SEEAEFVKGLYLLTSL---RHENIIRLRGFCCS---RGR  480 (689)
Q Consensus       410 ~f~~~~~lg~G~~g~Vy~~~~~--~g~~vavK~l~~~~~~-~~~~~f~~e~~~l~~l---~H~niv~l~g~~~~---~~~  480 (689)
                      +|...+.||+|+||.||+|+..  +|+.||+|+++..... .....+.+|+.++.++   +||||++++++|..   ...
T Consensus         2 ~Y~~~~~lg~G~~g~Vy~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~hpniv~~~~~~~~~~~~~~   81 (290)
T cd07862           2 QYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHLETFEHPNVVRLFDVCTVSRTDRE   81 (290)
T ss_pred             CcceeeEeccCCCeEEEEEEEcCCCCeEEEEEEEecccCCCCchHHHHHHHHHHHhhcccCCCCcceEEEEEecccCCCC
Confidence            6778899999999999999863  4788999998754322 2234566777766655   69999999998852   223


Q ss_pred             CeEEEEEEcCCCCCHHHHhhhcCCCCCCCCHHHHHHHHHHHHHHHhhhhCCCCCCCceeecCCCCCceeecCCCCeEEec
Q 005586          481 GECFLIYDFAPKGKLSKYLDQEEGSSNVLDWSTRVSIIIGIAKGIGYLHSSEVNKPAIVHRNLSVEKVLIDQQFNPLIAD  560 (689)
Q Consensus       481 ~~~~lV~e~~~~gsL~~~L~~~~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~~~ivH~dlk~~NiLl~~~~~~kl~D  560 (689)
                      ...++||||++ ++|.+++.....  ..+++.+++.|+.|++.||+|||+.+     |+||||||+|||+++++.+||+|
T Consensus        82 ~~~~lv~e~~~-~~l~~~~~~~~~--~~~~~~~~~~i~~qi~~aL~~lH~~~-----iiH~dlkp~Nil~~~~~~~kl~D  153 (290)
T cd07862          82 TKLTLVFEHVD-QDLTTYLDKVPE--PGVPTETIKDMMFQLLRGLDFLHSHR-----VVHRDLKPQNILVTSSGQIKLAD  153 (290)
T ss_pred             CcEEEEEccCC-CCHHHHHHhCCC--CCCCHHHHHHHHHHHHHHHHHHHHCC-----eeeCCCCHHHEEEcCCCCEEEcc
Confidence            56899999996 699999975432  34899999999999999999999987     99999999999999999999999


Q ss_pred             ccccccccCCceeeeecCCCCCCCCCccccccCCCCCcccchhHHHHHHHHHhCCCCcchhHHHHHhhhhhhHh------
Q 005586          561 CGLHKLLADDIVFSVLKTSAAMGYLAPEYVTTGRFTERSDIFAFGVIILQILTGSLVLTSSMRLAAESATFENF------  634 (689)
Q Consensus       561 fGla~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~ksDV~sfGvvl~elltG~~p~~~~~~~~~~~~~~~~~------  634 (689)
                      ||+++......  ......++..|+|||.+.+..++.++|||||||++|||++|+.||................      
T Consensus       154 fg~~~~~~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~~f~~~~~~~~~~~i~~~~~~~~~~  231 (290)
T cd07862         154 FGLARIYSFQM--ALTSVVVTLWYRAPEVLLQSSYATPVDLWSVGCIFAEMFRRKPLFRGSSDVDQLGKILDVIGLPGEE  231 (290)
T ss_pred             ccceEeccCCc--ccccccccccccChHHHhCCCCCCccchHHHHHHHHHHHcCCCCcCCCCHHHHHHHHHHHhCCCChh
Confidence            99998664431  2223457888999999988899999999999999999999999996543221111110000      


Q ss_pred             --------hccccC--CC-----CCHHHHHHHHHHHHHhccCCCCCCCCHHHHHHHH
Q 005586          635 --------IDRNLK--GK-----FSESEAAKLGKMALVCTHEDPENRPTMEAVIEEL  676 (689)
Q Consensus       635 --------~~~~~~--~~-----~~~~~~~~l~~l~~~Cl~~dp~~RPs~~evl~~L  676 (689)
                              ....+.  ..     ........+.+++.+|++.||++||++.|++++.
T Consensus       232 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~s~~~~l~hp  288 (290)
T cd07862         232 DWPRDVALPRQAFHSKSAQPIEKFVTDIDELGKDLLLKCLTFNPAKRISAYSALSHP  288 (290)
T ss_pred             hchhhhcccchhccCCCCCCHHHHccCCCHHHHHHHHHHhccCchhcCCHHHHhcCC
Confidence                    000000  00     0112345678999999999999999999999753

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 6 (CDK6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK6 is regulated by D-type cyclins and INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein, implicating it to function in regulating the early G1 phase of the cell cycle. It is expressed ubiquitously and is localized in the cytopla

>cd05116 PTKc_Syk Catalytic domain of the Protein Tyrosine Kinase, Spleen tyrosine kinase

Probab=100.00  E-value=4.2e-38  Score=321.04  Aligned_cols=246  Identities=22%  Similarity=0.403  Sum_probs=199.6

Q ss_pred             ccccCCcceEEEEEec---CCcEEEEEEecccCC-chHHHHHHHHHHHHhccCCCcceeEeeEEEcCCCCeEEEEEEcCC
Q 005586          416 LLGKGNFSSVYKGTLR---DGTLVAIRSINVTSC-KSEEAEFVKGLYLLTSLRHENIIRLRGFCCSRGRGECFLIYDFAP  491 (689)
Q Consensus       416 ~lg~G~~g~Vy~~~~~---~g~~vavK~l~~~~~-~~~~~~f~~e~~~l~~l~H~niv~l~g~~~~~~~~~~~lV~e~~~  491 (689)
                      .||+|+||.||+|.++   ++..+|+|+++.... ....++|.+|+.++++++||||+++++++.   .+..++||||++
T Consensus         2 ~lg~G~~g~v~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~---~~~~~lv~e~~~   78 (257)
T cd05116           2 ELGSGNFGTVKKGMYKMKKSEKTVAVKILKNDNNDPALKDELLREANVMQQLDNPYIVRMIGICE---AESWMLVMELAE   78 (257)
T ss_pred             cCCCcCCcceEEeEEecCCCceEEEEEEccCCCCcHHHHHHHHHHHHHHHhCCCCCcceEEEEEc---CCCcEEEEecCC
Confidence            5899999999999753   578999999875542 234568999999999999999999999883   246789999999


Q ss_pred             CCCHHHHhhhcCCCCCCCCHHHHHHHHHHHHHHHhhhhCCCCCCCceeecCCCCCceeecCCCCeEEecccccccccCCc
Q 005586          492 KGKLSKYLDQEEGSSNVLDWSTRVSIIIGIAKGIGYLHSSEVNKPAIVHRNLSVEKVLIDQQFNPLIADCGLHKLLADDI  571 (689)
Q Consensus       492 ~gsL~~~L~~~~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~~~ivH~dlk~~NiLl~~~~~~kl~DfGla~~~~~~~  571 (689)
                      +|+|.+++....    .+++..+..++.|++.||+|||+.+     |+||||||+||++++++.+||+|||+++.+....
T Consensus        79 ~~~L~~~l~~~~----~~~~~~~~~i~~qi~~al~~lH~~~-----i~H~dlkp~nill~~~~~~kl~Dfg~~~~~~~~~  149 (257)
T cd05116          79 LGPLNKFLQKNK----HVTEKNITELVHQVSMGMKYLEETN-----FVHRDLAARNVLLVTQHYAKISDFGLSKALGADE  149 (257)
T ss_pred             CCcHHHHHHhcC----CCCHHHHHHHHHHHHHHHHHHHHCC-----EeecccchhhEEEcCCCeEEECCCccccccCCCC
Confidence            999999997543    4889999999999999999999987     9999999999999999999999999998765432


Q ss_pred             eee--eecCCCCCCCCCccccccCCCCCcccchhHHHHHHHHHh-CCCCcchhHHHHHhhhhhhHhhccccCCCCCHHHH
Q 005586          572 VFS--VLKTSAAMGYLAPEYVTTGRFTERSDIFAFGVIILQILT-GSLVLTSSMRLAAESATFENFIDRNLKGKFSESEA  648 (689)
Q Consensus       572 ~~~--~~~~~~~~~y~aPE~~~~~~~~~ksDV~sfGvvl~ellt-G~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  648 (689)
                      ...  .....++..|+|||.+....++.++|||||||++|||+| |+.||.......     ..+.+........+...+
T Consensus       150 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~~~-----~~~~i~~~~~~~~~~~~~  224 (257)
T cd05116         150 NYYKAKTHGKWPVKWYAPECMNYYKFSSKSDVWSFGVLMWEAFSYGQKPYKGMKGNE-----VTQMIESGERMECPQRCP  224 (257)
T ss_pred             CeeeecCCCCCCccccCHhHhccCCcCchhHHHHHHHHHHHHHhCCCCCCCCCCHHH-----HHHHHHCCCCCCCCCCCC
Confidence            211  112233467999999988889999999999999999998 999986542221     122233333333445566


Q ss_pred             HHHHHHHHHhccCCCCCCCCHHHHHHHHHh
Q 005586          649 AKLGKMALVCTHEDPENRPTMEAVIEELTV  678 (689)
Q Consensus       649 ~~l~~l~~~Cl~~dp~~RPs~~evl~~L~~  678 (689)
                      .++.+++.+||+.||++||+|.+|+++|+.
T Consensus       225 ~~l~~li~~~~~~~p~~Rp~~~~i~~~l~~  254 (257)
T cd05116         225 PEMYDLMKLCWTYGVDERPGFAVVELRLRN  254 (257)
T ss_pred             HHHHHHHHHHhccCchhCcCHHHHHHHHhc
Confidence            789999999999999999999999999875

Protein Tyrosine Kinase (PTK) family; Spleen tyrosine kinase (Syk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk, together with Zap-70, form the Syk subfamily of kinases which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Syk was first cloned from the spleen, and its function in hematopoietic cells is well-established. Syk is involved in the signaling downstream of activated receptors (including B-cell and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferatio

>cd05098 PTKc_FGFR1 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 1

Probab=100.00  E-value=2e-38  Score=332.40  Aligned_cols=262  Identities=24%  Similarity=0.412  Sum_probs=208.1

Q ss_pred             ccCCcccccccCCcceEEEEEec--------CCcEEEEEEecccCCchHHHHHHHHHHHHhcc-CCCcceeEeeEEEcCC
Q 005586          409 QCFSEVNLLGKGNFSSVYKGTLR--------DGTLVAIRSINVTSCKSEEAEFVKGLYLLTSL-RHENIIRLRGFCCSRG  479 (689)
Q Consensus       409 ~~f~~~~~lg~G~~g~Vy~~~~~--------~g~~vavK~l~~~~~~~~~~~f~~e~~~l~~l-~H~niv~l~g~~~~~~  479 (689)
                      ++|...+.||+|+||.||+|+..        ++..+|+|.+..........++..|++++.++ +||||++++++|..  
T Consensus        18 ~~~~i~~~lg~G~~g~V~~~~~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~--   95 (307)
T cd05098          18 DRLVLGKPLGEGCFGQVVMAEAIGLDKEKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGKHKNIINLLGACTQ--   95 (307)
T ss_pred             HHeEEeeeeccCCCeeEEEeEEeccCCcccCccceEEEEeccCCCChHHHHHHHHHHHHHHHhcCCCCEeeEEEEEec--
Confidence            46788899999999999999753        23579999998654344556789999999999 79999999999854  


Q ss_pred             CCeEEEEEEcCCCCCHHHHhhhcCC------------CCCCCCHHHHHHHHHHHHHHHhhhhCCCCCCCceeecCCCCCc
Q 005586          480 RGECFLIYDFAPKGKLSKYLDQEEG------------SSNVLDWSTRVSIIIGIAKGIGYLHSSEVNKPAIVHRNLSVEK  547 (689)
Q Consensus       480 ~~~~~lV~e~~~~gsL~~~L~~~~~------------~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~~~ivH~dlk~~N  547 (689)
                      .+..++||||+++|+|.+++.....            ....++|.+++.++.|++.||+|||+.+     ++||||||+|
T Consensus        96 ~~~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~lH~~g-----i~H~dlkp~N  170 (307)
T cd05098          96 DGPLYVIVEYASKGNLREYLRARRPPGMEYCYNPTQVPEEQLSFKDLVSCAYQVARGMEYLASKK-----CIHRDLAARN  170 (307)
T ss_pred             CCceEEEEecCCCCcHHHHHHhcCCcccccccccccCccccCCHHHHHHHHHHHHHHHHHHHHCC-----cccccccHHh
Confidence            4678999999999999999976432            1235899999999999999999999987     9999999999


Q ss_pred             eeecCCCCeEEecccccccccCCceee-eecCCCCCCCCCccccccCCCCCcccchhHHHHHHHHHh-CCCCcchhHHHH
Q 005586          548 VLIDQQFNPLIADCGLHKLLADDIVFS-VLKTSAAMGYLAPEYVTTGRFTERSDIFAFGVIILQILT-GSLVLTSSMRLA  625 (689)
Q Consensus       548 iLl~~~~~~kl~DfGla~~~~~~~~~~-~~~~~~~~~y~aPE~~~~~~~~~ksDV~sfGvvl~ellt-G~~p~~~~~~~~  625 (689)
                      |++++++.+||+|||+++......... .....++..|+|||.+.+..++.++|||||||++|||++ |+.|+...... 
T Consensus       171 ill~~~~~~kL~dfg~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~el~~~g~~p~~~~~~~-  249 (307)
T cd05098         171 VLVTEDNVMKIADFGLARDIHHIDYYKKTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGSPYPGVPVE-  249 (307)
T ss_pred             eEEcCCCcEEECCCcccccccccchhhccccCCCccceeChHHhccCCCCcHHHHHHHHHHHHHHHcCCCCCCCcCCHH-
Confidence            999999999999999998664322111 112223467999999988889999999999999999998 88887543211 


Q ss_pred             HhhhhhhHhhccccCCCCCHHHHHHHHHHHHHhccCCCCCCCCHHHHHHHHHhhCCc
Q 005586          626 AESATFENFIDRNLKGKFSESEAAKLGKMALVCTHEDPENRPTMEAVIEELTVAAPV  682 (689)
Q Consensus       626 ~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~Cl~~dp~~RPs~~evl~~L~~~~p~  682 (689)
                          .+.+.+........+.....++.+++..|++.+|++||+|.||+++|+.+.+.
T Consensus       250 ----~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~evl~~l~~~~~~  302 (307)
T cd05098         250 ----ELFKLLKEGHRMDKPSNCTNELYMMMRDCWHAVPSQRPTFKQLVEDLDRILAL  302 (307)
T ss_pred             ----HHHHHHHcCCCCCCCCcCCHHHHHHHHHHcccChhhCcCHHHHHHHHHHHHHH
Confidence                11112222222233445567899999999999999999999999999887554

Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 1 (FGFR1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR1 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to

>PTZ00426 cAMP-dependent protein kinase catalytic subunit; Provisional

Probab=100.00  E-value=5.9e-39  Score=340.44  Aligned_cols=249  Identities=19%  Similarity=0.260  Sum_probs=202.8

Q ss_pred             ccCCcccccccCCcceEEEEEecC--CcEEEEEEecccCC--chHHHHHHHHHHHHhccCCCcceeEeeEEEcCCCCeEE
Q 005586          409 QCFSEVNLLGKGNFSSVYKGTLRD--GTLVAIRSINVTSC--KSEEAEFVKGLYLLTSLRHENIIRLRGFCCSRGRGECF  484 (689)
Q Consensus       409 ~~f~~~~~lg~G~~g~Vy~~~~~~--g~~vavK~l~~~~~--~~~~~~f~~e~~~l~~l~H~niv~l~g~~~~~~~~~~~  484 (689)
                      ++|...+.||+|+||.||+|..+.  +..||+|++.....  ......+.+|++++..++||||+++++++..  .+..+
T Consensus        30 ~~y~~~~~ig~G~~g~Vy~a~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~Iv~~~~~~~~--~~~~~  107 (340)
T PTZ00426         30 EDFNFIRTLGTGSFGRVILATYKNEDFPPVAIKRFEKSKIIKQKQVDHVFSERKILNYINHPFCVNLYGSFKD--ESYLY  107 (340)
T ss_pred             hhcEEEEEEeecCCeEEEEEEEECCCCeEEEEEEEEHHHhhhhhhHHHHHHHHHHHHhCCCCCCcceEEEEEe--CCEEE
Confidence            357778999999999999998653  46899999865421  2334678899999999999999999999854  47899


Q ss_pred             EEEEcCCCCCHHHHhhhcCCCCCCCCHHHHHHHHHHHHHHHhhhhCCCCCCCceeecCCCCCceeecCCCCeEEeccccc
Q 005586          485 LIYDFAPKGKLSKYLDQEEGSSNVLDWSTRVSIIIGIAKGIGYLHSSEVNKPAIVHRNLSVEKVLIDQQFNPLIADCGLH  564 (689)
Q Consensus       485 lV~e~~~~gsL~~~L~~~~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~~~ivH~dlk~~NiLl~~~~~~kl~DfGla  564 (689)
                      +||||+++|+|.+++....    .+++..+..++.|++.||+|||+.+     |+||||||+|||+++++.+||+|||++
T Consensus       108 lv~Ey~~~g~L~~~i~~~~----~~~~~~~~~~~~qi~~aL~~LH~~~-----ivHrDLkp~NILl~~~~~ikL~DFG~a  178 (340)
T PTZ00426        108 LVLEFVIGGEFFTFLRRNK----RFPNDVGCFYAAQIVLIFEYLQSLN-----IVYRDLKPENLLLDKDGFIKMTDFGFA  178 (340)
T ss_pred             EEEeCCCCCcHHHHHHHcC----CCCHHHHHHHHHHHHHHHHHHHHCC-----eEccCCCHHHEEECCCCCEEEecCCCC
Confidence            9999999999999997643    3889999999999999999999987     999999999999999999999999999


Q ss_pred             ccccCCceeeeecCCCCCCCCCccccccCCCCCcccchhHHHHHHHHHhCCCCcchhHHHHHhhhhhhHhhccccCCCCC
Q 005586          565 KLLADDIVFSVLKTSAAMGYLAPEYVTTGRFTERSDIFAFGVIILQILTGSLVLTSSMRLAAESATFENFIDRNLKGKFS  644 (689)
Q Consensus       565 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~ksDV~sfGvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~  644 (689)
                      +......    ....+|..|+|||++.+..++.++|||||||++|||+||+.||........    ...+....  ..++
T Consensus       179 ~~~~~~~----~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~ell~G~~Pf~~~~~~~~----~~~i~~~~--~~~p  248 (340)
T PTZ00426        179 KVVDTRT----YTLCGTPEYIAPEILLNVGHGKAADWWTLGIFIYEILVGCPPFYANEPLLI----YQKILEGI--IYFP  248 (340)
T ss_pred             eecCCCc----ceecCChhhcCHHHHhCCCCCccccccchhhHHHHHhcCCCCCCCCCHHHH----HHHHhcCC--CCCC
Confidence            8764322    234578899999999988899999999999999999999999975432211    11122111  1233


Q ss_pred             HHHHHHHHHHHHHhccCCCCCCC-----CHHHHHHHHHh
Q 005586          645 ESEAAKLGKMALVCTHEDPENRP-----TMEAVIEELTV  678 (689)
Q Consensus       645 ~~~~~~l~~l~~~Cl~~dp~~RP-----s~~evl~~L~~  678 (689)
                      ......+.+++.+|++.||++|+     +++|++++.+.
T Consensus       249 ~~~~~~~~~li~~~l~~dp~~R~~~~~~~~~~~~~hp~f  287 (340)
T PTZ00426        249 KFLDNNCKHLMKKLLSHDLTKRYGNLKKGAQNVKEHPWF  287 (340)
T ss_pred             CCCCHHHHHHHHHHcccCHHHcCCCCCCCHHHHHcCCCc
Confidence            34456788999999999999995     89999887543

>PTZ00283 serine/threonine protein kinase; Provisional

Probab=100.00  E-value=1.2e-38  Score=353.41  Aligned_cols=263  Identities=15%  Similarity=0.247  Sum_probs=209.4

Q ss_pred             HHHHHhccCCcccccccCCcceEEEEEec-CCcEEEEEEecccCC-chHHHHHHHHHHHHhccCCCcceeEeeEEEcCCC
Q 005586          403 EVESATQCFSEVNLLGKGNFSSVYKGTLR-DGTLVAIRSINVTSC-KSEEAEFVKGLYLLTSLRHENIIRLRGFCCSRGR  480 (689)
Q Consensus       403 ~l~~at~~f~~~~~lg~G~~g~Vy~~~~~-~g~~vavK~l~~~~~-~~~~~~f~~e~~~l~~l~H~niv~l~g~~~~~~~  480 (689)
                      +.....++|...+.||+|+||.||+|+.. +|+.||||++..... ......+.+|+..+..++|+||+++...+.....
T Consensus        26 ~~~~~~~rY~i~~~LG~G~fG~Vy~a~~~~~g~~vAvK~i~~~~~~~~~~~~~~~Ei~~l~~~~h~~iv~~~~~~~~~~~  105 (496)
T PTZ00283         26 TAKEQAKKYWISRVLGSGATGTVLCAKRVSDGEPFAVKVVDMEGMSEADKNRAQAEVCCLLNCDFFSIVKCHEDFAKKDP  105 (496)
T ss_pred             cccccCCCEEEEEEEecCCCEEEEEEEEcCCCCEEEEEEEecccCCHHHHHHHHHHHHHHhcCCCCcEEEeecceecccc
Confidence            33445578999999999999999999864 799999999976543 3345678899999999999999999876643321


Q ss_pred             ------CeEEEEEEcCCCCCHHHHhhhcCCCCCCCCHHHHHHHHHHHHHHHhhhhCCCCCCCceeecCCCCCceeecCCC
Q 005586          481 ------GECFLIYDFAPKGKLSKYLDQEEGSSNVLDWSTRVSIIIGIAKGIGYLHSSEVNKPAIVHRNLSVEKVLIDQQF  554 (689)
Q Consensus       481 ------~~~~lV~e~~~~gsL~~~L~~~~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~~~ivH~dlk~~NiLl~~~~  554 (689)
                            ...++||||+++|+|.++++........+++.....|+.|++.||+|||+.+     |+||||||+|||+++++
T Consensus       106 ~~~~~~~~i~lV~Ey~~~gsL~~~l~~~~~~~~~l~e~~~~~i~~qll~aL~~lH~~~-----IiHrDLKP~NILl~~~~  180 (496)
T PTZ00283        106 RNPENVLMIALVLDYANAGDLRQEIKSRAKTNRTFREHEAGLLFIQVLLAVHHVHSKH-----MIHRDIKSANILLCSNG  180 (496)
T ss_pred             cCcccceEEEEEEeCCCCCcHHHHHHHhhccCCCCCHHHHHHHHHHHHHHHHHHHhCC-----EecCCCCHHHEEEeCCC
Confidence                  1368999999999999999865444456899999999999999999999987     99999999999999999


Q ss_pred             CeEEecccccccccCCcee-eeecCCCCCCCCCccccccCCCCCcccchhHHHHHHHHHhCCCCcchhHHHHHhhhhhhH
Q 005586          555 NPLIADCGLHKLLADDIVF-SVLKTSAAMGYLAPEYVTTGRFTERSDIFAFGVIILQILTGSLVLTSSMRLAAESATFEN  633 (689)
Q Consensus       555 ~~kl~DfGla~~~~~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~ksDV~sfGvvl~elltG~~p~~~~~~~~~~~~~~~~  633 (689)
                      .+||+|||+++.+...... ......||..|+|||++.+..++.++|||||||++|||++|+.||.......    .+..
T Consensus       181 ~vkL~DFGls~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~~~s~k~DVwSlGvilyeLltG~~Pf~~~~~~~----~~~~  256 (496)
T PTZ00283        181 LVKLGDFGFSKMYAATVSDDVGRTFCGTPYYVAPEIWRRKPYSKKADMFSLGVLLYELLTLKRPFDGENMEE----VMHK  256 (496)
T ss_pred             CEEEEecccCeeccccccccccccccCCcceeCHHHhCCCCCCcHHHHHHHHHHHHHHHHCCCCCCCCCHHH----HHHH
Confidence            9999999999876432211 1223457889999999999999999999999999999999999996532211    1111


Q ss_pred             hhccccCCCCCHHHHHHHHHHHHHhccCCCCCCCCHHHHHHH
Q 005586          634 FIDRNLKGKFSESEAAKLGKMALVCTHEDPENRPTMEAVIEE  675 (689)
Q Consensus       634 ~~~~~~~~~~~~~~~~~l~~l~~~Cl~~dp~~RPs~~evl~~  675 (689)
                      ..... ....+...+.++.+++..||+.||++||++.+++++
T Consensus       257 ~~~~~-~~~~~~~~~~~l~~li~~~L~~dP~~RPs~~ell~~  297 (496)
T PTZ00283        257 TLAGR-YDPLPPSISPEMQEIVTALLSSDPKRRPSSSKLLNM  297 (496)
T ss_pred             HhcCC-CCCCCCCCCHHHHHHHHHHcccChhhCcCHHHHHhC
Confidence            11111 112344456789999999999999999999999876

>PTZ00267 NIMA-related protein kinase; Provisional

Probab=100.00  E-value=1.5e-38  Score=352.52  Aligned_cols=252  Identities=17%  Similarity=0.260  Sum_probs=202.1

Q ss_pred             CCcccccccCCcceEEEEEec-C-CcEEEEEEecccCCchHHHHHHHHHHHHhccCCCcceeEeeEEEcCCCCeEEEEEE
Q 005586          411 FSEVNLLGKGNFSSVYKGTLR-D-GTLVAIRSINVTSCKSEEAEFVKGLYLLTSLRHENIIRLRGFCCSRGRGECFLIYD  488 (689)
Q Consensus       411 f~~~~~lg~G~~g~Vy~~~~~-~-g~~vavK~l~~~~~~~~~~~f~~e~~~l~~l~H~niv~l~g~~~~~~~~~~~lV~e  488 (689)
                      |...+.||+|+||.||+|... + +..||+|.+.... ......+.+|+.+++.++|||||++++++..  .+..++|||
T Consensus        69 y~~~~~lg~G~~g~vy~a~~~~~~~~~vv~K~~~~~~-~~~~~~~~~E~~~l~~l~Hpniv~~~~~~~~--~~~~~lv~E  145 (478)
T PTZ00267         69 YVLTTLVGRNPTTAAFVATRGSDPKEKVVAKFVMLND-ERQAAYARSELHCLAACDHFGIVKHFDDFKS--DDKLLLIME  145 (478)
T ss_pred             EEEEEEEEeCCCcEEEEEEEcCCCCeEEEEEEcccCC-HHHHHHHHHHHHHHHhCCCCCEeEEEEEEEE--CCEEEEEEE
Confidence            667789999999999999864 4 6788888775443 3344578889999999999999999999854  478999999


Q ss_pred             cCCCCCHHHHhhhcCCCCCCCCHHHHHHHHHHHHHHHhhhhCCCCCCCceeecCCCCCceeecCCCCeEEeccccccccc
Q 005586          489 FAPKGKLSKYLDQEEGSSNVLDWSTRVSIIIGIAKGIGYLHSSEVNKPAIVHRNLSVEKVLIDQQFNPLIADCGLHKLLA  568 (689)
Q Consensus       489 ~~~~gsL~~~L~~~~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~~~ivH~dlk~~NiLl~~~~~~kl~DfGla~~~~  568 (689)
                      |+++|+|.++++.......++++.....++.|++.||+|||+.+     |+||||||+|||+++++.+||+|||+++...
T Consensus       146 ~~~gg~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~~lH~~~-----ivHrDlkp~NIll~~~~~~kL~DFgla~~~~  220 (478)
T PTZ00267        146 YGSGGDLNKQIKQRLKEHLPFQEYEVGLLFYQIVLALDEVHSRK-----MMHRDLKSANIFLMPTGIIKLGDFGFSKQYS  220 (478)
T ss_pred             CCCCCCHHHHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHhCC-----EEECCcCHHhEEECCCCcEEEEeCcCceecC
Confidence            99999999998764333346889999999999999999999987     9999999999999999999999999998765


Q ss_pred             CCcee-eeecCCCCCCCCCccccccCCCCCcccchhHHHHHHHHHhCCCCcchhHHHHHhhhhhhHhhccccCCCCCHHH
Q 005586          569 DDIVF-SVLKTSAAMGYLAPEYVTTGRFTERSDIFAFGVIILQILTGSLVLTSSMRLAAESATFENFIDRNLKGKFSESE  647 (689)
Q Consensus       569 ~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~ksDV~sfGvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  647 (689)
                      ..... ......||++|+|||++.+..++.++|||||||++|||+||+.||.......    .+..+..... ...+...
T Consensus       221 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~tg~~Pf~~~~~~~----~~~~~~~~~~-~~~~~~~  295 (478)
T PTZ00267        221 DSVSLDVASSFCGTPYYLAPELWERKRYSKKADMWSLGVILYELLTLHRPFKGPSQRE----IMQQVLYGKY-DPFPCPV  295 (478)
T ss_pred             CccccccccccCCCccccCHhHhCCCCCCcHHhHHHHHHHHHHHHhCCCCCCCCCHHH----HHHHHHhCCC-CCCCccC
Confidence            43211 1223457889999999999899999999999999999999999996432211    1111111111 1223345


Q ss_pred             HHHHHHHHHHhccCCCCCCCCHHHHHHH
Q 005586          648 AAKLGKMALVCTHEDPENRPTMEAVIEE  675 (689)
Q Consensus       648 ~~~l~~l~~~Cl~~dp~~RPs~~evl~~  675 (689)
                      +.++.+++..||+.||++||++.+++.+
T Consensus       296 s~~~~~li~~~L~~dP~~Rps~~~~l~~  323 (478)
T PTZ00267        296 SSGMKALLDPLLSKNPALRPTTQQLLHT  323 (478)
T ss_pred             CHHHHHHHHHHhccChhhCcCHHHHHhC
Confidence            5679999999999999999999999754

>cd07871 STKc_PCTAIRE3 Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-3 kinase

Probab=100.00  E-value=2e-38  Score=329.19  Aligned_cols=256  Identities=18%  Similarity=0.355  Sum_probs=197.5

Q ss_pred             ccCCcccccccCCcceEEEEEec-CCcEEEEEEecccCCchHHHHHHHHHHHHhccCCCcceeEeeEEEcCCCCeEEEEE
Q 005586          409 QCFSEVNLLGKGNFSSVYKGTLR-DGTLVAIRSINVTSCKSEEAEFVKGLYLLTSLRHENIIRLRGFCCSRGRGECFLIY  487 (689)
Q Consensus       409 ~~f~~~~~lg~G~~g~Vy~~~~~-~g~~vavK~l~~~~~~~~~~~f~~e~~~l~~l~H~niv~l~g~~~~~~~~~~~lV~  487 (689)
                      ++|...+.||+|+||.||+|..+ ++..||+|+++..........+.+|++++++++||||+++++++..  .+..++||
T Consensus         5 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~--~~~~~lv~   82 (288)
T cd07871           5 ETYVKLDKLGEGTYATVFKGRSKLTENLVALKEIRLEHEEGAPCTAIREVSLLKNLKHANIVTLHDIIHT--ERCLTLVF   82 (288)
T ss_pred             ccceEeeEEecCCCEEEEEEEECCCCCEEEEEEecccccCCcchhHHHHHHHHHhCCCCCEeeEEEEEcC--CCeEEEEE
Confidence            45778899999999999999876 6899999999765433344578899999999999999999998843  46789999


Q ss_pred             EcCCCCCHHHHhhhcCCCCCCCCHHHHHHHHHHHHHHHhhhhCCCCCCCceeecCCCCCceeecCCCCeEEecccccccc
Q 005586          488 DFAPKGKLSKYLDQEEGSSNVLDWSTRVSIIIGIAKGIGYLHSSEVNKPAIVHRNLSVEKVLIDQQFNPLIADCGLHKLL  567 (689)
Q Consensus       488 e~~~~gsL~~~L~~~~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~~~ivH~dlk~~NiLl~~~~~~kl~DfGla~~~  567 (689)
                      ||++ |+|.+++....   ..+++..+..++.|++.||+|||+.+     |+||||||+|||+++++.+||+|||+++..
T Consensus        83 e~~~-~~l~~~l~~~~---~~~~~~~~~~~~~qi~~aL~~LH~~~-----ivH~dlkp~Nil~~~~~~~kl~DfG~~~~~  153 (288)
T cd07871          83 EYLD-SDLKQYLDNCG---NLMSMHNVKIFMFQLLRGLSYCHKRK-----ILHRDLKPQNLLINEKGELKLADFGLARAK  153 (288)
T ss_pred             eCCC-cCHHHHHHhcC---CCCCHHHHHHHHHHHHHHHHHHHhCC-----cccCCCCHHHEEECCCCCEEECcCcceeec
Confidence            9997 59999987543   24788999999999999999999987     999999999999999999999999999765


Q ss_pred             cCCceeeeecCCCCCCCCCcccccc-CCCCCcccchhHHHHHHHHHhCCCCcchhHHHHHhhhh-----------hh---
Q 005586          568 ADDIVFSVLKTSAAMGYLAPEYVTT-GRFTERSDIFAFGVIILQILTGSLVLTSSMRLAAESAT-----------FE---  632 (689)
Q Consensus       568 ~~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~ksDV~sfGvvl~elltG~~p~~~~~~~~~~~~~-----------~~---  632 (689)
                      ..... ......++..|+|||.+.+ ..++.++||||+||++|||+||+.||............           +.   
T Consensus       154 ~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~  232 (288)
T cd07871         154 SVPTK-TYSNEVVTLWYRPPDVLLGSTEYSTPIDMWGVGCILYEMATGRPMFPGSTVKEELHLIFRLLGTPTEETWPGIT  232 (288)
T ss_pred             cCCCc-cccCceecccccChHHhcCCcccCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCChHHhhccc
Confidence            33211 1123356788999998865 56899999999999999999999998643211110000           00   


Q ss_pred             ------HhhccccCCCC----CHHHHHHHHHHHHHhccCCCCCCCCHHHHHHHH
Q 005586          633 ------NFIDRNLKGKF----SESEAAKLGKMALVCTHEDPENRPTMEAVIEEL  676 (689)
Q Consensus       633 ------~~~~~~~~~~~----~~~~~~~l~~l~~~Cl~~dp~~RPs~~evl~~L  676 (689)
                            +...+......    ......++.+++.+|++.||++|||++|++++-
T Consensus       233 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dll~~mL~~dp~~R~t~~~~l~hp  286 (288)
T cd07871         233 SNEEFRSYLFPQYRAQPLINHAPRLDTDGIDLLSSLLLYETKSRISAEAALRHS  286 (288)
T ss_pred             cchhhhccccCccCCCchHHhCCCCCHHHHHHHHHhcCcCcccCCCHHHHhcCC
Confidence                  00000000000    011245688999999999999999999998763

Serine/Threonine Kinases (STKs), PCTAIRE-3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-3 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-3 shows a restricted pattern of expression and is present in brain, kidney, and intestine. It is elevated in Alzheimer's disease (AD) and has been shown to associate with paired helical filament

>cd05593 STKc_PKB_gamma Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B gamma

Probab=100.00  E-value=1.2e-38  Score=336.93  Aligned_cols=245  Identities=23%  Similarity=0.318  Sum_probs=197.8

Q ss_pred             cccccCCcceEEEEEec-CCcEEEEEEecccCC--chHHHHHHHHHHHHhccCCCcceeEeeEEEcCCCCeEEEEEEcCC
Q 005586          415 NLLGKGNFSSVYKGTLR-DGTLVAIRSINVTSC--KSEEAEFVKGLYLLTSLRHENIIRLRGFCCSRGRGECFLIYDFAP  491 (689)
Q Consensus       415 ~~lg~G~~g~Vy~~~~~-~g~~vavK~l~~~~~--~~~~~~f~~e~~~l~~l~H~niv~l~g~~~~~~~~~~~lV~e~~~  491 (689)
                      +.||+|+||.||+++.+ +|+.||+|++.....  ......+.+|++++++++||||+++++++.  ..+..++||||++
T Consensus         1 ~~lG~G~~g~Vy~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~--~~~~~~lv~Ey~~   78 (328)
T cd05593           1 KLLGKGTFGKVILVREKASGKYYAMKILKKEVIIAKDEVAHTLTESRVLKNTRHPFLTSLKYSFQ--TKDRLCFVMEYVN   78 (328)
T ss_pred             CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCCcceEEEEE--cCCEEEEEEeCCC
Confidence            36999999999999875 689999999975432  234467889999999999999999999884  3578999999999


Q ss_pred             CCCHHHHhhhcCCCCCCCCHHHHHHHHHHHHHHHhhhhCCCCCCCceeecCCCCCceeecCCCCeEEecccccccccCCc
Q 005586          492 KGKLSKYLDQEEGSSNVLDWSTRVSIIIGIAKGIGYLHSSEVNKPAIVHRNLSVEKVLIDQQFNPLIADCGLHKLLADDI  571 (689)
Q Consensus       492 ~gsL~~~L~~~~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~~~ivH~dlk~~NiLl~~~~~~kl~DfGla~~~~~~~  571 (689)
                      +|+|..++....    .+++.++..++.|++.||+|||+.+     |+||||||+|||+++++.+||+|||+++......
T Consensus        79 ~g~L~~~l~~~~----~l~~~~~~~~~~qi~~aL~~LH~~~-----ivHrDikp~NIll~~~~~~kL~DfG~~~~~~~~~  149 (328)
T cd05593          79 GGELFFHLSRER----VFSEDRTRFYGAEIVSALDYLHSGK-----IVYRDLKLENLMLDKDGHIKITDFGLCKEGITDA  149 (328)
T ss_pred             CCCHHHHHHhcC----CCCHHHHHHHHHHHHHHHHHHHhCC-----eEecccCHHHeEECCCCcEEEecCcCCccCCCcc
Confidence            999999987543    4899999999999999999999987     9999999999999999999999999987543221


Q ss_pred             eeeeecCCCCCCCCCccccccCCCCCcccchhHHHHHHHHHhCCCCcchhHHHHHhhhhhhHhhccccCCCCCHHHHHHH
Q 005586          572 VFSVLKTSAAMGYLAPEYVTTGRFTERSDIFAFGVIILQILTGSLVLTSSMRLAAESATFENFIDRNLKGKFSESEAAKL  651 (689)
Q Consensus       572 ~~~~~~~~~~~~y~aPE~~~~~~~~~ksDV~sfGvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l  651 (689)
                      . ......++..|+|||++.+..++.++|||||||++|||+||+.||........    ...+...  ...++.....++
T Consensus       150 ~-~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~elltG~~Pf~~~~~~~~----~~~~~~~--~~~~p~~~~~~~  222 (328)
T cd05593         150 A-TMKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHEKL----FELILME--DIKFPRTLSADA  222 (328)
T ss_pred             c-ccccccCCcCccChhhhcCCCCCccCCccccchHHHHHhhCCCCCCCCCHHHH----HHHhccC--CccCCCCCCHHH
Confidence            1 12234578899999999988999999999999999999999999964322111    1111111  112333445678


Q ss_pred             HHHHHHhccCCCCCCC-----CHHHHHHHHH
Q 005586          652 GKMALVCTHEDPENRP-----TMEAVIEELT  677 (689)
Q Consensus       652 ~~l~~~Cl~~dp~~RP-----s~~evl~~L~  677 (689)
                      .+++.+|++.||++||     ++.|++++.+
T Consensus       223 ~~li~~~L~~dP~~R~~~~~~~~~~il~h~~  253 (328)
T cd05593         223 KSLLSGLLIKDPNKRLGGGPDDAKEIMRHSF  253 (328)
T ss_pred             HHHHHHHcCCCHHHcCCCCCCCHHHHhcCCC
Confidence            9999999999999997     8999998754

Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, gamma (or Akt3) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-gamma is predominantly expressed in neuronal tissues. Mice deficient in PKB-gamma show a reduction in brain weight due to the decreases in cell size and cell number. PKB-gamma has also been shown to be upregulate

>cd05035 PTKc_Axl_like Catalytic Domain of Axl-like Protein Tyrosine Kinases

Probab=100.00  E-value=6e-38  Score=322.53  Aligned_cols=259  Identities=24%  Similarity=0.405  Sum_probs=204.5

Q ss_pred             CCcccccccCCcceEEEEEecC----CcEEEEEEecccCC-chHHHHHHHHHHHHhccCCCcceeEeeEEEcCCC----C
Q 005586          411 FSEVNLLGKGNFSSVYKGTLRD----GTLVAIRSINVTSC-KSEEAEFVKGLYLLTSLRHENIIRLRGFCCSRGR----G  481 (689)
Q Consensus       411 f~~~~~lg~G~~g~Vy~~~~~~----g~~vavK~l~~~~~-~~~~~~f~~e~~~l~~l~H~niv~l~g~~~~~~~----~  481 (689)
                      |...+.||+|+||.||+|.+..    +..||+|+++.... .....+|.+|++.+++++||||+++++++.....    .
T Consensus         1 ~~~~~~lg~G~~g~v~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~   80 (273)
T cd05035           1 LKLGKILGEGEFGSVMEGQLSQDDGSQLKVAVKTMKLDIHTYSEIEEFLSEAACMKDFDHPNVMKLIGVCFEASSLQKIP   80 (273)
T ss_pred             CccccccCcCCCceEEEEEEecCCCCcceEEEEEeccCcCCHHHHHHHHHHHHHHHhCCCCCeeeEEeeeccCCccccCc
Confidence            4557899999999999998752    36799999986543 2345689999999999999999999998854322    2


Q ss_pred             eEEEEEEcCCCCCHHHHhhhcCC--CCCCCCHHHHHHHHHHHHHHHhhhhCCCCCCCceeecCCCCCceeecCCCCeEEe
Q 005586          482 ECFLIYDFAPKGKLSKYLDQEEG--SSNVLDWSTRVSIIIGIAKGIGYLHSSEVNKPAIVHRNLSVEKVLIDQQFNPLIA  559 (689)
Q Consensus       482 ~~~lV~e~~~~gsL~~~L~~~~~--~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~~~ivH~dlk~~NiLl~~~~~~kl~  559 (689)
                      ..++|+||+++|+|..++.....  ....+++.....++.|++.||+|||+.+     |+||||||+||++++++.+||+
T Consensus        81 ~~~~v~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~aL~~lH~~~-----i~H~dlkp~Nil~~~~~~~kl~  155 (273)
T cd05035          81 KPMVILPFMKHGDLHSFLLYSRLGGLPEKLPLQTLLKFMVDIALGMEYLSNRN-----FIHRDLAARNCMLREDMTVCVA  155 (273)
T ss_pred             ccEEEEeccCCCCHHHHHHHhhccCCcccCCHHHHHHHHHHHHHHHHHHHhCC-----eeccccchheEEECCCCeEEEC
Confidence            37899999999999999865432  2245899999999999999999999987     9999999999999999999999


Q ss_pred             cccccccccCCceee-eecCCCCCCCCCccccccCCCCCcccchhHHHHHHHHHh-CCCCcchhHHHHHhhhhhhHhhcc
Q 005586          560 DCGLHKLLADDIVFS-VLKTSAAMGYLAPEYVTTGRFTERSDIFAFGVIILQILT-GSLVLTSSMRLAAESATFENFIDR  637 (689)
Q Consensus       560 DfGla~~~~~~~~~~-~~~~~~~~~y~aPE~~~~~~~~~ksDV~sfGvvl~ellt-G~~p~~~~~~~~~~~~~~~~~~~~  637 (689)
                      |||+++.+....... ......+..|+|||++.+..++.++|||||||++|||++ |..|+.......     ..+.+..
T Consensus       156 dfg~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~Dv~SlG~il~el~~~g~~p~~~~~~~~-----~~~~~~~  230 (273)
T cd05035         156 DFGLSKKIYSGDYYRQGRIAKMPVKWIAIESLADRVYTSKSDVWAFGVTMWEIATRGQTPYPGVENHE-----IYDYLRH  230 (273)
T ss_pred             CccceeeccccccccccccccCCccccCHhhcccCCCCcccchHHHHHHHHHHHhCCCCCCCCCCHHH-----HHHHHHc
Confidence            999998765432211 112234567999999988889999999999999999999 888885432211     1111122


Q ss_pred             ccCCCCCHHHHHHHHHHHHHhccCCCCCCCCHHHHHHHHHhh
Q 005586          638 NLKGKFSESEAAKLGKMALVCTHEDPENRPTMEAVIEELTVA  679 (689)
Q Consensus       638 ~~~~~~~~~~~~~l~~l~~~Cl~~dp~~RPs~~evl~~L~~~  679 (689)
                      ......+...+.++.+++.+||+.||++||++.|+++.|+..
T Consensus       231 ~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~e~~~~l~~~  272 (273)
T cd05035         231 GNRLKQPEDCLDELYDLMYSCWRADPKDRPTFTKLREVLENI  272 (273)
T ss_pred             CCCCCCCcCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHhh
Confidence            222234455677899999999999999999999999999864

Protein Tyrosine Kinase (PTK) family; Axl subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The Axl subfamily consists of Axl, Tyro3 (or Sky), Mer (or Mertk), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl subfamily members are implicated in a variety of cellu

>cd05075 PTKc_Axl Catalytic domain of the Protein Tyrosine Kinase, Axl

Probab=100.00  E-value=5.3e-38  Score=322.94  Aligned_cols=258  Identities=24%  Similarity=0.418  Sum_probs=200.5

Q ss_pred             CcccccccCCcceEEEEEecC-Cc--EEEEEEecccCC-chHHHHHHHHHHHHhccCCCcceeEeeEEEcCC----CCeE
Q 005586          412 SEVNLLGKGNFSSVYKGTLRD-GT--LVAIRSINVTSC-KSEEAEFVKGLYLLTSLRHENIIRLRGFCCSRG----RGEC  483 (689)
Q Consensus       412 ~~~~~lg~G~~g~Vy~~~~~~-g~--~vavK~l~~~~~-~~~~~~f~~e~~~l~~l~H~niv~l~g~~~~~~----~~~~  483 (689)
                      ...+.||+|+||.||+|...+ +.  .||+|.++.... ......|.+|++++.+++|+||++++++|....    ....
T Consensus         2 ~i~~~ig~G~~g~V~~~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~   81 (272)
T cd05075           2 ALGKTLGEGEFGSVMEGQLNQDDSILKVAVKTMKIAICTRSEMEDFLSEAVCMKEFDHPNVMRLIGVCLQTVESEGYPSP   81 (272)
T ss_pred             ccccccCcccCceEEEeEEccCCCeeeEEEEecccCcCCHHHHHHHHHHHHHHHhCCCCCcceEEEEEccCCcccCCCCc
Confidence            346789999999999999764 33  589998876532 344578999999999999999999999875322    2346


Q ss_pred             EEEEEcCCCCCHHHHhhhcCC--CCCCCCHHHHHHHHHHHHHHHhhhhCCCCCCCceeecCCCCCceeecCCCCeEEecc
Q 005586          484 FLIYDFAPKGKLSKYLDQEEG--SSNVLDWSTRVSIIIGIAKGIGYLHSSEVNKPAIVHRNLSVEKVLIDQQFNPLIADC  561 (689)
Q Consensus       484 ~lV~e~~~~gsL~~~L~~~~~--~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~~~ivH~dlk~~NiLl~~~~~~kl~Df  561 (689)
                      ++|+||+++|+|.+++.....  ....++|.....++.|++.||+|||+.+     |+||||||+|||+++++.+||+||
T Consensus        82 ~~v~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~-----i~H~dlkp~Nil~~~~~~~kl~Df  156 (272)
T cd05075          82 VVILPFMKHGDLHSFLLYSRLGDCPQYLPTQMLVKFMTDIASGMEYLSSKS-----FIHRDLAARNCMLNENMNVCVADF  156 (272)
T ss_pred             EEEEEeCCCCcHHHHHHHhcccCCcccCCHHHHHHHHHHHHHHHHHHHHCC-----eeccccchhheEEcCCCCEEECCC
Confidence            899999999999998854321  2245899999999999999999999877     999999999999999999999999


Q ss_pred             cccccccCCceeee-ecCCCCCCCCCccccccCCCCCcccchhHHHHHHHHHh-CCCCcchhHHHHHhhhhhhHhhcccc
Q 005586          562 GLHKLLADDIVFSV-LKTSAAMGYLAPEYVTTGRFTERSDIFAFGVIILQILT-GSLVLTSSMRLAAESATFENFIDRNL  639 (689)
Q Consensus       562 Gla~~~~~~~~~~~-~~~~~~~~y~aPE~~~~~~~~~ksDV~sfGvvl~ellt-G~~p~~~~~~~~~~~~~~~~~~~~~~  639 (689)
                      |+++.+........ .....+..|+|||+..+..++.++|||||||++|||++ |+.|+.......     ..+.+...-
T Consensus       157 g~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~~~~-----~~~~~~~~~  231 (272)
T cd05075         157 GLSKKIYNGDYYRQGRIAKMPVKWIAIESLADRVYTTKSDVWSFGVTMWEIATRGQTPYPGVENSE-----IYDYLRQGN  231 (272)
T ss_pred             CcccccCcccceecCCcccCCcccCCHHHccCCCcChHHHHHHHHHHHHHHHcCCCCCCCCCCHHH-----HHHHHHcCC
Confidence            99987654332111 11234567999999998899999999999999999999 788885432211     111111111


Q ss_pred             CCCCCHHHHHHHHHHHHHhccCCCCCCCCHHHHHHHHHhh
Q 005586          640 KGKFSESEAAKLGKMALVCTHEDPENRPTMEAVIEELTVA  679 (689)
Q Consensus       640 ~~~~~~~~~~~l~~l~~~Cl~~dp~~RPs~~evl~~L~~~  679 (689)
                      ....+...+..+.+++.+||+.+|++||++.|++++|+.+
T Consensus       232 ~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~l~~~l~~~  271 (272)
T cd05075         232 RLKQPPDCLDGLYSLMSSCWLLNPKDRPSFETLRCELEKA  271 (272)
T ss_pred             CCCCCCCCCHHHHHHHHHHcCCCcccCcCHHHHHHHHHhh
Confidence            1122334556789999999999999999999999999864

Protein Tyrosine Kinase (PTK) family; Axl; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl is widely expressed in a variety of organs and cells including epithelial, mesenchymal, hematopoietic, as well as non-transfor

>cd05061 PTKc_InsR Catalytic domain of the Protein Tyrosine Kinase, Insulin Receptor

Probab=100.00  E-value=2.7e-38  Score=328.15  Aligned_cols=261  Identities=21%  Similarity=0.393  Sum_probs=205.2

Q ss_pred             HhccCCcccccccCCcceEEEEEec------CCcEEEEEEecccCCchHHHHHHHHHHHHhccCCCcceeEeeEEEcCCC
Q 005586          407 ATQCFSEVNLLGKGNFSSVYKGTLR------DGTLVAIRSINVTSCKSEEAEFVKGLYLLTSLRHENIIRLRGFCCSRGR  480 (689)
Q Consensus       407 at~~f~~~~~lg~G~~g~Vy~~~~~------~g~~vavK~l~~~~~~~~~~~f~~e~~~l~~l~H~niv~l~g~~~~~~~  480 (689)
                      .+++|+..+.||+|+||.||+|..+      .+..||+|.+...........|.+|+.++++++||||+++++++..  .
T Consensus         4 ~~~~~~i~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~--~   81 (288)
T cd05061           4 SREKITLLRELGQGSFGMVYEGNARDIIKGEAETRVAVKTVNESASLRERIEFLNEASVMKGFTCHHVVRLLGVVSK--G   81 (288)
T ss_pred             cHHHceeeeeecCCCCcEEEEEEEeccCCCCcceEEEEEECCCcCCHHHHHHHHHHHHHHHhCCCCCeeeEEEEEcC--C
Confidence            4567888999999999999999754      2558999998765434445678899999999999999999999844  4


Q ss_pred             CeEEEEEEcCCCCCHHHHhhhcCC------CCCCCCHHHHHHHHHHHHHHHhhhhCCCCCCCceeecCCCCCceeecCCC
Q 005586          481 GECFLIYDFAPKGKLSKYLDQEEG------SSNVLDWSTRVSIIIGIAKGIGYLHSSEVNKPAIVHRNLSVEKVLIDQQF  554 (689)
Q Consensus       481 ~~~~lV~e~~~~gsL~~~L~~~~~------~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~~~ivH~dlk~~NiLl~~~~  554 (689)
                      ...++||||+++|+|.++++....      .....++....+++.|++.||+|||+.+     |+||||||+||++++++
T Consensus        82 ~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~-----i~H~dikp~nili~~~~  156 (288)
T cd05061          82 QPTLVVMELMAHGDLKSYLRSLRPEAENNPGRPPPTLQEMIQMAAEIADGMAYLNAKK-----FVHRDLAARNCMVAHDF  156 (288)
T ss_pred             CCcEEEEeCCCCCCHHHHHHHhccccccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCC-----CcCCCCChheEEEcCCC
Confidence            678999999999999999975321      1234678888999999999999999887     99999999999999999


Q ss_pred             CeEEecccccccccCCceee-eecCCCCCCCCCccccccCCCCCcccchhHHHHHHHHHh-CCCCcchhHHHHHhhhhhh
Q 005586          555 NPLIADCGLHKLLADDIVFS-VLKTSAAMGYLAPEYVTTGRFTERSDIFAFGVIILQILT-GSLVLTSSMRLAAESATFE  632 (689)
Q Consensus       555 ~~kl~DfGla~~~~~~~~~~-~~~~~~~~~y~aPE~~~~~~~~~ksDV~sfGvvl~ellt-G~~p~~~~~~~~~~~~~~~  632 (689)
                      .+||+|||+++......... .....++..|+|||.+.++.++.++|||||||++|||++ |..|+......     ...
T Consensus       157 ~~~L~Dfg~~~~~~~~~~~~~~~~~~~~~~y~~pE~~~~~~~~~~~DvwslG~~l~el~~~~~~p~~~~~~~-----~~~  231 (288)
T cd05061         157 TVKIGDFGMTRDIYETDYYRKGGKGLLPVRWMAPESLKDGVFTTSSDMWSFGVVLWEITSLAEQPYQGLSNE-----QVL  231 (288)
T ss_pred             cEEECcCCccccccccccccccCCCcccccccCHHHhccCCCChHhHHHHHHHHHHHHHhCCCCCCCCCCHH-----HHH
Confidence            99999999998654322211 112234567999999988899999999999999999999 77787542211     111


Q ss_pred             HhhccccCCCCCHHHHHHHHHHHHHhccCCCCCCCCHHHHHHHHHhh
Q 005586          633 NFIDRNLKGKFSESEAAKLGKMALVCTHEDPENRPTMEAVIEELTVA  679 (689)
Q Consensus       633 ~~~~~~~~~~~~~~~~~~l~~l~~~Cl~~dp~~RPs~~evl~~L~~~  679 (689)
                      +.+........+...+..+.+++.+|++.||++||++.|+++.|+..
T Consensus       232 ~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~ll~~l~~~  278 (288)
T cd05061         232 KFVMDGGYLDQPDNCPERVTDLMRMCWQFNPKMRPTFLEIVNLLKDD  278 (288)
T ss_pred             HHHHcCCCCCCCCCCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHhh
Confidence            11111111123344467899999999999999999999999999863

Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR is a receptor tyr kinase (RTK) that is composed of two alphabeta heterodimers. Binding of the insulin ligand to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological function. InsR signaling plays an important role in many cellular processes including glucose homeostasis, glycogen synthesis, lipid and protein meta

>cd05103 PTKc_VEGFR2 Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 2

Probab=100.00  E-value=2.4e-38  Score=336.80  Aligned_cols=262  Identities=24%  Similarity=0.412  Sum_probs=204.3

Q ss_pred             ccCCcccccccCCcceEEEEEe------cCCcEEEEEEecccCCchHHHHHHHHHHHHhcc-CCCcceeEeeEEEcCCCC
Q 005586          409 QCFSEVNLLGKGNFSSVYKGTL------RDGTLVAIRSINVTSCKSEEAEFVKGLYLLTSL-RHENIIRLRGFCCSRGRG  481 (689)
Q Consensus       409 ~~f~~~~~lg~G~~g~Vy~~~~------~~g~~vavK~l~~~~~~~~~~~f~~e~~~l~~l-~H~niv~l~g~~~~~~~~  481 (689)
                      ++|...+.||+|+||.||+|..      .+++.||||+++..........+.+|+.++.++ +||||++++++|... ..
T Consensus         7 ~~~~~~~~lG~G~fg~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~~~~~~~~~-~~   85 (343)
T cd05103           7 DRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVVNLLGACTKP-GG   85 (343)
T ss_pred             hHhcccccccCCccceEEEEeeccCCccccceeEEEEEeccCCChHHHHHHHHHHHHHHhccCCccHhhhcceeecC-CC
Confidence            4677889999999999999974      357899999998655444556789999999999 689999999988644 35


Q ss_pred             eEEEEEEcCCCCCHHHHhhhcCCC--------------------------------------------------------
Q 005586          482 ECFLIYDFAPKGKLSKYLDQEEGS--------------------------------------------------------  505 (689)
Q Consensus       482 ~~~lV~e~~~~gsL~~~L~~~~~~--------------------------------------------------------  505 (689)
                      ..++||||+++|+|.++++.....                                                        
T Consensus        86 ~~~lv~ey~~~g~L~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  165 (343)
T cd05103          86 PLMVIVEFCKFGNLSNYLRSKRGEFVPYKTKDARFRQGKSGYGDISEDLKRRLDSITSSQSSASSGFVEEKSLSDVEEEE  165 (343)
T ss_pred             ceEEEEeccCCCcHHHHHHhcCCccccccccccccccccccccchhhhhhhhccccccccccccccccCCCccccchhhh
Confidence            678999999999999999753210                                                        


Q ss_pred             -------CCCCCHHHHHHHHHHHHHHHhhhhCCCCCCCceeecCCCCCceeecCCCCeEEecccccccccCCce-eeeec
Q 005586          506 -------SNVLDWSTRVSIIIGIAKGIGYLHSSEVNKPAIVHRNLSVEKVLIDQQFNPLIADCGLHKLLADDIV-FSVLK  577 (689)
Q Consensus       506 -------~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~~~ivH~dlk~~NiLl~~~~~~kl~DfGla~~~~~~~~-~~~~~  577 (689)
                             ...++|..+..++.|+++||+|||+.+     |+||||||+|||+++++.+||+|||+++....... .....
T Consensus       166 ~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~-----i~H~dikp~Nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~  240 (343)
T cd05103         166 AEQEDLYKKVLTLEDLICYSFQVAKGMEFLASRK-----CIHRDLAARNILLSENNVVKICDFGLARDIYKDPDYVRKGD  240 (343)
T ss_pred             hhhhhhhhccCCHHHHHHHHHHHHHHHHHHHhCC-----eecCCCccCeEEEcCCCcEEEEecccccccccCcchhhcCC
Confidence                   124788999999999999999999987     99999999999999999999999999986543221 11112


Q ss_pred             CCCCCCCCCccccccCCCCCcccchhHHHHHHHHHh-CCCCcchhHHHHHhhhhhhHhhccccCCCCCHHHHHHHHHHHH
Q 005586          578 TSAAMGYLAPEYVTTGRFTERSDIFAFGVIILQILT-GSLVLTSSMRLAAESATFENFIDRNLKGKFSESEAAKLGKMAL  656 (689)
Q Consensus       578 ~~~~~~y~aPE~~~~~~~~~ksDV~sfGvvl~ellt-G~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~  656 (689)
                      ..++..|+|||.+.+..++.++||||||+++|||++ |..|+.......    .+...+........+.....++.+++.
T Consensus       241 ~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~~----~~~~~~~~~~~~~~~~~~~~~~~~~~~  316 (343)
T cd05103         241 ARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKIDE----EFCRRLKEGTRMRAPDYTTPEMYQTML  316 (343)
T ss_pred             CCCCcceECcHHhcCCCCCchhhHHHHHHHHHHHHHCCCCCCCCccccH----HHHHHHhccCCCCCCCCCCHHHHHHHH
Confidence            234567999999988899999999999999999997 888885421110    111111111122222223457899999


Q ss_pred             HhccCCCCCCCCHHHHHHHHHhhC
Q 005586          657 VCTHEDPENRPTMEAVIEELTVAA  680 (689)
Q Consensus       657 ~Cl~~dp~~RPs~~evl~~L~~~~  680 (689)
                      .||+.+|++||++.||+++|+..-
T Consensus       317 ~cl~~~p~~Rps~~eil~~l~~~~  340 (343)
T cd05103         317 DCWHGEPSQRPTFSELVEHLGNLL  340 (343)
T ss_pred             HHccCChhhCcCHHHHHHHHHHHH
Confidence            999999999999999999998753

Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 2 (VEGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR2 (or Flk1) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. The carboxyl terminus of VEGFR2 plays an important role in its autophosp

>cd05032 PTKc_InsR_like Catalytic domain of Insulin Receptor-like Protein Tyrosine Kinases

Probab=100.00  E-value=2.7e-38  Score=326.06  Aligned_cols=257  Identities=23%  Similarity=0.417  Sum_probs=206.1

Q ss_pred             ccCCcccccccCCcceEEEEEecC------CcEEEEEEecccCCchHHHHHHHHHHHHhccCCCcceeEeeEEEcCCCCe
Q 005586          409 QCFSEVNLLGKGNFSSVYKGTLRD------GTLVAIRSINVTSCKSEEAEFVKGLYLLTSLRHENIIRLRGFCCSRGRGE  482 (689)
Q Consensus       409 ~~f~~~~~lg~G~~g~Vy~~~~~~------g~~vavK~l~~~~~~~~~~~f~~e~~~l~~l~H~niv~l~g~~~~~~~~~  482 (689)
                      ++|...+.||+|+||.||+|..++      +..||+|.+..........+|.+|+.++.+++||||+++++++..  ...
T Consensus         6 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~~aik~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~--~~~   83 (277)
T cd05032           6 EKITLIRELGQGSFGMVYEGLAKGVVKGEPETRVAIKTVNENASMRERIEFLNEASVMKEFNCHHVVRLLGVVST--GQP   83 (277)
T ss_pred             HHeeEEeEecCCCCceEEEEEEeccCCCCcceeEEEEecCCccCHHHHHHHHHHHHHHHhCCCCceeEEEEEEcC--CCC
Confidence            467778999999999999998752      468999998766544555689999999999999999999999854  477


Q ss_pred             EEEEEEcCCCCCHHHHhhhcCCC------CCCCCHHHHHHHHHHHHHHHhhhhCCCCCCCceeecCCCCCceeecCCCCe
Q 005586          483 CFLIYDFAPKGKLSKYLDQEEGS------SNVLDWSTRVSIIIGIAKGIGYLHSSEVNKPAIVHRNLSVEKVLIDQQFNP  556 (689)
Q Consensus       483 ~~lV~e~~~~gsL~~~L~~~~~~------~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~~~ivH~dlk~~NiLl~~~~~~  556 (689)
                      .++||||+++|+|.+++......      ...++|..++.++.|++.||.|||+.+     |+||||||+||++++++.+
T Consensus        84 ~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~-----i~H~di~p~nill~~~~~~  158 (277)
T cd05032          84 TLVVMELMAKGDLKSYLRSRRPEAENNPGLGPPTLQKFIQMAAEIADGMAYLAAKK-----FVHRDLAARNCMVAEDLTV  158 (277)
T ss_pred             cEEEEecCCCCCHHHHHHhcccchhhccCCCCCCHHHHHHHHHHHHHHHHHHHhCC-----ccccccChheEEEcCCCCE
Confidence            89999999999999999754321      224789999999999999999999887     9999999999999999999


Q ss_pred             EEecccccccccCCcee-eeecCCCCCCCCCccccccCCCCCcccchhHHHHHHHHHh-CCCCcchhHHHHHhhhhhhHh
Q 005586          557 LIADCGLHKLLADDIVF-SVLKTSAAMGYLAPEYVTTGRFTERSDIFAFGVIILQILT-GSLVLTSSMRLAAESATFENF  634 (689)
Q Consensus       557 kl~DfGla~~~~~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~ksDV~sfGvvl~ellt-G~~p~~~~~~~~~~~~~~~~~  634 (689)
                      ||+|||+++........ ......++..|+|||.+.+..++.++|||||||++||++| |+.|+.......     ..+.
T Consensus       159 kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~g~~p~~~~~~~~-----~~~~  233 (277)
T cd05032         159 KIGDFGMTRDIYETDYYRKGGKGLLPVRWMAPESLKDGVFTTKSDVWSFGVVLWEMATLAEQPYQGLSNEE-----VLKF  233 (277)
T ss_pred             EECCcccchhhccCcccccCCCCCccccccCHHHHhcCCCCcccchHHHHHHHHHhhccCCCCCccCCHHH-----HHHH
Confidence            99999999866443221 1122335678999999988889999999999999999998 888885432211     1111


Q ss_pred             hccccCCCCCHHHHHHHHHHHHHhccCCCCCCCCHHHHHHHHH
Q 005586          635 IDRNLKGKFSESEAAKLGKMALVCTHEDPENRPTMEAVIEELT  677 (689)
Q Consensus       635 ~~~~~~~~~~~~~~~~l~~l~~~Cl~~dp~~RPs~~evl~~L~  677 (689)
                      +........+...+.++.+++..||+.+|++|||+.|+++.|+
T Consensus       234 ~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~l~~~l~  276 (277)
T cd05032         234 VIDGGHLDLPENCPDKLLELMRMCWQYNPKMRPTFLEIVSSLK  276 (277)
T ss_pred             HhcCCCCCCCCCCCHHHHHHHHHHcCCChhhCCCHHHHHHHhc
Confidence            1111122334445778999999999999999999999999886

Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The InsR subfamily is composed of InsR, Insulin-like Growth Factor-1 Receptor (IGF-1R), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR and IGF-1R are receptor tyr kinases (RTKs) composed of two alphabeta heterodimers. Binding of the ligand (insulin, IGF-1, or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological

>KOG0658 consensus Glycogen synthase kinase-3 [Carbohydrate transport and metabolism]

Probab=100.00  E-value=1.9e-39  Score=321.88  Aligned_cols=253  Identities=21%  Similarity=0.313  Sum_probs=194.4

Q ss_pred             CCcccccccCCcceEEEEEec-CCcEEEEEEecccCCchHHHHHHHHHHHHhccCCCcceeEeeEEEcCCCC---eEEEE
Q 005586          411 FSEVNLLGKGNFSSVYKGTLR-DGTLVAIRSINVTSCKSEEAEFVKGLYLLTSLRHENIIRLRGFCCSRGRG---ECFLI  486 (689)
Q Consensus       411 f~~~~~lg~G~~g~Vy~~~~~-~g~~vavK~l~~~~~~~~~~~f~~e~~~l~~l~H~niv~l~g~~~~~~~~---~~~lV  486 (689)
                      |...+++|+|+||.||+|.+. ++..||||+...+..-     --+|+++|++++|||||+|.-++......   ...+|
T Consensus        26 ~~~~~liG~GsFg~Vyq~~~~e~~~~vAIKKv~~d~r~-----knrEl~im~~l~HpNIV~L~~~f~~~~~~d~~~lnlV  100 (364)
T KOG0658|consen   26 YEAVRLIGSGSFGVVYQAKLRETEEEVAIKKVLQDKRY-----KNRELQIMRKLDHPNIVRLLYFFSSSTESDEVYLNLV  100 (364)
T ss_pred             EEeeEEEeecccceEEEEEEcCCCceeEEEEecCCCCc-----CcHHHHHHHhcCCcCeeeEEEEEEecCCCchhHHHHH
Confidence            455789999999999999976 5789999998765421     12688999999999999999888765544   34589


Q ss_pred             EEcCCCCCHHHHhhhcCCCCCCCCHHHHHHHHHHHHHHHhhhhCCCCCCCceeecCCCCCceeecCC-CCeEEecccccc
Q 005586          487 YDFAPKGKLSKYLDQEEGSSNVLDWSTRVSIIIGIAKGIGYLHSSEVNKPAIVHRNLSVEKVLIDQQ-FNPLIADCGLHK  565 (689)
Q Consensus       487 ~e~~~~gsL~~~L~~~~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~~~ivH~dlk~~NiLl~~~-~~~kl~DfGla~  565 (689)
                      |||||. +|.++++.....+..++.....-+..|+.+||+|||+.+     |+||||||.|+|+|.+ +.+||+|||-|+
T Consensus       101 leymP~-tL~~~~r~~~~~~~~mp~~~iKLYt~Qlfrgl~yLh~~~-----IcHRDIKPqNlLvD~~tg~LKicDFGSAK  174 (364)
T KOG0658|consen  101 LEYMPE-TLYRVIRHYTRANQRMPLLEIKLYTYQLFRGLAYLHSHG-----ICHRDIKPQNLLVDPDTGVLKICDFGSAK  174 (364)
T ss_pred             HHhchH-HHHHHHHHHhhcCCCCceeeeHHHHHHHHHHHHHHHhcC-----cccCCCChheEEEcCCCCeEEeccCCcce
Confidence            999987 999999864333455777888889999999999999987     9999999999999976 899999999999


Q ss_pred             cccCCceeeeecCCCCCCCCCccccccC-CCCCcccchhHHHHHHHHHhCCCCcchhHHHHHhhhhh-------------
Q 005586          566 LLADDIVFSVLKTSAAMGYLAPEYVTTG-RFTERSDIFAFGVIILQILTGSLVLTSSMRLAAESATF-------------  631 (689)
Q Consensus       566 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~-~~~~ksDV~sfGvvl~elltG~~p~~~~~~~~~~~~~~-------------  631 (689)
                      .+..+....  .-..|..|+|||.+.+. .|+.+.||||.|||+.||+-|++-|.+.....+....+             
T Consensus       175 ~L~~~epni--SYicSRyYRaPELifga~~Yt~~IDiWSaGCV~aELl~g~plFpG~s~~dQL~eIik~lG~Pt~e~I~~  252 (364)
T KOG0658|consen  175 VLVKGEPNI--SYICSRYYRAPELIFGATEYTTSIDIWSAGCVMAELLKGQPLFPGDSSVDQLVEIIKVLGTPTREDIKS  252 (364)
T ss_pred             eeccCCCce--eEEEeccccCHHHHcCccccCceeEEhhhhHHHHHHhcCCcccCCCCHHHHHHHHHHHhCCCCHHHHhh
Confidence            886543221  12234569999998764 69999999999999999999998886532211111100             


Q ss_pred             -----hHhhccccCC-----CCCHHHHHHHHHHHHHhccCCCCCCCCHHHHHHHH
Q 005586          632 -----ENFIDRNLKG-----KFSESEAAKLGKMALVCTHEDPENRPTMEAVIEEL  676 (689)
Q Consensus       632 -----~~~~~~~~~~-----~~~~~~~~~l~~l~~~Cl~~dp~~RPs~~evl~~L  676 (689)
                           .+.-.+.++.     .+......+..+++.++++.+|.+|.++.|++.+-
T Consensus       253 mn~~y~~~~~p~ik~~~~~~~~~~~~~~d~~dll~~~L~Y~P~~R~~~~~~l~h~  307 (364)
T KOG0658|consen  253 MNPNYTEFKFPQIKAHPWHKVFFKRLPPDALDLLSKLLQYSPSKRLSALEALAHP  307 (364)
T ss_pred             cCcccccccCcccccccceeecccCCCHHHHHHHHHHhccChhhcCCHHHHhcch
Confidence                 0111111111     12334567899999999999999999999998763

>KOG0580 consensus Serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning]

Probab=100.00  E-value=5.5e-39  Score=299.86  Aligned_cols=254  Identities=23%  Similarity=0.366  Sum_probs=211.6

Q ss_pred             ccCCcccccccCCcceEEEEEec-CCcEEEEEEecccCC--chHHHHHHHHHHHHhccCCCcceeEeeEEEcCCCCeEEE
Q 005586          409 QCFSEVNLLGKGNFSSVYKGTLR-DGTLVAIRSINVTSC--KSEEAEFVKGLYLLTSLRHENIIRLRGFCCSRGRGECFL  485 (689)
Q Consensus       409 ~~f~~~~~lg~G~~g~Vy~~~~~-~g~~vavK~l~~~~~--~~~~~~f~~e~~~l~~l~H~niv~l~g~~~~~~~~~~~l  485 (689)
                      ++|...+.||+|.||.||.|+.+ ++-.||+|++.+...  ..-+.++.+|+++-+.++||||+++++|+.+  ....|+
T Consensus        22 ~dfeigr~LgkgkFG~vYlarekks~~IvalKVlfKsqi~~~~v~~qlrREiEIqs~L~hpnilrlY~~fhd--~~riyL   99 (281)
T KOG0580|consen   22 DDFEIGRPLGKGKFGNVYLAREKKSLFIVALKVLFKSQILKTQVEHQLRREIEIQSHLRHPNILRLYGYFHD--SKRIYL   99 (281)
T ss_pred             hhccccccccCCccccEeEeeeccCCcEEEEeeeeHHHHHHhcchhhhhheeEeecccCCccHHhhhhheec--cceeEE
Confidence            46788899999999999999976 688999999976643  2334689999999999999999999999965  477999


Q ss_pred             EEEcCCCCCHHHHhhhcCCCCCCCCHHHHHHHHHHHHHHHhhhhCCCCCCCceeecCCCCCceeecCCCCeEEecccccc
Q 005586          486 IYDFAPKGKLSKYLDQEEGSSNVLDWSTRVSIIIGIAKGIGYLHSSEVNKPAIVHRNLSVEKVLIDQQFNPLIADCGLHK  565 (689)
Q Consensus       486 V~e~~~~gsL~~~L~~~~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~~~ivH~dlk~~NiLl~~~~~~kl~DfGla~  565 (689)
                      ++||.++|.|...|+....  ..++......++.|+|.||.|+|..+     ||||||||+|+|++.++..||+|||.+.
T Consensus       100 ilEya~~gel~k~L~~~~~--~~f~e~~~a~Yi~q~A~Al~y~h~k~-----VIhRdiKpenlLlg~~~~lkiAdfGwsV  172 (281)
T KOG0580|consen  100 ILEYAPRGELYKDLQEGRM--KRFDEQRAATYIKQLANALLYCHLKR-----VIHRDIKPENLLLGSAGELKIADFGWSV  172 (281)
T ss_pred             EEEecCCchHHHHHHhccc--ccccccchhHHHHHHHHHHHHhccCC-----cccCCCCHHHhccCCCCCeeccCCCcee
Confidence            9999999999999985433  24777778889999999999999877     9999999999999999999999999987


Q ss_pred             cccCCceeeeecCCCCCCCCCccccccCCCCCcccchhHHHHHHHHHhCCCCcchhHHHHHhhhhhhHhhccccCCCCCH
Q 005586          566 LLADDIVFSVLKTSAAMGYLAPEYVTTGRFTERSDIFAFGVIILQILTGSLVLTSSMRLAAESATFENFIDRNLKGKFSE  645 (689)
Q Consensus       566 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~ksDV~sfGvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~  645 (689)
                      .-+.+   ......||+.|.+||.+.+...+.++|+|++||+.||++.|.+||.+.....    .+.++..  .+-.++.
T Consensus       173 ~~p~~---kR~tlcgt~dyl~pEmv~~~~hd~~Vd~w~lgvl~yeflvg~ppFes~~~~e----tYkrI~k--~~~~~p~  243 (281)
T KOG0580|consen  173 HAPSN---KRKTLCGTLDYLPPEMVEGRGHDKFVDLWSLGVLCYEFLVGLPPFESQSHSE----TYKRIRK--VDLKFPS  243 (281)
T ss_pred             ecCCC---CceeeecccccCCHhhcCCCCccchhhHHHHHHHHHHHHhcCCchhhhhhHH----HHHHHHH--ccccCCc
Confidence            55432   2233458899999999999999999999999999999999999997654222    2222221  1223456


Q ss_pred             HHHHHHHHHHHHhccCCCCCCCCHHHHHHHHHhhC
Q 005586          646 SEAAKLGKMALVCTHEDPENRPTMEAVIEELTVAA  680 (689)
Q Consensus       646 ~~~~~l~~l~~~Cl~~dp~~RPs~~evl~~L~~~~  680 (689)
                      ..+..+.+++.+|+..+|.+|.+..||+.+.+..+
T Consensus       244 ~is~~a~dlI~~ll~~~p~~r~~l~~v~~hpwI~a  278 (281)
T KOG0580|consen  244 TISGGAADLISRLLVKNPIERLALTEVMDHPWIVA  278 (281)
T ss_pred             ccChhHHHHHHHHhccCccccccHHHHhhhHHHHh
Confidence            66778999999999999999999999999877543

>cd05066 PTKc_EphR_A Catalytic domain of the Protein Tyrosine Kinases, Class EphA Ephrin Receptors

Probab=100.00  E-value=5.6e-38  Score=322.06  Aligned_cols=256  Identities=22%  Similarity=0.446  Sum_probs=204.5

Q ss_pred             ccCCcccccccCCcceEEEEEec----CCcEEEEEEecccCCchHHHHHHHHHHHHhccCCCcceeEeeEEEcCCCCeEE
Q 005586          409 QCFSEVNLLGKGNFSSVYKGTLR----DGTLVAIRSINVTSCKSEEAEFVKGLYLLTSLRHENIIRLRGFCCSRGRGECF  484 (689)
Q Consensus       409 ~~f~~~~~lg~G~~g~Vy~~~~~----~g~~vavK~l~~~~~~~~~~~f~~e~~~l~~l~H~niv~l~g~~~~~~~~~~~  484 (689)
                      ++|...+.||+|+||.||+|...    .+..+|+|.++..........|.+|+.++.+++||||+++++++..  .+..+
T Consensus         4 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~--~~~~~   81 (267)
T cd05066           4 SCIKIEKVIGAGEFGEVCSGRLKLPGKREIPVAIKTLKAGYTEKQRRDFLSEASIMGQFDHPNIIHLEGVVTK--SKPVM   81 (267)
T ss_pred             HHeEeeeeecccCCCceEEEEEecCCCCceEEEEEECCCCCCHHHHHHHHHHHHHHHhCCCCCcceEEEEEec--CCccE
Confidence            45777899999999999999864    2347999998765444456789999999999999999999999854  46789


Q ss_pred             EEEEcCCCCCHHHHhhhcCCCCCCCCHHHHHHHHHHHHHHHhhhhCCCCCCCceeecCCCCCceeecCCCCeEEeccccc
Q 005586          485 LIYDFAPKGKLSKYLDQEEGSSNVLDWSTRVSIIIGIAKGIGYLHSSEVNKPAIVHRNLSVEKVLIDQQFNPLIADCGLH  564 (689)
Q Consensus       485 lV~e~~~~gsL~~~L~~~~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~~~ivH~dlk~~NiLl~~~~~~kl~DfGla  564 (689)
                      +||||+++|+|.+++....+   .+++.+++.|+.|++.||+|||+.+     ++||||||+|||+++++.+|++|||++
T Consensus        82 lv~e~~~~~~L~~~~~~~~~---~~~~~~~~~i~~~i~~~l~~lH~~~-----i~h~dlkp~nili~~~~~~~l~dfg~~  153 (267)
T cd05066          82 IVTEYMENGSLDAFLRKHDG---QFTVIQLVGMLRGIASGMKYLSDMG-----YVHRDLAARNILVNSNLVCKVSDFGLS  153 (267)
T ss_pred             EEEEcCCCCCHHHHHHhcCC---CCCHHHHHHHHHHHHHHHHHHHHCC-----EeehhhchhcEEECCCCeEEeCCCCcc
Confidence            99999999999999976532   4899999999999999999999987     999999999999999999999999999


Q ss_pred             ccccCCceeee--ecCCCCCCCCCccccccCCCCCcccchhHHHHHHHHHh-CCCCcchhHHHHHhhhhhhHhhccccCC
Q 005586          565 KLLADDIVFSV--LKTSAAMGYLAPEYVTTGRFTERSDIFAFGVIILQILT-GSLVLTSSMRLAAESATFENFIDRNLKG  641 (689)
Q Consensus       565 ~~~~~~~~~~~--~~~~~~~~y~aPE~~~~~~~~~ksDV~sfGvvl~ellt-G~~p~~~~~~~~~~~~~~~~~~~~~~~~  641 (689)
                      +.+........  .....+..|+|||++.+..++.++||||||+++||+++ |+.|+.......    ....+. .....
T Consensus       154 ~~~~~~~~~~~~~~~~~~~~~y~~pe~~~~~~~~~~~Dv~slG~~l~ell~~g~~p~~~~~~~~----~~~~~~-~~~~~  228 (267)
T cd05066         154 RVLEDDPEAAYTTRGGKIPIRWTAPEAIAYRKFTSASDVWSYGIVMWEVMSYGERPYWEMSNQD----VIKAIE-EGYRL  228 (267)
T ss_pred             cccccccceeeecCCCccceeecCHhHhccCccCchhhhHHHHHHHHHHhcCCCCCcccCCHHH----HHHHHh-CCCcC
Confidence            87654322111  11223457999999998899999999999999999887 999985432111    111111 11111


Q ss_pred             CCCHHHHHHHHHHHHHhccCCCCCCCCHHHHHHHHHhh
Q 005586          642 KFSESEAAKLGKMALVCTHEDPENRPTMEAVIEELTVA  679 (689)
Q Consensus       642 ~~~~~~~~~l~~l~~~Cl~~dp~~RPs~~evl~~L~~~  679 (689)
                      ..+...+..+.+++.+|++.+|++||+|.++++.|+.+
T Consensus       229 ~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~i~~~l~~~  266 (267)
T cd05066         229 PAPMDCPAALHQLMLDCWQKDRNERPKFEQIVSILDKL  266 (267)
T ss_pred             CCCCCCCHHHHHHHHHHcccCchhCCCHHHHHHHHHhh
Confidence            22334456789999999999999999999999999864

Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; most class EphA receptors including EphA3, EphA4, EphA5, and EphA7, but excluding EphA1, EphA2 and EphA10; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. One exception is EphA4, which also binds ephrins-B2/B3. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellul

>cd05101 PTKc_FGFR2 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 2

Probab=100.00  E-value=3.9e-38  Score=329.64  Aligned_cols=262  Identities=24%  Similarity=0.417  Sum_probs=207.2

Q ss_pred             ccCCcccccccCCcceEEEEEec--------CCcEEEEEEecccCCchHHHHHHHHHHHHhcc-CCCcceeEeeEEEcCC
Q 005586          409 QCFSEVNLLGKGNFSSVYKGTLR--------DGTLVAIRSINVTSCKSEEAEFVKGLYLLTSL-RHENIIRLRGFCCSRG  479 (689)
Q Consensus       409 ~~f~~~~~lg~G~~g~Vy~~~~~--------~g~~vavK~l~~~~~~~~~~~f~~e~~~l~~l-~H~niv~l~g~~~~~~  479 (689)
                      ++|...+.||+|+||.||+|+..        ++..||+|.+..........++.+|+.++..+ +||||+++++++..  
T Consensus        15 ~~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~i~~~~~~~~~--   92 (304)
T cd05101          15 DKLTLGKPLGEGCFGQVVMAEALGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKNIINLLGACTQ--   92 (304)
T ss_pred             HHeeecceeeccCCceEEEEEEeccCCCCCCcceeEEeeecccccchHHHHHHHHHHHHHHhhccCCCchheeEEEec--
Confidence            45677789999999999999742        34579999987654344557899999999999 89999999999854  


Q ss_pred             CCeEEEEEEcCCCCCHHHHhhhcCC------------CCCCCCHHHHHHHHHHHHHHHhhhhCCCCCCCceeecCCCCCc
Q 005586          480 RGECFLIYDFAPKGKLSKYLDQEEG------------SSNVLDWSTRVSIIIGIAKGIGYLHSSEVNKPAIVHRNLSVEK  547 (689)
Q Consensus       480 ~~~~~lV~e~~~~gsL~~~L~~~~~------------~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~~~ivH~dlk~~N  547 (689)
                      ....++||||+++|+|.+++.....            ....++|.+++.++.|+++||+|||+.+     |+||||||+|
T Consensus        93 ~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~LH~~g-----ivH~dlkp~N  167 (304)
T cd05101          93 DGPLYVIVEYASKGNLREYLRARRPPGMEYSYDIARVPDEQMTFKDLVSCTYQVARGMEYLASQK-----CIHRDLAARN  167 (304)
T ss_pred             CCceEEEEecCCCCcHHHHHHhcCCcccccccccccCCcccccHHHHHHHHHHHHHHHHHHHHCC-----eeecccccce
Confidence            4678999999999999999976432            1235889999999999999999999987     9999999999


Q ss_pred             eeecCCCCeEEecccccccccCCceee-eecCCCCCCCCCccccccCCCCCcccchhHHHHHHHHHh-CCCCcchhHHHH
Q 005586          548 VLIDQQFNPLIADCGLHKLLADDIVFS-VLKTSAAMGYLAPEYVTTGRFTERSDIFAFGVIILQILT-GSLVLTSSMRLA  625 (689)
Q Consensus       548 iLl~~~~~~kl~DfGla~~~~~~~~~~-~~~~~~~~~y~aPE~~~~~~~~~ksDV~sfGvvl~ellt-G~~p~~~~~~~~  625 (689)
                      |++++++.+||+|||+++.+....... .....++..|+|||.+.+..++.++||||||+++|||+| |..|+.......
T Consensus       168 ili~~~~~~kl~D~g~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~~  247 (304)
T cd05101         168 VLVTENNVMKIADFGLARDVNNIDYYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFTLGGSPYPGIPVEE  247 (304)
T ss_pred             EEEcCCCcEEECCCccceecccccccccccCCCCCceeeCchhhccCCCCchhhHHHHHHHHHHHHcCCCCCcccCCHHH
Confidence            999999999999999998765432211 122334567999999988889999999999999999998 777775332111


Q ss_pred             HhhhhhhHhhccccCCCCCHHHHHHHHHHHHHhccCCCCCCCCHHHHHHHHHhhCCc
Q 005586          626 AESATFENFIDRNLKGKFSESEAAKLGKMALVCTHEDPENRPTMEAVIEELTVAAPV  682 (689)
Q Consensus       626 ~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~Cl~~dp~~RPs~~evl~~L~~~~p~  682 (689)
                           +.+.+........+...+..+.+++.+||+.+|++||+|.||++.|+.+...
T Consensus       248 -----~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rps~~e~l~~l~~~~~~  299 (304)
T cd05101         248 -----LFKLLKEGHRMDKPANCTNELYMMMRDCWHAIPSHRPTFKQLVEDLDRILTL  299 (304)
T ss_pred             -----HHHHHHcCCcCCCCCCCCHHHHHHHHHHcccChhhCCCHHHHHHHHHHHHHh
Confidence                 1111222222223345567899999999999999999999999999876543

Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 2 (FGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR2 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to

>cd08224 STKc_Nek6_Nek7 Catalytic domain of the Protein Serine/Threonine Kinases, Never In Mitosis gene A-related kinase 6 and 7

Probab=100.00  E-value=9.6e-38  Score=319.94  Aligned_cols=261  Identities=20%  Similarity=0.329  Sum_probs=209.5

Q ss_pred             ccCCcccccccCCcceEEEEEec-CCcEEEEEEecccC--CchHHHHHHHHHHHHhccCCCcceeEeeEEEcCCCCeEEE
Q 005586          409 QCFSEVNLLGKGNFSSVYKGTLR-DGTLVAIRSINVTS--CKSEEAEFVKGLYLLTSLRHENIIRLRGFCCSRGRGECFL  485 (689)
Q Consensus       409 ~~f~~~~~lg~G~~g~Vy~~~~~-~g~~vavK~l~~~~--~~~~~~~f~~e~~~l~~l~H~niv~l~g~~~~~~~~~~~l  485 (689)
                      ++|+..+.||+|+||.||+|... +|+.||+|.++...  .......+.+|++++++++|+|++++++++..  .+..++
T Consensus         2 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~ei~~l~~~~~~~i~~~~~~~~~--~~~~~l   79 (267)
T cd08224           2 GNFKIEKKIGKGQFSVVYKAICLLDGRVVALKKVQIFEMMDAKARQDCLKEIDLLKQLDHPNVIKYLASFIE--NNELNI   79 (267)
T ss_pred             CceeeeeeeccCCceEEEEEEEcCCCCEEEEEEeecccccchhhHHHHHHHHHHHHhCCCCCeeeeeeeeec--CCeEEE
Confidence            56888899999999999999987 79999999987432  22335689999999999999999999999854  467899


Q ss_pred             EEEcCCCCCHHHHhhhcCCCCCCCCHHHHHHHHHHHHHHHhhhhCCCCCCCceeecCCCCCceeecCCCCeEEecccccc
Q 005586          486 IYDFAPKGKLSKYLDQEEGSSNVLDWSTRVSIIIGIAKGIGYLHSSEVNKPAIVHRNLSVEKVLIDQQFNPLIADCGLHK  565 (689)
Q Consensus       486 V~e~~~~gsL~~~L~~~~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~~~ivH~dlk~~NiLl~~~~~~kl~DfGla~  565 (689)
                      ||||+++|+|.+++.........+++.+++.++.+++.||+|||+.+     |+||||||+||++++++.++|+|||+++
T Consensus        80 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~-----i~h~dl~p~nil~~~~~~~~l~d~~~~~  154 (267)
T cd08224          80 VLELADAGDLSRMIKHFKKQKRLIPERTIWKYFVQLCSALEHMHSKR-----IMHRDIKPANVFITATGVVKLGDLGLGR  154 (267)
T ss_pred             EEecCCCCCHHHHHHHhcccCCCcCHHHHHHHHHHHHHHHHHHHhCC-----EecCCcChhhEEECCCCcEEEeccceee
Confidence            99999999999999764333456899999999999999999999987     9999999999999999999999999987


Q ss_pred             cccCCceeeeecCCCCCCCCCccccccCCCCCcccchhHHHHHHHHHhCCCCcchhHHHHHhhhhhhHhhccccCCCCCH
Q 005586          566 LLADDIVFSVLKTSAAMGYLAPEYVTTGRFTERSDIFAFGVIILQILTGSLVLTSSMRLAAESATFENFIDRNLKGKFSE  645 (689)
Q Consensus       566 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~ksDV~sfGvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~  645 (689)
                      ........ .....++..|+|||++.+..++.++|||||||++|||++|+.|+........   ...+.+........+.
T Consensus       155 ~~~~~~~~-~~~~~~~~~y~apE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~---~~~~~~~~~~~~~~~~  230 (267)
T cd08224         155 FFSSKTTA-AHSLVGTPYYMSPERIHENGYNFKSDIWSLGCLLYEMAALQSPFYGDKMNLY---SLCKKIEKCDYPPLPA  230 (267)
T ss_pred             eccCCCcc-cceecCCccccCHHHhccCCCCchhcHHHHHHHHHHHHHCCCCcccCCccHH---HHHhhhhcCCCCCCCh
Confidence            65433211 1223467789999999888899999999999999999999999854321100   0111111111122222


Q ss_pred             -HHHHHHHHHHHHhccCCCCCCCCHHHHHHHHHhhC
Q 005586          646 -SEAAKLGKMALVCTHEDPENRPTMEAVIEELTVAA  680 (689)
Q Consensus       646 -~~~~~l~~l~~~Cl~~dp~~RPs~~evl~~L~~~~  680 (689)
                       .....+.+++..||..+|++||++.+|+++|+...
T Consensus       231 ~~~~~~~~~~i~~cl~~~p~~Rp~~~~il~~~~~~~  266 (267)
T cd08224         231 DHYSEELRDLVSRCINPDPEKRPDISYVLQVAKEMH  266 (267)
T ss_pred             hhcCHHHHHHHHHHcCCCcccCCCHHHHHHHHHHhc
Confidence             45668999999999999999999999999998764

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) and Nek7 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6/7 subfamily is part of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 and Nek7 are the shortest Neks, consisting only of the catalytic domain and a very short N-terminal extension. They show distinct expression patterns and both appear to be downstream substrates of Nek9. They are required for mitotic spindle formation and cytokinesis. They may a

>cd05038 PTKc_Jak_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases

Probab=100.00  E-value=4.4e-38  Score=325.53  Aligned_cols=262  Identities=24%  Similarity=0.415  Sum_probs=209.7

Q ss_pred             cCCcccccccCCcceEEEEEec-----CCcEEEEEEecccCCchHHHHHHHHHHHHhccCCCcceeEeeEEEcCCCCeEE
Q 005586          410 CFSEVNLLGKGNFSSVYKGTLR-----DGTLVAIRSINVTSCKSEEAEFVKGLYLLTSLRHENIIRLRGFCCSRGRGECF  484 (689)
Q Consensus       410 ~f~~~~~lg~G~~g~Vy~~~~~-----~g~~vavK~l~~~~~~~~~~~f~~e~~~l~~l~H~niv~l~g~~~~~~~~~~~  484 (689)
                      +|...+.||+|+||.||+|.+.     ++..||||.+..........+|.+|++.+++++|+||+++++++........+
T Consensus         5 ~~~~~~~ig~g~~~~v~~~~~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~ei~~l~~l~~~~i~~~~~~~~~~~~~~~~   84 (284)
T cd05038           5 HLKFIKQLGEGHFGKVELCRYDPLGDNTGEQVAVKSLNHSGEEQHRSDFEREIEILRTLDHENIVKYKGVCEKPGGRSLR   84 (284)
T ss_pred             hchhheeeccCCCeeEEEeeecCCCCCCceEEEEEEeccccchHHHHHHHHHHHHHHhCCCCChheEEeeeecCCCCceE
Confidence            4566789999999999999864     37899999998665333467899999999999999999999998665566789


Q ss_pred             EEEEcCCCCCHHHHhhhcCCCCCCCCHHHHHHHHHHHHHHHhhhhCCCCCCCceeecCCCCCceeecCCCCeEEeccccc
Q 005586          485 LIYDFAPKGKLSKYLDQEEGSSNVLDWSTRVSIIIGIAKGIGYLHSSEVNKPAIVHRNLSVEKVLIDQQFNPLIADCGLH  564 (689)
Q Consensus       485 lV~e~~~~gsL~~~L~~~~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~~~ivH~dlk~~NiLl~~~~~~kl~DfGla  564 (689)
                      +||||+++++|.+++.....   .++|..++.++.|++.||+|||+.+     |+||||||+||+++.++.+||+|||++
T Consensus        85 lv~e~~~~~~l~~~l~~~~~---~~~~~~~~~~~~~l~~aL~~lH~~~-----i~H~dl~p~nil~~~~~~~~l~dfg~~  156 (284)
T cd05038          85 LIMEYLPSGSLRDYLQRHRD---QINLKRLLLFSSQICKGMDYLGSQR-----YIHRDLAARNILVESEDLVKISDFGLA  156 (284)
T ss_pred             EEEecCCCCCHHHHHHhCcc---ccCHHHHHHHHHHHHHHHHHHHhCC-----eecCCCCHHhEEEcCCCCEEEcccccc
Confidence            99999999999999976542   4899999999999999999999987     999999999999999999999999999


Q ss_pred             ccccCCceee--eecCCCCCCCCCccccccCCCCCcccchhHHHHHHHHHhCCCCcchhHHHHH----------hhhhhh
Q 005586          565 KLLADDIVFS--VLKTSAAMGYLAPEYVTTGRFTERSDIFAFGVIILQILTGSLVLTSSMRLAA----------ESATFE  632 (689)
Q Consensus       565 ~~~~~~~~~~--~~~~~~~~~y~aPE~~~~~~~~~ksDV~sfGvvl~elltG~~p~~~~~~~~~----------~~~~~~  632 (689)
                      ..........  ......+..|+|||...+..++.++||||||+++|||+||+.|+........          ....+.
T Consensus       157 ~~~~~~~~~~~~~~~~~~~~~~~~Pe~~~~~~~~~~~Di~slG~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~  236 (284)
T cd05038         157 KVLPEDKDYYYVKEPGESPIFWYAPECLRTSKFSSASDVWSFGVTLYELFTYGDPSQSPPAEFLRMIGIAQGQMIVTRLL  236 (284)
T ss_pred             cccccCCcceeccCCCCCcccccCcHHHccCCCCcccchHHHhhhhheeeccCCCcccccchhccccccccccccHHHHH
Confidence            8776332111  1122344569999999888999999999999999999999998754321110          011222


Q ss_pred             HhhccccCCCCCHHHHHHHHHHHHHhccCCCCCCCCHHHHHHHHHhh
Q 005586          633 NFIDRNLKGKFSESEAAKLGKMALVCTHEDPENRPTMEAVIEELTVA  679 (689)
Q Consensus       633 ~~~~~~~~~~~~~~~~~~l~~l~~~Cl~~dp~~RPs~~evl~~L~~~  679 (689)
                      +.+........+..++.++.+++.+||+.+|++||+|.||+++|+.+
T Consensus       237 ~~~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rpt~~ei~~~l~~i  283 (284)
T cd05038         237 ELLKEGERLPRPPSCPDEVYDLMKLCWEAEPQDRPSFADLILIVDRL  283 (284)
T ss_pred             HHHHcCCcCCCCccCCHHHHHHHHHHhccChhhCCCHHHHHHHHhhc
Confidence            22333222233344567899999999999999999999999999875

Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; catalytic (c) domain (repeat 2). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Most Jaks are expressed in a wide variety of tissues, except for Jak3, which is expressed only in hematopoietic cells. Jaks are crucial for cytokine receptor signaling. They are activated by aut

>cd05055 PTKc_PDGFR Catalytic domain of the Protein Tyrosine Kinases, Platelet Derived Growth Factor Receptors

Probab=100.00  E-value=5.5e-38  Score=328.08  Aligned_cols=258  Identities=24%  Similarity=0.408  Sum_probs=206.1

Q ss_pred             ccCCcccccccCCcceEEEEEec------CCcEEEEEEecccCCchHHHHHHHHHHHHhcc-CCCcceeEeeEEEcCCCC
Q 005586          409 QCFSEVNLLGKGNFSSVYKGTLR------DGTLVAIRSINVTSCKSEEAEFVKGLYLLTSL-RHENIIRLRGFCCSRGRG  481 (689)
Q Consensus       409 ~~f~~~~~lg~G~~g~Vy~~~~~------~g~~vavK~l~~~~~~~~~~~f~~e~~~l~~l-~H~niv~l~g~~~~~~~~  481 (689)
                      ++|...+.||+|+||.||+|...      ++..||+|+++..........|.+|+++++++ +||||+++++++..  .+
T Consensus        35 ~~~~~~~~ig~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~--~~  112 (302)
T cd05055          35 NNLSFGKTLGAGAFGKVVEATAYGLSKSDAVMKVAVKMLKPTAHSSEREALMSELKIMSHLGNHENIVNLLGACTI--GG  112 (302)
T ss_pred             HHeEEcceeeccCCeeEEEEEEecCCCCCceeEEEEEecCccCChHHHHHHHHHHHHHHhccCCCCcceEEEEEec--CC
Confidence            56888899999999999999741      35689999987654444556899999999999 79999999999854  46


Q ss_pred             eEEEEEEcCCCCCHHHHhhhcCCCCCCCCHHHHHHHHHHHHHHHhhhhCCCCCCCceeecCCCCCceeecCCCCeEEecc
Q 005586          482 ECFLIYDFAPKGKLSKYLDQEEGSSNVLDWSTRVSIIIGIAKGIGYLHSSEVNKPAIVHRNLSVEKVLIDQQFNPLIADC  561 (689)
Q Consensus       482 ~~~lV~e~~~~gsL~~~L~~~~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~~~ivH~dlk~~NiLl~~~~~~kl~Df  561 (689)
                      ..++||||+++|+|.++++....  ..+++.++..++.|++.||+|||+.+     |+|+||||+|||+++++.+|++||
T Consensus       113 ~~~lv~e~~~~~~L~~~i~~~~~--~~l~~~~~~~i~~~i~~~l~~lH~~~-----ivH~dlkp~Nil~~~~~~~~l~df  185 (302)
T cd05055         113 PILVITEYCCYGDLLNFLRRKRE--SFLTLEDLLSFSYQVAKGMAFLASKN-----CIHRDLAARNVLLTHGKIVKICDF  185 (302)
T ss_pred             ceEEEEEcCCCCcHHHHHHhCCC--CCCCHHHHHHHHHHHHHHHHHHHHCC-----eehhhhccceEEEcCCCeEEECCC
Confidence            78999999999999999976432  23899999999999999999999987     999999999999999999999999


Q ss_pred             cccccccCCcee-eeecCCCCCCCCCccccccCCCCCcccchhHHHHHHHHHh-CCCCcchhHHHHHhhhhhhHhhcccc
Q 005586          562 GLHKLLADDIVF-SVLKTSAAMGYLAPEYVTTGRFTERSDIFAFGVIILQILT-GSLVLTSSMRLAAESATFENFIDRNL  639 (689)
Q Consensus       562 Gla~~~~~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~ksDV~sfGvvl~ellt-G~~p~~~~~~~~~~~~~~~~~~~~~~  639 (689)
                      |+++........ ......++..|+|||.+.+..++.++|||||||++|||+| |+.|+.......    .+.+.++...
T Consensus       186 g~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslGvil~el~t~g~~p~~~~~~~~----~~~~~~~~~~  261 (302)
T cd05055         186 GLARDIMNDSNYVVKGNARLPVKWMAPESIFNCVYTFESDVWSYGILLWEIFSLGSNPYPGMPVDS----KFYKLIKEGY  261 (302)
T ss_pred             cccccccCCCceeecCCCCcccccCCHhhhccCCCCcHhHHHHHHHHHHHHHhCCCCCcCCCCchH----HHHHHHHcCC
Confidence            999866443221 1112234567999999988899999999999999999998 999985432111    1122222222


Q ss_pred             CCCCCHHHHHHHHHHHHHhccCCCCCCCCHHHHHHHHHhh
Q 005586          640 KGKFSESEAAKLGKMALVCTHEDPENRPTMEAVIEELTVA  679 (689)
Q Consensus       640 ~~~~~~~~~~~l~~l~~~Cl~~dp~~RPs~~evl~~L~~~  679 (689)
                      ....+...+.++.+++.+|++.+|++||++.|+++.|+..
T Consensus       262 ~~~~~~~~~~~~~~li~~cl~~~p~~Rpt~~ell~~l~~~  301 (302)
T cd05055         262 RMAQPEHAPAEIYDIMKTCWDADPLKRPTFKQIVQLIGKQ  301 (302)
T ss_pred             cCCCCCCCCHHHHHHHHHHcCCCchhCcCHHHHHHHHHhh
Confidence            2222233456799999999999999999999999999864

Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) subfamily; catalytic (c) domain. The PDGFR subfamily consists of PDGFR alpha, PDGFR beta, KIT, CSF-1R, the mammalian FLT3, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. PDGFR kinase domains are autoinhibited by their juxtamembrane regions containing tyr residues. The binding to their ligands leads to recept

>cd05097 PTKc_DDR_like Catalytic domain of Discoidin Domain Receptor-like Protein Tyrosine Kinases

Probab=100.00  E-value=6e-38  Score=326.78  Aligned_cols=262  Identities=24%  Similarity=0.388  Sum_probs=201.7

Q ss_pred             ccCCcccccccCCcceEEEEEecC---------------CcEEEEEEecccCCchHHHHHHHHHHHHhccCCCcceeEee
Q 005586          409 QCFSEVNLLGKGNFSSVYKGTLRD---------------GTLVAIRSINVTSCKSEEAEFVKGLYLLTSLRHENIIRLRG  473 (689)
Q Consensus       409 ~~f~~~~~lg~G~~g~Vy~~~~~~---------------g~~vavK~l~~~~~~~~~~~f~~e~~~l~~l~H~niv~l~g  473 (689)
                      ++|...+.||+|+||.||++...+               ...||+|.+...........|.+|++++.+++|+|++++++
T Consensus         5 ~~~~~~~~lg~G~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~ei~~l~~l~h~~i~~~~~   84 (295)
T cd05097           5 QQLRLKEKLGEGQFGEVHLCEAEGLAEFLGEGAPEFDGQPVLVAVKMLRADVTKTARNDFLKEIKIMSRLKNPNIIRLLG   84 (295)
T ss_pred             HhCeehhccCCCCCceEEecccccchhhccccCcccCCCceEEEEEecCCCCCHHHHHHHHHHHHHHHhCCCCCcCeEEE
Confidence            467788999999999999987642               23589999876544445568999999999999999999999


Q ss_pred             EEEcCCCCeEEEEEEcCCCCCHHHHhhhcCC--------CCCCCCHHHHHHHHHHHHHHHhhhhCCCCCCCceeecCCCC
Q 005586          474 FCCSRGRGECFLIYDFAPKGKLSKYLDQEEG--------SSNVLDWSTRVSIIIGIAKGIGYLHSSEVNKPAIVHRNLSV  545 (689)
Q Consensus       474 ~~~~~~~~~~~lV~e~~~~gsL~~~L~~~~~--------~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~~~ivH~dlk~  545 (689)
                      ++..  ....++||||+++++|.+++.....        ....++|..++.++.|++.||+|||+.+     ++||||||
T Consensus        85 ~~~~--~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH~~~-----i~H~dlkp  157 (295)
T cd05097          85 VCVS--DDPLCMITEYMENGDLNQFLSQREIESTFTHANNIPSVSIANLLYMAVQIASGMKYLASLN-----FVHRDLAT  157 (295)
T ss_pred             EEcC--CCccEEEEecCCCCcHHHHHHhccccccccccccCCcccHHHHHHHHHHHHHHHHHHHhcC-----eeccccCh
Confidence            9854  5778999999999999999965321        1124789999999999999999999987     99999999


Q ss_pred             CceeecCCCCeEEecccccccccCCceee-eecCCCCCCCCCccccccCCCCCcccchhHHHHHHHHHh--CCCCcchhH
Q 005586          546 EKVLIDQQFNPLIADCGLHKLLADDIVFS-VLKTSAAMGYLAPEYVTTGRFTERSDIFAFGVIILQILT--GSLVLTSSM  622 (689)
Q Consensus       546 ~NiLl~~~~~~kl~DfGla~~~~~~~~~~-~~~~~~~~~y~aPE~~~~~~~~~ksDV~sfGvvl~ellt--G~~p~~~~~  622 (689)
                      +||++++++.+||+|||+++......... .....++..|+|||+..++.++.++|||||||++|||++  |..|+....
T Consensus       158 ~Nill~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwSlG~~l~el~~~~~~~p~~~~~  237 (295)
T cd05097         158 RNCLVGNHYTIKIADFGMSRNLYSGDYYRIQGRAVLPIRWMAWESILLGKFTTASDVWAFGVTLWEMFTLCKEQPYSLLS  237 (295)
T ss_pred             hhEEEcCCCcEEecccccccccccCcceeccCcCcCceeecChhhhccCCcCchhhHHHHHHHHHHHHHcCCCCCCcccC
Confidence            99999999999999999998664432211 112234567999999988899999999999999999998  556665322


Q ss_pred             HHHHhhhhhhHhhcc---ccCCCCCHHHHHHHHHHHHHhccCCCCCCCCHHHHHHHHHh
Q 005586          623 RLAAESATFENFIDR---NLKGKFSESEAAKLGKMALVCTHEDPENRPTMEAVIEELTV  678 (689)
Q Consensus       623 ~~~~~~~~~~~~~~~---~~~~~~~~~~~~~l~~l~~~Cl~~dp~~RPs~~evl~~L~~  678 (689)
                      ..... ....+..+.   ......+...+..+.+++.+||+.||++||+|.+|++.|+.
T Consensus       238 ~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~RPs~~~i~~~l~~  295 (295)
T cd05097         238 DEQVI-ENTGEFFRNQGRQIYLSQTPLCPSPVFKLMMRCWSRDIKDRPTFNKIHHFLRE  295 (295)
T ss_pred             hHHHH-HHHHHhhhhccccccCCCCCCCCHHHHHHHHHHcCCCchhCcCHHHHHHHHhC
Confidence            11110 011111111   11111223345689999999999999999999999999863

Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR)-like proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR-like proteins are members of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linked to a variety of human cancers including

>cd05614 STKc_MSK2_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 2

Probab=100.00  E-value=1.7e-38  Score=336.58  Aligned_cols=255  Identities=18%  Similarity=0.250  Sum_probs=199.0

Q ss_pred             cCCcccccccCCcceEEEEEec----CCcEEEEEEecccCC---chHHHHHHHHHHHHhcc-CCCcceeEeeEEEcCCCC
Q 005586          410 CFSEVNLLGKGNFSSVYKGTLR----DGTLVAIRSINVTSC---KSEEAEFVKGLYLLTSL-RHENIIRLRGFCCSRGRG  481 (689)
Q Consensus       410 ~f~~~~~lg~G~~g~Vy~~~~~----~g~~vavK~l~~~~~---~~~~~~f~~e~~~l~~l-~H~niv~l~g~~~~~~~~  481 (689)
                      +|...+.||+|+||.||+++..    +|+.||+|++.....   ......+..|++++.++ +|+||+++++++.  ..+
T Consensus         1 ~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~i~~~~~~~~--~~~   78 (332)
T cd05614           1 NFELLKVLGTGAYGKVFLVRKVTGHDTGKLYAMKVLQKAALVQKAKTVEHTRTERNVLEHVRQSPFLVTLHYAFQ--TEA   78 (332)
T ss_pred             CceEEEEEeecCCEEEEEEEEcccCCCCCEEEEEEEEHHHHhhhhhHHHHHHHHHHHHHhccCCCCcccEEEEEe--cCC
Confidence            4677899999999999999753    588999999875321   22345688899999999 5999999998874  357


Q ss_pred             eEEEEEEcCCCCCHHHHhhhcCCCCCCCCHHHHHHHHHHHHHHHhhhhCCCCCCCceeecCCCCCceeecCCCCeEEecc
Q 005586          482 ECFLIYDFAPKGKLSKYLDQEEGSSNVLDWSTRVSIIIGIAKGIGYLHSSEVNKPAIVHRNLSVEKVLIDQQFNPLIADC  561 (689)
Q Consensus       482 ~~~lV~e~~~~gsL~~~L~~~~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~~~ivH~dlk~~NiLl~~~~~~kl~Df  561 (689)
                      ..++||||+++|+|.+++....    .+++.....++.|++.||+|||+.+     |+||||||+|||+++++.+||+||
T Consensus        79 ~~~lv~e~~~~g~L~~~l~~~~----~~~~~~~~~~~~qi~~~l~~lH~~~-----ivHrDlkp~Nili~~~~~~kl~Df  149 (332)
T cd05614          79 KLHLILDYVSGGEMFTHLYQRD----NFSEDEVRFYSGEIILALEHLHKLG-----IVYRDIKLENILLDSEGHVVLTDF  149 (332)
T ss_pred             EEEEEEeCCCCCcHHHHHHHcC----CCCHHHHHHHHHHHHHHHHHHHHCC-----cEecCCCHHHeEECCCCCEEEeeC
Confidence            8899999999999999997643    3889999999999999999999987     999999999999999999999999


Q ss_pred             cccccccCCceeeeecCCCCCCCCCccccccC-CCCCcccchhHHHHHHHHHhCCCCcchhHHHHHhhhhhhHhhccccC
Q 005586          562 GLHKLLADDIVFSVLKTSAAMGYLAPEYVTTG-RFTERSDIFAFGVIILQILTGSLVLTSSMRLAAESATFENFIDRNLK  640 (689)
Q Consensus       562 Gla~~~~~~~~~~~~~~~~~~~y~aPE~~~~~-~~~~ksDV~sfGvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~  640 (689)
                      |+++..............||..|+|||++.+. .++.++|||||||++|||+||+.||...............+..  ..
T Consensus       150 G~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~~~~~~~~--~~  227 (332)
T cd05614         150 GLSKEFLSEEKERTYSFCGTIEYMAPEIIRGKGGHGKAVDWWSLGILIFELLTGASPFTLEGERNTQSEVSRRILK--CD  227 (332)
T ss_pred             cCCccccccCCCccccccCCccccCHHHhcCCCCCCCccccccchhhhhhhhcCCCCCCCCCCCCCHHHHHHHHhc--CC
Confidence            99986543322222334578899999998765 4789999999999999999999999532111000001111111  11


Q ss_pred             CCCCHHHHHHHHHHHHHhccCCCCCCC-----CHHHHHHHHH
Q 005586          641 GKFSESEAAKLGKMALVCTHEDPENRP-----TMEAVIEELT  677 (689)
Q Consensus       641 ~~~~~~~~~~l~~l~~~Cl~~dp~~RP-----s~~evl~~L~  677 (689)
                      ..++......+.+++.+|++.||++||     ++++++++.+
T Consensus       228 ~~~~~~~~~~~~~li~~~l~~dp~~R~~~~~~~~~~~l~h~~  269 (332)
T cd05614         228 PPFPSFIGPEAQDLLHKLLRKDPKKRLGAGPQGASEIKEHPF  269 (332)
T ss_pred             CCCCCCCCHHHHHHHHHHcCCCHHHcCCCCCCCHHHHHcCCC
Confidence            223334566788999999999999999     7889987754

Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK2, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydroph

>cd05051 PTKc_DDR Catalytic domain of the Protein Tyrosine Kinases, Discoidin Domain Receptors

Probab=100.00  E-value=6.3e-38  Score=326.65  Aligned_cols=262  Identities=26%  Similarity=0.418  Sum_probs=204.4

Q ss_pred             hccCCcccccccCCcceEEEEEecC-----------------CcEEEEEEecccCCchHHHHHHHHHHHHhccCCCccee
Q 005586          408 TQCFSEVNLLGKGNFSSVYKGTLRD-----------------GTLVAIRSINVTSCKSEEAEFVKGLYLLTSLRHENIIR  470 (689)
Q Consensus       408 t~~f~~~~~lg~G~~g~Vy~~~~~~-----------------g~~vavK~l~~~~~~~~~~~f~~e~~~l~~l~H~niv~  470 (689)
                      .++|...+.||+|+||.||+|...+                 +..||+|.+..........+|.+|++++++++||||++
T Consensus         4 ~~~~~~~~~lg~G~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~~~va~K~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~   83 (296)
T cd05051           4 RQPLNFVEKLGEGQFGEVHLCEADGLQDFSEKAFAENDNADAPVLVAVKVLRPDASDNAREDFLKEVKILSRLSDPNIAR   83 (296)
T ss_pred             hhhCcccccccCCCCccEEEEEeccCCcccccccccccccCCceeEEEEEecCccCHHHHHHHHHHHHHHHhcCCCCEeE
Confidence            3567788999999999999998642                 35689999987654555678999999999999999999


Q ss_pred             EeeEEEcCCCCeEEEEEEcCCCCCHHHHhhhcCCC-------CCCCCHHHHHHHHHHHHHHHhhhhCCCCCCCceeecCC
Q 005586          471 LRGFCCSRGRGECFLIYDFAPKGKLSKYLDQEEGS-------SNVLDWSTRVSIIIGIAKGIGYLHSSEVNKPAIVHRNL  543 (689)
Q Consensus       471 l~g~~~~~~~~~~~lV~e~~~~gsL~~~L~~~~~~-------~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~~~ivH~dl  543 (689)
                      +++++..  .+..++|+||+++++|.+++......       ...+++..++.++.|++.||+|||+.+     |+||||
T Consensus        84 ~~~~~~~--~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~al~~LH~~~-----i~H~dl  156 (296)
T cd05051          84 LLGVCTV--DPPLCMIMEYMENGDLNQFLQKHVAETSGLACNSKSLSFSTLLYMATQIASGMRYLESLN-----FVHRDL  156 (296)
T ss_pred             EEEEEec--CCCcEEEEecCCCCCHHHHHHhcccccccccccCCCCCHHHHHHHHHHHHHHHHHHHHcC-----cccccc
Confidence            9999854  46789999999999999999765421       125899999999999999999999987     999999


Q ss_pred             CCCceeecCCCCeEEecccccccccCCceee-eecCCCCCCCCCccccccCCCCCcccchhHHHHHHHHHh--CCCCcch
Q 005586          544 SVEKVLIDQQFNPLIADCGLHKLLADDIVFS-VLKTSAAMGYLAPEYVTTGRFTERSDIFAFGVIILQILT--GSLVLTS  620 (689)
Q Consensus       544 k~~NiLl~~~~~~kl~DfGla~~~~~~~~~~-~~~~~~~~~y~aPE~~~~~~~~~ksDV~sfGvvl~ellt--G~~p~~~  620 (689)
                      ||+||++++++.+||+|||+++......... .....++..|+|||++.+..++.++|||||||++|||++  |..|+..
T Consensus       157 kp~Nili~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~~~~~~~p~~~  236 (296)
T cd05051         157 ATRNCLVGKNYTIKIADFGMSRNLYSSDYYRVQGRAPLPIRWMAWESVLLGKFTTKSDVWAFGVTLWEILTLCREQPYEH  236 (296)
T ss_pred             chhceeecCCCceEEccccceeecccCcceeecCcCCCCceecCHHHhhcCCCCccchhhhhHHHHHHHHhcCCCCCCCC
Confidence            9999999999999999999998664432221 122334668999999988889999999999999999998  6677754


Q ss_pred             hHHHHHhhhhhhHhh---ccccCCCCCHHHHHHHHHHHHHhccCCCCCCCCHHHHHHHHH
Q 005586          621 SMRLAAESATFENFI---DRNLKGKFSESEAAKLGKMALVCTHEDPENRPTMEAVIEELT  677 (689)
Q Consensus       621 ~~~~~~~~~~~~~~~---~~~~~~~~~~~~~~~l~~l~~~Cl~~dp~~RPs~~evl~~L~  677 (689)
                      ......... .....   ........+...+.++.+++.+|++.||++||++.||++.|+
T Consensus       237 ~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~Rpt~~el~~~L~  295 (296)
T cd05051         237 LTDQQVIEN-AGHFFRDDGRQIYLPRPPNCPKDIYELMLECWRRDEEDRPTFREIHLFLQ  295 (296)
T ss_pred             cChHHHHHH-HHhccccccccccCCCccCCCHHHHHHHHHHhccChhcCCCHHHHHHHhc
Confidence            321111110 01110   001111122334568999999999999999999999999886

Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR) subfamily; catalytic (c) domain. The DDR subfamily consists of homologs of mammalian DDR1, DDR2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR subfamily members are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linke

>cd05605 STKc_GRK4_like Catalytic domain of G protein-coupled Receptor Kinase 4-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=3.4e-38  Score=326.88  Aligned_cols=257  Identities=21%  Similarity=0.283  Sum_probs=204.8

Q ss_pred             cCCcccccccCCcceEEEEEec-CCcEEEEEEecccCCc--hHHHHHHHHHHHHhccCCCcceeEeeEEEcCCCCeEEEE
Q 005586          410 CFSEVNLLGKGNFSSVYKGTLR-DGTLVAIRSINVTSCK--SEEAEFVKGLYLLTSLRHENIIRLRGFCCSRGRGECFLI  486 (689)
Q Consensus       410 ~f~~~~~lg~G~~g~Vy~~~~~-~g~~vavK~l~~~~~~--~~~~~f~~e~~~l~~l~H~niv~l~g~~~~~~~~~~~lV  486 (689)
                      .|+..+.||+|+||.||++... +++.||+|++......  .....+.+|++++++++||||+++++.+.  ..+..++|
T Consensus         1 ~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~--~~~~~~lv   78 (285)
T cd05605           1 TFRHYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKQILEKVNSRFVVSLAYAYE--TKDALCLV   78 (285)
T ss_pred             CceEEEEEecCCCeEEEEEEEcCCCceEEEEEEehhhhhhhhhHHHHHHHHHHHHhcCCCCEeeeeeeec--CCCeEEEE
Confidence            3667889999999999999875 6899999999754322  22356788999999999999999999884  34689999


Q ss_pred             EEcCCCCCHHHHhhhcCCCCCCCCHHHHHHHHHHHHHHHhhhhCCCCCCCceeecCCCCCceeecCCCCeEEeccccccc
Q 005586          487 YDFAPKGKLSKYLDQEEGSSNVLDWSTRVSIIIGIAKGIGYLHSSEVNKPAIVHRNLSVEKVLIDQQFNPLIADCGLHKL  566 (689)
Q Consensus       487 ~e~~~~gsL~~~L~~~~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~~~ivH~dlk~~NiLl~~~~~~kl~DfGla~~  566 (689)
                      |||+++|+|.+++....  ...+++..+..++.|++.||+|||+.+     |+||||||+||++++++.++|+|||+++.
T Consensus        79 ~e~~~~~~L~~~~~~~~--~~~~~~~~~~~~~~qi~~~l~~lH~~~-----ivH~dlkp~Nil~~~~~~~~l~Dfg~~~~  151 (285)
T cd05605          79 LTLMNGGDLKFHIYNMG--NPGFDEERAVFYAAEITCGLEDLHRER-----IVYRDLKPENILLDDYGHIRISDLGLAVE  151 (285)
T ss_pred             EeccCCCcHHHHHHhcC--cCCCCHHHHHHHHHHHHHHHHHHHHCC-----cEecCCCHHHEEECCCCCEEEeeCCCcee
Confidence            99999999999886542  234899999999999999999999987     99999999999999999999999999987


Q ss_pred             ccCCceeeeecCCCCCCCCCccccccCCCCCcccchhHHHHHHHHHhCCCCcchhHHHHHhhhhhhHhhccccCCCCCHH
Q 005586          567 LADDIVFSVLKTSAAMGYLAPEYVTTGRFTERSDIFAFGVIILQILTGSLVLTSSMRLAAESATFENFIDRNLKGKFSES  646 (689)
Q Consensus       567 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~ksDV~sfGvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  646 (689)
                      ......  .....++..|+|||++.+..++.++|||||||++|||++|+.||......... ..+...+.. ....++..
T Consensus       152 ~~~~~~--~~~~~~~~~y~aPE~~~~~~~~~~~Diws~G~~l~el~~g~~pf~~~~~~~~~-~~~~~~~~~-~~~~~~~~  227 (285)
T cd05605         152 IPEGET--IRGRVGTVGYMAPEVVKNERYTFSPDWWGLGCLIYEMIEGKSPFRQRKEKVKR-EEVERRVKE-DQEEYSEK  227 (285)
T ss_pred             cCCCCc--cccccCCCCccCcHHhcCCCCCccccchhHHHHHHHHHHCCCCCCCCchhhHH-HHHHHHhhh-cccccCcc
Confidence            643322  12335788899999998888999999999999999999999999653221111 111111111 12234445


Q ss_pred             HHHHHHHHHHHhccCCCCCCC-----CHHHHHHHHHhh
Q 005586          647 EAAKLGKMALVCTHEDPENRP-----TMEAVIEELTVA  679 (689)
Q Consensus       647 ~~~~l~~l~~~Cl~~dp~~RP-----s~~evl~~L~~~  679 (689)
                      .+..+.+++..|++.||++||     ++.+++++.+..
T Consensus       228 ~~~~~~~li~~~l~~~P~~R~~~~~~~~~~l~~~~~~~  265 (285)
T cd05605         228 FSEAARSICRQLLTKDPGFRLGCRGEGAEEVKAHPFFR  265 (285)
T ss_pred             cCHHHHHHHHHHccCCHHHhcCCCCCCHHHHhcCcCcc
Confidence            567789999999999999999     888998775443

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4-like group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. Members of the GRK4-like group include GRK4, GRK5,

>cd05596 STKc_ROCK Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase

Probab=100.00  E-value=1.3e-38  Score=342.03  Aligned_cols=255  Identities=14%  Similarity=0.254  Sum_probs=203.3

Q ss_pred             HhccCCcccccccCCcceEEEEEec-CCcEEEEEEecccCC--chHHHHHHHHHHHHhccCCCcceeEeeEEEcCCCCeE
Q 005586          407 ATQCFSEVNLLGKGNFSSVYKGTLR-DGTLVAIRSINVTSC--KSEEAEFVKGLYLLTSLRHENIIRLRGFCCSRGRGEC  483 (689)
Q Consensus       407 at~~f~~~~~lg~G~~g~Vy~~~~~-~g~~vavK~l~~~~~--~~~~~~f~~e~~~l~~l~H~niv~l~g~~~~~~~~~~  483 (689)
                      ..++|...+.||+|+||.||+|+.+ ++..||+|++.....  ......|.+|+.+++.++||||+++++++.  .....
T Consensus        41 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~il~~~~h~~iv~~~~~~~--~~~~~  118 (370)
T cd05596          41 KAEDFDVIKVIGRGAFGEVQLVRHKSSKQVYAMKLLSKFEMIKRSDSAFFWEERDIMAHANSEWIVQLHYAFQ--DDKYL  118 (370)
T ss_pred             CHHHcEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhhHHHHHHHHHHHHhCCCCCcceEEEEEe--cCCEE
Confidence            4567888999999999999999976 689999999965321  223456789999999999999999998884  45789


Q ss_pred             EEEEEcCCCCCHHHHhhhcCCCCCCCCHHHHHHHHHHHHHHHhhhhCCCCCCCceeecCCCCCceeecCCCCeEEecccc
Q 005586          484 FLIYDFAPKGKLSKYLDQEEGSSNVLDWSTRVSIIIGIAKGIGYLHSSEVNKPAIVHRNLSVEKVLIDQQFNPLIADCGL  563 (689)
Q Consensus       484 ~lV~e~~~~gsL~~~L~~~~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~~~ivH~dlk~~NiLl~~~~~~kl~DfGl  563 (689)
                      ++||||+++|+|.+++...     .++......++.|++.||+|||+.+     |+||||||+|||+++++.+||+|||+
T Consensus       119 ~lv~Ey~~gg~L~~~l~~~-----~l~~~~~~~~~~qi~~aL~~LH~~~-----ivHrDLkp~NILl~~~~~~kL~DfG~  188 (370)
T cd05596         119 YMVMEYMPGGDLVNLMSNY-----DIPEKWARFYTAEVVLALDAIHSMG-----FIHRDVKPDNMLLDKSGHLKLADFGT  188 (370)
T ss_pred             EEEEcCCCCCcHHHHHHhc-----CCCHHHHHHHHHHHHHHHHHHHHCC-----eeccCCCHHHEEEcCCCCEEEEeccc
Confidence            9999999999999998753     2777888899999999999999987     99999999999999999999999999


Q ss_pred             cccccCCceeeeecCCCCCCCCCccccccC----CCCCcccchhHHHHHHHHHhCCCCcchhHHHHHhhhhhhHhhcccc
Q 005586          564 HKLLADDIVFSVLKTSAAMGYLAPEYVTTG----RFTERSDIFAFGVIILQILTGSLVLTSSMRLAAESATFENFIDRNL  639 (689)
Q Consensus       564 a~~~~~~~~~~~~~~~~~~~y~aPE~~~~~----~~~~ksDV~sfGvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~  639 (689)
                      ++..............||+.|+|||++.+.    .++.++|||||||++|||+||+.||.......    .+..+.+...
T Consensus       189 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~DiwSlGvilyelltG~~Pf~~~~~~~----~~~~i~~~~~  264 (370)
T cd05596         189 CMKMDANGMVRCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGDTPFYADSLVG----TYSKIMDHKN  264 (370)
T ss_pred             eeeccCCCcccCCCCCCCcCeECHHHhccCCCCCCCCCceeeeehhHHHHHHHhCCCCcCCCCHHH----HHHHHHcCCC
Confidence            987654332222334688899999998653    47899999999999999999999997543221    1222222211


Q ss_pred             CCCCCH--HHHHHHHHHHHHhccCCCCC--CCCHHHHHHHHH
Q 005586          640 KGKFSE--SEAAKLGKMALVCTHEDPEN--RPTMEAVIEELT  677 (689)
Q Consensus       640 ~~~~~~--~~~~~l~~l~~~Cl~~dp~~--RPs~~evl~~L~  677 (689)
                      ...++.  ..+.++.+++..|++.+|++  ||++.|++++.+
T Consensus       265 ~~~~~~~~~~s~~~~~li~~~L~~~p~r~~R~s~~ell~h~~  306 (370)
T cd05596         265 SLTFPDDIEISKQAKDLICAFLTDREVRLGRNGVDEIKSHPF  306 (370)
T ss_pred             cCCCCCcCCCCHHHHHHHHHHccChhhccCCCCHHHHhcCcc
Confidence            111222  34678899999999999988  999999988754

Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK is also referred to as Rho-associated kinase or simply as Rho kinase. It contains an N-terminal extension, a catalytic kinase domain, and a long C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain. It is activated via in

>cd05058 PTKc_Met_Ron Catalytic domain of the Protein Tyrosine Kinases, Met and Ron

Probab=100.00  E-value=9e-38  Score=319.39  Aligned_cols=251  Identities=25%  Similarity=0.462  Sum_probs=195.3

Q ss_pred             cccccCCcceEEEEEec----CCcEEEEEEecccCCchHHHHHHHHHHHHhccCCCcceeEeeEEEcCCCCeEEEEEEcC
Q 005586          415 NLLGKGNFSSVYKGTLR----DGTLVAIRSINVTSCKSEEAEFVKGLYLLTSLRHENIIRLRGFCCSRGRGECFLIYDFA  490 (689)
Q Consensus       415 ~~lg~G~~g~Vy~~~~~----~g~~vavK~l~~~~~~~~~~~f~~e~~~l~~l~H~niv~l~g~~~~~~~~~~~lV~e~~  490 (689)
                      +.||+|+||.||+|.+.    ++..||+|++...........|.+|+.+++.++||||+++++++... .+..++|+||+
T Consensus         1 ~~lg~g~~g~v~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~-~~~~~lv~e~~   79 (262)
T cd05058           1 RVIGKGHFGCVYHGTLIDSDGQKIHCAVKSLNRITDLEEVEQFLKEGIIMKDFSHPNVLSLLGICLPS-EGSPLVVLPYM   79 (262)
T ss_pred             CcccccCCceEEEEEEecCCCceEEEEEEecCccCCHHHHHHHHHHHHHHccCCCCCcceEEEEeecC-CCCcEEEEecC
Confidence            46899999999999864    24679999986544344567899999999999999999999987543 34578999999


Q ss_pred             CCCCHHHHhhhcCCCCCCCCHHHHHHHHHHHHHHHhhhhCCCCCCCceeecCCCCCceeecCCCCeEEecccccccccCC
Q 005586          491 PKGKLSKYLDQEEGSSNVLDWSTRVSIIIGIAKGIGYLHSSEVNKPAIVHRNLSVEKVLIDQQFNPLIADCGLHKLLADD  570 (689)
Q Consensus       491 ~~gsL~~~L~~~~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~~~ivH~dlk~~NiLl~~~~~~kl~DfGla~~~~~~  570 (689)
                      ++|+|.+++.....   .+++..++.++.|+++||+|||+.+     ++||||||+|||+++++.+||+|||+++.+...
T Consensus        80 ~~~~L~~~~~~~~~---~~~~~~~~~~~~~i~~~l~~lH~~~-----i~H~dlk~~nili~~~~~~kl~dfg~~~~~~~~  151 (262)
T cd05058          80 KHGDLRNFIRSETH---NPTVKDLIGFGLQVAKGMEYLASKK-----FVHRDLAARNCMLDESFTVKVADFGLARDIYDK  151 (262)
T ss_pred             CCCCHHHHHHhcCC---CCCHHHHHHHHHHHHHHHHHHHhCC-----ccccccCcceEEEcCCCcEEECCccccccccCC
Confidence            99999999976432   3678888999999999999999887     999999999999999999999999999865433


Q ss_pred             ceee---eecCCCCCCCCCccccccCCCCCcccchhHHHHHHHHHhCC-CCcchhHHHHHhhhhhhHhhccccCCCCCHH
Q 005586          571 IVFS---VLKTSAAMGYLAPEYVTTGRFTERSDIFAFGVIILQILTGS-LVLTSSMRLAAESATFENFIDRNLKGKFSES  646 (689)
Q Consensus       571 ~~~~---~~~~~~~~~y~aPE~~~~~~~~~ksDV~sfGvvl~elltG~-~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  646 (689)
                      ....   .....++..|+|||++.+..++.++|||||||++|||++|+ .|+.......     ....+........+..
T Consensus       152 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~~~~~~~~~~~~~-----~~~~~~~~~~~~~~~~  226 (262)
T cd05058         152 EYYSVHNHTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVDSFD-----ITVYLLQGRRLLQPEY  226 (262)
T ss_pred             cceeecccccCcCCccccChhHhccCccchHHHHHHHHHHHHHHHcCCCCCCCCCCHHH-----HHHHHhcCCCCCCCCc
Confidence            2111   11233456799999998889999999999999999999964 4554321111     1111111111122233


Q ss_pred             HHHHHHHHHHHhccCCCCCCCCHHHHHHHHHhh
Q 005586          647 EAAKLGKMALVCTHEDPENRPTMEAVIEELTVA  679 (689)
Q Consensus       647 ~~~~l~~l~~~Cl~~dp~~RPs~~evl~~L~~~  679 (689)
                      .+..+.+++..||+.+|++||++.||+++|+.+
T Consensus       227 ~~~~~~~li~~cl~~~p~~Rp~~~~il~~l~~~  259 (262)
T cd05058         227 CPDPLYEVMLSCWHPKPEMRPTFSELVSRIEQI  259 (262)
T ss_pred             CCHHHHHHHHHHcCCChhhCCCHHHHHHHHHHH
Confidence            456799999999999999999999999999865

Protein Tyrosine Kinase (PTK) family; Met and Ron; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Met and Ron are receptor tyr kinases (RTKs) composed of an alpha-beta heterodimer. The extracellular alpha chain is disulfide linked to the beta chain, which contains an extracellular ligand-binding region with a sema domain, a PSI domain and four IPT repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Met binds to the ligand, hepatocyte growth factor/scatter factor (HGF/SF), and is also ca

>cd05047 PTKc_Tie Catalytic domain of Tie Protein Tyrosine Kinases

Probab=100.00  E-value=8.8e-38  Score=321.17  Aligned_cols=251  Identities=23%  Similarity=0.442  Sum_probs=197.0

Q ss_pred             cccccCCcceEEEEEecC-Cc--EEEEEEecccCCchHHHHHHHHHHHHhcc-CCCcceeEeeEEEcCCCCeEEEEEEcC
Q 005586          415 NLLGKGNFSSVYKGTLRD-GT--LVAIRSINVTSCKSEEAEFVKGLYLLTSL-RHENIIRLRGFCCSRGRGECFLIYDFA  490 (689)
Q Consensus       415 ~~lg~G~~g~Vy~~~~~~-g~--~vavK~l~~~~~~~~~~~f~~e~~~l~~l-~H~niv~l~g~~~~~~~~~~~lV~e~~  490 (689)
                      +.||+|+||.||+|.+++ |.  .+++|.++..........|.+|++++.++ +||||+++++++..  .+..++||||+
T Consensus         1 ~~lg~g~~g~v~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~--~~~~~lv~e~~   78 (270)
T cd05047           1 DVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIINLLGACEH--RGYLYLAIEYA   78 (270)
T ss_pred             CcCCCCCCceEEEEEEcCCCCeeEEEEEEccccCCHHHHHHHHHHHHHHHhhccCCCeeeEEEEEec--CCCceEEEEeC
Confidence            369999999999999863 43  57888887554445556899999999999 89999999999854  46789999999


Q ss_pred             CCCCHHHHhhhcCC------------CCCCCCHHHHHHHHHHHHHHHhhhhCCCCCCCceeecCCCCCceeecCCCCeEE
Q 005586          491 PKGKLSKYLDQEEG------------SSNVLDWSTRVSIIIGIAKGIGYLHSSEVNKPAIVHRNLSVEKVLIDQQFNPLI  558 (689)
Q Consensus       491 ~~gsL~~~L~~~~~------------~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~~~ivH~dlk~~NiLl~~~~~~kl  558 (689)
                      ++|+|.++++....            ....+++.+++.++.|++.||+|||+.+     ++||||||+||++++++.+||
T Consensus        79 ~~~~L~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~al~~lH~~~-----i~H~dikp~nili~~~~~~kl  153 (270)
T cd05047          79 PHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQKQ-----FIHRDLAARNILVGENYVAKI  153 (270)
T ss_pred             CCCcHHHHHHhccccccccccccccCCcCCCCHHHHHHHHHHHHHHHHHHHHCC-----EeecccccceEEEcCCCeEEE
Confidence            99999999976431            1234889999999999999999999887     999999999999999999999


Q ss_pred             ecccccccccCCceeeeecCCCCCCCCCccccccCCCCCcccchhHHHHHHHHHh-CCCCcchhHHHHHhhhhhhHhhcc
Q 005586          559 ADCGLHKLLADDIVFSVLKTSAAMGYLAPEYVTTGRFTERSDIFAFGVIILQILT-GSLVLTSSMRLAAESATFENFIDR  637 (689)
Q Consensus       559 ~DfGla~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~ksDV~sfGvvl~ellt-G~~p~~~~~~~~~~~~~~~~~~~~  637 (689)
                      +|||+++......  .......+..|+|||++....++.++|||||||++|||+| |+.||.......     ..+.+..
T Consensus       154 ~dfgl~~~~~~~~--~~~~~~~~~~y~apE~~~~~~~~~~~Di~slG~il~el~~~g~~pf~~~~~~~-----~~~~~~~  226 (270)
T cd05047         154 ADFGLSRGQEVYV--KKTMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPYCGMTCAE-----LYEKLPQ  226 (270)
T ss_pred             CCCCCccccchhh--hccCCCCccccCChHHHccCCCCchhhHHHHHHHHHHHHcCCCCCccccCHHH-----HHHHHhC
Confidence            9999986432111  1111223567999999988889999999999999999997 999985432111     1111122


Q ss_pred             ccCCCCCHHHHHHHHHHHHHhccCCCCCCCCHHHHHHHHHhh
Q 005586          638 NLKGKFSESEAAKLGKMALVCTHEDPENRPTMEAVIEELTVA  679 (689)
Q Consensus       638 ~~~~~~~~~~~~~l~~l~~~Cl~~dp~~RPs~~evl~~L~~~  679 (689)
                      ......+.....++.+++.+||+.+|.+||++.|+++.|..+
T Consensus       227 ~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~~l~~~  268 (270)
T cd05047         227 GYRLEKPLNCDDEVYDLMRQCWREKPYERPSFAQILVSLNRM  268 (270)
T ss_pred             CCCCCCCCcCCHHHHHHHHHHcccChhhCCCHHHHHHHHHHh
Confidence            222222333456789999999999999999999999999764

Protein Tyrosine Kinase (PTK) family; Tie subfamily; catalytic (c) domain. The Tie subfamily consists of Tie1 and Tie2. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie proteins are receptor tyr kinases (RTKs) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2, while no specific l

>cd05607 STKc_GRK7 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 7

Probab=100.00  E-value=5.9e-38  Score=323.73  Aligned_cols=248  Identities=22%  Similarity=0.278  Sum_probs=193.9

Q ss_pred             cccCCcceEEEEEec-CCcEEEEEEecccCC--chHHHHHHHHHHHHhccCCCcceeEeeEEEcCCCCeEEEEEEcCCCC
Q 005586          417 LGKGNFSSVYKGTLR-DGTLVAIRSINVTSC--KSEEAEFVKGLYLLTSLRHENIIRLRGFCCSRGRGECFLIYDFAPKG  493 (689)
Q Consensus       417 lg~G~~g~Vy~~~~~-~g~~vavK~l~~~~~--~~~~~~f~~e~~~l~~l~H~niv~l~g~~~~~~~~~~~lV~e~~~~g  493 (689)
                      ||+|+||.||+++.+ +|+.||+|++.....  ......+..|++++.+++||||+++.+++.  .....++||||+++|
T Consensus         1 lg~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~E~~il~~l~hp~i~~~~~~~~--~~~~~~lv~e~~~g~   78 (277)
T cd05607           1 LGKGGFGEVCAVQVKNTGKMYACKKLDKKRLKKKSGEKMALLEKEILEKVNSPFIVNLAYAFE--SKTHLCLVMSLMNGG   78 (277)
T ss_pred             CCCCCceEEEEEEEccCCcEEEEEEEcHHHhhcchhhHHHHHHHHHHHhcCCCcEEEEEEEEe--cCCeEEEEEecCCCC
Confidence            799999999999875 699999999975332  223445677999999999999999999884  357899999999999


Q ss_pred             CHHHHhhhcCCCCCCCCHHHHHHHHHHHHHHHhhhhCCCCCCCceeecCCCCCceeecCCCCeEEecccccccccCCcee
Q 005586          494 KLSKYLDQEEGSSNVLDWSTRVSIIIGIAKGIGYLHSSEVNKPAIVHRNLSVEKVLIDQQFNPLIADCGLHKLLADDIVF  573 (689)
Q Consensus       494 sL~~~L~~~~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~~~ivH~dlk~~NiLl~~~~~~kl~DfGla~~~~~~~~~  573 (689)
                      +|.+++.....  ..+++..+..++.|++.||+|||+.+     |+||||||+||++++++.+||+|||++........ 
T Consensus        79 ~L~~~~~~~~~--~~~~~~~~~~~~~qi~~al~~lH~~~-----ivH~dikp~Nili~~~~~~~l~Dfg~~~~~~~~~~-  150 (277)
T cd05607          79 DLKYHIYNVGE--RGLEMERVIHYSAQITCGILHLHSMD-----IVYRDMKPENVLLDDQGNCRLSDLGLAVELKDGKT-  150 (277)
T ss_pred             CHHHHHHhccc--cCCCHHHHHHHHHHHHHHHHHHHHCC-----EEEccCChHhEEEcCCCCEEEeeceeeeecCCCce-
Confidence            99998865432  34889999999999999999999987     99999999999999999999999999987654322 


Q ss_pred             eeecCCCCCCCCCccccccCCCCCcccchhHHHHHHHHHhCCCCcchhHHHHHhhhhhhHhhccccCCCCCHHHHHHHHH
Q 005586          574 SVLKTSAAMGYLAPEYVTTGRFTERSDIFAFGVIILQILTGSLVLTSSMRLAAESATFENFIDRNLKGKFSESEAAKLGK  653 (689)
Q Consensus       574 ~~~~~~~~~~y~aPE~~~~~~~~~ksDV~sfGvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~  653 (689)
                       .....++..|+|||++.+..++.++||||+||++|||++|+.|+....................... .......++.+
T Consensus       151 -~~~~~~~~~y~aPE~~~~~~~~~~~DvwslGv~l~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~  228 (277)
T cd05607         151 -ITQRAGTNGYMAPEILKEEPYSYPVDWFAMGCSIYEMVAGRTPFKDHKEKVAKEELKRRTLEDEVKF-EHQNFTEESKD  228 (277)
T ss_pred             -eeccCCCCCccCHHHHccCCCCCchhHHHHHHHHHHHHhCCCCCCCCcchhhHHHHHHHhhcccccc-ccccCCHHHHH
Confidence             2234578899999999988899999999999999999999999864321111111111111111110 11234567899


Q ss_pred             HHHHhccCCCCCCCCHHHHHHHH
Q 005586          654 MALVCTHEDPENRPTMEAVIEEL  676 (689)
Q Consensus       654 l~~~Cl~~dp~~RPs~~evl~~L  676 (689)
                      ++..|++.||++||+++|+++++
T Consensus       229 li~~~L~~~P~~R~~~~~~~~~~  251 (277)
T cd05607         229 ICRLFLAKKPEDRLGSREKNDDP  251 (277)
T ss_pred             HHHHHhccCHhhCCCCccchhhh
Confidence            99999999999999996655433

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK7 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK7, also called iodopsin kinase, belongs to the visual gr

>cd05095 PTKc_DDR2 Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 2

Probab=100.00  E-value=8.9e-38  Score=325.64  Aligned_cols=262  Identities=24%  Similarity=0.403  Sum_probs=203.1

Q ss_pred             ccCCcccccccCCcceEEEEEec-----------------CCcEEEEEEecccCCchHHHHHHHHHHHHhccCCCcceeE
Q 005586          409 QCFSEVNLLGKGNFSSVYKGTLR-----------------DGTLVAIRSINVTSCKSEEAEFVKGLYLLTSLRHENIIRL  471 (689)
Q Consensus       409 ~~f~~~~~lg~G~~g~Vy~~~~~-----------------~g~~vavK~l~~~~~~~~~~~f~~e~~~l~~l~H~niv~l  471 (689)
                      ++|+..+.||+|+||.||++...                 ++..||+|++..........+|.+|++++.+++|+||+++
T Consensus         5 ~~~~~~~~lg~G~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~~~   84 (296)
T cd05095           5 KRLTFKEKLGEGQFGEVHLCEAEGMEKFMDKDFSLDVSGNQPVLVAVKMLREDANKNARNDFLKEIKIMSRLKDPNIIRL   84 (296)
T ss_pred             hhceeeeeccCCCCCeEEecccccccccccccccccCCCCceeEEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCcceE
Confidence            46788899999999999998532                 2457999999865444556789999999999999999999


Q ss_pred             eeEEEcCCCCeEEEEEEcCCCCCHHHHhhhcCCC-------CCCCCHHHHHHHHHHHHHHHhhhhCCCCCCCceeecCCC
Q 005586          472 RGFCCSRGRGECFLIYDFAPKGKLSKYLDQEEGS-------SNVLDWSTRVSIIIGIAKGIGYLHSSEVNKPAIVHRNLS  544 (689)
Q Consensus       472 ~g~~~~~~~~~~~lV~e~~~~gsL~~~L~~~~~~-------~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~~~ivH~dlk  544 (689)
                      ++++..  .+..++||||+++|+|.+++......       ...+++.+...++.|++.||+|||+.+     |+|||||
T Consensus        85 ~~~~~~--~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~al~~lH~~~-----i~H~dlk  157 (296)
T cd05095          85 LAVCIT--SDPLCMITEYMENGDLNQFLSRHEPQEAAEKADVVTISYSTLIFMATQIASGMKYLSSLN-----FVHRDLA  157 (296)
T ss_pred             EEEEec--CCccEEEEEeCCCCcHHHHHHhcCcccccccccccccCHHHHHHHHHHHHHHHHHHHHCC-----eecccCC
Confidence            999854  46789999999999999999764321       124788999999999999999999987     9999999


Q ss_pred             CCceeecCCCCeEEecccccccccCCceeee-ecCCCCCCCCCccccccCCCCCcccchhHHHHHHHHHh--CCCCcchh
Q 005586          545 VEKVLIDQQFNPLIADCGLHKLLADDIVFSV-LKTSAAMGYLAPEYVTTGRFTERSDIFAFGVIILQILT--GSLVLTSS  621 (689)
Q Consensus       545 ~~NiLl~~~~~~kl~DfGla~~~~~~~~~~~-~~~~~~~~y~aPE~~~~~~~~~ksDV~sfGvvl~ellt--G~~p~~~~  621 (689)
                      |+|||+++++.+||+|||+++.+........ .....+..|+|||...++.++.++|||||||++|||+|  |..|+...
T Consensus       158 p~Nili~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~DiwSlG~~l~el~~~~~~~p~~~~  237 (296)
T cd05095         158 TRNCLVGKNYTIKIADFGMSRNLYSGDYYRIQGRAVLPIRWMSWESILLGKFTTASDVWAFGVTLWEILTLCKEQPYSQL  237 (296)
T ss_pred             hheEEEcCCCCEEeccCcccccccCCcceeccCcCcCccccCCHHHHhcCCccchhhhhHHHHHHHHHHHhCCCCCcccc
Confidence            9999999999999999999987644322111 11233567999999888889999999999999999998  66777533


Q ss_pred             HHHHHhhhhhhHhhccc---cCCCCCHHHHHHHHHHHHHhccCCCCCCCCHHHHHHHHHh
Q 005586          622 MRLAAESATFENFIDRN---LKGKFSESEAAKLGKMALVCTHEDPENRPTMEAVIEELTV  678 (689)
Q Consensus       622 ~~~~~~~~~~~~~~~~~---~~~~~~~~~~~~l~~l~~~Cl~~dp~~RPs~~evl~~L~~  678 (689)
                      ....... ...+.....   .....+..++..+.+++.+||+.||++||+|.||++.|+.
T Consensus       238 ~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rp~~~~i~~~l~~  296 (296)
T cd05095         238 SDEQVIE-NTGEFFRDQGRQVYLPKPALCPDSLYKLMLSCWRRNAKERPSFQEIHATLLE  296 (296)
T ss_pred             ChHHHHH-HHHHHHhhccccccCCCCCCCCHHHHHHHHHHcCCCcccCCCHHHHHHHHhC
Confidence            2111111 111111111   1111223455789999999999999999999999998863

Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 2 (DDR2) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR2 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR2 binds mostly to fibrillar collagens. More recently, it has been reported to also bind collagen X. DDR2 is widely expressed in many tissues wit

>KOG1024 consensus Receptor-like protein tyrosine kinase RYK/derailed [Signal transduction mechanisms]

Probab=100.00  E-value=2e-38  Score=313.99  Aligned_cols=270  Identities=18%  Similarity=0.315  Sum_probs=226.9

Q ss_pred             cCHHHHHHHhccCCcccccccCCcceEEEEEecC------CcEEEEEEecccCCchHHHHHHHHHHHHhccCCCcceeEe
Q 005586          399 LNLEEVESATQCFSEVNLLGKGNFSSVYKGTLRD------GTLVAIRSINVTSCKSEEAEFVKGLYLLTSLRHENIIRLR  472 (689)
Q Consensus       399 ~~~~~l~~at~~f~~~~~lg~G~~g~Vy~~~~~~------g~~vavK~l~~~~~~~~~~~f~~e~~~l~~l~H~niv~l~  472 (689)
                      -...++.....+++...++.+|.||.||+|.|++      .+.|-+|.++....+.....|..|...+..+.|||+.++.
T Consensus       274 ~r~~~l~v~r~Rv~l~~llqEGtFGri~~gI~~eEdt~n~~q~v~vKTvk~~AS~iQv~~~L~es~lly~~sH~nll~V~  353 (563)
T KOG1024|consen  274 RRLQELTVQRCRVRLSCLLQEGTFGRIYRGIWREEDTYNDCQEVLVKTVKQHASQIQVNLLLQESMLLYGASHPNLLSVL  353 (563)
T ss_pred             hhHHhhhhhhhheechhhhhcCchhheeeeeecccCCcchHHHHHHHHHHhcccHHHHHHHHHHHHHHhcCcCCCcccee
Confidence            3456677777889889999999999999997753      4567788888777667778899999999999999999999


Q ss_pred             eEEEcCCCCeEEEEEEcCCCCCHHHHhhhcCC----CCCCCCHHHHHHHHHHHHHHHhhhhCCCCCCCceeecCCCCCce
Q 005586          473 GFCCSRGRGECFLIYDFAPKGKLSKYLDQEEG----SSNVLDWSTRVSIIIGIAKGIGYLHSSEVNKPAIVHRNLSVEKV  548 (689)
Q Consensus       473 g~~~~~~~~~~~lV~e~~~~gsL~~~L~~~~~----~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~~~ivH~dlk~~Ni  548 (689)
                      +.+.+. ....+++|.++.-|+|..||...++    ..+.++-.+...+|.|++.|++|||..+     |||.||.++|+
T Consensus       354 ~V~ie~-~~~P~V~y~~~~~gNLK~FL~~Cr~~~~~~aqtvtt~qlV~masQla~am~hlh~~~-----ViHkDiAaRNC  427 (563)
T KOG1024|consen  354 GVSIED-YATPFVLYPATGVGNLKSFLQICRGDDPSYAQTVTTIQLVLMASQLAMAMEHLHNHG-----VIHKDIAARNC  427 (563)
T ss_pred             EEEeec-cCcceEEEeccCcchHHHHHHHhccCCCccccchhHHHHHHHHHHHHHHHHHHHhcC-----cccchhhhhcc
Confidence            999864 5678899999999999999985433    2345777888999999999999999988     99999999999


Q ss_pred             eecCCCCeEEecccccccccCC-ceeeeecCCCCCCCCCccccccCCCCCcccchhHHHHHHHHHh-CCCCcchhHHHHH
Q 005586          549 LIDQQFNPLIADCGLHKLLADD-IVFSVLKTSAAMGYLAPEYVTTGRFTERSDIFAFGVIILQILT-GSLVLTSSMRLAA  626 (689)
Q Consensus       549 Ll~~~~~~kl~DfGla~~~~~~-~~~~~~~~~~~~~y~aPE~~~~~~~~~ksDV~sfGvvl~ellt-G~~p~~~~~~~~~  626 (689)
                      ++|+..++||+|-.++|.+-+. ..+-.....++..||+||.+....|++++|||||||+||||+| |+.|+..-.    
T Consensus       428 vIdd~LqVkltDsaLSRDLFP~DYhcLGDnEnRPvkWMslEal~n~~yssasDvWsfGVllWELmtlg~~PyaeID----  503 (563)
T KOG1024|consen  428 VIDDQLQVKLTDSALSRDLFPGDYHCLGDNENRPVKWMSLEALQNSHYSSASDVWSFGVLLWELMTLGKLPYAEID----  503 (563)
T ss_pred             eehhheeEEeccchhccccCcccccccCCCCCCcccccCHHHHhhhhhcchhhhHHHHHHHHHHHhcCCCCccccC----
Confidence            9999999999999999976443 3333445567788999999999999999999999999999998 888885421    


Q ss_pred             hhhhhhHhhccccCCCCCHHHHHHHHHHHHHhccCCCCCCCCHHHHHHHHHhh
Q 005586          627 ESATFENFIDRNLKGKFSESEAAKLGKMALVCTHEDPENRPTMEAVIEELTVA  679 (689)
Q Consensus       627 ~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~Cl~~dp~~RPs~~evl~~L~~~  679 (689)
                       ...++.++....+...|-.+++++..+|..||+.+|++||+++|++..|.+-
T Consensus       504 -PfEm~~ylkdGyRlaQP~NCPDeLf~vMacCWallpeeRPsf~Qlv~cLseF  555 (563)
T KOG1024|consen  504 -PFEMEHYLKDGYRLAQPFNCPDELFTVMACCWALLPEERPSFSQLVICLSEF  555 (563)
T ss_pred             -HHHHHHHHhccceecCCCCCcHHHHHHHHHHHhcCcccCCCHHHHHHHHHHH
Confidence             2234445555666667788999999999999999999999999999998764

>cd05065 PTKc_EphR_B Catalytic domain of the Protein Tyrosine Kinases, Class EphB Ephrin Receptors

Probab=100.00  E-value=7.5e-38  Score=321.44  Aligned_cols=255  Identities=24%  Similarity=0.482  Sum_probs=203.0

Q ss_pred             cCCcccccccCCcceEEEEEec-CC---cEEEEEEecccCCchHHHHHHHHHHHHhccCCCcceeEeeEEEcCCCCeEEE
Q 005586          410 CFSEVNLLGKGNFSSVYKGTLR-DG---TLVAIRSINVTSCKSEEAEFVKGLYLLTSLRHENIIRLRGFCCSRGRGECFL  485 (689)
Q Consensus       410 ~f~~~~~lg~G~~g~Vy~~~~~-~g---~~vavK~l~~~~~~~~~~~f~~e~~~l~~l~H~niv~l~g~~~~~~~~~~~l  485 (689)
                      +|...+.||+|+||.||+|.++ ++   ..||+|.+..........+|..|+.++++++||||+++++++.  .....++
T Consensus         5 ~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~--~~~~~~l   82 (269)
T cd05065           5 CVKIEEVIGAGEFGEVCRGRLKLPGKREIFVAIKTLKSGYTEKQRRDFLSEASIMGQFDHPNIIHLEGVVT--KSRPVMI   82 (269)
T ss_pred             HeEEEeEecCCCCCeEEEEEEecCCCCceeEEEEEcCCCCCHHHHHHHHHHHHHHHhCCCcCcceEEEEEC--CCCceEE
Confidence            4566789999999999999975 23   3699999876544445678999999999999999999999984  4567899


Q ss_pred             EEEcCCCCCHHHHhhhcCCCCCCCCHHHHHHHHHHHHHHHhhhhCCCCCCCceeecCCCCCceeecCCCCeEEecccccc
Q 005586          486 IYDFAPKGKLSKYLDQEEGSSNVLDWSTRVSIIIGIAKGIGYLHSSEVNKPAIVHRNLSVEKVLIDQQFNPLIADCGLHK  565 (689)
Q Consensus       486 V~e~~~~gsL~~~L~~~~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~~~ivH~dlk~~NiLl~~~~~~kl~DfGla~  565 (689)
                      ||||+++|+|.+++....+   .+++.+++.++.|++.||+|||+.+     ++||||||+||+++.++.+|++|||+++
T Consensus        83 v~e~~~~~~L~~~l~~~~~---~~~~~~~~~i~~~l~~al~~lH~~g-----~~H~dl~p~nili~~~~~~kl~dfg~~~  154 (269)
T cd05065          83 ITEFMENGALDSFLRQNDG---QFTVIQLVGMLRGIAAGMKYLSEMN-----YVHRDLAARNILVNSNLVCKVSDFGLSR  154 (269)
T ss_pred             EEecCCCCcHHHHHhhCCC---CCCHHHHHHHHHHHHHHHHHHHHCC-----EeecccChheEEEcCCCcEEECCCcccc
Confidence            9999999999999976532   4899999999999999999999987     9999999999999999999999999988


Q ss_pred             cccCCceeee----ecCCCCCCCCCccccccCCCCCcccchhHHHHHHHHHh-CCCCcchhHHHHHhhhhhhHhhccccC
Q 005586          566 LLADDIVFSV----LKTSAAMGYLAPEYVTTGRFTERSDIFAFGVIILQILT-GSLVLTSSMRLAAESATFENFIDRNLK  640 (689)
Q Consensus       566 ~~~~~~~~~~----~~~~~~~~y~aPE~~~~~~~~~ksDV~sfGvvl~ellt-G~~p~~~~~~~~~~~~~~~~~~~~~~~  640 (689)
                      ..........    .....+..|+|||++.+..++.++|||||||++||+++ |+.|+.......     ..+.+.....
T Consensus       155 ~~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~DvwslG~~l~e~l~~g~~p~~~~~~~~-----~~~~i~~~~~  229 (269)
T cd05065         155 FLEDDTSDPTYTSSLGGKIPIRWTAPEAIAYRKFTSASDVWSYGIVMWEVMSYGERPYWDMSNQD-----VINAIEQDYR  229 (269)
T ss_pred             ccccCccccccccccCCCcceeecCHhHhccCcccchhhhhhhHHHHHHHhcCCCCCCCCCCHHH-----HHHHHHcCCc
Confidence            6643321111    11112346999999998899999999999999999987 999985432211     1111111122


Q ss_pred             CCCCHHHHHHHHHHHHHhccCCCCCCCCHHHHHHHHHhh
Q 005586          641 GKFSESEAAKLGKMALVCTHEDPENRPTMEAVIEELTVA  679 (689)
Q Consensus       641 ~~~~~~~~~~l~~l~~~Cl~~dp~~RPs~~evl~~L~~~  679 (689)
                      ...+.+.+..+.+++..||+.+|.+||+|.+|+..|+..
T Consensus       230 ~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~i~~~l~~~  268 (269)
T cd05065         230 LPPPMDCPTALHQLMLDCWQKDRNARPKFGQIVSTLDKM  268 (269)
T ss_pred             CCCcccCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHhh
Confidence            223344566789999999999999999999999998764

Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; class EphB receptors; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). Class EphB receptors bind to transmembrane ephrin-B ligands. There are six vertebrate EhpB receptors (EphB1-6), which display promiscuous interactions with three ephrin-B ligands. One exception is EphB2, which also interacts with ephrin A5. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephr

>cd05621 STKc_ROCK2 Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 2

Probab=100.00  E-value=2.4e-38  Score=339.55  Aligned_cols=260  Identities=14%  Similarity=0.251  Sum_probs=205.1

Q ss_pred             HHHHHhccCCcccccccCCcceEEEEEec-CCcEEEEEEecccCC--chHHHHHHHHHHHHhccCCCcceeEeeEEEcCC
Q 005586          403 EVESATQCFSEVNLLGKGNFSSVYKGTLR-DGTLVAIRSINVTSC--KSEEAEFVKGLYLLTSLRHENIIRLRGFCCSRG  479 (689)
Q Consensus       403 ~l~~at~~f~~~~~lg~G~~g~Vy~~~~~-~g~~vavK~l~~~~~--~~~~~~f~~e~~~l~~l~H~niv~l~g~~~~~~  479 (689)
                      ++....++|...+.||+|+||.||+++.+ +++.||+|.+.....  ......+.+|+.+++.++||||+++++++.  .
T Consensus        37 ~~~~~~~~y~~~~~lG~G~fg~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~i~~~~~hp~iv~~~~~~~--~  114 (370)
T cd05621          37 KLQMKAEDYDVVKVIGRGAFGEVQLVRHKSSQKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFANSPWVVQLFCAFQ--D  114 (370)
T ss_pred             hcCCCHHHCeEEEEEEecCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhhHHHHHHHHHHHHhCCCCCEeeEEEEEE--c
Confidence            34445678999999999999999999986 588999999865321  223456889999999999999999999884  4


Q ss_pred             CCeEEEEEEcCCCCCHHHHhhhcCCCCCCCCHHHHHHHHHHHHHHHhhhhCCCCCCCceeecCCCCCceeecCCCCeEEe
Q 005586          480 RGECFLIYDFAPKGKLSKYLDQEEGSSNVLDWSTRVSIIIGIAKGIGYLHSSEVNKPAIVHRNLSVEKVLIDQQFNPLIA  559 (689)
Q Consensus       480 ~~~~~lV~e~~~~gsL~~~L~~~~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~~~ivH~dlk~~NiLl~~~~~~kl~  559 (689)
                      ....++||||+++|+|.+++...     .+++.....++.|++.||+|||+.+     |+||||||+|||+++++.+||+
T Consensus       115 ~~~~~lv~Ey~~gg~L~~~l~~~-----~~~~~~~~~~~~qil~aL~~LH~~~-----IvHrDLKp~NILl~~~~~~kL~  184 (370)
T cd05621         115 DKYLYMVMEYMPGGDLVNLMSNY-----DVPEKWAKFYTAEVVLALDAIHSMG-----LIHRDVKPDNMLLDKHGHLKLA  184 (370)
T ss_pred             CCEEEEEEcCCCCCcHHHHHHhc-----CCCHHHHHHHHHHHHHHHHHHHHCC-----eEecCCCHHHEEECCCCCEEEE
Confidence            57899999999999999999653     2788889999999999999999987     9999999999999999999999


Q ss_pred             cccccccccCCceeeeecCCCCCCCCCccccccC----CCCCcccchhHHHHHHHHHhCCCCcchhHHHHHhhhhhhHhh
Q 005586          560 DCGLHKLLADDIVFSVLKTSAAMGYLAPEYVTTG----RFTERSDIFAFGVIILQILTGSLVLTSSMRLAAESATFENFI  635 (689)
Q Consensus       560 DfGla~~~~~~~~~~~~~~~~~~~y~aPE~~~~~----~~~~ksDV~sfGvvl~elltG~~p~~~~~~~~~~~~~~~~~~  635 (689)
                      |||+++.+............+|..|+|||++.+.    .++.++||||+||++|||+||+.||.......    .+..+.
T Consensus       185 DFG~a~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~~~~~~DiwSlG~ilyell~G~~Pf~~~~~~~----~~~~i~  260 (370)
T cd05621         185 DFGTCMKMDETGMVRCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLFEMLVGDTPFYADSLVG----TYSKIM  260 (370)
T ss_pred             ecccceecccCCceecccCCCCcccCCHHHHhccCCCCCCCcccCEEeehHHHHHHHhCCCCCCCCCHHH----HHHHHH
Confidence            9999987654332223345688999999998654    37899999999999999999999996543221    223333


Q ss_pred             ccccCCCCCH--HHHHHHHHHHHHhccCCCCC--CCCHHHHHHHHHh
Q 005586          636 DRNLKGKFSE--SEAAKLGKMALVCTHEDPEN--RPTMEAVIEELTV  678 (689)
Q Consensus       636 ~~~~~~~~~~--~~~~~l~~l~~~Cl~~dp~~--RPs~~evl~~L~~  678 (689)
                      +......++.  ..+..+.+++..|+..++.+  ||++.|++++.+.
T Consensus       261 ~~~~~~~~p~~~~~s~~~~~li~~~L~~~~~r~~R~~~~e~l~hp~~  307 (370)
T cd05621         261 DHKNSLNFPEDVEISKHAKNLICAFLTDREVRLGRNGVEEIKQHPFF  307 (370)
T ss_pred             hCCcccCCCCcccCCHHHHHHHHHHccCchhccCCCCHHHHhcCccc
Confidence            3221112222  33567888889999865544  8999999998654

Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK2 (or ROK-alpha) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK2 was the first identified target of activated RhoA, and was found

>cd05112 PTKc_Itk Catalytic domain of the Protein Tyrosine Kinase, Interleukin-2-inducible T-cell Kinase

Probab=100.00  E-value=6.2e-38  Score=319.45  Aligned_cols=251  Identities=23%  Similarity=0.478  Sum_probs=201.4

Q ss_pred             cCCcccccccCCcceEEEEEecCCcEEEEEEecccCCchHHHHHHHHHHHHhccCCCcceeEeeEEEcCCCCeEEEEEEc
Q 005586          410 CFSEVNLLGKGNFSSVYKGTLRDGTLVAIRSINVTSCKSEEAEFVKGLYLLTSLRHENIIRLRGFCCSRGRGECFLIYDF  489 (689)
Q Consensus       410 ~f~~~~~lg~G~~g~Vy~~~~~~g~~vavK~l~~~~~~~~~~~f~~e~~~l~~l~H~niv~l~g~~~~~~~~~~~lV~e~  489 (689)
                      +|+..+.||+|+||.||+|.+.++..+|+|.+.....  ...+|.+|++++.+++|||++++++++.  .....++||||
T Consensus         5 ~~~~~~~ig~g~~g~v~~~~~~~~~~~~~k~~~~~~~--~~~~~~~e~~~l~~l~~~~i~~~~~~~~--~~~~~~~v~e~   80 (256)
T cd05112           5 ELTLVQEIGSGQFGLVWLGYWLEKRKVAIKTIREGAM--SEEDFIEEAQVMMKLSHPKLVQLYGVCT--ERSPICLVFEF   80 (256)
T ss_pred             HeEEEeeecCcccceEEEEEEeCCCeEEEEECCCCCC--CHHHHHHHHHHHHhCCCCCeeeEEEEEc--cCCceEEEEEc
Confidence            4666789999999999999987788999999875432  3457999999999999999999999884  34678999999


Q ss_pred             CCCCCHHHHhhhcCCCCCCCCHHHHHHHHHHHHHHHhhhhCCCCCCCceeecCCCCCceeecCCCCeEEecccccccccC
Q 005586          490 APKGKLSKYLDQEEGSSNVLDWSTRVSIIIGIAKGIGYLHSSEVNKPAIVHRNLSVEKVLIDQQFNPLIADCGLHKLLAD  569 (689)
Q Consensus       490 ~~~gsL~~~L~~~~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~~~ivH~dlk~~NiLl~~~~~~kl~DfGla~~~~~  569 (689)
                      +++++|.+++....+   .++|..++.++.+++.||+|||+.+     ++||||||+||+++.++.+||+|||+++....
T Consensus        81 ~~~~~L~~~~~~~~~---~~~~~~~~~~~~~l~~~l~~lH~~~-----i~h~dl~p~ni~i~~~~~~~l~d~g~~~~~~~  152 (256)
T cd05112          81 MEHGCLSDYLRAQRG---KFSQETLLGMCLDVCEGMAYLESSN-----VIHRDLAARNCLVGENQVVKVSDFGMTRFVLD  152 (256)
T ss_pred             CCCCcHHHHHHhCcc---CCCHHHHHHHHHHHHHHHHHHHHCC-----ccccccccceEEEcCCCeEEECCCcceeeccc
Confidence            999999999976432   4789999999999999999999887     99999999999999999999999999886544


Q ss_pred             CceeeeecCCCCCCCCCccccccCCCCCcccchhHHHHHHHHHh-CCCCcchhHHHHHhhhhhhHhhccccCCCCCHHHH
Q 005586          570 DIVFSVLKTSAAMGYLAPEYVTTGRFTERSDIFAFGVIILQILT-GSLVLTSSMRLAAESATFENFIDRNLKGKFSESEA  648 (689)
Q Consensus       570 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~ksDV~sfGvvl~ellt-G~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  648 (689)
                      ...........+.+|+|||++.++.++.++||||||+++|||++ |+.|+........     .+.+........+...+
T Consensus       153 ~~~~~~~~~~~~~~~~aPe~~~~~~~~~~~Dv~slG~~l~el~~~g~~p~~~~~~~~~-----~~~~~~~~~~~~~~~~~  227 (256)
T cd05112         153 DQYTSSTGTKFPVKWSSPEVFSFSKYSSKSDVWSFGVLMWEVFSEGKTPYENRSNSEV-----VETINAGFRLYKPRLAS  227 (256)
T ss_pred             CcccccCCCccchhhcCHhHhccCCcChHHHHHHHHHHHHHHHcCCCCCCCcCCHHHH-----HHHHhCCCCCCCCCCCC
Confidence            32222222334568999999988889999999999999999998 8999864321111     11111111111122345


Q ss_pred             HHHHHHHHHhccCCCCCCCCHHHHHHHHH
Q 005586          649 AKLGKMALVCTHEDPENRPTMEAVIEELT  677 (689)
Q Consensus       649 ~~l~~l~~~Cl~~dp~~RPs~~evl~~L~  677 (689)
                      ..+.+++.+||+.+|++||++.||+++|.
T Consensus       228 ~~~~~l~~~~l~~~p~~Rp~~~~~l~~l~  256 (256)
T cd05112         228 QSVYELMQHCWKERPEDRPSFSLLLHQLA  256 (256)
T ss_pred             HHHHHHHHHHcccChhhCCCHHHHHHhhC
Confidence            77999999999999999999999999873

Protein Tyrosine Kinase (PTK) family; Interleukin-2 (IL-2)-inducible T-cell kinase (Itk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Itk (also known as Tsk or Emt) is a member of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activ

>cd08529 STKc_FA2-like Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii FA2 and similar domains

Probab=100.00  E-value=9.9e-38  Score=317.73  Aligned_cols=251  Identities=26%  Similarity=0.418  Sum_probs=204.8

Q ss_pred             cCCcccccccCCcceEEEEEec-CCcEEEEEEecccCC-chHHHHHHHHHHHHhccCCCcceeEeeEEEcCCCCeEEEEE
Q 005586          410 CFSEVNLLGKGNFSSVYKGTLR-DGTLVAIRSINVTSC-KSEEAEFVKGLYLLTSLRHENIIRLRGFCCSRGRGECFLIY  487 (689)
Q Consensus       410 ~f~~~~~lg~G~~g~Vy~~~~~-~g~~vavK~l~~~~~-~~~~~~f~~e~~~l~~l~H~niv~l~g~~~~~~~~~~~lV~  487 (689)
                      +|+..+.||+|++|.||+|..+ +|+.|++|.+..... .....++.+|++++++++||||+++++++..  .+..++||
T Consensus         1 ~~~~~~~l~~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~--~~~~~lv~   78 (256)
T cd08529           1 DFEILNKIGKGSFGVVFKVVRKADKRVYAMKQIDLSKMNRREREEAIDEARVLAKLDSSYIIRYYESFLD--KGKLNIVM   78 (256)
T ss_pred             CceEeEEecCCCCeEEEEEEEcCCCcEEEEEEeehhhCCHHHHHHHHHHHHHHHhcCCCCeehheeeecc--CCEEEEEE
Confidence            3667789999999999999875 689999999875432 3456789999999999999999999999854  47899999


Q ss_pred             EcCCCCCHHHHhhhcCCCCCCCCHHHHHHHHHHHHHHHhhhhCCCCCCCceeecCCCCCceeecCCCCeEEecccccccc
Q 005586          488 DFAPKGKLSKYLDQEEGSSNVLDWSTRVSIIIGIAKGIGYLHSSEVNKPAIVHRNLSVEKVLIDQQFNPLIADCGLHKLL  567 (689)
Q Consensus       488 e~~~~gsL~~~L~~~~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~~~ivH~dlk~~NiLl~~~~~~kl~DfGla~~~  567 (689)
                      ||+++++|.++++....  ..+++..+..++.|++.||.|||+.+     |+||||||+||++++++.+||+|||+++..
T Consensus        79 e~~~~~~L~~~l~~~~~--~~~~~~~~~~i~~~l~~al~~lH~~~-----i~h~dl~~~nili~~~~~~~l~df~~~~~~  151 (256)
T cd08529          79 EYAENGDLHKLLKMQRG--RPLPEDQVWRFFIQILLGLAHLHSKK-----ILHRDIKSLNLFLDAYDNVKIGDLGVAKLL  151 (256)
T ss_pred             EeCCCCcHHHHHHHhcC--CCCCHHHHHHHHHHHHHHHHHHHHCC-----cccCCCCcceEEEeCCCCEEEcccccceec
Confidence            99999999999986532  35899999999999999999999887     999999999999999999999999998876


Q ss_pred             cCCceeeeecCCCCCCCCCccccccCCCCCcccchhHHHHHHHHHhCCCCcchhHHHHHhhhhhhHhhccccCCCCCHHH
Q 005586          568 ADDIVFSVLKTSAAMGYLAPEYVTTGRFTERSDIFAFGVIILQILTGSLVLTSSMRLAAESATFENFIDRNLKGKFSESE  647 (689)
Q Consensus       568 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~ksDV~sfGvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  647 (689)
                      ...... .....++..|+|||+..+..++.++|||||||++|||+||+.|+........    ...+. .......+...
T Consensus       152 ~~~~~~-~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~----~~~~~-~~~~~~~~~~~  225 (256)
T cd08529         152 SDNTNF-ANTIVGTPYYLSPELCEDKPYNEKSDVWALGVVLYECCTGKHPFDANNQGAL----ILKII-RGVFPPVSQMY  225 (256)
T ss_pred             cCccch-hhccccCccccCHHHhcCCCCCCccchHHHHHHHHHHHhCCCCCCCCCHHHH----HHHHH-cCCCCCCcccc
Confidence            543221 1223467789999999988899999999999999999999999965432111    11111 11122233355


Q ss_pred             HHHHHHHHHHhccCCCCCCCCHHHHHHH
Q 005586          648 AAKLGKMALVCTHEDPENRPTMEAVIEE  675 (689)
Q Consensus       648 ~~~l~~l~~~Cl~~dp~~RPs~~evl~~  675 (689)
                      ...+.+++.+||+.+|++||++.+++++
T Consensus       226 ~~~~~~~i~~~l~~~p~~Rp~~~~ll~~  253 (256)
T cd08529         226 SQQLAQLIDQCLTKDYRQRPDTFQLLRN  253 (256)
T ss_pred             CHHHHHHHHHHccCCcccCcCHHHHhhC
Confidence            6789999999999999999999999876

Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii FA2-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii FA2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes FA2 and CNK4. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii FA2 was discovered in a genetic screen for deflagellation-defective mutants. It is essential for basal-body/centriole-associated microtubule severing, and plays a role in cell cyc

>cd05060 PTKc_Syk_like Catalytic domain of Spleen Tyrosine Kinase-like Protein Tyrosine Kinases

Probab=100.00  E-value=1.2e-37  Score=317.64  Aligned_cols=249  Identities=25%  Similarity=0.443  Sum_probs=200.7

Q ss_pred             cccccCCcceEEEEEec--C--CcEEEEEEecccCCchHHHHHHHHHHHHhccCCCcceeEeeEEEcCCCCeEEEEEEcC
Q 005586          415 NLLGKGNFSSVYKGTLR--D--GTLVAIRSINVTSCKSEEAEFVKGLYLLTSLRHENIIRLRGFCCSRGRGECFLIYDFA  490 (689)
Q Consensus       415 ~~lg~G~~g~Vy~~~~~--~--g~~vavK~l~~~~~~~~~~~f~~e~~~l~~l~H~niv~l~g~~~~~~~~~~~lV~e~~  490 (689)
                      +.||+|+||.||+|++.  +  +..||+|.+.........+++.+|+++++++.|+|||++++++.   ....++||||+
T Consensus         1 ~~ig~G~~g~v~~~~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~---~~~~~~v~e~~   77 (257)
T cd05060           1 KELGHGNFGSVVKGVYLMKSGKEVEVAVKTLKQEHIAAGKKEFLREASVMAQLDHPCIVRLIGVCK---GEPLMLVMELA   77 (257)
T ss_pred             CccCccCceeEEEeEeeccCCCcceEEEEecccccchHHHHHHHHHHHHHHhcCCCCeeeEEEEEc---CCceEEEEEeC
Confidence            46999999999999864  2  36899999987664445678999999999999999999999873   34679999999


Q ss_pred             CCCCHHHHhhhcCCCCCCCCHHHHHHHHHHHHHHHhhhhCCCCCCCceeecCCCCCceeecCCCCeEEecccccccccCC
Q 005586          491 PKGKLSKYLDQEEGSSNVLDWSTRVSIIIGIAKGIGYLHSSEVNKPAIVHRNLSVEKVLIDQQFNPLIADCGLHKLLADD  570 (689)
Q Consensus       491 ~~gsL~~~L~~~~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~~~ivH~dlk~~NiLl~~~~~~kl~DfGla~~~~~~  570 (689)
                      ++|+|.+++....    .+++..++.++.|++.||+|||..+     ++||||||+||++++++.+||+|||+++.+...
T Consensus        78 ~~~~L~~~l~~~~----~~~~~~~~~~~~qi~~~l~~lh~~~-----i~H~di~p~nili~~~~~~kl~df~~~~~~~~~  148 (257)
T cd05060          78 PLGPLLKYLKKRR----EIPVSDLKELAHQVAMGMAYLESKH-----FVHRDLAARNVLLVNRHQAKISDFGMSRALGAG  148 (257)
T ss_pred             CCCcHHHHHHhCC----CCCHHHHHHHHHHHHHHHHHHhhcC-----eeccCcccceEEEcCCCcEEeccccccceeecC
Confidence            9999999998653    4899999999999999999999887     999999999999999999999999999876443


Q ss_pred             ceee--eecCCCCCCCCCccccccCCCCCcccchhHHHHHHHHHh-CCCCcchhHHHHHhhhhhhHhhccccCCCCCHHH
Q 005586          571 IVFS--VLKTSAAMGYLAPEYVTTGRFTERSDIFAFGVIILQILT-GSLVLTSSMRLAAESATFENFIDRNLKGKFSESE  647 (689)
Q Consensus       571 ~~~~--~~~~~~~~~y~aPE~~~~~~~~~ksDV~sfGvvl~ellt-G~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  647 (689)
                      ....  .....++..|+|||.+.+..++.++|||||||++|||++ |+.||.......     +...+........+...
T Consensus       149 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~~~~~g~~p~~~~~~~~-----~~~~~~~~~~~~~~~~~  223 (257)
T cd05060         149 SDYYRATTAGRWPLKWYAPECINYGKFSSKSDVWSYGVTLWEAFSYGAKPYGEMKGAE-----VIAMLESGERLPRPEEC  223 (257)
T ss_pred             CcccccccCccccccccCHHHhcCCCCCccchHHHHHHHHHHHHcCCCCCcccCCHHH-----HHHHHHcCCcCCCCCCC
Confidence            2211  112223467999999988899999999999999999998 999986432211     11112111122233445


Q ss_pred             HHHHHHHHHHhccCCCCCCCCHHHHHHHHHhhC
Q 005586          648 AAKLGKMALVCTHEDPENRPTMEAVIEELTVAA  680 (689)
Q Consensus       648 ~~~l~~l~~~Cl~~dp~~RPs~~evl~~L~~~~  680 (689)
                      +..+.+++.+|+..+|++||++.++++.|+...
T Consensus       224 ~~~l~~li~~cl~~~p~~Rp~~~~l~~~l~~~~  256 (257)
T cd05060         224 PQEIYSIMLSCWKYRPEDRPTFSELESTFRRDP  256 (257)
T ss_pred             CHHHHHHHHHHhcCChhhCcCHHHHHHHHHhcc
Confidence            678999999999999999999999999998753

Protein Tyrosine Kinase (PTK) family; Spleen Tyrosine Kinase (Syk) subfamily; catalytic (c) domain. The Syk subfamily is composed of Syk, ZAP-70, Shark, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. They are involved in the signaling downstream of activated receptors (including B-cell, T-cell, and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferation, differentiation, survival, adhesion, mi

>cd07859 STKc_TDY_MAPK_plant Catalytic domain of the Serine/Threonine Kinases, TDY Mitogen-Activated Protein Kinases from Plants

Probab=100.00  E-value=4.8e-38  Score=334.06  Aligned_cols=259  Identities=20%  Similarity=0.354  Sum_probs=197.4

Q ss_pred             cCCcccccccCCcceEEEEEec-CCcEEEEEEecccCC-chHHHHHHHHHHHHhccCCCcceeEeeEEEcCCC---CeEE
Q 005586          410 CFSEVNLLGKGNFSSVYKGTLR-DGTLVAIRSINVTSC-KSEEAEFVKGLYLLTSLRHENIIRLRGFCCSRGR---GECF  484 (689)
Q Consensus       410 ~f~~~~~lg~G~~g~Vy~~~~~-~g~~vavK~l~~~~~-~~~~~~f~~e~~~l~~l~H~niv~l~g~~~~~~~---~~~~  484 (689)
                      +|...+.||+|+||.||+|+.. +|..||||++..... .....++.+|++++++++||||+++++++.....   ...+
T Consensus         1 ry~i~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~~~~~   80 (338)
T cd07859           1 RYKIQEVIGKGSYGVVCSAIDTHTGEKVAIKKINDVFEHVSDATRILREIKLLRLLRHPDIVEIKHIMLPPSRREFKDIY   80 (338)
T ss_pred             CeEEEEEEeecCCeEEEEEEECCCCCEEEEEEechhhccchhHHHHHHHHHHHHhCCCCCEeeecceEeccCCCCCceEE
Confidence            4677889999999999999975 689999999875322 2344578999999999999999999998854322   3479


Q ss_pred             EEEEcCCCCCHHHHhhhcCCCCCCCCHHHHHHHHHHHHHHHhhhhCCCCCCCceeecCCCCCceeecCCCCeEEeccccc
Q 005586          485 LIYDFAPKGKLSKYLDQEEGSSNVLDWSTRVSIIIGIAKGIGYLHSSEVNKPAIVHRNLSVEKVLIDQQFNPLIADCGLH  564 (689)
Q Consensus       485 lV~e~~~~gsL~~~L~~~~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~~~ivH~dlk~~NiLl~~~~~~kl~DfGla  564 (689)
                      +||||++ ++|.+++....    .+++..+..++.|+++||+|||+.+     |+||||||+|||+++++.+||+|||++
T Consensus        81 lv~e~~~-~~L~~~l~~~~----~~~~~~~~~i~~qi~~aL~~LH~~~-----ivH~dlkp~NIll~~~~~~kL~Dfg~~  150 (338)
T cd07859          81 VVFELME-SDLHQVIKAND----DLTPEHHQFFLYQLLRALKYIHTAN-----VFHRDLKPKNILANADCKLKICDFGLA  150 (338)
T ss_pred             EEEecCC-CCHHHHHHhcc----cCCHHHHHHHHHHHHHHHHHHHHCC-----eecCCCCHHHeEECCCCcEEEccCccc
Confidence            9999995 68999887543    4899999999999999999999987     999999999999999999999999999


Q ss_pred             ccccCCcee--eeecCCCCCCCCCcccccc--CCCCCcccchhHHHHHHHHHhCCCCcchhHHHHHhh------------
Q 005586          565 KLLADDIVF--SVLKTSAAMGYLAPEYVTT--GRFTERSDIFAFGVIILQILTGSLVLTSSMRLAAES------------  628 (689)
Q Consensus       565 ~~~~~~~~~--~~~~~~~~~~y~aPE~~~~--~~~~~ksDV~sfGvvl~elltG~~p~~~~~~~~~~~------------  628 (689)
                      +........  ......++..|+|||++.+  ..++.++|||||||++|||+||+.||..........            
T Consensus       151 ~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~~DvwSlGvvl~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~~  230 (338)
T cd07859         151 RVAFNDTPTAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKNVVHQLDLITDLLGTPSPE  230 (338)
T ss_pred             cccccccCccccccCCCCCCCcCCHHHHhccccccCchhHHHHHHHHHHHHHcCCCCCCCCChHHHHHHHHHHhCCCCHH
Confidence            865332111  1123457888999999865  678999999999999999999999985432110000            


Q ss_pred             -------hhhhHhhc---cccCCCCC---HHHHHHHHHHHHHhccCCCCCCCCHHHHHHHHHh
Q 005586          629 -------ATFENFID---RNLKGKFS---ESEAAKLGKMALVCTHEDPENRPTMEAVIEELTV  678 (689)
Q Consensus       629 -------~~~~~~~~---~~~~~~~~---~~~~~~l~~l~~~Cl~~dp~~RPs~~evl~~L~~  678 (689)
                             ....+.+.   +.......   ......+.+++.+|++.||++||+++|++++-+.
T Consensus       231 ~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~e~l~hp~f  293 (338)
T cd07859         231 TISRVRNEKARRYLSSMRKKQPVPFSQKFPNADPLALRLLERLLAFDPKDRPTAEEALADPYF  293 (338)
T ss_pred             HHHHhhhhhHHHHHHhhcccCCCchHHhcCCCChHHHHHHHHHcCcCcccCCCHHHHhcCchh
Confidence                   00000000   00000000   1124567899999999999999999999988654

Serine/Threonine Kinases (STKs), Plant TDY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TDY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. Oryza sativa contains at least 17 MAPKs. There are two subtypes of plant MAPKs based on the conserved phos

>cd05573 STKc_ROCK_NDR_like Catalytic domain of ROCK- and NDR kinase-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=1.5e-38  Score=339.77  Aligned_cols=253  Identities=19%  Similarity=0.297  Sum_probs=204.5

Q ss_pred             ccCCcccccccCCcceEEEEEec-CCcEEEEEEecccCC--chHHHHHHHHHHHHhccCCCcceeEeeEEEcCCCCeEEE
Q 005586          409 QCFSEVNLLGKGNFSSVYKGTLR-DGTLVAIRSINVTSC--KSEEAEFVKGLYLLTSLRHENIIRLRGFCCSRGRGECFL  485 (689)
Q Consensus       409 ~~f~~~~~lg~G~~g~Vy~~~~~-~g~~vavK~l~~~~~--~~~~~~f~~e~~~l~~l~H~niv~l~g~~~~~~~~~~~l  485 (689)
                      ++|...+.||+|+||.||+|... +|+.||+|++.....  ......+.+|++++..++||||+++++++.  ..+..++
T Consensus         1 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~--~~~~~~l   78 (350)
T cd05573           1 DDFEVIKVIGRGAFGEVWLVRDKDTGQVYAMKVLRKSDMIKRNQIAHVRAERDILADADSPWIVKLYYSFQ--DEEHLYL   78 (350)
T ss_pred             CCceEEEEEEeCCcEEEEEEEECCCCCEEEEEEEEHHHHhhccHHHHHHHHHHHHHhcCCCCccchhhhee--cCCeEEE
Confidence            36788899999999999999976 799999999975432  234567899999999999999999999884  3578999


Q ss_pred             EEEcCCCCCHHHHhhhcCCCCCCCCHHHHHHHHHHHHHHHhhhhCCCCCCCceeecCCCCCceeecCCCCeEEecccccc
Q 005586          486 IYDFAPKGKLSKYLDQEEGSSNVLDWSTRVSIIIGIAKGIGYLHSSEVNKPAIVHRNLSVEKVLIDQQFNPLIADCGLHK  565 (689)
Q Consensus       486 V~e~~~~gsL~~~L~~~~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~~~ivH~dlk~~NiLl~~~~~~kl~DfGla~  565 (689)
                      ||||+++|+|.+++....    .+++..+..++.|++.||+|||+.+     |+||||||+|||+++++.+||+|||+++
T Consensus        79 v~e~~~~~~L~~~l~~~~----~l~~~~~~~i~~qi~~aL~~LH~~g-----iiH~Dlkp~NIll~~~~~~kL~Dfg~~~  149 (350)
T cd05573          79 VMEYMPGGDLMNLLIRKD----VFPEETARFYIAELVLALDSVHKLG-----FIHRDIKPDNILIDADGHIKLADFGLCK  149 (350)
T ss_pred             EEcCCCCCCHHHHHHHcC----CCCHHHHHHHHHHHHHHHHHHHHCC-----eeccCCCHHHeEECCCCCEEeecCCCCc
Confidence            999999999999998652    4889999999999999999999987     9999999999999999999999999998


Q ss_pred             cccCCc----------------------------eeeeecCCCCCCCCCccccccCCCCCcccchhHHHHHHHHHhCCCC
Q 005586          566 LLADDI----------------------------VFSVLKTSAAMGYLAPEYVTTGRFTERSDIFAFGVIILQILTGSLV  617 (689)
Q Consensus       566 ~~~~~~----------------------------~~~~~~~~~~~~y~aPE~~~~~~~~~ksDV~sfGvvl~elltG~~p  617 (689)
                      ......                            ........+|..|+|||++.+..++.++|||||||++|||++|+.|
T Consensus       150 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~ell~g~~P  229 (350)
T cd05573         150 KMNKAKDREYYLNDSHNLLFRDNVLVRRRDHKQRRVRANSTVGTPDYIAPEVLRGTPYGLECDWWSLGVILYEMLYGFPP  229 (350)
T ss_pred             cCcccCcccccccccccccccccccccccccccccccccccccCccccCHHHHcCCCCCCceeeEecchhhhhhccCCCC
Confidence            765432                            0112234578899999999999999999999999999999999999


Q ss_pred             cchhHHHHHhhhhhhHhhc--cccCCCCCHHHHHHHHHHHHHhccCCCCCCCC-HHHHHHHHH
Q 005586          618 LTSSMRLAAESATFENFID--RNLKGKFSESEAAKLGKMALVCTHEDPENRPT-MEAVIEELT  677 (689)
Q Consensus       618 ~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~~~~~l~~l~~~Cl~~dp~~RPs-~~evl~~L~  677 (689)
                      |........    ...+..  ..+........+.++.+++..|+. ||++||+ +.|++++.+
T Consensus       230 f~~~~~~~~----~~~i~~~~~~~~~p~~~~~~~~~~~li~~ll~-dp~~R~~s~~~ll~hp~  287 (350)
T cd05573         230 FYSDTLQET----YNKIINWKESLRFPPDPPVSPEAIDLICRLLC-DPEDRLGSFEEIKSHPF  287 (350)
T ss_pred             CCCCCHHHH----HHHHhccCCcccCCCCCCCCHHHHHHHHHHcc-ChhhcCCCHHHHhcCCC
Confidence            965432211    111222  111111111236678899999997 9999999 999998754

Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) and Nuclear Dbf2-Related (NDR)-like kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK- and NDR-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include ROCK and ROCK-like proteins such as DMPK, MRCK, and CRIK, as well as NDR and NDR-like proteins such as LATS, CBK1 and Sid2p. ROCK and CRIK are effectors of the small GTPase Rho, while MRCK is an effector of the small GTPase Cdc42. NDR and NDR-like kinases contain an N-terminal regulatory (NTR) domain and an insert within the

>KOG0588 consensus Serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning]

Probab=100.00  E-value=1.6e-38  Score=334.39  Aligned_cols=246  Identities=25%  Similarity=0.392  Sum_probs=208.4

Q ss_pred             cccccccCCcceEEEEEec-CCcEEEEEEecccCC--chHHHHHHHHHHHHhccCCCcceeEeeEEEcCCCCeEEEEEEc
Q 005586          413 EVNLLGKGNFSSVYKGTLR-DGTLVAIRSINVTSC--KSEEAEFVKGLYLLTSLRHENIIRLRGFCCSRGRGECFLIYDF  489 (689)
Q Consensus       413 ~~~~lg~G~~g~Vy~~~~~-~g~~vavK~l~~~~~--~~~~~~f~~e~~~l~~l~H~niv~l~g~~~~~~~~~~~lV~e~  489 (689)
                      ..+.||.|+-|.|-.|++. +|+.+|||++.+...  ......+.+||-+|+-+.|||++++++.+  +...++|+|.||
T Consensus        16 LgkTLG~Gstg~vrlakh~~TGqlaaiKii~k~~~~s~s~~~~IerEIviMkLi~HpnVl~LydVw--e~~~~lylvlEy   93 (786)
T KOG0588|consen   16 LGKTLGKGSTGCVRLAKHAETGQLAAIKIIPKRSELSSSQPAGIEREIVIMKLIEHPNVLRLYDVW--ENKQHLYLVLEY   93 (786)
T ss_pred             ccccccCCCCceehhhhcccccceeEEEeeccccccccccccchhhhhHHHHHhcCCCeeeeeeee--ccCceEEEEEEe
Confidence            3578999999999999975 799999999987632  23346788999999999999999999998  456899999999


Q ss_pred             CCCCCHHHHhhhcCCCCCCCCHHHHHHHHHHHHHHHhhhhCCCCCCCceeecCCCCCceeecCCCCeEEecccccccccC
Q 005586          490 APKGKLSKYLDQEEGSSNVLDWSTRVSIIIGIAKGIGYLHSSEVNKPAIVHRNLSVEKVLIDQQFNPLIADCGLHKLLAD  569 (689)
Q Consensus       490 ~~~gsL~~~L~~~~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~~~ivH~dlk~~NiLl~~~~~~kl~DfGla~~~~~  569 (689)
                      +++|-|.+++-.++.    +.+.+..++..||..|+.|+|..+     |+|||+||+|+|||+.+.+||+|||+|..-.+
T Consensus        94 v~gGELFdylv~kG~----l~e~eaa~ff~QIi~gv~yCH~~~-----icHRDLKpENlLLd~~~nIKIADFGMAsLe~~  164 (786)
T KOG0588|consen   94 VPGGELFDYLVRKGP----LPEREAAHFFRQILDGVSYCHAFN-----ICHRDLKPENLLLDVKNNIKIADFGMASLEVP  164 (786)
T ss_pred             cCCchhHHHHHhhCC----CCCHHHHHHHHHHHHHHHHHhhhc-----ceeccCCchhhhhhcccCEeeeccceeecccC
Confidence            999999999987653    888999999999999999999988     99999999999999999999999999987665


Q ss_pred             CceeeeecCCCCCCCCCccccccCCC-CCcccchhHHHHHHHHHhCCCCcchhHHHHHhhhhhhHhhccccCC--CCCHH
Q 005586          570 DIVFSVLKTSAAMGYLAPEYVTTGRF-TERSDIFAFGVIILQILTGSLVLTSSMRLAAESATFENFIDRNLKG--KFSES  646 (689)
Q Consensus       570 ~~~~~~~~~~~~~~y~aPE~~~~~~~-~~ksDV~sfGvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~--~~~~~  646 (689)
                      +..  .....|++.|.|||++.+.+| ..++||||.|||||.|+||+.||++..-        ..++.+.-++  .+|..
T Consensus       165 gkl--LeTSCGSPHYA~PEIV~G~pYdG~~sDVWSCGVILfALLtG~LPFdDdNi--------r~LLlKV~~G~f~MPs~  234 (786)
T KOG0588|consen  165 GKL--LETSCGSPHYAAPEIVSGRPYDGRPSDVWSCGVILFALLTGKLPFDDDNI--------RVLLLKVQRGVFEMPSN  234 (786)
T ss_pred             Ccc--ccccCCCcccCCchhhcCCCCCCCccccchhHHHHHHHHhCCCCCCCccH--------HHHHHHHHcCcccCCCc
Confidence            542  223568899999999999999 5799999999999999999999986421        2222222222  34667


Q ss_pred             HHHHHHHHHHHhccCCCCCCCCHHHHHHHHHhh
Q 005586          647 EAAKLGKMALVCTHEDPENRPTMEAVIEELTVA  679 (689)
Q Consensus       647 ~~~~l~~l~~~Cl~~dp~~RPs~~evl~~L~~~  679 (689)
                      .+.++.+|+.+|+..||++|.|++||++|.+-.
T Consensus       235 Is~eaQdLLr~ml~VDp~~RiT~~eI~kHP~l~  267 (786)
T KOG0588|consen  235 ISSEAQDLLRRMLDVDPSTRITTEEILKHPFLS  267 (786)
T ss_pred             CCHHHHHHHHHHhccCccccccHHHHhhCchhh
Confidence            788899999999999999999999999997643

>cd05099 PTKc_FGFR4 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 4

Probab=100.00  E-value=1.2e-37  Score=327.43  Aligned_cols=260  Identities=24%  Similarity=0.418  Sum_probs=205.2

Q ss_pred             ccCCcccccccCCcceEEEEEec--------CCcEEEEEEecccCCchHHHHHHHHHHHHhcc-CCCcceeEeeEEEcCC
Q 005586          409 QCFSEVNLLGKGNFSSVYKGTLR--------DGTLVAIRSINVTSCKSEEAEFVKGLYLLTSL-RHENIIRLRGFCCSRG  479 (689)
Q Consensus       409 ~~f~~~~~lg~G~~g~Vy~~~~~--------~g~~vavK~l~~~~~~~~~~~f~~e~~~l~~l-~H~niv~l~g~~~~~~  479 (689)
                      ++|...+.||+|+||.||+|...        .+..||+|.++.........++.+|++++.++ +||||++++++|..  
T Consensus        12 ~~~~~~~~lg~G~~g~vy~~~~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~--   89 (314)
T cd05099          12 DRLVLGKPLGEGCFGQVVRAEAYGIDKSRPDQTVTVAVKMLKDNATDKDLADLISEMELMKLIGKHKNIINLLGVCTQ--   89 (314)
T ss_pred             HHeeeeeeecCCCcccEEEeeecccCCccCCcceEEEEEecCCCCChHHHHHHHHHHHHHHhccCCCCeeeEEEEEcc--
Confidence            46777899999999999999752        24579999988655445567899999999999 69999999999854  


Q ss_pred             CCeEEEEEEcCCCCCHHHHhhhcCC------------CCCCCCHHHHHHHHHHHHHHHhhhhCCCCCCCceeecCCCCCc
Q 005586          480 RGECFLIYDFAPKGKLSKYLDQEEG------------SSNVLDWSTRVSIIIGIAKGIGYLHSSEVNKPAIVHRNLSVEK  547 (689)
Q Consensus       480 ~~~~~lV~e~~~~gsL~~~L~~~~~------------~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~~~ivH~dlk~~N  547 (689)
                      .+..++||||+++|+|.+++.....            ....++|.++++++.|++.||+|||+.+     |+||||||+|
T Consensus        90 ~~~~~lv~e~~~~g~L~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~lH~~g-----i~H~dlkp~N  164 (314)
T cd05099          90 EGPLYVIVEYAAKGNLREFLRARRPPGPDYTFDITKVPEEQLSFKDLVSCAYQVARGMEYLESRR-----CIHRDLAARN  164 (314)
T ss_pred             CCceEEEEecCCCCcHHHHHHhcCCCcccccccccCCcccccCHHHHHHHHHHHHHHHHHHHHCC-----eeecccccee
Confidence            4678999999999999999976421            1235899999999999999999999987     9999999999


Q ss_pred             eeecCCCCeEEecccccccccCCceee-eecCCCCCCCCCccccccCCCCCcccchhHHHHHHHHHh-CCCCcchhHHHH
Q 005586          548 VLIDQQFNPLIADCGLHKLLADDIVFS-VLKTSAAMGYLAPEYVTTGRFTERSDIFAFGVIILQILT-GSLVLTSSMRLA  625 (689)
Q Consensus       548 iLl~~~~~~kl~DfGla~~~~~~~~~~-~~~~~~~~~y~aPE~~~~~~~~~ksDV~sfGvvl~ellt-G~~p~~~~~~~~  625 (689)
                      ||+++++.+||+|||+++......... .....++..|+|||.+.+..++.++|||||||++|||++ |+.|+.......
T Consensus       165 ill~~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~~l~el~~~g~~p~~~~~~~~  244 (314)
T cd05099         165 VLVTEDNVMKIADFGLARGVHDIDYYKKTSNGRLPVKWMAPEALFDRVYTHQSDVWSFGILMWEIFTLGGSPYPGIPVEE  244 (314)
T ss_pred             EEEcCCCcEEEccccccccccccccccccccCCCCccccCHHHHccCCcCccchhhHHHHHHHHHHhCCCCCCCCCCHHH
Confidence            999999999999999998765322111 112233457999999988889999999999999999999 888885432111


Q ss_pred             HhhhhhhHhhccccCCCCCHHHHHHHHHHHHHhccCCCCCCCCHHHHHHHHHhhC
Q 005586          626 AESATFENFIDRNLKGKFSESEAAKLGKMALVCTHEDPENRPTMEAVIEELTVAA  680 (689)
Q Consensus       626 ~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~Cl~~dp~~RPs~~evl~~L~~~~  680 (689)
                           +.+.+........+.....++.+++.+|++.+|++||++.|+++.|+...
T Consensus       245 -----~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~Rps~~~ll~~l~~~~  294 (314)
T cd05099         245 -----LFKLLREGHRMDKPSNCTHELYMLMRECWHAVPTQRPTFKQLVEALDKVL  294 (314)
T ss_pred             -----HHHHHHcCCCCCCCCCCCHHHHHHHHHHcCCCcccCcCHHHHHHHHHHHH
Confidence                 11111111122233445667889999999999999999999999998764

Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 4 (FGFR4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR4 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to

>cd05584 STKc_p70S6K Catalytic domain of the Protein Serine/Threonine Kinase, 70 kDa ribosomal protein S6 kinase

Probab=100.00  E-value=4e-38  Score=332.33  Aligned_cols=245  Identities=20%  Similarity=0.313  Sum_probs=197.0

Q ss_pred             cccccCCcceEEEEEe----cCCcEEEEEEecccCC---chHHHHHHHHHHHHhccCCCcceeEeeEEEcCCCCeEEEEE
Q 005586          415 NLLGKGNFSSVYKGTL----RDGTLVAIRSINVTSC---KSEEAEFVKGLYLLTSLRHENIIRLRGFCCSRGRGECFLIY  487 (689)
Q Consensus       415 ~~lg~G~~g~Vy~~~~----~~g~~vavK~l~~~~~---~~~~~~f~~e~~~l~~l~H~niv~l~g~~~~~~~~~~~lV~  487 (689)
                      +.||+|+||.||+++.    .+++.||+|+++....   ......+.+|++++++++||||+++++++..  .+..++||
T Consensus         2 ~~lg~G~~g~V~~~~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~E~~il~~l~hp~iv~~~~~~~~--~~~~~lv~   79 (323)
T cd05584           2 KVLGKGGYGKVFQVRKVTGADTGKIFAMKVLKKATIVRNQKDTAHTKAERNILEAVKHPFIVDLIYAFQT--GGKLYLIL   79 (323)
T ss_pred             ceeeecCCeEEEEEEEcccCCCCCEEEEEEEEHHHHHhhhhhHHHHHHHHHHHHhCCCCchhceeeEEec--CCeEEEEE
Confidence            5799999999999985    3588999999975421   2334567899999999999999999998854  46899999


Q ss_pred             EcCCCCCHHHHhhhcCCCCCCCCHHHHHHHHHHHHHHHhhhhCCCCCCCceeecCCCCCceeecCCCCeEEecccccccc
Q 005586          488 DFAPKGKLSKYLDQEEGSSNVLDWSTRVSIIIGIAKGIGYLHSSEVNKPAIVHRNLSVEKVLIDQQFNPLIADCGLHKLL  567 (689)
Q Consensus       488 e~~~~gsL~~~L~~~~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~~~ivH~dlk~~NiLl~~~~~~kl~DfGla~~~  567 (689)
                      ||+++|+|.+++....    .+.+..+..++.|++.||+|||+.+     |+||||||+|||+++++.+||+|||+++..
T Consensus        80 e~~~~~~L~~~~~~~~----~~~~~~~~~~~~qi~~~l~~lH~~~-----ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~  150 (323)
T cd05584          80 EYLSGGELFMHLEREG----IFMEDTACFYLSEISLALEHLHQQG-----IIYRDLKPENILLDAQGHVKLTDFGLCKES  150 (323)
T ss_pred             eCCCCchHHHHHHHcC----CCCHHHHHHHHHHHHHHHHHHHHCC-----eecCCCCHHHeEECCCCCEEEeeCcCCeec
Confidence            9999999999997643    3778888999999999999999987     999999999999999999999999998754


Q ss_pred             cCCceeeeecCCCCCCCCCccccccCCCCCcccchhHHHHHHHHHhCCCCcchhHHHHHhhhhhhHhhccccCCCCCHHH
Q 005586          568 ADDIVFSVLKTSAAMGYLAPEYVTTGRFTERSDIFAFGVIILQILTGSLVLTSSMRLAAESATFENFIDRNLKGKFSESE  647 (689)
Q Consensus       568 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~ksDV~sfGvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  647 (689)
                      ..... ......++..|+|||++.+..++.++|||||||++|||++|+.||.......    ....+....  ...+...
T Consensus       151 ~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~G~~pf~~~~~~~----~~~~~~~~~--~~~~~~~  223 (323)
T cd05584         151 IHEGT-VTHTFCGTIEYMAPEILMRSGHGKAVDWWSLGALMYDMLTGAPPFTAENRKK----TIDKILKGK--LNLPPYL  223 (323)
T ss_pred             ccCCC-cccccCCCccccChhhccCCCCCCcceecccHHHHHHHhcCCCCCCCCCHHH----HHHHHHcCC--CCCCCCC
Confidence            32211 1123457889999999998889999999999999999999999996543221    112222211  1233444


Q ss_pred             HHHHHHHHHHhccCCCCCCC-----CHHHHHHHHH
Q 005586          648 AAKLGKMALVCTHEDPENRP-----TMEAVIEELT  677 (689)
Q Consensus       648 ~~~l~~l~~~Cl~~dp~~RP-----s~~evl~~L~  677 (689)
                      ..++.+++.+|++.||++||     ++.+++++.+
T Consensus       224 ~~~~~~li~~~l~~~p~~R~~~~~~~~~~l~~h~~  258 (323)
T cd05584         224 TPEARDLLKKLLKRNPSSRLGAGPGDAAEVQSHPF  258 (323)
T ss_pred             CHHHHHHHHHHcccCHhHcCCCCCCCHHHHhcCCC
Confidence            66789999999999999999     8999887643

Serine/Threonine Kinases (STKs), 70 kDa ribosomal protein S6 kinase (p70S6K) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p70S6K subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p70S6K (or S6K) contains only one catalytic kinase domain, unlike p90 ribosomal S6 kinases (RSKs). It acts as a downstream effector of the STK mTOR (mammalian Target of Rapamycin) and plays a role in the regulation of the translation machinery during protein synthesis. p70S6K also plays a pivotal role in regulating cell size and glucose homeostasis. Its targets include S6, the translation initiation factor eIF3, and the in

>cd05050 PTKc_Musk Catalytic domain of the Protein Tyrosine Kinase, Muscle-specific kinase

Probab=100.00  E-value=8.4e-38  Score=324.48  Aligned_cols=258  Identities=22%  Similarity=0.417  Sum_probs=204.2

Q ss_pred             hccCCcccccccCCcceEEEEEec------CCcEEEEEEecccCCchHHHHHHHHHHHHhccCCCcceeEeeEEEcCCCC
Q 005586          408 TQCFSEVNLLGKGNFSSVYKGTLR------DGTLVAIRSINVTSCKSEEAEFVKGLYLLTSLRHENIIRLRGFCCSRGRG  481 (689)
Q Consensus       408 t~~f~~~~~lg~G~~g~Vy~~~~~------~g~~vavK~l~~~~~~~~~~~f~~e~~~l~~l~H~niv~l~g~~~~~~~~  481 (689)
                      .++|...+.||+|+||.||+|..+      ++..||+|++..........+|.+|+.++++++||||+++++++..  .+
T Consensus         4 ~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~ei~~l~~l~h~~iv~~~~~~~~--~~   81 (288)
T cd05050           4 RNNIEYVRDIGQGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASADMQADFQREAALMAEFDHPNIVKLLGVCAV--GK   81 (288)
T ss_pred             hHhceecccccccccccEEEEEEcccCCCCcceeEEEEecCCCcCHHHHHHHHHHHHHHHhcCCCchheEEEEEcC--CC
Confidence            456888899999999999999863      4688999999765544455789999999999999999999999843  46


Q ss_pred             eEEEEEEcCCCCCHHHHhhhcCC------------------CCCCCCHHHHHHHHHHHHHHHhhhhCCCCCCCceeecCC
Q 005586          482 ECFLIYDFAPKGKLSKYLDQEEG------------------SSNVLDWSTRVSIIIGIAKGIGYLHSSEVNKPAIVHRNL  543 (689)
Q Consensus       482 ~~~lV~e~~~~gsL~~~L~~~~~------------------~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~~~ivH~dl  543 (689)
                      ..++||||+++|+|.+++.....                  ....+++..++.++.|++.||+|||+.+     ++||||
T Consensus        82 ~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~aL~~lH~~~-----i~H~dl  156 (288)
T cd05050          82 PMCLLFEYMAYGDLNEFLRHRSPRAQCSLSHSTSSARKCGLNPLPLSCTEQLCIAKQVAAGMAYLSERK-----FVHRDL  156 (288)
T ss_pred             ccEEEEecCCCCCHHHHHHHcCccccccccccccccccccccccccCHHHHHHHHHHHHHHHHHHHhCC-----eecccc
Confidence            78999999999999999975321                  1124789999999999999999999887     999999


Q ss_pred             CCCceeecCCCCeEEecccccccccCCceee-eecCCCCCCCCCccccccCCCCCcccchhHHHHHHHHHh-CCCCcchh
Q 005586          544 SVEKVLIDQQFNPLIADCGLHKLLADDIVFS-VLKTSAAMGYLAPEYVTTGRFTERSDIFAFGVIILQILT-GSLVLTSS  621 (689)
Q Consensus       544 k~~NiLl~~~~~~kl~DfGla~~~~~~~~~~-~~~~~~~~~y~aPE~~~~~~~~~ksDV~sfGvvl~ellt-G~~p~~~~  621 (689)
                      ||+||++++++.+||+|||+++.+....... ......+..|+|||.+.+..++.++|||||||++|||++ |..|+...
T Consensus       157 ~p~nil~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~~~~~~p~~~~  236 (288)
T cd05050         157 ATRNCLVGENMVVKIADFGLSRNIYSADYYKASENDAIPIRWMPPESIFYNRYTTESDVWAYGVVLWEIFSYGMQPYYGM  236 (288)
T ss_pred             cHhheEecCCCceEECccccceecccCccccccCCCccChhhcCHHHHhcCCCCchhHHHHHHHHHHHHHhCCCCCCCCC
Confidence            9999999999999999999987654332111 112234567999999988899999999999999999998 87787543


Q ss_pred             HHHHHhhhhhhHhhccccCCCCCHHHHHHHHHHHHHhccCCCCCCCCHHHHHHHHH
Q 005586          622 MRLAAESATFENFIDRNLKGKFSESEAAKLGKMALVCTHEDPENRPTMEAVIEELT  677 (689)
Q Consensus       622 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~Cl~~dp~~RPs~~evl~~L~  677 (689)
                      ....    ....+.+... ...+...+.++.+++.+|++.+|++||++.|+++.|+
T Consensus       237 ~~~~----~~~~~~~~~~-~~~~~~~~~~l~~li~~~l~~~p~~Rpt~~el~~~l~  287 (288)
T cd05050         237 AHEE----VIYYVRDGNV-LSCPDNCPLELYNLMRLCWSKLPSDRPSFASINRILQ  287 (288)
T ss_pred             CHHH----HHHHHhcCCC-CCCCCCCCHHHHHHHHHHcccCcccCCCHHHHHHHhh
Confidence            2211    1111111111 1123345678999999999999999999999999886

Protein Tyrosine Kinase (PTK) family; Muscle-specific kinase (Musk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Musk is a receptor tyr kinase (RTK) containing an extracellular region with four immunoglobulin-like domains and a cysteine-rich cluster, a transmembrane segment, and an intracellular catalytic domain. Musk is expressed and concentrated in the postsynaptic membrane in skeletal muscle. It is essential for the establishment of the neuromuscular junction (NMJ), a peripheral synapse that conveys signals from motor neurons to muscle cells. Agrin, a large proteoglycan released from motor neurons, stimulates M

>cd05601 STKc_CRIK Catalytic domain of the Protein Serine/Threonine Kinase, Citron Rho-interacting kinase

Probab=100.00  E-value=1.3e-38  Score=337.22  Aligned_cols=254  Identities=20%  Similarity=0.281  Sum_probs=203.0

Q ss_pred             ccCCcccccccCCcceEEEEEec-CCcEEEEEEecccCC--chHHHHHHHHHHHHhccCCCcceeEeeEEEcCCCCeEEE
Q 005586          409 QCFSEVNLLGKGNFSSVYKGTLR-DGTLVAIRSINVTSC--KSEEAEFVKGLYLLTSLRHENIIRLRGFCCSRGRGECFL  485 (689)
Q Consensus       409 ~~f~~~~~lg~G~~g~Vy~~~~~-~g~~vavK~l~~~~~--~~~~~~f~~e~~~l~~l~H~niv~l~g~~~~~~~~~~~l  485 (689)
                      ++|...+.||+|+||.||++..+ +|+.||+|+++....  ......+.+|+.+++.++|+||+++++++..  .+..++
T Consensus         1 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~i~~~~~~~~i~~~~~~~~~--~~~~~l   78 (330)
T cd05601           1 KDFDVKSLVGRGHFGEVQVVREKATGDIYAMKVMKKSVLLAQETVSFFEEERDILSISNSPWIPQLQYAFQD--KDNLYL   78 (330)
T ss_pred             CCceEEEEEEeccCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCCcceeeEEec--CCeEEE
Confidence            36788899999999999999875 689999999986532  2344678899999999999999999998844  468999


Q ss_pred             EEEcCCCCCHHHHhhhcCCCCCCCCHHHHHHHHHHHHHHHhhhhCCCCCCCceeecCCCCCceeecCCCCeEEecccccc
Q 005586          486 IYDFAPKGKLSKYLDQEEGSSNVLDWSTRVSIIIGIAKGIGYLHSSEVNKPAIVHRNLSVEKVLIDQQFNPLIADCGLHK  565 (689)
Q Consensus       486 V~e~~~~gsL~~~L~~~~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~~~ivH~dlk~~NiLl~~~~~~kl~DfGla~  565 (689)
                      ||||+++|+|.+++....   ..+++.....++.|++.||+|||+.+     |+||||||+|||+++++.+||+|||+++
T Consensus        79 v~e~~~~~~L~~~l~~~~---~~l~~~~~~~~~~qi~~aL~~lH~~~-----i~H~Dlkp~NIll~~~~~~kL~Dfg~a~  150 (330)
T cd05601          79 VMEYQPGGDLLSLLNRYE---DQFDEDMAQFYLAELVLAIHSVHQMG-----YVHRDIKPENVLIDRTGHIKLADFGSAA  150 (330)
T ss_pred             EECCCCCCCHHHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHHCC-----eEcccCchHheEECCCCCEEeccCCCCe
Confidence            999999999999997653   24899999999999999999999987     9999999999999999999999999998


Q ss_pred             cccCCceeeeecCCCCCCCCCccccc------cCCCCCcccchhHHHHHHHHHhCCCCcchhHHHHHhhhhhhHhhcccc
Q 005586          566 LLADDIVFSVLKTSAAMGYLAPEYVT------TGRFTERSDIFAFGVIILQILTGSLVLTSSMRLAAESATFENFIDRNL  639 (689)
Q Consensus       566 ~~~~~~~~~~~~~~~~~~y~aPE~~~------~~~~~~ksDV~sfGvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~  639 (689)
                      .+............++..|+|||++.      ...++.++|||||||++|||++|+.||.......    .+..+.....
T Consensus       151 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~DiwslG~il~el~~g~~Pf~~~~~~~----~~~~i~~~~~  226 (330)
T cd05601         151 RLTANKMVNSKLPVGTPDYIAPEVLTTMNGDGKGTYGVECDWWSLGVIAYEMIYGRSPFHEGTSAK----TYNNIMNFQR  226 (330)
T ss_pred             ECCCCCceeeecccCCccccCHHHhccccccccCCCCCcceeecccceeeeeccCCCCCCCCCHHH----HHHHHHcCCC
Confidence            76544332333346788999999986      4567899999999999999999999996542221    1122221111


Q ss_pred             CCCCC--HHHHHHHHHHHHHhccCCCCCCCCHHHHHHHHH
Q 005586          640 KGKFS--ESEAAKLGKMALVCTHEDPENRPTMEAVIEELT  677 (689)
Q Consensus       640 ~~~~~--~~~~~~l~~l~~~Cl~~dp~~RPs~~evl~~L~  677 (689)
                      ...++  ...+..+.+++..|++ +|++||++.+++++-+
T Consensus       227 ~~~~~~~~~~~~~~~~li~~ll~-~p~~R~t~~~l~~h~~  265 (330)
T cd05601         227 FLKFPEDPKVSSDFLDLIQSLLC-GQKERLGYEGLCCHPF  265 (330)
T ss_pred             ccCCCCCCCCCHHHHHHHHHHcc-ChhhCCCHHHHhCCCC
Confidence            11111  1245678899999998 9999999999997644

Serine/Threonine Kinases (STKs), Citron Rho-interacting kinase (CRIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CRIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CRIK is also called citron kinase. It contains a catalytic domain, a central coiled-coil domain, and a C-terminal region containing a Rho-binding domain (RBD), a zinc finger, and a pleckstrin homology (PH) domain, in addition to other motifs. CRIK, an effector of the small GTPase Rho, plays an important function during cytokinesis and affects its contractile process. CRIK-deficient mice show severe ataxia and epilepsy as a result of abnor

>cd05034 PTKc_Src_like Catalytic domain of Src kinase-like Protein Tyrosine Kinases

Probab=100.00  E-value=8.7e-38  Score=319.32  Aligned_cols=255  Identities=27%  Similarity=0.498  Sum_probs=207.0

Q ss_pred             hccCCcccccccCCcceEEEEEecCCcEEEEEEecccCCchHHHHHHHHHHHHhccCCCcceeEeeEEEcCCCCeEEEEE
Q 005586          408 TQCFSEVNLLGKGNFSSVYKGTLRDGTLVAIRSINVTSCKSEEAEFVKGLYLLTSLRHENIIRLRGFCCSRGRGECFLIY  487 (689)
Q Consensus       408 t~~f~~~~~lg~G~~g~Vy~~~~~~g~~vavK~l~~~~~~~~~~~f~~e~~~l~~l~H~niv~l~g~~~~~~~~~~~lV~  487 (689)
                      .++|...+.||+|+||.||+|..+++..||||.+....  ....++.+|+.++++++|+||+++++++..  ....++||
T Consensus         5 ~~~~~i~~~ig~g~~~~v~~~~~~~~~~~~vK~~~~~~--~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~--~~~~~~v~   80 (261)
T cd05034           5 RESLKLERKLGAGQFGEVWMGTWNGTTKVAVKTLKPGT--MSPEAFLQEAQIMKKLRHDKLVQLYAVCSE--EEPIYIVT   80 (261)
T ss_pred             hhheeeeeeeccCcceEEEEEEEcCCceEEEEEecCCc--cCHHHHHHHHHHHhhCCCCCEeeeeeeeec--CCceEEEE
Confidence            35677889999999999999998888899999987653  234679999999999999999999998843  46789999


Q ss_pred             EcCCCCCHHHHhhhcCCCCCCCCHHHHHHHHHHHHHHHhhhhCCCCCCCceeecCCCCCceeecCCCCeEEecccccccc
Q 005586          488 DFAPKGKLSKYLDQEEGSSNVLDWSTRVSIIIGIAKGIGYLHSSEVNKPAIVHRNLSVEKVLIDQQFNPLIADCGLHKLL  567 (689)
Q Consensus       488 e~~~~gsL~~~L~~~~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~~~ivH~dlk~~NiLl~~~~~~kl~DfGla~~~  567 (689)
                      ||+++++|.+++....+  ..+++.++..++.+++.||+|||+.+     ++|+||||+||++++++.+|++|||+++.+
T Consensus        81 e~~~~~~L~~~i~~~~~--~~~~~~~~~~~~~~i~~al~~lh~~~-----i~h~di~p~nili~~~~~~~l~d~g~~~~~  153 (261)
T cd05034          81 EYMSKGSLLDFLKSGEG--KKLRLPQLVDMAAQIAEGMAYLESRN-----YIHRDLAARNILVGENLVCKIADFGLARLI  153 (261)
T ss_pred             eccCCCCHHHHHhcccc--CCCCHHHHHHHHHHHHHHHHHHHhCC-----cccCCcchheEEEcCCCCEEECccccceec
Confidence            99999999999986542  34899999999999999999999987     999999999999999999999999999876


Q ss_pred             cCCceeeeecCCCCCCCCCccccccCCCCCcccchhHHHHHHHHHh-CCCCcchhHHHHHhhhhhhHhhccccCCCCCHH
Q 005586          568 ADDIVFSVLKTSAAMGYLAPEYVTTGRFTERSDIFAFGVIILQILT-GSLVLTSSMRLAAESATFENFIDRNLKGKFSES  646 (689)
Q Consensus       568 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~ksDV~sfGvvl~ellt-G~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  646 (689)
                      .............+..|+|||.+.+..++.++|||||||++||++| |+.||.......    ... .+........+..
T Consensus       154 ~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~il~~l~t~g~~p~~~~~~~~----~~~-~~~~~~~~~~~~~  228 (261)
T cd05034         154 EDDEYTAREGAKFPIKWTAPEAANYGRFTIKSDVWSFGILLTEIVTYGRVPYPGMTNRE----VLE-QVERGYRMPRPPN  228 (261)
T ss_pred             cchhhhhhhccCCCccccCHHHhccCCcCchhHHHHHHHHHHHHHhCCCCCCCCCCHHH----HHH-HHHcCCCCCCCCC
Confidence            5432222222334567999999998889999999999999999999 999985432111    111 1111222223334


Q ss_pred             HHHHHHHHHHHhccCCCCCCCCHHHHHHHHHh
Q 005586          647 EAAKLGKMALVCTHEDPENRPTMEAVIEELTV  678 (689)
Q Consensus       647 ~~~~l~~l~~~Cl~~dp~~RPs~~evl~~L~~  678 (689)
                      .+.++.+++.+|++.+|++||+++++.+.|+.
T Consensus       229 ~~~~~~~~i~~~l~~~p~~Rp~~~~l~~~l~~  260 (261)
T cd05034         229 CPEELYDLMLQCWDKDPEERPTFEYLQSFLED  260 (261)
T ss_pred             CCHHHHHHHHHHcccCcccCCCHHHHHHHHhc
Confidence            46689999999999999999999999998864

Protein Tyrosine Kinase (PTK) family; Src kinase subfamily; catalytic (c) domain. Src subfamily members include Src, Lck, Hck, Blk, Lyn, Fgr, Fyn, Yrk, and Yes. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) proteins are cytoplasmic (or non-receptor) tyr kinases which are anchored to the plasma membrane. They contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-t

>cd05082 PTKc_Csk Catalytic domain of the Protein Tyrosine Kinase, C-terminal Src kinase

Probab=100.00  E-value=1.2e-37  Score=317.44  Aligned_cols=249  Identities=23%  Similarity=0.435  Sum_probs=201.4

Q ss_pred             ccCCcccccccCCcceEEEEEecCCcEEEEEEecccCCchHHHHHHHHHHHHhccCCCcceeEeeEEEcCCCCeEEEEEE
Q 005586          409 QCFSEVNLLGKGNFSSVYKGTLRDGTLVAIRSINVTSCKSEEAEFVKGLYLLTSLRHENIIRLRGFCCSRGRGECFLIYD  488 (689)
Q Consensus       409 ~~f~~~~~lg~G~~g~Vy~~~~~~g~~vavK~l~~~~~~~~~~~f~~e~~~l~~l~H~niv~l~g~~~~~~~~~~~lV~e  488 (689)
                      ++|...+.||+|+||.||+|..+ |..||+|.+....   ..+.|.+|+.++++++|+|++++++++... ....++|||
T Consensus         6 ~~~~~~~~lg~g~~~~v~~~~~~-~~~~~~k~~~~~~---~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~-~~~~~lv~e   80 (256)
T cd05082           6 KELKLLQTIGKGEFGDVMLGDYR-GNKVAVKCIKNDA---TAQAFLAEASVMTQLRHSNLVQLLGVIVEE-KGGLYIVTE   80 (256)
T ss_pred             HhCeeeeeecccCCCeEEEEEEc-CCcEEEEEeCCCc---hHHHHHHHHHHHHhCCCCCeeeEEEEEEcC-CCceEEEEE
Confidence            35777899999999999999876 7889999986532   345799999999999999999999987543 456899999


Q ss_pred             cCCCCCHHHHhhhcCCCCCCCCHHHHHHHHHHHHHHHhhhhCCCCCCCceeecCCCCCceeecCCCCeEEeccccccccc
Q 005586          489 FAPKGKLSKYLDQEEGSSNVLDWSTRVSIIIGIAKGIGYLHSSEVNKPAIVHRNLSVEKVLIDQQFNPLIADCGLHKLLA  568 (689)
Q Consensus       489 ~~~~gsL~~~L~~~~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~~~ivH~dlk~~NiLl~~~~~~kl~DfGla~~~~  568 (689)
                      |+++|+|.++++....  ..++|..++.++.|++.||+|||+.+     |+||||||+||++++++.+||+|||+++...
T Consensus        81 ~~~~~~L~~~~~~~~~--~~~~~~~~~~~~~~i~~~l~~lH~~~-----i~H~dlkp~nil~~~~~~~kl~dfg~~~~~~  153 (256)
T cd05082          81 YMAKGSLVDYLRSRGR--SVLGGDCLLKFSLDVCEAMEYLEANN-----FVHRDLAARNVLVSEDNVAKVSDFGLTKEAS  153 (256)
T ss_pred             CCCCCcHHHHHHhcCC--CCCCHHHHHHHHHHHHHHHHHHHhCC-----EeccccchheEEEcCCCcEEecCCccceecc
Confidence            9999999999976532  34889999999999999999999987     9999999999999999999999999988654


Q ss_pred             CCceeeeecCCCCCCCCCccccccCCCCCcccchhHHHHHHHHHh-CCCCcchhHHHHHhhhhhhHhhccccCCCCCHHH
Q 005586          569 DDIVFSVLKTSAAMGYLAPEYVTTGRFTERSDIFAFGVIILQILT-GSLVLTSSMRLAAESATFENFIDRNLKGKFSESE  647 (689)
Q Consensus       569 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~ksDV~sfGvvl~ellt-G~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  647 (689)
                      ...    .....+..|+|||++.+..++.++|||||||++|||++ |+.|+.......     ....+........+...
T Consensus       154 ~~~----~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~i~~~l~~~g~~p~~~~~~~~-----~~~~~~~~~~~~~~~~~  224 (256)
T cd05082         154 STQ----DTGKLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRIPLKD-----VVPRVEKGYKMDAPDGC  224 (256)
T ss_pred             ccC----CCCccceeecCHHHHccCCCCchhhhHHHHHHHHHHHhCCCCCCCCCCHHH-----HHHHHhcCCCCCCCCCC
Confidence            321    12234567999999988889999999999999999998 998885421111     11111112222333445


Q ss_pred             HHHHHHHHHHhccCCCCCCCCHHHHHHHHHh
Q 005586          648 AAKLGKMALVCTHEDPENRPTMEAVIEELTV  678 (689)
Q Consensus       648 ~~~l~~l~~~Cl~~dp~~RPs~~evl~~L~~  678 (689)
                      +..+.+++.+|++.+|++||++.+++++|+.
T Consensus       225 ~~~~~~li~~~l~~~p~~Rpt~~~l~~~l~~  255 (256)
T cd05082         225 PPVVYDVMKQCWHLDAATRPSFLQLREQLEH  255 (256)
T ss_pred             CHHHHHHHHHHhcCChhhCcCHHHHHHHHhc
Confidence            6789999999999999999999999999875

Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk catalyzes the tyr phosphorylation of the regulatory C-terminal tail of Src kinases, re

>cd05042 PTKc_Aatyk Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases

Probab=100.00  E-value=1.2e-37  Score=319.88  Aligned_cols=254  Identities=22%  Similarity=0.352  Sum_probs=191.2

Q ss_pred             ccccCCcceEEEEEecC---CcEEEEEEecccCCchHHHHHHHHHHHHhccCCCcceeEeeEEEcCCCCeEEEEEEcCCC
Q 005586          416 LLGKGNFSSVYKGTLRD---GTLVAIRSINVTSCKSEEAEFVKGLYLLTSLRHENIIRLRGFCCSRGRGECFLIYDFAPK  492 (689)
Q Consensus       416 ~lg~G~~g~Vy~~~~~~---g~~vavK~l~~~~~~~~~~~f~~e~~~l~~l~H~niv~l~g~~~~~~~~~~~lV~e~~~~  492 (689)
                      .||+|+||.||+|...+   ...+|+|.+...........|.+|++.++.++|+||+++++++..  ....++||||+++
T Consensus         2 ~lg~G~fg~v~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~e~~~~~~l~h~nii~~~~~~~~--~~~~~lv~e~~~~   79 (269)
T cd05042           2 EIGNGWFGKVLLGEAHRGMSKARVVVKELRASATPDEQLLFLQEVQPYRELNHPNVLQCLGQCIE--SIPYLLVLEFCPL   79 (269)
T ss_pred             cCCccCCceEEEEEEecCCCCeEEEEeecCccCChHHHHHHHHHHHHHHhCCCCCcceEEEEECC--CCceEEEEEeCCC
Confidence            59999999999997643   457888988765544556788999999999999999999999843  5679999999999


Q ss_pred             CCHHHHhhhcCCC-CCCCCHHHHHHHHHHHHHHHhhhhCCCCCCCceeecCCCCCceeecCCCCeEEecccccccccCCc
Q 005586          493 GKLSKYLDQEEGS-SNVLDWSTRVSIIIGIAKGIGYLHSSEVNKPAIVHRNLSVEKVLIDQQFNPLIADCGLHKLLADDI  571 (689)
Q Consensus       493 gsL~~~L~~~~~~-~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~~~ivH~dlk~~NiLl~~~~~~kl~DfGla~~~~~~~  571 (689)
                      |+|.+++...... ....++...+.++.|++.||+|||+.+     |+||||||+|||+++++.+||+|||+++......
T Consensus        80 g~L~~~l~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~-----ivH~dlkp~Nill~~~~~~kl~dfg~~~~~~~~~  154 (269)
T cd05042          80 GDLKNYLRSNRGMVAQMAQKDVLQRMACEVASGLLWLHQAD-----FIHSDLALRNCQLTADLSVKIGDYGLALEQYPED  154 (269)
T ss_pred             CcHHHHHHhccccccccccHHHHHHHHHHHHHHHHHHHhcC-----EecccccHhheEecCCCcEEEeccccccccccch
Confidence            9999999775432 233578888999999999999999987     9999999999999999999999999987543322


Q ss_pred             ee-eeecCCCCCCCCCcccccc-------CCCCCcccchhHHHHHHHHHh-CCCCcchhHHHHHhhhhhhHhhccccCCC
Q 005586          572 VF-SVLKTSAAMGYLAPEYVTT-------GRFTERSDIFAFGVIILQILT-GSLVLTSSMRLAAESATFENFIDRNLKGK  642 (689)
Q Consensus       572 ~~-~~~~~~~~~~y~aPE~~~~-------~~~~~ksDV~sfGvvl~ellt-G~~p~~~~~~~~~~~~~~~~~~~~~~~~~  642 (689)
                      .. ......++..|+|||++..       ..++.++|||||||++|||++ |+.|+..............+...+.....
T Consensus       155 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~~l~el~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~  234 (269)
T cd05042         155 YYITKDCHAVPLRWLAPELVEIRGQDLLPKDQTKKSNIWSLGVTMWELFTAADQPYPDLSDEQVLKQVVREQDIKLPKPQ  234 (269)
T ss_pred             heeccCCCCCcccccCHHHHhhccccccccccchhhHHHHHHHHHHHHHhCCCCCCCcCCHHHHHHHHhhccCccCCCCc
Confidence            11 1222334567999998643       356889999999999999999 77787543221111111111000001112


Q ss_pred             CCHHHHHHHHHHHHHhccCCCCCCCCHHHHHHHHH
Q 005586          643 FSESEAAKLGKMALVCTHEDPENRPTMEAVIEELT  677 (689)
Q Consensus       643 ~~~~~~~~l~~l~~~Cl~~dp~~RPs~~evl~~L~  677 (689)
                      .+......+.+++..|| .||++||+++||++.|.
T Consensus       235 ~~~~~~~~~~~~~~~~~-~dp~~Rpt~~~v~~~l~  268 (269)
T cd05042         235 LDLKYSDRWYEVMQFCW-LDPETRPTAEEVHELLT  268 (269)
T ss_pred             ccccCCHHHHHHHHHHh-cCcccccCHHHHHHHhc
Confidence            23344567788889998 59999999999998873

Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase (Aatyk) subfamily; catalytic (c) domain. The Aatyk subfamily is also referred to as the lemur tyrosine kinase (Lmtk) subfamily. It consists of Aatyk1 (Lmtk1), Aatyk2 (Lmtk2, Brek), Aatyk3 (Lmtk3), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk proteins are mostly receptor tyr kinases (RTKs) containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 does not contain a transmembrane segment and is a cytoplasmic (or nonreceptor) kinase. Aatyk proteins are classified as tyr kina

>cd05057 PTKc_EGFR_like Catalytic domain of Epidermal Growth Factor Receptor-like Protein Tyrosine Kinases

Probab=100.00  E-value=1.7e-37  Score=320.67  Aligned_cols=263  Identities=25%  Similarity=0.451  Sum_probs=210.3

Q ss_pred             ccCCcccccccCCcceEEEEEec-CCc----EEEEEEecccCCchHHHHHHHHHHHHhccCCCcceeEeeEEEcCCCCeE
Q 005586          409 QCFSEVNLLGKGNFSSVYKGTLR-DGT----LVAIRSINVTSCKSEEAEFVKGLYLLTSLRHENIIRLRGFCCSRGRGEC  483 (689)
Q Consensus       409 ~~f~~~~~lg~G~~g~Vy~~~~~-~g~----~vavK~l~~~~~~~~~~~f~~e~~~l~~l~H~niv~l~g~~~~~~~~~~  483 (689)
                      .+|...+.||+|+||.||+|..+ +|.    .||+|.+..........++.+|+..+++++||||++++++|..   ...
T Consensus         7 ~~~~~~~~ig~g~~g~v~~~~~~~~~~~~~~~~aik~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~---~~~   83 (279)
T cd05057           7 TELEKIKVLGSGAFGTVYKGVWIPEGEKVKIPVAIKVLREETSPKANKEILDEAYVMASVDHPHVVRLLGICLS---SQV   83 (279)
T ss_pred             HHcEEcceecCCCCccEEEEEEecCCCCcceEEEEEeccCCCCHHHHHHHHHHHHHHHhCCCCCcceEEEEEec---Cce
Confidence            35667789999999999999875 333    6899988776544555789999999999999999999999854   578


Q ss_pred             EEEEEcCCCCCHHHHhhhcCCCCCCCCHHHHHHHHHHHHHHHhhhhCCCCCCCceeecCCCCCceeecCCCCeEEecccc
Q 005586          484 FLIYDFAPKGKLSKYLDQEEGSSNVLDWSTRVSIIIGIAKGIGYLHSSEVNKPAIVHRNLSVEKVLIDQQFNPLIADCGL  563 (689)
Q Consensus       484 ~lV~e~~~~gsL~~~L~~~~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~~~ivH~dlk~~NiLl~~~~~~kl~DfGl  563 (689)
                      ++||||+++|+|.+++.....   .+++..++.++.|++.||+|||+.+     |+||||||+||++++++.+||+|||+
T Consensus        84 ~~v~e~~~~g~L~~~l~~~~~---~~~~~~~~~~~~qi~~~l~~LH~~~-----i~H~di~p~nil~~~~~~~kL~dfg~  155 (279)
T cd05057          84 QLITQLMPLGCLLDYVRNHKD---NIGSQYLLNWCVQIAKGMSYLEEKR-----LVHRDLAARNVLVKTPQHVKITDFGL  155 (279)
T ss_pred             EEEEecCCCCcHHHHHHhccC---CCCHHHHHHHHHHHHHHHHHHHhCC-----EEecccCcceEEEcCCCeEEECCCcc
Confidence            999999999999999986543   3899999999999999999999977     99999999999999999999999999


Q ss_pred             cccccCCce-eeeecCCCCCCCCCccccccCCCCCcccchhHHHHHHHHHh-CCCCcchhHHHHHhhhhhhHhhccccCC
Q 005586          564 HKLLADDIV-FSVLKTSAAMGYLAPEYVTTGRFTERSDIFAFGVIILQILT-GSLVLTSSMRLAAESATFENFIDRNLKG  641 (689)
Q Consensus       564 a~~~~~~~~-~~~~~~~~~~~y~aPE~~~~~~~~~ksDV~sfGvvl~ellt-G~~p~~~~~~~~~~~~~~~~~~~~~~~~  641 (689)
                      ++....... ........+..|+|||.+....++.++|||||||++||++| |+.|+.......     +.+.+......
T Consensus       156 ~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~~-----~~~~~~~~~~~  230 (279)
T cd05057         156 AKLLDVDEKEYHAEGGKVPIKWMALESILHRIYTHKSDVWSYGVTVWELMTFGAKPYEGIPAVE-----IPDLLEKGERL  230 (279)
T ss_pred             cccccCcccceecCCCcccccccCHHHhhcCCcCchhhHHHHHHHHHHHhcCCCCCCCCCCHHH-----HHHHHhCCCCC
Confidence            987653321 11112223467999999988889999999999999999999 999986542211     11122211112


Q ss_pred             CCCHHHHHHHHHHHHHhccCCCCCCCCHHHHHHHHHhhCCcccccc
Q 005586          642 KFSESEAAKLGKMALVCTHEDPENRPTMEAVIEELTVAAPVMATFL  687 (689)
Q Consensus       642 ~~~~~~~~~l~~l~~~Cl~~dp~~RPs~~evl~~L~~~~p~~~~~~  687 (689)
                      ..+..+...+.+++..||..+|.+||++.++++.|.......+.|+
T Consensus       231 ~~~~~~~~~~~~~~~~~l~~~p~~Rp~~~~l~~~l~~~~~~~~~~~  276 (279)
T cd05057         231 PQPPICTIDVYMVLVKCWMIDAESRPTFKELINEFSKMARDPQRYL  276 (279)
T ss_pred             CCCCCCCHHHHHHHHHHcCCChhhCCCHHHHHHHHHHHHhCCcceE
Confidence            2233455678999999999999999999999999998876665543

Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR) subfamily; catalytic (c) domain. EGFR (HER, ErbB) subfamily members include EGFR (HER1, ErbB1), HER2 (ErbB2), HER3 (ErbB3), HER4 (ErbB4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The EGFR proteins are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instea

>cd08229 STKc_Nek7 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 7

Probab=100.00  E-value=9.3e-38  Score=320.24  Aligned_cols=260  Identities=20%  Similarity=0.340  Sum_probs=206.6

Q ss_pred             cCCcccccccCCcceEEEEEec-CCcEEEEEEecccCC--chHHHHHHHHHHHHhccCCCcceeEeeEEEcCCCCeEEEE
Q 005586          410 CFSEVNLLGKGNFSSVYKGTLR-DGTLVAIRSINVTSC--KSEEAEFVKGLYLLTSLRHENIIRLRGFCCSRGRGECFLI  486 (689)
Q Consensus       410 ~f~~~~~lg~G~~g~Vy~~~~~-~g~~vavK~l~~~~~--~~~~~~f~~e~~~l~~l~H~niv~l~g~~~~~~~~~~~lV  486 (689)
                      +|...+.||+|+||.||+|... +|..+|||.+.....  .....+|.+|+.+++.++|+||+++++++..  .+..++|
T Consensus         3 ~y~~~~~ig~g~~g~v~~~~~~~~~~~~~vK~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~--~~~~~~v   80 (267)
T cd08229           3 NFRIEKKIGRGQFSEVYRATCLLDGVPVALKKVQIFDLMDAKARADCIKEIDLLKQLNHPNVIKYYASFIE--DNELNIV   80 (267)
T ss_pred             hhhhhhhhcccCCeEEEEEeecCCCceEEEEeeeehhhhhHHHHHHHHHHHHHHHHccCCchhhhhheeEe--CCeEEEE
Confidence            5677789999999999999964 799999998875432  2344689999999999999999999999855  4688999


Q ss_pred             EEcCCCCCHHHHhhhcCCCCCCCCHHHHHHHHHHHHHHHhhhhCCCCCCCceeecCCCCCceeecCCCCeEEeccccccc
Q 005586          487 YDFAPKGKLSKYLDQEEGSSNVLDWSTRVSIIIGIAKGIGYLHSSEVNKPAIVHRNLSVEKVLIDQQFNPLIADCGLHKL  566 (689)
Q Consensus       487 ~e~~~~gsL~~~L~~~~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~~~ivH~dlk~~NiLl~~~~~~kl~DfGla~~  566 (689)
                      |||+++++|.+++.........++|..++.++.|++.||+|||+.+     ++|+||||+||+++.++.++|+|||++..
T Consensus        81 ~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~-----i~H~dl~p~nili~~~~~~~l~dfg~~~~  155 (267)
T cd08229          81 LELADAGDLSRMIKHFKKQKRLIPEKTVWKYFVQLCSALEHMHSRR-----VMHRDIKPANVFITATGVVKLGDLGLGRF  155 (267)
T ss_pred             EEecCCCCHHHHHHHhhccCCCCCHHHHHHHHHHHHHHHHHHHHCC-----eecCCCCHHHEEEcCCCCEEECcchhhhc
Confidence            9999999999998754333446899999999999999999999987     99999999999999999999999999886


Q ss_pred             ccCCceeeeecCCCCCCCCCccccccCCCCCcccchhHHHHHHHHHhCCCCcchhHHHHHhhhhhhHhhccccCCCCCHH
Q 005586          567 LADDIVFSVLKTSAAMGYLAPEYVTTGRFTERSDIFAFGVIILQILTGSLVLTSSMRLAAESATFENFIDRNLKGKFSES  646 (689)
Q Consensus       567 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~ksDV~sfGvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  646 (689)
                      ...... ......++..|+|||++.+..++.++||||||+++|||++|+.|+........  .....+............
T Consensus       156 ~~~~~~-~~~~~~~~~~~~ape~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~--~~~~~~~~~~~~~~~~~~  232 (267)
T cd08229         156 FSSKTT-AAHSLVGTPYYMSPERIHENGYNFKSDIWSLGCLLYEMAALQSPFYGDKMNLY--SLCKKIEQCDYPPLPSDH  232 (267)
T ss_pred             cccCCc-ccccccCCcCccCHHHhcCCCccchhhHHHHHHHHHHHHhCCCCcccccchHH--HHhhhhhcCCCCCCCccc
Confidence            644321 11223467789999999888899999999999999999999999854321100  011111111111111234


Q ss_pred             HHHHHHHHHHHhccCCCCCCCCHHHHHHHHHhh
Q 005586          647 EAAKLGKMALVCTHEDPENRPTMEAVIEELTVA  679 (689)
Q Consensus       647 ~~~~l~~l~~~Cl~~dp~~RPs~~evl~~L~~~  679 (689)
                      ....+.+++.+||+.+|++||||.+|++.++..
T Consensus       233 ~~~~~~~li~~~l~~~p~~Rpt~~~i~~~~~~~  265 (267)
T cd08229         233 YSEELRQLVNMCINPDPEKRPDITYVYDVAKRM  265 (267)
T ss_pred             ccHHHHHHHHHhcCCCcccCCCHHHHHHHHhhh
Confidence            566899999999999999999999999998764

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 7 (Nek7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek7 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek7 is required for mitotic spindle formation and cytokinesis. It is enriched in the centrosome and is critical for microtubule nucleation. Nek7 is activated by Nek9 during mitosis, and may regulate the p70 ribosomal S6 kinase.

>KOG0589 consensus Serine/threonine protein kinase [General function prediction only]

Probab=100.00  E-value=1.2e-38  Score=330.83  Aligned_cols=253  Identities=19%  Similarity=0.342  Sum_probs=213.5

Q ss_pred             ccCCcccccccCCcceEEEEEec-CCcEEEEEEecccCCc-hHHHHHHHHHHHHhccCCCcceeEeeEEEcCCCCeEEEE
Q 005586          409 QCFSEVNLLGKGNFSSVYKGTLR-DGTLVAIRSINVTSCK-SEEAEFVKGLYLLTSLRHENIIRLRGFCCSRGRGECFLI  486 (689)
Q Consensus       409 ~~f~~~~~lg~G~~g~Vy~~~~~-~g~~vavK~l~~~~~~-~~~~~f~~e~~~l~~l~H~niv~l~g~~~~~~~~~~~lV  486 (689)
                      ++|...+.+|+|+||.++..+.+ +++.+|+|.+...... ..++...+|+.++++++|||||.+.+.+.++ ....+||
T Consensus         4 ~~Ye~~~~iG~GafG~a~lvrhk~~~~~~vlK~I~l~~~t~~~r~~A~~E~~lis~~~hP~iv~y~ds~~~~-~~~l~Iv   82 (426)
T KOG0589|consen    4 DNYEVLRQVGRGAFGSALLVRHKSDDKLYVLKKINLEKLTEPERRSAIQEMDLLSKLLHPNIVEYKDSFEED-GQLLCIV   82 (426)
T ss_pred             chhhhhhhcCccccchhhhhhhccCCceEEEEEEeccccCchhhHHHHHHHHHHHhccCCCeeeeccchhcC-CceEEEE
Confidence            45677889999999999999876 6889999999876643 3445788999999999999999999988553 3348999


Q ss_pred             EEcCCCCCHHHHhhhcCCCCCCCCHHHHHHHHHHHHHHHhhhhCCCCCCCceeecCCCCCceeecCCCCeEEeccccccc
Q 005586          487 YDFAPKGKLSKYLDQEEGSSNVLDWSTRVSIIIGIAKGIGYLHSSEVNKPAIVHRNLSVEKVLIDQQFNPLIADCGLHKL  566 (689)
Q Consensus       487 ~e~~~~gsL~~~L~~~~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~~~ivH~dlk~~NiLl~~~~~~kl~DfGla~~  566 (689)
                      |+|++||+|.+.+....+  ..+++...+.+..|++.|+.|||+..     |+|||||+.||+++++..+||+|||+|+.
T Consensus        83 m~Y~eGg~l~~~i~~~k~--~~f~E~~i~~~~~Q~~~av~ylH~~~-----iLHRDlK~~Nifltk~~~VkLgDfGlaK~  155 (426)
T KOG0589|consen   83 MEYCEGGDLAQLIKEQKG--VLFPEERILKWFVQILLAVNYLHENR-----VLHRDLKCANIFLTKDKKVKLGDFGLAKI  155 (426)
T ss_pred             EeecCCCCHHHHHHHHhh--ccccHHHHHHHHHHHHHHHHHHHhhh-----hhcccchhhhhhccccCceeecchhhhhh
Confidence            999999999999987653  35889999999999999999999876     99999999999999999999999999999


Q ss_pred             ccCCceeeeecCCCCCCCCCccccccCCCCCcccchhHHHHHHHHHhCCCCcchhHHHHHhhhhhhHhhccccCCCCCHH
Q 005586          567 LADDIVFSVLKTSAAMGYLAPEYVTTGRFTERSDIFAFGVIILQILTGSLVLTSSMRLAAESATFENFIDRNLKGKFSES  646 (689)
Q Consensus       567 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~ksDV~sfGvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  646 (689)
                      +..+.. ......||+.||.||.+.+.+|..|+|+||+||++|||++-+.+|...........+.     +......+..
T Consensus       156 l~~~~~-~a~tvvGTp~YmcPEil~d~pYn~KSDiWsLGC~~yEm~~lk~aF~a~~m~~Li~ki~-----~~~~~Plp~~  229 (426)
T KOG0589|consen  156 LNPEDS-LASTVVGTPYYMCPEILSDIPYNEKSDIWSLGCCLYEMCTLKPAFKASNMSELILKIN-----RGLYSPLPSM  229 (426)
T ss_pred             cCCchh-hhheecCCCcccCHHHhCCCCCCccCcchhhcchHHHHHhcccccCccchHHHHHHHh-----hccCCCCCcc
Confidence            977642 2234679999999999999999999999999999999999999997543332222222     2223345677


Q ss_pred             HHHHHHHHHHHhccCCCCCCCCHHHHHHH
Q 005586          647 EAAKLGKMALVCTHEDPENRPTMEAVIEE  675 (689)
Q Consensus       647 ~~~~l~~l~~~Cl~~dp~~RPs~~evl~~  675 (689)
                      .+.++..++..|++.+|+.||++.+++.+
T Consensus       230 ys~el~~lv~~~l~~~P~~RPsa~~LL~~  258 (426)
T KOG0589|consen  230 YSSELRSLVKSMLRKNPEHRPSALELLRR  258 (426)
T ss_pred             ccHHHHHHHHHHhhcCCccCCCHHHHhhC
Confidence            78899999999999999999999999987

>cd05056 PTKc_FAK Catalytic domain of the Protein Tyrosine Kinase, Focal Adhesion Kinase

Probab=100.00  E-value=1.6e-37  Score=319.21  Aligned_cols=256  Identities=23%  Similarity=0.433  Sum_probs=205.2

Q ss_pred             ccCCcccccccCCcceEEEEEecC----CcEEEEEEecccCCchHHHHHHHHHHHHhccCCCcceeEeeEEEcCCCCeEE
Q 005586          409 QCFSEVNLLGKGNFSSVYKGTLRD----GTLVAIRSINVTSCKSEEAEFVKGLYLLTSLRHENIIRLRGFCCSRGRGECF  484 (689)
Q Consensus       409 ~~f~~~~~lg~G~~g~Vy~~~~~~----g~~vavK~l~~~~~~~~~~~f~~e~~~l~~l~H~niv~l~g~~~~~~~~~~~  484 (689)
                      ++|...+.||+|+||.||+|...+    ...||+|...........+.|.+|+.++++++||||+++++++..   ...+
T Consensus         6 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~---~~~~   82 (270)
T cd05056           6 EDITLGRCIGEGQFGDVYQGVYMSPENEKIAVAVKTCKNCTSPSVREKFLQEAYIMRQFDHPHIVKLIGVITE---NPVW   82 (270)
T ss_pred             hhceeeeeeCCccceeEEEEEEecCCCCCcceEEEecCCcCCHHHHHHHHHHHHHHHhCCCCchhceeEEEcC---CCcE
Confidence            346677899999999999998653    346899988766544455689999999999999999999998843   4578


Q ss_pred             EEEEcCCCCCHHHHhhhcCCCCCCCCHHHHHHHHHHHHHHHhhhhCCCCCCCceeecCCCCCceeecCCCCeEEeccccc
Q 005586          485 LIYDFAPKGKLSKYLDQEEGSSNVLDWSTRVSIIIGIAKGIGYLHSSEVNKPAIVHRNLSVEKVLIDQQFNPLIADCGLH  564 (689)
Q Consensus       485 lV~e~~~~gsL~~~L~~~~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~~~ivH~dlk~~NiLl~~~~~~kl~DfGla  564 (689)
                      +||||+++|+|.+++....   ..+++..++.++.+++.||+|||+.+     ++||||||+||+++.++.+||+|||++
T Consensus        83 lv~e~~~~~~L~~~l~~~~---~~~~~~~~~~~~~~l~~~l~~lH~~~-----~~H~dl~p~nili~~~~~~~l~d~g~~  154 (270)
T cd05056          83 IVMELAPLGELRSYLQVNK---YSLDLASLILYSYQLSTALAYLESKR-----FVHRDIAARNVLVSSPDCVKLGDFGLS  154 (270)
T ss_pred             EEEEcCCCCcHHHHHHhCC---CCCCHHHHHHHHHHHHHHHHHHHhCC-----eeccccChheEEEecCCCeEEccCcee
Confidence            9999999999999997643   24899999999999999999999887     999999999999999999999999999


Q ss_pred             ccccCCceeeeecCCCCCCCCCccccccCCCCCcccchhHHHHHHHHHh-CCCCcchhHHHHHhhhhhhHhhccccCCCC
Q 005586          565 KLLADDIVFSVLKTSAAMGYLAPEYVTTGRFTERSDIFAFGVIILQILT-GSLVLTSSMRLAAESATFENFIDRNLKGKF  643 (689)
Q Consensus       565 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~ksDV~sfGvvl~ellt-G~~p~~~~~~~~~~~~~~~~~~~~~~~~~~  643 (689)
                      +..............++..|+|||.+....++.++|||||||++||+++ |+.||........    ... +........
T Consensus       155 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~pf~~~~~~~~----~~~-~~~~~~~~~  229 (270)
T cd05056         155 RYLEDESYYKASKGKLPIKWMAPESINFRRFTSASDVWMFGVCMWEILMLGVKPFQGVKNNDV----IGR-IENGERLPM  229 (270)
T ss_pred             eecccccceecCCCCccccccChhhhccCCCCchhhhHHHHHHHHHHHHcCCCCCCCCCHHHH----HHH-HHcCCcCCC
Confidence            8765543322223334567999999988889999999999999999996 9999864422111    111 111111123


Q ss_pred             CHHHHHHHHHHHHHhccCCCCCCCCHHHHHHHHHhhC
Q 005586          644 SESEAAKLGKMALVCTHEDPENRPTMEAVIEELTVAA  680 (689)
Q Consensus       644 ~~~~~~~l~~l~~~Cl~~dp~~RPs~~evl~~L~~~~  680 (689)
                      +...+..+.+++.+|+..+|++||++.++++.|....
T Consensus       230 ~~~~~~~~~~li~~~l~~~P~~Rpt~~~~~~~l~~~~  266 (270)
T cd05056         230 PPNCPPTLYSLMTKCWAYDPSKRPRFTELKAQLSDIL  266 (270)
T ss_pred             CCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHH
Confidence            3445678999999999999999999999999998754

Protein Tyrosine Kinase (PTK) family; Focal Adhesion Kinase (FAK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FAK is a cytoplasmic (or nonreceptor) tyr kinase that contains an autophosphorylation site and a FERM domain at the N-terminus, a central tyr kinase domain, proline-rich regions, and a C-terminal FAT (focal adhesion targeting) domain. FAK activity is dependent on integrin-mediated cell adhesion, which facilitates N-terminal autophosphorylation. Full activation is achieved by the phosphorylation of its two adjacent A-loop tyrosines. FAK is important in mediating signaling initiated at sites of cell adhesions

>cd05073 PTKc_Hck Catalytic domain of the Protein Tyrosine Kinase, Hematopoietic cell kinase

Probab=100.00  E-value=1.7e-37  Score=317.07  Aligned_cols=253  Identities=23%  Similarity=0.448  Sum_probs=204.5

Q ss_pred             ccCCcccccccCCcceEEEEEecCCcEEEEEEecccCCchHHHHHHHHHHHHhccCCCcceeEeeEEEcCCCCeEEEEEE
Q 005586          409 QCFSEVNLLGKGNFSSVYKGTLRDGTLVAIRSINVTSCKSEEAEFVKGLYLLTSLRHENIIRLRGFCCSRGRGECFLIYD  488 (689)
Q Consensus       409 ~~f~~~~~lg~G~~g~Vy~~~~~~g~~vavK~l~~~~~~~~~~~f~~e~~~l~~l~H~niv~l~g~~~~~~~~~~~lV~e  488 (689)
                      ++|...+.||+|+||.||+|...++..+|+|.+....  .....|.+|++++++++|+||+++.+++..   ...++|||
T Consensus         6 ~~~~~~~~lg~g~~~~vy~~~~~~~~~~~iK~~~~~~--~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~---~~~~~v~e   80 (260)
T cd05073           6 ESLKLEKKLGAGQFGEVWMATYNKHTKVAVKTMKPGS--MSVEAFLAEANVMKTLQHDKLVKLHAVVTK---EPIYIITE   80 (260)
T ss_pred             cceeEEeEecCccceEEEEEEecCCccEEEEecCCCh--hHHHHHHHHHHHHHhcCCCCcceEEEEEcC---CCeEEEEE
Confidence            4677789999999999999998888889999887542  344679999999999999999999998844   56899999


Q ss_pred             cCCCCCHHHHhhhcCCCCCCCCHHHHHHHHHHHHHHHhhhhCCCCCCCceeecCCCCCceeecCCCCeEEeccccccccc
Q 005586          489 FAPKGKLSKYLDQEEGSSNVLDWSTRVSIIIGIAKGIGYLHSSEVNKPAIVHRNLSVEKVLIDQQFNPLIADCGLHKLLA  568 (689)
Q Consensus       489 ~~~~gsL~~~L~~~~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~~~ivH~dlk~~NiLl~~~~~~kl~DfGla~~~~  568 (689)
                      |+++|+|.+++.....  ..++|.+++.++.|++.||+|||+.+     ++||||||+||+++.++.+||+|||+++...
T Consensus        81 ~~~~~~L~~~~~~~~~--~~~~~~~~~~~~~~l~~aL~~lH~~~-----i~H~dl~p~ni~i~~~~~~~l~d~~~~~~~~  153 (260)
T cd05073          81 FMAKGSLLDFLKSDEG--SKQPLPKLIDFSAQIAEGMAFIEQRN-----YIHRDLRAANILVSASLVCKIADFGLARVIE  153 (260)
T ss_pred             eCCCCcHHHHHHhCCc--cccCHHHHHHHHHHHHHHHHHHHhCC-----ccccccCcceEEEcCCCcEEECCCcceeecc
Confidence            9999999999976432  34889999999999999999999877     9999999999999999999999999998665


Q ss_pred             CCceeeeecCCCCCCCCCccccccCCCCCcccchhHHHHHHHHHh-CCCCcchhHHHHHhhhhhhHhhccccCCCCCHHH
Q 005586          569 DDIVFSVLKTSAAMGYLAPEYVTTGRFTERSDIFAFGVIILQILT-GSLVLTSSMRLAAESATFENFIDRNLKGKFSESE  647 (689)
Q Consensus       569 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~ksDV~sfGvvl~ellt-G~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  647 (689)
                      ...........++..|+|||++....++.++|||||||++||++| |+.|+........     .+.+........+...
T Consensus       154 ~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~~l~t~g~~p~~~~~~~~~-----~~~~~~~~~~~~~~~~  228 (260)
T cd05073         154 DNEYTAREGAKFPIKWTAPEAINFGSFTIKSDVWSFGILLMEIVTYGRIPYPGMSNPEV-----IRALERGYRMPRPENC  228 (260)
T ss_pred             CCCcccccCCcccccccCHhHhccCCcCccccchHHHHHHHHHHhcCCCCCCCCCHHHH-----HHHHhCCCCCCCcccC
Confidence            432222222334567999999988889999999999999999999 8988864322111     1111122222233445


Q ss_pred             HHHHHHHHHHhccCCCCCCCCHHHHHHHHHh
Q 005586          648 AAKLGKMALVCTHEDPENRPTMEAVIEELTV  678 (689)
Q Consensus       648 ~~~l~~l~~~Cl~~dp~~RPs~~evl~~L~~  678 (689)
                      +.++.+++.+|++.+|++||++.++.+.|+.
T Consensus       229 ~~~~~~~i~~~l~~~p~~Rp~~~~l~~~L~~  259 (260)
T cd05073         229 PEELYNIMMRCWKNRPEERPTFEYIQSVLDD  259 (260)
T ss_pred             CHHHHHHHHHHcccCcccCcCHHHHHHHHhc
Confidence            6679999999999999999999999999864

Protein Tyrosine Kinase (PTK) family; Hematopoietic cell kinase (Hck); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Hck is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pa

>cd05086 PTKc_Aatyk2 Catalytic domain of the Protein Tyrosine Kinase, Apoptosis-associated tyrosine kinase 2

Probab=100.00  E-value=2.3e-37  Score=317.78  Aligned_cols=254  Identities=19%  Similarity=0.313  Sum_probs=188.3

Q ss_pred             ccccCCcceEEEEEecCC---cEEEEEEecccCCchHHHHHHHHHHHHhccCCCcceeEeeEEEcCCCCeEEEEEEcCCC
Q 005586          416 LLGKGNFSSVYKGTLRDG---TLVAIRSINVTSCKSEEAEFVKGLYLLTSLRHENIIRLRGFCCSRGRGECFLIYDFAPK  492 (689)
Q Consensus       416 ~lg~G~~g~Vy~~~~~~g---~~vavK~l~~~~~~~~~~~f~~e~~~l~~l~H~niv~l~g~~~~~~~~~~~lV~e~~~~  492 (689)
                      .||+|+||.||+|...++   ..+++|.+...........|.+|+.+++.++||||++++++|..  ....++||||+++
T Consensus         2 ~lg~G~~g~v~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~e~~~~~~l~h~~iv~~~~~~~~--~~~~~lv~e~~~~   79 (268)
T cd05086           2 EIGNGWFGKVLLSEIYTDTGVARVVVKELKANASSKEQNEFLQQGDPYRILQHPNILQCLGQCVE--AIPYLLVFEYCEL   79 (268)
T ss_pred             cCCCCcCceEEEEEEEcCCCcceEEEEEecCCCChHHHHHHHHHHHHHhccCCcchhheEEEecC--CCccEEEEecCCC
Confidence            599999999999986433   35667777655444556789999999999999999999999854  4678999999999


Q ss_pred             CCHHHHhhhcCCCCCCCCHHHHHHHHHHHHHHHhhhhCCCCCCCceeecCCCCCceeecCCCCeEEecccccccccCCc-
Q 005586          493 GKLSKYLDQEEGSSNVLDWSTRVSIIIGIAKGIGYLHSSEVNKPAIVHRNLSVEKVLIDQQFNPLIADCGLHKLLADDI-  571 (689)
Q Consensus       493 gsL~~~L~~~~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~~~ivH~dlk~~NiLl~~~~~~kl~DfGla~~~~~~~-  571 (689)
                      |+|.++++........+++.....++.|+++||+|||+.+     ++||||||+|||+++++.+||+|||++....... 
T Consensus        80 ~~L~~~l~~~~~~~~~~~~~~~~~~~~~i~~al~~lH~~~-----i~H~dikp~nil~~~~~~~~l~Dfg~~~~~~~~~~  154 (268)
T cd05086          80 GDLKSYLSQEQWHRRNSQLLLLQRMACEIAAGVTHMHKHN-----FLHSDLALRNCFLTSDLTVKVGDYGIGPSRYKEDY  154 (268)
T ss_pred             CcHHHHHHhhhcccccccHHHHHHHHHHHHHHHHHHHHCC-----eeccCCccceEEEcCCccEEecccccccccCcchh
Confidence            9999999865433334677788899999999999999887     9999999999999999999999999986432221 


Q ss_pred             eeeeecCCCCCCCCCcccccc-------CCCCCcccchhHHHHHHHHHhC-CCCcchhHHHHHhhhhhhHhhccccCCCC
Q 005586          572 VFSVLKTSAAMGYLAPEYVTT-------GRFTERSDIFAFGVIILQILTG-SLVLTSSMRLAAESATFENFIDRNLKGKF  643 (689)
Q Consensus       572 ~~~~~~~~~~~~y~aPE~~~~-------~~~~~ksDV~sfGvvl~elltG-~~p~~~~~~~~~~~~~~~~~~~~~~~~~~  643 (689)
                      ........++..|+|||++..       ..++.++|||||||++|||+++ ..|+..............+..-...+...
T Consensus       155 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~~l~el~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~  234 (268)
T cd05086         155 IETEDDKCVPLRWLAPELVGEFHGGLITAEQTKPSNVWALGVTLWELFENAAQPYSHLSDREVLNHVIKDQQVKLFKPQL  234 (268)
T ss_pred             hhcccCCcCcccccCchhcccccCccccCCCCCcchhHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHhhcccccCCCcc
Confidence            111123346678999998743       2457899999999999999974 66774322211111111110000011122


Q ss_pred             CHHHHHHHHHHHHHhccCCCCCCCCHHHHHHHHH
Q 005586          644 SESEAAKLGKMALVCTHEDPENRPTMEAVIEELT  677 (689)
Q Consensus       644 ~~~~~~~l~~l~~~Cl~~dp~~RPs~~evl~~L~  677 (689)
                      .......+.+++..|| .+|++||+++||++.|.
T Consensus       235 ~~~~~~~~~~l~~~c~-~~P~~Rp~~~~i~~~l~  267 (268)
T cd05086         235 ELPYSERWYEVLQFCW-LSPEKRATAEEVHRLLT  267 (268)
T ss_pred             CCCCcHHHHHHHHHHh-hCcccCCCHHHHHHHhc
Confidence            2234567888999999 57999999999999874

Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 2 (Aatyk2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk2 is a member of the Aatyk subfamily of proteins, which are receptor kinases containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk2 is also called lemur tyrosine kinase 2 (Lmtk2) or brain-enriched kinase (Brek). It is expressed at high levels in early postnatal brain, and has been shown to play a role in nerve growth factor (NGF) signaling. Studies with knockout mice reveal that Aatyk2 is essential for late stage

>cd05594 STKc_PKB_alpha Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B alpha

Probab=100.00  E-value=2.8e-38  Score=333.89  Aligned_cols=245  Identities=22%  Similarity=0.315  Sum_probs=196.3

Q ss_pred             cccccCCcceEEEEEec-CCcEEEEEEecccCC--chHHHHHHHHHHHHhccCCCcceeEeeEEEcCCCCeEEEEEEcCC
Q 005586          415 NLLGKGNFSSVYKGTLR-DGTLVAIRSINVTSC--KSEEAEFVKGLYLLTSLRHENIIRLRGFCCSRGRGECFLIYDFAP  491 (689)
Q Consensus       415 ~~lg~G~~g~Vy~~~~~-~g~~vavK~l~~~~~--~~~~~~f~~e~~~l~~l~H~niv~l~g~~~~~~~~~~~lV~e~~~  491 (689)
                      +.||+|+||.||++..+ +|..||+|.+.....  ......+..|++++..++||||+++++++..  .+..++||||++
T Consensus         1 ~~lG~G~~g~V~~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~e~~~l~~~~hp~i~~~~~~~~~--~~~~~lv~E~~~   78 (325)
T cd05594           1 KLLGKGTFGKVILVKEKATGRYYAMKILKKEVIVAKDEVAHTLTENRVLQNSRHPFLTALKYSFQT--HDRLCFVMEYAN   78 (325)
T ss_pred             CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCCCceEEEEEc--CCEEEEEEeCCC
Confidence            36999999999999875 789999999975432  2334577889999999999999999998844  578999999999


Q ss_pred             CCCHHHHhhhcCCCCCCCCHHHHHHHHHHHHHHHhhhhC-CCCCCCceeecCCCCCceeecCCCCeEEecccccccccCC
Q 005586          492 KGKLSKYLDQEEGSSNVLDWSTRVSIIIGIAKGIGYLHS-SEVNKPAIVHRNLSVEKVLIDQQFNPLIADCGLHKLLADD  570 (689)
Q Consensus       492 ~gsL~~~L~~~~~~~~~l~~~~~~~ia~~ia~gL~yLH~-~~~~~~~ivH~dlk~~NiLl~~~~~~kl~DfGla~~~~~~  570 (689)
                      +|+|..++....    .+++..+..++.|++.||+|||+ .+     |+||||||+|||+++++.+||+|||+++.....
T Consensus        79 ~~~L~~~l~~~~----~l~~~~~~~~~~qi~~aL~~lH~~~~-----ivHrDikp~NIll~~~~~~kL~Dfg~~~~~~~~  149 (325)
T cd05594          79 GGELFFHLSRER----VFSEDRARFYGAEIVSALDYLHSEKN-----VVYRDLKLENLMLDKDGHIKITDFGLCKEGIKD  149 (325)
T ss_pred             CCcHHHHHHhcC----CCCHHHHHHHHHHHHHHHHHHHhcCC-----EEecCCCCCeEEECCCCCEEEecCCCCeecCCC
Confidence            999999887543    48999999999999999999997 55     999999999999999999999999998754322


Q ss_pred             ceeeeecCCCCCCCCCccccccCCCCCcccchhHHHHHHHHHhCCCCcchhHHHHHhhhhhhHhhccccCCCCCHHHHHH
Q 005586          571 IVFSVLKTSAAMGYLAPEYVTTGRFTERSDIFAFGVIILQILTGSLVLTSSMRLAAESATFENFIDRNLKGKFSESEAAK  650 (689)
Q Consensus       571 ~~~~~~~~~~~~~y~aPE~~~~~~~~~ksDV~sfGvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  650 (689)
                      .. ......++..|+|||++.+..++.++|||||||++|||+||+.||........    ...+....  ..++.....+
T Consensus       150 ~~-~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~tG~~Pf~~~~~~~~----~~~i~~~~--~~~p~~~~~~  222 (325)
T cd05594         150 GA-TMKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHEKL----FELILMEE--IRFPRTLSPE  222 (325)
T ss_pred             Cc-ccccccCCcccCCHHHHccCCCCCccccccccceeeeeccCCCCCCCCCHHHH----HHHHhcCC--CCCCCCCCHH
Confidence            11 11234578899999999988999999999999999999999999965322111    11111111  1233344567


Q ss_pred             HHHHHHHhccCCCCCCC-----CHHHHHHHHH
Q 005586          651 LGKMALVCTHEDPENRP-----TMEAVIEELT  677 (689)
Q Consensus       651 l~~l~~~Cl~~dp~~RP-----s~~evl~~L~  677 (689)
                      +.+++.+|++.||++|+     ++.+++++.+
T Consensus       223 ~~~li~~~L~~dP~~R~~~~~~~~~~il~h~~  254 (325)
T cd05594         223 AKSLLSGLLKKDPKQRLGGGPDDAKEIMQHKF  254 (325)
T ss_pred             HHHHHHHHhhcCHHHhCCCCCCCHHHHhcCCC
Confidence            89999999999999996     8999987744

Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, alpha (or Akt1) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-alpha is predominantly expressed in endothelial cells. It is critical for the regulation of angiogenesis and the maintenance of vascular integrity. It also plays a role in adipocyte differentiation. Mice deficien

>cd05110 PTKc_HER4 Catalytic domain of the Protein Tyrosine Kinase, HER4

Probab=100.00  E-value=9.2e-38  Score=326.67  Aligned_cols=258  Identities=25%  Similarity=0.431  Sum_probs=204.1

Q ss_pred             ccCCcccccccCCcceEEEEEec-CCc----EEEEEEecccCCchHHHHHHHHHHHHhccCCCcceeEeeEEEcCCCCeE
Q 005586          409 QCFSEVNLLGKGNFSSVYKGTLR-DGT----LVAIRSINVTSCKSEEAEFVKGLYLLTSLRHENIIRLRGFCCSRGRGEC  483 (689)
Q Consensus       409 ~~f~~~~~lg~G~~g~Vy~~~~~-~g~----~vavK~l~~~~~~~~~~~f~~e~~~l~~l~H~niv~l~g~~~~~~~~~~  483 (689)
                      ++|...+.||+|+||.||+|... +|.    .||+|.+..........+|.+|+.++++++||||++++|+|..   ...
T Consensus         7 ~~~~~~~~lg~G~~g~vy~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~l~h~niv~~~~~~~~---~~~   83 (303)
T cd05110           7 TELKRVKVLGSGAFGTVYKGIWVPEGETVKIPVAIKILNETTGPKANVEFMDEALIMASMDHPHLVRLLGVCLS---PTI   83 (303)
T ss_pred             hhceeccccccCCCccEEEEEEecCCCcceeeEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCcccEEEEEcC---CCc
Confidence            45677889999999999999864 443    5789988765544445679999999999999999999999854   346


Q ss_pred             EEEEEcCCCCCHHHHhhhcCCCCCCCCHHHHHHHHHHHHHHHhhhhCCCCCCCceeecCCCCCceeecCCCCeEEecccc
Q 005586          484 FLIYDFAPKGKLSKYLDQEEGSSNVLDWSTRVSIIIGIAKGIGYLHSSEVNKPAIVHRNLSVEKVLIDQQFNPLIADCGL  563 (689)
Q Consensus       484 ~lV~e~~~~gsL~~~L~~~~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~~~ivH~dlk~~NiLl~~~~~~kl~DfGl  563 (689)
                      ++|+||+++|+|.+++.....   .+++..++.++.|++.||+|||+.+     |+||||||+||++++++.+||+|||+
T Consensus        84 ~~v~e~~~~g~l~~~~~~~~~---~~~~~~~~~~~~qi~~~L~~LH~~~-----ivH~dikp~Nill~~~~~~kL~Dfg~  155 (303)
T cd05110          84 QLVTQLMPHGCLLDYVHEHKD---NIGSQLLLNWCVQIAKGMMYLEERR-----LVHRDLAARNVLVKSPNHVKITDFGL  155 (303)
T ss_pred             eeeehhcCCCCHHHHHHhccc---CCCHHHHHHHHHHHHHHHHHHhhcC-----eeccccccceeeecCCCceEEccccc
Confidence            799999999999999976432   4889999999999999999999987     99999999999999999999999999


Q ss_pred             cccccCCcee-eeecCCCCCCCCCccccccCCCCCcccchhHHHHHHHHHh-CCCCcchhHHHHHhhhhhhHhhccccCC
Q 005586          564 HKLLADDIVF-SVLKTSAAMGYLAPEYVTTGRFTERSDIFAFGVIILQILT-GSLVLTSSMRLAAESATFENFIDRNLKG  641 (689)
Q Consensus       564 a~~~~~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~ksDV~sfGvvl~ellt-G~~p~~~~~~~~~~~~~~~~~~~~~~~~  641 (689)
                      ++.+...... ......++..|+|||++.+..++.++|||||||++|||++ |+.|+.......     ..+.+......
T Consensus       156 ~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~DiwslG~~l~el~t~g~~p~~~~~~~~-----~~~~~~~~~~~  230 (303)
T cd05110         156 ARLLEGDEKEYNADGGKMPIKWMALECIHYRKFTHQSDVWSYGVTIWELMTFGGKPYDGIPTRE-----IPDLLEKGERL  230 (303)
T ss_pred             cccccCcccccccCCCccccccCCHHHhccCCCChHHHHHHHHHHHHHHHhCCCCCCCCCCHHH-----HHHHHHCCCCC
Confidence            9876533211 1222334568999999988899999999999999999998 888886432111     11222222111


Q ss_pred             CCCHHHHHHHHHHHHHhccCCCCCCCCHHHHHHHHHhhCCc
Q 005586          642 KFSESEAAKLGKMALVCTHEDPENRPTMEAVIEELTVAAPV  682 (689)
Q Consensus       642 ~~~~~~~~~l~~l~~~Cl~~dp~~RPs~~evl~~L~~~~p~  682 (689)
                      ..+..+...+.+++..||..+|++||+|+++++.|+.+...
T Consensus       231 ~~~~~~~~~~~~li~~c~~~~p~~Rp~~~~l~~~l~~~~~~  271 (303)
T cd05110         231 PQPPICTIDVYMVMVKCWMIDADSRPKFKELAAEFSRMARD  271 (303)
T ss_pred             CCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHhc
Confidence            22333456789999999999999999999999999886533

Protein Tyrosine Kinase (PTK) family; HER4 (ErbB4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER4 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as bindin

>cd06625 STKc_MEKK3_like Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=1.7e-37  Score=317.42  Aligned_cols=254  Identities=19%  Similarity=0.300  Sum_probs=204.9

Q ss_pred             ccCCcccccccCCcceEEEEEec-CCcEEEEEEecccCCc----hHHHHHHHHHHHHhccCCCcceeEeeEEEcCCCCeE
Q 005586          409 QCFSEVNLLGKGNFSSVYKGTLR-DGTLVAIRSINVTSCK----SEEAEFVKGLYLLTSLRHENIIRLRGFCCSRGRGEC  483 (689)
Q Consensus       409 ~~f~~~~~lg~G~~g~Vy~~~~~-~g~~vavK~l~~~~~~----~~~~~f~~e~~~l~~l~H~niv~l~g~~~~~~~~~~  483 (689)
                      ++|...+.||+|++|.||+|... ++..||+|.+......    .....+.+|++++.+++||||+++++++..  .+..
T Consensus         2 ~~~~~~~~lg~g~~~~vy~~~~~~~~~~~~lk~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~--~~~~   79 (263)
T cd06625           2 TNWRRGKLLGQGAFGRVYLCYDVDTGRELAVKQVPFDPDSPETKKEVNALECEIQLLKNLQHERIVQYYGCLRD--DETL   79 (263)
T ss_pred             CcccccceecCCCceEEEEEEEcCCCcEEEEEEEeecccchhhHHHHHHHHHHHHHHHhCCCCCeeeeEEEEcc--CCeE
Confidence            46788899999999999999865 6899999998754321    233578899999999999999999999854  4689


Q ss_pred             EEEEEcCCCCCHHHHhhhcCCCCCCCCHHHHHHHHHHHHHHHhhhhCCCCCCCceeecCCCCCceeecCCCCeEEecccc
Q 005586          484 FLIYDFAPKGKLSKYLDQEEGSSNVLDWSTRVSIIIGIAKGIGYLHSSEVNKPAIVHRNLSVEKVLIDQQFNPLIADCGL  563 (689)
Q Consensus       484 ~lV~e~~~~gsL~~~L~~~~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~~~ivH~dlk~~NiLl~~~~~~kl~DfGl  563 (689)
                      ++|+||+++++|.+++....    .+++..+..++.|++.||+|||+.+     |+||||||+||++++++.+||+|||+
T Consensus        80 ~~v~e~~~~~~l~~~~~~~~----~~~~~~~~~~~~~l~~~l~~lH~~~-----i~H~dl~p~nilv~~~~~~~l~dfg~  150 (263)
T cd06625          80 SIFMEYMPGGSVKDQLKAYG----ALTETVTRKYTRQILEGVEYLHSNM-----IVHRDIKGANILRDSAGNVKLGDFGA  150 (263)
T ss_pred             EEEEEECCCCcHHHHHHHhC----CCCHHHHHHHHHHHHHHHHHHHhCC-----eecCCCCHHHEEEcCCCCEEEeeccc
Confidence            99999999999999987643    3788999999999999999999987     99999999999999999999999999


Q ss_pred             cccccCCceeee--ecCCCCCCCCCccccccCCCCCcccchhHHHHHHHHHhCCCCcchhHHHHHhhhhhhHhhccccCC
Q 005586          564 HKLLADDIVFSV--LKTSAAMGYLAPEYVTTGRFTERSDIFAFGVIILQILTGSLVLTSSMRLAAESATFENFIDRNLKG  641 (689)
Q Consensus       564 a~~~~~~~~~~~--~~~~~~~~y~aPE~~~~~~~~~ksDV~sfGvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~  641 (689)
                      ++..........  ....++..|+|||.+.+..++.++||||||+++|||++|+.||.......    ............
T Consensus       151 ~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~----~~~~~~~~~~~~  226 (263)
T cd06625         151 SKRLQTICSSGTGMKSVTGTPYWMSPEVISGEGYGRKADVWSVGCTVVEMLTEKPPWAEFEAMA----AIFKIATQPTNP  226 (263)
T ss_pred             ceeccccccccccccCCCcCccccCcceeccCCCCchhhhHHHHHHHHHHHhCCCCccccchHH----HHHHHhccCCCC
Confidence            976543221111  22345678999999999889999999999999999999999986432211    111122222233


Q ss_pred             CCCHHHHHHHHHHHHHhccCCCCCCCCHHHHHHHHH
Q 005586          642 KFSESEAAKLGKMALVCTHEDPENRPTMEAVIEELT  677 (689)
Q Consensus       642 ~~~~~~~~~l~~l~~~Cl~~dp~~RPs~~evl~~L~  677 (689)
                      ..+......+.+++..||..+|.+||++.|++++.+
T Consensus       227 ~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~ll~~~~  262 (263)
T cd06625         227 QLPSHVSPDARNFLRRTFVENAKKRPSAEELLRHFF  262 (263)
T ss_pred             CCCccCCHHHHHHHHHHhhcCcccCCCHHHHhhCCC
Confidence            345556678999999999999999999999998753

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades t

>cd05626 STKc_LATS2 Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 2

Probab=100.00  E-value=7.4e-38  Score=337.93  Aligned_cols=253  Identities=18%  Similarity=0.254  Sum_probs=196.1

Q ss_pred             cCCcccccccCCcceEEEEEec-CCcEEEEEEecccCC--chHHHHHHHHHHHHhccCCCcceeEeeEEEcCCCCeEEEE
Q 005586          410 CFSEVNLLGKGNFSSVYKGTLR-DGTLVAIRSINVTSC--KSEEAEFVKGLYLLTSLRHENIIRLRGFCCSRGRGECFLI  486 (689)
Q Consensus       410 ~f~~~~~lg~G~~g~Vy~~~~~-~g~~vavK~l~~~~~--~~~~~~f~~e~~~l~~l~H~niv~l~g~~~~~~~~~~~lV  486 (689)
                      .|...+.||+|+||.||+|+.. +++.||+|++.....  ......+.+|++++.+++||||+++++++.+  .+..++|
T Consensus         2 ~f~~~~~LG~G~~g~Vy~~~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~E~~il~~l~h~~iv~l~~~~~~--~~~~~lv   79 (381)
T cd05626           2 MFVKIKTLGIGAFGEVCLACKVDTHALYAMKTLRKKDVLNRNQVAHVKAERDILAEADNEWVVKLYYSFQD--KDNLYFV   79 (381)
T ss_pred             CceEEEEEeecCCEEEEEEEECCCCCEEEEEEEEHHHhhhhHHHHHHHHHHHHHHhcCCCCeeeeEEEEec--CCEEEEE
Confidence            5778899999999999999875 689999999976432  2344678999999999999999999999854  5789999


Q ss_pred             EEcCCCCCHHHHhhhcCCCCCCCCHHHHHHHHHHHHHHHhhhhCCCCCCCceeecCCCCCceeecCCCCeEEeccccccc
Q 005586          487 YDFAPKGKLSKYLDQEEGSSNVLDWSTRVSIIIGIAKGIGYLHSSEVNKPAIVHRNLSVEKVLIDQQFNPLIADCGLHKL  566 (689)
Q Consensus       487 ~e~~~~gsL~~~L~~~~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~~~ivH~dlk~~NiLl~~~~~~kl~DfGla~~  566 (689)
                      |||+++|+|.+++....    .+++.....++.|++.||+|||+.+     |+||||||+|||++.++.+||+|||+++.
T Consensus        80 ~E~~~gg~L~~~l~~~~----~~~e~~~~~~~~qi~~aL~~LH~~g-----ivHrDlKp~Nili~~~~~~kL~DFGl~~~  150 (381)
T cd05626          80 MDYIPGGDMMSLLIRME----VFPEVLARFYIAELTLAIESVHKMG-----FIHRDIKPDNILIDLDGHIKLTDFGLCTG  150 (381)
T ss_pred             EecCCCCcHHHHHHhcC----CCCHHHHHHHHHHHHHHHHHHHhCC-----eeecCCcHHHEEECCCCCEEEeeCcCCcc
Confidence            99999999999997643    3888889999999999999999987     99999999999999999999999999764


Q ss_pred             ccCCce----------------------------------------------eeeecCCCCCCCCCccccccCCCCCccc
Q 005586          567 LADDIV----------------------------------------------FSVLKTSAAMGYLAPEYVTTGRFTERSD  600 (689)
Q Consensus       567 ~~~~~~----------------------------------------------~~~~~~~~~~~y~aPE~~~~~~~~~ksD  600 (689)
                      +.....                                              .......||..|+|||++.+..++.++|
T Consensus       151 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~~D  230 (381)
T cd05626         151 FRWTHNSKYYQKGSHIRQDSMEPSDLWDDVSNCRCGDRLKTLEQRATKQHQRCLAHSLVGTPNYIAPEVLLRKGYTQLCD  230 (381)
T ss_pred             cccccccccccccccccccccCcccccccccccccccccchhhccccccccccccccccCCccccCHHHHcCCCCCCccc
Confidence            321000                                              0001235788999999999888999999


Q ss_pred             chhHHHHHHHHHhCCCCcchhHHHHHhhhhhhHhhcc--ccCCCCCHHHHHHHHHHHHH--hccCCCCCCCCHHHHHHHH
Q 005586          601 IFAFGVIILQILTGSLVLTSSMRLAAESATFENFIDR--NLKGKFSESEAAKLGKMALV--CTHEDPENRPTMEAVIEEL  676 (689)
Q Consensus       601 V~sfGvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~~~~l~~l~~~--Cl~~dp~~RPs~~evl~~L  676 (689)
                      ||||||++|||+||+.||.........    ..++..  ............++.+++.+  |+..+|..||++.|++.+-
T Consensus       231 iwSlG~il~elltG~~Pf~~~~~~~~~----~~i~~~~~~~~~~~~~~~s~~~~dli~~ll~~~~~~~~R~~~~~~l~hp  306 (381)
T cd05626         231 WWSVGVILFEMLVGQPPFLAPTPTETQ----LKVINWENTLHIPPQVKLSPEAVDLITKLCCSAEERLGRNGADDIKAHP  306 (381)
T ss_pred             eeehhhHHHHHHhCCCCCcCCCHHHHH----HHHHccccccCCCCCCCCCHHHHHHHHHHccCcccccCCCCHHHHhcCc
Confidence            999999999999999999654322111    111111  11111111234456666655  6667777799999999875


Q ss_pred             H
Q 005586          677 T  677 (689)
Q Consensus       677 ~  677 (689)
                      +
T Consensus       307 ~  307 (381)
T cd05626         307 F  307 (381)
T ss_pred             c
Confidence            4

Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. LATS2 is an essential mitotic regulator responsible for coordinating accurate cytokinesis completion and governing the stabilization of other mitotic regulators. It is also critical in the maintenance of proper chromosome number, genomic stability, mitotic fidelity, and the integrity of centrosome duplication. Downregulation of LATS2 is associated with po

>cd05039 PTKc_Csk_like Catalytic domain of C-terminal Src kinase-like Protein Tyrosine Kinases

Probab=100.00  E-value=2e-37  Score=315.78  Aligned_cols=249  Identities=23%  Similarity=0.461  Sum_probs=205.0

Q ss_pred             ccCCcccccccCCcceEEEEEecCCcEEEEEEecccCCchHHHHHHHHHHHHhccCCCcceeEeeEEEcCCCCeEEEEEE
Q 005586          409 QCFSEVNLLGKGNFSSVYKGTLRDGTLVAIRSINVTSCKSEEAEFVKGLYLLTSLRHENIIRLRGFCCSRGRGECFLIYD  488 (689)
Q Consensus       409 ~~f~~~~~lg~G~~g~Vy~~~~~~g~~vavK~l~~~~~~~~~~~f~~e~~~l~~l~H~niv~l~g~~~~~~~~~~~lV~e  488 (689)
                      ++|...+.||+|+||.||+|... |+.||+|.+.....  ..+++.+|+.++.+++|+||+++++++..  ....++|||
T Consensus         6 ~~~~~~~~ig~g~~g~v~~~~~~-~~~v~iK~~~~~~~--~~~~~~~e~~~l~~l~~~~i~~~~~~~~~--~~~~~~v~e   80 (256)
T cd05039           6 KELKLGATIGKGEFGDVMLGDYR-GQKVAVKCLKDDST--AAQAFLAEASVMTTLRHPNLVQLLGVVLQ--GNPLYIVTE   80 (256)
T ss_pred             hhccceeeeecCCCceEEEEEec-CcEEEEEEeccchh--HHHHHHHHHHHHHhcCCcceeeeEEEEcC--CCCeEEEEE
Confidence            45677789999999999999876 78999999976542  45789999999999999999999999854  577899999


Q ss_pred             cCCCCCHHHHhhhcCCCCCCCCHHHHHHHHHHHHHHHhhhhCCCCCCCceeecCCCCCceeecCCCCeEEeccccccccc
Q 005586          489 FAPKGKLSKYLDQEEGSSNVLDWSTRVSIIIGIAKGIGYLHSSEVNKPAIVHRNLSVEKVLIDQQFNPLIADCGLHKLLA  568 (689)
Q Consensus       489 ~~~~gsL~~~L~~~~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~~~ivH~dlk~~NiLl~~~~~~kl~DfGla~~~~  568 (689)
                      |+++++|.+++.....  ..++|..+..++.|++.||.|||+.+     ++||||||+||++++++.+||+|||.++...
T Consensus        81 ~~~~~~L~~~~~~~~~--~~~~~~~~~~~~~qi~~~l~~lh~~~-----i~H~di~p~Nili~~~~~~~l~d~g~~~~~~  153 (256)
T cd05039          81 YMAKGSLVDYLRSRGR--AVITLAQQLGFALDVCEGMEYLEEKN-----FVHRDLAARNVLVSEDLVAKVSDFGLAKEAS  153 (256)
T ss_pred             ecCCCcHHHHHHhcCC--CCCCHHHHHHHHHHHHHHHHHHHhCC-----ccchhcccceEEEeCCCCEEEcccccccccc
Confidence            9999999999976542  24899999999999999999999987     9999999999999999999999999998764


Q ss_pred             CCceeeeecCCCCCCCCCccccccCCCCCcccchhHHHHHHHHHh-CCCCcchhHHHHHhhhhhhHhhccccCCCCCHHH
Q 005586          569 DDIVFSVLKTSAAMGYLAPEYVTTGRFTERSDIFAFGVIILQILT-GSLVLTSSMRLAAESATFENFIDRNLKGKFSESE  647 (689)
Q Consensus       569 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~ksDV~sfGvvl~ellt-G~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  647 (689)
                      ....    ....+..|+|||++.+..++.++||||||+++||+++ |+.|+.......     +.+.+....+...+...
T Consensus       154 ~~~~----~~~~~~~~~ape~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~~-----~~~~~~~~~~~~~~~~~  224 (256)
T cd05039         154 QGQD----SGKLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRIPLKD-----VVPHVEKGYRMEAPEGC  224 (256)
T ss_pred             cccc----cCCCcccccCchhhcCCcCCcHHHHHHHHHHHHHHHhcCCCCCCCCCHHH-----HHHHHhcCCCCCCccCC
Confidence            3221    2334567999999988889999999999999999997 999986432211     11111122222333445


Q ss_pred             HHHHHHHHHHhccCCCCCCCCHHHHHHHHHh
Q 005586          648 AAKLGKMALVCTHEDPENRPTMEAVIEELTV  678 (689)
Q Consensus       648 ~~~l~~l~~~Cl~~dp~~RPs~~evl~~L~~  678 (689)
                      +..+.+++.+|+..+|++||++.|++++|+.
T Consensus       225 ~~~~~~li~~~l~~~p~~Rp~~~~l~~~l~~  255 (256)
T cd05039         225 PPEVYKVMKDCWELDPAKRPTFKQLREQLAL  255 (256)
T ss_pred             CHHHHHHHHHHhccChhhCcCHHHHHHHHhc
Confidence            6789999999999999999999999999975

Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk) subfamily; catalytic (c) domain. The Csk subfamily is composed of Csk, Chk, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk and Chk are translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk

>cd05628 STKc_NDR1 Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 1

Probab=100.00  E-value=8.3e-38  Score=335.38  Aligned_cols=253  Identities=18%  Similarity=0.283  Sum_probs=193.4

Q ss_pred             ccCCcccccccCCcceEEEEEec-CCcEEEEEEecccCC--chHHHHHHHHHHHHhccCCCcceeEeeEEEcCCCCeEEE
Q 005586          409 QCFSEVNLLGKGNFSSVYKGTLR-DGTLVAIRSINVTSC--KSEEAEFVKGLYLLTSLRHENIIRLRGFCCSRGRGECFL  485 (689)
Q Consensus       409 ~~f~~~~~lg~G~~g~Vy~~~~~-~g~~vavK~l~~~~~--~~~~~~f~~e~~~l~~l~H~niv~l~g~~~~~~~~~~~l  485 (689)
                      ++|+..+.||+|+||.||+|... +++.||+|++.....  ......+.+|+.++.+++|+||+++++.+.+  ....++
T Consensus         1 ~~y~~~~~LG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~il~~~~~~~iv~~~~~~~~--~~~~~l   78 (363)
T cd05628           1 EDFESLKVIGRGAFGEVRLVQKKDTGHVYAMKILRKADMLEKEQVGHIRAERDILVEADSLWVVKMFYSFQD--KLNLYL   78 (363)
T ss_pred             CCceEeEEEEeCCCEEEEEEEECCCCCEEEEEEEEHHHHHHhhHHHHHHHHHHHHHhCCCCCcceEEEEEec--CCeEEE
Confidence            46888899999999999999875 689999999975431  2233578889999999999999999998844  578999


Q ss_pred             EEEcCCCCCHHHHhhhcCCCCCCCCHHHHHHHHHHHHHHHhhhhCCCCCCCceeecCCCCCceeecCCCCeEEecccccc
Q 005586          486 IYDFAPKGKLSKYLDQEEGSSNVLDWSTRVSIIIGIAKGIGYLHSSEVNKPAIVHRNLSVEKVLIDQQFNPLIADCGLHK  565 (689)
Q Consensus       486 V~e~~~~gsL~~~L~~~~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~~~ivH~dlk~~NiLl~~~~~~kl~DfGla~  565 (689)
                      ||||+++|+|.+++....    .+++.....++.|++.||+|||+.+     |+||||||+|||+++++.+||+|||+++
T Consensus        79 v~E~~~gg~L~~~l~~~~----~l~~~~~~~~~~qi~~aL~~lH~~g-----ivHrDlKp~NILi~~~~~vkL~DFGla~  149 (363)
T cd05628          79 IMEFLPGGDMMTLLMKKD----TLTEEETQFYIAETVLAIDSIHQLG-----FIHRDIKPDNLLLDSKGHVKLSDFGLCT  149 (363)
T ss_pred             EEcCCCCCcHHHHHHhcC----CCCHHHHHHHHHHHHHHHHHHHhCC-----eEecCCCHHHeEECCCCCEEEeeccCcc
Confidence            999999999999997643    4899999999999999999999988     9999999999999999999999999997


Q ss_pred             cccCCcee----------------------------------eeecCCCCCCCCCccccccCCCCCcccchhHHHHHHHH
Q 005586          566 LLADDIVF----------------------------------SVLKTSAAMGYLAPEYVTTGRFTERSDIFAFGVIILQI  611 (689)
Q Consensus       566 ~~~~~~~~----------------------------------~~~~~~~~~~y~aPE~~~~~~~~~ksDV~sfGvvl~el  611 (689)
                      .+......                                  ......||..|+|||++.+..++.++|||||||++|||
T Consensus       150 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~~~~~~~DvwSlGvil~el  229 (363)
T cd05628         150 GLKKAHRTEFYRNLNHSLPSDFTFQNMNSKRKAETWKRNRRQLAFSTVGTPDYIAPEVFMQTGYNKLCDWWSLGVIMYEM  229 (363)
T ss_pred             cccccccccccccccccccccccccccccccccchhhhccccccccccCCccccCHHHHcCCCCCCchhhhhhHHHHHHH
Confidence            65321100                                  01123588899999999998999999999999999999


Q ss_pred             HhCCCCcchhHHHHHhhhhhhHhhccccCCCCCH--HHHHHHHHHHHH--hccCCCCCCCCHHHHHHHH
Q 005586          612 LTGSLVLTSSMRLAAESATFENFIDRNLKGKFSE--SEAAKLGKMALV--CTHEDPENRPTMEAVIEEL  676 (689)
Q Consensus       612 ltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~--~~~~~l~~l~~~--Cl~~dp~~RPs~~evl~~L  676 (689)
                      ++|+.||.........    ..+........++.  ....++.+++.+  |...++..||++.|++++-
T Consensus       230 l~G~~Pf~~~~~~~~~----~~i~~~~~~~~~p~~~~~s~~~~~li~~l~~~~~~r~~r~~~~ei~~hp  294 (363)
T cd05628         230 LIGYPPFCSETPQETY----KKVMNWKETLIFPPEVPISEKAKDLILRFCCEWEHRIGAPGVEEIKTNP  294 (363)
T ss_pred             HhCCCCCCCCCHHHHH----HHHHcCcCcccCCCcCCCCHHHHHHHHHHcCChhhcCCCCCHHHHhCCC
Confidence            9999999654322211    11111000001111  123345555554  3333444679999999873

Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. NDR1 is highly expressed in thymus, mus

>cd06637 STKc_TNIK Catalytic domain of the Protein Serine/Threonine Kinase, Traf2- and Nck-interacting kinase

Probab=100.00  E-value=8.5e-38  Score=321.43  Aligned_cols=257  Identities=22%  Similarity=0.378  Sum_probs=201.5

Q ss_pred             HHhccCCcccccccCCcceEEEEEec-CCcEEEEEEecccCCchHHHHHHHHHHHHhcc-CCCcceeEeeEEEcCC----
Q 005586          406 SATQCFSEVNLLGKGNFSSVYKGTLR-DGTLVAIRSINVTSCKSEEAEFVKGLYLLTSL-RHENIIRLRGFCCSRG----  479 (689)
Q Consensus       406 ~at~~f~~~~~lg~G~~g~Vy~~~~~-~g~~vavK~l~~~~~~~~~~~f~~e~~~l~~l-~H~niv~l~g~~~~~~----  479 (689)
                      .+++.|+..+.||+|+||.||+|... +++.||+|++....  ....++..|+.++.++ +|+||+++++++....    
T Consensus         3 ~~~~~y~~~~~lg~g~~g~vy~~~~~~~~~~~aik~~~~~~--~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~~~~~~~   80 (272)
T cd06637           3 DPAGIFELVELVGNGTYGQVYKGRHVKTGQLAAIKVMDVTG--DEEEEIKQEINMLKKYSHHRNIATYYGAFIKKNPPGM   80 (272)
T ss_pred             ChhhhhhHHHheeecCCeEEEEEEEcCCCcEEEEEEEEcCC--ccHHHHHHHHHHHHHhcCCCCeeeEeeEEeecCCCCC
Confidence            35677888899999999999999875 68899999987543  3345788999999998 7999999999986532    


Q ss_pred             CCeEEEEEEcCCCCCHHHHhhhcCCCCCCCCHHHHHHHHHHHHHHHhhhhCCCCCCCceeecCCCCCceeecCCCCeEEe
Q 005586          480 RGECFLIYDFAPKGKLSKYLDQEEGSSNVLDWSTRVSIIIGIAKGIGYLHSSEVNKPAIVHRNLSVEKVLIDQQFNPLIA  559 (689)
Q Consensus       480 ~~~~~lV~e~~~~gsL~~~L~~~~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~~~ivH~dlk~~NiLl~~~~~~kl~  559 (689)
                      ....++||||+++|+|.+++.....  ..++|..+..++.|++.||+|||+.+     |+||||||+||++++++.+||+
T Consensus        81 ~~~~~iv~e~~~~~~L~~~l~~~~~--~~l~~~~~~~~~~qi~~~l~~LH~~~-----ivh~dl~~~nili~~~~~~~l~  153 (272)
T cd06637          81 DDQLWLVMEFCGAGSVTDLIKNTKG--NTLKEEWIAYICREILRGLSHLHQHK-----VIHRDIKGQNVLLTENAEVKLV  153 (272)
T ss_pred             CcEEEEEEEcCCCCcHHHHHHhccC--CCCCHHHHHHHHHHHHHHHHHHHHCC-----CccCCCCHHHEEECCCCCEEEc
Confidence            2468999999999999999986432  35889999999999999999999987     9999999999999999999999


Q ss_pred             cccccccccCCceeeeecCCCCCCCCCccccc-----cCCCCCcccchhHHHHHHHHHhCCCCcchhHHHHHhhhhhhHh
Q 005586          560 DCGLHKLLADDIVFSVLKTSAAMGYLAPEYVT-----TGRFTERSDIFAFGVIILQILTGSLVLTSSMRLAAESATFENF  634 (689)
Q Consensus       560 DfGla~~~~~~~~~~~~~~~~~~~y~aPE~~~-----~~~~~~ksDV~sfGvvl~elltG~~p~~~~~~~~~~~~~~~~~  634 (689)
                      |||+++....... ......++..|+|||++.     ...++.++|||||||++|||++|+.|+..........    ..
T Consensus       154 Dfg~~~~~~~~~~-~~~~~~g~~~y~aPE~~~~~~~~~~~~~~~~Dv~slGv~l~el~~g~~p~~~~~~~~~~~----~~  228 (272)
T cd06637         154 DFGVSAQLDRTVG-RRNTFIGTPYWMAPEVIACDENPDATYDFKSDLWSLGITAIEMAEGAPPLCDMHPMRALF----LI  228 (272)
T ss_pred             cCCCceecccccc-cCCcccccccccCHhHhccccCcCCCCCchhhHHHHHHHHHHHHhCCCCccccCHHHHHH----HH
Confidence            9999986543211 122234677899999986     3457889999999999999999999986432211111    01


Q ss_pred             hccccCCCCCHHHHHHHHHHHHHhccCCCCCCCCHHHHHHHH
Q 005586          635 IDRNLKGKFSESEAAKLGKMALVCTHEDPENRPTMEAVIEEL  676 (689)
Q Consensus       635 ~~~~~~~~~~~~~~~~l~~l~~~Cl~~dp~~RPs~~evl~~L  676 (689)
                      .............+.++.+++.+||..+|.+||++.|++++-
T Consensus       229 ~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~il~~~  270 (272)
T cd06637         229 PRNPAPRLKSKKWSKKFQSFIESCLVKNHSQRPTTEQLMKHP  270 (272)
T ss_pred             hcCCCCCCCCCCcCHHHHHHHHHHcCCChhhCCCHHHHhhCC
Confidence            111111111223456789999999999999999999998763

Serine/threonine kinases (STKs), Traf2- and Nck-interacting kinase (TNIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TNIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to mitogen-activated protein kinase (MAPK), kinase kinase kinase 4 (MAP4K4), and MAP4K6. MAP4Ks participate in some MAPK signaling pathways by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). TNIK is an effector of Rap2, a small GTP-binding protein from the Ras family. TNIK specifically activ

>PTZ00036 glycogen synthase kinase; Provisional

Probab=100.00  E-value=3.7e-38  Score=345.41  Aligned_cols=259  Identities=19%  Similarity=0.295  Sum_probs=195.8

Q ss_pred             HhccCCcccccccCCcceEEEEEec-CCcEEEEEEecccCCchHHHHHHHHHHHHhccCCCcceeEeeEEEcC------C
Q 005586          407 ATQCFSEVNLLGKGNFSSVYKGTLR-DGTLVAIRSINVTSCKSEEAEFVKGLYLLTSLRHENIIRLRGFCCSR------G  479 (689)
Q Consensus       407 at~~f~~~~~lg~G~~g~Vy~~~~~-~g~~vavK~l~~~~~~~~~~~f~~e~~~l~~l~H~niv~l~g~~~~~------~  479 (689)
                      ..++|...+.||+|+||.||+|... +++.||||++....     ....+|+.++++++|||||++++++...      .
T Consensus        64 ~~~~y~~~~~LG~G~fg~Vy~~~~~~~~~~vAiK~i~~~~-----~~~~~Ei~il~~l~h~niv~l~~~~~~~~~~~~~~  138 (440)
T PTZ00036         64 PNKSYKLGNIIGNGSFGVVYEAICIDTSEKVAIKKVLQDP-----QYKNRELLIMKNLNHINIIFLKDYYYTECFKKNEK  138 (440)
T ss_pred             cCCeEEEeEEEEeCCCEEEEEEEECCCCCEEEEEEEecCc-----chHHHHHHHHHhcCCCCCcceeeeEeecccccCCC
Confidence            3467888999999999999999975 68999999886432     2345799999999999999999886432      1


Q ss_pred             CCeEEEEEEcCCCCCHHHHhhhcCCCCCCCCHHHHHHHHHHHHHHHhhhhCCCCCCCceeecCCCCCceeecCCC-CeEE
Q 005586          480 RGECFLIYDFAPKGKLSKYLDQEEGSSNVLDWSTRVSIIIGIAKGIGYLHSSEVNKPAIVHRNLSVEKVLIDQQF-NPLI  558 (689)
Q Consensus       480 ~~~~~lV~e~~~~gsL~~~L~~~~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~~~ivH~dlk~~NiLl~~~~-~~kl  558 (689)
                      ....++||||++ ++|.+++.........+++.....++.|++.||+|||+.+     |+||||||+|||++.++ .+||
T Consensus       139 ~~~l~lvmE~~~-~~l~~~~~~~~~~~~~l~~~~~~~~~~qi~~gL~yLH~~~-----IiHrDLKp~NILl~~~~~~vkL  212 (440)
T PTZ00036        139 NIFLNVVMEFIP-QTVHKYMKHYARNNHALPLFLVKLYSYQLCRALAYIHSKF-----ICHRDLKPQNLLIDPNTHTLKL  212 (440)
T ss_pred             ceEEEEEEecCC-ccHHHHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHHCC-----EecCCcCHHHEEEcCCCCceee
Confidence            124678999997 5787777643333345899999999999999999999987     99999999999999664 7999


Q ss_pred             ecccccccccCCceeeeecCCCCCCCCCcccccc-CCCCCcccchhHHHHHHHHHhCCCCcchhHHHHHhhhhhh-----
Q 005586          559 ADCGLHKLLADDIVFSVLKTSAAMGYLAPEYVTT-GRFTERSDIFAFGVIILQILTGSLVLTSSMRLAAESATFE-----  632 (689)
Q Consensus       559 ~DfGla~~~~~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~ksDV~sfGvvl~elltG~~p~~~~~~~~~~~~~~~-----  632 (689)
                      +|||+++.+.....  .....++..|+|||++.+ ..++.++|||||||++|||+||+.||..............     
T Consensus       213 ~DFGla~~~~~~~~--~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlGvil~elltG~~pf~~~~~~~~~~~i~~~~~~p  290 (440)
T PTZ00036        213 CDFGSAKNLLAGQR--SVSYICSRFYRAPELMLGATNYTTHIDLWSLGCIIAEMILGYPIFSGQSSVDQLVRIIQVLGTP  290 (440)
T ss_pred             eccccchhccCCCC--cccCCCCcCccCHHHhcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCC
Confidence            99999987644321  123456788999999865 4689999999999999999999999965322111100000     


Q ss_pred             ---H--hhcc-------------ccCCCCCHHHHHHHHHHHHHhccCCCCCCCCHHHHHHHHHh
Q 005586          633 ---N--FIDR-------------NLKGKFSESEAAKLGKMALVCTHEDPENRPTMEAVIEELTV  678 (689)
Q Consensus       633 ---~--~~~~-------------~~~~~~~~~~~~~l~~l~~~Cl~~dp~~RPs~~evl~~L~~  678 (689)
                         .  ...+             .+...++...+.++.+++.+||+.||++||++.|++++.+.
T Consensus       291 ~~~~~~~~~~~~~~~~~~~~~~~~l~~~~p~~~~~~~~~li~~~L~~dP~~R~ta~e~l~hp~f  354 (440)
T PTZ00036        291 TEDQLKEMNPNYADIKFPDVKPKDLKKVFPKGTPDDAINFISQFLKYEPLKRLNPIEALADPFF  354 (440)
T ss_pred             CHHHHHHhchhhhcccCCccCchhHHHHhccCCCHHHHHHHHHHCCCChhHCcCHHHHhCChhH
Confidence               0  0000             00111222335678999999999999999999999988664

>PHA03212 serine/threonine kinase US3; Provisional

Probab=100.00  E-value=1.5e-37  Score=335.33  Aligned_cols=253  Identities=18%  Similarity=0.236  Sum_probs=197.0

Q ss_pred             hccCCcccccccCCcceEEEEEec-CCcEEEEEEecccCCchHHHHHHHHHHHHhccCCCcceeEeeEEEcCCCCeEEEE
Q 005586          408 TQCFSEVNLLGKGNFSSVYKGTLR-DGTLVAIRSINVTSCKSEEAEFVKGLYLLTSLRHENIIRLRGFCCSRGRGECFLI  486 (689)
Q Consensus       408 t~~f~~~~~lg~G~~g~Vy~~~~~-~g~~vavK~l~~~~~~~~~~~f~~e~~~l~~l~H~niv~l~g~~~~~~~~~~~lV  486 (689)
                      .++|+..+.||+|+||.||+|... +++.||+|...       ...+.+|++++++++|||||++++++..  ....++|
T Consensus        91 ~~~y~~~~~lg~G~~g~V~~~~d~~~~~~vaiK~~~-------~~~~~~E~~il~~l~HpnIv~~~~~~~~--~~~~~lv  161 (391)
T PHA03212         91 KAGFSILETFTPGAEGFAFACIDNKTCEHVVIKAGQ-------RGGTATEAHILRAINHPSIIQLKGTFTY--NKFTCLI  161 (391)
T ss_pred             cCCcEEEEEEcCCCCeEEEEEEECCCCCEEEEechh-------hhhhHHHHHHHHhCCCCCCCCEeEEEEE--CCeeEEE
Confidence            367999999999999999999875 68999999643       2357789999999999999999998854  4678999


Q ss_pred             EEcCCCCCHHHHhhhcCCCCCCCCHHHHHHHHHHHHHHHhhhhCCCCCCCceeecCCCCCceeecCCCCeEEeccccccc
Q 005586          487 YDFAPKGKLSKYLDQEEGSSNVLDWSTRVSIIIGIAKGIGYLHSSEVNKPAIVHRNLSVEKVLIDQQFNPLIADCGLHKL  566 (689)
Q Consensus       487 ~e~~~~gsL~~~L~~~~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~~~ivH~dlk~~NiLl~~~~~~kl~DfGla~~  566 (689)
                      +||+. ++|..++....    .+++.+++.|+.|++.||+|||+.+     |+||||||+|||+++++.+||+|||+++.
T Consensus       162 ~e~~~-~~L~~~l~~~~----~l~~~~~~~i~~qi~~aL~ylH~~~-----IvHrDiKP~NIll~~~~~vkL~DFG~a~~  231 (391)
T PHA03212        162 LPRYK-TDLYCYLAAKR----NIAICDILAIERSVLRAIQYLHENR-----IIHRDIKAENIFINHPGDVCLGDFGAACF  231 (391)
T ss_pred             EecCC-CCHHHHHHhcC----CCCHHHHHHHHHHHHHHHHHHHhCC-----cccCCCChHhEEEcCCCCEEEEeCCcccc
Confidence            99995 78998886543    3889999999999999999999987     99999999999999999999999999975


Q ss_pred             ccCCceeeeecCCCCCCCCCccccccCCCCCcccchhHHHHHHHHHhCCCCcchhHHH-------HHh------------
Q 005586          567 LADDIVFSVLKTSAAMGYLAPEYVTTGRFTERSDIFAFGVIILQILTGSLVLTSSMRL-------AAE------------  627 (689)
Q Consensus       567 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~ksDV~sfGvvl~elltG~~p~~~~~~~-------~~~------------  627 (689)
                      .............+|+.|+|||++.+..++.++|||||||++|||+||+.|+......       ...            
T Consensus       232 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~elltg~~p~~~~~~~~~~~~~~~~l~~i~~~~g~~p~  311 (391)
T PHA03212        232 PVDINANKYYGWAGTIATNAPELLARDPYGPAVDIWSAGIVLFEMATCHDSLFEKDGLDGDCDSDRQIKLIIRRSGTHPN  311 (391)
T ss_pred             cccccccccccccCccCCCChhhhcCCCCCcHHHHHHHHHHHHHHHHCCCCcCCcccccccCchhHHHHHHHHHhcCChh
Confidence            4332222223456889999999999889999999999999999999999876421100       000            


Q ss_pred             ------hhhhhHhh----ccccC--CCCC-----HHHHHHHHHHHHHhccCCCCCCCCHHHHHHHHHhh
Q 005586          628 ------SATFENFI----DRNLK--GKFS-----ESEAAKLGKMALVCTHEDPENRPTMEAVIEELTVA  679 (689)
Q Consensus       628 ------~~~~~~~~----~~~~~--~~~~-----~~~~~~l~~l~~~Cl~~dp~~RPs~~evl~~L~~~  679 (689)
                            ...+.+..    .....  ...+     ...+.++.+++.+|++.||++|||++|++++-+..
T Consensus       312 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~Li~~mL~~dP~~Rpta~elL~hp~f~  380 (391)
T PHA03212        312 EFPIDAQANLDEIYIGLAKKSSRKPGSRPLWTNLYELPIDLEYLICKMLAFDAHHRPSAEALLDFAAFQ  380 (391)
T ss_pred             hcCcchhHHHHHHHHHHHhccCCCCCCCCCHHHHhhhhhhHHHHHHHHhcCChhhCCCHHHHhcChhhc
Confidence                  00000000    00000  0000     12355788999999999999999999999887654

>cd05092 PTKc_TrkA Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase A

Probab=100.00  E-value=1.8e-37  Score=320.66  Aligned_cols=256  Identities=24%  Similarity=0.418  Sum_probs=202.2

Q ss_pred             ccCCcccccccCCcceEEEEEec------CCcEEEEEEecccCCchHHHHHHHHHHHHhccCCCcceeEeeEEEcCCCCe
Q 005586          409 QCFSEVNLLGKGNFSSVYKGTLR------DGTLVAIRSINVTSCKSEEAEFVKGLYLLTSLRHENIIRLRGFCCSRGRGE  482 (689)
Q Consensus       409 ~~f~~~~~lg~G~~g~Vy~~~~~------~g~~vavK~l~~~~~~~~~~~f~~e~~~l~~l~H~niv~l~g~~~~~~~~~  482 (689)
                      .+|...+.||+|+||.||++...      ++..+|+|.+.... ......|.+|++++++++|+||+++++++..  ...
T Consensus         5 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~~~~k~~~~~~-~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~--~~~   81 (280)
T cd05092           5 RDIVLKWELGEGAFGKVFLAECHNLLPEQDKMLVAVKALKEAS-ESARQDFQREAELLTVLQHQHIVRFYGVCTE--GRP   81 (280)
T ss_pred             HhceeccccCCccCCeEEEeEEecCCCCCCceEEEEEecCcCC-HHHHHHHHHHHHHHhcCCCCCCceEEEEEec--CCc
Confidence            35666789999999999999742      46689999887544 4455689999999999999999999999854  467


Q ss_pred             EEEEEEcCCCCCHHHHhhhcCCC-----------CCCCCHHHHHHHHHHHHHHHhhhhCCCCCCCceeecCCCCCceeec
Q 005586          483 CFLIYDFAPKGKLSKYLDQEEGS-----------SNVLDWSTRVSIIIGIAKGIGYLHSSEVNKPAIVHRNLSVEKVLID  551 (689)
Q Consensus       483 ~~lV~e~~~~gsL~~~L~~~~~~-----------~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~~~ivH~dlk~~NiLl~  551 (689)
                      .++||||+++|+|.++++.....           ...+++.+++.++.|++.||+|||+.+     |+||||||+|||++
T Consensus        82 ~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~~LH~~~-----i~H~dlkp~nil~~  156 (280)
T cd05092          82 LLMVFEYMRHGDLNRFLRSHGPDAKILAGGEDVAPGQLTLGQMLAIASQIASGMVYLASLH-----FVHRDLATRNCLVG  156 (280)
T ss_pred             eEEEEecCCCCCHHHHHHhcCcchhhhcccccCCccccCHHHHHHHHHHHHHHHHHHHHCC-----eecccccHhhEEEc
Confidence            89999999999999999764321           134899999999999999999999987     99999999999999


Q ss_pred             CCCCeEEecccccccccCCceee-eecCCCCCCCCCccccccCCCCCcccchhHHHHHHHHHh-CCCCcchhHHHHHhhh
Q 005586          552 QQFNPLIADCGLHKLLADDIVFS-VLKTSAAMGYLAPEYVTTGRFTERSDIFAFGVIILQILT-GSLVLTSSMRLAAESA  629 (689)
Q Consensus       552 ~~~~~kl~DfGla~~~~~~~~~~-~~~~~~~~~y~aPE~~~~~~~~~ksDV~sfGvvl~ellt-G~~p~~~~~~~~~~~~  629 (689)
                      +++.+||+|||+++.+....... .....++..|+|||++.+..++.++|||||||++|||++ |+.|+........   
T Consensus       157 ~~~~~kL~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~~~~~---  233 (280)
T cd05092         157 QGLVVKIGDFGMSRDIYSTDYYRVGGRTMLPIRWMPPESILYRKFTTESDIWSFGVVLWEIFTYGKQPWYQLSNTEA---  233 (280)
T ss_pred             CCCCEEECCCCceeEcCCCceeecCCCccccccccCHHHhccCCcCchhhHHHHHHHHHHHHcCCCCCCccCCHHHH---
Confidence            99999999999998654332211 112234567999999998899999999999999999999 8888854322111   


Q ss_pred             hhhHhhccccCCCCCHHHHHHHHHHHHHhccCCCCCCCCHHHHHHHHH
Q 005586          630 TFENFIDRNLKGKFSESEAAKLGKMALVCTHEDPENRPTMEAVIEELT  677 (689)
Q Consensus       630 ~~~~~~~~~~~~~~~~~~~~~l~~l~~~Cl~~dp~~RPs~~evl~~L~  677 (689)
                       ... +........+...+..+.+++.+||+.||++||++.||++.|+
T Consensus       234 -~~~-~~~~~~~~~~~~~~~~~~~li~~cl~~~P~~Rp~~~~l~~~l~  279 (280)
T cd05092         234 -IEC-ITQGRELERPRTCPPEVYAIMQGCWQREPQQRMVIKDIHSRLQ  279 (280)
T ss_pred             -HHH-HHcCccCCCCCCCCHHHHHHHHHHccCChhhCCCHHHHHHHHh
Confidence             111 1111111223344567899999999999999999999999886

Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase A (TrkA); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkA is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkA to its ligand, nerve growth factor (NGF), results in receptor oligomerization and activation of the catalytic domain. TrkA is expressed mainly in neural-crest-derived sensory

>cd05589 STKc_PKN Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase N

Probab=100.00  E-value=7.8e-38  Score=330.34  Aligned_cols=247  Identities=22%  Similarity=0.331  Sum_probs=194.3

Q ss_pred             CCcccccccCCcceEEEEEec-CCcEEEEEEecccCC--chHHHHHHHHHHH---HhccCCCcceeEeeEEEcCCCCeEE
Q 005586          411 FSEVNLLGKGNFSSVYKGTLR-DGTLVAIRSINVTSC--KSEEAEFVKGLYL---LTSLRHENIIRLRGFCCSRGRGECF  484 (689)
Q Consensus       411 f~~~~~lg~G~~g~Vy~~~~~-~g~~vavK~l~~~~~--~~~~~~f~~e~~~---l~~l~H~niv~l~g~~~~~~~~~~~  484 (689)
                      |...+.||+|+||.||+|..+ +|+.||||+++....  ....+.+..|+++   +++++||||+++++++..  .+..+
T Consensus         1 y~i~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~l~~e~~~~~~~~~l~hp~i~~~~~~~~~--~~~~~   78 (324)
T cd05589           1 FRCLAVLGRGHFGKVLLAEYKKTGELYAIKALKKGDIIARDEVESLMCEKRIFETANSERHPFLVNLFACFQT--EDHVC   78 (324)
T ss_pred             CeEEEEEeecCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhccccCCCChhceeeEEEc--CCEEE
Confidence            456789999999999999875 689999999975431  2233456666655   457789999999998843  57899


Q ss_pred             EEEEcCCCCCHHHHhhhcCCCCCCCCHHHHHHHHHHHHHHHhhhhCCCCCCCceeecCCCCCceeecCCCCeEEeccccc
Q 005586          485 LIYDFAPKGKLSKYLDQEEGSSNVLDWSTRVSIIIGIAKGIGYLHSSEVNKPAIVHRNLSVEKVLIDQQFNPLIADCGLH  564 (689)
Q Consensus       485 lV~e~~~~gsL~~~L~~~~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~~~ivH~dlk~~NiLl~~~~~~kl~DfGla  564 (689)
                      +||||+++|+|..+++..     .+++..+..++.|++.||+|||+.+     |+||||||+||++++++.+||+|||++
T Consensus        79 lv~E~~~~~~L~~~~~~~-----~l~~~~~~~~~~qi~~al~~lH~~~-----ivHrdlkp~Nill~~~~~~kL~Dfg~~  148 (324)
T cd05589          79 FVMEYAAGGDLMMHIHTD-----VFSEPRAVFYAACVVLGLQYLHENK-----IVYRDLKLDNLLLDTEGFVKIADFGLC  148 (324)
T ss_pred             EEEcCCCCCcHHHHhhcC-----CCCHHHHHHHHHHHHHHHHHHHhCC-----eEecCCCHHHeEECCCCcEEeCcccCC
Confidence            999999999999888642     3899999999999999999999987     999999999999999999999999998


Q ss_pred             ccccCCceeeeecCCCCCCCCCccccccCCCCCcccchhHHHHHHHHHhCCCCcchhHHHHHhhhhhhHhhccccCCCCC
Q 005586          565 KLLADDIVFSVLKTSAAMGYLAPEYVTTGRFTERSDIFAFGVIILQILTGSLVLTSSMRLAAESATFENFIDRNLKGKFS  644 (689)
Q Consensus       565 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~ksDV~sfGvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~  644 (689)
                      +....... ......++..|+|||.+.+..++.++|||||||++|||++|+.||........    ...+....  ..++
T Consensus       149 ~~~~~~~~-~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~il~el~~G~~pf~~~~~~~~----~~~i~~~~--~~~p  221 (324)
T cd05589         149 KEGMGFGD-RTSTFCGTPEFLAPEVLTETSYTRAVDWWGLGVLIYEMLVGESPFPGDDEEEV----FDSIVNDE--VRYP  221 (324)
T ss_pred             ccCCCCCC-cccccccCccccCHhHhcCCCCCcccchhhHHHHHHHHHhCCCCCCCCCHHHH----HHHHHhCC--CCCC
Confidence            75422111 11234578899999999998999999999999999999999999965422111    11111111  1233


Q ss_pred             HHHHHHHHHHHHHhccCCCCCCC-----CHHHHHHHH
Q 005586          645 ESEAAKLGKMALVCTHEDPENRP-----TMEAVIEEL  676 (689)
Q Consensus       645 ~~~~~~l~~l~~~Cl~~dp~~RP-----s~~evl~~L  676 (689)
                      ...+..+.+++.+|++.||++||     ++.+++++.
T Consensus       222 ~~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~l~~~~  258 (324)
T cd05589         222 RFLSREAISIMRRLLRRNPERRLGSGEKDAEDVKKQP  258 (324)
T ss_pred             CCCCHHHHHHHHHHhhcCHhHcCCCCCCCHHHHhhCC
Confidence            44466788999999999999999     577777654

Serine/Threonine Kinases (STKs), Protein Kinase N (PKN) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKN subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKN has a C-terminal catalytic domain that is highly homologous to PKCs. Its unique N-terminal regulatory region contains antiparallel coiled-coil (ACC) domains. In mammals, there are three PKN isoforms from different genes (designated PKN-alpha, beta, and gamma), which show different enzymatic properties, tissue distribution, and varied functions. PKN can be activated by the small GTPase Rho, and by fatty acids such as arachidonic and linoleic acids. It is involved

>cd06619 PKc_MKK5 Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 5

Probab=100.00  E-value=1.7e-37  Score=320.72  Aligned_cols=252  Identities=19%  Similarity=0.313  Sum_probs=199.7

Q ss_pred             cCCcccccccCCcceEEEEEec-CCcEEEEEEecccCCchHHHHHHHHHHHHhccCCCcceeEeeEEEcCCCCeEEEEEE
Q 005586          410 CFSEVNLLGKGNFSSVYKGTLR-DGTLVAIRSINVTSCKSEEAEFVKGLYLLTSLRHENIIRLRGFCCSRGRGECFLIYD  488 (689)
Q Consensus       410 ~f~~~~~lg~G~~g~Vy~~~~~-~g~~vavK~l~~~~~~~~~~~f~~e~~~l~~l~H~niv~l~g~~~~~~~~~~~lV~e  488 (689)
                      +|+..+.||+|+||.||+|... ++..||+|++..........+|.+|++++.+++||||+++++++..  .+..++|||
T Consensus         2 ~~~~~~~lg~g~~~~v~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~--~~~~~lv~e   79 (279)
T cd06619           2 DIQYQEILGHGNGGTVYKAYHLLTRRILAVKVIPLDITVELQKQIMSELEILYKCDSPYIIGFYGAFFV--ENRISICTE   79 (279)
T ss_pred             cchheeeeccCCCeEEEEEEEcCCCcEEEEEEEecCCChHHHHHHHHHHHHHHhCCCCCeeeEEEEEEE--CCEEEEEEe
Confidence            5677789999999999999864 7899999998765434455689999999999999999999999855  467899999


Q ss_pred             cCCCCCHHHHhhhcCCCCCCCCHHHHHHHHHHHHHHHhhhhCCCCCCCceeecCCCCCceeecCCCCeEEeccccccccc
Q 005586          489 FAPKGKLSKYLDQEEGSSNVLDWSTRVSIIIGIAKGIGYLHSSEVNKPAIVHRNLSVEKVLIDQQFNPLIADCGLHKLLA  568 (689)
Q Consensus       489 ~~~~gsL~~~L~~~~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~~~ivH~dlk~~NiLl~~~~~~kl~DfGla~~~~  568 (689)
                      |+++|+|..+.        .+++.....++.|++.||+|||+.+     |+|+||||+||+++.++.+||+|||++....
T Consensus        80 ~~~~~~l~~~~--------~~~~~~~~~~~~qi~~~l~~lH~~~-----i~H~dlkp~Nill~~~~~~~l~dfg~~~~~~  146 (279)
T cd06619          80 FMDGGSLDVYR--------KIPEHVLGRIAVAVVKGLTYLWSLK-----ILHRDVKPSNMLVNTRGQVKLCDFGVSTQLV  146 (279)
T ss_pred             cCCCCChHHhh--------cCCHHHHHHHHHHHHHHHHHHHHCC-----EeeCCCCHHHEEECCCCCEEEeeCCcceecc
Confidence            99999997652        2678888999999999999999987     9999999999999999999999999998654


Q ss_pred             CCceeeeecCCCCCCCCCccccccCCCCCcccchhHHHHHHHHHhCCCCcchhHHHHH---hhhhhhHhhccccCCCCCH
Q 005586          569 DDIVFSVLKTSAAMGYLAPEYVTTGRFTERSDIFAFGVIILQILTGSLVLTSSMRLAA---ESATFENFIDRNLKGKFSE  645 (689)
Q Consensus       569 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~ksDV~sfGvvl~elltG~~p~~~~~~~~~---~~~~~~~~~~~~~~~~~~~  645 (689)
                      ...   .....++..|+|||++.+..++.++|||||||++|||+||+.||........   .........+.........
T Consensus       147 ~~~---~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  223 (279)
T cd06619         147 NSI---AKTYVGTNAYMAPERISGEQYGIHSDVWSLGISFMELALGRFPYPQIQKNQGSLMPLQLLQCIVDEDPPVLPVG  223 (279)
T ss_pred             ccc---ccCCCCChhhcCceeecCCCCCCcchHHHHHHHHHHHHhCCCCchhhcccccccchHHHHHHHhccCCCCCCCC
Confidence            322   1223577889999999988999999999999999999999999864221110   0011111111111111112


Q ss_pred             HHHHHHHHHHHHhccCCCCCCCCHHHHHHHHHhh
Q 005586          646 SEAAKLGKMALVCTHEDPENRPTMEAVIEELTVA  679 (689)
Q Consensus       646 ~~~~~l~~l~~~Cl~~dp~~RPs~~evl~~L~~~  679 (689)
                      ....++.+++.+|++.+|++||+++|++++.+..
T Consensus       224 ~~~~~~~~li~~~l~~~P~~Rp~~~eil~~~~~~  257 (279)
T cd06619         224 QFSEKFVHFITQCMRKQPKERPAPENLMDHPFIV  257 (279)
T ss_pred             cCCHHHHHHHHHHhhCChhhCCCHHHHhcCcccc
Confidence            2345789999999999999999999999886543

Protein kinases (PKs), MAP kinase kinase 5 (MKK5) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK5, also referred to as MEK5, is a dual-specificity PK that p

>cd05592 STKc_nPKC_theta_delta Catalytic domain of the Protein Serine/Threonine Kinases, Novel Protein Kinase C theta and delta

Probab=100.00  E-value=9.3e-38  Score=328.42  Aligned_cols=243  Identities=19%  Similarity=0.305  Sum_probs=191.0

Q ss_pred             cccccCCcceEEEEEec-CCcEEEEEEecccCC--chHHHHHHHHHHHHhcc-CCCcceeEeeEEEcCCCCeEEEEEEcC
Q 005586          415 NLLGKGNFSSVYKGTLR-DGTLVAIRSINVTSC--KSEEAEFVKGLYLLTSL-RHENIIRLRGFCCSRGRGECFLIYDFA  490 (689)
Q Consensus       415 ~~lg~G~~g~Vy~~~~~-~g~~vavK~l~~~~~--~~~~~~f~~e~~~l~~l-~H~niv~l~g~~~~~~~~~~~lV~e~~  490 (689)
                      +.||+|+||.||+|..+ +++.||+|+++....  ......+..|..++... +||||+++++++..  .+..++||||+
T Consensus         1 ~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~hp~i~~~~~~~~~--~~~~~lv~e~~   78 (316)
T cd05592           1 KVLGKGSFGKVMLAELKGTNEFFAIKALKKDVVLEDDDVECTMVERRVLALAWEHPFLTHLFCTFQT--KEHLFFVMEYL   78 (316)
T ss_pred             CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhhHHHHHHHHHHHHhccCCCCccceeeEEEc--CCEEEEEEcCC
Confidence            36999999999999975 588999999975421  22334566677777654 89999999998843  57899999999


Q ss_pred             CCCCHHHHhhhcCCCCCCCCHHHHHHHHHHHHHHHhhhhCCCCCCCceeecCCCCCceeecCCCCeEEecccccccccCC
Q 005586          491 PKGKLSKYLDQEEGSSNVLDWSTRVSIIIGIAKGIGYLHSSEVNKPAIVHRNLSVEKVLIDQQFNPLIADCGLHKLLADD  570 (689)
Q Consensus       491 ~~gsL~~~L~~~~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~~~ivH~dlk~~NiLl~~~~~~kl~DfGla~~~~~~  570 (689)
                      ++|+|..++....    .+++.....++.|++.||+|||+.+     |+||||||+|||++.++.+||+|||+++.....
T Consensus        79 ~gg~L~~~~~~~~----~~~~~~~~~~~~qi~~al~~LH~~~-----ivH~dlkp~Nill~~~~~~kL~Dfg~a~~~~~~  149 (316)
T cd05592          79 NGGDLMFHIQSSG----RFDEARARFYAAEIICGLQFLHKKG-----IIYRDLKLDNVLLDKDGHIKIADFGMCKENMNG  149 (316)
T ss_pred             CCCcHHHHHHHcC----CCCHHHHHHHHHHHHHHHHHHHHCC-----EEeCCCCHHHeEECCCCCEEEccCcCCeECCCC
Confidence            9999999987643    3888999999999999999999987     999999999999999999999999999764322


Q ss_pred             ceeeeecCCCCCCCCCccccccCCCCCcccchhHHHHHHHHHhCCCCcchhHHHHHhhhhhhHhhccccCCCCCHHHHHH
Q 005586          571 IVFSVLKTSAAMGYLAPEYVTTGRFTERSDIFAFGVIILQILTGSLVLTSSMRLAAESATFENFIDRNLKGKFSESEAAK  650 (689)
Q Consensus       571 ~~~~~~~~~~~~~y~aPE~~~~~~~~~ksDV~sfGvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  650 (689)
                      . .......+|..|+|||++.+..++.++|||||||++|||++|+.||........    ...+..  ....++.....+
T Consensus       150 ~-~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ell~G~~Pf~~~~~~~~----~~~i~~--~~~~~~~~~~~~  222 (316)
T cd05592         150 E-GKASTFCGTPDYIAPEILKGQKYNESVDWWSFGVLLYEMLIGQSPFHGEDEDEL----FDSILN--DRPHFPRWISKE  222 (316)
T ss_pred             C-CccccccCCccccCHHHHcCCCCCCcccchhHHHHHHHHHhCCCCCCCCCHHHH----HHHHHc--CCCCCCCCCCHH
Confidence            2 122234578899999999988999999999999999999999999965322111    111111  112234445567


Q ss_pred             HHHHHHHhccCCCCCCCCHH-HHHHH
Q 005586          651 LGKMALVCTHEDPENRPTME-AVIEE  675 (689)
Q Consensus       651 l~~l~~~Cl~~dp~~RPs~~-evl~~  675 (689)
                      +.+++..||+.||++||++. +++++
T Consensus       223 ~~~ll~~~l~~~P~~R~~~~~~l~~h  248 (316)
T cd05592         223 AKDCLSKLFERDPTKRLGVDGDIRQH  248 (316)
T ss_pred             HHHHHHHHccCCHHHcCCChHHHHcC
Confidence            88999999999999999875 55543

Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta and delta-like isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an imp

>cd05100 PTKc_FGFR3 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 3

Probab=100.00  E-value=1.7e-37  Score=329.28  Aligned_cols=260  Identities=23%  Similarity=0.410  Sum_probs=205.8

Q ss_pred             ccCCcccccccCCcceEEEEEec--------CCcEEEEEEecccCCchHHHHHHHHHHHHhcc-CCCcceeEeeEEEcCC
Q 005586          409 QCFSEVNLLGKGNFSSVYKGTLR--------DGTLVAIRSINVTSCKSEEAEFVKGLYLLTSL-RHENIIRLRGFCCSRG  479 (689)
Q Consensus       409 ~~f~~~~~lg~G~~g~Vy~~~~~--------~g~~vavK~l~~~~~~~~~~~f~~e~~~l~~l-~H~niv~l~g~~~~~~  479 (689)
                      .+|...+.||+|+||.||+|...        .+..||+|.+..........+|.+|++++.++ +||||++++++|..  
T Consensus        12 ~~~~i~~~ig~G~~g~v~~~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~--   89 (334)
T cd05100          12 TRLTLGKPLGEGCFGQVVMAEAIGIDKDKPNKPVTVAVKMLKDDATDKDLSDLVSEMEMMKMIGKHKNIINLLGACTQ--   89 (334)
T ss_pred             hHeeecceeccccCCcEEEEEEeccCCccCCcceeEEEEEcccccCHHHHHHHHHHHHHHHhhcCCCCeeeeeEEEcc--
Confidence            35777899999999999999752        12478999887654444567899999999999 89999999999854  


Q ss_pred             CCeEEEEEEcCCCCCHHHHhhhcCC------------CCCCCCHHHHHHHHHHHHHHHhhhhCCCCCCCceeecCCCCCc
Q 005586          480 RGECFLIYDFAPKGKLSKYLDQEEG------------SSNVLDWSTRVSIIIGIAKGIGYLHSSEVNKPAIVHRNLSVEK  547 (689)
Q Consensus       480 ~~~~~lV~e~~~~gsL~~~L~~~~~------------~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~~~ivH~dlk~~N  547 (689)
                      .+..++||||+++|+|.+++.....            ....++|.+++.++.|++.||+|||+.+     |+||||||+|
T Consensus        90 ~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~~LH~~g-----ivH~dlkp~N  164 (334)
T cd05100          90 DGPLYVLVEYASKGNLREYLRARRPPGMDYSFDTCKLPEEQLTFKDLVSCAYQVARGMEYLASQK-----CIHRDLAARN  164 (334)
T ss_pred             CCceEEEEecCCCCcHHHHHHhcCCcccccccccccCccccCCHHHHHHHHHHHHHHHHHHHHCC-----eeccccccce
Confidence            4678999999999999999975421            1235899999999999999999999987     9999999999


Q ss_pred             eeecCCCCeEEecccccccccCCceee-eecCCCCCCCCCccccccCCCCCcccchhHHHHHHHHHh-CCCCcchhHHHH
Q 005586          548 VLIDQQFNPLIADCGLHKLLADDIVFS-VLKTSAAMGYLAPEYVTTGRFTERSDIFAFGVIILQILT-GSLVLTSSMRLA  625 (689)
Q Consensus       548 iLl~~~~~~kl~DfGla~~~~~~~~~~-~~~~~~~~~y~aPE~~~~~~~~~ksDV~sfGvvl~ellt-G~~p~~~~~~~~  625 (689)
                      |++++++.+||+|||+++......... .....++..|+|||++.+..++.++|||||||++|||++ |+.|+.......
T Consensus       165 ill~~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~~~~  244 (334)
T cd05100         165 VLVTEDNVMKIADFGLARDVHNIDYYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLLWEIFTLGGSPYPGIPVEE  244 (334)
T ss_pred             EEEcCCCcEEECCcccceecccccccccccCCCcCceEcCHHHhccCCcCchhhhHHHHHHHHHHHhcCCCCCCCCCHHH
Confidence            999999999999999998665432111 112233457999999998899999999999999999998 888875432111


Q ss_pred             HhhhhhhHhhccccCCCCCHHHHHHHHHHHHHhccCCCCCCCCHHHHHHHHHhhC
Q 005586          626 AESATFENFIDRNLKGKFSESEAAKLGKMALVCTHEDPENRPTMEAVIEELTVAA  680 (689)
Q Consensus       626 ~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~Cl~~dp~~RPs~~evl~~L~~~~  680 (689)
                           +...+........+...+.++.+++.+|++.+|++||+|.|+++.|+.+.
T Consensus       245 -----~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~Rps~~ell~~l~~~~  294 (334)
T cd05100         245 -----LFKLLKEGHRMDKPANCTHELYMIMRECWHAVPSQRPTFKQLVEDLDRVL  294 (334)
T ss_pred             -----HHHHHHcCCCCCCCCCCCHHHHHHHHHHcccChhhCcCHHHHHHHHHHHh
Confidence                 11112222222333445668999999999999999999999999998765

Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 3 (FGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR3 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to

>cd05618 STKc_aPKC_iota Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C iota

Probab=100.00  E-value=5.6e-38  Score=331.94  Aligned_cols=248  Identities=16%  Similarity=0.268  Sum_probs=194.6

Q ss_pred             cccccCCcceEEEEEec-CCcEEEEEEecccCC--chHHHHHHHHHHHHhcc-CCCcceeEeeEEEcCCCCeEEEEEEcC
Q 005586          415 NLLGKGNFSSVYKGTLR-DGTLVAIRSINVTSC--KSEEAEFVKGLYLLTSL-RHENIIRLRGFCCSRGRGECFLIYDFA  490 (689)
Q Consensus       415 ~~lg~G~~g~Vy~~~~~-~g~~vavK~l~~~~~--~~~~~~f~~e~~~l~~l-~H~niv~l~g~~~~~~~~~~~lV~e~~  490 (689)
                      +.||+|+||.||+|+.+ +++.||+|+++....  ......+..|+.++.++ +||||+++++++..  .+..++||||+
T Consensus         1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~~~~hp~iv~~~~~~~~--~~~~~lv~E~~   78 (329)
T cd05618           1 RVIGRGSYAKVLLVRLKKTERIYAMKVVKKELVNDDEDIDWVQTEKHVFEQASNHPFLVGLHSCFQT--ESRLFFVIEYV   78 (329)
T ss_pred             CeeeeCCCeEEEEEEECCCCCEEEEEEEEhhHhcchhHHHHHHHHHHHHHhcCCCCcCCceeeEEEe--CCEEEEEEeCC
Confidence            46999999999999976 688999999986432  23345678888888877 89999999998854  47899999999


Q ss_pred             CCCCHHHHhhhcCCCCCCCCHHHHHHHHHHHHHHHhhhhCCCCCCCceeecCCCCCceeecCCCCeEEecccccccccCC
Q 005586          491 PKGKLSKYLDQEEGSSNVLDWSTRVSIIIGIAKGIGYLHSSEVNKPAIVHRNLSVEKVLIDQQFNPLIADCGLHKLLADD  570 (689)
Q Consensus       491 ~~gsL~~~L~~~~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~~~ivH~dlk~~NiLl~~~~~~kl~DfGla~~~~~~  570 (689)
                      ++|+|..++....    .+++..+..|+.|++.||+|||+.+     |+||||||+||+++.++.+||+|||+++.....
T Consensus        79 ~~~~L~~~~~~~~----~l~~~~~~~i~~qi~~~l~~lH~~~-----ivH~Dikp~Nili~~~~~~kL~DfG~~~~~~~~  149 (329)
T cd05618          79 NGGDLMFHMQRQR----KLPEEHARFYSAEISLALNYLHERG-----IIYRDLKLDNVLLDSEGHIKLTDYGMCKEGLRP  149 (329)
T ss_pred             CCCCHHHHHHHcC----CCCHHHHHHHHHHHHHHHHHHHHCC-----eeeCCCCHHHEEECCCCCEEEeeCCccccccCC
Confidence            9999999886543    4899999999999999999999987     999999999999999999999999998754221


Q ss_pred             ceeeeecCCCCCCCCCccccccCCCCCcccchhHHHHHHHHHhCCCCcchhHHHH-----HhhhhhhHhhccccCCCCCH
Q 005586          571 IVFSVLKTSAAMGYLAPEYVTTGRFTERSDIFAFGVIILQILTGSLVLTSSMRLA-----AESATFENFIDRNLKGKFSE  645 (689)
Q Consensus       571 ~~~~~~~~~~~~~y~aPE~~~~~~~~~ksDV~sfGvvl~elltG~~p~~~~~~~~-----~~~~~~~~~~~~~~~~~~~~  645 (689)
                      .. ......+|..|+|||++.+..++.++|||||||++|||+||+.||.......     ........+...  ...++.
T Consensus       150 ~~-~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~Pf~~~~~~~~~~~~~~~~~~~~i~~~--~~~~p~  226 (329)
T cd05618         150 GD-TTSTFCGTPNYIAPEILRGEDYGFSVDWWALGVLMFEMMAGRSPFDIVGSSDNPDQNTEDYLFQVILEK--QIRIPR  226 (329)
T ss_pred             CC-ccccccCCccccCHHHHcCCCCCCccceecccHHHHHHhhCCCCCccCCCcCCcccccHHHHHHHHhcC--CCCCCC
Confidence            11 1123457889999999999999999999999999999999999985211000     000011111111  123445


Q ss_pred             HHHHHHHHHHHHhccCCCCCCCC------HHHHHHHH
Q 005586          646 SEAAKLGKMALVCTHEDPENRPT------MEAVIEEL  676 (689)
Q Consensus       646 ~~~~~l~~l~~~Cl~~dp~~RPs------~~evl~~L  676 (689)
                      ..+.++.+++.+|++.||++||+      +.+++++-
T Consensus       227 ~~~~~~~~ll~~~L~~dP~~R~~~~~~~~~~~i~~hp  263 (329)
T cd05618         227 SLSVKAASVLKSFLNKDPKERLGCHPQTGFADIQGHP  263 (329)
T ss_pred             CCCHHHHHHHHHHhcCCHHHcCCCCCCCCHHHHhcCC
Confidence            55678899999999999999998      57877663

Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, iota isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-iota is directly implicated in carcinogenesis. It is critical to oncogenic signaling mediated by Ras and Bcr-Abl. The PKC-iota gene is the target o

>cd06615 PKc_MEK Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase

Probab=100.00  E-value=2.8e-37  Score=323.73  Aligned_cols=259  Identities=19%  Similarity=0.319  Sum_probs=203.1

Q ss_pred             ccCCcccccccCCcceEEEEEec-CCcEEEEEEecccCCchHHHHHHHHHHHHhccCCCcceeEeeEEEcCCCCeEEEEE
Q 005586          409 QCFSEVNLLGKGNFSSVYKGTLR-DGTLVAIRSINVTSCKSEEAEFVKGLYLLTSLRHENIIRLRGFCCSRGRGECFLIY  487 (689)
Q Consensus       409 ~~f~~~~~lg~G~~g~Vy~~~~~-~g~~vavK~l~~~~~~~~~~~f~~e~~~l~~l~H~niv~l~g~~~~~~~~~~~lV~  487 (689)
                      ++|+..+.||+|+||.||++... +|..+|+|.+..........++.+|++++.+++||||+++++++..  .+..++||
T Consensus         1 ~~~~~~~~lg~G~~g~v~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~--~~~~~lv~   78 (308)
T cd06615           1 DDFEKLGELGAGNGGVVTKVLHRPSGLIMARKLIHLEIKPAIRNQIIRELKVLHECNSPYIVGFYGAFYS--DGEISICM   78 (308)
T ss_pred             CCceEEeeccCCCCeEEEEEEEcCCCeEEEEEEeccccCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEee--CCEEEEEe
Confidence            36788899999999999999875 6888999998765433345678999999999999999999999854  57899999


Q ss_pred             EcCCCCCHHHHhhhcCCCCCCCCHHHHHHHHHHHHHHHhhhhCC-CCCCCceeecCCCCCceeecCCCCeEEeccccccc
Q 005586          488 DFAPKGKLSKYLDQEEGSSNVLDWSTRVSIIIGIAKGIGYLHSS-EVNKPAIVHRNLSVEKVLIDQQFNPLIADCGLHKL  566 (689)
Q Consensus       488 e~~~~gsL~~~L~~~~~~~~~l~~~~~~~ia~~ia~gL~yLH~~-~~~~~~ivH~dlk~~NiLl~~~~~~kl~DfGla~~  566 (689)
                      ||+++++|.++++...    .+++..+..++.|+++||+|||+. +     ++||||||+||++++++.+||+|||+++.
T Consensus        79 ey~~~~~L~~~l~~~~----~~~~~~~~~~~~~i~~~l~~lH~~~~-----i~H~dl~p~nil~~~~~~~~l~dfg~~~~  149 (308)
T cd06615          79 EHMDGGSLDQVLKKAG----RIPENILGKISIAVLRGLTYLREKHK-----IMHRDVKPSNILVNSRGEIKLCDFGVSGQ  149 (308)
T ss_pred             eccCCCcHHHHHHhcC----CCCHHHHHHHHHHHHHHHHHHHhhCC-----EEECCCChHHEEEecCCcEEEccCCCccc
Confidence            9999999999997642    488999999999999999999973 4     99999999999999999999999999876


Q ss_pred             ccCCceeeeecCCCCCCCCCccccccCCCCCcccchhHHHHHHHHHhCCCCcchhHHHHHhhh---h-------------
Q 005586          567 LADDIVFSVLKTSAAMGYLAPEYVTTGRFTERSDIFAFGVIILQILTGSLVLTSSMRLAAESA---T-------------  630 (689)
Q Consensus       567 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~ksDV~sfGvvl~elltG~~p~~~~~~~~~~~~---~-------------  630 (689)
                      ......   ....++..|+|||.+.+..++.++|||||||++|||+||+.|+...........   .             
T Consensus       150 ~~~~~~---~~~~~~~~~~aPE~~~~~~~~~~~DiwslG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  226 (308)
T cd06615         150 LIDSMA---NSFVGTRSYMSPERLQGTHYTVQSDIWSLGLSLVEMAIGRYPIPPPDAKELEAMFGRPVSEGEAKESHRPV  226 (308)
T ss_pred             cccccc---ccCCCCcCccChhHhcCCCCCccchHHHHHHHHHHHHhCCCCCCCcchhhHHHhhcCccccccccCCcccc
Confidence            543211   223467789999999888899999999999999999999999853221110000   0             


Q ss_pred             ------------hhHhhccc---cCCCCC-HHHHHHHHHHHHHhccCCCCCCCCHHHHHHHHHhhCC
Q 005586          631 ------------FENFIDRN---LKGKFS-ESEAAKLGKMALVCTHEDPENRPTMEAVIEELTVAAP  681 (689)
Q Consensus       631 ------------~~~~~~~~---~~~~~~-~~~~~~l~~l~~~Cl~~dp~~RPs~~evl~~L~~~~p  681 (689)
                                  ..+..+..   .....+ .....++.+++.+|++.+|++||++.||+++.+....
T Consensus       227 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~ll~~~~~~~~  293 (308)
T cd06615         227 SGHPPDSPRPMAIFELLDYIVNEPPPKLPSGAFSDEFQDFVDKCLKKNPKERADLKELTKHPFIKRA  293 (308)
T ss_pred             cCCCCCccchhhHHHHHHHHhcCCCccCcCcccCHHHHHHHHHHccCChhhCcCHHHHhcChhhhhc
Confidence                        00000000   000011 1134568999999999999999999999999876543

Protein kinases (PKs), MAP/ERK kinase (MEK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 and MEK2 are dual-specificity PKs that phosphorylate and activate the down

>cd05599 STKc_NDR_like Catalytic domain of Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=5.1e-38  Score=337.38  Aligned_cols=253  Identities=17%  Similarity=0.259  Sum_probs=199.7

Q ss_pred             ccCCcccccccCCcceEEEEEec-CCcEEEEEEecccCC--chHHHHHHHHHHHHhccCCCcceeEeeEEEcCCCCeEEE
Q 005586          409 QCFSEVNLLGKGNFSSVYKGTLR-DGTLVAIRSINVTSC--KSEEAEFVKGLYLLTSLRHENIIRLRGFCCSRGRGECFL  485 (689)
Q Consensus       409 ~~f~~~~~lg~G~~g~Vy~~~~~-~g~~vavK~l~~~~~--~~~~~~f~~e~~~l~~l~H~niv~l~g~~~~~~~~~~~l  485 (689)
                      ++|+..+.||+|+||.||+|+.. +|+.||||++.....  ......+.+|++++..++||||+++++++..  .+..++
T Consensus         1 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~il~~l~h~~iv~~~~~~~~--~~~~~l   78 (364)
T cd05599           1 DDFESIKVIGRGAFGEVRLVQKKDTGHIYAMKKLRKSEMLEKEQVAHVRAERDILAEADNPWVVKLYYSFQD--ENYLYL   78 (364)
T ss_pred             CCceEEEEEEecCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCCcceEEEEEc--CCeEEE
Confidence            36888899999999999999976 689999999975421  2334568899999999999999999998844  578999


Q ss_pred             EEEcCCCCCHHHHhhhcCCCCCCCCHHHHHHHHHHHHHHHhhhhCCCCCCCceeecCCCCCceeecCCCCeEEecccccc
Q 005586          486 IYDFAPKGKLSKYLDQEEGSSNVLDWSTRVSIIIGIAKGIGYLHSSEVNKPAIVHRNLSVEKVLIDQQFNPLIADCGLHK  565 (689)
Q Consensus       486 V~e~~~~gsL~~~L~~~~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~~~ivH~dlk~~NiLl~~~~~~kl~DfGla~  565 (689)
                      ||||+++|+|.+++....    .+++..+..|+.|++.||+|||+.+     |+||||||+|||+++++.+||+|||+++
T Consensus        79 v~E~~~~g~L~~~l~~~~----~l~~~~~~~~~~qi~~aL~~lH~~~-----ivH~Dlkp~NIl~~~~~~~kl~Dfg~~~  149 (364)
T cd05599          79 IMEYLPGGDMMTLLMKKD----TFTEEETRFYIAETILAIDSIHKLG-----YIHRDIKPDNLLLDAKGHIKLSDFGLCT  149 (364)
T ss_pred             EECCCCCcHHHHHHHHcC----CCCHHHHHHHHHHHHHHHHHHHHCC-----eEeccCCHHHeEECCCCCEEEeecccce
Confidence            999999999999997643    3899999999999999999999987     9999999999999999999999999987


Q ss_pred             cccCCcee-------------------------------------eeecCCCCCCCCCccccccCCCCCcccchhHHHHH
Q 005586          566 LLADDIVF-------------------------------------SVLKTSAAMGYLAPEYVTTGRFTERSDIFAFGVII  608 (689)
Q Consensus       566 ~~~~~~~~-------------------------------------~~~~~~~~~~y~aPE~~~~~~~~~ksDV~sfGvvl  608 (689)
                      .+......                                     ......||+.|+|||++....++.++|||||||++
T Consensus       150 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il  229 (364)
T cd05599         150 GLKKSHRTEFYRILSHALPSNFLDFISKPMSSKRKAETWKRNRRALAYSTVGTPDYIAPEVFLQTGYNKECDWWSLGVIM  229 (364)
T ss_pred             eccccccccccccccccccccccccccccccccccccchhhcccccccccccCccccCHHHHcCCCCCCeeeeecchhHH
Confidence            65321100                                     00113478899999999988999999999999999


Q ss_pred             HHHHhCCCCcchhHHHHHhhhhhhHhhcc--ccCCCCCHHHHHHHHHHHHHhccCCCCCCCC---HHHHHHHHH
Q 005586          609 LQILTGSLVLTSSMRLAAESATFENFIDR--NLKGKFSESEAAKLGKMALVCTHEDPENRPT---MEAVIEELT  677 (689)
Q Consensus       609 ~elltG~~p~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~~~~l~~l~~~Cl~~dp~~RPs---~~evl~~L~  677 (689)
                      |||++|+.||........    ...+...  .+........+..+.+++.+|+. +|.+|++   +.|++++-+
T Consensus       230 ~el~~G~~Pf~~~~~~~~----~~~i~~~~~~~~~~~~~~~s~~~~~li~~ll~-~p~~R~~~~~~~~ll~h~~  298 (364)
T cd05599         230 YEMLVGYPPFCSDNPQET----YRKIINWKETLQFPDEVPLSPEAKDLIKRLCC-EAERRLGNNGVNEIKSHPF  298 (364)
T ss_pred             HHhhcCCCCCCCCCHHHH----HHHHHcCCCccCCCCCCCCCHHHHHHHHHHcc-CHhhcCCCCCHHHHhcCCC
Confidence            999999999965432211    1111111  11101111234567888888886 9999998   999988754

Serine/Threonine Kinases (STKs), Nuclear Dbf2-Related (NDR) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. NDR kinases regulate mitosis, cell growth, embryonic development, and neurological processes. They are also required for proper centrosome duplica

>cd07853 STKc_NLK Catalytic domain of the Serine/Threonine Kinase, Nemo-Like Kinase

Probab=100.00  E-value=6.5e-38  Score=337.41  Aligned_cols=260  Identities=19%  Similarity=0.263  Sum_probs=198.7

Q ss_pred             cCCcccccccCCcceEEEEEec-CCcEEEEEEecccCC-chHHHHHHHHHHHHhccCCCcceeEeeEEEcCCC---CeEE
Q 005586          410 CFSEVNLLGKGNFSSVYKGTLR-DGTLVAIRSINVTSC-KSEEAEFVKGLYLLTSLRHENIIRLRGFCCSRGR---GECF  484 (689)
Q Consensus       410 ~f~~~~~lg~G~~g~Vy~~~~~-~g~~vavK~l~~~~~-~~~~~~f~~e~~~l~~l~H~niv~l~g~~~~~~~---~~~~  484 (689)
                      +|+..+.||+|+||.||+|... +|+.||+|++..... ....+++.+|++++..++||||+++++++.....   ...+
T Consensus         1 ~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~   80 (372)
T cd07853           1 DVEPDRPIGYGAFGVVWSVTDPRDGKRVALKKMPNVFQNLVSCKRVFRELKMLCFFKHDNVLSALDILQPPHIDPFEEIY   80 (372)
T ss_pred             CCcccceeeeCCCEEEEEEEECCCCCEEEEEeccccccchHHHHHHHHHHHHHHhCCCCCcCCHhheecCCCccccceEE
Confidence            4677899999999999999974 799999999865422 2344678899999999999999999999854321   2689


Q ss_pred             EEEEcCCCCCHHHHhhhcCCCCCCCCHHHHHHHHHHHHHHHhhhhCCCCCCCceeecCCCCCceeecCCCCeEEeccccc
Q 005586          485 LIYDFAPKGKLSKYLDQEEGSSNVLDWSTRVSIIIGIAKGIGYLHSSEVNKPAIVHRNLSVEKVLIDQQFNPLIADCGLH  564 (689)
Q Consensus       485 lV~e~~~~gsL~~~L~~~~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~~~ivH~dlk~~NiLl~~~~~~kl~DfGla  564 (689)
                      +|+||+. ++|.+++...    ..+++..+..++.|++.||+|||+.+     |+||||||+|||+++++.+||+|||++
T Consensus        81 lv~e~~~-~~l~~~~~~~----~~l~~~~~~~~~~qi~~aL~~LH~~~-----ivH~dlkp~Nili~~~~~~kL~Dfg~a  150 (372)
T cd07853          81 VVTELMQ-SDLHKIIVSP----QPLSSDHVKVFLYQILRGLKYLHSAG-----ILHRDIKPGNLLVNSNCVLKICDFGLA  150 (372)
T ss_pred             EEeeccc-cCHHHHHhcC----CCCCHHHHHHHHHHHHHHHHHHHhCC-----eeCCCCChHHEEECCCCCEEeccccce
Confidence            9999996 6888887643    24899999999999999999999987     999999999999999999999999999


Q ss_pred             ccccCCceeeeecCCCCCCCCCccccccC-CCCCcccchhHHHHHHHHHhCCCCcchhHHHHHhhhh-------------
Q 005586          565 KLLADDIVFSVLKTSAAMGYLAPEYVTTG-RFTERSDIFAFGVIILQILTGSLVLTSSMRLAAESAT-------------  630 (689)
Q Consensus       565 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~-~~~~ksDV~sfGvvl~elltG~~p~~~~~~~~~~~~~-------------  630 (689)
                      +..............++..|+|||++.+. .++.++|||||||++|||++|+.||............             
T Consensus       151 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~i~~~~g~~~~~~~~  230 (372)
T cd07853         151 RVEEPDESKHMTQEVVTQYYRAPEILMGSRHYTSAVDIWSVGCIFAELLGRRILFQAQSPIQQLDLITDLLGTPSLEAMR  230 (372)
T ss_pred             eecccCccccCCCCCcCCCcCCHHHHcCCCCCCcHHHHHhHHHHHHHHHcCCCCCCCCCHHHHHHHHHHHcCCCCHHHHH
Confidence            86543322222233567789999998764 4789999999999999999999999643211110000             


Q ss_pred             -----hhHhhcc-ccCC-------CCCHHHHHHHHHHHHHhccCCCCCCCCHHHHHHHHHhh
Q 005586          631 -----FENFIDR-NLKG-------KFSESEAAKLGKMALVCTHEDPENRPTMEAVIEELTVA  679 (689)
Q Consensus       631 -----~~~~~~~-~~~~-------~~~~~~~~~l~~l~~~Cl~~dp~~RPs~~evl~~L~~~  679 (689)
                           ....+.. ....       ........++.+++.+|++.||++|||+.|++++.+..
T Consensus       231 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dP~~R~t~~e~l~hp~~~  292 (372)
T cd07853         231 SACEGARAHILRGPHKPPSLPVLYTLSSQATHEAVHLLCRMLVFDPDKRISAADALAHPYLD  292 (372)
T ss_pred             HhhHHHHHHHHhCCCCCCchHHhcccCCCCCHHHHHHHHHhCCCChhhCcCHHHHhcCHhhC
Confidence                 0000000 0000       01122356788999999999999999999999886543

Serine/Threonine Kinases (STKs), Nemo-Like Kinase (NLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mitogen-activated protein kinases (MAPKs) are important mediators of cellular responses to extracellular signals. NLK is an atypical MAPK that is not regulated by a MAPK kinase. It functions downstream of the MAPK kinase kinase Tak1, which also plays a role in activating the JNK and p38 MAPKs. The Tak1/NLK pathways are regulated by Wnts, a family of secreted proteins that is critical in the control of asymmetric division and cell polarity. NLK can phosphorylate transcription

>cd05044 PTKc_c-ros Catalytic domain of the Protein Tyrosine Kinase, C-ros

Probab=100.00  E-value=1.8e-37  Score=318.46  Aligned_cols=252  Identities=27%  Similarity=0.466  Sum_probs=199.2

Q ss_pred             cccccCCcceEEEEEecC-------CcEEEEEEecccCCchHHHHHHHHHHHHhccCCCcceeEeeEEEcCCCCeEEEEE
Q 005586          415 NLLGKGNFSSVYKGTLRD-------GTLVAIRSINVTSCKSEEAEFVKGLYLLTSLRHENIIRLRGFCCSRGRGECFLIY  487 (689)
Q Consensus       415 ~~lg~G~~g~Vy~~~~~~-------g~~vavK~l~~~~~~~~~~~f~~e~~~l~~l~H~niv~l~g~~~~~~~~~~~lV~  487 (689)
                      +.||+|+||.||+|...+       +..+|+|.+..........+|.+|++++++++||||+++++++..  .+..++||
T Consensus         1 ~~lg~g~~g~vy~~~~~~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~--~~~~~~v~   78 (269)
T cd05044           1 NFLGSGAFGEVYEGTATDILGPGSGPIRVAVKTLRKGATDQEKKEFLKEAHLMSNFNHPNIVKLLGVCLL--NEPQYIIM   78 (269)
T ss_pred             CccccccceeEEeeeecccccCcccceeehhhhhhcccchhhHHHHHHHHHHHHhcCCCCeeeEeeeecC--CCCeEEEE
Confidence            369999999999998752       257999988765433456789999999999999999999999844  46789999


Q ss_pred             EcCCCCCHHHHhhhcCCC---CCCCCHHHHHHHHHHHHHHHhhhhCCCCCCCceeecCCCCCceeecCCC-----CeEEe
Q 005586          488 DFAPKGKLSKYLDQEEGS---SNVLDWSTRVSIIIGIAKGIGYLHSSEVNKPAIVHRNLSVEKVLIDQQF-----NPLIA  559 (689)
Q Consensus       488 e~~~~gsL~~~L~~~~~~---~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~~~ivH~dlk~~NiLl~~~~-----~~kl~  559 (689)
                      ||+++|+|.++++.....   ...++|.+++.++.|++.||+|||+.+     ++|+||||+||+++.+.     .+|++
T Consensus        79 e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~-----i~H~dl~p~nil~~~~~~~~~~~~~l~  153 (269)
T cd05044          79 ELMEGGDLLSYLRDARVERFGPPLLTLKELLDICLDVAKGCVYLEQMH-----FIHRDLAARNCLVSEKGYDADRVVKIG  153 (269)
T ss_pred             eccCCCcHHHHHHHhhhcccCCccccHHHHHHHHHHHHHHHHHHHhCC-----cccCCCChheEEEecCCCCCCcceEEC
Confidence            999999999999754321   234889999999999999999999887     99999999999999887     89999


Q ss_pred             cccccccccCCceee-eecCCCCCCCCCccccccCCCCCcccchhHHHHHHHHHh-CCCCcchhHHHHHhhhhhhHhhcc
Q 005586          560 DCGLHKLLADDIVFS-VLKTSAAMGYLAPEYVTTGRFTERSDIFAFGVIILQILT-GSLVLTSSMRLAAESATFENFIDR  637 (689)
Q Consensus       560 DfGla~~~~~~~~~~-~~~~~~~~~y~aPE~~~~~~~~~ksDV~sfGvvl~ellt-G~~p~~~~~~~~~~~~~~~~~~~~  637 (689)
                      |||+++......... ......+..|+|||++.++.++.++|||||||++|||+| |+.|+.......     ....+..
T Consensus       154 dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~ellt~g~~p~~~~~~~~-----~~~~~~~  228 (269)
T cd05044         154 DFGLARDIYKSDYYRKEGEGLLPVRWMAPESLLDGKFTTQSDVWSFGVLMWEILTLGQQPYPALNNQE-----VLQHVTA  228 (269)
T ss_pred             CcccccccccccccccCcccCCCccccCHHHHccCCcccchhHHHHHHHHHHHHHcCCCCCcccCHHH-----HHHHHhc
Confidence            999998654332211 112234567999999999999999999999999999998 999985432211     1111222


Q ss_pred             ccCCCCCHHHHHHHHHHHHHhccCCCCCCCCHHHHHHHHHh
Q 005586          638 NLKGKFSESEAAKLGKMALVCTHEDPENRPTMEAVIEELTV  678 (689)
Q Consensus       638 ~~~~~~~~~~~~~l~~l~~~Cl~~dp~~RPs~~evl~~L~~  678 (689)
                      ......+...+..+.+++.+||+.+|++||++.++++.|+.
T Consensus       229 ~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~i~~~l~~  269 (269)
T cd05044         229 GGRLQKPENCPDKIYQLMTNCWAQDPSERPTFDRIQEILQN  269 (269)
T ss_pred             CCccCCcccchHHHHHHHHHHcCCCcccCCCHHHHHHHHhC
Confidence            22222334456788999999999999999999999999863

Protein Tyrosine Kinases (PTK) family; C-ros and Drosophila Sevenless proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The proto-oncogene c-ros encodes an orphan receptor tyr kinase (RTK) with an unknown ligand. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. C-ros is expressed in embryonic cells of the kidney, intestine and lung, but disappears soon after birth. It persists only in the adult epididymis. Male

>cd05040 PTKc_Ack_like Catalytic domain of the Protein Tyrosine Kinase, Activated Cdc42-associated kinase

Probab=100.00  E-value=2.9e-37  Score=314.73  Aligned_cols=249  Identities=26%  Similarity=0.406  Sum_probs=200.3

Q ss_pred             cccccCCcceEEEEEecC--C--cEEEEEEecccCCchHHHHHHHHHHHHhccCCCcceeEeeEEEcCCCCeEEEEEEcC
Q 005586          415 NLLGKGNFSSVYKGTLRD--G--TLVAIRSINVTSCKSEEAEFVKGLYLLTSLRHENIIRLRGFCCSRGRGECFLIYDFA  490 (689)
Q Consensus       415 ~~lg~G~~g~Vy~~~~~~--g--~~vavK~l~~~~~~~~~~~f~~e~~~l~~l~H~niv~l~g~~~~~~~~~~~lV~e~~  490 (689)
                      +.||+|++|.||+|.+.+  +  ..||+|.+.........+.|.+|++++++++||||+++++++..   ...++||||+
T Consensus         1 ~~ig~g~~~~v~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~---~~~~~v~e~~   77 (257)
T cd05040           1 KKLGDGSFGVVRRGEWSTSGGKVIPVAVKCLKSDKLSDIMDDFLKEAAIMHSLDHENLIRLYGVVLT---HPLMMVTELA   77 (257)
T ss_pred             CcCCccCcccEEeeeEecCCCCceEEEEeecCCcccHHHHHHHHHHHHHHhhcCCCCccceeEEEcC---CeEEEEEEec
Confidence            468999999999998753  3  36999999876644556789999999999999999999999854   6789999999


Q ss_pred             CCCCHHHHhhhcCCCCCCCCHHHHHHHHHHHHHHHhhhhCCCCCCCceeecCCCCCceeecCCCCeEEecccccccccCC
Q 005586          491 PKGKLSKYLDQEEGSSNVLDWSTRVSIIIGIAKGIGYLHSSEVNKPAIVHRNLSVEKVLIDQQFNPLIADCGLHKLLADD  570 (689)
Q Consensus       491 ~~gsL~~~L~~~~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~~~ivH~dlk~~NiLl~~~~~~kl~DfGla~~~~~~  570 (689)
                      ++|+|.+++.....  ..++|...+.++.|++.||+|||+.+     ++||||||+||++++++.+||+|||+++.....
T Consensus        78 ~~~~L~~~l~~~~~--~~~~~~~~~~~~~qi~~~L~~lH~~~-----i~H~di~p~nil~~~~~~~kl~dfg~~~~~~~~  150 (257)
T cd05040          78 PLGSLLDRLRKDAL--GHFLISTLCDYAVQIANGMRYLESKR-----FIHRDLAARNILLASDDKVKIGDFGLMRALPQN  150 (257)
T ss_pred             CCCcHHHHHHhccc--ccCcHHHHHHHHHHHHHHHHHHHhCC-----ccccccCcccEEEecCCEEEecccccccccccc
Confidence            99999999987542  35899999999999999999999987     999999999999999999999999999876542


Q ss_pred             cee--eeecCCCCCCCCCccccccCCCCCcccchhHHHHHHHHHh-CCCCcchhHHHHHhhhhhhHhhccccCCCCCHHH
Q 005586          571 IVF--SVLKTSAAMGYLAPEYVTTGRFTERSDIFAFGVIILQILT-GSLVLTSSMRLAAESATFENFIDRNLKGKFSESE  647 (689)
Q Consensus       571 ~~~--~~~~~~~~~~y~aPE~~~~~~~~~ksDV~sfGvvl~ellt-G~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  647 (689)
                      ...  ......++..|+|||++.+..++.++|||||||++|||+| |+.|+........    ...+.........+...
T Consensus       151 ~~~~~~~~~~~~~~~y~~pE~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~~~~----~~~~~~~~~~~~~~~~~  226 (257)
T cd05040         151 EDHYVMEEHLKVPFAWCAPESLRTRTFSHASDVWMFGVTLWEMFTYGEEPWAGLSGSQI----LKKIDKEGERLERPEAC  226 (257)
T ss_pred             ccceecccCCCCCceecCHHHhcccCcCchhhhHHHHHHHHHHHhCCCCCCCCCCHHHH----HHHHHhcCCcCCCCccC
Confidence            211  1112345678999999988899999999999999999999 9999854322111    11111111112223345


Q ss_pred             HHHHHHHHHHhccCCCCCCCCHHHHHHHHH
Q 005586          648 AAKLGKMALVCTHEDPENRPTMEAVIEELT  677 (689)
Q Consensus       648 ~~~l~~l~~~Cl~~dp~~RPs~~evl~~L~  677 (689)
                      +..+.+++.+|++.+|++||++.|+++.|.
T Consensus       227 ~~~~~~li~~~l~~~p~~Rps~~~~~~~l~  256 (257)
T cd05040         227 PQDIYNVMLQCWAHNPADRPTFAALREFLP  256 (257)
T ss_pred             CHHHHHHHHHHCCCCcccCCCHHHHHHHhc
Confidence            678999999999999999999999999875

Protein Tyrosine Kinase (PTK) family; Activated Cdc42-associated kinase (Ack) subfamily; catalytic (c) domain. Ack subfamily members include Ack1, thirty-eight-negative kinase 1 (Tnk1), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ack subfamily members are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal catalytic domain, an SH3 domain, a Cdc42-binding CRIB domain, and a proline-rich region. They are mainly expressed in brain and skeletal tissues and are involved in the regulation of cell adhesion and growth, receptor degradation, and axonal guidance. Ack1 is also associated with and

>cd05590 STKc_nPKC_eta Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C eta

Probab=100.00  E-value=7.2e-38  Score=329.86  Aligned_cols=244  Identities=19%  Similarity=0.283  Sum_probs=194.7

Q ss_pred             cccccCCcceEEEEEec-CCcEEEEEEecccCC--chHHHHHHHHHHHHhcc-CCCcceeEeeEEEcCCCCeEEEEEEcC
Q 005586          415 NLLGKGNFSSVYKGTLR-DGTLVAIRSINVTSC--KSEEAEFVKGLYLLTSL-RHENIIRLRGFCCSRGRGECFLIYDFA  490 (689)
Q Consensus       415 ~~lg~G~~g~Vy~~~~~-~g~~vavK~l~~~~~--~~~~~~f~~e~~~l~~l-~H~niv~l~g~~~~~~~~~~~lV~e~~  490 (689)
                      +.||+|+||.||+|+.+ +++.||+|++.....  ......+..|..++..+ +||||+++++++.  ..+..++||||+
T Consensus         1 ~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~h~~iv~~~~~~~--~~~~~~iv~Ey~   78 (320)
T cd05590           1 RVLGKGSFGKVMLARLKESGRLYAVKVLKKDVILQDDDVECTMTEKRILSLARNHPFLTQLYCCFQ--TPDRLFFVMEFV   78 (320)
T ss_pred             CeeeeCCCeEEEEEEEcCCCCEEEEEEEEHHHHhhccHHHHHHHHHHHHHhccCCCchhceeeEEE--cCCEEEEEEcCC
Confidence            36999999999999976 689999999875421  23445678888888877 6999999999884  357899999999


Q ss_pred             CCCCHHHHhhhcCCCCCCCCHHHHHHHHHHHHHHHhhhhCCCCCCCceeecCCCCCceeecCCCCeEEecccccccccCC
Q 005586          491 PKGKLSKYLDQEEGSSNVLDWSTRVSIIIGIAKGIGYLHSSEVNKPAIVHRNLSVEKVLIDQQFNPLIADCGLHKLLADD  570 (689)
Q Consensus       491 ~~gsL~~~L~~~~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~~~ivH~dlk~~NiLl~~~~~~kl~DfGla~~~~~~  570 (689)
                      ++|+|.+++....    .+++..+..++.|++.||+|||+.+     |+||||||+|||+++++.+||+|||+++.....
T Consensus        79 ~~g~L~~~i~~~~----~l~~~~~~~~~~ql~~~L~~lH~~~-----ivH~dlkp~NIli~~~~~~kL~DfG~~~~~~~~  149 (320)
T cd05590          79 NGGDLMFHIQKSR----RFDEARARFYAAEITSALMFLHDKG-----IIYRDLKLDNVLLDHEGHCKLADFGMCKEGIFN  149 (320)
T ss_pred             CCchHHHHHHHcC----CCCHHHHHHHHHHHHHHHHHHHHCC-----eEeCCCCHHHeEECCCCcEEEeeCCCCeecCcC
Confidence            9999999987643    3889999999999999999999987     999999999999999999999999998754222


Q ss_pred             ceeeeecCCCCCCCCCccccccCCCCCcccchhHHHHHHHHHhCCCCcchhHHHHHhhhhhhHhhccccCCCCCHHHHHH
Q 005586          571 IVFSVLKTSAAMGYLAPEYVTTGRFTERSDIFAFGVIILQILTGSLVLTSSMRLAAESATFENFIDRNLKGKFSESEAAK  650 (689)
Q Consensus       571 ~~~~~~~~~~~~~y~aPE~~~~~~~~~ksDV~sfGvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  650 (689)
                      .. ......++..|+|||++.+..++.++|||||||++|||++|+.||........    ...+....  ..++.....+
T Consensus       150 ~~-~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~Pf~~~~~~~~----~~~i~~~~--~~~~~~~~~~  222 (320)
T cd05590         150 GK-TTSTFCGTPDYIAPEILQEMLYGPSVDWWAMGVLLYEMLCGHAPFEAENEDDL----FEAILNDE--VVYPTWLSQD  222 (320)
T ss_pred             CC-cccccccCccccCHHHHcCCCCCCccchhhhHHHHHHHhhCCCCCCCCCHHHH----HHHHhcCC--CCCCCCCCHH
Confidence            11 12234578899999999988999999999999999999999999965432211    11111111  1223334567


Q ss_pred             HHHHHHHhccCCCCCCCCH------HHHHHHH
Q 005586          651 LGKMALVCTHEDPENRPTM------EAVIEEL  676 (689)
Q Consensus       651 l~~l~~~Cl~~dp~~RPs~------~evl~~L  676 (689)
                      +.+++..|++.||++||++      ++++++-
T Consensus       223 ~~~li~~~L~~dP~~R~~~~~~~~~~~~~~h~  254 (320)
T cd05590         223 AVDILKAFMTKNPTMRLGSLTLGGEEAILRHP  254 (320)
T ss_pred             HHHHHHHHcccCHHHCCCCCCCCCHHHHHcCC
Confidence            8999999999999999998      7777654

Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), eta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-eta is predominantly expressed in squamous epithelia, where it plays a crucial role in the signal

>cd05041 PTKc_Fes_like Catalytic domain of Fes-like Protein Tyrosine Kinases

Probab=100.00  E-value=3.9e-37  Score=312.56  Aligned_cols=248  Identities=25%  Similarity=0.466  Sum_probs=200.8

Q ss_pred             cccccCCcceEEEEEecCCcEEEEEEecccCCchHHHHHHHHHHHHhccCCCcceeEeeEEEcCCCCeEEEEEEcCCCCC
Q 005586          415 NLLGKGNFSSVYKGTLRDGTLVAIRSINVTSCKSEEAEFVKGLYLLTSLRHENIIRLRGFCCSRGRGECFLIYDFAPKGK  494 (689)
Q Consensus       415 ~~lg~G~~g~Vy~~~~~~g~~vavK~l~~~~~~~~~~~f~~e~~~l~~l~H~niv~l~g~~~~~~~~~~~lV~e~~~~gs  494 (689)
                      ++||+|+||.||++...+++.||+|++...........|.+|++++++++|+||+++++++..  ....++||||+++++
T Consensus         1 ~~lg~g~~g~v~~~~~~~~~~v~~K~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~--~~~~~~v~e~~~~~~   78 (251)
T cd05041           1 EKIGKGNFGDVYKGVLKGNTEVAVKTCRSTLPPDLKRKFLQEAEILKQYDHPNIVKLIGVCVQ--KQPIYIVMELVPGGS   78 (251)
T ss_pred             CccccCCCceEEEEEEeCCCcEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCeEEEEEEEec--CCCeEEEEEcCCCCc
Confidence            369999999999999877999999998766544455789999999999999999999999854  467899999999999


Q ss_pred             HHHHhhhcCCCCCCCCHHHHHHHHHHHHHHHhhhhCCCCCCCceeecCCCCCceeecCCCCeEEecccccccccCCceee
Q 005586          495 LSKYLDQEEGSSNVLDWSTRVSIIIGIAKGIGYLHSSEVNKPAIVHRNLSVEKVLIDQQFNPLIADCGLHKLLADDIVFS  574 (689)
Q Consensus       495 L~~~L~~~~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~~~ivH~dlk~~NiLl~~~~~~kl~DfGla~~~~~~~~~~  574 (689)
                      |.+++.....   .+++..++.++.+++.||+|||+.+     ++||||||+||++++++.+||+|||+++.........
T Consensus        79 l~~~l~~~~~---~~~~~~~~~~~~~~~~~l~~lH~~~-----i~h~di~p~nili~~~~~~~l~d~g~~~~~~~~~~~~  150 (251)
T cd05041          79 LLTFLRKKKN---RLTVKKLLQMSLDAAAGMEYLESKN-----CIHRDLAARNCLVGENNVLKISDFGMSREEEGGIYTV  150 (251)
T ss_pred             HHHHHHhcCC---CCCHHHHHHHHHHHHHHHHHHHhCC-----EehhhcCcceEEEcCCCcEEEeeccccccccCCccee
Confidence            9999976432   4789999999999999999999987     9999999999999999999999999998664322111


Q ss_pred             e-ecCCCCCCCCCccccccCCCCCcccchhHHHHHHHHHh-CCCCcchhHHHHHhhhhhhHhhccccCCCCCHHHHHHHH
Q 005586          575 V-LKTSAAMGYLAPEYVTTGRFTERSDIFAFGVIILQILT-GSLVLTSSMRLAAESATFENFIDRNLKGKFSESEAAKLG  652 (689)
Q Consensus       575 ~-~~~~~~~~y~aPE~~~~~~~~~ksDV~sfGvvl~ellt-G~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~  652 (689)
                      . .....+..|+|||.+.++.++.++|||||||++|||+| |..|+.......     ..+.+........+...+.++.
T Consensus       151 ~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~i~~~l~t~~~~p~~~~~~~~-----~~~~~~~~~~~~~~~~~~~~~~  225 (251)
T cd05041         151 SDGLKQIPIKWTAPEALNYGRYTSESDVWSYGILLWETFSLGDTPYPGMSNQQ-----TRERIESGYRMPAPQLCPEEIY  225 (251)
T ss_pred             ccccCcceeccCChHhhccCCCCcchhHHHHHHHHHHHHhccCCCCccCCHHH-----HHHHHhcCCCCCCCccCCHHHH
Confidence            1 11223456999999988899999999999999999999 788885442211     1111222222223445567899


Q ss_pred             HHHHHhccCCCCCCCCHHHHHHHHH
Q 005586          653 KMALVCTHEDPENRPTMEAVIEELT  677 (689)
Q Consensus       653 ~l~~~Cl~~dp~~RPs~~evl~~L~  677 (689)
                      +++.+|++.+|++||++.|+++.|+
T Consensus       226 ~li~~~l~~~p~~Rp~~~ell~~l~  250 (251)
T cd05041         226 RLMLQCWAYDPENRPSFSEIYNELQ  250 (251)
T ss_pred             HHHHHHhccChhhCcCHHHHHHHhh
Confidence            9999999999999999999999886

Protein Tyrosine Kinase (PTK) family; Fes subfamily; catalytic (c) domain. Fes subfamily members include Fes (or Fps), Fer, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr k

>cd06642 STKc_STK25-YSK1 Catalytic domain of the Protein Serine/Threonine Kinase, STK25 or Yeast Sps1/Ste20-related kinase 1

Probab=100.00  E-value=1.2e-37  Score=321.42  Aligned_cols=251  Identities=22%  Similarity=0.382  Sum_probs=203.2

Q ss_pred             cCCcccccccCCcceEEEEEec-CCcEEEEEEecccCCchHHHHHHHHHHHHhccCCCcceeEeeEEEcCCCCeEEEEEE
Q 005586          410 CFSEVNLLGKGNFSSVYKGTLR-DGTLVAIRSINVTSCKSEEAEFVKGLYLLTSLRHENIIRLRGFCCSRGRGECFLIYD  488 (689)
Q Consensus       410 ~f~~~~~lg~G~~g~Vy~~~~~-~g~~vavK~l~~~~~~~~~~~f~~e~~~l~~l~H~niv~l~g~~~~~~~~~~~lV~e  488 (689)
                      .|+..+.||+|+||.||+|... ++..||+|.+...........+.+|++++++++||||+++++++..  ....++|||
T Consensus         5 ~y~~~~~l~~g~~~~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~--~~~~~lv~e   82 (277)
T cd06642           5 LFTKLERIGKGSFGEVYKGIDNRTKEVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYITRYYGSYLK--GTKLWIIME   82 (277)
T ss_pred             HHHHHHHhcCCCCeeEEEEEEcCCCeEEEEEEeccccchHHHHHHHHHHHHHHcCCCCccHhhhccccc--CCceEEEEE
Confidence            3555678999999999999875 6889999998765544555689999999999999999999998843  567999999


Q ss_pred             cCCCCCHHHHhhhcCCCCCCCCHHHHHHHHHHHHHHHhhhhCCCCCCCceeecCCCCCceeecCCCCeEEeccccccccc
Q 005586          489 FAPKGKLSKYLDQEEGSSNVLDWSTRVSIIIGIAKGIGYLHSSEVNKPAIVHRNLSVEKVLIDQQFNPLIADCGLHKLLA  568 (689)
Q Consensus       489 ~~~~gsL~~~L~~~~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~~~ivH~dlk~~NiLl~~~~~~kl~DfGla~~~~  568 (689)
                      |+++++|.+++...     .+++..+..++.|+++|++|||+.+     ++|+||+|+||++++++.+|++|||+++.+.
T Consensus        83 ~~~~~~L~~~~~~~-----~~~~~~~~~~~~~i~~~l~~lH~~~-----ivH~dl~p~ni~i~~~~~~~l~dfg~~~~~~  152 (277)
T cd06642          83 YLGGGSALDLLKPG-----PLEETYIATILREILKGLDYLHSER-----KIHRDIKAANVLLSEQGDVKLADFGVAGQLT  152 (277)
T ss_pred             ccCCCcHHHHhhcC-----CCCHHHHHHHHHHHHHHHHHHhcCC-----eeccCCChheEEEeCCCCEEEcccccccccc
Confidence            99999999998642     4889999999999999999999987     9999999999999999999999999998765


Q ss_pred             CCceeeeecCCCCCCCCCccccccCCCCCcccchhHHHHHHHHHhCCCCcchhHHHHHhhhhhhHhhccccCCCCCHHHH
Q 005586          569 DDIVFSVLKTSAAMGYLAPEYVTTGRFTERSDIFAFGVIILQILTGSLVLTSSMRLAAESATFENFIDRNLKGKFSESEA  648 (689)
Q Consensus       569 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~ksDV~sfGvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  648 (689)
                      .... ......++..|+|||++.+..++.++|||||||++|||+||+.|+........     ...+............+
T Consensus       153 ~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~tg~~p~~~~~~~~~-----~~~~~~~~~~~~~~~~~  226 (277)
T cd06642         153 DTQI-KRNTFVGTPFWMAPEVIKQSAYDFKADIWSLGITAIELAKGEPPNSDLHPMRV-----LFLIPKNSPPTLEGQYS  226 (277)
T ss_pred             Ccch-hhhcccCcccccCHHHhCcCCCchhhhHHHHHHHHHHHHhCCCCCcccchhhH-----HhhhhcCCCCCCCcccC
Confidence            4321 11123467789999999988899999999999999999999999864321111     11111222222334456


Q ss_pred             HHHHHHHHHhccCCCCCCCCHHHHHHHHHh
Q 005586          649 AKLGKMALVCTHEDPENRPTMEAVIEELTV  678 (689)
Q Consensus       649 ~~l~~l~~~Cl~~dp~~RPs~~evl~~L~~  678 (689)
                      ..+.+++.+||+.+|++||+|.|++++.+.
T Consensus       227 ~~~~~li~~~l~~~p~~Rp~~~~il~~~~~  256 (277)
T cd06642         227 KPFKEFVEACLNKDPRFRPTAKELLKHKFI  256 (277)
T ss_pred             HHHHHHHHHHccCCcccCcCHHHHHHhHHH
Confidence            778999999999999999999999987653

Serine/threonine kinases (STKs), STK25 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK25 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. STK25 is also called Ste20/oxidant stress response kinase 1 (SOK1) or yeast Sps1/Ste20-related kinase 1 (YSK1). STK25 is localized in the Golgi apparatus through its interaction with the Golgi matrix protein GM130. It may play a role in the regulation of cell migration and polarization. STK25 binds and phosphorylates CCM3 (cerebral cavernous malformation 3), also called PCD10 (programmed cell death 10), and may play a role in apoptosis. Human STK25

>cd05591 STKc_nPKC_epsilon Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C epsilon

Probab=100.00  E-value=9.7e-38  Score=329.20  Aligned_cols=245  Identities=17%  Similarity=0.275  Sum_probs=195.5

Q ss_pred             cccccCCcceEEEEEec-CCcEEEEEEecccCC--chHHHHHHHHHHHHhcc-CCCcceeEeeEEEcCCCCeEEEEEEcC
Q 005586          415 NLLGKGNFSSVYKGTLR-DGTLVAIRSINVTSC--KSEEAEFVKGLYLLTSL-RHENIIRLRGFCCSRGRGECFLIYDFA  490 (689)
Q Consensus       415 ~~lg~G~~g~Vy~~~~~-~g~~vavK~l~~~~~--~~~~~~f~~e~~~l~~l-~H~niv~l~g~~~~~~~~~~~lV~e~~  490 (689)
                      +.||+|+||.||+|+.+ +|+.||+|++.....  ......+..|.+++..+ +||||+++++++..  .+..++||||+
T Consensus         1 ~~lG~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~il~~~~~hp~i~~~~~~~~~--~~~~~lv~E~~   78 (321)
T cd05591           1 KVLGKGSFGKVMLAELKGTDEVYAIKVLKKDVILQDDDVDCTMTEKRILALAAKHPFLTALHCCFQT--KDRLFFVMEYV   78 (321)
T ss_pred             CccccCCCeEEEEEEECCCCCEEEEEEEeHHHhhhhhHHHHHHHHHHHHHhccCCCCccceeeEEEc--CCeEEEEEeCC
Confidence            36999999999999876 588999999975431  23345678889988866 79999999999844  57899999999


Q ss_pred             CCCCHHHHhhhcCCCCCCCCHHHHHHHHHHHHHHHhhhhCCCCCCCceeecCCCCCceeecCCCCeEEecccccccccCC
Q 005586          491 PKGKLSKYLDQEEGSSNVLDWSTRVSIIIGIAKGIGYLHSSEVNKPAIVHRNLSVEKVLIDQQFNPLIADCGLHKLLADD  570 (689)
Q Consensus       491 ~~gsL~~~L~~~~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~~~ivH~dlk~~NiLl~~~~~~kl~DfGla~~~~~~  570 (689)
                      ++|+|..++....    .+++..+..++.|++.||+|||+.+     |+||||||+|||+++++.+||+|||+++.....
T Consensus        79 ~~~~L~~~l~~~~----~~~~~~~~~~~~qi~~aL~~LH~~~-----ivHrDikp~Nill~~~~~~kL~Dfg~~~~~~~~  149 (321)
T cd05591          79 NGGDLMFQIQRSR----KFDEPRSRFYAAEVTLALMFLHRHG-----VIYRDLKLDNILLDAEGHCKLADFGMCKEGILN  149 (321)
T ss_pred             CCCcHHHHHHHcC----CCCHHHHHHHHHHHHHHHHHHHHCC-----eeccCCCHHHeEECCCCCEEEeecccceecccC
Confidence            9999999987543    3889999999999999999999987     999999999999999999999999998754322


Q ss_pred             ceeeeecCCCCCCCCCccccccCCCCCcccchhHHHHHHHHHhCCCCcchhHHHHHhhhhhhHhhccccCCCCCHHHHHH
Q 005586          571 IVFSVLKTSAAMGYLAPEYVTTGRFTERSDIFAFGVIILQILTGSLVLTSSMRLAAESATFENFIDRNLKGKFSESEAAK  650 (689)
Q Consensus       571 ~~~~~~~~~~~~~y~aPE~~~~~~~~~ksDV~sfGvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  650 (689)
                      .. ......++..|+|||++.+..++.++|||||||++|||+||+.||........    +..+....  ..++.....+
T Consensus       150 ~~-~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~tg~~Pf~~~~~~~~----~~~i~~~~--~~~p~~~~~~  222 (321)
T cd05591         150 GV-TTTTFCGTPDYIAPEILQELEYGPSVDWWALGVLMYEMMAGQPPFEADNEDDL----FESILHDD--VLYPVWLSKE  222 (321)
T ss_pred             Cc-cccccccCccccCHHHHcCCCCCCccceechhHHHHHHhcCCCCCCCCCHHHH----HHHHHcCC--CCCCCCCCHH
Confidence            11 11234578899999999988999999999999999999999999965432211    11111111  1122334567


Q ss_pred             HHHHHHHhccCCCCCCC-------CHHHHHHHHH
Q 005586          651 LGKMALVCTHEDPENRP-------TMEAVIEELT  677 (689)
Q Consensus       651 l~~l~~~Cl~~dp~~RP-------s~~evl~~L~  677 (689)
                      +.+++..|++.||++||       ++.+++++.+
T Consensus       223 ~~~ll~~~L~~dp~~R~~~~~~~~~~~~~~~hp~  256 (321)
T cd05591         223 AVSILKAFMTKNPNKRLGCVASQGGEDAIKQHPF  256 (321)
T ss_pred             HHHHHHHHhccCHHHcCCCCCCCCCHHHHhcCCc
Confidence            88999999999999999       8888887653

Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), epsilon isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-epsilon has been shown to behave as an oncoprotein. Its overexpression contributes to

>cd06621 PKc_MAPKK_Pek1_like Catalytic domain of fungal Pek1-like dual-specificity MAP kinase kinases

Probab=100.00  E-value=3e-37  Score=320.24  Aligned_cols=262  Identities=18%  Similarity=0.316  Sum_probs=207.1

Q ss_pred             ccCCcccccccCCcceEEEEEec-CCcEEEEEEecccCCchHHHHHHHHHHHHhccCCCcceeEeeEEEcCCCCeEEEEE
Q 005586          409 QCFSEVNLLGKGNFSSVYKGTLR-DGTLVAIRSINVTSCKSEEAEFVKGLYLLTSLRHENIIRLRGFCCSRGRGECFLIY  487 (689)
Q Consensus       409 ~~f~~~~~lg~G~~g~Vy~~~~~-~g~~vavK~l~~~~~~~~~~~f~~e~~~l~~l~H~niv~l~g~~~~~~~~~~~lV~  487 (689)
                      ++|...+.||.|++|.||+|... +++.+|+|.+..........++.+|++++++++||||++++++|........++||
T Consensus         1 ~~~~~~~~lg~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~lv~   80 (287)
T cd06621           1 EKIVELSRLGEGAGGSVTKCRLKNTGMIFALKTITTDPNPDLQKQILRELEINKSCKSPYIVKYYGAFLDESSSSIGIAM   80 (287)
T ss_pred             CceEEEEEeccCCceEEEEEEECCCCeEEEEEEEecCCchHHHHHHHHHHHHHHhCCCCCeeeeeeEEEccCCCeEEEEE
Confidence            35777899999999999999985 68999999998655445567899999999999999999999999766666789999


Q ss_pred             EcCCCCCHHHHhhhcCCCCCCCCHHHHHHHHHHHHHHHhhhhCCCCCCCceeecCCCCCceeecCCCCeEEecccccccc
Q 005586          488 DFAPKGKLSKYLDQEEGSSNVLDWSTRVSIIIGIAKGIGYLHSSEVNKPAIVHRNLSVEKVLIDQQFNPLIADCGLHKLL  567 (689)
Q Consensus       488 e~~~~gsL~~~L~~~~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~~~ivH~dlk~~NiLl~~~~~~kl~DfGla~~~  567 (689)
                      ||+++++|.+++.........+++.....|+.|++.||+|||+.+     ++|+||+|+||++++++.++|+|||++...
T Consensus        81 e~~~~~~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~lH~~~-----i~H~dl~~~nil~~~~~~~~l~dfg~~~~~  155 (287)
T cd06621          81 EYCEGGSLDSIYKKVKKRGGRIGEKVLGKIAESVLKGLSYLHSRK-----IIHRDIKPSNILLTRKGQVKLCDFGVSGEL  155 (287)
T ss_pred             EecCCCCHHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCC-----cccCCCCHHHEEEecCCeEEEeeccccccc
Confidence            999999999988654333345889999999999999999999987     999999999999999999999999998765


Q ss_pred             cCCceeeeecCCCCCCCCCccccccCCCCCcccchhHHHHHHHHHhCCCCcchhHHHHHhhhhhhH-hhc---cccCCCC
Q 005586          568 ADDIVFSVLKTSAAMGYLAPEYVTTGRFTERSDIFAFGVIILQILTGSLVLTSSMRLAAESATFEN-FID---RNLKGKF  643 (689)
Q Consensus       568 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~ksDV~sfGvvl~elltG~~p~~~~~~~~~~~~~~~~-~~~---~~~~~~~  643 (689)
                      .....   ....++..|+|||.+.+..++.++||||+||++|||+||+.|+............... +.+   +.+....
T Consensus       156 ~~~~~---~~~~~~~~y~~pE~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  232 (287)
T cd06621         156 VNSLA---GTFTGTSFYMAPERIQGKPYSITSDVWSLGLTLLEVAQNRFPFPPEGEPPLGPIELLSYIVNMPNPELKDEP  232 (287)
T ss_pred             ccccc---ccccCCccccCHHHhcCCCCCchhhHHHHHHHHHHHHhCCCCCCcccCCCCChHHHHHHHhcCCchhhccCC
Confidence            43221   1234567899999998889999999999999999999999998644110000000111 111   1111111


Q ss_pred             C--HHHHHHHHHHHHHhccCCCCCCCCHHHHHHHHHh
Q 005586          644 S--ESEAAKLGKMALVCTHEDPENRPTMEAVIEELTV  678 (689)
Q Consensus       644 ~--~~~~~~l~~l~~~Cl~~dp~~RPs~~evl~~L~~  678 (689)
                      .  ...+..+.+++.+||+.+|++||++.|++++-+.
T Consensus       233 ~~~~~~~~~~~~li~~~l~~~p~~Rpt~~eil~~~~~  269 (287)
T cd06621         233 GNGIKWSEEFKDFIKQCLEKDPTRRPTPWDMLEHPWI  269 (287)
T ss_pred             CCCCchHHHHHHHHHHHcCCCcccCCCHHHHHhCccc
Confidence            1  2245678999999999999999999999987654

Protein kinases (PKs), MAP kinase kinase(MAPKK) subfamily, fungal Pek1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include

>cd06646 STKc_MAP4K5 Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 5

Probab=100.00  E-value=1.6e-37  Score=318.55  Aligned_cols=251  Identities=19%  Similarity=0.318  Sum_probs=198.4

Q ss_pred             ccCCcccccccCCcceEEEEEec-CCcEEEEEEecccCCchHHHHHHHHHHHHhccCCCcceeEeeEEEcCCCCeEEEEE
Q 005586          409 QCFSEVNLLGKGNFSSVYKGTLR-DGTLVAIRSINVTSCKSEEAEFVKGLYLLTSLRHENIIRLRGFCCSRGRGECFLIY  487 (689)
Q Consensus       409 ~~f~~~~~lg~G~~g~Vy~~~~~-~g~~vavK~l~~~~~~~~~~~f~~e~~~l~~l~H~niv~l~g~~~~~~~~~~~lV~  487 (689)
                      ++|+..+.||+|+||.||+|+.. +|+.||+|++.... ......+.+|+.++.+++||||+++++++..  .+..++|+
T Consensus         9 ~~y~~~~~lg~g~~g~vy~~~~~~~~~~~aik~~~~~~-~~~~~~~~~e~~~l~~~~h~~ii~~~~~~~~--~~~~~iv~   85 (267)
T cd06646           9 HDYELIQRVGSGTYGDVYKARNLHTGELAAVKIIKLEP-GDDFSLIQQEIFMVKECKHCNIVAYFGSYLS--REKLWICM   85 (267)
T ss_pred             hhcchhheeecCCCeEEEEEEECCCCeEEEEEEEecCc-cchHHHHHHHHHHHHhcCCCCeeeeeEEEEe--CCEEEEEE
Confidence            35777899999999999999974 78999999987543 2344578899999999999999999999854  46889999


Q ss_pred             EcCCCCCHHHHhhhcCCCCCCCCHHHHHHHHHHHHHHHhhhhCCCCCCCceeecCCCCCceeecCCCCeEEecccccccc
Q 005586          488 DFAPKGKLSKYLDQEEGSSNVLDWSTRVSIIIGIAKGIGYLHSSEVNKPAIVHRNLSVEKVLIDQQFNPLIADCGLHKLL  567 (689)
Q Consensus       488 e~~~~gsL~~~L~~~~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~~~ivH~dlk~~NiLl~~~~~~kl~DfGla~~~  567 (689)
                      ||+++++|.++++...    .+++..+..++.|++.||+|||+.+     |+||||||+||++++++.+||+|||+++.+
T Consensus        86 e~~~~~~L~~~~~~~~----~~~~~~~~~~~~qi~~~l~~lH~~~-----i~H~dl~p~nill~~~~~~~l~dfg~~~~~  156 (267)
T cd06646          86 EYCGGGSLQDIYHVTG----PLSELQIAYVCRETLQGLAYLHSKG-----KMHRDIKGANILLTDNGDVKLADFGVAAKI  156 (267)
T ss_pred             eCCCCCcHHHHHHhcC----CCCHHHHHHHHHHHHHHHHHHHHCC-----ccccCCCHHHEEECCCCCEEECcCccceee
Confidence            9999999999997543    4889999999999999999999887     999999999999999999999999999866


Q ss_pred             cCCceeeeecCCCCCCCCCccccc---cCCCCCcccchhHHHHHHHHHhCCCCcchhHHHHHhhhhhhHhhccccCC---
Q 005586          568 ADDIVFSVLKTSAAMGYLAPEYVT---TGRFTERSDIFAFGVIILQILTGSLVLTSSMRLAAESATFENFIDRNLKG---  641 (689)
Q Consensus       568 ~~~~~~~~~~~~~~~~y~aPE~~~---~~~~~~ksDV~sfGvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~---  641 (689)
                      ..... ......++..|+|||.+.   ...++.++|||||||++|||++|+.|+.........    ..........   
T Consensus       157 ~~~~~-~~~~~~~~~~y~~PE~~~~~~~~~~~~~~Dvws~G~il~el~~g~~p~~~~~~~~~~----~~~~~~~~~~~~~  231 (267)
T cd06646         157 TATIA-KRKSFIGTPYWMAPEVAAVEKNGGYNQLCDIWAVGITAIELAELQPPMFDLHPMRAL----FLMSKSNFQPPKL  231 (267)
T ss_pred             ccccc-ccCccccCccccCHhHcccccCCCCcchhhHHHHHHHHHHHHhCCCCccccchhhhh----eeeecCCCCCCCC
Confidence            43211 112234677899999874   345788999999999999999999998533211100    0000111111   


Q ss_pred             CCCHHHHHHHHHHHHHhccCCCCCCCCHHHHHHHH
Q 005586          642 KFSESEAAKLGKMALVCTHEDPENRPTMEAVIEEL  676 (689)
Q Consensus       642 ~~~~~~~~~l~~l~~~Cl~~dp~~RPs~~evl~~L  676 (689)
                      ......+..+.+++.+||+.+|++||++++++++|
T Consensus       232 ~~~~~~~~~~~~li~~~l~~~P~~Rp~~~~il~~l  266 (267)
T cd06646         232 KDKTKWSSTFHNFVKISLTKNPKKRPTAERLLTHL  266 (267)
T ss_pred             ccccccCHHHHHHHHHHhhCChhhCcCHHHHhcCC
Confidence            11123456889999999999999999999999875

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 5 (MAPKKKK5 or MAP4K5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated

>cd05587 STKc_cPKC Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C

Probab=100.00  E-value=1.3e-37  Score=328.59  Aligned_cols=248  Identities=19%  Similarity=0.269  Sum_probs=196.2

Q ss_pred             cCCcccccccCCcceEEEEEec-CCcEEEEEEecccC--CchHHHHHHHHHHHHhccCCC-cceeEeeEEEcCCCCeEEE
Q 005586          410 CFSEVNLLGKGNFSSVYKGTLR-DGTLVAIRSINVTS--CKSEEAEFVKGLYLLTSLRHE-NIIRLRGFCCSRGRGECFL  485 (689)
Q Consensus       410 ~f~~~~~lg~G~~g~Vy~~~~~-~g~~vavK~l~~~~--~~~~~~~f~~e~~~l~~l~H~-niv~l~g~~~~~~~~~~~l  485 (689)
                      +|...+.||+|+||.||+|+.+ +++.||+|++....  .......+..|++++..++|+ +|+++++++..  .+..++
T Consensus         1 ~y~~~~~lg~G~~g~Vy~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~~--~~~~~l   78 (324)
T cd05587           1 DFNFLMVLGKGSFGKVMLAERKGTDELYAIKILKKDVIIQDDDVECTMVEKRVLALPGKPPFLTQLHSCFQT--MDRLYF   78 (324)
T ss_pred             CceEEEEEeeccCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhcCCCCceeeeEEEEEc--CCEEEE
Confidence            4677899999999999999876 57899999997542  123456788899999999765 57788877743  468999


Q ss_pred             EEEcCCCCCHHHHhhhcCCCCCCCCHHHHHHHHHHHHHHHhhhhCCCCCCCceeecCCCCCceeecCCCCeEEecccccc
Q 005586          486 IYDFAPKGKLSKYLDQEEGSSNVLDWSTRVSIIIGIAKGIGYLHSSEVNKPAIVHRNLSVEKVLIDQQFNPLIADCGLHK  565 (689)
Q Consensus       486 V~e~~~~gsL~~~L~~~~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~~~ivH~dlk~~NiLl~~~~~~kl~DfGla~  565 (689)
                      ||||+++|+|.+++....    .+++..+..++.|++.||+|||+.+     |+||||||+|||+++++.+||+|||+++
T Consensus        79 v~E~~~~g~L~~~~~~~~----~~~~~~~~~~~~qi~~al~~lH~~~-----ivH~dlkp~Nill~~~~~~kL~Dfg~~~  149 (324)
T cd05587          79 VMEYVNGGDLMYHIQQVG----KFKEPHAVFYAAEIAIGLFFLHSKG-----IIYRDLKLDNVMLDAEGHIKIADFGMCK  149 (324)
T ss_pred             EEcCCCCCcHHHHHHHcC----CCCHHHHHHHHHHHHHHHHHHHHCC-----eEecCCCHHHeEEcCCCCEEEeecCcce
Confidence            999999999999997543    3889999999999999999999987     9999999999999999999999999987


Q ss_pred             cccCCceeeeecCCCCCCCCCccccccCCCCCcccchhHHHHHHHHHhCCCCcchhHHHHHhhhhhhHhhccccCCCCCH
Q 005586          566 LLADDIVFSVLKTSAAMGYLAPEYVTTGRFTERSDIFAFGVIILQILTGSLVLTSSMRLAAESATFENFIDRNLKGKFSE  645 (689)
Q Consensus       566 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~ksDV~sfGvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~  645 (689)
                      ....... ......++..|+|||++.+..++.++|||||||++|||+||+.||........    ...+...  ...++.
T Consensus       150 ~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~elltG~~pf~~~~~~~~----~~~i~~~--~~~~~~  222 (324)
T cd05587         150 ENIFGGK-TTRTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQPPFDGEDEDEL----FQSIMEH--NVSYPK  222 (324)
T ss_pred             ecCCCCC-ceeeecCCccccChhhhcCCCCCcccchhhhHHHHHHHHhCCCCCCCCCHHHH----HHHHHcC--CCCCCC
Confidence            5321111 12234578899999999999999999999999999999999999964322111    1111111  122334


Q ss_pred             HHHHHHHHHHHHhccCCCCCCCCH-----HHHHHH
Q 005586          646 SEAAKLGKMALVCTHEDPENRPTM-----EAVIEE  675 (689)
Q Consensus       646 ~~~~~l~~l~~~Cl~~dp~~RPs~-----~evl~~  675 (689)
                      ....++.+++.+|++.||++||+.     .++.++
T Consensus       223 ~~~~~~~~li~~~l~~~P~~R~~~~~~~~~~~~~h  257 (324)
T cd05587         223 SLSKEAVSICKGLLTKHPAKRLGCGPTGERDIREH  257 (324)
T ss_pred             CCCHHHHHHHHHHhhcCHHHcCCCCCCCHHHHhcC
Confidence            455678899999999999999976     666655

Serine/Threonine Kinases (STKs), Classical (or Conventional) Protein Kinase C (cPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. cPKCs contain a calcium-binding C2 region in their regulatory

>cd06620 PKc_MAPKK_Byr1_like Catalytic domain of fungal Byr1-like dual-specificity MAP kinase kinases

Probab=100.00  E-value=2.6e-37  Score=320.12  Aligned_cols=257  Identities=19%  Similarity=0.331  Sum_probs=204.3

Q ss_pred             ccCCcccccccCCcceEEEEEec-CCcEEEEEEecccCCchHHHHHHHHHHHHhccCCCcceeEeeEEEcCCCCeEEEEE
Q 005586          409 QCFSEVNLLGKGNFSSVYKGTLR-DGTLVAIRSINVTSCKSEEAEFVKGLYLLTSLRHENIIRLRGFCCSRGRGECFLIY  487 (689)
Q Consensus       409 ~~f~~~~~lg~G~~g~Vy~~~~~-~g~~vavK~l~~~~~~~~~~~f~~e~~~l~~l~H~niv~l~g~~~~~~~~~~~lV~  487 (689)
                      ++|+..+.||+|+||.||++... +|+.||+|++...........|.+|++++..++||||+++++++..  ....++||
T Consensus         5 ~~~~~~~~ig~g~~g~v~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~--~~~~~lv~   82 (284)
T cd06620           5 EDLETISDLGAGNGGSVSKVKHIPTGTVMAKKVVHIGAKSSVRKQILRELQIMHECRSPYIVSFYGAFLN--ENNICMCM   82 (284)
T ss_pred             HHHHHHHHcCCCCCeEEEEEEEcCCCcEEEEEEEEecCcchHHHHHHHHHHHHHHcCCCCcceEeeeEec--CCEEEEEE
Confidence            35666789999999999999875 6899999998765544556789999999999999999999999854  47899999


Q ss_pred             EcCCCCCHHHHhhhcCCCCCCCCHHHHHHHHHHHHHHHhhhhCCCCCCCceeecCCCCCceeecCCCCeEEecccccccc
Q 005586          488 DFAPKGKLSKYLDQEEGSSNVLDWSTRVSIIIGIAKGIGYLHSSEVNKPAIVHRNLSVEKVLIDQQFNPLIADCGLHKLL  567 (689)
Q Consensus       488 e~~~~gsL~~~L~~~~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~~~ivH~dlk~~NiLl~~~~~~kl~DfGla~~~  567 (689)
                      ||+++|+|.+++....    .+++.....++.+++.||.|||+..    .++||||||+||++++++.++|+|||++...
T Consensus        83 e~~~~~~L~~~~~~~~----~~~~~~~~~~~~~i~~~l~~LH~~~----~i~H~dl~p~nil~~~~~~~~l~d~gl~~~~  154 (284)
T cd06620          83 EFMDCGSLDRIYKKGG----PIPVEILGKIAVAVVEGLTYLYNVH----RIMHRDIKPSNILVNSRGQIKLCDFGVSGEL  154 (284)
T ss_pred             ecCCCCCHHHHHHhcc----CCCHHHHHHHHHHHHHHHHHHHHhc----CeeccCCCHHHEEECCCCcEEEccCCcccch
Confidence            9999999999987643    4899999999999999999999732    2999999999999999999999999998755


Q ss_pred             cCCceeeeecCCCCCCCCCccccccCCCCCcccchhHHHHHHHHHhCCCCcchhHHHHH---h----hhhhhHhhccccC
Q 005586          568 ADDIVFSVLKTSAAMGYLAPEYVTTGRFTERSDIFAFGVIILQILTGSLVLTSSMRLAA---E----SATFENFIDRNLK  640 (689)
Q Consensus       568 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~ksDV~sfGvvl~elltG~~p~~~~~~~~~---~----~~~~~~~~~~~~~  640 (689)
                      ....   .....++..|+|||++.+..++.++|||||||++|||+||+.||........   .    .......+.... 
T Consensus       155 ~~~~---~~~~~~~~~~~aPE~~~~~~~~~~~Di~slG~~l~~l~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-  230 (284)
T cd06620         155 INSI---ADTFVGTSTYMSPERIQGGKYTVKSDVWSLGISIIELALGKFPFAFSNIDDDGQDDPMGILDLLQQIVQEPP-  230 (284)
T ss_pred             hhhc---cCccccCcccCCHHHHccCCCCccchHHHHHHHHHHHHhCCCCCcccchhhhhhhhhhHHHHHHHHHhhccC-
Confidence            3321   1123577889999999888899999999999999999999999965322100   0    011112221111 


Q ss_pred             CCCC-HHHHHHHHHHHHHhccCCCCCCCCHHHHHHHHHhh
Q 005586          641 GKFS-ESEAAKLGKMALVCTHEDPENRPTMEAVIEELTVA  679 (689)
Q Consensus       641 ~~~~-~~~~~~l~~l~~~Cl~~dp~~RPs~~evl~~L~~~  679 (689)
                      ...+ ...+.++.+++.+|++.||++||++.|++++....
T Consensus       231 ~~~~~~~~~~~~~~li~~~l~~dp~~Rpt~~e~~~~~~~~  270 (284)
T cd06620         231 PRLPSSDFPEDLRDFVDACLLKDPTERPTPQQLCAMPPFI  270 (284)
T ss_pred             CCCCchhcCHHHHHHHHHHhcCCcccCcCHHHHhcCcccc
Confidence            1122 22456789999999999999999999999986443

Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal Byr1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include

>cd05588 STKc_aPKC Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C

Probab=100.00  E-value=9.3e-38  Score=330.35  Aligned_cols=250  Identities=16%  Similarity=0.262  Sum_probs=196.2

Q ss_pred             cccccCCcceEEEEEec-CCcEEEEEEecccCC--chHHHHHHHHHHHHhcc-CCCcceeEeeEEEcCCCCeEEEEEEcC
Q 005586          415 NLLGKGNFSSVYKGTLR-DGTLVAIRSINVTSC--KSEEAEFVKGLYLLTSL-RHENIIRLRGFCCSRGRGECFLIYDFA  490 (689)
Q Consensus       415 ~~lg~G~~g~Vy~~~~~-~g~~vavK~l~~~~~--~~~~~~f~~e~~~l~~l-~H~niv~l~g~~~~~~~~~~~lV~e~~  490 (689)
                      +.||+|+||.||+|+.+ +++.||+|+++....  ......+..|..++.++ +||||+++++++..  ....++||||+
T Consensus         1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~e~~il~~~~~hp~Iv~~~~~~~~--~~~~~lv~e~~   78 (329)
T cd05588           1 RVIGRGSYAKVLLVELKKTRRIYAMKVIKKELVNDDEDIDWVQTEKHVFETASNHPFLVGLHSCFQT--ESRLFFVIEFV   78 (329)
T ss_pred             CeEeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhccCCCCCCceEEEEEc--CCEEEEEEeCC
Confidence            36999999999999976 689999999986432  23345688899999998 79999999998844  57899999999


Q ss_pred             CCCCHHHHhhhcCCCCCCCCHHHHHHHHHHHHHHHhhhhCCCCCCCceeecCCCCCceeecCCCCeEEecccccccccCC
Q 005586          491 PKGKLSKYLDQEEGSSNVLDWSTRVSIIIGIAKGIGYLHSSEVNKPAIVHRNLSVEKVLIDQQFNPLIADCGLHKLLADD  570 (689)
Q Consensus       491 ~~gsL~~~L~~~~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~~~ivH~dlk~~NiLl~~~~~~kl~DfGla~~~~~~  570 (689)
                      ++|+|.+++....    .+++..+..++.|++.||+|||+.+     |+||||||+|||+++++.+||+|||+++.....
T Consensus        79 ~~g~L~~~~~~~~----~l~~~~~~~~~~qi~~~l~~lH~~~-----ivH~dlkp~Nili~~~~~~kL~Dfg~~~~~~~~  149 (329)
T cd05588          79 SGGDLMFHMQRQR----KLPEEHARFYSAEISLALNFLHERG-----IIYRDLKLDNVLLDAEGHIKLTDYGMCKEGIRP  149 (329)
T ss_pred             CCCCHHHHHHHcC----CCCHHHHHHHHHHHHHHHHHHHHCC-----eEecCCCHHHeEECCCCCEEECcCccccccccC
Confidence            9999999886543    4899999999999999999999987     999999999999999999999999998753221


Q ss_pred             ceeeeecCCCCCCCCCccccccCCCCCcccchhHHHHHHHHHhCCCCcchhHHHH-----HhhhhhhHhhccccCCCCCH
Q 005586          571 IVFSVLKTSAAMGYLAPEYVTTGRFTERSDIFAFGVIILQILTGSLVLTSSMRLA-----AESATFENFIDRNLKGKFSE  645 (689)
Q Consensus       571 ~~~~~~~~~~~~~y~aPE~~~~~~~~~ksDV~sfGvvl~elltG~~p~~~~~~~~-----~~~~~~~~~~~~~~~~~~~~  645 (689)
                      .. ......+|..|+|||++.+..++.++|||||||++|||+||+.||.......     ........+....  ...+.
T Consensus       150 ~~-~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~~l~el~~g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~--~~~p~  226 (329)
T cd05588         150 GD-TTSTFCGTPNYIAPEILRGEDYGFSVDWWALGVLMFEMMAGRSPFDIVGMSDNPDQNTEDYLFQVILEKQ--IRIPR  226 (329)
T ss_pred             CC-ccccccCCccccCHHHHcCCCCCCccceechHHHHHHHHHCCCCcccccccccccccchHHHHHHHHcCC--CCCCC
Confidence            11 1223457889999999999999999999999999999999999995321100     0000111111111  12344


Q ss_pred             HHHHHHHHHHHHhccCCCCCCCC------HHHHHHHHHh
Q 005586          646 SEAAKLGKMALVCTHEDPENRPT------MEAVIEELTV  678 (689)
Q Consensus       646 ~~~~~l~~l~~~Cl~~dp~~RPs------~~evl~~L~~  678 (689)
                      ..+.++.+++..|++.||++||+      +.|++++-+.
T Consensus       227 ~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~~i~~hp~~  265 (329)
T cd05588         227 SLSVKASSVLKGFLNKDPKERLGCHPQTGFRDIKSHPFF  265 (329)
T ss_pred             CCCHHHHHHHHHHhccCHHHcCCCCCCCCHHHHhcCCCC
Confidence            45667899999999999999987      7888876443

Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. They contain a C2-like region, instead of a calcium-binding (C2) region found in classical PKCs, in their regulatory domain. There are two aPKC isoforms, zeta and iota. aPKCs are involved in many cellular functions incl

>cd06654 STKc_PAK1 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 1

Probab=100.00  E-value=3.3e-37  Score=321.27  Aligned_cols=254  Identities=16%  Similarity=0.307  Sum_probs=203.5

Q ss_pred             ccCCcccccccCCcceEEEEEec-CCcEEEEEEecccCCchHHHHHHHHHHHHhccCCCcceeEeeEEEcCCCCeEEEEE
Q 005586          409 QCFSEVNLLGKGNFSSVYKGTLR-DGTLVAIRSINVTSCKSEEAEFVKGLYLLTSLRHENIIRLRGFCCSRGRGECFLIY  487 (689)
Q Consensus       409 ~~f~~~~~lg~G~~g~Vy~~~~~-~g~~vavK~l~~~~~~~~~~~f~~e~~~l~~l~H~niv~l~g~~~~~~~~~~~lV~  487 (689)
                      .+|+..+.||+|+||.||+|... ++..||+|.+..... .....+.+|+.+++.++|+||+++++++..  ....++||
T Consensus        20 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~v~ik~~~~~~~-~~~~~~~~e~~~l~~~~h~~v~~~~~~~~~--~~~~~lv~   96 (296)
T cd06654          20 KKYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQ-PKKELIINEILVMRENKNPNIVNYLDSYLV--GDELWVVM   96 (296)
T ss_pred             cceeeEEEecCCCCeEEEEEEECCCCcEEEEEEEecCCc-chHHHHHHHHHHHHhCCCCCEeeEEEEEEe--CCEEEEee
Confidence            46777889999999999999864 689999999876543 334678899999999999999999998854  46899999


Q ss_pred             EcCCCCCHHHHhhhcCCCCCCCCHHHHHHHHHHHHHHHhhhhCCCCCCCceeecCCCCCceeecCCCCeEEecccccccc
Q 005586          488 DFAPKGKLSKYLDQEEGSSNVLDWSTRVSIIIGIAKGIGYLHSSEVNKPAIVHRNLSVEKVLIDQQFNPLIADCGLHKLL  567 (689)
Q Consensus       488 e~~~~gsL~~~L~~~~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~~~ivH~dlk~~NiLl~~~~~~kl~DfGla~~~  567 (689)
                      ||+++++|.+++...     .+++.++..++.|++.||+|||+.+     |+||||||+||++++++.+||+|||+++..
T Consensus        97 e~~~~~~L~~~~~~~-----~~~~~~~~~i~~ql~~aL~~LH~~g-----i~H~dLkp~Nill~~~~~~kl~dfg~~~~~  166 (296)
T cd06654          97 EYLAGGSLTDVVTET-----CMDEGQIAAVCRECLQALEFLHSNQ-----VIHRDIKSDNILLGMDGSVKLTDFGFCAQI  166 (296)
T ss_pred             cccCCCCHHHHHHhc-----CCCHHHHHHHHHHHHHHHHHHHHCC-----cccCCCCHHHEEEcCCCCEEECccccchhc
Confidence            999999999998643     3789999999999999999999987     999999999999999999999999998765


Q ss_pred             cCCceeeeecCCCCCCCCCccccccCCCCCcccchhHHHHHHHHHhCCCCcchhHHHHHhhhhhhHhhccccCCCCCHHH
Q 005586          568 ADDIVFSVLKTSAAMGYLAPEYVTTGRFTERSDIFAFGVIILQILTGSLVLTSSMRLAAESATFENFIDRNLKGKFSESE  647 (689)
Q Consensus       568 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~ksDV~sfGvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  647 (689)
                      ..... ......++..|+|||.+.+..++.++|||||||++|||++|+.||.........   .............+...
T Consensus       167 ~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~s~Gvil~~l~~g~~pf~~~~~~~~~---~~~~~~~~~~~~~~~~~  242 (296)
T cd06654         167 TPEQS-KRSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMIEGEPPYLNENPLRAL---YLIATNGTPELQNPEKL  242 (296)
T ss_pred             ccccc-ccCcccCCccccCHHHHcCCCCCccchHHHHHHHHHHHHhCCCCCCCCCHHHhH---HHHhcCCCCCCCCcccc
Confidence            43221 112234677899999998888999999999999999999999999654221111   11111111111223345


Q ss_pred             HHHHHHHHHHhccCCCCCCCCHHHHHHHHHhh
Q 005586          648 AAKLGKMALVCTHEDPENRPTMEAVIEELTVA  679 (689)
Q Consensus       648 ~~~l~~l~~~Cl~~dp~~RPs~~evl~~L~~~  679 (689)
                      ...+.+++.+|+..+|++||++.|++++-+..
T Consensus       243 ~~~l~~li~~~l~~~p~~Rpt~~eil~~~~~~  274 (296)
T cd06654         243 SAIFRDFLNRCLDMDVEKRGSAKELLQHQFLK  274 (296)
T ss_pred             CHHHHHHHHHHCcCCcccCcCHHHHhhChhhh
Confidence            56789999999999999999999999875443

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 1, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK1 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding

>cd06638 STKc_myosinIIIA Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIA myosin

Probab=100.00  E-value=1.6e-37  Score=321.92  Aligned_cols=268  Identities=15%  Similarity=0.306  Sum_probs=207.6

Q ss_pred             cCHHHHHHHhccCCcccccccCCcceEEEEEec-CCcEEEEEEecccCCchHHHHHHHHHHHHhcc-CCCcceeEeeEEE
Q 005586          399 LNLEEVESATQCFSEVNLLGKGNFSSVYKGTLR-DGTLVAIRSINVTSCKSEEAEFVKGLYLLTSL-RHENIIRLRGFCC  476 (689)
Q Consensus       399 ~~~~~l~~at~~f~~~~~lg~G~~g~Vy~~~~~-~g~~vavK~l~~~~~~~~~~~f~~e~~~l~~l-~H~niv~l~g~~~  476 (689)
                      +.++.+..++++|+..+.||+|+||.||+|... +++.+|+|++....  ....++.+|+.++.++ +||||+++++++.
T Consensus         8 ~~~~~~~~~~~~~~~~~~lg~g~~~~vy~~~~~~~~~~~~ik~~~~~~--~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~   85 (286)
T cd06638           8 IIFDSFPDPSDTWEIIETIGKGTYGKVFKVLNKKNGSKAAVKILDPIH--DIDEEIEAEYNILKALSDHPNVVKFYGMYY   85 (286)
T ss_pred             EEeecCCCcccceeeeeeeccCCCcEEEEEEECCCCceeEEEeecccc--chHHHHHHHHHHHHHHhcCCCeeeeeeeee
Confidence            445666778889999999999999999999875 68899999876432  2345788899999999 6999999999885


Q ss_pred             cC---CCCeEEEEEEcCCCCCHHHHhhhcCCCCCCCCHHHHHHHHHHHHHHHhhhhCCCCCCCceeecCCCCCceeecCC
Q 005586          477 SR---GRGECFLIYDFAPKGKLSKYLDQEEGSSNVLDWSTRVSIIIGIAKGIGYLHSSEVNKPAIVHRNLSVEKVLIDQQ  553 (689)
Q Consensus       477 ~~---~~~~~~lV~e~~~~gsL~~~L~~~~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~~~ivH~dlk~~NiLl~~~  553 (689)
                      ..   ..+..++||||+++|+|.++++........+++..+..++.|++.||.|||+.+     |+||||||+||+++++
T Consensus        86 ~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~-----i~H~dlkp~nili~~~  160 (286)
T cd06638          86 KKDVKNGDQLWLVLELCNGGSVTDLVKGFLKRGERMEEPIIAYILHEALMGLQHLHVNK-----TIHRDVKGNNILLTTE  160 (286)
T ss_pred             ecccCCCCeEEEEEeecCCCCHHHHHHHhhccCccccHHHHHHHHHHHHHHHHHHHhCC-----ccccCCCHHhEEECCC
Confidence            32   335689999999999999998754333345889999999999999999999887     9999999999999999


Q ss_pred             CCeEEecccccccccCCceeeeecCCCCCCCCCcccccc-----CCCCCcccchhHHHHHHHHHhCCCCcchhHHHHHhh
Q 005586          554 FNPLIADCGLHKLLADDIVFSVLKTSAAMGYLAPEYVTT-----GRFTERSDIFAFGVIILQILTGSLVLTSSMRLAAES  628 (689)
Q Consensus       554 ~~~kl~DfGla~~~~~~~~~~~~~~~~~~~y~aPE~~~~-----~~~~~ksDV~sfGvvl~elltG~~p~~~~~~~~~~~  628 (689)
                      +.+||+|||+++.+..... ......++..|+|||++..     ..++.++|||||||++|||++|+.|+..........
T Consensus       161 ~~~kl~dfg~~~~~~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slGvi~~el~~g~~p~~~~~~~~~~~  239 (286)
T cd06638         161 GGVKLVDFGVSAQLTSTRL-RRNTSVGTPFWMAPEVIACEQQLDSTYDARCDVWSLGITAIELGDGDPPLADLHPMRALF  239 (286)
T ss_pred             CCEEEccCCceeecccCCC-ccccccCCCcccChhhhchhhhccccccchhhhhhHHHHHHHHhcCCCCCCCCchhHHHh
Confidence            9999999999886643321 1223457788999998753     457889999999999999999999986432211100


Q ss_pred             hhhhHhhccccCCCCCHHHHHHHHHHHHHhccCCCCCCCCHHHHHHHHH
Q 005586          629 ATFENFIDRNLKGKFSESEAAKLGKMALVCTHEDPENRPTMEAVIEELT  677 (689)
Q Consensus       629 ~~~~~~~~~~~~~~~~~~~~~~l~~l~~~Cl~~dp~~RPs~~evl~~L~  677 (689)
                       .........  ...+.....++.+++.+|++.||++||++.|+++++.
T Consensus       240 -~~~~~~~~~--~~~~~~~~~~~~~li~~~l~~~p~~Rps~~ell~~~~  285 (286)
T cd06638         240 -KIPRNPPPT--LHQPELWSNEFNDFIRKCLTKDYEKRPTVSDLLQHVF  285 (286)
T ss_pred             -hccccCCCc--ccCCCCcCHHHHHHHHHHccCCcccCCCHHHHhhccc
Confidence             000000000  0112223457899999999999999999999998764

Serine/threonine kinases (STKs), class IIIA myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. In photoreceptor cells, they may also function as cargo carriers during light-dependent translocation of proteins such as transducin and arrestin. Class IIIA myosin is highly expressed in retina and in inner ear

>cd05616 STKc_cPKC_beta Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C beta

Probab=100.00  E-value=1.8e-37  Score=327.51  Aligned_cols=248  Identities=21%  Similarity=0.294  Sum_probs=197.0

Q ss_pred             cCCcccccccCCcceEEEEEec-CCcEEEEEEecccCC--chHHHHHHHHHHHHhcc-CCCcceeEeeEEEcCCCCeEEE
Q 005586          410 CFSEVNLLGKGNFSSVYKGTLR-DGTLVAIRSINVTSC--KSEEAEFVKGLYLLTSL-RHENIIRLRGFCCSRGRGECFL  485 (689)
Q Consensus       410 ~f~~~~~lg~G~~g~Vy~~~~~-~g~~vavK~l~~~~~--~~~~~~f~~e~~~l~~l-~H~niv~l~g~~~~~~~~~~~l  485 (689)
                      +|...+.||+|+||.||+|+.+ +++.||+|++.....  ......+..|..++..+ +|++|+++++++..  .+..++
T Consensus         1 df~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~~--~~~~~l   78 (323)
T cd05616           1 DFNFLMVLGKGSFGKVMLAERKGTDELYAIKILKKDVVIQDDDVECTMVEKRVLALSGKPPFLTQLHSCFQT--MDRLYF   78 (323)
T ss_pred             CceEEEEEeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhccCCCeEeeEEEEEec--CCEEEE
Confidence            4677899999999999999876 578999999976432  22334577788888877 58999999988743  578999


Q ss_pred             EEEcCCCCCHHHHhhhcCCCCCCCCHHHHHHHHHHHHHHHhhhhCCCCCCCceeecCCCCCceeecCCCCeEEecccccc
Q 005586          486 IYDFAPKGKLSKYLDQEEGSSNVLDWSTRVSIIIGIAKGIGYLHSSEVNKPAIVHRNLSVEKVLIDQQFNPLIADCGLHK  565 (689)
Q Consensus       486 V~e~~~~gsL~~~L~~~~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~~~ivH~dlk~~NiLl~~~~~~kl~DfGla~  565 (689)
                      ||||+++|+|.+++....    .+++.++..++.|++.||+|||+.+     |+||||||+|||+++++.+||+|||+++
T Consensus        79 v~E~~~~g~L~~~~~~~~----~~~~~~~~~~~~qi~~aL~~LH~~~-----ivHrDlkp~Nill~~~~~~kL~DfG~~~  149 (323)
T cd05616          79 VMEYVNGGDLMYQIQQVG----RFKEPHAVFYAAEIAIGLFFLHSKG-----IIYRDLKLDNVMLDSEGHIKIADFGMCK  149 (323)
T ss_pred             EEcCCCCCCHHHHHHHcC----CCCHHHHHHHHHHHHHHHHHHHHCC-----EEecCCCHHHeEECCCCcEEEccCCCce
Confidence            999999999999987643    3889999999999999999999987     9999999999999999999999999987


Q ss_pred             cccCCceeeeecCCCCCCCCCccccccCCCCCcccchhHHHHHHHHHhCCCCcchhHHHHHhhhhhhHhhccccCCCCCH
Q 005586          566 LLADDIVFSVLKTSAAMGYLAPEYVTTGRFTERSDIFAFGVIILQILTGSLVLTSSMRLAAESATFENFIDRNLKGKFSE  645 (689)
Q Consensus       566 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~ksDV~sfGvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~  645 (689)
                      ....... ......|++.|+|||++.+..++.++|||||||++|||+||+.||.......    ....+....  ..++.
T Consensus       150 ~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~elltg~~Pf~~~~~~~----~~~~i~~~~--~~~p~  222 (323)
T cd05616         150 ENMWDGV-TTKTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQAPFEGEDEDE----LFQSIMEHN--VAYPK  222 (323)
T ss_pred             ecCCCCC-ccccCCCChhhcCHHHhcCCCCCCccchhchhHHHHHHHhCCCCCCCCCHHH----HHHHHHhCC--CCCCC
Confidence            5432211 1223457889999999999999999999999999999999999996542211    112222211  22344


Q ss_pred             HHHHHHHHHHHHhccCCCCCCCCH-----HHHHHH
Q 005586          646 SEAAKLGKMALVCTHEDPENRPTM-----EAVIEE  675 (689)
Q Consensus       646 ~~~~~l~~l~~~Cl~~dp~~RPs~-----~evl~~  675 (689)
                      ..+.++.+++.+|++.||++|++.     .++.++
T Consensus       223 ~~s~~~~~li~~~l~~~p~~R~~~~~~~~~~i~~h  257 (323)
T cd05616         223 SMSKEAVAICKGLMTKHPGKRLGCGPEGERDIKEH  257 (323)
T ss_pred             cCCHHHHHHHHHHcccCHHhcCCCCCCCHHHHhcC
Confidence            556788999999999999999984     666544

Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, beta isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, and

>cd08217 STKc_Nek2 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 2

Probab=100.00  E-value=3.9e-37  Score=314.65  Aligned_cols=260  Identities=20%  Similarity=0.371  Sum_probs=209.1

Q ss_pred             cCCcccccccCCcceEEEEEec-CCcEEEEEEecccCC-chHHHHHHHHHHHHhccCCCcceeEeeEEEcCCCCeEEEEE
Q 005586          410 CFSEVNLLGKGNFSSVYKGTLR-DGTLVAIRSINVTSC-KSEEAEFVKGLYLLTSLRHENIIRLRGFCCSRGRGECFLIY  487 (689)
Q Consensus       410 ~f~~~~~lg~G~~g~Vy~~~~~-~g~~vavK~l~~~~~-~~~~~~f~~e~~~l~~l~H~niv~l~g~~~~~~~~~~~lV~  487 (689)
                      +|+..+.||.|+||.||++... +|..||+|++..... ....+++..|++++++++|+||+++++++........+++|
T Consensus         1 ~y~~~~~lg~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~~~~   80 (265)
T cd08217           1 DYEVLETIGKGSFGTVRKVRRKSDGKILVWKEIDYGNMTEKEKQQLVSEVNILRELKHPNIVRYYDRIIDRSNQTLYIVM   80 (265)
T ss_pred             CceeeeeeccCCCeEEEEeeecCCCCEEEEEEEecccCCHHHHHHHHHHHHHHHhcCCCccceeeeeeecCCCCEEEEEe
Confidence            3667789999999999999865 688999999875432 33456789999999999999999999988766566789999


Q ss_pred             EcCCCCCHHHHhhhcCCCCCCCCHHHHHHHHHHHHHHHhhhhCCCCCCCceeecCCCCCceeecCCCCeEEecccccccc
Q 005586          488 DFAPKGKLSKYLDQEEGSSNVLDWSTRVSIIIGIAKGIGYLHSSEVNKPAIVHRNLSVEKVLIDQQFNPLIADCGLHKLL  567 (689)
Q Consensus       488 e~~~~gsL~~~L~~~~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~~~ivH~dlk~~NiLl~~~~~~kl~DfGla~~~  567 (689)
                      ||+++++|.+++.........+++..++.++.|++.||+|||..+.....++|+||||+||++++++.+||+|||++...
T Consensus        81 e~~~~~~L~~~l~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~~~~~~~i~h~dl~p~nili~~~~~~kl~d~g~~~~~  160 (265)
T cd08217          81 EYCEGGDLAQLIQKCKKERKYIEEEFIWRILTQLLLALYECHNRSDPGNTVLHRDLKPANIFLDANNNVKLGDFGLAKIL  160 (265)
T ss_pred             hhccCCCHHHHHHHHhhcccCCCHHHHHHHHHHHHHHHHHHhcCccccCcceecCCCHHHEEEecCCCEEEecccccccc
Confidence            99999999999976543345699999999999999999999932111233999999999999999999999999999877


Q ss_pred             cCCceeeeecCCCCCCCCCccccccCCCCCcccchhHHHHHHHHHhCCCCcchhHHHHHhhhhhhHhhccccCCCCCHHH
Q 005586          568 ADDIVFSVLKTSAAMGYLAPEYVTTGRFTERSDIFAFGVIILQILTGSLVLTSSMRLAAESATFENFIDRNLKGKFSESE  647 (689)
Q Consensus       568 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~ksDV~sfGvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  647 (689)
                      ...... .....++..|+|||.+.+..++.++||||||+++|||++|+.|+......     .+.+.+........+...
T Consensus       161 ~~~~~~-~~~~~~~~~~~~pE~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~-----~~~~~~~~~~~~~~~~~~  234 (265)
T cd08217         161 GHDSSF-AKTYVGTPYYMSPEQLNHMSYDEKSDIWSLGCLIYELCALSPPFTARNQL-----QLASKIKEGKFRRIPYRY  234 (265)
T ss_pred             cCCccc-ccccccCCCccChhhhcCCCCCchhHHHHHHHHHHHHHHCCCcccCcCHH-----HHHHHHhcCCCCCCcccc
Confidence            544321 12235678899999999888999999999999999999999998654211     112222222223345566


Q ss_pred             HHHHHHHHHHhccCCCCCCCCHHHHHHH
Q 005586          648 AAKLGKMALVCTHEDPENRPTMEAVIEE  675 (689)
Q Consensus       648 ~~~l~~l~~~Cl~~dp~~RPs~~evl~~  675 (689)
                      +.++.+++.+|++.+|++||++.+|+++
T Consensus       235 ~~~~~~l~~~~l~~~p~~Rp~~~~il~~  262 (265)
T cd08217         235 SSELNEVIKSMLNVDPDKRPSTEELLQL  262 (265)
T ss_pred             CHHHHHHHHHHccCCcccCCCHHHHhhC
Confidence            7789999999999999999999999986

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 2 (Nek2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek2 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek2 subfamily includes Aspergillus nidulans NIMA kinase, the founding member of the Nek family, which was identified in a screen for cell cycle mutants prevented from entering mitosis. NIMA is essential for mitotic entry and progression through mitosis, and its degradation is essential for mitotic exi

>cd05619 STKc_nPKC_theta Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C theta

Probab=100.00  E-value=1.5e-37  Score=326.69  Aligned_cols=243  Identities=19%  Similarity=0.299  Sum_probs=191.8

Q ss_pred             cccccCCcceEEEEEec-CCcEEEEEEecccCC--chHHHHHHHHHHHHhcc-CCCcceeEeeEEEcCCCCeEEEEEEcC
Q 005586          415 NLLGKGNFSSVYKGTLR-DGTLVAIRSINVTSC--KSEEAEFVKGLYLLTSL-RHENIIRLRGFCCSRGRGECFLIYDFA  490 (689)
Q Consensus       415 ~~lg~G~~g~Vy~~~~~-~g~~vavK~l~~~~~--~~~~~~f~~e~~~l~~l-~H~niv~l~g~~~~~~~~~~~lV~e~~  490 (689)
                      +.||+|+||.||+|+.. +++.||+|+++....  ......+..|..++... +||||+++++++..  .+..++||||+
T Consensus         1 ~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~hp~iv~~~~~~~~--~~~~~lv~ey~   78 (316)
T cd05619           1 KMLGKGSFGKVFLAELKGTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEHPFLTHLYCTFQT--KENLFFVMEYL   78 (316)
T ss_pred             CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhcchHHHHHHHHHHHHhccCCCcCcceEEEEEe--CCEEEEEEeCC
Confidence            36999999999999976 578999999976421  23345567788888764 89999999999854  47899999999


Q ss_pred             CCCCHHHHhhhcCCCCCCCCHHHHHHHHHHHHHHHhhhhCCCCCCCceeecCCCCCceeecCCCCeEEecccccccccCC
Q 005586          491 PKGKLSKYLDQEEGSSNVLDWSTRVSIIIGIAKGIGYLHSSEVNKPAIVHRNLSVEKVLIDQQFNPLIADCGLHKLLADD  570 (689)
Q Consensus       491 ~~gsL~~~L~~~~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~~~ivH~dlk~~NiLl~~~~~~kl~DfGla~~~~~~  570 (689)
                      ++|+|.+++....    .+++.+...++.|++.||+|||+.+     |+||||||+|||+++++.+||+|||+++.....
T Consensus        79 ~~g~L~~~l~~~~----~~~~~~~~~~~~qi~~al~~LH~~~-----ivHrdikp~Nil~~~~~~~kl~Dfg~~~~~~~~  149 (316)
T cd05619          79 NGGDLMFHIQSCH----KFDLPRATFYAAEIICGLQFLHSKG-----IVYRDLKLDNILLDTDGHIKIADFGMCKENMLG  149 (316)
T ss_pred             CCCcHHHHHHHcC----CCCHHHHHHHHHHHHHHHHHHHhCC-----eEeCCCCHHHEEECCCCCEEEccCCcceECCCC
Confidence            9999999997542    3889999999999999999999987     999999999999999999999999998753221


Q ss_pred             ceeeeecCCCCCCCCCccccccCCCCCcccchhHHHHHHHHHhCCCCcchhHHHHHhhhhhhHhhccccCCCCCHHHHHH
Q 005586          571 IVFSVLKTSAAMGYLAPEYVTTGRFTERSDIFAFGVIILQILTGSLVLTSSMRLAAESATFENFIDRNLKGKFSESEAAK  650 (689)
Q Consensus       571 ~~~~~~~~~~~~~y~aPE~~~~~~~~~ksDV~sfGvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  650 (689)
                      .. ......+|..|+|||++.+..++.++|||||||++|||++|+.||........    +..+ .. ....++.....+
T Consensus       150 ~~-~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~~G~~pf~~~~~~~~----~~~i-~~-~~~~~~~~~~~~  222 (316)
T cd05619         150 DA-KTCTFCGTPDYIAPEILLGQKYNTSVDWWSFGVLLYEMLIGQSPFHGHDEEEL----FQSI-RM-DNPCYPRWLTRE  222 (316)
T ss_pred             CC-ceeeecCCccccCHHHHcCCCCCchhhhhhHHHHHHHHHhCCCCCCCCCHHHH----HHHH-Hh-CCCCCCccCCHH
Confidence            11 12234578899999999988999999999999999999999999965322111    1111 10 111233334567


Q ss_pred             HHHHHHHhccCCCCCCCCHH-HHHHH
Q 005586          651 LGKMALVCTHEDPENRPTME-AVIEE  675 (689)
Q Consensus       651 l~~l~~~Cl~~dp~~RPs~~-evl~~  675 (689)
                      +.+++.+|++.||++||++. ++.++
T Consensus       223 ~~~li~~~l~~~P~~R~~~~~~l~~h  248 (316)
T cd05619         223 AKDILVKLFVREPERRLGVKGDIRQH  248 (316)
T ss_pred             HHHHHHHHhccCHhhcCCChHHHHcC
Confidence            88999999999999999997 66554

Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an important and non-redundant role in

>cd05622 STKc_ROCK1 Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 1

Probab=100.00  E-value=1.1e-37  Score=334.72  Aligned_cols=261  Identities=13%  Similarity=0.242  Sum_probs=204.2

Q ss_pred             HHHHHHhccCCcccccccCCcceEEEEEec-CCcEEEEEEecccCC--chHHHHHHHHHHHHhccCCCcceeEeeEEEcC
Q 005586          402 EEVESATQCFSEVNLLGKGNFSSVYKGTLR-DGTLVAIRSINVTSC--KSEEAEFVKGLYLLTSLRHENIIRLRGFCCSR  478 (689)
Q Consensus       402 ~~l~~at~~f~~~~~lg~G~~g~Vy~~~~~-~g~~vavK~l~~~~~--~~~~~~f~~e~~~l~~l~H~niv~l~g~~~~~  478 (689)
                      .++....++|...+.||+|+||.||+++.+ +++.||+|++.....  ......+.+|+.+++.++||||+++++.+.. 
T Consensus        36 ~~~~~~~~~y~i~~~lG~G~fg~Vy~~~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~e~~i~~~~~hp~iv~~~~~~~~-  114 (371)
T cd05622          36 RDLRMKAEDYEVVKVIGRGAFGEVQLVRHKSTRKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFANSPWVVQLFYAFQD-  114 (371)
T ss_pred             hhcCcchhhcEEEEEEeecCCeEEEEEEECCCCcEEEEEEEEHHHhhhhHHHHHHHHHHHHHHhCCCCCCCeEEEEEEc-
Confidence            344556688999999999999999999986 688999999864321  2234568899999999999999999998843 


Q ss_pred             CCCeEEEEEEcCCCCCHHHHhhhcCCCCCCCCHHHHHHHHHHHHHHHhhhhCCCCCCCceeecCCCCCceeecCCCCeEE
Q 005586          479 GRGECFLIYDFAPKGKLSKYLDQEEGSSNVLDWSTRVSIIIGIAKGIGYLHSSEVNKPAIVHRNLSVEKVLIDQQFNPLI  558 (689)
Q Consensus       479 ~~~~~~lV~e~~~~gsL~~~L~~~~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~~~ivH~dlk~~NiLl~~~~~~kl  558 (689)
                       ....++||||+++|+|.+++...     .++...+..++.|++.||+|||+.+     |+||||||+|||+++++.+||
T Consensus       115 -~~~~~lv~Ey~~gg~L~~~~~~~-----~~~~~~~~~~~~qi~~aL~~LH~~~-----ivHrDLkp~NIll~~~~~ikL  183 (371)
T cd05622         115 -DRYLYMVMEYMPGGDLVNLMSNY-----DVPEKWARFYTAEVVLALDAIHSMG-----FIHRDVKPDNMLLDKSGHLKL  183 (371)
T ss_pred             -CCEEEEEEcCCCCCcHHHHHHhc-----CCCHHHHHHHHHHHHHHHHHHHHCC-----EEeCCCCHHHEEECCCCCEEE
Confidence             57899999999999999998653     2778888899999999999999988     999999999999999999999


Q ss_pred             ecccccccccCCceeeeecCCCCCCCCCccccccC----CCCCcccchhHHHHHHHHHhCCCCcchhHHHHHhhhhhhHh
Q 005586          559 ADCGLHKLLADDIVFSVLKTSAAMGYLAPEYVTTG----RFTERSDIFAFGVIILQILTGSLVLTSSMRLAAESATFENF  634 (689)
Q Consensus       559 ~DfGla~~~~~~~~~~~~~~~~~~~y~aPE~~~~~----~~~~ksDV~sfGvvl~elltG~~p~~~~~~~~~~~~~~~~~  634 (689)
                      +|||+++.+............||+.|+|||++...    .++.++|||||||++|||++|+.||.......    .+..+
T Consensus       184 ~DfG~a~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~~~~DiwSlGvilyell~G~~Pf~~~~~~~----~~~~i  259 (371)
T cd05622         184 ADFGTCMKMNKEGMVRCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGDTPFYADSLVG----TYSKI  259 (371)
T ss_pred             EeCCceeEcCcCCcccccCcccCccccCHHHHhccCCCccCCCccceeehhHHHHHHHhCCCCCCCCCHHH----HHHHH
Confidence            99999987654332223345688999999998653    37899999999999999999999997543221    12222


Q ss_pred             hccccCCCCC--HHHHHHHHHHHHHhccCCCCC--CCCHHHHHHHHHh
Q 005586          635 IDRNLKGKFS--ESEAAKLGKMALVCTHEDPEN--RPTMEAVIEELTV  678 (689)
Q Consensus       635 ~~~~~~~~~~--~~~~~~l~~l~~~Cl~~dp~~--RPs~~evl~~L~~  678 (689)
                      ....-...++  ...+..+.+++..|+..++.+  ||++.|++++.+.
T Consensus       260 ~~~~~~~~~~~~~~~s~~~~~li~~~L~~~~~r~~r~~~~ei~~h~~~  307 (371)
T cd05622         260 MNHKNSLTFPDDNDISKEAKNLICAFLTDREVRLGRNGVEEIKRHLFF  307 (371)
T ss_pred             HcCCCcccCCCcCCCCHHHHHHHHHHcCChhhhcCCCCHHHHhcCccc
Confidence            2211111111  234667889999999844443  7899999987643

Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK1 (or ROK-beta) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK1 is preferentially expressed in the liver, lung, spleen, testes, an

>cd00192 PTKc Catalytic domain of Protein Tyrosine Kinases

Probab=100.00  E-value=5.2e-37  Score=313.04  Aligned_cols=251  Identities=29%  Similarity=0.531  Sum_probs=204.8

Q ss_pred             cccccCCcceEEEEEecC----CcEEEEEEecccCCchHHHHHHHHHHHHhccCCCcceeEeeEEEcCCCCeEEEEEEcC
Q 005586          415 NLLGKGNFSSVYKGTLRD----GTLVAIRSINVTSCKSEEAEFVKGLYLLTSLRHENIIRLRGFCCSRGRGECFLIYDFA  490 (689)
Q Consensus       415 ~~lg~G~~g~Vy~~~~~~----g~~vavK~l~~~~~~~~~~~f~~e~~~l~~l~H~niv~l~g~~~~~~~~~~~lV~e~~  490 (689)
                      +.||+|+||.||+|....    +..|++|.+.........+++.+|++.+.+++|+||+++++++..  ....++||||+
T Consensus         1 ~~ig~g~~g~v~~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~--~~~~~lv~e~~   78 (262)
T cd00192           1 KKLGEGAFGEVYKGKLKGKDGKTTEVAVKTLKEDASEEERKDFLKEARVMKKLGHPNVVRLLGVCTE--EEPLYLVLEYM   78 (262)
T ss_pred             CccccCCceEEEEEEEecCCCCCceEEeEeeccccchhHHHHHHHHHHHHhhcCCCChheeeeeecC--CCceEEEEEec
Confidence            469999999999999763    889999999876544446789999999999999999999999854  57899999999


Q ss_pred             CCCCHHHHhhhcCCC-----CCCCCHHHHHHHHHHHHHHHhhhhCCCCCCCceeecCCCCCceeecCCCCeEEecccccc
Q 005586          491 PKGKLSKYLDQEEGS-----SNVLDWSTRVSIIIGIAKGIGYLHSSEVNKPAIVHRNLSVEKVLIDQQFNPLIADCGLHK  565 (689)
Q Consensus       491 ~~gsL~~~L~~~~~~-----~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~~~ivH~dlk~~NiLl~~~~~~kl~DfGla~  565 (689)
                      ++++|.+++......     ...+++..+..++.|++.||+|||+.+     ++||||||+||++++++.+||+|||.++
T Consensus        79 ~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~l~~al~~lH~~~-----i~H~di~p~nili~~~~~~~l~dfg~~~  153 (262)
T cd00192          79 EGGDLLDYLRKSRPVFPSPEKSTLSLKDLLSFAIQIAKGMEYLASKK-----FVHRDLAARNCLVGEDLVVKISDFGLSR  153 (262)
T ss_pred             cCCcHHHHHhhccccccccccccCCHHHHHHHHHHHHHHHHHHHcCC-----cccCccCcceEEECCCCcEEEccccccc
Confidence            999999999875211     245899999999999999999999987     9999999999999999999999999998


Q ss_pred             cccCCce-eeeecCCCCCCCCCccccccCCCCCcccchhHHHHHHHHHh-CCCCcchhHHHHHhhhhhhHhhccccCCCC
Q 005586          566 LLADDIV-FSVLKTSAAMGYLAPEYVTTGRFTERSDIFAFGVIILQILT-GSLVLTSSMRLAAESATFENFIDRNLKGKF  643 (689)
Q Consensus       566 ~~~~~~~-~~~~~~~~~~~y~aPE~~~~~~~~~ksDV~sfGvvl~ellt-G~~p~~~~~~~~~~~~~~~~~~~~~~~~~~  643 (689)
                      ....... .......++..|+|||.+....++.++||||+||++|||++ |+.|+.......     +.+.+........
T Consensus       154 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~~-----~~~~~~~~~~~~~  228 (262)
T cd00192         154 DVYDDDYYRKKTGGKLPIRWMAPESLKDGIFTSKSDVWSFGVLLWEIFTLGATPYPGLSNEE-----VLEYLRKGYRLPK  228 (262)
T ss_pred             ccccccccccccCCCcCccccCHHHhccCCcchhhccHHHHHHHHHHHhcCCCCCCCCCHHH-----HHHHHHcCCCCCC
Confidence            7754321 12223446778999999988889999999999999999999 588886542111     1111111222233


Q ss_pred             CHHHHHHHHHHHHHhccCCCCCCCCHHHHHHHHH
Q 005586          644 SESEAAKLGKMALVCTHEDPENRPTMEAVIEELT  677 (689)
Q Consensus       644 ~~~~~~~l~~l~~~Cl~~dp~~RPs~~evl~~L~  677 (689)
                      +...+.++.+++.+|++.+|++||++.|++++|+
T Consensus       229 ~~~~~~~~~~li~~~l~~~p~~Rps~~~l~~~l~  262 (262)
T cd00192         229 PEYCPDELYELMLSCWQLDPEDRPTFSELVERLE  262 (262)
T ss_pred             CccCChHHHHHHHHHccCCcccCcCHHHHHHhhC
Confidence            4455778999999999999999999999999874

Protein Tyrosine Kinase (PTK) family, catalytic domain. This PTKc family is part of a larger superfamily that includes the catalytic domains of protein serine/threonine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. They can be classified into receptor and non-receptor tyr kinases. PTKs play important roles in many cellular processes including, lymphocyte activation, epithelium growth and maintenance, metabolism control, organogenesis regulation, survival, proliferation, differentiation, migration, adhesion, motility, and morphogenesis. Receptor tyr kinases (RTKs) are integral membrane proteins which contain an extracellular ligand-binding region, a transmembrane segment, and an intracellular tyr kinase domain. RTKs are usually activated through ligan

>KOG2052 consensus Activin A type IB receptor, serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=1.2e-37  Score=314.33  Aligned_cols=263  Identities=24%  Similarity=0.393  Sum_probs=202.7

Q ss_pred             ccCCcccccccCCcceEEEEEecCCcEEEEEEecccCCchHHHHHHHHHHHHhc--cCCCcceeEeeEEEcC--CCCeEE
Q 005586          409 QCFSEVNLLGKGNFSSVYKGTLRDGTLVAIRSINVTSCKSEEAEFVKGLYLLTS--LRHENIIRLRGFCCSR--GRGECF  484 (689)
Q Consensus       409 ~~f~~~~~lg~G~~g~Vy~~~~~~g~~vavK~l~~~~~~~~~~~f~~e~~~l~~--l~H~niv~l~g~~~~~--~~~~~~  484 (689)
                      .+....+.||+|.||.||+|.++ |..||||++...    +++.+.+|.++.+.  ++|+||+.+++.=...  .-.+++
T Consensus       211 rqI~L~e~IGkGRyGEVwrG~wr-Ge~VAVKiF~sr----dE~SWfrEtEIYqTvmLRHENILgFIaaD~~~~gs~TQLw  285 (513)
T KOG2052|consen  211 RQIVLQEIIGKGRFGEVWRGRWR-GEDVAVKIFSSR----DERSWFRETEIYQTVMLRHENILGFIAADNKDNGSWTQLW  285 (513)
T ss_pred             heeEEEEEecCccccceeecccc-CCceEEEEeccc----chhhhhhHHHHHHHHHhccchhhhhhhccccCCCceEEEE
Confidence            45666789999999999999998 889999999754    45567777777765  4999999988743211  124689


Q ss_pred             EEEEcCCCCCHHHHhhhcCCCCCCCCHHHHHHHHHHHHHHHhhhhCCC---CCCCceeecCCCCCceeecCCCCeEEecc
Q 005586          485 LIYDFAPKGKLSKYLDQEEGSSNVLDWSTRVSIIIGIAKGIGYLHSSE---VNKPAIVHRNLSVEKVLIDQQFNPLIADC  561 (689)
Q Consensus       485 lV~e~~~~gsL~~~L~~~~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~---~~~~~ivH~dlk~~NiLl~~~~~~kl~Df  561 (689)
                      ||++|-++|||.+||...     .++-...+++|..+|.||++||..-   .++|.|+|||||+.|||+.+++.+.|+|+
T Consensus       286 LvTdYHe~GSL~DyL~r~-----tv~~~~ml~LalS~AsGLaHLH~eI~GTqgKPaIAHRDlKSKNILVKkn~~C~IADL  360 (513)
T KOG2052|consen  286 LVTDYHEHGSLYDYLNRN-----TVTTEGMLKLALSIASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVKKNGTCCIADL  360 (513)
T ss_pred             EeeecccCCcHHHHHhhc-----cCCHHHHHHHHHHHhhhHHHHHHHHhcCCCCchhhccccccccEEEccCCcEEEeec
Confidence            999999999999999764     4888999999999999999999421   25899999999999999999999999999


Q ss_pred             cccccccCCc---eeeeecCCCCCCCCCccccccC----CC--CCcccchhHHHHHHHHHhC----------CCCcchhH
Q 005586          562 GLHKLLADDI---VFSVLKTSAAMGYLAPEYVTTG----RF--TERSDIFAFGVIILQILTG----------SLVLTSSM  622 (689)
Q Consensus       562 Gla~~~~~~~---~~~~~~~~~~~~y~aPE~~~~~----~~--~~ksDV~sfGvvl~elltG----------~~p~~~~~  622 (689)
                      |||.....+.   ........||.+|||||++...    .+  -..+||||||.|+||+...          +.||++..
T Consensus       361 GLAv~h~~~t~~idi~~N~rVGTKRYMAPEvLdetin~~~Fesyk~ADIYafgLVlWEiarRc~~ggi~eey~~Pyyd~V  440 (513)
T KOG2052|consen  361 GLAVRHDSDTDTIDIPPNPRVGTKRYMAPEVLDETINMKHFESYKRADIYAFGLVLWEIARRCESGGIVEEYQLPYYDVV  440 (513)
T ss_pred             eeeEEecccCCcccCCCCCccceeeccChHHhhhhcChhhhhhhhHHHHHHHHHHHHHHHHHhhcCCEehhhcCCcccCC
Confidence            9998765442   2234456799999999998643    12  2468999999999999863          45666544


Q ss_pred             HHHHhhhhhhHh-hccccCCCC-----CHHHHHHHHHHHHHhccCCCCCCCCHHHHHHHHHhhCC
Q 005586          623 RLAAESATFENF-IDRNLKGKF-----SESEAAKLGKMALVCTHEDPENRPTMEAVIEELTVAAP  681 (689)
Q Consensus       623 ~~~~~~~~~~~~-~~~~~~~~~-----~~~~~~~l~~l~~~Cl~~dp~~RPs~~evl~~L~~~~p  681 (689)
                      ......+++.++ -.+.+++.+     ..+++..+.++|..||..+|..|-|+--+-+.|.....
T Consensus       441 p~DPs~eeMrkVVCv~~~RP~ipnrW~s~~~l~~m~klMkeCW~~Np~aRltALriKKtl~~l~~  505 (513)
T KOG2052|consen  441 PSDPSFEEMRKVVCVQKLRPNIPNRWKSDPALRVMAKLMKECWYANPAARLTALRIKKTLAKLSN  505 (513)
T ss_pred             CCCCCHHHHhcceeecccCCCCCcccccCHHHHHHHHHHHHhhcCCchhhhHHHHHHHHHHHHhc
Confidence            332222222222 122333333     35678899999999999999999999999888877653

>cd06624 STKc_ASK Catalytic domain of the Protein Serine/Threonine Kinase, Apoptosis signal-regulating kinase

Probab=100.00  E-value=3.2e-37  Score=316.51  Aligned_cols=260  Identities=24%  Similarity=0.333  Sum_probs=202.2

Q ss_pred             HHHHhccCCcccccccCCcceEEEEEec-CCcEEEEEEecccCCchHHHHHHHHHHHHhccCCCcceeEeeEEEcCCCCe
Q 005586          404 VESATQCFSEVNLLGKGNFSSVYKGTLR-DGTLVAIRSINVTSCKSEEAEFVKGLYLLTSLRHENIIRLRGFCCSRGRGE  482 (689)
Q Consensus       404 l~~at~~f~~~~~lg~G~~g~Vy~~~~~-~g~~vavK~l~~~~~~~~~~~f~~e~~~l~~l~H~niv~l~g~~~~~~~~~  482 (689)
                      ++.+++.+.....||+|+||.||+|... ++..||+|.+.... ....+.+.+|++++++++|+||+++++++..  .+.
T Consensus         3 ~~~~~~~~~~~~~lg~g~~g~v~~~~~~~~~~~v~~k~~~~~~-~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~--~~~   79 (268)
T cd06624           3 YEYEYDENGERVVLGKGTYGIVYAARDLSTQVRIAIKEIPERD-SRYVQPLHEEIALHSYLKHRNIVQYLGSDSE--NGF   79 (268)
T ss_pred             cccccccCCceEEEecCCceEEEEeEecCCCcEEEEEEecCCC-HHHHHHHHHHHHHHHhcCCCCeeeeeeeecc--CCE
Confidence            3456667777789999999999999865 67889999987654 3445689999999999999999999999854  478


Q ss_pred             EEEEEEcCCCCCHHHHhhhcCCCCCCCCHHHHHHHHHHHHHHHhhhhCCCCCCCceeecCCCCCceeecC-CCCeEEecc
Q 005586          483 CFLIYDFAPKGKLSKYLDQEEGSSNVLDWSTRVSIIIGIAKGIGYLHSSEVNKPAIVHRNLSVEKVLIDQ-QFNPLIADC  561 (689)
Q Consensus       483 ~~lV~e~~~~gsL~~~L~~~~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~~~ivH~dlk~~NiLl~~-~~~~kl~Df  561 (689)
                      .++|+||+++++|.++++..... ...++..+..++.|++.||+|||+.+     |+||||||+||+++. ++.+||+||
T Consensus        80 ~~lv~e~~~~~~L~~~l~~~~~~-~~~~~~~~~~~~~qi~~al~~lH~~~-----i~h~dl~p~nil~~~~~~~~~l~df  153 (268)
T cd06624          80 FKIFMEQVPGGSLSALLRSKWGP-LKDNEQTIIFYTKQILEGLKYLHDNQ-----IVHRDIKGDNVLVNTYSGVVKISDF  153 (268)
T ss_pred             EEEEEecCCCCCHHHHHHHhccc-CCCcHHHHHHHHHHHHHHHHHHHHCC-----EeecCCCHHHEEEcCCCCeEEEecc
Confidence            99999999999999999864321 11278888999999999999999887     999999999999986 679999999


Q ss_pred             cccccccCCceeeeecCCCCCCCCCccccccCC--CCCcccchhHHHHHHHHHhCCCCcchhHHHHHhhhhhhHhhcccc
Q 005586          562 GLHKLLADDIVFSVLKTSAAMGYLAPEYVTTGR--FTERSDIFAFGVIILQILTGSLVLTSSMRLAAESATFENFIDRNL  639 (689)
Q Consensus       562 Gla~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~--~~~ksDV~sfGvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~  639 (689)
                      |++........ ......++..|+|||++.+..  ++.++|||||||++|||++|+.|+.........  .. .......
T Consensus       154 g~~~~~~~~~~-~~~~~~~~~~~~aPE~~~~~~~~~~~~~Dv~slGvvl~~l~~g~~p~~~~~~~~~~--~~-~~~~~~~  229 (268)
T cd06624         154 GTSKRLAGINP-CTETFTGTLQYMAPEVIDKGPRGYGAPADIWSLGCTIVEMATGKPPFIELGEPQAA--MF-KVGMFKI  229 (268)
T ss_pred             hhheecccCCC-ccccCCCCccccChhhhccccccCCchhhhHHHHHHHHHHHhCCCCCccccChhhh--Hh-hhhhhcc
Confidence            99876543221 112234678899999986543  789999999999999999999998543211100  00 0000011


Q ss_pred             CCCCCHHHHHHHHHHHHHhccCCCCCCCCHHHHHHHH
Q 005586          640 KGKFSESEAAKLGKMALVCTHEDPENRPTMEAVIEEL  676 (689)
Q Consensus       640 ~~~~~~~~~~~l~~l~~~Cl~~dp~~RPs~~evl~~L  676 (689)
                      ...++.....++.+++.+||+.+|++||++.|++++-
T Consensus       230 ~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~ll~~~  266 (268)
T cd06624         230 HPEIPESLSAEAKNFILRCFEPDPDKRASAHDLLQDP  266 (268)
T ss_pred             CCCCCcccCHHHHHHHHHHcCCCchhCCCHHHHHhCC
Confidence            2234445567789999999999999999999999863

Serine/threonine kinases (STKs), Apoptosis signal-regulating kinase (ASK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ASK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Subfamily members are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) and include ASK1, ASK2, and MAPKKK15. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. ASK1 (also called MAPKKK5) functions in the c-Jun N-terminal kina

>cd06651 STKc_MEKK3 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 3

Probab=100.00  E-value=6.7e-37  Score=313.86  Aligned_cols=253  Identities=20%  Similarity=0.332  Sum_probs=199.0

Q ss_pred             cCCcccccccCCcceEEEEEec-CCcEEEEEEecccCC----chHHHHHHHHHHHHhccCCCcceeEeeEEEcCCCCeEE
Q 005586          410 CFSEVNLLGKGNFSSVYKGTLR-DGTLVAIRSINVTSC----KSEEAEFVKGLYLLTSLRHENIIRLRGFCCSRGRGECF  484 (689)
Q Consensus       410 ~f~~~~~lg~G~~g~Vy~~~~~-~g~~vavK~l~~~~~----~~~~~~f~~e~~~l~~l~H~niv~l~g~~~~~~~~~~~  484 (689)
                      +|...+.||+|+||.||+|... +|..||+|++.....    ......+.+|+.++++++||||+++++++........+
T Consensus         3 ~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~   82 (266)
T cd06651           3 NWRRGKLLGQGAFGRVYLCYDVDTGRELAAKQVQFDPESPETSKEVSALECEIQLLKNLQHERIVQYYGCLRDRAEKTLT   82 (266)
T ss_pred             CccccceecCCCCEEEEEEEEcCCCcEEEEEEeecCcCCchhHHHHHHHHHHHHHHHHcCCCCeeeEEEEEEcCCCCEEE
Confidence            5777899999999999999875 689999999864421    12345788999999999999999999988655456788


Q ss_pred             EEEEcCCCCCHHHHhhhcCCCCCCCCHHHHHHHHHHHHHHHhhhhCCCCCCCceeecCCCCCceeecCCCCeEEeccccc
Q 005586          485 LIYDFAPKGKLSKYLDQEEGSSNVLDWSTRVSIIIGIAKGIGYLHSSEVNKPAIVHRNLSVEKVLIDQQFNPLIADCGLH  564 (689)
Q Consensus       485 lV~e~~~~gsL~~~L~~~~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~~~ivH~dlk~~NiLl~~~~~~kl~DfGla  564 (689)
                      +++||+++++|.+++....    .+++..++.++.|++.||+|||+.+     |+||||||+||++++++.+||+|||++
T Consensus        83 l~~e~~~~~~L~~~l~~~~----~l~~~~~~~~~~qi~~~l~~LH~~~-----i~H~~l~p~nil~~~~~~~~l~dfg~~  153 (266)
T cd06651          83 IFMEYMPGGSVKDQLKAYG----ALTESVTRKYTRQILEGMSYLHSNM-----IVHRDIKGANILRDSAGNVKLGDFGAS  153 (266)
T ss_pred             EEEeCCCCCcHHHHHHHcC----CCCHHHHHHHHHHHHHHHHHHHhCC-----eeeCCCCHHHEEECCCCCEEEccCCCc
Confidence            9999999999999997543    3789999999999999999999877     999999999999999999999999999


Q ss_pred             ccccCCce--eeeecCCCCCCCCCccccccCCCCCcccchhHHHHHHHHHhCCCCcchhHHHHHhhhhhhHhhccccCCC
Q 005586          565 KLLADDIV--FSVLKTSAAMGYLAPEYVTTGRFTERSDIFAFGVIILQILTGSLVLTSSMRLAAESATFENFIDRNLKGK  642 (689)
Q Consensus       565 ~~~~~~~~--~~~~~~~~~~~y~aPE~~~~~~~~~ksDV~sfGvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~  642 (689)
                      +.+.....  .......++.+|+|||++.+..++.++|||||||++|||+||+.||.......    .............
T Consensus       154 ~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~i~~el~~g~~pf~~~~~~~----~~~~~~~~~~~~~  229 (266)
T cd06651         154 KRLQTICMSGTGIRSVTGTPYWMSPEVISGEGYGRKADVWSLGCTVVEMLTEKPPWAEYEAMA----AIFKIATQPTNPQ  229 (266)
T ss_pred             cccccccccCCccccCCccccccCHHHhCCCCCCchhhhHHHHHHHHHHHHCCCCccccchHH----HHHHHhcCCCCCC
Confidence            86543111  11122346778999999998889999999999999999999999996432211    1111111111223


Q ss_pred             CCHHHHHHHHHHHHHhccCCCCCCCCHHHHHHHH
Q 005586          643 FSESEAAKLGKMALVCTHEDPENRPTMEAVIEEL  676 (689)
Q Consensus       643 ~~~~~~~~l~~l~~~Cl~~dp~~RPs~~evl~~L  676 (689)
                      ++......+..++ .||..+|++||+|+||+++-
T Consensus       230 ~~~~~~~~~~~li-~~~~~~p~~Rp~~~eil~hp  262 (266)
T cd06651         230 LPSHISEHARDFL-GCIFVEARHRPSAEELLRHP  262 (266)
T ss_pred             CchhcCHHHHHHH-HHhcCChhhCcCHHHHhcCc
Confidence            3444445566665 68889999999999998763

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK3 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development

>cd05629 STKc_NDR_like_fungal Catalytic domain of Fungal Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=1.1e-37  Score=336.34  Aligned_cols=254  Identities=18%  Similarity=0.236  Sum_probs=197.4

Q ss_pred             ccCCcccccccCCcceEEEEEec-CCcEEEEEEecccCC--chHHHHHHHHHHHHhccCCCcceeEeeEEEcCCCCeEEE
Q 005586          409 QCFSEVNLLGKGNFSSVYKGTLR-DGTLVAIRSINVTSC--KSEEAEFVKGLYLLTSLRHENIIRLRGFCCSRGRGECFL  485 (689)
Q Consensus       409 ~~f~~~~~lg~G~~g~Vy~~~~~-~g~~vavK~l~~~~~--~~~~~~f~~e~~~l~~l~H~niv~l~g~~~~~~~~~~~l  485 (689)
                      ++|...+.||+|+||.||++... +|+.||||++.....  ......+.+|++++.+++|||||++++++.  +....++
T Consensus         1 ~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~il~~l~hp~iv~~~~~~~--~~~~~~l   78 (377)
T cd05629           1 EDFHTVKVIGKGAFGEVRLVQKKDTGKIYAMKTLLKSEMFKKDQLAHVKAERDVLAESDSPWVVSLYYSFQ--DAQYLYL   78 (377)
T ss_pred             CCceEeEEEeecCCEEEEEEEECCCCCEEEEEEEEHHHHHHhHHHHHHHHHHHHHHhCCCCCcceEEEEEE--cCCeeEE
Confidence            36788899999999999999875 789999999865421  233467889999999999999999999984  4578999


Q ss_pred             EEEcCCCCCHHHHhhhcCCCCCCCCHHHHHHHHHHHHHHHhhhhCCCCCCCceeecCCCCCceeecCCCCeEEecccccc
Q 005586          486 IYDFAPKGKLSKYLDQEEGSSNVLDWSTRVSIIIGIAKGIGYLHSSEVNKPAIVHRNLSVEKVLIDQQFNPLIADCGLHK  565 (689)
Q Consensus       486 V~e~~~~gsL~~~L~~~~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~~~ivH~dlk~~NiLl~~~~~~kl~DfGla~  565 (689)
                      ||||+++|+|.+++....    .+++.....++.|++.||+|||+.+     |+||||||+|||++.++.+||+|||+++
T Consensus        79 v~E~~~gg~L~~~l~~~~----~~~~~~~~~~~~ql~~aL~~LH~~g-----ivHrDlkp~NIll~~~~~~kl~DfGla~  149 (377)
T cd05629          79 IMEFLPGGDLMTMLIKYD----TFSEDVTRFYMAECVLAIEAVHKLG-----FIHRDIKPDNILIDRGGHIKLSDFGLST  149 (377)
T ss_pred             EEeCCCCCcHHHHHHhcC----CCCHHHHHHHHHHHHHHHHHHHhCC-----eeccCCCHHHEEECCCCCEEEeeccccc
Confidence            999999999999997543    4888899999999999999999988     9999999999999999999999999996


Q ss_pred             cccCCcee----------------------------------------------eeecCCCCCCCCCccccccCCCCCcc
Q 005586          566 LLADDIVF----------------------------------------------SVLKTSAAMGYLAPEYVTTGRFTERS  599 (689)
Q Consensus       566 ~~~~~~~~----------------------------------------------~~~~~~~~~~y~aPE~~~~~~~~~ks  599 (689)
                      .+......                                              ......||.+|+|||++.+..++.++
T Consensus       150 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~  229 (377)
T cd05629         150 GFHKQHDSAYYQKLLQGKSNKNRIDNRNSVAVDSINLTMSSKDQIATWKKNRRLMAYSTVGTPDYIAPEIFLQQGYGQEC  229 (377)
T ss_pred             ccccccccccccccccccccccccccccccccccccccccchhhhhhhhhcccccccccCCCccccCHHHHccCCCCCce
Confidence            43210000                                              00013478899999999988999999


Q ss_pred             cchhHHHHHHHHHhCCCCcchhHHHHHhhhhhhHhhccccCCCCC--HHHHHHHHHHHHHhccCCCCCC---CCHHHHHH
Q 005586          600 DIFAFGVIILQILTGSLVLTSSMRLAAESATFENFIDRNLKGKFS--ESEAAKLGKMALVCTHEDPENR---PTMEAVIE  674 (689)
Q Consensus       600 DV~sfGvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~l~~l~~~Cl~~dp~~R---Ps~~evl~  674 (689)
                      |||||||++|||+||+.||........    +..+........++  .....++.+++..|+. +|.+|   +++.|+++
T Consensus       230 DiwSlGvil~elltG~~Pf~~~~~~~~----~~~i~~~~~~~~~p~~~~~s~~~~dli~~lL~-~~~~r~~r~~~~~~l~  304 (377)
T cd05629         230 DWWSLGAIMFECLIGWPPFCSENSHET----YRKIINWRETLYFPDDIHLSVEAEDLIRRLIT-NAENRLGRGGAHEIKS  304 (377)
T ss_pred             eeEecchhhhhhhcCCCCCCCCCHHHH----HHHHHccCCccCCCCCCCCCHHHHHHHHHHhc-CHhhcCCCCCHHHHhc
Confidence            999999999999999999964322111    11111100001111  1234578889999997 66665   69999998


Q ss_pred             HHHh
Q 005586          675 ELTV  678 (689)
Q Consensus       675 ~L~~  678 (689)
                      +.+.
T Consensus       305 hp~~  308 (377)
T cd05629         305 HPFF  308 (377)
T ss_pred             CCCc
Confidence            8643

Serine/Threonine Kinases (STKs), NDR kinase subfamily, fungal NDR-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group is composed of fungal NDR-like proteins including Saccharomyces cerevisiae CBK1 (or CBK1p), Schizosaccharomyces pombe Orb6 (or Orb6p), Ustilago maydis Ukc1 (or Ukc1p), and Neurospora crassa Cot1. Like NDR kinase, group members contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. CBK1 is an essential component in the RAM (regulation of

>KOG2345 consensus Serine/threonine protein kinase/TGF-beta stimulated factor [Transcription; Lipid transport and metabolism; Signal transduction mechanisms]

Probab=100.00  E-value=3.8e-38  Score=295.49  Aligned_cols=265  Identities=22%  Similarity=0.345  Sum_probs=210.1

Q ss_pred             hccCCcccccccCCcceEEEEE-ecCCcEEEEEEecccCCchHHHHHHHHHHHHhccCCCcceeEeeEEEcC---CCCeE
Q 005586          408 TQCFSEVNLLGKGNFSSVYKGT-LRDGTLVAIRSINVTSCKSEEAEFVKGLYLLTSLRHENIIRLRGFCCSR---GRGEC  483 (689)
Q Consensus       408 t~~f~~~~~lg~G~~g~Vy~~~-~~~g~~vavK~l~~~~~~~~~~~f~~e~~~l~~l~H~niv~l~g~~~~~---~~~~~  483 (689)
                      .++|.+.+.+|+|||.-||.++ +.++..+|+|++.-.. ..+.+..++|++.-++++|||++++++++..+   ...+.
T Consensus        20 ~~Ryri~~~LgeGGfsfv~LV~~~s~~~~YAlKkI~c~~-~~~~e~~~rEid~~rkf~s~~vl~l~dh~l~~~~D~~~~~   98 (302)
T KOG2345|consen   20 NKRYRIQRLLGEGGFSFVDLVKGLSTGHLYALKKILCHS-QEDIEEALREIDNHRKFNSPNVLRLVDHQLREEKDGKHEA   98 (302)
T ss_pred             CceEEEeeeecCCCceeeeeecccCcccchhhheeeccc-hHHHHHHHHHHHHHHhhCCcchHHHHHHHHHhhccCceeE
Confidence            4678889999999999999998 5689999999998765 45667889999999999999999999887533   23568


Q ss_pred             EEEEEcCCCCCHHHHhhhcCCCCCCCCHHHHHHHHHHHHHHHhhhhCCCCCCCceeecCCCCCceeecCCCCeEEecccc
Q 005586          484 FLIYDFAPKGKLSKYLDQEEGSSNVLDWSTRVSIIIGIAKGIGYLHSSEVNKPAIVHRNLSVEKVLIDQQFNPLIADCGL  563 (689)
Q Consensus       484 ~lV~e~~~~gsL~~~L~~~~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~~~ivH~dlk~~NiLl~~~~~~kl~DfGl  563 (689)
                      |+++.|...|+|.+.+.........+++.+.+.|..||.+||.+||+..   ||++||||||.|||+.+++.+++.|||.
T Consensus        99 yll~Pyy~~Gsl~d~i~~~k~kg~~~sE~~iL~if~gic~gL~~lH~~~---~~yAH~DiKP~NILls~~~~~vl~D~GS  175 (302)
T KOG2345|consen   99 YLLLPYYKRGSLLDEIERLKIKGNFVSEAQILWIFLGICRGLEALHEKE---PPYAHRDIKPANILLSDSGLPVLMDLGS  175 (302)
T ss_pred             EEEeehhccccHHHHHHHHhhcCCccCHHHHHHHHHHHHHHHHHHhccC---CcccccCCCcceeEecCCCceEEEeccC
Confidence            9999999999999999876655667999999999999999999999875   7899999999999999999999999999


Q ss_pred             cccccCCcee--------eeecCCCCCCCCCccccc---cCCCCCcccchhHHHHHHHHHhCCCCcchhHHHHHhhhhhh
Q 005586          564 HKLLADDIVF--------SVLKTSAAMGYLAPEYVT---TGRFTERSDIFAFGVIILQILTGSLVLTSSMRLAAESATFE  632 (689)
Q Consensus       564 a~~~~~~~~~--------~~~~~~~~~~y~aPE~~~---~~~~~~ksDV~sfGvvl~elltG~~p~~~~~~~~~~~~~~~  632 (689)
                      +....-....        .......|+-|+|||.+.   +...++++|||||||+||+|+.|..||+.....   ...+.
T Consensus       176 ~~~a~i~i~~~~~a~~lQe~a~e~Ct~pyRAPELf~vk~~~ti~ertDIWSLGCtLYa~mf~~sPfe~~~~~---GgSla  252 (302)
T KOG2345|consen  176 ATQAPIQIEGSRQALRLQEWAEERCTIPYRAPELFNVKSHCTITERTDIWSLGCTLYAMMFGESPFERIYQQ---GGSLA  252 (302)
T ss_pred             ccccceEeechHHHHHHHHHHHHhCCCcccCchheecccCcccccccchhhhhHHHHHHHHcCCcchHHhhc---CCeEE
Confidence            8765421110        111234577899999875   345689999999999999999999999643221   11110


Q ss_pred             -HhhccccCCCCCHHHHHHHHHHHHHhccCCCCCCCCHHHHHHHHHhh
Q 005586          633 -NFIDRNLKGKFSESEAAKLGKMALVCTHEDPENRPTMEAVIEELTVA  679 (689)
Q Consensus       633 -~~~~~~~~~~~~~~~~~~l~~l~~~Cl~~dp~~RPs~~evl~~L~~~  679 (689)
                       .+....+.-......++.+.+++.+|++.||.+||+..+++..++..
T Consensus       253 LAv~n~q~s~P~~~~yse~l~~lik~mlqvdP~qRP~i~~ll~~~d~L  300 (302)
T KOG2345|consen  253 LAVQNAQISIPNSSRYSEALHQLIKSMLQVDPNQRPTIPELLSKLDDL  300 (302)
T ss_pred             EeeeccccccCCCCCccHHHHHHHHHHhcCCcccCCCHHHHHHHHHhh
Confidence             01111111111122577899999999999999999999999988754

>cd05046 PTK_CCK4 Pseudokinase domain of the Protein Tyrosine Kinase, Colon Carcinoma Kinase 4

Probab=100.00  E-value=3.7e-37  Score=317.29  Aligned_cols=258  Identities=24%  Similarity=0.457  Sum_probs=203.9

Q ss_pred             ccCCcccccccCCcceEEEEEec------CCcEEEEEEecccCCchHHHHHHHHHHHHhccCCCcceeEeeEEEcCCCCe
Q 005586          409 QCFSEVNLLGKGNFSSVYKGTLR------DGTLVAIRSINVTSCKSEEAEFVKGLYLLTSLRHENIIRLRGFCCSRGRGE  482 (689)
Q Consensus       409 ~~f~~~~~lg~G~~g~Vy~~~~~------~g~~vavK~l~~~~~~~~~~~f~~e~~~l~~l~H~niv~l~g~~~~~~~~~  482 (689)
                      ++|+..+.||+|+||.||+|+.+      +...|++|.+..........+|.+|++++++++|+||+++++++.+  ...
T Consensus         5 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~--~~~   82 (275)
T cd05046           5 SNLQEITTLGRGEFGEVFLAKAKGIEEEGGETLVLVKALQKTKDENLQSEFRRELDMFRKLSHKNVVRLLGLCRE--AEP   82 (275)
T ss_pred             HhceeeeeecccceeEEEEEEeccCCcCCCcceEEEEccCCccchHHHHHHHHHHHHHHhcCCcceeeeEEEECC--CCc
Confidence            46778899999999999999864      3467999988765433345789999999999999999999999843  467


Q ss_pred             EEEEEEcCCCCCHHHHhhhcCCC-----CCCCCHHHHHHHHHHHHHHHhhhhCCCCCCCceeecCCCCCceeecCCCCeE
Q 005586          483 CFLIYDFAPKGKLSKYLDQEEGS-----SNVLDWSTRVSIIIGIAKGIGYLHSSEVNKPAIVHRNLSVEKVLIDQQFNPL  557 (689)
Q Consensus       483 ~~lV~e~~~~gsL~~~L~~~~~~-----~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~~~ivH~dlk~~NiLl~~~~~~k  557 (689)
                      .++||||+++|+|.+++......     ...+++..+..++.|++.||+|||+.+     |+||||||+||++++++.+|
T Consensus        83 ~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~l~~~~~~~~~~~l~~~l~~LH~~~-----i~H~dlkp~Nili~~~~~~~  157 (275)
T cd05046          83 HYMILEYTDLGDLKQFLRATKSKDEKLKPPPLSTKQKVALCTQIALGMDHLSNAR-----FVHRDLAARNCLVSSQREVK  157 (275)
T ss_pred             ceEEEEecCCCcHHHHHHhcccccccccccCCCHHHHHHHHHHHHHHHHHhhhcC-----cccCcCccceEEEeCCCcEE
Confidence            89999999999999999765421     125899999999999999999999987     99999999999999999999


Q ss_pred             EecccccccccCCceeeeecCCCCCCCCCccccccCCCCCcccchhHHHHHHHHHh-CCCCcchhHHHHHhhhhhhHhhc
Q 005586          558 IADCGLHKLLADDIVFSVLKTSAAMGYLAPEYVTTGRFTERSDIFAFGVIILQILT-GSLVLTSSMRLAAESATFENFID  636 (689)
Q Consensus       558 l~DfGla~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~ksDV~sfGvvl~ellt-G~~p~~~~~~~~~~~~~~~~~~~  636 (689)
                      ++|||+++..............++..|+|||.+.+..++.++||||||+++|||++ |..||.......    .......
T Consensus       158 l~~~~~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~~l~~~~~~p~~~~~~~~----~~~~~~~  233 (275)
T cd05046         158 VSLLSLSKDVYNSEYYKLRNALIPLRWLAPEAVQEDDFSTKSDVWSFGVLMWEVFTQGELPFYGLSDEE----VLNRLQA  233 (275)
T ss_pred             EcccccccccCcccccccCCceeEEeecChhhhccCCCCchhhHHHHHHHHHHHHhCCCCCccccchHH----HHHHHHc
Confidence            99999987554332222223345667999999988888999999999999999999 777885432111    1111111


Q ss_pred             cccCCCCCHHHHHHHHHHHHHhccCCCCCCCCHHHHHHHHH
Q 005586          637 RNLKGKFSESEAAKLGKMALVCTHEDPENRPTMEAVIEELT  677 (689)
Q Consensus       637 ~~~~~~~~~~~~~~l~~l~~~Cl~~dp~~RPs~~evl~~L~  677 (689)
                      .......+...+..+.+++.+|++.+|++||++.|++++|+
T Consensus       234 ~~~~~~~~~~~~~~l~~~i~~~l~~~p~~Rp~~~~~l~~l~  274 (275)
T cd05046         234 GKLELPVPEGCPSRLYKLMTRCWAVNPKDRPSFSELVSALG  274 (275)
T ss_pred             CCcCCCCCCCCCHHHHHHHHHHcCCCcccCCCHHHHHHHhc
Confidence            11112223344568999999999999999999999999885

Protein Tyrosine Kinase (PTK) family; Colon Carcinoma Kinase 4 (CCK4); pseudokinase domain. The PTKc (catalytic domain) family, to which this subfamily belongs, includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CCK4, also called protein tyrosine kinase 7 (PTK7), is an orphan receptor tyr kinase (RTK) containing an extracellular region with seven immunoglobulin domains, a transmembrane segment, and an intracellular inactive pseudokinase domain. Studies in mice reveal that CCK4 is essential for neural development. Mouse embryos containing a truncated CCK4 die perinatally and display craniorachischisis, a severe form of neural tube defect. The mechanism of action of the CCK4 pseudokinase is s

>cd05620 STKc_nPKC_delta Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C delta

Probab=100.00  E-value=1.6e-37  Score=326.54  Aligned_cols=244  Identities=19%  Similarity=0.272  Sum_probs=192.4

Q ss_pred             cccccCCcceEEEEEec-CCcEEEEEEecccCC--chHHHHHHHHHHHHhcc-CCCcceeEeeEEEcCCCCeEEEEEEcC
Q 005586          415 NLLGKGNFSSVYKGTLR-DGTLVAIRSINVTSC--KSEEAEFVKGLYLLTSL-RHENIIRLRGFCCSRGRGECFLIYDFA  490 (689)
Q Consensus       415 ~~lg~G~~g~Vy~~~~~-~g~~vavK~l~~~~~--~~~~~~f~~e~~~l~~l-~H~niv~l~g~~~~~~~~~~~lV~e~~  490 (689)
                      +.||+|+||.||+|+.+ +|..||+|.++....  ......+..|..++... +||||+++++++..  .+..++||||+
T Consensus         1 ~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~~--~~~~~lv~E~~   78 (316)
T cd05620           1 KVLGKGSFGKVLLAELKGKGEYFAVKALKKDVVLIDDDVECTMVEKRVLALAWENPFLTHLYCTFQT--KEHLFFVMEFL   78 (316)
T ss_pred             CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhcchHHHHHHHHHHHHhccCCCCccCeeEEEEe--CCEEEEEECCC
Confidence            46999999999999986 689999999975421  23345667788887754 89999999998844  57899999999


Q ss_pred             CCCCHHHHhhhcCCCCCCCCHHHHHHHHHHHHHHHhhhhCCCCCCCceeecCCCCCceeecCCCCeEEecccccccccCC
Q 005586          491 PKGKLSKYLDQEEGSSNVLDWSTRVSIIIGIAKGIGYLHSSEVNKPAIVHRNLSVEKVLIDQQFNPLIADCGLHKLLADD  570 (689)
Q Consensus       491 ~~gsL~~~L~~~~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~~~ivH~dlk~~NiLl~~~~~~kl~DfGla~~~~~~  570 (689)
                      ++|+|..++....    .+++.....++.|+++||+|||+.+     |+||||||+|||+++++.+||+|||+++.....
T Consensus        79 ~~g~L~~~i~~~~----~~~~~~~~~~~~qi~~~l~~lH~~~-----ivHrDlkp~Nil~~~~~~~kl~Dfg~~~~~~~~  149 (316)
T cd05620          79 NGGDLMFHIQDKG----RFDLYRATFYAAEIVCGLQFLHSKG-----IIYRDLKLDNVMLDRDGHIKIADFGMCKENVFG  149 (316)
T ss_pred             CCCcHHHHHHHcC----CCCHHHHHHHHHHHHHHHHHHHHCC-----eEecCCCHHHeEECCCCCEEeCccCCCeecccC
Confidence            9999999987643    3889999999999999999999987     999999999999999999999999998753221


Q ss_pred             ceeeeecCCCCCCCCCccccccCCCCCcccchhHHHHHHHHHhCCCCcchhHHHHHhhhhhhHhhccccCCCCCHHHHHH
Q 005586          571 IVFSVLKTSAAMGYLAPEYVTTGRFTERSDIFAFGVIILQILTGSLVLTSSMRLAAESATFENFIDRNLKGKFSESEAAK  650 (689)
Q Consensus       571 ~~~~~~~~~~~~~y~aPE~~~~~~~~~ksDV~sfGvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  650 (689)
                      .. ......++..|+|||++.+..++.++|||||||++|||++|+.||........    ...+...  ...++.....+
T Consensus       150 ~~-~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~el~~g~~Pf~~~~~~~~----~~~~~~~--~~~~~~~~~~~  222 (316)
T cd05620         150 DN-RASTFCGTPDYIAPEILQGLKYTFSVDWWSFGVLLYEMLIGQSPFHGDDEDEL----FESIRVD--TPHYPRWITKE  222 (316)
T ss_pred             CC-ceeccCCCcCccCHHHHcCCCCCcccchhhhHHHHHHHHhCCCCCCCCCHHHH----HHHHHhC--CCCCCCCCCHH
Confidence            11 12234578899999999999999999999999999999999999965422111    1111111  11233334567


Q ss_pred             HHHHHHHhccCCCCCCCCHH-HHHHHH
Q 005586          651 LGKMALVCTHEDPENRPTME-AVIEEL  676 (689)
Q Consensus       651 l~~l~~~Cl~~dp~~RPs~~-evl~~L  676 (689)
                      +.+++..|++.||++||++. ++.++.
T Consensus       223 ~~~li~~~l~~dP~~R~~~~~~~~~h~  249 (316)
T cd05620         223 SKDILEKLFERDPTRRLGVVGNIRGHP  249 (316)
T ss_pred             HHHHHHHHccCCHHHcCCChHHHHcCC
Confidence            88999999999999999984 666443

Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), delta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-delta plays a role in cell cycle regulation and programmed cell death in many cell types. I

>cd05570 STKc_PKC Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase C

Probab=100.00  E-value=1.6e-37  Score=327.09  Aligned_cols=244  Identities=19%  Similarity=0.305  Sum_probs=195.5

Q ss_pred             cccccCCcceEEEEEec-CCcEEEEEEecccCC--chHHHHHHHHHHHHhcc-CCCcceeEeeEEEcCCCCeEEEEEEcC
Q 005586          415 NLLGKGNFSSVYKGTLR-DGTLVAIRSINVTSC--KSEEAEFVKGLYLLTSL-RHENIIRLRGFCCSRGRGECFLIYDFA  490 (689)
Q Consensus       415 ~~lg~G~~g~Vy~~~~~-~g~~vavK~l~~~~~--~~~~~~f~~e~~~l~~l-~H~niv~l~g~~~~~~~~~~~lV~e~~  490 (689)
                      +.||+|+||.||+|..+ +++.||+|++.....  ......+..|++++..+ +||||+++++++..  .+..++||||+
T Consensus         1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~il~~~~~h~~i~~~~~~~~~--~~~~~lv~e~~   78 (318)
T cd05570           1 KVLGKGSFGKVLLAELKGTDELYAVKVLKKDVILQDDDVECTMTEKRVLALAGKHPFLTQLHSCFQT--KDRLFFVMEYV   78 (318)
T ss_pred             CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhHHHHHHHHHHHHHhccCCCCccceeeEEEc--CCEEEEEEcCC
Confidence            36999999999999986 588999999975431  23345677888898888 79999999998844  57899999999


Q ss_pred             CCCCHHHHhhhcCCCCCCCCHHHHHHHHHHHHHHHhhhhCCCCCCCceeecCCCCCceeecCCCCeEEecccccccccCC
Q 005586          491 PKGKLSKYLDQEEGSSNVLDWSTRVSIIIGIAKGIGYLHSSEVNKPAIVHRNLSVEKVLIDQQFNPLIADCGLHKLLADD  570 (689)
Q Consensus       491 ~~gsL~~~L~~~~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~~~ivH~dlk~~NiLl~~~~~~kl~DfGla~~~~~~  570 (689)
                      ++|+|..++....    .+++..+..++.|++.||+|||+.+     |+||||||+||++++++.+||+|||+++.....
T Consensus        79 ~~~~L~~~~~~~~----~l~~~~~~~~~~qi~~~l~~LH~~~-----ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~  149 (318)
T cd05570          79 NGGDLMFHIQRSG----RFDEPRARFYAAEIVLGLQFLHERG-----IIYRDLKLDNVLLDSEGHIKIADFGMCKEGILG  149 (318)
T ss_pred             CCCCHHHHHHHcC----CCCHHHHHHHHHHHHHHHHHHHhCC-----eEccCCCHHHeEECCCCcEEecccCCCeecCcC
Confidence            9999999987643    4899999999999999999999987     999999999999999999999999998753221


Q ss_pred             ceeeeecCCCCCCCCCccccccCCCCCcccchhHHHHHHHHHhCCCCcchhHHHHHhhhhhhHhhccccCCCCCHHHHHH
Q 005586          571 IVFSVLKTSAAMGYLAPEYVTTGRFTERSDIFAFGVIILQILTGSLVLTSSMRLAAESATFENFIDRNLKGKFSESEAAK  650 (689)
Q Consensus       571 ~~~~~~~~~~~~~y~aPE~~~~~~~~~ksDV~sfGvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  650 (689)
                      .. ......++..|+|||++.+..++.++|||||||++|||+||+.||........    ...+....  ..++...+..
T Consensus       150 ~~-~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslGvil~~l~~G~~pf~~~~~~~~----~~~i~~~~--~~~~~~~~~~  222 (318)
T cd05570         150 GV-TTSTFCGTPDYIAPEILSYQPYGPAVDWWALGVLLYEMLAGQSPFEGDDEDEL----FQSILEDE--VRYPRWLSKE  222 (318)
T ss_pred             CC-cccceecCccccCHHHhcCCCCCcchhhhhHHHHHHHHhhCCCCCCCCCHHHH----HHHHHcCC--CCCCCcCCHH
Confidence            11 11223477889999999999999999999999999999999999964322111    11111111  1233445667


Q ss_pred             HHHHHHHhccCCCCCCCCH-----HHHHHHH
Q 005586          651 LGKMALVCTHEDPENRPTM-----EAVIEEL  676 (689)
Q Consensus       651 l~~l~~~Cl~~dp~~RPs~-----~evl~~L  676 (689)
                      +.+++.+||+.||++||++     .+++++-
T Consensus       223 ~~~li~~~l~~dP~~R~s~~~~~~~~ll~~~  253 (318)
T cd05570         223 AKSILKSFLTKNPEKRLGCLPTGEQDIKGHP  253 (318)
T ss_pred             HHHHHHHHccCCHHHcCCCCCCCHHHHhcCC
Confidence            8999999999999999999     8888763

Serine/Threonine Kinases (STKs), Protein Kinase C (PKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, classical PKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. Novel PKCs are calcium-independent, but require DAG and PS for activity, while atypical PKCs only re

>KOG0694 consensus Serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=8.2e-38  Score=331.88  Aligned_cols=242  Identities=19%  Similarity=0.328  Sum_probs=200.0

Q ss_pred             hccCCcccccccCCcceEEEEEec-CCcEEEEEEecccCC--chHHHHHHHHHHHHhcc-CCCcceeEeeEEEcCCCCeE
Q 005586          408 TQCFSEVNLLGKGNFSSVYKGTLR-DGTLVAIRSINVTSC--KSEEAEFVKGLYLLTSL-RHENIIRLRGFCCSRGRGEC  483 (689)
Q Consensus       408 t~~f~~~~~lg~G~~g~Vy~~~~~-~g~~vavK~l~~~~~--~~~~~~f~~e~~~l~~l-~H~niv~l~g~~~~~~~~~~  483 (689)
                      -++|...++||+|.||+|+++.++ +++.+|||.+++...  ..+....+.|.+++.-. +||.++.++..+  ...+++
T Consensus       367 l~~F~~l~vLGkGsFGkV~lae~k~~~e~yAIK~LKK~~Il~~d~Ve~~~~EkrI~~la~~HPFL~~L~~~f--QT~~~l  444 (694)
T KOG0694|consen  367 LDDFRLLAVLGRGSFGKVLLAELKGTNEYYAIKVLKKGDILQRDEVESLMCEKRIFELANRHPFLVNLFSCF--QTKEHL  444 (694)
T ss_pred             ccceEEEEEeccCcCceEEEEEEcCCCcEEEEEEeeccceeccccHHHHHHHHHHHHHhccCCeEeeccccc--ccCCeE
Confidence            357888999999999999999987 688999999998763  34456677787777766 599999999877  556899


Q ss_pred             EEEEEcCCCCCHHHHhhhcCCCCCCCCHHHHHHHHHHHHHHHhhhhCCCCCCCceeecCCCCCceeecCCCCeEEecccc
Q 005586          484 FLIYDFAPKGKLSKYLDQEEGSSNVLDWSTRVSIIIGIAKGIGYLHSSEVNKPAIVHRNLSVEKVLIDQQFNPLIADCGL  563 (689)
Q Consensus       484 ~lV~e~~~~gsL~~~L~~~~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~~~ivH~dlk~~NiLl~~~~~~kl~DfGl  563 (689)
                      +.||||+.+|++..+.+.     ..+++.....+|..|+.||.|||+++     ||+||||-+|||||.+|.+||+|||+
T Consensus       445 ~fvmey~~Ggdm~~~~~~-----~~F~e~rarfyaAev~l~L~fLH~~~-----IIYRDlKLdNiLLD~eGh~kiADFGl  514 (694)
T KOG0694|consen  445 FFVMEYVAGGDLMHHIHT-----DVFSEPRARFYAAEVVLGLQFLHENG-----IIYRDLKLDNLLLDTEGHVKIADFGL  514 (694)
T ss_pred             EEEEEecCCCcEEEEEec-----ccccHHHHHHHHHHHHHHHHHHHhcC-----ceeeecchhheEEcccCcEEeccccc
Confidence            999999999995544432     24899999999999999999999998     99999999999999999999999999


Q ss_pred             ccccc-CCceeeeecCCCCCCCCCccccccCCCCCcccchhHHHHHHHHHhCCCCcchhHHHHHhhhhhhHhhccccCCC
Q 005586          564 HKLLA-DDIVFSVLKTSAAMGYLAPEYVTTGRFTERSDIFAFGVIILQILTGSLVLTSSMRLAAESATFENFIDRNLKGK  642 (689)
Q Consensus       564 a~~~~-~~~~~~~~~~~~~~~y~aPE~~~~~~~~~ksDV~sfGvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~  642 (689)
                      ++..- .+.  .+...-||+.|||||++.+..|+..+|+|||||+||||+.|..||.+....    ..+..++...  ..
T Consensus       515 cKe~m~~g~--~TsTfCGTpey~aPEil~e~~Yt~aVDWW~lGVLlyeML~Gq~PF~gddEe----e~FdsI~~d~--~~  586 (694)
T KOG0694|consen  515 CKEGMGQGD--RTSTFCGTPEFLAPEVLTEQSYTRAVDWWGLGVLLYEMLVGESPFPGDDEE----EVFDSIVNDE--VR  586 (694)
T ss_pred             ccccCCCCC--ccccccCChhhcChhhhccCcccchhhHHHHHHHHHHHHcCCCCCCCCCHH----HHHHHHhcCC--CC
Confidence            98543 222  233456899999999999999999999999999999999999999754322    2233333222  24


Q ss_pred             CCHHHHHHHHHHHHHhccCCCCCCCCH
Q 005586          643 FSESEAAKLGKMALVCTHEDPENRPTM  669 (689)
Q Consensus       643 ~~~~~~~~l~~l~~~Cl~~dp~~RPs~  669 (689)
                      ||...+.+...|+.+.+.++|++|.-+
T Consensus       587 yP~~ls~ea~~il~~ll~k~p~kRLG~  613 (694)
T KOG0694|consen  587 YPRFLSKEAIAIMRRLLRKNPEKRLGS  613 (694)
T ss_pred             CCCcccHHHHHHHHHHhccCcccccCC
Confidence            677778899999999999999999876

>cd05582 STKc_RSK_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, 90 kDa ribosomal protein S6 kinase

Probab=100.00  E-value=5.1e-38  Score=330.93  Aligned_cols=243  Identities=23%  Similarity=0.355  Sum_probs=195.3

Q ss_pred             cccccCCcceEEEEEe----cCCcEEEEEEecccCCc-hHHHHHHHHHHHHhccCCCcceeEeeEEEcCCCCeEEEEEEc
Q 005586          415 NLLGKGNFSSVYKGTL----RDGTLVAIRSINVTSCK-SEEAEFVKGLYLLTSLRHENIIRLRGFCCSRGRGECFLIYDF  489 (689)
Q Consensus       415 ~~lg~G~~g~Vy~~~~----~~g~~vavK~l~~~~~~-~~~~~f~~e~~~l~~l~H~niv~l~g~~~~~~~~~~~lV~e~  489 (689)
                      +.||+|+||.||+++.    .+|+.||+|++...... .....+..|++++++++||||+++++++..  .+..++||||
T Consensus         2 ~~lg~G~~g~Vy~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~--~~~~~lv~e~   79 (318)
T cd05582           2 KVLGQGSFGKVFLVRKITGPDAGQLYAMKVLKKATLKVRDRVRTKMERDILAEVNHPFIVKLHYAFQT--EGKLYLILDF   79 (318)
T ss_pred             ceeeeCCCEEEEEEEEeccCCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHhCCCCCcccEEEEEEc--CCEEEEEEcC
Confidence            5799999999999975    36899999999764322 234567889999999999999999998844  5789999999


Q ss_pred             CCCCCHHHHhhhcCCCCCCCCHHHHHHHHHHHHHHHhhhhCCCCCCCceeecCCCCCceeecCCCCeEEecccccccccC
Q 005586          490 APKGKLSKYLDQEEGSSNVLDWSTRVSIIIGIAKGIGYLHSSEVNKPAIVHRNLSVEKVLIDQQFNPLIADCGLHKLLAD  569 (689)
Q Consensus       490 ~~~gsL~~~L~~~~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~~~ivH~dlk~~NiLl~~~~~~kl~DfGla~~~~~  569 (689)
                      +++|+|.+++....    .+++..+..++.|+++||+|||+.+     |+||||||+||++++++.+||+|||+++....
T Consensus        80 ~~~~~L~~~l~~~~----~l~~~~~~~~~~qi~~~l~~lH~~~-----i~H~dlkp~Nil~~~~~~~kL~Dfg~~~~~~~  150 (318)
T cd05582          80 LRGGDLFTRLSKEV----MFTEEDVKFYLAELALALDHLHSLG-----IIYRDLKPENILLDEEGHIKLTDFGLSKESID  150 (318)
T ss_pred             CCCCcHHHHHHHcC----CCCHHHHHHHHHHHHHHHHHHHHCC-----EecCCCCHHHeEECCCCcEEEeeccCCcccCC
Confidence            99999999997543    4899999999999999999999987     99999999999999999999999999986543


Q ss_pred             CceeeeecCCCCCCCCCccccccCCCCCcccchhHHHHHHHHHhCCCCcchhHHHHHhhhhhhHhhccccCCCCCHHHHH
Q 005586          570 DIVFSVLKTSAAMGYLAPEYVTTGRFTERSDIFAFGVIILQILTGSLVLTSSMRLAAESATFENFIDRNLKGKFSESEAA  649 (689)
Q Consensus       570 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~ksDV~sfGvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  649 (689)
                      ... ......++..|+|||.+.+..++.++|||||||++|||+||+.||........    ...+....  ..++.....
T Consensus       151 ~~~-~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~il~el~tg~~p~~~~~~~~~----~~~i~~~~--~~~p~~~~~  223 (318)
T cd05582         151 HEK-KAYSFCGTVEYMAPEVVNRRGHTQSADWWSFGVLMFEMLTGSLPFQGKDRKET----MTMILKAK--LGMPQFLSP  223 (318)
T ss_pred             CCC-ceecccCChhhcCHHHHcCCCCCCccceeccceEeeeeccCCCCCCCCCHHHH----HHHHHcCC--CCCCCCCCH
Confidence            311 12234578899999999888899999999999999999999999965322111    11121111  123444566


Q ss_pred             HHHHHHHHhccCCCCCCCC-----HHHHHHH
Q 005586          650 KLGKMALVCTHEDPENRPT-----MEAVIEE  675 (689)
Q Consensus       650 ~l~~l~~~Cl~~dp~~RPs-----~~evl~~  675 (689)
                      .+.+++..|++.||++||+     +.+++++
T Consensus       224 ~~~~li~~~l~~~P~~R~~a~~~~~~~~~~~  254 (318)
T cd05582         224 EAQSLLRALFKRNPANRLGAGPDGVEEIKRH  254 (318)
T ss_pred             HHHHHHHHHhhcCHhHcCCCCCCCHHHHhCC
Confidence            7889999999999999999     5556654

Serine/Threonine Kinases (STKs), 90 kDa ribosomal protein S6 kinase (RSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. RSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family. They are activated by signaling inputs from extracellular regulated kinase (ERK) and phosphoinositide dependent kinase 1 (PDK1). ERK phosphorylates and activates the CTD of RSK, serving as a docking site for PDK1, which phosphorylates and activates the NTD, which in turn phosphorylate

>PRK13184 pknD serine/threonine-protein kinase; Reviewed

Probab=100.00  E-value=2.3e-37  Score=351.89  Aligned_cols=263  Identities=20%  Similarity=0.251  Sum_probs=202.6

Q ss_pred             ccCCcccccccCCcceEEEEEec-CCcEEEEEEecccCC--chHHHHHHHHHHHHhccCCCcceeEeeEEEcCCCCeEEE
Q 005586          409 QCFSEVNLLGKGNFSSVYKGTLR-DGTLVAIRSINVTSC--KSEEAEFVKGLYLLTSLRHENIIRLRGFCCSRGRGECFL  485 (689)
Q Consensus       409 ~~f~~~~~lg~G~~g~Vy~~~~~-~g~~vavK~l~~~~~--~~~~~~f~~e~~~l~~l~H~niv~l~g~~~~~~~~~~~l  485 (689)
                      ++|...+.||+|+||.||+|... +|+.||+|++.....  ....++|.+|++++++++||||+++++++..  .+..++
T Consensus         2 grYeIi~~LGkGgfG~VYlA~d~~tg~~VAIK~I~~~l~~~e~~~~rflrEi~ILs~L~HPNIVkl~~v~~d--~~~lyL   79 (932)
T PRK13184          2 QRYDIIRLIGKGGMGEVYLAYDPVCSRRVALKKIREDLSENPLLKKRFLREAKIAADLIHPGIVPVYSICSD--GDPVYY   79 (932)
T ss_pred             CCeEEEEEEecCCCEEEEEEEECCCCcEEEEEEECcccccCHHHHHHHHHHHHHHHhCCCcCcCeEEEEEee--CCEEEE
Confidence            46888899999999999999975 689999999975432  2334679999999999999999999999854  578999


Q ss_pred             EEEcCCCCCHHHHhhhcCC-------CCCCCCHHHHHHHHHHHHHHHhhhhCCCCCCCceeecCCCCCceeecCCCCeEE
Q 005586          486 IYDFAPKGKLSKYLDQEEG-------SSNVLDWSTRVSIIIGIAKGIGYLHSSEVNKPAIVHRNLSVEKVLIDQQFNPLI  558 (689)
Q Consensus       486 V~e~~~~gsL~~~L~~~~~-------~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~~~ivH~dlk~~NiLl~~~~~~kl  558 (689)
                      ||||+++|+|.+++.....       ....+++..++.|+.||++||+|||+.+     |+||||||+||+++.++.+||
T Consensus        80 VMEY~eGGSL~~lL~s~~~~~~l~e~~~~~lsv~~iL~I~~QIa~AL~yLHs~G-----IIHRDLKPeNILLd~dg~vKL  154 (932)
T PRK13184         80 TMPYIEGYTLKSLLKSVWQKESLSKELAEKTSVGAFLSIFHKICATIEYVHSKG-----VLHRDLKPDNILLGLFGEVVI  154 (932)
T ss_pred             EEEcCCCCCHHHHHHHhhhccccchhhhcccCHHHHHHHHHHHHHHHHHHHHCC-----ccccCCchheEEEcCCCCEEE
Confidence            9999999999999874211       1234678888999999999999999987     999999999999999999999


Q ss_pred             ecccccccccCCc-----------------eeeeecCCCCCCCCCccccccCCCCCcccchhHHHHHHHHHhCCCCcchh
Q 005586          559 ADCGLHKLLADDI-----------------VFSVLKTSAAMGYLAPEYVTTGRFTERSDIFAFGVIILQILTGSLVLTSS  621 (689)
Q Consensus       559 ~DfGla~~~~~~~-----------------~~~~~~~~~~~~y~aPE~~~~~~~~~ksDV~sfGvvl~elltG~~p~~~~  621 (689)
                      +|||+++......                 ........||..|+|||++.+..++.++|||||||++|||+||+.||...
T Consensus       155 iDFGLAk~i~~~~~~~~~l~~~~~~s~~s~~t~~g~~vGT~~YmAPE~l~g~~~S~kSDIWSLGVILyELLTG~~PF~~~  234 (932)
T PRK13184        155 LDWGAAIFKKLEEEDLLDIDVDERNICYSSMTIPGKIVGTPDYMAPERLLGVPASESTDIYALGVILYQMLTLSFPYRRK  234 (932)
T ss_pred             EecCcceecccccccccccccccccccccccccCCCCCCCCCCCCHHHhcCCCCCcHhHHHHHHHHHHHHHHCCCCCCCc
Confidence            9999998662110                 00011235788999999999999999999999999999999999999642


Q ss_pred             HHHHHhhhhhhHhhccccCCCCCHHHHHHHHHHHHHhccCCCCCCC-CHHHHHHHHHhhCC
Q 005586          622 MRLAAESATFENFIDRNLKGKFSESEAAKLGKMALVCTHEDPENRP-TMEAVIEELTVAAP  681 (689)
Q Consensus       622 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~Cl~~dp~~RP-s~~evl~~L~~~~p  681 (689)
                      ........  ....++.-. ......+..+.+++.+|++.||++|| +++++++.|+....
T Consensus       235 ~~~ki~~~--~~i~~P~~~-~p~~~iP~~L~~LI~rcL~~DP~kR~ss~eeLl~~Le~~lq  292 (932)
T PRK13184        235 KGRKISYR--DVILSPIEV-APYREIPPFLSQIAMKALAVDPAERYSSVQELKQDLEPHLQ  292 (932)
T ss_pred             chhhhhhh--hhccChhhc-cccccCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHHh
Confidence            21110000  001111000 00123345688999999999999995 67777777766533

>KOG1989 consensus ARK protein kinase family [Signal transduction mechanisms]

Probab=100.00  E-value=8.5e-38  Score=342.31  Aligned_cols=260  Identities=20%  Similarity=0.309  Sum_probs=208.8

Q ss_pred             ccCCcccccccCCcceEEEEEecCC-cEEEEEEecccCCchHHHHHHHHHHHHhccC-CCcceeEee-EEEc---CC-CC
Q 005586          409 QCFSEVNLLGKGNFSSVYKGTLRDG-TLVAIRSINVTSCKSEEAEFVKGLYLLTSLR-HENIIRLRG-FCCS---RG-RG  481 (689)
Q Consensus       409 ~~f~~~~~lg~G~~g~Vy~~~~~~g-~~vavK~l~~~~~~~~~~~f~~e~~~l~~l~-H~niv~l~g-~~~~---~~-~~  481 (689)
                      .+.++.++|.+|||+.||.|....+ ..||+|++-.. .+...+...+||++|++|+ |+|||.+++ ....   .. ..
T Consensus        37 ~~v~V~~vLAEGGFa~VYla~~~~~~~~~AlKrm~~~-de~~L~~v~~EI~~MK~L~gh~nIV~yidss~~~~~~~~~~~  115 (738)
T KOG1989|consen   37 HRVTVEKVLAEGGFAQVYLAQDVKGGKKYALKRMYVN-DEEALNAVKREIDIMKLLSGHKNIVSYIDSSAINRSSNNGVW  115 (738)
T ss_pred             EEEEEEEEEccCCcEEEEEEEecCCCceeeeeeeecC-CHHHHHHHHHHHHHHHHhcCCCceeeEeccccccccCCCcee
Confidence            3455678999999999999998765 99999999877 3566778999999999997 999999998 3221   12 35


Q ss_pred             eEEEEEEcCCCCCHHHHhhhcCCCCCCCCHHHHHHHHHHHHHHHhhhhCCCCCCCceeecCCCCCceeecCCCCeEEecc
Q 005586          482 ECFLIYDFAPKGKLSKYLDQEEGSSNVLDWSTRVSIIIGIAKGIGYLHSSEVNKPAIVHRNLSVEKVLIDQQFNPLIADC  561 (689)
Q Consensus       482 ~~~lV~e~~~~gsL~~~L~~~~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~~~ivH~dlk~~NiLl~~~~~~kl~Df  561 (689)
                      +++|.||||++|.|-+++......  .|++.++++|+.++++|+++||..   .|||||||||-+||||+.++..|||||
T Consensus       116 EvllLmEyC~gg~Lvd~mn~Rlq~--~lte~eVLkIf~dv~~AVa~mH~~---~pPiIHRDLKiENvLls~~g~~KLCDF  190 (738)
T KOG1989|consen  116 EVLLLMEYCKGGSLVDFMNTRLQT--RLTEDEVLKIFYDVCEAVAAMHYL---KPPIIHRDLKIENVLLSADGNYKLCDF  190 (738)
T ss_pred             EEEeehhhccCCcHHHHHHHHHhc--cCChHHHHHHHHHHHHHHHHHhcC---CCccchhhhhhhheEEcCCCCEEeCcc
Confidence            789999999999999999865543  399999999999999999999974   699999999999999999999999999


Q ss_pred             cccccccCCc--------eeeeecCCCCCCCCCcccc---ccCCCCCcccchhHHHHHHHHHhCCCCcchhHHHHHhhhh
Q 005586          562 GLHKLLADDI--------VFSVLKTSAAMGYLAPEYV---TTGRFTERSDIFAFGVIILQILTGSLVLTSSMRLAAESAT  630 (689)
Q Consensus       562 Gla~~~~~~~--------~~~~~~~~~~~~y~aPE~~---~~~~~~~ksDV~sfGvvl~elltG~~p~~~~~~~~~~~~~  630 (689)
                      |-+.-.-...        .........|+.|+|||.+   .+...++|+|||++||+||-|+....||+.....+.    
T Consensus       191 GSatt~~~~~~~~~e~~~ve~eI~k~TTp~YRsPEMIDlysg~pI~eKsDIWALGclLYkLCy~t~PFe~sg~laI----  266 (738)
T KOG1989|consen  191 GSATTKILSPTSAQEVNYVEEEIEKYTTPQYRSPEMIDLYSGLPIGEKSDIWALGCLLYKLCYFTTPFEESGKLAI----  266 (738)
T ss_pred             cccccccCCCccHHHHHHHHHHHHhhCCccccChHHHhhhcCCCCcchhHHHHHHHHHHHHHHhCCCcCcCcceeE----
Confidence            9875321110        0111223467889999986   356789999999999999999999999976533222    


Q ss_pred             hhHhhccccCCCCCHHHHHHHHHHHHHhccCCCCCCCCHHHHHHHHHhhCCc
Q 005586          631 FENFIDRNLKGKFSESEAAKLGKMALVCTHEDPENRPTMEAVIEELTVAAPV  682 (689)
Q Consensus       631 ~~~~~~~~~~~~~~~~~~~~l~~l~~~Cl~~dp~~RPs~~evl~~L~~~~p~  682 (689)
                          ++....-.-.+.....+..|+..||+.+|.+||++-||++.+.+++-.
T Consensus       267 ----lng~Y~~P~~p~ys~~l~~LI~~mL~~nP~~RPnI~Qv~~~~~~l~~~  314 (738)
T KOG1989|consen  267 ----LNGNYSFPPFPNYSDRLKDLIRTMLQPNPDERPNIYQVLEEIFELANK  314 (738)
T ss_pred             ----EeccccCCCCccHHHHHHHHHHHHhccCcccCCCHHHHHHHHHHHhcC
Confidence                222222122256788999999999999999999999999998777543

>cd07876 STKc_JNK2 Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 2

Probab=100.00  E-value=3.3e-37  Score=330.43  Aligned_cols=257  Identities=19%  Similarity=0.325  Sum_probs=198.4

Q ss_pred             hccCCcccccccCCcceEEEEEec-CCcEEEEEEecccCC-chHHHHHHHHHHHHhccCCCcceeEeeEEEcCCC----C
Q 005586          408 TQCFSEVNLLGKGNFSSVYKGTLR-DGTLVAIRSINVTSC-KSEEAEFVKGLYLLTSLRHENIIRLRGFCCSRGR----G  481 (689)
Q Consensus       408 t~~f~~~~~lg~G~~g~Vy~~~~~-~g~~vavK~l~~~~~-~~~~~~f~~e~~~l~~l~H~niv~l~g~~~~~~~----~  481 (689)
                      .++|...+.||+|+||.||++... +|..||+|++..... ......+.+|+.++..++||||+++++++.....    .
T Consensus        20 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~   99 (359)
T cd07876          20 LKRYQQLKPIGSGAQGIVCAAFDTVLGINVAVKKLSRPFQNQTHAKRAYRELVLLKCVNHKNIISLLNVFTPQKSLEEFQ   99 (359)
T ss_pred             hhceEEEEEeecCCCEEEEEEEEcCCCceeEEEEecccccchhHHHHHHHHHHHHHhCCCCCEeeeeeeeccCCCccccc
Confidence            467888999999999999999875 689999999975432 3345678899999999999999999998854321    3


Q ss_pred             eEEEEEEcCCCCCHHHHhhhcCCCCCCCCHHHHHHHHHHHHHHHhhhhCCCCCCCceeecCCCCCceeecCCCCeEEecc
Q 005586          482 ECFLIYDFAPKGKLSKYLDQEEGSSNVLDWSTRVSIIIGIAKGIGYLHSSEVNKPAIVHRNLSVEKVLIDQQFNPLIADC  561 (689)
Q Consensus       482 ~~~lV~e~~~~gsL~~~L~~~~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~~~ivH~dlk~~NiLl~~~~~~kl~Df  561 (689)
                      ..++||||+++ +|.+.++.      .+++..+..++.|++.||+|||+.+     |+||||||+|||++.++.+||+||
T Consensus       100 ~~~lv~e~~~~-~l~~~~~~------~~~~~~~~~~~~qi~~~L~~LH~~~-----ivHrDlkp~NIl~~~~~~~kl~Df  167 (359)
T cd07876         100 DVYLVMELMDA-NLCQVIHM------ELDHERMSYLLYQMLCGIKHLHSAG-----IIHRDLKPSNIVVKSDCTLKILDF  167 (359)
T ss_pred             eeEEEEeCCCc-CHHHHHhc------cCCHHHHHHHHHHHHHHHHHHHhCC-----cccCCCCHHHEEECCCCCEEEecC
Confidence            57999999965 67666643      2788889999999999999999987     999999999999999999999999


Q ss_pred             cccccccCCceeeeecCCCCCCCCCccccccCCCCCcccchhHHHHHHHHHhCCCCcchhHHHHHhhh------------
Q 005586          562 GLHKLLADDIVFSVLKTSAAMGYLAPEYVTTGRFTERSDIFAFGVIILQILTGSLVLTSSMRLAAESA------------  629 (689)
Q Consensus       562 Gla~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~ksDV~sfGvvl~elltG~~p~~~~~~~~~~~~------------  629 (689)
                      |+++......  ......+|..|+|||.+.+..++.++|||||||++|||+||+.||...........            
T Consensus       168 g~a~~~~~~~--~~~~~~~t~~y~aPE~~~~~~~~~~~DiwSlG~il~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~  245 (359)
T cd07876         168 GLARTACTNF--MMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGELVKGSVIFQGTDHIDQWNKVIEQLGTPSAEF  245 (359)
T ss_pred             CCccccccCc--cCCCCcccCCCCCchhccCCCCCcchhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCcHHH
Confidence            9998654322  12234567889999999999999999999999999999999999964321111100            


Q ss_pred             ------hhhHhhccc--cCC----------------CCCHHHHHHHHHHHHHhccCCCCCCCCHHHHHHHHHh
Q 005586          630 ------TFENFIDRN--LKG----------------KFSESEAAKLGKMALVCTHEDPENRPTMEAVIEELTV  678 (689)
Q Consensus       630 ------~~~~~~~~~--~~~----------------~~~~~~~~~l~~l~~~Cl~~dp~~RPs~~evl~~L~~  678 (689)
                            .........  ..+                ........++.+++.+|++.||++|||+.|++++.+.
T Consensus       246 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dP~~R~t~~e~l~hp~~  318 (359)
T cd07876         246 MNRLQPTVRNYVENRPQYPGISFEELFPDWIFPSESERDKLKTSQARDLLSKMLVIDPDKRISVDEALRHPYI  318 (359)
T ss_pred             HHHHHHHHHHHHhhCCCCCCcchhhhccccccccccccccccchhHHHHHHHHhccCcccCCCHHHHhcCchh
Confidence                  000111000  000                0011124568899999999999999999999998764

Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 2 (JNK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jn

>KOG0199 consensus ACK and related non-receptor tyrosine kinases [Signal transduction mechanisms]

Probab=100.00  E-value=5.3e-38  Score=330.49  Aligned_cols=256  Identities=26%  Similarity=0.441  Sum_probs=210.5

Q ss_pred             ccccccCCcceEEEEEec--CC--cEEEEEEecccCCchHHHHHHHHHHHHhccCCCcceeEeeEEEcCCCCeEEEEEEc
Q 005586          414 VNLLGKGNFSSVYKGTLR--DG--TLVAIRSINVTSCKSEEAEFVKGLYLLTSLRHENIIRLRGFCCSRGRGECFLIYDF  489 (689)
Q Consensus       414 ~~~lg~G~~g~Vy~~~~~--~g--~~vavK~l~~~~~~~~~~~f~~e~~~l~~l~H~niv~l~g~~~~~~~~~~~lV~e~  489 (689)
                      .++||+|.||.|++|.|.  +|  ..||||.++.........+|++|+.+|-+++|||+++|||+..+   ....+|+|.
T Consensus       115 ~e~LG~GsFgvV~rg~Wt~psgk~V~VAVKclr~d~l~~~mddflrEas~M~~L~H~hliRLyGvVl~---qp~mMV~EL  191 (1039)
T KOG0199|consen  115 YELLGEGSFGVVKRGTWTQPSGKHVNVAVKCLRDDSLNAIMDDFLREASHMLKLQHPHLIRLYGVVLD---QPAMMVFEL  191 (1039)
T ss_pred             HHHhcCcceeeEeeccccCCCCcEEeEEEEeccCCccchhHHHHHHHHHHHHhccCcceeEEeeeecc---chhhHHhhh
Confidence            478999999999999986  34  45899999987755577899999999999999999999999854   567899999


Q ss_pred             CCCCCHHHHhhhcCCCCCCCCHHHHHHHHHHHHHHHhhhhCCCCCCCceeecCCCCCceeecCCCCeEEecccccccccC
Q 005586          490 APKGKLSKYLDQEEGSSNVLDWSTRVSIIIGIAKGIGYLHSSEVNKPAIVHRNLSVEKVLIDQQFNPLIADCGLHKLLAD  569 (689)
Q Consensus       490 ~~~gsL~~~L~~~~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~~~ivH~dlk~~NiLl~~~~~~kl~DfGla~~~~~  569 (689)
                      .+.|+|.+.|++.  ....|-......+|.|||.||.||.+++     +|||||.++|+||-....+||+||||.|-+..
T Consensus       192 aplGSLldrLrka--~~~~llv~~Lcdya~QiA~aM~YLeskr-----lvHRDLAARNlllasprtVKI~DFGLmRaLg~  264 (1039)
T KOG0199|consen  192 APLGSLLDRLRKA--KKAILLVSRLCDYAMQIAKAMQYLESKR-----LVHRDLAARNLLLASPRTVKICDFGLMRALGE  264 (1039)
T ss_pred             cccchHHHHHhhc--cccceeHHHHHHHHHHHHHHHHHHhhhh-----hhhhhhhhhhheecccceeeeecccceeccCC
Confidence            9999999999982  2335777888899999999999999887     89999999999999999999999999998865


Q ss_pred             Cceeeeec--CCCCCCCCCccccccCCCCCcccchhHHHHHHHHHh-CCCCcchhHHHHHhhhhhhHhhccccCCCCCHH
Q 005586          570 DIVFSVLK--TSAAMGYLAPEYVTTGRFTERSDIFAFGVIILQILT-GSLVLTSSMRLAAESATFENFIDRNLKGKFSES  646 (689)
Q Consensus       570 ~~~~~~~~--~~~~~~y~aPE~~~~~~~~~ksDV~sfGvvl~ellt-G~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  646 (689)
                      +..+..+.  ..-.+.|.|||.+...+++.+||||+|||.+|||+| |..|+.+..     ...+.+.+|..-+...++.
T Consensus       265 ned~Yvm~p~rkvPfAWCaPEsLrh~kFShaSDvWmyGVTiWEMFtyGEePW~G~~-----g~qIL~~iD~~erLpRPk~  339 (1039)
T KOG0199|consen  265 NEDMYVMAPQRKVPFAWCAPESLRHRKFSHASDVWMYGVTIWEMFTYGEEPWVGCR-----GIQILKNIDAGERLPRPKY  339 (1039)
T ss_pred             CCcceEecCCCcCcccccCHhHhccccccccchhhhhhhhHHhhhccCCCCCCCCC-----HHHHHHhccccccCCCCCC
Confidence            44322222  223457999999999999999999999999999998 556664321     1123344555545566788


Q ss_pred             HHHHHHHHHHHhccCCCCCCCCHHHHHHH--HHhhCCccc
Q 005586          647 EAAKLGKMALVCTHEDPENRPTMEAVIEE--LTVAAPVMA  684 (689)
Q Consensus       647 ~~~~l~~l~~~Cl~~dp~~RPs~~evl~~--L~~~~p~~~  684 (689)
                      +++++++++..||...|++||++..+.++  +.++.|..+
T Consensus       340 csedIY~imk~cWah~paDRptFsair~~~~l~eaqp~~a  379 (1039)
T KOG0199|consen  340 CSEDIYQIMKNCWAHNPADRPTFSAIREDLVLAEAQPAVA  379 (1039)
T ss_pred             ChHHHHHHHHHhccCCccccccHHHHHHhHHHHhcCCcee
Confidence            99999999999999999999999999844  456666543

>KOG0594 consensus Protein kinase PCTAIRE and related kinases [General function prediction only]

Probab=100.00  E-value=1.8e-37  Score=308.85  Aligned_cols=259  Identities=22%  Similarity=0.368  Sum_probs=200.3

Q ss_pred             cCCcccccccCCcceEEEEEec-CCcEEEEEEecccCC-chHHHHHHHHHHHHhccCCCc-ceeEeeEEEcCC----CCe
Q 005586          410 CFSEVNLLGKGNFSSVYKGTLR-DGTLVAIRSINVTSC-KSEEAEFVKGLYLLTSLRHEN-IIRLRGFCCSRG----RGE  482 (689)
Q Consensus       410 ~f~~~~~lg~G~~g~Vy~~~~~-~g~~vavK~l~~~~~-~~~~~~f~~e~~~l~~l~H~n-iv~l~g~~~~~~----~~~  482 (689)
                      .|...++||+|+||+||+|+.+ +|+.||+|+++.... +.......+|+.++.+++|+| ||+|++++....    ...
T Consensus        12 ~~~~~eklGeGtyg~Vykar~~~~g~~VALKkirl~~~~EG~P~taiREisllk~L~~~~~iv~L~dv~~~~~~~~~~~~   91 (323)
T KOG0594|consen   12 DYEKVEKLGEGTYGVVYKARSKRTGKFVALKKIRLEFEEEGVPSTAIREISLLKRLSHANHIVRLHDVIHTSNNHRGIGK   91 (323)
T ss_pred             HHHHHHHhCCCCceEEEEEEEecCCCEEEEEEEeccccccCCCchhhHHHHHHHHhCCCcceEEEEeeeeecccccccce
Confidence            3455678999999999999865 799999999987754 223356689999999999999 999999997643    136


Q ss_pred             EEEEEEcCCCCCHHHHhhhcCCCCCCCCHHHHHHHHHHHHHHHhhhhCCCCCCCceeecCCCCCceeecCCCCeEEeccc
Q 005586          483 CFLIYDFAPKGKLSKYLDQEEGSSNVLDWSTRVSIIIGIAKGIGYLHSSEVNKPAIVHRNLSVEKVLIDQQFNPLIADCG  562 (689)
Q Consensus       483 ~~lV~e~~~~gsL~~~L~~~~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~~~ivH~dlk~~NiLl~~~~~~kl~DfG  562 (689)
                      .++|+||++ -+|..++.......+.++......++.|+++||+|||+++     |+||||||.|||++++|.+||+|||
T Consensus        92 l~lvfe~~d-~DL~~ymd~~~~~~~g~~~~~ik~~m~Qll~gl~~~H~~~-----IlHRDLKPQNlLi~~~G~lKlaDFG  165 (323)
T KOG0594|consen   92 LYLVFEFLD-RDLKKYMDSLPKKPQGLPPRLIKSFMRQLLRGLAFLHSHG-----ILHRDLKPQNLLISSSGVLKLADFG  165 (323)
T ss_pred             EEEEEEeec-ccHHHHHHhccccccCCCHHHHHHHHHHHHHHHHHHHhCC-----eecccCCcceEEECCCCcEeeeccc
Confidence            889999995 5999999876532234777889999999999999999988     9999999999999999999999999


Q ss_pred             ccccccCCceeeeecCCCCCCCCCccccccC-CCCCcccchhHHHHHHHHHhCCCCcchhHHHHHhhhhhhHhhcc----
Q 005586          563 LHKLLADDIVFSVLKTSAAMGYLAPEYVTTG-RFTERSDIFAFGVIILQILTGSLVLTSSMRLAAESATFENFIDR----  637 (689)
Q Consensus       563 la~~~~~~~~~~~~~~~~~~~y~aPE~~~~~-~~~~ksDV~sfGvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~----  637 (689)
                      +|+...-... .......|..|+|||++.+. .|+...||||+||++.||++++.-|............+.-+-.+    
T Consensus       166 lAra~~ip~~-~yt~evvTlWYRaPEvLlGs~~Ys~~vDiWs~GcIfaEm~~~~~LFpG~se~~ql~~If~~lGtP~e~~  244 (323)
T KOG0594|consen  166 LARAFSIPMR-TYTPEVVTLWYRAPEVLLGSTSYSTSVDIWSLGCIFAEMFTRRPLFPGDSEIDQLFRIFRLLGTPNEKD  244 (323)
T ss_pred             hHHHhcCCcc-cccccEEEeeccCHHHhcCCCcCCCCcchHhHHHHHHHHHhCCCCCCCCcHHHHHHHHHHHcCCCCccC
Confidence            9996542211 23345678889999999876 68999999999999999999998886543322222111110000    


Q ss_pred             --------ccCCCC-----C----HHH---HHHHHHHHHHhccCCCCCCCCHHHHHHH
Q 005586          638 --------NLKGKF-----S----ESE---AAKLGKMALVCTHEDPENRPTMEAVIEE  675 (689)
Q Consensus       638 --------~~~~~~-----~----~~~---~~~l~~l~~~Cl~~dp~~RPs~~evl~~  675 (689)
                              ..+..+     +    ...   .....+++..|++.+|.+|.|++.++.|
T Consensus       245 Wp~v~~~~~~k~~f~~~~~~~~l~~~~~~~~~~~~dll~~~L~y~p~~R~Sa~~al~h  302 (323)
T KOG0594|consen  245 WPGVSSLPDYKAPFPKWPGPKDLSSILPKLDPDGIELLSKLLQYDPAKRISAKGALTH  302 (323)
T ss_pred             CCCccccccccccCcCCCCccchHHhccccCccHHHHHHHHhccCcccCcCHHHHhcC
Confidence                    000000     1    111   2478899999999999999999999987

>cd08219 STKc_Nek3 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 3

Probab=100.00  E-value=4.3e-37  Score=313.12  Aligned_cols=251  Identities=16%  Similarity=0.311  Sum_probs=203.1

Q ss_pred             cCCcccccccCCcceEEEEEec-CCcEEEEEEecccCCchHHHHHHHHHHHHhccCCCcceeEeeEEEcCCCCeEEEEEE
Q 005586          410 CFSEVNLLGKGNFSSVYKGTLR-DGTLVAIRSINVTSCKSEEAEFVKGLYLLTSLRHENIIRLRGFCCSRGRGECFLIYD  488 (689)
Q Consensus       410 ~f~~~~~lg~G~~g~Vy~~~~~-~g~~vavK~l~~~~~~~~~~~f~~e~~~l~~l~H~niv~l~g~~~~~~~~~~~lV~e  488 (689)
                      +|+..+.||+|+||.||++... ++..+|+|.++........+.+.+|+.++++++|+||+++++.+..  .+..++|||
T Consensus         1 ~y~~~~~lg~g~~g~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~--~~~~~lv~e   78 (255)
T cd08219           1 QYNVLRVVGEGSFGRALLVQHVNSDQKYAMKEIRLPKSSSAVEDSRKEAVLLAKMKHPNIVAFKESFEA--DGHLYIVME   78 (255)
T ss_pred             CceEEEEeeccCCeEEEEEEEcCCCceEEEEEEEcCcchHHHHHHHHHHHHHHhCCCCCcceEEEEEEE--CCEEEEEEe
Confidence            3667789999999999999875 6899999998765444455788899999999999999999998844  578999999


Q ss_pred             cCCCCCHHHHhhhcCCCCCCCCHHHHHHHHHHHHHHHhhhhCCCCCCCceeecCCCCCceeecCCCCeEEeccccccccc
Q 005586          489 FAPKGKLSKYLDQEEGSSNVLDWSTRVSIIIGIAKGIGYLHSSEVNKPAIVHRNLSVEKVLIDQQFNPLIADCGLHKLLA  568 (689)
Q Consensus       489 ~~~~gsL~~~L~~~~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~~~ivH~dlk~~NiLl~~~~~~kl~DfGla~~~~  568 (689)
                      |+++|+|.+++....+  ..+++...+.++.|++.||.|||+.+     |+|+||||+||++++++.++++|||+++.+.
T Consensus        79 ~~~~~~l~~~~~~~~~--~~~~~~~~~~~~~~i~~al~~lH~~~-----i~H~dl~p~nili~~~~~~~l~dfg~~~~~~  151 (255)
T cd08219          79 YCDGGDLMQKIKLQRG--KLFPEDTILQWFVQMCLGVQHIHEKR-----VLHRDIKSKNIFLTQNGKVKLGDFGSARLLT  151 (255)
T ss_pred             eCCCCcHHHHHHhccC--CCCCHHHHHHHHHHHHHHHHHHhhCC-----cccCCCCcceEEECCCCcEEEcccCcceeec
Confidence            9999999999875432  34788999999999999999999987     9999999999999999999999999998665


Q ss_pred             CCceeeeecCCCCCCCCCccccccCCCCCcccchhHHHHHHHHHhCCCCcchhHHHHHhhhhhhHhhccccCCCCCHHHH
Q 005586          569 DDIVFSVLKTSAAMGYLAPEYVTTGRFTERSDIFAFGVIILQILTGSLVLTSSMRLAAESATFENFIDRNLKGKFSESEA  648 (689)
Q Consensus       569 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~ksDV~sfGvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  648 (689)
                      ..... .....++..|+|||++.+..++.++||||||+++|||++|+.||........    ...+. .......+....
T Consensus       152 ~~~~~-~~~~~~~~~~~aPE~~~~~~~~~~~Dv~slG~i~~~l~~g~~p~~~~~~~~~----~~~~~-~~~~~~~~~~~~  225 (255)
T cd08219         152 SPGAY-ACTYVGTPYYVPPEIWENMPYNNKSDIWSLGCILYELCTLKHPFQANSWKNL----ILKVC-QGSYKPLPSHYS  225 (255)
T ss_pred             ccccc-cccccCCccccCHHHHccCCcCchhhhhhhchhheehhhccCCCCCCCHHHH----HHHHh-cCCCCCCCcccC
Confidence            43221 1223567789999999888899999999999999999999999965322111    11111 111112334455


Q ss_pred             HHHHHHHHHhccCCCCCCCCHHHHHHH
Q 005586          649 AKLGKMALVCTHEDPENRPTMEAVIEE  675 (689)
Q Consensus       649 ~~l~~l~~~Cl~~dp~~RPs~~evl~~  675 (689)
                      ..+.+++.+||+.||++||++.|++..
T Consensus       226 ~~~~~li~~~l~~~P~~Rp~~~~il~~  252 (255)
T cd08219         226 YELRSLIKQMFKRNPRSRPSATTILSR  252 (255)
T ss_pred             HHHHHHHHHHHhCCcccCCCHHHHhhc
Confidence            678999999999999999999999864

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 3 (Nek3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek3 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek3 is primarily localized in the cytoplasm and shows no cell cycle-dependent changes in its activity. It is present in the axons of neurons and affects morphogenesis and polarity through its regulation of microtubule acetylation. Nek3 modulates the signaling of the prolactin receptor through its activati

>cd05632 STKc_GRK5 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 5

Probab=100.00  E-value=4.9e-37  Score=318.25  Aligned_cols=252  Identities=19%  Similarity=0.289  Sum_probs=200.2

Q ss_pred             CCcccccccCCcceEEEEEec-CCcEEEEEEecccCCc--hHHHHHHHHHHHHhccCCCcceeEeeEEEcCCCCeEEEEE
Q 005586          411 FSEVNLLGKGNFSSVYKGTLR-DGTLVAIRSINVTSCK--SEEAEFVKGLYLLTSLRHENIIRLRGFCCSRGRGECFLIY  487 (689)
Q Consensus       411 f~~~~~lg~G~~g~Vy~~~~~-~g~~vavK~l~~~~~~--~~~~~f~~e~~~l~~l~H~niv~l~g~~~~~~~~~~~lV~  487 (689)
                      |+..+.||+|+||.||+|... +++.||+|.+......  .....+.+|++++.+++|+|++.+.+++..  .+..++||
T Consensus         2 ~~~~~~lg~G~~g~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~il~~l~~~~i~~~~~~~~~--~~~~~lv~   79 (285)
T cd05632           2 FRQYRVLGKGGFGEVCACQVRATGKMYACKRLEKKRIKKRKGESMALNEKQILEKVNSQFVVNLAYAYET--KDALCLVL   79 (285)
T ss_pred             ceEEEEEecCCCeEEEEEEECCCCcEEEEEEeehhhhhhhhHHHHHHHHHHHHHHcCCcCceeEEEEEec--CCEEEEEE
Confidence            556788999999999999875 6899999998754322  223467889999999999999999988844  46899999


Q ss_pred             EcCCCCCHHHHhhhcCCCCCCCCHHHHHHHHHHHHHHHhhhhCCCCCCCceeecCCCCCceeecCCCCeEEecccccccc
Q 005586          488 DFAPKGKLSKYLDQEEGSSNVLDWSTRVSIIIGIAKGIGYLHSSEVNKPAIVHRNLSVEKVLIDQQFNPLIADCGLHKLL  567 (689)
Q Consensus       488 e~~~~gsL~~~L~~~~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~~~ivH~dlk~~NiLl~~~~~~kl~DfGla~~~  567 (689)
                      ||+++|+|.+++.....  ..+++..+..++.|++.||.|||+.+     |+||||||+||++++++.+||+|||++...
T Consensus        80 e~~~~~~L~~~~~~~~~--~~~~~~~~~~~~~ql~~~l~~lH~~~-----iiH~dikp~Nili~~~~~~kl~Dfg~~~~~  152 (285)
T cd05632          80 TIMNGGDLKFHIYNMGN--PGFEEERALFYAAEILCGLEDLHREN-----TVYRDLKPENILLDDYGHIRISDLGLAVKI  152 (285)
T ss_pred             EeccCccHHHHHHHhcC--CCCCHHHHHHHHHHHHHHHHHHHhCC-----eeecCCCHHHEEECCCCCEEEecCCcceec
Confidence            99999999999875432  34899999999999999999999987     999999999999999999999999998765


Q ss_pred             cCCceeeeecCCCCCCCCCccccccCCCCCcccchhHHHHHHHHHhCCCCcchhHHHHHhhhhhhHhhccccCCCCCHHH
Q 005586          568 ADDIVFSVLKTSAAMGYLAPEYVTTGRFTERSDIFAFGVIILQILTGSLVLTSSMRLAAESATFENFIDRNLKGKFSESE  647 (689)
Q Consensus       568 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~ksDV~sfGvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  647 (689)
                      .....  .....++..|+|||++.+..++.++|||||||++|||+||+.||...................  ...++...
T Consensus       153 ~~~~~--~~~~~g~~~~~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~P~~~~~~~~~~~~~~~~~~~~--~~~~~~~~  228 (285)
T cd05632         153 PEGES--IRGRVGTVGYMAPEVLNNQRYTLSPDYWGLGCLIYEMIEGQSPFRGRKEKVKREEVDRRVLET--EEVYSAKF  228 (285)
T ss_pred             CCCCc--ccCCCCCcCccChHHhcCCCCCcccchHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhhhcc--ccccCccC
Confidence            43221  123457889999999988899999999999999999999999996542221111111111111  11233444


Q ss_pred             HHHHHHHHHHhccCCCCCCCC-----HHHHHHH
Q 005586          648 AAKLGKMALVCTHEDPENRPT-----MEAVIEE  675 (689)
Q Consensus       648 ~~~l~~l~~~Cl~~dp~~RPs-----~~evl~~  675 (689)
                      ...+.+++..|++.||++||+     +.+++.+
T Consensus       229 ~~~~~~li~~~l~~~P~~R~~~~~~~~~~l~~~  261 (285)
T cd05632         229 SEEAKSICKMLLTKDPKQRLGCQEEGAGEVKRH  261 (285)
T ss_pred             CHHHHHHHHHHccCCHhHcCCCcccChHHHHcC
Confidence            567889999999999999999     7787766

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK5 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK5 is widely expressed in many tissues. It associates with

>cd06639 STKc_myosinIIIB Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIB myosin

Probab=100.00  E-value=3.9e-37  Score=319.92  Aligned_cols=267  Identities=21%  Similarity=0.354  Sum_probs=209.2

Q ss_pred             ccCHHHHHHHhccCCcccccccCCcceEEEEEec-CCcEEEEEEecccCCchHHHHHHHHHHHHhcc-CCCcceeEeeEE
Q 005586          398 RLNLEEVESATQCFSEVNLLGKGNFSSVYKGTLR-DGTLVAIRSINVTSCKSEEAEFVKGLYLLTSL-RHENIIRLRGFC  475 (689)
Q Consensus       398 ~~~~~~l~~at~~f~~~~~lg~G~~g~Vy~~~~~-~g~~vavK~l~~~~~~~~~~~f~~e~~~l~~l-~H~niv~l~g~~  475 (689)
                      .++++++..++++|...+.||+|+||.||++... +++.+|+|++....  ....++.+|+.++.++ +|||++++++++
T Consensus        11 ~~~~~~~~~~~~~y~~~~~l~~g~~~~vy~~~~~~~~~~~aik~~~~~~--~~~~~~~~e~~~l~~l~~h~ni~~~~~~~   88 (291)
T cd06639          11 MLGLESLGDPTDTWEIIETIGKGTYGKVYKVTNKKDGSLAAVKILDPIS--DVDEEIEAEYNILQSLPNHPNVVKFYGMF   88 (291)
T ss_pred             hhhcccCCCCCCCeEEEEEeecCCCeEEEEEEECCCCCEEEEEEecccc--cHHHHHHHHHHHHHHhcCCCCeEEEEEEE
Confidence            4566777788999999999999999999999875 68999999986542  2345678899999999 899999999998


Q ss_pred             EcCC---CCeEEEEEEcCCCCCHHHHhhhcCCCCCCCCHHHHHHHHHHHHHHHhhhhCCCCCCCceeecCCCCCceeecC
Q 005586          476 CSRG---RGECFLIYDFAPKGKLSKYLDQEEGSSNVLDWSTRVSIIIGIAKGIGYLHSSEVNKPAIVHRNLSVEKVLIDQ  552 (689)
Q Consensus       476 ~~~~---~~~~~lV~e~~~~gsL~~~L~~~~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~~~ivH~dlk~~NiLl~~  552 (689)
                      ...+   ....++||||+++|+|.++++........++|..++.++.|++.||+|||+.+     |+||||||+||++++
T Consensus        89 ~~~~~~~~~~~~lv~ey~~~~sL~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~-----ivH~dlkp~nili~~  163 (291)
T cd06639          89 YKADKLVGGQLWLVLELCNGGSVTELVKGLLICGQRLDEAMISYILYGALLGLQHLHNNR-----IIHRDVKGNNILLTT  163 (291)
T ss_pred             EeccccCCCeeEEEEEECCCCcHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHhCC-----eeccCCCHHHEEEcC
Confidence            6432   24689999999999999998754333345899999999999999999999877     999999999999999


Q ss_pred             CCCeEEecccccccccCCceeeeecCCCCCCCCCccccccC-----CCCCcccchhHHHHHHHHHhCCCCcchhHHHHHh
Q 005586          553 QFNPLIADCGLHKLLADDIVFSVLKTSAAMGYLAPEYVTTG-----RFTERSDIFAFGVIILQILTGSLVLTSSMRLAAE  627 (689)
Q Consensus       553 ~~~~kl~DfGla~~~~~~~~~~~~~~~~~~~y~aPE~~~~~-----~~~~ksDV~sfGvvl~elltG~~p~~~~~~~~~~  627 (689)
                      ++.+||+|||+++........ .....++..|+|||++...     .++.++|||||||++|||++|+.|+........ 
T Consensus       164 ~~~~kl~dfg~~~~~~~~~~~-~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Di~slGvi~~el~~g~~p~~~~~~~~~-  241 (291)
T cd06639         164 EGGVKLVDFGVSAQLTSTRLR-RNTSVGTPFWMAPEVIACEQQYDYSYDARCDVWSLGITAIELGDGDPPLFDMHPVKT-  241 (291)
T ss_pred             CCCEEEeecccchhccccccc-ccCccCCccccChhhhcCCCCcccccCCccchHHHHHHHHHHhhCCCCCCCCcHHHH-
Confidence            999999999998866432211 1223467789999987543     368999999999999999999999864322111 


Q ss_pred             hhhhhHhhcc-ccCCCCCHHHHHHHHHHHHHhccCCCCCCCCHHHHHHHH
Q 005586          628 SATFENFIDR-NLKGKFSESEAAKLGKMALVCTHEDPENRPTMEAVIEEL  676 (689)
Q Consensus       628 ~~~~~~~~~~-~~~~~~~~~~~~~l~~l~~~Cl~~dp~~RPs~~evl~~L  676 (689)
                         ..+.... ......++.....+.+++.+|++.+|++||++.|++++-
T Consensus       242 ---~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~il~~~  288 (291)
T cd06639         242 ---LFKIPRNPPPTLLHPEKWCRSFNHFISQCLIKDFEARPSVTHLLEHP  288 (291)
T ss_pred             ---HHHHhcCCCCCCCcccccCHHHHHHHHHHhhcChhhCcCHHHHhcCc
Confidence               1111100 001112333456799999999999999999999999873

Serine/threonine kinases (STKs), class IIIB myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. They may also function as cargo carriers during light-dependent translocation, in photoreceptor cells, of proteins such as transducin and arrestin. Class IIIB myosin is expressed highly in retina. It is also pre

>cd06609 STKc_MST3_like Catalytic domain of Mammalian Ste20-like protein kinase 3-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=5.2e-37  Score=316.08  Aligned_cols=253  Identities=20%  Similarity=0.381  Sum_probs=205.8

Q ss_pred             cCCcccccccCCcceEEEEEec-CCcEEEEEEecccCCchHHHHHHHHHHHHhccCCCcceeEeeEEEcCCCCeEEEEEE
Q 005586          410 CFSEVNLLGKGNFSSVYKGTLR-DGTLVAIRSINVTSCKSEEAEFVKGLYLLTSLRHENIIRLRGFCCSRGRGECFLIYD  488 (689)
Q Consensus       410 ~f~~~~~lg~G~~g~Vy~~~~~-~g~~vavK~l~~~~~~~~~~~f~~e~~~l~~l~H~niv~l~g~~~~~~~~~~~lV~e  488 (689)
                      +|+..+.||.|+||.||+|... +++.||+|.+...........+.+|++++++++|+||+++++++.+  ....++|+|
T Consensus         2 ~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~--~~~~~~v~e   79 (274)
T cd06609           2 LFTLLECIGKGSFGEVYKAIDKRTNQVVAIKVIDLEEAEDEIEDIQQEIQFLSQCRSPYITKYYGSFLK--GSKLWIIME   79 (274)
T ss_pred             hhhhhhhhcCCCCeEEEEEEECCCCeEEEEEEeeccccchHHHHHHHHHHHHHHcCCCCeeeeeEEEEE--CCeEEEEEE
Confidence            5777889999999999999976 6899999999765444555688999999999999999999998855  378999999


Q ss_pred             cCCCCCHHHHhhhcCCCCCCCCHHHHHHHHHHHHHHHhhhhCCCCCCCceeecCCCCCceeecCCCCeEEeccccccccc
Q 005586          489 FAPKGKLSKYLDQEEGSSNVLDWSTRVSIIIGIAKGIGYLHSSEVNKPAIVHRNLSVEKVLIDQQFNPLIADCGLHKLLA  568 (689)
Q Consensus       489 ~~~~gsL~~~L~~~~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~~~ivH~dlk~~NiLl~~~~~~kl~DfGla~~~~  568 (689)
                      |+++++|.+++...     .+++..+..++.|++.||.|||+.+     ++||||+|+||++++++.++|+|||+++.+.
T Consensus        80 ~~~~~~L~~~~~~~-----~~~~~~~~~~~~ql~~~l~~lh~~~-----i~h~dl~p~ni~i~~~~~~~l~d~g~~~~~~  149 (274)
T cd06609          80 YCGGGSCLDLLKPG-----KLDETYIAFILREVLLGLEYLHEEG-----KIHRDIKAANILLSEEGDVKLADFGVSGQLT  149 (274)
T ss_pred             eeCCCcHHHHHhhc-----CCCHHHHHHHHHHHHHHHHHHHhCC-----cccCCCCHHHEEECCCCCEEEcccccceeec
Confidence            99999999999754     4899999999999999999999987     9999999999999999999999999998775


Q ss_pred             CCceeeeecCCCCCCCCCccccccCCCCCcccchhHHHHHHHHHhCCCCcchhHHHHHhhhhhhHhhccccCCCCCHH-H
Q 005586          569 DDIVFSVLKTSAAMGYLAPEYVTTGRFTERSDIFAFGVIILQILTGSLVLTSSMRLAAESATFENFIDRNLKGKFSES-E  647 (689)
Q Consensus       569 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~ksDV~sfGvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~  647 (689)
                      .... ......++..|+|||++.+..++.++|||||||++|||+||+.|+........     ...+........... .
T Consensus       150 ~~~~-~~~~~~~~~~y~~PE~~~~~~~~~~sDv~slG~il~~l~tg~~p~~~~~~~~~-----~~~~~~~~~~~~~~~~~  223 (274)
T cd06609         150 STMS-KRNTFVGTPFWMAPEVIKQSGYDEKADIWSLGITAIELAKGEPPLSDLHPMRV-----LFLIPKNNPPSLEGNKF  223 (274)
T ss_pred             cccc-ccccccCCccccChhhhccCCCCchhhHHHHHHHHHHHHhCCCCcccCchHHH-----HHHhhhcCCCCCccccc
Confidence            4321 12233466789999999988899999999999999999999999864321111     011111111122222 4


Q ss_pred             HHHHHHHHHHhccCCCCCCCCHHHHHHHHHhhC
Q 005586          648 AAKLGKMALVCTHEDPENRPTMEAVIEELTVAA  680 (689)
Q Consensus       648 ~~~l~~l~~~Cl~~dp~~RPs~~evl~~L~~~~  680 (689)
                      ...+.+++.+||..+|++||++++++++-+...
T Consensus       224 ~~~~~~~l~~~l~~~p~~Rpt~~~il~~~~~~~  256 (274)
T cd06609         224 SKPFKDFVSLCLNKDPKERPSAKELLKHKFIKK  256 (274)
T ss_pred             CHHHHHHHHHHhhCChhhCcCHHHHhhChhhcC
Confidence            567889999999999999999999998765543

Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST3, MST4, STK25, Schizosaccharomyces pombe Nak1 and Sid1, Saccharomyces cerevisiae sporulation-specific protein 1 (SPS1), and related proteins. Nak1 is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Sid1 is a component in the septation initiation network (SIN)

>cd08528 STKc_Nek10 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 10

Probab=100.00  E-value=9.1e-37  Score=313.30  Aligned_cols=255  Identities=22%  Similarity=0.363  Sum_probs=201.2

Q ss_pred             cCCcccccccCCcceEEEEEecC--CcEEEEEEecccC---------CchHHHHHHHHHHHHhc-cCCCcceeEeeEEEc
Q 005586          410 CFSEVNLLGKGNFSSVYKGTLRD--GTLVAIRSINVTS---------CKSEEAEFVKGLYLLTS-LRHENIIRLRGFCCS  477 (689)
Q Consensus       410 ~f~~~~~lg~G~~g~Vy~~~~~~--g~~vavK~l~~~~---------~~~~~~~f~~e~~~l~~-l~H~niv~l~g~~~~  477 (689)
                      +|+..+.||+|+||.||+|..+.  ++.+|+|.+....         ......++..|+.++.+ ++||||+++++++..
T Consensus         1 ~y~~~~~ig~G~~~~v~~~~~~~~~~~~~avk~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~   80 (269)
T cd08528           1 EYAVLEHLGSGAFGCVYKVRKKNNGQNLLALKEINVHNPAFGKDKRERDKSIGDIVSEVTIIKEQLRHPNIVRYYKTFLE   80 (269)
T ss_pred             CchhhhhhcCCCCceEEEEEEcCCCCceeeeeEeeccccccccccccchHHHHHHHHHHHHHhhcCCCCCeeeEEeeEcc
Confidence            36677899999999999999864  7889999886432         12234567889988875 799999999999854


Q ss_pred             CCCCeEEEEEEcCCCCCHHHHhhhcCCCCCCCCHHHHHHHHHHHHHHHhhhhC-CCCCCCceeecCCCCCceeecCCCCe
Q 005586          478 RGRGECFLIYDFAPKGKLSKYLDQEEGSSNVLDWSTRVSIIIGIAKGIGYLHS-SEVNKPAIVHRNLSVEKVLIDQQFNP  556 (689)
Q Consensus       478 ~~~~~~~lV~e~~~~gsL~~~L~~~~~~~~~l~~~~~~~ia~~ia~gL~yLH~-~~~~~~~ivH~dlk~~NiLl~~~~~~  556 (689)
                        .+..++||||+++++|.+++.........+++..++.++.|++.||.|||+ .+     ++||||||+||++++++.+
T Consensus        81 --~~~~~lv~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~~-----i~H~dl~~~nil~~~~~~~  153 (269)
T cd08528          81 --NDRLYIVMDLIEGAPLGEHFNSLKEKKQRFTEERIWNIFVQMVLALRYLHKEKR-----IVHRDLTPNNIMLGEDDKV  153 (269)
T ss_pred             --CCeEEEEEecCCCCcHHHHHHHHHhccCCCCHHHHHHHHHHHHHHHHHhccCCc-----eeecCCCHHHEEECCCCcE
Confidence              578999999999999999986533333458999999999999999999996 44     9999999999999999999


Q ss_pred             EEecccccccccCCceeeeecCCCCCCCCCccccccCCCCCcccchhHHHHHHHHHhCCCCcchhHHHHHhhhhhhHhhc
Q 005586          557 LIADCGLHKLLADDIVFSVLKTSAAMGYLAPEYVTTGRFTERSDIFAFGVIILQILTGSLVLTSSMRLAAESATFENFID  636 (689)
Q Consensus       557 kl~DfGla~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~ksDV~sfGvvl~elltG~~p~~~~~~~~~~~~~~~~~~~  636 (689)
                      ||+|||++.......  ......++..|+|||.+.+..++.++||||||+++|||++|+.|+........    ...+.+
T Consensus       154 ~l~dfg~~~~~~~~~--~~~~~~~~~~~~~Pe~~~~~~~~~~~Dv~slG~ll~~l~~g~~p~~~~~~~~~----~~~~~~  227 (269)
T cd08528         154 TITDFGLAKQKQPES--KLTSVVGTILYSCPEIVKNEPYGEKADVWAFGCILYQMCTLQPPFYSTNMLSL----ATKIVE  227 (269)
T ss_pred             EEecccceeeccccc--ccccccCcccCcChhhhcCCCCchHHHHHHHHHHHHHHHhCCCcccccCHHHH----HHHHhh
Confidence            999999998765432  22234567889999999988899999999999999999999999864322111    111111


Q ss_pred             cccCCCCCHHHHHHHHHHHHHhccCCCCCCCCHHHHHHHHH
Q 005586          637 RNLKGKFSESEAAKLGKMALVCTHEDPENRPTMEAVIEELT  677 (689)
Q Consensus       637 ~~~~~~~~~~~~~~l~~l~~~Cl~~dp~~RPs~~evl~~L~  677 (689)
                      ..............+.+++.+||+.||++||++.||..++.
T Consensus       228 ~~~~~~~~~~~~~~l~~li~~cl~~~p~~Rp~~~e~~~~~~  268 (269)
T cd08528         228 AVYEPLPEGMYSEDVTDVITSCLTPDAEARPDIIQVSAMIS  268 (269)
T ss_pred             ccCCcCCcccCCHHHHHHHHHHCCCCCccCCCHHHHHHHhc
Confidence            11111111234567899999999999999999999999875

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 10 (Nek10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek10 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. No function has yet been ascribed to Nek10. The gene encoding Nek10 is a putative causative gene for breast cancer; it is located within a breast cancer susceptibility loci on chromosome 3p24.

>cd05630 STKc_GRK6 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 6

Probab=100.00  E-value=4.1e-37  Score=318.78  Aligned_cols=256  Identities=21%  Similarity=0.324  Sum_probs=202.7

Q ss_pred             CCcccccccCCcceEEEEEec-CCcEEEEEEecccCCc--hHHHHHHHHHHHHhccCCCcceeEeeEEEcCCCCeEEEEE
Q 005586          411 FSEVNLLGKGNFSSVYKGTLR-DGTLVAIRSINVTSCK--SEEAEFVKGLYLLTSLRHENIIRLRGFCCSRGRGECFLIY  487 (689)
Q Consensus       411 f~~~~~lg~G~~g~Vy~~~~~-~g~~vavK~l~~~~~~--~~~~~f~~e~~~l~~l~H~niv~l~g~~~~~~~~~~~lV~  487 (689)
                      |+..+.||+|+||.||++... +++.||+|.+......  .....+.+|+.++.+++|+|++++++.+..  .+..++||
T Consensus         2 f~~~~~ig~G~~g~v~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~~~~i~~~~~~~~~--~~~~~lv~   79 (285)
T cd05630           2 FRQYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGESMALNEKQILEKVNSRFVVSLAYAYET--KDALCLVL   79 (285)
T ss_pred             ceeeEEeecCCCeEEEEEEEcCCCceEEEEEEehhhccchHHHHHHHHHHHHHHhCCCCCeeeeeEEEec--CCEEEEEE
Confidence            566789999999999999876 6899999998754322  223567889999999999999999998844  46899999


Q ss_pred             EcCCCCCHHHHhhhcCCCCCCCCHHHHHHHHHHHHHHHhhhhCCCCCCCceeecCCCCCceeecCCCCeEEecccccccc
Q 005586          488 DFAPKGKLSKYLDQEEGSSNVLDWSTRVSIIIGIAKGIGYLHSSEVNKPAIVHRNLSVEKVLIDQQFNPLIADCGLHKLL  567 (689)
Q Consensus       488 e~~~~gsL~~~L~~~~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~~~ivH~dlk~~NiLl~~~~~~kl~DfGla~~~  567 (689)
                      ||+++|+|.+++.....  ..+++..+..++.|++.||.|||+.+     |+||||||+||++++++.++|+|||++...
T Consensus        80 e~~~g~~L~~~l~~~~~--~~l~~~~~~~~~~qi~~~l~~lH~~~-----iiH~dikp~Nil~~~~~~~~l~Dfg~~~~~  152 (285)
T cd05630          80 TLMNGGDLKFHIYHMGE--AGFEEGRAVFYAAEICCGLEDLHQER-----IVYRDLKPENILLDDHGHIRISDLGLAVHV  152 (285)
T ss_pred             EecCCCcHHHHHHHhcc--cCCCHHHHHHHHHHHHHHHHHHHhCC-----EEeCCCCHHHEEECCCCCEEEeeccceeec
Confidence            99999999999865432  34899999999999999999999887     999999999999999999999999998765


Q ss_pred             cCCceeeeecCCCCCCCCCccccccCCCCCcccchhHHHHHHHHHhCCCCcchhHHHHHhhhhhhHhhccccCCCCCHHH
Q 005586          568 ADDIVFSVLKTSAAMGYLAPEYVTTGRFTERSDIFAFGVIILQILTGSLVLTSSMRLAAESATFENFIDRNLKGKFSESE  647 (689)
Q Consensus       568 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~ksDV~sfGvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  647 (689)
                      .....  .....++..|+|||++.+..++.++|||||||++|||++|+.||......... .......+ .....++...
T Consensus       153 ~~~~~--~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~~l~~l~~g~~Pf~~~~~~~~~-~~~~~~~~-~~~~~~~~~~  228 (285)
T cd05630         153 PEGQT--IKGRVGTVGYMAPEVVKNERYTFSPDWWALGCLLYEMIAGQSPFQQRKKKIKR-EEVERLVK-EVQEEYSEKF  228 (285)
T ss_pred             CCCcc--ccCCCCCccccChHHHcCCCCCCccccHHHHHHHHHHHhCCCCCCCCCccchH-HHHHhhhh-hhhhhcCccC
Confidence            43321  12335788999999999889999999999999999999999999653211100 01111111 1111223334


Q ss_pred             HHHHHHHHHHhccCCCCCCCC-----HHHHHHHHHhh
Q 005586          648 AAKLGKMALVCTHEDPENRPT-----MEAVIEELTVA  679 (689)
Q Consensus       648 ~~~l~~l~~~Cl~~dp~~RPs-----~~evl~~L~~~  679 (689)
                      ...+.+++..|++.||++||+     +.|++++.+..
T Consensus       229 ~~~~~~li~~~l~~~p~~R~s~~~~~~~~~~~h~~~~  265 (285)
T cd05630         229 SPDARSLCKMLLCKDPKERLGCQGGGAREVKEHPLFK  265 (285)
T ss_pred             CHHHHHHHHHHhhcCHHHccCCCCCchHHHHcChhhh
Confidence            567899999999999999999     89999876543

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK6 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK6 is widely expressed in many tissues. t is expressed as

>PTZ00266 NIMA-related protein kinase; Provisional

Probab=100.00  E-value=4.5e-37  Score=350.77  Aligned_cols=263  Identities=16%  Similarity=0.293  Sum_probs=203.8

Q ss_pred             hccCCcccccccCCcceEEEEEec-CCcEEEEEEecccCC-chHHHHHHHHHHHHhccCCCcceeEeeEEEcCCCCeEEE
Q 005586          408 TQCFSEVNLLGKGNFSSVYKGTLR-DGTLVAIRSINVTSC-KSEEAEFVKGLYLLTSLRHENIIRLRGFCCSRGRGECFL  485 (689)
Q Consensus       408 t~~f~~~~~lg~G~~g~Vy~~~~~-~g~~vavK~l~~~~~-~~~~~~f~~e~~~l~~l~H~niv~l~g~~~~~~~~~~~l  485 (689)
                      .++|...+.||+|+||.||+|... ++..||+|.+..... ......|..|+.++.+++|||||++++++........++
T Consensus        12 l~~YeIl~kLG~GgFGtVYLAkdk~tg~~vAlKvIk~~~l~e~~~~~~~~EI~IL~~L~HPNIVrl~d~f~de~~~~lyI   91 (1021)
T PTZ00266         12 LNEYEVIKKIGNGRFGEVFLVKHKRTQEFFCWKAISYRGLKEREKSQLVIEVNVMRELKHKNIVRYIDRFLNKANQKLYI   91 (1021)
T ss_pred             cCCEEEEEEEecCCCeEEEEEEECCCCeEEEEEEEeccccCHHHHHHHHHHHHHHHHcCCCCcCeEEEEEEecCCCEEEE
Confidence            357888899999999999999976 578899999875532 334568999999999999999999999887666678999


Q ss_pred             EEEcCCCCCHHHHhhhcCCCCCCCCHHHHHHHHHHHHHHHhhhhCCCC--CCCceeecCCCCCceeecCC----------
Q 005586          486 IYDFAPKGKLSKYLDQEEGSSNVLDWSTRVSIIIGIAKGIGYLHSSEV--NKPAIVHRNLSVEKVLIDQQ----------  553 (689)
Q Consensus       486 V~e~~~~gsL~~~L~~~~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~--~~~~ivH~dlk~~NiLl~~~----------  553 (689)
                      ||||+++|+|.++|.........+++..++.|+.||+.||+|||+.+.  ...+||||||||+||||+.+          
T Consensus        92 VMEY~~gGSL~~lL~k~~~~~g~L~E~~Il~Ia~QIL~ALaYLHs~g~~~~~k~IVHRDLKPeNILL~s~~~~lg~i~~~  171 (1021)
T PTZ00266         92 LMEFCDAGDLSRNIQKCYKMFGKIEEHAIVDITRQLLHALAYCHNLKDGPNGERVLHRDLKPQNIFLSTGIRHIGKITAQ  171 (1021)
T ss_pred             EEeCCCCCcHHHHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHhcccccccCCceeccCcHHHeEeecCcccccccccc
Confidence            999999999999997643333459999999999999999999998531  11349999999999999643          


Q ss_pred             -------CCeEEecccccccccCCceeeeecCCCCCCCCCcccccc--CCCCCcccchhHHHHHHHHHhCCCCcchhHHH
Q 005586          554 -------FNPLIADCGLHKLLADDIVFSVLKTSAAMGYLAPEYVTT--GRFTERSDIFAFGVIILQILTGSLVLTSSMRL  624 (689)
Q Consensus       554 -------~~~kl~DfGla~~~~~~~~~~~~~~~~~~~y~aPE~~~~--~~~~~ksDV~sfGvvl~elltG~~p~~~~~~~  624 (689)
                             ..+||+|||+++.+.....  .....+|+.|+|||++.+  ..++.++|||||||+||||+||+.||......
T Consensus       172 ~~n~ng~~iVKLsDFGlAr~l~~~s~--~~s~vGTp~YmAPEvL~ge~~~~s~KSDVWSLG~ILYELLTGk~PF~~~~~~  249 (1021)
T PTZ00266        172 ANNLNGRPIAKIGDFGLSKNIGIESM--AHSCVGTPYYWSPELLLHETKSYDDKSDMWALGCIIYELCSGKTPFHKANNF  249 (1021)
T ss_pred             ccccCCCCceEEccCCcccccccccc--ccccCCCccccCHHHHhccCCCCCchhHHHHHHHHHHHHHHCCCCCCcCCcH
Confidence                   3489999999987654322  123457889999999854  45889999999999999999999999643221


Q ss_pred             HHhhhhhhHhhccccCCCCCHHHHHHHHHHHHHhccCCCCCCCCHHHHHHHHH
Q 005586          625 AAESATFENFIDRNLKGKFSESEAAKLGKMALVCTHEDPENRPTMEAVIEELT  677 (689)
Q Consensus       625 ~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~Cl~~dp~~RPs~~evl~~L~  677 (689)
                      ...    ...+...... .....+.++.+++..||+.+|++||++.|++++-+
T Consensus       250 ~ql----i~~lk~~p~l-pi~~~S~eL~dLI~~~L~~dPeeRPSa~QlL~h~~  297 (1021)
T PTZ00266        250 SQL----ISELKRGPDL-PIKGKSKELNILIKNLLNLSAKERPSALQCLGYQI  297 (1021)
T ss_pred             HHH----HHHHhcCCCC-CcCCCCHHHHHHHHHHhcCChhHCcCHHHHhccHH
Confidence            111    1111111100 01223567899999999999999999999996543

>cd05625 STKc_LATS1 Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 1

Probab=100.00  E-value=2.4e-37  Score=334.20  Aligned_cols=251  Identities=18%  Similarity=0.268  Sum_probs=192.9

Q ss_pred             cCCcccccccCCcceEEEEEec-CCcEEEEEEecccCC--chHHHHHHHHHHHHhccCCCcceeEeeEEEcCCCCeEEEE
Q 005586          410 CFSEVNLLGKGNFSSVYKGTLR-DGTLVAIRSINVTSC--KSEEAEFVKGLYLLTSLRHENIIRLRGFCCSRGRGECFLI  486 (689)
Q Consensus       410 ~f~~~~~lg~G~~g~Vy~~~~~-~g~~vavK~l~~~~~--~~~~~~f~~e~~~l~~l~H~niv~l~g~~~~~~~~~~~lV  486 (689)
                      +|...+.||+|+||.||+|+.. +++.||+|++.....  ......+.+|++++++++|||||++++.+..  .+..++|
T Consensus         2 ~f~~~~~LG~G~~g~Vy~a~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~E~~il~~~~h~~iv~~~~~~~~--~~~~~lv   79 (382)
T cd05625           2 MFVKIKTLGIGAFGEVCLARKVDTKALYAMKTLRKKDVLLRNQVAHVKAERDILAEADNEWVVRLYYSFQD--KDNLYFV   79 (382)
T ss_pred             CcEEEEEEEeCCCEEEEEEEECCCCCEEEEEEEeHHHhhhHHHHHHHHHHHHHHHhCCCCcCCeEEEEEEe--CCEEEEE
Confidence            5778899999999999999875 688999999975432  2334678899999999999999999999854  5789999


Q ss_pred             EEcCCCCCHHHHhhhcCCCCCCCCHHHHHHHHHHHHHHHhhhhCCCCCCCceeecCCCCCceeecCCCCeEEeccccccc
Q 005586          487 YDFAPKGKLSKYLDQEEGSSNVLDWSTRVSIIIGIAKGIGYLHSSEVNKPAIVHRNLSVEKVLIDQQFNPLIADCGLHKL  566 (689)
Q Consensus       487 ~e~~~~gsL~~~L~~~~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~~~ivH~dlk~~NiLl~~~~~~kl~DfGla~~  566 (689)
                      |||+++|+|.+++....    .+++.....++.|++.||+|||+.+     |+||||||+|||++.++.+||+|||+++.
T Consensus        80 ~E~~~gg~L~~~l~~~~----~~~e~~~~~~~~qi~~al~~lH~~~-----ivHrDlKp~NILl~~~g~~kL~DFGla~~  150 (382)
T cd05625          80 MDYIPGGDMMSLLIRMG----IFPEDLARFYIAELTCAVESVHKMG-----FIHRDIKPDNILIDRDGHIKLTDFGLCTG  150 (382)
T ss_pred             EeCCCCCcHHHHHHhcC----CCCHHHHHHHHHHHHHHHHHHHhCC-----eecCCCCHHHEEECCCCCEEEeECCCCcc
Confidence            99999999999997643    3788888999999999999999987     99999999999999999999999999753


Q ss_pred             ccCCce----------------------------------------------eeeecCCCCCCCCCccccccCCCCCccc
Q 005586          567 LADDIV----------------------------------------------FSVLKTSAAMGYLAPEYVTTGRFTERSD  600 (689)
Q Consensus       567 ~~~~~~----------------------------------------------~~~~~~~~~~~y~aPE~~~~~~~~~ksD  600 (689)
                      +.....                                              .......||..|+|||++.+..++.++|
T Consensus       151 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~~D  230 (382)
T cd05625         151 FRWTHDSKYYQSGDHVRQDSMDFSNEWGDPANCRCGDRLKPLERRAARQHQRCLAHSLVGTPNYIAPEVLLRTGYTQLCD  230 (382)
T ss_pred             ccccccccccccccccccccccccccccccccccccccccchhhhhccccccccccccccCcccCCHHHhcCCCCCCeee
Confidence            310000                                              0001235788999999999989999999


Q ss_pred             chhHHHHHHHHHhCCCCcchhHHHHHhhhhhhHhhc--cccCCCCCHHHHHHHHHHHHHhccCCCCCCCC---HHHHHHH
Q 005586          601 IFAFGVIILQILTGSLVLTSSMRLAAESATFENFID--RNLKGKFSESEAAKLGKMALVCTHEDPENRPT---MEAVIEE  675 (689)
Q Consensus       601 V~sfGvvl~elltG~~p~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~~~~~l~~l~~~Cl~~dp~~RPs---~~evl~~  675 (689)
                      |||+||++|||+||+.||........    ...+..  ...........+.++.+++.+++ .+|++|++   +.|++++
T Consensus       231 iwSlGvil~elltG~~Pf~~~~~~~~----~~~i~~~~~~~~~p~~~~~s~~~~~li~~l~-~~p~~R~~~~~~~ei~~h  305 (382)
T cd05625         231 WWSVGVILYEMLVGQPPFLAQTPLET----QMKVINWQTSLHIPPQAKLSPEASDLIIKLC-RGPEDRLGKNGADEIKAH  305 (382)
T ss_pred             EEechHHHHHHHhCCCCCCCCCHHHH----HHHHHccCCCcCCCCcccCCHHHHHHHHHHc-cCHhHcCCCCCHHHHhcC
Confidence            99999999999999999965422211    111111  11111111122445566665554 49999987   8888876


Q ss_pred             H
Q 005586          676 L  676 (689)
Q Consensus       676 L  676 (689)
                      -
T Consensus       306 p  306 (382)
T cd05625         306 P  306 (382)
T ss_pred             C
Confidence            4

Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. Promoter methylation, loss of heterozygosity, and missense mutations targeting the LATS1 gene have also been found in human sarcomas and ovarian cancers. In addition, decreased expression of LATS1 is associated with an aggressive phenotype an

>cd07874 STKc_JNK3 Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 3

Probab=100.00  E-value=3.7e-37  Score=329.55  Aligned_cols=258  Identities=17%  Similarity=0.290  Sum_probs=199.2

Q ss_pred             HhccCCcccccccCCcceEEEEEec-CCcEEEEEEecccCC-chHHHHHHHHHHHHhccCCCcceeEeeEEEcCC----C
Q 005586          407 ATQCFSEVNLLGKGNFSSVYKGTLR-DGTLVAIRSINVTSC-KSEEAEFVKGLYLLTSLRHENIIRLRGFCCSRG----R  480 (689)
Q Consensus       407 at~~f~~~~~lg~G~~g~Vy~~~~~-~g~~vavK~l~~~~~-~~~~~~f~~e~~~l~~l~H~niv~l~g~~~~~~----~  480 (689)
                      ..++|...+.||+|+||.||++... .++.||||++..... ......+.+|+.+++.++||||+++++++....    .
T Consensus        15 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~   94 (355)
T cd07874          15 VLKRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIISLLNVFTPQKSLEEF   94 (355)
T ss_pred             hhhceeEEEEeeecCCEEEEEEEecCCCceEEEEEeCCcccChHHHHHHHHHHHHHHHhCCCchhceeeeeecccccccc
Confidence            4468999999999999999999875 688999999875432 234467889999999999999999999875432    2


Q ss_pred             CeEEEEEEcCCCCCHHHHhhhcCCCCCCCCHHHHHHHHHHHHHHHhhhhCCCCCCCceeecCCCCCceeecCCCCeEEec
Q 005586          481 GECFLIYDFAPKGKLSKYLDQEEGSSNVLDWSTRVSIIIGIAKGIGYLHSSEVNKPAIVHRNLSVEKVLIDQQFNPLIAD  560 (689)
Q Consensus       481 ~~~~lV~e~~~~gsL~~~L~~~~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~~~ivH~dlk~~NiLl~~~~~~kl~D  560 (689)
                      ...++||||+++ +|.+.+..      .+++..+..++.|++.||+|||+.+     |+||||||+|||+++++.+||+|
T Consensus        95 ~~~~lv~e~~~~-~l~~~~~~------~l~~~~~~~~~~qi~~aL~~LH~~g-----ivHrDikp~Nill~~~~~~kl~D  162 (355)
T cd07874          95 QDVYLVMELMDA-NLCQVIQM------ELDHERMSYLLYQMLCGIKHLHSAG-----IIHRDLKPSNIVVKSDCTLKILD  162 (355)
T ss_pred             ceeEEEhhhhcc-cHHHHHhh------cCCHHHHHHHHHHHHHHHHHHHhCC-----cccCCCChHHEEECCCCCEEEee
Confidence            357999999964 67777643      2788999999999999999999987     99999999999999999999999


Q ss_pred             ccccccccCCceeeeecCCCCCCCCCccccccCCCCCcccchhHHHHHHHHHhCCCCcchhHHHHHhhhh----------
Q 005586          561 CGLHKLLADDIVFSVLKTSAAMGYLAPEYVTTGRFTERSDIFAFGVIILQILTGSLVLTSSMRLAAESAT----------  630 (689)
Q Consensus       561 fGla~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~ksDV~sfGvvl~elltG~~p~~~~~~~~~~~~~----------  630 (689)
                      ||+++.......  .....++..|+|||++.+..++.++|||||||++|||++|+.||............          
T Consensus       163 fg~~~~~~~~~~--~~~~~~t~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~  240 (355)
T cd07874         163 FGLARTAGTSFM--MTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMVRHKILFPGRDYIDQWNKVIEQLGTPCPE  240 (355)
T ss_pred             CcccccCCCccc--cCCccccCCccCHHHHcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHH
Confidence            999986644321  22345778899999999889999999999999999999999998643211111000          


Q ss_pred             --------hhHhhccccC------------------CCCCHHHHHHHHHHHHHhccCCCCCCCCHHHHHHHHHh
Q 005586          631 --------FENFIDRNLK------------------GKFSESEAAKLGKMALVCTHEDPENRPTMEAVIEELTV  678 (689)
Q Consensus       631 --------~~~~~~~~~~------------------~~~~~~~~~~l~~l~~~Cl~~dp~~RPs~~evl~~L~~  678 (689)
                              ...+++....                  .........++.+++.+|++.||++|||+.|++++.+.
T Consensus       241 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dP~~Rps~~ell~hp~~  314 (355)
T cd07874         241 FMKKLQPTVRNYVENRPKYAGLTFPKLFPDSLFPADSEHNKLKASQARDLLSKMLVIDPAKRISVDEALQHPYI  314 (355)
T ss_pred             HHHhhcHHHHHHHhcCCccccccchhhccccccccccccccccchHHHHHHHHHhcCCchhcCCHHHHhcCcch
Confidence                    0011100000                  00111224578899999999999999999999998544

Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 3 (JNK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK3 is expressed primarily in the brain, and to a lesser extent in the heart and testis. Mice deficient in Jnk3 are protected against kainic acid-induced seizures, strok

>cd06640 STKc_MST4 Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 4

Probab=100.00  E-value=1.1e-36  Score=314.23  Aligned_cols=252  Identities=20%  Similarity=0.371  Sum_probs=207.1

Q ss_pred             cCCcccccccCCcceEEEEEec-CCcEEEEEEecccCCchHHHHHHHHHHHHhccCCCcceeEeeEEEcCCCCeEEEEEE
Q 005586          410 CFSEVNLLGKGNFSSVYKGTLR-DGTLVAIRSINVTSCKSEEAEFVKGLYLLTSLRHENIIRLRGFCCSRGRGECFLIYD  488 (689)
Q Consensus       410 ~f~~~~~lg~G~~g~Vy~~~~~-~g~~vavK~l~~~~~~~~~~~f~~e~~~l~~l~H~niv~l~g~~~~~~~~~~~lV~e  488 (689)
                      .|+..+.||+|+||.||+|... ++..||+|.+...........|.+|++++++++||||+++++++..  ....++|||
T Consensus         5 ~y~~~~~lg~g~~~~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~--~~~~~lv~e   82 (277)
T cd06640           5 LFTKLERIGKGSFGEVFKGIDNRTQQVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYVTKYYGSYLK--GTKLWIIME   82 (277)
T ss_pred             hhhhhhhcccCCCeEEEEEEEccCCEEEEEEEEeccccHHHHHHHHHHHHHHHhCCCCCEeeEEEEEEE--CCEEEEEEe
Confidence            4666788999999999999975 5889999998866544556789999999999999999999999854  478999999


Q ss_pred             cCCCCCHHHHhhhcCCCCCCCCHHHHHHHHHHHHHHHhhhhCCCCCCCceeecCCCCCceeecCCCCeEEeccccccccc
Q 005586          489 FAPKGKLSKYLDQEEGSSNVLDWSTRVSIIIGIAKGIGYLHSSEVNKPAIVHRNLSVEKVLIDQQFNPLIADCGLHKLLA  568 (689)
Q Consensus       489 ~~~~gsL~~~L~~~~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~~~ivH~dlk~~NiLl~~~~~~kl~DfGla~~~~  568 (689)
                      |+++|+|.+++...     .+++.....++.|++.||+|||+.+     ++|+||+|+||++++++.++|+|||++....
T Consensus        83 ~~~~~~L~~~i~~~-----~l~~~~~~~~~~~l~~~l~~lh~~~-----ivH~dl~p~Nil~~~~~~~~l~dfg~~~~~~  152 (277)
T cd06640          83 YLGGGSALDLLRAG-----PFDEFQIATMLKEILKGLDYLHSEK-----KIHRDIKAANVLLSEQGDVKLADFGVAGQLT  152 (277)
T ss_pred             cCCCCcHHHHHhcC-----CCCHHHHHHHHHHHHHHHHHHHhCC-----ccCcCCChhhEEEcCCCCEEEcccccceecc
Confidence            99999999998642     3788999999999999999999987     9999999999999999999999999997664


Q ss_pred             CCceeeeecCCCCCCCCCccccccCCCCCcccchhHHHHHHHHHhCCCCcchhHHHHHhhhhhhHhhccccCCCCCHHHH
Q 005586          569 DDIVFSVLKTSAAMGYLAPEYVTTGRFTERSDIFAFGVIILQILTGSLVLTSSMRLAAESATFENFIDRNLKGKFSESEA  648 (689)
Q Consensus       569 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~ksDV~sfGvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  648 (689)
                      .... ......++..|+|||++.+..++.++|||||||++|||+||+.|+........     ...+............+
T Consensus       153 ~~~~-~~~~~~~~~~y~apE~~~~~~~~~~~Dv~slG~il~el~tg~~p~~~~~~~~~-----~~~~~~~~~~~~~~~~~  226 (277)
T cd06640         153 DTQI-KRNTFVGTPFWMAPEVIQQSAYDSKADIWSLGITAIELAKGEPPNSDMHPMRV-----LFLIPKNNPPTLTGEFS  226 (277)
T ss_pred             CCcc-ccccccCcccccCHhHhccCCCccHHHHHHHHHHHHHHHHCCCCCCCcChHhH-----hhhhhcCCCCCCchhhh
Confidence            4321 11223466789999999888899999999999999999999999864322111     11112222334455677


Q ss_pred             HHHHHHHHHhccCCCCCCCCHHHHHHHHHhh
Q 005586          649 AKLGKMALVCTHEDPENRPTMEAVIEELTVA  679 (689)
Q Consensus       649 ~~l~~l~~~Cl~~dp~~RPs~~evl~~L~~~  679 (689)
                      ..+.+++..||+.+|++||++.+++++....
T Consensus       227 ~~~~~li~~~l~~~p~~Rp~~~~il~~~~~~  257 (277)
T cd06640         227 KPFKEFIDACLNKDPSFRPTAKELLKHKFIV  257 (277)
T ss_pred             HHHHHHHHHHcccCcccCcCHHHHHhChHhh
Confidence            8899999999999999999999999886544

Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 4 (MST4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST4 is sometimes referred to as MASK (MST3 and SOK1-related kinase). It plays a role in mitogen-activated protein kinase (MAPK) signaling during cytoskeletal rearrangement, morphogenesis, and apoptosis. It influences cell growth and transformation by modulating the extracellular signal-regulated kinase (ERK) pathway. MST4 may also play a role in tumor formation and progression. It localizes in the Golgi apparatus by inter

>cd05597 STKc_DMPK_like Catalytic domain of Myotonic Dystrophy protein kinase-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=4.4e-37  Score=325.49  Aligned_cols=255  Identities=18%  Similarity=0.257  Sum_probs=196.2

Q ss_pred             ccCCcccccccCCcceEEEEEec-CCcEEEEEEecccC--CchHHHHHHHHHHHHhccCCCcceeEeeEEEcCCCCeEEE
Q 005586          409 QCFSEVNLLGKGNFSSVYKGTLR-DGTLVAIRSINVTS--CKSEEAEFVKGLYLLTSLRHENIIRLRGFCCSRGRGECFL  485 (689)
Q Consensus       409 ~~f~~~~~lg~G~~g~Vy~~~~~-~g~~vavK~l~~~~--~~~~~~~f~~e~~~l~~l~H~niv~l~g~~~~~~~~~~~l  485 (689)
                      ++|...+.||+|+||.||+++.+ +++.||+|++....  .....+.|.+|+.++..++|+||+++++++.  ..+..++
T Consensus         1 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~--~~~~~~l   78 (331)
T cd05597           1 DDFEILKVIGRGAFGEVAVVKMKNTGQVYAMKILNKWEMLKRAETACFREERDVLVNGDRRWITNLHYAFQ--DENNLYL   78 (331)
T ss_pred             CCceEEEEEEecCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhhHHHHHHHHHHHHhCCCCCCCceEEEEe--cCCeEEE
Confidence            36788899999999999999976 68999999997532  1233456889999999999999999999884  3578999


Q ss_pred             EEEcCCCCCHHHHhhhcCCCCCCCCHHHHHHHHHHHHHHHhhhhCCCCCCCceeecCCCCCceeecCCCCeEEecccccc
Q 005586          486 IYDFAPKGKLSKYLDQEEGSSNVLDWSTRVSIIIGIAKGIGYLHSSEVNKPAIVHRNLSVEKVLIDQQFNPLIADCGLHK  565 (689)
Q Consensus       486 V~e~~~~gsL~~~L~~~~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~~~ivH~dlk~~NiLl~~~~~~kl~DfGla~  565 (689)
                      ||||+++|+|.+++....   ..+++..+..++.||+.||+|||+.+     |+||||||+|||++.++.+||+|||+++
T Consensus        79 v~e~~~g~~L~~~l~~~~---~~~~~~~~~~~~~qi~~~l~~lH~~~-----ivH~dlkp~Nill~~~~~~kl~Dfg~~~  150 (331)
T cd05597          79 VMDYYVGGDLLTLLSKFE---DRLPEDMARFYLAEMVLAIDSVHQLG-----YVHRDIKPDNVLLDKNGHIRLADFGSCL  150 (331)
T ss_pred             EEecCCCCcHHHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHhCC-----eEECCCCHHHEEECCCCCEEEEECCcee
Confidence            999999999999997533   24889999999999999999999987     9999999999999999999999999987


Q ss_pred             cccCCceeeeecCCCCCCCCCcccccc-----CCCCCcccchhHHHHHHHHHhCCCCcchhHHHHHhhhhhhHhhccccC
Q 005586          566 LLADDIVFSVLKTSAAMGYLAPEYVTT-----GRFTERSDIFAFGVIILQILTGSLVLTSSMRLAAESATFENFIDRNLK  640 (689)
Q Consensus       566 ~~~~~~~~~~~~~~~~~~y~aPE~~~~-----~~~~~ksDV~sfGvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~  640 (689)
                      ..............+|..|+|||++..     ..++.++|||||||++|||++|+.||........    ...+......
T Consensus       151 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwslG~~l~el~~g~~Pf~~~~~~~~----~~~i~~~~~~  226 (331)
T cd05597         151 RLLADGTVQSNVAVGTPDYISPEILQAMEDGKGRYGPECDWWSLGVCMYEMLYGETPFYAESLVET----YGKIMNHKEH  226 (331)
T ss_pred             ecCCCCCccccceeccccccCHHHHhhccccccCCCCcceeehhhhHHHHHhhCCCCCCCCCHHHH----HHHHHcCCCc
Confidence            664433222222457889999999863     4578899999999999999999999965322111    1111111100


Q ss_pred             CCC---CHHHHHHHHHHHHHhccCCC--CCCCCHHHHHHHHH
Q 005586          641 GKF---SESEAAKLGKMALVCTHEDP--ENRPTMEAVIEELT  677 (689)
Q Consensus       641 ~~~---~~~~~~~l~~l~~~Cl~~dp--~~RPs~~evl~~L~  677 (689)
                      ...   ....+..+.+++.+|+..++  ..||++.+++++.+
T Consensus       227 ~~~~~~~~~~~~~~~~li~~ll~~~~~r~~r~~~~~~l~hp~  268 (331)
T cd05597         227 FQFPPDVTDVSEEAKDLIRRLICSPETRLGRNGLQDFKDHPF  268 (331)
T ss_pred             ccCCCccCCCCHHHHHHHHHHccCcccccCCCCHHHHhcCCC
Confidence            111   11235567777777665433  44889999998854

Serine/Threonine Kinases (STKs), Myotonic Dystrophy protein kinase (DMPK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The DMPK-like subfamily is composed of DMPK and DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK). Three isoforms of MRCK are known, named alpha, beta and gamma. The DMPK gene is implicated in myotonic dystrophy 1 (DM1), an inherited multisystemic disorder with symptoms that include muscle hyperexcitability, progressive muscle weakness and wasting, cataract development, testicular atrophy,

>cd05575 STKc_SGK Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase

Probab=100.00  E-value=2.5e-37  Score=326.32  Aligned_cols=243  Identities=21%  Similarity=0.349  Sum_probs=190.4

Q ss_pred             cccccCCcceEEEEEec-CCcEEEEEEecccCC--chHHHHHHHHHH-HHhccCCCcceeEeeEEEcCCCCeEEEEEEcC
Q 005586          415 NLLGKGNFSSVYKGTLR-DGTLVAIRSINVTSC--KSEEAEFVKGLY-LLTSLRHENIIRLRGFCCSRGRGECFLIYDFA  490 (689)
Q Consensus       415 ~~lg~G~~g~Vy~~~~~-~g~~vavK~l~~~~~--~~~~~~f~~e~~-~l~~l~H~niv~l~g~~~~~~~~~~~lV~e~~  490 (689)
                      +.||+|+||.||+|+.+ +|+.||+|++.....  .....++..|.. +++.++||||+++++++..  .+..++||||+
T Consensus         1 ~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~~~~~l~hp~iv~~~~~~~~--~~~~~lv~e~~   78 (323)
T cd05575           1 KVIGKGSFGKVLLAKHKADGKFYAVKVLQKKAILKKKEQKHIMAERNVLLKNVKHPFLVGLHYSFQT--ADKLYFVLDYV   78 (323)
T ss_pred             CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhHHHHHHHHHHHHHhhCCCCCCCCeeEEEEe--CCEEEEEEcCC
Confidence            36999999999999986 799999999975431  223345555554 5678999999999998844  57899999999


Q ss_pred             CCCCHHHHhhhcCCCCCCCCHHHHHHHHHHHHHHHhhhhCCCCCCCceeecCCCCCceeecCCCCeEEecccccccccCC
Q 005586          491 PKGKLSKYLDQEEGSSNVLDWSTRVSIIIGIAKGIGYLHSSEVNKPAIVHRNLSVEKVLIDQQFNPLIADCGLHKLLADD  570 (689)
Q Consensus       491 ~~gsL~~~L~~~~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~~~ivH~dlk~~NiLl~~~~~~kl~DfGla~~~~~~  570 (689)
                      ++|+|..++....    .+++..+..++.||+.||+|||+.+     |+||||||+|||+++++.+||+|||+++.....
T Consensus        79 ~~g~L~~~l~~~~----~~~~~~~~~~~~qi~~~l~~lH~~g-----ivH~dikp~NIll~~~~~~kl~Dfg~~~~~~~~  149 (323)
T cd05575          79 NGGELFFHLQRER----SFPEPRARFYAAEIASALGYLHSLN-----IIYRDLKPENILLDSQGHVVLTDFGLCKEGIEH  149 (323)
T ss_pred             CCCCHHHHHHhcC----CCCHHHHHHHHHHHHHHHHHHHHCC-----eEeCCCCHHHeEECCCCcEEEeccCCCcccccC
Confidence            9999999997643    4889999999999999999999987     999999999999999999999999998754222


Q ss_pred             ceeeeecCCCCCCCCCccccccCCCCCcccchhHHHHHHHHHhCCCCcchhHHHHHhhhhhhHhhccccCCCCCHHHHHH
Q 005586          571 IVFSVLKTSAAMGYLAPEYVTTGRFTERSDIFAFGVIILQILTGSLVLTSSMRLAAESATFENFIDRNLKGKFSESEAAK  650 (689)
Q Consensus       571 ~~~~~~~~~~~~~y~aPE~~~~~~~~~ksDV~sfGvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  650 (689)
                      .. ......++..|+|||++.+..++.++|||||||++|||++|+.||.......    ....+.....  ..+...+..
T Consensus       150 ~~-~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ell~g~~pf~~~~~~~----~~~~i~~~~~--~~~~~~~~~  222 (323)
T cd05575         150 SK-TTSTFCGTPEYLAPEVLRKQPYDRTVDWWCLGAVLYEMLYGLPPFYSRDTAE----MYDNILNKPL--RLKPNISVS  222 (323)
T ss_pred             CC-ccccccCChhhcChhhhcCCCCCccccccccchhhhhhhcCCCCCCCCCHHH----HHHHHHcCCC--CCCCCCCHH
Confidence            11 1223457889999999999999999999999999999999999996532211    1112222111  122334667


Q ss_pred             HHHHHHHhccCCCCCCCCHH----HHHHH
Q 005586          651 LGKMALVCTHEDPENRPTME----AVIEE  675 (689)
Q Consensus       651 l~~l~~~Cl~~dp~~RPs~~----evl~~  675 (689)
                      +.+++.+|++.||++||++.    |++++
T Consensus       223 ~~~li~~~l~~~p~~R~~~~~~~~~il~~  251 (323)
T cd05575         223 ARHLLEGLLQKDRTKRLGAKDDFLEIKNH  251 (323)
T ss_pred             HHHHHHHHhhcCHHhCCCCCCCHHHHHcC
Confidence            89999999999999999874    66554

Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGKs are activated by insulin and growth factors via phosphoinositide 3-kinase and PDK1. They activate ion channels, ion carriers, and the Na-K-ATPase, as well as regulate the activity of enzymes and transcription factors. SGKs play important roles in transport, hormone release, neuroexcitability, cell pr

>cd05076 PTK_Tyk2_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2

Probab=100.00  E-value=5.9e-37  Score=315.72  Aligned_cols=239  Identities=21%  Similarity=0.436  Sum_probs=186.1

Q ss_pred             ccccCCcceEEEEEecC-------------------------CcEEEEEEecccCCchHHHHHHHHHHHHhccCCCccee
Q 005586          416 LLGKGNFSSVYKGTLRD-------------------------GTLVAIRSINVTSCKSEEAEFVKGLYLLTSLRHENIIR  470 (689)
Q Consensus       416 ~lg~G~~g~Vy~~~~~~-------------------------g~~vavK~l~~~~~~~~~~~f~~e~~~l~~l~H~niv~  470 (689)
                      .||+|+||.||+|.+..                         ...|++|++.... .....+|.+|+.++++++||||++
T Consensus         2 ~lG~G~~~~vy~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~v~~k~~~~~~-~~~~~~~~~~~~~~~~l~h~niv~   80 (274)
T cd05076           2 HLGQGTRTNIYDGRLRVEGGGEPEEDEMEDEDPLVEGNNNGRELRVVLKVLDPSH-RDIALAFFETASLMSQVSHIHLAF   80 (274)
T ss_pred             CcCcccccceecceeEeccCCCCcccccccccccccccCCCeeeeEEEEecChHH-HHHHHHHHHHHHHHhcCCCCCeee
Confidence            59999999999997521                         2358899886543 233467899999999999999999


Q ss_pred             EeeEEEcCCCCeEEEEEEcCCCCCHHHHhhhcCCCCCCCCHHHHHHHHHHHHHHHhhhhCCCCCCCceeecCCCCCceee
Q 005586          471 LRGFCCSRGRGECFLIYDFAPKGKLSKYLDQEEGSSNVLDWSTRVSIIIGIAKGIGYLHSSEVNKPAIVHRNLSVEKVLI  550 (689)
Q Consensus       471 l~g~~~~~~~~~~~lV~e~~~~gsL~~~L~~~~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~~~ivH~dlk~~NiLl  550 (689)
                      ++++|..  ....++||||+++|+|..++....+   .+++..++.++.|+++||+|||+.+     |+||||||+|||+
T Consensus        81 ~~~~~~~--~~~~~lv~ey~~~g~L~~~l~~~~~---~~~~~~~~~i~~qi~~~l~~lH~~~-----iiH~dlkp~Nill  150 (274)
T cd05076          81 VHGVCVR--GSENIMVEEFVEHGPLDVCLRKEKG---RVPVAWKITVAQQLASALSYLEDKN-----LVHGNVCAKNILL  150 (274)
T ss_pred             EEEEEEe--CCceEEEEecCCCCcHHHHHHhcCC---CCCHHHHHHHHHHHHHHHHHHHcCC-----ccCCCCCcccEEE
Confidence            9999965  4678999999999999999975432   4889999999999999999999887     9999999999999


Q ss_pred             cCCC-------CeEEecccccccccCCceeeeecCCCCCCCCCcccccc-CCCCCcccchhHHHHHHHHH-hCCCCcchh
Q 005586          551 DQQF-------NPLIADCGLHKLLADDIVFSVLKTSAAMGYLAPEYVTT-GRFTERSDIFAFGVIILQIL-TGSLVLTSS  621 (689)
Q Consensus       551 ~~~~-------~~kl~DfGla~~~~~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~ksDV~sfGvvl~ell-tG~~p~~~~  621 (689)
                      ++++       .+|++|||++......     ....++..|+|||.+.+ ..++.++|||||||++|||+ +|+.|+...
T Consensus       151 ~~~~~~~~~~~~~kl~d~g~~~~~~~~-----~~~~~~~~~~aPe~~~~~~~~~~~~Dv~slG~~l~el~~~g~~p~~~~  225 (274)
T cd05076         151 ARLGLAEGTSPFIKLSDPGVSFTALSR-----EERVERIPWIAPECVPGGNSLSTAADKWSFGTTLLEICFDGEVPLKER  225 (274)
T ss_pred             eccCcccCccceeeecCCccccccccc-----cccccCCcccCchhhcCCCCCCcHHHHHHHHHHHHHHHhCCCCCcccc
Confidence            8654       3799999988644321     12235677999998865 56899999999999999994 789888643


Q ss_pred             HHHHHhhhhhhHhhccccCCCCCHHHHHHHHHHHHHhccCCCCCCCCHHHHHHHHH
Q 005586          622 MRLAAESATFENFIDRNLKGKFSESEAAKLGKMALVCTHEDPENRPTMEAVIEELT  677 (689)
Q Consensus       622 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~Cl~~dp~~RPs~~evl~~L~  677 (689)
                      .....     ........  ..+......+.+++.+||+.+|++||+|.+|+++|.
T Consensus       226 ~~~~~-----~~~~~~~~--~~~~~~~~~~~~li~~cl~~~p~~Rps~~~il~~L~  274 (274)
T cd05076         226 TPSEK-----ERFYEKKH--RLPEPSCKELATLISQCLTYEPTQRPSFRTILRDLT  274 (274)
T ss_pred             ChHHH-----HHHHHhcc--CCCCCCChHHHHHHHHHcccChhhCcCHHHHHHhhC
Confidence            22111     11111111  122223356899999999999999999999999873

Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalyt

>cd07872 STKc_PCTAIRE2 Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-2 kinase

Probab=100.00  E-value=3.6e-37  Score=323.16  Aligned_cols=260  Identities=18%  Similarity=0.360  Sum_probs=199.9

Q ss_pred             ccCCcccccccCCcceEEEEEec-CCcEEEEEEecccCCchHHHHHHHHHHHHhccCCCcceeEeeEEEcCCCCeEEEEE
Q 005586          409 QCFSEVNLLGKGNFSSVYKGTLR-DGTLVAIRSINVTSCKSEEAEFVKGLYLLTSLRHENIIRLRGFCCSRGRGECFLIY  487 (689)
Q Consensus       409 ~~f~~~~~lg~G~~g~Vy~~~~~-~g~~vavK~l~~~~~~~~~~~f~~e~~~l~~l~H~niv~l~g~~~~~~~~~~~lV~  487 (689)
                      ++|...+.||+|+||.||+|+.+ ++..||+|+++..........+.+|++++++++||||+++++++..  .+..++||
T Consensus         6 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~--~~~~~lv~   83 (309)
T cd07872           6 ETYIKLEKLGEGTYATVFKGRSKLTENLVALKEIRLEHEEGAPCTAIREVSLLKDLKHANIVTLHDIVHT--DKSLTLVF   83 (309)
T ss_pred             CceEEEEEecccCCEEEEEEEecCCCCeEEEEEeeccccCCcchhHHHHHHHHHhCCCCCcceEEEEEee--CCeEEEEE
Confidence            45777899999999999999876 6889999999765544444578899999999999999999999854  46799999


Q ss_pred             EcCCCCCHHHHhhhcCCCCCCCCHHHHHHHHHHHHHHHhhhhCCCCCCCceeecCCCCCceeecCCCCeEEecccccccc
Q 005586          488 DFAPKGKLSKYLDQEEGSSNVLDWSTRVSIIIGIAKGIGYLHSSEVNKPAIVHRNLSVEKVLIDQQFNPLIADCGLHKLL  567 (689)
Q Consensus       488 e~~~~gsL~~~L~~~~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~~~ivH~dlk~~NiLl~~~~~~kl~DfGla~~~  567 (689)
                      ||+++ +|.+++....   ..+++..+..++.|++.||+|||+.+     |+||||||+||++++++.+||+|||+++..
T Consensus        84 e~~~~-~l~~~~~~~~---~~~~~~~~~~~~~qi~~aL~~lH~~~-----ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~  154 (309)
T cd07872          84 EYLDK-DLKQYMDDCG---NIMSMHNVKIFLYQILRGLAYCHRRK-----VLHRDLKPQNLLINERGELKLADFGLARAK  154 (309)
T ss_pred             eCCCC-CHHHHHHhcC---CCCCHHHHHHHHHHHHHHHHHHHHCC-----eecCCCCHHHEEECCCCCEEECccccceec
Confidence            99975 8888886543   24789999999999999999999987     999999999999999999999999998765


Q ss_pred             cCCceeeeecCCCCCCCCCcccccc-CCCCCcccchhHHHHHHHHHhCCCCcchhHHHHHhhh-----------hhhHh-
Q 005586          568 ADDIVFSVLKTSAAMGYLAPEYVTT-GRFTERSDIFAFGVIILQILTGSLVLTSSMRLAAESA-----------TFENF-  634 (689)
Q Consensus       568 ~~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~ksDV~sfGvvl~elltG~~p~~~~~~~~~~~~-----------~~~~~-  634 (689)
                      ..... ......++..|+|||.+.+ ..++.++|||||||++|||+||+.||...........           .+..+ 
T Consensus       155 ~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~  233 (309)
T cd07872         155 SVPTK-TYSNEVVTLWYRPPDVLLGSSEYSTQIDMWGVGCIFFEMASGRPLFPGSTVEDELHLIFRLLGTPTEETWPGIS  233 (309)
T ss_pred             CCCcc-ccccccccccccCCHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHHhhhc
Confidence            33221 1122346778999998765 4688999999999999999999999964321111000           00000 


Q ss_pred             -----hccccCCC-------CCHHHHHHHHHHHHHhccCCCCCCCCHHHHHHHHHhhC
Q 005586          635 -----IDRNLKGK-------FSESEAAKLGKMALVCTHEDPENRPTMEAVIEELTVAA  680 (689)
Q Consensus       635 -----~~~~~~~~-------~~~~~~~~l~~l~~~Cl~~dp~~RPs~~evl~~L~~~~  680 (689)
                           .+......       .....+.++.+++.+|++.||++|||+.|++++.+...
T Consensus       234 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~t~~e~l~h~~~~~  291 (309)
T cd07872         234 SNDEFKNYNFPKYKPQPLINHAPRLDTEGIELLTKFLQYESKKRISAEEAMKHAYFRS  291 (309)
T ss_pred             chhhhhhhhcCccCCCchhhhccCCCHHHHHHHHHhccCChhhCCCHHHHhcChhhhh
Confidence                 00000000       00123457889999999999999999999999876553

Serine/Threonine Kinases (STKs), PCTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-2 is specifically expressed in neurons in the central nervous system, mainly in terminally differentiated neurons. It associates with Trap (Tudor repeat associator with PCTAIRE-2) and could play

>cd05077 PTK_Jak1_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinase, Janus kinase 1

Probab=100.00  E-value=1.6e-36  Score=310.41  Aligned_cols=239  Identities=20%  Similarity=0.420  Sum_probs=187.0

Q ss_pred             cccccCCcceEEEEEecC-------------CcEEEEEEecccCCchHHHHHHHHHHHHhccCCCcceeEeeEEEcCCCC
Q 005586          415 NLLGKGNFSSVYKGTLRD-------------GTLVAIRSINVTSCKSEEAEFVKGLYLLTSLRHENIIRLRGFCCSRGRG  481 (689)
Q Consensus       415 ~~lg~G~~g~Vy~~~~~~-------------g~~vavK~l~~~~~~~~~~~f~~e~~~l~~l~H~niv~l~g~~~~~~~~  481 (689)
                      +.||+|+||.||+|.+.+             ...|++|.+.... ......|.+|+.+++.++||||+++++++..  ..
T Consensus         1 ~~lg~G~~~~vy~~~~~~~~~~~~~~~~~~~~~~v~~k~~~~~~-~~~~~~~~~~~~~l~~l~hp~iv~~~~~~~~--~~   77 (262)
T cd05077           1 EHLGRGTRTQIYAGILNYKDDDEDDGYSYEKEIKVILKVLDPSH-RDISLAFFETASMMRQVSHKHIVLLYGVCVR--DV   77 (262)
T ss_pred             CccccCCcceEeeeecccCCCccccccchhhceeEEEeecChhh-hhHHHHHHHHHHHHHhCCCCCEeeEEEEEec--CC
Confidence            368999999999998532             2358889876543 3344578899999999999999999999854  46


Q ss_pred             eEEEEEEcCCCCCHHHHhhhcCCCCCCCCHHHHHHHHHHHHHHHhhhhCCCCCCCceeecCCCCCceeecCCCC------
Q 005586          482 ECFLIYDFAPKGKLSKYLDQEEGSSNVLDWSTRVSIIIGIAKGIGYLHSSEVNKPAIVHRNLSVEKVLIDQQFN------  555 (689)
Q Consensus       482 ~~~lV~e~~~~gsL~~~L~~~~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~~~ivH~dlk~~NiLl~~~~~------  555 (689)
                      ..++||||+++|+|..+++...   ..+++..+++|+.|+++||+|||+.+     |+||||||+|||++.++.      
T Consensus        78 ~~~lv~e~~~~~~l~~~~~~~~---~~~~~~~~~~i~~qi~~~l~~lH~~~-----ivH~dlkp~Nill~~~~~~~~~~~  149 (262)
T cd05077          78 ENIMVEEFVEFGPLDLFMHRKS---DVLTTPWKFKVAKQLASALSYLEDKD-----LVHGNVCTKNILLAREGIDGECGP  149 (262)
T ss_pred             CCEEEEecccCCCHHHHHHhcC---CCCCHHHHHHHHHHHHHHHHHhhhCC-----eECCCCCcccEEEecCCccCCCCc
Confidence            7899999999999999987543   24899999999999999999999987     999999999999987664      


Q ss_pred             -eEEecccccccccCCceeeeecCCCCCCCCCccccc-cCCCCCcccchhHHHHHHHHH-hCCCCcchhHHHHHhhhhhh
Q 005586          556 -PLIADCGLHKLLADDIVFSVLKTSAAMGYLAPEYVT-TGRFTERSDIFAFGVIILQIL-TGSLVLTSSMRLAAESATFE  632 (689)
Q Consensus       556 -~kl~DfGla~~~~~~~~~~~~~~~~~~~y~aPE~~~-~~~~~~ksDV~sfGvvl~ell-tG~~p~~~~~~~~~~~~~~~  632 (689)
                       +|++|||++......     ....++..|+|||.+. +..++.++|||||||++|||+ +|+.|+........     .
T Consensus       150 ~~~l~d~g~~~~~~~~-----~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~el~~~~~~p~~~~~~~~~-----~  219 (262)
T cd05077         150 FIKLSDPGIPITVLSR-----QECVERIPWIAPECVEDSKNLSIAADKWSFGTTLWEICYNGEIPLKDKTLAEK-----E  219 (262)
T ss_pred             eeEeCCCCCCccccCc-----ccccccccccChhhhcCCCCCCchhHHHHHHHHHHHHHhCCCCCCCCcchhHH-----H
Confidence             899999998765322     1234667899999886 466899999999999999997 58888754321111     1


Q ss_pred             HhhccccCCCCCHHHHHHHHHHHHHhccCCCCCCCCHHHHHHHH
Q 005586          633 NFIDRNLKGKFSESEAAKLGKMALVCTHEDPENRPTMEAVIEEL  676 (689)
Q Consensus       633 ~~~~~~~~~~~~~~~~~~l~~l~~~Cl~~dp~~RPs~~evl~~L  676 (689)
                      .+......  .......++.+++.+||+.||++||++.++++++
T Consensus       220 ~~~~~~~~--~~~~~~~~~~~li~~cl~~dp~~Rp~~~~il~~~  261 (262)
T cd05077         220 RFYEGQCM--LVTPSCKELADLMTHCMNYDPNQRPFFRAIMRDI  261 (262)
T ss_pred             HHHhcCcc--CCCCChHHHHHHHHHHcCCChhhCcCHHHHHHhc
Confidence            11111111  1112245788999999999999999999999876

Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic dom

>KOG0584 consensus Serine/threonine protein kinase [General function prediction only]

Probab=100.00  E-value=6.7e-38  Score=329.45  Aligned_cols=247  Identities=23%  Similarity=0.385  Sum_probs=201.0

Q ss_pred             cccccCCcceEEEEEec-CCcEEEEEEecccC---CchHHHHHHHHHHHHhccCCCcceeEeeEEEcCCCCeEEEEEEcC
Q 005586          415 NLLGKGNFSSVYKGTLR-DGTLVAIRSINVTS---CKSEEAEFVKGLYLLTSLRHENIIRLRGFCCSRGRGECFLIYDFA  490 (689)
Q Consensus       415 ~~lg~G~~g~Vy~~~~~-~g~~vavK~l~~~~---~~~~~~~f~~e~~~l~~l~H~niv~l~g~~~~~~~~~~~lV~e~~  490 (689)
                      .+||+|+|-+||||.+. +|..||.-.++...   .....+.|..|+.+|+.|+|||||+++.++.+......-+|+|.|
T Consensus        46 evLGrGafKtVYka~De~~giEVAWnqvk~~d~~q~~~~leR~~~Ev~lLKsL~H~NIirfy~SW~d~~n~~in~iTEL~  125 (632)
T KOG0584|consen   46 EVLGRGAFKTVYKAFDEEEGIEVAWNQVKIRDVTQSPEELERLYSEVHLLKSLKHPNIIRFYDSWVDTDNKTINFITELF  125 (632)
T ss_pred             hhcccccceeeeeccccccchhhHHHHHhHHHhhcChHHHHHHHHHHHHHccCCCCceeeeeeheecCCCceeeeeeecc
Confidence            57999999999999976 68888865444332   233447899999999999999999999999888777889999999


Q ss_pred             CCCCHHHHhhhcCCCCCCCCHHHHHHHHHHHHHHHhhhhCCCCCCCceeecCCCCCceeecC-CCCeEEecccccccccC
Q 005586          491 PKGKLSKYLDQEEGSSNVLDWSTRVSIIIGIAKGIGYLHSSEVNKPAIVHRNLSVEKVLIDQ-QFNPLIADCGLHKLLAD  569 (689)
Q Consensus       491 ~~gsL~~~L~~~~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~~~ivH~dlk~~NiLl~~-~~~~kl~DfGla~~~~~  569 (689)
                      ..|+|..|+...+.    ++.....++++||++||.|||+..   |||||||||-.||+|+. .|.+||+|.|||..+..
T Consensus       126 TSGtLr~Y~kk~~~----vn~kaik~W~RQILkGL~yLHs~~---PPIIHRDLKCDNIFinG~~G~VKIGDLGLAtl~r~  198 (632)
T KOG0584|consen  126 TSGTLREYRKKHRR----VNIKAIKSWCRQILKGLVYLHSQD---PPIIHRDLKCDNIFVNGNLGEVKIGDLGLATLLRK  198 (632)
T ss_pred             cCCcHHHHHHHhcc----CCHHHHHHHHHHHHHHhhhhhcCC---CCccccccccceEEEcCCcCceeecchhHHHHhhc
Confidence            99999999988753    788899999999999999999964   99999999999999985 68999999999998876


Q ss_pred             CceeeeecCCCCCCCCCccccccCCCCCcccchhHHHHHHHHHhCCCCcchhHHHHHhhhhhhHhhccccCCCCCHHHHH
Q 005586          570 DIVFSVLKTSAAMGYLAPEYVTTGRFTERSDIFAFGVIILQILTGSLVLTSSMRLAAESATFENFIDRNLKGKFSESEAA  649 (689)
Q Consensus       570 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~ksDV~sfGvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  649 (689)
                      ...   ....||+.|||||... ..|++.+||||||++|+||+|+..||..-...+...   ..++.......+..-...
T Consensus       199 s~a---ksvIGTPEFMAPEmYE-E~YnE~VDVYaFGMCmLEMvT~eYPYsEC~n~AQIY---KKV~SGiKP~sl~kV~dP  271 (632)
T KOG0584|consen  199 SHA---KSVIGTPEFMAPEMYE-ENYNELVDVYAFGMCMLEMVTSEYPYSECTNPAQIY---KKVTSGIKPAALSKVKDP  271 (632)
T ss_pred             ccc---ceeccCccccChHHHh-hhcchhhhhhhhhHHHHHHHhccCChhhhCCHHHHH---HHHHcCCCHHHhhccCCH
Confidence            532   2367999999999876 789999999999999999999999996543333322   222211111111111245


Q ss_pred             HHHHHHHHhccCCCCCCCCHHHHHHHH
Q 005586          650 KLGKMALVCTHEDPENRPTMEAVIEEL  676 (689)
Q Consensus       650 ~l~~l~~~Cl~~dp~~RPs~~evl~~L  676 (689)
                      ++.+++..|+.. .++|||+.|++++-
T Consensus       272 evr~fIekCl~~-~~~R~sa~eLL~d~  297 (632)
T KOG0584|consen  272 EVREFIEKCLAT-KSERLSAKELLKDP  297 (632)
T ss_pred             HHHHHHHHHhcC-chhccCHHHHhhCh
Confidence            789999999999 99999999999874

>cd05615 STKc_cPKC_alpha Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C alpha

Probab=100.00  E-value=5.1e-37  Score=323.86  Aligned_cols=242  Identities=19%  Similarity=0.288  Sum_probs=192.7

Q ss_pred             cCCcccccccCCcceEEEEEec-CCcEEEEEEecccCC--chHHHHHHHHHHHHhccC-CCcceeEeeEEEcCCCCeEEE
Q 005586          410 CFSEVNLLGKGNFSSVYKGTLR-DGTLVAIRSINVTSC--KSEEAEFVKGLYLLTSLR-HENIIRLRGFCCSRGRGECFL  485 (689)
Q Consensus       410 ~f~~~~~lg~G~~g~Vy~~~~~-~g~~vavK~l~~~~~--~~~~~~f~~e~~~l~~l~-H~niv~l~g~~~~~~~~~~~l  485 (689)
                      +|...+.||+|+||.||+|..+ +|+.||+|++.....  ......+..|.+++..+. |++|+++.+++..  .+..++
T Consensus         1 ~f~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~~--~~~~~l   78 (323)
T cd05615           1 DFNFLMVLGKGSFGKVMLAERKGTDELYAIKILKKDVVIQDDDVECTMVEKRVLALQDKPPFLTQLHSCFQT--VDRLYF   78 (323)
T ss_pred             CceEEEEEEecCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhccCCCchhheeeEEec--CCEEEE
Confidence            3667789999999999999875 689999999975421  233456888999998886 5677788887743  467999


Q ss_pred             EEEcCCCCCHHHHhhhcCCCCCCCCHHHHHHHHHHHHHHHhhhhCCCCCCCceeecCCCCCceeecCCCCeEEecccccc
Q 005586          486 IYDFAPKGKLSKYLDQEEGSSNVLDWSTRVSIIIGIAKGIGYLHSSEVNKPAIVHRNLSVEKVLIDQQFNPLIADCGLHK  565 (689)
Q Consensus       486 V~e~~~~gsL~~~L~~~~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~~~ivH~dlk~~NiLl~~~~~~kl~DfGla~  565 (689)
                      ||||+++|+|.+++....    .+++.++..|+.|++.||+|||+.+     |+||||||+|||+++++.+||+|||+++
T Consensus        79 v~Ey~~~g~L~~~i~~~~----~l~~~~~~~i~~qi~~al~~lH~~~-----ivHrDikp~Nill~~~~~ikL~Dfg~~~  149 (323)
T cd05615          79 VMEYVNGGDLMYHIQQVG----KFKEPQAVFYAAEISVGLFFLHRRG-----IIYRDLKLDNVMLDSEGHIKIADFGMCK  149 (323)
T ss_pred             EEcCCCCCcHHHHHHHcC----CCCHHHHHHHHHHHHHHHHHHHHCC-----eeccCCCHHHeEECCCCCEEEecccccc
Confidence            999999999999987643    3899999999999999999999987     9999999999999999999999999987


Q ss_pred             cccCCceeeeecCCCCCCCCCccccccCCCCCcccchhHHHHHHHHHhCCCCcchhHHHHHhhhhhhHhhccccCCCCCH
Q 005586          566 LLADDIVFSVLKTSAAMGYLAPEYVTTGRFTERSDIFAFGVIILQILTGSLVLTSSMRLAAESATFENFIDRNLKGKFSE  645 (689)
Q Consensus       566 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~ksDV~sfGvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~  645 (689)
                      ....... ......++..|+|||++.+..++.++|||||||++|||+||+.||.......    ....+....  ..++.
T Consensus       150 ~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~elltG~~pf~~~~~~~----~~~~i~~~~--~~~p~  222 (323)
T cd05615         150 EHMVDGV-TTRTFCGTPDYIAPEIIAYQPYGKSVDWWAYGVLLYEMLAGQPPFDGEDEDE----LFQSIMEHN--VSYPK  222 (323)
T ss_pred             ccCCCCc-cccCccCCccccCHHHHcCCCCCCccchhhhHHHHHHHHhCCCCCCCCCHHH----HHHHHHhCC--CCCCc
Confidence            5432211 1123347889999999998899999999999999999999999996542211    112222211  12344


Q ss_pred             HHHHHHHHHHHHhccCCCCCCCCH
Q 005586          646 SEAAKLGKMALVCTHEDPENRPTM  669 (689)
Q Consensus       646 ~~~~~l~~l~~~Cl~~dp~~RPs~  669 (689)
                      ..+.++.+++.+|++.+|++|++.
T Consensus       223 ~~~~~~~~li~~~l~~~p~~R~~~  246 (323)
T cd05615         223 SLSKEAVSICKGLMTKHPSKRLGC  246 (323)
T ss_pred             cCCHHHHHHHHHHcccCHhhCCCC
Confidence            456678999999999999999974

Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, a

>KOG0611 consensus Predicted serine/threonine protein kinase [General function prediction only]

Probab=100.00  E-value=9e-38  Score=310.15  Aligned_cols=248  Identities=23%  Similarity=0.403  Sum_probs=208.4

Q ss_pred             ccCCcccccccCCcceEEEEEe-cCCcEEEEEEecccCCchH--HHHHHHHHHHHhccCCCcceeEeeEEEcCCCCeEEE
Q 005586          409 QCFSEVNLLGKGNFSSVYKGTL-RDGTLVAIRSINVTSCKSE--EAEFVKGLYLLTSLRHENIIRLRGFCCSRGRGECFL  485 (689)
Q Consensus       409 ~~f~~~~~lg~G~~g~Vy~~~~-~~g~~vavK~l~~~~~~~~--~~~f~~e~~~l~~l~H~niv~l~g~~~~~~~~~~~l  485 (689)
                      .+|...+.||+|.||.|-+|.. ..|+.||||.+++...+.+  .-.+.+||++|+.++||||+.++.+|  ++.+...+
T Consensus        53 HRyE~~etLGkGTYGKVk~A~e~~sgR~VAiKsIrKdkIkdeqDlvhIRREIeIMSsLNHPhII~IyEVF--ENkdKIvi  130 (668)
T KOG0611|consen   53 HRYEITETLGKGTYGKVKLAYEHKSGREVAIKSIRKDKIKDEQDLVHIRREIEIMSSLNHPHIIQIYEVF--ENKDKIVI  130 (668)
T ss_pred             hHHHHHHHhcCCcccceeehhhccCCcEeehhhhhhhhcccHHHHHHHHHHHHHHhhcCCCceeehhhhh--cCCceEEE
Confidence            4566778999999999999986 5899999999998765443  45788999999999999999999998  66788999


Q ss_pred             EEEcCCCCCHHHHhhhcCCCCCCCCHHHHHHHHHHHHHHHhhhhCCCCCCCceeecCCCCCceeecCCCCeEEecccccc
Q 005586          486 IYDFAPKGKLSKYLDQEEGSSNVLDWSTRVSIIIGIAKGIGYLHSSEVNKPAIVHRNLSVEKVLIDQQFNPLIADCGLHK  565 (689)
Q Consensus       486 V~e~~~~gsL~~~L~~~~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~~~ivH~dlk~~NiLl~~~~~~kl~DfGla~  565 (689)
                      ||||..+|.|.+|+...+.    |++.+...+.+||..|+.|+|.++     ++|||||-+|||||+++++||+||||+.
T Consensus       131 vMEYaS~GeLYDYiSer~~----LsErEaRhfFRQIvSAVhYCHknr-----VvHRDLKLENILLD~N~NiKIADFGLSN  201 (668)
T KOG0611|consen  131 VMEYASGGELYDYISERGS----LSEREARHFFRQIVSAVHYCHKNR-----VVHRDLKLENILLDQNNNIKIADFGLSN  201 (668)
T ss_pred             EEEecCCccHHHHHHHhcc----ccHHHHHHHHHHHHHHHHHHhhcc-----ceecccchhheeecCCCCeeeeccchhh
Confidence            9999999999999987653    899999999999999999999987     8999999999999999999999999999


Q ss_pred             cccCCceeeeecCCCCCCCCCccccccCCC-CCcccchhHHHHHHHHHhCCCCcchhHHHHHhhhhhhHhhccccCCCCC
Q 005586          566 LLADDIVFSVLKTSAAMGYLAPEYVTTGRF-TERSDIFAFGVIILQILTGSLVLTSSMRLAAESATFENFIDRNLKGKFS  644 (689)
Q Consensus       566 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~-~~ksDV~sfGvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~  644 (689)
                      ++.++...  ....|++-|.+||++.+.+| .+.+|-||+||+||-|+.|..||++..        ...++...-.+.|.
T Consensus       202 ly~~~kfL--qTFCGSPLYASPEIvNG~PY~GPEVDsWsLGvLLYtLVyGtMPFDG~D--------hk~lvrQIs~GaYr  271 (668)
T KOG0611|consen  202 LYADKKFL--QTFCGSPLYASPEIVNGTPYKGPEVDSWSLGVLLYTLVYGTMPFDGRD--------HKRLVRQISRGAYR  271 (668)
T ss_pred             hhccccHH--HHhcCCcccCCccccCCCCCCCCccchhhHHHHHHHHhhcccccCCch--------HHHHHHHhhccccc
Confidence            88765432  22357788999999999988 589999999999999999999997542        22222222233332


Q ss_pred             -HHHHHHHHHHHHHhccCCCCCCCCHHHHHHHHH
Q 005586          645 -ESEAAKLGKMALVCTHEDPENRPTMEAVIEELT  677 (689)
Q Consensus       645 -~~~~~~l~~l~~~Cl~~dp~~RPs~~evl~~L~  677 (689)
                       ++.+....-++.+|+..+|++|-|+.+|..+-|
T Consensus       272 EP~~PSdA~gLIRwmLmVNP~RRATieDiAsHWW  305 (668)
T KOG0611|consen  272 EPETPSDASGLIRWMLMVNPERRATIEDIASHWW  305 (668)
T ss_pred             CCCCCchHHHHHHHHHhcCcccchhHHHHhhhhe
Confidence             233456778999999999999999999998765

>cd06612 STKc_MST1_2 Catalytic domain of the Protein Serine/Threonine Kinases, Mammalian Ste20-like protein kinase 1 and 2

Probab=100.00  E-value=8.9e-37  Score=310.73  Aligned_cols=250  Identities=21%  Similarity=0.402  Sum_probs=202.1

Q ss_pred             ccCCcccccccCCcceEEEEEecC-CcEEEEEEecccCCchHHHHHHHHHHHHhccCCCcceeEeeEEEcCCCCeEEEEE
Q 005586          409 QCFSEVNLLGKGNFSSVYKGTLRD-GTLVAIRSINVTSCKSEEAEFVKGLYLLTSLRHENIIRLRGFCCSRGRGECFLIY  487 (689)
Q Consensus       409 ~~f~~~~~lg~G~~g~Vy~~~~~~-g~~vavK~l~~~~~~~~~~~f~~e~~~l~~l~H~niv~l~g~~~~~~~~~~~lV~  487 (689)
                      ++|+..+.||+|+||.||+|..++ +..|++|.+....   ...+|.+|++++++++|+||+++++++..  ....++++
T Consensus         3 ~~y~~~~~i~~g~~~~v~~~~~~~~~~~~~~k~~~~~~---~~~~~~~e~~~~~~l~~~~i~~~~~~~~~--~~~~~l~~   77 (256)
T cd06612           3 EVFDILEKLGEGSYGSVYKAIHKETGQVVAIKVVPVEE---DLQEIIKEISILKQCDSPYIVKYYGSYFK--NTDLWIVM   77 (256)
T ss_pred             ccchhhhhhcCCCCeEEEEEEEcCCCcEEEEEEeecHH---HHHHHHHHHHHHHhCCCCcEeeeeeeeec--CCcEEEEE
Confidence            567888999999999999999874 8899999987543   25689999999999999999999999854  47899999


Q ss_pred             EcCCCCCHHHHhhhcCCCCCCCCHHHHHHHHHHHHHHHhhhhCCCCCCCceeecCCCCCceeecCCCCeEEecccccccc
Q 005586          488 DFAPKGKLSKYLDQEEGSSNVLDWSTRVSIIIGIAKGIGYLHSSEVNKPAIVHRNLSVEKVLIDQQFNPLIADCGLHKLL  567 (689)
Q Consensus       488 e~~~~gsL~~~L~~~~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~~~ivH~dlk~~NiLl~~~~~~kl~DfGla~~~  567 (689)
                      ||+++++|.+++....   ..++|.....++.|+++||.|||+.+     ++||||+|+||++++++.+||+|||++...
T Consensus        78 e~~~~~~L~~~l~~~~---~~l~~~~~~~~~~~l~~~l~~lh~~~-----i~H~dl~~~ni~~~~~~~~~l~dfg~~~~~  149 (256)
T cd06612          78 EYCGAGSVSDIMKITN---KTLTEEEIAAILYQTLKGLEYLHSNK-----KIHRDIKAGNILLNEEGQAKLADFGVSGQL  149 (256)
T ss_pred             ecCCCCcHHHHHHhCc---cCCCHHHHHHHHHHHHHHHHHHHHCC-----cccCCCCcceEEECCCCcEEEcccccchhc
Confidence            9999999999997543   34899999999999999999999987     999999999999999999999999999876


Q ss_pred             cCCceeeeecCCCCCCCCCccccccCCCCCcccchhHHHHHHHHHhCCCCcchhHHHHHhhhhhhHhhccccCCCCCHHH
Q 005586          568 ADDIVFSVLKTSAAMGYLAPEYVTTGRFTERSDIFAFGVIILQILTGSLVLTSSMRLAAESATFENFIDRNLKGKFSESE  647 (689)
Q Consensus       568 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~ksDV~sfGvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  647 (689)
                      ..... ......++..|+|||++.+..++.++|||||||++|||+||+.|+.......... ....  ........+...
T Consensus       150 ~~~~~-~~~~~~~~~~y~~PE~~~~~~~~~~~Di~s~G~il~~l~~g~~p~~~~~~~~~~~-~~~~--~~~~~~~~~~~~  225 (256)
T cd06612         150 TDTMA-KRNTVIGTPFWMAPEVIQEIGYNNKADIWSLGITAIEMAEGKPPYSDIHPMRAIF-MIPN--KPPPTLSDPEKW  225 (256)
T ss_pred             ccCcc-ccccccCCccccCHHHHhcCCCCchhhHHHHHHHHHHHHhCCCCCCCcchhhhhh-hhcc--CCCCCCCchhhc
Confidence            54321 1122346778999999988899999999999999999999999986432211100 0000  000011122334


Q ss_pred             HHHHHHHHHHhccCCCCCCCCHHHHHHH
Q 005586          648 AAKLGKMALVCTHEDPENRPTMEAVIEE  675 (689)
Q Consensus       648 ~~~l~~l~~~Cl~~dp~~RPs~~evl~~  675 (689)
                      ...+.+++.+||+.+|++||++.||+++
T Consensus       226 ~~~~~~~i~~~l~~~P~~Rps~~~il~~  253 (256)
T cd06612         226 SPEFNDFVKKCLVKDPEERPSAIQLLQH  253 (256)
T ss_pred             CHHHHHHHHHHHhcChhhCcCHHHHhcC
Confidence            5678999999999999999999999875

Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 1 (MST1) and MST2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST1/2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST1, MST2, and related proteins including Drosophila Hippo and Dictyostelium discoideum Krs1 (kinase responsive to stress 1). MST1/2 and Hippo are involved in a conserved pathway that governs cell contact inhibition, organ size control, and tumor development. MST1 activates the mitogen-activated protein kinases (MAPKs) p38 and c-Jun N-terminal kinase (JNK) through MKK7 (a

>cd05083 PTKc_Chk Catalytic domain of the Protein Tyrosine Kinase, Csk homologous kinase

Probab=100.00  E-value=9e-37  Score=310.61  Aligned_cols=247  Identities=21%  Similarity=0.455  Sum_probs=200.0

Q ss_pred             ccCCcccccccCCcceEEEEEecCCcEEEEEEecccCCchHHHHHHHHHHHHhccCCCcceeEeeEEEcCCCCeEEEEEE
Q 005586          409 QCFSEVNLLGKGNFSSVYKGTLRDGTLVAIRSINVTSCKSEEAEFVKGLYLLTSLRHENIIRLRGFCCSRGRGECFLIYD  488 (689)
Q Consensus       409 ~~f~~~~~lg~G~~g~Vy~~~~~~g~~vavK~l~~~~~~~~~~~f~~e~~~l~~l~H~niv~l~g~~~~~~~~~~~lV~e  488 (689)
                      ++|...+.||+|+||.||+|.. +++.||+|.+....   ....|.+|+.++.+++|||++++++++..   +..++|||
T Consensus         6 ~~~~~~~~lg~g~~g~v~~~~~-~~~~~~iK~~~~~~---~~~~~~~e~~~l~~~~~~~i~~~~~~~~~---~~~~~v~e   78 (254)
T cd05083           6 QKLTLGEIIGEGEFGAVLQGEY-TGQKVAVKNIKCDV---TAQAFLEETAVMTKLHHKNLVRLLGVILH---NGLYIVME   78 (254)
T ss_pred             HHceeeeeeccCCCCceEeccc-CCCceEEEeecCcc---hHHHHHHHHHHHHhCCCCCcCeEEEEEcC---CCcEEEEE
Confidence            3577789999999999999975 57889999986532   34578999999999999999999998853   34789999


Q ss_pred             cCCCCCHHHHhhhcCCCCCCCCHHHHHHHHHHHHHHHhhhhCCCCCCCceeecCCCCCceeecCCCCeEEeccccccccc
Q 005586          489 FAPKGKLSKYLDQEEGSSNVLDWSTRVSIIIGIAKGIGYLHSSEVNKPAIVHRNLSVEKVLIDQQFNPLIADCGLHKLLA  568 (689)
Q Consensus       489 ~~~~gsL~~~L~~~~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~~~ivH~dlk~~NiLl~~~~~~kl~DfGla~~~~  568 (689)
                      |+++|+|.+++.....  ..+++..++.++.|++.||+|||+.+     ++||||||+||+++.++.+||+|||+++...
T Consensus        79 ~~~~~~L~~~l~~~~~--~~~~~~~~~~~~~qi~~al~~lH~~~-----~~H~dl~p~nili~~~~~~kl~Dfg~~~~~~  151 (254)
T cd05083          79 LMSKGNLVNFLRTRGR--ALVSVIQLLQFSLDVAEGMEYLESKK-----LVHRDLAARNILVSEDGVAKVSDFGLARVGS  151 (254)
T ss_pred             CCCCCCHHHHHHhcCc--CCCCHHHHHHHHHHHHHHHHHHHhCC-----eeccccCcceEEEcCCCcEEECCCccceecc
Confidence            9999999999976532  34889999999999999999999887     9999999999999999999999999987643


Q ss_pred             CCceeeeecCCCCCCCCCccccccCCCCCcccchhHHHHHHHHHh-CCCCcchhHHHHHhhhhhhHhhccccCCCCCHHH
Q 005586          569 DDIVFSVLKTSAAMGYLAPEYVTTGRFTERSDIFAFGVIILQILT-GSLVLTSSMRLAAESATFENFIDRNLKGKFSESE  647 (689)
Q Consensus       569 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~ksDV~sfGvvl~ellt-G~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  647 (689)
                      ...    .....+..|+|||++.+..++.++|||||||++|||++ |+.|+.......     ..+.+....+...+...
T Consensus       152 ~~~----~~~~~~~~y~~pe~~~~~~~~~~~Dv~slG~~l~el~~~g~~p~~~~~~~~-----~~~~~~~~~~~~~~~~~  222 (254)
T cd05083         152 MGV----DNSKLPVKWTAPEALKHKKFSSKSDVWSYGVLLWEVFSYGRAPYPKMSLKE-----VKECVEKGYRMEPPEGC  222 (254)
T ss_pred             ccC----CCCCCCceecCHHHhccCCcCchhhHHHHHHHHHHHHhCCCCCCccCCHHH-----HHHHHhCCCCCCCCCcC
Confidence            321    12233467999999988899999999999999999998 999886432211     11122222222233445


Q ss_pred             HHHHHHHHHHhccCCCCCCCCHHHHHHHHHh
Q 005586          648 AAKLGKMALVCTHEDPENRPTMEAVIEELTV  678 (689)
Q Consensus       648 ~~~l~~l~~~Cl~~dp~~RPs~~evl~~L~~  678 (689)
                      +..+.+++.+||+.+|++||+++++++.|+.
T Consensus       223 ~~~~~~li~~~l~~~p~~Rp~~~~l~~~l~~  253 (254)
T cd05083         223 PADVYVLMTSCWETEPKKRPSFHKLREKLEK  253 (254)
T ss_pred             CHHHHHHHHHHcCCChhhCcCHHHHHHHHcc
Confidence            6788999999999999999999999998864

Protein Tyrosine Kinase (PTK) family; Csk homologous kinase (Chk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. Chk is also referred to as megakaryocyte-associated tyrosine kinase (Matk). To inhibit Src kinases, Chk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Chk inhibit Src ki

>cd05603 STKc_SGK2 Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 2

Probab=100.00  E-value=2.4e-37  Score=326.19  Aligned_cols=243  Identities=21%  Similarity=0.339  Sum_probs=189.7

Q ss_pred             cccccCCcceEEEEEec-CCcEEEEEEecccCC--chHHHHHHHHHH-HHhccCCCcceeEeeEEEcCCCCeEEEEEEcC
Q 005586          415 NLLGKGNFSSVYKGTLR-DGTLVAIRSINVTSC--KSEEAEFVKGLY-LLTSLRHENIIRLRGFCCSRGRGECFLIYDFA  490 (689)
Q Consensus       415 ~~lg~G~~g~Vy~~~~~-~g~~vavK~l~~~~~--~~~~~~f~~e~~-~l~~l~H~niv~l~g~~~~~~~~~~~lV~e~~  490 (689)
                      +.||+|+||.||+|+.. +|+.||+|++.....  .....++..|.. +++.++||||+++++++..  .+..++||||+
T Consensus         1 ~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~~l~~~~h~~iv~~~~~~~~--~~~~~lv~e~~   78 (321)
T cd05603           1 KVIGKGSFGKVLLAKRKSDGSFYAVKVLQKKTILKKKEQNHIMAERNVLLKNLKHPFLVGLHYSFQT--AEKLYFVLDYV   78 (321)
T ss_pred             CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHHHHhhHHHHHHHHHHHHHHhCCCCCccceeeEEEc--CCEEEEEEcCC
Confidence            36999999999999985 689999999875431  223345556654 6788999999999998843  57899999999


Q ss_pred             CCCCHHHHhhhcCCCCCCCCHHHHHHHHHHHHHHHhhhhCCCCCCCceeecCCCCCceeecCCCCeEEecccccccccCC
Q 005586          491 PKGKLSKYLDQEEGSSNVLDWSTRVSIIIGIAKGIGYLHSSEVNKPAIVHRNLSVEKVLIDQQFNPLIADCGLHKLLADD  570 (689)
Q Consensus       491 ~~gsL~~~L~~~~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~~~ivH~dlk~~NiLl~~~~~~kl~DfGla~~~~~~  570 (689)
                      ++|+|..++....    .+++.....++.||++||+|||+.+     |+||||||+||++++++.+||+|||+++.....
T Consensus        79 ~~~~L~~~l~~~~----~~~~~~~~~~~~qi~~~L~~lH~~~-----ivH~Dlkp~NIll~~~~~~kl~Dfg~~~~~~~~  149 (321)
T cd05603          79 NGGELFFHLQRER----CFLEPRARFYAAEVASAIGYLHSLN-----IIYRDLKPENILLDSQGHVVLTDFGLCKEGVEP  149 (321)
T ss_pred             CCCCHHHHHHHcC----CCCHHHHHHHHHHHHHHHHHHHHCC-----eEeccCCHHHeEECCCCCEEEccCCCCccCCCC
Confidence            9999998886542    3788888899999999999999987     999999999999999999999999998754222


Q ss_pred             ceeeeecCCCCCCCCCccccccCCCCCcccchhHHHHHHHHHhCCCCcchhHHHHHhhhhhhHhhccccCCCCCHHHHHH
Q 005586          571 IVFSVLKTSAAMGYLAPEYVTTGRFTERSDIFAFGVIILQILTGSLVLTSSMRLAAESATFENFIDRNLKGKFSESEAAK  650 (689)
Q Consensus       571 ~~~~~~~~~~~~~y~aPE~~~~~~~~~ksDV~sfGvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  650 (689)
                      .. ......++..|+|||.+.+..++.++|||||||++|||++|+.||.......    ....+....  ...+......
T Consensus       150 ~~-~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~----~~~~i~~~~--~~~~~~~~~~  222 (321)
T cd05603         150 EE-TTSTFCGTPEYLAPEVLRKEPYDRTVDWWCLGAVLYEMLYGLPPFYSRDVSQ----MYDNILHKP--LQLPGGKTVA  222 (321)
T ss_pred             CC-ccccccCCcccCCHHHhcCCCCCCcCcccccchhhhhhhcCCCCCCCCCHHH----HHHHHhcCC--CCCCCCCCHH
Confidence            11 1223457889999999998899999999999999999999999996542111    111222111  1233445667


Q ss_pred             HHHHHHHhccCCCCCCCCH----HHHHHH
Q 005586          651 LGKMALVCTHEDPENRPTM----EAVIEE  675 (689)
Q Consensus       651 l~~l~~~Cl~~dp~~RPs~----~evl~~  675 (689)
                      +.+++..|++.||++||+.    .|++++
T Consensus       223 ~~~li~~~l~~~p~~R~~~~~~~~~~~~~  251 (321)
T cd05603         223 ACDLLVGLLHKDQRRRLGAKADFLEIKNH  251 (321)
T ss_pred             HHHHHHHHccCCHhhcCCCCCCHHHHhCC
Confidence            8999999999999999875    455544

Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK2 shows a more restricted distribution that SGK1 and is most abundantly expressed in epithelial tissues including kidney, liver, pancreas, and the choroid plexus of the brain. In vitro cellular assays show that SGK2 can stimulate the activity of ion channels, the glutamate transporter EEAT4, and the glutamate receptors, GluR6 and GLUR1.

>KOG0660 consensus Mitogen-activated protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=1.1e-37  Score=308.94  Aligned_cols=260  Identities=22%  Similarity=0.321  Sum_probs=201.7

Q ss_pred             ccCCcccccccCCcceEEEEEec-CCcEEEEEEecccC-CchHHHHHHHHHHHHhccCCCcceeEeeEEEc---CCCCeE
Q 005586          409 QCFSEVNLLGKGNFSSVYKGTLR-DGTLVAIRSINVTS-CKSEEAEFVKGLYLLTSLRHENIIRLRGFCCS---RGRGEC  483 (689)
Q Consensus       409 ~~f~~~~~lg~G~~g~Vy~~~~~-~g~~vavK~l~~~~-~~~~~~~f~~e~~~l~~l~H~niv~l~g~~~~---~~~~~~  483 (689)
                      ..|...+.||+|+||.|+.|..+ +|..||||++...- .....++-.+|+++|+.++|+||+.+.+.+..   ..-...
T Consensus        22 ~~y~~~~~iG~GAyGvVcsA~~~~t~~~VAIKKi~~~F~~~~~akRtlRElklLr~~~HeNIi~l~di~~p~~~~~f~Dv  101 (359)
T KOG0660|consen   22 RYYVLIEPIGRGAYGVVCSAKDKRTGEKVAIKKILNPFENQIDAKRTLRELKLLRHLRHENIIGLLDIFRPPSRDKFNDV  101 (359)
T ss_pred             ceecccccccCcceeeEEEEEEcCCCCEeehhhhhhhhhchHHHHHHHHHHHHHHHhcCCCcceEEeeccccccccccee
Confidence            45555689999999999999975 79999999997332 24456788899999999999999999998754   223568


Q ss_pred             EEEEEcCCCCCHHHHhhhcCCCCCCCCHHHHHHHHHHHHHHHhhhhCCCCCCCceeecCCCCCceeecCCCCeEEecccc
Q 005586          484 FLIYDFAPKGKLSKYLDQEEGSSNVLDWSTRVSIIIGIAKGIGYLHSSEVNKPAIVHRNLSVEKVLIDQQFNPLIADCGL  563 (689)
Q Consensus       484 ~lV~e~~~~gsL~~~L~~~~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~~~ivH~dlk~~NiLl~~~~~~kl~DfGl  563 (689)
                      |+|+|+| .-+|...++...    .|+......+..|+++||.|+|+.+     |+||||||+|+|++.+...||+|||+
T Consensus       102 YiV~elM-etDL~~iik~~~----~L~d~H~q~f~YQiLrgLKyiHSAn-----ViHRDLKPsNll~n~~c~lKI~DFGL  171 (359)
T KOG0660|consen  102 YLVFELM-ETDLHQIIKSQQ----DLTDDHAQYFLYQILRGLKYIHSAN-----VIHRDLKPSNLLLNADCDLKICDFGL  171 (359)
T ss_pred             EEehhHH-hhHHHHHHHcCc----cccHHHHHHHHHHHHHhcchhhccc-----ccccccchhheeeccCCCEEeccccc
Confidence            9999999 569999998653    3888889999999999999999988     99999999999999999999999999


Q ss_pred             cccccCCcee-eeecCCCCCCCCCccccc-cCCCCCcccchhHHHHHHHHHhCCCCcchhHHHHHhhh-----------h
Q 005586          564 HKLLADDIVF-SVLKTSAAMGYLAPEYVT-TGRFTERSDIFAFGVIILQILTGSLVLTSSMRLAAESA-----------T  630 (689)
Q Consensus       564 a~~~~~~~~~-~~~~~~~~~~y~aPE~~~-~~~~~~ksDV~sfGvvl~elltG~~p~~~~~~~~~~~~-----------~  630 (689)
                      ||........ ..+....|.+|.|||.+. ...||...||||.||++.||++|++-|.+.....+...           .
T Consensus       172 AR~~~~~~~~~~mTeYVaTRWYRAPElll~~~~Yt~aiDiWSvGCI~AEmL~gkplFpG~d~v~Ql~lI~~~lGtP~~e~  251 (359)
T KOG0660|consen  172 ARYLDKFFEDGFMTEYVATRWYRAPELLLNSSEYTKAIDIWSVGCILAEMLTGKPLFPGKDYVHQLQLILELLGTPSEED  251 (359)
T ss_pred             eeeccccCcccchhcceeeeeecCHHHHhccccccchhhhhhhhHHHHHHHcCCCCCCCCchHHHHHHHHHhcCCCCHHH
Confidence            9988543111 123345678899999875 46799999999999999999999988865322111100           0


Q ss_pred             --------hhHhhcccc-CCCC-----CHHHHHHHHHHHHHhccCCCCCCCCHHHHHHHHHh
Q 005586          631 --------FENFIDRNL-KGKF-----SESEAAKLGKMALVCTHEDPENRPTMEAVIEELTV  678 (689)
Q Consensus       631 --------~~~~~~~~~-~~~~-----~~~~~~~l~~l~~~Cl~~dp~~RPs~~evl~~L~~  678 (689)
                              ....+.... ....     .+.......++..+++..||.+|+|++|.+++.-.
T Consensus       252 l~~i~s~~ar~yi~slp~~p~~~f~~~fp~a~p~AidLlekmL~fdP~kRita~eAL~hPYl  313 (359)
T KOG0660|consen  252 LQKIRSEKARPYIKSLPQIPKQPFSSIFPNANPLAIDLLEKMLVFDPKKRITAEEALAHPYL  313 (359)
T ss_pred             HHHhccHHHHHHHHhCCCCCCCCHHHHcCCCCHHHHHHHHHHhccCccccCCHHHHhcChhh
Confidence                    111111100 0011     12346678999999999999999999999988643

>cd05624 STKc_MRCK_beta Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase beta

Probab=100.00  E-value=4.5e-37  Score=325.43  Aligned_cols=255  Identities=18%  Similarity=0.252  Sum_probs=199.2

Q ss_pred             ccCCcccccccCCcceEEEEEec-CCcEEEEEEecccC--CchHHHHHHHHHHHHhccCCCcceeEeeEEEcCCCCeEEE
Q 005586          409 QCFSEVNLLGKGNFSSVYKGTLR-DGTLVAIRSINVTS--CKSEEAEFVKGLYLLTSLRHENIIRLRGFCCSRGRGECFL  485 (689)
Q Consensus       409 ~~f~~~~~lg~G~~g~Vy~~~~~-~g~~vavK~l~~~~--~~~~~~~f~~e~~~l~~l~H~niv~l~g~~~~~~~~~~~l  485 (689)
                      ++|...+.||+|+||.||+++.+ +++.||+|.+....  .......|.+|+.++..++|+||+++++++..  .+..++
T Consensus         1 d~y~i~~~lG~G~fg~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~l~~~~~~--~~~~~l   78 (331)
T cd05624           1 DDFEIIKVIGRGAFGEVAVVKMKHTERIYAMKILNKWEMLKRAETACFREERNVLVNGDCQWITTLHYAFQD--ENYLYL   78 (331)
T ss_pred             CCceEEEEEeeCCCeEEEEEEECCCCCEEEEEEEeHHHHHhhHHHHHHHHHHHHHHhCCCCCEeeEEEEEEc--CCEEEE
Confidence            46788899999999999999976 68899999987532  12334568889999999999999999998843  578999


Q ss_pred             EEEcCCCCCHHHHhhhcCCCCCCCCHHHHHHHHHHHHHHHhhhhCCCCCCCceeecCCCCCceeecCCCCeEEecccccc
Q 005586          486 IYDFAPKGKLSKYLDQEEGSSNVLDWSTRVSIIIGIAKGIGYLHSSEVNKPAIVHRNLSVEKVLIDQQFNPLIADCGLHK  565 (689)
Q Consensus       486 V~e~~~~gsL~~~L~~~~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~~~ivH~dlk~~NiLl~~~~~~kl~DfGla~  565 (689)
                      ||||+++|+|.+++.....   .+++..+..++.|++.||+|||+.+     |+||||||+|||++.++.+||+|||+++
T Consensus        79 v~Ey~~gg~L~~~l~~~~~---~l~~~~~~~~~~qi~~~L~~lH~~~-----iiHrDlkp~Nill~~~~~~kl~DfG~a~  150 (331)
T cd05624          79 VMDYYVGGDLLTLLSKFED---RLPEDMARFYIAEMVLAIHSIHQLH-----YVHRDIKPDNVLLDMNGHIRLADFGSCL  150 (331)
T ss_pred             EEeCCCCCcHHHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHHCC-----eeeccCchHHEEEcCCCCEEEEecccee
Confidence            9999999999999976432   4889999999999999999999987     9999999999999999999999999998


Q ss_pred             cccCCceeeeecCCCCCCCCCcccccc-----CCCCCcccchhHHHHHHHHHhCCCCcchhHHHHHhhhhhhHhhccccC
Q 005586          566 LLADDIVFSVLKTSAAMGYLAPEYVTT-----GRFTERSDIFAFGVIILQILTGSLVLTSSMRLAAESATFENFIDRNLK  640 (689)
Q Consensus       566 ~~~~~~~~~~~~~~~~~~y~aPE~~~~-----~~~~~ksDV~sfGvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~  640 (689)
                      ..............++.+|+|||++.+     +.++.++|||||||++|||++|+.||.......    ....+.....+
T Consensus       151 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwSlGvil~ell~g~~Pf~~~~~~~----~~~~i~~~~~~  226 (331)
T cd05624         151 KMNQDGTVQSSVAVGTPDYISPEILQAMEDGMGKYGPECDWWSLGVCMYEMLYGETPFYAESLVE----TYGKIMNHEER  226 (331)
T ss_pred             eccCCCceeeccccCCcccCCHHHHhccccCCCCCCCcccEEeeehhhhhhhhCCCCccCCCHHH----HHHHHHcCCCc
Confidence            765443322233458899999999865     467899999999999999999999996532211    11222221111


Q ss_pred             CCCC---HHHHHHHHHHHHHhccCCCCC--CCCHHHHHHHHH
Q 005586          641 GKFS---ESEAAKLGKMALVCTHEDPEN--RPTMEAVIEELT  677 (689)
Q Consensus       641 ~~~~---~~~~~~l~~l~~~Cl~~dp~~--RPs~~evl~~L~  677 (689)
                      ..++   ...+.++.+++.+|+..++++  |+++++++++.+
T Consensus       227 ~~~p~~~~~~~~~~~~li~~ll~~~~~~~~~~~~~~~~~h~~  268 (331)
T cd05624         227 FQFPSHITDVSEEAKDLIQRLICSRERRLGQNGIEDFKKHAF  268 (331)
T ss_pred             ccCCCccccCCHHHHHHHHHHccCchhhcCCCCHHHHhcCCC
Confidence            1111   223567888898888866544  568999987743

Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) beta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKbeta is expressed ubiquitously in many tissues.

>cd05598 STKc_LATS Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor

Probab=100.00  E-value=2e-37  Score=334.16  Aligned_cols=252  Identities=17%  Similarity=0.251  Sum_probs=195.0

Q ss_pred             cCCcccccccCCcceEEEEEec-CCcEEEEEEecccCC--chHHHHHHHHHHHHhccCCCcceeEeeEEEcCCCCeEEEE
Q 005586          410 CFSEVNLLGKGNFSSVYKGTLR-DGTLVAIRSINVTSC--KSEEAEFVKGLYLLTSLRHENIIRLRGFCCSRGRGECFLI  486 (689)
Q Consensus       410 ~f~~~~~lg~G~~g~Vy~~~~~-~g~~vavK~l~~~~~--~~~~~~f~~e~~~l~~l~H~niv~l~g~~~~~~~~~~~lV  486 (689)
                      +|...+.||+|+||.||+|+.. +++.||+|++.....  ......+.+|++++.+++||||+++++.+.+  .+..++|
T Consensus         2 ~y~~~~~lG~G~~g~V~~a~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~h~~iv~~~~~~~~--~~~~~lv   79 (376)
T cd05598           2 MFVKIKTIGIGAFGEVCLVRKVDTNALYAMKTLRKADVLMRNQAAHVKAERDILAEADNEWVVKLYYSFQD--KDNLYFV   79 (376)
T ss_pred             CceEEEEEEeCCCeEEEEEEECCCCCEEEEEEEcHHHHHhhhhHHHHHHHHHHHHhCCCCCcceEEEEEEc--CCEEEEE
Confidence            5788899999999999999875 689999999865421  2234568899999999999999999998844  5789999


Q ss_pred             EEcCCCCCHHHHhhhcCCCCCCCCHHHHHHHHHHHHHHHhhhhCCCCCCCceeecCCCCCceeecCCCCeEEeccccccc
Q 005586          487 YDFAPKGKLSKYLDQEEGSSNVLDWSTRVSIIIGIAKGIGYLHSSEVNKPAIVHRNLSVEKVLIDQQFNPLIADCGLHKL  566 (689)
Q Consensus       487 ~e~~~~gsL~~~L~~~~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~~~ivH~dlk~~NiLl~~~~~~kl~DfGla~~  566 (689)
                      |||+++|+|.+++....    .+++.....++.||+.||+|||+.+     |+||||||+|||++.++.+||+|||++..
T Consensus        80 ~E~~~~g~L~~~i~~~~----~~~~~~~~~~~~qi~~al~~lH~~~-----ivHrDlkp~Nill~~~~~ikL~DFG~a~~  150 (376)
T cd05598          80 MDYIPGGDMMSLLIRLG----IFEEDLARFYIAELTCAIESVHKMG-----FIHRDIKPDNILIDRDGHIKLTDFGLCTG  150 (376)
T ss_pred             EeCCCCCcHHHHHHhcC----CCCHHHHHHHHHHHHHHHHHHHHCC-----eEeCCCCHHHEEECCCCCEEEEeCCCCcc
Confidence            99999999999997643    3788888899999999999999987     99999999999999999999999999753


Q ss_pred             ccCCc------------------------------------------eeeeecCCCCCCCCCccccccCCCCCcccchhH
Q 005586          567 LADDI------------------------------------------VFSVLKTSAAMGYLAPEYVTTGRFTERSDIFAF  604 (689)
Q Consensus       567 ~~~~~------------------------------------------~~~~~~~~~~~~y~aPE~~~~~~~~~ksDV~sf  604 (689)
                      +....                                          ........||..|+|||++.+..++.++|||||
T Consensus       151 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSl  230 (376)
T cd05598         151 FRWTHDSKYYQKGDHHRQDSMEPSEEWSEIDRCRLKPLERRRKRQHQRCLAHSLVGTPNYIAPEVLLRTGYTQLCDWWSV  230 (376)
T ss_pred             ccccccccccccccccccccccccccccccccccccchhhhhhhhcccccccccCCCccccCHHHHcCCCCCcceeeeec
Confidence            21000                                          000012357889999999999899999999999


Q ss_pred             HHHHHHHHhCCCCcchhHHHHHhhhhhhHhhc--cccCCCCCHHHHHHHHHHHHHhccCCCCCCC---CHHHHHHHHH
Q 005586          605 GVIILQILTGSLVLTSSMRLAAESATFENFID--RNLKGKFSESEAAKLGKMALVCTHEDPENRP---TMEAVIEELT  677 (689)
Q Consensus       605 Gvvl~elltG~~p~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~~~~~l~~l~~~Cl~~dp~~RP---s~~evl~~L~  677 (689)
                      ||++|||+||+.||.........    ..+..  ...........+.++.+++.+|+ .+|++|+   ++.|++++.+
T Consensus       231 Gvilyell~G~~Pf~~~~~~~~~----~~i~~~~~~~~~~~~~~~s~~~~~li~~l~-~~p~~R~~~~t~~ell~h~~  303 (376)
T cd05598         231 GVILYEMLVGQPPFLADTPAETQ----LKVINWETTLHIPSQAKLSREASDLILRLC-CGAEDRLGKNGADEIKAHPF  303 (376)
T ss_pred             cceeeehhhCCCCCCCCCHHHHH----HHHhccCccccCCCCCCCCHHHHHHHHHHh-cCHhhcCCCCCHHHHhCCCC
Confidence            99999999999999654322111    11111  01111111123445666777765 4999999   8999998754

Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS was originally identified in Drosophila using a screen for genes whose inactivation led to overproliferation of cells. In tetrapods, there are two LATS isoforms, LATS1 and LATS2. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. LATS functions as a tumor suppressor and is implicated in cell cycle regulation.

>smart00219 TyrKc Tyrosine kinase, catalytic domain

Probab=100.00  E-value=2e-36  Score=308.21  Aligned_cols=251  Identities=29%  Similarity=0.536  Sum_probs=202.2

Q ss_pred             CcccccccCCcceEEEEEecC-----CcEEEEEEecccCCchHHHHHHHHHHHHhccCCCcceeEeeEEEcCCCCeEEEE
Q 005586          412 SEVNLLGKGNFSSVYKGTLRD-----GTLVAIRSINVTSCKSEEAEFVKGLYLLTSLRHENIIRLRGFCCSRGRGECFLI  486 (689)
Q Consensus       412 ~~~~~lg~G~~g~Vy~~~~~~-----g~~vavK~l~~~~~~~~~~~f~~e~~~l~~l~H~niv~l~g~~~~~~~~~~~lV  486 (689)
                      +..+.||+|+||.||++...+     +..||+|++...........+..|++.+.+++|+||+++++++..  .+..+++
T Consensus         2 ~~~~~lg~g~~g~v~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~--~~~~~~i   79 (258)
T smart00219        2 TLGKKLGEGAFGEVYKGTLKGLSGEKEVEVAVKTLKEDADEQQIEEFLREARIMRKLDHPNIVKLLGVCTE--EEPLMIV   79 (258)
T ss_pred             cccceeccCCCcceEEEEecCCCCCCCceEEEEEccCCCChHHHHHHHHHHHHHHhcCCCchheEEEEEcC--CCeeEEE
Confidence            456789999999999999763     488999999766544466789999999999999999999999854  4689999


Q ss_pred             EEcCCCCCHHHHhhhcCCCCCCCCHHHHHHHHHHHHHHHhhhhCCCCCCCceeecCCCCCceeecCCCCeEEeccccccc
Q 005586          487 YDFAPKGKLSKYLDQEEGSSNVLDWSTRVSIIIGIAKGIGYLHSSEVNKPAIVHRNLSVEKVLIDQQFNPLIADCGLHKL  566 (689)
Q Consensus       487 ~e~~~~gsL~~~L~~~~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~~~ivH~dlk~~NiLl~~~~~~kl~DfGla~~  566 (689)
                      |||+++++|.+++.....  ..+++.++..++.|++.||+|||+.+     ++||||||+||++++++.+||+|||+++.
T Consensus        80 ~e~~~~~~l~~~~~~~~~--~~~~~~~~~~~~~ql~~~l~~lh~~~-----~~h~dl~~~nil~~~~~~~~l~dfg~~~~  152 (258)
T smart00219       80 MEYMEGGDLLDYLRKNRP--KELSLSDLLSFALQIARGMEYLESKN-----FIHRDLAARNCLVGENLVVKISDFGLSRD  152 (258)
T ss_pred             EeccCCCCHHHHHHhhhh--ccCCHHHHHHHHHHHHHHHHHHhcCC-----eeecccccceEEEccCCeEEEcccCCcee
Confidence            999999999999976432  12899999999999999999999987     99999999999999999999999999987


Q ss_pred             ccCCceeeeecCCCCCCCCCccccccCCCCCcccchhHHHHHHHHHh-CCCCcchhHHHHHhhhhhhHhhccccCCCCCH
Q 005586          567 LADDIVFSVLKTSAAMGYLAPEYVTTGRFTERSDIFAFGVIILQILT-GSLVLTSSMRLAAESATFENFIDRNLKGKFSE  645 (689)
Q Consensus       567 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~ksDV~sfGvvl~ellt-G~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~  645 (689)
                      .............++..|+|||.+.+..++.++||||+|++++||++ |+.|+.......     +.+.+........+.
T Consensus       153 ~~~~~~~~~~~~~~~~~y~~Pe~~~~~~~~~~~Di~slG~i~~~l~~~g~~p~~~~~~~~-----~~~~~~~~~~~~~~~  227 (258)
T smart00219      153 LYDDDYYKKKGGKLPIRWMAPESLKDGKFTSKSDVWSFGVLLWEIFTLGESPYPGMSNEE-----VLEYLKKGYRLPKPE  227 (258)
T ss_pred             cccccccccccCCCcccccChHHhccCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCHHH-----HHHHHhcCCCCCCCC
Confidence            76543222222336678999999988889999999999999999998 778875421111     111111111222333


Q ss_pred             HHHHHHHHHHHHhccCCCCCCCCHHHHHHHH
Q 005586          646 SEAAKLGKMALVCTHEDPENRPTMEAVIEEL  676 (689)
Q Consensus       646 ~~~~~l~~l~~~Cl~~dp~~RPs~~evl~~L  676 (689)
                      ..+.++.+++.+|+..+|++||++.|+++.|
T Consensus       228 ~~~~~~~~~i~~~l~~~p~~Rpt~~~ll~~l  258 (258)
T smart00219      228 NCPPEIYKLMLQCWAEDPEDRPTFSELVEIL  258 (258)
T ss_pred             cCCHHHHHHHHHHCcCChhhCcCHHHHHhhC
Confidence            4567899999999999999999999998864

Phosphotransferases. Tyrosine-specific kinase subfamily.

>cd05623 STKc_MRCK_alpha Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase alpha

Probab=100.00  E-value=7.2e-37  Score=324.06  Aligned_cols=254  Identities=18%  Similarity=0.263  Sum_probs=196.7

Q ss_pred             ccCCcccccccCCcceEEEEEec-CCcEEEEEEecccCC--chHHHHHHHHHHHHhccCCCcceeEeeEEEcCCCCeEEE
Q 005586          409 QCFSEVNLLGKGNFSSVYKGTLR-DGTLVAIRSINVTSC--KSEEAEFVKGLYLLTSLRHENIIRLRGFCCSRGRGECFL  485 (689)
Q Consensus       409 ~~f~~~~~lg~G~~g~Vy~~~~~-~g~~vavK~l~~~~~--~~~~~~f~~e~~~l~~l~H~niv~l~g~~~~~~~~~~~l  485 (689)
                      ++|...+.||+|+||.||+++.+ +++.+|+|++.+...  ......|.+|+.++..++|+||+++++++.  ..+..++
T Consensus         1 ~~y~~~~~lG~G~fg~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~--~~~~~~l   78 (332)
T cd05623           1 EDFEILKVIGRGAFGEVAVVKLKNADKVFAMKILNKWEMLKRAETACFREERDVLVNGDNQWITTLHYAFQ--DENNLYL   78 (332)
T ss_pred             CCceEEEEEEeCCCeEEEEEEECCCCCEEEEEEEeHHHHHHhhHHHHHHHHHHHHhhCCCCCEeeEEEEEe--cCCEEEE
Confidence            36788899999999999999986 578899999864321  223356889999999999999999999884  3578999


Q ss_pred             EEEcCCCCCHHHHhhhcCCCCCCCCHHHHHHHHHHHHHHHhhhhCCCCCCCceeecCCCCCceeecCCCCeEEecccccc
Q 005586          486 IYDFAPKGKLSKYLDQEEGSSNVLDWSTRVSIIIGIAKGIGYLHSSEVNKPAIVHRNLSVEKVLIDQQFNPLIADCGLHK  565 (689)
Q Consensus       486 V~e~~~~gsL~~~L~~~~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~~~ivH~dlk~~NiLl~~~~~~kl~DfGla~  565 (689)
                      ||||+++|+|.++++....   .+++..+..++.|++.||+|||+.+     |+||||||+|||+++++.+||+|||+++
T Consensus        79 v~ey~~~g~L~~~l~~~~~---~l~~~~~~~~~~qi~~al~~lH~~~-----iiHrDlkp~Nili~~~~~~kL~DfG~a~  150 (332)
T cd05623          79 VMDYYVGGDLLTLLSKFED---RLPEDMARFYLAEMVIAIDSVHQLH-----YVHRDIKPDNILMDMNGHIRLADFGSCL  150 (332)
T ss_pred             EEeccCCCcHHHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHHCC-----eEecCCCHHHEEECCCCCEEEeecchhe
Confidence            9999999999999976432   4889999999999999999999987     9999999999999999999999999987


Q ss_pred             cccCCceeeeecCCCCCCCCCccccc-----cCCCCCcccchhHHHHHHHHHhCCCCcchhHHHHHhhhhhhHhhccccC
Q 005586          566 LLADDIVFSVLKTSAAMGYLAPEYVT-----TGRFTERSDIFAFGVIILQILTGSLVLTSSMRLAAESATFENFIDRNLK  640 (689)
Q Consensus       566 ~~~~~~~~~~~~~~~~~~y~aPE~~~-----~~~~~~ksDV~sfGvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~  640 (689)
                      ..............||..|+|||++.     ...++.++|||||||++|||++|+.||.......    .+..+......
T Consensus       151 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DvwSlGvil~ell~g~~Pf~~~~~~~----~~~~i~~~~~~  226 (332)
T cd05623         151 KLMEDGTVQSSVAVGTPDYISPEILQAMEDGKGKYGPECDWWSLGVCMYEMLYGETPFYAESLVE----TYGKIMNHKER  226 (332)
T ss_pred             ecccCCcceecccccCccccCHHHHhccccCCCCCCCcCCEEeeHHHHHHHhcCCCCCCCCCHHH----HHHHHhCCCcc
Confidence            65433222223345889999999986     3468899999999999999999999996532211    11122221111


Q ss_pred             CCC---CHHHHHHHHHHHHHhccCCCCC--CCCHHHHHHHH
Q 005586          641 GKF---SESEAAKLGKMALVCTHEDPEN--RPTMEAVIEEL  676 (689)
Q Consensus       641 ~~~---~~~~~~~l~~l~~~Cl~~dp~~--RPs~~evl~~L  676 (689)
                      ..+   ....+.++.+++.+|+..++.+  ||++.|++++-
T Consensus       227 ~~~p~~~~~~s~~~~~li~~ll~~~~~r~~r~~~~~~~~h~  267 (332)
T cd05623         227 FQFPAQVTDVSEDAKDLIRRLICSREHRLGQNGIEDFKQHP  267 (332)
T ss_pred             ccCCCccccCCHHHHHHHHHHccChhhhcCCCCHHHHhCCC
Confidence            111   1234567788888877654444  78999999884

Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKalpha is expressed ubiquitously in many tissues. It plays a role in the regulation of peripheral actin reorganization and neurite outgrowth. It may also play a role in the transferrin iron uptake pathw

>KOG0200 consensus Fibroblast/platelet-derived growth factor receptor and related receptor tyrosine kinases [Signal transduction mechanisms]

Probab=100.00  E-value=5.4e-37  Score=346.36  Aligned_cols=257  Identities=26%  Similarity=0.444  Sum_probs=215.3

Q ss_pred             CcccccccCCcceEEEEEec----C----CcEEEEEEecccCCchHHHHHHHHHHHHhcc-CCCcceeEeeEEEcCCCCe
Q 005586          412 SEVNLLGKGNFSSVYKGTLR----D----GTLVAIRSINVTSCKSEEAEFVKGLYLLTSL-RHENIIRLRGFCCSRGRGE  482 (689)
Q Consensus       412 ~~~~~lg~G~~g~Vy~~~~~----~----g~~vavK~l~~~~~~~~~~~f~~e~~~l~~l-~H~niv~l~g~~~~~~~~~  482 (689)
                      ...+.+|+|.||.|++|...    .    ...||||.++......+.+.+..|+++|..+ +|+||+.++|+|..  ++.
T Consensus       299 ~~~~~lg~g~fG~v~~~~~~~~~~~~~~~~~~VaVK~~k~~~~~~~~~~~~~El~~m~~~g~H~niv~llG~~t~--~~~  376 (609)
T KOG0200|consen  299 KLGKYLGEGAFGQVVKALLFGLSKALLSIYVTVAVKMLKENASSSEKKDLMSELNVLKELGKHPNIVNLLGACTQ--DGP  376 (609)
T ss_pred             cccceeecccccceEeEEEeecccccccceEEEEEEecccccCcHHHHHHHHHHHHHHHhcCCcchhhheeeecc--CCc
Confidence            34468999999999999853    1    4579999999887777788999999999999 69999999999955  678


Q ss_pred             EEEEEEcCCCCCHHHHhhhcC---------C-CC--CCCCHHHHHHHHHHHHHHHhhhhCCCCCCCceeecCCCCCceee
Q 005586          483 CFLIYDFAPKGKLSKYLDQEE---------G-SS--NVLDWSTRVSIIIGIAKGIGYLHSSEVNKPAIVHRNLSVEKVLI  550 (689)
Q Consensus       483 ~~lV~e~~~~gsL~~~L~~~~---------~-~~--~~l~~~~~~~ia~~ia~gL~yLH~~~~~~~~ivH~dlk~~NiLl  550 (689)
                      .++|+||++.|+|.++|+..+         . ..  ..++..+.+.++.|||.||+||++..     +|||||.++|||+
T Consensus       377 ~~~v~Ey~~~G~L~~~Lr~~r~~~~~~~~~~~~~~~~~L~~~dLlsfa~QIa~GMe~L~~~~-----~vHRDLAaRNVLi  451 (609)
T KOG0200|consen  377 LYVIVEYAEHGDLLEFLRKKRVTESIDGSGVFPNERDALTTKDLLSFAYQIANGMEYLASVP-----CVHRDLAARNVLI  451 (609)
T ss_pred             eEEEEEeccCCcHHHHHHhccccccccccCCCccccCCcCHHHHHHHHHHHHHHHHHHhhCC-----ccchhhhhhhEEe
Confidence            999999999999999998876         0 01  23889999999999999999999876     8999999999999


Q ss_pred             cCCCCeEEecccccccccCCceeeeecCC--CCCCCCCccccccCCCCCcccchhHHHHHHHHHh-CCCCcchhHHHHHh
Q 005586          551 DQQFNPLIADCGLHKLLADDIVFSVLKTS--AAMGYLAPEYVTTGRFTERSDIFAFGVIILQILT-GSLVLTSSMRLAAE  627 (689)
Q Consensus       551 ~~~~~~kl~DfGla~~~~~~~~~~~~~~~--~~~~y~aPE~~~~~~~~~ksDV~sfGvvl~ellt-G~~p~~~~~~~~~~  627 (689)
                      .++..+||+|||++|.......+......  -+..|||||.+....|+.|||||||||+||||+| |..|+....    .
T Consensus       452 ~~~~~~kIaDFGlar~~~~~~~y~~~~~~~~LP~kWmApEsl~~~~ft~kSDVWSfGI~L~EifsLG~~PYp~~~----~  527 (609)
T KOG0200|consen  452 TKNKVIKIADFGLARDHYNKDYYRTKSSAGTLPVKWMAPESLFDRVFTSKSDVWSFGILLWEIFTLGGTPYPGIP----P  527 (609)
T ss_pred             cCCCEEEEccccceeccCCCCceEecCCCCccceeecCHHHhccCcccccchhhHHHHHHHHHhhCCCCCCCCCC----c
Confidence            99999999999999977665555444333  3567999999999999999999999999999999 677775411    0


Q ss_pred             hhhhhHhhccccCCCCCHHHHHHHHHHHHHhccCCCCCCCCHHHHHHHHHhh
Q 005586          628 SATFENFIDRNLKGKFSESEAAKLGKMALVCTHEDPENRPTMEAVIEELTVA  679 (689)
Q Consensus       628 ~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~Cl~~dp~~RPs~~evl~~L~~~  679 (689)
                      ...+.+.+....+...|..+..++.++|..||+.+|++||++.|+++.+...
T Consensus       528 ~~~l~~~l~~G~r~~~P~~c~~eiY~iM~~CW~~~p~~RP~F~~~~~~~~~~  579 (609)
T KOG0200|consen  528 TEELLEFLKEGNRMEQPEHCSDEIYDLMKSCWNADPEDRPTFSECVEFFEKH  579 (609)
T ss_pred             HHHHHHHHhcCCCCCCCCCCCHHHHHHHHHHhCCCcccCCCHHHHHHHHHHH
Confidence            1122335555666677888899999999999999999999999999988773

>cd06605 PKc_MAPKK Catalytic domain of the dual-specificity Protein Kinase, Mitogen-Activated Protein Kinase Kinase

Probab=100.00  E-value=7.2e-37  Score=313.16  Aligned_cols=255  Identities=19%  Similarity=0.375  Sum_probs=205.5

Q ss_pred             cCCcccccccCCcceEEEEEec-CCcEEEEEEecccCCchHHHHHHHHHHHHhccCCCcceeEeeEEEcCCCCeEEEEEE
Q 005586          410 CFSEVNLLGKGNFSSVYKGTLR-DGTLVAIRSINVTSCKSEEAEFVKGLYLLTSLRHENIIRLRGFCCSRGRGECFLIYD  488 (689)
Q Consensus       410 ~f~~~~~lg~G~~g~Vy~~~~~-~g~~vavK~l~~~~~~~~~~~f~~e~~~l~~l~H~niv~l~g~~~~~~~~~~~lV~e  488 (689)
                      +|+..+.||+|+||.||++..+ +++.||+|++..........++.+|++++++++||||+++++++..  ....++|+|
T Consensus         2 ~~~~~~~ig~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~--~~~~~lv~e   79 (265)
T cd06605           2 DLEYLGELGAGNSGVVSKVLHRPTGKIMAVKTIRLEINEAIQKQILRELDILHKCNSPYIVGFYGAFYN--NGDISICME   79 (265)
T ss_pred             cchHHHHhcCCCCeEEEEEEEcCCCcEEEEEEEecccChHHHHHHHHHHHHHHHCCCCchhhhheeeec--CCEEEEEEE
Confidence            5667789999999999999986 6899999999876545566789999999999999999999999854  478999999


Q ss_pred             cCCCCCHHHHhhhcCCCCCCCCHHHHHHHHHHHHHHHhhhhC-CCCCCCceeecCCCCCceeecCCCCeEEecccccccc
Q 005586          489 FAPKGKLSKYLDQEEGSSNVLDWSTRVSIIIGIAKGIGYLHS-SEVNKPAIVHRNLSVEKVLIDQQFNPLIADCGLHKLL  567 (689)
Q Consensus       489 ~~~~gsL~~~L~~~~~~~~~l~~~~~~~ia~~ia~gL~yLH~-~~~~~~~ivH~dlk~~NiLl~~~~~~kl~DfGla~~~  567 (689)
                      |+++++|.+++....   ..+++.....++.|++.||+|||+ .+     ++||||||+||++++++.+||+|||.+...
T Consensus        80 ~~~~~~L~~~~~~~~---~~~~~~~~~~~~~~l~~~l~~lH~~~~-----i~H~dl~~~ni~~~~~~~~~l~d~g~~~~~  151 (265)
T cd06605          80 YMDGGSLDKILKEVQ---GRIPERILGKIAVAVLKGLTYLHEKHK-----IIHRDVKPSNILVNSRGQIKLCDFGVSGQL  151 (265)
T ss_pred             ecCCCcHHHHHHHcc---CCCCHHHHHHHHHHHHHHHHHHcCCCC-----eecCCCCHHHEEECCCCCEEEeecccchhh
Confidence            999999999997653   348889999999999999999998 76     999999999999999999999999998766


Q ss_pred             cCCceeeeecCCCCCCCCCccccccCCCCCcccchhHHHHHHHHHhCCCCcchhHHHHHh-hhhhhHhhccccCCCCCHH
Q 005586          568 ADDIVFSVLKTSAAMGYLAPEYVTTGRFTERSDIFAFGVIILQILTGSLVLTSSMRLAAE-SATFENFIDRNLKGKFSES  646 (689)
Q Consensus       568 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~ksDV~sfGvvl~elltG~~p~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~  646 (689)
                      ......   ...++..|+|||++.+..++.++||||||+++|||++|+.|+......... ........... ....+..
T Consensus       152 ~~~~~~---~~~~~~~y~~PE~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~  227 (265)
T cd06605         152 VNSLAK---TFVGTSSYMAPERIQGNDYSVKSDIWSLGLSLIELATGRFPYPPENDPPDGIFELLQYIVNEP-PPRLPSG  227 (265)
T ss_pred             HHHHhh---cccCChhccCHHHHcCCCCCchhhHHHHHHHHHHHHhCCCCCCccccccccHHHHHHHHhcCC-CCCCChh
Confidence            432211   145677899999999889999999999999999999999998643211000 01111111111 1122222


Q ss_pred             -HHHHHHHHHHHhccCCCCCCCCHHHHHHHHHh
Q 005586          647 -EAAKLGKMALVCTHEDPENRPTMEAVIEELTV  678 (689)
Q Consensus       647 -~~~~l~~l~~~Cl~~dp~~RPs~~evl~~L~~  678 (689)
                       ...++.+++..||..+|++||++.|++.+-+.
T Consensus       228 ~~~~~~~~li~~~l~~~p~~Rpt~~~ll~~~~~  260 (265)
T cd06605         228 KFSPDFQDFVNLCLIKDPRERPSYKELLEHPFI  260 (265)
T ss_pred             hcCHHHHHHHHHHcCCCchhCcCHHHHhhCchh
Confidence             56779999999999999999999999987554

Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK or MAP2K), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK or MAP3K). MAPKKs are dual-specificity

>cd06643 STKc_SLK Catalytic domain of the Protein Serine/Threonine Kinase, Ste20-like kinase

Probab=100.00  E-value=1.5e-36  Score=314.07  Aligned_cols=252  Identities=18%  Similarity=0.287  Sum_probs=198.8

Q ss_pred             CCcccccccCCcceEEEEEec-CCcEEEEEEecccCCchHHHHHHHHHHHHhccCCCcceeEeeEEEcCCCCeEEEEEEc
Q 005586          411 FSEVNLLGKGNFSSVYKGTLR-DGTLVAIRSINVTSCKSEEAEFVKGLYLLTSLRHENIIRLRGFCCSRGRGECFLIYDF  489 (689)
Q Consensus       411 f~~~~~lg~G~~g~Vy~~~~~-~g~~vavK~l~~~~~~~~~~~f~~e~~~l~~l~H~niv~l~g~~~~~~~~~~~lV~e~  489 (689)
                      |+..+.||+|+||.||+|... ++..+++|.+.... ......|.+|+++++.++|||++++++++..  ....++||||
T Consensus         7 ~~i~~~lg~g~~g~v~~~~~~~~~~~~~~k~~~~~~-~~~~~~~~~e~~~l~~l~h~~ii~~~~~~~~--~~~~~~v~e~   83 (282)
T cd06643           7 WEIIGELGDGAFGKVYKAQNKETGVLAAAKVIDTKS-EEELEDYMVEIDILASCDHPNIVKLLDAFYY--ENNLWILIEF   83 (282)
T ss_pred             HHHHhhcccCCCeEEEEEEECCCCeEEEEEEeCCCC-HHHHHHHHHHHHHHHHCCCCCeeeEEEEEee--CCEEEEEEEe
Confidence            445678999999999999976 57888999986543 3445679999999999999999999999854  4688999999


Q ss_pred             CCCCCHHHHhhhcCCCCCCCCHHHHHHHHHHHHHHHhhhhCCCCCCCceeecCCCCCceeecCCCCeEEecccccccccC
Q 005586          490 APKGKLSKYLDQEEGSSNVLDWSTRVSIIIGIAKGIGYLHSSEVNKPAIVHRNLSVEKVLIDQQFNPLIADCGLHKLLAD  569 (689)
Q Consensus       490 ~~~gsL~~~L~~~~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~~~ivH~dlk~~NiLl~~~~~~kl~DfGla~~~~~  569 (689)
                      +++|+|..++....   ..++|..+..++.|++.||+|||+.+     |+||||||+||+++.++.+||+|||+++....
T Consensus        84 ~~~~~l~~~~~~~~---~~l~~~~~~~~~~qi~~~L~~LH~~~-----i~H~dlkp~nili~~~~~~kl~dfg~~~~~~~  155 (282)
T cd06643          84 CAGGAVDAVMLELE---RPLTEPQIRVVCKQTLEALNYLHENK-----IIHRDLKAGNILFTLDGDIKLADFGVSAKNTR  155 (282)
T ss_pred             cCCCcHHHHHHhcC---CCCCHHHHHHHHHHHHHHHHHHHHCC-----eeecCCCcccEEEccCCCEEEccccccccccc
Confidence            99999999887533   24899999999999999999999987     99999999999999999999999999876543


Q ss_pred             CceeeeecCCCCCCCCCccccc-----cCCCCCcccchhHHHHHHHHHhCCCCcchhHHHHHhhhhhhHhhcc-ccCCCC
Q 005586          570 DIVFSVLKTSAAMGYLAPEYVT-----TGRFTERSDIFAFGVIILQILTGSLVLTSSMRLAAESATFENFIDR-NLKGKF  643 (689)
Q Consensus       570 ~~~~~~~~~~~~~~y~aPE~~~-----~~~~~~ksDV~sfGvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~-~~~~~~  643 (689)
                      ... ......++..|+|||++.     +..++.++|||||||++|||++|+.|+........    ....... ......
T Consensus       156 ~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slGvil~el~~g~~p~~~~~~~~~----~~~~~~~~~~~~~~  230 (282)
T cd06643         156 TIQ-RRDSFIGTPYWMAPEVVMCETSKDRPYDYKADVWSLGITLIEMAQIEPPHHELNPMRV----LLKIAKSEPPTLAQ  230 (282)
T ss_pred             ccc-ccccccccccccCHhhccccCCCCCCCCccchhhhHHHHHHHHccCCCCccccCHHHH----HHHHhhcCCCCCCC
Confidence            221 122345778899999974     34578899999999999999999999864322111    1111110 001112


Q ss_pred             CHHHHHHHHHHHHHhccCCCCCCCCHHHHHHHHHh
Q 005586          644 SESEAAKLGKMALVCTHEDPENRPTMEAVIEELTV  678 (689)
Q Consensus       644 ~~~~~~~l~~l~~~Cl~~dp~~RPs~~evl~~L~~  678 (689)
                      +.....++.+++..||+.+|.+||++.+++++.+.
T Consensus       231 ~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~~~~~  265 (282)
T cd06643         231 PSRWSSEFKDFLKKCLEKNVDARWTTTQLLQHPFV  265 (282)
T ss_pred             ccccCHHHHHHHHHHccCChhhCcCHHHHhcCCCE
Confidence            23345678999999999999999999999987543

Serine/threonine kinases (STKs), Ste20-like kinase (SLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It acts as a MAPK kinase kinase (MAPKKK) by phosphorylating ASK1, resulting in the phosphorylation of p38. SLK also plays a role in mediating actin reorganization. It is part of a microtubule-associated complex that is targeted at adhesion sites, and is required in focal adhesion turnover and in regulating cell migration.

>cd05602 STKc_SGK1 Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 1

Probab=100.00  E-value=4.3e-37  Score=324.82  Aligned_cols=242  Identities=21%  Similarity=0.323  Sum_probs=188.2

Q ss_pred             cccccCCcceEEEEEec-CCcEEEEEEecccCC--chHHHHHHHHH-HHHhccCCCcceeEeeEEEcCCCCeEEEEEEcC
Q 005586          415 NLLGKGNFSSVYKGTLR-DGTLVAIRSINVTSC--KSEEAEFVKGL-YLLTSLRHENIIRLRGFCCSRGRGECFLIYDFA  490 (689)
Q Consensus       415 ~~lg~G~~g~Vy~~~~~-~g~~vavK~l~~~~~--~~~~~~f~~e~-~~l~~l~H~niv~l~g~~~~~~~~~~~lV~e~~  490 (689)
                      +.||+|+||.||+|+.. +++.||+|++.....  .....++..|. .+++.++||||+++++++..  .+..++||||+
T Consensus         1 ~~lg~G~fg~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~~l~~~~h~~Iv~~~~~~~~--~~~~~lv~e~~   78 (325)
T cd05602           1 KVIGKGSFGKVLLARHKAEEKFYAVKVLQKKAILKKKEEKHIMSERNVLLKNVKHPFLVGLHFSFQT--ADKLYFVLDYI   78 (325)
T ss_pred             CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHHHhhhHHHHHHHHHHHHHHhCCCCCCCceeEEEEc--CCeEEEEEeCC
Confidence            36999999999999976 678899999975421  12233444444 45678999999999998844  57899999999


Q ss_pred             CCCCHHHHhhhcCCCCCCCCHHHHHHHHHHHHHHHhhhhCCCCCCCceeecCCCCCceeecCCCCeEEecccccccccCC
Q 005586          491 PKGKLSKYLDQEEGSSNVLDWSTRVSIIIGIAKGIGYLHSSEVNKPAIVHRNLSVEKVLIDQQFNPLIADCGLHKLLADD  570 (689)
Q Consensus       491 ~~gsL~~~L~~~~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~~~ivH~dlk~~NiLl~~~~~~kl~DfGla~~~~~~  570 (689)
                      ++|+|.+++....    .+.+.....++.|+++||+|||+.+     |+||||||+|||+++++.+||+|||+++.....
T Consensus        79 ~~~~L~~~~~~~~----~~~~~~~~~~~~qi~~~L~~lH~~g-----iiHrDlkp~Nili~~~~~~kl~DfG~a~~~~~~  149 (325)
T cd05602          79 NGGELFYHLQRER----CFLEPRARFYAAEIASALGYLHSLN-----IVYRDLKPENILLDSQGHIVLTDFGLCKENIEH  149 (325)
T ss_pred             CCCcHHHHHHhcC----CCCHHHHHHHHHHHHHHHHHHHHCC-----eEecCCCHHHeEECCCCCEEEccCCCCcccccC
Confidence            9999999997643    3777888889999999999999988     999999999999999999999999999754322


Q ss_pred             ceeeeecCCCCCCCCCccccccCCCCCcccchhHHHHHHHHHhCCCCcchhHHHHHhhhhhhHhhccccCCCCCHHHHHH
Q 005586          571 IVFSVLKTSAAMGYLAPEYVTTGRFTERSDIFAFGVIILQILTGSLVLTSSMRLAAESATFENFIDRNLKGKFSESEAAK  650 (689)
Q Consensus       571 ~~~~~~~~~~~~~y~aPE~~~~~~~~~ksDV~sfGvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  650 (689)
                      .. ......++..|+|||++.+..++.++|||||||++|||++|+.||........    +..+.....  ..+......
T Consensus       150 ~~-~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~----~~~i~~~~~--~~~~~~~~~  222 (325)
T cd05602         150 NG-TTSTFCGTPEYLAPEVLHKQPYDRTVDWWCLGAVLYEMLYGLPPFYSRNTAEM----YDNILNKPL--QLKPNITNS  222 (325)
T ss_pred             CC-CcccccCCccccCHHHHcCCCCCCccccccccHHHHHHhcCCCCCCCCCHHHH----HHHHHhCCc--CCCCCCCHH
Confidence            11 12234578899999999999999999999999999999999999965422211    112221111  122334567


Q ss_pred             HHHHHHHhccCCCCCCCCHHHHHH
Q 005586          651 LGKMALVCTHEDPENRPTMEAVIE  674 (689)
Q Consensus       651 l~~l~~~Cl~~dp~~RPs~~evl~  674 (689)
                      +.+++..|++.||.+||++.+.+.
T Consensus       223 ~~~li~~~l~~~p~~R~~~~~~~~  246 (325)
T cd05602         223 ARHLLEGLLQKDRTKRLGAKDDFM  246 (325)
T ss_pred             HHHHHHHHcccCHHHCCCCCCCHH
Confidence            899999999999999998774433

Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK1 is ubiquitously expressed and is under transcriptional control of numerous stimuli including cell stress (cell shrinkage), serum, hormones (gluco- and mineralocorticoids), gonadotropins, growth factors, interleukin-6, and other cytokines. It plays roles in sodium retention and potassium elimination in the kidney, nutrient transport, salt

>cd06652 STKc_MEKK2 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 2

Probab=100.00  E-value=2.7e-36  Score=309.12  Aligned_cols=254  Identities=19%  Similarity=0.275  Sum_probs=201.1

Q ss_pred             ccCCcccccccCCcceEEEEEec-CCcEEEEEEecccCC----chHHHHHHHHHHHHhccCCCcceeEeeEEEcCCCCeE
Q 005586          409 QCFSEVNLLGKGNFSSVYKGTLR-DGTLVAIRSINVTSC----KSEEAEFVKGLYLLTSLRHENIIRLRGFCCSRGRGEC  483 (689)
Q Consensus       409 ~~f~~~~~lg~G~~g~Vy~~~~~-~g~~vavK~l~~~~~----~~~~~~f~~e~~~l~~l~H~niv~l~g~~~~~~~~~~  483 (689)
                      ++|...+.||+|+||.||+|... +|..||+|.+.....    ......+.+|++++++++||||+++++++.+......
T Consensus         2 ~~~~~~~~l~~g~~g~v~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~   81 (265)
T cd06652           2 TNWRLGKLLGQGAFGRVYLCYDADTGRELAVKQVQFDPESPETSKEVNALECEIQLLKNLLHERIVQYYGCLRDPMERTL   81 (265)
T ss_pred             CcceEeeEEecCCceEEEEEEEcCCCcEEEEEEeecCcCCcccHHHHHHHHHHHHHHHhcCCCCeeeEEeEeccCCCceE
Confidence            35777899999999999999875 589999998864321    1234578899999999999999999998755444568


Q ss_pred             EEEEEcCCCCCHHHHhhhcCCCCCCCCHHHHHHHHHHHHHHHhhhhCCCCCCCceeecCCCCCceeecCCCCeEEecccc
Q 005586          484 FLIYDFAPKGKLSKYLDQEEGSSNVLDWSTRVSIIIGIAKGIGYLHSSEVNKPAIVHRNLSVEKVLIDQQFNPLIADCGL  563 (689)
Q Consensus       484 ~lV~e~~~~gsL~~~L~~~~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~~~ivH~dlk~~NiLl~~~~~~kl~DfGl  563 (689)
                      ++||||+++++|.+++....    .+++...++++.|++.||+|||+.+     |+|+||||+||++++++.+||+|||+
T Consensus        82 ~~v~e~~~~~~L~~~l~~~~----~~~~~~~~~~~~~l~~~l~~lH~~~-----i~H~dl~p~nil~~~~~~~~l~Dfg~  152 (265)
T cd06652          82 SIFMEHMPGGSIKDQLKSYG----ALTENVTRKYTRQILEGVSYLHSNM-----IVHRDIKGANILRDSVGNVKLGDFGA  152 (265)
T ss_pred             EEEEEecCCCcHHHHHHHcC----CCCHHHHHHHHHHHHHHHHHHHhCC-----EecCCCCHHHEEecCCCCEEECcCcc
Confidence            89999999999999987542    3788889999999999999999987     99999999999999999999999999


Q ss_pred             cccccCCce--eeeecCCCCCCCCCccccccCCCCCcccchhHHHHHHHHHhCCCCcchhHHHHHhhhhhhHhhccccCC
Q 005586          564 HKLLADDIV--FSVLKTSAAMGYLAPEYVTTGRFTERSDIFAFGVIILQILTGSLVLTSSMRLAAESATFENFIDRNLKG  641 (689)
Q Consensus       564 a~~~~~~~~--~~~~~~~~~~~y~aPE~~~~~~~~~ksDV~sfGvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~  641 (689)
                      ++.......  .......++..|+|||.+.+..++.++|||||||++|||++|+.|+........    ..+........
T Consensus       153 ~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~~g~~p~~~~~~~~~----~~~~~~~~~~~  228 (265)
T cd06652         153 SKRLQTICLSGTGMKSVTGTPYWMSPEVISGEGYGRKADIWSVGCTVVEMLTEKPPWAEFEAMAA----IFKIATQPTNP  228 (265)
T ss_pred             ccccccccccccccccCCCCccccChhhhcCCCCCcchhHHHHHHHHHHHhhCCCCCCccchHHH----HHHHhcCCCCC
Confidence            986543211  111223467789999999888899999999999999999999999864321111    11111111223


Q ss_pred             CCCHHHHHHHHHHHHHhccCCCCCCCCHHHHHHHH
Q 005586          642 KFSESEAAKLGKMALVCTHEDPENRPTMEAVIEEL  676 (689)
Q Consensus       642 ~~~~~~~~~l~~l~~~Cl~~dp~~RPs~~evl~~L  676 (689)
                      ..+......+.+++.+|+. +|++||+++||+++.
T Consensus       229 ~~~~~~~~~~~~~i~~~l~-~p~~Rp~~~~il~~~  262 (265)
T cd06652         229 VLPPHVSDHCRDFLKRIFV-EAKLRPSADELLRHT  262 (265)
T ss_pred             CCchhhCHHHHHHHHHHhc-ChhhCCCHHHHhcCc
Confidence            3455566778889999985 999999999998764

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 2 (MEKK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK2 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK2 also activates ERK1/2, c-Jun N-terminal kinase (JNK) and p38 through their re

>cd05617 STKc_aPKC_zeta Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C zeta

Probab=100.00  E-value=6.6e-37  Score=323.58  Aligned_cols=248  Identities=15%  Similarity=0.255  Sum_probs=194.0

Q ss_pred             cccccCCcceEEEEEec-CCcEEEEEEecccCC--chHHHHHHHHHHHHhcc-CCCcceeEeeEEEcCCCCeEEEEEEcC
Q 005586          415 NLLGKGNFSSVYKGTLR-DGTLVAIRSINVTSC--KSEEAEFVKGLYLLTSL-RHENIIRLRGFCCSRGRGECFLIYDFA  490 (689)
Q Consensus       415 ~~lg~G~~g~Vy~~~~~-~g~~vavK~l~~~~~--~~~~~~f~~e~~~l~~l-~H~niv~l~g~~~~~~~~~~~lV~e~~  490 (689)
                      +.||+|+||.||+|..+ +++.||+|++.....  ......+.+|+.++.++ +||||+++++++..  ....++||||+
T Consensus         1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~--~~~~~lv~e~~   78 (327)
T cd05617           1 RVIGRGSYAKVLLVRLKKNDQIYAMKVVKKELVHDDEDIDWVQTEKHVFEQASSNPFLVGLHSCFQT--TSRLFLVIEYV   78 (327)
T ss_pred             CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhhcCCCCEeeEEEEEEe--CCEEEEEEeCC
Confidence            36999999999999975 678999999986532  23345688999999888 69999999998844  47899999999


Q ss_pred             CCCCHHHHhhhcCCCCCCCCHHHHHHHHHHHHHHHhhhhCCCCCCCceeecCCCCCceeecCCCCeEEecccccccccCC
Q 005586          491 PKGKLSKYLDQEEGSSNVLDWSTRVSIIIGIAKGIGYLHSSEVNKPAIVHRNLSVEKVLIDQQFNPLIADCGLHKLLADD  570 (689)
Q Consensus       491 ~~gsL~~~L~~~~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~~~ivH~dlk~~NiLl~~~~~~kl~DfGla~~~~~~  570 (689)
                      ++|+|..++....    .+++..+..++.|++.||+|||+.+     |+||||||+|||+++++.+||+|||+++.....
T Consensus        79 ~~~~L~~~~~~~~----~l~~~~~~~~~~qi~~al~~lH~~~-----ivHrDlkp~Nili~~~~~~kl~Dfg~~~~~~~~  149 (327)
T cd05617          79 NGGDLMFHMQRQR----KLPEEHARFYAAEICIALNFLHERG-----IIYRDLKLDNVLLDADGHIKLTDYGMCKEGLGP  149 (327)
T ss_pred             CCCcHHHHHHHcC----CCCHHHHHHHHHHHHHHHHHHHHCC-----eeccCCCHHHEEEeCCCCEEEeccccceeccCC
Confidence            9999999886543    4899999999999999999999987     999999999999999999999999998753221


Q ss_pred             ceeeeecCCCCCCCCCccccccCCCCCcccchhHHHHHHHHHhCCCCcchhHHH---HHhhhhhhHhhccccCCCCCHHH
Q 005586          571 IVFSVLKTSAAMGYLAPEYVTTGRFTERSDIFAFGVIILQILTGSLVLTSSMRL---AAESATFENFIDRNLKGKFSESE  647 (689)
Q Consensus       571 ~~~~~~~~~~~~~y~aPE~~~~~~~~~ksDV~sfGvvl~elltG~~p~~~~~~~---~~~~~~~~~~~~~~~~~~~~~~~  647 (689)
                      .. ......+|..|+|||++.+..++.++|||||||++|||+||+.||......   .........+....  ...+...
T Consensus       150 ~~-~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~--~~~p~~~  226 (327)
T cd05617         150 GD-TTSTFCGTPNYIAPEILRGEEYGFSVDWWALGVLMFEMMAGRSPFDIITDNPDMNTEDYLFQVILEKP--IRIPRFL  226 (327)
T ss_pred             CC-ceecccCCcccCCHHHHCCCCCCchheeehhHHHHHHHHhCCCCCCccCCCcccccHHHHHHHHHhCC--CCCCCCC
Confidence            11 122345788999999999999999999999999999999999999532110   00000111111111  1233444


Q ss_pred             HHHHHHHHHHhccCCCCCCCC------HHHHHHHH
Q 005586          648 AAKLGKMALVCTHEDPENRPT------MEAVIEEL  676 (689)
Q Consensus       648 ~~~l~~l~~~Cl~~dp~~RPs------~~evl~~L  676 (689)
                      +..+.+++.+|++.||++||+      +.+++++-
T Consensus       227 ~~~~~~li~~~L~~dP~~R~~~~~~~~~~~i~~h~  261 (327)
T cd05617         227 SVKASHVLKGFLNKDPKERLGCQPQTGFSDIKSHT  261 (327)
T ss_pred             CHHHHHHHHHHhccCHHHcCCCCCCCCHHHHHcCC
Confidence            567889999999999999998      56777653

Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, zeta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-zeta plays a critical role in activating the glucose transport response. It is activated by glucose, insulin, and exercise through diverse pathways

>cd06617 PKc_MKK3_6 Catalytic domain of the dual-specificity Protein Kinases, MAP kinase kinases 3 and 6

Probab=100.00  E-value=1.4e-36  Score=314.26  Aligned_cols=257  Identities=18%  Similarity=0.354  Sum_probs=198.6

Q ss_pred             ccCCcccccccCCcceEEEEEec-CCcEEEEEEecccCCchHHHHHHHHHHH-HhccCCCcceeEeeEEEcCCCCeEEEE
Q 005586          409 QCFSEVNLLGKGNFSSVYKGTLR-DGTLVAIRSINVTSCKSEEAEFVKGLYL-LTSLRHENIIRLRGFCCSRGRGECFLI  486 (689)
Q Consensus       409 ~~f~~~~~lg~G~~g~Vy~~~~~-~g~~vavK~l~~~~~~~~~~~f~~e~~~-l~~l~H~niv~l~g~~~~~~~~~~~lV  486 (689)
                      ++|+..+.||+|+||.||+|..+ +|+.||+|+++.........++..|+.. ++..+||||+++++++..  .+..++|
T Consensus         1 ~~~~~~~~ig~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~~~~~~~iv~~~~~~~~--~~~~~lv   78 (283)
T cd06617           1 DDLEVIEELGRGAYGVVDKMRHVPTGTIMAVKRIRATVNSQEQKRLLMDLDISMRSVDCPYTVTFYGALFR--EGDVWIC   78 (283)
T ss_pred             CCceEEEEecccCCeEEEEEEEcCCCcEEEEEEEecCCCcHHHHHHHHHHHHHHHHcCCCCeeeeeEEEec--CCcEEEE
Confidence            36788899999999999999976 6999999999865444445566667765 566789999999999854  4678999


Q ss_pred             EEcCCCCCHHHHhhhcCCCCCCCCHHHHHHHHHHHHHHHhhhhCC-CCCCCceeecCCCCCceeecCCCCeEEecccccc
Q 005586          487 YDFAPKGKLSKYLDQEEGSSNVLDWSTRVSIIIGIAKGIGYLHSS-EVNKPAIVHRNLSVEKVLIDQQFNPLIADCGLHK  565 (689)
Q Consensus       487 ~e~~~~gsL~~~L~~~~~~~~~l~~~~~~~ia~~ia~gL~yLH~~-~~~~~~ivH~dlk~~NiLl~~~~~~kl~DfGla~  565 (689)
                      |||++ |+|.+++.........+++...+.++.|++.||+|||+. +     ++||||||+||++++++.+||+|||+++
T Consensus        79 ~e~~~-~~l~~~l~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~~-----i~h~dlkp~nil~~~~~~~kl~dfg~~~  152 (283)
T cd06617          79 MEVMD-TSLDKFYKKVYDKGLTIPEDILGKIAVSIVKALEYLHSKLS-----VIHRDVKPSNVLINRNGQVKLCDFGISG  152 (283)
T ss_pred             hhhhc-ccHHHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHhhcCC-----eecCCCCHHHEEECCCCCEEEeeccccc
Confidence            99996 789888876433335689999999999999999999986 5     9999999999999999999999999998


Q ss_pred             cccCCceeeeecCCCCCCCCCcccccc----CCCCCcccchhHHHHHHHHHhCCCCcchhHHHHHhhhhhhHhhccccCC
Q 005586          566 LLADDIVFSVLKTSAAMGYLAPEYVTT----GRFTERSDIFAFGVIILQILTGSLVLTSSMRLAAESATFENFIDRNLKG  641 (689)
Q Consensus       566 ~~~~~~~~~~~~~~~~~~y~aPE~~~~----~~~~~ksDV~sfGvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~  641 (689)
                      .......  .....++..|+|||.+.+    ..++.++|||||||++|||++|+.|+.......   .......... ..
T Consensus       153 ~~~~~~~--~~~~~~~~~y~aPE~~~~~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~---~~~~~~~~~~-~~  226 (283)
T cd06617         153 YLVDSVA--KTIDAGCKPYMAPERINPELNQKGYDVKSDVWSLGITMIELATGRFPYDSWKTPF---QQLKQVVEEP-SP  226 (283)
T ss_pred             ccccccc--cccccCCccccChhhcCCcccccccCccccchhhHHHHHHHHhCCCCCCccccCH---HHHHHHHhcC-CC
Confidence            6643221  122346778999998764    456899999999999999999999986421110   1111111111 11


Q ss_pred             CCC-HHHHHHHHHHHHHhccCCCCCCCCHHHHHHHHHhh
Q 005586          642 KFS-ESEAAKLGKMALVCTHEDPENRPTMEAVIEELTVA  679 (689)
Q Consensus       642 ~~~-~~~~~~l~~l~~~Cl~~dp~~RPs~~evl~~L~~~  679 (689)
                      ..+ ...+.++.+++..|+..+|++||++.+++++-+..
T Consensus       227 ~~~~~~~~~~l~~li~~~l~~~p~~Rp~~~~il~~~~~~  265 (283)
T cd06617         227 QLPAEKFSPEFQDFVNKCLKKNYKERPNYPELLQHPFFE  265 (283)
T ss_pred             CCCccccCHHHHHHHHHHccCChhhCcCHHHHhcCchhh
Confidence            111 22456799999999999999999999999865443

Protein kinases (PKs), MAP kinase kinase 3 (MKK3) and MKK6 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK3 and MKK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK3 and MKK6 are dual-specificity PKs

>cd07875 STKc_JNK1 Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 1

Probab=100.00  E-value=1.1e-36  Score=326.99  Aligned_cols=257  Identities=17%  Similarity=0.294  Sum_probs=198.9

Q ss_pred             hccCCcccccccCCcceEEEEEec-CCcEEEEEEecccCC-chHHHHHHHHHHHHhccCCCcceeEeeEEEcCC----CC
Q 005586          408 TQCFSEVNLLGKGNFSSVYKGTLR-DGTLVAIRSINVTSC-KSEEAEFVKGLYLLTSLRHENIIRLRGFCCSRG----RG  481 (689)
Q Consensus       408 t~~f~~~~~lg~G~~g~Vy~~~~~-~g~~vavK~l~~~~~-~~~~~~f~~e~~~l~~l~H~niv~l~g~~~~~~----~~  481 (689)
                      .++|...+.||+|+||.||+|... .++.||||++..... ......+.+|+.+++.++||||+++++++....    ..
T Consensus        23 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~ii~~~~~~~~~~~~~~~~  102 (364)
T cd07875          23 LKRYQNLKPIGSGAQGIVCAAYDAILERNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIIGLLNVFTPQKSLEEFQ  102 (364)
T ss_pred             hcceeEEEEeecCCCeEEEEEEECCCCcEEEEEEeCccccCchhHHHHHHHHHHHHhcCCCCccccceeecccccccccC
Confidence            467888999999999999999875 688999999975432 334567889999999999999999999874321    23


Q ss_pred             eEEEEEEcCCCCCHHHHhhhcCCCCCCCCHHHHHHHHHHHHHHHhhhhCCCCCCCceeecCCCCCceeecCCCCeEEecc
Q 005586          482 ECFLIYDFAPKGKLSKYLDQEEGSSNVLDWSTRVSIIIGIAKGIGYLHSSEVNKPAIVHRNLSVEKVLIDQQFNPLIADC  561 (689)
Q Consensus       482 ~~~lV~e~~~~gsL~~~L~~~~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~~~ivH~dlk~~NiLl~~~~~~kl~Df  561 (689)
                      ..++||||+++ +|.+++..      .+++..+..++.|++.||+|||+.+     |+||||||+|||+++++.+||+||
T Consensus       103 ~~~lv~e~~~~-~l~~~~~~------~~~~~~~~~~~~qi~~aL~~LH~~~-----ivH~Dlkp~NIll~~~~~~kL~Df  170 (364)
T cd07875         103 DVYIVMELMDA-NLCQVIQM------ELDHERMSYLLYQMLCGIKHLHSAG-----IIHRDLKPSNIVVKSDCTLKILDF  170 (364)
T ss_pred             eEEEEEeCCCC-CHHHHHHh------cCCHHHHHHHHHHHHHHHHHHhhCC-----eecCCCCHHHEEECCCCcEEEEeC
Confidence            57999999964 77777743      2788999999999999999999987     999999999999999999999999


Q ss_pred             cccccccCCceeeeecCCCCCCCCCccccccCCCCCcccchhHHHHHHHHHhCCCCcchhHHHHHhhhhhh---------
Q 005586          562 GLHKLLADDIVFSVLKTSAAMGYLAPEYVTTGRFTERSDIFAFGVIILQILTGSLVLTSSMRLAAESATFE---------  632 (689)
Q Consensus       562 Gla~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~ksDV~sfGvvl~elltG~~p~~~~~~~~~~~~~~~---------  632 (689)
                      |+++.......  .....++..|+|||++.+..++.++|||||||++|||+||+.||............+.         
T Consensus       171 G~a~~~~~~~~--~~~~~~t~~y~aPE~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~  248 (364)
T cd07875         171 GLARTAGTSFM--MTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMIKGGVLFPGTDHIDQWNKVIEQLGTPCPEF  248 (364)
T ss_pred             CCccccCCCCc--ccCCcccCCcCCHHHHhCCCCCchhhHHhHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCCHHH
Confidence            99987644321  1234578889999999999999999999999999999999999964322111111000         


Q ss_pred             ---------Hhhcc--ccC----------------CCCCHHHHHHHHHHHHHhccCCCCCCCCHHHHHHHHHh
Q 005586          633 ---------NFIDR--NLK----------------GKFSESEAAKLGKMALVCTHEDPENRPTMEAVIEELTV  678 (689)
Q Consensus       633 ---------~~~~~--~~~----------------~~~~~~~~~~l~~l~~~Cl~~dp~~RPs~~evl~~L~~  678 (689)
                               .....  ...                .........++.+++.+|++.||++|||+.|++++-+.
T Consensus       249 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dll~~mL~~dP~~R~t~~e~L~hp~~  321 (364)
T cd07875         249 MKKLQPTVRTYVENRPKYAGYSFEKLFPDVLFPADSEHNKLKASQARDLLSKMLVIDASKRISVDEALQHPYI  321 (364)
T ss_pred             HHhhhHHHHHHHhhCCCcCCCChHhhCccccccccccccccccHHHHHHHHHhcCcCcccCCCHHHHhcCccc
Confidence                     00000  000                00011124578899999999999999999999998654

Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 1 (JNK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jn

>cd08223 STKc_Nek4 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 4

Probab=100.00  E-value=2.3e-36  Score=307.99  Aligned_cols=252  Identities=21%  Similarity=0.393  Sum_probs=202.5

Q ss_pred             cCCcccccccCCcceEEEEEec-CCcEEEEEEecccCC-chHHHHHHHHHHHHhccCCCcceeEeeEEEcCCCCeEEEEE
Q 005586          410 CFSEVNLLGKGNFSSVYKGTLR-DGTLVAIRSINVTSC-KSEEAEFVKGLYLLTSLRHENIIRLRGFCCSRGRGECFLIY  487 (689)
Q Consensus       410 ~f~~~~~lg~G~~g~Vy~~~~~-~g~~vavK~l~~~~~-~~~~~~f~~e~~~l~~l~H~niv~l~g~~~~~~~~~~~lV~  487 (689)
                      +|+..+.||+|++|.||++..+ +++.||+|++..... ....+.+.+|++++++++|+|++++++.+.. .....++||
T Consensus         1 ~y~~~~~lg~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~-~~~~~~lv~   79 (257)
T cd08223           1 AYCFVRVVGKGSYGEVSLVRHRTDGKQYVIKKLNLRNASRRERKAAEQEAQLLSQLKHPNIVAYRESWEG-EDGLLYIVM   79 (257)
T ss_pred             CceEEEEecCCCCeEEEEEEEcCCCcEEEEEEEehhhcCHHHHHHHHHHHHHHHhCCCCCeeeeeeeecC-CCCEEEEEe
Confidence            3677899999999999999875 578999999975432 2345678999999999999999999987643 234678999


Q ss_pred             EcCCCCCHHHHhhhcCCCCCCCCHHHHHHHHHHHHHHHhhhhCCCCCCCceeecCCCCCceeecCCCCeEEecccccccc
Q 005586          488 DFAPKGKLSKYLDQEEGSSNVLDWSTRVSIIIGIAKGIGYLHSSEVNKPAIVHRNLSVEKVLIDQQFNPLIADCGLHKLL  567 (689)
Q Consensus       488 e~~~~gsL~~~L~~~~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~~~ivH~dlk~~NiLl~~~~~~kl~DfGla~~~  567 (689)
                      ||+++++|.+++.....  ..+++.+++.++.+++.|++|||+.+     |+||||||+||++++++.++|+|||+++..
T Consensus        80 e~~~~~~l~~~l~~~~~--~~l~~~~~~~~~~~l~~~l~~lH~~~-----i~H~di~p~nil~~~~~~~~l~df~~~~~~  152 (257)
T cd08223          80 GFCEGGDLYHKLKEQKG--KLLPENQVVEWFVQIAMALQYLHEKH-----ILHRDLKTQNVFLTRTNIIKVGDLGIARVL  152 (257)
T ss_pred             cccCCCcHHHHHHHhcC--CCCCHHHHHHHHHHHHHHHHHHHhCC-----eeccCCCchhEEEecCCcEEEecccceEEe
Confidence            99999999999976432  35899999999999999999999987     999999999999999999999999999866


Q ss_pred             cCCceeeeecCCCCCCCCCccccccCCCCCcccchhHHHHHHHHHhCCCCcchhHHHHHhhhhhhHhhccccCCCCCHHH
Q 005586          568 ADDIVFSVLKTSAAMGYLAPEYVTTGRFTERSDIFAFGVIILQILTGSLVLTSSMRLAAESATFENFIDRNLKGKFSESE  647 (689)
Q Consensus       568 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~ksDV~sfGvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  647 (689)
                      ..... ......++..|+|||++.+..++.++||||||++++||++|+.|+........    ...... ......+...
T Consensus       153 ~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~~l~~g~~~~~~~~~~~~----~~~~~~-~~~~~~~~~~  226 (257)
T cd08223         153 ENQCD-MASTLIGTPYYMSPELFSNKPYNYKSDVWALGCCVYEMATLKHAFNAKDMNSL----VYRIIE-GKLPPMPKDY  226 (257)
T ss_pred             cccCC-ccccccCCcCccChhHhcCCCCCchhhhHHHHHHHHHHHcCCCCCCCCCHHHH----HHHHHh-cCCCCCcccc
Confidence            43221 11223467789999999998999999999999999999999999864321111    111111 1112234455


Q ss_pred             HHHHHHHHHHhccCCCCCCCCHHHHHHH
Q 005586          648 AAKLGKMALVCTHEDPENRPTMEAVIEE  675 (689)
Q Consensus       648 ~~~l~~l~~~Cl~~dp~~RPs~~evl~~  675 (689)
                      ..++.+++.+|++.+|++||++.+++++
T Consensus       227 ~~~~~~li~~~l~~~p~~Rp~~~~~l~~  254 (257)
T cd08223         227 SPELGELIATMLSKRPEKRPSVKSILRQ  254 (257)
T ss_pred             CHHHHHHHHHHhccCcccCCCHHHHhcC
Confidence            6789999999999999999999999976

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 4 (Nek4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek4 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. Nek4 is highly abundant in the testis. Its specific function is unknown.

>cd08221 STKc_Nek9 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 9

Probab=100.00  E-value=2.8e-36  Score=307.22  Aligned_cols=252  Identities=20%  Similarity=0.366  Sum_probs=204.9

Q ss_pred             cCCcccccccCCcceEEEEEec-CCcEEEEEEecccCC-chHHHHHHHHHHHHhccCCCcceeEeeEEEcCCCCeEEEEE
Q 005586          410 CFSEVNLLGKGNFSSVYKGTLR-DGTLVAIRSINVTSC-KSEEAEFVKGLYLLTSLRHENIIRLRGFCCSRGRGECFLIY  487 (689)
Q Consensus       410 ~f~~~~~lg~G~~g~Vy~~~~~-~g~~vavK~l~~~~~-~~~~~~f~~e~~~l~~l~H~niv~l~g~~~~~~~~~~~lV~  487 (689)
                      +|+..+.||+|+||.||.++.. ++..+++|++..... .....++.+|++++++++|+||+++++++.+  .+..++||
T Consensus         1 ~y~~~~~ig~g~~g~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~--~~~~~~~~   78 (256)
T cd08221           1 HYIPIRVLGKGAFGEATLYRRTEDDSLVVWKEVNLTRLSEKERRDALNEIVILSLLQHPNIIAYYNHFMD--DNTLLIEM   78 (256)
T ss_pred             CceEeeEecccCCceEEEEEEcCCCcEEEEEEEeecccchhHHHHHHHHHHHHHhCCCCCeeEEEeEEec--CCeEEEEE
Confidence            4777899999999999999864 689999999876542 3445678999999999999999999999955  47899999


Q ss_pred             EcCCCCCHHHHhhhcCCCCCCCCHHHHHHHHHHHHHHHhhhhCCCCCCCceeecCCCCCceeecCCCCeEEecccccccc
Q 005586          488 DFAPKGKLSKYLDQEEGSSNVLDWSTRVSIIIGIAKGIGYLHSSEVNKPAIVHRNLSVEKVLIDQQFNPLIADCGLHKLL  567 (689)
Q Consensus       488 e~~~~gsL~~~L~~~~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~~~ivH~dlk~~NiLl~~~~~~kl~DfGla~~~  567 (689)
                      ||+++|+|.+++....  ...+++.++..++.|++.||+|||+.+     ++||||||+||++++++.+||+|||+++..
T Consensus        79 e~~~~~~L~~~~~~~~--~~~~~~~~~~~~~~~l~~~l~~lh~~~-----i~h~dl~p~ni~~~~~~~~kl~d~~~~~~~  151 (256)
T cd08221          79 EYANGGTLYDKIVRQK--GQLFEEEMVLWYLFQIVSAVSYIHKAG-----ILHRDIKTLNIFLTKAGLIKLGDFGISKIL  151 (256)
T ss_pred             EecCCCcHHHHHHhcc--ccCCCHHHHHHHHHHHHHHHHHHHhCC-----ccccCCChHhEEEeCCCCEEECcCcceEEc
Confidence            9999999999997653  235899999999999999999999987     999999999999999999999999999876


Q ss_pred             cCCceeeeecCCCCCCCCCccccccCCCCCcccchhHHHHHHHHHhCCCCcchhHHHHHhhhhhhHhhccccCCCCCHHH
Q 005586          568 ADDIVFSVLKTSAAMGYLAPEYVTTGRFTERSDIFAFGVIILQILTGSLVLTSSMRLAAESATFENFIDRNLKGKFSESE  647 (689)
Q Consensus       568 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~ksDV~sfGvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  647 (689)
                      ..... ......++..|+|||+..+..++.++||||||+++|||++|+.|+.......    ...++...... ..+...
T Consensus       152 ~~~~~-~~~~~~~~~~y~ape~~~~~~~~~~~Dv~slG~i~~~l~~g~~~~~~~~~~~----~~~~~~~~~~~-~~~~~~  225 (256)
T cd08221         152 GSEYS-MAETVVGTPYYMSPELCQGVKYNFKSDIWALGCVLYELLTLKRTFDATNPLN----LVVKIVQGNYT-PVVSVY  225 (256)
T ss_pred             ccccc-cccccCCCccccCHhhcCCCCCCCcchhHHHHHHHHHHHHCCCCCCCCCHHH----HHHHHHcCCCC-CCcccc
Confidence            44332 1223456788999999988889999999999999999999999986432111    11122221111 222344


Q ss_pred             HHHHHHHHHHhccCCCCCCCCHHHHHHHH
Q 005586          648 AAKLGKMALVCTHEDPENRPTMEAVIEEL  676 (689)
Q Consensus       648 ~~~l~~l~~~Cl~~dp~~RPs~~evl~~L  676 (689)
                      +.++.+++..||+.+|++||++.|+++++
T Consensus       226 ~~~~~~~i~~~l~~~p~~R~s~~~ll~~~  254 (256)
T cd08221         226 SSELISLVHSLLQQDPEKRPTADEVLDQP  254 (256)
T ss_pred             CHHHHHHHHHHcccCcccCCCHHHHhhCc
Confidence            66799999999999999999999999875

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 9 (Nek9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek9 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek9, also called Nercc1, is primarily a cytoplasmic protein but can also localize in the nucleus. It is involved in modulating chromosome alignment and splitting during mitosis. It interacts with the gamma-tubulin ring complex and the Ran GTPase, and is implicated in microtubule organization. Nek9 associa

>cd06629 STKc_MAPKKK_Bck1_like Catalytic domain of fungal Bck1-like MAP Kinase Kinase Kinases

Probab=100.00  E-value=1.6e-36  Score=311.97  Aligned_cols=255  Identities=20%  Similarity=0.330  Sum_probs=197.1

Q ss_pred             CCcccccccCCcceEEEEEec-CCcEEEEEEecccCCc---------hHHHHHHHHHHHHhccCCCcceeEeeEEEcCCC
Q 005586          411 FSEVNLLGKGNFSSVYKGTLR-DGTLVAIRSINVTSCK---------SEEAEFVKGLYLLTSLRHENIIRLRGFCCSRGR  480 (689)
Q Consensus       411 f~~~~~lg~G~~g~Vy~~~~~-~g~~vavK~l~~~~~~---------~~~~~f~~e~~~l~~l~H~niv~l~g~~~~~~~  480 (689)
                      |...+.||+|+||.||+|... +|+.||+|.++.....         ...+.+.+|++++.+++|||++++++++.  ..
T Consensus         3 ~~~~~~lg~g~~~~vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~--~~   80 (272)
T cd06629           3 WVKGELIGKGTYGRVYLALNVTTGEMMAVKQVELPATIAGRHDSRQKDMVKALRSEIETLKDLDHLNIVQYLGFET--TE   80 (272)
T ss_pred             eeecceecccCceEEEEEeecCCCceeeeeeeechhhhhcccchHHHHHHHHHHHHHHHHHhcCCCCcceEEEEec--cC
Confidence            556789999999999999865 6899999988643210         11246888999999999999999999984  35


Q ss_pred             CeEEEEEEcCCCCCHHHHhhhcCCCCCCCCHHHHHHHHHHHHHHHhhhhCCCCCCCceeecCCCCCceeecCCCCeEEec
Q 005586          481 GECFLIYDFAPKGKLSKYLDQEEGSSNVLDWSTRVSIIIGIAKGIGYLHSSEVNKPAIVHRNLSVEKVLIDQQFNPLIAD  560 (689)
Q Consensus       481 ~~~~lV~e~~~~gsL~~~L~~~~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~~~ivH~dlk~~NiLl~~~~~~kl~D  560 (689)
                      +..++||||+++|+|.++++...    .+++..+..++.|++.||.|||+.+     ++||||+|+||++++++.+|++|
T Consensus        81 ~~~~lv~e~~~~~~L~~~l~~~~----~l~~~~~~~~~~qi~~~l~~lH~~~-----i~H~dl~~~nil~~~~~~~~l~d  151 (272)
T cd06629          81 EYLSIFLEYVPGGSIGSCLRTYG----RFEEQLVRFFTEQVLEGLAYLHSKG-----ILHRDLKADNLLVDADGICKISD  151 (272)
T ss_pred             CceEEEEecCCCCcHHHHHhhcc----CCCHHHHHHHHHHHHHHHHHHhhCC-----eeecCCChhhEEEcCCCeEEEee
Confidence            78899999999999999997652    4899999999999999999999987     99999999999999999999999


Q ss_pred             ccccccccCCcee-eeecCCCCCCCCCccccccCC--CCCcccchhHHHHHHHHHhCCCCcchhHHHHHhhhhhhHhhcc
Q 005586          561 CGLHKLLADDIVF-SVLKTSAAMGYLAPEYVTTGR--FTERSDIFAFGVIILQILTGSLVLTSSMRLAAESATFENFIDR  637 (689)
Q Consensus       561 fGla~~~~~~~~~-~~~~~~~~~~y~aPE~~~~~~--~~~ksDV~sfGvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~  637 (689)
                      ||+++........ ......++..|+|||.+....  ++.++||||||+++||+++|+.|+...................
T Consensus       152 ~~~~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~  231 (272)
T cd06629         152 FGISKKSDDIYDNDQNMSMQGSVFWMAPEVIHSYSQGYSAKVDIWSLGCVVLEMFAGRRPWSDEEAIAAMFKLGNKRSAP  231 (272)
T ss_pred             ccccccccccccccccccccCCccccCHHHhccccCCCCccchhHHHHHHHHHHHhCCCCCcCcchHHHHHHhhccccCC
Confidence            9999865432111 122334677899999987654  7899999999999999999999985432211110000000011


Q ss_pred             ccCCCCCHHHHHHHHHHHHHhccCCCCCCCCHHHHHHHH
Q 005586          638 NLKGKFSESEAAKLGKMALVCTHEDPENRPTMEAVIEEL  676 (689)
Q Consensus       638 ~~~~~~~~~~~~~l~~l~~~Cl~~dp~~RPs~~evl~~L  676 (689)
                      .............+.+++..|++.+|++||++.||+++.
T Consensus       232 ~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~~~  270 (272)
T cd06629         232 PIPPDVSMNLSPVALDFLNACFTINPDNRPTARELLQHP  270 (272)
T ss_pred             cCCccccccCCHHHHHHHHHHhcCChhhCCCHHHHhhCC
Confidence            111112223467899999999999999999999999863

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Bck1-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Saccharomyces cerevisiae Bck1 and Schizosaccharomyces pombe Mkh1, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Budding yeast Bck1 is part of the cell inte

>cd05604 STKc_SGK3 Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 3

Probab=100.00  E-value=4e-37  Score=325.09  Aligned_cols=239  Identities=21%  Similarity=0.328  Sum_probs=188.0

Q ss_pred             cccccCCcceEEEEEec-CCcEEEEEEecccCC--chHHHHHHHHHH-HHhccCCCcceeEeeEEEcCCCCeEEEEEEcC
Q 005586          415 NLLGKGNFSSVYKGTLR-DGTLVAIRSINVTSC--KSEEAEFVKGLY-LLTSLRHENIIRLRGFCCSRGRGECFLIYDFA  490 (689)
Q Consensus       415 ~~lg~G~~g~Vy~~~~~-~g~~vavK~l~~~~~--~~~~~~f~~e~~-~l~~l~H~niv~l~g~~~~~~~~~~~lV~e~~  490 (689)
                      +.||+|+||.||+|+.. +|+.||+|++.....  .....++..|.. +++.++||||+++++++..  .+..++||||+
T Consensus         1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~~l~~~~hp~iv~~~~~~~~--~~~~~lv~e~~   78 (325)
T cd05604           1 KVIGKGSFGKVLLAKRKLDGKCYAVKVLQKKIVLNRKEQKHIMAERNVLLKNVKHPFLVGLHYSFQT--TEKLYFVLDFV   78 (325)
T ss_pred             CceeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHHhCCCCCCccEEEEEec--CCEEEEEEcCC
Confidence            36999999999999875 789999999975421  223345666655 5677999999999998844  57899999999


Q ss_pred             CCCCHHHHhhhcCCCCCCCCHHHHHHHHHHHHHHHhhhhCCCCCCCceeecCCCCCceeecCCCCeEEecccccccccCC
Q 005586          491 PKGKLSKYLDQEEGSSNVLDWSTRVSIIIGIAKGIGYLHSSEVNKPAIVHRNLSVEKVLIDQQFNPLIADCGLHKLLADD  570 (689)
Q Consensus       491 ~~gsL~~~L~~~~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~~~ivH~dlk~~NiLl~~~~~~kl~DfGla~~~~~~  570 (689)
                      ++|+|..++....    .+++.....++.||+.||+|||+.+     |+||||||+|||+++++.+||+|||+++.....
T Consensus        79 ~~~~L~~~l~~~~----~~~~~~~~~~~~qi~~al~~lH~~g-----ivH~Dlkp~NIll~~~~~~kL~DfG~~~~~~~~  149 (325)
T cd05604          79 NGGELFFHLQRER----SFPEPRARFYAAEIASALGYLHSIN-----IVYRDLKPENILLDSQGHVVLTDFGLCKEGIAQ  149 (325)
T ss_pred             CCCCHHHHHHHcC----CCCHHHHHHHHHHHHHHHHHHHHCC-----eeecCCCHHHeEECCCCCEEEeecCCcccCCCC
Confidence            9999999887543    4889999999999999999999987     999999999999999999999999998754221


Q ss_pred             ceeeeecCCCCCCCCCccccccCCCCCcccchhHHHHHHHHHhCCCCcchhHHHHHhhhhhhHhhccccCCCCCHHHHHH
Q 005586          571 IVFSVLKTSAAMGYLAPEYVTTGRFTERSDIFAFGVIILQILTGSLVLTSSMRLAAESATFENFIDRNLKGKFSESEAAK  650 (689)
Q Consensus       571 ~~~~~~~~~~~~~y~aPE~~~~~~~~~ksDV~sfGvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  650 (689)
                      .. ......++..|+|||++.+..++.++|||||||++|||++|+.||........    +..+.....  .........
T Consensus       150 ~~-~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~~G~~pf~~~~~~~~----~~~~~~~~~--~~~~~~~~~  222 (325)
T cd05604         150 SD-TTTTFCGTPEYLAPEVIRKQPYDNTVDWWCLGAVLYEMLYGLPPFYCRDVAEM----YDNILHKPL--VLRPGASLT  222 (325)
T ss_pred             CC-CcccccCChhhCCHHHHcCCCCCCcCccccccceehhhhcCCCCCCCCCHHHH----HHHHHcCCc--cCCCCCCHH
Confidence            11 12234578899999999999999999999999999999999999965422111    122222111  122234567


Q ss_pred             HHHHHHHhccCCCCCCCCHHH
Q 005586          651 LGKMALVCTHEDPENRPTMEA  671 (689)
Q Consensus       651 l~~l~~~Cl~~dp~~RPs~~e  671 (689)
                      +.+++..|++.+|++||++++
T Consensus       223 ~~~ll~~ll~~~p~~R~~~~~  243 (325)
T cd05604         223 AWSILEELLEKDRQRRLGAKE  243 (325)
T ss_pred             HHHHHHHHhccCHHhcCCCCC
Confidence            889999999999999998753

Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGK3 is expressed in most tissues and is most abundant in the embryo and adult heart and spleen. It was originally discovered in a screen for antiapoptotic genes. It phosphorylates and inhibits the proapoptotic proteins, Bad and FKHRL1. SGK3 also regulates many transporters, ion channels,

>cd05074 PTKc_Tyro3 Catalytic domain of the Protein Tyrosine Kinase, Tyro3

Probab=100.00  E-value=3.2e-36  Score=309.85  Aligned_cols=259  Identities=24%  Similarity=0.397  Sum_probs=200.7

Q ss_pred             CCcccccccCCcceEEEEEec----CCcEEEEEEecccCC-chHHHHHHHHHHHHhccCCCcceeEeeEEEcCCC----C
Q 005586          411 FSEVNLLGKGNFSSVYKGTLR----DGTLVAIRSINVTSC-KSEEAEFVKGLYLLTSLRHENIIRLRGFCCSRGR----G  481 (689)
Q Consensus       411 f~~~~~lg~G~~g~Vy~~~~~----~g~~vavK~l~~~~~-~~~~~~f~~e~~~l~~l~H~niv~l~g~~~~~~~----~  481 (689)
                      |...+.||+|+||.||+|.++    .+..||||++..... ....+++.+|++++++++||||+++++++.....    .
T Consensus         1 ~~~~~~ig~g~~g~v~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~~   80 (273)
T cd05074           1 FTLGRMLGKGEFGSVREAQLKSEDGSFQKVAVKMLKADIFSSSDIEEFLREAACMKEFDHPNVIKLIGVSLRSRAKGRLP   80 (273)
T ss_pred             CcchhcccCCCCCCEEeeEeeccCCCceEEEEEEeccccCChHHHHHHHHHHHHHhcCCCCCcceEEEEEccCCCCCccc
Confidence            455678999999999999864    368899999876532 3345678999999999999999999998854322    1


Q ss_pred             eEEEEEEcCCCCCHHHHhhhcCC--CCCCCCHHHHHHHHHHHHHHHhhhhCCCCCCCceeecCCCCCceeecCCCCeEEe
Q 005586          482 ECFLIYDFAPKGKLSKYLDQEEG--SSNVLDWSTRVSIIIGIAKGIGYLHSSEVNKPAIVHRNLSVEKVLIDQQFNPLIA  559 (689)
Q Consensus       482 ~~~lV~e~~~~gsL~~~L~~~~~--~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~~~ivH~dlk~~NiLl~~~~~~kl~  559 (689)
                      ..++++||+++|+|.+++.....  ....+++...++++.|++.||+|||+.+     |+||||||+||++++++.+||+
T Consensus        81 ~~~~~~~~~~~~~l~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~~-----i~H~dikp~nili~~~~~~kl~  155 (273)
T cd05074          81 IPMVILPFMKHGDLHTFLLMSRIGEEPFTLPLQTLVRFMIDIASGMEYLSSKN-----FIHRDLAARNCMLNENMTVCVA  155 (273)
T ss_pred             ceEEEEecCCCCcHHHHHHHhcccCCCCCCCHHHHHHHHHHHHHHHHHHHhCC-----EeecccchhhEEEcCCCCEEEC
Confidence            24789999999999998864321  1234789999999999999999999987     9999999999999999999999


Q ss_pred             cccccccccCCcee-eeecCCCCCCCCCccccccCCCCCcccchhHHHHHHHHHh-CCCCcchhHHHHHhhhhhhHhhcc
Q 005586          560 DCGLHKLLADDIVF-SVLKTSAAMGYLAPEYVTTGRFTERSDIFAFGVIILQILT-GSLVLTSSMRLAAESATFENFIDR  637 (689)
Q Consensus       560 DfGla~~~~~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~ksDV~sfGvvl~ellt-G~~p~~~~~~~~~~~~~~~~~~~~  637 (689)
                      |||+++........ ......++..|++||.+....++.++|||||||++|||++ |+.|+........    ...+.. 
T Consensus       156 dfg~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~sDi~slG~il~el~~~g~~p~~~~~~~~~----~~~~~~-  230 (273)
T cd05074         156 DFGLSKKIYSGDYYRQGCASKLPVKWLALESLADNVYTTHSDVWAFGVTMWEIMTRGQTPYAGVENSEI----YNYLIK-  230 (273)
T ss_pred             cccccccccCCcceecCCCccCchhhcCHhHHhcCccchhhhhHHHHHHHHHHhhCCCCCCCCCCHHHH----HHHHHc-
Confidence            99999876443211 1122234567999999988889999999999999999999 8888864422111    111111 


Q ss_pred             ccCCCCCHHHHHHHHHHHHHhccCCCCCCCCHHHHHHHHHhh
Q 005586          638 NLKGKFSESEAAKLGKMALVCTHEDPENRPTMEAVIEELTVA  679 (689)
Q Consensus       638 ~~~~~~~~~~~~~l~~l~~~Cl~~dp~~RPs~~evl~~L~~~  679 (689)
                      ......+......+.+++.+|++.+|++||++.|+++.|+.+
T Consensus       231 ~~~~~~~~~~~~~~~~l~~~~l~~~p~~Rps~~~~~~~l~~~  272 (273)
T cd05074         231 GNRLKQPPDCLEDVYELMCQCWSPEPKCRPSFQHLRDQLELI  272 (273)
T ss_pred             CCcCCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHhh
Confidence            111112233456899999999999999999999999999865

Protein Tyrosine Kinase (PTK) family; Tyro3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyro3 (or Sky) is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Tyro3 is predominantly expressed in the central nervous system and the brain, and functions as a neurotrophic fac

>cd06655 STKc_PAK2 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 2

Probab=100.00  E-value=1.5e-36  Score=316.31  Aligned_cols=252  Identities=16%  Similarity=0.315  Sum_probs=203.3

Q ss_pred             ccCCcccccccCCcceEEEEEe-cCCcEEEEEEecccCCchHHHHHHHHHHHHhccCCCcceeEeeEEEcCCCCeEEEEE
Q 005586          409 QCFSEVNLLGKGNFSSVYKGTL-RDGTLVAIRSINVTSCKSEEAEFVKGLYLLTSLRHENIIRLRGFCCSRGRGECFLIY  487 (689)
Q Consensus       409 ~~f~~~~~lg~G~~g~Vy~~~~-~~g~~vavK~l~~~~~~~~~~~f~~e~~~l~~l~H~niv~l~g~~~~~~~~~~~lV~  487 (689)
                      .+|+..+.||.|+||.||+|.. .+|+.|++|.+.... ......+.+|+..++.++||||+++++++..  .+..++|+
T Consensus        19 ~~y~~~~~lg~g~~g~vy~~~~~~~~~~v~iK~~~~~~-~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~--~~~~~lv~   95 (296)
T cd06655          19 KKYTRYEKIGQGASGTVFTAIDVATGQEVAIKQINLQK-QPKKELIINEILVMKELKNPNIVNFLDSFLV--GDELFVVM   95 (296)
T ss_pred             ceEEEEEEEecCCCeEEEEEEEcCCCcEEEEEEEeccc-CchHHHHHHHHHHHHhcCCCceeeeeeeEec--CceEEEEE
Confidence            3577788999999999999986 478999999987654 3345678899999999999999999999854  47899999


Q ss_pred             EcCCCCCHHHHhhhcCCCCCCCCHHHHHHHHHHHHHHHhhhhCCCCCCCceeecCCCCCceeecCCCCeEEecccccccc
Q 005586          488 DFAPKGKLSKYLDQEEGSSNVLDWSTRVSIIIGIAKGIGYLHSSEVNKPAIVHRNLSVEKVLIDQQFNPLIADCGLHKLL  567 (689)
Q Consensus       488 e~~~~gsL~~~L~~~~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~~~ivH~dlk~~NiLl~~~~~~kl~DfGla~~~  567 (689)
                      ||+++++|.+++...     .++|.++..++.|++.||+|||+.+     ++||||||+||++++++.+||+|||++...
T Consensus        96 e~~~~~~L~~~~~~~-----~l~~~~~~~i~~~l~~al~~LH~~~-----i~H~dL~p~Nili~~~~~~kl~dfg~~~~~  165 (296)
T cd06655          96 EYLAGGSLTDVVTET-----CMDEAQIAAVCRECLQALEFLHANQ-----VIHRDIKSDNVLLGMDGSVKLTDFGFCAQI  165 (296)
T ss_pred             EecCCCcHHHHHHhc-----CCCHHHHHHHHHHHHHHHHHHHHCC-----cccCCCCHHHEEECCCCCEEEccCccchhc
Confidence            999999999998643     3899999999999999999999987     999999999999999999999999998866


Q ss_pred             cCCceeeeecCCCCCCCCCccccccCCCCCcccchhHHHHHHHHHhCCCCcchhHHHHHhhhhhhHhh-ccccCCCCCHH
Q 005586          568 ADDIVFSVLKTSAAMGYLAPEYVTTGRFTERSDIFAFGVIILQILTGSLVLTSSMRLAAESATFENFI-DRNLKGKFSES  646 (689)
Q Consensus       568 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~ksDV~sfGvvl~elltG~~p~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~  646 (689)
                      ...... .....++..|+|||.+.+..++.++|||||||++|||+||+.||.........    .... ........+..
T Consensus       166 ~~~~~~-~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slGvil~~lltg~~pf~~~~~~~~~----~~~~~~~~~~~~~~~~  240 (296)
T cd06655         166 TPEQSK-RSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMVEGEPPYLNENPLRAL----YLIATNGTPELQNPEK  240 (296)
T ss_pred             cccccc-CCCcCCCccccCcchhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHH----HHHHhcCCcccCCccc
Confidence            443221 12234677899999998888999999999999999999999999653221111    1111 11111112334


Q ss_pred             HHHHHHHHHHHhccCCCCCCCCHHHHHHHHHh
Q 005586          647 EAAKLGKMALVCTHEDPENRPTMEAVIEELTV  678 (689)
Q Consensus       647 ~~~~l~~l~~~Cl~~dp~~RPs~~evl~~L~~  678 (689)
                      ....+.+++.+||..||++||++.+++++-+.
T Consensus       241 ~~~~~~~li~~~l~~dp~~Rpt~~~il~~~~~  272 (296)
T cd06655         241 LSPIFRDFLNRCLEMDVEKRGSAKELLQHPFL  272 (296)
T ss_pred             CCHHHHHHHHHHhhcChhhCCCHHHHhhChHh
Confidence            45678899999999999999999999987544

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 2, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK2 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding

>cd07863 STKc_CDK4 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 4

Probab=100.00  E-value=1.3e-36  Score=315.48  Aligned_cols=257  Identities=21%  Similarity=0.351  Sum_probs=193.6

Q ss_pred             cCCcccccccCCcceEEEEEec-CCcEEEEEEecccCCc-hHHHHHHHHHHHHhcc---CCCcceeEeeEEEcC---CCC
Q 005586          410 CFSEVNLLGKGNFSSVYKGTLR-DGTLVAIRSINVTSCK-SEEAEFVKGLYLLTSL---RHENIIRLRGFCCSR---GRG  481 (689)
Q Consensus       410 ~f~~~~~lg~G~~g~Vy~~~~~-~g~~vavK~l~~~~~~-~~~~~f~~e~~~l~~l---~H~niv~l~g~~~~~---~~~  481 (689)
                      +|...+.||+|+||.||+|..+ +|+.||+|.++..... .....+.+|+.++.++   +||||+++++++...   ...
T Consensus         1 ~y~~~~~lg~g~~g~v~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~h~ni~~~~~~~~~~~~~~~~   80 (288)
T cd07863           1 QYEPVAEIGVGAYGTVYKARDPHSGHFVALKSVRVQTNEDGLPLSTVREVALLKRLEAFDHPNIVRLMDVCATSRTDRET   80 (288)
T ss_pred             CceEeeEEeecCCeEEEEEEECCCCcEEEEEEeccCcCCCCCchHHHHHHHHHHHhhhcCCCCeeeeeeeeccccCCCCc
Confidence            4677889999999999999876 6899999998754322 2223456677766655   799999999987532   234


Q ss_pred             eEEEEEEcCCCCCHHHHhhhcCCCCCCCCHHHHHHHHHHHHHHHhhhhCCCCCCCceeecCCCCCceeecCCCCeEEecc
Q 005586          482 ECFLIYDFAPKGKLSKYLDQEEGSSNVLDWSTRVSIIIGIAKGIGYLHSSEVNKPAIVHRNLSVEKVLIDQQFNPLIADC  561 (689)
Q Consensus       482 ~~~lV~e~~~~gsL~~~L~~~~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~~~ivH~dlk~~NiLl~~~~~~kl~Df  561 (689)
                      ..++||||++ ++|.+++.....  ..+++..+..++.|++.||+|||+.+     |+||||||+||++++++.+||+||
T Consensus        81 ~~~lv~e~~~-~~l~~~~~~~~~--~~~~~~~~~~~~~qi~~al~~lH~~~-----ivH~dikp~Nili~~~~~~kl~df  152 (288)
T cd07863          81 KVTLVFEHVD-QDLRTYLDKVPP--PGLPAETIKDLMRQFLRGLDFLHANC-----IVHRDLKPENILVTSGGQVKLADF  152 (288)
T ss_pred             eEEEEEcccc-cCHHHHHHhcCC--CCCCHHHHHHHHHHHHHHHHHHHhCC-----eecCCCCHHHEEECCCCCEEECcc
Confidence            5799999997 589998875432  34899999999999999999999987     999999999999999999999999


Q ss_pred             cccccccCCceeeeecCCCCCCCCCccccccCCCCCcccchhHHHHHHHHHhCCCCcchhHHHHHhhhhhhHh-------
Q 005586          562 GLHKLLADDIVFSVLKTSAAMGYLAPEYVTTGRFTERSDIFAFGVIILQILTGSLVLTSSMRLAAESATFENF-------  634 (689)
Q Consensus       562 Gla~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~ksDV~sfGvvl~elltG~~p~~~~~~~~~~~~~~~~~-------  634 (689)
                      |+++......  ......++..|+|||++.+..++.++||||+||++|||++|+.||................       
T Consensus       153 g~~~~~~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~~l~~l~~g~~~f~~~~~~~~~~~~~~~~~~~~~~~  230 (288)
T cd07863         153 GLARIYSCQM--ALTPVVVTLWYRAPEVLLQSTYATPVDMWSVGCIFAEMFRRKPLFCGNSEADQLGKIFDLIGLPPEDD  230 (288)
T ss_pred             CccccccCcc--cCCCccccccccCchHhhCCCCCCcchhhhHHHHHHHHHhCCcCcCCCCHHHHHHHHHHHhCCCChhh
Confidence            9998764322  1123456788999999988899999999999999999999999985432211110000000       


Q ss_pred             hc-------cccCC-------CCCHHHHHHHHHHHHHhccCCCCCCCCHHHHHHHH
Q 005586          635 ID-------RNLKG-------KFSESEAAKLGKMALVCTHEDPENRPTMEAVIEEL  676 (689)
Q Consensus       635 ~~-------~~~~~-------~~~~~~~~~l~~l~~~Cl~~dp~~RPs~~evl~~L  676 (689)
                      ..       .....       ........++.+++.+|++.||++||++.|++++-
T Consensus       231 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~~~l~hp  286 (288)
T cd07863         231 WPRDVTLPRGAFSPRGPRPVQSVVPEIEESGAQLLLEMLTFNPHKRISAFRALQHP  286 (288)
T ss_pred             CcccccccccccCCCCCCchHHhCcCcCHHHHHHHHHHhccCcccCCCHHHHhcCC
Confidence            00       00000       00112355688999999999999999999998763

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 partners with all three D-type cyclins (D1, D2, and D3) and is also regulated by INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein and plays a role in regulating the early G1 phase of the cell cycle. It is expressed ubiquitou

>cd05078 PTK_Jak2_Jak3_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3

Probab=100.00  E-value=5.7e-37  Score=312.94  Aligned_cols=239  Identities=19%  Similarity=0.429  Sum_probs=187.6

Q ss_pred             cccccCCcceEEEEEecC--------CcEEEEEEecccCCchHHHHHHHHHHHHhccCCCcceeEeeEEEcCCCCeEEEE
Q 005586          415 NLLGKGNFSSVYKGTLRD--------GTLVAIRSINVTSCKSEEAEFVKGLYLLTSLRHENIIRLRGFCCSRGRGECFLI  486 (689)
Q Consensus       415 ~~lg~G~~g~Vy~~~~~~--------g~~vavK~l~~~~~~~~~~~f~~e~~~l~~l~H~niv~l~g~~~~~~~~~~~lV  486 (689)
                      +.||+|+||.||+|..+.        ...||+|.+.... ....++|.+|+.+++.++|||++++++++..  .+..++|
T Consensus         1 ~~lg~G~~~~Vy~~~~~~~~~~~~~~~~~~~~k~~~~~~-~~~~~~~~~e~~~l~~~~h~~iv~~~~~~~~--~~~~~lv   77 (258)
T cd05078           1 ESLGQGTFTKIFKGIRREVGDYGELHKTEVLLKVLDKSH-RNYSESFFEAASMMSQLSHKHLVLNYGVCVC--GDESIMV   77 (258)
T ss_pred             CCCCcccchhheeeeecccccccccccchhhHHhhcchh-HHHHHHHHHHHHHHHhCCCCChhheeeEEEe--CCCcEEE
Confidence            369999999999998642        2348888876443 3344678999999999999999999999865  3668999


Q ss_pred             EEcCCCCCHHHHhhhcCCCCCCCCHHHHHHHHHHHHHHHhhhhCCCCCCCceeecCCCCCceeecCCCC--------eEE
Q 005586          487 YDFAPKGKLSKYLDQEEGSSNVLDWSTRVSIIIGIAKGIGYLHSSEVNKPAIVHRNLSVEKVLIDQQFN--------PLI  558 (689)
Q Consensus       487 ~e~~~~gsL~~~L~~~~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~~~ivH~dlk~~NiLl~~~~~--------~kl  558 (689)
                      |||+++|+|.++++....   .++|..+++++.|++.||+|||+.+     |+||||||+||+++.++.        +|+
T Consensus        78 ~e~~~~g~L~~~l~~~~~---~~~~~~~~~~~~qi~~~l~~lH~~~-----iiH~dlkp~nili~~~~~~~~~~~~~~~l  149 (258)
T cd05078          78 QEYVKFGSLDTYLKKNKN---LINISWKLEVAKQLAWALHFLEDKG-----LTHGNVCAKNVLLIREEDRKTGNPPFIKL  149 (258)
T ss_pred             EecCCCCcHHHHHhcCCC---CCCHHHHHHHHHHHHHHHHHHHHCC-----eecCCCccceEEEecccccccCCCceEEe
Confidence            999999999999986542   4899999999999999999999987     999999999999988765        589


Q ss_pred             ecccccccccCCceeeeecCCCCCCCCCcccccc-CCCCCcccchhHHHHHHHHHhCC-CCcchhHHHHHhhhhhhHhhc
Q 005586          559 ADCGLHKLLADDIVFSVLKTSAAMGYLAPEYVTT-GRFTERSDIFAFGVIILQILTGS-LVLTSSMRLAAESATFENFID  636 (689)
Q Consensus       559 ~DfGla~~~~~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~ksDV~sfGvvl~elltG~-~p~~~~~~~~~~~~~~~~~~~  636 (689)
                      +|||++.......     ...++..|+|||++.+ ..++.++|||||||++|||++|. .|+....... .    ..+..
T Consensus       150 ~d~g~~~~~~~~~-----~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~~l~~g~~~~~~~~~~~~-~----~~~~~  219 (258)
T cd05078         150 SDPGISITVLPKE-----ILLERIPWVPPECIENPQNLSLAADKWSFGTTLWEIFSGGDKPLSALDSQK-K----LQFYE  219 (258)
T ss_pred             cccccccccCCch-----hccccCCccCchhccCCCCCCchhhHHHHHHHHHHHHcCCCCChhhccHHH-H----HHHHH
Confidence            9999887554321     2346678999999876 45799999999999999999995 4543221111 0    11111


Q ss_pred             cccCCCCCHHHHHHHHHHHHHhccCCCCCCCCHHHHHHHH
Q 005586          637 RNLKGKFSESEAAKLGKMALVCTHEDPENRPTMEAVIEEL  676 (689)
Q Consensus       637 ~~~~~~~~~~~~~~l~~l~~~Cl~~dp~~RPs~~evl~~L  676 (689)
                      .  ...++.....++.+++..||+.+|++||++++++++|
T Consensus       220 ~--~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~~l  257 (258)
T cd05078         220 D--RHQLPAPKWTELANLINQCMDYEPDFRPSFRAIIRDL  257 (258)
T ss_pred             c--cccCCCCCcHHHHHHHHHHhccChhhCCCHHHHHHhc
Confidence            1  1223333456789999999999999999999999987

Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity

>cd05627 STKc_NDR2 Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 2

Probab=100.00  E-value=5e-37  Score=329.03  Aligned_cols=253  Identities=19%  Similarity=0.289  Sum_probs=196.5

Q ss_pred             ccCCcccccccCCcceEEEEEec-CCcEEEEEEecccCC--chHHHHHHHHHHHHhccCCCcceeEeeEEEcCCCCeEEE
Q 005586          409 QCFSEVNLLGKGNFSSVYKGTLR-DGTLVAIRSINVTSC--KSEEAEFVKGLYLLTSLRHENIIRLRGFCCSRGRGECFL  485 (689)
Q Consensus       409 ~~f~~~~~lg~G~~g~Vy~~~~~-~g~~vavK~l~~~~~--~~~~~~f~~e~~~l~~l~H~niv~l~g~~~~~~~~~~~l  485 (689)
                      ++|+..+.||+|+||.||++..+ +++.||+|++.....  ......+..|+.++.+++||||+++++.+.  ..+..++
T Consensus         1 ~~f~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~iv~~~~~~~--~~~~~~l   78 (360)
T cd05627           1 DDFESLKVIGRGAFGEVRLVQKKDTGHIYAMKILRKADMLEKEQVAHIRAERDILVEADGAWVVKMFYSFQ--DKRNLYL   78 (360)
T ss_pred             CCceEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEHHHHhhhhhHHHHHHHHHHHHhCCCCCEeeEEEEEE--cCCEEEE
Confidence            36778899999999999999876 689999999975321  233457888999999999999999999884  4578999


Q ss_pred             EEEcCCCCCHHHHhhhcCCCCCCCCHHHHHHHHHHHHHHHhhhhCCCCCCCceeecCCCCCceeecCCCCeEEecccccc
Q 005586          486 IYDFAPKGKLSKYLDQEEGSSNVLDWSTRVSIIIGIAKGIGYLHSSEVNKPAIVHRNLSVEKVLIDQQFNPLIADCGLHK  565 (689)
Q Consensus       486 V~e~~~~gsL~~~L~~~~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~~~ivH~dlk~~NiLl~~~~~~kl~DfGla~  565 (689)
                      ||||+++|+|.+++....    .+++.....++.|++.||+|||+.+     |+||||||+|||++.++.+||+|||+++
T Consensus        79 v~E~~~gg~L~~~l~~~~----~l~~~~~~~~~~qi~~~L~~lH~~g-----ivHrDLkp~NIli~~~~~vkL~DfG~~~  149 (360)
T cd05627          79 IMEFLPGGDMMTLLMKKD----TLSEEATQFYIAETVLAIDAIHQLG-----FIHRDIKPDNLLLDAKGHVKLSDFGLCT  149 (360)
T ss_pred             EEeCCCCccHHHHHHhcC----CCCHHHHHHHHHHHHHHHHHHHHCC-----eEccCCCHHHEEECCCCCEEEeeccCCc
Confidence            999999999999997643    3889999999999999999999988     9999999999999999999999999987


Q ss_pred             cccCCcee----------------------------------eeecCCCCCCCCCccccccCCCCCcccchhHHHHHHHH
Q 005586          566 LLADDIVF----------------------------------SVLKTSAAMGYLAPEYVTTGRFTERSDIFAFGVIILQI  611 (689)
Q Consensus       566 ~~~~~~~~----------------------------------~~~~~~~~~~y~aPE~~~~~~~~~ksDV~sfGvvl~el  611 (689)
                      .+......                                  ......||..|+|||++.+..++.++|||||||++|||
T Consensus       150 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~APE~~~~~~~~~~~DiwSlGvilyel  229 (360)
T cd05627         150 GLKKAHRTEFYRNLTHNPPSDFSFQNMNSKRKAETWKKNRRQLAYSTVGTPDYIAPEVFMQTGYNKLCDWWSLGVIMYEM  229 (360)
T ss_pred             ccccccccccccccccCCcccccccccccccccccccccccccccccCCCccccCHHHHcCCCCCCcceeccccceeeec
Confidence            54321100                                  01123578899999999999999999999999999999


Q ss_pred             HhCCCCcchhHHHHHhhhhhhHhhccccCCCCCH--HHHHHHHHHHHHhccCCCCCCC---CHHHHHHHHH
Q 005586          612 LTGSLVLTSSMRLAAESATFENFIDRNLKGKFSE--SEAAKLGKMALVCTHEDPENRP---TMEAVIEELT  677 (689)
Q Consensus       612 ltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~--~~~~~l~~l~~~Cl~~dp~~RP---s~~evl~~L~  677 (689)
                      +||+.||........    +..+........++.  ..+.++.+++.+++ .||++|+   ++.|++++-+
T Consensus       230 ~tG~~Pf~~~~~~~~----~~~i~~~~~~~~~p~~~~~s~~~~~li~~l~-~~p~~R~~~~~~~ei~~hp~  295 (360)
T cd05627         230 LIGYPPFCSETPQET----YRKVMNWKETLVFPPEVPISEKAKDLILRFC-TDSENRIGSNGVEEIKSHPF  295 (360)
T ss_pred             ccCCCCCCCCCHHHH----HHHHHcCCCceecCCCCCCCHHHHHHHHHhc-cChhhcCCCCCHHHHhcCCC
Confidence            999999965432221    111111110001111  13456677777765 4999998   4788887754

Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. In addition, NDR2 plays a role in regul

>KOG0033 consensus Ca2+/calmodulin-dependent protein kinase, EF-Hand protein superfamily [Signal transduction mechanisms]

Probab=100.00  E-value=1.6e-38  Score=296.76  Aligned_cols=255  Identities=22%  Similarity=0.311  Sum_probs=207.4

Q ss_pred             ccCCcccccccCCcceEEEEEec-CCcEEEEEEecccCC-chHHHHHHHHHHHHhccCCCcceeEeeEEEcCCCCeEEEE
Q 005586          409 QCFSEVNLLGKGNFSSVYKGTLR-DGTLVAIRSINVTSC-KSEEAEFVKGLYLLTSLRHENIIRLRGFCCSRGRGECFLI  486 (689)
Q Consensus       409 ~~f~~~~~lg~G~~g~Vy~~~~~-~g~~vavK~l~~~~~-~~~~~~f~~e~~~l~~l~H~niv~l~g~~~~~~~~~~~lV  486 (689)
                      +.|+..+.||+|.|+.||++..+ +|+.+|+|.+..... ....+++.+|+++-+.++|||||+|..-+.+  ....++|
T Consensus        11 d~y~l~e~igkG~FSvVrRc~~~~tg~~fa~kiin~~k~~~~~~e~l~rEarIC~~LqHP~IvrL~~ti~~--~~~~ylv   88 (355)
T KOG0033|consen   11 DNYDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQKLEREARICRKLQHPNIVRLHDSIQE--ESFHYLV   88 (355)
T ss_pred             hhhhHHHHHccCchHHHHHHHhccchHHHHHHHhhhhhhccccHHHHHHHHHHHHhcCCCcEeehhhhhcc--cceeEEE
Confidence            34566688999999999999865 799999999876543 2355788999999999999999999987743  4788999


Q ss_pred             EEcCCCCCHHHHhhhcCCCCCCCCHHHHHHHHHHHHHHHhhhhCCCCCCCceeecCCCCCceeecC---CCCeEEecccc
Q 005586          487 YDFAPKGKLSKYLDQEEGSSNVLDWSTRVSIIIGIAKGIGYLHSSEVNKPAIVHRNLSVEKVLIDQ---QFNPLIADCGL  563 (689)
Q Consensus       487 ~e~~~~gsL~~~L~~~~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~~~ivH~dlk~~NiLl~~---~~~~kl~DfGl  563 (689)
                      +|+|++|+|..-+-...    ..++...-..+.||+++|.|+|.++     |||||+||+|++|-.   .--+|++|||+
T Consensus        89 Fe~m~G~dl~~eIV~R~----~ySEa~aSH~~rQiLeal~yCH~n~-----IvHRDvkP~nllLASK~~~A~vKL~~FGv  159 (355)
T KOG0033|consen   89 FDLVTGGELFEDIVARE----FYSEADASHCIQQILEALAYCHSNG-----IVHRDLKPENLLLASKAKGAAVKLADFGL  159 (355)
T ss_pred             EecccchHHHHHHHHHH----HHHHHHHHHHHHHHHHHHHHHHhcC-----ceeccCChhheeeeeccCCCceeecccce
Confidence            99999999987765542    3677888899999999999999988     999999999999953   34479999999


Q ss_pred             cccccCCceeeeecCCCCCCCCCccccccCCCCCcccchhHHHHHHHHHhCCCCcchhHHHHHhhhhhhHhhcccc--CC
Q 005586          564 HKLLADDIVFSVLKTSAAMGYLAPEYVTTGRFTERSDIFAFGVIILQILTGSLVLTSSMRLAAESATFENFIDRNL--KG  641 (689)
Q Consensus       564 a~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~ksDV~sfGvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~--~~  641 (689)
                      +..+.++.  ...+..||++|||||++...+|+..+|||+.||+||-|+.|..||.+...    ...+++++....  .+
T Consensus       160 Ai~l~~g~--~~~G~~GtP~fmaPEvvrkdpy~kpvDiW~cGViLfiLL~G~~PF~~~~~----~rlye~I~~g~yd~~~  233 (355)
T KOG0033|consen  160 AIEVNDGE--AWHGFAGTPGYLSPEVLKKDPYSKPVDIWACGVILYILLVGYPPFWDEDQ----HRLYEQIKAGAYDYPS  233 (355)
T ss_pred             EEEeCCcc--ccccccCCCcccCHHHhhcCCCCCcchhhhhhHHHHHHHhCCCCCCCccH----HHHHHHHhccccCCCC
Confidence            99887443  34456799999999999999999999999999999999999999976322    122333332221  22


Q ss_pred             CCCHHHHHHHHHHHHHhccCCCCCCCCHHHHHHHHHhhC
Q 005586          642 KFSESEAAKLGKMALVCTHEDPENRPTMEAVIEELTVAA  680 (689)
Q Consensus       642 ~~~~~~~~~l~~l~~~Cl~~dp~~RPs~~evl~~L~~~~  680 (689)
                      .+.....++..+++.+|+..||++|.|+.|.+++.|...
T Consensus       234 ~~w~~is~~Ak~LvrrML~~dP~kRIta~EAL~HpWi~~  272 (355)
T KOG0033|consen  234 PEWDTVTPEAKSLIRRMLTVNPKKRITADEALKHPWICN  272 (355)
T ss_pred             cccCcCCHHHHHHHHHHhccChhhhccHHHHhCCchhcc
Confidence            233455678999999999999999999999999877653

>cd08218 STKc_Nek1 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 1

Probab=100.00  E-value=2.7e-36  Score=307.36  Aligned_cols=251  Identities=19%  Similarity=0.372  Sum_probs=202.9

Q ss_pred             cCCcccccccCCcceEEEEEec-CCcEEEEEEecccCC-chHHHHHHHHHHHHhccCCCcceeEeeEEEcCCCCeEEEEE
Q 005586          410 CFSEVNLLGKGNFSSVYKGTLR-DGTLVAIRSINVTSC-KSEEAEFVKGLYLLTSLRHENIIRLRGFCCSRGRGECFLIY  487 (689)
Q Consensus       410 ~f~~~~~lg~G~~g~Vy~~~~~-~g~~vavK~l~~~~~-~~~~~~f~~e~~~l~~l~H~niv~l~g~~~~~~~~~~~lV~  487 (689)
                      +|+..+.||+|+||.||++... +|+.||+|++..... .....++.+|++++++++||||+++++++.  ..+..++||
T Consensus         1 ~y~~~~~lg~g~~g~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~--~~~~~~lv~   78 (256)
T cd08218           1 KYVKVKKIGEGSFGKAILVKSKEDGKQYVIKEINISKMSPKEREESRKEVAVLSNMKHPNIVQYQESFE--ENGNLYIVM   78 (256)
T ss_pred             CceEEEEeccCCceEEEEEEEcCCCCEEEEEEEEhHhCChHHHHHHHHHHHHHHhCCCCCeeeeEeeec--CCCeEEEEE
Confidence            4777899999999999999875 689999999875432 334568999999999999999999999884  457899999


Q ss_pred             EcCCCCCHHHHhhhcCCCCCCCCHHHHHHHHHHHHHHHhhhhCCCCCCCceeecCCCCCceeecCCCCeEEecccccccc
Q 005586          488 DFAPKGKLSKYLDQEEGSSNVLDWSTRVSIIIGIAKGIGYLHSSEVNKPAIVHRNLSVEKVLIDQQFNPLIADCGLHKLL  567 (689)
Q Consensus       488 e~~~~gsL~~~L~~~~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~~~ivH~dlk~~NiLl~~~~~~kl~DfGla~~~  567 (689)
                      ||+++++|.+++.....  ..+++.+++.++.|++.||+|||+.+     ++|+||+|+||+++.++.++|+|||++...
T Consensus        79 e~~~~~~l~~~~~~~~~--~~~~~~~~~~~~~~l~~~l~~lh~~~-----i~h~~l~~~nil~~~~~~~~l~d~~~~~~~  151 (256)
T cd08218          79 DYCEGGDLYKKINAQRG--VLFPEDQILDWFVQICLALKHVHDRK-----ILHRDIKSQNIFLTKDGTIKLGDFGIARVL  151 (256)
T ss_pred             ecCCCCcHHHHHHhccC--CCCCHHHHHHHHHHHHHHHHHHHhCC-----EecCCCCHHHEEEcCCCCEEEeeccceeec
Confidence            99999999999976432  24789999999999999999999987     999999999999999999999999999766


Q ss_pred             cCCceeeeecCCCCCCCCCccccccCCCCCcccchhHHHHHHHHHhCCCCcchhHHHHHhhhhhhHhhccccCCCCCHHH
Q 005586          568 ADDIVFSVLKTSAAMGYLAPEYVTTGRFTERSDIFAFGVIILQILTGSLVLTSSMRLAAESATFENFIDRNLKGKFSESE  647 (689)
Q Consensus       568 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~ksDV~sfGvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  647 (689)
                      ...... .....++..|+|||+..+..++.++|||||||+++||+||+.|+.......    ....++... ....+...
T Consensus       152 ~~~~~~-~~~~~~~~~~~~pe~~~~~~~~~~~Dv~slG~i~~~l~~g~~~~~~~~~~~----~~~~~~~~~-~~~~~~~~  225 (256)
T cd08218         152 NSTVEL-ARTCIGTPYYLSPEICENRPYNNKSDIWALGCVLYEMCTLKHAFEAGNMKN----LVLKIIRGS-YPPVSSHY  225 (256)
T ss_pred             Ccchhh-hhhccCCccccCHHHhCCCCCCCccchhHHHHHHHHHHcCCCCccCCCHHH----HHHHHhcCC-CCCCcccC
Confidence            443211 112346778999999988889999999999999999999999986432111    111111111 11233445


Q ss_pred             HHHHHHHHHHhccCCCCCCCCHHHHHHH
Q 005586          648 AAKLGKMALVCTHEDPENRPTMEAVIEE  675 (689)
Q Consensus       648 ~~~l~~l~~~Cl~~dp~~RPs~~evl~~  675 (689)
                      ..++.+++.+||+.+|++||+|.||+++
T Consensus       226 ~~~~~~li~~~l~~~p~~Rp~~~~vl~~  253 (256)
T cd08218         226 SYDLRNLVSQLFKRNPRDRPSVNSILEK  253 (256)
T ss_pred             CHHHHHHHHHHhhCChhhCcCHHHHhhC
Confidence            6779999999999999999999999986

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 1 (Nek1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek1 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek1 is associated with centrosomes throughout the cell cycle. It is involved in the formation of primary cilium and in the maintenance of centrosomes. It cycles through the nucleus and may be capable of relaying signals between the cilium and the nucleus. Nek1 is implicated in the development of polycysti

>cd06628 STKc_MAPKKK_Byr2_like Catalytic domain of fungal Byr2-like MAP Kinase Kinase Kinases

Probab=100.00  E-value=2.8e-36  Score=309.30  Aligned_cols=249  Identities=22%  Similarity=0.415  Sum_probs=199.4

Q ss_pred             CCcccccccCCcceEEEEEec-CCcEEEEEEecccCCch--------HHHHHHHHHHHHhccCCCcceeEeeEEEcCCCC
Q 005586          411 FSEVNLLGKGNFSSVYKGTLR-DGTLVAIRSINVTSCKS--------EEAEFVKGLYLLTSLRHENIIRLRGFCCSRGRG  481 (689)
Q Consensus       411 f~~~~~lg~G~~g~Vy~~~~~-~g~~vavK~l~~~~~~~--------~~~~f~~e~~~l~~l~H~niv~l~g~~~~~~~~  481 (689)
                      |.....||+|+||.||+|... +++.||+|.+.......        ..+.+.+|+.++++++||||+++++++..  .+
T Consensus         2 ~~~~~~ig~g~~~~v~~a~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~--~~   79 (267)
T cd06628           2 WIKGALIGSGSFGSVYLGMNASSGELMAVKQVELPSVSASSKDRKRSMLDALAREIALLKELQHENIVQYLGSSLD--AD   79 (267)
T ss_pred             ccccceeecCCCeEEEEEEecCCCcEEEEEEecCCCcccchhHHHHHHHHHHHHHHHHHHhcCCCCeeeEEEEEEe--CC
Confidence            556689999999999999875 68899999887543211        12568899999999999999999999854  46


Q ss_pred             eEEEEEEcCCCCCHHHHhhhcCCCCCCCCHHHHHHHHHHHHHHHhhhhCCCCCCCceeecCCCCCceeecCCCCeEEecc
Q 005586          482 ECFLIYDFAPKGKLSKYLDQEEGSSNVLDWSTRVSIIIGIAKGIGYLHSSEVNKPAIVHRNLSVEKVLIDQQFNPLIADC  561 (689)
Q Consensus       482 ~~~lV~e~~~~gsL~~~L~~~~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~~~ivH~dlk~~NiLl~~~~~~kl~Df  561 (689)
                      ..++||||+++++|.+++....    .+++..+..++.|++.||+|||+.+     ++||||||+||++++++.+||+||
T Consensus        80 ~~~lv~e~~~~~~L~~~l~~~~----~l~~~~~~~~~~~l~~~l~~lH~~~-----ivH~di~p~nil~~~~~~~~l~df  150 (267)
T cd06628          80 HLNIFLEYVPGGSVAALLNNYG----AFEETLVRNFVRQILKGLNYLHNRG-----IIHRDIKGANILVDNKGGIKISDF  150 (267)
T ss_pred             ccEEEEEecCCCCHHHHHHhcc----CccHHHHHHHHHHHHHHHHHHHhcC-----cccccCCHHHEEEcCCCCEEeccc
Confidence            7899999999999999997643    3889999999999999999999987     999999999999999999999999


Q ss_pred             cccccccCCceee-----eecCCCCCCCCCccccccCCCCCcccchhHHHHHHHHHhCCCCcchhHHHHHhhhhhhHhhc
Q 005586          562 GLHKLLADDIVFS-----VLKTSAAMGYLAPEYVTTGRFTERSDIFAFGVIILQILTGSLVLTSSMRLAAESATFENFID  636 (689)
Q Consensus       562 Gla~~~~~~~~~~-----~~~~~~~~~y~aPE~~~~~~~~~ksDV~sfGvvl~elltG~~p~~~~~~~~~~~~~~~~~~~  636 (689)
                      |+++.........     .....++..|+|||.+.+..++.++|||||||++|||+||+.||.......    .+.....
T Consensus       151 g~~~~~~~~~~~~~~~~~~~~~~~~~~y~~pe~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~----~~~~~~~  226 (267)
T cd06628         151 GISKKLEANSLSTKTNGARPSLQGSVFWMAPEVVKQTSYTRKADIWSLGCLVVEMLTGKHPFPDCTQLQ----AIFKIGE  226 (267)
T ss_pred             CCCcccccccccCCccccccccCCCcCccChhHhccCCCCchhhhHHHHHHHHHHhhCCCCCCCccHHH----HHHHHhc
Confidence            9998765321111     111236678999999988889999999999999999999999996532211    1111111


Q ss_pred             cccCCCCCHHHHHHHHHHHHHhccCCCCCCCCHHHHHHH
Q 005586          637 RNLKGKFSESEAAKLGKMALVCTHEDPENRPTMEAVIEE  675 (689)
Q Consensus       637 ~~~~~~~~~~~~~~l~~l~~~Cl~~dp~~RPs~~evl~~  675 (689)
                       ......+......+.+++.+||+.||.+||++.||+++
T Consensus       227 -~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~~  264 (267)
T cd06628         227 -NASPEIPSNISSEAIDFLEKTFEIDHNKRPTAAELLKH  264 (267)
T ss_pred             -cCCCcCCcccCHHHHHHHHHHccCCchhCcCHHHHhhC
Confidence             11223344456788999999999999999999999875

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Byr2-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Schizosaccharomyces pombe Byr2, Saccharomyces cerevisiae and Cryptococcus neoformans Ste11, and related proteins. They contain an N-terminal SAM (sterile alpha-motif) domain, which mediates protein-protein interaction, and a C-terminal catalytic domain. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate

>cd06610 STKc_OSR1_SPAK Catalytic domain of the Protein Serine/Threonine Kinases, Oxidative stress response kinase and Ste20-related proline alanine-rich kinase

Probab=100.00  E-value=2.9e-36  Score=308.82  Aligned_cols=255  Identities=21%  Similarity=0.368  Sum_probs=204.1

Q ss_pred             ccCCcccccccCCcceEEEEEec-CCcEEEEEEecccCCchHHHHHHHHHHHHhccCCCcceeEeeEEEcCCCCeEEEEE
Q 005586          409 QCFSEVNLLGKGNFSSVYKGTLR-DGTLVAIRSINVTSCKSEEAEFVKGLYLLTSLRHENIIRLRGFCCSRGRGECFLIY  487 (689)
Q Consensus       409 ~~f~~~~~lg~G~~g~Vy~~~~~-~g~~vavK~l~~~~~~~~~~~f~~e~~~l~~l~H~niv~l~g~~~~~~~~~~~lV~  487 (689)
                      ++|+..+.||+|+||.||+|... ++..+|+|++...........+.+|++.++.++|+|++++++.+..  .+..++|+
T Consensus         1 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~--~~~~~iv~   78 (267)
T cd06610           1 DDYELIEVIGVGATAVVYAAICLPNNEKVAIKRIDLEKCQTSVDELRKEVQAMSQCNHPNVVKYYTSFVV--GDELWLVM   78 (267)
T ss_pred             CcceeeeeecCCCCeEEEEEEEcCCCcEEEEEEeccCCcchHHHHHHHHHHHHHhcCCCCEEEEEEEEee--CCEEEEEE
Confidence            36788899999999999999865 6889999999765544466789999999999999999999998844  57899999


Q ss_pred             EcCCCCCHHHHhhhcCCCCCCCCHHHHHHHHHHHHHHHhhhhCCCCCCCceeecCCCCCceeecCCCCeEEecccccccc
Q 005586          488 DFAPKGKLSKYLDQEEGSSNVLDWSTRVSIIIGIAKGIGYLHSSEVNKPAIVHRNLSVEKVLIDQQFNPLIADCGLHKLL  567 (689)
Q Consensus       488 e~~~~gsL~~~L~~~~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~~~ivH~dlk~~NiLl~~~~~~kl~DfGla~~~  567 (689)
                      ||+++++|.++++.... ...+++.....++.|++.||+|||+.+     |+||||||+||++++++.+||+|||++..+
T Consensus        79 e~~~~~~l~~~~~~~~~-~~~~~~~~~~~~~~ql~~al~~lh~~~-----i~h~~l~p~ni~~~~~~~~~l~df~~~~~~  152 (267)
T cd06610          79 PYLSGGSLLDIMKSSYP-RGGLDEAIIATVLKEVLKGLEYLHSNG-----QIHRDIKAGNILLGEDGSVKIADFGVSASL  152 (267)
T ss_pred             eccCCCcHHHHHHHhcc-cCCCCHHHHHHHHHHHHHHHHHHHhCC-----eecCCCCHHhEEEcCCCCEEEcccchHHHh
Confidence            99999999999976432 134899999999999999999999987     999999999999999999999999998876


Q ss_pred             cCCcee---eeecCCCCCCCCCccccccC-CCCCcccchhHHHHHHHHHhCCCCcchhHHHHHhhhhhhHhhcc---ccC
Q 005586          568 ADDIVF---SVLKTSAAMGYLAPEYVTTG-RFTERSDIFAFGVIILQILTGSLVLTSSMRLAAESATFENFIDR---NLK  640 (689)
Q Consensus       568 ~~~~~~---~~~~~~~~~~y~aPE~~~~~-~~~~ksDV~sfGvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~---~~~  640 (689)
                      ......   ......++..|+|||++... .++.++|||||||++|||++|+.|+.......    .+.+....   .+.
T Consensus       153 ~~~~~~~~~~~~~~~~~~~y~~Pe~~~~~~~~~~~~Dv~slG~i~~~l~~g~~p~~~~~~~~----~~~~~~~~~~~~~~  228 (267)
T cd06610         153 ADGGDRTRKVRKTFVGTPCWMAPEVMEQVHGYDFKADIWSFGITAIELATGAAPYSKYPPMK----VLMLTLQNDPPSLE  228 (267)
T ss_pred             ccCccccccccccccCChhhcChHHHccccCcCcccchHhHhHHHHHHHhCCCCccccChhh----hHHHHhcCCCCCcC
Confidence            543221   11223467789999998776 78999999999999999999999986432211    11111111   111


Q ss_pred             CCC-CHHHHHHHHHHHHHhccCCCCCCCCHHHHHHH
Q 005586          641 GKF-SESEAAKLGKMALVCTHEDPENRPTMEAVIEE  675 (689)
Q Consensus       641 ~~~-~~~~~~~l~~l~~~Cl~~dp~~RPs~~evl~~  675 (689)
                      ... ....+.++.+++..|++.||++||++.|++++
T Consensus       229 ~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~ll~~  264 (267)
T cd06610         229 TGADYKKYSKSFRKMISLCLQKDPSKRPTAEELLKH  264 (267)
T ss_pred             CccccccccHHHHHHHHHHcCCChhhCcCHHHHhhC
Confidence            111 12345678999999999999999999999986

Serine/threonine kinases (STKs), oxidative stress response kinase (OSR1) and Ste20-related proline alanine-rich kinase (SPAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The OSR1 and SPAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SPAK is also referred to as STK39 or PASK (proline-alanine-rich STE20-related kinase). OSR1 and SPAK regulate the activity of cation-chloride cotransporters through direct interaction and phosphorylation. They are also implicated in cytoskeletal rearrangement, cell differentiation, transformation and proliferation. OSR1

>cd06631 STKc_YSK4 Catalytic domain of the Protein Serine/Threonine Kinase, Yeast Sps1/Ste20-related kinase 4

Probab=100.00  E-value=2.4e-36  Score=309.40  Aligned_cols=251  Identities=24%  Similarity=0.382  Sum_probs=200.2

Q ss_pred             cCCcccccccCCcceEEEEEecCCcEEEEEEecccCC-----chHHHHHHHHHHHHhccCCCcceeEeeEEEcCCCCeEE
Q 005586          410 CFSEVNLLGKGNFSSVYKGTLRDGTLVAIRSINVTSC-----KSEEAEFVKGLYLLTSLRHENIIRLRGFCCSRGRGECF  484 (689)
Q Consensus       410 ~f~~~~~lg~G~~g~Vy~~~~~~g~~vavK~l~~~~~-----~~~~~~f~~e~~~l~~l~H~niv~l~g~~~~~~~~~~~  484 (689)
                      +|...+.||+|+||.||+|...+|+.+|+|.+.....     ......+.+|++++++++|+||+++++++.+  .+..+
T Consensus         1 ~~~~~~~ig~g~~~~v~~~~~~~~~~~avk~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~--~~~~~   78 (265)
T cd06631           1 EWTKGEVLGKGAYGTVYCGLTNQGQLIAVKQVELDTSNVLAAEKEYEKLQEEVDLLKSLKHVNIVQYLGTCLD--DNTIS   78 (265)
T ss_pred             CccccceEeccCCeEEEEEEEcCCCeEEEEEeecCccchhhHHHHHHHHHHHHHHHHhcCCCCEeeEeeEeec--CCeEE
Confidence            3667789999999999999988899999999875421     1223568899999999999999999999954  47899


Q ss_pred             EEEEcCCCCCHHHHhhhcCCCCCCCCHHHHHHHHHHHHHHHhhhhCCCCCCCceeecCCCCCceeecCCCCeEEeccccc
Q 005586          485 LIYDFAPKGKLSKYLDQEEGSSNVLDWSTRVSIIIGIAKGIGYLHSSEVNKPAIVHRNLSVEKVLIDQQFNPLIADCGLH  564 (689)
Q Consensus       485 lV~e~~~~gsL~~~L~~~~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~~~ivH~dlk~~NiLl~~~~~~kl~DfGla  564 (689)
                      +||||+++++|.+++....    .+++..+..++.|++.||+|||+.+     |+|+||||+||++++++.+||+|||++
T Consensus        79 lv~e~~~~~~L~~~l~~~~----~~~~~~~~~~~~qi~~~l~~lH~~~-----i~H~dl~p~nil~~~~~~~~l~dfg~~  149 (265)
T cd06631          79 IFMEFVPGGSISSILNRFG----PLPEPVFCKYTKQILDGVAYLHNNC-----VVHRDIKGNNVMLMPNGIIKLIDFGCA  149 (265)
T ss_pred             EEEecCCCCcHHHHHHhcC----CCCHHHHHHHHHHHHHHHHHHHhCC-----cccCCcCHHhEEECCCCeEEeccchhh
Confidence            9999999999999997543    3789999999999999999999887     999999999999999999999999998


Q ss_pred             ccccCCc-----eeeeecCCCCCCCCCccccccCCCCCcccchhHHHHHHHHHhCCCCcchhHHHHHhhhhhhHhhcc-c
Q 005586          565 KLLADDI-----VFSVLKTSAAMGYLAPEYVTTGRFTERSDIFAFGVIILQILTGSLVLTSSMRLAAESATFENFIDR-N  638 (689)
Q Consensus       565 ~~~~~~~-----~~~~~~~~~~~~y~aPE~~~~~~~~~ksDV~sfGvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~-~  638 (689)
                      +......     ........++..|+|||++.+..++.++|||||||++|||+||+.||.........    ...... .
T Consensus       150 ~~~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~Dv~slG~~~~~l~~g~~p~~~~~~~~~~----~~~~~~~~  225 (265)
T cd06631         150 RRLAWVGLHGTHSNMLKSMHGTPYWMAPEVINESGYGRKSDIWSIGCTVFEMATGKPPLASMDRLAAM----FYIGAHRG  225 (265)
T ss_pred             HhhhhccccccccccccccCCCccccChhhhcCCCCcchhhHHHHHHHHHHHHhCCCccccCChHHHH----HHhhhccC
Confidence            7653211     01112234678899999999888999999999999999999999999643221111    011111 1


Q ss_pred             cCCCCCHHHHHHHHHHHHHhccCCCCCCCCHHHHHHH
Q 005586          639 LKGKFSESEAAKLGKMALVCTHEDPENRPTMEAVIEE  675 (689)
Q Consensus       639 ~~~~~~~~~~~~l~~l~~~Cl~~dp~~RPs~~evl~~  675 (689)
                      .....+.....++.+++.+||+.+|++||++.|++++
T Consensus       226 ~~~~~~~~~~~~~~~~i~~~l~~~p~~Rp~~~~~l~~  262 (265)
T cd06631         226 LMPRLPDSFSAAAIDFVTSCLTRDQHERPSALQLLRH  262 (265)
T ss_pred             CCCCCCCCCCHHHHHHHHHHhcCCcccCCCHHHHhcC
Confidence            1122333456678999999999999999999999875

Serine/threonine kinases (STKs), yeast Sps1/Ste20-related kinase 4 (YSK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YSK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. YSK4 is a putative MAPKKK, whose mammalian gene has been isolated. MAPKKKs (MKKKs or MAP3Ks) phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals.

>cd06632 STKc_MEKK1_plant Catalytic domain of the Protein Serine/Threonine Kinase, Plant MAP/ERK kinase kinase 1

Probab=100.00  E-value=2.7e-36  Score=307.46  Aligned_cols=249  Identities=23%  Similarity=0.369  Sum_probs=200.8

Q ss_pred             cCCcccccccCCcceEEEEEec-CCcEEEEEEecccCC----chHHHHHHHHHHHHhccCCCcceeEeeEEEcCCCCeEE
Q 005586          410 CFSEVNLLGKGNFSSVYKGTLR-DGTLVAIRSINVTSC----KSEEAEFVKGLYLLTSLRHENIIRLRGFCCSRGRGECF  484 (689)
Q Consensus       410 ~f~~~~~lg~G~~g~Vy~~~~~-~g~~vavK~l~~~~~----~~~~~~f~~e~~~l~~l~H~niv~l~g~~~~~~~~~~~  484 (689)
                      +|...+.||+|+||.||+|..+ ++..|++|.+.....    +...+.|.+|++++++++|+||+++++++..  ....+
T Consensus         1 ~~~~~~~ig~g~~~~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~--~~~~~   78 (258)
T cd06632           1 RWRKGELLGSGSFGSVYEGLNLDDGDFFAVKEVSLADDGQTGQEAVKQLEQEIALLSKLQHPNIVQYLGTERE--EDNLY   78 (258)
T ss_pred             CccccceeeecCCceEEEEEEcCCCcEEEEEEEEEccccccchHHHHHHHHHHHHHHhcCCCCchheeeeEec--CCeEE
Confidence            3666789999999999999986 799999999865432    2244679999999999999999999999843  47889


Q ss_pred             EEEEcCCCCCHHHHhhhcCCCCCCCCHHHHHHHHHHHHHHHhhhhCCCCCCCceeecCCCCCceeecCCCCeEEeccccc
Q 005586          485 LIYDFAPKGKLSKYLDQEEGSSNVLDWSTRVSIIIGIAKGIGYLHSSEVNKPAIVHRNLSVEKVLIDQQFNPLIADCGLH  564 (689)
Q Consensus       485 lV~e~~~~gsL~~~L~~~~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~~~ivH~dlk~~NiLl~~~~~~kl~DfGla  564 (689)
                      +||||+++++|.+++....    .+++..+..++.|++.||+|||+.+     |+|+||+|+||++++++.+||+|||++
T Consensus        79 lv~e~~~~~~L~~~~~~~~----~~~~~~~~~~~~~i~~~l~~lH~~~-----i~H~dl~~~ni~~~~~~~~kl~d~~~~  149 (258)
T cd06632          79 IFLELVPGGSLAKLLKKYG----SFPEPVIRLYTRQILLGLEYLHDRN-----TVHRDIKGANILVDTNGVVKLADFGMA  149 (258)
T ss_pred             EEEEecCCCcHHHHHHhcC----CCCHHHHHHHHHHHHHHHHHHHHCC-----cccCCCCHHHEEECCCCCEEEccCccc
Confidence            9999999999999997543    3889999999999999999999987     999999999999999999999999998


Q ss_pred             ccccCCceeeeecCCCCCCCCCccccccCC-CCCcccchhHHHHHHHHHhCCCCcchhHHHHHhhhhhhHhhccccCCCC
Q 005586          565 KLLADDIVFSVLKTSAAMGYLAPEYVTTGR-FTERSDIFAFGVIILQILTGSLVLTSSMRLAAESATFENFIDRNLKGKF  643 (689)
Q Consensus       565 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~-~~~ksDV~sfGvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~  643 (689)
                      .......  ......++..|+|||.+.... ++.++|+|||||++|||++|+.||.........    ............
T Consensus       150 ~~~~~~~--~~~~~~~~~~y~~pe~~~~~~~~~~~~D~~slG~~l~~l~~g~~pf~~~~~~~~~----~~~~~~~~~~~~  223 (258)
T cd06632         150 KQVVEFS--FAKSFKGSPYWMAPEVIAQQGGYGLAADIWSLGCTVLEMATGKPPWSQLEGVAAV----FKIGRSKELPPI  223 (258)
T ss_pred             eeccccc--cccccCCCcceeCHHHhcCCCCCCchhhhHHHHHHHHHHHhCCCCcccCcHHHHH----HHHHhcccCCCc
Confidence            8664432  122344677899999987766 899999999999999999999998654311111    111110111223


Q ss_pred             CHHHHHHHHHHHHHhccCCCCCCCCHHHHHHH
Q 005586          644 SESEAAKLGKMALVCTHEDPENRPTMEAVIEE  675 (689)
Q Consensus       644 ~~~~~~~l~~l~~~Cl~~dp~~RPs~~evl~~  675 (689)
                      +......+.+++.+||+.+|++||++.+++++
T Consensus       224 ~~~~~~~~~~li~~~l~~~p~~Rp~~~~~l~~  255 (258)
T cd06632         224 PDHLSDEAKDFILKCLQRDPSLRPTAAELLEH  255 (258)
T ss_pred             CCCcCHHHHHHHHHHhhcCcccCcCHHHHhcC
Confidence            34456778899999999999999999999875

Serine/threonine kinases (STKs), plant MAP/ERK kinase kinase 1 (MEKK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The plant MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of plant mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) including Arabidopsis thaliana MEKK1 and MAPKKK3. MEKK1 is a MAPKKK that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Arabidops

>PF00069 Pkinase: Protein kinase domain Protein kinase; unclassified specificity

Probab=100.00  E-value=7.4e-37  Score=311.95  Aligned_cols=254  Identities=27%  Similarity=0.485  Sum_probs=199.5

Q ss_pred             CCcccccccCCcceEEEEEec-CCcEEEEEEecccCCchHH-HHHHHHHHHHhccCCCcceeEeeEEEcCCCCeEEEEEE
Q 005586          411 FSEVNLLGKGNFSSVYKGTLR-DGTLVAIRSINVTSCKSEE-AEFVKGLYLLTSLRHENIIRLRGFCCSRGRGECFLIYD  488 (689)
Q Consensus       411 f~~~~~lg~G~~g~Vy~~~~~-~g~~vavK~l~~~~~~~~~-~~f~~e~~~l~~l~H~niv~l~g~~~~~~~~~~~lV~e  488 (689)
                      |+..+.||+|+||.||+++.. ++..||+|++......... ....+|+.++.+++||||+++++++..  ....++|||
T Consensus         1 y~~~~~lg~G~~g~v~~~~~~~~~~~~~~K~~~~~~~~~~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~--~~~~~~v~~   78 (260)
T PF00069_consen    1 YRLVKKLGSGGFGTVYKAKNKKNGQKVAVKIIDKSEIEEEEREENIREIKILRRLRHPNIVQILDVFQD--DNYLYIVME   78 (260)
T ss_dssp             EEEEEEEEEESSEEEEEEEETTTTEEEEEEEEESTTHHHHHHHHHHHHHHHHHHHTBTTBCHEEEEEEE--SSEEEEEEE
T ss_pred             CEEeEEEEeCCCEEEEEEEECCCCeEEEEEEeccccccccccchhhhhhhccccccccccccccccccc--ccccccccc
Confidence            445689999999999999986 5778999999877543332 244669999999999999999999965  578899999


Q ss_pred             cCCCCCHHHHhhhcCCCCCCCCHHHHHHHHHHHHHHHhhhhCCCCCCCceeecCCCCCceeecCCCCeEEeccccccccc
Q 005586          489 FAPKGKLSKYLDQEEGSSNVLDWSTRVSIIIGIAKGIGYLHSSEVNKPAIVHRNLSVEKVLIDQQFNPLIADCGLHKLLA  568 (689)
Q Consensus       489 ~~~~gsL~~~L~~~~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~~~ivH~dlk~~NiLl~~~~~~kl~DfGla~~~~  568 (689)
                      |+++++|.+++....    .+++..++.++.|+++||+|||+.+     |+|+||||+||++++++.++|+|||.+..+.
T Consensus        79 ~~~~~~L~~~l~~~~----~~~~~~~~~~~~qi~~~L~~Lh~~~-----i~H~dikp~NIl~~~~~~~~l~Dfg~~~~~~  149 (260)
T PF00069_consen   79 YCPGGSLQDYLQKNK----PLSEEEILKIAYQILEALAYLHSKG-----IVHRDIKPENILLDENGEVKLIDFGSSVKLS  149 (260)
T ss_dssp             EETTEBHHHHHHHHS----SBBHHHHHHHHHHHHHHHHHHHHTT-----EEESSBSGGGEEESTTSEEEESSGTTTEEST
T ss_pred             ccccccccccccccc----ccccccccccccccccccccccccc-----ccccccccccccccccccccccccccccccc
Confidence            999999999998332    4899999999999999999999987     9999999999999999999999999987642


Q ss_pred             CCceeeeecCCCCCCCCCccccc-cCCCCCcccchhHHHHHHHHHhCCCCcchhHHHHHhhhhhhHhhccccCC--CCCH
Q 005586          569 DDIVFSVLKTSAAMGYLAPEYVT-TGRFTERSDIFAFGVIILQILTGSLVLTSSMRLAAESATFENFIDRNLKG--KFSE  645 (689)
Q Consensus       569 ~~~~~~~~~~~~~~~y~aPE~~~-~~~~~~ksDV~sfGvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~--~~~~  645 (689)
                      .. ........++..|+|||.+. +..++.++||||+|+++|||++|+.|+....... ....+.+........  ....
T Consensus       150 ~~-~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~~~~p~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~  227 (260)
T PF00069_consen  150 EN-NENFNPFVGTPEYMAPEVLQQGKKYTRKSDIWSLGIILYELLTGKLPFEESNSDD-QLEIIEKILKRPLPSSSQQSR  227 (260)
T ss_dssp             ST-TSEBSSSSSSGGGSCHHHHTTTSSBSTHHHHHHHHHHHHHHHHSSSSSTTSSHHH-HHHHHHHHHHTHHHHHTTSHT
T ss_pred             cc-ccccccccccccccccccccccccccccccccccccccccccccccccccccchh-hhhhhhhcccccccccccccc
Confidence            21 12333456778899999998 7889999999999999999999999997641100 011111111110000  0011


Q ss_pred             HHHHHHHHHHHHhccCCCCCCCCHHHHHHHHH
Q 005586          646 SEAAKLGKMALVCTHEDPENRPTMEAVIEELT  677 (689)
Q Consensus       646 ~~~~~l~~l~~~Cl~~dp~~RPs~~evl~~L~  677 (689)
                      ....++.+++..|++.||++||++.+++++-+
T Consensus       228 ~~~~~l~~li~~~l~~~p~~R~~~~~l~~~~~  259 (260)
T PF00069_consen  228 EKSEELRDLIKKMLSKDPEQRPSAEELLKHPW  259 (260)
T ss_dssp             TSHHHHHHHHHHHSSSSGGGSTTHHHHHTSGG
T ss_pred             hhHHHHHHHHHHHccCChhHCcCHHHHhcCCC
Confidence            11378999999999999999999999997643

Serine/Threonine protein kinases, catalytic domain Tyrosine kinase, catalytic domain; InterPro: IPR017442 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases. Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. Eukaryotic protein kinases [, , , , ] are enzymes that belong to a very extensive family of proteins which share a conserved catalytic core common with both serine/threonine and tyrosine protein kinases. There are a number of conserved regions in the catalytic domain of protein kinases. In the N-terminal extremity of the catalytic domain there is a glycine-rich stretch of residues in the vicinity of a lysine residue, which has been shown to be involved in ATP binding. In the central part of the catalytic domain there is a conserved aspartic acid residue which is important for the catalytic activity of the enzyme []. This entry includes protein kinases from eukaryotes and viruses and may include some bacterial hits too.; GO: 0004672 protein kinase activity, 0005524 ATP binding, 0006468 protein phosphorylation; PDB: 3GC7_A 3ZYA_A 3MPT_A 3NEW_A 3MVM_A 1R3C_A 2FST_X 3E93_A 3HV5_B 3OCG_A ....

>cd06613 STKc_MAP4K3_like Catalytic domain of Mitogen-activated protein kinase kinase kinase kinase-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=4.5e-36  Score=306.61  Aligned_cols=254  Identities=20%  Similarity=0.318  Sum_probs=202.1

Q ss_pred             ccCCcccccccCCcceEEEEEec-CCcEEEEEEecccCCchHHHHHHHHHHHHhccCCCcceeEeeEEEcCCCCeEEEEE
Q 005586          409 QCFSEVNLLGKGNFSSVYKGTLR-DGTLVAIRSINVTSCKSEEAEFVKGLYLLTSLRHENIIRLRGFCCSRGRGECFLIY  487 (689)
Q Consensus       409 ~~f~~~~~lg~G~~g~Vy~~~~~-~g~~vavK~l~~~~~~~~~~~f~~e~~~l~~l~H~niv~l~g~~~~~~~~~~~lV~  487 (689)
                      ++|...+.||+|+||.||+|... +++.+++|.+.... ....+.+.+|++++++++||||+++++++..  ....+++|
T Consensus         3 ~~~~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~-~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~--~~~~~l~~   79 (262)
T cd06613           3 EDYELIQRIGSGTYGDVYKARDIATGELVAIKVIKLEP-GDDFEIIQQEISMLKECRHPNIVAYFGSYLR--RDKLWIVM   79 (262)
T ss_pred             cceEEEEEecCCCceEEEEeEecCCCCEEEEEEEEcCc-hhhHHHHHHHHHHHHhCCCCChhceEEEEEe--CCEEEEEE
Confidence            56788899999999999999875 57899999998654 2355789999999999999999999998854  47899999


Q ss_pred             EcCCCCCHHHHhhhcCCCCCCCCHHHHHHHHHHHHHHHhhhhCCCCCCCceeecCCCCCceeecCCCCeEEecccccccc
Q 005586          488 DFAPKGKLSKYLDQEEGSSNVLDWSTRVSIIIGIAKGIGYLHSSEVNKPAIVHRNLSVEKVLIDQQFNPLIADCGLHKLL  567 (689)
Q Consensus       488 e~~~~gsL~~~L~~~~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~~~ivH~dlk~~NiLl~~~~~~kl~DfGla~~~  567 (689)
                      ||+++++|.+++....   ..+++.++..++.|++.||+|||+.+     |+||||||+||++++++.+||+|||++...
T Consensus        80 e~~~~~~l~~~~~~~~---~~l~~~~~~~~~~ql~~~l~~lh~~~-----i~h~dl~p~ni~i~~~~~~~l~d~g~~~~~  151 (262)
T cd06613          80 EYCGGGSLQDIYQVTR---GPLSELQIAYVCRETLKGLAYLHETG-----KIHRDIKGANILLTEDGDVKLADFGVSAQL  151 (262)
T ss_pred             eCCCCCcHHHHHHhhc---cCCCHHHHHHHHHHHHHHHHHHHhCC-----ceecCCChhhEEECCCCCEEECccccchhh
Confidence            9999999999987652   24889999999999999999999987     999999999999999999999999998765


Q ss_pred             cCCceeeeecCCCCCCCCCccccccC---CCCCcccchhHHHHHHHHHhCCCCcchhHHHHHhhhhhhHhhccccCCCCC
Q 005586          568 ADDIVFSVLKTSAAMGYLAPEYVTTG---RFTERSDIFAFGVIILQILTGSLVLTSSMRLAAESATFENFIDRNLKGKFS  644 (689)
Q Consensus       568 ~~~~~~~~~~~~~~~~y~aPE~~~~~---~~~~ksDV~sfGvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~  644 (689)
                      ..... ......++..|+|||.+.+.   .++.++|||||||++|||+||+.|+..................+ ......
T Consensus       152 ~~~~~-~~~~~~~~~~y~~Pe~~~~~~~~~~~~~~Di~slG~~l~~~~tg~~p~~~~~~~~~~~~~~~~~~~~-~~~~~~  229 (262)
T cd06613         152 TATIA-KRKSFIGTPYWMAPEVAAVERKGGYDGKCDIWALGITAIELAELQPPMFDLHPMRALFLISKSNFPP-PKLKDK  229 (262)
T ss_pred             hhhhh-ccccccCCccccCchhhcccccCCcCchhhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhccCCC-ccccch
Confidence            43221 11223467789999998776   78999999999999999999999986432111111000000010 011123


Q ss_pred             HHHHHHHHHHHHHhccCCCCCCCCHHHHHHH
Q 005586          645 ESEAAKLGKMALVCTHEDPENRPTMEAVIEE  675 (689)
Q Consensus       645 ~~~~~~l~~l~~~Cl~~dp~~RPs~~evl~~  675 (689)
                      ...+.++.+++.+||..+|.+||++.+|+.+
T Consensus       230 ~~~~~~~~~li~~~l~~~p~~Rpt~~~il~~  260 (262)
T cd06613         230 EKWSPVFHDFIKKCLTKDPKKRPTATKLLQH  260 (262)
T ss_pred             hhhhHHHHHHHHHHcCCChhhCCCHHHHhcC
Confidence            3456789999999999999999999999864

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily includes MAP4K3, MAP4K1, MAP4K2, MAP4K5, and related proteins. Vertebrate members contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activ

>cd08227 PK_STRAD_alpha Pseudokinase domain of STE20-related kinase adapter protein alpha

Probab=100.00  E-value=2.3e-36  Score=319.56  Aligned_cols=256  Identities=16%  Similarity=0.323  Sum_probs=192.7

Q ss_pred             ccccccC--CcceEEEEEec-CCcEEEEEEecccCCch-HHHHHHHHHHHHhccCCCcceeEeeEEEcCCCCeEEEEEEc
Q 005586          414 VNLLGKG--NFSSVYKGTLR-DGTLVAIRSINVTSCKS-EEAEFVKGLYLLTSLRHENIIRLRGFCCSRGRGECFLIYDF  489 (689)
Q Consensus       414 ~~~lg~G--~~g~Vy~~~~~-~g~~vavK~l~~~~~~~-~~~~f~~e~~~l~~l~H~niv~l~g~~~~~~~~~~~lV~e~  489 (689)
                      .++||+|  +|++||++..+ +|..||+|++....... ....+.+|+++++.++||||+++++++..  .+..++||||
T Consensus         3 ~~~ig~G~~~~~~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~hpniv~~~~~~~~--~~~~~lv~e~   80 (327)
T cd08227           3 LTVIGRGFEDLMTVNLARYKPTGEYVTVRRINLEACTNEMVTFLQGELHVSKLFNHPNIVPYRATFIA--DNELWVVTSF   80 (327)
T ss_pred             hhhccccccceEEEEEEeecccCcEEEEEEechhhccHHHHHHHHHHHHHHHhcCCCCeeeEEEEEEE--CCEEEEEEec
Confidence            4689999  78899999875 78999999997654332 34567789999999999999999999954  4689999999


Q ss_pred             CCCCCHHHHhhhcCCCCCCCCHHHHHHHHHHHHHHHhhhhCCCCCCCceeecCCCCCceeecCCCCeEEecccccccccC
Q 005586          490 APKGKLSKYLDQEEGSSNVLDWSTRVSIIIGIAKGIGYLHSSEVNKPAIVHRNLSVEKVLIDQQFNPLIADCGLHKLLAD  569 (689)
Q Consensus       490 ~~~gsL~~~L~~~~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~~~ivH~dlk~~NiLl~~~~~~kl~DfGla~~~~~  569 (689)
                      +++|+|.+++.....  ..+++..++.++.|++.||+|||+.+     |+||||||+|||++.++.++++||+.......
T Consensus        81 ~~~~~l~~~~~~~~~--~~l~~~~~~~i~~qi~~~L~~LH~~~-----iiH~dlkp~Nil~~~~~~~~l~~~~~~~~~~~  153 (327)
T cd08227          81 MAYGSAKDLICTHFM--DGMSELAIAYILQGVLKALDYIHHMG-----YVHRSVKASHILISVDGKVYLSGLRSNLSMIN  153 (327)
T ss_pred             cCCCcHHHHHHhhcc--CCCCHHHHHHHHHHHHHHHHHHHHCC-----EecCCCChhhEEEecCCcEEEcccchhhcccc
Confidence            999999999975432  24899999999999999999999987     99999999999999999999999986543321


Q ss_pred             Cce-ee-----eecCCCCCCCCCcccccc--CCCCCcccchhHHHHHHHHHhCCCCcchhHHHHHh----hhhhhHhhcc
Q 005586          570 DIV-FS-----VLKTSAAMGYLAPEYVTT--GRFTERSDIFAFGVIILQILTGSLVLTSSMRLAAE----SATFENFIDR  637 (689)
Q Consensus       570 ~~~-~~-----~~~~~~~~~y~aPE~~~~--~~~~~ksDV~sfGvvl~elltG~~p~~~~~~~~~~----~~~~~~~~~~  637 (689)
                      ... ..     .....++..|+|||++.+  ..++.++|||||||++|||++|+.||.........    .......++.
T Consensus       154 ~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~  233 (327)
T cd08227         154 HGQRLRVVHDFPKYSVKVLPWLSPEVLQQNLQGYDAKSDIYSVGITACELANGHVPFKDMPATQMLLEKLNGTVPCLLDT  233 (327)
T ss_pred             ccccccccccccccccceecccChHHhhcccCCCCchhhHHHHHHHHHHHHHCCCCCCCcchhHHHHHHhcCCccccccc
Confidence            110 00     011234567999999875  45899999999999999999999999642211100    0000000000


Q ss_pred             -------------------cc-----------------CCCCCHHHHHHHHHHHHHhccCCCCCCCCHHHHHHHHHh
Q 005586          638 -------------------NL-----------------KGKFSESEAAKLGKMALVCTHEDPENRPTMEAVIEELTV  678 (689)
Q Consensus       638 -------------------~~-----------------~~~~~~~~~~~l~~l~~~Cl~~dp~~RPs~~evl~~L~~  678 (689)
                                         ..                 ...........+.+++.+||+.||++|||++|++++.+.
T Consensus       234 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rpt~~ell~~p~f  310 (327)
T cd08227         234 TTIPAEELTMKPSRSGANSGLGESTTVSTPRPSNGESSSHPYNRTFSPHFHHFVEQCLQRNPDARPSASTLLNHSFF  310 (327)
T ss_pred             cchhhhhcccCCcccCCcCCCCcccccCCcCccccCCcccccccccCHHHHHHHHHHHhhCchhcCCHHHHhcChhh
Confidence                               00                 000112235578999999999999999999999987544

Protein Kinase family, STE20-related kinase adapter protein (STRAD) alpha subfamily, pseudokinase domain. The STRAD alpha subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hype

>cd06656 STKc_PAK3 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 3

Probab=100.00  E-value=2e-36  Score=315.57  Aligned_cols=254  Identities=15%  Similarity=0.288  Sum_probs=203.4

Q ss_pred             ccCCcccccccCCcceEEEEEec-CCcEEEEEEecccCCchHHHHHHHHHHHHhccCCCcceeEeeEEEcCCCCeEEEEE
Q 005586          409 QCFSEVNLLGKGNFSSVYKGTLR-DGTLVAIRSINVTSCKSEEAEFVKGLYLLTSLRHENIIRLRGFCCSRGRGECFLIY  487 (689)
Q Consensus       409 ~~f~~~~~lg~G~~g~Vy~~~~~-~g~~vavK~l~~~~~~~~~~~f~~e~~~l~~l~H~niv~l~g~~~~~~~~~~~lV~  487 (689)
                      .+|...+.||+|+||.||+|... +|+.||+|.+..... .....+.+|+.+++.++|+||+++++++..  .+..++||
T Consensus        19 ~~y~~~~~lg~g~~g~v~~~~~~~~~~~vaiK~~~~~~~-~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~--~~~~~lv~   95 (297)
T cd06656          19 KKYTRFEKIGQGASGTVYTAIDIATGQEVAIKQMNLQQQ-PKKELIINEILVMRENKNPNIVNYLDSYLV--GDELWVVM   95 (297)
T ss_pred             hhceeeeeeccCCCeEEEEEEECCCCCEEEEEEEecCcc-chHHHHHHHHHHHHhCCCCCEeeEEEEEec--CCEEEEee
Confidence            56788899999999999999964 799999999976542 344678899999999999999999999854  57899999


Q ss_pred             EcCCCCCHHHHhhhcCCCCCCCCHHHHHHHHHHHHHHHhhhhCCCCCCCceeecCCCCCceeecCCCCeEEecccccccc
Q 005586          488 DFAPKGKLSKYLDQEEGSSNVLDWSTRVSIIIGIAKGIGYLHSSEVNKPAIVHRNLSVEKVLIDQQFNPLIADCGLHKLL  567 (689)
Q Consensus       488 e~~~~gsL~~~L~~~~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~~~ivH~dlk~~NiLl~~~~~~kl~DfGla~~~  567 (689)
                      ||+++++|.+++...     .+++..+..++.|++.||.|||+.+     |+||||||+||++++++.+||+|||++...
T Consensus        96 e~~~~~~L~~~~~~~-----~~~~~~~~~~~~~l~~~L~~LH~~~-----i~H~dL~p~Nili~~~~~~~l~Dfg~~~~~  165 (297)
T cd06656          96 EYLAGGSLTDVVTET-----CMDEGQIAAVCRECLQALDFLHSNQ-----VIHRDIKSDNILLGMDGSVKLTDFGFCAQI  165 (297)
T ss_pred             cccCCCCHHHHHHhC-----CCCHHHHHHHHHHHHHHHHHHHHCC-----cccCCCCHHHEEECCCCCEEECcCccceEc
Confidence            999999999998643     3789999999999999999999987     999999999999999999999999998765


Q ss_pred             cCCceeeeecCCCCCCCCCccccccCCCCCcccchhHHHHHHHHHhCCCCcchhHHHHHhhhhhhHhhccccCCCCCHHH
Q 005586          568 ADDIVFSVLKTSAAMGYLAPEYVTTGRFTERSDIFAFGVIILQILTGSLVLTSSMRLAAESATFENFIDRNLKGKFSESE  647 (689)
Q Consensus       568 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~ksDV~sfGvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  647 (689)
                      ...... .....++..|+|||.+.+..++.++|||||||++|||+||+.||..........   ............+...
T Consensus       166 ~~~~~~-~~~~~~~~~y~aPE~~~~~~~~~~~Di~slGvil~~l~tg~~pf~~~~~~~~~~---~~~~~~~~~~~~~~~~  241 (297)
T cd06656         166 TPEQSK-RSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMVEGEPPYLNENPLRALY---LIATNGTPELQNPERL  241 (297)
T ss_pred             cCCccC-cCcccCCccccCHHHHcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCcchhee---eeccCCCCCCCCcccc
Confidence            443211 112346778999999998889999999999999999999999995432111100   0000000011123344


Q ss_pred             HHHHHHHHHHhccCCCCCCCCHHHHHHHHHhh
Q 005586          648 AAKLGKMALVCTHEDPENRPTMEAVIEELTVA  679 (689)
Q Consensus       648 ~~~l~~l~~~Cl~~dp~~RPs~~evl~~L~~~  679 (689)
                      ...+.+++.+||+.+|++||++.+++++-+..
T Consensus       242 ~~~~~~li~~~l~~~p~~Rps~~~il~~~~~~  273 (297)
T cd06656         242 SAVFRDFLNRCLEMDVDRRGSAKELLQHPFLK  273 (297)
T ss_pred             CHHHHHHHHHHccCChhhCcCHHHHhcCchhc
Confidence            56788999999999999999999999976543

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 3, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK3 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding

>cd06622 PKc_MAPKK_PBS2_like Catalytic domain of fungal PBS2-like dual-specificity MAP kinase kinases

Probab=100.00  E-value=3.1e-36  Score=312.31  Aligned_cols=256  Identities=21%  Similarity=0.363  Sum_probs=203.5

Q ss_pred             cCCcccccccCCcceEEEEEec-CCcEEEEEEecccCCchHHHHHHHHHHHHhccCCCcceeEeeEEEcCCCCeEEEEEE
Q 005586          410 CFSEVNLLGKGNFSSVYKGTLR-DGTLVAIRSINVTSCKSEEAEFVKGLYLLTSLRHENIIRLRGFCCSRGRGECFLIYD  488 (689)
Q Consensus       410 ~f~~~~~lg~G~~g~Vy~~~~~-~g~~vavK~l~~~~~~~~~~~f~~e~~~l~~l~H~niv~l~g~~~~~~~~~~~lV~e  488 (689)
                      +|+..+.||+|+||.||++... +|..||+|.+..........+|.+|++++.+++|+||+++++++..  .+..++|||
T Consensus         2 ~~~~~~~ig~g~~g~v~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~--~~~~~lv~e   79 (286)
T cd06622           2 EIEVLDELGKGNYGSVYKVLHRPTGVTMAMKEIRLELDESKFNQIIMELDILHKAVSPYIVDFYGAFFI--EGAVYMCME   79 (286)
T ss_pred             hhhhhhhhcccCCeEEEEEEEcCCCcEEEEEEeecccCHHHHHHHHHHHHHHHhcCCCcHHhhhhheec--CCeEEEEEe
Confidence            5677889999999999999986 7899999998765434445689999999999999999999998854  478999999


Q ss_pred             cCCCCCHHHHhhhcCCCCCCCCHHHHHHHHHHHHHHHhhhhCC-CCCCCceeecCCCCCceeecCCCCeEEecccccccc
Q 005586          489 FAPKGKLSKYLDQEEGSSNVLDWSTRVSIIIGIAKGIGYLHSS-EVNKPAIVHRNLSVEKVLIDQQFNPLIADCGLHKLL  567 (689)
Q Consensus       489 ~~~~gsL~~~L~~~~~~~~~l~~~~~~~ia~~ia~gL~yLH~~-~~~~~~ivH~dlk~~NiLl~~~~~~kl~DfGla~~~  567 (689)
                      |+++++|..+++.... ...+++..+..++.+++.||.|||+. +     |+||||||+||+++.++.+||+|||++..+
T Consensus        80 ~~~~~~l~~~~~~~~~-~~~~~~~~~~~~~~~i~~~l~~LH~~~~-----i~H~dl~p~nil~~~~~~~~l~dfg~~~~~  153 (286)
T cd06622          80 YMDAGSLDKLYAGGVA-TEGIPEDVLRRITYAVVKGLKFLKEEHN-----IIHRDVKPTNVLVNGNGQVKLCDFGVSGNL  153 (286)
T ss_pred             ecCCCCHHHHHHhccc-cCCCCHHHHHHHHHHHHHHHHHHHhcCC-----EeeCCCCHHHEEECCCCCEEEeecCCcccc
Confidence            9999999999876421 23589999999999999999999963 4     999999999999999999999999998765


Q ss_pred             cCCceeeeecCCCCCCCCCccccccC------CCCCcccchhHHHHHHHHHhCCCCcchhHHHHHhhhhhhHhhccccCC
Q 005586          568 ADDIVFSVLKTSAAMGYLAPEYVTTG------RFTERSDIFAFGVIILQILTGSLVLTSSMRLAAESATFENFIDRNLKG  641 (689)
Q Consensus       568 ~~~~~~~~~~~~~~~~y~aPE~~~~~------~~~~ksDV~sfGvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~  641 (689)
                      .....   ....++..|+|||.+.+.      .++.++|||||||++|||+||+.||........ ...+..+.+. ...
T Consensus       154 ~~~~~---~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~-~~~~~~~~~~-~~~  228 (286)
T cd06622         154 VASLA---KTNIGCQSYMAPERIKSGGPNQNPTYTVQSDVWSLGLSILEMALGRYPYPPETYANI-FAQLSAIVDG-DPP  228 (286)
T ss_pred             cCCcc---ccCCCccCccCcchhcCCCCCccCCCCcccchHhHHHHHHHHHhCCCCCCCcchhhH-HHHHHHHhhc-CCC
Confidence            43221   123466789999998554      358899999999999999999999864321111 1111222221 122


Q ss_pred             CCCHHHHHHHHHHHHHhccCCCCCCCCHHHHHHHHHh
Q 005586          642 KFSESEAAKLGKMALVCTHEDPENRPTMEAVIEELTV  678 (689)
Q Consensus       642 ~~~~~~~~~l~~l~~~Cl~~dp~~RPs~~evl~~L~~  678 (689)
                      ..+.....++.+++.+|++.+|++||++.+++.+.+.
T Consensus       229 ~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~l~~~~~~  265 (286)
T cd06622         229 TLPSGYSDDAQDFVAKCLNKIPNRRPTYAQLLEHPWL  265 (286)
T ss_pred             CCCcccCHHHHHHHHHHcccCcccCCCHHHHhcChhh
Confidence            3445567789999999999999999999999987653

Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal PBS2-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include

>cd07868 STKc_CDK8 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 8

Probab=100.00  E-value=3.5e-36  Score=316.81  Aligned_cols=254  Identities=22%  Similarity=0.351  Sum_probs=189.5

Q ss_pred             ccccccCCcceEEEEEec---CCcEEEEEEecccCCchHHHHHHHHHHHHhccCCCcceeEeeEEEcCCCCeEEEEEEcC
Q 005586          414 VNLLGKGNFSSVYKGTLR---DGTLVAIRSINVTSCKSEEAEFVKGLYLLTSLRHENIIRLRGFCCSRGRGECFLIYDFA  490 (689)
Q Consensus       414 ~~~lg~G~~g~Vy~~~~~---~g~~vavK~l~~~~~~~~~~~f~~e~~~l~~l~H~niv~l~g~~~~~~~~~~~lV~e~~  490 (689)
                      .+.||+|+||.||+|+.+   +++.||+|.+....   ....+.+|++++++++||||+++++++........++||||+
T Consensus         6 ~~~lG~G~~g~Vy~~~~~~~~~~~~~aiK~~~~~~---~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~lv~e~~   82 (317)
T cd07868           6 GCKVGRGTYGHVYKAKRKDGKDDRDYALKQIEGTG---ISMSACREIALLRELKHPNVISLQKVFLSHADRKVWLLFDYA   82 (317)
T ss_pred             ccccccCCCeEEEEEEEccCCCCceEEEEEECCCC---CcHHHHHHHHHHHhcCCCCCcceeeeEecCCCcEEEEEEecc
Confidence            468999999999999865   46789999987543   234577899999999999999999988766667789999999


Q ss_pred             CCCCHHHHhhhcCC-----CCCCCCHHHHHHHHHHHHHHHhhhhCCCCCCCceeecCCCCCceee----cCCCCeEEecc
Q 005586          491 PKGKLSKYLDQEEG-----SSNVLDWSTRVSIIIGIAKGIGYLHSSEVNKPAIVHRNLSVEKVLI----DQQFNPLIADC  561 (689)
Q Consensus       491 ~~gsL~~~L~~~~~-----~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~~~ivH~dlk~~NiLl----~~~~~~kl~Df  561 (689)
                      + ++|.+++.....     ....+++.....|+.|++.||+|||+.+     |+||||||+|||+    +.++.+||+||
T Consensus        83 ~-~~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~-----ivHrDlkp~Nil~~~~~~~~~~~kl~Df  156 (317)
T cd07868          83 E-HDLWHIIKFHRASKANKKPVQLPRGMVKSLLYQILDGIHYLHANW-----VLHRDLKPANILVMGEGPERGRVKIADM  156 (317)
T ss_pred             C-CCHHHHHHhcccccccCCcccCCHHHHHHHHHHHHHHHHHHHhCC-----EEcCCCCHHHEEEecCCCCcCcEEEeec
Confidence            5 588888754321     1235889999999999999999999987     9999999999999    45678999999


Q ss_pred             cccccccCCce--eeeecCCCCCCCCCcccccc-CCCCCcccchhHHHHHHHHHhCCCCcchhHHHH---------Hhh-
Q 005586          562 GLHKLLADDIV--FSVLKTSAAMGYLAPEYVTT-GRFTERSDIFAFGVIILQILTGSLVLTSSMRLA---------AES-  628 (689)
Q Consensus       562 Gla~~~~~~~~--~~~~~~~~~~~y~aPE~~~~-~~~~~ksDV~sfGvvl~elltG~~p~~~~~~~~---------~~~-  628 (689)
                      |+++.......  .......+|..|+|||++.+ ..++.++||||+||++|||+||+.||.......         ... 
T Consensus       157 G~a~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~~f~~~~~~~~~~~~~~~~~~~~  236 (317)
T cd07868         157 GFARLFNSPLKPLADLDPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTSEPIFHCRQEDIKTSNPYHHDQLDR  236 (317)
T ss_pred             CceeccCCCCccccccCCccccccccCCHHHcCCCCcCchhhHHHHHHHHHHHHhCCCCccCCcccccccccccHHHHHH
Confidence            99987654321  11223457888999999876 458999999999999999999999985321100         000 


Q ss_pred             ----------hhhhHhh--------ccccCC-CC------------CHHHHHHHHHHHHHhccCCCCCCCCHHHHHHHH
Q 005586          629 ----------ATFENFI--------DRNLKG-KF------------SESEAAKLGKMALVCTHEDPENRPTMEAVIEEL  676 (689)
Q Consensus       629 ----------~~~~~~~--------~~~~~~-~~------------~~~~~~~l~~l~~~Cl~~dp~~RPs~~evl~~L  676 (689)
                                ..+.+..        ...... ..            ......++.+++.+|++.||++|||++|++++-
T Consensus       237 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dli~~mL~~dP~~R~t~~e~l~hp  315 (317)
T cd07868         237 IFNVMGFPADKDWEDIKKMPEHSTLMKDFRRNTYTNCSLIKYMEKHKVKPDSKAFHLLQKLLTMDPIKRITSEQAMQDP  315 (317)
T ss_pred             HHHhcCCCChHHhHHHhhccchhhhhhhhhccccCcccccchHHhcCCCCChHHHHHHHHHhccCcccCCCHHHHhcCC
Confidence                      0000000        000000 00            000123578999999999999999999999763

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK8 can act as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the multi-subunit core Mediator complex, a cofactor that is involved in regulating RNA p

>cd06641 STKc_MST3 Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 3

Probab=100.00  E-value=4.4e-36  Score=309.77  Aligned_cols=251  Identities=21%  Similarity=0.388  Sum_probs=203.3

Q ss_pred             cCCcccccccCCcceEEEEEec-CCcEEEEEEecccCCchHHHHHHHHHHHHhccCCCcceeEeeEEEcCCCCeEEEEEE
Q 005586          410 CFSEVNLLGKGNFSSVYKGTLR-DGTLVAIRSINVTSCKSEEAEFVKGLYLLTSLRHENIIRLRGFCCSRGRGECFLIYD  488 (689)
Q Consensus       410 ~f~~~~~lg~G~~g~Vy~~~~~-~g~~vavK~l~~~~~~~~~~~f~~e~~~l~~l~H~niv~l~g~~~~~~~~~~~lV~e  488 (689)
                      -|+..+.||+|+||.||+|... ++..||+|.+...........|.+|+..+.+++||||+++++++..  ....++|||
T Consensus         5 ~~~~~~~ig~G~~~~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~--~~~~~lv~e   82 (277)
T cd06641           5 LFTKLEKIGKGSFGEVFKGIDNRTQKVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYVTKYYGSYLK--DTKLWIIME   82 (277)
T ss_pred             hhhhheeEeecCCeEEEEEEECCCCcEEEEEEeccccchHHHHHHHHHHHHHHhcCCCCEeEEEEEEEe--CCeEEEEEE
Confidence            4666789999999999999865 6899999998765544556789999999999999999999999854  467899999


Q ss_pred             cCCCCCHHHHhhhcCCCCCCCCHHHHHHHHHHHHHHHhhhhCCCCCCCceeecCCCCCceeecCCCCeEEeccccccccc
Q 005586          489 FAPKGKLSKYLDQEEGSSNVLDWSTRVSIIIGIAKGIGYLHSSEVNKPAIVHRNLSVEKVLIDQQFNPLIADCGLHKLLA  568 (689)
Q Consensus       489 ~~~~gsL~~~L~~~~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~~~ivH~dlk~~NiLl~~~~~~kl~DfGla~~~~  568 (689)
                      |+++++|.+++...     .+++.....++.|++.|+.|||+.+     ++|+||||+||++++++.++|+|||+++...
T Consensus        83 ~~~~~~l~~~i~~~-----~~~~~~~~~~~~~l~~~l~~lh~~~-----i~h~dl~p~Ni~i~~~~~~~l~dfg~~~~~~  152 (277)
T cd06641          83 YLGGGSALDLLEPG-----PLDETQIATILREILKGLDYLHSEK-----KIHRDIKAANVLLSEHGEVKLADFGVAGQLT  152 (277)
T ss_pred             eCCCCcHHHHHhcC-----CCCHHHHHHHHHHHHHHHHHHccCC-----eecCCCCHHhEEECCCCCEEEeecccceecc
Confidence            99999999998642     3889999999999999999999987     9999999999999999999999999987664


Q ss_pred             CCceeeeecCCCCCCCCCccccccCCCCCcccchhHHHHHHHHHhCCCCcchhHHHHHhhhhhhHhhccccCCCCCHHHH
Q 005586          569 DDIVFSVLKTSAAMGYLAPEYVTTGRFTERSDIFAFGVIILQILTGSLVLTSSMRLAAESATFENFIDRNLKGKFSESEA  648 (689)
Q Consensus       569 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~ksDV~sfGvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  648 (689)
                      .... ......++..|+|||++.+..++.++|||||||++|||++|+.|+........     ...+.............
T Consensus       153 ~~~~-~~~~~~~~~~y~~PE~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~~~~-----~~~~~~~~~~~~~~~~~  226 (277)
T cd06641         153 DTQI-KRNTFVGTPFWMAPEVIKQSAYDSKADIWSLGITAIELAKGEPPHSELHPMKV-----LFLIPKNNPPTLEGNYS  226 (277)
T ss_pred             cchh-hhccccCCccccChhhhccCCCCchhhHHHHHHHHHHHHcCCCCCCccchHHH-----HHHHhcCCCCCCCcccC
Confidence            4321 11123467789999999888899999999999999999999999864322111     11111111222334456


Q ss_pred             HHHHHHHHHhccCCCCCCCCHHHHHHHHHh
Q 005586          649 AKLGKMALVCTHEDPENRPTMEAVIEELTV  678 (689)
Q Consensus       649 ~~l~~l~~~Cl~~dp~~RPs~~evl~~L~~  678 (689)
                      ..+.+++.+|++.+|++||++.+++++-..
T Consensus       227 ~~~~~~i~~~l~~~p~~Rp~~~~~l~~~~~  256 (277)
T cd06641         227 KPLKEFVEACLNKEPSFRPTAKELLKHKFI  256 (277)
T ss_pred             HHHHHHHHHHccCChhhCcCHHHHHhCHHH
Confidence            678899999999999999999999997433

Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST3 phosphorylates the STK NDR and may play a role in cell cycle progression and cell morphology. It may also regulate paxillin and consequently, cell migration. MST3 is present in human placenta, where it plays an essential role in the oxidative stress-induced apoptosis of trophoblasts in normal spontaneous delivery. Dysregulation of trophoblast apoptosis may result in pregnancy complications such as preeclampsia and int

>cd05037 PTK_Jak_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases

Probab=100.00  E-value=3.2e-36  Score=307.15  Aligned_cols=238  Identities=22%  Similarity=0.464  Sum_probs=188.2

Q ss_pred             cccccCCcceEEEEEecC-C----------cEEEEEEecccCCchHHHHHHHHHHHHhccCCCcceeEeeEEEcCCCCeE
Q 005586          415 NLLGKGNFSSVYKGTLRD-G----------TLVAIRSINVTSCKSEEAEFVKGLYLLTSLRHENIIRLRGFCCSRGRGEC  483 (689)
Q Consensus       415 ~~lg~G~~g~Vy~~~~~~-g----------~~vavK~l~~~~~~~~~~~f~~e~~~l~~l~H~niv~l~g~~~~~~~~~~  483 (689)
                      +.||+|+||.||+|.+++ +          ..|++|.+......  ...|.+|+.++++++||||+++++++..   ...
T Consensus         1 ~~lg~G~~~~v~~~~~~~~~~~~~~~~~~~~~v~~k~~~~~~~~--~~~~~~e~~~l~~l~h~~i~~~~~~~~~---~~~   75 (259)
T cd05037           1 EHLGQGTFTNIYKGVLRVQSDLDIVGPGQEVSVVLKVLGSDHRD--SLAFFETASLMSQLSHKHLVKLYGVCVR---DEN   75 (259)
T ss_pred             CcccccccceEEEEEEeccCCccccCCccceeeeeeccccchhh--HHHHHHHHHHHHcCCCcchhheeeEEec---CCc
Confidence            469999999999999864 3          25788877654322  5789999999999999999999999855   467


Q ss_pred             EEEEEcCCCCCHHHHhhhcCCCCCCCCHHHHHHHHHHHHHHHhhhhCCCCCCCceeecCCCCCceeecCCC-------Ce
Q 005586          484 FLIYDFAPKGKLSKYLDQEEGSSNVLDWSTRVSIIIGIAKGIGYLHSSEVNKPAIVHRNLSVEKVLIDQQF-------NP  556 (689)
Q Consensus       484 ~lV~e~~~~gsL~~~L~~~~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~~~ivH~dlk~~NiLl~~~~-------~~  556 (689)
                      ++||||+++|+|.+++.....   .+++..++.++.|++.||+|||+.+     |+||||||+||+++.++       .+
T Consensus        76 ~lv~e~~~~~~L~~~l~~~~~---~~~~~~~~~~~~~i~~~l~~LH~~~-----i~H~dlkp~Nill~~~~~~~~~~~~~  147 (259)
T cd05037          76 IMVEEYVKFGPLDVFLHREKN---NVSLHWKLDVAKQLASALHYLEDKK-----LVHGNVCGKNILVARYGLNEGYVPFI  147 (259)
T ss_pred             EEEEEcCCCCcHHHHHHhhcc---CCCHHHHHHHHHHHHHHHHHHhhCC-----eecccCccceEEEecCccccCCceeE
Confidence            899999999999999986542   4899999999999999999999887     99999999999999888       79


Q ss_pred             EEecccccccccCCceeeeecCCCCCCCCCccccccC--CCCCcccchhHHHHHHHHHh-CCCCcchhHHHHHhhhhhhH
Q 005586          557 LIADCGLHKLLADDIVFSVLKTSAAMGYLAPEYVTTG--RFTERSDIFAFGVIILQILT-GSLVLTSSMRLAAESATFEN  633 (689)
Q Consensus       557 kl~DfGla~~~~~~~~~~~~~~~~~~~y~aPE~~~~~--~~~~ksDV~sfGvvl~ellt-G~~p~~~~~~~~~~~~~~~~  633 (689)
                      ||+|||+++......     ...++..|+|||++...  .++.++|||||||++|||++ |..|+...... .....+  
T Consensus       148 kl~Dfg~a~~~~~~~-----~~~~~~~y~aPE~~~~~~~~~~~~~Di~slG~~~~~l~~~~~~p~~~~~~~-~~~~~~--  219 (259)
T cd05037         148 KLSDPGIPITVLSRE-----ERVERIPWIAPECIRNGQASLTIAADKWSFGTTLLEICSNGEEPLSTLSSS-EKERFY--  219 (259)
T ss_pred             EeCCCCccccccccc-----ccccCCCccChhhhcCCCCCcchhhHHHHHHHHHHHHHhCCCCCcccCCch-hHHHHH--
Confidence            999999998654311     22345679999998776  78999999999999999999 46666443211 111111  


Q ss_pred             hhccccCCCCCHHHHHHHHHHHHHhccCCCCCCCCHHHHHHHHH
Q 005586          634 FIDRNLKGKFSESEAAKLGKMALVCTHEDPENRPTMEAVIEELT  677 (689)
Q Consensus       634 ~~~~~~~~~~~~~~~~~l~~l~~~Cl~~dp~~RPs~~evl~~L~  677 (689)
                       ....   ..+......+.+++..||..+|++||++.||++.|.
T Consensus       220 -~~~~---~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~il~~l~  259 (259)
T cd05037         220 -QDQH---RLPMPDCAELANLINQCWTYDPTKRPSFRAILRDLN  259 (259)
T ss_pred             -hcCC---CCCCCCchHHHHHHHHHhccChhhCCCHHHHHHhcC
Confidence             0111   111112278899999999999999999999999873

Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; pseudokinase domain (repeat1). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the ki

>cd06645 STKc_MAP4K3 Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 3

Probab=100.00  E-value=2.1e-36  Score=310.23  Aligned_cols=252  Identities=21%  Similarity=0.327  Sum_probs=196.8

Q ss_pred             ccCCcccccccCCcceEEEEEec-CCcEEEEEEecccCCchHHHHHHHHHHHHhccCCCcceeEeeEEEcCCCCeEEEEE
Q 005586          409 QCFSEVNLLGKGNFSSVYKGTLR-DGTLVAIRSINVTSCKSEEAEFVKGLYLLTSLRHENIIRLRGFCCSRGRGECFLIY  487 (689)
Q Consensus       409 ~~f~~~~~lg~G~~g~Vy~~~~~-~g~~vavK~l~~~~~~~~~~~f~~e~~~l~~l~H~niv~l~g~~~~~~~~~~~lV~  487 (689)
                      ++|...+.||+|+||.||+|+.. +++.||+|.++... ......+.+|+.++..++||||+++++++..  .+..++|+
T Consensus         9 ~~~~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~-~~~~~~~~~e~~~~~~l~h~~ii~~~~~~~~--~~~~~lv~   85 (267)
T cd06645           9 EDFELIQRIGSGTYGDVYKARNVNTGELAAIKVIKLEP-GEDFAVVQQEIIMMKDCKHSNIVAYFGSYLR--RDKLWICM   85 (267)
T ss_pred             HHHHHHHHhCCCCCeEEEEEEEcCCCcEEEEEEEecCc-hhHHHHHHHHHHHHHhCCCCCeeeEEEEEEe--CCEEEEEE
Confidence            35666788999999999999875 68999999987654 3344568899999999999999999998854  47899999


Q ss_pred             EcCCCCCHHHHhhhcCCCCCCCCHHHHHHHHHHHHHHHhhhhCCCCCCCceeecCCCCCceeecCCCCeEEecccccccc
Q 005586          488 DFAPKGKLSKYLDQEEGSSNVLDWSTRVSIIIGIAKGIGYLHSSEVNKPAIVHRNLSVEKVLIDQQFNPLIADCGLHKLL  567 (689)
Q Consensus       488 e~~~~gsL~~~L~~~~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~~~ivH~dlk~~NiLl~~~~~~kl~DfGla~~~  567 (689)
                      ||+++++|.+++....    .+++.+.+.++.|++.||+|||+.+     |+|+||||+||+++.++.+||+|||++...
T Consensus        86 e~~~~~~L~~~~~~~~----~~~~~~~~~~~~~i~~~l~~lH~~~-----i~H~dlkp~nili~~~~~~~l~dfg~~~~~  156 (267)
T cd06645          86 EFCGGGSLQDIYHVTG----PLSESQIAYVSRETLQGLYYLHSKG-----KMHRDIKGANILLTDNGHVKLADFGVSAQI  156 (267)
T ss_pred             eccCCCcHHHHHHhcC----CCCHHHHHHHHHHHHHHHHHHHHCC-----eecCCCCHHHEEECCCCCEEECcceeeeEc
Confidence            9999999999987543    4889999999999999999999987     999999999999999999999999998765


Q ss_pred             cCCceeeeecCCCCCCCCCccccc---cCCCCCcccchhHHHHHHHHHhCCCCcchhHHHHHhhhh-hhHhhccccCCCC
Q 005586          568 ADDIVFSVLKTSAAMGYLAPEYVT---TGRFTERSDIFAFGVIILQILTGSLVLTSSMRLAAESAT-FENFIDRNLKGKF  643 (689)
Q Consensus       568 ~~~~~~~~~~~~~~~~y~aPE~~~---~~~~~~ksDV~sfGvvl~elltG~~p~~~~~~~~~~~~~-~~~~~~~~~~~~~  643 (689)
                      ..... ......++..|+|||++.   ...++.++|||||||++|||++|+.|+............ ......+....  
T Consensus       157 ~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~~~~DvwSlG~il~~l~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~--  233 (267)
T cd06645         157 TATIA-KRKSFIGTPYWMAPEVAAVERKGGYNQLCDIWAVGITAIELAELQPPMFDLHPMRALFLMTKSNFQPPKLKD--  233 (267)
T ss_pred             cCccc-ccccccCcccccChhhhccccCCCCCchhhhHHHHHHHHHHhcCCCCcccccchhhHHhhhccCCCCCcccc--
Confidence            43221 122345778899999874   456889999999999999999999998543211100000 00000011110  


Q ss_pred             CHHHHHHHHHHHHHhccCCCCCCCCHHHHHHH
Q 005586          644 SESEAAKLGKMALVCTHEDPENRPTMEAVIEE  675 (689)
Q Consensus       644 ~~~~~~~l~~l~~~Cl~~dp~~RPs~~evl~~  675 (689)
                      ....+..+.+++.+|++.+|++||++++|+++
T Consensus       234 ~~~~~~~~~~li~~~l~~~P~~R~~~~~ll~~  265 (267)
T cd06645         234 KMKWSNSFHHFVKMALTKNPKKRPTAEKLLQH  265 (267)
T ss_pred             cCCCCHHHHHHHHHHccCCchhCcCHHHHhcC
Confidence            01234568899999999999999999999875

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated

>cd06636 STKc_MAP4K4_6 Catalytic domain of the Protein Serine/Threonine Kinases, Mitogen-Activated Protein Kinase Kinase Kinase Kinase 4 and 6

Probab=100.00  E-value=2.6e-36  Score=312.27  Aligned_cols=263  Identities=22%  Similarity=0.372  Sum_probs=205.0

Q ss_pred             cCHHHHHHHhccCCcccccccCCcceEEEEEec-CCcEEEEEEecccCCchHHHHHHHHHHHHhcc-CCCcceeEeeEEE
Q 005586          399 LNLEEVESATQCFSEVNLLGKGNFSSVYKGTLR-DGTLVAIRSINVTSCKSEEAEFVKGLYLLTSL-RHENIIRLRGFCC  476 (689)
Q Consensus       399 ~~~~~l~~at~~f~~~~~lg~G~~g~Vy~~~~~-~g~~vavK~l~~~~~~~~~~~f~~e~~~l~~l-~H~niv~l~g~~~  476 (689)
                      .++.++..+.+.|+..+.||+|+||.||+|... +++.||+|.+....  ....++..|+.++.++ +|+||+++++++.
T Consensus         6 ~~~~~~~~~~~~~~~~~~lg~g~~~~v~~~~~~~~~~~~a~K~~~~~~--~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~   83 (282)
T cd06636           6 IDLSALRDPAGIFELVEVVGNGTYGQVYKGRHVKTGQLAAIKVMDVTE--DEEEEIKLEINMLKKYSHHRNIATYYGAFI   83 (282)
T ss_pred             hhhhhhcChhhhhhhheeeccCCCeEEEEEEEcCCCcEEEEEEEecCh--HHHHHHHHHHHHHHHhcCCCcEEEEeeehh
Confidence            355566667788999999999999999999975 68899999986542  3445788999999998 7999999999885


Q ss_pred             cC----CCCeEEEEEEcCCCCCHHHHhhhcCCCCCCCCHHHHHHHHHHHHHHHhhhhCCCCCCCceeecCCCCCceeecC
Q 005586          477 SR----GRGECFLIYDFAPKGKLSKYLDQEEGSSNVLDWSTRVSIIIGIAKGIGYLHSSEVNKPAIVHRNLSVEKVLIDQ  552 (689)
Q Consensus       477 ~~----~~~~~~lV~e~~~~gsL~~~L~~~~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~~~ivH~dlk~~NiLl~~  552 (689)
                      ..    .....++||||+++|+|.+++.....  ..+++..+..++.|+++||+|||+.+     |+||||||+||++++
T Consensus        84 ~~~~~~~~~~~~iv~e~~~~~~L~~~~~~~~~--~~~~~~~~~~~~~qi~~al~~LH~~~-----ivH~dl~~~nili~~  156 (282)
T cd06636          84 KKSPPGHDDQLWLVMEFCGAGSVTDLVKNTKG--NALKEDWIAYICREILRGLAHLHAHK-----VIHRDIKGQNVLLTE  156 (282)
T ss_pred             cccccCCCCEEEEEEEeCCCCcHHHHHHHccC--CCCCHHHHHHHHHHHHHHHHHHHHCC-----cccCCCCHHHEEECC
Confidence            32    24578999999999999999976432  34788889999999999999999987     999999999999999


Q ss_pred             CCCeEEecccccccccCCceeeeecCCCCCCCCCccccc-----cCCCCCcccchhHHHHHHHHHhCCCCcchhHHHHHh
Q 005586          553 QFNPLIADCGLHKLLADDIVFSVLKTSAAMGYLAPEYVT-----TGRFTERSDIFAFGVIILQILTGSLVLTSSMRLAAE  627 (689)
Q Consensus       553 ~~~~kl~DfGla~~~~~~~~~~~~~~~~~~~y~aPE~~~-----~~~~~~ksDV~sfGvvl~elltG~~p~~~~~~~~~~  627 (689)
                      ++.++|+|||+++....... ......++..|+|||.+.     ...++.++|||||||++|||+||+.|+........ 
T Consensus       157 ~~~~~l~dfg~~~~~~~~~~-~~~~~~~~~~y~aPE~l~~~~~~~~~~~~~~DvwslG~~l~el~~g~~p~~~~~~~~~-  234 (282)
T cd06636         157 NAEVKLVDFGVSAQLDRTVG-RRNTFIGTPYWMAPEVIACDENPDATYDYRSDIWSLGITAIEMAEGAPPLCDMHPMRA-  234 (282)
T ss_pred             CCCEEEeeCcchhhhhcccc-CCCcccccccccCHhhcCcccCcCcCCCcccchhHHHHHHHHHHhCCCCccccCHHhh-
Confidence            99999999999876532211 112234677899999875     34678899999999999999999999964322111 


Q ss_pred             hhhhhHhhccccCCCCCHHHHHHHHHHHHHhccCCCCCCCCHHHHHHH
Q 005586          628 SATFENFIDRNLKGKFSESEAAKLGKMALVCTHEDPENRPTMEAVIEE  675 (689)
Q Consensus       628 ~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~Cl~~dp~~RPs~~evl~~  675 (689)
                         .................+.++.+++..||+.||++||++.|++++
T Consensus       235 ---~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rp~~~ell~~  279 (282)
T cd06636         235 ---LFLIPRNPPPKLKSKKWSKKFIDFIEGCLVKNYLSRPSTEQLLKH  279 (282)
T ss_pred             ---hhhHhhCCCCCCcccccCHHHHHHHHHHhCCChhhCcCHHHHhcC
Confidence               111111111111122345679999999999999999999999875

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 4 (MAPKKKK4 or MAP4K4) and MAPKKKK6 (or MAP4K6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K4/MAP4K6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain. MAP4Ks (or MAPKKKKs) are involved in MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Ea

>cd07873 STKc_PCTAIRE1 Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-1 kinase

Probab=100.00  E-value=1.4e-36  Score=317.33  Aligned_cols=259  Identities=18%  Similarity=0.364  Sum_probs=198.9

Q ss_pred             ccCCcccccccCCcceEEEEEec-CCcEEEEEEecccCCchHHHHHHHHHHHHhccCCCcceeEeeEEEcCCCCeEEEEE
Q 005586          409 QCFSEVNLLGKGNFSSVYKGTLR-DGTLVAIRSINVTSCKSEEAEFVKGLYLLTSLRHENIIRLRGFCCSRGRGECFLIY  487 (689)
Q Consensus       409 ~~f~~~~~lg~G~~g~Vy~~~~~-~g~~vavK~l~~~~~~~~~~~f~~e~~~l~~l~H~niv~l~g~~~~~~~~~~~lV~  487 (689)
                      ++|...+.||+|+||.||+|..+ ++..||+|.+...........+.+|+.++++++||||+++++++..  .+..++||
T Consensus         6 ~~y~~~~~lg~g~~g~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~nI~~~~~~~~~--~~~~~lv~   83 (301)
T cd07873           6 ETYIKLDKLGEGTYATVYKGRSKLTDNLVALKEIRLEHEEGAPCTAIREVSLLKDLKHANIVTLHDIIHT--EKSLTLVF   83 (301)
T ss_pred             cceEEeeEeccCcCEEEEEEEEcCCCcEEEEEEEecccccCchhHHHHHHHHHHhcCCCCcceEEEEEec--CCeEEEEE
Confidence            45777899999999999999876 6889999999765444444568899999999999999999999854  57899999


Q ss_pred             EcCCCCCHHHHhhhcCCCCCCCCHHHHHHHHHHHHHHHhhhhCCCCCCCceeecCCCCCceeecCCCCeEEecccccccc
Q 005586          488 DFAPKGKLSKYLDQEEGSSNVLDWSTRVSIIIGIAKGIGYLHSSEVNKPAIVHRNLSVEKVLIDQQFNPLIADCGLHKLL  567 (689)
Q Consensus       488 e~~~~gsL~~~L~~~~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~~~ivH~dlk~~NiLl~~~~~~kl~DfGla~~~  567 (689)
                      ||++ ++|.+++....   ..+++.....++.|++.||+|||+.+     |+||||||+||++++++.+||+|||+++..
T Consensus        84 e~~~-~~l~~~l~~~~---~~~~~~~~~~~~~qi~~aL~~lH~~~-----i~H~dlkp~Nil~~~~~~~kl~dfg~~~~~  154 (301)
T cd07873          84 EYLD-KDLKQYLDDCG---NSINMHNVKLFLFQLLRGLNYCHRRK-----VLHRDLKPQNLLINERGELKLADFGLARAK  154 (301)
T ss_pred             eccc-cCHHHHHHhcC---CCCCHHHHHHHHHHHHHHHHHHHhCC-----eeCCCCCHHHEEECCCCcEEECcCcchhcc
Confidence            9997 69999987643   24889999999999999999999987     999999999999999999999999998765


Q ss_pred             cCCceeeeecCCCCCCCCCccccccC-CCCCcccchhHHHHHHHHHhCCCCcchhHHHHHhh-----------hhhhHhh
Q 005586          568 ADDIVFSVLKTSAAMGYLAPEYVTTG-RFTERSDIFAFGVIILQILTGSLVLTSSMRLAAES-----------ATFENFI  635 (689)
Q Consensus       568 ~~~~~~~~~~~~~~~~y~aPE~~~~~-~~~~ksDV~sfGvvl~elltG~~p~~~~~~~~~~~-----------~~~~~~~  635 (689)
                      ..... ......++..|+|||.+.+. .++.++|||||||++|||+||+.||..........           ..+..++
T Consensus       155 ~~~~~-~~~~~~~~~~y~~PE~~~~~~~~~~~~Dv~slG~~l~el~tg~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~~~  233 (301)
T cd07873         155 SIPTK-TYSNEVVTLWYRPPDILLGSTDYSTQIDMWGVGCIFYEMSTGRPLFPGSTVEEQLHFIFRILGTPTEETWPGIL  233 (301)
T ss_pred             CCCCC-cccccceeecccCcHHHhCCCCCccHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHcCCCChhhchhhh
Confidence            33211 11223456789999987653 57889999999999999999999986432111000           0000110


Q ss_pred             cc---------ccCCC----CCHHHHHHHHHHHHHhccCCCCCCCCHHHHHHHHHhh
Q 005586          636 DR---------NLKGK----FSESEAAKLGKMALVCTHEDPENRPTMEAVIEELTVA  679 (689)
Q Consensus       636 ~~---------~~~~~----~~~~~~~~l~~l~~~Cl~~dp~~RPs~~evl~~L~~~  679 (689)
                      +.         .....    ........+.+++.+|++.||.+|||++|++++-+..
T Consensus       234 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~ml~~dp~~R~t~~eil~h~~f~  290 (301)
T cd07873         234 SNEEFKSYNYPKYRADCLHNHAPRLDSDGAELLSKLLQFEGRKRISAEEAMKHPYFH  290 (301)
T ss_pred             ccccccccccCccccccHHhhcCCCCHHHHHHHHHHhcCCcccCcCHHHHhcCcccc
Confidence            00         00000    0112345688999999999999999999999876554

Serine/Threonine Kinases (STKs), PCTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-1 is expressed ubiquitously and is localized in the cytoplasm. Its kinase activity is cell cycle dependent and peaks at the S and G2 phases. PCTAIRE-1 is highly expressed in the brain and may pl

>cd06608 STKc_myosinIII_like Catalytic domain of Class III myosin-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=3.3e-36  Score=309.76  Aligned_cols=258  Identities=21%  Similarity=0.381  Sum_probs=203.4

Q ss_pred             HhccCCcccccccCCcceEEEEEec-CCcEEEEEEecccCCchHHHHHHHHHHHHhcc-CCCcceeEeeEEEcCC----C
Q 005586          407 ATQCFSEVNLLGKGNFSSVYKGTLR-DGTLVAIRSINVTSCKSEEAEFVKGLYLLTSL-RHENIIRLRGFCCSRG----R  480 (689)
Q Consensus       407 at~~f~~~~~lg~G~~g~Vy~~~~~-~g~~vavK~l~~~~~~~~~~~f~~e~~~l~~l-~H~niv~l~g~~~~~~----~  480 (689)
                      ++++|+..+.||+|+||.||+|..+ +++.+++|++....  ....+|.+|+.+++++ +|+||+++++++....    .
T Consensus         4 ~~~~y~~~~~l~~g~~~~v~~~~~~~~~~~~~~k~~~~~~--~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~~~~~~~~   81 (275)
T cd06608           4 PTGIFELVEVIGEGTYGKVYKARHKKTGQLVAIKIMDIIE--DEEEEIKEEYNILRKYSNHPNIATFYGAFIKKNPPGND   81 (275)
T ss_pred             chhheeheeeecCCCCeEEEEEEECCCCcEEEEEEEecCc--hhHHHHHHHHHHHHHhcCCCChheEEEEEEecCCCCcc
Confidence            5678999999999999999999985 67899999987653  2446799999999999 7999999999986533    3


Q ss_pred             CeEEEEEEcCCCCCHHHHhhhcCCCCCCCCHHHHHHHHHHHHHHHhhhhCCCCCCCceeecCCCCCceeecCCCCeEEec
Q 005586          481 GECFLIYDFAPKGKLSKYLDQEEGSSNVLDWSTRVSIIIGIAKGIGYLHSSEVNKPAIVHRNLSVEKVLIDQQFNPLIAD  560 (689)
Q Consensus       481 ~~~~lV~e~~~~gsL~~~L~~~~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~~~ivH~dlk~~NiLl~~~~~~kl~D  560 (689)
                      ...++||||+++++|.+++.........+++..+..++.|++.||+|||+.+     ++||||+|+||++++++.+||+|
T Consensus        82 ~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~ql~~al~~lH~~~-----i~H~~l~p~ni~~~~~~~~~l~d  156 (275)
T cd06608          82 DQLWLVMELCGGGSVTDLVKGLRKKGKRLKEEWIAYILRETLRGLAYLHENK-----VIHRDIKGQNILLTKNAEVKLVD  156 (275)
T ss_pred             eEEEEEEEcCCCCcHHHHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHhcCC-----cccCCCCHHHEEEccCCeEEECC
Confidence            4589999999999999998764422345899999999999999999999987     99999999999999999999999


Q ss_pred             ccccccccCCceeeeecCCCCCCCCCcccccc-----CCCCCcccchhHHHHHHHHHhCCCCcchhHHHHHhhhhhhHhh
Q 005586          561 CGLHKLLADDIVFSVLKTSAAMGYLAPEYVTT-----GRFTERSDIFAFGVIILQILTGSLVLTSSMRLAAESATFENFI  635 (689)
Q Consensus       561 fGla~~~~~~~~~~~~~~~~~~~y~aPE~~~~-----~~~~~ksDV~sfGvvl~elltG~~p~~~~~~~~~~~~~~~~~~  635 (689)
                      ||++........ ......++..|+|||++..     ..++.++|||||||++|||+||+.|+........    ..++.
T Consensus       157 ~~~~~~~~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~----~~~~~  231 (275)
T cd06608         157 FGVSAQLDSTLG-RRNTFIGTPYWMAPEVIACDEQPDASYDARSDVWSLGITAIELADGKPPLCDMHPMRA----LFKIP  231 (275)
T ss_pred             Cccceecccchh-hhcCccccccccCHhHhcccccccCCccccccHHHhHHHHHHHHhCCCCccccchHHH----HHHhh
Confidence            999876543221 1122346778999998753     3467899999999999999999999964321111    11111


Q ss_pred             cccc-CCCCCHHHHHHHHHHHHHhccCCCCCCCCHHHHHHHH
Q 005586          636 DRNL-KGKFSESEAAKLGKMALVCTHEDPENRPTMEAVIEEL  676 (689)
Q Consensus       636 ~~~~-~~~~~~~~~~~l~~l~~~Cl~~dp~~RPs~~evl~~L  676 (689)
                      .... ....+......+.+++.+|+..||++||++.|++++-
T Consensus       232 ~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rpt~~~ll~~~  273 (275)
T cd06608         232 RNPPPTLKSPENWSKKFNDFISECLIKNYEQRPFMEELLEHP  273 (275)
T ss_pred             ccCCCCCCchhhcCHHHHHHHHHHhhcChhhCcCHHHHhcCC
Confidence            1111 1111233566899999999999999999999998753

Serine/threonine kinases (STKs), Class III myosin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins with an N-terminal kinase catalytic domain and a C-terminal actin-binding motor domain. Class III myosins are present in the photoreceptors of invertebrates and vertebrates and in the auditory hair cells of mammals. The kinase domain of myosin III can phosphorylate several cytoskeletal proteins, conventional myosin regulatory light chains, and can autophosphorylate the C-terminal motor domain. Myosin I

>PHA03211 serine/threonine kinase US3; Provisional

Probab=100.00  E-value=1.2e-36  Score=332.42  Aligned_cols=252  Identities=18%  Similarity=0.223  Sum_probs=193.2

Q ss_pred             hccCCcccccccCCcceEEEEEec-CCcEEEEEEecccCCchHHHHHHHHHHHHhccCCCcceeEeeEEEcCCCCeEEEE
Q 005586          408 TQCFSEVNLLGKGNFSSVYKGTLR-DGTLVAIRSINVTSCKSEEAEFVKGLYLLTSLRHENIIRLRGFCCSRGRGECFLI  486 (689)
Q Consensus       408 t~~f~~~~~lg~G~~g~Vy~~~~~-~g~~vavK~l~~~~~~~~~~~f~~e~~~l~~l~H~niv~l~g~~~~~~~~~~~lV  486 (689)
                      ...|...+.||+|+||.||+|... .++.||||....       ..+.+|++++++++|+|||++++++..  .+..++|
T Consensus       168 ~~gy~i~~~Lg~G~~G~Vy~a~~~~~~~~vavK~~~~-------~~~~~E~~iL~~L~HpnIv~l~~~~~~--~~~~~lv  238 (461)
T PHA03211        168 GLGFAIHRALTPGSEGCVFESSHPDYPQRVVVKAGWY-------ASSVHEARLLRRLSHPAVLALLDVRVV--GGLTCLV  238 (461)
T ss_pred             cCCeEEEEEEccCCCeEEEEEEECCCCCEEEEecccc-------cCHHHHHHHHHHCCCCCCCcEEEEEEE--CCEEEEE
Confidence            346888999999999999999986 588999996432       246789999999999999999999854  4678999


Q ss_pred             EEcCCCCCHHHHhhhcCCCCCCCCHHHHHHHHHHHHHHHhhhhCCCCCCCceeecCCCCCceeecCCCCeEEeccccccc
Q 005586          487 YDFAPKGKLSKYLDQEEGSSNVLDWSTRVSIIIGIAKGIGYLHSSEVNKPAIVHRNLSVEKVLIDQQFNPLIADCGLHKL  566 (689)
Q Consensus       487 ~e~~~~gsL~~~L~~~~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~~~ivH~dlk~~NiLl~~~~~~kl~DfGla~~  566 (689)
                      |||+ .++|.+++....   ..++|.+++.|+.|+++||+|||+.+     |+||||||+|||++.++.+||+|||+++.
T Consensus       239 ~e~~-~~~L~~~l~~~~---~~l~~~~~~~i~~qi~~aL~yLH~~g-----IvHrDLKP~NILl~~~~~vkL~DFGla~~  309 (461)
T PHA03211        239 LPKY-RSDLYTYLGARL---RPLGLAQVTAVARQLLSAIDYIHGEG-----IIHRDIKTENVLVNGPEDICLGDFGAACF  309 (461)
T ss_pred             EEcc-CCCHHHHHHhcC---CCCCHHHHHHHHHHHHHHHHHHHHCC-----EEECcCCHHHEEECCCCCEEEcccCCcee
Confidence            9999 479999886543   24899999999999999999999987     99999999999999999999999999987


Q ss_pred             ccCCcee-eeecCCCCCCCCCccccccCCCCCcccchhHHHHHHHHHhCCCCcchhHHHHH---hhhhhhHhhcc-----
Q 005586          567 LADDIVF-SVLKTSAAMGYLAPEYVTTGRFTERSDIFAFGVIILQILTGSLVLTSSMRLAA---ESATFENFIDR-----  637 (689)
Q Consensus       567 ~~~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~ksDV~sfGvvl~elltG~~p~~~~~~~~~---~~~~~~~~~~~-----  637 (689)
                      ....... ......||..|+|||++.+..++.++|||||||++|||++|..|+........   ....+.+++..     
T Consensus       310 ~~~~~~~~~~~~~~GT~~Y~APE~~~~~~~~~~sDvwSlGviL~El~~g~~~lf~~~~~~~~~~~~~~l~~~i~~~~~~~  389 (461)
T PHA03211        310 ARGSWSTPFHYGIAGTVDTNAPEVLAGDPYTPSVDIWSAGLVIFEAAVHTASLFSASRGDERRPYDAQILRIIRQAQVHV  389 (461)
T ss_pred             cccccccccccccCCCcCCcCHHHHcCCCCCchHHHHHHHHHHHHHHHcCCCcccCCcccccCCcHHHHHHHHHhhcccc
Confidence            6433211 11234588999999999999999999999999999999998865532110000   00000000000     


Q ss_pred             ---------------------ccCCCCC----H---HHHHHHHHHHHHhccCCCCCCCCHHHHHHHHH
Q 005586          638 ---------------------NLKGKFS----E---SEAAKLGKMALVCTHEDPENRPTMEAVIEELT  677 (689)
Q Consensus       638 ---------------------~~~~~~~----~---~~~~~l~~l~~~Cl~~dp~~RPs~~evl~~L~  677 (689)
                                           .......    .   .....+.+++.+|++.||++|||+.|++++-+
T Consensus       390 ~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dli~~mL~~DP~~RPsa~elL~hp~  457 (461)
T PHA03211        390 DEFPQHAGSRLVSQYRHRAARNRRPAYTRPAWTRYYKLDLDVEYLVCRALTFDGARRPSAAELLRLPL  457 (461)
T ss_pred             ccCCCCcchHHHHHHHhhhhcccCCccCCcchhhhccccchHHHHHHHHcccChhhCcCHHHHhhCcc
Confidence                                 0000000    0   11236889999999999999999999998854

>KOG4279 consensus Serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=2.8e-37  Score=324.13  Aligned_cols=245  Identities=27%  Similarity=0.403  Sum_probs=200.9

Q ss_pred             ccccCCcceEEEEEec-CCcEEEEEEecccCCchHHHHHHHHHHHHhccCCCcceeEeeEEEcCCCCeEEEEEEcCCCCC
Q 005586          416 LLGKGNFSSVYKGTLR-DGTLVAIRSINVTSCKSEEAEFVKGLYLLTSLRHENIIRLRGFCCSRGRGECFLIYDFAPKGK  494 (689)
Q Consensus       416 ~lg~G~~g~Vy~~~~~-~g~~vavK~l~~~~~~~~~~~f~~e~~~l~~l~H~niv~l~g~~~~~~~~~~~lV~e~~~~gs  494 (689)
                      +||+|.||+||-|+.. +...+|||.+.... ....+-..+||.+-++++|.|||+++|.|.  .++..-|.||.+|+|+
T Consensus       582 VLGKGTYG~VYA~RD~~tqvrIaIKEIpekd-sr~~QPLhEEIaLH~~LrHkNIVrYLGs~s--enGf~kIFMEqVPGGS  658 (1226)
T KOG4279|consen  582 VLGKGTYGTVYAARDMDTQVRIAIKEIPEKD-SREVQPLHEEIALHSTLRHKNIVRYLGSVS--ENGFFKIFMEQVPGGS  658 (1226)
T ss_pred             EeecCceeEEEeeccccceeEEEeeeccccc-chhhccHHHHHHHHHHHhhHhHHHHhhccC--CCCeEEEEeecCCCCc
Confidence            8999999999999976 46779999998765 344567889999999999999999999884  3578889999999999


Q ss_pred             HHHHhhhcCCCCCCC--CHHHHHHHHHHHHHHHhhhhCCCCCCCceeecCCCCCceeecC-CCCeEEecccccccccCCc
Q 005586          495 LSKYLDQEEGSSNVL--DWSTRVSIIIGIAKGIGYLHSSEVNKPAIVHRNLSVEKVLIDQ-QFNPLIADCGLHKLLADDI  571 (689)
Q Consensus       495 L~~~L~~~~~~~~~l--~~~~~~~ia~~ia~gL~yLH~~~~~~~~ivH~dlk~~NiLl~~-~~~~kl~DfGla~~~~~~~  571 (689)
                      |.++|+.+-+.   +  .+.+.-.+..||++||.|||+..     |||||||-.|||++. .|.+||+|||-++.+..-.
T Consensus       659 LSsLLrskWGP---lKDNEstm~fYtkQILeGLkYLHen~-----IVHRDIKGDNVLvNTySGvlKISDFGTsKRLAgin  730 (1226)
T KOG4279|consen  659 LSSLLRSKWGP---LKDNESTMNFYTKQILEGLKYLHENK-----IVHRDIKGDNVLVNTYSGVLKISDFGTSKRLAGIN  730 (1226)
T ss_pred             HHHHHHhccCC---CccchhHHHHHHHHHHHHhhhhhhcc-----eeeccccCCcEEEeeccceEEecccccchhhccCC
Confidence            99999987652   4  66777788999999999999987     999999999999985 7899999999999876432


Q ss_pred             eeeeecCCCCCCCCCccccccC--CCCCcccchhHHHHHHHHHhCCCCcchhHHHHHhhhhhhHhhccccCCCCCHHHHH
Q 005586          572 VFSVLKTSAAMGYLAPEYVTTG--RFTERSDIFAFGVIILQILTGSLVLTSSMRLAAESATFENFIDRNLKGKFSESEAA  649 (689)
Q Consensus       572 ~~~~~~~~~~~~y~aPE~~~~~--~~~~ksDV~sfGvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  649 (689)
                      .. +....||..|||||++..+  .|..++|||||||.+.||.||++||......   ...+-++---...+.+|++.+.
T Consensus       731 P~-TETFTGTLQYMAPEvIDqG~RGYG~aADIWS~GCT~vEMATGrPPF~Elgsp---qAAMFkVGmyKvHP~iPeelsa  806 (1226)
T KOG4279|consen  731 PC-TETFTGTLQYMAPEVIDQGPRGYGKAADIWSFGCTMVEMATGRPPFVELGSP---QAAMFKVGMYKVHPPIPEELSA  806 (1226)
T ss_pred             cc-ccccccchhhhChHhhccCCcCCCchhhhhhccceeEeeccCCCCeeecCCh---hHhhhhhcceecCCCCcHHHHH
Confidence            22 2235689999999999765  4889999999999999999999999642111   0011111111234567889999


Q ss_pred             HHHHHHHHhccCCCCCCCCHHHHHHH
Q 005586          650 KLGKMALVCTHEDPENRPTMEAVIEE  675 (689)
Q Consensus       650 ~l~~l~~~Cl~~dp~~RPs~~evl~~  675 (689)
                      +...++.+|+.+||.+||++++++++
T Consensus       807 eak~FilrcFepd~~~R~sA~~LL~D  832 (1226)
T KOG4279|consen  807 EAKNFILRCFEPDPCDRPSAKDLLQD  832 (1226)
T ss_pred             HHHHHHHHHcCCCcccCccHHHhccC
Confidence            99999999999999999999999875

>cd06611 STKc_SLK_like Catalytic domain of Ste20-like kinase-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=4e-36  Score=310.45  Aligned_cols=256  Identities=18%  Similarity=0.330  Sum_probs=203.0

Q ss_pred             ccCCcccccccCCcceEEEEEec-CCcEEEEEEecccCCchHHHHHHHHHHHHhccCCCcceeEeeEEEcCCCCeEEEEE
Q 005586          409 QCFSEVNLLGKGNFSSVYKGTLR-DGTLVAIRSINVTSCKSEEAEFVKGLYLLTSLRHENIIRLRGFCCSRGRGECFLIY  487 (689)
Q Consensus       409 ~~f~~~~~lg~G~~g~Vy~~~~~-~g~~vavK~l~~~~~~~~~~~f~~e~~~l~~l~H~niv~l~g~~~~~~~~~~~lV~  487 (689)
                      ++|...+.||+|+||.||+|..+ ++..||+|.+.... ......|.+|++++++++||||+++++++..  ....++||
T Consensus         5 ~~~~i~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~-~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~--~~~~~lv~   81 (280)
T cd06611           5 DIWEIIGELGDGAFGKVYKAQHKETGLFAAAKIIQIES-EEELEDFMVEIDILSECKHPNIVGLYEAYFY--ENKLWILI   81 (280)
T ss_pred             hHHHHHHHhcCCCCceEEEEEEcCCCcEEEEEEEeeCC-HHHHHHHHHHHHHHHhCCCCceeEEEEEEec--CCeEEEEe
Confidence            46777889999999999999975 68999999987553 3445689999999999999999999999854  57889999


Q ss_pred             EcCCCCCHHHHhhhcCCCCCCCCHHHHHHHHHHHHHHHhhhhCCCCCCCceeecCCCCCceeecCCCCeEEecccccccc
Q 005586          488 DFAPKGKLSKYLDQEEGSSNVLDWSTRVSIIIGIAKGIGYLHSSEVNKPAIVHRNLSVEKVLIDQQFNPLIADCGLHKLL  567 (689)
Q Consensus       488 e~~~~gsL~~~L~~~~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~~~ivH~dlk~~NiLl~~~~~~kl~DfGla~~~  567 (689)
                      ||+++++|.+++....   ..+++.....++.|++.||.|||+.+     |+||||||+||+++.++.+||+|||++...
T Consensus        82 e~~~~~~L~~~~~~~~---~~l~~~~~~~~~~ql~~~l~~lh~~~-----i~h~dl~p~nili~~~~~~~l~d~g~~~~~  153 (280)
T cd06611          82 EFCDGGALDSIMLELE---RGLTEPQIRYVCRQMLEALNFLHSHK-----VIHRDLKAGNILLTLDGDVKLADFGVSAKN  153 (280)
T ss_pred             eccCCCcHHHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHHCC-----cccCCCChhhEEECCCCCEEEccCccchhh
Confidence            9999999999987643   24899999999999999999999987     999999999999999999999999998765


Q ss_pred             cCCceeeeecCCCCCCCCCccccc-----cCCCCCcccchhHHHHHHHHHhCCCCcchhHHHHHhhhhhhHhhccc-cCC
Q 005586          568 ADDIVFSVLKTSAAMGYLAPEYVT-----TGRFTERSDIFAFGVIILQILTGSLVLTSSMRLAAESATFENFIDRN-LKG  641 (689)
Q Consensus       568 ~~~~~~~~~~~~~~~~y~aPE~~~-----~~~~~~ksDV~sfGvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~-~~~  641 (689)
                      ..... ......++..|+|||.+.     ...++.++||||||+++|||++|+.|+.......    ....+.... ...
T Consensus       154 ~~~~~-~~~~~~~~~~y~~PE~~~~~~~~~~~~~~~sDi~slG~il~~l~~g~~p~~~~~~~~----~~~~~~~~~~~~~  228 (280)
T cd06611         154 KSTLQ-KRDTFIGTPYWMAPEVVACETFKDNPYDYKADIWSLGITLIELAQMEPPHHELNPMR----VLLKILKSEPPTL  228 (280)
T ss_pred             ccccc-ccceeecchhhcCHHHHhhcccCCCCCCccccHHHHHHHHHHHHhCCCCcccCCHHH----HHHHHhcCCCCCc
Confidence            43221 112234677899999874     3457789999999999999999999986532111    111111110 011


Q ss_pred             CCCHHHHHHHHHHHHHhccCCCCCCCCHHHHHHHHHhhC
Q 005586          642 KFSESEAAKLGKMALVCTHEDPENRPTMEAVIEELTVAA  680 (689)
Q Consensus       642 ~~~~~~~~~l~~l~~~Cl~~dp~~RPs~~evl~~L~~~~  680 (689)
                      ..+...+.++.+++..||+.+|++||++.+++++-+...
T Consensus       229 ~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~~~~~~~  267 (280)
T cd06611         229 DQPSKWSSSFNDFLKSCLVKDPDDRPTAAELLKHPFVSD  267 (280)
T ss_pred             CCcccCCHHHHHHHHHHhccChhhCcCHHHHhcChhhcc
Confidence            122334567889999999999999999999998865543

Serine/threonine kinases (STKs), Ste20-like kinase (SLK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of the subfamily include SLK, STK10 (also called LOK for lymphocyte-oriented kinase), SmSLK (Schistosoma mansoni SLK), and related proteins. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It also plays a role in mediating actin reorganization. STK10 is responsible in regulating the CD28 responsive element in T cells, as well as leukocyte function associated anti

>cd06644 STKc_STK10_LOK Catalytic domain of the Protein Serine/Threonine Kinase, STK10 or Lymphocyte-oriented kinase

Probab=100.00  E-value=7.9e-36  Score=310.30  Aligned_cols=254  Identities=20%  Similarity=0.323  Sum_probs=199.7

Q ss_pred             ccCCcccccccCCcceEEEEEec-CCcEEEEEEecccCCchHHHHHHHHHHHHhccCCCcceeEeeEEEcCCCCeEEEEE
Q 005586          409 QCFSEVNLLGKGNFSSVYKGTLR-DGTLVAIRSINVTSCKSEEAEFVKGLYLLTSLRHENIIRLRGFCCSRGRGECFLIY  487 (689)
Q Consensus       409 ~~f~~~~~lg~G~~g~Vy~~~~~-~g~~vavK~l~~~~~~~~~~~f~~e~~~l~~l~H~niv~l~g~~~~~~~~~~~lV~  487 (689)
                      +.|+..+.||+|+||.||+|+.. ++..|++|.+.... ....+.|.+|++++++++||||+++++++..  ....++||
T Consensus        12 ~~y~i~~~lg~g~~g~vy~~~~~~~~~~~~~k~~~~~~-~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~--~~~~~lv~   88 (292)
T cd06644          12 EVWEIIGELGDGAFGKVYKAKNKETGALAAAKVIETKS-EEELEDYMVEIEILATCNHPYIVKLLGAFYW--DGKLWIMI   88 (292)
T ss_pred             hhhhhhheecCCCCeEEEEEEECCCCceEEEEEeccCC-HHHHHHHHHHHHHHHhCCCCcEeeeEEEEEe--CCeEEEEE
Confidence            45667789999999999999976 58999999987653 3455789999999999999999999998854  46799999


Q ss_pred             EcCCCCCHHHHhhhcCCCCCCCCHHHHHHHHHHHHHHHhhhhCCCCCCCceeecCCCCCceeecCCCCeEEecccccccc
Q 005586          488 DFAPKGKLSKYLDQEEGSSNVLDWSTRVSIIIGIAKGIGYLHSSEVNKPAIVHRNLSVEKVLIDQQFNPLIADCGLHKLL  567 (689)
Q Consensus       488 e~~~~gsL~~~L~~~~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~~~ivH~dlk~~NiLl~~~~~~kl~DfGla~~~  567 (689)
                      ||+++++|..++.....   .+++..+..++.|++.||+|||+.+     ++||||||+||+++.++.+||+|||++...
T Consensus        89 e~~~~~~l~~~~~~~~~---~l~~~~~~~~~~ql~~~l~~lH~~~-----i~H~dlkp~Nili~~~~~~kl~dfg~~~~~  160 (292)
T cd06644          89 EFCPGGAVDAIMLELDR---GLTEPQIQVICRQMLEALQYLHSMK-----IIHRDLKAGNVLLTLDGDIKLADFGVSAKN  160 (292)
T ss_pred             ecCCCCcHHHHHHhhcC---CCCHHHHHHHHHHHHHHHHHHhcCC-----eeecCCCcceEEEcCCCCEEEccCccceec
Confidence            99999999988865432   4899999999999999999999987     999999999999999999999999998754


Q ss_pred             cCCceeeeecCCCCCCCCCccccc-----cCCCCCcccchhHHHHHHHHHhCCCCcchhHHHHHhhhhhhHhhcccc-CC
Q 005586          568 ADDIVFSVLKTSAAMGYLAPEYVT-----TGRFTERSDIFAFGVIILQILTGSLVLTSSMRLAAESATFENFIDRNL-KG  641 (689)
Q Consensus       568 ~~~~~~~~~~~~~~~~y~aPE~~~-----~~~~~~ksDV~sfGvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~-~~  641 (689)
                      ..... ......++..|+|||++.     ...++.++|||||||++|||++|+.|+.......    ...+...... ..
T Consensus       161 ~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slG~il~el~~g~~p~~~~~~~~----~~~~~~~~~~~~~  235 (292)
T cd06644         161 VKTLQ-RRDSFIGTPYWMAPEVVMCETMKDTPYDYKADIWSLGITLIEMAQIEPPHHELNPMR----VLLKIAKSEPPTL  235 (292)
T ss_pred             ccccc-ccceecCCccccCceeeccccccCCCCCchhhhHhHHHHHHHHhcCCCCCccccHHH----HHHHHhcCCCccC
Confidence            33211 112234667899999985     3456889999999999999999999986432111    1111111110 01


Q ss_pred             CCCHHHHHHHHHHHHHhccCCCCCCCCHHHHHHHHHh
Q 005586          642 KFSESEAAKLGKMALVCTHEDPENRPTMEAVIEELTV  678 (689)
Q Consensus       642 ~~~~~~~~~l~~l~~~Cl~~dp~~RPs~~evl~~L~~  678 (689)
                      ..+...+.++.+++.+||+.+|++||++.|++++-..
T Consensus       236 ~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~~~~~  272 (292)
T cd06644         236 SQPSKWSMEFRDFLKTALDKHPETRPSAAQLLEHPFV  272 (292)
T ss_pred             CCCcccCHHHHHHHHHHhcCCcccCcCHHHHhcCccc
Confidence            1223445678999999999999999999999986543

Serine/threonine kinases (STKs), STK10 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Other names for STK10 include lymphocyte-oriented kinase (LOK) and Xenopus polo-like kinase kinase 1 (xPlkk1). STK10 is highly expressed in lymphocytes and is responsible in regulating leukocyte function associated antigen (LFA-1)-mediated lymphocyte adhesion. It plays a role in regulating the CD28 responsive element in T cells, and may also function as a regulator of polo-like kinase 1 (Plk1), a protein which is overexpressed in multiple tumor types.

>cd07867 STKc_CDC2L6 Catalytic domain of Serine/Threonine Kinase, Cell Division Cycle 2-like 6

Probab=100.00  E-value=2.8e-36  Score=317.54  Aligned_cols=254  Identities=23%  Similarity=0.349  Sum_probs=189.0

Q ss_pred             ccccccCCcceEEEEEec---CCcEEEEEEecccCCchHHHHHHHHHHHHhccCCCcceeEeeEEEcCCCCeEEEEEEcC
Q 005586          414 VNLLGKGNFSSVYKGTLR---DGTLVAIRSINVTSCKSEEAEFVKGLYLLTSLRHENIIRLRGFCCSRGRGECFLIYDFA  490 (689)
Q Consensus       414 ~~~lg~G~~g~Vy~~~~~---~g~~vavK~l~~~~~~~~~~~f~~e~~~l~~l~H~niv~l~g~~~~~~~~~~~lV~e~~  490 (689)
                      ...||+|+||.||+|..+   ++..||+|.+....   ....+.+|++++++++||||+++++++........++||||+
T Consensus         6 g~~lG~G~~g~Vy~~~~~~~~~~~~~a~k~~~~~~---~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~lv~e~~   82 (317)
T cd07867           6 GCKVGRGTYGHVYKAKRKDGKDEKEYALKQIEGTG---ISMSACREIALLRELKHPNVIALQKVFLSHSDRKVWLLFDYA   82 (317)
T ss_pred             ceEeccCCCeeEEEEEecCCCccceEEEEEecCCC---CcHHHHHHHHHHHhCCCCCeeeEEEEEeccCCCeEEEEEeee
Confidence            368999999999999975   45789999987543   234678899999999999999999998766667889999999


Q ss_pred             CCCCHHHHhhhcCC-----CCCCCCHHHHHHHHHHHHHHHhhhhCCCCCCCceeecCCCCCceee----cCCCCeEEecc
Q 005586          491 PKGKLSKYLDQEEG-----SSNVLDWSTRVSIIIGIAKGIGYLHSSEVNKPAIVHRNLSVEKVLI----DQQFNPLIADC  561 (689)
Q Consensus       491 ~~gsL~~~L~~~~~-----~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~~~ivH~dlk~~NiLl----~~~~~~kl~Df  561 (689)
                      + ++|.+++.....     ....+++..+..++.|++.||+|||+.+     |+||||||+|||+    ++++.+||+||
T Consensus        83 ~-~~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~lH~~~-----ivH~Dlkp~Nil~~~~~~~~~~~kl~Df  156 (317)
T cd07867          83 E-HDLWHIIKFHRASKANKKPMQLPRSMVKSLLYQILDGIHYLHANW-----VLHRDLKPANILVMGEGPERGRVKIADM  156 (317)
T ss_pred             C-CcHHHHHHhhhccccCCCCccCCHHHHHHHHHHHHHHHHHHHhCC-----EEcCCCCHHHEEEccCCCCCCcEEEeec
Confidence            6 578887753221     1235889999999999999999999987     9999999999999    56789999999


Q ss_pred             cccccccCCce--eeeecCCCCCCCCCcccccc-CCCCCcccchhHHHHHHHHHhCCCCcchhHHHHH-----hh-----
Q 005586          562 GLHKLLADDIV--FSVLKTSAAMGYLAPEYVTT-GRFTERSDIFAFGVIILQILTGSLVLTSSMRLAA-----ES-----  628 (689)
Q Consensus       562 Gla~~~~~~~~--~~~~~~~~~~~y~aPE~~~~-~~~~~ksDV~sfGvvl~elltG~~p~~~~~~~~~-----~~-----  628 (689)
                      |+++.......  .......+|..|+|||++.+ ..++.++|||||||++|||+||+.||........     ..     
T Consensus       157 G~a~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~il~el~tg~~~f~~~~~~~~~~~~~~~~~~~~  236 (317)
T cd07867         157 GFARLFNSPLKPLADLDPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTSEPIFHCRQEDIKTSNPFHHDQLDR  236 (317)
T ss_pred             cceeccCCCcccccccCcceecccccCcHHhcCCCccCcHHHHHhHHHHHHHHHhCCCCcccccccccccccccHHHHHH
Confidence            99987654321  11223356788999999876 4579999999999999999999999853211000     00     


Q ss_pred             ----------hhhhHh---------hccccCCCC------------CHHHHHHHHHHHHHhccCCCCCCCCHHHHHHHH
Q 005586          629 ----------ATFENF---------IDRNLKGKF------------SESEAAKLGKMALVCTHEDPENRPTMEAVIEEL  676 (689)
Q Consensus       629 ----------~~~~~~---------~~~~~~~~~------------~~~~~~~l~~l~~~Cl~~dp~~RPs~~evl~~L  676 (689)
                                ..+.++         ........+            .......+.+++.+|++.||++|||+.|++++.
T Consensus       237 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~~l~~dP~~R~t~~e~l~hp  315 (317)
T cd07867         237 IFSVMGFPADKDWEDIRKMPEYPTLQKDFRRTTYANSSLIKYMEKHKVKPDSKVFLLLQKLLTMDPTKRITSEQALQDP  315 (317)
T ss_pred             HHHhcCCCChhhhhhhhhcccchhhhhhhcccccCCchhhhhhhcccCCCChHHHHHHHHHhccCcccccCHHHHhcCC
Confidence                      000000         000000000            001134578899999999999999999999763

Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 6 (CDC2L6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L6 is also called CDK8-like and was previously referred to as CDK11. However, this is a confusing nomenclature as CDC2L6 is distinct from CDC2L1, which is represented by the two protein products from its gene, called CDK11(p110) and CDK11(p58), as well as

>cd06658 STKc_PAK5 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 5

Probab=100.00  E-value=2.4e-36  Score=314.14  Aligned_cols=252  Identities=15%  Similarity=0.321  Sum_probs=199.4

Q ss_pred             cccccccCCcceEEEEEec-CCcEEEEEEecccCCchHHHHHHHHHHHHhccCCCcceeEeeEEEcCCCCeEEEEEEcCC
Q 005586          413 EVNLLGKGNFSSVYKGTLR-DGTLVAIRSINVTSCKSEEAEFVKGLYLLTSLRHENIIRLRGFCCSRGRGECFLIYDFAP  491 (689)
Q Consensus       413 ~~~~lg~G~~g~Vy~~~~~-~g~~vavK~l~~~~~~~~~~~f~~e~~~l~~l~H~niv~l~g~~~~~~~~~~~lV~e~~~  491 (689)
                      ....||+|+||.||++... ++..||||++.... ......+.+|+..+..++|+||+++++.+..  .+..++||||++
T Consensus        26 ~~~~lg~g~~g~v~~~~~~~~~~~vaiK~~~~~~-~~~~~~~~~e~~~l~~l~h~~ii~~~~~~~~--~~~~~lv~e~~~  102 (292)
T cd06658          26 SFIKIGEGSTGIVCIATEKHTGKQVAVKKMDLRK-QQRRELLFNEVVIMRDYHHENVVDMYNSYLV--GDELWVVMEFLE  102 (292)
T ss_pred             hhhcccCCCCeEEEEEEECCCCCEEEEEEEecch-HHHHHHHHHHHHHHHhCCCCcHHHHHHheec--CCeEEEEEeCCC
Confidence            3467999999999999875 68899999986543 3445678999999999999999999998854  578899999999


Q ss_pred             CCCHHHHhhhcCCCCCCCCHHHHHHHHHHHHHHHhhhhCCCCCCCceeecCCCCCceeecCCCCeEEecccccccccCCc
Q 005586          492 KGKLSKYLDQEEGSSNVLDWSTRVSIIIGIAKGIGYLHSSEVNKPAIVHRNLSVEKVLIDQQFNPLIADCGLHKLLADDI  571 (689)
Q Consensus       492 ~gsL~~~L~~~~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~~~ivH~dlk~~NiLl~~~~~~kl~DfGla~~~~~~~  571 (689)
                      +++|.+++...     .+++.++..++.|++.||+|||+.+     |+||||||+||++++++.+||+|||++.......
T Consensus       103 ~~~L~~~~~~~-----~l~~~~~~~~~~qi~~~l~~LH~~~-----ivH~dlkp~Nill~~~~~~kL~dfg~~~~~~~~~  172 (292)
T cd06658         103 GGALTDIVTHT-----RMNEEQIATVCLSVLRALSYLHNQG-----VIHRDIKSDSILLTSDGRIKLSDFGFCAQVSKEV  172 (292)
T ss_pred             CCcHHHHHhcC-----CCCHHHHHHHHHHHHHHHHHHHHCC-----EeecCCCHHHEEEcCCCCEEEccCcchhhccccc
Confidence            99999988542     3889999999999999999999987     9999999999999999999999999987654322


Q ss_pred             eeeeecCCCCCCCCCccccccCCCCCcccchhHHHHHHHHHhCCCCcchhHHHHHhhhhhhHhhccccCCCCCHHHHHHH
Q 005586          572 VFSVLKTSAAMGYLAPEYVTTGRFTERSDIFAFGVIILQILTGSLVLTSSMRLAAESATFENFIDRNLKGKFSESEAAKL  651 (689)
Q Consensus       572 ~~~~~~~~~~~~y~aPE~~~~~~~~~ksDV~sfGvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l  651 (689)
                      . ......++..|+|||+..+..++.++|||||||++|||++|+.|+......... ..+...+.+...  ........+
T Consensus       173 ~-~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slGvil~el~~g~~p~~~~~~~~~~-~~~~~~~~~~~~--~~~~~~~~~  248 (292)
T cd06658         173 P-KRKSLVGTPYWMAPEVISRLPYGTEVDIWSLGIMVIEMIDGEPPYFNEPPLQAM-RRIRDNLPPRVK--DSHKVSSVL  248 (292)
T ss_pred             c-cCceeecCccccCHHHHccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHH-HHHHhcCCCccc--cccccCHHH
Confidence            1 112234677899999998888999999999999999999999998643221111 111111111111  112335578


Q ss_pred             HHHHHHhccCCCCCCCCHHHHHHHHHhhCC
Q 005586          652 GKMALVCTHEDPENRPTMEAVIEELTVAAP  681 (689)
Q Consensus       652 ~~l~~~Cl~~dp~~RPs~~evl~~L~~~~p  681 (689)
                      .+++..|+..||++||++.|++++-+....
T Consensus       249 ~~li~~~l~~~P~~Rpt~~~il~~~~~~~~  278 (292)
T cd06658         249 RGFLDLMLVREPSQRATAQELLQHPFLKLA  278 (292)
T ss_pred             HHHHHHHccCChhHCcCHHHHhhChhhhcc
Confidence            899999999999999999999998655533

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 5, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK5 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK5 is mainly express

>cd07844 STKc_PCTAIRE_like Catalytic domain of PCTAIRE-like Serine/Threonine Kinases

Probab=100.00  E-value=5.2e-36  Score=311.46  Aligned_cols=256  Identities=19%  Similarity=0.366  Sum_probs=194.7

Q ss_pred             ccCCcccccccCCcceEEEEEec-CCcEEEEEEecccCCchHHHHHHHHHHHHhccCCCcceeEeeEEEcCCCCeEEEEE
Q 005586          409 QCFSEVNLLGKGNFSSVYKGTLR-DGTLVAIRSINVTSCKSEEAEFVKGLYLLTSLRHENIIRLRGFCCSRGRGECFLIY  487 (689)
Q Consensus       409 ~~f~~~~~lg~G~~g~Vy~~~~~-~g~~vavK~l~~~~~~~~~~~f~~e~~~l~~l~H~niv~l~g~~~~~~~~~~~lV~  487 (689)
                      ++|+..+.||+|+||.||+|..+ +++.||+|.+...........+.+|++++++++|+||+++++++..  .+..++||
T Consensus         5 ~~y~~~~~lg~g~~~~vy~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~--~~~~~lv~   82 (291)
T cd07844           5 ETYKKLDKLGEGSYATVYKGRSKLTGQLVALKEIRLEHEEGAPFTAIREASLLKDLKHANIVTLHDIIHT--KKTLTLVF   82 (291)
T ss_pred             cceeEEEEEeecCCeEEEEEEEcCCCcEEEEEEEecccccCCchhHHHHHHHHhhCCCcceeeEEEEEec--CCeEEEEE
Confidence            46778899999999999999976 6899999998765433334567889999999999999999999853  57899999


Q ss_pred             EcCCCCCHHHHhhhcCCCCCCCCHHHHHHHHHHHHHHHhhhhCCCCCCCceeecCCCCCceeecCCCCeEEecccccccc
Q 005586          488 DFAPKGKLSKYLDQEEGSSNVLDWSTRVSIIIGIAKGIGYLHSSEVNKPAIVHRNLSVEKVLIDQQFNPLIADCGLHKLL  567 (689)
Q Consensus       488 e~~~~gsL~~~L~~~~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~~~ivH~dlk~~NiLl~~~~~~kl~DfGla~~~  567 (689)
                      ||++ ++|.+++.....   .+++.....++.|+++||.|||+.+     |+||||||+||++++++.+||+|||+++..
T Consensus        83 e~~~-~~L~~~~~~~~~---~~~~~~~~~~~~ql~~al~~lH~~~-----i~H~dl~p~nil~~~~~~~kl~dfg~~~~~  153 (291)
T cd07844          83 EYLD-TDLKQYMDDCGG---GLSMHNVRLFLFQLLRGLAYCHQRR-----VLHRDLKPQNLLISERGELKLADFGLARAK  153 (291)
T ss_pred             ecCC-CCHHHHHHhCCC---CCCHHHHHHHHHHHHHHHHHHHhCC-----eecccCCHHHEEEcCCCCEEECcccccccc
Confidence            9997 599999876432   4889999999999999999999987     999999999999999999999999998754


Q ss_pred             cCCceeeeecCCCCCCCCCcccccc-CCCCCcccchhHHHHHHHHHhCCCCcchhHHHHHhhhhh------------hHh
Q 005586          568 ADDIVFSVLKTSAAMGYLAPEYVTT-GRFTERSDIFAFGVIILQILTGSLVLTSSMRLAAESATF------------ENF  634 (689)
Q Consensus       568 ~~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~ksDV~sfGvvl~elltG~~p~~~~~~~~~~~~~~------------~~~  634 (689)
                      ..... ......++..|+|||++.+ ..++.++|||||||++|||++|+.||.............            ...
T Consensus       154 ~~~~~-~~~~~~~~~~~~aPE~~~~~~~~~~~~Dv~slG~il~~l~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  232 (291)
T cd07844         154 SVPSK-TYSNEVVTLWYRPPDVLLGSTEYSTSLDMWGVGCIFYEMATGRPLFPGSTDVEDQLHKIFRVLGTPTEETWPGV  232 (291)
T ss_pred             CCCCc-cccccccccccCCcHHhhcCcccCcHHHHHHHHHHHHHHHhCCCCCCCCccHHHHHHHHHHhcCCCChhhhhhh
Confidence            32211 1112235678999998865 457899999999999999999999985432110000000            000


Q ss_pred             hc------cccCCCCC-------HHH--HHHHHHHHHHhccCCCCCCCCHHHHHHHH
Q 005586          635 ID------RNLKGKFS-------ESE--AAKLGKMALVCTHEDPENRPTMEAVIEEL  676 (689)
Q Consensus       635 ~~------~~~~~~~~-------~~~--~~~l~~l~~~Cl~~dp~~RPs~~evl~~L  676 (689)
                      .+      .......+       ...  ...+.+++..|++.+|++||++.|++++.
T Consensus       233 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~~p~~Rps~~e~l~~~  289 (291)
T cd07844         233 SSNPEFKPYSFPFYPPRPLINHAPRLDRIPHGEELALKFLQYEPKKRISAAEAMKHP  289 (291)
T ss_pred             hhccccccccccccCChhHHHhCcCCCCchhHHHHHHHHhccCcccccCHHHHhcCC
Confidence            00      00000000       011  26778999999999999999999998753

Serine/Threonine Kinases (STKs), PCTAIRE-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily share sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. The association of PCTAIRE-like proteins with cyclins has not been widely studied, although PFTAIRE-1 has been shown to function as a CDK which is regulated by cyclin D3 as well as the

>cd07846 STKc_CDKL2_3 Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 2 and 3

Probab=100.00  E-value=1.9e-36  Score=313.76  Aligned_cols=255  Identities=22%  Similarity=0.358  Sum_probs=197.3

Q ss_pred             ccCCcccccccCCcceEEEEEec-CCcEEEEEEecccCCc-hHHHHHHHHHHHHhccCCCcceeEeeEEEcCCCCeEEEE
Q 005586          409 QCFSEVNLLGKGNFSSVYKGTLR-DGTLVAIRSINVTSCK-SEEAEFVKGLYLLTSLRHENIIRLRGFCCSRGRGECFLI  486 (689)
Q Consensus       409 ~~f~~~~~lg~G~~g~Vy~~~~~-~g~~vavK~l~~~~~~-~~~~~f~~e~~~l~~l~H~niv~l~g~~~~~~~~~~~lV  486 (689)
                      ++|+..+.||+|+||.||+|..+ +++.||+|++...... .....+.+|+++++.++||||+++++++.  ..+..++|
T Consensus         1 ~~y~~~~~lg~g~~~~vy~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~--~~~~~~lv   78 (286)
T cd07846           1 EKYENLGLVGEGSYGMVMKCKHKETGQIVAIKKFLESEDDKMVKKIAMREIRMLKQLRHENLVNLIEVFR--RKKRLYLV   78 (286)
T ss_pred             CceeEeeeeccCCCeEEEEEEECCCCCEEEEEeHhhccCcchhhHHHHHHHHHHHhcCCcchhhHHHhcc--cCCeEEEE
Confidence            35778899999999999999986 5899999998754432 23457889999999999999999999984  45789999


Q ss_pred             EEcCCCCCHHHHhhhcCCCCCCCCHHHHHHHHHHHHHHHhhhhCCCCCCCceeecCCCCCceeecCCCCeEEeccccccc
Q 005586          487 YDFAPKGKLSKYLDQEEGSSNVLDWSTRVSIIIGIAKGIGYLHSSEVNKPAIVHRNLSVEKVLIDQQFNPLIADCGLHKL  566 (689)
Q Consensus       487 ~e~~~~gsL~~~L~~~~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~~~ivH~dlk~~NiLl~~~~~~kl~DfGla~~  566 (689)
                      |||+++++|.++.....    .++|..++.++.|++.||+|||+.+     |+||||+|+||++++++.+||+|||+++.
T Consensus        79 ~e~~~~~~l~~~~~~~~----~~~~~~~~~~~~~i~~~l~~LH~~~-----i~h~~l~p~ni~~~~~~~~~l~dfg~~~~  149 (286)
T cd07846          79 FEFVDHTVLDDLEKYPN----GLDESRVRKYLFQILRGIEFCHSHN-----IIHRDIKPENILVSQSGVVKLCDFGFART  149 (286)
T ss_pred             EecCCccHHHHHHhccC----CCCHHHHHHHHHHHHHHHHHHHHCC-----ccccCCCHHHEEECCCCcEEEEeeeeeee
Confidence            99999999988775432    3899999999999999999999987     99999999999999999999999999886


Q ss_pred             ccCCceeeeecCCCCCCCCCcccccc-CCCCCcccchhHHHHHHHHHhCCCCcchhHHHHHhhhhh----------hHh-
Q 005586          567 LADDIVFSVLKTSAAMGYLAPEYVTT-GRFTERSDIFAFGVIILQILTGSLVLTSSMRLAAESATF----------ENF-  634 (689)
Q Consensus       567 ~~~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~ksDV~sfGvvl~elltG~~p~~~~~~~~~~~~~~----------~~~-  634 (689)
                      ...... ......++..|+|||++.+ ..++.++|||||||++|||++|+.|+.............          .+. 
T Consensus       150 ~~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~el~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  228 (286)
T cd07846         150 LAAPGE-VYTDYVATRWYRAPELLVGDTKYGRAVDIWAVGCLVTEMLTGEPLFPGDSDIDQLYHIIKCLGNLIPRHQEIF  228 (286)
T ss_pred             ccCCcc-ccCcccceeeccCcHHhccccccCchHhHHHHHHHHHHHHcCCCCCCCCchHHHHHHHHHHhCCCchhhHHHh
Confidence            644321 1122346778999999865 457889999999999999999998885432111100000          000 


Q ss_pred             -----hccccCCCC---------CHHHHHHHHHHHHHhccCCCCCCCCHHHHHHH
Q 005586          635 -----IDRNLKGKF---------SESEAAKLGKMALVCTHEDPENRPTMEAVIEE  675 (689)
Q Consensus       635 -----~~~~~~~~~---------~~~~~~~l~~l~~~Cl~~dp~~RPs~~evl~~  675 (689)
                           ++.......         ....+..+.+++.+||+.+|++||++.+++++
T Consensus       229 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rp~~~~il~~  283 (286)
T cd07846         229 QKNPLFAGMRLPEVKEIEPLEKRFPKLSGLVLDLAKQCLRIDPDDRPSSSQLLHH  283 (286)
T ss_pred             ccchHhhccccccccCcchHHHhCCCcCHHHHHHHHHHhcCCcccchhHHHHhcC
Confidence                 000000000         11235679999999999999999999999876

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 2 (CDKL2) and CDKL3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL2 and CDKL3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL2, also called p56 KKIAMRE, is expressed in testis, kidney, lung, and brain. It functions mainly in mature neurons and plays an important role in learning and memory. Inactivation of CDKL3, also called NKI

>cd07861 STKc_CDK1_euk Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 1 from higher eukaryotes-like

Probab=100.00  E-value=3.7e-36  Score=311.44  Aligned_cols=256  Identities=23%  Similarity=0.378  Sum_probs=195.7

Q ss_pred             cCCcccccccCCcceEEEEEec-CCcEEEEEEecccCC-chHHHHHHHHHHHHhccCCCcceeEeeEEEcCCCCeEEEEE
Q 005586          410 CFSEVNLLGKGNFSSVYKGTLR-DGTLVAIRSINVTSC-KSEEAEFVKGLYLLTSLRHENIIRLRGFCCSRGRGECFLIY  487 (689)
Q Consensus       410 ~f~~~~~lg~G~~g~Vy~~~~~-~g~~vavK~l~~~~~-~~~~~~f~~e~~~l~~l~H~niv~l~g~~~~~~~~~~~lV~  487 (689)
                      +|...+.||+|+||.||+|..+ +|..||+|++..... ......+.+|+.++.+++||||+++++++..  ....++||
T Consensus         1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~--~~~~~~v~   78 (285)
T cd07861           1 DYTKIEKIGEGTYGVVYKGRNKKTGQIVAMKKIRLESEEEGVPSTAIREISLLKELQHPNIVCLQDVLMQ--ESRLYLIF   78 (285)
T ss_pred             CceEeeEecccCceEEEEEEECCCCcEEEEEEeccccccCCchHHHHHHHHHHHhcCCCCEeeeEEEEee--CCeEEEEE
Confidence            3667789999999999999975 689999999875432 2234678899999999999999999999854  57899999


Q ss_pred             EcCCCCCHHHHhhhcCCCCCCCCHHHHHHHHHHHHHHHhhhhCCCCCCCceeecCCCCCceeecCCCCeEEecccccccc
Q 005586          488 DFAPKGKLSKYLDQEEGSSNVLDWSTRVSIIIGIAKGIGYLHSSEVNKPAIVHRNLSVEKVLIDQQFNPLIADCGLHKLL  567 (689)
Q Consensus       488 e~~~~gsL~~~L~~~~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~~~ivH~dlk~~NiLl~~~~~~kl~DfGla~~~  567 (689)
                      ||++ ++|.+++..... ...+++..+..++.|+++||+|||+.+     |+||||||+||++++++.+||+|||+++..
T Consensus        79 e~~~-~~l~~~~~~~~~-~~~~~~~~~~~~~~qi~~~L~~lH~~~-----i~H~dl~p~nil~~~~~~~~l~dfg~~~~~  151 (285)
T cd07861          79 EFLS-MDLKKYLDSLPK-GQYMDAELVKSYLYQILQGILFCHSRR-----VLHRDLKPQNLLIDNKGVIKLADFGLARAF  151 (285)
T ss_pred             ecCC-CCHHHHHhcCCC-CCcCCHHHHHHHHHHHHHHHHHHHhCC-----eeecCCCHHHEEEcCCCcEEECcccceeec
Confidence            9997 689988865432 235899999999999999999999987     999999999999999999999999998765


Q ss_pred             cCCceeeeecCCCCCCCCCccccccC-CCCCcccchhHHHHHHHHHhCCCCcchhHHHHHhhhhh---------------
Q 005586          568 ADDIVFSVLKTSAAMGYLAPEYVTTG-RFTERSDIFAFGVIILQILTGSLVLTSSMRLAAESATF---------------  631 (689)
Q Consensus       568 ~~~~~~~~~~~~~~~~y~aPE~~~~~-~~~~ksDV~sfGvvl~elltG~~p~~~~~~~~~~~~~~---------------  631 (689)
                      ..... ......++..|+|||.+.+. .++.++|||||||++|||+||+.|+............+               
T Consensus       152 ~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~~l~tg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  230 (285)
T cd07861         152 GIPVR-VYTHEVVTLWYRAPEVLLGSPRYSTPVDIWSIGTIFAEMATKKPLFHGDSEIDQLFRIFRILGTPTEDVWPGVT  230 (285)
T ss_pred             CCCcc-cccCCcccccccChHHhcCCCCcCcHHHHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHHHhCCCChhhhhcch
Confidence            43211 11223456789999987654 57899999999999999999999986432111100000               


Q ss_pred             -----hHhhccccCC---CCCHHHHHHHHHHHHHhccCCCCCCCCHHHHHHH
Q 005586          632 -----ENFIDRNLKG---KFSESEAAKLGKMALVCTHEDPENRPTMEAVIEE  675 (689)
Q Consensus       632 -----~~~~~~~~~~---~~~~~~~~~l~~l~~~Cl~~dp~~RPs~~evl~~  675 (689)
                           ....+.....   ......+.++.+++.+|++.||++||++.+|+++
T Consensus       231 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rpt~~~ll~~  282 (285)
T cd07861         231 SLPDYKNTFPKWKKGSLRSAVKNLDEDGLDLLEKMLIYDPAKRISAKKALNH  282 (285)
T ss_pred             hhHHHHhhccccCcchhHHhcCCCCHHHHHHHHHHhcCChhhCCCHHHHhcC
Confidence                 0000000000   0011235577899999999999999999999876

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyclin A complex controls G2

>cd06626 STKc_MEKK4 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 4

Probab=100.00  E-value=8.4e-36  Score=305.00  Aligned_cols=251  Identities=22%  Similarity=0.392  Sum_probs=200.7

Q ss_pred             cCCcccccccCCcceEEEEEec-CCcEEEEEEecccCCc-hHHHHHHHHHHHHhccCCCcceeEeeEEEcCCCCeEEEEE
Q 005586          410 CFSEVNLLGKGNFSSVYKGTLR-DGTLVAIRSINVTSCK-SEEAEFVKGLYLLTSLRHENIIRLRGFCCSRGRGECFLIY  487 (689)
Q Consensus       410 ~f~~~~~lg~G~~g~Vy~~~~~-~g~~vavK~l~~~~~~-~~~~~f~~e~~~l~~l~H~niv~l~g~~~~~~~~~~~lV~  487 (689)
                      +|...+.||+|+||.||+|... +++.|++|.+...... ...+.+..|++++++++|+||+++++++.  ..+..++|+
T Consensus         1 ~y~~~~~lg~G~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~~~~l~~~~i~~~~~~~~--~~~~~~lv~   78 (264)
T cd06626           1 RWQRGNKIGGGTFGKVYTAVNLDTGELMAVKEIRIQDNDPKTIKEIADEMKVLELLKHPNLVKYYGVEV--HREKVYIFM   78 (264)
T ss_pred             CceeeeEeecCCCcEEEEEEECCCCcEEEEEEEECcccchHHHHHHHHHHHHHHhCCCCChhheeeeEe--cCCEEEEEE
Confidence            4677789999999999999875 6899999999866532 35678999999999999999999999874  357899999


Q ss_pred             EcCCCCCHHHHhhhcCCCCCCCCHHHHHHHHHHHHHHHhhhhCCCCCCCceeecCCCCCceeecCCCCeEEecccccccc
Q 005586          488 DFAPKGKLSKYLDQEEGSSNVLDWSTRVSIIIGIAKGIGYLHSSEVNKPAIVHRNLSVEKVLIDQQFNPLIADCGLHKLL  567 (689)
Q Consensus       488 e~~~~gsL~~~L~~~~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~~~ivH~dlk~~NiLl~~~~~~kl~DfGla~~~  567 (689)
                      ||+++++|.+++....    .+++..+..|+.+++.||+|||+.+     |+|+||+|+||++++++.+||+|||++...
T Consensus        79 e~~~~~~L~~~~~~~~----~~~~~~~~~i~~~i~~~l~~lh~~~-----i~H~dl~~~nil~~~~~~~kl~d~g~~~~~  149 (264)
T cd06626          79 EYCSGGTLEELLEHGR----ILDEHVIRVYTLQLLEGLAYLHSHG-----IVHRDIKPANIFLDHNGVIKLGDFGCAVKL  149 (264)
T ss_pred             ecCCCCcHHHHHhhcC----CCChHHHHHHHHHHHHHHHHHHHCC-----cccCCCCHHHEEECCCCCEEEccccccccc
Confidence            9999999999997642    3788999999999999999999987     999999999999999999999999999876


Q ss_pred             cCCceeee---ecCCCCCCCCCccccccCC---CCCcccchhHHHHHHHHHhCCCCcchhHHHHHhhhhhhHhhccccCC
Q 005586          568 ADDIVFSV---LKTSAAMGYLAPEYVTTGR---FTERSDIFAFGVIILQILTGSLVLTSSMRLAAESATFENFIDRNLKG  641 (689)
Q Consensus       568 ~~~~~~~~---~~~~~~~~y~aPE~~~~~~---~~~ksDV~sfGvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~  641 (689)
                      ........   ....++..|+|||++.+..   ++.++||||||+++||+++|+.||..............    .....
T Consensus       150 ~~~~~~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~~~~Dv~s~G~il~~l~~g~~pf~~~~~~~~~~~~~~----~~~~~  225 (264)
T cd06626         150 KNNTTTMGEEVQSLAGTPAYMAPEVITGGKGKGHGRAADIWSLGCVVLEMATGKRPWSELDNEFQIMFHVG----AGHKP  225 (264)
T ss_pred             CCCCCcccccccCCcCCcCccChhhccCCCCCCCCcccchHHHHHHHHHHHhCCCCccCCcchHHHHHHHh----cCCCC
Confidence            54322111   1234677899999988766   88999999999999999999999964321111100000    01111


Q ss_pred             CCCHH--HHHHHHHHHHHhccCCCCCCCCHHHHHHH
Q 005586          642 KFSES--EAAKLGKMALVCTHEDPENRPTMEAVIEE  675 (689)
Q Consensus       642 ~~~~~--~~~~l~~l~~~Cl~~dp~~RPs~~evl~~  675 (689)
                      ..+..  ....+.+++..||+.+|++||++.|++.+
T Consensus       226 ~~~~~~~~~~~~~~li~~~l~~~p~~R~~~~~i~~~  261 (264)
T cd06626         226 PIPDSLQLSPEGKDFLDRCLESDPKKRPTASELLQH  261 (264)
T ss_pred             CCCcccccCHHHHHHHHHHccCCcccCCCHHHHhcC
Confidence            22222  26678899999999999999999999865

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 4 (MEKK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK4 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK4 activates the c-Jun N-terminal kinase (JNK) and p38 MAPK signaling pathways by directly activating their respective MAPKKs, MKK4

>cd06623 PKc_MAPKK_plant_like Catalytic domain of Plant dual-specificity MAP kinase kinases and similar proteins

Probab=100.00  E-value=8e-36  Score=305.03  Aligned_cols=254  Identities=20%  Similarity=0.375  Sum_probs=206.6

Q ss_pred             cCCcccccccCCcceEEEEEec-CCcEEEEEEecccCCchHHHHHHHHHHHHhccCCCcceeEeeEEEcCCCCeEEEEEE
Q 005586          410 CFSEVNLLGKGNFSSVYKGTLR-DGTLVAIRSINVTSCKSEEAEFVKGLYLLTSLRHENIIRLRGFCCSRGRGECFLIYD  488 (689)
Q Consensus       410 ~f~~~~~lg~G~~g~Vy~~~~~-~g~~vavK~l~~~~~~~~~~~f~~e~~~l~~l~H~niv~l~g~~~~~~~~~~~lV~e  488 (689)
                      +|...+.||+|++|.||+|..+ ++..|++|++..........+|.+|++.+.+++|+||+++++++..  ....++|||
T Consensus         2 ~~~~~~~i~~g~~~~v~~~~~~~~~~~~~vk~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~--~~~~~lv~e   79 (264)
T cd06623           2 DLERVKVLGQGSSGVVYKVRHKPTGKIYALKKIHVDGDEEFRKQLLRELKTLRSCESPYVVKCYGAFYK--EGEISIVLE   79 (264)
T ss_pred             cceeeeeeeecCCeEEEEEEEcCCCcEEEEEEeccCcchHHHHHHHHHHHHHHhcCCCCeeeEEEEEcc--CCeEEEEEE
Confidence            5777899999999999999987 5999999999876543456789999999999999999999999854  478999999


Q ss_pred             cCCCCCHHHHhhhcCCCCCCCCHHHHHHHHHHHHHHHhhhhC-CCCCCCceeecCCCCCceeecCCCCeEEecccccccc
Q 005586          489 FAPKGKLSKYLDQEEGSSNVLDWSTRVSIIIGIAKGIGYLHS-SEVNKPAIVHRNLSVEKVLIDQQFNPLIADCGLHKLL  567 (689)
Q Consensus       489 ~~~~gsL~~~L~~~~~~~~~l~~~~~~~ia~~ia~gL~yLH~-~~~~~~~ivH~dlk~~NiLl~~~~~~kl~DfGla~~~  567 (689)
                      |+++++|.+++...    ..+++..++.++.|+++||+|||+ .+     ++||||+|+||++++++.++|+|||++...
T Consensus        80 ~~~~~~L~~~l~~~----~~l~~~~~~~~~~~l~~~l~~lh~~~~-----~~H~~l~~~ni~~~~~~~~~l~df~~~~~~  150 (264)
T cd06623          80 YMDGGSLADLLKKV----GKIPEPVLAYIARQILKGLDYLHTKRH-----IIHRDIKPSNLLINSKGEVKIADFGISKVL  150 (264)
T ss_pred             ecCCCcHHHHHHHc----CCCCHHHHHHHHHHHHHHHHHHhccCC-----CccCCCCHHHEEECCCCCEEEccCccceec
Confidence            99999999999764    248999999999999999999999 87     999999999999999999999999999876


Q ss_pred             cCCceeeeecCCCCCCCCCccccccCCCCCcccchhHHHHHHHHHhCCCCcchhHHHHHhhhhhhHhhccccCCCCCHH-
Q 005586          568 ADDIVFSVLKTSAAMGYLAPEYVTTGRFTERSDIFAFGVIILQILTGSLVLTSSMRLAAESATFENFIDRNLKGKFSES-  646 (689)
Q Consensus       568 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~ksDV~sfGvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-  646 (689)
                      ....... ....++..|+|||.+.+..++.++||||||+++|||+||+.|+....+. ........+.. ......+.. 
T Consensus       151 ~~~~~~~-~~~~~~~~y~~pE~~~~~~~~~~~Dv~slG~il~~l~tg~~p~~~~~~~-~~~~~~~~~~~-~~~~~~~~~~  227 (264)
T cd06623         151 ENTLDQC-NTFVGTVTYMSPERIQGESYSYAADIWSLGLTLLECALGKFPFLPPGQP-SFFELMQAICD-GPPPSLPAEE  227 (264)
T ss_pred             ccCCCcc-cceeecccccCHhhhCCCCCCchhhHHHHHHHHHHHHhCCCCCcccccc-CHHHHHHHHhc-CCCCCCCccc
Confidence            5432211 1234567899999999888999999999999999999999998654310 00111111111 111222333 


Q ss_pred             HHHHHHHHHHHhccCCCCCCCCHHHHHHHHH
Q 005586          647 EAAKLGKMALVCTHEDPENRPTMEAVIEELT  677 (689)
Q Consensus       647 ~~~~l~~l~~~Cl~~dp~~RPs~~evl~~L~  677 (689)
                      .+..+.+++..|++.+|++||++.|++++-+
T Consensus       228 ~~~~l~~li~~~l~~~p~~R~~~~~ll~~~~  258 (264)
T cd06623         228 FSPEFRDFISACLQKDPKKRPSAAELLQHPF  258 (264)
T ss_pred             CCHHHHHHHHHHccCChhhCCCHHHHHhCHH
Confidence            5678999999999999999999999998743

Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, Plant MAPKKs and similar proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of

>PTZ00284 protein kinase; Provisional

Probab=100.00  E-value=3.8e-36  Score=333.11  Aligned_cols=261  Identities=17%  Similarity=0.235  Sum_probs=194.9

Q ss_pred             HHHHHHhccCCcccccccCCcceEEEEEec-CCcEEEEEEecccCCchHHHHHHHHHHHHhccCC------CcceeEeeE
Q 005586          402 EEVESATQCFSEVNLLGKGNFSSVYKGTLR-DGTLVAIRSINVTSCKSEEAEFVKGLYLLTSLRH------ENIIRLRGF  474 (689)
Q Consensus       402 ~~l~~at~~f~~~~~lg~G~~g~Vy~~~~~-~g~~vavK~l~~~~~~~~~~~f~~e~~~l~~l~H------~niv~l~g~  474 (689)
                      +++...+++|...+.||+|+||.||+|... .++.||||+++...  ....++..|++++.+++|      .+++.++++
T Consensus       122 ~~~~~~~~~y~i~~~lG~G~fg~V~~a~~~~~~~~vAvK~i~~~~--~~~~~~~~e~~~l~~l~~~~~~~~~~i~~i~~~  199 (467)
T PTZ00284        122 EDIDVSTQRFKILSLLGEGTFGKVVEAWDRKRKEYCAVKIVRNVP--KYTRDAKIEIQFMEKVRQADPADRFPLMKIQRY  199 (467)
T ss_pred             CccccCCCcEEEEEEEEeccCEEEEEEEEcCCCeEEEEEEEecch--hhHHHHHHHHHHHHHHhhcCcccCcceeeeEEE
Confidence            344456788999999999999999999875 68899999996432  223345567777666654      458899988


Q ss_pred             EEcCCCCeEEEEEEcCCCCCHHHHhhhcCCCCCCCCHHHHHHHHHHHHHHHhhhhC-CCCCCCceeecCCCCCceeecCC
Q 005586          475 CCSRGRGECFLIYDFAPKGKLSKYLDQEEGSSNVLDWSTRVSIIIGIAKGIGYLHS-SEVNKPAIVHRNLSVEKVLIDQQ  553 (689)
Q Consensus       475 ~~~~~~~~~~lV~e~~~~gsL~~~L~~~~~~~~~l~~~~~~~ia~~ia~gL~yLH~-~~~~~~~ivH~dlk~~NiLl~~~  553 (689)
                      +... ....++|||++ +++|.+++....    .+++..+..|+.||+.||+|||+ .+     ||||||||+|||++.+
T Consensus       200 ~~~~-~~~~~iv~~~~-g~~l~~~l~~~~----~l~~~~~~~i~~qi~~aL~yLH~~~g-----IiHrDlKP~NILl~~~  268 (467)
T PTZ00284        200 FQNE-TGHMCIVMPKY-GPCLLDWIMKHG----PFSHRHLAQIIFQTGVALDYFHTELH-----LMHTDLKPENILMETS  268 (467)
T ss_pred             EEcC-CceEEEEEecc-CCCHHHHHHHcC----CCCHHHHHHHHHHHHHHHHHHHhcCC-----eecCCCCHHHEEEecC
Confidence            8543 45789999998 778999887643    48999999999999999999997 46     9999999999999876


Q ss_pred             C----------------CeEEecccccccccCCceeeeecCCCCCCCCCccccccCCCCCcccchhHHHHHHHHHhCCCC
Q 005586          554 F----------------NPLIADCGLHKLLADDIVFSVLKTSAAMGYLAPEYVTTGRFTERSDIFAFGVIILQILTGSLV  617 (689)
Q Consensus       554 ~----------------~~kl~DfGla~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~ksDV~sfGvvl~elltG~~p  617 (689)
                      +                .+||+|||.+......    .....+|..|+|||++.+..++.++|||||||++|||+||+.|
T Consensus       269 ~~~~~~~~~~~~~~~~~~vkl~DfG~~~~~~~~----~~~~~gt~~Y~APE~~~~~~~~~~~DiwSlGvil~elltG~~p  344 (467)
T PTZ00284        269 DTVVDPVTNRALPPDPCRVRICDLGGCCDERHS----RTAIVSTRHYRSPEVVLGLGWMYSTDMWSMGCIIYELYTGKLL  344 (467)
T ss_pred             CcccccccccccCCCCceEEECCCCccccCccc----cccccCCccccCcHHhhcCCCCcHHHHHHHHHHHHHHHhCCCC
Confidence            5                4999999987643221    2234578899999999999999999999999999999999999


Q ss_pred             cchhHHHHHhhh-------------------hhhHhhccc--cCCCCC---------------HHHHHHHHHHHHHhccC
Q 005586          618 LTSSMRLAAESA-------------------TFENFIDRN--LKGKFS---------------ESEAAKLGKMALVCTHE  661 (689)
Q Consensus       618 ~~~~~~~~~~~~-------------------~~~~~~~~~--~~~~~~---------------~~~~~~l~~l~~~Cl~~  661 (689)
                      |...........                   ...++.+..  +.....               ......+.+++..|++.
T Consensus       345 f~~~~~~~~~~~i~~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dli~~mL~~  424 (467)
T PTZ00284        345 YDTHDNLEHLHLMEKTLGRLPSEWAGRCGTEEARLLYNSAGQLRPCTDPKHLARIARARPVREVIRDDLLCDLIYGLLHY  424 (467)
T ss_pred             CCCCChHHHHHHHHHHcCCCCHHHHhhccchhHHHHhhhcccccccCCHHHHHhhhcccchhhhhchHHHHHHHHHhCCc
Confidence            964321110000                   000011100  000000               01234577999999999


Q ss_pred             CCCCCCCHHHHHHHHHhh
Q 005586          662 DPENRPTMEAVIEELTVA  679 (689)
Q Consensus       662 dp~~RPs~~evl~~L~~~  679 (689)
                      ||++|||++|+++|-+..
T Consensus       425 dP~~R~ta~e~L~Hp~~~  442 (467)
T PTZ00284        425 DRQKRLNARQMTTHPYVL  442 (467)
T ss_pred             ChhhCCCHHHHhcCcccc
Confidence            999999999999986654

>cd06917 STKc_NAK1_like Catalytic domain of Fungal Nak1-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=7.6e-36  Score=307.86  Aligned_cols=253  Identities=21%  Similarity=0.419  Sum_probs=201.9

Q ss_pred             cCCcccccccCCcceEEEEEec-CCcEEEEEEecccCCchHHHHHHHHHHHHhccC---CCcceeEeeEEEcCCCCeEEE
Q 005586          410 CFSEVNLLGKGNFSSVYKGTLR-DGTLVAIRSINVTSCKSEEAEFVKGLYLLTSLR---HENIIRLRGFCCSRGRGECFL  485 (689)
Q Consensus       410 ~f~~~~~lg~G~~g~Vy~~~~~-~g~~vavK~l~~~~~~~~~~~f~~e~~~l~~l~---H~niv~l~g~~~~~~~~~~~l  485 (689)
                      .|+..+.||+|+||.||+|... ++..||+|.+..........++.+|++++++++   |||++++++++..  ....++
T Consensus         2 ~y~~~~~l~~g~~g~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~e~~~l~~l~~~~~~~vi~~~~~~~~--~~~~~l   79 (277)
T cd06917           2 LYQRLELIGRGAYGAVYRGKHVPTGRVVALKIINLDTPDDDVSDIQREVALLSQLRQSQPPNITKYYGSYLK--GPRLWI   79 (277)
T ss_pred             hhhhhhheeccCCceEEEEEEcCCCcEEEEEEecCCCCchhHHHHHHHHHHHHHhccCCCCCeeeEeeeeee--CCEEEE
Confidence            3666789999999999999974 789999999876554455667889999999997   9999999998854  467899


Q ss_pred             EEEcCCCCCHHHHhhhcCCCCCCCCHHHHHHHHHHHHHHHhhhhCCCCCCCceeecCCCCCceeecCCCCeEEecccccc
Q 005586          486 IYDFAPKGKLSKYLDQEEGSSNVLDWSTRVSIIIGIAKGIGYLHSSEVNKPAIVHRNLSVEKVLIDQQFNPLIADCGLHK  565 (689)
Q Consensus       486 V~e~~~~gsL~~~L~~~~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~~~ivH~dlk~~NiLl~~~~~~kl~DfGla~  565 (689)
                      ||||+++++|.+++...     .+++...+.++.|++.||.|||+.+     |+||||+|+||++++++.++|+|||++.
T Consensus        80 v~e~~~~~~L~~~~~~~-----~l~~~~~~~i~~~i~~~l~~lh~~~-----i~H~dl~p~ni~i~~~~~~~l~dfg~~~  149 (277)
T cd06917          80 IMEYAEGGSVRTLMKAG-----PIAEKYISVIIREVLVALKYIHKVG-----VIHRDIKAANILVTNTGNVKLCDFGVAA  149 (277)
T ss_pred             EEecCCCCcHHHHHHcc-----CCCHHHHHHHHHHHHHHHHHHHhCC-----cccCCcCHHHEEEcCCCCEEEccCCcee
Confidence            99999999999998643     4899999999999999999999987     9999999999999999999999999998


Q ss_pred             cccCCceeeeecCCCCCCCCCccccccC-CCCCcccchhHHHHHHHHHhCCCCcchhHHHHHhhhhhhHhhccccCCCCC
Q 005586          566 LLADDIVFSVLKTSAAMGYLAPEYVTTG-RFTERSDIFAFGVIILQILTGSLVLTSSMRLAAESATFENFIDRNLKGKFS  644 (689)
Q Consensus       566 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~-~~~~ksDV~sfGvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~  644 (689)
                      .+..... ......++..|+|||.+.++ .++.++|||||||++|||++|+.|+........    .. .+........+
T Consensus       150 ~~~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~~ll~g~~p~~~~~~~~~----~~-~~~~~~~~~~~  223 (277)
T cd06917         150 LLNQNSS-KRSTFVGTPYWMAPEVITEGKYYDTKADIWSLGITIYEMATGNPPYSDVDAFRA----MM-LIPKSKPPRLE  223 (277)
T ss_pred             ecCCCcc-ccccccCCcceeCHHHhccCCccccchhHHHHHHHHHHHHhCCCCCCCCChhhh----hh-ccccCCCCCCC
Confidence            7654331 12233577789999988654 468999999999999999999999964322111    00 00011111111


Q ss_pred             H-HHHHHHHHHHHHhccCCCCCCCCHHHHHHHHHhhC
Q 005586          645 E-SEAAKLGKMALVCTHEDPENRPTMEAVIEELTVAA  680 (689)
Q Consensus       645 ~-~~~~~l~~l~~~Cl~~dp~~RPs~~evl~~L~~~~  680 (689)
                      . ..+.++.+++.+|++.||++||++.|++++-+...
T Consensus       224 ~~~~~~~~~~~i~~~l~~~p~~R~~~~~il~~~~~~~  260 (277)
T cd06917         224 DNGYSKLLREFVAACLDEEPKERLSAEELLKSKWIKA  260 (277)
T ss_pred             cccCCHHHHHHHHHHcCCCcccCcCHHHHhhChHhhc
Confidence            1 24567899999999999999999999998765543

Serine/threonine kinases (STKs), Nak1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nak1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of Schizosaccharomyces pombe Nak1, Saccharomyces cerevisiae Kic1p (kinase that interacts with Cdc31p) and related proteins. Nak1 (also known as N-rich kinase 1), is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Kic1p is required by budding yeast for cell integrity and morphogenesis. Kic1p interacts with Cdc31p, the yeast homologue of cent

>cd08220 STKc_Nek8 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 8

Probab=100.00  E-value=8.7e-36  Score=303.43  Aligned_cols=250  Identities=22%  Similarity=0.397  Sum_probs=201.1

Q ss_pred             cCCcccccccCCcceEEEEEec-CCcEEEEEEecccCC-chHHHHHHHHHHHHhccCCCcceeEeeEEEcCCCCeEEEEE
Q 005586          410 CFSEVNLLGKGNFSSVYKGTLR-DGTLVAIRSINVTSC-KSEEAEFVKGLYLLTSLRHENIIRLRGFCCSRGRGECFLIY  487 (689)
Q Consensus       410 ~f~~~~~lg~G~~g~Vy~~~~~-~g~~vavK~l~~~~~-~~~~~~f~~e~~~l~~l~H~niv~l~g~~~~~~~~~~~lV~  487 (689)
                      +|...+.||+|+||.||++... ++..+|+|++..... ......+.+|++++++++|||++++++.+..  .+..++||
T Consensus         1 ~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~--~~~~~lv~   78 (256)
T cd08220           1 KYEKIRVVGRGAFGIVHLCRRKADQKLVIIKQIPVEQMTKDERLAAQNECQVLKLLSHPNIIEYYENFLE--DKALMIVM   78 (256)
T ss_pred             CceEEEEecccCceEEEEEEEcCCCcEEEEEEEeccccccHHHHHHHHHHHHHhhCCCCchhheeeeEec--CCEEEEEE
Confidence            4677889999999999999875 688999999876532 3345689999999999999999999998743  57899999


Q ss_pred             EcCCCCCHHHHhhhcCCCCCCCCHHHHHHHHHHHHHHHhhhhCCCCCCCceeecCCCCCceeecCC-CCeEEeccccccc
Q 005586          488 DFAPKGKLSKYLDQEEGSSNVLDWSTRVSIIIGIAKGIGYLHSSEVNKPAIVHRNLSVEKVLIDQQ-FNPLIADCGLHKL  566 (689)
Q Consensus       488 e~~~~gsL~~~L~~~~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~~~ivH~dlk~~NiLl~~~-~~~kl~DfGla~~  566 (689)
                      ||+++++|.+++.....  ..+++..+..++.+++.||+|||+.+     |+||||||+||+++++ +.+||+|||+++.
T Consensus        79 e~~~~~~L~~~~~~~~~--~~~~~~~~~~~~~~i~~~l~~lh~~~-----i~h~dl~~~nil~~~~~~~~~l~d~~~~~~  151 (256)
T cd08220          79 EYAPGGTLAEYIQKRCN--SLLDEDTILHFFVQILLALHHVHTKL-----ILHRDLKTQNILLDKHKMVVKIGDFGISKI  151 (256)
T ss_pred             ecCCCCCHHHHHHHhcc--cCCCHHHHHHHHHHHHHHHHHHHhCC-----eecCCCCHHHEEEcCCCCEEEEccCCCcee
Confidence            99999999999976432  34899999999999999999999987     9999999999999865 4689999999987


Q ss_pred             ccCCceeeeecCCCCCCCCCccccccCCCCCcccchhHHHHHHHHHhCCCCcchhHHHHHhhhhhhHhhccccCCCCCHH
Q 005586          567 LADDIVFSVLKTSAAMGYLAPEYVTTGRFTERSDIFAFGVIILQILTGSLVLTSSMRLAAESATFENFIDRNLKGKFSES  646 (689)
Q Consensus       567 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~ksDV~sfGvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  646 (689)
                      ......  .....++..|+|||.+.+..++.++||||||+++|||++|+.|+........    ...... ......+..
T Consensus       152 ~~~~~~--~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~~l~~~~~~~~~~~~~~~----~~~~~~-~~~~~~~~~  224 (256)
T cd08220         152 LSSKSK--AYTVVGTPCYISPELCEGKPYNQKSDIWALGCVLYELASLKRAFEAANLPAL----VLKIMS-GTFAPISDR  224 (256)
T ss_pred             cCCCcc--ccccccCCcccCchhccCCCCCcccchHHHHHHHHHHHhCCCCcccCchHHH----HHHHHh-cCCCCCCCC
Confidence            654321  1123467789999999888899999999999999999999999865322111    111111 111123334


Q ss_pred             HHHHHHHHHHHhccCCCCCCCCHHHHHHH
Q 005586          647 EAAKLGKMALVCTHEDPENRPTMEAVIEE  675 (689)
Q Consensus       647 ~~~~l~~l~~~Cl~~dp~~RPs~~evl~~  675 (689)
                      ....+.+++..||+.+|++||++.|++++
T Consensus       225 ~~~~l~~li~~~l~~~p~~Rpt~~~ll~~  253 (256)
T cd08220         225 YSPDLRQLILSMLNLDPSKRPQLSQIMAQ  253 (256)
T ss_pred             cCHHHHHHHHHHccCChhhCCCHHHHhhC
Confidence            56679999999999999999999999876

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 8 (Nek8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek8 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek8 contains an N-terminal kinase catalytic domain and a C-terminal RCC1 (regulator of chromosome condensation) domain. A double point mutation in Nek8 causes cystic kidney disease in mice that genetically resembles human autosomal recessive polycystic kidney disease (ARPKD). Nek8 is also associated with

>cd07870 STKc_PFTAIRE2 Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-2 kinase

Probab=100.00  E-value=8.1e-36  Score=310.05  Aligned_cols=257  Identities=20%  Similarity=0.336  Sum_probs=195.4

Q ss_pred             HhccCCcccccccCCcceEEEEEec-CCcEEEEEEecccCCchHHHHHHHHHHHHhccCCCcceeEeeEEEcCCCCeEEE
Q 005586          407 ATQCFSEVNLLGKGNFSSVYKGTLR-DGTLVAIRSINVTSCKSEEAEFVKGLYLLTSLRHENIIRLRGFCCSRGRGECFL  485 (689)
Q Consensus       407 at~~f~~~~~lg~G~~g~Vy~~~~~-~g~~vavK~l~~~~~~~~~~~f~~e~~~l~~l~H~niv~l~g~~~~~~~~~~~l  485 (689)
                      ++++|...+.||+|+||.||+|... +|..||+|++...........+.+|+.++++++|+||+++.+++..  .+..++
T Consensus         3 ~~~~y~~~~~ig~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~--~~~~~l   80 (291)
T cd07870           3 AATSYLNLEKLGEGSYATVYKGISRINGQLVALKVISMKTEEGVPFTAIREASLLKGLKHANIVLLHDIIHT--KETLTF   80 (291)
T ss_pred             ccceeEEEEEEEecCCEEEEEEEEcCCCcEEEEEEecccCcCCCcHHHHHHHHHHHhcCCCCEeEEEEEEec--CCeEEE
Confidence            4567888999999999999999875 6899999999765434444567899999999999999999999854  467899


Q ss_pred             EEEcCCCCCHHHHhhhcCCCCCCCCHHHHHHHHHHHHHHHhhhhCCCCCCCceeecCCCCCceeecCCCCeEEecccccc
Q 005586          486 IYDFAPKGKLSKYLDQEEGSSNVLDWSTRVSIIIGIAKGIGYLHSSEVNKPAIVHRNLSVEKVLIDQQFNPLIADCGLHK  565 (689)
Q Consensus       486 V~e~~~~gsL~~~L~~~~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~~~ivH~dlk~~NiLl~~~~~~kl~DfGla~  565 (689)
                      |+||++ ++|.+++....   ..+++..+..++.|++.||+|||+.+     |+||||||+||+++.++.+||+|||+++
T Consensus        81 v~e~~~-~~l~~~~~~~~---~~~~~~~~~~~~~qi~~~L~~lH~~~-----i~H~dlkp~Nil~~~~~~~~l~Dfg~~~  151 (291)
T cd07870          81 VFEYMH-TDLAQYMIQHP---GGLHPYNVRLFMFQLLRGLAYIHGQH-----ILHRDLKPQNLLISYLGELKLADFGLAR  151 (291)
T ss_pred             EEeccc-CCHHHHHHhCC---CCCCHHHHHHHHHHHHHHHHHHHhCC-----cccCCCChHHEEEcCCCcEEEecccccc
Confidence            999995 78877775432   23788888999999999999999987     9999999999999999999999999987


Q ss_pred             cccCCceeeeecCCCCCCCCCccccccC-CCCCcccchhHHHHHHHHHhCCCCcchhHHHHHhhhhhh------------
Q 005586          566 LLADDIVFSVLKTSAAMGYLAPEYVTTG-RFTERSDIFAFGVIILQILTGSLVLTSSMRLAAESATFE------------  632 (689)
Q Consensus       566 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~-~~~~ksDV~sfGvvl~elltG~~p~~~~~~~~~~~~~~~------------  632 (689)
                      ....... ......++..|+|||.+.+. .++.++|||||||++|||+||+.||..............            
T Consensus       152 ~~~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~~l~~g~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~  230 (291)
T cd07870         152 AKSIPSQ-TYSSEVVTLWYRPPDVLLGATDYSSALDIWGAGCIFIEMLQGQPAFPGVSDVFEQLEKIWTVLGVPTEDTWP  230 (291)
T ss_pred             ccCCCCC-CCCCccccccccCCceeecCCCCCcHHHHHHHHHHHHHHHhCCCCCCCchhHHHHHHHHHHHcCCCChhhhh
Confidence            6533211 11223457789999998754 578899999999999999999999864322111000000            


Q ss_pred             ------HhhccccCCCCC---------HHHHHHHHHHHHHhccCCCCCCCCHHHHHHH
Q 005586          633 ------NFIDRNLKGKFS---------ESEAAKLGKMALVCTHEDPENRPTMEAVIEE  675 (689)
Q Consensus       633 ------~~~~~~~~~~~~---------~~~~~~l~~l~~~Cl~~dp~~RPs~~evl~~  675 (689)
                            ...........+         ......+.+++.+|++.||++|||+.|++.+
T Consensus       231 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~~l~~dp~~R~t~~~~l~h  288 (291)
T cd07870         231 GVSKLPNYKPEWFLPCKPQQLRVVWKRLSRPPKAEDLASQMLMMFPKDRISAQDALLH  288 (291)
T ss_pred             hhhhcccccchhccccCCcchhhhccccCCChHHHHHHHHHhCcCcccCcCHHHHhcC
Confidence                  000000000000         0124578899999999999999999999875

Serine/Threonine Kinases (STKs), PFTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-2 is also referred to as ALS2CR7 (amyotrophic lateral sclerosis 2 (juvenile) chromosome region candidate 7). It may be associated with amyotrophic lateral sclerosis 2 (ALS2), an autosomal recess

>KOG0032 consensus Ca2+/calmodulin-dependent protein kinase, EF-Hand protein superfamily [Signal transduction mechanisms]

Probab=100.00  E-value=7e-36  Score=315.23  Aligned_cols=256  Identities=20%  Similarity=0.329  Sum_probs=214.7

Q ss_pred             hccCCcccccccCCcceEEEEEecC-CcEEEEEEecccCCch--HHHHHHHHHHHHhccC-CCcceeEeeEEEcCCCCeE
Q 005586          408 TQCFSEVNLLGKGNFSSVYKGTLRD-GTLVAIRSINVTSCKS--EEAEFVKGLYLLTSLR-HENIIRLRGFCCSRGRGEC  483 (689)
Q Consensus       408 t~~f~~~~~lg~G~~g~Vy~~~~~~-g~~vavK~l~~~~~~~--~~~~f~~e~~~l~~l~-H~niv~l~g~~~~~~~~~~  483 (689)
                      .+.|...+.||+|.||.||+++.+. |+.+|+|.+.+.....  ......+|+.+|+++. |||||.+.+.+  +.....
T Consensus        34 ~~~Y~l~~~lG~G~Fg~v~~~~~~~tg~~~A~K~i~k~~~~~~~~~~~v~~Ev~il~~l~~hpniv~l~~~~--e~~~~~  111 (382)
T KOG0032|consen   34 KEKYELGRELGRGQFGVVYLCREKSTGKEVACKVIPKRKLRGKEDREDVRREVAILQQLSGHPNIVQLKDAF--EDPDSV  111 (382)
T ss_pred             cccEEehhhhCCCCceEEEEEEecCCCceeEEEEeehhhccccccHHHHHHHHHHHHhccCCCCEEEEEEEE--EcCCeE
Confidence            3456777899999999999999874 9999999998766433  3468899999999998 99999999999  445789


Q ss_pred             EEEEEcCCCCCHHHHhhhcCCCCCCCCHHHHHHHHHHHHHHHhhhhCCCCCCCceeecCCCCCceeecCC----CCeEEe
Q 005586          484 FLIYDFAPKGKLSKYLDQEEGSSNVLDWSTRVSIIIGIAKGIGYLHSSEVNKPAIVHRNLSVEKVLIDQQ----FNPLIA  559 (689)
Q Consensus       484 ~lV~e~~~~gsL~~~L~~~~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~~~ivH~dlk~~NiLl~~~----~~~kl~  559 (689)
                      ++|||++.+|.|.+.+...    . +++.....++.|++.++.|||+.+     |+||||||+|+|+...    +.+|++
T Consensus       112 ~lvmEL~~GGeLfd~i~~~----~-~sE~da~~~~~~il~av~~lH~~g-----vvHrDlKpEN~L~~~~~~~~~~ik~~  181 (382)
T KOG0032|consen  112 YLVMELCEGGELFDRIVKK----H-YSERDAAGIIRQILEAVKYLHSLG-----VVHRDLKPENLLLASKDEGSGRIKLI  181 (382)
T ss_pred             EEEEEecCCchHHHHHHHc----c-CCHHHHHHHHHHHHHHHHHHHhCC-----ceeccCCHHHeeeccccCCCCcEEEe
Confidence            9999999999999999765    1 889999999999999999999988     9999999999999743    479999


Q ss_pred             cccccccccCCceeeeecCCCCCCCCCccccccCCCCCcccchhHHHHHHHHHhCCCCcchhHHHHHhhhhhhHhhcc--
Q 005586          560 DCGLHKLLADDIVFSVLKTSAAMGYLAPEYVTTGRFTERSDIFAFGVIILQILTGSLVLTSSMRLAAESATFENFIDR--  637 (689)
Q Consensus       560 DfGla~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~ksDV~sfGvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~--  637 (689)
                      |||+++.....  .......||+.|+|||++....|+.++||||.||++|.|++|..||........    +..+...  
T Consensus       182 DFGla~~~~~~--~~~~~~~Gtp~y~APEvl~~~~y~~~~DiWS~Gvi~yiLL~G~~PF~~~~~~~~----~~~i~~~~~  255 (382)
T KOG0032|consen  182 DFGLAKFIKPG--ERLHTIVGTPEYVAPEVLGGRPYGDEVDVWSIGVILYILLSGVPPFWGETEFEI----FLAILRGDF  255 (382)
T ss_pred             eCCCceEccCC--ceEeeecCCccccCchhhcCCCCCcccchhHHHHHHHHHhhCCCCCcCCChhHH----HHHHHcCCC
Confidence            99999988763  244567799999999999999999999999999999999999999976543222    1222222  


Q ss_pred             ccCCCCCHHHHHHHHHHHHHhccCCCCCCCCHHHHHHHHHhhCC
Q 005586          638 NLKGKFSESEAAKLGKMALVCTHEDPENRPTMEAVIEELTVAAP  681 (689)
Q Consensus       638 ~~~~~~~~~~~~~l~~l~~~Cl~~dp~~RPs~~evl~~L~~~~p  681 (689)
                      ..........+..+.+++..|+..||.+|+++.++++|.|....
T Consensus       256 ~f~~~~w~~is~~akd~i~~ll~~dp~~R~ta~~~L~HpWi~~~  299 (382)
T KOG0032|consen  256 DFTSEPWDDISESAKDFIRKLLEFDPRKRLTAAQALQHPWIKSI  299 (382)
T ss_pred             CCCCCCccccCHHHHHHHHHhcccCcccCCCHHHHhcCccccCC
Confidence            22333445668889999999999999999999999999775544

>cd06607 STKc_TAO Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids proteins

Probab=100.00  E-value=1.7e-35  Score=310.23  Aligned_cols=252  Identities=21%  Similarity=0.373  Sum_probs=199.3

Q ss_pred             ccCCcccccccCCcceEEEEEec-CCcEEEEEEecccCC--chHHHHHHHHHHHHhccCCCcceeEeeEEEcCCCCeEEE
Q 005586          409 QCFSEVNLLGKGNFSSVYKGTLR-DGTLVAIRSINVTSC--KSEEAEFVKGLYLLTSLRHENIIRLRGFCCSRGRGECFL  485 (689)
Q Consensus       409 ~~f~~~~~lg~G~~g~Vy~~~~~-~g~~vavK~l~~~~~--~~~~~~f~~e~~~l~~l~H~niv~l~g~~~~~~~~~~~l  485 (689)
                      +.|...+.||+|+||.||+|... +|+.||+|++.....  ....+++.+|++++++++||||+++.++|..  .+..++
T Consensus        15 ~~y~~~~~lg~g~~g~vy~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~~Ei~~l~~l~h~niv~~~~~~~~--~~~~~l   92 (307)
T cd06607          15 KLFTDLREIGHGSFGAVYFARDVRTNEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQQLRHPNTIEYKGCYLR--EHTAWL   92 (307)
T ss_pred             hhhhhheeecCCCCeEEEEEEEcCCCcEEEEEEEeccccCcHHHHHHHHHHHHHHHhCCCCCEEEEEEEEEe--CCeEEE
Confidence            45777889999999999999875 689999999865432  2334678999999999999999999999954  467899


Q ss_pred             EEEcCCCCCHHHHhhhcCCCCCCCCHHHHHHHHHHHHHHHhhhhCCCCCCCceeecCCCCCceeecCCCCeEEecccccc
Q 005586          486 IYDFAPKGKLSKYLDQEEGSSNVLDWSTRVSIIIGIAKGIGYLHSSEVNKPAIVHRNLSVEKVLIDQQFNPLIADCGLHK  565 (689)
Q Consensus       486 V~e~~~~gsL~~~L~~~~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~~~ivH~dlk~~NiLl~~~~~~kl~DfGla~  565 (689)
                      ||||++ |++.+++....   ..+++..+..++.|++.||.|||+.+     |+||||+|+||++++++.+||+|||+++
T Consensus        93 v~e~~~-g~l~~~~~~~~---~~l~~~~~~~~~~ql~~~L~~LH~~~-----i~H~dl~p~nIl~~~~~~~kL~dfg~~~  163 (307)
T cd06607          93 VMEYCL-GSASDILEVHK---KPLQEVEIAAICHGALQGLAYLHSHE-----RIHRDIKAGNILLTEPGTVKLADFGSAS  163 (307)
T ss_pred             EHHhhC-CCHHHHHHHcc---cCCCHHHHHHHHHHHHHHHHHHHHCC-----ceecCCCcccEEECCCCCEEEeecCcce
Confidence            999996 67877776433   24899999999999999999999987     9999999999999999999999999987


Q ss_pred             cccCCceeeeecCCCCCCCCCccccc---cCCCCCcccchhHHHHHHHHHhCCCCcchhHHHHHhhhhhhHhhccccCCC
Q 005586          566 LLADDIVFSVLKTSAAMGYLAPEYVT---TGRFTERSDIFAFGVIILQILTGSLVLTSSMRLAAESATFENFIDRNLKGK  642 (689)
Q Consensus       566 ~~~~~~~~~~~~~~~~~~y~aPE~~~---~~~~~~ksDV~sfGvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~  642 (689)
                      ......     ...++..|+|||++.   ...++.++||||||+++|||+||+.|+.........    ...........
T Consensus       164 ~~~~~~-----~~~~~~~y~aPE~~~~~~~~~~~~~sDv~s~G~il~el~tg~~p~~~~~~~~~~----~~~~~~~~~~~  234 (307)
T cd06607         164 LVSPAN-----SFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSAL----YHIAQNDSPTL  234 (307)
T ss_pred             ecCCCC-----CccCCccccCceeeeccCCCCCCcccchHHHHHHHHHHHcCCCCCCCccHHHHH----HHHhcCCCCCC
Confidence            654321     234667899999874   456889999999999999999999998643221110    01111111111


Q ss_pred             CCHHHHHHHHHHHHHhccCCCCCCCCHHHHHHHHHhhC
Q 005586          643 FSESEAAKLGKMALVCTHEDPENRPTMEAVIEELTVAA  680 (689)
Q Consensus       643 ~~~~~~~~l~~l~~~Cl~~dp~~RPs~~evl~~L~~~~  680 (689)
                      .....+..+.+++.+||+.+|++||+|.+++++.+...
T Consensus       235 ~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~~~~~~~  272 (307)
T cd06607         235 SSNDWSDYFRNFVDSCLQKIPQDRPSSEELLKHRFVLR  272 (307)
T ss_pred             CchhhCHHHHHHHHHHhcCChhhCcCHHHHhcChhhcc
Confidence            12345678999999999999999999999998866543

Serine/threonine kinases (STKs), thousand-and-one amino acids (TAO) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. They activate the MAPKs, p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activating the respective MAP/ERK kinases (MEKs, also known as MKKs or MAPKKs), MEK3/MEK6 and MKK4/MKK7. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Vertebrates contain three TAO subfamily

>cd07878 STKc_p38beta_MAPK11 Catalytic domain of the Serine/Threonine Kinase, p38beta Mitogen-Activated Protein Kinase

Probab=100.00  E-value=3.4e-36  Score=320.59  Aligned_cols=258  Identities=18%  Similarity=0.290  Sum_probs=197.8

Q ss_pred             HHhccCCcccccccCCcceEEEEEec-CCcEEEEEEecccCC-chHHHHHHHHHHHHhccCCCcceeEeeEEEcCC----
Q 005586          406 SATQCFSEVNLLGKGNFSSVYKGTLR-DGTLVAIRSINVTSC-KSEEAEFVKGLYLLTSLRHENIIRLRGFCCSRG----  479 (689)
Q Consensus       406 ~at~~f~~~~~lg~G~~g~Vy~~~~~-~g~~vavK~l~~~~~-~~~~~~f~~e~~~l~~l~H~niv~l~g~~~~~~----  479 (689)
                      ...++|...+.||+|+||.||+|... ++..||||++..... ......+.+|++++.+++||||+++++++....    
T Consensus        12 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~   91 (343)
T cd07878          12 EVPERYQNLTPVGSGAYGSVCSAYDTRLRQKVAVKKLSRPFQSLIHARRTYRELRLLKHMKHENVIGLLDVFTPATSIEN   91 (343)
T ss_pred             hhhhhhhhheecccCCCeEEEEEEECCCCCEEEEEEeCchhhhhHHHHHHHHHHHHHHhcCCCchhhhhhhhcccccccc
Confidence            34578889999999999999999864 688999999875432 223456789999999999999999998774321    


Q ss_pred             CCeEEEEEEcCCCCCHHHHhhhcCCCCCCCCHHHHHHHHHHHHHHHhhhhCCCCCCCceeecCCCCCceeecCCCCeEEe
Q 005586          480 RGECFLIYDFAPKGKLSKYLDQEEGSSNVLDWSTRVSIIIGIAKGIGYLHSSEVNKPAIVHRNLSVEKVLIDQQFNPLIA  559 (689)
Q Consensus       480 ~~~~~lV~e~~~~gsL~~~L~~~~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~~~ivH~dlk~~NiLl~~~~~~kl~  559 (689)
                      ....++++|++ +++|.+++...     .+++..+..++.|++.||+|||+.+     |+||||||+|||+++++.+||+
T Consensus        92 ~~~~~~~~~~~-~~~l~~~~~~~-----~l~~~~~~~i~~qi~~aL~~LH~~~-----ivHrdikp~Nil~~~~~~~kl~  160 (343)
T cd07878          92 FNEVYLVTNLM-GADLNNIVKCQ-----KLSDEHVQFLIYQLLRGLKYIHSAG-----IIHRDLKPSNVAVNEDCELRIL  160 (343)
T ss_pred             cCcEEEEeecC-CCCHHHHHhcC-----CCCHHHHHHHHHHHHHHHHHHHHCC-----eecccCChhhEEECCCCCEEEc
Confidence            24578999998 78999887542     3899999999999999999999987     9999999999999999999999


Q ss_pred             cccccccccCCceeeeecCCCCCCCCCcccccc-CCCCCcccchhHHHHHHHHHhCCCCcchhHHHHHhhhhh-------
Q 005586          560 DCGLHKLLADDIVFSVLKTSAAMGYLAPEYVTT-GRFTERSDIFAFGVIILQILTGSLVLTSSMRLAAESATF-------  631 (689)
Q Consensus       560 DfGla~~~~~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~ksDV~sfGvvl~elltG~~p~~~~~~~~~~~~~~-------  631 (689)
                      |||+++......    ....++..|+|||++.+ ..++.++|||||||++|||++|+.||.............       
T Consensus       161 Dfg~~~~~~~~~----~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~  236 (343)
T cd07878         161 DFGLARQADDEM----TGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLKGKALFPGNDYIDQLKRIMEVVGTPS  236 (343)
T ss_pred             CCccceecCCCc----CCccccccccCchHhcCCccCCchhhhHhHHHHHHHHHHCCCCCCCCCHHHHHHHHHHHhCCCC
Confidence            999998765432    23357788999999876 568999999999999999999999985422110000000       


Q ss_pred             hHhhc-----------cccCCCCCH--------HHHHHHHHHHHHhccCCCCCCCCHHHHHHHHHhh
Q 005586          632 ENFID-----------RNLKGKFSE--------SEAAKLGKMALVCTHEDPENRPTMEAVIEELTVA  679 (689)
Q Consensus       632 ~~~~~-----------~~~~~~~~~--------~~~~~l~~l~~~Cl~~dp~~RPs~~evl~~L~~~  679 (689)
                      .+...           ..+ ...+.        .....+.+++.+|++.||++|||+.|++++-+..
T Consensus       237 ~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~li~~mL~~dp~~R~s~~ell~hp~~~  302 (343)
T cd07878         237 PEVLKKISSEHARKYIQSL-PHMPQQDLKKIFRGANPLAIDLLEKMLVLDSDKRISASEALAHPYFS  302 (343)
T ss_pred             HHHHHhcchhhHHHHhhcc-ccccchhHHHhccCCCHHHHHHHHHHcCCChhhCCCHHHHhcCcchh
Confidence            00000           000 00010        1233578999999999999999999999886554

Serine/Threonine Kinases (STKs), p38beta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38beta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38beta, also called MAPK11, is

>cd06616 PKc_MKK4 Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 4

Probab=100.00  E-value=4.7e-36  Score=311.28  Aligned_cols=256  Identities=20%  Similarity=0.378  Sum_probs=196.2

Q ss_pred             cCCcccccccCCcceEEEEEec-CCcEEEEEEecccCCchHHHHHHHHHHHHhccC-CCcceeEeeEEEcCCCCeEEEEE
Q 005586          410 CFSEVNLLGKGNFSSVYKGTLR-DGTLVAIRSINVTSCKSEEAEFVKGLYLLTSLR-HENIIRLRGFCCSRGRGECFLIY  487 (689)
Q Consensus       410 ~f~~~~~lg~G~~g~Vy~~~~~-~g~~vavK~l~~~~~~~~~~~f~~e~~~l~~l~-H~niv~l~g~~~~~~~~~~~lV~  487 (689)
                      +|...+.||+|+||.||++... +|+.||+|++...........+.+|+.++.++. |+||+++++++..  ....+++|
T Consensus         5 ~~~~~~~lg~G~~g~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~e~~~l~~~~~~~~iv~~~~~~~~--~~~~~~~~   82 (288)
T cd06616           5 DLKDLGEIGRGAFGTVNKMLHKPSGTIMAVKRIRSTVDEKEQKRLLMDLDVVMRSSDCPYIVKFYGALFR--EGDCWICM   82 (288)
T ss_pred             HhHHHHHhCCCCceEEEEEEECCCCCEEEEEEehhccChHHHHHHHHHHHHHHHhcCCCCEeeeeeEEec--CCcEEEEE
Confidence            3445678999999999999875 689999999986654455678999999999996 9999999998854  46788999


Q ss_pred             EcCCCCCHHHHhhhc-CCCCCCCCHHHHHHHHHHHHHHHhhhhCC-CCCCCceeecCCCCCceeecCCCCeEEecccccc
Q 005586          488 DFAPKGKLSKYLDQE-EGSSNVLDWSTRVSIIIGIAKGIGYLHSS-EVNKPAIVHRNLSVEKVLIDQQFNPLIADCGLHK  565 (689)
Q Consensus       488 e~~~~gsL~~~L~~~-~~~~~~l~~~~~~~ia~~ia~gL~yLH~~-~~~~~~ivH~dlk~~NiLl~~~~~~kl~DfGla~  565 (689)
                      ||++ +++.++.... ......+++....+++.+++.||+|||+. +     |+||||||+||+++.++.+||+|||+++
T Consensus        83 e~~~-~~l~~l~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~lh~~~~-----i~H~dlkp~Nil~~~~~~~kl~dfg~~~  156 (288)
T cd06616          83 ELMD-ISLDKFYKYVYEVLKSVIPEEILGKIAVATVKALNYLKEELK-----IIHRDVKPSNILLDRNGNIKLCDFGISG  156 (288)
T ss_pred             eccc-CCHHHHHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHhhcCC-----eeccCCCHHHEEEccCCcEEEeecchhH
Confidence            9986 4555543211 01123589999999999999999999974 4     9999999999999999999999999997


Q ss_pred             cccCCceeeeecCCCCCCCCCccccccC---CCCCcccchhHHHHHHHHHhCCCCcchhHHHHHhhhhhhHhh---cccc
Q 005586          566 LLADDIVFSVLKTSAAMGYLAPEYVTTG---RFTERSDIFAFGVIILQILTGSLVLTSSMRLAAESATFENFI---DRNL  639 (689)
Q Consensus       566 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~---~~~~ksDV~sfGvvl~elltG~~p~~~~~~~~~~~~~~~~~~---~~~~  639 (689)
                      .......  .....++..|+|||++.+.   .++.++|||||||++|||++|+.||.......   ..+.+..   .+.+
T Consensus       157 ~~~~~~~--~~~~~~~~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~---~~~~~~~~~~~~~~  231 (288)
T cd06616         157 QLVDSIA--KTRDAGCRPYMAPERIDPSARDGYDVRSDVWSLGITLYEVATGKFPYPKWNSVF---DQLTQVVKGDPPIL  231 (288)
T ss_pred             HhccCCc--cccccCccCccCHHHhccccccCCcchhhhhHHHHHHHHHHhCCCCchhcchHH---HHHhhhcCCCCCcC
Confidence            6543321  1223467789999998766   68999999999999999999999986432111   1111111   1112


Q ss_pred             CCCCCHHHHHHHHHHHHHhccCCCCCCCCHHHHHHHHHh
Q 005586          640 KGKFSESEAAKLGKMALVCTHEDPENRPTMEAVIEELTV  678 (689)
Q Consensus       640 ~~~~~~~~~~~l~~l~~~Cl~~dp~~RPs~~evl~~L~~  678 (689)
                      ........+.++.+++.+|++.+|++||++.||+++-+.
T Consensus       232 ~~~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~i~~~~~~  270 (288)
T cd06616         232 SNSEEREFSPSFVNFINLCLIKDESKRPKYKELLEHPFI  270 (288)
T ss_pred             CCcCCCccCHHHHHHHHHHccCChhhCcCHHHHhcChhh
Confidence            222223356789999999999999999999999987543

Protein kinases (PKs), MAP kinase kinase 4 (MKK4) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK4 is a dual-specificity PK that phosphorylates and activates

>cd07847 STKc_CDKL1_4 Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 1 and 4

Probab=100.00  E-value=1.2e-35  Score=307.82  Aligned_cols=256  Identities=18%  Similarity=0.305  Sum_probs=197.0

Q ss_pred             ccCCcccccccCCcceEEEEEec-CCcEEEEEEecccCC-chHHHHHHHHHHHHhccCCCcceeEeeEEEcCCCCeEEEE
Q 005586          409 QCFSEVNLLGKGNFSSVYKGTLR-DGTLVAIRSINVTSC-KSEEAEFVKGLYLLTSLRHENIIRLRGFCCSRGRGECFLI  486 (689)
Q Consensus       409 ~~f~~~~~lg~G~~g~Vy~~~~~-~g~~vavK~l~~~~~-~~~~~~f~~e~~~l~~l~H~niv~l~g~~~~~~~~~~~lV  486 (689)
                      ++|+..+.||+|+||.||+|+.+ +|+.||+|++..... ....+.|.+|++++.+++|+|++++++++..  ....++|
T Consensus         1 ~~y~~~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~--~~~~~~v   78 (286)
T cd07847           1 EKYEKLSKIGEGSYGVVFKCRNRETGQIVAIKKFVESEDDPVIKKIALREIRMLKQLKHPNLVNLIEVFRR--KRKLHLV   78 (286)
T ss_pred             CceeeeeeecccCCeEEEEEEECCCCcEEEEEEEeecccCccccHHHHHHHHHHHhCCCCCEeeeeeEEee--CCEEEEE
Confidence            35777889999999999999986 689999999875432 2233568899999999999999999999854  4678999


Q ss_pred             EEcCCCCCHHHHhhhcCCCCCCCCHHHHHHHHHHHHHHHhhhhCCCCCCCceeecCCCCCceeecCCCCeEEeccccccc
Q 005586          487 YDFAPKGKLSKYLDQEEGSSNVLDWSTRVSIIIGIAKGIGYLHSSEVNKPAIVHRNLSVEKVLIDQQFNPLIADCGLHKL  566 (689)
Q Consensus       487 ~e~~~~gsL~~~L~~~~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~~~ivH~dlk~~NiLl~~~~~~kl~DfGla~~  566 (689)
                      |||+++++|..++....    .++|..++.++.|++.||+|||+.+     ++||||||+||++++++.+||+|||++..
T Consensus        79 ~e~~~~~~l~~~~~~~~----~~~~~~~~~~~~ql~~~l~~LH~~~-----i~H~dl~p~nil~~~~~~~~l~dfg~~~~  149 (286)
T cd07847          79 FEYCDHTVLNELEKNPR----GVPEHLIKKIIWQTLQAVNFCHKHN-----CIHRDVKPENILITKQGQIKLCDFGFARI  149 (286)
T ss_pred             EeccCccHHHHHHhCCC----CCCHHHHHHHHHHHHHHHHHHHHCC-----ceecCCChhhEEEcCCCcEEECcccccee
Confidence            99999998888765432    3899999999999999999999987     99999999999999999999999999987


Q ss_pred             ccCCceeeeecCCCCCCCCCcccccc-CCCCCcccchhHHHHHHHHHhCCCCcchhHHHHHhh---hhhh-------Hhh
Q 005586          567 LADDIVFSVLKTSAAMGYLAPEYVTT-GRFTERSDIFAFGVIILQILTGSLVLTSSMRLAAES---ATFE-------NFI  635 (689)
Q Consensus       567 ~~~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~ksDV~sfGvvl~elltG~~p~~~~~~~~~~~---~~~~-------~~~  635 (689)
                      ...... ......++..|+|||++.+ ..++.++|||||||++|||+||+.||..........   ....       +..
T Consensus       150 ~~~~~~-~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~i~~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~  228 (286)
T cd07847         150 LTGPGD-DYTDYVATRWYRAPELLVGDTQYGPPVDVWAIGCVFAELLTGQPLWPGKSDVDQLYLIRKTLGDLIPRHQQIF  228 (286)
T ss_pred             cCCCcc-cccCcccccccCCHHHHhCCCCcCchhhhHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCChHHhhhc
Confidence            654321 1112345677999999865 457899999999999999999999986432111100   0000       000


Q ss_pred             cc----------ccCCCCC-----HHHHHHHHHHHHHhccCCCCCCCCHHHHHHHH
Q 005586          636 DR----------NLKGKFS-----ESEAAKLGKMALVCTHEDPENRPTMEAVIEEL  676 (689)
Q Consensus       636 ~~----------~~~~~~~-----~~~~~~l~~l~~~Cl~~dp~~RPs~~evl~~L  676 (689)
                      +.          ......+     ......+.+++.+|++.+|++||++.|++++.
T Consensus       229 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~eil~~~  284 (286)
T cd07847         229 STNQFFKGLSIPEPETREPLESKFPNISSPALSFLKGCLQMDPTERLSCEELLEHP  284 (286)
T ss_pred             ccccccccccCCCcccccCHHHHhccCCHHHHHHHHHHhcCCccccCCHHHHhcCC
Confidence            00          0000000     12246788999999999999999999998763

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 1 (CDKL1) and CDKL4 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL1 and CDKL4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL1, also called p42 KKIALRE, is a glial protein that is upregulated in gliosis. It is present in neuroblastoma and A431 human carcinoma cells, and may be implicated in neoplastic transformation. The functio

>cd07832 STKc_CCRK Catalytic domain of the Serine/Threonine Kinase, Cell Cycle-Related Kinase

Probab=100.00  E-value=6.4e-36  Score=309.74  Aligned_cols=256  Identities=20%  Similarity=0.321  Sum_probs=200.1

Q ss_pred             cCCcccccccCCcceEEEEEec-CCcEEEEEEecccCC-chHHHHHHHHHHHHhccCCCcceeEeeEEEcCCCCeEEEEE
Q 005586          410 CFSEVNLLGKGNFSSVYKGTLR-DGTLVAIRSINVTSC-KSEEAEFVKGLYLLTSLRHENIIRLRGFCCSRGRGECFLIY  487 (689)
Q Consensus       410 ~f~~~~~lg~G~~g~Vy~~~~~-~g~~vavK~l~~~~~-~~~~~~f~~e~~~l~~l~H~niv~l~g~~~~~~~~~~~lV~  487 (689)
                      +|...+.||+|+||.||+|... +|+.||+|++..... ......+.+|+.++++++||||+++++++..  ....++||
T Consensus         1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~vK~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~--~~~~~~v~   78 (286)
T cd07832           1 RYKILGRIGEGAHGIVFKAKDRETGETVALKKVALRRLEGGIPNQALREIKALQACQHPYVVKLLDVFPH--GSGFVLVM   78 (286)
T ss_pred             CceEEeecccCCCcEEEEEEECCCCceEEEEEEEcccccchhhHHHHHHHHHHHhCCCCCCcceeeEEec--CCeeEEEe
Confidence            3667789999999999999975 689999999976543 2334679999999999999999999999854  57889999


Q ss_pred             EcCCCCCHHHHhhhcCCCCCCCCHHHHHHHHHHHHHHHhhhhCCCCCCCceeecCCCCCceeecCCCCeEEecccccccc
Q 005586          488 DFAPKGKLSKYLDQEEGSSNVLDWSTRVSIIIGIAKGIGYLHSSEVNKPAIVHRNLSVEKVLIDQQFNPLIADCGLHKLL  567 (689)
Q Consensus       488 e~~~~gsL~~~L~~~~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~~~ivH~dlk~~NiLl~~~~~~kl~DfGla~~~  567 (689)
                      ||+ +++|.+++....   ..+++.++..++.|+++||+|||+.+     ++|+||||+||++++++.++|+|||++...
T Consensus        79 e~~-~~~L~~~~~~~~---~~~~~~~~~~~~~~i~~~l~~lH~~~-----i~H~dl~p~ni~~~~~~~~~l~dfg~~~~~  149 (286)
T cd07832          79 EYM-PSDLSEVLRDEE---RPLPEAQVKSYMRMLLKGVAYMHANG-----IMHRDLKPANLLISADGVLKIADFGLARLF  149 (286)
T ss_pred             ccc-CCCHHHHHHhcC---CCCCHHHHHHHHHHHHHHHHHHHHCC-----eecCCcCHHHEEEcCCCcEEEeeeeecccc
Confidence            999 999999987643   34899999999999999999999987     999999999999999999999999999876


Q ss_pred             cCCceeeeecCCCCCCCCCccccccC-CCCCcccchhHHHHHHHHHhCCCCcchhHHHHHhhhhhhHh-----------h
Q 005586          568 ADDIVFSVLKTSAAMGYLAPEYVTTG-RFTERSDIFAFGVIILQILTGSLVLTSSMRLAAESATFENF-----------I  635 (689)
Q Consensus       568 ~~~~~~~~~~~~~~~~y~aPE~~~~~-~~~~ksDV~sfGvvl~elltG~~p~~~~~~~~~~~~~~~~~-----------~  635 (689)
                      ............++..|+|||.+.+. .++.++||||+|+++|||+||+.|+...............+           .
T Consensus       150 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~~l~~l~tg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  229 (286)
T cd07832         150 SEEEPRLYSHQVATRWYRAPELLYGARKYDPGVDLWAVGCIFAELLNGSPLFPGENDIEQLAIVFRTLGTPNEETWPGLT  229 (286)
T ss_pred             cCCCCCccccccCcccccCceeeeccccCCchhHHHHHHHHHHHHHcCCcCcCCCCHHHHHHHHHHHcCCCChHHHhhcc
Confidence            54332122234577889999998654 46899999999999999999988775432211111100000           0


Q ss_pred             ---c--c-ccCC-------CCCHHHHHHHHHHHHHhccCCCCCCCCHHHHHHHH
Q 005586          636 ---D--R-NLKG-------KFSESEAAKLGKMALVCTHEDPENRPTMEAVIEEL  676 (689)
Q Consensus       636 ---~--~-~~~~-------~~~~~~~~~l~~l~~~Cl~~dp~~RPs~~evl~~L  676 (689)
                         +  . ....       ....+....+.+++.+|++.+|++||++++++++.
T Consensus       230 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~R~~~~~~l~h~  283 (286)
T cd07832         230 SLPDYNKITFPESKPIPLEEIFPDASPEALDLLKGLLVYDPSKRLSAAEALRHP  283 (286)
T ss_pred             CcchhhcccCCCCCcchHHHhCCCccHHHHHHHHHHhccChhhCCCHHHHhhCc
Confidence               0  0 0000       00112357889999999999999999999999874

Serine/Threonine Kinases (STKs), Cell Cycle-Related Kinase (CCRK) p42 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CCRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CCRK was previously called p42. It is a Cyclin-Dependent Kinase (CDK)-Activating Kinase (CAK) which is essential for the activation of CDK2. It is indispensable for cell growth and has been implicated in the progression of glioblastoma multiforme. In the heart, a splice variant of CCRK with a different C-terminal half is expressed, this variant promotes cardiac cell growth and survival and is significantly down-regulated during the development of hea

>cd06659 STKc_PAK6 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 6

Probab=100.00  E-value=4.9e-36  Score=312.58  Aligned_cols=253  Identities=15%  Similarity=0.302  Sum_probs=200.1

Q ss_pred             ccccccCCcceEEEEEec-CCcEEEEEEecccCCchHHHHHHHHHHHHhccCCCcceeEeeEEEcCCCCeEEEEEEcCCC
Q 005586          414 VNLLGKGNFSSVYKGTLR-DGTLVAIRSINVTSCKSEEAEFVKGLYLLTSLRHENIIRLRGFCCSRGRGECFLIYDFAPK  492 (689)
Q Consensus       414 ~~~lg~G~~g~Vy~~~~~-~g~~vavK~l~~~~~~~~~~~f~~e~~~l~~l~H~niv~l~g~~~~~~~~~~~lV~e~~~~  492 (689)
                      ...||+|+||.||+|... +++.||+|.+.... ......+.+|+.++..++||||+++++++..  .+..++|+||+++
T Consensus        26 ~~~ig~g~~g~v~~~~~~~~~~~v~iK~~~~~~-~~~~~~~~~e~~~l~~l~hp~i~~~~~~~~~--~~~~~iv~e~~~~  102 (297)
T cd06659          26 YIKIGEGSTGIVCIAREKHSGRQVAVKMMDLRK-QQRRELLFNEVVIMRDYQHQNVVEMYKSYLV--GEELWVLMEFLQG  102 (297)
T ss_pred             hhhcCCCCceeEEEEEEcCCCCEEEEEEEEecc-cchHHHHHHHHHHHHhCCCCchhhhhhheee--CCeEEEEEecCCC
Confidence            457999999999999875 68999999987654 2345678899999999999999999998854  4789999999999


Q ss_pred             CCHHHHhhhcCCCCCCCCHHHHHHHHHHHHHHHhhhhCCCCCCCceeecCCCCCceeecCCCCeEEecccccccccCCce
Q 005586          493 GKLSKYLDQEEGSSNVLDWSTRVSIIIGIAKGIGYLHSSEVNKPAIVHRNLSVEKVLIDQQFNPLIADCGLHKLLADDIV  572 (689)
Q Consensus       493 gsL~~~L~~~~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~~~ivH~dlk~~NiLl~~~~~~kl~DfGla~~~~~~~~  572 (689)
                      ++|.+++...     .+++..++.++.|++.||+|||+.+     |+||||||+||++++++.+||+|||+++.......
T Consensus       103 ~~L~~~~~~~-----~~~~~~~~~~~~qi~~~L~~LH~~~-----ivH~dl~p~Nill~~~~~~kL~dfg~~~~~~~~~~  172 (297)
T cd06659         103 GALTDIVSQT-----RLNEEQIATVCESVLQALCYLHSQG-----VIHRDIKSDSILLTLDGRVKLSDFGFCAQISKDVP  172 (297)
T ss_pred             CCHHHHHhhc-----CCCHHHHHHHHHHHHHHHHHHHhCC-----eecCCCCHHHeEEccCCcEEEeechhHhhcccccc
Confidence            9999987542     3889999999999999999999987     99999999999999999999999999876543321


Q ss_pred             eeeecCCCCCCCCCccccccCCCCCcccchhHHHHHHHHHhCCCCcchhHHHHHhhhhhhHhhccccCCCCCHHHHHHHH
Q 005586          573 FSVLKTSAAMGYLAPEYVTTGRFTERSDIFAFGVIILQILTGSLVLTSSMRLAAESATFENFIDRNLKGKFSESEAAKLG  652 (689)
Q Consensus       573 ~~~~~~~~~~~y~aPE~~~~~~~~~ksDV~sfGvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~  652 (689)
                       ......++..|+|||++.+..++.++|||||||++|||++|+.||......... ..+......  ...........+.
T Consensus       173 -~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~~g~~p~~~~~~~~~~-~~~~~~~~~--~~~~~~~~~~~l~  248 (297)
T cd06659         173 -KRKSLVGTPYWMAPEVISRTPYGTEVDIWSLGIMVIEMVDGEPPYFSDSPVQAM-KRLRDSPPP--KLKNAHKISPVLR  248 (297)
T ss_pred             -cccceecCccccCHHHHccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHH-HHHhccCCC--CccccCCCCHHHH
Confidence             112234678899999998888999999999999999999999998643211110 011100000  0111222345688


Q ss_pred             HHHHHhccCCCCCCCCHHHHHHHHHhhCCcc
Q 005586          653 KMALVCTHEDPENRPTMEAVIEELTVAAPVM  683 (689)
Q Consensus       653 ~l~~~Cl~~dp~~RPs~~evl~~L~~~~p~~  683 (689)
                      +++..|++.+|++||++.+++++-.......
T Consensus       249 ~~i~~~l~~~P~~Rps~~~ll~~~~~~~~~~  279 (297)
T cd06659         249 DFLERMLTREPQERATAQELLDHPFLLQTGL  279 (297)
T ss_pred             HHHHHHhcCCcccCcCHHHHhhChhhccCCC
Confidence            9999999999999999999999866655443

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 6, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK6 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK6 may play a role i

>cd06648 STKc_PAK_II Catalytic domain of the Protein Serine/Threonine Kinase, Group II p21-activated kinase

Probab=100.00  E-value=8.8e-36  Score=308.82  Aligned_cols=254  Identities=15%  Similarity=0.321  Sum_probs=201.4

Q ss_pred             cCCcccccccCCcceEEEEEec-CCcEEEEEEecccCCchHHHHHHHHHHHHhccCCCcceeEeeEEEcCCCCeEEEEEE
Q 005586          410 CFSEVNLLGKGNFSSVYKGTLR-DGTLVAIRSINVTSCKSEEAEFVKGLYLLTSLRHENIIRLRGFCCSRGRGECFLIYD  488 (689)
Q Consensus       410 ~f~~~~~lg~G~~g~Vy~~~~~-~g~~vavK~l~~~~~~~~~~~f~~e~~~l~~l~H~niv~l~g~~~~~~~~~~~lV~e  488 (689)
                      +|...+.||+|++|.||++... +++.|++|++.... ....+.+.+|+.++.+++||||+++++++..  .+..++|+|
T Consensus        20 ~~~~~~~lg~g~~g~v~~~~~~~~~~~~~iK~~~~~~-~~~~~~~~~e~~~l~~~~h~~vv~~~~~~~~--~~~~~~v~e   96 (285)
T cd06648          20 YLDNFVKIGEGSTGIVCIATDKSTGRQVAVKKMDLRK-QQRRELLFNEVVIMRDYQHPNIVEMYSSYLV--GDELWVVME   96 (285)
T ss_pred             hhhcceEeccCCCeEEEEEEECCCCCEEEEEEEeccc-hhHHHHHHHHHHHHHHcCCCChheEEEEEEc--CCeEEEEEe
Confidence            3555679999999999999864 78999999986543 3345678899999999999999999998854  578899999


Q ss_pred             cCCCCCHHHHhhhcCCCCCCCCHHHHHHHHHHHHHHHhhhhCCCCCCCceeecCCCCCceeecCCCCeEEeccccccccc
Q 005586          489 FAPKGKLSKYLDQEEGSSNVLDWSTRVSIIIGIAKGIGYLHSSEVNKPAIVHRNLSVEKVLIDQQFNPLIADCGLHKLLA  568 (689)
Q Consensus       489 ~~~~gsL~~~L~~~~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~~~ivH~dlk~~NiLl~~~~~~kl~DfGla~~~~  568 (689)
                      |+++++|.+++...     .+++..+..++.|++.||+|||+.+     |+||||||+||++++++.+||+|||++....
T Consensus        97 ~~~~~~L~~~~~~~-----~~~~~~~~~~~~ql~~~l~~lH~~~-----i~H~dl~p~Nil~~~~~~~~l~d~g~~~~~~  166 (285)
T cd06648          97 FLEGGALTDIVTHT-----RMNEEQIATVCLAVLKALSFLHAQG-----VIHRDIKSDSILLTSDGRVKLSDFGFCAQVS  166 (285)
T ss_pred             ccCCCCHHHHHHhC-----CCCHHHHHHHHHHHHHHHHHHHhCC-----eecCCCChhhEEEcCCCcEEEcccccchhhc
Confidence            99999999998762     3889999999999999999999987     9999999999999999999999999887654


Q ss_pred             CCceeeeecCCCCCCCCCccccccCCCCCcccchhHHHHHHHHHhCCCCcchhHHHHHhhhhhhHhhccccCCCCCHHHH
Q 005586          569 DDIVFSVLKTSAAMGYLAPEYVTTGRFTERSDIFAFGVIILQILTGSLVLTSSMRLAAESATFENFIDRNLKGKFSESEA  648 (689)
Q Consensus       569 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~ksDV~sfGvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  648 (689)
                      .... ......++..|+|||...+..++.++|||||||++|||++|+.|+......... ..+.....+...  ......
T Consensus       167 ~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slGv~l~ell~g~~p~~~~~~~~~~-~~~~~~~~~~~~--~~~~~~  242 (285)
T cd06648         167 KEVP-RRKSLVGTPYWMAPEVISRLPYGTEVDIWSLGIMVIEMVDGEPPYFNEPPLQAM-KRIRDNLPPKLK--NLHKVS  242 (285)
T ss_pred             cCCc-ccccccCCccccCHHHhcCCCCCCcccHHHHHHHHHHHHhCCCCCcCCCHHHHH-HHHHhcCCCCCc--ccccCC
Confidence            3321 112234678899999998888999999999999999999999998643221111 111111111111  112245


Q ss_pred             HHHHHHHHHhccCCCCCCCCHHHHHHHHHhhC
Q 005586          649 AKLGKMALVCTHEDPENRPTMEAVIEELTVAA  680 (689)
Q Consensus       649 ~~l~~l~~~Cl~~dp~~RPs~~evl~~L~~~~  680 (689)
                      ..+.+++.+||+.+|++||++.+++++-....
T Consensus       243 ~~l~~li~~~l~~~p~~Rpt~~~il~~~~~~~  274 (285)
T cd06648         243 PRLRSFLDRMLVRDPAQRATAAELLNHPFLAK  274 (285)
T ss_pred             HHHHHHHHHHcccChhhCcCHHHHccCccccc
Confidence            67999999999999999999999998755443

Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group II, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group II PAKs, also called non-conventional PAKs, include PAK4, PAK5, and PAK6. Group II PAKs contain PBD (p21-binding domain) and catalytic domains, but lack other motifs foun

>KOG0599 consensus Phosphorylase kinase gamma subunit [Carbohydrate transport and metabolism]

Probab=100.00  E-value=1.4e-36  Score=287.79  Aligned_cols=255  Identities=24%  Similarity=0.373  Sum_probs=205.4

Q ss_pred             ccCCcccccccCCcceEEEEEec-CCcEEEEEEecccCCc-------hHHHHHHHHHHHHhcc-CCCcceeEeeEEEcCC
Q 005586          409 QCFSEVNLLGKGNFSSVYKGTLR-DGTLVAIRSINVTSCK-------SEEAEFVKGLYLLTSL-RHENIIRLRGFCCSRG  479 (689)
Q Consensus       409 ~~f~~~~~lg~G~~g~Vy~~~~~-~g~~vavK~l~~~~~~-------~~~~~f~~e~~~l~~l-~H~niv~l~g~~~~~~  479 (689)
                      +.|...+.||.|..++|-++..+ +|.+.|+|++......       .-..+-.+|+.+|+++ .||+|+.+.++|  +.
T Consensus        17 ~~y~pkeilgrgvss~vrRci~k~t~~e~a~kii~~~at~~~~e~~~~~~EaT~~Ev~ILRqv~GHP~II~l~D~y--es   94 (411)
T KOG0599|consen   17 AKYEPKEILGRGVSSVVRRCIHKETGKEFAVKIIDVTATTESGETPYEMREATRQEISILRQVMGHPYIIDLQDVY--ES   94 (411)
T ss_pred             hhcChHHHhcccchhhhhhhhhcccccceeEEEEEecccccCCccHHHHHHHHHHHHHHHHHhcCCCcEEEeeeec--cC
Confidence            45666789999999999999875 6889999999754321       1123456789999998 699999999998  55


Q ss_pred             CCeEEEEEEcCCCCCHHHHhhhcCCCCCCCCHHHHHHHHHHHHHHHhhhhCCCCCCCceeecCCCCCceeecCCCCeEEe
Q 005586          480 RGECFLIYDFAPKGKLSKYLDQEEGSSNVLDWSTRVSIIIGIAKGIGYLHSSEVNKPAIVHRNLSVEKVLIDQQFNPLIA  559 (689)
Q Consensus       480 ~~~~~lV~e~~~~gsL~~~L~~~~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~~~ivH~dlk~~NiLl~~~~~~kl~  559 (689)
                      +...++|+|.|+.|-|.++|...-    .+++..-.+|+.|+.+|++|||...     ||||||||+|||+|++.++||+
T Consensus        95 ~sF~FlVFdl~prGELFDyLts~V----tlSEK~tR~iMrqlfegVeylHa~~-----IVHRDLKpENILlddn~~i~is  165 (411)
T KOG0599|consen   95 DAFVFLVFDLMPRGELFDYLTSKV----TLSEKETRRIMRQLFEGVEYLHARN-----IVHRDLKPENILLDDNMNIKIS  165 (411)
T ss_pred             cchhhhhhhhcccchHHHHhhhhe----eecHHHHHHHHHHHHHHHHHHHHhh-----hhhcccChhheeeccccceEEe
Confidence            678999999999999999998654    4888999999999999999999987     9999999999999999999999


Q ss_pred             cccccccccCCceeeeecCCCCCCCCCccccc------cCCCCCcccchhHHHHHHHHHhCCCCcchhHHHHHhhhhhhH
Q 005586          560 DCGLHKLLADDIVFSVLKTSAAMGYLAPEYVT------TGRFTERSDIFAFGVIILQILTGSLVLTSSMRLAAESATFEN  633 (689)
Q Consensus       560 DfGla~~~~~~~~~~~~~~~~~~~y~aPE~~~------~~~~~~ksDV~sfGvvl~elltG~~p~~~~~~~~~~~~~~~~  633 (689)
                      |||++..+..+.  ......||+||.|||.+.      ...|+..+|.|+.||+||-|+.|.+||...........+++.
T Consensus       166 DFGFa~~l~~Ge--kLrelCGTPgYLAPEtikC~m~e~~pGYs~EVD~Wa~GVImyTLLaGcpPFwHRkQmlMLR~ImeG  243 (411)
T KOG0599|consen  166 DFGFACQLEPGE--KLRELCGTPGYLAPETIKCSMYENHPGYSKEVDEWACGVIMYTLLAGCPPFWHRKQMLMLRMIMEG  243 (411)
T ss_pred             ccceeeccCCch--hHHHhcCCCcccChhheeeecccCCCCccchhhHHHHHHHHHHHHcCCCchhHHHHHHHHHHHHhc
Confidence            999999887654  334567999999999874      245889999999999999999999999654332222111111


Q ss_pred             hhccccCCCCCHHHHHHHHHHHHHhccCCCCCCCCHHHHHHHHHh
Q 005586          634 FIDRNLKGKFSESEAAKLGKMALVCTHEDPENRPTMEAVIEELTV  678 (689)
Q Consensus       634 ~~~~~~~~~~~~~~~~~l~~l~~~Cl~~dp~~RPs~~evl~~L~~  678 (689)
                      -  -.++..-..+.+....+++.+|++.||++|.|.+|++.+...
T Consensus       244 k--yqF~speWadis~~~KdLIsrlLqVdp~~Ritake~LaHpff  286 (411)
T KOG0599|consen  244 K--YQFRSPEWADISATVKDLISRLLQVDPTKRITAKEALAHPFF  286 (411)
T ss_pred             c--cccCCcchhhccccHHHHHHHHHeeCchhcccHHHHhcChHH
Confidence            0  011222234567789999999999999999999999988655

>cd05609 STKc_MAST Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine kinase

Probab=100.00  E-value=9.6e-36  Score=311.73  Aligned_cols=253  Identities=18%  Similarity=0.268  Sum_probs=196.4

Q ss_pred             ccCCcccccccCCcceEEEEEec-CCcEEEEEEecccCC--chHHHHHHHHHHHHhccCCCcceeEeeEEEcCCCCeEEE
Q 005586          409 QCFSEVNLLGKGNFSSVYKGTLR-DGTLVAIRSINVTSC--KSEEAEFVKGLYLLTSLRHENIIRLRGFCCSRGRGECFL  485 (689)
Q Consensus       409 ~~f~~~~~lg~G~~g~Vy~~~~~-~g~~vavK~l~~~~~--~~~~~~f~~e~~~l~~l~H~niv~l~g~~~~~~~~~~~l  485 (689)
                      ++|...+.||+|+||.||++..+ +++.||+|.+.....  ......+.+|++++..++||||+++++.+..  .+..++
T Consensus         1 ~~y~~~~~l~~g~~~~v~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~--~~~~~l   78 (305)
T cd05609           1 EDFETIKLISNGAYGAVYLVRHKETRQRFAMKKINKQNLILRNQIQQVFVERDILTFAENPFVVSMFCSFET--KRHLCM   78 (305)
T ss_pred             CCceEeeEeecCCCeeEEEEEECCCCcEEEEEEeehhhhhhHHHHHHHHHHHHHHHhCCCCCeeeeEEEEec--CCEEEE
Confidence            36778899999999999999976 578999999876532  2334578899999999999999999998843  568899


Q ss_pred             EEEcCCCCCHHHHhhhcCCCCCCCCHHHHHHHHHHHHHHHhhhhCCCCCCCceeecCCCCCceeecCCCCeEEecccccc
Q 005586          486 IYDFAPKGKLSKYLDQEEGSSNVLDWSTRVSIIIGIAKGIGYLHSSEVNKPAIVHRNLSVEKVLIDQQFNPLIADCGLHK  565 (689)
Q Consensus       486 V~e~~~~gsL~~~L~~~~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~~~ivH~dlk~~NiLl~~~~~~kl~DfGla~  565 (689)
                      ||||+++++|.+++....    .+++..+..++.|++.||+|||+.+     ++||||||+||++++++.+||+|||+++
T Consensus        79 v~e~~~g~~L~~~l~~~~----~~~~~~~~~~~~~i~~~l~~lH~~~-----i~H~dl~p~NIll~~~~~~~l~dfg~~~  149 (305)
T cd05609          79 VMEYVEGGDCATLLKNIG----ALPVDMARMYFAETVLALEYLHNYG-----IVHRDLKPDNLLITSMGHIKLTDFGLSK  149 (305)
T ss_pred             EEecCCCCcHHHHHHHcC----CCCHHHHHHHHHHHHHHHHHHHHCC-----ccccCCchHHEEECCCCCEEEeeCCCcc
Confidence            999999999999997643    4889999999999999999999987     9999999999999999999999999987


Q ss_pred             cccCCce--------------eeeecCCCCCCCCCccccccCCCCCcccchhHHHHHHHHHhCCCCcchhHHHHHhhhhh
Q 005586          566 LLADDIV--------------FSVLKTSAAMGYLAPEYVTTGRFTERSDIFAFGVIILQILTGSLVLTSSMRLAAESATF  631 (689)
Q Consensus       566 ~~~~~~~--------------~~~~~~~~~~~y~aPE~~~~~~~~~ksDV~sfGvvl~elltG~~p~~~~~~~~~~~~~~  631 (689)
                      .......              .......++..|+|||++....++.++|||||||++|||++|+.||........    .
T Consensus       150 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~vl~el~~g~~pf~~~~~~~~----~  225 (305)
T cd05609         150 IGLMSLTTNLYEGHIEKDTREFLDKQVCGTPEYIAPEVILRQGYGKPVDWWAMGIILYEFLVGCVPFFGDTPEEL----F  225 (305)
T ss_pred             ccCcCccccccccccccchhhccccCCccCccccCchhccCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHH----H
Confidence            4211100              001112456789999999888899999999999999999999999864322111    1


Q ss_pred             hHhhccccC-CCCCHHHHHHHHHHHHHhccCCCCCCCCH---HHHHHHH
Q 005586          632 ENFIDRNLK-GKFSESEAAKLGKMALVCTHEDPENRPTM---EAVIEEL  676 (689)
Q Consensus       632 ~~~~~~~~~-~~~~~~~~~~l~~l~~~Cl~~dp~~RPs~---~evl~~L  676 (689)
                      ......... .......+.++.+++.+||+.+|++||++   .+++++.
T Consensus       226 ~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~~~~~~~~ll~~~  274 (305)
T cd05609         226 GQVISDDIEWPEGDEALPADAQDLISRLLRQNPLERLGTGGAFEVKQHR  274 (305)
T ss_pred             HHHHhcccCCCCccccCCHHHHHHHHHHhccChhhccCccCHHHHHhCc
Confidence            111111110 01111345678999999999999999985   5555543

Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. There are four mammalian MAST kinases, named MAST1-MAST4. MAST1 is also referred to as syntrophin-associated STK (SAST), while MAST2 is also called MAST205. MAST kinases are cytoskeletal associated kinases of unknown function that a

>PHA03209 serine/threonine kinase US3; Provisional

Probab=100.00  E-value=1e-35  Score=318.24  Aligned_cols=252  Identities=17%  Similarity=0.259  Sum_probs=190.9

Q ss_pred             HhccCCcccccccCCcceEEEEEec-CCcEEEEEEecccCCchHHHHHHHHHHHHhccCCCcceeEeeEEEcCCCCeEEE
Q 005586          407 ATQCFSEVNLLGKGNFSSVYKGTLR-DGTLVAIRSINVTSCKSEEAEFVKGLYLLTSLRHENIIRLRGFCCSRGRGECFL  485 (689)
Q Consensus       407 at~~f~~~~~lg~G~~g~Vy~~~~~-~g~~vavK~l~~~~~~~~~~~f~~e~~~l~~l~H~niv~l~g~~~~~~~~~~~l  485 (689)
                      ...+|...+.||+|+||.||+|... ++..||+|.....       ....|+.++++++||||+++++++..  ....++
T Consensus        64 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~valK~~~~~-------~~~~E~~~l~~l~h~~iv~~~~~~~~--~~~~~l  134 (357)
T PHA03209         64 ASLGYTVIKTLTPGSEGRVFVATKPGQPDPVVLKIGQKG-------TTLIEAMLLQNVNHPSVIRMKDTLVS--GAITCM  134 (357)
T ss_pred             hhcCcEEEEEecCCCCeEEEEEEECCCCceEEEEeCCcc-------ccHHHHHHHHhCCCCCCcChhheEEe--CCeeEE
Confidence            3457999999999999999999976 5788999975432       23468999999999999999999855  467899


Q ss_pred             EEEcCCCCCHHHHhhhcCCCCCCCCHHHHHHHHHHHHHHHhhhhCCCCCCCceeecCCCCCceeecCCCCeEEecccccc
Q 005586          486 IYDFAPKGKLSKYLDQEEGSSNVLDWSTRVSIIIGIAKGIGYLHSSEVNKPAIVHRNLSVEKVLIDQQFNPLIADCGLHK  565 (689)
Q Consensus       486 V~e~~~~gsL~~~L~~~~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~~~ivH~dlk~~NiLl~~~~~~kl~DfGla~  565 (689)
                      |+||+ .|+|.+++....   ..++|..++.|+.||+.||+|||+.+     |+||||||+|||+++++.+||+|||+++
T Consensus       135 v~e~~-~~~l~~~l~~~~---~~~~~~~~~~i~~qi~~aL~~LH~~~-----ivHrDlkp~Nill~~~~~~kl~DfG~a~  205 (357)
T PHA03209        135 VLPHY-SSDLYTYLTKRS---RPLPIDQALIIEKQILEGLRYLHAQR-----IIHRDVKTENIFINDVDQVCIGDLGAAQ  205 (357)
T ss_pred             EEEcc-CCcHHHHHHhcc---CCCCHHHHHHHHHHHHHHHHHHHHCC-----eecCCCCHHHEEECCCCCEEEecCcccc
Confidence            99999 578999887543   34899999999999999999999987     9999999999999999999999999997


Q ss_pred             cccCCceeeeecCCCCCCCCCccccccCCCCCcccchhHHHHHHHHHhCCCCcchhH------HHHHhhhhhhHhh----
Q 005586          566 LLADDIVFSVLKTSAAMGYLAPEYVTTGRFTERSDIFAFGVIILQILTGSLVLTSSM------RLAAESATFENFI----  635 (689)
Q Consensus       566 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~ksDV~sfGvvl~elltG~~p~~~~~------~~~~~~~~~~~~~----  635 (689)
                      ......  ......+|..|+|||++.+..++.++|||||||++|||+++..|+....      ........+.+++    
T Consensus       206 ~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvvl~ell~~~~~~f~~~~~~~~~~~~~~~~~l~~~~~~~~  283 (357)
T PHA03209        206 FPVVAP--AFLGLAGTVETNAPEVLARDKYNSKADIWSAGIVLFEMLAYPSTIFEDPPSTPEEYVKSCHSHLLKIISTLK  283 (357)
T ss_pred             ccccCc--ccccccccccccCCeecCCCCCCchhhHHHHHHHHHHHHHcCCccccCCCCcHHHHHHHHHHHHHHHHHHhc
Confidence            543321  1223457889999999999999999999999999999999665542110      0000000011100    


Q ss_pred             -------------------ccccC--CCCC-------HHHHHHHHHHHHHhccCCCCCCCCHHHHHHHHHh
Q 005586          636 -------------------DRNLK--GKFS-------ESEAAKLGKMALVCTHEDPENRPTMEAVIEELTV  678 (689)
Q Consensus       636 -------------------~~~~~--~~~~-------~~~~~~l~~l~~~Cl~~dp~~RPs~~evl~~L~~  678 (689)
                                         +....  ....       ......+.+++..||+.||++|||+.||+++-+.
T Consensus       284 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dP~~Rpta~e~l~hp~f  354 (357)
T PHA03209        284 VHPEEFPRDPGSRLVRGFIEYASLERQPYTRYPCFQRVNLPIDGEFLVHKMLTFDAAMRPSAEEILNYPMF  354 (357)
T ss_pred             cChhhcCCCCccHHHHHHHhhcccCCCcccccHHHhccCCCchHHHHHHHHHcCCcccCcCHHHHhcCchh
Confidence                               00000  0000       0113345679999999999999999999987543

>cd05574 STKc_phototropin_like Catalytic domain of Phototropin-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=1.1e-35  Score=313.05  Aligned_cols=255  Identities=20%  Similarity=0.291  Sum_probs=203.8

Q ss_pred             cCCcccccccCCcceEEEEEec-CCcEEEEEEecccCCc--hHHHHHHHHHHHHhccCCCcceeEeeEEEcCCCCeEEEE
Q 005586          410 CFSEVNLLGKGNFSSVYKGTLR-DGTLVAIRSINVTSCK--SEEAEFVKGLYLLTSLRHENIIRLRGFCCSRGRGECFLI  486 (689)
Q Consensus       410 ~f~~~~~lg~G~~g~Vy~~~~~-~g~~vavK~l~~~~~~--~~~~~f~~e~~~l~~l~H~niv~l~g~~~~~~~~~~~lV  486 (689)
                      +|...+.||+|+||.||+|... +++.||+|.+......  ...+.+..|++++..++|+||+++++++.  .....++|
T Consensus         2 ~y~~~~~ig~g~~g~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~--~~~~~~lv   79 (316)
T cd05574           2 HFKKIKLLGKGDVGRVFLVRLKGTGKLFALKVLDKKEMIKRNKVKRVLTEQEILATLDHPFLPTLYASFQ--TETYLCLV   79 (316)
T ss_pred             ceEEeeeecCCccEEEEEEEEcCCCcEEEEEEEeccccchHHHHHHHHHHHHHHHhCCCCCchhheeeee--cCCEEEEE
Confidence            5778899999999999999976 5899999999865433  24567899999999999999999999884  35789999


Q ss_pred             EEcCCCCCHHHHhhhcCCCCCCCCHHHHHHHHHHHHHHHhhhhCCCCCCCceeecCCCCCceeecCCCCeEEeccccccc
Q 005586          487 YDFAPKGKLSKYLDQEEGSSNVLDWSTRVSIIIGIAKGIGYLHSSEVNKPAIVHRNLSVEKVLIDQQFNPLIADCGLHKL  566 (689)
Q Consensus       487 ~e~~~~gsL~~~L~~~~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~~~ivH~dlk~~NiLl~~~~~~kl~DfGla~~  566 (689)
                      |||+++++|.+++....  ...+++..+..++.|++.||+|||+.+     ++||||||+||+++.++.++|+|||++..
T Consensus        80 ~e~~~~~~L~~~~~~~~--~~~l~~~~~~~~~~qi~~~l~~lH~~~-----i~H~dlkp~Nili~~~~~~~l~dfg~~~~  152 (316)
T cd05574          80 MDYCPGGELFRLLQRQP--GKCLSEEVARFYAAEVLLALEYLHLLG-----IVYRDLKPENILLHESGHIMLSDFDLSKQ  152 (316)
T ss_pred             EEecCCCCHHHHHHhCC--CCccCHHHHHHHHHHHHHHHHHHHHCC-----eeccCCChHHeEEcCCCCEEEeecchhhc
Confidence            99999999999987543  235899999999999999999999987     99999999999999999999999999875


Q ss_pred             ccCCcee----------------------------eeecCCCCCCCCCccccccCCCCCcccchhHHHHHHHHHhCCCCc
Q 005586          567 LADDIVF----------------------------SVLKTSAAMGYLAPEYVTTGRFTERSDIFAFGVIILQILTGSLVL  618 (689)
Q Consensus       567 ~~~~~~~----------------------------~~~~~~~~~~y~aPE~~~~~~~~~ksDV~sfGvvl~elltG~~p~  618 (689)
                      .......                            ......++..|+|||++.+..++.++||||||+++|||++|+.||
T Consensus       153 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Di~slG~ll~~l~~g~~pf  232 (316)
T cd05574         153 SDVEPPPVSKALRKGSRRSSVNSIPSETFSEEPSFRSNSFVGTEEYIAPEVISGDGHGSAVDWWTLGILLYEMLYGTTPF  232 (316)
T ss_pred             ccccccccccccccccccccccccchhhhcccccCCCCCCcCccCCcCHHHHcCCCCCchHHHHHHHHHHHHHhhCCCCC
Confidence            5322100                            001124677899999999888999999999999999999999999


Q ss_pred             chhHHHHHhhhhhhHhhccccCCCCCHHHHHHHHHHHHHhccCCCCCCCC----HHHHHHHHH
Q 005586          619 TSSMRLAAESATFENFIDRNLKGKFSESEAAKLGKMALVCTHEDPENRPT----MEAVIEELT  677 (689)
Q Consensus       619 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~Cl~~dp~~RPs----~~evl~~L~  677 (689)
                      ......    ..+.++.+...........+..+.+++.+|++.||++||+    +.|++.+-+
T Consensus       233 ~~~~~~----~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~R~s~~~~~~~ll~~~~  291 (316)
T cd05574         233 KGSNRD----ETFSNILKKEVTFPGSPPVSSSARDLIRKLLVKDPSKRLGSKRGAAEIKQHPF  291 (316)
T ss_pred             CCCchH----HHHHHHhcCCccCCCccccCHHHHHHHHHHccCCHhHCCCchhhHHHHHcCch
Confidence            644222    1222233222221112225678999999999999999999    777777643

Serine/Threonine Kinases (STKs), Phototropin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The phototropin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Included in this subfamily are plant phototropins and predominantly uncharacterized fungal STKs whose catalytic domains resemble the phototropin kinase domain. One protein from Neurospora crassa is called nrc-2. Phototropins are blue-light receptors that control responses such as phototropism, stromatal opening, and chloroplast movement in order to optimize the photosynthetic efficiency of plants. They are light-activated STKs that contain an N-termin

>KOG0577 consensus Serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=1e-36  Score=315.16  Aligned_cols=257  Identities=22%  Similarity=0.377  Sum_probs=209.5

Q ss_pred             cCCcccccccCCcceEEEEEe-cCCcEEEEEEecccCCchH--HHHHHHHHHHHhccCCCcceeEeeEEEcCCCCeEEEE
Q 005586          410 CFSEVNLLGKGNFSSVYKGTL-RDGTLVAIRSINVTSCKSE--EAEFVKGLYLLTSLRHENIIRLRGFCCSRGRGECFLI  486 (689)
Q Consensus       410 ~f~~~~~lg~G~~g~Vy~~~~-~~g~~vavK~l~~~~~~~~--~~~f~~e~~~l~~l~H~niv~l~g~~~~~~~~~~~lV  486 (689)
                      .|+..+.||.|+||.||-|+. ++...||||++.-......  -+++.+|+++|.+++|||++.+.|+|..+  ...++|
T Consensus        27 lf~dLrEIGHGSFGAVYfArd~~n~evVAIKKMsySGKQs~EKWqDIlKEVrFL~~l~HPntieYkgCyLre--~TaWLV  104 (948)
T KOG0577|consen   27 LFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDILKEVRFLRQLRHPNTIEYKGCYLRE--HTAWLV  104 (948)
T ss_pred             HHHHHHHhcCCccceeEEeeccCccceeeeeeccccccccHHHHHHHHHHHHHHHhccCCCcccccceeecc--chHHHH
Confidence            466778899999999999986 4788999999976543322  26899999999999999999999988654  568999


Q ss_pred             EEcCCCCCHHHHhhhcCCCCCCCCHHHHHHHHHHHHHHHhhhhCCCCCCCceeecCCCCCceeecCCCCeEEeccccccc
Q 005586          487 YDFAPKGKLSKYLDQEEGSSNVLDWSTRVSIIIGIAKGIGYLHSSEVNKPAIVHRNLSVEKVLIDQQFNPLIADCGLHKL  566 (689)
Q Consensus       487 ~e~~~~gsL~~~L~~~~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~~~ivH~dlk~~NiLl~~~~~~kl~DfGla~~  566 (689)
                      |||| -||-.++|.-..   .++...++-.|..|++.||+|||+.+     .||||||+-||||++.|.||++|||.+..
T Consensus       105 MEYC-lGSAsDlleVhk---KplqEvEIAAi~~gaL~gLaYLHS~~-----~IHRDiKAGNILLse~g~VKLaDFGSAsi  175 (948)
T KOG0577|consen  105 MEYC-LGSASDLLEVHK---KPLQEVEIAAITHGALQGLAYLHSHN-----RIHRDIKAGNILLSEPGLVKLADFGSASI  175 (948)
T ss_pred             HHHH-hccHHHHHHHHh---ccchHHHHHHHHHHHHHHHHHHHHhh-----HHhhhccccceEecCCCeeeeccccchhh
Confidence            9999 578888876543   35888899999999999999999988     89999999999999999999999999987


Q ss_pred             ccCCceeeeecCCCCCCCCCccccc---cCCCCCcccchhHHHHHHHHHhCCCCcchhHHHHHhhhhhhHhhccccCCCC
Q 005586          567 LADDIVFSVLKTSAAMGYLAPEYVT---TGRFTERSDIFAFGVIILQILTGSLVLTSSMRLAAESATFENFIDRNLKGKF  643 (689)
Q Consensus       567 ~~~~~~~~~~~~~~~~~y~aPE~~~---~~~~~~ksDV~sfGvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~  643 (689)
                      +.+.     ....||+.|||||++.   .+.|+-|+||||+||.-.||.-.++|+....-..... .+.+--.|.+.   
T Consensus       176 ~~PA-----nsFvGTPywMAPEVILAMDEGqYdgkvDvWSLGITCIELAERkPPlFnMNAMSALY-HIAQNesPtLq---  246 (948)
T KOG0577|consen  176 MAPA-----NSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSALY-HIAQNESPTLQ---  246 (948)
T ss_pred             cCch-----hcccCCccccchhHheeccccccCCccceeeccchhhhhhhcCCCccCchHHHHHH-HHHhcCCCCCC---
Confidence            7643     3457999999999975   5789999999999999999999999985432211111 11111122332   


Q ss_pred             CHHHHHHHHHHHHHhccCCCCCCCCHHHHHHHHHhhCCccccc
Q 005586          644 SESEAAKLGKMALVCTHEDPENRPTMEAVIEELTVAAPVMATF  686 (689)
Q Consensus       644 ~~~~~~~l~~l~~~Cl~~dp~~RPs~~evl~~L~~~~p~~~~~  686 (689)
                      ..+.+..+..++..|+++-|.+|||..+++++--..++++++-
T Consensus       247 s~eWS~~F~~Fvd~CLqKipqeRptse~ll~H~fv~R~Rp~tv  289 (948)
T KOG0577|consen  247 SNEWSDYFRNFVDSCLQKIPQERPTSEELLKHRFVLRERPPTV  289 (948)
T ss_pred             CchhHHHHHHHHHHHHhhCcccCCcHHHHhhcchhccCCCchH
Confidence            4567889999999999999999999999999987777776653

>cd05586 STKc_Sck1_like Catalytic domain of Suppressor of loss of cAMP-dependent protein kinase-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=2.6e-36  Score=319.58  Aligned_cols=243  Identities=20%  Similarity=0.284  Sum_probs=187.1

Q ss_pred             cccCCcceEEEEEec-CCcEEEEEEecccCC--chHHHHHHHHHHHHhcc---CCCcceeEeeEEEcCCCCeEEEEEEcC
Q 005586          417 LGKGNFSSVYKGTLR-DGTLVAIRSINVTSC--KSEEAEFVKGLYLLTSL---RHENIIRLRGFCCSRGRGECFLIYDFA  490 (689)
Q Consensus       417 lg~G~~g~Vy~~~~~-~g~~vavK~l~~~~~--~~~~~~f~~e~~~l~~l---~H~niv~l~g~~~~~~~~~~~lV~e~~  490 (689)
                      ||+|+||.||+|+.+ +|+.||+|++.....  ......+..|..++.+.   +||||+++++++..  ....++||||+
T Consensus         1 lG~G~~g~Vy~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~p~i~~~~~~~~~--~~~~~lv~e~~   78 (330)
T cd05586           1 IGKGTFGQVYQVRKKDTRRIYAMKVLSKKEIVAKKEVAHTIGERNILVRTLLDESPFIVGLKFSFQT--DSDLYLVTDYM   78 (330)
T ss_pred             CCCCCceEEEEEEECCCCCEEEEEEEeHHHHhhhhHHHHHHHHHHHHHHhccCCCCcCcceEEEEec--CCeEEEEEcCC
Confidence            799999999999876 689999999865421  12234556677777665   69999999998843  57899999999


Q ss_pred             CCCCHHHHhhhcCCCCCCCCHHHHHHHHHHHHHHHhhhhCCCCCCCceeecCCCCCceeecCCCCeEEecccccccccCC
Q 005586          491 PKGKLSKYLDQEEGSSNVLDWSTRVSIIIGIAKGIGYLHSSEVNKPAIVHRNLSVEKVLIDQQFNPLIADCGLHKLLADD  570 (689)
Q Consensus       491 ~~gsL~~~L~~~~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~~~ivH~dlk~~NiLl~~~~~~kl~DfGla~~~~~~  570 (689)
                      ++|+|.+++....    .+++.....++.||++||+|||+.+     |+||||||+|||+++++.+||+|||+++.....
T Consensus        79 ~~g~L~~~l~~~~----~~~~~~~~~~~~qil~al~~LH~~~-----ivHrDlkp~Nili~~~~~~kl~Dfg~a~~~~~~  149 (330)
T cd05586          79 SGGELFWHLQKEG----RFSEDRAKFYIAELVLALEHLHKYD-----IVYRDLKPENILLDATGHIALCDFGLSKANLTD  149 (330)
T ss_pred             CCChHHHHHHhcC----CCCHHHHHHHHHHHHHHHHHHHHCC-----eEeccCCHHHeEECCCCCEEEecCCcCcCCCCC
Confidence            9999999987543    3889999999999999999999987     999999999999999999999999998754322


Q ss_pred             ceeeeecCCCCCCCCCccccccC-CCCCcccchhHHHHHHHHHhCCCCcchhHHHHHhhhhhhHhhccccCCCCC-HHHH
Q 005586          571 IVFSVLKTSAAMGYLAPEYVTTG-RFTERSDIFAFGVIILQILTGSLVLTSSMRLAAESATFENFIDRNLKGKFS-ESEA  648 (689)
Q Consensus       571 ~~~~~~~~~~~~~y~aPE~~~~~-~~~~ksDV~sfGvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~  648 (689)
                      .. ......||..|+|||.+.+. .++.++|||||||++|||+||+.||........    +..+.....  .++ ....
T Consensus       150 ~~-~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwslGvil~elltG~~Pf~~~~~~~~----~~~i~~~~~--~~~~~~~~  222 (330)
T cd05586         150 NK-TTNTFCGTTEYLAPEVLLDEKGYTKHVDFWSLGVLVFEMCCGWSPFYAEDTQQM----YRNIAFGKV--RFPKNVLS  222 (330)
T ss_pred             CC-CccCccCCccccCHHHHcCCCCCCCccceeccccEEEEeccCCCCCCCCCHHHH----HHHHHcCCC--CCCCccCC
Confidence            11 12234578899999998764 479999999999999999999999865322111    111111111  111 1235


Q ss_pred             HHHHHHHHHhccCCCCCCC----CHHHHHHHHH
Q 005586          649 AKLGKMALVCTHEDPENRP----TMEAVIEELT  677 (689)
Q Consensus       649 ~~l~~l~~~Cl~~dp~~RP----s~~evl~~L~  677 (689)
                      .++.+++.+|++.||++||    ++.|++++.+
T Consensus       223 ~~~~~li~~~L~~~P~~R~~~~~~~~~ll~h~~  255 (330)
T cd05586         223 DEGRQFVKGLLNRNPQHRLGAHRDAVELKEHPF  255 (330)
T ss_pred             HHHHHHHHHHcCCCHHHCCCCCCCHHHHhcCcc
Confidence            6788999999999999998    5777776543

Serine/Threonine Kinases (STKs), Fission yeast Suppressor of loss of cAMP-dependent protein kinase (Sck1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sck1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the Schizosaccharomyces pombe STK Sck1. Sck1 plays a role in trehalase activation triggered by glucose and a nitrogen source. Trehalase catalyzes the cleavage of the disaccharide trehalose to glucose. Trehalose, as a carbohydrate reserve and stress metabolite, plays an important role in the response of

>cd07839 STKc_CDK5 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 5

Probab=100.00  E-value=3.4e-36  Score=311.61  Aligned_cols=255  Identities=18%  Similarity=0.332  Sum_probs=194.1

Q ss_pred             cCCcccccccCCcceEEEEEec-CCcEEEEEEecccCCc-hHHHHHHHHHHHHhccCCCcceeEeeEEEcCCCCeEEEEE
Q 005586          410 CFSEVNLLGKGNFSSVYKGTLR-DGTLVAIRSINVTSCK-SEEAEFVKGLYLLTSLRHENIIRLRGFCCSRGRGECFLIY  487 (689)
Q Consensus       410 ~f~~~~~lg~G~~g~Vy~~~~~-~g~~vavK~l~~~~~~-~~~~~f~~e~~~l~~l~H~niv~l~g~~~~~~~~~~~lV~  487 (689)
                      +|...+.||+|+||.||+|... +|..||+|++...... .....+.+|++++++++||||+++++++.+  ....++|+
T Consensus         1 ~y~~~~~l~~g~~~~vy~~~~~~~g~~~~~k~~~~~~~~~~~~~~~~~ei~~l~~l~h~~i~~~~~~~~~--~~~~~lv~   78 (284)
T cd07839           1 KYEKLEKIGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRLYDVLHS--DKKLTLVF   78 (284)
T ss_pred             CceeEEEecccCCeEEEEEEECCCCcEEEEEEeecccccccCccchhHHHHHHHhcCCCCeeeHHHHhcc--CCceEEEE
Confidence            3667789999999999999975 6899999998754322 223567889999999999999999998843  56899999


Q ss_pred             EcCCCCCHHHHhhhcCCCCCCCCHHHHHHHHHHHHHHHhhhhCCCCCCCceeecCCCCCceeecCCCCeEEecccccccc
Q 005586          488 DFAPKGKLSKYLDQEEGSSNVLDWSTRVSIIIGIAKGIGYLHSSEVNKPAIVHRNLSVEKVLIDQQFNPLIADCGLHKLL  567 (689)
Q Consensus       488 e~~~~gsL~~~L~~~~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~~~ivH~dlk~~NiLl~~~~~~kl~DfGla~~~  567 (689)
                      ||++ ++|.+++.....   .+++.....++.||++||.|||+.+     |+||||||+||+++.++.+||+|||+++..
T Consensus        79 e~~~-~~l~~~~~~~~~---~~~~~~~~~~~~qi~~al~~LH~~~-----i~H~dl~~~nil~~~~~~~~l~dfg~~~~~  149 (284)
T cd07839          79 EYCD-QDLKKYFDSCNG---DIDPEIVKSFMFQLLKGLAFCHSHN-----VLHRDLKPQNLLINKNGELKLADFGLARAF  149 (284)
T ss_pred             ecCC-CCHHHHHHhcCC---CCCHHHHHHHHHHHHHHHHHHHHCC-----EecCCCCHHHEEEcCCCcEEECccchhhcc
Confidence            9996 588888765432   4899999999999999999999987     999999999999999999999999999865


Q ss_pred             cCCceeeeecCCCCCCCCCccccccC-CCCCcccchhHHHHHHHHHhCCCCcchhHHHHHhhhh---------------h
Q 005586          568 ADDIVFSVLKTSAAMGYLAPEYVTTG-RFTERSDIFAFGVIILQILTGSLVLTSSMRLAAESAT---------------F  631 (689)
Q Consensus       568 ~~~~~~~~~~~~~~~~y~aPE~~~~~-~~~~ksDV~sfGvvl~elltG~~p~~~~~~~~~~~~~---------------~  631 (689)
                      ..... ......++..|+|||.+.+. .++.++|||||||++|||+||+.|+............               .
T Consensus       150 ~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  228 (284)
T cd07839         150 GIPVR-CYSAEVVTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPLFPGNDVDDQLKRIFRLLGTPTEESWPGV  228 (284)
T ss_pred             CCCCC-CcCCCccccCCcChHHHhCCcccCcHHHHHHHHHHHHHHHhcCCCCcCCCCHHHHHHHHHHHhCCCChHHhHHh
Confidence            43221 11223457789999988764 4689999999999999999999886322111000000               0


Q ss_pred             hHhhccccCCCC---------CHHHHHHHHHHHHHhccCCCCCCCCHHHHHHHH
Q 005586          632 ENFIDRNLKGKF---------SESEAAKLGKMALVCTHEDPENRPTMEAVIEEL  676 (689)
Q Consensus       632 ~~~~~~~~~~~~---------~~~~~~~l~~l~~~Cl~~dp~~RPs~~evl~~L  676 (689)
                      .+..+......+         ....+.++.+++.+|++.||++|||+.|++++.
T Consensus       229 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~t~~~il~h~  282 (284)
T cd07839         229 SKLPDYKPYPMYPATTSLVNVVPKLNSTGRDLLQNLLVCNPVQRISAEEALQHP  282 (284)
T ss_pred             hhcccccccCCCCCcchhhhhcccCCHHHHHHHHHHhcCChhhcCCHHHHhcCC
Confidence            000110000001         112356788999999999999999999998764

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 5 (CDK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK5 is unusual in that it is regulated by non-cyclin proteins, p35 and p39. It is highly expressed in the nervous system and is critical in normal neural development and function. It plays a role in neuronal migration and differentiation, and is also

>cd07833 STKc_CDKL Catalytic domain of Cyclin-Dependent protein Kinase Like Serine/Threonine Kinases

Probab=100.00  E-value=6.5e-36  Score=310.06  Aligned_cols=255  Identities=20%  Similarity=0.367  Sum_probs=198.6

Q ss_pred             cCCcccccccCCcceEEEEEec-CCcEEEEEEecccCC-chHHHHHHHHHHHHhccCCCcceeEeeEEEcCCCCeEEEEE
Q 005586          410 CFSEVNLLGKGNFSSVYKGTLR-DGTLVAIRSINVTSC-KSEEAEFVKGLYLLTSLRHENIIRLRGFCCSRGRGECFLIY  487 (689)
Q Consensus       410 ~f~~~~~lg~G~~g~Vy~~~~~-~g~~vavK~l~~~~~-~~~~~~f~~e~~~l~~l~H~niv~l~g~~~~~~~~~~~lV~  487 (689)
                      +|+..+.||+|+||.||+|..+ +++.||+|+++.... ......+.+|++++++++|+||+++++++..  .+..++||
T Consensus         2 ~y~~~~~i~~g~~~~v~~~~~~~~~~~v~vK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~--~~~~~iv~   79 (288)
T cd07833           2 KYEVLGVVGEGAYGVVLKCRNKATGEIVAIKKFKESEDDEDVKKTALREVKVLRQLRHENIVNLKEAFRR--KGRLYLVF   79 (288)
T ss_pred             ceeEEEEecccCCeeEEEEEeCCCCcEEEEehhhhhcccccchhHHHHHHHHHHhcCCCCeeehhheEEE--CCEEEEEE
Confidence            5778899999999999999986 588999999876432 2334678999999999999999999999854  56899999


Q ss_pred             EcCCCCCHHHHhhhcCCCCCCCCHHHHHHHHHHHHHHHhhhhCCCCCCCceeecCCCCCceeecCCCCeEEecccccccc
Q 005586          488 DFAPKGKLSKYLDQEEGSSNVLDWSTRVSIIIGIAKGIGYLHSSEVNKPAIVHRNLSVEKVLIDQQFNPLIADCGLHKLL  567 (689)
Q Consensus       488 e~~~~gsL~~~L~~~~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~~~ivH~dlk~~NiLl~~~~~~kl~DfGla~~~  567 (689)
                      ||++++.+..+....    ..+++.....++.|++.||+|||+.+     ++||||+|+||++++++.+||+|||++...
T Consensus        80 e~~~~~~l~~~~~~~----~~~~~~~~~~~~~~i~~~l~~LH~~~-----i~H~dl~~~ni~~~~~~~~kl~d~g~~~~~  150 (288)
T cd07833          80 EYVERTLLELLEASP----GGLPPDAVRSYIWQLLQAIAYCHSHN-----IIHRDIKPENILVSESGVLKLCDFGFARAL  150 (288)
T ss_pred             ecCCCCHHHHHHhcC----CCCCHHHHHHHHHHHHHHHHHHHHCC-----eecCCCCHHHeEECCCCCEEEEeeeccccc
Confidence            999987777665432    23889999999999999999999987     999999999999999999999999999876


Q ss_pred             cCCceeeeecCCCCCCCCCccccccC-CCCCcccchhHHHHHHHHHhCCCCcchhHHHHHhhhh----------hhHhh-
Q 005586          568 ADDIVFSVLKTSAAMGYLAPEYVTTG-RFTERSDIFAFGVIILQILTGSLVLTSSMRLAAESAT----------FENFI-  635 (689)
Q Consensus       568 ~~~~~~~~~~~~~~~~y~aPE~~~~~-~~~~ksDV~sfGvvl~elltG~~p~~~~~~~~~~~~~----------~~~~~-  635 (689)
                      ............++..|+|||++.+. .++.++||||||+++|||++|+.|+............          ..... 
T Consensus       151 ~~~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~~Dv~slG~~l~~l~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  230 (288)
T cd07833         151 RARPASPLTDYVATRWYRAPELLVGDTNYGKPVDVWAIGCIMAELLDGEPLFPGDSDIDQLYLIQKCLGPLPPSHQELFS  230 (288)
T ss_pred             CCCccccccCcccccCCcCCchhcCCCCcCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHhhhcc
Confidence            55432122233456789999999887 7899999999999999999999988643211100000          00000 


Q ss_pred             -ccccC--------------CCCCHHHHHHHHHHHHHhccCCCCCCCCHHHHHHH
Q 005586          636 -DRNLK--------------GKFSESEAAKLGKMALVCTHEDPENRPTMEAVIEE  675 (689)
Q Consensus       636 -~~~~~--------------~~~~~~~~~~l~~l~~~Cl~~dp~~RPs~~evl~~  675 (689)
                       ++...              ..++...+.++.+++..||..+|++||++++++++
T Consensus       231 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~~  285 (288)
T cd07833         231 SNPRFAGVAFPEPSQPESLERRYPGKVSSPALDFLKACLRMDPKERLTCDELLQH  285 (288)
T ss_pred             cCccccccccCCCCCcHHHHHhcCCccchHHHHHHHHHhccCchhcccHHHHhcC
Confidence             00000              01122236789999999999999999999999875

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like (CDKL) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDKL1-5 and similar proteins. Some CDKLs, like CDKL1 and CDKL3, may be implicated in transformation and others, like CDKL3 and CDKL5, are associated with mental retardation when impaired. CDKL2 plays a role in learning

>cd06630 STKc_MEKK1 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 1

Probab=100.00  E-value=2.1e-35  Score=302.87  Aligned_cols=255  Identities=22%  Similarity=0.365  Sum_probs=201.6

Q ss_pred             cCCcccccccCCcceEEEEEe-cCCcEEEEEEecccCCc-----hHHHHHHHHHHHHhccCCCcceeEeeEEEcCCCCeE
Q 005586          410 CFSEVNLLGKGNFSSVYKGTL-RDGTLVAIRSINVTSCK-----SEEAEFVKGLYLLTSLRHENIIRLRGFCCSRGRGEC  483 (689)
Q Consensus       410 ~f~~~~~lg~G~~g~Vy~~~~-~~g~~vavK~l~~~~~~-----~~~~~f~~e~~~l~~l~H~niv~l~g~~~~~~~~~~  483 (689)
                      +|+..+.||+|+||.||+|.. .++..||+|.+......     .....+.+|++.+++++|+||+++++++.  ..+..
T Consensus         1 ~~~~~~~lg~g~~~~v~~~~~~~~~~~~alk~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~--~~~~~   78 (268)
T cd06630           1 EWLKGQQLGTGAFSSCYQARDVKTGTLMAVKQVTYVRNTSSEQEEVVEALRKEIRLMARLNHPHIIRMLGATC--EDSHF   78 (268)
T ss_pred             CccccceecCcCceEEEEEEEcCCCcEEEEEEeecccCCchhHHHHHHHHHHHHHHHHHcCCCceehhhceec--cCCeE
Confidence            366778999999999999986 47899999998754321     13468899999999999999999999984  35788


Q ss_pred             EEEEEcCCCCCHHHHhhhcCCCCCCCCHHHHHHHHHHHHHHHhhhhCCCCCCCceeecCCCCCceeecCCC-CeEEeccc
Q 005586          484 FLIYDFAPKGKLSKYLDQEEGSSNVLDWSTRVSIIIGIAKGIGYLHSSEVNKPAIVHRNLSVEKVLIDQQF-NPLIADCG  562 (689)
Q Consensus       484 ~lV~e~~~~gsL~~~L~~~~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~~~ivH~dlk~~NiLl~~~~-~~kl~DfG  562 (689)
                      ++||||+++++|.+++....    .+++..+..++.|++.||+|||+.+     ++|+||||+||+++.++ .+||+|||
T Consensus        79 ~~v~e~~~~~~L~~~l~~~~----~~~~~~~~~~~~ql~~al~~LH~~~-----i~H~~i~~~nil~~~~~~~~~l~dfg  149 (268)
T cd06630          79 NLFVEWMAGGSVSHLLSKYG----AFKEAVIINYTEQLLRGLSYLHENQ-----IIHRDVKGANLLIDSTGQRLRIADFG  149 (268)
T ss_pred             EEEEeccCCCcHHHHHHHhC----CCCHHHHHHHHHHHHHHHHHHHhCC-----eecCCCCHHHEEEcCCCCEEEEcccc
Confidence            99999999999999997543    4889999999999999999999987     99999999999998776 58999999


Q ss_pred             ccccccCCceee---eecCCCCCCCCCccccccCCCCCcccchhHHHHHHHHHhCCCCcchhHHHHHhhhhhhHhhcccc
Q 005586          563 LHKLLADDIVFS---VLKTSAAMGYLAPEYVTTGRFTERSDIFAFGVIILQILTGSLVLTSSMRLAAESATFENFIDRNL  639 (689)
Q Consensus       563 la~~~~~~~~~~---~~~~~~~~~y~aPE~~~~~~~~~ksDV~sfGvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~  639 (689)
                      .+..+.......   .....++..|+|||.+.+..++.++||||+|+++|||++|+.|+........ .....+......
T Consensus       150 ~~~~~~~~~~~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~~~~-~~~~~~~~~~~~  228 (268)
T cd06630         150 AAARLAAKGTGAGEFQGQLLGTIAFMAPEVLRGEQYGRSCDVWSVGCVIIEMATAKPPWNAEKHSNH-LALIFKIASATT  228 (268)
T ss_pred             cccccccccccCCccccccccccceeCHhHhccCCCCcccchHHHHHHHHHHHhCCCCCCCCCCcch-HHHHHHHhccCC
Confidence            988765431110   1123467789999999888899999999999999999999999853221110 011111111122


Q ss_pred             CCCCCHHHHHHHHHHHHHhccCCCCCCCCHHHHHHHH
Q 005586          640 KGKFSESEAAKLGKMALVCTHEDPENRPTMEAVIEEL  676 (689)
Q Consensus       640 ~~~~~~~~~~~l~~l~~~Cl~~dp~~RPs~~evl~~L  676 (689)
                      ....+.....++.+++.+|+..+|++||++.|++++-
T Consensus       229 ~~~~~~~~~~~~~~~i~~~l~~~p~~R~~~~~ll~~~  265 (268)
T cd06630         229 APSIPEHLSPGLRDVTLRCLELQPEDRPPSRELLKHP  265 (268)
T ss_pred             CCCCchhhCHHHHHHHHHHcCCCcccCcCHHHHhcCc
Confidence            2344555677899999999999999999999998753

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 1 (MEKK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK1 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK1 activates the extracellular signal-regulated kinase 1/2 (ERK1/2) and c-Jun N-terminal kinase (JNK) pathways by activating their

>PHA03207 serine/threonine kinase US3; Provisional

Probab=100.00  E-value=1e-35  Score=322.22  Aligned_cols=254  Identities=16%  Similarity=0.254  Sum_probs=196.9

Q ss_pred             hccCCcccccccCCcceEEEEEec---CCcEEEEEEecccCCchHHHHHHHHHHHHhccCCCcceeEeeEEEcCCCCeEE
Q 005586          408 TQCFSEVNLLGKGNFSSVYKGTLR---DGTLVAIRSINVTSCKSEEAEFVKGLYLLTSLRHENIIRLRGFCCSRGRGECF  484 (689)
Q Consensus       408 t~~f~~~~~lg~G~~g~Vy~~~~~---~g~~vavK~l~~~~~~~~~~~f~~e~~~l~~l~H~niv~l~g~~~~~~~~~~~  484 (689)
                      ..+|...+.||+|+||.||++...   .+..||+|.+....      .+.+|++++++++|||||++++++..  ....+
T Consensus        91 ~~~y~i~~~Lg~G~~g~Vy~~~~~~~~~~~~v~vK~~~~~~------~~~~E~~il~~l~h~~iv~~~~~~~~--~~~~~  162 (392)
T PHA03207         91 RMQYNILSSLTPGSEGEVFVCTKHGDEQRKKVIVKAVTGGK------TPGREIDILKTISHRAIINLIHAYRW--KSTVC  162 (392)
T ss_pred             cCceEEEEeecCCCCeEEEEEEEcCCccceeEEEEeccccc------cHHHHHHHHHhcCCCCccceeeeEee--CCEEE
Confidence            356888999999999999999754   36789999876432      35689999999999999999998843  46789


Q ss_pred             EEEEcCCCCCHHHHhhhcCCCCCCCCHHHHHHHHHHHHHHHhhhhCCCCCCCceeecCCCCCceeecCCCCeEEeccccc
Q 005586          485 LIYDFAPKGKLSKYLDQEEGSSNVLDWSTRVSIIIGIAKGIGYLHSSEVNKPAIVHRNLSVEKVLIDQQFNPLIADCGLH  564 (689)
Q Consensus       485 lV~e~~~~gsL~~~L~~~~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~~~ivH~dlk~~NiLl~~~~~~kl~DfGla  564 (689)
                      +||||+. ++|.+++...    ..++|.+++.|+.|++.||+|||+.+     |+||||||+|||+++++.+||+|||++
T Consensus       163 lv~e~~~-~~l~~~l~~~----~~l~~~~~~~i~~ql~~aL~~LH~~g-----ivHrDlkp~Nill~~~~~~~l~DfG~a  232 (392)
T PHA03207        163 MVMPKYK-CDLFTYVDRS----GPLPLEQAITIQRRLLEALAYLHGRG-----IIHRDVKTENIFLDEPENAVLGDFGAA  232 (392)
T ss_pred             EEehhcC-CCHHHHHHhc----CCCCHHHHHHHHHHHHHHHHHHHHCC-----ccccCCCHHHEEEcCCCCEEEccCccc
Confidence            9999995 6899888432    24899999999999999999999987     999999999999999999999999999


Q ss_pred             ccccCCcee-eeecCCCCCCCCCccccccCCCCCcccchhHHHHHHHHHhCCCCcchhHHH---HHhhh-----------
Q 005586          565 KLLADDIVF-SVLKTSAAMGYLAPEYVTTGRFTERSDIFAFGVIILQILTGSLVLTSSMRL---AAESA-----------  629 (689)
Q Consensus       565 ~~~~~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~ksDV~sfGvvl~elltG~~p~~~~~~~---~~~~~-----------  629 (689)
                      +........ ......+|..|+|||++.+..++.++|||||||++|||++|+.||......   .....           
T Consensus       233 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGvil~el~~g~~pf~~~~~~~~~~~l~~i~~~~~~~~~~  312 (392)
T PHA03207        233 CKLDAHPDTPQCYGWSGTLETNSPELLALDPYCAKTDIWSAGLVLFEMSVKNVTLFGKQVKSSSSQLRSIIRCMQVHPLE  312 (392)
T ss_pred             cccCcccccccccccccccCccCHhHhcCCCCCchhhHHHHHHHHHHHHHCCCCCCCCCCCCcHHHHHHHHHHhccCccc
Confidence            866543221 122346889999999999889999999999999999999999998542110   00000           


Q ss_pred             -----------hhhHhhccccCCCCC-------HHHHHHHHHHHHHhccCCCCCCCCHHHHHHHHHhhC
Q 005586          630 -----------TFENFIDRNLKGKFS-------ESEAAKLGKMALVCTHEDPENRPTMEAVIEELTVAA  680 (689)
Q Consensus       630 -----------~~~~~~~~~~~~~~~-------~~~~~~l~~l~~~Cl~~dp~~RPs~~evl~~L~~~~  680 (689)
                                 .+.++ ....+..+.       .....++.+++.+|+..||++||++.|++.+-+...
T Consensus       313 ~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~li~~ml~~dp~~Rpsa~e~l~~p~f~~  380 (392)
T PHA03207        313 FPQNGSTNLCKHFKQY-AIVLRPPYTIPPVIRKYGMHMDVEYLIAKMLTFDQEFRPSAQDILSLPLFTK  380 (392)
T ss_pred             cCCccchhHHHHHHhh-cccccCCccccchhhccCcchhHHHHHHHHhccChhhCCCHHHHhhCchhhc
Confidence                       00000 000111111       012346778999999999999999999999977654

>cd06635 STKc_TAO1 Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 1

Probab=100.00  E-value=4.8e-35  Score=308.14  Aligned_cols=254  Identities=19%  Similarity=0.368  Sum_probs=200.9

Q ss_pred             CCcccccccCCcceEEEEEec-CCcEEEEEEecccCC--chHHHHHHHHHHHHhccCCCcceeEeeEEEcCCCCeEEEEE
Q 005586          411 FSEVNLLGKGNFSSVYKGTLR-DGTLVAIRSINVTSC--KSEEAEFVKGLYLLTSLRHENIIRLRGFCCSRGRGECFLIY  487 (689)
Q Consensus       411 f~~~~~lg~G~~g~Vy~~~~~-~g~~vavK~l~~~~~--~~~~~~f~~e~~~l~~l~H~niv~l~g~~~~~~~~~~~lV~  487 (689)
                      |...+.||+|+||.||+|... +|..||+|++.....  .....++.+|++++++++|||++++++++..  ....++||
T Consensus        27 f~~~~~lg~G~~~~v~~~~~~~~~~~valK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~--~~~~~lv~  104 (317)
T cd06635          27 FTDLREIGHGSFGAVYFARDVRTNEVVAIKKMSYSGKQSNEKWQDIIKEVKFLQRIKHPNSIEYKGCYLR--EHTAWLVM  104 (317)
T ss_pred             hhhhheeccCCCeEEEEEEEcCCCcEEEEEEEecCCCCchHHHHHHHHHHHHHHhCCCCCEEEEEEEEee--CCeEEEEE
Confidence            556788999999999999975 689999999875432  2334578999999999999999999999854  46789999


Q ss_pred             EcCCCCCHHHHhhhcCCCCCCCCHHHHHHHHHHHHHHHhhhhCCCCCCCceeecCCCCCceeecCCCCeEEecccccccc
Q 005586          488 DFAPKGKLSKYLDQEEGSSNVLDWSTRVSIIIGIAKGIGYLHSSEVNKPAIVHRNLSVEKVLIDQQFNPLIADCGLHKLL  567 (689)
Q Consensus       488 e~~~~gsL~~~L~~~~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~~~ivH~dlk~~NiLl~~~~~~kl~DfGla~~~  567 (689)
                      ||++ |+|.+.+....   ..++|.++..++.|++.||.|||+.+     |+||||+|+||++++++.+||+|||++...
T Consensus       105 e~~~-g~l~~~~~~~~---~~l~~~~~~~i~~~i~~~l~~lH~~~-----i~H~dL~p~Nil~~~~~~~kl~dfg~~~~~  175 (317)
T cd06635         105 EYCL-GSASDLLEVHK---KPLQEVEIAAITHGALQGLAYLHSHN-----MIHRDIKAGNILLTEPGQVKLADFGSASIA  175 (317)
T ss_pred             eCCC-CCHHHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHHCC-----cccCCCCcccEEECCCCCEEEecCCCcccc
Confidence            9996 58888876443   24899999999999999999999987     999999999999999999999999998765


Q ss_pred             cCCceeeeecCCCCCCCCCccccc---cCCCCCcccchhHHHHHHHHHhCCCCcchhHHHHHhhhhhhHhhccccCCCCC
Q 005586          568 ADDIVFSVLKTSAAMGYLAPEYVT---TGRFTERSDIFAFGVIILQILTGSLVLTSSMRLAAESATFENFIDRNLKGKFS  644 (689)
Q Consensus       568 ~~~~~~~~~~~~~~~~y~aPE~~~---~~~~~~ksDV~sfGvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~  644 (689)
                      ...     ....++..|+|||++.   .+.++.++|||||||++|||++|+.|+........    ...+..........
T Consensus       176 ~~~-----~~~~~~~~y~aPE~~~~~~~~~~~~~~Dv~slGvil~el~~g~~p~~~~~~~~~----~~~~~~~~~~~~~~  246 (317)
T cd06635         176 SPA-----NSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSA----LYHIAQNESPTLQS  246 (317)
T ss_pred             CCc-----ccccCCccccChhhhhcCCCCCCCccccHHHHHHHHHHHHhCCCCCCCccHHHH----HHHHHhccCCCCCC
Confidence            432     1234677899999974   45689999999999999999999999854321111    11111111111222


Q ss_pred             HHHHHHHHHHHHHhccCCCCCCCCHHHHHHHHHhhCCccc
Q 005586          645 ESEAAKLGKMALVCTHEDPENRPTMEAVIEELTVAAPVMA  684 (689)
Q Consensus       645 ~~~~~~l~~l~~~Cl~~dp~~RPs~~evl~~L~~~~p~~~  684 (689)
                      ......+.+++.+|++.+|++||++.+|++++........
T Consensus       247 ~~~~~~l~~li~~~l~~~p~~Rpt~~~il~~~~~~~~~~~  286 (317)
T cd06635         247 NEWSDYFRNFVDSCLQKIPQDRPTSEELLKHMFVLRERPE  286 (317)
T ss_pred             ccccHHHHHHHHHHccCCcccCcCHHHHHhChhhhccCcc
Confidence            3456678999999999999999999999998877665543

Serine/threonine kinases (STKs), thousand-and-one amino acids 1 (TAO1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO1 is sometimes referred to as prostate-derived sterile 20-like kinase 2 (PSK2). TAO1 activates the p38 MAPK through direct interaction with and activation of MEK3. TAO1 is highly expressed in the brain and may play a role in neuron

>cd07843 STKc_CDC2L1 Catalytic domain of the Serine/Threonine Kinase, Cell Division Cycle 2-like 1

Probab=100.00  E-value=1.3e-35  Score=308.75  Aligned_cols=257  Identities=17%  Similarity=0.332  Sum_probs=198.7

Q ss_pred             ccCCcccccccCCcceEEEEEec-CCcEEEEEEecccCCc-hHHHHHHHHHHHHhccCCCcceeEeeEEEcCCCCeEEEE
Q 005586          409 QCFSEVNLLGKGNFSSVYKGTLR-DGTLVAIRSINVTSCK-SEEAEFVKGLYLLTSLRHENIIRLRGFCCSRGRGECFLI  486 (689)
Q Consensus       409 ~~f~~~~~lg~G~~g~Vy~~~~~-~g~~vavK~l~~~~~~-~~~~~f~~e~~~l~~l~H~niv~l~g~~~~~~~~~~~lV  486 (689)
                      ++|+..+.||+|+||.||+|..+ +++.+|+|.++..... .....+.+|+.++.+++||||+++++++........++|
T Consensus         5 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~~~lv   84 (293)
T cd07843           5 DEYEKLNRIEEGTYGVVYRARDKKTGEIVALKKLKMEKEKEGFPITSLREINILLKLQHPNIVTVKEVVVGSNLDKIYMV   84 (293)
T ss_pred             hhhhhhhhhcCCCCeEEEEEEECCCCcEEEEEEEeeccccccchhhHHHHHHHHHhcCCCCEEEEEEEEEecCCCcEEEE
Confidence            35777889999999999999986 6899999999755422 223467789999999999999999999866555789999


Q ss_pred             EEcCCCCCHHHHhhhcCCCCCCCCHHHHHHHHHHHHHHHhhhhCCCCCCCceeecCCCCCceeecCCCCeEEeccccccc
Q 005586          487 YDFAPKGKLSKYLDQEEGSSNVLDWSTRVSIIIGIAKGIGYLHSSEVNKPAIVHRNLSVEKVLIDQQFNPLIADCGLHKL  566 (689)
Q Consensus       487 ~e~~~~gsL~~~L~~~~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~~~ivH~dlk~~NiLl~~~~~~kl~DfGla~~  566 (689)
                      |||++ ++|.+++.....   .+++..++.++.|++.||+|||+.+     |+||||||+||++++++.+||+|||+++.
T Consensus        85 ~e~~~-~~L~~~~~~~~~---~l~~~~~~~i~~qi~~aL~~LH~~~-----i~H~dl~p~nili~~~~~~~l~d~g~~~~  155 (293)
T cd07843          85 MEYVE-HDLKSLMETMKQ---PFLQSEVKCLMLQLLSGVAHLHDNW-----ILHRDLKTSNLLLNNRGILKICDFGLARE  155 (293)
T ss_pred             ehhcC-cCHHHHHHhccC---CCCHHHHHHHHHHHHHHHHHHHHCC-----eeeccCCHHHEEECCCCcEEEeecCceee
Confidence            99997 599999876432   4899999999999999999999987     99999999999999999999999999987


Q ss_pred             ccCCceeeeecCCCCCCCCCccccccC-CCCCcccchhHHHHHHHHHhCCCCcchhHHHHHhhhhhh-------------
Q 005586          567 LADDIVFSVLKTSAAMGYLAPEYVTTG-RFTERSDIFAFGVIILQILTGSLVLTSSMRLAAESATFE-------------  632 (689)
Q Consensus       567 ~~~~~~~~~~~~~~~~~y~aPE~~~~~-~~~~ksDV~sfGvvl~elltG~~p~~~~~~~~~~~~~~~-------------  632 (689)
                      ...... ......++..|+|||.+.+. .++.++|+||||+++|||++|+.|+..............             
T Consensus       156 ~~~~~~-~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~~  234 (293)
T cd07843         156 YGSPLK-PYTQLVVTLWYRAPELLLGAKEYSTAIDMWSVGCIFAELLTKKPLFPGKSEIDQLNKIFKLLGTPTEKIWPGF  234 (293)
T ss_pred             ccCCcc-ccccccccccccCchhhcCCccccchhhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCchHHHHHh
Confidence            654321 11223456789999988654 468999999999999999999999864322111100000             


Q ss_pred             -H-----------hhccccCCCCCHH-HHHHHHHHHHHhccCCCCCCCCHHHHHHH
Q 005586          633 -N-----------FIDRNLKGKFSES-EAAKLGKMALVCTHEDPENRPTMEAVIEE  675 (689)
Q Consensus       633 -~-----------~~~~~~~~~~~~~-~~~~l~~l~~~Cl~~dp~~RPs~~evl~~  675 (689)
                       +           .....+...++.. ....+.+++..|++.+|++||++.|++++
T Consensus       235 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~R~t~~ell~~  290 (293)
T cd07843         235 SELPGAKKKTFTKYPYNQLRKKFPALSLSDNGFDLLNRLLTYDPAKRISAEDALKH  290 (293)
T ss_pred             hccchhcccccccccchhhhccccccCCChHHHHHHHHHhccCccccCCHHHHhcC
Confidence             0           0000011112221 35678899999999999999999999875

Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 1 (CDC2L1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L1, also called PITSLRE, exists in different isoforms which are named using the alias CDK11(p). The CDC2L1 gene produces two protein products, CDK11(p110) and CDK11(p58). CDC2L1 is also represented by the caspase-processed CDK11(p46). CDK11(p110), the

>KOG0574 consensus STE20-like serine/threonine kinase MST [Signal transduction mechanisms]

Probab=100.00  E-value=9.1e-38  Score=299.28  Aligned_cols=249  Identities=20%  Similarity=0.356  Sum_probs=209.0

Q ss_pred             CCcccccccCCcceEEEEEec-CCcEEEEEEecccCCchHHHHHHHHHHHHhccCCCcceeEeeEEEcCCCCeEEEEEEc
Q 005586          411 FSEVNLLGKGNFSSVYKGTLR-DGTLVAIRSINVTSCKSEEAEFVKGLYLLTSLRHENIIRLRGFCCSRGRGECFLIYDF  489 (689)
Q Consensus       411 f~~~~~lg~G~~g~Vy~~~~~-~g~~vavK~l~~~~~~~~~~~f~~e~~~l~~l~H~niv~l~g~~~~~~~~~~~lV~e~  489 (689)
                      |...++||+|+||.||+|.++ .|..||||.+....   +.+++.+|+.+|++.+.|++|++||-|..  ...+++||||
T Consensus        35 FDi~~KLGEGSYGSV~KAIH~EsG~v~AIK~VPV~s---DLQEIIKEISIMQQC~S~yVVKYYGSYFK--~sDLWIVMEY  109 (502)
T KOG0574|consen   35 FDIVGKLGEGSYGSVHKAIHRESGHVLAIKKVPVDT---DLQEIIKEISIMQQCKSKYVVKYYGSYFK--HSDLWIVMEY  109 (502)
T ss_pred             HHHHHHhcCCcchHHHHHHHhccCcEEEEEecCccc---hHHHHHHHHHHHHHcCCchhhhhhhhhcc--CCceEeehhh
Confidence            445689999999999999987 69999999988753   56789999999999999999999997743  4679999999


Q ss_pred             CCCCCHHHHhhhcCCCCCCCCHHHHHHHHHHHHHHHhhhhCCCCCCCceeecCCCCCceeecCCCCeEEecccccccccC
Q 005586          490 APKGKLSKYLDQEEGSSNVLDWSTRVSIIIGIAKGIGYLHSSEVNKPAIVHRNLSVEKVLIDQQFNPLIADCGLHKLLAD  569 (689)
Q Consensus       490 ~~~gsL~~~L~~~~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~~~ivH~dlk~~NiLl~~~~~~kl~DfGla~~~~~  569 (689)
                      |-.|+..+.++..+   .+|.+.+.-.|....++||+|||...     -||||||+-||||+.+|.+|++|||.+..+.+
T Consensus       110 CGAGSiSDI~R~R~---K~L~E~EIs~iL~~TLKGL~YLH~~~-----KIHRDIKAGNILLNT~G~AKLADFGVAGQLTD  181 (502)
T KOG0574|consen  110 CGAGSISDIMRARR---KPLSEQEISAVLRDTLKGLQYLHDLK-----KIHRDIKAGNILLNTDGIAKLADFGVAGQLTD  181 (502)
T ss_pred             cCCCcHHHHHHHhc---CCccHHHHHHHHHHHHhHHHHHHHHH-----HHHhhcccccEEEcccchhhhhhccccchhhh
Confidence            99999999998654   46999999999999999999999876     69999999999999999999999999988765


Q ss_pred             CceeeeecCCCCCCCCCccccccCCCCCcccchhHHHHHHHHHhCCCCcchhHHHHHhhhhhhHhhccccCCCCCHHHHH
Q 005586          570 DIVFSVLKTSAAMGYLAPEYVTTGRFTERSDIFAFGVIILQILTGSLVLTSSMRLAAESATFENFIDRNLKGKFSESEAA  649 (689)
Q Consensus       570 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~ksDV~sfGvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  649 (689)
                      .. .....+.||+.|||||++..-.|..++||||+|+...||..|++|+.+-...   ...+.--..+.-.-..++..+.
T Consensus       182 TM-AKRNTVIGTPFWMAPEVI~EIGY~~~ADIWSLGITaIEMAEG~PPYsDIHPM---RAIFMIPT~PPPTF~KPE~WS~  257 (502)
T KOG0574|consen  182 TM-AKRNTVIGTPFWMAPEVIEEIGYDTKADIWSLGITAIEMAEGRPPYSDIHPM---RAIFMIPTKPPPTFKKPEEWSS  257 (502)
T ss_pred             hH-HhhCccccCcccccHHHHHHhccchhhhHhhhcchhhhhhcCCCCccccccc---ceeEeccCCCCCCCCChHhhhh
Confidence            32 2344567999999999999999999999999999999999999999653211   1111111111112234678899


Q ss_pred             HHHHHHHHhccCCCCCCCCHHHHHHHH
Q 005586          650 KLGKMALVCTHEDPENRPTMEAVIEEL  676 (689)
Q Consensus       650 ~l~~l~~~Cl~~dp~~RPs~~evl~~L  676 (689)
                      ++.+++..|+.+.|++|-|+-+++++-
T Consensus       258 ~F~DFi~~CLiK~PE~R~TA~~L~~H~  284 (502)
T KOG0574|consen  258 EFNDFIRSCLIKKPEERKTALRLCEHT  284 (502)
T ss_pred             HHHHHHHHHhcCCHHHHHHHHHHhhhh
Confidence            999999999999999999999998874

>cd05580 STKc_PKA Catalytic domain of the Protein Serine/Threonine Kinase, cAMP-dependent protein kinase

Probab=100.00  E-value=1.9e-35  Score=307.08  Aligned_cols=247  Identities=20%  Similarity=0.321  Sum_probs=202.1

Q ss_pred             ccCCcccccccCCcceEEEEEec-CCcEEEEEEecccCC--chHHHHHHHHHHHHhccCCCcceeEeeEEEcCCCCeEEE
Q 005586          409 QCFSEVNLLGKGNFSSVYKGTLR-DGTLVAIRSINVTSC--KSEEAEFVKGLYLLTSLRHENIIRLRGFCCSRGRGECFL  485 (689)
Q Consensus       409 ~~f~~~~~lg~G~~g~Vy~~~~~-~g~~vavK~l~~~~~--~~~~~~f~~e~~~l~~l~H~niv~l~g~~~~~~~~~~~l  485 (689)
                      ++|+..+.||+|+||.||++... +++.||+|.+.....  ......+.+|++++++++||||+++++++..  ....++
T Consensus         1 ~~y~~~~~ig~g~~~~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~--~~~~~~   78 (290)
T cd05580           1 DDFEFIKTLGTGSFGRVMLVRHKGSGKYYALKILSKAKIVKLKQVEHVLNEKRILQSIRHPFLVNLYGSFQD--DSNLYL   78 (290)
T ss_pred             CceEEEEEeecCCCeEEEEEEEcCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCccceeeEEEc--CCeEEE
Confidence            35778899999999999999976 689999999875432  2334678899999999999999999998854  477899


Q ss_pred             EEEcCCCCCHHHHhhhcCCCCCCCCHHHHHHHHHHHHHHHhhhhCCCCCCCceeecCCCCCceeecCCCCeEEecccccc
Q 005586          486 IYDFAPKGKLSKYLDQEEGSSNVLDWSTRVSIIIGIAKGIGYLHSSEVNKPAIVHRNLSVEKVLIDQQFNPLIADCGLHK  565 (689)
Q Consensus       486 V~e~~~~gsL~~~L~~~~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~~~ivH~dlk~~NiLl~~~~~~kl~DfGla~  565 (689)
                      ||||+++++|.+++....    .+++..+..++.|++.||.|||+.+     |+||||+|+||++++++.+||+|||+++
T Consensus        79 v~e~~~~~~L~~~~~~~~----~l~~~~~~~~~~qil~~l~~lH~~~-----i~H~dl~p~nili~~~~~~kl~dfg~~~  149 (290)
T cd05580          79 VMEYVPGGELFSHLRKSG----RFPEPVARFYAAQVVLALEYLHSLD-----IVYRDLKPENLLLDSDGYIKITDFGFAK  149 (290)
T ss_pred             EEecCCCCCHHHHHHHcC----CCCHHHHHHHHHHHHHHHHHHHHCC-----EecCCCCHHHEEECCCCCEEEeeCCCcc
Confidence            999999999999997653    4889999999999999999999987     9999999999999999999999999998


Q ss_pred             cccCCceeeeecCCCCCCCCCccccccCCCCCcccchhHHHHHHHHHhCCCCcchhHHHHHhhhhhhHhhccccCCCCCH
Q 005586          566 LLADDIVFSVLKTSAAMGYLAPEYVTTGRFTERSDIFAFGVIILQILTGSLVLTSSMRLAAESATFENFIDRNLKGKFSE  645 (689)
Q Consensus       566 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~ksDV~sfGvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~  645 (689)
                      .....    .....++..|+|||.+.+...+.++||||||+++|||++|+.|+.......    ........  ...++.
T Consensus       150 ~~~~~----~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~----~~~~~~~~--~~~~~~  219 (290)
T cd05580         150 RVKGR----TYTLCGTPEYLAPEIILSKGYGKAVDWWALGILIYEMLAGYPPFFDDNPIQ----IYEKILEG--KVRFPS  219 (290)
T ss_pred             ccCCC----CCCCCCCccccChhhhcCCCCCccccHHHHHHHHHHHHhCCCCCCCCCHHH----HHHHHhcC--CccCCc
Confidence            76543    123356788999999988888999999999999999999999986543211    11111111  112334


Q ss_pred             HHHHHHHHHHHHhccCCCCCCC-----CHHHHHHHH
Q 005586          646 SEAAKLGKMALVCTHEDPENRP-----TMEAVIEEL  676 (689)
Q Consensus       646 ~~~~~l~~l~~~Cl~~dp~~RP-----s~~evl~~L  676 (689)
                      .....+.+++.+||+.+|.+||     +.+|++++-
T Consensus       220 ~~~~~l~~li~~~l~~~p~~R~~~~~~~~~~l~~~~  255 (290)
T cd05580         220 FFSPDAKDLIRNLLQVDLTKRLGNLKNGVNDIKNHP  255 (290)
T ss_pred             cCCHHHHHHHHHHccCCHHHccCcccCCHHHHHcCc
Confidence            4467889999999999999999     778887654

Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This subfamily is composed of the cAMP-dependent proteins kinases, PKA and PRKX. The inactive PKA holoenzyme is a heterotetramer composed of two phosphorylated and active catalytic (C) subunits with a dimer of regulatory (R) subunits. Activation is achieved through the binding of the important second messenger cAMP to the R subunits, which leads to the dissociation of PKA into the R dimer and two active C subunits. PKA is present ubi

>cd07860 STKc_CDK2_3 Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase 2 and 3

Probab=100.00  E-value=1.1e-35  Score=307.87  Aligned_cols=255  Identities=20%  Similarity=0.378  Sum_probs=194.7

Q ss_pred             cCCcccccccCCcceEEEEEec-CCcEEEEEEecccCC-chHHHHHHHHHHHHhccCCCcceeEeeEEEcCCCCeEEEEE
Q 005586          410 CFSEVNLLGKGNFSSVYKGTLR-DGTLVAIRSINVTSC-KSEEAEFVKGLYLLTSLRHENIIRLRGFCCSRGRGECFLIY  487 (689)
Q Consensus       410 ~f~~~~~lg~G~~g~Vy~~~~~-~g~~vavK~l~~~~~-~~~~~~f~~e~~~l~~l~H~niv~l~g~~~~~~~~~~~lV~  487 (689)
                      +|+..+.||+|++|.||+|+.. +|+.||||++..... ......+.+|++++++++||||+++++++.  +.+..++||
T Consensus         1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~--~~~~~~~v~   78 (284)
T cd07860           1 NFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLLDVIH--TENKLYLVF   78 (284)
T ss_pred             CceeeeeecCCCceEEEEEEECCCCCEEEEEEccccccccccchHHHHHHHHHHhcCCCCCcchhhhcc--cCCcEEEEe
Confidence            4777889999999999999875 689999999875432 223357889999999999999999999984  457899999


Q ss_pred             EcCCCCCHHHHhhhcCCCCCCCCHHHHHHHHHHHHHHHhhhhCCCCCCCceeecCCCCCceeecCCCCeEEecccccccc
Q 005586          488 DFAPKGKLSKYLDQEEGSSNVLDWSTRVSIIIGIAKGIGYLHSSEVNKPAIVHRNLSVEKVLIDQQFNPLIADCGLHKLL  567 (689)
Q Consensus       488 e~~~~gsL~~~L~~~~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~~~ivH~dlk~~NiLl~~~~~~kl~DfGla~~~  567 (689)
                      ||++ ++|.+++.....  ..+++..+..++.|++.||+|||+.+     ++||||+|+||++++++.+||+|||+++..
T Consensus        79 e~~~-~~l~~~~~~~~~--~~l~~~~~~~~~~~i~~~l~~lh~~~-----i~H~~l~p~nill~~~~~~~l~dfg~~~~~  150 (284)
T cd07860          79 EFLH-QDLKKFMDASPL--SGIPLPLIKSYLFQLLQGLAFCHSHR-----VLHRDLKPQNLLINTEGAIKLADFGLARAF  150 (284)
T ss_pred             eccc-cCHHHHHHhCCC--CCCCHHHHHHHHHHHHHHHHHHHHCC-----eecCCCCHHHEEECCCCCEEEeeccchhhc
Confidence            9995 689999876432  35899999999999999999999887     999999999999999999999999998765


Q ss_pred             cCCceeeeecCCCCCCCCCccccccCC-CCCcccchhHHHHHHHHHhCCCCcchhHHHHHhhhhhh--------------
Q 005586          568 ADDIVFSVLKTSAAMGYLAPEYVTTGR-FTERSDIFAFGVIILQILTGSLVLTSSMRLAAESATFE--------------  632 (689)
Q Consensus       568 ~~~~~~~~~~~~~~~~y~aPE~~~~~~-~~~ksDV~sfGvvl~elltG~~p~~~~~~~~~~~~~~~--------------  632 (689)
                      ..... ......++..|+|||.+.+.. ++.++|||||||++|||+||+.||..............              
T Consensus       151 ~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~~l~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  229 (284)
T cd07860         151 GVPVR-TYTHEVVTLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVT  229 (284)
T ss_pred             ccCcc-ccccccccccccCCeEEecCCCCCcHHHHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHHHhCCCChhhhhhhh
Confidence            43211 112223567899999887644 58899999999999999999999854321111000000              


Q ss_pred             Hh---hcc--ccCCC----CCHHHHHHHHHHHHHhccCCCCCCCCHHHHHHH
Q 005586          633 NF---IDR--NLKGK----FSESEAAKLGKMALVCTHEDPENRPTMEAVIEE  675 (689)
Q Consensus       633 ~~---~~~--~~~~~----~~~~~~~~l~~l~~~Cl~~dp~~RPs~~evl~~  675 (689)
                      ..   ...  .....    .......++.+++.+|++.||++||+++|++++
T Consensus       230 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~~l~~  281 (284)
T cd07860         230 SLPDYKPSFPKWARQDFSKVVPPLDEDGRDLLSQMLHYDPNKRISAKAALAH  281 (284)
T ss_pred             HHHHHHhhcccccccCHHHHcccCCHHHHHHHHHhcCCCcccCCCHHHHhcC
Confidence            00   000  00000    001124567899999999999999999999876

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 2 (CDK2) and CDK3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK2/3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK2 is regulated by cyclin E or cyclin A. Upon activation by cyclin E, it phosphorylates the retinoblastoma (pRb) protein which activates E2F mediated transcription and allows cells to move into S phase. The CDK2/cyclin A complex

>cd06647 STKc_PAK_I Catalytic domain of the Protein Serine/Threonine Kinase, Group I p21-activated kinase

Probab=100.00  E-value=1.8e-35  Score=307.73  Aligned_cols=252  Identities=16%  Similarity=0.315  Sum_probs=201.2

Q ss_pred             ccCCcccccccCCcceEEEEEec-CCcEEEEEEecccCCchHHHHHHHHHHHHhccCCCcceeEeeEEEcCCCCeEEEEE
Q 005586          409 QCFSEVNLLGKGNFSSVYKGTLR-DGTLVAIRSINVTSCKSEEAEFVKGLYLLTSLRHENIIRLRGFCCSRGRGECFLIY  487 (689)
Q Consensus       409 ~~f~~~~~lg~G~~g~Vy~~~~~-~g~~vavK~l~~~~~~~~~~~f~~e~~~l~~l~H~niv~l~g~~~~~~~~~~~lV~  487 (689)
                      ++|...+.||+|+||.||+|... ++..||+|.+.... ....+.+.+|+.++++++|||++++++++..  .+..++|+
T Consensus        19 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~v~iK~~~~~~-~~~~~~~~~e~~~l~~l~hp~i~~~~~~~~~--~~~~~lv~   95 (293)
T cd06647          19 KKYTRFEKIGQGASGTVYTAIDVATGQEVAIKQMNLQQ-QPKKELIINEILVMRENKHPNIVNYLDSYLV--GDELWVVM   95 (293)
T ss_pred             hhceeeeEecCCCCeEEEEEEEcCCCCEEEEEEecccc-chHHHHHHHHHHHHhhcCCCCeeehhheeee--CCcEEEEE
Confidence            46777899999999999999864 68899999986543 3344678999999999999999999999854  46789999


Q ss_pred             EcCCCCCHHHHhhhcCCCCCCCCHHHHHHHHHHHHHHHhhhhCCCCCCCceeecCCCCCceeecCCCCeEEecccccccc
Q 005586          488 DFAPKGKLSKYLDQEEGSSNVLDWSTRVSIIIGIAKGIGYLHSSEVNKPAIVHRNLSVEKVLIDQQFNPLIADCGLHKLL  567 (689)
Q Consensus       488 e~~~~gsL~~~L~~~~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~~~ivH~dlk~~NiLl~~~~~~kl~DfGla~~~  567 (689)
                      ||+++++|.+++...     .+++..+..++.|++.||+|||+.+     ++||||||+||++++++.+||+|||++...
T Consensus        96 e~~~~~~L~~~~~~~-----~l~~~~~~~i~~~l~~al~~LH~~g-----i~H~dL~p~Nili~~~~~~kL~dfg~~~~~  165 (293)
T cd06647          96 EYLAGGSLTDVVTET-----CMDEGQIAAVCRECLQALEFLHSNQ-----VIHRDIKSDNILLGMDGSVKLTDFGFCAQI  165 (293)
T ss_pred             ecCCCCcHHHHHhhc-----CCCHHHHHHHHHHHHHHHHHHHhCC-----EeeccCCHHHEEEcCCCCEEEccCcceecc
Confidence            999999999999753     3789999999999999999999987     999999999999999999999999998765


Q ss_pred             cCCceeeeecCCCCCCCCCccccccCCCCCcccchhHHHHHHHHHhCCCCcchhHHHHHhhhhhhHhhccccCCCCCHHH
Q 005586          568 ADDIVFSVLKTSAAMGYLAPEYVTTGRFTERSDIFAFGVIILQILTGSLVLTSSMRLAAESATFENFIDRNLKGKFSESE  647 (689)
Q Consensus       568 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~ksDV~sfGvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  647 (689)
                      ..... ......++..|+|||.+....++.++|||||||++||+++|+.||.......... ...  .........+...
T Consensus       166 ~~~~~-~~~~~~~~~~y~~PE~~~~~~~~~~~Dv~slG~ll~~ll~g~~pf~~~~~~~~~~-~~~--~~~~~~~~~~~~~  241 (293)
T cd06647         166 TPEQS-KRSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMVEGEPPYLNENPLRALY-LIA--TNGTPELQNPEKL  241 (293)
T ss_pred             ccccc-ccccccCChhhcCchhhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCChhhhee-ehh--cCCCCCCCCcccc
Confidence            43321 1122346778999999988889999999999999999999999996432211100 000  0011111112334


Q ss_pred             HHHHHHHHHHhccCCCCCCCCHHHHHHHHH
Q 005586          648 AAKLGKMALVCTHEDPENRPTMEAVIEELT  677 (689)
Q Consensus       648 ~~~l~~l~~~Cl~~dp~~RPs~~evl~~L~  677 (689)
                      ...+.+++..||+.+|++||++.+++.+-.
T Consensus       242 ~~~l~~li~~~l~~~p~~Rp~~~~il~h~~  271 (293)
T cd06647         242 SAIFRDFLNRCLEMDVEKRGSAKELLQHPF  271 (293)
T ss_pred             CHHHHHHHHHHccCChhhCcCHHHHhcCHH
Confidence            567889999999999999999999998843

Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group I, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAKs from higher eukaryotes are classified into two groups (I and II), according to their bi

>cd07841 STKc_CDK7 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 7

Probab=100.00  E-value=1.6e-35  Score=308.80  Aligned_cols=258  Identities=22%  Similarity=0.320  Sum_probs=198.7

Q ss_pred             cCCcccccccCCcceEEEEEec-CCcEEEEEEecccCCc----hHHHHHHHHHHHHhccCCCcceeEeeEEEcCCCCeEE
Q 005586          410 CFSEVNLLGKGNFSSVYKGTLR-DGTLVAIRSINVTSCK----SEEAEFVKGLYLLTSLRHENIIRLRGFCCSRGRGECF  484 (689)
Q Consensus       410 ~f~~~~~lg~G~~g~Vy~~~~~-~g~~vavK~l~~~~~~----~~~~~f~~e~~~l~~l~H~niv~l~g~~~~~~~~~~~  484 (689)
                      +|...+.||+|+||.||+|... +|+.||+|++......    .....+..|++++.+++|+||+++++++..  .+..+
T Consensus         1 ~y~~~~~lg~g~~~~vy~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~--~~~~~   78 (298)
T cd07841           1 RYEKGKKLGEGTYAVVYKARDKETGRIVAIKKIKLGERKEAKDGINFTALREIKLLQELKHPNIIGLLDVFGH--KSNIN   78 (298)
T ss_pred             CceeeeeeeeccccEEEEEEECCCCcEEEEEEEeccccccccchhhHHHHHHHHHHhhcCCCCChhhhheeec--CCEEE
Confidence            3667789999999999999975 6899999999765432    123567789999999999999999999955  57899


Q ss_pred             EEEEcCCCCCHHHHhhhcCCCCCCCCHHHHHHHHHHHHHHHhhhhCCCCCCCceeecCCCCCceeecCCCCeEEeccccc
Q 005586          485 LIYDFAPKGKLSKYLDQEEGSSNVLDWSTRVSIIIGIAKGIGYLHSSEVNKPAIVHRNLSVEKVLIDQQFNPLIADCGLH  564 (689)
Q Consensus       485 lV~e~~~~gsL~~~L~~~~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~~~ivH~dlk~~NiLl~~~~~~kl~DfGla  564 (689)
                      +||||+ +|+|.+++....   ..+++..++.++.|+++||+|||+.+     |+||||||+||+++.++.+||+|||++
T Consensus        79 lv~e~~-~~~L~~~i~~~~---~~~~~~~~~~~~~qi~~al~~lH~~~-----i~H~dl~p~nill~~~~~~~l~dfg~~  149 (298)
T cd07841          79 LVFEFM-ETDLEKVIKDKS---IVLTPADIKSYMLMTLRGLEYLHSNW-----ILHRDLKPNNLLIASDGVLKLADFGLA  149 (298)
T ss_pred             EEEccc-CCCHHHHHhccC---CCCCHHHHHHHHHHHHHHHHHHHhCC-----eeecCCChhhEEEcCCCCEEEccceee
Confidence            999999 999999997643   24899999999999999999999987     999999999999999999999999999


Q ss_pred             ccccCCceeeeecCCCCCCCCCcccccc-CCCCCcccchhHHHHHHHHHhCCCCcchhHHHHHhhhhhhH----------
Q 005586          565 KLLADDIVFSVLKTSAAMGYLAPEYVTT-GRFTERSDIFAFGVIILQILTGSLVLTSSMRLAAESATFEN----------  633 (689)
Q Consensus       565 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~ksDV~sfGvvl~elltG~~p~~~~~~~~~~~~~~~~----------  633 (689)
                      +....... ......++..|+|||.+.+ ..++.++|||||||++|||++|..|+...............          
T Consensus       150 ~~~~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~e~~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  228 (298)
T cd07841         150 RSFGSPNR-KMTHQVVTRWYRAPELLFGARHYGVGVDMWSVGCIFAELLLRVPFLPGDSDIDQLGKIFEALGTPTEENWP  228 (298)
T ss_pred             eeccCCCc-cccccccceeeeCHHHHhCCCCCCcHHHHHHHHHHHHHHHcCCccccCCccHHHHHHHHHHcCCCchhhhh
Confidence            87654321 1122235667999998854 45789999999999999999998777532221111111000          


Q ss_pred             -------hhccccCCCC-----CHHHHHHHHHHHHHhccCCCCCCCCHHHHHHHHHhh
Q 005586          634 -------FIDRNLKGKF-----SESEAAKLGKMALVCTHEDPENRPTMEAVIEELTVA  679 (689)
Q Consensus       634 -------~~~~~~~~~~-----~~~~~~~l~~l~~~Cl~~dp~~RPs~~evl~~L~~~  679 (689)
                             ..........     ......++.+++.+|++.||++||++.|++++-+..
T Consensus       229 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~s~~e~l~~~~~~  286 (298)
T cd07841         229 GVTSLPDYVEFKPFPPTPLKQIFPAASDDALDLLQRLLTLNPNKRITARQALEHPYFS  286 (298)
T ss_pred             hcccccccccccccCCcchhhhcccccHHHHHHHHHHhcCCcccCcCHHHHhhCcccc
Confidence                   0000000001     122356789999999999999999999999985544

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 7 (CDK7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK7 plays essential roles in the cell cycle and in transcription. It associates with cyclin H and MAT1 and acts as a CDK-Activating Kinase (CAK) by phosphorylating and activating cell cycle CDKs (CDK1/2/4/6). In the brain, it activates CDK5. CDK7 is

>cd08530 STKc_CNK2-like Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii CNK2, and similar domains

Probab=100.00  E-value=2.1e-35  Score=300.51  Aligned_cols=251  Identities=22%  Similarity=0.367  Sum_probs=206.1

Q ss_pred             cCCcccccccCCcceEEEEEec-CCcEEEEEEecccCC-chHHHHHHHHHHHHhccCCCcceeEeeEEEcCCCCeEEEEE
Q 005586          410 CFSEVNLLGKGNFSSVYKGTLR-DGTLVAIRSINVTSC-KSEEAEFVKGLYLLTSLRHENIIRLRGFCCSRGRGECFLIY  487 (689)
Q Consensus       410 ~f~~~~~lg~G~~g~Vy~~~~~-~g~~vavK~l~~~~~-~~~~~~f~~e~~~l~~l~H~niv~l~g~~~~~~~~~~~lV~  487 (689)
                      +|+..+.||+|+||.||++..+ ++..+|+|++..... .....++.+|++++++++|+||+++++++..  ....++||
T Consensus         1 ~y~~~~~i~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~--~~~~~~v~   78 (256)
T cd08530           1 DFKVLKKLGKGSYGSVYKVKRLSDNQFYALKEVDLGSMSQKEREDAVNEIRILASVNHPNIISYKEAFLD--GNKLCIVM   78 (256)
T ss_pred             CceEeeeecCCCceeEEEEEECCCCCEEEEEEEehhhccHHHHHHHHHHHHHHHhCCCCCchhhhhhhcc--CCEEEEEe
Confidence            4667789999999999999865 788999999876432 3345678899999999999999999998854  47899999


Q ss_pred             EcCCCCCHHHHhhhcCCCCCCCCHHHHHHHHHHHHHHHhhhhCCCCCCCceeecCCCCCceeecCCCCeEEecccccccc
Q 005586          488 DFAPKGKLSKYLDQEEGSSNVLDWSTRVSIIIGIAKGIGYLHSSEVNKPAIVHRNLSVEKVLIDQQFNPLIADCGLHKLL  567 (689)
Q Consensus       488 e~~~~gsL~~~L~~~~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~~~ivH~dlk~~NiLl~~~~~~kl~DfGla~~~  567 (689)
                      ||+++++|.+++.........+++..++.++.|++.||+|||+.+     ++|+||+|+||++++++.+|++|||+++..
T Consensus        79 e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~l~~al~~lh~~~-----i~h~~l~~~ni~~~~~~~~kl~d~g~~~~~  153 (256)
T cd08530          79 EYAPFGDLSKAISKRKKKRKLIPEQEIWRIFIQLLRGLQALHEQK-----ILHRDLKSANILLVANDLVKIGDLGISKVL  153 (256)
T ss_pred             hhcCCCCHHHHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHhhCC-----cccCCCCcceEEEecCCcEEEeeccchhhh
Confidence            999999999999764333346899999999999999999999987     999999999999999999999999999877


Q ss_pred             cCCceeeeecCCCCCCCCCccccccCCCCCcccchhHHHHHHHHHhCCCCcchhHHHHHhhhhhhHhhccccCCCCCHHH
Q 005586          568 ADDIVFSVLKTSAAMGYLAPEYVTTGRFTERSDIFAFGVIILQILTGSLVLTSSMRLAAESATFENFIDRNLKGKFSESE  647 (689)
Q Consensus       568 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~ksDV~sfGvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  647 (689)
                      ....   .....++..|+|||...+..++.++|+||||+++|||++|+.|+.......     +...+........+...
T Consensus       154 ~~~~---~~~~~~~~~~~~Pe~~~~~~~~~~~D~~slG~~~~~l~~g~~p~~~~~~~~-----~~~~~~~~~~~~~~~~~  225 (256)
T cd08530         154 KKNM---AKTQIGTPHYMAPEVWKGRPYSYKSDIWSLGCLLYEMATFAPPFEARSMQD-----LRYKVQRGKYPPIPPIY  225 (256)
T ss_pred             ccCC---cccccCCccccCHHHHCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHH-----HHHHHhcCCCCCCchhh
Confidence            5541   122346778999999998889999999999999999999999986432211     11112222222344566


Q ss_pred             HHHHHHHHHHhccCCCCCCCCHHHHHHH
Q 005586          648 AAKLGKMALVCTHEDPENRPTMEAVIEE  675 (689)
Q Consensus       648 ~~~l~~l~~~Cl~~dp~~RPs~~evl~~  675 (689)
                      ..++.+++..|++.+|++||++.|++++
T Consensus       226 ~~~~~~li~~~l~~~p~~Rp~~~~~l~~  253 (256)
T cd08530         226 SQDLQNFIRSMLQVKPKLRPNCDKILAS  253 (256)
T ss_pred             CHHHHHHHHHHcCCCcccCCCHHHHhcC
Confidence            7789999999999999999999999876

Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii Never In Mitosis gene A (NIMA)-related kinase 1 (CNK2)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii CNK2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes CNK1, and -2. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii CNK2 has both cilliary and cell cycle functions. It influences flagellar length through promoting flagellar disassembly, an

>cd08225 STKc_Nek5 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 5

Probab=100.00  E-value=1.8e-35  Score=301.28  Aligned_cols=252  Identities=18%  Similarity=0.372  Sum_probs=201.2

Q ss_pred             cCCcccccccCCcceEEEEEec-CCcEEEEEEecccCC-chHHHHHHHHHHHHhccCCCcceeEeeEEEcCCCCeEEEEE
Q 005586          410 CFSEVNLLGKGNFSSVYKGTLR-DGTLVAIRSINVTSC-KSEEAEFVKGLYLLTSLRHENIIRLRGFCCSRGRGECFLIY  487 (689)
Q Consensus       410 ~f~~~~~lg~G~~g~Vy~~~~~-~g~~vavK~l~~~~~-~~~~~~f~~e~~~l~~l~H~niv~l~g~~~~~~~~~~~lV~  487 (689)
                      +|...+.||+|+||.||+|..+ +|..||+|.+..... ......+.+|++++++++|+||+++++++.  .....++|+
T Consensus         1 ~~~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~E~~~l~~~~h~~i~~~~~~~~--~~~~~~lv~   78 (257)
T cd08225           1 RYEIIKKIGEGSFGKIYLAKAKSDSEHCVIKEIDLTKMPVKEKEASKKEVILLAKMKHPNIVTFFASFQ--ENGRLFIVM   78 (257)
T ss_pred             CceEEEEecCCCcceEEEEEEcCCCceEEEEEeeHhhccchhhHHHHHHHHHHHhCCCCChhhhhheec--cCCeEEEEE
Confidence            4677889999999999999986 588999999876432 234467889999999999999999999884  357899999


Q ss_pred             EcCCCCCHHHHhhhcCCCCCCCCHHHHHHHHHHHHHHHhhhhCCCCCCCceeecCCCCCceeecCCC-CeEEeccccccc
Q 005586          488 DFAPKGKLSKYLDQEEGSSNVLDWSTRVSIIIGIAKGIGYLHSSEVNKPAIVHRNLSVEKVLIDQQF-NPLIADCGLHKL  566 (689)
Q Consensus       488 e~~~~gsL~~~L~~~~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~~~ivH~dlk~~NiLl~~~~-~~kl~DfGla~~  566 (689)
                      ||+++++|.+++.....  ..++|..+..++.|++.||+|||+.+     ++|+||||+||++++++ .+||+|||.+..
T Consensus        79 e~~~~~~L~~~~~~~~~--~~~~~~~~~~~~~~l~~~l~~lh~~~-----i~H~dl~~~nil~~~~~~~~~l~d~~~~~~  151 (257)
T cd08225          79 EYCDGGDLMKRINRQRG--VLFSEDQILSWFVQISLGLKHIHDRK-----ILHRDIKSQNIFLSKNGMVAKLGDFGIARQ  151 (257)
T ss_pred             ecCCCCcHHHHHHhccC--CCCCHHHHHHHHHHHHHHHHHHHHCC-----cccccCCHHHEEEcCCCCeEEecccccchh
Confidence            99999999999976432  34899999999999999999999987     99999999999999885 469999999987


Q ss_pred             ccCCceeeeecCCCCCCCCCccccccCCCCCcccchhHHHHHHHHHhCCCCcchhHHHHHhhhhhhHhhccccCCCCCHH
Q 005586          567 LADDIVFSVLKTSAAMGYLAPEYVTTGRFTERSDIFAFGVIILQILTGSLVLTSSMRLAAESATFENFIDRNLKGKFSES  646 (689)
Q Consensus       567 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~ksDV~sfGvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  646 (689)
                      ...... ......++..|+|||+..+..++.++|||||||++|||++|+.|+.......    ...+...... ......
T Consensus       152 ~~~~~~-~~~~~~~~~~~~ape~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~----~~~~~~~~~~-~~~~~~  225 (257)
T cd08225         152 LNDSME-LAYTCVGTPYYLSPEICQNRPYNNKTDIWSLGCVLYELCTLKHPFEGNNLHQ----LVLKICQGYF-APISPN  225 (257)
T ss_pred             ccCCcc-cccccCCCccccCHHHHcCCCCCchhhHHHHHHHHHHHHhCCCCCCCccHHH----HHHHHhcccC-CCCCCC
Confidence            654321 1122346778999999988889999999999999999999999986432111    1122222111 112233


Q ss_pred             HHHHHHHHHHHhccCCCCCCCCHHHHHHHH
Q 005586          647 EAAKLGKMALVCTHEDPENRPTMEAVIEEL  676 (689)
Q Consensus       647 ~~~~l~~l~~~Cl~~dp~~RPs~~evl~~L  676 (689)
                      ...++.+++.+|++.+|++||++.|++++.
T Consensus       226 ~~~~~~~~i~~~l~~~p~~Rpt~~~ll~~~  255 (257)
T cd08225         226 FSRDLRSLISQLFKVSPRDRPSITSILKRP  255 (257)
T ss_pred             CCHHHHHHHHHHhccChhhCcCHHHHhhCC
Confidence            456799999999999999999999998763

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 5 (Nek5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek5 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. The specific function of Nek5 is unknown.

>cd05572 STKc_cGK_PKG Catalytic domain of the Protein Serine/Threonine Kinase, cGMP-dependent protein kinase

Probab=100.00  E-value=3e-35  Score=300.78  Aligned_cols=247  Identities=18%  Similarity=0.278  Sum_probs=200.4

Q ss_pred             cccCCcceEEEEEec-CCcEEEEEEecccCC--chHHHHHHHHHHHHhccCCCcceeEeeEEEcCCCCeEEEEEEcCCCC
Q 005586          417 LGKGNFSSVYKGTLR-DGTLVAIRSINVTSC--KSEEAEFVKGLYLLTSLRHENIIRLRGFCCSRGRGECFLIYDFAPKG  493 (689)
Q Consensus       417 lg~G~~g~Vy~~~~~-~g~~vavK~l~~~~~--~~~~~~f~~e~~~l~~l~H~niv~l~g~~~~~~~~~~~lV~e~~~~g  493 (689)
                      ||.|+||.||+|... +++.||+|++.....  ....+.+.+|++++++++||||+++++++.+  ....++|+||++++
T Consensus         1 lg~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~--~~~~~lv~e~~~~~   78 (262)
T cd05572           1 LGVGGFGRVELVKVKSKNRTFALKCVKKRHIVETGQQEHIFSEKEILEECNHPFIVKLYRTFKD--KKYIYMLMEYCLGG   78 (262)
T ss_pred             CCCCCceEEEEEEECCCCcEEEEEEEehhcchhhhHHHHHHHHHHHHHhCCCCCEeeeeeeEEc--CCccEEEEecCCCC
Confidence            689999999999986 589999999976542  2345679999999999999999999998843  46789999999999


Q ss_pred             CHHHHhhhcCCCCCCCCHHHHHHHHHHHHHHHhhhhCCCCCCCceeecCCCCCceeecCCCCeEEecccccccccCCcee
Q 005586          494 KLSKYLDQEEGSSNVLDWSTRVSIIIGIAKGIGYLHSSEVNKPAIVHRNLSVEKVLIDQQFNPLIADCGLHKLLADDIVF  573 (689)
Q Consensus       494 sL~~~L~~~~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~~~ivH~dlk~~NiLl~~~~~~kl~DfGla~~~~~~~~~  573 (689)
                      +|.+++....    .+++..+..++.|++.||+|||+.+     ++|+||||+||++++++.+||+|||+++......  
T Consensus        79 ~L~~~l~~~~----~l~~~~~~~~~~~i~~~l~~lH~~~-----~~h~dl~~~nilv~~~~~~~l~df~~~~~~~~~~--  147 (262)
T cd05572          79 ELWTILRDRG----LFDEYTARFYIACVVLAFEYLHNRG-----IIYRDLKPENLLLDSNGYVKLVDFGFAKKLKSGQ--  147 (262)
T ss_pred             cHHHHHhhcC----CCCHHHHHHHHHHHHHHHHHHhhCC-----cccCCCCHHHEEEcCCCCEEEeeCCcccccCccc--
Confidence            9999997643    3889999999999999999999987     9999999999999999999999999998775432  


Q ss_pred             eeecCCCCCCCCCccccccCCCCCcccchhHHHHHHHHHhCCCCcchhHHHHHhhhhhhHhhccccCCCCCHHHHHHHHH
Q 005586          574 SVLKTSAAMGYLAPEYVTTGRFTERSDIFAFGVIILQILTGSLVLTSSMRLAAESATFENFIDRNLKGKFSESEAAKLGK  653 (689)
Q Consensus       574 ~~~~~~~~~~y~aPE~~~~~~~~~ksDV~sfGvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~  653 (689)
                      ......++..|+|||.+.+..++.++|+||||+++|||++|+.|+.......  ......+.+......++.....++.+
T Consensus       148 ~~~~~~~~~~~~~PE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~--~~~~~~~~~~~~~~~~~~~~~~~~~~  225 (262)
T cd05572         148 KTWTFCGTPEYVAPEIILNKGYDFSVDYWSLGILLYELLTGRPPFGEDDEDP--MEIYNDILKGNGKLEFPNYIDKAAKD  225 (262)
T ss_pred             ccccccCCcCccChhHhcCCCCCChhhhhhhHHHHHHHHhCCCCcCCCCCCH--HHHHHHHhccCCCCCCCcccCHHHHH
Confidence            1122346778999999988889999999999999999999999996543100  11122222222233444445778999


Q ss_pred             HHHHhccCCCCCCCC-----HHHHHHHHHh
Q 005586          654 MALVCTHEDPENRPT-----MEAVIEELTV  678 (689)
Q Consensus       654 l~~~Cl~~dp~~RPs-----~~evl~~L~~  678 (689)
                      ++..||+.+|++||+     ++|++++-+.
T Consensus       226 ~i~~~l~~~p~~R~~~~~~~~~~l~~~~~~  255 (262)
T cd05572         226 LIKQLLRRNPEERLGNLKGGIKDIKKHKWF  255 (262)
T ss_pred             HHHHHccCChhhCcCCcccCHHHHhcChhh
Confidence            999999999999999     7888876553

Serine/Threonine Kinases (STKs), cGMP-dependent protein kinase (cGK or PKG) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mammals have two cGK isoforms from different genes, cGKI and cGKII. cGKI exists as two splice variants, cGKI-alpha and cGKI-beta. cGK consists of an N-terminal regulatory domain containing a dimerization and an autoinhibitory pseudosubstrate region, two cGMP-binding domains, and a C-terminal catalytic domain. Binding of cGMP to both binding sites releases the inhibition of the catalytic center by the pseudosubstrate region, allowi

>cd06653 STKc_MEKK3_like_1 Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=5.5e-35  Score=299.32  Aligned_cols=253  Identities=19%  Similarity=0.299  Sum_probs=202.8

Q ss_pred             ccCCcccccccCCcceEEEEEec-CCcEEEEEEecccC----CchHHHHHHHHHHHHhccCCCcceeEeeEEEcCCCCeE
Q 005586          409 QCFSEVNLLGKGNFSSVYKGTLR-DGTLVAIRSINVTS----CKSEEAEFVKGLYLLTSLRHENIIRLRGFCCSRGRGEC  483 (689)
Q Consensus       409 ~~f~~~~~lg~G~~g~Vy~~~~~-~g~~vavK~l~~~~----~~~~~~~f~~e~~~l~~l~H~niv~l~g~~~~~~~~~~  483 (689)
                      ++|...+.||+|+||.||+|... +|..||+|++....    .......|.+|++++++++|+||+++++++........
T Consensus         2 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~~~ei~~l~~l~h~~i~~~~~~~~~~~~~~~   81 (264)
T cd06653           2 VNWRLGKLLGRGAFGEVYLCYDADTGRELAVKQVPFDPDSQETSKEVNALECEIQLLKNLRHDRIVQYYGCLRDPEEKKL   81 (264)
T ss_pred             CceeeeeeEccCCCeEEEEEEEcCCCCEEEEEEEecCcccchhhHHHHHHHHHHHHHHHcCCCCcceEEEEEEcCCCCEE
Confidence            35778899999999999999875 68999999885431    12344688999999999999999999999866555678


Q ss_pred             EEEEEcCCCCCHHHHhhhcCCCCCCCCHHHHHHHHHHHHHHHhhhhCCCCCCCceeecCCCCCceeecCCCCeEEecccc
Q 005586          484 FLIYDFAPKGKLSKYLDQEEGSSNVLDWSTRVSIIIGIAKGIGYLHSSEVNKPAIVHRNLSVEKVLIDQQFNPLIADCGL  563 (689)
Q Consensus       484 ~lV~e~~~~gsL~~~L~~~~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~~~ivH~dlk~~NiLl~~~~~~kl~DfGl  563 (689)
                      ++|+||+++++|.+++....    .+++...+.++.|++.||.|||+.+     ++|+||||+||++++++.++|+|||+
T Consensus        82 ~~v~e~~~~~~L~~~~~~~~----~l~~~~~~~~~~~i~~al~~LH~~~-----i~H~dl~p~ni~i~~~~~~~l~dfg~  152 (264)
T cd06653          82 SIFVEYMPGGSIKDQLKAYG----ALTENVTRRYTRQILQGVSYLHSNM-----IVHRDIKGANILRDSAGNVKLGDFGA  152 (264)
T ss_pred             EEEEEeCCCCcHHHHHHHcC----CCCHHHHHHHHHHHHHHHHHHHhCC-----EecCCCCHHHEEEcCCCCEEECcccc
Confidence            89999999999999987543    3788999999999999999999987     99999999999999999999999999


Q ss_pred             cccccCCce--eeeecCCCCCCCCCccccccCCCCCcccchhHHHHHHHHHhCCCCcchhHHHHHhhhhhhHhhccccCC
Q 005586          564 HKLLADDIV--FSVLKTSAAMGYLAPEYVTTGRFTERSDIFAFGVIILQILTGSLVLTSSMRLAAESATFENFIDRNLKG  641 (689)
Q Consensus       564 a~~~~~~~~--~~~~~~~~~~~y~aPE~~~~~~~~~ksDV~sfGvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~  641 (689)
                      ++.......  .......++..|+|||++.+..++.++|||||||++|||++|+.||.......    .+.+........
T Consensus       153 ~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~----~~~~~~~~~~~~  228 (264)
T cd06653         153 SKRIQTICMSGTGIKSVTGTPYWMSPEVISGEGYGRKADVWSVACTVVEMLTEKPPWAEYEAMA----AIFKIATQPTKP  228 (264)
T ss_pred             ccccccccccCccccccCCcccccCHhhhcCCCCCccccHHHHHHHHHHHHhCCCCCCccCHHH----HHHHHHcCCCCC
Confidence            986532111  01112346778999999988889999999999999999999999996532211    112222222233


Q ss_pred             CCCHHHHHHHHHHHHHhccCCCCCCCCHHHHHHH
Q 005586          642 KFSESEAAKLGKMALVCTHEDPENRPTMEAVIEE  675 (689)
Q Consensus       642 ~~~~~~~~~l~~l~~~Cl~~dp~~RPs~~evl~~  675 (689)
                      ..+.....++.+++..|+. +|.+||+..+++.+
T Consensus       229 ~~p~~~~~~~~~~i~~~l~-~~~~r~~~~~~~~~  261 (264)
T cd06653         229 MLPDGVSDACRDFLKQIFV-EEKRRPTAEFLLRH  261 (264)
T ss_pred             CCCcccCHHHHHHHHHHhc-CcccCccHHHHhcC
Confidence            4556667789999999999 57999999998865

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain, functionally uncharacterized subgroup 1. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MEKK3-like subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phospho

>cd07831 STKc_MOK Catalytic domain of the Serine/Threonine Kinase, MAPK/MAK/MRK Overlapping Kinase

Probab=100.00  E-value=3.5e-35  Score=303.59  Aligned_cols=254  Identities=21%  Similarity=0.294  Sum_probs=194.1

Q ss_pred             CCcccccccCCcceEEEEEec-CCcEEEEEEecccCCchHHHHHHHHHHHHhccC-CCcceeEeeEEEcCCCCeEEEEEE
Q 005586          411 FSEVNLLGKGNFSSVYKGTLR-DGTLVAIRSINVTSCKSEEAEFVKGLYLLTSLR-HENIIRLRGFCCSRGRGECFLIYD  488 (689)
Q Consensus       411 f~~~~~lg~G~~g~Vy~~~~~-~g~~vavK~l~~~~~~~~~~~f~~e~~~l~~l~-H~niv~l~g~~~~~~~~~~~lV~e  488 (689)
                      |...+.||+|+||.||+|... +++.||+|+++............+|+..+.++. |+|++++++++.+...+..++|+|
T Consensus         1 y~~~~~lg~g~~~~v~~~~~~~~~~~~aik~~~~~~~~~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~~~~~~~~lv~e   80 (282)
T cd07831           1 YKILGKIGEGTFSEVLKAQSRKTGKYYAIKCMKKHFKSLEQVNNLREIQALRRLSPHPNILRLIEVLFDRKTGRLALVFE   80 (282)
T ss_pred             CceEeeccccccceEEEEEEcCCCcEEEEEEehhccCCchhhhHHHHHHHHhhcCCCCCccceEEEEecCCCCcEEEEEe
Confidence            455688999999999999875 689999999876543333345567899999985 999999999997654478999999


Q ss_pred             cCCCCCHHHHhhhcCCCCCCCCHHHHHHHHHHHHHHHhhhhCCCCCCCceeecCCCCCceeecCCCCeEEeccccccccc
Q 005586          489 FAPKGKLSKYLDQEEGSSNVLDWSTRVSIIIGIAKGIGYLHSSEVNKPAIVHRNLSVEKVLIDQQFNPLIADCGLHKLLA  568 (689)
Q Consensus       489 ~~~~gsL~~~L~~~~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~~~ivH~dlk~~NiLl~~~~~~kl~DfGla~~~~  568 (689)
                      |++ |+|.+++....   ..++|.++..++.|++.||+|||+.+     ++||||||+||++++ +.+||+|||+++...
T Consensus        81 ~~~-~~l~~~l~~~~---~~~~~~~~~~~~~qi~~~L~~LH~~~-----i~H~dl~p~ni~l~~-~~~kl~dfg~~~~~~  150 (282)
T cd07831          81 LMD-MNLYELIKGRK---RPLPEKRVKSYMYQLLKSLDHMHRNG-----IFHRDIKPENILIKD-DILKLADFGSCRGIY  150 (282)
T ss_pred             cCC-ccHHHHHHhcc---CCCCHHHHHHHHHHHHHHHHHHHHCC-----ceecccCHHHEEEcC-CCeEEEecccccccc
Confidence            996 68888887543   24899999999999999999999987     999999999999999 999999999998764


Q ss_pred             CCceeeeecCCCCCCCCCcccccc-CCCCCcccchhHHHHHHHHHhCCCCcchhHHHHHhhhh----------hhHhhcc
Q 005586          569 DDIVFSVLKTSAAMGYLAPEYVTT-GRFTERSDIFAFGVIILQILTGSLVLTSSMRLAAESAT----------FENFIDR  637 (689)
Q Consensus       569 ~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~ksDV~sfGvvl~elltG~~p~~~~~~~~~~~~~----------~~~~~~~  637 (689)
                      .....  ....++..|+|||++.. ..++.++|||||||++|||++|+.||............          ..+....
T Consensus       151 ~~~~~--~~~~~~~~y~aPE~~~~~~~~~~~~Di~slGv~l~el~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  228 (282)
T cd07831         151 SKPPY--TEYISTRWYRAPECLLTDGYYGPKMDIWAVGCVFFEILSLFPLFPGTNELDQIAKIHDVLGTPDAEVLKKFRK  228 (282)
T ss_pred             cCCCc--CCCCCCcccCChhHhhcCCCCCcchhHHHHHHHHHHHHcCCcCCCCCCHHHHHHHHHHHcCCCCHHHHHhhcc
Confidence            43211  12346778999997654 55789999999999999999999999643211100000          0000000


Q ss_pred             cc--CCCC-----------CHHHHHHHHHHHHHhccCCCCCCCCHHHHHHHH
Q 005586          638 NL--KGKF-----------SESEAAKLGKMALVCTHEDPENRPTMEAVIEEL  676 (689)
Q Consensus       638 ~~--~~~~-----------~~~~~~~l~~l~~~Cl~~dp~~RPs~~evl~~L  676 (689)
                      .-  ...+           ....+..+.+++.+|++.+|++||++.+++++-
T Consensus       229 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~~~~~~l~~~  280 (282)
T cd07831         229 SRHMNYNFPSKKGTGLRKLLPNASAEGLDLLKKLLAYDPDERITAKQALRHP  280 (282)
T ss_pred             cccccccCcccccccHHHHcccccHHHHHHHHHHhccCcccccCHHHHhhCC
Confidence            00  0000           123467899999999999999999999999863

Serine/Threonine Kinases (STKs), MAPK/MAK/MRK Overlapping Kinase (MOK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MOK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MOK, also called Renal tumor antigen 1 (RAGE-1), is widely expressed and is enriched in testis, kidney, lung, and brain. It is expressed in approximately 50% of renal cell carcinomas (RCC) and is a potential target for immunotherapy. MOK is stabilized by its association with the HSP90 molecular chaperone. It is induced by the transcription factor Cdx2 and may be involved in regulating intestinal epithelial development and differentiation.

>KOG0610 consensus Putative serine/threonine protein kinase [General function prediction only]

Probab=100.00  E-value=1.9e-35  Score=296.40  Aligned_cols=252  Identities=20%  Similarity=0.259  Sum_probs=204.2

Q ss_pred             CCcccccccCCcceEEEEEecC-CcEEEEEEecccCC--chHHHHHHHHHHHHhccCCCcceeEeeEEEcCCCCeEEEEE
Q 005586          411 FSEVNLLGKGNFSSVYKGTLRD-GTLVAIRSINVTSC--KSEEAEFVKGLYLLTSLRHENIIRLRGFCCSRGRGECFLIY  487 (689)
Q Consensus       411 f~~~~~lg~G~~g~Vy~~~~~~-g~~vavK~l~~~~~--~~~~~~f~~e~~~l~~l~H~niv~l~g~~~~~~~~~~~lV~  487 (689)
                      |...+.||+|.-|+||++++++ +..+|+|++.+...  .....+...|-++|+.++||.++.||+.+  +.....++||
T Consensus        79 f~llk~LG~GdiG~VyL~~l~~t~~~fAmKVmdK~~l~~rkKl~Ra~tE~eIL~~lDHPFlPTLYa~f--et~~~~cl~m  156 (459)
T KOG0610|consen   79 FRLLKRLGCGDIGTVYLVELRGTNCLFAMKVMDKESLASRKKLKRAQTEREILSLLDHPFLPTLYASF--ETDKYSCLVM  156 (459)
T ss_pred             HHHHHHcCCCCceeEEEEEecCCCceEEEEEecHHHHhhhhHHHHHHHHHHHHHhcCCCccchhhhee--eccceeEEEE
Confidence            4446789999999999999974 68999999987643  23345667788999999999999999998  4568899999


Q ss_pred             EcCCCCCHHHHhhhcCCCCCCCCHHHHHHHHHHHHHHHhhhhCCCCCCCceeecCCCCCceeecCCCCeEEecccccccc
Q 005586          488 DFAPKGKLSKYLDQEEGSSNVLDWSTRVSIIIGIAKGIGYLHSSEVNKPAIVHRNLSVEKVLIDQQFNPLIADCGLHKLL  567 (689)
Q Consensus       488 e~~~~gsL~~~L~~~~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~~~ivH~dlk~~NiLl~~~~~~kl~DfGla~~~  567 (689)
                      |||+||+|...++...+  ..++......+|.+|+-||+|||-.|     ||.|||||+||||.++|++-|+||.|+...
T Consensus       157 eyCpGGdL~~LrqkQp~--~~fse~~aRFYaAEvl~ALEYLHmlG-----ivYRDLKPENILvredGHIMLsDFDLS~~~  229 (459)
T KOG0610|consen  157 EYCPGGDLHSLRQKQPG--KRFSESAARFYAAEVLLALEYLHMLG-----IVYRDLKPENILVREDGHIMLSDFDLSLRC  229 (459)
T ss_pred             ecCCCccHHHHHhhCCC--CccchhhHHHHHHHHHHHHHHHHhhc-----eeeccCCcceeEEecCCcEEeeeccccccC
Confidence            99999999999986543  45899999999999999999999998     999999999999999999999999997654


Q ss_pred             cCCc-------------------------------e-e-----------------------eeecCCCCCCCCCcccccc
Q 005586          568 ADDI-------------------------------V-F-----------------------SVLKTSAAMGYLAPEYVTT  592 (689)
Q Consensus       568 ~~~~-------------------------------~-~-----------------------~~~~~~~~~~y~aPE~~~~  592 (689)
                      ....                               . .                       ......||-.|+|||++.+
T Consensus       230 ~~~Pt~~~s~~~~~~~~~~~~~~~~~s~f~~r~~~~~~~~~k~~~~~~~~~p~~~aep~~~RSnSFVGThEYlAPEvI~G  309 (459)
T KOG0610|consen  230 PVSPTLVKSSSPRSSGSQPSCRSRQPSCFSPRCLSSSKKRKKKDESASRSLPELVAEPTGARSNSFVGTHEYLAPEVIRG  309 (459)
T ss_pred             CCCCeeeccCCCCCCCCCcccccccccccccchhccccccccccccccccchhhhcCCCCccccccccccccccceeeec
Confidence            2100                               0 0                       0001235667999999999


Q ss_pred             CCCCCcccchhHHHHHHHHHhCCCCcchhHHHHHhhhhhhHhhccccCCCCCHHHHHHHHHHHHHhccCCCCCCCC----
Q 005586          593 GRFTERSDIFAFGVIILQILTGSLVLTSSMRLAAESATFENFIDRNLKGKFSESEAAKLGKMALVCTHEDPENRPT----  668 (689)
Q Consensus       593 ~~~~~ksDV~sfGvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~Cl~~dp~~RPs----  668 (689)
                      ...+.++|+|+|||++|||+.|+.||-+..+.    ..+..++-+.+.-......+..+.+|+..-+.+||.+|..    
T Consensus       310 ~GHgsAVDWWtfGIflYEmLyG~TPFKG~~~~----~Tl~NIv~~~l~Fp~~~~vs~~akDLIr~LLvKdP~kRlg~~rG  385 (459)
T KOG0610|consen  310 EGHGSAVDWWTFGIFLYEMLYGTTPFKGSNNK----ETLRNIVGQPLKFPEEPEVSSAAKDLIRKLLVKDPSKRLGSKRG  385 (459)
T ss_pred             CCCCchhhHHHHHHHHHHHHhCCCCcCCCCch----hhHHHHhcCCCcCCCCCcchhHHHHHHHHHhccChhhhhccccc
Confidence            99999999999999999999999999765433    3445555544443223356788999999999999999998    


Q ss_pred             HHHHHHH
Q 005586          669 MEAVIEE  675 (689)
Q Consensus       669 ~~evl~~  675 (689)
                      +.||-+|
T Consensus       386 A~eIK~H  392 (459)
T KOG0610|consen  386 AAEIKRH  392 (459)
T ss_pred             hHHhhcC
Confidence            7777655

>cd07840 STKc_CDK9_like Catalytic domain of Cyclin-Dependent protein Kinase 9-like Serine/Threonine Kinases

Probab=100.00  E-value=3.5e-35  Score=304.19  Aligned_cols=257  Identities=23%  Similarity=0.415  Sum_probs=197.2

Q ss_pred             CCcccccccCCcceEEEEEec-CCcEEEEEEecccC-CchHHHHHHHHHHHHhccCCCcceeEeeEEEcCCCCeEEEEEE
Q 005586          411 FSEVNLLGKGNFSSVYKGTLR-DGTLVAIRSINVTS-CKSEEAEFVKGLYLLTSLRHENIIRLRGFCCSRGRGECFLIYD  488 (689)
Q Consensus       411 f~~~~~lg~G~~g~Vy~~~~~-~g~~vavK~l~~~~-~~~~~~~f~~e~~~l~~l~H~niv~l~g~~~~~~~~~~~lV~e  488 (689)
                      |...+.||+|+||.||+|... +|+.+|+|++.... .......+.+|++++.+++|+|++++++++.....+..++|||
T Consensus         1 y~~~~~l~~g~~~~vy~~~~~~~~~~~~~K~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~lv~e   80 (287)
T cd07840           1 YEKIAQIGEGTYGQVYKARNKKTGELVALKKIRMENEKEGFPITAIREIKLLQKLRHPNIVRLKEIVTSKGKGSIYMVFE   80 (287)
T ss_pred             CeeeEEeccCCCeEEEEEEECCCCeEEEEEEEecccccccchHHHHHHHHHHHhccCCCeeeheeeEecCCCCcEEEEec
Confidence            456788999999999999976 58999999998764 2233457889999999999999999999986543478999999


Q ss_pred             cCCCCCHHHHhhhcCCCCCCCCHHHHHHHHHHHHHHHhhhhCCCCCCCceeecCCCCCceeecCCCCeEEeccccccccc
Q 005586          489 FAPKGKLSKYLDQEEGSSNVLDWSTRVSIIIGIAKGIGYLHSSEVNKPAIVHRNLSVEKVLIDQQFNPLIADCGLHKLLA  568 (689)
Q Consensus       489 ~~~~gsL~~~L~~~~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~~~ivH~dlk~~NiLl~~~~~~kl~DfGla~~~~  568 (689)
                      |++ ++|.+++....   ..+++..++.++.|+++||+|||+.+     ++|+||||+||++++++.+||+|||++....
T Consensus        81 ~~~-~~l~~~~~~~~---~~~~~~~~~~i~~~i~~al~~LH~~~-----~~h~dl~p~nil~~~~~~~~l~d~g~~~~~~  151 (287)
T cd07840          81 YMD-HDLTGLLDSPE---VKFTESQIKCYMKQLLEGLQYLHSNG-----ILHRDIKGSNILINNDGVLKLADFGLARPYT  151 (287)
T ss_pred             ccc-ccHHHHHhccC---CCCCHHHHHHHHHHHHHHHHHHHHCC-----ceeccCcHHHeEEcCCCCEEEccccceeecc
Confidence            997 48998886542   24899999999999999999999987     9999999999999999999999999998765


Q ss_pred             CCceeeeecCCCCCCCCCcccccc-CCCCCcccchhHHHHHHHHHhCCCCcchhHHHHHhhhhhh-----------Hhhc
Q 005586          569 DDIVFSVLKTSAAMGYLAPEYVTT-GRFTERSDIFAFGVIILQILTGSLVLTSSMRLAAESATFE-----------NFID  636 (689)
Q Consensus       569 ~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~ksDV~sfGvvl~elltG~~p~~~~~~~~~~~~~~~-----------~~~~  636 (689)
                      ...........++..|+|||.+.+ ..++.++||||||+++|||+||+.|+..............           ...+
T Consensus       152 ~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~Dv~slG~~l~el~t~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  231 (287)
T cd07840         152 KRNSADYTNRVITLWYRPPELLLGATRYGPEVDMWSVGCILAELFLGKPIFQGSTELEQLEKIFELCGSPTDENWPGVSK  231 (287)
T ss_pred             CCCcccccccccccccCCceeeEccccCChHHHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCchhhcccccc
Confidence            443212223345677999997764 4578999999999999999999999864322111000000           0000


Q ss_pred             ----cccC----------CCCCHHHHHHHHHHHHHhccCCCCCCCCHHHHHHHH
Q 005586          637 ----RNLK----------GKFSESEAAKLGKMALVCTHEDPENRPTMEAVIEEL  676 (689)
Q Consensus       637 ----~~~~----------~~~~~~~~~~l~~l~~~Cl~~dp~~RPs~~evl~~L  676 (689)
                          ....          ..+...++.++.+++..|++.+|++||++.+++++-
T Consensus       232 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rp~~~~~l~~~  285 (287)
T cd07840         232 LPWFENLKPKKPYKRRLREFFKHLIDPSALDLLDKLLTLDPKKRISADQALQHE  285 (287)
T ss_pred             chhhhhccccccchhHHHHHhcccCCHHHHHHHHHHcCCChhhCcCHHHHhhCc
Confidence                0000          000111256789999999999999999999998753

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK9 and CDK12 from higher eukaryotes, yeast BUR1, C-type plant CDKs (CdkC), and similar proteins. CDK9, BUR1, and CdkC are functionally equivalent. They act as a kinase for the C-terminal domain of RNA po

>cd06614 STKc_PAK Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase

Probab=100.00  E-value=6.2e-35  Score=302.62  Aligned_cols=257  Identities=19%  Similarity=0.363  Sum_probs=206.1

Q ss_pred             HhccCCcccccccCCcceEEEEEec-CCcEEEEEEecccCCchHHHHHHHHHHHHhccCCCcceeEeeEEEcCCCCeEEE
Q 005586          407 ATQCFSEVNLLGKGNFSSVYKGTLR-DGTLVAIRSINVTSCKSEEAEFVKGLYLLTSLRHENIIRLRGFCCSRGRGECFL  485 (689)
Q Consensus       407 at~~f~~~~~lg~G~~g~Vy~~~~~-~g~~vavK~l~~~~~~~~~~~f~~e~~~l~~l~H~niv~l~g~~~~~~~~~~~l  485 (689)
                      .++.|...+.||+|+||.||+|..+ ++..|++|++.....  ....+.+|++.+.+++|+|++++++++...  ...++
T Consensus        17 ~~~~~~~~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~--~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~--~~~~l   92 (286)
T cd06614          17 PRELYKNLEKIGEGASGEVYKATDRATGKEVAIKKMRLRKQ--NKELIINEILIMKDCKHPNIVDYYDSYLVG--DELWV   92 (286)
T ss_pred             ccccchHhHhccCCCCeEEEEEEEccCCcEEEEEEEecCch--hHHHHHHHHHHHHHCCCCCeeEEEEEEEEC--CEEEE
Confidence            4556777889999999999999987 689999999976542  456789999999999999999999998654  78999


Q ss_pred             EEEcCCCCCHHHHhhhcCCCCCCCCHHHHHHHHHHHHHHHhhhhCCCCCCCceeecCCCCCceeecCCCCeEEecccccc
Q 005586          486 IYDFAPKGKLSKYLDQEEGSSNVLDWSTRVSIIIGIAKGIGYLHSSEVNKPAIVHRNLSVEKVLIDQQFNPLIADCGLHK  565 (689)
Q Consensus       486 V~e~~~~gsL~~~L~~~~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~~~ivH~dlk~~NiLl~~~~~~kl~DfGla~  565 (689)
                      |+||+++++|.+++....   ..+++..+..++.+++.||+|||+.+     |+|+||+|+||+++.++.+||+|||++.
T Consensus        93 v~e~~~~~~L~~~l~~~~---~~l~~~~~~~i~~~i~~~L~~lH~~g-----i~H~dl~p~ni~i~~~~~~~l~d~~~~~  164 (286)
T cd06614          93 VMEYMDGGSLTDIITQNF---VRMNEPQIAYVCREVLQGLEYLHSQN-----VIHRDIKSDNILLSKDGSVKLADFGFAA  164 (286)
T ss_pred             EEeccCCCcHHHHHHHhc---cCCCHHHHHHHHHHHHHHHHHHHhCC-----eeeCCCChhhEEEcCCCCEEECccchhh
Confidence            999999999999998754   25899999999999999999999987     9999999999999999999999999987


Q ss_pred             cccCCceeeeecCCCCCCCCCccccccCCCCCcccchhHHHHHHHHHhCCCCcchhHHHHHhhhhhhHhhccccCC-CCC
Q 005586          566 LLADDIVFSVLKTSAAMGYLAPEYVTTGRFTERSDIFAFGVIILQILTGSLVLTSSMRLAAESATFENFIDRNLKG-KFS  644 (689)
Q Consensus       566 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~ksDV~sfGvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~-~~~  644 (689)
                      ....... ......++..|+|||++.+..++.++|||||||++|||++|+.|+........    ........... ...
T Consensus       165 ~~~~~~~-~~~~~~~~~~y~~PE~~~~~~~~~~~Dv~slGvil~~l~~g~~p~~~~~~~~~----~~~~~~~~~~~~~~~  239 (286)
T cd06614         165 QLTKEKS-KRNSVVGTPYWMAPEVIKRKDYGPKVDIWSLGIMCIEMAEGEPPYLREPPLRA----LFLITTKGIPPLKNP  239 (286)
T ss_pred             hhccchh-hhccccCCcccCCHhHhcCCCCCCccccHHHHHHHHHHHhCCCCCCCCCHHHH----HHHHHhcCCCCCcch
Confidence            5543221 11123356789999999888899999999999999999999999864322111    11111111111 112


Q ss_pred             HHHHHHHHHHHHHhccCCCCCCCCHHHHHHHHHhhC
Q 005586          645 ESEAAKLGKMALVCTHEDPENRPTMEAVIEELTVAA  680 (689)
Q Consensus       645 ~~~~~~l~~l~~~Cl~~dp~~RPs~~evl~~L~~~~  680 (689)
                      ......+.+++.+|++.+|.+||++.+++++.....
T Consensus       240 ~~~~~~l~~li~~~l~~~p~~Rpt~~~il~~~~~~~  275 (286)
T cd06614         240 EKWSPEFKDFLNKCLVKDPEKRPSAEELLQHPFLKK  275 (286)
T ss_pred             hhCCHHHHHHHHHHhccChhhCcCHHHHhhChHhhc
Confidence            224567999999999999999999999998765443

Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAK deregulation is associated with tumor development. PAKs from higher eukaryotes are classified into two grou

>cd05578 STKc_Yank1 Catalytic domain of the Protein Serine/Threonine Kinase, Yank1

Probab=100.00  E-value=1.3e-35  Score=302.65  Aligned_cols=249  Identities=21%  Similarity=0.298  Sum_probs=202.4

Q ss_pred             cCCcccccccCCcceEEEEEec-CCcEEEEEEecccCC--chHHHHHHHHHHHHhccCCCcceeEeeEEEcCCCCeEEEE
Q 005586          410 CFSEVNLLGKGNFSSVYKGTLR-DGTLVAIRSINVTSC--KSEEAEFVKGLYLLTSLRHENIIRLRGFCCSRGRGECFLI  486 (689)
Q Consensus       410 ~f~~~~~lg~G~~g~Vy~~~~~-~g~~vavK~l~~~~~--~~~~~~f~~e~~~l~~l~H~niv~l~g~~~~~~~~~~~lV  486 (689)
                      +|...+.||+|+||.||+|... ++..||+|.+.....  ....+.+.+|++++++++||||+++++++  ......++|
T Consensus         1 ~y~~~~~i~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~--~~~~~~~lv   78 (258)
T cd05578           1 HFELLRVIGKGAFGKVCIVQKRDTKKMFAMKYMNKQKCVEKGSVRNVLNERRILQELNHPFLVNLWYSF--QDEENMYLV   78 (258)
T ss_pred             CceEEEEeccCCCceEEEEEEccCCcEEEEEEEehhhhcchhHHHHHHHHHHHHHhCCCCChHHHHHhh--cCCCeEEEE
Confidence            4677899999999999999986 689999999975432  23457899999999999999999999988  445789999


Q ss_pred             EEcCCCCCHHHHhhhcCCCCCCCCHHHHHHHHHHHHHHHhhhhCCCCCCCceeecCCCCCceeecCCCCeEEeccccccc
Q 005586          487 YDFAPKGKLSKYLDQEEGSSNVLDWSTRVSIIIGIAKGIGYLHSSEVNKPAIVHRNLSVEKVLIDQQFNPLIADCGLHKL  566 (689)
Q Consensus       487 ~e~~~~gsL~~~L~~~~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~~~ivH~dlk~~NiLl~~~~~~kl~DfGla~~  566 (689)
                      +||+++++|.+++...    ..+++.....|+.|+++||.|||+.+     ++|+||||+||++++++.++|+|||++..
T Consensus        79 ~e~~~~~~L~~~l~~~----~~l~~~~~~~~~~~i~~~l~~lh~~~-----i~h~dl~~~nil~~~~~~~~l~d~~~~~~  149 (258)
T cd05578          79 VDLLLGGDLRYHLSQK----VKFSEEQVKFWICEIVLALEYLHSKG-----IIHRDIKPDNILLDEQGHVHITDFNIATK  149 (258)
T ss_pred             EeCCCCCCHHHHHHhc----CCcCHHHHHHHHHHHHHHHHHHHhCC-----eeccCCCHHHeEEcCCCCEEEeecccccc
Confidence            9999999999999765    24889999999999999999999887     99999999999999999999999999886


Q ss_pred             ccCCceeeeecCCCCCCCCCccccccCCCCCcccchhHHHHHHHHHhCCCCcchhHHHHHhhhhhhHhhccccCCCCCHH
Q 005586          567 LADDIVFSVLKTSAAMGYLAPEYVTTGRFTERSDIFAFGVIILQILTGSLVLTSSMRLAAESATFENFIDRNLKGKFSES  646 (689)
Q Consensus       567 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~ksDV~sfGvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  646 (689)
                      .....  ......++..|+|||.+.+..++.++||||||+++|||++|+.|+.......  ...+...... .....+..
T Consensus       150 ~~~~~--~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~--~~~~~~~~~~-~~~~~~~~  224 (258)
T cd05578         150 VTPDT--LTTSTSGTPGYMAPEVLCRQGYSVAVDWWSLGVTAYECLRGKRPYRGHSRTI--RDQIRAKQET-ADVLYPAT  224 (258)
T ss_pred             cCCCc--cccccCCChhhcCHHHHcccCCCCcccchhhHHHHHHHHhCCCCCCCCCccH--HHHHHHHhcc-ccccCccc
Confidence            65432  1223446678999999988889999999999999999999999986542210  1111111111 22334455


Q ss_pred             HHHHHHHHHHHhccCCCCCCCCH--HHHHH
Q 005586          647 EAAKLGKMALVCTHEDPENRPTM--EAVIE  674 (689)
Q Consensus       647 ~~~~l~~l~~~Cl~~dp~~RPs~--~evl~  674 (689)
                      .+..+.+++.+||+.||.+||++  +|+++
T Consensus       225 ~~~~~~~~i~~~l~~~p~~R~~~~~~~l~~  254 (258)
T cd05578         225 WSTEAIDAINKLLERDPQKRLGDNLKDLKN  254 (258)
T ss_pred             CcHHHHHHHHHHccCChhHcCCccHHHHhc
Confidence            56889999999999999999999  66654

Serine/Threonine Kinases (STKs), Yank1 or STK32A subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Yank1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily contains uncharacterized STKs with similarity to the human protein designated Yank1 or STK32A.

>cd07836 STKc_Pho85 Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Pho85

Probab=100.00  E-value=2.8e-35  Score=304.71  Aligned_cols=256  Identities=23%  Similarity=0.414  Sum_probs=198.1

Q ss_pred             cCCcccccccCCcceEEEEEec-CCcEEEEEEecccCCchHHHHHHHHHHHHhccCCCcceeEeeEEEcCCCCeEEEEEE
Q 005586          410 CFSEVNLLGKGNFSSVYKGTLR-DGTLVAIRSINVTSCKSEEAEFVKGLYLLTSLRHENIIRLRGFCCSRGRGECFLIYD  488 (689)
Q Consensus       410 ~f~~~~~lg~G~~g~Vy~~~~~-~g~~vavK~l~~~~~~~~~~~f~~e~~~l~~l~H~niv~l~g~~~~~~~~~~~lV~e  488 (689)
                      +|+..+.||+|++|.||+|+.. +|..||||++...........+.+|++++++++|+||+++++++..  .+..++|||
T Consensus         1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~--~~~~~lv~e   78 (284)
T cd07836           1 NFKQLEKLGEGTYATVYKGRNRTTGEIVALKEIHLDAEEGTPSTAIREISLMKELKHENIVRLHDVIHT--ENKLMLVFE   78 (284)
T ss_pred             CceEeeeeccCCceEEEEEEECCCCeEEEEEEecccccccchHHHHHHHHHHHhhcCCCEeeeeeeEee--CCcEEEEEe
Confidence            4777899999999999999986 6899999999866544445678899999999999999999999854  467899999


Q ss_pred             cCCCCCHHHHhhhcCCCCCCCCHHHHHHHHHHHHHHHhhhhCCCCCCCceeecCCCCCceeecCCCCeEEeccccccccc
Q 005586          489 FAPKGKLSKYLDQEEGSSNVLDWSTRVSIIIGIAKGIGYLHSSEVNKPAIVHRNLSVEKVLIDQQFNPLIADCGLHKLLA  568 (689)
Q Consensus       489 ~~~~gsL~~~L~~~~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~~~ivH~dlk~~NiLl~~~~~~kl~DfGla~~~~  568 (689)
                      |++ |+|.+++..... ...+++..+..++.|+++||+|||+.+     ++||||||+||++++++.+|++|||+++...
T Consensus        79 ~~~-~~l~~~~~~~~~-~~~~~~~~~~~~~~qi~~~l~~lH~~~-----i~h~dl~p~ni~~~~~~~~~l~d~g~~~~~~  151 (284)
T cd07836          79 YMD-KDLKKYMDTHGV-RGALDPNTVKSFTYQLLKGIAFCHENR-----VLHRDLKPQNLLINKRGELKLADFGLARAFG  151 (284)
T ss_pred             cCC-ccHHHHHHhcCC-CCCcCHHHHHHHHHHHHHHHHHHHHCC-----eeeCCCCHHHEEECCCCcEEEeecchhhhhc
Confidence            998 489998875432 235899999999999999999999987     9999999999999999999999999997654


Q ss_pred             CCceeeeecCCCCCCCCCccccccC-CCCCcccchhHHHHHHHHHhCCCCcchhHHHHHhhhhh-----------hHhhc
Q 005586          569 DDIVFSVLKTSAAMGYLAPEYVTTG-RFTERSDIFAFGVIILQILTGSLVLTSSMRLAAESATF-----------ENFID  636 (689)
Q Consensus       569 ~~~~~~~~~~~~~~~y~aPE~~~~~-~~~~ksDV~sfGvvl~elltG~~p~~~~~~~~~~~~~~-----------~~~~~  636 (689)
                      .... ......++..|++||.+.+. .++.++|||||||++|||++|+.|+............+           ..+.+
T Consensus       152 ~~~~-~~~~~~~~~~y~~PE~~~~~~~~~~~~Dv~slG~~l~~l~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  230 (284)
T cd07836         152 IPVN-TFSNEVVTLWYRAPDVLLGSRTYSTSIDIWSVGCIMAEMITGRPLFPGTNNEDQLLKIFRIMGTPTESTWPGISQ  230 (284)
T ss_pred             CCcc-ccccccccccccChHHhcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCChhhHHHHhc
Confidence            3211 11223456789999987654 56899999999999999999999986432211111000           00000


Q ss_pred             -cccCCCC-----------CHHHHHHHHHHHHHhccCCCCCCCCHHHHHHH
Q 005586          637 -RNLKGKF-----------SESEAAKLGKMALVCTHEDPENRPTMEAVIEE  675 (689)
Q Consensus       637 -~~~~~~~-----------~~~~~~~l~~l~~~Cl~~dp~~RPs~~evl~~  675 (689)
                       +.+...+           .+..+..+.+++..|++.||++||++.|++++
T Consensus       231 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~p~~R~~~~~~l~~  281 (284)
T cd07836         231 LPEYKPTFPRYPPQDLQQLFPHADPLGIDLLHRLLQLNPELRISAHDALQH  281 (284)
T ss_pred             CchhcccccCCChHHHHHHhhhcCcHHHHHHHHHhcCCcccCCCHHHHhcC
Confidence             0011111           11235678899999999999999999999875

Serine/Threonine Kinases (STKs), Pho85 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Pho85 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Pho85 is a multifunctional Cyclin-Dependent protein Kinase (CDK) in yeast. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Pho85 is regulated by 10 different cyclins (Pcls) and plays a role in G1 progression, cell polarity, phosphate and glycogen metabolism, gene expression, and in signaling changes in the environment.

>cd07852 STKc_MAPK15 Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase 15

Probab=100.00  E-value=3e-35  Score=312.49  Aligned_cols=258  Identities=20%  Similarity=0.331  Sum_probs=198.1

Q ss_pred             hccCCcccccccCCcceEEEEEec-CCcEEEEEEecccC-CchHHHHHHHHHHHHhcc-CCCcceeEeeEEEcCCCCeEE
Q 005586          408 TQCFSEVNLLGKGNFSSVYKGTLR-DGTLVAIRSINVTS-CKSEEAEFVKGLYLLTSL-RHENIIRLRGFCCSRGRGECF  484 (689)
Q Consensus       408 t~~f~~~~~lg~G~~g~Vy~~~~~-~g~~vavK~l~~~~-~~~~~~~f~~e~~~l~~l-~H~niv~l~g~~~~~~~~~~~  484 (689)
                      .++|+..+.||+|+||.||+|... +|+.||+|++.... .......+.+|+.++.++ +||||+++++++........+
T Consensus         6 ~~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~vK~~~~~~~~~~~~~~~~~E~~~l~~l~~h~ni~~~~~~~~~~~~~~~~   85 (337)
T cd07852           6 LRKYEILQKLGKGAYGIVWKAIDRRTKEVVALKKIFDAFRNATDAQRTFREIMFLQELGDHPNIVKLLNVIKAENDKDIY   85 (337)
T ss_pred             hhHHHHhHhhcCCCCeeEEEEEEcCCCeEEEEEeeccccCcchhhhhhhHHHHHHHHhcCCCCccceeeeeccCCCceEE
Confidence            456778899999999999999976 68899999986432 223445678899999999 999999999998655556789


Q ss_pred             EEEEcCCCCCHHHHhhhcCCCCCCCCHHHHHHHHHHHHHHHhhhhCCCCCCCceeecCCCCCceeecCCCCeEEeccccc
Q 005586          485 LIYDFAPKGKLSKYLDQEEGSSNVLDWSTRVSIIIGIAKGIGYLHSSEVNKPAIVHRNLSVEKVLIDQQFNPLIADCGLH  564 (689)
Q Consensus       485 lV~e~~~~gsL~~~L~~~~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~~~ivH~dlk~~NiLl~~~~~~kl~DfGla  564 (689)
                      +||||++ ++|..++...     .++|..+..++.|++.||+|||+.+     |+||||||+||++++++.+||+|||++
T Consensus        86 lv~e~~~-~~L~~~~~~~-----~~~~~~~~~i~~qi~~~L~~LH~~~-----i~H~dl~p~nill~~~~~~kl~d~g~~  154 (337)
T cd07852          86 LVFEYME-TDLHAVIRAN-----ILEDVHKRYIMYQLLKALKYIHSGN-----VIHRDLKPSNILLNSDCRVKLADFGLA  154 (337)
T ss_pred             EEecccc-cCHHHHHhcC-----CCCHHHHHHHHHHHHHHHHHHHHCC-----eecCCCCHHHEEEcCCCcEEEeeccch
Confidence            9999997 5999988653     4889999999999999999999987     999999999999999999999999999


Q ss_pred             ccccCCcee----eeecCCCCCCCCCcccccc-CCCCCcccchhHHHHHHHHHhCCCCcchhHHHHHhhh----------
Q 005586          565 KLLADDIVF----SVLKTSAAMGYLAPEYVTT-GRFTERSDIFAFGVIILQILTGSLVLTSSMRLAAESA----------  629 (689)
Q Consensus       565 ~~~~~~~~~----~~~~~~~~~~y~aPE~~~~-~~~~~ksDV~sfGvvl~elltG~~p~~~~~~~~~~~~----------  629 (689)
                      +........    ......++..|+|||++.+ ..++.++||||||+++|||+||+.||...........          
T Consensus       155 ~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~sDi~slG~~l~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~  234 (337)
T cd07852         155 RSLSELEENPENPVLTDYVATRWYRAPEILLGSTRYTKGVDMWSVGCILGEMLLGKPLFPGTSTLNQLEKIIEVIGPPSA  234 (337)
T ss_pred             hccccccccccCcchhcccccccccCceeeeccccccccchHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCH
Confidence            866443211    1122346778999998755 4578999999999999999999999853211110000          


Q ss_pred             ---------hhhHhhccccCC------CCCHHHHHHHHHHHHHhccCCCCCCCCHHHHHHHH
Q 005586          630 ---------TFENFIDRNLKG------KFSESEAAKLGKMALVCTHEDPENRPTMEAVIEEL  676 (689)
Q Consensus       630 ---------~~~~~~~~~~~~------~~~~~~~~~l~~l~~~Cl~~dp~~RPs~~evl~~L  676 (689)
                               ...++++.....      ........++.+++.+|++.||++||++.+++++-
T Consensus       235 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~P~~Rps~~~il~~~  296 (337)
T cd07852         235 EDIESIKSPFAATMLDSLPSRPRKPLDELLPKASDDALDLLKKLLVFNPNKRLTAEEALEHP  296 (337)
T ss_pred             HHHHHHHhhhHHHhhhhcccccccchhhhccCCCHHHHHHHHHhccCCcccccCHHHHhhCh
Confidence                     000111100000      00111356789999999999999999999999874

Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 15 (MAPK15) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK15 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. Human MAPK15 is also called Extracellular signal Regulated Kinase 8 (ERK8) while the rat protein is called ERK7. ERK7 and ERK8 display both similar and different biochemical properties. They autophosphorylate and activate themselves and do not require upstream activating kinases. ERK7 is constitutively active and is not affected by extracellular stimul

>cd06606 STKc_MAPKKK Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-Activated Protein Kinase Kinase Kinase

Probab=100.00  E-value=8.5e-35  Score=295.98  Aligned_cols=255  Identities=24%  Similarity=0.365  Sum_probs=207.7

Q ss_pred             cCCcccccccCCcceEEEEEec-CCcEEEEEEecccCC-chHHHHHHHHHHHHhccCCCcceeEeeEEEcCCCCeEEEEE
Q 005586          410 CFSEVNLLGKGNFSSVYKGTLR-DGTLVAIRSINVTSC-KSEEAEFVKGLYLLTSLRHENIIRLRGFCCSRGRGECFLIY  487 (689)
Q Consensus       410 ~f~~~~~lg~G~~g~Vy~~~~~-~g~~vavK~l~~~~~-~~~~~~f~~e~~~l~~l~H~niv~l~g~~~~~~~~~~~lV~  487 (689)
                      +|...+.||+|++|.||+|..+ +++.|++|++..... ....+.+.+|++.+++++|+||+++++.+........++|+
T Consensus         1 ~~~~~~~i~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~lv~   80 (260)
T cd06606           1 EWTRGELLGRGSFGSVYLALDKDTGELMAVKSVELSGDSEEELEALEREIRILSSLQHPNIVRYYGSERDEEKNTLNIFL   80 (260)
T ss_pred             CceeeeEeeecCceEEEEEEECCCCcEEEEEEeeccccchHHHHHHHHHHHHHHHcCCCCEeeEEEEEecCCCCeEEEEE
Confidence            3667789999999999999987 799999999876542 23457899999999999999999999998654336789999


Q ss_pred             EcCCCCCHHHHhhhcCCCCCCCCHHHHHHHHHHHHHHHhhhhCCCCCCCceeecCCCCCceeecCCCCeEEecccccccc
Q 005586          488 DFAPKGKLSKYLDQEEGSSNVLDWSTRVSIIIGIAKGIGYLHSSEVNKPAIVHRNLSVEKVLIDQQFNPLIADCGLHKLL  567 (689)
Q Consensus       488 e~~~~gsL~~~L~~~~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~~~ivH~dlk~~NiLl~~~~~~kl~DfGla~~~  567 (689)
                      ||+++++|.+++....    .++|..+..++.|++.||+|||+.+     ++|+||+|+||++++++.+||+|||.+...
T Consensus        81 e~~~~~~L~~~~~~~~----~~~~~~~~~~~~~l~~~l~~lh~~~-----~~h~dl~p~ni~i~~~~~~~l~d~~~~~~~  151 (260)
T cd06606          81 EYVSGGSLSSLLKKFG----KLPEPVIRKYTRQILEGLAYLHSNG-----IVHRDIKGANILVDSDGVVKLADFGCAKRL  151 (260)
T ss_pred             EecCCCcHHHHHHHcC----CCCHHHHHHHHHHHHHHHHHHHHCC-----ccccCCCHHHEEEcCCCCEEEcccccEEec
Confidence            9999999999997653    5899999999999999999999987     999999999999999999999999999876


Q ss_pred             cCCcee-eeecCCCCCCCCCccccccCCCCCcccchhHHHHHHHHHhCCCCcchhHHHHHhhhhhhHhhccccCCCCCHH
Q 005586          568 ADDIVF-SVLKTSAAMGYLAPEYVTTGRFTERSDIFAFGVIILQILTGSLVLTSSMRLAAESATFENFIDRNLKGKFSES  646 (689)
Q Consensus       568 ~~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~ksDV~sfGvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  646 (689)
                      ...... ......++..|+|||...+...+.++||||||++++||++|+.|+.......   ...............+..
T Consensus       152 ~~~~~~~~~~~~~~~~~y~~pE~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~---~~~~~~~~~~~~~~~~~~  228 (260)
T cd06606         152 GDIETGEGTGSVRGTPYWMAPEVIRGEEYGRAADIWSLGCTVIEMATGKPPWSELGNPM---AALYKIGSSGEPPEIPEH  228 (260)
T ss_pred             ccccccccccCCCCCccccCHhhhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCchH---HHHHhccccCCCcCCCcc
Confidence            554321 1223446678999999988889999999999999999999999986543111   111111111222334555


Q ss_pred             HHHHHHHHHHHhccCCCCCCCCHHHHHHHH
Q 005586          647 EAAKLGKMALVCTHEDPENRPTMEAVIEEL  676 (689)
Q Consensus       647 ~~~~l~~l~~~Cl~~dp~~RPs~~evl~~L  676 (689)
                      ....+.+++.+|++.+|++||++.|++++-
T Consensus       229 ~~~~l~~~i~~~l~~~p~~Rp~~~~ll~~~  258 (260)
T cd06606         229 LSEEAKDFLRKCLRRDPKKRPTADELLQHP  258 (260)
T ss_pred             cCHHHHHHHHHhCcCChhhCCCHHHHhhCC
Confidence            578899999999999999999999999864

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKKKs (MKKKs or MAP3Ks) are also called MAP/ERK kinase kinases (MEKKs) in some cases. They phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. This subfamily is composed of the Apoptosis Signal-regulating Kinases ASK1 (or MAPKK

>cd07845 STKc_CDK10 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 10

Probab=100.00  E-value=5e-35  Score=306.91  Aligned_cols=261  Identities=22%  Similarity=0.370  Sum_probs=200.3

Q ss_pred             ccCCcccccccCCcceEEEEEec-CCcEEEEEEecccCCc-hHHHHHHHHHHHHhccCCCcceeEeeEEEcCCCCeEEEE
Q 005586          409 QCFSEVNLLGKGNFSSVYKGTLR-DGTLVAIRSINVTSCK-SEEAEFVKGLYLLTSLRHENIIRLRGFCCSRGRGECFLI  486 (689)
Q Consensus       409 ~~f~~~~~lg~G~~g~Vy~~~~~-~g~~vavK~l~~~~~~-~~~~~f~~e~~~l~~l~H~niv~l~g~~~~~~~~~~~lV  486 (689)
                      ++|...+.||+|+||.||+|..+ +|+.||+|+++..... .....+.+|+.++.+++|+||+++++++.....+..++|
T Consensus         7 ~~y~~~~~ig~g~~~~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~lv   86 (309)
T cd07845           7 TEFEKLNRIGEGTYGIVYRARDTTSGEIVALKKVRMDNERDGIPISSLREITLLLNLRHPNIVELKEVVVGKHLDSIFLV   86 (309)
T ss_pred             cceeEeeeeeecCCEEEEEEEECCCCcEEEEEEEEeccCCCCCcchhhHHHHHHHhCCCCCCcceEEEEecCCCCeEEEE
Confidence            46788899999999999999975 6899999998754322 223456789999999999999999999876555678999


Q ss_pred             EEcCCCCCHHHHhhhcCCCCCCCCHHHHHHHHHHHHHHHhhhhCCCCCCCceeecCCCCCceeecCCCCeEEeccccccc
Q 005586          487 YDFAPKGKLSKYLDQEEGSSNVLDWSTRVSIIIGIAKGIGYLHSSEVNKPAIVHRNLSVEKVLIDQQFNPLIADCGLHKL  566 (689)
Q Consensus       487 ~e~~~~gsL~~~L~~~~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~~~ivH~dlk~~NiLl~~~~~~kl~DfGla~~  566 (689)
                      |||++ ++|.+++....   ..+++.++..++.|++.||+|||+.+     ++||||||+||++++++.+||+|||+++.
T Consensus        87 ~e~~~-~~l~~~l~~~~---~~l~~~~~~~~~~qi~~~l~~lH~~~-----i~H~dl~p~nil~~~~~~~kL~dfg~~~~  157 (309)
T cd07845          87 MEYCE-QDLASLLDNMP---TPFSESQVKCLMLQLLRGLQYLHENF-----IIHRDLKVSNLLLTDKGCLKIADFGLART  157 (309)
T ss_pred             EecCC-CCHHHHHHhcc---cCCCHHHHHHHHHHHHHHHHHHHhCC-----eecCCCCHHHEEECCCCCEEECccceeee
Confidence            99996 58988887543   35899999999999999999999987     99999999999999999999999999987


Q ss_pred             ccCCceeeeecCCCCCCCCCcccccc-CCCCCcccchhHHHHHHHHHhCCCCcchhHHHHHhhhhhh-----------Hh
Q 005586          567 LADDIVFSVLKTSAAMGYLAPEYVTT-GRFTERSDIFAFGVIILQILTGSLVLTSSMRLAAESATFE-----------NF  634 (689)
Q Consensus       567 ~~~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~ksDV~sfGvvl~elltG~~p~~~~~~~~~~~~~~~-----------~~  634 (689)
                      ...... ......++..|+|||.+.+ ..++.++||||+||++|||++|+.||..............           .+
T Consensus       158 ~~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslG~il~el~~g~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~~  236 (309)
T cd07845         158 YGLPAK-PMTPKVVTLWYRAPELLLGCTTYTTAIDMWAVGCILAELLAHKPLLPGKSEIEQLDLIIQLLGTPNESIWPGF  236 (309)
T ss_pred             cCCccC-CCCcccccccccChhhhcCCCCcCchHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCChhhchhh
Confidence            654321 1122234667999998865 4578999999999999999999999864322111110000           00


Q ss_pred             hccc------cCCC-C------CHHHHHHHHHHHHHhccCCCCCCCCHHHHHHHHHhh
Q 005586          635 IDRN------LKGK-F------SESEAAKLGKMALVCTHEDPENRPTMEAVIEELTVA  679 (689)
Q Consensus       635 ~~~~------~~~~-~------~~~~~~~l~~l~~~Cl~~dp~~RPs~~evl~~L~~~  679 (689)
                      .+..      .... .      .......+.+++..|++.||++||++.|++++.+..
T Consensus       237 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~ml~~dp~~R~t~~~il~h~~f~  294 (309)
T cd07845         237 SDLPLVGKFTLPKQPYNNLKHKFPWLSEAGLRLLNFLLMYDPKKRATAEEALESSYFK  294 (309)
T ss_pred             hcccccccccccCCCCCchHHhccccCHHHHHHHHHHhcCChhhCcCHHHHhcChhhc
Confidence            0000      0000 0      011256678999999999999999999999987765

Serine/Threonine Kinases (STKs), Cyclin-dependent protein Kinase 10 (CDK10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK10, also called PISSLRE, is essential for cell growth and proliferation, and acts through the G2/M phase of the cell cycle. CDK10 has also been identified as an important factor in endocrine therapy resistance in breast cancer. CDK10 silencing

>cd07837 STKc_CdkB_plant Catalytic domain of the Serine/Threonine Kinase, Plant B-type Cyclin-Dependent protein Kinase

Probab=100.00  E-value=4.4e-35  Score=305.04  Aligned_cols=260  Identities=20%  Similarity=0.310  Sum_probs=195.3

Q ss_pred             ccCCcccccccCCcceEEEEEec-CCcEEEEEEecccCCc-hHHHHHHHHHHHHhccC-CCcceeEeeEEEcCCC---Ce
Q 005586          409 QCFSEVNLLGKGNFSSVYKGTLR-DGTLVAIRSINVTSCK-SEEAEFVKGLYLLTSLR-HENIIRLRGFCCSRGR---GE  482 (689)
Q Consensus       409 ~~f~~~~~lg~G~~g~Vy~~~~~-~g~~vavK~l~~~~~~-~~~~~f~~e~~~l~~l~-H~niv~l~g~~~~~~~---~~  482 (689)
                      ++|+..+.||+|+||.||+|... +|+.||+|++...... .....+.+|+.++++++ ||||+++++++.....   ..
T Consensus         1 ~~y~~~~~lg~g~~g~vy~~~~~~~~~~v~lK~~~~~~~~~~~~~~~~~E~~~l~~l~~~~~i~~~~~~~~~~~~~~~~~   80 (295)
T cd07837           1 DAYEKLEKIGEGTYGKVYKARDKNTGKLVALKKTRLEMDEEGIPPTALREISLLQMLSESIYIVRLLDVEHVEEKNGKPS   80 (295)
T ss_pred             CCceEeeEecccCCeEEEEEEECCCCcEEEEEeehhhccccCCchHHHHHHHHHHHccCCCCccceeeeEeecCCCCCce
Confidence            35778899999999999999976 6899999998754322 23357889999999995 6999999998854321   23


Q ss_pred             EEEEEEcCCCCCHHHHhhhcCCC-CCCCCHHHHHHHHHHHHHHHhhhhCCCCCCCceeecCCCCCceeecC-CCCeEEec
Q 005586          483 CFLIYDFAPKGKLSKYLDQEEGS-SNVLDWSTRVSIIIGIAKGIGYLHSSEVNKPAIVHRNLSVEKVLIDQ-QFNPLIAD  560 (689)
Q Consensus       483 ~~lV~e~~~~gsL~~~L~~~~~~-~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~~~ivH~dlk~~NiLl~~-~~~~kl~D  560 (689)
                      .++||||+++ +|.+++...... ...+++..++.++.||+.||+|||+.+     |+||||||+||+++. ++.+||+|
T Consensus        81 ~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~L~~LH~~~-----i~H~dl~~~nil~~~~~~~~kl~d  154 (295)
T cd07837          81 LYLVFEYLDS-DLKKFMDSNGRGPGRPLPAKTIKSFMYQLLKGVAHCHKHG-----VMHRDLKPQNLLVDKQKGLLKIAD  154 (295)
T ss_pred             EEEEeeccCc-CHHHHHHHhcccCCCCCCHHHHHHHHHHHHHHHHHHHHCC-----eeecCCChHHEEEecCCCeEEEee
Confidence            7999999985 899988754332 346899999999999999999999987     999999999999998 89999999


Q ss_pred             ccccccccCCceeeeecCCCCCCCCCcccccc-CCCCCcccchhHHHHHHHHHhCCCCcchhHHHHHhhhhhhHhhcc--
Q 005586          561 CGLHKLLADDIVFSVLKTSAAMGYLAPEYVTT-GRFTERSDIFAFGVIILQILTGSLVLTSSMRLAAESATFENFIDR--  637 (689)
Q Consensus       561 fGla~~~~~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~ksDV~sfGvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~--  637 (689)
                      ||+++....... ......+++.|+|||++.+ ..++.++|||||||++|||+||+.||............+...-.+  
T Consensus       155 fg~~~~~~~~~~-~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~~~~~~~~~~~~~~~~~~~~~~~~  233 (295)
T cd07837         155 LGLGRAFSIPVK-SYTHEIVTLWYRAPEVLLGSTHYSTPVDIWSVGCIFAEMSRKQPLFPGDSELQQLLHIFKLLGTPTE  233 (295)
T ss_pred             cccceecCCCcc-ccCCcccccCCCChHHhhCCCCCCchHHHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHHHhCCCCh
Confidence            999876533211 1112245678999998865 457899999999999999999999986432211111100000000  


Q ss_pred             ----------------ccCC----CCCHHHHHHHHHHHHHhccCCCCCCCCHHHHHHH
Q 005586          638 ----------------NLKG----KFSESEAAKLGKMALVCTHEDPENRPTMEAVIEE  675 (689)
Q Consensus       638 ----------------~~~~----~~~~~~~~~l~~l~~~Cl~~dp~~RPs~~evl~~  675 (689)
                                      ....    ...+....++.+++.+|++.+|++||++.|++.+
T Consensus       234 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~R~~~~eil~~  291 (295)
T cd07837         234 QVWPGVSKLRDWHEFPQWKPQDLSRAVPDLSPEGLDLLQKMLRYDPAKRISAKAALTH  291 (295)
T ss_pred             hhCcchhhccchhhcCcccchhHHHhccccCHHHHHHHHHHccCChhhcCCHHHHhcC
Confidence                            0000    0011245678899999999999999999999876

Serine/Threonine Kinases (STKs), Plant B-type Cyclin-Dependent protein Kinase (CdkB) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CdkB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. The plant-specific B-type CDKs are expressed from the late S to the M phase of the cell cycle. They are characterized by the cyclin binding motif PPT[A/T]LRE. They play a role in controlling mitosis and integrating developm

>cd07835 STKc_CDK1_like Catalytic domain of Cyclin-Dependent protein Kinase 1-like Serine/Threonine Kinases

Probab=100.00  E-value=3.5e-35  Score=303.92  Aligned_cols=254  Identities=22%  Similarity=0.384  Sum_probs=194.7

Q ss_pred             CCcccccccCCcceEEEEEec-CCcEEEEEEecccCCc-hHHHHHHHHHHHHhccCCCcceeEeeEEEcCCCCeEEEEEE
Q 005586          411 FSEVNLLGKGNFSSVYKGTLR-DGTLVAIRSINVTSCK-SEEAEFVKGLYLLTSLRHENIIRLRGFCCSRGRGECFLIYD  488 (689)
Q Consensus       411 f~~~~~lg~G~~g~Vy~~~~~-~g~~vavK~l~~~~~~-~~~~~f~~e~~~l~~l~H~niv~l~g~~~~~~~~~~~lV~e  488 (689)
                      |+..+.||+|++|.||+|..+ +|..||+|++...... .....+.+|++.+++++|||++++++++..  .+..++|||
T Consensus         1 y~~~~~l~~g~~~~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~E~~~l~~l~~~~iv~~~~~~~~--~~~~~iv~e   78 (283)
T cd07835           1 YQKVEKIGEGTYGVVYKARDKLTGEIVALKKIRLETEDEGVPSTAIREISLLKELNHPNIVRLLDVVHS--ENKLYLVFE   78 (283)
T ss_pred             CchheEecCCCCeEEEEEEEcCCCCEEEEEEeecccccccchhHHHHHHHHHHhcCCCCccCHhheecc--CCeEEEEEe
Confidence            456788999999999999875 7999999999765422 233578899999999999999999999854  578999999


Q ss_pred             cCCCCCHHHHhhhcCCCCCCCCHHHHHHHHHHHHHHHhhhhCCCCCCCceeecCCCCCceeecCCCCeEEeccccccccc
Q 005586          489 FAPKGKLSKYLDQEEGSSNVLDWSTRVSIIIGIAKGIGYLHSSEVNKPAIVHRNLSVEKVLIDQQFNPLIADCGLHKLLA  568 (689)
Q Consensus       489 ~~~~gsL~~~L~~~~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~~~ivH~dlk~~NiLl~~~~~~kl~DfGla~~~~  568 (689)
                      |++ ++|.+++.....  ..+++..++.++.|+++||+|||+.+     ++||||+|+||++++++.+||+|||+++.+.
T Consensus        79 ~~~-~~l~~~~~~~~~--~~~~~~~~~~~~~~i~~~L~~lH~~~-----~~H~dl~p~nil~~~~~~~~l~df~~~~~~~  150 (283)
T cd07835          79 FLD-LDLKKYMDSSPL--TGLDPPLIKSYLYQLLQGIAYCHSHR-----VLHRDLKPQNLLIDREGALKLADFGLARAFG  150 (283)
T ss_pred             ccC-cCHHHHHhhCCC--CCCCHHHHHHHHHHHHHHHHHHHHCC-----eeCCCCCHHHEEEcCCCcEEEeecccccccC
Confidence            995 799999876432  35899999999999999999999877     9999999999999999999999999997654


Q ss_pred             CCceeeeecCCCCCCCCCccccccC-CCCCcccchhHHHHHHHHHhCCCCcchhHHHHHhhhhhh---------------
Q 005586          569 DDIVFSVLKTSAAMGYLAPEYVTTG-RFTERSDIFAFGVIILQILTGSLVLTSSMRLAAESATFE---------------  632 (689)
Q Consensus       569 ~~~~~~~~~~~~~~~y~aPE~~~~~-~~~~ksDV~sfGvvl~elltG~~p~~~~~~~~~~~~~~~---------------  632 (689)
                      .... ......++..|+|||++.+. .++.++|||||||++|||+||+.||..............               
T Consensus       151 ~~~~-~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  229 (283)
T cd07835         151 VPVR-TYTHEVVTLWYRAPEILLGSRQYSTPVDIWSIGCIFAEMVNRRPLFPGDSEIDQLFRIFRTLGTPDEDVWPGVTS  229 (283)
T ss_pred             CCcc-ccCccccccCCCCCceeecCcccCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCChHHhhhhhh
Confidence            3211 11122356789999987654 578999999999999999999999854322111000000               


Q ss_pred             --Hhhccc--cC----CCCCHHHHHHHHHHHHHhccCCCCCCCCHHHHHHH
Q 005586          633 --NFIDRN--LK----GKFSESEAAKLGKMALVCTHEDPENRPTMEAVIEE  675 (689)
Q Consensus       633 --~~~~~~--~~----~~~~~~~~~~l~~l~~~Cl~~dp~~RPs~~evl~~  675 (689)
                        ++....  ..    ..........+.+++.+|++.||++||+++|++++
T Consensus       230 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~il~~  280 (283)
T cd07835         230 LPDYKPTFPKWARQDLSKVVPNLDEDGLDLLSKMLVYDPAKRISAKAALQH  280 (283)
T ss_pred             chhhhhhcccccccchhhhcCCCCHHHHHHHHHHhcCChhhCcCHHHHhcC
Confidence              000000  00    00111224678899999999999999999999875

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes, plants, and yeasts, as well as CDK2 and CDK3. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyc

>cd07849 STKc_ERK1_2_like Catalytic domain of Extracellular signal-Regulated Kinase 1 and 2-like Serine/Threonine Kinases

Probab=100.00  E-value=2.1e-35  Score=313.46  Aligned_cols=259  Identities=20%  Similarity=0.332  Sum_probs=197.4

Q ss_pred             hccCCcccccccCCcceEEEEEec-CCcEEEEEEecccCCchHHHHHHHHHHHHhccCCCcceeEeeEEEcCC---CCeE
Q 005586          408 TQCFSEVNLLGKGNFSSVYKGTLR-DGTLVAIRSINVTSCKSEEAEFVKGLYLLTSLRHENIIRLRGFCCSRG---RGEC  483 (689)
Q Consensus       408 t~~f~~~~~lg~G~~g~Vy~~~~~-~g~~vavK~l~~~~~~~~~~~f~~e~~~l~~l~H~niv~l~g~~~~~~---~~~~  483 (689)
                      +++|...+.||+|+||.||+|... +|+.||+|++...........+.+|+.++++++||||+++++++....   ....
T Consensus         4 ~~~y~i~~~lg~G~~g~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~   83 (336)
T cd07849           4 GPRYQNLSYIGEGAYGMVCSATHKPTGVKVAIKKISPFEHQTFCQRTLREIKILRRFKHENIIGILDIIRPPSFESFNDV   83 (336)
T ss_pred             ccceEEEEEEEecCCeEEEEEEEcCCCCeEEEEEecccccchhHHHHHHHHHHHHhCCCCCcCchhheeecccccccceE
Confidence            467888999999999999999865 689999999875443445567889999999999999999999875432   2357


Q ss_pred             EEEEEcCCCCCHHHHhhhcCCCCCCCCHHHHHHHHHHHHHHHhhhhCCCCCCCceeecCCCCCceeecCCCCeEEecccc
Q 005586          484 FLIYDFAPKGKLSKYLDQEEGSSNVLDWSTRVSIIIGIAKGIGYLHSSEVNKPAIVHRNLSVEKVLIDQQFNPLIADCGL  563 (689)
Q Consensus       484 ~lV~e~~~~gsL~~~L~~~~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~~~ivH~dlk~~NiLl~~~~~~kl~DfGl  563 (689)
                      ++|+||++ ++|.+++...     .+++..+..++.|++.||+|||+.+     |+||||||+||++++++.+||+|||+
T Consensus        84 ~lv~e~~~-~~l~~~~~~~-----~l~~~~~~~i~~ql~~aL~~LH~~~-----ivH~dlkp~Nill~~~~~~kl~dfg~  152 (336)
T cd07849          84 YIVQELME-TDLYKLIKTQ-----HLSNDHIQYFLYQILRGLKYIHSAN-----VLHRDLKPSNLLLNTNCDLKICDFGL  152 (336)
T ss_pred             EEEehhcc-cCHHHHHhcC-----CCCHHHHHHHHHHHHHHHHHHHhCC-----eeccCCCHHHEEECCCCCEEECcccc
Confidence            99999996 5888887543     3899999999999999999999987     99999999999999999999999999


Q ss_pred             cccccCCceee--eecCCCCCCCCCcccccc-CCCCCcccchhHHHHHHHHHhCCCCcchhHHHHHhh-----------h
Q 005586          564 HKLLADDIVFS--VLKTSAAMGYLAPEYVTT-GRFTERSDIFAFGVIILQILTGSLVLTSSMRLAAES-----------A  629 (689)
Q Consensus       564 a~~~~~~~~~~--~~~~~~~~~y~aPE~~~~-~~~~~ksDV~sfGvvl~elltG~~p~~~~~~~~~~~-----------~  629 (689)
                      ++.........  .....++..|+|||.+.+ ..++.++|||||||++|||++|+.||..........           .
T Consensus       153 ~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslGvil~el~~G~~~f~~~~~~~~~~~~~~~~~~~~~~  232 (336)
T cd07849         153 ARIADPEHDHTGFLTEYVATRWYRAPEIMLNSKGYTKAIDIWSVGCILAEMLSNRPLFPGKDYLHQLNLILGVLGTPSQE  232 (336)
T ss_pred             eeeccccccccCCcCCcCcCCCccChHHhhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHcCCCCHH
Confidence            98654322111  112346778999998754 468999999999999999999999985432111000           0


Q ss_pred             hhhHhhccc-------c--CCCCC-----HHHHHHHHHHHHHhccCCCCCCCCHHHHHHHHH
Q 005586          630 TFENFIDRN-------L--KGKFS-----ESEAAKLGKMALVCTHEDPENRPTMEAVIEELT  677 (689)
Q Consensus       630 ~~~~~~~~~-------~--~~~~~-----~~~~~~l~~l~~~Cl~~dp~~RPs~~evl~~L~  677 (689)
                      .+..+.+..       .  ....+     .....++.+++.+||+.||++||++.|++++-+
T Consensus       233 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rpt~~e~l~hp~  294 (336)
T cd07849         233 DLNCIISLRARNYIKSLPFKPKVPWNKLFPNADPKALDLLDKMLTFNPHKRITVEEALAHPY  294 (336)
T ss_pred             HHHHhhchhhhhHHhhcCcCCcccHHHHhcccCcHHHHHHHHHcCCChhhCcCHHHHhcCcc
Confidence            011101000       0  00000     123467889999999999999999999998843

Serine/Threonine Kinases (STKs), Extracellular signal-regulated kinases 1 and 2 (ERK1/2) and Fus3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. This ERK1/2-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the mitogen-activated protein kinases (MAPKs) ERK1, ERK2, baker's yeast Fus3, and similar proteins. MAPK pathways are important mediators of cellular responses to extracellular signals. ERK1/2 activation is preferentially by mitogenic factors, differentiation stimuli, and cytokines, through a kinase cascade involving the MAPK kinases MEK1/2 and a MAPK kinase

>cd06618 PKc_MKK7 Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 7

Probab=100.00  E-value=6.4e-35  Score=304.14  Aligned_cols=254  Identities=17%  Similarity=0.365  Sum_probs=196.4

Q ss_pred             ccCCcccccccCCcceEEEEEecC-CcEEEEEEecccCCchHHHHHHHHHHHHhccC-CCcceeEeeEEEcCCCCeEEEE
Q 005586          409 QCFSEVNLLGKGNFSSVYKGTLRD-GTLVAIRSINVTSCKSEEAEFVKGLYLLTSLR-HENIIRLRGFCCSRGRGECFLI  486 (689)
Q Consensus       409 ~~f~~~~~lg~G~~g~Vy~~~~~~-g~~vavK~l~~~~~~~~~~~f~~e~~~l~~l~-H~niv~l~g~~~~~~~~~~~lV  486 (689)
                      ++|...+.||+|+||.||+|..++ ++.||||+++.........++..|+.++.+.. ||||+++++++..  ....++|
T Consensus        15 ~~~~~~~~lg~g~~~~v~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~--~~~~~~v   92 (296)
T cd06618          15 NDLENLGEIGSGTCGQVYKMRFKKTGHVMAVKQMRRTGNKEENKRILMDLDVVLKSHDCPYIVKCYGYFIT--DSDVFIC   92 (296)
T ss_pred             chheeeeEeeccCCeEEEEEEECCCCeEEEEEEEeccCChHHHHHHHHHHHHHHhccCCCchHhhheeeec--CCeEEEE
Confidence            346677899999999999999874 89999999986554445567778888777775 9999999999954  4689999


Q ss_pred             EEcCCCCCHHHHhhhcCCCCCCCCHHHHHHHHHHHHHHHhhhhCC-CCCCCceeecCCCCCceeecCCCCeEEecccccc
Q 005586          487 YDFAPKGKLSKYLDQEEGSSNVLDWSTRVSIIIGIAKGIGYLHSS-EVNKPAIVHRNLSVEKVLIDQQFNPLIADCGLHK  565 (689)
Q Consensus       487 ~e~~~~gsL~~~L~~~~~~~~~l~~~~~~~ia~~ia~gL~yLH~~-~~~~~~ivH~dlk~~NiLl~~~~~~kl~DfGla~  565 (689)
                      |||++ +++.+++....   ..+++..+..|+.|++.||+|||+. +     |+||||+|+||++++++.+||+|||++.
T Consensus        93 ~e~~~-~~l~~l~~~~~---~~l~~~~~~~i~~~i~~~l~~lH~~~~-----i~H~dl~p~nill~~~~~~kL~dfg~~~  163 (296)
T cd06618          93 MELMS-TCLDKLLKRIQ---GPIPEDILGKMTVAIVKALHYLKEKHG-----VIHRDVKPSNILLDASGNVKLCDFGISG  163 (296)
T ss_pred             eeccC-cCHHHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHhhCC-----EecCCCcHHHEEEcCCCCEEECccccch
Confidence            99985 57777765532   2589999999999999999999973 4     9999999999999999999999999998


Q ss_pred             cccCCceeeeecCCCCCCCCCccccccCC----CCCcccchhHHHHHHHHHhCCCCcchhHHHHHhhhhhhHhhccccCC
Q 005586          566 LLADDIVFSVLKTSAAMGYLAPEYVTTGR----FTERSDIFAFGVIILQILTGSLVLTSSMRLAAESATFENFIDRNLKG  641 (689)
Q Consensus       566 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~----~~~ksDV~sfGvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~  641 (689)
                      .+.....  .....++..|+|||.+.+..    ++.++||||||+++|||++|+.|+......   .......+......
T Consensus       164 ~~~~~~~--~~~~~~~~~y~aPE~~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~---~~~~~~~~~~~~~~  238 (296)
T cd06618         164 RLVDSKA--KTRSAGCAAYMAPERIDPPDPNPKYDIRADVWSLGISLVELATGQFPYKNCKTE---FEVLTKILQEEPPS  238 (296)
T ss_pred             hccCCCc--ccCCCCCccccCHhhcCCCCCccccccchhHHHHHHHHHHHHhCCCCCCcchhH---HHHHHHHhcCCCCC
Confidence            6644321  12234667899999987554    789999999999999999999998642111   01111222221110


Q ss_pred             -CCCHHHHHHHHHHHHHhccCCCCCCCCHHHHHHHHHh
Q 005586          642 -KFSESEAAKLGKMALVCTHEDPENRPTMEAVIEELTV  678 (689)
Q Consensus       642 -~~~~~~~~~l~~l~~~Cl~~dp~~RPs~~evl~~L~~  678 (689)
                       ........++.+++.+|++.||++||++.+++++.+.
T Consensus       239 ~~~~~~~~~~l~~li~~~l~~~p~~Rp~~~~il~~~~~  276 (296)
T cd06618         239 LPPNEGFSPDFCSFVDLCLTKDHRKRPKYRELLQHPFI  276 (296)
T ss_pred             CCCCCCCCHHHHHHHHHHccCChhhCCCHHHHhcChhh
Confidence             1111245678999999999999999999999988653

Protein kinases (PKs), MAP kinase kinase 7 (MKK7) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK7 is a dual-specificity PK that phosphorylates and activates it

>cd05122 PKc_STE Catalytic domain of STE family Protein Kinases

Probab=100.00  E-value=1.4e-34  Score=293.08  Aligned_cols=248  Identities=23%  Similarity=0.422  Sum_probs=201.4

Q ss_pred             cCCcccccccCCcceEEEEEec-CCcEEEEEEecccCCchHHHHHHHHHHHHhccCCCcceeEeeEEEcCCCCeEEEEEE
Q 005586          410 CFSEVNLLGKGNFSSVYKGTLR-DGTLVAIRSINVTSCKSEEAEFVKGLYLLTSLRHENIIRLRGFCCSRGRGECFLIYD  488 (689)
Q Consensus       410 ~f~~~~~lg~G~~g~Vy~~~~~-~g~~vavK~l~~~~~~~~~~~f~~e~~~l~~l~H~niv~l~g~~~~~~~~~~~lV~e  488 (689)
                      +|...+.||+|++|.||++..+ ++..+++|++..... .....+.+|++.+++++|+|++++++++..  ....++++|
T Consensus         1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~~k~~~~~~~-~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~--~~~~~l~~e   77 (253)
T cd05122           1 LFEILEKIGKGGFGEVYKARHKRTGKEVAIKVIKLESK-EKKEKIINEIQILKKCKHPNIVKYYGSYLK--KDELWIVME   77 (253)
T ss_pred             CceeeeeeccCCceEEEEEEECCCCcEEEEEEecccch-hHHHHHHHHHHHHHhCCCCCEeEEEEEEec--CCeEEEEEe
Confidence            3667789999999999999986 789999999977653 355789999999999999999999998854  467899999


Q ss_pred             cCCCCCHHHHhhhcCCCCCCCCHHHHHHHHHHHHHHHhhhhCCCCCCCceeecCCCCCceeecCCCCeEEeccccccccc
Q 005586          489 FAPKGKLSKYLDQEEGSSNVLDWSTRVSIIIGIAKGIGYLHSSEVNKPAIVHRNLSVEKVLIDQQFNPLIADCGLHKLLA  568 (689)
Q Consensus       489 ~~~~gsL~~~L~~~~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~~~ivH~dlk~~NiLl~~~~~~kl~DfGla~~~~  568 (689)
                      |+++++|.+++....   ..+++..+..++.+++.||+|||+.+     ++||||+|+||++++++.+||+|||.+....
T Consensus        78 ~~~~~~L~~~~~~~~---~~~~~~~~~~i~~~i~~~l~~lh~~~-----i~h~dl~p~ni~i~~~~~~~l~d~~~~~~~~  149 (253)
T cd05122          78 FCSGGSLKDLLKSTN---QTLTESQIAYVCKELLKGLEYLHSNG-----IIHRDIKAANILLTSDGEVKLIDFGLSAQLS  149 (253)
T ss_pred             cCCCCcHHHHHhhcC---CCCCHHHHHHHHHHHHHHHHHhhcCC-----EecCCCCHHHEEEccCCeEEEeecccccccc
Confidence            999999999987653   24899999999999999999999977     9999999999999999999999999988765


Q ss_pred             CCceeeeecCCCCCCCCCccccccCCCCCcccchhHHHHHHHHHhCCCCcchhHHHHHhhhhhhHhhccccCCCCCHH--
Q 005586          569 DDIVFSVLKTSAAMGYLAPEYVTTGRFTERSDIFAFGVIILQILTGSLVLTSSMRLAAESATFENFIDRNLKGKFSES--  646 (689)
Q Consensus       569 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~ksDV~sfGvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~--  646 (689)
                      ....  .....++..|+|||++.+..++.++||||||++++||++|+.|+.......... ...   . ......+..  
T Consensus       150 ~~~~--~~~~~~~~~~~~PE~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~-~~~---~-~~~~~~~~~~~  222 (253)
T cd05122         150 DTKA--RNTMVGTPYWMAPEVINGKPYDYKADIWSLGITAIELAEGKPPYSELPPMKALF-KIA---T-NGPPGLRNPEK  222 (253)
T ss_pred             cccc--ccceecCCcccCHHHHcCCCCCccccHHHHHHHHHHHHhCCCCCCCCchHHHHH-HHH---h-cCCCCcCcccc
Confidence            4321  123346678999999988889999999999999999999999986432111100 000   0 111111111  


Q ss_pred             HHHHHHHHHHHhccCCCCCCCCHHHHHHH
Q 005586          647 EAAKLGKMALVCTHEDPENRPTMEAVIEE  675 (689)
Q Consensus       647 ~~~~l~~l~~~Cl~~dp~~RPs~~evl~~  675 (689)
                      ....+.+++..|++.||++||++.|++++
T Consensus       223 ~~~~~~~~i~~~l~~~p~~R~t~~~~l~~  251 (253)
T cd05122         223 WSDEFKDFLKKCLQKNPEKRPTAEQLLKH  251 (253)
T ss_pred             cCHHHHHHHHHHccCChhhCCCHHHHhcC
Confidence            25679999999999999999999999876

Protein Kinases (PKs), STE family, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The STE family is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases (STKs), protein tyrosine kinases (PTKs), RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This family is composed of STKs, and some dual-specificity PKs that phosphorylate both threonine and tyrosine residues of target proteins. Most members are kinases involved in mitogen-activated protein kinase (MAPK) signaling cascades, acting as MAPK kinases (MAPKKs), MAPK kinase kinases (MAPKKKs), or MAPK kinase kinase kinases (MAP4Ks). The MAPK signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core

>cd07842 STKc_CDK8_like Catalytic domain of Cyclin-Dependent protein Kinase 8-like Serine/Threonine Kinases

Probab=100.00  E-value=5.5e-35  Score=307.39  Aligned_cols=260  Identities=22%  Similarity=0.328  Sum_probs=195.8

Q ss_pred             cCCcccccccCCcceEEEEEec---CCcEEEEEEecccCC--chHHHHHHHHHHHHhccCCCcceeEeeEEEcCCCCeEE
Q 005586          410 CFSEVNLLGKGNFSSVYKGTLR---DGTLVAIRSINVTSC--KSEEAEFVKGLYLLTSLRHENIIRLRGFCCSRGRGECF  484 (689)
Q Consensus       410 ~f~~~~~lg~G~~g~Vy~~~~~---~g~~vavK~l~~~~~--~~~~~~f~~e~~~l~~l~H~niv~l~g~~~~~~~~~~~  484 (689)
                      .|...+.||+|+||.||+|...   ++..||+|.+.....  ......+.+|+.++.+++||||+++++++........+
T Consensus         1 ~y~~~~~ig~g~~g~v~~~~~~~~~~~~~~alK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~   80 (316)
T cd07842           1 KYEIEGCIGRGTYGRVYKAKRKNGKDGKEYAIKKFKGDKEQYTGISQSACREIALLRELKHENVVSLVEVFLEHADKSVY   80 (316)
T ss_pred             CceEEEEeccCCcEEEEEEEecCCCCCCeEEEEEeccccccccCccHHHHHHHHHHHhcCCCCccceEEEEeCCCCceEE
Confidence            3667789999999999999975   478999999986431  22235678899999999999999999999765557899


Q ss_pred             EEEEcCCCCCHHHHhhhcCCC-CCCCCHHHHHHHHHHHHHHHhhhhCCCCCCCceeecCCCCCceeecC----CCCeEEe
Q 005586          485 LIYDFAPKGKLSKYLDQEEGS-SNVLDWSTRVSIIIGIAKGIGYLHSSEVNKPAIVHRNLSVEKVLIDQ----QFNPLIA  559 (689)
Q Consensus       485 lV~e~~~~gsL~~~L~~~~~~-~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~~~ivH~dlk~~NiLl~~----~~~~kl~  559 (689)
                      +||||+++ +|.+++...... ...+++...+.|+.|++.||+|||+.+     |+||||||+||+++.    ++.+||+
T Consensus        81 lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~-----i~h~dlkp~Nil~~~~~~~~~~~kl~  154 (316)
T cd07842          81 LLFDYAEH-DLWQIIKFHRQAKRVSIPPSMVKSLLWQILNGVHYLHSNW-----VLHRDLKPANILVMGEGPERGVVKIG  154 (316)
T ss_pred             EEEeCCCc-CHHHHHHhhccCCCcCcCHHHHHHHHHHHHHHHHHHHhCC-----EeeCCCCHHHEEEcCCCCccceEEEC
Confidence            99999975 777777543322 225889999999999999999999987     999999999999999    9999999


Q ss_pred             cccccccccCCce--eeeecCCCCCCCCCccccccC-CCCCcccchhHHHHHHHHHhCCCCcchhHHHH-----Hhhhhh
Q 005586          560 DCGLHKLLADDIV--FSVLKTSAAMGYLAPEYVTTG-RFTERSDIFAFGVIILQILTGSLVLTSSMRLA-----AESATF  631 (689)
Q Consensus       560 DfGla~~~~~~~~--~~~~~~~~~~~y~aPE~~~~~-~~~~ksDV~sfGvvl~elltG~~p~~~~~~~~-----~~~~~~  631 (689)
                      |||+++.......  .......++..|+|||++.+. .++.++|||||||+++||++|+.|+.......     .....+
T Consensus       155 Dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~~l~~~~~~~~~~~~~~~~~~~~~~~~~  234 (316)
T cd07842         155 DLGLARLFNAPLKPLADLDPVVVTIWYRAPELLLGARHYTKAIDIWAIGCIFAELLTLEPIFKGREAKIKKSNPFQRDQL  234 (316)
T ss_pred             CCccccccCCCcccccccCCccccccccCHHHHhCCCCCCcHHHHHHHHHHHHHHHhcCCCCcCCcccccccchhHHHHH
Confidence            9999987644321  112233467789999987664 57899999999999999999999985332110     000000


Q ss_pred             h------------------------HhhccccCCCCC---------H--HHHHHHHHHHHHhccCCCCCCCCHHHHHHH
Q 005586          632 E------------------------NFIDRNLKGKFS---------E--SEAAKLGKMALVCTHEDPENRPTMEAVIEE  675 (689)
Q Consensus       632 ~------------------------~~~~~~~~~~~~---------~--~~~~~l~~l~~~Cl~~dp~~RPs~~evl~~  675 (689)
                      .                        ...+......++         .  ....++.+++.+|++.||++||++.|++++
T Consensus       235 ~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rps~~eil~~  313 (316)
T cd07842         235 ERIFEVLGTPTEKDWPDIKKMPEYDTLMKDFKTKTYPSNSLAKWMEKHKKPDSQGFDLLRKLLEYDPTKRITAEEALEH  313 (316)
T ss_pred             HHHHHHhCCCchhHHHHHhhcccchhhhhhccCCCCCCccHHHHHHhccCCCHHHHHHHHHHhcCCcccCcCHHHHhcC
Confidence            0                        000000011111         0  234568899999999999999999999876

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK8, CDC2L6, and similar proteins. CDK8 functions as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the

>KOG0986 consensus G protein-coupled receptor kinase [Signal transduction mechanisms]

Probab=100.00  E-value=7.5e-36  Score=301.13  Aligned_cols=252  Identities=19%  Similarity=0.268  Sum_probs=204.7

Q ss_pred             HHhccCCcccccccCCcceEEEEEec-CCcEEEEEEecccCCc--hHHHHHHHHHHHHhccCCCcceeEeeEEEcCCCCe
Q 005586          406 SATQCFSEVNLLGKGNFSSVYKGTLR-DGTLVAIRSINVTSCK--SEEAEFVKGLYLLTSLRHENIIRLRGFCCSRGRGE  482 (689)
Q Consensus       406 ~at~~f~~~~~lg~G~~g~Vy~~~~~-~g~~vavK~l~~~~~~--~~~~~f~~e~~~l~~l~H~niv~l~g~~~~~~~~~  482 (689)
                      ...+.|...++||+||||.||-++.+ +|+.+|.|++.+...+  ..+.-...|-++|.+++.+.||.+--.|  +..+.
T Consensus       182 vt~n~F~~~RvlGkGGFGEV~acqvraTGKMYAcKkL~KKRiKkr~ge~maLnEk~iL~kV~s~FiVslaYAf--eTkd~  259 (591)
T KOG0986|consen  182 VTKNTFRVYRVLGKGGFGEVCACQVRATGKMYACKKLDKKRIKKRKGETMALNEKQILEKVSSPFIVSLAYAF--ETKDA  259 (591)
T ss_pred             ccccceeeeEEEecccccceeEEEEecchhhHHHHHHHHHHHHHhhhhHHhhHHHHHHHHhccCcEEEEeeee--cCCCc
Confidence            34577889999999999999999987 6999999998766543  3445678899999999999999985444  45688


Q ss_pred             EEEEEEcCCCCCHHHHhhhcCCCCCCCCHHHHHHHHHHHHHHHhhhhCCCCCCCceeecCCCCCceeecCCCCeEEeccc
Q 005586          483 CFLIYDFAPKGKLSKYLDQEEGSSNVLDWSTRVSIIIGIAKGIGYLHSSEVNKPAIVHRNLSVEKVLIDQQFNPLIADCG  562 (689)
Q Consensus       483 ~~lV~e~~~~gsL~~~L~~~~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~~~ivH~dlk~~NiLl~~~~~~kl~DfG  562 (689)
                      +++|+..|.+|||.-+|...+.  ..+++...+.+|.+|+.||++||...     ||.||+||+|||||+.|+++|+|.|
T Consensus       260 LClVLtlMNGGDLkfHiyn~g~--~gF~e~ra~FYAAEi~cGLehlH~~~-----iVYRDLKPeNILLDd~GhvRISDLG  332 (591)
T KOG0986|consen  260 LCLVLTLMNGGDLKFHIYNHGN--PGFDEQRARFYAAEIICGLEHLHRRR-----IVYRDLKPENILLDDHGHVRISDLG  332 (591)
T ss_pred             eEEEEEeecCCceeEEeeccCC--CCCchHHHHHHHHHHHhhHHHHHhcc-----eeeccCChhheeeccCCCeEeeccc
Confidence            9999999999999999987653  34999999999999999999999887     9999999999999999999999999


Q ss_pred             ccccccCCceeeeecCCCCCCCCCccccccCCCCCcccchhHHHHHHHHHhCCCCcchhHHHHHhhhhhhHhhccccCCC
Q 005586          563 LHKLLADDIVFSVLKTSAAMGYLAPEYVTTGRFTERSDIFAFGVIILQILTGSLVLTSSMRLAAESATFENFIDRNLKGK  642 (689)
Q Consensus       563 la~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~ksDV~sfGvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~  642 (689)
                      ||..+.+....  ....||.||||||++.++.|+...|.||+||++|||+.|+.||........+ ..+.+.+- .-..+
T Consensus       333 LAvei~~g~~~--~~rvGT~GYMAPEvl~ne~Y~~s~Dwf~lGCllYemi~G~sPFr~~KeKvk~-eEvdrr~~-~~~~e  408 (591)
T KOG0986|consen  333 LAVEIPEGKPI--RGRVGTVGYMAPEVLQNEVYDFSPDWFSLGCLLYEMIAGHSPFRQRKEKVKR-EEVDRRTL-EDPEE  408 (591)
T ss_pred             eEEecCCCCcc--ccccCcccccCHHHHcCCcccCCccHHHHHhHHHHHHcccCchhhhhhhhhH-HHHHHHHh-cchhh
Confidence            99988776532  3347999999999999999999999999999999999999999643221111 11111110 11224


Q ss_pred             CCHHHHHHHHHHHHHhccCCCCCCCCHH
Q 005586          643 FSESEAAKLGKMALVCTHEDPENRPTME  670 (689)
Q Consensus       643 ~~~~~~~~l~~l~~~Cl~~dp~~RPs~~  670 (689)
                      +++.-++++..+...-+++||++|.-.+
T Consensus       409 y~~kFS~eakslc~~LL~Kdp~~RLGcr  436 (591)
T KOG0986|consen  409 YSDKFSEEAKSLCEGLLTKDPEKRLGCR  436 (591)
T ss_pred             cccccCHHHHHHHHHHHccCHHHhccCC
Confidence            5666677888899999999999996543

>cd05633 STKc_GRK3 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 3

Probab=100.00  E-value=1e-34  Score=299.87  Aligned_cols=247  Identities=18%  Similarity=0.273  Sum_probs=189.6

Q ss_pred             ccccCCcceEEEEEec-CCcEEEEEEecccCCc--hHHHHHHHHHHH---HhccCCCcceeEeeEEEcCCCCeEEEEEEc
Q 005586          416 LLGKGNFSSVYKGTLR-DGTLVAIRSINVTSCK--SEEAEFVKGLYL---LTSLRHENIIRLRGFCCSRGRGECFLIYDF  489 (689)
Q Consensus       416 ~lg~G~~g~Vy~~~~~-~g~~vavK~l~~~~~~--~~~~~f~~e~~~---l~~l~H~niv~l~g~~~~~~~~~~~lV~e~  489 (689)
                      .||+|+||.||++... +|+.+|+|.+......  .....+.+|..+   +...+||||+.+++++..  .+..++||||
T Consensus         1 ~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~~~~~~~--~~~~~lv~e~   78 (279)
T cd05633           1 IIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMTYAFHT--PDKLCFILDL   78 (279)
T ss_pred             CcccCCCeEEEEEEECCCCcEEEEEEEEccccccchHHHHHHHHHHHHHHHhhCCCCcEeEEEEEEec--CCeEEEEEec
Confidence            4899999999999875 6899999998754322  222334455433   334579999999988854  4678999999


Q ss_pred             CCCCCHHHHhhhcCCCCCCCCHHHHHHHHHHHHHHHhhhhCCCCCCCceeecCCCCCceeecCCCCeEEecccccccccC
Q 005586          490 APKGKLSKYLDQEEGSSNVLDWSTRVSIIIGIAKGIGYLHSSEVNKPAIVHRNLSVEKVLIDQQFNPLIADCGLHKLLAD  569 (689)
Q Consensus       490 ~~~gsL~~~L~~~~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~~~ivH~dlk~~NiLl~~~~~~kl~DfGla~~~~~  569 (689)
                      +++|+|.+++....    .++|.....|+.|++.||+|||+.+     |+||||||+||++++++.+||+|||++.....
T Consensus        79 ~~~~~L~~~i~~~~----~l~~~~~~~i~~qi~~al~~lH~~~-----ivH~dikp~Nil~~~~~~~~l~dfg~~~~~~~  149 (279)
T cd05633          79 MNGGDLHYHLSQHG----VFSEKEMRFYATEIILGLEHMHNRF-----VVYRDLKPANILLDEHGHVRISDLGLACDFSK  149 (279)
T ss_pred             CCCCCHHHHHHhcC----CCCHHHHHHHHHHHHHHHHHHHHCC-----cCCCCCCHHHEEECCCCCEEEccCCcceeccc
Confidence            99999999987543    4899999999999999999999987     99999999999999999999999999876543


Q ss_pred             CceeeeecCCCCCCCCCcccccc-CCCCCcccchhHHHHHHHHHhCCCCcchhHHHHHhhhhhhHhhccccCCCCCHHHH
Q 005586          570 DIVFSVLKTSAAMGYLAPEYVTT-GRFTERSDIFAFGVIILQILTGSLVLTSSMRLAAESATFENFIDRNLKGKFSESEA  648 (689)
Q Consensus       570 ~~~~~~~~~~~~~~y~aPE~~~~-~~~~~ksDV~sfGvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  648 (689)
                      ..   .....++..|+|||.+.+ ..++.++|||||||++|||+||+.||........  ...... ........+....
T Consensus       150 ~~---~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~--~~~~~~-~~~~~~~~~~~~~  223 (279)
T cd05633         150 KK---PHASVGTHGYMAPEVLQKGTAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDK--HEIDRM-TLTVNVELPDSFS  223 (279)
T ss_pred             cC---ccCcCCCcCccCHHHhcCCCCCCchhhhHHHHHHHHHHHhCCCCcCCCCCcCH--HHHHHH-hhcCCcCCccccC
Confidence            22   122357889999998864 5579999999999999999999999964311100  011111 1111223344556


Q ss_pred             HHHHHHHHHhccCCCCCCC-----CHHHHHHHHHhh
Q 005586          649 AKLGKMALVCTHEDPENRP-----TMEAVIEELTVA  679 (689)
Q Consensus       649 ~~l~~l~~~Cl~~dp~~RP-----s~~evl~~L~~~  679 (689)
                      .++.+++..|++.||++||     +++|++++....
T Consensus       224 ~~~~~li~~~l~~~p~~R~~~~~~~~~~~~~h~~~~  259 (279)
T cd05633         224 PELKSLLEGLLQRDVSKRLGCLGRGAQEVKEHVFFK  259 (279)
T ss_pred             HHHHHHHHHHhcCCHHHhcCCCCCCHHHHHhCcccc
Confidence            7889999999999999999     699999886543

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK3 (also known as beta-adrenergic receptor kinase 2) is wi

>cd07850 STKc_JNK Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase

Probab=100.00  E-value=1.1e-34  Score=310.16  Aligned_cols=258  Identities=18%  Similarity=0.312  Sum_probs=199.3

Q ss_pred             HhccCCcccccccCCcceEEEEEec-CCcEEEEEEecccC-CchHHHHHHHHHHHHhccCCCcceeEeeEEEcCC----C
Q 005586          407 ATQCFSEVNLLGKGNFSSVYKGTLR-DGTLVAIRSINVTS-CKSEEAEFVKGLYLLTSLRHENIIRLRGFCCSRG----R  480 (689)
Q Consensus       407 at~~f~~~~~lg~G~~g~Vy~~~~~-~g~~vavK~l~~~~-~~~~~~~f~~e~~~l~~l~H~niv~l~g~~~~~~----~  480 (689)
                      ..++|+..+.||+|+||.||+|... +|+.||+|++.... ......++.+|+.++.+++||||+++++++....    .
T Consensus        14 ~~~~y~~~~~lg~g~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~   93 (353)
T cd07850          14 VLKRYQNLKPIGSGAQGIVCAAYDTVTGQNVAIKKLSRPFQNVTHAKRAYRELVLMKLVNHKNIIGLLNVFTPQKSLEEF   93 (353)
T ss_pred             hhcceEEEEEeccCCCEEEEEEEECCCCCEEEEEecCccccChhHHHHHHHHHHHHHhcCCCCCcceeeeeccCCCcccc
Confidence            3467888999999999999999875 78999999986532 2233457788999999999999999999875332    1


Q ss_pred             CeEEEEEEcCCCCCHHHHhhhcCCCCCCCCHHHHHHHHHHHHHHHhhhhCCCCCCCceeecCCCCCceeecCCCCeEEec
Q 005586          481 GECFLIYDFAPKGKLSKYLDQEEGSSNVLDWSTRVSIIIGIAKGIGYLHSSEVNKPAIVHRNLSVEKVLIDQQFNPLIAD  560 (689)
Q Consensus       481 ~~~~lV~e~~~~gsL~~~L~~~~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~~~ivH~dlk~~NiLl~~~~~~kl~D  560 (689)
                      ...++||||++ ++|.+.+...      +++.....++.|++.||+|||+.+     |+||||||+||++++++.+||+|
T Consensus        94 ~~~~lv~e~~~-~~l~~~~~~~------l~~~~~~~~~~ql~~aL~~LH~~g-----i~H~dlkp~Nil~~~~~~~kL~D  161 (353)
T cd07850          94 QDVYLVMELMD-ANLCQVIQMD------LDHERMSYLLYQMLCGIKHLHSAG-----IIHRDLKPSNIVVKSDCTLKILD  161 (353)
T ss_pred             CcEEEEEeccC-CCHHHHHhhc------CCHHHHHHHHHHHHHHHHHHHhCC-----eeeCCCCHHHEEECCCCCEEEcc
Confidence            35799999995 5888887532      788899999999999999999987     99999999999999999999999


Q ss_pred             ccccccccCCceeeeecCCCCCCCCCccccccCCCCCcccchhHHHHHHHHHhCCCCcchhHHHHHhhhh----------
Q 005586          561 CGLHKLLADDIVFSVLKTSAAMGYLAPEYVTTGRFTERSDIFAFGVIILQILTGSLVLTSSMRLAAESAT----------  630 (689)
Q Consensus       561 fGla~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~ksDV~sfGvvl~elltG~~p~~~~~~~~~~~~~----------  630 (689)
                      ||+++.......  .....++..|+|||.+.+..++.++|||||||++|||++|+.||............          
T Consensus       162 fg~~~~~~~~~~--~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~  239 (353)
T cd07850         162 FGLARTAGTSFM--MTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMIRGTVLFPGTDHIDQWNKIIEQLGTPSDE  239 (353)
T ss_pred             CccceeCCCCCC--CCCCcccccccCHHHHhCCCCCCchhhHhHHHHHHHHHHCCCCCCCCCHHHHHHHHHHhcCCCCHH
Confidence            999987654321  12234677899999999989999999999999999999999998643211111000          


Q ss_pred             --------hhHhhcccc---------------CC----CCCHHHHHHHHHHHHHhccCCCCCCCCHHHHHHHHHh
Q 005586          631 --------FENFIDRNL---------------KG----KFSESEAAKLGKMALVCTHEDPENRPTMEAVIEELTV  678 (689)
Q Consensus       631 --------~~~~~~~~~---------------~~----~~~~~~~~~l~~l~~~Cl~~dp~~RPs~~evl~~L~~  678 (689)
                              .....+...               ..    ........++.+++.+|++.||++||++.|++++-+.
T Consensus       240 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~eiL~~~~~  314 (353)
T cd07850         240 FMSRLQPTVRNYVENRPKYAGYSFEELFPDVLFPPDSESHNKLKASQARDLLSKMLVIDPEKRISVDDALQHPYI  314 (353)
T ss_pred             HHHHhhhhhhHHhhcCCCCCCcchhhhCcccccCcccccccccchhHHHHHHHHHcCCChhhCcCHHHHhcChhH
Confidence                    000000000               00    0011235678899999999999999999999988654

Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase (JNK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. They are also essential regulators of physiological and pathological processes and are involved in the pathogenesis of several diseases such as diabetes, atherosclerosis, stroke, Parkinson's and Alzheimer's. Vetebrates harbor three different JNK

>cd05577 STKc_GRK Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase

Probab=100.00  E-value=7.8e-35  Score=300.45  Aligned_cols=247  Identities=20%  Similarity=0.276  Sum_probs=194.5

Q ss_pred             cccCCcceEEEEEec-CCcEEEEEEecccCC--chHHHHHHHHHHHHhccCCCcceeEeeEEEcCCCCeEEEEEEcCCCC
Q 005586          417 LGKGNFSSVYKGTLR-DGTLVAIRSINVTSC--KSEEAEFVKGLYLLTSLRHENIIRLRGFCCSRGRGECFLIYDFAPKG  493 (689)
Q Consensus       417 lg~G~~g~Vy~~~~~-~g~~vavK~l~~~~~--~~~~~~f~~e~~~l~~l~H~niv~l~g~~~~~~~~~~~lV~e~~~~g  493 (689)
                      ||+|+||+||++..+ +|+.||+|.+.....  ......|..|++++++++||||+++++++.  ..+..++||||++++
T Consensus         1 lg~g~~g~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~--~~~~~~lv~e~~~~~   78 (277)
T cd05577           1 LGKGGFGEVCACQVKATGKMYACKKLDKKRLKKRKGEQMALNEKKILEKVSSRFIVSLAYAFE--TKDDLCLVMTLMNGG   78 (277)
T ss_pred             CCCCCceeEEEEEEcCCCcEEEEEEEehhhhhhhhhhHHHHHHHHHHHhCCCCCEeeeeeEEe--cCCeEEEEEecCCCC
Confidence            689999999999865 689999999875432  223456788999999999999999999884  357899999999999


Q ss_pred             CHHHHhhhcCCCCCCCCHHHHHHHHHHHHHHHhhhhCCCCCCCceeecCCCCCceeecCCCCeEEecccccccccCCcee
Q 005586          494 KLSKYLDQEEGSSNVLDWSTRVSIIIGIAKGIGYLHSSEVNKPAIVHRNLSVEKVLIDQQFNPLIADCGLHKLLADDIVF  573 (689)
Q Consensus       494 sL~~~L~~~~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~~~ivH~dlk~~NiLl~~~~~~kl~DfGla~~~~~~~~~  573 (689)
                      +|.+++.....  ..+++..+..++.|++.||.|||+.+     ++||||+|+||++++++.+||+|||+++....... 
T Consensus        79 ~L~~~l~~~~~--~~~~~~~~~~~~~ql~~~l~~lH~~~-----i~H~di~p~Nil~~~~~~~~l~dfg~~~~~~~~~~-  150 (277)
T cd05577          79 DLKYHIYNVGE--PGFPEARAIFYAAQIICGLEHLHQRR-----IVYRDLKPENVLLDDHGNVRISDLGLAVELKGGKK-  150 (277)
T ss_pred             cHHHHHHHcCc--CCCCHHHHHHHHHHHHHHHHHHHhCC-----cccCCCCHHHEEECCCCCEEEccCcchhhhccCCc-
Confidence            99999976542  35899999999999999999999987     99999999999999999999999999876643221 


Q ss_pred             eeecCCCCCCCCCccccccCCCCCcccchhHHHHHHHHHhCCCCcchhHHHHHhhhhhhHhhccccCCCCCHHHHHHHHH
Q 005586          574 SVLKTSAAMGYLAPEYVTTGRFTERSDIFAFGVIILQILTGSLVLTSSMRLAAESATFENFIDRNLKGKFSESEAAKLGK  653 (689)
Q Consensus       574 ~~~~~~~~~~y~aPE~~~~~~~~~ksDV~sfGvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~  653 (689)
                       .....++..|+|||++.+..++.++|||||||++|||++|+.||......... ..+.+... ......+......+.+
T Consensus       151 -~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~-~~~~~~~~-~~~~~~~~~~~~~~~~  227 (277)
T cd05577         151 -IKGRAGTPGYMAPEVLQGEVYDFSVDWFALGCTLYEMIAGRSPFRQRKEKVEK-EELKRRTL-EMAVEYPDKFSPEAKD  227 (277)
T ss_pred             -cccccCCCCcCCHHHhcCCCCCchhhhHHHHHHHHHHhhCCCCCCCCcccccH-HHHHhccc-cccccCCccCCHHHHH
Confidence             12234667899999998888999999999999999999999998643221100 01111110 1111233344677899


Q ss_pred             HHHHhccCCCCCCC-----CHHHHHHHH
Q 005586          654 MALVCTHEDPENRP-----TMEAVIEEL  676 (689)
Q Consensus       654 l~~~Cl~~dp~~RP-----s~~evl~~L  676 (689)
                      ++.+||+.+|++||     +..+++.+.
T Consensus       228 li~~~l~~~p~~R~~~~~~~~~~ll~h~  255 (277)
T cd05577         228 LCEALLQKDPEKRLGCRGGSADEVREHP  255 (277)
T ss_pred             HHHHHccCChhHccCCCcccHHHHHhCh
Confidence            99999999999999     777777654

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. GRKs contain a central catalytic domain, flanked by N- and C-terminal extensions. The N-terminus contains an RGS (regulator of

>cd07864 STKc_CDK12 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 12

Probab=100.00  E-value=8.3e-35  Score=304.04  Aligned_cols=259  Identities=19%  Similarity=0.336  Sum_probs=197.3

Q ss_pred             HhccCCcccccccCCcceEEEEEec-CCcEEEEEEecccCC-chHHHHHHHHHHHHhccCCCcceeEeeEEEcCC-----
Q 005586          407 ATQCFSEVNLLGKGNFSSVYKGTLR-DGTLVAIRSINVTSC-KSEEAEFVKGLYLLTSLRHENIIRLRGFCCSRG-----  479 (689)
Q Consensus       407 at~~f~~~~~lg~G~~g~Vy~~~~~-~g~~vavK~l~~~~~-~~~~~~f~~e~~~l~~l~H~niv~l~g~~~~~~-----  479 (689)
                      +.++|+..+.||+|+||.||+|..+ +|+.||+|+++.... ......+.+|++++++++||||+++++++.+..     
T Consensus         5 ~~~~~~~~~~lg~g~~g~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~e~~~~~~l~h~~i~~~~~~~~~~~~~~~~   84 (302)
T cd07864           5 CVDKFDIIGQIGEGTYGQVYKARDKDTGELVALKKVRLDNEKEGFPITAIREIKILRQLNHRNIVNLKEIVTDKQDALDF   84 (302)
T ss_pred             hhhhhheeeeecccCCEEEEEEEECCCCcEEEEEEEeecccccCchHHHHHHHHHHHhCCCCCeeeeeheecCcchhhhc
Confidence            4567888999999999999999986 689999999975432 223356788999999999999999999885432     


Q ss_pred             ---CCeEEEEEEcCCCCCHHHHhhhcCCCCCCCCHHHHHHHHHHHHHHHhhhhCCCCCCCceeecCCCCCceeecCCCCe
Q 005586          480 ---RGECFLIYDFAPKGKLSKYLDQEEGSSNVLDWSTRVSIIIGIAKGIGYLHSSEVNKPAIVHRNLSVEKVLIDQQFNP  556 (689)
Q Consensus       480 ---~~~~~lV~e~~~~gsL~~~L~~~~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~~~ivH~dlk~~NiLl~~~~~~  556 (689)
                         ....++|+||+++ ++..++....   ..+++..+..|+.|++.||+|||+.+     |+||||||+||++++++.+
T Consensus        85 ~~~~~~~~lv~e~~~~-~l~~~l~~~~---~~~~~~~~~~i~~qi~~aL~~LH~~~-----i~H~dl~p~nili~~~~~~  155 (302)
T cd07864          85 KKDKGAFYLVFEYMDH-DLMGLLESGL---VHFSEDHIKSFMKQLLEGLNYCHKKN-----FLHRDIKCSNILLNNKGQI  155 (302)
T ss_pred             cccCCcEEEEEcccCc-cHHHHHhcCC---CCCCHHHHHHHHHHHHHHHHHHHhCC-----eecCCCCHHHEEECCCCcE
Confidence               2378999999975 7777776532   24899999999999999999999987     9999999999999999999


Q ss_pred             EEecccccccccCCceeeeecCCCCCCCCCcccccc-CCCCCcccchhHHHHHHHHHhCCCCcchhHHHHHhhhhhhHh-
Q 005586          557 LIADCGLHKLLADDIVFSVLKTSAAMGYLAPEYVTT-GRFTERSDIFAFGVIILQILTGSLVLTSSMRLAAESATFENF-  634 (689)
Q Consensus       557 kl~DfGla~~~~~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~ksDV~sfGvvl~elltG~~p~~~~~~~~~~~~~~~~~-  634 (689)
                      ||+|||+++..............++..|+|||.+.+ ..++.++|||||||++|||++|+.|+......... ..+.+. 
T Consensus       156 kl~dfg~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~Di~slG~~~~el~~g~~~~~~~~~~~~~-~~~~~~~  234 (302)
T cd07864         156 KLADFGLARLYNSEESRPYTNKVITLWYRPPELLLGEERYGPAIDVWSCGCILGELFTKKPIFQANQELAQL-ELISRLC  234 (302)
T ss_pred             EeCcccccccccCCcccccccceeccCccChHHhcCCCCCCchhHHHHHHHHHHHHHhCCCCCCCCChHHHH-HHHHHHh
Confidence            999999998765433212222334667999998764 45789999999999999999999998643211110 000000 


Q ss_pred             -----------hccccC----------C---CCCHHHHHHHHHHHHHhccCCCCCCCCHHHHHHH
Q 005586          635 -----------IDRNLK----------G---KFSESEAAKLGKMALVCTHEDPENRPTMEAVIEE  675 (689)
Q Consensus       635 -----------~~~~~~----------~---~~~~~~~~~l~~l~~~Cl~~dp~~RPs~~evl~~  675 (689)
                                 ......          .   ......+..+.+++..||+.+|++||++.+++++
T Consensus       235 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rp~~~~il~~  299 (302)
T cd07864         235 GSPCPAVWPDVIKLPYFNTMKPKKQYRRRLREEFSFIPTPALDLLDHMLTLDPSKRCTAEEALNS  299 (302)
T ss_pred             CCCChhhcccccccccccccccccccccchhhhcCCCCHHHHHHHHHHccCChhhCCCHHHHhcC
Confidence                       000000          0   0011125678999999999999999999999875

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 12 (CDK12) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK12 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK12 is also called Cdc2-related protein kinase 7 (CRK7) or Cdc2-related kinase arginine/serine-rich (CrkRS). It is a unique CDK that contains an arginine/serine-rich (RS) domain, which is predominantly found in splicing factors. CDK12 is widely

>cd08215 STKc_Nek Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase

Probab=100.00  E-value=2e-34  Score=293.15  Aligned_cols=253  Identities=19%  Similarity=0.384  Sum_probs=205.5

Q ss_pred             cCCcccccccCCcceEEEEEec-CCcEEEEEEecccCC-chHHHHHHHHHHHHhccCCCcceeEeeEEEcCCCCeEEEEE
Q 005586          410 CFSEVNLLGKGNFSSVYKGTLR-DGTLVAIRSINVTSC-KSEEAEFVKGLYLLTSLRHENIIRLRGFCCSRGRGECFLIY  487 (689)
Q Consensus       410 ~f~~~~~lg~G~~g~Vy~~~~~-~g~~vavK~l~~~~~-~~~~~~f~~e~~~l~~l~H~niv~l~g~~~~~~~~~~~lV~  487 (689)
                      +|...+.||+|+||.||++... ++..||+|++..... .....++.+|++++++++|+|++++++.+..  ....++|+
T Consensus         1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~~~~~~~~~~--~~~~~lv~   78 (258)
T cd08215           1 KYEIIKQIGKGSFGKVYLVRRKSDGKLYVLKEIDLSNMSEKEREDALNEVKILKKLNHPNIIKYYESFEE--KGKLCIVM   78 (258)
T ss_pred             CceEEeeeccCCCeEEEEEEEcCCCcEEEEEEeecccCChHHHHHHHHHHHHHHhcCCCChhheEEEEec--CCEEEEEE
Confidence            4677789999999999999976 689999999976543 2455678999999999999999999998854  47899999


Q ss_pred             EcCCCCCHHHHhhhcCCCCCCCCHHHHHHHHHHHHHHHhhhhCCCCCCCceeecCCCCCceeecCCCCeEEecccccccc
Q 005586          488 DFAPKGKLSKYLDQEEGSSNVLDWSTRVSIIIGIAKGIGYLHSSEVNKPAIVHRNLSVEKVLIDQQFNPLIADCGLHKLL  567 (689)
Q Consensus       488 e~~~~gsL~~~L~~~~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~~~ivH~dlk~~NiLl~~~~~~kl~DfGla~~~  567 (689)
                      ||+++++|.+++.........+++..+..++.+++.||+|||+.+     ++|+||+|+||++++++.++|+|||++...
T Consensus        79 e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~-----~~H~dl~~~nil~~~~~~~~l~d~~~~~~~  153 (258)
T cd08215          79 EYADGGDLSQKIKKQKKEGKPFPEEQILDWFVQLCLALKYLHSRK-----ILHRDIKPQNIFLTSNGLVKLGDFGISKVL  153 (258)
T ss_pred             EecCCCcHHHHHHHhhccCCCcCHHHHHHHHHHHHHHHHHHHhCC-----EecccCChHHeEEcCCCcEEECCccceeec
Confidence            999999999999875322346899999999999999999999987     999999999999999999999999999876


Q ss_pred             cCCceeeeecCCCCCCCCCccccccCCCCCcccchhHHHHHHHHHhCCCCcchhHHHHHhhhhhhHhhccccCCCCCHHH
Q 005586          568 ADDIVFSVLKTSAAMGYLAPEYVTTGRFTERSDIFAFGVIILQILTGSLVLTSSMRLAAESATFENFIDRNLKGKFSESE  647 (689)
Q Consensus       568 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~ksDV~sfGvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  647 (689)
                      ..... ......++..|+|||...+..++.++||||+|++++||++|+.|+.......    ........ .....+...
T Consensus       154 ~~~~~-~~~~~~~~~~y~~pe~~~~~~~~~~~Dv~slG~~~~~l~~g~~p~~~~~~~~----~~~~~~~~-~~~~~~~~~  227 (258)
T cd08215         154 SSTVD-LAKTVVGTPYYLSPELCQNKPYNYKSDIWSLGCVLYELCTLKHPFEGENLLE----LALKILKG-QYPPIPSQY  227 (258)
T ss_pred             ccCcc-eecceeeeecccChhHhccCCCCccccHHHHHHHHHHHHcCCCCCCCCcHHH----HHHHHhcC-CCCCCCCCC
Confidence            54431 1122346677999999988889999999999999999999999986432111    11111111 122233445


Q ss_pred             HHHHHHHHHHhccCCCCCCCCHHHHHHH
Q 005586          648 AAKLGKMALVCTHEDPENRPTMEAVIEE  675 (689)
Q Consensus       648 ~~~l~~l~~~Cl~~dp~~RPs~~evl~~  675 (689)
                      ...+.+++..|+..+|++||++.|++++
T Consensus       228 ~~~~~~~i~~~l~~~p~~Rp~~~~ll~~  255 (258)
T cd08215         228 SSELRNLVSSLLQKDPEERPSIAQILQS  255 (258)
T ss_pred             CHHHHHHHHHHcCCChhhCcCHHHHhcC
Confidence            6789999999999999999999999876

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase (Nek) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek family is composed of 11 different mammalian members (Nek1-11) with similarity to the catalytic domain of Aspergillus nidulans NIMA kinase, the founding member of the Nek family which was identified in a screen for cell cycle mutants that were prevented from entering mitosis. Neks contain a conserved N-terminal catalytic domain and a more divergent C-terminal regulatory region of various sizes and structures. They

>cd08226 PK_STRAD_beta Pseudokinase domain of STE20-related kinase adapter protein beta

Probab=100.00  E-value=1.9e-34  Score=305.13  Aligned_cols=255  Identities=20%  Similarity=0.344  Sum_probs=192.7

Q ss_pred             cccccC--CcceEEEEEec-CCcEEEEEEecccCCc-hHHHHHHHHHHHHhccCCCcceeEeeEEEcCCCCeEEEEEEcC
Q 005586          415 NLLGKG--NFSSVYKGTLR-DGTLVAIRSINVTSCK-SEEAEFVKGLYLLTSLRHENIIRLRGFCCSRGRGECFLIYDFA  490 (689)
Q Consensus       415 ~~lg~G--~~g~Vy~~~~~-~g~~vavK~l~~~~~~-~~~~~f~~e~~~l~~l~H~niv~l~g~~~~~~~~~~~lV~e~~  490 (689)
                      ..||+|  +||+||++... +|+.||+|++...... ...+.+.+|+.+++.++||||+++++++..  .+..++|+||+
T Consensus         4 ~~ig~g~~~~~~v~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~~~~l~h~niv~~~~~~~~--~~~~~~v~e~~   81 (328)
T cd08226           4 VEIGRGFCNLTSVYLARHTPTGTLVTVRITDLENCTEEHLKALQNEVVLSHFFRHPNIMTSWTVFTT--GSWLWVISPFM   81 (328)
T ss_pred             HHhCCcccCceeEEEEEEcCCCcEEEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCcceEeeeEec--CCceEEEEecc
Confidence            357776  89999999975 7999999998765432 334678899999999999999999999954  46789999999


Q ss_pred             CCCCHHHHhhhcCCCCCCCCHHHHHHHHHHHHHHHhhhhCCCCCCCceeecCCCCCceeecCCCCeEEecccccccccCC
Q 005586          491 PKGKLSKYLDQEEGSSNVLDWSTRVSIIIGIAKGIGYLHSSEVNKPAIVHRNLSVEKVLIDQQFNPLIADCGLHKLLADD  570 (689)
Q Consensus       491 ~~gsL~~~L~~~~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~~~ivH~dlk~~NiLl~~~~~~kl~DfGla~~~~~~  570 (689)
                      ++|+|.+++.....  ..+++..+..++.|++.||+|||+.+     |+||||||+||+++.++.+|++||+.+......
T Consensus        82 ~~~~l~~~l~~~~~--~~~~~~~~~~~~~qi~~aL~~lH~~~-----ivHrDlkp~Nill~~~~~~~~~~~~~~~~~~~~  154 (328)
T cd08226          82 AYGSANSLLKTYFP--EGMSEALIGNILFGALRGLNYLHQNG-----YIHRNIKASHILISGDGLVSLSGLSHLYSLVRN  154 (328)
T ss_pred             cCCCHHHHHHhhcc--cCCCHHHHHHHHHHHHHHHHHHHhCC-----eecCCCCHHHEEEeCCCcEEEechHHHhhhhcc
Confidence            99999999986532  24889999999999999999999887     999999999999999999999999865433211


Q ss_pred             cee-e-----eecCCCCCCCCCccccccC--CCCCcccchhHHHHHHHHHhCCCCcchhHHHHHhhhhhh----------
Q 005586          571 IVF-S-----VLKTSAAMGYLAPEYVTTG--RFTERSDIFAFGVIILQILTGSLVLTSSMRLAAESATFE----------  632 (689)
Q Consensus       571 ~~~-~-----~~~~~~~~~y~aPE~~~~~--~~~~ksDV~sfGvvl~elltG~~p~~~~~~~~~~~~~~~----------  632 (689)
                      ... .     .....++..|+|||++.+.  .++.++|||||||++|||++|+.||............+.          
T Consensus       155 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~DiwslG~~l~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~  234 (328)
T cd08226         155 GQKAKVVYDFPQFSTSVLPWLSPELLRQDLYGYNVKSDIYSVGITACELATGRVPFQDMLRTQMLLQKLKGPPYSPLDIT  234 (328)
T ss_pred             CccccccccccccccCccCccChhhhcCCCCCCCchhhHHHHHHHHHHHHhCCCCCCCcChHHHHHHHhcCCCCCCcccc
Confidence            100 0     0011234569999998763  478999999999999999999999964322111000000          


Q ss_pred             -------------------------------HhhccccCCCCCHHHHHHHHHHHHHhccCCCCCCCCHHHHHHHHHh
Q 005586          633 -------------------------------NFIDRNLKGKFSESEAAKLGKMALVCTHEDPENRPTMEAVIEELTV  678 (689)
Q Consensus       633 -------------------------------~~~~~~~~~~~~~~~~~~l~~l~~~Cl~~dp~~RPs~~evl~~L~~  678 (689)
                                                     ...+..+...........+.+++.+||+.||++|||+.|++++.+.
T Consensus       235 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rpta~e~l~~~~~  311 (328)
T cd08226         235 TFPCEESRMKNSQSGVDSGIGESVVAAGMTQTMTSERLRTPSSKTFSPAFQNLVELCLQQDPEKRPSASSLLSHAFF  311 (328)
T ss_pred             ccchhhhhhccchhhhhcccccchhccccccccccccccchhhhhhhHHHHHHHHHHccCCcccCCCHHHHhhCHHH
Confidence                                           0000011111223456789999999999999999999999987654

Protein Kinase family, STE20-related kinase adapter protein (STRAD) beta subfamily, pseudokinase domain. The STRAD-beta subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpig

>cd05613 STKc_MSK1_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 1

Probab=100.00  E-value=1.3e-34  Score=300.77  Aligned_cols=253  Identities=19%  Similarity=0.292  Sum_probs=196.2

Q ss_pred             cCCcccccccCCcceEEEEEe----cCCcEEEEEEecccCC---chHHHHHHHHHHHHhcc-CCCcceeEeeEEEcCCCC
Q 005586          410 CFSEVNLLGKGNFSSVYKGTL----RDGTLVAIRSINVTSC---KSEEAEFVKGLYLLTSL-RHENIIRLRGFCCSRGRG  481 (689)
Q Consensus       410 ~f~~~~~lg~G~~g~Vy~~~~----~~g~~vavK~l~~~~~---~~~~~~f~~e~~~l~~l-~H~niv~l~g~~~~~~~~  481 (689)
                      +|+..+.||+|+||.||++..    .+|..||+|++.....   ....+.+.+|++++.++ +|+||+++++++.  ...
T Consensus         1 ~y~~~~~lg~G~~g~v~~~~~~~~~~~g~~~aiK~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~i~~~~~~~~--~~~   78 (290)
T cd05613           1 NFELLKVLGTGAYGKVFLVRKVSGHDSGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHIRQSPFLVTLHYAFQ--TDT   78 (290)
T ss_pred             CceeeeeeccCCcceEEEEEeccCCCCCceEEEEEeehhhhhhcchHHHHHHHHHHHHHhcccCCChhceeeEee--cCC
Confidence            366778999999999999986    3689999999875431   22346788999999999 5999999998874  346


Q ss_pred             eEEEEEEcCCCCCHHHHhhhcCCCCCCCCHHHHHHHHHHHHHHHhhhhCCCCCCCceeecCCCCCceeecCCCCeEEecc
Q 005586          482 ECFLIYDFAPKGKLSKYLDQEEGSSNVLDWSTRVSIIIGIAKGIGYLHSSEVNKPAIVHRNLSVEKVLIDQQFNPLIADC  561 (689)
Q Consensus       482 ~~~lV~e~~~~gsL~~~L~~~~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~~~ivH~dlk~~NiLl~~~~~~kl~Df  561 (689)
                      ..++||||+++++|.+++....    .+++.....++.|+++||+|||+.+     ++||||||+|||+++++.+||+||
T Consensus        79 ~~~lv~e~~~~~~L~~~l~~~~----~l~~~~~~~~~~qi~~al~~lH~~~-----i~H~dl~p~nil~~~~~~~kl~df  149 (290)
T cd05613          79 KLHLILDYINGGELFTHLSQRE----RFKEQEVQIYSGEIVLALEHLHKLG-----IIYRDIKLENILLDSNGHVVLTDF  149 (290)
T ss_pred             eEEEEEecCCCCcHHHHHHHcC----CCCHHHHHHHHHHHHHHHHHHHhCC-----eeccCCCHHHeEECCCCCEEEeeC
Confidence            7899999999999999997643    3788999999999999999999987     999999999999999999999999


Q ss_pred             cccccccCCceeeeecCCCCCCCCCccccccC--CCCCcccchhHHHHHHHHHhCCCCcchhHHHHHhhhhhhHhhcccc
Q 005586          562 GLHKLLADDIVFSVLKTSAAMGYLAPEYVTTG--RFTERSDIFAFGVIILQILTGSLVLTSSMRLAAESATFENFIDRNL  639 (689)
Q Consensus       562 Gla~~~~~~~~~~~~~~~~~~~y~aPE~~~~~--~~~~ksDV~sfGvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~  639 (689)
                      |+++..............++..|+|||.+...  .++.++||||||+++|||+||+.|+...............+...  
T Consensus       150 g~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~Dv~slG~~l~~ll~g~~p~~~~~~~~~~~~~~~~~~~~--  227 (290)
T cd05613         150 GLSKEFHEDEVERAYSFCGTIEYMAPDIVRGGDGGHDKAVDWWSMGVLMYELLTGASPFTVDGEKNSQAEISRRILKS--  227 (290)
T ss_pred             ccceecccccccccccccCCcccCChhhccCCCCCCCccccHHHHHHHHHHHhcCCCCCCcCCccccHHHHHHHhhcc--
Confidence            99987654332222234567889999998753  46789999999999999999999985321111111111111111  


Q ss_pred             CCCCCHHHHHHHHHHHHHhccCCCCCCC-----CHHHHHHH
Q 005586          640 KGKFSESEAAKLGKMALVCTHEDPENRP-----TMEAVIEE  675 (689)
Q Consensus       640 ~~~~~~~~~~~l~~l~~~Cl~~dp~~RP-----s~~evl~~  675 (689)
                      ...++......+.+++.+|++.||++||     +..+++.+
T Consensus       228 ~~~~~~~~~~~~~~ll~~~l~~~p~~R~~~~~~~~~~l~~~  268 (290)
T cd05613         228 EPPYPQEMSALAKDIIQRLLMKDPKKRLGCGPSDADEIKKH  268 (290)
T ss_pred             CCCCCccCCHHHHHHHHHHhcCCHHHhcCCCCCCHHHHHcC
Confidence            1123444566789999999999999997     77777765

Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK1, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydroph

>cd06634 STKc_TAO2 Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 2

Probab=100.00  E-value=2.1e-34  Score=301.99  Aligned_cols=254  Identities=20%  Similarity=0.375  Sum_probs=199.1

Q ss_pred             cCCcccccccCCcceEEEEEec-CCcEEEEEEecccC--CchHHHHHHHHHHHHhccCCCcceeEeeEEEcCCCCeEEEE
Q 005586          410 CFSEVNLLGKGNFSSVYKGTLR-DGTLVAIRSINVTS--CKSEEAEFVKGLYLLTSLRHENIIRLRGFCCSRGRGECFLI  486 (689)
Q Consensus       410 ~f~~~~~lg~G~~g~Vy~~~~~-~g~~vavK~l~~~~--~~~~~~~f~~e~~~l~~l~H~niv~l~g~~~~~~~~~~~lV  486 (689)
                      .|+..+.||+|+||.||+|... ++..+|+|.+....  ......++.+|+++++.++|+|++++++++..  ....++|
T Consensus        16 ~~~~~~~lg~g~~g~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~--~~~~~lv   93 (308)
T cd06634          16 LFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPNTIQYRGCYLR--EHTAWLV   93 (308)
T ss_pred             HHHHHHheeeCCCEEEEEEEEcCCCcEEEEEEEecccccChHHHHHHHHHHHHHHhCCCCCcccEEEEEEc--CCeeEEE
Confidence            3556688999999999999975 68899999986432  22334578899999999999999999999855  4678999


Q ss_pred             EEcCCCCCHHHHhhhcCCCCCCCCHHHHHHHHHHHHHHHhhhhCCCCCCCceeecCCCCCceeecCCCCeEEeccccccc
Q 005586          487 YDFAPKGKLSKYLDQEEGSSNVLDWSTRVSIIIGIAKGIGYLHSSEVNKPAIVHRNLSVEKVLIDQQFNPLIADCGLHKL  566 (689)
Q Consensus       487 ~e~~~~gsL~~~L~~~~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~~~ivH~dlk~~NiLl~~~~~~kl~DfGla~~  566 (689)
                      |||+. |++.+++....   ..+++.++..++.|++.||.|||+.+     ++||||||+||++++++.+||+|||++..
T Consensus        94 ~e~~~-~~l~~~~~~~~---~~l~~~~~~~~~~~l~~~l~~LH~~~-----i~H~dl~p~nil~~~~~~~kl~dfg~~~~  164 (308)
T cd06634          94 MEYCL-GSASDLLEVHK---KPLQEVEIAAVTHGALQGLAYLHSHN-----MIHRDVKAGNILLSEPGLVKLGDFGSASI  164 (308)
T ss_pred             EEccC-CCHHHHHHHcC---CCCCHHHHHHHHHHHHHHHHHHHhCC-----cccCCCCHHhEEECCCCcEEECCccccee
Confidence            99996 68888876433   24889999999999999999999887     99999999999999999999999999876


Q ss_pred             ccCCceeeeecCCCCCCCCCccccc---cCCCCCcccchhHHHHHHHHHhCCCCcchhHHHHHhhhhhhHhhccccCCCC
Q 005586          567 LADDIVFSVLKTSAAMGYLAPEYVT---TGRFTERSDIFAFGVIILQILTGSLVLTSSMRLAAESATFENFIDRNLKGKF  643 (689)
Q Consensus       567 ~~~~~~~~~~~~~~~~~y~aPE~~~---~~~~~~ksDV~sfGvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~  643 (689)
                      .....     ...++..|+|||.+.   ...++.++|||||||++|||++|+.|+........    .............
T Consensus       165 ~~~~~-----~~~~~~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~----~~~~~~~~~~~~~  235 (308)
T cd06634         165 MAPAN-----XFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSA----LYHIAQNESPALQ  235 (308)
T ss_pred             ecCcc-----cccCCccccCHHHHhhcccCCCCcccchHHHHHHHHHHHcCCCCCccccHHHH----HHHHhhcCCCCcC
Confidence            54321     234677899999874   35678999999999999999999999854321111    0111111111111


Q ss_pred             CHHHHHHHHHHHHHhccCCCCCCCCHHHHHHHHHhhCCcc
Q 005586          644 SESEAAKLGKMALVCTHEDPENRPTMEAVIEELTVAAPVM  683 (689)
Q Consensus       644 ~~~~~~~l~~l~~~Cl~~dp~~RPs~~evl~~L~~~~p~~  683 (689)
                      .......+.+++.+||+.+|++||++.+++++.+......
T Consensus       236 ~~~~~~~~~~li~~cl~~~P~~Rp~~~~ll~~~~~~~~~~  275 (308)
T cd06634         236 SGHWSEYFRNFVDSCLQKIPQDRPTSEVLLKHRFVLRERP  275 (308)
T ss_pred             cccccHHHHHHHHHHhhCCcccCCCHHHHhhCccccccCC
Confidence            2345677899999999999999999999999877665443

Serine/threonine kinases (STKs), thousand-and-one amino acids 2 (TAO2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Human TAO2 is also known as prostate-derived Ste20-like kinase (PSK) and was identified in a screen for overexpressed RNAs in prostate cancer. TAO2 activates both p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activatin

>PHA02882 putative serine/threonine kinase; Provisional

Probab=100.00  E-value=1.6e-34  Score=300.65  Aligned_cols=258  Identities=16%  Similarity=0.159  Sum_probs=183.7

Q ss_pred             ccCCcccccccCCcceEEEEEecC----CcEEEEEEecccCCch--H--------HHHHHHHHHHHhccCCCcceeEeeE
Q 005586          409 QCFSEVNLLGKGNFSSVYKGTLRD----GTLVAIRSINVTSCKS--E--------EAEFVKGLYLLTSLRHENIIRLRGF  474 (689)
Q Consensus       409 ~~f~~~~~lg~G~~g~Vy~~~~~~----g~~vavK~l~~~~~~~--~--------~~~f~~e~~~l~~l~H~niv~l~g~  474 (689)
                      ++|...+.||+|+||.||+|...+    +..+|+|.........  +        ......+...+..+.|+|+++++++
T Consensus        12 ~~y~i~~~LG~G~fG~Vy~~~~~~~~~~~~~~~~k~~~~~~~~~~~e~~~~~~~~~~~~~~~~~~~~~~~h~~i~~~~~~   91 (294)
T PHA02882         12 KEWKIDKLIGCGGFGCVYETQCASDHCINNQAVAKIENLENETIVMETLVYNNIYDIDKIALWKNIHNIDHLGIPKYYGC   91 (294)
T ss_pred             CceEEeeEEecCCCceEEEEEEcCCcccccceEEEeccccCCchhhHHHHHHhhhhHHHHHHHHHhccCCCCCCCcEEEe
Confidence            467788999999999999999764    4556666543322111  0        1122334455667899999999987


Q ss_pred             EEcCCC--CeEEEEEEcCCCCCHHHHhhhcCCCCCCCCHHHHHHHHHHHHHHHhhhhCCCCCCCceeecCCCCCceeecC
Q 005586          475 CCSRGR--GECFLIYDFAPKGKLSKYLDQEEGSSNVLDWSTRVSIIIGIAKGIGYLHSSEVNKPAIVHRNLSVEKVLIDQ  552 (689)
Q Consensus       475 ~~~~~~--~~~~lV~e~~~~gsL~~~L~~~~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~~~ivH~dlk~~NiLl~~  552 (689)
                      +.....  ...++++|++. .++.+.+....    ..++.....|+.|+++||+|||+.+     |+||||||+|||++.
T Consensus        92 ~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~----~~~~~~~~~i~~qi~~~l~~lH~~~-----iiHrDiKp~Nill~~  161 (294)
T PHA02882         92 GSFKRCRMYYRFILLEKLV-ENTKEIFKRIK----CKNKKLIKNIMKDMLTTLEYIHEHG-----ISHGDIKPENIMVDG  161 (294)
T ss_pred             eeEecCCceEEEEEEehhc-cCHHHHHHhhc----cCCHHHHHHHHHHHHHHHHHHHhCC-----eecCCCCHHHEEEcC
Confidence            643322  13467778774 36666665432    2567888999999999999999987     999999999999999


Q ss_pred             CCCeEEecccccccccCCce------eeeecCCCCCCCCCccccccCCCCCcccchhHHHHHHHHHhCCCCcchhHHHHH
Q 005586          553 QFNPLIADCGLHKLLADDIV------FSVLKTSAAMGYLAPEYVTTGRFTERSDIFAFGVIILQILTGSLVLTSSMRLAA  626 (689)
Q Consensus       553 ~~~~kl~DfGla~~~~~~~~------~~~~~~~~~~~y~aPE~~~~~~~~~ksDV~sfGvvl~elltG~~p~~~~~~~~~  626 (689)
                      ++.+||+|||+++.+.....      .......+|..|+|||+..+..++.++|||||||++|||++|+.||........
T Consensus       162 ~~~~~l~DFGla~~~~~~~~~~~~~~~~~~~~~gt~~y~ape~~~~~~~~~~~DiwSlG~~l~el~~g~~P~~~~~~~~~  241 (294)
T PHA02882        162 NNRGYIIDYGIASHFIIHGKHIEYSKEQKDLHRGTLYYAGLDAHNGACVTRRGDLESLGYCMLKWAGIKLPWKGFGHNGN  241 (294)
T ss_pred             CCcEEEEEcCCceeeccCCcccccccccccccCCCccccCHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCccccchH
Confidence            99999999999986642211      011223588899999999999999999999999999999999999964421110


Q ss_pred             -hhhhhhHhhccccCCC-CCHHHHHHHHHHHHHhccCCCCCCCCHHHHHHHH
Q 005586          627 -ESATFENFIDRNLKGK-FSESEAAKLGKMALVCTHEDPENRPTMEAVIEEL  676 (689)
Q Consensus       627 -~~~~~~~~~~~~~~~~-~~~~~~~~l~~l~~~Cl~~dp~~RPs~~evl~~L  676 (689)
                       ......+++.+...+. .....+..+.+++..|+..+|++||++.++++.+
T Consensus       242 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~rp~~~~l~~~~  293 (294)
T PHA02882        242 LIHAAKCDFIKRLHEGKIKIKNANKFIYDFIECVTKLSYEEKPDYDALIKIF  293 (294)
T ss_pred             HHHHhHHHHHHHhhhhhhccCCCCHHHHHHHHHHHhCCCCCCCCHHHHHHhh
Confidence             0000111111111111 1123357799999999999999999999999876

>PLN00009 cyclin-dependent kinase A; Provisional

Probab=100.00  E-value=1.6e-34  Score=300.77  Aligned_cols=260  Identities=20%  Similarity=0.337  Sum_probs=195.3

Q ss_pred             ccCCcccccccCCcceEEEEEec-CCcEEEEEEecccCC-chHHHHHHHHHHHHhccCCCcceeEeeEEEcCCCCeEEEE
Q 005586          409 QCFSEVNLLGKGNFSSVYKGTLR-DGTLVAIRSINVTSC-KSEEAEFVKGLYLLTSLRHENIIRLRGFCCSRGRGECFLI  486 (689)
Q Consensus       409 ~~f~~~~~lg~G~~g~Vy~~~~~-~g~~vavK~l~~~~~-~~~~~~f~~e~~~l~~l~H~niv~l~g~~~~~~~~~~~lV  486 (689)
                      ++|+..+.||+|++|.||+|..+ +|+.||+|++..... ......+.+|++++++++||||+++++++..  ....++|
T Consensus         2 ~~y~~~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~--~~~~~lv   79 (294)
T PLN00009          2 DQYEKVEKIGEGTYGVVYKARDRVTNETIALKKIRLEQEDEGVPSTAIREISLLKEMQHGNIVRLQDVVHS--EKRLYLV   79 (294)
T ss_pred             CceEEEEEecCCCCEEEEEEEecCCCcEEEEEehhhccccccchHHHHHHHHHHHhccCCCEeeEEEEEec--CCeEEEE
Confidence            46778899999999999999976 689999999865432 2234578899999999999999999999854  5789999


Q ss_pred             EEcCCCCCHHHHhhhcCCCCCCCCHHHHHHHHHHHHHHHhhhhCCCCCCCceeecCCCCCceeecC-CCCeEEecccccc
Q 005586          487 YDFAPKGKLSKYLDQEEGSSNVLDWSTRVSIIIGIAKGIGYLHSSEVNKPAIVHRNLSVEKVLIDQ-QFNPLIADCGLHK  565 (689)
Q Consensus       487 ~e~~~~gsL~~~L~~~~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~~~ivH~dlk~~NiLl~~-~~~~kl~DfGla~  565 (689)
                      |||++ ++|.+++.....  ..+++.....++.|++.||+|||+.+     ++||||||+||++++ ++.+||+|||+++
T Consensus        80 ~e~~~-~~l~~~~~~~~~--~~~~~~~~~~~~~qi~~aL~~LH~~~-----i~H~dl~p~nill~~~~~~~kl~dfg~~~  151 (294)
T PLN00009         80 FEYLD-LDLKKHMDSSPD--FAKNPRLIKTYLYQILRGIAYCHSHR-----VLHRDLKPQNLLIDRRTNALKLADFGLAR  151 (294)
T ss_pred             Eeccc-ccHHHHHHhCCC--CCcCHHHHHHHHHHHHHHHHHHHhCC-----eeCCCCCcceEEEECCCCEEEEccccccc
Confidence            99996 588888754332  23678888899999999999999987     999999999999985 5678999999997


Q ss_pred             cccCCceeeeecCCCCCCCCCccccccC-CCCCcccchhHHHHHHHHHhCCCCcchhHHHHHhhhhhh-------Hhh--
Q 005586          566 LLADDIVFSVLKTSAAMGYLAPEYVTTG-RFTERSDIFAFGVIILQILTGSLVLTSSMRLAAESATFE-------NFI--  635 (689)
Q Consensus       566 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~-~~~~ksDV~sfGvvl~elltG~~p~~~~~~~~~~~~~~~-------~~~--  635 (689)
                      ....... ......++..|+|||++.+. .++.++|||||||++|||+||+.|+............+.       +..  
T Consensus       152 ~~~~~~~-~~~~~~~~~~y~~PE~~~~~~~~~~~~Dv~slG~i~~~l~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~  230 (294)
T PLN00009        152 AFGIPVR-TFTHEVVTLWYRAPEILLGSRHYSTPVDIWSVGCIFAEMVNQKPLFPGDSEIDELFKIFRILGTPNEETWPG  230 (294)
T ss_pred             ccCCCcc-ccccCceeecccCHHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCChhhccc
Confidence            6543211 11223456789999988664 578999999999999999999999864322111110000       000  


Q ss_pred             --------c--cccCCC----CCHHHHHHHHHHHHHhccCCCCCCCCHHHHHHHHHhh
Q 005586          636 --------D--RNLKGK----FSESEAAKLGKMALVCTHEDPENRPTMEAVIEELTVA  679 (689)
Q Consensus       636 --------~--~~~~~~----~~~~~~~~l~~l~~~Cl~~dp~~RPs~~evl~~L~~~  679 (689)
                              .  +.....    .....+.++.+++.+|++.+|++||++.+++++-+..
T Consensus       231 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rps~~~~l~~~~~~  288 (294)
T PLN00009        231 VTSLPDYKSAFPKWPPKDLATVVPTLEPAGVDLLSKMLRLDPSKRITARAALEHEYFK  288 (294)
T ss_pred             cccchhhhhhcccCCCCCHHHhCcCCChHHHHHHHHHccCChhhCcCHHHHhcCchHh
Confidence                    0  000000    0112345688999999999999999999999875543

>PHA03390 pk1 serine/threonine-protein kinase 1; Provisional

Probab=100.00  E-value=3.2e-34  Score=294.15  Aligned_cols=250  Identities=19%  Similarity=0.247  Sum_probs=191.9

Q ss_pred             HHHHHhccCCccccc--ccCCcceEEEEEec-CCcEEEEEEecccCCchHHHHHHHHHHHHhcc-CCCcceeEeeEEEcC
Q 005586          403 EVESATQCFSEVNLL--GKGNFSSVYKGTLR-DGTLVAIRSINVTSCKSEEAEFVKGLYLLTSL-RHENIIRLRGFCCSR  478 (689)
Q Consensus       403 ~l~~at~~f~~~~~l--g~G~~g~Vy~~~~~-~g~~vavK~l~~~~~~~~~~~f~~e~~~l~~l-~H~niv~l~g~~~~~  478 (689)
                      +.....++|...+.+  |+|+||.||++..+ ++..+|+|.+........      |+.....+ +||||+++++++.. 
T Consensus         8 ~~~~~~~~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~k~~~~~~~~~~------e~~~~~~~~~h~~iv~~~~~~~~-   80 (267)
T PHA03390          8 ELVQFLKNCEIVKKLKLIDGKFGKVSVLKHKPTQKLFVQKIIKAKNFNAI------EPMVHQLMKDNPNFIKLYYSVTT-   80 (267)
T ss_pred             HHHHHHHhhccccceeecCCCceEEEEEEEcCCCcEEEEEEEehhhcchh------hHHHHHHhhcCCCEEEEEEEEec-
Confidence            334444566666666  99999999999875 688999999875432111      12122112 79999999999854 


Q ss_pred             CCCeEEEEEEcCCCCCHHHHhhhcCCCCCCCCHHHHHHHHHHHHHHHhhhhCCCCCCCceeecCCCCCceeecCCC-CeE
Q 005586          479 GRGECFLIYDFAPKGKLSKYLDQEEGSSNVLDWSTRVSIIIGIAKGIGYLHSSEVNKPAIVHRNLSVEKVLIDQQF-NPL  557 (689)
Q Consensus       479 ~~~~~~lV~e~~~~gsL~~~L~~~~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~~~ivH~dlk~~NiLl~~~~-~~k  557 (689)
                       .+..++||||+++|+|.+++....    .++|.++..++.|+++||.|||+.+     ++||||||+||+++.++ .++
T Consensus        81 -~~~~~iv~e~~~~~~L~~~l~~~~----~l~~~~~~~~~~qi~~~l~~lH~~~-----i~H~dl~p~nil~~~~~~~~~  150 (267)
T PHA03390         81 -LKGHVLIMDYIKDGDLFDLLKKEG----KLSEAEVKKIIRQLVEALNDLHKHN-----IIHNDIKLENVLYDRAKDRIY  150 (267)
T ss_pred             -CCeeEEEEEcCCCCcHHHHHHhcC----CCCHHHHHHHHHHHHHHHHHHHhCC-----eeeCCCCHHHEEEeCCCCeEE
Confidence             468999999999999999997653    4899999999999999999999987     99999999999999998 999


Q ss_pred             EecccccccccCCceeeeecCCCCCCCCCccccccCCCCCcccchhHHHHHHHHHhCCCCcchhHHHHHhhhhhhHhhcc
Q 005586          558 IADCGLHKLLADDIVFSVLKTSAAMGYLAPEYVTTGRFTERSDIFAFGVIILQILTGSLVLTSSMRLAAESATFENFIDR  637 (689)
Q Consensus       558 l~DfGla~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~ksDV~sfGvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~  637 (689)
                      |+|||+++......     ...++..|+|||++.+..++.++|||||||++|||++|+.|+............+......
T Consensus       151 l~dfg~~~~~~~~~-----~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~  225 (267)
T PHA03390        151 LCDYGLCKIIGTPS-----CYDGTLDYFSPEKIKGHNYDVSFDWWAVGVLTYELLTGKHPFKEDEDEELDLESLLKRQQK  225 (267)
T ss_pred             EecCccceecCCCc-----cCCCCCcccChhhhcCCCCCchhhHHHHHHHHHHHHHCCCCCCCCCcchhhHHHHHHhhcc
Confidence            99999988664332     2346788999999998889999999999999999999999996432211111111111111


Q ss_pred             ccCCCCCHHHHHHHHHHHHHhccCCCCCCCC-HHHHHHHH
Q 005586          638 NLKGKFSESEAAKLGKMALVCTHEDPENRPT-MEAVIEEL  676 (689)
Q Consensus       638 ~~~~~~~~~~~~~l~~l~~~Cl~~dp~~RPs-~~evl~~L  676 (689)
                      .  .......+..+.+++..|++.+|++||+ ++|++++-
T Consensus       226 ~--~~~~~~~~~~~~~li~~~l~~~p~~R~~~~~~~l~h~  263 (267)
T PHA03390        226 K--LPFIKNVSKNANDFVQSMLKYNINYRLTNYNEIIKHP  263 (267)
T ss_pred             c--CCcccccCHHHHHHHHHHhccChhhCCchHHHHhcCC
Confidence            1  1223345678999999999999999995 79998764

>cd05583 STKc_MSK_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase

Probab=100.00  E-value=1.7e-34  Score=299.69  Aligned_cols=254  Identities=21%  Similarity=0.295  Sum_probs=195.3

Q ss_pred             CCcccccccCCcceEEEEEec----CCcEEEEEEecccCC---chHHHHHHHHHHHHhcc-CCCcceeEeeEEEcCCCCe
Q 005586          411 FSEVNLLGKGNFSSVYKGTLR----DGTLVAIRSINVTSC---KSEEAEFVKGLYLLTSL-RHENIIRLRGFCCSRGRGE  482 (689)
Q Consensus       411 f~~~~~lg~G~~g~Vy~~~~~----~g~~vavK~l~~~~~---~~~~~~f~~e~~~l~~l-~H~niv~l~g~~~~~~~~~  482 (689)
                      |+..+.||+|+||.||+++..    +++.||||.++....   ......+.+|++++.++ +||||+++.+.+.  ....
T Consensus         2 ~~~~~~ig~G~~~~vy~~~~~~~~~~~~~~avk~~~~~~~~~~~~~~~~~~~E~~~l~~~~~~~~i~~~~~~~~--~~~~   79 (288)
T cd05583           2 FELLRVLGTGAYGKVFLVRKVGGHDAGKLYAMKVLKKATIVQKAKTAEHTRTERQVLEAVRRCPFLVTLHYAFQ--TDTK   79 (288)
T ss_pred             ceEEEEeccCCCceEEEEEEeccccCCcEEEEEEEehHHHHhhhhHHHHHHHHHHHHHhccCCcchhhhheeee--cCCE
Confidence            666789999999999999753    578899999875321   22345788999999999 5999999998874  3467


Q ss_pred             EEEEEEcCCCCCHHHHhhhcCCCCCCCCHHHHHHHHHHHHHHHhhhhCCCCCCCceeecCCCCCceeecCCCCeEEeccc
Q 005586          483 CFLIYDFAPKGKLSKYLDQEEGSSNVLDWSTRVSIIIGIAKGIGYLHSSEVNKPAIVHRNLSVEKVLIDQQFNPLIADCG  562 (689)
Q Consensus       483 ~~lV~e~~~~gsL~~~L~~~~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~~~ivH~dlk~~NiLl~~~~~~kl~DfG  562 (689)
                      .++||||+++|+|.+++....    .+++.....++.|+++||+|||+.+     ++||||||+||+++.++.++|+|||
T Consensus        80 ~~lv~e~~~~~~L~~~~~~~~----~~~~~~~~~~~~ql~~~l~~lH~~~-----~~H~dl~p~nil~~~~~~~~l~dfg  150 (288)
T cd05583          80 LHLILDYVNGGELFTHLYQRE----HFTESEVRVYIAEIVLALDHLHQLG-----IIYRDIKLENILLDSEGHVVLTDFG  150 (288)
T ss_pred             EEEEEecCCCCcHHHHHhhcC----CcCHHHHHHHHHHHHHHHHHHHHCC-----eeccCCCHHHeEECCCCCEEEEECc
Confidence            899999999999999987542    4889999999999999999999877     9999999999999999999999999


Q ss_pred             ccccccCCceeeeecCCCCCCCCCccccccCC--CCCcccchhHHHHHHHHHhCCCCcchhHHHHHhhhhhhHhhccccC
Q 005586          563 LHKLLADDIVFSVLKTSAAMGYLAPEYVTTGR--FTERSDIFAFGVIILQILTGSLVLTSSMRLAAESATFENFIDRNLK  640 (689)
Q Consensus       563 la~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~--~~~ksDV~sfGvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~  640 (689)
                      +++..............++..|+|||.+.+..  .+.++||||||+++|||+||+.|+...............+...  .
T Consensus       151 ~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~Dv~slG~il~el~tg~~p~~~~~~~~~~~~~~~~~~~~--~  228 (288)
T cd05583         151 LSKEFLAEEEERAYSFCGTIEYMAPEVIRGGSGGHDKAVDWWSLGVLTFELLTGASPFTVDGEQNSQSEISRRILKS--K  228 (288)
T ss_pred             cccccccccccccccccCCccccCHHHhcCCCCCCcchhhhHHHHHHHHHHHhCCCCcccCcccchHHHHHHHHHcc--C
Confidence            98865443222222234677899999987655  7889999999999999999999985321111111111111111  1


Q ss_pred             CCCCHHHHHHHHHHHHHhccCCCCCCCCHHHHHHHHH
Q 005586          641 GKFSESEAAKLGKMALVCTHEDPENRPTMEAVIEELT  677 (689)
Q Consensus       641 ~~~~~~~~~~l~~l~~~Cl~~dp~~RPs~~evl~~L~  677 (689)
                      ...+......+.+++.+|++.+|++|||+.++.+.|.
T Consensus       229 ~~~~~~~~~~l~~li~~~l~~~p~~R~t~~~~~~~l~  265 (288)
T cd05583         229 PPFPKTMSAEARDFIQKLLEKDPKKRLGANGADEIKN  265 (288)
T ss_pred             CCCCcccCHHHHHHHHHHhcCCHhhccCcchHHHHhc
Confidence            1233344567889999999999999999877755443

Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, in response to various stimuli such as growth factors, hormones, neurotransmitters, cellular stress, and pro-inflammatory cytokines

>cd06657 STKc_PAK4 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 4

Probab=100.00  E-value=3.3e-34  Score=298.02  Aligned_cols=247  Identities=16%  Similarity=0.330  Sum_probs=196.3

Q ss_pred             cccccCCcceEEEEEec-CCcEEEEEEecccCCchHHHHHHHHHHHHhccCCCcceeEeeEEEcCCCCeEEEEEEcCCCC
Q 005586          415 NLLGKGNFSSVYKGTLR-DGTLVAIRSINVTSCKSEEAEFVKGLYLLTSLRHENIIRLRGFCCSRGRGECFLIYDFAPKG  493 (689)
Q Consensus       415 ~~lg~G~~g~Vy~~~~~-~g~~vavK~l~~~~~~~~~~~f~~e~~~l~~l~H~niv~l~g~~~~~~~~~~~lV~e~~~~g  493 (689)
                      ..||+|+||.||++..+ +|..||+|++.... ......+.+|+.++++++|+|++++++++..  .+..++||||++++
T Consensus        26 ~~lg~g~~g~v~~~~~~~~~~~v~iK~~~~~~-~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~--~~~~~lv~e~~~~~  102 (292)
T cd06657          26 IKIGEGSTGIVCIATVKSSGKLVAVKKMDLRK-QQRRELLFNEVVIMRDYQHENVVEMYNSYLV--GDELWVVMEFLEGG  102 (292)
T ss_pred             HHcCCCCCeEEEEEEEcCCCeEEEEEEecccc-hhHHHHHHHHHHHHHhcCCcchhheeeEEEe--CCEEEEEEecCCCC
Confidence            57999999999999875 78999999986543 3445679999999999999999999998854  47899999999999


Q ss_pred             CHHHHhhhcCCCCCCCCHHHHHHHHHHHHHHHhhhhCCCCCCCceeecCCCCCceeecCCCCeEEecccccccccCCcee
Q 005586          494 KLSKYLDQEEGSSNVLDWSTRVSIIIGIAKGIGYLHSSEVNKPAIVHRNLSVEKVLIDQQFNPLIADCGLHKLLADDIVF  573 (689)
Q Consensus       494 sL~~~L~~~~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~~~ivH~dlk~~NiLl~~~~~~kl~DfGla~~~~~~~~~  573 (689)
                      +|.+++...     .+++.....++.|++.||+|||+.+     ++||||||+||++++++.++|+|||++........ 
T Consensus       103 ~L~~~~~~~-----~~~~~~~~~~~~ql~~~l~~lH~~g-----ivH~dl~p~Nilv~~~~~~~l~dfg~~~~~~~~~~-  171 (292)
T cd06657         103 ALTDIVTHT-----RMNEEQIAAVCLAVLKALSVLHAQG-----VIHRDIKSDSILLTHDGRVKLSDFGFCAQVSKEVP-  171 (292)
T ss_pred             cHHHHHhcC-----CCCHHHHHHHHHHHHHHHHHHHHCC-----eecCCCCHHHEEECCCCCEEEcccccceecccccc-
Confidence            999987542     3789999999999999999999987     99999999999999999999999999876543221 


Q ss_pred             eeecCCCCCCCCCccccccCCCCCcccchhHHHHHHHHHhCCCCcchhHHHHHhhhhhhHhhccccCCCCCHHHHHHHHH
Q 005586          574 SVLKTSAAMGYLAPEYVTTGRFTERSDIFAFGVIILQILTGSLVLTSSMRLAAESATFENFIDRNLKGKFSESEAAKLGK  653 (689)
Q Consensus       574 ~~~~~~~~~~y~aPE~~~~~~~~~ksDV~sfGvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~  653 (689)
                      ......++.+|+|||++.+..++.++|||||||++|||++|+.|+......... ....+...+.+.  ........+.+
T Consensus       172 ~~~~~~~~~~y~~pE~~~~~~~~~~~Dv~slGvil~el~tg~~p~~~~~~~~~~-~~~~~~~~~~~~--~~~~~~~~l~~  248 (292)
T cd06657         172 RRKSLVGTPYWMAPELISRLPYGPEVDIWSLGIMVIEMVDGEPPYFNEPPLKAM-KMIRDNLPPKLK--NLHKVSPSLKG  248 (292)
T ss_pred             cccccccCccccCHHHhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHH-HHHHhhCCcccC--CcccCCHHHHH
Confidence            112234678899999998888999999999999999999999998643221110 111111111111  11233556889


Q ss_pred             HHHHhccCCCCCCCCHHHHHHHHHh
Q 005586          654 MALVCTHEDPENRPTMEAVIEELTV  678 (689)
Q Consensus       654 l~~~Cl~~dp~~RPs~~evl~~L~~  678 (689)
                      ++.+||+.+|.+||++.+++++-+.
T Consensus       249 li~~~l~~~P~~R~~~~~ll~~~~~  273 (292)
T cd06657         249 FLDRLLVRDPAQRATAAELLKHPFL  273 (292)
T ss_pred             HHHHHHhCCcccCcCHHHHhcChHH
Confidence            9999999999999999999987443

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 4, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK4 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK4 regulates cell mo

>cd06627 STKc_Cdc7_like Catalytic domain of Cell division control protein 7-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=5.8e-34  Score=289.39  Aligned_cols=249  Identities=23%  Similarity=0.413  Sum_probs=202.3

Q ss_pred             cCCcccccccCCcceEEEEEec-CCcEEEEEEecccCCc-hHHHHHHHHHHHHhccCCCcceeEeeEEEcCCCCeEEEEE
Q 005586          410 CFSEVNLLGKGNFSSVYKGTLR-DGTLVAIRSINVTSCK-SEEAEFVKGLYLLTSLRHENIIRLRGFCCSRGRGECFLIY  487 (689)
Q Consensus       410 ~f~~~~~lg~G~~g~Vy~~~~~-~g~~vavK~l~~~~~~-~~~~~f~~e~~~l~~l~H~niv~l~g~~~~~~~~~~~lV~  487 (689)
                      +|+..+.||+|++|.||+|... +++.|++|.+...... .....+.+|++++.+++|+|++++++++..  ....++||
T Consensus         1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~--~~~~~~v~   78 (254)
T cd06627           1 NYQLGDLIGRGAFGVVYKGLNLETGDFVAIKQISLEKIKEEALKSIMQEIDLLKNLKHPNIVKYIGSIET--SDSLYIIL   78 (254)
T ss_pred             CceeeeEEcccCCeEEEEEEEcCCCcEEEEEEecccccCHHHHHHHHHHHHHHHhCCCCCccEEEEEEEe--CCEEEEEE
Confidence            3667789999999999999876 6889999999866432 345689999999999999999999999854  47899999


Q ss_pred             EcCCCCCHHHHhhhcCCCCCCCCHHHHHHHHHHHHHHHhhhhCCCCCCCceeecCCCCCceeecCCCCeEEecccccccc
Q 005586          488 DFAPKGKLSKYLDQEEGSSNVLDWSTRVSIIIGIAKGIGYLHSSEVNKPAIVHRNLSVEKVLIDQQFNPLIADCGLHKLL  567 (689)
Q Consensus       488 e~~~~gsL~~~L~~~~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~~~ivH~dlk~~NiLl~~~~~~kl~DfGla~~~  567 (689)
                      ||+++++|.+++...    ..+++..+..++.|++.||.|||+.+     |+||||||+||++++++.+||+|||++...
T Consensus        79 e~~~~~~L~~~~~~~----~~l~~~~~~~~~~~i~~~l~~lH~~~-----i~H~dl~p~ni~i~~~~~~~l~d~~~~~~~  149 (254)
T cd06627          79 EYAENGSLRQIIKKF----GPFPESLVAVYVYQVLQGLAYLHEQG-----VIHRDIKAANILTTKDGVVKLADFGVATKL  149 (254)
T ss_pred             ecCCCCcHHHHHHhc----cCCCHHHHHHHHHHHHHHHHHHhhCC-----cccCCCCHHHEEECCCCCEEEeccccceec
Confidence            999999999998764    24899999999999999999999987     999999999999999999999999999876


Q ss_pred             cCCceeeeecCCCCCCCCCccccccCCCCCcccchhHHHHHHHHHhCCCCcchhHHHHHhhhhhhHhhccccCCCCCHHH
Q 005586          568 ADDIVFSVLKTSAAMGYLAPEYVTTGRFTERSDIFAFGVIILQILTGSLVLTSSMRLAAESATFENFIDRNLKGKFSESE  647 (689)
Q Consensus       568 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~ksDV~sfGvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  647 (689)
                      ...... .....++..|+|||...+..++.++||||+|+++|||++|+.|+........    ..... .......+...
T Consensus       150 ~~~~~~-~~~~~~~~~y~~pe~~~~~~~~~~~Dv~~lG~~l~~l~~g~~p~~~~~~~~~----~~~~~-~~~~~~~~~~~  223 (254)
T cd06627         150 NDVSKD-DASVVGTPYWMAPEVIEMSGASTASDIWSLGCTVIELLTGNPPYYDLNPMAA----LFRIV-QDDHPPLPEGI  223 (254)
T ss_pred             CCCccc-ccccccchhhcCHhhhcCCCCCcchhHHHHHHHHHHHHhCCCCCCCccHHHH----HHHHh-ccCCCCCCCCC
Confidence            543321 1223467789999998887889999999999999999999999864322111    11111 11112233444


Q ss_pred             HHHHHHHHHHhccCCCCCCCCHHHHHHH
Q 005586          648 AAKLGKMALVCTHEDPENRPTMEAVIEE  675 (689)
Q Consensus       648 ~~~l~~l~~~Cl~~dp~~RPs~~evl~~  675 (689)
                      +..+.+++.+|+..+|++||++.|++.+
T Consensus       224 ~~~~~~~i~~~l~~~p~~R~~~~~~l~~  251 (254)
T cd06627         224 SPELKDFLMQCFQKDPNLRPTAKQLLKH  251 (254)
T ss_pred             CHHHHHHHHHHHhCChhhCcCHHHHhcC
Confidence            6788999999999999999999999864

Serine/threonine kinases (STKs), (Cdc7)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Cdc7-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include Schizosaccharomyces pombe Cdc7, Saccharomyces cerevisiae Cdc15, Arabidopsis thaliana mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) epsilon, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Fission yeast

>KOG0667 consensus Dual-specificity tyrosine-phosphorylation regulated kinase [General function prediction only]

Probab=100.00  E-value=1.5e-34  Score=307.35  Aligned_cols=254  Identities=19%  Similarity=0.274  Sum_probs=198.8

Q ss_pred             cCCcccccccCCcceEEEEEec-CCcEEEEEEecccCCchHHHHHHHHHHHHhccC-C-----CcceeEeeEEEcCCCCe
Q 005586          410 CFSEVNLLGKGNFSSVYKGTLR-DGTLVAIRSINVTSCKSEEAEFVKGLYLLTSLR-H-----ENIIRLRGFCCSRGRGE  482 (689)
Q Consensus       410 ~f~~~~~lg~G~~g~Vy~~~~~-~g~~vavK~l~~~~~~~~~~~f~~e~~~l~~l~-H-----~niv~l~g~~~~~~~~~  482 (689)
                      +|...++||+|.||.|-+|... +++.||||+++...  .-..+-..|+++|..++ |     -|+|++++|+..  +++
T Consensus       187 rY~V~e~LGkGtFGQVvk~~d~~T~e~VAIKIiKN~k--~f~~Q~~~Ei~iL~~ln~~d~~~~~n~Vrm~d~F~f--r~H  262 (586)
T KOG0667|consen  187 RYEVLEVLGKGSFGQVVKAYDHKTGEIVAIKIIKNKK--RFLRQAQIEIRILELLNKHDPDDKYNIVRMLDYFYF--RNH  262 (586)
T ss_pred             EEEEEEEecccccceeEEEEecCCCcEEEEEeeccCh--HHHHHHHHHHHHHHHHhccCCCCCeeEEEeeecccc--ccc
Confidence            7888999999999999999865 69999999998763  33456678999999997 4     499999999955  589


Q ss_pred             EEEEEEcCCCCCHHHHhhhcCCCCCCCCHHHHHHHHHHHHHHHhhhhCCCCCCCceeecCCCCCceeecCC--CCeEEec
Q 005586          483 CFLIYDFAPKGKLSKYLDQEEGSSNVLDWSTRVSIIIGIAKGIGYLHSSEVNKPAIVHRNLSVEKVLIDQQ--FNPLIAD  560 (689)
Q Consensus       483 ~~lV~e~~~~gsL~~~L~~~~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~~~ivH~dlk~~NiLl~~~--~~~kl~D  560 (689)
                      .+||+|.+. -+|.++|+.+.-.  .++......|+.||+.||.+||+.+     |||+||||+||||.+.  ..+||+|
T Consensus       263 lciVfELL~-~NLYellK~n~f~--Glsl~~ir~~~~Qil~~L~~L~~l~-----IIHcDLKPENILL~~~~r~~vKVID  334 (586)
T KOG0667|consen  263 LCIVFELLS-TNLYELLKNNKFR--GLSLPLVRKFAQQILTALLFLHELG-----IIHCDLKPENILLKDPKRSRIKVID  334 (586)
T ss_pred             eeeeehhhh-hhHHHHHHhcCCC--CCCHHHHHHHHHHHHHHHHHHHhCC-----eeeccCChhheeeccCCcCceeEEe
Confidence            999999994 5999999887543  4889999999999999999999988     9999999999999754  4689999


Q ss_pred             ccccccccCCceeeeecCCCCCCCCCccccccCCCCCcccchhHHHHHHHHHhCCCCcchhHHHHHhhhh----------
Q 005586          561 CGLHKLLADDIVFSVLKTSAAMGYLAPEYVTTGRFTERSDIFAFGVIILQILTGSLVLTSSMRLAAESAT----------  630 (689)
Q Consensus       561 fGla~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~ksDV~sfGvvl~elltG~~p~~~~~~~~~~~~~----------  630 (689)
                      ||.+....+..+ .   -.-+..|+|||++.+.+|+.+.||||||||+.||+||.+.|.+..........          
T Consensus       335 FGSSc~~~q~vy-t---YiQSRfYRAPEVILGlpY~~~IDmWSLGCIlAEL~tG~PLfpG~ne~DQl~~I~e~lG~Pp~~  410 (586)
T KOG0667|consen  335 FGSSCFESQRVY-T---YIQSRFYRAPEVILGLPYDTAIDMWSLGCILAELFTGEPLFPGDNEYDQLARIIEVLGLPPPK  410 (586)
T ss_pred             cccccccCCcce-e---eeeccccccchhhccCCCCCccceeehhhhHHhHhcCccccCCCCHHHHHHHHHHHhCCCCHH
Confidence            999987766443 1   22345699999999999999999999999999999998776443211100000          


Q ss_pred             -------hhHhh--------------------------------ccccCC--------CCCHHHHHHHHHHHHHhccCCC
Q 005586          631 -------FENFI--------------------------------DRNLKG--------KFSESEAAKLGKMALVCTHEDP  663 (689)
Q Consensus       631 -------~~~~~--------------------------------~~~~~~--------~~~~~~~~~l~~l~~~Cl~~dp  663 (689)
                             ...++                                +.....        ......-..+.+++.+|+..||
T Consensus       411 mL~~~~~~~kff~~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~P~~~~~l~~~~~~~~~~~F~dflk~~L~~dP  490 (586)
T KOG0667|consen  411 MLDTAKKAHKFFTSLKGFPRLCVETSAPRGTKSPEVRKYYRKARLERRGPPGSRSLESGLPKADDKLFIDFLKRCLEWDP  490 (586)
T ss_pred             HHHhccccceehhccCCceeeeeeecccccccchhhhhhhhhhcccccCCCCCcccchhcccccHHHHHHHHHHHhccCc
Confidence                   00000                                000000        0011335568999999999999


Q ss_pred             CCCCCHHHHHHHHHhh
Q 005586          664 ENRPTMEAVIEELTVA  679 (689)
Q Consensus       664 ~~RPs~~evl~~L~~~  679 (689)
                      .+|+|..|+++|-+..
T Consensus       491 ~~R~tp~qal~Hpfl~  506 (586)
T KOG0667|consen  491 AERITPAQALNHPFLT  506 (586)
T ss_pred             hhcCCHHHHhcCcccc
Confidence            9999999999987654

>cd05118 STKc_CMGC Catalytic domain of CMGC family Serine/Threonine Kinases

Probab=100.00  E-value=3e-34  Score=296.70  Aligned_cols=254  Identities=23%  Similarity=0.385  Sum_probs=197.7

Q ss_pred             CCcccccccCCcceEEEEEec-CCcEEEEEEecccCCc-hHHHHHHHHHHHHhccCCCcceeEeeEEEcCCCCeEEEEEE
Q 005586          411 FSEVNLLGKGNFSSVYKGTLR-DGTLVAIRSINVTSCK-SEEAEFVKGLYLLTSLRHENIIRLRGFCCSRGRGECFLIYD  488 (689)
Q Consensus       411 f~~~~~lg~G~~g~Vy~~~~~-~g~~vavK~l~~~~~~-~~~~~f~~e~~~l~~l~H~niv~l~g~~~~~~~~~~~lV~e  488 (689)
                      |...+.||+|++|.||+|... +|+.+++|++...... .....+.+|++++++++|+||+++++++..  ....++|+|
T Consensus         1 y~~~~~i~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~--~~~~~~v~e   78 (283)
T cd05118           1 YQKLGKIGEGTYGVVYKARDKLTGEIVAIKKIKLRFESEGIPKTALREIKLLKELNHPNIIKLLDVFRH--KGDLYLVFE   78 (283)
T ss_pred             CccceeeecCCCceEEEEEcCCCCcEEEEEEeccccccchhHHHHHHHHHHHHHhcCCCcchHHHhhcc--CCCEEEEEe
Confidence            445678999999999999875 7899999998765432 345678899999999999999999999844  478999999


Q ss_pred             cCCCCCHHHHhhhcCCCCCCCCHHHHHHHHHHHHHHHhhhhCCCCCCCceeecCCCCCceeecCCCCeEEeccccccccc
Q 005586          489 FAPKGKLSKYLDQEEGSSNVLDWSTRVSIIIGIAKGIGYLHSSEVNKPAIVHRNLSVEKVLIDQQFNPLIADCGLHKLLA  568 (689)
Q Consensus       489 ~~~~gsL~~~L~~~~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~~~ivH~dlk~~NiLl~~~~~~kl~DfGla~~~~  568 (689)
                      |+++ +|.+++....   ..+++..+..++.|++.||+|||+.+     |+|+||||+||++++++.+||+|||.+....
T Consensus        79 ~~~~-~l~~~l~~~~---~~~~~~~~~~~~~~i~~~l~~LH~~~-----i~H~dl~p~nili~~~~~~~l~df~~~~~~~  149 (283)
T cd05118          79 FMDT-DLYKLIKDRQ---RGLPESLIKSYLYQLLQGLAFCHSHG-----ILHRDLKPENLLINTEGVLKLADFGLARSFG  149 (283)
T ss_pred             ccCC-CHHHHHHhhc---ccCCHHHHHHHHHHHHHHHHHHHHCC-----eeecCcCHHHEEECCCCcEEEeeeeeeEecC
Confidence            9975 8988887643   24899999999999999999999987     9999999999999999999999999998765


Q ss_pred             CCceeeeecCCCCCCCCCccccccC-CCCCcccchhHHHHHHHHHhCCCCcchhHHHHHhhhhhh-----------Hhhc
Q 005586          569 DDIVFSVLKTSAAMGYLAPEYVTTG-RFTERSDIFAFGVIILQILTGSLVLTSSMRLAAESATFE-----------NFID  636 (689)
Q Consensus       569 ~~~~~~~~~~~~~~~y~aPE~~~~~-~~~~ksDV~sfGvvl~elltG~~p~~~~~~~~~~~~~~~-----------~~~~  636 (689)
                      .... ......++..|+|||.+.+. .++.++||||||+++|||+||+.||..............           .+.+
T Consensus       150 ~~~~-~~~~~~~~~~~~~PE~~~~~~~~~~~~Di~slG~~l~~l~tg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  228 (283)
T cd05118         150 SPVR-PYTHYVVTRWYRAPELLLGDKGYSTPVDIWSVGCIFAELLSRRPLFPGKSEIDQLFKIFRTLGTPDPEVWPKFTS  228 (283)
T ss_pred             CCcc-cccCccCcccccCcHHHhcCCCCCchhHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHcCCCchHhcccchh
Confidence            5431 11223456779999998776 789999999999999999999999854322111100000           0000


Q ss_pred             ---c---ccC-------CCCCHHHHHHHHHHHHHhccCCCCCCCCHHHHHHHH
Q 005586          637 ---R---NLK-------GKFSESEAAKLGKMALVCTHEDPENRPTMEAVIEEL  676 (689)
Q Consensus       637 ---~---~~~-------~~~~~~~~~~l~~l~~~Cl~~dp~~RPs~~evl~~L  676 (689)
                         .   ...       .........++.+++..||+.||.+||++.+++.+-
T Consensus       229 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rp~~~~ll~~~  281 (283)
T cd05118         229 LARNYKFSFPKKAGMPLPKLFPNASPQALDLLSQMLHYDPHKRITAEQALAHP  281 (283)
T ss_pred             hhhhhhhhhccccccCHHHhhhhhCHHHHHHHHHHhccCcccCcCHHHHhhCC
Confidence               0   000       001123467899999999999999999999998763

Serine/Threonine Kinases (STKs), CMGC family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CMGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The CMGC family consists of Cyclin-Dependent protein Kinases (CDKs), Mitogen-activated protein kinases (MAPKs) such as Extracellular signal-regulated kinase (ERKs), c-Jun N-terminal kinases (JNKs), and p38, and similar proteins. CDKs belong to a large subfamily of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. MAPKs serve as important mediators of cellular responses to extracellular signals. They

>cd07830 STKc_MAK_like Catalytic domain of Male germ cell-Associated Kinase-like Serine/Threonine Kinases

Probab=100.00  E-value=2.2e-34  Score=297.85  Aligned_cols=253  Identities=23%  Similarity=0.365  Sum_probs=194.8

Q ss_pred             CCcccccccCCcceEEEEEec-CCcEEEEEEecccCCchHHHHHHHHHHHHhccC-CCcceeEeeEEEcCCCCeEEEEEE
Q 005586          411 FSEVNLLGKGNFSSVYKGTLR-DGTLVAIRSINVTSCKSEEAEFVKGLYLLTSLR-HENIIRLRGFCCSRGRGECFLIYD  488 (689)
Q Consensus       411 f~~~~~lg~G~~g~Vy~~~~~-~g~~vavK~l~~~~~~~~~~~f~~e~~~l~~l~-H~niv~l~g~~~~~~~~~~~lV~e  488 (689)
                      |...+.||+|+||.||+|... +++.|++|++.............+|+..+.+++ |+|++++++++..  .+..++|||
T Consensus         1 y~~~~~ig~g~~g~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~--~~~~~lv~e   78 (283)
T cd07830           1 YKVIKQLGDGTFGSVYLARNKETGELVAIKKMKKKFYSWEECMNLREVKSLRKLNEHPNIVKLKEVFRE--NDELYFVFE   78 (283)
T ss_pred             CeeheeeccCCceEEEEEEECCCCcEEEEEEehhhccchhHHHHHHHHHHHHhccCCCCchhHHHHhhc--CCcEEEEEe
Confidence            456688999999999999986 588999999876543334445667999999999 9999999999844  578999999


Q ss_pred             cCCCCCHHHHhhhcCCCCCCCCHHHHHHHHHHHHHHHhhhhCCCCCCCceeecCCCCCceeecCCCCeEEeccccccccc
Q 005586          489 FAPKGKLSKYLDQEEGSSNVLDWSTRVSIIIGIAKGIGYLHSSEVNKPAIVHRNLSVEKVLIDQQFNPLIADCGLHKLLA  568 (689)
Q Consensus       489 ~~~~gsL~~~L~~~~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~~~ivH~dlk~~NiLl~~~~~~kl~DfGla~~~~  568 (689)
                      |+ +|+|.+++.....  ..++|..+..++.|+++||.|||+.+     ++|+||+|+||++++++.++|+|||+++...
T Consensus        79 ~~-~~~l~~~~~~~~~--~~~~~~~~~~~~~~l~~~l~~Lh~~~-----i~H~dl~~~ni~i~~~~~~~l~d~~~~~~~~  150 (283)
T cd07830          79 YM-EGNLYQLMKDRKG--KPFSESVIRSIIYQILQGLAHIHKHG-----FFHRDLKPENLLVSGPEVVKIADFGLAREIR  150 (283)
T ss_pred             cC-CCCHHHHHHhccc--ccCCHHHHHHHHHHHHHHHHHHHHCC-----cccCCCChhhEEEcCCCCEEEeecccceecc
Confidence            99 8899999876542  34899999999999999999999987     9999999999999999999999999998665


Q ss_pred             CCceeeeecCCCCCCCCCccccc-cCCCCCcccchhHHHHHHHHHhCCCCcchhHHHHHhhh-----------------h
Q 005586          569 DDIVFSVLKTSAAMGYLAPEYVT-TGRFTERSDIFAFGVIILQILTGSLVLTSSMRLAAESA-----------------T  630 (689)
Q Consensus       569 ~~~~~~~~~~~~~~~y~aPE~~~-~~~~~~ksDV~sfGvvl~elltG~~p~~~~~~~~~~~~-----------------~  630 (689)
                      ....  .....++..|+|||.+. ...++.++||||||++++||++|+.|+...........                 .
T Consensus       151 ~~~~--~~~~~~~~~~~aPE~~~~~~~~~~~~Di~s~G~~l~el~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  228 (283)
T cd07830         151 SRPP--YTDYVSTRWYRAPEILLRSTSYSSPVDIWALGCIMAELYTLRPLFPGSSEIDQLYKICSVLGTPTKQDWPEGYK  228 (283)
T ss_pred             CCCC--cCCCCCcccccCceeeecCcCcCCccchhhHHHHHHHHHhCCCccCCCChHHHHHHHHHhcCCCChhhhhhHhh
Confidence            4321  12234667899999875 44578999999999999999999998854321110000                 0


Q ss_pred             hhHhhccccCC-------CCCHHHHHHHHHHHHHhccCCCCCCCCHHHHHHH
Q 005586          631 FENFIDRNLKG-------KFSESEAAKLGKMALVCTHEDPENRPTMEAVIEE  675 (689)
Q Consensus       631 ~~~~~~~~~~~-------~~~~~~~~~l~~l~~~Cl~~dp~~RPs~~evl~~  675 (689)
                      ....++.....       .........+.+++.+|++.+|++||++.|++.+
T Consensus       229 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rpt~~ei~~~  280 (283)
T cd07830         229 LASKLGFRFPQFAPTSLHQLIPNASPEAIDLIKDMLRWDPKKRPTASQALQH  280 (283)
T ss_pred             hhccccccccccccccHHHHcccCCHHHHHHHHHhcccCcccCCCHHHHhhC
Confidence            00000000000       0011124679999999999999999999999876

Serine/Threonine Kinases (STKs), Male germ cell-Associated Kinase (MAK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of human MAK and MAK-related kinase (MRK), Saccharomyces cerevisiae Ime2p, Schizosaccharomyces pombe Mei4-dependent protein 3 (Mde3) and Pit1, Caenorhabditis elegans dyf-5, Arabidopsis thaliana MHK, and similar proteins. These proteins play important roles during meiosis. MAK is highly expressed in testicular cells specifically in the meiotic phase, but is not essential for spermatogenesis and fertili

>cd05579 STKc_MAST_like Catalytic domain of Microtubule-associated serine/threonine kinase-like proteins

Probab=100.00  E-value=2.1e-34  Score=294.42  Aligned_cols=242  Identities=21%  Similarity=0.357  Sum_probs=192.7

Q ss_pred             cccCCcceEEEEEec-CCcEEEEEEecccCC--chHHHHHHHHHHHHhccCCCcceeEeeEEEcCCCCeEEEEEEcCCCC
Q 005586          417 LGKGNFSSVYKGTLR-DGTLVAIRSINVTSC--KSEEAEFVKGLYLLTSLRHENIIRLRGFCCSRGRGECFLIYDFAPKG  493 (689)
Q Consensus       417 lg~G~~g~Vy~~~~~-~g~~vavK~l~~~~~--~~~~~~f~~e~~~l~~l~H~niv~l~g~~~~~~~~~~~lV~e~~~~g  493 (689)
                      ||+|+||.||+++.. +|+.+++|.+.....  ......+.+|++++.+++||||+++++.+.  .....++||||++++
T Consensus         1 lg~g~~~~vy~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~--~~~~~~lv~e~~~~~   78 (265)
T cd05579           1 ISKGAYGRVFLAKKKSTGDIYAIKVIKKADMIRKNQVDQVLTERDILSQAQSPYVVKLYYSFQ--GKKNLYLVMEYLPGG   78 (265)
T ss_pred             CCCCCceEEEEEEECCCCCEEEEEEecchhhhhhhHHHHHHHHHHHHHhCCCcchhHHHHhee--cCcEEEEEEecCCCC
Confidence            689999999999987 499999999876542  234567899999999999999999998874  357889999999999


Q ss_pred             CHHHHhhhcCCCCCCCCHHHHHHHHHHHHHHHhhhhCCCCCCCceeecCCCCCceeecCCCCeEEecccccccccCCce-
Q 005586          494 KLSKYLDQEEGSSNVLDWSTRVSIIIGIAKGIGYLHSSEVNKPAIVHRNLSVEKVLIDQQFNPLIADCGLHKLLADDIV-  572 (689)
Q Consensus       494 sL~~~L~~~~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~~~ivH~dlk~~NiLl~~~~~~kl~DfGla~~~~~~~~-  572 (689)
                      +|.+++....    .+++..+..++.|++.||+|||+.+     ++||||+|+||++++++.+||+|||++........ 
T Consensus        79 ~L~~~l~~~~----~~~~~~~~~i~~qi~~~L~~lH~~~-----i~H~di~~~nil~~~~~~~~l~dfg~~~~~~~~~~~  149 (265)
T cd05579          79 DLASLLENVG----SLDEDVARIYIAEIVLALEYLHSNG-----IIHRDLKPDNILIDSNGHLKLTDFGLSKVGLVRRQI  149 (265)
T ss_pred             cHHHHHHHcC----CCCHHHHHHHHHHHHHHHHHHHHcC-----eecCCCCHHHeEEcCCCCEEEEecccchhcccCccc
Confidence            9999997643    4899999999999999999999887     99999999999999999999999999875433211 


Q ss_pred             ------eeeecCCCCCCCCCccccccCCCCCcccchhHHHHHHHHHhCCCCcchhHHHHHhhhhhhHhhccccCCCCCHH
Q 005586          573 ------FSVLKTSAAMGYLAPEYVTTGRFTERSDIFAFGVIILQILTGSLVLTSSMRLAAESATFENFIDRNLKGKFSES  646 (689)
Q Consensus       573 ------~~~~~~~~~~~y~aPE~~~~~~~~~ksDV~sfGvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  646 (689)
                            .......++..|+|||.......+.++||||||+++||++||+.|+.......    ..........  ..+..
T Consensus       150 ~~~~~~~~~~~~~~~~~~~~Pe~~~~~~~~~~~Dv~slG~~~~~l~~g~~p~~~~~~~~----~~~~~~~~~~--~~~~~  223 (265)
T cd05579         150 NLNDDEKEDKRIVGTPDYIAPEVILGQGHSKTVDWWSLGCILYEFLVGIPPFHGETPEE----IFQNILNGKI--EWPED  223 (265)
T ss_pred             ccccccccccCcccCccccCHHHhcCCCCCcchhhHHHHHHHHHHHhCCCCCCCCCHHH----HHHHHhcCCc--CCCcc
Confidence                  01122345678999999988889999999999999999999999986432211    1111111111  12222


Q ss_pred             H--HHHHHHHHHHhccCCCCCCCCH---HHHHHH
Q 005586          647 E--AAKLGKMALVCTHEDPENRPTM---EAVIEE  675 (689)
Q Consensus       647 ~--~~~l~~l~~~Cl~~dp~~RPs~---~evl~~  675 (689)
                      .  +..+.+++..|++.+|++||++   .+++++
T Consensus       224 ~~~~~~~~~~i~~~l~~~p~~Rpt~~~~~~~l~~  257 (265)
T cd05579         224 VEVSDEAIDLISKLLVPDPEKRLGAKSIEEIKNH  257 (265)
T ss_pred             ccCCHHHHHHHHHHhcCCHhhcCCCccHHHHhcC
Confidence            2  6788999999999999999999   555543

Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MAST kinase subfamily includes MAST kinases, MAST-like (MASTL) kinases, and fungal kinases with similarity to Saccharomyces cerevisiae Rim15 and Schizosaccharomyces pombe cek1. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. MASTL kinases carry only a catalytic domain which contains a long insert re

>cd07838 STKc_CDK4_6_like Catalytic domain of Cyclin-Dependent protein Kinase 4 and 6-like Serine/Threonine Kinases

Probab=100.00  E-value=6.7e-34  Score=294.68  Aligned_cols=255  Identities=20%  Similarity=0.348  Sum_probs=193.3

Q ss_pred             CCcccccccCCcceEEEEEec-CCcEEEEEEecccCCc-hHHHHHHHHHHHHhcc---CCCcceeEeeEEEcCCC---Ce
Q 005586          411 FSEVNLLGKGNFSSVYKGTLR-DGTLVAIRSINVTSCK-SEEAEFVKGLYLLTSL---RHENIIRLRGFCCSRGR---GE  482 (689)
Q Consensus       411 f~~~~~lg~G~~g~Vy~~~~~-~g~~vavK~l~~~~~~-~~~~~f~~e~~~l~~l---~H~niv~l~g~~~~~~~---~~  482 (689)
                      |+..+.||+|+||.||+|+.+ +++.||+|+++..... .....+.+|+.++.++   +|+|++++++++.....   ..
T Consensus         1 y~~~~~l~~g~~~~v~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~h~~i~~~~~~~~~~~~~~~~~   80 (287)
T cd07838           1 YEELAEIGEGAYGTVYKARDLNTGRFVALKKVRVPLSEEGIPLSTLREIALLKQLESFEHPNIVRLLDVCHGPRTDRELK   80 (287)
T ss_pred             CeEEEEecccCceEEEEEEECCCCCEEEEEEeccccccchhhhhHHHHHHHHHHhhccCCCCcceEEEEEeeccCCCCce
Confidence            456789999999999999987 4899999999754322 2234566777766655   69999999999865422   13


Q ss_pred             EEEEEEcCCCCCHHHHhhhcCCCCCCCCHHHHHHHHHHHHHHHhhhhCCCCCCCceeecCCCCCceeecCCCCeEEeccc
Q 005586          483 CFLIYDFAPKGKLSKYLDQEEGSSNVLDWSTRVSIIIGIAKGIGYLHSSEVNKPAIVHRNLSVEKVLIDQQFNPLIADCG  562 (689)
Q Consensus       483 ~~lV~e~~~~gsL~~~L~~~~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~~~ivH~dlk~~NiLl~~~~~~kl~DfG  562 (689)
                      .+++|||++ ++|.+++.....  ..++|..++.++.|++.||+|||+.+     ++|+||+|+||++++++.+||+|||
T Consensus        81 ~~l~~e~~~-~~l~~~l~~~~~--~~l~~~~~~~~~~~i~~al~~LH~~~-----i~h~~l~~~nili~~~~~~~l~dfg  152 (287)
T cd07838          81 LTLVFEHVD-QDLATYLSKCPK--PGLPPETIKDLMRQLLRGVDFLHSHR-----IVHRDLKPQNILVTSDGQVKIADFG  152 (287)
T ss_pred             eEEEehhcc-cCHHHHHHHccC--CCCCHHHHHHHHHHHHHHHHHHHHCC-----eeeccCChhhEEEccCCCEEEeccC
Confidence            899999997 589998876432  24899999999999999999999987     9999999999999999999999999


Q ss_pred             ccccccCCceeeeecCCCCCCCCCccccccCCCCCcccchhHHHHHHHHHhCCCCcchhHHHHHhhhhhhHh--------
Q 005586          563 LHKLLADDIVFSVLKTSAAMGYLAPEYVTTGRFTERSDIFAFGVIILQILTGSLVLTSSMRLAAESATFENF--------  634 (689)
Q Consensus       563 la~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~ksDV~sfGvvl~elltG~~p~~~~~~~~~~~~~~~~~--------  634 (689)
                      ++........  .....++..|+|||++.+..++.++|||||||++|||+||+.|+............+...        
T Consensus       153 ~~~~~~~~~~--~~~~~~~~~~~~PE~~~~~~~~~~~Di~s~G~~l~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  230 (287)
T cd07838         153 LARIYSFEMA--LTSVVVTLWYRAPEVLLQSSYATPVDMWSVGCIFAELFRRRPLFRGTSEADQLDKIFDVIGLPSEEEW  230 (287)
T ss_pred             cceeccCCcc--cccccccccccChHHhccCCCCCcchhhhHHHHHHHHHhCCCcccCCChHHHHHHHHHHcCCCChHhc
Confidence            9987644321  122345678999999998899999999999999999999999886432221111111100        


Q ss_pred             ----------hccccCC---CCCHHHHHHHHHHHHHhccCCCCCCCCHHHHHHH
Q 005586          635 ----------IDRNLKG---KFSESEAAKLGKMALVCTHEDPENRPTMEAVIEE  675 (689)
Q Consensus       635 ----------~~~~~~~---~~~~~~~~~l~~l~~~Cl~~dp~~RPs~~evl~~  675 (689)
                                .......   .........+.+++.+||+.||++||++.|++++
T Consensus       231 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rp~~~~il~~  284 (287)
T cd07838         231 PRNVSLPRSSFPSYTPRSFKSFVPEICEEGLDLLKKMLTFNPHKRISAFEALQH  284 (287)
T ss_pred             CCCcccchhhcccccccchhhhhhhhhHHHHHHHHHHhccCCccCCCHHHHhcC
Confidence                      0000000   0012235678899999999999999999999875

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) and CDK6-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4/6-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 and CDK6 partner with D-type cyclins to regulate the early G1 phase of the cell cycle. They are the first kinase activated by mitogenic signals to release cells from the G0 arrested state. CDK4 and CDK6 are both

>cd07879 STKc_p38delta_MAPK13 Catalytic domain of the Serine/Threonine Kinase, p38delta Mitogen-Activated Protein Kinase

Probab=100.00  E-value=1.6e-34  Score=307.31  Aligned_cols=252  Identities=20%  Similarity=0.319  Sum_probs=191.9

Q ss_pred             hccCCcccccccCCcceEEEEEec-CCcEEEEEEecccCC-chHHHHHHHHHHHHhccCCCcceeEeeEEEcCC----CC
Q 005586          408 TQCFSEVNLLGKGNFSSVYKGTLR-DGTLVAIRSINVTSC-KSEEAEFVKGLYLLTSLRHENIIRLRGFCCSRG----RG  481 (689)
Q Consensus       408 t~~f~~~~~lg~G~~g~Vy~~~~~-~g~~vavK~l~~~~~-~~~~~~f~~e~~~l~~l~H~niv~l~g~~~~~~----~~  481 (689)
                      .++|...+.||+|+||.||+|... +|..||+|++..... ......+.+|++++++++||||+++++++....    ..
T Consensus        14 ~~~y~~~~~ig~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~~~   93 (342)
T cd07879          14 PERYTSLKQVGSGAYGSVCSAIDKRTGEKVAIKKLSRPFQSEIFAKRAYRELTLLKHMQHENVIGLLDVFTSAVSGDEFQ   93 (342)
T ss_pred             ccceEEEEEeeecCCeEEEEEEeCCCCcEEEEEEecCccccccchhHHHHHHHHHHhcCCCCccchhheecccccCCCCc
Confidence            368888999999999999999965 689999999875422 223356889999999999999999999885432    13


Q ss_pred             eEEEEEEcCCCCCHHHHhhhcCCCCCCCCHHHHHHHHHHHHHHHhhhhCCCCCCCceeecCCCCCceeecCCCCeEEecc
Q 005586          482 ECFLIYDFAPKGKLSKYLDQEEGSSNVLDWSTRVSIIIGIAKGIGYLHSSEVNKPAIVHRNLSVEKVLIDQQFNPLIADC  561 (689)
Q Consensus       482 ~~~lV~e~~~~gsL~~~L~~~~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~~~ivH~dlk~~NiLl~~~~~~kl~Df  561 (689)
                      ..++|+||+.. +|..+..      ..+++..+..++.|+++||+|||+.+     |+||||||+||++++++.+||+||
T Consensus        94 ~~~lv~e~~~~-~l~~~~~------~~~~~~~~~~~~~qi~~aL~~LH~~~-----i~H~dlkp~NIll~~~~~~kL~df  161 (342)
T cd07879          94 DFYLVMPYMQT-DLQKIMG------HPLSEDKVQYLVYQMLCGLKYIHSAG-----IIHRDLKPGNLAVNEDCELKILDF  161 (342)
T ss_pred             eEEEEeccccc-CHHHHHc------CCCCHHHHHHHHHHHHHHHHHHHHCC-----cccCCCCHHHEEECCCCCEEEeeC
Confidence            56899999964 7776652      13889999999999999999999987     999999999999999999999999


Q ss_pred             cccccccCCceeeeecCCCCCCCCCcccccc-CCCCCcccchhHHHHHHHHHhCCCCcchhHHHHHhhhhh---------
Q 005586          562 GLHKLLADDIVFSVLKTSAAMGYLAPEYVTT-GRFTERSDIFAFGVIILQILTGSLVLTSSMRLAAESATF---------  631 (689)
Q Consensus       562 Gla~~~~~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~ksDV~sfGvvl~elltG~~p~~~~~~~~~~~~~~---------  631 (689)
                      |+++......    ....++..|+|||.+.+ ..++.++|||||||++|||++|+.||............+         
T Consensus       162 g~~~~~~~~~----~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slGvil~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~  237 (342)
T cd07879         162 GLARHADAEM----TGYVVTRWYRAPEVILNWMHYNQTVDIWSVGCIMAEMLTGKTLFKGKDYLDQLTQILKVTGVPGPE  237 (342)
T ss_pred             CCCcCCCCCC----CCceeeecccChhhhcCccccCchHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCCHH
Confidence            9998654321    12345677999999876 468899999999999999999999996432111100000         


Q ss_pred             -hHhhccc----c---CCCCC--------HHHHHHHHHHHHHhccCCCCCCCCHHHHHHH
Q 005586          632 -ENFIDRN----L---KGKFS--------ESEAAKLGKMALVCTHEDPENRPTMEAVIEE  675 (689)
Q Consensus       632 -~~~~~~~----~---~~~~~--------~~~~~~l~~l~~~Cl~~dp~~RPs~~evl~~  675 (689)
                       .+.....    .   ....+        .....++.+++.+|++.||++||++.|++.+
T Consensus       238 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~R~~~~e~l~h  297 (342)
T cd07879         238 FVQKLEDKAAKSYIKSLPKYPRKDFSTLFPKASPQAVDLLEKMLELDVDKRLTATEALEH  297 (342)
T ss_pred             HHHHhcccchHHHHhhcCCcccchHHHHhcCCCHHHHHHHHHHcCCChhhCcCHHHHhcC
Confidence             0000000    0   00000        1234568899999999999999999999976

Serine/Threonine Kinases (STKs), p38delta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38delta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38delta, also called MAPK13

>cd05611 STKc_Rim15_like Catalytic domain of fungal Rim15-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=4.4e-34  Score=291.83  Aligned_cols=244  Identities=21%  Similarity=0.268  Sum_probs=188.1

Q ss_pred             cccccCCcceEEEEEec-CCcEEEEEEecccCC--chHHHHHHHHHHH-HhccCCCcceeEeeEEEcCCCCeEEEEEEcC
Q 005586          415 NLLGKGNFSSVYKGTLR-DGTLVAIRSINVTSC--KSEEAEFVKGLYL-LTSLRHENIIRLRGFCCSRGRGECFLIYDFA  490 (689)
Q Consensus       415 ~~lg~G~~g~Vy~~~~~-~g~~vavK~l~~~~~--~~~~~~f~~e~~~-l~~l~H~niv~l~g~~~~~~~~~~~lV~e~~  490 (689)
                      +.||+|+||.||+|... +|+.||+|++.....  ......+..|..+ ....+|+|++++++++..  .+..++|+||+
T Consensus         2 ~~l~~g~~~~v~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~--~~~~~lv~e~~   79 (260)
T cd05611           2 KPISKGAFGSVYLAKKRSTGDYFAIKVLKKSDMIAKNQVTNVKAERAIMMIQGESPYVAKLYYSFQS--KDYLYLVMEYL   79 (260)
T ss_pred             ccCCcCCCeeEEEEEecCCCCeEEEEEecchhhhHHHHHHHHHHHHHHHhhcCCCCCeeeeeeeEEc--CCeEEEEEecc
Confidence            46999999999999875 689999999875432  1222344555444 445589999999999843  57899999999


Q ss_pred             CCCCHHHHhhhcCCCCCCCCHHHHHHHHHHHHHHHhhhhCCCCCCCceeecCCCCCceeecCCCCeEEecccccccccCC
Q 005586          491 PKGKLSKYLDQEEGSSNVLDWSTRVSIIIGIAKGIGYLHSSEVNKPAIVHRNLSVEKVLIDQQFNPLIADCGLHKLLADD  570 (689)
Q Consensus       491 ~~gsL~~~L~~~~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~~~ivH~dlk~~NiLl~~~~~~kl~DfGla~~~~~~  570 (689)
                      ++++|.+++....    .+++..+..++.|++.||.|||+.+     ++||||+|+||++++++.+||+|||+++.....
T Consensus        80 ~~~~L~~~l~~~~----~~~~~~~~~i~~qi~~aL~~lH~~~-----i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~~  150 (260)
T cd05611          80 NGGDCASLIKTLG----GLPEDWAKQYIAEVVLGVEDLHQRG-----IIHRDIKPENLLIDQTGHLKLTDFGLSRNGLEN  150 (260)
T ss_pred             CCCCHHHHHHHcC----CCCHHHHHHHHHHHHHHHHHHHHCC-----eecCCCCHHHeEECCCCcEEEeecccceecccc
Confidence            9999999997543    3788999999999999999999987     999999999999999999999999998764331


Q ss_pred             ceeeeecCCCCCCCCCccccccCCCCCcccchhHHHHHHHHHhCCCCcchhHHHHHhhhhhhHhhccc--cCCCCCHHHH
Q 005586          571 IVFSVLKTSAAMGYLAPEYVTTGRFTERSDIFAFGVIILQILTGSLVLTSSMRLAAESATFENFIDRN--LKGKFSESEA  648 (689)
Q Consensus       571 ~~~~~~~~~~~~~y~aPE~~~~~~~~~ksDV~sfGvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~  648 (689)
                           ....++..|+|||.+.+..++.++||||||+++|||+||+.|+........    +.......  .........+
T Consensus       151 -----~~~~~~~~y~~pe~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~----~~~~~~~~~~~~~~~~~~~~  221 (260)
T cd05611         151 -----KKFVGTPDYLAPETILGVGDDKMSDWWSLGCVIFEFLFGYPPFHAETPDAV----FDNILSRRINWPEEVKEFCS  221 (260)
T ss_pred             -----ccCCCCcCccChhhhcCCCCcchhhhHHHHHHHHHHHHCCCCCCCCCHHHH----HHHHHhcccCCCCcccccCC
Confidence                 123466789999999888889999999999999999999999964322111    11111111  1111222346


Q ss_pred             HHHHHHHHHhccCCCCCCCCH---HHHHHHHHh
Q 005586          649 AKLGKMALVCTHEDPENRPTM---EAVIEELTV  678 (689)
Q Consensus       649 ~~l~~l~~~Cl~~dp~~RPs~---~evl~~L~~  678 (689)
                      ..+.+++..|++.+|++||++   .|++.+.+.
T Consensus       222 ~~~~~~i~~~l~~~p~~R~~~~~~~~~l~~~~~  254 (260)
T cd05611         222 PEAVDLINRLLCMDPAKRLGANGYQEIKSHPFF  254 (260)
T ss_pred             HHHHHHHHHHccCCHHHccCCCcHHHHHcChHh
Confidence            789999999999999999965   566655443

Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, fungal Rim15-like kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include Saccharomyces cerevisiae Rim15, Schizosaccharomyces pombe cek1, and similar fungal proteins. They contain a central catalytic domain, which contains an insert relative to MAST kinases. In addition, Rim15 contains a C-terminal signal receiver (REC) domain while cek1 contains an N-terminal PAS domain. Rim15 (or Rim15p) functions as a regulator of meiosis. It acts as a do

>cd08222 STKc_Nek11 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 11

Probab=100.00  E-value=3.2e-34  Score=292.85  Aligned_cols=252  Identities=18%  Similarity=0.315  Sum_probs=196.0

Q ss_pred             cCCcccccccCCcceEEEEEec-CCcEEEEEEeccc---C-CchHHHHHHHHHHHHhccCCCcceeEeeEEEcCCCCeEE
Q 005586          410 CFSEVNLLGKGNFSSVYKGTLR-DGTLVAIRSINVT---S-CKSEEAEFVKGLYLLTSLRHENIIRLRGFCCSRGRGECF  484 (689)
Q Consensus       410 ~f~~~~~lg~G~~g~Vy~~~~~-~g~~vavK~l~~~---~-~~~~~~~f~~e~~~l~~l~H~niv~l~g~~~~~~~~~~~  484 (689)
                      +|...+.||+|+||.||++... .+..+++|.++..   . ......++..|+.++++++||||+++++++..  ....+
T Consensus         1 ~y~i~~~ig~g~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~--~~~~~   78 (260)
T cd08222           1 RYILQQRLGKGSFGTVYLVKDKKAVAEERLKVLKEIPVGELNPNETVQANQEAQLLSKLDHPAIVKFHASFLE--RDAFC   78 (260)
T ss_pred             CceeeeeecCCCCceEEEEEecCCCCcceEEEeccccccccCcchHHHHHHHHHHHHhCCCCcHHHHHHHHhc--CCceE
Confidence            4667789999999999999875 3444555555432   1 12334567789999999999999999998844  46789


Q ss_pred             EEEEcCCCCCHHHHhhhcCCCCCCCCHHHHHHHHHHHHHHHhhhhCCCCCCCceeecCCCCCceeecCCCCeEEeccccc
Q 005586          485 LIYDFAPKGKLSKYLDQEEGSSNVLDWSTRVSIIIGIAKGIGYLHSSEVNKPAIVHRNLSVEKVLIDQQFNPLIADCGLH  564 (689)
Q Consensus       485 lV~e~~~~gsL~~~L~~~~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~~~ivH~dlk~~NiLl~~~~~~kl~DfGla  564 (689)
                      +||||+++++|.+++.........+++..++.++.|++.||.|||+.+     ++|+||||+||++++ +.+||+|||++
T Consensus        79 lv~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~-----i~h~~l~~~nili~~-~~~~l~d~g~~  152 (260)
T cd08222          79 IITEYCEGRDLDCKLEELKHTGKTLSENQVCEWFIQLLLGVHYMHQRR-----ILHRDLKAKNIFLKN-NLLKIGDFGVS  152 (260)
T ss_pred             EEEEeCCCCCHHHHHHHHhhcccccCHHHHHHHHHHHHHHHHHHHHcC-----ccccCCChhheEeec-CCEeecccCce
Confidence            999999999999999764433456999999999999999999999987     999999999999986 56999999998


Q ss_pred             ccccCCceeeeecCCCCCCCCCccccccCCCCCcccchhHHHHHHHHHhCCCCcchhHHHHHhhhhhhHhhccccCCCCC
Q 005586          565 KLLADDIVFSVLKTSAAMGYLAPEYVTTGRFTERSDIFAFGVIILQILTGSLVLTSSMRLAAESATFENFIDRNLKGKFS  644 (689)
Q Consensus       565 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~ksDV~sfGvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~  644 (689)
                      +....... ......++..|+|||...+..++.++||||||+++|||++|+.|+........    ...... ......+
T Consensus       153 ~~~~~~~~-~~~~~~~~~~~~~pe~~~~~~~~~~~Dv~slG~~~~~l~~~~~~~~~~~~~~~----~~~~~~-~~~~~~~  226 (260)
T cd08222         153 RLLMGSCD-LATTFTGTPYYMSPEALKHQGYDSKSDIWSLGCILYEMCCLAHAFEGQNFLSV----VLRIVE-GPTPSLP  226 (260)
T ss_pred             eecCCCcc-cccCCCCCcCccCHHHHccCCCCchhhHHHHHHHHHHHHhCCCCCCCccHHHH----HHHHHc-CCCCCCc
Confidence            87643321 11223467789999998888889999999999999999999999864322111    111111 1122334


Q ss_pred             HHHHHHHHHHHHHhccCCCCCCCCHHHHHHH
Q 005586          645 ESEAAKLGKMALVCTHEDPENRPTMEAVIEE  675 (689)
Q Consensus       645 ~~~~~~l~~l~~~Cl~~dp~~RPs~~evl~~  675 (689)
                      .....++.+++.+||+.+|++||++.|++++
T Consensus       227 ~~~~~~~~~li~~~l~~~p~~Rp~~~~il~~  257 (260)
T cd08222         227 ETYSRQLNSIMQSMLNKDPSLRPSAAEILRN  257 (260)
T ss_pred             chhcHHHHHHHHHHhcCChhhCcCHHHHhhC
Confidence            5566789999999999999999999999986

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 11 (Nek11) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek11 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek11 is involved, through direct phosphorylation, in regulating the degradation of Cdc25A (Cell Division Cycle 25 homolog A), which plays a role in cell cycle progression and in activating cyclin dependent kinases. Nek11 is activated by CHK1 (CHeckpoint Kinase 1) and may be involved in the G2/M check

>cd07855 STKc_ERK5 Catalytic domain of the Serine/Threonine Kinase, Extracellular signal-Regulated Kinase 5

Probab=100.00  E-value=1.5e-34  Score=306.68  Aligned_cols=261  Identities=19%  Similarity=0.320  Sum_probs=200.2

Q ss_pred             ccCCcccccccCCcceEEEEEec-CCcEEEEEEecccCC-chHHHHHHHHHHHHhccCCCcceeEeeEEEcC--CCCeEE
Q 005586          409 QCFSEVNLLGKGNFSSVYKGTLR-DGTLVAIRSINVTSC-KSEEAEFVKGLYLLTSLRHENIIRLRGFCCSR--GRGECF  484 (689)
Q Consensus       409 ~~f~~~~~lg~G~~g~Vy~~~~~-~g~~vavK~l~~~~~-~~~~~~f~~e~~~l~~l~H~niv~l~g~~~~~--~~~~~~  484 (689)
                      ++|+..+.||+|+||.||+|... +|..||+|++..... ......+.+|+.++.+++||||+++++++...  .....+
T Consensus         5 ~~y~~~~~lg~g~~g~v~~~~~~~~~~~valK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~   84 (334)
T cd07855           5 SRYKPIENIGSGAYGVVCSAIDTRSGKKVAIKKIPHAFDVPTLAKRTLRELKILRHFKHDNIIAIRDILRPPGADFKDVY   84 (334)
T ss_pred             hceeeeeeeecCCCeEEEEEEEcCCCCEEEEEEeccccccccchHHHHHHHHHHHhcCCCCccCHHHhccccCCCCceEE
Confidence            57888899999999999999875 699999999976532 23345778899999999999999999877432  235689


Q ss_pred             EEEEcCCCCCHHHHhhhcCCCCCCCCHHHHHHHHHHHHHHHhhhhCCCCCCCceeecCCCCCceeecCCCCeEEeccccc
Q 005586          485 LIYDFAPKGKLSKYLDQEEGSSNVLDWSTRVSIIIGIAKGIGYLHSSEVNKPAIVHRNLSVEKVLIDQQFNPLIADCGLH  564 (689)
Q Consensus       485 lV~e~~~~gsL~~~L~~~~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~~~ivH~dlk~~NiLl~~~~~~kl~DfGla  564 (689)
                      +||||+. |+|.+++....    .+++.....++.|++.||+|||+.+     |+||||||+||++++++.+||+|||++
T Consensus        85 lv~e~~~-~~l~~~~~~~~----~~~~~~~~~i~~qi~~aL~~LH~~~-----ivH~dlkp~Nil~~~~~~~kl~dfg~~  154 (334)
T cd07855          85 VVMDLME-SDLHHIIHSDQ----PLTEEHIRYFLYQLLRGLKYIHSAN-----VIHRDLKPSNLLVNEDCELRIGDFGMA  154 (334)
T ss_pred             EEEehhh-hhHHHHhccCC----CCCHHHHHHHHHHHHHHHHHHHHCC-----eecCCCCHHHEEEcCCCcEEecccccc
Confidence            9999995 68999986542    3899999999999999999999987     999999999999999999999999999


Q ss_pred             ccccCCceee---eecCCCCCCCCCcccccc-CCCCCcccchhHHHHHHHHHhCCCCcchhHHHHHh-------------
Q 005586          565 KLLADDIVFS---VLKTSAAMGYLAPEYVTT-GRFTERSDIFAFGVIILQILTGSLVLTSSMRLAAE-------------  627 (689)
Q Consensus       565 ~~~~~~~~~~---~~~~~~~~~y~aPE~~~~-~~~~~ksDV~sfGvvl~elltG~~p~~~~~~~~~~-------------  627 (689)
                      +.........   .....++..|+|||.+.+ ..++.++|||||||++|||++|+.||.........             
T Consensus       155 ~~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~Di~slG~~l~el~~g~~pf~~~~~~~~~~~~~~~~g~~~~~  234 (334)
T cd07855         155 RGLSSSPTEHKYFMTEYVATRWYRAPELLLSLPEYTTAIDMWSVGCIFAEMLGRRQLFPGKNYVHQLKLILSVLGSPSEE  234 (334)
T ss_pred             eeecccCcCCCcccccccccccccChHHhcCCcccccccchHHHHHHHHHHHcCCCccCCCChHHHHHHHHHHhCCChhH
Confidence            7654322111   112356778999998765 46899999999999999999999999543211000             


Q ss_pred             ------hhhhhHhhcc-ccCCCC-----CHHHHHHHHHHHHHhccCCCCCCCCHHHHHHHHHhh
Q 005586          628 ------SATFENFIDR-NLKGKF-----SESEAAKLGKMALVCTHEDPENRPTMEAVIEELTVA  679 (689)
Q Consensus       628 ------~~~~~~~~~~-~~~~~~-----~~~~~~~l~~l~~~Cl~~dp~~RPs~~evl~~L~~~  679 (689)
                            .....+..+. ......     ....+.++.+++..|++.+|++||++.+++.+.+..
T Consensus       235 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~~l~~~~~~  298 (334)
T cd07855         235 VLNRIGSDRVRKYIQNLPRKQPVPWSKIFPKASPEALDLLSQMLQFDPEERITVEQALQHPFLA  298 (334)
T ss_pred             hhhhhchhhHHHHHhhcccCCCCCHHHHcccCCHHHHHHHHHHccCChhhCcCHHHHHhChhhh
Confidence                  0001111110 000111     122467899999999999999999999999987664

Serine/Threonine Kinases (STKs), Extracellular signal-Regulated Kinase 5 (ERK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ERK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. ERK5, also called Big MAPK1 (BMK1) or MAPK7, has a unique C-terminal extension, making it approximately twice as big as other MAPKs. This extension contains transcriptional activation capability which is inhibited by the N-terminal half. ERK5 is activated in response to growth factors and stress by a cascade that leads to its phosphorylation by the

>KOG1035 consensus eIF-2alpha kinase GCN2 [Translation, ribosomal structure and biogenesis]

Probab=100.00  E-value=6.8e-35  Score=325.29  Aligned_cols=256  Identities=22%  Similarity=0.387  Sum_probs=194.9

Q ss_pred             HHhccCCcccccccCCcceEEEEEec-CCcEEEEEEecccCCchHHHHHHHHHHHHhccCCCcceeEeeEEEcCC-----
Q 005586          406 SATQCFSEVNLLGKGNFSSVYKGTLR-DGTLVAIRSINVTSCKSEEAEFVKGLYLLTSLRHENIIRLRGFCCSRG-----  479 (689)
Q Consensus       406 ~at~~f~~~~~lg~G~~g~Vy~~~~~-~g~~vavK~l~~~~~~~~~~~f~~e~~~l~~l~H~niv~l~g~~~~~~-----  479 (689)
                      +-..+|.+.++||+||||.|||++-+ ||+.||||++.............+|++++++++|||||+++..+.+..     
T Consensus       476 RY~~DFEEL~lLGkGGFG~VvkVRNKlDGr~YAIKKIpl~~s~~~~skI~rEVk~LArLnHpNVVRYysAWVEs~~~~~~  555 (1351)
T KOG1035|consen  476 RYLNDFEELELLGKGGFGSVVKVRNKLDGREYAIKKIPLKASDKLYSKILREVKLLARLNHPNVVRYYSAWVESTAELTV  555 (1351)
T ss_pred             hHhhhhHHHHHhcCCCCceEEEEeecccchhhhhhhccCchHHHHHHHHHHHHHHHhhcCCcceeeeehhhhccCCcccc
Confidence            34467888899999999999999987 899999999988765555678899999999999999999986443210     


Q ss_pred             --------------------------------------------------------------------------------
Q 005586          480 --------------------------------------------------------------------------------  479 (689)
Q Consensus       480 --------------------------------------------------------------------------------  479 (689)
                                                                                                      
T Consensus       556 ~ei~~~~~~~~sQs~s~~~~~~~~~q~t~~p~~~~~~~~~~~~dd~sss~~~~~~~~~~~~d~e~~d~dedg~~~S~tS~  635 (1351)
T KOG1035|consen  556 LEIVASDSESRSQSASKYNGVDIRYQPTSSPSLTLSELDSEDEDDKSSSYTTRKASYESSTDEENDDSDEDGRNLSNTSD  635 (1351)
T ss_pred             ccccccchhhhcccCCCcccceeeeccCCCcccCcchhhccccCccccccccccccccccCCcccccccccccccccccc
Confidence                                                                                            


Q ss_pred             ------------------------C--------CeEEEEEEcCCCCCHHHHhhhcCCCCCCCCHHHHHHHHHHHHHHHhh
Q 005586          480 ------------------------R--------GECFLIYDFAPKGKLSKYLDQEEGSSNVLDWSTRVSIIIGIAKGIGY  527 (689)
Q Consensus       480 ------------------------~--------~~~~lV~e~~~~gsL~~~L~~~~~~~~~l~~~~~~~ia~~ia~gL~y  527 (689)
                                              .        ...||=||||+.-.+.++++.+....   .-...+++.++|++||+|
T Consensus       636 ~e~~~~~d~~~ess~s~~~~~n~~e~~~~~q~~~~LYIQMEyCE~~ll~~iI~~N~~~~---~~d~~wrLFreIlEGLaY  712 (1351)
T KOG1035|consen  636 SEGSVILDDTSESSESIPKTENSSEPMVPVQKPLILYIQMEYCEKTLLRDIIRRNHFNS---QRDEAWRLFREILEGLAY  712 (1351)
T ss_pred             cCCccccCcchhhhhhccccCCccccccccccceEEEEEHhhhhhhHHHHHHHhcccch---hhHHHHHHHHHHHHHHHH
Confidence                                    0        12467788888877777777654211   245567899999999999


Q ss_pred             hhCCCCCCCceeecCCCCCceeecCCCCeEEeccccccccc----C-------------CceeeeecCCCCCCCCCcccc
Q 005586          528 LHSSEVNKPAIVHRNLSVEKVLIDQQFNPLIADCGLHKLLA----D-------------DIVFSVLKTSAAMGYLAPEYV  590 (689)
Q Consensus       528 LH~~~~~~~~ivH~dlk~~NiLl~~~~~~kl~DfGla~~~~----~-------------~~~~~~~~~~~~~~y~aPE~~  590 (689)
                      +|+.+     ||||||||.||+||++..+||+|||+|....    .             ......+...||.-|+|||.+
T Consensus       713 IH~~g-----iIHRDLKP~NIFLd~~~~VKIGDFGLAt~~~~~~~~~d~~~~~~~~~~g~~~~~~Ts~VGTalYvAPEll  787 (1351)
T KOG1035|consen  713 IHDQG-----IIHRDLKPRNIFLDSRNSVKIGDFGLATDLKENLESIDQDLSFSTNRAGSNDGDLTSQVGTALYVAPELL  787 (1351)
T ss_pred             HHhCc-----eeeccCCcceeEEcCCCCeeecccccchhhhhhhhhHhhccCccccccCCCCcccccccceeeeecHHHh
Confidence            99988     9999999999999999999999999998732    0             011123345677889999998


Q ss_pred             ccC---CCCCcccchhHHHHHHHHHhCCCCcchhHHHHHhhhhhhHhhccccC--CCCCHHHHHHHHHHHHHhccCCCCC
Q 005586          591 TTG---RFTERSDIFAFGVIILQILTGSLVLTSSMRLAAESATFENFIDRNLK--GKFSESEAAKLGKMALVCTHEDPEN  665 (689)
Q Consensus       591 ~~~---~~~~ksDV~sfGvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~l~~l~~~Cl~~dp~~  665 (689)
                      .+.   +|+.|+|+||+|||++||+.   ||...+..+..   +..+-+..+.  ..+....+..-.+++.++++.||.+
T Consensus       788 ~~~~~~~Yn~KiDmYSLGIVlFEM~y---PF~TsMERa~i---L~~LR~g~iP~~~~f~~~~~~~e~slI~~Ll~hdP~k  861 (1351)
T KOG1035|consen  788 SDTSSNKYNSKIDMYSLGIVLFEMLY---PFGTSMERASI---LTNLRKGSIPEPADFFDPEHPEEASLIRWLLSHDPSK  861 (1351)
T ss_pred             cccccccccchhhhHHHHHHHHHHhc---cCCchHHHHHH---HHhcccCCCCCCcccccccchHHHHHHHHHhcCCCcc
Confidence            764   49999999999999999996   56544433222   2222222221  2234455667789999999999999


Q ss_pred             CCCHHHHHHH
Q 005586          666 RPTMEAVIEE  675 (689)
Q Consensus       666 RPs~~evl~~  675 (689)
                      |||+.|++..
T Consensus       862 RPtA~eLL~s  871 (1351)
T KOG1035|consen  862 RPTATELLNS  871 (1351)
T ss_pred             CCCHHHHhhc
Confidence            9999999864

>KOG0596 consensus Dual specificity; serine/threonine and tyrosine kinase [Cell cycle control, cell division, chromosome partitioning]

Probab=100.00  E-value=1.4e-34  Score=298.68  Aligned_cols=252  Identities=19%  Similarity=0.336  Sum_probs=202.8

Q ss_pred             cCCcccccccCCcceEEEEEecCCcEEEEEEecccC-CchHHHHHHHHHHHHhccC-CCcceeEeeEEEcCCCCeEEEEE
Q 005586          410 CFSEVNLLGKGNFSSVYKGTLRDGTLVAIRSINVTS-CKSEEAEFVKGLYLLTSLR-HENIIRLRGFCCSRGRGECFLIY  487 (689)
Q Consensus       410 ~f~~~~~lg~G~~g~Vy~~~~~~g~~vavK~l~~~~-~~~~~~~f~~e~~~l~~l~-H~niv~l~g~~~~~~~~~~~lV~  487 (689)
                      .|+..+.||+||.+.||++.-.+.+.+|+|++.... ..+...-|..|+..|.+++ |.+||+|++|-..  .+..|+||
T Consensus       362 ~Yeilk~iG~GGSSkV~kV~~s~~~iyalkkv~~~~~D~qtl~gy~nEI~lL~KLkg~~~IIqL~DYEv~--d~~lYmvm  439 (677)
T KOG0596|consen  362 EYEILKQIGSGGSSKVFKVLNSDKQIYALKKVVLLEADNQTLDGYRNEIALLNKLKGHDKIIQLYDYEVT--DGYLYMVM  439 (677)
T ss_pred             hhhHHHhhcCCCcceeeeeecCCCcchhhhHHHHhhcCHHHHHHHHHHHHHHHHhcCCceEEEEeeeecc--CceEEEEe
Confidence            466678999999999999998888888888876443 3455678999999999995 9999999999755  57899999


Q ss_pred             EcCCCCCHHHHhhhcCCCCCCCCHHHHHHHHHHHHHHHhhhhCCCCCCCceeecCCCCCceeecCCCCeEEecccccccc
Q 005586          488 DFAPKGKLSKYLDQEEGSSNVLDWSTRVSIIIGIAKGIGYLHSSEVNKPAIVHRNLSVEKVLIDQQFNPLIADCGLHKLL  567 (689)
Q Consensus       488 e~~~~gsL~~~L~~~~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~~~ivH~dlk~~NiLl~~~~~~kl~DfGla~~~  567 (689)
                      ||- .-||..+|.+....  ..+| .+..+..|++.++.+.|+.+     |||.||||.|+|+-+ |.+||+|||+|..+
T Consensus       440 E~G-d~DL~kiL~k~~~~--~~~~-~lk~ywkqML~aV~~IH~~g-----IVHSDLKPANFLlVk-G~LKLIDFGIA~aI  509 (677)
T KOG0596|consen  440 ECG-DIDLNKILKKKKSI--DPDW-FLKFYWKQMLLAVKTIHQHG-----IVHSDLKPANFLLVK-GRLKLIDFGIANAI  509 (677)
T ss_pred             ecc-cccHHHHHHhccCC--CchH-HHHHHHHHHHHHHHHHHHhc-----eeecCCCcccEEEEe-eeEEeeeechhccc
Confidence            998 56999999887543  3456 67789999999999999988     999999999999975 68999999999988


Q ss_pred             cCCcee-eeecCCCCCCCCCccccccC-----------CCCCcccchhHHHHHHHHHhCCCCcchhHHHHHhhhhhhHhh
Q 005586          568 ADDIVF-SVLKTSAAMGYLAPEYVTTG-----------RFTERSDIFAFGVIILQILTGSLVLTSSMRLAAESATFENFI  635 (689)
Q Consensus       568 ~~~~~~-~~~~~~~~~~y~aPE~~~~~-----------~~~~ksDV~sfGvvl~elltG~~p~~~~~~~~~~~~~~~~~~  635 (689)
                      ..+... -.....||+.||+||.+...           +.+.+|||||+||+||+|+.|+.||..-...   ...+..+.
T Consensus       510 ~~DTTsI~kdsQvGT~NYMsPEAl~~~~s~~~~~~~k~Ki~r~SDvWSLGCILYqMvYgktPf~~~~n~---~aKl~aI~  586 (677)
T KOG0596|consen  510 QPDTTSIVKDSQVGTVNYMSPEALTDMSSSRENGKSKIKISRKSDVWSLGCILYQMVYGKTPFGQIINQ---IAKLHAIT  586 (677)
T ss_pred             CccccceeeccccCcccccCHHHHhhccccccCCCcceeecCccchhhhhhHHHHHHhcCCchHHHHHH---HHHHHhhc
Confidence            765432 22345799999999987532           2568999999999999999999999754322   23455566


Q ss_pred             ccccCCCCCHH-HHHHHHHHHHHhccCCCCCCCCHHHHHHHH
Q 005586          636 DRNLKGKFSES-EAAKLGKMALVCTHEDPENRPTMEAVIEEL  676 (689)
Q Consensus       636 ~~~~~~~~~~~-~~~~l~~l~~~Cl~~dp~~RPs~~evl~~L  676 (689)
                      ++...-.|+.- ...++.++|..|+++||.+||+..|++++-
T Consensus       587 ~P~~~Iefp~~~~~~~li~~mK~CL~rdPkkR~si~eLLqhp  628 (677)
T KOG0596|consen  587 DPNHEIEFPDIPENDELIDVMKCCLARDPKKRWSIPELLQHP  628 (677)
T ss_pred             CCCccccccCCCCchHHHHHHHHHHhcCcccCCCcHHHhcCc
Confidence            66544344321 123399999999999999999999999874

>KOG0983 consensus Mitogen-activated protein kinase (MAPK) kinase MKK7/JNKK2 [Signal transduction mechanisms]

Probab=100.00  E-value=5.2e-35  Score=277.42  Aligned_cols=245  Identities=19%  Similarity=0.383  Sum_probs=195.1

Q ss_pred             ccccccCCcceEEEEEec-CCcEEEEEEecccCCchHHHHHHHHHHHHhccC-CCcceeEeeEEEcCCCCeEEEEEEcCC
Q 005586          414 VNLLGKGNFSSVYKGTLR-DGTLVAIRSINVTSCKSEEAEFVKGLYLLTSLR-HENIIRLRGFCCSRGRGECFLIYDFAP  491 (689)
Q Consensus       414 ~~~lg~G~~g~Vy~~~~~-~g~~vavK~l~~~~~~~~~~~f~~e~~~l~~l~-H~niv~l~g~~~~~~~~~~~lV~e~~~  491 (689)
                      ...||.|..|.|++++++ .|..+|||.+.....+.+.+.+...+.++..-+ .|.||+-+|||...  ..+++.||.|.
T Consensus        97 l~dlGsGtcG~V~k~~~rs~~~iiAVK~M~rt~Nkee~kRILmDldvv~~s~dcpyIV~c~GyFi~n--~dV~IcMelMs  174 (391)
T KOG0983|consen   97 LGDLGSGTCGQVWKMRFRSTGHIIAVKQMRRTGNKEENKRILMDLDVVLKSHDCPYIVQCFGYFITN--TDVFICMELMS  174 (391)
T ss_pred             HHhhcCCCccceEEEEEcccceEEEEEeecccCCHHHHHHHHHhhhHHhhccCCCeeeeeeeEEeeC--chHHHHHHHHH
Confidence            456999999999999987 589999999998877777778888888877765 89999999999764  56788899984


Q ss_pred             CCCHHHHhhhcCCCCCCCCHHHHHHHHHHHHHHHhhhhCCCCCCCceeecCCCCCceeecCCCCeEEecccccccccCCc
Q 005586          492 KGKLSKYLDQEEGSSNVLDWSTRVSIIIGIAKGIGYLHSSEVNKPAIVHRNLSVEKVLIDQQFNPLIADCGLHKLLADDI  571 (689)
Q Consensus       492 ~gsL~~~L~~~~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~~~ivH~dlk~~NiLl~~~~~~kl~DfGla~~~~~~~  571 (689)
                       .-++.+|....   .++++...=++...+.+||.||-+.+.    |+|||+||+|||+|+.|++|++|||++..+.+..
T Consensus       175 -~C~ekLlkrik---~piPE~ilGk~tva~v~AL~YLKeKH~----viHRDvKPSNILlDe~GniKlCDFGIsGrlvdSk  246 (391)
T KOG0983|consen  175 -TCAEKLLKRIK---GPIPERILGKMTVAIVKALYYLKEKHG----VIHRDVKPSNILLDERGNIKLCDFGISGRLVDSK  246 (391)
T ss_pred             -HHHHHHHHHhc---CCchHHhhhhhHHHHHHHHHHHHHhcc----eeecccCccceEEccCCCEEeecccccceeeccc
Confidence             35666665443   247777778899999999999987664    9999999999999999999999999998887654


Q ss_pred             eeeeecCCCCCCCCCcccccc---CCCCCcccchhHHHHHHHHHhCCCCcchh-HHHHHhhhhhhHhhc---cccCCCCC
Q 005586          572 VFSVLKTSAAMGYLAPEYVTT---GRFTERSDIFAFGVIILQILTGSLVLTSS-MRLAAESATFENFID---RNLKGKFS  644 (689)
Q Consensus       572 ~~~~~~~~~~~~y~aPE~~~~---~~~~~ksDV~sfGvvl~elltG~~p~~~~-~~~~~~~~~~~~~~~---~~~~~~~~  644 (689)
                        ...+..|.+.|||||.+.-   .+|+.++|||||||.|+||.||+.||... .....    +..+++   +.+.+.  
T Consensus       247 --AhtrsAGC~~YMaPERidp~~~~kYDiRaDVWSlGITlveLaTg~yPy~~c~tdFe~----ltkvln~ePP~L~~~--  318 (391)
T KOG0983|consen  247 --AHTRSAGCAAYMAPERIDPPDKPKYDIRADVWSLGITLVELATGQYPYKGCKTDFEV----LTKVLNEEPPLLPGH--  318 (391)
T ss_pred             --ccccccCCccccCccccCCCCCCccchhhhhhhhccchhhhhcccCCCCCCCccHHH----HHHHHhcCCCCCCcc--
Confidence              2345667788999999864   46899999999999999999999999652 11111    112222   222221  


Q ss_pred             HHHHHHHHHHHHHhccCCCCCCCCHHHHHHHH
Q 005586          645 ESEAAKLGKMALVCTHEDPENRPTMEAVIEEL  676 (689)
Q Consensus       645 ~~~~~~l~~l~~~Cl~~dp~~RPs~~evl~~L  676 (689)
                      ..-+..+.+++..|+++|+.+||...+++++-
T Consensus       319 ~gFSp~F~~fv~~CL~kd~r~RP~Y~~Ll~h~  350 (391)
T KOG0983|consen  319 MGFSPDFQSFVKDCLTKDHRKRPKYNKLLEHP  350 (391)
T ss_pred             cCcCHHHHHHHHHHhhcCcccCcchHHHhcCc
Confidence            22467899999999999999999999999763

>cd08216 PK_STRAD Pseudokinase domain of STE20-related kinase adapter protein

Probab=100.00  E-value=6e-34  Score=299.38  Aligned_cols=255  Identities=16%  Similarity=0.260  Sum_probs=190.1

Q ss_pred             cccccCCcceEEEEEecCCcEEEEEEecccC-CchHHHHHHHHHHHHhccCCCcceeEeeEEEcCCCCeEEEEEEcCCCC
Q 005586          415 NLLGKGNFSSVYKGTLRDGTLVAIRSINVTS-CKSEEAEFVKGLYLLTSLRHENIIRLRGFCCSRGRGECFLIYDFAPKG  493 (689)
Q Consensus       415 ~~lg~G~~g~Vy~~~~~~g~~vavK~l~~~~-~~~~~~~f~~e~~~l~~l~H~niv~l~g~~~~~~~~~~~lV~e~~~~g  493 (689)
                      +.+|.|+++.||++.. +|+.||+|++.... .......+.+|++++++++|+||+++++++..  .+..+++|||+++|
T Consensus         8 ~~~~~~~~v~~~~~~~-~~~~~avK~~~~~~~~~~~~~~~~~Ei~~l~~l~h~~i~~~~~~~~~--~~~~~~~~e~~~~~   84 (314)
T cd08216           8 KCFEDLMIVHLAKHKP-TNTLVAVKKINLDSCSKEDLKLLQQEIITSRQLQHPNILPYVTSFIV--DSELYVVSPLMAYG   84 (314)
T ss_pred             HhhcCCceEEEEEecC-CCCEEEEEEEeccccchhHHHHHHHHHHHHHhcCCcchhhhhheeec--CCeEEEEEeccCCC
Confidence            3445555555555544 68999999997652 23455789999999999999999999998854  47789999999999


Q ss_pred             CHHHHhhhcCCCCCCCCHHHHHHHHHHHHHHHhhhhCCCCCCCceeecCCCCCceeecCCCCeEEecccccccccCCce-
Q 005586          494 KLSKYLDQEEGSSNVLDWSTRVSIIIGIAKGIGYLHSSEVNKPAIVHRNLSVEKVLIDQQFNPLIADCGLHKLLADDIV-  572 (689)
Q Consensus       494 sL~~~L~~~~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~~~ivH~dlk~~NiLl~~~~~~kl~DfGla~~~~~~~~-  572 (689)
                      +|.+++.....  ..+++.....++.|++.||+|||+.+     |+||||||+||+++.++.+||+|||.+..+..... 
T Consensus        85 ~l~~~l~~~~~--~~~~~~~~~~~~~~l~~~L~~LH~~~-----ivH~dlk~~Nili~~~~~~kl~d~~~~~~~~~~~~~  157 (314)
T cd08216          85 SCEDLLKTHFP--EGLPELAIAFILKDVLNALDYIHSKG-----FIHRSVKASHILLSGDGKVVLSGLRYSVSMIKHGKR  157 (314)
T ss_pred             CHHHHHHHhcc--cCCCHHHHHHHHHHHHHHHHHHHHCC-----eecCCCCcceEEEecCCceEEecCccceeecccccc
Confidence            99999986532  24888999999999999999999987     99999999999999999999999998875532211 


Q ss_pred             -----eeeecCCCCCCCCCcccccc--CCCCCcccchhHHHHHHHHHhCCCCcchhHHHHHhhhhhh----Hhhc-----
Q 005586          573 -----FSVLKTSAAMGYLAPEYVTT--GRFTERSDIFAFGVIILQILTGSLVLTSSMRLAAESATFE----NFID-----  636 (689)
Q Consensus       573 -----~~~~~~~~~~~y~aPE~~~~--~~~~~ksDV~sfGvvl~elltG~~p~~~~~~~~~~~~~~~----~~~~-----  636 (689)
                           .......++..|+|||++..  ..++.++|||||||++|||++|+.||..............    ..++     
T Consensus       158 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~Diws~G~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~  237 (314)
T cd08216         158 QRVVHDFPKSSVKNLPWLSPEVLQQNLQGYNEKSDIYSVGITACELANGHVPFKDMPATQMLLEKVRGTVPCLLDKSTYP  237 (314)
T ss_pred             ccccccccccccccccccCHHHhcCCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhccCccccccCchh
Confidence                 01122345667999999865  3578999999999999999999999964321111000000    0000     


Q ss_pred             ---------------cc----cCCCCCHHHHHHHHHHHHHhccCCCCCCCCHHHHHHHHHhh
Q 005586          637 ---------------RN----LKGKFSESEAAKLGKMALVCTHEDPENRPTMEAVIEELTVA  679 (689)
Q Consensus       637 ---------------~~----~~~~~~~~~~~~l~~l~~~Cl~~dp~~RPs~~evl~~L~~~  679 (689)
                                     +.    ...........++.+++.+||+.||++||++.|++++....
T Consensus       238 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~ll~~p~~~  299 (314)
T cd08216         238 LYEDSMSQSRSSNEHPNNRDSVDHPYTRTFSEHFHQFVELCLQRDPESRPSASQLLNHSFFK  299 (314)
T ss_pred             hhcCCcCcccccccccchhhhhhcchhhHHHHHHHHHHHHHhhcCCCcCcCHHHHhcCchHh
Confidence                           00    00011223456789999999999999999999999876543

Protein Kinase family, STE20-related kinase adapter protein (STRAD) subfamily, pseudokinase domain. The STRAD subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpigmentation of the buc

>KOG4717 consensus Serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=2.1e-34  Score=293.83  Aligned_cols=251  Identities=20%  Similarity=0.337  Sum_probs=209.5

Q ss_pred             CCcccccccCCcceEEEEEec-CCcEEEEEEecccCCc-hHHHHHHHHHHHHhccCCCcceeEeeEEEcCCCCeEEEEEE
Q 005586          411 FSEVNLLGKGNFSSVYKGTLR-DGTLVAIRSINVTSCK-SEEAEFVKGLYLLTSLRHENIIRLRGFCCSRGRGECFLIYD  488 (689)
Q Consensus       411 f~~~~~lg~G~~g~Vy~~~~~-~g~~vavK~l~~~~~~-~~~~~f~~e~~~l~~l~H~niv~l~g~~~~~~~~~~~lV~e  488 (689)
                      |...+.||+|.|..|-+|++- .|..||||++.+...+ .....+.+|++.|+-++|||||+||.+.  ......|+|.|
T Consensus        20 YDLekTlG~GHFAVVKLArHVFTGekVAVKviDKTKlD~~st~hlfqEVRCMKLVQHpNiVRLYEVi--DTQTKlyLiLE   97 (864)
T KOG4717|consen   20 YDLEKTLGRGHFAVVKLARHVFTGEKVAVKVIDKTKLDTLSTGHLFQEVRCMKLVQHPNIVRLYEVI--DTQTKLYLILE   97 (864)
T ss_pred             ehhhhhhcCCceehhhhhhhhcccceeEEEEecccccchhhhhHHHHHHHHHHHhcCcCeeeeeehh--cccceEEEEEE
Confidence            444578999999999999864 7999999999877643 3346788999999999999999999987  44577999999


Q ss_pred             cCCCCCHHHHhhhcCCCCCCCCHHHHHHHHHHHHHHHhhhhCCCCCCCceeecCCCCCceeec-CCCCeEEecccccccc
Q 005586          489 FAPKGKLSKYLDQEEGSSNVLDWSTRVSIIIGIAKGIGYLHSSEVNKPAIVHRNLSVEKVLID-QQFNPLIADCGLHKLL  567 (689)
Q Consensus       489 ~~~~gsL~~~L~~~~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~~~ivH~dlk~~NiLl~-~~~~~kl~DfGla~~~  567 (689)
                      .-.+|+|.+|+.++..   .+.+....++..||..|+.|+|+.+     +|||||||+||.+- +-|-+|+.|||++..+
T Consensus        98 LGD~GDl~DyImKHe~---Gl~E~La~kYF~QI~~AI~YCHqLH-----VVHRDLKPENVVFFEKlGlVKLTDFGFSNkf  169 (864)
T KOG4717|consen   98 LGDGGDLFDYIMKHEE---GLNEDLAKKYFAQIVHAISYCHQLH-----VVHRDLKPENVVFFEKLGLVKLTDFGFSNKF  169 (864)
T ss_pred             ecCCchHHHHHHhhhc---cccHHHHHHHHHHHHHHHHHHhhhh-----hhcccCCcceeEEeeecCceEeeeccccccC
Confidence            9999999999987653   3888999999999999999999988     89999999999876 5688999999999876


Q ss_pred             cCCceeeeecCCCCCCCCCccccccCCCC-CcccchhHHHHHHHHHhCCCCcchhHHHHHhhhhhhHhhccccCCCCCHH
Q 005586          568 ADDIVFSVLKTSAAMGYLAPEYVTTGRFT-ERSDIFAFGVIILQILTGSLVLTSSMRLAAESATFENFIDRNLKGKFSES  646 (689)
Q Consensus       568 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~-~ksDV~sfGvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  646 (689)
                      .++.  ......|+..|.|||++.+..|+ +++||||+||+||-|+.|+.||.....    ...+..++|-..  ..|.-
T Consensus       170 ~PG~--kL~TsCGSLAYSAPEILLGDsYDAPAVDiWSLGVILyMLVCGq~PFqeAND----SETLTmImDCKY--tvPsh  241 (864)
T KOG4717|consen  170 QPGK--KLTTSCGSLAYSAPEILLGDSYDAPAVDIWSLGVILYMLVCGQPPFQEAND----SETLTMIMDCKY--TVPSH  241 (864)
T ss_pred             CCcc--hhhcccchhhccCchhhhcCccCCcchhhhHHHHHHHHHHhCCCccccccc----hhhhhhhhcccc--cCchh
Confidence            5543  23334577889999999999996 689999999999999999999975433    234455555443  46777


Q ss_pred             HHHHHHHHHHHhccCCCCCCCCHHHHHHHHHhh
Q 005586          647 EAAKLGKMALVCTHEDPENRPTMEAVIEELTVA  679 (689)
Q Consensus       647 ~~~~l~~l~~~Cl~~dp~~RPs~~evl~~L~~~  679 (689)
                      .+.++.+++..|+..||.+|-+.+||+..-|.-
T Consensus       242 vS~eCrdLI~sMLvRdPkkRAslEeI~s~~Wlq  274 (864)
T KOG4717|consen  242 VSKECRDLIQSMLVRDPKKRASLEEIVSTSWLQ  274 (864)
T ss_pred             hhHHHHHHHHHHHhcCchhhccHHHHhcccccc
Confidence            888999999999999999999999999775543

>cd05606 STKc_beta_ARK Catalytic domain of the Protein Serine/Threonine Kinase, beta-adrenergic receptor kinase

Probab=100.00  E-value=6.4e-34  Score=293.77  Aligned_cols=247  Identities=19%  Similarity=0.278  Sum_probs=189.4

Q ss_pred             ccccCCcceEEEEEec-CCcEEEEEEecccCCc--hHHHHHHHHHH---HHhccCCCcceeEeeEEEcCCCCeEEEEEEc
Q 005586          416 LLGKGNFSSVYKGTLR-DGTLVAIRSINVTSCK--SEEAEFVKGLY---LLTSLRHENIIRLRGFCCSRGRGECFLIYDF  489 (689)
Q Consensus       416 ~lg~G~~g~Vy~~~~~-~g~~vavK~l~~~~~~--~~~~~f~~e~~---~l~~l~H~niv~l~g~~~~~~~~~~~lV~e~  489 (689)
                      .||+|+||.||+|... +|+.||+|.+......  .....+..|..   .++...||||+++++++..  .+..++||||
T Consensus         1 ~ig~g~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~~~~~~~--~~~~~~v~e~   78 (278)
T cd05606           1 IIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMSYAFHT--PDKLSFILDL   78 (278)
T ss_pred             CcccCCCeEEEEEEEecCCCEEEEEEeeccccccchhHHHHHHHHHHHHHHHhCCCCcEeeeeeeeec--CCEEEEEEec
Confidence            4899999999999875 6899999998764322  22223444443   4445689999999988843  4789999999


Q ss_pred             CCCCCHHHHhhhcCCCCCCCCHHHHHHHHHHHHHHHhhhhCCCCCCCceeecCCCCCceeecCCCCeEEecccccccccC
Q 005586          490 APKGKLSKYLDQEEGSSNVLDWSTRVSIIIGIAKGIGYLHSSEVNKPAIVHRNLSVEKVLIDQQFNPLIADCGLHKLLAD  569 (689)
Q Consensus       490 ~~~gsL~~~L~~~~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~~~ivH~dlk~~NiLl~~~~~~kl~DfGla~~~~~  569 (689)
                      +++|+|.+++....    .++|..+..++.|+++||+|||+.+     |+||||||+||++++++.+||+|||+++....
T Consensus        79 ~~g~~L~~~l~~~~----~l~~~~~~~~~~ql~~~l~~lH~~~-----i~H~di~p~nili~~~~~~kl~dfg~~~~~~~  149 (278)
T cd05606          79 MNGGDLHYHLSQHG----VFSEAEMRFYAAEIILGLEHMHNRF-----VVYRDLKPANILLDEHGHVRISDLGLACDFSK  149 (278)
T ss_pred             CCCCcHHHHHHhcC----CCCHHHHHHHHHHHHHHHHHHHHCC-----EEcCCCCHHHEEECCCCCEEEccCcCccccCc
Confidence            99999999886532    4899999999999999999999987     99999999999999999999999999876543


Q ss_pred             CceeeeecCCCCCCCCCccccccC-CCCCcccchhHHHHHHHHHhCCCCcchhHHHHHhhhhhhHhhccccCCCCCHHHH
Q 005586          570 DIVFSVLKTSAAMGYLAPEYVTTG-RFTERSDIFAFGVIILQILTGSLVLTSSMRLAAESATFENFIDRNLKGKFSESEA  648 (689)
Q Consensus       570 ~~~~~~~~~~~~~~y~aPE~~~~~-~~~~ksDV~sfGvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  648 (689)
                      ..   .....++..|+|||.+.++ .++.++|||||||++|||++|+.||.........  ...... .......+...+
T Consensus       150 ~~---~~~~~~~~~y~aPE~~~~~~~~~~~~Di~s~G~~l~~l~~g~~p~~~~~~~~~~--~~~~~~-~~~~~~~~~~~s  223 (278)
T cd05606         150 KK---PHASVGTHGYMAPEVLQKGVAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKH--EIDRMT-LTMAVELPDSFS  223 (278)
T ss_pred             cC---CcCcCCCcCCcCcHHhcCCCCCCcccchHhHHHHHHHHHhCCCCCCCCCccchH--HHHHHh-hccCCCCCCcCC
Confidence            22   1223577889999998754 6899999999999999999999999653211110  011111 011122333446


Q ss_pred             HHHHHHHHHhccCCCCCCC-----CHHHHHHHHHhh
Q 005586          649 AKLGKMALVCTHEDPENRP-----TMEAVIEELTVA  679 (689)
Q Consensus       649 ~~l~~l~~~Cl~~dp~~RP-----s~~evl~~L~~~  679 (689)
                      .++.+++.+|+..+|++||     ++.+++++.+..
T Consensus       224 ~~~~~li~~~l~~~p~~R~~~~~~~~~~ll~~~~~~  259 (278)
T cd05606         224 PELRSLLEGLLQRDVNRRLGCLGRGAQEVKEHPFFR  259 (278)
T ss_pred             HHHHHHHHHHhhcCHHhccCCCCCCHHHHHhCcccc
Confidence            7899999999999999999     999999876543

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, beta-adrenergic receptor kinase (beta-ARK) group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. The beta-ARK group is co

>cd07865 STKc_CDK9 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 9

Probab=100.00  E-value=7.7e-34  Score=297.76  Aligned_cols=258  Identities=17%  Similarity=0.324  Sum_probs=193.3

Q ss_pred             ccCCcccccccCCcceEEEEEec-CCcEEEEEEecccCC-chHHHHHHHHHHHHhccCCCcceeEeeEEEcCC------C
Q 005586          409 QCFSEVNLLGKGNFSSVYKGTLR-DGTLVAIRSINVTSC-KSEEAEFVKGLYLLTSLRHENIIRLRGFCCSRG------R  480 (689)
Q Consensus       409 ~~f~~~~~lg~G~~g~Vy~~~~~-~g~~vavK~l~~~~~-~~~~~~f~~e~~~l~~l~H~niv~l~g~~~~~~------~  480 (689)
                      ++|+..+.||+|+||.||+|..+ +++.||||++..... ......+.+|++++++++||||++++++|....      .
T Consensus        12 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~aik~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~   91 (310)
T cd07865          12 SKYEKLAKIGQGTFGEVFKARHKKTKQIVALKKVLMENEKEGFPITALREIKILQLLKHENVVNLIEICRTKATPYNRYK   91 (310)
T ss_pred             hheEEEEEeecCCCEEEEEEEECCCCcEEEEEEEeccCCcCCchhHHHHHHHHHHhCCCCCccceEEEEecccccccCCC
Confidence            46888899999999999999975 689999999865432 222345678999999999999999999885432      2


Q ss_pred             CeEEEEEEcCCCCCHHHHhhhcCCCCCCCCHHHHHHHHHHHHHHHhhhhCCCCCCCceeecCCCCCceeecCCCCeEEec
Q 005586          481 GECFLIYDFAPKGKLSKYLDQEEGSSNVLDWSTRVSIIIGIAKGIGYLHSSEVNKPAIVHRNLSVEKVLIDQQFNPLIAD  560 (689)
Q Consensus       481 ~~~~lV~e~~~~gsL~~~L~~~~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~~~ivH~dlk~~NiLl~~~~~~kl~D  560 (689)
                      ...++||||+. ++|.+++....   ..+++.+.+.++.|++.||+|||+.+     ++|+||||+||++++++.+||+|
T Consensus        92 ~~~~lv~e~~~-~~l~~~l~~~~---~~~~~~~~~~i~~qi~~al~~lH~~~-----i~H~dl~p~nil~~~~~~~kl~d  162 (310)
T cd07865          92 GSFYLVFEFCE-HDLAGLLSNKN---VKFTLSEIKKVMKMLLNGLYYIHRNK-----ILHRDMKAANILITKDGILKLAD  162 (310)
T ss_pred             ceEEEEEcCCC-cCHHHHHHhcc---cCCCHHHHHHHHHHHHHHHHHHHHCC-----eeccCCCHHHEEECCCCcEEECc
Confidence            35699999996 58888886543   24899999999999999999999987     99999999999999999999999


Q ss_pred             ccccccccCCcee---eeecCCCCCCCCCccccccC-CCCCcccchhHHHHHHHHHhCCCCcchhHHHHHhhhhhhHhh-
Q 005586          561 CGLHKLLADDIVF---SVLKTSAAMGYLAPEYVTTG-RFTERSDIFAFGVIILQILTGSLVLTSSMRLAAESATFENFI-  635 (689)
Q Consensus       561 fGla~~~~~~~~~---~~~~~~~~~~y~aPE~~~~~-~~~~ksDV~sfGvvl~elltG~~p~~~~~~~~~~~~~~~~~~-  635 (689)
                      ||++.........   ......++..|+|||.+.+. .++.++||||||+++|||+||+.|+......... ..+..+. 
T Consensus       163 fg~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~~l~el~t~~~~~~~~~~~~~~-~~~~~~~~  241 (310)
T cd07865         163 FGLARAFSLSKNSKPNRYTNRVVTLWYRPPELLLGERDYGPPIDMWGAGCIMAEMWTRSPIMQGNTEQHQL-TLISQLCG  241 (310)
T ss_pred             CCCcccccCCcccCCCCccCcccCccccCcHHhcCCcccCchhhhHHHHHHHHHHHhCCCCCCCCCHHHHH-HHHHHHhC
Confidence            9999866432211   11123356789999987654 4788999999999999999999988643221100 0000000 


Q ss_pred             ----------------cc-ccCCCC---------CHHHHHHHHHHHHHhccCCCCCCCCHHHHHHHH
Q 005586          636 ----------------DR-NLKGKF---------SESEAAKLGKMALVCTHEDPENRPTMEAVIEEL  676 (689)
Q Consensus       636 ----------------~~-~~~~~~---------~~~~~~~l~~l~~~Cl~~dp~~RPs~~evl~~L  676 (689)
                                      +. ......         +......+.+++..|++.||++||+++|++++-
T Consensus       242 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~dli~~~l~~~P~~R~t~~e~l~h~  308 (310)
T cd07865         242 SITPEVWPGVDKLELFKKMELPQGQKRKVKERLKPYVKDPHALDLIDKLLVLDPAKRIDADTALNHD  308 (310)
T ss_pred             CCChhhcccccchhhhhhccCCCccchhhHHhcccccCCHHHHHHHHHHhcCChhhccCHHHHhcCC
Confidence                            00 000000         001234577999999999999999999999763

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK9 together with a cyclin partner (cyclin T1, T2a, T2b, or K) is the main component of distinct positive transcription elongation factors (P-TEFb), which function as Ser2 C-terminal domain kinases of RNA polymerase II. P-TEFb participates in multipl

>cd07858 STKc_TEY_MAPK_plant Catalytic domain of the Serine/Threonine Kinases, TEY Mitogen-Activated Protein Kinases from Plants

Probab=100.00  E-value=2.7e-34  Score=305.02  Aligned_cols=259  Identities=17%  Similarity=0.305  Sum_probs=197.4

Q ss_pred             ccCCcccccccCCcceEEEEEec-CCcEEEEEEecccC-CchHHHHHHHHHHHHhccCCCcceeEeeEEEcCCC---CeE
Q 005586          409 QCFSEVNLLGKGNFSSVYKGTLR-DGTLVAIRSINVTS-CKSEEAEFVKGLYLLTSLRHENIIRLRGFCCSRGR---GEC  483 (689)
Q Consensus       409 ~~f~~~~~lg~G~~g~Vy~~~~~-~g~~vavK~l~~~~-~~~~~~~f~~e~~~l~~l~H~niv~l~g~~~~~~~---~~~  483 (689)
                      ++|...+.||+|+||.||+|... +|+.||||++.... .......+.+|+.++..++|+||+++++++.....   ...
T Consensus         5 ~~y~~~~~lg~G~~~~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~ni~~~~~~~~~~~~~~~~~~   84 (337)
T cd07858           5 TKYVPIKPIGRGAYGIVCSAKNSETNEKVAIKKIANAFDNRIDAKRTLREIKLLRHLDHENVIAIKDIMPPPHREAFNDV   84 (337)
T ss_pred             cceeEEEEeccCCCeEEEEEEecCCCCeEEEEEecccccccchhHHHHHHHHHHHhcCCCCccchHHheecccccccCcE
Confidence            46888899999999999999875 68999999987542 22334567889999999999999999998754321   357


Q ss_pred             EEEEEcCCCCCHHHHhhhcCCCCCCCCHHHHHHHHHHHHHHHhhhhCCCCCCCceeecCCCCCceeecCCCCeEEecccc
Q 005586          484 FLIYDFAPKGKLSKYLDQEEGSSNVLDWSTRVSIIIGIAKGIGYLHSSEVNKPAIVHRNLSVEKVLIDQQFNPLIADCGL  563 (689)
Q Consensus       484 ~lV~e~~~~gsL~~~L~~~~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~~~ivH~dlk~~NiLl~~~~~~kl~DfGl  563 (689)
                      ++||||+. ++|.+++....    .+++.....++.|++.||.|||+.+     ++||||||+||+++.++.+||+|||+
T Consensus        85 ~lv~e~~~-~~L~~~~~~~~----~l~~~~~~~i~~qi~~aL~~LH~~~-----i~H~dlkp~Nil~~~~~~~kL~Dfg~  154 (337)
T cd07858          85 YIVYELMD-TDLHQIIRSSQ----TLSDDHCQYFLYQLLRGLKYIHSAN-----VLHRDLKPSNLLLNANCDLKICDFGL  154 (337)
T ss_pred             EEEEeCCC-CCHHHHHhcCC----CCCHHHHHHHHHHHHHHHHHHHhCC-----EecCCCCHHHEEEcCCCCEEECcCcc
Confidence            99999996 78998886542    4899999999999999999999987     99999999999999999999999999


Q ss_pred             cccccCCceeeeecCCCCCCCCCcccccc-CCCCCcccchhHHHHHHHHHhCCCCcchhHHHHHhh--------------
Q 005586          564 HKLLADDIVFSVLKTSAAMGYLAPEYVTT-GRFTERSDIFAFGVIILQILTGSLVLTSSMRLAAES--------------  628 (689)
Q Consensus       564 a~~~~~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~ksDV~sfGvvl~elltG~~p~~~~~~~~~~~--------------  628 (689)
                      ++....... ......++..|+|||.+.. ..++.++|||||||++|||++|+.||..........              
T Consensus       155 ~~~~~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~  233 (337)
T cd07858         155 ARTTSEKGD-FMTEYVVTRWYRAPELLLNCSEYTTAIDVWSVGCIFAELLGRKPLFPGKDYVHQLKLITELLGSPSEEDL  233 (337)
T ss_pred             ccccCCCcc-cccccccccCccChHHHhcCCCCCCcccHHHHHHHHHHHHcCCCCCCCCChHHHHHHHHHHhCCCChHHh
Confidence            986644321 1122346778999998765 468999999999999999999999985431110000              


Q ss_pred             -----hhhhHhhcccc---CC---CCCHHHHHHHHHHHHHhccCCCCCCCCHHHHHHHHHh
Q 005586          629 -----ATFENFIDRNL---KG---KFSESEAAKLGKMALVCTHEDPENRPTMEAVIEELTV  678 (689)
Q Consensus       629 -----~~~~~~~~~~~---~~---~~~~~~~~~l~~l~~~Cl~~dp~~RPs~~evl~~L~~  678 (689)
                           ....+.+....   ..   ......+.++.+++.+|++.+|++||+++|++++-+.
T Consensus       234 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rps~~ell~h~~~  294 (337)
T cd07858         234 GFIRNEKARRYIRSLPYTPRQSFARLFPHANPLAIDLLEKMLVFDPSKRITVEEALAHPYL  294 (337)
T ss_pred             hhcCchhhhHHHHhcCcccccCHHHHcccCCHHHHHHHHHHhcCChhhccCHHHHHcCcch
Confidence                 00000110000   00   0012345678999999999999999999999988443

Serine/Threonine Kinases (STKs), Plant TEY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TEY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. There are two subtypes of plant MAPKs based on the conserved phosphorylation motif present in the activati

>PHA03210 serine/threonine kinase US3; Provisional

Probab=100.00  E-value=1.1e-34  Score=322.63  Aligned_cols=266  Identities=16%  Similarity=0.229  Sum_probs=188.2

Q ss_pred             HhccCCcccccccCCcceEEEEEecC--CcEEEEEEe--------------ccc--CCchHHHHHHHHHHHHhccCCCcc
Q 005586          407 ATQCFSEVNLLGKGNFSSVYKGTLRD--GTLVAIRSI--------------NVT--SCKSEEAEFVKGLYLLTSLRHENI  468 (689)
Q Consensus       407 at~~f~~~~~lg~G~~g~Vy~~~~~~--g~~vavK~l--------------~~~--~~~~~~~~f~~e~~~l~~l~H~ni  468 (689)
                      ..++|...+.||+|+||.||++.++.  +..+++|.+              .+.  ........|.+|++++++++||||
T Consensus       146 ~~~~Y~ii~~LG~G~fG~Vyl~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~Ei~il~~l~HpnI  225 (501)
T PHA03210        146 FLAHFRVIDDLPAGAFGKIFICALRASTEEAEARRGVNSTNQGKPKCERLIAKRVKAGSRAAIQLENEILALGRLNHENI  225 (501)
T ss_pred             hhhccEEEeEecCCCCcceEEEEEeccchhhhhhhccccccccchhhhhhHhHHhhcchHHHHHHHHHHHHHHhCCCCCc
Confidence            34689999999999999999987642  222222211              100  112234578899999999999999


Q ss_pred             eeEeeEEEcCCCCeEEEEEEcCCCCCHHHHhhhcCCC-CCCCCHHHHHHHHHHHHHHHhhhhCCCCCCCceeecCCCCCc
Q 005586          469 IRLRGFCCSRGRGECFLIYDFAPKGKLSKYLDQEEGS-SNVLDWSTRVSIIIGIAKGIGYLHSSEVNKPAIVHRNLSVEK  547 (689)
Q Consensus       469 v~l~g~~~~~~~~~~~lV~e~~~~gsL~~~L~~~~~~-~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~~~ivH~dlk~~N  547 (689)
                      |++++++..  .+..++|+|++. ++|.+++...... ...........|+.|++.||+|||+.+     ||||||||+|
T Consensus       226 v~l~~~~~~--~~~~~lv~e~~~-~~l~~~l~~~~~~~~~~~~~~~~~~i~~ql~~aL~yLH~~g-----IiHrDLKP~N  297 (501)
T PHA03210        226 LKIEEILRS--EANTYMITQKYD-FDLYSFMYDEAFDWKDRPLLKQTRAIMKQLLCAVEYIHDKK-----LIHRDIKLEN  297 (501)
T ss_pred             CcEeEEEEE--CCeeEEEEeccc-cCHHHHHhhccccccccccHHHHHHHHHHHHHHHHHHHhCC-----eecCCCCHHH
Confidence            999999854  467899999984 6788877543211 112334566789999999999999987     9999999999


Q ss_pred             eeecCCCCeEEecccccccccCCceeeeecCCCCCCCCCccccccCCCCCcccchhHHHHHHHHHhCCCCc-chhHH--H
Q 005586          548 VLIDQQFNPLIADCGLHKLLADDIVFSVLKTSAAMGYLAPEYVTTGRFTERSDIFAFGVIILQILTGSLVL-TSSMR--L  624 (689)
Q Consensus       548 iLl~~~~~~kl~DfGla~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~ksDV~sfGvvl~elltG~~p~-~~~~~--~  624 (689)
                      ||+++++.+||+|||+++.+............|+..|+|||++.+..++.++|||||||++|||++|+.++ .....  .
T Consensus       298 ILl~~~~~vkL~DFGla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~ell~~~~~p~~~~~~~~~  377 (501)
T PHA03210        298 IFLNCDGKIVLGDFGTAMPFEKEREAFDYGWVGTVATNSPEILAGDGYCEITDIWSCGLILLDMLSHDFCPIGDGGGKPG  377 (501)
T ss_pred             EEECCCCCEEEEeCCCceecCcccccccccccCCcCCCCchhhcCCCCCcHHHHHHHHHHHHHHHHCCCCCccCCCCCHH
Confidence            99999999999999999877554332233346888999999999999999999999999999999988543 21100  0


Q ss_pred             HHhhh-----------------hhhHhhccc-cC--C-CCCH-----HHHHHHHHHHHHhccCCCCCCCCHHHHHHHHHh
Q 005586          625 AAESA-----------------TFENFIDRN-LK--G-KFSE-----SEAAKLGKMALVCTHEDPENRPTMEAVIEELTV  678 (689)
Q Consensus       625 ~~~~~-----------------~~~~~~~~~-~~--~-~~~~-----~~~~~l~~l~~~Cl~~dp~~RPs~~evl~~L~~  678 (689)
                      .....                 .+.+.++.. ..  . ..+.     .....+.+++.+|++.||++||++.|++++.+.
T Consensus       378 ~~~~~~~~~~~~~~~~~p~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~li~kmL~~DP~~Rpsa~elL~hp~f  457 (501)
T PHA03210        378 KQLLKIIDSLSVCDEEFPDPPCKLFDYIDSAEIDHAGHSVPPLIRNLGLPADFEYPLVKMLTFDWHLRPGAAELLALPLF  457 (501)
T ss_pred             HHHHHHHHhcccChhhcCCcHHHHHHHhhhhhcccCccchhhHHHhcCCChHHHHHHHHHhccCcccCcCHHHHhhChhh
Confidence            00000                 000111100 00  0 0000     112356778899999999999999999988765


Q ss_pred             hC
Q 005586          679 AA  680 (689)
Q Consensus       679 ~~  680 (689)
                      ..
T Consensus       458 ~~  459 (501)
T PHA03210        458 SA  459 (501)
T ss_pred             hc
Confidence            43

>cd06633 STKc_TAO3 Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 3

Probab=100.00  E-value=1.3e-33  Score=296.66  Aligned_cols=248  Identities=19%  Similarity=0.357  Sum_probs=194.1

Q ss_pred             CCcccccccCCcceEEEEEec-CCcEEEEEEecccCC--chHHHHHHHHHHHHhccCCCcceeEeeEEEcCCCCeEEEEE
Q 005586          411 FSEVNLLGKGNFSSVYKGTLR-DGTLVAIRSINVTSC--KSEEAEFVKGLYLLTSLRHENIIRLRGFCCSRGRGECFLIY  487 (689)
Q Consensus       411 f~~~~~lg~G~~g~Vy~~~~~-~g~~vavK~l~~~~~--~~~~~~f~~e~~~l~~l~H~niv~l~g~~~~~~~~~~~lV~  487 (689)
                      |...+.||+|+||.||+|... +|..|++|++.....  ......+.+|++++++++|||++++++++.+  ....++||
T Consensus        23 ~~~~~~lg~g~~g~v~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~--~~~~~lv~  100 (313)
T cd06633          23 FVGLHEIGHGSFGAVYFATNSHTNEVVAVKKMSYSGKQTNEKWQDIIKEVKFLQQLKHPNTIEYKGCYLK--EHTAWLVM  100 (313)
T ss_pred             hhcceeeccCCCeEEEEEEECCCCcEEEEEEEeccccCchHHHHHHHHHHHHHHhCCCCCCccEEEEEEe--CCEEEEEE
Confidence            555678999999999999875 689999999875432  2334578899999999999999999999854  47789999


Q ss_pred             EcCCCCCHHHHhhhcCCCCCCCCHHHHHHHHHHHHHHHhhhhCCCCCCCceeecCCCCCceeecCCCCeEEecccccccc
Q 005586          488 DFAPKGKLSKYLDQEEGSSNVLDWSTRVSIIIGIAKGIGYLHSSEVNKPAIVHRNLSVEKVLIDQQFNPLIADCGLHKLL  567 (689)
Q Consensus       488 e~~~~gsL~~~L~~~~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~~~ivH~dlk~~NiLl~~~~~~kl~DfGla~~~  567 (689)
                      ||+. |++.+++....   ..++|.++..++.|++.||+|||+.+     ++||||||+||++++++.+||+|||++...
T Consensus       101 e~~~-~~l~~~l~~~~---~~l~~~~~~~~~~qi~~al~~LH~~g-----i~H~dl~p~nili~~~~~~kL~dfg~~~~~  171 (313)
T cd06633         101 EYCL-GSASDLLEVHK---KPLQEVEIAAITHGALQGLAYLHSHN-----MIHRDIKAGNILLTEPGQVKLADFGSASKS  171 (313)
T ss_pred             ecCC-CCHHHHHHhcC---CCCCHHHHHHHHHHHHHHHHHHHHCC-----eecCCCChhhEEECCCCCEEEeecCCCccc
Confidence            9995 68888876533   34899999999999999999999987     999999999999999999999999998654


Q ss_pred             cCCceeeeecCCCCCCCCCccccc---cCCCCCcccchhHHHHHHHHHhCCCCcchhHHHHHhhhhhhHhhccccCCCCC
Q 005586          568 ADDIVFSVLKTSAAMGYLAPEYVT---TGRFTERSDIFAFGVIILQILTGSLVLTSSMRLAAESATFENFIDRNLKGKFS  644 (689)
Q Consensus       568 ~~~~~~~~~~~~~~~~y~aPE~~~---~~~~~~ksDV~sfGvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~  644 (689)
                      ...     ....++..|+|||++.   ...++.++|||||||++|||++|+.|+.........    .............
T Consensus       172 ~~~-----~~~~~~~~y~aPE~~~~~~~~~~~~~sDv~slGvil~el~~g~~p~~~~~~~~~~----~~~~~~~~~~~~~  242 (313)
T cd06633         172 SPA-----NSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSAL----YHIAQNDSPTLQS  242 (313)
T ss_pred             CCC-----CCccccccccChhhccccCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCChHHHH----HHHHhcCCCCCCc
Confidence            321     1234677899999974   456889999999999999999999998653221111    1111111111112


Q ss_pred             HHHHHHHHHHHHHhccCCCCCCCCHHHHHHHHHh
Q 005586          645 ESEAAKLGKMALVCTHEDPENRPTMEAVIEELTV  678 (689)
Q Consensus       645 ~~~~~~l~~l~~~Cl~~dp~~RPs~~evl~~L~~  678 (689)
                      ......+.+++.+|++.+|++||++.+++.+-+.
T Consensus       243 ~~~~~~l~~li~~~l~~~P~~Rp~~~~~l~~~~~  276 (313)
T cd06633         243 NEWTDSFRGFVDYCLQKIPQERPASAELLRHDFV  276 (313)
T ss_pred             cccCHHHHHHHHHHccCChhhCcCHHHHhcCccc
Confidence            2334568899999999999999999999987443

Serine/threonine kinases (STKs), thousand-and-one amino acids 3 (TAO3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO3 is also known as JIK (JNK inhibitory kinase) or KFC (kinase from chicken). It specifically activates c-Jun N-terminal kinase (JNK), presumably by phosphorylating and activating MKK4/MKK7. In Saccharomyces cerevisiae, TAO3 is a co

>cd05581 STKc_PDK1 Catalytic domain of the Protein Serine/Threonine Kinase, Phosphoinositide-dependent kinase 1

Probab=100.00  E-value=3.3e-34  Score=295.75  Aligned_cols=250  Identities=24%  Similarity=0.356  Sum_probs=202.9

Q ss_pred             ccCCcccccccCCcceEEEEEec-CCcEEEEEEecccCC--chHHHHHHHHHHHHhccC-CCcceeEeeEEEcCCCCeEE
Q 005586          409 QCFSEVNLLGKGNFSSVYKGTLR-DGTLVAIRSINVTSC--KSEEAEFVKGLYLLTSLR-HENIIRLRGFCCSRGRGECF  484 (689)
Q Consensus       409 ~~f~~~~~lg~G~~g~Vy~~~~~-~g~~vavK~l~~~~~--~~~~~~f~~e~~~l~~l~-H~niv~l~g~~~~~~~~~~~  484 (689)
                      ++|...+.||+|+||.||+|..+ +|..||+|++.....  ......+.+|++++.+++ ||||+++++++.  ..+..+
T Consensus         1 ~~y~~~~~lg~g~~~~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~e~~~~~~l~~~~~i~~~~~~~~--~~~~~~   78 (280)
T cd05581           1 DDFKFGKIIGEGSFSTVVLAKEKETNKEYAIKILDKRQLIKEKKVKYVKIEKEVLTRLNGHPGIIKLYYTFQ--DEENLY   78 (280)
T ss_pred             CCceEeeeecCCCceEEEEEEEcCCCCEEEEEEechHhccchHHHHHHHHHHHHHHhcccCCCchhHHHHhc--CCceEE
Confidence            36777889999999999999976 799999999876432  234467889999999998 999999999884  457899


Q ss_pred             EEEEcCCCCCHHHHhhhcCCCCCCCCHHHHHHHHHHHHHHHhhhhCCCCCCCceeecCCCCCceeecCCCCeEEeccccc
Q 005586          485 LIYDFAPKGKLSKYLDQEEGSSNVLDWSTRVSIIIGIAKGIGYLHSSEVNKPAIVHRNLSVEKVLIDQQFNPLIADCGLH  564 (689)
Q Consensus       485 lV~e~~~~gsL~~~L~~~~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~~~ivH~dlk~~NiLl~~~~~~kl~DfGla  564 (689)
                      +||||+++++|.+++....    .+++..+..|+.|++.||+|||+.+     ++|+||||+||+++.++.++++|||++
T Consensus        79 lv~e~~~~~~L~~~l~~~~----~l~~~~~~~i~~ql~~~l~~Lh~~~-----~~H~dl~~~ni~i~~~~~~~l~df~~~  149 (280)
T cd05581          79 FVLEYAPNGELLQYIRKYG----SLDEKCTRFYAAEILLALEYLHSKG-----IIHRDLKPENILLDKDMHIKITDFGTA  149 (280)
T ss_pred             EEEcCCCCCcHHHHHHHcC----CCCHHHHHHHHHHHHHHHHHHHHCC-----eeecCCCHHHeEECCCCCEEecCCccc
Confidence            9999999999999997653    4899999999999999999999987     999999999999999999999999998


Q ss_pred             ccccCCce-------------------eeeecCCCCCCCCCccccccCCCCCcccchhHHHHHHHHHhCCCCcchhHHHH
Q 005586          565 KLLADDIV-------------------FSVLKTSAAMGYLAPEYVTTGRFTERSDIFAFGVIILQILTGSLVLTSSMRLA  625 (689)
Q Consensus       565 ~~~~~~~~-------------------~~~~~~~~~~~y~aPE~~~~~~~~~ksDV~sfGvvl~elltG~~p~~~~~~~~  625 (689)
                      ........                   .......++..|+|||......++.++||||||++++|+++|+.|+.......
T Consensus       150 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Pe~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~  229 (280)
T cd05581         150 KVLDPNSSPESNKGDATNIDSQIEKNRRRFASFVGTAEYVSPELLNEKPAGKSSDLWALGCIIYQMLTGKPPFRGSNEYL  229 (280)
T ss_pred             cccCCccccccCCCCCccccccccccccccccccCCccccCHHHhCCCCCChhhhHHHHHHHHHHHHhCCCCCCCccHHH
Confidence            86644321                   11112235678999999988889999999999999999999999986543211


Q ss_pred             HhhhhhhHhhccccCCCCCHHHHHHHHHHHHHhccCCCCCCCCH----HHHHHH
Q 005586          626 AESATFENFIDRNLKGKFSESEAAKLGKMALVCTHEDPENRPTM----EAVIEE  675 (689)
Q Consensus       626 ~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~Cl~~dp~~RPs~----~evl~~  675 (689)
                          .+.....  .....+......+.+++.+|++.+|++||++    +|++++
T Consensus       230 ----~~~~~~~--~~~~~~~~~~~~~~~li~~~l~~~p~~R~~~~~~~~~ll~~  277 (280)
T cd05581         230 ----TFQKILK--LEYSFPPNFPPDAKDLIEKLLVLDPQDRLGVNEGYDELKAH  277 (280)
T ss_pred             ----HHHHHHh--cCCCCCCccCHHHHHHHHHHhcCCHhhCCCcccCHHHHhcC
Confidence                1122221  1223444456789999999999999999999    887765

Serine/Threonine Kinases (STKs), Phosphoinositide-dependent kinase 1 (PDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PDK1 carries an N-terminal catalytic domain and a C-terminal pleckstrin homology (PH) domain that binds phosphoinositides. It phosphorylates the activation loop of AGC kinases that are regulated by PI3K such as PKB, SGK, and PKC, among others, and is crucial for their activation. Thus, it contributes in regulating many processes including metabolism, growth, proliferation, and survival. PDK1 also has the ability to auto

>cd07877 STKc_p38alpha_MAPK14 Catalytic domain of the Serine/Threonine Kinase, p38alpha Mitogen-Activated Protein Kinase

Probab=100.00  E-value=8.3e-34  Score=302.23  Aligned_cols=265  Identities=20%  Similarity=0.297  Sum_probs=201.8

Q ss_pred             CHHHHHHHhccCCcccccccCCcceEEEEEec-CCcEEEEEEecccCC-chHHHHHHHHHHHHhccCCCcceeEeeEEEc
Q 005586          400 NLEEVESATQCFSEVNLLGKGNFSSVYKGTLR-DGTLVAIRSINVTSC-KSEEAEFVKGLYLLTSLRHENIIRLRGFCCS  477 (689)
Q Consensus       400 ~~~~l~~at~~f~~~~~lg~G~~g~Vy~~~~~-~g~~vavK~l~~~~~-~~~~~~f~~e~~~l~~l~H~niv~l~g~~~~  477 (689)
                      ...++..++++|...+.||+|+||.||+|... +|+.||+|++..... ......+.+|+.++.+++||||+++++++..
T Consensus         8 ~~~~~~~~~~~y~~~~~lg~G~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~Ei~~l~~l~h~~iv~~~~~~~~   87 (345)
T cd07877           8 LNKTIWEVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDVFTP   87 (345)
T ss_pred             HHHHHhhccCceEEEEEeeecCCeEEEEEEEcCCCeEEEEEEecCcchhhHHHHHHHHHHHHHHHcCCCcccceeeeeee
Confidence            34567778899999999999999999999864 789999999975432 2234578899999999999999999998743


Q ss_pred             CC----CCeEEEEEEcCCCCCHHHHhhhcCCCCCCCCHHHHHHHHHHHHHHHhhhhCCCCCCCceeecCCCCCceeecCC
Q 005586          478 RG----RGECFLIYDFAPKGKLSKYLDQEEGSSNVLDWSTRVSIIIGIAKGIGYLHSSEVNKPAIVHRNLSVEKVLIDQQ  553 (689)
Q Consensus       478 ~~----~~~~~lV~e~~~~gsL~~~L~~~~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~~~ivH~dlk~~NiLl~~~  553 (689)
                      ..    ....+++++++ +++|.+++...     .+++..+..++.|+++||+|||+.+     |+||||||+||+++++
T Consensus        88 ~~~~~~~~~~~lv~~~~-~~~L~~~~~~~-----~l~~~~~~~i~~qi~~aL~~LH~~~-----ivH~dlkp~NIll~~~  156 (345)
T cd07877          88 ARSLEEFNDVYLVTHLM-GADLNNIVKCQ-----KLTDDHVQFLIYQILRGLKYIHSAD-----IIHRDLKPSNLAVNED  156 (345)
T ss_pred             cccccccccEEEEehhc-ccCHHHHHhcC-----CCCHHHHHHHHHHHHHHHHHHHHCC-----eeecCCChHHEEEcCC
Confidence            21    23467888877 78998887643     3899999999999999999999987     9999999999999999


Q ss_pred             CCeEEecccccccccCCceeeeecCCCCCCCCCcccccc-CCCCCcccchhHHHHHHHHHhCCCCcchhHHHHHhhh---
Q 005586          554 FNPLIADCGLHKLLADDIVFSVLKTSAAMGYLAPEYVTT-GRFTERSDIFAFGVIILQILTGSLVLTSSMRLAAESA---  629 (689)
Q Consensus       554 ~~~kl~DfGla~~~~~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~ksDV~sfGvvl~elltG~~p~~~~~~~~~~~~---  629 (689)
                      +.+||+|||+++......    ....++..|+|||.+.+ ..++.++|||||||++|||++|+.|+...........   
T Consensus       157 ~~~kl~dfg~~~~~~~~~----~~~~~~~~y~aPE~~~~~~~~~~~~DvwslG~il~el~~g~~pf~~~~~~~~~~~~~~  232 (345)
T cd07877         157 CELKILDFGLARHTDDEM----TGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILR  232 (345)
T ss_pred             CCEEEecccccccccccc----cccccCCCccCHHHHhCccCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHH
Confidence            999999999988654321    22346778999998766 4678999999999999999999999853211100000   


Q ss_pred             --------hh--------hHhh---ccccCCCC---CHHHHHHHHHHHHHhccCCCCCCCCHHHHHHHHHhh
Q 005586          630 --------TF--------ENFI---DRNLKGKF---SESEAAKLGKMALVCTHEDPENRPTMEAVIEELTVA  679 (689)
Q Consensus       630 --------~~--------~~~~---~~~~~~~~---~~~~~~~l~~l~~~Cl~~dp~~RPs~~evl~~L~~~  679 (689)
                              ..        ..++   .......+   ......++.+++..|++.||++||++.+++.+-+..
T Consensus       233 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~t~~e~l~h~~f~  304 (345)
T cd07877         233 LVGTPGAELLKKISSESARNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAHAYFA  304 (345)
T ss_pred             HhCCCCHHHHhhcccHhHHHHHHHhcccCCcchhhhcCCCCHHHHHHHHHHcCCChhhcCCHHHHhcChhhh
Confidence                    00        0000   00000000   011245688999999999999999999999886544

Serine/Threonine Kinases (STKs), p38alpha subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38alpha subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38alpha, also called MAPK14

>cd07856 STKc_Sty1_Hog1 Catalytic domain of the Serine/Threonine Kinases, Fungal Mitogen-Activated Protein Kinases Sty1 and Hog1

Probab=100.00  E-value=9.6e-34  Score=299.46  Aligned_cols=259  Identities=22%  Similarity=0.313  Sum_probs=199.4

Q ss_pred             HHHHhccCCcccccccCCcceEEEEEec-CCcEEEEEEecccCC-chHHHHHHHHHHHHhccCCCcceeEeeEEEcCCCC
Q 005586          404 VESATQCFSEVNLLGKGNFSSVYKGTLR-DGTLVAIRSINVTSC-KSEEAEFVKGLYLLTSLRHENIIRLRGFCCSRGRG  481 (689)
Q Consensus       404 l~~at~~f~~~~~lg~G~~g~Vy~~~~~-~g~~vavK~l~~~~~-~~~~~~f~~e~~~l~~l~H~niv~l~g~~~~~~~~  481 (689)
                      +..++++|+..+.||+|+||.||+|... +|+.||+|++..... ....+.+.+|++++.+++||||+++++++... ..
T Consensus         5 ~~~~~~~y~~~~~ig~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~-~~   83 (328)
T cd07856           5 VFEITNRYVDLQPVGMGAFGLVCSARDQLTGQNVAIKKIMKPFSTPVLAKRTYRELKLLKHLRHENIISLSDIFISP-LE   83 (328)
T ss_pred             eeccccceEEEEeecccCCeEEEEEEECCCCCEEEEEEecccccccchhHHHHHHHHHHHhcCCCCeeeEeeeEecC-CC
Confidence            3456788999999999999999999865 799999998865322 23446788999999999999999999988543 35


Q ss_pred             eEEEEEEcCCCCCHHHHhhhcCCCCCCCCHHHHHHHHHHHHHHHhhhhCCCCCCCceeecCCCCCceeecCCCCeEEecc
Q 005586          482 ECFLIYDFAPKGKLSKYLDQEEGSSNVLDWSTRVSIIIGIAKGIGYLHSSEVNKPAIVHRNLSVEKVLIDQQFNPLIADC  561 (689)
Q Consensus       482 ~~~lV~e~~~~gsL~~~L~~~~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~~~ivH~dlk~~NiLl~~~~~~kl~Df  561 (689)
                      ..++|+||+ +++|.++++..     .+++.....++.|+++||+|||+.+     |+||||||+||++++++.+||+||
T Consensus        84 ~~~lv~e~~-~~~L~~~~~~~-----~~~~~~~~~~~~ql~~aL~~LH~~~-----iiH~dl~p~Nili~~~~~~~l~df  152 (328)
T cd07856          84 DIYFVTELL-GTDLHRLLTSR-----PLEKQFIQYFLYQILRGLKYVHSAG-----VVHRDLKPSNILINENCDLKICDF  152 (328)
T ss_pred             cEEEEeehh-ccCHHHHHhcC-----CCCHHHHHHHHHHHHHHHHHHHhCC-----cccCCCCHHHEeECCCCCEEeCcc
Confidence            688999999 56899888643     3788888899999999999999987     999999999999999999999999


Q ss_pred             cccccccCCceeeeecCCCCCCCCCcccccc-CCCCCcccchhHHHHHHHHHhCCCCcchhHHHHHhh---h--------
Q 005586          562 GLHKLLADDIVFSVLKTSAAMGYLAPEYVTT-GRFTERSDIFAFGVIILQILTGSLVLTSSMRLAAES---A--------  629 (689)
Q Consensus       562 Gla~~~~~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~ksDV~sfGvvl~elltG~~p~~~~~~~~~~~---~--------  629 (689)
                      |+++......    ....++..|+|||++.+ ..++.++|||||||++|||+||+.||..........   .        
T Consensus       153 g~~~~~~~~~----~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~el~tg~~~f~~~~~~~~~~~~~~~~~~~~~~  228 (328)
T cd07856         153 GLARIQDPQM----TGYVSTRYYRAPEIMLTWQKYDVEVDIWSAGCIFAEMLEGKPLFPGKDHVNQFSIITDLLGTPPDD  228 (328)
T ss_pred             ccccccCCCc----CCCcccccccCceeeeccCCcCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHH
Confidence            9987653321    12345678999998766 568999999999999999999999985432110000   0        


Q ss_pred             --------hhhHhhcc-ccCCCCCH-----HHHHHHHHHHHHhccCCCCCCCCHHHHHHHHHh
Q 005586          630 --------TFENFIDR-NLKGKFSE-----SEAAKLGKMALVCTHEDPENRPTMEAVIEELTV  678 (689)
Q Consensus       630 --------~~~~~~~~-~~~~~~~~-----~~~~~l~~l~~~Cl~~dp~~RPs~~evl~~L~~  678 (689)
                              ...+++.. ......+.     .....+.+++.+|++.+|++||++.+++.+-+.
T Consensus       229 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~t~~ell~~~~~  291 (328)
T cd07856         229 VINTICSENTLRFVQSLPKREPVPFSEKFKNADPSAIDLLEKMLVFDPQKRISAAEALAHPYL  291 (328)
T ss_pred             HHHhccchhhHHHHhhccccCCCcHHHHcCCCCHHHHHHHHHHcCCChhhCCCHHHHhcCCcc
Confidence                    00000000 00111111     234678999999999999999999999988544

Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) Sty1/Hog1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sty1/Hog1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs Sty1 from Schizosaccharomyces pombe, Hog1 from Saccharomyces cerevisiae, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. Sty1 and Hog1 are stress-activated MAPKs that partipate in transcriptional regulation in response to stress. Sty1 is activated in response to oxidative stress, osmotic stress, and U

>cd07834 STKc_MAPK Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase

Probab=100.00  E-value=4.6e-34  Score=302.49  Aligned_cols=260  Identities=22%  Similarity=0.322  Sum_probs=200.6

Q ss_pred             cCCcccccccCCcceEEEEEec-CCcEEEEEEecccCC-chHHHHHHHHHHHHhccCCCcceeEeeEEEcCC---CCeEE
Q 005586          410 CFSEVNLLGKGNFSSVYKGTLR-DGTLVAIRSINVTSC-KSEEAEFVKGLYLLTSLRHENIIRLRGFCCSRG---RGECF  484 (689)
Q Consensus       410 ~f~~~~~lg~G~~g~Vy~~~~~-~g~~vavK~l~~~~~-~~~~~~f~~e~~~l~~l~H~niv~l~g~~~~~~---~~~~~  484 (689)
                      +|...+.||+|+||.||+|+.. +|..||+|++..... ....+.+.+|++++++++|+||+++++++....   ....+
T Consensus         1 ~y~i~~~ig~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~~~~   80 (330)
T cd07834           1 RYELLKPIGSGAYGVVCSAVDKRTGRKVAIKKISNVFDDLIDAKRILREIKLLRHLRHENIIGLLDILRPPSPEDFNDVY   80 (330)
T ss_pred             CceeeeeecCCCCeEEEEEEeCCCCcEEEEEeeccccccchhhhhHHHHHHHHHhcCCcchhhhhhhhcccCcccccceE
Confidence            4677889999999999999976 589999999876542 334567999999999999999999999885432   13689


Q ss_pred             EEEEcCCCCCHHHHhhhcCCCCCCCCHHHHHHHHHHHHHHHhhhhCCCCCCCceeecCCCCCceeecCCCCeEEeccccc
Q 005586          485 LIYDFAPKGKLSKYLDQEEGSSNVLDWSTRVSIIIGIAKGIGYLHSSEVNKPAIVHRNLSVEKVLIDQQFNPLIADCGLH  564 (689)
Q Consensus       485 lV~e~~~~gsL~~~L~~~~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~~~ivH~dlk~~NiLl~~~~~~kl~DfGla  564 (689)
                      +||||++ ++|.+++....    .+++..+..++.|++.||+|||+.+     |+||||||.||++++++.++|+|||++
T Consensus        81 lv~e~~~-~~l~~~l~~~~----~l~~~~~~~i~~~l~~~l~~LH~~g-----i~H~dlkp~nili~~~~~~~L~dfg~~  150 (330)
T cd07834          81 IVTELME-TDLHKVIKSPQ----PLTDDHIQYFLYQILRGLKYLHSAN-----VIHRDLKPSNILVNSNCDLKICDFGLA  150 (330)
T ss_pred             EEecchh-hhHHHHHhCCC----CCCHHHHHHHHHHHHHHHHHHHhCC-----eecCCCCHHHEEEcCCCCEEEcccCce
Confidence            9999997 58998887543    5899999999999999999999987     999999999999999999999999999


Q ss_pred             ccccCCce--eeeecCCCCCCCCCccccccC-CCCCcccchhHHHHHHHHHhCCCCcchhHHHHHhhhhh----------
Q 005586          565 KLLADDIV--FSVLKTSAAMGYLAPEYVTTG-RFTERSDIFAFGVIILQILTGSLVLTSSMRLAAESATF----------  631 (689)
Q Consensus       565 ~~~~~~~~--~~~~~~~~~~~y~aPE~~~~~-~~~~ksDV~sfGvvl~elltG~~p~~~~~~~~~~~~~~----------  631 (689)
                      ........  .......++..|+|||.+.+. .++.++||||||+++|||++|+.||.............          
T Consensus       151 ~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~sDi~slG~il~~l~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~  230 (330)
T cd07834         151 RGVDPDEDEKGFLTEYVVTRWYRAPELLLSSSRYTKAIDIWSVGCIFAELLTRKPLFPGRDYIDQLNLIVEVLGTPSEED  230 (330)
T ss_pred             EeecccccccccccccccccCcCCceeeecccCCCcchhHHHHHHHHHHHHcCCCCcCCCCHHHHHHHHHHhcCCCChhH
Confidence            87654321  111223456779999999887 78999999999999999999999986432211100000          


Q ss_pred             ---------hHhhcc-ccCCC-----CCHHHHHHHHHHHHHhccCCCCCCCCHHHHHHHHHhh
Q 005586          632 ---------ENFIDR-NLKGK-----FSESEAAKLGKMALVCTHEDPENRPTMEAVIEELTVA  679 (689)
Q Consensus       632 ---------~~~~~~-~~~~~-----~~~~~~~~l~~l~~~Cl~~dp~~RPs~~evl~~L~~~  679 (689)
                               .+.+.. .....     ........+.+++.+||+.+|++||++.+++++.+..
T Consensus       231 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~ll~~~~~~  293 (330)
T cd07834         231 LKFITSEKARNYLKSLPKKPKKPLSKLFPGASPEAIDLLEKMLVFDPKKRITADEALAHPYLA  293 (330)
T ss_pred             hhhccccchhhHHhhcccCCcchhHHhcccCCHHHHHHHHHHccCChhhCCCHHHHHhCccHH
Confidence                     000000 00000     0112356789999999999999999999999885443

Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs serve as important mediators of cellular responses to extracellular signals. They control critical cellular functions including differentiation, proliferation, migration, and apoptosis. They are also implicated in the pathogenesis of many diseases including multiple types of cancer, stroke, diabetes, and chronic inflammation. Typical MAPK pathways involve a triple kinase core cascade comprising of the MAPK, which is phosphorylated and

>cd07866 STKc_BUR1 Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Bypass UAS Requirement 1 and similar proteins

Probab=100.00  E-value=1.1e-33  Score=296.61  Aligned_cols=260  Identities=22%  Similarity=0.331  Sum_probs=194.0

Q ss_pred             hccCCcccccccCCcceEEEEEec-CCcEEEEEEecccCCch-HHHHHHHHHHHHhccCCCcceeEeeEEEcCC------
Q 005586          408 TQCFSEVNLLGKGNFSSVYKGTLR-DGTLVAIRSINVTSCKS-EEAEFVKGLYLLTSLRHENIIRLRGFCCSRG------  479 (689)
Q Consensus       408 t~~f~~~~~lg~G~~g~Vy~~~~~-~g~~vavK~l~~~~~~~-~~~~f~~e~~~l~~l~H~niv~l~g~~~~~~------  479 (689)
                      .++|...+.||+|+||.||+|..+ +++.||+|++....... ....+.+|++++.+++||||+++++++....      
T Consensus         7 ~~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~~   86 (311)
T cd07866           7 LRDYEILGKLGEGTFGEVYKARQIKTGRVVALKKILMHNEKDGFPITALREIKILKKLKHPNVVPLIDMAVERPDKSKRK   86 (311)
T ss_pred             cccEEEEEEeccCCCEEEEEEEECCCCcEEEEEEEEeccCCCCcchhHHHHHHHHHhcCCCCccchhhheeccccccccc
Confidence            357888899999999999999976 68999999986543222 2346778999999999999999999875432      


Q ss_pred             CCeEEEEEEcCCCCCHHHHhhhcCCCCCCCCHHHHHHHHHHHHHHHhhhhCCCCCCCceeecCCCCCceeecCCCCeEEe
Q 005586          480 RGECFLIYDFAPKGKLSKYLDQEEGSSNVLDWSTRVSIIIGIAKGIGYLHSSEVNKPAIVHRNLSVEKVLIDQQFNPLIA  559 (689)
Q Consensus       480 ~~~~~lV~e~~~~gsL~~~L~~~~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~~~ivH~dlk~~NiLl~~~~~~kl~  559 (689)
                      ....++|+||++. +|...+....   ..+++..+..++.|+++||+|||+.+     |+||||||+||++++++.+||+
T Consensus        87 ~~~~~lv~~~~~~-~l~~~~~~~~---~~~~~~~~~~i~~~l~~al~~lH~~~-----i~H~dl~p~nil~~~~~~~~l~  157 (311)
T cd07866          87 RGSVYMVTPYMDH-DLSGLLENPS---VKLTESQIKCYMLQLLEGINYLHENH-----ILHRDIKAANILIDNQGILKIA  157 (311)
T ss_pred             CceEEEEEecCCc-CHHHHHhccc---cCCCHHHHHHHHHHHHHHHHHHHhCC-----eecCCCCHHHEEECCCCCEEEC
Confidence            2357999999964 7877776532   24899999999999999999999987     9999999999999999999999


Q ss_pred             cccccccccCCceee----------eecCCCCCCCCCccccccC-CCCCcccchhHHHHHHHHHhCCCCcchhHHHHHhh
Q 005586          560 DCGLHKLLADDIVFS----------VLKTSAAMGYLAPEYVTTG-RFTERSDIFAFGVIILQILTGSLVLTSSMRLAAES  628 (689)
Q Consensus       560 DfGla~~~~~~~~~~----------~~~~~~~~~y~aPE~~~~~-~~~~ksDV~sfGvvl~elltG~~p~~~~~~~~~~~  628 (689)
                      |||+++.........          .....++..|+|||.+.+. .++.++|||||||++|||++|+.|+..........
T Consensus       158 dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~el~~g~~~~~~~~~~~~~~  237 (311)
T cd07866         158 DFGLARPYDGPPPNPKGGGGGGTRKYTNLVVTRWYRPPELLLGERRYTTAVDIWGIGCVFAEMFTRRPILQGKSDIDQLH  237 (311)
T ss_pred             cCccchhccCCCcccccCCcccccccccceeccCcCChHHhhCCCccCchhHhHHHHHHHHHHHhCCCCCCCCCHHHHHH
Confidence            999998654322111          1122346679999987654 57899999999999999999999986432211111


Q ss_pred             hhhh-----------------HhhccccCCCCC-------HHHHHHHHHHHHHhccCCCCCCCCHHHHHHHH
Q 005586          629 ATFE-----------------NFIDRNLKGKFS-------ESEAAKLGKMALVCTHEDPENRPTMEAVIEEL  676 (689)
Q Consensus       629 ~~~~-----------------~~~~~~~~~~~~-------~~~~~~l~~l~~~Cl~~dp~~RPs~~evl~~L  676 (689)
                      ..+.                 ...+.......+       ......+.+++.+|++.||++||++.|++.+-
T Consensus       238 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~p~~R~t~~ell~~~  309 (311)
T cd07866         238 LIFKLCGTPTEETWPGWRSLPGCEGVHSFTNYPRTLEERFGKLGPEGLDLLSKLLSLDPYKRLTASDALEHP  309 (311)
T ss_pred             HHHHHhCCCChhhchhhhhcccccccccCCCCCccHHHHcccCChhHHHHHHHHcccCcccCcCHHHHhcCC
Confidence            0000                 000000000011       11235688999999999999999999998753

Serine/Threonine Kinases (STKs), Bypass UAS Requirement 1 (BUR1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The BUR1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. BUR1, also called SGV1, is a yeast Cyclin-Dependent protein Kinase (CDK) that is functionally equivalent to mammalian CDK9. It associates with the cyclin BUR2. BUR genes were orginally identified in a genetic

>cd07829 STKc_CDK_like Catalytic domain of Cyclin-Dependent protein Kinase-like Serine/Threonine Kinases

Probab=100.00  E-value=9.2e-34  Score=292.85  Aligned_cols=254  Identities=21%  Similarity=0.387  Sum_probs=196.4

Q ss_pred             CCcccccccCCcceEEEEEec-CCcEEEEEEecccCC-chHHHHHHHHHHHHhccCCCcceeEeeEEEcCCCCeEEEEEE
Q 005586          411 FSEVNLLGKGNFSSVYKGTLR-DGTLVAIRSINVTSC-KSEEAEFVKGLYLLTSLRHENIIRLRGFCCSRGRGECFLIYD  488 (689)
Q Consensus       411 f~~~~~lg~G~~g~Vy~~~~~-~g~~vavK~l~~~~~-~~~~~~f~~e~~~l~~l~H~niv~l~g~~~~~~~~~~~lV~e  488 (689)
                      |+..+.||+|+||.||+|+.. +++.||+|.+..... ......+..|+.++++++|+|++++++++.+  .+..++|||
T Consensus         1 y~~~~~ig~g~~~~vy~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~--~~~~~~v~e   78 (282)
T cd07829           1 YEKLEKLGEGTYGVVYKARDKKTGEIVALKKIRLDNEEEGIPSTALREISLLKELKHPNIVKLLDVIHT--ERKLYLVFE   78 (282)
T ss_pred             CeeehcccccCcceEEEeeecCCCcEEEEEEeccccccccccHHHHHHHHHHHhcCCCCHHHHHhhhhc--CCceEEEec
Confidence            445678999999999999976 599999999986542 2234678899999999999999999999854  478999999


Q ss_pred             cCCCCCHHHHhhhcCCCCCCCCHHHHHHHHHHHHHHHhhhhCCCCCCCceeecCCCCCceeecCCCCeEEeccccccccc
Q 005586          489 FAPKGKLSKYLDQEEGSSNVLDWSTRVSIIIGIAKGIGYLHSSEVNKPAIVHRNLSVEKVLIDQQFNPLIADCGLHKLLA  568 (689)
Q Consensus       489 ~~~~gsL~~~L~~~~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~~~ivH~dlk~~NiLl~~~~~~kl~DfGla~~~~  568 (689)
                      |++ ++|.+++....   ..+++..+..++.++++||+|||+.+     |+||||+|+||++++++.+||+|||+++...
T Consensus        79 ~~~-~~l~~~i~~~~---~~~~~~~~~~~~~~i~~~l~~LH~~~-----i~H~~l~~~ni~~~~~~~~~l~d~g~~~~~~  149 (282)
T cd07829          79 YCD-MDLKKYLDKRP---GPLSPNLIKSIMYQLLRGLAYCHSHR-----ILHRDLKPQNILINRDGVLKLADFGLARAFG  149 (282)
T ss_pred             CcC-cCHHHHHHhhc---cCCCHHHHHHHHHHHHHHHHHHHHCC-----cccCCCChheEEEcCCCCEEEecCCcccccC
Confidence            997 59999998653   24899999999999999999999987     9999999999999999999999999998764


Q ss_pred             CCceeeeecCCCCCCCCCccccccC-CCCCcccchhHHHHHHHHHhCCCCcchhHHHHHhhh-----------hhhHhh-
Q 005586          569 DDIVFSVLKTSAAMGYLAPEYVTTG-RFTERSDIFAFGVIILQILTGSLVLTSSMRLAAESA-----------TFENFI-  635 (689)
Q Consensus       569 ~~~~~~~~~~~~~~~y~aPE~~~~~-~~~~ksDV~sfGvvl~elltG~~p~~~~~~~~~~~~-----------~~~~~~-  635 (689)
                      .... .......+..|+|||.+.+. .++.++|||||||++|||++|+.|+...........           .+..+. 
T Consensus       150 ~~~~-~~~~~~~~~~~~aPE~~~~~~~~~~~~Dv~slG~~l~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  228 (282)
T cd07829         150 IPLR-TYTHEVVTLWYRAPEILLGSKHYSTAVDIWSVGCIFAEMITGKPLFPGDSEIDQLFKIFQILGTPTEESWPGVTK  228 (282)
T ss_pred             CCcc-ccCccccCcCcCChHHhcCCcCCCccccHHHHHHHHHHHHhCCCCCCCccHHHHHHHHHHHhCCCcHHHHHhhcc
Confidence            4321 11223345679999998776 789999999999999999999999865322111000           000000 


Q ss_pred             ----ccccCC-------CCCHHHHHHHHHHHHHhccCCCCCCCCHHHHHHHH
Q 005586          636 ----DRNLKG-------KFSESEAAKLGKMALVCTHEDPENRPTMEAVIEEL  676 (689)
Q Consensus       636 ----~~~~~~-------~~~~~~~~~l~~l~~~Cl~~dp~~RPs~~evl~~L  676 (689)
                          +.....       .........+.+++..|++.+|++||++.+++.+-
T Consensus       229 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rp~~~~~l~~p  280 (282)
T cd07829         229 LPDYKPTFPKFPPKDLEKVLPRLDPEGIDLLSKMLQYNPAKRISAKEALKHP  280 (282)
T ss_pred             cccccccccccCccchHHhcccccHHHHHHHHHhhccCcccCCCHHHHhhCc
Confidence                000000       00011256799999999999999999999998764

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase (CDK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKs are partly regulated by their subcellular localization, which defines substrate phosphorylation and the resulting specific function. CDK1, CDK2, CDK4, and CDK6 have well-defined functions in the cell cycle, such as the regulation of the

>cd07880 STKc_p38gamma_MAPK12 Catalytic domain of the Serine/Threonine Kinase, p38gamma Mitogen-Activated Protein Kinase

Probab=100.00  E-value=1.4e-33  Score=300.14  Aligned_cols=257  Identities=21%  Similarity=0.330  Sum_probs=196.7

Q ss_pred             HHhccCCcccccccCCcceEEEEEec-CCcEEEEEEecccCC-chHHHHHHHHHHHHhccCCCcceeEeeEEEcCCC---
Q 005586          406 SATQCFSEVNLLGKGNFSSVYKGTLR-DGTLVAIRSINVTSC-KSEEAEFVKGLYLLTSLRHENIIRLRGFCCSRGR---  480 (689)
Q Consensus       406 ~at~~f~~~~~lg~G~~g~Vy~~~~~-~g~~vavK~l~~~~~-~~~~~~f~~e~~~l~~l~H~niv~l~g~~~~~~~---  480 (689)
                      ...++|+..+.||+|+||.||+|... +|..||||++..... ......+.+|++++.+++||||+++++++.....   
T Consensus        12 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~   91 (343)
T cd07880          12 EVPDRYRDLKQVGSGAYGTVCSALDRRTGAKVAIKKLYRPFQSELFAKRAYRELRLLKHMKHENVIGLLDVFTPDLSLDR   91 (343)
T ss_pred             ccccceEEEEEeeecCCeEEEEEEECCCCcEEEEEEecccccchHHHHHHHHHHHHHHhcCCCCccceeeeecCCccccc
Confidence            34678999999999999999999865 799999999865332 2234568899999999999999999998854321   


Q ss_pred             -CeEEEEEEcCCCCCHHHHhhhcCCCCCCCCHHHHHHHHHHHHHHHhhhhCCCCCCCceeecCCCCCceeecCCCCeEEe
Q 005586          481 -GECFLIYDFAPKGKLSKYLDQEEGSSNVLDWSTRVSIIIGIAKGIGYLHSSEVNKPAIVHRNLSVEKVLIDQQFNPLIA  559 (689)
Q Consensus       481 -~~~~lV~e~~~~gsL~~~L~~~~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~~~ivH~dlk~~NiLl~~~~~~kl~  559 (689)
                       ...++||||+ +++|.+++...     .+++..+..++.|+++||+|||+.+     |+||||||+||++++++.+||+
T Consensus        92 ~~~~~lv~e~~-~~~l~~~~~~~-----~l~~~~~~~i~~qi~~al~~LH~~g-----i~H~dlkp~Nill~~~~~~kl~  160 (343)
T cd07880          92 FHDFYLVMPFM-GTDLGKLMKHE-----KLSEDRIQFLVYQMLKGLKYIHAAG-----IIHRDLKPGNLAVNEDCELKIL  160 (343)
T ss_pred             cceEEEEEecC-CCCHHHHHhcC-----CCCHHHHHHHHHHHHHHHHHHHhCC-----eecCCCCHHHEEEcCCCCEEEe
Confidence             2468999999 77999888642     3899999999999999999999987     9999999999999999999999


Q ss_pred             cccccccccCCceeeeecCCCCCCCCCcccccc-CCCCCcccchhHHHHHHHHHhCCCCcchhHHHHHhhhh--------
Q 005586          560 DCGLHKLLADDIVFSVLKTSAAMGYLAPEYVTT-GRFTERSDIFAFGVIILQILTGSLVLTSSMRLAAESAT--------  630 (689)
Q Consensus       560 DfGla~~~~~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~ksDV~sfGvvl~elltG~~p~~~~~~~~~~~~~--------  630 (689)
                      |||+++......    ....++..|+|||.+.+ ..++.++|||||||++||+++|+.||............        
T Consensus       161 dfg~~~~~~~~~----~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~ll~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~  236 (343)
T cd07880         161 DFGLARQTDSEM----TGYVVTRWYRAPEVILNWMHYTQTVDIWSVGCIMAEMLTGKPLFKGHDHLDQLMEIMKVTGTPS  236 (343)
T ss_pred             ecccccccccCc----cccccCCcccCHHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCC
Confidence            999998664322    22345778999998875 45889999999999999999999999643211110000        


Q ss_pred             --hh---------Hhhcc--ccCC----CCCHHHHHHHHHHHHHhccCCCCCCCCHHHHHHHHH
Q 005586          631 --FE---------NFIDR--NLKG----KFSESEAAKLGKMALVCTHEDPENRPTMEAVIEELT  677 (689)
Q Consensus       631 --~~---------~~~~~--~~~~----~~~~~~~~~l~~l~~~Cl~~dp~~RPs~~evl~~L~  677 (689)
                        +.         .....  ....    ........++.+++.+|++.||++||++.+++++-+
T Consensus       237 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~R~t~~~~l~~~~  300 (343)
T cd07880         237 KEFVQKLQSEDAKNYVKKLPRFRKKDFRSLLPNANPLAVNVLEKMLVLDAESRITAAEALAHPY  300 (343)
T ss_pred             HHHHHhhcchhHHHHHHhccccCcchHHHhccCCChHHHHHHHHHcCCChhhCCCHHHHhcCcc
Confidence              00         00000  0000    001123456889999999999999999999997643

Serine/Threonine Kinases (STKs), p38gamma subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38gamma subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38gamma, also called MAPK12

>PTZ00024 cyclin-dependent protein kinase; Provisional

Probab=100.00  E-value=2.7e-33  Score=297.24  Aligned_cols=253  Identities=21%  Similarity=0.289  Sum_probs=191.4

Q ss_pred             ccccccCCcceEEEEEec-CCcEEEEEEecccCCch-------------HHHHHHHHHHHHhccCCCcceeEeeEEEcCC
Q 005586          414 VNLLGKGNFSSVYKGTLR-DGTLVAIRSINVTSCKS-------------EEAEFVKGLYLLTSLRHENIIRLRGFCCSRG  479 (689)
Q Consensus       414 ~~~lg~G~~g~Vy~~~~~-~g~~vavK~l~~~~~~~-------------~~~~f~~e~~~l~~l~H~niv~l~g~~~~~~  479 (689)
                      .+.||+|+||.||+|..+ +++.||||++.......             ....+.+|++++.+++|+||+++++++..  
T Consensus        14 ~~~ig~G~~g~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~--   91 (335)
T PTZ00024         14 GAHLGEGTYGKVEKAYDTLTGKIVAIKKVKIIEISNDVTKDRQLVGMCGIHFTTLRELKIMNEIKHENIMGLVDVYVE--   91 (335)
T ss_pred             hhcccCCCceeEEEEEECCCCCeEEEEEeeccccccccccchhhhcccccchhHHHHHHHHHhCCCcceeeeeEEEec--
Confidence            467999999999999975 68999999986543211             01257899999999999999999999854  


Q ss_pred             CCeEEEEEEcCCCCCHHHHhhhcCCCCCCCCHHHHHHHHHHHHHHHhhhhCCCCCCCceeecCCCCCceeecCCCCeEEe
Q 005586          480 RGECFLIYDFAPKGKLSKYLDQEEGSSNVLDWSTRVSIIIGIAKGIGYLHSSEVNKPAIVHRNLSVEKVLIDQQFNPLIA  559 (689)
Q Consensus       480 ~~~~~lV~e~~~~gsL~~~L~~~~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~~~ivH~dlk~~NiLl~~~~~~kl~  559 (689)
                      .+..++||||++ |+|.+++....    .+++.....++.|++.||+|||+.+     |+||||||+||++++++.+||+
T Consensus        92 ~~~~~lv~e~~~-~~l~~~l~~~~----~~~~~~~~~~~~ql~~aL~~LH~~~-----i~H~dl~~~nill~~~~~~kl~  161 (335)
T PTZ00024         92 GDFINLVMDIMA-SDLKKVVDRKI----RLTESQVKCILLQILNGLNVLHKWY-----FMHRDLSPANIFINSKGICKIA  161 (335)
T ss_pred             CCcEEEEEeccc-cCHHHHHHhcC----CCCHHHHHHHHHHHHHHHHHHHhCC-----eecccccHHHeEECCCCCEEEC
Confidence            468899999996 69999986532    3889999999999999999999987     9999999999999999999999


Q ss_pred             cccccccccCCce-------------eeeecCCCCCCCCCccccccC-CCCCcccchhHHHHHHHHHhCCCCcchhHHHH
Q 005586          560 DCGLHKLLADDIV-------------FSVLKTSAAMGYLAPEYVTTG-RFTERSDIFAFGVIILQILTGSLVLTSSMRLA  625 (689)
Q Consensus       560 DfGla~~~~~~~~-------------~~~~~~~~~~~y~aPE~~~~~-~~~~ksDV~sfGvvl~elltG~~p~~~~~~~~  625 (689)
                      |||+++.......             .......++..|+|||++.+. .++.++|||||||++|||+||+.|+.......
T Consensus       162 dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~el~tg~~p~~~~~~~~  241 (335)
T PTZ00024        162 DFGLARRYGYPPYSDTLSKDETMQRREEMTSKVVTLWYRAPELLMGAEKYHFAVDMWSVGCIFAELLTGKPLFPGENEID  241 (335)
T ss_pred             CccceeecccccccccccccccccccccccccccccCCCCChhcccCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHH
Confidence            9999986652110             011122346679999998764 46899999999999999999999986543221


Q ss_pred             HhhhhhhHhhccc---------------cCCC-------CCHHHHHHHHHHHHHhccCCCCCCCCHHHHHHHHHh
Q 005586          626 AESATFENFIDRN---------------LKGK-------FSESEAAKLGKMALVCTHEDPENRPTMEAVIEELTV  678 (689)
Q Consensus       626 ~~~~~~~~~~~~~---------------~~~~-------~~~~~~~~l~~l~~~Cl~~dp~~RPs~~evl~~L~~  678 (689)
                      .........-.+.               ....       .......++.+++..|++.+|++||++.|++.+.+.
T Consensus       242 ~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~s~~~~l~~~~~  316 (335)
T PTZ00024        242 QLGRIFELLGTPNEDNWPQAKKLPLYTEFTPRKPKDLKTIFPNASDDAIDLLQSLLKLNPLERISAKEALKHEYF  316 (335)
T ss_pred             HHHHHHHHhCCCchhhCcchhhcccccccCcCCcccHHHhCcCCChHHHHHHHHHcCCCchhccCHHHHhcCccc
Confidence            1111000000000               0000       011225678899999999999999999999987654

>KOG1006 consensus Mitogen-activated protein kinase (MAPK) kinase MKK4 [Signal transduction mechanisms]

Probab=100.00  E-value=1.3e-35  Score=280.71  Aligned_cols=248  Identities=19%  Similarity=0.323  Sum_probs=192.8

Q ss_pred             ccccccCCcceEEEEEec-CCcEEEEEEecccCCchHHHHHHHHHHHHhcc-CCCcceeEeeEEEcCCCCeEEEEEEcCC
Q 005586          414 VNLLGKGNFSSVYKGTLR-DGTLVAIRSINVTSCKSEEAEFVKGLYLLTSL-RHENIIRLRGFCCSRGRGECFLIYDFAP  491 (689)
Q Consensus       414 ~~~lg~G~~g~Vy~~~~~-~g~~vavK~l~~~~~~~~~~~f~~e~~~l~~l-~H~niv~l~g~~~~~~~~~~~lV~e~~~  491 (689)
                      ...||.|+||+|+|-.++ .|+..|||+++......+++++..|.+...+- +.||||+++|.+..+  +..++.||.|.
T Consensus        69 lg~iG~G~fG~V~KM~hk~sg~~mAVKrIr~~n~~keq~rll~e~d~~mks~~cp~IVkfyGa~F~E--GdcWiCMELMd  146 (361)
T KOG1006|consen   69 LGEIGNGAFGTVNKMLHKPSGKLMAVKRIRSNNIEKEQKRLLMEHDTVMKSSNCPNIVKFYGALFSE--GDCWICMELMD  146 (361)
T ss_pred             HHHhcCCcchhhhhhhcCccCcEEEEEEeeeccchHHHHHHHHHHHHHHhhcCCcHHHHHhhhhhcC--CceeeeHHHHh
Confidence            357999999999999876 79999999999887777888999999875555 799999999998664  67999999994


Q ss_pred             CCCHHHHh---hhcCCCCCCCCHHHHHHHHHHHHHHHhhhhCCCCCCCceeecCCCCCceeecCCCCeEEeccccccccc
Q 005586          492 KGKLSKYL---DQEEGSSNVLDWSTRVSIIIGIAKGIGYLHSSEVNKPAIVHRNLSVEKVLIDQQFNPLIADCGLHKLLA  568 (689)
Q Consensus       492 ~gsL~~~L---~~~~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~~~ivH~dlk~~NiLl~~~~~~kl~DfGla~~~~  568 (689)
                       -||..+-   +...  ...+++.-.-+|+.....||.||-+..    .|||||+||+|||||..|.+|++|||++..+.
T Consensus       147 -~SlDklYk~vy~vq--~~~ipE~Ilg~ItvatV~AL~yLK~~l----kiIHRDvKPSNILldr~G~vKLCDFGIcGqLv  219 (361)
T KOG1006|consen  147 -ISLDKLYKRVYSVQ--KSRIPENILGHITVATVDALDYLKEEL----KIIHRDVKPSNILLDRHGDVKLCDFGICGQLV  219 (361)
T ss_pred             -hhHHHHHHHHHHHH--hccCcHhhhhheeeeehhHHHHHHHHh----hhhhccCChhheEEecCCCEeeecccchHhHH
Confidence             4665543   2222  234788877889999999999998654    39999999999999999999999999998876


Q ss_pred             CCceeeeecCCCCCCCCCcccccc--CCCCCcccchhHHHHHHHHHhCCCCcchhHHHHHhhhhhhHhhc--c-ccCCC-
Q 005586          569 DDIVFSVLKTSAAMGYLAPEYVTT--GRFTERSDIFAFGVIILQILTGSLVLTSSMRLAAESATFENFID--R-NLKGK-  642 (689)
Q Consensus       569 ~~~~~~~~~~~~~~~y~aPE~~~~--~~~~~ksDV~sfGvvl~elltG~~p~~~~~~~~~~~~~~~~~~~--~-~~~~~-  642 (689)
                      +...  .....|...|||||.+..  ..|+-+|||||+|+.|||+.||+.|+..+...-..   +..+..  + .+... 
T Consensus       220 ~SiA--kT~daGCrpYmAPERi~p~~~gyDiRSDvWSLGITL~EvAtG~fPyr~w~svfeq---l~~Vv~gdpp~l~~~~  294 (361)
T KOG1006|consen  220 DSIA--KTVDAGCRPYMAPERIDPSDKGYDIRSDVWSLGITLYEVATGNFPYRKWDSVFEQ---LCQVVIGDPPILLFDK  294 (361)
T ss_pred             HHHH--hhhccCCccccChhccCCccCCcchhhhhhhhcceEeeeecCCCCcchHHHHHHH---HHHHHcCCCCeecCcc
Confidence            5432  122345566999999864  34899999999999999999999999876542211   111111  1 11111 


Q ss_pred             CCHHHHHHHHHHHHHhccCCCCCCCCHHHHHHH
Q 005586          643 FSESEAAKLGKMALVCTHEDPENRPTMEAVIEE  675 (689)
Q Consensus       643 ~~~~~~~~l~~l~~~Cl~~dp~~RPs~~evl~~  675 (689)
                      -....+..+.+.+..|+.+|-..||++.++.++
T Consensus       295 ~~~~~s~~~~~fintCl~Kd~~~Rpky~~Lk~~  327 (361)
T KOG1006|consen  295 ECVHYSFSMVRFINTCLIKDRSDRPKYDDLKKF  327 (361)
T ss_pred             cccccCHHHHHHHHHHhhcccccCcchhhhhcC
Confidence            112356789999999999999999999998764

>cd07854 STKc_MAPK4_6 Catalytic domain of the Serine/Threonine Kinases, Mitogen-Activated Protein Kinases 4 and 6

Probab=100.00  E-value=1.9e-33  Score=299.16  Aligned_cols=258  Identities=18%  Similarity=0.315  Sum_probs=193.2

Q ss_pred             ccCCcccccccCCcceEEEEEec-CCcEEEEEEecccCCchHHHHHHHHHHHHhccCCCcceeEeeEEEcCCC-------
Q 005586          409 QCFSEVNLLGKGNFSSVYKGTLR-DGTLVAIRSINVTSCKSEEAEFVKGLYLLTSLRHENIIRLRGFCCSRGR-------  480 (689)
Q Consensus       409 ~~f~~~~~lg~G~~g~Vy~~~~~-~g~~vavK~l~~~~~~~~~~~f~~e~~~l~~l~H~niv~l~g~~~~~~~-------  480 (689)
                      .+|...+.||+|+||.||+|... +|..||+|++..... ...+.+.+|++++++++||||+++++++.....       
T Consensus         5 ~~y~~~~~Lg~g~~g~vy~~~~~~~~~~v~iK~i~~~~~-~~~~~~~~Ei~~l~~l~h~~i~~~~~~~~~~~~~~~~~~~   83 (342)
T cd07854           5 SRYMDLRPLGCGSNGLVFSAVDSDCDKRVAVKKIVLTDP-QSVKHALREIKIIRRLDHDNIVKVYEVLGPSGSDLTEDVG   83 (342)
T ss_pred             cceEEEEEecCCCCEEEEEEEECCCCcEEEEEEEecCCC-chHHHHHHHHHHHHhcCCCcchhhHhhhcccccccccccc
Confidence            46788899999999999999875 689999999876543 345678899999999999999999987643221       


Q ss_pred             -----CeEEEEEEcCCCCCHHHHhhhcCCCCCCCCHHHHHHHHHHHHHHHhhhhCCCCCCCceeecCCCCCceeec-CCC
Q 005586          481 -----GECFLIYDFAPKGKLSKYLDQEEGSSNVLDWSTRVSIIIGIAKGIGYLHSSEVNKPAIVHRNLSVEKVLID-QQF  554 (689)
Q Consensus       481 -----~~~~lV~e~~~~gsL~~~L~~~~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~~~ivH~dlk~~NiLl~-~~~  554 (689)
                           ...++||||++ ++|.+++...     .+++.....++.|+++||.|||+.+     |+||||||+||+++ +++
T Consensus        84 ~~~~~~~~~lv~e~~~-~~L~~~~~~~-----~l~~~~~~~~~~qi~~aL~~LH~~g-----ivH~dikp~Nili~~~~~  152 (342)
T cd07854          84 SLTELNSVYIVQEYME-TDLANVLEQG-----PLSEEHARLFMYQLLRGLKYIHSAN-----VLHRDLKPANVFINTEDL  152 (342)
T ss_pred             cccccceEEEEeeccc-ccHHHHHHcC-----CCCHHHHHHHHHHHHHHHHHHHhCC-----cccCCCCHHHEEEcCCCc
Confidence                 35789999997 5898888542     3889999999999999999999987     99999999999998 456


Q ss_pred             CeEEecccccccccCCceee--eecCCCCCCCCCcccccc-CCCCCcccchhHHHHHHHHHhCCCCcchhHHHHHhhhhh
Q 005586          555 NPLIADCGLHKLLADDIVFS--VLKTSAAMGYLAPEYVTT-GRFTERSDIFAFGVIILQILTGSLVLTSSMRLAAESATF  631 (689)
Q Consensus       555 ~~kl~DfGla~~~~~~~~~~--~~~~~~~~~y~aPE~~~~-~~~~~ksDV~sfGvvl~elltG~~p~~~~~~~~~~~~~~  631 (689)
                      .+|++|||+++.+.......  .....++..|+|||.+.. ..++.++|||||||++|||++|+.||.............
T Consensus       153 ~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwSlGvil~el~~g~~pf~~~~~~~~~~~~~  232 (342)
T cd07854         153 VLKIGDFGLARIVDPHYSHKGYLSEGLVTKWYRSPRLLLSPNNYTKAIDMWAAGCIFAEMLTGKPLFAGAHELEQMQLIL  232 (342)
T ss_pred             eEEECCcccceecCCccccccccccccccccccCHHHHhCccccCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHH
Confidence            78999999998654321111  112345678999998654 467889999999999999999999996432111100000


Q ss_pred             -----------h-------Hhhc-cccCCCCC-----HHHHHHHHHHHHHhccCCCCCCCCHHHHHHHHHh
Q 005586          632 -----------E-------NFID-RNLKGKFS-----ESEAAKLGKMALVCTHEDPENRPTMEAVIEELTV  678 (689)
Q Consensus       632 -----------~-------~~~~-~~~~~~~~-----~~~~~~l~~l~~~Cl~~dp~~RPs~~evl~~L~~  678 (689)
                                 .       .... .......+     .....++.+++..|++.||++||++.|++++-+.
T Consensus       233 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~ell~h~~~  303 (342)
T cd07854         233 ESVPVVREEDRNELLNVIPSFVRNDGGEPRRPLRDLLPGVNPEALDFLEQILTFNPMDRLTAEEALMHPYM  303 (342)
T ss_pred             HhcCCCChHHhhhhhhhhhhhhhhcccccCCCHHHHccCCCHHHHHHHHHHhCCCchhccCHHHHhCCCcc
Confidence                       0       0000 00000001     1234578899999999999999999999977544

Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 4 (MAPK4) and MAPK6 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK4/6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. MAPK4 is also called ERK4 or p63MAPK, while MAPK6 is also called ERK3 or p97MAPK. MAPK4 and MAPK6 are atypical MAPKs that are not regulated by MAP2Ks. MAPK6 is expressed ubiquitously with highest amounts in brain and skeletal muscle. It may be involved in the control of cell differentiation by negatively regulating cell cycle progressi

>KOG4250 consensus TANK binding protein kinase TBK1 [Signal transduction mechanisms]

Probab=100.00  E-value=7.8e-34  Score=302.37  Aligned_cols=199  Identities=25%  Similarity=0.421  Sum_probs=174.3

Q ss_pred             ccccccCCcceEEEEEec-CCcEEEEEEecccCCchHHHHHHHHHHHHhccCCCcceeEeeEEEcCC----CCeEEEEEE
Q 005586          414 VNLLGKGNFSSVYKGTLR-DGTLVAIRSINVTSCKSEEAEFVKGLYLLTSLRHENIIRLRGFCCSRG----RGECFLIYD  488 (689)
Q Consensus       414 ~~~lg~G~~g~Vy~~~~~-~g~~vavK~l~~~~~~~~~~~f~~e~~~l~~l~H~niv~l~g~~~~~~----~~~~~lV~e  488 (689)
                      .+.||+|+||.||+|+.+ .|+.||||.++........+...+|+++|++++|+|||++++.-....    .+...+|||
T Consensus        18 ~e~LG~Ga~g~V~rgrnketG~~vAvK~~~~~~~~r~~e~~~~EieilkKLnh~NIVk~f~iee~~~~~~~~~~~vlvmE   97 (732)
T KOG4250|consen   18 DERLGKGAFGNVYRGRNKETGRLVAVKTFNKESSLRPRERWCREIEILKKLNHPNIVKLFDIEETKFLGLVTRLPVLVME   97 (732)
T ss_pred             hhhhcCCccceeeeecccccccchhHHhhhhhcccchHHHHHHHHHHHHHcCchhhhhhcccCCccccCcccccceEEEe
Confidence            467999999999999965 799999999998877777888999999999999999999998653333    456889999


Q ss_pred             cCCCCCHHHHhhhcCCCCCCCCHHHHHHHHHHHHHHHhhhhCCCCCCCceeecCCCCCceeec--CCCC--eEEeccccc
Q 005586          489 FAPKGKLSKYLDQEEGSSNVLDWSTRVSIIIGIAKGIGYLHSSEVNKPAIVHRNLSVEKVLID--QQFN--PLIADCGLH  564 (689)
Q Consensus       489 ~~~~gsL~~~L~~~~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~~~ivH~dlk~~NiLl~--~~~~--~kl~DfGla  564 (689)
                      ||.+|||...|...+. ...|++.+.+.+..++..||.|||+++     |+||||||.||++-  ++++  -||+|||.|
T Consensus        98 yC~gGsL~~~L~~PEN-~~GLpE~e~l~lL~d~~~al~~LrEn~-----IvHRDlKP~NIvl~~Gedgq~IyKLtDfG~A  171 (732)
T KOG4250|consen   98 YCSGGSLRKVLNSPEN-AYGLPESEFLDLLSDLVSALRHLRENG-----IVHRDLKPGNIVLQIGEDGQSIYKLTDFGAA  171 (732)
T ss_pred             ecCCCcHHHHhcCccc-ccCCCHHHHHHHHHHHHHHHHHHHHcC-----ceeccCCCCcEEEeecCCCceEEeeeccccc
Confidence            9999999999987653 245999999999999999999999887     99999999999994  3344  499999999


Q ss_pred             ccccCCceeeeecCCCCCCCCCcccccc-CCCCCcccchhHHHHHHHHHhCCCCcch
Q 005586          565 KLLADDIVFSVLKTSAAMGYLAPEYVTT-GRFTERSDIFAFGVIILQILTGSLVLTS  620 (689)
Q Consensus       565 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~ksDV~sfGvvl~elltG~~p~~~  620 (689)
                      |.+.++.  ......||..|.+||.+.. +.|+..+|.|||||++||.+||..||..
T Consensus       172 rel~d~s--~~~S~vGT~~YLhPel~E~q~~y~~tVDLWS~GvtlY~caTG~lPF~p  226 (732)
T KOG4250|consen  172 RELDDNS--LFTSLVGTEEYLHPELYERQKKYTATVDLWSFGVTLYECATGELPFIP  226 (732)
T ss_pred             ccCCCCC--eeeeecCchhhcChHHHhhccCcCceeehhhhhhHHHHHhccCCCCCc
Confidence            9998876  4455679999999999984 7899999999999999999999999953

>cd05123 STKc_AGC Catalytic domain of AGC family Protein Serine/Threonine Kinases

Probab=100.00  E-value=4.1e-33  Score=282.63  Aligned_cols=241  Identities=23%  Similarity=0.334  Sum_probs=195.2

Q ss_pred             cccCCcceEEEEEec-CCcEEEEEEecccCCc--hHHHHHHHHHHHHhccCCCcceeEeeEEEcCCCCeEEEEEEcCCCC
Q 005586          417 LGKGNFSSVYKGTLR-DGTLVAIRSINVTSCK--SEEAEFVKGLYLLTSLRHENIIRLRGFCCSRGRGECFLIYDFAPKG  493 (689)
Q Consensus       417 lg~G~~g~Vy~~~~~-~g~~vavK~l~~~~~~--~~~~~f~~e~~~l~~l~H~niv~l~g~~~~~~~~~~~lV~e~~~~g  493 (689)
                      ||+|+||.||++... +++.+|+|++......  .....+..|++++++++||||+++++.+.  .....++||||++++
T Consensus         1 lg~G~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~--~~~~~~~v~e~~~~~   78 (250)
T cd05123           1 LGKGSFGKVLLVRKKDTGKLYAMKVLKKKKIIKRKEVEHTLTERNILSRINHPFIVKLHYAFQ--TEEKLYLVLEYAPGG   78 (250)
T ss_pred             CCCCCceEEEEEEECCCCcEEEEEEeehhhhcchHHHHHHHHHHHHHHHcCCCcHHHHHHHee--cCCeeEEEEecCCCC
Confidence            689999999999976 5899999998765432  24568899999999999999999998873  457899999999999


Q ss_pred             CHHHHhhhcCCCCCCCCHHHHHHHHHHHHHHHhhhhCCCCCCCceeecCCCCCceeecCCCCeEEecccccccccCCcee
Q 005586          494 KLSKYLDQEEGSSNVLDWSTRVSIIIGIAKGIGYLHSSEVNKPAIVHRNLSVEKVLIDQQFNPLIADCGLHKLLADDIVF  573 (689)
Q Consensus       494 sL~~~L~~~~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~~~ivH~dlk~~NiLl~~~~~~kl~DfGla~~~~~~~~~  573 (689)
                      +|.+++....    .+++.....++.|++.||.|||+.+     ++|+||+|+||++++++.++|+|||++........ 
T Consensus        79 ~L~~~l~~~~----~l~~~~~~~~~~qi~~~l~~lh~~~-----~~H~~l~p~ni~~~~~~~~~l~d~~~~~~~~~~~~-  148 (250)
T cd05123          79 ELFSHLSKEG----RFSEERARFYAAEIVLALEYLHSLG-----IIYRDLKPENILLDADGHIKLTDFGLAKELSSEGS-  148 (250)
T ss_pred             cHHHHHHhcC----CCCHHHHHHHHHHHHHHHHHHHHCC-----ceecCCCcceEEEcCCCcEEEeecCcceecccCCC-
Confidence            9999997653    3899999999999999999999977     99999999999999999999999999887644321 


Q ss_pred             eeecCCCCCCCCCccccccCCCCCcccchhHHHHHHHHHhCCCCcchhHHHHHhhhhhhHhhccccCCCCCHHHHHHHHH
Q 005586          574 SVLKTSAAMGYLAPEYVTTGRFTERSDIFAFGVIILQILTGSLVLTSSMRLAAESATFENFIDRNLKGKFSESEAAKLGK  653 (689)
Q Consensus       574 ~~~~~~~~~~y~aPE~~~~~~~~~ksDV~sfGvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~  653 (689)
                      ......++..|+|||...+...+.++|+||||+++||+++|+.|+......    .....+..  ....++......+.+
T Consensus       149 ~~~~~~~~~~~~~Pe~~~~~~~~~~~D~~slG~~~~~l~~g~~p~~~~~~~----~~~~~~~~--~~~~~~~~~~~~l~~  222 (250)
T cd05123         149 RTNTFCGTPEYLAPEVLLGKGYGKAVDWWSLGVLLYEMLTGKPPFYAEDRK----EIYEKILK--DPLRFPEFLSPEARD  222 (250)
T ss_pred             cccCCcCCccccChHHhCCCCCCchhhHHHHHHHHHHHHHCCCCCCCCCHH----HHHHHHhc--CCCCCCCCCCHHHHH
Confidence            122344677899999998888899999999999999999999999643221    11111211  122334444678899


Q ss_pred             HHHHhccCCCCCCCCH---HHHHHH
Q 005586          654 MALVCTHEDPENRPTM---EAVIEE  675 (689)
Q Consensus       654 l~~~Cl~~dp~~RPs~---~evl~~  675 (689)
                      ++.+|+..||++||++   .+++++
T Consensus       223 ~i~~~l~~~p~~R~~~~~~~~l~~~  247 (250)
T cd05123         223 LISGLLQKDPTKRLGSGGAEEIKAH  247 (250)
T ss_pred             HHHHHhcCCHhhCCCcccHHHHHhC
Confidence            9999999999999999   565544

Serine/Threonine Kinases (STKs), AGC (Protein Kinases A, G and C) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The AGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and Phosphoinositide 3-Kinase (PI3K). Members of this family include cAMP-dependent Protein Kinase (PKA), cGMP-dependent Protein Kinase (PKG), Protein Kinase C (PKC), Protein Kinase B (PKB), G protein-coupled Receptor Kinase (GRK), Serum- and Glucocorticoid-induced Kinase (SGK), and 70 kDa ribosomal Protein S6 Kinase (p70S6K or S6K), among others. AGC kinases share an activation mechanism based on the phosphorylation of up to three sites: the activation loop (A-loop), the hydrophobic motif (HM) and the

>KOG0579 consensus Ste20-like serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=1.9e-34  Score=299.93  Aligned_cols=251  Identities=18%  Similarity=0.283  Sum_probs=199.5

Q ss_pred             ccccccCCcceEEEEEecC-CcEEEEEEecccCCchHHHHHHHHHHHHhccCCCcceeEeeEEEcCCCCeEEEEEEcCCC
Q 005586          414 VNLLGKGNFSSVYKGTLRD-GTLVAIRSINVTSCKSEEAEFVKGLYLLTSLRHENIIRLRGFCCSRGRGECFLIYDFAPK  492 (689)
Q Consensus       414 ~~~lg~G~~g~Vy~~~~~~-g~~vavK~l~~~~~~~~~~~f~~e~~~l~~l~H~niv~l~g~~~~~~~~~~~lV~e~~~~  492 (689)
                      +..||.|+||.||+|+-++ +...|.|++.... ..+..+|+-||++|+.+.||+||+|++.|+.+  +.++++.|||.|
T Consensus        37 iGELGDGAFGKVyKA~nket~~lAAaKvIetks-eEELEDylVEIeILa~CdHP~ivkLl~ayy~e--nkLwiliEFC~G  113 (1187)
T KOG0579|consen   37 IGELGDGAFGKVYKAVNKETKLLAAAKVIETKS-EEELEDYLVEIEILAECDHPVIVKLLSAYYFE--NKLWILIEFCGG  113 (1187)
T ss_pred             HhhhcCccchhhhhhhcccchhhhhhhhhcccc-hhHHhhhhhhhhhhhcCCChHHHHHHHHHhcc--CceEEEEeecCC
Confidence            3568999999999999774 4556677776544 45567899999999999999999999866544  678999999999


Q ss_pred             CCHHHHhhhcCCCCCCCCHHHHHHHHHHHHHHHhhhhCCCCCCCceeecCCCCCceeecCCCCeEEecccccccccCCce
Q 005586          493 GKLSKYLDQEEGSSNVLDWSTRVSIIIGIAKGIGYLHSSEVNKPAIVHRNLSVEKVLIDQQFNPLIADCGLHKLLADDIV  572 (689)
Q Consensus       493 gsL~~~L~~~~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~~~ivH~dlk~~NiLl~~~~~~kl~DfGla~~~~~~~~  572 (689)
                      |.+...+-.-+   ..|...++.-++.+++.||.|||+..     |||||||+-|||++-+|.++++|||.+....... 
T Consensus       114 GAVDaimlEL~---r~LtE~QIqvvc~q~ldALn~LHs~~-----iIHRDLKAGNiL~TldGdirLADFGVSAKn~~t~-  184 (1187)
T KOG0579|consen  114 GAVDAIMLELG---RVLTEDQIQVVCYQVLDALNWLHSQN-----IIHRDLKAGNILLTLDGDIRLADFGVSAKNKSTR-  184 (1187)
T ss_pred             chHhHHHHHhc---cccchHHHHHHHHHHHHHHHHHhhcc-----hhhhhccccceEEEecCcEeeecccccccchhHH-
Confidence            99998876543   35899999999999999999999987     9999999999999999999999999986443211 


Q ss_pred             eeeecCCCCCCCCCccccc-----cCCCCCcccchhHHHHHHHHHhCCCCcchhHHHHHhhhhhhHhhccccCCCCCHHH
Q 005586          573 FSVLKTSAAMGYLAPEYVT-----TGRFTERSDIFAFGVIILQILTGSLVLTSSMRLAAESATFENFIDRNLKGKFSESE  647 (689)
Q Consensus       573 ~~~~~~~~~~~y~aPE~~~-----~~~~~~ksDV~sfGvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  647 (689)
                      .......||+.|||||++.     ..+|+.++||||||+.|.||..+.+|........+... +..--.+.+  -.|...
T Consensus       185 qkRDsFIGTPYWMAPEVvmCET~KD~PYDykaDiWSlGITLIEMAqiEPPHhelnpMRVllK-iaKSePPTL--lqPS~W  261 (1187)
T KOG0579|consen  185 QKRDSFIGTPYWMAPEVVMCETFKDQPYDYKADIWSLGITLIEMAQIEPPHHELNPMRVLLK-IAKSEPPTL--LQPSHW  261 (1187)
T ss_pred             hhhccccCCcccccchheeeccccCCCchhhhhHHhhhhHHHHHhccCCCccccchHHHHHH-HhhcCCCcc--cCcchh
Confidence            1223456899999999864     56899999999999999999999998754322211111 111111222  235667


Q ss_pred             HHHHHHHHHHhccCCCCCCCCHHHHHHHHHhh
Q 005586          648 AAKLGKMALVCTHEDPENRPTMEAVIEELTVA  679 (689)
Q Consensus       648 ~~~l~~l~~~Cl~~dp~~RPs~~evl~~L~~~  679 (689)
                      ...+.++..+|+..+|..||+.++++++.+..
T Consensus       262 s~~F~DfLk~cL~Knp~~Rp~aaqll~Hpfv~  293 (1187)
T KOG0579|consen  262 SRSFSDFLKRCLVKNPRNRPPAAQLLKHPFVQ  293 (1187)
T ss_pred             hhHHHHHHHHHHhcCCccCCCHHHHhhCcccc
Confidence            88899999999999999999999999987655

>cd07857 STKc_MPK1 Catalytic domain of the Serine/Threonine Kinase, Fungal Mitogen-Activated Protein Kinase MPK1

Probab=100.00  E-value=5e-33  Score=294.77  Aligned_cols=259  Identities=20%  Similarity=0.249  Sum_probs=193.6

Q ss_pred             cCCcccccccCCcceEEEEEec-C--CcEEEEEEecccCC-chHHHHHHHHHHHHhcc-CCCcceeEeeEEEcC--CCCe
Q 005586          410 CFSEVNLLGKGNFSSVYKGTLR-D--GTLVAIRSINVTSC-KSEEAEFVKGLYLLTSL-RHENIIRLRGFCCSR--GRGE  482 (689)
Q Consensus       410 ~f~~~~~lg~G~~g~Vy~~~~~-~--g~~vavK~l~~~~~-~~~~~~f~~e~~~l~~l-~H~niv~l~g~~~~~--~~~~  482 (689)
                      +|...+.||+|+||.||++... +  +..||+|++..... ....+.+.+|++++.++ +||||+++++++...  ....
T Consensus         1 ~y~~~~~lg~G~~g~vy~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~~~~~~   80 (332)
T cd07857           1 RYELIKELGQGAYGIVCSARNAETSEEETVAIKKITNVFSKKILAKRALRELKLLRHFRGHKNITCLYDMDIVFPGNFNE   80 (332)
T ss_pred             CceEEEEccccCCeEEEEEEeCCCCcCceEEEEEeccccccchhHHHHHHHHHHHHHhcCCCChheeeeeeeeccccCCc
Confidence            3667789999999999999975 4  78999999875432 22346788999999999 599999999875322  2245


Q ss_pred             EEEEEEcCCCCCHHHHhhhcCCCCCCCCHHHHHHHHHHHHHHHhhhhCCCCCCCceeecCCCCCceeecCCCCeEEeccc
Q 005586          483 CFLIYDFAPKGKLSKYLDQEEGSSNVLDWSTRVSIIIGIAKGIGYLHSSEVNKPAIVHRNLSVEKVLIDQQFNPLIADCG  562 (689)
Q Consensus       483 ~~lV~e~~~~gsL~~~L~~~~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~~~ivH~dlk~~NiLl~~~~~~kl~DfG  562 (689)
                      .++++||+. ++|.+++....    .+++..+..++.|++.||+|||+.+     |+||||||+||++++++.+||+|||
T Consensus        81 ~~~~~e~~~-~~L~~~l~~~~----~~~~~~~~~~~~qi~~aL~~LH~~g-----ivH~dlkp~Nili~~~~~~kl~Dfg  150 (332)
T cd07857          81 LYLYEELME-ADLHQIIRSGQ----PLTDAHFQSFIYQILCGLKYIHSAN-----VLHRDLKPGNLLVNADCELKICDFG  150 (332)
T ss_pred             EEEEEeccc-CCHHHHHhcCC----CCCHHHHHHHHHHHHHHHHHHHhCC-----cccCCCCHHHeEEcCCCCEEeCcCC
Confidence            788899985 68999986532    4899999999999999999999987     9999999999999999999999999


Q ss_pred             ccccccCCcee---eeecCCCCCCCCCcccccc-CCCCCcccchhHHHHHHHHHhCCCCcchhHHHHHhh----------
Q 005586          563 LHKLLADDIVF---SVLKTSAAMGYLAPEYVTT-GRFTERSDIFAFGVIILQILTGSLVLTSSMRLAAES----------  628 (689)
Q Consensus       563 la~~~~~~~~~---~~~~~~~~~~y~aPE~~~~-~~~~~ksDV~sfGvvl~elltG~~p~~~~~~~~~~~----------  628 (689)
                      +++........   ......++..|+|||++.+ ..++.++|||||||++|||++|+.|+..........          
T Consensus       151 ~a~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~Di~slGv~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~  230 (332)
T cd07857         151 LARGFSENPGENAGFMTEYVATRWYRAPEIMLSFQSYTKAIDVWSVGCILAELLGRKPVFKGKDYVDQLNQILQVLGTPD  230 (332)
T ss_pred             CceecccccccccccccCcccCccccCcHHHhCCCCCCcHHHHHHHHHHHHHHHhCCcCCCCCCHHHHHHHHHHHhCCCC
Confidence            99866432211   1122356788999998765 468999999999999999999999986432110000          


Q ss_pred             -hhhhHhhcc-----------ccCCC---CCHHHHHHHHHHHHHhccCCCCCCCCHHHHHHHHHh
Q 005586          629 -ATFENFIDR-----------NLKGK---FSESEAAKLGKMALVCTHEDPENRPTMEAVIEELTV  678 (689)
Q Consensus       629 -~~~~~~~~~-----------~~~~~---~~~~~~~~l~~l~~~Cl~~dp~~RPs~~evl~~L~~  678 (689)
                       ..+.++.++           .....   ........+.+++.+|++.||++||++.|++++-+.
T Consensus       231 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~t~~~ll~~~~~  295 (332)
T cd07857         231 EETLSRIGSPKAQNYIRSLPNIPKKPFESIFPNANPLALDLLEKLLAFDPTKRISVEEALEHPYL  295 (332)
T ss_pred             HHHHHhhhhhhHHHHHHhccccCCcchHhhCCCCCHHHHHHHHHHccCCcccCCCHHHHhcChhh
Confidence             000000000           00000   011124678999999999999999999999987544

Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) MPK1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MPK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs MPK1 from Saccharomyces cerevisiae, Pmk1 from Schizosaccharomyces pombe, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. MPK1 (also called Slt2) and Pmk1 (also called Spm1) are stress-activated MAPKs that regulate the cell wall integrity (CWI) pathway, and are therefore important in the maintainance of cell shape, cell wall co

>KOG0586 consensus Serine/threonine protein kinase [General function prediction only]

Probab=100.00  E-value=1.5e-33  Score=296.44  Aligned_cols=249  Identities=24%  Similarity=0.403  Sum_probs=205.2

Q ss_pred             ccCCcccccccCCcceEEEEEec-CCcEEEEEEecccCCc-hHHHHHHHHHHHHhccCCCcceeEeeEEEcCCCCeEEEE
Q 005586          409 QCFSEVNLLGKGNFSSVYKGTLR-DGTLVAIRSINVTSCK-SEEAEFVKGLYLLTSLRHENIIRLRGFCCSRGRGECFLI  486 (689)
Q Consensus       409 ~~f~~~~~lg~G~~g~Vy~~~~~-~g~~vavK~l~~~~~~-~~~~~f~~e~~~l~~l~H~niv~l~g~~~~~~~~~~~lV  486 (689)
                      ..|.....||+|.|+.|..|+.. .|..||||.+.+.... ...+.+.+|+++|..++|||||+++.+..  ....+|+|
T Consensus        56 g~y~i~~tig~g~f~~V~La~~~~t~~~VaiK~idkt~ln~~~~~k~~rev~imk~l~HPnIvkl~~v~~--t~~~lylV  133 (596)
T KOG0586|consen   56 GLYVIIKTIGKGNFAKVKLARHILTGTEVAIKIIDKTQLNPSKRQKLGREVDIMKSLNHPNIVKLFSVIE--TEATLYLV  133 (596)
T ss_pred             cceeeeeeeccceeEEEEeeEecCCCceEEEEEehhcccChHHHHHHHHHHHHHHhcCCcceeeeeeeee--ecceeEEE
Confidence            45667789999999999999976 6999999999877643 23356899999999999999999999884  45789999


Q ss_pred             EEcCCCCCHHHHhhhcCCCCCCCCHHHHHHHHHHHHHHHhhhhCCCCCCCceeecCCCCCceeecCCCCeEEeccccccc
Q 005586          487 YDFAPKGKLSKYLDQEEGSSNVLDWSTRVSIIIGIAKGIGYLHSSEVNKPAIVHRNLSVEKVLIDQQFNPLIADCGLHKL  566 (689)
Q Consensus       487 ~e~~~~gsL~~~L~~~~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~~~ivH~dlk~~NiLl~~~~~~kl~DfGla~~  566 (689)
                      |||..+|.++++|..+..    +.......+..|+.+|++|||+..     |+|||||++||||+.++++||+|||++..
T Consensus       134 ~eya~~ge~~~yl~~~gr----~~e~~ar~~F~q~vsaveYcH~k~-----ivHrdLk~eNilL~~~mnikIaDfgfS~~  204 (596)
T KOG0586|consen  134 MEYASGGELFDYLVKHGR----MKEKEARAKFRQIVSAVEYCHSKN-----IVHRDLKAENILLDENMNIKIADFGFSTF  204 (596)
T ss_pred             EEeccCchhHHHHHhccc----chhhhhhhhhHHHHHHHHHHhhcc-----eeccccchhhcccccccceeeecccccee
Confidence            999999999999987754    445777889999999999999988     99999999999999999999999999988


Q ss_pred             ccCCceeeeecCCCCCCCCCccccccCCC-CCcccchhHHHHHHHHHhCCCCcchhHHHHHhhhhhhHhhccccCCC--C
Q 005586          567 LADDIVFSVLKTSAAMGYLAPEYVTTGRF-TERSDIFAFGVIILQILTGSLVLTSSMRLAAESATFENFIDRNLKGK--F  643 (689)
Q Consensus       567 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~-~~ksDV~sfGvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~--~  643 (689)
                      +.....  .....|++.|.|||++.+.+| ++++|+||+||++|-|+.|..||++..        +.+.-++.++++  +
T Consensus       205 ~~~~~~--lqt~cgsppyAaPEl~~g~~y~gpe~D~Wslgvvly~LV~GsLPFDG~~--------lk~Lr~rvl~gk~rI  274 (596)
T KOG0586|consen  205 FDYGLM--LQTFCGSPPYAAPELFNGKKYDGPEVDIWSLGVVLYALVEGSLPFDGQN--------LKELRPRVLRGKYRI  274 (596)
T ss_pred             eccccc--ccccCCCCCccChHhhcCcccCCcceehhhhhhhheeeeecccccCCcc--------cccccchheeeeecc
Confidence            764432  223457788999999999887 589999999999999999999997542        122222233332  2


Q ss_pred             CHHHHHHHHHHHHHhccCCCCCCCCHHHHHHHHHh
Q 005586          644 SESEAAKLGKMALVCTHEDPENRPTMEAVIEELTV  678 (689)
Q Consensus       644 ~~~~~~~l~~l~~~Cl~~dp~~RPs~~evl~~L~~  678 (689)
                      +.-...+..+++++.+..+|.+|++++++.++-|.
T Consensus       275 p~~ms~dce~lLrk~lvl~Pskr~~~dqim~~~W~  309 (596)
T KOG0586|consen  275 PFYMSCDCEDLLRKFLVLNPSKRGPCDQIMKDRWR  309 (596)
T ss_pred             cceeechhHHHHHHhhccCccccCCHHHhhhhccc
Confidence            33345678899999999999999999999877543

>cd07851 STKc_p38 Catalytic domain of the Serine/Threonine Kinase, p38 Mitogen-Activated Protein Kinase

Probab=100.00  E-value=1.2e-33  Score=300.93  Aligned_cols=256  Identities=21%  Similarity=0.322  Sum_probs=196.4

Q ss_pred             HhccCCcccccccCCcceEEEEEec-CCcEEEEEEecccCC-chHHHHHHHHHHHHhccCCCcceeEeeEEEcCCC----
Q 005586          407 ATQCFSEVNLLGKGNFSSVYKGTLR-DGTLVAIRSINVTSC-KSEEAEFVKGLYLLTSLRHENIIRLRGFCCSRGR----  480 (689)
Q Consensus       407 at~~f~~~~~lg~G~~g~Vy~~~~~-~g~~vavK~l~~~~~-~~~~~~f~~e~~~l~~l~H~niv~l~g~~~~~~~----  480 (689)
                      ..++|...+.||+|+||.||+|+.. ++..||+|++..... ......+.+|+.++++++|||++++++++.....    
T Consensus        13 ~~~~y~~~~~ig~g~~g~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~   92 (343)
T cd07851          13 VPDRYQNLSPVGSGAYGQVCSAFDTKTGRKVAIKKLSRPFQSAIHAKRTYRELRLLKHMDHENVIGLLDVFTPASSLEDF   92 (343)
T ss_pred             ccCceEEEEEeccCCceEEEEEEECCCCcEEEEEecccccchhhHHHHHHHHHHHHHhccCCCHHHHHHHhhcccccccc
Confidence            4567888999999999999999986 688999999875422 2234567889999999999999999987643221    


Q ss_pred             CeEEEEEEcCCCCCHHHHhhhcCCCCCCCCHHHHHHHHHHHHHHHhhhhCCCCCCCceeecCCCCCceeecCCCCeEEec
Q 005586          481 GECFLIYDFAPKGKLSKYLDQEEGSSNVLDWSTRVSIIIGIAKGIGYLHSSEVNKPAIVHRNLSVEKVLIDQQFNPLIAD  560 (689)
Q Consensus       481 ~~~~lV~e~~~~gsL~~~L~~~~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~~~ivH~dlk~~NiLl~~~~~~kl~D  560 (689)
                      ...++|+||+ +++|.+++...     .+++..+..++.|+++||+|||+.+     |+||||||+||++++++.+||+|
T Consensus        93 ~~~~lv~e~~-~~~L~~~~~~~-----~l~~~~~~~~~~ql~~aL~~LH~~g-----i~H~dlkp~Nill~~~~~~kL~d  161 (343)
T cd07851          93 QDVYLVTHLM-GADLNNIVKCQ-----KLSDDHIQFLVYQILRGLKYIHSAG-----IIHRDLKPSNIAVNEDCELKILD  161 (343)
T ss_pred             ccEEEEEecC-CCCHHHHHhcC-----CCCHHHHHHHHHHHHHHHHHHHHCC-----eecCCCCHHHeEECCCCCEEEcc
Confidence            2489999999 67999998652     4899999999999999999999987     99999999999999999999999


Q ss_pred             ccccccccCCceeeeecCCCCCCCCCcccccc-CCCCCcccchhHHHHHHHHHhCCCCcchhHHHHHhhhhh--------
Q 005586          561 CGLHKLLADDIVFSVLKTSAAMGYLAPEYVTT-GRFTERSDIFAFGVIILQILTGSLVLTSSMRLAAESATF--------  631 (689)
Q Consensus       561 fGla~~~~~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~ksDV~sfGvvl~elltG~~p~~~~~~~~~~~~~~--------  631 (689)
                      ||++......    .....++..|+|||.+.+ ..++.++|||||||++||++||+.||.............        
T Consensus       162 fg~~~~~~~~----~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslGv~l~elltg~~pf~~~~~~~~~~~i~~~~~~~~~  237 (343)
T cd07851         162 FGLARHTDDE----MTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGKTLFPGSDHIDQLKRIMNLVGTPDE  237 (343)
T ss_pred             cccccccccc----ccCCcccccccCHHHHhCCCCCCchHhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCCH
Confidence            9999866433    122345677999998765 367899999999999999999999986432211100000        


Q ss_pred             -----------hHhhcccc---CCCC---CHHHHHHHHHHHHHhccCCCCCCCCHHHHHHHHH
Q 005586          632 -----------ENFIDRNL---KGKF---SESEAAKLGKMALVCTHEDPENRPTMEAVIEELT  677 (689)
Q Consensus       632 -----------~~~~~~~~---~~~~---~~~~~~~l~~l~~~Cl~~dp~~RPs~~evl~~L~  677 (689)
                                 ..++....   +..+   ....+.++.+++.+|++.+|++|||+.||+++-+
T Consensus       238 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~l~dli~~~l~~~P~~Rpt~~ell~h~~  300 (343)
T cd07851         238 ELLQKISSESARNYIQSLPQMPKKDFKEVFSGANPLAIDLLEKMLVLDPDKRITAAEALAHPY  300 (343)
T ss_pred             HHHhhccchhHHHHHHhccccCCCCHHHHhccCCHHHHHHHHHhCCCChhhCCCHHHHhcCCC
Confidence                       00000000   0000   0123568999999999999999999999998743

Serine/Threonine Kinases (STKs), p38 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They function in the regulation of the cell cycle, cell development, cell differentiation, senescence, tumorigenesis, apoptosis, pain development and pain progression, and immune responses. p38 kinases are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK

>KOG0666 consensus Cyclin C-dependent kinase CDK8 [Transcription]

Probab=100.00  E-value=4.4e-34  Score=275.66  Aligned_cols=260  Identities=23%  Similarity=0.344  Sum_probs=196.0

Q ss_pred             cCCcccccccCCcceEEEEEec---C--CcEEEEEEecccCCchH-HHHHHHHHHHHhccCCCcceeEeeEEEcCCCCeE
Q 005586          410 CFSEVNLLGKGNFSSVYKGTLR---D--GTLVAIRSINVTSCKSE-EAEFVKGLYLLTSLRHENIIRLRGFCCSRGRGEC  483 (689)
Q Consensus       410 ~f~~~~~lg~G~~g~Vy~~~~~---~--g~~vavK~l~~~~~~~~-~~~f~~e~~~l~~l~H~niv~l~g~~~~~~~~~~  483 (689)
                      .|.....||+|.||.||+|+-+   +  ...+|+|+++.++.... .....+||.+++.++|||++.|..++... +..+
T Consensus        25 ~ye~ig~Ig~GTYG~VykA~~~~~n~kr~k~yAiKkfk~~kd~tGiS~SAcREiaL~REl~h~nvi~Lv~Vfl~~-d~~v  103 (438)
T KOG0666|consen   25 EYEGIGKIGRGTYGKVYKAVRKNTNDKRTKEYAIKKFKGEKDGTGISMSACREIALLRELKHPNVISLVKVFLSH-DKKV  103 (438)
T ss_pred             HhhccceecccccceeeEeeeccCCcccchhhHHHHHhccCCCCCcCHHHHHHHHHHHHhcCCcchhHHHHHhcc-CceE
Confidence            4777889999999999999643   2  33799999987654322 25678999999999999999999988654 5789


Q ss_pred             EEEEEcCCCCCHHHHhhhcCCC-CCCCCHHHHHHHHHHHHHHHhhhhCCCCCCCceeecCCCCCceeecCC----CCeEE
Q 005586          484 FLIYDFAPKGKLSKYLDQEEGS-SNVLDWSTRVSIIIGIAKGIGYLHSSEVNKPAIVHRNLSVEKVLIDQQ----FNPLI  558 (689)
Q Consensus       484 ~lV~e~~~~gsL~~~L~~~~~~-~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~~~ivH~dlk~~NiLl~~~----~~~kl  558 (689)
                      ++++||.+. ||...++-.+.. ...++-.....|+.||+.|+.|||++.     |+||||||.|||+..+    |.+||
T Consensus       104 ~l~fdYAEh-DL~~II~fHr~~~~~~lp~~mvKsilwQil~Gv~YLH~NW-----vlHRDLKPaNIlvmgdgperG~VKI  177 (438)
T KOG0666|consen  104 WLLFDYAEH-DLWHIIKFHRASKAKQLPRSMVKSILWQILDGVHYLHSNW-----VLHRDLKPANILVMGDGPERGRVKI  177 (438)
T ss_pred             EEEehhhhh-hHHHHHHHhccchhccCCHHHHHHHHHHHHhhhHHHhhhh-----eeeccCCcceEEEeccCCccCeeEe
Confidence            999999975 899888765432 245888899999999999999999998     9999999999999877    89999


Q ss_pred             ecccccccccCCc--eeeeecCCCCCCCCCccccccC-CCCCcccchhHHHHHHHHHhCCCCcchhHHH---------HH
Q 005586          559 ADCGLHKLLADDI--VFSVLKTSAAMGYLAPEYVTTG-RFTERSDIFAFGVIILQILTGSLVLTSSMRL---------AA  626 (689)
Q Consensus       559 ~DfGla~~~~~~~--~~~~~~~~~~~~y~aPE~~~~~-~~~~ksDV~sfGvvl~elltG~~p~~~~~~~---------~~  626 (689)
                      +|+|++|.+.+.-  ......+..|++|+|||.+.+. .||.+.||||.||++.||+|-++-|......         ..
T Consensus       178 aDlGlaR~~~~plkpl~s~d~VVVTiWYRAPELLLGa~hYT~AiDvWAiGCIfaElLtl~PlF~g~E~k~~~~~Pfq~dQ  257 (438)
T KOG0666|consen  178 ADLGLARLFNNPLKPLASLDPVVVTIWYRAPELLLGARHYTKAIDVWAIGCIFAELLTLEPLFKGREEKIKTKNPFQHDQ  257 (438)
T ss_pred             ecccHHHHhhccccccccCCceEEEEEecChHHhcccccccchhhhHHHHHHHHHHHccCccccchhhhcccCCCchHHH
Confidence            9999999886532  2233456678999999998874 6899999999999999999977655321100         00


Q ss_pred             hhhhh------------------------hHhhccccCCCC-CH-------HHHHHHHHHHHHhccCCCCCCCCHHHHHH
Q 005586          627 ESATF------------------------ENFIDRNLKGKF-SE-------SEAAKLGKMALVCTHEDPENRPTMEAVIE  674 (689)
Q Consensus       627 ~~~~~------------------------~~~~~~~~~~~~-~~-------~~~~~l~~l~~~Cl~~dp~~RPs~~evl~  674 (689)
                      ..+++                        .++-.... ... -.       .-.....++...++..||.+|.|+++.++
T Consensus       258 l~rIf~vLG~Pt~~~Wp~lkk~Pe~q~~ls~f~~~~~-~n~sL~~~~~~~k~k~~~a~~LL~klL~yDP~kRIta~qAle  336 (438)
T KOG0666|consen  258 LDRIFEVLGTPTDKDWPDLKKMPEYQTLLSDFRRHYY-DNVSLHKYYHKHKVKDPSALDLLQKLLTYDPIKRITAEQALE  336 (438)
T ss_pred             HHHHHHHcCCCccccchhhhhCcchHHHHHHhHHhhc-CcchHHHHHHHhcCCCchHHHHHHHHhccCchhhccHHHHhc
Confidence            00000                        00000000 000 00       01223788999999999999999999998


Q ss_pred             HHH
Q 005586          675 ELT  677 (689)
Q Consensus       675 ~L~  677 (689)
                      +.-
T Consensus       337 h~y  339 (438)
T KOG0666|consen  337 HPY  339 (438)
T ss_pred             ccc
Confidence            853

>PLN03224 probable serine/threonine protein kinase; Provisional

Probab=100.00  E-value=1.2e-32  Score=300.22  Aligned_cols=266  Identities=18%  Similarity=0.274  Sum_probs=188.0

Q ss_pred             HhccCCcccccccCCcceEEEEEe-----------------cCCcEEEEEEecccCCchHHHH--------------HHH
Q 005586          407 ATQCFSEVNLLGKGNFSSVYKGTL-----------------RDGTLVAIRSINVTSCKSEEAE--------------FVK  455 (689)
Q Consensus       407 at~~f~~~~~lg~G~~g~Vy~~~~-----------------~~g~~vavK~l~~~~~~~~~~~--------------f~~  455 (689)
                      ..++|...++||+|+||.||+|.+                 .+++.||||++..... ...++              +..
T Consensus       143 ~~d~F~i~~~LG~GgFG~VYkG~~~~~~~~~v~~~~~~~~~~~~r~VAVK~l~~~~~-~~~~~fl~e~~~~~~~~e~~~v  221 (507)
T PLN03224        143 SSDDFQLRDKLGGGNFGITFEGLRLQADDQGVTQRSKLTAEQKKRRVVLKRVNMDRQ-GVRQDFLKTGTLAKGSAETGMV  221 (507)
T ss_pred             cccCceEeeEeecCCCeEEEEEEecccccchhhhhccccccccCceEEEEEecccch-hhHHHHHhhhhhhhcccchhHH
Confidence            356899999999999999999964                 2457899999875432 22223              344


Q ss_pred             HHHHHhccCCCcc-----eeEeeEEEcC------CCCeEEEEEEcCCCCCHHHHhhhcCCC-------------------
Q 005586          456 GLYLLTSLRHENI-----IRLRGFCCSR------GRGECFLIYDFAPKGKLSKYLDQEEGS-------------------  505 (689)
Q Consensus       456 e~~~l~~l~H~ni-----v~l~g~~~~~------~~~~~~lV~e~~~~gsL~~~L~~~~~~-------------------  505 (689)
                      |+.++.+++|.++     +++++||...      ..++.++||||+++|+|.++++...+.                   
T Consensus       222 E~~~l~~l~~~~l~~~~~~~~lg~~~~~~~~g~~~~~~~~LV~Ey~~~gsL~~~L~~~~~~~~~~L~e~l~~g~~l~~~~  301 (507)
T PLN03224        222 EAYMCAKIKRNPIAAASCAEYLGYFTSNTADGAFTKGSQWLVWKFESDATLGDALDGKLGPFPGCLEEFMMAGKKIPDNM  301 (507)
T ss_pred             HHHHHHHhhcccchhhhhhhhhhhcccccccccccCCceEEEEEcCCCCcHHHHHhhccCCCcchHHHHHhcCCchhhhc
Confidence            6777888877655     6778887532      235689999999999999999753210                   


Q ss_pred             -CCCCCHHHHHHHHHHHHHHHhhhhCCCCCCCceeecCCCCCceeecCCCCeEEecccccccccCCceeeeecCCCCCCC
Q 005586          506 -SNVLDWSTRVSIIIGIAKGIGYLHSSEVNKPAIVHRNLSVEKVLIDQQFNPLIADCGLHKLLADDIVFSVLKTSAAMGY  584 (689)
Q Consensus       506 -~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~~~ivH~dlk~~NiLl~~~~~~kl~DfGla~~~~~~~~~~~~~~~~~~~y  584 (689)
                       ...++|..+..|+.|++.||+|||+.+     |+||||||+|||+++++.+||+|||+++.+.............++.|
T Consensus       302 ~~~~~~~~~~~~i~~ql~~aL~~lH~~~-----ivHrDLKp~NILl~~~~~~kL~DFGla~~~~~~~~~~~~~g~~tp~Y  376 (507)
T PLN03224        302 PQDKRDINVIKGVMRQVLTGLRKLHRIG-----IVHRDIKPENLLVTVDGQVKIIDFGAAVDMCTGINFNPLYGMLDPRY  376 (507)
T ss_pred             ccccCCHHHHHHHHHHHHHHHHHHHHCC-----eecCCCchHhEEECCCCcEEEEeCcCccccccCCccCccccCCCcce
Confidence             123578889999999999999999887     99999999999999999999999999976644322222223346789


Q ss_pred             CCccccccCCC----------------------CCcccchhHHHHHHHHHhCCC-CcchhHHHHHhh----hh---hhHh
Q 005586          585 LAPEYVTTGRF----------------------TERSDIFAFGVIILQILTGSL-VLTSSMRLAAES----AT---FENF  634 (689)
Q Consensus       585 ~aPE~~~~~~~----------------------~~ksDV~sfGvvl~elltG~~-p~~~~~~~~~~~----~~---~~~~  634 (689)
                      +|||.+.....                      ..+.||||+||+++||++|.. |+..........    ..   +...
T Consensus       377 ~aPE~l~~~~~~~~~~~~~~~~~l~~~~~~yg~~~~~DvwSlGvil~em~~~~l~p~~~~~~f~~~~~~~~~~~~~~r~~  456 (507)
T PLN03224        377 SPPEELVMPQSCPRAPAPAMAALLSPFAWLYGRPDLFDSYTAGVLLMQMCVPELRPVANIRLFNTELRQYDNDLNRWRMY  456 (507)
T ss_pred             eChhhhcCCCCCCccchhhhhhhhhhhHHhcCCCCccchhhHHHHHHHHHhCCCCCccchhhhhhHHhhccchHHHHHhh
Confidence            99998754321                      235799999999999999985 554321111100    01   1111


Q ss_pred             hccccCCCCCHHHHHHHHHHHHHhccCCC---CCCCCHHHHHHHHHh
Q 005586          635 IDRNLKGKFSESEAAKLGKMALVCTHEDP---ENRPTMEAVIEELTV  678 (689)
Q Consensus       635 ~~~~~~~~~~~~~~~~l~~l~~~Cl~~dp---~~RPs~~evl~~L~~  678 (689)
                      ......-...........+++.+++..+|   .+|+|++|+++|.+.
T Consensus       457 ~~~~~~~~~~d~~s~~~~dLi~~LL~~~~~~~~~RlSa~eaL~Hp~f  503 (507)
T PLN03224        457 KGQKYDFSLLDRNKEAGWDLACKLITKRDQANRGRLSVGQALSHRFF  503 (507)
T ss_pred             cccCCCcccccccChHHHHHHHHHhccCCCCcccCCCHHHHhCCCCc
Confidence            11111111123345678899999999766   689999999998765

>KOG0612 consensus Rho-associated, coiled-coil containing protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=1.5e-33  Score=312.15  Aligned_cols=259  Identities=19%  Similarity=0.275  Sum_probs=212.3

Q ss_pred             HHHHHHhccCCcccccccCCcceEEEEEec-CCcEEEEEEecccC--CchHHHHHHHHHHHHhccCCCcceeEeeEEEcC
Q 005586          402 EEVESATQCFSEVNLLGKGNFSSVYKGTLR-DGTLVAIRSINVTS--CKSEEAEFVKGLYLLTSLRHENIIRLRGFCCSR  478 (689)
Q Consensus       402 ~~l~~at~~f~~~~~lg~G~~g~Vy~~~~~-~g~~vavK~l~~~~--~~~~~~~f~~e~~~l~~l~H~niv~l~g~~~~~  478 (689)
                      .++.--.++|.+.++||+|+||.|..++++ .++.||+|++++..  ...+..-|..|-.+|..-+.+-||++.-.|  .
T Consensus        68 ~~lrl~~~DfeilKvIGrGaFGEV~lVr~k~t~~VYAMK~lnK~eMlKr~~tA~F~EERDimv~~ns~Wiv~LhyAF--Q  145 (1317)
T KOG0612|consen   68 KELRLKAEDFEILKVIGRGAFGEVALVRHKSTEKVYAMKILNKWEMLKRAETACFREERDIMVFGNSEWIVQLHYAF--Q  145 (1317)
T ss_pred             HHHhCCHHhhHHHHHhcccccceeEEEEeeccccchhHHHhhHHHHhhchhHHHHHHHhHHHHcCCcHHHHHHHHHh--c
Confidence            445555678999999999999999999986 68999999998632  133456799999999999999999997555  5


Q ss_pred             CCCeEEEEEEcCCCCCHHHHhhhcCCCCCCCCHHHHHHHHHHHHHHHhhhhCCCCCCCceeecCCCCCceeecCCCCeEE
Q 005586          479 GRGECFLIYDFAPKGKLSKYLDQEEGSSNVLDWSTRVSIIIGIAKGIGYLHSSEVNKPAIVHRNLSVEKVLIDQQFNPLI  558 (689)
Q Consensus       479 ~~~~~~lV~e~~~~gsL~~~L~~~~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~~~ivH~dlk~~NiLl~~~~~~kl  558 (689)
                      +..+.|+|||||+||||-.++....    .++......++.+|..||+-+|+.|     +|||||||.|||||.+|++||
T Consensus       146 D~~~LYlVMdY~pGGDlltLlSk~~----~~pE~~ArFY~aEiVlAldslH~mg-----yVHRDiKPDNvLld~~GHikL  216 (1317)
T KOG0612|consen  146 DERYLYLVMDYMPGGDLLTLLSKFD----RLPEDWARFYTAEIVLALDSLHSMG-----YVHRDIKPDNVLLDKSGHIKL  216 (1317)
T ss_pred             CccceEEEEecccCchHHHHHhhcC----CChHHHHHHHHHHHHHHHHHHHhcc-----ceeccCCcceeEecccCcEee
Confidence            5689999999999999999998764    3888888899999999999999999     899999999999999999999


Q ss_pred             ecccccccccCCceeeeecCCCCCCCCCcccccc-----CCCCCcccchhHHHHHHHHHhCCCCcchhHHHHHhhhhhhH
Q 005586          559 ADCGLHKLLADDIVFSVLKTSAAMGYLAPEYVTT-----GRFTERSDIFAFGVIILQILTGSLVLTSSMRLAAESATFEN  633 (689)
Q Consensus       559 ~DfGla~~~~~~~~~~~~~~~~~~~y~aPE~~~~-----~~~~~ksDV~sfGvvl~elltG~~p~~~~~~~~~~~~~~~~  633 (689)
                      +|||-+-.+..+.........||+.|++||++..     +.|+..+|+||+||++|||+.|..||+...-.    ..+..
T Consensus       217 ADFGsClkm~~dG~V~s~~aVGTPDYISPEvLqs~~~~~g~yG~ecDwWSlGV~~YEMlyG~TPFYadslv----eTY~K  292 (1317)
T KOG0612|consen  217 ADFGSCLKMDADGTVRSSVAVGTPDYISPEVLQSQGDGKGEYGRECDWWSLGVFMYEMLYGETPFYADSLV----ETYGK  292 (1317)
T ss_pred             ccchhHHhcCCCCcEEeccccCCCCccCHHHHHhhcCCccccCCccchhhhHHHHHHHHcCCCcchHHHHH----HHHHH
Confidence            9999998887665556666789999999999752     57899999999999999999999999865433    23444


Q ss_pred             hhccccCCCCC--HHHHHHHHHHHHHhccCCCCCCCC---HHHHHHHH
Q 005586          634 FIDRNLKGKFS--ESEAAKLGKMALVCTHEDPENRPT---MEAVIEEL  676 (689)
Q Consensus       634 ~~~~~~~~~~~--~~~~~~l~~l~~~Cl~~dp~~RPs---~~evl~~L  676 (689)
                      +++..-.-.+|  .+.+.+..+++..-+. +|+.|-.   +.++-.|.
T Consensus       293 Im~hk~~l~FP~~~~VSeeakdLI~~ll~-~~e~RLgrngiedik~Hp  339 (1317)
T KOG0612|consen  293 IMNHKESLSFPDETDVSEEAKDLIEALLC-DREVRLGRNGIEDIKNHP  339 (1317)
T ss_pred             HhchhhhcCCCcccccCHHHHHHHHHHhc-ChhhhcccccHHHHHhCc
Confidence            44443222344  3456778888877554 8888888   88887664

>KOG4645 consensus MAPKKK (MAP kinase kinase kinase) SSK2 and related serine/threonine protein kinases [Signal transduction mechanisms]

Probab=100.00  E-value=2.1e-34  Score=322.75  Aligned_cols=255  Identities=21%  Similarity=0.346  Sum_probs=202.6

Q ss_pred             HHhccCCcccccccCCcceEEEEEe-cCCcEEEEEEecccCC-chHHHHHHHHHHHHhccCCCcceeEeeEEEcCCCCeE
Q 005586          406 SATQCFSEVNLLGKGNFSSVYKGTL-RDGTLVAIRSINVTSC-KSEEAEFVKGLYLLTSLRHENIIRLRGFCCSRGRGEC  483 (689)
Q Consensus       406 ~at~~f~~~~~lg~G~~g~Vy~~~~-~~g~~vavK~l~~~~~-~~~~~~f~~e~~~l~~l~H~niv~l~g~~~~~~~~~~  483 (689)
                      ..+-+++....||.|.||.||-|.. .+|...|+|.++.... .+......+|+.++..++|||+|+++|+-..  ++..
T Consensus      1232 nV~~rWqrg~~Ig~G~fG~VYtavN~~tGellAvKEI~iq~~~~k~~~~i~eEm~vlE~lnHpNlV~YyGVEvH--Rekv 1309 (1509)
T KOG4645|consen 1232 NVTFRWQRGNFIGGGTFGKVYTAVNLDTGELLAVKEIKIQDSDHKTFKLIAEEMKVLEGLNHPNLVRYYGVEVH--REKV 1309 (1509)
T ss_pred             cceeeeccccccCCcceeeeEEeecCCccchhhhhhhhcCccccccCcchHHHHHHHHhccCccccccCceeec--HHHH
Confidence            3455677788999999999999984 5799999999876543 3334678899999999999999999998744  5788


Q ss_pred             EEEEEcCCCCCHHHHhhhcCCCCCCCCHHHHHHHHHHHHHHHhhhhCCCCCCCceeecCCCCCceeecCCCCeEEecccc
Q 005586          484 FLIYDFAPKGKLSKYLDQEEGSSNVLDWSTRVSIIIGIAKGIGYLHSSEVNKPAIVHRNLSVEKVLIDQQFNPLIADCGL  563 (689)
Q Consensus       484 ~lV~e~~~~gsL~~~L~~~~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~~~ivH~dlk~~NiLl~~~~~~kl~DfGl  563 (689)
                      +|.||||++|+|.+.+...+.    .++..-..+-.|++.|++|||+.|     ||||||||.||+|+.+|.+|.+|||.
T Consensus      1310 ~IFMEyC~~GsLa~ll~~gri----~dE~vt~vyt~qll~gla~LH~~g-----IVHRDIK~aNI~Ld~~g~iK~~DFGs 1380 (1509)
T KOG4645|consen 1310 YIFMEYCEGGSLASLLEHGRI----EDEMVTRVYTKQLLEGLAYLHEHG-----IVHRDIKPANILLDFNGLIKYGDFGS 1380 (1509)
T ss_pred             HHHHHHhccCcHHHHHHhcch----hhhhHHHHHHHHHHHHHHHHHhcC-----ceecCCCccceeeecCCcEEeecccc
Confidence            999999999999999975432    455555667889999999999988     99999999999999999999999999


Q ss_pred             cccccCCcee---eeecCCCCCCCCCccccccCC---CCCcccchhHHHHHHHHHhCCCCcchhHHHHHhhhhhhHhhcc
Q 005586          564 HKLLADDIVF---SVLKTSAAMGYLAPEYVTTGR---FTERSDIFAFGVIILQILTGSLVLTSSMRLAAESATFENFIDR  637 (689)
Q Consensus       564 a~~~~~~~~~---~~~~~~~~~~y~aPE~~~~~~---~~~ksDV~sfGvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~  637 (689)
                      |+........   ......||+-|||||++.+..   -.-+.||||+|||++||+||++|+.....  .| .++-. +.-
T Consensus      1381 a~ki~~~~~~~~~el~~~~GT~~YMAPEvit~t~~kG~~~A~DiWslGCVVlEM~tGkrPW~~~dn--e~-aIMy~-V~~ 1456 (1509)
T KOG4645|consen 1381 AVKIKNNAQTMPGELQSMMGTPMYMAPEVITGTKGKGHGGAADIWSLGCVVLEMATGKRPWAELDN--EW-AIMYH-VAA 1456 (1509)
T ss_pred             eeEecCchhcCCHHHHhhcCCchhcCchhhcccccCCCCcchhhhcccceEEEeecCCCchhhccc--hh-HHHhH-Hhc
Confidence            9877654211   122346888899999997643   35689999999999999999999853211  01 11111 112


Q ss_pred             ccCCCCCHHHHHHHHHHHHHhccCCCCCCCCHHHHHHH
Q 005586          638 NLKGKFSESEAAKLGKMALVCTHEDPENRPTMEAVIEE  675 (689)
Q Consensus       638 ~~~~~~~~~~~~~l~~l~~~Cl~~dp~~RPs~~evl~~  675 (689)
                      ..++.+|+..+.+-.+++..|+..||++|.++.|++++
T Consensus      1457 gh~Pq~P~~ls~~g~dFle~Cl~~dP~~Rw~~~qlle~ 1494 (1509)
T KOG4645|consen 1457 GHKPQIPERLSSEGRDFLEHCLEQDPKMRWTASQLLEH 1494 (1509)
T ss_pred             cCCCCCchhhhHhHHHHHHHHHhcCchhhhHHHHHHHh
Confidence            34456777788888999999999999999999888875

>cd05610 STKc_MASTL Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine-like kinase

Probab=100.00  E-value=1.3e-32  Score=315.55  Aligned_cols=146  Identities=23%  Similarity=0.344  Sum_probs=128.6

Q ss_pred             ccCCcccccccCCcceEEEEEec-CCcEEEEEEecccCC--chHHHHHHHHHHHHhccCCCcceeEeeEEEcCCCCeEEE
Q 005586          409 QCFSEVNLLGKGNFSSVYKGTLR-DGTLVAIRSINVTSC--KSEEAEFVKGLYLLTSLRHENIIRLRGFCCSRGRGECFL  485 (689)
Q Consensus       409 ~~f~~~~~lg~G~~g~Vy~~~~~-~g~~vavK~l~~~~~--~~~~~~f~~e~~~l~~l~H~niv~l~g~~~~~~~~~~~l  485 (689)
                      ++|...+.||+|+||.||+|... +++.||||+++....  ......+..|+.++..++||||+++++++..  ....++
T Consensus         4 ~~y~i~~~LG~G~fg~Vy~a~~~~~~~~vAiKvi~~~~~~~~~~~~~~~~E~~~l~~l~hp~Iv~~~~~~~~--~~~~~l   81 (669)
T cd05610           4 EEFVIVKPISRGAFGKVYLGRKKNNSKLYAVKVVKKADMINKNMVHQVQAERDALALSKSPFIVHLYYSLQS--ANNVYL   81 (669)
T ss_pred             CCEEEEEEEecCCCeEEEEEEECCCCcEEEEEEEehhhccCHHHHHHHHHHHHHHHhcCCCCcCeEEEEEEE--CCEEEE
Confidence            46778899999999999999986 689999999975432  2234678899999999999999999988744  468999


Q ss_pred             EEEcCCCCCHHHHhhhcCCCCCCCCHHHHHHHHHHHHHHHhhhhCCCCCCCceeecCCCCCceeecCCCCeEEecccccc
Q 005586          486 IYDFAPKGKLSKYLDQEEGSSNVLDWSTRVSIIIGIAKGIGYLHSSEVNKPAIVHRNLSVEKVLIDQQFNPLIADCGLHK  565 (689)
Q Consensus       486 V~e~~~~gsL~~~L~~~~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~~~ivH~dlk~~NiLl~~~~~~kl~DfGla~  565 (689)
                      ||||+++++|.++++...    .+++...+.|+.||+.||+|||+.+     |+||||||+|||++.++.+||+|||+++
T Consensus        82 VmEy~~g~~L~~li~~~~----~l~~~~~~~i~~qil~aL~yLH~~g-----IiHrDLKP~NILl~~~g~vkL~DFGls~  152 (669)
T cd05610          82 VMEYLIGGDVKSLLHIYG----YFDEEMAVKYISEVALALDYLHRHG-----IIHRDLKPDNMLISNEGHIKLTDFGLSK  152 (669)
T ss_pred             EEeCCCCCCHHHHHHhcC----CCCHHHHHHHHHHHHHHHHHHHhCC-----EEeCCccHHHEEEcCCCCEEEEeCCCCc
Confidence            999999999999997543    3788999999999999999999987     9999999999999999999999999986

Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST-like (MASTL) kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. The MASTL kinases in this group carry only a catalytic domain, which contains a long insertion relative to MAST kinases. The human MASTL gene has also been labelled FLJ14813. A missense mutation in FLJ1481

>cd05576 STKc_RPK118_like Catalytic domain of the Protein Serine/Threonine Kinases, RPK118 and similar proteins

Probab=100.00  E-value=9.6e-33  Score=278.01  Aligned_cols=219  Identities=17%  Similarity=0.186  Sum_probs=175.4

Q ss_pred             CCcceEEEEEec-CCcEEEEEEecccCCchHHHHHHHHHHHHhccCCCcceeEeeEEEcCCCCeEEEEEEcCCCCCHHHH
Q 005586          420 GNFSSVYKGTLR-DGTLVAIRSINVTSCKSEEAEFVKGLYLLTSLRHENIIRLRGFCCSRGRGECFLIYDFAPKGKLSKY  498 (689)
Q Consensus       420 G~~g~Vy~~~~~-~g~~vavK~l~~~~~~~~~~~f~~e~~~l~~l~H~niv~l~g~~~~~~~~~~~lV~e~~~~gsL~~~  498 (689)
                      |.||.||+++.+ +|+.||+|++....      .+.+|...+....||||+++++++..  .+..++||||+++|+|.++
T Consensus         4 g~~~~v~~~~~~~~~~~~~~K~i~~~~------~~~~~~~~~~~~~~~~i~~~~~~~~~--~~~~~lv~e~~~~~~L~~~   75 (237)
T cd05576           4 GVIDKVLLVMDTRTQQTFILKGLRKSS------EYSRERLTIIPHCVPNMVCLHKYIVS--EDSVFLVLQHAEGGKLWSH   75 (237)
T ss_pred             cccceEEEEEEccCCcEEEEEeecchh------hhhhHHHHHHhcCCCceeehhhheec--CCeEEEEEecCCCCCHHHH
Confidence            899999999975 78999999987543      23445555666789999999998854  4789999999999999999


Q ss_pred             hhhcCCCCCCCCHHHHHHHHHHHHHHHhhhhCCCCCCCceeecCCCCCceeecCCCCeEEecccccccccCCceeeeecC
Q 005586          499 LDQEEGSSNVLDWSTRVSIIIGIAKGIGYLHSSEVNKPAIVHRNLSVEKVLIDQQFNPLIADCGLHKLLADDIVFSVLKT  578 (689)
Q Consensus       499 L~~~~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~~~ivH~dlk~~NiLl~~~~~~kl~DfGla~~~~~~~~~~~~~~  578 (689)
                      +....    .+++.....++.|+++||+|||+.+     |+||||||+||++++++.++++|||.+..+....    ...
T Consensus        76 l~~~~----~l~~~~~~~~~~ql~~~l~~lH~~~-----i~H~dlkp~Nil~~~~~~~~l~df~~~~~~~~~~----~~~  142 (237)
T cd05576          76 ISKFL----NIPEECVKRWAAEMVVALDALHREG-----IVCRDLNPNNILLDDRGHIQLTYFSRWSEVEDSC----DGE  142 (237)
T ss_pred             HHHhc----CCCHHHHHHHHHHHHHHHHHHHhCC-----eeccCCCHHHEEEcCCCCEEEecccchhcccccc----ccC
Confidence            97643    3899999999999999999999987     9999999999999999999999999887654421    123


Q ss_pred             CCCCCCCCccccccCCCCCcccchhHHHHHHHHHhCCCCcchhHHHHHhhhhhhHhhccccCCCCCHHHHHHHHHHHHHh
Q 005586          579 SAAMGYLAPEYVTTGRFTERSDIFAFGVIILQILTGSLVLTSSMRLAAESATFENFIDRNLKGKFSESEAAKLGKMALVC  658 (689)
Q Consensus       579 ~~~~~y~aPE~~~~~~~~~ksDV~sfGvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~C  658 (689)
                      .++..|+|||...+..++.++||||+|+++|||++|+.|+.......          ........+......+.+++.+|
T Consensus       143 ~~~~~y~aPE~~~~~~~~~~~DvwslG~il~el~~g~~~~~~~~~~~----------~~~~~~~~~~~~~~~~~~li~~~  212 (237)
T cd05576         143 AVENMYCAPEVGGISEETEACDWWSLGAILFELLTGKTLVECHPSGI----------NTHTTLNIPEWVSEEARSLLQQL  212 (237)
T ss_pred             CcCccccCCcccCCCCCCchhhHHHHHHHHHHHHHCcchhhcCchhc----------ccccccCCcccCCHHHHHHHHHH
Confidence            34567999999988889999999999999999999998764321100          00001112333456789999999


Q ss_pred             ccCCCCCCCCH
Q 005586          659 THEDPENRPTM  669 (689)
Q Consensus       659 l~~dp~~RPs~  669 (689)
                      ++.||++||++
T Consensus       213 l~~dp~~R~~~  223 (237)
T cd05576         213 LQFNPTERLGA  223 (237)
T ss_pred             ccCCHHHhcCC
Confidence            99999999996

Serine/Threonine Kinases (STKs), RPK118-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RPK118-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily show similarity to human RPK118, which contains an N-terminal Phox homology (PX) domain, a Microtubule Interacting and Trafficking (MIT) domain, and a kinase domain containing a long insert. Also included in the family is human RPK60 (or ribosomal protein S6 kinase-like 1), which also contains MIT and kinase domains but lacks a PX domain. RPK118 binds sphingosine kinase, a key enzyme in the synthesis of sphingosine 1-phospha

>KOG1151 consensus Tousled-like protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=4.2e-33  Score=279.66  Aligned_cols=257  Identities=21%  Similarity=0.343  Sum_probs=199.3

Q ss_pred             ccCCcccccccCCcceEEEEEe-cCCcEEEEEEecccCCchHH------HHHHHHHHHHhccCCCcceeEeeEEEcCCCC
Q 005586          409 QCFSEVNLLGKGNFSSVYKGTL-RDGTLVAIRSINVTSCKSEE------AEFVKGLYLLTSLRHENIIRLRGFCCSRGRG  481 (689)
Q Consensus       409 ~~f~~~~~lg~G~~g~Vy~~~~-~~g~~vavK~l~~~~~~~~~------~~f~~e~~~l~~l~H~niv~l~g~~~~~~~~  481 (689)
                      ++|-..++||+|||+.||+|+. ...+.||||+-..+....++      +...+|.++-+.+.||.||++|+|+.-. .+
T Consensus       463 ~RYLlLhLLGrGGFSEVyKAFDl~EqRYvAvKIHqlNK~WrdEKKeNYhKHAcREyrIHKeLDHpRIVKlYDyfslD-td  541 (775)
T KOG1151|consen  463 DRYLLLHLLGRGGFSEVYKAFDLTEQRYVAVKIHQLNKNWRDEKKENYHKHACREYRIHKELDHPRIVKLYDYFSLD-TD  541 (775)
T ss_pred             HHHHHHHHhccccHHHHHHhcccchhheeeEeeehhccchhhHhhhhHHHHHHHHHhhhhccCcceeeeeeeeeeec-cc
Confidence            4555678999999999999985 46889999998766542222      4567889999999999999999998653 56


Q ss_pred             eEEEEEEcCCCCCHHHHhhhcCCCCCCCCHHHHHHHHHHHHHHHhhhhCCCCCCCceeecCCCCCceeec---CCCCeEE
Q 005586          482 ECFLIYDFAPKGKLSKYLDQEEGSSNVLDWSTRVSIIIGIAKGIGYLHSSEVNKPAIVHRNLSVEKVLID---QQFNPLI  558 (689)
Q Consensus       482 ~~~lV~e~~~~gsL~~~L~~~~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~~~ivH~dlk~~NiLl~---~~~~~kl  558 (689)
                      ..+-|.||+++-+|.-||+.+.    .+++.+...|+.||..||.||.+.   +|||||-||||.||||-   ..|++||
T Consensus       542 sFCTVLEYceGNDLDFYLKQhk----lmSEKEARSIiMQiVnAL~YLNEi---kpPIIHYDLKPgNILLv~GtacGeIKI  614 (775)
T KOG1151|consen  542 SFCTVLEYCEGNDLDFYLKQHK----LMSEKEARSIIMQIVNALKYLNEI---KPPIIHYDLKPGNILLVNGTACGEIKI  614 (775)
T ss_pred             cceeeeeecCCCchhHHHHhhh----hhhHHHHHHHHHHHHHHHHHHhcc---CCCeeeeccCCccEEEecCcccceeEe
Confidence            7899999999999999998765    388999999999999999999875   59999999999999995   4688999


Q ss_pred             ecccccccccCCceee------eecCCCCCCCCCcccccc----CCCCCcccchhHHHHHHHHHhCCCCcchhHHHHHhh
Q 005586          559 ADCGLHKLLADDIVFS------VLKTSAAMGYLAPEYVTT----GRFTERSDIFAFGVIILQILTGSLVLTSSMRLAAES  628 (689)
Q Consensus       559 ~DfGla~~~~~~~~~~------~~~~~~~~~y~aPE~~~~----~~~~~ksDV~sfGvvl~elltG~~p~~~~~~~~~~~  628 (689)
                      .||||++.|.++.+..      .....||.+|++||.+.-    .+.+.|+||||.||++|..+.|+.||......-. .
T Consensus       615 TDFGLSKIMdddSy~~vdGmeLTSQgAGTYWYLPPEcFvVgkePPKIsnKVDVWSvGVIFyQClYGrKPFGhnqsQQd-I  693 (775)
T KOG1151|consen  615 TDFGLSKIMDDDSYNSVDGMELTSQGAGTYWYLPPECFVVGKEPPKISNKVDVWSVGVIFYQCLYGRKPFGHNQSQQD-I  693 (775)
T ss_pred             eecchhhhccCCccCcccceeeecccCceeeecCcceeecCCCCCccccceeeEeeehhhhhhhccCCCCCCchhHHH-H
Confidence            9999999998765432      234568999999998643    3578999999999999999999999975422110 0


Q ss_pred             hhhhHhhccccCCCCC--HHHHHHHHHHHHHhccCCCCCCCCHHHHHHH
Q 005586          629 ATFENFIDRNLKGKFS--ESEAAKLGKMALVCTHEDPENRPTMEAVIEE  675 (689)
Q Consensus       629 ~~~~~~~~~~~~~~~~--~~~~~~l~~l~~~Cl~~dp~~RPs~~evl~~  675 (689)
                      ....-++... .-.+|  +..+.+...++.+|++.--++|....++..+
T Consensus       694 LqeNTIlkAt-EVqFP~KPvVsseAkaFIRRCLaYRKeDR~DV~qLA~d  741 (775)
T KOG1151|consen  694 LQENTILKAT-EVQFPPKPVVSSEAKAFIRRCLAYRKEDRIDVQQLACD  741 (775)
T ss_pred             Hhhhchhcce-eccCCCCCccCHHHHHHHHHHHHhhhhhhhhHHHHccC
Confidence            0000011110 00111  2345678899999999999999988887654

>KOG0690 consensus Serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=4e-33  Score=270.15  Aligned_cols=250  Identities=24%  Similarity=0.334  Sum_probs=199.0

Q ss_pred             hccCCcccccccCCcceEEEEEec-CCcEEEEEEecccCC--chHHHHHHHHHHHHhccCCCcceeEeeEEEcCCCCeEE
Q 005586          408 TQCFSEVNLLGKGNFSSVYKGTLR-DGTLVAIRSINVTSC--KSEEAEFVKGLYLLTSLRHENIIRLRGFCCSRGRGECF  484 (689)
Q Consensus       408 t~~f~~~~~lg~G~~g~Vy~~~~~-~g~~vavK~l~~~~~--~~~~~~f~~e~~~l~~l~H~niv~l~g~~~~~~~~~~~  484 (689)
                      .++|...++||+|.||+|-+++-+ .|+.+|+|+++++-.  +.+...-..|-++|+..+||.+..|.--+  ...+..+
T Consensus       167 m~dFdfLKvLGkGTFGKVIL~rEKat~k~YAiKIlkKeviiakdEVAHTlTE~RVL~~~~HPFLt~LKYsF--Qt~drlC  244 (516)
T KOG0690|consen  167 MEDFDFLKVLGKGTFGKVILCREKATGKLYAIKILKKEVIIAKDEVAHTLTENRVLQNCRHPFLTSLKYSF--QTQDRLC  244 (516)
T ss_pred             cchhhHHHHhcCCccceEEEEeecccCceeehhhhhhhheeehHHhhhhhhHHHHHHhccCcHHHHhhhhh--ccCceEE
Confidence            357888899999999999999876 799999999987643  34445667889999999999998885444  4467899


Q ss_pred             EEEEcCCCCCHHHHhhhcCCCCCCCCHHHHHHHHHHHHHHHhhhhCCCCCCCceeecCCCCCceeecCCCCeEEeccccc
Q 005586          485 LIYDFAPKGKLSKYLDQEEGSSNVLDWSTRVSIIIGIAKGIGYLHSSEVNKPAIVHRNLSVEKVLIDQQFNPLIADCGLH  564 (689)
Q Consensus       485 lV~e~~~~gsL~~~L~~~~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~~~ivH~dlk~~NiLl~~~~~~kl~DfGla  564 (689)
                      +||||..+|.|.-+|...+    .+++.....+-.+|..||.|||+.+     ||.||+|-+|.|||+||++||+|||++
T Consensus       245 FVMeyanGGeLf~HLsrer----~FsE~RtRFYGaEIvsAL~YLHs~~-----ivYRDlKLENLlLDkDGHIKitDFGLC  315 (516)
T KOG0690|consen  245 FVMEYANGGELFFHLSRER----VFSEDRTRFYGAEIVSALGYLHSRN-----IVYRDLKLENLLLDKDGHIKITDFGLC  315 (516)
T ss_pred             EEEEEccCceEeeehhhhh----cccchhhhhhhHHHHHHhhhhhhCC-----eeeeechhhhheeccCCceEeeecccc
Confidence            9999999999999987654    3777777788999999999999987     999999999999999999999999999


Q ss_pred             ccccCCceeeeecCCCCCCCCCccccccCCCCCcccchhHHHHHHHHHhCCCCcchhHHHHHhhhhhhHhhccccCCCCC
Q 005586          565 KLLADDIVFSVLKTSAAMGYLAPEYVTTGRFTERSDIFAFGVIILQILTGSLVLTSSMRLAAESATFENFIDRNLKGKFS  644 (689)
Q Consensus       565 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~ksDV~sfGvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~  644 (689)
                      +.--... .......||+.|+|||++....|...+|.|..|||||||+.|+.||+......    -++-++-..+  .+|
T Consensus       316 KE~I~~g-~t~kTFCGTPEYLAPEVleDnDYgraVDWWG~GVVMYEMmCGRLPFyn~dh~k----LFeLIl~ed~--kFP  388 (516)
T KOG0690|consen  316 KEEIKYG-DTTKTFCGTPEYLAPEVLEDNDYGRAVDWWGVGVVMYEMMCGRLPFYNKDHEK----LFELILMEDL--KFP  388 (516)
T ss_pred             hhccccc-ceeccccCChhhcCchhhccccccceeehhhhhHHHHHHHhccCcccccchhH----HHHHHHhhhc--cCC
Confidence            8432211 12334568999999999999999999999999999999999999997643221    1222222222  355


Q ss_pred             HHHHHHHHHHHHHhccCCCCCCC-----CHHHHHHH
Q 005586          645 ESEAAKLGKMALVCTHEDPENRP-----TMEAVIEE  675 (689)
Q Consensus       645 ~~~~~~l~~l~~~Cl~~dp~~RP-----s~~evl~~  675 (689)
                      ...+.+...+..--+.+||.+|.     .+.||.++
T Consensus       389 r~ls~eAktLLsGLL~kdP~kRLGgGpdDakEi~~h  424 (516)
T KOG0690|consen  389 RTLSPEAKTLLSGLLKKDPKKRLGGGPDDAKEIMRH  424 (516)
T ss_pred             ccCCHHHHHHHHHHhhcChHhhcCCCchhHHHHHhh
Confidence            55667788888888999999994     35555443

>KOG0603 consensus Ribosomal protein S6 kinase [Signal transduction mechanisms]

Probab=99.98  E-value=8.5e-33  Score=292.43  Aligned_cols=248  Identities=19%  Similarity=0.282  Sum_probs=200.8

Q ss_pred             HhccCCcccccccCCcceEEEEEec-CCcEEEEEEecccCCchHHHHHHHHHHHHhcc-CCCcceeEeeEEEcCCCCeEE
Q 005586          407 ATQCFSEVNLLGKGNFSSVYKGTLR-DGTLVAIRSINVTSCKSEEAEFVKGLYLLTSL-RHENIIRLRGFCCSRGRGECF  484 (689)
Q Consensus       407 at~~f~~~~~lg~G~~g~Vy~~~~~-~g~~vavK~l~~~~~~~~~~~f~~e~~~l~~l-~H~niv~l~g~~~~~~~~~~~  484 (689)
                      .++.|.....+|.|+|+.|-++... +++..+||++.....     +-.+|+.++... +||||+++.+.+  .+..+.+
T Consensus       320 ~~~~y~~~~~~~~gs~s~~~~~~~~~t~~~~~vkii~~~~~-----~~~~e~~~~~~~~~h~niv~~~~v~--~~~~~~~  392 (612)
T KOG0603|consen  320 FTESYEFREELGEGSFSAVKYCESSPTDQEPAVKIISKRAD-----DNQDEIPISLLVRDHPNIVKSHDVY--EDGKEIY  392 (612)
T ss_pred             cchhhccccccCCCCccceeeeeccccccchhheecccccc-----ccccccchhhhhcCCCcceeeccee--cCCceee
Confidence            3566777788999999999999875 688999999976521     233566565555 799999999998  5568899


Q ss_pred             EEEEcCCCCCHHHHhhhcCCCCCCCCHHHHHHHHHHHHHHHhhhhCCCCCCCceeecCCCCCceee-cCCCCeEEecccc
Q 005586          485 LIYDFAPKGKLSKYLDQEEGSSNVLDWSTRVSIIIGIAKGIGYLHSSEVNKPAIVHRNLSVEKVLI-DQQFNPLIADCGL  563 (689)
Q Consensus       485 lV~e~~~~gsL~~~L~~~~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~~~ivH~dlk~~NiLl-~~~~~~kl~DfGl  563 (689)
                      +|||++.+|-+.+.+.....    .. ..+..|+.+++.|+.|||+.|     +|||||||+|||+ ++.++++|+|||.
T Consensus       393 ~v~e~l~g~ell~ri~~~~~----~~-~e~~~w~~~lv~Av~~LH~~g-----vvhRDLkp~NIL~~~~~g~lrltyFG~  462 (612)
T KOG0603|consen  393 LVMELLDGGELLRRIRSKPE----FC-SEASQWAAELVSAVDYLHEQG-----VVHRDLKPGNILLDGSAGHLRLTYFGF  462 (612)
T ss_pred             eeehhccccHHHHHHHhcch----hH-HHHHHHHHHHHHHHHHHHhcC-----eeecCCChhheeecCCCCcEEEEEech
Confidence            99999999877777765431    23 677789999999999999988     9999999999999 6999999999999


Q ss_pred             cccccCCceeeeecCCCCCCCCCccccccCCCCCcccchhHHHHHHHHHhCCCCcchhHHHHHhhhhhhHhhccccCCCC
Q 005586          564 HKLLADDIVFSVLKTSAAMGYLAPEYVTTGRFTERSDIFAFGVIILQILTGSLVLTSSMRLAAESATFENFIDRNLKGKF  643 (689)
Q Consensus       564 a~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~ksDV~sfGvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~  643 (689)
                      ++....+    .....-|..|.|||+.....|++++|+||+|++||||++|+.|+......       .++..+...+.+
T Consensus       463 a~~~~~~----~~tp~~t~~y~APEvl~~~~yt~acD~WSLGvlLy~ML~G~tp~~~~P~~-------~ei~~~i~~~~~  531 (612)
T KOG0603|consen  463 WSELERS----CDTPALTLQYVAPEVLAIQEYTEACDWWSLGVLLYEMLTGRTLFAAHPAG-------IEIHTRIQMPKF  531 (612)
T ss_pred             hhhCchh----hcccchhhcccChhhhccCCCCcchhhHHHHHHHHHHHhCCCccccCCch-------HHHHHhhcCCcc
Confidence            9988765    22234567799999999999999999999999999999999999654322       223333334455


Q ss_pred             CHHHHHHHHHHHHHhccCCCCCCCCHHHHHHHHHh-hCCc
Q 005586          644 SESEAAKLGKMALVCTHEDPENRPTMEAVIEELTV-AAPV  682 (689)
Q Consensus       644 ~~~~~~~l~~l~~~Cl~~dp~~RPs~~evl~~L~~-~~p~  682 (689)
                      ....+..+.+|+..|++.||.+||+|.++..+-+. ..|.
T Consensus       532 s~~vS~~AKdLl~~LL~~dP~~Rl~~~~i~~h~w~~~~~t  571 (612)
T KOG0603|consen  532 SECVSDEAKDLLQQLLQVDPALRLGADEIGAHPWFLSHPT  571 (612)
T ss_pred             ccccCHHHHHHHHHhccCChhhCcChhhhccCcchhcCCC
Confidence            57778899999999999999999999999988777 4443

>KOG0604 consensus MAP kinase-activated protein kinase 2 [Signal transduction mechanisms]

Probab=99.98  E-value=2e-32  Score=263.21  Aligned_cols=255  Identities=19%  Similarity=0.273  Sum_probs=197.8

Q ss_pred             hccCCc-ccccccCCcceEEEEEec-CCcEEEEEEecccCCchHHHHHHHHHHHHhcc-CCCcceeEeeEEEc--CCCCe
Q 005586          408 TQCFSE-VNLLGKGNFSSVYKGTLR-DGTLVAIRSINVTSCKSEEAEFVKGLYLLTSL-RHENIIRLRGFCCS--RGRGE  482 (689)
Q Consensus       408 t~~f~~-~~~lg~G~~g~Vy~~~~~-~g~~vavK~l~~~~~~~~~~~f~~e~~~l~~l-~H~niv~l~g~~~~--~~~~~  482 (689)
                      |++|+. .++||-|-.|.|-.+..+ +|+.+|+|++...      ....+|+++--.. .|||||.++++|..  .+...
T Consensus        60 tedY~is~qvLG~GinGkV~~C~~k~T~ekfALKvL~Ds------~KARrEVeLHw~~s~h~~iV~IidVyeNs~~~rkc  133 (400)
T KOG0604|consen   60 TEDYSISWQVLGAGINGKVVQCVHKRTQEKFALKVLLDS------PKARREVELHWMASGHPHIVSIIDVYENSYQGRKC  133 (400)
T ss_pred             hhhheehhhhhccccCCceEEEEeccchhhhHHHHHhcC------HHHHhHhhhhhhhcCCCceEEeehhhhhhccCcee
Confidence            444544 368999999999999876 7899999998653      2345677654444 69999999998732  23456


Q ss_pred             EEEEEEcCCCCCHHHHhhhcCCCCCCCCHHHHHHHHHHHHHHHhhhhCCCCCCCceeecCCCCCceeecC---CCCeEEe
Q 005586          483 CFLIYDFAPKGKLSKYLDQEEGSSNVLDWSTRVSIIIGIAKGIGYLHSSEVNKPAIVHRNLSVEKVLIDQ---QFNPLIA  559 (689)
Q Consensus       483 ~~lV~e~~~~gsL~~~L~~~~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~~~ivH~dlk~~NiLl~~---~~~~kl~  559 (689)
                      +++|||.|++|.|...+++.+.  .++++.+.-.|+.||..|+.|||+.+     |.||||||+|+|...   +-..||+
T Consensus       134 LLiVmE~meGGeLfsriq~~g~--~afTErea~eI~~qI~~Av~~lH~~n-----IAHRDlKpENLLyt~t~~na~lKLt  206 (400)
T KOG0604|consen  134 LLIVMECMEGGELFSRIQDRGD--QAFTEREASEIMKQIGLAVRYLHSMN-----IAHRDLKPENLLYTTTSPNAPLKLT  206 (400)
T ss_pred             eEeeeecccchHHHHHHHHccc--ccchHHHHHHHHHHHHHHHHHHHhcc-----hhhccCChhheeeecCCCCcceEec
Confidence            7899999999999999987653  56999999999999999999999988     999999999999974   5568999


Q ss_pred             cccccccccCCceeeeecCCCCCCCCCccccccCCCCCcccchhHHHHHHHHHhCCCCcchhHHHHHhhhhhhHhhcccc
Q 005586          560 DCGLHKLLADDIVFSVLKTSAAMGYLAPEYVTTGRFTERSDIFAFGVIILQILTGSLVLTSSMRLAAESATFENFIDRNL  639 (689)
Q Consensus       560 DfGla~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~ksDV~sfGvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~  639 (689)
                      |||+|+.-....  ......-|+.|.|||++...+|+...|+||+||++|-|+.|.+||++....+... .+..-+. ..
T Consensus       207 DfGFAK~t~~~~--~L~TPc~TPyYvaPevlg~eKydkscdmwSlgVimYIlLCGyPPFYS~hg~aisp-gMk~rI~-~g  282 (400)
T KOG0604|consen  207 DFGFAKETQEPG--DLMTPCFTPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGYPPFYSNHGLAISP-GMKRRIR-TG  282 (400)
T ss_pred             ccccccccCCCc--cccCCcccccccCHHHhCchhcCCCCCccchhHHHHHhhcCCCcccccCCccCCh-hHHhHhh-cc
Confidence            999999765322  2223345788999999999999999999999999999999999998753322111 1111111 01


Q ss_pred             CCCCC----HHHHHHHHHHHHHhccCCCCCCCCHHHHHHHHHhh
Q 005586          640 KGKFS----ESEAAKLGKMALVCTHEDPENRPTMEAVIEELTVA  679 (689)
Q Consensus       640 ~~~~~----~~~~~~l~~l~~~Cl~~dp~~RPs~~evl~~L~~~  679 (689)
                      .-.+|    ...++...++++..+..+|++|.|+.|++.+-|..
T Consensus       283 qy~FP~pEWs~VSe~aKdlIR~LLkt~PteRlTI~~~m~hpwi~  326 (400)
T KOG0604|consen  283 QYEFPEPEWSCVSEAAKDLIRKLLKTEPTERLTIEEVMDHPWIN  326 (400)
T ss_pred             CccCCChhHhHHHHHHHHHHHHHhcCCchhheeHHHhhcCchhc
Confidence            11233    34577889999999999999999999999887654

>KOG0587 consensus Traf2- and Nck-interacting kinase and related germinal center kinase (GCK) family protein kinases [Signal transduction mechanisms]

Probab=99.98  E-value=6.4e-32  Score=292.94  Aligned_cols=264  Identities=22%  Similarity=0.386  Sum_probs=214.5

Q ss_pred             CHHHHHHHhccCCcccccccCCcceEEEEEe-cCCcEEEEEEecccCCchHHHHHHHHHHHHhcc-CCCcceeEeeEEEc
Q 005586          400 NLEEVESATQCFSEVNLLGKGNFSSVYKGTL-RDGTLVAIRSINVTSCKSEEAEFVKGLYLLTSL-RHENIIRLRGFCCS  477 (689)
Q Consensus       400 ~~~~l~~at~~f~~~~~lg~G~~g~Vy~~~~-~~g~~vavK~l~~~~~~~~~~~f~~e~~~l~~l-~H~niv~l~g~~~~  477 (689)
                      .++.+...++-|.+.+.||+|.+|.||+++. ++|+.+|+|++....  ....+...|.+++... .|||++.++|++.-
T Consensus        10 ~~~~lpdp~d~~ei~evig~Gtygkv~k~k~~~~~~~aa~kI~~~~~--d~deEiE~eynil~~~~~hpnv~~fyg~~~k   87 (953)
T KOG0587|consen   10 DLSSLPDPADIFEIIEVIGNGTYGKVYKGRHVKTGQLAAIKIMDPTE--DEEEEIELEYNMLKKYSHHPNVATFYGAFIK   87 (953)
T ss_pred             chhhCCCCCCccEEEEEEeeccceeEEEEeeeecCceeeeEeecCCc--cccHHHHHHHHHHHhccCCCCcceEEEEEEE
Confidence            3444455667788889999999999999985 479999999987664  3345677788888877 69999999999864


Q ss_pred             C---CCCeEEEEEEcCCCCCHHHHhhhcCCCCCCCCHHHHHHHHHHHHHHHhhhhCCCCCCCceeecCCCCCceeecCCC
Q 005586          478 R---GRGECFLIYDFAPKGKLSKYLDQEEGSSNVLDWSTRVSIIIGIAKGIGYLHSSEVNKPAIVHRNLSVEKVLIDQQF  554 (689)
Q Consensus       478 ~---~~~~~~lV~e~~~~gsL~~~L~~~~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~~~ivH~dlk~~NiLl~~~~  554 (689)
                      .   .++++++|||||.+||..++++.-.  ...+.|.....|++++++|+.+||...     ++|||||-.|||+++++
T Consensus        88 ~~~~~~DqLWLVMEfC~gGSVTDLVKn~~--g~rl~E~~IaYI~re~lrgl~HLH~nk-----viHRDikG~NiLLT~e~  160 (953)
T KOG0587|consen   88 KDPGNGDQLWLVMEFCGGGSVTDLVKNTK--GNRLKEEWIAYILREILRGLAHLHNNK-----VIHRDIKGQNVLLTENA  160 (953)
T ss_pred             ecCCCCCeEEEEeeccCCccHHHHHhhhc--ccchhhHHHHHHHHHHHHHHHHHhhcc-----eeeecccCceEEEeccC
Confidence            3   3578999999999999999998765  456999999999999999999999877     99999999999999999


Q ss_pred             CeEEecccccccccCCceeeeecCCCCCCCCCcccccc-----CCCCCcccchhHHHHHHHHHhCCCCcchhHHHHHhhh
Q 005586          555 NPLIADCGLHKLLADDIVFSVLKTSAAMGYLAPEYVTT-----GRFTERSDIFAFGVIILQILTGSLVLTSSMRLAAESA  629 (689)
Q Consensus       555 ~~kl~DfGla~~~~~~~~~~~~~~~~~~~y~aPE~~~~-----~~~~~ksDV~sfGvvl~elltG~~p~~~~~~~~~~~~  629 (689)
                      .+|+.|||++..+..... ......||+.|||||++.-     ..|+.++|+||+|++..||.-|.+|+.+..+...   
T Consensus       161 ~VKLvDFGvSaQldsT~g-rRnT~iGtP~WMAPEViac~e~~d~tyd~R~D~WsLGITaIEladG~PPl~DmHPmra---  236 (953)
T KOG0587|consen  161 EVKLVDFGVSAQLDSTVG-RRNTFIGTPYWMAPEVIACDESPDATYDYRSDLWSLGITAIEMAEGAPPLCDMHPMRA---  236 (953)
T ss_pred             cEEEeeeeeeeeeecccc-cccCcCCCcccccceeeecccCCCCCcccccchhhccceeehhcCCCCCccCcchhhh---
Confidence            999999999988765432 2334568999999999863     3477899999999999999999999976533221   


Q ss_pred             hhhHhhccccCCCCCHHHHHHHHHHHHHhccCCCCCCCCHHHHHHHH
Q 005586          630 TFENFIDRNLKGKFSESEAAKLGKMALVCTHEDPENRPTMEAVIEEL  676 (689)
Q Consensus       630 ~~~~~~~~~~~~~~~~~~~~~l~~l~~~Cl~~dp~~RPs~~evl~~L  676 (689)
                      -+.-.-.|..+..-++...+++.+++..|+.+|-++||++.+++++-
T Consensus       237 LF~IpRNPPPkLkrp~kWs~~FndFIs~cL~Kd~e~RP~~~~ll~hp  283 (953)
T KOG0587|consen  237 LFLIPRNPPPKLKRPKKWSKKFNDFISTCLVKDYEQRPSTEELLKHP  283 (953)
T ss_pred             hccCCCCCCccccchhhHHHHHHHHHHHHHhhccccCcchhhhccCC
Confidence            11111223334445778899999999999999999999999998763

>smart00220 S_TKc Serine/Threonine protein kinases, catalytic domain

Probab=99.97  E-value=2.6e-31  Score=267.19  Aligned_cols=239  Identities=25%  Similarity=0.382  Sum_probs=191.9

Q ss_pred             CcceEEEEEec-CCcEEEEEEecccCCchHHHHHHHHHHHHhccCCCcceeEeeEEEcCCCCeEEEEEEcCCCCCHHHHh
Q 005586          421 NFSSVYKGTLR-DGTLVAIRSINVTSCKSEEAEFVKGLYLLTSLRHENIIRLRGFCCSRGRGECFLIYDFAPKGKLSKYL  499 (689)
Q Consensus       421 ~~g~Vy~~~~~-~g~~vavK~l~~~~~~~~~~~f~~e~~~l~~l~H~niv~l~g~~~~~~~~~~~lV~e~~~~gsL~~~L  499 (689)
                      +||.||+|... +|+.+|+|++...........|.+|++.+++++|+|++++++++..  ....++++||+++++|.+++
T Consensus         1 ~~g~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~--~~~~~l~~e~~~~~~L~~~~   78 (244)
T smart00220        1 SFGKVYLARDKKTGKLVAIKVIKKEKIKKKRERILREISILKKLKHPNIVRLYDVFED--EDKLYLVMEYCDGGDLFDLL   78 (244)
T ss_pred             CceEEEEEEECCCCcEEEEEEecccccccHHHHHHHHHHHHHhCCCCcHHHHHhheee--CCEEEEEEeCCCCCCHHHHH
Confidence            58999999987 4899999999876533336789999999999999999999999854  46889999999999999999


Q ss_pred             hhcCCCCCCCCHHHHHHHHHHHHHHHhhhhCCCCCCCceeecCCCCCceeecCCCCeEEecccccccccCCceeeeecCC
Q 005586          500 DQEEGSSNVLDWSTRVSIIIGIAKGIGYLHSSEVNKPAIVHRNLSVEKVLIDQQFNPLIADCGLHKLLADDIVFSVLKTS  579 (689)
Q Consensus       500 ~~~~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~~~ivH~dlk~~NiLl~~~~~~kl~DfGla~~~~~~~~~~~~~~~  579 (689)
                      .....    +++..++.++.+++++++|||+.+     ++|+||+|+||++++++.++|+|||.+.......  ......
T Consensus        79 ~~~~~----~~~~~~~~~~~~l~~~l~~lh~~~-----i~h~~i~~~ni~~~~~~~~~l~d~~~~~~~~~~~--~~~~~~  147 (244)
T smart00220       79 KKRGR----LSEDEARFYARQILSALEYLHSNG-----IIHRDLKPENILLDEDGHVKLADFGLARQLDPGG--LLTTFV  147 (244)
T ss_pred             HhccC----CCHHHHHHHHHHHHHHHHHHHHcC-----eecCCcCHHHeEECCCCcEEEccccceeeecccc--cccccc
Confidence            76432    789999999999999999999987     9999999999999999999999999998765432  222344


Q ss_pred             CCCCCCCccccccCCCCCcccchhHHHHHHHHHhCCCCcchhHHHHHhhhhhhHhhccccCCCCCH-HHHHHHHHHHHHh
Q 005586          580 AAMGYLAPEYVTTGRFTERSDIFAFGVIILQILTGSLVLTSSMRLAAESATFENFIDRNLKGKFSE-SEAAKLGKMALVC  658 (689)
Q Consensus       580 ~~~~y~aPE~~~~~~~~~ksDV~sfGvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~l~~l~~~C  658 (689)
                      ++..|++||......++.++||||||++++||++|+.|+........   ................ ....++.+++.+|
T Consensus       148 ~~~~~~~pE~~~~~~~~~~~Di~slG~~l~~l~~~~~p~~~~~~~~~---~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~  224 (244)
T smart00220      148 GTPEYMAPEVLLGKGYGKAVDVWSLGVILYELLTGKPPFPGDDQLLE---LFKKIGKPKPPFPPPEWKISPEAKDLIRKL  224 (244)
T ss_pred             CCcCCCCHHHHccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCcHHH---HHHHHhccCCCCccccccCCHHHHHHHHHH
Confidence            66789999999888899999999999999999999999865211111   1111111111100000 1456899999999


Q ss_pred             ccCCCCCCCCHHHHHHH
Q 005586          659 THEDPENRPTMEAVIEE  675 (689)
Q Consensus       659 l~~dp~~RPs~~evl~~  675 (689)
                      +..+|++||++.+++++
T Consensus       225 l~~~p~~Rp~~~~~~~~  241 (244)
T smart00220      225 LVKDPEKRLTAEEALQH  241 (244)
T ss_pred             ccCCchhccCHHHHhhC
Confidence            99999999999999974

Phosphotransferases. Serine or threonine-specific kinase subfamily.

>PLN03225 Serine/threonine-protein kinase SNT7; Provisional

Probab=99.97  E-value=7.3e-32  Score=301.79  Aligned_cols=263  Identities=17%  Similarity=0.192  Sum_probs=173.2

Q ss_pred             HhccCCcccccccCCcceEEEEEec-C----CcEEEEEEecccCCchHHHHHHHHHHHHhccCCCcceeEeeEE----Ec
Q 005586          407 ATQCFSEVNLLGKGNFSSVYKGTLR-D----GTLVAIRSINVTSCKSEEAEFVKGLYLLTSLRHENIIRLRGFC----CS  477 (689)
Q Consensus       407 at~~f~~~~~lg~G~~g~Vy~~~~~-~----g~~vavK~l~~~~~~~~~~~f~~e~~~l~~l~H~niv~l~g~~----~~  477 (689)
                      ..++|...+.||+|+||.||+|.+. +    +..||+|++....   ....+..|  .+....+.+++.+...+    ..
T Consensus       130 ~~~~y~l~~~LG~G~FG~VYka~~~~~~~~~~~~vAvK~~~~~~---~~e~~~~e--~l~~~~~~~~~~~~~~~~~~~~~  204 (566)
T PLN03225        130 KKDDFVLGKKLGEGAFGVVYKASLVNKQSKKEGKYVLKKATEYG---AVEIWMNE--RVRRACPNSCADFVYGFLEPVSS  204 (566)
T ss_pred             ccCCeEEeEEEeeCCCeEEEEEEEcCCccccCcEEEEEEecccc---hhHHHHHH--HHHhhchhhHHHHHHhhhccccc
Confidence            4568889999999999999999986 4    6899999876432   11111111  12222233333222111    11


Q ss_pred             CCCCeEEEEEEcCCCCCHHHHhhhcCCC----------------CCCCCHHHHHHHHHHHHHHHhhhhCCCCCCCceeec
Q 005586          478 RGRGECFLIYDFAPKGKLSKYLDQEEGS----------------SNVLDWSTRVSIIIGIAKGIGYLHSSEVNKPAIVHR  541 (689)
Q Consensus       478 ~~~~~~~lV~e~~~~gsL~~~L~~~~~~----------------~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~~~ivH~  541 (689)
                      ....+.++||||+++++|.++++.....                .....+.....|+.|++.||+|||+.+     |+||
T Consensus       205 ~~~~~~~LV~ey~~~gsL~~~l~~~~~~~~v~~~l~~~~~~l~~~~~r~~~~i~~i~~qll~aL~yLH~~g-----IiHR  279 (566)
T PLN03225        205 KKEDEYWLVWRYEGESTLADLMQSKEFPYNVEPYLLGKVQDLPKGLERENKIIQTIMRQILFALDGLHSTG-----IVHR  279 (566)
T ss_pred             ccCCceEEEEEecCCCcHHHHHHhcCCchhHHHHhccchhhccccchhhHHHHHHHHHHHHHHHHHHHHCC-----EEeC
Confidence            3456799999999999999998754210                001123345679999999999999987     9999


Q ss_pred             CCCCCceeecC-CCCeEEecccccccccCCceeeeecCCCCCCCCCccccccC----------------------CCCCc
Q 005586          542 NLSVEKVLIDQ-QFNPLIADCGLHKLLADDIVFSVLKTSAAMGYLAPEYVTTG----------------------RFTER  598 (689)
Q Consensus       542 dlk~~NiLl~~-~~~~kl~DfGla~~~~~~~~~~~~~~~~~~~y~aPE~~~~~----------------------~~~~k  598 (689)
                      ||||+|||+++ ++.+||+|||+++.+............++++|||||.+...                      .++.+
T Consensus       280 DLKP~NILl~~~~~~~KL~DFGlA~~l~~~~~~~~~~~~~t~~Y~APE~~~~~~~~~~~~~~~~~~~~sp~l~~~~~~~k  359 (566)
T PLN03225        280 DVKPQNIIFSEGSGSFKIIDLGAAADLRVGINYIPKEFLLDPRYAAPEQYIMSTQTPSAPSAPVATALSPVLWQLNLPDR  359 (566)
T ss_pred             cCCHHHEEEeCCCCcEEEEeCCCccccccccccCCcccccCCCccChHHhhccCCCCCCccccccccccchhccccCCCC
Confidence            99999999996 58999999999987654332222334567899999965321                      24456


Q ss_pred             ccchhHHHHHHHHHhCCCCcchhHHHHHh---h-----hhhhHhhccccCCC----C--CHHHHHHHHHHHHHhccCCCC
Q 005586          599 SDIFAFGVIILQILTGSLVLTSSMRLAAE---S-----ATFENFIDRNLKGK----F--SESEAAKLGKMALVCTHEDPE  664 (689)
Q Consensus       599 sDV~sfGvvl~elltG~~p~~~~~~~~~~---~-----~~~~~~~~~~~~~~----~--~~~~~~~l~~l~~~Cl~~dp~  664 (689)
                      +|||||||+||||+++..+..........   .     ..+.....+.....    +  .........+++..|++.||+
T Consensus       360 ~DVwSlGviL~el~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~dLi~~mL~~dP~  439 (566)
T PLN03225        360 FDIYSAGLIFLQMAFPNLRSDSNLIQFNRQLKRNDYDLVAWRKLVEPRASPDLRRGFEVLDLDGGAGWELLKSMMRFKGR  439 (566)
T ss_pred             cccHHHHHHHHHHHhCcCCCchHHHHHHHHHHhcCCcHHHHHHhhccccchhhhhhhhhccccchHHHHHHHHHccCCcc
Confidence            79999999999999988776543211100   0     01111111110000    0  001122345899999999999


Q ss_pred             CCCCHHHHHHHHHhh
Q 005586          665 NRPTMEAVIEELTVA  679 (689)
Q Consensus       665 ~RPs~~evl~~L~~~  679 (689)
                      +|||+.|++++-+..
T Consensus       440 kR~ta~e~L~Hpff~  454 (566)
T PLN03225        440 QRISAKAALAHPYFD  454 (566)
T ss_pred             cCCCHHHHhCCcCcC
Confidence            999999999986654

>KOG0662 consensus Cyclin-dependent kinase CDK5 [Intracellular trafficking, secretion, and vesicular transport; Signal transduction mechanisms]

Probab=99.97  E-value=3.2e-31  Score=236.74  Aligned_cols=255  Identities=20%  Similarity=0.361  Sum_probs=190.3

Q ss_pred             cCCcccccccCCcceEEEEEec-CCcEEEEEEecccCCch-HHHHHHHHHHHHhccCCCcceeEeeEEEcCCCCeEEEEE
Q 005586          410 CFSEVNLLGKGNFSSVYKGTLR-DGTLVAIRSINVTSCKS-EEAEFVKGLYLLTSLRHENIIRLRGFCCSRGRGECFLIY  487 (689)
Q Consensus       410 ~f~~~~~lg~G~~g~Vy~~~~~-~g~~vavK~l~~~~~~~-~~~~f~~e~~~l~~l~H~niv~l~g~~~~~~~~~~~lV~  487 (689)
                      .|...++||+|.||+||+|+.+ .+..||+|+++...... -.....+||-+++.++|+|||++++...+  ....-+|+
T Consensus         3 ~ydkmekigegtygtvfkarn~~t~eivalkrvrlddddegvpssalreicllkelkhknivrl~dvlhs--dkkltlvf   80 (292)
T KOG0662|consen    3 KYDKMEKIGEGTYGTVFKARNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRLHDVLHS--DKKLTLVF   80 (292)
T ss_pred             chHHHHhhcCCcceeeEecccCCccceEEEEEEeccCCCCCCcHHHHHHHHHHHHhhhcceeehhhhhcc--CceeEEeH
Confidence            3555688999999999999865 68899999998765433 34678899999999999999999998743  46788999


Q ss_pred             EcCCCCCHHHHhhhcCCCCCCCCHHHHHHHHHHHHHHHhhhhCCCCCCCceeecCCCCCceeecCCCCeEEecccccccc
Q 005586          488 DFAPKGKLSKYLDQEEGSSNVLDWSTRVSIIIGIAKGIGYLHSSEVNKPAIVHRNLSVEKVLIDQQFNPLIADCGLHKLL  567 (689)
Q Consensus       488 e~~~~gsL~~~L~~~~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~~~ivH~dlk~~NiLl~~~~~~kl~DfGla~~~  567 (689)
                      ||+. .+|..+...-.+   .++......++.|+++||.|+|+.+     +.|||+||.|.|++.+|+.|++|||+++-+
T Consensus        81 e~cd-qdlkkyfdslng---~~d~~~~rsfmlqllrgl~fchshn-----vlhrdlkpqnllin~ngelkladfglaraf  151 (292)
T KOG0662|consen   81 EFCD-QDLKKYFDSLNG---DLDPEIVRSFMLQLLRGLGFCHSHN-----VLHRDLKPQNLLINRNGELKLADFGLARAF  151 (292)
T ss_pred             HHhh-HHHHHHHHhcCC---cCCHHHHHHHHHHHHhhhhhhhhhh-----hhhccCCcceEEeccCCcEEecccchhhhc
Confidence            9995 489988876554   3889999999999999999999988     899999999999999999999999999987


Q ss_pred             cCCceeeeecCCCCCCCCCccccccCC-CCCcccchhHHHHHHHHHhCCCC-cchhHHHHHhhhhhh-------------
Q 005586          568 ADDIVFSVLKTSAAMGYLAPEYVTTGR-FTERSDIFAFGVIILQILTGSLV-LTSSMRLAAESATFE-------------  632 (689)
Q Consensus       568 ~~~~~~~~~~~~~~~~y~aPE~~~~~~-~~~ksDV~sfGvvl~elltG~~p-~~~~~~~~~~~~~~~-------------  632 (689)
                      +-... .......|.+|.+|.++.+.+ |+...|+||-||++.|+.....| |.+..-.....+++.             
T Consensus       152 gipvr-cysaevvtlwyrppdvlfgakly~tsidmwsagcifaelanagrplfpg~dvddqlkrif~~lg~p~ed~wps~  230 (292)
T KOG0662|consen  152 GIPVR-CYSAEVVTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPLFPGNDVDDQLKRIFRLLGTPTEDQWPSM  230 (292)
T ss_pred             CCceE-eeeceeeeeeccCcceeeeeehhccchHhhhcchHHHHHhhcCCCCCCCCcHHHHHHHHHHHhCCCccccCCcc
Confidence            65432 223345688999999988765 78999999999999999875444 432211111111111             


Q ss_pred             -HhhccccCCCCCH---------HHHHHHHHHHHHhccCCCCCCCCHHHHHHHH
Q 005586          633 -NFIDRNLKGKFSE---------SEAAKLGKMALVCTHEDPENRPTMEAVIEEL  676 (689)
Q Consensus       633 -~~~~~~~~~~~~~---------~~~~~l~~l~~~Cl~~dp~~RPs~~evl~~L  676 (689)
                       ...|....+.++.         .....=+++...-+.-+|.+|.++++.+++.
T Consensus       231 t~lpdyk~yp~ypattswsqivp~lns~grdllqkll~cnp~qrisaeaalqhp  284 (292)
T KOG0662|consen  231 TKLPDYKPYPIYPATTSWSQIVPKLNSTGRDLLQKLLKCNPAQRISAEAALQHP  284 (292)
T ss_pred             ccCCCCcccCCccccchHHHHhhhhcchhHHHHHHHhccCcccccCHHHHhcCc
Confidence             1111111112221         1111224555555666999999999988864

>KOG0607 consensus MAP kinase-interacting kinase and related serine/threonine protein kinases [Signal transduction mechanisms]

Probab=99.97  E-value=1.7e-31  Score=258.57  Aligned_cols=258  Identities=20%  Similarity=0.347  Sum_probs=198.0

Q ss_pred             HHHHHHHhccCCcccccccCCcceEEEEE-ecCCcEEEEEEecccCCchHHHHHHHHHHHHhccC-CCcceeEeeEEEcC
Q 005586          401 LEEVESATQCFSEVNLLGKGNFSSVYKGT-LRDGTLVAIRSINVTSCKSEEAEFVKGLYLLTSLR-HENIIRLRGFCCSR  478 (689)
Q Consensus       401 ~~~l~~at~~f~~~~~lg~G~~g~Vy~~~-~~~g~~vavK~l~~~~~~~~~~~f~~e~~~l~~l~-H~niv~l~g~~~~~  478 (689)
                      ++++-+-|+     +.||+|+|+.|--++ +.+|.++|||++.+.. ...+....+|++++...+ |+||++|+.|+  +
T Consensus        75 F~d~YkLt~-----e~LGeGAyasVqtcv~i~t~~EYAVKiidKq~-gHsR~RvfREVe~f~~Cqgh~nilqLiefF--E  146 (463)
T KOG0607|consen   75 FEDMYKLTS-----ELLGEGAYASVQTCVSIQTGKEYAVKIIDKQP-GHSRSRVFREVETFYQCQGHKNILQLIEFF--E  146 (463)
T ss_pred             HHHHHHhHH-----HHhcCccceeeeeeeeeccchhhhhhhhhcCC-chHHHHHHHHHHHHHHhcCCccHHHHHHHh--c
Confidence            455555553     789999999999886 5689999999998764 445667889999999995 99999999999  5


Q ss_pred             CCCeEEEEEEcCCCCCHHHHhhhcCCCCCCCCHHHHHHHHHHHHHHHhhhhCCCCCCCceeecCCCCCceeecCCCC---
Q 005586          479 GRGECFLIYDFAPKGKLSKYLDQEEGSSNVLDWSTRVSIIIGIAKGIGYLHSSEVNKPAIVHRNLSVEKVLIDQQFN---  555 (689)
Q Consensus       479 ~~~~~~lV~e~~~~gsL~~~L~~~~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~~~ivH~dlk~~NiLl~~~~~---  555 (689)
                      +....|+|||-|.+|.|..++++..    .+++.+...+..+||.||.|||..+     |.|||+||+|||-.+...   
T Consensus       147 dd~~FYLVfEKm~GGplLshI~~~~----~F~E~EAs~vvkdia~aLdFlH~kg-----IAHRDlKPENiLC~~pn~vsP  217 (463)
T KOG0607|consen  147 DDTRFYLVFEKMRGGPLLSHIQKRK----HFNEREASRVVKDIASALDFLHTKG-----IAHRDLKPENILCESPNKVSP  217 (463)
T ss_pred             ccceEEEEEecccCchHHHHHHHhh----hccHHHHHHHHHHHHHHHHHHhhcC-----cccccCCccceeecCCCCcCc
Confidence            5678999999999999999998764    3889999999999999999999998     999999999999976554   


Q ss_pred             eEEecccccccccCCcee------eeecCCCCCCCCCccccc-----cCCCCCcccchhHHHHHHHHHhCCCCcchhH--
Q 005586          556 PLIADCGLHKLLADDIVF------SVLKTSAAMGYLAPEYVT-----TGRFTERSDIFAFGVIILQILTGSLVLTSSM--  622 (689)
Q Consensus       556 ~kl~DfGla~~~~~~~~~------~~~~~~~~~~y~aPE~~~-----~~~~~~ksDV~sfGvvl~elltG~~p~~~~~--  622 (689)
                      +||+||.|..-.......      ......|+..|||||++.     ...|+.+.|.||+|||||-|+.|.+||.+.-  
T Consensus       218 vKiCDfDLgSg~k~~~~~spastP~L~tPvGSAEfMAPEVVd~fv~qA~~YDKrCDlwSLGvIlYImLsGYpPFvG~Cg~  297 (463)
T KOG0607|consen  218 VKICDFDLGSGIKLNNDCSPASTPELLTPVGSAEFMAPEVVDVFVDQATFYDKRCDLWSLGVILYIMLSGYPPFVGHCGA  297 (463)
T ss_pred             eeeeccccccccccCCCCCCCCCccccCcccchhhcchhHHhhhccccccccccccHHHHHHHHHHHHhCCCCccCccCC
Confidence            699999887544322111      122234566799999863     2458899999999999999999999995421  


Q ss_pred             -----HHH----HhhhhhhHhhccccCCCCCHH----HHHHHHHHHHHhccCCCCCCCCHHHHHHHHH
Q 005586          623 -----RLA----AESATFENFIDRNLKGKFSES----EAAKLGKMALVCTHEDPENRPTMEAVIEELT  677 (689)
Q Consensus       623 -----~~~----~~~~~~~~~~~~~~~~~~~~~----~~~~l~~l~~~Cl~~dp~~RPs~~evl~~L~  677 (689)
                           +..    -...-++.+.+.  .-.+|+.    .+.+..+++..-+..|+.+|-++.+++.+.+
T Consensus       298 dCGWdrGe~Cr~CQ~~LFesIQEG--kYeFPdkdWahIS~eakdlisnLlvrda~~rlsa~~vlnhPw  363 (463)
T KOG0607|consen  298 DCGWDRGEVCRVCQNKLFESIQEG--KYEFPDKDWAHISSEAKDLISNLLVRDAKQRLSAAQVLNHPW  363 (463)
T ss_pred             cCCccCCCccHHHHHHHHHHHhcc--CCcCChhhhHHhhHHHHHHHHHHHhccHHhhhhhhhccCCcc
Confidence                 110    011122222221  1233433    3667778888888899999999999998654

>KOG4236 consensus Serine/threonine protein kinase PKC mu/PKD and related proteins [Signal transduction mechanisms]

Probab=99.97  E-value=1.2e-31  Score=274.40  Aligned_cols=246  Identities=20%  Similarity=0.320  Sum_probs=196.6

Q ss_pred             ccccccCCcceEEEEEec-CCcEEEEEEecccCC-chHHHHHHHHHHHHhccCCCcceeEeeEEEcCCCCeEEEEEEcCC
Q 005586          414 VNLLGKGNFSSVYKGTLR-DGTLVAIRSINVTSC-KSEEAEFVKGLYLLTSLRHENIIRLRGFCCSRGRGECFLIYDFAP  491 (689)
Q Consensus       414 ~~~lg~G~~g~Vy~~~~~-~g~~vavK~l~~~~~-~~~~~~f~~e~~~l~~l~H~niv~l~g~~~~~~~~~~~lV~e~~~  491 (689)
                      .++||+|-||+||-|.++ +|+.||||++.+.+. .+.+.+..+|+.+|++++||.||.+.-.|  +..+..++|||-+.
T Consensus       569 devLGSGQFG~VYgg~hRktGrdVAvKvIdKlrFp~kqesqlR~EVaILq~l~HPGiV~le~M~--ET~ervFVVMEKl~  646 (888)
T KOG4236|consen  569 DEVLGSGQFGTVYGGKHRKTGRDVAVKVIDKLRFPTKQESQLRNEVAILQNLHHPGIVNLECMF--ETPERVFVVMEKLH  646 (888)
T ss_pred             HhhccCCcceeeecceecccCceeeeeeeecccCCCchHHHHHHHHHHHHhcCCCCeeEEEEee--cCCceEEEEehhhc
Confidence            479999999999999986 799999999987764 44567899999999999999999998766  56788999999995


Q ss_pred             CCCHHHHhhhcCCCCCCCCHHHHHHHHHHHHHHHhhhhCCCCCCCceeecCCCCCceeecC---CCCeEEeccccccccc
Q 005586          492 KGKLSKYLDQEEGSSNVLDWSTRVSIIIGIAKGIGYLHSSEVNKPAIVHRNLSVEKVLIDQ---QFNPLIADCGLHKLLA  568 (689)
Q Consensus       492 ~gsL~~~L~~~~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~~~ivH~dlk~~NiLl~~---~~~~kl~DfGla~~~~  568 (689)
                      +.=|+-.|....+   .|+...-..+..||+.||.|||..+     |+|+||||+||||..   --++||+|||+||..+
T Consensus       647 GDMLEMILSsEkg---RL~er~TkFlvtQIL~ALr~LH~kn-----IvHCDLKPENVLLas~~~FPQvKlCDFGfARiIg  718 (888)
T KOG4236|consen  647 GDMLEMILSSEKG---RLPERITKFLVTQILVALRYLHFKN-----IVHCDLKPENVLLASASPFPQVKLCDFGFARIIG  718 (888)
T ss_pred             chHHHHHHHhhcc---cchHHHHHHHHHHHHHHHHHhhhcc-----eeeccCCchheeeccCCCCCceeeccccceeecc
Confidence            5444545554443   3888888889999999999999988     999999999999964   3579999999999988


Q ss_pred             CCceeeeecCCCCCCCCCccccccCCCCCcccchhHHHHHHHHHhCCCCcchhHHHHHhhhhhhHhhcccc--CCCCCHH
Q 005586          569 DDIVFSVLKTSAAMGYLAPEYVTTGRFTERSDIFAFGVIILQILTGSLVLTSSMRLAAESATFENFIDRNL--KGKFSES  646 (689)
Q Consensus       569 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~ksDV~sfGvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~  646 (689)
                      +....  ....||+.|.|||++.++.|...-|+||.||++|--++|..||.......      +++.+..+  ......+
T Consensus       719 EksFR--rsVVGTPAYLaPEVLrnkGyNrSLDMWSVGVIiYVsLSGTFPFNEdEdIn------dQIQNAaFMyPp~PW~e  790 (888)
T KOG4236|consen  719 EKSFR--RSVVGTPAYLAPEVLRNKGYNRSLDMWSVGVIIYVSLSGTFPFNEDEDIN------DQIQNAAFMYPPNPWSE  790 (888)
T ss_pred             hhhhh--hhhcCCccccCHHHHhhccccccccceeeeEEEEEEecccccCCCccchh------HHhhccccccCCCchhh
Confidence            76532  24679999999999999999999999999999999999999997543221      11111111  1122345


Q ss_pred             HHHHHHHHHHHhccCCCCCCCCHHHHHHHHH
Q 005586          647 EAAKLGKMALVCTHEDPENRPTMEAVIEELT  677 (689)
Q Consensus       647 ~~~~l~~l~~~Cl~~dp~~RPs~~evl~~L~  677 (689)
                      ......+++..-++..-++|-+..+-+.+.|
T Consensus       791 is~~AidlIn~LLqVkm~kRysvdk~lsh~W  821 (888)
T KOG4236|consen  791 ISPEAIDLINNLLQVKMRKRYSVDKSLSHPW  821 (888)
T ss_pred             cCHHHHHHHHHHHHHHHHHhcchHhhccchh
Confidence            5667778888888888889999888776654

>KOG0669 consensus Cyclin T-dependent kinase CDK9 [Cell cycle control, cell division, chromosome partitioning]

Probab=99.97  E-value=1.9e-32  Score=257.03  Aligned_cols=263  Identities=20%  Similarity=0.350  Sum_probs=193.9

Q ss_pred             CCcccccccCCcceEEEEEec-CCcEEEEEEecccCCc-hHHHHHHHHHHHHhccCCCcceeEeeEEEcC------CCCe
Q 005586          411 FSEVNLLGKGNFSSVYKGTLR-DGTLVAIRSINVTSCK-SEEAEFVKGLYLLTSLRHENIIRLRGFCCSR------GRGE  482 (689)
Q Consensus       411 f~~~~~lg~G~~g~Vy~~~~~-~g~~vavK~l~~~~~~-~~~~~f~~e~~~l~~l~H~niv~l~g~~~~~------~~~~  482 (689)
                      |....+||+|.||.||+|+.+ .|+.||+|+..-+..+ .-.....+|+++|..++|+|++.++..|...      .+..
T Consensus        19 yek~~kigqGtfgeVFkAr~~n~~kkvalkkvlmeneKeGfpitalreikiL~~lkHenv~nliEic~tk~Tp~~r~r~t   98 (376)
T KOG0669|consen   19 YEKLAKIGQGTFGEVFKARSKNTGKKVALKKVLMENEKEGFPITALREIKILQLLKHENVVNLIEICRTKATPTNRDRAT   98 (376)
T ss_pred             HHHHHhcCCchHHHHHHHhhcCccchhHHHHHHHhccccCCcHHHHHHHHHHHHhcchhHHHHHHHHhhccCCcccccce
Confidence            334578999999999999976 5788898876533211 2224567899999999999999999988532      2345


Q ss_pred             EEEEEEcCCCCCHHHHhhhcCCCCCCCCHHHHHHHHHHHHHHHhhhhCCCCCCCceeecCCCCCceeecCCCCeEEeccc
Q 005586          483 CFLIYDFAPKGKLSKYLDQEEGSSNVLDWSTRVSIIIGIAKGIGYLHSSEVNKPAIVHRNLSVEKVLIDQQFNPLIADCG  562 (689)
Q Consensus       483 ~~lV~e~~~~gsL~~~L~~~~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~~~ivH~dlk~~NiLl~~~~~~kl~DfG  562 (689)
                      .++|+++++. +|..+|....   ..++..+..+++.++..||.|+|...     |+|||+|+.|||++.++..||+|||
T Consensus        99 ~ylVf~~ceh-DLaGlLsn~~---vr~sls~Ikk~Mk~Lm~GL~~iHr~k-----ilHRDmKaaNvLIt~dgilklADFG  169 (376)
T KOG0669|consen   99 FYLVFDFCEH-DLAGLLSNRK---VRFSLSEIKKVMKGLMNGLYYIHRNK-----ILHRDMKAANVLITKDGILKLADFG  169 (376)
T ss_pred             eeeeHHHhhh-hHHHHhcCcc---ccccHHHHHHHHHHHHHHHHHHHHhh-----HHhhcccHhhEEEcCCceEEeeccc
Confidence            8999999965 8999987653   34888999999999999999999987     9999999999999999999999999


Q ss_pred             ccccccCCc-e--eeeecCCCCCCCCCcccccc-CCCCCcccchhHHHHHHHHHhCCCCcchhHHHHHhh----------
Q 005586          563 LHKLLADDI-V--FSVLKTSAAMGYLAPEYVTT-GRFTERSDIFAFGVIILQILTGSLVLTSSMRLAAES----------  628 (689)
Q Consensus       563 la~~~~~~~-~--~~~~~~~~~~~y~aPE~~~~-~~~~~ksDV~sfGvvl~elltG~~p~~~~~~~~~~~----------  628 (689)
                      ++|.+.... .  ........|..|++||.+.+ ..|+++.|||.-||+|.||.||.+-+..........          
T Consensus       170 lar~fs~~~n~~kprytnrvvTLwYrppEllLG~r~yg~~iDiWgAgCimaeMwtrspimqgnteqqql~~Is~LcGs~t  249 (376)
T KOG0669|consen  170 LARAFSTSKNVVKPRYTNRVVTLWYRPPELLLGDREYGPPIDIWGAGCIMAEMWTRSPIMQGNTEQQQLHLISQLCGSIT  249 (376)
T ss_pred             cccceecccccCCCCcccceeeeecCCHHHhhcccccCCcchhHhHHHHHHHHHccCccccCChHHHHHHHHHHHhccCC
Confidence            998664321 1  11223345788999999876 468999999999999999999988775433221100          


Q ss_pred             ---------hhhhHhh--ccccCCCCC--HHH------HHHHHHHHHHhccCCCCCCCCHHHHHHHHHhhCCc
Q 005586          629 ---------ATFENFI--DRNLKGKFS--ESE------AAKLGKMALVCTHEDPENRPTMEAVIEELTVAAPV  682 (689)
Q Consensus       629 ---------~~~~~~~--~~~~~~~~~--~~~------~~~l~~l~~~Cl~~dp~~RPs~~evl~~L~~~~p~  682 (689)
                               ..+.+.+  .+-..+.+.  ++.      ..+..+++...+..||.+|++.++++.+-..-...
T Consensus       250 kevWP~~d~lpL~~sie~ePl~~~~~rkv~n~~kp~~kd~~a~dLle~ll~~DP~kR~~ad~alnh~~F~kdp  322 (376)
T KOG0669|consen  250 KEVWPNVDNLPLYQSIELEPLPKGQKRKVKNRLKPYVKDDEALDLLEKLLKLDPTKRIDADQALNHDFFWKDP  322 (376)
T ss_pred             cccCCCcccchHHHhccCCCCCcchhhhhhhhcccccCChhHHHHHHHHhccCcccCcchHhhhchhhhhcCC
Confidence                     0111111  110111110  111      23677888899999999999999999887655433

>KOG0696 consensus Serine/threonine protein kinase [Signal transduction mechanisms]

Probab=99.97  E-value=2.2e-31  Score=265.29  Aligned_cols=240  Identities=21%  Similarity=0.302  Sum_probs=190.9

Q ss_pred             cCCcccccccCCcceEEEEEec-CCcEEEEEEecccCC--chHHHHHHHHHHHHhcc-CCCcceeEeeEEEcCCCCeEEE
Q 005586          410 CFSEVNLLGKGNFSSVYKGTLR-DGTLVAIRSINVTSC--KSEEAEFVKGLYLLTSL-RHENIIRLRGFCCSRGRGECFL  485 (689)
Q Consensus       410 ~f~~~~~lg~G~~g~Vy~~~~~-~g~~vavK~l~~~~~--~~~~~~f~~e~~~l~~l-~H~niv~l~g~~~~~~~~~~~l  485 (689)
                      +|....+||+|+||.|-+|.-+ +...+|||++++.-.  ....+--+.|-++|+-- +-|.++++...+  ...+.+|.
T Consensus       350 DFnFl~VlGKGSFGKVlLaerkgtdELyAiKiLkKDViiQdDDvectm~EKrvLAL~~kppFL~qlHScF--QTmDRLyF  427 (683)
T KOG0696|consen  350 DFNFLMVLGKGSFGKVLLAERKGTDELYAIKILKKDVIIQDDDVECTMVEKRVLALPGKPPFLVQLHSCF--QTMDRLYF  427 (683)
T ss_pred             ccceEEEeccCccceeeeecccCcchhhhhhhhccceeeecCcccceehhhhheecCCCCchHHHHHHHh--hhhhheee
Confidence            6888899999999999999876 467899999986532  11222234556666655 678889888776  44678999


Q ss_pred             EEEcCCCCCHHHHhhhcCCCCCCCCHHHHHHHHHHHHHHHhhhhCCCCCCCceeecCCCCCceeecCCCCeEEecccccc
Q 005586          486 IYDFAPKGKLSKYLDQEEGSSNVLDWSTRVSIIIGIAKGIGYLHSSEVNKPAIVHRNLSVEKVLIDQQFNPLIADCGLHK  565 (689)
Q Consensus       486 V~e~~~~gsL~~~L~~~~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~~~ivH~dlk~~NiLl~~~~~~kl~DfGla~  565 (689)
                      ||||+.+|+|--++++.+.    +.+.....+|.+||-||-|||+.+     ||.||||..|||||.+|++||+|||+++
T Consensus       428 VMEyvnGGDLMyhiQQ~Gk----FKEp~AvFYAaEiaigLFFLh~kg-----IiYRDLKLDNvmLd~eGHiKi~DFGmcK  498 (683)
T KOG0696|consen  428 VMEYVNGGDLMYHIQQVGK----FKEPVAVFYAAEIAIGLFFLHSKG-----IIYRDLKLDNVMLDSEGHIKIADFGMCK  498 (683)
T ss_pred             EEEEecCchhhhHHHHhcc----cCCchhhhhhHHHHHHhhhhhcCC-----eeeeeccccceEeccCCceEeeeccccc
Confidence            9999999999999987654    666778899999999999999998     9999999999999999999999999998


Q ss_pred             cccCCceeeeecCCCCCCCCCccccccCCCCCcccchhHHHHHHHHHhCCCCcchhHHHHHhhhhhhHhhccccCCCCCH
Q 005586          566 LLADDIVFSVLKTSAAMGYLAPEYVTTGRFTERSDIFAFGVIILQILTGSLVLTSSMRLAAESATFENFIDRNLKGKFSE  645 (689)
Q Consensus       566 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~ksDV~sfGvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~  645 (689)
                      .---+.. .+....||+.|+|||++...+|+..+|+|||||+||||+.|++||+.....    ..+..+.+..  -.||.
T Consensus       499 Eni~~~~-TTkTFCGTPdYiAPEIi~YqPYgksvDWWa~GVLLyEmlaGQpPFdGeDE~----elF~aI~ehn--vsyPK  571 (683)
T KOG0696|consen  499 ENIFDGV-TTKTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQPPFDGEDED----ELFQAIMEHN--VSYPK  571 (683)
T ss_pred             ccccCCc-ceeeecCCCcccccceEEecccccchhHHHHHHHHHHHHcCCCCCCCCCHH----HHHHHHHHcc--CcCcc
Confidence            5322211 223345889999999999999999999999999999999999999765322    2233333333  24677


Q ss_pred             HHHHHHHHHHHHhccCCCCCCC
Q 005586          646 SEAAKLGKMALVCTHEDPENRP  667 (689)
Q Consensus       646 ~~~~~l~~l~~~Cl~~dp~~RP  667 (689)
                      ..+.+...+...-+...|.+|.
T Consensus       572 slSkEAv~ickg~ltK~P~kRL  593 (683)
T KOG0696|consen  572 SLSKEAVAICKGLLTKHPGKRL  593 (683)
T ss_pred             cccHHHHHHHHHHhhcCCcccc
Confidence            7778888888888889999884

>KOG0671 consensus LAMMER dual specificity kinases [Signal transduction mechanisms]

Probab=99.97  E-value=3.9e-31  Score=263.06  Aligned_cols=259  Identities=18%  Similarity=0.280  Sum_probs=199.1

Q ss_pred             hccCCcccccccCCcceEEEEEec-CCcEEEEEEecccCCchHHHHHHHHHHHHhccCCC------cceeEeeEEEcCCC
Q 005586          408 TQCFSEVNLLGKGNFSSVYKGTLR-DGTLVAIRSINVTSCKSEEAEFVKGLYLLTSLRHE------NIIRLRGFCCSRGR  480 (689)
Q Consensus       408 t~~f~~~~~lg~G~~g~Vy~~~~~-~g~~vavK~l~~~~~~~~~~~f~~e~~~l~~l~H~------niv~l~g~~~~~~~  480 (689)
                      +++|.....+|+|.||.|-.+..+ .+..||||+++...  .-....+-|+++|+++.+.      -+|.+.+|+  +..
T Consensus        88 ~~Ry~i~~~lGeGtFGkV~ec~D~~~~~~vAlKIik~V~--kYreAa~iEi~vLqki~~~DP~g~~rcv~m~~wF--dyr  163 (415)
T KOG0671|consen   88 TNRYEIVDLLGEGTFGKVVECWDRETKEHVALKIIKNVD--KYREAALIEIEVLQKINESDPNGKFRCVQMRDWF--DYR  163 (415)
T ss_pred             ccceehhhhhcCCcccceEEEeecCCCceehHHHHHHHH--HHhhHHHHHHHHHHHHHhcCCCCceEEEeeehhh--hcc
Confidence            678899999999999999999875 47899999997543  3334567789999999432      478888888  456


Q ss_pred             CeEEEEEEcCCCCCHHHHhhhcCCCCCCCCHHHHHHHHHHHHHHHhhhhCCCCCCCceeecCCCCCceeecC--------
Q 005586          481 GECFLIYDFAPKGKLSKYLDQEEGSSNVLDWSTRVSIIIGIAKGIGYLHSSEVNKPAIVHRNLSVEKVLIDQ--------  552 (689)
Q Consensus       481 ~~~~lV~e~~~~gsL~~~L~~~~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~~~ivH~dlk~~NiLl~~--------  552 (689)
                      ++.++|+|.| +-|+.++|..+.  ..+++..+...|+.|+.++++|||+.+     ++|-||||+|||+.+        
T Consensus       164 ghiCivfell-G~S~~dFlk~N~--y~~fpi~~ir~m~~QL~~sv~fLh~~k-----l~HTDLKPENILfvss~~~~~~~  235 (415)
T KOG0671|consen  164 GHICIVFELL-GLSTFDFLKENN--YIPFPIDHIRHMGYQLLESVAFLHDLK-----LTHTDLKPENILFVSSEYFKTYN  235 (415)
T ss_pred             CceEEEEecc-ChhHHHHhccCC--ccccchHHHHHHHHHHHHHHHHHHhcc-----eeecCCChheEEEeccceEEEec
Confidence            8899999998 669999998754  345888899999999999999999988     999999999999931        


Q ss_pred             ------------CCCeEEecccccccccCCceeeeecCCCCCCCCCccccccCCCCCcccchhHHHHHHHHHhCCCCcch
Q 005586          553 ------------QFNPLIADCGLHKLLADDIVFSVLKTSAAMGYLAPEYVTTGRFTERSDIFAFGVIILQILTGSLVLTS  620 (689)
Q Consensus       553 ------------~~~~kl~DfGla~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~ksDV~sfGvvl~elltG~~p~~~  620 (689)
                                  +..+||.|||-|+.-.+..    .....|-.|+|||++.+-.++.++||||+||+|.|+.||...|+.
T Consensus       236 ~k~~~~~~r~~ks~~I~vIDFGsAtf~~e~h----s~iVsTRHYRAPEViLgLGwS~pCDvWSiGCIL~ElytG~~LFqt  311 (415)
T KOG0671|consen  236 PKKKVCFIRPLKSTAIKVIDFGSATFDHEHH----STIVSTRHYRAPEVILGLGWSQPCDVWSIGCILVELYTGETLFQT  311 (415)
T ss_pred             cCCccceeccCCCcceEEEecCCcceeccCc----ceeeeccccCCchheeccCcCCccCceeeeeEEEEeeccceeccc
Confidence                        3458999999998765543    233456779999999999999999999999999999999987753


Q ss_pred             hH---HHHHhhhhh----hHhhccc----------cC-------C----------------CCCHHHHHHHHHHHHHhcc
Q 005586          621 SM---RLAAESATF----ENFIDRN----------LK-------G----------------KFSESEAAKLGKMALVCTH  660 (689)
Q Consensus       621 ~~---~~~~~~~~~----~~~~~~~----------~~-------~----------------~~~~~~~~~l~~l~~~Cl~  660 (689)
                      -.   ..+.-+..+    ..++.+.          +.       +                .....+..++.+|+..++.
T Consensus       312 Hen~EHLaMMerIlGp~P~~mi~r~~~~Kyf~~~rldw~e~~~~~~~k~v~~~ckpl~~~~~~~d~e~~~LfDLl~~mL~  391 (415)
T KOG0671|consen  312 HENLEHLAMMERILGPIPSRMIKKTRKEKYFRRGRLDWPEVSSKGKSKYVFEPCKPLKKYMLQDDLEHVQLFDLLRRMLE  391 (415)
T ss_pred             CCcHHHHHHHHHhhCCCcHHHhhhhhhHhhhhcccccCccccccccchhhhcCCccHHHHhccCcHHHhHHHHHHHHHHc
Confidence            21   111100000    0001100          00       0                0123567789999999999


Q ss_pred             CCCCCCCCHHHHHHHHHhhCCc
Q 005586          661 EDPENRPTMEAVIEELTVAAPV  682 (689)
Q Consensus       661 ~dp~~RPs~~evl~~L~~~~p~  682 (689)
                      .||.+|+|..|++++-......
T Consensus       392 fDP~~RiTl~EAL~HpFF~~~~  413 (415)
T KOG0671|consen  392 FDPARRITLREALSHPFFARLT  413 (415)
T ss_pred             cCccccccHHHHhcCHHhhcCC
Confidence            9999999999999987766543

>KOG0984 consensus Mitogen-activated protein kinase (MAPK) kinase MKK3/MKK6 [Signal transduction mechanisms]

Probab=99.97  E-value=2.7e-31  Score=242.73  Aligned_cols=200  Identities=19%  Similarity=0.349  Sum_probs=166.3

Q ss_pred             ccccccCCcceEEEEEec-CCcEEEEEEecccCCchHHHHHHHHHHHHhcc-CCCcceeEeeEEEcCCCCeEEEEEEcCC
Q 005586          414 VNLLGKGNFSSVYKGTLR-DGTLVAIRSINVTSCKSEEAEFVKGLYLLTSL-RHENIIRLRGFCCSRGRGECFLIYDFAP  491 (689)
Q Consensus       414 ~~~lg~G~~g~Vy~~~~~-~g~~vavK~l~~~~~~~~~~~f~~e~~~l~~l-~H~niv~l~g~~~~~~~~~~~lV~e~~~  491 (689)
                      ...||+|+||.|-+-++. +|+..|+|+++..-..+.+++...|+.+..+- ..|.+|.++|.+..+  ...++.||.|.
T Consensus        51 i~elGrGayG~vekmrh~~sg~imAvKri~~tvn~q~q~r~L~dldi~~r~~~CPf~V~FyGa~~re--gdvwIcME~M~  128 (282)
T KOG0984|consen   51 IEELGRGAYGVVEKMRHIQSGTIMAVKRIRATVNSQEQKRLLMDLDIIMRTVDCPFTVHFYGALFRE--GDVWICMELMD  128 (282)
T ss_pred             hhhhcCCccchhhheeeccCCeEEEEeeehhhcChHHHHHHHHhhhhhccCCCCCeEEEeehhhhcc--ccEEEeHHHhh
Confidence            467999999999888875 79999999998876667778888899876655 799999999987543  67999999994


Q ss_pred             CCCHHHHhhhcCCCCCCCCHHHHHHHHHHHHHHHhhhhCCCCCCCceeecCCCCCceeecCCCCeEEecccccccccCCc
Q 005586          492 KGKLSKYLDQEEGSSNVLDWSTRVSIIIGIAKGIGYLHSSEVNKPAIVHRNLSVEKVLIDQQFNPLIADCGLHKLLADDI  571 (689)
Q Consensus       492 ~gsL~~~L~~~~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~~~ivH~dlk~~NiLl~~~~~~kl~DfGla~~~~~~~  571 (689)
                       -||..+-++.-.....+++.-.=+||..|.+||.|||+.-.    +||||+||+|||++.+|++|++|||++..+.+..
T Consensus       129 -tSldkfy~~v~~~g~~ipE~vlGkIa~Svv~al~~L~~kL~----vIHRDvKPsNiLIn~~GqVKiCDFGIsG~L~dSi  203 (282)
T KOG0984|consen  129 -TSLDKFYRKVLKKGGTIPEDVLGKIAVSVVHALEFLHSKLS----VIHRDVKPSNILINYDGQVKICDFGISGYLVDSI  203 (282)
T ss_pred             -hhHHHHHHHHHhcCCcCchHHhhHhHHHHHHHHHHHHHHhh----hhhccCCcceEEEccCCcEEEcccccceeehhhh
Confidence             58888766543344568888889999999999999998643    9999999999999999999999999998886643


Q ss_pred             eeeeecCCCCCCCCCcccccc----CCCCCcccchhHHHHHHHHHhCCCCcchhH
Q 005586          572 VFSVLKTSAAMGYLAPEYVTT----GRFTERSDIFAFGVIILQILTGSLVLTSSM  622 (689)
Q Consensus       572 ~~~~~~~~~~~~y~aPE~~~~----~~~~~ksDV~sfGvvl~elltG~~p~~~~~  622 (689)
                      ..  .-..|...|||||.+..    ..|+-||||||+|+.+.||.+++.|+..+.
T Consensus       204 Ak--t~daGCkpYmaPEri~~e~n~~gY~vksDvWSLGItmiElA~lr~PY~~w~  256 (282)
T KOG0984|consen  204 AK--TMDAGCKPYMAPERINPELNQKGYSVKSDVWSLGITMIEMAILRFPYESWG  256 (282)
T ss_pred             HH--HHhcCCCccCChhhcCcccCcccceeehhhhhhhhhhhhhhhccccccccC
Confidence            21  11345567999999753    368999999999999999999999998763

>KOG1027 consensus Serine/threonine protein kinase and endoribonuclease ERN1/IRE1, sensor of the unfolded protein response pathway [Signal transduction mechanisms]

Probab=99.97  E-value=9.5e-31  Score=282.61  Aligned_cols=247  Identities=26%  Similarity=0.385  Sum_probs=186.0

Q ss_pred             CCcccccccCCcc-eEEEEEecCCcEEEEEEecccCCchHHHHHHHHHHHHhcc-CCCcceeEeeEEEcCCCCeEEEEEE
Q 005586          411 FSEVNLLGKGNFS-SVYKGTLRDGTLVAIRSINVTSCKSEEAEFVKGLYLLTSL-RHENIIRLRGFCCSRGRGECFLIYD  488 (689)
Q Consensus       411 f~~~~~lg~G~~g-~Vy~~~~~~g~~vavK~l~~~~~~~~~~~f~~e~~~l~~l-~H~niv~l~g~~~~~~~~~~~lV~e  488 (689)
                      |...+++|.|+-| .||+|... |+.||||++-.+.    ..-..+|+..|..- +|||||+++  |.+.+++..||..|
T Consensus       511 ~~~~eilG~Gs~Gt~Vf~G~ye-~R~VAVKrll~e~----~~~A~rEi~lL~eSD~H~NviRyy--c~E~d~qF~YIalE  583 (903)
T KOG1027|consen  511 FSPKEILGYGSNGTVVFRGVYE-GREVAVKRLLEEF----FDFAQREIQLLQESDEHPNVIRYY--CSEQDRQFLYIALE  583 (903)
T ss_pred             eccHHHcccCCCCcEEEEEeeC-CceehHHHHhhHh----HHHHHHHHHHHHhccCCCceEEEE--eeccCCceEEEEeh
Confidence            4445778998876 57999996 8899999987543    23346899999888 699999985  56678889999999


Q ss_pred             cCCCCCHHHHhhhcCCCCCCCCHHHHHHHHHHHHHHHhhhhCCCCCCCceeecCCCCCceeecC---C--CCeEEecccc
Q 005586          489 FAPKGKLSKYLDQEEGSSNVLDWSTRVSIIIGIAKGIGYLHSSEVNKPAIVHRNLSVEKVLIDQ---Q--FNPLIADCGL  563 (689)
Q Consensus       489 ~~~~gsL~~~L~~~~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~~~ivH~dlk~~NiLl~~---~--~~~kl~DfGl  563 (689)
                      .| ..+|.+++...........-...+.+..|+++||++||+.+     ||||||||.||||+.   +  ..++|+|||+
T Consensus       584 LC-~~sL~dlie~~~~d~~~~~~i~~~~~l~q~~~GlaHLHsl~-----iVHRDLkPQNILI~~~~~~~~~ra~iSDfgl  657 (903)
T KOG1027|consen  584 LC-ACSLQDLIESSGLDVEMQSDIDPISVLSQIASGLAHLHSLK-----IVHRDLKPQNILISVPSADGTLRAKISDFGL  657 (903)
T ss_pred             Hh-hhhHHHHHhccccchhhcccccHHHHHHHHHHHHHHHHhcc-----cccccCCCceEEEEccCCCcceeEEeccccc
Confidence            99 56999999874111111111344678899999999999987     999999999999986   3  4689999999


Q ss_pred             cccccCCc--eeeeecCCCCCCCCCccccccCCCCCcccchhHHHHHHHHHhC-CCCcchhHHHHHhhhhhhHhhccccC
Q 005586          564 HKLLADDI--VFSVLKTSAAMGYLAPEYVTTGRFTERSDIFAFGVIILQILTG-SLVLTSSMRLAAESATFENFIDRNLK  640 (689)
Q Consensus       564 a~~~~~~~--~~~~~~~~~~~~y~aPE~~~~~~~~~ksDV~sfGvvl~elltG-~~p~~~~~~~~~~~~~~~~~~~~~~~  640 (689)
                      ++.+..+.  ........||-||+|||.+...+-+.++|+||+|||+|+.+|| +.||.+.......  ++....  .+.
T Consensus       658 sKkl~~~~sS~~r~s~~sGt~GW~APE~L~~~~~~~avDiFslGCvfyYvltgG~HpFGd~~~R~~N--Il~~~~--~L~  733 (903)
T KOG1027|consen  658 SKKLAGGKSSFSRLSGGSGTSGWQAPEQLREDRKTQAVDIFSLGCVFYYVLTGGSHPFGDSLERQAN--ILTGNY--TLV  733 (903)
T ss_pred             ccccCCCcchhhcccCCCCcccccCHHHHhccccCcccchhhcCceEEEEecCCccCCCchHHhhhh--hhcCcc--cee
Confidence            99886543  2234456789999999999998888999999999999999997 8999765322111  110000  000


Q ss_pred             CCCCHHHHHHHHHHHHHhccCCCCCCCCHHHHHHH
Q 005586          641 GKFSESEAAKLGKMALVCTHEDPENRPTMEAVIEE  675 (689)
Q Consensus       641 ~~~~~~~~~~l~~l~~~Cl~~dp~~RPs~~evl~~  675 (689)
                       ........+..+|+.+|++.||..||++.+|+.|
T Consensus       734 -~L~~~~d~eA~dLI~~ml~~dP~~RPsa~~VL~H  767 (903)
T KOG1027|consen  734 -HLEPLPDCEAKDLISRMLNPDPQLRPSATDVLNH  767 (903)
T ss_pred             -eeccCchHHHHHHHHHhcCCCcccCCCHHHHhCC
Confidence             0011111188899999999999999999999865

>KOG0608 consensus Warts/lats-like serine threonine kinases [Cell cycle control, cell division, chromosome partitioning]

Probab=99.96  E-value=6.6e-30  Score=266.72  Aligned_cols=235  Identities=19%  Similarity=0.337  Sum_probs=183.6

Q ss_pred             ccCCcccccccCCcceEEEEEe-cCCcEEEEEEecccCC--chHHHHHHHHHHHHhccCCCcceeEeeEEEcCCCCeEEE
Q 005586          409 QCFSEVNLLGKGNFSSVYKGTL-RDGTLVAIRSINVTSC--KSEEAEFVKGLYLLTSLRHENIIRLRGFCCSRGRGECFL  485 (689)
Q Consensus       409 ~~f~~~~~lg~G~~g~Vy~~~~-~~g~~vavK~l~~~~~--~~~~~~f~~e~~~l~~l~H~niv~l~g~~~~~~~~~~~l  485 (689)
                      .-|..++.||-|+||+|.+++- ++...+|.|.+++.+.  .........|-.+|+....+-||+|+--|  .+.+.+|+
T Consensus       629 SmFvkik~iGvGAFGeV~Lv~KvDT~~lYAmKTLrKaDVl~rnQvaHVKAERDILAEADn~WVVrLyySF--QDkdnLYF  706 (1034)
T KOG0608|consen  629 SMFVKIKTIGVGAFGEVCLVRKVDTRALYAMKTLRKADVLMRNQVAHVKAERDILAEADNEWVVRLYYSF--QDKDNLYF  706 (1034)
T ss_pred             cceEEEeeecccccceeEEEeecchhhHHHHhhhHHHHHHhhhhhhhhhhhhhhHhhcCCcceEEEEEEe--ccCCceEE
Confidence            4577788999999999999974 4577899999987653  23345677899999999999999997655  55688999


Q ss_pred             EEEcCCCCCHHHHhhhcCCCCCCCCHHHHHHHHHHHHHHHhhhhCCCCCCCceeecCCCCCceeecCCCCeEEecccccc
Q 005586          486 IYDFAPKGKLSKYLDQEEGSSNVLDWSTRVSIIIGIAKGIGYLHSSEVNKPAIVHRNLSVEKVLIDQQFNPLIADCGLHK  565 (689)
Q Consensus       486 V~e~~~~gsL~~~L~~~~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~~~ivH~dlk~~NiLl~~~~~~kl~DfGla~  565 (689)
                      ||||+++|++-.+|...+    .+++.....++.+++.|+++.|..|     +|||||||.|||||.||++||.||||+.
T Consensus       707 VMdYIPGGDmMSLLIrmg----IFeE~LARFYIAEltcAiesVHkmG-----FIHRDiKPDNILIDrdGHIKLTDFGLCT  777 (1034)
T KOG0608|consen  707 VMDYIPGGDMMSLLIRMG----IFEEDLARFYIAELTCAIESVHKMG-----FIHRDIKPDNILIDRDGHIKLTDFGLCT  777 (1034)
T ss_pred             EEeccCCccHHHHHHHhc----cCHHHHHHHHHHHHHHHHHHHHhcc-----ceecccCccceEEccCCceeeeeccccc
Confidence            999999999999997654    3788888889999999999999998     9999999999999999999999999975


Q ss_pred             ccc---CCcee--------------------------------------eeecCCCCCCCCCccccccCCCCCcccchhH
Q 005586          566 LLA---DDIVF--------------------------------------SVLKTSAAMGYLAPEYVTTGRFTERSDIFAF  604 (689)
Q Consensus       566 ~~~---~~~~~--------------------------------------~~~~~~~~~~y~aPE~~~~~~~~~ksDV~sf  604 (689)
                      -+.   +..++                                      ......||..|+|||++....|+.-+|+||.
T Consensus       778 GfRWTHdskYYq~gdH~RqDSmep~~e~~d~~~~lkvL~~ra~~~h~r~~ahslvgt~nyiapevl~r~g~~q~cdwws~  857 (1034)
T KOG0608|consen  778 GFRWTHDSKYYQEGDHHRQDSMEPSPEWADISKCLKVLERRAMRQHQRILAHSLVGTPNYIAPEVLARTGYTQLCDWWSV  857 (1034)
T ss_pred             cceeccccccccCCCccccccCCCchhhccccccchHHHHHHHhhhhhhhhhhhcCCCcccChHHhcccCccccchhhHh
Confidence            431   11000                                      0011357888999999999999999999999


Q ss_pred             HHHHHHHHhCCCCcchhHHHHHh--hhhhhHhhccccCCCCCHHHHHHHHHH
Q 005586          605 GVIILQILTGSLVLTSSMRLAAE--SATFENFIDRNLKGKFSESEAAKLGKM  654 (689)
Q Consensus       605 Gvvl~elltG~~p~~~~~~~~~~--~~~~~~~~~~~~~~~~~~~~~~~l~~l  654 (689)
                      |||||||+.|+.||-........  ...++.+++-...+....++..-+.+|
T Consensus       858 gvil~em~~g~~pf~~~tp~~tq~kv~nw~~~l~~~~~~~ls~e~~~li~kL  909 (1034)
T KOG0608|consen  858 GVILYEMLVGQPPFLADTPGETQYKVINWRNFLHIPYQGNLSKEALDLIQKL  909 (1034)
T ss_pred             hHHHHHHhhCCCCccCCCCCcceeeeeehhhccccccccccCHHHHHHHHHH
Confidence            99999999999999654332221  224455555555555555555444444

>KOG0614 consensus cGMP-dependent protein kinase [Signal transduction mechanisms]

Probab=99.96  E-value=1.7e-30  Score=265.39  Aligned_cols=250  Identities=18%  Similarity=0.282  Sum_probs=203.4

Q ss_pred             CcccccccCCcceEEEEEecCCc-EEEEEEecccCC--chHHHHHHHHHHHHhccCCCcceeEeeEEEcCCCCeEEEEEE
Q 005586          412 SEVNLLGKGNFSSVYKGTLRDGT-LVAIRSINVTSC--KSEEAEFVKGLYLLTSLRHENIIRLRGFCCSRGRGECFLIYD  488 (689)
Q Consensus       412 ~~~~~lg~G~~g~Vy~~~~~~g~-~vavK~l~~~~~--~~~~~~f~~e~~~l~~l~H~niv~l~g~~~~~~~~~~~lV~e  488 (689)
                      .....||-||||.|=++..+... .+|+|.+++...  ...+.....|-.+|.+.+.|.||++|.-|  .+...+|++||
T Consensus       423 ~~iaTLGvGgFGRVELV~~~~~~~~fAlKilkK~hIVdtkQqeHv~sEr~Im~~~~s~fIvrLYrTf--rd~kyvYmLmE  500 (732)
T KOG0614|consen  423 KRIATLGVGGFGRVELVKVNSQKATFALKILKKKHIVDTKQQEHVFSERNIMMECRSDFIVRLYRTF--RDSKYVYMLME  500 (732)
T ss_pred             hhhhhcccCccceEEEEEecccchHHHHHHHhHhhccchhHHHHHHhHHHHHHhcCchHHHHHHHHh--ccchhhhhhHH
Confidence            34457999999999999887433 488888876542  33455778899999999999999999877  55688999999


Q ss_pred             cCCCCCHHHHhhhcCCCCCCCCHHHHHHHHHHHHHHHhhhhCCCCCCCceeecCCCCCceeecCCCCeEEeccccccccc
Q 005586          489 FAPKGKLSKYLDQEEGSSNVLDWSTRVSIIIGIAKGIGYLHSSEVNKPAIVHRNLSVEKVLIDQQFNPLIADCGLHKLLA  568 (689)
Q Consensus       489 ~~~~gsL~~~L~~~~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~~~ivH~dlk~~NiLl~~~~~~kl~DfGla~~~~  568 (689)
                      -|-+|.|...|++.+.    ++..+...++..+.+|++|||+.+     ||.|||||+|.+||.+|-+||.|||+|+.+.
T Consensus       501 aClGGElWTiLrdRg~----Fdd~tarF~~acv~EAfeYLH~k~-----iIYRDLKPENllLd~~Gy~KLVDFGFAKki~  571 (732)
T KOG0614|consen  501 ACLGGELWTILRDRGS----FDDYTARFYVACVLEAFEYLHRKG-----IIYRDLKPENLLLDNRGYLKLVDFGFAKKIG  571 (732)
T ss_pred             hhcCchhhhhhhhcCC----cccchhhhhHHHHHHHHHHHHhcC-----ceeccCChhheeeccCCceEEeehhhHHHhc
Confidence            9999999999987653    888888999999999999999998     9999999999999999999999999999887


Q ss_pred             CCceeeeecCCCCCCCCCccccccCCCCCcccchhHHHHHHHHHhCCCCcchhHHHHHhhhhhhHhhccccCCCCCHHHH
Q 005586          569 DDIVFSVLKTSAAMGYLAPEYVTTGRFTERSDIFAFGVIILQILTGSLVLTSSMRLAAESATFENFIDRNLKGKFSESEA  648 (689)
Q Consensus       569 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~ksDV~sfGvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  648 (689)
                      .+.  .+....||+.|.|||++.+...+..+|.||+|+++|||+||++||...........++.. +|   ...+|....
T Consensus       572 ~g~--KTwTFcGTpEYVAPEIILnKGHD~avDyWaLGIli~ELL~G~pPFs~~dpmktYn~ILkG-id---~i~~Pr~I~  645 (732)
T KOG0614|consen  572 SGR--KTWTFCGTPEYVAPEIILNKGHDRAVDYWALGILIYELLTGSPPFSGVDPMKTYNLILKG-ID---KIEFPRRIT  645 (732)
T ss_pred             cCC--ceeeecCCcccccchhhhccCcchhhHHHHHHHHHHHHHcCCCCCCCCchHHHHHHHHhh-hh---hhhcccccc
Confidence            654  333456899999999999999999999999999999999999999765443333222221 11   123455666


Q ss_pred             HHHHHHHHHhccCCCCCCCC-----HHHHHHHHHh
Q 005586          649 AKLGKMALVCTHEDPENRPT-----MEAVIEELTV  678 (689)
Q Consensus       649 ~~l~~l~~~Cl~~dp~~RPs-----~~evl~~L~~  678 (689)
                      ....+++++-+...|.+|.-     +.|+-+|-|.
T Consensus       646 k~a~~Lik~LCr~~P~ERLG~~~~gI~DIkkH~Wf  680 (732)
T KOG0614|consen  646 KTATDLIKKLCRDNPTERLGYQKGGINDIKKHRWF  680 (732)
T ss_pred             hhHHHHHHHHHhcCcHhhhccccCChHHHHhhhhh
Confidence            77888888888899999976     6777777654

>cd00180 PKc Catalytic domain of Protein Kinases

Probab=99.96  E-value=6.3e-28  Score=236.55  Aligned_cols=212  Identities=32%  Similarity=0.566  Sum_probs=182.0

Q ss_pred             cccCCcceEEEEEecC-CcEEEEEEecccCCchHHHHHHHHHHHHhccCCCcceeEeeEEEcCCCCeEEEEEEcCCCCCH
Q 005586          417 LGKGNFSSVYKGTLRD-GTLVAIRSINVTSCKSEEAEFVKGLYLLTSLRHENIIRLRGFCCSRGRGECFLIYDFAPKGKL  495 (689)
Q Consensus       417 lg~G~~g~Vy~~~~~~-g~~vavK~l~~~~~~~~~~~f~~e~~~l~~l~H~niv~l~g~~~~~~~~~~~lV~e~~~~gsL  495 (689)
                      ||+|.+|.||++...+ |+.+++|++...........+.+|++.+.+++|++++++++++..  ....++++||+++++|
T Consensus         1 l~~g~~~~v~~~~~~~~~~~~~~K~~~~~~~~~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~--~~~~~~~~e~~~~~~l   78 (215)
T cd00180           1 LGEGGFGTVYLARDKKTGKKVAIKIIKKEDSSSLLEELLREIEILKKLNHPNIVKLYGVFED--ENHLYLVMEYCEGGSL   78 (215)
T ss_pred             CCcCCceEEEEEEecCCCcEEEEEEeccccchhHHHHHHHHHHHHHhcCCCCeeeEeeeeec--CCeEEEEEecCCCCcH
Confidence            6899999999999864 899999999876533245689999999999999999999999854  3688999999999999


Q ss_pred             HHHhhhcCCCCCCCCHHHHHHHHHHHHHHHhhhhCCCCCCCceeecCCCCCceeecC-CCCeEEecccccccccCCceee
Q 005586          496 SKYLDQEEGSSNVLDWSTRVSIIIGIAKGIGYLHSSEVNKPAIVHRNLSVEKVLIDQ-QFNPLIADCGLHKLLADDIVFS  574 (689)
Q Consensus       496 ~~~L~~~~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~~~ivH~dlk~~NiLl~~-~~~~kl~DfGla~~~~~~~~~~  574 (689)
                      .+++....   ..+++..+..++.+++++++|||+.+     ++|+||+|.||++++ ++.++|+|||.+........ .
T Consensus        79 ~~~~~~~~---~~~~~~~~~~~~~~l~~~l~~lh~~~-----~~H~dl~~~ni~~~~~~~~~~l~d~~~~~~~~~~~~-~  149 (215)
T cd00180          79 KDLLKENE---GKLSEDEILRILLQILEGLEYLHSNG-----IIHRDLKPENILLDSDNGKVKLADFGLSKLLTSDKS-L  149 (215)
T ss_pred             HHHHHhcc---CCCCHHHHHHHHHHHHHHHHHHHhCC-----eeccCCCHhhEEEeCCCCcEEEecCCceEEccCCcc-h
Confidence            99997652   24889999999999999999999987     999999999999999 89999999999986654321 1


Q ss_pred             eecCCCCCCCCCccccccC-CCCCcccchhHHHHHHHHHhCCCCcchhHHHHHhhhhhhHhhccccCCCCCHHHHHHHHH
Q 005586          575 VLKTSAAMGYLAPEYVTTG-RFTERSDIFAFGVIILQILTGSLVLTSSMRLAAESATFENFIDRNLKGKFSESEAAKLGK  653 (689)
Q Consensus       575 ~~~~~~~~~y~aPE~~~~~-~~~~ksDV~sfGvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~  653 (689)
                      .....+...|++||..... .++.++|+|++|++++||                                     ..+.+
T Consensus       150 ~~~~~~~~~~~~pe~~~~~~~~~~~~D~~~lg~~~~~l-------------------------------------~~~~~  192 (215)
T cd00180         150 LKTIVGTPAYMAPEVLLGKGYYSEKSDIWSLGVILYEL-------------------------------------PELKD  192 (215)
T ss_pred             hhcccCCCCccChhHhcccCCCCchhhhHHHHHHHHHH-------------------------------------HHHHH
Confidence            1223456679999998877 788999999999999998                                     56889


Q ss_pred             HHHHhccCCCCCCCCHHHHHHHH
Q 005586          654 MALVCTHEDPENRPTMEAVIEEL  676 (689)
Q Consensus       654 l~~~Cl~~dp~~RPs~~evl~~L  676 (689)
                      ++..|++.+|++||++.++++.+
T Consensus       193 ~l~~~l~~~p~~R~~~~~l~~~~  215 (215)
T cd00180         193 LIRKMLQKDPEKRPSAKEILEHL  215 (215)
T ss_pred             HHHHHhhCCcccCcCHHHHhhCC
Confidence            99999999999999999998753

Protein Kinases (PKs), catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The PK family is part of a larger superfamily that includes the catalytic domains of RIO kinases, aminoglycoside phosphotransferase, choline kinase, phosphoinositide 3-kinase (PI3K), and actin-fragmin kinase. PKs make up a large family of serine/threonine kinases, protein tyrosine kinases (PTKs), and dual-specificity PKs that phosphorylate both serine/threonine and tyrosine residues of target proteins. Majority of protein phosphorylation, about 95%, occurs on serine residues while only 1% occurs on tyrosine residues. Protein phosphorylation is a mechanism by which a wide variety of cellular proteins, such as enzymes and membrane channels, are reversibly regulated in response to certain stimuli. PKs often function as components of signal transduction pathways in which

>PLN00113 leucine-rich repeat receptor-like protein kinase; Provisional

Probab=99.96  E-value=2.7e-28  Score=294.63  Aligned_cols=211  Identities=40%  Similarity=0.657  Sum_probs=150.0

Q ss_pred             ChHHHHHHHHHHHccCCCCCccCCCCCCCCCCCCCcceEEcCCCCCEEEEEcCCCCcccccCcCcCCCCCCCEEEccCCc
Q 005586           24 GNTELRALLDLKASLDPENKLLQSWTENGDPCSGSFEGIACNEHRKVANISLQGKGLTGKLSPSLSGLKCLSGLYLHYNS  103 (689)
Q Consensus        24 ~~~~~~all~~k~~~~~~~~~~~~W~~~~~~C~~~w~gv~C~~~~~v~~l~L~~~~l~g~~~~~~~~l~~L~~L~L~~N~  103 (689)
                      .+.|+.||++||++++++...+.+|+.+.++|  .|.||+|+..++|+.|+|++|+++|.+++.|..+++|++|+|++|+
T Consensus        27 ~~~~~~~l~~~~~~~~~~~~~~~~w~~~~~~c--~w~gv~c~~~~~v~~L~L~~~~i~~~~~~~~~~l~~L~~L~Ls~n~  104 (968)
T PLN00113         27 HAEELELLLSFKSSINDPLKYLSNWNSSADVC--LWQGITCNNSSRVVSIDLSGKNISGKISSAIFRLPYIQTINLSNNQ  104 (968)
T ss_pred             CHHHHHHHHHHHHhCCCCcccCCCCCCCCCCC--cCcceecCCCCcEEEEEecCCCccccCChHHhCCCCCCEEECCCCc
Confidence            56899999999999965555678998777888  7999999877899999999999999999999999999999999999


Q ss_pred             ccccCCcccc-CCCCCcEEEecccCCCCCCC----------------------ccccCCccccEEeeecccCCCCCchhc
Q 005586          104 LSGEIPKEIR-NLTELTDLYLDVNNLSGNIP----------------------PEIGSMASLQVLQLCCNQLTGNIPAQI  160 (689)
Q Consensus       104 l~g~~p~~~~-~l~~L~~L~Ls~N~l~g~~p----------------------~~~~~l~~L~~L~Ls~N~l~g~~p~~~  160 (689)
                      ++|.+|..+. ++++|++|+|++|+++|.+|                      ..++++++|++|+|++|.+++.+|..+
T Consensus       105 ~~~~ip~~~~~~l~~L~~L~Ls~n~l~~~~p~~~l~~L~~L~Ls~n~~~~~~p~~~~~l~~L~~L~L~~n~l~~~~p~~~  184 (968)
T PLN00113        105 LSGPIPDDIFTTSSSLRYLNLSNNNFTGSIPRGSIPNLETLDLSNNMLSGEIPNDIGSFSSLKVLDLGGNVLVGKIPNSL  184 (968)
T ss_pred             cCCcCChHHhccCCCCCEEECcCCccccccCccccCCCCEEECcCCcccccCChHHhcCCCCCEEECccCcccccCChhh
Confidence            9998887754 77777777777777665554                      444555555555555555555555555


Q ss_pred             CCCCCCCEEeccCCcCCCCCCcccCCCCCCCeeeccCCcCCCCchhhhhCCCCCcEEecccCcCCcccchhHHhcc
Q 005586          161 GSLKSLSVLTLQHNRLNGGIPDSLGNLGKLKRLDLSFNSLFGTIPESLANNAELLFLDVQNNTLSGIVPSALKRLN  236 (689)
Q Consensus       161 ~~l~~L~~L~l~~N~l~~~~p~~~~~l~~L~~L~ls~N~l~g~~p~~l~~~~~L~~l~l~~N~l~~~~p~~~~~~~  236 (689)
                      +++++|++|+|++|++++.+|..++++++|+.|+|++|++++.+|..+..+++|++|++++|++++.+|..+..+.
T Consensus       185 ~~l~~L~~L~L~~n~l~~~~p~~l~~l~~L~~L~L~~n~l~~~~p~~l~~l~~L~~L~L~~n~l~~~~p~~l~~l~  260 (968)
T PLN00113        185 TNLTSLEFLTLASNQLVGQIPRELGQMKSLKWIYLGYNNLSGEIPYEIGGLTSLNHLDLVYNNLTGPIPSSLGNLK  260 (968)
T ss_pred             hhCcCCCeeeccCCCCcCcCChHHcCcCCccEEECcCCccCCcCChhHhcCCCCCEEECcCceeccccChhHhCCC
Confidence            5555555555555555555555555555555555555555555555555555555555555555555555555443

>KOG0695 consensus Serine/threonine protein kinase [Signal transduction mechanisms]

Probab=99.95  E-value=1.2e-28  Score=239.84  Aligned_cols=245  Identities=16%  Similarity=0.280  Sum_probs=189.2

Q ss_pred             ccCCcccccccCCcceEEEEEec-CCcEEEEEEecccCCc--hHHHHHHHHHHHHhcc-CCCcceeEeeEEEcCCCCeEE
Q 005586          409 QCFSEVNLLGKGNFSSVYKGTLR-DGTLVAIRSINVTSCK--SEEAEFVKGLYLLTSL-RHENIIRLRGFCCSRGRGECF  484 (689)
Q Consensus       409 ~~f~~~~~lg~G~~g~Vy~~~~~-~g~~vavK~l~~~~~~--~~~~~f~~e~~~l~~l-~H~niv~l~g~~~~~~~~~~~  484 (689)
                      ++|...++||+|+|.+|-.++++ +.+.+|+|+++++-..  ....-...|-.+..+. +||.+|-+..++.  .....+
T Consensus       250 ~df~ll~vigrgsyakvl~~~~~~t~qiyamkvvkkel~nddedidwvqtek~vfe~asn~pflvglhscfq--tesrlf  327 (593)
T KOG0695|consen  250 QDFDLLRVIGRGSYAKVLLVRLKKTDQIYAMKVVKKELVNDDEDIDWVQTEKHVFEQASNNPFLVGLHSCFQ--TESRLF  327 (593)
T ss_pred             ccceeeeeecCcchhhhhheehcccceeeehhhHHHHhcCCcccchhHHhhHHHHHhccCCCeEEehhhhhc--ccceEE
Confidence            46778899999999999999976 6788999999865432  2222334555566655 7999999988773  346789


Q ss_pred             EEEEcCCCCCHHHHhhhcCCCCCCCCHHHHHHHHHHHHHHHhhhhCCCCCCCceeecCCCCCceeecCCCCeEEeccccc
Q 005586          485 LIYDFAPKGKLSKYLDQEEGSSNVLDWSTRVSIIIGIAKGIGYLHSSEVNKPAIVHRNLSVEKVLIDQQFNPLIADCGLH  564 (689)
Q Consensus       485 lV~e~~~~gsL~~~L~~~~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~~~ivH~dlk~~NiLl~~~~~~kl~DfGla  564 (689)
                      +|.||+++|+|--+++..+    .+++.....+..+|..||.|||+.+     ||.||||..|||+|..|++|+.|||+.
T Consensus       328 fvieyv~ggdlmfhmqrqr----klpeeharfys~ei~lal~flh~rg-----iiyrdlkldnvlldaeghikltdygmc  398 (593)
T KOG0695|consen  328 FVIEYVNGGDLMFHMQRQR----KLPEEHARFYSAEICLALNFLHERG-----IIYRDLKLDNVLLDAEGHIKLTDYGMC  398 (593)
T ss_pred             EEEEEecCcceeeehhhhh----cCcHHHhhhhhHHHHHHHHHHhhcC-----eeeeeccccceEEccCCceeecccchh
Confidence            9999999999987776543    3888888899999999999999998     999999999999999999999999999


Q ss_pred             ccccCCceeeeecCCCCCCCCCccccccCCCCCcccchhHHHHHHHHHhCCCCcchhHH----HHHhhhhhhHhhccccC
Q 005586          565 KLLADDIVFSVLKTSAAMGYLAPEYVTTGRFTERSDIFAFGVIILQILTGSLVLTSSMR----LAAESATFENFIDRNLK  640 (689)
Q Consensus       565 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~ksDV~sfGvvl~elltG~~p~~~~~~----~~~~~~~~~~~~~~~~~  640 (689)
                      +.--.+.. .+....||+.|+|||++.+..|...+|+|++||+|+||+.|+.||+-...    ...+.--+.-++.+.+ 
T Consensus       399 ke~l~~gd-~tstfcgtpnyiapeilrgeeygfsvdwwalgvlmfemmagrspfdivgm~n~d~ntedylfqvilekqi-  476 (593)
T KOG0695|consen  399 KEGLGPGD-TTSTFCGTPNYIAPEILRGEEYGFSVDWWALGVLMFEMMAGRSPFDIVGMDNPDMNTEDYLFQVILEKQI-  476 (593)
T ss_pred             hcCCCCCc-ccccccCCCcccchhhhcccccCceehHHHHHHHHHHHHcCCCCcceecCCCcccchhHHHHHHHhhhcc-
Confidence            85322211 12234588999999999999999999999999999999999999963211    1111111222233322 


Q ss_pred             CCCCHHHHHHHHHHHHHhccCCCCCCC
Q 005586          641 GKFSESEAAKLGKMALVCTHEDPENRP  667 (689)
Q Consensus       641 ~~~~~~~~~~l~~l~~~Cl~~dp~~RP  667 (689)
                       .+|...+.+...+...-+.+||.+|.
T Consensus       477 -riprslsvkas~vlkgflnkdp~erl  502 (593)
T KOG0695|consen  477 -RIPRSLSVKASHVLKGFLNKDPKERL  502 (593)
T ss_pred             -cccceeehhhHHHHHHhhcCCcHHhc
Confidence             24555667788888899999999985

>KOG0668 consensus Casein kinase II, alpha subunit [Signal transduction mechanisms; Cell cycle control, cell division, chromosome partitioning; Transcription]

Probab=99.95  E-value=1.7e-28  Score=227.54  Aligned_cols=252  Identities=17%  Similarity=0.294  Sum_probs=193.4

Q ss_pred             ccCCcccccccCCcceEEEEE-ecCCcEEEEEEecccCCchHHHHHHHHHHHHhccC-CCcceeEeeEEEcCCCCeEEEE
Q 005586          409 QCFSEVNLLGKGNFSSVYKGT-LRDGTLVAIRSINVTSCKSEEAEFVKGLYLLTSLR-HENIIRLRGFCCSRGRGECFLI  486 (689)
Q Consensus       409 ~~f~~~~~lg~G~~g~Vy~~~-~~~g~~vavK~l~~~~~~~~~~~f~~e~~~l~~l~-H~niv~l~g~~~~~~~~~~~lV  486 (689)
                      ++|+..+++|+|.|+.||.|. ..+...++||.++..    ..+.+.+|+++|..++ ||||+.|++...+.......+|
T Consensus        38 ddYeivrk~GRGKYSEVFeg~~~~~~eK~ViKiLKPV----kkkKIkREikIL~nL~gg~NIi~L~DiV~Dp~SktpaLi  113 (338)
T KOG0668|consen   38 DDYEIVRKVGRGKYSEVFEGINITNNEKCVIKILKPV----KKKKIKREIKILQNLRGGPNIIKLLDIVKDPESKTPSLI  113 (338)
T ss_pred             chHHHHHHHcCccHhhHhcccccCCCceEEEeeechH----HHHHHHHHHHHHHhccCCCCeeehhhhhcCccccCchhH
Confidence            567778999999999999997 457889999999854    3457889999999997 9999999999877777788999


Q ss_pred             EEcCCCCCHHHHhhhcCCCCCCCCHHHHHHHHHHHHHHHhhhhCCCCCCCceeecCCCCCceeecC-CCCeEEecccccc
Q 005586          487 YDFAPKGKLSKYLDQEEGSSNVLDWSTRVSIIIGIAKGIGYLHSSEVNKPAIVHRNLSVEKVLIDQ-QFNPLIADCGLHK  565 (689)
Q Consensus       487 ~e~~~~gsL~~~L~~~~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~~~ivH~dlk~~NiLl~~-~~~~kl~DfGla~  565 (689)
                      +||+.|.+...+-.       .|+-......+.++++||.|+|++|     |.|||+||.||++|. ....+|.|+|+|.
T Consensus       114 FE~v~n~Dfk~ly~-------tl~d~dIryY~~elLkALdyCHS~G-----ImHRDVKPhNvmIdh~~rkLrlIDWGLAE  181 (338)
T KOG0668|consen  114 FEYVNNTDFKQLYP-------TLTDYDIRYYIYELLKALDYCHSMG-----IMHRDVKPHNVMIDHELRKLRLIDWGLAE  181 (338)
T ss_pred             hhhhccccHHHHhh-------hhchhhHHHHHHHHHHHHhHHHhcC-----cccccCCcceeeechhhceeeeeecchHh
Confidence            99999988776653       2677788889999999999999999     999999999999996 5678999999999


Q ss_pred             cccCCceeeeecCCCCCCCCCcccccc-CCCCCcccchhHHHHHHHHHhCCCCcchhH---HHHHh--------------
Q 005586          566 LLADDIVFSVLKTSAAMGYLAPEYVTT-GRFTERSDIFAFGVIILQILTGSLVLTSSM---RLAAE--------------  627 (689)
Q Consensus       566 ~~~~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~ksDV~sfGvvl~elltG~~p~~~~~---~~~~~--------------  627 (689)
                      +......+...  ..+..|.-||.+.. ..|+..-|+|||||++.+|+..+.||-...   .+.+.              
T Consensus       182 FYHp~~eYnVR--VASRyfKGPELLVdy~~YDYSLD~WS~GcmlA~miFrkepFFhG~dN~DQLVkIakVLGt~el~~Yl  259 (338)
T KOG0668|consen  182 FYHPGKEYNVR--VASRYFKGPELLVDYQMYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQLVKIAKVLGTDELYAYL  259 (338)
T ss_pred             hcCCCceeeee--eehhhcCCchheeechhccccHHHHHHHHHHHHHHhccCcccCCCCCHHHHHHHHHHhChHHHHHHH
Confidence            98776544332  23445788998765 457889999999999999999999984221   11100              


Q ss_pred             -------hhhhhHhhccccCC---CC-----CHHHHHHHHHHHHHhccCCCCCCCCHHHHHHHHHh
Q 005586          628 -------SATFENFIDRNLKG---KF-----SESEAAKLGKMALVCTHEDPENRPTMEAVIEELTV  678 (689)
Q Consensus       628 -------~~~~~~~~~~~~~~---~~-----~~~~~~~l~~l~~~Cl~~dp~~RPs~~evl~~L~~  678 (689)
                             ...+.+++.+..+.   .+     ..-...++.++...-+..|-.+|||++|.+.+...
T Consensus       260 ~KY~i~Ldp~~~~i~~~~~rk~w~~Fi~~~n~hl~~peaiDlldklLrYDHqeRlTakEam~HpyF  325 (338)
T KOG0668|consen  260 NKYQIDLDPQFEDILGRHSRKPWSRFINSENQHLVSPEAIDLLDKLLRYDHQERLTAKEAMAHPYF  325 (338)
T ss_pred             HHHccCCChhHhhHhhccccccHHHhCCccccccCChHHHHHHHHHHhhccccccchHHHhcCchH
Confidence                   00111111111100   00     01124678888888999999999999999877543

>KOG0664 consensus Nemo-like MAPK-related serine/threonine protein kinase [Signal transduction mechanisms]

Probab=99.95  E-value=7.4e-30  Score=242.07  Aligned_cols=255  Identities=19%  Similarity=0.322  Sum_probs=190.0

Q ss_pred             ccccccCCcceEEEEEec-CCcEEEEEEecccCC-chHHHHHHHHHHHHhccCCCcceeEeeEEEcCCC---CeEEEEEE
Q 005586          414 VNLLGKGNFSSVYKGTLR-DGTLVAIRSINVTSC-KSEEAEFVKGLYLLTSLRHENIIRLRGFCCSRGR---GECFLIYD  488 (689)
Q Consensus       414 ~~~lg~G~~g~Vy~~~~~-~g~~vavK~l~~~~~-~~~~~~f~~e~~~l~~l~H~niv~l~g~~~~~~~---~~~~lV~e  488 (689)
                      .+.||-|+||.||....+ +|+.||.|++..... -...+.+.+|+++|..++|.|++..+++......   .+.|+|+|
T Consensus        58 DRPIGYGAFGVVWsVTDPRdgrrvalkK~pnvfq~L~s~krvFre~kmLcfFkHdNVLSaLDILQPph~dfFqEiYV~TE  137 (449)
T KOG0664|consen   58 DRPIGYGAFGVVWSVTDPRSGKRVALKKMPNVFQNLASCKRVFREIKMLSSFRHDNVLSLLDILQPANPSFFQELYVLTE  137 (449)
T ss_pred             CCcccccceeEEEeccCCCCccchhHhhcchHHHHHHHHHHHHHHHHHHHhhccccHHHHHHhcCCCCchHHHHHHHHHH
Confidence            478999999999999875 899999999864321 2334678899999999999999999876532211   35678889


Q ss_pred             cCCCCCHHHHhhhcCCCCCCCCHHHHHHHHHHHHHHHhhhhCCCCCCCceeecCCCCCceeecCCCCeEEeccccccccc
Q 005586          489 FAPKGKLSKYLDQEEGSSNVLDWSTRVSIIIGIAKGIGYLHSSEVNKPAIVHRNLSVEKVLIDQQFNPLIADCGLHKLLA  568 (689)
Q Consensus       489 ~~~~gsL~~~L~~~~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~~~ivH~dlk~~NiLl~~~~~~kl~DfGla~~~~  568 (689)
                      .|. .+|.+.+-.    .+.++-....-+..||++||.|||+.+     |.||||||-|.|++.+...||+|||++|.-.
T Consensus       138 LmQ-SDLHKIIVS----PQ~Ls~DHvKVFlYQILRGLKYLHsA~-----ILHRDIKPGNLLVNSNCvLKICDFGLARvee  207 (449)
T KOG0664|consen  138 LMQ-SDLHKIIVS----PQALTPDHVKVFVYQILRGLKYLHTAN-----ILHRDIKPGNLLVNSNCILKICDFGLARTWD  207 (449)
T ss_pred             HHH-hhhhheecc----CCCCCcchhhhhHHHHHhhhHHHhhcc-----hhhccCCCccEEeccCceEEecccccccccc
Confidence            884 477777653    346888888899999999999999988     9999999999999999999999999999776


Q ss_pred             CCceeeeecCCCCCCCCCcccccc-CCCCCcccchhHHHHHHHHHhCCCCcchhHHHHHh-------------------h
Q 005586          569 DDIVFSVLKTSAAMGYLAPEYVTT-GRFTERSDIFAFGVIILQILTGSLVLTSSMRLAAE-------------------S  628 (689)
Q Consensus       569 ~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~ksDV~sfGvvl~elltG~~p~~~~~~~~~~-------------------~  628 (689)
                      .+..........|-.|+|||.+.+ +.|+.+.||||.||++.|++..+..|.........                   +
T Consensus       208 ~d~~~hMTqEVVTQYYRAPEiLMGaRhYs~AvDiWSVGCIFaELLgRrILFQAq~PiqQL~lItdLLGTPs~EaMr~ACE  287 (449)
T KOG0664|consen  208 QRDRLNMTHEVVTQYYRAPELLMGARRYTGAVDIWSVGCIFAELLQRKILFQAAGPIEQLQMIIDLLGTPSQEAMKYACE  287 (449)
T ss_pred             hhhhhhhHHHHHHHHhccHHHhhcchhhcCccceehhhHHHHHHHhhhhhhhccChHHHHHHHHHHhCCCcHHHHHHHhh
Confidence            555444444456678999999887 46899999999999999999888776432111000                   0


Q ss_pred             hhhhHhhccccCCC---------CCHHHHHHHHHHHHHhccCCCCCCCCHHHHHHHHHh
Q 005586          629 ATFENFIDRNLKGK---------FSESEAAKLGKMALVCTHEDPENRPTMEAVIEELTV  678 (689)
Q Consensus       629 ~~~~~~~~~~~~~~---------~~~~~~~~l~~l~~~Cl~~dp~~RPs~~evl~~L~~  678 (689)
                      +.-..++....+..         -+.....+...+.+.++..||.+|.+..+.+.++..
T Consensus       288 GAk~H~LR~~~k~Ps~~vLYtlsS~~~~~heav~~~~~~l~~d~dkris~~~A~~~~~~  346 (449)
T KOG0664|consen  288 GAKNHVLRAGLRAPDTQRLYKIASPDDKNHEAVDLLQKLLHFDPDKRISVEEALQHRYL  346 (449)
T ss_pred             hhHHHhhccCCCCCCccceeeecCCcccchHHHHHHHHHhCCCCcccccHhhhcccccc
Confidence            00011111111111         112334566777888899999999999998876543

>KOG0665 consensus Jun-N-terminal kinase (JNK) [Signal transduction mechanisms]

Probab=99.95  E-value=3.5e-28  Score=236.63  Aligned_cols=254  Identities=20%  Similarity=0.305  Sum_probs=192.6

Q ss_pred             ccCCcccccccCCcceEEEEEec-CCcEEEEEEecccCC-chHHHHHHHHHHHHhccCCCcceeEeeEEEcCC----CCe
Q 005586          409 QCFSEVNLLGKGNFSSVYKGTLR-DGTLVAIRSINVTSC-KSEEAEFVKGLYLLTSLRHENIIRLRGFCCSRG----RGE  482 (689)
Q Consensus       409 ~~f~~~~~lg~G~~g~Vy~~~~~-~g~~vavK~l~~~~~-~~~~~~f~~e~~~l~~l~H~niv~l~g~~~~~~----~~~  482 (689)
                      .+|.....+|.|.- .|..+... .++.||+|++..... ....+...+|...+..++|+||++++.++....    -.+
T Consensus        17 ~Ry~nL~p~~~g~~-~v~~a~D~v~~~~v~ikk~~~pf~n~~~akra~rel~l~~~v~~~nii~l~n~ftP~~~l~~~~e   95 (369)
T KOG0665|consen   17 KRYVNLKPIGSGAQ-IVVAAFDQVLGRPVAIKKLSRPFQNQTHAKRAYRELKLMKCVNHKNIISLLNVFTPQKTLEEFQE   95 (369)
T ss_pred             eeeeeecccCCCCc-eEEecchhhccCceehhhhcCccccCccchhhhhhhhhhhhhcccceeeeeeccCccccHHHHHh
Confidence            35666778888887 66666543 588999998865421 234456778999999999999999999884321    135


Q ss_pred             EEEEEEcCCCCCHHHHhhhcCCCCCCCCHHHHHHHHHHHHHHHhhhhCCCCCCCceeecCCCCCceeecCCCCeEEeccc
Q 005586          483 CFLIYDFAPKGKLSKYLDQEEGSSNVLDWSTRVSIIIGIAKGIGYLHSSEVNKPAIVHRNLSVEKVLIDQQFNPLIADCG  562 (689)
Q Consensus       483 ~~lV~e~~~~gsL~~~L~~~~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~~~ivH~dlk~~NiLl~~~~~~kl~DfG  562 (689)
                      .|+||||| .++|...++..      ++-.+...|..|+..|+.|||+.+     |+||||||+||++..+...||.|||
T Consensus        96 ~y~v~e~m-~~nl~~vi~~e------lDH~tis~i~yq~~~~ik~lhs~~-----IihRdLkPsnivv~~~~~lKi~dfg  163 (369)
T KOG0665|consen   96 VYLVMELM-DANLCQVILME------LDHETISYILYQMLCGIKHLHSAG-----IIHRDLKPSNIVVNSDCTLKILDFG  163 (369)
T ss_pred             HHHHHHhh-hhHHHHHHHHh------cchHHHHHHHHHHHHHHHHHHhcc-----eeecccCcccceecchhheeeccch
Confidence            79999999 56999998832      677888999999999999999988     9999999999999999999999999


Q ss_pred             ccccccCCceeeeecCCCCCCCCCccccccCCCCCcccchhHHHHHHHHHhCCCCcchhHHHHHhhhhh-----------
Q 005586          563 LHKLLADDIVFSVLKTSAAMGYLAPEYVTTGRFTERSDIFAFGVIILQILTGSLVLTSSMRLAAESATF-----------  631 (689)
Q Consensus       563 la~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~ksDV~sfGvvl~elltG~~p~~~~~~~~~~~~~~-----------  631 (689)
                      +|+.-..+  ........+..|.|||++.+..+.+.+||||.||++.||++|+.-|.+..+...+....           
T Consensus       164 ~ar~e~~~--~~mtpyVvtRyyrapevil~~~~ke~vdiwSvGci~gEli~~~Vlf~g~d~idQ~~ki~~~lgtpd~~F~  241 (369)
T KOG0665|consen  164 LARTEDTD--FMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGELILGTVLFPGKDHIDQWNKIIEQLGTPDPSFM  241 (369)
T ss_pred             hhcccCcc--cccCchhheeeccCchheeccCCcccchhhhhhhHHHHHhhceEEecCchHHHHHHHHHHHhcCCCHHHH
Confidence            99865544  22233445667999999999889999999999999999999998775433222221111           


Q ss_pred             ----------------------hHhhccc-cCC--CCCHHHHHHHHHHHHHhccCCCCCCCCHHHHHHHHH
Q 005586          632 ----------------------ENFIDRN-LKG--KFSESEAAKLGKMALVCTHEDPENRPTMEAVIEELT  677 (689)
Q Consensus       632 ----------------------~~~~~~~-~~~--~~~~~~~~~l~~l~~~Cl~~dp~~RPs~~evl~~L~  677 (689)
                                            .+.+... +..  +.+......+.+++.+|+..+|++|-+.+++++|.-
T Consensus       242 ~qL~~~~r~yv~~~~~y~~~~f~~~fpD~~f~~~~e~~~~~~~~ardll~~MLvi~pe~Risv~daL~HPY  312 (369)
T KOG0665|consen  242 KQLQPTVRNYVENRPQYQAISFSELFPDSLFPVVLEGSKLDCSLARDLLSKMLVIDPEKRISVDDALRHPY  312 (369)
T ss_pred             HHhhHHHHHHhhcChHhhccchhhhCCcccccccccCCccchHHHHHHHHHhhccChhhcccHHHHhcCCe
Confidence                                  0111111 000  011234567889999999999999999999998853

>smart00221 STYKc Protein kinase; unclassified specificity

Probab=99.95  E-value=7.1e-27  Score=232.42  Aligned_cols=200  Identities=28%  Similarity=0.482  Sum_probs=169.0

Q ss_pred             CCcccccccCCcceEEEEEecC-CcEEEEEEecccCCchHHHHHHHHHHHHhccCCCcceeEeeEEEcCCCCeEEEEEEc
Q 005586          411 FSEVNLLGKGNFSSVYKGTLRD-GTLVAIRSINVTSCKSEEAEFVKGLYLLTSLRHENIIRLRGFCCSRGRGECFLIYDF  489 (689)
Q Consensus       411 f~~~~~lg~G~~g~Vy~~~~~~-g~~vavK~l~~~~~~~~~~~f~~e~~~l~~l~H~niv~l~g~~~~~~~~~~~lV~e~  489 (689)
                      |...+.||+|++|.||++...+ +..+++|.+.........+.+.+|++.+.+++|+|++++++++..  ....++++||
T Consensus         1 ~~~~~~i~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~e~~~~~~~~~~~i~~~~~~~~~--~~~~~~v~e~   78 (225)
T smart00221        1 YELGKKLGEGAFGKVYLARDKGTGELVAVKVLKKEKTEKQREEFLREIRILKKLKHPNIVKLYGVFED--PEPLYLVMEY   78 (225)
T ss_pred             CceeeEeecCCCeEEEEEEEcCCCcEEEEEeeccccchHHHHHHHHHHHHHHhCCCCChhhheeeeec--CCceEEEEec
Confidence            4456789999999999999875 899999999866533256789999999999999999999999854  4678999999


Q ss_pred             CCCCCHHHHhhhcCCCCCCCCHHHHHHHHHHHHHHHhhhhCCCCCCCceeecCCCCCceeecCCCCeEEecccccccccC
Q 005586          490 APKGKLSKYLDQEEGSSNVLDWSTRVSIIIGIAKGIGYLHSSEVNKPAIVHRNLSVEKVLIDQQFNPLIADCGLHKLLAD  569 (689)
Q Consensus       490 ~~~gsL~~~L~~~~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~~~ivH~dlk~~NiLl~~~~~~kl~DfGla~~~~~  569 (689)
                      +++++|.+++.....   .+++..+..++.+++.++.|||+.+     ++|+|++++||+++.++.++|+|||.+.....
T Consensus        79 ~~~~~L~~~~~~~~~---~~~~~~~~~~~~~l~~~l~~lh~~~-----i~h~di~~~ni~v~~~~~~~l~d~g~~~~~~~  150 (225)
T smart00221       79 CEGGDLFDYLRKKGG---KLSEEEARFYLRQILEALEYLHSLG-----IVHRDLKPENILLGMDGLVKLADFGLARFIHR  150 (225)
T ss_pred             cCCCCHHHHHHhccc---CCCHHHHHHHHHHHHHHHHHHHhCC-----eecCCCCHHHEEEcCCCCEEEeeCceeeEecC
Confidence            999999999976432   1789999999999999999999887     99999999999999999999999999987754


Q ss_pred             CceeeeecCCCCCCCCCcccc-ccCCCCCcccchhHHHHHHHHHhCCCCcch
Q 005586          570 DIVFSVLKTSAAMGYLAPEYV-TTGRFTERSDIFAFGVIILQILTGSLVLTS  620 (689)
Q Consensus       570 ~~~~~~~~~~~~~~y~aPE~~-~~~~~~~ksDV~sfGvvl~elltG~~p~~~  620 (689)
                      ..........++..|++||.. ....++.++|||+||++++||++|+.||..
T Consensus       151 ~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~~Dv~~lG~~~~~l~~g~~pf~~  202 (225)
T smart00221      151 DLAALLKTVKGTPFYLAPEVLLGGKGYGEAVDIWSLGVILYELLWGPEPFSG  202 (225)
T ss_pred             cccccccceeccCCcCCHhHhcCCCCCCchhhHHHHHHHHHHHHHCCCCccc
Confidence            320011123355679999998 667788899999999999999999999965

Phosphotransferases. The specificity of this class of kinases can not be predicted. Possible dual-specificity Ser/Thr/Tyr kinase.

>KOG1152 consensus Signal transduction serine/threonine kinase with PAS/PAC sensor domain [Signal transduction mechanisms]

Probab=99.94  E-value=2.1e-27  Score=246.39  Aligned_cols=197  Identities=21%  Similarity=0.299  Sum_probs=166.9

Q ss_pred             ccCCcccccccCCcceEEEEEec-CCcEEEEEEecccCCc--hH-----HHHHHHHHHHHhccC---CCcceeEeeEEEc
Q 005586          409 QCFSEVNLLGKGNFSSVYKGTLR-DGTLVAIRSINVTSCK--SE-----EAEFVKGLYLLTSLR---HENIIRLRGFCCS  477 (689)
Q Consensus       409 ~~f~~~~~lg~G~~g~Vy~~~~~-~g~~vavK~l~~~~~~--~~-----~~~f~~e~~~l~~l~---H~niv~l~g~~~~  477 (689)
                      .+|+..+.+|+|+||.|+.|.++ +...|+||.+.+++.-  ..     .-..-.||++|+.++   |+||++++.|+  
T Consensus       561 s~yttlq~lG~GAyGkV~lai~K~n~~eVViK~I~KeRIL~DtWvrDrkLGtVp~EIqIla~l~~~sH~NIlKlLdfF--  638 (772)
T KOG1152|consen  561 SDYTTLQPLGEGAYGKVNLAIHKENNYEVVIKMIFKERILVDTWVRDRKLGTVPSEIQILATLNKHSHENILKLLDFF--  638 (772)
T ss_pred             ccceeeeeccccccceEEEeeecccceEEEeeehhhhhhhhhhhhcccccCccchhHHHHHHhhhcCccchhhhhhee--
Confidence            45888899999999999999987 5678999999876531  11     113446899999997   99999999999  


Q ss_pred             CCCCeEEEEEEcC-CCCCHHHHhhhcCCCCCCCCHHHHHHHHHHHHHHHhhhhCCCCCCCceeecCCCCCceeecCCCCe
Q 005586          478 RGRGECFLIYDFA-PKGKLSKYLDQEEGSSNVLDWSTRVSIIIGIAKGIGYLHSSEVNKPAIVHRNLSVEKVLIDQQFNP  556 (689)
Q Consensus       478 ~~~~~~~lV~e~~-~~gsL~~~L~~~~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~~~ivH~dlk~~NiLl~~~~~~  556 (689)
                      ++.+.+|++||-- ++-+|.+++..+.    .+++.+..-|..||+.|+++||+.+     |||||||-+||.++.+|-+
T Consensus       639 Eddd~yyl~te~hg~gIDLFd~IE~kp----~m~E~eAk~IFkQV~agi~hlh~~~-----ivhrdikdenvivd~~g~~  709 (772)
T KOG1152|consen  639 EDDDYYYLETEVHGEGIDLFDFIEFKP----RMDEPEAKLIFKQVVAGIKHLHDQG-----IVHRDIKDENVIVDSNGFV  709 (772)
T ss_pred             ecCCeeEEEecCCCCCcchhhhhhccC----ccchHHHHHHHHHHHhccccccccC-----ceecccccccEEEecCCeE
Confidence            6678899999865 5569999997654    3899999999999999999999998     9999999999999999999


Q ss_pred             EEecccccccccCCceeeeecCCCCCCCCCccccccCCC-CCcccchhHHHHHHHHHhCCCCcc
Q 005586          557 LIADCGLHKLLADDIVFSVLKTSAAMGYLAPEYVTTGRF-TERSDIFAFGVIILQILTGSLVLT  619 (689)
Q Consensus       557 kl~DfGla~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~-~~ksDV~sfGvvl~elltG~~p~~  619 (689)
                      ||.|||-+.....+.   .....||++|.|||++.+.+| ...-|||++|++||-++....||+
T Consensus       710 klidfgsaa~~ksgp---fd~f~gtv~~aapevl~g~~y~gk~qdiwalgillytivykenpyy  770 (772)
T KOG1152|consen  710 KLIDFGSAAYTKSGP---FDVFVGTVDYAAPEVLGGEKYLGKPQDIWALGILLYTIVYKENPYY  770 (772)
T ss_pred             EEeeccchhhhcCCC---cceeeeeccccchhhhCCCccCCCcchhhhhhheeeEEEeccCCCc
Confidence            999999988766543   233468999999999999888 566899999999999999888875

>KOG1290 consensus Serine/threonine protein kinase [Signal transduction mechanisms]

Probab=99.94  E-value=5.8e-26  Score=232.00  Aligned_cols=133  Identities=20%  Similarity=0.299  Sum_probs=110.9

Q ss_pred             ccCCcccccccCCcceEEEEEec-CCcEEEEEEecccCCchHHHHHHHHHHHHhccC-----C---CcceeEeeEEEcC-
Q 005586          409 QCFSEVNLLGKGNFSSVYKGTLR-DGTLVAIRSINVTSCKSEEAEFVKGLYLLTSLR-----H---ENIIRLRGFCCSR-  478 (689)
Q Consensus       409 ~~f~~~~~lg~G~~g~Vy~~~~~-~g~~vavK~l~~~~~~~~~~~f~~e~~~l~~l~-----H---~niv~l~g~~~~~-  478 (689)
                      .+|...++||=|.|++||+|... +.+.||+|+.+...  .-.+..+.||++|++++     |   ..||+|+++|... 
T Consensus        78 gRY~v~rKLGWGHFSTVWLawDtq~~r~VAlKVvKSAq--hYtEaAlDEIklL~~v~~~Dp~~~~~~~VV~LlD~FkhsG  155 (590)
T KOG1290|consen   78 GRYHVQRKLGWGHFSTVWLAWDTQNKRYVALKVVKSAQ--HYTEAALDEIKLLQQVREGDPNDPGKKCVVQLLDHFKHSG  155 (590)
T ss_pred             ceEEEEEeccccccceeEEEeeccCCeEEEEEEEehhh--HHHHHHHHHHHHHHHHHhcCCCCCCCceeeeeeccceecC
Confidence            57888899999999999999875 67899999987543  23346778999999984     2   3699999988543 


Q ss_pred             -CCCeEEEEEEcCCCCCHHHHhhhcCCCCCCCCHHHHHHHHHHHHHHHhhhhCCCCCCCceeecCCCCCceee
Q 005586          479 -GRGECFLIYDFAPKGKLSKYLDQEEGSSNVLDWSTRVSIIIGIAKGIGYLHSSEVNKPAIVHRNLSVEKVLI  550 (689)
Q Consensus       479 -~~~~~~lV~e~~~~gsL~~~L~~~~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~~~ivH~dlk~~NiLl  550 (689)
                       .+.++++|+||+ +.+|..++....-  ..++...+.+|+.||+.||.|||..+.    |||-||||+|||+
T Consensus       156 pNG~HVCMVfEvL-GdnLLklI~~s~Y--rGlpl~~VK~I~~qvL~GLdYLH~ecg----IIHTDlKPENvLl  221 (590)
T KOG1290|consen  156 PNGQHVCMVFEVL-GDNLLKLIKYSNY--RGLPLSCVKEICRQVLTGLDYLHRECG----IIHTDLKPENVLL  221 (590)
T ss_pred             CCCcEEEEEehhh-hhHHHHHHHHhCC--CCCcHHHHHHHHHHHHHHHHHHHHhcC----ccccCCCcceeee
Confidence             346899999999 7799999976543  348889999999999999999998764    9999999999999

>KOG1345 consensus Serine/threonine kinase [Signal transduction mechanisms]

Probab=99.93  E-value=1.1e-26  Score=220.88  Aligned_cols=247  Identities=20%  Similarity=0.346  Sum_probs=179.7

Q ss_pred             ccCCcccccccCCcceEEEEEec-CCcEEEEEEecccCCchHHHHHHHHHHHHhcc-CCCcceeEeeEEEcCCCCeEEEE
Q 005586          409 QCFSEVNLLGKGNFSSVYKGTLR-DGTLVAIRSINVTSCKSEEAEFVKGLYLLTSL-RHENIIRLRGFCCSRGRGECFLI  486 (689)
Q Consensus       409 ~~f~~~~~lg~G~~g~Vy~~~~~-~g~~vavK~l~~~~~~~~~~~f~~e~~~l~~l-~H~niv~l~g~~~~~~~~~~~lV  486 (689)
                      +.|.+.+.+|+|.||.+-+++++ ..+.+|+|.+...  ....++|.+|..---.+ .|.||+.-|+...+. .+.++++
T Consensus        24 d~y~I~k~lgeG~FgkIlL~eHr~s~t~ivlKavp~p--~tt~~dF~rEfhY~~~Ls~H~hIi~tY~vaFqt-~d~YvF~  100 (378)
T KOG1345|consen   24 DVYTINKQLGEGRFGKILLAEHRQSKTRIVLKAVPRP--QTTQADFVREFHYSFFLSPHQHIIDTYEVAFQT-SDAYVFV  100 (378)
T ss_pred             hhhhHHHHhcccceeeEEeeeccCCceEEEeeccCcc--hhhHHHHHHHhccceeeccchhhhHHHHHHhhc-CceEEEe
Confidence            45777889999999999999987 5788999988765  34567899998654455 599999988765543 4678899


Q ss_pred             EEcCCCCCHHHHhhhcCCCCCCCCHHHHHHHHHHHHHHHhhhhCCCCCCCceeecCCCCCceeec--CCCCeEEeccccc
Q 005586          487 YDFAPKGKLSKYLDQEEGSSNVLDWSTRVSIIIGIAKGIGYLHSSEVNKPAIVHRNLSVEKVLID--QQFNPLIADCGLH  564 (689)
Q Consensus       487 ~e~~~~gsL~~~L~~~~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~~~ivH~dlk~~NiLl~--~~~~~kl~DfGla  564 (689)
                      +||.|.|||.+.+...+     +.+..-.+++.|++.|+.|+|+.+     +||||||.+|||+-  +...+|++|||++
T Consensus       101 qE~aP~gdL~snv~~~G-----igE~~~K~v~~ql~SAi~fMHskn-----lVHRdlK~eNiLif~~df~rvKlcDFG~t  170 (378)
T KOG1345|consen  101 QEFAPRGDLRSNVEAAG-----IGEANTKKVFAQLLSAIEFMHSKN-----LVHRDLKAENILIFDADFYRVKLCDFGLT  170 (378)
T ss_pred             eccCccchhhhhcCccc-----ccHHHHHHHHHHHHHHHHHhhccc-----hhhcccccceEEEecCCccEEEeeecccc
Confidence            99999999998886533     677788899999999999999988     99999999999994  4568999999998


Q ss_pred             ccccCCceeeeecCCCCCCCCCcccccc---C--CCCCcccchhHHHHHHHHHhCCCCcchhHHHHHhhhhhhHhhcc--
Q 005586          565 KLLADDIVFSVLKTSAAMGYLAPEYVTT---G--RFTERSDIFAFGVIILQILTGSLVLTSSMRLAAESATFENFIDR--  637 (689)
Q Consensus       565 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~---~--~~~~ksDV~sfGvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~--  637 (689)
                      +..+...    .....+..|.+||....   +  ...+.+|||.||++++..+||+.|+....-.......++....+  
T Consensus       171 ~k~g~tV----~~~~~~~~y~~pe~~~~~~ne~~~~~ps~D~WqfGIi~f~cltG~~PWQka~~~d~~Y~~~~~w~~rk~  246 (378)
T KOG1345|consen  171 RKVGTTV----KYLEYVNNYHAPELCDTVVNEKLVVNPSTDIWQFGIIFFYCLTGKFPWQKASIMDKPYWEWEQWLKRKN  246 (378)
T ss_pred             cccCcee----hhhhhhcccCCcHHHhhccccceEecccccchheeeeeeeeecCCCcchhhhccCchHHHHHHHhcccC
Confidence            7654321    11223345999997643   2  35678999999999999999999996321111111112222111  


Q ss_pred             -ccCCCCCHHHHHHHHHHHHHhccCCCCCCCCHHHHH
Q 005586          638 -NLKGKFSESEAAKLGKMALVCTHEDPENRPTMEAVI  673 (689)
Q Consensus       638 -~~~~~~~~~~~~~l~~l~~~Cl~~dp~~RPs~~evl  673 (689)
                       .+... ...-+..+.++..+-+..+|++|=...++-
T Consensus       247 ~~~P~~-F~~fs~~a~r~Fkk~lt~~~~drcki~~~k  282 (378)
T KOG1345|consen  247 PALPKK-FNPFSEKALRLFKKSLTPRFKDRCKIWTAK  282 (378)
T ss_pred             ccCchh-hcccCHHHHHHHHHhcCCcccccchhHHHH
Confidence             11111 112345677888888899999884444443

>KOG0195 consensus Integrin-linked kinase [Signal transduction mechanisms]

Probab=99.93  E-value=6.8e-27  Score=221.96  Aligned_cols=247  Identities=21%  Similarity=0.394  Sum_probs=193.5

Q ss_pred             cccccCCcceEEEEEecCCcEEEEEEecccCCch-HHHHHHHHHHHHhccCCCcceeEeeEEEcCCCCeEEEEEEcCCCC
Q 005586          415 NLLGKGNFSSVYKGTLRDGTLVAIRSINVTSCKS-EEAEFVKGLYLLTSLRHENIIRLRGFCCSRGRGECFLIYDFAPKG  493 (689)
Q Consensus       415 ~~lg~G~~g~Vy~~~~~~g~~vavK~l~~~~~~~-~~~~f~~e~~~l~~l~H~niv~l~g~~~~~~~~~~~lV~e~~~~g  493 (689)
                      .+|.+...|..|+|++. |..+++|+++...... ..++|..|.-.|+.+.||||++++|.|.  .+....++..|||.|
T Consensus       196 tkl~e~hsgelwrgrwq-gndivakil~vr~~t~risrdfneefp~lrifshpnilpvlgacn--sppnlv~isq~mp~g  272 (448)
T KOG0195|consen  196 TKLAESHSGELWRGRWQ-GNDIVAKILNVREVTARISRDFNEEFPALRIFSHPNILPVLGACN--SPPNLVIISQYMPFG  272 (448)
T ss_pred             hhhccCCCccccccccc-CcchhhhhhhhhhcchhhcchhhhhCcceeeecCCchhhhhhhcc--CCCCceEeeeeccch
Confidence            36888999999999997 4556668887665432 3368999999999999999999999994  457889999999999


Q ss_pred             CHHHHhhhcCCCCCCCCHHHHHHHHHHHHHHHhhhhCCCCCCCceeecCCCCCceeecCCCCeEEecccccccccCCcee
Q 005586          494 KLSKYLDQEEGSSNVLDWSTRVSIIIGIAKGIGYLHSSEVNKPAIVHRNLSVEKVLIDQQFNPLIADCGLHKLLADDIVF  573 (689)
Q Consensus       494 sL~~~L~~~~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~~~ivH~dlk~~NiLl~~~~~~kl~DfGla~~~~~~~~~  573 (689)
                      +|...||+..  .-..+-.+..++|.++|+|++|||+..   |-|.---|.+..|++|++.++||+- +-+++     ..
T Consensus       273 slynvlhe~t--~vvvd~sqav~faldiargmaflhsle---p~ipr~~lns~hvmidedltarism-ad~kf-----sf  341 (448)
T KOG0195|consen  273 SLYNVLHEQT--SVVVDHSQAVRFALDIARGMAFLHSLE---PMIPRFYLNSKHVMIDEDLTARISM-ADTKF-----SF  341 (448)
T ss_pred             HHHHHHhcCc--cEEEecchHHHHHHHHHhhHHHHhhcc---hhhhhhhcccceEEecchhhhheec-cccee-----ee
Confidence            9999999754  345777889999999999999999975   4344457999999999999999862 11111     11


Q ss_pred             eeecCCCCCCCCCccccccCCC---CCcccchhHHHHHHHHHhCCCCcchhHHHHHhhhhhhHhhccccCCCCCHHHHHH
Q 005586          574 SVLKTSAAMGYLAPEYVTTGRF---TERSDIFAFGVIILQILTGSLVLTSSMRLAAESATFENFIDRNLKGKFSESEAAK  650 (689)
Q Consensus       574 ~~~~~~~~~~y~aPE~~~~~~~---~~ksDV~sfGvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  650 (689)
                      ...+..-.+.||+||.+...+-   -..+|+|||.+++||+.|...||.+.......    .++.-..++..+|+..+..
T Consensus       342 qe~gr~y~pawmspealqrkped~n~raadmwsfaillwel~trevpfadlspmecg----mkialeglrv~ippgis~h  417 (448)
T KOG0195|consen  342 QEVGRAYSPAWMSPEALQRKPEDLNIRAADMWSFAILLWELNTREVPFADLSPMECG----MKIALEGLRVHIPPGISRH  417 (448)
T ss_pred             eccccccCcccCCHHHHhcCchhcchhhhhHHHHHHHHHHhhccccccccCCchhhh----hhhhhccccccCCCCccHH
Confidence            1112223456999999876653   35799999999999999999999765433222    2233346677788888999


Q ss_pred             HHHHHHHhccCCCCCCCCHHHHHHHHHhh
Q 005586          651 LGKMALVCTHEDPENRPTMEAVIEELTVA  679 (689)
Q Consensus       651 l~~l~~~Cl~~dp~~RPs~~evl~~L~~~  679 (689)
                      +.+++.-|...||.+||.+..|+-.|+..
T Consensus       418 m~klm~icmnedpgkrpkfdmivpilekm  446 (448)
T KOG0195|consen  418 MNKLMNICMNEDPGKRPKFDMIVPILEKM  446 (448)
T ss_pred             HHHHHHHHhcCCCCcCCCcceehhhHHHh
Confidence            99999999999999999999999888764

>smart00750 KIND kinase non-catalytic C-lobe domain

Probab=99.93  E-value=8.2e-26  Score=216.41  Aligned_cols=167  Identities=16%  Similarity=0.203  Sum_probs=127.5

Q ss_pred             CCHHHHhhhcCCCCCCCCHHHHHHHHHHHHHHHhhhhCCCCCCCceeecCCCCCceeecCCCCeEEecccccccccCCce
Q 005586          493 GKLSKYLDQEEGSSNVLDWSTRVSIIIGIAKGIGYLHSSEVNKPAIVHRNLSVEKVLIDQQFNPLIADCGLHKLLADDIV  572 (689)
Q Consensus       493 gsL~~~L~~~~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~~~ivH~dlk~~NiLl~~~~~~kl~DfGla~~~~~~~~  572 (689)
                      |+|.++++...   ..++|.+++.|+.|+++||+|||+.+           ||+|||+++++.+|+  ||+++...... 
T Consensus         1 GsL~~~l~~~~---~~l~~~~~~~i~~qi~~~L~~lH~~~-----------kp~Nil~~~~~~~~~--fG~~~~~~~~~-   63 (176)
T smart00750        1 VSLADILEVRG---RPLNEEEIWAVCLQCLRALRELHRQA-----------KSGNILLTWDGLLKL--DGSVAFKTPEQ-   63 (176)
T ss_pred             CcHHHHHHHhC---CCCCHHHHHHHHHHHHHHHHHHHhcC-----------CcccEeEcCccceee--ccceEeecccc-
Confidence            78999998643   24999999999999999999999752           999999999999999  99998765432 


Q ss_pred             eeeecCCCCCCCCCccccccCCCCCcccchhHHHHHHHHHhCCCCcchhHHHHHhhhhhhHhhccccCC--CCCHHHHH-
Q 005586          573 FSVLKTSAAMGYLAPEYVTTGRFTERSDIFAFGVIILQILTGSLVLTSSMRLAAESATFENFIDRNLKG--KFSESEAA-  649 (689)
Q Consensus       573 ~~~~~~~~~~~y~aPE~~~~~~~~~ksDV~sfGvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~-  649 (689)
                           ..++..|||||++.+..++.++|||||||++|||+||+.|+............+.....+....  ..+..... 
T Consensus        64 -----~~g~~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  138 (176)
T smart00750       64 -----SRVDPYFMAPEVIQGQSYTEKADIYSLGITLYEALDYELPYNEERELSAILEILLNGMPADDPRDRSNLESVSAA  138 (176)
T ss_pred             -----CCCcccccChHHhcCCCCcchhhHHHHHHHHHHHHhCCCCccccchhcHHHHHHHHHhccCCccccccHHHHHhh
Confidence                 2577899999999999999999999999999999999999864322111111111111111000  11222233 


Q ss_pred             -HHHHHHHHhccCCCCCCCCHHHHHHHHHhhCC
Q 005586          650 -KLGKMALVCTHEDPENRPTMEAVIEELTVAAP  681 (689)
Q Consensus       650 -~l~~l~~~Cl~~dp~~RPs~~evl~~L~~~~p  681 (689)
                       ++.+++.+|++.+|++||++.|+++++....+
T Consensus       139 ~~~~~~i~~cl~~~p~~Rp~~~~ll~~~~~~~~  171 (176)
T smart00750      139 RSFADFMRVCASRLPQRREAANHYLAHCRALFA  171 (176)
T ss_pred             hhHHHHHHHHHhcccccccCHHHHHHHHHHHHH
Confidence             69999999999999999999999999987643

It is an interaction domain identified as being similar to the C-terminal protein kinase catalytic fold (C lobe). Its presence at the N terminus of signalling proteins and the absence of the active-site residues in the catalytic and activation loops suggest that it folds independently and is likely to be non-catalytic. The occurrence of KIND only in metazoa implies that it has evolved from the catalytic protein kinase domain into an interaction domain possibly by keeping the substrate-binding features

>PLN00181 protein SPA1-RELATED; Provisional

Probab=99.93  E-value=1.3e-26  Score=272.63  Aligned_cols=202  Identities=15%  Similarity=0.162  Sum_probs=143.2

Q ss_pred             ccCC-CcceeEeeEEEcC-----CCCeEEEEEEcCCCCCHHHHhhhcCCCCCCCCHHHHHHHHHHHHHHHhhhhCCCCCC
Q 005586          462 SLRH-ENIIRLRGFCCSR-----GRGECFLIYDFAPKGKLSKYLDQEEGSSNVLDWSTRVSIIIGIAKGIGYLHSSEVNK  535 (689)
Q Consensus       462 ~l~H-~niv~l~g~~~~~-----~~~~~~lV~e~~~~gsL~~~L~~~~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~  535 (689)
                      .++| +||++++++|...     ..+..+.++||+ .++|.++|....   ..+++.+++.|+.||++||+|||+.+   
T Consensus        28 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~-~~~L~~~l~~~~---~~~~~~~~~~i~~qi~~al~~lH~~g---  100 (793)
T PLN00181         28 SLSHIDYVRSLLGSHKEGNLDGLDDDSIVRALECE-DVSLRQWLDNPD---RSVDAFECFHVFRQIVEIVNAAHSQG---  100 (793)
T ss_pred             hhhHHHHHHHhhcccCCccccccccchhhhhhccC-CccHHHHHhccc---ccccHHHHHHHHHHHHHHHHHHHhCC---
Confidence            4455 5888888876211     123467788988 569999997532   34899999999999999999999988   


Q ss_pred             CceeecCCCCCceeecC-------------------CCCeEEecccccccccCCce---------------eeeecCCCC
Q 005586          536 PAIVHRNLSVEKVLIDQ-------------------QFNPLIADCGLHKLLADDIV---------------FSVLKTSAA  581 (689)
Q Consensus       536 ~~ivH~dlk~~NiLl~~-------------------~~~~kl~DfGla~~~~~~~~---------------~~~~~~~~~  581 (689)
                        |+||||||+||||+.                   ++.+|++|||+++.......               .......+|
T Consensus       101 --IvHrDlKP~NiLl~~~~~~k~~d~~~~~~~~~~~~~~~ki~DfG~a~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt  178 (793)
T PLN00181        101 --IVVHNVRPSCFVMSSFNHVSFIESASCSDSGSDEDATTKSREIGSSRREEILSERRIEKLEEVKKQPFPMKQILAMEM  178 (793)
T ss_pred             --eeeccCCchhEEEcccCcEEEeeccccCcccccccCcccccccccccccccccccchhhhhccccCCCcccccccCCC
Confidence              999999999999954                   45567777777764321000               000112467


Q ss_pred             CCCCCccccccCCCCCcccchhHHHHHHHHHhCCCCcchhHHHHHhhhhhhHhhccccCCCCCHHHHHHHHHHHHHhccC
Q 005586          582 MGYLAPEYVTTGRFTERSDIFAFGVIILQILTGSLVLTSSMRLAAESATFENFIDRNLKGKFSESEAAKLGKMALVCTHE  661 (689)
Q Consensus       582 ~~y~aPE~~~~~~~~~ksDV~sfGvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~Cl~~  661 (689)
                      ..|||||++.+..++.++|||||||+||||++|..|+........  ........+     .......+...++.+||+.
T Consensus       179 ~~Y~APE~~~~~~~~~~sDVwSlGviL~ELl~~~~~~~~~~~~~~--~~~~~~~~~-----~~~~~~~~~~~~~~~~L~~  251 (793)
T PLN00181        179 SWYTSPEEDNGSSSNCASDVYRLGVLLFELFCPVSSREEKSRTMS--SLRHRVLPP-----QILLNWPKEASFCLWLLHP  251 (793)
T ss_pred             cceEChhhhccCCCCchhhhhhHHHHHHHHhhCCCchhhHHHHHH--HHHHhhcCh-----hhhhcCHHHHHHHHHhCCC
Confidence            789999999999999999999999999999999888653211110  000111111     1111233456888899999


Q ss_pred             CCCCCCCHHHHHHHHHhh
Q 005586          662 DPENRPTMEAVIEELTVA  679 (689)
Q Consensus       662 dp~~RPs~~evl~~L~~~  679 (689)
                      +|.+||+|.|++++.+..
T Consensus       252 ~P~~Rps~~eil~h~~~~  269 (793)
T PLN00181        252 EPSCRPSMSELLQSEFIN  269 (793)
T ss_pred             ChhhCcChHHHhhchhhh
Confidence            999999999999886654

>KOG0576 consensus Mitogen-activated protein kinase kinase kinase kinase (MAP4K), germinal center kinase family [Signal transduction mechanisms]

Probab=99.93  E-value=5.4e-27  Score=247.35  Aligned_cols=252  Identities=19%  Similarity=0.296  Sum_probs=197.3

Q ss_pred             ccCCcccccccCCcceEEEEEec-CCcEEEEEEecccCCchHHHHHHHHHHHHhccCCCcceeEeeEEEcCCCCeEEEEE
Q 005586          409 QCFSEVNLLGKGNFSSVYKGTLR-DGTLVAIRSINVTSCKSEEAEFVKGLYLLTSLRHENIIRLRGFCCSRGRGECFLIY  487 (689)
Q Consensus       409 ~~f~~~~~lg~G~~g~Vy~~~~~-~g~~vavK~l~~~~~~~~~~~f~~e~~~l~~l~H~niv~l~g~~~~~~~~~~~lV~  487 (689)
                      ++|.....+|.|.||.|||++.+ .+...|+|.++... .....-..+|+-++...+|||||.++|-|..  ++..++.|
T Consensus        15 ddyellqrvgsgTygdvyKaRd~~s~elaavkvVkLep-~dd~~~iqqei~~~~dc~h~nivay~gsylr--~dklwicM   91 (829)
T KOG0576|consen   15 DDYELLQRVGSGTYGDVYKARDKRSGELAAVKVVKLEP-GDDFSGIQQEIGMLRDCRHPNIVAYFGSYLR--RDKLWICM   91 (829)
T ss_pred             cchhheeeecCCcccchhhhcccccCchhhheeeeccC-CccccccccceeeeecCCCcChHHHHhhhhh--hcCcEEEE
Confidence            46677789999999999999975 79999999998765 3344556788999999999999999998854  46789999


Q ss_pred             EcCCCCCHHHHhhhcCCCCCCCCHHHHHHHHHHHHHHHhhhhCCCCCCCceeecCCCCCceeecCCCCeEEecccccccc
Q 005586          488 DFAPKGKLSKYLDQEEGSSNVLDWSTRVSIIIGIAKGIGYLHSSEVNKPAIVHRNLSVEKVLIDQQFNPLIADCGLHKLL  567 (689)
Q Consensus       488 e~~~~gsL~~~L~~~~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~~~ivH~dlk~~NiLl~~~~~~kl~DfGla~~~  567 (689)
                      ||+.+|+|++.-+...    ++++.+.-...++..+||+|||+.+     =+|||||-.|||+++.+.+|++|||.+...
T Consensus        92 EycgggslQdiy~~Tg----plselqiayvcRetl~gl~ylhs~g-----k~hRdiKGanilltd~gDvklaDfgvsaqi  162 (829)
T KOG0576|consen   92 EYCGGGSLQDIYHVTG----PLSELQIAYVCRETLQGLKYLHSQG-----KIHRDIKGANILLTDEGDVKLADFGVSAQI  162 (829)
T ss_pred             EecCCCcccceeeecc----cchhHHHHHHHhhhhccchhhhcCC-----cccccccccceeecccCceeecccCchhhh
Confidence            9999999999877543    4888888889999999999999988     599999999999999999999999998766


Q ss_pred             cCCceeeeecCCCCCCCCCccccc---cCCCCCcccchhHHHHHHHHHhCCCCcchhHHHHHhhhhhhHhhc-cccCCCC
Q 005586          568 ADDIVFSVLKTSAAMGYLAPEYVT---TGRFTERSDIFAFGVIILQILTGSLVLTSSMRLAAESATFENFID-RNLKGKF  643 (689)
Q Consensus       568 ~~~~~~~~~~~~~~~~y~aPE~~~---~~~~~~ksDV~sfGvvl~elltG~~p~~~~~~~~~~~~~~~~~~~-~~~~~~~  643 (689)
                      .... .+.....||+.|||||+..   .+.|.+++|||+.|+...|+---+.|..+...............+ +.++  -
T Consensus       163 tati-~KrksfiGtpywmapEvaaverkggynqlcdiwa~gitAiel~eLqpplfdlhpmr~l~LmTkS~~qpp~lk--D  239 (829)
T KOG0576|consen  163 TATI-AKRKSFIGTPYWMAPEVAAVERKGGYNQLCDIWALGITAIELGELQPPLFDLHPMRALFLMTKSGFQPPTLK--D  239 (829)
T ss_pred             hhhh-hhhhcccCCccccchhHHHHHhcccccccccccccccchhhhhhcCCcccccchHHHHHHhhccCCCCCccc--C
Confidence            5432 1233456899999999864   467899999999999999998888776443221111000011111 1121  1


Q ss_pred             CHHHHHHHHHHHHHhccCCCCCCCCHHHHHHH
Q 005586          644 SESEAAKLGKMALVCTHEDPENRPTMEAVIEE  675 (689)
Q Consensus       644 ~~~~~~~l~~l~~~Cl~~dp~~RPs~~evl~~  675 (689)
                      .......+-++++.|+..+|++||+...++++
T Consensus       240 k~kws~~fh~fvK~altknpKkRptaeklL~h  271 (829)
T KOG0576|consen  240 KTKWSEFFHNFVKGALTKNPKKRPTAEKLLQH  271 (829)
T ss_pred             CccchHHHHHHHHHHhcCCCccCCChhhheec
Confidence            23446678899999999999999999887754

>KOG0670 consensus U4/U6-associated splicing factor PRP4 [RNA processing and modification]

Probab=99.93  E-value=2.6e-26  Score=235.44  Aligned_cols=263  Identities=17%  Similarity=0.232  Sum_probs=198.0

Q ss_pred             ccCHHHHHHHhccCCcccccccCCcceEEEEEec-CCcEEEEEEecccCCchHHHHHHHHHHHHhccC------CCccee
Q 005586          398 RLNLEEVESATQCFSEVNLLGKGNFSSVYKGTLR-DGTLVAIRSINVTSCKSEEAEFVKGLYLLTSLR------HENIIR  470 (689)
Q Consensus       398 ~~~~~~l~~at~~f~~~~~lg~G~~g~Vy~~~~~-~g~~vavK~l~~~~~~~~~~~f~~e~~~l~~l~------H~niv~  470 (689)
                      ++.+.|+..  .+|......|+|-|+.|.+|... -|..||||++..+.  ...+.=.+|+++|.+|+      --++++
T Consensus       423 rv~igE~LD--~RY~V~~~~GkGvFs~Vvra~D~~r~~~vAiKIIRnNE--~M~KtGl~EleiLkKL~~AD~Edk~Hclr  498 (752)
T KOG0670|consen  423 RVRIGELLD--SRYEVQGYTGKGVFSTVVRARDQARGQEVAIKIIRNNE--VMHKTGLKELEILKKLNDADPEDKFHCLR  498 (752)
T ss_pred             EEehhhhhc--ceeEEEeccccceeeeeeeccccCCCCeeEEEEeecch--HHhhhhhHHHHHHHHhhccCchhhhHHHH
Confidence            344445443  57888889999999999999875 48899999998764  23345568899999985      347788


Q ss_pred             EeeEEEcCCCCeEEEEEEcCCCCCHHHHhhhcCCCCCCCCHHHHHHHHHHHHHHHhhhhCCCCCCCceeecCCCCCceee
Q 005586          471 LRGFCCSRGRGECFLIYDFAPKGKLSKYLDQEEGSSNVLDWSTRVSIIIGIAKGIGYLHSSEVNKPAIVHRNLSVEKVLI  550 (689)
Q Consensus       471 l~g~~~~~~~~~~~lV~e~~~~gsL~~~L~~~~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~~~ivH~dlk~~NiLl  550 (689)
                      |+..|.  ...++++|+|-+ .-+|.+.|...+. +-.|....+..++.|+..||..|-..+     |+|.||||.|||+
T Consensus       499 l~r~F~--hknHLClVFE~L-slNLRevLKKyG~-nvGL~ikaVRsYaqQLflALklLK~c~-----vlHaDIKPDNiLV  569 (752)
T KOG0670|consen  499 LFRHFK--HKNHLCLVFEPL-SLNLREVLKKYGR-NVGLHIKAVRSYAQQLFLALKLLKKCG-----VLHADIKPDNILV  569 (752)
T ss_pred             HHHHhh--hcceeEEEehhh-hchHHHHHHHhCc-ccceeehHHHHHHHHHHHHHHHHHhcC-----eeecccCccceEe
Confidence            877663  358899999988 4599999987653 345888899999999999999999877     9999999999999


Q ss_pred             cCC-CCeEEecccccccccCCceeeeecCCCCCCCCCccccccCCCCCcccchhHHHHHHHHHhCCCCcchhHHHHHhh-
Q 005586          551 DQQ-FNPLIADCGLHKLLADDIVFSVLKTSAAMGYLAPEYVTTGRFTERSDIFAFGVIILQILTGSLVLTSSMRLAAES-  628 (689)
Q Consensus       551 ~~~-~~~kl~DfGla~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~ksDV~sfGvvl~elltG~~p~~~~~~~~~~~-  628 (689)
                      ++. ...||||||-|....+....+..   .+-.|.|||++.+.+|+...|+||.||.||||.||+..|.+........ 
T Consensus       570 NE~k~iLKLCDfGSA~~~~eneitPYL---VSRFYRaPEIiLG~~yd~~iD~WSvgctLYElYtGkIlFpG~TNN~MLrl  646 (752)
T KOG0670|consen  570 NESKNILKLCDFGSASFASENEITPYL---VSRFYRAPEIILGLPYDYPIDTWSVGCTLYELYTGKILFPGRTNNQMLRL  646 (752)
T ss_pred             ccCcceeeeccCccccccccccccHHH---HHHhccCcceeecCcccCCccceeeceeeEEeeccceecCCCCcHHHHHH
Confidence            975 45699999999877665443322   2234999999999999999999999999999999998886432110000 


Q ss_pred             ---------------hhh---------------------------hHhhcc------ccC--CCCCHH---HHHHHHHHH
Q 005586          629 ---------------ATF---------------------------ENFIDR------NLK--GKFSES---EAAKLGKMA  655 (689)
Q Consensus       629 ---------------~~~---------------------------~~~~~~------~~~--~~~~~~---~~~~l~~l~  655 (689)
                                     ..+                           ...+.|      .+.  ..++.+   ...++.+|.
T Consensus       647 ~me~KGk~p~KmlRKgqF~dqHFD~d~nf~~~e~D~vT~r~~~~vm~~vkPtkdl~s~l~~~q~~~deq~~~~~~~rdLL  726 (752)
T KOG0670|consen  647 FMELKGKFPNKMLRKGQFKDQHFDQDLNFLYIEVDKVTEREKRTVMVNVKPTKDLGSELIAVQRLPDEQPKIVQQLRDLL  726 (752)
T ss_pred             HHHhcCCCcHHHhhhcchhhhhcccccceEEEeccccccceeEEEecccCcchhHHHHHhccCCCCchhHHHHHHHHHHH
Confidence                           000                           000011      111  112333   356788999


Q ss_pred             HHhccCCCCCCCCHHHHHHHH
Q 005586          656 LVCTHEDPENRPTMEAVIEEL  676 (689)
Q Consensus       656 ~~Cl~~dp~~RPs~~evl~~L  676 (689)
                      ..|+..||++|.+..|.+++.
T Consensus       727 dkml~LdP~KRit~nqAL~Hp  747 (752)
T KOG0670|consen  727 DKMLILDPEKRITVNQALKHP  747 (752)
T ss_pred             HHHhccChhhcCCHHHHhcCC
Confidence            999999999999999999874

>KOG1167 consensus Serine/threonine protein kinase of the CDC7 subfamily involved in DNA synthesis, repair and recombination [Replication, recombination and repair]

Probab=99.91  E-value=1.7e-24  Score=218.96  Aligned_cols=256  Identities=24%  Similarity=0.352  Sum_probs=191.4

Q ss_pred             HHHHhccCCcccccccCCcceEEEEEec----CCcEEEEEEecccCCchHHHHHHHHHHHHhcc-CCCcceeEeeEEEcC
Q 005586          404 VESATQCFSEVNLLGKGNFSSVYKGTLR----DGTLVAIRSINVTSCKSEEAEFVKGLYLLTSL-RHENIIRLRGFCCSR  478 (689)
Q Consensus       404 l~~at~~f~~~~~lg~G~~g~Vy~~~~~----~g~~vavK~l~~~~~~~~~~~f~~e~~~l~~l-~H~niv~l~g~~~~~  478 (689)
                      +....+.|...++||+|.|++||++.+.    .+..||+|.+....   .......|++.|..+ -|.||+++.+++  .
T Consensus        31 ~p~~~~~~~~v~kigeGsFssv~~a~~~~~~~~~~~valk~i~~ts---~p~ri~~El~~L~~~gG~~ni~~~~~~~--r  105 (418)
T KOG1167|consen   31 IPFISNAYKVVNKIGEGSFSSVYKATDIEQDTKRRYVALKAIYRTS---SPSRILNELEMLYRLGGSDNIIKLNGCF--R  105 (418)
T ss_pred             hhhhhhhhhhhccccccchhhhhhhhHhhhccccceEeeeeccccc---CchHHHHHHHHHHHhccchhhhcchhhh--c
Confidence            3345567888999999999999999864    46789999997654   334688999999999 499999999877  6


Q ss_pred             CCCeEEEEEEcCCCCCHHHHhhhcCCCCCCCCHHHHHHHHHHHHHHHhhhhCCCCCCCceeecCCCCCceeecCC-CCeE
Q 005586          479 GRGECFLIYDFAPKGKLSKYLDQEEGSSNVLDWSTRVSIIIGIAKGIGYLHSSEVNKPAIVHRNLSVEKVLIDQQ-FNPL  557 (689)
Q Consensus       479 ~~~~~~lV~e~~~~gsL~~~L~~~~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~~~ivH~dlk~~NiLl~~~-~~~k  557 (689)
                      ..+...+|+||++.....++...       ++......+.+.+.+||+++|+.|     ||||||||+|+|.+.. +.-.
T Consensus       106 nnd~v~ivlp~~~H~~f~~l~~~-------l~~~~i~~Yl~~ll~Al~~~h~~G-----IvHRDiKpsNFL~n~~t~rg~  173 (418)
T KOG1167|consen  106 NNDQVAIVLPYFEHDRFRDLYRS-------LSLAEIRWYLRNLLKALAHLHKNG-----IVHRDIKPSNFLYNRRTQRGV  173 (418)
T ss_pred             cCCeeEEEecccCccCHHHHHhc-------CCHHHHHHHHHHHHHHhhhhhccC-----ccccCCCccccccccccCCce
Confidence            67899999999999999988864       667888899999999999999998     9999999999999864 5568


Q ss_pred             EecccccccccCC-----------------------------------cee--------eeecCCCCCCCCCcccccc-C
Q 005586          558 IADCGLHKLLADD-----------------------------------IVF--------SVLKTSAAMGYLAPEYVTT-G  593 (689)
Q Consensus       558 l~DfGla~~~~~~-----------------------------------~~~--------~~~~~~~~~~y~aPE~~~~-~  593 (689)
                      |.|||+|......                                   ...        ......||+||.|||++.. .
T Consensus       174 LvDFgLA~~~d~~~~~~~s~~~~~~~~~~~~g~~~~~~~~~~~~~p~g~~~~~~~~r~~~~anrAGT~GfRaPEvL~k~~  253 (418)
T KOG1167|consen  174 LVDFGLAQRYDGYQQTEHSRSYSGRHATPAMGKDVHCQSVATASKPAGYYRRCNDGRPSERANRAGTPGFRAPEVLFRCP  253 (418)
T ss_pred             EEechhHHHHHhhhhhhhhhhhhcccCCccccCcccccccccccCCCCceeccCCCccceecccCCCCCCCchHHHhhcc
Confidence            9999998722100                                   000        0112458999999999865 4


Q ss_pred             CCCCcccchhHHHHHHHHHhCCCCcchhH------------------HH-HHhhhh--h---------hHh------hc-
Q 005586          594 RFTERSDIFAFGVIILQILTGSLVLTSSM------------------RL-AAESAT--F---------ENF------ID-  636 (689)
Q Consensus       594 ~~~~ksDV~sfGvvl~elltG~~p~~~~~------------------~~-~~~~~~--~---------~~~------~~-  636 (689)
                      ..++++||||-||+++-+++++.||-...                  +. +...+.  +         .+.      ++ 
T Consensus       254 ~QttaiDiws~GVI~Lslls~~~PFf~a~dd~~al~ei~tifG~~~mrk~A~l~g~~~l~~ksn~~~~~e~~~~f~s~~~  333 (418)
T KOG1167|consen  254 RQTTAIDIWSAGVILLSLLSRRYPFFKAKDDADALAEIATIFGSAEMRKCAALPGRILLWQKSNIPTIPELRVNFETLHI  333 (418)
T ss_pred             CcCCccceeeccceeehhhccccccccCccccchHHHHHHHhChHHHHHHhhcCCceeeeccccccccHHHHhchhccCh
Confidence            56899999999999999999999983210                  00 000000  0         000      00 


Q ss_pred             cccCC-C--------CCHHHHHHHHHHHHHhccCCCCCCCCHHHHHHHH
Q 005586          637 RNLKG-K--------FSESEAAKLGKMALVCTHEDPENRPTMEAVIEEL  676 (689)
Q Consensus       637 ~~~~~-~--------~~~~~~~~l~~l~~~Cl~~dp~~RPs~~evl~~L  676 (689)
                      ..+.. .        ..+..+..++++..+|+..+|.+|.+++|.+++.
T Consensus       334 ~~~~~~~q~n~~~~~~~d~~~~~~~dlLdk~le~np~kRitAEeALkHp  382 (418)
T KOG1167|consen  334 ESIYKSRQPNTEREIGSDVFPALLLDLLDKCLELNPQKRITAEDALKHP  382 (418)
T ss_pred             hhcccccccceeeccccccccHHHHHHHHHHccCChhhcccHHHHhcCc
Confidence            00000 0        0111244788999999999999999999999874

>PRK09188 serine/threonine protein kinase; Provisional

Probab=99.90  E-value=2.1e-23  Score=218.54  Aligned_cols=166  Identities=16%  Similarity=0.145  Sum_probs=127.2

Q ss_pred             HhccCCcccccccCCcceEEEEEec--CCcEEEEEEecccC----CchHHHHHHHHHHHHhccCCCcceeEeeEEEcCCC
Q 005586          407 ATQCFSEVNLLGKGNFSSVYKGTLR--DGTLVAIRSINVTS----CKSEEAEFVKGLYLLTSLRHENIIRLRGFCCSRGR  480 (689)
Q Consensus       407 at~~f~~~~~lg~G~~g~Vy~~~~~--~g~~vavK~l~~~~----~~~~~~~f~~e~~~l~~l~H~niv~l~g~~~~~~~  480 (689)
                      ..++|...+.||+|+||+||+|.++  +++.||||++....    .......|.+|+++|.+++|+|+++.+..+     
T Consensus        16 ~~~~Y~~~~~IG~G~fg~Vy~a~~~~~~~~~vAiK~~~~~~~~~~~~~~~~~~~~E~~iL~~L~h~~iv~~l~~~-----   90 (365)
T PRK09188         16 LSARFVETAVLKRDVFSTVERGYFAGDPGTARAVRRRVSEVPWWSKPLARHLAAREIRALKTVRGIGVVPQLLAT-----   90 (365)
T ss_pred             ccCCceEccEEeecCcEEEEEEEEcCCCCeEEEEEEecccccccccHHHHHHHHHHHHHHHhccCCCCCcEEEEc-----
Confidence            3456888899999999999999875  57888999875331    122356799999999999999999633222     


Q ss_pred             CeEEEEEEcCCCCCHHHHhhhcCCCCCCCCHHHHHHHHHHHHHHHhhhhCCCCCCCceeecCC-CCCceeecCCCCeEEe
Q 005586          481 GECFLIYDFAPKGKLSKYLDQEEGSSNVLDWSTRVSIIIGIAKGIGYLHSSEVNKPAIVHRNL-SVEKVLIDQQFNPLIA  559 (689)
Q Consensus       481 ~~~~lV~e~~~~gsL~~~L~~~~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~~~ivH~dl-k~~NiLl~~~~~~kl~  559 (689)
                      +..++||||+++++|... ..       ..   ...++.++++||+|||+.+     |+|||| ||+|||++.++.+||+
T Consensus        91 ~~~~LVmE~~~G~~L~~~-~~-------~~---~~~~~~~i~~aL~~lH~~g-----IiHrDL~KP~NILv~~~~~ikLi  154 (365)
T PRK09188         91 GKDGLVRGWTEGVPLHLA-RP-------HG---DPAWFRSAHRALRDLHRAG-----ITHNDLAKPQNWLMGPDGEAAVI  154 (365)
T ss_pred             CCcEEEEEccCCCCHHHh-Cc-------cc---hHHHHHHHHHHHHHHHHCC-----CeeCCCCCcceEEEcCCCCEEEE
Confidence            357999999999999732 11       11   1457889999999999987     999999 9999999999999999


Q ss_pred             cccccccccCCceee-------eecCCCCCCCCCccccccC
Q 005586          560 DCGLHKLLADDIVFS-------VLKTSAAMGYLAPEYVTTG  593 (689)
Q Consensus       560 DfGla~~~~~~~~~~-------~~~~~~~~~y~aPE~~~~~  593 (689)
                      |||+++.+.......       .....+++.|+|||++...
T Consensus       155 DFGlA~~~~~~~~~~~~~~~~d~~~~~~~~~~~~pe~~~~~  195 (365)
T PRK09188        155 DFQLASVFRRRGALYRIAAYEDLRHLLKHKRTYAPDALTPR  195 (365)
T ss_pred             ECccceecccCcchhhhhhhhhhhhhhccCccCCcccCChh
Confidence            999999765432111       1233466779999998653

>COG0515 SPS1 Serine/threonine protein kinase [General function prediction only / Signal transduction mechanisms / Transcription / DNA replication, recombination, and repair]

Probab=99.87  E-value=4.8e-21  Score=201.14  Aligned_cols=255  Identities=25%  Similarity=0.399  Sum_probs=195.7

Q ss_pred             CCcccccccCCcceEEEEEecCCcEEEEEEecccCCch--HHHHHHHHHHHHhccCCC-cceeEeeEEEcCCCCeEEEEE
Q 005586          411 FSEVNLLGKGNFSSVYKGTLRDGTLVAIRSINVTSCKS--EEAEFVKGLYLLTSLRHE-NIIRLRGFCCSRGRGECFLIY  487 (689)
Q Consensus       411 f~~~~~lg~G~~g~Vy~~~~~~g~~vavK~l~~~~~~~--~~~~f~~e~~~l~~l~H~-niv~l~g~~~~~~~~~~~lV~  487 (689)
                      |...+.||.|+||.||++...  ..+++|.+.......  ....|.+|+.+++.+.|+ +++++.+++.  .....++++
T Consensus         2 ~~~~~~l~~g~~~~v~~~~~~--~~~~~k~~~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~--~~~~~~~~~   77 (384)
T COG0515           2 YRILRKLGEGSFGEVYLARDR--KLVALKVLAKKLESKSKEVERFLREIQILASLNHPPNIVKLYDFFQ--DEGSLYLVM   77 (384)
T ss_pred             ceeEEeecCCCCeEEEEEEec--cEEEEEeechhhccchhHHHHHHHHHHHHHHccCCcceeeEEEEEe--cCCEEEEEE
Confidence            455678999999999999987  789999998766444  367899999999999988 7999999883  334579999


Q ss_pred             EcCCCCCHHHHhhhcCCCCCCCCHHHHHHHHHHHHHHHhhhhCCCCCCCceeecCCCCCceeecCCC-CeEEeccccccc
Q 005586          488 DFAPKGKLSKYLDQEEGSSNVLDWSTRVSIIIGIAKGIGYLHSSEVNKPAIVHRNLSVEKVLIDQQF-NPLIADCGLHKL  566 (689)
Q Consensus       488 e~~~~gsL~~~L~~~~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~~~ivH~dlk~~NiLl~~~~-~~kl~DfGla~~  566 (689)
                      ||+.++++.+++...... ..+.......++.|++.++.|+|+.+     ++|||+||+||+++... .+++.|||.++.
T Consensus        78 ~~~~~~~l~~~~~~~~~~-~~~~~~~~~~~~~~~~~~l~~~H~~~-----~~hrd~kp~nil~~~~~~~~~l~dfg~~~~  151 (384)
T COG0515          78 EYVDGGSLEDLLKKIGRK-GPLSESEALFILAQILSALEYLHSKG-----IIHRDIKPENILLDRDGRVVKLIDFGLAKL  151 (384)
T ss_pred             ecCCCCcHHHHHHhcccc-cCCCHHHHHHHHHHHHHHHHHHHhCC-----eeccCCCHHHeeecCCCCeEEEeccCccee
Confidence            999999999777654311 24788899999999999999999987     99999999999999988 799999999986


Q ss_pred             ccCCcee-----eeecCCCCCCCCCcccccc---CCCCCcccchhHHHHHHHHHhCCCCcchhHH---HHHhhhhhhHhh
Q 005586          567 LADDIVF-----SVLKTSAAMGYLAPEYVTT---GRFTERSDIFAFGVIILQILTGSLVLTSSMR---LAAESATFENFI  635 (689)
Q Consensus       567 ~~~~~~~-----~~~~~~~~~~y~aPE~~~~---~~~~~ksDV~sfGvvl~elltG~~p~~~~~~---~~~~~~~~~~~~  635 (689)
                      +......     ......++..|+|||.+.+   ..+....|+||+|++++++++|..|+.....   .......+....
T Consensus       152 ~~~~~~~~~~~~~~~~~~~t~~~~~pe~~~~~~~~~~~~~~D~~s~g~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~  231 (384)
T COG0515         152 LPDPGSTSSIPALPSTSVGTPGYMAPEVLLGLSLAYASSSSDIWSLGITLYELLTGLPPFEGEKNSSATSQTLKIILELP  231 (384)
T ss_pred             cCCCCccccccccccccccccccCCHHHhcCCCCCCCCchHhHHHHHHHHHHHHhCCCCCCCCCccccHHHHHHHHHhcC
Confidence            6543321     2344567889999999987   5788999999999999999999999754432   111111111111


Q ss_pred             ccccCCCCC----HHHHHHHHHHHHHhccCCCCCCCCHHHHHHH
Q 005586          636 DRNLKGKFS----ESEAAKLGKMALVCTHEDPENRPTMEAVIEE  675 (689)
Q Consensus       636 ~~~~~~~~~----~~~~~~l~~l~~~Cl~~dp~~RPs~~evl~~  675 (689)
                      .+.......    ......+.++...|+..+|..|.++.+....
T Consensus       232 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~r~~~~~~~~~  275 (384)
T COG0515         232 TPSLASPLSPSNPELISKAASDLLKKLLAKDPKNRLSSSSDLSH  275 (384)
T ss_pred             CcccccccCccccchhhHHHHHHHHHHHhcCchhcCCHHHHhhc
Confidence            110111111    1123578899999999999999999987765

>KOG1164 consensus Casein kinase (serine/threonine/tyrosine protein kinase) [Signal transduction mechanisms]

Probab=99.87  E-value=5.2e-21  Score=201.19  Aligned_cols=261  Identities=17%  Similarity=0.184  Sum_probs=190.3

Q ss_pred             cCCcccccccCCcceEEEEEecCC--cEEEEEEecccCCchHHHHHHHHHHHHhccCC----CcceeEeeEEEcCCCCeE
Q 005586          410 CFSEVNLLGKGNFSSVYKGTLRDG--TLVAIRSINVTSCKSEEAEFVKGLYLLTSLRH----ENIIRLRGFCCSRGRGEC  483 (689)
Q Consensus       410 ~f~~~~~lg~G~~g~Vy~~~~~~g--~~vavK~l~~~~~~~~~~~f~~e~~~l~~l~H----~niv~l~g~~~~~~~~~~  483 (689)
                      +|...+.||+|+||.||++...+.  ..+|+|.-......... .+..|..++..+.+    +++..+++... ......
T Consensus        19 ~~~i~~~iG~G~fG~V~~v~~~~~~~~~~a~K~e~~~~~~~~~-~l~~E~~vl~~l~~~~~~~~~~~~~~~G~-~~~~~~   96 (322)
T KOG1164|consen   19 RYKLGKKIGEGGFGAVYLVSDKSEKNKEYAKKLEKKELGSKPS-VLKIEIQVLKKLEKKNGPSHFPKLLDHGR-STEDFN   96 (322)
T ss_pred             ceEEeeeccccCCceEEEEEecCCCCeeEEEEEEEecccCCCc-cchhHHHHHHHHhhhcCCCCCCEEEEecc-CCCcee
Confidence            678889999999999999997643  57888887665433222 67788888888863    57777777653 234678


Q ss_pred             EEEEEcCCCCCHHHHhhhcCCCCCCCCHHHHHHHHHHHHHHHhhhhCCCCCCCceeecCCCCCceeecCC-----CCeEE
Q 005586          484 FLIYDFAPKGKLSKYLDQEEGSSNVLDWSTRVSIIIGIAKGIGYLHSSEVNKPAIVHRNLSVEKVLIDQQ-----FNPLI  558 (689)
Q Consensus       484 ~lV~e~~~~gsL~~~L~~~~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~~~ivH~dlk~~NiLl~~~-----~~~kl  558 (689)
                      ++||+.+ +.+|.++.....  ...++-.+.+.|+.|++.+|.++|+.|     ++||||||.|+++...     ..+.|
T Consensus        97 ~iVM~l~-G~sL~dl~~~~~--~~~fs~~T~l~ia~q~l~~l~~lH~~G-----~iHRDiKp~N~~~g~~~~~~~~~~~l  168 (322)
T KOG1164|consen   97 FIVMSLL-GPSLEDLRKRNP--PGRFSRKTVLRIAIQNLNALEDLHSKG-----FIHRDIKPENFVVGQSSRSEVRTLYL  168 (322)
T ss_pred             EEEEecc-CccHHHHHHhCC--CCCcCHhHHHHHHHHHHHHHHHHHhcC-----cccCCcCHHHeeecCCCCcccceEEE
Confidence            9999988 889999876544  345899999999999999999999998     9999999999999865     46899


Q ss_pred             ecccccc--cccCCce---ee----eecCCCCCCCCCccccccCCCCCcccchhHHHHHHHHHhCCCCcchhHHHHHhhh
Q 005586          559 ADCGLHK--LLADDIV---FS----VLKTSAAMGYLAPEYVTTGRFTERSDIFAFGVIILQILTGSLVLTSSMRLAAESA  629 (689)
Q Consensus       559 ~DfGla~--~~~~~~~---~~----~~~~~~~~~y~aPE~~~~~~~~~ksDV~sfGvvl~elltG~~p~~~~~~~~~~~~  629 (689)
                      .|||+++  .......   ..    .....||..|.++....+...+.+.|+||++.++.|++.|..|+........ ..
T Consensus       169 lDfGlar~~~~~~~~~~~~~~~r~~~~~~rGT~ry~S~~~H~~~e~~r~DDles~~Y~l~el~~g~LPW~~~~~~~~-~~  247 (322)
T KOG1164|consen  169 LDFGLARRFKYVGDSGGNLRPPRPQKGLFRGTLRYASINVHLGIEQGRRDDLESLFYMLLELLKGSLPWEALEMTDL-KS  247 (322)
T ss_pred             EecCCCccccccCCCCcccccCCCCccCCCCccccccHHHhCCCccCCchhhhhHHHHHHHHhcCCCCCccccccch-HH
Confidence            9999998  3322111   11    1234589999999999999999999999999999999999999854321111 11


Q ss_pred             hhhHhhccccCCCCCHHHHHHHHHHHHHhccCCCCCCCCHHHHHHHHHhhCC
Q 005586          630 TFENFIDRNLKGKFSESEAAKLGKMALVCTHEDPENRPTMEAVIEELTVAAP  681 (689)
Q Consensus       630 ~~~~~~~~~~~~~~~~~~~~~l~~l~~~Cl~~dp~~RPs~~evl~~L~~~~p  681 (689)
                      .+.+................++.++...+-..+..++|....+...++....
T Consensus       248 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Pdy~~~~~~l~~~~~  299 (322)
T KOG1164|consen  248 KFEKDPRKLLTDRFGDLKPEEFAKILEYIDSLDYEDKPDYEKLAELLKDVFD  299 (322)
T ss_pred             HHHHHhhhhccccccCCChHHHHHHHHHhhccCCcCCCCHHHHHHHHHHHHH
Confidence            1111111111110112234456666666666899999999999988766633

>KOG0590 consensus Checkpoint kinase and related serine/threonine protein kinases [Cell cycle control, cell division, chromosome partitioning]

Probab=99.83  E-value=2e-21  Score=217.01  Aligned_cols=254  Identities=18%  Similarity=0.220  Sum_probs=182.2

Q ss_pred             ccccccCCcceEEEEEec-CCcEEEEEEec----ccCCc-hHHHHHHHHHHHHhccCCCcceeEeeEEEcCCCCeEEEEE
Q 005586          414 VNLLGKGNFSSVYKGTLR-DGTLVAIRSIN----VTSCK-SEEAEFVKGLYLLTSLRHENIIRLRGFCCSRGRGECFLIY  487 (689)
Q Consensus       414 ~~~lg~G~~g~Vy~~~~~-~g~~vavK~l~----~~~~~-~~~~~f~~e~~~l~~l~H~niv~l~g~~~~~~~~~~~lV~  487 (689)
                      .+++|.|++|.|+..... .....+.|...    ..... .-...+..|..+-..++|+|++..+..+.+.  ....-+|
T Consensus       323 ~~~~g~ga~g~~~~~~~~~~~~~~~~~~~r~~~~~~~s~~~~~~~i~sE~~i~~~l~h~~~~e~l~~~~~~--~~~~~~m  400 (601)
T KOG0590|consen  323 GRVLGSGAYGSVRIAKRRSDLKSFPEKEFRVRVKPTESERKYNYNITSEFCIGSSLSHPNIIETLDIVQEI--DGILQSM  400 (601)
T ss_pred             cceeeecccCceEEEEecCCCccchhhhhhcccCCcccHHHHhhhhhhheeecccccCCchhhhHHHHhhc--ccchhhh
Confidence            578999999988877643 34444444333    11111 1112366677788889999998887766433  3344459


Q ss_pred             EcCCCCCHHHHhhhcCCCCCCCCHHHHHHHHHHHHHHHhhhhCCCCCCCceeecCCCCCceeecCCCCeEEecccccccc
Q 005586          488 DFAPKGKLSKYLDQEEGSSNVLDWSTRVSIIIGIAKGIGYLHSSEVNKPAIVHRNLSVEKVLIDQQFNPLIADCGLHKLL  567 (689)
Q Consensus       488 e~~~~gsL~~~L~~~~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~~~ivH~dlk~~NiLl~~~~~~kl~DfGla~~~  567 (689)
                      ||++. +|..++....    .+.-.++..+..|+..|+.|+|+.|     |.|||+|++|++++.++.+||+|||.+...
T Consensus       401 E~~~~-Dlf~~~~~~~----~~~~~e~~c~fKqL~~Gv~y~h~~G-----iahrdlK~enll~~~~g~lki~Dfg~~~vf  470 (601)
T KOG0590|consen  401 EYCPY-DLFSLVMSNG----KLTPLEADCFFKQLLRGVKYLHSMG-----LAHRDLKLENLLVTENGILKIIDFGAASVF  470 (601)
T ss_pred             hcccH-HHHHHHhccc----ccchhhhhHHHHHHHHHHHHHHhcC-----ceeccCccccEEEecCCceEEeecCcceee
Confidence            99999 9999997642    3777888899999999999999998     999999999999999999999999998765


Q ss_pred             cCCce---eeeecCCCCCCCCCccccccCCCCC-cccchhHHHHHHHHHhCCCCcchhHHHHHh---hhhhhHhhccccC
Q 005586          568 ADDIV---FSVLKTSAAMGYLAPEYVTTGRFTE-RSDIFAFGVIILQILTGSLVLTSSMRLAAE---SATFENFIDRNLK  640 (689)
Q Consensus       568 ~~~~~---~~~~~~~~~~~y~aPE~~~~~~~~~-ksDV~sfGvvl~elltG~~p~~~~~~~~~~---~~~~~~~~~~~~~  640 (689)
                      .-+..   ....+..|+-.|+|||++.+..|.+ ..||||.||++..|++|+.|+.........   .....+.-...-.
T Consensus       471 ~~~~e~~~~~~~g~~gS~pY~apE~~~~~~ydpr~vDiwS~~ii~~~m~~~~~~Wk~a~~~~~~~~~~~~~~~~~~~~~~  550 (601)
T KOG0590|consen  471 RYPWEKNIHESSGIVGSDPYLAPEVLTGKEYDPRAVDVWSCGIIYICMILGRFPWKVAKKSDNSFKTNNYSDQRNIFEGP  550 (601)
T ss_pred             ccCcchhhhhhcCcccCCcCcCcccccccccCcchhhhhhccceEEEEecCCCccccccccccchhhhccccccccccCh
Confidence            43222   3344556777899999999999976 589999999999999999998532211100   0000000000000


Q ss_pred             CCCCHHHHHHHHHHHHHhccCCCCCCCCHHHHHHHHHhh
Q 005586          641 GKFSESEAAKLGKMALVCTHEDPENRPTMEAVIEELTVA  679 (689)
Q Consensus       641 ~~~~~~~~~~l~~l~~~Cl~~dp~~RPs~~evl~~L~~~  679 (689)
                      .......+.+...++.++++.||++|-++++|+++-|..
T Consensus       551 ~~~~~~lp~~~~~~~~~~l~~~P~~R~ti~~i~~d~W~~  589 (601)
T KOG0590|consen  551 NRLLSLLPRETRIIIYRMLQLDPTKRITIEQILNDEWIR  589 (601)
T ss_pred             HHHHHhchhhHHHHHHHHccCChhheecHHHHhhChHhh
Confidence            011234466788999999999999999999999886654

>cd05147 RIO1_euk RIO kinase family; eukaryotic RIO1, catalytic domain

Probab=99.82  E-value=2.9e-20  Score=179.34  Aligned_cols=140  Identities=18%  Similarity=0.158  Sum_probs=107.9

Q ss_pred             cccccCCcceEEEEEecCCcEEEEEEecccCCch-H-------HHHH-----------------HHHHHHHhccCCCcce
Q 005586          415 NLLGKGNFSSVYKGTLRDGTLVAIRSINVTSCKS-E-------EAEF-----------------VKGLYLLTSLRHENII  469 (689)
Q Consensus       415 ~~lg~G~~g~Vy~~~~~~g~~vavK~l~~~~~~~-~-------~~~f-----------------~~e~~~l~~l~H~niv  469 (689)
                      ..||+|+||.||+|..++|+.||||+++...... .       ...|                 ..|++.+.++.|+++.
T Consensus         3 ~~ig~G~~~~Vy~a~~~~g~~vAvKv~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~v~   82 (190)
T cd05147           3 GCISTGKEANVYHATTANGEERAIKIYKTSILVFKDRDRYVSGEFRFRHGYCKSNPRKMVRTWAEKEMRNLKRLVTAGIP   82 (190)
T ss_pred             CccccccceEEEEEECCCCCEEEEEEEEecccccccHHHhhcCCchhhccccCCCHHHHHHHHHHHHHHHHHHHHHCCCC
Confidence            5799999999999998899999999997643110 0       1122                 3499999999887764


Q ss_pred             eEeeEEEcCCCCeEEEEEEcCCCCCHHHHhhhcCCCCCCCCHHHHHHHHHHHHHHHhhh-hCCCCCCCceeecCCCCCce
Q 005586          470 RLRGFCCSRGRGECFLIYDFAPKGKLSKYLDQEEGSSNVLDWSTRVSIIIGIAKGIGYL-HSSEVNKPAIVHRNLSVEKV  548 (689)
Q Consensus       470 ~l~g~~~~~~~~~~~lV~e~~~~gsL~~~L~~~~~~~~~l~~~~~~~ia~~ia~gL~yL-H~~~~~~~~ivH~dlk~~Ni  548 (689)
                      ....+..    ...++||||++++++.......    ..+++.+...++.|++.+|+|+ |+.+     |+||||||+||
T Consensus        83 ~p~~~~~----~~~~iVmE~i~g~~l~~~~~~~----~~~~~~~~~~i~~qi~~~L~~l~H~~g-----iiHrDlkP~NI  149 (190)
T cd05147          83 CPEPILL----KSHVLVMEFIGDDGWAAPRLKD----APLSESKARELYLQVIQIMRILYQDCR-----LVHADLSEYNL  149 (190)
T ss_pred             CCcEEEe----cCCEEEEEEeCCCCCcchhhhc----CCCCHHHHHHHHHHHHHHHHHHHHhCC-----cccCCCCHHHE
Confidence            4333321    2238999999988776543222    2488899999999999999999 6777     99999999999


Q ss_pred             eecCCCCeEEeccccccccc
Q 005586          549 LIDQQFNPLIADCGLHKLLA  568 (689)
Q Consensus       549 Ll~~~~~~kl~DfGla~~~~  568 (689)
                      |++ ++.++|+|||++....
T Consensus       150 li~-~~~v~LiDFG~a~~~~  168 (190)
T cd05147         150 LYH-DGKLYIIDVSQSVEHD  168 (190)
T ss_pred             EEE-CCcEEEEEccccccCC
Confidence            998 4789999999987543

The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO1 is present in archaea, bacteria and eukaryotes. This subfamily is composed of RIO1 proteins from eukaryotes. RIO1 is essential for survival and is required for 18S rRNA processing, proper cell cycle progression and c

>KOG1240 consensus Protein kinase containing WD40 repeats [Signal transduction mechanisms]

Probab=99.82  E-value=3.4e-21  Score=213.99  Aligned_cols=248  Identities=21%  Similarity=0.271  Sum_probs=179.1

Q ss_pred             cCCcccccccCCcceEEEEEecCCcEEEEEEecccCCchHHHHHHHHHHH--HhccCCCcceeEeeEEEcCCCCeEEEEE
Q 005586          410 CFSEVNLLGKGNFSSVYKGTLRDGTLVAIRSINVTSCKSEEAEFVKGLYL--LTSLRHENIIRLRGFCCSRGRGECFLIY  487 (689)
Q Consensus       410 ~f~~~~~lg~G~~g~Vy~~~~~~g~~vavK~l~~~~~~~~~~~f~~e~~~--l~~l~H~niv~l~g~~~~~~~~~~~lV~  487 (689)
                      ++...+.+|.+.|=+|.+|+.++|. |+||++-+.......+.|.++++-  ..-++|||.+++.-+-  ......|+|-
T Consensus        24 e~~~~~~LGstRFlKv~r~k~~eG~-vVvKVFvk~~p~~sL~~~~qrL~~ik~~l~~~pn~lPfqk~~--~t~kAAylvR  100 (1431)
T KOG1240|consen   24 ECHYVENLGSTRFLKVARAKDREGL-VVVKVFVKQDPTISLRPFKQRLEEIKFALMKAPNCLPFQKVL--VTDKAAYLVR  100 (1431)
T ss_pred             ceeeecccCchhhhhhhhccCCCce-EEEEEEeccCCCCCchHHHHHHHHHHHHhhcCCcccchHHHH--HhhHHHHHHH
Confidence            3555688999999999999999887 889999776644444455554433  4455899999987653  3335567888


Q ss_pred             EcCCCCCHHHHhhhcCCCCCCCCHHHHHHHHHHHHHHHhhhhCCCCCCCceeecCCCCCceeecCCCCeEEeccccccc-
Q 005586          488 DFAPKGKLSKYLDQEEGSSNVLDWSTRVSIIIGIAKGIGYLHSSEVNKPAIVHRNLSVEKVLIDQQFNPLIADCGLHKL-  566 (689)
Q Consensus       488 e~~~~gsL~~~L~~~~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~~~ivH~dlk~~NiLl~~~~~~kl~DfGla~~-  566 (689)
                      +|+. -+|.+.|....    -+...+.+-||.|++.||..+|..+     |.|||||++|||++....+.|+||.--|. 
T Consensus       101 qyvk-hnLyDRlSTRP----FL~~iEKkWiaFQLL~al~qcH~~g-----VcHGDIKsENILiTSWNW~~LtDFAsFKPt  170 (1431)
T KOG1240|consen  101 QYVK-HNLYDRLSTRP----FLVLIEKKWIAFQLLKALSQCHKLG-----VCHGDIKSENILITSWNWLYLTDFASFKPT  170 (1431)
T ss_pred             HHHh-hhhhhhhccch----HHHHHHHHHHHHHHHHHHHHHHHcC-----ccccccccceEEEeeechhhhhcccccCCc
Confidence            8884 48888886543    3777788899999999999999988     99999999999999999999999987653 


Q ss_pred             -ccCCc----eeeeecCCCCCCCCCccccccC-----------CCCCcccchhHHHHHHHHHh-CCCCcchhHHHHHhhh
Q 005586          567 -LADDI----VFSVLKTSAAMGYLAPEYVTTG-----------RFTERSDIFAFGVIILQILT-GSLVLTSSMRLAAESA  629 (689)
Q Consensus       567 -~~~~~----~~~~~~~~~~~~y~aPE~~~~~-----------~~~~ksDV~sfGvvl~ellt-G~~p~~~~~~~~~~~~  629 (689)
                       ++.+.    .+-......-..|+|||.+...           ..+++.||||.|||+.||++ |++||.-..-.+-...
T Consensus       171 YLPeDNPadf~fFFDTSrRRtCYiAPERFv~~~~~~~~~q~~~~L~paMDIFS~GCViaELf~Eg~PlF~LSQL~aYr~~  250 (1431)
T KOG1240|consen  171 YLPEDNPADFTFFFDTSRRRTCYIAPERFVSALGKTSVGQDAPLLTPAMDIFSAGCVIAELFLEGRPLFTLSQLLAYRSG  250 (1431)
T ss_pred             cCCCCCcccceEEEecCCceeeecChHhhhccccccccCCcccccChhhhhhhhhHHHHHHHhcCCCcccHHHHHhHhcc
Confidence             23322    2222233344579999987541           15788999999999999988 6777754322111111


Q ss_pred             ---hhhHhhccccCCCCCHHHHHHHHHHHHHhccCCCCCCCCHHHHHHHHHh
Q 005586          630 ---TFENFIDRNLKGKFSESEAAKLGKMALVCTHEDPENRPTMEAVIEELTV  678 (689)
Q Consensus       630 ---~~~~~~~~~~~~~~~~~~~~~l~~l~~~Cl~~dp~~RPs~~evl~~L~~  678 (689)
                         ..+..+.        .-+...+++++..|++.||++|-++++.++.-+.
T Consensus       251 ~~~~~e~~Le--------~Ied~~~Rnlil~Mi~rdPs~RlSAedyL~~yrG  294 (1431)
T KOG1240|consen  251 NADDPEQLLE--------KIEDVSLRNLILSMIQRDPSKRLSAEDYLQKYRG  294 (1431)
T ss_pred             CccCHHHHHH--------hCcCccHHHHHHHHHccCchhccCHHHHHHhhhc
Confidence               1111110        0012257899999999999999999999987443

>KOG1163 consensus Casein kinase (serine/threonine/tyrosine protein kinase) [Signal transduction mechanisms]

Probab=99.82  E-value=6.9e-20  Score=171.92  Aligned_cols=255  Identities=16%  Similarity=0.236  Sum_probs=189.5

Q ss_pred             ccCCcccccccCCcceEEEEE-ecCCcEEEEEEecccCCchHHHHHHHHHHHHhccCC-CcceeEeeEEEcCCCCeEEEE
Q 005586          409 QCFSEVNLLGKGNFSSVYKGT-LRDGTLVAIRSINVTSCKSEEAEFVKGLYLLTSLRH-ENIIRLRGFCCSRGRGECFLI  486 (689)
Q Consensus       409 ~~f~~~~~lg~G~~g~Vy~~~-~~~g~~vavK~l~~~~~~~~~~~f~~e~~~l~~l~H-~niv~l~g~~~~~~~~~~~lV  486 (689)
                      +.|...+.||+|+||.+|.|. ..+|..||||.=....   ...+...|.++...++| ..|..++.|.  .+...-.+|
T Consensus        15 gky~lvrkiGsGSFGdIy~~~~i~~ge~VAiK~Es~~a---~hpqL~yEskvY~iL~~g~GiP~i~~y~--~e~~ynvlV   89 (341)
T KOG1163|consen   15 GKYKLVRKIGSGSFGDIYLGISITSGEEVAIKLESSKA---KHPQLLYESKVYRILQGGVGIPHIRHYG--TEKDYNVLV   89 (341)
T ss_pred             cceEEEEeecCCchhheeeeeeccCCceEEEEeecccC---CCcchhHHHHHHHHhccCCCCchhhhhc--cccccceee
Confidence            468888999999999999997 4689999999755432   23457778888888875 5666666665  335677899


Q ss_pred             EEcCCCCCHHHHhhhcCCCCCCCCHHHHHHHHHHHHHHHhhhhCCCCCCCceeecCCCCCceeecCC---CCeEEecccc
Q 005586          487 YDFAPKGKLSKYLDQEEGSSNVLDWSTRVSIIIGIAKGIGYLHSSEVNKPAIVHRNLSVEKVLIDQQ---FNPLIADCGL  563 (689)
Q Consensus       487 ~e~~~~gsL~~~L~~~~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~~~ivH~dlk~~NiLl~~~---~~~kl~DfGl  563 (689)
                      ||.+ +.||++++.-...   .++..+.+-.|-|++.-++|+|..+     +|||||||+|+|..-+   ..+.++|||+
T Consensus        90 MdLL-GPsLEdLfnfC~R---~ftmkTvLMLaDQml~RiEyvH~r~-----fiHRDIKPdNFLMGlgrh~~kl~LIDFGL  160 (341)
T KOG1163|consen   90 MDLL-GPSLEDLFNFCSR---RFTMKTVLMLADQMLSRIEYVHLRN-----FIHRDIKPDNFLMGLGRHCNKLYLIDFGL  160 (341)
T ss_pred             eecc-CccHHHHHHHHhh---hhhHHhHHHHHHHHHHHHHHHHhhc-----cccccCCccceeeccccccceEEEEeccc
Confidence            9998 8899999876543   4889999999999999999999988     9999999999999743   4577999999


Q ss_pred             cccccCCce------eeeecCCCCCCCCCccccccCCCCCcccchhHHHHHHHHHhCCCCcchhHHHHHhhhhhhHhhcc
Q 005586          564 HKLLADDIV------FSVLKTSAAMGYLAPEYVTTGRFTERSDIFAFGVIILQILTGSLVLTSSMRLAAESATFENFIDR  637 (689)
Q Consensus       564 a~~~~~~~~------~~~~~~~~~~~y~aPE~~~~~~~~~ksDV~sfGvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~  637 (689)
                      |+.+.+...      .......||.+|.+--...+...+.+-|+=|.|.||...-.|..|+.+... .......+.+...
T Consensus       161 aKky~d~~t~~HIpyre~r~ltGTaRYASinAh~g~eqSRRDDmeSvgYvLmYfnrG~LPWQglka-~tk~QKyEkI~Ek  239 (341)
T KOG1163|consen  161 AKKYRDIRTRQHIPYREDRNLTGTARYASINAHLGIEQSRRDDMESVGYVLMYFNRGSLPWQGLKA-ATKKQKYEKISEK  239 (341)
T ss_pred             hhhhccccccccCccccCCccceeeeehhhhhhhhhhhhhhhhhhhhcceeeeeecCCCcccccch-hhHHHHHHHHHHh
Confidence            997754321      112234578888877666666778899999999999999999999975422 2222223333222


Q ss_pred             ccCC---CCCHHHHHHHHHHHHHhccCCCCCCCCHHHHHHHHHh
Q 005586          638 NLKG---KFSESEAAKLGKMALVCTHEDPENRPTMEAVIEELTV  678 (689)
Q Consensus       638 ~~~~---~~~~~~~~~l~~l~~~Cl~~dp~~RPs~~evl~~L~~  678 (689)
                      ...-   ......+.++.-.+..|-..--++-|....+-+..+.
T Consensus       240 K~s~~ie~LC~G~P~EF~myl~Y~R~L~F~E~Pdy~ylrqlFri  283 (341)
T KOG1163|consen  240 KMSTPIEVLCKGFPAEFAMYLNYCRGLGFEEKPDYMYLRQLFRI  283 (341)
T ss_pred             hcCCCHHHHhCCCcHHHHHHHHHHhhcCCCCCCcHHHHHHHHHH
Confidence            2211   1122336678888888988888889988777665543

>PRK10359 lipopolysaccharide core biosynthesis protein; Provisional

Probab=99.82  E-value=2.3e-20  Score=181.96  Aligned_cols=174  Identities=11%  Similarity=0.101  Sum_probs=134.9

Q ss_pred             HhccCCcccccccCCcceEEEEEecCCcEEEEEEecccCCchHH--HH------HHHHHHHHhccCCCcceeEeeEEEcC
Q 005586          407 ATQCFSEVNLLGKGNFSSVYKGTLRDGTLVAIRSINVTSCKSEE--AE------FVKGLYLLTSLRHENIIRLRGFCCSR  478 (689)
Q Consensus       407 at~~f~~~~~lg~G~~g~Vy~~~~~~g~~vavK~l~~~~~~~~~--~~------f~~e~~~l~~l~H~niv~l~g~~~~~  478 (689)
                      ..++|...+++|.|+||.||.... ++..+|+|.+.......+.  ..      |.+|++.+.+++|++|..+..++...
T Consensus        29 l~~~y~~~~~l~~~~f~~v~l~~~-~~~~~iiKvf~~~~~~~~~~~~~f~~g~~~e~Ea~~l~rL~~~GI~~~~d~~~~~  107 (232)
T PRK10359         29 LSYNIKTIKVFRNIDDTKVSLIDT-DYGKYILKVFAPKVKRTERFLKSFVKGDYYENLIVQTDRVRSEGLASLNDFYLLA  107 (232)
T ss_pred             hhCceEEEEEecCCCceEEEEEec-CCCcEEEEEechhcCchHHHHHhhhhhHHHHHHHHHHHHHHHCCCCcceEeeeec
Confidence            457899999999999999999765 5778999999765432221  22      68999999999999999999886533


Q ss_pred             C------CCeEEEEEEcCCCCCHHHHhhhcCCCCCCCCHHHHHHHHHHHHHHHhhhhCCCCCCCceeecCCCCCceeecC
Q 005586          479 G------RGECFLIYDFAPKGKLSKYLDQEEGSSNVLDWSTRVSIIIGIAKGIGYLHSSEVNKPAIVHRNLSVEKVLIDQ  552 (689)
Q Consensus       479 ~------~~~~~lV~e~~~~gsL~~~L~~~~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~~~ivH~dlk~~NiLl~~  552 (689)
                      .      ....++||||+++.+|.++..        ++.    ....+++.+|..+|..+     ++|||+||+||++++
T Consensus       108 ~~~~~~~~~~~~lvmEyi~G~tL~~~~~--------~~~----~~~~~i~~~l~~lH~~g-----i~H~Dikp~Nili~~  170 (232)
T PRK10359        108 ERKTLRYAHTYIMLIEYIEGVELNDMPE--------ISE----DVKAKIKASIESLHQHG-----MVSGDPHKGNFIVSK  170 (232)
T ss_pred             ccccccccCCeEEEEEEECCccHHHhhh--------ccH----HHHHHHHHHHHHHHHcC-----CccCCCChHHEEEeC
Confidence            2      235789999999999988732        222    24568999999999988     999999999999999


Q ss_pred             CCCeEEecccccccccCCceeeeecCCCCCCCCCccccccCCCCCcccchhHHHHHHHHH
Q 005586          553 QFNPLIADCGLHKLLADDIVFSVLKTSAAMGYLAPEYVTTGRFTERSDIFAFGVIILQIL  612 (689)
Q Consensus       553 ~~~~kl~DfGla~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~ksDV~sfGvvl~ell  612 (689)
                      ++ ++++|||..+....+...             ..++....+..++|+|||||.+.-+.
T Consensus       171 ~g-i~liDfg~~~~~~e~~a~-------------d~~vler~y~~~~di~~lg~~~~~~~  216 (232)
T PRK10359        171 NG-LRIIDLSGKRCTAQRKAK-------------DRIDLERHYGIKNEIKDLGYYLLIYK  216 (232)
T ss_pred             CC-EEEEECCCcccccchhhH-------------HHHHHHhHhcccccccceeEeehHHH
Confidence            88 999999988755332110             11344556778999999999886543

>KOG1023 consensus Natriuretic peptide receptor, guanylate cyclase [Signal transduction mechanisms]

Probab=99.82  E-value=4.3e-20  Score=196.80  Aligned_cols=214  Identities=25%  Similarity=0.396  Sum_probs=160.3

Q ss_pred             HhccCCCcceeEeeEEEcCCCCeEEEEEEcCCCCCHHHHhhhcCCCCCCCCHHHHHHHHHHHHHHHhhhhCCCCCCCcee
Q 005586          460 LTSLRHENIIRLRGFCCSRGRGECFLIYDFAPKGKLSKYLDQEEGSSNVLDWSTRVSIIIGIAKGIGYLHSSEVNKPAIV  539 (689)
Q Consensus       460 l~~l~H~niv~l~g~~~~~~~~~~~lV~e~~~~gsL~~~L~~~~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~~~iv  539 (689)
                      |..+.|.|+.+++|.+...  ...++|.+|+..|+|.+.+....   ..++|.-...+.+++++||+|||..    |-..
T Consensus         1 l~~l~h~n~~~f~g~~~~~--~~~~~i~~~c~rGsl~D~i~~~~---~~~d~~F~~s~~rdi~~Gl~ylh~s----~i~~   71 (484)
T KOG1023|consen    1 LRQLDHDNLNKFIGASVDG--PEMIVIWEYCSRGSLLDILSNED---IKLDYFFILSFIRDISKGLAYLHNS----PIGY   71 (484)
T ss_pred             CcccchhhhhhheeeEecC--CceEEEEeeecCccHHhHHhccc---cCccHHHHHHHHHHHHHHHHHHhcC----ccee
Confidence            4578999999999999765  78899999999999999998743   3599999999999999999999964    3349


Q ss_pred             ecCCCCCceeecCCCCeEEecccccccccCCce-eeeecCCCCCCCCCccccccC---C----CCCcccchhHHHHHHHH
Q 005586          540 HRNLSVEKVLIDQQFNPLIADCGLHKLLADDIV-FSVLKTSAAMGYLAPEYVTTG---R----FTERSDIFAFGVIILQI  611 (689)
Q Consensus       540 H~dlk~~NiLl~~~~~~kl~DfGla~~~~~~~~-~~~~~~~~~~~y~aPE~~~~~---~----~~~ksDV~sfGvvl~el  611 (689)
                      |+.++++|+++|..+.+|++|||+......... ..........-|.|||.+...   .    .+.+.||||||++++|+
T Consensus        72 hg~l~s~nClvd~~w~lklt~~Gl~~~~~~~~~~~~~~~~~~~~lw~aPellr~~~~~~~~~~~~~~gdiYs~~ii~~ei  151 (484)
T KOG1023|consen   72 HGALKSSNCLVDSRWVLKLTDFGLNSLLEETAEPEAHHPIRKALLWTAPELLRGALSQSLESALTQKGDIYSFGIIMYEI  151 (484)
T ss_pred             eeeeccccceeeeeEEEEechhhhcccccccccccccchhHHHHhccCHHHhcccccccccccccccCCeehHHHHHHHH
Confidence            999999999999999999999999887643100 011111122459999998653   1    47789999999999999


Q ss_pred             HhCCCCcchhHHHHHhhhhhhHhhc---cccCCCCC-H-HHHHHHHHHHHHhccCCCCCCCCHHHHHHHHHhhCCc
Q 005586          612 LTGSLVLTSSMRLAAESATFENFID---RNLKGKFS-E-SEAAKLGKMALVCTHEDPENRPTMEAVIEELTVAAPV  682 (689)
Q Consensus       612 ltG~~p~~~~~~~~~~~~~~~~~~~---~~~~~~~~-~-~~~~~l~~l~~~Cl~~dp~~RPs~~evl~~L~~~~p~  682 (689)
                      ++.+.||............+..+.+   ..+++... . +...++..++..||..+|++||++++|-..++..-..
T Consensus       152 ~~r~~~~~~~~~~~~~~eii~~~~~~~~~~~rP~i~~~~e~~~~l~~l~~~cw~e~P~~rPs~~~i~~~~~~~~~~  227 (484)
T KOG1023|consen  152 LFRSGPFDLRNLVEDPDEIILRVKKGGSNPFRPSIELLNELPPELLLLVARCWEEIPEKRPSIEQIRSKLLTINKG  227 (484)
T ss_pred             HhccCccccccccCChHHHHHHHHhcCCCCcCcchhhhhhcchHHHHHHHHhcccChhhCccHHHHHhhhhhhccc
Confidence            9999999753222111111111111   11232222 1 3344799999999999999999999999888776553

>PLN03150 hypothetical protein; Provisional

Probab=99.81  E-value=1.7e-19  Score=204.63  Aligned_cols=142  Identities=39%  Similarity=0.673  Sum_probs=99.7

Q ss_pred             cCChHHHHHHHHHHHccCCCCCccCCCCCCCCCCCC---CcceEEcCCCCCEEEEEcCCCCcccccCcCcCCCCCCCEEE
Q 005586           22 VCGNTELRALLDLKASLDPENKLLQSWTENGDPCSG---SFEGIACNEHRKVANISLQGKGLTGKLSPSLSGLKCLSGLY   98 (689)
Q Consensus        22 ~~~~~~~~all~~k~~~~~~~~~~~~W~~~~~~C~~---~w~gv~C~~~~~v~~l~L~~~~l~g~~~~~~~~l~~L~~L~   98 (689)
                      .+.++|..||+++|.++..+..  .+|+  +++|..   .|.||.|+....           .        ....++.|+
T Consensus       368 ~t~~~~~~aL~~~k~~~~~~~~--~~W~--g~~C~p~~~~w~Gv~C~~~~~-----------~--------~~~~v~~L~  424 (623)
T PLN03150        368 KTLLEEVSALQTLKSSLGLPLR--FGWN--GDPCVPQQHPWSGADCQFDST-----------K--------GKWFIDGLG  424 (623)
T ss_pred             ccCchHHHHHHHHHHhcCCccc--CCCC--CCCCCCcccccccceeeccCC-----------C--------CceEEEEEE
Confidence            4567899999999999864322  3795  567742   599999952110           0        001245566


Q ss_pred             ccCCcccccCCccccCCCCCcEEEecccCCCCCCCccccCCccccEEeeecccCCCCCchhcCCCCCCCEEeccCCcCCC
Q 005586           99 LHYNSLSGEIPKEIRNLTELTDLYLDVNNLSGNIPPEIGSMASLQVLQLCCNQLTGNIPAQIGSLKSLSVLTLQHNRLNG  178 (689)
Q Consensus        99 L~~N~l~g~~p~~~~~l~~L~~L~Ls~N~l~g~~p~~~~~l~~L~~L~Ls~N~l~g~~p~~~~~l~~L~~L~l~~N~l~~  178 (689)
                      |++|.|+|.+|..++.|++|+.|+|++|+|+|.+|..++.+++|+.|+|++|+++|.+|..++++++|+.|+|++|+++|
T Consensus       425 L~~n~L~g~ip~~i~~L~~L~~L~Ls~N~l~g~iP~~~~~l~~L~~LdLs~N~lsg~iP~~l~~L~~L~~L~Ls~N~l~g  504 (623)
T PLN03150        425 LDNQGLRGFIPNDISKLRHLQSINLSGNSIRGNIPPSLGSITSLEVLDLSYNSFNGSIPESLGQLTSLRILNLNGNSLSG  504 (623)
T ss_pred             CCCCCccccCCHHHhCCCCCCEEECCCCcccCcCChHHhCCCCCCEEECCCCCCCCCCchHHhcCCCCCEEECcCCcccc
Confidence            66666667777777777777777777777777777777777777777777777777777777777777777777777777


Q ss_pred             CCCcccCC
Q 005586          179 GIPDSLGN  186 (689)
Q Consensus       179 ~~p~~~~~  186 (689)
                      .+|..++.
T Consensus       505 ~iP~~l~~  512 (623)
T PLN03150        505 RVPAALGG  512 (623)
T ss_pred             cCChHHhh
Confidence            77766543

>cd05145 RIO1_like RIO kinase family; RIO1, RIO3 and similar proteins, catalytic domain

Probab=99.81  E-value=2.6e-19  Score=173.40  Aligned_cols=141  Identities=17%  Similarity=0.154  Sum_probs=111.4

Q ss_pred             ccccccCCcceEEEEEecCCcEEEEEEecccCCch-------------------------HHHHHHHHHHHHhccCCCcc
Q 005586          414 VNLLGKGNFSSVYKGTLRDGTLVAIRSINVTSCKS-------------------------EEAEFVKGLYLLTSLRHENI  468 (689)
Q Consensus       414 ~~~lg~G~~g~Vy~~~~~~g~~vavK~l~~~~~~~-------------------------~~~~f~~e~~~l~~l~H~ni  468 (689)
                      ...||+|+||.||+|...+|+.||||+++......                         ....+..|.+.+.++.|+++
T Consensus         2 ~~~ig~G~~~~Vy~a~~~~g~~vavKv~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i   81 (190)
T cd05145           2 NGCISTGKEANVYHARTGDGEELAVKIYKTSTLSFKDRDKYIEGDPRFRSRYSKSNPRKLVFAWAEKEFRNLKRLYEAGV   81 (190)
T ss_pred             CceeecCCCcEEEEEEcCCCCEEEEEEEEcCcceEeeHHHHhcCCcccccccccCCHHHHHHHHHHHHHHHHHHHHhCCC
Confidence            36799999999999998889999999998653110                         01234578999999999998


Q ss_pred             eeEeeEEEcCCCCeEEEEEEcCCCCCHHHH-hhhcCCCCCCCCHHHHHHHHHHHHHHHhhhhC-CCCCCCceeecCCCCC
Q 005586          469 IRLRGFCCSRGRGECFLIYDFAPKGKLSKY-LDQEEGSSNVLDWSTRVSIIIGIAKGIGYLHS-SEVNKPAIVHRNLSVE  546 (689)
Q Consensus       469 v~l~g~~~~~~~~~~~lV~e~~~~gsL~~~-L~~~~~~~~~l~~~~~~~ia~~ia~gL~yLH~-~~~~~~~ivH~dlk~~  546 (689)
                      .....+...    ..++||||++++++... +..     ..++..+...++.+++.++.|+|+ .+     |+||||||+
T Consensus        82 ~~p~~~~~~----~~~lVmE~~~g~~~~~~~l~~-----~~~~~~~~~~i~~~l~~~l~~lH~~~g-----ivHrDlkP~  147 (190)
T cd05145          82 PVPEPILLK----KNVLVMEFIGDDGSPAPRLKD-----VPLEEEEAEELYEQVVEQMRRLYQEAG-----LVHGDLSEY  147 (190)
T ss_pred             CCceEEEec----CCEEEEEEecCCCchhhhhhh-----ccCCHHHHHHHHHHHHHHHHHHHHhCC-----EecCCCChh
Confidence            655544322    24899999998865433 332     136778889999999999999999 77     999999999


Q ss_pred             ceeecCCCCeEEecccccccccC
Q 005586          547 KVLIDQQFNPLIADCGLHKLLAD  569 (689)
Q Consensus       547 NiLl~~~~~~kl~DfGla~~~~~  569 (689)
                      ||+++ ++.++|+|||+++.+..
T Consensus       148 NIll~-~~~~~liDFG~a~~~~~  169 (190)
T cd05145         148 NILYH-DGKPYIIDVSQAVELDH  169 (190)
T ss_pred             hEEEE-CCCEEEEEcccceecCC
Confidence            99999 88999999999986654

The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO1 is present in archaea, bacteria and eukaryotes. In addition, RIO3 is present in multicellular eukaryotes. RIO1 is essential for survival and is required for 18S rRNA processing, proper cell cycle pro

>KOG0617 consensus Ras suppressor protein (contains leucine-rich repeats) [Signal transduction mechanisms]

Probab=99.80  E-value=1.1e-21  Score=174.80  Aligned_cols=174  Identities=29%  Similarity=0.488  Sum_probs=156.3

Q ss_pred             CCCEEEEEcCCCCcccccCcCcCCCCCCCEEEccCCcccccCCccccCCCCCcEEEecccCCCCCCCccccCCccccEEe
Q 005586           67 HRKVANISLQGKGLTGKLSPSLSGLKCLSGLYLHYNSLSGEIPKEIRNLTELTDLYLDVNNLSGNIPPEIGSMASLQVLQ  146 (689)
Q Consensus        67 ~~~v~~l~L~~~~l~g~~~~~~~~l~~L~~L~L~~N~l~g~~p~~~~~l~~L~~L~Ls~N~l~g~~p~~~~~l~~L~~L~  146 (689)
                      ..+++.|.|++|.|+ .+|+.+..|.+|+.|++++|+|+ .+|..++.|++|++|+++-|++. .+|..|+.++.|+.||
T Consensus        32 ~s~ITrLtLSHNKl~-~vppnia~l~nlevln~~nnqie-~lp~~issl~klr~lnvgmnrl~-~lprgfgs~p~levld  108 (264)
T KOG0617|consen   32 MSNITRLTLSHNKLT-VVPPNIAELKNLEVLNLSNNQIE-ELPTSISSLPKLRILNVGMNRLN-ILPRGFGSFPALEVLD  108 (264)
T ss_pred             hhhhhhhhcccCcee-ecCCcHHHhhhhhhhhcccchhh-hcChhhhhchhhhheecchhhhh-cCccccCCCchhhhhh
Confidence            457899999999998 78899999999999999999999 89999999999999999999998 8999999999999999


Q ss_pred             eecccCC-CCCchhcCCCCCCCEEeccCCcCCCCCCcccCCCCCCCeeeccCCcCCCCchhhhhCCCCCcEEecccCcCC
Q 005586          147 LCCNQLT-GNIPAQIGSLKSLSVLTLQHNRLNGGIPDSLGNLGKLKRLDLSFNSLFGTIPESLANNAELLFLDVQNNTLS  225 (689)
Q Consensus       147 Ls~N~l~-g~~p~~~~~l~~L~~L~l~~N~l~~~~p~~~~~l~~L~~L~ls~N~l~g~~p~~l~~~~~L~~l~l~~N~l~  225 (689)
                      |.+|++. ..+|..|..++.|+.|+|++|.+. .+|..++++++|+.|.+..|.+- .+|..++.++.|+.|.+++|+++
T Consensus       109 ltynnl~e~~lpgnff~m~tlralyl~dndfe-~lp~dvg~lt~lqil~lrdndll-~lpkeig~lt~lrelhiqgnrl~  186 (264)
T KOG0617|consen  109 LTYNNLNENSLPGNFFYMTTLRALYLGDNDFE-ILPPDVGKLTNLQILSLRDNDLL-SLPKEIGDLTRLRELHIQGNRLT  186 (264)
T ss_pred             ccccccccccCCcchhHHHHHHHHHhcCCCcc-cCChhhhhhcceeEEeeccCchh-hCcHHHHHHHHHHHHhcccceee
Confidence            9999997 478999999999999999999999 89999999999999999999998 89999999999999999999999


Q ss_pred             cccchhHHhcc-----CccccccCCC
Q 005586          226 GIVPSALKRLN-----GGFQFQNNPG  246 (689)
Q Consensus       226 ~~~p~~~~~~~-----~~~~~~~n~~  246 (689)
                      -..|+ +..+.     ..+...+|||
T Consensus       187 vlppe-l~~l~l~~~k~v~r~E~NPw  211 (264)
T KOG0617|consen  187 VLPPE-LANLDLVGNKQVMRMEENPW  211 (264)
T ss_pred             ecChh-hhhhhhhhhHHHHhhhhCCC
Confidence            66554 44332     1234556665

>KOG1165 consensus Casein kinase (serine/threonine/tyrosine protein kinase) [Signal transduction mechanisms]

Probab=99.79  E-value=1.8e-18  Score=169.63  Aligned_cols=254  Identities=18%  Similarity=0.205  Sum_probs=182.8

Q ss_pred             cCCcccccccCCcceEEEEE-ecCCcEEEEEEecccCCchHHHHHHHHHHHHhccC-CCcceeEeeEEEcCCCCeEEEEE
Q 005586          410 CFSEVNLLGKGNFSSVYKGT-LRDGTLVAIRSINVTSCKSEEAEFVKGLYLLTSLR-HENIIRLRGFCCSRGRGECFLIY  487 (689)
Q Consensus       410 ~f~~~~~lg~G~~g~Vy~~~-~~~g~~vavK~l~~~~~~~~~~~f~~e~~~l~~l~-H~niv~l~g~~~~~~~~~~~lV~  487 (689)
                      .|...++||+|.||.++.|+ +-++..||||.=...   .+.-+...|.+..+.+. .++|..++-|  ...+.+-.+|+
T Consensus        29 hyrVGkKIGeGsFG~lf~G~Nl~nne~VAIKfEPrk---S~APQLrdEYr~YKlL~g~~GIP~vYYF--GqeG~~NiLVi  103 (449)
T KOG1165|consen   29 HYRVGKKIGEGSFGVLFLGKNLYNNEPVAIKFEPRK---SEAPQLRDEYRTYKLLGGTEGIPQVYYF--GQEGKYNILVI  103 (449)
T ss_pred             cceeccccccCcceeeecccccccCceEEEEecccc---CCcchHHHHHHHHHHHcCCCCCCceeee--ccccchhhhhh
Confidence            47778999999999999997 457999999964432   23345667777777664 5788777533  34456678999


Q ss_pred             EcCCCCCHHHHhhhcCCCCCCCCHHHHHHHHHHHHHHHhhhhCCCCCCCceeecCCCCCceeecCC-----CCeEEeccc
Q 005586          488 DFAPKGKLSKYLDQEEGSSNVLDWSTRVSIIIGIAKGIGYLHSSEVNKPAIVHRNLSVEKVLIDQQ-----FNPLIADCG  562 (689)
Q Consensus       488 e~~~~gsL~~~L~~~~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~~~ivH~dlk~~NiLl~~~-----~~~kl~DfG  562 (689)
                      |.+ +.||+++..-...   .++..++..||.|+..-++|+|+..     +|.|||||+|+||...     ..+.|.|||
T Consensus       104 dLL-GPSLEDLFD~CgR---~FSvKTV~miA~Qmi~rie~vH~k~-----LIYRDIKPdNFLIGrp~~k~~n~IhiiDFG  174 (449)
T KOG1165|consen  104 DLL-GPSLEDLFDLCGR---RFSVKTVAMIAKQMITRIEYVHEKD-----LIYRDIKPDNFLIGRPGTKDANVIHIIDFG  174 (449)
T ss_pred             hhh-CcCHHHHHHHhcC---cccHHhHHHHHHHHHHHHHHHHhcc-----eeecccCccceeecCCCCCCCceEEEEecc
Confidence            998 8899999876543   4899999999999999999999988     9999999999999743     347899999


Q ss_pred             ccccccCCce------eeeecCCCCCCCCCccccccCCCCCcccchhHHHHHHHHHhCCCCcchhHHHHHhhhhhhHhhc
Q 005586          563 LHKLLADDIV------FSVLKTSAAMGYLAPEYVTTGRFTERSDIFAFGVIILQILTGSLVLTSSMRLAAESATFENFID  636 (689)
Q Consensus       563 la~~~~~~~~------~~~~~~~~~~~y~aPE~~~~~~~~~ksDV~sfGvvl~elltG~~p~~~~~~~~~~~~~~~~~~~  636 (689)
                      +|+.+.+...      .......||.+||+--...+.+-+.+-|.=|+|-|+++.+.|..|+.+.. .+......+.+-+
T Consensus       175 mAK~YrDp~TkqHIPYrE~KSLsGTARYMSINTHlGrEQSRRDDLEaLGHvFmYFLRGsLPWQGLK-A~tnK~kYeKIGe  253 (449)
T KOG1165|consen  175 MAKEYRDPKTKQHIPYREHKSLSGTARYMSINTHLGREQSRRDDLEALGHVFMYFLRGSLPWQGLK-ADTNKEKYEKIGE  253 (449)
T ss_pred             chhhhcCccccccCccccccccccceeeeEeeccccchhhhhhhHHHhhhhhhhhccCCCcccccc-CcchHHHHHHhcc
Confidence            9998765432      12234568999999988889999999999999999999999999996531 1111222222222


Q ss_pred             cccCCC---CCHHHHHHHHHHHHHhccCCCCCCCCHHHHHHHHHh
Q 005586          637 RNLKGK---FSESEAAKLGKMALVCTHEDPENRPTMEAVIEELTV  678 (689)
Q Consensus       637 ~~~~~~---~~~~~~~~l~~l~~~Cl~~dp~~RPs~~evl~~L~~  678 (689)
                      ..-...   ..+..+.++..-+..--..+-.+-|..+-+..-+..
T Consensus       254 ~Kr~T~i~~Lc~g~P~efa~Yl~yvR~L~F~E~PDYdylr~Lf~d  298 (449)
T KOG1165|consen  254 TKRSTPIEVLCEGFPEEFATYLRYVRRLDFFETPDYDYLRKLFDD  298 (449)
T ss_pred             ccccCCHHHHHhcCHHHHHHHHHHHHhcCcccCCCHHHHHHHHHH
Confidence            111100   112224445544444445677788888776555443

>KOG4158 consensus BRPK/PTEN-induced protein kinase [Signal transduction mechanisms]

Probab=99.79  E-value=4.4e-19  Score=177.51  Aligned_cols=195  Identities=17%  Similarity=0.237  Sum_probs=138.7

Q ss_pred             CCCcceeEeeEEEcC-------------------------CCCeEEEEEEcCCCCCHHHHhhhcCCCCCCCCHHHHHHHH
Q 005586          464 RHENIIRLRGFCCSR-------------------------GRGECFLIYDFAPKGKLSKYLDQEEGSSNVLDWSTRVSII  518 (689)
Q Consensus       464 ~H~niv~l~g~~~~~-------------------------~~~~~~lV~e~~~~gsL~~~L~~~~~~~~~l~~~~~~~ia  518 (689)
                      +|||||++.++|+++                         .+...|+||.-.+ -+|.++|....     .+...+.-|+
T Consensus       274 ~HPNIvri~~aF~dsv~~lPda~~~YPdalp~R~~p~g~g~~~tlylvMkrY~-~tLr~yl~~~~-----~s~r~~~~~l  347 (598)
T KOG4158|consen  274 KHPNIVRIQTAFIDSVKVLPDAIERYPDALPARWYPSGAGEPKTLYLVMKRYR-QTLREYLWTRH-----RSYRTGRVIL  347 (598)
T ss_pred             CCCCEEeehhhhhhhhccCCchhhhCcccccceecccccCCCceEEEehhcch-hhHHHHHhcCC-----CchHHHHHHH
Confidence            699999999887643                         1245788988774 48999997643     4556677799


Q ss_pred             HHHHHHHhhhhCCCCCCCceeecCCCCCceee--cCCCC--eEEecccccccccC-----CceeeeecCCCCCCCCCccc
Q 005586          519 IGIAKGIGYLHSSEVNKPAIVHRNLSVEKVLI--DQQFN--PLIADCGLHKLLAD-----DIVFSVLKTSAAMGYLAPEY  589 (689)
Q Consensus       519 ~~ia~gL~yLH~~~~~~~~ivH~dlk~~NiLl--~~~~~--~kl~DfGla~~~~~-----~~~~~~~~~~~~~~y~aPE~  589 (689)
                      .|+++|..|||..+     |.|||+|+.|||+  |+|..  ..|+|||.+---..     ..........|...-||||+
T Consensus       348 aQlLEav~hL~~hg-----vAhRDlKSDNiL~ElddD~~P~LVvaDFGCcLAd~~hGlqlpy~S~~Vd~GGNa~lmAPEi  422 (598)
T KOG4158|consen  348 AQLLEAVTHLHKHG-----VAHRDLKSDNILLELDDDEIPQLVVADFGCCLADDNHGLQLPYESDEVDLGGNAKLMAPEI  422 (598)
T ss_pred             HHHHHHHHHHHHcc-----chhhcccccceEEEecCCCCcEEEEcccceeeeccccccccccccccccCCCcceecchhh
Confidence            99999999999988     9999999999999  44544  47899998642221     11111222234455899998


Q ss_pred             cccCC------CCCcccchhHHHHHHHHHhCCCCcchhHHHHHhhhhhhHhhccccCCCCCHHHHHHHHHHHHHhccCCC
Q 005586          590 VTTGR------FTERSDIFAFGVIILQILTGSLVLTSSMRLAAESATFENFIDRNLKGKFSESEAAKLGKMALVCTHEDP  663 (689)
Q Consensus       590 ~~~~~------~~~ksDV~sfGvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~Cl~~dp  663 (689)
                      ....+      --.|+|.|+.|.+.||+++...||+...+.......+.+..-+    ..++.++..+.+++..-+++||
T Consensus       423 ~ta~PGp~avvny~kAD~WA~GalaYEIfg~~NPFY~rGem~L~~r~Yqe~qLP----alp~~vpp~~rqlV~~lL~r~p  498 (598)
T KOG4158|consen  423 ATAVPGPNAVVNYEKADTWAAGALAYEIFGRSNPFYKRGEMLLDTRTYQESQLP----ALPSRVPPVARQLVFDLLKRDP  498 (598)
T ss_pred             hhcCCCCceeeccchhhhhhhhhhHHHHhccCCcccccchheechhhhhhhhCC----CCcccCChHHHHHHHHHhcCCc
Confidence            76432      1369999999999999999999998643332222233222222    3455566678899999999999


Q ss_pred             CCCCCHHHHH
Q 005586          664 ENRPTMEAVI  673 (689)
Q Consensus       664 ~~RPs~~evl  673 (689)
                      .+||+..-..
T Consensus       499 skRvsp~iAA  508 (598)
T KOG4158|consen  499 SKRVSPNIAA  508 (598)
T ss_pred             cccCCccHHH
Confidence            9999865443

>PRK12274 serine/threonine protein kinase; Provisional

Probab=99.79  E-value=7e-19  Score=167.71  Aligned_cols=185  Identities=14%  Similarity=0.056  Sum_probs=136.6

Q ss_pred             cccccccCCcceEEEEEecCCcEEEEEEecccCCc---hHHHHHHHHHHHHhccC-CCcceeEeeEEEcCCCCeEEEEEE
Q 005586          413 EVNLLGKGNFSSVYKGTLRDGTLVAIRSINVTSCK---SEEAEFVKGLYLLTSLR-HENIIRLRGFCCSRGRGECFLIYD  488 (689)
Q Consensus       413 ~~~~lg~G~~g~Vy~~~~~~g~~vavK~l~~~~~~---~~~~~f~~e~~~l~~l~-H~niv~l~g~~~~~~~~~~~lV~e  488 (689)
                      ....|++|+||+||.+.- ++..++.+.+....--   .....|.+|+++|.++. |+++.+++++.      ..+++||
T Consensus         6 ~~~~l~~~~f~~v~~~~~-~~~k~~~~~l~~~~~~~~~~~~~l~~rE~~iL~~L~~~~~vP~ll~~~------~~~lvme   78 (218)
T PRK12274          6 VNEPLKSDTFGRILLVRG-GERKFVRRDLSAAPWWLRGVAWWLARREALALRQLDGLPRTPRLLHWD------GRHLDRS   78 (218)
T ss_pred             cceeecCCCcceEEEeec-CCceeeecccccchhhhhhHHHHHHHHHHHHHHhcCCCCCCCEEEEEc------CEEEEEe
Confidence            357899999999997765 5778887877654321   11235889999999995 58899998862      3589999


Q ss_pred             cCCCCCHHHHhhhcCCCCCCCCHHHHHHHHHHHHHHHhhhhCCCCCCCceeecCC-CCCceeecCCCCeEEecccccccc
Q 005586          489 FAPKGKLSKYLDQEEGSSNVLDWSTRVSIIIGIAKGIGYLHSSEVNKPAIVHRNL-SVEKVLIDQQFNPLIADCGLHKLL  567 (689)
Q Consensus       489 ~~~~gsL~~~L~~~~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~~~ivH~dl-k~~NiLl~~~~~~kl~DfGla~~~  567 (689)
                      |+++.+|...+..           ....+..|++.+|.|+|+.+     |+|||| ||.|||+++++.++|+|||++...
T Consensus        79 yI~G~~L~~~~~~-----------~~~~~~~qi~~~L~~lH~~G-----IvHrDL~kp~NILv~~~g~i~LIDFG~A~~~  142 (218)
T PRK12274         79 YLAGAAMYQRPPR-----------GDLAYFRAARRLLQQLHRCG-----VAHNDLAKEANWLVQEDGSPAVIDFQLAVRG  142 (218)
T ss_pred             eecCccHHhhhhh-----------hhHHHHHHHHHHHHHHHHCc-----CccCCCCCcceEEEcCCCCEEEEECCCceec
Confidence            9999998754321           11357789999999999988     999999 799999999999999999999855


Q ss_pred             cCCcee----e--------eecCCCCCCCCCccccccC-CCC-CcccchhHHHHHHHHHhCCCCcch
Q 005586          568 ADDIVF----S--------VLKTSAAMGYLAPEYVTTG-RFT-ERSDIFAFGVIILQILTGSLVLTS  620 (689)
Q Consensus       568 ~~~~~~----~--------~~~~~~~~~y~aPE~~~~~-~~~-~ksDV~sfGvvl~elltG~~p~~~  620 (689)
                      ......    .        ......+..|++|+...-. ..+ ...+.++-|.-+|.++|++.+..+
T Consensus       143 ~~~~~~~r~L~~rDl~~llk~~~~y~~~~l~~~~~~~l~~~~~~~~~w~~~g~~~~~~~~~~~~~~~  209 (218)
T PRK12274        143 NPRARWMRLLAREDLRHLLKHKRMYCPAALTPVERRVLKRTSWIRELWFATGKPVYRFVTRRVLHWE  209 (218)
T ss_pred             CCcchHHHHHHHHHHHHHHHHHHhcCCCCCCHHHHhhhccchhHHHHHHHhcchHHHHHhccCCccc
Confidence            432210    0        0012245667777753221 223 567899999999999999988643

>KOG0603 consensus Ribosomal protein S6 kinase [Signal transduction mechanisms]

Probab=99.78  E-value=7.5e-20  Score=194.53  Aligned_cols=226  Identities=22%  Similarity=0.340  Sum_probs=176.6

Q ss_pred             ccccCCcceEEEEE----ecCCcEEEEEEecccCCchH-HHHHHHHHHHHhccC-CCcceeEeeEEEcCCCCeEEEEEEc
Q 005586          416 LLGKGNFSSVYKGT----LRDGTLVAIRSINVTSCKSE-EAEFVKGLYLLTSLR-HENIIRLRGFCCSRGRGECFLIYDF  489 (689)
Q Consensus       416 ~lg~G~~g~Vy~~~----~~~g~~vavK~l~~~~~~~~-~~~f~~e~~~l~~l~-H~niv~l~g~~~~~~~~~~~lV~e~  489 (689)
                      .+|+|.||.|+.++    .+.|..+|.|.+++...... ......|..++..++ ||.+|++.-.+  ..+...+++.+|
T Consensus         1 vlg~g~~gkvfLvrk~~g~da~~~yamkvl~k~t~~~~~~~~t~~er~il~~~~~~~f~v~lhyaf--qt~~kl~l~ld~   78 (612)
T KOG0603|consen    1 VLGQGSYGKVFLVRKAGGADAGHLYAMKVLKKATLKVRDRTHTKQERIILAFVHNTPFLVKLHYAF--QTDGKLYLILDF   78 (612)
T ss_pred             CCCcCCCcchHHHHHhccccccchhhhhcccccccccccccccccHHHHHhhccCCCceeeeeeee--ccccchhHhhhh
Confidence            37899999999865    23578899998876543221 124566788888887 99999986544  345678999999


Q ss_pred             CCCCCHHHHhhhcCCCCCCCCHHHHHHHHHHHHHHHhhhhCCCCCCCceeecCCCCCceeecCCCCeEEecccccccccC
Q 005586          490 APKGKLSKYLDQEEGSSNVLDWSTRVSIIIGIAKGIGYLHSSEVNKPAIVHRNLSVEKVLIDQQFNPLIADCGLHKLLAD  569 (689)
Q Consensus       490 ~~~gsL~~~L~~~~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~~~ivH~dlk~~NiLl~~~~~~kl~DfGla~~~~~  569 (689)
                      ..+|+|...+....    .++..........+|-+++++|+.+     |+|||+|++||+++.+|++|+.|||+++...+
T Consensus        79 ~rgg~lft~l~~~~----~f~~~~~~~~~aelaLald~lh~l~-----iiyrd~k~enilld~~Ghi~~tdfglske~v~  149 (612)
T KOG0603|consen   79 LRGGDLFTRLSKEV----MFDELDVAFYLAELALALDHLHKLG-----IAYRDYKLENVLLLLEGHIKLTDFGLSKEAVK  149 (612)
T ss_pred             cccchhhhccccCC----chHHHHHHHHHHHHHHHHhhcchhH-----HHHhcccccceeecccCccccCCchhhhHhHh
Confidence            99999998887654    3667777788889999999999998     99999999999999999999999999997755


Q ss_pred             CceeeeecCCCCCCCCCccccccCCCCCcccchhHHHHHHHHHhCCCCcchhHHHHHhhhhhhHhhccccCCCCCHHHHH
Q 005586          570 DIVFSVLKTSAAMGYLAPEYVTTGRFTERSDIFAFGVIILQILTGSLVLTSSMRLAAESATFENFIDRNLKGKFSESEAA  649 (689)
Q Consensus       570 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~ksDV~sfGvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  649 (689)
                      ....     .||..|||||++.  .....+|.||||++++||+||..||...        .+..++.  ....+|.+...
T Consensus       150 ~~~~-----cgt~eymApEI~~--gh~~a~D~ws~gvl~felltg~~pf~~~--------~~~~Il~--~~~~~p~~l~~  212 (612)
T KOG0603|consen  150 EKIA-----CGTYEYRAPEIIN--GHLSAADWWSFGVLAFELLTGTLPFGGD--------TMKRILK--AELEMPRELSA  212 (612)
T ss_pred             hhhc-----ccchhhhhhHhhh--ccCCcccchhhhhhHHHHhhCCCCCchH--------HHHHHhh--hccCCchhhhH
Confidence            4321     5788899999987  4678999999999999999999999751        1111211  12245666777


Q ss_pred             HHHHHHHHhccCCCCCCCCH
Q 005586          650 KLGKMALVCTHEDPENRPTM  669 (689)
Q Consensus       650 ~l~~l~~~Cl~~dp~~RPs~  669 (689)
                      .+..+.......+|..|--.
T Consensus       213 ~a~~~~~~l~~r~p~nrLg~  232 (612)
T KOG0603|consen  213 EARSLFRQLFKRNPENRLGA  232 (612)
T ss_pred             HHHHHHHHHHhhCHHHHhcc
Confidence            77888888888888888654

>PRK10345 hypothetical protein; Provisional

Probab=99.76  E-value=7.8e-18  Score=163.87  Aligned_cols=137  Identities=23%  Similarity=0.328  Sum_probs=105.1

Q ss_pred             CcccccccCCcceEEEEEec-CCcEEEEEEecccCCchHHHHHHHHHHHHhcc-----CCCcceeEeeEEEcCCC-CeEE
Q 005586          412 SEVNLLGKGNFSSVYKGTLR-DGTLVAIRSINVTSCKSEEAEFVKGLYLLTSL-----RHENIIRLRGFCCSRGR-GECF  484 (689)
Q Consensus       412 ~~~~~lg~G~~g~Vy~~~~~-~g~~vavK~l~~~~~~~~~~~f~~e~~~l~~l-----~H~niv~l~g~~~~~~~-~~~~  484 (689)
                      ...+.||+|+||.||.  ++ ++.. +||++.... ....+++.+|++++.++     .||||++++|++....+ +..+
T Consensus         5 ~~~~~LG~G~~~~Vy~--hp~~~~k-~IKv~~~~~-~~~~~~~~rEi~~l~~L~~~~~~h~nIvr~yg~~et~~g~g~v~   80 (210)
T PRK10345          5 SEQSPLGTGRHRKCYA--HPEDAQR-CIKIVYHRG-DGGDKEIRRELKYYAHLSRRLIDWSGIPRYYGTVETDCGTGYVY   80 (210)
T ss_pred             CCcceecCCCceEEEE--CCCCcCe-EEEEEeccc-cchHHHHHHHHHHHHHhhccCCCCcccceeeEEEEeCCCCeEEE
Confidence            3457899999999996  44 4444 689887653 23456799999999999     57999999999855421 2333


Q ss_pred             -EEEEc--CCCCCHHHHhhhcCCCCCCCCHHHHHHHHHHHHHHH-hhhhCCCCCCCceeecCCCCCceeecC----CCCe
Q 005586          485 -LIYDF--APKGKLSKYLDQEEGSSNVLDWSTRVSIIIGIAKGI-GYLHSSEVNKPAIVHRNLSVEKVLIDQ----QFNP  556 (689)
Q Consensus       485 -lV~e~--~~~gsL~~~L~~~~~~~~~l~~~~~~~ia~~ia~gL-~yLH~~~~~~~~ivH~dlk~~NiLl~~----~~~~  556 (689)
                       +|+||  +++|+|.+++....     +++.  ..++.+++.++ +|||+.+     |+||||||+|||++.    ++.+
T Consensus        81 ~~I~e~~G~~~~tL~~~l~~~~-----~~e~--~~~~~~~L~~l~~yLh~~~-----IvhrDlKp~NILl~~~~~~~~~~  148 (210)
T PRK10345         81 DVIADFDGKPSITLTEFAEQCR-----YEED--VAQLRQLLKKLKRYLLDNR-----IVTMELKPQNILCQRISESEVIP  148 (210)
T ss_pred             EEEecCCCCcchhHHHHHHccc-----ccHh--HHHHHHHHHHHHHHHHHCC-----EeecCCCHHHEEEeccCCCCCcE
Confidence             78999  66899999996531     4544  35678888888 9999988     999999999999974    3479


Q ss_pred             EEeccccc
Q 005586          557 LIADCGLH  564 (689)
Q Consensus       557 kl~DfGla  564 (689)
                      +|+||+-+
T Consensus       149 ~LiDg~G~  156 (210)
T PRK10345        149 VVCDNIGE  156 (210)
T ss_pred             EEEECCCC
Confidence            99995433

>KOG4194 consensus Membrane glycoprotein LIG-1 [Signal transduction mechanisms]

Probab=99.76  E-value=5.1e-20  Score=192.02  Aligned_cols=192  Identities=23%  Similarity=0.269  Sum_probs=168.2

Q ss_pred             CEEEEEcCCCCcccccCcCcCCCCCCCEEEccCCcccccCCccccCCCCCcEEEecccCCCCCCCccccCCccccEEeee
Q 005586           69 KVANISLQGKGLTGKLSPSLSGLKCLSGLYLHYNSLSGEIPKEIRNLTELTDLYLDVNNLSGNIPPEIGSMASLQVLQLC  148 (689)
Q Consensus        69 ~v~~l~L~~~~l~g~~~~~~~~l~~L~~L~L~~N~l~g~~p~~~~~l~~L~~L~Ls~N~l~g~~p~~~~~l~~L~~L~Ls  148 (689)
                      ++..|+|..|+++..-.+.+.+|+.|+.|+||+|.|+...++++..+++|++|+||+|+|+..-+..|..|.+|++|+|+
T Consensus       270 kme~l~L~~N~l~~vn~g~lfgLt~L~~L~lS~NaI~rih~d~WsftqkL~~LdLs~N~i~~l~~~sf~~L~~Le~LnLs  349 (873)
T KOG4194|consen  270 KMEHLNLETNRLQAVNEGWLFGLTSLEQLDLSYNAIQRIHIDSWSFTQKLKELDLSSNRITRLDEGSFRVLSQLEELNLS  349 (873)
T ss_pred             ccceeecccchhhhhhcccccccchhhhhccchhhhheeecchhhhcccceeEeccccccccCChhHHHHHHHhhhhccc
Confidence            57788888888888888888999999999999999999999999999999999999999997778889999999999999


Q ss_pred             cccCCCCCchhcCCCCCCCEEeccCCcCCCCCCc---ccCCCCCCCeeeccCCcCCCCchhhhhCCCCCcEEecccCcCC
Q 005586          149 CNQLTGNIPAQIGSLKSLSVLTLQHNRLNGGIPD---SLGNLGKLKRLDLSFNSLFGTIPESLANNAELLFLDVQNNTLS  225 (689)
Q Consensus       149 ~N~l~g~~p~~~~~l~~L~~L~l~~N~l~~~~p~---~~~~l~~L~~L~ls~N~l~g~~p~~l~~~~~L~~l~l~~N~l~  225 (689)
                      +|.++..--..|..+.+|++|||++|.|++.|-+   .|..|++|+.|+|.+|+|....-.+|.++..|++|||.+|.|.
T Consensus       350 ~Nsi~~l~e~af~~lssL~~LdLr~N~ls~~IEDaa~~f~gl~~LrkL~l~gNqlk~I~krAfsgl~~LE~LdL~~Naia  429 (873)
T KOG4194|consen  350 HNSIDHLAEGAFVGLSSLHKLDLRSNELSWCIEDAAVAFNGLPSLRKLRLTGNQLKSIPKRAFSGLEALEHLDLGDNAIA  429 (873)
T ss_pred             ccchHHHHhhHHHHhhhhhhhcCcCCeEEEEEecchhhhccchhhhheeecCceeeecchhhhccCcccceecCCCCcce
Confidence            9999877777888999999999999999988765   4778999999999999999666689999999999999999999


Q ss_pred             cccchhHHhccC-ccccccCCCCCCCCCCCCccccc
Q 005586          226 GIVPSALKRLNG-GFQFQNNPGLCGDGIASLRACTV  260 (689)
Q Consensus       226 ~~~p~~~~~~~~-~~~~~~n~~~c~~~~~~l~~~~~  260 (689)
                      .+-|++|..+.- .+.+..-..+|+|.+.++...-.
T Consensus       430 SIq~nAFe~m~Lk~Lv~nSssflCDCql~Wl~qWl~  465 (873)
T KOG4194|consen  430 SIQPNAFEPMELKELVMNSSSFLCDCQLKWLAQWLY  465 (873)
T ss_pred             eecccccccchhhhhhhcccceEEeccHHHHHHHHH
Confidence            999999987632 35566667899999988776543

>PF14531 Kinase-like: Kinase-like; PDB: 3DZO_A 2W1Z_A 3BYV_A 3Q5Z_A 3Q60_A

Probab=99.74  E-value=1.6e-17  Score=166.87  Aligned_cols=234  Identities=19%  Similarity=0.286  Sum_probs=150.0

Q ss_pred             cccccccCCcceEEEEEec-CCcEEEEEEecccCC--chHHHHHHHHHHHHhccCC-----------CcceeEeeEEEc-
Q 005586          413 EVNLLGKGNFSSVYKGTLR-DGTLVAIRSINVTSC--KSEEAEFVKGLYLLTSLRH-----------ENIIRLRGFCCS-  477 (689)
Q Consensus       413 ~~~~lg~G~~g~Vy~~~~~-~g~~vavK~l~~~~~--~~~~~~f~~e~~~l~~l~H-----------~niv~l~g~~~~-  477 (689)
                      ..+.||.|+++.||.+.+. +|+.+|+|.+.....  ....+++.+|.-....+.+           .-++++--.-.. 
T Consensus        16 ~~~~i~~g~~~~v~~v~d~~t~~~~avkvf~~~~~~~~~~~~~~~~e~l~~~~~~~~~~p~~a~~~~r~l~P~d~~~i~~   95 (288)
T PF14531_consen   16 RGRIIGKGGFSIVFEVTDVETGEEFAVKVFLLPADASANEYEQLKEEQLAITLFPGVKNPKEAYRHLRFLVPLDLLRIPG   95 (288)
T ss_dssp             EEEEEEEETTEEEEEEEETTTTEEEEEEEEEESSTTHTTHHHHHHHHHHGGGGSTT--SHHHHHHHH-B---SEEEEETT
T ss_pred             EccccccCCceEEEEEEEccCCceEEEEEEecccccchHHHHHHHHHHHHhhhhccCCCHHHHHHhceEEeeeEEEEEcC
Confidence            3578999999999999986 589999999865442  3345677777765555333           222222111111 


Q ss_pred             ------CCC--C-----eEEEEEEcCCCCCHHHHhhh---cCCCCCCCCHHHHHHHHHHHHHHHhhhhCCCCCCCceeec
Q 005586          478 ------RGR--G-----ECFLIYDFAPKGKLSKYLDQ---EEGSSNVLDWSTRVSIIIGIAKGIGYLHSSEVNKPAIVHR  541 (689)
Q Consensus       478 ------~~~--~-----~~~lV~e~~~~gsL~~~L~~---~~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~~~ivH~  541 (689)
                            ...  .     ..+++|+-+ .+||.+++..   .......+....|+.+..|+.+.+++||+.|     ++|+
T Consensus        96 ~~~~~~~~~~~~~~~v~n~~~l~P~~-~~dL~~~~~~l~~~~~~~~~l~~~arl~lT~Q~I~lvA~Lh~~G-----lVHg  169 (288)
T PF14531_consen   96 KPPFFERGPGQSIYWVLNRFLLMPRA-QGDLQDLVEALFSRAQTHSPLAFAARLSLTVQMIRLVANLHSYG-----LVHG  169 (288)
T ss_dssp             S-SEEEECETTEEEEEESEEEEEE---SEEHHHHHHHHHHHTTTSHHHHHHHHHHHHHHHHHHHHHHHHTT-----EEES
T ss_pred             CCcceecCCCCccceeehhhhccchh-hhcHHHHHHHHhhcccccchhHHHHHHHHHHHHHHHHHHHhhcc-----eEec
Confidence                  000  1     236677777 5688888642   2222223556678889999999999999998     9999


Q ss_pred             CCCCCceeecCCCCeEEecccccccccCCceeeeecCCCCCCCCCcccccc--------CCCCCcccchhHHHHHHHHHh
Q 005586          542 NLSVEKVLIDQQFNPLIADCGLHKLLADDIVFSVLKTSAAMGYLAPEYVTT--------GRFTERSDIFAFGVIILQILT  613 (689)
Q Consensus       542 dlk~~NiLl~~~~~~kl~DfGla~~~~~~~~~~~~~~~~~~~y~aPE~~~~--------~~~~~ksDV~sfGvvl~ellt  613 (689)
                      ||||+|++++++|.++|+||+.....+.....    ...+..|.+||....        -.++.+.|.|++|+++|.|.+
T Consensus       170 di~~~nfll~~~G~v~Lg~F~~~~r~g~~~~~----~~~~~~~~PPe~~~~~~~~~~~~~~~t~~~DaW~LG~~ly~lWC  245 (288)
T PF14531_consen  170 DIKPENFLLDQDGGVFLGDFSSLVRAGTRYRC----SEFPVAFTPPELESCAGQFGQNNAPYTFATDAWQLGITLYSLWC  245 (288)
T ss_dssp             T-SGGGEEE-TTS-EEE--GGGEEETTEEEEG----GGS-TTTS-HHHHHHHTSCHHSEEEE-HHHHHHHHHHHHHHHHH
T ss_pred             ccceeeEEEcCCCCEEEcChHHHeecCceeec----cCCCcccCChhhhhhhcccCcccceeeeccCHHHHHHHHHHHHH
Confidence            99999999999999999999877655442211    233466999997643        247889999999999999999


Q ss_pred             CCCCcchhHHHHHhhhhhhHhhccccCCCCCHHHHHHHHHHHHHhccCCCCCC
Q 005586          614 GSLVLTSSMRLAAESATFENFIDRNLKGKFSESEAAKLGKMALVCTHEDPENR  666 (689)
Q Consensus       614 G~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~Cl~~dp~~R  666 (689)
                      |+.|+...........        .+.  ...+.++.+..++...++.+|++|
T Consensus       246 ~~lPf~~~~~~~~~~~--------~f~--~C~~~Pe~v~~LI~~lL~~~~~~R  288 (288)
T PF14531_consen  246 GRLPFGLSSPEADPEW--------DFS--RCRDMPEPVQFLIRGLLQRNPEDR  288 (288)
T ss_dssp             SS-STCCCGGGSTSGG--------GGT--TSS---HHHHHHHHHHT-SSGGGS
T ss_pred             ccCCCCCCCccccccc--------cch--hcCCcCHHHHHHHHHHccCCcccC
Confidence            9999974422111111        111  122567789999999999999987

>cd05144 RIO2_C RIO kinase family; RIO2, C-terminal catalytic domain

Probab=99.71  E-value=6.8e-17  Score=157.68  Aligned_cols=147  Identities=18%  Similarity=0.129  Sum_probs=112.9

Q ss_pred             HHHHHHhccCCcccccccCCcceEEEEEecCCcEEEEEEecccCCc---------------------hHHHHHHHHHHHH
Q 005586          402 EEVESATQCFSEVNLLGKGNFSSVYKGTLRDGTLVAIRSINVTSCK---------------------SEEAEFVKGLYLL  460 (689)
Q Consensus       402 ~~l~~at~~f~~~~~lg~G~~g~Vy~~~~~~g~~vavK~l~~~~~~---------------------~~~~~f~~e~~~l  460 (689)
                      +++......|...+.||+|+||.||+|..++|+.||||++......                     .....+..|...+
T Consensus         8 ~~~~~~~~~~~~~~~i~~G~~g~Vy~~~~~~g~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l   87 (198)
T cd05144           8 HTLVKRGVVESLGNQIGVGKESDVYLALDPDGNPVALKFHRLGRTSFRKVKRKRDYLGDRKHASWLYLSRLAAQKEFAAL   87 (198)
T ss_pred             HHHHHcCchhhcCCccccCcceEEEEEEcCCCCEEEEEEEecccchhhhhcchHHHHhccccchhHHHhHHHHHHHHHHH
Confidence            3444444447778999999999999999888999999987653210                     0112367788999


Q ss_pred             hccCCCc--ceeEeeEEEcCCCCeEEEEEEcCCCCCHHHHhhhcCCCCCCCCHHHHHHHHHHHHHHHhhhhCCCCCCCce
Q 005586          461 TSLRHEN--IIRLRGFCCSRGRGECFLIYDFAPKGKLSKYLDQEEGSSNVLDWSTRVSIIIGIAKGIGYLHSSEVNKPAI  538 (689)
Q Consensus       461 ~~l~H~n--iv~l~g~~~~~~~~~~~lV~e~~~~gsL~~~L~~~~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~~~i  538 (689)
                      .++.|++  +...++.      ...++||||+++++|......          .....++.+++.++.++|+.+     |
T Consensus        88 ~~l~~~~i~v~~~~~~------~~~~lv~e~~~g~~L~~~~~~----------~~~~~~~~~i~~~l~~lh~~g-----i  146 (198)
T cd05144          88 KALYEEGFPVPKPIDW------NRHAVVMEYIDGVELYRVRVL----------EDPEEVLDEILEEIVKAYKHG-----I  146 (198)
T ss_pred             HHHHHcCCCCCceeec------CCceEEEEEeCCcchhhcccc----------ccHHHHHHHHHHHHHHHHHCC-----C
Confidence            9998874  4444432      345899999999998765421          223568899999999999977     9


Q ss_pred             eecCCCCCceeecCCCCeEEecccccccccC
Q 005586          539 VHRNLSVEKVLIDQQFNPLIADCGLHKLLAD  569 (689)
Q Consensus       539 vH~dlk~~NiLl~~~~~~kl~DfGla~~~~~  569 (689)
                      +||||||.||+++++++++|+|||++.....
T Consensus       147 ~H~Dl~p~Nill~~~~~~~liDfg~~~~~~~  177 (198)
T cd05144         147 IHGDLSEFNILVDDDEKIYIIDWPQMVSTDH  177 (198)
T ss_pred             CcCCCCcccEEEcCCCcEEEEECCccccCCC
Confidence            9999999999999999999999999875543

The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO2 is present in archaea and eukaryotes. It contains an N-terminal winged helix (wHTH) domain and a C-terminal RIO kinase catalytic domain. The wHTH domain is primarily seen in DNA-binding proteins, although some wHTH dom

>PRK14879 serine/threonine protein kinase; Provisional

Probab=99.70  E-value=1.2e-16  Score=157.75  Aligned_cols=135  Identities=14%  Similarity=0.284  Sum_probs=111.8

Q ss_pred             cccccCCcceEEEEEecCCcEEEEEEecccCCch-------HHHHHHHHHHHHhccCCCcceeEeeEEEcCCCCeEEEEE
Q 005586          415 NLLGKGNFSSVYKGTLRDGTLVAIRSINVTSCKS-------EEAEFVKGLYLLTSLRHENIIRLRGFCCSRGRGECFLIY  487 (689)
Q Consensus       415 ~~lg~G~~g~Vy~~~~~~g~~vavK~l~~~~~~~-------~~~~f~~e~~~l~~l~H~niv~l~g~~~~~~~~~~~lV~  487 (689)
                      +.||+|++|.||+|.. +|..|++|+........       ....+.+|++++..++|+++.....++...  ...++||
T Consensus         2 ~~l~~G~~~~vy~~~~-~~~~~~vK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~~p~~~~~~~--~~~~lv~   78 (211)
T PRK14879          2 KLIKRGAEAEIYLGDF-LGIKAVIKWRIPKRYRHPELDERIRRERTRREARIMSRARKAGVNVPAVYFVDP--ENFIIVM   78 (211)
T ss_pred             cccccCceEEEEEEee-CCCceEEEEeCCcCCcChHHHHHHHHHHHHHHHHHHHHHHHCCCCCCeEEEEeC--CCCEEEE
Confidence            5799999999999988 57789999865433211       124688899999999999988777776443  5678999


Q ss_pred             EcCCCCCHHHHhhhcCCCCCCCCHHHHHHHHHHHHHHHhhhhCCCCCCCceeecCCCCCceeecCCCCeEEeccccccc
Q 005586          488 DFAPKGKLSKYLDQEEGSSNVLDWSTRVSIIIGIAKGIGYLHSSEVNKPAIVHRNLSVEKVLIDQQFNPLIADCGLHKL  566 (689)
Q Consensus       488 e~~~~gsL~~~L~~~~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~~~ivH~dlk~~NiLl~~~~~~kl~DfGla~~  566 (689)
                      ||+++++|.+++...       .+ .+..++.+++.+|.++|+.+     ++|||++|.|||++ ++.++|+|||.++.
T Consensus        79 e~~~G~~L~~~~~~~-------~~-~~~~i~~~i~~~l~~lH~~~-----i~H~Dl~p~Nil~~-~~~~~liDf~~a~~  143 (211)
T PRK14879         79 EYIEGEPLKDLINSN-------GM-EELELSREIGRLVGKLHSAG-----IIHGDLTTSNMILS-GGKIYLIDFGLAEF  143 (211)
T ss_pred             EEeCCcCHHHHHHhc-------cH-HHHHHHHHHHHHHHHHHhCC-----cccCCCCcccEEEE-CCCEEEEECCcccC
Confidence            999999999998642       22 78899999999999999987     99999999999999 78999999998864

>PRK09605 bifunctional UGMP family protein/serine/threonine protein kinase; Validated

Probab=99.69  E-value=1e-16  Score=180.10  Aligned_cols=140  Identities=16%  Similarity=0.197  Sum_probs=110.5

Q ss_pred             hccCCcccccccCCcceEEEEEecCCcEEEEEEecccCCc------hHHHHHHHHHHHHhccCCCcceeEeeEEEcCCCC
Q 005586          408 TQCFSEVNLLGKGNFSSVYKGTLRDGTLVAIRSINVTSCK------SEEAEFVKGLYLLTSLRHENIIRLRGFCCSRGRG  481 (689)
Q Consensus       408 t~~f~~~~~lg~G~~g~Vy~~~~~~g~~vavK~l~~~~~~------~~~~~f~~e~~~l~~l~H~niv~l~g~~~~~~~~  481 (689)
                      ...|...+.||+|+||.||+|.+.+...++.++.......      .....+.+|++++.+++|++++....++...  .
T Consensus       332 ~~~~~~~~~iG~G~~g~Vy~~~~~~~~~v~k~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~~p~~~~~~~--~  409 (535)
T PRK09605        332 KRRKIPDHLIGKGAEADIKKGEYLGRDAVIKERVPKGYRHPELDERLRTERTRAEARLLSEARRAGVPTPVIYDVDP--E  409 (535)
T ss_pred             ccccCccceeccCCcEEEEEEeecCccceeEEEecccccchhHHHHHHHHHHHHHHHHHHhhcccCCCeeEEEEEeC--C
Confidence            3445567899999999999998865443333323221111      1235688999999999999999887777543  4


Q ss_pred             eEEEEEEcCCCCCHHHHhhhcCCCCCCCCHHHHHHHHHHHHHHHhhhhCCCCCCCceeecCCCCCceeecCCCCeEEecc
Q 005586          482 ECFLIYDFAPKGKLSKYLDQEEGSSNVLDWSTRVSIIIGIAKGIGYLHSSEVNKPAIVHRNLSVEKVLIDQQFNPLIADC  561 (689)
Q Consensus       482 ~~~lV~e~~~~gsL~~~L~~~~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~~~ivH~dlk~~NiLl~~~~~~kl~Df  561 (689)
                      ..++||||+++++|.+++.            .+..++.+++++|.|||+.+     |+||||||+|||+ +++.++|+||
T Consensus       410 ~~~lv~E~~~g~~L~~~l~------------~~~~~~~~i~~~L~~lH~~g-----iiHrDlkp~NILl-~~~~~~liDF  471 (535)
T PRK09605        410 EKTIVMEYIGGKDLKDVLE------------GNPELVRKVGEIVAKLHKAG-----IVHGDLTTSNFIV-RDDRLYLIDF  471 (535)
T ss_pred             CCEEEEEecCCCcHHHHHH------------HHHHHHHHHHHHHHHHHhCC-----CccCCCChHHEEE-ECCcEEEEeC
Confidence            5789999999999999875            34678999999999999987     9999999999999 6789999999


Q ss_pred             cccccc
Q 005586          562 GLHKLL  567 (689)
Q Consensus       562 Gla~~~  567 (689)
                      |+++..
T Consensus       472 Gla~~~  477 (535)
T PRK09605        472 GLGKYS  477 (535)
T ss_pred             cccccC
Confidence            998753

>smart00090 RIO RIO-like kinase

Probab=99.69  E-value=1.4e-16  Score=159.08  Aligned_cols=144  Identities=15%  Similarity=0.101  Sum_probs=109.9

Q ss_pred             cCCcccccccCCcceEEEEE--ecCCcEEEEEEecccCCc-------------------h----HHHHHHHHHHHHhccC
Q 005586          410 CFSEVNLLGKGNFSSVYKGT--LRDGTLVAIRSINVTSCK-------------------S----EEAEFVKGLYLLTSLR  464 (689)
Q Consensus       410 ~f~~~~~lg~G~~g~Vy~~~--~~~g~~vavK~l~~~~~~-------------------~----~~~~f~~e~~~l~~l~  464 (689)
                      .|...+.||+|+||.||+|.  ..+|+.||+|+++.....                   .    ....+..|++.+.++.
T Consensus        29 ~~~i~~~Lg~G~~g~Vy~a~~~~~~g~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~L~~L~  108 (237)
T smart00090       29 LSAIGGCISTGKEANVYHALDFDGSGKERAVKIYRTGTLEFKRRDRYVDGDFRFKYRKINPRKLVRLWAEKEFRNLQRLY  108 (237)
T ss_pred             hHHhCCeeccCcceeEEEEEecCCCCcEEEEEEEEcCcceecchhhhcccchhhccCCCCHHHHHHHHHHHHHHHHHHHH
Confidence            46677899999999999998  568999999998754210                   0    1124568999999997


Q ss_pred             CCc--ceeEeeEEEcCCCCeEEEEEEcCCCCCHHHHhhhcCCCCCCCCHHHHHHHHHHHHHHHhhhhCCCCCCCceeecC
Q 005586          465 HEN--IIRLRGFCCSRGRGECFLIYDFAPKGKLSKYLDQEEGSSNVLDWSTRVSIIIGIAKGIGYLHSSEVNKPAIVHRN  542 (689)
Q Consensus       465 H~n--iv~l~g~~~~~~~~~~~lV~e~~~~gsL~~~L~~~~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~~~ivH~d  542 (689)
                      +..  +.+++++      ...++||||+++++|........    .++..+...++.|++.+++|||+.+.    |+|||
T Consensus       109 ~~~i~~p~~~~~------~~~~lV~E~~~g~~L~~~~~~~~----~~~~~~~~~i~~qi~~~l~~LH~~g~----iiH~D  174 (237)
T smart00090      109 EAGVPVPKPIAW------RRNVLVMEFIGGDGLPAPRLKDV----EPEEEEEFELYDDILEEMRKLYKEGE----LVHGD  174 (237)
T ss_pred             hcCCCCCeeeEe------cCceEEEEEecCCcccccccccC----CcchHHHHHHHHHHHHHHHHHHhcCC----EEeCC
Confidence            643  3344432      12479999999988876643221    24555678899999999999998763    89999


Q ss_pred             CCCCceeecCCCCeEEeccccccccc
Q 005586          543 LSVEKVLIDQQFNPLIADCGLHKLLA  568 (689)
Q Consensus       543 lk~~NiLl~~~~~~kl~DfGla~~~~  568 (689)
                      |||+||+++ ++.++|+|||.+....
T Consensus       175 ikp~NIli~-~~~i~LiDFg~a~~~~  199 (237)
T smart00090      175 LSEYNILVH-DGKVVIIDVSQSVELD  199 (237)
T ss_pred             CChhhEEEE-CCCEEEEEChhhhccC
Confidence            999999999 8899999999987544

>KOG4237 consensus Extracellular matrix protein slit, contains leucine-rich and EGF-like repeats [Extracellular structures; Signal transduction mechanisms]

Probab=99.69  E-value=2.5e-18  Score=172.23  Aligned_cols=199  Identities=22%  Similarity=0.257  Sum_probs=156.4

Q ss_pred             ceEEcCC----------CCCEEEEEcCCCCcccccCcCcCCCCCCCEEEccCCcccccCCccccCCCCCcEEEecc-cCC
Q 005586           60 EGIACNE----------HRKVANISLQGKGLTGKLSPSLSGLKCLSGLYLHYNSLSGEIPKEIRNLTELTDLYLDV-NNL  128 (689)
Q Consensus        60 ~gv~C~~----------~~~v~~l~L~~~~l~g~~~~~~~~l~~L~~L~L~~N~l~g~~p~~~~~l~~L~~L~Ls~-N~l  128 (689)
                      .-|.|+.          ....+.|+|..|+|+-..|.+|+.|.+|+.||||+|+|+-+-|+.|.+|++|..|-+.+ |+|
T Consensus        49 ~~VdCr~~GL~eVP~~LP~~tveirLdqN~I~~iP~~aF~~l~~LRrLdLS~N~Is~I~p~AF~GL~~l~~Lvlyg~NkI  128 (498)
T KOG4237|consen   49 GIVDCRGKGLTEVPANLPPETVEIRLDQNQISSIPPGAFKTLHRLRRLDLSKNNISFIAPDAFKGLASLLSLVLYGNNKI  128 (498)
T ss_pred             ceEEccCCCcccCcccCCCcceEEEeccCCcccCChhhccchhhhceecccccchhhcChHhhhhhHhhhHHHhhcCCch
Confidence            4478863          34679999999999988889999999999999999999999999999999988886655 999


Q ss_pred             CCCCCccccCCccccEEeeecccCCCCC----------------------------------------------------
Q 005586          129 SGNIPPEIGSMASLQVLQLCCNQLTGNI----------------------------------------------------  156 (689)
Q Consensus       129 ~g~~p~~~~~l~~L~~L~Ls~N~l~g~~----------------------------------------------------  156 (689)
                      +...-..|++|.+|+.|.+.-|++.-..                                                    
T Consensus       129 ~~l~k~~F~gL~slqrLllNan~i~Cir~~al~dL~~l~lLslyDn~~q~i~~~tf~~l~~i~tlhlA~np~icdCnL~w  208 (498)
T KOG4237|consen  129 TDLPKGAFGGLSSLQRLLLNANHINCIRQDALRDLPSLSLLSLYDNKIQSICKGTFQGLAAIKTLHLAQNPFICDCNLPW  208 (498)
T ss_pred             hhhhhhHhhhHHHHHHHhcChhhhcchhHHHHHHhhhcchhcccchhhhhhccccccchhccchHhhhcCccccccccch
Confidence            8433334555544444333332222100                                                    


Q ss_pred             ---------------------------------------------------------c-hhcCCCCCCCEEeccCCcCCC
Q 005586          157 ---------------------------------------------------------P-AQIGSLKSLSVLTLQHNRLNG  178 (689)
Q Consensus       157 ---------------------------------------------------------p-~~~~~l~~L~~L~l~~N~l~~  178 (689)
                                                                               | ..|..|++|++|+|++|++++
T Consensus       209 la~~~a~~~ietsgarc~~p~rl~~~Ri~q~~a~kf~c~~esl~s~~~~~d~~d~~cP~~cf~~L~~L~~lnlsnN~i~~  288 (498)
T KOG4237|consen  209 LADDLAMNPIETSGARCVSPYRLYYKRINQEDARKFLCSLESLPSRLSSEDFPDSICPAKCFKKLPNLRKLNLSNNKITR  288 (498)
T ss_pred             hhhHHhhchhhcccceecchHHHHHHHhcccchhhhhhhHHhHHHhhccccCcCCcChHHHHhhcccceEeccCCCccch
Confidence                                                                     0 124556788999999999998


Q ss_pred             CCCcccCCCCCCCeeeccCCcCCCCchhhhhCCCCCcEEecccCcCCcccchhHHhccC--ccccccCCCCCCCCCCCCc
Q 005586          179 GIPDSLGNLGKLKRLDLSFNSLFGTIPESLANNAELLFLDVQNNTLSGIVPSALKRLNG--GFQFQNNPGLCGDGIASLR  256 (689)
Q Consensus       179 ~~p~~~~~l~~L~~L~ls~N~l~g~~p~~l~~~~~L~~l~l~~N~l~~~~p~~~~~~~~--~~~~~~n~~~c~~~~~~l~  256 (689)
                      .-+.+|..+..++.|.|..|+|...-...|.++..|+.|+|.+|+|+..-|.+|..+..  .+.+..||+.|.|.+.++.
T Consensus       289 i~~~aFe~~a~l~eL~L~~N~l~~v~~~~f~~ls~L~tL~L~~N~it~~~~~aF~~~~~l~~l~l~~Np~~CnC~l~wl~  368 (498)
T KOG4237|consen  289 IEDGAFEGAAELQELYLTRNKLEFVSSGMFQGLSGLKTLSLYDNQITTVAPGAFQTLFSLSTLNLLSNPFNCNCRLAWLG  368 (498)
T ss_pred             hhhhhhcchhhhhhhhcCcchHHHHHHHhhhccccceeeeecCCeeEEEecccccccceeeeeehccCcccCccchHHHH
Confidence            88888999999999999999988666678889999999999999999999999987654  5678899999999988776


Q ss_pred             cc
Q 005586          257 AC  258 (689)
Q Consensus       257 ~~  258 (689)
                      ..
T Consensus       369 ~W  370 (498)
T KOG4237|consen  369 EW  370 (498)
T ss_pred             HH
Confidence            54

>KOG1033 consensus eIF-2alpha kinase PEK/EIF2AK3 [Translation, ribosomal structure and biogenesis]

Probab=99.68  E-value=2e-17  Score=172.86  Aligned_cols=171  Identities=21%  Similarity=0.343  Sum_probs=131.1

Q ss_pred             eEEEEEEcCCCCCHHHHhhhcCCCCCCCCHHHHHHHHHHHHHHHhhhhCCCCCCCceeecCCCCCceeecCCCCeEEecc
Q 005586          482 ECFLIYDFAPKGKLSKYLDQEEGSSNVLDWSTRVSIIIGIAKGIGYLHSSEVNKPAIVHRNLSVEKVLIDQQFNPLIADC  561 (689)
Q Consensus       482 ~~~lV~e~~~~gsL~~~L~~~~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~~~ivH~dlk~~NiLl~~~~~~kl~Df  561 (689)
                      ..++.|+++...+|.+||..... ....+|...+.++.|++.|++|   ++     .+|||+||.||+...+.++||.||
T Consensus       330 ~lyI~Mn~c~~~tledWl~rr~~-~e~~s~s~~~~~~~q~~~~~~y---k~-----~ihrdlkp~nif~~~d~q~kIgDF  400 (516)
T KOG1033|consen  330 YLYIQMNLCEKETLEDWLRRRRT-GEERSLSLMLDIFKQIAPAVEY---KG-----LIHRDLKPSNIFFSDDDQLKIGDF  400 (516)
T ss_pred             chhhhhhhhhhhhHHHHhhCCCc-ccccchhHHHHHHHhhccchhh---cc-----chhhhccccccccccchhhhhhhh
Confidence            57899999999999999975443 3457888999999999999999   45     799999999999999999999999


Q ss_pred             cccccccCCc-----eeeeecCCCCCCCCCccccccCCCCCcccchhHHHHHHHHHh-CCCCcchhHHHHHhhhhhhHhh
Q 005586          562 GLHKLLADDI-----VFSVLKTSAAMGYLAPEYVTTGRFTERSDIFAFGVIILQILT-GSLVLTSSMRLAAESATFENFI  635 (689)
Q Consensus       562 Gla~~~~~~~-----~~~~~~~~~~~~y~aPE~~~~~~~~~ksDV~sfGvvl~ellt-G~~p~~~~~~~~~~~~~~~~~~  635 (689)
                      |+...+....     ........+|..||+||.+.+..|+.|+|+||+|++|+|+++ -..++.       ..+.+.++-
T Consensus       401 gl~ts~~~~~~~~~~~a~~t~~~gt~~YmsPEQi~g~~y~~kvdIyaLGlil~EL~~~f~T~~e-------r~~t~~d~r  473 (516)
T KOG1033|consen  401 GLVTSQDKDETVAPAAASHTQQVGTLLYMSPEQIRGQQYSEKVDIYALGLILAELLIQFSTQFE-------RIATLTDIR  473 (516)
T ss_pred             hheeecccCCcccchhhhhhhcccccccCCHHHHhhhhhhhhcchhhHHHHHHHHHHHhccHHH-------HHHhhhhhh
Confidence            9988776543     233445678899999999999999999999999999999997 222111       112222222


Q ss_pred             cc----ccCCCCCHHHHHHHHHHHHHhccCCCCCCCCHHHHH
Q 005586          636 DR----NLKGKFSESEAAKLGKMALVCTHEDPENRPTMEAVI  673 (689)
Q Consensus       636 ~~----~~~~~~~~~~~~~l~~l~~~Cl~~dp~~RPs~~evl  673 (689)
                      |.    .....++     +-..+..+++.+.|++||++.++.
T Consensus       474 ~g~ip~~~~~d~p-----~e~~ll~~lls~~p~~RP~~~~~~  510 (516)
T KOG1033|consen  474 DGIIPPEFLQDYP-----EEYTLLQQLLSPSPEERPSAIEVA  510 (516)
T ss_pred             cCCCChHHhhcCc-----HHHHHHHHhcCCCcccCchHHHHh
Confidence            22    2222233     235688899999999999655553

>TIGR03724 arch_bud32 Kae1-associated kinase Bud32

Probab=99.68  E-value=2.3e-16  Score=154.12  Aligned_cols=131  Identities=18%  Similarity=0.288  Sum_probs=104.9

Q ss_pred             ccccCCcceEEEEEecCCcEEEEEEecccCCc-------hHHHHHHHHHHHHhccCCCcceeEeeEEEcCCCCeEEEEEE
Q 005586          416 LLGKGNFSSVYKGTLRDGTLVAIRSINVTSCK-------SEEAEFVKGLYLLTSLRHENIIRLRGFCCSRGRGECFLIYD  488 (689)
Q Consensus       416 ~lg~G~~g~Vy~~~~~~g~~vavK~l~~~~~~-------~~~~~f~~e~~~l~~l~H~niv~l~g~~~~~~~~~~~lV~e  488 (689)
                      .||+|+||.||+|.+ +|..|++|+.......       ....++.+|++++..++|+++.....++...  ...++|||
T Consensus         1 ~ig~G~~~~vy~~~~-~~~~~viK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~~p~~~~~~~--~~~~lv~e   77 (199)
T TIGR03724         1 LIAKGAEAIIYLGDF-LGLKAVIKERVPKSYRHPELDERIRRERTRNEARLLSRARKAGVNTPVVYDVDP--DNKTIVME   77 (199)
T ss_pred             CCCCCceEEEEEeec-CCccEEEEEecCCcCcCchHHHHHHHHHHHHHHHHHHHHHHCCCCCCEEEEEEC--CCCEEEEE
Confidence            489999999999996 4788999986543211       1235678899999999988765554444333  45689999


Q ss_pred             cCCCCCHHHHhhhcCCCCCCCCHHHHHHHHHHHHHHHhhhhCCCCCCCceeecCCCCCceeecCCCCeEEeccccccc
Q 005586          489 FAPKGKLSKYLDQEEGSSNVLDWSTRVSIIIGIAKGIGYLHSSEVNKPAIVHRNLSVEKVLIDQQFNPLIADCGLHKL  566 (689)
Q Consensus       489 ~~~~gsL~~~L~~~~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~~~ivH~dlk~~NiLl~~~~~~kl~DfGla~~  566 (689)
                      |+++++|.+++....     .      .++.+++.+|.+||+.+     ++|||++|.||+++ ++.+++.|||+++.
T Consensus        78 ~~~g~~l~~~~~~~~-----~------~~~~~i~~~l~~lH~~g-----i~H~Dl~~~Nil~~-~~~~~liDfg~a~~  138 (199)
T TIGR03724        78 YIEGKPLKDVIEEGN-----D------ELLREIGRLVGKLHKAG-----IVHGDLTTSNIIVR-DDKLYLIDFGLGKY  138 (199)
T ss_pred             EECCccHHHHHhhcH-----H------HHHHHHHHHHHHHHHCC-----eecCCCCcceEEEE-CCcEEEEECCCCcC
Confidence            999999999875421     1      78999999999999987     99999999999999 88999999998865

Members of this protein family are the Bud32 protein associated with Kae1 (kinase-associated endopeptidase 1) in the Archaea. In many Archaeal genomes, Kae1 and Bud32 are fused. The complex is homologous to the Kae1 and Bud32 subunits of the eukaryotic KEOPS complex, an apparently ancient protein kinase-containing molecular machine.

>KOG1166 consensus Mitotic checkpoint serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning]

Probab=99.66  E-value=2.1e-16  Score=180.03  Aligned_cols=194  Identities=19%  Similarity=0.265  Sum_probs=150.6

Q ss_pred             HHhccCCcccccccCCcceEEEEEecCCcEEEEEEecccCCchHHHHHHHHHHHHhccC---CCcceeEeeEEEcCCCCe
Q 005586          406 SATQCFSEVNLLGKGNFSSVYKGTLRDGTLVAIRSINVTSCKSEEAEFVKGLYLLTSLR---HENIIRLRGFCCSRGRGE  482 (689)
Q Consensus       406 ~at~~f~~~~~lg~G~~g~Vy~~~~~~g~~vavK~l~~~~~~~~~~~f~~e~~~l~~l~---H~niv~l~g~~~~~~~~~  482 (689)
                      ..-+.|.+.+.||+|+||+||+|...+|+.||+|+=+.....    +|.--.+++.||+   -+-|..+...+.  ..+.
T Consensus       695 ~~~~~~~I~~e~G~g~y~~vy~a~~~~~~~~alK~e~P~~~W----EfYI~~q~~~RLk~~~~~~~~~~~~a~~--~~~~  768 (974)
T KOG1166|consen  695 VGGEKFCISKEIGEGSYGSVYVATHSNGKLVALKVEKPPNPW----EFYICLQVMERLKPQMLPSIMHISSAHV--FQNA  768 (974)
T ss_pred             ecceeEEEEeeeccccceEEEEeecCCCcEEEEEeecCCCce----eeeehHHHHHhhchhhhcchHHHHHHHc--cCCc
Confidence            344677888999999999999999988999999987655432    2333334455555   111222222221  1356


Q ss_pred             EEEEEEcCCCCCHHHHhhhcCCCCCCCCHHHHHHHHHHHHHHHhhhhCCCCCCCceeecCCCCCceeec-------CCCC
Q 005586          483 CFLIYDFAPKGKLSKYLDQEEGSSNVLDWSTRVSIIIGIAKGIGYLHSSEVNKPAIVHRNLSVEKVLID-------QQFN  555 (689)
Q Consensus       483 ~~lV~e~~~~gsL~~~L~~~~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~~~ivH~dlk~~NiLl~-------~~~~  555 (689)
                      .++|+||.+.|+|.+++...    ..++|...+.++.|+++-+++||..+     |||+||||+|.||.       +...
T Consensus       769 S~lv~ey~~~Gtlld~~N~~----~~m~e~lv~~~~~qml~ive~lH~~~-----IIHgDiKPDNfll~~~~~~~~~~~~  839 (974)
T KOG1166|consen  769 SVLVSEYSPYGTLLDLINTN----KVMDEYLVMFFSCQMLRIVEHLHAMG-----IIHGDIKPDNFLLRREICADSDSKG  839 (974)
T ss_pred             ceeeeeccccccHHHhhccC----CCCCchhhhHHHHHHHHHHHHHHhcc-----eecccCCcceeEeecccCCCCcccc
Confidence            78999999999999999843    35999999999999999999999988     99999999999995       2345


Q ss_pred             eEEecccccccc---cCCceeeeecCCCCCCCCCccccccCCCCCcccchhHHHHHHHHHhCCC
Q 005586          556 PLIADCGLHKLL---ADDIVFSVLKTSAAMGYLAPEYVTTGRFTERSDIFAFGVIILQILTGSL  616 (689)
Q Consensus       556 ~kl~DfGla~~~---~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~ksDV~sfGvvl~elltG~~  616 (689)
                      ++|+|||-+-.|   .+.  .......+|-++-.+|...++.++.+.|-|.+.-+++-|+-|+.
T Consensus       840 l~lIDfG~siDm~lfp~~--~~F~~~~~td~f~C~EM~~grpWtYq~DyfGlAa~~h~mLFG~y  901 (974)
T KOG1166|consen  840 LYLIDFGRSIDMKLFPDG--TKFKAVWHTDLFDCIEMREGRPWTYQIDYFGLAATVHVMLFGKY  901 (974)
T ss_pred             eEEEecccceeeeEcCCC--cEEeeeeccccchhHHHhcCCCCchhhhhHHHHHHHHHHHHHHH
Confidence            799999998755   232  24445567778999999999999999999999999999999974

>KOG0444 consensus Cytoskeletal regulator Flightless-I (contains leucine-rich and gelsolin repeats) [Cytoskeleton]

Probab=99.65  E-value=1.4e-17  Score=174.83  Aligned_cols=162  Identities=29%  Similarity=0.389  Sum_probs=80.4

Q ss_pred             CEEEEEcCCCCcccccCcCcCCCCCCCEEEccCCcccccCCccccCCCCCcEEEecccCCCCCCCccccCCccccEEeee
Q 005586           69 KVANISLQGKGLTGKLSPSLSGLKCLSGLYLHYNSLSGEIPKEIRNLTELTDLYLDVNNLSGNIPPEIGSMASLQVLQLC  148 (689)
Q Consensus        69 ~v~~l~L~~~~l~g~~~~~~~~l~~L~~L~L~~N~l~g~~p~~~~~l~~L~~L~Ls~N~l~g~~p~~~~~l~~L~~L~Ls  148 (689)
                      .++.|+|++|.|+ ..|..+..-.++-+|+||+|+|..+...-|.+|+.|-+||||+|+|. .+|+.+..|..|+.|+|+
T Consensus       104 dLt~lDLShNqL~-EvP~~LE~AKn~iVLNLS~N~IetIPn~lfinLtDLLfLDLS~NrLe-~LPPQ~RRL~~LqtL~Ls  181 (1255)
T KOG0444|consen  104 DLTILDLSHNQLR-EVPTNLEYAKNSIVLNLSYNNIETIPNSLFINLTDLLFLDLSNNRLE-MLPPQIRRLSMLQTLKLS  181 (1255)
T ss_pred             cceeeecchhhhh-hcchhhhhhcCcEEEEcccCccccCCchHHHhhHhHhhhccccchhh-hcCHHHHHHhhhhhhhcC
Confidence            4556666666655 45555555555555555555555222233445555555555555555 445554444444444444


Q ss_pred             cc-------------------------------------------------cCCCCCchhcCCCCCCCEEeccCCcCCCC
Q 005586          149 CN-------------------------------------------------QLTGNIPAQIGSLKSLSVLTLQHNRLNGG  179 (689)
Q Consensus       149 ~N-------------------------------------------------~l~g~~p~~~~~l~~L~~L~l~~N~l~~~  179 (689)
                      +|                                                 .|. .+|+.+.++.+|+.|+||+|+++ .
T Consensus       182 ~NPL~hfQLrQLPsmtsL~vLhms~TqRTl~N~Ptsld~l~NL~dvDlS~N~Lp-~vPecly~l~~LrrLNLS~N~it-e  259 (1255)
T KOG0444|consen  182 NNPLNHFQLRQLPSMTSLSVLHMSNTQRTLDNIPTSLDDLHNLRDVDLSENNLP-IVPECLYKLRNLRRLNLSGNKIT-E  259 (1255)
T ss_pred             CChhhHHHHhcCccchhhhhhhcccccchhhcCCCchhhhhhhhhccccccCCC-cchHHHhhhhhhheeccCcCcee-e
Confidence            44                                                 443 34444444444444444444444 3


Q ss_pred             CCcccCCCCCCCeeeccCCcCCCCchhhhhCCCCCcEEecccCcCC-cccchhHHhc
Q 005586          180 IPDSLGNLGKLKRLDLSFNSLFGTIPESLANNAELLFLDVQNNTLS-GIVPSALKRL  235 (689)
Q Consensus       180 ~p~~~~~l~~L~~L~ls~N~l~g~~p~~l~~~~~L~~l~l~~N~l~-~~~p~~~~~~  235 (689)
                      +....+...+|++|+||.|+|+ .+|..+..+++|+.|.+.+|+|+ .-+|+.++.+
T Consensus       260 L~~~~~~W~~lEtLNlSrNQLt-~LP~avcKL~kL~kLy~n~NkL~FeGiPSGIGKL  315 (1255)
T KOG0444|consen  260 LNMTEGEWENLETLNLSRNQLT-VLPDAVCKLTKLTKLYANNNKLTFEGIPSGIGKL  315 (1255)
T ss_pred             eeccHHHHhhhhhhccccchhc-cchHHHhhhHHHHHHHhccCcccccCCccchhhh
Confidence            3333334444444445555554 45555555555555555555553 2234444433

>KOG4194 consensus Membrane glycoprotein LIG-1 [Signal transduction mechanisms]

Probab=99.63  E-value=1.2e-16  Score=167.09  Aligned_cols=165  Identities=22%  Similarity=0.258  Sum_probs=79.6

Q ss_pred             CEEEEEcCCCCcccccCcCcCCCCCCCEEEccCCcccccCCccccCCCCCcEEEecccCCCCCCCccccCCccccEEeee
Q 005586           69 KVANISLQGKGLTGKLSPSLSGLKCLSGLYLHYNSLSGEIPKEIRNLTELTDLYLDVNNLSGNIPPEIGSMASLQVLQLC  148 (689)
Q Consensus        69 ~v~~l~L~~~~l~g~~~~~~~~l~~L~~L~L~~N~l~g~~p~~~~~l~~L~~L~Ls~N~l~g~~p~~~~~l~~L~~L~Ls  148 (689)
                      ++..|+|++|.|+..--..|.+|.+|.+|-|+.|+++...+..|.+|++|+.|+|..|++.-.---.|.+|++|+.|.|.
T Consensus       174 ni~~L~La~N~It~l~~~~F~~lnsL~tlkLsrNrittLp~r~Fk~L~~L~~LdLnrN~irive~ltFqgL~Sl~nlklq  253 (873)
T KOG4194|consen  174 NIKKLNLASNRITTLETGHFDSLNSLLTLKLSRNRITTLPQRSFKRLPKLESLDLNRNRIRIVEGLTFQGLPSLQNLKLQ  253 (873)
T ss_pred             CceEEeeccccccccccccccccchheeeecccCcccccCHHHhhhcchhhhhhccccceeeehhhhhcCchhhhhhhhh
Confidence            34555555555554444455555555555555555554444445555555555555555541112233333333333333


Q ss_pred             cccCCCCCchhcCCCCCCCEEeccCCcCCCCCCcccCCCCCCCeeeccCCcCCCCchhhhhCCCCCcEEecccCcCCccc
Q 005586          149 CNQLTGNIPAQIGSLKSLSVLTLQHNRLNGGIPDSLGNLGKLKRLDLSFNSLFGTIPESLANNAELLFLDVQNNTLSGIV  228 (689)
Q Consensus       149 ~N~l~g~~p~~~~~l~~L~~L~l~~N~l~~~~p~~~~~l~~L~~L~ls~N~l~g~~p~~l~~~~~L~~l~l~~N~l~~~~  228 (689)
                      .|.++..-...|..|.++++|+|+.|+++..--.++.+|++|+.|+||+|.+...-++++....+|+.|+|++|+|+...
T Consensus       254 rN~I~kL~DG~Fy~l~kme~l~L~~N~l~~vn~g~lfgLt~L~~L~lS~NaI~rih~d~WsftqkL~~LdLs~N~i~~l~  333 (873)
T KOG4194|consen  254 RNDISKLDDGAFYGLEKMEHLNLETNRLQAVNEGWLFGLTSLEQLDLSYNAIQRIHIDSWSFTQKLKELDLSSNRITRLD  333 (873)
T ss_pred             hcCcccccCcceeeecccceeecccchhhhhhcccccccchhhhhccchhhhheeecchhhhcccceeEeccccccccCC
Confidence            33333222233334444455555555555444444555555555555555555444555555555555555555555555


Q ss_pred             chhHH
Q 005586          229 PSALK  233 (689)
Q Consensus       229 p~~~~  233 (689)
                      ++.|.
T Consensus       334 ~~sf~  338 (873)
T KOG4194|consen  334 EGSFR  338 (873)
T ss_pred             hhHHH
Confidence            54443

>KOG0617 consensus Ras suppressor protein (contains leucine-rich repeats) [Signal transduction mechanisms]

Probab=99.62  E-value=2.3e-17  Score=147.30  Aligned_cols=153  Identities=28%  Similarity=0.455  Sum_probs=136.6

Q ss_pred             cCCCCCCCEEEccCCcccccCCccccCCCCCcEEEecccCCCCCCCccccCCccccEEeeecccCCCCCchhcCCCCCCC
Q 005586           88 LSGLKCLSGLYLHYNSLSGEIPKEIRNLTELTDLYLDVNNLSGNIPPEIGSMASLQVLQLCCNQLTGNIPAQIGSLKSLS  167 (689)
Q Consensus        88 ~~~l~~L~~L~L~~N~l~g~~p~~~~~l~~L~~L~Ls~N~l~g~~p~~~~~l~~L~~L~Ls~N~l~g~~p~~~~~l~~L~  167 (689)
                      +.++++.+.|-||+|+|+ .+|+.+..|.+|+.|++++|+++ .+|..+..++.|+.|+++-|++. .+|..|+.++.|+
T Consensus        29 Lf~~s~ITrLtLSHNKl~-~vppnia~l~nlevln~~nnqie-~lp~~issl~klr~lnvgmnrl~-~lprgfgs~p~le  105 (264)
T KOG0617|consen   29 LFNMSNITRLTLSHNKLT-VVPPNIAELKNLEVLNLSNNQIE-ELPTSISSLPKLRILNVGMNRLN-ILPRGFGSFPALE  105 (264)
T ss_pred             ccchhhhhhhhcccCcee-ecCCcHHHhhhhhhhhcccchhh-hcChhhhhchhhhheecchhhhh-cCccccCCCchhh
Confidence            456788889999999999 78889999999999999999999 89999999999999999999998 8999999999999


Q ss_pred             EEeccCCcCCC-CCCcccCCCCCCCeeeccCCcCCCCchhhhhCCCCCcEEecccCcCCcccchhHHhccC--ccccccC
Q 005586          168 VLTLQHNRLNG-GIPDSLGNLGKLKRLDLSFNSLFGTIPESLANNAELLFLDVQNNTLSGIVPSALKRLNG--GFQFQNN  244 (689)
Q Consensus       168 ~L~l~~N~l~~-~~p~~~~~l~~L~~L~ls~N~l~g~~p~~l~~~~~L~~l~l~~N~l~~~~p~~~~~~~~--~~~~~~n  244 (689)
                      .|||++|+++. .+|..|..+..|+.|+|++|.|. .+|..++.+++|+.|.+..|.+- .+|..++.+..  .+..++|
T Consensus       106 vldltynnl~e~~lpgnff~m~tlralyl~dndfe-~lp~dvg~lt~lqil~lrdndll-~lpkeig~lt~lrelhiqgn  183 (264)
T KOG0617|consen  106 VLDLTYNNLNENSLPGNFFYMTTLRALYLGDNDFE-ILPPDVGKLTNLQILSLRDNDLL-SLPKEIGDLTRLRELHIQGN  183 (264)
T ss_pred             hhhccccccccccCCcchhHHHHHHHHHhcCCCcc-cCChhhhhhcceeEEeeccCchh-hCcHHHHHHHHHHHHhcccc
Confidence            99999999974 57999999999999999999999 88889999999999999999987 45666665543  4566666


Q ss_pred             C
Q 005586          245 P  245 (689)
Q Consensus       245 ~  245 (689)
                      .
T Consensus       184 r  184 (264)
T KOG0617|consen  184 R  184 (264)
T ss_pred             e
Confidence            4

>KOG0606 consensus Microtubule-associated serine/threonine kinase and related proteins [Signal transduction mechanisms; General function prediction only]

Probab=99.59  E-value=1e-15  Score=170.81  Aligned_cols=206  Identities=23%  Similarity=0.350  Sum_probs=138.6

Q ss_pred             ccCCcccccccCCcceEEEEEecC-CcEEEEEEecccCCchHHHHHHHHHHHHhccCCCcceeEeeEEEcCCCCeEEEEE
Q 005586          409 QCFSEVNLLGKGNFSSVYKGTLRD-GTLVAIRSINVTSCKSEEAEFVKGLYLLTSLRHENIIRLRGFCCSRGRGECFLIY  487 (689)
Q Consensus       409 ~~f~~~~~lg~G~~g~Vy~~~~~~-g~~vavK~l~~~~~~~~~~~f~~e~~~l~~l~H~niv~l~g~~~~~~~~~~~lV~  487 (689)
                      .+|..++.|..|+||.||..+++. .+..|. ++++...            ++     +||..+.        +..++| 
T Consensus        83 ~df~~IklisngAygavylvrh~~trqrfa~-kiNkq~l------------il-----Rnilt~a--------~npfvv-  135 (1205)
T KOG0606|consen   83 SDFNTIKLISNGAYGAVYLVRHKETRQRFAM-KINKQNL------------IL-----RNILTFA--------GNPFVV-  135 (1205)
T ss_pred             cccceeEeeccCCCCceeeeeccccccchhh-cccccch------------hh-----hcccccc--------CCccee-
Confidence            567788999999999999999873 566776 3332210            11     1233222        122333 


Q ss_pred             EcCCCCCHHHHhhhcCCCCCCCCHHHHHHHHHHHHHHHhhhhCCCCCCCceeecCCCCCceeecCCCCeEEecccccccc
Q 005586          488 DFAPKGKLSKYLDQEEGSSNVLDWSTRVSIIIGIAKGIGYLHSSEVNKPAIVHRNLSVEKVLIDQQFNPLIADCGLHKLL  567 (689)
Q Consensus       488 e~~~~gsL~~~L~~~~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~~~ivH~dlk~~NiLl~~~~~~kl~DfGla~~~  567 (689)
                           ||-...++..+.    ++-        +++.+++|||+.+     |+|||+||.|.+++.-|++|+.|||+++.-
T Consensus       136 -----gDc~tllk~~g~----lPv--------dmvla~Eylh~yg-----ivhrdlkpdnllIT~mGhiKlTDfgLsk~G  193 (1205)
T KOG0606|consen  136 -----GDCATLLKNIGP----LPV--------DMVLAVEYLHSYG-----IVHRDLKPDNLLITSMGHIKLTDFGLSKKG  193 (1205)
T ss_pred             -----chhhhhcccCCC----Ccc--------hhhHHhHhhccCC-----eecCCCCCCcceeeecccccccchhhhhhh
Confidence                 555555543221    221        2278899999987     999999999999999999999999998753


Q ss_pred             cC--------Cc------eeeeecCCCCCCCCCccccccCCCCCcccchhHHHHHHHHHhCCCCcchhHHHHHhhhhhhH
Q 005586          568 AD--------DI------VFSVLKTSAAMGYLAPEYVTTGRFTERSDIFAFGVIILQILTGSLVLTSSMRLAAESATFEN  633 (689)
Q Consensus       568 ~~--------~~------~~~~~~~~~~~~y~aPE~~~~~~~~~ksDV~sfGvvl~elltG~~p~~~~~~~~~~~~~~~~  633 (689)
                      -.        +.      ........+|+.|+|||++....|...+|+|++|+++||.+.|..||........    +..
T Consensus       194 Lms~atnl~eg~I~k~t~Ef~dKqvcgTPeyiaPeVilrqgygkpvdwwamGiIlyeFLVgcvpffGdtpeel----fg~  269 (1205)
T KOG0606|consen  194 LMSLATNLKEGHIEKDTHEFQDKQVCGTPEYIAPEVILRQGYGKPVDWWAMGIILYEFLVGCVPFFGDTPEEL----FGQ  269 (1205)
T ss_pred             hhhccchhhhcchHHHHHHhhhccccCCccccChhhhhhhccCCCccHHHHHHHHHHHheeeeeccCCCHHHH----Hhh
Confidence            11        10      1112235789999999999999999999999999999999999999976532211    111


Q ss_pred             hhccc-cCCCCCHHHHHHHHHHHHHhccCCCCCCC
Q 005586          634 FIDRN-LKGKFSESEAAKLGKMALVCTHEDPENRP  667 (689)
Q Consensus       634 ~~~~~-~~~~~~~~~~~~l~~l~~~Cl~~dp~~RP  667 (689)
                      ++... ...+-.+....++.+++.+-++.+|.+|-
T Consensus       270 visd~i~wpE~dea~p~Ea~dli~~LL~qnp~~Rl  304 (1205)
T KOG0606|consen  270 VISDDIEWPEEDEALPPEAQDLIEQLLRQNPLCRL  304 (1205)
T ss_pred             hhhhhccccccCcCCCHHHHHHHHHHHHhChHhhc
Confidence            21111 11111233345677788888888998884

>KOG0444 consensus Cytoskeletal regulator Flightless-I (contains leucine-rich and gelsolin repeats) [Cytoskeleton]

Probab=99.59  E-value=1.4e-16  Score=167.38  Aligned_cols=153  Identities=31%  Similarity=0.424  Sum_probs=116.7

Q ss_pred             CCEEEEEcCCCCcccccCcCcCCCCCCCEEEccCCcccccCCccccCCCCCcEEEecccCCC-CCCCccccCCccccEEe
Q 005586           68 RKVANISLQGKGLTGKLSPSLSGLKCLSGLYLHYNSLSGEIPKEIRNLTELTDLYLDVNNLS-GNIPPEIGSMASLQVLQ  146 (689)
Q Consensus        68 ~~v~~l~L~~~~l~g~~~~~~~~l~~L~~L~L~~N~l~g~~p~~~~~l~~L~~L~Ls~N~l~-g~~p~~~~~l~~L~~L~  146 (689)
                      .+++.|.|...+|. .+|.+++.|.+|++|.+++|+|. .+-.+++.|+.|+.+++..|+|. .-||.++..|..|+.||
T Consensus        32 t~~~WLkLnrt~L~-~vPeEL~~lqkLEHLs~~HN~L~-~vhGELs~Lp~LRsv~~R~N~LKnsGiP~diF~l~dLt~lD  109 (1255)
T KOG0444|consen   32 TQMTWLKLNRTKLE-QVPEELSRLQKLEHLSMAHNQLI-SVHGELSDLPRLRSVIVRDNNLKNSGIPTDIFRLKDLTILD  109 (1255)
T ss_pred             hheeEEEechhhhh-hChHHHHHHhhhhhhhhhhhhhH-hhhhhhccchhhHHHhhhccccccCCCCchhcccccceeee
Confidence            46777777777765 67778888888888888888877 55567777888888888888776 23677788888888888


Q ss_pred             eecccCCCCCchhcCCCCCCCEEeccCCcCCCCCCcc-cCCCCCCCeeeccCCcCCCCchhhhhCCCCCcEEecccCcCC
Q 005586          147 LCCNQLTGNIPAQIGSLKSLSVLTLQHNRLNGGIPDS-LGNLGKLKRLDLSFNSLFGTIPESLANNAELLFLDVQNNTLS  225 (689)
Q Consensus       147 Ls~N~l~g~~p~~~~~l~~L~~L~l~~N~l~~~~p~~-~~~l~~L~~L~ls~N~l~g~~p~~l~~~~~L~~l~l~~N~l~  225 (689)
                      ||+|+|. ..|..+..-.++-.|+||+|++. .||.. |.+|..|-.||||+|+|. .+|..+..+..|++|+|++|.|.
T Consensus       110 LShNqL~-EvP~~LE~AKn~iVLNLS~N~Ie-tIPn~lfinLtDLLfLDLS~NrLe-~LPPQ~RRL~~LqtL~Ls~NPL~  186 (1255)
T KOG0444|consen  110 LSHNQLR-EVPTNLEYAKNSIVLNLSYNNIE-TIPNSLFINLTDLLFLDLSNNRLE-MLPPQIRRLSMLQTLKLSNNPLN  186 (1255)
T ss_pred             cchhhhh-hcchhhhhhcCcEEEEcccCccc-cCCchHHHhhHhHhhhccccchhh-hcCHHHHHHhhhhhhhcCCChhh
Confidence            8888887 67777777788888888888887 55554 567778888888888887 56666777888888888888764

>cd05119 RIO RIO kinase family, catalytic domain

Probab=99.58  E-value=8e-15  Score=141.72  Aligned_cols=138  Identities=18%  Similarity=0.188  Sum_probs=98.2

Q ss_pred             ccccccCCcceEEEEEecCCcEEEEEEecccCCch-HHHHH----------------------HHHHHHHhccCCCc--c
Q 005586          414 VNLLGKGNFSSVYKGTLRDGTLVAIRSINVTSCKS-EEAEF----------------------VKGLYLLTSLRHEN--I  468 (689)
Q Consensus       414 ~~~lg~G~~g~Vy~~~~~~g~~vavK~l~~~~~~~-~~~~f----------------------~~e~~~l~~l~H~n--i  468 (689)
                      .+.||+|+||.||+|...+|+.||||++....... ....+                      ..|.+.+.++.+..  +
T Consensus         2 ~~~lg~G~~g~Vy~a~~~~~~~vavKv~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~~~   81 (187)
T cd05119           2 GGPIGTGKEADVYLALDGDGEPVAVKIYRTGRTSFKKRKRYRTGDYRFGRKKSNWRYLSRLWAEKEFRNLKRLYEAGVPV   81 (187)
T ss_pred             CcccccccceeEEEEECCCCCEEEEEEEecCccchhhhhhhhHHHHHhccCCcchhhhhhHHHHHHHHHHHHHHHcCCCC
Confidence            36799999999999998889999999987543211 11111                      34566666665443  3


Q ss_pred             eeEeeEEEcCCCCeEEEEEEcCCCCCHHHH-hhhcCCCCCCCCHHHHHHHHHHHHHHHhhhhC-CCCCCCceeecCCCCC
Q 005586          469 IRLRGFCCSRGRGECFLIYDFAPKGKLSKY-LDQEEGSSNVLDWSTRVSIIIGIAKGIGYLHS-SEVNKPAIVHRNLSVE  546 (689)
Q Consensus       469 v~l~g~~~~~~~~~~~lV~e~~~~gsL~~~-L~~~~~~~~~l~~~~~~~ia~~ia~gL~yLH~-~~~~~~~ivH~dlk~~  546 (689)
                      .+.+++      ...++||||++++++... +....     .. .....++.+++.++.++|. .+     |+||||||+
T Consensus        82 ~~~~~~------~~~~lv~e~~~g~~~~~~~l~~~~-----~~-~~~~~~~~~~~~~l~~lh~~~~-----ivH~Dl~p~  144 (187)
T cd05119          82 PKPIDL------NRHVLVMEFIGGDGIPAPRLKDVR-----LL-EDPEELYDQILELMRKLYREAG-----LVHGDLSEY  144 (187)
T ss_pred             CceEec------CCCEEEEEEeCCCCccChhhhhhh-----hc-ccHHHHHHHHHHHHHHHhhccC-----cCcCCCChh
Confidence            333332      235899999999654321 21110     11 4567899999999999998 66     999999999


Q ss_pred             ceeecCCCCeEEecccccccccC
Q 005586          547 KVLIDQQFNPLIADCGLHKLLAD  569 (689)
Q Consensus       547 NiLl~~~~~~kl~DfGla~~~~~  569 (689)
                      ||+++ ++.++++|||.+.....
T Consensus       145 Nili~-~~~~~liDfg~a~~~~~  166 (187)
T cd05119         145 NILVD-DGKVYIIDVPQAVEIDH  166 (187)
T ss_pred             hEEEE-CCcEEEEECcccccccC
Confidence            99999 89999999999875543

The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases present in archaea, bacteria and eukaryotes. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. RIO kinases contain a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. Most organisms contain at least two RIO kinases, RIO1 and RIO2. A third protein, RIO3, is present in multicellular eukaryotes. In yeast, RIO1 and RIO2 are essential for survival. They funct

>cd05120 APH_ChoK_like Aminoglycoside 3'-phosphotransferase (APH) and Choline Kinase (ChoK) family

Probab=99.58  E-value=2e-14  Score=133.11  Aligned_cols=135  Identities=16%  Similarity=0.133  Sum_probs=111.3

Q ss_pred             ccccccCCcceEEEEEecCCcEEEEEEecccCCchHHHHHHHHHHHHhccCC--CcceeEeeEEEcCCCCeEEEEEEcCC
Q 005586          414 VNLLGKGNFSSVYKGTLRDGTLVAIRSINVTSCKSEEAEFVKGLYLLTSLRH--ENIIRLRGFCCSRGRGECFLIYDFAP  491 (689)
Q Consensus       414 ~~~lg~G~~g~Vy~~~~~~g~~vavK~l~~~~~~~~~~~f~~e~~~l~~l~H--~niv~l~g~~~~~~~~~~~lV~e~~~  491 (689)
                      .+.||+|.++.||++...+ ..+++|.......   ...+.+|+..+..++|  .++.+++++..  ..+..++++||++
T Consensus         3 ~~~i~~g~~~~v~~~~~~~-~~~~iK~~~~~~~---~~~~~~e~~~~~~l~~~~~~~p~~~~~~~--~~~~~~~v~e~~~   76 (155)
T cd05120           3 IKLLKGGLTNRVYLLGTKD-EDYVLKINPSREK---GADREREVAILQLLARKGLPVPKVLASGE--SDGWSYLLMEWIE   76 (155)
T ss_pred             ceecccccccceEEEEecC-CeEEEEecCCCCc---hhHHHHHHHHHHHHHHcCCCCCeEEEEcC--CCCccEEEEEecC
Confidence            4679999999999999864 7899999866542   4578899999999977  58888888763  3467899999998


Q ss_pred             CCCHHHHhhhcCCCCCCCCHHHHHHHHHHHHHHHhhhhCCCCCCCceeecCCCCCceeecCCCCeEEecccccccc
Q 005586          492 KGKLSKYLDQEEGSSNVLDWSTRVSIIIGIAKGIGYLHSSEVNKPAIVHRNLSVEKVLIDQQFNPLIADCGLHKLL  567 (689)
Q Consensus       492 ~gsL~~~L~~~~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~~~ivH~dlk~~NiLl~~~~~~kl~DfGla~~~  567 (689)
                      ++.+..+           ++.....++.+++++++++|...  ...++|+|++|.||++++.+.+++.|||.++..
T Consensus        77 g~~~~~~-----------~~~~~~~~~~~~~~~l~~lh~~~--~~~i~H~Dl~~~Nil~~~~~~~~l~Df~~~~~~  139 (155)
T cd05120          77 GETLDEV-----------SEEEKEDIAEQLAELLAKLHQLP--LLVLCHGDLHPGNILVDDGKILGIIDWEYAGYG  139 (155)
T ss_pred             CeecccC-----------CHHHHHHHHHHHHHHHHHHhCCC--ceEEEecCCCcceEEEECCcEEEEEecccccCC
Confidence            8766543           45667789999999999999853  245999999999999999999999999988643

The APH/ChoK family is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). The family is composed of APH, ChoK, ethanolamine kinase (ETNK), macrolide 2'-phosphotransferase (MPH2'), an unusual homoserine kinase, and uncharacterized proteins with similarity to the N-terminal domain of acyl-CoA dehydrogenase 10 (ACAD10). The members of this family catalyze the transfer of the gamma-phosphoryl group from ATP (or CTP) to small molecule substrates such as aminoglycosides, macrolides, choline, ethanolamine, and homoserine. Phosphorylation of the antibiotics, aminoglycosides and macrolides, leads to their inactivation and to bacterial antibiotic resistance. Phosphorylation of choline, ethanolamine, and homoserine serves

>PRK01723 3-deoxy-D-manno-octulosonic-acid kinase; Reviewed

Probab=99.56  E-value=3.2e-14  Score=142.36  Aligned_cols=138  Identities=15%  Similarity=0.133  Sum_probs=106.3

Q ss_pred             ccccc-cCCcceEEEEEecCCcEEEEEEecccCC------------chHHHHHHHHHHHHhccCCCcc--eeEeeEEEcC
Q 005586          414 VNLLG-KGNFSSVYKGTLRDGTLVAIRSINVTSC------------KSEEAEFVKGLYLLTSLRHENI--IRLRGFCCSR  478 (689)
Q Consensus       414 ~~~lg-~G~~g~Vy~~~~~~g~~vavK~l~~~~~------------~~~~~~f~~e~~~l~~l~H~ni--v~l~g~~~~~  478 (689)
                      ...|| .||.|+||.+... +..++||++.....            ......+.+|++++.+++|+++  +..+++....
T Consensus        36 ~~~lg~~~g~gtv~~v~~~-~~~~vlk~~~r~~~i~kv~~~~~~~~~~~~~r~~rE~~ll~~L~~~gi~vP~pl~~~~~~  114 (239)
T PRK01723         36 ARVVGSAKGRGTTWFVQTP-GVNWVLRHYRRGGLIGKLSKDRYLFTGLERTRAFAEFRLLAQLYEAGLPVPRPIAARVVR  114 (239)
T ss_pred             CceeecCCCCccEEEEEeC-CceEEEEEeeEcchHHhhhhhcccccchhhhHHHHHHHHHHHHHhCCCCCceeEeeeeee
Confidence            46788 8999999999886 67889998853210            1223568889999999998885  6677765433


Q ss_pred             CCC--eEEEEEEcCCC-CCHHHHhhhcCCCCCCCCHHHHHHHHHHHHHHHhhhhCCCCCCCceeecCCCCCceeecCCCC
Q 005586          479 GRG--ECFLIYDFAPK-GKLSKYLDQEEGSSNVLDWSTRVSIIIGIAKGIGYLHSSEVNKPAIVHRNLSVEKVLIDQQFN  555 (689)
Q Consensus       479 ~~~--~~~lV~e~~~~-gsL~~~L~~~~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~~~ivH~dlk~~NiLl~~~~~  555 (689)
                      ...  ..++|+||+++ .+|.+++...     .++..    .+.+++.+|.+||+.+     |+||||||.|||++.++.
T Consensus       115 ~~~~~~~~lV~e~l~G~~~L~~~l~~~-----~l~~~----~~~~i~~~l~~lH~~G-----I~HrDlkp~NILv~~~~~  180 (239)
T PRK01723        115 HGLFYRADILIERIEGARDLVALLQEA-----PLSEE----QWQAIGQLIARFHDAG-----VYHADLNAHNILLDPDGK  180 (239)
T ss_pred             cCcceeeeEEEEecCCCCCHHHHHhcC-----CCCHH----HHHHHHHHHHHHHHCC-----CCCCCCCchhEEEcCCCC
Confidence            221  23599999997 6999988642     24433    3568999999999988     999999999999999999


Q ss_pred             eEEeccccccc
Q 005586          556 PLIADCGLHKL  566 (689)
Q Consensus       556 ~kl~DfGla~~  566 (689)
                      ++|+|||.++.
T Consensus       181 v~LIDfg~~~~  191 (239)
T PRK01723        181 FWLIDFDRGEL  191 (239)
T ss_pred             EEEEECCCccc
Confidence            99999998764

>KOG1266 consensus Protein kinase [Signal transduction mechanisms]

Probab=99.51  E-value=1.2e-14  Score=142.76  Aligned_cols=207  Identities=21%  Similarity=0.300  Sum_probs=142.5

Q ss_pred             HHhccCCCcceeEeeEEEcCC---CCeEEEEEEcCCCCCHHHHhhhcCCCCCCCCHHHHHHHHHHHHHHHhhhhCCCCCC
Q 005586          459 LLTSLRHENIIRLRGFCCSRG---RGECFLIYDFAPKGKLSKYLDQEEGSSNVLDWSTRVSIIIGIAKGIGYLHSSEVNK  535 (689)
Q Consensus       459 ~l~~l~H~niv~l~g~~~~~~---~~~~~lV~e~~~~gsL~~~L~~~~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~  535 (689)
                      -|-++.|.|||++..|+.+..   ..+..++.|||..|++..+|+........+....-.+++.||..||.|||+   |.
T Consensus       120 nllqlvHsnlvkfH~yw~d~K~~e~~rviFiteymssgs~~~fLkrt~~~~~a~~~~~wkkw~tqIlsal~yLhs---~~  196 (458)
T KOG1266|consen  120 NLLQLVHSNLVKFHKYWTDKKYEEKPRVIFITEYMSSGSLKQFLKRTKKNQKALFQKAWKKWCTQILSALSYLHS---CD  196 (458)
T ss_pred             HHHHHHHHHHHHHHHhhcccccccccceEEEEecccchhHHHHHHHHHHhhhhhhHHHHHHHHHHHHhhhhhhhc---cC
Confidence            455667999999999885432   345789999999999999998765444456667778899999999999998   46


Q ss_pred             CceeecCCCCCceeecCCCCeEEecccccccccC---CceeeeecCCCCCCCCCccccccCCCCCcccchhHHHHHHHHH
Q 005586          536 PAIVHRNLSVEKVLIDQQFNPLIADCGLHKLLAD---DIVFSVLKTSAAMGYLAPEYVTTGRFTERSDIFAFGVIILQIL  612 (689)
Q Consensus       536 ~~ivH~dlk~~NiLl~~~~~~kl~DfGla~~~~~---~~~~~~~~~~~~~~y~aPE~~~~~~~~~ksDV~sfGvvl~ell  612 (689)
                      |||+|+++.-+-|++..++-+|+.--........   ..........+-++|.+||+-.....+..+|||+||...+||.
T Consensus       197 PpiihgnlTc~tifiq~ngLIkig~~ap~s~h~s~~~~~~~Ek~~~~~~~g~~a~~sg~~tn~~~a~dIy~fgmcAlema  276 (458)
T KOG1266|consen  197 PPIIHGNLTCDTIFIQHNGLIKIGSVAPDSTHPSVNSTREAEKSVNTSLPGFSAPESGTTTNTTGASDIYKFGMCALEMA  276 (458)
T ss_pred             CccccCCcchhheeecCCceEEecccCccccchhhhhhhHhhhhccccCCccccCCcCcccccccchhhhhhhHHHHHHH
Confidence            9999999999999999999888753221111100   0000111234557899999887777888999999999999998


Q ss_pred             hCCCCcchhHHHHHhhhhhhHhhccccCCCCCHHHHHHHHHHHHHhccCCCCCCCCHHHHHHHH
Q 005586          613 TGSLVLTSSMRLAAESATFENFIDRNLKGKFSESEAAKLGKMALVCTHEDPENRPTMEAVIEEL  676 (689)
Q Consensus       613 tG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~Cl~~dp~~RPs~~evl~~L  676 (689)
                      .+..-..........    ++.+.....+    .+...-...+..|++..|..||+|++++.+.
T Consensus       277 ilEiq~tnseS~~~~----ee~ia~~i~~----len~lqr~~i~kcl~~eP~~rp~ar~llfHp  332 (458)
T KOG1266|consen  277 ILEIQSTNSESKVEV----EENIANVIIG----LENGLQRGSITKCLEGEPNGRPDARLLLFHP  332 (458)
T ss_pred             HheeccCCCcceeeh----hhhhhhheee----ccCccccCcCcccccCCCCCCcchhhhhcCc
Confidence            876542211111111    1111111100    0011123466789999999999999998664

>KOG0472 consensus Leucine-rich repeat protein [Function unknown]

Probab=99.51  E-value=2e-16  Score=158.78  Aligned_cols=169  Identities=27%  Similarity=0.381  Sum_probs=125.4

Q ss_pred             CEEEEEcCCCCcccccCcCcCCCCCCCEEEccCCcccccCCccccCCCCCcEEEecccCCCCCCCccccCCccccEEeee
Q 005586           69 KVANISLQGKGLTGKLSPSLSGLKCLSGLYLHYNSLSGEIPKEIRNLTELTDLYLDVNNLSGNIPPEIGSMASLQVLQLC  148 (689)
Q Consensus        69 ~v~~l~L~~~~l~g~~~~~~~~l~~L~~L~L~~N~l~g~~p~~~~~l~~L~~L~Ls~N~l~g~~p~~~~~l~~L~~L~Ls  148 (689)
                      .+..++..+|+++ .+|+.++++..|..|++.+|++....|..+. ++.|++||...|-++ .+|++++.|.+|..|||.
T Consensus       138 ~l~dl~~~~N~i~-slp~~~~~~~~l~~l~~~~n~l~~l~~~~i~-m~~L~~ld~~~N~L~-tlP~~lg~l~~L~~LyL~  214 (565)
T KOG0472|consen  138 DLEDLDATNNQIS-SLPEDMVNLSKLSKLDLEGNKLKALPENHIA-MKRLKHLDCNSNLLE-TLPPELGGLESLELLYLR  214 (565)
T ss_pred             hhhhhhccccccc-cCchHHHHHHHHHHhhccccchhhCCHHHHH-HHHHHhcccchhhhh-cCChhhcchhhhHHHHhh
Confidence            3455666677776 6777778888888888888888855554444 888888888888887 788888888888888888


Q ss_pred             cccCCCCCchhcCCCCCCCEEeccCCcCCCCCCcccC-CCCCCCeeeccCCcCCCCchhhhhCCCCCcEEecccCcCCcc
Q 005586          149 CNQLTGNIPAQIGSLKSLSVLTLQHNRLNGGIPDSLG-NLGKLKRLDLSFNSLFGTIPESLANNAELLFLDVQNNTLSGI  227 (689)
Q Consensus       149 ~N~l~g~~p~~~~~l~~L~~L~l~~N~l~~~~p~~~~-~l~~L~~L~ls~N~l~g~~p~~l~~~~~L~~l~l~~N~l~~~  227 (689)
                      .|++. .+| +|.++..|.+|+++.|++. .+|.... ++.+|..|||..|+++ ..|+.+.-+.+|.+||+++|.+++.
T Consensus       215 ~Nki~-~lP-ef~gcs~L~Elh~g~N~i~-~lpae~~~~L~~l~vLDLRdNklk-e~Pde~clLrsL~rLDlSNN~is~L  290 (565)
T KOG0472|consen  215 RNKIR-FLP-EFPGCSLLKELHVGENQIE-MLPAEHLKHLNSLLVLDLRDNKLK-EVPDEICLLRSLERLDLSNNDISSL  290 (565)
T ss_pred             hcccc-cCC-CCCccHHHHHHHhcccHHH-hhHHHHhcccccceeeeccccccc-cCchHHHHhhhhhhhcccCCccccC
Confidence            88887 666 7888888888888888887 6776655 7888888888888888 7788888888888888888888876


Q ss_pred             cchhHHhcc-CccccccCC
Q 005586          228 VPSALKRLN-GGFQFQNNP  245 (689)
Q Consensus       228 ~p~~~~~~~-~~~~~~~n~  245 (689)
                      .+. ++.+. ..+.+.|||
T Consensus       291 p~s-LgnlhL~~L~leGNP  308 (565)
T KOG0472|consen  291 PYS-LGNLHLKFLALEGNP  308 (565)
T ss_pred             Ccc-cccceeeehhhcCCc
Confidence            543 33331 134455554

>KOG0472 consensus Leucine-rich repeat protein [Function unknown]

Probab=99.50  E-value=1.4e-15  Score=152.87  Aligned_cols=152  Identities=32%  Similarity=0.440  Sum_probs=136.3

Q ss_pred             CEEEEEcCCCCcccccCcCcCCCCCCCEE-EccCCcccccCCccccCCCCCcEEEecccCCCCCCCccccCCccccEEee
Q 005586           69 KVANISLQGKGLTGKLSPSLSGLKCLSGL-YLHYNSLSGEIPKEIRNLTELTDLYLDVNNLSGNIPPEIGSMASLQVLQL  147 (689)
Q Consensus        69 ~v~~l~L~~~~l~g~~~~~~~~l~~L~~L-~L~~N~l~g~~p~~~~~l~~L~~L~Ls~N~l~g~~p~~~~~l~~L~~L~L  147 (689)
                      -|+.+++++|+|. .+|..+..+..+.+. ++++|.+ +.+|..++.+++|..|+|++|-+. .+|.+++.+..||.||+
T Consensus       389 ~Vt~VnfskNqL~-elPk~L~~lkelvT~l~lsnn~i-sfv~~~l~~l~kLt~L~L~NN~Ln-~LP~e~~~lv~Lq~Lnl  465 (565)
T KOG0472|consen  389 IVTSVNFSKNQLC-ELPKRLVELKELVTDLVLSNNKI-SFVPLELSQLQKLTFLDLSNNLLN-DLPEEMGSLVRLQTLNL  465 (565)
T ss_pred             ceEEEecccchHh-hhhhhhHHHHHHHHHHHhhcCcc-ccchHHHHhhhcceeeecccchhh-hcchhhhhhhhhheecc
Confidence            3899999999997 788888888877664 5555555 599999999999999999999998 89999999999999999


Q ss_pred             ecccCCCCCchhcCCCCCCCEEeccCCcCCCCCCcccCCCCCCCeeeccCCcCCCCchhhhhCCCCCcEEecccCcCC
Q 005586          148 CCNQLTGNIPAQIGSLKSLSVLTLQHNRLNGGIPDSLGNLGKLKRLDLSFNSLFGTIPESLANNAELLFLDVQNNTLS  225 (689)
Q Consensus       148 s~N~l~g~~p~~~~~l~~L~~L~l~~N~l~~~~p~~~~~l~~L~~L~ls~N~l~g~~p~~l~~~~~L~~l~l~~N~l~  225 (689)
                      |.|+|. .+|..+..+..|+.+-.++|++...-|+.+.+|.+|.+|||.+|.+. .+|..++++.+|++|++.+|+|.
T Consensus       466 S~NrFr-~lP~~~y~lq~lEtllas~nqi~~vd~~~l~nm~nL~tLDL~nNdlq-~IPp~LgnmtnL~hLeL~gNpfr  541 (565)
T KOG0472|consen  466 SFNRFR-MLPECLYELQTLETLLASNNQIGSVDPSGLKNMRNLTTLDLQNNDLQ-QIPPILGNMTNLRHLELDGNPFR  541 (565)
T ss_pred             cccccc-cchHHHhhHHHHHHHHhccccccccChHHhhhhhhcceeccCCCchh-hCChhhccccceeEEEecCCccC
Confidence            999998 89999888888998888889999655666999999999999999999 88999999999999999999998

>KOG0532 consensus Leucine-rich repeat (LRR) protein, contains calponin homology domain [Cytoskeleton]

Probab=99.47  E-value=1.3e-15  Score=159.47  Aligned_cols=167  Identities=32%  Similarity=0.510  Sum_probs=89.3

Q ss_pred             EEEEEcCCCCcccccCcCcCCCCCCCEEEccCCcccccCCccccCCCCCcEEEecccCCCCCCCccccCCccccEEeeec
Q 005586           70 VANISLQGKGLTGKLSPSLSGLKCLSGLYLHYNSLSGEIPKEIRNLTELTDLYLDVNNLSGNIPPEIGSMASLQVLQLCC  149 (689)
Q Consensus        70 v~~l~L~~~~l~g~~~~~~~~l~~L~~L~L~~N~l~g~~p~~~~~l~~L~~L~Ls~N~l~g~~p~~~~~l~~L~~L~Ls~  149 (689)
                      .+..+|+.|.++ .+|..++.+..|+.|.|..|.+. .+|..+.+|..|++|||+.|+++ .+|..++.|+ |+.|-+++
T Consensus        77 t~~aDlsrNR~~-elp~~~~~f~~Le~liLy~n~~r-~ip~~i~~L~~lt~l~ls~NqlS-~lp~~lC~lp-Lkvli~sN  152 (722)
T KOG0532|consen   77 TVFADLSRNRFS-ELPEEACAFVSLESLILYHNCIR-TIPEAICNLEALTFLDLSSNQLS-HLPDGLCDLP-LKVLIVSN  152 (722)
T ss_pred             hhhhhccccccc-cCchHHHHHHHHHHHHHHhccce-ecchhhhhhhHHHHhhhccchhh-cCChhhhcCc-ceeEEEec
Confidence            445566666665 45555555555555555555555 55555555555555555555555 5555555554 55555555


Q ss_pred             ccCCCCCchhcCCCCCCCEEeccCCcCCCCCCcccCCCCCCCeeeccCCcCCCCchhhhhCCCCCcEEecccCcCCcccc
Q 005586          150 NQLTGNIPAQIGSLKSLSVLTLQHNRLNGGIPDSLGNLGKLKRLDLSFNSLFGTIPESLANNAELLFLDVQNNTLSGIVP  229 (689)
Q Consensus       150 N~l~g~~p~~~~~l~~L~~L~l~~N~l~~~~p~~~~~l~~L~~L~ls~N~l~g~~p~~l~~~~~L~~l~l~~N~l~~~~p  229 (689)
                      |+++ .+|..++.+..|..||.+.|.+. .+|..++++.+|+.|++..|++. .+|+.+..++ |..||++.|+++ .+|
T Consensus       153 Nkl~-~lp~~ig~~~tl~~ld~s~nei~-slpsql~~l~slr~l~vrRn~l~-~lp~El~~Lp-Li~lDfScNkis-~iP  227 (722)
T KOG0532|consen  153 NKLT-SLPEEIGLLPTLAHLDVSKNEIQ-SLPSQLGYLTSLRDLNVRRNHLE-DLPEELCSLP-LIRLDFSCNKIS-YLP  227 (722)
T ss_pred             Cccc-cCCcccccchhHHHhhhhhhhhh-hchHHhhhHHHHHHHHHhhhhhh-hCCHHHhCCc-eeeeecccCcee-ecc
Confidence            5554 45555555555555555555555 45555555555555555555555 3444444332 555555555554 334


Q ss_pred             hhHHhccC--ccccccCC
Q 005586          230 SALKRLNG--GFQFQNNP  245 (689)
Q Consensus       230 ~~~~~~~~--~~~~~~n~  245 (689)
                      -.|..+..  .+.+.+||
T Consensus       228 v~fr~m~~Lq~l~LenNP  245 (722)
T KOG0532|consen  228 VDFRKMRHLQVLQLENNP  245 (722)
T ss_pred             hhhhhhhhheeeeeccCC
Confidence            44444432  23444444

>TIGR01982 UbiB 2-polyprenylphenol 6-hydroxylase

Probab=99.45  E-value=3.8e-13  Score=146.22  Aligned_cols=147  Identities=17%  Similarity=0.224  Sum_probs=106.3

Q ss_pred             cCCcccccccCCcceEEEEEecCCcEEEEEEecccCCch---------------------------------------HH
Q 005586          410 CFSEVNLLGKGNFSSVYKGTLRDGTLVAIRSINVTSCKS---------------------------------------EE  450 (689)
Q Consensus       410 ~f~~~~~lg~G~~g~Vy~~~~~~g~~vavK~l~~~~~~~---------------------------------------~~  450 (689)
                      .|+ .+.||.|++|.||+|++++|+.||||+.+....+.                                       .+
T Consensus       119 ~fd-~~plasaSigQVh~A~l~~G~~VaVKv~rp~i~~~i~~Dl~~l~~~~~~~~~~~~~~~~~~~~~~~~e~~~~l~~E  197 (437)
T TIGR01982       119 EFE-EKPLAAASIAQVHRARLVDGKEVAVKVLRPGIEKTIAADIALLYRLARIVERLSPDSRRLRPTEVVKEFEKTLRRE  197 (437)
T ss_pred             hCC-CcceeeeehhheEEEEecCCCEEEEEeeCCCcHHHHHHHHHHHHHHHHHHHHhCccccccCHHHHHHHHHHHHHHH
Confidence            344 36899999999999999999999999986542100                                       01


Q ss_pred             HHHHHHHHHHhcc----CCCcceeEeeEEEcCCCCeEEEEEEcCCCCCHHHHhhhcCCCCCCCCHHHHHHHHHHHHH-HH
Q 005586          451 AEFVKGLYLLTSL----RHENIIRLRGFCCSRGRGECFLIYDFAPKGKLSKYLDQEEGSSNVLDWSTRVSIIIGIAK-GI  525 (689)
Q Consensus       451 ~~f~~e~~~l~~l----~H~niv~l~g~~~~~~~~~~~lV~e~~~~gsL~~~L~~~~~~~~~l~~~~~~~ia~~ia~-gL  525 (689)
                      -+|..|.+.+.++    +|.+-+.+-..+.+- ....++||||+++++|.++.......   .   .+.+++..++. .+
T Consensus       198 ldf~~Ea~n~~~~~~~~~~~~~v~vP~v~~~~-~~~~vLvmE~i~G~~L~~~~~~~~~~---~---~~~~ia~~~~~~~l  270 (437)
T TIGR01982       198 LDLRREAANASELGENFKNDPGVYVPEVYWDR-TSERVLTMEWIDGIPLSDIAALDEAG---L---DRKALAENLARSFL  270 (437)
T ss_pred             HCHHHHHHHHHHHHHhcCCCCCEEeCCEehhh-cCCceEEEEeECCcccccHHHHHhcC---C---CHHHHHHHHHHHHH
Confidence            1355566655555    244444444444322 34579999999999999887543211   2   24567777766 47


Q ss_pred             hhhhCCCCCCCceeecCCCCCceeecCCCCeEEecccccccccC
Q 005586          526 GYLHSSEVNKPAIVHRNLSVEKVLIDQQFNPLIADCGLHKLLAD  569 (689)
Q Consensus       526 ~yLH~~~~~~~~ivH~dlk~~NiLl~~~~~~kl~DfGla~~~~~  569 (689)
                      .++|..+     ++|+|++|.||++++++.+++.|||+++.+.+
T Consensus       271 ~ql~~~g-----~~H~D~hPgNilv~~~g~i~liDfG~~~~l~~  309 (437)
T TIGR01982       271 NQVLRDG-----FFHADLHPGNIFVLKDGKIIALDFGIVGRLSE  309 (437)
T ss_pred             HHHHhCC-----ceeCCCCcccEEECCCCcEEEEeCCCeeECCH
Confidence            8889877     99999999999999999999999999987754

This model represents the enzyme (UbiB) which catalyzes the first hydroxylation step in the ubiquinone biosynthetic pathway in bacteria. It is believed that the reaction is 2-polyprenylphenol - 6-hydroxy-2-polyprenylphenol. This model finds hits primarily in the proteobacteria. The gene is also known as AarF in certain species.

>KOG0590 consensus Checkpoint kinase and related serine/threonine protein kinases [Cell cycle control, cell division, chromosome partitioning]

Probab=99.45  E-value=1.5e-14  Score=162.04  Aligned_cols=253  Identities=18%  Similarity=0.252  Sum_probs=180.1

Q ss_pred             CCcccccccCCcceEEEEEec--CCcEEEEEEecccC-CchHHHHHHHHHHHHhccC-CCcceeEeeEEEcCCCCeEEEE
Q 005586          411 FSEVNLLGKGNFSSVYKGTLR--DGTLVAIRSINVTS-CKSEEAEFVKGLYLLTSLR-HENIIRLRGFCCSRGRGECFLI  486 (689)
Q Consensus       411 f~~~~~lg~G~~g~Vy~~~~~--~g~~vavK~l~~~~-~~~~~~~f~~e~~~l~~l~-H~niv~l~g~~~~~~~~~~~lV  486 (689)
                      |...+.||+|.|+.|-.....  ....+|+|.+.... ..........|..+=..+. |+|++.+++..  ...+..+++
T Consensus        22 ~~~~~~ig~gs~~~~~~~~~~~~~~~~~a~~~~s~~~~~~~~~~~i~~e~~~~~~~s~h~n~~~~~~~~--~~~~~~~~~   99 (601)
T KOG0590|consen   22 YKLSRSIGKGSFSSSALASNSRDPESSSATKPISIPPKSEDSSEHIDTETDIQKKLSKHSNTVHMIEPS--SSPRSYLLS   99 (601)
T ss_pred             ccccccccccccchhhhhhhcCCCcceeeccCCCCCCCccchhhhcCccccccccccccccccccCCcc--CCCcccccc
Confidence            445567999999999888754  34556666665443 1122233344666656665 99999999977  556788999


Q ss_pred             EEcCCCCCHHHHh-hhcCCCCCCCCHHHHHHHHHHHHHHHhhhh-CCCCCCCceeecCCCCCceeecCCC-CeEEecccc
Q 005586          487 YDFAPKGKLSKYL-DQEEGSSNVLDWSTRVSIIIGIAKGIGYLH-SSEVNKPAIVHRNLSVEKVLIDQQF-NPLIADCGL  563 (689)
Q Consensus       487 ~e~~~~gsL~~~L-~~~~~~~~~l~~~~~~~ia~~ia~gL~yLH-~~~~~~~~ivH~dlk~~NiLl~~~~-~~kl~DfGl  563 (689)
                      .||.++|++.+-+ +....   ..+-.....+..|+..++.|+| ..+     +.|||+||+|.+++..+ ..|++|||+
T Consensus       100 ~~~s~g~~~f~~i~~~~~~---~~~~~~~~~~~~ql~s~l~~~H~~~~-----~~h~~ikP~n~~l~~s~~~l~~~df~~  171 (601)
T KOG0590|consen  100 LSYSDGGSLFSKISHPDST---GTSSSSASRYLPQLNSGLSYLHPENG-----VTHRDIKPSNSLLDESGSALKIADFGL  171 (601)
T ss_pred             cCcccccccccccccCCcc---CCCCcchhhhhhhhccCccccCcccc-----cccCCCCCccchhccCCCcccCCCchh
Confidence            9999999999888 43321   2344455678899999999999 666     89999999999999999 999999999


Q ss_pred             cccccC--CceeeeecCCC-CCCCCCccccccC-CCCCcccchhHHHHHHHHHhCCCCcchhHHHHHhhhhhhHhhcccc
Q 005586          564 HKLLAD--DIVFSVLKTSA-AMGYLAPEYVTTG-RFTERSDIFAFGVIILQILTGSLVLTSSMRLAAESATFENFIDRNL  639 (689)
Q Consensus       564 a~~~~~--~~~~~~~~~~~-~~~y~aPE~~~~~-~~~~ksDV~sfGvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~  639 (689)
                      |..+..  +.........| ++-|+|||...+. ...+..|+||.|+++.-+++|..|..........   +..+.....
T Consensus       172 At~~~~~~g~~~~~~~~~g~s~~y~a~E~~~~~~~~~~~~d~~S~g~~l~~~~~g~~p~~~~~~~~~~---~~~~~~~~~  248 (601)
T KOG0590|consen  172 ATAYRNKNGAERSLKDRCGSSPPYGAPEHLSGKAYRGPSVDVWSLGIVLSAMLTGELPWDFPSRKDGR---YSSWKSNKG  248 (601)
T ss_pred             hccccccCCcceeeecccCCCCCCCCcccccchhhcCCCcccccccccccccccCCCCcccccccccc---ceeeccccc
Confidence            987655  33334444556 8889999998874 4467899999999999999999998654322211   111111110


Q ss_pred             --CCCCCHHHHHHHHHHHHHhccCCCCCCCCHHHHHHHH
Q 005586          640 --KGKFSESEAAKLGKMALVCTHEDPENRPTMEAVIEEL  676 (689)
Q Consensus       640 --~~~~~~~~~~~l~~l~~~Cl~~dp~~RPs~~evl~~L  676 (689)
                        .............++...++..+|..|.+.+++..+-
T Consensus       249 ~~~~~~~~~~~~~~~~~l~k~l~~~~~~r~s~~~~~~d~  287 (601)
T KOG0590|consen  249 RFTQLPWNSISDQAHDLLHKILKENPSNRLSIEELKLDN  287 (601)
T ss_pred             ccccCccccCChhhhhcccccccCCchhccccccccccc
Confidence              1111223345567777888889999999998886553

>PRK15387 E3 ubiquitin-protein ligase SspH2; Provisional

Probab=99.45  E-value=2.8e-13  Score=153.89  Aligned_cols=72  Identities=33%  Similarity=0.438  Sum_probs=34.5

Q ss_pred             CCCEEeccCCcCCCCCCcccCCCCCCCeeeccCCcCCCCchhhhhCCCCCcEEecccCcCCcccchhHHhccC--ccccc
Q 005586          165 SLSVLTLQHNRLNGGIPDSLGNLGKLKRLDLSFNSLFGTIPESLANNAELLFLDVQNNTLSGIVPSALKRLNG--GFQFQ  242 (689)
Q Consensus       165 ~L~~L~l~~N~l~~~~p~~~~~l~~L~~L~ls~N~l~g~~p~~l~~~~~L~~l~l~~N~l~~~~p~~~~~~~~--~~~~~  242 (689)
                      +|+.|+|++|+|+ .+|...   ++|+.|++++|+|++ +|...   .+|+.|++++|+|+ .+|..+..+..  .+.+.
T Consensus       383 ~L~~LdLs~N~Lt-~LP~l~---s~L~~LdLS~N~Lss-IP~l~---~~L~~L~Ls~NqLt-~LP~sl~~L~~L~~LdLs  453 (788)
T PRK15387        383 GLKELIVSGNRLT-SLPVLP---SELKELMVSGNRLTS-LPMLP---SGLLSLSVYRNQLT-RLPESLIHLSSETTVNLE  453 (788)
T ss_pred             ccceEEecCCccc-CCCCcc---cCCCEEEccCCcCCC-CCcch---hhhhhhhhccCccc-ccChHHhhccCCCeEECC
Confidence            4556666666665 344322   345555666665553 34321   23445555555555 34444443332  23444


Q ss_pred             cCC
Q 005586          243 NNP  245 (689)
Q Consensus       243 ~n~  245 (689)
                      +|+
T Consensus       454 ~N~  456 (788)
T PRK15387        454 GNP  456 (788)
T ss_pred             CCC
Confidence            444

>PRK15370 E3 ubiquitin-protein ligase SlrP; Provisional

Probab=99.38  E-value=8.1e-13  Score=150.99  Aligned_cols=143  Identities=27%  Similarity=0.445  Sum_probs=86.3

Q ss_pred             CCEEEEEcCCCCcccccCcCcCCCCCCCEEEccCCcccccCCccccCCCCCcEEEecccCCCCCCCccccCCccccEEee
Q 005586           68 RKVANISLQGKGLTGKLSPSLSGLKCLSGLYLHYNSLSGEIPKEIRNLTELTDLYLDVNNLSGNIPPEIGSMASLQVLQL  147 (689)
Q Consensus        68 ~~v~~l~L~~~~l~g~~~~~~~~l~~L~~L~L~~N~l~g~~p~~~~~l~~L~~L~Ls~N~l~g~~p~~~~~l~~L~~L~L  147 (689)
                      .+++.|+|++|.|+ .+|..+.  .+|+.|+|++|+|+ .+|..+.  ++|+.|+|++|+|+ .+|..+.  ++|+.|+|
T Consensus       220 ~nL~~L~Ls~N~Lt-sLP~~l~--~~L~~L~Ls~N~L~-~LP~~l~--s~L~~L~Ls~N~L~-~LP~~l~--~sL~~L~L  290 (754)
T PRK15370        220 GNIKTLYANSNQLT-SIPATLP--DTIQEMELSINRIT-ELPERLP--SALQSLDLFHNKIS-CLPENLP--EELRYLSV  290 (754)
T ss_pred             cCCCEEECCCCccc-cCChhhh--ccccEEECcCCccC-cCChhHh--CCCCEEECcCCccC-ccccccC--CCCcEEEC
Confidence            46788888888887 4565443  46777888888777 5666553  46777777777777 4666554  46777777


Q ss_pred             ecccCCCCCchhcCC-------------------CCCCCEEeccCCcCCCCCCcccCCCCCCCeeeccCCcCCCCchhhh
Q 005586          148 CCNQLTGNIPAQIGS-------------------LKSLSVLTLQHNRLNGGIPDSLGNLGKLKRLDLSFNSLFGTIPESL  208 (689)
Q Consensus       148 s~N~l~g~~p~~~~~-------------------l~~L~~L~l~~N~l~~~~p~~~~~l~~L~~L~ls~N~l~g~~p~~l  208 (689)
                      ++|+|++ +|..+..                   .++|+.|++++|.+++ +|..+.  ++|+.|+|++|+|+ .+|..+
T Consensus       291 s~N~Lt~-LP~~lp~sL~~L~Ls~N~Lt~LP~~l~~sL~~L~Ls~N~Lt~-LP~~l~--~sL~~L~Ls~N~L~-~LP~~l  365 (754)
T PRK15370        291 YDNSIRT-LPAHLPSGITHLNVQSNSLTALPETLPPGLKTLEAGENALTS-LPASLP--PELQVLDVSKNQIT-VLPETL  365 (754)
T ss_pred             CCCcccc-CcccchhhHHHHHhcCCccccCCccccccceeccccCCcccc-CChhhc--CcccEEECCCCCCC-cCChhh
Confidence            7777763 3433220                   1345555555555552 444332  45666666666655 344433


Q ss_pred             hCCCCCcEEecccCcCCc
Q 005586          209 ANNAELLFLDVQNNTLSG  226 (689)
Q Consensus       209 ~~~~~L~~l~l~~N~l~~  226 (689)
                      .  ++|+.|+|++|+|+.
T Consensus       366 p--~~L~~LdLs~N~Lt~  381 (754)
T PRK15370        366 P--PTITTLDVSRNALTN  381 (754)
T ss_pred             c--CCcCEEECCCCcCCC
Confidence            2  456666666666654

>KOG0532 consensus Leucine-rich repeat (LRR) protein, contains calponin homology domain [Cytoskeleton]

Probab=99.37  E-value=2.7e-14  Score=149.63  Aligned_cols=154  Identities=30%  Similarity=0.509  Sum_probs=140.9

Q ss_pred             EEEEEcCCCCcccccCcCcCCCCCCCEEEccCCcccccCCccccCCCCCcEEEecccCCCCCCCccccCCccccEEeeec
Q 005586           70 VANISLQGKGLTGKLSPSLSGLKCLSGLYLHYNSLSGEIPKEIRNLTELTDLYLDVNNLSGNIPPEIGSMASLQVLQLCC  149 (689)
Q Consensus        70 v~~l~L~~~~l~g~~~~~~~~l~~L~~L~L~~N~l~g~~p~~~~~l~~L~~L~Ls~N~l~g~~p~~~~~l~~L~~L~Ls~  149 (689)
                      +..+.|..|.+. .+|..+++|..|++|||+.|+++ .+|..++.|+ |+.|-+++|+++ .+|..++.+..|..||.+.
T Consensus       100 Le~liLy~n~~r-~ip~~i~~L~~lt~l~ls~NqlS-~lp~~lC~lp-Lkvli~sNNkl~-~lp~~ig~~~tl~~ld~s~  175 (722)
T KOG0532|consen  100 LESLILYHNCIR-TIPEAICNLEALTFLDLSSNQLS-HLPDGLCDLP-LKVLIVSNNKLT-SLPEEIGLLPTLAHLDVSK  175 (722)
T ss_pred             HHHHHHHhccce-ecchhhhhhhHHHHhhhccchhh-cCChhhhcCc-ceeEEEecCccc-cCCcccccchhHHHhhhhh
Confidence            556778888887 89999999999999999999999 8999999887 999999999998 8999999999999999999


Q ss_pred             ccCCCCCchhcCCCCCCCEEeccCCcCCCCCCcccCCCCCCCeeeccCCcCCCCchhhhhCCCCCcEEecccCcCCcccc
Q 005586          150 NQLTGNIPAQIGSLKSLSVLTLQHNRLNGGIPDSLGNLGKLKRLDLSFNSLFGTIPESLANNAELLFLDVQNNTLSGIVP  229 (689)
Q Consensus       150 N~l~g~~p~~~~~l~~L~~L~l~~N~l~~~~p~~~~~l~~L~~L~ls~N~l~g~~p~~l~~~~~L~~l~l~~N~l~~~~p  229 (689)
                      |++. .+|..++++.+|+.|.+..|++. .+|..+..| .|..||+|.|+++ .+|-.|..+..|++|-|.+|.|... |
T Consensus       176 nei~-slpsql~~l~slr~l~vrRn~l~-~lp~El~~L-pLi~lDfScNkis-~iPv~fr~m~~Lq~l~LenNPLqSP-P  250 (722)
T KOG0532|consen  176 NEIQ-SLPSQLGYLTSLRDLNVRRNHLE-DLPEELCSL-PLIRLDFSCNKIS-YLPVDFRKMRHLQVLQLENNPLQSP-P  250 (722)
T ss_pred             hhhh-hchHHhhhHHHHHHHHHhhhhhh-hCCHHHhCC-ceeeeecccCcee-ecchhhhhhhhheeeeeccCCCCCC-h
Confidence            9998 88999999999999999999999 688888865 5899999999999 8999999999999999999999855 4


Q ss_pred             hhH
Q 005586          230 SAL  232 (689)
Q Consensus       230 ~~~  232 (689)
                      ..+
T Consensus       251 AqI  253 (722)
T KOG0532|consen  251 AQI  253 (722)
T ss_pred             HHH
Confidence            443

>PRK15370 E3 ubiquitin-protein ligase SlrP; Provisional

Probab=99.36  E-value=1.1e-12  Score=149.79  Aligned_cols=141  Identities=27%  Similarity=0.531  Sum_probs=105.7

Q ss_pred             CEEEEEcCCCCcccccCcCcCCCCCCCEEEccCCcccccCCccccCCCCCcEEEecccCCCCCCCccccCCccccEEeee
Q 005586           69 KVANISLQGKGLTGKLSPSLSGLKCLSGLYLHYNSLSGEIPKEIRNLTELTDLYLDVNNLSGNIPPEIGSMASLQVLQLC  148 (689)
Q Consensus        69 ~v~~l~L~~~~l~g~~~~~~~~l~~L~~L~L~~N~l~g~~p~~~~~l~~L~~L~Ls~N~l~g~~p~~~~~l~~L~~L~Ls  148 (689)
                      +.+.|+|++++++ .+|..+.  +.|+.|+|++|+|+ .+|..+.  ++|+.|+|++|+|+ .+|..+.  .+|+.|+|+
T Consensus       179 ~~~~L~L~~~~Lt-sLP~~Ip--~~L~~L~Ls~N~Lt-sLP~~l~--~nL~~L~Ls~N~Lt-sLP~~l~--~~L~~L~Ls  249 (754)
T PRK15370        179 NKTELRLKILGLT-TIPACIP--EQITTLILDNNELK-SLPENLQ--GNIKTLYANSNQLT-SIPATLP--DTIQEMELS  249 (754)
T ss_pred             CceEEEeCCCCcC-cCCcccc--cCCcEEEecCCCCC-cCChhhc--cCCCEEECCCCccc-cCChhhh--ccccEEECc
Confidence            4688999999888 4666553  57889999999998 5666554  58899999999988 5676654  478888888


Q ss_pred             cccCCCCCchhcCCCCCCCEEeccCCcCCCCCCcccCCCCCCCeeeccCCcCCCCchhhhhCCCCCcEEecccCcCCcc
Q 005586          149 CNQLTGNIPAQIGSLKSLSVLTLQHNRLNGGIPDSLGNLGKLKRLDLSFNSLFGTIPESLANNAELLFLDVQNNTLSGI  227 (689)
Q Consensus       149 ~N~l~g~~p~~~~~l~~L~~L~l~~N~l~~~~p~~~~~l~~L~~L~ls~N~l~g~~p~~l~~~~~L~~l~l~~N~l~~~  227 (689)
                      +|+++ .+|..+.  .+|+.|+|++|+|+ .+|..+.  ++|+.|+|++|+|++ +|..+.  ++|+.|++++|+|+..
T Consensus       250 ~N~L~-~LP~~l~--s~L~~L~Ls~N~L~-~LP~~l~--~sL~~L~Ls~N~Lt~-LP~~lp--~sL~~L~Ls~N~Lt~L  319 (754)
T PRK15370        250 INRIT-ELPERLP--SALQSLDLFHNKIS-CLPENLP--EELRYLSVYDNSIRT-LPAHLP--SGITHLNVQSNSLTAL  319 (754)
T ss_pred             CCccC-cCChhHh--CCCCEEECcCCccC-ccccccC--CCCcEEECCCCcccc-Ccccch--hhHHHHHhcCCccccC
Confidence            88887 6676664  47888888888888 5777654  478888888888884 454432  3577777788877754

>KOG0618 consensus Serine/threonine phosphatase 2C containing leucine-rich repeats, similar to SCN circadian oscillatory protein (SCOP) [Signal transduction mechanisms]

Probab=99.36  E-value=3.3e-14  Score=156.80  Aligned_cols=161  Identities=34%  Similarity=0.509  Sum_probs=107.5

Q ss_pred             ccCcCcCCCCCCCEEEccCCcccccCCccc--------------------------cCCCCCcEEEecccCCCCCCCccc
Q 005586           83 KLSPSLSGLKCLSGLYLHYNSLSGEIPKEI--------------------------RNLTELTDLYLDVNNLSGNIPPEI  136 (689)
Q Consensus        83 ~~~~~~~~l~~L~~L~L~~N~l~g~~p~~~--------------------------~~l~~L~~L~Ls~N~l~g~~p~~~  136 (689)
                      .+|+.+..++.|++|+|..|+|. .+|+.+                          ...+.|+.|+|.+|.|+...-+.|
T Consensus       301 yip~~le~~~sL~tLdL~~N~L~-~lp~~~l~v~~~~l~~ln~s~n~l~~lp~~~e~~~~~Lq~LylanN~Ltd~c~p~l  379 (1081)
T KOG0618|consen  301 YIPPFLEGLKSLRTLDLQSNNLP-SLPDNFLAVLNASLNTLNVSSNKLSTLPSYEENNHAALQELYLANNHLTDSCFPVL  379 (1081)
T ss_pred             hCCCcccccceeeeeeehhcccc-ccchHHHhhhhHHHHHHhhhhccccccccccchhhHHHHHHHHhcCcccccchhhh
Confidence            45666666777777777777765 333221                          122336666666777766665566


Q ss_pred             cCCccccEEeeecccCCCCCchhcCCCCCCCEEeccCCcCCCCCCcccCCCCCCCeeeccCCcCCCCchhhhhCCCCCcE
Q 005586          137 GSMASLQVLQLCCNQLTGNIPAQIGSLKSLSVLTLQHNRLNGGIPDSLGNLGKLKRLDLSFNSLFGTIPESLANNAELLF  216 (689)
Q Consensus       137 ~~l~~L~~L~Ls~N~l~g~~p~~~~~l~~L~~L~l~~N~l~~~~p~~~~~l~~L~~L~ls~N~l~g~~p~~l~~~~~L~~  216 (689)
                      .+...|+.|+|++|+|.......+.++..|++|+||+|+|+ .+|+.+.+++.|++|...+|+|. ..| .+..++.|+.
T Consensus       380 ~~~~hLKVLhLsyNrL~~fpas~~~kle~LeeL~LSGNkL~-~Lp~tva~~~~L~tL~ahsN~l~-~fP-e~~~l~qL~~  456 (1081)
T KOG0618|consen  380 VNFKHLKVLHLSYNRLNSFPASKLRKLEELEELNLSGNKLT-TLPDTVANLGRLHTLRAHSNQLL-SFP-ELAQLPQLKV  456 (1081)
T ss_pred             ccccceeeeeecccccccCCHHHHhchHHhHHHhcccchhh-hhhHHHHhhhhhHHHhhcCCcee-ech-hhhhcCcceE
Confidence            77777888888888887444445677888888888888887 67788888888888888888887 666 6777888888


Q ss_pred             EecccCcCCccc-chhHH-hccCccccccCCCC
Q 005586          217 LDVQNNTLSGIV-PSALK-RLNGGFQFQNNPGL  247 (689)
Q Consensus       217 l~l~~N~l~~~~-p~~~~-~~~~~~~~~~n~~~  247 (689)
                      +|++.|+|+... |.... .--.-+.+++|.++
T Consensus       457 lDlS~N~L~~~~l~~~~p~p~LkyLdlSGN~~l  489 (1081)
T KOG0618|consen  457 LDLSCNNLSEVTLPEALPSPNLKYLDLSGNTRL  489 (1081)
T ss_pred             EecccchhhhhhhhhhCCCcccceeeccCCccc
Confidence            888888887443 22222 10113567777753

>PRK15387 E3 ubiquitin-protein ligase SspH2; Provisional

Probab=99.35  E-value=3.4e-12  Score=145.09  Aligned_cols=52  Identities=31%  Similarity=0.283  Sum_probs=33.8

Q ss_pred             CCCCeeeccCCcCCCCchhhhhCCCCCcEEecccCcCCcccchhHHhccCccccccCC
Q 005586          188 GKLKRLDLSFNSLFGTIPESLANNAELLFLDVQNNTLSGIVPSALKRLNGGFQFQNNP  245 (689)
Q Consensus       188 ~~L~~L~ls~N~l~g~~p~~l~~~~~L~~l~l~~N~l~~~~p~~~~~~~~~~~~~~n~  245 (689)
                      .+|+.|+|++|+|++ +|..   .++|+.|++++|+|++ +|.....+. .+.+.+|.
T Consensus       382 ~~L~~LdLs~N~Lt~-LP~l---~s~L~~LdLS~N~Lss-IP~l~~~L~-~L~Ls~Nq  433 (788)
T PRK15387        382 SGLKELIVSGNRLTS-LPVL---PSELKELMVSGNRLTS-LPMLPSGLL-SLSVYRNQ  433 (788)
T ss_pred             cccceEEecCCcccC-CCCc---ccCCCEEEccCCcCCC-CCcchhhhh-hhhhccCc
Confidence            367788888888884 5543   3578889999999986 455443332 24455553

>cd00116 LRR_RI Leucine-rich repeats (LRRs), ribonuclease inhibitor (RI)-like subfamily

Probab=99.31  E-value=3.5e-13  Score=141.91  Aligned_cols=159  Identities=26%  Similarity=0.343  Sum_probs=110.4

Q ss_pred             CCCEEEEEcCCCCcccccCcCcCCCCC---CCEEEccCCcccc----cCCccccCC-CCCcEEEecccCCCCC----CCc
Q 005586           67 HRKVANISLQGKGLTGKLSPSLSGLKC---LSGLYLHYNSLSG----EIPKEIRNL-TELTDLYLDVNNLSGN----IPP  134 (689)
Q Consensus        67 ~~~v~~l~L~~~~l~g~~~~~~~~l~~---L~~L~L~~N~l~g----~~p~~~~~l-~~L~~L~Ls~N~l~g~----~p~  134 (689)
                      ..+++.|+|++|.+.+..+..+..+..   |++|++++|++++    .+...+..+ ++|+.|+|++|.+++.    ++.
T Consensus        80 ~~~L~~L~l~~~~~~~~~~~~~~~l~~~~~L~~L~ls~~~~~~~~~~~l~~~l~~~~~~L~~L~L~~n~l~~~~~~~~~~  159 (319)
T cd00116          80 GCGLQELDLSDNALGPDGCGVLESLLRSSSLQELKLNNNGLGDRGLRLLAKGLKDLPPALEKLVLGRNRLEGASCEALAK  159 (319)
T ss_pred             cCceeEEEccCCCCChhHHHHHHHHhccCcccEEEeeCCccchHHHHHHHHHHHhCCCCceEEEcCCCcCCchHHHHHHH
Confidence            457888888888887666666655555   8888888888773    344455666 7888888888888743    233


Q ss_pred             cccCCccccEEeeecccCCCC----CchhcCCCCCCCEEeccCCcCCCC----CCcccCCCCCCCeeeccCCcCCCCchh
Q 005586          135 EIGSMASLQVLQLCCNQLTGN----IPAQIGSLKSLSVLTLQHNRLNGG----IPDSLGNLGKLKRLDLSFNSLFGTIPE  206 (689)
Q Consensus       135 ~~~~l~~L~~L~Ls~N~l~g~----~p~~~~~l~~L~~L~l~~N~l~~~----~p~~~~~l~~L~~L~ls~N~l~g~~p~  206 (689)
                      .+..+++|+.|+|++|.+++.    ++..+..+++|++|+|++|.+++.    ++..+..+++|++|++++|.+++....
T Consensus       160 ~~~~~~~L~~L~l~~n~l~~~~~~~l~~~l~~~~~L~~L~L~~n~i~~~~~~~l~~~~~~~~~L~~L~ls~n~l~~~~~~  239 (319)
T cd00116         160 ALRANRDLKELNLANNGIGDAGIRALAEGLKANCNLEVLDLNNNGLTDEGASALAETLASLKSLEVLNLGDNNLTDAGAA  239 (319)
T ss_pred             HHHhCCCcCEEECcCCCCchHHHHHHHHHHHhCCCCCEEeccCCccChHHHHHHHHHhcccCCCCEEecCCCcCchHHHH
Confidence            456667788888888888742    334455667888888888887643    334556677888888888888753333


Q ss_pred             hhhC-----CCCCcEEecccCcCC
Q 005586          207 SLAN-----NAELLFLDVQNNTLS  225 (689)
Q Consensus       207 ~l~~-----~~~L~~l~l~~N~l~  225 (689)
                      .+..     .+.|+.|++++|.++
T Consensus       240 ~l~~~~~~~~~~L~~L~l~~n~i~  263 (319)
T cd00116         240 ALASALLSPNISLLTLSLSCNDIT  263 (319)
T ss_pred             HHHHHHhccCCCceEEEccCCCCC
Confidence            3322     367888888888876

LRRs are 20-29 residue sequence motifs present in many proteins that participate in protein-protein interactions and have different functions and cellular locations. LRRs correspond to structural units consisting of a beta strand (LxxLxLxxN/CxL conserved pattern) and an alpha helix. This alignment contains 12 strands corresponding to 11 full repeats, consistent with the extent observed in the subfamily acting as Ran GTPase Activating Proteins (RanGAP1).

>KOG0618 consensus Serine/threonine phosphatase 2C containing leucine-rich repeats, similar to SCN circadian oscillatory protein (SCOP) [Signal transduction mechanisms]

Probab=99.31  E-value=2e-13  Score=150.77  Aligned_cols=151  Identities=32%  Similarity=0.465  Sum_probs=126.9

Q ss_pred             CEEEEEcCCCCcccccCcCc-------------------------CCCCCCCEEEccCCcccccCCccccCCCCCcEEEe
Q 005586           69 KVANISLQGKGLTGKLSPSL-------------------------SGLKCLSGLYLHYNSLSGEIPKEIRNLTELTDLYL  123 (689)
Q Consensus        69 ~v~~l~L~~~~l~g~~~~~~-------------------------~~l~~L~~L~L~~N~l~g~~p~~~~~l~~L~~L~L  123 (689)
                      .+..|+|..|+|....+..|                         ...+.|+.|+|.+|+|+...=+.|.+.++|+.|+|
T Consensus       311 sL~tLdL~~N~L~~lp~~~l~v~~~~l~~ln~s~n~l~~lp~~~e~~~~~Lq~LylanN~Ltd~c~p~l~~~~hLKVLhL  390 (1081)
T KOG0618|consen  311 SLRTLDLQSNNLPSLPDNFLAVLNASLNTLNVSSNKLSTLPSYEENNHAALQELYLANNHLTDSCFPVLVNFKHLKVLHL  390 (1081)
T ss_pred             eeeeeeehhccccccchHHHhhhhHHHHHHhhhhccccccccccchhhHHHHHHHHhcCcccccchhhhccccceeeeee
Confidence            48899999998864322111                         12355788999999999887778999999999999


Q ss_pred             cccCCCCCCCc-cccCCccccEEeeecccCCCCCchhcCCCCCCCEEeccCCcCCCCCCcccCCCCCCCeeeccCCcCCC
Q 005586          124 DVNNLSGNIPP-EIGSMASLQVLQLCCNQLTGNIPAQIGSLKSLSVLTLQHNRLNGGIPDSLGNLGKLKRLDLSFNSLFG  202 (689)
Q Consensus       124 s~N~l~g~~p~-~~~~l~~L~~L~Ls~N~l~g~~p~~~~~l~~L~~L~l~~N~l~~~~p~~~~~l~~L~~L~ls~N~l~g  202 (689)
                      ++|+|. .+|+ .+.++..|++|+||+|+|+ .+|..+.++..|++|...+|++. .+| .+..++.|+.+|+|.|+|+.
T Consensus       391 syNrL~-~fpas~~~kle~LeeL~LSGNkL~-~Lp~tva~~~~L~tL~ahsN~l~-~fP-e~~~l~qL~~lDlS~N~L~~  466 (1081)
T KOG0618|consen  391 SYNRLN-SFPASKLRKLEELEELNLSGNKLT-TLPDTVANLGRLHTLRAHSNQLL-SFP-ELAQLPQLKVLDLSCNNLSE  466 (1081)
T ss_pred             cccccc-cCCHHHHhchHHhHHHhcccchhh-hhhHHHHhhhhhHHHhhcCCcee-ech-hhhhcCcceEEecccchhhh
Confidence            999998 5554 5789999999999999999 89999999999999999999999 788 79999999999999999985


Q ss_pred             C-chhhhhCCCCCcEEecccCcC
Q 005586          203 T-IPESLANNAELLFLDVQNNTL  224 (689)
Q Consensus       203 ~-~p~~l~~~~~L~~l~l~~N~l  224 (689)
                      . +|... ..++|++|||++|.=
T Consensus       467 ~~l~~~~-p~p~LkyLdlSGN~~  488 (1081)
T KOG0618|consen  467 VTLPEAL-PSPNLKYLDLSGNTR  488 (1081)
T ss_pred             hhhhhhC-CCcccceeeccCCcc
Confidence            4 44333 348999999999973

>PLN03150 hypothetical protein; Provisional

Probab=99.30  E-value=3.1e-12  Score=145.58  Aligned_cols=94  Identities=44%  Similarity=0.682  Sum_probs=90.9

Q ss_pred             CCcEEEecccCCCCCCCccccCCccccEEeeecccCCCCCchhcCCCCCCCEEeccCCcCCCCCCcccCCCCCCCeeecc
Q 005586          117 ELTDLYLDVNNLSGNIPPEIGSMASLQVLQLCCNQLTGNIPAQIGSLKSLSVLTLQHNRLNGGIPDSLGNLGKLKRLDLS  196 (689)
Q Consensus       117 ~L~~L~Ls~N~l~g~~p~~~~~l~~L~~L~Ls~N~l~g~~p~~~~~l~~L~~L~l~~N~l~~~~p~~~~~l~~L~~L~ls  196 (689)
                      .++.|+|++|.|+|.+|..++++++|+.|+|++|+|+|.+|..++++++|+.|+|++|+|+|.+|+.++++++|+.|+|+
T Consensus       419 ~v~~L~L~~n~L~g~ip~~i~~L~~L~~L~Ls~N~l~g~iP~~~~~l~~L~~LdLs~N~lsg~iP~~l~~L~~L~~L~Ls  498 (623)
T PLN03150        419 FIDGLGLDNQGLRGFIPNDISKLRHLQSINLSGNSIRGNIPPSLGSITSLEVLDLSYNSFNGSIPESLGQLTSLRILNLN  498 (623)
T ss_pred             EEEEEECCCCCccccCCHHHhCCCCCCEEECCCCcccCcCChHHhCCCCCCEEECCCCCCCCCCchHHhcCCCCCEEECc
Confidence            47899999999999999999999999999999999999999999999999999999999999999999999999999999


Q ss_pred             CCcCCCCchhhhhC
Q 005586          197 FNSLFGTIPESLAN  210 (689)
Q Consensus       197 ~N~l~g~~p~~l~~  210 (689)
                      +|+++|.+|..+..
T Consensus       499 ~N~l~g~iP~~l~~  512 (623)
T PLN03150        499 GNSLSGRVPAALGG  512 (623)
T ss_pred             CCcccccCChHHhh
Confidence            99999999998865

>cd05151 ChoK Choline Kinase (ChoK)

Probab=99.27  E-value=1.7e-11  Score=116.26  Aligned_cols=132  Identities=17%  Similarity=0.078  Sum_probs=97.4

Q ss_pred             ccccccCCcceEEEEEecCCcEEEEEEecccCCchHHHHHHHHHHHHhccCCCccee-EeeEEEcCCCCeEEEEEEcCCC
Q 005586          414 VNLLGKGNFSSVYKGTLRDGTLVAIRSINVTSCKSEEAEFVKGLYLLTSLRHENIIR-LRGFCCSRGRGECFLIYDFAPK  492 (689)
Q Consensus       414 ~~~lg~G~~g~Vy~~~~~~g~~vavK~l~~~~~~~~~~~f~~e~~~l~~l~H~niv~-l~g~~~~~~~~~~~lV~e~~~~  492 (689)
                      .+.++.|.++.||++... |..|++|.......  ....+.+|++.+..+.+.++++ ++.+.  .  ...++||||+++
T Consensus         3 ~~~l~~G~~~~vy~~~~~-~~~~~lK~~~~~~~--~~~~~~~E~~~l~~l~~~~~~P~~~~~~--~--~~~~lv~e~i~G   75 (170)
T cd05151           3 ISPLKGGMTNKNYRVEVA-NKKYVVRIPGNGTE--LLINRENEAENSKLAAEAGIGPKLYYFD--P--ETGVLITEFIEG   75 (170)
T ss_pred             eeecCCcccCceEEEEEC-CeEEEEEeCCCCcc--cccCHHHHHHHHHHHHHhCCCCceEEEe--C--CCCeEEEEecCC
Confidence            357899999999999876 77899998765431  2235678888888887666554 44332  2  234799999999


Q ss_pred             CCHHHHhhhcCCCCCCCCHHHHHHHHHHHHHHHhhhhCCCCCCCceeecCCCCCceeecCCCCeEEecccccc
Q 005586          493 GKLSKYLDQEEGSSNVLDWSTRVSIIIGIAKGIGYLHSSEVNKPAIVHRNLSVEKVLIDQQFNPLIADCGLHK  565 (689)
Q Consensus       493 gsL~~~L~~~~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~~~ivH~dlk~~NiLl~~~~~~kl~DfGla~  565 (689)
                      .++...    .     .   ....++.+++++|+.||+.+.....++|+|++|.||+++ ++.+++.|||.+.
T Consensus        76 ~~l~~~----~-----~---~~~~~~~~l~~~l~~LH~~~~~~~~~~HgD~~~~Nil~~-~~~~~liDf~~a~  135 (170)
T cd05151          76 SELLTE----D-----F---SDPENLEKIAKLLKKLHSSPLPDLVPCHNDLLPGNFLLD-DGRLWLIDWEYAG  135 (170)
T ss_pred             Cccccc----c-----c---cCHHHHHHHHHHHHHHhCCCCCCceeecCCCCcCcEEEE-CCeEEEEeccccc
Confidence            877543    0     0   113456789999999998763344579999999999999 6689999999875

The ChoK subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). It is composed of bacterial and eukaryotic choline kinases, as well as eukaryotic ethanolamine kinase. ChoK catalyzes the transfer of the gamma-phosphoryl group from ATP (or CTP) to its substrate, choline, producing phosphorylcholine (PCho), a precursor to the biosynthesis of two major membrane phospholipids, phosphatidylcholine (PC), and sphingomyelin (SM). Although choline is the preferred substrate, ChoK also shows substantial activity towards ethanolamine and its N-methylated derivatives. Bacterial ChoK is also referred to as licA protein. ETNK catalyzes the transfer of the gamma-phosphoryl group from CTP to ethanolamine (Etn), the first step in the CDP-Etn pathway for the formation of the major ph

>PRK04750 ubiB putative ubiquinone biosynthesis protein UbiB; Reviewed

Probab=99.27  E-value=1.8e-11  Score=134.59  Aligned_cols=148  Identities=11%  Similarity=0.143  Sum_probs=97.7

Q ss_pred             hccCCcccccccCCcceEEEEEecC-CcEEEEEEecccCCc---------------------------------h-----
Q 005586          408 TQCFSEVNLLGKGNFSSVYKGTLRD-GTLVAIRSINVTSCK---------------------------------S-----  448 (689)
Q Consensus       408 t~~f~~~~~lg~G~~g~Vy~~~~~~-g~~vavK~l~~~~~~---------------------------------~-----  448 (689)
                      ...|+. +.||+|++|.||+|++++ |+.||||+.+....+                                 .     
T Consensus       119 F~~fd~-~PlasaSiaQVh~A~l~~~G~~VAVKV~rP~i~~~I~~Dl~~l~~~a~~l~~~~~~~~~l~~~~~v~e~~~~l  197 (537)
T PRK04750        119 FDDFDI-KPLASASIAQVHFARLKDNGREVVVKVLRPDILPVIDADLALMYRLARWVERLLPDGRRLKPREVVAEFEKTL  197 (537)
T ss_pred             HHhcCh-hhhcCCCccEEEEEEECCCCCEEEEEEeCcchHHHHHHHHHHHHHHHHHHHHhCcccccCCHHHHHHHHHHHH
Confidence            345666 789999999999999987 999999999754210                                 0     


Q ss_pred             -HHHHHHHHHHHHhccC----CCcceeEeeEEEcCCCCeEEEEEEcCCCCCHHHHh--hhcCCCCCCCCHHHHHHHHHHH
Q 005586          449 -EEAEFVKGLYLLTSLR----HENIIRLRGFCCSRGRGECFLIYDFAPKGKLSKYL--DQEEGSSNVLDWSTRVSIIIGI  521 (689)
Q Consensus       449 -~~~~f~~e~~~l~~l~----H~niv~l~g~~~~~~~~~~~lV~e~~~~gsL~~~L--~~~~~~~~~l~~~~~~~ia~~i  521 (689)
                       .+-+|.+|+..+.+++    +.+.+.+-.++++- ..+.++||||++++.+.++-  ...+.....+.......+..| 
T Consensus       198 ~~ElD~~~Ea~N~~~~~~~f~~~~~v~VP~v~~d~-st~~VLvmE~i~G~~l~d~~~l~~~g~d~~~la~~~v~~~~~Q-  275 (537)
T PRK04750        198 HDELDLMREAANASQLRRNFEDSDMLYVPEVYWDY-CSETVMVMERMYGIPVSDVAALRAAGTDMKLLAERGVEVFFTQ-  275 (537)
T ss_pred             HHhhCHHHHHHHHHHHHHHccCCCCeecceeeccc-CCCceEEEeeecCccHHhHHHHHhcCCCHHHHHHHHHHHHHHH-
Confidence             0123555555555553    55555554444332 35678999999999998753  221100011222222222333 


Q ss_pred             HHHHhhhhCCCCCCCceeecCCCCCceeecCCC----CeEEecccccccccC
Q 005586          522 AKGIGYLHSSEVNKPAIVHRNLSVEKVLIDQQF----NPLIADCGLHKLLAD  569 (689)
Q Consensus       522 a~gL~yLH~~~~~~~~ivH~dlk~~NiLl~~~~----~~kl~DfGla~~~~~  569 (689)
                            ++..+     ++|+|+||.||+++.++    .+++.|||++..+..
T Consensus       276 ------if~~G-----ffHaDpHPGNIlv~~~g~~~~~i~llDFGivg~l~~  316 (537)
T PRK04750        276 ------VFRDG-----FFHADMHPGNIFVSYDPPENPRYIALDFGIVGSLNK  316 (537)
T ss_pred             ------HHhCC-----eeeCCCChHHeEEecCCCCCCeEEEEecceEEECCH
Confidence                  33445     99999999999999988    999999999987754

>PLN03210 Resistant to P

Probab=99.27  E-value=1.8e-11  Score=149.25  Aligned_cols=159  Identities=25%  Similarity=0.301  Sum_probs=83.6

Q ss_pred             CEEEEEcCCCCcccccCcCcCCCCCCCEEEccCCcccccCCccccCCCCCcEEEecccCCCCCCCccccCCccccEEeee
Q 005586           69 KVANISLQGKGLTGKLSPSLSGLKCLSGLYLHYNSLSGEIPKEIRNLTELTDLYLDVNNLSGNIPPEIGSMASLQVLQLC  148 (689)
Q Consensus        69 ~v~~l~L~~~~l~g~~~~~~~~l~~L~~L~L~~N~l~g~~p~~~~~l~~L~~L~Ls~N~l~g~~p~~~~~l~~L~~L~Ls  148 (689)
                      +++.|+|.++.+. .++..+..+++|+.|+|++|...+.+|. ++.+++|+.|+|++|..-..+|..++++++|+.|+++
T Consensus       612 ~L~~L~L~~s~l~-~L~~~~~~l~~Lk~L~Ls~~~~l~~ip~-ls~l~~Le~L~L~~c~~L~~lp~si~~L~~L~~L~L~  689 (1153)
T PLN03210        612 NLVKLQMQGSKLE-KLWDGVHSLTGLRNIDLRGSKNLKEIPD-LSMATNLETLKLSDCSSLVELPSSIQYLNKLEDLDMS  689 (1153)
T ss_pred             CCcEEECcCcccc-ccccccccCCCCCEEECCCCCCcCcCCc-cccCCcccEEEecCCCCccccchhhhccCCCCEEeCC
Confidence            4555555555544 3444444555555555554433334442 4445555555555544334445555555555555554


Q ss_pred             cccCCCCCchhcCCCC---------------------CCCEEeccCCcCCCCCCccc-----------------------
Q 005586          149 CNQLTGNIPAQIGSLK---------------------SLSVLTLQHNRLNGGIPDSL-----------------------  184 (689)
Q Consensus       149 ~N~l~g~~p~~~~~l~---------------------~L~~L~l~~N~l~~~~p~~~-----------------------  184 (689)
                      +|...+.+|..+ +++                     +|+.|+|++|.+. .+|..+                       
T Consensus       690 ~c~~L~~Lp~~i-~l~sL~~L~Lsgc~~L~~~p~~~~nL~~L~L~~n~i~-~lP~~~~l~~L~~L~l~~~~~~~l~~~~~  767 (1153)
T PLN03210        690 RCENLEILPTGI-NLKSLYRLNLSGCSRLKSFPDISTNISWLDLDETAIE-EFPSNLRLENLDELILCEMKSEKLWERVQ  767 (1153)
T ss_pred             CCCCcCccCCcC-CCCCCCEEeCCCCCCccccccccCCcCeeecCCCccc-cccccccccccccccccccchhhcccccc
Confidence            443333344322 233                     3444445555543 344321                       


Q ss_pred             -------CCCCCCCeeeccCCcCCCCchhhhhCCCCCcEEecccCcCCcccchh
Q 005586          185 -------GNLGKLKRLDLSFNSLFGTIPESLANNAELLFLDVQNNTLSGIVPSA  231 (689)
Q Consensus       185 -------~~l~~L~~L~ls~N~l~g~~p~~l~~~~~L~~l~l~~N~l~~~~p~~  231 (689)
                             ...++|+.|+|++|...+.+|..+.++++|+.|++++|..-+.+|..
T Consensus       768 ~l~~~~~~~~~sL~~L~Ls~n~~l~~lP~si~~L~~L~~L~Ls~C~~L~~LP~~  821 (1153)
T PLN03210        768 PLTPLMTMLSPSLTRLFLSDIPSLVELPSSIQNLHKLEHLEIENCINLETLPTG  821 (1153)
T ss_pred             ccchhhhhccccchheeCCCCCCccccChhhhCCCCCCEEECCCCCCcCeeCCC
Confidence                   11246777777777777778888888888888888876544455543

syringae 6; Provisional

>cd00116 LRR_RI Leucine-rich repeats (LRRs), ribonuclease inhibitor (RI)-like subfamily

Probab=99.27  E-value=8.2e-13  Score=139.07  Aligned_cols=159  Identities=24%  Similarity=0.295  Sum_probs=101.9

Q ss_pred             CEEEEEcCCCCccc------ccCcCcCCCCCCCEEEccCCcccccCCccccCCCC---CcEEEecccCCCC----CCCcc
Q 005586           69 KVANISLQGKGLTG------KLSPSLSGLKCLSGLYLHYNSLSGEIPKEIRNLTE---LTDLYLDVNNLSG----NIPPE  135 (689)
Q Consensus        69 ~v~~l~L~~~~l~g------~~~~~~~~l~~L~~L~L~~N~l~g~~p~~~~~l~~---L~~L~Ls~N~l~g----~~p~~  135 (689)
                      .++.++++++.+.+      .++..+..+++|+.|+|++|.+.+..+..+..+.+   |++|++++|++++    .+...
T Consensus        52 ~l~~l~l~~~~~~~~~~~~~~~~~~l~~~~~L~~L~l~~~~~~~~~~~~~~~l~~~~~L~~L~ls~~~~~~~~~~~l~~~  131 (319)
T cd00116          52 SLKELCLSLNETGRIPRGLQSLLQGLTKGCGLQELDLSDNALGPDGCGVLESLLRSSSLQELKLNNNGLGDRGLRLLAKG  131 (319)
T ss_pred             CceEEeccccccCCcchHHHHHHHHHHhcCceeEEEccCCCCChhHHHHHHHHhccCcccEEEeeCCccchHHHHHHHHH
Confidence            46677777766652      23345666777777777777777666666655555   7777777777763    22334


Q ss_pred             ccCC-ccccEEeeecccCCCC----CchhcCCCCCCCEEeccCCcCCCC----CCcccCCCCCCCeeeccCCcCCCC---
Q 005586          136 IGSM-ASLQVLQLCCNQLTGN----IPAQIGSLKSLSVLTLQHNRLNGG----IPDSLGNLGKLKRLDLSFNSLFGT---  203 (689)
Q Consensus       136 ~~~l-~~L~~L~Ls~N~l~g~----~p~~~~~l~~L~~L~l~~N~l~~~----~p~~~~~l~~L~~L~ls~N~l~g~---  203 (689)
                      +..+ ++|+.|+|++|.+++.    ++..+..+++|++|+|++|.+++.    ++..+..+++|+.|++++|.+++.   
T Consensus       132 l~~~~~~L~~L~L~~n~l~~~~~~~~~~~~~~~~~L~~L~l~~n~l~~~~~~~l~~~l~~~~~L~~L~L~~n~i~~~~~~  211 (319)
T cd00116         132 LKDLPPALEKLVLGRNRLEGASCEALAKALRANRDLKELNLANNGIGDAGIRALAEGLKANCNLEVLDLNNNGLTDEGAS  211 (319)
T ss_pred             HHhCCCCceEEEcCCCcCCchHHHHHHHHHHhCCCcCEEECcCCCCchHHHHHHHHHHHhCCCCCEEeccCCccChHHHH
Confidence            4555 6777777777777742    233455666777777777777642    333445556777777777777643   


Q ss_pred             -chhhhhCCCCCcEEecccCcCCcc
Q 005586          204 -IPESLANNAELLFLDVQNNTLSGI  227 (689)
Q Consensus       204 -~p~~l~~~~~L~~l~l~~N~l~~~  227 (689)
                       ++..+..+++|++|++++|.+++.
T Consensus       212 ~l~~~~~~~~~L~~L~ls~n~l~~~  236 (319)
T cd00116         212 ALAETLASLKSLEVLNLGDNNLTDA  236 (319)
T ss_pred             HHHHHhcccCCCCEEecCCCcCchH
Confidence             233455567777777777777653

LRRs are 20-29 residue sequence motifs present in many proteins that participate in protein-protein interactions and have different functions and cellular locations. LRRs correspond to structural units consisting of a beta strand (LxxLxLxxN/CxL conserved pattern) and an alpha helix. This alignment contains 12 strands corresponding to 11 full repeats, consistent with the extent observed in the subfamily acting as Ran GTPase Activating Proteins (RanGAP1).

>KOG0601 consensus Cyclin-dependent kinase WEE1 [Cell cycle control, cell division, chromosome partitioning]

Probab=99.26  E-value=6.1e-12  Score=134.77  Aligned_cols=248  Identities=21%  Similarity=0.256  Sum_probs=170.7

Q ss_pred             cCCccccccc--CCcceEEEEEe--c-CCcEEEEEEecccCC-chHHHHHHHHHHHHhcc-CCCcceeEeeEEEcCCCCe
Q 005586          410 CFSEVNLLGK--GNFSSVYKGTL--R-DGTLVAIRSINVTSC-KSEEAEFVKGLYLLTSL-RHENIIRLRGFCCSRGRGE  482 (689)
Q Consensus       410 ~f~~~~~lg~--G~~g~Vy~~~~--~-~g~~vavK~l~~~~~-~~~~~~f~~e~~~l~~l-~H~niv~l~g~~~~~~~~~  482 (689)
                      .|.....+|.  |.+|.||.+..  + ++..+|+|+-+.... ......=.+|...-.++ .|+|.|+....+  .+++.
T Consensus       115 ~~~~~~~~g~~~g~~~s~~~~~~~~~~s~~~~a~k~s~~p~s~p~~~~~k~~~~~s~~~i~~~~~~v~~~~~~--e~~~~  192 (524)
T KOG0601|consen  115 RFPISSRTGSLPGSKGSVFKSRCTNSESPHKFAVKKSKIPFSPPLDSKRKLREFLSHHKIDSHENPVRDSPAW--EGSGI  192 (524)
T ss_pred             hcccccccccCCCCCceeecccCCcccCCcccccccccCCCCCccccccccchhhcccccCccccccccCccc--ccCCc
Confidence            3555678999  99999999987  3 688899988433221 11111223445555555 499999977666  44678


Q ss_pred             EEEEEEcCCCCCHHHHhhhcCCCCCCCCHHHHHHHHHHHHH----HHhhhhCCCCCCCceeecCCCCCceeecCC-CCeE
Q 005586          483 CFLIYDFAPKGKLSKYLDQEEGSSNVLDWSTRVSIIIGIAK----GIGYLHSSEVNKPAIVHRNLSVEKVLIDQQ-FNPL  557 (689)
Q Consensus       483 ~~lV~e~~~~gsL~~~L~~~~~~~~~l~~~~~~~ia~~ia~----gL~yLH~~~~~~~~ivH~dlk~~NiLl~~~-~~~k  557 (689)
                      .++-+|++ +.+|..+-+....   .++....+.+..+...    |+.++|+..     |+|-|+||.||+..++ ...+
T Consensus       193 lfiqtE~~-~~sl~~~~~~~~~---~~p~~~l~~~~~~~~~~~~~al~~~hs~~-----~~~~~~kp~~i~~~~~~~s~~  263 (524)
T KOG0601|consen  193 LFIQTELC-GESLQSYCHTPCN---FLPDNLLWNSLRDWLSRDVTALSHLHSNN-----IVHDDLKPANIFTTSDWTSCK  263 (524)
T ss_pred             ceeeeccc-cchhHHhhhcccc---cCCchhhhhHHhhhhhcccccccccCCCc-----ccccccchhheecccccceee
Confidence            88888988 5788888776433   2444555566666666    999999877     9999999999999999 8899


Q ss_pred             EecccccccccCCceee----eecCCCCCCCCCccccccCCCCCcccchhHHHHHHHHHhCCCCcchhHHHHHhhhhhhH
Q 005586          558 IADCGLHKLLADDIVFS----VLKTSAAMGYLAPEYVTTGRFTERSDIFAFGVIILQILTGSLVLTSSMRLAAESATFEN  633 (689)
Q Consensus       558 l~DfGla~~~~~~~~~~----~~~~~~~~~y~aPE~~~~~~~~~ksDV~sfGvvl~elltG~~p~~~~~~~~~~~~~~~~  633 (689)
                      +.|||+...+.+.....    .....+...|++||.. .+.++.+.|+|++|.+.+|..++..+.... ....|    .+
T Consensus       264 ~~df~~v~~i~~~~~~~~~~~~~r~~~~~~Y~~ke~~-~~l~~~~~di~sl~ev~l~~~l~~~~~~~g-~~~~W----~~  337 (524)
T KOG0601|consen  264 LTDFGLVSKISDGNFSSVFKVSKRPEGDCIYAAKELL-NGLATFASDIFSLGEVILEAILGSHLPSVG-KNSSW----SQ  337 (524)
T ss_pred             cCCcceeEEccCCccccceeeeecCCCCceEeChhhh-ccccchHhhhcchhhhhHhhHhhcccccCC-CCCCc----cc
Confidence            99999998876654211    1222455669999976 457899999999999999999986654221 00111    11


Q ss_pred             hhccccCCCCCHHHHHHHHHHHHHhccCCCCCCCCHHHHHH
Q 005586          634 FIDRNLKGKFSESEAAKLGKMALVCTHEDPENRPTMEAVIE  674 (689)
Q Consensus       634 ~~~~~~~~~~~~~~~~~l~~l~~~Cl~~dp~~RPs~~evl~  674 (689)
                      +-...+..++...-..++......+++.+|..|++.+.+..
T Consensus       338 ~r~~~ip~e~~~~~s~~l~~~~~~~~d~~~~~~~~~q~~~~  378 (524)
T KOG0601|consen  338 LRQGYIPLEFCEGGSSSLRSVTSQMLDEDPRLRLTAQILTA  378 (524)
T ss_pred             cccccCchhhhcCcchhhhhHHHHhcCcchhhhhHHHHHhc
Confidence            11111222233333445666888999999999999888764

>PLN03210 Resistant to P

Probab=99.26  E-value=3e-11  Score=147.34  Aligned_cols=127  Identities=22%  Similarity=0.247  Sum_probs=97.6

Q ss_pred             CCEEEEEcCCCCcccccCcCcCCCCCCCEEEccCCcccccCCccccCCCCCcEEEecccCCCCCCCccccCCccccEEee
Q 005586           68 RKVANISLQGKGLTGKLSPSLSGLKCLSGLYLHYNSLSGEIPKEIRNLTELTDLYLDVNNLSGNIPPEIGSMASLQVLQL  147 (689)
Q Consensus        68 ~~v~~l~L~~~~l~g~~~~~~~~l~~L~~L~L~~N~l~g~~p~~~~~l~~L~~L~Ls~N~l~g~~p~~~~~l~~L~~L~L  147 (689)
                      .+++.|++.++.+. .+|..| .+.+|+.|+|++|+|. .+|..+..+++|+.|+|++|..-+.+| .++.+++|+.|+|
T Consensus       589 ~~Lr~L~~~~~~l~-~lP~~f-~~~~L~~L~L~~s~l~-~L~~~~~~l~~Lk~L~Ls~~~~l~~ip-~ls~l~~Le~L~L  664 (1153)
T PLN03210        589 PKLRLLRWDKYPLR-CMPSNF-RPENLVKLQMQGSKLE-KLWDGVHSLTGLRNIDLRGSKNLKEIP-DLSMATNLETLKL  664 (1153)
T ss_pred             cccEEEEecCCCCC-CCCCcC-CccCCcEEECcCcccc-ccccccccCCCCCEEECCCCCCcCcCC-ccccCCcccEEEe
Confidence            35788888887775 667666 5688899999998887 677788888999999998876555777 4788889999999


Q ss_pred             ecccCCCCCchhcCCCCCCCEEeccCCcCCCCCCcccCCCCCCCeeeccCCc
Q 005586          148 CCNQLTGNIPAQIGSLKSLSVLTLQHNRLNGGIPDSLGNLGKLKRLDLSFNS  199 (689)
Q Consensus       148 s~N~l~g~~p~~~~~l~~L~~L~l~~N~l~~~~p~~~~~l~~L~~L~ls~N~  199 (689)
                      ++|.....+|..++++++|+.|++++|..-+.+|..+ ++++|+.|++++|.
T Consensus       665 ~~c~~L~~lp~si~~L~~L~~L~L~~c~~L~~Lp~~i-~l~sL~~L~Lsgc~  715 (1153)
T PLN03210        665 SDCSSLVELPSSIQYLNKLEDLDMSRCENLEILPTGI-NLKSLYRLNLSGCS  715 (1153)
T ss_pred             cCCCCccccchhhhccCCCCEEeCCCCCCcCccCCcC-CCCCCCEEeCCCCC
Confidence            8887777888888889999999998865545677654 56666666665553

syringae 6; Provisional

>KOG0601 consensus Cyclin-dependent kinase WEE1 [Cell cycle control, cell division, chromosome partitioning]

Probab=99.20  E-value=1.6e-11  Score=131.58  Aligned_cols=248  Identities=20%  Similarity=0.220  Sum_probs=173.0

Q ss_pred             HhccCCcccccccCCcceEEEEEec--CCcEEEEEEecccCCchHHHHH-HHHHHHHhcc-CCCcceeEeeEEEcCCCCe
Q 005586          407 ATQCFSEVNLLGKGNFSSVYKGTLR--DGTLVAIRSINVTSCKSEEAEF-VKGLYLLTSL-RHENIIRLRGFCCSRGRGE  482 (689)
Q Consensus       407 at~~f~~~~~lg~G~~g~Vy~~~~~--~g~~vavK~l~~~~~~~~~~~f-~~e~~~l~~l-~H~niv~l~g~~~~~~~~~  482 (689)
                      -+.+|.....||.|.|+.|++...+  ++..|++|.+.........+.| ..|+.+...+ -|.+++....-+..  .+.
T Consensus       263 ~~~df~~v~~i~~~~~~~~~~~~~r~~~~~~Y~~ke~~~~l~~~~~di~sl~ev~l~~~l~~~~~~~g~~~~W~~--~r~  340 (524)
T KOG0601|consen  263 KLTDFGLVSKISDGNFSSVFKVSKRPEGDCIYAAKELLNGLATFASDIFSLGEVILEAILGSHLPSVGKNSSWSQ--LRQ  340 (524)
T ss_pred             ecCCcceeEEccCCccccceeeeecCCCCceEeChhhhccccchHhhhcchhhhhHhhHhhcccccCCCCCCccc--ccc
Confidence            4457888999999999999998754  6889999988766543333222 4555555555 48888876544422  245


Q ss_pred             EEEEEEcCCCCCHHHHhhhcCCCCCCCCHHHHHHHHHHHHHHHhhhhCCCCCCCceeecCCCCCceeecCC-CCeEEecc
Q 005586          483 CFLIYDFAPKGKLSKYLDQEEGSSNVLDWSTRVSIIIGIAKGIGYLHSSEVNKPAIVHRNLSVEKVLIDQQ-FNPLIADC  561 (689)
Q Consensus       483 ~~lV~e~~~~gsL~~~L~~~~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~~~ivH~dlk~~NiLl~~~-~~~kl~Df  561 (689)
                      .++=-||++++++...+..    ...++...++++..+++.++.++|+..     ++|+|+||+||++..+ +.-+++||
T Consensus       341 ~~ip~e~~~~~s~~l~~~~----~~~~d~~~~~~~~~q~~~~l~~i~s~~-----~~~~d~~psni~i~~~~~~~~~~~~  411 (524)
T KOG0601|consen  341 GYIPLEFCEGGSSSLRSVT----SQMLDEDPRLRLTAQILTALNVIHSKL-----FVHLDVKPSNILISNDGFFSKLGDF  411 (524)
T ss_pred             ccCchhhhcCcchhhhhHH----HHhcCcchhhhhHHHHHhccccccchh-----hhcccccccceeeccchhhhhcccc
Confidence            6688899999988877632    234777888999999999999999887     9999999999999986 88899999


Q ss_pred             cccccccCCceeeeecCCCCCCCC--CccccccCCCCCcccchhHHHHHHHHHhCCCCcchhHHHHHhhhhhhHhhcccc
Q 005586          562 GLHKLLADDIVFSVLKTSAAMGYL--APEYVTTGRFTERSDIFAFGVIILQILTGSLVLTSSMRLAAESATFENFIDRNL  639 (689)
Q Consensus       562 Gla~~~~~~~~~~~~~~~~~~~y~--aPE~~~~~~~~~ksDV~sfGvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~  639 (689)
                      |.+..+.-..   .. ....-+++  +++......+..+.|+||||.-+.|.++|..-......+..        +....
T Consensus       412 ~~~t~~~~~~---~~-~~~~~r~~p~~~~~~e~~~~~~~~~~~sl~~~~~e~~~~~~ls~~~~~~~~--------i~~~~  479 (524)
T KOG0601|consen  412 GCWTRLAFSS---GV-FHHIDRLYPIAEILLEDYPHLSKADIFSLGLSVDEAITGSPLSESGVQSLT--------IRSGD  479 (524)
T ss_pred             ccccccceec---cc-ccccccccccchhhccccccccccccccccccccccccCcccCccccccee--------eeccc
Confidence            9987532211   11 11222344  45545556778999999999999999998754332211110        00111


Q ss_pred             CCCCCHHHHHHHHHHHHHhccCCCCCCCCHHHHHHHHHh
Q 005586          640 KGKFSESEAAKLGKMALVCTHEDPENRPTMEAVIEELTV  678 (689)
Q Consensus       640 ~~~~~~~~~~~l~~l~~~Cl~~dp~~RPs~~evl~~L~~  678 (689)
                      ....+. ...++..++..+..+++..||.+.++..+...
T Consensus       480 ~p~~~~-~~~~~q~~~kv~~~~~~~~~~l~~~l~~~~~~  517 (524)
T KOG0601|consen  480 TPNLPG-LKLQLQVLLKVMINPDRKRRPSAVELSLHSEF  517 (524)
T ss_pred             ccCCCc-hHHhhhhhhhhhcCCccccchhhhhhcccchh
Confidence            111122 22667778888899999999999988776544

>KOG1259 consensus Nischarin, modulator of integrin alpha5 subunit action [Signal transduction mechanisms; Cytoskeleton]

Probab=99.16  E-value=2.7e-12  Score=124.78  Aligned_cols=136  Identities=25%  Similarity=0.301  Sum_probs=110.4

Q ss_pred             cCCCCCCCEEEccCCcccccCCccccCCCCCcEEEecccCCCCCCCccccCCccccEEeeecccCCCCCchhcCCCCCCC
Q 005586           88 LSGLKCLSGLYLHYNSLSGEIPKEIRNLTELTDLYLDVNNLSGNIPPEIGSMASLQVLQLCCNQLTGNIPAQIGSLKSLS  167 (689)
Q Consensus        88 ~~~l~~L~~L~L~~N~l~g~~p~~~~~l~~L~~L~Ls~N~l~g~~p~~~~~l~~L~~L~Ls~N~l~g~~p~~~~~l~~L~  167 (689)
                      +.....|++||||+|.|+ .+..+..-+++++.|+||+|++. .+- .+..|++|+.||||+|.++ .+-.+-..|.+.+
T Consensus       280 ~dTWq~LtelDLS~N~I~-~iDESvKL~Pkir~L~lS~N~i~-~v~-nLa~L~~L~~LDLS~N~Ls-~~~Gwh~KLGNIK  355 (490)
T KOG1259|consen  280 ADTWQELTELDLSGNLIT-QIDESVKLAPKLRRLILSQNRIR-TVQ-NLAELPQLQLLDLSGNLLA-ECVGWHLKLGNIK  355 (490)
T ss_pred             cchHhhhhhccccccchh-hhhhhhhhccceeEEecccccee-eeh-hhhhcccceEeecccchhH-hhhhhHhhhcCEe
Confidence            334567999999999998 77788888899999999999998 343 3888999999999999998 5555556788899


Q ss_pred             EEeccCCcCCCCCCcccCCCCCCCeeeccCCcCCCCc-hhhhhCCCCCcEEecccCcCCcccc
Q 005586          168 VLTLQHNRLNGGIPDSLGNLGKLKRLDLSFNSLFGTI-PESLANNAELLFLDVQNNTLSGIVP  229 (689)
Q Consensus       168 ~L~l~~N~l~~~~p~~~~~l~~L~~L~ls~N~l~g~~-p~~l~~~~~L~~l~l~~N~l~~~~p  229 (689)
                      .|.|+.|.+.. + +.++.|-+|..||+++|++...- -..++++|.|+.|.|.+|.|++.+.
T Consensus       356 tL~La~N~iE~-L-SGL~KLYSLvnLDl~~N~Ie~ldeV~~IG~LPCLE~l~L~~NPl~~~vd  416 (490)
T KOG1259|consen  356 TLKLAQNKIET-L-SGLRKLYSLVNLDLSSNQIEELDEVNHIGNLPCLETLRLTGNPLAGSVD  416 (490)
T ss_pred             eeehhhhhHhh-h-hhhHhhhhheeccccccchhhHHHhcccccccHHHHHhhcCCCccccch
Confidence            99999998862 2 34677788999999999987321 2467889999999999999998765

>PF14580 LRR_9: Leucine-rich repeat; PDB: 2JE1_D 2JE0_A 2JQD_A

Probab=99.15  E-value=2.8e-11  Score=113.50  Aligned_cols=126  Identities=25%  Similarity=0.300  Sum_probs=43.0

Q ss_pred             cCCCCCCCEEEccCCcccccCCcccc-CCCCCcEEEecccCCCCCCCccccCCccccEEeeecccCCCCCchhc-CCCCC
Q 005586           88 LSGLKCLSGLYLHYNSLSGEIPKEIR-NLTELTDLYLDVNNLSGNIPPEIGSMASLQVLQLCCNQLTGNIPAQI-GSLKS  165 (689)
Q Consensus        88 ~~~l~~L~~L~L~~N~l~g~~p~~~~-~l~~L~~L~Ls~N~l~g~~p~~~~~l~~L~~L~Ls~N~l~g~~p~~~-~~l~~  165 (689)
                      +.+...+++|+|++|.|+. + +.++ .|.+|+.|||++|.++ .++ .+..+++|+.|+|++|+++. +...+ ..+++
T Consensus        15 ~~n~~~~~~L~L~~n~I~~-I-e~L~~~l~~L~~L~Ls~N~I~-~l~-~l~~L~~L~~L~L~~N~I~~-i~~~l~~~lp~   89 (175)
T PF14580_consen   15 YNNPVKLRELNLRGNQIST-I-ENLGATLDKLEVLDLSNNQIT-KLE-GLPGLPRLKTLDLSNNRISS-ISEGLDKNLPN   89 (175)
T ss_dssp             -----------------------S--TT-TT--EEE-TTS--S---T-T----TT--EEE--SS---S--CHHHHHH-TT
T ss_pred             ccccccccccccccccccc-c-cchhhhhcCCCEEECCCCCCc-ccc-CccChhhhhhcccCCCCCCc-cccchHHhCCc
Confidence            3445567888888888873 3 2354 5778888888888887 343 46677888888888888874 43333 35788


Q ss_pred             CCEEeccCCcCCCCC-CcccCCCCCCCeeeccCCcCCCCc---hhhhhCCCCCcEEe
Q 005586          166 LSVLTLQHNRLNGGI-PDSLGNLGKLKRLDLSFNSLFGTI---PESLANNAELLFLD  218 (689)
Q Consensus       166 L~~L~l~~N~l~~~~-p~~~~~l~~L~~L~ls~N~l~g~~---p~~l~~~~~L~~l~  218 (689)
                      |+.|+|++|++...- -..+..+++|+.|+|.+|.++...   ...+..+|+|+.||
T Consensus        90 L~~L~L~~N~I~~l~~l~~L~~l~~L~~L~L~~NPv~~~~~YR~~vi~~lP~Lk~LD  146 (175)
T PF14580_consen   90 LQELYLSNNKISDLNELEPLSSLPKLRVLSLEGNPVCEKKNYRLFVIYKLPSLKVLD  146 (175)
T ss_dssp             --EEE-TTS---SCCCCGGGGG-TT--EEE-TT-GGGGSTTHHHHHHHH-TT-SEET
T ss_pred             CCEEECcCCcCCChHHhHHHHcCCCcceeeccCCcccchhhHHHHHHHHcChhheeC
Confidence            888888888876321 134566777777777777776331   12345567777766

>COG4886 Leucine-rich repeat (LRR) protein [Function unknown]

Probab=99.14  E-value=2.1e-11  Score=132.44  Aligned_cols=156  Identities=33%  Similarity=0.532  Sum_probs=117.8

Q ss_pred             CCEEEEEcCCCCcccccCcCcCCCC-CCCEEEccCCcccccCCccccCCCCCcEEEecccCCCCCCCccccCCccccEEe
Q 005586           68 RKVANISLQGKGLTGKLSPSLSGLK-CLSGLYLHYNSLSGEIPKEIRNLTELTDLYLDVNNLSGNIPPEIGSMASLQVLQ  146 (689)
Q Consensus        68 ~~v~~l~L~~~~l~g~~~~~~~~l~-~L~~L~L~~N~l~g~~p~~~~~l~~L~~L~Ls~N~l~g~~p~~~~~l~~L~~L~  146 (689)
                      ..++.+++.+|.++ .+++....+. +|+.|++++|++. .+|..+..+++|+.|++++|+++ .+|...+.+++|+.|+
T Consensus       116 ~~l~~L~l~~n~i~-~i~~~~~~~~~nL~~L~l~~N~i~-~l~~~~~~l~~L~~L~l~~N~l~-~l~~~~~~~~~L~~L~  192 (394)
T COG4886         116 TNLTSLDLDNNNIT-DIPPLIGLLKSNLKELDLSDNKIE-SLPSPLRNLPNLKNLDLSFNDLS-DLPKLLSNLSNLNNLD  192 (394)
T ss_pred             cceeEEecCCcccc-cCccccccchhhcccccccccchh-hhhhhhhccccccccccCCchhh-hhhhhhhhhhhhhhee
Confidence            46888899888887 6777777774 8999999999988 67777888999999999999998 7777777888899999


Q ss_pred             eecccCCCCCchhcCCCCCCCEEeccCCcCCCCCCcccCCCCCCCeeeccCCcCCCCchhhhhCCCCCcEEecccCcCCc
Q 005586          147 LCCNQLTGNIPAQIGSLKSLSVLTLQHNRLNGGIPDSLGNLGKLKRLDLSFNSLFGTIPESLANNAELLFLDVQNNTLSG  226 (689)
Q Consensus       147 Ls~N~l~g~~p~~~~~l~~L~~L~l~~N~l~~~~p~~~~~l~~L~~L~ls~N~l~g~~p~~l~~~~~L~~l~l~~N~l~~  226 (689)
                      +++|+++ .+|..+..+..|+.|.+++|++. .++..+.++.++..|.+++|++. .++..+..+++++.|++++|.++.
T Consensus       193 ls~N~i~-~l~~~~~~~~~L~~l~~~~N~~~-~~~~~~~~~~~l~~l~l~~n~~~-~~~~~~~~l~~l~~L~~s~n~i~~  269 (394)
T COG4886         193 LSGNKIS-DLPPEIELLSALEELDLSNNSII-ELLSSLSNLKNLSGLELSNNKLE-DLPESIGNLSNLETLDLSNNQISS  269 (394)
T ss_pred             ccCCccc-cCchhhhhhhhhhhhhhcCCcce-ecchhhhhcccccccccCCceee-eccchhccccccceeccccccccc
Confidence            9999988 67776666666888888888544 45556666666666666666665 335556666667777777776665


Q ss_pred             ccc
Q 005586          227 IVP  229 (689)
Q Consensus       227 ~~p  229 (689)
                      ..+
T Consensus       270 i~~  272 (394)
T COG4886         270 ISS  272 (394)
T ss_pred             ccc
Confidence            443

>cd05154 ACAD10_11_like Acyl-CoA dehydrogenase (ACAD) 10 and 11, N-terminal domain, and similar proteins

Probab=99.13  E-value=4.3e-10  Score=111.63  Aligned_cols=148  Identities=19%  Similarity=0.238  Sum_probs=111.6

Q ss_pred             ccccccCCcceEEEEEecCCcEEEEEEecccCCchHHHHHHHHHHHHhccCC--CcceeEeeEEEcCC-CCeEEEEEEcC
Q 005586          414 VNLLGKGNFSSVYKGTLRDGTLVAIRSINVTSCKSEEAEFVKGLYLLTSLRH--ENIIRLRGFCCSRG-RGECFLIYDFA  490 (689)
Q Consensus       414 ~~~lg~G~~g~Vy~~~~~~g~~vavK~l~~~~~~~~~~~f~~e~~~l~~l~H--~niv~l~g~~~~~~-~~~~~lV~e~~  490 (689)
                      .+.|+.|..+.||++...+|..+++|............++..|.+++..+++  .++.+++.+..... .+..++||||+
T Consensus         3 ~~~l~~G~~n~~~~v~~~~g~~~ilK~~~~~~~~~~~~~~~~E~~~~~~l~~~~~~vp~~~~~~~~~~~~~~~~~v~e~i   82 (223)
T cd05154           3 VRQLSGGQSNLTYLLTAGGGRRLVLRRPPPGALLPSAHDVAREYRVLRALAGTGVPVPKVLALCEDPSVLGTPFYVMERV   82 (223)
T ss_pred             ceecCCCccceEEEEEecCCcceEEEeCCCcccCcccccHHHHHHHHHHhhCCCCCCCCEEEECCCCCccCCceEEEEEe
Confidence            3578999999999999877789999997654322234578899999999876  44566777663321 12468999999


Q ss_pred             CCCCHHHHhhhcCCCCCCCCHHHHHHHHHHHHHHHhhhhCCCC-------------------------------------
Q 005586          491 PKGKLSKYLDQEEGSSNVLDWSTRVSIIIGIAKGIGYLHSSEV-------------------------------------  533 (689)
Q Consensus       491 ~~gsL~~~L~~~~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~-------------------------------------  533 (689)
                      ++.++.+.+..     ..++...+..++.+++++|++||+...                                     
T Consensus        83 ~G~~l~~~~~~-----~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  157 (223)
T cd05154          83 DGRVLRDRLLR-----PELSPEERRALARALADTLAALHSVDPAAVGLGDLGRPGGYLERQVARWRRQYDASRTDEPPAM  157 (223)
T ss_pred             CCEecCCCCCC-----CCCCHHHHHHHHHHHHHHHHHHhCCChhhcCCcccCCCCchHHHHHHHHHHHHHhhcccccHHH
Confidence            99888776532     136777888899999999999996321                                     


Q ss_pred             --------------CCCceeecCCCCCceeecC--CCCeEEeccccccc
Q 005586          534 --------------NKPAIVHRNLSVEKVLIDQ--QFNPLIADCGLHKL  566 (689)
Q Consensus       534 --------------~~~~ivH~dlk~~NiLl~~--~~~~kl~DfGla~~  566 (689)
                                    ....++|+|+.+.||++++  +..+.|.||+.+..
T Consensus       158 ~~~~~~~~~~~~~~~~~~l~HgD~~~~Nil~~~~~~~~~~iID~e~~~~  206 (223)
T cd05154         158 ERLLRWLEAHLPADSRPGLVHGDYRLGNVLFHPDEPRVVAVLDWELATL  206 (223)
T ss_pred             HHHHHHHHhhCCCCCCcEEEECCCCcccEEEcCCCCcEEEEEecccccc
Confidence                          1355799999999999998  66689999997753

This subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). This subfamily is composed of bacterial and eukaryotic proteins with similarity to the N-terminal domains of vertebrate ACAD10 and ACAD11. ACADs are a family of flavoproteins that are involved in the beta-oxidation of fatty acyl-CoA derivatives. ACAD deficiency can cause metabolic disorders including muscle fatigue, hypoglycemia, and hepatic lipidosis, among them. There are at least 11 distinct ACADs, some of which show distinct substrate specificities to either straight-chain or branched-chain fatty acids. ACAD10 is widely expressed in human tissues and is highly expressed in liver, kidney, pancreas, and spleen. ACAD10 and ACAD11 contain

>KOG1243 consensus Protein kinase [General function prediction only]

Probab=99.12  E-value=8.8e-10  Score=119.35  Aligned_cols=167  Identities=17%  Similarity=0.199  Sum_probs=120.9

Q ss_pred             cCCcEEEEEEecccCCchHHHHHHHHHHHHhccCCCcceeEeeEEEcCCCCeEEEEEEcCCCCCHHHHhhhcCCCCCCCC
Q 005586          431 RDGTLVAIRSINVTSCKSEEAEFVKGLYLLTSLRHENIIRLRGFCCSRGRGECFLIYDFAPKGKLSKYLDQEEGSSNVLD  510 (689)
Q Consensus       431 ~~g~~vavK~l~~~~~~~~~~~f~~e~~~l~~l~H~niv~l~g~~~~~~~~~~~lV~e~~~~gsL~~~L~~~~~~~~~l~  510 (689)
                      .++.+|.|...+.... .......+.++.|+.+|||||++++.-+..  .+..|+|+|-+.  -|..++...       .
T Consensus        35 ~~~~~vsVF~~~~~~~-~~~~~~~~A~k~lKtlRHP~Il~yL~t~e~--~~~~ylvTErV~--Pl~~~lk~l-------~  102 (690)
T KOG1243|consen   35 ADGGPVSVFVYKRSNG-EVTELAKRAVKRLKTLRHPNILSYLDTTEE--EGTLYLVTERVR--PLETVLKEL-------G  102 (690)
T ss_pred             ccCCceEEEEEeCCCc-hhhHHHHHHHHHhhhccCchhhhhhhhhcc--cCceEEEeeccc--cHHHHHHHh-------H
Confidence            3688888888876543 334456777889999999999999987743  468899999884  466666542       2


Q ss_pred             HHHHHHHHHHHHHHHhhhhCCCCCCCceeecCCCCCceeecCCCCeEEecccccccccCCceeeeecCCCCCCCCCcccc
Q 005586          511 WSTRVSIIIGIAKGIGYLHSSEVNKPAIVHRNLSVEKVLIDQQFNPLIADCGLHKLLADDIVFSVLKTSAAMGYLAPEYV  590 (689)
Q Consensus       511 ~~~~~~ia~~ia~gL~yLH~~~~~~~~ivH~dlk~~NiLl~~~~~~kl~DfGla~~~~~~~~~~~~~~~~~~~y~aPE~~  590 (689)
                      -....-.+.||+.||.|||..+.    ++|++|.-..|++++.|+.||++|-++........ ......--..|..|+.+
T Consensus       103 ~~~v~~Gl~qIl~AL~FL~~d~~----lvHgNv~~~SVfVn~~GeWkLggle~v~~~~~~~~-~~~~~~~~~s~~~P~~~  177 (690)
T KOG1243|consen  103 KEEVCLGLFQILAALSFLNDDCN----LVHGNVCKDSVFVNESGEWKLGGLELVSKASGFNA-PAKSLYLIESFDDPEEI  177 (690)
T ss_pred             HHHHHHHHHHHHHHHHHHhccCC----eeeccEeeeeEEEcCCCcEEEeeeEEEeccccCCc-ccccchhhhcccChhhc
Confidence            34555678999999999997654    99999999999999999999999988764432211 00000011236777754


Q ss_pred             ccCCCCCcccchhHHHHHHHHHhCCC
Q 005586          591 TTGRFTERSDIFAFGVIILQILTGSL  616 (689)
Q Consensus       591 ~~~~~~~ksDV~sfGvvl~elltG~~  616 (689)
                      ....  -..|.|-||++++|++.|..
T Consensus       178 ~~s~--~s~D~~~Lg~li~el~ng~~  201 (690)
T KOG1243|consen  178 DPSE--WSIDSWGLGCLIEELFNGSL  201 (690)
T ss_pred             Cccc--cchhhhhHHHHHHHHhCccc
Confidence            3222  34699999999999999943

>COG4886 Leucine-rich repeat (LRR) protein [Function unknown]

Probab=99.10  E-value=5.1e-11  Score=129.36  Aligned_cols=149  Identities=30%  Similarity=0.480  Sum_probs=102.8

Q ss_pred             EEEcCCCCcccccCcCcCCCCCCCEEEccCCcccccCCccccCCC-CCcEEEecccCCCCCCCccccCCccccEEeeecc
Q 005586           72 NISLQGKGLTGKLSPSLSGLKCLSGLYLHYNSLSGEIPKEIRNLT-ELTDLYLDVNNLSGNIPPEIGSMASLQVLQLCCN  150 (689)
Q Consensus        72 ~l~L~~~~l~g~~~~~~~~l~~L~~L~L~~N~l~g~~p~~~~~l~-~L~~L~Ls~N~l~g~~p~~~~~l~~L~~L~Ls~N  150 (689)
                      .+++..+.+...+ ..+..++.++.|++.+|.++ .+|.....++ +|+.|++++|++. .+|..++.+++|+.|++++|
T Consensus        97 ~l~~~~~~~~~~~-~~~~~~~~l~~L~l~~n~i~-~i~~~~~~~~~nL~~L~l~~N~i~-~l~~~~~~l~~L~~L~l~~N  173 (394)
T COG4886          97 SLDLNLNRLRSNI-SELLELTNLTSLDLDNNNIT-DIPPLIGLLKSNLKELDLSDNKIE-SLPSPLRNLPNLKNLDLSFN  173 (394)
T ss_pred             eeeccccccccCc-hhhhcccceeEEecCCcccc-cCccccccchhhcccccccccchh-hhhhhhhccccccccccCCc
Confidence            3556665553222 23344567777777777777 5666666664 7777788887777 66667777777888888888


Q ss_pred             cCCCCCchhcCCCCCCCEEeccCCcCCCCCCcccCCCCCCCeeeccCCcCCCCchhhhhCCCCCcEEecccCcCCc
Q 005586          151 QLTGNIPAQIGSLKSLSVLTLQHNRLNGGIPDSLGNLGKLKRLDLSFNSLFGTIPESLANNAELLFLDVQNNTLSG  226 (689)
Q Consensus       151 ~l~g~~p~~~~~l~~L~~L~l~~N~l~~~~p~~~~~l~~L~~L~ls~N~l~g~~p~~l~~~~~L~~l~l~~N~l~~  226 (689)
                      +++ .+|...+.+++|+.|++++|+++ .+|.....+..|++|++++|++. .++..+..+.++..+.+.+|++..
T Consensus       174 ~l~-~l~~~~~~~~~L~~L~ls~N~i~-~l~~~~~~~~~L~~l~~~~N~~~-~~~~~~~~~~~l~~l~l~~n~~~~  246 (394)
T COG4886         174 DLS-DLPKLLSNLSNLNNLDLSGNKIS-DLPPEIELLSALEELDLSNNSII-ELLSSLSNLKNLSGLELSNNKLED  246 (394)
T ss_pred             hhh-hhhhhhhhhhhhhheeccCCccc-cCchhhhhhhhhhhhhhcCCcce-ecchhhhhcccccccccCCceeee
Confidence            777 56665557777777778887777 67766666666777777777544 455566777777777777777654

>cd05146 RIO3_euk RIO kinase family; eukaryotic RIO3, catalytic domain

Probab=99.07  E-value=2.2e-09  Score=102.73  Aligned_cols=137  Identities=15%  Similarity=0.090  Sum_probs=97.5

Q ss_pred             cccccCCcceEEEEEecC-------CcEEEEEEecccCC---------------------chHHHHHH----HHHHHHhc
Q 005586          415 NLLGKGNFSSVYKGTLRD-------GTLVAIRSINVTSC---------------------KSEEAEFV----KGLYLLTS  462 (689)
Q Consensus       415 ~~lg~G~~g~Vy~~~~~~-------g~~vavK~l~~~~~---------------------~~~~~~f~----~e~~~l~~  462 (689)
                      ..||.|.-+.||.|.-.+       +..+|||+.+....                     ....+.+.    +|.+.|.+
T Consensus         3 g~i~~GKEa~V~~~~~~~~~~~~~~~~~~avKi~r~~~~~Fk~~~~y~~~~~rf~~~~~k~~~~~~~~~wa~kE~r~L~r   82 (197)
T cd05146           3 GCISTGKESVVLHANGGSNETEQVIPTECAIKVFKTTLNEFKNRDKYIKDDYRFKDRFSKLNPRKIIRMWAEKEMHNLKR   82 (197)
T ss_pred             CccccCcceEEEEEecCcccccccCCceEEEEEEeccceeEcChhhhccCCcccccCcCCCCHHHHHHHHHHHHHHHHHH
Confidence            469999999999998553       47999998863211                     01122333    78999998


Q ss_pred             cCC--CcceeEeeEEEcCCCCeEEEEEEcCCCCCHHH-HhhhcCCCCCCCCHHHHHHHHHHHHHHHhhh-hCCCCCCCce
Q 005586          463 LRH--ENIIRLRGFCCSRGRGECFLIYDFAPKGKLSK-YLDQEEGSSNVLDWSTRVSIIIGIAKGIGYL-HSSEVNKPAI  538 (689)
Q Consensus       463 l~H--~niv~l~g~~~~~~~~~~~lV~e~~~~gsL~~-~L~~~~~~~~~l~~~~~~~ia~~ia~gL~yL-H~~~~~~~~i  538 (689)
                      +.-  -++..++++      ..-++||||+.++.+.. .|.+.     .++..+...+..+++.+|.+| |..+     |
T Consensus        83 l~~~Gv~vP~pi~~------~~~~lvME~Ig~~~~~~~~Lkd~-----~~~~~~~~~i~~~i~~~l~~l~H~~g-----l  146 (197)
T cd05146          83 MQKAGIPCPEVVVL------KKHVLVMSFIGDDQVPAPKLKDA-----KLNDEEMKNAYYQVLSMMKQLYKECN-----L  146 (197)
T ss_pred             HHHcCCCCCeEEEe------cCCEEEEEEcCCCCccchhhhcc-----ccCHHHHHHHHHHHHHHHHHHHHhCC-----e
Confidence            853  456666654      23579999997654421 22221     244455667889999999999 7776     9


Q ss_pred             eecCCCCCceeecCCCCeEEeccccccccc
Q 005586          539 VHRNLSVEKVLIDQQFNPLIADCGLHKLLA  568 (689)
Q Consensus       539 vH~dlk~~NiLl~~~~~~kl~DfGla~~~~  568 (689)
                      |||||++.||++++ +.+.|+|||.+....
T Consensus       147 VHGDLs~~NIL~~~-~~v~iIDF~qav~~~  175 (197)
T cd05146         147 VHADLSEYNMLWHD-GKVWFIDVSQSVEPT  175 (197)
T ss_pred             ecCCCCHHHEEEEC-CcEEEEECCCceeCC
Confidence            99999999999974 679999999876543

The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO3 is present only in multicellular eukaryotes. Its function is still unknown.

>KOG4237 consensus Extracellular matrix protein slit, contains leucine-rich and EGF-like repeats [Extracellular structures; Signal transduction mechanisms]

Probab=99.00  E-value=3.2e-11  Score=121.74  Aligned_cols=169  Identities=25%  Similarity=0.341  Sum_probs=89.4

Q ss_pred             ceEEcCCCCCEEEEEcCCCCcccccCcCcCCCCCCCEEEccCCcccccCCccccCCCCCcEEEecccCCCCCCCccccCC
Q 005586           60 EGIACNEHRKVANISLQGKGLTGKLSPSLSGLKCLSGLYLHYNSLSGEIPKEIRNLTELTDLYLDVNNLSGNIPPEIGSM  139 (689)
Q Consensus        60 ~gv~C~~~~~v~~l~L~~~~l~g~~~~~~~~l~~L~~L~L~~N~l~g~~p~~~~~l~~L~~L~Ls~N~l~g~~p~~~~~l  139 (689)
                      .+-+|+... -..++-.+.+|+ .+|..+-  ..-+.|+|..|+|+...|..|+.+++|+.||||+|+|+-.-|.+|..+
T Consensus        39 ~pC~Cs~~~-g~~VdCr~~GL~-eVP~~LP--~~tveirLdqN~I~~iP~~aF~~l~~LRrLdLS~N~Is~I~p~AF~GL  114 (498)
T KOG4237|consen   39 APCTCSDVE-GGIVDCRGKGLT-EVPANLP--PETVEIRLDQNQISSIPPGAFKTLHRLRRLDLSKNNISFIAPDAFKGL  114 (498)
T ss_pred             CCcccCCCC-CceEEccCCCcc-cCcccCC--CcceEEEeccCCcccCChhhccchhhhceecccccchhhcChHhhhhh
Confidence            344565433 345566666666 4444331  233456666666665555556666666666666666665555555555


Q ss_pred             ccccEEeeec-ccCCCCCchhcCCCCCCCEEeccCCcCCCCCCcccCCCCCCCeeeccCCcCCCCchhhhhCCCCCcEEe
Q 005586          140 ASLQVLQLCC-NQLTGNIPAQIGSLKSLSVLTLQHNRLNGGIPDSLGNLGKLKRLDLSFNSLFGTIPESLANNAELLFLD  218 (689)
Q Consensus       140 ~~L~~L~Ls~-N~l~g~~p~~~~~l~~L~~L~l~~N~l~~~~p~~~~~l~~L~~L~ls~N~l~g~~p~~l~~~~~L~~l~  218 (689)
                      .+|..|-+.+ |+|+...-..|++|.+|+.|                        .+.-|++.-...+.|..+++|..|.
T Consensus       115 ~~l~~Lvlyg~NkI~~l~k~~F~gL~slqrL------------------------llNan~i~Cir~~al~dL~~l~lLs  170 (498)
T KOG4237|consen  115 ASLLSLVLYGNNKITDLPKGAFGGLSSLQRL------------------------LLNANHINCIRQDALRDLPSLSLLS  170 (498)
T ss_pred             HhhhHHHhhcCCchhhhhhhHhhhHHHHHHH------------------------hcChhhhcchhHHHHHHhhhcchhc
Confidence            5555444433 55553333344444444444                        4444444444444455555555555


Q ss_pred             cccCcCCcccchhHHhccC--ccccccCCCCCCCCCCCCc
Q 005586          219 VQNNTLSGIVPSALKRLNG--GFQFQNNPGLCGDGIASLR  256 (689)
Q Consensus       219 l~~N~l~~~~p~~~~~~~~--~~~~~~n~~~c~~~~~~l~  256 (689)
                      +-+|.+..+.-..|..+..  .+.+.-||+.|.|.++++.
T Consensus       171 lyDn~~q~i~~~tf~~l~~i~tlhlA~np~icdCnL~wla  210 (498)
T KOG4237|consen  171 LYDNKIQSICKGTFQGLAAIKTLHLAQNPFICDCNLPWLA  210 (498)
T ss_pred             ccchhhhhhccccccchhccchHhhhcCccccccccchhh
Confidence            5555554333333333322  3556778888998776543

>KOG1259 consensus Nischarin, modulator of integrin alpha5 subunit action [Signal transduction mechanisms; Cytoskeleton]

Probab=98.98  E-value=5.2e-11  Score=115.96  Aligned_cols=130  Identities=25%  Similarity=0.300  Sum_probs=108.7

Q ss_pred             CEEEEEcCCCCcccccCcCcCCCCCCCEEEccCCcccccCCccccCCCCCcEEEecccCCCCCCCccccCCccccEEeee
Q 005586           69 KVANISLQGKGLTGKLSPSLSGLKCLSGLYLHYNSLSGEIPKEIRNLTELTDLYLDVNNLSGNIPPEIGSMASLQVLQLC  148 (689)
Q Consensus        69 ~v~~l~L~~~~l~g~~~~~~~~l~~L~~L~L~~N~l~g~~p~~~~~l~~L~~L~Ls~N~l~g~~p~~~~~l~~L~~L~Ls  148 (689)
                      .++.+||++|.++ .+..+..-++.++.|++|+|+|. .+- .+..|++|+.||||+|.++ .+-..=.+|-+.+.|.|+
T Consensus       285 ~LtelDLS~N~I~-~iDESvKL~Pkir~L~lS~N~i~-~v~-nLa~L~~L~~LDLS~N~Ls-~~~Gwh~KLGNIKtL~La  360 (490)
T KOG1259|consen  285 ELTELDLSGNLIT-QIDESVKLAPKLRRLILSQNRIR-TVQ-NLAELPQLQLLDLSGNLLA-ECVGWHLKLGNIKTLKLA  360 (490)
T ss_pred             hhhhccccccchh-hhhhhhhhccceeEEecccccee-eeh-hhhhcccceEeecccchhH-hhhhhHhhhcCEeeeehh
Confidence            4688999999998 77888888999999999999998 333 3889999999999999998 555555678899999999


Q ss_pred             cccCCCCCchhcCCCCCCCEEeccCCcCCCC-CCcccCCCCCCCeeeccCCcCCCCc
Q 005586          149 CNQLTGNIPAQIGSLKSLSVLTLQHNRLNGG-IPDSLGNLGKLKRLDLSFNSLFGTI  204 (689)
Q Consensus       149 ~N~l~g~~p~~~~~l~~L~~L~l~~N~l~~~-~p~~~~~l~~L~~L~ls~N~l~g~~  204 (689)
                      .|.+..  -..+..|-+|..||+++|++... --..+|+|+-|++|.|.+|.+.+.+
T Consensus       361 ~N~iE~--LSGL~KLYSLvnLDl~~N~Ie~ldeV~~IG~LPCLE~l~L~~NPl~~~v  415 (490)
T KOG1259|consen  361 QNKIET--LSGLRKLYSLVNLDLSSNQIEELDEVNHIGNLPCLETLRLTGNPLAGSV  415 (490)
T ss_pred             hhhHhh--hhhhHhhhhheeccccccchhhHHHhcccccccHHHHHhhcCCCccccc
Confidence            999863  24578889999999999999732 1246899999999999999999553

>PF14580 LRR_9: Leucine-rich repeat; PDB: 2JE1_D 2JE0_A 2JQD_A

Probab=98.97  E-value=3.9e-10  Score=105.80  Aligned_cols=111  Identities=32%  Similarity=0.439  Sum_probs=44.2

Q ss_pred             ccCCCCCcEEEecccCCCCCCCcccc-CCccccEEeeecccCCCCCchhcCCCCCCCEEeccCCcCCCCCCccc-CCCCC
Q 005586          112 IRNLTELTDLYLDVNNLSGNIPPEIG-SMASLQVLQLCCNQLTGNIPAQIGSLKSLSVLTLQHNRLNGGIPDSL-GNLGK  189 (689)
Q Consensus       112 ~~~l~~L~~L~Ls~N~l~g~~p~~~~-~l~~L~~L~Ls~N~l~g~~p~~~~~l~~L~~L~l~~N~l~~~~p~~~-~~l~~  189 (689)
                      +.+..++++|+|++|.|+ .| +.++ .+.+|+.|+|++|+++. ++ .+..++.|+.|+|++|+++ .+++.+ ..+++
T Consensus        15 ~~n~~~~~~L~L~~n~I~-~I-e~L~~~l~~L~~L~Ls~N~I~~-l~-~l~~L~~L~~L~L~~N~I~-~i~~~l~~~lp~   89 (175)
T PF14580_consen   15 YNNPVKLRELNLRGNQIS-TI-ENLGATLDKLEVLDLSNNQITK-LE-GLPGLPRLKTLDLSNNRIS-SISEGLDKNLPN   89 (175)
T ss_dssp             -----------------------S--TT-TT--EEE-TTS--S---T-T----TT--EEE--SS----S-CHHHHHH-TT
T ss_pred             cccccccccccccccccc-cc-cchhhhhcCCCEEECCCCCCcc-cc-CccChhhhhhcccCCCCCC-ccccchHHhCCc
Confidence            456668999999999998 44 3566 58899999999999984 43 5888999999999999999 565555 46899


Q ss_pred             CCeeeccCCcCCCCc-hhhhhCCCCCcEEecccCcCCcc
Q 005586          190 LKRLDLSFNSLFGTI-PESLANNAELLFLDVQNNTLSGI  227 (689)
Q Consensus       190 L~~L~ls~N~l~g~~-p~~l~~~~~L~~l~l~~N~l~~~  227 (689)
                      |+.|+|++|++...- -..+..+++|+.|+|.+|+++..
T Consensus        90 L~~L~L~~N~I~~l~~l~~L~~l~~L~~L~L~~NPv~~~  128 (175)
T PF14580_consen   90 LQELYLSNNKISDLNELEPLSSLPKLRVLSLEGNPVCEK  128 (175)
T ss_dssp             --EEE-TTS---SCCCCGGGGG-TT--EEE-TT-GGGGS
T ss_pred             CCEEECcCCcCCChHHhHHHHcCCCcceeeccCCcccch
Confidence            999999999997431 24677899999999999998744

>COG3642 Mn2+-dependent serine/threonine protein kinase [Signal transduction mechanisms]

Probab=98.95  E-value=9.2e-09  Score=95.00  Aligned_cols=132  Identities=14%  Similarity=0.256  Sum_probs=94.1

Q ss_pred             cccccCCcceEEEEEecCCcEEEEEE-ecccCCch------HHHHHHHHHHHHhccCCCcceeEeeEEEcCCCCeEEEEE
Q 005586          415 NLLGKGNFSSVYKGTLRDGTLVAIRS-INVTSCKS------EEAEFVKGLYLLTSLRHENIIRLRGFCCSRGRGECFLIY  487 (689)
Q Consensus       415 ~~lg~G~~g~Vy~~~~~~g~~vavK~-l~~~~~~~------~~~~f~~e~~~l~~l~H~niv~l~g~~~~~~~~~~~lV~  487 (689)
                      ..+++|+-..+|.+.+.+. .+++|. +.+.-...      ....-.+|.+++.+++--.|-.-+=|.++  .+...++|
T Consensus         2 ~~i~~GAEa~i~~~~~~g~-~av~K~Ri~K~YR~p~LD~klrr~Rt~~Earil~~a~~~GV~~P~v~dvD--~~~~~I~m   78 (204)
T COG3642           2 DLIKQGAEAIIYLTDFLGL-PAVVKERIPKRYRHPELDEKLRRERTRREARILAKAREAGVPVPIVYDVD--PDNGLIVM   78 (204)
T ss_pred             chhhCCcceeEEeeeccCc-ceEEEeecCcccCChHHHHHHHHHHHHHHHHHHHHHHHcCCCCCeEEEEc--CCCCEEEE
Confidence            3688999999999987543 455554 33222111      12355678889888863333222223322  45678999


Q ss_pred             EcCCCCCHHHHhhhcCCCCCCCCHHHHHHHHHHHHHHHhhhhCCCCCCCceeecCCCCCceeecCCCCeEEeccccccc
Q 005586          488 DFAPKGKLSKYLDQEEGSSNVLDWSTRVSIIIGIAKGIGYLHSSEVNKPAIVHRNLSVEKVLIDQQFNPLIADCGLHKL  566 (689)
Q Consensus       488 e~~~~gsL~~~L~~~~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~~~ivH~dlk~~NiLl~~~~~~kl~DfGla~~  566 (689)
                      ||+++-.|.+.+...           +..++..|-+-+.-||..+     |+|+||.++||.+..+. +.+.||||+..
T Consensus        79 e~I~G~~lkd~l~~~-----------~~~~~r~vG~~vg~lH~~g-----ivHGDLTtsNiIl~~~~-i~~IDfGLg~~  140 (204)
T COG3642          79 EYIEGELLKDALEEA-----------RPDLLREVGRLVGKLHKAG-----IVHGDLTTSNIILSGGR-IYFIDFGLGEF  140 (204)
T ss_pred             EEeCChhHHHHHHhc-----------chHHHHHHHHHHHHHHhcC-----eecCCCccceEEEeCCc-EEEEECCcccc
Confidence            999999998888653           2456777888888999988     99999999999998875 99999999874

>KOG3087 consensus Serine/threonine protein kinase [General function prediction only]

Probab=98.94  E-value=1.2e-08  Score=93.74  Aligned_cols=143  Identities=20%  Similarity=0.277  Sum_probs=99.9

Q ss_pred             cccccccCCcceEEEEEecCCcEEEEEE-ecccCC------chHHHHHHHHHHHHhccCCCcceeEeeEEEcCCCCeEEE
Q 005586          413 EVNLLGKGNFSSVYKGTLRDGTLVAIRS-INVTSC------KSEEAEFVKGLYLLTSLRHENIIRLRGFCCSRGRGECFL  485 (689)
Q Consensus       413 ~~~~lg~G~~g~Vy~~~~~~g~~vavK~-l~~~~~------~~~~~~f~~e~~~l~~l~H~niv~l~g~~~~~~~~~~~l  485 (689)
                      ...+|-+|+-+.|+++.+. |+...||. +.+.-.      +-..+.-.+|++.|.+++--.|.--.-|+++...  -.+
T Consensus        11 ~l~likQGAEArv~~~~~~-Ge~~iIK~Rf~K~YRHP~LD~kLtr~Rt~~Ear~l~k~~~~GI~~P~l~~~D~~~--~~i   87 (229)
T KOG3087|consen   11 SLELIKQGAEARVPRGSFS-GEAAIIKERFSKRYRHPALDQKLTRKRTKQEARLLAKCRALGIPAPRLIFIDTYG--GQI   87 (229)
T ss_pred             cceeeeccceeeEeeeccC-CceeEEeecccccccchHHHHHHHHHHHHHHHHHHHHHHHhCCCCceEEEEecCC--CeE
Confidence            3568999999999999987 66655554 332221      1123567789999998864444443334444433  358


Q ss_pred             EEEcCCC-CCHHHHhhhcCCCCCCCCHHHHHHHHHHHHHHHhhhhCCCCCCCceeecCCCCCceeecCCCC---eEEecc
Q 005586          486 IYDFAPK-GKLSKYLDQEEGSSNVLDWSTRVSIIIGIAKGIGYLHSSEVNKPAIVHRNLSVEKVLIDQQFN---PLIADC  561 (689)
Q Consensus       486 V~e~~~~-gsL~~~L~~~~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~~~ivH~dlk~~NiLl~~~~~---~kl~Df  561 (689)
                      +|||+++ .++.+++...... +..+ ......+..|-+-+.-||..+     |+|+||.++||+|..++.   +-+.||
T Consensus        88 ~ME~~~g~~~vk~~i~~~~~~-~~~d-~~~~~~~~~iG~~igklH~nd-----iiHGDLTTSNill~~~~~~~~~~lIdf  160 (229)
T KOG3087|consen   88 YMEFIDGASTVKDFILSTMED-ESED-EGLAELARRIGELIGKLHDND-----IIHGDLTTSNILLRSDGNQITPILIDF  160 (229)
T ss_pred             EEEeccchhHHHHHHHHHccC-cccc-hhHHHHHHHHHHHHHHhhhCC-----eecccccccceEEecCCCcCceEEEee
Confidence            9999976 4888888764321 1112 222678888999999999988     999999999999976554   479999


Q ss_pred             cccc
Q 005586          562 GLHK  565 (689)
Q Consensus       562 Gla~  565 (689)
                      |++.
T Consensus       161 gls~  164 (229)
T KOG3087|consen  161 GLSS  164 (229)
T ss_pred             cchh
Confidence            9975

>KOG3741 consensus Poly(A) ribonuclease subunit [RNA processing and modification]

Probab=98.89  E-value=2.3e-08  Score=105.11  Aligned_cols=170  Identities=20%  Similarity=0.318  Sum_probs=125.9

Q ss_pred             ceEEEEEec-CCcEEEEEEecccCCchHHHHHHHHHHHHhccCCCcceeEeeEEE--cCCCCeEEEEEEcCCC-CCHHHH
Q 005586          423 SSVYKGTLR-DGTLVAIRSINVTSCKSEEAEFVKGLYLLTSLRHENIIRLRGFCC--SRGRGECFLIYDFAPK-GKLSKY  498 (689)
Q Consensus       423 g~Vy~~~~~-~g~~vavK~l~~~~~~~~~~~f~~e~~~l~~l~H~niv~l~g~~~--~~~~~~~~lV~e~~~~-gsL~~~  498 (689)
                      .+.||+... ||..|++||++..+.. .......-++..+++.|+|+|++..++.  .-+....++||+|.|+ ++|.+.
T Consensus       290 ~Ttyk~~s~~DG~~YvLkRlhg~r~~-~~nk~t~lve~wkkl~h~NvV~frevf~t~tF~D~SlvlvYDYyP~s~TL~d~  368 (655)
T KOG3741|consen  290 ITTYKATSNVDGNAYVLKRLHGDRDQ-STNKDTSLVEAWKKLCHTNVVPFREVFLTYTFGDLSLVLVYDYYPSSPTLYDL  368 (655)
T ss_pred             ceeEeeeeccCCceeeeeeecccccc-CcccchHHHHHHHHhccCceeehhhhhhhhccCcceEEEEEecCCCCchHHHH
Confidence            578999865 8999999999544321 1112334567889999999999988764  1233568899999997 577665


Q ss_pred             hhhcCC-----------CCCCCCHHHHHHHHHHHHHHHhhhhCCCCCCCceeecCCCCCceeecCCCCeEEecccccccc
Q 005586          499 LDQEEG-----------SSNVLDWSTRVSIIIGIAKGIGYLHSSEVNKPAIVHRNLSVEKVLIDQQFNPLIADCGLHKLL  567 (689)
Q Consensus       499 L~~~~~-----------~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~~~ivH~dlk~~NiLl~~~~~~kl~DfGla~~~  567 (689)
                      -.....           .+...++...|.++.|++.||.++|+.|     +.-+-|.+++|+++.+.+++|+.+|..-.+
T Consensus       369 ~F~~~~~t~~~n~~~~~~~~~~~e~~lW~y~~QLtaaL~sIHssG-----LAck~L~~~kIlv~G~~RIriS~C~i~Dvl  443 (655)
T KOG3741|consen  369 YFANPPFTKRTNSFYPSQNLKAPEEVLWSYISQLTAALYSIHSSG-----LACKTLDLKKILVTGKMRIRISGCGIMDVL  443 (655)
T ss_pred             HccCCccccccccccccCCCCchHHHHHHHHHHHHHHHHHHHhcC-----ceeecccHhHeEeeCcceEEEecccceeee
Confidence            432211           1234678889999999999999999988     788999999999999999999999987655


Q ss_pred             cCCceeeeecCCCCCCCCCccccccCCCCCcccchhHHHHHHHHHhCCC
Q 005586          568 ADDIVFSVLKTSAAMGYLAPEYVTTGRFTERSDIFAFGVIILQILTGSL  616 (689)
Q Consensus       568 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~ksDV~sfGvvl~elltG~~  616 (689)
                      ..+..               |-+.+   -.+-|.=.||.+++-|.||..
T Consensus       444 ~~d~~---------------~~le~---~Qq~D~~~lG~ll~aLAt~~~  474 (655)
T KOG3741|consen  444 QEDPT---------------EPLES---QQQNDLRDLGLLLLALATGTE  474 (655)
T ss_pred             cCCCC---------------cchhH---HhhhhHHHHHHHHHHHhhccc
Confidence            44320               11111   246788899999999999954

>PF13855 LRR_8: Leucine rich repeat; PDB: 2O6S_A 3A79_B 3RFS_A 3G39_A 3VQ2_A 3VQ1_B 2Z64_A 2Z66_C 3FXI_A 2Z63_A

Probab=98.89  E-value=1.2e-09  Score=84.29  Aligned_cols=60  Identities=33%  Similarity=0.426  Sum_probs=35.0

Q ss_pred             CCCEEEccCCcccccCCccccCCCCCcEEEecccCCCCCCCccccCCccccEEeeecccC
Q 005586           93 CLSGLYLHYNSLSGEIPKEIRNLTELTDLYLDVNNLSGNIPPEIGSMASLQVLQLCCNQL  152 (689)
Q Consensus        93 ~L~~L~L~~N~l~g~~p~~~~~l~~L~~L~Ls~N~l~g~~p~~~~~l~~L~~L~Ls~N~l  152 (689)
                      +|++|+|++|+|+...+..|.++++|++|+|++|+++...|..|.++++|++|++++|+|
T Consensus         2 ~L~~L~l~~n~l~~i~~~~f~~l~~L~~L~l~~N~l~~i~~~~f~~l~~L~~L~l~~N~l   61 (61)
T PF13855_consen    2 NLESLDLSNNKLTEIPPDSFSNLPNLETLDLSNNNLTSIPPDAFSNLPNLRYLDLSNNNL   61 (61)
T ss_dssp             TESEEEETSSTESEECTTTTTTGTTESEEEETSSSESEEETTTTTTSTTESEEEETSSSB
T ss_pred             cCcEEECCCCCCCccCHHHHcCCCCCCEeEccCCccCccCHHHHcCCCCCCEEeCcCCcC
Confidence            456666666666644445556666666666666666544445555566666666655543

...

>PF13855 LRR_8: Leucine rich repeat; PDB: 2O6S_A 3A79_B 3RFS_A 3G39_A 3VQ2_A 3VQ1_B 2Z64_A 2Z66_C 3FXI_A 2Z63_A

Probab=98.82  E-value=2.3e-09  Score=82.66  Aligned_cols=61  Identities=31%  Similarity=0.433  Sum_probs=34.9

Q ss_pred             CCCcEEEecccCCCCCCCccccCCccccEEeeecccCCCCCchhcCCCCCCCEEeccCCcC
Q 005586          116 TELTDLYLDVNNLSGNIPPEIGSMASLQVLQLCCNQLTGNIPAQIGSLKSLSVLTLQHNRL  176 (689)
Q Consensus       116 ~~L~~L~Ls~N~l~g~~p~~~~~l~~L~~L~Ls~N~l~g~~p~~~~~l~~L~~L~l~~N~l  176 (689)
                      ++|++|+|++|+|+...+..|.++++|++|++++|+++...|..|.++++|++|++++|+|
T Consensus         1 p~L~~L~l~~n~l~~i~~~~f~~l~~L~~L~l~~N~l~~i~~~~f~~l~~L~~L~l~~N~l   61 (61)
T PF13855_consen    1 PNLESLDLSNNKLTEIPPDSFSNLPNLETLDLSNNNLTSIPPDAFSNLPNLRYLDLSNNNL   61 (61)
T ss_dssp             TTESEEEETSSTESEECTTTTTTGTTESEEEETSSSESEEETTTTTTSTTESEEEETSSSB
T ss_pred             CcCcEEECCCCCCCccCHHHHcCCCCCCEeEccCCccCccCHHHHcCCCCCCEEeCcCCcC
Confidence            3456666666666644344555566666666666666555555555566666666655543

...

>KOG0606 consensus Microtubule-associated serine/threonine kinase and related proteins [Signal transduction mechanisms; General function prediction only]

Probab=98.82  E-value=1.2e-09  Score=123.06  Aligned_cols=247  Identities=19%  Similarity=0.199  Sum_probs=159.0

Q ss_pred             ccCCcccccccCCcceEEEEEec-CCcEEEEEEecccC--CchHHHHHHHHHHHHhccCCCcceeEeeEEEcCCCCeEEE
Q 005586          409 QCFSEVNLLGKGNFSSVYKGTLR-DGTLVAIRSINVTS--CKSEEAEFVKGLYLLTSLRHENIIRLRGFCCSRGRGECFL  485 (689)
Q Consensus       409 ~~f~~~~~lg~G~~g~Vy~~~~~-~g~~vavK~l~~~~--~~~~~~~f~~e~~~l~~l~H~niv~l~g~~~~~~~~~~~l  485 (689)
                      +.|...+-+.+|.++.++.+.-. .|...++|......  .+...+....+-.++-..+||-++...--+  ......++
T Consensus       804 d~~~i~~p~qS~sp~ss~p~~pa~sgh~~~~~v~~~ap~i~~~~~~s~r~~s~~~i~p~~P~v~~~~~s~--~~rsP~~L  881 (1205)
T KOG0606|consen  804 DGFEITKPSQSGSPSSSFPASPAGSGHTRPSKVHGLAPKIRTNDYESIRSKSNILITPRSPAVVRSFPSF--PCRSPLPL  881 (1205)
T ss_pred             ccceecccccCCCCcccccCCccccccccchhhhccchhhccccccccCCccCccccCCCCceecccCCC--CCCCCcch
Confidence            34555677889999999887643 34334444332211  011111122222222223445555432211  23467889


Q ss_pred             EEEcCCCCCHHHHhhhcCCCCCCCCHHHHHHHHHHHHHHHhhhhCCCCCCCceeecCCCCCceeecCCCCeEEecccccc
Q 005586          486 IYDFAPKGKLSKYLDQEEGSSNVLDWSTRVSIIIGIAKGIGYLHSSEVNKPAIVHRNLSVEKVLIDQQFNPLIADCGLHK  565 (689)
Q Consensus       486 V~e~~~~gsL~~~L~~~~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~~~ivH~dlk~~NiLl~~~~~~kl~DfGla~  565 (689)
                      |++|..+++|..-||....    .+..-.......+..+++|||...     +.|||++|.|.+...++..+++|||...
T Consensus       882 ~~~~~~~~~~~Skl~~~~~----~saepaRs~i~~~vqs~e~L~s~~-----r~h~~~~p~~~l~~~~gh~~l~~~~t~~  952 (1205)
T KOG0606|consen  882 VGHYLNGGDLPSKLHNSGC----LSAEPARSPILERVQSLESLHSSL-----RKHRDLKPDSLLIAYDGHRPLTDFGTLS  952 (1205)
T ss_pred             hhHHhccCCchhhhhcCCC----cccccccchhHHHHhhhhccccch-----hhcccccccchhhcccCCcccCcccccc
Confidence            9999999999999987653    222222334455677899999865     7999999999999999999999998433


Q ss_pred             cccC------C---------------c---------eeeeecCCCCCCCCCccccccCCCCCcccchhHHHHHHHHHhCC
Q 005586          566 LLAD------D---------------I---------VFSVLKTSAAMGYLAPEYVTTGRFTERSDIFAFGVIILQILTGS  615 (689)
Q Consensus       566 ~~~~------~---------------~---------~~~~~~~~~~~~y~aPE~~~~~~~~~ksDV~sfGvvl~elltG~  615 (689)
                      ....      .               .         ........+|..|.+||...+......+|+|+.|++++|.++|.
T Consensus       953 ~vg~~~p~~~~sg~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~t~~~laPe~~lg~~hgs~ad~~~~g~~l~e~l~g~ 1032 (1205)
T KOG0606|consen  953 KVGLIPPTTDLSGPSSSGTPRRLSRSERRPQLSADEARRKHAVVGTPDYLAPEILLGRRHGSAADWWSSGVCLFEVLTGI 1032 (1205)
T ss_pred             ccccccCcCCcccccccCccccccccccccccccchhhccccccCCCcccCCcccccccCCCcchhhhhhhhhhhhhcCC
Confidence            2110      0               0         00112245678899999999999999999999999999999999


Q ss_pred             CCcchhHHHHHhhhhhhHhhccccC-CCCCHHHHHHHHHHHHHhccCCCCCCCCHH
Q 005586          616 LVLTSSMRLAAESATFENFIDRNLK-GKFSESEAAKLGKMALVCTHEDPENRPTME  670 (689)
Q Consensus       616 ~p~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~l~~l~~~Cl~~dp~~RPs~~  670 (689)
                      .|+.......    .++.++..... ...+.+...+...+...-+..+|.+|-.|.
T Consensus      1033 pp~na~tpq~----~f~ni~~~~~~~p~g~~~~s~~aq~~~~~ll~~~~~qr~~a~ 1084 (1205)
T KOG0606|consen 1033 PPFNAETPQQ----IFENILNRDIPWPEGPEEGSYEAQDLINRLLTEEPTQRLGAK 1084 (1205)
T ss_pred             CCCCCcchhh----hhhccccCCCCCCCCccccChhhhhhhhhhhccCchhccCcc
Confidence            9997654322    23333333222 233455566677777777788888886665

>PRK15123 lipopolysaccharide core heptose(I) kinase RfaP; Provisional

Probab=98.82  E-value=8.1e-08  Score=97.30  Aligned_cols=144  Identities=13%  Similarity=0.084  Sum_probs=100.5

Q ss_pred             cccccCCcceEEEEEecCCcEEEEEEecccCCc----------hHHHHHHHHHHHHhccCCC--cceeEeeEEEcCC---
Q 005586          415 NLLGKGNFSSVYKGTLRDGTLVAIRSINVTSCK----------SEEAEFVKGLYLLTSLRHE--NIIRLRGFCCSRG---  479 (689)
Q Consensus       415 ~~lg~G~~g~Vy~~~~~~g~~vavK~l~~~~~~----------~~~~~f~~e~~~l~~l~H~--niv~l~g~~~~~~---  479 (689)
                      +.+-+-....|++..+ +|+.|.||+.....-.          .....+.+|.+.+.++...  ...++++|.....   
T Consensus        28 e~v~~~~~rrvvr~~~-~g~~~~vKr~~~~~~~~~~k~l~~~~~p~~~a~rE~~~l~~L~~~GIptP~pVa~~e~~~~~~  106 (268)
T PRK15123         28 EVFRELEGRRTLRFEL-AGKSYFLKWHRGTGWGEIFKNLLSLRMPVLGADREWRAIHRLHEVGVDTMTGVAFGERGSNPA  106 (268)
T ss_pred             cEEecCCCceEEEEEE-CCEEEEEEEecCCcHHHHhhhhcccccccHHHHHHHHHHHHHHHcCCCCCCeeEEEEecCCCc
Confidence            4455445556777766 5788999987433211          1112477888888887432  3334455543221   


Q ss_pred             CCeEEEEEEcCCCC-CHHHHhhhcCCCCCCCCHHHHHHHHHHHHHHHhhhhCCCCCCCceeecCCCCCceeecC------
Q 005586          480 RGECFLIYDFAPKG-KLSKYLDQEEGSSNVLDWSTRVSIIIGIAKGIGYLHSSEVNKPAIVHRNLSVEKVLIDQ------  552 (689)
Q Consensus       480 ~~~~~lV~e~~~~g-sL~~~L~~~~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~~~ivH~dlk~~NiLl~~------  552 (689)
                      ....++|+|++++. +|.+++.....  ...+...+..++.+++..+.-||..|     |+|+|++++|||++.      
T Consensus       107 ~~~s~LVte~l~~~~sL~~~~~~~~~--~~~~~~~~~~ll~~la~~i~~LH~~G-----i~HgDL~~~NiLl~~~~~~~~  179 (268)
T PRK15123        107 TRTSFIITEDLAPTISLEDYCADWAT--NPPDPRLKRMLIKRVATMVRDMHAAG-----INHRDCYICHFLLHLPFPGRE  179 (268)
T ss_pred             cceeEEEEeeCCCCccHHHHHHhhcc--cCCCHHHHHHHHHHHHHHHHHHHHCc-----CccCCCChhhEEEeccccCCC
Confidence            23578999999886 89999854221  22455677789999999999999998     999999999999985      


Q ss_pred             -CCCeEEeccccccc
Q 005586          553 -QFNPLIADCGLHKL  566 (689)
Q Consensus       553 -~~~~kl~DfGla~~  566 (689)
                       ++.+.++||+.++.
T Consensus       180 ~~~~~~LIDl~r~~~  194 (268)
T PRK15123        180 EDLKLSVIDLHRAQI  194 (268)
T ss_pred             CCceEEEEECCcccc
Confidence             46789999998753

>PF01163 RIO1: RIO1 family; InterPro: IPR018934 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases

Probab=98.75  E-value=5.7e-08  Score=92.76  Aligned_cols=126  Identities=21%  Similarity=0.204  Sum_probs=81.3

Q ss_pred             eEEEEEecCCcEEEEEEecccCC-------------------------chHHHHHHHHHHHHhccCCC--cceeEeeEEE
Q 005586          424 SVYKGTLRDGTLVAIRSINVTSC-------------------------KSEEAEFVKGLYLLTSLRHE--NIIRLRGFCC  476 (689)
Q Consensus       424 ~Vy~~~~~~g~~vavK~l~~~~~-------------------------~~~~~~f~~e~~~l~~l~H~--niv~l~g~~~  476 (689)
                      .||.|...+|..+|+|..+....                         ........+|.+.|.++..-  ++.+++.+. 
T Consensus         1 ~Vy~~~~~~~~~~a~K~~r~~~~~Fk~~~~y~~~~~r~~~~~~~~~~~~~~~~~~~~E~~~L~~l~~~Gv~vP~p~~~~-   79 (188)
T PF01163_consen    1 DVYHAIDPDGEEVAVKIYRTGRTSFKRRKKYRDYDYRFKKYRHKSSWRYLIREWAKKEFRNLKRLYEAGVPVPKPYDYN-   79 (188)
T ss_dssp             EEEEEEECTTEEEEEEEE-S---SS-HHHHHTTTSTTSTTC--G--CHHHHHHHHHHHHHHHHHCCCTT-SS--EEEEE-
T ss_pred             CEEEEECCCCCEEEEEEeccCceEEEEeeeeecccchhcccccccCHHHHHHHHHHHHHHHHHHHHHCCccCCcEEEEe-
Confidence            38999999999999999864210                         00123567899999999765  456666543 


Q ss_pred             cCCCCeEEEEEEcCC--CCCHHHHhhhcCCCCCCCCHHHHHHHHHHHHHHHhh-hhCCCCCCCceeecCCCCCceeecCC
Q 005586          477 SRGRGECFLIYDFAP--KGKLSKYLDQEEGSSNVLDWSTRVSIIIGIAKGIGY-LHSSEVNKPAIVHRNLSVEKVLIDQQ  553 (689)
Q Consensus       477 ~~~~~~~~lV~e~~~--~gsL~~~L~~~~~~~~~l~~~~~~~ia~~ia~gL~y-LH~~~~~~~~ivH~dlk~~NiLl~~~  553 (689)
                           .-++||||++  +..+..+....      ++......+..+++..+.. +|..+     |+|+|+.+.||+++++
T Consensus        80 -----~~~ivME~I~~~G~~~~~l~~~~------~~~~~~~~~~~~il~~~~~~~~~~g-----ivHGDLs~~NIlv~~~  143 (188)
T PF01163_consen   80 -----RNVIVMEYIGEDGVPLPRLKDVD------LSPEEPKELLEEILEEIIKMLHKAG-----IVHGDLSEYNILVDDG  143 (188)
T ss_dssp             -----TTEEEEE--EETTEEGGCHHHCG------GGGSTHHHHHHHHHHHHHHHHHCTT-----EEESS-STTSEEEETT
T ss_pred             -----CCEEEEEecCCCccchhhHHhcc------ccchhHHHHHHHHHHHHHHHHHhcC-----ceecCCChhhEEeecc
Confidence                 2369999998  44444332221      1123345677777776666 46777     9999999999999988


Q ss_pred             CCeEEecccccccc
Q 005586          554 FNPLIADCGLHKLL  567 (689)
Q Consensus       554 ~~~kl~DfGla~~~  567 (689)
                       .+.|+|||.+...
T Consensus       144 -~~~iIDf~qav~~  156 (188)
T PF01163_consen  144 -KVYIIDFGQAVDS  156 (188)
T ss_dssp             -CEEE--GTTEEET
T ss_pred             -eEEEEecCcceec
Confidence             9999999987644

Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. This entry represents RIO kinase, they exhibit little sequence similarity with eukaryotic protein kinases, and are classified as atypical protein kinases []. The conformation of ATP when bound to the RIO kinases is unique when compared with ePKs, such as serine/threonine kinases or the insulin receptor tyrosine kinase, suggesting that the detailed mechanism by which the catalytic aspartate of RIO kinases participates in phosphoryl transfer may not be identical to that employed in known serine/threonine ePKs. Representatives of the RIO family are present in organisms varying from Archaea to humans, although the RIO3 proteins have only been identified in multicellular eukaryotes, to date. Yeast Rio1 and Rio2 proteins are required for proper cell cycle progression and chromosome maintenance, and are necessary for survival of the cells. These proteins are involved in the processing of 20 S pre-rRNA via late 18 S rRNA processing. ; GO: 0003824 catalytic activity, 0005524 ATP binding; PDB: 1TQP_A 1ZAR_A 1TQI_A 1ZAO_A 1TQM_A 3RE4_A 1ZTH_B 1ZP9_A 1ZTF_A.

>KOG4579 consensus Leucine-rich repeat (LRR) protein associated with apoptosis in muscle tissue [General function prediction only]

Probab=98.66  E-value=1.1e-09  Score=95.12  Aligned_cols=82  Identities=28%  Similarity=0.440  Sum_probs=45.5

Q ss_pred             CCcEEEecccCCCCCCCccccC-CccccEEeeecccCCCCCchhcCCCCCCCEEeccCCcCCCCCCcccCCCCCCCeeec
Q 005586          117 ELTDLYLDVNNLSGNIPPEIGS-MASLQVLQLCCNQLTGNIPAQIGSLKSLSVLTLQHNRLNGGIPDSLGNLGKLKRLDL  195 (689)
Q Consensus       117 ~L~~L~Ls~N~l~g~~p~~~~~-l~~L~~L~Ls~N~l~g~~p~~~~~l~~L~~L~l~~N~l~~~~p~~~~~l~~L~~L~l  195 (689)
                      .|+..+|++|.|. .+|+.|.. .+.++.|+|++|+++ .+|.+++.++.|+.|+++.|.|. ..|..+..|.+|-.|+.
T Consensus        54 el~~i~ls~N~fk-~fp~kft~kf~t~t~lNl~~neis-dvPeE~Aam~aLr~lNl~~N~l~-~~p~vi~~L~~l~~Lds  130 (177)
T KOG4579|consen   54 ELTKISLSDNGFK-KFPKKFTIKFPTATTLNLANNEIS-DVPEELAAMPALRSLNLRFNPLN-AEPRVIAPLIKLDMLDS  130 (177)
T ss_pred             eEEEEecccchhh-hCCHHHhhccchhhhhhcchhhhh-hchHHHhhhHHhhhcccccCccc-cchHHHHHHHhHHHhcC
Confidence            3444456666655 34444432 335556666666665 55555666666666666666665 45555555556666666


Q ss_pred             cCCcCC
Q 005586          196 SFNSLF  201 (689)
Q Consensus       196 s~N~l~  201 (689)
                      .+|.+.
T Consensus       131 ~~na~~  136 (177)
T KOG4579|consen  131 PENARA  136 (177)
T ss_pred             CCCccc
Confidence            666555

>KOG3207 consensus Beta-tubulin folding cofactor E [Posttranslational modification, protein turnover, chaperones]

Probab=98.63  E-value=3.8e-09  Score=108.40  Aligned_cols=156  Identities=25%  Similarity=0.203  Sum_probs=75.4

Q ss_pred             CEEEEEcCCCCcccccC--cCcCCCCCCCEEEccCCcccccCC--ccccCCCCCcEEEecccCCCCCCCccc-cCCcccc
Q 005586           69 KVANISLQGKGLTGKLS--PSLSGLKCLSGLYLHYNSLSGEIP--KEIRNLTELTDLYLDVNNLSGNIPPEI-GSMASLQ  143 (689)
Q Consensus        69 ~v~~l~L~~~~l~g~~~--~~~~~l~~L~~L~L~~N~l~g~~p--~~~~~l~~L~~L~Ls~N~l~g~~p~~~-~~l~~L~  143 (689)
                      .++.+.|.+.... ..+  .....|++++.||||.|-|....|  .-...|++|+.|+|+.|+|.-..-... ..++.|+
T Consensus       122 kL~~IsLdn~~V~-~~~~~~~~k~~~~v~~LdLS~NL~~nw~~v~~i~eqLp~Le~LNls~Nrl~~~~~s~~~~~l~~lK  200 (505)
T KOG3207|consen  122 KLREISLDNYRVE-DAGIEEYSKILPNVRDLDLSRNLFHNWFPVLKIAEQLPSLENLNLSSNRLSNFISSNTTLLLSHLK  200 (505)
T ss_pred             hhhheeecCcccc-ccchhhhhhhCCcceeecchhhhHHhHHHHHHHHHhcccchhcccccccccCCccccchhhhhhhh
Confidence            4455555544432 111  234456667777777776664433  234566777777777777653332221 2345566


Q ss_pred             EEeeecccCCC-CCchhcCCCCCCCEEeccCCcCCCCCCcccCCCCCCCeeeccCCcCCCCc-hhhhhCCCCCcEEeccc
Q 005586          144 VLQLCCNQLTG-NIPAQIGSLKSLSVLTLQHNRLNGGIPDSLGNLGKLKRLDLSFNSLFGTI-PESLANNAELLFLDVQN  221 (689)
Q Consensus       144 ~L~Ls~N~l~g-~~p~~~~~l~~L~~L~l~~N~l~~~~p~~~~~l~~L~~L~ls~N~l~g~~-p~~l~~~~~L~~l~l~~  221 (689)
                      .|.|+.+.|+- .+-..+..+++|+.|+|..|...+.--.....+..|+.|||++|++-... -...+.++.|..|++++
T Consensus       201 ~L~l~~CGls~k~V~~~~~~fPsl~~L~L~~N~~~~~~~~~~~i~~~L~~LdLs~N~li~~~~~~~~~~l~~L~~Lnls~  280 (505)
T KOG3207|consen  201 QLVLNSCGLSWKDVQWILLTFPSLEVLYLEANEIILIKATSTKILQTLQELDLSNNNLIDFDQGYKVGTLPGLNQLNLSS  280 (505)
T ss_pred             eEEeccCCCCHHHHHHHHHhCCcHHHhhhhcccccceecchhhhhhHHhhccccCCcccccccccccccccchhhhhccc
Confidence            66666665551 11112334455555555555322222223333445555555555554221 02234445555555555


Q ss_pred             CcCC
Q 005586          222 NTLS  225 (689)
Q Consensus       222 N~l~  225 (689)
                      +.++
T Consensus       281 tgi~  284 (505)
T KOG3207|consen  281 TGIA  284 (505)
T ss_pred             cCcc
Confidence            5444

>PF08263 LRRNT_2: Leucine rich repeat N-terminal domain; InterPro: IPR013210 Leucine-rich repeats (LRR) consist of 2-45 motifs of 20-30 amino acids in length that generally folds into an arc or horseshoe shape []

Probab=98.62  E-value=4.3e-08  Score=69.30  Aligned_cols=39  Identities=41%  Similarity=0.899  Sum_probs=29.9

Q ss_pred             hHHHHHHHHHHHccC-CCCCccCCCCCC--CCCCCCCcceEEcC
Q 005586           25 NTELRALLDLKASLD-PENKLLQSWTEN--GDPCSGSFEGIACN   65 (689)
Q Consensus        25 ~~~~~all~~k~~~~-~~~~~~~~W~~~--~~~C~~~w~gv~C~   65 (689)
                      ++|++||++||+++. ++...+.+|+.+  .+||  +|.||+|+
T Consensus         2 ~~d~~aLl~~k~~l~~~~~~~l~~W~~~~~~~~C--~W~GV~Cd   43 (43)
T PF08263_consen    2 NQDRQALLAFKKSLNNDPSGVLSSWNPSSDSDPC--SWSGVTCD   43 (43)
T ss_dssp             HHHHHHHHHHHHCTT-SC-CCCTT--TT--S-CC--CSTTEEE-
T ss_pred             cHHHHHHHHHHHhcccccCcccccCCCcCCCCCe--eeccEEeC
Confidence            679999999999997 455678999986  7899  69999995

LRRs occur in proteins ranging from viruses to eukaryotes, and appear to provide a structural framework for the formation of protein-protein interactions [, ].Proteins containing LRRs include tyrosine kinase receptors, cell-adhesion molecules, virulence factors, and extracellular matrix-binding glycoproteins, and are involved in a variety of biological processes, including signal transduction, cell adhesion, DNA repair, recombination, transcription, RNA processing, disease resistance, apoptosis, and the immune response []. Sequence analyses of LRR proteins suggested the existence of several different subfamilies of LRRs. The significance of this classification is that repeats from different subfamilies never occur simultaneously and have most probably evolved independently. It is, however, now clear that all major classes of LRR have curved horseshoe structures with a parallel beta sheet on the concave side and mostly helical elements on the convex side. At least six families of LRR proteins, characterised by different lengths and consensus sequences of the repeats, have been identified. Eleven-residue segments of the LRRs (LxxLxLxxN/CxL), corresponding to the beta-strand and adjacent loop regions, are conserved in LRR proteins, whereas the remaining parts of the repeats (herein termed variable) may be very different. Despite the differences, each of the variable parts contains two half-turns at both ends and a "linear" segment (as the chain follows a linear path overall), usually formed by a helix, in the middle. The concave face and the adjacent loops are the most common protein interaction surfaces on LRR proteins. 3D structure of some LRR proteins-ligand complexes show that the concave surface of LRR domain is ideal for interaction with alpha-helix, thus supporting earlier conclusions that the elongated and curved LRR structure provides an outstanding framework for achieving diverse protein-protein interactions []. Molecular modeling suggests that the conserved pattern LxxLxL, which is shorter than the previously proposed LxxLxLxxN/CxL is sufficient to impart the characteristic horseshoe curvature to proteins with 20- to 30-residue repeats []. This domain is often found at the N terminus of tandem leucine rich repeats.; PDB: 3RGZ_A 3RJ0_A 3RIZ_A 3RGX_A 1OGQ_A.

>KOG2137 consensus Protein kinase [Signal transduction mechanisms]

Probab=98.60  E-value=1.1e-08  Score=111.48  Aligned_cols=154  Identities=21%  Similarity=0.295  Sum_probs=104.4

Q ss_pred             HHHHHHHhhhhCCCCCCCceeecCCCCCceeecCCCCeEEecccccccccCCceeeeec--------CCCCCCCCCcccc
Q 005586          519 IGIAKGIGYLHSSEVNKPAIVHRNLSVEKVLIDQQFNPLIADCGLHKLLADDIVFSVLK--------TSAAMGYLAPEYV  590 (689)
Q Consensus       519 ~~ia~gL~yLH~~~~~~~~ivH~dlk~~NiLl~~~~~~kl~DfGla~~~~~~~~~~~~~--------~~~~~~y~aPE~~  590 (689)
                      .+++.||.|+|..    +.+||++|.|++|.+++.+..||+.|+.+........+....        ......|.|||++
T Consensus       106 ~~v~dgl~flh~s----Ak~VH~ni~p~~i~~na~~~wkl~Gf~f~v~~~~~~~~p~~~yd~~lp~~~~~~~~f~apE~~  181 (700)
T KOG2137|consen  106 GNVADGLAFLHRS----AKVVHGNIQPEAIVVNANGDWKLAGFSFCVNANGPTEYPFSEYDPPLPLLLQPHLNFLAPEYL  181 (700)
T ss_pred             hcccchhhhhccC----cceeecccchhheeeccCcceeeccchhhhccCCCCccccccCCCCCChhhccCcccccchhh
Confidence            3455999999963    569999999999999999999999999876544322111110        1122459999999


Q ss_pred             ccCCCCCcccchhHHHHHHHHHhCCCCcchhHHHHHhhhhhhHhhccccCCCCCHHHHHHHHHHHHHhccCCCCCCCCHH
Q 005586          591 TTGRFTERSDIFAFGVIILQILTGSLVLTSSMRLAAESATFENFIDRNLKGKFSESEAAKLGKMALVCTHEDPENRPTME  670 (689)
Q Consensus       591 ~~~~~~~ksDV~sfGvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~Cl~~dp~~RPs~~  670 (689)
                      .....+.++|+||+||++|-+..|+.+.-....... ...+....+..-...+....+.++.+-+.+.+..++.-||++.
T Consensus       182 ~~~~~~~~sd~fSlG~li~~i~~~gk~i~~a~~~~~-~~~~~~~~~~~~~~~~s~~~p~el~~~l~k~l~~~~~~rp~~~  260 (700)
T KOG2137|consen  182 LGTTNTPASDVFSLGVLIYTIYNGGKSIIAANGGLL-SYSFSRNLLNAGAFGYSNNLPSELRESLKKLLNGDSAVRPTLD  260 (700)
T ss_pred             ccccccccccceeeeeEEEEEecCCcchhhccCCcc-hhhhhhcccccccccccccCcHHHHHHHHHHhcCCcccCcchh
Confidence            998889999999999999999955444321111000 0111111111112233445567888888899999999999988


Q ss_pred             HHHHHHH
Q 005586          671 AVIEELT  677 (689)
Q Consensus       671 evl~~L~  677 (689)
                      ++.....
T Consensus       261 ~l~~~~f  267 (700)
T KOG2137|consen  261 LLLSIPF  267 (700)
T ss_pred             hhhcccc
Confidence            8865443

>KOG4579 consensus Leucine-rich repeat (LRR) protein associated with apoptosis in muscle tissue [General function prediction only]

Probab=98.54  E-value=1.6e-09  Score=94.02  Aligned_cols=137  Identities=24%  Similarity=0.298  Sum_probs=97.0

Q ss_pred             cCCCCCEEEEEcCCCCcccccCcC---cCCCCCCCEEEccCCcccccCCcccc-CCCCCcEEEecccCCCCCCCccccCC
Q 005586           64 CNEHRKVANISLQGKGLTGKLSPS---LSGLKCLSGLYLHYNSLSGEIPKEIR-NLTELTDLYLDVNNLSGNIPPEIGSM  139 (689)
Q Consensus        64 C~~~~~v~~l~L~~~~l~g~~~~~---~~~l~~L~~L~L~~N~l~g~~p~~~~-~l~~L~~L~Ls~N~l~g~~p~~~~~l  139 (689)
                      |++......++|+++.|- .++..   +.....|+..+|++|.|. .+|+.|. ..+.++.|+|++|.|+ .+|.++..+
T Consensus        23 cedakE~h~ldLssc~lm-~i~davy~l~~~~el~~i~ls~N~fk-~fp~kft~kf~t~t~lNl~~neis-dvPeE~Aam   99 (177)
T KOG4579|consen   23 CEDAKELHFLDLSSCQLM-YIADAVYMLSKGYELTKISLSDNGFK-KFPKKFTIKFPTATTLNLANNEIS-DVPEELAAM   99 (177)
T ss_pred             hHHHHHhhhcccccchhh-HHHHHHHHHhCCceEEEEecccchhh-hCCHHHhhccchhhhhhcchhhhh-hchHHHhhh
Confidence            555555666777777764 45554   344556667799999998 5555554 4468899999999998 889999999


Q ss_pred             ccccEEeeecccCCCCCchhcCCCCCCCEEeccCCcCCCCCCcccCCCCCCCeeeccCCcCCCCch
Q 005586          140 ASLQVLQLCCNQLTGNIPAQIGSLKSLSVLTLQHNRLNGGIPDSLGNLGKLKRLDLSFNSLFGTIP  205 (689)
Q Consensus       140 ~~L~~L~Ls~N~l~g~~p~~~~~l~~L~~L~l~~N~l~~~~p~~~~~l~~L~~L~ls~N~l~g~~p  205 (689)
                      +.|+.|+++.|.|. ..|..+..|.+|-.|+..+|.+. .||-.+-.-..+-..++.+|.+.+.-+
T Consensus       100 ~aLr~lNl~~N~l~-~~p~vi~~L~~l~~Lds~~na~~-eid~dl~~s~~~al~~lgnepl~~~~~  163 (177)
T KOG4579|consen  100 PALRSLNLRFNPLN-AEPRVIAPLIKLDMLDSPENARA-EIDVDLFYSSLPALIKLGNEPLGDETK  163 (177)
T ss_pred             HHhhhcccccCccc-cchHHHHHHHhHHHhcCCCCccc-cCcHHHhccccHHHHHhcCCcccccCc
Confidence            99999999999998 67777777999999999999887 666553222222233445555554444

>KOG1859 consensus Leucine-rich repeat proteins [General function prediction only]

Probab=98.48  E-value=1e-08  Score=111.13  Aligned_cols=126  Identities=26%  Similarity=0.293  Sum_probs=78.3

Q ss_pred             CCcEEEecccCCCCCCCccccCCccccEEeeecccCCCCCchhcCCCCCCCEEeccCCcCCCCCCcc-cCCCCCCCeeec
Q 005586          117 ELTDLYLDVNNLSGNIPPEIGSMASLQVLQLCCNQLTGNIPAQIGSLKSLSVLTLQHNRLNGGIPDS-LGNLGKLKRLDL  195 (689)
Q Consensus       117 ~L~~L~Ls~N~l~g~~p~~~~~l~~L~~L~Ls~N~l~g~~p~~~~~l~~L~~L~l~~N~l~~~~p~~-~~~l~~L~~L~l  195 (689)
                      .|...+.++|+|. ....++.-++.|+.|||++|+++..-  .+..|+.|++|||++|.|. .+|.. ...+ .|+.|++
T Consensus       165 ~L~~a~fsyN~L~-~mD~SLqll~ale~LnLshNk~~~v~--~Lr~l~~LkhLDlsyN~L~-~vp~l~~~gc-~L~~L~l  239 (1096)
T KOG1859|consen  165 KLATASFSYNRLV-LMDESLQLLPALESLNLSHNKFTKVD--NLRRLPKLKHLDLSYNCLR-HVPQLSMVGC-KLQLLNL  239 (1096)
T ss_pred             hHhhhhcchhhHH-hHHHHHHHHHHhhhhccchhhhhhhH--HHHhcccccccccccchhc-cccccchhhh-hheeeee
Confidence            4666677777776 56666666777777777777776442  6677777777777777777 45542 2223 3777777


Q ss_pred             cCCcCCCCchhhhhCCCCCcEEecccCcCCcccchh-HHhccC--ccccccCCCCCC
Q 005586          196 SFNSLFGTIPESLANNAELLFLDVQNNTLSGIVPSA-LKRLNG--GFQFQNNPGLCG  249 (689)
Q Consensus       196 s~N~l~g~~p~~l~~~~~L~~l~l~~N~l~~~~p~~-~~~~~~--~~~~~~n~~~c~  249 (689)
                      ++|.++..  ..+.++.+|+.|||+.|-|++----. +..+..  .+.+.|||-.|.
T Consensus       240 rnN~l~tL--~gie~LksL~~LDlsyNll~~hseL~pLwsLs~L~~L~LeGNPl~c~  294 (1096)
T KOG1859|consen  240 RNNALTTL--RGIENLKSLYGLDLSYNLLSEHSELEPLWSLSSLIVLWLEGNPLCCA  294 (1096)
T ss_pred             cccHHHhh--hhHHhhhhhhccchhHhhhhcchhhhHHHHHHHHHHHhhcCCccccC
Confidence            77777632  24566777777777777776543211 111111  345677776665

>PF06293 Kdo: Lipopolysaccharide kinase (Kdo/WaaP) family; InterPro: IPR010440 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases

Probab=98.47  E-value=1.2e-06  Score=85.91  Aligned_cols=107  Identities=23%  Similarity=0.249  Sum_probs=81.3

Q ss_pred             HHHHHHHHHHhccC--CCcceeEeeEEEcCCC--CeEEEEEEcCCCC-CHHHHhhhcCCCCCCCCHHHHHHHHHHHHHHH
Q 005586          451 AEFVKGLYLLTSLR--HENIIRLRGFCCSRGR--GECFLIYDFAPKG-KLSKYLDQEEGSSNVLDWSTRVSIIIGIAKGI  525 (689)
Q Consensus       451 ~~f~~e~~~l~~l~--H~niv~l~g~~~~~~~--~~~~lV~e~~~~g-sL~~~L~~~~~~~~~l~~~~~~~ia~~ia~gL  525 (689)
                      ..+.+|...+.++.  .-...+.+++......  ...++|+|++++. +|.+++.....    .+...+..++.++++.+
T Consensus        56 ~ra~~E~~~~~~L~~~Gi~tP~pva~~~~r~~~~~~s~lite~l~~~~~L~~~~~~~~~----~~~~~~~~ll~~l~~~i  131 (206)
T PF06293_consen   56 SRAKREWRNLQRLREAGIPTPEPVAYGERRKGGGYRSYLITEALPGAQDLRDLLQQWEQ----LDPSQRRELLRALARLI  131 (206)
T ss_pred             hHHHHHHHHHHHHHHcCCCCCcEEEEEEEcCCCceeEEEEEEeCCCcccHHHHHHhhcc----cchhhHHHHHHHHHHHH
Confidence            45677777777764  3334455555543221  3458999999984 89999876332    45566788999999999


Q ss_pred             hhhhCCCCCCCceeecCCCCCceeecCCC---CeEEeccccccc
Q 005586          526 GYLHSSEVNKPAIVHRNLSVEKVLIDQQF---NPLIADCGLHKL  566 (689)
Q Consensus       526 ~yLH~~~~~~~~ivH~dlk~~NiLl~~~~---~~kl~DfGla~~  566 (689)
                      +-||..+     |+|+|+++.|||++.+.   .+.++||+-++.
T Consensus       132 ~~lH~~g-----i~H~Dl~~~NILv~~~~~~~~~~lIDld~~~~  170 (206)
T PF06293_consen  132 AKLHDAG-----IYHGDLNPSNILVDPDDGQYRFYLIDLDRMRF  170 (206)
T ss_pred             HHHHHCc-----CCCCCCCcccEEEeCCCCceeEEEEcchhcee
Confidence            9999998     99999999999999887   789999997664

Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. This entry represents lipopolysaccharide kinases which are related to protein kinases IPR000719 from INTERPRO. This family includes waaP (rfaP) gene product is required for the addition of phosphate to O-4 of the first heptose residue of the lipopolysaccharide (LPS) inner core region. It has previously been shown that WaaP is necessary for resistance to hydrophobic and polycationic antimicrobials in E. coli and that it is required for virulence in invasive strains of Salmonella enterica [].; GO: 0005524 ATP binding, 0016773 phosphotransferase activity, alcohol group as acceptor, 0009103 lipopolysaccharide biosynthetic process, 0016020 membrane

>KOG3207 consensus Beta-tubulin folding cofactor E [Posttranslational modification, protein turnover, chaperones]

Probab=98.46  E-value=4e-08  Score=101.09  Aligned_cols=157  Identities=24%  Similarity=0.272  Sum_probs=118.5

Q ss_pred             CCEEEEEcCCCCcccccC--cCcCCCCCCCEEEccCCcccccCCcc-ccCCCCCcEEEecccCCCCC-CCccccCCcccc
Q 005586           68 RKVANISLQGKGLTGKLS--PSLSGLKCLSGLYLHYNSLSGEIPKE-IRNLTELTDLYLDVNNLSGN-IPPEIGSMASLQ  143 (689)
Q Consensus        68 ~~v~~l~L~~~~l~g~~~--~~~~~l~~L~~L~L~~N~l~g~~p~~-~~~l~~L~~L~Ls~N~l~g~-~p~~~~~l~~L~  143 (689)
                      .+|+.|||+.|-+...-+  .-...|++|+.|+|+.|+|.-..... -..++.|+.|.|+.+.|+-. +-..+..+|+|.
T Consensus       146 ~~v~~LdLS~NL~~nw~~v~~i~eqLp~Le~LNls~Nrl~~~~~s~~~~~l~~lK~L~l~~CGls~k~V~~~~~~fPsl~  225 (505)
T KOG3207|consen  146 PNVRDLDLSRNLFHNWFPVLKIAEQLPSLENLNLSSNRLSNFISSNTTLLLSHLKQLVLNSCGLSWKDVQWILLTFPSLE  225 (505)
T ss_pred             CcceeecchhhhHHhHHHHHHHHHhcccchhcccccccccCCccccchhhhhhhheEEeccCCCCHHHHHHHHHhCCcHH
Confidence            479999999998775433  23567999999999999987433322 23678999999999999821 122345679999


Q ss_pred             EEeeecccCCCCCchhcCCCCCCCEEeccCCcCCCCCC--cccCCCCCCCeeeccCCcCCCC-chhh-----hhCCCCCc
Q 005586          144 VLQLCCNQLTGNIPAQIGSLKSLSVLTLQHNRLNGGIP--DSLGNLGKLKRLDLSFNSLFGT-IPES-----LANNAELL  215 (689)
Q Consensus       144 ~L~Ls~N~l~g~~p~~~~~l~~L~~L~l~~N~l~~~~p--~~~~~l~~L~~L~ls~N~l~g~-~p~~-----l~~~~~L~  215 (689)
                      .|+|..|...+.-......+..|+.|||++|++- ..+  ...+.++.|+.|+++.+.+... .|+.     ...+++|+
T Consensus       226 ~L~L~~N~~~~~~~~~~~i~~~L~~LdLs~N~li-~~~~~~~~~~l~~L~~Lnls~tgi~si~~~d~~s~~kt~~f~kL~  304 (505)
T KOG3207|consen  226 VLYLEANEIILIKATSTKILQTLQELDLSNNNLI-DFDQGYKVGTLPGLNQLNLSSTGIASIAEPDVESLDKTHTFPKLE  304 (505)
T ss_pred             HhhhhcccccceecchhhhhhHHhhccccCCccc-ccccccccccccchhhhhccccCcchhcCCCccchhhhcccccce
Confidence            9999999644444445566788999999999987 455  4578899999999999988743 3332     45678999


Q ss_pred             EEecccCcCC
Q 005586          216 FLDVQNNTLS  225 (689)
Q Consensus       216 ~l~l~~N~l~  225 (689)
                      +|++..|++.
T Consensus       305 ~L~i~~N~I~  314 (505)
T KOG3207|consen  305 YLNISENNIR  314 (505)
T ss_pred             eeecccCccc
Confidence            9999999985

>PRK09902 hypothetical protein; Provisional

Probab=98.43  E-value=4.5e-06  Score=80.23  Aligned_cols=140  Identities=11%  Similarity=0.122  Sum_probs=102.2

Q ss_pred             cccCCcceEEEEEecCCcEEEEEEecccCC-----chHHHHHHHHHHHHhccCC--CcceeEeeEEE-c--CCCCeEEEE
Q 005586          417 LGKGNFSSVYKGTLRDGTLVAIRSINVTSC-----KSEEAEFVKGLYLLTSLRH--ENIIRLRGFCC-S--RGRGECFLI  486 (689)
Q Consensus       417 lg~G~~g~Vy~~~~~~g~~vavK~l~~~~~-----~~~~~~f~~e~~~l~~l~H--~niv~l~g~~~-~--~~~~~~~lV  486 (689)
                      -|+||-+.|++-.+. |..+-+|+-...-.     .-.+..|.+|...|.++..  -.+.+.+ |+. .  .....-+||
T Consensus        26 ~~rgG~SgV~r~~~~-g~~~ylKrq~nhl~~s~r~P~g~ptf~rE~~~L~~L~~~GvPVP~pv-f~~~~k~~~~~rA~LV  103 (216)
T PRK09902         26 YRRNGMSGVQCVERN-GKKLYVKRMTHHLFHSVRYPFGRPTIVREVAVIKELERAGVIVPKIV-FGEAVKIEGEWRALLV  103 (216)
T ss_pred             cCCCCcceEEEEEeC-CcEEEEEeccCcccccccCCCCchHHHHHHHHHHHHHHcCCCCCccc-eeeeeccCCceEEEEE
Confidence            467888889998775 44688887642111     2356789999999998853  3344444 331 1  112346899


Q ss_pred             EEcCCC-CCHHHHhhhcCCCCCCCCHHHHHHHHHHHHHHHhhhhCCCCCCCceeecCCCCCceeecCCCC--eEEecccc
Q 005586          487 YDFAPK-GKLSKYLDQEEGSSNVLDWSTRVSIIIGIAKGIGYLHSSEVNKPAIVHRNLSVEKVLIDQQFN--PLIADCGL  563 (689)
Q Consensus       487 ~e~~~~-gsL~~~L~~~~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~~~ivH~dlk~~NiLl~~~~~--~kl~DfGl  563 (689)
                      +|-+++ -+|.+++.+..-  .+.+...+..+..+++..++-||..+     +.|+|+.+.||+++.++.  +++.||.-
T Consensus       104 Te~L~g~~~L~~~l~~~~~--~~~~~~~k~~il~~va~~ia~LH~~G-----v~Hgdly~khIll~~~g~~~v~lIDlEk  176 (216)
T PRK09902        104 TEDMAGFISIADWYAQHAV--SPYSDEVRQAMLKAVALAFKKMHSVN-----RQHGCCYVRHIYVKTEGKAEAGFLDLEK  176 (216)
T ss_pred             EEeCCCCccHHHHHhcCCc--CCcchHHHHHHHHHHHHHHHHHHHCC-----CcCCCCCHhheeecCCCCeeEEEEEhhc
Confidence            997764 589999865432  23567778899999999999999998     999999999999986666  89999986


Q ss_pred             cc
Q 005586          564 HK  565 (689)
Q Consensus       564 a~  565 (689)
                      ++
T Consensus       177 ~r  178 (216)
T PRK09902        177 SR  178 (216)
T ss_pred             cc
Confidence            65

>KOG1859 consensus Leucine-rich repeat proteins [General function prediction only]

Probab=98.38  E-value=6.2e-09  Score=112.69  Aligned_cols=126  Identities=29%  Similarity=0.388  Sum_probs=87.0

Q ss_pred             CCCEEEccCCcccccCCccccCCCCCcEEEecccCCCCCCCccccCCccccEEeeecccCCCCCch-hcCCCCCCCEEec
Q 005586           93 CLSGLYLHYNSLSGEIPKEIRNLTELTDLYLDVNNLSGNIPPEIGSMASLQVLQLCCNQLTGNIPA-QIGSLKSLSVLTL  171 (689)
Q Consensus        93 ~L~~L~L~~N~l~g~~p~~~~~l~~L~~L~Ls~N~l~g~~p~~~~~l~~L~~L~Ls~N~l~g~~p~-~~~~l~~L~~L~l  171 (689)
                      .|.+.+.+.|+|. .+-..+.-++.|++|||++|+++..  +.+..|+.|+.|||++|+|. .+|. ....+. |+.|.|
T Consensus       165 ~L~~a~fsyN~L~-~mD~SLqll~ale~LnLshNk~~~v--~~Lr~l~~LkhLDlsyN~L~-~vp~l~~~gc~-L~~L~l  239 (1096)
T KOG1859|consen  165 KLATASFSYNRLV-LMDESLQLLPALESLNLSHNKFTKV--DNLRRLPKLKHLDLSYNCLR-HVPQLSMVGCK-LQLLNL  239 (1096)
T ss_pred             hHhhhhcchhhHH-hHHHHHHHHHHhhhhccchhhhhhh--HHHHhcccccccccccchhc-cccccchhhhh-heeeee
Confidence            3666677777776 5666677778888888888888733  26777788888888888887 3443 333444 888888


Q ss_pred             cCCcCCCCCCcccCCCCCCCeeeccCCcCCCCch-hhhhCCCCCcEEecccCcCC
Q 005586          172 QHNRLNGGIPDSLGNLGKLKRLDLSFNSLFGTIP-ESLANNAELLFLDVQNNTLS  225 (689)
Q Consensus       172 ~~N~l~~~~p~~~~~l~~L~~L~ls~N~l~g~~p-~~l~~~~~L~~l~l~~N~l~  225 (689)
                      ++|.++ .+- .+.+|.+|+.|||+.|-|++.-- ..+..+..|..|+|.+|.+.
T Consensus       240 rnN~l~-tL~-gie~LksL~~LDlsyNll~~hseL~pLwsLs~L~~L~LeGNPl~  292 (1096)
T KOG1859|consen  240 RNNALT-TLR-GIENLKSLYGLDLSYNLLSEHSELEPLWSLSSLIVLWLEGNPLC  292 (1096)
T ss_pred             cccHHH-hhh-hHHhhhhhhccchhHhhhhcchhhhHHHHHHHHHHHhhcCCccc
Confidence            888877 232 36778888888888887765321 22445667778888888875

>KOG0531 consensus Protein phosphatase 1, regulatory subunit, and related proteins [Signal transduction mechanisms]

Probab=98.37  E-value=1.2e-07  Score=103.36  Aligned_cols=104  Identities=27%  Similarity=0.318  Sum_probs=66.5

Q ss_pred             CCEEEEEcCCCCcccccCcCcCCCCCCCEEEccCCcccccCCccccCCCCCcEEEecccCCCCCCCccccCCccccEEee
Q 005586           68 RKVANISLQGKGLTGKLSPSLSGLKCLSGLYLHYNSLSGEIPKEIRNLTELTDLYLDVNNLSGNIPPEIGSMASLQVLQL  147 (689)
Q Consensus        68 ~~v~~l~L~~~~l~g~~~~~~~~l~~L~~L~L~~N~l~g~~p~~~~~l~~L~~L~Ls~N~l~g~~p~~~~~l~~L~~L~L  147 (689)
                      ..+..|+|.+|.|.+... .+..+++|++|+|++|.|+...+  +..|+.|+.|++++|.++. + ..+..+.+|+.|++
T Consensus        95 ~~l~~l~l~~n~i~~i~~-~l~~~~~L~~L~ls~N~I~~i~~--l~~l~~L~~L~l~~N~i~~-~-~~~~~l~~L~~l~l  169 (414)
T KOG0531|consen   95 KSLEALDLYDNKIEKIEN-LLSSLVNLQVLDLSFNKITKLEG--LSTLTLLKELNLSGNLISD-I-SGLESLKSLKLLDL  169 (414)
T ss_pred             cceeeeeccccchhhccc-chhhhhcchheeccccccccccc--hhhccchhhheeccCcchh-c-cCCccchhhhcccC
Confidence            456777777777764332 25667777777777777774443  4556667777777777762 2 34455777777777


Q ss_pred             ecccCCCCCc-hhcCCCCCCCEEeccCCcCC
Q 005586          148 CCNQLTGNIP-AQIGSLKSLSVLTLQHNRLN  177 (689)
Q Consensus       148 s~N~l~g~~p-~~~~~l~~L~~L~l~~N~l~  177 (689)
                      ++|+++..-+ . +..+.+|+.+++.+|.+.
T Consensus       170 ~~n~i~~ie~~~-~~~~~~l~~l~l~~n~i~  199 (414)
T KOG0531|consen  170 SYNRIVDIENDE-LSELISLEELDLGGNSIR  199 (414)
T ss_pred             Ccchhhhhhhhh-hhhccchHHHhccCCchh
Confidence            7777764333 1 456666777777777665

>COG0478 RIO-like serine/threonine protein kinase fused to N-terminal HTH domain [Signal transduction mechanisms]

Probab=98.34  E-value=3e-06  Score=83.24  Aligned_cols=134  Identities=17%  Similarity=0.153  Sum_probs=93.1

Q ss_pred             cccccccCCcceEEEEEecCCcEEEEEEecccCC---------------------chHHHHHHHHHHHHhccCCC--cce
Q 005586          413 EVNLLGKGNFSSVYKGTLRDGTLVAIRSINVTSC---------------------KSEEAEFVKGLYLLTSLRHE--NII  469 (689)
Q Consensus       413 ~~~~lg~G~~g~Vy~~~~~~g~~vavK~l~~~~~---------------------~~~~~~f~~e~~~l~~l~H~--niv  469 (689)
                      ..+.||-|.-+.||.|..++|.++|||.-+....                     ........+|.++|.++.-.  .+.
T Consensus        95 iG~~IGvGKEsdVY~~~~~~g~~~~vKfHR~GrtsFrkvk~~R~y~~~~~h~sWl~~sRl~A~rEf~~L~~L~~~G~~VP  174 (304)
T COG0478          95 IGTKIGVGKESDVYVAIDPKGRKVAVKFHRLGRTSFRKVKRNRDYLADKEHGSWLYVSRLAAEREFEALQRLYPEGVKVP  174 (304)
T ss_pred             hccccccCccceEEEEECCCCCEEEEEEeecCchhhhhhcchhhhhccccCcchhhhHHHHHHHHHHHHHHhhhcCCCCC
Confidence            3578999999999999999999999997643221                     01123567888999998655  666


Q ss_pred             eEeeEEEcCCCCeEEEEEEcCCCCCHHHHhhhcCCCCCCCCHHHHHHHHHHHHHHHhhhhCCCCCCCceeecCCCCCcee
Q 005586          470 RLRGFCCSRGRGECFLIYDFAPKGKLSKYLDQEEGSSNVLDWSTRVSIIIGIAKGIGYLHSSEVNKPAIVHRNLSVEKVL  549 (689)
Q Consensus       470 ~l~g~~~~~~~~~~~lV~e~~~~gsL~~~L~~~~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~~~ivH~dlk~~NiL  549 (689)
                      +.+++      +.-++||||+++--|...=         ++-...-.|+..|++-+.-.-..|     |||+|+..-||+
T Consensus       175 ~P~~~------nRHaVvMe~ieG~eL~~~r---------~~~en~~~il~~il~~~~~~~~~G-----iVHGDlSefNIl  234 (304)
T COG0478         175 KPIAW------NRHAVVMEYIEGVELYRLR---------LDVENPDEILDKILEEVRKAYRRG-----IVHGDLSEFNIL  234 (304)
T ss_pred             Ccccc------ccceeeeehcccceeeccc---------CcccCHHHHHHHHHHHHHHHHHcC-----ccccCCchheEE
Confidence            66654      2357999999875443321         111112233444444444443445     999999999999


Q ss_pred             ecCCCCeEEeccccccc
Q 005586          550 IDQQFNPLIADCGLHKL  566 (689)
Q Consensus       550 l~~~~~~kl~DfGla~~  566 (689)
                      +++|+.+.+.||-.+..
T Consensus       235 V~~dg~~~vIDwPQ~v~  251 (304)
T COG0478         235 VTEDGDIVVIDWPQAVP  251 (304)
T ss_pred             EecCCCEEEEeCccccc
Confidence            99999999999986643

>KOG0531 consensus Protein phosphatase 1, regulatory subunit, and related proteins [Signal transduction mechanisms]

Probab=98.32  E-value=1.3e-07  Score=103.00  Aligned_cols=130  Identities=32%  Similarity=0.389  Sum_probs=67.8

Q ss_pred             CCCCCCEEEccCCcccccCCccccCCCCCcEEEecccCCCCCCCccccCCccccEEeeecccCCCCCchhcCCCCCCCEE
Q 005586           90 GLKCLSGLYLHYNSLSGEIPKEIRNLTELTDLYLDVNNLSGNIPPEIGSMASLQVLQLCCNQLTGNIPAQIGSLKSLSVL  169 (689)
Q Consensus        90 ~l~~L~~L~L~~N~l~g~~p~~~~~l~~L~~L~Ls~N~l~g~~p~~~~~l~~L~~L~Ls~N~l~g~~p~~~~~l~~L~~L  169 (689)
                      .+..++.+++..|.+.. +-..+..+++|+.|+|.+|+|. .+...+..+++|++|+|++|+++...  .+..++.|+.|
T Consensus        70 ~l~~l~~l~l~~n~i~~-~~~~l~~~~~l~~l~l~~n~i~-~i~~~l~~~~~L~~L~ls~N~I~~i~--~l~~l~~L~~L  145 (414)
T KOG0531|consen   70 SLTSLKELNLRQNLIAK-ILNHLSKLKSLEALDLYDNKIE-KIENLLSSLVNLQVLDLSFNKITKLE--GLSTLTLLKEL  145 (414)
T ss_pred             HhHhHHhhccchhhhhh-hhcccccccceeeeeccccchh-hcccchhhhhcchheecccccccccc--chhhccchhhh
Confidence            34445555555555552 2233555566666666666665 33333555566666666666665332  24444556666


Q ss_pred             eccCCcCCCCCCcccCCCCCCCeeeccCCcCCCCch-hhhhCCCCCcEEecccCcCCc
Q 005586          170 TLQHNRLNGGIPDSLGNLGKLKRLDLSFNSLFGTIP-ESLANNAELLFLDVQNNTLSG  226 (689)
Q Consensus       170 ~l~~N~l~~~~p~~~~~l~~L~~L~ls~N~l~g~~p-~~l~~~~~L~~l~l~~N~l~~  226 (689)
                      ++++|.++ .+. .+..+..|+.+++++|+++..-+ . +..+.+++.+++.+|.+.-
T Consensus       146 ~l~~N~i~-~~~-~~~~l~~L~~l~l~~n~i~~ie~~~-~~~~~~l~~l~l~~n~i~~  200 (414)
T KOG0531|consen  146 NLSGNLIS-DIS-GLESLKSLKLLDLSYNRIVDIENDE-LSELISLEELDLGGNSIRE  200 (414)
T ss_pred             eeccCcch-hcc-CCccchhhhcccCCcchhhhhhhhh-hhhccchHHHhccCCchhc
Confidence            66666665 222 24445566666666666553322 1 3445555566666665543

>COG4248 Uncharacterized protein with protein kinase and helix-hairpin-helix DNA-binding domains [General function prediction only]

Probab=98.23  E-value=1e-05  Score=83.45  Aligned_cols=254  Identities=16%  Similarity=0.162  Sum_probs=147.9

Q ss_pred             ccccccCCcceEEEEEecCCcEEEEEEecccCCchHHHHHHHHHHHHhcc-CCCcceeEeeE----EEcCCCCe-EEEEE
Q 005586          414 VNLLGKGNFSSVYKGTLRDGTLVAIRSINVTSCKSEEAEFVKGLYLLTSL-RHENIIRLRGF----CCSRGRGE-CFLIY  487 (689)
Q Consensus       414 ~~~lg~G~~g~Vy~~~~~~g~~vavK~l~~~~~~~~~~~f~~e~~~l~~l-~H~niv~l~g~----~~~~~~~~-~~lV~  487 (689)
                      .+.||+|+-+.+|-.-.- +..|| |++...-. ....+-   +..|... .||-+-.=+.|    .+..++.. .-++|
T Consensus        16 gr~LgqGgea~ly~l~e~-~d~VA-KIYh~Ppp-a~~aqk---~a~la~~p~~p~~~~rvaWPqa~L~G~~~~~~iGflm   89 (637)
T COG4248          16 GRPLGQGGEADLYTLGEV-RDQVA-KIYHAPPP-AAQAQK---VAELAATPDAPLLNYRVAWPQATLHGGRRGKVIGFLM   89 (637)
T ss_pred             CccccCCccceeeecchh-hchhh-eeecCCCc-hHHHHH---HHHhccCCCCcchhhhhcccHHHhhCCCccceeEEec
Confidence            467999999999864311 22344 66654331 112221   2333333 45543321111    11122222 44566


Q ss_pred             EcCCCC-CHHHHhhh--cCCCCCCCCHHHHHHHHHHHHHHHhhhhCCCCCCCceeecCCCCCceeecCCCCeEEeccccc
Q 005586          488 DFAPKG-KLSKYLDQ--EEGSSNVLDWSTRVSIIIGIAKGIGYLHSSEVNKPAIVHRNLSVEKVLIDQQFNPLIADCGLH  564 (689)
Q Consensus       488 e~~~~g-sL~~~L~~--~~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~~~ivH~dlk~~NiLl~~~~~~kl~DfGla  564 (689)
                      ..+++- -...++..  .+.+-...+|.-.+..++.+|.+.+-||..|     .+-+|+.++|+|+.++..+.+.|-.--
T Consensus        90 P~v~g~~pI~~~y~p~tRRqs~P~~~w~fllrvaRnlA~aFA~lH~~G-----h~vGDVn~~~~lVsd~~~V~LVdsDsf  164 (637)
T COG4248          90 PKVSGKEPIHMIYSPATRRQSYPHCAWDFLLRVARNLASAFATLHEHG-----HVVGDVNQNSFLVSDDSKVVLVDSDSF  164 (637)
T ss_pred             ccCCCccchhhhcCchhhcccCCccccHHHHHHHHHHHHHHHHHHhcC-----CcccccCccceeeecCceEEEEcccce
Confidence            666543 22223221  1122345889999999999999999999988     578999999999999999999874322


Q ss_pred             ccccCCceeeeecCCCCCCCCCccccc-----cCCCCCcccchhHHHHHHHHHhC-CCCcchhHHH---------HHhhh
Q 005586          565 KLLADDIVFSVLKTSAAMGYLAPEYVT-----TGRFTERSDIFAFGVIILQILTG-SLVLTSSMRL---------AAESA  629 (689)
Q Consensus       565 ~~~~~~~~~~~~~~~~~~~y~aPE~~~-----~~~~~~ksDV~sfGvvl~elltG-~~p~~~~~~~---------~~~~~  629 (689)
                      .....+.  ......+...|.+||.-.     +..-+...|-|.+||+++|++.| +.||.+-...         .....
T Consensus       165 qi~~ng~--~~~cpVg~~eftPPElQ~~~sf~g~~r~~~hD~FGLavLiF~lL~ggrHPysGI~~~~~ap~p~E~~Ia~g  242 (637)
T COG4248         165 QINANGT--LHLCPVGVSEFTPPELQTLPSFVGFERTANHDNFGLAVLIFHLLFGGRHPYSGIPLISDAPNPLETDIAHG  242 (637)
T ss_pred             eeccCCc--eEecccCccccCCHHHhccccccccCCCccccchhHHHHHHHHHhcCCCCCCcccccCCCCCcchhhhhcc
Confidence            2222222  222345667799999754     33457889999999999999987 8888542100         00011


Q ss_pred             hhhHhhcc--ccCC---CCC-HHHHHHHHHHHHHhccCC--CCCCCCHHHHHHHHHhhC
Q 005586          630 TFENFIDR--NLKG---KFS-ESEAAKLGKMALVCTHED--PENRPTMEAVIEELTVAA  680 (689)
Q Consensus       630 ~~~~~~~~--~~~~---~~~-~~~~~~l~~l~~~Cl~~d--p~~RPs~~evl~~L~~~~  680 (689)
                      .+...-+.  .++.   ..+ .-....+..+..+|+...  +.-||+.+.-+..|...+
T Consensus       243 ~f~ya~~~~~g~~p~P~~~P~~~Lpp~vqAlF~qaF~~~~~~~~RP~a~aW~aAl~al~  301 (637)
T COG4248         243 RFAYASDQRRGLKPPPRSIPLSMLPPDVQALFQQAFTESGVATPRPTAKAWVAALDALR  301 (637)
T ss_pred             eeeechhccCCCCCCCCCCChhhcCHHHHHHHHHHhcccCCCCCCCCHHHHHHHHHHHH
Confidence            11111111  1110   111 122445677788888754  468999998887766543

>COG0661 AarF Predicted unusual protein kinase [General function prediction only]

Probab=98.23  E-value=7.3e-06  Score=90.08  Aligned_cols=147  Identities=13%  Similarity=0.174  Sum_probs=96.4

Q ss_pred             cCCcccccccCCcceEEEEEecCCcEEEEEEecccCCc---------------------------------------hHH
Q 005586          410 CFSEVNLLGKGNFSSVYKGTLRDGTLVAIRSINVTSCK---------------------------------------SEE  450 (689)
Q Consensus       410 ~f~~~~~lg~G~~g~Vy~~~~~~g~~vavK~l~~~~~~---------------------------------------~~~  450 (689)
                      .|. .+.|+.++-|.||+|++++|+.||||+.+..-.+                                       ..+
T Consensus       127 eF~-~~PiAsASIaQVH~A~L~sG~~VAVKVqrPgi~~~i~~DL~il~~~a~~~~~~~~~~~~l~~~~vv~e~~~~l~~E  205 (517)
T COG0661         127 EFE-PEPIASASIAQVHRAVLKSGEEVAVKVQRPGIRERIEADLKLLRRLARLIKRLPPGGRRLDLVEVVDEFEKRLREE  205 (517)
T ss_pred             HcC-CCchhhhhHhhheeEEecCCCEEEEEecCCChHHHHHHHHHHHHHHHHHHHHcCCccccCChHHHHHHHHHHHHHH
Confidence            444 3689999999999999999999999998532100                                       011


Q ss_pred             HHHHHHHHHHhcc----CCCcceeEeeEEEcCCCCeEEEEEEcCCCCCHHHHhhhcCCCCCCCCHHHHHHHHHHHHHH-H
Q 005586          451 AEFVKGLYLLTSL----RHENIIRLRGFCCSRGRGECFLIYDFAPKGKLSKYLDQEEGSSNVLDWSTRVSIIIGIAKG-I  525 (689)
Q Consensus       451 ~~f~~e~~~l~~l----~H~niv~l~g~~~~~~~~~~~lV~e~~~~gsL~~~L~~~~~~~~~l~~~~~~~ia~~ia~g-L  525 (689)
                      -+|.+|..-+.++    +...-+.+=..|++- .....++|||++|-.+.+........   .+   +..|+..++++ +
T Consensus       206 lDy~~EA~n~~~~~~nf~~~~~v~VP~V~we~-t~~~VLtmE~i~Gi~i~d~~~l~~~g---~d---~k~ia~~~~~~f~  278 (517)
T COG0661         206 LDYRREAANAERFRENFKDDPDVYVPKVYWEY-TTRRVLTMEWIDGIKISDIAALKSAG---ID---RKELAELLVRAFL  278 (517)
T ss_pred             hCHHHHHHHHHHHHHHcCCCCCeEeceeehhc-cCCcEEEEEeeCCEecccHHHHHhcC---CC---HHHHHHHHHHHHH
Confidence            2444555555544    233333444445432 35678999999998888884322211   44   23333333332 2


Q ss_pred             hhhhCCCCCCCceeecCCCCCceeecCCCCeEEecccccccccC
Q 005586          526 GYLHSSEVNKPAIVHRNLSVEKVLIDQQFNPLIADCGLHKLLAD  569 (689)
Q Consensus       526 ~yLH~~~~~~~~ivH~dlk~~NiLl~~~~~~kl~DfGla~~~~~  569 (689)
                      ..+-..+     +.|.|..|-||+++.+++.-+.|||+...+.+
T Consensus       279 ~q~~~dg-----ffHaDpHpGNi~v~~~g~i~~lDfGi~g~l~~  317 (517)
T COG0661         279 RQLLRDG-----FFHADPHPGNILVRSDGRIVLLDFGIVGRLDP  317 (517)
T ss_pred             HHHHhcC-----ccccCCCccceEEecCCcEEEEcCcceecCCH
Confidence            2222234     89999999999999999999999999887754

>TIGR02172 Fb_sc_TIGR02172 Fibrobacter succinogenes paralogous family TIGR02172

Probab=98.21  E-value=2.1e-05  Score=78.13  Aligned_cols=139  Identities=11%  Similarity=0.143  Sum_probs=81.3

Q ss_pred             cccccCCcceEEEEEecCCcEEEEEEecccCCchHHHHHHHHHHHHhccCCCcc--eeEeeEEEcCCCCeEEEEEEcCCC
Q 005586          415 NLLGKGNFSSVYKGTLRDGTLVAIRSINVTSCKSEEAEFVKGLYLLTSLRHENI--IRLRGFCCSRGRGECFLIYDFAPK  492 (689)
Q Consensus       415 ~~lg~G~~g~Vy~~~~~~g~~vavK~l~~~~~~~~~~~f~~e~~~l~~l~H~ni--v~l~g~~~~~~~~~~~lV~e~~~~  492 (689)
                      ..||+|..+.||+.   .|..+++|......   ......+|.+++..+..-.+  .+.++++  +..+...+|||+++|
T Consensus         7 ~~i~~G~t~~~y~~---~~~~~VlR~~~~~~---~~~~i~~E~~~l~~l~~~glpvP~~~~~~--~~~~~~glv~e~i~G   78 (226)
T TIGR02172         7 TQTGEGGNGESYTH---KTGKWMLKLYNPGF---DKETIKREFDASRKVFSLGIPTPHPFDLV--EDGGRLGLIYELIVG   78 (226)
T ss_pred             eeecCCCCcceeEe---cCCCEEEEeCCCCC---CHHHHHHHHHHHHHHHHcCCCCCceEEEE--ecCCeeeeeeeecCC
Confidence            57999999999984   24567788876533   22345788888888764433  4555555  334556789999988


Q ss_pred             CC-HHHHh---------------------hhcCCCCCCCCHHHHHHHH-----------HHH-HHHHhhhhCCCCCCCce
Q 005586          493 GK-LSKYL---------------------DQEEGSSNVLDWSTRVSII-----------IGI-AKGIGYLHSSEVNKPAI  538 (689)
Q Consensus       493 gs-L~~~L---------------------~~~~~~~~~l~~~~~~~ia-----------~~i-a~gL~yLH~~~~~~~~i  538 (689)
                      .+ +...+                     |......  .....+..-.           ..+ .....+|... ...+.+
T Consensus        79 ~~~~~~~~~~~~~~~~~l~~~la~~l~~lH~~~~~~--~~l~~~~~~~~~~l~~~~~~~~~~~~~l~~~l~~~-~~~~~~  155 (226)
T TIGR02172        79 KRSFSRIISDNPSRLEEIAKIFAEMAKKLHSTKCDT--STFQSYKEKIRKFIEEKDFVPKDYKEKARAFIKEV-PDTSTC  155 (226)
T ss_pred             ccchhhhhcCCHHHHHHHHHHHHHHHHHHhCCCCCC--CcHHHHHHHHHHHHHhccCCCHHHHHHHHHHHHhC-CCCCce
Confidence            63 22111                     1110000  1111100000           000 1112223221 134567


Q ss_pred             eecCCCCCceeecCCCCeEEecccccc
Q 005586          539 VHRNLSVEKVLIDQQFNPLIADCGLHK  565 (689)
Q Consensus       539 vH~dlk~~NiLl~~~~~~kl~DfGla~  565 (689)
                      +|+|+.|.||++++++ +.|.||+.+.
T Consensus       156 ~HgD~~~~Nii~~~~~-~~iIDwe~a~  181 (226)
T TIGR02172       156 LHGDFQIGNLITSGKG-TYWIDLGDFG  181 (226)
T ss_pred             EecCCCCCcEEEcCCC-cEEEechhcC
Confidence            9999999999999988 9999999764

This model describes a paralogous family of five proteins, likely to be enzymes, in the rumen bacterium Fibrobacter succinogenes S85. Members show homology to proteins described by PFAM model pfam01636, a phosphotransferase enzyme family associated with resistance to aminoglycoside antibiotics. However, members of this family score below the current trusted and noise cutoffs for pfam01636.

>KOG4658 consensus Apoptotic ATPase [Signal transduction mechanisms]

Probab=98.19  E-value=1.2e-06  Score=102.45  Aligned_cols=148  Identities=27%  Similarity=0.294  Sum_probs=97.4

Q ss_pred             CEEEEEcCCCCcccccCcCcCCCCCCCEEEccCCc--ccccCCccccCCCCCcEEEecccCCCCCCCccccCCccccEEe
Q 005586           69 KVANISLQGKGLTGKLSPSLSGLKCLSGLYLHYNS--LSGEIPKEIRNLTELTDLYLDVNNLSGNIPPEIGSMASLQVLQ  146 (689)
Q Consensus        69 ~v~~l~L~~~~l~g~~~~~~~~l~~L~~L~L~~N~--l~g~~p~~~~~l~~L~~L~Ls~N~l~g~~p~~~~~l~~L~~L~  146 (689)
                      .+..+.+-+|.+. .++... ..+.|++|-+..|.  +.-..++.|..++.|++||||+|.=-+.+|..+++|-+|++|+
T Consensus       524 ~~rr~s~~~~~~~-~~~~~~-~~~~L~tLll~~n~~~l~~is~~ff~~m~~LrVLDLs~~~~l~~LP~~I~~Li~LryL~  601 (889)
T KOG4658|consen  524 SVRRMSLMNNKIE-HIAGSS-ENPKLRTLLLQRNSDWLLEISGEFFRSLPLLRVLDLSGNSSLSKLPSSIGELVHLRYLD  601 (889)
T ss_pred             heeEEEEeccchh-hccCCC-CCCccceEEEeecchhhhhcCHHHHhhCcceEEEECCCCCccCcCChHHhhhhhhhccc
Confidence            3445555555443 222222 22367888888886  4434444577788888888888776667888888888888888


Q ss_pred             eecccCCCCCchhcCCCCCCCEEeccCCcCCCCCCcccCCCCCCCeeeccCCc--CCCCchhhhhCCCCCcEEec
Q 005586          147 LCCNQLTGNIPAQIGSLKSLSVLTLQHNRLNGGIPDSLGNLGKLKRLDLSFNS--LFGTIPESLANNAELLFLDV  219 (689)
Q Consensus       147 Ls~N~l~g~~p~~~~~l~~L~~L~l~~N~l~~~~p~~~~~l~~L~~L~ls~N~--l~g~~p~~l~~~~~L~~l~l  219 (689)
                      |++..++ .+|..+++|..|.+|++..+.-...+|..+..|.+|++|.+....  .+...-..+.++.+|+.+..
T Consensus       602 L~~t~I~-~LP~~l~~Lk~L~~Lnl~~~~~l~~~~~i~~~L~~Lr~L~l~~s~~~~~~~~l~el~~Le~L~~ls~  675 (889)
T KOG4658|consen  602 LSDTGIS-HLPSGLGNLKKLIYLNLEVTGRLESIPGILLELQSLRVLRLPRSALSNDKLLLKELENLEHLENLSI  675 (889)
T ss_pred             ccCCCcc-ccchHHHHHHhhheeccccccccccccchhhhcccccEEEeeccccccchhhHHhhhcccchhhhee
Confidence            8888887 788888888888888888777655666666678888888776554  22223334444555555444

>KOG1909 consensus Ran GTPase-activating protein [RNA processing and modification; Nuclear structure; Signal transduction mechanisms]

Probab=98.16  E-value=5.1e-07  Score=90.69  Aligned_cols=158  Identities=23%  Similarity=0.293  Sum_probs=71.9

Q ss_pred             CCEEEEEcCCCCcccc----cCcCcCCCCCCCEEEccCC---cccccCCcc-------ccCCCCCcEEEecccCCCCCCC
Q 005586           68 RKVANISLQGKGLTGK----LSPSLSGLKCLSGLYLHYN---SLSGEIPKE-------IRNLTELTDLYLDVNNLSGNIP  133 (689)
Q Consensus        68 ~~v~~l~L~~~~l~g~----~~~~~~~l~~L~~L~L~~N---~l~g~~p~~-------~~~l~~L~~L~Ls~N~l~g~~p  133 (689)
                      ..++.|+|++|.+.-.    +...+.+.++|+.-++|.=   ++...+|..       +..+++|+.||||.|.|.-.-+
T Consensus        30 ~s~~~l~lsgnt~G~EAa~~i~~~L~~~~~L~~v~~sd~ftGR~~~Ei~e~L~~l~~aL~~~~~L~~ldLSDNA~G~~g~  109 (382)
T KOG1909|consen   30 DSLTKLDLSGNTFGTEAARAIAKVLASKKELREVNLSDMFTGRLKDEIPEALKMLSKALLGCPKLQKLDLSDNAFGPKGI  109 (382)
T ss_pred             CceEEEeccCCchhHHHHHHHHHHHhhcccceeeehHhhhcCCcHHHHHHHHHHHHHHHhcCCceeEeeccccccCccch
Confidence            3566677777665422    2233444455555555431   122223322       2334455555555555543333


Q ss_pred             ccc----cCCccccEEeeecccCCCCCc--------------hhcCCCCCCCEEeccCCcCCCC----CCcccCCCCCCC
Q 005586          134 PEI----GSMASLQVLQLCCNQLTGNIP--------------AQIGSLKSLSVLTLQHNRLNGG----IPDSLGNLGKLK  191 (689)
Q Consensus       134 ~~~----~~l~~L~~L~Ls~N~l~g~~p--------------~~~~~l~~L~~L~l~~N~l~~~----~p~~~~~l~~L~  191 (689)
                      ..|    ..+.+|+.|+|.+|.+. ..-              .-.++-+.|+++..++|++...    +...|...+.|+
T Consensus       110 ~~l~~ll~s~~~L~eL~L~N~Glg-~~ag~~l~~al~~l~~~kk~~~~~~Lrv~i~~rNrlen~ga~~~A~~~~~~~~le  188 (382)
T KOG1909|consen  110 RGLEELLSSCTDLEELYLNNCGLG-PEAGGRLGRALFELAVNKKAASKPKLRVFICGRNRLENGGATALAEAFQSHPTLE  188 (382)
T ss_pred             HHHHHHHHhccCHHHHhhhcCCCC-hhHHHHHHHHHHHHHHHhccCCCcceEEEEeeccccccccHHHHHHHHHhccccc
Confidence            322    33455555555555543 111              1122334555555555555421    112334445555


Q ss_pred             eeeccCCcCCCC----chhhhhCCCCCcEEecccCcCCc
Q 005586          192 RLDLSFNSLFGT----IPESLANNAELLFLDVQNNTLSG  226 (689)
Q Consensus       192 ~L~ls~N~l~g~----~p~~l~~~~~L~~l~l~~N~l~~  226 (689)
                      .+.++.|.+.-.    +-..|..+++|+.|||++|.|+-
T Consensus       189 evr~~qN~I~~eG~~al~eal~~~~~LevLdl~DNtft~  227 (382)
T KOG1909|consen  189 EVRLSQNGIRPEGVTALAEALEHCPHLEVLDLRDNTFTL  227 (382)
T ss_pred             eEEEecccccCchhHHHHHHHHhCCcceeeecccchhhh
Confidence            555555554311    22344555555555555555553

---

Homologous Structure Templates

Structure Templates Detected by BLAST

Original result of BLAST against Protein Data Bank

ID	Length	Definition	E-value
Query	689
3tl8_A	349	The Avrptob-Bak1 Complex Reveals Two Structurally S		5e-46
3uim_A	326	Structural Basis For The Impact Of Phosphorylation		5e-45
3hgk_A	327	Crystal Structure Of Effect Protein Avrptob Complex		8e-37
2qkw_B	321	Structural Basis For Activation Of Plant Immunity B		9e-37
3rgx_A	768	Structural Insight Into Brassinosteroid Perception		4e-25
3rgx_A	768	Structural Insight Into Brassinosteroid Perception		1e-16
3riz_A	772	Crystal Structure Of The Plant Steroid Receptor Bri		4e-25
3riz_A	772	Crystal Structure Of The Plant Steroid Receptor Bri		1e-16
2nry_A	307	Crystal Structure Of Irak-4 Length = 307		7e-24
2oib_A	301	Crystal Structure Of Irak4 Kinase Domain Apo Form L		1e-23
2nru_A	307	Crystal Structure Of Irak-4 Length = 307		1e-23
2o8y_A	298	Apo Irak4 Kinase Domain Length = 298		1e-21
1ogq_A	313	The Crystal Structure Of Pgip (Polygalacturonase In		1e-21
4bbe_A	298	Aminoalkylpyrimidine Inhibitor Complexes With Jak2		3e-20
3ugc_A	295	Structural Basis Of Jak2 Inhibition By The Type Ii		5e-20
4f0f_A	287	Crystal Structure Of The Roco4 Kinase Domain Bound		5e-20
2g15_A	318	Structural Characterization Of Autoinhibited C-Met		5e-20
4gg5_A	319	Crystal Structure Of Cmet In Complex With Novel Inh		7e-20
2wd1_A	292	Human C-Met Kinase In Complex With Azaindole Inhibi		7e-20
3q6u_A	308	Structure Of The Apo Met Receptor Kinase In The Dua		7e-20
4e6d_A	298	Jak2 Kinase (Jh1 Domain) Triple Mutant In Complex W		7e-20
3f66_A	298	Human C-Met Kinase In Complex With Quinoxaline Inhi		8e-20
3i5n_A	309	Crystal Structure Of C-Met With Triazolopyridazine		9e-20
2wgj_A	306	X-Ray Structure Of Pf-02341066 Bound To The Kinase		9e-20
3lq8_A	302	Structure Of The Kinase Domain Of C-Met Bound To Xl		9e-20
2rfn_A	310	X-ray Structure Of C-met With Inhibitor. Length = 3		1e-19
2xa4_A	298	Inhibitors Of Jak2 Kinase Domain Length = 298		1e-19
4f1m_A	287	Crystal Structure Of The G1179s Roco4 Kinase Domain		2e-19
1mqb_A	333	Crystal Structure Of Ephrin A2 (Epha2) Receptor Pro		2e-19
2w1i_A	326	Structure Determination Of Aurora Kinase In Complex		2e-19
4f1o_A	287	Crystal Structure Of The L1180t Mutant Roco4 Kinase		2e-19
3tjc_A	298	Co-Crystal Structure Of Jak2 With Thienopyridine 8		2e-19
3lpb_A	295	Crystal Structure Of Jak2 Complexed With A Potent 2		2e-19
2b7a_A	293	The Structural Basis Of Janus Kinase 2 Inhibition B		2e-19
3e62_A	293	Fragment Based Discovery Of Jak-2 Inhibitors Length		2e-19
3q32_A	301	Structure Of Janus Kinase 2 With A Pyrrolotriazine		2e-19
4hge_A	300	Jak2 Kinase (Jh1 Domain) In Complex With Compound 8		2e-19
4e4m_A	302	Jak2 Kinase (Jh1 Domain) In Complex With Compound 3		2e-19
3rvg_A	303	Crystals Structure Of Jak2 With A 1-Amino-5h-Pyrido		2e-19
3jy9_A	311	Janus Kinase 2 Inhibitors Length = 311		2e-19
3io7_A	313	2-Aminopyrazolo[1,5-A]pyrimidines As Potent And Sel		2e-19
4aqc_A	301	Triazolopyridine-Based Inhibitor Of Janus Kinase 2		2e-19
3q6w_A	307	Structure Of Dually-phosphorylated Met Receptor Kin		3e-19
3geq_A	286	Structural Basis For The Chemical Rescue Of Src Kin		5e-19
3dqw_A	286	C-Src Kinase Domain Thr338ile Mutant In Complex Wit		7e-19
3g6h_A	286	Src Thr338ile Inhibited In The Dfg-Asp-Out Conforma		7e-19
2oiq_A	286	Crystal Structure Of Chicken C-Src Kinase Domain In		7e-19
2dq7_X	283	Crystal Structure Of Fyn Kinase Domain Complexed Wi		8e-19
3svv_A	286	Crystal Structure Of T338c C-Src Covalently Bound T		9e-19
2ptk_A	453	Chicken Src Tyrosine Kinase Length = 453		9e-19
3u4w_A	275	Src In Complex With Dna-Templated Macrocyclic Inhib		1e-18
3d7u_B	277	Structural Basis For The Recognition Of C-Src By It		1e-18
2qq7_A	286	Crystal Structure Of Drug Resistant Src Kinase Doma		1e-18
3c1x_A	373	Crystal Structure Of The Tyrosine Kinase Domain Of		1e-18
2h8h_A	535	Src Kinase In Complex With A Quinazoline Inhibitor		1e-18
3a4p_A	319	Human C-Met Kinase Domain Complexed With 6-Benzylox		1e-18
3p86_A	309	Crystal Structure Of Ctr1 Kinase Domain Mutant D676		1e-18
3oez_A	286	Crystal Structure Of The L317i Mutant Of The Chicke		1e-18
2hwo_A	286	Crystal Structure Of Src Kinase Domain In Complex W		1e-18
3dkc_A	317	Sgx Clone 5698a65kfg1h1 Length = 317		2e-18
3qti_A	314	C-Met Kinase In Complex With Nvp-Bvu972 Length = 31		2e-18
1r0p_A	312	Crystal Structure Of The Tyrosine Kinase Domain Of		2e-18
3cth_A	314	Crystal Structure Of The Tyrosine Kinase Domain Of		2e-18
3dkg_A	317	Sgx Clone 5698a109kfg1h1 Length = 317		2e-18
1fmk_A	452	Crystal Structure Of Human Tyrosine-Protein Kinase		2e-18
1y57_A	452	Structure Of Unphosphorylated C-Src In Complex With		2e-18
2bdf_A	279	Src Kinase In Complex With Inhibitor Ap23451 Length		2e-18
1ksw_A	452	Structure Of Human C-Src Tyrosine Kinase (Thr338gly		3e-18
2hk5_A	270	Hck Kinase In Complex With Lck Targetted Inhibitor		4e-18
1opk_A	495	Structural Basis For The Auto-Inhibition Of C-Abl T		4e-18
1yol_A	283	Crystal Structure Of Src Kinase Domain In Complex W		4e-18
1yoj_A	283	Crystal Structure Of Src Kinase Domain Length = 283		5e-18
1qcf_A	454	Crystal Structure Of Hck In Complex With A Src Fami		5e-18
4e4l_A	302	Jak1 Kinase (Jh1 Domain) In Complex With Compound 3		6e-18
3ppz_A	309	Crystal Structure Of Ctr1 Kinase Domain In Complex		8e-18
3eyg_A	290	Crystal Structures Of Jak1 And Jak2 Inhibitor Compl		8e-18
1opl_A	537	Structural Basis For The Auto-Inhibition Of C-Abl T		8e-18
3mpm_A	267	Lck Complexed With A Pyrazolopyrimidine Length = 26		8e-18
2fo0_A	495	Organization Of The Sh3-Sh2 Unit In Active And Inac		9e-18
1yi6_A	276	C-Term Tail Segment Of Human Tyrosine Kinase (258-5		9e-18
2zm1_A	285	Crystal Structure Of Imidazo Pyrazin 1 Bound To The		1e-17
3kxz_A	287	The Complex Crystal Structure Of Lck With A Probe M		1e-17
2pl0_A	289	Lck Bound To Imatinib Length = 289		1e-17
3kmm_A	288	Structure Of Human Lck Kinase With A Small Molecule		2e-17
1qpe_A	279	Structural Analysis Of The Lymphocyte-Specific Kina		2e-17
2ofu_A	273	X-Ray Crystal Structure Of 2-Aminopyrimidine Carbam		2e-17
4hvd_A	314	Jak3 Kinase Domain In Complex With 2-cyclopropyl-5h		2e-17
1yvj_A	290	Crystal Structure Of The Jak3 Kinase Domain In Comp		2e-17
3bys_A	277	Co-Crystal Structure Of Lck And Aminopyrimidine Ami		2e-17
3lck_A	271	The Kinase Domain Of Human Lymphocyte Kinase (Lck),		2e-17
3bym_A	272	X-Ray Co-Crystal Structure Aminobenzimidazole Triaz		2e-17
2ofv_A	277	Crystal Structure Of Aminoquinazoline 1 Bound To Lc		2e-17
2of2_A	271	Crystal Structure Of Furanopyrimidine 8 Bound To Lc		2e-17
2r4b_A	321	Erbb4 Kinase Domain Complexed With A Thienopyrimidi		2e-17
3pjc_A	315	Crystal Structure Of Jak3 Complexed With A Potent A		3e-17
3lxk_A	327	Structural And Thermodynamic Characterization Of Th		3e-17
1fpu_A	293	Crystal Structure Of Abl Kinase Domain In Complex W		3e-17
2og8_A	265	Crystal Structure Of Aminoquinazoline 36 Bound To L		3e-17
3oxz_A	284	Crystal Structure Of Abl Kinase Domain Bound With A		3e-17
2z60_A	288	Crystal Structure Of The T315i Mutant Of Abl Kinase		4e-17
3bbt_B	328	Crystal Structure Of The Erbb4 Kinase In Complex Wi		4e-17
2qoh_A	288	Crystal Structure Of Abl Kinase Bound With Ppy-a Le		4e-17
3oy3_A	284	Crystal Structure Of Abl T315i Mutant Kinase Domain		4e-17
3dk6_A	293	Crystal Structure Of Mutant Abl Kinase Domain In Co		6e-17
3qrj_A	277	The Crystal Structure Of Human Abl1 Kinase Domain T		7e-17
3qri_A	277	The Crystal Structure Of Human Abl1 Kinase Domain I		7e-17
2g2f_A	287	A Src-Like Inactive Conformation In The Abl Tyrosin		7e-17
2f4j_A	287	Structure Of The Kinase Domain Of An Imatinib-Resis		7e-17
3cd3_A	377	Crystal Structure Of Phosphorylated Human Feline Sa		8e-17
2e2b_A	293	Crystal Structure Of The C-Abl Kinase Domain In Com		8e-17
3bkb_A	377	Crystal Structure Of Human Feline Sarcoma Viral Onc		8e-17
2v7a_A	286	Crystal Structure Of The T315i Abl Mutant In Comple		8e-17
2gqg_A	278	X-Ray Crystal Structure Of Dasatinib (Bms-354825) B		8e-17
2hzi_A	277	Abl Kinase Domain In Complex With Pd180970 Length =		8e-17
3dk7_A	277	Crystal Structure Of Mutant Abl Kinase Domain In Co		9e-17
2hz0_A	270	Abl Kinase Domain In Complex With Nvp-Aeg082 Length		9e-17
2hiw_A	287	Crystal Structure Of Inactive Conformation Abl Kina		9e-17
2g1t_A	287	A Src-Like Inactive Conformation In The Abl Tyrosin		9e-17
3pyy_A	298	Discovery And Characterization Of A Cell-Permeable,		1e-16
2hyy_A	273	Human Abl Kinase Domain In Complex With Imatinib (S		1e-16
3dk3_A	293	Crystal Structure Of Mutant Abl Kinase Domain In Co		1e-16
3kul_A	325	Kinase Domain Of Human Ephrin Type-A Receptor 8 (Ep		2e-16
2zv7_A	279	Lyn Tyrosine Kinase Domain, Apo Form Length = 279		2e-16
3a4o_X	286	Lyn Kinase Domain Length = 286		2e-16
3dtc_A	271	Crystal Structure Of Mixed-Lineage Kinase Mlk1 Comp		3e-16
3kul_B	325	Kinase Domain Of Human Ephrin Type-A Receptor 8 (Ep		3e-16
1ad5_A	438	Src Family Kinase Hck-Amp-Pnp Complex Length = 438		3e-16
3miy_A	266	X-Ray Crystal Structure Of Itk Complexed With Sunit		4e-16
3gvu_A	292	The Crystal Structure Of Human Abl2 In Complex With		5e-16
3qgw_A	286	Crystal Structure Of Itk Kinase Bound To An Inhibit		6e-16
4hct_A	269	Crystal Structure Of Itk In Complex With Compound 5		8e-16
3v5j_A	266	Crystal Structure Of Interleukin-2 Inducible T-Cell		1e-15
2qoo_A	373	Human Epha3 Kinase And Juxtamembrane Region, Y596f:		1e-15
1jpa_A	312	Crystal Structure Of Unphosphorylated Ephb2 Recepto		1e-15
1qpd_A	279	Structural Analysis Of The Lymphocyte-specific Kina		1e-15
1sm2_A	264	Crystal Structure Of The Phosphorylated Interleukin		1e-15
3pls_A	298	Ron In Complex With Ligand Amp-Pnp Length = 298		2e-15
2qoi_A	373	Human Epha3 Kinase And Juxtamembrane Region, Y596f:		2e-15
3fxx_A	371	Human Epha3 Kinase And Juxtamembrane Region Bound T		2e-15
2qof_A	373	Human Epha3 Kinase And Juxtamembrane Region, Y596f		2e-15
2qod_A	373	Human Epha3 Kinase And Juxtamembrane Region, Y602f		2e-15
2gsf_A	373	The Human Epha3 Receptor Tyrosine Kinase And Juxtam		2e-15
2qok_A	373	Human Epha3 Kinase And Juxtamembrane Region, Y596f:		2e-15
2qol_A	373	Human Epha3 Kinase And Juxtamembrane Region, Y596:y		2e-15
3dzq_A	361	Human Epha3 Kinase Domain In Complex With Inhibitor		2e-15
2qoc_A	344	Human Epha3 Kinase Domain, Phosphorylated, Amp-Pnp		2e-15
2rei_A	318	Kinase Domain Of Human Ephrin Type-a Receptor 7 (ep		2e-15
2hen_A	286	Crystal Structure Of The Ephb2 Receptor Kinase Doma		3e-15
2jiv_A	328	Crystal Structure Of Egfr Kinase Domain T790m Mutat		3e-15
3nyx_A	302	Non-Phosphorylated Tyk2 Jh1 Domain With Quinoline-T		3e-15
3gen_A	283	The 1.6 A Crystal Structure Of Human Bruton's Tyros		3e-15
3t9t_A	267	Crystal Structure Of Btk Mutant (F435t,K596r) Compl		4e-15
3g2f_A	336	Crystal Structure Of The Kinase Domain Of Bone Morp		4e-15
3lmg_A	344	Crystal Structure Of The Erbb3 Kinase Domain In Com		4e-15
2j5e_A	327	Crystal Structure Of Egfr Kinase Domain In Complex		4e-15
3kex_A	325	Crystal Structure Of The Catalytically Inactive Kin		4e-15
3ocs_A	271	Crystal Structure Of Bruton's Tyrosine Kinase In Co		5e-15
3pix_A	274	Crystal Structure Of Btk Kinase Domain Complexed Wi		5e-15
3k54_A	283	Structures Of Human Bruton's Tyrosine Kinase In Act		6e-15
3ika_A	331	Crystal Structure Of Egfr 696-1022 T790m Mutant Cov		6e-15
3nz0_A	302	Non-Phosphorylated Tyk2 Kinase With Cmp6 Length = 3		6e-15
2jit_A	327	Crystal Structure Of Egfr Kinase Domain T790m Mutat		6e-15
3p08_A	267	Crystal Structure Of The Human Btk Kinase Domain Le		6e-15
4g5p_A	330	Crystal Structure Of Egfr Kinase T790m In Complex W		7e-15
2qo7_A	373	Human Epha3 Kinase And Juxtamembrane Region, Dephos		7e-15
2jiu_A	328	Crystal Structure Of Egfr Kinase Domain T790m Mutat		7e-15
4i24_A	329	Structure Of T790m Egfr Kinase Domain Co-crystalliz		7e-15
2qon_A	373	Human Epha3 Kinase And Juxtamembrane Region, Y596f:		8e-15
1m14_A	333	Tyrosine Kinase Domain From Epidermal Growth Factor		8e-15
2qob_A	344	Human Epha3 Kinase Domain, Base Structure Length =		8e-15
2gs7_A	330	Crystal Structure Of The Inactive Egfr Kinase Domai		8e-15
2j5f_A	327	Crystal Structure Of Egfr Kinase Domain In Complex		8e-15
3vjo_A	334	Crystal Structure Of The Wild-Type Egfr Kinase Doma		9e-15
2p0c_A	313	Catalytic Domain Of The Proto-Oncogene Tyrosine-Pro		9e-15
1k2p_A	263	Crystal Structure Of Bruton's Tyrosine Kinase Domai		9e-15
4hjo_A	337	Crystal Structure Of The Inactive Egfr Tyrosine Kin		9e-15
4i23_A	329	Crystal Structure Of The Wild-type Egfr Kinase Doma		9e-15
4g5j_A	330	Crystal Structure Of Egfr Kinase In Complex With Bi		9e-15
1xkk_A	352	Egfr Kinase Domain Complexed With A Quinazoline Inh		9e-15
2gs2_A	330	Crystal Structure Of The Active Egfr Kinase Domain		1e-14
3lzb_A	327	Egfr Kinase Domain Complexed With An Imidazo[2,1-B]		1e-14
3oct_A	265	Crystal Structure Of Bruton's Tyrosine Kinase Mutan		1e-14
3bel_A	315	X-Ray Structure Of Egfr In Complex With Oxime Inhib		1e-14
3gop_A	361	Crystal Structure Of The Egf Receptor Juxtamembrane		2e-14
2a19_B	284	Pkr Kinase Domain- Eif2alpha- Amp-Pnp Complex. Leng		3e-14
2r2p_A	295	Kinase Domain Of Human Ephrin Type-A Receptor 5 (Ep		3e-14
4h1j_A	293	Crystal Structure Of Pyk2 With The Pyrazole 13a Len		3e-14
2rfd_A	324	Crystal Structure Of The Complex Between The Egfr K		3e-14
3uiu_A	306	Crystal Structure Of Apo-Pkr Kinase Domain Length =		3e-14
4i21_A	329	Crystal Structure Of L858r + T790m Egfr Kinase Doma		3e-14
4i1z_A	329	Crystal Structure Of The Monomeric (v948r) Form Of		3e-14
3w2o_A	331	Egfr Kinase Domain T790m/l858r Mutant With Tak-285		3e-14
3fzo_A	277	Crystal Structure Of Pyk2-Apo, Proline-Rich Tyrosin		3e-14
3cc6_A	281	Crystal Structure Of Kinase Domain Of Protein Tyros		3e-14
3ug1_A	334	Crystal Structure Of The Mutated Egfr Kinase Domain		4e-14
2itt_A	327	Crystal Structure Of Egfr Kinase Domain L858r Mutat		4e-14
4i20_A	329	Crystal Structure Of Monomeric (v948r) Primary Onco		4e-14
2eb3_A	334	Crystal Structure Of Mutated Egfr Kinase Domain (L8		4e-14
4aw5_A	291	Complex Of The Ephb4 Kinase Domain With An Oxindole		5e-14
2eb2_A	334	Crystal Structure Of Mutated Egfr Kinase Domain (G7		5e-14
2itn_A	327	Crystal Structure Of Egfr Kinase Domain G719s Mutat		5e-14
2vwu_A	302	Ephb4 Kinase Domain Inhibitor Complex Length = 302		7e-14
3lxn_A	318	Structural And Thermodynamic Characterization Of Th		7e-14
3s95_A	310	Crystal Structure Of The Human Limk1 Kinase Domain		7e-14
2eva_A	307	Structural Basis For The Interaction Of Tak1 Kinase		7e-14
4gs6_A	315	Irreversible Inhibition Of Tak1 Kinase By 5z-7-oxoz		7e-14
3ekk_A	307	Insulin Receptor Kinase Complexed With An Inhibitor		8e-14
1p14_A	306	Crystal Structure Of A Catalytic-Loop Mutant Of The		8e-14
3pp0_A	338	Crystal Structure Of The Kinase Domain Of Human Her		8e-14
3qup_A	323	Inhibitor Bound Structure Of The Kinase Domain Of T		1e-13
1k3a_A	299	Structure Of The Insulin-Like Growth Factor 1 Recep		1e-13
2z8c_A	303	Phosphorylated Insulin Receptor Tyrosine Kinase In		1e-13
2zm3_A	308	Complex Structure Of Insulin-Like Growth Factor Rec		1e-13
2ozo_A	613	Autoinhibited Intact Human Zap-70 Length = 613		1e-13
3i81_A	315	Crystal Structure Of Insulin-Like Growth Factor 1 R		1e-13
1m7n_A	322	Crystal Structure Of Unactivated Apo Insulin-Like G		2e-13
3qqu_A	301	Cocrystal Structure Of Unphosphorylated Igf With Py		2e-13
1ir3_A	306	Phosphorylated Insulin Receptor Tyrosine Kinase In		2e-13
1i44_A	306	Crystallographic Studies Of An Activation Loop Muta		2e-13
3o23_A	305	Human Unphosphorylated Igf1-R Kinase Domain In Comp		2e-13
1irk_A	306	Crystal Structure Of The Tyrosine Kinase Domain Of		2e-13
2oj9_A	307	Structure Of Igf-1r Kinase Domain Complexed With A		2e-13
1jqh_A	308	Igf-1 Receptor Kinase Domain Length = 308		2e-13
3lvp_A	336	Crystal Structure Of Bisphosphorylated Igf1-R Kinas		2e-13
1b6c_B	342	Crystal Structure Of The Cytoplasmic Domain Of The		2e-13
1py5_A	326	Crystal Structure Of Tgf-Beta Receptor I Kinase Wit		2e-13
1rqq_A	306	Crystal Structure Of The Insulin Receptor Kinase In		2e-13
1rw8_A	301	Crystal Structure Of Tgf-Beta Receptor I Kinase Wit		3e-13
3tzm_A	309	Tgf-Beta Receptor Type 1 In Complex With Sb431542 L		3e-13
1vjy_A	303	Crystal Structure Of A Naphthyridine Inhibitor Of H		3e-13
2pvy_A	324	Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D		3e-13
2wot_A	306	Alk5 In Complex With 4-((5,6-Dimethyl-2-(2-Pyridyl)		3e-13
3dak_A	290	Crystal Structure Of Domain-Swapped Osr1 Kinase Dom		3e-13
2vwi_A	303	Structure Of The Osr1 Kinase, A Hypertension Drug T		3e-13
2pvf_A	334	Crystal Structure Of Tyrosine Phosphorylated Activa		3e-13
2pwl_A	324	Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D		3e-13
2pzr_A	324	Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D		3e-13
3cly_A	334	Crystal Structure Of Fgf Receptor 2 (Fgfr2) Kinase		3e-13
2pzp_A	324	Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D		4e-13
2hel_A	306	Crystal Structure Of A Mutant Epha4 Kinase Domain (		4e-13
3sxr_A	268	Crystal Structure Of Bmx Non-Receptor Tyrosine Kina		4e-13
3eta_A	317	Kinase Domain Of Insulin Receptor Complexed With A		4e-13
2y6m_A	291	Crystal Structure Of Epha4 Kinase Domain Length = 2		4e-13
4e1z_A	291	Structure Of Mouse Tyk-2 Complexed To A 3-Aminoinda		4e-13
2pz5_A	324	Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D		4e-13
4e20_A	290	Structure Of Mouse Tyk-2 Complexed To A 3-Aminoinda		4e-13
3b2t_A	311	Structure Of Phosphotransferase Length = 311		5e-13
2xyu_A	285	Crystal Structure Of Epha4 Kinase Domain In Complex		5e-13
3d94_A	301	Crystal Structure Of The Insulin-Like Growth Factor		5e-13
2psq_A	370	Crystal Structure Of Unphosphorylated Unactivated W		5e-13
3cjf_A	309	Crystal Structure Of Vegfr2 In Complex With A 3,4,5		5e-13
3ri1_A	313	Crystal Structure Of The Catalytic Domain Of Fgfr2		5e-13
1gjo_A	316	The Fgfr2 Tyrosine Kinase Domain Length = 316		5e-13
1p4o_A	322	Structure Of Apo Unactivated Igf-1r Kinase Domain A		6e-13
2wqb_A	324	Structure Of The Tie2 Kinase Domain In Complex With		6e-13
3q4t_A	322	Crystal Structure Of Activin Receptor Type-Iia (Acv		7e-13
3lw0_A	304	Igf-1rk In Complex With Ligand Msc1609119a-1 Length		7e-13
3kxx_A	317	Structure Of The Mutant Fibroblast Growth Factor Re		8e-13
1u59_A	287	Crystal Structure Of The Zap-70 Kinase Domain In Co		8e-13
2py3_A	324	Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D		9e-13
2q0b_A	324	Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D		9e-13
3tt0_A	382	Co-Structure Of Fibroblast Growth Factor Receptor 1		1e-12
4apc_A	350	Crystal Structure Of Human Nima-Related Kinase 1 (N		1e-12
3cjg_A	309	Crystal Structure Of Vegfr2 In Complex With A 3,4,5		1e-12
3gqi_A	326	Crystal Structure Of Activated Receptor Tyrosine Ki		1e-12
3rhx_B	306	Crystal Structure Of The Catalytic Domain Of Fgfr1		1e-12
3gql_A	326	Crystal Structure Of Activated Receptor Tyrosine Ki		1e-12
3c4f_A	302	Fgfr Tyrosine Kinase Domain In Complex With 3-(3- M		1e-12
4fl2_A	636	Structural And Biophysical Characterization Of The		1e-12
4f63_A	309	Crystal Structure Of Human Fibroblast Growth Factor		2e-12
1fgk_A	310	Crystal Structure Of The Tyrosine Kinase Domain Of		2e-12
4fl3_A	635	Structural And Biophysical Characterization Of The		2e-12
3v5q_A	297	Discovery Of A Selective Trk Inhibitor With Efficac		2e-12
3js2_A	317	Crystal Structure Of Minimal Kinase Domain Of Fibro		2e-12
4aoj_A	329	Human Trka In Complex With The Inhibitor Az-23 Leng		2e-12
2oo8_X	317	Synthesis, Structural Analysis, And Sar Studies Of		2e-12
4f4p_A	273	Syk In Complex With Ligand Lasw836 Length = 273		2e-12
1fvr_A	327	Tie2 Kinase Domain Length = 327		2e-12
3emg_A	291	Discovery And Sar Of Novel 4-Thiazolyl-2- Phenylami		2e-12
3srv_B	277	Crystal Structure Of Spleen Tyrosine Kinase (Syk) I		2e-12
3c7q_A	316	Structure Of Vegfr2 Kinase Domain In Complex With B		2e-12
4gt5_A	306	Crystal Structure Of The Inactive Trka Kinase Domai		3e-12
4gt4_A	308	Structure Of Unliganded, Inactive Ror2 Kinase Domai		3e-12
3vnt_A	318	Crystal Structure Of The Kinase Domain Of Human Veg		3e-12
2xir_A	316	Crystal Structure Of The Vegfr2 Kinase Domain In Co		3e-12
4f0i_A	300	Crystal Structure Of Apo Trka Length = 300		3e-12
4agc_A	353	Crystal Structure Of Vegfr2 (Juxtamembrane And Kina		3e-12
4dfl_A	274	Crystal Structure Of Spleen Tyrosine Kinase Complex		3e-12
3zzw_A	289	Crystal Structure Of The Kinase Domain Of Ror2 Leng		3e-12
1xba_A	291	Crystal Structure Of Apo Syk Tyrosine Kinase Domain		3e-12
3tub_A	293	Crystal Structure Of Syk Kinase Domain With 1-(5-(6		3e-12
3vf8_A	299	Crystal Structure Of Spleen Tyrosine Kinase Syk Cat		3e-12
2bfy_A	284	Complex Of Aurora-B With Incenp And Hesperidin. Len		3e-12
2oh4_A	316	Crystal Structure Of Vegfr2 With A Benzimidazole-Ur		4e-12
2wtv_A	285	Aurora-A Inhibitor Structure Length = 285		4e-12
2wtw_A	285	Aurora-A Inhibitor Structure (2nd Crystal Form) Len		4e-12
3u6j_A	314	Crystal Structure Of The Vegfr2 Kinase Domain In Co		4e-12
3ewh_A	314	Crystal Structure Of The Vegfr2 Kinase Domain In Co		4e-12
1ywn_A	316	Vegfr2 In Complex With A Novel 4-amino-furo[2,3-d]p		5e-12
3h9r_A	330	Crystal Structure Of The Kinase Domain Of Type I Ac		7e-12
1vr2_A	316	Human Vascular Endothelial Growth Factor Receptor 2		7e-12
2p2i_A	314	Crystal Structure Of The Vegfr2 Kinase Domain In Co		8e-12
3srv_A	277	Crystal Structure Of Spleen Tyrosine Kinase (Syk) I		9e-12
2p2h_A	314	Crystal Structure Of The Vegfr2 Kinase Domain In Co		9e-12
4dym_A	301	Crystal Structure Of The Acvr1 Kinase Domain In Com		1e-11
3mdy_A	337	Crystal Structure Of The Cytoplasmic Domain Of The		1e-11
2vrx_A	285	Structure Of Aurora B Kinase In Complex With Zm4474		1e-11
3mtf_A	301	Crystal Structure Of The Acvr1 Kinase In Complex Wi		1e-11
2bfx_B	284	Mechanism Of Aurora-B Activation By Incenp And Inhi		1e-11
4hzs_A	341	Crystal Structure Of Ack1 Kinase Domain With C-term		1e-11
4af3_A	292	Human Aurora B Kinase In Complex With Incenp And Vx		1e-11
4asz_A	299	Crystal Structure Of Apo Trkb Kinase Domain Length		2e-11
3eqp_B	276	Crystal Structure Of Ack1 With Compound T95 Length		2e-11
1u54_A	291	Crystal Structures Of The Phosphorylated And Unphos		2e-11
1u46_A	291	Crystal Structure Of The Unphosphorylated Kinase Do		2e-11
4ewh_B	275	Co-Crystal Structure Of Ack1 With Inhibitor Length		2e-11
2bmc_A	306	Aurora-2 T287d T288d Complexed With Pha-680632 Leng		2e-11
3kmw_A	271	Crystal Structure Of The IlkALPHA-Parvin Core Compl		2e-11
3coh_A	268	Crystal Structure Of Aurora-A In Complex With A Pen		2e-11
1k9a_A	450	Crystal Structure Analysis Of Full-Length Carboxyl-		2e-11
2jkm_A	276	Focal Adhesion Kinase Catalytic Domain In Complex W		2e-11
2j4z_A	306	Structure Of Aurora-2 In Complex With Pha-680626 Le		2e-11
4aaa_A	331	Crystal Structure Of The Human Cdkl2 Kinase Domain		2e-11
4ebw_A	304	Structure Of Focal Adhesion Kinase Catalytic Domain		2e-11
3pxk_A	282	Focal Adhesion Kinase Catalytic Domain In Complex W		3e-11
3qbn_A	281	Structure Of Human Aurora A In Complex With A Diami		3e-11
2etm_A	281	Crystal Structure Of Focal Adhesion Kinase Domain C		3e-11
1mp8_A	281	Crystal Structure Of Focal Adhesion Kinase (Fak) Le		3e-11
2j0m_B	276	Crystal Structure A Two-Chain Complex Between The F		3e-11
2j0j_A	656	Crystal Structure Of A Fragment Of Focal Adhesion K		3e-11
2jkk_A	276	Focal Adhesion Kinase Catalytic Domain In Complex W		3e-11
2pk9_A	317	Structure Of The Pho85-pho80 Cdk-cyclin Complex Of		3e-11
3bz3_A	276	Crystal Structure Analysis Of Focal Adhesion Kinase		3e-11
2j50_A	280	Structure Of Aurora-2 In Complex With Pha-739358 Le		3e-11
2xru_A	280	Aurora-A T288e Complexed With Pha-828300 Length = 2		4e-11
2qlu_A	314	Crystal Structure Of Activin Receptor Type Ii Kinas		4e-11
2j0k_A	656	Crystal Structure Of A Fragment Of Focal Adhesion K		4e-11
3r21_A	271	Design, Synthesis, And Biological Evaluation Of Pyr		4e-11
2dwb_A	285	Aurora-A Kinase Complexed With Amppnp Length = 285		4e-11
1muo_A	297	Crystal Structure Of Aurora-2, An Oncogenic Serine-		4e-11
2c6e_A	283	Aurora A Kinase Activated Mutant (T287d) In Complex		4e-11
3nrm_A	283	Imidazo[1,2-A]pyrazine-Based Aurora Kinase Inhibito		5e-11
2c6d_A	275	Aurora A Kinase Activated Mutant (T287d) In Complex		5e-11
2xng_A	283	Structure Of Aurora-A Bound To A Selective Imidazop		5e-11
1ol5_A	282	Structure Of Aurora-A 122-403, Phosphorylated On Th		5e-11
3unz_A	279	Aurora A In Complex With Rpm1679 Length = 279		5e-11
3fdn_A	279	Structure-Based Drug Design Of Novel Aurora Kinase		5e-11
2x6d_A	285	Aurora-A Bound To An Inhibitor Length = 285		5e-11
3lau_A	287	Crystal Structure Of Aurora2 Kinase In Complex With		5e-11
3o50_A	267	Crystal Structure Of Benzamide 9 Bound To Auroraa L		6e-11
1mq4_A	272	Crystal Structure Of Aurora-A Protein Kinase Length		6e-11
3e5a_A	268	Crystal Structure Of Aurora A In Complex With Vx-68		6e-11
3ha6_A	268	Crystal Structure Of Aurora A In Complex With Tpx2		6e-11
3d7u_A	263	Structural Basis For The Recognition Of C-Src By It		6e-11
3h0y_A	268	Aurora A In Complex With A Bisanilinopyrimidine Len		7e-11
3d7t_A	269	Structural Basis For The Recognition Of C-Src By It		7e-11
1byg_A	278	Kinase Domain Of Human C-Terminal Src Kinase (Csk)		7e-11
2w1c_A	275	Structure Determination Of Aurora Kinase In Complex		8e-11
2w1d_A	275	Structure Determination Of Aurora Kinase In Complex		8e-11
2j0l_A	276	Crystal Structure Of A The Active Conformation Of T		8e-11
1luf_A	343	Crystal Structure Of The Musk Tyrosine Kinase: Insi		9e-11
2wqe_A	262	Structure Of S155r Aurora-A Somatic Mutant Length =		9e-11
3daj_A	272	Crystal Structure Of Aurora A Complexed With An Inh		1e-10
2ivv_A	314	Crystal Structure Of Phosphorylated Ret Tyrosine Ki		1e-10
3d14_A	272	Crystal Structure Of Mouse Aurora A (Asn186->gly, L		1e-10
4hzr_A	277	Crystal Structure Of Ack1 Kinase Domain Length = 27		1e-10
2wqm_A	310	Structure Of Apo Human Nek7 Length = 310		1e-10
2ivt_A	314	Crystal Structure Of Phosphorylated Ret Tyrosine Ki		1e-10
2ivs_A	314	Crystal Structure Of Non-Phosphorylated Ret Tyrosin		1e-10
4id7_A	273	Ack1 Kinase In Complex With The Inhibitor Cis-3-[8-		1e-10
3c4c_A	280	B-Raf Kinase In Complex With Plx4720 Length = 280		1e-10
4fk3_A	292	B-Raf Kinase V600e Oncogenic Mutant In Complex With		2e-10
1ol6_A	282	Structure Of Unphosphorylated D274n Mutant Of Auror		2e-10
2xne_A	272	Structure Of Aurora-A Bound To An Imidazopyrazine I		2e-10
3og7_A	289	B-Raf Kinase V600e Oncogenic Mutant In Complex With		2e-10
2jav_A	279	Human Kinase With Pyrrole-Indolinone Ligand Length		3e-10
1rjb_A	344	Crystal Structure Of Flt3 Length = 344		4e-10
2w5a_A	279	Human Nek2 Kinase Adp-Bound Length = 279		4e-10
3my0_A	305	Crystal Structure Of The Acvrl1 (Alk1) Kinase Domai		5e-10
2fb8_A	281	Structure Of The B-Raf Kinase Domain Bound To Sb-59		6e-10
3q96_A	282	B-Raf Kinase Domain In Complex With A Tetrahydronap		6e-10
2ogv_A	317	Crystal Structure Of The Autoinhibited Human C-Fms		6e-10
4h58_A	275	Braf In Complex With Compound 3 Length = 275		7e-10
4dbn_A	284	Crystal Structure Of The Kinase Domain Of Human B-R		7e-10
3d4q_A	307	Pyrazole-Based Inhibitors Of B-Raf Kinase Length =		8e-10
1uwh_A	276	The Complex Of Wild Type B-Raf And Bay439006 Length		8e-10
3ii5_A	306	The Complex Of Wild-Type B-Raf With Pyrazolo Pyrimi		8e-10
1uwj_A	276	The Complex Of Mutant V599e B-raf And Bay439006 Len		8e-10
3lco_A	324	Inhibitor Bound To A Dfg-Out Structure Of The Kinas		9e-10
3lcd_A	329	Inhibitor Bound To A Dfg-In Structure Of The Kinase		9e-10
3idp_A	300	B-Raf V600e Kinase Domain In Complex With An Aminoi		9e-10
2jc6_A	334	Crystal Structure Of Human Calmodulin-Dependent Pro		1e-09
4g9r_A	307	B-Raf V600e Kinase Domain Bound To A Type Ii Dihydr		1e-09
1fot_A	318	Structure Of The Unliganded Camp-Dependent Protein		1e-09
3kmu_A	271	Crystal Structure Of The IlkALPHA-Parvin Core Compl		1e-09
2y94_A	476	Structure Of An Active Form Of Mammalian Ampk Lengt		1e-09
4a4x_A	279	Nek2-Ede Bound To Cct248662 Length = 279		2e-09
1u5q_A	348	Crystal Structure Of The Tao2 Kinase Domain: Activa		2e-09
1a06_A	332	Calmodulin-Dependent Protein Kinase From Rat Length		2e-09
2z7q_A	321	Crystal Structure Of The N-Terminal Kinase Domain O		3e-09
4fg7_A	293	Crystal Structure Of Human Calcium/calmodulin-depen		3e-09
2gcd_A	309	Tao2 Kinase Domain-Staurosporine Structure Length =		4e-09
2xik_A	294	Structure Of Human Ysk1 (Yeast Sps1-Ste20-Related K		4e-09
4fg9_A	320	Crystal Structure Of Human Calcium/calmodulin-depen		5e-09
2buj_A	317	Crystal Structure Of The Human Serine-Threonine Kin		5e-09
4fg8_A	315	Crystal Structure Of Human Calcium/calmodulin-depen		5e-09
4eqm_A	294	Structural Analysis Of Staphylococcus Aureus Serine		5e-09
2wzj_A	327	Catalytic And Uba Domain Of Kinase Mark2(PAR-1) K82		6e-09
4fvr_A	289	Crystal Structure Of The Jak2 Pseudokinase Domain M		6e-09
3omv_A	307	Crystal Structure Of C-Raf (Raf-1) Length = 307		6e-09
1zmv_A	327	Catalytic And Ubiqutin-Associated Domains Of Mark2P		6e-09
4fvp_A	289	Crystal Structure Of The Jak2 Pseudokinase Domain (		7e-09
3a7f_A	303	Human Mst3 Kinase Length = 303		7e-09
2i1m_A	333	Cfms Tyrosine Kinase (Tie2 Kid) In Complex With An		8e-09
3g0f_A	336	Kit Kinase Domain Mutant D816h In Complex With Suni		9e-09
1zmw_A	327	Catalytic And Ubiqutin-Associated Domains Of Mark2P		9e-09
3zhp_C	294	Human Mst3 (stk24) In Complex With Mo25beta Length		9e-09
2i0v_A	335	C-Fms Tyrosine Kinase In Complex With A Quinolone I		1e-08
1t46_A	313	Structural Basis For The Autoinhibition And Sti-571		1e-08
3mtl_A	324	Crystal Structure Of The Pctaire1 Kinase In Complex		1e-08
3g0e_A	336	Kit Kinase Domain In Complex With Sunitinib Length		1e-08
2h6d_A	276	Protein Kinase Domain Of The Human 5'-Amp-Activated		1e-08
3ckw_A	304	Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3		1e-08
1t45_A	331	Structural Basis For The Autoinhibition And Sti-571		1e-08
1pkg_A	329	Structure Of A C-kit Kinase Product Complex Length		1e-08
3ckx_A	304	Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3		1e-08
2jed_A	352	The Crystal Structure Of The Kinase Domain Of The P		1e-08
3bea_A	333	Cfms Tyrosine Kinase (Tie2 Kid) In Complex With A P		2e-08
1zmu_A	327	Catalytic And Ubiqutin-Associated Domains Of Mark2P		2e-08
2r0i_A	327	Crystal Structure Of A Kinase Mark2PAR-1 Mutant Len		2e-08
1xjd_A	345	Crystal Structure Of Pkc-Theta Complexed With Staur		3e-08
2w9f_B	306	Crystal Structure Of Cdk4 In Complex With A D-Type		3e-08
3g51_A	325	Structural Diversity Of The Active Conformation Of		3e-08
2fh9_A	274	Structure And Dimerization Of The Kinase Domain Fro		3e-08
3mn3_A	271	An Inhibited Conformation For The Protein Kinase Do		3e-08
2x7f_A	326	Crystal Structure Of The Kinase Domain Of Human Tra		3e-08
3hyh_A	275	Crystal Structure Of The Protein Kinase Domain Of Y		3e-08
3ubd_A	304	Structure Of N-Terminal Domain Of Rsk2 Kinase In Co		4e-08
4el9_A	305	Structure Of N-Terminal Kinase Domain Of Rsk2 With		4e-08
3iec_A	319	Helicobacter Pylori Caga Inhibits Par1MARK FAMILY K		4e-08
3ggf_A	301	Crystal Structure Of Human SerineTHREONINE-Protein		4e-08
3dae_A	283	Crystal Structure Of Phosphorylated Snf1 Kinase Dom		4e-08
1v0o_A	288	Structure Of P. Falciparum Pfpk5-Indirubin-5-Sulpho		4e-08
3fe3_A	328	Crystal Structure Of The Kinase Mark3PAR-1: T211a-S		4e-08
3fpq_A	290	Crystal Structure Of The Kinase Domain Of Wnk1 Leng		4e-08
3cok_A	278	Crystal Structure Of Plk4 Kinase Length = 278		4e-08
1v0b_A	288	Crystal Structure Of The T198a Mutant Of Pfpk5 Leng		4e-08
2qnj_A	328	Kinase And Ubiquitin-Associated Domains Of Mark3PAR		5e-08
2w99_B	306	Crystal Structure Of Cdk4 In Complex With A D-Type		5e-08
1ob3_A	288	Structure Of P. Falciparum Pfpk5 Length = 288		5e-08
2yza_A	276	Crystal Structure Of Kinase Domain Of Human 5'-Amp-		6e-08
3zgw_A	347	Crystal Structure Of Maternal Embryonic Leucine Zip		7e-08
1y8g_A	327	Catalytic And Ubiqutin-Associated Domains Of Mark2P		7e-08
3is5_A	285	Crystal Structure Of Cdpk Kinase Domain From Toxopl		7e-08
2y4i_B	319	Ksr2-Mek1 Heterodimer Length = 319		7e-08
2w96_B	306	Crystal Structure Of Cdk4 In Complex With A D-Type		7e-08
3ku2_A	507	Crystal Structure Of Inactivated Form Of Cdpk1 From		7e-08
3g33_A	308	Crystal Structure Of Cdk4CYCLIN D3 Length = 308		7e-08
3i79_A	484	Calcium-Dependent Protein Kinase 1 From Toxoplasma		7e-08
2yjr_A	342	Structure Of F1174l Mutant Anaplastic Lymphoma Kina		8e-08
3hx4_A	508	Crystal Structure Of Cdpk1 Of Toxoplasma Gondii, Tg		8e-08
1zy4_A	303	Crystal Structure Of Eif2alpha Protein Kinase Gcn2:		1e-07
4fnw_A	327	Crystal Structure Of The Apo F1174l Anaplastic Lymp		1e-07
3qa8_A	676	Crystal Structure Of Inhibitor Of Kappa B Kinase Be		1e-07
3niz_A	311	Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5		1e-07
3rzf_A	677	Crystal Structure Of Inhibitor Of Kappab Kinase Bet		1e-07
4eop_A	300	Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3		1e-07
1y6a_A	366	Crystal Structure Of Vegfr2 In Complex With A 2-Ani		1e-07
3vhk_A	368	Crystal Structure Of The Vegfr2 Kinase Domain In Co		1e-07
2qkr_A	313	Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5		1e-07
3vhe_A	359	Crystal Structure Of Human Vegfr2 Kinase Domain Wit		1e-07
4eoo_A	299	Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3		1e-07
3vid_A	356	Crystal Structure Of Human Vegfr2 Kinase Domain Wit		1e-07
3hng_A	360	Crystal Structure Of Vegfr1 In Complex With N-(4-ch		2e-07
4eom_A	301	Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Hum		2e-07
3ma6_A	298	Crystal Structure Of Kinase Domain Of Tgcdpk1 In Pr		2e-07
3oz6_A	388	Crystal Structure Of Mapk From Cryptosporidium Parv		2e-07
2xb7_A	315	Structure Of Human Anaplastic Lymphoma Kinase In Co		2e-07
2yhv_A	342	Structure Of L1196m Mutant Anaplastic Lymphoma Kina		2e-07
3igo_A	486	Crystal Structure Of Cryptosporidium Parvum Cdpk1,		2e-07
4erw_A	306	Cdk2 In Complex With Staurosporine Length = 306		2e-07
2yfx_A	327	Structure Of L1196m Mutant Anaplastic Lymphoma Kina		2e-07
4eon_A	300	Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Hum		2e-07
2xp2_A	327	Structure Of The Human Anaplastic Lymphoma Kinase I		2e-07
4fnx_A	327	Crystal Structure Of The Apo R1275q Anaplastic Lymp		2e-07
3dfa_A	286	Crystal Structure Of Kinase Domain Of Calcium-depen		2e-07
1gz8_A	299	Human Cyclin Dependent Kinase 2 Complexed With The		2e-07
2wei_A	287	Crystal Structure Of The Kinase Domain Of Cryptospo		2e-07
1ogu_A	302	Structure Of Human Thr160-phospho Cdk2/cyclin A Com		2e-07
2yjs_A	342	Structure Of C1156y Mutant Anaplastic Lymphoma Kina		3e-07
1h1p_A	303	Structure Of Human Thr160-Phospho Cdk2CYCLIN A COMP		3e-07
4eoq_A	301	Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Co		3e-07
4bcq_A	301	Structure Of Cdk2 In Complex With Cyclin A And A 2-		3e-07
3aox_A	344	X-Ray Crystal Structure Of Human Anaplastic Lymphom		3e-07
4eos_A	300	Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Co		3e-07
4fnz_A	327	Crystal Structure Of Human Anaplastic Lymphoma Kina		3e-07
4dce_A	333	Crystal Structure Of Human Anaplastic Lymphoma Kina		3e-07
1bi8_A	326	Mechanism Of G1 Cyclin Dependent Kinase Inhibition		3e-07
3qhr_A	298	Structure Of A Pcdk2CYCLINA TRANSITION-State Mimic		3e-07
4i3z_A	296	Structure Of Pcdk2CYCLINA BOUND TO ADP AND 2 MAGNES		3e-07
3bht_A	300	Structure Of Phosphorylated Thr160 Cdk2CYCLIN A IN		3e-07
1qmz_A	299	Phosphorylated Cdk2-Cyclyin A-Substrate Peptide Com		3e-07
1w98_A	298	The Structural Basis Of Cdk2 Activation By Cyclin E		3e-07
3pxf_A	306	Cdk2 In Complex With Two Molecules Of 8-Anilino-1-N		3e-07
1e9h_A	297	Thr 160 Phosphorylated Cdk2-Human Cyclin A3 Complex		3e-07
1jst_A	298	Phosphorylated Cyclin-Dependent Kinase-2 Bound To C		3e-07
1vyw_A	309	Structure Of Cdk2CYCLIN A WITH PNU-292137 Length =		3e-07
3pj8_A	299	Structure Of Cdk2 In Complex With A Pyrazolo[4,3-D]		3e-07
3ezr_A	300	Cdk-2 With Indazole Inhibitor 17 Bound At Its Activ		3e-07
2w17_A	299	Cdk2 In Complex With The Imidazole Pyrimidine Amide		4e-07
1fin_A	298	Cyclin A-Cyclin-Dependent Kinase 2 Complex Length =		4e-07
1pf8_A	298	Crystal Structure Of Human Cyclin-dependent Kinase		4e-07
2jgz_A	289	Crystal Structure Of Phospho-Cdk2 In Complex With C		4e-07
1h4l_A	292	Structure And Regulation Of The Cdk5-P25(Nck5a) Com		4e-07
1oit_A	299	Imidazopyridines: A Potent And Selective Class Of C		4e-07
3l9p_A	367	Crystal Structure Of The Anaplastic Lymphoma Kinase		5e-07
3lct_A	344	Crystal Structure Of The Anaplastic Lymphoma Kinase		5e-07
4fob_A	353	Crystal Structure Of Human Anaplastic Lymphoma Kina		5e-07
1zxe_A	303	Crystal Structure Of Eif2alpha Protein Kinase Gcn2:		5e-07
3nup_A	307	Cdk6 (Monomeric) In Complex With Inhibitor Length =		5e-07
1jow_B	308	Crystal Structure Of A Complex Of Human Cdk6 And A		5e-07
2jam_A	304	Crystal Structure Of Human Calmodulin-Dependent Pro		6e-07
4eoi_A	299	Thr 160 Phosphorylated Cdk2 K89d, Q131e - Human Cyc		6e-07
3i7c_A	484	Calcium-Dependent Protein Kinase 1 From Toxoplasma		6e-07
2zoq_A	382	Structural Dissection Of Human Mitogen-Activated Ki		7e-07
1zyc_A	303	Crystal Structure Of Eif2alpha Protein Kinase Gcn2:		7e-07
2hak_A	328	Catalytic And Ubiqutin-Associated Domains Of Mark1P		9e-07
1oir_A	299	Imidazopyridines: A Potent And Selective Class Of C		1e-06
1h01_A	298	Cdk2 In Complex With A Disubstituted 2, 4-Bis Anili		1e-06
2iw8_A	302	Structure Of Human Thr160-Phospho Cdk2-Cyclin A F82		1e-06
2iw6_A	302	Structure Of Human Thr160-Phospho Cdk2-Cyclin A Com		1e-06
2bdw_A	362	Crystal Structure Of The Auto-Inhibited Kinase Doma		1e-06
1ung_A	292	Structural Mechanism For The Inhibition Of Cdk5-P25		1e-06
4eoj_A	302	Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Huma		2e-06
3txo_A	353	Pkc Eta Kinase In Complex With A Naphthyridine Leng		2e-06
3kl8_A	269	Camkiintide Inhibitor Complex Length = 269		2e-06
4eok_A	300	Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Huma		2e-06
2y7j_A	365	Structure Of Human Phosphorylase Kinase, Gamma 2 Le		2e-06
3kk8_A	284	Camkii Substrate Complex A Length = 284		2e-06
3kk9_A	282	Camkii Substrate Complex B Length = 282		2e-06
2y4i_C	395	Ksr2-Mek1 Heterodimer Length = 395		3e-06
1ua2_A	346	Crystal Structure Of Human Cdk7 Length = 346		3e-06
1gzk_A	315	Molecular Mechanism For The Regulation Of Protein K		3e-06
1mrv_A	339	Crystal Structure Of An Inactive Akt2 Kinase Domain		4e-06
3a60_A	327	Crystal Structure Of Unphosphorylated P70s6k1 (Form		4e-06
1gzn_A	335	Structure Of Pkb Kinase Domain Length = 335		4e-06
3com_A	314	Crystal Structure Of Mst1 Kinase Length = 314		4e-06
3a62_A	327	Crystal Structure Of Phosphorylated P70s6k1 Length		4e-06
1ql6_A	298	The Catalytic Mechanism Of Phosphorylase Kinase Pro		4e-06
3eqc_A	360	X-Ray Structure Of The Human Mitogen-Activated Prot		5e-06
2ydj_A	276	Discovery Of Checkpoint Kinase Inhibitor Azd7762 By		6e-06
3sls_A	304	Crystal Structure Of Human Mek-1 Kinase In Complex		6e-06
3orx_A	316	Pdk1 Mutant Bound To Allosteric Disulfide Fragment		6e-06
4fsz_A	279	Crystal Structure Of The Chk1 Length = 279		6e-06
1zys_A	273	Co-Crystal Structure Of Checkpoint Kinase Chk1 With		6e-06
4fsy_A	279	Crystal Structure Of The Chk1 Length = 279		7e-06
1q3d_A	424	Gsk-3 Beta Complexed With Staurosporine Length = 42		7e-06
1pyx_A	422	Gsk-3 Beta Complexed With Amp-Pnp Length = 422		7e-06
1i09_A	420	Structure Of Glycogen Synthase Kinase-3 (Gsk3b) Len		7e-06
1r0e_A	391	Glycogen Synthase Kinase-3 Beta In Complex With 3-I		7e-06
1q5k_A	414	Crystal Structure Of Glycogen Synthase Kinase 3 In		7e-06
2e9v_A	268	Structure Of H-Chk1 Complexed With A859017 Length =		7e-06
4acc_A	465	Gsk3b In Complex With Inhibitor Length = 465		7e-06
2hog_A	322	Crystal Structure Of Chek1 In Complex With Inhibito		7e-06
2ayp_A	269	Crystal Structure Of Chk1 With An Indol Inhibitor L		7e-06
3say_A	430	Crystal Structure Of Human Glycogen Synthase Kinase		8e-06
2ghg_A	269	H-Chk1 Complexed With A431994 Length = 269		8e-06
1phk_A	298	Two Structures Of The Catalytic Domain Of Phosphory		8e-06
3jvr_A	271	Characterization Of The Chk1 Allosteric Inhibitor B		8e-06
2r0u_A	323	Crystal Structure Of Chek1 In Complex With Inhibito		8e-06
2phk_A	277	The Crystal Structure Of A Phosphorylase Kinase Pep		8e-06
2br1_A	297	Structure-Based Design Of Novel Chk1 Inhibitors: In		8e-06
1ia8_A	289	The 1.7 A Crystal Structure Of Human Cell Cycle Che		8e-06
1zlt_A	295	Crystal Structure Of Chk1 Complexed With A Hymenald		8e-06
4fsn_A	278	Crystal Structure Of The Chk1 Length = 278		8e-06
2o5k_A	372	Crystal Structure Of Gsk3beta In Complex With A Ben		8e-06
1gii_A	298	Human Cyclin Dependent Kinase 2 Complexed With The		8e-06
1gng_A	378	Glycogen Synthase Kinase-3 Beta (Gsk3) Complex With		8e-06
4fst_A	269	Crystal Structure Of The Chk1 Length = 269		8e-06
4afj_A	367	5-Aryl-4-Carboxamide-1,3-Oxazoles: Potent And Selec		8e-06
4fsm_A	279	Crystal Structure Of The Chk1 Length = 279		8e-06
3ot3_A	273	X-Ray Crystal Structure Of Compound 22k Bound To Hu		8e-06
4fsw_A	279	Crystal Structure Of The Chk1 Length = 279		9e-06
2jdo_A	342	Structure Of Pkb-Beta (Akt2) Complexed With Isoquin		9e-06
2x8e_A	276	Discovery Of A Novel Class Of Triazolones As Checkp		9e-06
3h4j_B	336	Crystal Structure Of Pombe Ampk Kdaid Fragment Leng		9e-06
1o6k_A	336	Structure Of Activated Form Of Pkb Kinase Domain S4		9e-06
3f7z_A	350	X-ray Co-crystal Structure Of Glycogen Synthase Kin		9e-06
3e87_A	335	Crystal Structures Of The Kinase Domain Of Akt2 In		9e-06
4dit_A	382	Crystal Structure Of Gsk3beta In Complex With A Imi		9e-06
3zrk_A	371	Identification Of 2-(4-Pyridyl)thienopyridinones As		1e-05
3gb2_A	353	Gsk3beta Inhibitor Complex Length = 353		1e-05
1o6l_A	337	Crystal Structure Of An Activated Akt/protein Kinas		1e-05
4ft3_A	279	Crystal Structure Of The Chk1 Length = 279		1e-05
2ow3_A	352	Glycogen Synthase Kinase-3 Beta In Complex With Bis		1e-05
1h8f_A	352	Glycogen Synthase Kinase 3 Beta. Length = 352		1e-05
3zdi_A	350	Glycogen Synthase Kinase 3 Beta Complexed With Axin		1e-05
3sd0_A	350	Identification Of A Glycogen Synthase Kinase-3b Inh		1e-05
1yrp_A	278	Catalytic Domain Of Human Zip Kinase Phosphorylated		1e-05
1uv5_A	350	Glycogen Synthase Kinase 3 Beta Complexed With 6-Br		1e-05
4b8c_D	727	Nuclease Module Of The Yeast Ccr4-Not Complex Lengt		1e-05
3o96_A	446	Crystal Structure Of Human Akt1 With An Allosteric		1e-05
4ec8_A	373	Structure Of Full Length Cdk9 In Complex With Cycli		1e-05
4ejn_A	446	Crystal Structure Of Autoinhibited Form Of Akt1 In		1e-05
3f69_A	311	Crystal Structure Of The Mycobacterium Tuberculosis		2e-05
3f61_A	311	Crystal Structure Of M. Tuberculosis Pknb Leu33aspV		2e-05
1o9u_A	350	Glycogen Synthase Kinase 3 Beta Complexed With Axin		2e-05
1s9j_A	341	X-Ray Structure Of The Human Mitogen-Activated Prot		2e-05
2fsl_X	367	Mitogen Activated Protein Kinase P38alpha (D176a+f3		2e-05
2p55_A	333	X-Ray Structure Of The Human Mitogen-Activated Prot		2e-05
3rgf_A	405	Crystal Structure Of Human Cdk8CYCC Length = 405		2e-05
3cqu_A	342	Crystal Structure Of Akt-1 Complexed With Substrate		2e-05
2fst_X	367	Mitogen Activated Protein Kinase P38alpha (d176a+f3		2e-05
3gbz_A	329	Structure Of The Cmgc Cdk Kinase From Giardia Lambl		2e-05
3blh_A	331	Crystal Structure Of Human Cdk9CYCLINT1 Length = 33		2e-05
2fso_X	367	Mitogen Activated Protein Kinase P38alpha (D176a) A		2e-05
3mi9_A	351	Crystal Structure Of Hiv-1 Tat Complexed With Human		2e-05
2biy_A	310	Structure Of Pdk1-S241a Mutant Kinase Domain Length		2e-05
3mbl_A	328	Crystal Structure Of The Human Mitogen-Activated Pr		2e-05
3dv3_A	322	Mek1 With Pf-04622664 Bound Length = 322		2e-05
3rny_A	346	Crystal Structure Of Human Rsk1 C-Terminal Kinase D		2e-05
3ocb_A	341	Akt1 Kinase Domain With Pyrrolopyrimidine Inhibitor		2e-05
2wnt_A	330	Crystal Structure Of The Human Ribosomal Protein S6		3e-05
3f88_A	349	Glycogen Synthase Kinase 3beta Inhibitor Complex Le		3e-05
4gv1_A	340	Pkb Alpha In Complex With Azd5363 Length = 340		3e-05
3d83_A	360	Crystal Structure Of P38 Kinase In Complex With A B		3e-05
3orn_A	307	Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In		3e-05
3bhy_A	283	Crystal Structure Of Human Death Associated Protein		3e-05
2r5t_A	373	Crystal Structure Of Inactive Serum And Glucocortic		3e-05
3ori_A	311	Mycobacterium Tuberculosis Pknb Kinase Domain L33d		3e-05
1mru_A	311	Intracellular SerTHR PROTEIN KINASE DOMAIN OF Mycob		3e-05
4an2_A	301	Crystal Structures Of Human Mek1 With Carboxamide-B		3e-05
1cm8_A	367	Phosphorylated Map Kinase P38-Gamma Length = 367		3e-05
3orm_A	311	Mycobacterium Tuberculosis Pknb Kinase Domain D76a		3e-05
1s9i_A	354	X-Ray Structure Of The Human Mitogen-Activated Prot		4e-05
1o6y_A	299	Catalytic Domain Of Pknb Kinase From Mycobacterium		4e-05
4fsu_A	279	Crystal Structure Of The Chk1 Length = 279		4e-05
2j90_A	304	Crystal Structure Of Human Zip Kinase In Complex Wi		4e-05
1zws_A	288	Crystal Structure Of The Catalytic Domain Of Human		4e-05
3d7z_A	360	Crystal Structure Of P38 Kinase In Complex With A B		5e-05
4bc6_A	293	Crystal Structure Of Human Serine Threonine Kinase-		6e-05
2r7b_A	312	Crystal Structure Of The Phosphoinositide-Dependent		6e-05
1z9x_A	321	Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal		6e-05
2a27_A	321	Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal		6e-05
3mh0_A	360	Mutagenesis Of P38 Map Kinase Eshtablishes Key Role		6e-05
1wmk_A	321	Human Death-Associated Kinase Drp-1, Mutant S308d D		6e-05
3gcp_A	360	Human P38 Map Kinase In Complex With Sb203580 Lengt		6e-05
2a2a_A	321	High-resolution Crystallographic Analysis Of The Au		6e-05
1vzo_A	355	The Structure Of The N-Terminal Kinase Domain Of Ms		7e-05
3e92_A	371	Crystal Structure Of P38 Kinase In Complex With A B		7e-05
2bal_A	365	P38alpha Map Kinase Bound To Pyrazoloamine Length =		7e-05
4a07_A	311	Human Pdk1 Kinase Domain In Complex With Allosteric		7e-05
2j7t_A	302	Crystal Structure Of Human Serine Threonine Kinase-		7e-05
4fr4_A	384	Crystal Structure Of Human SerineTHREONINE-Protein		8e-05
3py3_A	380	Crystal Structure Of Phosphorylated P38alpha Map Ki		8e-05
3nnx_A	354	Crystal Structure Of Phosphorylated P38 Alpha In Co		8e-05
4e5a_X	360	The W197a Mutant Of P38a Map Kinase Length = 360		8e-05
3iop_A	312	Pdk-1 In Complex With The Inhibitor Compound-8i Len		8e-05
2vz6_A	313	Structure Of Human Calcium Calmodulin Dependent Pro		8e-05
1uu3_A	310	Structure Of Human Pdk1 Kinase Domain In Complex Wi		8e-05
2xch_A	309	Crystal Structure Of Pdk1 In Complex With A Pyrazol		8e-05
3qc4_A	314	Pdk1 In Complex With Dfg-Out Inhibitor Xxx Length =		9e-05
1bmk_A	379	The Complex Structure Of The Map Kinase P38SB218655		9e-05
3h9o_A	311	Phosphoinositide-Dependent Protein Kinase 1 (Pdk-1)		9e-05
4gsb_A	364	Monoclinic Crystal Form Of The Apo-Erk2 Length = 36		9e-05
3rwp_A	311	Discovery Of A Novel, Potent And Selective Inhibito		9e-05
4bcf_A	331	Structure Of Cdk9 In Complex With Cyclin T And A 2-		9e-05
3tg1_A	380	Crystal Structure Of P38alpha In Complex With A Map		9e-05
2y8o_A	362	Crystal Structure Of Human P38alpha Complexed With		9e-05
3nnu_A	354	Crystal Structure Of P38 Alpha In Complex With Dp13		9e-05
3hrc_A	311	Crystal Structure Of A Mutant Of Human Pdk1 Kinase		9e-05
3kn5_A	325	Crystal Structure Of The C-Terminal Kinase Domain O		9e-05
1h1w_A	289	High Resolution Crystal Structure Of The Human Pdk1		9e-05
3nax_A	311	Pdk1 In Complex With Inhibitor Mp7 Length = 311		9e-05
4g31_A	299	Crystal Structure Of Gsk6414 Bound To Perk (R587-R1		1e-04
3ody_X	360	Crystal Structure Of P38alpha Y323q Active Mutant L		1e-04
1ove_A	366	The Structure Of P38 Alpha In Complex With A Dihydr		1e-04
3sc1_A	311	Novel Isoquinolone Pdk1 Inhibitors Discovered Throu		1e-04
3dt1_A	383	P38 Complexed With A Quinazoline Inhibitor Length =		1e-04
1lew_A	360	Crystal Structure Of Map Kinase P38 Complexed To Th		1e-04
3od6_X	360	Crystal Structure Of P38alpha Y323t Active Mutant L		1e-04
3kq7_A	380	Structure Of Human P38alpha With N-[4-Methyl-3-(6-{		1e-04
1bl6_A	379	The Complex Structure Of The Map Kinase P38SB216995		1e-04
2baq_A	365	P38alpha Bound To Ro3201195 Length = 365		1e-04
3pwy_A	311	Crystal Structure Of An Extender (Spd28345)-Modifie		1e-04
3hvc_A	362	Crystal Structure Of Human P38alpha Map Kinase Leng		1e-04
3hec_A	348	P38 In Complex With Imatinib Length = 348		1e-04
1uu9_A	286	Structure Of Human Pdk1 Kinase Domain In Complex Wi		1e-04
3odz_X	360	Crystal Structure Of P38alpha Y323r Active Mutant L		1e-04
3mpt_A	371	Crystal Structure Of P38 Kinase In Complex With A P		1e-04
3k3i_A	350	P38alpha Bound To Novel Dgf-Out Compound Pf-0021595		1e-04
3gcu_A	360	Human P38 Map Kinase In Complex With Rl48 Length =		1e-04
1z5m_A	286	Crystal Structure Of N1-[3-[[5-bromo-2-[[3-[(1-pyrr		1e-04
2lgc_A	359	Joint Nmr And X-Ray Refinement Reveals The Structur		1e-04
3mh2_A	360	Mutagenesis Of P38 Map Kinase Establishes Key Roles		1e-04
3s3i_A	349	P38 Kinase Crystal Structure In Complex With Small		1e-04
3k3j_A	362	P38alpha Bound To Novel Dfg-Out Compound Pf-0041612		1e-04
2gtm_A	348	Mutated Mouse P38 Map Kinase Domain In Complex With		1e-04
2baj_A	365	P38alpha Bound To Pyrazolourea Length = 365		1e-04
1zzl_A	351	Crystal Structure Of P38 With Triazolopyridine Leng		1e-04
3oef_X	360	Crystal Structure Of Y323f Inactive Mutant Of P38al		1e-04
3hrb_A	359	P38 Kinase Crystal Structure In Complex With Small		1e-04
1oz1_A	372	P38 Mitogen-Activated Kinase In Complex With 4-Azai		1e-04
3fi4_A	372	P38 Kinase Crystal Structure In Complex With Ro4499		1e-04
2gfs_A	372	P38 Kinase Crystal Structure In Complex With Ro3201		1e-04
3zsg_A	362	X-Ray Structure Of P38alpha Bound To Tak-715 Length		1e-04
1gol_A	364	Coordinates Of Rat Map Kinase Erk2 With An Arginine		1e-04
3iw4_A	360	Crystal Structure Of Pkc Alpha In Complex With Nvp-		1e-04
1di9_A	360	The Structure Of P38 Mitogen-Activated Protein Kina		1e-04
3tei_A	362	Crystal Structure Of Human Erk2 Complexed With A Ma		1e-04
2npq_A	367	A Novel Lipid Binding Site In The P38 Alpha Map Kin		1e-04
1m7q_A	366	Crystal Structure Of P38 Map Kinase In Complex With		1e-04
3nus_A	286	Phosphoinositide-Dependent Kinase-1 (Pdk1) With Fra		1e-04
1ian_A	366	Human P38 Map Kinase Inhibitor Complex Length = 366		1e-04
4ewq_A	383	Human P38 Alpha Mapk In Complex With A Pyridazine B		1e-04
3mh1_A	360	Mutagenesis Of P38 Map Kinase Establishes Key Roles		1e-04
2v7o_A	336	Crystal Structure Of Human Calcium-Calmodulin-Depen		1e-04
2oza_B	366	Structure Of P38alpha Complex Length = 366		1e-04
4h3q_A	362	Crystal Structure Of Human Erk2 Complexed With A Ma		1e-04
3mh3_A	360	Mutagenesis Of P38 Map Kinase Establishes Key Roles		1e-04
1yw2_A	360	Mutated Mus Musculus P38 Kinase (Mp38) Length = 360		1e-04
2acx_A	576	Crystal Structure Of G Protein Coupled Receptor Kin		1e-04
4fux_A	360	Crystal Structure Of The Erk2 Complexed With E75 Le		1e-04
1ywr_A	360	Crystal Structure Analysis Of Inactive P38 Kinase D		1e-04
3nay_A	311	Pdk1 In Complex With Inhibitor Mp6 Length = 311		1e-04
3nun_A	292	Phosphoinositide-Dependent Kinase-1 (Pdk1) With Lea		1e-04
3nyn_A	576	Crystal Structure Of G Protein-Coupled Receptor Kin		1e-04
3sa0_A	360	Complex Of Erk2 With Norathyriol Length = 360		1e-04
4fv7_A	360	Crystal Structure Of The Erk2 Complexed With E94 Le		1e-04
3pfq_A	674	Crystal Structure And Allosteric Activation Of Prot		1e-04
2ghl_A	348	Mutant Mus Musculus P38 Kinase Domain In Complex Wi		1e-04
2xck_A	309	Crystal Structure Of Pdk1 In Complex With A Pyrazol		2e-04
3aln_A	327	Crystal Structure Of Human Non-Phosphorylated Mkk4		2e-04
2ya9_A	361	Crystal Structure Of The Autoinhibited Form Of Mous		2e-04
2y9q_A	362	Crystal Structure Of Human Erk2 Complexed With A Ma		2e-04
2ojg_A	380	Crystal Structure Of Erk2 In Complex With N,n-dimet		2e-04
4fv6_A	360	Crystal Structure Of The Erk2 Complexed With E57 Le		2e-04
1wzy_A	368	Crystal Structure Of Human Erk2 Complexed With A Py		2e-04
1tvo_A	368	The Structure Of Erk2 In Complex With A Small Molec		2e-04
2i0e_A	353	Structure Of Catalytic Domain Of Human Protein Kina		2e-04
3qyw_A	364	Crystal Structure Of Erk2 In Complex With An Inhibi		2e-04
3p4k_A	370	The Third Conformation Of P38a Map Kinase Observed		2e-04
2dyl_A	318	Crystal Structure Of Human Mitogen-Activated Protei		2e-04
3soa_A	444	Full-Length Human Camkii Length = 444		2e-04
3q4z_A	306	Structure Of Unphosphorylated Pak1 Kinase Domain Le		3e-04
2w4o_A	349	Crystal Structure Of Human Camk4 In Complex With 4-		3e-04
4fie_A	423	Full-Length Human Pak4 Length = 423		3e-04
3r63_A	358	Structure Of Erk2 (Spe) Mutant (S246e) Length = 358		3e-04
3o71_A	358	Crystal Structure Of Erk2DCC PEPTIDE COMPLEX Length		3e-04
3zuv_A	364	Crystal Structure Of A Designed Selected Ankyrin Re		3e-04
2erk_A	365	Phosphorylated Map Kinase Erk2 Length = 365		3e-04
3zu7_A	365	Crystal Structure Of A Designed Selected Ankyrin Re		3e-04
2z7l_A	366	Unphosphorylated Mitogen Activated Protein Kinase E		3e-04
3c9w_A	357	Crystal Structure Of Erk-2 With Hypothemycin Covale		3e-04
2fys_B	364	Crystal Structure Of Erk2 Complex With Kim Peptide		3e-04
4fif_A	346	Catalytic Domain Of Human Pak4 With Rpkplvdp Peptid		4e-04
2wel_A	327	Crystal Structure Of Su6656-Bound CalciumCALMODULIN		4e-04
2x4z_A	296	Crystal Structure Of The Human P21-Activated Kinase		4e-04
2vn9_A	301	Crystal Structure Of Human Calcium Calmodulin Depen		4e-04
4exu_A	371	Mapk13, Inactive Form Length = 371		4e-04
2cdz_A	303	Crystal Structure Of The Human P21-Activated Kinase		4e-04
2q0n_A	301	Structure Of Human P21 Activating Kinase 4 (Pak4) I		4e-04
2bva_A	292	Crystal Structure Of The Human P21-Activated Kinase		4e-04
3fme_A	290	Crystal Structure Of Human Mitogen-Activated Protei		5e-04
2gph_A	364	Docking Motif Interactions In The Map Kinase Erk2 L		5e-04
2puu_A	348	Crystal Structure Of P38 Complex With 1-(5-Tert-But		7e-04
1f3m_C	297	Crystal Structure Of Human SerineTHREONINE KINASE P		7e-04
3fxz_A	297	Crystal Structure Of Pak1 Kinase Domain With Ruthen		7e-04
1yhv_A	297	Crystal Structure Of Pak1 Kinase Domain With Two Po		8e-04
3oht_A	389	Crystal Structure Of Salmo Salar P38alpha Length =		8e-04
3q52_A	306	Structure Of Phosphorylated Pak1 Kinase Domain Leng		8e-04
4agu_A	311	Crystal Structure Of The Human Cdkl1 Kinase Domain		8e-04
1pme_A	380	Structure Of Penta Mutant Human Erk2 Map Kinase Com		8e-04

>pdb|3TL8|A Chain A, The Avrptob-Bak1 Complex Reveals Two Structurally Similar Kinaseinteracting Domains In A Single Type Iii Effector Length = 349

Iteration: 1
 Score =  182 bits (462), Expect = 5e-46,   Method: Compositional matrix adjust.
 Identities = 95/298 (31%), Positives = 162/298 (54%), Gaps = 18/298 (6%)
Query: 393 HLNSF-RLNLEEVESATQCFSEVNLLGKGNFSSVYKGTLRDGTLVAIRSINVTSCKSEEA 451
           HL    R +L E++ A+  FS  N+LG+G F  VYKG L DGTLVA++ +     +  E 
Sbjct: 21  HLGQLKRFSLRELQVASDNFSNKNILGRGGFGKVYKGRLADGTLVAVKRLKEERXQGGEL 80
Query: 452 EFVKGLYLLTSLRHENIIRLRGFCCSRGRGECFLIYDFAPKGKLSKYLDQEEGSSNVLDW 511
           +F   + +++   H N++RLRGFC +    E  L+Y +   G ++  L +   S   LDW
Sbjct: 81  QFQTEVEMISMAVHRNLLRLRGFCMT--PTERLLVYPYMANGSVASCLRERPESQPPLDW 138
Query: 512 STRVSIIIGIAKGIGYLHSSEVNKPAIVHRNLSVEKVLIDQQFNPLIADCGLHKLLADDI 571
             R  I +G A+G+ YLH      P I+HR++    +L+D++F  ++ D GL KL+    
Sbjct: 139 PKRQRIALGSARGLAYLHDH--CDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLMDYKD 196
Query: 572 VFSVLKTSAAMGYLAPEYVTTGRFTERSDIFAFGVIILQILTGS-------------LVL 618
                     +G++APEY++TG+ +E++D+F +GV++L+++TG              ++L
Sbjct: 197 XHVXXAVRGTIGHIAPEYLSTGKSSEKTDVFGYGVMLLELITGQRAFDLARLANDDDVML 256
Query: 619 TSSMRLAAESATFENFIDRNLKGKFSESEAAKLGKMALVCTHEDPENRPTMEAVIEEL 676
              ++   +    E  +D +L+G + + E  +L ++AL+CT   P  RP M  V+  L
Sbjct: 257 LDWVKGLLKEKKLEALVDVDLQGNYKDEEVEQLIQVALLCTQSSPMERPKMSEVVRML 314

>pdb|3UIM|A Chain A, Structural Basis For The Impact Of Phosphorylation On Plant Receptor- Like Kinase Bak1 Activation Length = 326

Iteration: 1
 Score =  179 bits (454), Expect = 5e-45,   Method: Compositional matrix adjust.
 Identities = 93/298 (31%), Positives = 160/298 (53%), Gaps = 18/298 (6%)
Query: 393 HLNSF-RLNLEEVESATQCFSEVNLLGKGNFSSVYKGTLRDGTLVAIRSINVTSCKSEEA 451
           HL    R +L E++ A+  F   N+LG+G F  VYKG L DG LVA++ +     +  E 
Sbjct: 13  HLGQLKRFSLRELQVASDNFXNKNILGRGGFGKVYKGRLADGXLVAVKRLKEERTQGGEL 72
Query: 452 EFVKGLYLLTSLRHENIIRLRGFCCSRGRGECFLIYDFAPKGKLSKYLDQEEGSSNVLDW 511
           +F   + +++   H N++RLRGFC +    E  L+Y +   G ++  L +   S   LDW
Sbjct: 73  QFQTEVEMISMAVHRNLLRLRGFCMT--PTERLLVYPYMANGSVASCLRERPESQPPLDW 130
Query: 512 STRVSIIIGIAKGIGYLHSSEVNKPAIVHRNLSVEKVLIDQQFNPLIADCGLHKLLADDI 571
             R  I +G A+G+ YLH      P I+HR++    +L+D++F  ++ D GL KL+    
Sbjct: 131 PKRQRIALGSARGLAYLHDH--CDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLMDYKD 188
Query: 572 VFSVLKTSAAMGYLAPEYVTTGRFTERSDIFAFGVIILQILTGS-------------LVL 618
                     +G++APEY++TG+ +E++D+F +GV++L+++TG              ++L
Sbjct: 189 XHVXXAVRGXIGHIAPEYLSTGKSSEKTDVFGYGVMLLELITGQRAFDLARLANDDDVML 248
Query: 619 TSSMRLAAESATFENFIDRNLKGKFSESEAAKLGKMALVCTHEDPENRPTMEAVIEEL 676
              ++   +    E  +D +L+G + + E  +L ++AL+CT   P  RP M  V+  L
Sbjct: 249 LDWVKGLLKEKKLEALVDVDLQGNYKDEEVEQLIQVALLCTQSSPMERPKMSEVVRML 306

>pdb|3HGK|A Chain A, Crystal Structure Of Effect Protein Avrptob Complexed With Kinase Pto Length = 327

Iteration: 1
 Score =  152 bits (383), Expect = 8e-37,   Method: Compositional matrix adjust.
 Identities = 98/300 (32%), Positives = 148/300 (49%), Gaps = 24/300 (8%)
Query: 394 LNSFRLNLEEVESATQCFSEVNLLGKGNFSSVYKGTLRDGTLVAIRSINVTSCKSEEAEF 453
             S+R+ L ++E AT  F    L+G G F  VYKG LRDG  VA++     S +  E   
Sbjct: 24  FESYRVPLVDLEEATNNFDHKFLIGHGVFGKVYKGVLRDGAKVALKRRTPESSQGIEEFE 83
Query: 454 VKGLYLLTSLRHENIIRLRGFCCSRGRGECFLIYDFAPKGKLSKYLDQEEGSSNVLDWST 513
            +    L+  RH +++ L GFC  R   E  LIY +   G L ++L   +  +  + W  
Sbjct: 84  TEIE-TLSFCRHPHLVSLIGFCDERN--EMILIYKYMENGNLKRHLYGSDLPTMSMSWEQ 140
Query: 514 RVSIIIGIAKGIGYLHSSEVNKPAIVHRNLSVEKVLIDQQFNPLIADCGLHKL---LADD 570
           R+ I IG A+G+ YLH+      AI+HR++    +L+D+ F P I D G+ K    L   
Sbjct: 141 RLEICIGAARGLHYLHTR-----AIIHRDVKSINILLDENFVPKITDFGISKKGTELGQT 195
Query: 571 IVFSVLKTSAAMGYLAPEYVTTGRFTERSDIFAFGVIILQILTGSLVLTSSM-------- 622
            +  V+K    +GY+ PEY   GR TE+SD+++FGV++ ++L     +  S+        
Sbjct: 196 HLXXVVK--GTLGYIDPEYFIKGRLTEKSDVYSFGVVLFEVLCARSAIVQSLPREMVNLA 253
Query: 623 RLAAES---ATFENFIDRNLKGKFSESEAAKLGKMALVCTHEDPENRPTMEAVIEELTVA 679
             A ES      E  +D NL  K       K G  A+ C     E+RP+M  V+ +L  A
Sbjct: 254 EWAVESHNNGQLEQIVDPNLADKIRPESLRKFGDTAVKCLALSSEDRPSMGDVLWKLEYA 313

>pdb|2QKW|B Chain B, Structural Basis For Activation Of Plant Immunity By Bacterial Effector Protein Avrpto Length = 321

Iteration: 1
 Score =  152 bits (383), Expect = 9e-37,   Method: Compositional matrix adjust.
 Identities = 96/298 (32%), Positives = 145/298 (48%), Gaps = 20/298 (6%)
Query: 394 LNSFRLNLEEVESATQCFSEVNLLGKGNFSSVYKGTLRDGTLVAIRSINVTSCKSEEAEF 453
             S+R+ L ++E AT  F    L+G G F  VYKG LRDG  VA++     S +  E   
Sbjct: 24  FESYRVPLVDLEEATNNFDHKFLIGHGVFGKVYKGVLRDGAKVALKRRTPESSQGIEEFE 83
Query: 454 VKGLYLLTSLRHENIIRLRGFCCSRGRGECFLIYDFAPKGKLSKYLDQEEGSSNVLDWST 513
            +    L+  RH +++ L GFC  R   E  LIY +   G L ++L   +  +  + W  
Sbjct: 84  TEIE-TLSFCRHPHLVSLIGFCDERN--EMILIYKYMENGNLKRHLYGSDLPTMSMSWEQ 140
Query: 514 RVSIIIGIAKGIGYLHSSEVNKPAIVHRNLSVEKVLIDQQFNPLIADCGLHKLLAD-DIV 572
           R+ I IG A+G+ YLH+      AI+HR++    +L+D+ F P I D G+ K   + D  
Sbjct: 141 RLEICIGAARGLHYLHTR-----AIIHRDVKSINILLDENFVPKITDFGISKKGTELDQT 195
Query: 573 FSVLKTSAAMGYLAPEYVTTGRFTERSDIFAFGVIILQILTGSLVLTSSM--------RL 624
                    +GY+ PEY   GR TE+SD+++FGV++ ++L     +  S+          
Sbjct: 196 HLXXVVKGTLGYIDPEYFIKGRLTEKSDVYSFGVVLFEVLCARSAIVQSLPREMVNLAEW 255
Query: 625 AAES---ATFENFIDRNLKGKFSESEAAKLGKMALVCTHEDPENRPTMEAVIEELTVA 679
           A ES      E  +D NL  K       K G  A+ C     E+RP+M  V+ +L  A
Sbjct: 256 AVESHNNGQLEQIVDPNLADKIRPESLRKFGDTAVKCLALSSEDRPSMGDVLWKLEYA 313

>pdb|3RGX|A Chain A, Structural Insight Into Brassinosteroid Perception By Bri1 Length = 768

Iteration: 1
 Score =  113 bits (282), Expect = 4e-25,   Method: Compositional matrix adjust.
 Identities = 67/173 (38%), Positives = 101/173 (58%)
Query: 65  NEHRKVANISLQGKGLTGKLSPSLSGLKCLSGLYLHYNSLSGEIPKEIRNLTELTDLYLD 124
           N    +  + LQ  G TGK+ P+LS    L  L+L +N LSG IP  + +L++L DL L 
Sbjct: 391 NPKNTLQELYLQNNGFTGKIPPTLSNCSELVSLHLSFNYLSGTIPSSLGSLSKLRDLKLW 450
Query: 125 VNNLSGNIPPEIGSMASLQVLQLCCNQLTGNIPAQIGSLKSLSVLTLQHNRLNGGIPDSL 184
           +N L G IP E+  + +L+ L L  N LTG IP+ + +  +L+ ++L +NRL G IP  +
Sbjct: 451 LNMLEGEIPQELMYVKTLETLILDFNDLTGEIPSGLSNCTNLNWISLSNNRLTGEIPKWI 510
Query: 185 GNLGKLKRLDLSFNSLFGTIPESLANNAELLFLDVQNNTLSGIVPSALKRLNG 237
           G L  L  L LS NS  G IP  L +   L++LD+  N  +G +P+A+ + +G
Sbjct: 511 GRLENLAILKLSNNSFSGNIPAELGDCRSLIWLDLNTNLFNGTIPAAMFKQSG 563

>pdb|3RGX|A Chain A, Structural Insight Into Brassinosteroid Perception By Bri1 Length = 768

Iteration: 1
 Score = 84.7 bits (208), Expect = 1e-16,   Method: Compositional matrix adjust.
 Identities = 51/126 (40%), Positives = 71/126 (56%), Gaps = 11/126 (8%)
Query: 130 GNIPPEIGSMASLQVLQLCCNQLTGNIPAQIGSLKSLSVLTLQHNRLNGGIPDSLGNLGK 189
           G+  P   +  S+  L +  N L+G IP +IGS+  L +L L HN ++G IPD +G+L  
Sbjct: 622 GHTSPTFDNNGSMMFLDMSYNMLSGYIPKEIGSMPYLFILNLGHNDISGSIPDEVGDLRG 681
Query: 190 LKRLDLSFNSLFGTIPESLANNAELLFLDVQNNTLSGIVPSALKRLNGGFQ------FQN 243
           L  LDLS N L G IP++++    L  +D+ NN LSG +P       G F+      F N
Sbjct: 682 LNILDLSSNKLDGRIPQAMSALTMLTEIDLSNNNLSGPIPEM-----GQFETFPPAKFLN 736
Query: 244 NPGLCG 249
           NPGLCG
Sbjct: 737 NPGLCG 742

>pdb|3RIZ|A Chain A, Crystal Structure Of The Plant Steroid Receptor Bri1 Ectodomain Length = 772

Iteration: 1
 Score =  113 bits (282), Expect = 4e-25,   Method: Compositional matrix adjust.
 Identities = 67/173 (38%), Positives = 101/173 (58%)
Query: 65  NEHRKVANISLQGKGLTGKLSPSLSGLKCLSGLYLHYNSLSGEIPKEIRNLTELTDLYLD 124
           N    +  + LQ  G TGK+ P+LS    L  L+L +N LSG IP  + +L++L DL L 
Sbjct: 388 NPKNTLQELYLQNNGFTGKIPPTLSNCSELVSLHLSFNYLSGTIPSSLGSLSKLRDLKLW 447
Query: 125 VNNLSGNIPPEIGSMASLQVLQLCCNQLTGNIPAQIGSLKSLSVLTLQHNRLNGGIPDSL 184
           +N L G IP E+  + +L+ L L  N LTG IP+ + +  +L+ ++L +NRL G IP  +
Sbjct: 448 LNMLEGEIPQELMYVKTLETLILDFNDLTGEIPSGLSNCTNLNWISLSNNRLTGEIPKWI 507
Query: 185 GNLGKLKRLDLSFNSLFGTIPESLANNAELLFLDVQNNTLSGIVPSALKRLNG 237
           G L  L  L LS NS  G IP  L +   L++LD+  N  +G +P+A+ + +G
Sbjct: 508 GRLENLAILKLSNNSFSGNIPAELGDCRSLIWLDLNTNLFNGTIPAAMFKQSG 560

>pdb|3RIZ|A Chain A, Crystal Structure Of The Plant Steroid Receptor Bri1 Ectodomain Length = 772

Iteration: 1
 Score = 85.1 bits (209), Expect = 1e-16,   Method: Compositional matrix adjust.
 Identities = 51/126 (40%), Positives = 71/126 (56%), Gaps = 11/126 (8%)
Query: 130 GNIPPEIGSMASLQVLQLCCNQLTGNIPAQIGSLKSLSVLTLQHNRLNGGIPDSLGNLGK 189
           G+  P   +  S+  L +  N L+G IP +IGS+  L +L L HN ++G IPD +G+L  
Sbjct: 619 GHTSPTFDNNGSMMFLDMSYNMLSGYIPKEIGSMPYLFILNLGHNDISGSIPDEVGDLRG 678
Query: 190 LKRLDLSFNSLFGTIPESLANNAELLFLDVQNNTLSGIVPSALKRLNGGFQ------FQN 243
           L  LDLS N L G IP++++    L  +D+ NN LSG +P       G F+      F N
Sbjct: 679 LNILDLSSNKLDGRIPQAMSALTMLTEIDLSNNNLSGPIPEM-----GQFETFPPAKFLN 733
Query: 244 NPGLCG 249
           NPGLCG
Sbjct: 734 NPGLCG 739

>pdb|2NRY|A Chain A, Crystal Structure Of Irak-4 Length = 307

Iteration: 1
 Score =  108 bits (271), Expect = 7e-24,   Method: Compositional matrix adjust.
 Identities = 89/301 (29%), Positives = 149/301 (49%), Gaps = 36/301 (11%)
Query: 403 EVESATQCFSEV------NLLGKGNFSSVYKGTLRDGTLVAIRSINVTSCKSEE--AEFV 454
           E+++ T  F E       N +G+G F  VYKG + + T+   +   +    +EE   +F 
Sbjct: 19  ELKNVTNNFDERPISVGGNKMGEGGFGVVYKGYVNNTTVAVKKLAAMVDITTEELKQQFD 78
Query: 455 KGLYLLTSLRHENIIRLRGFCCSRGRGECFLIYDFAPKGKLSKYLDQEEGSSNVLDWSTR 514
           + + ++   +HEN++ L GF  S G   C L+Y + P G L   L   +G+   L W  R
Sbjct: 79  QEIKVMAKCQHENLVELLGFS-SDGDDLC-LVYVYMPNGSLLDRLSCLDGTPP-LSWHMR 135
Query: 515 VSIIIGIAKGIGYLHSSEVNKPAIVHRNLSVEKVLIDQQFNPLIADCGLHKL---LADDI 571
             I  G A GI +LH +       +HR++    +L+D+ F   I+D GL +     A  +
Sbjct: 136 CKIAQGAANGINFLHENHH-----IHRDIKSANILLDEAFTAKISDFGLARASEKFAQTV 190
Query: 572 VFSVLKTSAAMGYLAPEYVTTGRFTERSDIFAFGVIILQILTG----------SLVLTSS 621
           + S +  + A  Y+APE +  G  T +SDI++FGV++L+I+TG           L+L   
Sbjct: 191 MXSRIVGTTA--YMAPEALR-GEITPKSDIYSFGVVLLEIITGLPAVDEHREPQLLLDIK 247
Query: 622 MRLAAESATFENFIDRNLKGKFSESEAAKLGKMALVCTHEDPENRPTMEAV---IEELTV 678
             +  E  T E++ID+ +    S S  A +  +A  C HE    RP ++ V   ++E+T 
Sbjct: 248 EEIEDEEKTIEDYIDKKMNDADSTSVEA-MYSVASQCLHEKKNKRPDIKKVQQLLQEMTA 306
Query: 679 A 679
           +
Sbjct: 307 S 307

>pdb|2OIB|A Chain A, Crystal Structure Of Irak4 Kinase Domain Apo Form Length = 301

Iteration: 1
 Score =  108 bits (270), Expect = 1e-23,   Method: Compositional matrix adjust.
 Identities = 93/315 (29%), Positives = 153/315 (48%), Gaps = 42/315 (13%)
Query: 390 SREHLNSFRLNLEEVESATQCFSEV------NLLGKGNFSSVYKGTLRDGTLVAIRSINV 443
           +R H  SF     E+++ T  F E       N +G+G F  VYKG + + T+   +   +
Sbjct: 4   TRFHSFSFY----ELKNVTNNFDERPISVGGNKMGEGGFGVVYKGYVNNTTVAVKKLAAM 59
Query: 444 TSCKSEE--AEFVKGLYLLTSLRHENIIRLRGFCCSRGRGECFLIYDFAPKGKLSKYLDQ 501
               +EE   +F + + ++   +HEN++ L GF  S G   C L+Y + P G L   L  
Sbjct: 60  VDITTEELKQQFDQEIKVMAKCQHENLVELLGFS-SDGDDLC-LVYVYMPNGSLLDRLSC 117
Query: 502 EEGSSNVLDWSTRVSIIIGIAKGIGYLHSSEVNKPAIVHRNLSVEKVLIDQQFNPLIADC 561
            +G+   L W  R  I  G A GI +LH +       +HR++    +L+D+ F   I+D 
Sbjct: 118 LDGTPP-LSWHMRCKIAQGAANGINFLHENHH-----IHRDIKSANILLDEAFTAKISDF 171
Query: 562 GL----HKLLADDIVFSVLKTSAAMGYLAPEYVTTGRFTERSDIFAFGVIILQILTG--- 614
           GL     K     +   ++ T+A   Y+APE +  G  T +SDI++FGV++L+I+TG   
Sbjct: 172 GLARASEKFAQXVMXXRIVGTTA---YMAPEALR-GEITPKSDIYSFGVVLLEIITGLPA 227
Query: 615 -------SLVLTSSMRLAAESATFENFIDRNLKGKFSESEAAKLGKMALVCTHEDPENRP 667
                   L+L     +  E  T E++ID+ +    S S  A +  +A  C HE    RP
Sbjct: 228 VDEHREPQLLLDIKEEIEDEEKTIEDYIDKKMNDADSTSVEA-MYSVASQCLHEKKNKRP 286
Query: 668 TMEAV---IEELTVA 679
            ++ V   ++E+T +
Sbjct: 287 DIKKVQQLLQEMTAS 301

>pdb|2NRU|A Chain A, Crystal Structure Of Irak-4 Length = 307

Iteration: 1
 Score =  108 bits (269), Expect = 1e-23,   Method: Compositional matrix adjust.
 Identities = 89/302 (29%), Positives = 148/302 (49%), Gaps = 38/302 (12%)
Query: 403 EVESATQCFSEV------NLLGKGNFSSVYKGTLRDGTLVAIRSINVTSCKSEE--AEFV 454
           E+++ T  F E       N +G+G F  VYKG + + T+   +   +    +EE   +F 
Sbjct: 19  ELKNVTNNFDERPISVGGNKMGEGGFGVVYKGYVNNTTVAVKKLAAMVDITTEELKQQFD 78
Query: 455 KGLYLLTSLRHENIIRLRGFCCSRGRGECFLIYDFAPKGKLSKYLDQEEGSSNVLDWSTR 514
           + + ++   +HEN++ L GF  S G   C L+Y + P G L   L   +G+   L W  R
Sbjct: 79  QEIKVMAKCQHENLVELLGFS-SDGDDLC-LVYVYMPNGSLLDRLSCLDGTPP-LSWHMR 135
Query: 515 VSIIIGIAKGIGYLHSSEVNKPAIVHRNLSVEKVLIDQQFNPLIADCGL----HKLLADD 570
             I  G A GI +LH +       +HR++    +L+D+ F   I+D GL     K     
Sbjct: 136 CKIAQGAANGINFLHENHH-----IHRDIKSANILLDEAFTAKISDFGLARASEKFAQTV 190
Query: 571 IVFSVLKTSAAMGYLAPEYVTTGRFTERSDIFAFGVIILQILTG----------SLVLTS 620
           +   ++ T+A   Y+APE +  G  T +SDI++FGV++L+I+TG           L+L  
Sbjct: 191 MXXRIVGTTA---YMAPEALR-GEITPKSDIYSFGVVLLEIITGLPAVDEHREPQLLLDI 246
Query: 621 SMRLAAESATFENFIDRNLKGKFSESEAAKLGKMALVCTHEDPENRPTMEAV---IEELT 677
              +  E  T E++ID+ +    S S  A +  +A  C HE    RP ++ V   ++E+T
Sbjct: 247 KEEIEDEEKTIEDYIDKKMNDADSTSVEA-MYSVASQCLHEKKNKRPDIKKVQQLLQEMT 305
Query: 678 VA 679
            +
Sbjct: 306 AS 307

>pdb|2O8Y|A Chain A, Apo Irak4 Kinase Domain Length = 298

Iteration: 1
 Score =  101 bits (252), Expect = 1e-21,   Method: Compositional matrix adjust.
 Identities = 87/291 (29%), Positives = 137/291 (47%), Gaps = 33/291 (11%)
Query: 403 EVESATQCFSEV------NLLGKGNFSSVYKGTLRDGTLVAIRSINVTSCKSEE--AEFV 454
           E+++ T  F E       N  G+G F  VYKG + + T+   +   +    +EE   +F 
Sbjct: 10  ELKNVTNNFDERPISVGGNKXGEGGFGVVYKGYVNNTTVAVKKLAAMVDITTEELKQQFD 69
Query: 455 KGLYLLTSLRHENIIRLRGFCCSRGRGECFLIYDFAPKGKLSKYLDQEEGSSNVLDWSTR 514
           + + +    +HEN++ L GF  S G   C L+Y + P G L   L   +G+   L W  R
Sbjct: 70  QEIKVXAKCQHENLVELLGFS-SDGDDLC-LVYVYXPNGSLLDRLSCLDGTPP-LSWHXR 126
Query: 515 VSIIIGIAKGIGYLHSSEVNKPAIVHRNLSVEKVLIDQQFNPLIADCGLHKLLADDIVFS 574
             I  G A GI +LH +       +HR++    +L+D+ F   I+D GL +  A +    
Sbjct: 127 CKIAQGAANGINFLHENHH-----IHRDIKSANILLDEAFTAKISDFGLAR--ASEKFAQ 179
Query: 575 VLKTSAAMG---YLAPEYVTTGRFTERSDIFAFGVIILQILTG----------SLVLTSS 621
            +  S  +G   Y APE +  G  T +SDI++FGV++L+I+TG           L+L   
Sbjct: 180 XVXXSRIVGTTAYXAPEALR-GEITPKSDIYSFGVVLLEIITGLPAVDEHREPQLLLDIK 238
Query: 622 MRLAAESATFENFIDRNLKGKFSESEAAKLGKMALVCTHEDPENRPTMEAV 672
             +  E  T E++ID+      S S  A    +A  C HE    RP ++ V
Sbjct: 239 EEIEDEEKTIEDYIDKKXNDADSTSVEAXYS-VASQCLHEKKNKRPDIKKV 288

>pdb|1OGQ|A Chain A, The Crystal Structure Of Pgip (Polygalacturonase Inhibiting Protein), A Leucine Rich Repeat Protein Involved In Plant Defense Length = 313

Iteration: 1
 Score =  101 bits (252), Expect = 1e-21,   Method: Compositional matrix adjust.
 Identities = 75/212 (35%), Positives = 110/212 (51%), Gaps = 9/212 (4%)
Query: 22  VCGNTELRALLDLKASLDPENKLLQSWTENGDPCSGSFEGIACN---EHRKVANISLQGK 78
           +C   + +ALL +K  L      L SW    D C+ ++ G+ C+   +  +V N+ L G 
Sbjct: 2   LCNPQDKQALLQIKKDLG-NPTTLSSWLPTTDCCNRTWLGVLCDTDTQTYRVNNLDLSGL 60
Query: 79  GLTGK--LSPSLSGLKCLSGLYLH-YNSLSGEIPKEIRNLTELTDLYLDVNNLSGNIPPE 135
            L     +  SL+ L  L+ LY+   N+L G IP  I  LT+L  LY+   N+SG IP  
Sbjct: 61  NLPKPYPIPSSLANLPYLNFLYIGGINNLVGPIPPAIAKLTQLHYLYITHTNVSGAIPDF 120
Query: 136 IGSMASLQVLQLCCNQLTGNIPAQIGSLKSLSVLTLQHNRLNGGIPDSLGNLGKL-KRLD 194
           +  + +L  L    N L+G +P  I SL +L  +T   NR++G IPDS G+  KL   + 
Sbjct: 121 LSQIKTLVTLDFSYNALSGTLPPSISSLPNLVGITFDGNRISGAIPDSYGSFSKLFTSMT 180
Query: 195 LSFNSLFGTIPESLANNAELLFLDVQNNTLSG 226
           +S N L G IP + A N  L F+D+  N L G
Sbjct: 181 ISRNRLTGKIPPTFA-NLNLAFVDLSRNMLEG 211

>pdb|4BBE|A Chain A, Aminoalkylpyrimidine Inhibitor Complexes With Jak2 Length = 298

Iteration: 1
 Score = 97.4 bits (241), Expect = 3e-20,   Method: Compositional matrix adjust.
 Identities = 63/204 (30%), Positives = 108/204 (52%), Gaps = 16/204 (7%)
Query: 417 LGKGNFSSV---YKGTLRD--GTLVAIRSINVTSCKSEEAEFVKGLYLLTSLRHENIIRL 471
           LGKGNF SV       L+D  G +VA++ +   S +    +F + + +L SL+H+NI++ 
Sbjct: 19  LGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQ-HSTEEHLRDFEREIEILKSLQHDNIVKY 77
Query: 472 RGFCCSRGRGECFLIYDFAPKGKLSKYLDQEEGSSNVLDWSTRVSIIIGIAKGIGYLHSS 531
           +G C S GR    LI ++ P G L  YL + +     +D    +     I KG+ YL + 
Sbjct: 78  KGVCYSAGRRNLKLIMEYLPYGSLRDYLQKHKER---IDHIKLLQYTSQICKGMEYLGTK 134
Query: 532 EVNKPAIVHRNLSVEKVLIDQQFNPLIADCGLHKLLADDIVFSVLKT--SAAMGYLAPEY 589
                  +HRNL+   +L++ +    I D GL K+L  D  +  +K    + + + APE 
Sbjct: 135 RY-----IHRNLATRNILVENENRVKIGDFGLTKVLPQDKEYYKVKEPGESPIFWYAPES 189
Query: 590 VTTGRFTERSDIFAFGVIILQILT 613
           +T  +F+  SD+++FGV++ ++ T
Sbjct: 190 LTESKFSVASDVWSFGVVLYELFT 213

>pdb|3UGC|A Chain A, Structural Basis Of Jak2 Inhibition By The Type Ii Inhibtor Nvp-Bbt594 Length = 295

Iteration: 1
 Score = 96.3 bits (238), Expect = 5e-20,   Method: Compositional matrix adjust.
 Identities = 63/204 (30%), Positives = 108/204 (52%), Gaps = 16/204 (7%)
Query: 417 LGKGNFSSV---YKGTLRD--GTLVAIRSINVTSCKSEEAEFVKGLYLLTSLRHENIIRL 471
           LGKGNF SV       L+D  G +VA++ +   S +    +F + + +L SL+H+NI++ 
Sbjct: 18  LGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQ-HSTEEHLRDFEREIEILKSLQHDNIVKY 76
Query: 472 RGFCCSRGRGECFLIYDFAPKGKLSKYLDQEEGSSNVLDWSTRVSIIIGIAKGIGYLHSS 531
           +G C S GR    LI ++ P G L  YL + +     +D    +     I KG+ YL + 
Sbjct: 77  KGVCYSAGRRNLKLIMEYLPYGSLRDYLQKHKER---IDHIKLLQYTSQICKGMEYLGTK 133
Query: 532 EVNKPAIVHRNLSVEKVLIDQQFNPLIADCGLHKLLADDIVFSVLKT--SAAMGYLAPEY 589
                  +HR+L+   +L++ +    I D GL K+L  D  F  +K    + + + APE 
Sbjct: 134 RY-----IHRDLATRNILVENENRVKIGDFGLTKVLPQDKEFFKVKEPGESPIFWYAPES 188
Query: 590 VTTGRFTERSDIFAFGVIILQILT 613
           +T  +F+  SD+++FGV++ ++ T
Sbjct: 189 LTESKFSVASDVWSFGVVLYELFT 212

>pdb|4F0F|A Chain A, Crystal Structure Of The Roco4 Kinase Domain Bound To Appcp From D. Discoideum Length = 287

Iteration: 1
 Score = 96.3 bits (238), Expect = 5e-20,   Method: Compositional matrix adjust.
 Identities = 82/310 (26%), Positives = 149/310 (48%), Gaps = 43/310 (13%)
Query: 384 LNGTGFSREHLNSFRLNLEEVESATQCFSEVNLLGKGNFSSVYKGTL-RDGTLVAIRSIN 442
           + G+ F +  L +   N  E+E   Q       +GKG F  V+KG L +D ++VAI+S+ 
Sbjct: 3   MGGSEFPKSRLPTLADN--EIEYEKQ-------IGKGGFGLVHKGRLVKDKSVVAIKSLI 53
Query: 443 VTSCKSEE------AEFVKGLYLLTSLRHENIIRLRGFCCSRGRGECFLIYDFAPKGKL- 495
           +   + E        EF + ++++++L H NI++L G   +  R    ++ +F P G L 
Sbjct: 54  LGDSEGETEMIEKFQEFQREVFIMSNLNHPNIVKLYGLMHNPPR----MVMEFVPCGDLY 109
Query: 496 SKYLDQEEGSSNVLDWSTRVSIIIGIAKGIGYLHSSEVNKPAIVHRNLSVEKVLID--QQ 553
            + LD+    ++ + WS ++ +++ IA GI Y+ +     P IVHR+L    + +    +
Sbjct: 110 HRLLDK----AHPIKWSVKLRLMLDIALGIEYMQN---QNPPIVHRDLRSPNIFLQSLDE 162
Query: 554 FNPL---IADCGLHKLLADDIVFSVLKTSAAMGYLAPEYVTTGR--FTERSDIFAFGVII 608
             P+   +AD GL    +   V SV        ++APE +      +TE++D ++F +I+
Sbjct: 163 NAPVCAKVADFGL----SQQSVHSVSGLLGNFQWMAPETIGAEEESYTEKADTYSFAMIL 218
Query: 609 LQILTGSLVLTSSMRLAAESATFENFI-DRNLKGKFSESEAAKLGKMALVCTHEDPENRP 667
             ILTG          +     F N I +  L+    E    +L  +  +C   DP+ RP
Sbjct: 219 YTILTGEGPFDE---YSYGKIKFINMIREEGLRPTIPEDCPPRLRNVIELCWSGDPKKRP 275
Query: 668 TMEAVIEELT 677
               +++EL+
Sbjct: 276 HFSYIVKELS 285

>pdb|2G15|A Chain A, Structural Characterization Of Autoinhibited C-Met Kinase Length = 318

Iteration: 1
 Score = 96.3 bits (238), Expect = 5e-20,   Method: Compositional matrix adjust.
 Identities = 75/287 (26%), Positives = 142/287 (49%), Gaps = 31/287 (10%)
Query: 411 FSEVNLLGKGNFSSVYKGTL--RDGTLV--AIRSINVTSCKSEEAEFVKGLYLLTSLRHE 466
           F+EV  +G+G+F  VY GTL   DG  +  A++S+N  +   E ++F+    ++    H 
Sbjct: 52  FNEV--IGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHP 109
Query: 467 NIIRLRGFCCSRGRGECFLIYDFAPKGKLSKYLDQEEGSSNVLDWSTRVSIIIGIAKGIG 526
           N++ L G C  R  G   ++  +   G L  ++  E  +  V D    +   + +AKG+ 
Sbjct: 110 NVLSLLGICL-RSEGSPLVVLPYMKHGDLRNFIRNETHNPTVKD---LIGFGLQVAKGMK 165
Query: 527 YLHSSEVNKPAIVHRNLSVEKVLIDQQFNPLIADCGLHKLLADDIVFSVLKTSAA---MG 583
           YL S +      VHR+L+    ++D++F   +AD GL + + D   +SV   + A   + 
Sbjct: 166 YLASKK-----FVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEYYSVHNKTGAKLPVK 220
Query: 584 YLAPEYVTTGRFTERSDIFAFGVIILQILTGSLVLTSSMRLAAESATFENFIDRNLKGKF 643
           ++A E + T +FT +SD+++FGV++ ++      +T       +  TF+  +   L+G+ 
Sbjct: 221 WMALESLQTQKFTTKSDVWSFGVLLWEL------MTRGAPPYPDVNTFDITV-YLLQGRR 273
Query: 644 ---SESEAAKLGKMALVCTHEDPENRPTMEAVIEELTVAAPVMATFL 687
               E     L ++ L C H   E RP+   ++  ++    + +TF+
Sbjct: 274 LLQPEYCPDPLYEVMLKCWHPKAEMRPSFSELVSRISA---IFSTFI 317

>pdb|4GG5|A Chain A, Crystal Structure Of Cmet In Complex With Novel Inhibitor Length = 319

Iteration: 1
 Score = 95.9 bits (237), Expect = 7e-20,   Method: Compositional matrix adjust.
 Identities = 75/287 (26%), Positives = 142/287 (49%), Gaps = 31/287 (10%)
Query: 411 FSEVNLLGKGNFSSVYKGTL--RDGTLV--AIRSINVTSCKSEEAEFVKGLYLLTSLRHE 466
           F+EV  +G+G+F  VY GTL   DG  +  A++S+N  +   E ++F+    ++    H 
Sbjct: 53  FNEV--IGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHP 110
Query: 467 NIIRLRGFCCSRGRGECFLIYDFAPKGKLSKYLDQEEGSSNVLDWSTRVSIIIGIAKGIG 526
           N++ L G C  R  G   ++  +   G L  ++  E  +  V D    +   + +AKG+ 
Sbjct: 111 NVLSLLGICL-RSEGSPLVVLPYMKHGDLRNFIRNETHNPTVKD---LIGFGLQVAKGMK 166
Query: 527 YLHSSEVNKPAIVHRNLSVEKVLIDQQFNPLIADCGLHKLLADDIVFSVLKTSAA---MG 583
           YL S +      VHR+L+    ++D++F   +AD GL + + D   +SV   + A   + 
Sbjct: 167 YLASKK-----FVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEYYSVHNKTGAKLPVK 221
Query: 584 YLAPEYVTTGRFTERSDIFAFGVIILQILTGSLVLTSSMRLAAESATFENFIDRNLKGKF 643
           ++A E + T +FT +SD+++FGV++ ++      +T       +  TF+  +   L+G+ 
Sbjct: 222 WMALESLQTQKFTTKSDVWSFGVLLWEL------MTRGAPPYPDVNTFDITV-YLLQGRR 274
Query: 644 ---SESEAAKLGKMALVCTHEDPENRPTMEAVIEELTVAAPVMATFL 687
               E     L ++ L C H   E RP+   ++  ++    + +TF+
Sbjct: 275 LLQPEYCPDPLYEVMLKCWHPKAEMRPSFSELVSRISA---IFSTFI 318

>pdb|2WD1|A Chain A, Human C-Met Kinase In Complex With Azaindole Inhibitor Length = 292

Iteration: 1
 Score = 95.9 bits (237), Expect = 7e-20,   Method: Compositional matrix adjust.
 Identities = 75/287 (26%), Positives = 142/287 (49%), Gaps = 31/287 (10%)
Query: 411 FSEVNLLGKGNFSSVYKGTL--RDGTLV--AIRSINVTSCKSEEAEFVKGLYLLTSLRHE 466
           F+EV  +G+G+F  VY GTL   DG  +  A++S+N  +   E ++F+    ++    H 
Sbjct: 26  FNEV--IGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHP 83
Query: 467 NIIRLRGFCCSRGRGECFLIYDFAPKGKLSKYLDQEEGSSNVLDWSTRVSIIIGIAKGIG 526
           N++ L G C  R  G   ++  +   G L  ++  E  +  V D    +   + +AKG+ 
Sbjct: 84  NVLSLLGICL-RSEGSPLVVLPYMKHGDLRNFIRNETHNPTVKD---LIGFGLQVAKGMK 139
Query: 527 YLHSSEVNKPAIVHRNLSVEKVLIDQQFNPLIADCGLHKLLADDIVFSVLKTSAA---MG 583
           YL S +      VHR+L+    ++D++F   +AD GL + + D   +SV   + A   + 
Sbjct: 140 YLASKK-----FVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEYYSVHNKTGAKLPVK 194
Query: 584 YLAPEYVTTGRFTERSDIFAFGVIILQILTGSLVLTSSMRLAAESATFENFIDRNLKGKF 643
           ++A E + T +FT +SD+++FGV++ ++      +T       +  TF+  +   L+G+ 
Sbjct: 195 WMALESLQTQKFTTKSDVWSFGVLLWEL------MTRGAPPYPDVNTFDITV-YLLQGRR 247
Query: 644 ---SESEAAKLGKMALVCTHEDPENRPTMEAVIEELTVAAPVMATFL 687
               E     L ++ L C H   E RP+   ++  ++    + +TF+
Sbjct: 248 LLQPEYCPDPLYEVMLKCWHPKAEMRPSFSELVSRISA---IFSTFI 291

>pdb|3Q6U|A Chain A, Structure Of The Apo Met Receptor Kinase In The Dually-Phosphorylated, Activated State Length = 308

Iteration: 1
 Score = 95.9 bits (237), Expect = 7e-20,   Method: Compositional matrix adjust.
 Identities = 75/287 (26%), Positives = 142/287 (49%), Gaps = 31/287 (10%)
Query: 411 FSEVNLLGKGNFSSVYKGTL--RDGTLV--AIRSINVTSCKSEEAEFVKGLYLLTSLRHE 466
           F+EV  +G+G+F  VY GTL   DG  +  A++S+N  +   E ++F+    ++    H 
Sbjct: 34  FNEV--IGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHP 91
Query: 467 NIIRLRGFCCSRGRGECFLIYDFAPKGKLSKYLDQEEGSSNVLDWSTRVSIIIGIAKGIG 526
           N++ L G C  R  G   ++  +   G L  ++  E  +  V D    +   + +AKG+ 
Sbjct: 92  NVLSLLGICL-RSEGSPLVVLPYMKHGDLRNFIRNETHNPTVKD---LIGFGLQVAKGMK 147
Query: 527 YLHSSEVNKPAIVHRNLSVEKVLIDQQFNPLIADCGLHKLLADDIVFSVLKTSAA---MG 583
           YL S +      VHR+L+    ++D++F   +AD GL + + D   +SV   + A   + 
Sbjct: 148 YLASKK-----FVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEYYSVHNKTGAKLPVK 202
Query: 584 YLAPEYVTTGRFTERSDIFAFGVIILQILTGSLVLTSSMRLAAESATFENFIDRNLKGKF 643
           ++A E + T +FT +SD+++FGV++ ++      +T       +  TF+  +   L+G+ 
Sbjct: 203 WMALESLQTQKFTTKSDVWSFGVLLWEL------MTRGAPPYPDVNTFDITV-YLLQGRR 255
Query: 644 ---SESEAAKLGKMALVCTHEDPENRPTMEAVIEELTVAAPVMATFL 687
               E     L ++ L C H   E RP+   ++  ++    + +TF+
Sbjct: 256 LLQPEYCPDPLYEVMLKCWHPKAEMRPSFSELVSRISA---IFSTFI 299

>pdb|4E6D|A Chain A, Jak2 Kinase (Jh1 Domain) Triple Mutant In Complex With Compound 7 Length = 298

Iteration: 1
 Score = 95.9 bits (237), Expect = 7e-20,   Method: Compositional matrix adjust.
 Identities = 63/204 (30%), Positives = 108/204 (52%), Gaps = 16/204 (7%)
Query: 417 LGKGNFSSV---YKGTLRD--GTLVAIRSINVTSCKSEEAEFVKGLYLLTSLRHENIIRL 471
           LGKGNF SV       L+D  G +VA++ +   S +    +F + + +L SL+H+NI++ 
Sbjct: 21  LGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQ-HSTEEHLRDFEREIEILKSLQHDNIVKY 79
Query: 472 RGFCCSRGRGECFLIYDFAPKGKLSKYLDQEEGSSNVLDWSTRVSIIIGIAKGIGYLHSS 531
           +G C S GR    LI +F P G L +YL + +     +D    +     I KG+ YL + 
Sbjct: 80  KGVCYSAGRRNLKLIMEFLPYGSLREYLQKHKER---IDHIKLLQYTSQICKGMEYLGTK 136
Query: 532 EVNKPAIVHRNLSVEKVLIDQQFNPLIADCGLHKLLADDIVFSVLKT--SAAMGYLAPEY 589
                  +HR+L+   +L++ +    I D GL K+L  D     +K    + + + APE 
Sbjct: 137 RY-----IHRDLATRNILVENENRVKIGDFGLTKVLPQDKEXXKVKEPGESPIFWYAPES 191
Query: 590 VTTGRFTERSDIFAFGVIILQILT 613
           +T  +F+  SD+++FGV++ ++ T
Sbjct: 192 LTESKFSVASDVWSFGVVLYELFT 215

>pdb|3F66|A Chain A, Human C-Met Kinase In Complex With Quinoxaline Inhibitor Length = 298

Iteration: 1
 Score = 95.9 bits (237), Expect = 8e-20,   Method: Compositional matrix adjust.
 Identities = 75/287 (26%), Positives = 142/287 (49%), Gaps = 31/287 (10%)
Query: 411 FSEVNLLGKGNFSSVYKGTL--RDGTLV--AIRSINVTSCKSEEAEFVKGLYLLTSLRHE 466
           F+EV  +G+G+F  VY GTL   DG  +  A++S+N  +   E ++F+    ++    H 
Sbjct: 29  FNEV--IGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHP 86
Query: 467 NIIRLRGFCCSRGRGECFLIYDFAPKGKLSKYLDQEEGSSNVLDWSTRVSIIIGIAKGIG 526
           N++ L G C  R  G   ++  +   G L  ++  E  +  V D    +   + +AKG+ 
Sbjct: 87  NVLSLLGICL-RSEGSPLVVLPYMKHGDLRNFIRNETHNPTVKD---LIGFGLQVAKGMK 142
Query: 527 YLHSSEVNKPAIVHRNLSVEKVLIDQQFNPLIADCGLHKLLADDIVFSVLKTSAA---MG 583
           YL S +      VHR+L+    ++D++F   +AD GL + + D   +SV   + A   + 
Sbjct: 143 YLASKK-----FVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEYYSVHNKTGAKLPVK 197
Query: 584 YLAPEYVTTGRFTERSDIFAFGVIILQILTGSLVLTSSMRLAAESATFENFIDRNLKGKF 643
           ++A E + T +FT +SD+++FGV++ ++      +T       +  TF+  +   L+G+ 
Sbjct: 198 WMALESLQTQKFTTKSDVWSFGVLLWEL------MTRGAPPYPDVNTFDITV-YLLQGRR 250
Query: 644 ---SESEAAKLGKMALVCTHEDPENRPTMEAVIEELTVAAPVMATFL 687
               E     L ++ L C H   E RP+   ++  ++    + +TF+
Sbjct: 251 LLQPEYCPDPLYEVMLKCWHPKAEMRPSFSELVSRISA---IFSTFI 294

>pdb|3I5N|A Chain A, Crystal Structure Of C-Met With Triazolopyridazine Inhibitor 13 Length = 309

Iteration: 1
 Score = 95.5 bits (236), Expect = 9e-20,   Method: Compositional matrix adjust.
 Identities = 75/287 (26%), Positives = 142/287 (49%), Gaps = 31/287 (10%)
Query: 411 FSEVNLLGKGNFSSVYKGTL--RDGTLV--AIRSINVTSCKSEEAEFVKGLYLLTSLRHE 466
           F+EV  +G+G+F  VY GTL   DG  +  A++S+N  +   E ++F+    ++    H 
Sbjct: 33  FNEV--IGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHP 90
Query: 467 NIIRLRGFCCSRGRGECFLIYDFAPKGKLSKYLDQEEGSSNVLDWSTRVSIIIGIAKGIG 526
           N++ L G C  R  G   ++  +   G L  ++  E  +  V D    +   + +AKG+ 
Sbjct: 91  NVLSLLGICL-RSEGSPLVVLPYMKHGDLRNFIRNETHNPTVKD---LIGFGLQVAKGMK 146
Query: 527 YLHSSEVNKPAIVHRNLSVEKVLIDQQFNPLIADCGLHKLLADDIVFSVLKTSAA---MG 583
           YL S +      VHR+L+    ++D++F   +AD GL + + D   +SV   + A   + 
Sbjct: 147 YLASKK-----FVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEYYSVHNKTGAKLPVK 201
Query: 584 YLAPEYVTTGRFTERSDIFAFGVIILQILTGSLVLTSSMRLAAESATFENFIDRNLKGKF 643
           ++A E + T +FT +SD+++FGV++ ++      +T       +  TF+  +   L+G+ 
Sbjct: 202 WMALESLQTQKFTTKSDVWSFGVLLWEL------MTRGAPPYPDVNTFDITV-YLLQGRR 254
Query: 644 ---SESEAAKLGKMALVCTHEDPENRPTMEAVIEELTVAAPVMATFL 687
               E     L ++ L C H   E RP+   ++  ++    + +TF+
Sbjct: 255 LLQPEYCPDPLYEVMLKCWHPKAEMRPSFSELVSRISA---IFSTFI 298

>pdb|2WGJ|A Chain A, X-Ray Structure Of Pf-02341066 Bound To The Kinase Domain Of C-Met Length = 306

Iteration: 1
 Score = 95.5 bits (236), Expect = 9e-20,   Method: Compositional matrix adjust.
 Identities = 75/287 (26%), Positives = 142/287 (49%), Gaps = 31/287 (10%)
Query: 411 FSEVNLLGKGNFSSVYKGTL--RDGTLV--AIRSINVTSCKSEEAEFVKGLYLLTSLRHE 466
           F+EV  +G+G+F  VY GTL   DG  +  A++S+N  +   E ++F+    ++    H 
Sbjct: 31  FNEV--IGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHP 88
Query: 467 NIIRLRGFCCSRGRGECFLIYDFAPKGKLSKYLDQEEGSSNVLDWSTRVSIIIGIAKGIG 526
           N++ L G C  R  G   ++  +   G L  ++  E  +  V D    +   + +AKG+ 
Sbjct: 89  NVLSLLGICL-RSEGSPLVVLPYMKHGDLRNFIRNETHNPTVKD---LIGFGLQVAKGMK 144
Query: 527 YLHSSEVNKPAIVHRNLSVEKVLIDQQFNPLIADCGLHKLLADDIVFSVLKTSAA---MG 583
           YL S +      VHR+L+    ++D++F   +AD GL + + D   +SV   + A   + 
Sbjct: 145 YLASKK-----FVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEYYSVHNKTGAKLPVK 199
Query: 584 YLAPEYVTTGRFTERSDIFAFGVIILQILTGSLVLTSSMRLAAESATFENFIDRNLKGKF 643
           ++A E + T +FT +SD+++FGV++ ++      +T       +  TF+  +   L+G+ 
Sbjct: 200 WMALESLQTQKFTTKSDVWSFGVLLWEL------MTRGAPPYPDVNTFDITV-YLLQGRR 252
Query: 644 ---SESEAAKLGKMALVCTHEDPENRPTMEAVIEELTVAAPVMATFL 687
               E     L ++ L C H   E RP+   ++  ++    + +TF+
Sbjct: 253 LLQPEYCPDPLYEVMLKCWHPKAEMRPSFSELVSRISA---IFSTFI 296

>pdb|3LQ8|A Chain A, Structure Of The Kinase Domain Of C-Met Bound To Xl880 (Gsk1 Length = 302

Iteration: 1
 Score = 95.5 bits (236), Expect = 9e-20,   Method: Compositional matrix adjust.
 Identities = 75/287 (26%), Positives = 142/287 (49%), Gaps = 31/287 (10%)
Query: 411 FSEVNLLGKGNFSSVYKGTL--RDGTLV--AIRSINVTSCKSEEAEFVKGLYLLTSLRHE 466
           F+EV  +G+G+F  VY GTL   DG  +  A++S+N  +   E ++F+    ++    H 
Sbjct: 32  FNEV--IGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHP 89
Query: 467 NIIRLRGFCCSRGRGECFLIYDFAPKGKLSKYLDQEEGSSNVLDWSTRVSIIIGIAKGIG 526
           N++ L G C  R  G   ++  +   G L  ++  E  +  V D    +   + +AKG+ 
Sbjct: 90  NVLSLLGICL-RSEGSPLVVLPYMKHGDLRNFIRNETHNPTVKD---LIGFGLQVAKGMK 145
Query: 527 YLHSSEVNKPAIVHRNLSVEKVLIDQQFNPLIADCGLHKLLADDIVFSVLKTSAA---MG 583
           YL S +      VHR+L+    ++D++F   +AD GL + + D   +SV   + A   + 
Sbjct: 146 YLASKK-----FVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEYYSVHNKTGAKLPVK 200
Query: 584 YLAPEYVTTGRFTERSDIFAFGVIILQILTGSLVLTSSMRLAAESATFENFIDRNLKGKF 643
           ++A E + T +FT +SD+++FGV++ ++      +T       +  TF+  +   L+G+ 
Sbjct: 201 WMALESLQTQKFTTKSDVWSFGVLLWEL------MTRGAPPYPDVNTFDITV-YLLQGRR 253
Query: 644 ---SESEAAKLGKMALVCTHEDPENRPTMEAVIEELTVAAPVMATFL 687
               E     L ++ L C H   E RP+   ++  ++    + +TF+
Sbjct: 254 LLQPEYCPDPLYEVMLKCWHPKAEMRPSFSELVSRISA---IFSTFI 297

>pdb|2RFN|A Chain A, X-ray Structure Of C-met With Inhibitor. Length = 310

Iteration: 1
 Score = 95.1 bits (235), Expect = 1e-19,   Method: Compositional matrix adjust.
 Identities = 75/287 (26%), Positives = 142/287 (49%), Gaps = 31/287 (10%)
Query: 411 FSEVNLLGKGNFSSVYKGTL--RDGTLV--AIRSINVTSCKSEEAEFVKGLYLLTSLRHE 466
           F+EV  +G+G+F  VY GTL   DG  +  A++S+N  +   E ++F+    ++    H 
Sbjct: 34  FNEV--IGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHP 91
Query: 467 NIIRLRGFCCSRGRGECFLIYDFAPKGKLSKYLDQEEGSSNVLDWSTRVSIIIGIAKGIG 526
           N++ L G C  R  G   ++  +   G L  ++  E  +  V D    +   + +AKG+ 
Sbjct: 92  NVLSLLGICL-RSEGSPLVVLPYMKHGDLRNFIRNETHNPTVKD---LIGFGLQVAKGMK 147
Query: 527 YLHSSEVNKPAIVHRNLSVEKVLIDQQFNPLIADCGLHKLLADDIVFSVLKTSAA---MG 583
           YL S +      VHR+L+    ++D++F   +AD GL + + D   +SV   + A   + 
Sbjct: 148 YLASKK-----FVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEYYSVHNKTGAKLPVK 202
Query: 584 YLAPEYVTTGRFTERSDIFAFGVIILQILTGSLVLTSSMRLAAESATFENFIDRNLKGKF 643
           ++A E + T +FT +SD+++FGV++ ++      +T       +  TF+  +   L+G+ 
Sbjct: 203 WMALESLQTQKFTTKSDVWSFGVLLWEL------MTRGAPPYPDVNTFDITV-YLLQGRR 255
Query: 644 ---SESEAAKLGKMALVCTHEDPENRPTMEAVIEELTVAAPVMATFL 687
               E     L ++ L C H   E RP+   ++  ++    + +TF+
Sbjct: 256 LLQPEYCPDPLYEVMLKCWHPKAEMRPSFSELVSRISA---IFSTFI 299

>pdb|2XA4|A Chain A, Inhibitors Of Jak2 Kinase Domain Length = 298

Iteration: 1
 Score = 94.7 bits (234), Expect = 1e-19,   Method: Compositional matrix adjust.
 Identities = 62/204 (30%), Positives = 107/204 (52%), Gaps = 16/204 (7%)
Query: 417 LGKGNFSSV---YKGTLRD--GTLVAIRSINVTSCKSEEAEFVKGLYLLTSLRHENIIRL 471
           LGKGNF SV       L+D  G +VA++ +   S +    +F + + +L SL+H+NI++ 
Sbjct: 21  LGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQ-HSTEEHLRDFEREIEILKSLQHDNIVKY 79
Query: 472 RGFCCSRGRGECFLIYDFAPKGKLSKYLDQEEGSSNVLDWSTRVSIIIGIAKGIGYLHSS 531
           +G C S GR    LI ++ P G L  YL   +  +  +D    +     I KG+ YL + 
Sbjct: 80  KGVCYSAGRRNLKLIMEYLPYGSLRDYL---QAHAERIDHIKLLQYTSQICKGMEYLGTK 136
Query: 532 EVNKPAIVHRNLSVEKVLIDQQFNPLIADCGLHKLLADDIVFSVLKT--SAAMGYLAPEY 589
                  +HR+L+   +L++ +    I D GL K+L  D     +K    + + + APE 
Sbjct: 137 RY-----IHRDLATRNILVENENRVKIGDFGLTKVLPQDKEXXKVKEPGESPIFWYAPES 191
Query: 590 VTTGRFTERSDIFAFGVIILQILT 613
           +T  +F+  SD+++FGV++ ++ T
Sbjct: 192 LTESKFSVASDVWSFGVVLYELFT 215

>pdb|4F1M|A Chain A, Crystal Structure Of The G1179s Roco4 Kinase Domain Bound To Appcp From D. Discoideum Length = 287

Iteration: 1
 Score = 94.7 bits (234), Expect = 2e-19,   Method: Compositional matrix adjust.
 Identities = 80/307 (26%), Positives = 146/307 (47%), Gaps = 37/307 (12%)
Query: 384 LNGTGFSREHLNSFRLNLEEVESATQCFSEVNLLGKGNFSSVYKGTL-RDGTLVAIRSIN 442
           + G+ F +  L +   N  E+E   Q       +GKG F  V+KG L +D ++VAI+S+ 
Sbjct: 3   MGGSEFPKSRLPTLADN--EIEYEKQ-------IGKGGFGLVHKGRLVKDKSVVAIKSLI 53
Query: 443 VTSCKSEE------AEFVKGLYLLTSLRHENIIRLRGFCCSRGRGECFLIYDFAPKGKL- 495
           +   + E        EF + ++++++L H NI++L G   +  R    ++ +F P G L 
Sbjct: 54  LGDSEGETEMIEKFQEFQREVFIMSNLNHPNIVKLYGLMHNPPR----MVMEFVPCGDLY 109
Query: 496 SKYLDQEEGSSNVLDWSTRVSIIIGIAKGIGYLHSSEVNKPAIVHRNLSVEKVLID--QQ 553
            + LD+    ++ + WS ++ +++ IA GI Y+ +     P IVHR+L    + +    +
Sbjct: 110 HRLLDK----AHPIKWSVKLRLMLDIALGIEYMQN---QNPPIVHRDLRSPNIFLQSLDE 162
Query: 554 FNPLIADCGLHKLLADDIVFSVLKTSAAMGYLAPEYVTTGR--FTERSDIFAFGVIILQI 611
             P+ A      L +   V SV        ++APE +      +TE++D ++F +I+  I
Sbjct: 163 NAPVCAKVADFSL-SQQSVHSVSGLLGNFQWMAPETIGAEEESYTEKADTYSFAMILYTI 221
Query: 612 LTGSLVLTSSMRLAAESATFENFI-DRNLKGKFSESEAAKLGKMALVCTHEDPENRPTME 670
           LTG          +     F N I +  L+    E    +L  +  +C   DP+ RP   
Sbjct: 222 LTGEGPFDE---YSYGKIKFINMIREEGLRPTIPEDCPPRLRNVIELCWSGDPKKRPHFS 278
Query: 671 AVIEELT 677
            +++EL+
Sbjct: 279 YIVKELS 285

>pdb|1MQB|A Chain A, Crystal Structure Of Ephrin A2 (Epha2) Receptor Protein Kinase Length = 333

Iteration: 1
 Score = 94.4 bits (233), Expect = 2e-19,   Method: Compositional matrix adjust.
 Identities = 56/211 (26%), Positives = 107/211 (50%), Gaps = 17/211 (8%)
Query: 410 CFSEVNLLGKGNFSSVYKGTLRDGT-----LVAIRSINVTSCKSEEAEFVKGLYLLTSLR 464
           C +   ++G G F  VYKG L+  +      VAI+++     + +  +F+    ++    
Sbjct: 45  CVTRQKVIGAGEFGEVYKGMLKTSSGKKEVPVAIKTLKAGYTEKQRVDFLGEAGIMGQFS 104
Query: 465 HENIIRLRGFCCSRGRGECFLIYDFAPKGKLSKYLDQEEGSSNVLDWSTRVSIIIGIAKG 524
           H NIIRL G           +I ++   G L K+L +++G  +VL     V ++ GIA G
Sbjct: 105 HHNIIRLEGVISKYK--PMMIITEYMENGALDKFLREKDGEFSVLQ---LVGMLRGIAAG 159
Query: 525 IGYLHSSEVNKPAIVHRNLSVEKVLIDQQFNPLIADCGLHKLLADD--IVFSVLKTSAAM 582
           + YL +        VHR+L+   +L++      ++D GL ++L DD    ++       +
Sbjct: 160 MKYLANMNY-----VHRDLAARNILVNSNLVCKVSDFGLSRVLEDDPEATYTTSGGKIPI 214
Query: 583 GYLAPEYVTTGRFTERSDIFAFGVIILQILT 613
            + APE ++  +FT  SD+++FG+++ +++T
Sbjct: 215 RWTAPEAISYRKFTSASDVWSFGIVMWEVMT 245

>pdb|2W1I|A Chain A, Structure Determination Of Aurora Kinase In Complex With Inhibitor Length = 326

Iteration: 1
 Score = 94.4 bits (233), Expect = 2e-19,   Method: Compositional matrix adjust.
 Identities = 62/204 (30%), Positives = 107/204 (52%), Gaps = 16/204 (7%)
Query: 417 LGKGNFSSV---YKGTLRD--GTLVAIRSINVTSCKSEEAEFVKGLYLLTSLRHENIIRL 471
           LGKGNF SV       L+D  G +VA++ +   S +    +F + + +L SL+H+NI++ 
Sbjct: 49  LGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQ-HSTEEHLRDFEREIEILKSLQHDNIVKY 107
Query: 472 RGFCCSRGRGECFLIYDFAPKGKLSKYLDQEEGSSNVLDWSTRVSIIIGIAKGIGYLHSS 531
           +G C S GR    LI ++ P G L  YL + +     +D    +     I KG+ YL + 
Sbjct: 108 KGVCYSAGRRNLKLIMEYLPYGSLRDYLQKHKER---IDHIKLLQYTSQICKGMEYLGTK 164
Query: 532 EVNKPAIVHRNLSVEKVLIDQQFNPLIADCGLHKLLADDIVFSVLKT--SAAMGYLAPEY 589
                  +HR+L+   +L++ +    I D GL K+L  D     +K    + + + APE 
Sbjct: 165 RY-----IHRDLATRNILVENENRVKIGDFGLTKVLPQDKEXXKVKEPGESPIFWYAPES 219
Query: 590 VTTGRFTERSDIFAFGVIILQILT 613
           +T  +F+  SD+++FGV++ ++ T
Sbjct: 220 LTESKFSVASDVWSFGVVLYELFT 243

>pdb|4F1O|A Chain A, Crystal Structure Of The L1180t Mutant Roco4 Kinase Domain From D. Discoideum Bound To Appcp Length = 287

Iteration: 1
 Score = 94.4 bits (233), Expect = 2e-19,   Method: Compositional matrix adjust.
 Identities = 81/310 (26%), Positives = 148/310 (47%), Gaps = 43/310 (13%)
Query: 384 LNGTGFSREHLNSFRLNLEEVESATQCFSEVNLLGKGNFSSVYKGTL-RDGTLVAIRSIN 442
           + G+ F +  L +   N  E+E   Q       +GKG F  V+KG L +D ++VAI+S+ 
Sbjct: 3   MGGSEFPKSRLPTLADN--EIEYEKQ-------IGKGGFGLVHKGRLVKDKSVVAIKSLI 53
Query: 443 VTSCKSEE------AEFVKGLYLLTSLRHENIIRLRGFCCSRGRGECFLIYDFAPKGKL- 495
           +   + E        EF + ++++++L H NI++L G   +  R    ++ +F P G L 
Sbjct: 54  LGDSEGETEMIEKFQEFQREVFIMSNLNHPNIVKLYGLMHNPPR----MVMEFVPCGDLY 109
Query: 496 SKYLDQEEGSSNVLDWSTRVSIIIGIAKGIGYLHSSEVNKPAIVHRNLSVEKVLID--QQ 553
            + LD+    ++ + WS ++ +++ IA GI Y+ +     P IVHR+L    + +    +
Sbjct: 110 HRLLDK----AHPIKWSVKLRLMLDIALGIEYMQN---QNPPIVHRDLRSPNIFLQSLDE 162
Query: 554 FNPL---IADCGLHKLLADDIVFSVLKTSAAMGYLAPEYVTTGR--FTERSDIFAFGVII 608
             P+   +AD G     +   V SV        ++APE +      +TE++D ++F +I+
Sbjct: 163 NAPVCAKVADFGT----SQQSVHSVSGLLGNFQWMAPETIGAEEESYTEKADTYSFAMIL 218
Query: 609 LQILTGSLVLTSSMRLAAESATFENFI-DRNLKGKFSESEAAKLGKMALVCTHEDPENRP 667
             ILTG          +     F N I +  L+    E    +L  +  +C   DP+ RP
Sbjct: 219 YTILTGEGPFDE---YSYGKIKFINMIREEGLRPTIPEDCPPRLRNVIELCWSGDPKKRP 275
Query: 668 TMEAVIEELT 677
               +++EL+
Sbjct: 276 HFSYIVKELS 285

>pdb|3TJC|A Chain A, Co-Crystal Structure Of Jak2 With Thienopyridine 8 Length = 298

Iteration: 1
 Score = 94.4 bits (233), Expect = 2e-19,   Method: Compositional matrix adjust.
 Identities = 62/204 (30%), Positives = 107/204 (52%), Gaps = 16/204 (7%)
Query: 417 LGKGNFSSV---YKGTLRD--GTLVAIRSINVTSCKSEEAEFVKGLYLLTSLRHENIIRL 471
           LGKGNF SV       L+D  G +VA++ +   S +    +F + + +L SL+H+NI++ 
Sbjct: 21  LGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQ-HSTEEHLRDFEREIEILKSLQHDNIVKY 79
Query: 472 RGFCCSRGRGECFLIYDFAPKGKLSKYLDQEEGSSNVLDWSTRVSIIIGIAKGIGYLHSS 531
           +G C S GR    LI ++ P G L  YL + +     +D    +     I KG+ YL + 
Sbjct: 80  KGVCYSAGRRNLKLIMEYLPYGSLRDYLQKHKER---IDHIKLLQYTSQICKGMEYLGTK 136
Query: 532 EVNKPAIVHRNLSVEKVLIDQQFNPLIADCGLHKLLADDIVFSVLKT--SAAMGYLAPEY 589
                  +HR+L+   +L++ +    I D GL K+L  D     +K    + + + APE 
Sbjct: 137 RY-----IHRDLATRNILVENENRVKIGDFGLTKVLPQDKEXXKVKEPGESPIFWYAPES 191
Query: 590 VTTGRFTERSDIFAFGVIILQILT 613
           +T  +F+  SD+++FGV++ ++ T
Sbjct: 192 LTESKFSVASDVWSFGVVLYELFT 215

>pdb|3LPB|A Chain A, Crystal Structure Of Jak2 Complexed With A Potent 2,8-Diaryl Quinoxaline Inhibitor Length = 295

Iteration: 1
 Score = 94.4 bits (233), Expect = 2e-19,   Method: Compositional matrix adjust.
 Identities = 62/204 (30%), Positives = 107/204 (52%), Gaps = 16/204 (7%)
Query: 417 LGKGNFSSV---YKGTLRD--GTLVAIRSINVTSCKSEEAEFVKGLYLLTSLRHENIIRL 471
           LGKGNF SV       L+D  G +VA++ +   S +    +F + + +L SL+H+NI++ 
Sbjct: 18  LGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQ-HSTEEHLRDFEREIEILKSLQHDNIVKY 76
Query: 472 RGFCCSRGRGECFLIYDFAPKGKLSKYLDQEEGSSNVLDWSTRVSIIIGIAKGIGYLHSS 531
           +G C S GR    LI ++ P G L  YL + +     +D    +     I KG+ YL + 
Sbjct: 77  KGVCYSAGRRNLKLIMEYLPYGSLRDYLQKHKER---IDHIKLLQYTSQICKGMEYLGTK 133
Query: 532 EVNKPAIVHRNLSVEKVLIDQQFNPLIADCGLHKLLADDIVFSVLKT--SAAMGYLAPEY 589
                  +HR+L+   +L++ +    I D GL K+L  D     +K    + + + APE 
Sbjct: 134 RY-----IHRDLATRNILVENENRVKIGDFGLTKVLPQDKEXXKVKEPGESPIFWYAPES 188
Query: 590 VTTGRFTERSDIFAFGVIILQILT 613
           +T  +F+  SD+++FGV++ ++ T
Sbjct: 189 LTESKFSVASDVWSFGVVLYELFT 212

>pdb|2B7A|A Chain A, The Structural Basis Of Janus Kinase 2 Inhibition By A Potent And Specific Pan-Janus Kinase Inhibitor Length = 293

Iteration: 1
 Score = 94.0 bits (232), Expect = 2e-19,   Method: Compositional matrix adjust.
 Identities = 62/204 (30%), Positives = 107/204 (52%), Gaps = 16/204 (7%)
Query: 417 LGKGNFSSV---YKGTLRD--GTLVAIRSINVTSCKSEEAEFVKGLYLLTSLRHENIIRL 471
           LGKGNF SV       L+D  G +VA++ +   S +    +F + + +L SL+H+NI++ 
Sbjct: 16  LGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQ-HSTEEHLRDFEREIEILKSLQHDNIVKY 74
Query: 472 RGFCCSRGRGECFLIYDFAPKGKLSKYLDQEEGSSNVLDWSTRVSIIIGIAKGIGYLHSS 531
           +G C S GR    LI ++ P G L  YL + +     +D    +     I KG+ YL + 
Sbjct: 75  KGVCYSAGRRNLKLIMEYLPYGSLRDYLQKHKER---IDHIKLLQYTSQICKGMEYLGTK 131
Query: 532 EVNKPAIVHRNLSVEKVLIDQQFNPLIADCGLHKLLADDIVFSVLKT--SAAMGYLAPEY 589
                  +HR+L+   +L++ +    I D GL K+L  D     +K    + + + APE 
Sbjct: 132 RY-----IHRDLATRNILVENENRVKIGDFGLTKVLPQDKEXXKVKEPGESPIFWYAPES 186
Query: 590 VTTGRFTERSDIFAFGVIILQILT 613
           +T  +F+  SD+++FGV++ ++ T
Sbjct: 187 LTESKFSVASDVWSFGVVLYELFT 210

>pdb|3E62|A Chain A, Fragment Based Discovery Of Jak-2 Inhibitors Length = 293

Iteration: 1
 Score = 94.0 bits (232), Expect = 2e-19,   Method: Compositional matrix adjust.
 Identities = 62/204 (30%), Positives = 107/204 (52%), Gaps = 16/204 (7%)
Query: 417 LGKGNFSSV---YKGTLRD--GTLVAIRSINVTSCKSEEAEFVKGLYLLTSLRHENIIRL 471
           LGKGNF SV       L+D  G +VA++ +   S +    +F + + +L SL+H+NI++ 
Sbjct: 17  LGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQ-HSTEEHLRDFEREIEILKSLQHDNIVKY 75
Query: 472 RGFCCSRGRGECFLIYDFAPKGKLSKYLDQEEGSSNVLDWSTRVSIIIGIAKGIGYLHSS 531
           +G C S GR    LI ++ P G L  YL + +     +D    +     I KG+ YL + 
Sbjct: 76  KGVCYSAGRRNLKLIMEYLPYGSLRDYLQKHKER---IDHIKLLQYTSQICKGMEYLGTK 132
Query: 532 EVNKPAIVHRNLSVEKVLIDQQFNPLIADCGLHKLLADDIVFSVLKT--SAAMGYLAPEY 589
                  +HR+L+   +L++ +    I D GL K+L  D     +K    + + + APE 
Sbjct: 133 RY-----IHRDLATRNILVENENRVKIGDFGLTKVLPQDKEXXKVKEPGESPIFWYAPES 187
Query: 590 VTTGRFTERSDIFAFGVIILQILT 613
           +T  +F+  SD+++FGV++ ++ T
Sbjct: 188 LTESKFSVASDVWSFGVVLYELFT 211

>pdb|3Q32|A Chain A, Structure Of Janus Kinase 2 With A Pyrrolotriazine Inhibitor Length = 301

Iteration: 1
 Score = 94.0 bits (232), Expect = 2e-19,   Method: Compositional matrix adjust.
 Identities = 62/204 (30%), Positives = 107/204 (52%), Gaps = 16/204 (7%)
Query: 417 LGKGNFSSV---YKGTLRD--GTLVAIRSINVTSCKSEEAEFVKGLYLLTSLRHENIIRL 471
           LGKGNF SV       L+D  G +VA++ +   S +    +F + + +L SL+H+NI++ 
Sbjct: 18  LGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQ-HSTEEHLRDFEREIEILKSLQHDNIVKY 76
Query: 472 RGFCCSRGRGECFLIYDFAPKGKLSKYLDQEEGSSNVLDWSTRVSIIIGIAKGIGYLHSS 531
           +G C S GR    LI ++ P G L  YL + +     +D    +     I KG+ YL + 
Sbjct: 77  KGVCYSAGRRNLKLIMEYLPYGSLRDYLQKHKER---IDHIKLLQYTSQICKGMEYLGTK 133
Query: 532 EVNKPAIVHRNLSVEKVLIDQQFNPLIADCGLHKLLADDIVFSVLKT--SAAMGYLAPEY 589
                  +HR+L+   +L++ +    I D GL K+L  D     +K    + + + APE 
Sbjct: 134 RY-----IHRDLATRNILVENENRVKIGDFGLTKVLPQDKEXXKVKEPGESPIFWYAPES 188
Query: 590 VTTGRFTERSDIFAFGVIILQILT 613
           +T  +F+  SD+++FGV++ ++ T
Sbjct: 189 LTESKFSVASDVWSFGVVLYELFT 212

>pdb|4HGE|A Chain A, Jak2 Kinase (Jh1 Domain) In Complex With Compound 8 Length = 300

Iteration: 1
 Score = 94.0 bits (232), Expect = 2e-19,   Method: Compositional matrix adjust.
 Identities = 62/204 (30%), Positives = 107/204 (52%), Gaps = 16/204 (7%)
Query: 417 LGKGNFSSV---YKGTLRD--GTLVAIRSINVTSCKSEEAEFVKGLYLLTSLRHENIIRL 471
           LGKGNF SV       L+D  G +VA++ +   S +    +F + + +L SL+H+NI++ 
Sbjct: 23  LGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQ-HSTEEHLRDFEREIEILKSLQHDNIVKY 81
Query: 472 RGFCCSRGRGECFLIYDFAPKGKLSKYLDQEEGSSNVLDWSTRVSIIIGIAKGIGYLHSS 531
           +G C S GR    LI ++ P G L  YL + +     +D    +     I KG+ YL + 
Sbjct: 82  KGVCYSAGRRNLKLIMEYLPYGSLRDYLQKHKER---IDHIKLLQYTSQICKGMEYLGTK 138
Query: 532 EVNKPAIVHRNLSVEKVLIDQQFNPLIADCGLHKLLADDIVFSVLKT--SAAMGYLAPEY 589
                  +HR+L+   +L++ +    I D GL K+L  D     +K    + + + APE 
Sbjct: 139 RY-----IHRDLATRNILVENENRVKIGDFGLTKVLPQDKEXXKVKEPGESPIFWYAPES 193
Query: 590 VTTGRFTERSDIFAFGVIILQILT 613
           +T  +F+  SD+++FGV++ ++ T
Sbjct: 194 LTESKFSVASDVWSFGVVLYELFT 217

>pdb|4E4M|A Chain A, Jak2 Kinase (Jh1 Domain) In Complex With Compound 30 Length = 302

Iteration: 1
 Score = 94.0 bits (232), Expect = 2e-19,   Method: Compositional matrix adjust.
 Identities = 62/204 (30%), Positives = 107/204 (52%), Gaps = 16/204 (7%)
Query: 417 LGKGNFSSV---YKGTLRD--GTLVAIRSINVTSCKSEEAEFVKGLYLLTSLRHENIIRL 471
           LGKGNF SV       L+D  G +VA++ +   S +    +F + + +L SL+H+NI++ 
Sbjct: 25  LGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQ-HSTEEHLRDFEREIEILKSLQHDNIVKY 83
Query: 472 RGFCCSRGRGECFLIYDFAPKGKLSKYLDQEEGSSNVLDWSTRVSIIIGIAKGIGYLHSS 531
           +G C S GR    LI ++ P G L  YL + +     +D    +     I KG+ YL + 
Sbjct: 84  KGVCYSAGRRNLKLIMEYLPYGSLRDYLQKHKER---IDHIKLLQYTSQICKGMEYLGTK 140
Query: 532 EVNKPAIVHRNLSVEKVLIDQQFNPLIADCGLHKLLADDIVFSVLKT--SAAMGYLAPEY 589
                  +HR+L+   +L++ +    I D GL K+L  D     +K    + + + APE 
Sbjct: 141 RY-----IHRDLATRNILVENENRVKIGDFGLTKVLPQDKEXXKVKEPGESPIFWYAPES 195
Query: 590 VTTGRFTERSDIFAFGVIILQILT 613
           +T  +F+  SD+++FGV++ ++ T
Sbjct: 196 LTESKFSVASDVWSFGVVLYELFT 219

>pdb|3RVG|A Chain A, Crystals Structure Of Jak2 With A 1-Amino-5h-Pyrido[4,3-B]indol-4- Carboxamide Inhibitor Length = 303

Iteration: 1
 Score = 94.0 bits (232), Expect = 2e-19,   Method: Compositional matrix adjust.
 Identities = 62/204 (30%), Positives = 107/204 (52%), Gaps = 16/204 (7%)
Query: 417 LGKGNFSSV---YKGTLRD--GTLVAIRSINVTSCKSEEAEFVKGLYLLTSLRHENIIRL 471
           LGKGNF SV       L+D  G +VA++ +   S +    +F + + +L SL+H+NI++ 
Sbjct: 22  LGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQ-HSTEEHLRDFEREIEILKSLQHDNIVKY 80
Query: 472 RGFCCSRGRGECFLIYDFAPKGKLSKYLDQEEGSSNVLDWSTRVSIIIGIAKGIGYLHSS 531
           +G C S GR    LI ++ P G L  YL + +     +D    +     I KG+ YL + 
Sbjct: 81  KGVCYSAGRRNLKLIMEYLPYGSLRDYLQKHKER---IDHIKLLQYTSQICKGMEYLGTK 137
Query: 532 EVNKPAIVHRNLSVEKVLIDQQFNPLIADCGLHKLLADDIVFSVLKT--SAAMGYLAPEY 589
                  +HR+L+   +L++ +    I D GL K+L  D     +K    + + + APE 
Sbjct: 138 RY-----IHRDLATRNILVENENRVKIGDFGLTKVLPQDKEXXKVKEPGESPIFWYAPES 192
Query: 590 VTTGRFTERSDIFAFGVIILQILT 613
           +T  +F+  SD+++FGV++ ++ T
Sbjct: 193 LTESKFSVASDVWSFGVVLYELFT 216

>pdb|3JY9|A Chain A, Janus Kinase 2 Inhibitors Length = 311

Iteration: 1
 Score = 94.0 bits (232), Expect = 2e-19,   Method: Compositional matrix adjust.
 Identities = 62/204 (30%), Positives = 107/204 (52%), Gaps = 16/204 (7%)
Query: 417 LGKGNFSSV---YKGTLRD--GTLVAIRSINVTSCKSEEAEFVKGLYLLTSLRHENIIRL 471
           LGKGNF SV       L+D  G +VA++ +   S +    +F + + +L SL+H+NI++ 
Sbjct: 36  LGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQ-HSTEEHLRDFEREIEILKSLQHDNIVKY 94
Query: 472 RGFCCSRGRGECFLIYDFAPKGKLSKYLDQEEGSSNVLDWSTRVSIIIGIAKGIGYLHSS 531
           +G C S GR    LI ++ P G L  YL + +     +D    +     I KG+ YL + 
Sbjct: 95  KGVCYSAGRRNLKLIMEYLPYGSLRDYLQKHKER---IDHIKLLQYTSQICKGMEYLGTK 151
Query: 532 EVNKPAIVHRNLSVEKVLIDQQFNPLIADCGLHKLLADDIVFSVLKT--SAAMGYLAPEY 589
                  +HR+L+   +L++ +    I D GL K+L  D     +K    + + + APE 
Sbjct: 152 RY-----IHRDLATRNILVENENRVKIGDFGLTKVLPQDKEXXKVKEPGESPIFWYAPES 206
Query: 590 VTTGRFTERSDIFAFGVIILQILT 613
           +T  +F+  SD+++FGV++ ++ T
Sbjct: 207 LTESKFSVASDVWSFGVVLYELFT 230

>pdb|3IO7|A Chain A, 2-Aminopyrazolo[1,5-A]pyrimidines As Potent And Selective Inhibitors Of Jak2 Length = 313

Iteration: 1
 Score = 94.0 bits (232), Expect = 2e-19,   Method: Compositional matrix adjust.
 Identities = 62/204 (30%), Positives = 107/204 (52%), Gaps = 16/204 (7%)
Query: 417 LGKGNFSSV---YKGTLRD--GTLVAIRSINVTSCKSEEAEFVKGLYLLTSLRHENIIRL 471
           LGKGNF SV       L+D  G +VA++ +   S +    +F + + +L SL+H+NI++ 
Sbjct: 36  LGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQ-HSTEEHLRDFEREIEILKSLQHDNIVKY 94
Query: 472 RGFCCSRGRGECFLIYDFAPKGKLSKYLDQEEGSSNVLDWSTRVSIIIGIAKGIGYLHSS 531
           +G C S GR    LI ++ P G L  YL + +     +D    +     I KG+ YL + 
Sbjct: 95  KGVCYSAGRRNLKLIMEYLPYGSLRDYLQKHKER---IDHIKLLQYTSQICKGMEYLGTK 151
Query: 532 EVNKPAIVHRNLSVEKVLIDQQFNPLIADCGLHKLLADDIVFSVLKT--SAAMGYLAPEY 589
                  +HR+L+   +L++ +    I D GL K+L  D     +K    + + + APE 
Sbjct: 152 RY-----IHRDLATRNILVENENRVKIGDFGLTKVLPQDKEXXKVKEPGESPIFWYAPES 206
Query: 590 VTTGRFTERSDIFAFGVIILQILT 613
           +T  +F+  SD+++FGV++ ++ T
Sbjct: 207 LTESKFSVASDVWSFGVVLYELFT 230

>pdb|4AQC|A Chain A, Triazolopyridine-Based Inhibitor Of Janus Kinase 2 Length = 301

Iteration: 1
 Score = 94.0 bits (232), Expect = 2e-19,   Method: Compositional matrix adjust.
 Identities = 62/204 (30%), Positives = 107/204 (52%), Gaps = 16/204 (7%)
Query: 417 LGKGNFSSV---YKGTLRD--GTLVAIRSINVTSCKSEEAEFVKGLYLLTSLRHENIIRL 471
           LGKGNF SV       L+D  G +VA++ +   S +    +F + + +L SL+H+NI++ 
Sbjct: 24  LGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQ-HSTEEHLRDFEREIEILKSLQHDNIVKY 82
Query: 472 RGFCCSRGRGECFLIYDFAPKGKLSKYLDQEEGSSNVLDWSTRVSIIIGIAKGIGYLHSS 531
           +G C S GR    LI ++ P G L  YL + +     +D    +     I KG+ YL + 
Sbjct: 83  KGVCYSAGRRNLKLIMEYLPYGSLRDYLQKHKER---IDHIKLLQYTSQICKGMEYLGTK 139
Query: 532 EVNKPAIVHRNLSVEKVLIDQQFNPLIADCGLHKLLADDIVFSVLKT--SAAMGYLAPEY 589
                  +HR+L+   +L++ +    I D GL K+L  D     +K    + + + APE 
Sbjct: 140 RY-----IHRDLATRNILVENENRVKIGDFGLTKVLPQDKEXXKVKEPGESPIFWYAPES 194
Query: 590 VTTGRFTERSDIFAFGVIILQILT 613
           +T  +F+  SD+++FGV++ ++ T
Sbjct: 195 LTESKFSVASDVWSFGVVLYELFT 218

>pdb|3Q6W|A Chain A, Structure Of Dually-phosphorylated Met Receptor Kinase In Complex With An Mk-2461 Analog With Specificity For The Activated Receptor Length = 307

Iteration: 1
 Score = 94.0 bits (232), Expect = 3e-19,   Method: Compositional matrix adjust.
 Identities = 75/287 (26%), Positives = 141/287 (49%), Gaps = 31/287 (10%)
Query: 411 FSEVNLLGKGNFSSVYKGTL--RDGTLV--AIRSINVTSCKSEEAEFVKGLYLLTSLRHE 466
           F+EV  +G+G+F  VY GTL   DG  +  A++S+N  +   E ++F+    ++    H 
Sbjct: 33  FNEV--IGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHP 90
Query: 467 NIIRLRGFCCSRGRGECFLIYDFAPKGKLSKYLDQEEGSSNVLDWSTRVSIIIGIAKGIG 526
           N++ L G C  R  G   ++  +   G L  ++  E  +  V D    +   + +AKG+ 
Sbjct: 91  NVLSLLGICL-RSEGSPLVVLPYMKHGDLRNFIRNETHNPTVKD---LIGFGLQVAKGMK 146
Query: 527 YLHSSEVNKPAIVHRNLSVEKVLIDQQFNPLIADCGLHKLLADDIVFSVLKTSAA---MG 583
           YL S +      VHR+L+    ++D++F   +AD GL + + D    SV   + A   + 
Sbjct: 147 YLASKK-----FVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEXXSVHNKTGAKLPVK 201
Query: 584 YLAPEYVTTGRFTERSDIFAFGVIILQILTGSLVLTSSMRLAAESATFENFIDRNLKGKF 643
           ++A E + T +FT +SD+++FGV++ ++      +T       +  TF+  +   L+G+ 
Sbjct: 202 WMALESLQTQKFTTKSDVWSFGVLLWEL------MTRGAPPYPDVNTFDITV-YLLQGRR 254
Query: 644 ---SESEAAKLGKMALVCTHEDPENRPTMEAVIEELTVAAPVMATFL 687
               E     L ++ L C H   E RP+   ++  ++    + +TF+
Sbjct: 255 LLQPEYCPDPLYEVMLKCWHPKAEMRPSFSELVSRISA---IFSTFI 298

>pdb|3GEQ|A Chain A, Structural Basis For The Chemical Rescue Of Src Kinase Activity Length = 286

Iteration: 1
 Score = 93.2 bits (230), Expect = 5e-19,   Method: Compositional matrix adjust.
 Identities = 66/254 (25%), Positives = 116/254 (45%), Gaps = 16/254 (6%)
Query: 417 LGKGNFSSVYKGTLRDGTLVAIRSINVTSCKSEEAEFVKGLYLLTSLRHENIIRLRGFCC 476
           LG+G F  V+ GT    T VAI+++   +   E   F++   ++  LRHE +++L     
Sbjct: 26  LGQGCFGEVWMGTWNGTTRVAIKTLKPGTMSPEA--FLQEAQVMKKLRHEKLVQLYAVVS 83
Query: 477 SRGRGECFLIYDFAPKGKLSKYLDQEEGSSNVLDWSTRVSIIIGIAKGIGYLHSSEVNKP 536
                  +++ ++  KG L  +L  E G    L     V +   IA G+ Y     V + 
Sbjct: 84  EE---PIYIVTEYMSKGSLLDFLKGEMG--KYLRLPQLVDMAAQIASGMAY-----VERM 133
Query: 537 AIVHRNLSVEKVLIDQQFNPLIADCGLHKLLADDIVFSVLKTSAAMGYLAPEYVTTGRFT 596
             VHR+L+   +L+ +     +AD GL +L+ D+   +       + + APE    GRFT
Sbjct: 134 NYVHRDLAAANILVGENLVCKVADFGLARLIEDNEYTARQGAKFPIKWTAPEAALYGRFT 193
Query: 597 ERSDIFAFGVIILQILTGSLVLTSSMRLAAESATFENFIDRNLKGKFSESEAAKLGKMAL 656
            +SD+++FG+++ ++ T   V    M     +    + ++R  +          L  +  
Sbjct: 194 IKSDVWSFGILLTELTTKGRVPYPGMV----NREVLDQVERGYRMPCPPECPESLHDLMC 249
Query: 657 VCTHEDPENRPTME 670
            C  +DPE RPT E
Sbjct: 250 QCWRKDPEERPTFE 263

>pdb|3DQW|A Chain A, C-Src Kinase Domain Thr338ile Mutant In Complex With Atpgs Length = 286

Iteration: 1
 Score = 92.4 bits (228), Expect = 7e-19,   Method: Compositional matrix adjust.
 Identities = 66/254 (25%), Positives = 115/254 (45%), Gaps = 16/254 (6%)
Query: 417 LGKGNFSSVYKGTLRDGTLVAIRSINVTSCKSEEAEFVKGLYLLTSLRHENIIRLRGFCC 476
           LG+G F  V+ GT    T VAI+++   +   E   F++   ++  LRHE +++L     
Sbjct: 26  LGQGCFGEVWMGTWNGTTRVAIKTLKPGTMSPEA--FLQEAQVMKKLRHEKLVQLYAVVS 83
Query: 477 SRGRGECFLIYDFAPKGKLSKYLDQEEGSSNVLDWSTRVSIIIGIAKGIGYLHSSEVNKP 536
                  +++ ++  KG L  +L  E G    L     V +   IA G+ Y     V + 
Sbjct: 84  EE---PIYIVIEYMSKGSLLDFLKGEMG--KYLRLPQLVDMAAQIASGMAY-----VERM 133
Query: 537 AIVHRNLSVEKVLIDQQFNPLIADCGLHKLLADDIVFSVLKTSAAMGYLAPEYVTTGRFT 596
             VHR+L    +L+ +     +AD GL +L+ D+   +       + + APE    GRFT
Sbjct: 134 NYVHRDLRAANILVGENLVCKVADFGLARLIEDNEXTARQGAKFPIKWTAPEAALYGRFT 193
Query: 597 ERSDIFAFGVIILQILTGSLVLTSSMRLAAESATFENFIDRNLKGKFSESEAAKLGKMAL 656
            +SD+++FG+++ ++ T   V    M     +    + ++R  +          L  +  
Sbjct: 194 IKSDVWSFGILLTELTTKGRVPYPGMV----NREVLDQVERGYRMPCPPECPESLHDLMC 249
Query: 657 VCTHEDPENRPTME 670
            C  +DPE RPT E
Sbjct: 250 QCWRKDPEERPTFE 263

>pdb|3G6H|A Chain A, Src Thr338ile Inhibited In The Dfg-Asp-Out Conformation Length = 286

Iteration: 1
 Score = 92.4 bits (228), Expect = 7e-19,   Method: Compositional matrix adjust.
 Identities = 66/254 (25%), Positives = 115/254 (45%), Gaps = 16/254 (6%)
Query: 417 LGKGNFSSVYKGTLRDGTLVAIRSINVTSCKSEEAEFVKGLYLLTSLRHENIIRLRGFCC 476
           LG+G F  V+ GT    T VAI+++   +   E   F++   ++  LRHE +++L     
Sbjct: 26  LGQGCFGEVWMGTWNGTTRVAIKTLKPGTMSPEA--FLQEAQVMKKLRHEKLVQLYAVVS 83
Query: 477 SRGRGECFLIYDFAPKGKLSKYLDQEEGSSNVLDWSTRVSIIIGIAKGIGYLHSSEVNKP 536
                  +++ ++  KG L  +L  E G    L     V +   IA G+ Y     V + 
Sbjct: 84  EE---PIYIVIEYMSKGSLLDFLKGEMG--KYLRLPQLVDMAAQIASGMAY-----VERM 133
Query: 537 AIVHRNLSVEKVLIDQQFNPLIADCGLHKLLADDIVFSVLKTSAAMGYLAPEYVTTGRFT 596
             VHR+L    +L+ +     +AD GL +L+ D+   +       + + APE    GRFT
Sbjct: 134 NYVHRDLRAANILVGENLVCKVADFGLARLIEDNEYTARQGAKFPIKWTAPEAALYGRFT 193
Query: 597 ERSDIFAFGVIILQILTGSLVLTSSMRLAAESATFENFIDRNLKGKFSESEAAKLGKMAL 656
            +SD+++FG+++ ++ T   V    M     +    + ++R  +          L  +  
Sbjct: 194 IKSDVWSFGILLTELTTKGRVPYPGMV----NREVLDQVERGYRMPCPPECPESLHDLMC 249
Query: 657 VCTHEDPENRPTME 670
            C  +DPE RPT E
Sbjct: 250 QCWRKDPEERPTFE 263

>pdb|2OIQ|A Chain A, Crystal Structure Of Chicken C-Src Kinase Domain In Complex With The Cancer Drug Imatinib. Length = 286

Iteration: 1
 Score = 92.4 bits (228), Expect = 7e-19,   Method: Compositional matrix adjust.
 Identities = 66/254 (25%), Positives = 115/254 (45%), Gaps = 16/254 (6%)
Query: 417 LGKGNFSSVYKGTLRDGTLVAIRSINVTSCKSEEAEFVKGLYLLTSLRHENIIRLRGFCC 476
           LG+G F  V+ GT    T VAI+++   +   E   F++   ++  LRHE +++L     
Sbjct: 26  LGQGCFGEVWMGTWNGTTRVAIKTLKPGTMSPEA--FLQEAQVMKKLRHEKLVQLYAVVS 83
Query: 477 SRGRGECFLIYDFAPKGKLSKYLDQEEGSSNVLDWSTRVSIIIGIAKGIGYLHSSEVNKP 536
                  +++ ++  KG L  +L  E G    L     V +   IA G+ Y     V + 
Sbjct: 84  EE---PIYIVTEYMSKGSLLDFLKGEMG--KYLRLPQLVDMAAQIASGMAY-----VERM 133
Query: 537 AIVHRNLSVEKVLIDQQFNPLIADCGLHKLLADDIVFSVLKTSAAMGYLAPEYVTTGRFT 596
             VHR+L    +L+ +     +AD GL +L+ D+   +       + + APE    GRFT
Sbjct: 134 NYVHRDLRAANILVGENLVCKVADFGLARLIEDNEYTARQGAKFPIKWTAPEAALYGRFT 193
Query: 597 ERSDIFAFGVIILQILTGSLVLTSSMRLAAESATFENFIDRNLKGKFSESEAAKLGKMAL 656
            +SD+++FG+++ ++ T   V    M     +    + ++R  +          L  +  
Sbjct: 194 IKSDVWSFGILLTELTTKGRVPYPGMV----NREVLDQVERGYRMPCPPECPESLHDLMC 249
Query: 657 VCTHEDPENRPTME 670
            C  +DPE RPT E
Sbjct: 250 QCWRKDPEERPTFE 263

>pdb|2DQ7|X Chain X, Crystal Structure Of Fyn Kinase Domain Complexed With Staurosporine Length = 283

Iteration: 1
 Score = 92.4 bits (228), Expect = 8e-19,   Method: Compositional matrix adjust.
 Identities = 64/259 (24%), Positives = 119/259 (45%), Gaps = 20/259 (7%)
Query: 414 VNLLGKGNFSSVYKGTLRDGTLVAIRSINVTSCKSEEAEFVKGLYLLTSLRHENIIRLRG 473
           +  LG G F  V+ GT    T VAI+++   +   E   F++   ++  L+H+ +++L  
Sbjct: 14  IKRLGNGQFGEVWMGTWNGNTKVAIKTLKPGTMSPES--FLEEAQIMKKLKHDKLVQLYA 71
Query: 474 FCCSRGRGECFLIYDFAPKGKLSKYLDQEEGSSNVLDWSTRVSIIIGIAKGIGYLHSSEV 533
                     +++ ++  KG L  +L   EG +  L     V +   +A G+ Y     +
Sbjct: 72  VVSEE---PIYIVTEYMNKGSLLDFLKDGEGRA--LKLPNLVDMAAQVAAGMAY-----I 121
Query: 534 NKPAIVHRNLSVEKVLIDQQFNPLIADCGLHKLLADDIVFSVLKTSAAMGYLAPEYVTTG 593
            +   +HR+L    +L+       IAD GL +L+ D+   +       + + APE    G
Sbjct: 122 ERMNYIHRDLRSANILVGNGLICKIADFGLARLIEDNEXTARQGAKFPIKWTAPEAALYG 181
Query: 594 RFTERSDIFAFGVIILQILTGSLVLTSSM--RLAAESATFENFIDRNLKGKFSESEAAKL 651
           RFT +SD+++FG+++ +++T   V    M  R   E       ++R  +    +     L
Sbjct: 182 RFTIKSDVWSFGILLTELVTKGRVPYPGMNNREVLEQ------VERGYRMPCPQDCPISL 235
Query: 652 GKMALVCTHEDPENRPTME 670
            ++ + C  +DPE RPT E
Sbjct: 236 HELMIHCWKKDPEERPTFE 254

>pdb|3SVV|A Chain A, Crystal Structure Of T338c C-Src Covalently Bound To Vinylsulfonamide- Pyrazolopyrimidine 9 Length = 286

Iteration: 1
 Score = 92.0 bits (227), Expect = 9e-19,   Method: Compositional matrix adjust.
 Identities = 66/254 (25%), Positives = 115/254 (45%), Gaps = 16/254 (6%)
Query: 417 LGKGNFSSVYKGTLRDGTLVAIRSINVTSCKSEEAEFVKGLYLLTSLRHENIIRLRGFCC 476
           LG+G F  V+ GT    T VAI+++   +   E   F++   ++  LRHE +++L     
Sbjct: 26  LGQGCFGEVWMGTWNGTTRVAIKTLKPGTMSPEA--FLQEAQVMKKLRHEKLVQLYAVVS 83
Query: 477 SRGRGECFLIYDFAPKGKLSKYLDQEEGSSNVLDWSTRVSIIIGIAKGIGYLHSSEVNKP 536
                  +++ ++  KG L  +L  E G    L     V +   IA G+ Y     V + 
Sbjct: 84  EE---PIYIVCEYMSKGSLLDFLKGEMG--KYLRLPQLVDMAAQIASGMAY-----VERM 133
Query: 537 AIVHRNLSVEKVLIDQQFNPLIADCGLHKLLADDIVFSVLKTSAAMGYLAPEYVTTGRFT 596
             VHR+L    +L+ +     +AD GL +L+ D+   +       + + APE    GRFT
Sbjct: 134 NYVHRDLRAANILVGENLVCKVADFGLARLIEDNEYTARQGAKFPIKWTAPEAALYGRFT 193
Query: 597 ERSDIFAFGVIILQILTGSLVLTSSMRLAAESATFENFIDRNLKGKFSESEAAKLGKMAL 656
            +SD+++FG+++ ++ T   V    M     +    + ++R  +          L  +  
Sbjct: 194 IKSDVWSFGILLTELTTKGRVPYPGMV----NREVLDQVERGYRMPCPPECPESLHDLMC 249
Query: 657 VCTHEDPENRPTME 670
            C  +DPE RPT E
Sbjct: 250 QCWRKDPEERPTFE 263

>pdb|2PTK|A Chain A, Chicken Src Tyrosine Kinase Length = 453

Iteration: 1
 Score = 92.0 bits (227), Expect = 9e-19,   Method: Compositional matrix adjust.
 Identities = 66/254 (25%), Positives = 115/254 (45%), Gaps = 16/254 (6%)
Query: 417 LGKGNFSSVYKGTLRDGTLVAIRSINVTSCKSEEAEFVKGLYLLTSLRHENIIRLRGFCC 476
           LG+G F  V+ GT    T VAI+++   +   E   F++   ++  LRHE +++L     
Sbjct: 193 LGQGCFGEVWMGTWNGTTRVAIKTLKPGNMSPEA--FLQEAQVMKKLRHEKLVQLYAVVS 250
Query: 477 SRGRGECFLIYDFAPKGKLSKYLDQEEGSSNVLDWSTRVSIIIGIAKGIGYLHSSEVNKP 536
                  +++ ++  KG L  +L  E G    L     V +   IA G+ Y     V + 
Sbjct: 251 EE---PIYIVTEYMSKGSLLDFLKGEMG--KYLRLPQLVDMAAQIASGMAY-----VERM 300
Query: 537 AIVHRNLSVEKVLIDQQFNPLIADCGLHKLLADDIVFSVLKTSAAMGYLAPEYVTTGRFT 596
             VHR+L    +L+ +     +AD GL +L+ D+   +       + + APE    GRFT
Sbjct: 301 NYVHRDLRAANILVGENLVCKVADFGLGRLIEDNEYTARQGAKFPIKWTAPEAALYGRFT 360
Query: 597 ERSDIFAFGVIILQILTGSLVLTSSMRLAAESATFENFIDRNLKGKFSESEAAKLGKMAL 656
            +SD+++FG+++ ++ T   V    M     +    + ++R  +          L  +  
Sbjct: 361 IKSDVWSFGILLTELTTKGRVPYPGMV----NREVLDQVERGYRMPCPPECPESLHDLMC 416
Query: 657 VCTHEDPENRPTME 670
            C  +DPE RPT E
Sbjct: 417 QCWRKDPEERPTFE 430

>pdb|3U4W|A Chain A, Src In Complex With Dna-Templated Macrocyclic Inhibitor Mc4b Length = 275

Iteration: 1
 Score = 92.0 bits (227), Expect = 1e-18,   Method: Compositional matrix adjust.
 Identities = 66/254 (25%), Positives = 115/254 (45%), Gaps = 16/254 (6%)
Query: 417 LGKGNFSSVYKGTLRDGTLVAIRSINVTSCKSEEAEFVKGLYLLTSLRHENIIRLRGFCC 476
           LG+G F  V+ GT    T VAI+++   +   E   F++   ++  LRHE +++L     
Sbjct: 15  LGQGCFGEVWMGTWNGTTRVAIKTLKPGTMSPEA--FLQEAQVMKKLRHEKLVQLYAVVS 72
Query: 477 SRGRGECFLIYDFAPKGKLSKYLDQEEGSSNVLDWSTRVSIIIGIAKGIGYLHSSEVNKP 536
                  +++ ++  KG L  +L  E G    L     V +   IA G+ Y     V + 
Sbjct: 73  EE---PIYIVTEYMSKGSLLDFLKGEMG--KYLRLPQLVDMAAQIASGMAY-----VERM 122
Query: 537 AIVHRNLSVEKVLIDQQFNPLIADCGLHKLLADDIVFSVLKTSAAMGYLAPEYVTTGRFT 596
             VHR+L    +L+ +     +AD GL +L+ D+   +       + + APE    GRFT
Sbjct: 123 NYVHRDLRAANILVGENLVCKVADFGLARLIEDNEYTARQGAKFPIKWTAPEAALYGRFT 182
Query: 597 ERSDIFAFGVIILQILTGSLVLTSSMRLAAESATFENFIDRNLKGKFSESEAAKLGKMAL 656
            +SD+++FG+++ ++ T   V    M     +    + ++R  +          L  +  
Sbjct: 183 IKSDVWSFGILLTELTTKGRVPYPGMV----NREVLDQVERGYRMPCPPECPESLHDLMC 238
Query: 657 VCTHEDPENRPTME 670
            C  +DPE RPT E
Sbjct: 239 QCWRKDPEERPTFE 252

>pdb|3D7U|B Chain B, Structural Basis For The Recognition Of C-Src By Its Inactivator Csk Length = 277

Iteration: 1
 Score = 92.0 bits (227), Expect = 1e-18,   Method: Compositional matrix adjust.
 Identities = 66/254 (25%), Positives = 115/254 (45%), Gaps = 16/254 (6%)
Query: 417 LGKGNFSSVYKGTLRDGTLVAIRSINVTSCKSEEAEFVKGLYLLTSLRHENIIRLRGFCC 476
           LG+G F  V+ GT    T VAI+++   +   E   F++   ++  LRHE +++L     
Sbjct: 17  LGQGCFGEVWMGTWNGTTRVAIKTLKPGTMSPEA--FLQEAQVMKKLRHEKLVQLYAVVS 74
Query: 477 SRGRGECFLIYDFAPKGKLSKYLDQEEGSSNVLDWSTRVSIIIGIAKGIGYLHSSEVNKP 536
                  +++ ++  KG L  +L  E G    L     V +   IA G+ Y     V + 
Sbjct: 75  EE---PIYIVTEYMSKGSLLDFLKGEMG--KYLRLPQLVDMAAQIASGMAY-----VERM 124
Query: 537 AIVHRNLSVEKVLIDQQFNPLIADCGLHKLLADDIVFSVLKTSAAMGYLAPEYVTTGRFT 596
             VHR+L    +L+ +     +AD GL +L+ D+   +       + + APE    GRFT
Sbjct: 125 NYVHRDLRAANILVGENLVCKVADFGLARLIEDNEYTARQGAKFPIKWTAPEAALYGRFT 184
Query: 597 ERSDIFAFGVIILQILTGSLVLTSSMRLAAESATFENFIDRNLKGKFSESEAAKLGKMAL 656
            +SD+++FG+++ ++ T   V    M     +    + ++R  +          L  +  
Sbjct: 185 IKSDVWSFGILLTELTTKGRVPYPGMV----NREVLDQVERGYRMPCPPECPESLHDLMC 240
Query: 657 VCTHEDPENRPTME 670
            C  +DPE RPT E
Sbjct: 241 QCWRKDPEERPTFE 254

>pdb|2QQ7|A Chain A, Crystal Structure Of Drug Resistant Src Kinase Domain With Irreversible Inhibitor Length = 286

Iteration: 1
 Score = 92.0 bits (227), Expect = 1e-18,   Method: Compositional matrix adjust.
 Identities = 66/254 (25%), Positives = 115/254 (45%), Gaps = 16/254 (6%)
Query: 417 LGKGNFSSVYKGTLRDGTLVAIRSINVTSCKSEEAEFVKGLYLLTSLRHENIIRLRGFCC 476
           LG+G F  V+ GT    T VAI+++   +   E   F++   ++  LRHE +++L     
Sbjct: 26  LGQGCFGEVWMGTWNGTTRVAIKTLKPGTMSPEA--FLQEAQVMKKLRHEKLVQLYAVVS 83
Query: 477 SRGRGECFLIYDFAPKGKLSKYLDQEEGSSNVLDWSTRVSIIIGIAKGIGYLHSSEVNKP 536
                  +++ ++  KG L  +L  E G    L     V +   IA G+ Y     V + 
Sbjct: 84  EE---PIYIVMEYMSKGCLLDFLKGEMG--KYLRLPQLVDMAAQIASGMAY-----VERM 133
Query: 537 AIVHRNLSVEKVLIDQQFNPLIADCGLHKLLADDIVFSVLKTSAAMGYLAPEYVTTGRFT 596
             VHR+L    +L+ +     +AD GL +L+ D+   +       + + APE    GRFT
Sbjct: 134 NYVHRDLRAANILVGENLVCKVADFGLARLIEDNEYTARQGAKFPIKWTAPEAALYGRFT 193
Query: 597 ERSDIFAFGVIILQILTGSLVLTSSMRLAAESATFENFIDRNLKGKFSESEAAKLGKMAL 656
            +SD+++FG+++ ++ T   V    M     +    + ++R  +          L  +  
Sbjct: 194 IKSDVWSFGILLTELTTKGRVPYPGMV----NREVLDQVERGYRMPCPPECPESLHDLMC 249
Query: 657 VCTHEDPENRPTME 670
            C  +DPE RPT E
Sbjct: 250 QCWRKDPEERPTFE 263

>pdb|3C1X|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The Hepatocyte Growth Factor Receptor C-Met In Complex With A Pyrrolotriazine Based Inhibitor Length = 373

Iteration: 1
 Score = 91.7 bits (226), Expect = 1e-18,   Method: Compositional matrix adjust.
 Identities = 74/287 (25%), Positives = 141/287 (49%), Gaps = 31/287 (10%)
Query: 411 FSEVNLLGKGNFSSVYKGTL--RDGTLV--AIRSINVTSCKSEEAEFVKGLYLLTSLRHE 466
           F+EV  +G+G+F  VY GTL   DG  +  A++S+N  +   E ++F+    ++    H 
Sbjct: 93  FNEV--IGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHP 150
Query: 467 NIIRLRGFCCSRGRGECFLIYDFAPKGKLSKYLDQEEGSSNVLDWSTRVSIIIGIAKGIG 526
           N++ L G C  R  G   ++  +   G L  ++  E  +  V D    +   + +AKG+ 
Sbjct: 151 NVLSLLGICL-RSEGSPLVVLPYMKHGDLRNFIRNETHNPTVKDL---IGFGLQVAKGMK 206
Query: 527 YLHSSEVNKPAIVHRNLSVEKVLIDQQFNPLIADCGLHKLLADDIVFSVLKTSAA---MG 583
           +L S +      VHR+L+    ++D++F   +AD GL + + D    SV   + A   + 
Sbjct: 207 FLASKK-----FVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEFDSVHNKTGAKLPVK 261
Query: 584 YLAPEYVTTGRFTERSDIFAFGVIILQILTGSLVLTSSMRLAAESATFENFIDRNLKGKF 643
           ++A E + T +FT +SD+++FGV++ ++      +T       +  TF+  +   L+G+ 
Sbjct: 262 WMALESLQTQKFTTKSDVWSFGVLLWEL------MTRGAPPYPDVNTFDITV-YLLQGRR 314
Query: 644 ---SESEAAKLGKMALVCTHEDPENRPTMEAVIEELTVAAPVMATFL 687
               E     L ++ L C H   E RP+   ++  ++    + +TF+
Sbjct: 315 LLQPEYCPDPLYEVMLKCWHPKAEMRPSFSELVSRISA---IFSTFI 358

>pdb|2H8H|A Chain A, Src Kinase In Complex With A Quinazoline Inhibitor Length = 535

Iteration: 1
 Score = 91.7 bits (226), Expect = 1e-18,   Method: Compositional matrix adjust.
 Identities = 65/254 (25%), Positives = 115/254 (45%), Gaps = 16/254 (6%)
Query: 417 LGKGNFSSVYKGTLRDGTLVAIRSINVTSCKSEEAEFVKGLYLLTSLRHENIIRLRGFCC 476
           LG+G F  V+ GT    T VAI+++   +   E   F++   ++  LRHE +++L     
Sbjct: 275 LGQGCFGEVWMGTWNGTTRVAIKTLKPGTMSPEA--FLQEAQVMKKLRHEKLVQLYAVVS 332
Query: 477 SRGRGECFLIYDFAPKGKLSKYLDQEEGSSNVLDWSTRVSIIIGIAKGIGYLHSSEVNKP 536
                  +++ ++  KG L  +L  E G    L     V +   IA G+ Y     V + 
Sbjct: 333 EE---PIYIVTEYMSKGSLLDFLKGETG--KYLRLPQLVDMAAQIASGMAY-----VERM 382
Query: 537 AIVHRNLSVEKVLIDQQFNPLIADCGLHKLLADDIVFSVLKTSAAMGYLAPEYVTTGRFT 596
             VHR+L    +L+ +     +AD GL +L+ D+   +       + + APE    GRFT
Sbjct: 383 NYVHRDLRAANILVGENLVCKVADFGLARLIEDNEYTARQGAKFPIKWTAPEAALYGRFT 442
Query: 597 ERSDIFAFGVIILQILTGSLVLTSSMRLAAESATFENFIDRNLKGKFSESEAAKLGKMAL 656
            +SD+++FG+++ ++ T   V    M     +    + ++R  +          L  +  
Sbjct: 443 IKSDVWSFGILLTELTTKGRVPYPGMV----NREVLDQVERGYRMPCPPECPESLHDLMC 498
Query: 657 VCTHEDPENRPTME 670
            C  ++PE RPT E
Sbjct: 499 QCWRKEPEERPTFE 512

>pdb|3A4P|A Chain A, Human C-Met Kinase Domain Complexed With 6-Benzyloxyquinoline Inhibitor Length = 319

Iteration: 1
 Score = 91.7 bits (226), Expect = 1e-18,   Method: Compositional matrix adjust.
 Identities = 74/287 (25%), Positives = 141/287 (49%), Gaps = 31/287 (10%)
Query: 411 FSEVNLLGKGNFSSVYKGTL--RDGTLV--AIRSINVTSCKSEEAEFVKGLYLLTSLRHE 466
           F+EV  +G+G+F  VY GTL   DG  +  A++S+N  +   E ++F+    ++    H 
Sbjct: 39  FNEV--IGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHP 96
Query: 467 NIIRLRGFCCSRGRGECFLIYDFAPKGKLSKYLDQEEGSSNVLDWSTRVSIIIGIAKGIG 526
           N++ L G C  R  G   ++  +   G L  ++  E  +  V D    +   + +AKG+ 
Sbjct: 97  NVLSLLGICL-RSEGSPLVVLPYMKHGDLRNFIRNETHNPTVKD---LIGFGLQVAKGMK 152
Query: 527 YLHSSEVNKPAIVHRNLSVEKVLIDQQFNPLIADCGLHKLLADDIVFSVLKTSAA---MG 583
           +L S +      VHR+L+    ++D++F   +AD GL + + D    SV   + A   + 
Sbjct: 153 FLASKK-----FVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEFDSVHNKTGAKLPVK 207
Query: 584 YLAPEYVTTGRFTERSDIFAFGVIILQILTGSLVLTSSMRLAAESATFENFIDRNLKGKF 643
           ++A E + T +FT +SD+++FGV++ ++      +T       +  TF+  +   L+G+ 
Sbjct: 208 WMALESLQTQKFTTKSDVWSFGVLLWEL------MTRGAPPYPDVNTFDITV-YLLQGRR 260
Query: 644 ---SESEAAKLGKMALVCTHEDPENRPTMEAVIEELTVAAPVMATFL 687
               E     L ++ L C H   E RP+   ++  ++    + +TF+
Sbjct: 261 LLQPEYCPDPLYEVMLKCWHPKAEMRPSFSELVSRISA---IFSTFI 304

>pdb|3P86|A Chain A, Crystal Structure Of Ctr1 Kinase Domain Mutant D676n In Complex With Staurosporine Length = 309

Iteration: 1
 Score = 91.7 bits (226), Expect = 1e-18,   Method: Compositional matrix adjust.
 Identities = 58/201 (28%), Positives = 107/201 (53%), Gaps = 15/201 (7%)
Query: 417 LGKGNFSSVYKGTLRDGTLVAIRSINVTSCKSEEA-EFVKGLYLLTSLRHENIIRLRGFC 475
           +G G+F +V++     G+ VA++ +      +E   EF++ + ++  LRH NI+   G  
Sbjct: 45  IGAGSFGTVHRAEWH-GSDVAVKILMEQDFHAERVNEFLREVAIMKRLRHPNIVLFMGAV 103
Query: 476 CSRGRGECFLIYDFAPKGKLSKYLDQEEGSSNVLDWSTRVSIIIGIAKGIGYLHSSEVNK 535
                    ++ ++  +G L + L  + G+   LD   R+S+   +AKG+ YLH+     
Sbjct: 104 TQPP--NLSIVTEYLSRGSLYRLL-HKSGAREQLDERRRLSMAYDVAKGMNYLHN---RN 157
Query: 536 PAIVHRNLSVEKVLIDQQFNPLIADCGLHKLLADDIVFSVLKTSAAMG---YLAPEYVTT 592
           P IVHRNL    +L+D+++   + D GL +L A     + L + +A G   ++APE +  
Sbjct: 158 PPIVHRNLKSPNLLVDKKYTVKVCDFGLSRLKAS----TFLSSKSAAGTPEWMAPEVLRD 213
Query: 593 GRFTERSDIFAFGVIILQILT 613
               E+SD+++FGVI+ ++ T
Sbjct: 214 EPSNEKSDVYSFGVILWELAT 234

>pdb|3OEZ|A Chain A, Crystal Structure Of The L317i Mutant Of The Chicken C-Src Tyrosine Kinase Domain Complexed With Imatinib Length = 286

Iteration: 1
 Score = 91.7 bits (226), Expect = 1e-18,   Method: Compositional matrix adjust.
 Identities = 65/254 (25%), Positives = 115/254 (45%), Gaps = 16/254 (6%)
Query: 417 LGKGNFSSVYKGTLRDGTLVAIRSINVTSCKSEEAEFVKGLYLLTSLRHENIIRLRGFCC 476
           LG+G F  V+ GT    T VAI+++   +   E   F++   ++  +RHE +++L     
Sbjct: 26  LGQGCFGEVWMGTWNGTTRVAIKTLKPGTMSPEA--FLQEAQVMKKIRHEKLVQLYAVVS 83
Query: 477 SRGRGECFLIYDFAPKGKLSKYLDQEEGSSNVLDWSTRVSIIIGIAKGIGYLHSSEVNKP 536
                  +++ ++  KG L  +L  E G    L     V +   IA G+ Y     V + 
Sbjct: 84  EE---PIYIVTEYMSKGSLLDFLKGEMG--KYLRLPQLVDMAAQIASGMAY-----VERM 133
Query: 537 AIVHRNLSVEKVLIDQQFNPLIADCGLHKLLADDIVFSVLKTSAAMGYLAPEYVTTGRFT 596
             VHR+L    +L+ +     +AD GL +L+ D+   +       + + APE    GRFT
Sbjct: 134 NYVHRDLRAANILVGENLVCKVADFGLARLIEDNEYTARQGAKFPIKWTAPEAALYGRFT 193
Query: 597 ERSDIFAFGVIILQILTGSLVLTSSMRLAAESATFENFIDRNLKGKFSESEAAKLGKMAL 656
            +SD+++FG+++ ++ T   V    M     +    + ++R  +          L  +  
Sbjct: 194 IKSDVWSFGILLTELTTKGRVPYPGMV----NREVLDQVERGYRMPCPPECPESLHDLMC 249
Query: 657 VCTHEDPENRPTME 670
            C  +DPE RPT E
Sbjct: 250 QCWRKDPEERPTFE 263

>pdb|2HWO|A Chain A, Crystal Structure Of Src Kinase Domain In Complex With Covalent Inhibitor Length = 286

Iteration: 1
 Score = 91.7 bits (226), Expect = 1e-18,   Method: Compositional matrix adjust.
 Identities = 66/254 (25%), Positives = 115/254 (45%), Gaps = 16/254 (6%)
Query: 417 LGKGNFSSVYKGTLRDGTLVAIRSINVTSCKSEEAEFVKGLYLLTSLRHENIIRLRGFCC 476
           LG+G F  V+ GT    T VAI+++   +   E   F++   ++  LRHE +++L     
Sbjct: 26  LGQGCFGEVWMGTWNGTTRVAIKTLKPGTMSPEA--FLQEAQVMKKLRHEKLVQLYAVVS 83
Query: 477 SRGRGECFLIYDFAPKGKLSKYLDQEEGSSNVLDWSTRVSIIIGIAKGIGYLHSSEVNKP 536
                  +++ ++  KG L  +L  E G    L     V +   IA G+ Y     V + 
Sbjct: 84  EE---PIYIVTEYMSKGCLLDFLKGEMG--KYLRLPQLVDMAAQIASGMAY-----VERM 133
Query: 537 AIVHRNLSVEKVLIDQQFNPLIADCGLHKLLADDIVFSVLKTSAAMGYLAPEYVTTGRFT 596
             VHR+L    +L+ +     +AD GL +L+ D+   +       + + APE    GRFT
Sbjct: 134 NYVHRDLRAANILVGENLVCKVADFGLARLIEDNEYTARQGAKFPIKWTAPEAALYGRFT 193
Query: 597 ERSDIFAFGVIILQILTGSLVLTSSMRLAAESATFENFIDRNLKGKFSESEAAKLGKMAL 656
            +SD+++FG+++ ++ T   V    M     +    + ++R  +          L  +  
Sbjct: 194 IKSDVWSFGILLTELTTKGRVPYPGMV----NREVLDQVERGYRMPCPPECPESLHDLMC 249
Query: 657 VCTHEDPENRPTME 670
            C  +DPE RPT E
Sbjct: 250 QCWRKDPEERPTFE 263

>pdb|3DKC|A Chain A, Sgx Clone 5698a65kfg1h1 Length = 317

Iteration: 1
 Score = 91.3 bits (225), Expect = 2e-18,   Method: Compositional matrix adjust.
 Identities = 74/287 (25%), Positives = 141/287 (49%), Gaps = 31/287 (10%)
Query: 411 FSEVNLLGKGNFSSVYKGTL--RDGTLV--AIRSINVTSCKSEEAEFVKGLYLLTSLRHE 466
           F+EV  +G+G+F  VY GTL   DG  +  A++S+N  +   E ++F+    ++    H 
Sbjct: 35  FNEV--IGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHP 92
Query: 467 NIIRLRGFCCSRGRGECFLIYDFAPKGKLSKYLDQEEGSSNVLDWSTRVSIIIGIAKGIG 526
           N++ L G C  R  G   ++  +   G L  ++  E  +  V D    +   + +AKG+ 
Sbjct: 93  NVLSLLGICL-RSEGSPLVVLPYMKHGDLRNFIRNETHNPTVKD---LIGFGLQVAKGMK 148
Query: 527 YLHSSEVNKPAIVHRNLSVEKVLIDQQFNPLIADCGLHKLLADDIVFSVLKTSAA---MG 583
           +L S +      VHR+L+    ++D++F   +AD GL + + D    SV   + A   + 
Sbjct: 149 FLASKK-----FVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEFDSVHNKTGAKLPVK 203
Query: 584 YLAPEYVTTGRFTERSDIFAFGVIILQILTGSLVLTSSMRLAAESATFENFIDRNLKGKF 643
           ++A E + T +FT +SD+++FGV++ ++      +T       +  TF+  +   L+G+ 
Sbjct: 204 WMALESLQTQKFTTKSDVWSFGVLLWEL------MTRGAPPYPDVNTFDITV-YLLQGRR 256
Query: 644 ---SESEAAKLGKMALVCTHEDPENRPTMEAVIEELTVAAPVMATFL 687
               E     L ++ L C H   E RP+   ++  ++    + +TF+
Sbjct: 257 LLQPEYCPDPLYEVMLKCWHPKAEMRPSFSELVSRISA---IFSTFI 300

>pdb|3QTI|A Chain A, C-Met Kinase In Complex With Nvp-Bvu972 Length = 314

Iteration: 1
 Score = 91.3 bits (225), Expect = 2e-18,   Method: Compositional matrix adjust.
 Identities = 74/287 (25%), Positives = 141/287 (49%), Gaps = 31/287 (10%)
Query: 411 FSEVNLLGKGNFSSVYKGTL--RDGTLV--AIRSINVTSCKSEEAEFVKGLYLLTSLRHE 466
           F+EV  +G+G+F  VY GTL   DG  +  A++S+N  +   E ++F+    ++    H 
Sbjct: 34  FNEV--IGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHP 91
Query: 467 NIIRLRGFCCSRGRGECFLIYDFAPKGKLSKYLDQEEGSSNVLDWSTRVSIIIGIAKGIG 526
           N++ L G C  R  G   ++  +   G L  ++  E  +  V D    +   + +AKG+ 
Sbjct: 92  NVLSLLGICL-RSEGSPLVVLPYMKHGDLRNFIRNETHNPTVKD---LIGFGLQVAKGMK 147
Query: 527 YLHSSEVNKPAIVHRNLSVEKVLIDQQFNPLIADCGLHKLLADDIVFSVLKTSAA---MG 583
           +L S +      VHR+L+    ++D++F   +AD GL + + D    SV   + A   + 
Sbjct: 148 FLASKK-----FVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEFDSVHNKTGAKLPVK 202
Query: 584 YLAPEYVTTGRFTERSDIFAFGVIILQILTGSLVLTSSMRLAAESATFENFIDRNLKGKF 643
           ++A E + T +FT +SD+++FGV++ ++      +T       +  TF+  +   L+G+ 
Sbjct: 203 WMALESLQTQKFTTKSDVWSFGVLLWEL------MTRGAPPYPDVNTFDITV-YLLQGRR 255
Query: 644 ---SESEAAKLGKMALVCTHEDPENRPTMEAVIEELTVAAPVMATFL 687
               E     L ++ L C H   E RP+   ++  ++    + +TF+
Sbjct: 256 LLQPEYCPDPLYEVMLKCWHPKAEMRPSFSELVSRISA---IFSTFI 299

>pdb|1R0P|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The Hepatocyte Growth Factor Receptor C-Met In Complex With The Microbial Alkaloid K-252a Length = 312

Iteration: 1
 Score = 91.3 bits (225), Expect = 2e-18,   Method: Compositional matrix adjust.
 Identities = 74/287 (25%), Positives = 141/287 (49%), Gaps = 31/287 (10%)
Query: 411 FSEVNLLGKGNFSSVYKGTL--RDGTLV--AIRSINVTSCKSEEAEFVKGLYLLTSLRHE 466
           F+EV  +G+G+F  VY GTL   DG  +  A++S+N  +   E ++F+    ++    H 
Sbjct: 32  FNEV--IGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHP 89
Query: 467 NIIRLRGFCCSRGRGECFLIYDFAPKGKLSKYLDQEEGSSNVLDWSTRVSIIIGIAKGIG 526
           N++ L G C  R  G   ++  +   G L  ++  E  +  V D    +   + +AKG+ 
Sbjct: 90  NVLSLLGICL-RSEGSPLVVLPYMKHGDLRNFIRNETHNPTVKD---LIGFGLQVAKGMK 145
Query: 527 YLHSSEVNKPAIVHRNLSVEKVLIDQQFNPLIADCGLHKLLADDIVFSVLKTSAA---MG 583
           +L S +      VHR+L+    ++D++F   +AD GL + + D    SV   + A   + 
Sbjct: 146 FLASKK-----FVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEFDSVHNKTGAKLPVK 200
Query: 584 YLAPEYVTTGRFTERSDIFAFGVIILQILTGSLVLTSSMRLAAESATFENFIDRNLKGKF 643
           ++A E + T +FT +SD+++FGV++ ++      +T       +  TF+  +   L+G+ 
Sbjct: 201 WMALESLQTQKFTTKSDVWSFGVLLWEL------MTRGAPPYPDVNTFDITV-YLLQGRR 253
Query: 644 ---SESEAAKLGKMALVCTHEDPENRPTMEAVIEELTVAAPVMATFL 687
               E     L ++ L C H   E RP+   ++  ++    + +TF+
Sbjct: 254 LLQPEYCPDPLYEVMLKCWHPKAEMRPSFSELVSRISA---IFSTFI 297

>pdb|3CTH|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The Hepatocyte Growth Factor Receptor C-Met In Complex With A Aminopyridine Based Inhibitor Length = 314

Iteration: 1
 Score = 91.3 bits (225), Expect = 2e-18,   Method: Compositional matrix adjust.
 Identities = 74/287 (25%), Positives = 141/287 (49%), Gaps = 31/287 (10%)
Query: 411 FSEVNLLGKGNFSSVYKGTL--RDGTLV--AIRSINVTSCKSEEAEFVKGLYLLTSLRHE 466
           F+EV  +G+G+F  VY GTL   DG  +  A++S+N  +   E ++F+    ++    H 
Sbjct: 34  FNEV--IGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHP 91
Query: 467 NIIRLRGFCCSRGRGECFLIYDFAPKGKLSKYLDQEEGSSNVLDWSTRVSIIIGIAKGIG 526
           N++ L G C  R  G   ++  +   G L  ++  E  +  V D    +   + +AKG+ 
Sbjct: 92  NVLSLLGICL-RSEGSPLVVLPYMKHGDLRNFIRNETHNPTVKD---LIGFGLQVAKGMK 147
Query: 527 YLHSSEVNKPAIVHRNLSVEKVLIDQQFNPLIADCGLHKLLADDIVFSVLKTSAA---MG 583
           +L S +      VHR+L+    ++D++F   +AD GL + + D    SV   + A   + 
Sbjct: 148 FLASKK-----FVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEFDSVHNKTGAKLPVK 202
Query: 584 YLAPEYVTTGRFTERSDIFAFGVIILQILTGSLVLTSSMRLAAESATFENFIDRNLKGKF 643
           ++A E + T +FT +SD+++FGV++ ++      +T       +  TF+  +   L+G+ 
Sbjct: 203 WMALESLQTQKFTTKSDVWSFGVLLWEL------MTRGAPPYPDVNTFDITV-YLLQGRR 255
Query: 644 ---SESEAAKLGKMALVCTHEDPENRPTMEAVIEELTVAAPVMATFL 687
               E     L ++ L C H   E RP+   ++  ++    + +TF+
Sbjct: 256 LLQPEYCPDPLYEVMLKCWHPKAEMRPSFSELVSRISA---IFSTFI 299

>pdb|3DKG|A Chain A, Sgx Clone 5698a109kfg1h1 Length = 317

Iteration: 1
 Score = 91.3 bits (225), Expect = 2e-18,   Method: Compositional matrix adjust.
 Identities = 74/287 (25%), Positives = 141/287 (49%), Gaps = 31/287 (10%)
Query: 411 FSEVNLLGKGNFSSVYKGTL--RDGTLV--AIRSINVTSCKSEEAEFVKGLYLLTSLRHE 466
           F+EV  +G+G+F  VY GTL   DG  +  A++S+N  +   E ++F+    ++    H 
Sbjct: 35  FNEV--IGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHP 92
Query: 467 NIIRLRGFCCSRGRGECFLIYDFAPKGKLSKYLDQEEGSSNVLDWSTRVSIIIGIAKGIG 526
           N++ L G C  R  G   ++  +   G L  ++  E  +  V D    +   + +AKG+ 
Sbjct: 93  NVLSLLGICL-RSEGSPLVVLPYMKHGDLRNFIRNETHNPTVKD---LIGFGLQVAKGMK 148
Query: 527 YLHSSEVNKPAIVHRNLSVEKVLIDQQFNPLIADCGLHKLLADDIVFSVLKTSAA---MG 583
           +L S +      VHR+L+    ++D++F   +AD GL + + D    SV   + A   + 
Sbjct: 149 FLASKK-----FVHRDLAARNCMLDEKFTVKVADFGLARDMLDKEFDSVHNKTGAKLPVK 203
Query: 584 YLAPEYVTTGRFTERSDIFAFGVIILQILTGSLVLTSSMRLAAESATFENFIDRNLKGKF 643
           ++A E + T +FT +SD+++FGV++ ++      +T       +  TF+  +   L+G+ 
Sbjct: 204 WMALESLQTQKFTTKSDVWSFGVLLWEL------MTRGAPPYPDVNTFDITV-YLLQGRR 256
Query: 644 ---SESEAAKLGKMALVCTHEDPENRPTMEAVIEELTVAAPVMATFL 687
               E     L ++ L C H   E RP+   ++  ++    + +TF+
Sbjct: 257 LLQPEYCPDPLYEVMLKCWHPKAEMRPSFSELVSRISA---IFSTFI 300

>pdb|1FMK|A Chain A, Crystal Structure Of Human Tyrosine-Protein Kinase C-Src Length = 452

Iteration: 1
 Score = 90.9 bits (224), Expect = 2e-18,   Method: Compositional matrix adjust.
 Identities = 65/254 (25%), Positives = 115/254 (45%), Gaps = 16/254 (6%)
Query: 417 LGKGNFSSVYKGTLRDGTLVAIRSINVTSCKSEEAEFVKGLYLLTSLRHENIIRLRGFCC 476
           LG+G F  V+ GT    T VAI+++   +   E   F++   ++  LRHE +++L     
Sbjct: 192 LGQGCFGEVWMGTWNGTTRVAIKTLKPGTMSPEA--FLQEAQVMKKLRHEKLVQLYAVVS 249
Query: 477 SRGRGECFLIYDFAPKGKLSKYLDQEEGSSNVLDWSTRVSIIIGIAKGIGYLHSSEVNKP 536
                  +++ ++  KG L  +L  E G    L     V +   IA G+ Y     V + 
Sbjct: 250 EE---PIYIVTEYMSKGSLLDFLKGETG--KYLRLPQLVDMAAQIASGMAY-----VERM 299
Query: 537 AIVHRNLSVEKVLIDQQFNPLIADCGLHKLLADDIVFSVLKTSAAMGYLAPEYVTTGRFT 596
             VHR+L    +L+ +     +AD GL +L+ D+   +       + + APE    GRFT
Sbjct: 300 NYVHRDLRAANILVGENLVCKVADFGLARLIEDNEYTARQGAKFPIKWTAPEAALYGRFT 359
Query: 597 ERSDIFAFGVIILQILTGSLVLTSSMRLAAESATFENFIDRNLKGKFSESEAAKLGKMAL 656
            +SD+++FG+++ ++ T   V    M     +    + ++R  +          L  +  
Sbjct: 360 IKSDVWSFGILLTELTTKGRVPYPGMV----NREVLDQVERGYRMPCPPECPESLHDLMC 415
Query: 657 VCTHEDPENRPTME 670
            C  ++PE RPT E
Sbjct: 416 QCWRKEPEERPTFE 429

>pdb|1Y57|A Chain A, Structure Of Unphosphorylated C-Src In Complex With An Inhibitor Length = 452

Iteration: 1
 Score = 90.9 bits (224), Expect = 2e-18,   Method: Compositional matrix adjust.
 Identities = 65/254 (25%), Positives = 115/254 (45%), Gaps = 16/254 (6%)
Query: 417 LGKGNFSSVYKGTLRDGTLVAIRSINVTSCKSEEAEFVKGLYLLTSLRHENIIRLRGFCC 476
           LG+G F  V+ GT    T VAI+++   +   E   F++   ++  LRHE +++L     
Sbjct: 192 LGQGCFGEVWMGTWNGTTRVAIKTLKPGTMSPEA--FLQEAQVMKKLRHEKLVQLYAVVS 249
Query: 477 SRGRGECFLIYDFAPKGKLSKYLDQEEGSSNVLDWSTRVSIIIGIAKGIGYLHSSEVNKP 536
                  +++ ++  KG L  +L  E G    L     V +   IA G+ Y     V + 
Sbjct: 250 EE---PIYIVTEYMSKGSLLDFLKGETG--KYLRLPQLVDMAAQIASGMAY-----VERM 299
Query: 537 AIVHRNLSVEKVLIDQQFNPLIADCGLHKLLADDIVFSVLKTSAAMGYLAPEYVTTGRFT 596
             VHR+L    +L+ +     +AD GL +L+ D+   +       + + APE    GRFT
Sbjct: 300 NYVHRDLRAANILVGENLVCKVADFGLARLIEDNEYTARQGAKFPIKWTAPEAALYGRFT 359
Query: 597 ERSDIFAFGVIILQILTGSLVLTSSMRLAAESATFENFIDRNLKGKFSESEAAKLGKMAL 656
            +SD+++FG+++ ++ T   V    M     +    + ++R  +          L  +  
Sbjct: 360 IKSDVWSFGILLTELTTKGRVPYPGMV----NREVLDQVERGYRMPCPPECPESLHDLMC 415
Query: 657 VCTHEDPENRPTME 670
            C  ++PE RPT E
Sbjct: 416 QCWRKEPEERPTFE 429

>pdb|2BDF|A Chain A, Src Kinase In Complex With Inhibitor Ap23451 Length = 279

Iteration: 1
 Score = 90.5 bits (223), Expect = 2e-18,   Method: Compositional matrix adjust.
 Identities = 65/254 (25%), Positives = 115/254 (45%), Gaps = 16/254 (6%)
Query: 417 LGKGNFSSVYKGTLRDGTLVAIRSINVTSCKSEEAEFVKGLYLLTSLRHENIIRLRGFCC 476
           LG+G F  V+ GT    T VAI+++   +   E   F++   ++  LRHE +++L     
Sbjct: 19  LGQGCFGEVWMGTWNGTTRVAIKTLKPGTMSPEA--FLQEAQVMKKLRHEKLVQLYAVVS 76
Query: 477 SRGRGECFLIYDFAPKGKLSKYLDQEEGSSNVLDWSTRVSIIIGIAKGIGYLHSSEVNKP 536
                  +++ ++  KG L  +L  E G    L     V +   IA G+ Y     V + 
Sbjct: 77  EE---PIYIVTEYMSKGSLLDFLKGETG--KYLRLPQLVDMAAQIASGMAY-----VERM 126
Query: 537 AIVHRNLSVEKVLIDQQFNPLIADCGLHKLLADDIVFSVLKTSAAMGYLAPEYVTTGRFT 596
             VHR+L    +L+ +     +AD GL +L+ D+   +       + + APE    GRFT
Sbjct: 127 NYVHRDLRAANILVGENLVCKVADFGLARLIEDNEYTARQGAKFPIKWTAPEAALYGRFT 186
Query: 597 ERSDIFAFGVIILQILTGSLVLTSSMRLAAESATFENFIDRNLKGKFSESEAAKLGKMAL 656
            +SD+++FG+++ ++ T   V    M     +    + ++R  +          L  +  
Sbjct: 187 IKSDVWSFGILLTELTTKGRVPYPGMV----NREVLDQVERGYRMPCPPECPESLHDLMC 242
Query: 657 VCTHEDPENRPTME 670
            C  ++PE RPT E
Sbjct: 243 QCWRKEPEERPTFE 256

>pdb|1KSW|A Chain A, Structure Of Human C-Src Tyrosine Kinase (Thr338gly Mutant) In Complex With N6-Benzyl Adp Length = 452

Iteration: 1
 Score = 90.5 bits (223), Expect = 3e-18,   Method: Compositional matrix adjust.
 Identities = 65/254 (25%), Positives = 115/254 (45%), Gaps = 16/254 (6%)
Query: 417 LGKGNFSSVYKGTLRDGTLVAIRSINVTSCKSEEAEFVKGLYLLTSLRHENIIRLRGFCC 476
           LG+G F  V+ GT    T VAI+++   +   E   F++   ++  LRHE +++L     
Sbjct: 192 LGQGCFGEVWMGTWNGTTRVAIKTLKPGTMSPEA--FLQEAQVMKKLRHEKLVQLYAVVS 249
Query: 477 SRGRGECFLIYDFAPKGKLSKYLDQEEGSSNVLDWSTRVSIIIGIAKGIGYLHSSEVNKP 536
                  +++ ++  KG L  +L  E G    L     V +   IA G+ Y     V + 
Sbjct: 250 EE---PIYIVGEYMSKGSLLDFLKGETG--KYLRLPQLVDMAAQIASGMAY-----VERM 299
Query: 537 AIVHRNLSVEKVLIDQQFNPLIADCGLHKLLADDIVFSVLKTSAAMGYLAPEYVTTGRFT 596
             VHR+L    +L+ +     +AD GL +L+ D+   +       + + APE    GRFT
Sbjct: 300 NYVHRDLRAANILVGENLVCKVADFGLARLIEDNEYTARQGAKFPIKWTAPEAALYGRFT 359
Query: 597 ERSDIFAFGVIILQILTGSLVLTSSMRLAAESATFENFIDRNLKGKFSESEAAKLGKMAL 656
            +SD+++FG+++ ++ T   V    M     +    + ++R  +          L  +  
Sbjct: 360 IKSDVWSFGILLTELTTKGRVPYPGMV----NREVLDQVERGYRMPCPPECPESLHDLMC 415
Query: 657 VCTHEDPENRPTME 670
            C  ++PE RPT E
Sbjct: 416 QCWRKEPEERPTFE 429

>pdb|2HK5|A Chain A, Hck Kinase In Complex With Lck Targetted Inhibitor Pg- 1009247 Length = 270

Iteration: 1
 Score = 90.1 bits (222), Expect = 4e-18,   Method: Compositional matrix adjust.
 Identities = 61/256 (23%), Positives = 118/256 (46%), Gaps = 16/256 (6%)
Query: 417 LGKGNFSSVYKGTLRDGTLVAIRSINVTSCKSEEAEFVKGLYLLTSLRHENIIRLRGFCC 476
           LG G F  V+  T    T VA++++   S   E   F+    ++ +L+H+ +++L     
Sbjct: 23  LGAGQFGEVWMATYNKHTKVAVKTMKPGSMSVEA--FLAEANVMKTLQHDKLVKLHAVVT 80
Query: 477 SRGRGECFLIYDFAPKGKLSKYLDQEEGSSNVLDWSTRVSIIIGIAKGIGYLHSSEVNKP 536
              +   ++I +F  KG L  +L  +EGS   L     +     IA+G+ ++        
Sbjct: 81  ---KEPIYIITEFMAKGSLLDFLKSDEGSKQPL--PKLIDFSAQIAEGMAFIEQRNY--- 132
Query: 537 AIVHRNLSVEKVLIDQQFNPLIADCGLHKLLADDIVFSVLKTSAAMGYLAPEYVTTGRFT 596
             +HR+L    +L+       IAD GL +++ D+   +       + + APE +  G FT
Sbjct: 133 --IHRDLRAANILVSASLVCKIADFGLARVIEDNEYTAREGAKFPIKWTAPEAINFGSFT 190
Query: 597 ERSDIFAFGVIILQILTGSLVLTSSMRLAAESATFENFIDRNLKGKFSESEAAKLGKMAL 656
            +SD+++FG+++++I+T   +    M     +      ++R  +    E+   +L  + +
Sbjct: 191 IKSDVWSFGILLMEIVTYGRIPYPGM----SNPEVIRALERGYRMPRPENCPEELYNIMM 246
Query: 657 VCTHEDPENRPTMEAV 672
            C    PE RPT E +
Sbjct: 247 RCWKNRPEERPTFEYI 262

>pdb|1OPK|A Chain A, Structural Basis For The Auto-Inhibition Of C-Abl Tyrosine Kinase Length = 495

Iteration: 1
 Score = 90.1 bits (222), Expect = 4e-18,   Method: Compositional matrix adjust.
 Identities = 64/260 (24%), Positives = 128/260 (49%), Gaps = 22/260 (8%)
Query: 417 LGKGNFSSVYKGTLRDGTL-VAIRSINVTSCKSEEAEFVKGLYLLTSLRHENIIRLRGFC 475
           LG G +  VY+G  +  +L VA++++   + + EE  F+K   ++  ++H N+++L G C
Sbjct: 228 LGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVEE--FLKEAAVMKEIKHPNLVQLLGVC 285
Query: 476 CSRGRGECFLIYDFAPKGKLSKYL---DQEEGSSNVLDWSTRVSIIIGIAKGIGYLHSSE 532
                   ++I +F   G L  YL   +++E S+ VL     + +   I+  + YL    
Sbjct: 286 TREP--PFYIITEFMTYGNLLDYLRECNRQEVSAVVL-----LYMATQISSAMEYL---- 334
Query: 533 VNKPAIVHRNLSVEKVLIDQQFNPLIADCGLHKLLADDIVFSVLKTSAAMGYLAPEYVTT 592
             K   +HRNL+    L+ +     +AD GL +L+  D   +       + + APE +  
Sbjct: 335 -EKKNFIHRNLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHAGAKFPIKWTAPESLAY 393
Query: 593 GRFTERSDIFAFGVIILQILTGSLVLTSSMRLAAESATFENFIDRNLKGKFSESEAAKLG 652
            +F+ +SD++AFGV++ +I T  +     + L   S  +E  ++++ + +  E    K+ 
Sbjct: 394 NKFSIKSDVWAFGVLLWEIATYGMSPYPGIDL---SQVYE-LLEKDYRMERPEGCPEKVY 449
Query: 653 KMALVCTHEDPENRPTMEAV 672
           ++   C   +P +RP+   +
Sbjct: 450 ELMRACWQWNPSDRPSFAEI 469

>pdb|1YOL|A Chain A, Crystal Structure Of Src Kinase Domain In Complex With Cgp77675 Length = 283

Iteration: 1
 Score = 90.1 bits (222), Expect = 4e-18,   Method: Compositional matrix adjust.
 Identities = 65/254 (25%), Positives = 115/254 (45%), Gaps = 16/254 (6%)
Query: 417 LGKGNFSSVYKGTLRDGTLVAIRSINVTSCKSEEAEFVKGLYLLTSLRHENIIRLRGFCC 476
           LG+G F  V+ GT    T VAI+++   +   E   F++   ++  LRHE +++L     
Sbjct: 23  LGQGCFGEVWMGTWNGTTRVAIKTLKPGTMSPEA--FLQEAQVMKKLRHEKLVQLYAVVS 80
Query: 477 SRGRGECFLIYDFAPKGKLSKYLDQEEGSSNVLDWSTRVSIIIGIAKGIGYLHSSEVNKP 536
                  +++ ++  KG L  +L  E G    L     V +   IA G+ Y     V + 
Sbjct: 81  EE---PIYIVTEYMNKGSLLDFLKGETG--KYLRLPQLVDMSAQIASGMAY-----VERM 130
Query: 537 AIVHRNLSVEKVLIDQQFNPLIADCGLHKLLADDIVFSVLKTSAAMGYLAPEYVTTGRFT 596
             VHR+L    +L+ +     +AD GL +L+ D+   +       + + APE    GRFT
Sbjct: 131 NYVHRDLRAANILVGENLVCKVADFGLARLIEDNEYTARQGAKFPIKWTAPEAALYGRFT 190
Query: 597 ERSDIFAFGVIILQILTGSLVLTSSMRLAAESATFENFIDRNLKGKFSESEAAKLGKMAL 656
            +SD+++FG+++ ++ T   V    M     +    + ++R  +          L  +  
Sbjct: 191 IKSDVWSFGILLTELTTKGRVPYPGMV----NREVLDQVERGYRMPCPPECPESLHDLMC 246
Query: 657 VCTHEDPENRPTME 670
            C  ++PE RPT E
Sbjct: 247 QCWRKEPEERPTFE 260

>pdb|1YOJ|A Chain A, Crystal Structure Of Src Kinase Domain Length = 283

Iteration: 1
 Score = 89.7 bits (221), Expect = 5e-18,   Method: Compositional matrix adjust.
 Identities = 65/254 (25%), Positives = 115/254 (45%), Gaps = 16/254 (6%)
Query: 417 LGKGNFSSVYKGTLRDGTLVAIRSINVTSCKSEEAEFVKGLYLLTSLRHENIIRLRGFCC 476
           LG+G F  V+ GT    T VAI+++   +   E   F++   ++  LRHE +++L     
Sbjct: 23  LGQGCFGEVWMGTWNGTTRVAIKTLKPGTMSPEA--FLQEAQVMKKLRHEKLVQLYAVVS 80
Query: 477 SRGRGECFLIYDFAPKGKLSKYLDQEEGSSNVLDWSTRVSIIIGIAKGIGYLHSSEVNKP 536
                  +++ ++  KG L  +L  E G    L     V +   IA G+ Y     V + 
Sbjct: 81  EE---PIYIVTEYMNKGSLLDFLKGETG--KYLRLPQLVDMSAQIASGMAY-----VERM 130
Query: 537 AIVHRNLSVEKVLIDQQFNPLIADCGLHKLLADDIVFSVLKTSAAMGYLAPEYVTTGRFT 596
             VHR+L    +L+ +     +AD GL +L+ D+   +       + + APE    GRFT
Sbjct: 131 NYVHRDLRAANILVGENLVCKVADFGLARLIEDNEWTARQGAKFPIKWTAPEAALYGRFT 190
Query: 597 ERSDIFAFGVIILQILTGSLVLTSSMRLAAESATFENFIDRNLKGKFSESEAAKLGKMAL 656
            +SD+++FG+++ ++ T   V    M     +    + ++R  +          L  +  
Sbjct: 191 IKSDVWSFGILLTELTTKGRVPYPGMV----NREVLDQVERGYRMPCPPECPESLHDLMC 246
Query: 657 VCTHEDPENRPTME 670
            C  ++PE RPT E
Sbjct: 247 QCWRKEPEERPTFE 260

>pdb|1QCF|A Chain A, Crystal Structure Of Hck In Complex With A Src Family- Selective Tyrosine Kinase Inhibitor Length = 454

Iteration: 1
 Score = 89.7 bits (221), Expect = 5e-18,   Method: Compositional matrix adjust.
 Identities = 61/256 (23%), Positives = 118/256 (46%), Gaps = 16/256 (6%)
Query: 417 LGKGNFSSVYKGTLRDGTLVAIRSINVTSCKSEEAEFVKGLYLLTSLRHENIIRLRGFCC 476
           LG G F  V+  T    T VA++++   S   E   F+    ++ +L+H+ +++L     
Sbjct: 196 LGAGQFGEVWMATYNKHTKVAVKTMKPGSMSVEA--FLAEANVMKTLQHDKLVKLHAVVT 253
Query: 477 SRGRGECFLIYDFAPKGKLSKYLDQEEGSSNVLDWSTRVSIIIGIAKGIGYLHSSEVNKP 536
              +   ++I +F  KG L  +L  +EGS   L     +     IA+G+ ++        
Sbjct: 254 ---KEPIYIITEFMAKGSLLDFLKSDEGSKQPL--PKLIDFSAQIAEGMAFIEQRNY--- 305
Query: 537 AIVHRNLSVEKVLIDQQFNPLIADCGLHKLLADDIVFSVLKTSAAMGYLAPEYVTTGRFT 596
             +HR+L    +L+       IAD GL +++ D+   +       + + APE +  G FT
Sbjct: 306 --IHRDLRAANILVSASLVCKIADFGLARVIEDNEYTAREGAKFPIKWTAPEAINFGSFT 363
Query: 597 ERSDIFAFGVIILQILTGSLVLTSSMRLAAESATFENFIDRNLKGKFSESEAAKLGKMAL 656
            +SD+++FG+++++I+T   +    M     +      ++R  +    E+   +L  + +
Sbjct: 364 IKSDVWSFGILLMEIVTYGRIPYPGM----SNPEVIRALERGYRMPRPENCPEELYNIMM 419
Query: 657 VCTHEDPENRPTMEAV 672
            C    PE RPT E +
Sbjct: 420 RCWKNRPEERPTFEYI 435

>pdb|4E4L|A Chain A, Jak1 Kinase (Jh1 Domain) In Complex With Compound 30 Length = 302

Iteration: 1
 Score = 89.4 bits (220), Expect = 6e-18,   Method: Compositional matrix adjust.
 Identities = 64/215 (29%), Positives = 108/215 (50%), Gaps = 15/215 (6%)
Query: 417 LGKGNFSSV----YKGTLRD-GTLVAIRSINVTSCKSEEAEFVKGLYLLTSLRHENIIRL 471
           LG+G+F  V    Y     + G  VA++S+   S  +  A+  K + +L +L HENI++ 
Sbjct: 29  LGEGHFGKVELCRYDPEGDNTGEQVAVKSLKPESGGNHIADLKKEIEILRNLYHENIVKY 88
Query: 472 RGFCCSRGRGECFLIYDFAPKGKLSKYLDQEEGSSNVLDWSTRVSIIIGIAKGIGYLHSS 531
           +G C   G     LI +F P G L +YL +   + N ++   ++   + I KG+ YL S 
Sbjct: 89  KGICTEDGGNGIKLIMEFLPSGSLKEYLPK---NKNKINLKQQLKYAVQICKGMDYLGSR 145
Query: 532 EVNKPAIVHRNLSVEKVLIDQQFNPLIADCGLHKLLADDIVFSVLKT--SAAMGYLAPEY 589
           +      VHR+L+   VL++ +    I D GL K +  D     +K    + + + APE 
Sbjct: 146 QY-----VHRDLAARNVLVESEHQVKIGDFGLTKAIETDKEXXTVKDDRDSPVFWYAPEC 200
Query: 590 VTTGRFTERSDIFAFGVIILQILTGSLVLTSSMRL 624
           +   +F   SD+++FGV + ++LT     +S M L
Sbjct: 201 LMQSKFYIASDVWSFGVTLHELLTYCDSDSSPMAL 235

>pdb|3PPZ|A Chain A, Crystal Structure Of Ctr1 Kinase Domain In Complex With Staurosporine Length = 309

Iteration: 1
 Score = 89.0 bits (219), Expect = 8e-18,   Method: Compositional matrix adjust.
 Identities = 57/199 (28%), Positives = 106/199 (53%), Gaps = 11/199 (5%)
Query: 417 LGKGNFSSVYKGTLRDGTLVAIRSINVTSCKSEEA-EFVKGLYLLTSLRHENIIRLRGFC 475
           +G G+F +V++     G+ VA++ +      +E   EF++ + ++  LRH NI+   G  
Sbjct: 45  IGAGSFGTVHRAEWH-GSDVAVKILMEQDFHAERVNEFLREVAIMKRLRHPNIVLFMGAV 103
Query: 476 CSRGRGECFLIYDFAPKGKLSKYLDQEEGSSNVLDWSTRVSIIIGIAKGIGYLHSSEVNK 535
                    ++ ++  +G L + L  + G+   LD   R+S+   +AKG+ YLH+     
Sbjct: 104 TQPP--NLSIVTEYLSRGSLYRLL-HKSGAREQLDERRRLSMAYDVAKGMNYLHN---RN 157
Query: 536 PAIVHRNLSVEKVLIDQQFNPLIADCGLHKLLADDIVFSVLKTSAAMG-YLAPEYVTTGR 594
           P IVHR+L    +L+D+++   + D GL +L A   + S  K +A    ++APE +    
Sbjct: 158 PPIVHRDLKSPNLLVDKKYTVKVCDFGLSRLKASXFLXS--KXAAGTPEWMAPEVLRDEP 215
Query: 595 FTERSDIFAFGVIILQILT 613
             E+SD+++FGVI+ ++ T
Sbjct: 216 SNEKSDVYSFGVILWELAT 234

>pdb|3EYG|A Chain A, Crystal Structures Of Jak1 And Jak2 Inhibitor Complexes Length = 290

Iteration: 1
 Score = 89.0 bits (219), Expect = 8e-18,   Method: Compositional matrix adjust.
 Identities = 58/194 (29%), Positives = 99/194 (51%), Gaps = 10/194 (5%)
Query: 433 GTLVAIRSINVTSCKSEEAEFVKGLYLLTSLRHENIIRLRGFCCSRGRGECFLIYDFAPK 492
           G  VA++S+   S  +  A+  K + +L +L HENI++ +G C   G     LI +F P 
Sbjct: 38  GEQVAVKSLKPESGGNHIADLKKEIEILRNLYHENIVKYKGICTEDGGNGIKLIMEFLPS 97
Query: 493 GKLSKYLDQEEGSSNVLDWSTRVSIIIGIAKGIGYLHSSEVNKPAIVHRNLSVEKVLIDQ 552
           G L +YL +   + N ++   ++   + I KG+ YL S +      VHR+L+   VL++ 
Sbjct: 98  GSLKEYLPK---NKNKINLKQQLKYAVQICKGMDYLGSRQY-----VHRDLAARNVLVES 149
Query: 553 QFNPLIADCGLHKLLADDIVFSVLK--TSAAMGYLAPEYVTTGRFTERSDIFAFGVIILQ 610
           +    I D GL K +  D     +K    + + + APE +   +F   SD+++FGV + +
Sbjct: 150 EHQVKIGDFGLTKAIETDKEXXTVKDDRDSPVFWYAPECLMQSKFYIASDVWSFGVTLHE 209
Query: 611 ILTGSLVLTSSMRL 624
           +LT     +S M L
Sbjct: 210 LLTYCDSDSSPMAL 223

>pdb|1OPL|A Chain A, Structural Basis For The Auto-Inhibition Of C-Abl Tyrosine Kinase Length = 537

Iteration: 1
 Score = 89.0 bits (219), Expect = 8e-18,   Method: Compositional matrix adjust.
 Identities = 63/260 (24%), Positives = 128/260 (49%), Gaps = 22/260 (8%)
Query: 417 LGKGNFSSVYKGTLRDGTL-VAIRSINVTSCKSEEAEFVKGLYLLTSLRHENIIRLRGFC 475
           LG G +  VY+G  +  +L VA++++   + + EE  F+K   ++  ++H N+++L G C
Sbjct: 267 LGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVEE--FLKEAAVMKEIKHPNLVQLLGVC 324
Query: 476 CSRGRGECFLIYDFAPKGKLSKYL---DQEEGSSNVLDWSTRVSIIIGIAKGIGYLHSSE 532
                   ++I +F   G L  YL   +++E ++ VL     + +   I+  + YL    
Sbjct: 325 TREP--PFYIITEFMTYGNLLDYLRECNRQEVNAVVL-----LYMATQISSAMEYL---- 373
Query: 533 VNKPAIVHRNLSVEKVLIDQQFNPLIADCGLHKLLADDIVFSVLKTSAAMGYLAPEYVTT 592
             K   +HRNL+    L+ +     +AD GL +L+  D   +       + + APE +  
Sbjct: 374 -EKKNFIHRNLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHAGAKFPIKWTAPESLAY 432
Query: 593 GRFTERSDIFAFGVIILQILTGSLVLTSSMRLAAESATFENFIDRNLKGKFSESEAAKLG 652
            +F+ +SD++AFGV++ +I T  +     + L   S  +E  ++++ + +  E    K+ 
Sbjct: 433 NKFSIKSDVWAFGVLLWEIATYGMSPYPGIDL---SQVYE-LLEKDYRMERPEGCPEKVY 488
Query: 653 KMALVCTHEDPENRPTMEAV 672
           ++   C   +P +RP+   +
Sbjct: 489 ELMRACWQWNPSDRPSFAEI 508

>pdb|3MPM|A Chain A, Lck Complexed With A Pyrazolopyrimidine Length = 267

Iteration: 1
 Score = 89.0 bits (219), Expect = 8e-18,   Method: Compositional matrix adjust.
 Identities = 66/280 (23%), Positives = 127/280 (45%), Gaps = 19/280 (6%)
Query: 403 EVESATQCFSEVNLLGKGNFSSVYKGTLRDGTLVAIRSINVTSCKSEEAEFVKGLYLLTS 462
           E E   +    V  LG G F  V+ G     T VA++S+   S   +   F+    L+  
Sbjct: 3   EWEVPRETLKLVERLGAGQFGEVWMGYYNGHTKVAVKSLKQGSMSPDA--FLAEANLMKQ 60
Query: 463 LRHENIIRLRGFCCSRGRGECFLIYDFAPKGKLSKYLDQEEGSSNVLDWSTRVSIIIGIA 522
           L+H+ ++RL            ++I ++   G L  +L    G    ++    + +   IA
Sbjct: 61  LQHQRLVRLYAVVTQE---PIYIITEYMENGSLVDFLKTPSGIKLTIN--KLLDMAAQIA 115
Query: 523 KGIGYLHSSEVNKPAIVHRNLSVEKVLIDQQFNPLIADCGLHKLLADDIVFSVLKTSAAM 582
           +G+ ++          +HRNL    +L+    +  IAD GL +L+ D+   +       +
Sbjct: 116 EGMAFIEERNY-----IHRNLRAANILVSDTLSCKIADFGLARLIEDNEYTAREGAKFPI 170
Query: 583 GYLAPEYVTTGRFTERSDIFAFGVIILQILTGSLVLTSSMRLAAESATFENFIDRNLKGK 642
            + APE +  G FT +SD+++FG+++ +I+T   +    M         +N ++R  +  
Sbjct: 171 KWTAPEAINYGTFTIKSDVWSFGILLTEIVTHGRIPYPGM---TNPEVIQN-LERGYRMV 226
Query: 643 FSESEAAKLGKMALVCTHEDPENRPT---MEAVIEELTVA 679
             ++   +L ++  +C  E PE+RPT   + +V+E+   A
Sbjct: 227 RPDNCPEELYQLMRLCWKERPEDRPTFDYLRSVLEDFFTA 266

>pdb|1YI6|A Chain A, C-Term Tail Segment Of Human Tyrosine Kinase (258-533) Length = 276

Iteration: 1
 Score = 89.0 bits (219), Expect = 9e-18,   Method: Compositional matrix adjust.
 Identities = 65/254 (25%), Positives = 114/254 (44%), Gaps = 16/254 (6%)
Query: 417 LGKGNFSSVYKGTLRDGTLVAIRSINVTSCKSEEAEFVKGLYLLTSLRHENIIRLRGFCC 476
           LG+G F  V+ GT    T VAI+++   +   E   F++   ++  LRHE +++L     
Sbjct: 16  LGQGCFGEVWMGTWNGTTRVAIKTLKPGTMSPEA--FLQEAQVMKKLRHEKLVQLYAVVS 73
Query: 477 SRGRGECFLIYDFAPKGKLSKYLDQEEGSSNVLDWSTRVSIIIGIAKGIGYLHSSEVNKP 536
                   ++ ++  KG L  +L  E G    L     V +   IA G+ Y     V + 
Sbjct: 74  EE---PIXIVTEYMSKGSLLDFLKGETG--KYLRLPQLVDMAAQIASGMAY-----VERM 123
Query: 537 AIVHRNLSVEKVLIDQQFNPLIADCGLHKLLADDIVFSVLKTSAAMGYLAPEYVTTGRFT 596
             VHR+L    +L+ +     +AD GL +L+ D+   +       + + APE    GRFT
Sbjct: 124 NYVHRDLRAANILVGENLVCKVADFGLARLIEDNEXTARQGAKFPIKWTAPEAALYGRFT 183
Query: 597 ERSDIFAFGVIILQILTGSLVLTSSMRLAAESATFENFIDRNLKGKFSESEAAKLGKMAL 656
            +SD+++FG+++ ++ T   V    M     +    + ++R  +          L  +  
Sbjct: 184 IKSDVWSFGILLTELTTKGRVPYPGMV----NREVLDQVERGYRMPCPPECPESLHDLMC 239
Query: 657 VCTHEDPENRPTME 670
            C  ++PE RPT E
Sbjct: 240 QCWRKEPEERPTFE 253

>pdb|2ZM1|A Chain A, Crystal Structure Of Imidazo Pyrazin 1 Bound To The Kinase Domain Of Human Lck, (Auto-Phosphorylated On Tyr394) Length = 285

Iteration: 1
 Score = 88.2 bits (217), Expect = 1e-17,   Method: Compositional matrix adjust.
 Identities = 65/281 (23%), Positives = 128/281 (45%), Gaps = 19/281 (6%)
Query: 402 EEVESATQCFSEVNLLGKGNFSSVYKGTLRDGTLVAIRSINVTSCKSEEAEFVKGLYLLT 461
           +E E   +    V  LG G F  V+ G     T VA++S+   S   +   F+    L+ 
Sbjct: 12  DEWEVPRETLKLVERLGAGQFGEVWMGYYNGHTKVAVKSLKQGSMSPDA--FLAEANLMK 69
Query: 462 SLRHENIIRLRGFCCSRGRGECFLIYDFAPKGKLSKYLDQEEGSSNVLDWSTRVSIIIGI 521
            L+H+ ++RL            ++I ++   G L  +L    G    ++    + +   I
Sbjct: 70  QLQHQRLVRLYAVVTQEP---IYIITEYMENGSLVDFLKTPSGIKLTIN--KLLDMAAQI 124
Query: 522 AKGIGYLHSSEVNKPAIVHRNLSVEKVLIDQQFNPLIADCGLHKLLADDIVFSVLKTSAA 581
           A+G+ ++          +HR+L    +L+    +  IAD GL +L+ D+   +       
Sbjct: 125 AEGMAFIEERNY-----IHRDLRAANILVSDTLSCKIADFGLARLIEDNEXTAREGAKFP 179
Query: 582 MGYLAPEYVTTGRFTERSDIFAFGVIILQILTGSLVLTSSMRLAAESATFENFIDRNLKG 641
           + + APE +  G FT +SD+++FG+++ +I+T   +    M         +N ++R  + 
Sbjct: 180 IKWTAPEAINYGTFTIKSDVWSFGILLTEIVTHGRIPYPGM---TNPEVIQN-LERGYRM 235
Query: 642 KFSESEAAKLGKMALVCTHEDPENRPT---MEAVIEELTVA 679
              ++   +L ++  +C  E PE+RPT   + +V+E+   A
Sbjct: 236 VRPDNCPEELYQLMRLCWKERPEDRPTFDYLRSVLEDFFTA 276

>pdb|3KXZ|A Chain A, The Complex Crystal Structure Of Lck With A Probe Molecule W259 Length = 287

Iteration: 1
 Score = 88.2 bits (217), Expect = 1e-17,   Method: Compositional matrix adjust.
 Identities = 65/281 (23%), Positives = 128/281 (45%), Gaps = 19/281 (6%)
Query: 402 EEVESATQCFSEVNLLGKGNFSSVYKGTLRDGTLVAIRSINVTSCKSEEAEFVKGLYLLT 461
           +E E   +    V  LG G F  V+ G     T VA++S+   S   +   F+    L+ 
Sbjct: 14  DEWEVPRETLKLVERLGAGQFGEVWMGYYNGHTKVAVKSLKQGSMSPDA--FLAEANLMK 71
Query: 462 SLRHENIIRLRGFCCSRGRGECFLIYDFAPKGKLSKYLDQEEGSSNVLDWSTRVSIIIGI 521
            L+H+ ++RL            ++I ++   G L  +L    G    ++    + +   I
Sbjct: 72  QLQHQRLVRLYAVVTQE---PIYIITEYMENGSLVDFLKTPSGIKLTIN--KLLDMAAQI 126
Query: 522 AKGIGYLHSSEVNKPAIVHRNLSVEKVLIDQQFNPLIADCGLHKLLADDIVFSVLKTSAA 581
           A+G+ ++          +HR+L    +L+    +  IAD GL +L+ D+   +       
Sbjct: 127 AEGMAFIEERNY-----IHRDLRAANILVSDTLSCKIADFGLARLIEDNEXTAREGAKFP 181
Query: 582 MGYLAPEYVTTGRFTERSDIFAFGVIILQILTGSLVLTSSMRLAAESATFENFIDRNLKG 641
           + + APE +  G FT +SD+++FG+++ +I+T   +    M         +N ++R  + 
Sbjct: 182 IKWTAPEAINYGTFTIKSDVWSFGILLTEIVTHGRIPYPGM---TNPEVIQN-LERGYRM 237
Query: 642 KFSESEAAKLGKMALVCTHEDPENRPT---MEAVIEELTVA 679
              ++   +L ++  +C  E PE+RPT   + +V+E+   A
Sbjct: 238 VRPDNCPEELYQLMRLCWKERPEDRPTFDYLRSVLEDFFTA 278

>pdb|2PL0|A Chain A, Lck Bound To Imatinib Length = 289

Iteration: 1
 Score = 88.2 bits (217), Expect = 1e-17,   Method: Compositional matrix adjust.
 Identities = 65/281 (23%), Positives = 128/281 (45%), Gaps = 19/281 (6%)
Query: 402 EEVESATQCFSEVNLLGKGNFSSVYKGTLRDGTLVAIRSINVTSCKSEEAEFVKGLYLLT 461
           +E E   +    V  LG G F  V+ G     T VA++S+   S   +   F+    L+ 
Sbjct: 16  DEWEVPRETLKLVERLGAGQFGEVWMGYYNGHTKVAVKSLKQGSMSPDA--FLAEANLMK 73
Query: 462 SLRHENIIRLRGFCCSRGRGECFLIYDFAPKGKLSKYLDQEEGSSNVLDWSTRVSIIIGI 521
            L+H+ ++RL            ++I ++   G L  +L    G    ++    + +   I
Sbjct: 74  QLQHQRLVRLYAVVTQE---PIYIITEYMENGSLVDFLKTPSGIKLTIN--KLLDMAAQI 128
Query: 522 AKGIGYLHSSEVNKPAIVHRNLSVEKVLIDQQFNPLIADCGLHKLLADDIVFSVLKTSAA 581
           A+G+ ++          +HR+L    +L+    +  IAD GL +L+ D+   +       
Sbjct: 129 AEGMAFIEERNY-----IHRDLRAANILVSDTLSCKIADFGLARLIEDNEYTAREGAKFP 183
Query: 582 MGYLAPEYVTTGRFTERSDIFAFGVIILQILTGSLVLTSSMRLAAESATFENFIDRNLKG 641
           + + APE +  G FT +SD+++FG+++ +I+T   +    M         +N ++R  + 
Sbjct: 184 IKWTAPEAINYGTFTIKSDVWSFGILLTEIVTHGRIPYPGM---TNPEVIQN-LERGYRM 239
Query: 642 KFSESEAAKLGKMALVCTHEDPENRPT---MEAVIEELTVA 679
              ++   +L ++  +C  E PE+RPT   + +V+E+   A
Sbjct: 240 VRPDNCPEELYQLMRLCWKERPEDRPTFDYLRSVLEDFFTA 280

>pdb|3KMM|A Chain A, Structure Of Human Lck Kinase With A Small Molecule Inhibitor Length = 288

Iteration: 1
 Score = 88.2 bits (217), Expect = 2e-17,   Method: Compositional matrix adjust.
 Identities = 65/281 (23%), Positives = 128/281 (45%), Gaps = 19/281 (6%)
Query: 402 EEVESATQCFSEVNLLGKGNFSSVYKGTLRDGTLVAIRSINVTSCKSEEAEFVKGLYLLT 461
           +E E   +    V  LG G F  V+ G     T VA++S+   S   +   F+    L+ 
Sbjct: 15  DEWEVPRETLKLVERLGAGQFGEVWMGYYNGHTKVAVKSLKQGSMSPDA--FLAEANLMK 72
Query: 462 SLRHENIIRLRGFCCSRGRGECFLIYDFAPKGKLSKYLDQEEGSSNVLDWSTRVSIIIGI 521
            L+H+ ++RL            ++I ++   G L  +L    G    ++    + +   I
Sbjct: 73  QLQHQRLVRLYAVVTQEP---IYIITEYMENGSLVDFLKTPSGIKLTIN--KLLDMAAQI 127
Query: 522 AKGIGYLHSSEVNKPAIVHRNLSVEKVLIDQQFNPLIADCGLHKLLADDIVFSVLKTSAA 581
           A+G+ ++          +HR+L    +L+    +  IAD GL +L+ D+   +       
Sbjct: 128 AEGMAFIEERNY-----IHRDLRAANILVSDTLSCKIADFGLARLIEDNEXTAREGAKFP 182
Query: 582 MGYLAPEYVTTGRFTERSDIFAFGVIILQILTGSLVLTSSMRLAAESATFENFIDRNLKG 641
           + + APE +  G FT +SD+++FG+++ +I+T   +    M         +N ++R  + 
Sbjct: 183 IKWTAPEAINYGTFTIKSDVWSFGILLTEIVTHGRIPYPGM---TNPEVIQN-LERGYRM 238
Query: 642 KFSESEAAKLGKMALVCTHEDPENRPT---MEAVIEELTVA 679
              ++   +L ++  +C  E PE+RPT   + +V+E+   A
Sbjct: 239 VRPDNCPEELYQLMRLCWKERPEDRPTFDYLRSVLEDFFTA 279

>pdb|1QPE|A Chain A, Structural Analysis Of The Lymphocyte-Specific Kinase Lck In Complex With Non-Selective And Src Family Selective Kinase Inhibitors Length = 279

Iteration: 1
 Score = 87.8 bits (216), Expect = 2e-17,   Method: Compositional matrix adjust.
 Identities = 65/281 (23%), Positives = 128/281 (45%), Gaps = 19/281 (6%)
Query: 402 EEVESATQCFSEVNLLGKGNFSSVYKGTLRDGTLVAIRSINVTSCKSEEAEFVKGLYLLT 461
           +E E   +    V  LG G F  V+ G     T VA++S+   S   +   F+    L+ 
Sbjct: 6   DEWEVPRETLKLVERLGAGQFGEVWMGYYNGHTKVAVKSLKQGSMSPDA--FLAEANLMK 63
Query: 462 SLRHENIIRLRGFCCSRGRGECFLIYDFAPKGKLSKYLDQEEGSSNVLDWSTRVSIIIGI 521
            L+H+ ++RL            ++I ++   G L  +L    G    ++    + +   I
Sbjct: 64  QLQHQRLVRLYAVVTQEP---IYIITEYMENGSLVDFLKTPSGIKLTIN--KLLDMAAQI 118
Query: 522 AKGIGYLHSSEVNKPAIVHRNLSVEKVLIDQQFNPLIADCGLHKLLADDIVFSVLKTSAA 581
           A+G+ ++          +HR+L    +L+    +  IAD GL +L+ D+   +       
Sbjct: 119 AEGMAFIEERNY-----IHRDLRAANILVSDTLSCKIADFGLARLIEDNEXTAREGAKFP 173
Query: 582 MGYLAPEYVTTGRFTERSDIFAFGVIILQILTGSLVLTSSMRLAAESATFENFIDRNLKG 641
           + + APE +  G FT +SD+++FG+++ +I+T   +    M         +N ++R  + 
Sbjct: 174 IKWTAPEAINYGTFTIKSDVWSFGILLTEIVTHGRIPYPGM---TNPEVIQN-LERGYRM 229
Query: 642 KFSESEAAKLGKMALVCTHEDPENRPT---MEAVIEELTVA 679
              ++   +L ++  +C  E PE+RPT   + +V+E+   A
Sbjct: 230 VRPDNCPEELYQLMRLCWKERPEDRPTFDYLRSVLEDFFTA 270

>pdb|2OFU|A Chain A, X-Ray Crystal Structure Of 2-Aminopyrimidine Carbamate 43 Bound To Lck Length = 273

Iteration: 1
 Score = 87.8 bits (216), Expect = 2e-17,   Method: Compositional matrix adjust.
 Identities = 65/281 (23%), Positives = 128/281 (45%), Gaps = 19/281 (6%)
Query: 402 EEVESATQCFSEVNLLGKGNFSSVYKGTLRDGTLVAIRSINVTSCKSEEAEFVKGLYLLT 461
           +E E   +    V  LG G F  V+ G     T VA++S+   S   +   F+    L+ 
Sbjct: 8   DEWEVPRETLKLVERLGAGQFGEVWMGYYNGHTKVAVKSLKQGSMSPDA--FLAEANLMK 65
Query: 462 SLRHENIIRLRGFCCSRGRGECFLIYDFAPKGKLSKYLDQEEGSSNVLDWSTRVSIIIGI 521
            L+H+ ++RL            ++I ++   G L  +L    G    ++    + +   I
Sbjct: 66  QLQHQRLVRLYAVVTQEP---IYIITEYMENGSLVDFLKTPSGIKLTIN--KLLDMAAQI 120
Query: 522 AKGIGYLHSSEVNKPAIVHRNLSVEKVLIDQQFNPLIADCGLHKLLADDIVFSVLKTSAA 581
           A+G+ ++          +HR+L    +L+    +  IAD GL +L+ D+   +       
Sbjct: 121 AEGMAFIEERNY-----IHRDLRAANILVSDTLSCKIADFGLARLIEDNEXTAREGAKFP 175
Query: 582 MGYLAPEYVTTGRFTERSDIFAFGVIILQILTGSLVLTSSMRLAAESATFENFIDRNLKG 641
           + + APE +  G FT +SD+++FG+++ +I+T   +    M         +N ++R  + 
Sbjct: 176 IKWTAPEAINYGTFTIKSDVWSFGILLTEIVTHGRIPYPGM---TNPEVIQN-LERGYRM 231
Query: 642 KFSESEAAKLGKMALVCTHEDPENRPT---MEAVIEELTVA 679
              ++   +L ++  +C  E PE+RPT   + +V+E+   A
Sbjct: 232 VRPDNCPEELYQLMRLCWKERPEDRPTFDYLRSVLEDFFTA 272

>pdb|4HVD|A Chain A, Jak3 Kinase Domain In Complex With 2-cyclopropyl-5h-pyrrolo[2,3- B]pyrazine-7-carboxylic Acid ((s)-1,2,2-trimethyl-propyl)-amide Length = 314

Iteration: 1
 Score = 87.8 bits (216), Expect = 2e-17,   Method: Compositional matrix adjust.
 Identities = 72/282 (25%), Positives = 135/282 (47%), Gaps = 26/282 (9%)
Query: 414 VNLLGKGNFSSV---YKGTLRD--GTLVAIRSINVTSCKSEEAEFVKGLYLLTSLRHENI 468
           ++ LGKGNF SV       L D  G LVA++ +   S   ++ +F + + +L +L  + I
Sbjct: 15  ISQLGKGNFGSVELCRYDPLGDNTGALVAVKQLQ-HSGPDQQRDFQREIQILKALHSDFI 73
Query: 469 IRLRGFCCSRGRGECFLIYDFAPKGKLSKYLDQEEGSSNVLDWSTRVSIIIGIAKGIGYL 528
           ++ RG     GR    L+ ++ P G L  +L +       LD S  +     I KG+ YL
Sbjct: 74  VKYRGVSYGPGRQSLRLVMEYLPSGCLRDFLQRHRAR---LDASRLLLYSSQICKGMEYL 130
Query: 529 HSSEVNKPAIVHRNLSVEKVLIDQQFNPLIADCGLHKLLADDIVFSVLKT--SAAMGYLA 586
            S        VHR+L+   +L++ + +  IAD GL KLL  D  + V++    + + + A
Sbjct: 131 GSRRC-----VHRDLAARNILVESEAHVKIADFGLAKLLPLDKDYYVVREPGQSPIFWYA 185
Query: 587 PEYVTTGRFTERSDIFAFGVIILQILTGS----------LVLTSSMRLAAESATFENFID 636
           PE ++   F+ +SD+++FGV++ ++ T            L +  S R     +     ++
Sbjct: 186 PESLSDNIFSRQSDVWSFGVVLYELFTYCDKSCSPSAEFLRMMGSERDVPALSRLLELLE 245
Query: 637 RNLKGKFSESEAAKLGKMALVCTHEDPENRPTMEAVIEELTV 678
              +     +  A++ ++  +C    P++RP+  A+  +L +
Sbjct: 246 EGQRLPAPPACPAEVHELMKLCWAPSPQDRPSFSALGPQLDM 287

>pdb|1YVJ|A Chain A, Crystal Structure Of The Jak3 Kinase Domain In Complex With A Staurosporine Analogue Length = 290

Iteration: 1
 Score = 87.8 bits (216), Expect = 2e-17,   Method: Compositional matrix adjust.
 Identities = 63/207 (30%), Positives = 108/207 (52%), Gaps = 16/207 (7%)
Query: 414 VNLLGKGNFSSV---YKGTLRD--GTLVAIRSINVTSCKSEEAEFVKGLYLLTSLRHENI 468
           ++ LGKGNF SV       L D  G LVA++ +   S   ++ +F + + +L +L  + I
Sbjct: 12  ISQLGKGNFGSVELCRYDPLGDNTGALVAVKQLQ-HSGPDQQRDFQREIQILKALHSDFI 70
Query: 469 IRLRGFCCSRGRGECFLIYDFAPKGKLSKYLDQEEGSSNVLDWSTRVSIIIGIAKGIGYL 528
           ++ RG     GR E  L+ ++ P G L  +L +       LD S  +     I KG+ YL
Sbjct: 71  VKYRGVSYGPGRPELRLVMEYLPSGCLRDFLQRHRAR---LDASRLLLYSSQICKGMEYL 127
Query: 529 HSSEVNKPAIVHRNLSVEKVLIDQQFNPLIADCGLHKLLADDIVFSVLKT--SAAMGYLA 586
            S        VHR+L+   +L++ + +  IAD GL KLL  D    V++    + + + A
Sbjct: 128 GSRRC-----VHRDLAARNILVESEAHVKIADFGLAKLLPLDKDXXVVREPGQSPIFWYA 182
Query: 587 PEYVTTGRFTERSDIFAFGVIILQILT 613
           PE ++   F+ +SD+++FGV++ ++ T
Sbjct: 183 PESLSDNIFSRQSDVWSFGVVLYELFT 209

>pdb|3BYS|A Chain A, Co-Crystal Structure Of Lck And Aminopyrimidine Amide 10b Length = 277

Iteration: 1
 Score = 87.4 bits (215), Expect = 2e-17,   Method: Compositional matrix adjust.
 Identities = 65/281 (23%), Positives = 128/281 (45%), Gaps = 19/281 (6%)
Query: 402 EEVESATQCFSEVNLLGKGNFSSVYKGTLRDGTLVAIRSINVTSCKSEEAEFVKGLYLLT 461
           +E E   +    V  LG G F  V+ G     T VA++S+   S   +   F+    L+ 
Sbjct: 12  DEWEVPRETLKLVERLGAGQFGEVWMGYYNGHTKVAVKSLKQGSMSPDA--FLAEANLMK 69
Query: 462 SLRHENIIRLRGFCCSRGRGECFLIYDFAPKGKLSKYLDQEEGSSNVLDWSTRVSIIIGI 521
            L+H+ ++RL            ++I ++   G L  +L    G    ++    + +   I
Sbjct: 70  QLQHQRLVRLYAVVTQEP---IYIITEYMENGSLVDFLKTPSGIKLTIN--KLLDMAAQI 124
Query: 522 AKGIGYLHSSEVNKPAIVHRNLSVEKVLIDQQFNPLIADCGLHKLLADDIVFSVLKTSAA 581
           A+G+ ++          +HR+L    +L+    +  IAD GL +L+ D+   +       
Sbjct: 125 AEGMAFIEERNY-----IHRDLRAANILVSDTLSCKIADFGLARLIEDNEYTAREGAKFP 179
Query: 582 MGYLAPEYVTTGRFTERSDIFAFGVIILQILTGSLVLTSSMRLAAESATFENFIDRNLKG 641
           + + APE +  G FT +SD+++FG+++ +I+T   +    M         +N ++R  + 
Sbjct: 180 IKWTAPEAINYGTFTIKSDVWSFGILLTEIVTHGRIPYPGM---TNPEVIQN-LERGYRM 235
Query: 642 KFSESEAAKLGKMALVCTHEDPENRPT---MEAVIEELTVA 679
              ++   +L ++  +C  E PE+RPT   + +V+E+   A
Sbjct: 236 VRPDNCPEELYQLMRLCWKERPEDRPTFDYLRSVLEDFFTA 276

>pdb|3LCK|A Chain A, The Kinase Domain Of Human Lymphocyte Kinase (Lck), Activated Form (Auto-Phosphorylated On Tyr394) Length = 271

Iteration: 1
 Score = 87.4 bits (215), Expect = 2e-17,   Method: Compositional matrix adjust.
 Identities = 65/281 (23%), Positives = 128/281 (45%), Gaps = 19/281 (6%)
Query: 402 EEVESATQCFSEVNLLGKGNFSSVYKGTLRDGTLVAIRSINVTSCKSEEAEFVKGLYLLT 461
           +E E   +    V  LG G F  V+ G     T VA++S+   S   +   F+    L+ 
Sbjct: 6   DEWEVPRETLKLVERLGAGQFGEVWMGYYNGHTKVAVKSLKQGSMSPDA--FLAEANLMK 63
Query: 462 SLRHENIIRLRGFCCSRGRGECFLIYDFAPKGKLSKYLDQEEGSSNVLDWSTRVSIIIGI 521
            L+H+ ++RL            ++I ++   G L  +L    G    ++    + +   I
Sbjct: 64  QLQHQRLVRLYAVVTQE---PIYIITEYMENGSLVDFLKTPSGIKLTIN--KLLDMAAQI 118
Query: 522 AKGIGYLHSSEVNKPAIVHRNLSVEKVLIDQQFNPLIADCGLHKLLADDIVFSVLKTSAA 581
           A+G+ ++          +HR+L    +L+    +  IAD GL +L+ D+   +       
Sbjct: 119 AEGMAFIEERNY-----IHRDLRAANILVSDTLSCKIADFGLARLIEDNEXTAREGAKFP 173
Query: 582 MGYLAPEYVTTGRFTERSDIFAFGVIILQILTGSLVLTSSMRLAAESATFENFIDRNLKG 641
           + + APE +  G FT +SD+++FG+++ +I+T   +    M         +N ++R  + 
Sbjct: 174 IKWTAPEAINYGTFTIKSDVWSFGILLTEIVTHGRIPYPGM---TNPEVIQN-LERGYRM 229
Query: 642 KFSESEAAKLGKMALVCTHEDPENRPT---MEAVIEELTVA 679
              ++   +L ++  +C  E PE+RPT   + +V+E+   A
Sbjct: 230 VRPDNCPEELYQLMRLCWKERPEDRPTFDYLRSVLEDFFTA 270

>pdb|3BYM|A Chain A, X-Ray Co-Crystal Structure Aminobenzimidazole Triazine 1 Bound To Lck Length = 272

Iteration: 1
 Score = 87.4 bits (215), Expect = 2e-17,   Method: Compositional matrix adjust.
 Identities = 65/281 (23%), Positives = 128/281 (45%), Gaps = 19/281 (6%)
Query: 402 EEVESATQCFSEVNLLGKGNFSSVYKGTLRDGTLVAIRSINVTSCKSEEAEFVKGLYLLT 461
           +E E   +    V  LG G F  V+ G     T VA++S+   S   +   F+    L+ 
Sbjct: 7   DEWEVPRETLKLVERLGAGQFGEVWMGYYNGHTKVAVKSLKQGSMSPDA--FLAEANLMK 64
Query: 462 SLRHENIIRLRGFCCSRGRGECFLIYDFAPKGKLSKYLDQEEGSSNVLDWSTRVSIIIGI 521
            L+H+ ++RL            ++I ++   G L  +L    G    ++    + +   I
Sbjct: 65  QLQHQRLVRLYAVVTQEP---IYIITEYMENGSLVDFLKTPSGIKLTIN--KLLDMAAQI 119
Query: 522 AKGIGYLHSSEVNKPAIVHRNLSVEKVLIDQQFNPLIADCGLHKLLADDIVFSVLKTSAA 581
           A+G+ ++          +HR+L    +L+    +  IAD GL +L+ D+   +       
Sbjct: 120 AEGMAFIEERNY-----IHRDLRAANILVSDTLSCKIADFGLARLIEDNEXTAREGAKFP 174
Query: 582 MGYLAPEYVTTGRFTERSDIFAFGVIILQILTGSLVLTSSMRLAAESATFENFIDRNLKG 641
           + + APE +  G FT +SD+++FG+++ +I+T   +    M         +N ++R  + 
Sbjct: 175 IKWTAPEAINYGTFTIKSDVWSFGILLTEIVTHGRIPYPGM---TNPEVIQN-LERGYRM 230
Query: 642 KFSESEAAKLGKMALVCTHEDPENRPT---MEAVIEELTVA 679
              ++   +L ++  +C  E PE+RPT   + +V+E+   A
Sbjct: 231 VRPDNCPEELYQLMRLCWKERPEDRPTFDYLRSVLEDFFTA 271

>pdb|2OFV|A Chain A, Crystal Structure Of Aminoquinazoline 1 Bound To Lck Length = 277

Iteration: 1
 Score = 87.4 bits (215), Expect = 2e-17,   Method: Compositional matrix adjust.
 Identities = 65/281 (23%), Positives = 128/281 (45%), Gaps = 19/281 (6%)
Query: 402 EEVESATQCFSEVNLLGKGNFSSVYKGTLRDGTLVAIRSINVTSCKSEEAEFVKGLYLLT 461
           +E E   +    V  LG G F  V+ G     T VA++S+   S   +   F+    L+ 
Sbjct: 11  DEWEVPRETLKLVERLGAGQFGEVWMGYYNGHTKVAVKSLKQGSMSPDA--FLAEANLMK 68
Query: 462 SLRHENIIRLRGFCCSRGRGECFLIYDFAPKGKLSKYLDQEEGSSNVLDWSTRVSIIIGI 521
            L+H+ ++RL            ++I ++   G L  +L    G    ++    + +   I
Sbjct: 69  QLQHQRLVRLYAVVTQEP---IYIITEYMENGSLVDFLKTPSGIKLTIN--KLLDMAAQI 123
Query: 522 AKGIGYLHSSEVNKPAIVHRNLSVEKVLIDQQFNPLIADCGLHKLLADDIVFSVLKTSAA 581
           A+G+ ++          +HR+L    +L+    +  IAD GL +L+ D+   +       
Sbjct: 124 AEGMAFIEERNY-----IHRDLRAANILVSDTLSCKIADFGLARLIEDNEYTAREGAKFP 178
Query: 582 MGYLAPEYVTTGRFTERSDIFAFGVIILQILTGSLVLTSSMRLAAESATFENFIDRNLKG 641
           + + APE +  G FT +SD+++FG+++ +I+T   +    M         +N ++R  + 
Sbjct: 179 IKWTAPEAINYGTFTIKSDVWSFGILLTEIVTHGRIPYPGM---TNPEVIQN-LERGYRM 234
Query: 642 KFSESEAAKLGKMALVCTHEDPENRPT---MEAVIEELTVA 679
              ++   +L ++  +C  E PE+RPT   + +V+E+   A
Sbjct: 235 VRPDNCPEELYQLMRLCWKERPEDRPTFDYLRSVLEDFFTA 275

>pdb|2OF2|A Chain A, Crystal Structure Of Furanopyrimidine 8 Bound To Lck Length = 271

Iteration: 1
 Score = 87.4 bits (215), Expect = 2e-17,   Method: Compositional matrix adjust.
 Identities = 65/281 (23%), Positives = 128/281 (45%), Gaps = 19/281 (6%)
Query: 402 EEVESATQCFSEVNLLGKGNFSSVYKGTLRDGTLVAIRSINVTSCKSEEAEFVKGLYLLT 461
           +E E   +    V  LG G F  V+ G     T VA++S+   S   +   F+    L+ 
Sbjct: 6   DEWEVPRETLKLVERLGAGQFGEVWMGYYNGHTKVAVKSLKQGSMSPDA--FLAEANLMK 63
Query: 462 SLRHENIIRLRGFCCSRGRGECFLIYDFAPKGKLSKYLDQEEGSSNVLDWSTRVSIIIGI 521
            L+H+ ++RL            ++I ++   G L  +L    G    ++    + +   I
Sbjct: 64  QLQHQRLVRLYAVVTQE---PIYIITEYMENGSLVDFLKTPSGIKLTIN--KLLDMAAQI 118
Query: 522 AKGIGYLHSSEVNKPAIVHRNLSVEKVLIDQQFNPLIADCGLHKLLADDIVFSVLKTSAA 581
           A+G+ ++          +HR+L    +L+    +  IAD GL +L+ D+   +       
Sbjct: 119 AEGMAFIEERNY-----IHRDLRAANILVSDTLSCKIADFGLARLIEDNEYTAREGAKFP 173
Query: 582 MGYLAPEYVTTGRFTERSDIFAFGVIILQILTGSLVLTSSMRLAAESATFENFIDRNLKG 641
           + + APE +  G FT +SD+++FG+++ +I+T   +    M         +N ++R  + 
Sbjct: 174 IKWTAPEAINYGTFTIKSDVWSFGILLTEIVTHGRIPYPGM---TNPEVIQN-LERGYRM 229
Query: 642 KFSESEAAKLGKMALVCTHEDPENRPT---MEAVIEELTVA 679
              ++   +L ++  +C  E PE+RPT   + +V+E+   A
Sbjct: 230 VRPDNCPEELYQLMRLCWKERPEDRPTFDYLRSVLEDFFTA 270

>pdb|2R4B|A Chain A, Erbb4 Kinase Domain Complexed With A Thienopyrimidine Inhibitor Length = 321

Iteration: 1
 Score = 87.4 bits (215), Expect = 2e-17,   Method: Compositional matrix adjust.
 Identities = 62/212 (29%), Positives = 107/212 (50%), Gaps = 23/212 (10%)
Query: 411 FSEVNLLGKGNFSSVYKGT-LRDGTLV----AIRSINVTSCKSEEAEFVKGLYLLTSLRH 465
              V +LG G F +VYKG  + +G  V    AI+ +N T+      EF+    ++ S+ H
Sbjct: 40  LKRVKVLGSGAFGTVYKGIWVPEGETVKIPVAIKILNETTGPKANVEFMDEALIMASMDH 99
Query: 466 ENIIRLRGFCCSRGRGECFLIYDFAPKGKLSKYLDQEE---GSSNVLDWSTRVSIIIGIA 522
            +++RL G C S       L+    P G L +Y+ + +   GS  +L+W       + IA
Sbjct: 100 PHLVRLLGVCLS---PTIQLVTQLMPHGCLLEYVHEHKDNIGSQLLLNWC------VQIA 150
Query: 523 KGIGYLHSSEVNKPAIVHRNLSVEKVLIDQQFNPLIADCGLHKLL-ADDIVFSVLKTSAA 581
           KG+ YL         +VHR+L+   VL+    +  I D GL +LL  D+  ++       
Sbjct: 151 KGMMYLEERR-----LVHRDLAARNVLVKSPNHVKITDFGLARLLEGDEKEYNADGGKMP 205
Query: 582 MGYLAPEYVTTGRFTERSDIFAFGVIILQILT 613
           + ++A E +   +FT +SD++++GV I +++T
Sbjct: 206 IKWMALECIHYRKFTHQSDVWSYGVTIWELMT 237

>pdb|3PJC|A Chain A, Crystal Structure Of Jak3 Complexed With A Potent Atp Site Inhibitor Showing High Selectivity Within The Janus Kinase Family Length = 315

Iteration: 1
 Score = 87.4 bits (215), Expect = 3e-17,   Method: Compositional matrix adjust.
 Identities = 62/207 (29%), Positives = 108/207 (52%), Gaps = 16/207 (7%)
Query: 414 VNLLGKGNFSSV---YKGTLRD--GTLVAIRSINVTSCKSEEAEFVKGLYLLTSLRHENI 468
           ++ LGKGNF SV       L D  G LVA++ +   S   ++ +F + + +L +L  + I
Sbjct: 16  ISQLGKGNFGSVELCRYDPLGDNTGALVAVKQLQ-HSGPDQQRDFQREIQILKALHSDFI 74
Query: 469 IRLRGFCCSRGRGECFLIYDFAPKGKLSKYLDQEEGSSNVLDWSTRVSIIIGIAKGIGYL 528
           ++ RG     GR    L+ ++ P G L  +L +       LD S  +     I KG+ YL
Sbjct: 75  VKYRGVSYGPGRQSLRLVMEYLPSGCLRDFLQRHRAR---LDASRLLLYSSQICKGMEYL 131
Query: 529 HSSEVNKPAIVHRNLSVEKVLIDQQFNPLIADCGLHKLLADDIVFSVLKT--SAAMGYLA 586
            S        VHR+L+   +L++ + +  IAD GL KLL  D  + V++    + + + A
Sbjct: 132 GSRRC-----VHRDLAARNILVESEAHVKIADFGLAKLLPLDKDYYVVREPGQSPIFWYA 186
Query: 587 PEYVTTGRFTERSDIFAFGVIILQILT 613
           PE ++   F+ +SD+++FGV++ ++ T
Sbjct: 187 PESLSDNIFSRQSDVWSFGVVLYELFT 213

>pdb|3LXK|A Chain A, Structural And Thermodynamic Characterization Of The Tyk2 And Jak3 Kinase Domains In Complex With Cp-690550 And Cmp-6 Length = 327

Iteration: 1
 Score = 87.0 bits (214), Expect = 3e-17,   Method: Compositional matrix adjust.
 Identities = 62/207 (29%), Positives = 108/207 (52%), Gaps = 16/207 (7%)
Query: 414 VNLLGKGNFSSV---YKGTLRD--GTLVAIRSINVTSCKSEEAEFVKGLYLLTSLRHENI 468
           ++ LGKGNF SV       L D  G LVA++ +   S   ++ +F + + +L +L  + I
Sbjct: 28  ISQLGKGNFGSVELCRYDPLGDNTGALVAVKQLQ-HSGPDQQRDFQREIQILKALHSDFI 86
Query: 469 IRLRGFCCSRGRGECFLIYDFAPKGKLSKYLDQEEGSSNVLDWSTRVSIIIGIAKGIGYL 528
           ++ RG     GR    L+ ++ P G L  +L +       LD S  +     I KG+ YL
Sbjct: 87  VKYRGVSYGPGRQSLRLVMEYLPSGCLRDFLQRHRAR---LDASRLLLYSSQICKGMEYL 143
Query: 529 HSSEVNKPAIVHRNLSVEKVLIDQQFNPLIADCGLHKLLADDIVFSVLKT--SAAMGYLA 586
            S        VHR+L+   +L++ + +  IAD GL KLL  D  + V++    + + + A
Sbjct: 144 GSRRC-----VHRDLAARNILVESEAHVKIADFGLAKLLPLDKDYYVVREPGQSPIFWYA 198
Query: 587 PEYVTTGRFTERSDIFAFGVIILQILT 613
           PE ++   F+ +SD+++FGV++ ++ T
Sbjct: 199 PESLSDNIFSRQSDVWSFGVVLYELFT 225

>pdb|1FPU|A Chain A, Crystal Structure Of Abl Kinase Domain In Complex With A Small Molecule Inhibitor Length = 293

Iteration: 1
 Score = 87.0 bits (214), Expect = 3e-17,   Method: Compositional matrix adjust.
 Identities = 63/260 (24%), Positives = 128/260 (49%), Gaps = 22/260 (8%)
Query: 417 LGKGNFSSVYKGTLRDGTL-VAIRSINVTSCKSEEAEFVKGLYLLTSLRHENIIRLRGFC 475
           LG G +  VY+G  +  +L VA++++   + + EE  F+K   ++  ++H N+++L G C
Sbjct: 26  LGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVEE--FLKEAAVMKEIKHPNLVQLLGVC 83
Query: 476 CSRGRGECFLIYDFAPKGKLSKYL---DQEEGSSNVLDWSTRVSIIIGIAKGIGYLHSSE 532
                   ++I +F   G L  YL   +++E S+ VL     + +   I+  + YL    
Sbjct: 84  TREP--PFYIITEFMTYGNLLDYLRECNRQEVSAVVL-----LYMATQISSAMEYL---- 132
Query: 533 VNKPAIVHRNLSVEKVLIDQQFNPLIADCGLHKLLADDIVFSVLKTSAAMGYLAPEYVTT 592
             K   +HR+L+    L+ +     +AD GL +L+  D   +       + + APE +  
Sbjct: 133 -EKKNFIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHAGAKFPIKWTAPESLAY 191
Query: 593 GRFTERSDIFAFGVIILQILTGSLVLTSSMRLAAESATFENFIDRNLKGKFSESEAAKLG 652
            +F+ +SD++AFGV++ +I T  +     + L   S  +E  ++++ + +  E    K+ 
Sbjct: 192 NKFSIKSDVWAFGVLLWEIATYGMSPYPGIDL---SQVYE-LLEKDYRMERPEGCPEKVY 247
Query: 653 KMALVCTHEDPENRPTMEAV 672
           ++   C   +P +RP+   +
Sbjct: 248 ELMRACWQWNPSDRPSFAEI 267

>pdb|2OG8|A Chain A, Crystal Structure Of Aminoquinazoline 36 Bound To Lck Length = 265

Iteration: 1
 Score = 87.0 bits (214), Expect = 3e-17,   Method: Compositional matrix adjust.
 Identities = 65/281 (23%), Positives = 128/281 (45%), Gaps = 19/281 (6%)
Query: 402 EEVESATQCFSEVNLLGKGNFSSVYKGTLRDGTLVAIRSINVTSCKSEEAEFVKGLYLLT 461
           +E E   +    V  LG G F  V+ G     T VA++S+   S   +   F+    L+ 
Sbjct: 1   DEWEVPRETLKLVERLGAGQFGEVWMGYYNGHTKVAVKSLKQGSMSPDA--FLAEANLMK 58
Query: 462 SLRHENIIRLRGFCCSRGRGECFLIYDFAPKGKLSKYLDQEEGSSNVLDWSTRVSIIIGI 521
            L+H+ ++RL            ++I ++   G L  +L    G    ++    + +   I
Sbjct: 59  QLQHQRLVRLYAVVTQE---PIYIITEYMENGSLVDFLKTPSGIKLTIN--KLLDMAAQI 113
Query: 522 AKGIGYLHSSEVNKPAIVHRNLSVEKVLIDQQFNPLIADCGLHKLLADDIVFSVLKTSAA 581
           A+G+ ++          +HR+L    +L+    +  IAD GL +L+ D+   +       
Sbjct: 114 AEGMAFIEERNY-----IHRDLRAANILVSDTLSCKIADFGLARLIEDNEYTAREGAKFP 168
Query: 582 MGYLAPEYVTTGRFTERSDIFAFGVIILQILTGSLVLTSSMRLAAESATFENFIDRNLKG 641
           + + APE +  G FT +SD+++FG+++ +I+T   +    M         +N ++R  + 
Sbjct: 169 IKWTAPEAINYGTFTIKSDVWSFGILLTEIVTHGRIPYPGM---TNPEVIQN-LERGYRM 224
Query: 642 KFSESEAAKLGKMALVCTHEDPENRPT---MEAVIEELTVA 679
              ++   +L ++  +C  E PE+RPT   + +V+E+   A
Sbjct: 225 VRPDNCPEELYQLMRLCWKERPEDRPTFDYLRSVLEDFFTA 265

>pdb|3OXZ|A Chain A, Crystal Structure Of Abl Kinase Domain Bound With A Dfg-Out Inhibitor Ap24534 Length = 284

Iteration: 1
 Score = 87.0 bits (214), Expect = 3e-17,   Method: Compositional matrix adjust.
 Identities = 63/260 (24%), Positives = 128/260 (49%), Gaps = 22/260 (8%)
Query: 417 LGKGNFSSVYKGTLRDGTL-VAIRSINVTSCKSEEAEFVKGLYLLTSLRHENIIRLRGFC 475
           LG G +  VY+G  +  +L VA++++   + + EE  F+K   ++  ++H N+++L G C
Sbjct: 21  LGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVEE--FLKEAAVMKEIKHPNLVQLLGVC 78
Query: 476 CSRGRGECFLIYDFAPKGKLSKYL---DQEEGSSNVLDWSTRVSIIIGIAKGIGYLHSSE 532
                   ++I +F   G L  YL   +++E S+ VL     + +   I+  + YL    
Sbjct: 79  TREP--PFYIITEFMTYGNLLDYLRECNRQEVSAVVL-----LYMATQISSAMEYL---- 127
Query: 533 VNKPAIVHRNLSVEKVLIDQQFNPLIADCGLHKLLADDIVFSVLKTSAAMGYLAPEYVTT 592
             K   +HR+L+    L+ +     +AD GL +L+  D   +       + + APE +  
Sbjct: 128 -EKKNFIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHAGAKFPIKWTAPESLAY 186
Query: 593 GRFTERSDIFAFGVIILQILTGSLVLTSSMRLAAESATFENFIDRNLKGKFSESEAAKLG 652
            +F+ +SD++AFGV++ +I T  +     + L   S  +E  ++++ + +  E    K+ 
Sbjct: 187 NKFSIKSDVWAFGVLLWEIATYGMSPYPGIDL---SQVYE-LLEKDYRMERPEGCPEKVY 242
Query: 653 KMALVCTHEDPENRPTMEAV 672
           ++   C   +P +RP+   +
Sbjct: 243 ELMRACWQWNPSDRPSFAEI 262

>pdb|2Z60|A Chain A, Crystal Structure Of The T315i Mutant Of Abl Kinase Bound With Ppy-A Length = 288

Iteration: 1
 Score = 86.7 bits (213), Expect = 4e-17,   Method: Compositional matrix adjust.
 Identities = 63/260 (24%), Positives = 128/260 (49%), Gaps = 22/260 (8%)
Query: 417 LGKGNFSSVYKGTLRDGTL-VAIRSINVTSCKSEEAEFVKGLYLLTSLRHENIIRLRGFC 475
           LG G +  VY+G  +  +L VA++++   + + EE  F+K   ++  ++H N+++L G C
Sbjct: 21  LGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVEE--FLKEAAVMKEIKHPNLVQLLGVC 78
Query: 476 CSRGRGECFLIYDFAPKGKLSKYL---DQEEGSSNVLDWSTRVSIIIGIAKGIGYLHSSE 532
                   ++I +F   G L  YL   +++E S+ VL     + +   I+  + YL    
Sbjct: 79  TREP--PFYIIIEFMTYGNLLDYLRECNRQEVSAVVL-----LYMATQISSAMEYL---- 127
Query: 533 VNKPAIVHRNLSVEKVLIDQQFNPLIADCGLHKLLADDIVFSVLKTSAAMGYLAPEYVTT 592
             K   +HR+L+    L+ +     +AD GL +L+  D   +       + + APE +  
Sbjct: 128 -EKKNFIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHAGAKFPIKWTAPESLAY 186
Query: 593 GRFTERSDIFAFGVIILQILTGSLVLTSSMRLAAESATFENFIDRNLKGKFSESEAAKLG 652
            +F+ +SD++AFGV++ +I T  +     + L   S  +E  ++++ + +  E    K+ 
Sbjct: 187 NKFSIKSDVWAFGVLLWEIATYGMSPYPGIDL---SQVYE-LLEKDYRMERPEGCPEKVY 242
Query: 653 KMALVCTHEDPENRPTMEAV 672
           ++   C   +P +RP+   +
Sbjct: 243 ELMRACWQWNPSDRPSFAEI 262

>pdb|3BBT|B Chain B, Crystal Structure Of The Erbb4 Kinase In Complex With Lapatinib Length = 328

Iteration: 1
 Score = 86.7 bits (213), Expect = 4e-17,   Method: Compositional matrix adjust.
 Identities = 62/212 (29%), Positives = 107/212 (50%), Gaps = 23/212 (10%)
Query: 411 FSEVNLLGKGNFSSVYKGT-LRDGTLV----AIRSINVTSCKSEEAEFVKGLYLLTSLRH 465
              V +LG G F +VYKG  + +G  V    AI+ +N T+      EF+    ++ S+ H
Sbjct: 17  LKRVKVLGSGAFGTVYKGIWVPEGETVKIPVAIKILNETTGPKANVEFMDEALIMASMDH 76
Query: 466 ENIIRLRGFCCSRGRGECFLIYDFAPKGKLSKYLDQEE---GSSNVLDWSTRVSIIIGIA 522
            +++RL G C S       L+    P G L +Y+ + +   GS  +L+W       + IA
Sbjct: 77  PHLVRLLGVCLS---PTIQLVTQLMPHGCLLEYVHEHKDNIGSQLLLNWC------VQIA 127
Query: 523 KGIGYLHSSEVNKPAIVHRNLSVEKVLIDQQFNPLIADCGLHKLL-ADDIVFSVLKTSAA 581
           KG+ YL         +VHR+L+   VL+    +  I D GL +LL  D+  ++       
Sbjct: 128 KGMMYLEERR-----LVHRDLAARNVLVKSPNHVKITDFGLARLLEGDEKEYNADGGKMP 182
Query: 582 MGYLAPEYVTTGRFTERSDIFAFGVIILQILT 613
           + ++A E +   +FT +SD++++GV I +++T
Sbjct: 183 IKWMALECIHYRKFTHQSDVWSYGVTIWELMT 214

>pdb|2QOH|A Chain A, Crystal Structure Of Abl Kinase Bound With Ppy-a Length = 288

Iteration: 1
 Score = 86.7 bits (213), Expect = 4e-17,   Method: Compositional matrix adjust.
 Identities = 63/260 (24%), Positives = 128/260 (49%), Gaps = 22/260 (8%)
Query: 417 LGKGNFSSVYKGTLRDGTL-VAIRSINVTSCKSEEAEFVKGLYLLTSLRHENIIRLRGFC 475
           LG G +  VY+G  +  +L VA++++   + + EE  F+K   ++  ++H N+++L G C
Sbjct: 21  LGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVEE--FLKEAAVMKEIKHPNLVQLLGVC 78
Query: 476 CSRGRGECFLIYDFAPKGKLSKYL---DQEEGSSNVLDWSTRVSIIIGIAKGIGYLHSSE 532
                   ++I +F   G L  YL   +++E S+ VL     + +   I+  + YL    
Sbjct: 79  TREP--PFYIITEFMTYGNLLDYLRECNRQEVSAVVL-----LYMATQISSAMEYL---- 127
Query: 533 VNKPAIVHRNLSVEKVLIDQQFNPLIADCGLHKLLADDIVFSVLKTSAAMGYLAPEYVTT 592
             K   +HR+L+    L+ +     +AD GL +L+  D   +       + + APE +  
Sbjct: 128 -EKKNFIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHAGAKFPIKWTAPESLAY 186
Query: 593 GRFTERSDIFAFGVIILQILTGSLVLTSSMRLAAESATFENFIDRNLKGKFSESEAAKLG 652
            +F+ +SD++AFGV++ +I T  +     + L   S  +E  ++++ + +  E    K+ 
Sbjct: 187 NKFSIKSDVWAFGVLLWEIATYGMSPYPGIDL---SQVYE-LLEKDYRMERPEGCPEKVY 242
Query: 653 KMALVCTHEDPENRPTMEAV 672
           ++   C   +P +RP+   +
Sbjct: 243 ELMRACWQWNPSDRPSFAEI 262

>pdb|3OY3|A Chain A, Crystal Structure Of Abl T315i Mutant Kinase Domain Bound With A Dfg- Out Inhibitor Ap24589 Length = 284

Iteration: 1
 Score = 86.7 bits (213), Expect = 4e-17,   Method: Compositional matrix adjust.
 Identities = 63/260 (24%), Positives = 128/260 (49%), Gaps = 22/260 (8%)
Query: 417 LGKGNFSSVYKGTLRDGTL-VAIRSINVTSCKSEEAEFVKGLYLLTSLRHENIIRLRGFC 475
           LG G +  VY+G  +  +L VA++++   + + EE  F+K   ++  ++H N+++L G C
Sbjct: 21  LGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVEE--FLKEAAVMKEIKHPNLVQLLGVC 78
Query: 476 CSRGRGECFLIYDFAPKGKLSKYL---DQEEGSSNVLDWSTRVSIIIGIAKGIGYLHSSE 532
                   ++I +F   G L  YL   +++E S+ VL     + +   I+  + YL    
Sbjct: 79  TREP--PFYIIIEFMTYGNLLDYLRECNRQEVSAVVL-----LYMATQISSAMEYL---- 127
Query: 533 VNKPAIVHRNLSVEKVLIDQQFNPLIADCGLHKLLADDIVFSVLKTSAAMGYLAPEYVTT 592
             K   +HR+L+    L+ +     +AD GL +L+  D   +       + + APE +  
Sbjct: 128 -EKKNFIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHAGAKFPIKWTAPESLAY 186
Query: 593 GRFTERSDIFAFGVIILQILTGSLVLTSSMRLAAESATFENFIDRNLKGKFSESEAAKLG 652
            +F+ +SD++AFGV++ +I T  +     + L   S  +E  ++++ + +  E    K+ 
Sbjct: 187 NKFSIKSDVWAFGVLLWEIATYGMSPYPGIDL---SQVYE-LLEKDYRMERPEGCPEKVY 242
Query: 653 KMALVCTHEDPENRPTMEAV 672
           ++   C   +P +RP+   +
Sbjct: 243 ELMRACWQWNPSDRPSFAEI 262

>pdb|3DK6|A Chain A, Crystal Structure Of Mutant Abl Kinase Domain In Complex With Small Molecule Fragment Length = 293

Iteration: 1
 Score = 85.9 bits (211), Expect = 6e-17,   Method: Compositional matrix adjust.
 Identities = 62/260 (23%), Positives = 126/260 (48%), Gaps = 22/260 (8%)
Query: 417 LGKGNFSSVYKGTLRDGTL-VAIRSINVTSCKSEEAEFVKGLYLLTSLRHENIIRLRGFC 475
           LG G F  VY+G  +  +L VA++++   + + EE  F+K   ++  ++H N+++L G C
Sbjct: 19  LGGGQFGEVYEGVWKKYSLTVAVKTLKEDTMEVEE--FLKEAAVMKEIKHPNLVQLLGVC 76
Query: 476 CSRGRGECFLIYDFAPKGKLSKYL---DQEEGSSNVLDWSTRVSIIIGIAKGIGYLHSSE 532
                   ++I +F   G L  YL   +++E S+ VL     + +   I+  + YL    
Sbjct: 77  TREP--PFYIITEFMTYGNLLDYLRECNRQEVSAVVL-----LYMATQISSAMEYL---- 125
Query: 533 VNKPAIVHRNLSVEKVLIDQQFNPLIADCGLHKLLADDIVFSVLKTSAAMGYLAPEYVTT 592
             K   +HR+L+    L+ +     +AD GL +L+  D   +       + + APE +  
Sbjct: 126 -EKKNFIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTXTAHAGAKFPIKWTAPESLAY 184
Query: 593 GRFTERSDIFAFGVIILQILTGSLVLTSSMRLAAESATFENFIDRNLKGKFSESEAAKLG 652
            +F+ +SD++AFGV++ +I T  +    S     + +     ++++ + +  E    K+ 
Sbjct: 185 NKFSIKSDVWAFGVLLWEIATYGM----SPYPGIDPSQVYELLEKDYRMERPEGCPEKVY 240
Query: 653 KMALVCTHEDPENRPTMEAV 672
           ++   C   +P +RP+   +
Sbjct: 241 ELMRACWQWNPSDRPSFAEI 260

>pdb|3QRJ|A Chain A, The Crystal Structure Of Human Abl1 Kinase Domain T315i Mutant In Complex With Dcc-2036 Length = 277

Iteration: 1
 Score = 85.9 bits (211), Expect = 7e-17,   Method: Compositional matrix adjust.
 Identities = 62/260 (23%), Positives = 128/260 (49%), Gaps = 22/260 (8%)
Query: 417 LGKGNFSSVYKGTLRDGTL-VAIRSINVTSCKSEEAEFVKGLYLLTSLRHENIIRLRGFC 475
           LG G +  VY+G  +  +L VA++++   + + EE  F+K   ++  ++H N+++L G C
Sbjct: 26  LGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVEE--FLKEAAVMKEIKHPNLVQLLGVC 83
Query: 476 CSRGRGECFLIYDFAPKGKLSKYL---DQEEGSSNVLDWSTRVSIIIGIAKGIGYLHSSE 532
                   ++I +F   G L  YL   +++E ++ VL     + +   I+  + YL    
Sbjct: 84  TREP--PFYIIIEFMTYGNLLDYLRECNRQEVNAVVL-----LYMATQISSAMEYL---- 132
Query: 533 VNKPAIVHRNLSVEKVLIDQQFNPLIADCGLHKLLADDIVFSVLKTSAAMGYLAPEYVTT 592
             K   +HR+L+    L+ +     +AD GL +L+  D   +       + + APE +  
Sbjct: 133 -EKKNFIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHAGAKFPIKWTAPESLAY 191
Query: 593 GRFTERSDIFAFGVIILQILTGSLVLTSSMRLAAESATFENFIDRNLKGKFSESEAAKLG 652
            +F+ +SD++AFGV++ +I T  +     + L   S  +E  ++++ + +  E    K+ 
Sbjct: 192 NKFSIKSDVWAFGVLLWEIATYGMSPYPGIDL---SQVYE-LLEKDYRMERPEGCPEKVY 247
Query: 653 KMALVCTHEDPENRPTMEAV 672
           ++   C   +P +RP+   +
Sbjct: 248 ELMRACWQWNPSDRPSFAEI 267

>pdb|3QRI|A Chain A, The Crystal Structure Of Human Abl1 Kinase Domain In Complex With Dcc- 2036 Length = 277

Iteration: 1
 Score = 85.9 bits (211), Expect = 7e-17,   Method: Compositional matrix adjust.
 Identities = 62/260 (23%), Positives = 128/260 (49%), Gaps = 22/260 (8%)
Query: 417 LGKGNFSSVYKGTLRDGTL-VAIRSINVTSCKSEEAEFVKGLYLLTSLRHENIIRLRGFC 475
           LG G +  VY+G  +  +L VA++++   + + EE  F+K   ++  ++H N+++L G C
Sbjct: 26  LGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVEE--FLKEAAVMKEIKHPNLVQLLGVC 83
Query: 476 CSRGRGECFLIYDFAPKGKLSKYL---DQEEGSSNVLDWSTRVSIIIGIAKGIGYLHSSE 532
                   ++I +F   G L  YL   +++E ++ VL     + +   I+  + YL    
Sbjct: 84  TREP--PFYIITEFMTYGNLLDYLRECNRQEVNAVVL-----LYMATQISSAMEYL---- 132
Query: 533 VNKPAIVHRNLSVEKVLIDQQFNPLIADCGLHKLLADDIVFSVLKTSAAMGYLAPEYVTT 592
             K   +HR+L+    L+ +     +AD GL +L+  D   +       + + APE +  
Sbjct: 133 -EKKNFIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHAGAKFPIKWTAPESLAY 191
Query: 593 GRFTERSDIFAFGVIILQILTGSLVLTSSMRLAAESATFENFIDRNLKGKFSESEAAKLG 652
            +F+ +SD++AFGV++ +I T  +     + L   S  +E  ++++ + +  E    K+ 
Sbjct: 192 NKFSIKSDVWAFGVLLWEIATYGMSPYPGIDL---SQVYE-LLEKDYRMERPEGCPEKVY 247
Query: 653 KMALVCTHEDPENRPTMEAV 672
           ++   C   +P +RP+   +
Sbjct: 248 ELMRACWQWNPSDRPSFAEI 267

>pdb|2G2F|A Chain A, A Src-Like Inactive Conformation In The Abl Tyrosine Kinase Domain Length = 287

Iteration: 1
 Score = 85.9 bits (211), Expect = 7e-17,   Method: Compositional matrix adjust.
 Identities = 62/260 (23%), Positives = 128/260 (49%), Gaps = 22/260 (8%)
Query: 417 LGKGNFSSVYKGTLRDGTL-VAIRSINVTSCKSEEAEFVKGLYLLTSLRHENIIRLRGFC 475
           LG G +  VY+G  +  +L VA++++   + + EE  F+K   ++  ++H N+++L G C
Sbjct: 23  LGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVEE--FLKEAAVMKEIKHPNLVQLLGVC 80
Query: 476 CSRGRGECFLIYDFAPKGKLSKYL---DQEEGSSNVLDWSTRVSIIIGIAKGIGYLHSSE 532
                   ++I +F   G L  YL   +++E ++ VL     + +   I+  + YL    
Sbjct: 81  TREP--PFYIITEFMTYGNLLDYLRECNRQEVNAVVL-----LYMATQISSAMEYL---- 129
Query: 533 VNKPAIVHRNLSVEKVLIDQQFNPLIADCGLHKLLADDIVFSVLKTSAAMGYLAPEYVTT 592
             K   +HR+L+    L+ +     +AD GL +L+  D   +       + + APE +  
Sbjct: 130 -EKKNFIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTYTAPAGAKFPIKWTAPESLAY 188
Query: 593 GRFTERSDIFAFGVIILQILTGSLVLTSSMRLAAESATFENFIDRNLKGKFSESEAAKLG 652
            +F+ +SD++AFGV++ +I T  +     + L   S  +E  ++++ + +  E    K+ 
Sbjct: 189 NKFSIKSDVWAFGVLLWEIATYGMSPYPGIDL---SQVYE-LLEKDYRMERPEGCPEKVY 244
Query: 653 KMALVCTHEDPENRPTMEAV 672
           ++   C   +P +RP+   +
Sbjct: 245 ELMRACWQWNPSDRPSFAEI 264

>pdb|2F4J|A Chain A, Structure Of The Kinase Domain Of An Imatinib-Resistant Abl Mutant In Complex With The Aurora Kinase Inhibitor Vx-680 Length = 287

Iteration: 1
 Score = 85.9 bits (211), Expect = 7e-17,   Method: Compositional matrix adjust.
 Identities = 62/260 (23%), Positives = 128/260 (49%), Gaps = 22/260 (8%)
Query: 417 LGKGNFSSVYKGTLRDGTL-VAIRSINVTSCKSEEAEFVKGLYLLTSLRHENIIRLRGFC 475
           LG G +  VY+G  +  +L VA++++   + + EE  F+K   ++  ++H N+++L G C
Sbjct: 22  LGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVEE--FLKEAAVMKEIKHPNLVQLLGVC 79
Query: 476 CSRGRGECFLIYDFAPKGKLSKYL---DQEEGSSNVLDWSTRVSIIIGIAKGIGYLHSSE 532
                   ++I +F   G L  YL   +++E ++ VL     + +   I+  + YL    
Sbjct: 80  TREP--PFYIITEFMTYGNLLDYLRECNRQEVNAVVL-----LYMATQISSAMEYL---- 128
Query: 533 VNKPAIVHRNLSVEKVLIDQQFNPLIADCGLHKLLADDIVFSVLKTSAAMGYLAPEYVTT 592
             K   +HR+L+    L+ +     +AD GL +L+  D   +       + + APE +  
Sbjct: 129 -EKKNFIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTYTAPAGAKFPIKWTAPESLAY 187
Query: 593 GRFTERSDIFAFGVIILQILTGSLVLTSSMRLAAESATFENFIDRNLKGKFSESEAAKLG 652
            +F+ +SD++AFGV++ +I T  +     + L   S  +E  ++++ + +  E    K+ 
Sbjct: 188 NKFSIKSDVWAFGVLLWEIATYGMSPYPGIDL---SQVYE-LLEKDYRMERPEGCPEKVY 243
Query: 653 KMALVCTHEDPENRPTMEAV 672
           ++   C   +P +RP+   +
Sbjct: 244 ELMRACWQWNPSDRPSFAEI 263

>pdb|3CD3|A Chain A, Crystal Structure Of Phosphorylated Human Feline Sarcoma Viral Oncogene Homologue (V-Fes) In Complex With Staurosporine And A Consensus Peptide Length = 377

Iteration: 1
 Score = 85.9 bits (211), Expect = 8e-17,   Method: Compositional matrix adjust.
 Identities = 64/262 (24%), Positives = 121/262 (46%), Gaps = 16/262 (6%)
Query: 417 LGKGNFSSVYKGTLR-DGTLVAIRSINVTSCKSEEAEFVKGLYLLTSLRHENIIRLRGFC 475
           +G+GNF  V+ G LR D TLVA++S   T     +A+F++   +L    H NI+RL G C
Sbjct: 122 IGRGNFGEVFSGRLRADNTLVAVKSCRETLPPDLKAKFLQEARILKQYSHPNIVRLIGVC 181
Query: 476 CSRGRGECFLIYDFAPKGKLSKYLDQEEGSSNVLDWSTRVSIIIGIAKGIGYLHSSEVNK 535
               +   +++ +    G    +L  E     V    T + ++   A G+ YL S     
Sbjct: 182 TQ--KQPIYIVMELVQGGDFLTFLRTEGARLRV---KTLLQMVGDAAAGMEYLESK---- 232
Query: 536 PAIVHRNLSVEKVLIDQQFNPLIADCGLHKLLADDI-VFSVLKTSAAMGYLAPEYVTTGR 594
              +HR+L+    L+ ++    I+D G+ +  AD +   S       + + APE +  GR
Sbjct: 233 -CCIHRDLAARNCLVTEKNVLKISDFGMSREEADGVXAASGGLRQVPVKWTAPEALNYGR 291
Query: 595 FTERSDIFAFGVIILQILTGSLVLTSSMRLAAESATFENFIDRNLKGKFSESEAAKLGKM 654
           ++  SD+++FG+++ +  +    L +S      +     F+++  +    E     + ++
Sbjct: 292 YSSESDVWSFGILLWETFS----LGASPYPNLSNQQTREFVEKGGRLPCPELCPDAVFRL 347
Query: 655 ALVCTHEDPENRPTMEAVIEEL 676
              C   +P  RP+   + +EL
Sbjct: 348 MEQCWAYEPGQRPSFSTIYQEL 369

>pdb|2E2B|A Chain A, Crystal Structure Of The C-Abl Kinase Domain In Complex With Inno-406 Length = 293

Iteration: 1
 Score = 85.9 bits (211), Expect = 8e-17,   Method: Compositional matrix adjust.
 Identities = 62/260 (23%), Positives = 128/260 (49%), Gaps = 22/260 (8%)
Query: 417 LGKGNFSSVYKGTLRDGTL-VAIRSINVTSCKSEEAEFVKGLYLLTSLRHENIIRLRGFC 475
           LG G +  VY+G  +  +L VA++++   + + EE  F+K   ++  ++H N+++L G C
Sbjct: 26  LGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVEE--FLKEAAVMKEIKHPNLVQLLGVC 83
Query: 476 CSRGRGECFLIYDFAPKGKLSKYL---DQEEGSSNVLDWSTRVSIIIGIAKGIGYLHSSE 532
                   ++I +F   G L  YL   +++E ++ VL     + +   I+  + YL    
Sbjct: 84  TREP--PFYIITEFMTYGNLLDYLRECNRQEVNAVVL-----LYMATQISSAMEYL---- 132
Query: 533 VNKPAIVHRNLSVEKVLIDQQFNPLIADCGLHKLLADDIVFSVLKTSAAMGYLAPEYVTT 592
             K   +HR+L+    L+ +     +AD GL +L+  D   +       + + APE +  
Sbjct: 133 -EKKNFIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHAGAKFPIKWTAPESLAY 191
Query: 593 GRFTERSDIFAFGVIILQILTGSLVLTSSMRLAAESATFENFIDRNLKGKFSESEAAKLG 652
            +F+ +SD++AFGV++ +I T  +     + L   S  +E  ++++ + +  E    K+ 
Sbjct: 192 NKFSIKSDVWAFGVLLWEIATYGMSPYPGIDL---SQVYE-LLEKDYRMERPEGCPEKVY 247
Query: 653 KMALVCTHEDPENRPTMEAV 672
           ++   C   +P +RP+   +
Sbjct: 248 ELMRACWQWNPSDRPSFAEI 267

>pdb|3BKB|A Chain A, Crystal Structure Of Human Feline Sarcoma Viral Oncogene Homologue (V- Fes) Length = 377

Iteration: 1
 Score = 85.5 bits (210), Expect = 8e-17,   Method: Compositional matrix adjust.
 Identities = 66/262 (25%), Positives = 123/262 (46%), Gaps = 16/262 (6%)
Query: 417 LGKGNFSSVYKGTLR-DGTLVAIRSINVTSCKSEEAEFVKGLYLLTSLRHENIIRLRGFC 475
           +G+GNF  V+ G LR D TLVA++S   T     +A+F++   +L    H NI+RL G C
Sbjct: 122 IGRGNFGEVFSGRLRADNTLVAVKSCRETLPPDLKAKFLQEARILKQYSHPNIVRLIGVC 181
Query: 476 CSRGRGECFLIYDFAPKGKLSKYLDQEEGSSNVLDWSTRVSIIIGIAKGIGYLHSSEVNK 535
               +   +++ +    G    +L  E     V    T + ++   A G+ YL S     
Sbjct: 182 TQ--KQPIYIVMELVQGGDFLTFLRTEGARLRV---KTLLQMVGDAAAGMEYLESK---- 232
Query: 536 PAIVHRNLSVEKVLIDQQFNPLIADCGLHKLLADDI-VFSVLKTSAAMGYLAPEYVTTGR 594
              +HR+L+    L+ ++    I+D G+ +  AD +   S       + + APE +  GR
Sbjct: 233 -CCIHRDLAARNCLVTEKNVLKISDFGMSREEADGVYAASGGLRQVPVKWTAPEALNYGR 291
Query: 595 FTERSDIFAFGVIILQILTGSLVLTSSMRLAAESATFENFIDRNLKGKFSESEAAKLGKM 654
           ++  SD+++FG+++ +  T SL  +    L+ +      F+++  +    E     + ++
Sbjct: 292 YSSESDVWSFGILLWE--TFSLGASPYPNLSNQQT--REFVEKGGRLPCPELCPDAVFRL 347
Query: 655 ALVCTHEDPENRPTMEAVIEEL 676
              C   +P  RP+   + +EL
Sbjct: 348 MEQCWAYEPGQRPSFSTIYQEL 369

>pdb|2V7A|A Chain A, Crystal Structure Of The T315i Abl Mutant In Complex With The Inhibitor Pha-739358 Length = 286

Iteration: 1
 Score = 85.5 bits (210), Expect = 8e-17,   Method: Compositional matrix adjust.
 Identities = 62/260 (23%), Positives = 128/260 (49%), Gaps = 22/260 (8%)
Query: 417 LGKGNFSSVYKGTLRDGTL-VAIRSINVTSCKSEEAEFVKGLYLLTSLRHENIIRLRGFC 475
           LG G +  VY+G  +  +L VA++++   + + EE  F+K   ++  ++H N+++L G C
Sbjct: 22  LGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVEE--FLKEAAVMKEIKHPNLVQLLGVC 79
Query: 476 CSRGRGECFLIYDFAPKGKLSKYL---DQEEGSSNVLDWSTRVSIIIGIAKGIGYLHSSE 532
                   ++I +F   G L  YL   +++E ++ VL     + +   I+  + YL    
Sbjct: 80  TREP--PFYIIIEFMTYGNLLDYLRECNRQEVNAVVL-----LYMATQISSAMEYL---- 128
Query: 533 VNKPAIVHRNLSVEKVLIDQQFNPLIADCGLHKLLADDIVFSVLKTSAAMGYLAPEYVTT 592
             K   +HR+L+    L+ +     +AD GL +L+  D   +       + + APE +  
Sbjct: 129 -EKKNFIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTXTAHAGAKFPIKWTAPESLAY 187
Query: 593 GRFTERSDIFAFGVIILQILTGSLVLTSSMRLAAESATFENFIDRNLKGKFSESEAAKLG 652
            +F+ +SD++AFGV++ +I T  +     + L   S  +E  ++++ + +  E    K+ 
Sbjct: 188 NKFSIKSDVWAFGVLLWEIATYGMSPYPGIDL---SQVYE-LLEKDYRMERPEGCPEKVY 243
Query: 653 KMALVCTHEDPENRPTMEAV 672
           ++   C   +P +RP+   +
Sbjct: 244 ELMRACWQWNPSDRPSFAEI 263

>pdb|2GQG|A Chain A, X-Ray Crystal Structure Of Dasatinib (Bms-354825) Bound To Activated Abl Kinase Domain Length = 278

Iteration: 1
 Score = 85.5 bits (210), Expect = 8e-17,   Method: Compositional matrix adjust.
 Identities = 62/260 (23%), Positives = 128/260 (49%), Gaps = 22/260 (8%)
Query: 417 LGKGNFSSVYKGTLRDGTL-VAIRSINVTSCKSEEAEFVKGLYLLTSLRHENIIRLRGFC 475
           LG G +  VY+G  +  +L VA++++   + + EE  F+K   ++  ++H N+++L G C
Sbjct: 26  LGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVEE--FLKEAAVMKEIKHPNLVQLLGVC 83
Query: 476 CSRGRGECFLIYDFAPKGKLSKYL---DQEEGSSNVLDWSTRVSIIIGIAKGIGYLHSSE 532
                   ++I +F   G L  YL   +++E ++ VL     + +   I+  + YL    
Sbjct: 84  TREP--PFYIITEFMTYGNLLDYLRECNRQEVNAVVL-----LYMATQISSAMEYL---- 132
Query: 533 VNKPAIVHRNLSVEKVLIDQQFNPLIADCGLHKLLADDIVFSVLKTSAAMGYLAPEYVTT 592
             K   +HR+L+    L+ +     +AD GL +L+  D   +       + + APE +  
Sbjct: 133 -EKKNFIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTXTAHAGAKFPIKWTAPESLAY 191
Query: 593 GRFTERSDIFAFGVIILQILTGSLVLTSSMRLAAESATFENFIDRNLKGKFSESEAAKLG 652
            +F+ +SD++AFGV++ +I T  +     + L   S  +E  ++++ + +  E    K+ 
Sbjct: 192 NKFSIKSDVWAFGVLLWEIATYGMSPYPGIDL---SQVYE-LLEKDYRMERPEGCPEKVY 247
Query: 653 KMALVCTHEDPENRPTMEAV 672
           ++   C   +P +RP+   +
Sbjct: 248 ELMRACWQWNPSDRPSFAEI 267

>pdb|2HZI|A Chain A, Abl Kinase Domain In Complex With Pd180970 Length = 277

Iteration: 1
 Score = 85.5 bits (210), Expect = 8e-17,   Method: Compositional matrix adjust.
 Identities = 62/260 (23%), Positives = 128/260 (49%), Gaps = 22/260 (8%)
Query: 417 LGKGNFSSVYKGTLRDGTL-VAIRSINVTSCKSEEAEFVKGLYLLTSLRHENIIRLRGFC 475
           LG G +  VY+G  +  +L VA++++   + + EE  F+K   ++  ++H N+++L G C
Sbjct: 25  LGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVEE--FLKEAAVMKEIKHPNLVQLLGVC 82
Query: 476 CSRGRGECFLIYDFAPKGKLSKYL---DQEEGSSNVLDWSTRVSIIIGIAKGIGYLHSSE 532
                   ++I +F   G L  YL   +++E ++ VL     + +   I+  + YL    
Sbjct: 83  TREP--PFYIITEFMTYGNLLDYLRECNRQEVNAVVL-----LYMATQISSAMEYL---- 131
Query: 533 VNKPAIVHRNLSVEKVLIDQQFNPLIADCGLHKLLADDIVFSVLKTSAAMGYLAPEYVTT 592
             K   +HR+L+    L+ +     +AD GL +L+  D   +       + + APE +  
Sbjct: 132 -EKKNFIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHAGAKFPIKWTAPESLAY 190
Query: 593 GRFTERSDIFAFGVIILQILTGSLVLTSSMRLAAESATFENFIDRNLKGKFSESEAAKLG 652
            +F+ +SD++AFGV++ +I T  +     + L   S  +E  ++++ + +  E    K+ 
Sbjct: 191 NKFSIKSDVWAFGVLLWEIATYGMSPYPGIDL---SQVYE-LLEKDYRMERPEGCPEKVY 246
Query: 653 KMALVCTHEDPENRPTMEAV 672
           ++   C   +P +RP+   +
Sbjct: 247 ELMRACWQWNPSDRPSFAEI 266

>pdb|3DK7|A Chain A, Crystal Structure Of Mutant Abl Kinase Domain In Complex With Small Molecule Fragment Length = 277

Iteration: 1
 Score = 85.5 bits (210), Expect = 9e-17,   Method: Compositional matrix adjust.
 Identities = 61/260 (23%), Positives = 126/260 (48%), Gaps = 22/260 (8%)
Query: 417 LGKGNFSSVYKGTLRDGTL-VAIRSINVTSCKSEEAEFVKGLYLLTSLRHENIIRLRGFC 475
           LG G +  VY+G  +  +L VA++++   + + EE  F+K   ++  ++H N+++L G C
Sbjct: 19  LGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVEE--FLKEAAVMKEIKHPNLVQLLGVC 76
Query: 476 CSRGRGECFLIYDFAPKGKLSKYL---DQEEGSSNVLDWSTRVSIIIGIAKGIGYLHSSE 532
                   ++I +F   G L  YL   +++E S+ VL     + +   I+  + YL    
Sbjct: 77  TREP--PFYIIIEFMTYGNLLDYLRECNRQEVSAVVL-----LYMATQISSAMEYL---- 125
Query: 533 VNKPAIVHRNLSVEKVLIDQQFNPLIADCGLHKLLADDIVFSVLKTSAAMGYLAPEYVTT 592
             K   +HR+L+    L+ +     +AD GL +L+  D   +       + + APE +  
Sbjct: 126 -EKKNFIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTXTAHAGAKFPIKWTAPESLAY 184
Query: 593 GRFTERSDIFAFGVIILQILTGSLVLTSSMRLAAESATFENFIDRNLKGKFSESEAAKLG 652
            +F+ +SD++AFGV++ +I T  +    S     + +     ++++ + +  E    K+ 
Sbjct: 185 NKFSIKSDVWAFGVLLWEIATYGM----SPYPGIDPSQVYELLEKDYRMERPEGCPEKVY 240
Query: 653 KMALVCTHEDPENRPTMEAV 672
           ++   C   +P +RP+   +
Sbjct: 241 ELMRACWQWNPSDRPSFAEI 260

>pdb|2HZ0|A Chain A, Abl Kinase Domain In Complex With Nvp-Aeg082 Length = 270

Iteration: 1
 Score = 85.5 bits (210), Expect = 9e-17,   Method: Compositional matrix adjust.
 Identities = 62/260 (23%), Positives = 128/260 (49%), Gaps = 22/260 (8%)
Query: 417 LGKGNFSSVYKGTLRDGTL-VAIRSINVTSCKSEEAEFVKGLYLLTSLRHENIIRLRGFC 475
           LG G +  VY+G  +  +L VA++++   + + EE  F+K   ++  ++H N+++L G C
Sbjct: 21  LGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVEE--FLKEAAVMKEIKHPNLVQLLGVC 78
Query: 476 CSRGRGECFLIYDFAPKGKLSKYL---DQEEGSSNVLDWSTRVSIIIGIAKGIGYLHSSE 532
                   ++I +F   G L  YL   +++E ++ VL     + +   I+  + YL    
Sbjct: 79  TREP--PFYIITEFMTYGNLLDYLRECNRQEVNAVVL-----LYMATQISSAMEYL---- 127
Query: 533 VNKPAIVHRNLSVEKVLIDQQFNPLIADCGLHKLLADDIVFSVLKTSAAMGYLAPEYVTT 592
             K   +HR+L+    L+ +     +AD GL +L+  D   +       + + APE +  
Sbjct: 128 -EKKNFIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHAGAKFPIKWTAPESLAY 186
Query: 593 GRFTERSDIFAFGVIILQILTGSLVLTSSMRLAAESATFENFIDRNLKGKFSESEAAKLG 652
            +F+ +SD++AFGV++ +I T  +     + L   S  +E  ++++ + +  E    K+ 
Sbjct: 187 NKFSIKSDVWAFGVLLWEIATYGMSPYPGIDL---SQVYE-LLEKDYRMERPEGCPEKVY 242
Query: 653 KMALVCTHEDPENRPTMEAV 672
           ++   C   +P +RP+   +
Sbjct: 243 ELMRACWQWNPSDRPSFAEI 262

>pdb|2HIW|A Chain A, Crystal Structure Of Inactive Conformation Abl Kinase Catalytic Domain Complexed With Type Ii Inhibitor Length = 287

Iteration: 1
 Score = 85.5 bits (210), Expect = 9e-17,   Method: Compositional matrix adjust.
 Identities = 62/260 (23%), Positives = 128/260 (49%), Gaps = 22/260 (8%)
Query: 417 LGKGNFSSVYKGTLRDGTL-VAIRSINVTSCKSEEAEFVKGLYLLTSLRHENIIRLRGFC 475
           LG G +  VY+G  +  +L VA++++   + + EE  F+K   ++  ++H N+++L G C
Sbjct: 23  LGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVEE--FLKEAAVMKEIKHPNLVQLLGVC 80
Query: 476 CSRGRGECFLIYDFAPKGKLSKYL---DQEEGSSNVLDWSTRVSIIIGIAKGIGYLHSSE 532
                   ++I +F   G L  YL   +++E ++ VL     + +   I+  + YL    
Sbjct: 81  TREP--PFYIITEFMTYGNLLDYLRECNRQEVNAVVL-----LYMATQISSAMEYL---- 129
Query: 533 VNKPAIVHRNLSVEKVLIDQQFNPLIADCGLHKLLADDIVFSVLKTSAAMGYLAPEYVTT 592
             K   +HR+L+    L+ +     +AD GL +L+  D   +       + + APE +  
Sbjct: 130 -EKKNFIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHAGAKFPIKWTAPESLAY 188
Query: 593 GRFTERSDIFAFGVIILQILTGSLVLTSSMRLAAESATFENFIDRNLKGKFSESEAAKLG 652
            +F+ +SD++AFGV++ +I T  +     + L   S  +E  ++++ + +  E    K+ 
Sbjct: 189 NKFSIKSDVWAFGVLLWEIATYGMSPYPGIDL---SQVYE-LLEKDYRMERPEGCPEKVY 244
Query: 653 KMALVCTHEDPENRPTMEAV 672
           ++   C   +P +RP+   +
Sbjct: 245 ELMRACWQWNPSDRPSFAEI 264

>pdb|2G1T|A Chain A, A Src-Like Inactive Conformation In The Abl Tyrosine Kinase Domain Length = 287

Iteration: 1
 Score = 85.5 bits (210), Expect = 9e-17,   Method: Compositional matrix adjust.
 Identities = 62/260 (23%), Positives = 128/260 (49%), Gaps = 22/260 (8%)
Query: 417 LGKGNFSSVYKGTLRDGTL-VAIRSINVTSCKSEEAEFVKGLYLLTSLRHENIIRLRGFC 475
           LG G +  VY+G  +  +L VA++++   + + EE  F+K   ++  ++H N+++L G C
Sbjct: 23  LGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVEE--FLKEAAVMKEIKHPNLVQLLGVC 80
Query: 476 CSRGRGECFLIYDFAPKGKLSKYL---DQEEGSSNVLDWSTRVSIIIGIAKGIGYLHSSE 532
                   ++I +F   G L  YL   +++E ++ VL     + +   I+  + YL    
Sbjct: 81  TREP--PFYIITEFMTYGNLLDYLRECNRQEVNAVVL-----LYMATQISSAMEYL---- 129
Query: 533 VNKPAIVHRNLSVEKVLIDQQFNPLIADCGLHKLLADDIVFSVLKTSAAMGYLAPEYVTT 592
             K   +HR+L+    L+ +     +AD GL +L+  D   +       + + APE +  
Sbjct: 130 -EKKNFIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHAGAKFPIKWTAPESLAY 188
Query: 593 GRFTERSDIFAFGVIILQILTGSLVLTSSMRLAAESATFENFIDRNLKGKFSESEAAKLG 652
            +F+ +SD++AFGV++ +I T  +     + L   S  +E  ++++ + +  E    K+ 
Sbjct: 189 NKFSIKSDVWAFGVLLWEIATYGMSPYPGIDL---SQVYE-LLEKDYRMERPEGCPEKVY 244
Query: 653 KMALVCTHEDPENRPTMEAV 672
           ++   C   +P +RP+   +
Sbjct: 245 ELMRACWQWNPSDRPSFAEI 264

>pdb|3PYY|A Chain A, Discovery And Characterization Of A Cell-Permeable, Small-Molecule C- Abl Kinase Activator That Binds To The Myristoyl Binding Site Length = 298

Iteration: 1
 Score = 85.1 bits (209), Expect = 1e-16,   Method: Compositional matrix adjust.
 Identities = 62/260 (23%), Positives = 128/260 (49%), Gaps = 22/260 (8%)
Query: 417 LGKGNFSSVYKGTLRDGTL-VAIRSINVTSCKSEEAEFVKGLYLLTSLRHENIIRLRGFC 475
           LG G +  VY+G  +  +L VA++++   + + EE  F+K   ++  ++H N+++L G C
Sbjct: 34  LGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVEE--FLKEAAVMKEIKHPNLVQLLGVC 91
Query: 476 CSRGRGECFLIYDFAPKGKLSKYL---DQEEGSSNVLDWSTRVSIIIGIAKGIGYLHSSE 532
                   ++I +F   G L  YL   +++E ++ VL     + +   I+  + YL    
Sbjct: 92  TREP--PFYIITEFMTYGNLLDYLRECNRQEVNAVVL-----LYMATQISSAMEYL---- 140
Query: 533 VNKPAIVHRNLSVEKVLIDQQFNPLIADCGLHKLLADDIVFSVLKTSAAMGYLAPEYVTT 592
             K   +HR+L+    L+ +     +AD GL +L+  D   +       + + APE +  
Sbjct: 141 -EKKNFIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHAGAKFPIKWTAPESLAY 199
Query: 593 GRFTERSDIFAFGVIILQILTGSLVLTSSMRLAAESATFENFIDRNLKGKFSESEAAKLG 652
            +F+ +SD++AFGV++ +I T  +     + L   S  +E  ++++ + +  E    K+ 
Sbjct: 200 NKFSIKSDVWAFGVLLWEIATYGMSPYPGIDL---SQVYE-LLEKDYRMERPEGCPEKVY 255
Query: 653 KMALVCTHEDPENRPTMEAV 672
           ++   C   +P +RP+   +
Sbjct: 256 ELMRACWQWNPSDRPSFAEI 275

>pdb|2HYY|A Chain A, Human Abl Kinase Domain In Complex With Imatinib (Sti571, Glivec) Length = 273

Iteration: 1
 Score = 85.1 bits (209), Expect = 1e-16,   Method: Compositional matrix adjust.
 Identities = 62/260 (23%), Positives = 128/260 (49%), Gaps = 22/260 (8%)
Query: 417 LGKGNFSSVYKGTLRDGTL-VAIRSINVTSCKSEEAEFVKGLYLLTSLRHENIIRLRGFC 475
           LG G +  VY+G  +  +L VA++++   + + EE  F+K   ++  ++H N+++L G C
Sbjct: 21  LGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVEE--FLKEAAVMKEIKHPNLVQLLGVC 78
Query: 476 CSRGRGECFLIYDFAPKGKLSKYL---DQEEGSSNVLDWSTRVSIIIGIAKGIGYLHSSE 532
                   ++I +F   G L  YL   +++E ++ VL     + +   I+  + YL    
Sbjct: 79  TREP--PFYIITEFMTYGNLLDYLRECNRQEVNAVVL-----LYMATQISSAMEYL---- 127
Query: 533 VNKPAIVHRNLSVEKVLIDQQFNPLIADCGLHKLLADDIVFSVLKTSAAMGYLAPEYVTT 592
             K   +HR+L+    L+ +     +AD GL +L+  D   +       + + APE +  
Sbjct: 128 -EKKNFIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHAGAKFPIKWTAPESLAY 186
Query: 593 GRFTERSDIFAFGVIILQILTGSLVLTSSMRLAAESATFENFIDRNLKGKFSESEAAKLG 652
            +F+ +SD++AFGV++ +I T  +     + L   S  +E  ++++ + +  E    K+ 
Sbjct: 187 NKFSIKSDVWAFGVLLWEIATYGMSPYPGIDL---SQVYE-LLEKDYRMERPEGCPEKVY 242
Query: 653 KMALVCTHEDPENRPTMEAV 672
           ++   C   +P +RP+   +
Sbjct: 243 ELMRACWQWNPSDRPSFAEI 262

>pdb|3DK3|A Chain A, Crystal Structure Of Mutant Abl Kinase Domain In Complex With Small Molecule Fragment Length = 293

Iteration: 1
 Score = 85.1 bits (209), Expect = 1e-16,   Method: Compositional matrix adjust.
 Identities = 61/260 (23%), Positives = 126/260 (48%), Gaps = 22/260 (8%)
Query: 417 LGKGNFSSVYKGTLRDGTL-VAIRSINVTSCKSEEAEFVKGLYLLTSLRHENIIRLRGFC 475
           LG G +  VY+G  +  +L VA++++   + + EE  F+K   ++  ++H N+++L G C
Sbjct: 19  LGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVEE--FLKEAAVMKEIKHPNLVQLLGVC 76
Query: 476 CSRGRGECFLIYDFAPKGKLSKYL---DQEEGSSNVLDWSTRVSIIIGIAKGIGYLHSSE 532
                   ++I +F   G L  YL   +++E S+ VL     + +   I+  + YL    
Sbjct: 77  TREP--PFYIITEFMTYGNLLDYLRECNRQEVSAVVL-----LYMATQISSAMEYL---- 125
Query: 533 VNKPAIVHRNLSVEKVLIDQQFNPLIADCGLHKLLADDIVFSVLKTSAAMGYLAPEYVTT 592
             K   +HR+L+    L+ +     +AD GL +L+  D   +       + + APE +  
Sbjct: 126 -EKKNFIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTFTAHAGAKFPIKWTAPESLAY 184
Query: 593 GRFTERSDIFAFGVIILQILTGSLVLTSSMRLAAESATFENFIDRNLKGKFSESEAAKLG 652
            +F+ +SD++AFGV++ +I T  +    S     + +     ++++ + +  E    K+ 
Sbjct: 185 NKFSIKSDVWAFGVLLWEIATYGM----SPYPGIDPSQVYELLEKDYRMERPEGCPEKVY 240
Query: 653 KMALVCTHEDPENRPTMEAV 672
           ++   C   +P +RP+   +
Sbjct: 241 ELMRACWQWNPSDRPSFAEI 260

>pdb|3KUL|A Chain A, Kinase Domain Of Human Ephrin Type-A Receptor 8 (Epha8) Length = 325

Iteration: 1
 Score = 84.7 bits (208), Expect = 2e-16,   Method: Compositional matrix adjust.
 Identities = 68/305 (22%), Positives = 135/305 (44%), Gaps = 49/305 (16%)
Query: 386 GTGFSREHLNSFRLNLEEV----ESATQCFSEVNLLGKGNFSSVYKGTLRDGTLVAIRSI 441
           G  F+RE + + R+++E++    +S   C+  + + G+ +              VAI+++
Sbjct: 39  GRSFTRE-IEASRIHIEKIIGSGDSGEVCYGRLRVPGQRDVP------------VAIKAL 85
Query: 442 NVTSCKSEEAEFVKGLYLLTSLRHENIIRLRGFCCSRGRGECFLIYDFAPKGKLSKYLDQ 501
                + +  +F+    ++    H NIIRL G   +RGR    ++ ++   G L  +L  
Sbjct: 86  KAGYTERQRRDFLSEASIMGQFDHPNIIRLEG-VVTRGR-LAMIVTEYMENGSLDTFLRT 143
Query: 502 EEGSSNVLDWSTRVSIIIGIAKGIGYLHSSEVNKPAIVHRNLSVEKVLIDQQFNPLIADC 561
            +G   ++     V ++ G+  G+ YL     +    VHR+L+   VL+D      ++D 
Sbjct: 144 HDGQFTIMQL---VGMLRGVGAGMRYL-----SDLGYVHRDLAARNVLVDSNLVCKVSDF 195
Query: 562 GLHKLLAD--DIVFSVLKTSAAMGYLAPEYVTTGRFTERSDIFAFGVIILQILTGSLVLT 619
           GL ++L D  D  ++       + + APE +    F+  SD+++FGV++ ++        
Sbjct: 196 GLSRVLEDDPDAAYTTTGGKIPIRWTAPEAIAFRTFSSASDVWSFGVVMWEV-------- 247
Query: 620 SSMRLAAESATFENFIDRNLKGKFSESE--AAKLG------KMALVCTHEDPENRPTMEA 671
               LA     + N  +R++     E     A +G      ++ L C H+D   RP    
Sbjct: 248 ----LAYGERPYWNMTNRDVISSVEEGYRLPAPMGCPHALHQLMLDCWHKDRAQRPRFSQ 303
Query: 672 VIEEL 676
           ++  L
Sbjct: 304 IVSVL 308

>pdb|2ZV7|A Chain A, Lyn Tyrosine Kinase Domain, Apo Form Length = 279

Iteration: 1
 Score = 84.7 bits (208), Expect = 2e-16,   Method: Compositional matrix adjust.
 Identities = 66/270 (24%), Positives = 128/270 (47%), Gaps = 20/270 (7%)
Query: 414 VNLLGKGNFSSVYKGTLRDGTLVAIRSINVTSCKSEEAEFVKGLYLLTSLRHENIIRLRG 473
           V  LG G F  V+ G   + T VA++++   +   +   F++   L+ +L+H+ ++RL  
Sbjct: 17  VKKLGAGQFGEVWMGYYNNSTKVAVKTLKPGTMSVQA--FLEEANLMKTLQHDKLVRL-- 72
Query: 474 FCCSRGRGECFLIYDFAPKGKLSKYLDQEEGSSNVLDWSTRVSIIIGIAKGIGYLHSSEV 533
           +         ++I +F  KG L  +L  +EG   +L     +     IA+G+ Y     +
Sbjct: 73  YAVVTKEEPIYIITEFMAKGSLLDFLKSDEGGKVLL--PKLIDFSAQIAEGMAY-----I 125
Query: 534 NKPAIVHRNLSVEKVLIDQQFNPLIADCGLHKLLADDIVFSVLKTSAAMGYLAPEYVTTG 593
            +   +HR+L    VL+ +     IAD GL +++ D+   +       + + APE +  G
Sbjct: 126 ERKNYIHRDLRAANVLVSESLMCKIADFGLARVIEDNEYTAREGAKFPIKWTAPEAINFG 185
Query: 594 RFTERSDIFAFGVIILQILT-GSLVLTSSMRLAAESATFENFIDRNLKGKFSESEAAKLG 652
            FT +S++++FG+++ +I+T G +           SA  + +  R  + +    E   + 
Sbjct: 186 CFTIKSNVWSFGILLYEIVTYGKIPYPGRTNADVMSALSQGY--RMPRMENCPDELYDIM 243
Query: 653 KMALVCTHEDPENRPT---MEAVIEELTVA 679
           KM   C  E  E RPT   +++V+++   A
Sbjct: 244 KM---CWKEKAEERPTFDYLQSVLDDFYTA 270

>pdb|3A4O|X Chain X, Lyn Kinase Domain Length = 286

Iteration: 1
 Score = 84.0 bits (206), Expect = 2e-16,   Method: Compositional matrix adjust.
 Identities = 65/270 (24%), Positives = 128/270 (47%), Gaps = 20/270 (7%)
Query: 414 VNLLGKGNFSSVYKGTLRDGTLVAIRSINVTSCKSEEAEFVKGLYLLTSLRHENIIRLRG 473
           V  LG G F  V+ G   + T VA++++   +   +   F++   L+ +L+H+ ++RL  
Sbjct: 18  VKRLGAGQFGEVWMGYYNNSTKVAVKTLKPGTMSVQA--FLEEANLMKTLQHDKLVRL-- 73
Query: 474 FCCSRGRGECFLIYDFAPKGKLSKYLDQEEGSSNVLDWSTRVSIIIGIAKGIGYLHSSEV 533
           +         ++I ++  KG L  +L  +EG   +L     +     IA+G+ Y     +
Sbjct: 74  YAVVTREEPIYIITEYMAKGSLLDFLKSDEGGKVLL--PKLIDFSAQIAEGMAY-----I 126
Query: 534 NKPAIVHRNLSVEKVLIDQQFNPLIADCGLHKLLADDIVFSVLKTSAAMGYLAPEYVTTG 593
            +   +HR+L    VL+ +     IAD GL +++ D+   +       + + APE +  G
Sbjct: 127 ERKNYIHRDLRAANVLVSESLMCKIADFGLARVIEDNEYTAREGAKFPIKWTAPEAINFG 186
Query: 594 RFTERSDIFAFGVIILQILT-GSLVLTSSMRLAAESATFENFIDRNLKGKFSESEAAKLG 652
            FT +SD+++FG+++ +I+T G +           +A  + +  R  + +    E   + 
Sbjct: 187 CFTIKSDVWSFGILLYEIVTYGKIPYPGRTNADVMTALSQGY--RMPRVENCPDELYDIM 244
Query: 653 KMALVCTHEDPENRPT---MEAVIEELTVA 679
           KM   C  E  E RPT   +++V+++   A
Sbjct: 245 KM---CWKEKAEERPTFDYLQSVLDDFYTA 271

>pdb|3DTC|A Chain A, Crystal Structure Of Mixed-Lineage Kinase Mlk1 Complexed With Compound 16 Length = 271

Iteration: 1
 Score = 84.0 bits (206), Expect = 3e-16,   Method: Compositional matrix adjust.
 Identities = 75/288 (26%), Positives = 132/288 (45%), Gaps = 30/288 (10%)
Query: 401 LEEVESATQCFSEVNLLGKGNFSSVYKGTLRDGTLVAIRSINVTSCK--SEEAEFVKG-L 457
           L E++ A     E+  +G G F  VY+     G  VA+++      +  S+  E V+   
Sbjct: 1   LLEIDFAELTLEEI--IGIGGFGKVYRA-FWIGDEVAVKAARHDPDEDISQTIENVRQEA 57
Query: 458 YLLTSLRHENIIRLRGFCCSRGRGECFLIYDFAPKGKLSKYLDQEEGSSNVLDWSTRVSI 517
            L   L+H NII LRG C         L+ +FA  G L++ L  +    ++L     V+ 
Sbjct: 58  KLFAMLKHPNIIALRGVCLKEP--NLCLVMEFARGGPLNRVLSGKRIPPDIL-----VNW 110
Query: 518 IIGIAKGIGYLHSSEVNKPAIVHRNLSVEKVLIDQQF------NPL--IADCGLHKLLAD 569
            + IA+G+ YLH   +    I+HR+L    +LI Q+       N +  I D GL +    
Sbjct: 111 AVQIARGMNYLHDEAIV--PIIHRDLKSSNILILQKVENGDLSNKILKITDFGLAREWHR 168
Query: 570 DIVFSVLKTSAAMGYLAPEYVTTGRFTERSDIFAFGVIILQILTGSLVLTSSMRLAAESA 629
               + +  + A  ++APE +    F++ SD++++GV++ ++LTG +       LA    
Sbjct: 169 T---TKMSAAGAYAWMAPEVIRASMFSKGSDVWSYGVLLWELLTGEVPFRGIDGLAVAYG 225
Query: 630 TFENFIDRNLKGKFSESEAAKLGKMALVCTHEDPENRPTMEAVIEELT 677
              N +   +     E       K+   C + DP +RP+   ++++LT
Sbjct: 226 VAMNKLALPIPSTCPEP----FAKLMEDCWNPDPHSRPSFTNILDQLT 269

>pdb|3KUL|B Chain B, Kinase Domain Of Human Ephrin Type-A Receptor 8 (Epha8) Length = 325

Iteration: 1
 Score = 84.0 bits (206), Expect = 3e-16,   Method: Compositional matrix adjust.
 Identities = 69/305 (22%), Positives = 135/305 (44%), Gaps = 49/305 (16%)
Query: 386 GTGFSREHLNSFRLNLEEV----ESATQCFSEVNLLGKGNFSSVYKGTLRDGTLVAIRSI 441
           G  F+RE + + R+++E++    +S   C+  + + G+ +              VAI+++
Sbjct: 39  GRSFTRE-IEASRIHIEKIIGSGDSGEVCYGRLRVPGQRDVP------------VAIKAL 85
Query: 442 NVTSCKSEEAEFVKGLYLLTSLRHENIIRLRGFCCSRGRGECFLIYDFAPKGKLSKYLDQ 501
                + +  +F+    ++    H NIIRL G   +RGR    ++ ++   G L  +L  
Sbjct: 86  KAGYTERQRRDFLSEASIMGQFDHPNIIRLEG-VVTRGR-LAMIVTEYMENGSLDTFLRT 143
Query: 502 EEGSSNVLDWSTRVSIIIGIAKGIGYLHSSEVNKPAIVHRNLSVEKVLIDQQFNPLIADC 561
            +G   ++     V ++ G+  G+ YL     +    VHR+L+   VL+D      ++D 
Sbjct: 144 HDGQFTIMQL---VGMLRGVGAGMRYL-----SDLGYVHRDLAARNVLVDSNLVCKVSDF 195
Query: 562 GLHKLLADDIVFSVLKTSAAMG--YLAPEYVTTGRFTERSDIFAFGVIILQILTGSLVLT 619
           GL ++L DD   +   T   +   + APE +    F+  SD+++FGV++ ++        
Sbjct: 196 GLSRVLEDDPDAAXTTTGGKIPIRWTAPEAIAFRTFSSASDVWSFGVVMWEV-------- 247
Query: 620 SSMRLAAESATFENFIDRNLKGKFSESE--AAKLG------KMALVCTHEDPENRPTMEA 671
               LA     + N  +R++     E     A +G      ++ L C H+D   RP    
Sbjct: 248 ----LAYGERPYWNMTNRDVISSVEEGYRLPAPMGCPHALHQLMLDCWHKDRAQRPRFSQ 303
Query: 672 VIEEL 676
           ++  L
Sbjct: 304 IVSVL 308

>pdb|1AD5|A Chain A, Src Family Kinase Hck-Amp-Pnp Complex Length = 438

Iteration: 1
 Score = 84.0 bits (206), Expect = 3e-16,   Method: Compositional matrix adjust.
 Identities = 61/256 (23%), Positives = 115/256 (44%), Gaps = 26/256 (10%)
Query: 417 LGKGNFSSVYKGTLRDGTLVAIRSINVTSCKSEEAEFVKGLYLLTSLRHENIIRLRGFCC 476
           LG G F  V+  T    T VA++++   S   E   F+    ++ +L+H+ +++L     
Sbjct: 190 LGAGQFGEVWMATYNKHTKVAVKTMKPGSMSVEA--FLAEANVMKTLQHDKLVKLHAVVT 247
Query: 477 SRGRGECFLIYDFAPKGKLSKYLDQEEGSSNVLDWSTRVSIIIGIAKGIGYLHSSEVNKP 536
              +   ++I +F  KG L  +L  +EGS   L     +     IA+G+ ++        
Sbjct: 248 ---KEPIYIITEFMAKGSLLDFLKSDEGSKQPL--PKLIDFSAQIAEGMAFIEQRNY--- 299
Query: 537 AIVHRNLSVEKVLIDQQFNPLIADCGLHKLLADDIVFSVLKTSAAMGYLAPEYVTTGRFT 596
             +HR+L    +L+       IAD GL ++ A             + + APE +  G FT
Sbjct: 300 --IHRDLRAANILVSASLVCKIADFGLARVGA----------KFPIKWTAPEAINFGSFT 347
Query: 597 ERSDIFAFGVIILQILTGSLVLTSSMRLAAESATFENFIDRNLKGKFSESEAAKLGKMAL 656
            +SD+++FG+++++I+T   +    M     +      ++R  +    E+   +L  + +
Sbjct: 348 IKSDVWSFGILLMEIVTYGRIPYPGM----SNPEVIRALERGYRMPRPENCPEELYNIMM 403
Query: 657 VCTHEDPENRPTMEAV 672
            C    PE RPT E +
Sbjct: 404 RCWKNRPEERPTFEYI 419

>pdb|3MIY|A Chain A, X-Ray Crystal Structure Of Itk Complexed With Sunitinib Length = 266

Iteration: 1
 Score = 83.2 bits (204), Expect = 4e-16,   Method: Compositional matrix adjust.
 Identities = 59/273 (21%), Positives = 127/273 (46%), Gaps = 28/273 (10%)
Query: 414 VNLLGKGNFSSVYKGTLRDGTLVAIRSINVTSCKSEEAEFVKGLYLLTSLRHENIIRLRG 473
           V  +G G F  V+ G   +   VAI++I   +   E+  F++   ++  L H  +++L G
Sbjct: 12  VQEIGSGQFGLVHLGYWLNKDKVAIKTIREGAMSEED--FIEEAEVMMKLSHPKLVQLYG 69
Query: 474 FCCSRGRGECFLIYDFAPKGKLSKYLDQEEGSSNVLDWSTRVSIIIGIAKGIGYLHSSEV 533
            C  +      L+++F   G LS YL  + G   +    T + + + + +G+ YL  +  
Sbjct: 70  VCLEQA--PICLVFEFMEHGCLSDYLRTQRG---LFAAETLLGMCLDVCEGMAYLEEA-- 122
Query: 534 NKPAIVHRNLSVEKVLIDQQFNPLIADCGLHKLLADDIVFSVLKTSAAMGYLAPEYVTTG 593
              +++HR+L+    L+ +     ++D G+ + + DD   S   T   + + +PE  +  
Sbjct: 123 ---SVIHRDLAARNCLVGENQVIKVSDFGMTRFVLDDQYTSSTGTKFPVKWASPEVFSFS 179
Query: 594 RFTERSDIFAFGVIILQILTGSLVLTSSMRLAAESATFENFID------RNLKGKFSESE 647
           R++ +SD+++FGV++ ++        S  ++  E+ +    ++      R  K + + + 
Sbjct: 180 RYSSKSDVWSFGVLMWEVF-------SEGKIPYENRSNSEVVEDISTGFRLYKPRLASTH 232
Query: 648 AAKLGKMALVCTHEDPENRPTMEAVIEELTVAA 680
             ++      C  E PE+RP    ++ +L   A
Sbjct: 233 VYQIMNH---CWKERPEDRPAFSRLLRQLAAIA 262

>pdb|3GVU|A Chain A, The Crystal Structure Of Human Abl2 In Complex With Gleevec Length = 292

Iteration: 1
 Score = 82.8 bits (203), Expect = 5e-16,   Method: Compositional matrix adjust.
 Identities = 60/256 (23%), Positives = 123/256 (48%), Gaps = 22/256 (8%)
Query: 417 LGKGNFSSVYKGTLRDGTL-VAIRSINVTSCKSEEAEFVKGLYLLTSLRHENIIRLRGFC 475
           LG G +  VY G  +  +L VA++++   + + EE  F+K   ++  ++H N+++L G C
Sbjct: 40  LGGGQYGEVYVGVWKKYSLTVAVKTLKEDTMEVEE--FLKEAAVMKEIKHPNLVQLLGVC 97
Query: 476 CSRGRGECFLIYDFAPKGKLSKYL---DQEEGSSNVLDWSTRVSIIIGIAKGIGYLHSSE 532
                   +++ ++ P G L  YL   ++EE ++ VL     + +   I+  + YL    
Sbjct: 98  TLEP--PFYIVTEYMPYGNLLDYLRECNREEVTAVVL-----LYMATQISSAMEYL---- 146
Query: 533 VNKPAIVHRNLSVEKVLIDQQFNPLIADCGLHKLLADDIVFSVLKTSAAMGYLAPEYVTT 592
             K   +HR+L+    L+ +     +AD GL +L+  D   +       + + APE +  
Sbjct: 147 -EKKNFIHRDLAARNCLVGENHVVKVADFGLSRLMTGDTYTAHAGAKFPIKWTAPESLAY 205
Query: 593 GRFTERSDIFAFGVIILQILTGSLVLTSSMRLAAESATFENFIDRNLKGKFSESEAAKLG 652
             F+ +SD++AFGV++ +I T  +     + L    +   + +++  + +  E    K+ 
Sbjct: 206 NTFSIKSDVWAFGVLLWEIATYGMSPYPGIDL----SQVYDLLEKGYRMEQPEGCPPKVY 261
Query: 653 KMALVCTHEDPENRPT 668
           ++   C    P +RP+
Sbjct: 262 ELMRACWKWSPADRPS 277

>pdb|3QGW|A Chain A, Crystal Structure Of Itk Kinase Bound To An Inhibitor Length = 286

Iteration: 1
 Score = 82.8 bits (203), Expect = 6e-16,   Method: Compositional matrix adjust.
 Identities = 60/273 (21%), Positives = 126/273 (46%), Gaps = 28/273 (10%)
Query: 414 VNLLGKGNFSSVYKGTLRDGTLVAIRSINVTSCKSEEAEFVKGLYLLTSLRHENIIRLRG 473
           V  +G G F  V+ G   +   VAI++I   S    E +F++   ++  L H  +++L G
Sbjct: 32  VQEIGSGQFGLVHLGYWLNKDKVAIKTIKEGSMS--EDDFIEEAEVMMKLSHPKLVQLYG 89
Query: 474 FCCSRGRGECFLIYDFAPKGKLSKYLDQEEGSSNVLDWSTRVSIIIGIAKGIGYLHSSEV 533
            C  +      L+++F   G LS YL  + G   +    T + + + + +G+ YL  +  
Sbjct: 90  VCLEQA--PICLVFEFMEHGCLSDYLRTQRG---LFAAETLLGMCLDVCEGMAYLEEA-- 142
Query: 534 NKPAIVHRNLSVEKVLIDQQFNPLIADCGLHKLLADDIVFSVLKTSAAMGYLAPEYVTTG 593
               ++HR+L+    L+ +     ++D G+ + + DD   S   T   + + +PE  +  
Sbjct: 143 ---CVIHRDLAARNCLVGENQVIKVSDFGMTRFVLDDQYTSSTGTKFPVKWASPEVFSFS 199
Query: 594 RFTERSDIFAFGVIILQILTGSLVLTSSMRLAAESATFENFID------RNLKGKFSESE 647
           R++ +SD+++FGV++ ++        S  ++  E+ +    ++      R  K + + + 
Sbjct: 200 RYSSKSDVWSFGVLMWEVF-------SEGKIPYENRSNSEVVEDISTGFRLYKPRLASTH 252
Query: 648 AAKLGKMALVCTHEDPENRPTMEAVIEELTVAA 680
             ++      C  E PE+RP    ++ +L   A
Sbjct: 253 VYQIMNH---CWKERPEDRPAFSRLLRQLAEIA 282

>pdb|4HCT|A Chain A, Crystal Structure Of Itk In Complex With Compound 52 Length = 269

Iteration: 1
 Score = 82.4 bits (202), Expect = 8e-16,   Method: Compositional matrix adjust.
 Identities = 59/273 (21%), Positives = 126/273 (46%), Gaps = 28/273 (10%)
Query: 414 VNLLGKGNFSSVYKGTLRDGTLVAIRSINVTSCKSEEAEFVKGLYLLTSLRHENIIRLRG 473
           V  +G G F  V+ G   +   VAI++I   +   E+  F++   ++  L H  +++L G
Sbjct: 15  VQEIGSGQFGLVHLGYWLNKDKVAIKTIREGAMSEED--FIEEAEVMMKLSHPKLVQLYG 72
Query: 474 FCCSRGRGECFLIYDFAPKGKLSKYLDQEEGSSNVLDWSTRVSIIIGIAKGIGYLHSSEV 533
            C  +      L+++F   G LS YL  + G   +    T + + + + +G+ YL  +  
Sbjct: 73  VCLEQA--PICLVFEFMEHGCLSDYLRTQRG---LFAAETLLGMCLDVCEGMAYLEEA-- 125
Query: 534 NKPAIVHRNLSVEKVLIDQQFNPLIADCGLHKLLADDIVFSVLKTSAAMGYLAPEYVTTG 593
               ++HR+L+    L+ +     ++D G+ + + DD   S   T   + + +PE  +  
Sbjct: 126 ---CVIHRDLAARNCLVGENQVIKVSDFGMTRFVLDDQYTSSTGTKFPVKWASPEVFSFS 182
Query: 594 RFTERSDIFAFGVIILQILTGSLVLTSSMRLAAESATFENFID------RNLKGKFSESE 647
           R++ +SD+++FGV++ ++        S  ++  E+ +    ++      R  K + + + 
Sbjct: 183 RYSSKSDVWSFGVLMWEVF-------SEGKIPYENRSNSEVVEDISTGFRLYKPRLASTH 235
Query: 648 AAKLGKMALVCTHEDPENRPTMEAVIEELTVAA 680
             ++      C  E PE+RP    ++ +L   A
Sbjct: 236 VYQIMNH---CWRERPEDRPAFSRLLRQLAEIA 265

>pdb|3V5J|A Chain A, Crystal Structure Of Interleukin-2 Inducible T-Cell Kinase Itk Catalytic Domain With Thienopyrazolylindole Inhibitor 090 Length = 266

Iteration: 1
 Score = 82.0 bits (201), Expect = 1e-15,   Method: Compositional matrix adjust.
 Identities = 59/273 (21%), Positives = 126/273 (46%), Gaps = 28/273 (10%)
Query: 414 VNLLGKGNFSSVYKGTLRDGTLVAIRSINVTSCKSEEAEFVKGLYLLTSLRHENIIRLRG 473
           V  +G G F  V+ G   +   VAI++I   +   E+  F++   ++  L H  +++L G
Sbjct: 12  VQEIGSGQFGLVHLGYWLNKDKVAIKTIREGAMSEED--FIEEAEVMMKLSHPKLVQLYG 69
Query: 474 FCCSRGRGECFLIYDFAPKGKLSKYLDQEEGSSNVLDWSTRVSIIIGIAKGIGYLHSSEV 533
            C  +      L+++F   G LS YL  + G   +    T + + + + +G+ YL  +  
Sbjct: 70  VCLEQA--PICLVFEFMEHGCLSDYLRTQRG---LFAAETLLGMCLDVCEGMAYLEEA-- 122
Query: 534 NKPAIVHRNLSVEKVLIDQQFNPLIADCGLHKLLADDIVFSVLKTSAAMGYLAPEYVTTG 593
               ++HR+L+    L+ +     ++D G+ + + DD   S   T   + + +PE  +  
Sbjct: 123 ---CVIHRDLAARNCLVGENQVIKVSDFGMTRFVLDDQYTSSTGTKFPVKWASPEVFSFS 179
Query: 594 RFTERSDIFAFGVIILQILTGSLVLTSSMRLAAESATFENFID------RNLKGKFSESE 647
           R++ +SD+++FGV++ ++        S  ++  E+ +    ++      R  K + + + 
Sbjct: 180 RYSSKSDVWSFGVLMWEVF-------SEGKIPYENRSNSEVVEDISTGFRLYKPRLASTH 232
Query: 648 AAKLGKMALVCTHEDPENRPTMEAVIEELTVAA 680
             ++      C  E PE+RP    ++ +L   A
Sbjct: 233 VYQIMNH---CWKERPEDRPAFSRLLRQLAEIA 262

>pdb|2QOO|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f:y742f Triple Mutant Length = 373

Iteration: 1
 Score = 81.6 bits (200), Expect = 1e-15,   Method: Compositional matrix adjust.
 Identities = 61/267 (22%), Positives = 118/267 (44%), Gaps = 24/267 (8%)
Query: 415 NLLGKGNFSSVYKGTLR----DGTLVAIRSINVTSCKSEEAEFVKGLYLLTSLRHENIIR 470
            ++G G F  V  G L+        VAI+++ V   + +  +F+    ++    H NIIR
Sbjct: 51  KVVGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYTEKQRRDFLGEASIMGQFDHPNIIR 110
Query: 471 LRGFCCSRGRGECFLIYDFAPKGKLSKYLDQEEGSSNVLDWSTRVSIIIGIAKGIGYLHS 530
           L G           ++ ++   G L  +L + +    V+     V ++ GIA G+ YL  
Sbjct: 111 LEGVVTKSK--PVMIVTEYMENGSLDSFLRKHDAQFTVIQ---LVGMLRGIASGMKYLSD 165
Query: 531 SEVNKPAIVHRNLSVEKVLIDQQFNPLIADCGLHKLLADD--IVFSVLKTSAAMGYLAPE 588
                   VHR+L+   +LI+      ++D GL ++L DD    ++       + + +PE
Sbjct: 166 M-----GFVHRDLAARNILINSNLVCKVSDFGLSRVLEDDPEAAYTTRGGKIPIRWTSPE 220
Query: 589 YVTTGRFTERSDIFAFGVIILQILTGSLVLTSSMRLAAESATFE--NFIDRNLKGKFSES 646
            +   +FT  SD++++G+++ +      V++   R   E +  +    +D   +      
Sbjct: 221 AIAYRKFTSASDVWSYGIVLWE------VMSYGERPYWEMSNQDVIKAVDEGYRLPPPMD 274
Query: 647 EAAKLGKMALVCTHEDPENRPTMEAVI 673
             A L ++ L C  +D  NRP  E ++
Sbjct: 275 CPAALYQLMLDCWQKDRNNRPKFEQIV 301

>pdb|1JPA|A Chain A, Crystal Structure Of Unphosphorylated Ephb2 Receptor Tyrosine Kinase And Juxtamembrane Region Length = 312

Iteration: 1
 Score = 81.6 bits (200), Expect = 1e-15,   Method: Compositional matrix adjust.
 Identities = 63/275 (22%), Positives = 122/275 (44%), Gaps = 22/275 (8%)
Query: 410 CFSEVNLLGKGNFSSVYKGTLR----DGTLVAIRSINVTSCKSEEAEFVKGLYLLTSLRH 465
           C     ++G G F  V  G L+        VAI+++     + +  +F+    ++    H
Sbjct: 34  CVKIEQVIGAGEFGEVCSGHLKLPGKREIFVAIKTLKSGYTEKQRRDFLSEASIMGQFDH 93
Query: 466 ENIIRLRGFCCSRGRGECFLIYDFAPKGKLSKYLDQEEGSSNVLDWSTRVSIIIGIAKGI 525
            N+I L G           +I +F   G L  +L Q +G   V+     V ++ GIA G+
Sbjct: 94  PNVIHLEGVVTKST--PVMIITEFMENGSLDSFLRQNDGQFTVI---QLVGMLRGIAAGM 148
Query: 526 GYLHSSEVNKPAIVHRNLSVEKVLIDQQFNPLIADCGLHKLLADDI----VFSVLKTSAA 581
            YL  +++N    VHR+L+   +L++      ++D GL + L DD       S L     
Sbjct: 149 KYL--ADMN---YVHRDLAARNILVNSNLVCKVSDFGLSRFLEDDTSDPTYTSALGGKIP 203
Query: 582 MGYLAPEYVTTGRFTERSDIFAFGVIILQILTGSLVLTSSMRLAAESATFENFIDRNLKG 641
           + + APE +   +FT  SD++++G+++ ++++        M     +    N I+++ + 
Sbjct: 204 IRWTAPEAIQYRKFTSASDVWSYGIVMWEVMSYGERPYWDM----TNQDVINAIEQDYRL 259
Query: 642 KFSESEAAKLGKMALVCTHEDPENRPTMEAVIEEL 676
                  + L ++ L C  +D  +RP    ++  L
Sbjct: 260 PPPMDCPSALHQLMLDCWQKDRNHRPKFGQIVNTL 294

>pdb|1QPD|A Chain A, Structural Analysis Of The Lymphocyte-specific Kinase Lck In Complex With Non-selective And Src Family Selective Kinase Inhibitors Length = 279

Iteration: 1
 Score = 81.6 bits (200), Expect = 1e-15,   Method: Compositional matrix adjust.
 Identities = 63/278 (22%), Positives = 124/278 (44%), Gaps = 19/278 (6%)
Query: 405 ESATQCFSEVNLLGKGNFSSVYKGTLRDGTLVAIRSINVTSCKSEEAEFVKGLYLLTSLR 464
           E   +    V  LG G    V+ G     T VA++S+   S   +   F+    L+  L+
Sbjct: 9   EVPRETLKLVERLGAGQAGEVWMGYYNGHTKVAVKSLKQGSMSPDA--FLAEANLMKQLQ 66
Query: 465 HENIIRLRGFCCSRGRGECFLIYDFAPKGKLSKYLDQEEGSSNVLDWSTRVSIIIGIAKG 524
           H+ ++RL            ++I ++   G L  +L    G    ++    + +   IA+G
Sbjct: 67  HQRLVRLYAVVTQE---PIYIITEYMENGSLVDFLKTPSGIKLTIN--KLLDMAAQIAEG 121
Query: 525 IGYLHSSEVNKPAIVHRNLSVEKVLIDQQFNPLIADCGLHKLLADDIVFSVLKTSAAMGY 584
           + ++          +HR+L    +L+    +  IAD GL +L+ D    +       + +
Sbjct: 122 MAFIEERNY-----IHRDLRAANILVSDTLSCKIADFGLARLIEDAEXTAREGAKFPIKW 176
Query: 585 LAPEYVTTGRFTERSDIFAFGVIILQILTGSLVLTSSMRLAAESATFENFIDRNLKGKFS 644
            APE +  G FT +SD+++FG+++ +I+T   +    M         +N ++R  +    
Sbjct: 177 TAPEAINYGTFTIKSDVWSFGILLTEIVTHGRIPYPGM---TNPEVIQN-LERGYRMVRP 232
Query: 645 ESEAAKLGKMALVCTHEDPENRPT---MEAVIEELTVA 679
           ++   +L ++  +C  E PE+RPT   + +V+E+   A
Sbjct: 233 DNCPEELYQLMRLCWKERPEDRPTFDYLRSVLEDFFTA 270

>pdb|1SM2|A Chain A, Crystal Structure Of The Phosphorylated Interleukin-2 Tyrosine Kinase Catalytic Domain Length = 264

Iteration: 1
 Score = 81.6 bits (200), Expect = 1e-15,   Method: Compositional matrix adjust.
 Identities = 59/273 (21%), Positives = 126/273 (46%), Gaps = 28/273 (10%)
Query: 414 VNLLGKGNFSSVYKGTLRDGTLVAIRSINVTSCKSEEAEFVKGLYLLTSLRHENIIRLRG 473
           V  +G G F  V+ G   +   VAI++I   +   E+  F++   ++  L H  +++L G
Sbjct: 10  VQEIGSGQFGLVHLGYWLNKDKVAIKTIREGAMSEED--FIEEAEVMMKLSHPKLVQLYG 67
Query: 474 FCCSRGRGECFLIYDFAPKGKLSKYLDQEEGSSNVLDWSTRVSIIIGIAKGIGYLHSSEV 533
            C  +      L+++F   G LS YL  + G   +    T + + + + +G+ YL  +  
Sbjct: 68  VCLEQA--PICLVFEFMEHGCLSDYLRTQRG---LFAAETLLGMCLDVCEGMAYLEEA-- 120
Query: 534 NKPAIVHRNLSVEKVLIDQQFNPLIADCGLHKLLADDIVFSVLKTSAAMGYLAPEYVTTG 593
               ++HR+L+    L+ +     ++D G+ + + DD   S   T   + + +PE  +  
Sbjct: 121 ---CVIHRDLAARNCLVGENQVIKVSDFGMTRFVLDDQYTSSTGTKFPVKWASPEVFSFS 177
Query: 594 RFTERSDIFAFGVIILQILTGSLVLTSSMRLAAESATFENFID------RNLKGKFSESE 647
           R++ +SD+++FGV++ ++        S  ++  E+ +    ++      R  K + + + 
Sbjct: 178 RYSSKSDVWSFGVLMWEVF-------SEGKIPYENRSNSEVVEDISTGFRLYKPRLASTH 230
Query: 648 AAKLGKMALVCTHEDPENRPTMEAVIEELTVAA 680
             ++      C  E PE+RP    ++ +L   A
Sbjct: 231 VYQIMNH---CWKERPEDRPAFSRLLRQLAEIA 260

>pdb|3PLS|A Chain A, Ron In Complex With Ligand Amp-Pnp Length = 298

Iteration: 1
 Score = 81.3 bits (199), Expect = 2e-15,   Method: Compositional matrix adjust.
 Identities = 69/270 (25%), Positives = 127/270 (47%), Gaps = 22/270 (8%)
Query: 415 NLLGKGNFSSVYKGTLRDGTL----VAIRSIN-VTSCKSEEAEFVKGLYLLTSLRHENII 469
            ++GKG+F  VY G   D        AI+S++ +T  +  EA   +GL L+  L H N++
Sbjct: 27  RVIGKGHFGVVYHGEYIDQAQNRIQCAIKSLSRITEMQQVEAFLREGL-LMRGLNHPNVL 85
Query: 470 RLRGFCCSRGRGECFLIYDFAPKGKLSKYLDQEEGSSNVLDWSTRVSIIIGIAKGIGYLH 529
            L G       G   ++  +   G L +++   + +  V D    +S  + +A+G+ YL 
Sbjct: 86  ALIGIMLP-PEGLPHVLLPYMCHGDLLQFIRSPQRNPTVKDL---ISFGLQVARGMEYLA 141
Query: 530 SSEVNKPAIVHRNLSVEKVLIDQQFNPLIADCGLHKLLADDIVFSVLKTSAA---MGYLA 586
             +      VHR+L+    ++D+ F   +AD GL + + D   +SV +   A   + + A
Sbjct: 142 EQK-----FVHRDLAARNCMLDESFTVKVADFGLARDILDREYYSVQQHRHARLPVKWTA 196
Query: 587 PEYVTTGRFTERSDIFAFGVIILQILTGSLVLTSSMRLAAESATFENFIDRNLKGKFSES 646
            E + T RFT +SD+++FGV++ ++LT        +    +     +F+ +  +    E 
Sbjct: 197 LESLQTYRFTTKSDVWSFGVLLWELLTRGAPPYRHI----DPFDLTHFLAQGRRLPQPEY 252
Query: 647 EAAKLGKMALVCTHEDPENRPTMEAVIEEL 676
               L ++   C   DP  RPT   ++ E+
Sbjct: 253 CPDSLYQVMQQCWEADPAVRPTFRVLVGEV 282

>pdb|2QOI|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f Double Mutant Length = 373

Iteration: 1
 Score = 81.3 bits (199), Expect = 2e-15,   Method: Compositional matrix adjust.
 Identities = 61/267 (22%), Positives = 118/267 (44%), Gaps = 24/267 (8%)
Query: 415 NLLGKGNFSSVYKGTLR----DGTLVAIRSINVTSCKSEEAEFVKGLYLLTSLRHENIIR 470
            ++G G F  V  G L+        VAI+++ V   + +  +F+    ++    H NIIR
Sbjct: 51  KVVGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYTEKQRRDFLGEASIMGQFDHPNIIR 110
Query: 471 LRGFCCSRGRGECFLIYDFAPKGKLSKYLDQEEGSSNVLDWSTRVSIIIGIAKGIGYLHS 530
           L G           ++ ++   G L  +L + +    V+     V ++ GIA G+ YL  
Sbjct: 111 LEGVVTKSK--PVMIVTEYMENGSLDSFLRKHDAQFTVIQ---LVGMLRGIASGMKYLSD 165
Query: 531 SEVNKPAIVHRNLSVEKVLIDQQFNPLIADCGLHKLLADD--IVFSVLKTSAAMGYLAPE 588
                   VHR+L+   +LI+      ++D GL ++L DD    ++       + + +PE
Sbjct: 166 M-----GYVHRDLAARNILINSNLVCKVSDFGLSRVLEDDPEAAYTTRGGKIPIRWTSPE 220
Query: 589 YVTTGRFTERSDIFAFGVIILQILTGSLVLTSSMRLAAESATFE--NFIDRNLKGKFSES 646
            +   +FT  SD++++G+++ +      V++   R   E +  +    +D   +      
Sbjct: 221 AIAYRKFTSASDVWSYGIVLWE------VMSYGERPYWEMSNQDVIKAVDEGYRLPPPMD 274
Query: 647 EAAKLGKMALVCTHEDPENRPTMEAVI 673
             A L ++ L C  +D  NRP  E ++
Sbjct: 275 CPAALYQLMLDCWQKDRNNRPKFEQIV 301

>pdb|3FXX|A Chain A, Human Epha3 Kinase And Juxtamembrane Region Bound To Substrate Kqwdnye[ptyr]iw Length = 371

Iteration: 1
 Score = 81.3 bits (199), Expect = 2e-15,   Method: Compositional matrix adjust.
 Identities = 61/267 (22%), Positives = 118/267 (44%), Gaps = 24/267 (8%)
Query: 415 NLLGKGNFSSVYKGTLR----DGTLVAIRSINVTSCKSEEAEFVKGLYLLTSLRHENIIR 470
            ++G G F  V  G L+        VAI+++ V   + +  +F+    ++    H NIIR
Sbjct: 49  KVVGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYTEKQRRDFLGEASIMGQFDHPNIIR 108
Query: 471 LRGFCCSRGRGECFLIYDFAPKGKLSKYLDQEEGSSNVLDWSTRVSIIIGIAKGIGYLHS 530
           L G           ++ ++   G L  +L + +    V+     V ++ GIA G+ YL  
Sbjct: 109 LEGVVTKSK--PVMIVTEYMENGSLDSFLRKHDAQFTVIQ---LVGMLRGIASGMKYLSD 163
Query: 531 SEVNKPAIVHRNLSVEKVLIDQQFNPLIADCGLHKLLADD--IVFSVLKTSAAMGYLAPE 588
                   VHR+L+   +LI+      ++D GL ++L DD    ++       + + +PE
Sbjct: 164 M-----GYVHRDLAARNILINSNLVCKVSDFGLSRVLEDDPEAAYTTRGGKIPIRWTSPE 218
Query: 589 YVTTGRFTERSDIFAFGVIILQILTGSLVLTSSMRLAAESATFE--NFIDRNLKGKFSES 646
            +   +FT  SD++++G+++ +      V++   R   E +  +    +D   +      
Sbjct: 219 AIAYRKFTSASDVWSYGIVLWE------VMSYGERPYWEMSNQDVIKAVDEGYRLPPPMD 272
Query: 647 EAAKLGKMALVCTHEDPENRPTMEAVI 673
             A L ++ L C  +D  NRP  E ++
Sbjct: 273 CPAALYQLMLDCWQKDRNNRPKFEQIV 299

>pdb|2QOF|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f Mutant Length = 373

Iteration: 1
 Score = 81.3 bits (199), Expect = 2e-15,   Method: Compositional matrix adjust.
 Identities = 61/267 (22%), Positives = 118/267 (44%), Gaps = 24/267 (8%)
Query: 415 NLLGKGNFSSVYKGTLR----DGTLVAIRSINVTSCKSEEAEFVKGLYLLTSLRHENIIR 470
            ++G G F  V  G L+        VAI+++ V   + +  +F+    ++    H NIIR
Sbjct: 51  KVVGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYTEKQRRDFLGEASIMGQFDHPNIIR 110
Query: 471 LRGFCCSRGRGECFLIYDFAPKGKLSKYLDQEEGSSNVLDWSTRVSIIIGIAKGIGYLHS 530
           L G           ++ ++   G L  +L + +    V+     V ++ GIA G+ YL  
Sbjct: 111 LEGVVTKSK--PVMIVTEYMENGSLDSFLRKHDAQFTVIQ---LVGMLRGIASGMKYLSD 165
Query: 531 SEVNKPAIVHRNLSVEKVLIDQQFNPLIADCGLHKLLADD--IVFSVLKTSAAMGYLAPE 588
                   VHR+L+   +LI+      ++D GL ++L DD    ++       + + +PE
Sbjct: 166 M-----GYVHRDLAARNILINSNLVCKVSDFGLSRVLEDDPEAAYTTRGGKIPIRWTSPE 220
Query: 589 YVTTGRFTERSDIFAFGVIILQILTGSLVLTSSMRLAAESATFE--NFIDRNLKGKFSES 646
            +   +FT  SD++++G+++ +      V++   R   E +  +    +D   +      
Sbjct: 221 AIAYRKFTSASDVWSYGIVLWE------VMSYGERPYWEMSNQDVIKAVDEGYRLPPPMD 274
Query: 647 EAAKLGKMALVCTHEDPENRPTMEAVI 673
             A L ++ L C  +D  NRP  E ++
Sbjct: 275 CPAALYQLMLDCWQKDRNNRPKFEQIV 301

>pdb|2QOD|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y602f Mutant Length = 373

Iteration: 1
 Score = 81.3 bits (199), Expect = 2e-15,   Method: Compositional matrix adjust.
 Identities = 61/267 (22%), Positives = 118/267 (44%), Gaps = 24/267 (8%)
Query: 415 NLLGKGNFSSVYKGTLR----DGTLVAIRSINVTSCKSEEAEFVKGLYLLTSLRHENIIR 470
            ++G G F  V  G L+        VAI+++ V   + +  +F+    ++    H NIIR
Sbjct: 51  KVVGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYTEKQRRDFLGEASIMGQFDHPNIIR 110
Query: 471 LRGFCCSRGRGECFLIYDFAPKGKLSKYLDQEEGSSNVLDWSTRVSIIIGIAKGIGYLHS 530
           L G           ++ ++   G L  +L + +    V+     V ++ GIA G+ YL  
Sbjct: 111 LEGVVTKSK--PVMIVTEYMENGSLDSFLRKHDAQFTVIQ---LVGMLRGIASGMKYLSD 165
Query: 531 SEVNKPAIVHRNLSVEKVLIDQQFNPLIADCGLHKLLADD--IVFSVLKTSAAMGYLAPE 588
                   VHR+L+   +LI+      ++D GL ++L DD    ++       + + +PE
Sbjct: 166 M-----GYVHRDLAARNILINSNLVCKVSDFGLSRVLEDDPEAAYTTRGGKIPIRWTSPE 220
Query: 589 YVTTGRFTERSDIFAFGVIILQILTGSLVLTSSMRLAAESATFE--NFIDRNLKGKFSES 646
            +   +FT  SD++++G+++ +      V++   R   E +  +    +D   +      
Sbjct: 221 AIAYRKFTSASDVWSYGIVLWE------VMSYGERPYWEMSNQDVIKAVDEGYRLPPPMD 274
Query: 647 EAAKLGKMALVCTHEDPENRPTMEAVI 673
             A L ++ L C  +D  NRP  E ++
Sbjct: 275 CPAALYQLMLDCWQKDRNNRPKFEQIV 301

>pdb|2GSF|A Chain A, The Human Epha3 Receptor Tyrosine Kinase And Juxtamembrane Region Length = 373

Iteration: 1
 Score = 81.3 bits (199), Expect = 2e-15,   Method: Compositional matrix adjust.
 Identities = 61/267 (22%), Positives = 118/267 (44%), Gaps = 24/267 (8%)
Query: 415 NLLGKGNFSSVYKGTLR----DGTLVAIRSINVTSCKSEEAEFVKGLYLLTSLRHENIIR 470
            ++G G F  V  G L+        VAI+++ V   + +  +F+    ++    H NIIR
Sbjct: 51  KVVGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYTEKQRRDFLGEASIMGQFDHPNIIR 110
Query: 471 LRGFCCSRGRGECFLIYDFAPKGKLSKYLDQEEGSSNVLDWSTRVSIIIGIAKGIGYLHS 530
           L G           ++ ++   G L  +L + +    V+     V ++ GIA G+ YL  
Sbjct: 111 LEGVVTKSK--PVMIVTEYMENGSLDSFLRKHDAQFTVIQ---LVGMLRGIASGMKYLSD 165
Query: 531 SEVNKPAIVHRNLSVEKVLIDQQFNPLIADCGLHKLLADD--IVFSVLKTSAAMGYLAPE 588
                   VHR+L+   +LI+      ++D GL ++L DD    ++       + + +PE
Sbjct: 166 M-----GYVHRDLAARNILINSNLVCKVSDFGLSRVLEDDPEAAYTTRGGKIPIRWTSPE 220
Query: 589 YVTTGRFTERSDIFAFGVIILQILTGSLVLTSSMRLAAESATFE--NFIDRNLKGKFSES 646
            +   +FT  SD++++G+++ +      V++   R   E +  +    +D   +      
Sbjct: 221 AIAYRKFTSASDVWSYGIVLWE------VMSYGERPYWEMSNQDVIKAVDEGYRLPPPMD 274
Query: 647 EAAKLGKMALVCTHEDPENRPTMEAVI 673
             A L ++ L C  +D  NRP  E ++
Sbjct: 275 CPAALYQLMLDCWQKDRNNRPKFEQIV 301

>pdb|2QOK|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f:s768a Triple Mutant Length = 373

Iteration: 1
 Score = 80.9 bits (198), Expect = 2e-15,   Method: Compositional matrix adjust.
 Identities = 61/267 (22%), Positives = 118/267 (44%), Gaps = 24/267 (8%)
Query: 415 NLLGKGNFSSVYKGTLR----DGTLVAIRSINVTSCKSEEAEFVKGLYLLTSLRHENIIR 470
            ++G G F  V  G L+        VAI+++ V   + +  +F+    ++    H NIIR
Sbjct: 51  KVVGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYTEKQRRDFLGEASIMGQFDHPNIIR 110
Query: 471 LRGFCCSRGRGECFLIYDFAPKGKLSKYLDQEEGSSNVLDWSTRVSIIIGIAKGIGYLHS 530
           L G           ++ ++   G L  +L + +    V+     V ++ GIA G+ YL  
Sbjct: 111 LEGVVTKSK--PVMIVTEYMENGSLDSFLRKHDAQFTVIQ---LVGMLRGIASGMKYLSD 165
Query: 531 SEVNKPAIVHRNLSVEKVLIDQQFNPLIADCGLHKLLADD--IVFSVLKTSAAMGYLAPE 588
                   VHR+L+   +LI+      ++D GL ++L DD    ++       + + +PE
Sbjct: 166 M-----GYVHRDLAARNILINSNLVCKVSDFGLARVLEDDPEAAYTTRGGKIPIRWTSPE 220
Query: 589 YVTTGRFTERSDIFAFGVIILQILTGSLVLTSSMRLAAESATFE--NFIDRNLKGKFSES 646
            +   +FT  SD++++G+++ +      V++   R   E +  +    +D   +      
Sbjct: 221 AIAYRKFTSASDVWSYGIVLWE------VMSYGERPYWEMSNQDVIKAVDEGYRLPPPMD 274
Query: 647 EAAKLGKMALVCTHEDPENRPTMEAVI 673
             A L ++ L C  +D  NRP  E ++
Sbjct: 275 CPAALYQLMLDCWQKDRNNRPKFEQIV 301

>pdb|2QOL|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596:y602:s768g Triple Mutant Length = 373

Iteration: 1
 Score = 80.9 bits (198), Expect = 2e-15,   Method: Compositional matrix adjust.
 Identities = 61/267 (22%), Positives = 118/267 (44%), Gaps = 24/267 (8%)
Query: 415 NLLGKGNFSSVYKGTLR----DGTLVAIRSINVTSCKSEEAEFVKGLYLLTSLRHENIIR 470
            ++G G F  V  G L+        VAI+++ V   + +  +F+    ++    H NIIR
Sbjct: 51  KVVGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYTEKQRRDFLGEASIMGQFDHPNIIR 110
Query: 471 LRGFCCSRGRGECFLIYDFAPKGKLSKYLDQEEGSSNVLDWSTRVSIIIGIAKGIGYLHS 530
           L G           ++ ++   G L  +L + +    V+     V ++ GIA G+ YL  
Sbjct: 111 LEGVVTKSK--PVMIVTEYMENGSLDSFLRKHDAQFTVIQ---LVGMLRGIASGMKYLSD 165
Query: 531 SEVNKPAIVHRNLSVEKVLIDQQFNPLIADCGLHKLLADD--IVFSVLKTSAAMGYLAPE 588
                   VHR+L+   +LI+      ++D GL ++L DD    ++       + + +PE
Sbjct: 166 M-----GYVHRDLAARNILINSNLVCKVSDFGLGRVLEDDPEAAYTTRGGKIPIRWTSPE 220
Query: 589 YVTTGRFTERSDIFAFGVIILQILTGSLVLTSSMRLAAESATFE--NFIDRNLKGKFSES 646
            +   +FT  SD++++G+++ +      V++   R   E +  +    +D   +      
Sbjct: 221 AIAYRKFTSASDVWSYGIVLWE------VMSYGERPYWEMSNQDVIKAVDEGYRLPPPMD 274
Query: 647 EAAKLGKMALVCTHEDPENRPTMEAVI 673
             A L ++ L C  +D  NRP  E ++
Sbjct: 275 CPAALYQLMLDCWQKDRNNRPKFEQIV 301

>pdb|3DZQ|A Chain A, Human Epha3 Kinase Domain In Complex With Inhibitor Awl-Ii- 38.3 Length = 361

Iteration: 1
 Score = 80.9 bits (198), Expect = 2e-15,   Method: Compositional matrix adjust.
 Identities = 61/267 (22%), Positives = 118/267 (44%), Gaps = 24/267 (8%)
Query: 415 NLLGKGNFSSVYKGTLR----DGTLVAIRSINVTSCKSEEAEFVKGLYLLTSLRHENIIR 470
            ++G G F  V  G L+        VAI+++ V   + +  +F+    ++    H NIIR
Sbjct: 39  KVVGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYTEKQRRDFLGEASIMGQFDHPNIIR 98
Query: 471 LRGFCCSRGRGECFLIYDFAPKGKLSKYLDQEEGSSNVLDWSTRVSIIIGIAKGIGYLHS 530
           L G           ++ ++   G L  +L + +    V+     V ++ GIA G+ YL  
Sbjct: 99  LEGVVTKSK--PVMIVTEYMENGSLDSFLRKHDAQFTVIQ---LVGMLRGIASGMKYLSD 153
Query: 531 SEVNKPAIVHRNLSVEKVLIDQQFNPLIADCGLHKLLADD--IVFSVLKTSAAMGYLAPE 588
                   VHR+L+   +LI+      ++D GL ++L DD    ++       + + +PE
Sbjct: 154 M-----GYVHRDLAARNILINSNLVCKVSDFGLSRVLEDDPEAAYTTRGGKIPIRWTSPE 208
Query: 589 YVTTGRFTERSDIFAFGVIILQILTGSLVLTSSMRLAAESATFE--NFIDRNLKGKFSES 646
            +   +FT  SD++++G+++ +      V++   R   E +  +    +D   +      
Sbjct: 209 AIAYRKFTSASDVWSYGIVLWE------VMSYGERPYWEMSNQDVIKAVDEGYRLPPPMD 262
Query: 647 EAAKLGKMALVCTHEDPENRPTMEAVI 673
             A L ++ L C  +D  NRP  E ++
Sbjct: 263 CPAALYQLMLDCWQKDRNNRPKFEQIV 289

>pdb|2QOC|A Chain A, Human Epha3 Kinase Domain, Phosphorylated, Amp-Pnp Bound Structure Length = 344

Iteration: 1
 Score = 80.9 bits (198), Expect = 2e-15,   Method: Compositional matrix adjust.
 Identities = 61/267 (22%), Positives = 118/267 (44%), Gaps = 24/267 (8%)
Query: 415 NLLGKGNFSSVYKGTLR----DGTLVAIRSINVTSCKSEEAEFVKGLYLLTSLRHENIIR 470
            ++G G F  V  G L+        VAI+++ V   + +  +F+    ++    H NIIR
Sbjct: 22  KVVGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYTEKQRRDFLGEASIMGQFDHPNIIR 81
Query: 471 LRGFCCSRGRGECFLIYDFAPKGKLSKYLDQEEGSSNVLDWSTRVSIIIGIAKGIGYLHS 530
           L G           ++ ++   G L  +L + +    V+     V ++ GIA G+ YL  
Sbjct: 82  LEGVVTKSK--PVMIVTEYMENGSLDSFLRKHDAQFTVIQ---LVGMLRGIASGMKYLSD 136
Query: 531 SEVNKPAIVHRNLSVEKVLIDQQFNPLIADCGLHKLLADD--IVFSVLKTSAAMGYLAPE 588
                   VHR+L+   +LI+      ++D GL ++L DD    ++       + + +PE
Sbjct: 137 M-----GYVHRDLAARNILINSNLVCKVSDFGLSRVLEDDPEAAYTTRGGKIPIRWTSPE 191
Query: 589 YVTTGRFTERSDIFAFGVIILQILTGSLVLTSSMRLAAESATFE--NFIDRNLKGKFSES 646
            +   +FT  SD++++G+++ +      V++   R   E +  +    +D   +      
Sbjct: 192 AIAYRKFTSASDVWSYGIVLWE------VMSYGERPYWEMSNQDVIKAVDEGYRLPPPMD 245
Query: 647 EAAKLGKMALVCTHEDPENRPTMEAVI 673
             A L ++ L C  +D  NRP  E ++
Sbjct: 246 CPAALYQLMLDCWQKDRNNRPKFEQIV 272

>pdb|2REI|A Chain A, Kinase Domain Of Human Ephrin Type-a Receptor 7 (epha7) Length = 318

Iteration: 1
 Score = 80.9 bits (198), Expect = 2e-15,   Method: Compositional matrix adjust.
 Identities = 50/210 (23%), Positives = 103/210 (49%), Gaps = 16/210 (7%)
Query: 410 CFSEVNLLGKGNFSSVYKGTLR----DGTLVAIRSINVTSCKSEEAEFVKGLYLLTSLRH 465
           C     ++G G F  V  G L+        VAI+++ V   + +  +F+    ++    H
Sbjct: 44  CIKIERVIGAGEFGEVCSGRLKLPGKRDVAVAIKTLKVGYTEKQRRDFLCEASIMGQFDH 103
Query: 466 ENIIRLRGFCCSRGRGECFLIYDFAPKGKLSKYLDQEEGSSNVLDWSTRVSIIIGIAKGI 525
            N++ L G   +RG+    ++ +F   G L  +L + +G   V+     V ++ GIA G+
Sbjct: 104 PNVVHLEG-VVTRGK-PVMIVIEFMENGALDAFLRKHDGQFTVI---QLVGMLRGIAAGM 158
Query: 526 GYLHSSEVNKPAIVHRNLSVEKVLIDQQFNPLIADCGLHKLLADD--IVFSVLKTSAAMG 583
            YL          VHR+L+   +L++      ++D GL +++ DD   V++       + 
Sbjct: 159 RYLADM-----GYVHRDLAARNILVNSNLVCKVSDFGLSRVIEDDPEAVYTTTGGKIPVR 213
Query: 584 YLAPEYVTTGRFTERSDIFAFGVIILQILT 613
           + APE +   +FT  SD++++G+++ ++++
Sbjct: 214 WTAPEAIQYRKFTSASDVWSYGIVMWEVMS 243

>pdb|2HEN|A Chain A, Crystal Structure Of The Ephb2 Receptor Kinase Domain In Complex With Adp Length = 286

Iteration: 1
 Score = 80.5 bits (197), Expect = 3e-15,   Method: Compositional matrix adjust.
 Identities = 63/275 (22%), Positives = 121/275 (44%), Gaps = 22/275 (8%)
Query: 410 CFSEVNLLGKGNFSSVYKGTLR----DGTLVAIRSINVTSCKSEEAEFVKGLYLLTSLRH 465
           C     ++G G F  V  G L+        VAI+++     + +  +F+    ++    H
Sbjct: 8   CVKIEQVIGAGEFGEVCSGHLKLPGKREIFVAIKTLKSGYTEKQRRDFLSEASIMGQFDH 67
Query: 466 ENIIRLRGFCCSRGRGECFLIYDFAPKGKLSKYLDQEEGSSNVLDWSTRVSIIIGIAKGI 525
            N+I L G           +I +F   G L  +L Q +G   V+     V ++ GIA G+
Sbjct: 68  PNVIHLEGVVTKST--PVMIITEFMENGSLDSFLRQNDGQFTVIQ---LVGMLRGIAAGM 122
Query: 526 GYLHSSEVNKPAIVHRNLSVEKVLIDQQFNPLIADCGLHKLLADDI----VFSVLKTSAA 581
            YL  +++N    VHR L+   +L++      ++D GL + L DD       S L     
Sbjct: 123 KYL--ADMN---YVHRALAARNILVNSNLVCKVSDFGLSRFLEDDTSDPTYTSALGGKIP 177
Query: 582 MGYLAPEYVTTGRFTERSDIFAFGVIILQILTGSLVLTSSMRLAAESATFENFIDRNLKG 641
           + + APE +   +FT  SD++++G+++ ++++        M     +    N I+++ + 
Sbjct: 178 IRWTAPEAIQYRKFTSASDVWSYGIVMWEVMSYGERPYWDM----TNQDVINAIEQDYRL 233
Query: 642 KFSESEAAKLGKMALVCTHEDPENRPTMEAVIEEL 676
                  + L ++ L C  +D  +RP    ++  L
Sbjct: 234 PPPMDCPSALHQLMLDCWQKDRNHRPKFGQIVNTL 268

>pdb|2JIV|A Chain A, Crystal Structure Of Egfr Kinase Domain T790m Mutation In Compex With Hki-272 Length = 328

Iteration: 1
 Score = 80.5 bits (197), Expect = 3e-15,   Method: Compositional matrix adjust.
 Identities = 57/212 (26%), Positives = 102/212 (48%), Gaps = 23/212 (10%)
Query: 411 FSEVNLLGKGNFSSVYKGTL-----RDGTLVAIRSINVTSCKSEEAEFVKGLYLLTSLRH 465
           F ++ +LG G F +VYKG       +    VAI+ +   +      E +   Y++ S+ +
Sbjct: 18  FKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDN 77
Query: 466 ENIIRLRGFCCSRGRGECFLIYDFAPKGKLSKYLDQEE---GSSNVLDWSTRVSIIIGIA 522
            ++ RL G C +       LI    P G L  Y+ + +   GS  +L+W       + IA
Sbjct: 78  PHVCRLLGICLT---STVQLIMQLMPFGXLLDYVREHKDNIGSQYLLNWC------VQIA 128
Query: 523 KGIGYLHSSEVNKPAIVHRNLSVEKVLIDQQFNPLIADCGLHKLL-ADDIVFSVLKTSAA 581
           KG+ YL         +VHR+L+   VL+    +  I D GL KLL A++  +        
Sbjct: 129 KGMNYLEDRR-----LVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVP 183
Query: 582 MGYLAPEYVTTGRFTERSDIFAFGVIILQILT 613
           + ++A E +    +T +SD++++GV + +++T
Sbjct: 184 IKWMALESILHRIYTHQSDVWSYGVTVWELMT 215

>pdb|3NYX|A Chain A, Non-Phosphorylated Tyk2 Jh1 Domain With Quinoline-Thiadiazole- Thiophene Inhibitor Length = 302

Iteration: 1
 Score = 80.1 bits (196), Expect = 3e-15,   Method: Compositional matrix adjust.
 Identities = 58/212 (27%), Positives = 107/212 (50%), Gaps = 21/212 (9%)
Query: 411 FSEVNLLGKGNFSSV----YKGTLRDGT--LVAIRSINVTSCKSEEAEFVKGLYLLTSLR 464
             ++  LG+G+F  V    Y  T  DGT  +VA++++         + + + + +L +L 
Sbjct: 16  LKKIRDLGEGHFGKVSLYCYDPT-NDGTGEMVAVKALKADCGPQHRSGWKQEIDILRTLY 74
Query: 465 HENIIRLRGFCCSRGRGECFLIYDFAPKGKLSKYLDQEE-GSSNVLDWSTRVSIIIGIAK 523
           HE+II+ +G C  +G     L+ ++ P G L  YL +   G + +L ++ +      I +
Sbjct: 75  HEHIIKYKGCCEDQGEKSLQLVMEYVPLGSLRDYLPRHSIGLAQLLLFAQQ------ICE 128
Query: 524 GIGYLHSSEVNKPAIVHRNLSVEKVLIDQQFNPLIADCGLHKLLADDIVFSVLKT--SAA 581
           G+ YLHS        +HRNL+   VL+D      I D GL K + +   +  ++    + 
Sbjct: 129 GMAYLHSQHY-----IHRNLAARNVLLDNDRLVKIGDFGLAKAVPEGHEYYRVREDGDSP 183
Query: 582 MGYLAPEYVTTGRFTERSDIFAFGVIILQILT 613
           + + APE +   +F   SD+++FGV + ++LT
Sbjct: 184 VFWYAPECLKEYKFYYASDVWSFGVTLYELLT 215

>pdb|3GEN|A Chain A, The 1.6 A Crystal Structure Of Human Bruton's Tyrosine Kinase Bound To A Pyrrolopyrimidine-Containing Compound Length = 283

Iteration: 1
 Score = 80.1 bits (196), Expect = 3e-15,   Method: Compositional matrix adjust.
 Identities = 67/257 (26%), Positives = 118/257 (45%), Gaps = 16/257 (6%)
Query: 417 LGKGNFSSVYKGTLRDGTLVAIRSINVTSCKSEEAEFVKGLYLLTSLRHENIIRLRGFCC 476
           LG G F  V  G  R    VAI+ I   S    E EF++   ++ +L HE +++L G C 
Sbjct: 32  LGTGQFGVVKYGKWRGQYDVAIKMIKEGSMS--EDEFIEEAKVMMNLSHEKLVQLYGVCT 89
Query: 477 SRGRGECFLIYDFAPKGKLSKYLDQEEGSSNVLDWSTRVSIIIGIAKGIGYLHSSEVNKP 536
            +     F+I ++   G L  YL +             + +   + + + YL S +    
Sbjct: 90  KQR--PIFIITEYMANGCLLNYLREMRHRFQT---QQLLEMCKDVCEAMEYLESKQ---- 140
Query: 537 AIVHRNLSVEKVLIDQQFNPLIADCGLHKLLADDIVFSVLKTSAAMGYLAPEYVTTGRFT 596
             +HR+L+    L++ Q    ++D GL + + DD   S + +   + +  PE +   +F+
Sbjct: 141 -FLHRDLAARNCLVNDQGVVKVSDFGLSRYVLDDEYTSSVGSKFPVRWSPPEVLMYSKFS 199
Query: 597 ERSDIFAFGVIILQILTGSLVLTSSMRLAAESATFENFIDRNLKGKFSESEAAKLGKMAL 656
            +SDI+AFGV++ +I   SL      R    S T E+ I + L+       + K+  +  
Sbjct: 200 SKSDIWAFGVLMWEIY--SLGKMPYERF-TNSETAEH-IAQGLRLYRPHLASEKVYTIMY 255
Query: 657 VCTHEDPENRPTMEAVI 673
            C HE  + RPT + ++
Sbjct: 256 SCWHEKADERPTFKILL 272

>pdb|3T9T|A Chain A, Crystal Structure Of Btk Mutant (F435t,K596r) Complexed With Imidazo[1,5-A]quinoxaline Length = 267

Iteration: 1
 Score = 80.1 bits (196), Expect = 4e-15,   Method: Compositional matrix adjust.
 Identities = 59/273 (21%), Positives = 125/273 (45%), Gaps = 28/273 (10%)
Query: 414 VNLLGKGNFSSVYKGTLRDGTLVAIRSINVTSCKSEEAEFVKGLYLLTSLRHENIIRLRG 473
           V  +G G F  V+ G   +   VAI++I   +   E+  F++   ++  L H  +++L G
Sbjct: 13  VQEIGSGQFGLVHLGYWLNKDKVAIKTIREGAMSEED--FIEEAEVMMKLSHPKLVQLYG 70
Query: 474 FCCSRGRGECFLIYDFAPKGKLSKYLDQEEGSSNVLDWSTRVSIIIGIAKGIGYLHSSEV 533
            C  +      L+ +F   G LS YL  + G   +    T + + + + +G+ YL  +  
Sbjct: 71  VCLEQA--PICLVTEFMEHGCLSDYLRTQRG---LFAAETLLGMCLDVCEGMAYLEEA-- 123
Query: 534 NKPAIVHRNLSVEKVLIDQQFNPLIADCGLHKLLADDIVFSVLKTSAAMGYLAPEYVTTG 593
               ++HR+L+    L+ +     ++D G+ + + DD   S   T   + + +PE  +  
Sbjct: 124 ---CVIHRDLAARNCLVGENQVIKVSDFGMTRFVLDDQYTSSTGTKFPVKWASPEVFSFS 180
Query: 594 RFTERSDIFAFGVIILQILTGSLVLTSSMRLAAESATFENFID------RNLKGKFSESE 647
           R++ +SD+++FGV++ ++        S  ++  E+ +    ++      R  K + + + 
Sbjct: 181 RYSSKSDVWSFGVLMWEVF-------SEGKIPYENRSNSEVVEDISTGFRLYKPRLASTH 233
Query: 648 AAKLGKMALVCTHEDPENRPTMEAVIEELTVAA 680
             ++      C  E PE+RP    ++ +L   A
Sbjct: 234 VYQIMNH---CWRERPEDRPAFSRLLRQLAEIA 263

>pdb|3G2F|A Chain A, Crystal Structure Of The Kinase Domain Of Bone Morphogenetic Protein Receptor Type Ii (Bmpr2) At 2.35 A Resolution Length = 336

Iteration: 1
 Score = 80.1 bits (196), Expect = 4e-15,   Method: Compositional matrix adjust.
 Identities = 81/308 (26%), Positives = 133/308 (43%), Gaps = 55/308 (17%)
Query: 414 VNLLGKGNFSSVYKGTLRDGTLVAIRSINVTSCKSEEAEFV--KGLYLLTSLRHENIIRL 471
           + L+G+G + +VYKG+L D   VA++  +  + ++    F+  K +Y +  + H+NI R 
Sbjct: 18  LELIGRGRYGAVYKGSL-DERPVAVKVFSFANRQN----FINEKNIYRVPLMEHDNIARF 72
Query: 472 ---RGFCCSRGRGECFLIYDFAPKGKLSKYLDQEEGSSNVLDWSTRVSIIIGIAKGIGYL 528
                   + GR E  L+ ++ P G L KYL     S +  DW +   +   + +G+ YL
Sbjct: 73  IVGDERVTADGRMEYLLVMEYYPNGSLXKYL-----SLHTSDWVSSCRLAHSVTRGLAYL 127
Query: 529 HSS----EVNKPAIVHRNLSVEKVLIDQQFNPLIADCGLH-KLLADDIVFSVLKTSAAMG 583
           H+     +  KPAI HR+L+   VL+      +I+D GL  +L  + +V    + +AA+ 
Sbjct: 128 HTELPRGDHYKPAISHRDLNSRNVLVKNDGTCVISDFGLSMRLTGNRLVRPGEEDNAAIS 187
Query: 584 ------YLAPEYVTTGRFTERS--------DIFAFGVIILQILT-------GSLVLTSSM 622
                 Y+APE V  G    R         D++A G+I  +I         G  V    M
Sbjct: 188 EVGTIRYMAPE-VLEGAVNLRDXESALKQVDMYALGLIYWEIFMRCTDLFPGESVPEYQM 246
Query: 623 RLAAESATFENFIDRNL-----KGKFSESEAAKLGKMALV--------CTHEDPENRPTM 669
               E      F D  +     K +    EA K   +A+         C  +D E R T 
Sbjct: 247 AFQTEVGNHPTFEDMQVLVSREKQRPKFPEAWKENSLAVRSLKETIEDCWDQDAEARLTA 306
Query: 670 EAVIEELT 677
           +   E + 
Sbjct: 307 QXAEERMA 314

>pdb|3LMG|A Chain A, Crystal Structure Of The Erbb3 Kinase Domain In Complex With Amp-Pnp Length = 344

Iteration: 1
 Score = 80.1 bits (196), Expect = 4e-15,   Method: Compositional matrix adjust.
 Identities = 77/284 (27%), Positives = 131/284 (46%), Gaps = 37/284 (13%)
Query: 411 FSEVNLLGKGNFSSVYKGT-LRDGTLVAIR-SINVTSCKSEEAEF---VKGLYLLTSLRH 465
             ++ +LG G F +V+KG  + +G  + I   I V   KS    F      +  + SL H
Sbjct: 33  LRKLKVLGSGVFGTVHKGVWIPEGESIKIPVCIKVIEDKSGRQSFQAVTDHMLAIGSLDH 92
Query: 466 ENIIRLRGFCCSRGRGECFLIYDFAPKGKLSKYLDQEEGSSN---VLDWSTRVSIIIGIA 522
            +I+RL G C         L+  + P G L  ++ Q  G+     +L+W  +      IA
Sbjct: 93  AHIVRLLGLCPG---SSLQLVTQYLPLGSLLDHVRQHRGALGPQLLLNWGVQ------IA 143
Query: 523 KGIGYLHSSEVNKPAIVHRNLSVEKVLIDQQFNPLIADCGLHKLLADD---IVFSVLKTS 579
           KG+ YL         +VHRNL+   VL+       +AD G+  LL  D   +++S  KT 
Sbjct: 144 KGMYYLEEH-----GMVHRNLAARNVLLKSPSQVQVADFGVADLLPPDDKQLLYSEAKTP 198
Query: 580 AAMGYLAPEYVTTGRFTERSDIFAFGVIILQILTGSLVLTSSMRLAAESATFENFIDRNL 639
             + ++A E +  G++T +SD++++GV + +++T      + +RLA      E       
Sbjct: 199 --IKWMALESIHFGKYTHQSDVWSYGVTVWELMTFGAEPYAGLRLAEVPDLLE------- 249
Query: 640 KG-KFSESEAAKLG-KMALV-CTHEDPENRPTMEAVIEELTVAA 680
           KG + ++ +   +   M +V C   D   RPT + +  E T  A
Sbjct: 250 KGERLAQPQICTIDVYMVMVKCWMIDENIRPTFKELANEFTRMA 293

>pdb|2J5E|A Chain A, Crystal Structure Of Egfr Kinase Domain In Complex With An Irreversible Inhibitor 13-Jab Length = 327

Iteration: 1
 Score = 80.1 bits (196), Expect = 4e-15,   Method: Compositional matrix adjust.
 Identities = 57/212 (26%), Positives = 102/212 (48%), Gaps = 23/212 (10%)
Query: 411 FSEVNLLGKGNFSSVYKGTL-----RDGTLVAIRSINVTSCKSEEAEFVKGLYLLTSLRH 465
           F ++ +LG G F +VYKG       +    VAI+ +   +      E +   Y++ S+ +
Sbjct: 17  FKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDN 76
Query: 466 ENIIRLRGFCCSRGRGECFLIYDFAPKGKLSKYLDQEE---GSSNVLDWSTRVSIIIGIA 522
            ++ RL G C +       LI    P G L  Y+ + +   GS  +L+W       + IA
Sbjct: 77  PHVCRLLGICLT---STVQLITQLMPFGXLLDYVREHKDNIGSQYLLNWC------VQIA 127
Query: 523 KGIGYLHSSEVNKPAIVHRNLSVEKVLIDQQFNPLIADCGLHKLL-ADDIVFSVLKTSAA 581
           KG+ YL         +VHR+L+   VL+    +  I D GL KLL A++  +        
Sbjct: 128 KGMNYLEDRR-----LVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVP 182
Query: 582 MGYLAPEYVTTGRFTERSDIFAFGVIILQILT 613
           + ++A E +    +T +SD++++GV + +++T
Sbjct: 183 IKWMALESILHRIYTHQSDVWSYGVTVWELMT 214

>pdb|3KEX|A Chain A, Crystal Structure Of The Catalytically Inactive Kinase Domain Of The Human Epidermal Growth Factor Receptor 3 (Her3) Length = 325

Iteration: 1
 Score = 79.7 bits (195), Expect = 4e-15,   Method: Compositional matrix adjust.
 Identities = 77/284 (27%), Positives = 131/284 (46%), Gaps = 37/284 (13%)
Query: 411 FSEVNLLGKGNFSSVYKGT-LRDGTLVAIR-SINVTSCKSEEAEF---VKGLYLLTSLRH 465
             ++ +LG G F +V+KG  + +G  + I   I V   KS    F      +  + SL H
Sbjct: 15  LRKLKVLGSGVFGTVHKGVWIPEGESIKIPVCIKVIEDKSGRQSFQAVTDHMLAIGSLDH 74
Query: 466 ENIIRLRGFCCSRGRGECFLIYDFAPKGKLSKYLDQEEGSSN---VLDWSTRVSIIIGIA 522
            +I+RL G C         L+  + P G L  ++ Q  G+     +L+W  +      IA
Sbjct: 75  AHIVRLLGLCPG---SSLQLVTQYLPLGSLLDHVRQHRGALGPQLLLNWGVQ------IA 125
Query: 523 KGIGYLHSSEVNKPAIVHRNLSVEKVLIDQQFNPLIADCGLHKLLADD---IVFSVLKTS 579
           KG+ YL         +VHRNL+   VL+       +AD G+  LL  D   +++S  KT 
Sbjct: 126 KGMYYLEEH-----GMVHRNLAARNVLLKSPSQVQVADFGVADLLPPDDKQLLYSEAKTP 180
Query: 580 AAMGYLAPEYVTTGRFTERSDIFAFGVIILQILTGSLVLTSSMRLAAESATFENFIDRNL 639
             + ++A E +  G++T +SD++++GV + +++T      + +RLA      E       
Sbjct: 181 --IKWMALESIHFGKYTHQSDVWSYGVTVWELMTFGAEPYAGLRLAEVPDLLE------- 231
Query: 640 KG-KFSESEAAKLG-KMALV-CTHEDPENRPTMEAVIEELTVAA 680
           KG + ++ +   +   M +V C   D   RPT + +  E T  A
Sbjct: 232 KGERLAQPQICTIDVYMVMVKCWMIDENIRPTFKELANEFTRMA 275

>pdb|3OCS|A Chain A, Crystal Structure Of Bruton's Tyrosine Kinase In Complex With Inhibitor Cgi1746 Length = 271

Iteration: 1
 Score = 79.7 bits (195), Expect = 5e-15,   Method: Compositional matrix adjust.
 Identities = 67/257 (26%), Positives = 118/257 (45%), Gaps = 16/257 (6%)
Query: 417 LGKGNFSSVYKGTLRDGTLVAIRSINVTSCKSEEAEFVKGLYLLTSLRHENIIRLRGFCC 476
           LG G F  V  G  R    VAI+ I   S    E EF++   ++ +L HE +++L G C 
Sbjct: 17  LGTGQFGVVKYGKWRGQYDVAIKMIKEGSMS--EDEFIEEAKVMMNLSHEKLVQLYGVCT 74
Query: 477 SRGRGECFLIYDFAPKGKLSKYLDQEEGSSNVLDWSTRVSIIIGIAKGIGYLHSSEVNKP 536
            +     F+I ++   G L  YL +             + +   + + + YL S +    
Sbjct: 75  KQR--PIFIITEYMANGCLLNYLREMRHRFQT---QQLLEMCKDVCEAMEYLESKQ---- 125
Query: 537 AIVHRNLSVEKVLIDQQFNPLIADCGLHKLLADDIVFSVLKTSAAMGYLAPEYVTTGRFT 596
             +HR+L+    L++ Q    ++D GL + + DD   S + +   + +  PE +   +F+
Sbjct: 126 -FLHRDLAARNCLVNDQGVVKVSDFGLSRYVLDDEYTSSVGSKFPVRWSPPEVLMYSKFS 184
Query: 597 ERSDIFAFGVIILQILTGSLVLTSSMRLAAESATFENFIDRNLKGKFSESEAAKLGKMAL 656
            +SDI+AFGV++ +I   SL      R    S T E+ I + L+       + K+  +  
Sbjct: 185 SKSDIWAFGVLMWEIY--SLGKMPYERF-TNSETAEH-IAQGLRLYRPHLASEKVYTIMY 240
Query: 657 VCTHEDPENRPTMEAVI 673
            C HE  + RPT + ++
Sbjct: 241 SCWHEKADERPTFKILL 257

>pdb|3PIX|A Chain A, Crystal Structure Of Btk Kinase Domain Complexed With 2-Isopropyl-7- (4-Methyl-Piperazin-1-Yl)-4-(5-Methyl-2h-Pyrazol-3- Ylamino)-2h- Phthalazin-1-One Length = 274

Iteration: 1
 Score = 79.7 bits (195), Expect = 5e-15,   Method: Compositional matrix adjust.
 Identities = 67/257 (26%), Positives = 118/257 (45%), Gaps = 16/257 (6%)
Query: 417 LGKGNFSSVYKGTLRDGTLVAIRSINVTSCKSEEAEFVKGLYLLTSLRHENIIRLRGFCC 476
           LG G F  V  G  R    VAI+ I   S    E EF++   ++ +L HE +++L G C 
Sbjct: 23  LGTGQFGVVKYGKWRGQYDVAIKMIKEGSMS--EDEFIEEAKVMMNLSHEKLVQLYGVCT 80
Query: 477 SRGRGECFLIYDFAPKGKLSKYLDQEEGSSNVLDWSTRVSIIIGIAKGIGYLHSSEVNKP 536
            +     F+I ++   G L  YL +             + +   + + + YL S +    
Sbjct: 81  KQR--PIFIITEYMANGCLLNYLREMRHRFQT---QQLLEMCKDVCEAMEYLESKQ---- 131
Query: 537 AIVHRNLSVEKVLIDQQFNPLIADCGLHKLLADDIVFSVLKTSAAMGYLAPEYVTTGRFT 596
             +HR+L+    L++ Q    ++D GL + + DD   S + +   + +  PE +   +F+
Sbjct: 132 -FLHRDLAARNCLVNDQGVVKVSDFGLSRYVLDDEYTSSVGSKFPVRWSPPEVLMYSKFS 190
Query: 597 ERSDIFAFGVIILQILTGSLVLTSSMRLAAESATFENFIDRNLKGKFSESEAAKLGKMAL 656
            +SDI+AFGV++ +I   SL      R    S T E+ I + L+       + K+  +  
Sbjct: 191 SKSDIWAFGVLMWEIY--SLGKMPYERF-TNSETAEH-IAQGLRLYRPHLASEKVYTIMY 246
Query: 657 VCTHEDPENRPTMEAVI 673
            C HE  + RPT + ++
Sbjct: 247 SCWHEKADERPTFKILL 263

>pdb|3K54|A Chain A, Structures Of Human Bruton's Tyrosine Kinase In Active And Inactive Conformations Suggests A Mechanism Of Activation For Tec Family Kinases Length = 283

Iteration: 1
 Score = 79.7 bits (195), Expect = 6e-15,   Method: Compositional matrix adjust.
 Identities = 67/257 (26%), Positives = 118/257 (45%), Gaps = 16/257 (6%)
Query: 417 LGKGNFSSVYKGTLRDGTLVAIRSINVTSCKSEEAEFVKGLYLLTSLRHENIIRLRGFCC 476
           LG G F  V  G  R    VAI+ I   S    E EF++   ++ +L HE +++L G C 
Sbjct: 32  LGTGQFGVVKYGKWRGQYDVAIKMIKEGSMS--EDEFIEEAKVMMNLSHEKLVQLYGVCT 89
Query: 477 SRGRGECFLIYDFAPKGKLSKYLDQEEGSSNVLDWSTRVSIIIGIAKGIGYLHSSEVNKP 536
            +     F+I ++   G L  YL +             + +   + + + YL S +    
Sbjct: 90  KQR--PIFIITEYMANGCLLNYLREMRHRFQT---QQLLEMCKDVCEAMEYLESKQ---- 140
Query: 537 AIVHRNLSVEKVLIDQQFNPLIADCGLHKLLADDIVFSVLKTSAAMGYLAPEYVTTGRFT 596
             +HR+L+    L++ Q    ++D GL + + DD   S + +   + +  PE +   +F+
Sbjct: 141 -FLHRDLAARNCLVNDQGVVKVSDFGLSRYVLDDEETSSVGSKFPVRWSPPEVLMYSKFS 199
Query: 597 ERSDIFAFGVIILQILTGSLVLTSSMRLAAESATFENFIDRNLKGKFSESEAAKLGKMAL 656
            +SDI+AFGV++ +I   SL      R    S T E+ I + L+       + K+  +  
Sbjct: 200 SKSDIWAFGVLMWEIY--SLGKMPYERF-TNSETAEH-IAQGLRLYRPHLASEKVYTIMY 255
Query: 657 VCTHEDPENRPTMEAVI 673
            C HE  + RPT + ++
Sbjct: 256 SCWHEKADERPTFKILL 272

>pdb|3IKA|A Chain A, Crystal Structure Of Egfr 696-1022 T790m Mutant Covalently Binding To Wz4002 Length = 331

Iteration: 1
 Score = 79.3 bits (194), Expect = 6e-15,   Method: Compositional matrix adjust.
 Identities = 57/212 (26%), Positives = 102/212 (48%), Gaps = 23/212 (10%)
Query: 411 FSEVNLLGKGNFSSVYKGTL-----RDGTLVAIRSINVTSCKSEEAEFVKGLYLLTSLRH 465
           F ++ +LG G F +VYKG       +    VAI+ +   +      E +   Y++ S+ +
Sbjct: 21  FKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDN 80
Query: 466 ENIIRLRGFCCSRGRGECFLIYDFAPKGKLSKYLDQEE---GSSNVLDWSTRVSIIIGIA 522
            ++ RL G C +       LI    P G L  Y+ + +   GS  +L+W       + IA
Sbjct: 81  PHVCRLLGICLT---STVQLIMQLMPFGCLLDYVREHKDNIGSQYLLNWC------VQIA 131
Query: 523 KGIGYLHSSEVNKPAIVHRNLSVEKVLIDQQFNPLIADCGLHKLL-ADDIVFSVLKTSAA 581
           KG+ YL         +VHR+L+   VL+    +  I D GL KLL A++  +        
Sbjct: 132 KGMNYLEDRR-----LVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVP 186
Query: 582 MGYLAPEYVTTGRFTERSDIFAFGVIILQILT 613
           + ++A E +    +T +SD++++GV + +++T
Sbjct: 187 IKWMALESILHRIYTHQSDVWSYGVTVWELMT 218

>pdb|3NZ0|A Chain A, Non-Phosphorylated Tyk2 Kinase With Cmp6 Length = 302

Iteration: 1
 Score = 79.3 bits (194), Expect = 6e-15,   Method: Compositional matrix adjust.
 Identities = 57/212 (26%), Positives = 107/212 (50%), Gaps = 21/212 (9%)
Query: 411 FSEVNLLGKGNFSSV----YKGTLRDGT--LVAIRSINVTSCKSEEAEFVKGLYLLTSLR 464
             ++  LG+G+F  V    Y  T  DGT  +VA++++         + + + + +L +L 
Sbjct: 16  LKKIRDLGEGHFGKVSLYCYDPT-NDGTGEMVAVKALKADCGPQHRSGWKQEIDILRTLY 74
Query: 465 HENIIRLRGFCCSRGRGECFLIYDFAPKGKLSKYLDQEE-GSSNVLDWSTRVSIIIGIAK 523
           HE+II+ +G C  +G     L+ ++ P G L  YL +   G + +L ++ +      I +
Sbjct: 75  HEHIIKYKGCCEDQGEKSLQLVMEYVPLGSLRDYLPRHSIGLAQLLLFAQQ------ICE 128
Query: 524 GIGYLHSSEVNKPAIVHRNLSVEKVLIDQQFNPLIADCGLHKLLADDIVFSVLKT--SAA 581
           G+ YLH+        +HRNL+   VL+D      I D GL K + +   +  ++    + 
Sbjct: 129 GMAYLHAQHY-----IHRNLAARNVLLDNDRLVKIGDFGLAKAVPEGHEYYRVREDGDSP 183
Query: 582 MGYLAPEYVTTGRFTERSDIFAFGVIILQILT 613
           + + APE +   +F   SD+++FGV + ++LT
Sbjct: 184 VFWYAPECLKEYKFYYASDVWSFGVTLYELLT 215

>pdb|2JIT|A Chain A, Crystal Structure Of Egfr Kinase Domain T790m Mutation Length = 327

Iteration: 1
 Score = 79.3 bits (194), Expect = 6e-15,   Method: Compositional matrix adjust.
 Identities = 57/212 (26%), Positives = 102/212 (48%), Gaps = 23/212 (10%)
Query: 411 FSEVNLLGKGNFSSVYKGTL-----RDGTLVAIRSINVTSCKSEEAEFVKGLYLLTSLRH 465
           F ++ +LG G F +VYKG       +    VAI+ +   +      E +   Y++ S+ +
Sbjct: 17  FKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDN 76
Query: 466 ENIIRLRGFCCSRGRGECFLIYDFAPKGKLSKYLDQEE---GSSNVLDWSTRVSIIIGIA 522
            ++ RL G C +       LI    P G L  Y+ + +   GS  +L+W       + IA
Sbjct: 77  PHVCRLLGICLT---STVQLIMQLMPFGCLLDYVREHKDNIGSQYLLNWC------VQIA 127
Query: 523 KGIGYLHSSEVNKPAIVHRNLSVEKVLIDQQFNPLIADCGLHKLL-ADDIVFSVLKTSAA 581
           KG+ YL         +VHR+L+   VL+    +  I D GL KLL A++  +        
Sbjct: 128 KGMNYLEDRR-----LVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVP 182
Query: 582 MGYLAPEYVTTGRFTERSDIFAFGVIILQILT 613
           + ++A E +    +T +SD++++GV + +++T
Sbjct: 183 IKWMALESILHRIYTHQSDVWSYGVTVWELMT 214

>pdb|3P08|A Chain A, Crystal Structure Of The Human Btk Kinase Domain Length = 267

Iteration: 1
 Score = 79.3 bits (194), Expect = 6e-15,   Method: Compositional matrix adjust.
 Identities = 67/257 (26%), Positives = 118/257 (45%), Gaps = 16/257 (6%)
Query: 417 LGKGNFSSVYKGTLRDGTLVAIRSINVTSCKSEEAEFVKGLYLLTSLRHENIIRLRGFCC 476
           LG G F  V  G  R    VAI+ I   S    E EF++   ++ +L HE +++L G C 
Sbjct: 16  LGTGQFGVVKYGKWRGQYDVAIKMIKEGSMS--EDEFIEEAKVMMNLSHEKLVQLYGVCT 73
Query: 477 SRGRGECFLIYDFAPKGKLSKYLDQEEGSSNVLDWSTRVSIIIGIAKGIGYLHSSEVNKP 536
            +     F+I ++   G L  YL +             + +   + + + YL S +    
Sbjct: 74  KQR--PIFIITEYMANGCLLNYLREMRHRFQT---QQLLEMCKDVCEAMEYLESKQ---- 124
Query: 537 AIVHRNLSVEKVLIDQQFNPLIADCGLHKLLADDIVFSVLKTSAAMGYLAPEYVTTGRFT 596
             +HR+L+    L++ Q    ++D GL + + DD   S + +   + +  PE +   +F+
Sbjct: 125 -FLHRDLAARNCLVNDQGVVKVSDFGLSRYVLDDEYTSSVGSKFPVRWSPPEVLMYSKFS 183
Query: 597 ERSDIFAFGVIILQILTGSLVLTSSMRLAAESATFENFIDRNLKGKFSESEAAKLGKMAL 656
            +SDI+AFGV++ +I   SL      R    S T E+ I + L+       + K+  +  
Sbjct: 184 SKSDIWAFGVLMWEIY--SLGKMPYERF-TNSETAEH-IAQGLRLYRPHLASEKVYTIMY 239
Query: 657 VCTHEDPENRPTMEAVI 673
            C HE  + RPT + ++
Sbjct: 240 SCWHEKADERPTFKILL 256

>pdb|4G5P|A Chain A, Crystal Structure Of Egfr Kinase T790m In Complex With Bibw2992 Length = 330

Iteration: 1
 Score = 79.3 bits (194), Expect = 7e-15,   Method: Compositional matrix adjust.
 Identities = 57/212 (26%), Positives = 102/212 (48%), Gaps = 23/212 (10%)
Query: 411 FSEVNLLGKGNFSSVYKGTL-----RDGTLVAIRSINVTSCKSEEAEFVKGLYLLTSLRH 465
           F ++ +LG G F +VYKG       +    VAI+ +   +      E +   Y++ S+ +
Sbjct: 20  FKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDN 79
Query: 466 ENIIRLRGFCCSRGRGECFLIYDFAPKGKLSKYLDQEE---GSSNVLDWSTRVSIIIGIA 522
            ++ RL G C +       LI    P G L  Y+ + +   GS  +L+W       + IA
Sbjct: 80  PHVCRLLGICLT---STVQLIMQLMPFGCLLDYVREHKDNIGSQYLLNWC------VQIA 130
Query: 523 KGIGYLHSSEVNKPAIVHRNLSVEKVLIDQQFNPLIADCGLHKLL-ADDIVFSVLKTSAA 581
           KG+ YL         +VHR+L+   VL+    +  I D GL KLL A++  +        
Sbjct: 131 KGMNYLEDRR-----LVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVP 185
Query: 582 MGYLAPEYVTTGRFTERSDIFAFGVIILQILT 613
           + ++A E +    +T +SD++++GV + +++T
Sbjct: 186 IKWMALESILHRIYTHQSDVWSYGVTVWELMT 217

>pdb|2QO7|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Dephosphorylated, Amp-Pnp Bound Length = 373

Iteration: 1
 Score = 79.3 bits (194), Expect = 7e-15,   Method: Compositional matrix adjust.
 Identities = 61/267 (22%), Positives = 117/267 (43%), Gaps = 24/267 (8%)
Query: 415 NLLGKGNFSSVYKGTLR----DGTLVAIRSINVTSCKSEEAEFVKGLYLLTSLRHENIIR 470
            ++G G F  V  G L+        VAI+++ V   + +  +F+    ++    H NIIR
Sbjct: 51  KVVGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYTEKQRRDFLGEASIMGQFDHPNIIR 110
Query: 471 LRGFCCSRGRGECFLIYDFAPKGKLSKYLDQEEGSSNVLDWSTRVSIIIGIAKGIGYLHS 530
           L G           ++ +    G L  +L + +    V+     V ++ GIA G+ YL  
Sbjct: 111 LEGVVTKSK--PVMIVTEXMENGSLDSFLRKHDAQFTVIQ---LVGMLRGIASGMKYLSD 165
Query: 531 SEVNKPAIVHRNLSVEKVLIDQQFNPLIADCGLHKLLADD--IVFSVLKTSAAMGYLAPE 588
                   VHR+L+   +LI+      ++D GL ++L DD    ++       + + +PE
Sbjct: 166 M-----GYVHRDLAARNILINSNLVCKVSDFGLSRVLEDDPEAAYTTRGGKIPIRWTSPE 220
Query: 589 YVTTGRFTERSDIFAFGVIILQILTGSLVLTSSMRLAAESATFE--NFIDRNLKGKFSES 646
            +   +FT  SD++++G+++ +      V++   R   E +  +    +D   +      
Sbjct: 221 AIAYRKFTSASDVWSYGIVLWE------VMSYGERPYWEMSNQDVIKAVDEGYRLPPPMD 274
Query: 647 EAAKLGKMALVCTHEDPENRPTMEAVI 673
             A L ++ L C  +D  NRP  E ++
Sbjct: 275 CPAALYQLMLDCWQKDRNNRPKFEQIV 301

>pdb|2JIU|A Chain A, Crystal Structure Of Egfr Kinase Domain T790m Mutation In Complex With Aee788 Length = 328

Iteration: 1
 Score = 79.3 bits (194), Expect = 7e-15,   Method: Compositional matrix adjust.
 Identities = 57/212 (26%), Positives = 102/212 (48%), Gaps = 23/212 (10%)
Query: 411 FSEVNLLGKGNFSSVYKGTL-----RDGTLVAIRSINVTSCKSEEAEFVKGLYLLTSLRH 465
           F ++ +LG G F +VYKG       +    VAI+ +   +      E +   Y++ S+ +
Sbjct: 18  FKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDN 77
Query: 466 ENIIRLRGFCCSRGRGECFLIYDFAPKGKLSKYLDQEE---GSSNVLDWSTRVSIIIGIA 522
            ++ RL G C +       LI    P G L  Y+ + +   GS  +L+W       + IA
Sbjct: 78  PHVCRLLGICLT---STVQLIMQLMPFGCLLDYVREHKDNIGSQYLLNWC------VQIA 128
Query: 523 KGIGYLHSSEVNKPAIVHRNLSVEKVLIDQQFNPLIADCGLHKLL-ADDIVFSVLKTSAA 581
           KG+ YL         +VHR+L+   VL+    +  I D GL KLL A++  +        
Sbjct: 129 KGMNYLEDRR-----LVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVP 183
Query: 582 MGYLAPEYVTTGRFTERSDIFAFGVIILQILT 613
           + ++A E +    +T +SD++++GV + +++T
Sbjct: 184 IKWMALESILHRIYTHQSDVWSYGVTVWELMT 215

>pdb|4I24|A Chain A, Structure Of T790m Egfr Kinase Domain Co-crystallized With Dacomitinib Length = 329

Iteration: 1
 Score = 79.3 bits (194), Expect = 7e-15,   Method: Compositional matrix adjust.
 Identities = 57/212 (26%), Positives = 102/212 (48%), Gaps = 23/212 (10%)
Query: 411 FSEVNLLGKGNFSSVYKGTL-----RDGTLVAIRSINVTSCKSEEAEFVKGLYLLTSLRH 465
           F ++ +LG G F +VYKG       +    VAI+ +   +      E +   Y++ S+ +
Sbjct: 19  FKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDN 78
Query: 466 ENIIRLRGFCCSRGRGECFLIYDFAPKGKLSKYLDQEE---GSSNVLDWSTRVSIIIGIA 522
            ++ RL G C +       LI    P G L  Y+ + +   GS  +L+W       + IA
Sbjct: 79  PHVCRLLGICLT---STVQLIMQLMPFGCLLDYVREHKDNIGSQYLLNWC------VQIA 129
Query: 523 KGIGYLHSSEVNKPAIVHRNLSVEKVLIDQQFNPLIADCGLHKLL-ADDIVFSVLKTSAA 581
           KG+ YL         +VHR+L+   VL+    +  I D GL KLL A++  +        
Sbjct: 130 KGMNYLEDRR-----LVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVP 184
Query: 582 MGYLAPEYVTTGRFTERSDIFAFGVIILQILT 613
           + ++A E +    +T +SD++++GV + +++T
Sbjct: 185 IKWMALESILHRIYTHQSDVWSYGVTVWELMT 216

>pdb|2QON|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f:y742a Triple Mutant Length = 373

Iteration: 1
 Score = 79.0 bits (193), Expect = 8e-15,   Method: Compositional matrix adjust.
 Identities = 61/267 (22%), Positives = 117/267 (43%), Gaps = 24/267 (8%)
Query: 415 NLLGKGNFSSVYKGTLR----DGTLVAIRSINVTSCKSEEAEFVKGLYLLTSLRHENIIR 470
            ++G G F  V  G L+        VAI+++ V   + +  +F+    ++    H NIIR
Sbjct: 51  KVVGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYTEKQRRDFLGEASIMGQFDHPNIIR 110
Query: 471 LRGFCCSRGRGECFLIYDFAPKGKLSKYLDQEEGSSNVLDWSTRVSIIIGIAKGIGYLHS 530
           L G           ++ +    G L  +L + +    V+     V ++ GIA G+ YL  
Sbjct: 111 LEGVVTKSK--PVMIVTEXMENGSLDSFLRKHDAQFTVIQ---LVGMLRGIASGMKYLSD 165
Query: 531 SEVNKPAIVHRNLSVEKVLIDQQFNPLIADCGLHKLLADD--IVFSVLKTSAAMGYLAPE 588
                   VHR+L+   +LI+      ++D GL ++L DD    ++       + + +PE
Sbjct: 166 M-----GAVHRDLAARNILINSNLVCKVSDFGLSRVLEDDPEAAYTTRGGKIPIRWTSPE 220
Query: 589 YVTTGRFTERSDIFAFGVIILQILTGSLVLTSSMRLAAESATFE--NFIDRNLKGKFSES 646
            +   +FT  SD++++G+++ +      V++   R   E +  +    +D   +      
Sbjct: 221 AIAYRKFTSASDVWSYGIVLWE------VMSYGERPYWEMSNQDVIKAVDEGYRLPPPMD 274
Query: 647 EAAKLGKMALVCTHEDPENRPTMEAVI 673
             A L ++ L C  +D  NRP  E ++
Sbjct: 275 CPAALYQLMLDCWQKDRNNRPKFEQIV 301

>pdb|1M14|A Chain A, Tyrosine Kinase Domain From Epidermal Growth Factor Receptor Length = 333

Iteration: 1
 Score = 79.0 bits (193), Expect = 8e-15,   Method: Compositional matrix adjust.
 Identities = 57/212 (26%), Positives = 102/212 (48%), Gaps = 23/212 (10%)
Query: 411 FSEVNLLGKGNFSSVYKGTL-----RDGTLVAIRSINVTSCKSEEAEFVKGLYLLTSLRH 465
           F ++ +LG G F +VYKG       +    VAI+ +   +      E +   Y++ S+ +
Sbjct: 23  FKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDN 82
Query: 466 ENIIRLRGFCCSRGRGECFLIYDFAPKGKLSKYLDQEE---GSSNVLDWSTRVSIIIGIA 522
            ++ RL G C +       LI    P G L  Y+ + +   GS  +L+W       + IA
Sbjct: 83  PHVCRLLGICLT---STVQLITQLMPFGCLLDYVREHKDNIGSQYLLNWC------VQIA 133
Query: 523 KGIGYLHSSEVNKPAIVHRNLSVEKVLIDQQFNPLIADCGLHKLL-ADDIVFSVLKTSAA 581
           KG+ YL         +VHR+L+   VL+    +  I D GL KLL A++  +        
Sbjct: 134 KGMNYLEDRR-----LVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVP 188
Query: 582 MGYLAPEYVTTGRFTERSDIFAFGVIILQILT 613
           + ++A E +    +T +SD++++GV + +++T
Sbjct: 189 IKWMALESILHRIYTHQSDVWSYGVTVWELMT 220

>pdb|2QOB|A Chain A, Human Epha3 Kinase Domain, Base Structure Length = 344

Iteration: 1
 Score = 79.0 bits (193), Expect = 8e-15,   Method: Compositional matrix adjust.
 Identities = 61/267 (22%), Positives = 117/267 (43%), Gaps = 24/267 (8%)
Query: 415 NLLGKGNFSSVYKGTLR----DGTLVAIRSINVTSCKSEEAEFVKGLYLLTSLRHENIIR 470
            ++G G F  V  G L+        VAI+++ V   + +  +F+    ++    H NIIR
Sbjct: 22  KVVGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYTEKQRRDFLGEASIMGQFDHPNIIR 81
Query: 471 LRGFCCSRGRGECFLIYDFAPKGKLSKYLDQEEGSSNVLDWSTRVSIIIGIAKGIGYLHS 530
           L G           ++ +    G L  +L + +    V+     V ++ GIA G+ YL  
Sbjct: 82  LEGVVTKSK--PVMIVTEXMENGSLDSFLRKHDAQFTVIQ---LVGMLRGIASGMKYLSD 136
Query: 531 SEVNKPAIVHRNLSVEKVLIDQQFNPLIADCGLHKLLADD--IVFSVLKTSAAMGYLAPE 588
                   VHR+L+   +LI+      ++D GL ++L DD    ++       + + +PE
Sbjct: 137 M-----GYVHRDLAARNILINSNLVCKVSDFGLSRVLEDDPEAAYTTRGGKIPIRWTSPE 191
Query: 589 YVTTGRFTERSDIFAFGVIILQILTGSLVLTSSMRLAAESATFE--NFIDRNLKGKFSES 646
            +   +FT  SD++++G+++ +      V++   R   E +  +    +D   +      
Sbjct: 192 AIAYRKFTSASDVWSYGIVLWE------VMSYGERPYWEMSNQDVIKAVDEGYRLPPPMD 245
Query: 647 EAAKLGKMALVCTHEDPENRPTMEAVI 673
             A L ++ L C  +D  NRP  E ++
Sbjct: 246 CPAALYQLMLDCWQKDRNNRPKFEQIV 272

>pdb|2GS7|A Chain A, Crystal Structure Of The Inactive Egfr Kinase Domain In Complex With Amp-Pnp Length = 330

Iteration: 1
 Score = 79.0 bits (193), Expect = 8e-15,   Method: Compositional matrix adjust.
 Identities = 57/212 (26%), Positives = 102/212 (48%), Gaps = 23/212 (10%)
Query: 411 FSEVNLLGKGNFSSVYKGTL-----RDGTLVAIRSINVTSCKSEEAEFVKGLYLLTSLRH 465
           F ++ +LG G F +VYKG       +    VAI+ +   +      E +   Y++ S+ +
Sbjct: 20  FKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDN 79
Query: 466 ENIIRLRGFCCSRGRGECFLIYDFAPKGKLSKYLDQEE---GSSNVLDWSTRVSIIIGIA 522
            ++ RL G C +       LI    P G L  Y+ + +   GS  +L+W       + IA
Sbjct: 80  PHVCRLLGICLT---STVQLITQLMPFGCLLDYVREHKDNIGSQYLLNWC------VQIA 130
Query: 523 KGIGYLHSSEVNKPAIVHRNLSVEKVLIDQQFNPLIADCGLHKLL-ADDIVFSVLKTSAA 581
           KG+ YL         +VHR+L+   VL+    +  I D GL KLL A++  +        
Sbjct: 131 KGMNYLEDRR-----LVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVP 185
Query: 582 MGYLAPEYVTTGRFTERSDIFAFGVIILQILT 613
           + ++A E +    +T +SD++++GV + +++T
Sbjct: 186 IKWMALESILHRIYTHQSDVWSYGVTVWELMT 217

>pdb|2J5F|A Chain A, Crystal Structure Of Egfr Kinase Domain In Complex With An Irreversible Inhibitor 34-Jab Length = 327

Iteration: 1
 Score = 79.0 bits (193), Expect = 8e-15,   Method: Compositional matrix adjust.
 Identities = 57/212 (26%), Positives = 102/212 (48%), Gaps = 23/212 (10%)
Query: 411 FSEVNLLGKGNFSSVYKGTL-----RDGTLVAIRSINVTSCKSEEAEFVKGLYLLTSLRH 465
           F ++ +LG G F +VYKG       +    VAI+ +   +      E +   Y++ S+ +
Sbjct: 17  FKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDN 76
Query: 466 ENIIRLRGFCCSRGRGECFLIYDFAPKGKLSKYLDQEE---GSSNVLDWSTRVSIIIGIA 522
            ++ RL G C +       LI    P G L  Y+ + +   GS  +L+W       + IA
Sbjct: 77  PHVCRLLGICLT---STVQLITQLMPFGCLLDYVREHKDNIGSQYLLNWC------VQIA 127
Query: 523 KGIGYLHSSEVNKPAIVHRNLSVEKVLIDQQFNPLIADCGLHKLL-ADDIVFSVLKTSAA 581
           KG+ YL         +VHR+L+   VL+    +  I D GL KLL A++  +        
Sbjct: 128 KGMNYLEDRR-----LVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVP 182
Query: 582 MGYLAPEYVTTGRFTERSDIFAFGVIILQILT 613
           + ++A E +    +T +SD++++GV + +++T
Sbjct: 183 IKWMALESILHRIYTHQSDVWSYGVTVWELMT 214

>pdb|3VJO|A Chain A, Crystal Structure Of The Wild-Type Egfr Kinase Domain In Complex With Amppnp Length = 334

Iteration: 1
 Score = 79.0 bits (193), Expect = 9e-15,   Method: Compositional matrix adjust.
 Identities = 57/212 (26%), Positives = 102/212 (48%), Gaps = 23/212 (10%)
Query: 411 FSEVNLLGKGNFSSVYKGTL-----RDGTLVAIRSINVTSCKSEEAEFVKGLYLLTSLRH 465
           F ++ +LG G F +VYKG       +    VAI+ +   +      E +   Y++ S+ +
Sbjct: 24  FKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDN 83
Query: 466 ENIIRLRGFCCSRGRGECFLIYDFAPKGKLSKYLDQEE---GSSNVLDWSTRVSIIIGIA 522
            ++ RL G C +       LI    P G L  Y+ + +   GS  +L+W       + IA
Sbjct: 84  PHVCRLLGICLT---STVQLITQLMPFGCLLDYVREHKDNIGSQYLLNWC------VQIA 134
Query: 523 KGIGYLHSSEVNKPAIVHRNLSVEKVLIDQQFNPLIADCGLHKLL-ADDIVFSVLKTSAA 581
           KG+ YL         +VHR+L+   VL+    +  I D GL KLL A++  +        
Sbjct: 135 KGMNYLEDRR-----LVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVP 189
Query: 582 MGYLAPEYVTTGRFTERSDIFAFGVIILQILT 613
           + ++A E +    +T +SD++++GV + +++T
Sbjct: 190 IKWMALESILHRIYTHQSDVWSYGVTVWELMT 221

>pdb|2P0C|A Chain A, Catalytic Domain Of The Proto-Oncogene Tyrosine-Protein Kina Length = 313

Iteration: 1
 Score = 79.0 bits (193), Expect = 9e-15,   Method: Compositional matrix adjust.
 Identities = 71/281 (25%), Positives = 127/281 (45%), Gaps = 23/281 (8%)
Query: 415 NLLGKGNFSSVYKGTLR--DGT--LVAIRSINV-TSCKSEEAEFVKGLYLLTSLRHENII 469
            +LG+G F SV +G L+  DGT   VA++++ +  S + E  EF+     +    H N+I
Sbjct: 40  KILGEGEFGSVMEGNLKQEDGTSLKVAVKTMKLDNSSQREIEEFLSEAACMKDFSHPNVI 99
Query: 470 RLRGFCC---SRGRGECFLIYDFAPKGKLSKYL--DQEEGSSNVLDWSTRVSIIIGIAKG 524
           RL G C    S+G  +  +I  F   G L  YL   + E     +   T +  ++ IA G
Sbjct: 100 RLLGVCIEMSSQGIPKPMVILPFMKYGDLHTYLLYSRLETGPKHIPLQTLLKFMVDIALG 159
Query: 525 IGYLHSSEVNKPAIVHRNLSVEKVLIDQQFNPLIADCGL-HKLLADDIVFSVLKTSAAMG 583
           + YL +        +HR+L+    ++       +AD GL  K+ + D           + 
Sbjct: 160 MEYLSNRN-----FLHRDLAARNCMLRDDMTVCVADFGLSKKIYSGDYYRQGRIAKMPVK 214
Query: 584 YLAPEYVTTGRFTERSDIFAFGVIILQILTGSLVLTSSMRLAAESATFENFIDRNLKGKF 643
           ++A E +    +T +SD++AFGV + +I T  +          ++    +++    + K 
Sbjct: 215 WIAIESLADRVYTSKSDVWAFGVTMWEIATRGMTPYP----GVQNHEMYDYLLHGHRLKQ 270
Query: 644 SESEAAKLGKMALVCTHEDPENRPTMEAV---IEELTVAAP 681
            E    +L ++   C   DP +RPT   +   +E+L  + P
Sbjct: 271 PEDCLDELYEIMYSCWRTDPLDRPTFSVLRLQLEKLLESLP 311

>pdb|1K2P|A Chain A, Crystal Structure Of Bruton's Tyrosine Kinase Domain Length = 263

Iteration: 1
 Score = 79.0 bits (193), Expect = 9e-15,   Method: Compositional matrix adjust.
 Identities = 67/257 (26%), Positives = 118/257 (45%), Gaps = 16/257 (6%)
Query: 417 LGKGNFSSVYKGTLRDGTLVAIRSINVTSCKSEEAEFVKGLYLLTSLRHENIIRLRGFCC 476
           LG G F  V  G  R    VAI+ I   S    E EF++   ++ +L HE +++L G C 
Sbjct: 12  LGTGQFGVVKYGKWRGQYDVAIKMIKEGSMS--EDEFIEEAKVMMNLSHEKLVQLYGVCT 69
Query: 477 SRGRGECFLIYDFAPKGKLSKYLDQEEGSSNVLDWSTRVSIIIGIAKGIGYLHSSEVNKP 536
            +     F+I ++   G L  YL +             + +   + + + YL S +    
Sbjct: 70  KQR--PIFIITEYMANGCLLNYLREMRHRFQT---QQLLEMCKDVCEAMEYLESKQ---- 120
Query: 537 AIVHRNLSVEKVLIDQQFNPLIADCGLHKLLADDIVFSVLKTSAAMGYLAPEYVTTGRFT 596
             +HR+L+    L++ Q    ++D GL + + DD   S + +   + +  PE +   +F+
Sbjct: 121 -FLHRDLAARNCLVNDQGVVKVSDFGLSRYVLDDEYTSSVGSKFPVRWSPPEVLMYSKFS 179
Query: 597 ERSDIFAFGVIILQILTGSLVLTSSMRLAAESATFENFIDRNLKGKFSESEAAKLGKMAL 656
            +SDI+AFGV++ +I   SL      R    S T E+ I + L+       + K+  +  
Sbjct: 180 SKSDIWAFGVLMWEIY--SLGKMPYERF-TNSETAEH-IAQGLRLYRPHLASEKVYTIMY 235
Query: 657 VCTHEDPENRPTMEAVI 673
            C HE  + RPT + ++
Sbjct: 236 SCWHEKADERPTFKILL 252

>pdb|4HJO|A Chain A, Crystal Structure Of The Inactive Egfr Tyrosine Kinase Domain With Erlotinib Length = 337

Iteration: 1
 Score = 79.0 bits (193), Expect = 9e-15,   Method: Compositional matrix adjust.
 Identities = 57/212 (26%), Positives = 102/212 (48%), Gaps = 23/212 (10%)
Query: 411 FSEVNLLGKGNFSSVYKGTL-----RDGTLVAIRSINVTSCKSEEAEFVKGLYLLTSLRH 465
           F ++ +LG G F +VYKG       +    VAI+ +   +      E +   Y++ S+ +
Sbjct: 27  FKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDN 86
Query: 466 ENIIRLRGFCCSRGRGECFLIYDFAPKGKLSKYLDQEE---GSSNVLDWSTRVSIIIGIA 522
            ++ RL G C +       LI    P G L  Y+ + +   GS  +L+W       + IA
Sbjct: 87  PHVCRLLGICLT---STVQLITQLMPFGCLLDYVREHKDNIGSQYLLNWC------VQIA 137
Query: 523 KGIGYLHSSEVNKPAIVHRNLSVEKVLIDQQFNPLIADCGLHKLL-ADDIVFSVLKTSAA 581
           KG+ YL         +VHR+L+   VL+    +  I D GL KLL A++  +        
Sbjct: 138 KGMNYLEDRR-----LVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVP 192
Query: 582 MGYLAPEYVTTGRFTERSDIFAFGVIILQILT 613
           + ++A E +    +T +SD++++GV + +++T
Sbjct: 193 IKWMALESILHRIYTHQSDVWSYGVTVWELMT 224

>pdb|4I23|A Chain A, Crystal Structure Of The Wild-type Egfr Kinase Domain In Complex With Dacomitinib (soaked) Length = 329

Iteration: 1
 Score = 79.0 bits (193), Expect = 9e-15,   Method: Compositional matrix adjust.
 Identities = 57/212 (26%), Positives = 102/212 (48%), Gaps = 23/212 (10%)
Query: 411 FSEVNLLGKGNFSSVYKGTL-----RDGTLVAIRSINVTSCKSEEAEFVKGLYLLTSLRH 465
           F ++ +LG G F +VYKG       +    VAI+ +   +      E +   Y++ S+ +
Sbjct: 19  FKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDN 78
Query: 466 ENIIRLRGFCCSRGRGECFLIYDFAPKGKLSKYLDQEE---GSSNVLDWSTRVSIIIGIA 522
            ++ RL G C +       LI    P G L  Y+ + +   GS  +L+W       + IA
Sbjct: 79  PHVCRLLGICLT---STVQLITQLMPFGCLLDYVREHKDNIGSQYLLNWC------VQIA 129
Query: 523 KGIGYLHSSEVNKPAIVHRNLSVEKVLIDQQFNPLIADCGLHKLL-ADDIVFSVLKTSAA 581
           KG+ YL         +VHR+L+   VL+    +  I D GL KLL A++  +        
Sbjct: 130 KGMNYLEDRR-----LVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVP 184
Query: 582 MGYLAPEYVTTGRFTERSDIFAFGVIILQILT 613
           + ++A E +    +T +SD++++GV + +++T
Sbjct: 185 IKWMALESILHRIYTHQSDVWSYGVTVWELMT 216

>pdb|4G5J|A Chain A, Crystal Structure Of Egfr Kinase In Complex With Bibw2992 Length = 330

Iteration: 1
 Score = 79.0 bits (193), Expect = 9e-15,   Method: Compositional matrix adjust.
 Identities = 57/212 (26%), Positives = 102/212 (48%), Gaps = 23/212 (10%)
Query: 411 FSEVNLLGKGNFSSVYKGTL-----RDGTLVAIRSINVTSCKSEEAEFVKGLYLLTSLRH 465
           F ++ +LG G F +VYKG       +    VAI+ +   +      E +   Y++ S+ +
Sbjct: 20  FKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDN 79
Query: 466 ENIIRLRGFCCSRGRGECFLIYDFAPKGKLSKYLDQEE---GSSNVLDWSTRVSIIIGIA 522
            ++ RL G C +       LI    P G L  Y+ + +   GS  +L+W       + IA
Sbjct: 80  PHVCRLLGICLT---STVQLITQLMPFGCLLDYVREHKDNIGSQYLLNWC------VQIA 130
Query: 523 KGIGYLHSSEVNKPAIVHRNLSVEKVLIDQQFNPLIADCGLHKLL-ADDIVFSVLKTSAA 581
           KG+ YL         +VHR+L+   VL+    +  I D GL KLL A++  +        
Sbjct: 131 KGMNYLEDRR-----LVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVP 185
Query: 582 MGYLAPEYVTTGRFTERSDIFAFGVIILQILT 613
           + ++A E +    +T +SD++++GV + +++T
Sbjct: 186 IKWMALESILHRIYTHQSDVWSYGVTVWELMT 217

>pdb|1XKK|A Chain A, Egfr Kinase Domain Complexed With A Quinazoline Inhibitor- Gw572016 Length = 352

Iteration: 1
 Score = 79.0 bits (193), Expect = 9e-15,   Method: Compositional matrix adjust.
 Identities = 57/212 (26%), Positives = 102/212 (48%), Gaps = 23/212 (10%)
Query: 411 FSEVNLLGKGNFSSVYKGTL-----RDGTLVAIRSINVTSCKSEEAEFVKGLYLLTSLRH 465
           F ++ +LG G F +VYKG       +    VAI+ +   +      E +   Y++ S+ +
Sbjct: 42  FKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDN 101
Query: 466 ENIIRLRGFCCSRGRGECFLIYDFAPKGKLSKYLDQEE---GSSNVLDWSTRVSIIIGIA 522
            ++ RL G C +       LI    P G L  Y+ + +   GS  +L+W       + IA
Sbjct: 102 PHVCRLLGICLT---STVQLITQLMPFGCLLDYVREHKDNIGSQYLLNWC------VQIA 152
Query: 523 KGIGYLHSSEVNKPAIVHRNLSVEKVLIDQQFNPLIADCGLHKLL-ADDIVFSVLKTSAA 581
           KG+ YL         +VHR+L+   VL+    +  I D GL KLL A++  +        
Sbjct: 153 KGMNYLEDRR-----LVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVP 207
Query: 582 MGYLAPEYVTTGRFTERSDIFAFGVIILQILT 613
           + ++A E +    +T +SD++++GV + +++T
Sbjct: 208 IKWMALESILHRIYTHQSDVWSYGVTVWELMT 239

>pdb|2GS2|A Chain A, Crystal Structure Of The Active Egfr Kinase Domain Length = 330

Iteration: 1
 Score = 78.6 bits (192), Expect = 1e-14,   Method: Compositional matrix adjust.
 Identities = 57/212 (26%), Positives = 102/212 (48%), Gaps = 23/212 (10%)
Query: 411 FSEVNLLGKGNFSSVYKGTL-----RDGTLVAIRSINVTSCKSEEAEFVKGLYLLTSLRH 465
           F ++ +LG G F +VYKG       +    VAI+ +   +      E +   Y++ S+ +
Sbjct: 20  FKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDN 79
Query: 466 ENIIRLRGFCCSRGRGECFLIYDFAPKGKLSKYLDQEE---GSSNVLDWSTRVSIIIGIA 522
            ++ RL G C +       LI    P G L  Y+ + +   GS  +L+W       + IA
Sbjct: 80  PHVCRLLGICLT---STVQLITQLMPFGCLLDYVREHKDNIGSQYLLNWC------VQIA 130
Query: 523 KGIGYLHSSEVNKPAIVHRNLSVEKVLIDQQFNPLIADCGLHKLL-ADDIVFSVLKTSAA 581
           KG+ YL         +VHR+L+   VL+    +  I D GL KLL A++  +        
Sbjct: 131 KGMNYLEDRR-----LVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVP 185
Query: 582 MGYLAPEYVTTGRFTERSDIFAFGVIILQILT 613
           + ++A E +    +T +SD++++GV + +++T
Sbjct: 186 IKWMALESILHRIYTHQSDVWSYGVTVWELMT 217

>pdb|3LZB|A Chain A, Egfr Kinase Domain Complexed With An Imidazo[2,1-B]thiazole Inhibitor Length = 327

Iteration: 1
 Score = 78.6 bits (192), Expect = 1e-14,   Method: Compositional matrix adjust.
 Identities = 57/212 (26%), Positives = 102/212 (48%), Gaps = 23/212 (10%)
Query: 411 FSEVNLLGKGNFSSVYKGTL-----RDGTLVAIRSINVTSCKSEEAEFVKGLYLLTSLRH 465
           F ++ +LG G F +VYKG       +    VAI+ +   +      E +   Y++ S+ +
Sbjct: 17  FKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDN 76
Query: 466 ENIIRLRGFCCSRGRGECFLIYDFAPKGKLSKYLDQEE---GSSNVLDWSTRVSIIIGIA 522
            ++ RL G C +       LI    P G L  Y+ + +   GS  +L+W       + IA
Sbjct: 77  PHVCRLLGICLT---STVQLITQLMPFGCLLDYVREHKDNIGSQYLLNWC------VQIA 127
Query: 523 KGIGYLHSSEVNKPAIVHRNLSVEKVLIDQQFNPLIADCGLHKLL-ADDIVFSVLKTSAA 581
           KG+ YL         +VHR+L+   VL+    +  I D GL KLL A++  +        
Sbjct: 128 KGMNYLEDRR-----LVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVP 182
Query: 582 MGYLAPEYVTTGRFTERSDIFAFGVIILQILT 613
           + ++A E +    +T +SD++++GV + +++T
Sbjct: 183 IKWMALESILHRIYTHQSDVWSYGVTVWELMT 214

>pdb|3OCT|A Chain A, Crystal Structure Of Bruton's Tyrosine Kinase Mutant V555r In Complex With Dasatinib Length = 265

Iteration: 1
 Score = 78.2 bits (191), Expect = 1e-14,   Method: Compositional matrix adjust.
 Identities = 67/257 (26%), Positives = 117/257 (45%), Gaps = 16/257 (6%)
Query: 417 LGKGNFSSVYKGTLRDGTLVAIRSINVTSCKSEEAEFVKGLYLLTSLRHENIIRLRGFCC 476
           LG G F  V  G  R    VAI+ I   S    E EF++   ++ +L HE +++L G C 
Sbjct: 17  LGTGQFGVVKYGKWRGQYDVAIKMIKEGSMS--EDEFIEEAKVMMNLSHEKLVQLYGVCT 74
Query: 477 SRGRGECFLIYDFAPKGKLSKYLDQEEGSSNVLDWSTRVSIIIGIAKGIGYLHSSEVNKP 536
            +     F+I ++   G L  YL +             + +   + + + YL S +    
Sbjct: 75  KQR--PIFIITEYMANGCLLNYLREMRHRFQT---QQLLEMCKDVCEAMEYLESKQ---- 125
Query: 537 AIVHRNLSVEKVLIDQQFNPLIADCGLHKLLADDIVFSVLKTSAAMGYLAPEYVTTGRFT 596
             +HR+L+    L++ Q    ++D GL + + DD   S   +   + +  PE +   +F+
Sbjct: 126 -FLHRDLAARNCLVNDQGVVKVSDFGLSRYVLDDEYTSSRGSKFPVRWSPPEVLMYSKFS 184
Query: 597 ERSDIFAFGVIILQILTGSLVLTSSMRLAAESATFENFIDRNLKGKFSESEAAKLGKMAL 656
            +SDI+AFGV++ +I   SL      R    S T E+ I + L+       + K+  +  
Sbjct: 185 SKSDIWAFGVLMWEIY--SLGKMPYERF-TNSETAEH-IAQGLRLYRPHLASEKVYTIMY 240
Query: 657 VCTHEDPENRPTMEAVI 673
            C HE  + RPT + ++
Sbjct: 241 SCWHEKADERPTFKILL 257

>pdb|3BEL|A Chain A, X-Ray Structure Of Egfr In Complex With Oxime Inhibitor Length = 315

Iteration: 1
 Score = 78.2 bits (191), Expect = 1e-14,   Method: Compositional matrix adjust.
 Identities = 57/212 (26%), Positives = 102/212 (48%), Gaps = 23/212 (10%)
Query: 411 FSEVNLLGKGNFSSVYKGTL-----RDGTLVAIRSINVTSCKSEEAEFVKGLYLLTSLRH 465
           F ++ +LG G F +VYKG       +    VAI+ +   +      E +   Y++ S+ +
Sbjct: 11  FKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDN 70
Query: 466 ENIIRLRGFCCSRGRGECFLIYDFAPKGKLSKYLDQEE---GSSNVLDWSTRVSIIIGIA 522
            ++ RL G C +       LI    P G L  Y+ + +   GS  +L+W       + IA
Sbjct: 71  PHVCRLLGICLT---STVQLITQLMPFGCLLDYVREHKDNIGSQYLLNWC------VQIA 121
Query: 523 KGIGYLHSSEVNKPAIVHRNLSVEKVLIDQQFNPLIADCGLHKLL-ADDIVFSVLKTSAA 581
           KG+ YL         +VHR+L+   VL+    +  I D GL KLL A++  +        
Sbjct: 122 KGMNYLEDRR-----LVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVP 176
Query: 582 MGYLAPEYVTTGRFTERSDIFAFGVIILQILT 613
           + ++A E +    +T +SD++++GV + +++T
Sbjct: 177 IKWMALESILHRIYTHQSDVWSYGVTVWELMT 208

>pdb|3GOP|A Chain A, Crystal Structure Of The Egf Receptor Juxtamembrane And Kinase Domains Length = 361

Iteration: 1
 Score = 77.8 bits (190), Expect = 2e-14,   Method: Compositional matrix adjust.
 Identities = 57/212 (26%), Positives = 101/212 (47%), Gaps = 23/212 (10%)
Query: 411 FSEVNLLGKGNFSSVYKGTL-----RDGTLVAIRSINVTSCKSEEAEFVKGLYLLTSLRH 465
           F ++ +LG G F +VYKG       +    VAI  +   +      E +   Y++ S+ +
Sbjct: 51  FKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIMELREATSPKANKEILDEAYVMASVDN 110
Query: 466 ENIIRLRGFCCSRGRGECFLIYDFAPKGKLSKYLDQEE---GSSNVLDWSTRVSIIIGIA 522
            ++ RL G C +       LI    P G L  Y+ + +   GS  +L+W       + IA
Sbjct: 111 PHVCRLLGICLT---STVQLITQLMPFGCLLDYVREHKDNIGSQYLLNWC------VQIA 161
Query: 523 KGIGYLHSSEVNKPAIVHRNLSVEKVLIDQQFNPLIADCGLHKLL-ADDIVFSVLKTSAA 581
           KG+ YL         +VHR+L+   VL+    +  I D GL KLL A++  +        
Sbjct: 162 KGMNYLEDRR-----LVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVP 216
Query: 582 MGYLAPEYVTTGRFTERSDIFAFGVIILQILT 613
           + ++A E +    +T +SD++++GV + +++T
Sbjct: 217 IKWMALESILHRIYTHQSDVWSYGVTVWELMT 248

>pdb|2A19|B Chain B, Pkr Kinase Domain- Eif2alpha- Amp-Pnp Complex. Length = 284

Iteration: 1
 Score = 77.4 bits (189), Expect = 3e-14,   Method: Compositional matrix adjust.
 Identities = 69/284 (24%), Positives = 126/284 (44%), Gaps = 41/284 (14%)
Query: 411 FSEVNLLGKGNFSSVYKGTLR-DGTLVAIRSINVTSCKSEEAEFVKGLYLLTSLRHENII 469
           F E+ L+G G F  V+K   R DG    I+ +   + K+E     + +  L  L H NI+
Sbjct: 13  FKEIELIGSGGFGQVFKAKHRIDGKTYVIKRVKYNNEKAE-----REVKALAKLDHVNIV 67
Query: 470 RLRGFC--------------CSRGRGEC-FLIYDFAPKGKLSKYLDQEEGSSNVLDWSTR 514
              G C               SR + +C F+  +F  KG L +++++  G    LD    
Sbjct: 68  HYNG-CWDGFDYDPETSSKNSSRSKTKCLFIQMEFCDKGTLEQWIEKRRGEK--LDKVLA 124
Query: 515 VSIIIGIAKGIGYLHSSEVNKPAIVHRNLSVEKVLIDQQFNPLIADCGLHKLLADDIVFS 574
           + +   I KG+ Y+HS +     +++R+L    + +       I D GL   L +D    
Sbjct: 125 LELFEQITKGVDYIHSKK-----LINRDLKPSNIFLVDTKQVKIGDFGLVTSLKND--GK 177
Query: 575 VLKTSAAMGYLAPEYVTTGRFTERSDIFAFGVIILQILTGSLVLTSSMRLAAESATFENF 634
             ++   + Y++PE +++  + +  D++A G+I+ ++L    V  ++      S  F + 
Sbjct: 178 RXRSKGTLRYMSPEQISSQDYGKEVDLYALGLILAELLH---VCDTAFET---SKFFTDL 231
Query: 635 IDRNLKGKFSESEAAKLGKMALVCTHEDPENRPTMEAVIEELTV 678
            D  +   F + E   L K+      + PE+RP    ++  LTV
Sbjct: 232 RDGIISDIFDKKEKTLLQKLL----SKKPEDRPNTSEILRTLTV 271

>pdb|2R2P|A Chain A, Kinase Domain Of Human Ephrin Type-A Receptor 5 (Epha5) Length = 295

Iteration: 1
 Score = 77.4 bits (189), Expect = 3e-14,   Method: Compositional matrix adjust.
 Identities = 51/218 (23%), Positives = 105/218 (48%), Gaps = 18/218 (8%)
Query: 402 EEVESATQCFSEVNLLGKGNFSSVYKGTLR----DGTLVAIRSINVTSCKSEEAEFVKGL 457
           +E+E++  C +   ++G G F  V  G L+        VAI+++ V   + +  +F+   
Sbjct: 17  KEIEAS--CITIERVIGAGEFGEVCSGRLKLPGKRELPVAIKTLKVGYTEKQRRDFLGEA 74
Query: 458 YLLTSLRHENIIRLRGFCCSRGRGECFLIYDFAPKGKLSKYLDQEEGSSNVLDWSTRVSI 517
            ++    H NII L G           ++ ++   G L  +L + +G   V+     V +
Sbjct: 75  SIMGQFDHPNIIHLEGVVTKSK--PVMIVTEYMENGSLDTFLKKNDGQFTVIQ---LVGM 129
Query: 518 IIGIAKGIGYLHSSEVNKPAIVHRNLSVEKVLIDQQFNPLIADCGLHKLLADD--IVFSV 575
           + GI+ G+ YL          VHR+L+   +LI+      ++D GL ++L DD    ++ 
Sbjct: 130 LRGISAGMKYLSDM-----GYVHRDLAARNILINSNLVCKVSDFGLSRVLEDDPEAAYTT 184
Query: 576 LKTSAAMGYLAPEYVTTGRFTERSDIFAFGVIILQILT 613
                 + + APE +   +FT  SD++++G+++ ++++
Sbjct: 185 RGGKIPIRWTAPEAIAFRKFTSASDVWSYGIVMWEVVS 222

>pdb|4H1J|A Chain A, Crystal Structure Of Pyk2 With The Pyrazole 13a Length = 293

Iteration: 1
 Score = 77.0 bits (188), Expect = 3e-14,   Method: Compositional matrix adjust.
 Identities = 55/204 (26%), Positives = 102/204 (50%), Gaps = 17/204 (8%)
Query: 415 NLLGKGNFSSVYKGTLRDGTLVAIRSINVTSCKSE-----EAEFVKGLYLLTSLRHENII 469
            +LG+G F  VY+G   +     I ++ V +CK +     + +F+    ++ +L H +I+
Sbjct: 30  RILGEGFFGEVYEGVYTNHKGEKI-NVAVKTCKKDCTLDNKEKFMSEAVIMKNLDHPHIV 88
Query: 470 RLRGFCCSRGRGECFLIYDFAPKGKLSKYLDQEEGSSNVLDWSTRVSIIIGIAKGIGYLH 529
           +L G          ++I +  P G+L  YL++ + S  VL   T V   + I K + YL 
Sbjct: 89  KLIGII---EEEPTWIIMELYPYGELGHYLERNKNSLKVL---TLVLYSLQICKAMAYLE 142
Query: 530 SSEVNKPAIVHRNLSVEKVLIDQQFNPLIADCGLHKLLADDIVFSVLKTSAAMGYLAPEY 589
           S  +N    VHR+++V  +L+       + D GL + + D+  +    T   + +++PE 
Sbjct: 143 S--IN---CVHRDIAVRNILVASPECVKLGDFGLSRYIEDEDYYKASVTRLPIKWMSPES 197
Query: 590 VTTGRFTERSDIFAFGVIILQILT 613
           +   RFT  SD++ F V + +IL+
Sbjct: 198 INFRRFTTASDVWMFAVCMWEILS 221

>pdb|2RFD|A Chain A, Crystal Structure Of The Complex Between The Egfr Kinase Domain And A Mig6 Peptide Length = 324

Iteration: 1
 Score = 77.0 bits (188), Expect = 3e-14,   Method: Compositional matrix adjust.
 Identities = 56/212 (26%), Positives = 102/212 (48%), Gaps = 23/212 (10%)
Query: 411 FSEVNLLGKGNFSSVYKGTL-----RDGTLVAIRSINVTSCKSEEAEFVKGLYLLTSLRH 465
           F ++ +LG G F +VYKG       +    VAI+ +   +      E +   Y++ S+ +
Sbjct: 14  FKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDN 73
Query: 466 ENIIRLRGFCCSRGRGECFLIYDFAPKGKLSKYLDQEE---GSSNVLDWSTRVSIIIGIA 522
            ++ RL G C +       LI    P G L  Y+ + +   GS  +L+W       + IA
Sbjct: 74  PHVCRLLGICLT---STVQLITQLMPFGCLLDYVREHKDNIGSQYLLNWC------VQIA 124
Query: 523 KGIGYLHSSEVNKPAIVHRNLSVEKVLIDQQFNPLIADCGLHKLL-ADDIVFSVLKTSAA 581
           +G+ YL         +VHR+L+   VL+    +  I D GL KLL A++  +        
Sbjct: 125 EGMNYLEDRR-----LVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVP 179
Query: 582 MGYLAPEYVTTGRFTERSDIFAFGVIILQILT 613
           + ++A E +    +T +SD++++GV + +++T
Sbjct: 180 IKWMALESILHRIYTHQSDVWSYGVTVWELMT 211

>pdb|3UIU|A Chain A, Crystal Structure Of Apo-Pkr Kinase Domain Length = 306

Iteration: 1
 Score = 77.0 bits (188), Expect = 3e-14,   Method: Compositional matrix adjust.
 Identities = 71/297 (23%), Positives = 126/297 (42%), Gaps = 54/297 (18%)
Query: 411 FSEVNLLGKGNFSSVYKGTLR-DGTLVAIRSINVTSCKSEEAEFVKGLYLLTSLRHENII 469
           F E+ L+G G F  V+K   R DG    IR +   + K+E     + +  L  L H NI+
Sbjct: 14  FKEIELIGSGGFGQVFKAKHRIDGKTYVIRRVKYNNEKAE-----REVKALAKLDHVNIV 68
Query: 470 RLRGFC---------------------------CSRGRGEC-FLIYDFAPKGKLSKYLDQ 501
              G C                            SR + +C F+  +F  KG L +++++
Sbjct: 69  HYNG-CWDGFDYDPETSDDSLESSDYDPENSKNSSRSKTKCLFIQMEFCDKGTLEQWIEK 127
Query: 502 EEGSSNVLDWSTRVSIIIGIAKGIGYLHSSEVNKPAIVHRNLSVEKVLIDQQFNPLIADC 561
             G    LD    + +   I KG+ Y+HS +     ++HR+L    + +       I D 
Sbjct: 128 RRGEK--LDKVLALELFEQITKGVDYIHSKK-----LIHRDLKPSNIFLVDTKQVKIGDF 180
Query: 562 GLHKLLADDIVFSVLKTSAAMGYLAPEYVTTGRFTERSDIFAFGVIILQILTGSLVLTSS 621
           GL   L +D      ++   + Y++PE +++  + +  D++A G+I+ ++L    V  ++
Sbjct: 181 GLVTSLKND--GKRTRSKGTLRYMSPEQISSQDYGKEVDLYALGLILAELLH---VCDTA 235
Query: 622 MRLAAESATFENFIDRNLKGKFSESEAAKLGKMALVCTHEDPENRPTMEAVIEELTV 678
                 S  F +  D  +   F + E   L K+      + PE+RP    ++  LTV
Sbjct: 236 FET---SKFFTDLRDGIISDIFDKKEKTLLQKLL----SKKPEDRPNTSEILRTLTV 285

>pdb|4I21|A Chain A, Crystal Structure Of L858r + T790m Egfr Kinase Domain In Complex With Mig6 Peptide Length = 329

Iteration: 1
 Score = 77.0 bits (188), Expect = 3e-14,   Method: Compositional matrix adjust.
 Identities = 56/212 (26%), Positives = 101/212 (47%), Gaps = 23/212 (10%)
Query: 411 FSEVNLLGKGNFSSVYKGTL-----RDGTLVAIRSINVTSCKSEEAEFVKGLYLLTSLRH 465
           F ++ +LG G F +VYKG       +    VAI+ +   +      E +   Y++ S+ +
Sbjct: 19  FKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDN 78
Query: 466 ENIIRLRGFCCSRGRGECFLIYDFAPKGKLSKYLDQEE---GSSNVLDWSTRVSIIIGIA 522
            ++ RL G C +       LI    P G L  Y+ + +   GS  +L+W       + IA
Sbjct: 79  PHVCRLLGICLT---STVQLIMQLMPFGCLLDYVREHKDNIGSQYLLNWC------VQIA 129
Query: 523 KGIGYLHSSEVNKPAIVHRNLSVEKVLIDQQFNPLIADCGLHKLL-ADDIVFSVLKTSAA 581
           KG+ YL         +VHR+L+   VL+    +  I D G  KLL A++  +        
Sbjct: 130 KGMNYLEDRR-----LVHRDLAARNVLVKTPQHVKITDFGRAKLLGAEEKEYHAEGGKVP 184
Query: 582 MGYLAPEYVTTGRFTERSDIFAFGVIILQILT 613
           + ++A E +    +T +SD++++GV + +++T
Sbjct: 185 IKWMALESILHRIYTHQSDVWSYGVTVWELMT 216

>pdb|4I1Z|A Chain A, Crystal Structure Of The Monomeric (v948r) Form Of The Gefitinib/erlotinib Resistant Egfr Kinase Domain L858r+t790m Length = 329

Iteration: 1
 Score = 77.0 bits (188), Expect = 3e-14,   Method: Compositional matrix adjust.
 Identities = 56/212 (26%), Positives = 101/212 (47%), Gaps = 23/212 (10%)
Query: 411 FSEVNLLGKGNFSSVYKGTL-----RDGTLVAIRSINVTSCKSEEAEFVKGLYLLTSLRH 465
           F ++ +LG G F +VYKG       +    VAI+ +   +      E +   Y++ S+ +
Sbjct: 19  FKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDN 78
Query: 466 ENIIRLRGFCCSRGRGECFLIYDFAPKGKLSKYLDQEE---GSSNVLDWSTRVSIIIGIA 522
            ++ RL G C +       LI    P G L  Y+ + +   GS  +L+W       + IA
Sbjct: 79  PHVCRLLGICLT---STVQLIMQLMPFGCLLDYVREHKDNIGSQYLLNWC------VQIA 129
Query: 523 KGIGYLHSSEVNKPAIVHRNLSVEKVLIDQQFNPLIADCGLHKLL-ADDIVFSVLKTSAA 581
           KG+ YL         +VHR+L+   VL+    +  I D G  KLL A++  +        
Sbjct: 130 KGMNYLEDRR-----LVHRDLAARNVLVKTPQHVKITDFGRAKLLGAEEKEYHAEGGKVP 184
Query: 582 MGYLAPEYVTTGRFTERSDIFAFGVIILQILT 613
           + ++A E +    +T +SD++++GV + +++T
Sbjct: 185 IKWMALESILHRIYTHQSDVWSYGVTVWELMT 216

>pdb|3W2O|A Chain A, Egfr Kinase Domain T790m/l858r Mutant With Tak-285 Length = 331

Iteration: 1
 Score = 77.0 bits (188), Expect = 3e-14,   Method: Compositional matrix adjust.
 Identities = 56/212 (26%), Positives = 101/212 (47%), Gaps = 23/212 (10%)
Query: 411 FSEVNLLGKGNFSSVYKGTL-----RDGTLVAIRSINVTSCKSEEAEFVKGLYLLTSLRH 465
           F ++ +LG G F +VYKG       +    VAI+ +   +      E +   Y++ S+ +
Sbjct: 21  FKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDN 80
Query: 466 ENIIRLRGFCCSRGRGECFLIYDFAPKGKLSKYLDQEE---GSSNVLDWSTRVSIIIGIA 522
            ++ RL G C +       LI    P G L  Y+ + +   GS  +L+W       + IA
Sbjct: 81  PHVCRLLGICLT---STVQLIMQLMPFGCLLDYVREHKDNIGSQYLLNWC------VQIA 131
Query: 523 KGIGYLHSSEVNKPAIVHRNLSVEKVLIDQQFNPLIADCGLHKLL-ADDIVFSVLKTSAA 581
           KG+ YL         +VHR+L+   VL+    +  I D G  KLL A++  +        
Sbjct: 132 KGMNYLEDRR-----LVHRDLAARNVLVKTPQHVKITDFGRAKLLGAEEKEYHAEGGKVP 186
Query: 582 MGYLAPEYVTTGRFTERSDIFAFGVIILQILT 613
           + ++A E +    +T +SD++++GV + +++T
Sbjct: 187 IKWMALESILHRIYTHQSDVWSYGVTVWELMT 218

>pdb|3FZO|A Chain A, Crystal Structure Of Pyk2-Apo, Proline-Rich Tyrosine Kinase Length = 277

Iteration: 1
 Score = 77.0 bits (188), Expect = 3e-14,   Method: Compositional matrix adjust.
 Identities = 55/204 (26%), Positives = 102/204 (50%), Gaps = 17/204 (8%)
Query: 415 NLLGKGNFSSVYKGTLRDGTLVAIRSINVTSCKSE-----EAEFVKGLYLLTSLRHENII 469
            +LG+G F  VY+G   +     I ++ V +CK +     + +F+    ++ +L H +I+
Sbjct: 14  RILGEGFFGEVYEGVYTNHKGEKI-NVAVKTCKKDCTLDNKEKFMSEAVIMKNLDHPHIV 72
Query: 470 RLRGFCCSRGRGECFLIYDFAPKGKLSKYLDQEEGSSNVLDWSTRVSIIIGIAKGIGYLH 529
           +L G          ++I +  P G+L  YL++ + S  VL   T V   + I K + YL 
Sbjct: 73  KLIGII---EEEPTWIIMELYPYGELGHYLERNKNSLKVL---TLVLYSLQICKAMAYLE 126
Query: 530 SSEVNKPAIVHRNLSVEKVLIDQQFNPLIADCGLHKLLADDIVFSVLKTSAAMGYLAPEY 589
           S  +N    VHR+++V  +L+       + D GL + + D+  +    T   + +++PE 
Sbjct: 127 S--IN---CVHRDIAVRNILVASPECVKLGDFGLSRYIEDEDYYKASVTRLPIKWMSPES 181
Query: 590 VTTGRFTERSDIFAFGVIILQILT 613
           +   RFT  SD++ F V + +IL+
Sbjct: 182 INFRRFTTASDVWMFAVCMWEILS 205

>pdb|3CC6|A Chain A, Crystal Structure Of Kinase Domain Of Protein Tyrosine Kinase 2 Beta (ptk2b) Length = 281

Iteration: 1
 Score = 77.0 bits (188), Expect = 3e-14,   Method: Compositional matrix adjust.
 Identities = 55/204 (26%), Positives = 102/204 (50%), Gaps = 17/204 (8%)
Query: 415 NLLGKGNFSSVYKGTLRDGTLVAIRSINVTSCKSE-----EAEFVKGLYLLTSLRHENII 469
            +LG+G F  VY+G   +     I ++ V +CK +     + +F+    ++ +L H +I+
Sbjct: 18  RILGEGFFGEVYEGVYTNHKGEKI-NVAVKTCKKDCTLDNKEKFMSEAVIMKNLDHPHIV 76
Query: 470 RLRGFCCSRGRGECFLIYDFAPKGKLSKYLDQEEGSSNVLDWSTRVSIIIGIAKGIGYLH 529
           +L G          ++I +  P G+L  YL++ + S  VL   T V   + I K + YL 
Sbjct: 77  KLIGII---EEEPTWIIMELYPYGELGHYLERNKNSLKVL---TLVLYSLQICKAMAYLE 130
Query: 530 SSEVNKPAIVHRNLSVEKVLIDQQFNPLIADCGLHKLLADDIVFSVLKTSAAMGYLAPEY 589
           S  +N    VHR+++V  +L+       + D GL + + D+  +    T   + +++PE 
Sbjct: 131 S--IN---CVHRDIAVRNILVASPECVKLGDFGLSRYIEDEDYYKASVTRLPIKWMSPES 185
Query: 590 VTTGRFTERSDIFAFGVIILQILT 613
           +   RFT  SD++ F V + +IL+
Sbjct: 186 INFRRFTTASDVWMFAVCMWEILS 209

>pdb|3UG1|A Chain A, Crystal Structure Of The Mutated Egfr Kinase Domain (G719sT790M) IN The Apo Form Length = 334

Iteration: 1
 Score = 76.6 bits (187), Expect = 4e-14,   Method: Compositional matrix adjust.
 Identities = 56/212 (26%), Positives = 101/212 (47%), Gaps = 23/212 (10%)
Query: 411 FSEVNLLGKGNFSSVYKGTL-----RDGTLVAIRSINVTSCKSEEAEFVKGLYLLTSLRH 465
           F ++ +L  G F +VYKG       +    VAI+ +   +      E +   Y++ S+ +
Sbjct: 24  FKKIKVLSSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDN 83
Query: 466 ENIIRLRGFCCSRGRGECFLIYDFAPKGKLSKYLDQEE---GSSNVLDWSTRVSIIIGIA 522
            ++ RL G C +       LI    P G L  Y+ + +   GS  +L+W       + IA
Sbjct: 84  PHVCRLLGICLT---STVQLIMQLMPFGCLLDYVREHKDNIGSQYLLNWC------VQIA 134
Query: 523 KGIGYLHSSEVNKPAIVHRNLSVEKVLIDQQFNPLIADCGLHKLL-ADDIVFSVLKTSAA 581
           KG+ YL         +VHR+L+   VL+    +  I D GL KLL A++  +        
Sbjct: 135 KGMNYLEDRR-----LVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVP 189
Query: 582 MGYLAPEYVTTGRFTERSDIFAFGVIILQILT 613
           + ++A E +    +T +SD++++GV + +++T
Sbjct: 190 IKWMALESILHRIYTHQSDVWSYGVTVWELMT 221

>pdb|2ITT|A Chain A, Crystal Structure Of Egfr Kinase Domain L858r Mutation In Complex With Aee788 Length = 327

Iteration: 1
 Score = 76.6 bits (187), Expect = 4e-14,   Method: Compositional matrix adjust.
 Identities = 56/212 (26%), Positives = 101/212 (47%), Gaps = 23/212 (10%)
Query: 411 FSEVNLLGKGNFSSVYKGTL-----RDGTLVAIRSINVTSCKSEEAEFVKGLYLLTSLRH 465
           F ++ +LG G F +VYKG       +    VAI+ +   +      E +   Y++ S+ +
Sbjct: 17  FKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDN 76
Query: 466 ENIIRLRGFCCSRGRGECFLIYDFAPKGKLSKYLDQEE---GSSNVLDWSTRVSIIIGIA 522
            ++ RL G C +       LI    P G L  Y+ + +   GS  +L+W       + IA
Sbjct: 77  PHVCRLLGICLT---STVQLITQLMPFGCLLDYVREHKDNIGSQYLLNWC------VQIA 127
Query: 523 KGIGYLHSSEVNKPAIVHRNLSVEKVLIDQQFNPLIADCGLHKLL-ADDIVFSVLKTSAA 581
           KG+ YL         +VHR+L+   VL+    +  I D G  KLL A++  +        
Sbjct: 128 KGMNYLEDRR-----LVHRDLAARNVLVKTPQHVKITDFGRAKLLGAEEKEYHAEGGKVP 182
Query: 582 MGYLAPEYVTTGRFTERSDIFAFGVIILQILT 613
           + ++A E +    +T +SD++++GV + +++T
Sbjct: 183 IKWMALESILHRIYTHQSDVWSYGVTVWELMT 214

>pdb|4I20|A Chain A, Crystal Structure Of Monomeric (v948r) Primary Oncogenic Mutant L858r Egfr Kinase Domain Length = 329

Iteration: 1
 Score = 76.6 bits (187), Expect = 4e-14,   Method: Compositional matrix adjust.
 Identities = 56/212 (26%), Positives = 101/212 (47%), Gaps = 23/212 (10%)
Query: 411 FSEVNLLGKGNFSSVYKGTL-----RDGTLVAIRSINVTSCKSEEAEFVKGLYLLTSLRH 465
           F ++ +LG G F +VYKG       +    VAI+ +   +      E +   Y++ S+ +
Sbjct: 19  FKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDN 78
Query: 466 ENIIRLRGFCCSRGRGECFLIYDFAPKGKLSKYLDQEE---GSSNVLDWSTRVSIIIGIA 522
            ++ RL G C +       LI    P G L  Y+ + +   GS  +L+W       + IA
Sbjct: 79  PHVCRLLGICLT---STVQLITQLMPFGCLLDYVREHKDNIGSQYLLNWC------VQIA 129
Query: 523 KGIGYLHSSEVNKPAIVHRNLSVEKVLIDQQFNPLIADCGLHKLL-ADDIVFSVLKTSAA 581
           KG+ YL         +VHR+L+   VL+    +  I D G  KLL A++  +        
Sbjct: 130 KGMNYLEDRR-----LVHRDLAARNVLVKTPQHVKITDFGRAKLLGAEEKEYHAEGGKVP 184
Query: 582 MGYLAPEYVTTGRFTERSDIFAFGVIILQILT 613
           + ++A E +    +T +SD++++GV + +++T
Sbjct: 185 IKWMALESILHRIYTHQSDVWSYGVTVWELMT 216

>pdb|2EB3|A Chain A, Crystal Structure Of Mutated Egfr Kinase Domain (L858r) In Complex With Amppnp Length = 334

Iteration: 1
 Score = 76.6 bits (187), Expect = 4e-14,   Method: Compositional matrix adjust.
 Identities = 56/212 (26%), Positives = 101/212 (47%), Gaps = 23/212 (10%)
Query: 411 FSEVNLLGKGNFSSVYKGTL-----RDGTLVAIRSINVTSCKSEEAEFVKGLYLLTSLRH 465
           F ++ +LG G F +VYKG       +    VAI+ +   +      E +   Y++ S+ +
Sbjct: 24  FKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDN 83
Query: 466 ENIIRLRGFCCSRGRGECFLIYDFAPKGKLSKYLDQEE---GSSNVLDWSTRVSIIIGIA 522
            ++ RL G C +       LI    P G L  Y+ + +   GS  +L+W       + IA
Sbjct: 84  PHVCRLLGICLT---STVQLITQLMPFGCLLDYVREHKDNIGSQYLLNWC------VQIA 134
Query: 523 KGIGYLHSSEVNKPAIVHRNLSVEKVLIDQQFNPLIADCGLHKLL-ADDIVFSVLKTSAA 581
           KG+ YL         +VHR+L+   VL+    +  I D G  KLL A++  +        
Sbjct: 135 KGMNYLEDRR-----LVHRDLAARNVLVKTPQHVKITDFGRAKLLGAEEKEYHAEGGKVP 189
Query: 582 MGYLAPEYVTTGRFTERSDIFAFGVIILQILT 613
           + ++A E +    +T +SD++++GV + +++T
Sbjct: 190 IKWMALESILHRIYTHQSDVWSYGVTVWELMT 221

>pdb|4AW5|A Chain A, Complex Of The Ephb4 Kinase Domain With An Oxindole Inhibitor Length = 291

Iteration: 1
 Score = 76.3 bits (186), Expect = 5e-14,   Method: Compositional matrix adjust.
 Identities = 62/269 (23%), Positives = 118/269 (43%), Gaps = 22/269 (8%)
Query: 416 LLGKGNFSSVYKGTLR----DGTLVAIRSINVTSCKSEEAEFVKGLYLLTSLRHENIIRL 471
           ++G G F  V +G L+      + VAI+++     + +  EF+    ++    H NIIRL
Sbjct: 21  VIGAGEFGEVCRGRLKAPGKKESCVAIKTLKGGYTERQRREFLSEASIMGQFEHPNIIRL 80
Query: 472 RGFCCSRGRGECFLIYDFAPKGKLSKYLDQEEGSSNVLDWSTRVSIIIGIAKGIGYLHSS 531
            G   +       ++ +F   G L  +L   +G   V+     V ++ GIA G+ YL   
Sbjct: 81  EGVVTNSM--PVMILTEFMENGALDSFLRLNDGQFTVIQ---LVGMLRGIASGMRYLAEM 135
Query: 532 EVNKPAIVHRNLSVEKVLIDQQFNPLIADCGLHKLL----ADDIVFSVLKTSAAMGYLAP 587
                + VHR+L+   +L++      ++D GL + L    +D    S L     + + AP
Sbjct: 136 -----SYVHRDLAARNILVNSNLVCKVSDFGLSRFLEENSSDPTYTSSLGGKIPIRWTAP 190
Query: 588 EYVTTGRFTERSDIFAFGVIILQILTGSLVLTSSMRLAAESATFENFIDRNLKGKFSESE 647
           E +   +FT  SD +++G+++ ++++        M     +    N I+++ +       
Sbjct: 191 EAIAFRKFTSASDAWSYGIVMWEVMSFGERPYWDM----SNQDVINAIEQDYRLPPPPDC 246
Query: 648 AAKLGKMALVCTHEDPENRPTMEAVIEEL 676
              L ++ L C  +D   RP    V+  L
Sbjct: 247 PTSLHQLMLDCWQKDRNARPRFPQVVSAL 275

>pdb|2EB2|A Chain A, Crystal Structure Of Mutated Egfr Kinase Domain (G719s) Length = 334

Iteration: 1
 Score = 76.3 bits (186), Expect = 5e-14,   Method: Compositional matrix adjust.
 Identities = 56/212 (26%), Positives = 101/212 (47%), Gaps = 23/212 (10%)
Query: 411 FSEVNLLGKGNFSSVYKGTL-----RDGTLVAIRSINVTSCKSEEAEFVKGLYLLTSLRH 465
           F ++ +L  G F +VYKG       +    VAI+ +   +      E +   Y++ S+ +
Sbjct: 24  FKKIKVLSSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDN 83
Query: 466 ENIIRLRGFCCSRGRGECFLIYDFAPKGKLSKYLDQEE---GSSNVLDWSTRVSIIIGIA 522
            ++ RL G C +       LI    P G L  Y+ + +   GS  +L+W       + IA
Sbjct: 84  PHVCRLLGICLT---STVQLITQLMPFGCLLDYVREHKDNIGSQYLLNWC------VQIA 134
Query: 523 KGIGYLHSSEVNKPAIVHRNLSVEKVLIDQQFNPLIADCGLHKLL-ADDIVFSVLKTSAA 581
           KG+ YL         +VHR+L+   VL+    +  I D GL KLL A++  +        
Sbjct: 135 KGMNYLEDRR-----LVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVP 189
Query: 582 MGYLAPEYVTTGRFTERSDIFAFGVIILQILT 613
           + ++A E +    +T +SD++++GV + +++T
Sbjct: 190 IKWMALESILHRIYTHQSDVWSYGVTVWELMT 221

>pdb|2ITN|A Chain A, Crystal Structure Of Egfr Kinase Domain G719s Mutation In Complex With Amp-Pnp Length = 327

Iteration: 1
 Score = 76.3 bits (186), Expect = 5e-14,   Method: Compositional matrix adjust.
 Identities = 56/212 (26%), Positives = 101/212 (47%), Gaps = 23/212 (10%)
Query: 411 FSEVNLLGKGNFSSVYKGTL-----RDGTLVAIRSINVTSCKSEEAEFVKGLYLLTSLRH 465
           F ++ +L  G F +VYKG       +    VAI+ +   +      E +   Y++ S+ +
Sbjct: 17  FKKIKVLSSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDN 76
Query: 466 ENIIRLRGFCCSRGRGECFLIYDFAPKGKLSKYLDQEE---GSSNVLDWSTRVSIIIGIA 522
            ++ RL G C +       LI    P G L  Y+ + +   GS  +L+W       + IA
Sbjct: 77  PHVCRLLGICLT---STVQLITQLMPFGCLLDYVREHKDNIGSQYLLNWC------VQIA 127
Query: 523 KGIGYLHSSEVNKPAIVHRNLSVEKVLIDQQFNPLIADCGLHKLL-ADDIVFSVLKTSAA 581
           KG+ YL         +VHR+L+   VL+    +  I D GL KLL A++  +        
Sbjct: 128 KGMNYLEDRR-----LVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVP 182
Query: 582 MGYLAPEYVTTGRFTERSDIFAFGVIILQILT 613
           + ++A E +    +T +SD++++GV + +++T
Sbjct: 183 IKWMALESILHRIYTHQSDVWSYGVTVWELMT 214

>pdb|2VWU|A Chain A, Ephb4 Kinase Domain Inhibitor Complex Length = 302

Iteration: 1
 Score = 75.9 bits (185), Expect = 7e-14,   Method: Compositional matrix adjust.
 Identities = 62/269 (23%), Positives = 118/269 (43%), Gaps = 22/269 (8%)
Query: 416 LLGKGNFSSVYKGTLR----DGTLVAIRSINVTSCKSEEAEFVKGLYLLTSLRHENIIRL 471
           ++G G F  V +G L+      + VAI+++     + +  EF+    ++    H NIIRL
Sbjct: 23  VIGAGEFGEVCRGRLKAPGKKESCVAIKTLKGGYTERQRREFLSEASIMGQFEHPNIIRL 82
Query: 472 RGFCCSRGRGECFLIYDFAPKGKLSKYLDQEEGSSNVLDWSTRVSIIIGIAKGIGYLHSS 531
            G   +       ++ +F   G L  +L   +G   V+     V ++ GIA G+ YL   
Sbjct: 83  EGVVTNSM--PVMILTEFMENGALDSFLRLNDGQFTVIQL---VGMLRGIASGMRYLAEM 137
Query: 532 EVNKPAIVHRNLSVEKVLIDQQFNPLIADCGLHKLL----ADDIVFSVLKTSAAMGYLAP 587
                + VHR+L+   +L++      ++D GL + L    +D    S L     + + AP
Sbjct: 138 -----SYVHRDLAARNILVNSNLVCKVSDFGLSRFLEENSSDPTETSSLGGKIPIRWTAP 192
Query: 588 EYVTTGRFTERSDIFAFGVIILQILTGSLVLTSSMRLAAESATFENFIDRNLKGKFSESE 647
           E +   +FT  SD +++G+++ ++++        M     +    N I+++ +       
Sbjct: 193 EAIAFRKFTSASDAWSYGIVMWEVMSFGERPYWDM----SNQDVINAIEQDYRLPPPPDC 248
Query: 648 AAKLGKMALVCTHEDPENRPTMEAVIEEL 676
              L ++ L C  +D   RP    V+  L
Sbjct: 249 PTSLHQLMLDCWQKDRNARPRFPQVVSAL 277

>pdb|3LXN|A Chain A, Structural And Thermodynamic Characterization Of The Tyk2 And Jak3 Kinase Domains In Complex With Cp-690550 And Cmp-6 Length = 318

Iteration: 1
 Score = 75.9 bits (185), Expect = 7e-14,   Method: Compositional matrix adjust.
 Identities = 56/212 (26%), Positives = 106/212 (50%), Gaps = 21/212 (9%)
Query: 411 FSEVNLLGKGNFSSV----YKGTLRDGT--LVAIRSINVTSCKSEEAEFVKGLYLLTSLR 464
             ++  LG+G+F  V    Y  T  DGT  +VA++++   +     + + + + +L +L 
Sbjct: 33  LKKIRDLGEGHFGKVSLYCYDPT-NDGTGEMVAVKALKADAGPQHRSGWKQEIDILRTLY 91
Query: 465 HENIIRLRGFCCSRGRGECFLIYDFAPKGKLSKYLDQEE-GSSNVLDWSTRVSIIIGIAK 523
           HE+II+ +G C   G     L+ ++ P G L  YL +   G + +L ++ +      I +
Sbjct: 92  HEHIIKYKGCCEDAGAASLQLVMEYVPLGSLRDYLPRHSIGLAQLLLFAQQ------ICE 145
Query: 524 GIGYLHSSEVNKPAIVHRNLSVEKVLIDQQFNPLIADCGLHKLLADDIVFSVLKT--SAA 581
           G+ YLH+        +HR+L+   VL+D      I D GL K + +      ++    + 
Sbjct: 146 GMAYLHAQHY-----IHRDLAARNVLLDNDRLVKIGDFGLAKAVPEGHEXYRVREDGDSP 200
Query: 582 MGYLAPEYVTTGRFTERSDIFAFGVIILQILT 613
           + + APE +   +F   SD+++FGV + ++LT
Sbjct: 201 VFWYAPECLKEYKFYYASDVWSFGVTLYELLT 232

>pdb|3S95|A Chain A, Crystal Structure Of The Human Limk1 Kinase Domain In Complex With Staurosporine Length = 310

Iteration: 1
 Score = 75.9 bits (185), Expect = 7e-14,   Method: Compositional matrix adjust.
 Identities = 67/271 (24%), Positives = 113/271 (41%), Gaps = 34/271 (12%)
Query: 416 LLGKGNFSSVYKGTLRDGTLVAIRSINVTSCKSEEAEFVKGLYLLTSLRHENIIRLRGFC 475
           +LGKG F    K T R+   V +    +   +  +  F+K + ++  L H N+++  G  
Sbjct: 17  VLGKGCFGQAIKVTHRETGEVMVMKELIRFDEETQRTFLKEVKVMRCLEHPNVLKFIGVL 76
Query: 476 CSRGRGECFLIYDFAPKGKLSKYLDQEEGSSNVLDWSTRVSIIIGIAKGIGYLHSSEVNK 535
               R     I ++   G L   +   +       WS RVS    IA G+ YLHS     
Sbjct: 77  YKDKRLN--FITEYIKGGTLRGIIKSMDSQ---YPWSQRVSFAKDIASGMAYLHSMN--- 128
Query: 536 PAIVHRNLSVEKVLIDQQFNPLIADCGLHKLLADDI-----VFSVLKTSAAMGY------ 584
             I+HR+L+    L+ +  N ++AD GL +L+ D+      + S+ K      Y      
Sbjct: 129 --IIHRDLNSHNCLVRENKNVVVADFGLARLMVDEKTQPEGLRSLKKPDRKKRYTVVGNP 186
Query: 585 --LAPEYVTTGRFTERSDIFAFGVIILQIL----TGSLVLTSSMRLAAESATFENFIDRN 638
             +APE +    + E+ D+F+FG+++ +I+         L  +M           F+DR 
Sbjct: 187 YWMAPEMINGRSYDEKVDVFSFGIVLCEIIGRVNADPDYLPRTMDFG---LNVRGFLDRY 243
Query: 639 LKGKFSESEAAKLGKMALVCTHEDPENRPTM 669
                  S       + + C   DPE RP+ 
Sbjct: 244 CPPNCPPS----FFPITVRCCDLDPEKRPSF 270

>pdb|2EVA|A Chain A, Structural Basis For The Interaction Of Tak1 Kinase With Its Activating Protein Tab1 Length = 307

Iteration: 1
 Score = 75.9 bits (185), Expect = 7e-14,   Method: Compositional matrix adjust.
 Identities = 63/269 (23%), Positives = 119/269 (44%), Gaps = 29/269 (10%)
Query: 415 NLLGKGNFSSVYKGTLRDGTLVAIRSINVTSCKSEEAEFVKGLYLLTSLRHENIIRLRGF 474
            ++G+G F  V K   R    VAI+ I     +SE   F+  L  L+ + H NI++L G 
Sbjct: 14  EVVGRGAFGVVCKAKWR-AKDVAIKQIE---SESERKAFIVELRQLSRVNHPNIVKLYGA 69
Query: 475 CCSRGRGECFLIYDFAPKGKLSKYLDQEEG-----SSNVLDWSTRVSIIIGIAKGIGYLH 529
           C +       L+ ++A  G L   L   E      +++ + W  + S      +G+ YLH
Sbjct: 70  CLN----PVCLVMEYAEGGSLYNVLHGAEPLPYYTAAHAMSWCLQCS------QGVAYLH 119
Query: 530 SSEVNKPAIVHRNLSVEKVLIDQQFNPL-IADCGLHKLLADDIVFSVLKTSAAMGYLAPE 588
           S +    A++HR+L    +L+      L I D G     A DI   +     +  ++APE
Sbjct: 120 SMQPK--ALIHRDLKPPNLLLVAGGTVLKICDFGT----ACDIQTHMTNNKGSAAWMAPE 173
Query: 589 YVTTGRFTERSDIFAFGVIILQILTGSLVLTSSMRLAAESATFENFIDRNLKGKFSESEA 648
                 ++E+ D+F++G+I+ +++T          +   +      +    +    ++  
Sbjct: 174 VFEGSNYSEKCDVFSWGIILWEVITRRKPFDE---IGGPAFRIMWAVHNGTRPPLIKNLP 230
Query: 649 AKLGKMALVCTHEDPENRPTMEAVIEELT 677
             +  +   C  +DP  RP+ME +++ +T
Sbjct: 231 KPIESLMTRCWSKDPSQRPSMEEIVKIMT 259

>pdb|4GS6|A Chain A, Irreversible Inhibition Of Tak1 Kinase By 5z-7-oxozeaenol Length = 315

Iteration: 1
 Score = 75.9 bits (185), Expect = 7e-14,   Method: Compositional matrix adjust.
 Identities = 63/269 (23%), Positives = 119/269 (44%), Gaps = 29/269 (10%)
Query: 415 NLLGKGNFSSVYKGTLRDGTLVAIRSINVTSCKSEEAEFVKGLYLLTSLRHENIIRLRGF 474
            ++G+G F  V K   R    VAI+ I     +SE   F+  L  L+ + H NI++L G 
Sbjct: 15  EVVGRGAFGVVCKAKWR-AKDVAIKQIE---SESERKAFIVELRQLSRVNHPNIVKLYGA 70
Query: 475 CCSRGRGECFLIYDFAPKGKLSKYLDQEEG-----SSNVLDWSTRVSIIIGIAKGIGYLH 529
           C +       L+ ++A  G L   L   E      +++ + W  + S      +G+ YLH
Sbjct: 71  CLN----PVCLVMEYAEGGSLYNVLHGAEPLPYYTAAHAMSWCLQCS------QGVAYLH 120
Query: 530 SSEVNKPAIVHRNLSVEKVLIDQQFNPL-IADCGLHKLLADDIVFSVLKTSAAMGYLAPE 588
           S +    A++HR+L    +L+      L I D G     A DI   +     +  ++APE
Sbjct: 121 SMQPK--ALIHRDLKPPNLLLVAGGTVLKICDFGT----ACDIQTHMTNNKGSAAWMAPE 174
Query: 589 YVTTGRFTERSDIFAFGVIILQILTGSLVLTSSMRLAAESATFENFIDRNLKGKFSESEA 648
                 ++E+ D+F++G+I+ +++T          +   +      +    +    ++  
Sbjct: 175 VFEGSNYSEKCDVFSWGIILWEVITRRKPFDE---IGGPAFRIMWAVHNGTRPPLIKNLP 231
Query: 649 AKLGKMALVCTHEDPENRPTMEAVIEELT 677
             +  +   C  +DP  RP+ME +++ +T
Sbjct: 232 KPIESLMTRCWSKDPSQRPSMEEIVKIMT 260

>pdb|3EKK|A Chain A, Insulin Receptor Kinase Complexed With An Inhibitor Length = 307

Iteration: 1
 Score = 75.9 bits (185), Expect = 8e-14,   Method: Compositional matrix adjust.
 Identities = 67/288 (23%), Positives = 126/288 (43%), Gaps = 30/288 (10%)
Query: 402 EEVESATQCFSEVNLLGKGNFSSVYKGTLRD------GTLVAIRSINVTSCKSEEAEFVK 455
           +E E + +  + +  LG+G+F  VY+G  RD       T VA++++N ++   E  EF+ 
Sbjct: 11  DEWEVSREKITLLRELGQGSFGMVYEGNARDIIKGEAETRVAVKTVNESASLRERIEFLN 70
Query: 456 GLYLLTSLRHENIIRLRGFCCSRGRGECFLIYDFAPKGKLSKYLD--QEEGSSNV----L 509
              ++      +++RL G   S+G+    ++ +    G L  YL   + E  +N      
Sbjct: 71  EASVMKGFTCHHVVRLLG-VVSKGQ-PTLVVMELMAHGDLKSYLRSLRPEAENNPGRPPP 128
Query: 510 DWSTRVSIIIGIAKGIGYLHSSEVNKPAIVHRNLSVEKVLIDQQFNPLIADCGLHK-LLA 568
                + +   IA G+ YL     N    VHRNL+    ++   F   I D G+ + +  
Sbjct: 129 TLQEMIQMAAEIADGMAYL-----NAKKFVHRNLAARNCMVAHDFTVKIGDFGMTRDIYE 183
Query: 569 DDIVFSVLKTSAAMGYLAPEYVTTGRFTERSDIFAFGVIILQILTGSLVLTSSMRLAAES 628
            D      K    + ++APE +  G FT  SD+++FGV++ +I       TS      + 
Sbjct: 184 TDYYRKGGKGLLPVRWMAPESLKDGVFTTSSDMWSFGVVLWEI-------TSLAEQPYQG 236
Query: 629 ATFENFIDRNLKGKFSESE---AAKLGKMALVCTHEDPENRPTMEAVI 673
            + E  +   + G + +       ++  +  +C   +P  RPT   ++
Sbjct: 237 LSNEQVLKFVMDGGYLDQPDNCPERVTDLMRMCWQFNPNMRPTFLEIV 284

>pdb|1P14|A Chain A, Crystal Structure Of A Catalytic-Loop Mutant Of The Insulin Receptor Tyrosine Kinase Length = 306

Iteration: 1
 Score = 75.9 bits (185), Expect = 8e-14,   Method: Compositional matrix adjust.
 Identities = 67/288 (23%), Positives = 126/288 (43%), Gaps = 30/288 (10%)
Query: 402 EEVESATQCFSEVNLLGKGNFSSVYKGTLRD------GTLVAIRSINVTSCKSEEAEFVK 455
           +E E + +  + +  LG+G+F  VY+G  RD       T VA++++N ++   E  EF+ 
Sbjct: 10  DEWEVSREKITLLRELGQGSFGMVYEGNARDIIKGEAETRVAVKTVNESASLRERIEFLN 69
Query: 456 GLYLLTSLRHENIIRLRGFCCSRGRGECFLIYDFAPKGKLSKYLD--QEEGSSNV----L 509
              ++      +++RL G   S+G+    ++ +    G L  YL   + E  +N      
Sbjct: 70  EASVMKGFTCHHVVRLLG-VVSKGQ-PTLVVMELMAHGDLKSYLRSLRPEAENNPGRPPP 127
Query: 510 DWSTRVSIIIGIAKGIGYLHSSEVNKPAIVHRNLSVEKVLIDQQFNPLIADCGLHK-LLA 568
                + +   IA G+ YL     N    VHRNL+    ++   F   I D G+ + +  
Sbjct: 128 TLQEMIQMAAEIADGMAYL-----NAKKFVHRNLAARNCMVAHDFTVKIGDFGMTRDIYE 182
Query: 569 DDIVFSVLKTSAAMGYLAPEYVTTGRFTERSDIFAFGVIILQILTGSLVLTSSMRLAAES 628
            D      K    + ++APE +  G FT  SD+++FGV++ +I       TS      + 
Sbjct: 183 TDYYRKGGKGLLPVRWMAPESLKDGVFTTSSDMWSFGVVLWEI-------TSLAEQPYQG 235
Query: 629 ATFENFIDRNLKGKFSESE---AAKLGKMALVCTHEDPENRPTMEAVI 673
            + E  +   + G + +       ++  +  +C   +P  RPT   ++
Sbjct: 236 LSNEQVLKFVMDGGYLDQPDNCPERVTDLMRMCWQFNPNMRPTFLEIV 283

>pdb|3PP0|A Chain A, Crystal Structure Of The Kinase Domain Of Human Her2 (Erbb2). Length = 338

Iteration: 1
 Score = 75.5 bits (184), Expect = 8e-14,   Method: Compositional matrix adjust.
 Identities = 57/212 (26%), Positives = 100/212 (47%), Gaps = 23/212 (10%)
Query: 411 FSEVNLLGKGNFSSVYKGT-LRDG----TLVAIRSINVTSCKSEEAEFVKGLYLLTSLRH 465
             +V +LG G F +VYKG  + DG      VAI+ +   +      E +   Y++  +  
Sbjct: 19  LRKVKVLGSGAFGTVYKGIWIPDGENVKIPVAIKVLRENTSPKANKEILDEAYVMAGVGS 78
Query: 466 ENIIRLRGFCCSRGRGECFLIYDFAPKGKLSKYLDQEEG---SSNVLDWSTRVSIIIGIA 522
             + RL G C +       L+    P G L  ++ +  G   S ++L+W  +      IA
Sbjct: 79  PYVSRLLGICLT---STVQLVTQLMPYGCLLDHVRENRGRLGSQDLLNWCMQ------IA 129
Query: 523 KGIGYLHSSEVNKPAIVHRNLSVEKVLIDQQFNPLIADCGLHKLL-ADDIVFSVLKTSAA 581
           KG+ YL         +VHR+L+   VL+    +  I D GL +LL  D+  +        
Sbjct: 130 KGMSYLEDVR-----LVHRDLAARNVLVKSPNHVKITDFGLARLLDIDETEYHADGGKVP 184
Query: 582 MGYLAPEYVTTGRFTERSDIFAFGVIILQILT 613
           + ++A E +   RFT +SD++++GV + +++T
Sbjct: 185 IKWMALESILRRRFTHQSDVWSYGVTVWELMT 216

>pdb|3QUP|A Chain A, Inhibitor Bound Structure Of The Kinase Domain Of The Murine Receptor Tyrosine Kinase Tyro3 (Sky) Length = 323

Iteration: 1
 Score = 75.5 bits (184), Expect = 1e-13,   Method: Compositional matrix adjust.
 Identities = 77/305 (25%), Positives = 132/305 (43%), Gaps = 25/305 (8%)
Query: 384 LNGTGFSREHLNSFRLNLEEVESATQCFSEVNLLGKGNFSSVYKGTLR--DGTLV--AIR 439
           L+  G S E     +  LE+V    Q F+   +LGKG F SV +  L+  DG+ V  A++
Sbjct: 2   LDSLGISDE----LKEKLEDVLIPEQQFTLGRMLGKGEFGSVREAQLKQEDGSFVKVAVK 57
Query: 440 SINVTSCKSEE-AEFVKGLYLLTSLRHENIIRLRGFCC-SRGRGEC---FLIYDFAPKGK 494
            +      S +  EF++    +    H ++ +L G    SR +G      +I  F   G 
Sbjct: 58  MLKADIIASSDIEEFLREAACMKEFDHPHVAKLVGVSLRSRAKGRLPIPMVILPFMKHGD 117
Query: 495 LSKYLDQEEGSSNV--LDWSTRVSIIIGIAKGIGYLHSSEVNKPAIVHRNLSVEKVLIDQ 552
           L  +L       N   L   T V  ++ IA G+ YL S        +HR+L+    ++ +
Sbjct: 118 LHAFLLASRIGENPFNLPLQTLVRFMVDIACGMEYLSSRN-----FIHRDLAARNCMLAE 172
Query: 553 QFNPLIADCGL-HKLLADDIVFSVLKTSAAMGYLAPEYVTTGRFTERSDIFAFGVIILQI 611
                +AD GL  K+ + D       +   + +LA E +    +T  SD++AFGV + +I
Sbjct: 173 DMTVCVADFGLSRKIYSGDYYRQGCASKLPVKWLALESLADNLYTVHSDVWAFGVTMWEI 232
Query: 612 LTGSLVLTSSMRLAAESATFENFIDRNLKGKFSESEAAKLGKMALVCTHEDPENRPTMEA 671
           +T      + +    E+A   N++    + K       ++  +   C   DP+ RP+   
Sbjct: 233 MTRGQTPYAGI----ENAEIYNYLIGGNRLKQPPECMEEVYDLMYQCWSADPKQRPSFTC 288
Query: 672 VIEEL 676
           +  EL
Sbjct: 289 LRMEL 293

>pdb|1K3A|A Chain A, Structure Of The Insulin-Like Growth Factor 1 Receptor Kinase Length = 299

Iteration: 1
 Score = 75.1 bits (183), Expect = 1e-13,   Method: Compositional matrix adjust.
 Identities = 61/225 (27%), Positives = 113/225 (50%), Gaps = 20/225 (8%)
Query: 402 EEVESATQCFSEVNLLGKGNFSSVY----KGTLRDG--TLVAIRSINVTSCKSEEAEFVK 455
           +E E A +  +    LG+G+F  VY    KG ++D   T VAI+++N  +   E  EF+ 
Sbjct: 3   DEWEVAREKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEFLN 62
Query: 456 GLYLLTSLRHENIIRLRGFCCSRGRGECFLIYDFAPKGKLSKYLD--QEEGSSNVLDWST 513
              ++      +++RL G   S+G+    +I +   +G L  YL   + E  +N +    
Sbjct: 63  EASVMKEFNCHHVVRLLG-VVSQGQ-PTLVIMELMTRGDLKSYLRSLRPEMENNPVLAPP 120
Query: 514 RVSIIIG----IAKGIGYLHSSEVNKPAIVHRNLSVEKVLIDQQFNPLIADCGLHKLLAD 569
            +S +I     IA G+ YL++++      VHR+L+    ++ + F   I D G+ + + +
Sbjct: 121 SLSKMIQMAGEIADGMAYLNANK-----FVHRDLAARNCMVAEDFTVKIGDFGMTRDIXE 175
Query: 570 -DIVFSVLKTSAAMGYLAPEYVTTGRFTERSDIFAFGVIILQILT 613
            D      K    + +++PE +  G FT  SD+++FGV++ +I T
Sbjct: 176 TDXXRKGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIAT 220

>pdb|2Z8C|A Chain A, Phosphorylated Insulin Receptor Tyrosine Kinase In Complex With (4-{[5-Carbamoyl-4-(3-Methylanilino)pyrimidin-2- Yl]amino}phenyl)acetic Acid Length = 303

Iteration: 1
 Score = 75.1 bits (183), Expect = 1e-13,   Method: Compositional matrix adjust.
 Identities = 66/288 (22%), Positives = 128/288 (44%), Gaps = 30/288 (10%)
Query: 402 EEVESATQCFSEVNLLGKGNFSSVYKGTLRD------GTLVAIRSINVTSCKSEEAEFVK 455
           +E E + +  + +  LG+G+F  VY+G  RD       T VA++++N ++   E  EF+ 
Sbjct: 7   DEWEVSREKITLLRELGQGSFGMVYEGNARDIIKGEAETRVAVKTVNESASLRERIEFLN 66
Query: 456 GLYLLTSLRHENIIRLRGFCCSRGRGECFLIYDFAPKGKLSKYLD--QEEGSSNV----L 509
              ++      +++RL G   S+G+    ++ +    G L  YL   + E  +N      
Sbjct: 67  EASVMKGFTCHHVVRLLG-VVSKGQ-PTLVVMELMAHGDLKSYLRSLRPEAENNPGRPPP 124
Query: 510 DWSTRVSIIIGIAKGIGYLHSSEVNKPAIVHRNLSVEKVLIDQQFNPLIADCGLHKLLAD 569
                + +   IA G+ YL     N    VHR+L+    ++   F   I D G+ + + +
Sbjct: 125 TLQEMIQMAAEIADGMAYL-----NAKKFVHRDLAARNCMVAHDFTVKIGDFGMTRDIXE 179
Query: 570 -DIVFSVLKTSAAMGYLAPEYVTTGRFTERSDIFAFGVIILQILTGSLVLTSSMRLAAES 628
            D      K    + ++APE +  G FT  SD+++FGV++ +I       TS      + 
Sbjct: 180 TDXXRKGGKGLLPVRWMAPESLKDGVFTTSSDMWSFGVVLWEI-------TSLAEQPYQG 232
Query: 629 ATFENFIDRNLKGKFSESE---AAKLGKMALVCTHEDPENRPTMEAVI 673
            + E  +   + G + +       ++  +  +C   +P+ RPT   ++
Sbjct: 233 LSNEQVLKFVMDGGYLDQPDNCPERVTDLMRMCWQFNPKMRPTFLEIV 280

>pdb|2ZM3|A Chain A, Complex Structure Of Insulin-Like Growth Factor Receptor And Isoquinolinedione Inhibitor Length = 308

Iteration: 1
 Score = 74.7 bits (182), Expect = 1e-13,   Method: Compositional matrix adjust.
 Identities = 61/225 (27%), Positives = 113/225 (50%), Gaps = 20/225 (8%)
Query: 402 EEVESATQCFSEVNLLGKGNFSSVY----KGTLRDG--TLVAIRSINVTSCKSEEAEFVK 455
           +E E A +  +    LG+G+F  VY    KG ++D   T VAI+++N  +   E  EF+ 
Sbjct: 12  DEWEVAREKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEFLN 71
Query: 456 GLYLLTSLRHENIIRLRGFCCSRGRGECFLIYDFAPKGKLSKYLD--QEEGSSNVLDWST 513
              ++      +++RL G   S+G+    +I +   +G L  YL   + E  +N +    
Sbjct: 72  EASVMKEFNCHHVVRLLG-VVSQGQ-PTLVIMELMTRGDLKSYLRSLRPEMENNPVLAPP 129
Query: 514 RVSIIIG----IAKGIGYLHSSEVNKPAIVHRNLSVEKVLIDQQFNPLIADCGLHKLLAD 569
            +S +I     IA G+ YL++++      VHR+L+    ++ + F   I D G+ + + +
Sbjct: 130 SLSKMIQMAGEIADGMAYLNANK-----FVHRDLAARNCMVAEDFTVKIGDFGMTRDIXE 184
Query: 570 -DIVFSVLKTSAAMGYLAPEYVTTGRFTERSDIFAFGVIILQILT 613
            D      K    + +++PE +  G FT  SD+++FGV++ +I T
Sbjct: 185 TDXXRKGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIAT 229

>pdb|2OZO|A Chain A, Autoinhibited Intact Human Zap-70 Length = 613

Iteration: 1
 Score = 74.7 bits (182), Expect = 1e-13,   Method: Compositional matrix adjust.
 Identities = 55/202 (27%), Positives = 97/202 (48%), Gaps = 16/202 (7%)
Query: 417 LGKGNFSSVYKGTLR---DGTLVAIRSINVTSCKSEEAEFVKGLYLLTSLRHENIIRLRG 473
           LG GNF SV +G  R       VAI+ +   + K++  E ++   ++  L +  I+RL G
Sbjct: 344 LGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKADTEEMMREAQIMHQLDNPYIVRLIG 403
Query: 474 FCCSRGRGECFLIYDFAPKGKLSKYLDQEEGSSNVLDWSTRVSIIIGIAKGIGYLHSSEV 533
            C +       L+ + A  G L K+L    G    +  S    ++  ++ G+ YL     
Sbjct: 404 VCQAEA---LMLVMEMAGGGPLHKFL---VGKREEIPVSNVAELLHQVSMGMKYLEEKN- 456
Query: 534 NKPAIVHRNLSVEKVLIDQQFNPLIADCGLHKLLADDIVFSVLKTSA--AMGYLAPEYVT 591
                VHRNL+   VL+  +    I+D GL K L  D  +   +++    + + APE + 
Sbjct: 457 ----FVHRNLAARNVLLVNRHYAKISDFGLSKALGADDSYYTARSAGKWPLKWYAPECIN 512
Query: 592 TGRFTERSDIFAFGVIILQILT 613
             +F+ RSD++++GV + + L+
Sbjct: 513 FRKFSSRSDVWSYGVTMWEALS 534

>pdb|3I81|A Chain A, Crystal Structure Of Insulin-Like Growth Factor 1 Receptor (Igf-1r-Wt) Complex With Bms-754807 [1-(4-((5-Cyclopropyl- 1h-Pyrazol-3-Yl)amino)pyrrolo[2,1-F][1,2, 4]triazin-2-Yl)-N- (6-Fluoro-3-Pyridinyl)-2-Methyl-L-Prolinamide] Length = 315

Iteration: 1
 Score = 74.7 bits (182), Expect = 1e-13,   Method: Compositional matrix adjust.
 Identities = 61/225 (27%), Positives = 112/225 (49%), Gaps = 20/225 (8%)
Query: 402 EEVESATQCFSEVNLLGKGNFSSVY----KGTLRDG--TLVAIRSINVTSCKSEEAEFVK 455
           +E E A +  +    LG+G+F  VY    KG ++D   T VAI+++N  +   E  EF+ 
Sbjct: 11  DEWEVAREKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEFLN 70
Query: 456 GLYLLTSLRHENIIRLRGFCCSRGRGECFLIYDFAPKGKLSKYLD--QEEGSSNVLDWST 513
              ++      +++RL G   S+G+    +I +   +G L  YL   + E  +N +    
Sbjct: 71  EASVMKEFNCHHVVRLLG-VVSQGQ-PTLVIMELMTRGDLKSYLRSLRPEMENNPVLAPP 128
Query: 514 RVSIIIG----IAKGIGYLHSSEVNKPAIVHRNLSVEKVLIDQQFNPLIADCGLHK-LLA 568
            +S +I     IA G+ YL++++      VHR+L+    ++ + F   I D G+ + +  
Sbjct: 129 SLSKMIQMAGEIADGMAYLNANK-----FVHRDLAARNCMVAEDFTVKIGDFGMTRDIYE 183
Query: 569 DDIVFSVLKTSAAMGYLAPEYVTTGRFTERSDIFAFGVIILQILT 613
            D      K    + +++PE +  G FT  SD+++FGV++ +I T
Sbjct: 184 TDYYRKGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIAT 228

>pdb|1M7N|A Chain A, Crystal Structure Of Unactivated Apo Insulin-Like Growth Factor-1 Receptor Kinase Domain Length = 322

Iteration: 1
 Score = 74.7 bits (182), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 61/225 (27%), Positives = 112/225 (49%), Gaps = 20/225 (8%)
Query: 402 EEVESATQCFSEVNLLGKGNFSSVY----KGTLRDG--TLVAIRSINVTSCKSEEAEFVK 455
           +E E A +  +    LG+G+F  VY    KG ++D   T VAI+++N  +   E  EF+ 
Sbjct: 18  DEWEVAREKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEFLN 77
Query: 456 GLYLLTSLRHENIIRLRGFCCSRGRGECFLIYDFAPKGKLSKYLD--QEEGSSNVLDWST 513
              ++      +++RL G   S+G+    +I +   +G L  YL   + E  +N +    
Sbjct: 78  EASVMKEFNCHHVVRLLG-VVSQGQP-TLVIMELMTRGDLKSYLRSLRPEMENNPVLAPP 135
Query: 514 RVSIIIG----IAKGIGYLHSSEVNKPAIVHRNLSVEKVLIDQQFNPLIADCGLHK-LLA 568
            +S +I     IA G+ YL++++      VHR+L+    ++ + F   I D G+ + +  
Sbjct: 136 SLSKMIQMAGEIADGMAYLNANK-----FVHRDLAARNCMVAEDFTVKIGDFGMTRDIYE 190
Query: 569 DDIVFSVLKTSAAMGYLAPEYVTTGRFTERSDIFAFGVIILQILT 613
            D      K    + +++PE +  G FT  SD+++FGV++ +I T
Sbjct: 191 TDYYRKGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIAT 235

>pdb|3QQU|A Chain A, Cocrystal Structure Of Unphosphorylated Igf With Pyrimidine 8 Length = 301

Iteration: 1
 Score = 74.7 bits (182), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 61/225 (27%), Positives = 112/225 (49%), Gaps = 20/225 (8%)
Query: 402 EEVESATQCFSEVNLLGKGNFSSVY----KGTLRDG--TLVAIRSINVTSCKSEEAEFVK 455
           +E E A +  +    LG+G+F  VY    KG ++D   T VAI+++N  +   E  EF+ 
Sbjct: 5   DEWEVAREKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEFLN 64
Query: 456 GLYLLTSLRHENIIRLRGFCCSRGRGECFLIYDFAPKGKLSKYLD--QEEGSSNVLDWST 513
              ++      +++RL G   S+G+    +I +   +G L  YL   + E  +N +    
Sbjct: 65  EASVMKEFNCHHVVRLLG-VVSQGQ-PTLVIMELMTRGDLKSYLRSLRPEMENNPVLAPP 122
Query: 514 RVSIIIG----IAKGIGYLHSSEVNKPAIVHRNLSVEKVLIDQQFNPLIADCGLHK-LLA 568
            +S +I     IA G+ YL++++      VHR+L+    ++ + F   I D G+ + +  
Sbjct: 123 SLSKMIQMAGEIADGMAYLNANK-----FVHRDLAARNCMVAEDFTVKIGDFGMTRDIYE 177
Query: 569 DDIVFSVLKTSAAMGYLAPEYVTTGRFTERSDIFAFGVIILQILT 613
            D      K    + +++PE +  G FT  SD+++FGV++ +I T
Sbjct: 178 TDYYRKGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIAT 222

>pdb|1IR3|A Chain A, Phosphorylated Insulin Receptor Tyrosine Kinase In Complex With Peptide Substrate And Atp Analog Length = 306

Iteration: 1
 Score = 74.7 bits (182), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 66/288 (22%), Positives = 128/288 (44%), Gaps = 30/288 (10%)
Query: 402 EEVESATQCFSEVNLLGKGNFSSVYKGTLRD------GTLVAIRSINVTSCKSEEAEFVK 455
           +E E + +  + +  LG+G+F  VY+G  RD       T VA++++N ++   E  EF+ 
Sbjct: 10  DEWEVSREKITLLRELGQGSFGMVYEGNARDIIKGEAETRVAVKTVNESASLRERIEFLN 69
Query: 456 GLYLLTSLRHENIIRLRGFCCSRGRGECFLIYDFAPKGKLSKYLD--QEEGSSNV----L 509
              ++      +++RL G   S+G+    ++ +    G L  YL   + E  +N      
Sbjct: 70  EASVMKGFTCHHVVRLLG-VVSKGQ-PTLVVMELMAHGDLKSYLRSLRPEAENNPGRPPP 127
Query: 510 DWSTRVSIIIGIAKGIGYLHSSEVNKPAIVHRNLSVEKVLIDQQFNPLIADCGLHKLLAD 569
                + +   IA G+ YL     N    VHR+L+    ++   F   I D G+ + + +
Sbjct: 128 TLQEMIQMAAEIADGMAYL-----NAKKFVHRDLAARNCMVAHDFTVKIGDFGMTRDIXE 182
Query: 570 -DIVFSVLKTSAAMGYLAPEYVTTGRFTERSDIFAFGVIILQILTGSLVLTSSMRLAAES 628
            D      K    + ++APE +  G FT  SD+++FGV++ +I       TS      + 
Sbjct: 183 TDXXRKGGKGLLPVRWMAPESLKDGVFTTSSDMWSFGVVLWEI-------TSLAEQPYQG 235
Query: 629 ATFENFIDRNLKGKFSESE---AAKLGKMALVCTHEDPENRPTMEAVI 673
            + E  +   + G + +       ++  +  +C   +P+ RPT   ++
Sbjct: 236 LSNEQVLKFVMDGGYLDQPDNCPERVTDLMRMCWQFNPKMRPTFLEIV 283

>pdb|1I44|A Chain A, Crystallographic Studies Of An Activation Loop Mutant Of The Insulin Receptor Tyrosine Kinase Length = 306

Iteration: 1
 Score = 74.7 bits (182), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 67/292 (22%), Positives = 127/292 (43%), Gaps = 38/292 (13%)
Query: 402 EEVESATQCFSEVNLLGKGNFSSVYKGTLRD------GTLVAIRSINVTSCKSEEAEFVK 455
           +E E + +  + +  LG+G+F  VY+G  RD       T VA++++N ++   E  EF+ 
Sbjct: 10  DEWEVSREKITLLRELGQGSFGMVYEGNARDIIKGEAETRVAVKTVNESASLRERIEFLN 69
Query: 456 GLYLLTSLRHENIIRLRGFCCSRGRGECFLIYDFAPKGKLSKYLD--QEEGSSNV----L 509
              ++      +++RL G   S+G+    ++ +    G L  YL   + E  +N      
Sbjct: 70  EASVMKGFTCHHVVRLLG-VVSKGQ-PTLVVMELMAHGDLKSYLRSLRPEAENNPGRPPP 127
Query: 510 DWSTRVSIIIGIAKGIGYLHSSEVNKPAIVHRNLSVEKVLIDQQFNPLIADCGLHKLLAD 569
                + +   IA G+ YL     N    VHR+L+    ++   F   I D G+ +    
Sbjct: 128 TLQEMIQMAAEIADGMAYL-----NAKKFVHRDLAARNCMVAHDFTVKIGDFGMTR---- 178
Query: 570 DIVFSVLKTSAAMG-----YLAPEYVTTGRFTERSDIFAFGVIILQILTGSLVLTSSMRL 624
           DI  +        G     ++APE +  G FT  SD+++FGV++ +I       TS    
Sbjct: 179 DIYETAYYRKGGKGLLPVRWMAPESLKDGVFTTSSDMWSFGVVLWEI-------TSLAEQ 231
Query: 625 AAESATFENFIDRNLKGKFSESE---AAKLGKMALVCTHEDPENRPTMEAVI 673
             +  + E  +   + G + +       ++  +  +C   +P+ RPT   ++
Sbjct: 232 PYQGLSNEQVLKFVMDGGYLDQPDNCPERVTDLMRMCWQFNPKMRPTFLEIV 283

>pdb|3O23|A Chain A, Human Unphosphorylated Igf1-R Kinase Domain In Complex With An Hydantoin Inhibitor Length = 305

Iteration: 1
 Score = 74.7 bits (182), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 61/225 (27%), Positives = 112/225 (49%), Gaps = 20/225 (8%)
Query: 402 EEVESATQCFSEVNLLGKGNFSSVY----KGTLRDG--TLVAIRSINVTSCKSEEAEFVK 455
           +E E A +  +    LG+G+F  VY    KG ++D   T VAI+++N  +   E  EF+ 
Sbjct: 9   DEWEVAREKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEFLN 68
Query: 456 GLYLLTSLRHENIIRLRGFCCSRGRGECFLIYDFAPKGKLSKYLD--QEEGSSNVLDWST 513
              ++      +++RL G   S+G+    +I +   +G L  YL   + E  +N +    
Sbjct: 69  EASVMKEFNCHHVVRLLG-VVSQGQ-PTLVIMELMTRGDLKSYLRSLRPEMENNPVLAPP 126
Query: 514 RVSIIIG----IAKGIGYLHSSEVNKPAIVHRNLSVEKVLIDQQFNPLIADCGLHK-LLA 568
            +S +I     IA G+ YL++++      VHR+L+    ++ + F   I D G+ + +  
Sbjct: 127 SLSKMIQMAGEIADGMAYLNANK-----FVHRDLAARNCMVAEDFTVKIGDFGMTRDIYE 181
Query: 569 DDIVFSVLKTSAAMGYLAPEYVTTGRFTERSDIFAFGVIILQILT 613
            D      K    + +++PE +  G FT  SD+++FGV++ +I T
Sbjct: 182 TDYYRKGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIAT 226

>pdb|1IRK|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The Human Insulin Receptor Length = 306

Iteration: 1
 Score = 74.7 bits (182), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 66/288 (22%), Positives = 127/288 (44%), Gaps = 30/288 (10%)
Query: 402 EEVESATQCFSEVNLLGKGNFSSVYKGTLRD------GTLVAIRSINVTSCKSEEAEFVK 455
           +E E + +  + +  LG+G+F  VY+G  RD       T VA++++N ++   E  EF+ 
Sbjct: 10  DEWEVSREKITLLRELGQGSFGMVYEGNARDIIKGEAETRVAVKTVNESASLRERIEFLN 69
Query: 456 GLYLLTSLRHENIIRLRGFCCSRGRGECFLIYDFAPKGKLSKYLD--QEEGSSNV----L 509
              ++      +++RL G   S+G+    ++ +    G L  YL   + E  +N      
Sbjct: 70  EASVMKGFTCHHVVRLLG-VVSKGQ-PTLVVMELMAHGDLKSYLRSLRPEAENNPGRPPP 127
Query: 510 DWSTRVSIIIGIAKGIGYLHSSEVNKPAIVHRNLSVEKVLIDQQFNPLIADCGLHK-LLA 568
                + +   IA G+ YL     N    VHR+L+    ++   F   I D G+ + +  
Sbjct: 128 TLQEMIQMAAEIADGMAYL-----NAKKFVHRDLAARNCMVAHDFTVKIGDFGMTRDIYE 182
Query: 569 DDIVFSVLKTSAAMGYLAPEYVTTGRFTERSDIFAFGVIILQILTGSLVLTSSMRLAAES 628
            D      K    + ++APE +  G FT  SD+++FGV++ +I       TS      + 
Sbjct: 183 TDYYRKGGKGLLPVRWMAPESLKDGVFTTSSDMWSFGVVLWEI-------TSLAEQPYQG 235
Query: 629 ATFENFIDRNLKGKFSESE---AAKLGKMALVCTHEDPENRPTMEAVI 673
            + E  +   + G + +       ++  +  +C   +P+ RPT   ++
Sbjct: 236 LSNEQVLKFVMDGGYLDQPDNCPERVTDLMRMCWQFNPKMRPTFLEIV 283

>pdb|2OJ9|A Chain A, Structure Of Igf-1r Kinase Domain Complexed With A Benzimidazole Inhibitor Length = 307

Iteration: 1
 Score = 74.7 bits (182), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 61/225 (27%), Positives = 112/225 (49%), Gaps = 20/225 (8%)
Query: 402 EEVESATQCFSEVNLLGKGNFSSVY----KGTLRDG--TLVAIRSINVTSCKSEEAEFVK 455
           +E E A +  +    LG+G+F  VY    KG ++D   T VAI+++N  +   E  EF+ 
Sbjct: 11  DEWEVAREKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEFLN 70
Query: 456 GLYLLTSLRHENIIRLRGFCCSRGRGECFLIYDFAPKGKLSKYLD--QEEGSSNVLDWST 513
              ++      +++RL G   S+G+    +I +   +G L  YL   + E  +N +    
Sbjct: 71  EASVMKEFNCHHVVRLLG-VVSQGQ-PTLVIMELMTRGDLKSYLRSLRPEMENNPVLAPP 128
Query: 514 RVSIIIG----IAKGIGYLHSSEVNKPAIVHRNLSVEKVLIDQQFNPLIADCGLHK-LLA 568
            +S +I     IA G+ YL++++      VHR+L+    ++ + F   I D G+ + +  
Sbjct: 129 SLSKMIQMAGEIADGMAYLNANK-----FVHRDLAARNCMVAEDFTVKIGDFGMTRDIYE 183
Query: 569 DDIVFSVLKTSAAMGYLAPEYVTTGRFTERSDIFAFGVIILQILT 613
            D      K    + +++PE +  G FT  SD+++FGV++ +I T
Sbjct: 184 TDYYRKGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIAT 228

>pdb|1JQH|A Chain A, Igf-1 Receptor Kinase Domain Length = 308

Iteration: 1
 Score = 74.3 bits (181), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 61/225 (27%), Positives = 112/225 (49%), Gaps = 20/225 (8%)
Query: 402 EEVESATQCFSEVNLLGKGNFSSVY----KGTLRDG--TLVAIRSINVTSCKSEEAEFVK 455
           +E E A +  +    LG+G+F  VY    KG ++D   T VAI+++N  +   E  EF+ 
Sbjct: 12  DEWEVAREKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEFLN 71
Query: 456 GLYLLTSLRHENIIRLRGFCCSRGRGECFLIYDFAPKGKLSKYLD--QEEGSSNVLDWST 513
              ++      +++RL G   S+G+    +I +   +G L  YL   + E  +N +    
Sbjct: 72  EASVMKEFNCHHVVRLLG-VVSQGQ-PTLVIMELMTRGDLKSYLRSLRPEMENNPVLAPP 129
Query: 514 RVSIIIG----IAKGIGYLHSSEVNKPAIVHRNLSVEKVLIDQQFNPLIADCGLHK-LLA 568
            +S +I     IA G+ YL++++      VHR+L+    ++ + F   I D G+ + +  
Sbjct: 130 SLSKMIQMAGEIADGMAYLNANK-----FVHRDLAARNCMVAEDFTVKIGDFGMTRDIYE 184
Query: 569 DDIVFSVLKTSAAMGYLAPEYVTTGRFTERSDIFAFGVIILQILT 613
            D      K    + +++PE +  G FT  SD+++FGV++ +I T
Sbjct: 185 TDYYRKGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIAT 229

>pdb|3LVP|A Chain A, Crystal Structure Of Bisphosphorylated Igf1-R Kinase Domain (2p) In Complex With A Bis-Azaindole Inhibitor Length = 336

Iteration: 1
 Score = 74.3 bits (181), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 61/225 (27%), Positives = 112/225 (49%), Gaps = 20/225 (8%)
Query: 402 EEVESATQCFSEVNLLGKGNFSSVY----KGTLRDG--TLVAIRSINVTSCKSEEAEFVK 455
           +E E A +  +    LG+G+F  VY    KG ++D   T VAI+++N  +   E  EF+ 
Sbjct: 40  DEWEVAREKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEFLN 99
Query: 456 GLYLLTSLRHENIIRLRGFCCSRGRGECFLIYDFAPKGKLSKYLD--QEEGSSNVLDWST 513
              ++      +++RL G   S+G+    +I +   +G L  YL   + E  +N +    
Sbjct: 100 EASVMKEFNCHHVVRLLG-VVSQGQ-PTLVIMELMTRGDLKSYLRSLRPEMENNPVLAPP 157
Query: 514 RVSIIIG----IAKGIGYLHSSEVNKPAIVHRNLSVEKVLIDQQFNPLIADCGLHK-LLA 568
            +S +I     IA G+ YL++++      VHR+L+    ++ + F   I D G+ + +  
Sbjct: 158 SLSKMIQMAGEIADGMAYLNANK-----FVHRDLAARNCMVAEDFTVKIGDFGMTRDIYE 212
Query: 569 DDIVFSVLKTSAAMGYLAPEYVTTGRFTERSDIFAFGVIILQILT 613
            D      K    + +++PE +  G FT  SD+++FGV++ +I T
Sbjct: 213 TDYYRKGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIAT 257

>pdb|1B6C|B Chain B, Crystal Structure Of The Cytoplasmic Domain Of The Type I Tgf-Beta Receptor In Complex With Fkbp12 Length = 342

Iteration: 1
 Score = 74.3 bits (181), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 60/213 (28%), Positives = 100/213 (46%), Gaps = 30/213 (14%)
Query: 417 LGKGNFSSVYKGTLRDGTLVAIRSINVTSCKSEEAEFVKG-LYLLTSLRHENIIRLRGFC 475
           +GKG F  V++G  R G  VA++   + S + E + F +  +Y    LRHENI+   GF 
Sbjct: 50  IGKGRFGEVWRGKWR-GEEVAVK---IFSSREERSWFREAEIYQTVMLRHENIL---GFI 102
Query: 476 CSRGRG-----ECFLIYDFAPKGKLSKYLDQEEGSSNVLDWSTRVSIIIGIAKGIGYLHS 530
            +  +      + +L+ D+   G L  YL++   +   +     + + +  A G+ +LH 
Sbjct: 103 AADNKDNGTWTQLWLVSDYHEHGSLFDYLNRYTVTVEGM-----IKLALSTASGLAHLHM 157
Query: 531 SEVN---KPAIVHRNLSVEKVLIDQQFNPLIADCGL---HKLLADDIVFSVLKTSAAMGY 584
             V    KPAI HR+L  + +L+ +     IAD GL   H    D I  +         Y
Sbjct: 158 EIVGTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAVRHDSATDTIDIAPNHRVGTKRY 217
Query: 585 LAPEY----VTTGRFT--ERSDIFAFGVIILQI 611
           +APE     +    F   +R+DI+A G++  +I
Sbjct: 218 MAPEVLDDSINMKHFESFKRADIYAMGLVFWEI 250

>pdb|1PY5|A Chain A, Crystal Structure Of Tgf-Beta Receptor I Kinase With Inhibitor Length = 326

Iteration: 1
 Score = 73.9 bits (180), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 60/213 (28%), Positives = 100/213 (46%), Gaps = 30/213 (14%)
Query: 417 LGKGNFSSVYKGTLRDGTLVAIRSINVTSCKSEEAEFVKG-LYLLTSLRHENIIRLRGFC 475
           +GKG F  V++G  R G  VA++   + S + E + F +  +Y    LRHENI+   GF 
Sbjct: 37  IGKGRFGEVWRGKWR-GEEVAVK---IFSSREERSWFREAEIYQTVMLRHENIL---GFI 89
Query: 476 CSRGRG-----ECFLIYDFAPKGKLSKYLDQEEGSSNVLDWSTRVSIIIGIAKGIGYLHS 530
            +  +      + +L+ D+   G L  YL++   +   +     + + +  A G+ +LH 
Sbjct: 90  AADNKDNGTWTQLWLVSDYHEHGSLFDYLNRYTVTVEGM-----IKLALSTASGLAHLHM 144
Query: 531 SEVN---KPAIVHRNLSVEKVLIDQQFNPLIADCGL---HKLLADDIVFSVLKTSAAMGY 584
             V    KPAI HR+L  + +L+ +     IAD GL   H    D I  +         Y
Sbjct: 145 EIVGTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAVRHDSATDTIDIAPNHRVGTKRY 204
Query: 585 LAPEY----VTTGRFT--ERSDIFAFGVIILQI 611
           +APE     +    F   +R+DI+A G++  +I
Sbjct: 205 MAPEVLDDSINMKHFESFKRADIYAMGLVFWEI 237

>pdb|1RQQ|A Chain A, Crystal Structure Of The Insulin Receptor Kinase In Complex With The Sh2 Domain Of Aps Length = 306

Iteration: 1
 Score = 73.9 bits (180), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 66/288 (22%), Positives = 127/288 (44%), Gaps = 30/288 (10%)
Query: 402 EEVESATQCFSEVNLLGKGNFSSVYKGTLRD------GTLVAIRSINVTSCKSEEAEFVK 455
           +E E + +  + +  LG+G+F  VY+G  RD       T VA++++N ++   E  EF+ 
Sbjct: 10  DEWEVSREKITLLRELGQGSFGMVYEGNARDIIKGEAETRVAVKTVNESASLRERIEFLN 69
Query: 456 GLYLLTSLRHENIIRLRGFCCSRGRGECFLIYDFAPKGKLSKYLD--QEEGSSNV----L 509
              ++      +++RL G   S+G+    ++ +    G L  YL   + E  +N      
Sbjct: 70  EASVMKGFTCHHVVRLLG-VVSKGQ-PTLVVMELMAHGDLKSYLRSLRPEAENNPGRPPP 127
Query: 510 DWSTRVSIIIGIAKGIGYLHSSEVNKPAIVHRNLSVEKVLIDQQFNPLIADCGLHKLLAD 569
                + +   IA G+ YL     N    VHR+L+    ++   F   I D G+ + + +
Sbjct: 128 TLQEMIQMAAEIADGMAYL-----NAKKFVHRDLAARNCMVAHDFTVKIGDFGMTRDIXE 182
Query: 570 -DIVFSVLKTSAAMGYLAPEYVTTGRFTERSDIFAFGVIILQILTGSLVLTSSMRLAAES 628
            D      K    + ++APE +  G FT  SD+++FGV++ +I       TS      + 
Sbjct: 183 TDXXRKGGKGLLPVRWMAPESLKDGVFTTSSDMWSFGVVLWEI-------TSLAEQPYQG 235
Query: 629 ATFENFIDRNLKGKFSESE---AAKLGKMALVCTHEDPENRPTMEAVI 673
            + E  +   + G + +       ++  +  +C   +P  RPT   ++
Sbjct: 236 LSNEQVLKFVMDGGYLDQPDNCPERVTDLMRMCWQFNPNMRPTFLEIV 283

>pdb|1RW8|A Chain A, Crystal Structure Of Tgf-Beta Receptor I Kinase With Atp Site Inhibitor Length = 301

Iteration: 1
 Score = 73.9 bits (180), Expect = 3e-13,   Method: Compositional matrix adjust.
 Identities = 60/213 (28%), Positives = 100/213 (46%), Gaps = 30/213 (14%)
Query: 417 LGKGNFSSVYKGTLRDGTLVAIRSINVTSCKSEEAEFVKG-LYLLTSLRHENIIRLRGFC 475
           +GKG F  V++G  R G  VA++   + S + E + F +  +Y    LRHENI+   GF 
Sbjct: 12  IGKGRFGEVWRGKWR-GEEVAVK---IFSSREERSWFREAEIYQTVMLRHENIL---GFI 64
Query: 476 CSRGRG-----ECFLIYDFAPKGKLSKYLDQEEGSSNVLDWSTRVSIIIGIAKGIGYLHS 530
            +  +      + +L+ D+   G L  YL++   +   +     + + +  A G+ +LH 
Sbjct: 65  AADNKDNGTWTQLWLVSDYHEHGSLFDYLNRYTVTVEGM-----IKLALSTASGLAHLHM 119
Query: 531 SEVN---KPAIVHRNLSVEKVLIDQQFNPLIADCGL---HKLLADDIVFSVLKTSAAMGY 584
             V    KPAI HR+L  + +L+ +     IAD GL   H    D I  +         Y
Sbjct: 120 EIVGTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAVRHDSATDTIDIAPNHRVGTKRY 179
Query: 585 LAPEY----VTTGRFT--ERSDIFAFGVIILQI 611
           +APE     +    F   +R+DI+A G++  +I
Sbjct: 180 MAPEVLDDSINMKHFESFKRADIYAMGLVFWEI 212

>pdb|3TZM|A Chain A, Tgf-Beta Receptor Type 1 In Complex With Sb431542 Length = 309

Iteration: 1
 Score = 73.9 bits (180), Expect = 3e-13,   Method: Compositional matrix adjust.
 Identities = 60/213 (28%), Positives = 100/213 (46%), Gaps = 30/213 (14%)
Query: 417 LGKGNFSSVYKGTLRDGTLVAIRSINVTSCKSEEAEFVKG-LYLLTSLRHENIIRLRGFC 475
           +GKG F  V++G  R G  VA++   + S + E + F +  +Y    LRHENI+   GF 
Sbjct: 17  IGKGRFGEVWRGKWR-GEEVAVK---IFSSREERSWFREAEIYQTVMLRHENIL---GFI 69
Query: 476 CSRGRG-----ECFLIYDFAPKGKLSKYLDQEEGSSNVLDWSTRVSIIIGIAKGIGYLHS 530
            +  +      + +L+ D+   G L  YL++   +   +     + + +  A G+ +LH 
Sbjct: 70  AADNKDNGTWTQLWLVSDYHEHGSLFDYLNRYTVTVEGM-----IKLALSTASGLAHLHM 124
Query: 531 SEVN---KPAIVHRNLSVEKVLIDQQFNPLIADCGL---HKLLADDIVFSVLKTSAAMGY 584
             V    KPAI HR+L  + +L+ +     IAD GL   H    D I  +         Y
Sbjct: 125 EIVGTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAVRHDSATDTIDIAPNHRVGTKRY 184
Query: 585 LAPEY----VTTGRFT--ERSDIFAFGVIILQI 611
           +APE     +    F   +R+DI+A G++  +I
Sbjct: 185 MAPEVLDDSINMKHFESFKRADIYAMGLVFWEI 217

>pdb|1VJY|A Chain A, Crystal Structure Of A Naphthyridine Inhibitor Of Human Tgf- Beta Type I Receptor Length = 303

Iteration: 1
 Score = 73.9 bits (180), Expect = 3e-13,   Method: Compositional matrix adjust.
 Identities = 60/213 (28%), Positives = 100/213 (46%), Gaps = 30/213 (14%)
Query: 417 LGKGNFSSVYKGTLRDGTLVAIRSINVTSCKSEEAEFVKG-LYLLTSLRHENIIRLRGFC 475
           +GKG F  V++G  R G  VA++   + S + E + F +  +Y    LRHENI+   GF 
Sbjct: 11  IGKGRFGEVWRGKWR-GEEVAVK---IFSSREERSWFREAEIYQTVMLRHENIL---GFI 63
Query: 476 CSRGRG-----ECFLIYDFAPKGKLSKYLDQEEGSSNVLDWSTRVSIIIGIAKGIGYLHS 530
            +  +      + +L+ D+   G L  YL++   +   +     + + +  A G+ +LH 
Sbjct: 64  AADNKDNGTWTQLWLVSDYHEHGSLFDYLNRYTVTVEGM-----IKLALSTASGLAHLHM 118
Query: 531 SEVN---KPAIVHRNLSVEKVLIDQQFNPLIADCGL---HKLLADDIVFSVLKTSAAMGY 584
             V    KPAI HR+L  + +L+ +     IAD GL   H    D I  +         Y
Sbjct: 119 EIVGTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAVRHDSATDTIDIAPNHRVGTKRY 178
Query: 585 LAPEY----VTTGRFT--ERSDIFAFGVIILQI 611
           +APE     +    F   +R+DI+A G++  +I
Sbjct: 179 MAPEVLDDSINMKHFESFKRADIYAMGLVFWEI 211

>pdb|2PVY|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic K659n Mutation Responsible For An Unclassified Craniosynostosis Syndrome. Length = 324

Iteration: 1
 Score = 73.9 bits (180), Expect = 3e-13,   Method: Compositional matrix adjust.
 Identities = 66/282 (23%), Positives = 123/282 (43%), Gaps = 33/282 (11%)
Query: 417 LGKGNFSSVY--------KGTLRDGTLVAIRSINVTSCKSEEAEFVKGLYLLTSL-RHEN 467
           LG+G F  V         K   ++   VA++ +   + + + ++ V  + ++  + +H+N
Sbjct: 43  LGEGAFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKN 102
Query: 468 IIRLRGFCCSRGRGECFLIYDFAPKGKLSKYL------------DQEEGSSNVLDWSTRV 515
           II L G C   G    ++I ++A KG L +YL            D        + +   V
Sbjct: 103 IINLLGACTQDG--PLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLV 160
Query: 516 SIIIGIAKGIGYLHSSEVNKPAIVHRNLSVEKVLIDQQFNPLIADCGLHKLLAD-DIVFS 574
           S    +A+G+ YL S +      +HR+L+   VL+ +     IAD GL + + + D   +
Sbjct: 161 SCTYQLARGMEYLASQKC-----IHRDLAARNVLVTENNVMKIADFGLARDINNIDYYKN 215
Query: 575 VLKTSAAMGYLAPEYVTTGRFTERSDIFAFGVIILQILTGSLVLTSSMRLAAESATFENF 634
                  + ++APE +    +T +SD+++FGV++ +I T    L  S             
Sbjct: 216 TTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFT----LGGSPYPGIPVEELFKL 271
Query: 635 IDRNLKGKFSESEAAKLGKMALVCTHEDPENRPTMEAVIEEL 676
           +    +     +   +L  M   C H  P  RPT + ++E+L
Sbjct: 272 LKEGHRMDKPANCTNELYMMMRDCWHAVPSQRPTFKQLVEDL 313

>pdb|2WOT|A Chain A, Alk5 In Complex With 4-((5,6-Dimethyl-2-(2-Pyridyl)-3- Pyridyl)oxy)-N-(3,4,5-Trimethoxyphenyl)pyridin-2-Amine Length = 306

Iteration: 1
 Score = 73.9 bits (180), Expect = 3e-13,   Method: Compositional matrix adjust.
 Identities = 60/213 (28%), Positives = 100/213 (46%), Gaps = 30/213 (14%)
Query: 417 LGKGNFSSVYKGTLRDGTLVAIRSINVTSCKSEEAEFVKG-LYLLTSLRHENIIRLRGFC 475
           +GKG F  V++G  R G  VA++   + S + E + F +  +Y    LRHENI+   GF 
Sbjct: 14  IGKGRFGEVWRGKWR-GEEVAVK---IFSSREERSWFREAEIYQTVMLRHENIL---GFI 66
Query: 476 CSRGRG-----ECFLIYDFAPKGKLSKYLDQEEGSSNVLDWSTRVSIIIGIAKGIGYLHS 530
            +  +      + +L+ D+   G L  YL++   +   +     + + +  A G+ +LH 
Sbjct: 67  AADNKDNGTWTQLWLVSDYHEHGSLFDYLNRYTVTVEGM-----IKLALSTASGLAHLHM 121
Query: 531 SEVN---KPAIVHRNLSVEKVLIDQQFNPLIADCGL---HKLLADDIVFSVLKTSAAMGY 584
             V    KPAI HR+L  + +L+ +     IAD GL   H    D I  +         Y
Sbjct: 122 EIVGTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAVRHDSATDTIDIAPNHRVGTKRY 181
Query: 585 LAPEY----VTTGRFT--ERSDIFAFGVIILQI 611
           +APE     +    F   +R+DI+A G++  +I
Sbjct: 182 MAPEVLDDSINMKHFESFKRADIYAMGLVFWEI 214

>pdb|3DAK|A Chain A, Crystal Structure Of Domain-Swapped Osr1 Kinase Domain Length = 290

Iteration: 1
 Score = 73.9 bits (180), Expect = 3e-13,   Method: Compositional matrix adjust.
 Identities = 62/250 (24%), Positives = 116/250 (46%), Gaps = 28/250 (11%)
Query: 436 VAIRSINVTSCKSEEAEFVKGLYLLTSLRHENIIRLRGFCCSRGRGECFLIYDFAPKGK- 494
           VAI+ IN+  C++   E +K +  ++   H NI+    +     + E +L+      G  
Sbjct: 38  VAIKRINLEKCQTSMDELLKEIQAMSQCHHPNIVSY--YTSFVVKDELWLVMKLLSGGSV 95
Query: 495 ---LSKYLDQEEGSSNVLDWSTRVSIIIGIAKGIGYLHSSEVNKPAIVHRNLSVEKVLID 551
              +   + + E  S VLD ST  +I+  + +G+ YLH     K   +HR++    +L+ 
Sbjct: 96  LDIIKHIVAKGEHKSGVLDESTIATILREVLEGLEYLH-----KNGQIHRDVKAGNILLG 150
Query: 552 QQFNPLIADCGLHKLLAD--DIVFSVLKTS--AAMGYLAPEYVTTGR-FTERSDIFAFGV 606
           +  +  IAD G+   LA   DI  + ++ +      ++APE +   R +  ++DI++FG+
Sbjct: 151 EDGSVQIADFGVSAFLATGGDITRNKVRKTFVGTPCWMAPEVMEQVRGYDFKADIWSFGI 210
Query: 607 IILQILTGSLVLTSSMRLAAESATFEN--------FIDRNLKGKFSESEAAKLGKMALVC 658
             +++ TG+        +     T +N          D+ +  K+ +S      KM  +C
Sbjct: 211 TAIELATGAAPYHKYPPMKVLMLTLQNDPPSLETGVQDKEMLKKYGKS----FRKMISLC 266
Query: 659 THEDPENRPT 668
             +DPE RPT
Sbjct: 267 LQKDPEKRPT 276

>pdb|2VWI|A Chain A, Structure Of The Osr1 Kinase, A Hypertension Drug Target Length = 303

Iteration: 1
 Score = 73.9 bits (180), Expect = 3e-13,   Method: Compositional matrix adjust.
 Identities = 62/250 (24%), Positives = 116/250 (46%), Gaps = 28/250 (11%)
Query: 436 VAIRSINVTSCKSEEAEFVKGLYLLTSLRHENIIRLRGFCCSRGRGECFLIYDFAPKGK- 494
           VAI+ IN+  C++   E +K +  ++   H NI+    +     + E +L+      G  
Sbjct: 43  VAIKRINLEKCQTSMDELLKEIQAMSQCHHPNIVSY--YTSFVVKDELWLVMKLLSGGSV 100
Query: 495 ---LSKYLDQEEGSSNVLDWSTRVSIIIGIAKGIGYLHSSEVNKPAIVHRNLSVEKVLID 551
              +   + + E  S VLD ST  +I+  + +G+ YLH     K   +HR++    +L+ 
Sbjct: 101 LDIIKHIVAKGEHKSGVLDESTIATILREVLEGLEYLH-----KNGQIHRDVKAGNILLG 155
Query: 552 QQFNPLIADCGLHKLLAD--DIVFSVLKTS--AAMGYLAPEYVTTGR-FTERSDIFAFGV 606
           +  +  IAD G+   LA   DI  + ++ +      ++APE +   R +  ++DI++FG+
Sbjct: 156 EDGSVQIADFGVSAFLATGGDITRNKVRKTFVGTPCWMAPEVMEQVRGYDFKADIWSFGI 215
Query: 607 IILQILTGSLVLTSSMRLAAESATFEN--------FIDRNLKGKFSESEAAKLGKMALVC 658
             +++ TG+        +     T +N          D+ +  K+ +S      KM  +C
Sbjct: 216 TAIELATGAAPYHKYPPMKVLMLTLQNDPPSLETGVQDKEMLKKYGKS----FRKMISLC 271
Query: 659 THEDPENRPT 668
             +DPE RPT
Sbjct: 272 LQKDPEKRPT 281

>pdb|2PVF|A Chain A, Crystal Structure Of Tyrosine Phosphorylated Activated Fgf Receptor 2 (Fgfr2) Kinase Domain In Complex With Atp Analog And Substrate Peptide Length = 334

Iteration: 1
 Score = 73.6 bits (179), Expect = 3e-13,   Method: Compositional matrix adjust.
 Identities = 67/282 (23%), Positives = 125/282 (44%), Gaps = 33/282 (11%)
Query: 417 LGKGNFSSVY--------KGTLRDGTLVAIRSINVTSCKSEEAEFVKGLYLLTSL-RHEN 467
           LG+G F  V         K   ++   VA++ +   + + + ++ V  + ++  + +H+N
Sbjct: 43  LGEGAFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKN 102
Query: 468 IIRLRGFCCSRGRGECFLIYDFAPKGKLSKYLDQE-----EGSSNV-------LDWSTRV 515
           II L G C   G    ++I ++A KG L +YL        E S ++       + +   V
Sbjct: 103 IINLLGACTQDG--PLYVIVEYASKGNLREYLRARRPPGMEXSYDINRVPEEQMTFKDLV 160
Query: 516 SIIIGIAKGIGYLHSSEVNKPAIVHRNLSVEKVLIDQQFNPLIADCGLHKLLAD-DIVFS 574
           S    +A+G+ YL S +      +HR+L+   VL+ +     IAD GL + + + D    
Sbjct: 161 SCTYQLARGMEYLASQKC-----IHRDLAARNVLVTENNVMKIADFGLARDINNIDXXKK 215
Query: 575 VLKTSAAMGYLAPEYVTTGRFTERSDIFAFGVIILQILTGSLVLTSSMRLAAESATFENF 634
                  + ++APE +    +T +SD+++FGV++ +I T    L  S             
Sbjct: 216 TTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFT----LGGSPYPGIPVEELFKL 271
Query: 635 IDRNLKGKFSESEAAKLGKMALVCTHEDPENRPTMEAVIEEL 676
           +    +     +   +L  M   C H  P  RPT + ++E+L
Sbjct: 272 LKEGHRMDKPANCTNELYMMMRDCWHAVPSQRPTFKQLVEDL 313

>pdb|2PWL|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic N549h Mutation Responsible For Crouzon Syndrome. Length = 324

Iteration: 1
 Score = 73.6 bits (179), Expect = 3e-13,   Method: Compositional matrix adjust.
 Identities = 66/282 (23%), Positives = 122/282 (43%), Gaps = 33/282 (11%)
Query: 417 LGKGNFSSVY--------KGTLRDGTLVAIRSINVTSCKSEEAEFVKGLYLLTSL-RHEN 467
           LG+G F  V         K   ++   VA++ +   + + + ++ V  + ++  + +H+N
Sbjct: 43  LGEGAFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKN 102
Query: 468 IIRLRGFCCSRGRGECFLIYDFAPKGKLSKYL------------DQEEGSSNVLDWSTRV 515
           II L G C   G    ++I ++A KG L +YL            D        + +   V
Sbjct: 103 IIHLLGACTQDG--PLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLV 160
Query: 516 SIIIGIAKGIGYLHSSEVNKPAIVHRNLSVEKVLIDQQFNPLIADCGLHKLLAD-DIVFS 574
           S    +A+G+ YL S +      +HR+L+   VL+ +     IAD GL + + + D    
Sbjct: 161 SCTYQLARGMEYLASQKC-----IHRDLAARNVLVTENNVMKIADFGLARDINNIDYYKK 215
Query: 575 VLKTSAAMGYLAPEYVTTGRFTERSDIFAFGVIILQILTGSLVLTSSMRLAAESATFENF 634
                  + ++APE +    +T +SD+++FGV++ +I T    L  S             
Sbjct: 216 TTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFT----LGGSPYPGIPVEELFKL 271
Query: 635 IDRNLKGKFSESEAAKLGKMALVCTHEDPENRPTMEAVIEEL 676
           +    +     +   +L  M   C H  P  RPT + ++E+L
Sbjct: 272 LKEGHRMDKPANCTNELYMMMRDCWHAVPSQRPTFKQLVEDL 313

>pdb|2PZR|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic K641r Mutation Responsible For Pfeiffer Syndrome Length = 324

Iteration: 1
 Score = 73.6 bits (179), Expect = 3e-13,   Method: Compositional matrix adjust.
 Identities = 66/282 (23%), Positives = 122/282 (43%), Gaps = 33/282 (11%)
Query: 417 LGKGNFSSVY--------KGTLRDGTLVAIRSINVTSCKSEEAEFVKGLYLLTSL-RHEN 467
           LG+G F  V         K   ++   VA++ +   + + + ++ V  + ++  + +H+N
Sbjct: 43  LGEGAFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKN 102
Query: 468 IIRLRGFCCSRGRGECFLIYDFAPKGKLSKYL------------DQEEGSSNVLDWSTRV 515
           II L G C   G    ++I ++A KG L +YL            D        + +   V
Sbjct: 103 IINLLGACTQDG--PLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLV 160
Query: 516 SIIIGIAKGIGYLHSSEVNKPAIVHRNLSVEKVLIDQQFNPLIADCGLHKLLAD-DIVFS 574
           S    +A+G+ YL S +      +HR+L+   VL+ +     IAD GL + + + D    
Sbjct: 161 SCTYQLARGMEYLASQKC-----IHRDLAARNVLVTENNVMRIADFGLARDINNIDYYKK 215
Query: 575 VLKTSAAMGYLAPEYVTTGRFTERSDIFAFGVIILQILTGSLVLTSSMRLAAESATFENF 634
                  + ++APE +    +T +SD+++FGV++ +I T    L  S             
Sbjct: 216 TTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFT----LGGSPYPGIPVEELFKL 271
Query: 635 IDRNLKGKFSESEAAKLGKMALVCTHEDPENRPTMEAVIEEL 676
           +    +     +   +L  M   C H  P  RPT + ++E+L
Sbjct: 272 LKEGHRMDKPANCTNELYMMMRDCWHAVPSQRPTFKQLVEDL 313

>pdb|3CLY|A Chain A, Crystal Structure Of Fgf Receptor 2 (Fgfr2) Kinase Domains Trapped In Trans-Phosphorylation Reaction Length = 334

Iteration: 1
 Score = 73.6 bits (179), Expect = 3e-13,   Method: Compositional matrix adjust.
 Identities = 66/282 (23%), Positives = 122/282 (43%), Gaps = 33/282 (11%)
Query: 417 LGKGNFSSVY--------KGTLRDGTLVAIRSINVTSCKSEEAEFVKGLYLLTSL-RHEN 467
           LG+G F  V         K   ++   VA++ +   + + + ++ V  + ++  + +H+N
Sbjct: 43  LGEGAFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKN 102
Query: 468 IIRLRGFCCSRGRGECFLIYDFAPKGKLSKYL------------DQEEGSSNVLDWSTRV 515
           II L G C   G    ++I ++A KG L +YL            D        + +   V
Sbjct: 103 IINLLGACTQDG--PLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLV 160
Query: 516 SIIIGIAKGIGYLHSSEVNKPAIVHRNLSVEKVLIDQQFNPLIADCGLHKLLAD-DIVFS 574
           S    +A+G+ YL S +      +HR+L+   VL+ +     IAD GL + + + D    
Sbjct: 161 SCTYQLARGMEYLASQKC-----IHRDLAARNVLVTENNVMKIADFGLARDINNIDXXKK 215
Query: 575 VLKTSAAMGYLAPEYVTTGRFTERSDIFAFGVIILQILTGSLVLTSSMRLAAESATFENF 634
                  + ++APE +    +T +SD+++FGV++ +I T    L  S             
Sbjct: 216 TTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFT----LGGSPYPGIPVEELFKL 271
Query: 635 IDRNLKGKFSESEAAKLGKMALVCTHEDPENRPTMEAVIEEL 676
           +    +     +   +L  M   C H  P  RPT + ++E+L
Sbjct: 272 LKEGHRMDKPANCTNELYMMMRDCWHAVPSQRPTFKQLVEDL 313

>pdb|2PZP|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic K526e Mutation Responsible For Crouzon Syndrome Length = 324

Iteration: 1
 Score = 73.6 bits (179), Expect = 4e-13,   Method: Compositional matrix adjust.
 Identities = 66/282 (23%), Positives = 122/282 (43%), Gaps = 33/282 (11%)
Query: 417 LGKGNFSSVY--------KGTLRDGTLVAIRSINVTSCKSEEAEFVKGLYLLTSL-RHEN 467
           LG+G F  V         K   ++   VA++ +   + + + ++ V  + ++  + +H+N
Sbjct: 43  LGEGAFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEEDLSDLVSEMEMMKMIGKHKN 102
Query: 468 IIRLRGFCCSRGRGECFLIYDFAPKGKLSKYL------------DQEEGSSNVLDWSTRV 515
           II L G C   G    ++I ++A KG L +YL            D        + +   V
Sbjct: 103 IINLLGACTQDG--PLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLV 160
Query: 516 SIIIGIAKGIGYLHSSEVNKPAIVHRNLSVEKVLIDQQFNPLIADCGLHKLLAD-DIVFS 574
           S    +A+G+ YL S +      +HR+L+   VL+ +     IAD GL + + + D    
Sbjct: 161 SCTYQLARGMEYLASQKC-----IHRDLAARNVLVTENNVMKIADFGLARDINNIDYYKK 215
Query: 575 VLKTSAAMGYLAPEYVTTGRFTERSDIFAFGVIILQILTGSLVLTSSMRLAAESATFENF 634
                  + ++APE +    +T +SD+++FGV++ +I T    L  S             
Sbjct: 216 TTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFT----LGGSPYPGIPVEELFKL 271
Query: 635 IDRNLKGKFSESEAAKLGKMALVCTHEDPENRPTMEAVIEEL 676
           +    +     +   +L  M   C H  P  RPT + ++E+L
Sbjct: 272 LKEGHRMDKPANCTNELYMMMRDCWHAVPSQRPTFKQLVEDL 313

>pdb|2HEL|A Chain A, Crystal Structure Of A Mutant Epha4 Kinase Domain (Y742a) Length = 306

Iteration: 1
 Score = 73.6 bits (179), Expect = 4e-13,   Method: Compositional matrix adjust.
 Identities = 49/217 (22%), Positives = 98/217 (45%), Gaps = 20/217 (9%)
Query: 405 ESATQCFSEVNLLGKGNFSSVYKGTLR----DGTLVAIRSINVTSCKSEEAEFVKGLYLL 460
           E    C     ++G G F  V  G L+        VAI+++       +  +F+    ++
Sbjct: 25  EIDASCIKIEKVIGVGEFGEVCSGRLKVPGKREICVAIKTLKAGYTDKQRRDFLSEASIM 84
Query: 461 TSLRHENIIRLRGFC--CSRGRGECFLIYDFAPKGKLSKYLDQEEGSSNVLDWSTRVSII 518
               H NII L G    C        +I ++   G L  +L + +G   V+     V ++
Sbjct: 85  GQFDHPNIIHLEGVVTKCK----PVMIITEYMENGSLDAFLRKNDGRFTVI---QLVGML 137
Query: 519 IGIAKGIGYLHSSEVNKPAIVHRNLSVEKVLIDQQFNPLIADCGLHKLLADD--IVFSVL 576
            GI  G+ YL        + VHR+L+   +L++      ++D G+ ++L DD    ++  
Sbjct: 138 RGIGSGMKYLSDM-----SAVHRDLAARNILVNSNLVCKVSDFGMSRVLEDDPEAAYTTR 192
Query: 577 KTSAAMGYLAPEYVTTGRFTERSDIFAFGVIILQILT 613
                + + APE +   +FT  SD++++G+++ ++++
Sbjct: 193 GGKIPIRWTAPEAIAYRKFTSASDVWSYGIVMWEVMS 229

>pdb|3SXR|A Chain A, Crystal Structure Of Bmx Non-Receptor Tyrosine Kinase Complex With Dasatinib Length = 268

Iteration: 1
 Score = 73.6 bits (179), Expect = 4e-13,   Method: Compositional matrix adjust.
 Identities = 56/260 (21%), Positives = 116/260 (44%), Gaps = 22/260 (8%)
Query: 417 LGKGNFSSVYKGTLRDGTLVAIRSINVTSCKSEEAEFVKGLYLLTSLRHENIIRLRGFCC 476
           LG G F  V  G  +    VA++ I   S    E EF +    +  L H  +++  G C 
Sbjct: 16  LGSGQFGVVKLGKWKGQYDVAVKMIKEGSMS--EDEFFQEAQTMMKLSHPKLVKFYGVCS 73
Query: 477 SRGRGECFLIYDFAPKGKLSKYLDQEEGSSNVLDWSTRVSIIIGIAKGIGYLHSSEVNKP 536
                  +++ ++   G L  YL         L+ S  + +   + +G+ +L S +    
Sbjct: 74  KEY--PIYIVTEYISNGCLLNYL---RSHGKGLEPSQLLEMCYDVCEGMAFLESHQ---- 124
Query: 537 AIVHRNLSVEKVLIDQQFNPLIADCGLHKLLADDIVFSVLKTSAAMGYLAPEYVTTGRFT 596
             +HR+L+    L+D+     ++D G+ + + DD   S + T   + + APE     +++
Sbjct: 125 -FIHRDLAARNCLVDRDLCVKVSDFGMTRYVLDDQYVSSVGTKFPVKWSAPEVFHYFKYS 183
Query: 597 ERSDIFAFGVIILQILT-GSLV--LTSSMRLAAESATFENFIDRNLKGKFSESEAAKLGK 653
            +SD++AFG+++ ++ + G +   L ++  +  + +        +L        +  + +
Sbjct: 184 SKSDVWAFGILMWEVFSLGKMPYDLYTNSEVVLKVSQGHRLYRPHLA-------SDTIYQ 236
Query: 654 MALVCTHEDPENRPTMEAVI 673
           +   C HE PE RPT + ++
Sbjct: 237 IMYSCWHELPEKRPTFQQLL 256

>pdb|3ETA|A Chain A, Kinase Domain Of Insulin Receptor Complexed With A Pyrrolo Pyridine Inhibitor Length = 317

Iteration: 1
 Score = 73.6 bits (179), Expect = 4e-13,   Method: Compositional matrix adjust.
 Identities = 64/273 (23%), Positives = 120/273 (43%), Gaps = 30/273 (10%)
Query: 417 LGKGNFSSVYKGTLRD------GTLVAIRSINVTSCKSEEAEFVKGLYLLTSLRHENIIR 470
           LG+G+F  VY+G  RD       T VA++++N ++   E  EF+    ++      +++R
Sbjct: 24  LGQGSFGMVYEGNARDIIKGEAETRVAVKTVNESASLRERIEFLNEASVMKGFTCHHVVR 83
Query: 471 LRGFCCSRGRGECFLIYDFAPKGKLSKYLD--QEEGSSNV----LDWSTRVSIIIGIAKG 524
           L G   S+G+    ++ +    G L  YL   + E  +N           + +   IA G
Sbjct: 84  LLG-VVSKGQ-PTLVVMELMAHGDLKSYLRSLRPEAENNPGRPPPTLQEMIQMAAEIADG 141
Query: 525 IGYLHSSEVNKPAIVHRNLSVEKVLIDQQFNPLIADCGLHK-LLADDIVFSVLKTSAAMG 583
           + YL     N    VHR+L+    ++   F   I D G+ + +   D      K    + 
Sbjct: 142 MAYL-----NAKKFVHRDLAARNCMVAHDFTVKIGDFGMTRDIYETDYYRKGGKGLLPVR 196
Query: 584 YLAPEYVTTGRFTERSDIFAFGVIILQILTGSLVLTSSMRLAAESATFENFIDRNLKGKF 643
           ++APE +  G FT  SD+++FGV++ +I       TS      +  + E  +   + G +
Sbjct: 197 WMAPESLKDGVFTTSSDMWSFGVVLWEI-------TSLAEQPYQGLSNEQVLKFVMDGGY 249
Query: 644 SESE---AAKLGKMALVCTHEDPENRPTMEAVI 673
            +       ++  +  +C   +P+ RPT   ++
Sbjct: 250 LDQPDNCPERVTDLMRMCWQFNPKMRPTFLEIV 282

>pdb|2Y6M|A Chain A, Crystal Structure Of Epha4 Kinase Domain Length = 291

Iteration: 1
 Score = 73.2 bits (178), Expect = 4e-13,   Method: Compositional matrix adjust.
 Identities = 49/217 (22%), Positives = 98/217 (45%), Gaps = 20/217 (9%)
Query: 405 ESATQCFSEVNLLGKGNFSSVYKGTLR----DGTLVAIRSINVTSCKSEEAEFVKGLYLL 460
           E    C     ++G G F  V  G L+        VAI+++       +  +F+    ++
Sbjct: 10  EIDASCIKIEKVIGVGEFGEVCSGRLKVPGKREICVAIKTLKAGYTDKQRRDFLSEASIM 69
Query: 461 TSLRHENIIRLRGFC--CSRGRGECFLIYDFAPKGKLSKYLDQEEGSSNVLDWSTRVSII 518
               H NII L G    C        +I ++   G L  +L + +G   V+     V ++
Sbjct: 70  GQFDHPNIIHLEGVVTKCK----PVMIITEYMENGSLDAFLRKNDGRFTVI---QLVGML 122
Query: 519 IGIAKGIGYLHSSEVNKPAIVHRNLSVEKVLIDQQFNPLIADCGLHKLLADD--IVFSVL 576
            GI  G+ YL        + VHR+L+   +L++      ++D G+ ++L DD    ++  
Sbjct: 123 RGIGSGMKYLSDM-----SYVHRDLAARNILVNSNLVCKVSDFGMSRVLEDDPEAAYTTR 177
Query: 577 KTSAAMGYLAPEYVTTGRFTERSDIFAFGVIILQILT 613
                + + APE +   +FT  SD++++G+++ ++++
Sbjct: 178 GGKIPIRWTAPEAIAYRKFTSASDVWSYGIVMWEVMS 214

>pdb|4E1Z|A Chain A, Structure Of Mouse Tyk-2 Complexed To A 3-Aminoindazole Inhibitor Length = 291

Iteration: 1
 Score = 73.2 bits (178), Expect = 4e-13,   Method: Compositional matrix adjust.
 Identities = 55/212 (25%), Positives = 106/212 (50%), Gaps = 21/212 (9%)
Query: 411 FSEVNLLGKGNFSSV----YKGTLRDGT--LVAIRSINVTSCKSEEAEFVKGLYLLTSLR 464
             ++  LG+G+F  V    Y  T  DGT  +VA++++         + + + + +L +L 
Sbjct: 11  LKKIRDLGEGHFGKVSLYCYDPT-NDGTGEMVAVKALKEGCGPQLRSGWQREIEILRTLY 69
Query: 465 HENIIRLRGFCCSRGRGECFLIYDFAPKGKLSKYLDQE-EGSSNVLDWSTRVSIIIGIAK 523
           HE+I++ +G C  +G     L+ ++ P G L  YL +   G + +L ++ +      I +
Sbjct: 70  HEHIVKYKGCCEDQGEKSVQLVMEYVPLGSLRDYLPRHCVGLAQLLLFAQQ------ICE 123
Query: 524 GIGYLHSSEVNKPAIVHRNLSVEKVLIDQQFNPLIADCGLHKLLADDIVFSVLKT--SAA 581
           G+ YLH+        +HR L+   VL+D      I D GL K + +   +  ++    + 
Sbjct: 124 GMAYLHAQH-----YIHRALAARNVLLDNDRLVKIGDFGLAKAVPEGHEYYRVREDGDSP 178
Query: 582 MGYLAPEYVTTGRFTERSDIFAFGVIILQILT 613
           + + APE +   +F   SD+++FGV + ++LT
Sbjct: 179 VFWYAPECLKECKFYYASDVWSFGVTLYELLT 210

>pdb|2PZ5|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic N549t Mutation Responsible For Pfeiffer Syndrome Length = 324

Iteration: 1
 Score = 73.2 bits (178), Expect = 4e-13,   Method: Compositional matrix adjust.
 Identities = 66/282 (23%), Positives = 122/282 (43%), Gaps = 33/282 (11%)
Query: 417 LGKGNFSSVY--------KGTLRDGTLVAIRSINVTSCKSEEAEFVKGLYLLTSL-RHEN 467
           LG+G F  V         K   ++   VA++ +   + + + ++ V  + ++  + +H+N
Sbjct: 43  LGEGAFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKN 102
Query: 468 IIRLRGFCCSRGRGECFLIYDFAPKGKLSKYL------------DQEEGSSNVLDWSTRV 515
           II L G C   G    ++I ++A KG L +YL            D        + +   V
Sbjct: 103 IITLLGACTQDG--PLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLV 160
Query: 516 SIIIGIAKGIGYLHSSEVNKPAIVHRNLSVEKVLIDQQFNPLIADCGLHKLLAD-DIVFS 574
           S    +A+G+ YL S +      +HR+L+   VL+ +     IAD GL + + + D    
Sbjct: 161 SCTYQLARGMEYLASQKC-----IHRDLAARNVLVTENNVMKIADFGLARDINNIDYYKK 215
Query: 575 VLKTSAAMGYLAPEYVTTGRFTERSDIFAFGVIILQILTGSLVLTSSMRLAAESATFENF 634
                  + ++APE +    +T +SD+++FGV++ +I T    L  S             
Sbjct: 216 TTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFT----LGGSPYPGIPVEELFKL 271
Query: 635 IDRNLKGKFSESEAAKLGKMALVCTHEDPENRPTMEAVIEEL 676
           +    +     +   +L  M   C H  P  RPT + ++E+L
Sbjct: 272 LKEGHRMDKPANCTNELYMMMRDCWHAVPSQRPTFKQLVEDL 313

>pdb|4E20|A Chain A, Structure Of Mouse Tyk-2 Complexed To A 3-Aminoindazole Inhibitor Length = 290

Iteration: 1
 Score = 73.2 bits (178), Expect = 4e-13,   Method: Compositional matrix adjust.
 Identities = 55/212 (25%), Positives = 106/212 (50%), Gaps = 21/212 (9%)
Query: 411 FSEVNLLGKGNFSSV----YKGTLRDGT--LVAIRSINVTSCKSEEAEFVKGLYLLTSLR 464
             ++  LG+G+F  V    Y  T  DGT  +VA++++         + + + + +L +L 
Sbjct: 10  LKKIRDLGEGHFGKVSLYCYDPT-NDGTGEMVAVKALKEGCGPQLRSGWQREIEILRTLY 68
Query: 465 HENIIRLRGFCCSRGRGECFLIYDFAPKGKLSKYLDQE-EGSSNVLDWSTRVSIIIGIAK 523
           HE+I++ +G C  +G     L+ ++ P G L  YL +   G + +L ++ +      I +
Sbjct: 69  HEHIVKYKGCCEDQGEKSVQLVMEYVPLGSLRDYLPRHCVGLAQLLLFAQQ------ICE 122
Query: 524 GIGYLHSSEVNKPAIVHRNLSVEKVLIDQQFNPLIADCGLHKLLADDIVFSVLKT--SAA 581
           G+ YLH+        +HR L+   VL+D      I D GL K + +   +  ++    + 
Sbjct: 123 GMAYLHAQHY-----IHRALAARNVLLDNDRLVKIGDFGLAKAVPEGHEYYRVREDGDSP 177
Query: 582 MGYLAPEYVTTGRFTERSDIFAFGVIILQILT 613
           + + APE +   +F   SD+++FGV + ++LT
Sbjct: 178 VFWYAPECLKECKFYYASDVWSFGVTLYELLT 209

>pdb|3B2T|A Chain A, Structure Of Phosphotransferase Length = 311

Iteration: 1
 Score = 73.2 bits (178), Expect = 5e-13,   Method: Compositional matrix adjust.
 Identities = 66/282 (23%), Positives = 122/282 (43%), Gaps = 33/282 (11%)
Query: 417 LGKGNFSSVY--------KGTLRDGTLVAIRSINVTSCKSEEAEFVKGLYLLTSL-RHEN 467
           LG+G F  V         K   ++   VA++ +   + + + ++ V  + ++  + +H+N
Sbjct: 30  LGEGCFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKN 89
Query: 468 IIRLRGFCCSRGRGECFLIYDFAPKGKLSKYL------------DQEEGSSNVLDWSTRV 515
           II L G C   G    ++I ++A KG L +YL            D        + +   V
Sbjct: 90  IINLLGACTQDG--PLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLV 147
Query: 516 SIIIGIAKGIGYLHSSEVNKPAIVHRNLSVEKVLIDQQFNPLIADCGLHKLLAD-DIVFS 574
           S    +A+G+ YL S +      +HR+L+   VL+ +     IAD GL + + + D    
Sbjct: 148 SCTYQLARGMEYLASQKC-----IHRDLTARNVLVTENNVMKIADFGLARDINNIDYYKK 202
Query: 575 VLKTSAAMGYLAPEYVTTGRFTERSDIFAFGVIILQILTGSLVLTSSMRLAAESATFENF 634
                  + ++APE +    +T +SD+++FGV++ +I T    L  S             
Sbjct: 203 TTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFT----LGGSPYPGIPVEELFKL 258
Query: 635 IDRNLKGKFSESEAAKLGKMALVCTHEDPENRPTMEAVIEEL 676
           +    +     +   +L  M   C H  P  RPT + ++E+L
Sbjct: 259 LKEGHRMDKPANCTNELYMMMRDCWHAVPSQRPTFKQLVEDL 300

>pdb|2XYU|A Chain A, Crystal Structure Of Epha4 Kinase Domain In Complex With Vuf 12058 Length = 285

Iteration: 1
 Score = 73.2 bits (178), Expect = 5e-13,   Method: Compositional matrix adjust.
 Identities = 49/217 (22%), Positives = 98/217 (45%), Gaps = 20/217 (9%)
Query: 405 ESATQCFSEVNLLGKGNFSSVYKGTLR----DGTLVAIRSINVTSCKSEEAEFVKGLYLL 460
           E    C     ++G G F  V  G L+        VAI+++       +  +F+    ++
Sbjct: 4   EIDASCIKIEKVIGVGEFGEVCSGRLKVPGKREICVAIKTLKAGYTDKQRRDFLSEASIM 63
Query: 461 TSLRHENIIRLRGFC--CSRGRGECFLIYDFAPKGKLSKYLDQEEGSSNVLDWSTRVSII 518
               H NII L G    C        +I ++   G L  +L + +G   V+     V ++
Sbjct: 64  GQFDHPNIIHLEGVVTKCK----PVMIITEYMENGSLDAFLRKNDGRFTVI---QLVGML 116
Query: 519 IGIAKGIGYLHSSEVNKPAIVHRNLSVEKVLIDQQFNPLIADCGLHKLLADD--IVFSVL 576
            GI  G+ YL        + VHR+L+   +L++      ++D G+ ++L DD    ++  
Sbjct: 117 RGIGSGMKYLSDM-----SYVHRDLAARNILVNSNLVCKVSDFGMSRVLEDDPEAAYTTR 171
Query: 577 KTSAAMGYLAPEYVTTGRFTERSDIFAFGVIILQILT 613
                + + APE +   +FT  SD++++G+++ ++++
Sbjct: 172 GGKIPIRWTAPEAIAYRKFTSASDVWSYGIVMWEVMS 208

>pdb|3D94|A Chain A, Crystal Structure Of The Insulin-Like Growth Factor-1 Receptor Kinase In Complex With Pqip Length = 301

Iteration: 1
 Score = 73.2 bits (178), Expect = 5e-13,   Method: Compositional matrix adjust.
 Identities = 61/225 (27%), Positives = 111/225 (49%), Gaps = 20/225 (8%)
Query: 402 EEVESATQCFSEVNLLGKGNFSSVY----KGTLRDG--TLVAIRSINVTSCKSEEAEFVK 455
           +E E A +  +    LG+G+F  VY    KG ++D   T VAI+++N  +   E  EF+ 
Sbjct: 5   DEWEVAREKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEFLN 64
Query: 456 GLYLLTSLRHENIIRLRGFCCSRGRGECFLIYDFAPKGKLSKYLD--QEEGSSNVLDWST 513
              ++      +++RL G   S+G+    +I +   +G L  YL   + E  +N +    
Sbjct: 65  EASVMKEFNCHHVVRLLG-VVSQGQ-PTLVIMELMTRGDLKSYLRSLRPEMENNPVLAPP 122
Query: 514 RVSIIIG----IAKGIGYLHSSEVNKPAIVHRNLSVEKVLIDQQFNPLIADCGLHK-LLA 568
            +S +I     IA G+ YL++++      VHR+L+     + + F   I D G+ + +  
Sbjct: 123 SLSKMIQMAGEIADGMAYLNANK-----FVHRDLAARNCXVAEDFTVKIGDFGMTRDIYE 177
Query: 569 DDIVFSVLKTSAAMGYLAPEYVTTGRFTERSDIFAFGVIILQILT 613
            D      K    + +++PE +  G FT  SD+++FGV++ +I T
Sbjct: 178 TDYYRKGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIAT 222

>pdb|2PSQ|A Chain A, Crystal Structure Of Unphosphorylated Unactivated Wild Type Fgf Receptor 2 (Fgfr2) Kinase Domain Length = 370

Iteration: 1
 Score = 73.2 bits (178), Expect = 5e-13,   Method: Compositional matrix adjust.
 Identities = 66/282 (23%), Positives = 122/282 (43%), Gaps = 33/282 (11%)
Query: 417 LGKGNFSSVY--------KGTLRDGTLVAIRSINVTSCKSEEAEFVKGLYLLTSL-RHEN 467
           LG+G F  V         K   ++   VA++ +   + + + ++ V  + ++  + +H+N
Sbjct: 89  LGEGCFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKN 148
Query: 468 IIRLRGFCCSRGRGECFLIYDFAPKGKLSKYL------------DQEEGSSNVLDWSTRV 515
           II L G C   G    ++I ++A KG L +YL            D        + +   V
Sbjct: 149 IINLLGACTQDG--PLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLV 206
Query: 516 SIIIGIAKGIGYLHSSEVNKPAIVHRNLSVEKVLIDQQFNPLIADCGLHKLLAD-DIVFS 574
           S    +A+G+ YL S +      +HR+L+   VL+ +     IAD GL + + + D    
Sbjct: 207 SCTYQLARGMEYLASQKC-----IHRDLAARNVLVTENNVMKIADFGLARDINNIDYYKK 261
Query: 575 VLKTSAAMGYLAPEYVTTGRFTERSDIFAFGVIILQILTGSLVLTSSMRLAAESATFENF 634
                  + ++APE +    +T +SD+++FGV++ +I T    L  S             
Sbjct: 262 TTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFT----LGGSPYPGIPVEELFKL 317
Query: 635 IDRNLKGKFSESEAAKLGKMALVCTHEDPENRPTMEAVIEEL 676
           +    +     +   +L  M   C H  P  RPT + ++E+L
Sbjct: 318 LKEGHRMDKPANCTNELYMMMRDCWHAVPSQRPTFKQLVEDL 359

>pdb|3CJF|A Chain A, Crystal Structure Of Vegfr2 In Complex With A 3,4,5-Trimethoxy Aniline Containing Pyrimidine Length = 309

Iteration: 1
 Score = 73.2 bits (178), Expect = 5e-13,   Method: Compositional matrix adjust.
 Identities = 66/277 (23%), Positives = 123/277 (44%), Gaps = 27/277 (9%)
Query: 417 LGKGNFSSVYK----GTLRDGTL--VAIRSINVTSCKSEEAEFVKGLYLLTSLRHE-NII 469
           LG+G F  V +    G  +  T   VA++ +   +  SE    +  L +L  + H  N++
Sbjct: 35  LGRGAFGQVIEADAFGIDKTATXRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVV 94
Query: 470 RLRGFCCSRGRGECFLIYDFAPKGKLSKYLDQEEGS--------SNVLDWSTRVSIIIGI 521
            L G C   G G   +I +F   G LS YL  +            + L     +     +
Sbjct: 95  NLLGACTKPG-GPLMVIVEFCKFGNLSTYLRSKRNEFVPYKDLYKDFLTLEHLIXYSFQV 153
Query: 522 AKGIGYLHSSEVNKPAIVHRNLSVEKVLIDQQFNPLIADCGLHKLLADDIVFSVLKTSA- 580
           AKG+ +L S +      +HR+L+   +L+ ++    I D GL + +  D  + V K  A 
Sbjct: 154 AKGMEFLASRKX-----IHRDLAARNILLSEKNVVKIXDFGLARDIYKDPDY-VRKGDAR 207
Query: 581 -AMGYLAPEYVTTGRFTERSDIFAFGVIILQILTGSLVLTSSMRLAAESATFENFIDRNL 639
             + ++APE +    +T +SD+++FGV++ +I +        +++  E   F   +    
Sbjct: 208 LPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKIDEE---FXRRLKEGT 264
Query: 640 KGKFSESEAAKLGKMALVCTHEDPENRPTMEAVIEEL 676
           + +  +    ++ +  L C H +P  RPT   ++E L
Sbjct: 265 RMRAPDYTTPEMYQTMLDCWHGEPSQRPTFSELVEHL 301

>pdb|3RI1|A Chain A, Crystal Structure Of The Catalytic Domain Of Fgfr2 Kinase In Complex With Arq 069 Length = 313

Iteration: 1
 Score = 73.2 bits (178), Expect = 5e-13,   Method: Compositional matrix adjust.
 Identities = 66/282 (23%), Positives = 122/282 (43%), Gaps = 33/282 (11%)
Query: 417 LGKGNFSSVY--------KGTLRDGTLVAIRSINVTSCKSEEAEFVKGLYLLTSL-RHEN 467
           LG+G F  V         K   ++   VA++ +   + + + ++ V  + ++  + +H+N
Sbjct: 32  LGEGCFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKN 91
Query: 468 IIRLRGFCCSRGRGECFLIYDFAPKGKLSKYL------------DQEEGSSNVLDWSTRV 515
           II L G C   G    ++I ++A KG L +YL            D        + +   V
Sbjct: 92  IINLLGACTQDG--PLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLV 149
Query: 516 SIIIGIAKGIGYLHSSEVNKPAIVHRNLSVEKVLIDQQFNPLIADCGLHKLLAD-DIVFS 574
           S    +A+G+ YL S +      +HR+L+   VL+ +     IAD GL + + + D    
Sbjct: 150 SCTYQLARGMEYLASQKC-----IHRDLAARNVLVTENNVMKIADFGLARDINNIDYYKK 204
Query: 575 VLKTSAAMGYLAPEYVTTGRFTERSDIFAFGVIILQILTGSLVLTSSMRLAAESATFENF 634
                  + ++APE +    +T +SD+++FGV++ +I T    L  S             
Sbjct: 205 TTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFT----LGGSPYPGIPVEELFKL 260
Query: 635 IDRNLKGKFSESEAAKLGKMALVCTHEDPENRPTMEAVIEEL 676
           +    +     +   +L  M   C H  P  RPT + ++E+L
Sbjct: 261 LKEGHRMDKPANCTNELYMMMRDCWHAVPSQRPTFKQLVEDL 302

>pdb|1GJO|A Chain A, The Fgfr2 Tyrosine Kinase Domain Length = 316

Iteration: 1
 Score = 72.8 bits (177), Expect = 5e-13,   Method: Compositional matrix adjust.
 Identities = 66/282 (23%), Positives = 122/282 (43%), Gaps = 33/282 (11%)
Query: 417 LGKGNFSSVY--------KGTLRDGTLVAIRSINVTSCKSEEAEFVKGLYLLTSL-RHEN 467
           LG+G F  V         K   ++   VA++ +   + + + ++ V  + ++  + +H+N
Sbjct: 35  LGEGCFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKN 94
Query: 468 IIRLRGFCCSRGRGECFLIYDFAPKGKLSKYL------------DQEEGSSNVLDWSTRV 515
           II L G C   G    ++I ++A KG L +YL            D        + +   V
Sbjct: 95  IINLLGACTQDG--PLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLV 152
Query: 516 SIIIGIAKGIGYLHSSEVNKPAIVHRNLSVEKVLIDQQFNPLIADCGLHKLLAD-DIVFS 574
           S    +A+G+ YL S +      +HR+L+   VL+ +     IAD GL + + + D    
Sbjct: 153 SCTYQLARGMEYLASQKC-----IHRDLAARNVLVTENNVMKIADFGLARDINNIDYYKK 207
Query: 575 VLKTSAAMGYLAPEYVTTGRFTERSDIFAFGVIILQILTGSLVLTSSMRLAAESATFENF 634
                  + ++APE +    +T +SD+++FGV++ +I T    L  S             
Sbjct: 208 TTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFT----LGGSPYPGIPVEELFKL 263
Query: 635 IDRNLKGKFSESEAAKLGKMALVCTHEDPENRPTMEAVIEEL 676
           +    +     +   +L  M   C H  P  RPT + ++E+L
Sbjct: 264 LKEGHRMDKPANCTNELYMMMRDCWHAVPSQRPTFKQLVEDL 305

>pdb|1P4O|A Chain A, Structure Of Apo Unactivated Igf-1r Kinase Domain At 1.5a Resolution. Length = 322

Iteration: 1
 Score = 72.8 bits (177), Expect = 6e-13,   Method: Compositional matrix adjust.
 Identities = 60/225 (26%), Positives = 112/225 (49%), Gaps = 20/225 (8%)
Query: 402 EEVESATQCFSEVNLLGKGNFSSVY----KGTLRDG--TLVAIRSINVTSCKSEEAEFVK 455
           +E E A +  +    LG+G+F  VY    KG ++D   T VAI+++N  +   E  EF+ 
Sbjct: 18  DEWEVAREKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEFLN 77
Query: 456 GLYLLTSLRHENIIRLRGFCCSRGRGECFLIYDFAPKGKLSKYLD--QEEGSSNVLDWST 513
              ++      +++RL G   S+G+    +I +   +G L  YL   +   ++N +    
Sbjct: 78  EASVMKEFNCHHVVRLLG-VVSQGQ-PTLVIMELMTRGDLKSYLRSLRPAMANNPVLAPP 135
Query: 514 RVSIIIG----IAKGIGYLHSSEVNKPAIVHRNLSVEKVLIDQQFNPLIADCGLHK-LLA 568
            +S +I     IA G+ YL++++      VHR+L+    ++ + F   I D G+ + +  
Sbjct: 136 SLSKMIQMAGEIADGMAYLNANK-----FVHRDLAARNCMVAEDFTVKIGDFGMTRDIYE 190
Query: 569 DDIVFSVLKTSAAMGYLAPEYVTTGRFTERSDIFAFGVIILQILT 613
            D      K    + +++PE +  G FT  SD+++FGV++ +I T
Sbjct: 191 TDYYRKGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIAT 235

>pdb|2WQB|A Chain A, Structure Of The Tie2 Kinase Domain In Complex With A Thiazolopyrimidine Inhibitor Length = 324

Iteration: 1
 Score = 72.8 bits (177), Expect = 6e-13,   Method: Compositional matrix adjust.
 Identities = 52/215 (24%), Positives = 100/215 (46%), Gaps = 25/215 (11%)
Query: 415 NLLGKGNFSSVYKGTLRDGTL---VAIRSINVTSCKSEEAEFVKGLYLLTSL-RHENIIR 470
           +++G+GNF  V K  ++   L    AI+ +   + K +  +F   L +L  L  H NII 
Sbjct: 28  DVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIIN 87
Query: 471 LRGFCCSRGRGECFLIYDFAPKGKLSKYLDQEE------------GSSNVLDWSTRVSII 518
           L G C    RG  +L  ++AP G L  +L +               +++ L     +   
Sbjct: 88  LLGAC--EHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFA 145
Query: 519 IGIAKGIGYLHSSEVNKPAIVHRNLSVEKVLIDQQFNPLIADCGLHKLLADDIVFSVLKT 578
             +A+G+ YL   +      +HRNL+   +L+ + +   IAD GL +    ++       
Sbjct: 146 ADVARGMDYLSQKQ-----FIHRNLAARNILVGENYVAKIADFGLSR--GQEVYVKKTMG 198
Query: 579 SAAMGYLAPEYVTTGRFTERSDIFAFGVIILQILT 613
              + ++A E +    +T  SD++++GV++ +I++
Sbjct: 199 RLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVS 233

>pdb|3Q4T|A Chain A, Crystal Structure Of Activin Receptor Type-Iia (Acvr2a) Kinase Domain In Complex With Dorsomorphin Length = 322

Iteration: 1
 Score = 72.8 bits (177), Expect = 7e-13,   Method: Compositional matrix adjust.
 Identities = 60/212 (28%), Positives = 102/212 (48%), Gaps = 31/212 (14%)
Query: 418 GKGNFSSVYKGTLRDGTLVAIRSINVTSCKSEEAEFVKGLYLLTSLRHENIIRLRGFCCS 477
            +G F  V+K  L +   VA++   +   +S + E+   +Y L  ++HENI++   F  +
Sbjct: 33  ARGRFGCVWKAQLLN-EYVAVKIFPIQDKQSWQNEY--EVYSLPGMKHENILQ---FIGA 86
Query: 478 RGRG-----ECFLIYDFAPKGKLSKYLDQEEGSSNVLDWSTRVSIIIGIAKGIGYLHS-- 530
             RG     + +LI  F  KG LS +L      +NV+ W+    I   +A+G+ YLH   
Sbjct: 87  EKRGTSVDVDLWLITAFHEKGSLSDFL-----KANVVSWNELCHIAETMARGLAYLHEDI 141
Query: 531 ---SEVNKPAIVHRNLSVEKVLIDQQFNPLIADCGLHKLLADDIVFSVLKTSAAMG---Y 584
               + +KPAI HR++  + VL+       IAD GL   L  +   S   T   +G   Y
Sbjct: 142 PGLKDGHKPAISHRDIKSKNVLLKNNLTACIADFGL--ALKFEAGKSAGDTHGQVGTRRY 199
Query: 585 LAPEYVTTGRFTERS-----DIFAFGVIILQI 611
           +APE +      +R      D++A G+++ ++
Sbjct: 200 MAPEVLEGAINFQRDAFLRIDMYAMGLVLWEL 231

>pdb|3LW0|A Chain A, Igf-1rk In Complex With Ligand Msc1609119a-1 Length = 304

Iteration: 1
 Score = 72.8 bits (177), Expect = 7e-13,   Method: Compositional matrix adjust.
 Identities = 60/225 (26%), Positives = 110/225 (48%), Gaps = 20/225 (8%)
Query: 402 EEVESATQCFSEVNLLGKGNFSSVY----KGTLRDG--TLVAIRSINVTSCKSEEAEFVK 455
           +E E A +  +    LG+G+F  VY    KG ++D   T VAI+++N  +   E  EF+ 
Sbjct: 8   DEWEVAREKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEFLN 67
Query: 456 GLYLLTSLRHENIIRLRGFCCSRGRGECFLIYDFAPKGKLSKYLDQ---EEGSSNVL--- 509
              ++      +++RL G   S+G+    +I +   +G L  YL        ++ VL   
Sbjct: 68  EASVMKEFNCHHVVRLLG-VVSQGQ-PTLVIMELMTRGDLKSYLRSLRPAMANNPVLAPP 125
Query: 510 DWSTRVSIIIGIAKGIGYLHSSEVNKPAIVHRNLSVEKVLIDQQFNPLIADCGLHK-LLA 568
             S  + +   IA G+ YL++++      VHR+L+    ++ + F   I D G+ + +  
Sbjct: 126 SLSKMIQMAGEIADGMAYLNANK-----FVHRDLAARNCMVAEDFTVKIGDFGMTRDIYE 180
Query: 569 DDIVFSVLKTSAAMGYLAPEYVTTGRFTERSDIFAFGVIILQILT 613
            D      K    + +++PE +  G FT  SD+++FGV++ +I T
Sbjct: 181 TDYYRKGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIAT 225

>pdb|3KXX|A Chain A, Structure Of The Mutant Fibroblast Growth Factor Receptor 1 Length = 317

Iteration: 1
 Score = 72.4 bits (176), Expect = 8e-13,   Method: Compositional matrix adjust.
 Identities = 67/282 (23%), Positives = 119/282 (42%), Gaps = 33/282 (11%)
Query: 417 LGKGNFSSVY--------KGTLRDGTLVAIRSINVTSCKSEEAEFVKGLYLLTSL-RHEN 467
           LG+G F  V         K      T VA++ +   + + + ++ +  + ++  + +H+N
Sbjct: 36  LGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGKHKN 95
Query: 468 IIRLRGFCCSRGRGECFLIYDFAPKGKLSKYLDQEE------------GSSNVLDWSTRV 515
           II L G C   G    ++I ++A KG L +YL   E                 L     V
Sbjct: 96  IINLLGACTQDG--PLYVIVEYASKGNLREYLQAREPPGLEYSYNPSHNPEEQLSSKDLV 153
Query: 516 SIIIGIAKGIGYLHSSEVNKPAIVHRNLSVEKVLIDQQFNPLIADCGLHKLLAD-DIVFS 574
           S    +A+G+ YL S +      +HR+L+   VL+ +     IAD GL + +   D    
Sbjct: 154 SCAYQVARGMEYLASKKC-----IHRDLAARNVLVTEDNVMKIADFGLARDIHHIDYYKK 208
Query: 575 VLKTSAAMGYLAPEYVTTGRFTERSDIFAFGVIILQILTGSLVLTSSMRLAAESATFENF 634
                  + ++APE +    +T +SD+++FGV++ +I T    L  S             
Sbjct: 209 TTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFT----LGGSPYPGVPVEELFKL 264
Query: 635 IDRNLKGKFSESEAAKLGKMALVCTHEDPENRPTMEAVIEEL 676
           +    +     +   +L  M   C H  P  RPT + ++E+L
Sbjct: 265 LKEGHRMDKPSNCTNELYMMMRDCWHAVPSQRPTFKQLVEDL 306

>pdb|1U59|A Chain A, Crystal Structure Of The Zap-70 Kinase Domain In Complex With Staurosporine Length = 287

Iteration: 1
 Score = 72.4 bits (176), Expect = 8e-13,   Method: Compositional matrix adjust.
 Identities = 58/205 (28%), Positives = 100/205 (48%), Gaps = 22/205 (10%)
Query: 417 LGKGNFSSVYKGTLR---DGTLVAIRSINVTSCKSEEAEFVKGLYLLTSLRHENIIRLRG 473
           LG GNF SV +G  R       VAI+ +   + K++  E ++   ++  L +  I+RL G
Sbjct: 18  LGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKADTEEMMREAQIMHQLDNPYIVRLIG 77
Query: 474 FCCSRGRGECFLIYDFAPKGKLSKYL---DQEEGSSNVLDWSTRVSIIIGIAKGIGYLHS 530
            C +       L+ + A  G L K+L    +E   SNV +   +VS+      G+ YL  
Sbjct: 78  VCQAEA---LMLVMEMAGGGPLHKFLVGKREEIPVSNVAELLHQVSM------GMKYLEE 128
Query: 531 SEVNKPAIVHRNLSVEKVLIDQQFNPLIADCGLHKLLADDIVFSVLKTSAA--MGYLAPE 588
                   VHR+L+   VL+  +    I+D GL K L  D  +   +++    + + APE
Sbjct: 129 KN-----FVHRDLAARNVLLVNRHYAKISDFGLSKALGADDSYYTARSAGKWPLKWYAPE 183
Query: 589 YVTTGRFTERSDIFAFGVIILQILT 613
            +   +F+ RSD++++GV + + L+
Sbjct: 184 CINFRKFSSRSDVWSYGVTMWEALS 208

>pdb|2PY3|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic E565g Mutation Responsible For Pfeiffer Syndrome Length = 324

Iteration: 1
 Score = 72.4 bits (176), Expect = 9e-13,   Method: Compositional matrix adjust.
 Identities = 66/282 (23%), Positives = 121/282 (42%), Gaps = 33/282 (11%)
Query: 417 LGKGNFSSVY--------KGTLRDGTLVAIRSINVTSCKSEEAEFVKGLYLLTSL-RHEN 467
           LG+G F  V         K   ++   VA++ +   + + + ++ V  + ++  + +H+N
Sbjct: 43  LGEGAFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKN 102
Query: 468 IIRLRGFCCSRGRGECFLIYDFAPKGKLSKYL------------DQEEGSSNVLDWSTRV 515
           II L G C   G    ++I  +A KG L +YL            D        + +   V
Sbjct: 103 IINLLGACTQDG--PLYVIVGYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLV 160
Query: 516 SIIIGIAKGIGYLHSSEVNKPAIVHRNLSVEKVLIDQQFNPLIADCGLHKLLAD-DIVFS 574
           S    +A+G+ YL S +      +HR+L+   VL+ +     IAD GL + + + D    
Sbjct: 161 SCTYQLARGMEYLASQKC-----IHRDLAARNVLVTENNVMKIADFGLARDINNIDYYKK 215
Query: 575 VLKTSAAMGYLAPEYVTTGRFTERSDIFAFGVIILQILTGSLVLTSSMRLAAESATFENF 634
                  + ++APE +    +T +SD+++FGV++ +I T    L  S             
Sbjct: 216 TTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFT----LGGSPYPGIPVEELFKL 271
Query: 635 IDRNLKGKFSESEAAKLGKMALVCTHEDPENRPTMEAVIEEL 676
           +    +     +   +L  M   C H  P  RPT + ++E+L
Sbjct: 272 LKEGHRMDKPANCTNELYMMMRDCWHAVPSQRPTFKQLVEDL 313

>pdb|2Q0B|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic E565a Mutation Responsible For Pfeiffer Syndrome Length = 324

Iteration: 1
 Score = 72.0 bits (175), Expect = 9e-13,   Method: Compositional matrix adjust.
 Identities = 66/282 (23%), Positives = 121/282 (42%), Gaps = 33/282 (11%)
Query: 417 LGKGNFSSVY--------KGTLRDGTLVAIRSINVTSCKSEEAEFVKGLYLLTSL-RHEN 467
           LG+G F  V         K   ++   VA++ +   + + + ++ V  + ++  + +H+N
Sbjct: 43  LGEGAFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKN 102
Query: 468 IIRLRGFCCSRGRGECFLIYDFAPKGKLSKYL------------DQEEGSSNVLDWSTRV 515
           II L G C   G    ++I  +A KG L +YL            D        + +   V
Sbjct: 103 IINLLGACTQDG--PLYVIVAYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLV 160
Query: 516 SIIIGIAKGIGYLHSSEVNKPAIVHRNLSVEKVLIDQQFNPLIADCGLHKLLAD-DIVFS 574
           S    +A+G+ YL S +      +HR+L+   VL+ +     IAD GL + + + D    
Sbjct: 161 SCTYQLARGMEYLASQKC-----IHRDLAARNVLVTENNVMKIADFGLARDINNIDYYKK 215
Query: 575 VLKTSAAMGYLAPEYVTTGRFTERSDIFAFGVIILQILTGSLVLTSSMRLAAESATFENF 634
                  + ++APE +    +T +SD+++FGV++ +I T    L  S             
Sbjct: 216 TTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFT----LGGSPYPGIPVEELFKL 271
Query: 635 IDRNLKGKFSESEAAKLGKMALVCTHEDPENRPTMEAVIEEL 676
           +    +     +   +L  M   C H  P  RPT + ++E+L
Sbjct: 272 LKEGHRMDKPANCTNELYMMMRDCWHAVPSQRPTFKQLVEDL 313

>pdb|3TT0|A Chain A, Co-Structure Of Fibroblast Growth Factor Receptor 1 Kinase Domain With 3-(2,6-Dichloro-3, 5-Dimethoxy-Phenyl)-1-{6-[4-(4-Ethyl-Piperazin-1- Yl)-Phenylamino]-Pyrimidin-4-Yl}-1-Methyl-Urea (Bgj398) Length = 382

Iteration: 1
 Score = 72.0 bits (175), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 69/287 (24%), Positives = 123/287 (42%), Gaps = 43/287 (14%)
Query: 417 LGKGNFSSVY--------KGTLRDGTLVAIRSINVTSCKSEEAEFVKGLYLLTSL-RHEN 467
           LG+G F  V         K      T VA++ +   + + + ++ +  + ++  + +H+N
Sbjct: 77  LGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGKHKN 136
Query: 468 IIRLRGFCCSRGRGECFLIYDFAPKGKLSKYLD-----------------QEEGSSNVLD 510
           II L G C   G    ++I ++A KG L +YL                  +E+ SS  L 
Sbjct: 137 IINLLGACTQDG--PLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLSSKDL- 193
Query: 511 WSTRVSIIIGIAKGIGYLHSSEVNKPAIVHRNLSVEKVLIDQQFNPLIADCGLHKLLAD- 569
               VS    +A+G+ YL S +      +HR+L+   VL+ +     IAD GL + +   
Sbjct: 194 ----VSCAYQVARGMEYLASKKC-----IHRDLAARNVLVTEDNVMKIADFGLARDIHHI 244
Query: 570 DIVFSVLKTSAAMGYLAPEYVTTGRFTERSDIFAFGVIILQILTGSLVLTSSMRLAAESA 629
           D           + ++APE +    +T +SD+++FGV++ +I T    L  S        
Sbjct: 245 DYYKKTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFT----LGGSPYPGVPVE 300
Query: 630 TFENFIDRNLKGKFSESEAAKLGKMALVCTHEDPENRPTMEAVIEEL 676
                +    +     +   +L  M   C H  P  RPT + ++E+L
Sbjct: 301 ELFKLLKEGHRMDKPSNCTNELYMMMRDCWHAVPSQRPTFKQLVEDL 347

>pdb|4APC|A Chain A, Crystal Structure Of Human Nima-Related Kinase 1 (Nek1) Length = 350

Iteration: 1
 Score = 71.6 bits (174), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 57/284 (20%), Positives = 133/284 (46%), Gaps = 37/284 (13%)
Query: 411 FSEVNLLGKGNF-SSVYKGTLRDGTLVAIRSINVTSCKSEE-AEFVKGLYLLTSLRHENI 468
           +  +  +G+G+F  ++   +  DG    I+ IN++   S+E  E  + + +L +++H NI
Sbjct: 26  YVRLQKIGEGSFGKAILVKSTEDGRQYVIKEINISRMSSKEREESRREVAVLANMKHPNI 85
Query: 469 IRLRGFCCSRGRGECFLIYDFAPKGKLSKYLDQEEG----SSNVLDWSTRVSIIIGIAKG 524
           ++ R        G  +++ D+   G L K ++ ++G       +LDW       + I   
Sbjct: 86  VQYRE--SFEENGSLYIVMDYCEGGDLFKRINAQKGVLFQEDQILDW------FVQICLA 137
Query: 525 IGYLHSSEVNKPAIVHRNLSVEKVLIDQQFNPLIADCGLHKLLADDIVFSVLKTSAAMG- 583
           + ++H  +     I+HR++  + + + +     + D G+ ++L   +  +     A +G 
Sbjct: 138 LKHVHDRK-----ILHRDIKSQNIFLTKDGTVQLGDFGIARVLNSTVELA----RACIGT 188
Query: 584 --YLAPEYVTTGRFTERSDIFAFGVIILQILTGSLVLTSSMRLAAESATFENFIDRNLKG 641
             YL+PE      +  +SDI+A G ++ ++ T        ++ A E+ + +N + + + G
Sbjct: 189 PYYLSPEICENKPYNNKSDIWALGCVLYELCT--------LKHAFEAGSMKNLVLKIISG 240
Query: 642 KF---SESEAAKLGKMALVCTHEDPENRPTMEAVIEELTVAAPV 682
            F   S   +  L  +       +P +RP++ +++E+  +A  +
Sbjct: 241 SFPPVSLHYSYDLRSLVSQLFKRNPRDRPSVNSILEKGFIAKRI 284

>pdb|3CJG|A Chain A, Crystal Structure Of Vegfr2 In Complex With A 3,4,5-Trimethoxy Aniline Containing Pyrimidine Length = 309

Iteration: 1
 Score = 71.6 bits (174), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 66/277 (23%), Positives = 123/277 (44%), Gaps = 27/277 (9%)
Query: 417 LGKGNFSSVYK----GTLRDGTL--VAIRSINVTSCKSEEAEFVKGLYLLTSLRHE-NII 469
           LG+G F  V +    G  +  T   VA++ +   +  SE    +  L +L  + H  N++
Sbjct: 35  LGRGAFGQVIEADAFGIDKTATXRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVV 94
Query: 470 RLRGFCCSRGRGECFLIYDFAPKGKLSKYLDQEEGS--------SNVLDWSTRVSIIIGI 521
            L G C   G G   +I +F   G LS YL  +            + L     +     +
Sbjct: 95  NLLGACTKPG-GPLMVIVEFCKFGNLSTYLRSKRNEFVPYKDLYKDFLTLEHLICYSFQV 153
Query: 522 AKGIGYLHSSEVNKPAIVHRNLSVEKVLIDQQFNPLIADCGLHKLLADDIVFSVLKTSA- 580
           AKG+ +L S +      +HR+L+   +L+ ++    I D GL + +  D  + V K  A 
Sbjct: 154 AKGMEFLASRKX-----IHRDLAARNILLSEKNVVKICDFGLARDIYKDPDY-VRKGDAR 207
Query: 581 -AMGYLAPEYVTTGRFTERSDIFAFGVIILQILTGSLVLTSSMRLAAESATFENFIDRNL 639
             + ++APE +    +T +SD+++FGV++ +I +        +++  E   F   +    
Sbjct: 208 LPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKIDEE---FCRRLKEGT 264
Query: 640 KGKFSESEAAKLGKMALVCTHEDPENRPTMEAVIEEL 676
           + +  +    ++ +  L C H +P  RPT   ++E L
Sbjct: 265 RMRAPDYTTPEMYQTMLDCWHGEPSQRPTFSELVEHL 301

>pdb|3GQI|A Chain A, Crystal Structure Of Activated Receptor Tyrosine Kinase In Complex With Substrates Length = 326

Iteration: 1
 Score = 71.6 bits (174), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 69/287 (24%), Positives = 123/287 (42%), Gaps = 43/287 (14%)
Query: 417 LGKGNFSSVY--------KGTLRDGTLVAIRSINVTSCKSEEAEFVKGLYLLTSL-RHEN 467
           LG+G F  V         K      T VA++ +   + + + ++ +  + ++  + +H+N
Sbjct: 36  LGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGKHKN 95
Query: 468 IIRLRGFCCSRGRGECFLIYDFAPKGKLSKYLD-----------------QEEGSSNVLD 510
           II L G C   G    ++I ++A KG L +YL                  +E+ SS  L 
Sbjct: 96  IINLLGACTQDG--PLYVIVEYASKGNLREYLQARRPPGLEFSFNPSHNPEEQLSSKDL- 152
Query: 511 WSTRVSIIIGIAKGIGYLHSSEVNKPAIVHRNLSVEKVLIDQQFNPLIADCGLHKLLAD- 569
               VS    +A+G+ YL S +      +HR+L+   VL+ +     IAD GL + +   
Sbjct: 153 ----VSCAYQVARGMEYLASKKC-----IHRDLAARNVLVTEDNVMKIADFGLARDIHHI 203
Query: 570 DIVFSVLKTSAAMGYLAPEYVTTGRFTERSDIFAFGVIILQILTGSLVLTSSMRLAAESA 629
           D           + ++APE +    +T +SD+++FGV++ +I T    L  S        
Sbjct: 204 DXXKKTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFT----LGGSPYPGVPVE 259
Query: 630 TFENFIDRNLKGKFSESEAAKLGKMALVCTHEDPENRPTMEAVIEEL 676
                +    +     +   +L  M   C H  P  RPT + ++E+L
Sbjct: 260 ELFKLLKEGHRMDKPSNCTNELYMMMRDCWHAVPSQRPTFKQLVEDL 306

>pdb|3RHX|B Chain B, Crystal Structure Of The Catalytic Domain Of Fgfr1 Kinase In Complex With Arq 069 Length = 306

Iteration: 1
 Score = 71.6 bits (174), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 69/287 (24%), Positives = 123/287 (42%), Gaps = 43/287 (14%)
Query: 417 LGKGNFSSVY--------KGTLRDGTLVAIRSINVTSCKSEEAEFVKGLYLLTSL-RHEN 467
           LG+G F  V         K      T VA++ +   + + + ++ +  + ++  + +H+N
Sbjct: 25  LGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGKHKN 84
Query: 468 IIRLRGFCCSRGRGECFLIYDFAPKGKLSKYLD-----------------QEEGSSNVLD 510
           II L G C   G    ++I ++A KG L +YL                  +E+ SS  L 
Sbjct: 85  IINLLGACTQDG--PLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLSSKDL- 141
Query: 511 WSTRVSIIIGIAKGIGYLHSSEVNKPAIVHRNLSVEKVLIDQQFNPLIADCGLHKLLAD- 569
               VS    +A+G+ YL S +      +HR+L+   VL+ +     IAD GL + +   
Sbjct: 142 ----VSCAYQVARGMEYLASKKC-----IHRDLAARNVLVTEDNVMKIADFGLARDIHHI 192
Query: 570 DIVFSVLKTSAAMGYLAPEYVTTGRFTERSDIFAFGVIILQILTGSLVLTSSMRLAAESA 629
           D           + ++APE +    +T +SD+++FGV++ +I T    L  S        
Sbjct: 193 DYYKKTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFT----LGGSPYPGVPVE 248
Query: 630 TFENFIDRNLKGKFSESEAAKLGKMALVCTHEDPENRPTMEAVIEEL 676
                +    +     +   +L  M   C H  P  RPT + ++E+L
Sbjct: 249 ELFKLLKEGHRMDKPSNCTNELYMMMRDCWHAVPSQRPTFKQLVEDL 295

>pdb|3GQL|A Chain A, Crystal Structure Of Activated Receptor Tyrosine Kinase In Complex With Substrates Length = 326

Iteration: 1
 Score = 71.6 bits (174), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 69/287 (24%), Positives = 123/287 (42%), Gaps = 43/287 (14%)
Query: 417 LGKGNFSSVY--------KGTLRDGTLVAIRSINVTSCKSEEAEFVKGLYLLTSL-RHEN 467
           LG+G F  V         K      T VA++ +   + + + ++ +  + ++  + +H+N
Sbjct: 36  LGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGKHKN 95
Query: 468 IIRLRGFCCSRGRGECFLIYDFAPKGKLSKYLD-----------------QEEGSSNVLD 510
           II L G C   G    ++I ++A KG L +YL                  +E+ SS  L 
Sbjct: 96  IINLLGACTQDG--PLYVIVEYASKGNLREYLQARRPPGLEYCYNPSHNPEEQLSSKDL- 152
Query: 511 WSTRVSIIIGIAKGIGYLHSSEVNKPAIVHRNLSVEKVLIDQQFNPLIADCGLHKLLAD- 569
               VS    +A+G+ YL S +      +HR+L+   VL+ +     IAD GL + +   
Sbjct: 153 ----VSCAYQVARGMEYLASKKC-----IHRDLAARNVLVTEDNVMKIADFGLARDIHHI 203
Query: 570 DIVFSVLKTSAAMGYLAPEYVTTGRFTERSDIFAFGVIILQILTGSLVLTSSMRLAAESA 629
           D           + ++APE +    +T +SD+++FGV++ +I T    L  S        
Sbjct: 204 DYYKKTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFT----LGGSPYPGVPVE 259
Query: 630 TFENFIDRNLKGKFSESEAAKLGKMALVCTHEDPENRPTMEAVIEEL 676
                +    +     +   +L  M   C H  P  RPT + ++E+L
Sbjct: 260 ELFKLLKEGHRMDKPSNCTNELYMMMRDCWHAVPSQRPTFKQLVEDL 306

>pdb|3C4F|A Chain A, Fgfr Tyrosine Kinase Domain In Complex With 3-(3- Methoxybenzyl)-7-Azaindole Length = 302

Iteration: 1
 Score = 71.6 bits (174), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 69/287 (24%), Positives = 123/287 (42%), Gaps = 43/287 (14%)
Query: 417 LGKGNFSSVY--------KGTLRDGTLVAIRSINVTSCKSEEAEFVKGLYLLTSL-RHEN 467
           LG+G F  V         K      T VA++ +   + + + ++ +  + ++  + +H+N
Sbjct: 21  LGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGKHKN 80
Query: 468 IIRLRGFCCSRGRGECFLIYDFAPKGKLSKYLD-----------------QEEGSSNVLD 510
           II L G C   G    ++I ++A KG L +YL                  +E+ SS  L 
Sbjct: 81  IINLLGACTQDG--PLYVIVEYASKGNLREYLQARRPPGLEYCYNPSHNPEEQLSSKDL- 137
Query: 511 WSTRVSIIIGIAKGIGYLHSSEVNKPAIVHRNLSVEKVLIDQQFNPLIADCGLHKLLAD- 569
               VS    +A+G+ YL S +      +HR+L+   VL+ +     IAD GL + +   
Sbjct: 138 ----VSCAYQVARGMEYLASKKC-----IHRDLAARNVLVTEDNVMKIADFGLARDIHHI 188
Query: 570 DIVFSVLKTSAAMGYLAPEYVTTGRFTERSDIFAFGVIILQILTGSLVLTSSMRLAAESA 629
           D           + ++APE +    +T +SD+++FGV++ +I T    L  S        
Sbjct: 189 DYYKKTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFT----LGGSPYPGVPVE 244
Query: 630 TFENFIDRNLKGKFSESEAAKLGKMALVCTHEDPENRPTMEAVIEEL 676
                +    +     +   +L  M   C H  P  RPT + ++E+L
Sbjct: 245 ELFKLLKEGHRMDKPSNCTNELYMMMRDCWHAVPSQRPTFKQLVEDL 291

>pdb|4FL2|A Chain A, Structural And Biophysical Characterization Of The Syk Activation Switch Length = 636

Iteration: 1
 Score = 71.6 bits (174), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 67/265 (25%), Positives = 121/265 (45%), Gaps = 28/265 (10%)
Query: 417 LGKGNFSSVYKGTLRDGTLVAIRSINVTSCKSEEA----EFVKGLYLLTSLRHENIIRLR 472
           LG GNF +V KG  +   +V   ++ +   ++ +     E +    ++  L +  I+R+ 
Sbjct: 378 LGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIVRMI 437
Query: 473 GFCCSRGRGECFLIYDFAPKGKLSKYLDQEEGSSNVLDWSTRVSIIIGIAKGIGYLHSSE 532
           G C +       L+ + A  G L+KYL Q   + +V D    + ++  ++ G+ YL  S 
Sbjct: 438 GICEAES---WMLVMEMAELGPLNKYLQQ---NRHVKD-KNIIELVHQVSMGMKYLEESN 490
Query: 533 VNKPAIVHRNLSVEKVLIDQQFNPLIADCGLHKLLADDIVFSVLKTSAA--MGYLAPEYV 590
                 VHR+L+   VL+  Q    I+D GL K L  D  +   +T     + + APE +
Sbjct: 491 -----FVHRDLAARNVLLVTQHYAKISDFGLSKALRADENYYKAQTHGKWPVKWYAPECI 545
Query: 591 TTGRFTERSDIFAFGVIILQILTGSLVLTSSMRLAAESATFENFIDRNLKGKFSESEAA- 649
              +F+ +SD+++FGV++ +  +        M+ +  +A  E       KG+     A  
Sbjct: 546 NYYKFSSKSDVWSFGVLMWEAFSYGQKPYRGMKGSEVTAMLE-------KGERMGCPAGC 598
Query: 650 --KLGKMALVCTHEDPENRPTMEAV 672
             ++  +  +C   D ENRP   AV
Sbjct: 599 PREMYDLMNLCWTYDVENRPGFAAV 623

>pdb|4F63|A Chain A, Crystal Structure Of Human Fibroblast Growth Factor Receptor 1 Kinase Domain In Complex With Compound 1 Length = 309

Iteration: 1
 Score = 71.6 bits (174), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 69/287 (24%), Positives = 123/287 (42%), Gaps = 43/287 (14%)
Query: 417 LGKGNFSSVY--------KGTLRDGTLVAIRSINVTSCKSEEAEFVKGLYLLTSL-RHEN 467
           LG+G F  V         K      T VA++ +   + + + ++ +  + ++  + +H+N
Sbjct: 28  LGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGKHKN 87
Query: 468 IIRLRGFCCSRGRGECFLIYDFAPKGKLSKYLD-----------------QEEGSSNVLD 510
           II L G C   G    ++I ++A KG L +YL                  +E+ SS  L 
Sbjct: 88  IINLLGACTQDG--PLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLSSKDL- 144
Query: 511 WSTRVSIIIGIAKGIGYLHSSEVNKPAIVHRNLSVEKVLIDQQFNPLIADCGLHKLLAD- 569
               VS    +A+G+ YL S +      +HR+L+   VL+ +     IAD GL + +   
Sbjct: 145 ----VSCAYQVARGMEYLASKKC-----IHRDLAARNVLVTEDNVMKIADFGLARDIHHI 195
Query: 570 DIVFSVLKTSAAMGYLAPEYVTTGRFTERSDIFAFGVIILQILTGSLVLTSSMRLAAESA 629
           D           + ++APE +    +T +SD+++FGV++ +I T    L  S        
Sbjct: 196 DYYKKTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFT----LGGSPYPGVPVE 251
Query: 630 TFENFIDRNLKGKFSESEAAKLGKMALVCTHEDPENRPTMEAVIEEL 676
                +    +     +   +L  M   C H  P  RPT + ++E+L
Sbjct: 252 ELFKLLKEGHRMDKPSNCTNELYMMMRDCWHAVPSQRPTFKQLVEDL 298

>pdb|1FGK|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of Fibroblast Growth Factor Receptor 1 Length = 310

Iteration: 1
 Score = 71.6 bits (174), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 69/287 (24%), Positives = 123/287 (42%), Gaps = 43/287 (14%)
Query: 417 LGKGNFSSVY--------KGTLRDGTLVAIRSINVTSCKSEEAEFVKGLYLLTSL-RHEN 467
           LG+G F  V         K      T VA++ +   + + + ++ +  + ++  + +H+N
Sbjct: 29  LGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGKHKN 88
Query: 468 IIRLRGFCCSRGRGECFLIYDFAPKGKLSKYLD-----------------QEEGSSNVLD 510
           II L G C   G    ++I ++A KG L +YL                  +E+ SS  L 
Sbjct: 89  IINLLGACTQDG--PLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLSSKDL- 145
Query: 511 WSTRVSIIIGIAKGIGYLHSSEVNKPAIVHRNLSVEKVLIDQQFNPLIADCGLHKLLAD- 569
               VS    +A+G+ YL S +      +HR+L+   VL+ +     IAD GL + +   
Sbjct: 146 ----VSCAYQVARGMEYLASKKC-----IHRDLAARNVLVTEDNVMKIADFGLARDIHHI 196
Query: 570 DIVFSVLKTSAAMGYLAPEYVTTGRFTERSDIFAFGVIILQILTGSLVLTSSMRLAAESA 629
           D           + ++APE +    +T +SD+++FGV++ +I T    L  S        
Sbjct: 197 DYYKKTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFT----LGGSPYPGVPVE 252
Query: 630 TFENFIDRNLKGKFSESEAAKLGKMALVCTHEDPENRPTMEAVIEEL 676
                +    +     +   +L  M   C H  P  RPT + ++E+L
Sbjct: 253 ELFKLLKEGHRMDKPSNCTNELYMMMRDCWHAVPSQRPTFKQLVEDL 299

>pdb|4FL3|A Chain A, Structural And Biophysical Characterization Of The Syk Activation Switch Length = 635

Iteration: 1
 Score = 71.2 bits (173), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 67/265 (25%), Positives = 121/265 (45%), Gaps = 28/265 (10%)
Query: 417 LGKGNFSSVYKGTLRDGTLVAIRSINVTSCKSEEA----EFVKGLYLLTSLRHENIIRLR 472
           LG GNF +V KG  +   +V   ++ +   ++ +     E +    ++  L +  I+R+ 
Sbjct: 377 LGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIVRMI 436
Query: 473 GFCCSRGRGECFLIYDFAPKGKLSKYLDQEEGSSNVLDWSTRVSIIIGIAKGIGYLHSSE 532
           G C +       L+ + A  G L+KYL Q   + +V D    + ++  ++ G+ YL  S 
Sbjct: 437 GICEAES---WMLVMEMAELGPLNKYLQQ---NRHVKD-KNIIELVHQVSMGMKYLEESN 489
Query: 533 VNKPAIVHRNLSVEKVLIDQQFNPLIADCGLHKLLADDIVFSVLKTSAA--MGYLAPEYV 590
                 VHR+L+   VL+  Q    I+D GL K L  D  +   +T     + + APE +
Sbjct: 490 -----FVHRDLAARNVLLVTQHYAKISDFGLSKALRADENYYKAQTHGKWPVKWYAPECI 544
Query: 591 TTGRFTERSDIFAFGVIILQILTGSLVLTSSMRLAAESATFENFIDRNLKGKFSESEAA- 649
              +F+ +SD+++FGV++ +  +        M+ +  +A  E       KG+     A  
Sbjct: 545 NYYKFSSKSDVWSFGVLMWEAFSYGQKPYRGMKGSEVTAMLE-------KGERMGCPAGC 597
Query: 650 --KLGKMALVCTHEDPENRPTMEAV 672
             ++  +  +C   D ENRP   AV
Sbjct: 598 PREMYDLMNLCWTYDVENRPGFAAV 622

>pdb|3V5Q|A Chain A, Discovery Of A Selective Trk Inhibitor With Efficacy In Rodent Cancer Tumor Models Length = 297

Iteration: 1
 Score = 71.2 bits (173), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 57/217 (26%), Positives = 102/217 (47%), Gaps = 29/217 (13%)
Query: 417 LGKGNFSSVYKGT------LRDGTLVAIRSINVTSCKSEEAEFVKGLYLLTSLRHENIIR 470
           LG+G F  V+          +D  LVA++++   +  + + +F +   LLT+L+HE+I++
Sbjct: 23  LGEGAFGKVFLAECYNLSPTKDKMLVAVKALKDPTLAARK-DFQREAELLTNLQHEHIVK 81
Query: 471 LRGFCCSRGRGE-CFLIYDFAPKGKLSKYLD------------QEEGSSNVLDWSTRVSI 517
             G C   G G+   +++++   G L+K+L             Q   +   L  S  + I
Sbjct: 82  FYGVC---GDGDPLIMVFEYMKHGDLNKFLRAHGPDAMILVDGQPRQAKGELGLSQMLHI 138
Query: 518 IIGIAKGIGYLHSSEVNKPAIVHRNLSVEKVLIDQQFNPLIADCGLHKLLADDIVFSVL- 576
              IA G+ YL S        VHR+L+    L+       I D G+ + +     + V  
Sbjct: 139 ASQIASGMVYLASQH-----FVHRDLATRNCLVGANLLVKIGDFGMSRDVYSTDYYRVGG 193
Query: 577 KTSAAMGYLAPEYVTTGRFTERSDIFAFGVIILQILT 613
            T   + ++ PE +   +FT  SD+++FGVI+ +I T
Sbjct: 194 HTMLPIRWMPPESIMYRKFTTESDVWSFGVILWEIFT 230

>pdb|3JS2|A Chain A, Crystal Structure Of Minimal Kinase Domain Of Fibroblast Growth Factor Receptor 1 In Complex With 5-(2-Thienyl) Nicotinic Acid Length = 317

Iteration: 1
 Score = 71.2 bits (173), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 69/287 (24%), Positives = 123/287 (42%), Gaps = 43/287 (14%)
Query: 417 LGKGNFSSVY--------KGTLRDGTLVAIRSINVTSCKSEEAEFVKGLYLLTSL-RHEN 467
           LG+G F  V         K      T VA++ +   + + + ++ +  + ++  + +H+N
Sbjct: 36  LGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGKHKN 95
Query: 468 IIRLRGFCCSRGRGECFLIYDFAPKGKLSKYLD-----------------QEEGSSNVLD 510
           II L G C   G    ++I ++A KG L +YL                  +E+ SS  L 
Sbjct: 96  IINLLGACTQDG--PLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLSSKDL- 152
Query: 511 WSTRVSIIIGIAKGIGYLHSSEVNKPAIVHRNLSVEKVLIDQQFNPLIADCGLHKLLAD- 569
               VS    +A+G+ YL S +      +HR+L+   VL+ +     IAD GL + +   
Sbjct: 153 ----VSCAYQVARGMEYLASKKC-----IHRDLAARNVLVTEDNVMKIADFGLARDIHHI 203
Query: 570 DIVFSVLKTSAAMGYLAPEYVTTGRFTERSDIFAFGVIILQILTGSLVLTSSMRLAAESA 629
           D           + ++APE +    +T +SD+++FGV++ +I T    L  S        
Sbjct: 204 DYYKKTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFT----LGGSPYPGVPVE 259
Query: 630 TFENFIDRNLKGKFSESEAAKLGKMALVCTHEDPENRPTMEAVIEEL 676
                +    +     +   +L  M   C H  P  RPT + ++E+L
Sbjct: 260 ELFKLLKEGHRMDKPSNCTNELYMMMRDCWHAVPSQRPTFKQLVEDL 306

>pdb|4AOJ|A Chain A, Human Trka In Complex With The Inhibitor Az-23 Length = 329

Iteration: 1
 Score = 71.2 bits (173), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 54/215 (25%), Positives = 103/215 (47%), Gaps = 26/215 (12%)
Query: 417 LGKGNFSSVYKGTL------RDGTLVAIRSINVTSCKSEEAEFVKGLYLLTSLRHENIIR 470
           LG+G F  V+          +D  LVA++++   S +S   +F +   LLT L+H++I+R
Sbjct: 49  LGEGAFGKVFLAECHNLLPEQDKMLVAVKALKEAS-ESARQDFQREAELLTMLQHQHIVR 107
Query: 471 LRGFCCSRGRGECFLIYDFAPKGKLSKYLDQ-----------EEGSSNVLDWSTRVSIII 519
             G  C+ GR    +++++   G L+++L             E+ +   L     +++  
Sbjct: 108 FFG-VCTEGR-PLLMVFEYMRHGDLNRFLRSHGPDAKLLAGGEDVAPGPLGLGQLLAVAS 165
Query: 520 GIAKGIGYLHSSEVNKPAIVHRNLSVEKVLIDQQFNPLIADCGLHKLLADDIVFSVL-KT 578
            +A G+ YL          VHR+L+    L+ Q     I D G+ + +     + V  +T
Sbjct: 166 QVAAGMVYLAGLH-----FVHRDLATRNCLVGQGLVVKIGDFGMSRDIYSTDYYRVGGRT 220
Query: 579 SAAMGYLAPEYVTTGRFTERSDIFAFGVIILQILT 613
              + ++ PE +   +FT  SD+++FGV++ +I T
Sbjct: 221 MLPIRWMPPESILYRKFTTESDVWSFGVVLWEIFT 255

>pdb|2OO8|X Chain X, Synthesis, Structural Analysis, And Sar Studies Of Triazine Derivatives As Potent, Selective Tie-2 Inhibitors Length = 317

Iteration: 1
 Score = 71.2 bits (173), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 51/215 (23%), Positives = 100/215 (46%), Gaps = 25/215 (11%)
Query: 415 NLLGKGNFSSVYKGTLRDGTL---VAIRSINVTSCKSEEAEFVKGLYLLTSL-RHENIIR 470
           +++G+GNF  V K  ++   L    AI+ +   + K +  +F   L +L  L  H NII 
Sbjct: 21  DVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIIN 80
Query: 471 LRGFCCSRGRGECFLIYDFAPKGKLSKYLDQEE------------GSSNVLDWSTRVSII 518
           L G C    RG  +L  ++AP G L  +L +               +++ L     +   
Sbjct: 81  LLGAC--EHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFA 138
Query: 519 IGIAKGIGYLHSSEVNKPAIVHRNLSVEKVLIDQQFNPLIADCGLHKLLADDIVFSVLKT 578
             +A+G+ YL   +      +HR+L+   +L+ + +   IAD GL +    ++       
Sbjct: 139 ADVARGMDYLSQKQ-----FIHRDLAARNILVGENYVAKIADFGLSR--GQEVYVKKTMG 191
Query: 579 SAAMGYLAPEYVTTGRFTERSDIFAFGVIILQILT 613
              + ++A E +    +T  SD++++GV++ +I++
Sbjct: 192 RLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVS 226

>pdb|4F4P|A Chain A, Syk In Complex With Ligand Lasw836 Length = 273

Iteration: 1
 Score = 70.9 bits (172), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 67/265 (25%), Positives = 121/265 (45%), Gaps = 28/265 (10%)
Query: 417 LGKGNFSSVYKGTLRDGTLVAIRSINVTSCKSEEA----EFVKGLYLLTSLRHENIIRLR 472
           LG GNF +V KG  +   +V   ++ +   ++ +     E +    ++  L +  I+R+ 
Sbjct: 13  LGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIVRMI 72
Query: 473 GFCCSRGRGECFLIYDFAPKGKLSKYLDQEEGSSNVLDWSTRVSIIIGIAKGIGYLHSSE 532
           G C +       L+ + A  G L+KYL Q   + +V D    + ++  ++ G+ YL  S 
Sbjct: 73  GICEAES---WMLVMEMAELGPLNKYLQQ---NRHVKD-KNIIELVHQVSMGMKYLEESN 125
Query: 533 VNKPAIVHRNLSVEKVLIDQQFNPLIADCGLHKLLADDIVFSVLKTSAA--MGYLAPEYV 590
                 VHR+L+   VL+  Q    I+D GL K L  D  +   +T     + + APE +
Sbjct: 126 -----FVHRDLAARNVLLVTQHYAKISDFGLSKALRADENYYKAQTHGKWPVKWYAPECI 180
Query: 591 TTGRFTERSDIFAFGVIILQILTGSLVLTSSMRLAAESATFENFIDRNLKGKFSESEAA- 649
              +F+ +SD+++FGV++ +  +        M+ +  +A  E       KG+     A  
Sbjct: 181 NYYKFSSKSDVWSFGVLMWEAFSYGQKPYRGMKGSEVTAMLE-------KGERMGCPAGC 233
Query: 650 --KLGKMALVCTHEDPENRPTMEAV 672
             ++  +  +C   D ENRP   AV
Sbjct: 234 PREMYDLMNLCWTYDVENRPGFAAV 258

>pdb|1FVR|A Chain A, Tie2 Kinase Domain Length = 327

Iteration: 1
 Score = 70.9 bits (172), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 51/215 (23%), Positives = 100/215 (46%), Gaps = 25/215 (11%)
Query: 415 NLLGKGNFSSVYKGTLRDGTL---VAIRSINVTSCKSEEAEFVKGLYLLTSL-RHENIIR 470
           +++G+GNF  V K  ++   L    AI+ +   + K +  +F   L +L  L  H NII 
Sbjct: 31  DVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIIN 90
Query: 471 LRGFCCSRGRGECFLIYDFAPKGKLSKYLDQEE------------GSSNVLDWSTRVSII 518
           L G C    RG  +L  ++AP G L  +L +               +++ L     +   
Sbjct: 91  LLGAC--EHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFA 148
Query: 519 IGIAKGIGYLHSSEVNKPAIVHRNLSVEKVLIDQQFNPLIADCGLHKLLADDIVFSVLKT 578
             +A+G+ YL   +      +HR+L+   +L+ + +   IAD GL +    ++       
Sbjct: 149 ADVARGMDYLSQKQ-----FIHRDLAARNILVGENYVAKIADFGLSR--GQEVYVKKTMG 201
Query: 579 SAAMGYLAPEYVTTGRFTERSDIFAFGVIILQILT 613
              + ++A E +    +T  SD++++GV++ +I++
Sbjct: 202 RLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVS 236

>pdb|3EMG|A Chain A, Discovery And Sar Of Novel 4-Thiazolyl-2- Phenylaminopyrimidines As Potent Inhibitors Of Spleen Tyrosine Kinase (Syk) Length = 291

Iteration: 1
 Score = 70.9 bits (172), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 67/265 (25%), Positives = 121/265 (45%), Gaps = 28/265 (10%)
Query: 417 LGKGNFSSVYKGTLRDGTLVAIRSINVTSCKSEEA----EFVKGLYLLTSLRHENIIRLR 472
           LG GNF +V KG  +   +V   ++ +   ++ +     E +    ++  L +  I+R+ 
Sbjct: 33  LGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIVRMI 92
Query: 473 GFCCSRGRGECFLIYDFAPKGKLSKYLDQEEGSSNVLDWSTRVSIIIGIAKGIGYLHSSE 532
           G C +       L+ + A  G L+KYL Q   + +V D    + ++  ++ G+ YL  S 
Sbjct: 93  GICEAES---WMLVMEMAELGPLNKYLQQ---NRHVKD-KNIIELVHQVSMGMKYLEESN 145
Query: 533 VNKPAIVHRNLSVEKVLIDQQFNPLIADCGLHKLLADDIVFSVLKTSAA--MGYLAPEYV 590
                 VHR+L+   VL+  Q    I+D GL K L  D  +   +T     + + APE +
Sbjct: 146 -----FVHRDLAARNVLLVTQHYAKISDFGLSKALRADENYYKAQTHGKWPVKWYAPECI 200
Query: 591 TTGRFTERSDIFAFGVIILQILTGSLVLTSSMRLAAESATFENFIDRNLKGKFSESEAA- 649
              +F+ +SD+++FGV++ +  +        M+ +  +A  E       KG+     A  
Sbjct: 201 NYYKFSSKSDVWSFGVLMWEAFSYGQKPYRGMKGSEVTAMLE-------KGERMGCPAGC 253
Query: 650 --KLGKMALVCTHEDPENRPTMEAV 672
             ++  +  +C   D ENRP   AV
Sbjct: 254 PREMYDLMNLCWTYDVENRPGFAAV 278

>pdb|3SRV|B Chain B, Crystal Structure Of Spleen Tyrosine Kinase (Syk) In Complex With A Diaminopyrimidine Carboxamide Inhibitor Length = 277

Iteration: 1
 Score = 70.9 bits (172), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 67/265 (25%), Positives = 121/265 (45%), Gaps = 28/265 (10%)
Query: 417 LGKGNFSSVYKGTLRDGTLVAIRSINVTSCKSEEA----EFVKGLYLLTSLRHENIIRLR 472
           LG GNF +V KG  +   +V   ++ +   ++ +     E +    ++  L +  I+R+ 
Sbjct: 19  LGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIVRMI 78
Query: 473 GFCCSRGRGECFLIYDFAPKGKLSKYLDQEEGSSNVLDWSTRVSIIIGIAKGIGYLHSSE 532
           G C +       L+ + A  G L+KYL Q   + +V D    + ++  ++ G+ YL  S 
Sbjct: 79  GICEAES---WMLVMEMAELGPLNKYLQQ---NRHVKD-KNIIELVHQVSMGMKYLEESN 131
Query: 533 VNKPAIVHRNLSVEKVLIDQQFNPLIADCGLHKLLADDIVFSVLKTSAA--MGYLAPEYV 590
                 VHR+L+   VL+  Q    I+D GL K L  D  +   +T     + + APE +
Sbjct: 132 -----FVHRDLAARNVLLVTQHYAKISDFGLSKALRADENYYKAQTHGKWPVKWYAPECI 186
Query: 591 TTGRFTERSDIFAFGVIILQILTGSLVLTSSMRLAAESATFENFIDRNLKGKFSESEAA- 649
              +F+ +SD+++FGV++ +  +        M+ +  +A  E       KG+     A  
Sbjct: 187 NYYKFSSKSDVWSFGVLMWEAFSYGQKPYRGMKGSEVTAMLE-------KGERMGCPAGC 239
Query: 650 --KLGKMALVCTHEDPENRPTMEAV 672
             ++  +  +C   D ENRP   AV
Sbjct: 240 PREMYDLMNLCWTYDVENRPGFAAV 264

>pdb|3C7Q|A Chain A, Structure Of Vegfr2 Kinase Domain In Complex With Bibf1120 Length = 316

Iteration: 1
 Score = 70.9 bits (172), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 67/279 (24%), Positives = 123/279 (44%), Gaps = 29/279 (10%)
Query: 417 LGKGNFSSVYK----GTLRDGTL--VAIRSINVTSCKSEEAEFVKGLYLLTSLRHE-NII 469
           LG+G F  V +    G  +  T   VA++ +   +  SE    +  L +L  + H  N++
Sbjct: 37  LGRGAFGQVIEADAFGIDKTATXRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVV 96
Query: 470 RLRGFCCSRGRGECFLIYDFAPKGKLSKYL----------DQEEGSSNVLDWSTRVSIII 519
            L G C   G G   +I +F   G LS YL            E+   + L     +    
Sbjct: 97  NLLGACTKPG-GPLMVIVEFCKFGNLSTYLRSKRNEFVPYKPEDLYKDFLTLEHLIXYSF 155
Query: 520 GIAKGIGYLHSSEVNKPAIVHRNLSVEKVLIDQQFNPLIADCGLHKLLADDIVFSVLKTS 579
            +AKG+ +L S +      +HR+L+   +L+ ++    I D GL + +  D    V K  
Sbjct: 156 QVAKGMEFLASRKX-----IHRDLAARNILLSEKNVVKICDFGLARDIXKDPD-XVRKGD 209
Query: 580 A--AMGYLAPEYVTTGRFTERSDIFAFGVIILQILTGSLVLTSSMRLAAESATFENFIDR 637
           A   + ++APE +    +T +SD+++FGV++ +I +        +++  E   F   +  
Sbjct: 210 ARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKIDEE---FCRRLKE 266
Query: 638 NLKGKFSESEAAKLGKMALVCTHEDPENRPTMEAVIEEL 676
             + +  +    ++ +  L C H +P  RPT   ++E L
Sbjct: 267 GTRMRAPDYTTPEMYQTMLDCWHGEPSQRPTFSELVEHL 305

>pdb|4GT5|A Chain A, Crystal Structure Of The Inactive Trka Kinase Domain Length = 306

Iteration: 1
 Score = 70.9 bits (172), Expect = 3e-12,   Method: Compositional matrix adjust.
 Identities = 54/215 (25%), Positives = 103/215 (47%), Gaps = 26/215 (12%)
Query: 417 LGKGNFSSVYKGTL------RDGTLVAIRSINVTSCKSEEAEFVKGLYLLTSLRHENIIR 470
           LG+G F  V+          +D  LVA++++   S +S   +F +   LLT L+H++I+R
Sbjct: 26  LGEGAFGKVFLAECHNLLPEQDKMLVAVKALKEAS-ESARQDFQREAELLTMLQHQHIVR 84
Query: 471 LRGFCCSRGRGECFLIYDFAPKGKLSKYLDQ-----------EEGSSNVLDWSTRVSIII 519
             G  C+ GR    +++++   G L+++L             E+ +   L     +++  
Sbjct: 85  FFG-VCTEGR-PLLMVFEYMRHGDLNRFLRSHGPDAKLLAGGEDVAPGPLGLGQLLAVAS 142
Query: 520 GIAKGIGYLHSSEVNKPAIVHRNLSVEKVLIDQQFNPLIADCGLHKLLADDIVFSVL-KT 578
            +A G+ YL          VHR+L+    L+ Q     I D G+ + +     + V  +T
Sbjct: 143 QVAAGMVYLAGLH-----FVHRDLATRNCLVGQGLVVKIGDFGMSRDIYSTDYYRVGGRT 197
Query: 579 SAAMGYLAPEYVTTGRFTERSDIFAFGVIILQILT 613
              + ++ PE +   +FT  SD+++FGV++ +I T
Sbjct: 198 MLPIRWMPPESILYRKFTTESDVWSFGVVLWEIFT 232

>pdb|4GT4|A Chain A, Structure Of Unliganded, Inactive Ror2 Kinase Domain Length = 308

Iteration: 1
 Score = 70.9 bits (172), Expect = 3e-12,   Method: Compositional matrix adjust.
 Identities = 60/236 (25%), Positives = 106/236 (44%), Gaps = 28/236 (11%)
Query: 400 NLEEVESATQCFSEVNLLGKGNFSSVYKGTL------RDGTLVAIRSINVTSCKSEEAEF 453
            L+E+  +   F E   LG+  F  VYKG L           VAI+++   +      EF
Sbjct: 19  KLKEISLSAVRFMEE--LGEDRFGKVYKGHLFGPAPGEQTQAVAIKTLKDKAEGPLREEF 76
Query: 454 VKGLYLLTSLRHENIIRLRGFCCSRGRGECFLIYDFAPKGKLSKYL------------DQ 501
                L   L+H N++ L G           +I+ +   G L ++L            D 
Sbjct: 77  RHEAMLRARLQHPNVVCLLGVVTKDQ--PLSMIFSYCSHGDLHEFLVMRSPHSDVGSTDD 134
Query: 502 EEGSSNVLDWSTRVSIIIGIAKGIGYLHSSEVNKPAIVHRNLSVEKVLIDQQFNPLIADC 561
           +    + L+    V ++  IA G+ YL S  V     VH++L+   VL+  + N  I+D 
Sbjct: 135 DRTVKSALEPPDFVHLVAQIAAGMEYLSSHHV-----VHKDLATRNVLVYDKLNVKISDL 189
Query: 562 GLHKLLADDIVFSVLKTSA-AMGYLAPEYVTTGRFTERSDIFAFGVIILQILTGSL 616
           GL + +     + +L  S   + ++APE +  G+F+  SDI+++GV++ ++ +  L
Sbjct: 190 GLFREVYAADYYKLLGNSLLPIRWMAPEAIMYGKFSIDSDIWSYGVVLWEVFSYGL 245

>pdb|3VNT|A Chain A, Crystal Structure Of The Kinase Domain Of Human Vegfr2 With A [1, 3]thiazolo[5,4-B]pyridine Derivative Length = 318

Iteration: 1
 Score = 70.5 bits (171), Expect = 3e-12,   Method: Compositional matrix adjust.
 Identities = 67/281 (23%), Positives = 124/281 (44%), Gaps = 31/281 (11%)
Query: 417 LGKGNFSSVYK----GTLRDGTL--VAIRSINVTSCKSEEAEFVKGLYLLTSLRHE-NII 469
           LG+G F  V +    G  +  T   VA++ +   +  SE    +  L +L  + H  N++
Sbjct: 37  LGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVV 96
Query: 470 RLRGFCCSRGRGECFLIYDFAPKGKLSKYLDQ------------EEGSSNVLDWSTRVSI 517
            L G C   G G   +I +F   G LS YL              E+   + L     +  
Sbjct: 97  NLLGACTKPG-GPLMVIVEFCKFGNLSTYLRSKRNEFVPYKEAPEDLYKDFLTLEHLICY 155
Query: 518 IIGIAKGIGYLHSSEVNKPAIVHRNLSVEKVLIDQQFNPLIADCGLHKLLADDIVFSVLK 577
              +AKG+ +L S +      +HR+L+   +L+ ++    I D GL + +  D  + V K
Sbjct: 156 SFQVAKGMEFLASRKC-----IHRDLAARNILLSEKNVVKICDFGLARDIYKDPDY-VRK 209
Query: 578 TSA--AMGYLAPEYVTTGRFTERSDIFAFGVIILQILTGSLVLTSSMRLAAESATFENFI 635
             A   + ++APE +    +T +SD+++FGV++ +I +        +++  E   F   +
Sbjct: 210 GDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKIDEE---FCRRL 266
Query: 636 DRNLKGKFSESEAAKLGKMALVCTHEDPENRPTMEAVIEEL 676
               + +  +    ++ +  L C H +P  RPT   ++E L
Sbjct: 267 KEGTRMRAPDYTTPEMYQTMLDCWHGEPSQRPTFSELVEHL 307

>pdb|2XIR|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With Pf-00337210 (N,2-Dimethyl-6-(7-(2-Morpholinoethoxy) Quinolin-4-Yloxy)benzofuran-3-Carboxamide) Length = 316

Iteration: 1
 Score = 70.5 bits (171), Expect = 3e-12,   Method: Compositional matrix adjust.
 Identities = 67/281 (23%), Positives = 124/281 (44%), Gaps = 31/281 (11%)
Query: 417 LGKGNFSSVYK----GTLRDGTL--VAIRSINVTSCKSEEAEFVKGLYLLTSLRHE-NII 469
           LG+G F  V +    G  +  T   VA++ +   +  SE    +  L +L  + H  N++
Sbjct: 35  LGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVV 94
Query: 470 RLRGFCCSRGRGECFLIYDFAPKGKLSKYLDQ------------EEGSSNVLDWSTRVSI 517
            L G C   G G   +I +F   G LS YL              E+   + L     +  
Sbjct: 95  NLLGACTKPG-GPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICY 153
Query: 518 IIGIAKGIGYLHSSEVNKPAIVHRNLSVEKVLIDQQFNPLIADCGLHKLLADDIVFSVLK 577
              +AKG+ +L S +      +HR+L+   +L+ ++    I D GL + +  D  + V K
Sbjct: 154 SFQVAKGMEFLASRKC-----IHRDLAARNILLSEKNVVKICDFGLARDIYKDPDY-VRK 207
Query: 578 TSA--AMGYLAPEYVTTGRFTERSDIFAFGVIILQILTGSLVLTSSMRLAAESATFENFI 635
             A   + ++APE +    +T +SD+++FGV++ +I +        +++  E   F   +
Sbjct: 208 GDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKIDEE---FCRRL 264
Query: 636 DRNLKGKFSESEAAKLGKMALVCTHEDPENRPTMEAVIEEL 676
               + +  +    ++ +  L C H +P  RPT   ++E L
Sbjct: 265 KEGTRMRAPDYTTPEMYQTMLDCWHGEPSQRPTFSELVEHL 305

>pdb|4F0I|A Chain A, Crystal Structure Of Apo Trka Length = 300

Iteration: 1
 Score = 70.5 bits (171), Expect = 3e-12,   Method: Compositional matrix adjust.
 Identities = 54/215 (25%), Positives = 103/215 (47%), Gaps = 26/215 (12%)
Query: 417 LGKGNFSSVYKGTL------RDGTLVAIRSINVTSCKSEEAEFVKGLYLLTSLRHENIIR 470
           LG+G F  V+          +D  LVA++++   S +S   +F +   LLT L+H++I+R
Sbjct: 20  LGEGAFGKVFLAECHNLLPEQDKMLVAVKALKEAS-ESARQDFQREAELLTMLQHQHIVR 78
Query: 471 LRGFCCSRGRGECFLIYDFAPKGKLSKYLDQ-----------EEGSSNVLDWSTRVSIII 519
             G  C+ GR    +++++   G L+++L             E+ +   L     +++  
Sbjct: 79  FFG-VCTEGR-PLLMVFEYMRHGDLNRFLRSHGPDAKLLAGGEDVAPGPLGLGQLLAVAS 136
Query: 520 GIAKGIGYLHSSEVNKPAIVHRNLSVEKVLIDQQFNPLIADCGLHKLLADDIVFSVL-KT 578
            +A G+ YL          VHR+L+    L+ Q     I D G+ + +     + V  +T
Sbjct: 137 QVAAGMVYLAGLH-----FVHRDLATRNCLVGQGLVVKIGDFGMSRDIYSTDYYRVGGRT 191
Query: 579 SAAMGYLAPEYVTTGRFTERSDIFAFGVIILQILT 613
              + ++ PE +   +FT  SD+++FGV++ +I T
Sbjct: 192 MLPIRWMPPESILYRKFTTESDVWSFGVVLWEIFT 226

>pdb|4AGC|A Chain A, Crystal Structure Of Vegfr2 (Juxtamembrane And Kinase Domains) In Complex With Axitinib (Ag-013736) (N-Methyl-2-( 3-((E)-2-Pyridin-2-Yl-Vinyl)-1h-Indazol-6-Ylsulfanyl)- Benzamide) Length = 353

Iteration: 1
 Score = 70.5 bits (171), Expect = 3e-12,   Method: Compositional matrix adjust.
 Identities = 67/281 (23%), Positives = 124/281 (44%), Gaps = 31/281 (11%)
Query: 417 LGKGNFSSVYK----GTLRDGTL--VAIRSINVTSCKSEEAEFVKGLYLLTSLRHE-NII 469
           LG+G F  V +    G  +  T   VA++ +   +  SE    +  L +L  + H  N++
Sbjct: 72  LGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVV 131
Query: 470 RLRGFCCSRGRGECFLIYDFAPKGKLSKYLDQ------------EEGSSNVLDWSTRVSI 517
            L G C   G G   +I +F   G LS YL              E+   + L     +  
Sbjct: 132 NLLGACTKPG-GPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICY 190
Query: 518 IIGIAKGIGYLHSSEVNKPAIVHRNLSVEKVLIDQQFNPLIADCGLHKLLADDIVFSVLK 577
              +AKG+ +L S +      +HR+L+   +L+ ++    I D GL + +  D  + V K
Sbjct: 191 SFQVAKGMEFLASRKC-----IHRDLAARNILLSEKNVVKICDFGLARDIYKDPDY-VRK 244
Query: 578 TSA--AMGYLAPEYVTTGRFTERSDIFAFGVIILQILTGSLVLTSSMRLAAESATFENFI 635
             A   + ++APE +    +T +SD+++FGV++ +I +        +++  E   F   +
Sbjct: 245 GDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKIDEE---FCRRL 301
Query: 636 DRNLKGKFSESEAAKLGKMALVCTHEDPENRPTMEAVIEEL 676
               + +  +    ++ +  L C H +P  RPT   ++E L
Sbjct: 302 KEGTRMRAPDYTTPEMYQTMLDCWHGEPSQRPTFSELVEHL 342

>pdb|4DFL|A Chain A, Crystal Structure Of Spleen Tyrosine Kinase Complexed With A Sulfonamidopyrazine Piperidine Inhibitor Length = 274

Iteration: 1
 Score = 70.5 bits (171), Expect = 3e-12,   Method: Compositional matrix adjust.
 Identities = 67/265 (25%), Positives = 121/265 (45%), Gaps = 28/265 (10%)
Query: 417 LGKGNFSSVYKGTLRDGTLVAIRSINVTSCKSEEA----EFVKGLYLLTSLRHENIIRLR 472
           LG GNF +V KG  +   +V   ++ +   ++ +     E +    ++  L +  I+R+ 
Sbjct: 15  LGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIVRMI 74
Query: 473 GFCCSRGRGECFLIYDFAPKGKLSKYLDQEEGSSNVLDWSTRVSIIIGIAKGIGYLHSSE 532
           G C +       L+ + A  G L+KYL Q   + +V D    + ++  ++ G+ YL  S 
Sbjct: 75  GICEAES---WMLVMEMAELGPLNKYLQQ---NRHVKD-KNIIELVHQVSMGMKYLEESN 127
Query: 533 VNKPAIVHRNLSVEKVLIDQQFNPLIADCGLHKLLADDIVFSVLKTSAA--MGYLAPEYV 590
                 VHR+L+   VL+  Q    I+D GL K L  D  +   +T     + + APE +
Sbjct: 128 -----FVHRDLAARNVLLVTQHYAKISDFGLSKALRADENYYKAQTHGKWPVKWYAPECI 182
Query: 591 TTGRFTERSDIFAFGVIILQILTGSLVLTSSMRLAAESATFENFIDRNLKGKFSESEAA- 649
              +F+ +SD+++FGV++ +  +        M+ +  +A  E       KG+     A  
Sbjct: 183 NYYKFSSKSDVWSFGVLMWEAFSYGQKPYRGMKGSEVTAMLE-------KGERMGCPAGC 235
Query: 650 --KLGKMALVCTHEDPENRPTMEAV 672
             ++  +  +C   D ENRP   AV
Sbjct: 236 PREMYDLMNLCWTYDVENRPGFAAV 260

>pdb|3ZZW|A Chain A, Crystal Structure Of The Kinase Domain Of Ror2 Length = 289

Iteration: 1
 Score = 70.5 bits (171), Expect = 3e-12,   Method: Compositional matrix adjust.
 Identities = 60/236 (25%), Positives = 106/236 (44%), Gaps = 28/236 (11%)
Query: 400 NLEEVESATQCFSEVNLLGKGNFSSVYKGTL------RDGTLVAIRSINVTSCKSEEAEF 453
            L+E+  +   F E   LG+  F  VYKG L           VAI+++   +      EF
Sbjct: 2   KLKEISLSAVRFMEE--LGEDRFGKVYKGHLFGPAPGEQTQAVAIKTLKDKAEGPLREEF 59
Query: 454 VKGLYLLTSLRHENIIRLRGFCCSRGRGECFLIYDFAPKGKLSKYL------------DQ 501
                L   L+H N++ L G           +I+ +   G L ++L            D 
Sbjct: 60  RHEAMLRARLQHPNVVCLLGVVTKDQ--PLSMIFSYCSHGDLHEFLVMRSPHSDVGSTDD 117
Query: 502 EEGSSNVLDWSTRVSIIIGIAKGIGYLHSSEVNKPAIVHRNLSVEKVLIDQQFNPLIADC 561
           +    + L+    V ++  IA G+ YL S  V     VH++L+   VL+  + N  I+D 
Sbjct: 118 DRTVKSALEPPDFVHLVAQIAAGMEYLSSHHV-----VHKDLATRNVLVYDKLNVKISDL 172
Query: 562 GLHKLLADDIVFSVLKTSA-AMGYLAPEYVTTGRFTERSDIFAFGVIILQILTGSL 616
           GL + +     + +L  S   + ++APE +  G+F+  SDI+++GV++ ++ +  L
Sbjct: 173 GLFREVYAADYYKLLGNSLLPIRWMAPEAIMYGKFSIDSDIWSYGVVLWEVFSYGL 228

>pdb|1XBA|A Chain A, Crystal Structure Of Apo Syk Tyrosine Kinase Domain Length = 291

Iteration: 1
 Score = 70.5 bits (171), Expect = 3e-12,   Method: Compositional matrix adjust.
 Identities = 67/265 (25%), Positives = 121/265 (45%), Gaps = 28/265 (10%)
Query: 417 LGKGNFSSVYKGTLRDGTLVAIRSINVTSCKSEEA----EFVKGLYLLTSLRHENIIRLR 472
           LG GNF +V KG  +   +V   ++ +   ++ +     E +    ++  L +  I+R+ 
Sbjct: 25  LGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIVRMI 84
Query: 473 GFCCSRGRGECFLIYDFAPKGKLSKYLDQEEGSSNVLDWSTRVSIIIGIAKGIGYLHSSE 532
           G C +       L+ + A  G L+KYL Q   + +V D    + ++  ++ G+ YL  S 
Sbjct: 85  GICEAES---WMLVMEMAELGPLNKYLQQ---NRHVKD-KNIIELVHQVSMGMKYLEESN 137
Query: 533 VNKPAIVHRNLSVEKVLIDQQFNPLIADCGLHKLLADDIVFSVLKTSAA--MGYLAPEYV 590
                 VHR+L+   VL+  Q    I+D GL K L  D  +   +T     + + APE +
Sbjct: 138 -----FVHRDLAARNVLLVTQHYAKISDFGLSKALRADENYYKAQTHGKWPVKWYAPECI 192
Query: 591 TTGRFTERSDIFAFGVIILQILTGSLVLTSSMRLAAESATFENFIDRNLKGKFSESEAA- 649
              +F+ +SD+++FGV++ +  +        M+ +  +A  E       KG+     A  
Sbjct: 193 NYYKFSSKSDVWSFGVLMWEAFSYGQKPYRGMKGSEVTAMLE-------KGERMGCPAGC 245
Query: 650 --KLGKMALVCTHEDPENRPTMEAV 672
             ++  +  +C   D ENRP   AV
Sbjct: 246 PREMYDLMNLCWTYDVENRPGFAAV 270

>pdb|3TUB|A Chain A, Crystal Structure Of Syk Kinase Domain With 1-(5-(6,7- Dimethoxyquinolin-4-Yloxy)pyridin-2-Yl)-3-((1r,2s)-2- Phenylcyclopropyl)urea Length = 293

Iteration: 1
 Score = 70.1 bits (170), Expect = 3e-12,   Method: Compositional matrix adjust.
 Identities = 67/265 (25%), Positives = 121/265 (45%), Gaps = 28/265 (10%)
Query: 417 LGKGNFSSVYKGTLRDGTLVAIRSINVTSCKSEEA----EFVKGLYLLTSLRHENIIRLR 472
           LG GNF +V KG  +   +V   ++ +   ++ +     E +    ++  L +  I+R+ 
Sbjct: 35  LGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIVRMI 94
Query: 473 GFCCSRGRGECFLIYDFAPKGKLSKYLDQEEGSSNVLDWSTRVSIIIGIAKGIGYLHSSE 532
           G C +       L+ + A  G L+KYL Q   + +V D    + ++  ++ G+ YL  S 
Sbjct: 95  GICEAES---WMLVMEMAELGPLNKYLQQ---NRHVKD-KNIIELVHQVSMGMKYLEESN 147
Query: 533 VNKPAIVHRNLSVEKVLIDQQFNPLIADCGLHKLLADDIVFSVLKTSAA--MGYLAPEYV 590
                 VHR+L+   VL+  Q    I+D GL K L  D  +   +T     + + APE +
Sbjct: 148 -----FVHRDLAARNVLLVTQHYAKISDFGLSKALRADENYYKAQTHGKWPVKWYAPECI 202
Query: 591 TTGRFTERSDIFAFGVIILQILTGSLVLTSSMRLAAESATFENFIDRNLKGKFSESEAA- 649
              +F+ +SD+++FGV++ +  +        M+ +  +A  E       KG+     A  
Sbjct: 203 NYYKFSSKSDVWSFGVLMWEAFSYGQKPYRGMKGSEVTAMLE-------KGERMGCPAGC 255
Query: 650 --KLGKMALVCTHEDPENRPTMEAV 672
             ++  +  +C   D ENRP   AV
Sbjct: 256 PREMYDLMNLCWTYDVENRPGFAAV 280

>pdb|3VF8|A Chain A, Crystal Structure Of Spleen Tyrosine Kinase Syk Catalytic Domain With Pyrazolylbenzimidazole Inhibitor 416 Length = 299

Iteration: 1
 Score = 70.1 bits (170), Expect = 3e-12,   Method: Compositional matrix adjust.
 Identities = 67/265 (25%), Positives = 121/265 (45%), Gaps = 28/265 (10%)
Query: 417 LGKGNFSSVYKGTLRDGTLVAIRSINVTSCKSEEA----EFVKGLYLLTSLRHENIIRLR 472
           LG GNF +V KG  +   +V   ++ +   ++ +     E +    ++  L +  I+R+ 
Sbjct: 35  LGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIVRMI 94
Query: 473 GFCCSRGRGECFLIYDFAPKGKLSKYLDQEEGSSNVLDWSTRVSIIIGIAKGIGYLHSSE 532
           G C +       L+ + A  G L+KYL Q   + +V D    + ++  ++ G+ YL  S 
Sbjct: 95  GICEAES---WMLVMEMAELGPLNKYLQQ---NRHVKD-KNIIELVHQVSMGMKYLEESN 147
Query: 533 VNKPAIVHRNLSVEKVLIDQQFNPLIADCGLHKLLADDIVFSVLKTSAA--MGYLAPEYV 590
                 VHR+L+   VL+  Q    I+D GL K L  D  +   +T     + + APE +
Sbjct: 148 -----FVHRDLAARNVLLVTQHYAKISDFGLSKALRADENYYKAQTHGKWPVKWYAPECI 202
Query: 591 TTGRFTERSDIFAFGVIILQILTGSLVLTSSMRLAAESATFENFIDRNLKGKFSESEAA- 649
              +F+ +SD+++FGV++ +  +        M+ +  +A  E       KG+     A  
Sbjct: 203 NYYKFSSKSDVWSFGVLMWEAFSYGQKPYRGMKGSEVTAMLE-------KGERMGCPAGC 255
Query: 650 --KLGKMALVCTHEDPENRPTMEAV 672
             ++  +  +C   D ENRP   AV
Sbjct: 256 PREMYDLMNLCWTYDVENRPGFAAV 280

>pdb|2BFY|A Chain A, Complex Of Aurora-B With Incenp And Hesperidin. Length = 284

Iteration: 1
 Score = 70.1 bits (170), Expect = 3e-12,   Method: Compositional matrix adjust.
 Identities = 70/280 (25%), Positives = 122/280 (43%), Gaps = 37/280 (13%)
Query: 411 FSEVNLLGKGNFSSVYKGTLRDGTLV-AIRSINVTSCKSE--EAEFVKGLYLLTSLRHEN 467
           F  V  LGKG F +VY    +    + A++ +  +  + E  E +  + + + + LRH N
Sbjct: 16  FDIVRPLGKGKFGNVYLAREKQNKFIMALKVLFKSQLEKEGVEHQLRREIEIQSHLRHPN 75
Query: 468 IIRLRGFCCSRGRGECFLIYDFAPKGKLSKYLDQEEGSSNVLDWSTRVSIIIGIAKGIGY 527
           I+R+  +   R R   +L+ +FAP+G+L K L Q+ G     D     + +  +A  + Y
Sbjct: 76  ILRMYNYFHDRKR--IYLMLEFAPRGELYKEL-QKHGR---FDEQRSATFMEELADALHY 129
Query: 528 LHSSEVNKPAIVHRNLSVEKVLIDQQFNPLIADCGLHKLLADDIVFSVLKTS-------A 580
            H  +V     +HR++  E +L+  +    IAD G          +SV   S        
Sbjct: 130 CHERKV-----IHRDIKPENLLMGYKGELKIADFG----------WSVHAPSLRRRXMCG 174
Query: 581 AMGYLAPEYVTTGRFTERSDIFAFGVIILQILTGSLVLTSSMRLAAESATFENFIDRNLK 640
            + YL PE +      E+ D++  GV+  + L G     S     + + T    ++ +LK
Sbjct: 175 TLDYLPPEMIEGKTHDEKVDLWCAGVLCYEFLVGMPPFDS----PSHTETHRRIVNVDLK 230
Query: 641 GKFSESEAAKLGKMALVCTHEDPENRPTMEAVIEELTVAA 680
                S+ +K     L+  H  P  R  ++ V+E   V A
Sbjct: 231 FPPFLSDGSKDLISKLLRYH--PPQRLPLKGVMEHPWVKA 268

>pdb|2OH4|A Chain A, Crystal Structure Of Vegfr2 With A Benzimidazole-Urea Inhibitor Length = 316

Iteration: 1
 Score = 70.1 bits (170), Expect = 4e-12,   Method: Compositional matrix adjust.
 Identities = 67/280 (23%), Positives = 123/280 (43%), Gaps = 30/280 (10%)
Query: 417 LGKGNFSSVYK----GTLRDGTL--VAIRSINVTSCKSEEAEFVKGLYLLTSLRHE-NII 469
           LG+G F  V +    G  +  T   VA++ +   +  SE    +  L +L  + H  N++
Sbjct: 36  LGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVV 95
Query: 470 RLRGFCCSRGRGECFLIYDFAPKGKLSKYLDQ-----------EEGSSNVLDWSTRVSII 518
            L G C   G G   +I +F   G LS YL             E+   + L     +   
Sbjct: 96  NLLGACTKPG-GPLMVIVEFCKFGNLSTYLRSKRNEFVPYKTPEDLYKDFLTLEHLICYS 154
Query: 519 IGIAKGIGYLHSSEVNKPAIVHRNLSVEKVLIDQQFNPLIADCGLHKLLADDIVFSVLKT 578
             +AKG+ +L S +      +HR+L+   +L+ ++    I D GL + +  D    V K 
Sbjct: 155 FQVAKGMEFLASRKC-----IHRDLAARNILLSEKNVVKICDFGLARDIXKDPD-XVRKG 208
Query: 579 SA--AMGYLAPEYVTTGRFTERSDIFAFGVIILQILTGSLVLTSSMRLAAESATFENFID 636
            A   + ++APE +    +T +SD+++FGV++ +I +        +++  E   F   + 
Sbjct: 209 DARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKIDEE---FCRRLK 265
Query: 637 RNLKGKFSESEAAKLGKMALVCTHEDPENRPTMEAVIEEL 676
              + +  +    ++ +  L C H +P  RPT   ++E L
Sbjct: 266 EGTRMRAPDYTTPEMYQTMLDCWHGEPSQRPTFSELVEHL 305

>pdb|2WTV|A Chain A, Aurora-A Inhibitor Structure Length = 285

Iteration: 1
 Score = 70.1 bits (170), Expect = 4e-12,   Method: Compositional matrix adjust.
 Identities = 65/276 (23%), Positives = 118/276 (42%), Gaps = 41/276 (14%)
Query: 417 LGKGNFSSVYKGTLRDGTLV-AIRSINVTSCKSE--EAEFVKGLYLLTSLRHENIIRLRG 473
           LGKG F +VY    +    + A++ +     +    E +  + + + + LRH NI+RL G
Sbjct: 21  LGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRLYG 80
Query: 474 FCCSRGRGECFLIYDFAPKGKLSKYLDQEEGSSNVLDWSTRVSIIIGIAKGIGYLHSSEV 533
           +     R   +LI ++AP+G++ K L +     +  D     + I  +A  + Y HS  V
Sbjct: 81  YFHDATR--VYLILEYAPRGEVYKELQK----LSKFDEQRTATYITELANALSYCHSKRV 134
Query: 534 NKPAIVHRNLSVEKVLIDQQFNPLIADCGLHKLLADDIVFSVLKTSA-------AMGYLA 586
                +HR++  E +L+       IAD G          +SV   S+        + YL 
Sbjct: 135 -----IHRDIKPENLLLGSAGELKIADFG----------WSVHAPSSRRXXLXGTLDYLP 179
Query: 587 PEYVTTGRFTERSDIFAFGVIILQILTGSLVLTSSMRLAAESATFENFIDRNLKGKFSES 646
           PE +      E+ D+++ GV+  + L G        +   E+ T++    R  + +F+  
Sbjct: 180 PEMIEGRMHDEKVDLWSLGVLCYEFLVG--------KPPFEANTYQETYKRISRVEFTFP 231
Query: 647 EAAKLGKMALVCT--HEDPENRPTMEAVIEELTVAA 680
           +    G   L+      +P  RP +  V+E   + A
Sbjct: 232 DFVTEGARDLISRLLKHNPSQRPMLREVLEHPWITA 267

>pdb|2WTW|A Chain A, Aurora-A Inhibitor Structure (2nd Crystal Form) Length = 285

Iteration: 1
 Score = 70.1 bits (170), Expect = 4e-12,   Method: Compositional matrix adjust.
 Identities = 65/276 (23%), Positives = 118/276 (42%), Gaps = 41/276 (14%)
Query: 417 LGKGNFSSVYKGTLRDGTLV-AIRSINVTSCKSE--EAEFVKGLYLLTSLRHENIIRLRG 473
           LGKG F +VY    +    + A++ +     +    E +  + + + + LRH NI+RL G
Sbjct: 21  LGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRLYG 80
Query: 474 FCCSRGRGECFLIYDFAPKGKLSKYLDQEEGSSNVLDWSTRVSIIIGIAKGIGYLHSSEV 533
           +     R   +LI ++AP+G++ K L +     +  D     + I  +A  + Y HS  V
Sbjct: 81  YFHDATR--VYLILEYAPRGEVYKELQK----LSKFDEQRTATYITELANALSYCHSKRV 134
Query: 534 NKPAIVHRNLSVEKVLIDQQFNPLIADCGLHKLLADDIVFSVLKTSA-------AMGYLA 586
                +HR++  E +L+       IAD G          +SV   S+        + YL 
Sbjct: 135 -----IHRDIKPENLLLGSAGELKIADFG----------WSVHAPSSRRTTLCGTLDYLP 179
Query: 587 PEYVTTGRFTERSDIFAFGVIILQILTGSLVLTSSMRLAAESATFENFIDRNLKGKFSES 646
           PE +      E+ D+++ GV+  + L G        +   E+ T++    R  + +F+  
Sbjct: 180 PEMIEGRMHDEKVDLWSLGVLCYEFLVG--------KPPFEANTYQETYKRISRVEFTFP 231
Query: 647 EAAKLGKMALVCT--HEDPENRPTMEAVIEELTVAA 680
           +    G   L+      +P  RP +  V+E   + A
Sbjct: 232 DFVTEGARDLISRLLKHNPSQRPMLREVLEHPWITA 267

>pdb|3U6J|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Pyrazolone Inhibitor Length = 314

Iteration: 1
 Score = 70.1 bits (170), Expect = 4e-12,   Method: Compositional matrix adjust.
 Identities = 67/281 (23%), Positives = 124/281 (44%), Gaps = 31/281 (11%)
Query: 417 LGKGNFSSVYK----GTLRDGTL--VAIRSINVTSCKSEEAEFVKGLYLLTSLRHE-NII 469
           LG+G F  V +    G  +  T   VA++ +   +  SE    +  L +L  + H  N++
Sbjct: 26  LGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVV 85
Query: 470 RLRGFCCSRGRGECFLIYDFAPKGKLSKYLDQ------------EEGSSNVLDWSTRVSI 517
            L G C   G G   +I +F   G LS YL              E+   + L     +  
Sbjct: 86  NLLGACTKPG-GPLMVITEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICY 144
Query: 518 IIGIAKGIGYLHSSEVNKPAIVHRNLSVEKVLIDQQFNPLIADCGLHKLLADDIVFSVLK 577
              +AKG+ +L S +      +HR+L+   +L+ ++    I D GL + +  D  + V K
Sbjct: 145 SFQVAKGMEFLASRKC-----IHRDLAARNILLSEKNVVKICDFGLARDIYKDPDY-VRK 198
Query: 578 TSA--AMGYLAPEYVTTGRFTERSDIFAFGVIILQILTGSLVLTSSMRLAAESATFENFI 635
             A   + ++APE +    +T +SD+++FGV++ +I +        +++  E   F   +
Sbjct: 199 GDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKIDEE---FCRRL 255
Query: 636 DRNLKGKFSESEAAKLGKMALVCTHEDPENRPTMEAVIEEL 676
               + +  +    ++ +  L C H +P  RPT   ++E L
Sbjct: 256 KEGTRMRAPDYTTPEMYQTMLDCWHGEPSQRPTFSELVEHL 296

>pdb|3EWH|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Pyridyl-Pyrimidine Benzimidazole Inhibitor Length = 314

Iteration: 1
 Score = 70.1 bits (170), Expect = 4e-12,   Method: Compositional matrix adjust.
 Identities = 67/281 (23%), Positives = 124/281 (44%), Gaps = 31/281 (11%)
Query: 417 LGKGNFSSVYK----GTLRDGTL--VAIRSINVTSCKSEEAEFVKGLYLLTSLRHE-NII 469
           LG+G F  V +    G  +  T   VA++ +   +  SE    +  L +L  + H  N++
Sbjct: 26  LGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVV 85
Query: 470 RLRGFCCSRGRGECFLIYDFAPKGKLSKYLDQ------------EEGSSNVLDWSTRVSI 517
            L G C   G G   +I +F   G LS YL              E+   + L     +  
Sbjct: 86  NLLGACTKPG-GPLMVITEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICY 144
Query: 518 IIGIAKGIGYLHSSEVNKPAIVHRNLSVEKVLIDQQFNPLIADCGLHKLLADDIVFSVLK 577
              +AKG+ +L S +      +HR+L+   +L+ ++    I D GL + +  D  + V K
Sbjct: 145 SFQVAKGMEFLASRKC-----IHRDLAARNILLSEKNVVKICDFGLARDIYKDPDY-VRK 198
Query: 578 TSA--AMGYLAPEYVTTGRFTERSDIFAFGVIILQILTGSLVLTSSMRLAAESATFENFI 635
             A   + ++APE +    +T +SD+++FGV++ +I +        +++  E   F   +
Sbjct: 199 GDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKIDEE---FCRRL 255
Query: 636 DRNLKGKFSESEAAKLGKMALVCTHEDPENRPTMEAVIEEL 676
               + +  +    ++ +  L C H +P  RPT   ++E L
Sbjct: 256 KEGTRMRAPDYTTPEMYQTMLDCWHGEPSQRPTFSELVEHL 296

>pdb|1YWN|A Chain A, Vegfr2 In Complex With A Novel 4-amino-furo[2,3-d]pyrimidine Length = 316

Iteration: 1
 Score = 69.7 bits (169), Expect = 5e-12,   Method: Compositional matrix adjust.
 Identities = 67/281 (23%), Positives = 123/281 (43%), Gaps = 31/281 (11%)
Query: 417 LGKGNFSSVYK----GTLRDGTL--VAIRSINVTSCKSEEAEFVKGLYLLTSLRHE-NII 469
           LG+G F  V +    G  +  T   VA++ +   +  SE    +  L +L  + H  N++
Sbjct: 35  LGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVV 94
Query: 470 RLRGFCCSRGRGECFLIYDFAPKGKLSKYLDQ------------EEGSSNVLDWSTRVSI 517
            L G C   G G   +I +F   G LS YL              E+   + L     +  
Sbjct: 95  NLLGACTKPG-GPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICY 153
Query: 518 IIGIAKGIGYLHSSEVNKPAIVHRNLSVEKVLIDQQFNPLIADCGLHKLLADDIVFSVLK 577
              +AKG+ +L S +      +HR+L+   +L+ ++    I D GL + +  D    V K
Sbjct: 154 SFQVAKGMEFLASRKC-----IHRDLAARNILLSEKNVVKICDFGLARDIXKDPD-XVRK 207
Query: 578 TSA--AMGYLAPEYVTTGRFTERSDIFAFGVIILQILTGSLVLTSSMRLAAESATFENFI 635
             A   + ++APE +    +T +SD+++FGV++ +I +        +++  E   F   +
Sbjct: 208 GDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKIDEE---FCRRL 264
Query: 636 DRNLKGKFSESEAAKLGKMALVCTHEDPENRPTMEAVIEEL 676
               + +  +    ++ +  L C H +P  RPT   ++E L
Sbjct: 265 KEGTRMRAPDYTTPEMYQTMLDCWHGEPSQRPTFSELVEHL 305

>pdb|3H9R|A Chain A, Crystal Structure Of The Kinase Domain Of Type I Activin Receptor (Acvr1) In Complex With Fkbp12 And Dorsomorphin Length = 330

Iteration: 1
 Score = 69.3 bits (168), Expect = 7e-12,   Method: Compositional matrix adjust.
 Identities = 76/295 (25%), Positives = 131/295 (44%), Gaps = 46/295 (15%)
Query: 417 LGKGNFSSVYKGTLRDGTLVAIRSINVTSCKSEEAEFVKG-LYLLTSLRHENIIRLRGFC 475
           +GKG +  V++G+ + G  VA++   + S + E++ F +  LY    LRHENI+   GF 
Sbjct: 45  VGKGRYGEVWRGSWQ-GENVAVK---IFSSRDEKSWFRETELYNTVMLRHENIL---GFI 97
Query: 476 CS-----RGRGECFLIYDFAPKGKLSKYLDQEEGSSNVLDWSTRVSIIIGIAKGIGYLHS 530
            S         + +LI  +   G L  YL         LD  + + I++ IA G+ +LH 
Sbjct: 98  ASDMTSRHSSTQLWLITHYHEMGSLYDYL-----QLTTLDTVSCLRIVLSIASGLAHLHI 152
Query: 531 S---EVNKPAIVHRNLSVEKVLIDQQFNPLIADCGL---HKLLADDIVFSVLKTSAAMGY 584
                  KPAI HR+L  + +L+ +     IAD GL   H    + +            Y
Sbjct: 153 EIFGTQGKPAIAHRDLKSKNILVKKNGQCCIADLGLAVMHSQSTNQLDVGNNPRVGTKRY 212
Query: 585 LAPEY------VTTGRFTERSDIFAFGVIILQI----LTGSLVLTSS---MRLAAESATF 631
           +APE       V      +R DI+AFG+++ ++    ++  +V         +     +F
Sbjct: 213 MAPEVLDETIQVDCFDSYKRVDIWAFGLVLWEVARRMVSNGIVEDYKPPFYDVVPNDPSF 272
Query: 632 ENF-----IDR---NLKGK-FSESEAAKLGKMALVCTHEDPENRPTMEAVIEELT 677
           E+      +D+   N+  + FS+     L K+   C +++P  R T   + + LT
Sbjct: 273 EDMRKVVCVDQQRPNIPNRWFSDPTLTSLAKLMKECWYQNPSARLTALRIKKTLT 327

>pdb|1VR2|A Chain A, Human Vascular Endothelial Growth Factor Receptor 2 (Kdr) Kinase Domain Length = 316

Iteration: 1
 Score = 69.3 bits (168), Expect = 7e-12,   Method: Compositional matrix adjust.
 Identities = 67/281 (23%), Positives = 123/281 (43%), Gaps = 31/281 (11%)
Query: 417 LGKGNFSSVYK----GTLRDGTL--VAIRSINVTSCKSEEAEFVKGLYLLTSLRHE-NII 469
           LG+G F  V +    G  +  T   VA++ +   +  SE    +  L +L  + H  N++
Sbjct: 35  LGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVV 94
Query: 470 RLRGFCCSRGRGECFLIYDFAPKGKLSKYLDQ------------EEGSSNVLDWSTRVSI 517
            L G C   G G   +I +F   G LS YL              E+   + L     +  
Sbjct: 95  NLLGACTKPG-GPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICY 153
Query: 518 IIGIAKGIGYLHSSEVNKPAIVHRNLSVEKVLIDQQFNPLIADCGLHKLLADDIVFSVLK 577
              +AKG+ +L S +      +HR+L+   +L+ ++    I D GL + +  D    V K
Sbjct: 154 SFQVAKGMEFLASRKC-----IHRDLAARNILLSEKNVVKICDFGLARDIYKDPD-XVRK 207
Query: 578 TSA--AMGYLAPEYVTTGRFTERSDIFAFGVIILQILTGSLVLTSSMRLAAESATFENFI 635
             A   + ++APE +    +T +SD+++FGV++ +I +        +++  E   F   +
Sbjct: 208 GDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKIDEE---FCRRL 264
Query: 636 DRNLKGKFSESEAAKLGKMALVCTHEDPENRPTMEAVIEEL 676
               + +  +    ++ +  L C H +P  RPT   ++E L
Sbjct: 265 KEGTRMRAPDYTTPEMYQTMLDCWHGEPSQRPTFSELVEHL 305

>pdb|2P2I|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Nicotinamide Inhibitor Length = 314

Iteration: 1
 Score = 68.9 bits (167), Expect = 8e-12,   Method: Compositional matrix adjust.
 Identities = 67/281 (23%), Positives = 123/281 (43%), Gaps = 31/281 (11%)
Query: 417 LGKGNFSSVYK----GTLRDGTL--VAIRSINVTSCKSEEAEFVKGLYLLTSLRHE-NII 469
           LG+G F  V +    G  +  T   VA++ +   +  SE    +  L +L  + H  N++
Sbjct: 26  LGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVV 85
Query: 470 RLRGFCCSRGRGECFLIYDFAPKGKLSKYLDQ------------EEGSSNVLDWSTRVSI 517
            L G C   G G   +I +F   G LS YL              E+   + L     +  
Sbjct: 86  NLLGACTKPG-GPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICY 144
Query: 518 IIGIAKGIGYLHSSEVNKPAIVHRNLSVEKVLIDQQFNPLIADCGLHKLLADDIVFSVLK 577
              +AKG+ +L S +      +HR+L+   +L+ ++    I D GL + +  D    V K
Sbjct: 145 SFQVAKGMEFLASRKC-----IHRDLAARNILLSEKNVVKICDFGLARDIXKDPD-XVRK 198
Query: 578 TSA--AMGYLAPEYVTTGRFTERSDIFAFGVIILQILTGSLVLTSSMRLAAESATFENFI 635
             A   + ++APE +    +T +SD+++FGV++ +I +        +++  E   F   +
Sbjct: 199 GDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKIDEE---FCRRL 255
Query: 636 DRNLKGKFSESEAAKLGKMALVCTHEDPENRPTMEAVIEEL 676
               + +  +    ++ +  L C H +P  RPT   ++E L
Sbjct: 256 KEGTRMRAPDYTTPEMYQTMLDCWHGEPSQRPTFSELVEHL 296

>pdb|3SRV|A Chain A, Crystal Structure Of Spleen Tyrosine Kinase (Syk) In Complex With A Diaminopyrimidine Carboxamide Inhibitor Length = 277

Iteration: 1
 Score = 68.9 bits (167), Expect = 9e-12,   Method: Compositional matrix adjust.
 Identities = 67/265 (25%), Positives = 120/265 (45%), Gaps = 28/265 (10%)
Query: 417 LGKGNFSSVYKGTLRDGTLVAIRSINVTSCKSEEA----EFVKGLYLLTSLRHENIIRLR 472
           LG GNF +V KG  +   +V   ++ +   ++ +     E +    ++  L +  I+R+ 
Sbjct: 19  LGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIVRMI 78
Query: 473 GFCCSRGRGECFLIYDFAPKGKLSKYLDQEEGSSNVLDWSTRVSIIIGIAKGIGYLHSSE 532
           G C +       L+ + A  G L+KYL Q   + +V D    + ++  ++ G+ YL  S 
Sbjct: 79  GICEAES---WMLVMEMAELGPLNKYLQQ---NRHVKD-KNIIELVHQVSMGMKYLEESN 131
Query: 533 VNKPAIVHRNLSVEKVLIDQQFNPLIADCGLHKLLADDIVFSVLKTSAA--MGYLAPEYV 590
                 VHR+L+   VL+  Q    I+D GL K L  D      +T     + + APE +
Sbjct: 132 -----FVHRDLAARNVLLVTQHYAKISDFGLSKALRADENXYKAQTHGKWPVKWYAPECI 186
Query: 591 TTGRFTERSDIFAFGVIILQILTGSLVLTSSMRLAAESATFENFIDRNLKGKFSESEAA- 649
              +F+ +SD+++FGV++ +  +        M+ +  +A  E       KG+     A  
Sbjct: 187 NYYKFSSKSDVWSFGVLMWEAFSYGQKPYRGMKGSEVTAMLE-------KGERMGCPAGC 239
Query: 650 --KLGKMALVCTHEDPENRPTMEAV 672
             ++  +  +C   D ENRP   AV
Sbjct: 240 PREMYDLMNLCWTYDVENRPGFAAV 264

>pdb|2P2H|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Pyridinyl-Triazine Inhibitor Length = 314

Iteration: 1
 Score = 68.9 bits (167), Expect = 9e-12,   Method: Compositional matrix adjust.
 Identities = 67/281 (23%), Positives = 123/281 (43%), Gaps = 31/281 (11%)
Query: 417 LGKGNFSSVYK----GTLRDGTL--VAIRSINVTSCKSEEAEFVKGLYLLTSLRHE-NII 469
           LG+G F  V +    G  +  T   VA++ +   +  SE    +  L +L  + H  N++
Sbjct: 26  LGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVV 85
Query: 470 RLRGFCCSRGRGECFLIYDFAPKGKLSKYLDQ------------EEGSSNVLDWSTRVSI 517
            L G C   G G   +I +F   G LS YL              E+   + L     +  
Sbjct: 86  NLLGACTKPG-GPLMVITEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICY 144
Query: 518 IIGIAKGIGYLHSSEVNKPAIVHRNLSVEKVLIDQQFNPLIADCGLHKLLADDIVFSVLK 577
              +AKG+ +L S +      +HR+L+   +L+ ++    I D GL + +  D    V K
Sbjct: 145 SFQVAKGMEFLASRKC-----IHRDLAARNILLSEKNVVKICDFGLARDIXKDPD-XVRK 198
Query: 578 TSA--AMGYLAPEYVTTGRFTERSDIFAFGVIILQILTGSLVLTSSMRLAAESATFENFI 635
             A   + ++APE +    +T +SD+++FGV++ +I +        +++  E   F   +
Sbjct: 199 GDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKIDEE---FCRRL 255
Query: 636 DRNLKGKFSESEAAKLGKMALVCTHEDPENRPTMEAVIEEL 676
               + +  +    ++ +  L C H +P  RPT   ++E L
Sbjct: 256 KEGTRMRAPDYTTPEMYQTMLDCWHGEPSQRPTFSELVEHL 296

>pdb|4DYM|A Chain A, Crystal Structure Of The Acvr1 Kinase Domain In Complex With The Imidazo[1,2-B]pyridazine Inhibitor K00135 Length = 301

Iteration: 1
 Score = 68.6 bits (166), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 76/295 (25%), Positives = 131/295 (44%), Gaps = 46/295 (15%)
Query: 417 LGKGNFSSVYKGTLRDGTLVAIRSINVTSCKSEEAEFVKG-LYLLTSLRHENIIRLRGFC 475
           +GKG +  V++G+ + G  VA++   + S + E++ F +  LY    LRHENI+   GF 
Sbjct: 16  VGKGRYGEVWRGSWQ-GENVAVK---IFSSRDEKSWFRETELYNTVMLRHENIL---GFI 68
Query: 476 CS-----RGRGECFLIYDFAPKGKLSKYLDQEEGSSNVLDWSTRVSIIIGIAKGIGYLHS 530
            S         + +LI  +   G L  YL         LD  + + I++ IA G+ +LH 
Sbjct: 69  ASDMTSRHSSTQLWLITHYHEMGSLYDYL-----QLTTLDTVSCLRIVLSIASGLAHLHI 123
Query: 531 S---EVNKPAIVHRNLSVEKVLIDQQFNPLIADCGL---HKLLADDIVFSVLKTSAAMGY 584
                  KPAI HR+L  + +L+ +     IAD GL   H    + +            Y
Sbjct: 124 EIFGTQGKPAIAHRDLKSKNILVKKNGQCCIADLGLAVMHSQSTNQLDVGNNPRVGTKRY 183
Query: 585 LAPEY------VTTGRFTERSDIFAFGVIILQI----LTGSLVLTSS---MRLAAESATF 631
           +APE       V      +R DI+AFG+++ ++    ++  +V         +     +F
Sbjct: 184 MAPEVLDETIQVDCFDSYKRVDIWAFGLVLWEVARRMVSNGIVEDYKPPFYDVVPNDPSF 243
Query: 632 ENF-----IDR---NLKGK-FSESEAAKLGKMALVCTHEDPENRPTMEAVIEELT 677
           E+      +D+   N+  + FS+     L K+   C +++P  R T   + + LT
Sbjct: 244 EDMRKVVCVDQQRPNIPNRWFSDPTLTSLAKLMKECWYQNPSARLTALRIKKTLT 298

>pdb|3MDY|A Chain A, Crystal Structure Of The Cytoplasmic Domain Of The Bone Morp Protein Receptor Type-1b (Bmpr1b) In Complex With Fkbp12 An 193189 Length = 337

Iteration: 1
 Score = 68.6 bits (166), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 73/290 (25%), Positives = 128/290 (44%), Gaps = 48/290 (16%)
Query: 414 VNLLGKGNFSSVYKGTLRDGTLVAIRSINVTSCKSEEAEFVKG--LYLLTSLRHENIIRL 471
           V  +GKG +  V+ G  R G  VA++    T    EEA + +   +Y    +RHENI+  
Sbjct: 42  VKQIGKGRYGEVWMGKWR-GEKVAVKVFFTT----EEASWFRETEIYQTVLMRHENIL-- 94
Query: 472 RGFCCSRGRG-----ECFLIYDFAPKGKLSKYLDQEEGSSNVLDWSTRVSIIIGIAKGIG 526
            GF  +  +G     + +LI D+   G L  YL      S  LD  + + +      G+ 
Sbjct: 95  -GFIAADIKGTGSWTQLYLITDYHENGSLYDYL-----KSTTLDAKSMLKLAYSSVSGLC 148
Query: 527 YLHS---SEVNKPAIVHRNLSVEKVLIDQQFNPLIADCGLHKLLADDIVFSVLKTSAAMG 583
           +LH+   S   KPAI HR+L  + +L+ +     IAD GL      D     +  +  +G
Sbjct: 149 HLHTEIFSTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAVKFISDTNEVDIPPNTRVG 208
Query: 584 ---YLAPEY----VTTGRFTER--SDIFAFGVIILQI----LTGSLVLTSSM---RLAAE 627
              Y+ PE     +    F     +D+++FG+I+ ++    ++G +V    +    L   
Sbjct: 209 TKRYMPPEVLDESLNRNHFQSYIMADMYSFGLILWEVARRCVSGGIVEEYQLPYHDLVPS 268
Query: 628 SATFENFID----RNLKGKF-----SESEAAKLGKMALVCTHEDPENRPT 668
             ++E+  +    + L+  F     S+    ++GK+   C   +P +R T
Sbjct: 269 DPSYEDMREIVCIKKLRPSFPNRWSSDECLRQMGKLMTECWAHNPASRLT 318

>pdb|2VRX|A Chain A, Structure Of Aurora B Kinase In Complex With Zm447439 Length = 285

Iteration: 1
 Score = 68.6 bits (166), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 66/267 (24%), Positives = 120/267 (44%), Gaps = 23/267 (8%)
Query: 417 LGKGNFSSVYKGTLRDGTLV-AIRSINVTSCKSE--EAEFVKGLYLLTSLRHENIIRLRG 473
           LGKG F +VY    +    + A++ +  +  + E  E +  + + + + LRH NI+R+  
Sbjct: 23  LGKGKFGNVYLAREKQNKFIMALKVLFKSQLEKEGVEHQLRREIEIQSHLRHPNILRMYN 82
Query: 474 FCCSRGRGECFLIYDFAPKGKLSKYLDQEEGSSNVLDWSTRVSIIIGIAKGIGYLHSSEV 533
           +   R R   +L+ +FAP+G+L K L Q+ G     D     + +  +A  + Y H  +V
Sbjct: 83  YFHDRKR--IYLMLEFAPRGELYKEL-QKHGR---FDEQRSATFMEELADALHYCHERKV 136
Query: 534 NKPAIVHRNLSVEKVLIDQQFNPLIADCGLHKLLADDIVFSVLKTSAAMGYLAPEYVTTG 593
                +HR++  E +L+  +    IAD G   + A  +    +     + YL PE +   
Sbjct: 137 -----IHRDIKPENLLMGYKGELKIADFGW-SVHAPSLRRRXM--CGTLDYLPPEMIEGK 188
Query: 594 RFTERSDIFAFGVIILQILTGSLVLTSSMRLAAESATFENFIDRNLKGKFSESEAAKLGK 653
              E+ D++  GV+  + L G     S     + + T    ++ +LK     S+ +K   
Sbjct: 189 THDEKVDLWCAGVLCYEFLVGMPPFDS----PSHTETHRRIVNVDLKFPPFLSDGSKDLI 244
Query: 654 MALVCTHEDPENRPTMEAVIEELTVAA 680
             L+  H  P  R  ++ V+E   V A
Sbjct: 245 SKLLRYH--PPQRLPLKGVMEHPWVKA 269

>pdb|3MTF|A Chain A, Crystal Structure Of The Acvr1 Kinase In Complex With A 2- Aminopyridine Inhibitor Length = 301

Iteration: 1
 Score = 68.6 bits (166), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 76/295 (25%), Positives = 131/295 (44%), Gaps = 46/295 (15%)
Query: 417 LGKGNFSSVYKGTLRDGTLVAIRSINVTSCKSEEAEFVKG-LYLLTSLRHENIIRLRGFC 475
           +GKG +  V++G+ + G  VA++   + S + E++ F +  LY    LRHENI+   GF 
Sbjct: 16  VGKGRYGEVWRGSWQ-GENVAVK---IFSSRDEKSWFRETELYNTVMLRHENIL---GFI 68
Query: 476 CS-----RGRGECFLIYDFAPKGKLSKYLDQEEGSSNVLDWSTRVSIIIGIAKGIGYLHS 530
            S         + +LI  +   G L  YL         LD  + + I++ IA G+ +LH 
Sbjct: 69  ASDMTSRHSSTQLWLITHYHEMGSLYDYL-----QLTTLDTVSCLRIVLSIASGLAHLHI 123
Query: 531 S---EVNKPAIVHRNLSVEKVLIDQQFNPLIADCGL---HKLLADDIVFSVLKTSAAMGY 584
                  KPAI HR+L  + +L+ +     IAD GL   H    + +            Y
Sbjct: 124 EIFGTQGKPAIAHRDLKSKNILVKKNGQCCIADLGLAVMHSQSTNQLDVGNNPRVGTKRY 183
Query: 585 LAPEY------VTTGRFTERSDIFAFGVIILQI----LTGSLVLTSS---MRLAAESATF 631
           +APE       V      +R DI+AFG+++ ++    ++  +V         +     +F
Sbjct: 184 MAPEVLDETIQVDCFDSYKRVDIWAFGLVLWEVARRMVSNGIVEDYKPPFYDVVPNDPSF 243
Query: 632 ENF-----IDR---NLKGK-FSESEAAKLGKMALVCTHEDPENRPTMEAVIEELT 677
           E+      +D+   N+  + FS+     L K+   C +++P  R T   + + LT
Sbjct: 244 EDMRKVVCVDQQRPNIPNRWFSDPTLTSLAKLMKECWYQNPSARLTALRIKKTLT 298

>pdb|4HZS|A Chain A, Crystal Structure Of Ack1 Kinase Domain With C-terminal Sh3 Domain Length = 341

Iteration: 1
 Score = 68.2 bits (165), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 67/274 (24%), Positives = 114/274 (41%), Gaps = 24/274 (8%)
Query: 417 LGKGNFSSVYKGTLR----DGTLVAIRSINVTSCKSEEA--EFVKGLYLLTSLRHENIIR 470
           LG G+F  V +G           VA++ +        EA  +F++ +  + SL H N+IR
Sbjct: 20  LGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLDHRNLIR 79
Query: 471 LRGFCCSRGRGECFLIYDFAPKGKLSKYLDQEEGSSNVLDWSTRVSIIIGIAKGIGYLHS 530
           L G   +       ++ + AP G L   L + +G   +    T     + +A+G+GYL S
Sbjct: 80  LYGVVLT---PPMKMVTELAPLGSLLDRLRKHQGHFLL---GTLSRYAVQVAEGMGYLES 133
Query: 531 SEVNKPAIVHRNLSVEKVLIDQQFNPLIADCGLHKLLA--DDIVFSVLKTSAAMGYLAPE 588
                   +HR+L+   +L+  +    I D GL + L   DD             + APE
Sbjct: 134 KR-----FIHRDLAARNLLLATRDLVKIGDFGLMRALPQNDDHYVMQEHRKVPFAWCAPE 188
Query: 589 YVTTGRFTERSDIFAFGVIILQILTGSLVLTSSMRLAAESATFENFIDRN-LKGKFSESE 647
            + T  F+  SD + FGV + ++ T          +    +   + ID+   +    E  
Sbjct: 189 SLKTRTFSHASDTWMFGVTLWEMFT----YGQEPWIGLNGSQILHKIDKEGERLPRPEDC 244
Query: 648 AAKLGKMALVCTHEDPENRPTMEAVIEELTVAAP 681
              +  + + C    PE+RPT  A+ + L  A P
Sbjct: 245 PQDIYNVMVQCWAHKPEDRPTFVALRDFLLEAQP 278

>pdb|4AF3|A Chain A, Human Aurora B Kinase In Complex With Incenp And Vx-680 Length = 292

Iteration: 1
 Score = 68.2 bits (165), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 58/227 (25%), Positives = 106/227 (46%), Gaps = 21/227 (9%)
Query: 417 LGKGNFSSVYKGTLRDGT-LVAIRSINVTSCKSE--EAEFVKGLYLLTSLRHENIIRLRG 473
           LGKG F +VY    +    +VA++ +  +  + E  E +  + + +   L H NI+RL  
Sbjct: 31  LGKGKFGNVYLAREKKSHFIVALKVLFKSQIEKEGVEHQLRREIEIQAHLHHPNILRLYN 90
Query: 474 FCCSRGRGECFLIYDFAPKGKLSKYLDQEEGSSNVLDWSTRVSIIIGIAKGIGYLHSSEV 533
           +   R R   +LI ++AP+G+L K L +    S   D     +I+  +A  + Y H  +V
Sbjct: 91  YFYDRRR--IYLILEYAPRGELYKELQK----SCTFDEQRTATIMEELADALMYCHGKKV 144
Query: 534 NKPAIVHRNLSVEKVLIDQQFNPLIADCGLHKLLADDIVFSVLKTSAAMGYLAPEYVTTG 593
                +HR++  E +L+  +    IAD G   + A  +    +     + YL PE +   
Sbjct: 145 -----IHRDIKPENLLLGLKGELKIADFGW-SVHAPSLRRKTM--CGTLDYLPPEMIEGR 196
Query: 594 RFTERSDIFAFGVIILQILTGSLVLTSSMRLAAESATFENFIDRNLK 640
              E+ D++  GV+  ++L G+    S    A+ + T+   +  +LK
Sbjct: 197 MHNEKVDLWCIGVLCYELLVGNPPFES----ASHNETYRRIVKVDLK 239

>pdb|4ASZ|A Chain A, Crystal Structure Of Apo Trkb Kinase Domain Length = 299

Iteration: 1
 Score = 68.2 bits (165), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 54/213 (25%), Positives = 97/213 (45%), Gaps = 24/213 (11%)
Query: 417 LGKGNFSSVYKGTL------RDGTLVAIRSINVTSCKSEEAEFVKGLYLLTSLRHENIIR 470
           LG+G F  V+          +D  LVA++++   S  +   +F +   LLT+L+HE+I++
Sbjct: 21  LGEGAFGKVFLAECYNLCPEQDKILVAVKTLKDAS-DNARKDFHREAELLTNLQHEHIVK 79
Query: 471 LRGFCCSRGRGECFLIYDFAPKGKLSKYLDQ---------EEGSSNVLDWSTRVSIIIGI 521
             G C         +++++   G L+K+L           E      L  S  + I   I
Sbjct: 80  FYGVCVEGD--PLIMVFEYMKHGDLNKFLRAHGPDAVLMAEGNPPTELTQSQMLHIAQQI 137
Query: 522 AKGIGYLHSSEVNKPAIVHRNLSVEKVLIDQQFNPLIADCGLHKLLADDIVFSVL-KTSA 580
           A G+ YL S        VHR+L+    L+ +     I D G+ + +     + V   T  
Sbjct: 138 AAGMVYLASQH-----FVHRDLATRNCLVGENLLVKIGDFGMSRDVYSTDYYRVGGHTML 192
Query: 581 AMGYLAPEYVTTGRFTERSDIFAFGVIILQILT 613
            + ++ PE +   +FT  SD+++ GV++ +I T
Sbjct: 193 PIRWMPPESIMYRKFTTESDVWSLGVVLWEIFT 225

>pdb|3EQP|B Chain B, Crystal Structure Of Ack1 With Compound T95 Length = 276

Iteration: 1
 Score = 68.2 bits (165), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 67/274 (24%), Positives = 114/274 (41%), Gaps = 24/274 (8%)
Query: 417 LGKGNFSSVYKGTLR----DGTLVAIRSINVTSCKSEEA--EFVKGLYLLTSLRHENIIR 470
           LG G+F  V +G           VA++ +        EA  +F++ +  + SL H N+IR
Sbjct: 16  LGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLDHRNLIR 75
Query: 471 LRGFCCSRGRGECFLIYDFAPKGKLSKYLDQEEGSSNVLDWSTRVSIIIGIAKGIGYLHS 530
           L G   +       ++ + AP G L   L + +G   +    T     + +A+G+GYL S
Sbjct: 76  LYGVVLT---PPMKMVTELAPLGSLLDRLRKHQGHFLL---GTLSRYAVQVAEGMGYLES 129
Query: 531 SEVNKPAIVHRNLSVEKVLIDQQFNPLIADCGLHKLLA--DDIVFSVLKTSAAMGYLAPE 588
                   +HR+L+   +L+  +    I D GL + L   DD             + APE
Sbjct: 130 KR-----FIHRDLAARNLLLATRDLVKIGDFGLMRALPQNDDHYVMQEHRKVPFAWCAPE 184
Query: 589 YVTTGRFTERSDIFAFGVIILQILTGSLVLTSSMRLAAESATFENFIDRN-LKGKFSESE 647
            + T  F+  SD + FGV + ++ T          +    +   + ID+   +    E  
Sbjct: 185 SLKTRTFSHASDTWMFGVTLWEMFT----YGQEPWIGLNGSQILHKIDKEGERLPRPEDC 240
Query: 648 AAKLGKMALVCTHEDPENRPTMEAVIEELTVAAP 681
              +  + + C    PE+RPT  A+ + L  A P
Sbjct: 241 PQDIYNVMVQCWAHKPEDRPTFVALRDFLLEAQP 274

>pdb|1U54|A Chain A, Crystal Structures Of The Phosphorylated And Unphosphorylated Kinase Domains Of The Cdc42-Associated Tyrosine Kinase Ack1 Bound To Amp-Pcp Length = 291

Iteration: 1
 Score = 67.8 bits (164), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 67/274 (24%), Positives = 114/274 (41%), Gaps = 24/274 (8%)
Query: 417 LGKGNFSSVYKGTLR----DGTLVAIRSINVTSCKSEEA--EFVKGLYLLTSLRHENIIR 470
           LG G+F  V +G           VA++ +        EA  +F++ +  + SL H N+IR
Sbjct: 26  LGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLDHRNLIR 85
Query: 471 LRGFCCSRGRGECFLIYDFAPKGKLSKYLDQEEGSSNVLDWSTRVSIIIGIAKGIGYLHS 530
           L G   +       ++ + AP G L   L + +G   +    T     + +A+G+GYL S
Sbjct: 86  LYGVVLT---PPMKMVTELAPLGSLLDRLRKHQGHFLL---GTLSRYAVQVAEGMGYLES 139
Query: 531 SEVNKPAIVHRNLSVEKVLIDQQFNPLIADCGLHKLLA--DDIVFSVLKTSAAMGYLAPE 588
                   +HR+L+   +L+  +    I D GL + L   DD             + APE
Sbjct: 140 KR-----FIHRDLAARNLLLATRDLVKIGDFGLMRALPQNDDHXVMQEHRKVPFAWCAPE 194
Query: 589 YVTTGRFTERSDIFAFGVIILQILTGSLVLTSSMRLAAESATFENFIDRN-LKGKFSESE 647
            + T  F+  SD + FGV + ++ T          +    +   + ID+   +    E  
Sbjct: 195 SLKTRTFSHASDTWMFGVTLWEMFT----YGQEPWIGLNGSQILHKIDKEGERLPRPEDC 250
Query: 648 AAKLGKMALVCTHEDPENRPTMEAVIEELTVAAP 681
              +  + + C    PE+RPT  A+ + L  A P
Sbjct: 251 PQDIYNVMVQCWAHKPEDRPTFVALRDFLLEAQP 284

>pdb|1U46|A Chain A, Crystal Structure Of The Unphosphorylated Kinase Domain Of The Tyrosine Kinase Ack1 Length = 291

Iteration: 1
 Score = 67.8 bits (164), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 67/274 (24%), Positives = 114/274 (41%), Gaps = 24/274 (8%)
Query: 417 LGKGNFSSVYKGTLR----DGTLVAIRSINVTSCKSEEA--EFVKGLYLLTSLRHENIIR 470
           LG G+F  V +G           VA++ +        EA  +F++ +  + SL H N+IR
Sbjct: 26  LGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLDHRNLIR 85
Query: 471 LRGFCCSRGRGECFLIYDFAPKGKLSKYLDQEEGSSNVLDWSTRVSIIIGIAKGIGYLHS 530
           L G   +       ++ + AP G L   L + +G   +    T     + +A+G+GYL S
Sbjct: 86  LYGVVLT---PPMKMVTELAPLGSLLDRLRKHQGHFLL---GTLSRYAVQVAEGMGYLES 139
Query: 531 SEVNKPAIVHRNLSVEKVLIDQQFNPLIADCGLHKLLA--DDIVFSVLKTSAAMGYLAPE 588
                   +HR+L+   +L+  +    I D GL + L   DD             + APE
Sbjct: 140 KR-----FIHRDLAARNLLLATRDLVKIGDFGLMRALPQNDDHYVMQEHRKVPFAWCAPE 194
Query: 589 YVTTGRFTERSDIFAFGVIILQILTGSLVLTSSMRLAAESATFENFIDRN-LKGKFSESE 647
            + T  F+  SD + FGV + ++ T          +    +   + ID+   +    E  
Sbjct: 195 SLKTRTFSHASDTWMFGVTLWEMFT----YGQEPWIGLNGSQILHKIDKEGERLPRPEDC 250
Query: 648 AAKLGKMALVCTHEDPENRPTMEAVIEELTVAAP 681
              +  + + C    PE+RPT  A+ + L  A P
Sbjct: 251 PQDIYNVMVQCWAHKPEDRPTFVALRDFLLEAQP 284

>pdb|4EWH|B Chain B, Co-Crystal Structure Of Ack1 With Inhibitor Length = 275

Iteration: 1
 Score = 67.8 bits (164), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 67/274 (24%), Positives = 114/274 (41%), Gaps = 24/274 (8%)
Query: 417 LGKGNFSSVYKGTLR----DGTLVAIRSINVTSCKSEEA--EFVKGLYLLTSLRHENIIR 470
           LG G+F  V +G           VA++ +        EA  +F++ +  + SL H N+IR
Sbjct: 16  LGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLDHRNLIR 75
Query: 471 LRGFCCSRGRGECFLIYDFAPKGKLSKYLDQEEGSSNVLDWSTRVSIIIGIAKGIGYLHS 530
           L G   +       ++ + AP G L   L + +G   +    T     + +A+G+GYL S
Sbjct: 76  LYGVVLT---PPMKMVTELAPLGSLLDRLRKHQGHFLL---GTLSRYAVQVAEGMGYLES 129
Query: 531 SEVNKPAIVHRNLSVEKVLIDQQFNPLIADCGLHKLLA--DDIVFSVLKTSAAMGYLAPE 588
                   +HR+L+   +L+  +    I D GL + L   DD             + APE
Sbjct: 130 KR-----FIHRDLAARNLLLATRDLVKIGDFGLMRALPQNDDHXVMQEHRKVPFAWCAPE 184
Query: 589 YVTTGRFTERSDIFAFGVIILQILTGSLVLTSSMRLAAESATFENFIDRN-LKGKFSESE 647
            + T  F+  SD + FGV + ++ T          +    +   + ID+   +    E  
Sbjct: 185 SLKTRTFSHASDTWMFGVTLWEMFT----YGQEPWIGLNGSQILHKIDKEGERLPRPEDC 240
Query: 648 AAKLGKMALVCTHEDPENRPTMEAVIEELTVAAP 681
              +  + + C    PE+RPT  A+ + L  A P
Sbjct: 241 PQDIYNVMVQCWAHKPEDRPTFVALRDFLLEAQP 274

>pdb|2BMC|A Chain A, Aurora-2 T287d T288d Complexed With Pha-680632 Length = 306

Iteration: 1
 Score = 67.8 bits (164), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 64/273 (23%), Positives = 117/273 (42%), Gaps = 35/273 (12%)
Query: 417 LGKGNFSSVYKGTLRDGTLV-AIRSINVTSCKSE--EAEFVKGLYLLTSLRHENIIRLRG 473
           LGKG F +VY    +    + A++ +     +    E +  + + + + LRH NI+RL G
Sbjct: 42  LGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRLYG 101
Query: 474 FCCSRGRGECFLIYDFAPKGKLSKYLDQEEGSSNVLDWSTRVSIIIGIAKGIGYLHSSEV 533
           +     R   +LI ++AP G + + L +     +  D     + I  +A  + Y HS  V
Sbjct: 102 YFHDATR--VYLILEYAPLGTVYRELQK----LSKFDEQRTATYITELANALSYCHSKRV 155
Query: 534 NKPAIVHRNLSVEKVLIDQQFNPLIADCG--LHKLLA--DDIVFSVLKTSAAMGYLAPEY 589
                +HR++  E +L+       IAD G  +H   +  DD+          + YL PE 
Sbjct: 156 -----IHRDIKPENLLLGSAGELKIADFGWSVHAPSSRRDDLC-------GTLDYLPPEM 203
Query: 590 VTTGRFTERSDIFAFGVIILQILTGSLVLTSSMRLAAESATFENFIDRNLKGKFSESEAA 649
           +      E+ D+++ GV+  + L G        +   E+ T++    R  + +F+  +  
Sbjct: 204 IEGRMHDEKVDLWSLGVLCYEFLVG--------KPPFEANTYQETYKRISRVEFTFPDFV 255
Query: 650 KLGKMALVCT--HEDPENRPTMEAVIEELTVAA 680
             G   L+      +P  RP +  V+E   + A
Sbjct: 256 TEGARDLISRLLKHNPSQRPMLREVLEHPWITA 288

>pdb|3KMW|A Chain A, Crystal Structure Of The IlkALPHA-Parvin Core Complex (Mgatp) Length = 271

Iteration: 1
 Score = 67.8 bits (164), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 64/276 (23%), Positives = 123/276 (44%), Gaps = 35/276 (12%)
Query: 411 FSEVNLLGKGNFS---SVYKGTLRDGTLVAIRSINVTSCKSEEA-EFVKGLYLLTSLRHE 466
           F ++N L K N +    ++KG  + G  + ++ + V    + ++ +F +    L    H 
Sbjct: 9   FKQLNFLTKLNENHSGELWKGRWQ-GNDIVVKVLKVRDWSTRKSRDFNEECPRLRIFSHP 67
Query: 467 NIIRLRGFCCSRGRGECFLIYDFAPKGKLSKYLDQEEGSSNVLDWSTRVSIIIGIAKGIG 526
           N++ + G C S       LI  + P G L   L   EG++ V+D S  V   + +A+G+ 
Sbjct: 68  NVLPVLGACQSPPAPHPTLITHWMPYGSLYNVL--HEGTNFVVDQSQAVKFALDMARGMA 125
Query: 527 YLHSSEVNKPAIVHRNLSVEKVLIDQQFNPLIADCGLHKLLADDIVFSVLKTSA--AMGY 584
           +LH+ E   P I    L+   V+ID+     I+          D+ FS        A  +
Sbjct: 126 FLHTLE---PLIPRHALNSRSVMIDEDMTARISMA--------DVKFSFQSPGRMYAPAW 174
Query: 585 LAPEYVT-----TGRFTERSDIFAFGVIILQILTGSLVLT--SSMRLAAESATFENFIDR 637
           +APE +      T R +  +D+++F V++ +++T  +     S+M +  + A        
Sbjct: 175 VAPEALQKKPEDTNRRS--ADMWSFAVLLWELVTREVPFADLSNMEIGMKVAL------E 226
Query: 638 NLKGKFSESEAAKLGKMALVCTHEDPENRPTMEAVI 673
            L+       +  + K+  +C +EDP  RP  + ++
Sbjct: 227 GLRPTIPPGISPHVSKLMKICMNEDPAKRPKFDMIV 262

>pdb|3COH|A Chain A, Crystal Structure Of Aurora-A In Complex With A Pentacyclic Inhibitor Length = 268

Iteration: 1
 Score = 67.8 bits (164), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 64/276 (23%), Positives = 119/276 (43%), Gaps = 41/276 (14%)
Query: 417 LGKGNFSSVYKGTLRDGTLV-AIRSINVTSCKSE--EAEFVKGLYLLTSLRHENIIRLRG 473
           LGKG F +VY    ++   + A++ +     +    E +  + + + + LRH NI+RL G
Sbjct: 16  LGKGKFGNVYLAREKNSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRLYG 75
Query: 474 FCCSRGRGECFLIYDFAPKGKLSKYLDQEEGSSNVLDWSTRVSIIIGIAKGIGYLHSSEV 533
           +     R   +LI ++AP G + + L +     +  D     + I  +A  + Y HS +V
Sbjct: 76  YFHDSTR--VYLILEYAPLGTVYRELQK----LSKFDEQRTATYITELANALSYCHSKKV 129
Query: 534 NKPAIVHRNLSVEKVLIDQQFNPLIADCGLHKLLADDIVFSVLKTSA-------AMGYLA 586
                +HR++  E +L+       IAD G          +SV   S+        + YL 
Sbjct: 130 -----IHRDIKPENLLLGSAGELKIADFG----------WSVHAPSSRRAALCGTLDYLP 174
Query: 587 PEYVTTGRFTERSDIFAFGVIILQILTGSLVLTSSMRLAAESATFENFIDRNLKGKFSES 646
           PE +      E+ D+++ GV+  + L G        +   E+ T+++   R  + +F+  
Sbjct: 175 PEMIEGRMHDEKVDLWSLGVLCYEFLVG--------KPPFEANTYQDTYKRISRVEFTFP 226
Query: 647 EAAKLGKMALVCT--HEDPENRPTMEAVIEELTVAA 680
           +    G   L+      +P  RP +  V+E   + A
Sbjct: 227 DFVTEGARDLISRLLKHNPSQRPMLREVLEHPWITA 262

>pdb|1K9A|A Chain A, Crystal Structure Analysis Of Full-Length Carboxyl-Terminal Src Kinase At 2.5 A Resolution Length = 450

Iteration: 1
 Score = 67.8 bits (164), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 66/264 (25%), Positives = 118/264 (44%), Gaps = 28/264 (10%)
Query: 417 LGKGNFSSVYKGTLRDGTLVAIRSINVTSCKSEEAEFVKGLYLLTSLRHENIIRLRGFCC 476
           +GKG F  V  G  R G  VA++ I   +       F+    ++T LRH N+++L G   
Sbjct: 201 IGKGEFGDVMLGDYR-GNKVAVKCIKNDATAQA---FLAEASVMTQLRHSNLVQLLGVIV 256
Query: 477 SRGRGECFLIYDFAPKGKLSKYLDQEEGSSNVLDWSTRVSIIIGIAKGIGYLHSSEVNKP 536
              +G  +++ ++  KG L  YL +  G S VL     +   + + + + YL  +     
Sbjct: 257 EE-KGGLYIVTEYMAKGSLVDYL-RSRGRS-VLGGDCLLKFSLDVCEAMEYLEGNN---- 309
Query: 537 AIVHRNLSVEKVLIDQQFNPLIADCGLHKLLADDIVFSVLKTSA-AMGYLAPEYVTTGRF 595
             VHR+L+   VL+ +     ++D GL K  +     S   T    + + APE +   +F
Sbjct: 310 -FVHRDLAARNVLVSEDNVAKVSDFGLTKEAS-----STQDTGKLPVKWTAPEALREKKF 363
Query: 596 TERSDIFAFGVIILQILTGSLVLTSSMRLAAESATFENFIDRNLKG-KFSESEAAKLGKM 654
           + +SD+++FG+++ +I        S  R+       ++ + R  KG K    +       
Sbjct: 364 STKSDVWSFGILLWEIY-------SFGRVPYPRIPLKDVVPRVEKGYKMDAPDGCPPAVY 416
Query: 655 ALV--CTHEDPENRPTMEAVIEEL 676
            ++  C H D   RPT   + E+L
Sbjct: 417 DVMKNCWHLDAATRPTFLQLREQL 440

>pdb|2JKM|A Chain A, Focal Adhesion Kinase Catalytic Domain In Complex With Bis- Anilino Pyrimidine Inhibitor Length = 276

Iteration: 1
 Score = 67.4 bits (163), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 47/200 (23%), Positives = 89/200 (44%), Gaps = 15/200 (7%)
Query: 417 LGKGNFSSVYKGTLRD----GTLVAIRSINVTSCKSEEAEFVKGLYLLTSLRHENIIRLR 472
           +G+G F  V++G           VAI++    +  S   +F++    +    H +I++L 
Sbjct: 18  IGEGQFGDVHQGIYMSPENPAMAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVKLI 77
Query: 473 GFCCSRGRGECFLIYDFAPKGKLSKYLDQEEGSSNVLDWSTRVSIIIGIAKGIGYLHSSE 532
           G          ++I +    G+L  +L   + S   LD ++ +     ++  + YL S  
Sbjct: 78  GVITE---NPVWIIMELCTLGELRSFLQVRKYS---LDLASLILYAYQLSTALAYLESKR 131
Query: 533 VNKPAIVHRNLSVEKVLIDQQFNPLIADCGLHKLLADDIVFSVLKTSAAMGYLAPEYVTT 592
                 VHR+++   VL+       + D GL + + D   +   K    + ++APE +  
Sbjct: 132 -----FVHRDIAARNVLVSSNDCVKLGDFGLSRYMEDSTYYKASKGKLPIKWMAPESINF 186
Query: 593 GRFTERSDIFAFGVIILQIL 612
            RFT  SD++ FGV + +IL
Sbjct: 187 RRFTSASDVWMFGVCMWEIL 206

>pdb|2J4Z|A Chain A, Structure Of Aurora-2 In Complex With Pha-680626 Length = 306

Iteration: 1
 Score = 67.4 bits (163), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 64/276 (23%), Positives = 116/276 (42%), Gaps = 41/276 (14%)
Query: 417 LGKGNFSSVYKGTLRDGTLV-AIRSINVTSCKSE--EAEFVKGLYLLTSLRHENIIRLRG 473
           LGKG F +VY    +    + A++ +     +    E +  + + + + LRH NI+RL G
Sbjct: 42  LGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRLYG 101
Query: 474 FCCSRGRGECFLIYDFAPKGKLSKYLDQEEGSSNVLDWSTRVSIIIGIAKGIGYLHSSEV 533
           +     R   +LI ++AP G + + L +     +  D     + I  +A  + Y HS  V
Sbjct: 102 YFHDATR--VYLILEYAPLGTVYRELQK----LSKFDEQRTATYITELANALSYCHSKRV 155
Query: 534 NKPAIVHRNLSVEKVLIDQQFNPLIADCGLHKLLADDIVFSVLKTSA-------AMGYLA 586
                +HR++  E +L+       IAD G          +SV   S+        + YL 
Sbjct: 156 -----IHRDIKPENLLLGSAGELKIADFG----------WSVHAPSSRRTTLCGTLDYLP 200
Query: 587 PEYVTTGRFTERSDIFAFGVIILQILTGSLVLTSSMRLAAESATFENFIDRNLKGKFSES 646
           PE +      E+ D+++ GV+  + L G        +   E+ T++    R  + +F+  
Sbjct: 201 PEMIEGRMHDEKVDLWSLGVLCYEFLVG--------KPPFEANTYQETYKRISRVEFTFP 252
Query: 647 EAAKLGKMALVCT--HEDPENRPTMEAVIEELTVAA 680
           +    G   L+      +P  RP +  V+E   + A
Sbjct: 253 DFVTEGARDLISRLLKHNPSQRPMLREVLEHPWITA 288

>pdb|4AAA|A Chain A, Crystal Structure Of The Human Cdkl2 Kinase Domain Length = 331

Iteration: 1
 Score = 67.4 bits (163), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 60/223 (26%), Positives = 102/223 (45%), Gaps = 35/223 (15%)
Query: 406 SATQCFSEVNLLGKGNFSSVYKGTLRD-GTLVAIRSINVTSCKSEEAEFVKGL-----YL 459
            + + +  + L+G+G++  V K   +D G +VAI+       +S++ + VK +      L
Sbjct: 22  QSMEKYENLGLVGEGSYGMVMKCRNKDTGRIVAIKKF----LESDDDKMVKKIAMREIKL 77
Query: 460 LTSLRHENIIRLRGFCCSRGRGECFLIYDFAPKGKLSKYLDQEEGSSNVLDWSTRVSIII 519
           L  LRHEN++ L   C  + R   +L+++F         LD  E   N LD+      + 
Sbjct: 78  LKQLRHENLVNLLEVCKKKKR--WYLVFEFVD----HTILDDLELFPNGLDYQVVQKYLF 131
Query: 520 GIAKGIGYLHSSEVNKPAIVHRNLSVEKVLIDQQFNPLIADCGLHKLLA------DDIVF 573
            I  GIG+ HS       I+HR++  E +L+ Q     + D G  + LA      DD V 
Sbjct: 132 QIINGIGFCHSHN-----IIHRDIKPENILVSQSGVVKLCDFGFARTLAAPGEVYDDEV- 185
Query: 574 SVLKTSAAMGYLAPE-YVTTGRFTERSDIFAFGVIILQILTGS 615
                 A   Y APE  V   ++ +  D++A G ++ ++  G 
Sbjct: 186 ------ATRWYRAPELLVGDVKYGKAVDVWAIGCLVTEMFMGE 222

>pdb|4EBW|A Chain A, Structure Of Focal Adhesion Kinase Catalytic Domain In Complex With Novel Allosteric Inhibitor Length = 304

Iteration: 1
 Score = 67.4 bits (163), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 47/200 (23%), Positives = 89/200 (44%), Gaps = 15/200 (7%)
Query: 417 LGKGNFSSVYKGTLRD----GTLVAIRSINVTSCKSEEAEFVKGLYLLTSLRHENIIRLR 472
           +G+G F  V++G           VAI++    +  S   +F++    +    H +I++L 
Sbjct: 46  IGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVKLI 105
Query: 473 GFCCSRGRGECFLIYDFAPKGKLSKYLDQEEGSSNVLDWSTRVSIIIGIAKGIGYLHSSE 532
           G          ++I +    G+L  +L   + S   LD ++ +     ++  + YL S  
Sbjct: 106 GVITE---NPVWIIMELCTLGELRSFLQVRKYS---LDLASLILYAYQLSTALAYLESKR 159
Query: 533 VNKPAIVHRNLSVEKVLIDQQFNPLIADCGLHKLLADDIVFSVLKTSAAMGYLAPEYVTT 592
                 VHR+++   VL+       + D GL + + D   +   K    + ++APE +  
Sbjct: 160 -----FVHRDIAARNVLVSSNDCVKLGDFGLSRYMEDSTYYKASKGKLPIKWMAPESINF 214
Query: 593 GRFTERSDIFAFGVIILQIL 612
            RFT  SD++ FGV + +IL
Sbjct: 215 RRFTSASDVWMFGVCMWEIL 234

>pdb|3PXK|A Chain A, Focal Adhesion Kinase Catalytic Domain In Complex With Pyrrolo[2,3- D]thiazole Length = 282

Iteration: 1
 Score = 67.4 bits (163), Expect = 3e-11,   Method: Compositional matrix adjust.
 Identities = 47/200 (23%), Positives = 89/200 (44%), Gaps = 15/200 (7%)
Query: 417 LGKGNFSSVYKGTLRD----GTLVAIRSINVTSCKSEEAEFVKGLYLLTSLRHENIIRLR 472
           +G+G F  V++G           VAI++    +  S   +F++    +    H +I++L 
Sbjct: 21  IGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVKLI 80
Query: 473 GFCCSRGRGECFLIYDFAPKGKLSKYLDQEEGSSNVLDWSTRVSIIIGIAKGIGYLHSSE 532
           G          ++I +    G+L  +L   + S   LD ++ +     ++  + YL S  
Sbjct: 81  GVITE---NPVWIIMELCTLGELRSFLQVRKYS---LDLASLILYAYQLSTALAYLESKR 134
Query: 533 VNKPAIVHRNLSVEKVLIDQQFNPLIADCGLHKLLADDIVFSVLKTSAAMGYLAPEYVTT 592
                 VHR+++   VL+       + D GL + + D   +   K    + ++APE +  
Sbjct: 135 -----FVHRDIAARNVLVSSNDCVKLGDFGLSRYMEDSTYYKASKGKLPIKWMAPESINF 189
Query: 593 GRFTERSDIFAFGVIILQIL 612
            RFT  SD++ FGV + +IL
Sbjct: 190 RRFTSASDVWMFGVCMWEIL 209

>pdb|3QBN|A Chain A, Structure Of Human Aurora A In Complex With A Diaminopyrimidine Length = 281

Iteration: 1
 Score = 67.4 bits (163), Expect = 3e-11,   Method: Compositional matrix adjust.
 Identities = 64/269 (23%), Positives = 115/269 (42%), Gaps = 27/269 (10%)
Query: 417 LGKGNFSSVYKGTLRDGTLV-AIRSINVTSCKSE--EAEFVKGLYLLTSLRHENIIRLRG 473
           LGKG F +VY    +    + A++ +     +    E +  + + + + LRH NI+RL G
Sbjct: 17  LGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRLYG 76
Query: 474 FCCSRGRGECFLIYDFAPKGKLSKYLDQEEGSSNVLDWSTRVSIIIGIAKGIGYLHSSEV 533
           +     R   +LI ++AP G + + L +     +  D     + I  +A  + Y HS  V
Sbjct: 77  YFHDATR--VYLILEYAPLGTVYRELQK----LSKFDEQRTATYITELANALSYCHSKRV 130
Query: 534 NKPAIVHRNLSVEKVLIDQQFNPLIADCGLHKLLADDIVFSVLKTSAAMGYLAPEYVTTG 593
                +HR++  E +L+       IAD G     A     + L  S  + YL PE +   
Sbjct: 131 -----IHRDIKPENLLLGSAGELKIADFGW-SCHAPSSRRTTL--SGTLDYLPPEMIEGR 182
Query: 594 RFTERSDIFAFGVIILQILTGSLVLTSSMRLAAESATFENFIDRNLKGKFSESEAAKLGK 653
              E+ D+++ GV+  + L G        +   E+ T++    R  + +F+  +    G 
Sbjct: 183 MHDEKVDLWSLGVLCYEFLVG--------KPPFEANTYQETYKRISRVEFTFPDFVTEGA 234
Query: 654 MALVCT--HEDPENRPTMEAVIEELTVAA 680
             L+      +P  RP +  V+E   + A
Sbjct: 235 RDLISRLLKHNPSQRPMLREVLEHPWITA 263

>pdb|2ETM|A Chain A, Crystal Structure Of Focal Adhesion Kinase Domain Complexed With 7h-Pyrrolo [2,3-D] Pyrimidine Derivative Length = 281

Iteration: 1
 Score = 67.4 bits (163), Expect = 3e-11,   Method: Compositional matrix adjust.
 Identities = 47/200 (23%), Positives = 89/200 (44%), Gaps = 15/200 (7%)
Query: 417 LGKGNFSSVYKGTLRD----GTLVAIRSINVTSCKSEEAEFVKGLYLLTSLRHENIIRLR 472
           +G+G F  V++G           VAI++    +  S   +F++    +    H +I++L 
Sbjct: 20  IGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVKLI 79
Query: 473 GFCCSRGRGECFLIYDFAPKGKLSKYLDQEEGSSNVLDWSTRVSIIIGIAKGIGYLHSSE 532
           G          ++I +    G+L  +L   + S   LD ++ +     ++  + YL S  
Sbjct: 80  GVITE---NPVWIIMELCTLGELRSFLQVRKYS---LDLASLILYAYQLSTALAYLESKR 133
Query: 533 VNKPAIVHRNLSVEKVLIDQQFNPLIADCGLHKLLADDIVFSVLKTSAAMGYLAPEYVTT 592
                 VHR+++   VL+       + D GL + + D   +   K    + ++APE +  
Sbjct: 134 -----FVHRDIAARNVLVSSNDCVKLGDFGLSRYMEDSTYYKASKGKLPIKWMAPESINF 188
Query: 593 GRFTERSDIFAFGVIILQIL 612
            RFT  SD++ FGV + +IL
Sbjct: 189 RRFTSASDVWMFGVCMWEIL 208

>pdb|1MP8|A Chain A, Crystal Structure Of Focal Adhesion Kinase (Fak) Length = 281

Iteration: 1
 Score = 67.4 bits (163), Expect = 3e-11,   Method: Compositional matrix adjust.
 Identities = 47/200 (23%), Positives = 89/200 (44%), Gaps = 15/200 (7%)
Query: 417 LGKGNFSSVYKGTLRD----GTLVAIRSINVTSCKSEEAEFVKGLYLLTSLRHENIIRLR 472
           +G+G F  V++G           VAI++    +  S   +F++    +    H +I++L 
Sbjct: 23  IGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVKLI 82
Query: 473 GFCCSRGRGECFLIYDFAPKGKLSKYLDQEEGSSNVLDWSTRVSIIIGIAKGIGYLHSSE 532
           G          ++I +    G+L  +L   + S   LD ++ +     ++  + YL S  
Sbjct: 83  GVITE---NPVWIIMELCTLGELRSFLQVRKYS---LDLASLILYAYQLSTALAYLESKR 136
Query: 533 VNKPAIVHRNLSVEKVLIDQQFNPLIADCGLHKLLADDIVFSVLKTSAAMGYLAPEYVTT 592
                 VHR+++   VL+       + D GL + + D   +   K    + ++APE +  
Sbjct: 137 -----FVHRDIAARNVLVSSNDCVKLGDFGLSRYMEDSTYYKASKGKLPIKWMAPESINF 191
Query: 593 GRFTERSDIFAFGVIILQIL 612
            RFT  SD++ FGV + +IL
Sbjct: 192 RRFTSASDVWMFGVCMWEIL 211

>pdb|2J0M|B Chain B, Crystal Structure A Two-Chain Complex Between The Ferm And Kinase Domains Of Focal Adhesion Kinase. Length = 276

Iteration: 1
 Score = 67.4 bits (163), Expect = 3e-11,   Method: Compositional matrix adjust.
 Identities = 47/200 (23%), Positives = 89/200 (44%), Gaps = 15/200 (7%)
Query: 417 LGKGNFSSVYKGTLRD----GTLVAIRSINVTSCKSEEAEFVKGLYLLTSLRHENIIRLR 472
           +G+G F  V++G           VAI++    +  S   +F++    +    H +I++L 
Sbjct: 18  IGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVKLI 77
Query: 473 GFCCSRGRGECFLIYDFAPKGKLSKYLDQEEGSSNVLDWSTRVSIIIGIAKGIGYLHSSE 532
           G          ++I +    G+L  +L   + S   LD ++ +     ++  + YL S  
Sbjct: 78  GVITE---NPVWIIMELCTLGELRSFLQVRKYS---LDLASLILYAYQLSTALAYLESKR 131
Query: 533 VNKPAIVHRNLSVEKVLIDQQFNPLIADCGLHKLLADDIVFSVLKTSAAMGYLAPEYVTT 592
                 VHR+++   VL+       + D GL + + D   +   K    + ++APE +  
Sbjct: 132 -----FVHRDIAARNVLVSSNDCVKLGDFGLSRYMEDSTYYKASKGKLPIKWMAPESINF 186
Query: 593 GRFTERSDIFAFGVIILQIL 612
            RFT  SD++ FGV + +IL
Sbjct: 187 RRFTSASDVWMFGVCMWEIL 206

>pdb|2J0J|A Chain A, Crystal Structure Of A Fragment Of Focal Adhesion Kinase Containing The Ferm And Kinase Domains Length = 656

Iteration: 1
 Score = 67.4 bits (163), Expect = 3e-11,   Method: Compositional matrix adjust.
 Identities = 47/200 (23%), Positives = 89/200 (44%), Gaps = 15/200 (7%)
Query: 417 LGKGNFSSVYKGTLRD----GTLVAIRSINVTSCKSEEAEFVKGLYLLTSLRHENIIRLR 472
           +G+G F  V++G           VAI++    +  S   +F++    +    H +I++L 
Sbjct: 398 IGEGQFGDVHQGIYMSPENPAMAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVKLI 457
Query: 473 GFCCSRGRGECFLIYDFAPKGKLSKYLDQEEGSSNVLDWSTRVSIIIGIAKGIGYLHSSE 532
           G          ++I +    G+L  +L   + S   LD ++ +     ++  + YL S  
Sbjct: 458 GVITE---NPVWIIMELCTLGELRSFLQVRKFS---LDLASLILYAYQLSTALAYLESKR 511
Query: 533 VNKPAIVHRNLSVEKVLIDQQFNPLIADCGLHKLLADDIVFSVLKTSAAMGYLAPEYVTT 592
                 VHR+++   VL+       + D GL + + D   +   K    + ++APE +  
Sbjct: 512 -----FVHRDIAARNVLVSSNDCVKLGDFGLSRYMEDSTYYKASKGKLPIKWMAPESINF 566
Query: 593 GRFTERSDIFAFGVIILQIL 612
            RFT  SD++ FGV + +IL
Sbjct: 567 RRFTSASDVWMFGVCMWEIL 586

>pdb|2JKK|A Chain A, Focal Adhesion Kinase Catalytic Domain In Complex With Bis- Anilino Pyrimidine Inhibitor Length = 276

Iteration: 1
 Score = 67.0 bits (162), Expect = 3e-11,   Method: Compositional matrix adjust.
 Identities = 47/200 (23%), Positives = 89/200 (44%), Gaps = 15/200 (7%)
Query: 417 LGKGNFSSVYKGTLRD----GTLVAIRSINVTSCKSEEAEFVKGLYLLTSLRHENIIRLR 472
           +G+G F  V++G           VAI++    +  S   +F++    +    H +I++L 
Sbjct: 18  IGEGQFGDVHQGIYMSPENPAMAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVKLI 77
Query: 473 GFCCSRGRGECFLIYDFAPKGKLSKYLDQEEGSSNVLDWSTRVSIIIGIAKGIGYLHSSE 532
           G          ++I +    G+L  +L   + S   LD ++ +     ++  + YL S  
Sbjct: 78  GVITE---NPVWIIMELCTLGELRSFLQVRKFS---LDLASLILYAYQLSTALAYLESKR 131
Query: 533 VNKPAIVHRNLSVEKVLIDQQFNPLIADCGLHKLLADDIVFSVLKTSAAMGYLAPEYVTT 592
                 VHR+++   VL+       + D GL + + D   +   K    + ++APE +  
Sbjct: 132 -----FVHRDIAARNVLVSATDCVKLGDFGLSRYMEDSTYYKASKGKLPIKWMAPESINF 186
Query: 593 GRFTERSDIFAFGVIILQIL 612
            RFT  SD++ FGV + +IL
Sbjct: 187 RRFTSASDVWMFGVCMWEIL 206

>pdb|2PK9|A Chain A, Structure Of The Pho85-pho80 Cdk-cyclin Complex Of The Phosphate-responsive Signal Transduction Pathway Length = 317

Iteration: 1
 Score = 67.0 bits (162), Expect = 3e-11,   Method: Compositional matrix adjust.
 Identities = 51/215 (23%), Positives = 107/215 (49%), Gaps = 15/215 (6%)
Query: 406 SATQCFSEVNLLGKGNFSSVYKGTLRD-GTLVAIRSINVTSCKSEEAEFVKGLYLLTSLR 464
           S++  F ++  LG G +++VYKG  +  G  VA++ + + S +   +  ++ + L+  L+
Sbjct: 2   SSSSQFKQLEKLGNGTYATVYKGLNKTTGVYVALKEVKLDSEEGTPSTAIREISLMKELK 61
Query: 465 HENIIRLRGFCCSRGRGECFLIYDFAPKGKLSKYLDQEE--GSSNVLDWSTRVSIIIGIA 522
           HENI+RL     +  +    L+++F     L KY+D      +   L+ +        + 
Sbjct: 62  HENIVRLYDVIHTENK--LTLVFEFM-DNDLKKYMDSRTVGNTPRGLELNLVKYFQWQLL 118
Query: 523 KGIGYLHSSEVNKPAIVHRNLSVEKVLIDQQFNPLIADCGLHKLLADDI-VFSVLKTSAA 581
           +G+ + H ++     I+HR+L  + +LI+++    + D GL +     +  FS       
Sbjct: 119 QGLAFCHENK-----ILHRDLKPQNLLINKRGQLKLGDFGLARAFGIPVNTFS--SEVVT 171
Query: 582 MGYLAPEYVTTGR-FTERSDIFAFGVIILQILTGS 615
           + Y AP+ +   R ++   DI++ G I+ +++TG 
Sbjct: 172 LWYRAPDVLMGSRTYSTSIDIWSCGCILAEMITGK 206

>pdb|3BZ3|A Chain A, Crystal Structure Analysis Of Focal Adhesion Kinase With A Methanesulfonamide Diaminopyrimidine Inhibitor Length = 276

Iteration: 1
 Score = 67.0 bits (162), Expect = 3e-11,   Method: Compositional matrix adjust.
 Identities = 47/200 (23%), Positives = 89/200 (44%), Gaps = 15/200 (7%)
Query: 417 LGKGNFSSVYKGTLRD----GTLVAIRSINVTSCKSEEAEFVKGLYLLTSLRHENIIRLR 472
           +G+G F  V++G           VAI++    +  S   +F++    +    H +I++L 
Sbjct: 15  IGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVKLI 74
Query: 473 GFCCSRGRGECFLIYDFAPKGKLSKYLDQEEGSSNVLDWSTRVSIIIGIAKGIGYLHSSE 532
           G          ++I +    G+L  +L   + S   LD ++ +     ++  + YL S  
Sbjct: 75  GVITE---NPVWIIMELCTLGELRSFLQVRKYS---LDLASLILYAYQLSTALAYLESKR 128
Query: 533 VNKPAIVHRNLSVEKVLIDQQFNPLIADCGLHKLLADDIVFSVLKTSAAMGYLAPEYVTT 592
                 VHR+++   VL+       + D GL + + D   +   K    + ++APE +  
Sbjct: 129 -----FVHRDIAARNVLVSSNDCVKLGDFGLSRYMEDSTYYKASKGKLPIKWMAPESINF 183
Query: 593 GRFTERSDIFAFGVIILQIL 612
            RFT  SD++ FGV + +IL
Sbjct: 184 RRFTSASDVWMFGVCMWEIL 203

>pdb|2J50|A Chain A, Structure Of Aurora-2 In Complex With Pha-739358 Length = 280

Iteration: 1
 Score = 67.0 bits (162), Expect = 3e-11,   Method: Compositional matrix adjust.
 Identities = 64/276 (23%), Positives = 116/276 (42%), Gaps = 41/276 (14%)
Query: 417 LGKGNFSSVYKGTLRDGTLV-AIRSINVTSCKSE--EAEFVKGLYLLTSLRHENIIRLRG 473
           LGKG F +VY    +    + A++ +     +    E +  + + + + LRH NI+RL G
Sbjct: 16  LGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRLYG 75
Query: 474 FCCSRGRGECFLIYDFAPKGKLSKYLDQEEGSSNVLDWSTRVSIIIGIAKGIGYLHSSEV 533
           +     R   +LI ++AP G + + L +     +  D     + I  +A  + Y HS  V
Sbjct: 76  YFHDATR--VYLILEYAPLGTVYRELQK----LSKFDEQRTATYITELANALSYCHSKRV 129
Query: 534 NKPAIVHRNLSVEKVLIDQQFNPLIADCGLHKLLADDIVFSVLKTSA-------AMGYLA 586
                +HR++  E +L+       IAD G          +SV   S+        + YL 
Sbjct: 130 -----IHRDIKPENLLLGSAGELKIADFG----------WSVHAPSSRRTTLCGTLDYLP 174
Query: 587 PEYVTTGRFTERSDIFAFGVIILQILTGSLVLTSSMRLAAESATFENFIDRNLKGKFSES 646
           PE +      E+ D+++ GV+  + L G        +   E+ T++    R  + +F+  
Sbjct: 175 PEMIEGRMHDEKVDLWSLGVLCYEFLVG--------KPPFEANTYQETYKRISRVEFTFP 226
Query: 647 EAAKLGKMALVCT--HEDPENRPTMEAVIEELTVAA 680
           +    G   L+      +P  RP +  V+E   + A
Sbjct: 227 DFVTEGARDLISRLLKHNPSQRPMLREVLEHPWITA 262

>pdb|2XRU|A Chain A, Aurora-A T288e Complexed With Pha-828300 Length = 280

Iteration: 1
 Score = 67.0 bits (162), Expect = 4e-11,   Method: Compositional matrix adjust.
 Identities = 64/276 (23%), Positives = 116/276 (42%), Gaps = 41/276 (14%)
Query: 417 LGKGNFSSVYKGTLRDGTLV-AIRSINVTSCKSE--EAEFVKGLYLLTSLRHENIIRLRG 473
           LGKG F +VY    +    + A++ +     +    E +  + + + + LRH NI+RL G
Sbjct: 16  LGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRLYG 75
Query: 474 FCCSRGRGECFLIYDFAPKGKLSKYLDQEEGSSNVLDWSTRVSIIIGIAKGIGYLHSSEV 533
           +     R   +LI ++AP G + + L +     +  D     + I  +A  + Y HS  V
Sbjct: 76  YFHDATR--VYLILEYAPLGTVYRELQK----LSKFDEQRTATYITELANALSYCHSKRV 129
Query: 534 NKPAIVHRNLSVEKVLIDQQFNPLIADCGLHKLLADDIVFSVLKTSA-------AMGYLA 586
                +HR++  E +L+       IAD G          +SV   S+        + YL 
Sbjct: 130 -----IHRDIKPENLLLGSAGELKIADFG----------WSVHAPSSRRTELCGTLDYLP 174
Query: 587 PEYVTTGRFTERSDIFAFGVIILQILTGSLVLTSSMRLAAESATFENFIDRNLKGKFSES 646
           PE +      E+ D+++ GV+  + L G        +   E+ T++    R  + +F+  
Sbjct: 175 PEMIEGRMHDEKVDLWSLGVLCYEFLVG--------KPPFEANTYQETYKRISRVEFTFP 226
Query: 647 EAAKLGKMALVCT--HEDPENRPTMEAVIEELTVAA 680
           +    G   L+      +P  RP +  V+E   + A
Sbjct: 227 DFVTEGARDLISRLLKHNPSQRPMLREVLEHPWITA 262

>pdb|2QLU|A Chain A, Crystal Structure Of Activin Receptor Type Ii Kinase Domain From Human Length = 314

Iteration: 1
 Score = 67.0 bits (162), Expect = 4e-11,   Method: Compositional matrix adjust.
 Identities = 54/223 (24%), Positives = 105/223 (47%), Gaps = 40/223 (17%)
Query: 414 VNLLGKGNFSSVYKGTLRDGTLVAIRSINVTSCKSEEAEFVKGLYLLTSLRHENIIRLRG 473
           + +  +G F  V+K  L +   VA++   +   +S ++E  + ++    ++HEN+++   
Sbjct: 20  LEIKARGRFGCVWKAQLMN-DFVAVKIFPLQDKQSWQSE--REIFSTPGMKHENLLQ--- 73
Query: 474 FCCSRGRG-----ECFLIYDFAPKGKLSKYLDQEEGSSNVLDWSTRVSIIIGIAKGIGYL 528
           F  +  RG     E +LI  F  KG L+ YL       N++ W+    +   +++G+ YL
Sbjct: 74  FIAAEKRGSNLEVELWLITAFHDKGSLTDYL-----KGNIITWNELCHVAETMSRGLSYL 128
Query: 529 HSS------EVNKPAIVHRNLSVEKVLIDQQFNPLIADCGLHKLLADDIVFSVLK----T 578
           H        E +KP+I HR+   + VL+      ++AD GL       + F   K    T
Sbjct: 129 HEDVPWCRGEGHKPSIAHRDFKSKNVLLKSDLTAVLADFGL------AVRFEPGKPPGDT 182
Query: 579 SAAMG---YLAPEYVTTGRFTERS-----DIFAFGVIILQILT 613
              +G   Y+APE +      +R      D++A G+++ ++++
Sbjct: 183 HGQVGTRRYMAPEVLEGAINFQRDAFLRIDMYAMGLVLWELVS 225

>pdb|2J0K|A Chain A, Crystal Structure Of A Fragment Of Focal Adhesion Kinase Containing The Ferm And Kinase Domains. Length = 656

Iteration: 1
 Score = 67.0 bits (162), Expect = 4e-11,   Method: Compositional matrix adjust.
 Identities = 47/200 (23%), Positives = 89/200 (44%), Gaps = 15/200 (7%)
Query: 417 LGKGNFSSVYKGTLRD----GTLVAIRSINVTSCKSEEAEFVKGLYLLTSLRHENIIRLR 472
           +G+G F  V++G           VAI++    +  S   +F++    +    H +I++L 
Sbjct: 398 IGEGQFGDVHQGIYMSPENPAMAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVKLI 457
Query: 473 GFCCSRGRGECFLIYDFAPKGKLSKYLDQEEGSSNVLDWSTRVSIIIGIAKGIGYLHSSE 532
           G          ++I +    G+L  +L   + S   LD ++ +     ++  + YL S  
Sbjct: 458 GVITE---NPVWIIMELCTLGELRSFLQVRKFS---LDLASLILYAYQLSTALAYLESKR 511
Query: 533 VNKPAIVHRNLSVEKVLIDQQFNPLIADCGLHKLLADDIVFSVLKTSAAMGYLAPEYVTT 592
                 VHR+++   VL+       + D GL + + D   +   K    + ++APE +  
Sbjct: 512 -----FVHRDIAARNVLVSATDCVKLGDFGLSRYMEDSTYYKASKGKLPIKWMAPESINF 566
Query: 593 GRFTERSDIFAFGVIILQIL 612
            RFT  SD++ FGV + +IL
Sbjct: 567 RRFTSASDVWMFGVCMWEIL 586

>pdb|3R21|A Chain A, Design, Synthesis, And Biological Evaluation Of Pyrazolopyridine- Sulfonamides As Potent Multiple-Mitotic Kinase (Mmk) Inhibitors (Part I) Length = 271

Iteration: 1
 Score = 66.6 bits (161), Expect = 4e-11,   Method: Compositional matrix adjust.
 Identities = 64/276 (23%), Positives = 116/276 (42%), Gaps = 41/276 (14%)
Query: 417 LGKGNFSSVYKGTLRDGTLV-AIRSINVTSCKSE--EAEFVKGLYLLTSLRHENIIRLRG 473
           LGKG F +VY    +    + A++ +     +    E +  + + + + LRH NI+RL G
Sbjct: 19  LGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRLYG 78
Query: 474 FCCSRGRGECFLIYDFAPKGKLSKYLDQEEGSSNVLDWSTRVSIIIGIAKGIGYLHSSEV 533
           +     R   +LI ++AP G + + L +     +  D     + I  +A  + Y HS  V
Sbjct: 79  YFHDATR--VYLILEYAPLGTVYRELQK----LSKFDEQRTATYITELANALSYCHSKRV 132
Query: 534 NKPAIVHRNLSVEKVLIDQQFNPLIADCGLHKLLADDIVFSVLKTSA-------AMGYLA 586
                +HR++  E +L+       IAD G          +SV   S+        + YL 
Sbjct: 133 -----IHRDIKPENLLLGSAGELKIADFG----------WSVHAPSSRRDDLCGTLDYLP 177
Query: 587 PEYVTTGRFTERSDIFAFGVIILQILTGSLVLTSSMRLAAESATFENFIDRNLKGKFSES 646
           PE +      E+ D+++ GV+  + L G        +   E+ T++    R  + +F+  
Sbjct: 178 PEMIEGRMHDEKVDLWSLGVLCYEFLVG--------KPPFEANTYQETYKRISRVEFTFP 229
Query: 647 EAAKLGKMALVCT--HEDPENRPTMEAVIEELTVAA 680
           +    G   L+      +P  RP +  V+E   + A
Sbjct: 230 DFVTEGARDLISRLLKHNPSQRPMLREVLEHPWITA 265

>pdb|2DWB|A Chain A, Aurora-A Kinase Complexed With Amppnp Length = 285

Iteration: 1
 Score = 66.6 bits (161), Expect = 4e-11,   Method: Compositional matrix adjust.
 Identities = 64/276 (23%), Positives = 116/276 (42%), Gaps = 41/276 (14%)
Query: 417 LGKGNFSSVYKGTLRDGTLV-AIRSINVTSCKSE--EAEFVKGLYLLTSLRHENIIRLRG 473
           LGKG F +VY    +    + A++ +     +    E +  + + + + LRH NI+RL G
Sbjct: 21  LGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRLYG 80
Query: 474 FCCSRGRGECFLIYDFAPKGKLSKYLDQEEGSSNVLDWSTRVSIIIGIAKGIGYLHSSEV 533
           +     R   +LI ++AP G + + L +     +  D     + I  +A  + Y HS  V
Sbjct: 81  YFHDATR--VYLILEYAPLGTVYRELQK----LSKFDEQRTATYITELANALSYCHSKRV 134
Query: 534 NKPAIVHRNLSVEKVLIDQQFNPLIADCGLHKLLADDIVFSVLKTSA-------AMGYLA 586
                +HR++  E +L+       IAD G          +SV   S+        + YL 
Sbjct: 135 -----IHRDIKPENLLLGSAGELKIADFG----------WSVHAPSSRRTTLCGTLDYLP 179
Query: 587 PEYVTTGRFTERSDIFAFGVIILQILTGSLVLTSSMRLAAESATFENFIDRNLKGKFSES 646
           PE +      E+ D+++ GV+  + L G        +   E+ T++    R  + +F+  
Sbjct: 180 PEXIEGRXHDEKVDLWSLGVLCYEFLVG--------KPPFEANTYQETYKRISRVEFTFP 231
Query: 647 EAAKLGKMALVCT--HEDPENRPTMEAVIEELTVAA 680
           +    G   L+      +P  RP +  V+E   + A
Sbjct: 232 DFVTEGARDLISRLLKHNPSQRPXLREVLEHPWITA 267

>pdb|1MUO|A Chain A, Crystal Structure Of Aurora-2, An Oncogenic Serine- Threonine Kinase Length = 297

Iteration: 1
 Score = 66.6 bits (161), Expect = 4e-11,   Method: Compositional matrix adjust.
 Identities = 64/276 (23%), Positives = 116/276 (42%), Gaps = 41/276 (14%)
Query: 417 LGKGNFSSVYKGTLRDGTLV-AIRSINVTSCKSE--EAEFVKGLYLLTSLRHENIIRLRG 473
           LGKG F +VY    +    + A++ +     +    E +  + + + + LRH NI+RL G
Sbjct: 33  LGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRLYG 92
Query: 474 FCCSRGRGECFLIYDFAPKGKLSKYLDQEEGSSNVLDWSTRVSIIIGIAKGIGYLHSSEV 533
           +     R   +LI ++AP G + + L +     +  D     + I  +A  + Y HS  V
Sbjct: 93  YFHDATR--VYLILEYAPLGTVYRELQK----LSKFDEQRTATYITELANALSYCHSKRV 146
Query: 534 NKPAIVHRNLSVEKVLIDQQFNPLIADCGLHKLLADDIVFSVLKTSA-------AMGYLA 586
                +HR++  E +L+       IAD G          +SV   S+        + YL 
Sbjct: 147 -----IHRDIKPENLLLGSAGELKIADFG----------WSVHAPSSRRTTLCGTLDYLP 191
Query: 587 PEYVTTGRFTERSDIFAFGVIILQILTGSLVLTSSMRLAAESATFENFIDRNLKGKFSES 646
           PE +      E+ D+++ GV+  + L G        +   E+ T++    R  + +F+  
Sbjct: 192 PEMIEGRMHDEKVDLWSLGVLCYEFLVG--------KPPFEANTYQETYKRISRVEFTFP 243
Query: 647 EAAKLGKMALVCT--HEDPENRPTMEAVIEELTVAA 680
           +    G   L+      +P  RP +  V+E   + A
Sbjct: 244 DFVTEGARDLISRLLKHNPSQRPMLREVLEHPWITA 279

>pdb|2C6E|A Chain A, Aurora A Kinase Activated Mutant (T287d) In Complex With A 5-Aminopyrimidinyl Quinazoline Inhibitor Length = 283

Iteration: 1
 Score = 66.6 bits (161), Expect = 4e-11,   Method: Compositional matrix adjust.
 Identities = 64/276 (23%), Positives = 116/276 (42%), Gaps = 41/276 (14%)
Query: 417 LGKGNFSSVYKGTLRDGTLV-AIRSINVTSCKSE--EAEFVKGLYLLTSLRHENIIRLRG 473
           LGKG F +VY    +    + A++ +     +    E +  + + + + LRH NI+RL G
Sbjct: 21  LGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRLYG 80
Query: 474 FCCSRGRGECFLIYDFAPKGKLSKYLDQEEGSSNVLDWSTRVSIIIGIAKGIGYLHSSEV 533
           +     R   +LI ++AP G + + L +     +  D     + I  +A  + Y HS  V
Sbjct: 81  YFHDATR--VYLILEYAPLGTVYRELQK----LSKFDEQRTATYITELANALSYCHSKRV 134
Query: 534 NKPAIVHRNLSVEKVLIDQQFNPLIADCGLHKLLADDIVFSVLKTSA-------AMGYLA 586
                +HR++  E +L+       IAD G          +SV   S+        + YL 
Sbjct: 135 -----IHRDIKPENLLLGSAGELKIADFG----------WSVHAPSSRRTDLCGTLDYLP 179
Query: 587 PEYVTTGRFTERSDIFAFGVIILQILTGSLVLTSSMRLAAESATFENFIDRNLKGKFSES 646
           PE +      E+ D+++ GV+  + L G        +   E+ T++    R  + +F+  
Sbjct: 180 PEMIEGRMHDEKVDLWSLGVLCYEFLVG--------KPPFEANTYQETYKRISRVEFTFP 231
Query: 647 EAAKLGKMALVCT--HEDPENRPTMEAVIEELTVAA 680
           +    G   L+      +P  RP +  V+E   + A
Sbjct: 232 DFVTEGARDLISRLLKHNPSQRPMLREVLEHPWITA 267

>pdb|3NRM|A Chain A, Imidazo[1,2-A]pyrazine-Based Aurora Kinase Inhibitors Length = 283

Iteration: 1
 Score = 66.6 bits (161), Expect = 5e-11,   Method: Compositional matrix adjust.
 Identities = 64/276 (23%), Positives = 116/276 (42%), Gaps = 41/276 (14%)
Query: 417 LGKGNFSSVYKGTLRDGTLV-AIRSINVTSCKSE--EAEFVKGLYLLTSLRHENIIRLRG 473
           LGKG F +VY    +    + A++ +     +    E +  + + + + LRH NI+RL G
Sbjct: 19  LGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRLYG 78
Query: 474 FCCSRGRGECFLIYDFAPKGKLSKYLDQEEGSSNVLDWSTRVSIIIGIAKGIGYLHSSEV 533
           +     R   +LI ++AP G + + L +     +  D     + I  +A  + Y HS  V
Sbjct: 79  YFHDATR--VYLILEYAPLGTVYRELQK----LSKFDEQRTATYITELANALSYCHSKRV 132
Query: 534 NKPAIVHRNLSVEKVLIDQQFNPLIADCGLHKLLADDIVFSVLKTSA-------AMGYLA 586
                +HR++  E +L+       IAD G          +SV   S+        + YL 
Sbjct: 133 -----IHRDIKPENLLLGSAGELKIADFG----------WSVHAPSSRRAALCGTLDYLP 177
Query: 587 PEYVTTGRFTERSDIFAFGVIILQILTGSLVLTSSMRLAAESATFENFIDRNLKGKFSES 646
           PE +      E+ D+++ GV+  + L G        +   E+ T++    R  + +F+  
Sbjct: 178 PEMIEGRMHDEKVDLWSLGVLCYEFLVG--------KPPFEANTYQETYKRISRVEFTFP 229
Query: 647 EAAKLGKMALVCT--HEDPENRPTMEAVIEELTVAA 680
           +    G   L+      +P  RP +  V+E   + A
Sbjct: 230 DFVTEGARDLISRLLKHNPSQRPMLREVLEHPWITA 265

>pdb|2C6D|A Chain A, Aurora A Kinase Activated Mutant (T287d) In Complex With Adpnp Length = 275

Iteration: 1
 Score = 66.6 bits (161), Expect = 5e-11,   Method: Compositional matrix adjust.
 Identities = 64/276 (23%), Positives = 116/276 (42%), Gaps = 41/276 (14%)
Query: 417 LGKGNFSSVYKGTLRDGTLV-AIRSINVTSCKSE--EAEFVKGLYLLTSLRHENIIRLRG 473
           LGKG F +VY    +    + A++ +     +    E +  + + + + LRH NI+RL G
Sbjct: 16  LGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRLYG 75
Query: 474 FCCSRGRGECFLIYDFAPKGKLSKYLDQEEGSSNVLDWSTRVSIIIGIAKGIGYLHSSEV 533
           +     R   +LI ++AP G + + L +     +  D     + I  +A  + Y HS  V
Sbjct: 76  YFHDATR--VYLILEYAPLGTVYRELQK----LSKFDEQRTATYITELANALSYCHSKRV 129
Query: 534 NKPAIVHRNLSVEKVLIDQQFNPLIADCGLHKLLADDIVFSVLKTSA-------AMGYLA 586
                +HR++  E +L+       IAD G          +SV   S+        + YL 
Sbjct: 130 -----IHRDIKPENLLLGSAGELKIADFG----------WSVHAPSSRRTDLCGTLDYLP 174
Query: 587 PEYVTTGRFTERSDIFAFGVIILQILTGSLVLTSSMRLAAESATFENFIDRNLKGKFSES 646
           PE +      E+ D+++ GV+  + L G        +   E+ T++    R  + +F+  
Sbjct: 175 PEMIEGRMHDEKVDLWSLGVLCYEFLVG--------KPPFEANTYQETYKRISRVEFTFP 226
Query: 647 EAAKLGKMALVCT--HEDPENRPTMEAVIEELTVAA 680
           +    G   L+      +P  RP +  V+E   + A
Sbjct: 227 DFVTEGARDLISRLLKHNPSQRPMLREVLEHPWITA 262

>pdb|2XNG|A Chain A, Structure Of Aurora-A Bound To A Selective Imidazopyrazine Inhibitor Length = 283

Iteration: 1
 Score = 66.6 bits (161), Expect = 5e-11,   Method: Compositional matrix adjust.
 Identities = 64/276 (23%), Positives = 116/276 (42%), Gaps = 41/276 (14%)
Query: 417 LGKGNFSSVYKGTLRDGTLV-AIRSINVTSCKSE--EAEFVKGLYLLTSLRHENIIRLRG 473
           LGKG F +VY    +    + A++ +     +    E +  + + + + LRH NI+RL G
Sbjct: 19  LGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRLYG 78
Query: 474 FCCSRGRGECFLIYDFAPKGKLSKYLDQEEGSSNVLDWSTRVSIIIGIAKGIGYLHSSEV 533
           +     R   +LI ++AP G + + L +     +  D     + I  +A  + Y HS  V
Sbjct: 79  YFHDATR--VYLILEYAPLGTVYRELQK----LSKFDEQRTATYITELANALSYCHSKRV 132
Query: 534 NKPAIVHRNLSVEKVLIDQQFNPLIADCGLHKLLADDIVFSVLKTSA-------AMGYLA 586
                +HR++  E +L+       IAD G          +SV   S+        + YL 
Sbjct: 133 -----IHRDIKPENLLLGSAGELKIADFG----------WSVHAPSSRRTTLCGTLDYLP 177
Query: 587 PEYVTTGRFTERSDIFAFGVIILQILTGSLVLTSSMRLAAESATFENFIDRNLKGKFSES 646
           PE +      E+ D+++ GV+  + L G        +   E+ T++    R  + +F+  
Sbjct: 178 PEMIEGRMHDEKVDLWSLGVLCYEFLVG--------KPPFEANTYQETYKRISRVEFTFP 229
Query: 647 EAAKLGKMALVCT--HEDPENRPTMEAVIEELTVAA 680
           +    G   L+      +P  RP +  V+E   + A
Sbjct: 230 DFVTEGARDLISRLLKHNPSQRPMLREVLEHPWITA 265

>pdb|1OL5|A Chain A, Structure Of Aurora-A 122-403, Phosphorylated On Thr287, Thr288 And Bound To Tpx2 1-43 Length = 282

Iteration: 1
 Score = 66.2 bits (160), Expect = 5e-11,   Method: Compositional matrix adjust.
 Identities = 64/276 (23%), Positives = 116/276 (42%), Gaps = 41/276 (14%)
Query: 417 LGKGNFSSVYKGTLRDGTLV-AIRSINVTSCKSE--EAEFVKGLYLLTSLRHENIIRLRG 473
           LGKG F +VY    +    + A++ +     +    E +  + + + + LRH NI+RL G
Sbjct: 18  LGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRLYG 77
Query: 474 FCCSRGRGECFLIYDFAPKGKLSKYLDQEEGSSNVLDWSTRVSIIIGIAKGIGYLHSSEV 533
           +     R   +LI ++AP G + + L +     +  D     + I  +A  + Y HS  V
Sbjct: 78  YFHDATR--VYLILEYAPLGTVYRELQK----LSKFDEQRTATYITELANALSYCHSKRV 131
Query: 534 NKPAIVHRNLSVEKVLIDQQFNPLIADCGLHKLLADDIVFSVLKTSA-------AMGYLA 586
                +HR++  E +L+       IAD G          +SV   S+        + YL 
Sbjct: 132 -----IHRDIKPENLLLGSAGELKIADFG----------WSVHAPSSRRXXLCGTLDYLP 176
Query: 587 PEYVTTGRFTERSDIFAFGVIILQILTGSLVLTSSMRLAAESATFENFIDRNLKGKFSES 646
           PE +      E+ D+++ GV+  + L G        +   E+ T++    R  + +F+  
Sbjct: 177 PEMIEGRMHDEKVDLWSLGVLCYEFLVG--------KPPFEANTYQETYKRISRVEFTFP 228
Query: 647 EAAKLGKMALVCT--HEDPENRPTMEAVIEELTVAA 680
           +    G   L+      +P  RP +  V+E   + A
Sbjct: 229 DFVTEGARDLISRLLKHNPSQRPMLREVLEHPWITA 264

>pdb|3UNZ|A Chain A, Aurora A In Complex With Rpm1679 Length = 279

Iteration: 1
 Score = 66.2 bits (160), Expect = 5e-11,   Method: Compositional matrix adjust.
 Identities = 64/276 (23%), Positives = 116/276 (42%), Gaps = 41/276 (14%)
Query: 417 LGKGNFSSVYKGTLRDGTLV-AIRSINVTSCKSE--EAEFVKGLYLLTSLRHENIIRLRG 473
           LGKG F +VY    +    + A++ +     +    E +  + + + + LRH NI+RL G
Sbjct: 17  LGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRLYG 76
Query: 474 FCCSRGRGECFLIYDFAPKGKLSKYLDQEEGSSNVLDWSTRVSIIIGIAKGIGYLHSSEV 533
           +     R   +LI ++AP G + + L +     +  D     + I  +A  + Y HS  V
Sbjct: 77  YFHDATR--VYLILEYAPLGTVYRELQK----LSKFDEQRTATYITELANALSYCHSKRV 130
Query: 534 NKPAIVHRNLSVEKVLIDQQFNPLIADCGLHKLLADDIVFSVLKTSA-------AMGYLA 586
                +HR++  E +L+       IAD G          +SV   S+        + YL 
Sbjct: 131 -----IHRDIKPENLLLGSAGELKIADFG----------WSVHAPSSRRDTLCGTLDYLP 175
Query: 587 PEYVTTGRFTERSDIFAFGVIILQILTGSLVLTSSMRLAAESATFENFIDRNLKGKFSES 646
           PE +      E+ D+++ GV+  + L G        +   E+ T++    R  + +F+  
Sbjct: 176 PEMIEGRMHDEKVDLWSLGVLCYEFLVG--------KPPFEANTYQETYKRISRVEFTFP 227
Query: 647 EAAKLGKMALVCT--HEDPENRPTMEAVIEELTVAA 680
           +    G   L+      +P  RP +  V+E   + A
Sbjct: 228 DFVTEGARDLISRLLKHNPSQRPMLREVLEHPWITA 263

>pdb|3FDN|A Chain A, Structure-Based Drug Design Of Novel Aurora Kinase A Inhibitors: Structure Basis For Potency And Specificity Length = 279

Iteration: 1
 Score = 66.2 bits (160), Expect = 5e-11,   Method: Compositional matrix adjust.
 Identities = 64/276 (23%), Positives = 116/276 (42%), Gaps = 41/276 (14%)
Query: 417 LGKGNFSSVYKGTLRDGTLV-AIRSINVTSCKSE--EAEFVKGLYLLTSLRHENIIRLRG 473
           LGKG F +VY    +    + A++ +     +    E +  + + + + LRH NI+RL G
Sbjct: 17  LGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRLYG 76
Query: 474 FCCSRGRGECFLIYDFAPKGKLSKYLDQEEGSSNVLDWSTRVSIIIGIAKGIGYLHSSEV 533
           +     R   +LI ++AP G + + L +     +  D     + I  +A  + Y HS  V
Sbjct: 77  YFHDATR--VYLILEYAPLGTVYRELQK----LSKFDEQRTATYITELANALSYCHSKRV 130
Query: 534 NKPAIVHRNLSVEKVLIDQQFNPLIADCGLHKLLADDIVFSVLKTSA-------AMGYLA 586
                +HR++  E +L+       IAD G          +SV   S+        + YL 
Sbjct: 131 -----IHRDIKPENLLLGSAGELKIADFG----------WSVHAPSSRRTDLCGTLDYLP 175
Query: 587 PEYVTTGRFTERSDIFAFGVIILQILTGSLVLTSSMRLAAESATFENFIDRNLKGKFSES 646
           PE +      E+ D+++ GV+  + L G        +   E+ T++    R  + +F+  
Sbjct: 176 PEMIEGRMHDEKVDLWSLGVLCYEFLVG--------KPPFEANTYQETYKRISRVEFTFP 227
Query: 647 EAAKLGKMALVCT--HEDPENRPTMEAVIEELTVAA 680
           +    G   L+      +P  RP +  V+E   + A
Sbjct: 228 DFVTEGARDLISRLLKHNPSQRPMLREVLEHPWITA 263

>pdb|2X6D|A Chain A, Aurora-A Bound To An Inhibitor Length = 285

Iteration: 1
 Score = 66.2 bits (160), Expect = 5e-11,   Method: Compositional matrix adjust.
 Identities = 64/276 (23%), Positives = 116/276 (42%), Gaps = 41/276 (14%)
Query: 417 LGKGNFSSVYKGTLRDGTLV-AIRSINVTSCKSE--EAEFVKGLYLLTSLRHENIIRLRG 473
           LGKG F +VY    +    + A++ +     +    E +  + + + + LRH NI+RL G
Sbjct: 21  LGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRLYG 80
Query: 474 FCCSRGRGECFLIYDFAPKGKLSKYLDQEEGSSNVLDWSTRVSIIIGIAKGIGYLHSSEV 533
           +     R   +LI ++AP G + + L +     +  D     + I  +A  + Y HS  V
Sbjct: 81  YFHDATR--VYLILEYAPLGTVYRELQK----LSKFDEQRTATYITELANALSYCHSKRV 134
Query: 534 NKPAIVHRNLSVEKVLIDQQFNPLIADCGLHKLLADDIVFSVLKTSA-------AMGYLA 586
                +HR++  E +L+       IAD G          +SV   S+        + YL 
Sbjct: 135 -----IHRDIKPENLLLGSAGELKIADFG----------WSVHAPSSRRTTLCGTLDYLP 179
Query: 587 PEYVTTGRFTERSDIFAFGVIILQILTGSLVLTSSMRLAAESATFENFIDRNLKGKFSES 646
           PE +      E+ D+++ GV+  + L G        +   E+ T++    R  + +F+  
Sbjct: 180 PEMIEGRMHDEKVDLWSLGVLCYEFLVG--------KPPFEANTYQETYKRISRVEFTFP 231
Query: 647 EAAKLGKMALVCT--HEDPENRPTMEAVIEELTVAA 680
           +    G   L+      +P  RP +  V+E   + A
Sbjct: 232 DFVTEGARDLISRLLKHNPSQRPMLREVLEHPWITA 267

>pdb|3LAU|A Chain A, Crystal Structure Of Aurora2 Kinase In Complex With A Gsk3beta Inhibitor Length = 287

Iteration: 1
 Score = 66.2 bits (160), Expect = 5e-11,   Method: Compositional matrix adjust.
 Identities = 64/276 (23%), Positives = 116/276 (42%), Gaps = 41/276 (14%)
Query: 417 LGKGNFSSVYKGTLRDGTLV-AIRSINVTSCKSE--EAEFVKGLYLLTSLRHENIIRLRG 473
           LGKG F +VY    +    + A++ +     +    E +  + + + + LRH NI+RL G
Sbjct: 16  LGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRLYG 75
Query: 474 FCCSRGRGECFLIYDFAPKGKLSKYLDQEEGSSNVLDWSTRVSIIIGIAKGIGYLHSSEV 533
           +     R   +LI ++AP G + + L +     +  D     + I  +A  + Y HS  V
Sbjct: 76  YFHDATR--VYLILEYAPLGTVYRELQK----LSKFDEQRTATYITELANALSYCHSKRV 129
Query: 534 NKPAIVHRNLSVEKVLIDQQFNPLIADCGLHKLLADDIVFSVLKTSA-------AMGYLA 586
                +HR++  E +L+       IAD G          +SV   S+        + YL 
Sbjct: 130 -----IHRDIKPENLLLGSAGELKIADFG----------WSVHAPSSRRTDLCGTLDYLP 174
Query: 587 PEYVTTGRFTERSDIFAFGVIILQILTGSLVLTSSMRLAAESATFENFIDRNLKGKFSES 646
           PE +      E+ D+++ GV+  + L G        +   E+ T++    R  + +F+  
Sbjct: 175 PEMIEGRMHDEKVDLWSLGVLCYEFLVG--------KPPFEANTYQETYKRISRVEFTFP 226
Query: 647 EAAKLGKMALVCT--HEDPENRPTMEAVIEELTVAA 680
           +    G   L+      +P  RP +  V+E   + A
Sbjct: 227 DFVTEGARDLISRLLKHNPSQRPMLREVLEHPWITA 262

>pdb|3O50|A Chain A, Crystal Structure Of Benzamide 9 Bound To Auroraa Length = 267

Iteration: 1
 Score = 66.2 bits (160), Expect = 6e-11,   Method: Compositional matrix adjust.
 Identities = 64/276 (23%), Positives = 116/276 (42%), Gaps = 41/276 (14%)
Query: 417 LGKGNFSSVYKGTLRDGTLV-AIRSINVTSCKSE--EAEFVKGLYLLTSLRHENIIRLRG 473
           LGKG F +VY    +    + A++ +     +    E +  + + + + LRH NI+RL G
Sbjct: 15  LGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRLYG 74
Query: 474 FCCSRGRGECFLIYDFAPKGKLSKYLDQEEGSSNVLDWSTRVSIIIGIAKGIGYLHSSEV 533
           +     R   +LI ++AP G + + L +     +  D     + I  +A  + Y HS  V
Sbjct: 75  YFHDATR--VYLILEYAPLGTVYRELQK----LSKFDEQRTATYITELANALSYCHSKRV 128
Query: 534 NKPAIVHRNLSVEKVLIDQQFNPLIADCGLHKLLADDIVFSVLKTSA-------AMGYLA 586
                +HR++  E +L+       IAD G          +SV   S+        + YL 
Sbjct: 129 -----IHRDIKPENLLLGSAGELKIADFG----------WSVHAPSSRRTTLCGTLDYLP 173
Query: 587 PEYVTTGRFTERSDIFAFGVIILQILTGSLVLTSSMRLAAESATFENFIDRNLKGKFSES 646
           PE +      E+ D+++ GV+  + L G        +   E+ T++    R  + +F+  
Sbjct: 174 PEMIEGRMHDEKVDLWSLGVLCYEFLVG--------KPPFEANTYQETYKRISRVEFTFP 225
Query: 647 EAAKLGKMALVCT--HEDPENRPTMEAVIEELTVAA 680
           +    G   L+      +P  RP +  V+E   + A
Sbjct: 226 DFVTEGARDLISRLLKHNPSQRPMLREVLEHPWITA 261

>pdb|1MQ4|A Chain A, Crystal Structure Of Aurora-A Protein Kinase Length = 272

Iteration: 1
 Score = 66.2 bits (160), Expect = 6e-11,   Method: Compositional matrix adjust.
 Identities = 64/276 (23%), Positives = 116/276 (42%), Gaps = 41/276 (14%)
Query: 417 LGKGNFSSVYKGTLRDGTLV-AIRSINVTSCKSE--EAEFVKGLYLLTSLRHENIIRLRG 473
           LGKG F +VY    +    + A++ +     +    E +  + + + + LRH NI+RL G
Sbjct: 20  LGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRLYG 79
Query: 474 FCCSRGRGECFLIYDFAPKGKLSKYLDQEEGSSNVLDWSTRVSIIIGIAKGIGYLHSSEV 533
           +     R   +LI ++AP G + + L +     +  D     + I  +A  + Y HS  V
Sbjct: 80  YFHDATR--VYLILEYAPLGTVYRELQK----LSKFDEQRTATYITELANALSYCHSKRV 133
Query: 534 NKPAIVHRNLSVEKVLIDQQFNPLIADCGLHKLLADDIVFSVLKTSA-------AMGYLA 586
                +HR++  E +L+       IAD G          +SV   S+        + YL 
Sbjct: 134 -----IHRDIKPENLLLGSAGELKIADFG----------WSVHAPSSRRTTLCGTLDYLP 178
Query: 587 PEYVTTGRFTERSDIFAFGVIILQILTGSLVLTSSMRLAAESATFENFIDRNLKGKFSES 646
           PE +      E+ D+++ GV+  + L G        +   E+ T++    R  + +F+  
Sbjct: 179 PEMIEGRMHDEKVDLWSLGVLCYEFLVG--------KPPFEANTYQETYKRISRVEFTFP 230
Query: 647 EAAKLGKMALVCT--HEDPENRPTMEAVIEELTVAA 680
           +    G   L+      +P  RP +  V+E   + A
Sbjct: 231 DFVTEGARDLISRLLKHNPSQRPMLREVLEHPWITA 266

>pdb|3E5A|A Chain A, Crystal Structure Of Aurora A In Complex With Vx-680 And Tpx2 Length = 268

Iteration: 1
 Score = 66.2 bits (160), Expect = 6e-11,   Method: Compositional matrix adjust.
 Identities = 64/276 (23%), Positives = 116/276 (42%), Gaps = 41/276 (14%)
Query: 417 LGKGNFSSVYKGTLRDGTLV-AIRSINVTSCKSE--EAEFVKGLYLLTSLRHENIIRLRG 473
           LGKG F +VY    +    + A++ +     +    E +  + + + + LRH NI+RL G
Sbjct: 16  LGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRLYG 75
Query: 474 FCCSRGRGECFLIYDFAPKGKLSKYLDQEEGSSNVLDWSTRVSIIIGIAKGIGYLHSSEV 533
           +     R   +LI ++AP G + + L +     +  D     + I  +A  + Y HS  V
Sbjct: 76  YFHDATR--VYLILEYAPLGTVYRELQK----LSKFDEQRTATYITELANALSYCHSKRV 129
Query: 534 NKPAIVHRNLSVEKVLIDQQFNPLIADCGLHKLLADDIVFSVLKTSA-------AMGYLA 586
                +HR++  E +L+       IAD G          +SV   S+        + YL 
Sbjct: 130 -----IHRDIKPENLLLGSAGELKIADFG----------WSVHAPSSRRTXLCGTLDYLP 174
Query: 587 PEYVTTGRFTERSDIFAFGVIILQILTGSLVLTSSMRLAAESATFENFIDRNLKGKFSES 646
           PE +      E+ D+++ GV+  + L G        +   E+ T++    R  + +F+  
Sbjct: 175 PEMIEGRMHDEKVDLWSLGVLCYEFLVG--------KPPFEANTYQETYKRISRVEFTFP 226
Query: 647 EAAKLGKMALVCT--HEDPENRPTMEAVIEELTVAA 680
           +    G   L+      +P  RP +  V+E   + A
Sbjct: 227 DFVTEGARDLISRLLKHNPSQRPMLREVLEHPWITA 262

>pdb|3HA6|A Chain A, Crystal Structure Of Aurora A In Complex With Tpx2 And Compound 10 Length = 268

Iteration: 1
 Score = 66.2 bits (160), Expect = 6e-11,   Method: Compositional matrix adjust.
 Identities = 64/276 (23%), Positives = 116/276 (42%), Gaps = 41/276 (14%)
Query: 417 LGKGNFSSVYKGTLRDGTLV-AIRSINVTSCKSE--EAEFVKGLYLLTSLRHENIIRLRG 473
           LGKG F +VY    +    + A++ +     +    E +  + + + + LRH NI+RL G
Sbjct: 16  LGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRLYG 75
Query: 474 FCCSRGRGECFLIYDFAPKGKLSKYLDQEEGSSNVLDWSTRVSIIIGIAKGIGYLHSSEV 533
           +     R   +LI ++AP G + + L +     +  D     + I  +A  + Y HS  V
Sbjct: 76  YFHDATR--VYLILEYAPLGTVYRELQK----LSKFDEQRTATYITELANALSYCHSKRV 129
Query: 534 NKPAIVHRNLSVEKVLIDQQFNPLIADCGLHKLLADDIVFSVLKTSA-------AMGYLA 586
                +HR++  E +L+       IAD G          +SV   S+        + YL 
Sbjct: 130 -----IHRDIKPENLLLGSAGELKIADFG----------WSVHAPSSRRXXLCGTLDYLP 174
Query: 587 PEYVTTGRFTERSDIFAFGVIILQILTGSLVLTSSMRLAAESATFENFIDRNLKGKFSES 646
           PE +      E+ D+++ GV+  + L G        +   E+ T++    R  + +F+  
Sbjct: 175 PEMIEGRMHDEKVDLWSLGVLCYEFLVG--------KPPFEANTYQETYKRISRVEFTFP 226
Query: 647 EAAKLGKMALVCT--HEDPENRPTMEAVIEELTVAA 680
           +    G   L+      +P  RP +  V+E   + A
Sbjct: 227 DFVTEGARDLISRLLKHNPSQRPMLREVLEHPWITA 262

>pdb|3D7U|A Chain A, Structural Basis For The Recognition Of C-Src By Its Inactivator Csk Length = 263

Iteration: 1
 Score = 66.2 bits (160), Expect = 6e-11,   Method: Compositional matrix adjust.
 Identities = 65/264 (24%), Positives = 118/264 (44%), Gaps = 28/264 (10%)
Query: 417 LGKGNFSSVYKGTLRDGTLVAIRSINVTSCKSEEAEFVKGLYLLTSLRHENIIRLRGFCC 476
           +GKG F  V  G  R G  VA++ I   +       F+    ++T LRH N+++L G   
Sbjct: 14  IGKGEFGDVMLGDYR-GNKVAVKCIKNDATAQA---FLAEASVMTQLRHSNLVQLLGVIV 69
Query: 477 SRGRGECFLIYDFAPKGKLSKYLDQEEGSSNVLDWSTRVSIIIGIAKGIGYLHSSEVNKP 536
              +G  +++ ++  KG L  YL +  G S VL     +   + + + + YL  +     
Sbjct: 70  EE-KGGLYIVTEYMAKGSLVDYL-RSRGRS-VLGGDCLLKFSLDVCEAMEYLEGNN---- 122
Query: 537 AIVHRNLSVEKVLIDQQFNPLIADCGLHKLLADDIVFSVLKTSA-AMGYLAPEYVTTGRF 595
             VHR+L+   VL+ +     ++D GL K  +     S   T    + + APE +   +F
Sbjct: 123 -FVHRDLAARNVLVSEDNVAKVSDFGLTKEAS-----STQDTGKLPVKWTAPEALREKKF 176
Query: 596 TERSDIFAFGVIILQILTGSLVLTSSMRLAAESATFENFIDRNLKG-KFSESEAAKLGKM 654
           + +SD+++FG+++ +I        S  R+       ++ + R  KG K    +       
Sbjct: 177 STKSDVWSFGILLWEIY-------SFGRVPYPRIPLKDVVPRVEKGYKMDAPDGCPPAVY 229
Query: 655 ALV--CTHEDPENRPTMEAVIEEL 676
            ++  C H D   RP+   + E+L
Sbjct: 230 EVMKNCWHLDAAMRPSFLQLREQL 253

>pdb|3H0Y|A Chain A, Aurora A In Complex With A Bisanilinopyrimidine Length = 268

Iteration: 1
 Score = 65.9 bits (159), Expect = 7e-11,   Method: Compositional matrix adjust.
 Identities = 64/276 (23%), Positives = 116/276 (42%), Gaps = 41/276 (14%)
Query: 417 LGKGNFSSVYKGTLRDGTLV-AIRSINVTSCKSE--EAEFVKGLYLLTSLRHENIIRLRG 473
           LGKG F +VY    +    + A++ +     +    E +  + + + + LRH NI+RL G
Sbjct: 16  LGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRLYG 75
Query: 474 FCCSRGRGECFLIYDFAPKGKLSKYLDQEEGSSNVLDWSTRVSIIIGIAKGIGYLHSSEV 533
           +     R   +LI ++AP G + + L +     +  D     + I  +A  + Y HS  V
Sbjct: 76  YFHDATR--VYLILEYAPLGTVYRELQK----LSKFDEQRTATYITELANALSYCHSKRV 129
Query: 534 NKPAIVHRNLSVEKVLIDQQFNPLIADCGLHKLLADDIVFSVLKTSA-------AMGYLA 586
                +HR++  E +L+       IAD G          +SV   S+        + YL 
Sbjct: 130 -----IHRDIKPENLLLGSAGELKIADFG----------WSVHAPSSRRAALCGTLDYLP 174
Query: 587 PEYVTTGRFTERSDIFAFGVIILQILTGSLVLTSSMRLAAESATFENFIDRNLKGKFSES 646
           PE +      E+ D+++ GV+  + L G        +   E+ T++    R  + +F+  
Sbjct: 175 PEMIEGRMHDEKVDLWSLGVLCYEFLVG--------KPPFEANTYQETYKRISRVEFTFP 226
Query: 647 EAAKLGKMALVCT--HEDPENRPTMEAVIEELTVAA 680
           +    G   L+      +P  RP +  V+E   + A
Sbjct: 227 DFVTEGARDLISRLLKHNPSQRPMLREVLEHPWITA 262

>pdb|3D7T|A Chain A, Structural Basis For The Recognition Of C-Src By Its Inactivator Csk Length = 269

Iteration: 1
 Score = 65.9 bits (159), Expect = 7e-11,   Method: Compositional matrix adjust.
 Identities = 64/263 (24%), Positives = 115/263 (43%), Gaps = 26/263 (9%)
Query: 417 LGKGNFSSVYKGTLRDGTLVAIRSINVTSCKSEEAEFVKGLYLLTSLRHENIIRLRGFCC 476
           +GKG F  V  G  R G  VA++ I   +       F+    ++T LRH N+++L G   
Sbjct: 20  IGKGEFGDVMLGDYR-GNKVAVKCIKNDATAQA---FLAEASVMTQLRHSNLVQLLGVIV 75
Query: 477 SRGRGECFLIYDFAPKGKLSKYLDQEEGSSNVLDWSTRVSIIIGIAKGIGYLHSSEVNKP 536
              +G  +++ ++  KG L  YL +  G S VL     +   + + + + YL  +     
Sbjct: 76  EE-KGGLYIVTEYMAKGSLVDYL-RSRGRS-VLGGDCLLKFSLDVCEAMEYLEGNN---- 128
Query: 537 AIVHRNLSVEKVLIDQQFNPLIADCGLHKLLADDIVFSVLKTSAAMGYLAPEYVTTGRFT 596
             VHR+L+   VL+ +     ++D GL K  +       L       + APE +    F+
Sbjct: 129 -FVHRDLAARNVLVSEDNVAKVSDFGLTKEASSTQDTGKLPVK----WTAPEALREAAFS 183
Query: 597 ERSDIFAFGVIILQILTGSLVLTSSMRLAAESATFENFIDRNLKG-KFSESEAAKLGKMA 655
            +SD+++FG+++ +I        S  R+       ++ + R  KG K    +        
Sbjct: 184 TKSDVWSFGILLWEIY-------SFGRVPYPRIPLKDVVPRVEKGYKMDAPDGCPPAVYE 236
Query: 656 LV--CTHEDPENRPTMEAVIEEL 676
           ++  C H D   RP+   + E+L
Sbjct: 237 VMKNCWHLDAAMRPSFLQLREQL 259

>pdb|1BYG|A Chain A, Kinase Domain Of Human C-Terminal Src Kinase (Csk) In Complex With Inhibitor Staurosporine Length = 278

Iteration: 1
 Score = 65.9 bits (159), Expect = 7e-11,   Method: Compositional matrix adjust.
 Identities = 65/264 (24%), Positives = 118/264 (44%), Gaps = 28/264 (10%)
Query: 417 LGKGNFSSVYKGTLRDGTLVAIRSINVTSCKSEEAEFVKGLYLLTSLRHENIIRLRGFCC 476
           +GKG F  V  G  R G  VA++ I   +       F+    ++T LRH N+++L G   
Sbjct: 29  IGKGEFGDVMLGDYR-GNKVAVKCIKNDATAQA---FLAEASVMTQLRHSNLVQLLGVIV 84
Query: 477 SRGRGECFLIYDFAPKGKLSKYLDQEEGSSNVLDWSTRVSIIIGIAKGIGYLHSSEVNKP 536
              +G  +++ ++  KG L  YL +  G S VL     +   + + + + YL  +     
Sbjct: 85  EE-KGGLYIVTEYMAKGSLVDYL-RSRGRS-VLGGDCLLKFSLDVCEAMEYLEGNN---- 137
Query: 537 AIVHRNLSVEKVLIDQQFNPLIADCGLHKLLADDIVFSVLKTSA-AMGYLAPEYVTTGRF 595
             VHR+L+   VL+ +     ++D GL K  +     S   T    + + APE +   +F
Sbjct: 138 -FVHRDLAARNVLVSEDNVAKVSDFGLTKEAS-----STQDTGKLPVKWTAPEALREKKF 191
Query: 596 TERSDIFAFGVIILQILTGSLVLTSSMRLAAESATFENFIDRNLKG-KFSESEAAKLGKM 654
           + +SD+++FG+++ +I        S  R+       ++ + R  KG K    +       
Sbjct: 192 STKSDVWSFGILLWEIY-------SFGRVPYPRIPLKDVVPRVEKGYKMDAPDGCPPAVY 244
Query: 655 ALV--CTHEDPENRPTMEAVIEEL 676
            ++  C H D   RP+   + E+L
Sbjct: 245 EVMKNCWHLDAAMRPSFLQLREQL 268

>pdb|2W1C|A Chain A, Structure Determination Of Aurora Kinase In Complex With Inhibitor Length = 275

Iteration: 1
 Score = 65.9 bits (159), Expect = 8e-11,   Method: Compositional matrix adjust.
 Identities = 64/276 (23%), Positives = 116/276 (42%), Gaps = 41/276 (14%)
Query: 417 LGKGNFSSVYKGTLRDGTLV-AIRSINVTSCKSE--EAEFVKGLYLLTSLRHENIIRLRG 473
           LGKG F +VY    +    + A++ +     +    E +  + + + + LRH NI+RL G
Sbjct: 19  LGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRLYG 78
Query: 474 FCCSRGRGECFLIYDFAPKGKLSKYLDQEEGSSNVLDWSTRVSIIIGIAKGIGYLHSSEV 533
           +     R   +LI ++AP G + + L +     +  D     + I  +A  + Y HS  V
Sbjct: 79  YFHDATR--VYLILEYAPLGTVYRELQK----LSKFDEQRTATYITELANALSYCHSKRV 132
Query: 534 NKPAIVHRNLSVEKVLIDQQFNPLIADCGLHKLLADDIVFSVLKTSA-------AMGYLA 586
                +HR++  E +L+       IAD G          +SV   S+        + YL 
Sbjct: 133 -----IHRDIKPENLLLGSAGELKIADFG----------WSVHAPSSRRXXLCGTLDYLP 177
Query: 587 PEYVTTGRFTERSDIFAFGVIILQILTGSLVLTSSMRLAAESATFENFIDRNLKGKFSES 646
           PE +      E+ D+++ GV+  + L G        +   E+ T++    R  + +F+  
Sbjct: 178 PEMIEGRMHDEKVDLWSLGVLCYEFLVG--------KPPFEANTYQETYKRISRVEFTFP 229
Query: 647 EAAKLGKMALVCT--HEDPENRPTMEAVIEELTVAA 680
           +    G   L+      +P  RP +  V+E   + A
Sbjct: 230 DFVTEGARDLISRLLKHNPSQRPMLREVLEHPWITA 265

>pdb|2W1D|A Chain A, Structure Determination Of Aurora Kinase In Complex With Inhibitor Length = 275

Iteration: 1
 Score = 65.9 bits (159), Expect = 8e-11,   Method: Compositional matrix adjust.
 Identities = 64/276 (23%), Positives = 116/276 (42%), Gaps = 41/276 (14%)
Query: 417 LGKGNFSSVYKGTLRDGTLV-AIRSINVTSCKSE--EAEFVKGLYLLTSLRHENIIRLRG 473
           LGKG F +VY    +    + A++ +     +    E +  + + + + LRH NI+RL G
Sbjct: 19  LGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRLYG 78
Query: 474 FCCSRGRGECFLIYDFAPKGKLSKYLDQEEGSSNVLDWSTRVSIIIGIAKGIGYLHSSEV 533
           +     R   +LI ++AP G + + L +     +  D     + I  +A  + Y HS  V
Sbjct: 79  YFHDATR--VYLILEYAPLGTVYRELQK----LSKFDEQRTATYITELANALSYCHSKRV 132
Query: 534 NKPAIVHRNLSVEKVLIDQQFNPLIADCGLHKLLADDIVFSVLKTSA-------AMGYLA 586
                +HR++  E +L+       IAD G          +SV   S+        + YL 
Sbjct: 133 -----IHRDIKPENLLLGSAGELKIADFG----------WSVHAPSSRRTTLCGTLDYLP 177
Query: 587 PEYVTTGRFTERSDIFAFGVIILQILTGSLVLTSSMRLAAESATFENFIDRNLKGKFSES 646
           PE +      E+ D+++ GV+  + L G        +   E+ T++    R  + +F+  
Sbjct: 178 PEMIEGRMHDEKVDLWSLGVLCYEFLVG--------KPPFEANTYQETYKRISRVEFTFP 229
Query: 647 EAAKLGKMALVCT--HEDPENRPTMEAVIEELTVAA 680
           +    G   L+      +P  RP +  V+E   + A
Sbjct: 230 DFVTEGARDLISRLLKHNPSQRPMLREVLEHPWITA 265

>pdb|2J0L|A Chain A, Crystal Structure Of A The Active Conformation Of The Kinase Domain Of Focal Adhesion Kinase With A Phosphorylated Activation Loop Length = 276

Iteration: 1
 Score = 65.9 bits (159), Expect = 8e-11,   Method: Compositional matrix adjust.
 Identities = 47/200 (23%), Positives = 88/200 (44%), Gaps = 15/200 (7%)
Query: 417 LGKGNFSSVYKGTLRD----GTLVAIRSINVTSCKSEEAEFVKGLYLLTSLRHENIIRLR 472
           +G+G F  V++G           VAI++    +  S   +F++    +    H +I++L 
Sbjct: 18  IGEGQFGDVHQGIYMSPENPAMAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVKLI 77
Query: 473 GFCCSRGRGECFLIYDFAPKGKLSKYLDQEEGSSNVLDWSTRVSIIIGIAKGIGYLHSSE 532
           G          ++I +    G+L  +L   + S   LD ++ +     ++  + YL S  
Sbjct: 78  GVITE---NPVWIIMELCTLGELRSFLQVRKFS---LDLASLILYAYQLSTALAYLESKR 131
Query: 533 VNKPAIVHRNLSVEKVLIDQQFNPLIADCGLHKLLADDIVFSVLKTSAAMGYLAPEYVTT 592
                 VHR+++   VL+       + D GL + + D       K    + ++APE +  
Sbjct: 132 -----FVHRDIAARNVLVSSNDCVKLGDFGLSRYMEDSTXXKASKGKLPIKWMAPESINF 186
Query: 593 GRFTERSDIFAFGVIILQIL 612
            RFT  SD++ FGV + +IL
Sbjct: 187 RRFTSASDVWMFGVCMWEIL 206

>pdb|1LUF|A Chain A, Crystal Structure Of The Musk Tyrosine Kinase: Insights Into Receptor Autoregulation Length = 343

Iteration: 1
 Score = 65.5 bits (158), Expect = 9e-11,   Method: Compositional matrix adjust.
 Identities = 64/282 (22%), Positives = 122/282 (43%), Gaps = 38/282 (13%)
Query: 414 VNLLGKGNFSSVYKG------TLRDGTLVAIRSINVTSCKSEEAEFVKGLYLLTSLRHEN 467
           V  +G+G F  V++            T+VA++ +   +    +A+F +   L+    + N
Sbjct: 52  VRDIGEGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASADMQADFQREAALMAEFDNPN 111
Query: 468 IIRLRGFCCSRGRGECFLIYDFAPKGKLSKYLDQEEG------SSNVLDWSTRVS----- 516
           I++L G C + G+  C L++++   G L+++L           S + L    RVS     
Sbjct: 112 IVKLLGVC-AVGKPMC-LLFEYMAYGDLNEFLRSMSPHTVCSLSHSDLSTRARVSSPGPP 169
Query: 517 ---------IIIGIAKGIGYLHSSEVNKPAIVHRNLSVEKVLIDQQFNPLIADCGLHK-L 566
                    I   +A G+ YL   +      VHR+L+    L+ +     IAD GL + +
Sbjct: 170 PLSCAEQLCIARQVAAGMAYLSERK-----FVHRDLATRNCLVGENMVVKIADFGLSRNI 224
Query: 567 LADDIVFSVLKTSAAMGYLAPEYVTTGRFTERSDIFAFGVIILQILTGSLVLTSSMRLAA 626
            + D   +    +  + ++ PE +   R+T  SD++A+GV++ +I +  L     M   A
Sbjct: 225 YSADYYKADGNDAIPIRWMPPESIFYNRYTTESDVWAYGVVLWEIFSYGLQPYYGM---A 281
Query: 627 ESATFENFIDRNLKGKFSESEAAKLGKMALVCTHEDPENRPT 668
                    D N+     E+   +L  +  +C  + P +RP+
Sbjct: 282 HEEVIYYVRDGNILA-CPENCPLELYNLMRLCWSKLPADRPS 322

>pdb|2WQE|A Chain A, Structure Of S155r Aurora-A Somatic Mutant Length = 262

Iteration: 1
 Score = 65.5 bits (158), Expect = 9e-11,   Method: Compositional matrix adjust.
 Identities = 64/276 (23%), Positives = 116/276 (42%), Gaps = 41/276 (14%)
Query: 417 LGKGNFSSVYKGTLRDGTLV-AIRSINVTSCKSE--EAEFVKGLYLLTSLRHENIIRLRG 473
           LGKG F +VY    +    + A++ +     +    E +  + + + + LRH NI+RL G
Sbjct: 13  LGKGKFGNVYLAREKQRKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRLYG 72
Query: 474 FCCSRGRGECFLIYDFAPKGKLSKYLDQEEGSSNVLDWSTRVSIIIGIAKGIGYLHSSEV 533
           +     R   +LI ++AP G + + L +     +  D     + I  +A  + Y HS  V
Sbjct: 73  YFHDATR--VYLILEYAPLGTVYRELQK----LSKFDEQRTATYITELANALSYCHSKRV 126
Query: 534 NKPAIVHRNLSVEKVLIDQQFNPLIADCGLHKLLADDIVFSVLKTSA-------AMGYLA 586
                +HR++  E +L+       IAD G          +SV   S+        + YL 
Sbjct: 127 -----IHRDIKPENLLLGSAGELKIADFG----------WSVHAPSSRRTTLCGTLDYLP 171
Query: 587 PEYVTTGRFTERSDIFAFGVIILQILTGSLVLTSSMRLAAESATFENFIDRNLKGKFSES 646
           PE +      E+ D+++ GV+  + L G        +   E+ T++    R  + +F+  
Sbjct: 172 PEMIEGRMHDEKVDLWSLGVLCYEFLVG--------KPPFEANTYQETYKRISRVEFTFP 223
Query: 647 EAAKLGKMALVCT--HEDPENRPTMEAVIEELTVAA 680
           +    G   L+      +P  RP +  V+E   + A
Sbjct: 224 DFVTEGARDLISRLLKHNPSQRPMLREVLEHPWITA 259

>pdb|3DAJ|A Chain A, Crystal Structure Of Aurora A Complexed With An Inhibitor Discovered Through Site-Directed Dynamic Tethering Length = 272

Iteration: 1
 Score = 65.5 bits (158), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 64/263 (24%), Positives = 113/263 (42%), Gaps = 40/263 (15%)
Query: 417 LGKGNFSSVYKGTLRDGTLV-AIRSINVTSCKSE--EAEFVKGLYLLTSLRHENIIRLRG 473
           LGKG F +VY    R    + A++ +  T  +    E +  + + + + LRH NI+RL G
Sbjct: 20  LGKGKFGNVYLARERQSKFILALKVLFKTQLEKAGVEHQLRREVEIQSHLRHPNILRLYG 79
Query: 474 FCCSRGRGECFLIYDFAPKGKLSKYLDQEEGSSNVLDWSTRVSIIIGIAKGIGYLHSSEV 533
           +     R   +LI ++AP G + + L +     +  D     + I  +A  + Y HS  V
Sbjct: 80  YFHDATR--VYLILEYAPLGTVYRELQK----LSRFDEQRTATYITELANALSYCHSKRV 133
Query: 534 NKPAIVHRNLSVEKVLIDQQFNPLIADCGLHKLLADDIVFSVLKTSA-------AMGYLA 586
                +HR++  E +L+       IAD G          +SV   S+        + YL 
Sbjct: 134 -----IHRDIKPENLLLGSNGELKIADFG----------WSVHAPSSRRDTLCGTLDYLP 178
Query: 587 PEYVTTGRFTERSDIFAFGVIILQILTG------SLVLTSSMRLAAESATFENFID---R 637
           PE +      E+ D+++ GV+  + L G           +  R++    TF +F+    R
Sbjct: 179 PEMIEGRMHDEKVDLWSLGVLCYEFLVGMPPFEAHTYQETYRRISRVEFTFPDFVTEGAR 238
Query: 638 NLKGKFSESEAAKLGKMALVCTH 660
           +L  +  +  A++   +A V  H
Sbjct: 239 DLISRLLKHNASQRLTLAEVLEH 261

>pdb|2IVV|A Chain A, Crystal Structure Of Phosphorylated Ret Tyrosine Kinase Domain Complexed With The Inhibitor Pp1 Length = 314

Iteration: 1
 Score = 65.5 bits (158), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 61/287 (21%), Positives = 124/287 (43%), Gaps = 38/287 (13%)
Query: 417 LGKGNFSSVYKGTL-----RDG-TLVAIRSINVTSCKSEEAEFVKGLYLLTSLRHENIIR 470
           LG+G F  V K T      R G T VA++ +   +  SE  + +    +L  + H ++I+
Sbjct: 31  LGEGEFGKVVKATAFHLKGRAGYTTVAVKMLKENASPSELRDLLSEFNVLKQVNHPHVIK 90
Query: 471 LRGFCCSRGRGECFLIYDFAPKGKLSKYLDQ--------------------EEGSSNVLD 510
           L G C     G   LI ++A  G L  +L +                    +      L 
Sbjct: 91  LYGACSQ--DGPLLLIVEYAKYGSLRGFLRESRKVGPGYLGSGGSRNSSSLDHPDERALT 148
Query: 511 WSTRVSIIIGIAKGIGYLHSSEVNKPAIVHRNLSVEKVLIDQQFNPLIADCGLHK-LLAD 569
               +S    I++G+ YL        ++VHR+L+   +L+ +     I+D GL + +  +
Sbjct: 149 MGDLISFAWQISQGMQYLAEM-----SLVHRDLAARNILVAEGRKMKISDFGLSRDVYEE 203
Query: 570 DIVFSVLKTSAAMGYLAPEYVTTGRFTERSDIFAFGVIILQILTGSLVLTSSMRLAAESA 629
           D      +    + ++A E +    +T +SD+++FGV++ +I+T    L  +        
Sbjct: 204 DSXVKRSQGRIPVKWMAIESLFDHIYTTQSDVWSFGVLLWEIVT----LGGNPYPGIPPE 259
Query: 630 TFENFIDRNLKGKFSESEAAKLGKMALVCTHEDPENRPTMEAVIEEL 676
              N +    + +  ++ + ++ ++ L C  ++P+ RP    + ++L
Sbjct: 260 RLFNLLKTGHRMERPDNCSEEMYRLMLQCWKQEPDKRPVFADISKDL 306

>pdb|3D14|A Chain A, Crystal Structure Of Mouse Aurora A (Asn186->gly, Lys240->arg, Met302- >leu) In Complex With 1-{5-[2-(Thieno[3,2-D]pyrimidin-4-Ylamino)- Ethyl]- Thiazol-2-Yl}-3-(3-Trifluoromethyl-Phenyl)-Urea Length = 272

Iteration: 1
 Score = 65.5 bits (158), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 64/263 (24%), Positives = 113/263 (42%), Gaps = 40/263 (15%)
Query: 417 LGKGNFSSVYKGTLRDGTLV-AIRSINVTSCKSE--EAEFVKGLYLLTSLRHENIIRLRG 473
           LGKG F +VY    R    + A++ +  T  +    E +  + + + + LRH NI+RL G
Sbjct: 20  LGKGKFGNVYLARERQSKFILALKVLFKTQLEKAGVEHQLRREVEIQSHLRHPNILRLYG 79
Query: 474 FCCSRGRGECFLIYDFAPKGKLSKYLDQEEGSSNVLDWSTRVSIIIGIAKGIGYLHSSEV 533
           +     R   +LI ++AP G + + L +     +  D     + I  +A  + Y HS  V
Sbjct: 80  YFHDATR--VYLILEYAPLGTVYRELQK----LSRFDEQRTATYITELANALSYCHSKRV 133
Query: 534 NKPAIVHRNLSVEKVLIDQQFNPLIADCGLHKLLADDIVFSVLKTSA-------AMGYLA 586
                +HR++  E +L+       IAD G          +SV   S+        + YL 
Sbjct: 134 -----IHRDIKPENLLLGSNGELKIADFG----------WSVHAPSSRRTTLCGTLDYLP 178
Query: 587 PEYVTTGRFTERSDIFAFGVIILQILTG------SLVLTSSMRLAAESATFENFID---R 637
           PE +      E+ D+++ GV+  + L G           +  R++    TF +F+    R
Sbjct: 179 PEMIEGRMHDEKVDLWSLGVLCYEFLVGMPPFEAHTYQETYRRISRVEFTFPDFVTEGAR 238
Query: 638 NLKGKFSESEAAKLGKMALVCTH 660
           +L  +  +  A++   +A V  H
Sbjct: 239 DLISRLLKHNASQRLTLAEVLEH 261

>pdb|4HZR|A Chain A, Crystal Structure Of Ack1 Kinase Domain Length = 277

Iteration: 1
 Score = 65.1 bits (157), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 66/272 (24%), Positives = 113/272 (41%), Gaps = 24/272 (8%)
Query: 417 LGKGNFSSVYKGTLR----DGTLVAIRSINVTSCKSEEA--EFVKGLYLLTSLRHENIIR 470
           LG G+F  V +G           VA++ +        EA  +F++ +  + SL H N+IR
Sbjct: 20  LGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLDHRNLIR 79
Query: 471 LRGFCCSRGRGECFLIYDFAPKGKLSKYLDQEEGSSNVLDWSTRVSIIIGIAKGIGYLHS 530
           L G   +       ++ + AP G L   L + +G   +    T     + +A+G+GYL S
Sbjct: 80  LYGVVLT---PPMKMVTELAPLGSLLDRLRKHQGHFLL---GTLSRYAVQVAEGMGYLES 133
Query: 531 SEVNKPAIVHRNLSVEKVLIDQQFNPLIADCGLHKLLA--DDIVFSVLKTSAAMGYLAPE 588
                   +HR+L+   +L+  +    I D GL + L   DD             + APE
Sbjct: 134 KR-----FIHRDLAARNLLLATRDLVKIGDFGLMRALPQNDDHYVMQEHRKVPFAWCAPE 188
Query: 589 YVTTGRFTERSDIFAFGVIILQILTGSLVLTSSMRLAAESATFENFIDRN-LKGKFSESE 647
            + T  F+  SD + FGV + ++ T          +    +   + ID+   +    E  
Sbjct: 189 SLKTRTFSHASDTWMFGVTLWEMFT----YGQEPWIGLNGSQILHKIDKEGERLPRPEDC 244
Query: 648 AAKLGKMALVCTHEDPENRPTMEAVIEELTVA 679
              +  + + C    PE+RPT  A+ + L  A
Sbjct: 245 PQDIYNVMVQCWAHKPEDRPTFVALRDFLLEA 276

>pdb|2WQM|A Chain A, Structure Of Apo Human Nek7 Length = 310

Iteration: 1
 Score = 65.1 bits (157), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 60/268 (22%), Positives = 115/268 (42%), Gaps = 27/268 (10%)
Query: 417 LGKGNFSSVYKGT-LRDGTLVAIRSINVTSCKSEEA--EFVKGLYLLTSLRHENIIRLRG 473
           +G+G FS VY+   L DG  VA++ + +      +A  + +K + LL  L H N+I+   
Sbjct: 40  IGRGQFSEVYRAACLLDGVPVALKKVQIFDLMDAKARADCIKEIDLLKQLNHPNVIKY-- 97
Query: 474 FCCSRGRGECFLIYDFAPKGKLSKYLDQEEGSSNVLDWSTRVSIIIGIAKGIGYLHSSEV 533
           +       E  ++ + A  G LS+ +   +    ++   T     + +   + ++HS  V
Sbjct: 98  YASFIEDNELNIVLELADAGDLSRMIKHFKKQKRLIPERTVWKYFVQLCSALEHMHSRRV 157
Query: 534 NKPAIVHRNLSVEKVLIDQQFNPLIADCGLHKLLADDIVFSVLKTSAAMG------YLAP 587
                +HR++    V I       + D GL +  +        KT+AA        Y++P
Sbjct: 158 -----MHRDIKPANVFITATGVVKLGDLGLGRFFSS-------KTTAAHSLVGTPYYMSP 205
Query: 588 EYVTTGRFTERSDIFAFGVIILQILT-GSLVLTSSMRLAAESATFENFIDRNLKGKFSES 646
           E +    +  +SDI++ G ++ ++    S      M L +     E      L    S+ 
Sbjct: 206 ERIHENGYNFKSDIWSLGCLLYEMAALQSPFYGDKMNLYSLCKKIEQCDYPPLP---SDH 262
Query: 647 EAAKLGKMALVCTHEDPENRPTMEAVIE 674
            + +L ++  +C + DPE RP +  V +
Sbjct: 263 YSEELRQLVNMCINPDPEKRPDVTYVYD 290

>pdb|2IVT|A Chain A, Crystal Structure Of Phosphorylated Ret Tyrosine Kinase Domain Length = 314

Iteration: 1
 Score = 65.1 bits (157), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 61/287 (21%), Positives = 124/287 (43%), Gaps = 38/287 (13%)
Query: 417 LGKGNFSSVYKGTL-----RDG-TLVAIRSINVTSCKSEEAEFVKGLYLLTSLRHENIIR 470
           LG+G F  V K T      R G T VA++ +   +  SE  + +    +L  + H ++I+
Sbjct: 31  LGEGEFGKVVKATAFHLKGRAGYTTVAVKMLKENASPSELRDLLSEFNVLKQVNHPHVIK 90
Query: 471 LRGFCCSRGRGECFLIYDFAPKGKLSKYLDQ--------------------EEGSSNVLD 510
           L G C     G   LI ++A  G L  +L +                    +      L 
Sbjct: 91  LYGACSQ--DGPLLLIVEYAKYGSLRGFLRESRKVGPGYLGSGGSRNSSSLDHPDERALT 148
Query: 511 WSTRVSIIIGIAKGIGYLHSSEVNKPAIVHRNLSVEKVLIDQQFNPLIADCGLHK-LLAD 569
               +S    I++G+ YL   +     +VHR+L+   +L+ +     I+D GL + +  +
Sbjct: 149 MGDLISFAWQISQGMQYLAEMK-----LVHRDLAARNILVAEGRKMKISDFGLSRDVYEE 203
Query: 570 DIVFSVLKTSAAMGYLAPEYVTTGRFTERSDIFAFGVIILQILTGSLVLTSSMRLAAESA 629
           D      +    + ++A E +    +T +SD+++FGV++ +I+T    L  +        
Sbjct: 204 DSXVKRSQGRIPVKWMAIESLFDHIYTTQSDVWSFGVLLWEIVT----LGGNPYPGIPPE 259
Query: 630 TFENFIDRNLKGKFSESEAAKLGKMALVCTHEDPENRPTMEAVIEEL 676
              N +    + +  ++ + ++ ++ L C  ++P+ RP    + ++L
Sbjct: 260 RLFNLLKTGHRMERPDNCSEEMYRLMLQCWKQEPDKRPVFADISKDL 306

>pdb|2IVS|A Chain A, Crystal Structure Of Non-Phosphorylated Ret Tyrosine Kinase Domain Length = 314

Iteration: 1
 Score = 65.1 bits (157), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 61/287 (21%), Positives = 124/287 (43%), Gaps = 38/287 (13%)
Query: 417 LGKGNFSSVYKGTL-----RDG-TLVAIRSINVTSCKSEEAEFVKGLYLLTSLRHENIIR 470
           LG+G F  V K T      R G T VA++ +   +  SE  + +    +L  + H ++I+
Sbjct: 31  LGEGEFGKVVKATAFHLKGRAGYTTVAVKMLKENASPSELRDLLSEFNVLKQVNHPHVIK 90
Query: 471 LRGFCCSRGRGECFLIYDFAPKGKLSKYLDQ--------------------EEGSSNVLD 510
           L G C     G   LI ++A  G L  +L +                    +      L 
Sbjct: 91  LYGACSQ--DGPLLLIVEYAKYGSLRGFLRESRKVGPGYLGSGGSRNSSSLDHPDERALT 148
Query: 511 WSTRVSIIIGIAKGIGYLHSSEVNKPAIVHRNLSVEKVLIDQQFNPLIADCGLHK-LLAD 569
               +S    I++G+ YL   +     +VHR+L+   +L+ +     I+D GL + +  +
Sbjct: 149 MGDLISFAWQISQGMQYLAEMK-----LVHRDLAARNILVAEGRKMKISDFGLSRDVYEE 203
Query: 570 DIVFSVLKTSAAMGYLAPEYVTTGRFTERSDIFAFGVIILQILTGSLVLTSSMRLAAESA 629
           D      +    + ++A E +    +T +SD+++FGV++ +I+T    L  +        
Sbjct: 204 DSYVKRSQGRIPVKWMAIESLFDHIYTTQSDVWSFGVLLWEIVT----LGGNPYPGIPPE 259
Query: 630 TFENFIDRNLKGKFSESEAAKLGKMALVCTHEDPENRPTMEAVIEEL 676
              N +    + +  ++ + ++ ++ L C  ++P+ RP    + ++L
Sbjct: 260 RLFNLLKTGHRMERPDNCSEEMYRLMLQCWKQEPDKRPVFADISKDL 306

>pdb|4ID7|A Chain A, Ack1 Kinase In Complex With The Inhibitor Cis-3-[8-amino-1-(4- Phenoxyphenyl)imidazo[1,5-a]pyrazin-3-yl]cyclobutanol Length = 273

Iteration: 1
 Score = 65.1 bits (157), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 66/272 (24%), Positives = 113/272 (41%), Gaps = 24/272 (8%)
Query: 417 LGKGNFSSVYKGTLR----DGTLVAIRSINVTSCKSEEA--EFVKGLYLLTSLRHENIIR 470
           LG G+F  V +G           VA++ +        EA  +F++ +  + SL H N+IR
Sbjct: 16  LGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLDHRNLIR 75
Query: 471 LRGFCCSRGRGECFLIYDFAPKGKLSKYLDQEEGSSNVLDWSTRVSIIIGIAKGIGYLHS 530
           L G   +       ++ + AP G L   L + +G   +    T     + +A+G+GYL S
Sbjct: 76  LYGVVLT---PPMKMVTELAPLGSLLDRLRKHQGHFLL---GTLSRYAVQVAEGMGYLES 129
Query: 531 SEVNKPAIVHRNLSVEKVLIDQQFNPLIADCGLHKLLA--DDIVFSVLKTSAAMGYLAPE 588
                   +HR+L+   +L+  +    I D GL + L   DD             + APE
Sbjct: 130 KR-----FIHRDLAARNLLLATRDLVKIGDFGLMRALPQNDDHYVMQEHRKVPFAWCAPE 184
Query: 589 YVTTGRFTERSDIFAFGVIILQILTGSLVLTSSMRLAAESATFENFIDRN-LKGKFSESE 647
            + T  F+  SD + FGV + ++ T          +    +   + ID+   +    E  
Sbjct: 185 SLKTRTFSHASDTWMFGVTLWEMFT----YGQEPWIGLNGSQILHKIDKEGERLPRPEDC 240
Query: 648 AAKLGKMALVCTHEDPENRPTMEAVIEELTVA 679
              +  + + C    PE+RPT  A+ + L  A
Sbjct: 241 PQDIYNVMVQCWAHKPEDRPTFVALRDFLLEA 272

>pdb|3C4C|A Chain A, B-Raf Kinase In Complex With Plx4720 Length = 280

Iteration: 1
 Score = 64.7 bits (156), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 50/207 (24%), Positives = 100/207 (48%), Gaps = 22/207 (10%)
Query: 417 LGKGNFSSVYKGTLRDGTLVAIRSINVTSCKSEEAE-FVKGLYLLTSLRHENIIRLRGFC 475
           +G G+F +VYKG       VA++ +NVT+   ++ + F   + +L   RH NI+   G+ 
Sbjct: 20  IGSGSFGTVYKGKWHGD--VAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFMGYS 77
Query: 476 CSRGRGECFLIYDFAPKGKLSKYLDQEEGSSNVLDWSTRVSIIIGIAKGIGYLHSSEVNK 535
               + +  ++  +     L  +L     S    +    + I    A+G+ YLH+     
Sbjct: 78  T---KPQLAIVTQWCEGSSLYHHL---HASETKFEMKKLIDIARQTARGMDYLHAK---- 127
Query: 536 PAIVHRNLSVEKVLIDQQFNPLIADCGLHKL---LADDIVFSVLKTSAAMGYLAPEYVT- 591
            +I+HR+L    + + +     I D GL  +    +    F  L  S ++ ++APE +  
Sbjct: 128 -SIIHRDLKSNNIFLHEDNTVKIGDFGLATVKSRWSGSHQFEQL--SGSILWMAPEVIRM 184
Query: 592 --TGRFTERSDIFAFGVIILQILTGSL 616
             +  ++ +SD++AFG+++ +++TG L
Sbjct: 185 QDSNPYSFQSDVYAFGIVLYELMTGQL 211

>pdb|4FK3|A Chain A, B-Raf Kinase V600e Oncogenic Mutant In Complex With Plx3203 Length = 292

Iteration: 1
 Score = 64.7 bits (156), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 50/207 (24%), Positives = 99/207 (47%), Gaps = 22/207 (10%)
Query: 417 LGKGNFSSVYKGTLRDGTLVAIRSINVTSCKSEEAE-FVKGLYLLTSLRHENIIRLRGFC 475
           +G G+F +VYKG       VA++ +NVT+   ++ + F   + +L   RH NI+   G+ 
Sbjct: 32  IGSGSFGTVYKGKWHGD--VAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFMGYS 89
Query: 476 CSRGRGECFLIYDFAPKGKLSKYLDQEEGSSNVLDWSTRVSIIIGIAKGIGYLHSSEVNK 535
               + +  ++  +     L  +L     S    +    + I    A+G+ YLH+     
Sbjct: 90  T---KPQLAIVTQWCEGSSLYHHL---HASETKFEMKKLIDIARQTARGMDYLHAK---- 139
Query: 536 PAIVHRNLSVEKVLIDQQFNPLIADCGL---HKLLADDIVFSVLKTSAAMGYLAPEYVT- 591
            +I+HR+L    + + +     I D GL       +    F  L  S ++ ++APE +  
Sbjct: 140 -SIIHRDLKSNNIFLHEDNTVKIGDFGLATEKSRWSGSHQFEQL--SGSILWMAPEVIRM 196
Query: 592 --TGRFTERSDIFAFGVIILQILTGSL 616
             +  ++ +SD++AFG+++ +++TG L
Sbjct: 197 QDSNPYSFQSDVYAFGIVLYELMTGQL 223

>pdb|1OL6|A Chain A, Structure Of Unphosphorylated D274n Mutant Of Aurora-a Length = 282

Iteration: 1
 Score = 64.7 bits (156), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 63/276 (22%), Positives = 116/276 (42%), Gaps = 41/276 (14%)
Query: 417 LGKGNFSSVYKGTLRDGTLV-AIRSINVTSCKSE--EAEFVKGLYLLTSLRHENIIRLRG 473
           LGKG F +VY    +    + A++ +     +    E +  + + + + LRH NI+RL G
Sbjct: 18  LGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRLYG 77
Query: 474 FCCSRGRGECFLIYDFAPKGKLSKYLDQEEGSSNVLDWSTRVSIIIGIAKGIGYLHSSEV 533
           +     R   +LI ++AP G + + L +     +  D     + I  +A  + Y HS  V
Sbjct: 78  YFHDATR--VYLILEYAPLGTVYRELQK----LSKFDEQRTATYITELANALSYCHSKRV 131
Query: 534 NKPAIVHRNLSVEKVLIDQQFNPLIADCGLHKLLADDIVFSVLKTSA-------AMGYLA 586
                +HR++  E +L+       IA+ G          +SV   S+        + YL 
Sbjct: 132 -----IHRDIKPENLLLGSAGELKIANFG----------WSVHAPSSRRTTLCGTLDYLP 176
Query: 587 PEYVTTGRFTERSDIFAFGVIILQILTGSLVLTSSMRLAAESATFENFIDRNLKGKFSES 646
           PE +      E+ D+++ GV+  + L G        +   E+ T++    R  + +F+  
Sbjct: 177 PEMIEGRMHDEKVDLWSLGVLCYEFLVG--------KPPFEANTYQETYKRISRVEFTFP 228
Query: 647 EAAKLGKMALVCT--HEDPENRPTMEAVIEELTVAA 680
           +    G   L+      +P  RP +  V+E   + A
Sbjct: 229 DFVTEGARDLISRLLKHNPSQRPMLREVLEHPWITA 264

>pdb|2XNE|A Chain A, Structure Of Aurora-A Bound To An Imidazopyrazine Inhibitor Length = 272

Iteration: 1
 Score = 64.3 bits (155), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 63/276 (22%), Positives = 116/276 (42%), Gaps = 41/276 (14%)
Query: 417 LGKGNFSSVYKGTLRDGTLV-AIRSINVTSCKSE--EAEFVKGLYLLTSLRHENIIRLRG 473
           LGKG F +VY    +    + A++ +     +    E +  + + + + LRH NI+RL G
Sbjct: 19  LGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRLYG 78
Query: 474 FCCSRGRGECFLIYDFAPKGKLSKYLDQEEGSSNVLDWSTRVSIIIGIAKGIGYLHSSEV 533
           +     R   +LI ++AP G + + L +     +  D     + I  +A  + Y HS  V
Sbjct: 79  YFHDATR--VYLILEYAPLGTVYRELQK----LSKFDEQRTATYITELANALSYCHSKRV 132
Query: 534 NKPAIVHRNLSVEKVLIDQQFNPLIADCGLHKLLADDIVFSVLKTSA-------AMGYLA 586
                +HR++  E +L+       IA+ G          +SV   S+        + YL 
Sbjct: 133 -----IHRDIKPENLLLGSAGELKIANFG----------WSVHAPSSRRTTLCGTLDYLP 177
Query: 587 PEYVTTGRFTERSDIFAFGVIILQILTGSLVLTSSMRLAAESATFENFIDRNLKGKFSES 646
           PE +      E+ D+++ GV+  + L G        +   E+ T++    R  + +F+  
Sbjct: 178 PEMIEGRMHDEKVDLWSLGVLCYEFLVG--------KPPFEANTYQETYKRISRVEFTFP 229
Query: 647 EAAKLGKMALVCT--HEDPENRPTMEAVIEELTVAA 680
           +    G   L+      +P  RP +  V+E   + A
Sbjct: 230 DFVTEGARDLISRLLKHNPSQRPMLREVLEHPWITA 265

>pdb|3OG7|A Chain A, B-Raf Kinase V600e Oncogenic Mutant In Complex With Plx4032 Length = 289

Iteration: 1
 Score = 64.3 bits (155), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 50/207 (24%), Positives = 99/207 (47%), Gaps = 22/207 (10%)
Query: 417 LGKGNFSSVYKGTLRDGTLVAIRSINVTSCKSEEAE-FVKGLYLLTSLRHENIIRLRGFC 475
           +G G+F +VYKG       VA++ +NVT+   ++ + F   + +L   RH NI+   G+ 
Sbjct: 32  IGSGSFGTVYKGKWHGD--VAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFMGYS 89
Query: 476 CSRGRGECFLIYDFAPKGKLSKYLDQEEGSSNVLDWSTRVSIIIGIAKGIGYLHSSEVNK 535
            +    +  ++  +     L  +L     S    +    + I    A+G+ YLH+     
Sbjct: 90  TA---PQLAIVTQWCEGSSLYHHL---HASETKFEMKKLIDIARQTARGMDYLHAK---- 139
Query: 536 PAIVHRNLSVEKVLIDQQFNPLIADCGL---HKLLADDIVFSVLKTSAAMGYLAPEYVT- 591
            +I+HR+L    + + +     I D GL       +    F  L  S ++ ++APE +  
Sbjct: 140 -SIIHRDLKSNNIFLHEDNTVKIGDFGLATEKSRWSGSHQFEQL--SGSILWMAPEVIRM 196
Query: 592 --TGRFTERSDIFAFGVIILQILTGSL 616
             +  ++ +SD++AFG+++ +++TG L
Sbjct: 197 QDSNPYSFQSDVYAFGIVLYELMTGQL 223

>pdb|2JAV|A Chain A, Human Kinase With Pyrrole-Indolinone Ligand Length = 279

Iteration: 1
 Score = 63.9 bits (154), Expect = 3e-10,   Method: Compositional matrix adjust.
 Identities = 57/282 (20%), Positives = 120/282 (42%), Gaps = 30/282 (10%)
Query: 406 SATQCFSEVNLLGKGNFSSVYKGTLR-DGTLVAIRSINVTS-CKSEEAEFVKGLYLLTSL 463
           S  + +  +  +G G++    K   + DG ++  + ++  S  ++E+   V  + LL  L
Sbjct: 3   SRAEDYEVLYTIGTGSYGRCQKIRRKSDGKILVWKELDYGSMTEAEKQMLVSEVNLLREL 62
Query: 464 RHENIIRLRGFCCSRGRGECFLIYDFAPKGKLSKYLDQEEGSSNVLDWSTRVSIIIGIAK 523
           +H NI+R       R     +++ ++   G L+  + +       LD    + ++  +  
Sbjct: 63  KHPNIVRYYDRIIDRTNTTLYIVMEYCEGGDLASVITKGTKERQYLDEEFVLRVMTQLTL 122
Query: 524 GIGYLHSSEVNKPAIVHRNLSVEKVLIDQQFNPLIADCGLHKLLADDIVFSVLKTSAAMG 583
            +   H        ++HR+L    V +D + N  + D GL ++L  D  F+     A +G
Sbjct: 123 ALKECHRRSDGGHTVLHRDLKPANVFLDGKQNVKLGDFGLARILNHDTSFA----KAFVG 178
Query: 584 ---YLAPEYVTTGRFTERSDIFAFGVIILQILTGSLVLTSSMRLAAESATFENFIDRNLK 640
              Y++PE +    + E+SDI++ G ++ +             L A    F  F  + L 
Sbjct: 179 TPYYMSPEQMNRMSYNEKSDIWSLGCLLYE-------------LCALMPPFTAFSQKELA 225
Query: 641 GKFSESE--------AAKLGKMALVCTHEDPENRPTMEAVIE 674
           GK  E +        + +L ++     +    +RP++E ++E
Sbjct: 226 GKIREGKFRRIPYRYSDELNEIITRMLNLKDYHRPSVEEILE 267

>pdb|1RJB|A Chain A, Crystal Structure Of Flt3 Length = 344

Iteration: 1
 Score = 63.5 bits (153), Expect = 4e-10,   Method: Compositional matrix adjust.
 Identities = 59/227 (25%), Positives = 104/227 (45%), Gaps = 36/227 (15%)
Query: 415 NLLGKGNFSSVYKGTL----RDGT--LVAIRSINVTSCKSEEAEFVKGLYLLTSL-RHEN 467
            +LG G F  V   T     + G    VA++ +   +  SE    +  L ++T L  HEN
Sbjct: 51  KVLGSGAFGKVMNATAYGISKTGVSIQVAVKMLKEKADSSEREALMSELKMMTQLGSHEN 110
Query: 468 IIRLRGFCCSRGRGECFLIYDFAPKGKLSKYLD-------------------QEEGSSNV 508
           I+ L G C   G    +LI+++   G L  YL                    +EE   NV
Sbjct: 111 IVNLLGACTLSG--PIYLIFEYCCYGDLLNYLRSKREKFSEDEIEYENQKRLEEEEDLNV 168
Query: 509 LDWSTRVSIIIGIAKGIGYLHSSEVNKPAIVHRNLSVEKVLIDQQFNPLIADCGLHKLLA 568
           L +   +     +AKG+ +L        + VHR+L+   VL+       I D GL + + 
Sbjct: 169 LTFEDLLCFAYQVAKGMEFLEFK-----SCVHRDLAARNVLVTHGKVVKICDFGLARDIM 223
Query: 569 DDIVFSVLKTSAAM--GYLAPEYVTTGRFTERSDIFAFGVIILQILT 613
            D  + V++ +A +   ++APE +  G +T +SD++++G+++ +I +
Sbjct: 224 SDSNY-VVRGNARLPVKWMAPESLFEGIYTIKSDVWSYGILLWEIFS 269

>pdb|2W5A|A Chain A, Human Nek2 Kinase Adp-Bound Length = 279

Iteration: 1
 Score = 63.5 bits (153), Expect = 4e-10,   Method: Compositional matrix adjust.
 Identities = 57/280 (20%), Positives = 119/280 (42%), Gaps = 26/280 (9%)
Query: 406 SATQCFSEVNLLGKGNFSSVYKGTLR-DGTLVAIRSINVTS-CKSEEAEFVKGLYLLTSL 463
           S  + +  +  +G G++    K   + DG ++  + ++  S  ++E+   V  + LL  L
Sbjct: 3   SRAEDYEVLYTIGTGSYGRCQKIRRKSDGKILVWKELDYGSMTEAEKQMLVSEVNLLREL 62
Query: 464 RHENIIRLRGFCCSRGRGECFLIYDFAPKGKLSKYLDQEEGSSNVLDWSTRVSIIIGIAK 523
           +H NI+R       R     +++ ++   G L+  + +       LD    + ++  +  
Sbjct: 63  KHPNIVRYYDRIIDRTNTTLYIVMEYCEGGDLASVITKGTKERQYLDEEFVLRVMTQLTL 122
Query: 524 GIGYLHSSEVNKPAIVHRNLSVEKVLIDQQFNPLIADCGLHKLLADDIVFSVLKTSAAMG 583
            +   H        ++HR+L    V +D + N  + D GL ++L  D  F+  KT     
Sbjct: 123 ALKECHRRSDGGHTVLHRDLKPANVFLDGKQNVKLGDFGLARILNHDTSFA--KTFVGTP 180
Query: 584 -YLAPEYVTTGRFTERSDIFAFGVIILQILTGSLVLTSSMRLAAESATFENFIDRNLKGK 642
            Y++PE +    + E+SDI++ G ++ +             L A    F  F  + L GK
Sbjct: 181 YYMSPEQMNRMSYNEKSDIWSLGCLLYE-------------LCALMPPFTAFSQKELAGK 227
Query: 643 FSESE--------AAKLGKMALVCTHEDPENRPTMEAVIE 674
             E +        + +L ++     +    +RP++E ++E
Sbjct: 228 IREGKFRRIPYRYSDELNEIITRMLNLKDYHRPSVEEILE 267

>pdb|3MY0|A Chain A, Crystal Structure Of The Acvrl1 (Alk1) Kinase Domain Bound To Ldn- 193189 Length = 305

Iteration: 1
 Score = 63.2 bits (152), Expect = 5e-10,   Method: Compositional matrix adjust.
 Identities = 58/222 (26%), Positives = 103/222 (46%), Gaps = 30/222 (13%)
Query: 414 VNLLGKGNFSSVYKGTLRDGTLVAIRSINVTSCKSEEAEFVKG-LYLLTSLRHENIIRLR 472
           V  +GKG +  V++G L  G  VA++   + S + E++ F +  +Y    LRH+NI+   
Sbjct: 13  VECVGKGRYGEVWRG-LWHGESVAVK---IFSSRDEQSWFRETEIYNTVLLRHDNIL--- 65
Query: 473 GFCCS-----RGRGECFLIYDFAPKGKLSKYLDQEEGSSNVLDWSTRVSIIIGIAKGIGY 527
           GF  S         + +LI  +   G L  +L ++      L+    + + +  A G+ +
Sbjct: 66  GFIASDMTSRNSSTQLWLITHYHEHGSLYDFLQRQ-----TLEPHLALRLAVSAACGLAH 120
Query: 528 LHSS---EVNKPAIVHRNLSVEKVLIDQQFNPLIADCGLHKLLADDIVFSVLKTSAAMG- 583
           LH        KPAI HR+     VL+       IAD GL  + +    +  +  +  +G 
Sbjct: 121 LHVEIFGTQGKPAIAHRDFKSRNVLVKSNLQCCIADLGLAVMHSQGSDYLDIGNNPRVGT 180
Query: 584 --YLAPEYVTTGRFTE------RSDIFAFGVIILQILTGSLV 617
             Y+APE +     T+       +DI+AFG+++ +I   ++V
Sbjct: 181 KRYMAPEVLDEQIRTDCFESYKWTDIWAFGLVLWEIARRTIV 222

>pdb|2FB8|A Chain A, Structure Of The B-Raf Kinase Domain Bound To Sb-590885 Length = 281

Iteration: 1
 Score = 62.8 bits (151), Expect = 6e-10,   Method: Compositional matrix adjust.
 Identities = 50/207 (24%), Positives = 100/207 (48%), Gaps = 22/207 (10%)
Query: 417 LGKGNFSSVYKGTLRDGTLVAIRSINVTSCKSEEAE-FVKGLYLLTSLRHENIIRLRGFC 475
           +G G+F +VYKG       VA++ +NVT+   ++ + F   + +L   RH NI+   G+ 
Sbjct: 21  IGSGSFGTVYKGKWHGD--VAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFMGYS 78
Query: 476 CSRGRGECFLIYDFAPKGKLSKYLDQEEGSSNVLDWSTRVSIIIGIAKGIGYLHSSEVNK 535
               + +  ++  +     L  +L   E    ++     + I    A+G+ YLH+     
Sbjct: 79  T---KPQLAIVTQWCEGSSLYHHLHIIETKFEMI---KLIDIARQTAQGMDYLHAK---- 128
Query: 536 PAIVHRNLSVEKVLIDQQFNPLIADCGLHKL---LADDIVFSVLKTSAAMGYLAPEYVT- 591
            +I+HR+L    + + +     I D GL  +    +    F  L  S ++ ++APE +  
Sbjct: 129 -SIIHRDLKSNNIFLHEDLTVKIGDFGLATVKSRWSGSHQFEQL--SGSILWMAPEVIRM 185
Query: 592 --TGRFTERSDIFAFGVIILQILTGSL 616
                ++ +SD++AFG+++ +++TG L
Sbjct: 186 QDKNPYSFQSDVYAFGIVLYELMTGQL 212

>pdb|3Q96|A Chain A, B-Raf Kinase Domain In Complex With A Tetrahydronaphthalene Inhibitor Length = 282

Iteration: 1
 Score = 62.8 bits (151), Expect = 6e-10,   Method: Compositional matrix adjust.
 Identities = 50/207 (24%), Positives = 100/207 (48%), Gaps = 22/207 (10%)
Query: 417 LGKGNFSSVYKGTLRDGTLVAIRSINVTSCKSEEAE-FVKGLYLLTSLRHENIIRLRGFC 475
           +G G+F +VYKG       VA++ +NVT+   ++ + F   + +L   RH NI+   G+ 
Sbjct: 18  IGSGSFGTVYKGKWHGD--VAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFMGYS 75
Query: 476 CSRGRGECFLIYDFAPKGKLSKYLDQEEGSSNVLDWSTRVSIIIGIAKGIGYLHSSEVNK 535
               + +  ++  +     L  +L   E    ++     + I    A+G+ YLH+     
Sbjct: 76  T---KPQLAIVTQWCEGSSLYHHLHIIETKFEMI---KLIDIARQTAQGMDYLHAK---- 125
Query: 536 PAIVHRNLSVEKVLIDQQFNPLIADCGLHKL---LADDIVFSVLKTSAAMGYLAPEYVT- 591
            +I+HR+L    + + +     I D GL  +    +    F  L  S ++ ++APE +  
Sbjct: 126 -SIIHRDLKSNNIFLHEDLTVKIGDFGLATVKSRWSGSHQFEQL--SGSILWMAPEVIRM 182
Query: 592 --TGRFTERSDIFAFGVIILQILTGSL 616
                ++ +SD++AFG+++ +++TG L
Sbjct: 183 QDKNPYSFQSDVYAFGIVLYELMTGQL 209

>pdb|2OGV|A Chain A, Crystal Structure Of The Autoinhibited Human C-Fms Kinase Domain Length = 317

Iteration: 1
 Score = 62.8 bits (151), Expect = 6e-10,   Method: Compositional matrix adjust.
 Identities = 69/286 (24%), Positives = 134/286 (46%), Gaps = 56/286 (19%)
Query: 417 LGKGNFSSVYKGTL-----RDGTL-VAIRSINVTSCKSEEAEFVKGLYLLTSL-RHENII 469
           LG G F  V + T       D  L VA++ +  T+   E+   +  L +++ L +HENI+
Sbjct: 46  LGAGAFGKVVEATAFGLGKEDAVLKVAVKMLKSTAHADEKEALMSELKIMSHLGQHENIV 105
Query: 470 RLRGFCCSRGRGECFLIYDFAPKGKLSKYL--------DQEEGS----SNVLDWSTRVSI 517
            L G  C+ G G   +I ++   G L  +L        D+E+G      ++L +S++V  
Sbjct: 106 NLLG-ACTHG-GPVLVITEYCCYGDLLNFLRRKAEADLDKEDGRPLELRDLLHFSSQV-- 161
Query: 518 IIGIAKGIGYLHSSEVNKPAIVHRNLSVEKVLIDQQFNPLIADCGLHKLLADDIVFSVLK 577
               A+G+ +L S        +HR+++   VL+       I D GL + + +D  + ++K
Sbjct: 162 ----AQGMAFLASKNC-----IHRDVAARNVLLTNGHVAKIGDFGLARDIMNDSNY-IVK 211
Query: 578 TSAAM--GYLAPEYVTTGRFTERSDIFAFGVIILQILT-------GSLVLTSSMRLAAES 628
            +A +   ++APE +    +T +SD++++G+++ +I +       G LV +   +L  + 
Sbjct: 212 GNARLPVKWMAPESIFDCVYTVQSDVWSYGILLWEIFSLGLNPYPGILVNSKFYKLVKDG 271
Query: 629 ATFEN--FIDRNLKGKFSESEAAKLGKMALVCTHEDPENRPTMEAV 672
                  F  +N+   +S  +A         C   +P +RPT + +
Sbjct: 272 YQMAQPAFAPKNI---YSIMQA---------CWALEPTHRPTFQQI 305

>pdb|4H58|A Chain A, Braf In Complex With Compound 3 Length = 275

Iteration: 1
 Score = 62.8 bits (151), Expect = 7e-10,   Method: Compositional matrix adjust.
 Identities = 50/207 (24%), Positives = 100/207 (48%), Gaps = 22/207 (10%)
Query: 417 LGKGNFSSVYKGTLRDGTLVAIRSINVTSCKSEEAE-FVKGLYLLTSLRHENIIRLRGFC 475
           +G G+F +VYKG       VA++ +NVT+   ++ + F   + +L   RH NI+   G+ 
Sbjct: 16  IGSGSFGTVYKGKWHGD--VAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFMGYS 73
Query: 476 CSRGRGECFLIYDFAPKGKLSKYLDQEEGSSNVLDWSTRVSIIIGIAKGIGYLHSSEVNK 535
               + +  ++  +     L  +L   E    ++     + I    A+G+ YLH+     
Sbjct: 74  T---KPQLAIVTQWCEGSSLYHHLHIIETKFEMI---KLIDIARQTAQGMDYLHAK---- 123
Query: 536 PAIVHRNLSVEKVLIDQQFNPLIADCGLHKL---LADDIVFSVLKTSAAMGYLAPEYVT- 591
            +I+HR+L    + + +     I D GL  +    +    F  L  S ++ ++APE +  
Sbjct: 124 -SIIHRDLKSNNIFLHEDLTVKIGDFGLATVKSRWSGSHQFEQL--SGSILWMAPEVIRM 180
Query: 592 --TGRFTERSDIFAFGVIILQILTGSL 616
                ++ +SD++AFG+++ +++TG L
Sbjct: 181 QDKNPYSFQSDVYAFGIVLYELMTGQL 207

>pdb|4DBN|A Chain A, Crystal Structure Of The Kinase Domain Of Human B-Raf With A [1, 3]thiazolo[5,4-B]pyridine Derivative Length = 284

Iteration: 1
 Score = 62.8 bits (151), Expect = 7e-10,   Method: Compositional matrix adjust.
 Identities = 50/207 (24%), Positives = 100/207 (48%), Gaps = 22/207 (10%)
Query: 417 LGKGNFSSVYKGTLRDGTLVAIRSINVTSCKSEEAE-FVKGLYLLTSLRHENIIRLRGFC 475
           +G G+F +VYKG       VA++ +NVT+   ++ + F   + +L   RH NI+   G+ 
Sbjct: 21  IGSGSFGTVYKGKWHGD--VAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFMGYS 78
Query: 476 CSRGRGECFLIYDFAPKGKLSKYLDQEEGSSNVLDWSTRVSIIIGIAKGIGYLHSSEVNK 535
               + +  ++  +     L  +L   E    ++     + I    A+G+ YLH+     
Sbjct: 79  T---KPQLAIVTQWCEGSSLYHHLHIIETKFEMI---KLIDIARQTAQGMDYLHAK---- 128
Query: 536 PAIVHRNLSVEKVLIDQQFNPLIADCGLHKL---LADDIVFSVLKTSAAMGYLAPEYVT- 591
            +I+HR+L    + + +     I D GL  +    +    F  L  S ++ ++APE +  
Sbjct: 129 -SIIHRDLKSNNIFLHEDLTVKIGDFGLATVKSRWSGSHQFEQL--SGSILWMAPEVIRM 185
Query: 592 --TGRFTERSDIFAFGVIILQILTGSL 616
                ++ +SD++AFG+++ +++TG L
Sbjct: 186 QDKNPYSFQSDVYAFGIVLYELMTGQL 212

>pdb|3D4Q|A Chain A, Pyrazole-Based Inhibitors Of B-Raf Kinase Length = 307

Iteration: 1
 Score = 62.4 bits (150), Expect = 8e-10,   Method: Compositional matrix adjust.
 Identities = 50/207 (24%), Positives = 100/207 (48%), Gaps = 22/207 (10%)
Query: 417 LGKGNFSSVYKGTLRDGTLVAIRSINVTSCKSEEAE-FVKGLYLLTSLRHENIIRLRGFC 475
           +G G+F +VYKG       VA++ +NVT+   ++ + F   + +L   RH NI+   G+ 
Sbjct: 44  IGSGSFGTVYKGKWHGD--VAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFMGYS 101
Query: 476 CSRGRGECFLIYDFAPKGKLSKYLDQEEGSSNVLDWSTRVSIIIGIAKGIGYLHSSEVNK 535
               + +  ++  +     L  +L   E    ++     + I    A+G+ YLH+     
Sbjct: 102 T---KPQLAIVTQWCEGSSLYHHLHIIETKFEMI---KLIDIARQTAQGMDYLHAK---- 151
Query: 536 PAIVHRNLSVEKVLIDQQFNPLIADCGLHKL---LADDIVFSVLKTSAAMGYLAPEYVT- 591
            +I+HR+L    + + +     I D GL  +    +    F  L  S ++ ++APE +  
Sbjct: 152 -SIIHRDLKSNNIFLHEDLTVKIGDFGLATVKSRWSGSHQFEQL--SGSILWMAPEVIRM 208
Query: 592 --TGRFTERSDIFAFGVIILQILTGSL 616
                ++ +SD++AFG+++ +++TG L
Sbjct: 209 QDKNPYSFQSDVYAFGIVLYELMTGQL 235

>pdb|1UWH|A Chain A, The Complex Of Wild Type B-Raf And Bay439006 Length = 276

Iteration: 1
 Score = 62.4 bits (150), Expect = 8e-10,   Method: Compositional matrix adjust.
 Identities = 50/207 (24%), Positives = 100/207 (48%), Gaps = 22/207 (10%)
Query: 417 LGKGNFSSVYKGTLRDGTLVAIRSINVTSCKSEEAE-FVKGLYLLTSLRHENIIRLRGFC 475
           +G G+F +VYKG       VA++ +NVT+   ++ + F   + +L   RH NI+   G+ 
Sbjct: 16  IGSGSFGTVYKGKWHGD--VAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFMGYS 73
Query: 476 CSRGRGECFLIYDFAPKGKLSKYLDQEEGSSNVLDWSTRVSIIIGIAKGIGYLHSSEVNK 535
            +    +  ++  +     L  +L   E    ++     + I    A+G+ YLH+     
Sbjct: 74  TA---PQLAIVTQWCEGSSLYHHLHIIETKFEMI---KLIDIARQTAQGMDYLHAK---- 123
Query: 536 PAIVHRNLSVEKVLIDQQFNPLIADCGLHKL---LADDIVFSVLKTSAAMGYLAPEYVT- 591
            +I+HR+L    + + +     I D GL  +    +    F  L  S ++ ++APE +  
Sbjct: 124 -SIIHRDLKSNNIFLHEDLTVKIGDFGLATVKSRWSGSHQFEQL--SGSILWMAPEVIRM 180
Query: 592 --TGRFTERSDIFAFGVIILQILTGSL 616
                ++ +SD++AFG+++ +++TG L
Sbjct: 181 QDKNPYSFQSDVYAFGIVLYELMTGQL 207

>pdb|3II5|A Chain A, The Complex Of Wild-Type B-Raf With Pyrazolo Pyrimidine Inhibitor Length = 306

Iteration: 1
 Score = 62.4 bits (150), Expect = 8e-10,   Method: Compositional matrix adjust.
 Identities = 50/207 (24%), Positives = 100/207 (48%), Gaps = 22/207 (10%)
Query: 417 LGKGNFSSVYKGTLRDGTLVAIRSINVTSCKSEEAE-FVKGLYLLTSLRHENIIRLRGFC 475
           +G G+F +VYKG       VA++ +NVT+   ++ + F   + +L   RH NI+   G+ 
Sbjct: 43  IGSGSFGTVYKGKWHGD--VAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFMGYS 100
Query: 476 CSRGRGECFLIYDFAPKGKLSKYLDQEEGSSNVLDWSTRVSIIIGIAKGIGYLHSSEVNK 535
               + +  ++  +     L  +L   E    ++     + I    A+G+ YLH+     
Sbjct: 101 T---KPQLAIVTQWCEGSSLYHHLHIIETKFEMI---KLIDIARQTAQGMDYLHAK---- 150
Query: 536 PAIVHRNLSVEKVLIDQQFNPLIADCGLHKL---LADDIVFSVLKTSAAMGYLAPEYVT- 591
            +I+HR+L    + + +     I D GL  +    +    F  L  S ++ ++APE +  
Sbjct: 151 -SIIHRDLKSNNIFLHEDLTVKIGDFGLATVKSRWSGSHQFEQL--SGSILWMAPEVIRM 207
Query: 592 --TGRFTERSDIFAFGVIILQILTGSL 616
                ++ +SD++AFG+++ +++TG L
Sbjct: 208 QDKNPYSFQSDVYAFGIVLYELMTGQL 234

>pdb|1UWJ|A Chain A, The Complex Of Mutant V599e B-raf And Bay439006 Length = 276

Iteration: 1
 Score = 62.4 bits (150), Expect = 8e-10,   Method: Compositional matrix adjust.
 Identities = 50/207 (24%), Positives = 99/207 (47%), Gaps = 22/207 (10%)
Query: 417 LGKGNFSSVYKGTLRDGTLVAIRSINVTSCKSEEAE-FVKGLYLLTSLRHENIIRLRGFC 475
           +G G+F +VYKG       VA++ +NVT+   ++ + F   + +L   RH NI+   G+ 
Sbjct: 16  IGSGSFGTVYKGKWHGD--VAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFMGYS 73
Query: 476 CSRGRGECFLIYDFAPKGKLSKYLDQEEGSSNVLDWSTRVSIIIGIAKGIGYLHSSEVNK 535
               + +  ++  +     L  +L   E    ++     + I    A+G+ YLH+     
Sbjct: 74  T---KPQLAIVTQWCEGSSLYHHLHIIETKFEMI---KLIDIARQTAQGMDYLHAK---- 123
Query: 536 PAIVHRNLSVEKVLIDQQFNPLIADCGL---HKLLADDIVFSVLKTSAAMGYLAPEYVT- 591
            +I+HR+L    + + +     I D GL       +    F  L  S ++ ++APE +  
Sbjct: 124 -SIIHRDLKSNNIFLHEDLTVKIGDFGLATEKSRWSGSHQFEQL--SGSILWMAPEVIRM 180
Query: 592 --TGRFTERSDIFAFGVIILQILTGSL 616
                ++ +SD++AFG+++ +++TG L
Sbjct: 181 QDKNPYSFQSDVYAFGIVLYELMTGQL 207

>pdb|3LCO|A Chain A, Inhibitor Bound To A Dfg-Out Structure Of The Kinase Domain Of Csf-1r Length = 324

Iteration: 1
 Score = 62.4 bits (150), Expect = 9e-10,   Method: Compositional matrix adjust.
 Identities = 71/298 (23%), Positives = 135/298 (45%), Gaps = 67/298 (22%)
Query: 417 LGKGNFSSVYKGTL-----RDGTL-VAIRSINVTSCKSEEAEFVKGLYLLTSL-RHENII 469
           LG G F  V + T       D  L VA++ +  T+   E+   +  L +++ L +HENI+
Sbjct: 39  LGAGAFGKVVEATAFGLGKEDAVLKVAVKMLKSTAHADEKEALMSELKIMSHLGQHENIV 98
Query: 470 RLRG-------------FCCS-------RGRGECFLIYDFAPKGKLSKYLDQEEGS---- 505
            L G             +CC        R + E  L    AP G+  + LD+E+G     
Sbjct: 99  NLLGACTHGGPVLVITEYCCYGDLLNFLRRKAEAMLGPSLAP-GQDPEGLDKEDGRPLEL 157
Query: 506 SNVLDWSTRVSIIIGIAKGIGYLHSSEVNKPAIVHRNLSVEKVLIDQQFNPLIADCGLHK 565
            ++L +S++V      A+G+ +L S        +HR+++   VL+       I D GL +
Sbjct: 158 RDLLHFSSQV------AQGMAFLASKNC-----IHRDVAARNVLLTNGHVAKIGDFGLAR 206
Query: 566 LLADDIVFSVLKTSAAM--GYLAPEYVTTGRFTERSDIFAFGVIILQILT-------GSL 616
            + +D  + ++K +A +   ++APE +    +T +SD++++G+++ +I +       G L
Sbjct: 207 DIMNDSNY-IVKGNARLPVKWMAPESIFDCVYTVQSDVWSYGILLWEIFSLGLNPYPGIL 265
Query: 617 VLTSSMRLAAESATFEN--FIDRNLKGKFSESEAAKLGKMALVCTHEDPENRPTMEAV 672
           V +   +L  +        F  +N+   +S  +A         C   +P +RPT + +
Sbjct: 266 VNSKFYKLVKDGYQMAQPAFAPKNI---YSIMQA---------CWALEPTHRPTFQQI 311

>pdb|3LCD|A Chain A, Inhibitor Bound To A Dfg-In Structure Of The Kinase Domain Of Csf-1r Length = 329

Iteration: 1
 Score = 62.4 bits (150), Expect = 9e-10,   Method: Compositional matrix adjust.
 Identities = 69/286 (24%), Positives = 134/286 (46%), Gaps = 56/286 (19%)
Query: 417 LGKGNFSSVYKGTL-----RDGTL-VAIRSINVTSCKSEEAEFVKGLYLLTSL-RHENII 469
           LG G F  V + T       D  L VA++ +  T+   E+   +  L +++ L +HENI+
Sbjct: 54  LGAGAFGKVVEATAFGLGKEDAVLKVAVKMLKSTAHADEKEALMSELKIMSHLGQHENIV 113
Query: 470 RLRGFCCSRGRGECFLIYDFAPKGKLSKYL--------DQEEGS----SNVLDWSTRVSI 517
            L G  C+ G G   +I ++   G L  +L        D+E+G      ++L +S++V  
Sbjct: 114 NLLG-ACTHG-GPVLVITEYCCYGDLLNFLRRKAEADLDKEDGRPLELRDLLHFSSQV-- 169
Query: 518 IIGIAKGIGYLHSSEVNKPAIVHRNLSVEKVLIDQQFNPLIADCGLHKLLADDIVFSVLK 577
               A+G+ +L S        +HR+++   VL+       I D GL + + +D  + ++K
Sbjct: 170 ----AQGMAFLASKNC-----IHRDVAARNVLLTNGHVAKIGDFGLARDIMNDSNY-IVK 219
Query: 578 TSAAM--GYLAPEYVTTGRFTERSDIFAFGVIILQILT-------GSLVLTSSMRLAAES 628
            +A +   ++APE +    +T +SD++++G+++ +I +       G LV +   +L  + 
Sbjct: 220 GNARLPVKWMAPESIFDCVYTVQSDVWSYGILLWEIFSLGLNPYPGILVNSKFYKLVKDG 279
Query: 629 ATFEN--FIDRNLKGKFSESEAAKLGKMALVCTHEDPENRPTMEAV 672
                  F  +N+   +S  +A         C   +P +RPT + +
Sbjct: 280 YQMAQPAFAPKNI---YSIMQA---------CWALEPTHRPTFQQI 313

>pdb|3IDP|A Chain A, B-Raf V600e Kinase Domain In Complex With An Aminoisoquinoline Inhibitor Length = 300

Iteration: 1
 Score = 62.0 bits (149), Expect = 9e-10,   Method: Compositional matrix adjust.
 Identities = 50/207 (24%), Positives = 99/207 (47%), Gaps = 22/207 (10%)
Query: 417 LGKGNFSSVYKGTLRDGTLVAIRSINVTSCKSEEAE-FVKGLYLLTSLRHENIIRLRGFC 475
           +G G+F +VYKG       VA++ +NVT+   ++ + F   + +L   RH NI+   G+ 
Sbjct: 36  IGSGSFGTVYKGKWHGD--VAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFMGYS 93
Query: 476 CSRGRGECFLIYDFAPKGKLSKYLDQEEGSSNVLDWSTRVSIIIGIAKGIGYLHSSEVNK 535
               + +  ++  +     L  +L   E    ++     + I    A+G+ YLH+     
Sbjct: 94  T---KPQLAIVTQWCEGSSLYHHLHIIETKFEMI---KLIDIARQTAQGMDYLHAK---- 143
Query: 536 PAIVHRNLSVEKVLIDQQFNPLIADCGL---HKLLADDIVFSVLKTSAAMGYLAPEYVT- 591
            +I+HR+L    + + +     I D GL       +    F  L  S ++ ++APE +  
Sbjct: 144 -SIIHRDLKSNNIFLHEDLTVKIGDFGLATEKSRWSGSHQFEQL--SGSILWMAPEVIRM 200
Query: 592 --TGRFTERSDIFAFGVIILQILTGSL 616
                ++ +SD++AFG+++ +++TG L
Sbjct: 201 QDKNPYSFQSDVYAFGIVLYELMTGQL 227

>pdb|2JC6|A Chain A, Crystal Structure Of Human Calmodulin-Dependent Protein Kinase 1d Length = 334

Iteration: 1
 Score = 62.0 bits (149), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 62/230 (26%), Positives = 102/230 (44%), Gaps = 17/230 (7%)
Query: 389 FSREHLNSFRLNLEEVESATQCFSEVNLLGKGNFSSVYKGTLR-DGTLVAIRSINVTSCK 447
            +RE+  S     ++ E   + F     LG G FS V     +  G L A++ I   + K
Sbjct: 2   MARENGESSSSWKKQAEDIKKIFEFKETLGTGAFSEVVLAEEKATGKLFAVKCIPKKALK 61
Query: 448 SEEAEFVKGLYLLTSLRHENIIRLRGFCCSRGRGECFLIYDFAPKGKLSKYLDQEEGSSN 507
            +E+     + +L  ++HENI+ L     S      +L+      G+L   +  E+G   
Sbjct: 62  GKESSIENEIAVLRKIKHENIVALEDIYESPNH--LYLVMQLVSGGELFDRI-VEKGFYT 118
Query: 508 VLDWSTRVSIIIGIAKGIGYLHSSEVNKPAIVHRNLSVEKVLI---DQQFNPLIADCGLH 564
             D ST   +I  +   + YLH     +  IVHR+L  E +L    D++   +I+D GL 
Sbjct: 119 EKDAST---LIRQVLDAVYYLH-----RMGIVHRDLKPENLLYYSQDEESKIMISDFGLS 170
Query: 565 KLLADDIVFSVLKTSAAMGYLAPEYVTTGRFTERSDIFAFGVIILQILTG 614
           K+     V S        GY+APE +    +++  D ++ GVI   +L G
Sbjct: 171 KMEGKGDVMST--ACGTPGYVAPEVLAQKPYSKAVDCWSIGVIAYILLCG 218

>pdb|4G9R|A Chain A, B-Raf V600e Kinase Domain Bound To A Type Ii Dihydroquinazoline Inhibitor Length = 307

Iteration: 1
 Score = 62.0 bits (149), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 50/207 (24%), Positives = 99/207 (47%), Gaps = 22/207 (10%)
Query: 417 LGKGNFSSVYKGTLRDGTLVAIRSINVTSCKSEEAE-FVKGLYLLTSLRHENIIRLRGFC 475
           +G G+F +VYKG       VA++ +NVT+   ++ + F   + +L   RH NI+   G+ 
Sbjct: 44  IGSGSFGTVYKGKWHGD--VAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFMGYS 101
Query: 476 CSRGRGECFLIYDFAPKGKLSKYLDQEEGSSNVLDWSTRVSIIIGIAKGIGYLHSSEVNK 535
               + +  ++  +     L  +L   E    ++     + I    A+G+ YLH+     
Sbjct: 102 T---KPQLAIVTQWCEGSSLYHHLHIIETKFEMI---KLIDIARQTAQGMDYLHAK---- 151
Query: 536 PAIVHRNLSVEKVLIDQQFNPLIADCGL---HKLLADDIVFSVLKTSAAMGYLAPEYVT- 591
            +I+HR+L    + + +     I D GL       +    F  L  S ++ ++APE +  
Sbjct: 152 -SIIHRDLKSNNIFLHEDLTVKIGDFGLATEKSRWSGSHQFEQL--SGSILWMAPEVIRM 208
Query: 592 --TGRFTERSDIFAFGVIILQILTGSL 616
                ++ +SD++AFG+++ +++TG L
Sbjct: 209 QDKNPYSFQSDVYAFGIVLYELMTGQL 235

>pdb|1FOT|A Chain A, Structure Of The Unliganded Camp-Dependent Protein Kinase Catalytic Subunit From Saccharomyces Cerevisiae Length = 318

Iteration: 1
 Score = 62.0 bits (149), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 68/279 (24%), Positives = 124/279 (44%), Gaps = 28/279 (10%)
Query: 409 QCFSEVNLLGKGNFSSVYKGTLR-DGTLVAIRSIN---VTSCKSEEAEFVKGLYLLTSLR 464
           Q F  +  LG G+F  V+    R +G   A++ +    V   K  E    + L +L+ + 
Sbjct: 6   QDFQILRTLGTGSFGRVHLIRSRHNGRYYAMKVLKKEIVVRLKQVEHTNDERL-MLSIVT 64
Query: 465 HENIIRLRGFCCSRGRGECFLIYDFAPKGKLSKYLDQEEGSSNVLDWSTRVSIIIGIAKG 524
           H  IIR+ G    +   + F+I D+   G+L   L + +   N +       + + +   
Sbjct: 65  HPFIIRMWG--TFQDAQQIFMIMDYIEGGELFSLLRKSQRFPNPVAKFYAAEVCLALE-- 120
Query: 525 IGYLHSSEVNKPAIVHRNLSVEKVLIDQQFNPLIADCGLHKLLADDIVFSVLKTSAAMGY 584
             YLHS +     I++R+L  E +L+D+  +  I D G  K + D + + +  T     Y
Sbjct: 121 --YLHSKD-----IIYRDLKPENILLDKNGHIKITDFGFAKYVPD-VTYXLCGTP---DY 169
Query: 585 LAPEYVTTGRFTERSDIFAFGVIILQILTG------SLVLTSSMRLAAESATFENFIDRN 638
           +APE V+T  + +  D ++FG++I ++L G      S  + +  ++      F  F + +
Sbjct: 170 IAPEVVSTKPYNKSIDWWSFGILIYEMLAGYTPFYDSNTMKTYEKILNAELRFPPFFNED 229
Query: 639 LKGKFSESEAAKLGKMA--LVCTHEDPENRPTMEAVIEE 675
           +K   S      L +    L    ED +N P  + V+ E
Sbjct: 230 VKDLLSRLITRDLSQRLGNLQNGTEDVKNHPWFKEVVWE 268

>pdb|3KMU|A Chain A, Crystal Structure Of The IlkALPHA-Parvin Core Complex (Apo) Length = 271

Iteration: 1
 Score = 61.6 bits (148), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 63/276 (22%), Positives = 118/276 (42%), Gaps = 35/276 (12%)
Query: 411 FSEVNLLGKGNFS---SVYKGTLRDGTLVAIRSINVTSCKSEEA-EFVKGLYLLTSLRHE 466
           F ++N L K N +    ++KG  + G  + ++ + V    + ++ +F +    L    H 
Sbjct: 9   FKQLNFLTKLNENHSGELWKGRWQ-GNDIVVKVLKVRDWSTRKSRDFNEECPRLRIFSHP 67
Query: 467 NIIRLRGFCCSRGRGECFLIYDFAPKGKLSKYLDQEEGSSNVLDWSTRVSIIIGIAKGIG 526
           N++ + G C S       LI  + P G L   L   EG++ V+D S  V   +  A+G  
Sbjct: 68  NVLPVLGACQSPPAPHPTLITHWXPYGSLYNVL--HEGTNFVVDQSQAVKFALDXARGXA 125
Query: 527 YLHSSEVNKPAIVHRNLSVEKVLIDQQFNPLIADCGLHKLLADDIVFSVLKTSA--AMGY 584
           +LH+ E   P I    L+   V ID+     I+          D+ FS        A  +
Sbjct: 126 FLHTLE---PLIPRHALNSRSVXIDEDXTARISXA--------DVKFSFQSPGRXYAPAW 174
Query: 585 LAPEYVT-----TGRFTERSDIFAFGVIILQILTGSLVLT--SSMRLAAESATFENFIDR 637
           +APE +      T R +  +D ++F V++ +++T  +     S+  +  + A        
Sbjct: 175 VAPEALQKKPEDTNRRS--ADXWSFAVLLWELVTREVPFADLSNXEIGXKVAL------E 226
Query: 638 NLKGKFSESEAAKLGKMALVCTHEDPENRPTMEAVI 673
            L+       +  + K+  +C +EDP  RP  + ++
Sbjct: 227 GLRPTIPPGISPHVSKLXKICXNEDPAKRPKFDXIV 262

>pdb|2Y94|A Chain A, Structure Of An Active Form Of Mammalian Ampk Length = 476

Iteration: 1
 Score = 61.6 bits (148), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 59/208 (28%), Positives = 96/208 (46%), Gaps = 21/208 (10%)
Query: 415 NLLGKGNFSSVYKGTLR-DGTLVAIRSINVTSCKSEEA--EFVKGLYLLTSLRHENIIRL 471
           + LG G F  V  G     G  VA++ +N    +S +   +  + +  L   RH +II+L
Sbjct: 22  DTLGVGTFGKVKVGKHELTGHKVAVKILNRQKIRSLDVVGKIRREIQNLKLFRHPHIIKL 81
Query: 472 RGFCCSRGRGECFLIYDFAPKGKLSKYLDQEEGSSNVLDWSTRVSIIIGIAKGIGYLHSS 531
                +    + F++ ++   G+L  Y+      +  LD      +   I  G+ Y H  
Sbjct: 82  YQVISTPS--DIFMVMEYVSGGELFDYI----CKNGRLDEKESRRLFQQILSGVDYCH-- 133
Query: 532 EVNKPAIVHRNLSVEKVLIDQQFNPLIADCGLHKLLADDIVFSVLKTS-AAMGYLAPEYV 590
              +  +VHR+L  E VL+D   N  IAD GL  +++D      L+ S  +  Y APE V
Sbjct: 134 ---RHMVVHRDLKPENVLLDAHMNAKIADFGLSNMMSDG---EFLRXSCGSPNYAAPE-V 186
Query: 591 TTGRFT--ERSDIFAFGVIILQILTGSL 616
            +GR       DI++ GVI+  +L G+L
Sbjct: 187 ISGRLYAGPEVDIWSSGVILYALLCGTL 214

>pdb|4A4X|A Chain A, Nek2-Ede Bound To Cct248662 Length = 279

Iteration: 1
 Score = 61.6 bits (148), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 55/279 (19%), Positives = 118/279 (42%), Gaps = 24/279 (8%)
Query: 406 SATQCFSEVNLLGKGNFSSVYKGTLR-DGTLVAIRSINVTS-CKSEEAEFVKGLYLLTSL 463
           S  + +  +  +G G++    K   + DG ++  + ++  S  ++E+   V  + LL  L
Sbjct: 3   SRAEDYEVLYTIGTGSYGRCQKIRRKSDGKILVWKELDYGSMTEAEKQMLVSEVNLLREL 62
Query: 464 RHENIIRLRGFCCSRGRGECFLIYDFAPKGKLSKYLDQEEGSSNVLDWSTRVSIIIGIAK 523
           +H NI+R       R     +++ ++   G L+  + +       LD    + ++  +  
Sbjct: 63  KHPNIVRYYDRIIDRTNTTLYIVMEYCEGGDLASVITKGTKERQYLDEEFVLRVMTQLTL 122
Query: 524 GIGYLHSSEVNKPAIVHRNLSVEKVLIDQQFNPLIADCGLHKLLADDIVFSVLKTSAAMG 583
            +   H        ++HR+L    V +D + N  + D GL ++L  D  F+  +      
Sbjct: 123 ALKECHRRSDGGHTVLHRDLKPANVFLDGKQNVKLGDFGLARILNHDEDFAK-EFVGTPY 181
Query: 584 YLAPEYVTTGRFTERSDIFAFGVIILQILTGSLVLTSSMRLAAESATFENFIDRNLKGKF 643
           Y++PE +    + E+SDI++ G ++ +             L A    F  F  + L GK 
Sbjct: 182 YMSPEQMNRMSYNEKSDIWSLGCLLYE-------------LCALMPPFTAFSQKELAGKI 228
Query: 644 SESE--------AAKLGKMALVCTHEDPENRPTMEAVIE 674
            E +        + +L ++     +    +RP++E ++E
Sbjct: 229 REGKFRRIPYRYSDELNEIITRMLNLKDYHRPSVEEILE 267

>pdb|1U5Q|A Chain A, Crystal Structure Of The Tao2 Kinase Domain: Activation And Specifity Of A Ste20p Map3k Length = 348

Iteration: 1
 Score = 61.2 bits (147), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 60/280 (21%), Positives = 121/280 (43%), Gaps = 26/280 (9%)
Query: 405 ESATQCFSEVNLLGKGNFSSVY-KGTLRDGTLVAIRSINVTSCKSEEA--EFVKGLYLLT 461
           +   + FS++  +G G+F +VY    +R+  +VAI+ ++ +  +S E   + +K +  L 
Sbjct: 50  DDPEKLFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQ 109
Query: 462 SLRHENIIRLRGFCCSRGRGECFLIYDFAPKGKLSKYLDQEEGSSNVLDWSTRVSIIIGI 521
            LRH N I+ RG  C       +L+ ++     L    D  E     L      ++  G 
Sbjct: 110 KLRHPNTIQYRG--CYLREHTAWLVMEYC----LGSASDLLEVHKKPLQEVEIAAVTHGA 163
Query: 522 AKGIGYLHSSEVNKPAIVHRNLSVEKVLIDQQFNPLIADCGLHKLLADDIVFSVLKTSAA 581
            +G+ YLHS       ++HR++    +L+ +     + D G   ++A    F        
Sbjct: 164 LQGLAYLHSHN-----MIHRDVKAGNILLSEPGLVKLGDFGSASIMAPANXF-----VGT 213
Query: 582 MGYLAPEYVTT---GRFTERSDIFAFGVIILQILTGSLVLTSSMRLAAESATFENFIDRN 638
             ++APE +     G++  + D+++ G+  +++      L +   ++A     +N     
Sbjct: 214 PYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSALYHIAQNESPAL 273
Query: 639 LKGKFSESEAAKLGKMALVCTHEDPENRPTMEAVIEELTV 678
             G +SE            C  + P++RPT E +++   V
Sbjct: 274 QSGHWSEY----FRNFVDSCLQKIPQDRPTSEVLLKHRFV 309

>pdb|1A06|A Chain A, Calmodulin-Dependent Protein Kinase From Rat Length = 332

Iteration: 1
 Score = 60.8 bits (146), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 73/285 (25%), Positives = 121/285 (42%), Gaps = 25/285 (8%)
Query: 402 EEVESATQCFSEVNLLGKGNFSSVYKGT-LRDGTLVAIRSINVTSCKSEEAEFVKGLYLL 460
           ++ E     +   ++LG G FS V      R   LVAI+ I   + + +E      + +L
Sbjct: 11  KQAEDIRDIYDFRDVLGTGAFSEVILAEDKRTQKLVAIKCIAKKALEGKEGSMENEIAVL 70
Query: 461 TSLRHENIIRLRGFCCSRGRGECFLIYDFAPKGKLSKYLDQEEGSSNVLDWSTRVSIIIG 520
             ++H NI+ L     S G    +LI      G+L   +  E+G     D S    +I  
Sbjct: 71  HKIKHPNIVALDDIYESGGH--LYLIMQLVSGGELFDRI-VEKGFYTERDAS---RLIFQ 124
Query: 521 IAKGIGYLHSSEVNKPAIVHRNLSVEKVL---IDQQFNPLIADCGLHKLLADDIVFSVLK 577
           +   + YLH        IVHR+L  E +L   +D+    +I+D GL K+   +   SVL 
Sbjct: 125 VLDAVKYLHDL-----GIVHRDLKPENLLYYSLDEDSKIMISDFGLSKM---EDPGSVLS 176
Query: 578 TSAAM-GYLAPEYVTTGRFTERSDIFAFGVIILQILTG--SLVLTSSMRLAAESATFENF 634
           T+    GY+APE +    +++  D ++ GVI   +L G       +  +L  +    E  
Sbjct: 177 TACGTPGYVAPEVLAQKPYSKAVDCWSIGVIAYILLCGYPPFYDENDAKLFEQILKAEYE 236
Query: 635 IDRNLKGKFSESEAAKLGKMALVCTHEDPENRPTMEAVIEELTVA 679
            D       S+S    +  +      +DPE R T E  ++   +A
Sbjct: 237 FDSPYWDDISDSAKDFIRHL----MEKDPEKRFTCEQALQHPWIA 277

>pdb|2Z7Q|A Chain A, Crystal Structure Of The N-Terminal Kinase Domain Of Human Rsk-1 Bound To Amp-Pcp Length = 321

Iteration: 1
 Score = 60.8 bits (146), Expect = 3e-09,   Method: Compositional matrix adjust.
 Identities = 59/219 (26%), Positives = 103/219 (47%), Gaps = 19/219 (8%)
Query: 411 FSEVNLLGKGNFSSVY---KGTLRD-GTLVAIRSINVTSCKSEEAEFVKGLY-LLTSLRH 465
           F  + +LG+G+F  V+   K T  D G L A++ +   + K  +    K    +L  + H
Sbjct: 30  FELLKVLGQGSFGKVFLVRKVTRPDSGHLYAMKVLKKATLKVRDRVRTKMERDILADVNH 89
Query: 466 ENIIRLRGFCCSRGRGECFLIYDFAPKGKLSKYLDQEEGSSNVLDWSTRVSIIIG-IAKG 524
             +++L      +  G+ +LI DF   G L   L +E     V+     V   +  +A G
Sbjct: 90  PFVVKLH--YAFQTEGKLYLILDFLRGGDLFTRLSKE-----VMFTEEDVKFYLAELALG 142
Query: 525 IGYLHSSEVNKPAIVHRNLSVEKVLIDQQFNPLIADCGLHKLLADDIVFSVLKTSAAMGY 584
           + +LHS       I++R+L  E +L+D++ +  + D GL K  A D           + Y
Sbjct: 143 LDHLHSL-----GIIYRDLKPENILLDEEGHIKLTDFGLSKE-AIDHEKKAYSFCGTVEY 196
Query: 585 LAPEYVTTGRFTERSDIFAFGVIILQILTGSLVLTSSMR 623
           +APE V     +  +D +++GV++ ++LTGSL      R
Sbjct: 197 MAPEVVNRQGHSHSADWWSYGVLMFEMLTGSLPFQGKDR 235

>pdb|4FG7|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase I 1-293 In Complex With Atp Length = 293

Iteration: 1
 Score = 60.8 bits (146), Expect = 3e-09,   Method: Compositional matrix adjust.
 Identities = 73/285 (25%), Positives = 121/285 (42%), Gaps = 25/285 (8%)
Query: 402 EEVESATQCFSEVNLLGKGNFSSVYKGT-LRDGTLVAIRSINVTSCKSEEAEFVKGLYLL 460
           ++ E     +   ++LG G FS V      R   LVAI+ I   + + +E      + +L
Sbjct: 11  KQAEDIRDIYDFRDVLGTGAFSEVILAEDKRTQKLVAIKCIAKEALEGKEGSMENEIAVL 70
Query: 461 TSLRHENIIRLRGFCCSRGRGECFLIYDFAPKGKLSKYLDQEEGSSNVLDWSTRVSIIIG 520
             ++H NI+ L     S G    +LI      G+L   +  E+G     D S    +I  
Sbjct: 71  HKIKHPNIVALDDIYESGGH--LYLIMQLVSGGELFDRI-VEKGFYTERDAS---RLIFQ 124
Query: 521 IAKGIGYLHSSEVNKPAIVHRNLSVEKVL---IDQQFNPLIADCGLHKLLADDIVFSVLK 577
           +   + YLH        IVHR+L  E +L   +D+    +I+D GL K+   +   SVL 
Sbjct: 125 VLDAVKYLHDL-----GIVHRDLKPENLLYYSLDEDSKIMISDFGLSKM---EDPGSVLS 176
Query: 578 TSAAM-GYLAPEYVTTGRFTERSDIFAFGVIILQILTG--SLVLTSSMRLAAESATFENF 634
           T+    GY+APE +    +++  D ++ GVI   +L G       +  +L  +    E  
Sbjct: 177 TACGTPGYVAPEVLAQKPYSKAVDCWSIGVIAYILLCGYPPFYDENDAKLFEQILKAEYE 236
Query: 635 IDRNLKGKFSESEAAKLGKMALVCTHEDPENRPTMEAVIEELTVA 679
            D       S+S    +  +      +DPE R T E  ++   +A
Sbjct: 237 FDSPYWDDISDSAKDFIRHL----MEKDPEKRFTCEQALQHPWIA 277

>pdb|2GCD|A Chain A, Tao2 Kinase Domain-Staurosporine Structure Length = 309

Iteration: 1
 Score = 60.1 bits (144), Expect = 4e-09,   Method: Compositional matrix adjust.
 Identities = 60/280 (21%), Positives = 121/280 (43%), Gaps = 26/280 (9%)
Query: 405 ESATQCFSEVNLLGKGNFSSVY-KGTLRDGTLVAIRSINVTSCKSEEA--EFVKGLYLLT 461
           +   + FS++  +G G+F +VY    +R+  +VAI+ ++ +  +S E   + +K +  L 
Sbjct: 11  DDPEKLFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQ 70
Query: 462 SLRHENIIRLRGFCCSRGRGECFLIYDFAPKGKLSKYLDQEEGSSNVLDWSTRVSIIIGI 521
            LRH N I+ RG  C       +L+ ++     L    D  E     L      ++  G 
Sbjct: 71  KLRHPNTIQYRG--CYLREHTAWLVMEYC----LGSASDLLEVHKKPLQEVEIAAVTHGA 124
Query: 522 AKGIGYLHSSEVNKPAIVHRNLSVEKVLIDQQFNPLIADCGLHKLLADDIVFSVLKTSAA 581
            +G+ YLHS       ++HR++    +L+ +     + D G   ++A    F        
Sbjct: 125 LQGLAYLHSHN-----MIHRDVKAGNILLSEPGLVKLGDFGSASIMAPANXF-----VGT 174
Query: 582 MGYLAPEYVTT---GRFTERSDIFAFGVIILQILTGSLVLTSSMRLAAESATFENFIDRN 638
             ++APE +     G++  + D+++ G+  +++      L +   ++A     +N     
Sbjct: 175 PYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSALYHIAQNESPAL 234
Query: 639 LKGKFSESEAAKLGKMALVCTHEDPENRPTMEAVIEELTV 678
             G +SE            C  + P++RPT E +++   V
Sbjct: 235 QSGHWSEY----FRNFVDSCLQKIPQDRPTSEVLLKHRFV 270

>pdb|2XIK|A Chain A, Structure Of Human Ysk1 (Yeast Sps1-Ste20-Related Kinase 1) Length = 294

Iteration: 1
 Score = 60.1 bits (144), Expect = 4e-09,   Method: Compositional matrix adjust.
 Identities = 65/291 (22%), Positives = 130/291 (44%), Gaps = 34/291 (11%)
Query: 388 GFSREHLNSFRLNLEEVESATQCFSEVNLLGKGNFSSVYKGTL-RDGTLVAIRSINVTSC 446
           GF+ +H    R++ EE+      F++++ +GKG+F  VYKG       +VAI+ I++   
Sbjct: 7   GFANQHS---RVDPEEL------FTKLDRIGKGSFGEVYKGIDNHTKEVVAIKIIDLEEA 57
Query: 447 KSEEAEFVKGLYLLTSLRHENIIRLRGFCCSRGRGECFLIYDFAPKGKLSKYLDQEEGSS 506
           + E  +  + + +L+      I R  G      +   ++I ++   G     L       
Sbjct: 58  EDEIEDIQQEITVLSQCDSPYITRYFGSYLKSTK--LWIIMEYLGGGSALDLL-----KP 110
Query: 507 NVLDWSTRVSIIIGIAKGIGYLHSSEVNKPAIVHRNLSVEKVLIDQQFNPLIADCGLHKL 566
             L+ +   +I+  I KG+ YLHS        +HR++    VL+ +Q +  +AD G+   
Sbjct: 111 GPLEETYIATILREILKGLDYLHSERK-----IHRDIKAANVLLSEQGDVKLADFGVAGQ 165
Query: 567 LADDIVFSVLKTSAAMG---YLAPEYVTTGRFTERSDIFAFGVIILQILTGSLVLTSSMR 623
           L D    + +K +  +G   ++APE +    +  ++DI++ G+  +++  G      +  
Sbjct: 166 LTD----TQIKRNXFVGTPFWMAPEVIKQSAYDFKADIWSLGITAIELAKGE---PPNSD 218
Query: 624 LAAESATFENFIDRNLKGKFSESEAAKLGKMALVCTHEDPENRPTMEAVIE 674
           L      F   I +N         +    +    C ++DP  RPT + +++
Sbjct: 219 LHPMRVLF--LIPKNSPPTLEGQHSKPFKEFVEACLNKDPRFRPTAKELLK 267

>pdb|4FG9|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase I 1-320 In Complex With Atp Length = 320

Iteration: 1
 Score = 59.7 bits (143), Expect = 5e-09,   Method: Compositional matrix adjust.
 Identities = 73/285 (25%), Positives = 121/285 (42%), Gaps = 25/285 (8%)
Query: 402 EEVESATQCFSEVNLLGKGNFSSVYKGT-LRDGTLVAIRSINVTSCKSEEAEFVKGLYLL 460
           ++ E     +   ++LG G FS V      R   LVAI+ I   + + +E      + +L
Sbjct: 11  KQAEDIRDIYDFRDVLGTGAFSEVILAEDKRTQKLVAIKCIAKEALEGKEGSMENEIAVL 70
Query: 461 TSLRHENIIRLRGFCCSRGRGECFLIYDFAPKGKLSKYLDQEEGSSNVLDWSTRVSIIIG 520
             ++H NI+ L     S G    +LI      G+L   +  E+G     D S    +I  
Sbjct: 71  HKIKHPNIVALDDIYESGGH--LYLIMQLVSGGELFDRI-VEKGFYTERDAS---RLIFQ 124
Query: 521 IAKGIGYLHSSEVNKPAIVHRNLSVEKVL---IDQQFNPLIADCGLHKLLADDIVFSVLK 577
           +   + YLH        IVHR+L  E +L   +D+    +I+D GL K+   +   SVL 
Sbjct: 125 VLDAVKYLHDL-----GIVHRDLKPENLLYYSLDEDSKIMISDFGLSKM---EDPGSVLS 176
Query: 578 TSAAM-GYLAPEYVTTGRFTERSDIFAFGVIILQILTG--SLVLTSSMRLAAESATFENF 634
           T+    GY+APE +    +++  D ++ GVI   +L G       +  +L  +    E  
Sbjct: 177 TACGTPGYVAPEVLAQKPYSKAVDCWSIGVIAYILLCGYPPFYDENDAKLFEQILKAEYE 236
Query: 635 IDRNLKGKFSESEAAKLGKMALVCTHEDPENRPTMEAVIEELTVA 679
            D       S+S    +  +      +DPE R T E  ++   +A
Sbjct: 237 FDSPYWDDISDSAKDFIRHL----MEKDPEKRFTCEQALQHPWIA 277

>pdb|2BUJ|A Chain A, Crystal Structure Of The Human Serine-Threonine Kinase 16 In Complex With Staurosporine Length = 317

Iteration: 1
 Score = 59.7 bits (143), Expect = 5e-09,   Method: Compositional matrix adjust.
 Identities = 67/285 (23%), Positives = 119/285 (41%), Gaps = 29/285 (10%)
Query: 414 VNLLGKGNFSSV-YKGTLRDGTLVAIRSINVTSCKS-EEAEFVKGLYLLTSLRHENIIRL 471
           +  LG+G FS V     L DG   A++ I     +  EEA+    ++ L    H NI+RL
Sbjct: 34  IQKLGEGGFSYVDLVEGLHDGHFYALKRILCHEQQDREEAQREADMHRL--FNHPNILRL 91
Query: 472 RGFCCSRGRG---ECFLIYDFAPKGKLSKYLDQEEGSSNVLDWSTRVSIIIGIAKGIGYL 528
             +C  R RG   E +L+  F  +G L   +++ +   N L     + +++GI +G+  +
Sbjct: 92  VAYCL-RERGAKHEAWLLLPFFKRGTLWNEIERLKDKGNFLTEDQILWLLLGICRGLEAI 150
Query: 529 HSSEVNKPAIVHRNLSVEKVLIDQQFNPLIADCGLHKLLADDIVFS----VLKTSAA--- 581
           H+         HR+L    +L+  +  P++ D G        +  S     L+  AA   
Sbjct: 151 HAK-----GYAHRDLKPTNILLGDEGQPVLMDLGSMNQACIHVEGSRQALTLQDWAAQRC 205
Query: 582 -MGYLAPEYVTTGR---FTERSDIFAFGVIILQILTGSLVLTSSMRLAAESA-TFENFID 636
            + Y APE  +        ER+D+++ G ++  ++ G        +     A   +N + 
Sbjct: 206 TISYRAPELFSVQSHCVIDERTDVWSLGCVLYAMMFGEGPYDMVFQKGDSVALAVQNQLS 265
Query: 637 RNLKGKFSESEAAKLGKMALVCTHEDPENRPTMEAVIEELTVAAP 681
                + S +    L  M  V    DP  RP +  ++ +L    P
Sbjct: 266 IPQSPRHSSALWQLLNSMMTV----DPHQRPHIPLLLSQLEALQP 306

>pdb|4FG8|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase I 1-315 In Complex With Atp Length = 315

Iteration: 1
 Score = 59.7 bits (143), Expect = 5e-09,   Method: Compositional matrix adjust.
 Identities = 73/285 (25%), Positives = 121/285 (42%), Gaps = 25/285 (8%)
Query: 402 EEVESATQCFSEVNLLGKGNFSSVYKGT-LRDGTLVAIRSINVTSCKSEEAEFVKGLYLL 460
           ++ E     +   ++LG G FS V      R   LVAI+ I   + + +E      + +L
Sbjct: 11  KQAEDIRDIYDFRDVLGTGAFSEVILAEDKRTQKLVAIKCIAKEALEGKEGSMENEIAVL 70
Query: 461 TSLRHENIIRLRGFCCSRGRGECFLIYDFAPKGKLSKYLDQEEGSSNVLDWSTRVSIIIG 520
             ++H NI+ L     S G    +LI      G+L   +  E+G     D S    +I  
Sbjct: 71  HKIKHPNIVALDDIYESGGH--LYLIMQLVSGGELFDRI-VEKGFYTERDAS---RLIFQ 124
Query: 521 IAKGIGYLHSSEVNKPAIVHRNLSVEKVL---IDQQFNPLIADCGLHKLLADDIVFSVLK 577
           +   + YLH        IVHR+L  E +L   +D+    +I+D GL K+   +   SVL 
Sbjct: 125 VLDAVKYLHDL-----GIVHRDLKPENLLYYSLDEDSKIMISDFGLSKM---EDPGSVLS 176
Query: 578 TSAAM-GYLAPEYVTTGRFTERSDIFAFGVIILQILTG--SLVLTSSMRLAAESATFENF 634
           T+    GY+APE +    +++  D ++ GVI   +L G       +  +L  +    E  
Sbjct: 177 TACGTPGYVAPEVLAQKPYSKAVDCWSIGVIAYILLCGYPPFYDENDAKLFEQILKAEYE 236
Query: 635 IDRNLKGKFSESEAAKLGKMALVCTHEDPENRPTMEAVIEELTVA 679
            D       S+S    +  +      +DPE R T E  ++   +A
Sbjct: 237 FDSPYWDDISDSAKDFIRHL----MEKDPEKRFTCEQALQHPWIA 277

>pdb|4EQM|A Chain A, Structural Analysis Of Staphylococcus Aureus SerineTHREONINE KINASE Pknb Length = 294

Iteration: 1
 Score = 59.7 bits (143), Expect = 5e-09,   Method: Compositional matrix adjust.
 Identities = 56/211 (26%), Positives = 102/211 (48%), Gaps = 28/211 (13%)
Query: 414 VNLLGKGNFSSVYKGTLRDGTL----VAIRSINVTSCKSEEA--EFVKGLYLLTSLRHEN 467
           V+ LG G  S+VY   L + T+    VAI++I +   + EE    F + ++  + L H+N
Sbjct: 16  VDKLGGGGMSTVY---LAEDTILNIKVAIKAIFIPPREKEETLKRFEREVHNSSQLSHQN 72
Query: 468 IIRLRGFCCSRGRGECF-LIYDFAPKGKLSKYLDQEEGSSNVLDWSTRVSIIIGIAKGIG 526
           I+ +          +C+ L+ ++     LS+Y++    S   L   T ++    I  GI 
Sbjct: 73  IVSM---IDVDEEDDCYYLVMEYIEGPTLSEYIE----SHGPLSVDTAINFTNQILDGIK 125
Query: 527 YLHSSEVNKPAIVHRNLSVEKVLIDQQFNPLIADCGLHKLLADDIVFSVLKTSAAMG--- 583
           + H        IVHR++  + +LID      I D G+ K L++    S+ +T+  +G   
Sbjct: 126 HAHDMR-----IVHRDIKPQNILIDSNKTLKIFDFGIAKALSE---TSLTQTNHVLGTVQ 177
Query: 584 YLAPEYVTTGRFTERSDIFAFGVIILQILTG 614
           Y +PE        E +DI++ G+++ ++L G
Sbjct: 178 YFSPEQAKGEATDECTDIYSIGIVLYEMLVG 208

>pdb|2WZJ|A Chain A, Catalytic And Uba Domain Of Kinase Mark2(PAR-1) K82r, T208e Double Mutant Length = 327

Iteration: 1
 Score = 59.7 bits (143), Expect = 6e-09,   Method: Compositional matrix adjust.
 Identities = 64/269 (23%), Positives = 118/269 (43%), Gaps = 36/269 (13%)
Query: 417 LGKGNFSSVYKGT-LRDGTLVAIRSINVTSCKSEE-AEFVKGLYLLTSLRHENIIRLRGF 474
           +GKGNF+ V     +  G  VA+R I+ T   S    +  + + ++  L H NI++L  F
Sbjct: 22  IGKGNFAKVKLARHILTGKEVAVRIIDKTQLNSSSLQKLFREVRIMKVLNHPNIVKL--F 79
Query: 475 CCSRGRGECFLIYDFAPKGKLSKYLDQEEGSSNVLDWSTRVSIIIGIAKGIGYLHSSEVN 534
                    +L+ ++A  G++  YL    G     +   +   I+     + Y H     
Sbjct: 80  EVIETEKTLYLVMEYASGGEVFDYL-VAHGRMKEKEARAKFRQIVS---AVQYCHQK--- 132
Query: 535 KPAIVHRNLSVEKVLIDQQFNPLIADCGLHKLLADDIVF--SVLKTSAAMGYLAPEYVTT 592
              IVHR+L  E +L+D   N  IAD G     +++  F   + +   +  Y APE    
Sbjct: 133 --FIVHRDLKAENLLLDADMNIKIADFG----FSNEFTFGNKLDEFCGSPPYAAPELFQG 186
Query: 593 GRFT-ERSDIFAFGVIILQILTGSLVLTSSMRLAAESATFENFIDRNLKGKFS-----ES 646
            ++     D+++ GVI+  +++GSL          +    +   +R L+GK+       +
Sbjct: 187 KKYDGPEVDVWSLGVILYTLVSGSLPF--------DGQNLKELRERVLRGKYRIPFYMST 238
Query: 647 EAAKLGKMALVCTHEDPENRPTMEAVIEE 675
           +   L K  L+    +P  R T+E ++++
Sbjct: 239 DCENLLKKFLIL---NPSKRGTLEQIMKD 264

>pdb|4FVR|A Chain A, Crystal Structure Of The Jak2 Pseudokinase Domain Mutant V617f (Mg- Atp-Bound Form) Length = 289

Iteration: 1
 Score = 59.3 bits (142), Expect = 6e-09,   Method: Compositional matrix adjust.
 Identities = 58/273 (21%), Positives = 122/273 (44%), Gaps = 31/273 (11%)
Query: 417 LGKGNFSSVYKGTLRD--------GTLVAIRSINVTSCKSEEAEFVKGLYLLTSLRHENI 468
           LG+G F+ ++KG  R+         T V ++ ++       E+ F +   +++ L H+++
Sbjct: 16  LGQGTFTKIFKGVRREVGDYGQLHETEVLLKVLDKAHRNYSES-FFEAASMMSKLSHKHL 74
Query: 469 IRLRGFC-CSRGRGECFLIYDFAPKGKLSKYLDQEEGSSNVLDWSTRVSIIIGIAKGIGY 527
           +   G C C     E  L+ +F   G L  YL + +   N+L W   V+  +  A     
Sbjct: 75  VLNYGVCFCG---DENILVQEFVKFGSLDTYLKKNKNCINIL-WKLEVAKQLAWA----- 125
Query: 528 LHSSEVNKPAIVHRNLSVEKVLIDQQFNPLIADCGLHKLLADDIVFSVLKT---SAAMGY 584
           +H  E N   ++H N+  + +L+ ++ +    +    KL    I  +VL        + +
Sbjct: 126 MHFLEEN--TLIHGNVCAKNILLIREEDRKTGNPPFIKLSDPGISITVLPKDILQERIPW 183
Query: 585 LAPEYVTTGR-FTERSDIFAFGVIILQILTGSLVLTSSMRLAAESATFENFIDRNLKGKF 643
           + PE +   +     +D ++FG  + +I +G     S++    +   +E+      + + 
Sbjct: 184 VPPECIENPKNLNLATDKWSFGTTLWEICSGGDKPLSALDSQRKLQFYED------RHQL 237
Query: 644 SESEAAKLGKMALVCTHEDPENRPTMEAVIEEL 676
              +AA+L  +   C   +P++RP+  A+I +L
Sbjct: 238 PAPKAAELANLINNCMDYEPDHRPSFRAIIRDL 270

>pdb|3OMV|A Chain A, Crystal Structure Of C-Raf (Raf-1) Length = 307

Iteration: 1
 Score = 59.3 bits (142), Expect = 6e-09,   Method: Compositional matrix adjust.
 Identities = 50/213 (23%), Positives = 100/213 (46%), Gaps = 21/213 (9%)
Query: 412 SEVNL---LGKGNFSSVYKGTLRDGTLVAIRSINVTSCKSEEAE-FVKGLYLLTSLRHEN 467
           SEV L   +G G+F +VYKG       VA++ + V     E+ + F   + +L   RH N
Sbjct: 36  SEVMLSTRIGSGSFGTVYKGKWHGD--VAVKILKVVDPTPEQFQAFRNEVAVLRKTRHVN 93
Query: 468 IIRLRGFCCSRGRGECFLIYDFAPKGKLSKYLDQEEGSSNVLDWSTRVSIIIGIAKGIGY 527
           I+   G+     +    ++  +     L K+L  +E    +      + I    A+G+ Y
Sbjct: 94  ILLFMGYMT---KDNLAIVTQWCEGSSLYKHLHVQETKFQMFQ---LIDIARQTAQGMDY 147
Query: 528 LHSSEVNKPAIVHRNLSVEKVLIDQQFNPLIADCGLHKLLAD-DIVFSVLKTSAAMGYLA 586
           LH+       I+HR++    + + +     I D GL  + +       V + + ++ ++A
Sbjct: 148 LHAKN-----IIHRDMKSNNIFLHEGLTVKIGDFGLATVKSRWSGSQQVEQPTGSVLWMA 202
Query: 587 PEYVT---TGRFTERSDIFAFGVIILQILTGSL 616
           PE +       F+ +SD++++G+++ +++TG L
Sbjct: 203 PEVIRMQDNNPFSFQSDVYSYGIVLYELMTGEL 235

>pdb|1ZMV|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: K82r Mutant Length = 327

Iteration: 1
 Score = 59.3 bits (142), Expect = 6e-09,   Method: Compositional matrix adjust.
 Identities = 66/269 (24%), Positives = 119/269 (44%), Gaps = 36/269 (13%)
Query: 417 LGKGNFSSVYKGT-LRDGTLVAIRSINVTSCKSEE-AEFVKGLYLLTSLRHENIIRLRGF 474
           +GKGNF+ V     +  G  VA+R I+ T   S    +  + + ++  L H NI++L  F
Sbjct: 22  IGKGNFAKVKLARHILTGKEVAVRIIDKTQLNSSSLQKLFREVRIMKVLNHPNIVKL--F 79
Query: 475 CCSRGRGECFLIYDFAPKGKLSKYLDQEEGSSNVLDWSTRVSIIIGIAKGIGYLHSSEVN 534
                    +L+ ++A  G++  YL    G     +   +   I+     + Y H     
Sbjct: 80  EVIETEKTLYLVMEYASGGEVFDYL-VAHGRMKEKEARAKFRQIVS---AVQYCHQK--- 132
Query: 535 KPAIVHRNLSVEKVLIDQQFNPLIADCGLHKLLADDIVF-SVLKT-SAAMGYLAPEYVTT 592
              IVHR+L  E +L+D   N  IAD G     +++  F + L T   +  Y APE    
Sbjct: 133 --FIVHRDLKAENLLLDADMNIKIADFG----FSNEFTFGNKLDTFCGSPPYAAPELFQG 186
Query: 593 GRFT-ERSDIFAFGVIILQILTGSLVLTSSMRLAAESATFENFIDRNLKGKFS-----ES 646
            ++     D+++ GVI+  +++GSL          +    +   +R L+GK+       +
Sbjct: 187 KKYDGPEVDVWSLGVILYTLVSGSLPF--------DGQNLKELRERVLRGKYRIPFYMST 238
Query: 647 EAAKLGKMALVCTHEDPENRPTMEAVIEE 675
           +   L K  L+    +P  R T+E ++++
Sbjct: 239 DCENLLKKFLIL---NPSKRGTLEQIMKD 264

>pdb|4FVP|A Chain A, Crystal Structure Of The Jak2 Pseudokinase Domain (Apo Form) Length = 289

Iteration: 1
 Score = 59.3 bits (142), Expect = 7e-09,   Method: Compositional matrix adjust.
 Identities = 58/273 (21%), Positives = 122/273 (44%), Gaps = 31/273 (11%)
Query: 417 LGKGNFSSVYKGTLRD--------GTLVAIRSINVTSCKSEEAEFVKGLYLLTSLRHENI 468
           LG+G F+ ++KG  R+         T V ++ ++       E+ F +   +++ L H+++
Sbjct: 16  LGQGTFTKIFKGVRREVGDYGQLHETEVLLKVLDKAHRNYSES-FFEAASMMSKLSHKHL 74
Query: 469 IRLRGFC-CSRGRGECFLIYDFAPKGKLSKYLDQEEGSSNVLDWSTRVSIIIGIAKGIGY 527
           +   G C C     E  L+ +F   G L  YL + +   N+L W   V+  +  A     
Sbjct: 75  VLNYGVCVCG---DENILVQEFVKFGSLDTYLKKNKNCINIL-WKLEVAKQLAAA----- 125
Query: 528 LHSSEVNKPAIVHRNLSVEKVLIDQQFNPLIADCGLHKLLADDIVFSVLKT---SAAMGY 584
           +H  E N   ++H N+  + +L+ ++ +    +    KL    I  +VL        + +
Sbjct: 126 MHFLEEN--TLIHGNVCAKNILLIREEDRKTGNPPFIKLSDPGISITVLPKDILQERIPW 183
Query: 585 LAPEYVTTGR-FTERSDIFAFGVIILQILTGSLVLTSSMRLAAESATFENFIDRNLKGKF 643
           + PE +   +     +D ++FG  + +I +G     S++    +   +E+      + + 
Sbjct: 184 VPPECIENPKNLNLATDKWSFGTTLWEICSGGDKPLSALDSQRKLQFYED------RHQL 237
Query: 644 SESEAAKLGKMALVCTHEDPENRPTMEAVIEEL 676
              +AA+L  +   C   +P++RP+  A+I +L
Sbjct: 238 PAPKAAELANLINNCMDYEPDHRPSFRAIIRDL 270

>pdb|3A7F|A Chain A, Human Mst3 Kinase Length = 303

Iteration: 1
 Score = 59.3 bits (142), Expect = 7e-09,   Method: Compositional matrix adjust.
 Identities = 60/274 (21%), Positives = 125/274 (45%), Gaps = 33/274 (12%)
Query: 409 QCFSEVNLLGKGNFSSVYKGTL-RDGTLVAIRSINVTSCKSEEAEFVKGLYLLTSLRHEN 467
           + F+++  +GKG+F  V+KG   R   +VAI+ I++   + E  +  + + +L+      
Sbjct: 22  ELFTKLEKIGKGSFGEVFKGIDNRTQKVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPY 81
Query: 468 IIRLRGFCCSRGRGECFLIYDFAPKGKLSKYLDQEEGSSNVLDWSTRVSIIIGIAKGIGY 527
           + +  G      +   ++I ++   G     L+        LD +   +I+  I KG+ Y
Sbjct: 82  VTKYYGSYLKDTK--LWIIMEYLGGGSALDLLE-----PGPLDETQIATILREILKGLDY 134
Query: 528 LHSSEVNKPAIVHRNLSVEKVLIDQQFNPLIADCGLHKLLADDIVFSVLKTSAAMG---Y 584
           LHS +      +HR++    VL+ +     +AD G+   L D    + +K +  +G   +
Sbjct: 135 LHSEKK-----IHRDIKAANVLLSEHGEVKLADFGVAGQLTD----TQIKRNXFVGTPFW 185
Query: 585 LAPEYVTTGRFTERSDIFAFGVIILQILTGSLVLTSSMRLAAESATFENFIDRN----LK 640
           +APE +    +  ++DI++ G+  +++  G         L      F   I +N    L+
Sbjct: 186 MAPEVIKQSAYDSKADIWSLGITAIELARGE---PPHSELHPMKVLF--LIPKNNPPTLE 240
Query: 641 GKFSESEAAKLGKMALVCTHEDPENRPTMEAVIE 674
           G +S+     L +    C +++P  RPT + +++
Sbjct: 241 GNYSKP----LKEFVEACLNKEPSFRPTAKELLK 270

>pdb|2I1M|A Chain A, Cfms Tyrosine Kinase (Tie2 Kid) In Complex With An Arylamide Inhibitor Length = 333

Iteration: 1
 Score = 58.9 bits (141), Expect = 8e-09,   Method: Compositional matrix adjust.
 Identities = 69/282 (24%), Positives = 130/282 (46%), Gaps = 44/282 (15%)
Query: 417 LGKGNFSSVYKGTL-----RDGTL-VAIRSINVTSCKSEEAEFVKGLYLLTSL-RHENII 469
           LG G F  V + T       D  L VA++ +  T+   E+   +  L +++ L +HENI+
Sbjct: 54  LGAGAFGKVVEATAFGLGKEDAVLKVAVKMLKSTAHADEKEALMSELKIMSHLGQHENIV 113
Query: 470 RLRGFCCSRGRGECFLIYDFAPKGKLSKYLDQEEGSSNVLDWSTRVSIIIGIAKGIGYLH 529
            L G  C+ G G   +I ++   G L  +L ++   S VL+     +I    A     LH
Sbjct: 114 NLLG-ACTHG-GPVLVITEYCCYGDLLNFLRRK---SRVLETDPAFAIANSTASTRDLLH 168
Query: 530 -SSEVNK-------PAIVHRNLSVEKVLIDQQFNPLIADCGLHKLLADDIVFSVLKTSAA 581
            SS+V +          +HR+++   VL+       I D GL + + +D  + ++K +A 
Sbjct: 169 FSSQVAQGMAFLASKNCIHRDVAARNVLLTNGHVAKIGDFGLARDIMNDSNY-IVKGNAR 227
Query: 582 M--GYLAPEYVTTGRFTERSDIFAFGVIILQILT-------GSLVLTSSMRLAAESATFE 632
           +   ++APE +    +T +SD++++G+++ +I +       G LV +   +L  +     
Sbjct: 228 LPVKWMAPESIFDCVYTVQSDVWSYGILLWEIFSLGLNPYPGILVNSKFYKLVKDGYQMA 287
Query: 633 N--FIDRNLKGKFSESEAAKLGKMALVCTHEDPENRPTMEAV 672
              F  +N+   +S  +A         C   +P +RPT + +
Sbjct: 288 QPAFAPKNI---YSIMQA---------CWALEPTHRPTFQQI 317

>pdb|3G0F|A Chain A, Kit Kinase Domain Mutant D816h In Complex With Sunitinib Length = 336

Iteration: 1
 Score = 58.9 bits (141), Expect = 9e-09,   Method: Compositional matrix adjust.
 Identities = 63/281 (22%), Positives = 121/281 (43%), Gaps = 34/281 (12%)
Query: 417 LGKGNFSSVYKGTLR-----DGTL-VAIRSINVTSCKSEEAEFVKGLYLLTSL-RHENII 469
           LG G F  V + T       D  + VA++ +  ++  +E    +  L +L+ L  H NI+
Sbjct: 54  LGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSAHLTEREALMSELKVLSYLGNHMNIV 113
Query: 470 RLRGFCCSRGRGECFLIYDFAPKGKLSKYLDQEEGSSNVLDWSTRV-------------- 515
            L G  C+ G G   +I ++   G L  +L ++  S      S  +              
Sbjct: 114 NLLG-ACTIG-GPTLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELALDLEDLL 171
Query: 516 SIIIGIAKGIGYLHSSEVNKPAIVHRNLSVEKVLIDQQFNPLIADCGLHKLLADDIVFSV 575
           S    +AKG+ +L S        +HR+L+   +L+       I D GL + + +D  + V
Sbjct: 172 SFSYQVAKGMAFLASKNC-----IHRDLAARNILLTHGRITKICDFGLARHIKNDSNY-V 225
Query: 576 LKTSAAM--GYLAPEYVTTGRFTERSDIFAFGVIILQILTGSLVLTSSMRLAAESATFEN 633
           +K +A +   ++APE +    +T  SD++++G+ + ++ +        M +    + F  
Sbjct: 226 VKGNARLPVKWMAPESIFNCVYTFESDVWSYGIFLWELFSLGSSPYPGMPV---DSKFYK 282
Query: 634 FIDRNLKGKFSESEAAKLGKMALVCTHEDPENRPTMEAVIE 674
            I    +    E   A++  +   C   DP  RPT + +++
Sbjct: 283 MIKEGFRMLSPEHAPAEMYDIMKTCWDADPLKRPTFKQIVQ 323

>pdb|1ZMW|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: T208aS212A INACTIVE DOUBLE MUTANT Length = 327

Iteration: 1
 Score = 58.9 bits (141), Expect = 9e-09,   Method: Compositional matrix adjust.
 Identities = 66/270 (24%), Positives = 118/270 (43%), Gaps = 38/270 (14%)
Query: 417 LGKGNFSSVYKGT-LRDGTLVAIRSINVTSCKSEE-AEFVKGLYLLTSLRHENIIRLRGF 474
           +GKGNF+ V     +  G  VA++ I+ T   S    +  + + ++  L H NI++L  F
Sbjct: 22  IGKGNFAKVKLARHILTGKEVAVKIIDKTQLNSSSLQKLFREVRIMKVLNHPNIVKL--F 79
Query: 475 CCSRGRGECFLIYDFAPKGKLSKYLDQEEGSSNVLDWSTRVSIIIGIAKGIGYLHSSEVN 534
                    +L+ ++A  G++  YL    G     +   +   I+     + Y H     
Sbjct: 80  EVIETEKTLYLVMEYASGGEVFDYL-VAHGRMKEKEARAKFRQIVS---AVQYCHQK--- 132
Query: 535 KPAIVHRNLSVEKVLIDQQFNPLIADCGLHKLLADDIVFSVLKTSAAMG---YLAPEYVT 591
              IVHR+L  E +L+D   N  IAD G     +++  F   K  A  G   Y APE   
Sbjct: 133 --FIVHRDLKAENLLLDADMNIKIADFG----FSNEFTFGN-KLDAFCGAPPYAAPELFQ 185
Query: 592 TGRFT-ERSDIFAFGVIILQILTGSLVLTSSMRLAAESATFENFIDRNLKGKFS-----E 645
             ++     D+++ GVI+  +++GSL          +    +   +R L+GK+       
Sbjct: 186 GKKYDGPEVDVWSLGVILYTLVSGSLPF--------DGQNLKELRERVLRGKYRIPFYMS 237
Query: 646 SEAAKLGKMALVCTHEDPENRPTMEAVIEE 675
           ++   L K  L+    +P  R T+E ++++
Sbjct: 238 TDCENLLKKFLIL---NPSKRGTLEQIMKD 264

>pdb|3ZHP|C Chain C, Human Mst3 (stk24) In Complex With Mo25beta Length = 294

Iteration: 1
 Score = 58.9 bits (141), Expect = 9e-09,   Method: Compositional matrix adjust.
 Identities = 60/274 (21%), Positives = 125/274 (45%), Gaps = 33/274 (12%)
Query: 409 QCFSEVNLLGKGNFSSVYKGTL-RDGTLVAIRSINVTSCKSEEAEFVKGLYLLTSLRHEN 467
           + F+++  +GKG+F  V+KG   R   +VAI+ I++   + E  +  + + +L+      
Sbjct: 27  ELFTKLEKIGKGSFGEVFKGIDNRTQKVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPY 86
Query: 468 IIRLRGFCCSRGRGECFLIYDFAPKGKLSKYLDQEEGSSNVLDWSTRVSIIIGIAKGIGY 527
           + +  G      +   ++I ++   G     L+        LD +   +I+  I KG+ Y
Sbjct: 87  VTKYYGSYLKDTK--LWIIMEYLGGGSALDLLE-----PGPLDETQIATILREILKGLDY 139
Query: 528 LHSSEVNKPAIVHRNLSVEKVLIDQQFNPLIADCGLHKLLADDIVFSVLKTSAAMG---Y 584
           LHS +      +HR++    VL+ +     +AD G+   L D    + +K +  +G   +
Sbjct: 140 LHSEKK-----IHRDIKAANVLLSEHGEVKLADFGVAGQLTD----TQIKRNTFVGTPFW 190
Query: 585 LAPEYVTTGRFTERSDIFAFGVIILQILTGSLVLTSSMRLAAESATFENFIDRN----LK 640
           +APE +    +  ++DI++ G+  +++  G         L      F   I +N    L+
Sbjct: 191 MAPEVIKQSAYDSKADIWSLGITAIELARGE---PPHSELHPMKVLF--LIPKNNPPTLE 245
Query: 641 GKFSESEAAKLGKMALVCTHEDPENRPTMEAVIE 674
           G +S+     L +    C +++P  RPT + +++
Sbjct: 246 GNYSKP----LKEFVEACLNKEPSFRPTAKELLK 275

>pdb|2I0V|A Chain A, C-Fms Tyrosine Kinase In Complex With A Quinolone Inhibitor Length = 335

Iteration: 1
 Score = 58.9 bits (141), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 67/292 (22%), Positives = 133/292 (45%), Gaps = 62/292 (21%)
Query: 417 LGKGNFSSVYKGTL-----RDGTL-VAIRSINVTSCKSEEAEFVKGLYLLTSL-RHENII 469
           LG G F  V + T       D  L VA++ +  T+   E+   +  L +++ L +HENI+
Sbjct: 54  LGAGAFGKVVEATAFGLGKEDAVLKVAVKMLKSTAHADEKEALMSELKIMSHLGQHENIV 113
Query: 470 RLRGFCCSRGRGECFLIYDFAPKGKLSKYL------------------DQEEGSSNVLDW 511
            L G  C+ G G   +I ++   G L  +L                  +++  S ++L +
Sbjct: 114 NLLG-ACTHG-GPVLVITEYCCYGDLLNFLRRKRPPGLEYSYNPSHNPEEQLSSRDLLHF 171
Query: 512 STRVSIIIGIAKGIGYLHSSEVNKPAIVHRNLSVEKVLIDQQFNPLIADCGLHKLLADDI 571
           S++V      A+G+ +L S        +HR+++   VL+       I D GL + + +D 
Sbjct: 172 SSQV------AQGMAFLASKNC-----IHRDVAARNVLLTNGHVAKIGDFGLARDIMNDS 220
Query: 572 VFSVLKTSAAM--GYLAPEYVTTGRFTERSDIFAFGVIILQILT-------GSLVLTSSM 622
            + ++K +A +   ++APE +    +T +SD++++G+++ +I +       G LV +   
Sbjct: 221 NY-IVKGNARLPVKWMAPESIFDCVYTVQSDVWSYGILLWEIFSLGLNPYPGILVNSKFY 279
Query: 623 RLAAESATFEN--FIDRNLKGKFSESEAAKLGKMALVCTHEDPENRPTMEAV 672
           +L  +        F  +N+   +S  +A         C   +P +RPT + +
Sbjct: 280 KLVKDGYQMAQPAFAPKNI---YSIMQA---------CWALEPTHRPTFQQI 319

>pdb|1T46|A Chain A, Structural Basis For The Autoinhibition And Sti-571 Inhibition Of C-kit Tyrosine Kinase Length = 313

Iteration: 1
 Score = 58.5 bits (140), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 63/281 (22%), Positives = 122/281 (43%), Gaps = 34/281 (12%)
Query: 417 LGKGNFSSVYKGTLR-----DGTL-VAIRSINVTSCKSEEAEFVKGLYLLTSL-RHENII 469
           LG G F  V + T       D  + VA++ +  ++  +E    +  L +L+ L  H NI+
Sbjct: 31  LGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSAHLTEREALMSELKVLSYLGNHMNIV 90
Query: 470 RLRGFCCSRGRGECFLIYDFAPKGKLSKYLDQEEGSSNVLDWSTRV-------------- 515
            L G  C+ G G   +I ++   G L  +L ++  S      S  +              
Sbjct: 91  NLLG-ACTIG-GPTLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELALDLEDLL 148
Query: 516 SIIIGIAKGIGYLHSSEVNKPAIVHRNLSVEKVLIDQQFNPLIADCGLHKLLADDIVFSV 575
           S    +AKG+ +L S        +HR+L+   +L+       I D GL + + +D  + V
Sbjct: 149 SFSYQVAKGMAFLASKNC-----IHRDLAARNILLTHGRITKICDFGLARDIKNDSNY-V 202
Query: 576 LKTSAAM--GYLAPEYVTTGRFTERSDIFAFGVIILQILTGSLVLTSSMRLAAESATFEN 633
           +K +A +   ++APE +    +T  SD++++G+ + ++ +        M + ++   F  
Sbjct: 203 VKGNARLPVKWMAPESIFNCVYTFESDVWSYGIFLWELFSLGSSPYPGMPVDSK---FYK 259
Query: 634 FIDRNLKGKFSESEAAKLGKMALVCTHEDPENRPTMEAVIE 674
            I    +    E   A++  +   C   DP  RPT + +++
Sbjct: 260 MIKEGFRMLSPEHAPAEMYDIMKTCWDADPLKRPTFKQIVQ 300

>pdb|3MTL|A Chain A, Crystal Structure Of The Pctaire1 Kinase In Complex With Ind E804 Length = 324

Iteration: 1
 Score = 58.5 bits (140), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 47/209 (22%), Positives = 98/209 (46%), Gaps = 16/209 (7%)
Query: 409 QCFSEVNLLGKGNFSSVYKGTLR-DGTLVAIRSINVTSCKSEEAEFVKGLYLLTSLRHEN 467
           + + +++ LG+G +++VYKG  +    LVA++ I +   +      ++ + LL  L+H N
Sbjct: 2   ETYIKLDKLGEGTYATVYKGKSKLTDNLVALKEIRLEHEEGAPCTAIREVSLLKDLKHAN 61
Query: 468 IIRLRGFCCSRGRGECFLIYDFAPKGKLSKYLDQEEGSSNVLDWSTRVSIIIGIAKGIGY 527
           I+ L     +       L++++  K  L +YLD      N+++       +  + +G+ Y
Sbjct: 62  IVTLHDIIHT--EKSLTLVFEYLDKD-LKQYLDD---CGNIINMHNVKLFLFQLLRGLAY 115
Query: 528 LHSSEVNKPAIVHRNLSVEKVLIDQQFNPLIADCGLHKLLADDIVFSVLKTSAAMGYLAP 587
            H  +V     +HR+L  + +LI+++    +AD GL +  A  I            +  P
Sbjct: 116 CHRQKV-----LHRDLKPQNLLINERGELKLADFGLAR--AKSIPTKTYDNEVVTLWYRP 168
Query: 588 EYVTTGR--FTERSDIFAFGVIILQILTG 614
             +  G   ++ + D++  G I  ++ TG
Sbjct: 169 PDILLGSTDYSTQIDMWGVGCIFYEMATG 197

>pdb|3G0E|A Chain A, Kit Kinase Domain In Complex With Sunitinib Length = 336

Iteration: 1
 Score = 58.5 bits (140), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 63/281 (22%), Positives = 121/281 (43%), Gaps = 34/281 (12%)
Query: 417 LGKGNFSSVYKGTLR-----DGTL-VAIRSINVTSCKSEEAEFVKGLYLLTSL-RHENII 469
           LG G F  V + T       D  + VA++ +  ++  +E    +  L +L+ L  H NI+
Sbjct: 54  LGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSAHLTEREALMSELKVLSYLGNHMNIV 113
Query: 470 RLRGFCCSRGRGECFLIYDFAPKGKLSKYLDQEEGSSNVLDWSTRV-------------- 515
            L G  C+ G G   +I ++   G L  +L ++  S      S  +              
Sbjct: 114 NLLG-ACTIG-GPTLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELALDLEDLL 171
Query: 516 SIIIGIAKGIGYLHSSEVNKPAIVHRNLSVEKVLIDQQFNPLIADCGLHKLLADDIVFSV 575
           S    +AKG+ +L S        +HR+L+   +L+       I D GL + + +D  + V
Sbjct: 172 SFSYQVAKGMAFLASKNC-----IHRDLAARNILLTHGRITKICDFGLARDIKNDSNY-V 225
Query: 576 LKTSAAM--GYLAPEYVTTGRFTERSDIFAFGVIILQILTGSLVLTSSMRLAAESATFEN 633
           +K +A +   ++APE +    +T  SD++++G+ + ++ +        M +    + F  
Sbjct: 226 VKGNARLPVKWMAPESIFNCVYTFESDVWSYGIFLWELFSLGSSPYPGMPV---DSKFYK 282
Query: 634 FIDRNLKGKFSESEAAKLGKMALVCTHEDPENRPTMEAVIE 674
            I    +    E   A++  +   C   DP  RPT + +++
Sbjct: 283 MIKEGFRMLSPEHAPAEMYDIMKTCWDADPLKRPTFKQIVQ 323

>pdb|2H6D|A Chain A, Protein Kinase Domain Of The Human 5'-Amp-Activated Protein Kinase Catalytic Subunit Alpha-2 (Ampk Alpha-2 Chain) Length = 276

Iteration: 1
 Score = 58.5 bits (140), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 59/208 (28%), Positives = 98/208 (47%), Gaps = 21/208 (10%)
Query: 415 NLLGKGNFSSVYKGTLR-DGTLVAIRSINVTSCKSEEA--EFVKGLYLLTSLRHENIIRL 471
           + LG G F  V  G  +  G  VA++ +N    +S +   +  + +  L   RH +II+L
Sbjct: 17  DTLGVGTFGKVKIGEHQLTGHKVAVKILNRQKIRSLDVVGKIKREIQNLKLFRHPHIIKL 76
Query: 472 RGFCCSRGRGECFLIYDFAPKGKLSKYLDQEEGSSNVLDWSTRVSIIIGIAKGIGYLHSS 531
                +    + F++ ++   G+L  Y+ +      V +   R  +   I   + Y H  
Sbjct: 77  YQVISTPT--DFFMVMEYVSGGELFDYICKH---GRVEEMEAR-RLFQQILSAVDYCH-- 128
Query: 532 EVNKPAIVHRNLSVEKVLIDQQFNPLIADCGLHKLLADDIVFSVLKTS-AAMGYLAPEYV 590
              +  +VHR+L  E VL+D   N  IAD GL  +++D      L+TS  +  Y APE V
Sbjct: 129 ---RHMVVHRDLKPENVLLDAHMNAKIADFGLSNMMSDG---EFLRTSCGSPNYAAPE-V 181
Query: 591 TTGRFTE--RSDIFAFGVIILQILTGSL 616
            +GR       DI++ GVI+  +L G+L
Sbjct: 182 ISGRLYAGPEVDIWSCGVILYALLCGTL 209

>pdb|3CKW|A Chain A, Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3, Stk24) Length = 304

Iteration: 1
 Score = 58.2 bits (139), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 60/274 (21%), Positives = 125/274 (45%), Gaps = 33/274 (12%)
Query: 409 QCFSEVNLLGKGNFSSVYKGTL-RDGTLVAIRSINVTSCKSEEAEFVKGLYLLTSLRHEN 467
           + F+++  +GKG+F  V+KG   R   +VAI+ I++   + E  +  + + +L+      
Sbjct: 7   ELFTKLEKIGKGSFGEVFKGIDNRTQKVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPY 66
Query: 468 IIRLRGFCCSRGRGECFLIYDFAPKGKLSKYLDQEEGSSNVLDWSTRVSIIIGIAKGIGY 527
           + +  G      +   ++I ++   G     L+        LD +   +I+  I KG+ Y
Sbjct: 67  VTKYYGSYLKDTK--LWIIMEYLGGGSALDLLE-----PGPLDETQIATILREILKGLDY 119
Query: 528 LHSSEVNKPAIVHRNLSVEKVLIDQQFNPLIADCGLHKLLADDIVFSVLKTSAAMG---Y 584
           LHS +      +HR++    VL+ +     +AD G+   L D    + +K +  +G   +
Sbjct: 120 LHSEKK-----IHRDIKAANVLLSEHGEVKLADFGVAGQLTD----TQIKRNTFVGTPFW 170
Query: 585 LAPEYVTTGRFTERSDIFAFGVIILQILTGSLVLTSSMRLAAESATFENFIDRN----LK 640
           +APE +    +  ++DI++ G+  +++  G         L      F   I +N    L+
Sbjct: 171 MAPEVIKQSAYDSKADIWSLGITAIELARGE---PPHSELHPMKVLF--LIPKNNPPTLE 225
Query: 641 GKFSESEAAKLGKMALVCTHEDPENRPTMEAVIE 674
           G +S+     L +    C +++P  RPT + +++
Sbjct: 226 GNYSKP----LKEFVEACLNKEPSFRPTAKELLK 255

>pdb|1T45|A Chain A, Structural Basis For The Autoinhibition And Sti-571 Inhibition Of C- Kit Tyrosine Kinase Length = 331

Iteration: 1
 Score = 58.2 bits (139), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 63/281 (22%), Positives = 121/281 (43%), Gaps = 34/281 (12%)
Query: 417 LGKGNFSSVYKGTLR-----DGTL-VAIRSINVTSCKSEEAEFVKGLYLLTSL-RHENII 469
           LG G F  V + T       D  + VA++ +  ++  +E    +  L +L+ L  H NI+
Sbjct: 49  LGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSAHLTEREALMSELKVLSYLGNHMNIV 108
Query: 470 RLRGFCCSRGRGECFLIYDFAPKGKLSKYLDQEEGSSNVLDWSTRV-------------- 515
            L G  C+ G G   +I ++   G L  +L ++  S      S  +              
Sbjct: 109 NLLG-ACTIG-GPTLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELALDLEDLL 166
Query: 516 SIIIGIAKGIGYLHSSEVNKPAIVHRNLSVEKVLIDQQFNPLIADCGLHKLLADDIVFSV 575
           S    +AKG+ +L S        +HR+L+   +L+       I D GL + + +D  + V
Sbjct: 167 SFSYQVAKGMAFLASKNC-----IHRDLAARNILLTHGRITKICDFGLARDIKNDSNY-V 220
Query: 576 LKTSAAM--GYLAPEYVTTGRFTERSDIFAFGVIILQILTGSLVLTSSMRLAAESATFEN 633
           +K +A +   ++APE +    +T  SD++++G+ + ++ +        M +    + F  
Sbjct: 221 VKGNARLPVKWMAPESIFNCVYTFESDVWSYGIFLWELFSLGSSPYPGMPV---DSKFYK 277
Query: 634 FIDRNLKGKFSESEAAKLGKMALVCTHEDPENRPTMEAVIE 674
            I    +    E   A++  +   C   DP  RPT + +++
Sbjct: 278 MIKEGFRMLSPEHAPAEMYDIMKTCWDADPLKRPTFKQIVQ 318

>pdb|1PKG|A Chain A, Structure Of A C-kit Kinase Product Complex Length = 329

Iteration: 1
 Score = 58.2 bits (139), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 63/281 (22%), Positives = 121/281 (43%), Gaps = 34/281 (12%)
Query: 417 LGKGNFSSVYKGTLR-----DGTL-VAIRSINVTSCKSEEAEFVKGLYLLTSL-RHENII 469
           LG G F  V + T       D  + VA++ +  ++  +E    +  L +L+ L  H NI+
Sbjct: 47  LGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSAHLTEREALMSELKVLSYLGNHMNIV 106
Query: 470 RLRGFCCSRGRGECFLIYDFAPKGKLSKYLDQEEGSSNVLDWSTRV-------------- 515
            L G  C+ G G   +I ++   G L  +L ++  S      S  +              
Sbjct: 107 NLLG-ACTIG-GPTLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELALDLEDLL 164
Query: 516 SIIIGIAKGIGYLHSSEVNKPAIVHRNLSVEKVLIDQQFNPLIADCGLHKLLADDIVFSV 575
           S    +AKG+ +L S        +HR+L+   +L+       I D GL + + +D  + V
Sbjct: 165 SFSYQVAKGMAFLASKNC-----IHRDLAARNILLTHGRITKICDFGLARDIKNDSNY-V 218
Query: 576 LKTSAAM--GYLAPEYVTTGRFTERSDIFAFGVIILQILTGSLVLTSSMRLAAESATFEN 633
           +K +A +   ++APE +    +T  SD++++G+ + ++ +        M +    + F  
Sbjct: 219 VKGNARLPVKWMAPESIFNCVYTFESDVWSYGIFLWELFSLGSSPYPGMPV---DSKFYK 275
Query: 634 FIDRNLKGKFSESEAAKLGKMALVCTHEDPENRPTMEAVIE 674
            I    +    E   A++  +   C   DP  RPT + +++
Sbjct: 276 MIKEGFRMLSPEHAPAEMYDIMKTCWDADPLKRPTFKQIVQ 316

>pdb|3CKX|A Chain A, Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3, Stk24) In Complex With Staurosporine Length = 304

Iteration: 1
 Score = 58.2 bits (139), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 60/274 (21%), Positives = 125/274 (45%), Gaps = 33/274 (12%)
Query: 409 QCFSEVNLLGKGNFSSVYKGTL-RDGTLVAIRSINVTSCKSEEAEFVKGLYLLTSLRHEN 467
           + F+++  +GKG+F  V+KG   R   +VAI+ I++   + E  +  + + +L+      
Sbjct: 7   ELFTKLEKIGKGSFGEVFKGIDNRTQKVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPY 66
Query: 468 IIRLRGFCCSRGRGECFLIYDFAPKGKLSKYLDQEEGSSNVLDWSTRVSIIIGIAKGIGY 527
           + +  G      +   ++I ++   G     L+        LD +   +I+  I KG+ Y
Sbjct: 67  VTKYYGSYLKDTK--LWIIMEYLGGGSALDLLE-----PGPLDETQIATILREILKGLDY 119
Query: 528 LHSSEVNKPAIVHRNLSVEKVLIDQQFNPLIADCGLHKLLADDIVFSVLKTSAAMG---Y 584
           LHS +      +HR++    VL+ +     +AD G+   L D    + +K +  +G   +
Sbjct: 120 LHSEKK-----IHRDIKAANVLLSEHGEVKLADFGVAGQLTD----TQIKRNXFVGTPFW 170
Query: 585 LAPEYVTTGRFTERSDIFAFGVIILQILTGSLVLTSSMRLAAESATFENFIDRN----LK 640
           +APE +    +  ++DI++ G+  +++  G         L      F   I +N    L+
Sbjct: 171 MAPEVIKQSAYDSKADIWSLGITAIELARGE---PPHSELHPMKVLF--LIPKNNPPTLE 225
Query: 641 GKFSESEAAKLGKMALVCTHEDPENRPTMEAVIE 674
           G +S+     L +    C +++P  RPT + +++
Sbjct: 226 GNYSKP----LKEFVEACLNKEPSFRPTAKELLK 255

>pdb|2JED|A Chain A, The Crystal Structure Of The Kinase Domain Of The Protein Kinase C Theta In Complex With Nvp-Xaa228 At 2.32a Resolution. Length = 352

Iteration: 1
 Score = 58.2 bits (139), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 69/283 (24%), Positives = 121/283 (42%), Gaps = 35/283 (12%)
Query: 394 LNSFRLNLEEVESATQCFSEVNLLGKGNFSSVYKGTLRD-GTLVAIRSIN---VTSCKSE 449
           LN  R +L+ ++   + F    +LGKG+F  V+    +      AI+++    V      
Sbjct: 4   LNKERPSLQ-IKLKIEDFELHKMLGKGSFGKVFLAEFKKTNQFFAIKALKKDVVLMDDDV 62
Query: 450 EAEFVKGLYLLTSLRHENIIRLRGFCCSRGRGECFLIYDFAPKGKLSKYLDQEEGSSNVL 509
           E   V+   L  +  H  +  +  FC  + +   F + ++   G L  ++     S +  
Sbjct: 63  ECTMVEKRVLSLAWEHPFLTHM--FCTFQTKENLFFVMEYLNGGDLMYHIQ----SCHKF 116
Query: 510 DWSTRVSIIIGIAKGIGYLHSSEVNKPAIVHRNLSVEKVLIDQQFNPLIADCGLHK--LL 567
           D S        I  G+ +LHS       IV+R+L ++ +L+D+  +  IAD G+ K  +L
Sbjct: 117 DLSRATFYAAEIILGLQFLHSK-----GIVYRDLKLDNILLDKDGHIKIADFGMCKENML 171
Query: 568 ADDIVFSVLKTSAAMG---YLAPEYVTTGRFTERSDIFAFGVIILQILTGSLVLTSSMRL 624
            D       KT+   G   Y+APE +   ++    D ++FGV++ ++L G     S    
Sbjct: 172 GD------AKTNEFCGTPDYIAPEILLGQKYNHSVDWWSFGVLLYEMLIGQ----SPFHG 221
Query: 625 AAESATFENF-IDRNLKGKFSESEAAKLGKMALVCTHEDPENR 666
             E   F +  +D     ++ E EA  L     V    +PE R
Sbjct: 222 QDEEELFHSIRMDNPFYPRWLEKEAKDLLVKLFV---REPEKR 261

>pdb|3BEA|A Chain A, Cfms Tyrosine Kinase (Tie2 Kid) In Complex With A Pyrimidinopyridone Inhibitor Length = 333

Iteration: 1
 Score = 58.2 bits (139), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 69/287 (24%), Positives = 132/287 (45%), Gaps = 54/287 (18%)
Query: 417 LGKGNFSSVYKGTL-----RDGTL-VAIRSINVTSCKSEEAEFVKGLYLLTSL-RHENII 469
           LG G F  V + T       D  L VA++ +  T+   E+   +  L +++ L +HENI+
Sbjct: 54  LGAGAFGKVVEATAFGLGKEDAVLKVAVKMLKSTAHADEKEALMSELKIMSHLGQHENIV 113
Query: 470 RLRGFCCSRGRGECFLIYDFAPKGKLSKYLDQEEGSSNVLD-----------WSTR--VS 516
            L G  C+ G G   +I ++   G L  +L ++   S VL+            STR  + 
Sbjct: 114 NLLG-ACTHG-GPVLVITEYCCYGDLLNFLRRK---SRVLETDPAFAIANSTLSTRDLLH 168
Query: 517 IIIGIAKGIGYLHSSEVNKPAIVHRNLSVEKVLIDQQFNPLIADCGLHKLLADDIVFSVL 576
               +A+G+ +L S        +HR+++   VL+       I D GL + + +D  + ++
Sbjct: 169 FSSQVAQGMAFLASKNC-----IHRDVAARNVLLTNGHVAKIGDFGLARDIMNDSNY-IV 222
Query: 577 KTSAAM--GYLAPEYVTTGRFTERSDIFAFGVIILQILT-------GSLVLTSSMRLAAE 627
           K +A +   ++APE +    +T +SD++++G+++ +I +       G LV +   +L  +
Sbjct: 223 KGNARLPVKWMAPESIFDCVYTVQSDVWSYGILLWEIFSLGLNPYPGILVNSKFYKLVKD 282
Query: 628 SATFEN--FIDRNLKGKFSESEAAKLGKMALVCTHEDPENRPTMEAV 672
                   F  +N+   +S  +A         C   +P +RPT + +
Sbjct: 283 GYQMAQPAFAPKNI---YSIMQA---------CWALEPTHRPTFQQI 317

>pdb|1ZMU|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: Wild Type Length = 327

Iteration: 1
 Score = 58.2 bits (139), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 65/269 (24%), Positives = 119/269 (44%), Gaps = 36/269 (13%)
Query: 417 LGKGNFSSVYKGT-LRDGTLVAIRSINVTSCKSEE-AEFVKGLYLLTSLRHENIIRLRGF 474
           +GKGNF+ V     +  G  VA++ I+ T   S    +  + + ++  L H NI++L  F
Sbjct: 22  IGKGNFAKVKLARHILTGKEVAVKIIDKTQLNSSSLQKLFREVRIMKVLNHPNIVKL--F 79
Query: 475 CCSRGRGECFLIYDFAPKGKLSKYLDQEEGSSNVLDWSTRVSIIIGIAKGIGYLHSSEVN 534
                    +L+ ++A  G++  YL    G     +   +   I+     + Y H     
Sbjct: 80  EVIETEKTLYLVMEYASGGEVFDYL-VAHGRMKEKEARAKFRQIVS---AVQYCHQK--- 132
Query: 535 KPAIVHRNLSVEKVLIDQQFNPLIADCGLHKLLADDIVF-SVLKT-SAAMGYLAPEYVTT 592
              IVHR+L  E +L+D   N  IAD G     +++  F + L T   +  Y APE    
Sbjct: 133 --FIVHRDLKAENLLLDADMNIKIADFG----FSNEFTFGNKLDTFCGSPPYAAPELFQG 186
Query: 593 GRFT-ERSDIFAFGVIILQILTGSLVLTSSMRLAAESATFENFIDRNLKGKFS-----ES 646
            ++     D+++ GVI+  +++GSL          +    +   +R L+GK+       +
Sbjct: 187 KKYDGPEVDVWSLGVILYTLVSGSLPF--------DGQNLKELRERVLRGKYRIPFYMST 238
Query: 647 EAAKLGKMALVCTHEDPENRPTMEAVIEE 675
           +   L K  L+    +P  R T+E ++++
Sbjct: 239 DCENLLKKFLIL---NPSKRGTLEQIMKD 264

>pdb|2R0I|A Chain A, Crystal Structure Of A Kinase Mark2PAR-1 Mutant Length = 327

Iteration: 1
 Score = 57.8 bits (138), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 65/269 (24%), Positives = 119/269 (44%), Gaps = 36/269 (13%)
Query: 417 LGKGNFSSVYKGT-LRDGTLVAIRSINVTSCKSEE-AEFVKGLYLLTSLRHENIIRLRGF 474
           +GKGNF+ V     +  G  VA++ I+ T   S    +  + + ++  L H NI++L  F
Sbjct: 22  IGKGNFAKVKLARHILTGKEVAVKIIDKTQLNSSSLQKLFREVRIMKVLNHPNIVKL--F 79
Query: 475 CCSRGRGECFLIYDFAPKGKLSKYLDQEEGSSNVLDWSTRVSIIIGIAKGIGYLHSSEVN 534
                    +L+ ++A  G++  YL    G     +   +   I+     + Y H     
Sbjct: 80  EVIETEKTLYLVMEYASGGEVFDYL-VAHGRMKEKEARAKFRQIVS---AVQYCHQK--- 132
Query: 535 KPAIVHRNLSVEKVLIDQQFNPLIADCGLHKLLADDIVF-SVLKT-SAAMGYLAPEYVTT 592
              IVHR+L  E +L+D   N  IAD G     +++  F + L T   +  Y APE    
Sbjct: 133 --FIVHRDLKAENLLLDADMNIKIADFG----FSNEFTFGNKLDTFCGSPPYAAPELFQG 186
Query: 593 GRFT-ERSDIFAFGVIILQILTGSLVLTSSMRLAAESATFENFIDRNLKGKFS-----ES 646
            ++     D+++ GVI+  +++GSL          +    +   +R L+GK+       +
Sbjct: 187 KKYDGPEVDVWSLGVILYTLVSGSLPF--------DGQNLKELRERVLRGKYRIPFYMST 238
Query: 647 EAAKLGKMALVCTHEDPENRPTMEAVIEE 675
           +   L K  L+    +P  R T+E ++++
Sbjct: 239 DCENLLKKFLIL---NPSKRGTLEQIMKD 264

>pdb|1XJD|A Chain A, Crystal Structure Of Pkc-Theta Complexed With Staurosporine At 2a Resolution Length = 345

Iteration: 1
 Score = 57.4 bits (137), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 64/262 (24%), Positives = 111/262 (42%), Gaps = 34/262 (12%)
Query: 415 NLLGKGNFSSVYKGTLRD-GTLVAIRSIN---VTSCKSEEAEFVKGLYLLTSLRHENIIR 470
            +LGKG+F  V+    +      AI+++    V      E   V+   L  +  H  +  
Sbjct: 23  KMLGKGSFGKVFLAEFKKTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEHPFLTH 82
Query: 471 LRGFCCSRGRGECFLIYDFAPKGKLSKYLDQEEGSSNVLDWSTRVSIIIGIAKGIGYLHS 530
           +  FC  + +   F + ++   G L  ++     S +  D S        I  G+ +LHS
Sbjct: 83  M--FCTFQTKENLFFVMEYLNGGDLMYHIQ----SCHKFDLSRATFYAAEIILGLQFLHS 136
Query: 531 SEVNKPAIVHRNLSVEKVLIDQQFNPLIADCGLHK--LLADDIVFSVLKTSAAMG---YL 585
                  IV+R+L ++ +L+D+  +  IAD G+ K  +L D       KT+   G   Y+
Sbjct: 137 K-----GIVYRDLKLDNILLDKDGHIKIADFGMCKENMLGD------AKTNXFCGTPDYI 185
Query: 586 APEYVTTGRFTERSDIFAFGVIILQILTGSLVLTSSMRLAAESATFENF-IDRNLKGKFS 644
           APE +   ++    D ++FGV++ ++L G     S      E   F +  +D     ++ 
Sbjct: 186 APEILLGQKYNHSVDWWSFGVLLYEMLIGQ----SPFHGQDEEELFHSIRMDNPFYPRWL 241
Query: 645 ESEAAKLGKMALVCTHEDPENR 666
           E EA  L     V    +PE R
Sbjct: 242 EKEAKDLLVKLFV---REPEKR 260

>pdb|2W9F|B Chain B, Crystal Structure Of Cdk4 In Complex With A D-Type Cyclin Length = 306

Iteration: 1
 Score = 57.4 bits (137), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 57/217 (26%), Positives = 99/217 (45%), Gaps = 24/217 (11%)
Query: 407 ATQCFSEVNLLGKGNFSSVYKGTLRD---GTLVAIRSINVTSCKS----EEAEFVKGLYL 459
           AT  +  V  +G G + +VYK   RD   G  VA++S+ V + +          V  L  
Sbjct: 2   ATSRYEPVAEIGVGAYGTVYKA--RDPHSGHFVALKSVRVPNGEEGLPISTVREVALLRR 59
Query: 460 LTSLRHENIIRLRGFCC-SRGRGE--CFLIYDFAPKGKLSKYLDQEEGSSNVLDWSTRVS 516
           L +  H N++RL   C  SR   E    L+++   +  L  YLD+       L   T   
Sbjct: 60  LEAFEHPNVVRLMDVCATSRTDREIKVTLVFEHVDQ-DLRTYLDKAPPPG--LPAETIKD 116
Query: 517 IIIGIAKGIGYLHSSEVNKPAIVHRNLSVEKVLIDQQFNPLIADCGLHKLLADDI-VFSV 575
           ++    +G+ +LH++      IVHR+L  E +L+       +AD GL ++ +  + +F V
Sbjct: 117 LMRQFLRGLDFLHAN-----CIVHRDLKPENILVTSGGTVKLADFGLARIYSYQMALFPV 171
Query: 576 LKTSAAMGYLAPEYVTTGRFTERSDIFAFGVIILQIL 612
           + T   + Y APE +    +    D+++ G I  ++ 
Sbjct: 172 VVT---LWYRAPEVLLQSTYATPVDMWSVGCIFAEMF 205

>pdb|3G51|A Chain A, Structural Diversity Of The Active Conformation Of The N- Terminal Kinase Domain Of P90 Ribosomal S6 Kinase 2 Length = 325

Iteration: 1
 Score = 57.0 bits (136), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 56/219 (25%), Positives = 100/219 (45%), Gaps = 19/219 (8%)
Query: 411 FSEVNLLGKGNFSSVYKGTLRDGT----LVAIRSINVTSCKSEEAEFVKGLY-LLTSLRH 465
           F  + +LG+G+F  V+      G+    L A++ +   + K  +    K    +L  + H
Sbjct: 26  FELLKVLGQGSFGKVFLVKKISGSDARQLYAMKVLKKATLKVRDRVRTKMERDILVEVNH 85
Query: 466 ENIIRLRGFCCSRGRGECFLIYDFAPKGKLSKYLDQEEGSSNVLDWSTRVSIIIG-IAKG 524
             I++L      +  G+ +LI DF   G L   L +E     V+     V   +  +A  
Sbjct: 86  PFIVKLH--YAFQTEGKLYLILDFLRGGDLFTRLSKE-----VMFTEEDVKFYLAELALA 138
Query: 525 IGYLHSSEVNKPAIVHRNLSVEKVLIDQQFNPLIADCGLHKLLADDIVFSVLKTSAAMGY 584
           + +LHS       I++R+L  E +L+D++ +  + D GL K   D            + Y
Sbjct: 139 LDHLHSL-----GIIYRDLKPENILLDEEGHIKLTDFGLSKESIDHEK-KAYSFCGTVEY 192
Query: 585 LAPEYVTTGRFTERSDIFAFGVIILQILTGSLVLTSSMR 623
           +APE V     T+ +D ++FGV++ ++LTG+L      R
Sbjct: 193 MAPEVVNRRGHTQSADWWSFGVLMFEMLTGTLPFQGKDR 231

>pdb|2FH9|A Chain A, Structure And Dimerization Of The Kinase Domain From Yeast Snf1 Length = 274

Iteration: 1
 Score = 57.0 bits (136), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 59/213 (27%), Positives = 98/213 (46%), Gaps = 24/213 (11%)
Query: 411 FSEVNLLGKGNFSSV---YKGTLRDGTLVAIRSIN--VTSCKSEEAEFVKGLYLLTSLRH 465
           +  V  LG+G+F  V   Y  T   G  VA++ IN  V +    +    + +  L  LRH
Sbjct: 10  YQIVKTLGEGSFGKVKLAYHTT--TGQKVALKIINKKVLAKSDMQGRIEREISYLRLLRH 67
Query: 466 ENIIRLRGFCCSRGRGECFLIYDFAPKGKLSKYLDQEEGSSNVLDWSTRVSIIIGIAKGI 525
            +II+L  +   + + E  ++ ++A   +L  Y+ Q +  S              I   +
Sbjct: 68  PHIIKL--YDVIKSKDEIIMVIEYA-GNELFDYIVQRDKMSE----QEARRFFQQIISAV 120
Query: 526 GYLHSSEVNKPAIVHRNLSVEKVLIDQQFNPLIADCGLHKLLADDIVFSVLKTS-AAMGY 584
            Y H  +     IVHR+L  E +L+D+  N  IAD GL  ++ D    + LKTS  +  Y
Sbjct: 121 EYCHRHK-----IVHRDLKPENLLLDEHLNVKIADFGLSNIMTDG---NFLKTSCGSPNY 172
Query: 585 LAPEYVTTGRFT-ERSDIFAFGVIILQILTGSL 616
            APE ++   +     D+++ GVI+  +L   L
Sbjct: 173 AAPEVISGKLYAGPEVDVWSCGVILYVMLCRRL 205

>pdb|3MN3|A Chain A, An Inhibited Conformation For The Protein Kinase Domain Of The Saccharomyces Cerevisiae Ampk Homolog Snf1 Length = 271

Iteration: 1
 Score = 57.0 bits (136), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 59/213 (27%), Positives = 98/213 (46%), Gaps = 24/213 (11%)
Query: 411 FSEVNLLGKGNFSSV---YKGTLRDGTLVAIRSIN--VTSCKSEEAEFVKGLYLLTSLRH 465
           +  V  LG+G+F  V   Y  T   G  VA++ IN  V +    +    + +  L  LRH
Sbjct: 6   YQIVKTLGEGSFGKVKLAYHTT--TGQKVALKIINKKVLAKSDMQGRIEREISYLRLLRH 63
Query: 466 ENIIRLRGFCCSRGRGECFLIYDFAPKGKLSKYLDQEEGSSNVLDWSTRVSIIIGIAKGI 525
            +II+L  +   + + E  ++ ++A   +L  Y+ Q +  S              I   +
Sbjct: 64  PHIIKL--YDVIKSKDEIIMVIEYA-GNELFDYIVQRDKMSE----QEARRFFQQIISAV 116
Query: 526 GYLHSSEVNKPAIVHRNLSVEKVLIDQQFNPLIADCGLHKLLADDIVFSVLKTS-AAMGY 584
            Y H  +     IVHR+L  E +L+D+  N  IAD GL  ++ D    + LKTS  +  Y
Sbjct: 117 EYCHRHK-----IVHRDLKPENLLLDEHLNVKIADFGLSNIMTDG---NFLKTSCGSPNY 168
Query: 585 LAPEYVTTGRFT-ERSDIFAFGVIILQILTGSL 616
            APE ++   +     D+++ GVI+  +L   L
Sbjct: 169 AAPEVISGKLYAGPEVDVWSCGVILYVMLCRRL 201

>pdb|2X7F|A Chain A, Crystal Structure Of The Kinase Domain Of Human Traf2- And Nck-Interacting Kinase With Wee1chk1 Inhibitor Length = 326

Iteration: 1
 Score = 57.0 bits (136), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 63/291 (21%), Positives = 126/291 (43%), Gaps = 33/291 (11%)
Query: 399 LNLEEVESATQCFSEVNLLGKGNFSSVYKGT-LRDGTLVAIRSINVTSCKSEEAEFVKGL 457
           ++L  +      F  V L+G G +  VYKG  ++ G L AI+ ++VT    EE E  + +
Sbjct: 14  IDLSALRDPAGIFELVELVGNGTYGQVYKGRHVKTGQLAAIKVMDVTG--DEEEEIKQEI 71
Query: 458 YLLTSL-RHENIIRLRGFCCSRG----RGECFLIYDFAPKGKLSKYLDQEEGSSNVLDWS 512
            +L     H NI    G    +       + +L+ +F   G ++  +   +G++   +W 
Sbjct: 72  NMLKKYSHHRNIATYYGAFIKKNPPGMDDQLWLVMEFCGAGSVTDLIKNTKGNTLKEEWI 131
Query: 513 TRVSIIIGIAKGIGYLHSSEVNKPAIVHRNLSVEKVLIDQQFNPLIADCGLHKLLADDIV 572
               I   I +G+ +LH  +V     +HR++  + VL+ +     + D G+   L     
Sbjct: 132 --AYICREILRGLSHLHQHKV-----IHRDIKGQNVLLTENAEVKLVDFGVSAQLDR--- 181
Query: 573 FSVLKTSAAMG---YLAPEYVT-----TGRFTERSDIFAFGVIILQILTGSLVLTSSMRL 624
            +V + +  +G   ++APE +         +  +SD+++ G+  +++  G+  L     +
Sbjct: 182 -TVGRRNTFIGTPYWMAPEVIACDENPDATYDFKSDLWSLGITAIEMAEGAPPLCD---M 237
Query: 625 AAESATFENFIDRNLKGKF-SESEAAKLGKMALVCTHEDPENRPTMEAVIE 674
               A F   I RN   +  S+  + K       C  ++   RP  E +++
Sbjct: 238 HPMRALF--LIPRNPAPRLKSKKWSKKFQSFIESCLVKNHSQRPATEQLMK 286

>pdb|3HYH|A Chain A, Crystal Structure Of The Protein Kinase Domain Of Yeast Amp-Activated Protein Kinase Snf1 Length = 275

Iteration: 1
 Score = 57.0 bits (136), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 59/213 (27%), Positives = 98/213 (46%), Gaps = 24/213 (11%)
Query: 411 FSEVNLLGKGNFSSV---YKGTLRDGTLVAIRSIN--VTSCKSEEAEFVKGLYLLTSLRH 465
           +  V  LG+G+F  V   Y  T   G  VA++ IN  V +    +    + +  L  LRH
Sbjct: 15  YQIVKTLGEGSFGKVKLAYHTT--TGQKVALKIINKKVLAKSDMQGRIEREISYLRLLRH 72
Query: 466 ENIIRLRGFCCSRGRGECFLIYDFAPKGKLSKYLDQEEGSSNVLDWSTRVSIIIGIAKGI 525
            +II+L  +   + + E  ++ ++A   +L  Y+ Q +  S              I   +
Sbjct: 73  PHIIKL--YDVIKSKDEIIMVIEYA-GNELFDYIVQRDKMSE----QEARRFFQQIISAV 125
Query: 526 GYLHSSEVNKPAIVHRNLSVEKVLIDQQFNPLIADCGLHKLLADDIVFSVLKTS-AAMGY 584
            Y H  +     IVHR+L  E +L+D+  N  IAD GL  ++ D    + LKTS  +  Y
Sbjct: 126 EYCHRHK-----IVHRDLKPENLLLDEHLNVKIADFGLSNIMTDG---NFLKTSCGSPNY 177
Query: 585 LAPEYVTTGRFT-ERSDIFAFGVIILQILTGSL 616
            APE ++   +     D+++ GVI+  +L   L
Sbjct: 178 AAPEVISGKLYAGPEVDVWSCGVILYVMLCRRL 210

>pdb|3UBD|A Chain A, Structure Of N-Terminal Domain Of Rsk2 Kinase In Complex With Flavonoid Glycoside Sl0101 Length = 304

Iteration: 1
 Score = 57.0 bits (136), Expect = 4e-08,   Method: Compositional matrix adjust.
 Identities = 56/219 (25%), Positives = 100/219 (45%), Gaps = 19/219 (8%)
Query: 411 FSEVNLLGKGNFSSVYKGTLRDGT----LVAIRSINVTSCKSEEAEFVKGLY-LLTSLRH 465
           F  + +LG+G+F  V+      G+    L A++ +   + K  +    K    +L  + H
Sbjct: 26  FELLKVLGQGSFGKVFLVKKISGSDARQLYAMKVLKKATLKVRDRVRTKMERDILVEVNH 85
Query: 466 ENIIRLRGFCCSRGRGECFLIYDFAPKGKLSKYLDQEEGSSNVLDWSTRVSIIIG-IAKG 524
             I++L      +  G+ +LI DF   G L   L +E     V+     V   +  +A  
Sbjct: 86  PFIVKLH--YAFQTEGKLYLILDFLRGGDLFTRLSKE-----VMFTEEDVKFYLAELALA 138
Query: 525 IGYLHSSEVNKPAIVHRNLSVEKVLIDQQFNPLIADCGLHKLLADDIVFSVLKTSAAMGY 584
           + +LHS       I++R+L  E +L+D++ +  + D GL K   D            + Y
Sbjct: 139 LDHLHSL-----GIIYRDLKPENILLDEEGHIKLTDFGLSKESIDHEK-KAYSFCGTVEY 192
Query: 585 LAPEYVTTGRFTERSDIFAFGVIILQILTGSLVLTSSMR 623
           +APE V     T+ +D ++FGV++ ++LTG+L      R
Sbjct: 193 MAPEVVNRRGHTQSADWWSFGVLMFEMLTGTLPFQGKDR 231

>pdb|4EL9|A Chain A, Structure Of N-Terminal Kinase Domain Of Rsk2 With Afzelin Length = 305

Iteration: 1
 Score = 57.0 bits (136), Expect = 4e-08,   Method: Compositional matrix adjust.
 Identities = 56/219 (25%), Positives = 100/219 (45%), Gaps = 19/219 (8%)
Query: 411 FSEVNLLGKGNFSSVYKGTLRDGT----LVAIRSINVTSCKSEEAEFVKGLY-LLTSLRH 465
           F  + +LG+G+F  V+      G+    L A++ +   + K  +    K    +L  + H
Sbjct: 27  FELLKVLGQGSFGKVFLVKKISGSDARQLYAMKVLKKATLKVRDRVRTKMERDILVEVNH 86
Query: 466 ENIIRLRGFCCSRGRGECFLIYDFAPKGKLSKYLDQEEGSSNVLDWSTRVSIIIG-IAKG 524
             I++L      +  G+ +LI DF   G L   L +E     V+     V   +  +A  
Sbjct: 87  PFIVKLH--YAFQTEGKLYLILDFLRGGDLFTRLSKE-----VMFTEEDVKFYLAELALA 139
Query: 525 IGYLHSSEVNKPAIVHRNLSVEKVLIDQQFNPLIADCGLHKLLADDIVFSVLKTSAAMGY 584
           + +LHS       I++R+L  E +L+D++ +  + D GL K   D            + Y
Sbjct: 140 LDHLHSL-----GIIYRDLKPENILLDEEGHIKLTDFGLSKESIDHEK-KAYSFCGTVEY 193
Query: 585 LAPEYVTTGRFTERSDIFAFGVIILQILTGSLVLTSSMR 623
           +APE V     T+ +D ++FGV++ ++LTG+L      R
Sbjct: 194 MAPEVVNRRGHTQSADWWSFGVLMFEMLTGTLPFQGKDR 232

>pdb|3IEC|A Chain A, Helicobacter Pylori Caga Inhibits Par1MARK FAMILY KINASES BY Mimicking Host Substrates Length = 319

Iteration: 1
 Score = 57.0 bits (136), Expect = 4e-08,   Method: Compositional matrix adjust.
 Identities = 64/269 (23%), Positives = 118/269 (43%), Gaps = 36/269 (13%)
Query: 417 LGKGNFSSVYKGT-LRDGTLVAIRSINVTSCKSEEAE-FVKGLYLLTSLRHENIIRLRGF 474
           +GKGNF+ V     +  G  VA++ I+ T   S   +   + + ++  L H NI++L  F
Sbjct: 15  IGKGNFAKVKLARHILTGKEVAVKIIDKTQLNSSSLQKLFREVRIMKVLNHPNIVKL--F 72
Query: 475 CCSRGRGECFLIYDFAPKGKLSKYLDQEEGSSNVLDWSTRVSIIIGIAKGIGYLHSSEVN 534
                    +L+ ++A  G++  YL     +   +      +    I   + Y H     
Sbjct: 73  EVIETEKTLYLVMEYASGGEVFDYL----VAHGWMKEKEARAKFRQIVSAVQYCHQK--- 125
Query: 535 KPAIVHRNLSVEKVLIDQQFNPLIADCGLHKLLADDIVF-SVLKT-SAAMGYLAPEYVTT 592
              IVHR+L  E +L+D   N  IAD G     +++  F + L T   +  Y APE    
Sbjct: 126 --FIVHRDLKAENLLLDADMNIKIADFG----FSNEFTFGNKLDTFCGSPPYAAPELFQG 179
Query: 593 GRFT-ERSDIFAFGVIILQILTGSLVLTSSMRLAAESATFENFIDRNLKGKFS-----ES 646
            ++     D+++ GVI+  +++GSL          +    +   +R L+GK+       +
Sbjct: 180 KKYDGPEVDVWSLGVILYTLVSGSLPF--------DGQNLKELRERVLRGKYRIPFYMST 231
Query: 647 EAAKLGKMALVCTHEDPENRPTMEAVIEE 675
           +   L K  L+    +P  R T+E ++++
Sbjct: 232 DCENLLKKFLIL---NPSKRGTLEQIMKD 257

>pdb|3GGF|A Chain A, Crystal Structure Of Human SerineTHREONINE-Protein Kinase Mst4 In Complex With An Quinazolin Length = 301

Iteration: 1
 Score = 57.0 bits (136), Expect = 4e-08,   Method: Compositional matrix adjust.
 Identities = 59/279 (21%), Positives = 126/279 (45%), Gaps = 33/279 (11%)
Query: 404 VESATQCFSEVNLLGKGNFSSVYKGTL-RDGTLVAIRSINVTSCKSEEAEFVKGLYLLTS 462
           +    + F+++  +GKG+F  V+KG   R   +VAI+ I++   + E  +  + + +L+ 
Sbjct: 18  IADPEELFTKLERIGKGSFGEVFKGIDNRTQQVVAIKIIDLEEAEDEIEDIQQEITVLSQ 77
Query: 463 LRHENIIRLRGFCCSRGRGECFLIYDFAPKGKLSKYLDQEEGSSNVLDWSTRVSIIIGIA 522
                + +  G      +   ++I ++   G     L      +   D     +++  I 
Sbjct: 78  CDSSYVTKYYGSYLKGSK--LWIIMEYLGGGSALDLL-----RAGPFDEFQIATMLKEIL 130
Query: 523 KGIGYLHSSEVNKPAIVHRNLSVEKVLIDQQFNPLIADCGLHKLLADDIVFSVLKTSAAM 582
           KG+ YLHS +      +HR++    VL+ +Q +  +AD G+   L D    + +K +  +
Sbjct: 131 KGLDYLHSEKK-----IHRDIKAANVLLSEQGDVKLADFGVAGQLTD----TQIKRNTFV 181
Query: 583 G---YLAPEYVTTGRFTERSDIFAFGVIILQILTGSLVLTSSMRLAAESATFENFIDRN- 638
           G   ++APE +    +  ++DI++ G+  +++  G      +  +      F   I +N 
Sbjct: 182 GTPFWMAPEVIQQSAYDSKADIWSLGITAIELAKGE---PPNSDMHPMRVLF--LIPKNN 236
Query: 639 ---LKGKFSESEAAKLGKMALVCTHEDPENRPTMEAVIE 674
              L G F++S      +    C ++DP  RPT + +++
Sbjct: 237 PPTLVGDFTKS----FKEFIDACLNKDPSFRPTAKELLK 271

>pdb|3DAE|A Chain A, Crystal Structure Of Phosphorylated Snf1 Kinase Domain Length = 283

Iteration: 1
 Score = 57.0 bits (136), Expect = 4e-08,   Method: Compositional matrix adjust.
 Identities = 59/213 (27%), Positives = 98/213 (46%), Gaps = 24/213 (11%)
Query: 411 FSEVNLLGKGNFSSV---YKGTLRDGTLVAIRSIN--VTSCKSEEAEFVKGLYLLTSLRH 465
           +  V  LG+G+F  V   Y  T   G  VA++ IN  V +    +    + +  L  LRH
Sbjct: 16  YQIVKTLGEGSFGKVKLAYHTT--TGQKVALKIINKKVLAKSDMQGRIEREISYLRLLRH 73
Query: 466 ENIIRLRGFCCSRGRGECFLIYDFAPKGKLSKYLDQEEGSSNVLDWSTRVSIIIGIAKGI 525
            +II+L  +   + + E  ++ ++A   +L  Y+ Q +  S              I   +
Sbjct: 74  PHIIKL--YDVIKSKDEIIMVIEYA-GNELFDYIVQRDKMSE----QEARRFFQQIISAV 126
Query: 526 GYLHSSEVNKPAIVHRNLSVEKVLIDQQFNPLIADCGLHKLLADDIVFSVLKTS-AAMGY 584
            Y H  +     IVHR+L  E +L+D+  N  IAD GL  ++ D    + LKTS  +  Y
Sbjct: 127 EYCHRHK-----IVHRDLKPENLLLDEHLNVKIADFGLSNIMTDG---NFLKTSCGSPNY 178
Query: 585 LAPEYVTTGRFT-ERSDIFAFGVIILQILTGSL 616
            APE ++   +     D+++ GVI+  +L   L
Sbjct: 179 AAPEVISGKLYAGPEVDVWSCGVILYVMLCRRL 211

>pdb|1V0O|A Chain A, Structure Of P. Falciparum Pfpk5-Indirubin-5-Sulphonate Ligand Complex Length = 288

Iteration: 1
 Score = 56.6 bits (135), Expect = 4e-08,   Method: Compositional matrix adjust.
 Identities = 51/203 (25%), Positives = 97/203 (47%), Gaps = 18/203 (8%)
Query: 417 LGKGNFSSVYKGTLRDGTLVAIRSINVTSCKSEE---AEFVKGLYLLTSLRHENIIRLRG 473
           +G+G +  VYK     G   A++ I +   K +E   +  ++ + +L  L+H NI++L  
Sbjct: 10  IGEGTYGVVYKAQNNYGETFALKKIRLE--KEDEGIPSTTIREISILKELKHSNIVKLYD 67
Query: 474 FCCSRGRGECFLIYDFAPKGKLSKYLDQEEGSSNVLDWSTRVSIIIGIAKGIGYLHSSEV 533
              ++ R    L+++   +  L K LD  EG    L+  T  S ++ +  GI Y H   V
Sbjct: 68  VIHTKKR--LVLVFEHLDQD-LKKLLDVCEGG---LESVTAKSFLLQLLNGIAYCHDRRV 121
Query: 534 NKPAIVHRNLSVEKVLIDQQFNPLIADCGLHKLLADDIVFSVLKTSAAMGYLAPEYVT-T 592
                +HR+L  + +LI+++    IAD GL +      V         + Y AP+ +  +
Sbjct: 122 -----LHRDLKPQNLLINREGELKIADFGLARAFGIP-VRKYTHEVVTLWYRAPDVLMGS 175
Query: 593 GRFTERSDIFAFGVIILQILTGS 615
            +++   DI++ G I  +++ G+
Sbjct: 176 KKYSTTIDIWSVGCIFAEMVNGT 198

>pdb|3FE3|A Chain A, Crystal Structure Of The Kinase Mark3PAR-1: T211a-S215a Double Mutant Length = 328

Iteration: 1
 Score = 56.6 bits (135), Expect = 4e-08,   Method: Compositional matrix adjust.
 Identities = 70/276 (25%), Positives = 120/276 (43%), Gaps = 40/276 (14%)
Query: 417 LGKGNFSSVYKGT-LRDGTLVAIRSINVTSCK-SEEAEFVKGLYLLTSLRHENIIRLRGF 474
           +GKGNF+ V     +  G  VAI+ I+ T    +   +  + + ++  L H NI++L  F
Sbjct: 23  IGKGNFAKVKLARHILTGREVAIKIIDKTQLNPTSLQKLFREVRIMKILNHPNIVKL--F 80
Query: 475 CCSRGRGECFLIYDFAPKGKLSKYLDQEEGSSNVLDWSTRVSIIIGIAKGIGYLHSSEVN 534
                    +LI ++A  G++  YL    G     +  ++   I+     + Y H     
Sbjct: 81  EVIETEKTLYLIMEYASGGEVFDYL-VAHGRMKEKEARSKFRQIVS---AVQYCHQKR-- 134
Query: 535 KPAIVHRNLSVEKVLIDQQFNPLIADCGLHKLLADDIVFSV-LKTSAAMG---YLAPEYV 590
              IVHR+L  E +L+D   N  IAD G          F+V  K  A  G   Y APE  
Sbjct: 135 ---IVHRDLKAENLLLDADMNIKIADFGFSN------EFTVGGKLDAFCGAPPYAAPELF 185
Query: 591 TTGRFT-ERSDIFAFGVIILQILTGSLVLTSSMRLAAESATFENFIDRNLKGKFS----- 644
              ++     D+++ GVI+  +++GSL          +    +   +R L+GK+      
Sbjct: 186 QGKKYDGPEVDVWSLGVILYTLVSGSLPF--------DGQNLKELRERVLRGKYRIPFYM 237
Query: 645 ESEAAKLGKMALVCTHEDPENRPTMEAVIEELTVAA 680
            ++   L K  LV    +P  R T+E ++++  + A
Sbjct: 238 STDCENLLKRFLVL---NPIKRGTLEQIMKDRWINA 270

>pdb|3FPQ|A Chain A, Crystal Structure Of The Kinase Domain Of Wnk1 Length = 290

Iteration: 1
 Score = 56.6 bits (135), Expect = 4e-08,   Method: Compositional matrix adjust.
 Identities = 57/203 (28%), Positives = 87/203 (42%), Gaps = 18/203 (8%)
Query: 417 LGKGNFSSVYKGTLRDGTLVAIRSINVTS---CKSEEAEFVKGLYLLTSLRHENIIRLRG 473
           +G+G+F +VYKG L   T V +    +      KSE   F +    L  L+H NI+R   
Sbjct: 34  IGRGSFKTVYKG-LDTETTVEVAWCELQDRKLTKSERQRFKEEAEXLKGLQHPNIVRFYD 92
Query: 474 FCCS--RGRGECFLIYDFAPKGKLSKYLDQEEGSSNVLDWSTRVSIIIGIAKGIGYLHSS 531
              S  +G+    L+ +    G L  YL +      V       S    I KG+ +LH+ 
Sbjct: 93  SWESTVKGKKCIVLVTELXTSGTLKTYLKR----FKVXKIKVLRSWCRQILKGLQFLHT- 147
Query: 532 EVNKPAIVHRNLSVEKVLIDQQFNPL-IADCGLHKLLADDIVFSVLKTSAAMGYLAPEYV 590
               P I+HR+L  + + I      + I D GL  L       +V+ T     + APE  
Sbjct: 148 --RTPPIIHRDLKCDNIFITGPTGSVKIGDLGLATLKRASFAKAVIGTPE---FXAPEXY 202
Query: 591 TTGRFTERSDIFAFGVIILQILT 613
              ++ E  D++AFG   L+  T
Sbjct: 203 EE-KYDESVDVYAFGXCXLEXAT 224

>pdb|3COK|A Chain A, Crystal Structure Of Plk4 Kinase Length = 278

Iteration: 1
 Score = 56.6 bits (135), Expect = 4e-08,   Method: Compositional matrix adjust.
 Identities = 54/210 (25%), Positives = 97/210 (46%), Gaps = 20/210 (9%)
Query: 411 FSEVNLLGKGNFSSVYKG-TLRDGTLVAIRSINVTSC-KSEEAEFVKG-LYLLTSLRHEN 467
           F   NLLGKG+F+ VY+  ++  G  VAI+ I+  +  K+   + V+  + +   L+H +
Sbjct: 13  FKVGNLLGKGSFAGVYRAESIHTGLEVAIKMIDKKAMYKAGMVQRVQNEVKIHCQLKHPS 72
Query: 468 IIRLRGFCCSRGRGECFLIYDFAPKGKLSKYLDQEEGSSNVLDWSTRVSIIIGIAKGIGY 527
           I+ L  +         +L+ +    G++++YL   +        +     +  I  G+ Y
Sbjct: 73  ILELYNYF--EDSNYVYLVLEMCHNGEMNRYL---KNRVKPFSENEARHFMHQIITGMLY 127
Query: 528 LHSSEVNKPAIVHRNLSVEKVLIDQQFNPLIADCGLHKLLADDIVFSVLKTSAAMG---Y 584
           LHS       I+HR+L++  +L+ +  N  IAD G    LA  +     K     G   Y
Sbjct: 128 LHSH-----GILHRDLTLSNLLLTRNMNIKIADFG----LATQLKMPHEKHYTLCGTPNY 178
Query: 585 LAPEYVTTGRFTERSDIFAFGVIILQILTG 614
           ++PE  T       SD+++ G +   +L G
Sbjct: 179 ISPEIATRSAHGLESDVWSLGCMFYTLLIG 208

>pdb|1V0B|A Chain A, Crystal Structure Of The T198a Mutant Of Pfpk5 Length = 288

Iteration: 1
 Score = 56.6 bits (135), Expect = 4e-08,   Method: Compositional matrix adjust.
 Identities = 51/203 (25%), Positives = 97/203 (47%), Gaps = 18/203 (8%)
Query: 417 LGKGNFSSVYKGTLRDGTLVAIRSINVTSCKSEE---AEFVKGLYLLTSLRHENIIRLRG 473
           +G+G +  VYK     G   A++ I +   K +E   +  ++ + +L  L+H NI++L  
Sbjct: 10  IGEGTYGVVYKAQNNYGETFALKKIRLE--KEDEGIPSTTIREISILKELKHSNIVKLYD 67
Query: 474 FCCSRGRGECFLIYDFAPKGKLSKYLDQEEGSSNVLDWSTRVSIIIGIAKGIGYLHSSEV 533
              ++ R    L+++   +  L K LD  EG    L+  T  S ++ +  GI Y H   V
Sbjct: 68  VIHTKKR--LVLVFEHLDQD-LKKLLDVCEGG---LESVTAKSFLLQLLNGIAYCHDRRV 121
Query: 534 NKPAIVHRNLSVEKVLIDQQFNPLIADCGLHKLLADDIVFSVLKTSAAMGYLAPEYVT-T 592
                +HR+L  + +LI+++    IAD GL +      V         + Y AP+ +  +
Sbjct: 122 -----LHRDLKPQNLLINREGELKIADFGLARAFGIP-VRKYTHEVVTLWYRAPDVLMGS 175
Query: 593 GRFTERSDIFAFGVIILQILTGS 615
            +++   DI++ G I  +++ G+
Sbjct: 176 KKYSTTIDIWSVGCIFAEMVNGA 198

>pdb|2QNJ|A Chain A, Kinase And Ubiquitin-Associated Domains Of Mark3PAR-1 Length = 328

Iteration: 1
 Score = 56.6 bits (135), Expect = 5e-08,   Method: Compositional matrix adjust.
 Identities = 68/273 (24%), Positives = 115/273 (42%), Gaps = 34/273 (12%)
Query: 417 LGKGNFSSVYKGT-LRDGTLVAIRSINVTSCKSEE-AEFVKGLYLLTSLRHENIIRLRGF 474
           +GKGNF+ V     +  G  VAI+ I+ T        +  + + ++  L H NI++L  F
Sbjct: 20  IGKGNFAKVKLARHILTGREVAIKIIDKTQLNPTSLQKLFREVRIMKILNHPNIVKL--F 77
Query: 475 CCSRGRGECFLIYDFAPKGKLSKYLDQEEGSSNVLDWSTRVSIIIGIAKGIGYLHSSEVN 534
                    +LI ++A  G++  YL     +   +      S    I   + Y H     
Sbjct: 78  EVIETEKTLYLIMEYASGGEVFDYL----VAHGRMKEKEARSKFRQIVSAVQYCHQKR-- 131
Query: 535 KPAIVHRNLSVEKVLIDQQFNPLIADCGLHKLLADDIVFSVLKT-SAAMGYLAPEYVTTG 593
              IVHR+L  E +L+D   N  IAD G         V   L T   +  Y APE     
Sbjct: 132 ---IVHRDLKAENLLLDADMNIKIADFGFSNEFT---VGGKLDTFCGSPPYAAPELFQGK 185
Query: 594 RFT-ERSDIFAFGVIILQILTGSLVLTSSMRLAAESATFENFIDRNLKGKFS-----ESE 647
           ++     D+++ GVI+  +++GSL          +    +   +R L+GK+       ++
Sbjct: 186 KYDGPEVDVWSLGVILYTLVSGSLPF--------DGQNLKELRERVLRGKYRIPFYMSTD 237
Query: 648 AAKLGKMALVCTHEDPENRPTMEAVIEELTVAA 680
              L K  LV    +P  R T+E ++++  + A
Sbjct: 238 CENLLKRFLVL---NPIKRGTLEQIMKDRWINA 267

>pdb|2W99|B Chain B, Crystal Structure Of Cdk4 In Complex With A D-Type Cyclin Length = 306

Iteration: 1
 Score = 56.6 bits (135), Expect = 5e-08,   Method: Compositional matrix adjust.
 Identities = 54/216 (25%), Positives = 97/216 (44%), Gaps = 22/216 (10%)
Query: 407 ATQCFSEVNLLGKGNFSSVYKGTLRD---GTLVAIRSINVTSCKS----EEAEFVKGLYL 459
           AT  +  V  +G G + +VYK   RD   G  VA++S+ V + +          V  L  
Sbjct: 2   ATSRYEPVAEIGVGAYGTVYKA--RDPHSGHFVALKSVRVPNGEEGLPISTVREVALLRR 59
Query: 460 LTSLRHENIIRLRGFCC-SRGRGE--CFLIYDFAPKGKLSKYLDQEEGSSNVLDWSTRVS 516
           L +  H N++RL   C  SR   E    L+++   +  L  YLD+       L   T   
Sbjct: 60  LEAFEHPNVVRLMDVCATSRTDREIKVTLVFEHVDQ-DLRTYLDKAPPPG--LPAETIKD 116
Query: 517 IIIGIAKGIGYLHSSEVNKPAIVHRNLSVEKVLIDQQFNPLIADCGLHKLLADDIVFSVL 576
           ++    +G+ +LH++      IVHR+L  E +L+       +AD GL ++ +  +  + +
Sbjct: 117 LMRQFLRGLDFLHAN-----CIVHRDLKPENILVTSGGTVKLADFGLARIYSYQMALAPV 171
Query: 577 KTSAAMGYLAPEYVTTGRFTERSDIFAFGVIILQIL 612
             +  + Y APE +    +    D+++ G I  ++ 
Sbjct: 172 VVT--LWYRAPEVLLQSTYATPVDMWSVGCIFAEMF 205

>pdb|1OB3|A Chain A, Structure Of P. Falciparum Pfpk5 Length = 288

Iteration: 1
 Score = 56.2 bits (134), Expect = 5e-08,   Method: Compositional matrix adjust.
 Identities = 51/203 (25%), Positives = 97/203 (47%), Gaps = 18/203 (8%)
Query: 417 LGKGNFSSVYKGTLRDGTLVAIRSINVTSCKSEE---AEFVKGLYLLTSLRHENIIRLRG 473
           +G+G +  VYK     G   A++ I +   K +E   +  ++ + +L  L+H NI++L  
Sbjct: 10  IGEGTYGVVYKAQNNYGETFALKKIRLE--KEDEGIPSTTIREISILKELKHSNIVKLYD 67
Query: 474 FCCSRGRGECFLIYDFAPKGKLSKYLDQEEGSSNVLDWSTRVSIIIGIAKGIGYLHSSEV 533
              ++ R    L+++   +  L K LD  EG    L+  T  S ++ +  GI Y H   V
Sbjct: 68  VIHTKKR--LVLVFEHLDQD-LKKLLDVCEGG---LESVTAKSFLLQLLNGIAYCHDRRV 121
Query: 534 NKPAIVHRNLSVEKVLIDQQFNPLIADCGLHKLLADDIVFSVLKTSAAMGYLAPEYVT-T 592
                +HR+L  + +LI+++    IAD GL +      V         + Y AP+ +  +
Sbjct: 122 -----LHRDLKPQNLLINREGELKIADFGLARAFGIP-VRKYTHEIVTLWYRAPDVLMGS 175
Query: 593 GRFTERSDIFAFGVIILQILTGS 615
            +++   DI++ G I  +++ G+
Sbjct: 176 KKYSTTIDIWSVGCIFAEMVNGT 198

>pdb|2YZA|A Chain A, Crystal Structure Of Kinase Domain Of Human 5'-Amp-Activated Protein Kinase Alpha-2 Subunit Mutant (T172d) Length = 276

Iteration: 1
 Score = 56.2 bits (134), Expect = 6e-08,   Method: Compositional matrix adjust.
 Identities = 58/208 (27%), Positives = 97/208 (46%), Gaps = 21/208 (10%)
Query: 415 NLLGKGNFSSVYKGTLR-DGTLVAIRSINVTSCKSEEA--EFVKGLYLLTSLRHENIIRL 471
           + LG G F  V  G  +  G  VA++ +N    +S +   +  + +  L   RH +II+L
Sbjct: 17  DTLGVGTFGKVKIGEHQLTGHKVAVKILNRQKIRSLDVVGKIKREIQNLKLFRHPHIIKL 76
Query: 472 RGFCCSRGRGECFLIYDFAPKGKLSKYLDQEEGSSNVLDWSTRVSIIIGIAKGIGYLHSS 531
                +    + F++ ++   G+L  Y+ +      V +   R  +   I   + Y H  
Sbjct: 77  YQVISTPT--DFFMVMEYVSGGELFDYICKH---GRVEEMEAR-RLFQQILSAVDYCH-- 128
Query: 532 EVNKPAIVHRNLSVEKVLIDQQFNPLIADCGLHKLLADDIVFSVLKTS-AAMGYLAPEYV 590
              +  +VHR+L  E VL+D   N  IAD GL  +++D      L+ S  +  Y APE V
Sbjct: 129 ---RHMVVHRDLKPENVLLDAHMNAKIADFGLSNMMSDG---EFLRDSCGSPNYAAPE-V 181
Query: 591 TTGRFTE--RSDIFAFGVIILQILTGSL 616
            +GR       DI++ GVI+  +L G+L
Sbjct: 182 ISGRLYAGPEVDIWSCGVILYALLCGTL 209

>pdb|1Y8G|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: Inactive Double Mutant With Selenomethionine Length = 327

Iteration: 1
 Score = 56.2 bits (134), Expect = 7e-08,   Method: Compositional matrix adjust.
 Identities = 66/270 (24%), Positives = 116/270 (42%), Gaps = 38/270 (14%)
Query: 417 LGKGNFSSVYKGT-LRDGTLVAIRSINVTSCKSEE-AEFVKGLYLLTSLRHENIIRLRGF 474
           +GKGNF+ V     +  G  VA++ I+ T   S    +  + + +   L H NI++L  F
Sbjct: 22  IGKGNFAKVKLARHILTGKEVAVKIIDKTQLNSSSLQKLFREVRIXKVLNHPNIVKL--F 79
Query: 475 CCSRGRGECFLIYDFAPKGKLSKYLDQEEGSSNVLDWSTRVSIIIGIAKGIGYLHSSEVN 534
                    +L+ ++A  G++  YL    G     +   +   I+     + Y H     
Sbjct: 80  EVIETEKTLYLVXEYASGGEVFDYL-VAHGRXKEKEARAKFRQIVS---AVQYCHQK--- 132
Query: 535 KPAIVHRNLSVEKVLIDQQFNPLIADCGLHKLLADDIVFSVLKTSAAMG---YLAPEYVT 591
              IVHR+L  E +L+D   N  IAD G     +++  F   K  A  G   Y APE   
Sbjct: 133 --FIVHRDLKAENLLLDADXNIKIADFG----FSNEFTFGN-KLDAFCGAPPYAAPELFQ 185
Query: 592 TGRFT-ERSDIFAFGVIILQILTGSLVLTSSMRLAAESATFENFIDRNLKGKFS-----E 645
             ++     D+++ GVI+  +++GSL          +    +   +R L+GK+       
Sbjct: 186 GKKYDGPEVDVWSLGVILYTLVSGSLPF--------DGQNLKELRERVLRGKYRIPFYXS 237
Query: 646 SEAAKLGKMALVCTHEDPENRPTMEAVIEE 675
           ++   L K  L+    +P  R T+E + ++
Sbjct: 238 TDCENLLKKFLIL---NPSKRGTLEQIXKD 264

>pdb|3IS5|A Chain A, Crystal Structure Of Cdpk Kinase Domain From Toxoplasma Gondii, Tgme49_018720 Length = 285

Iteration: 1
 Score = 56.2 bits (134), Expect = 7e-08,   Method: Compositional matrix adjust.
 Identities = 67/265 (25%), Positives = 116/265 (43%), Gaps = 25/265 (9%)
Query: 417 LGKGNFSSVYKGTLRD-GTLVAIRSINVTSCKSEEAEFVKGLYLLTSLRHENIIRLRGFC 475
           LG G F  V+    R  G    I++IN    +    +    + +L SL H NII++  F 
Sbjct: 30  LGSGAFGDVHLVEERSSGLERVIKTINKDRSQVPMEQIEAEIEVLKSLDHPNIIKI--FE 87
Query: 476 CSRGRGECFLIYDFAPKGKLSKYLDQEEGSSNVLDWSTRVSIIIGIAKGIGYLHSSEVNK 535
                   +++ +    G+L + +   +     L       ++  +   + Y HS  V  
Sbjct: 88  VFEDYHNMYIVMETCEGGELLERIVSAQARGKALSEGYVAELMKQMMNALAYFHSQHV-- 145
Query: 536 PAIVHRNLSVEKVLIDQQ--FNPL-IADCGLHKLLADDIVFSVLKTSAAMG---YLAPEY 589
              VH++L  E +L       +P+ I D GL +L   D       ++ A G   Y+APE 
Sbjct: 146 ---VHKDLKPENILFQDTSPHSPIKIIDFGLAELFKSD-----EHSTNAAGTALYMAPE- 196
Query: 590 VTTGRFTERSDIFAFGVIILQILTGSLVLT-SSMRLAAESATFENFIDRNLKGKFSESEA 648
           V     T + DI++ GV++  +LTG L  T +S+    + AT++   +  ++ +    +A
Sbjct: 197 VFKRDVTFKCDIWSAGVVMYFLLTGCLPFTGTSLEEVQQKATYKE-PNYAVECRPLTPQA 255
Query: 649 AKLGKMALVCTHEDPENRPTMEAVI 673
             L K  L    +DPE RP+   V+
Sbjct: 256 VDLLKQMLT---KDPERRPSAAQVL 277

>pdb|2Y4I|B Chain B, Ksr2-Mek1 Heterodimer Length = 319

Iteration: 1
 Score = 55.8 bits (133), Expect = 7e-08,   Method: Compositional matrix adjust.
 Identities = 71/288 (24%), Positives = 115/288 (39%), Gaps = 55/288 (19%)
Query: 415 NLLGKGNFSSVYKGTLRDGTLVAIRSINVTSCKSEEAE-FVKGLYLLTSLRHENIIRLRG 473
            L+GKG F  VY G  R    VAIR I++     ++ + F + +      RHEN++   G
Sbjct: 39  ELIGKGRFGQVYHG--RWHGEVAIRLIDIERDNEDQLKAFKREVMAYRQTRHENVVLFMG 96
Query: 474 FCCS-----------RGRGECFLIYDFAPKGKLSKYLDQEEGSSNVLDWSTRVSIIIGIA 522
            C S           +GR     +Y      K+            VLD +    I   I 
Sbjct: 97  ACMSPPHLAIITSLCKGR----TLYSVVRDAKI------------VLDVNKTRQIAQEIV 140
Query: 523 KGIGYLHSSEVNKPAIVHRNLSVEKVLIDQQFNPLIADCGLHK----LLADDIVFSVLKT 578
           KG+GYLH+       I+H++L  + V  D     +I D GL      L A      +   
Sbjct: 141 KGMGYLHAK-----GILHKDLKSKNVFYDNG-KVVITDFGLFSISGVLQAGRREDKLRIQ 194
Query: 579 SAAMGYLAPEYVTTGR---------FTERSDIFAFGVIILQILTGSLVLTSSMRLAAESA 629
           +  + +LAPE +             F++ SD+FA G I  ++        +     AE+ 
Sbjct: 195 NGWLCHLAPEIIRQLSPDTEEDKLPFSKHSDVFALGTIWYELHAREWPFKTQ---PAEAI 251
Query: 630 TFENFIDRNLKGKFSESEAAK-LGKMALVCTHEDPENRPTMEAVIEEL 676
            ++  +   +K   S+    K +  + L C   + E RPT   +++ L
Sbjct: 252 IWQ--MGTGMKPNLSQIGMGKEISDILLFCWAFEQEERPTFTKLMDML 297

>pdb|2W96|B Chain B, Crystal Structure Of Cdk4 In Complex With A D-Type Cyclin Length = 306

Iteration: 1
 Score = 55.8 bits (133), Expect = 7e-08,   Method: Compositional matrix adjust.
 Identities = 54/216 (25%), Positives = 96/216 (44%), Gaps = 22/216 (10%)
Query: 407 ATQCFSEVNLLGKGNFSSVYKGTLRD---GTLVAIRSINVTSCKS----EEAEFVKGLYL 459
           AT  +  V  +G G + +VYK   RD   G  VA++S+ V + +          V  L  
Sbjct: 2   ATSRYEPVAEIGVGAYGTVYKA--RDPHSGHFVALKSVRVPNGEEGLPISTVREVALLRR 59
Query: 460 LTSLRHENIIRLRGFCC-SRGRGE--CFLIYDFAPKGKLSKYLDQEEGSSNVLDWSTRVS 516
           L +  H N++RL   C  SR   E    L+++   +  L  YLD+       L   T   
Sbjct: 60  LEAFEHPNVVRLMDVCATSRTDREIKVTLVFEHVDQ-DLRTYLDKAPPPG--LPAETIKD 116
Query: 517 IIIGIAKGIGYLHSSEVNKPAIVHRNLSVEKVLIDQQFNPLIADCGLHKLLADDIVFSVL 576
           ++    +G+ +LH++      IVHR+L  E +L+       +AD GL ++ +  +    +
Sbjct: 117 LMRQFLRGLDFLHAN-----CIVHRDLKPENILVTSGGTVKLADFGLARIYSYQMALDPV 171
Query: 577 KTSAAMGYLAPEYVTTGRFTERSDIFAFGVIILQIL 612
             +  + Y APE +    +    D+++ G I  ++ 
Sbjct: 172 VVT--LWYRAPEVLLQSTYATPVDMWSVGCIFAEMF 205

>pdb|3KU2|A Chain A, Crystal Structure Of Inactivated Form Of Cdpk1 From Toxoplasma Gondii, Tgme49.101440 Length = 507

Iteration: 1
 Score = 55.8 bits (133), Expect = 7e-08,   Method: Compositional matrix adjust.
 Identities = 64/228 (28%), Positives = 105/228 (46%), Gaps = 38/228 (16%)
Query: 404 VESATQCFSE----VNLLGKGNFSSVY--KGTLRDGTLVAIRSINVTSCK--SEEAEFVK 455
           V+ +T  FS+      +LGKG+F  V   K  +  G   A++ I+    K  +++   ++
Sbjct: 40  VQHSTAIFSDRYKGQRVLGKGSFGEVILCKDKIT-GQECAVKVISKRQVKQKTDKESLLR 98
Query: 456 GLYLLTSLRHENIIRLRGFCCSRGRGECFLIYDFAPKGKLSKYLDQEEGSSNVLDWSTRV 515
            + LL  L H NI++L  F     +G  +L+ +    G+L   +   +  S V       
Sbjct: 99  EVQLLKQLDHPNIMKLYEFF--EDKGYFYLVGEVYTGGELFDEIISRKRFSEV----DAA 152
Query: 516 SIIIGIAKGIGYLHSSEVNKPAIVHRNLSVEKVLID---QQFNPLIADCGLH------KL 566
            II  +  GI Y+H     K  IVHR+L  E +L++   +  N  I D GL       K 
Sbjct: 153 RIIRQVLSGITYMH-----KNKIVHRDLKPENLLLESKSKDANIRIIDFGLSTHFEASKK 207
Query: 567 LADDIVFSVLKTSAAMGYLAPEYVTTGRFTERSDIFAFGVIILQILTG 614
           + D I            Y+APE V  G + E+ D+++ GVI+  +L+G
Sbjct: 208 MKDKI--------GTAYYIAPE-VLHGTYDEKCDVWSTGVILYILLSG 246

>pdb|3G33|A Chain A, Crystal Structure Of Cdk4CYCLIN D3 Length = 308

Iteration: 1
 Score = 55.8 bits (133), Expect = 7e-08,   Method: Compositional matrix adjust.
 Identities = 54/219 (24%), Positives = 96/219 (43%), Gaps = 25/219 (11%)
Query: 407 ATQCFSEVNLLGKGNFSSVYKGTLRD---GTLVAIRSINVTSCKSEEAEF-------VKG 456
           AT  +  V  +G G + +VYK   RD   G  VA++S+ V +               V  
Sbjct: 7   ATSRYEPVAEIGVGAYGTVYKA--RDPHSGHFVALKSVRVPNGGGGGGGLPISTVREVAL 64
Query: 457 LYLLTSLRHENIIRLRGFCC-SRGRGE--CFLIYDFAPKGKLSKYLDQEEGSSNVLDWST 513
           L  L +  H N++RL   C  SR   E    L+++   +  L  YLD+       L   T
Sbjct: 65  LRRLEAFEHPNVVRLMDVCATSRTDREIKVTLVFEHVDQ-DLRTYLDKAPPPG--LPAET 121
Query: 514 RVSIIIGIAKGIGYLHSSEVNKPAIVHRNLSVEKVLIDQQFNPLIADCGLHKLLADDIVF 573
              ++    +G+ +LH++      IVHR+L  E +L+       +AD GL ++ +  +  
Sbjct: 122 IKDLMRQFLRGLDFLHAN-----CIVHRDLKPENILVTSGGTVKLADFGLARIYSYQMAL 176
Query: 574 SVLKTSAAMGYLAPEYVTTGRFTERSDIFAFGVIILQIL 612
           + +  +  + Y APE +    +    D+++ G I  ++ 
Sbjct: 177 TPVVVT--LWYRAPEVLLQSTYATPVDMWSVGCIFAEMF 213

>pdb|3I79|A Chain A, Calcium-Dependent Protein Kinase 1 From Toxoplasma Gondii (Tgcdpk1) Length = 484

Iteration: 1
 Score = 55.8 bits (133), Expect = 7e-08,   Method: Compositional matrix adjust.
 Identities = 64/228 (28%), Positives = 105/228 (46%), Gaps = 38/228 (16%)
Query: 404 VESATQCFSE----VNLLGKGNFSSVY--KGTLRDGTLVAIRSINVTSCK--SEEAEFVK 455
           V+ +T  FS+      +LGKG+F  V   K  +  G   A++ I+    K  +++   ++
Sbjct: 17  VQHSTAIFSDRYKGQRVLGKGSFGEVILCKDKIT-GQECAVKVISKRQVKQKTDKESLLR 75
Query: 456 GLYLLTSLRHENIIRLRGFCCSRGRGECFLIYDFAPKGKLSKYLDQEEGSSNVLDWSTRV 515
            + LL  L H NI++L  F     +G  +L+ +    G+L   +   +  S V       
Sbjct: 76  EVQLLKQLDHPNIMKLYEFF--EDKGYFYLVGEVYTGGELFDEIISRKRFSEV----DAA 129
Query: 516 SIIIGIAKGIGYLHSSEVNKPAIVHRNLSVEKVLID---QQFNPLIADCGLH------KL 566
            II  +  GI Y+H     K  IVHR+L  E +L++   +  N  I D GL       K 
Sbjct: 130 RIIRQVLSGITYMH-----KNKIVHRDLKPENLLLESKSKDANIRIIDFGLSTHFEASKK 184
Query: 567 LADDIVFSVLKTSAAMGYLAPEYVTTGRFTERSDIFAFGVIILQILTG 614
           + D I            Y+APE V  G + E+ D+++ GVI+  +L+G
Sbjct: 185 MKDKI--------GTAYYIAPE-VLHGTYDEKCDVWSTGVILYILLSG 223

>pdb|2YJR|A Chain A, Structure Of F1174l Mutant Anaplastic Lymphoma Kinase Length = 342

Iteration: 1
 Score = 55.8 bits (133), Expect = 8e-08,   Method: Compositional matrix adjust.
 Identities = 55/276 (19%), Positives = 112/276 (40%), Gaps = 30/276 (10%)
Query: 417 LGKGNFSSVYKGTLR------DGTLVAIRSINVTSCKSEEAEFVKGLYLLTSLRHENIIR 470
           LG G F  VY+G +           VA++++     + +E +F+    +++ L H+NI+R
Sbjct: 53  LGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISKLNHQNIVR 112
Query: 471 LRGFCCSRGRGECFLIYDFAPKGKLSKYLDQ------EEGSSNVLDWSTRVSIIIGIAKG 524
             G   S      F++ +    G L  +L +      +  S  +LD    + +   IA G
Sbjct: 113 CIGV--SLQSLPRFILLELMAGGDLKSFLRETRPRPSQPSSLAMLDL---LHVARDIACG 167
Query: 525 IGYLHSSEVNKPAIVHRNLSVEKVLIDQQFNPLIADCGLHKLLADDIVFSVLKTSA---- 580
             YL  +       +HR+++    L+       +A  G   +  D    S  +       
Sbjct: 168 CQYLEENH-----FIHRDIAARNCLLTCPGPGRVAKIGDFGMARDIYRASYYRKGGCAML 222
Query: 581 AMGYLAPEYVTTGRFTERSDIFAFGVIILQILTGSLVLTSSMRLAAESATFENFIDRNLK 640
            + ++ PE    G FT ++D ++FGV++ +I +   +   S      +     F+    +
Sbjct: 223 PVKWMPPEAFMEGIFTSKTDTWSFGVLLWEIFSLGYMPYPS----KSNQEVLEFVTSGGR 278
Query: 641 GKFSESEAAKLGKMALVCTHEDPENRPTMEAVIEEL 676
               ++    + ++   C    PE+RP    ++E +
Sbjct: 279 MDPPKNCPGPVYRIMTQCWQHQPEDRPNFAIILERI 314

>pdb|3HX4|A Chain A, Crystal Structure Of Cdpk1 Of Toxoplasma Gondii, Tgme49_101440, In Presence Of Calcium Length = 508

Iteration: 1
 Score = 55.8 bits (133), Expect = 8e-08,   Method: Compositional matrix adjust.
 Identities = 64/228 (28%), Positives = 105/228 (46%), Gaps = 38/228 (16%)
Query: 404 VESATQCFSE----VNLLGKGNFSSVY--KGTLRDGTLVAIRSINVTSCK--SEEAEFVK 455
           V+ +T  FS+      +LGKG+F  V   K  +  G   A++ I+    K  +++   ++
Sbjct: 41  VQHSTAIFSDRYKGQRVLGKGSFGEVILCKDKIT-GQECAVKVISKRQVKQKTDKESLLR 99
Query: 456 GLYLLTSLRHENIIRLRGFCCSRGRGECFLIYDFAPKGKLSKYLDQEEGSSNVLDWSTRV 515
            + LL  L H NI++L  F     +G  +L+ +    G+L   +   +  S V       
Sbjct: 100 EVQLLKQLDHPNIMKLYEFF--EDKGYFYLVGEVYTGGELFDEIISRKRFSEV----DAA 153
Query: 516 SIIIGIAKGIGYLHSSEVNKPAIVHRNLSVEKVLID---QQFNPLIADCGLH------KL 566
            II  +  GI Y+H     K  IVHR+L  E +L++   +  N  I D GL       K 
Sbjct: 154 RIIRQVLSGITYMH-----KNKIVHRDLKPENLLLESKSKDANIRIIDFGLSTHFEASKK 208
Query: 567 LADDIVFSVLKTSAAMGYLAPEYVTTGRFTERSDIFAFGVIILQILTG 614
           + D I            Y+APE V  G + E+ D+++ GVI+  +L+G
Sbjct: 209 MKDKI--------GTAYYIAPE-VLHGTYDEKCDVWSTGVILYILLSG 247

>pdb|1ZY4|A Chain A, Crystal Structure Of Eif2alpha Protein Kinase Gcn2: R794g Hyperactivating Mutant In Apo Form. Length = 303

Iteration: 1
 Score = 55.5 bits (132), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 68/288 (23%), Positives = 120/288 (41%), Gaps = 50/288 (17%)
Query: 411 FSEVNLLGKGNFSSVYKG-TLRDGTLVAIRSINVTSCKSEEAEFVKGLYLLTSLRHENII 469
           F E+ +LG+G F  V K     D    AI+ I  T  K   +  +  + LL SL H+ ++
Sbjct: 8   FEEIAVLGQGAFGQVVKARNALDSRYYAIKKIRHTEEKL--STILSEVMLLASLNHQYVV 65
Query: 470 RL-------RGFC----CSRGRGECFLIYDFAPKGKLSKYLDQEEGSSNVLDWSTRVSII 518
           R        R F       + +   F+  ++   G L   +  E  +    ++     + 
Sbjct: 66  RYYAAWLERRNFVKPMTAVKKKSTLFIQMEYCENGTLYDLIHSENLNQQRDEYW---RLF 122
Query: 519 IGIAKGIGYLHSSEVNKPAIVHRNLSVEKVLIDQQFNPLIADCGLH----------KLLA 568
             I + + Y+HS       I+HR+L    + ID+  N  I D GL           KL +
Sbjct: 123 RQILEALSYIHSQ-----GIIHRDLKPMNIFIDESRNVKIGDFGLAKNVHRSLDILKLDS 177
Query: 569 DDIVFSVLKTSAAMG---YLAPEYVT-TGRFTERSDIFAFGVIILQIL----TGSLVLTS 620
            ++  S    ++A+G   Y+A E +  TG + E+ D+++ G+I  +++    TG   +  
Sbjct: 178 QNLPGSSDNLTSAIGTAMYVATEVLDGTGHYNEKIDMYSLGIIFFEMIYPFSTGMERVNI 237
Query: 621 SMRLAAESATF-ENFIDRNLKGKFSESEAAKLGKMALVCTHEDPENRP 667
             +L + S  F  +F D  +K +          K+  +    DP  RP
Sbjct: 238 LKKLRSVSIEFPPDFDDNKMKVE---------KKIIRLLIDHDPNKRP 276

>pdb|4FNW|A Chain A, Crystal Structure Of The Apo F1174l Anaplastic Lymphoma Kinase Catalytic Domain Length = 327

Iteration: 1
 Score = 55.5 bits (132), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 55/276 (19%), Positives = 112/276 (40%), Gaps = 30/276 (10%)
Query: 417 LGKGNFSSVYKGTLR------DGTLVAIRSINVTSCKSEEAEFVKGLYLLTSLRHENIIR 470
           LG G F  VY+G +           VA++++     + +E +F+    +++ L H+NI+R
Sbjct: 39  LGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISKLNHQNIVR 98
Query: 471 LRGFCCSRGRGECFLIYDFAPKGKLSKYLDQ------EEGSSNVLDWSTRVSIIIGIAKG 524
             G   S      F++ +    G L  +L +      +  S  +LD    + +   IA G
Sbjct: 99  CIGV--SLQSLPRFILLELMAGGDLKSFLRETRPRPSQPSSLAMLDL---LHVARDIACG 153
Query: 525 IGYLHSSEVNKPAIVHRNLSVEKVLIDQQFNPLIADCGLHKLLADDIVFSVLKTSA---- 580
             YL  +       +HR+++    L+       +A  G   +  D    S  +       
Sbjct: 154 CQYLEENH-----FIHRDIAARNCLLTCPGPGRVAKIGDFGMARDIYRASYYRKGGCAML 208
Query: 581 AMGYLAPEYVTTGRFTERSDIFAFGVIILQILTGSLVLTSSMRLAAESATFENFIDRNLK 640
            + ++ PE    G FT ++D ++FGV++ +I +   +   S      +     F+    +
Sbjct: 209 PVKWMPPEAFMEGIFTSKTDTWSFGVLLWEIFSLGYMPYPS----KSNQEVLEFVTSGGR 264
Query: 641 GKFSESEAAKLGKMALVCTHEDPENRPTMEAVIEEL 676
               ++    + ++   C    PE+RP    ++E +
Sbjct: 265 MDPPKNCPGPVYRIMTQCWQHQPEDRPNFAIILERI 300

>pdb|3QA8|A Chain A, Crystal Structure Of Inhibitor Of Kappa B Kinase Beta Length = 676

Iteration: 1
 Score = 55.5 bits (132), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 50/206 (24%), Positives = 88/206 (42%), Gaps = 16/206 (7%)
Query: 417 LGKGNFSSVYKGTLRD-GTLVAIRSINVTSCKSEEAEFVKGLYLLTSLRHENIIRLR--- 472
           LG G F  V +   +D G  VAI+             +   + ++  L H N++  R   
Sbjct: 22  LGTGGFGYVLRWIHQDTGEQVAIKQCRQELSPKNRERWCLEIQIMKKLNHPNVVSAREVP 81
Query: 473 -GFCCSRGRGECFLIYDFAPKGKLSKYLDQEEGSSNVLDWSTRVSIIIGIAKGIGYLHSS 531
            G           L  ++   G L KYL+Q E    + +   R +++  I+  + YLH +
Sbjct: 82  DGLQKLAPNDLPLLAMEYCEGGDLRKYLNQFENCCGLKEGPIR-TLLSDISSALRYLHEN 140
Query: 532 EVNKPAIVHRNLSVEKVLID---QQFNPLIADCGLHKLLADDIVFSVLKTSAAMGYLAPE 588
                 I+HR+L  E +++    Q+    I D G  K L    + +  +    + YLAPE
Sbjct: 141 R-----IIHRDLKPENIVLQPGPQRLIHKIIDLGYAKELDQGELCT--EFVGTLQYLAPE 193
Query: 589 YVTTGRFTERSDIFAFGVIILQILTG 614
            +   ++T   D ++FG +  + +TG
Sbjct: 194 LLEQKKYTVTVDYWSFGTLAFECITG 219

>pdb|3NIZ|A Chain A, Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5_2510 With Adp Bound Length = 311

Iteration: 1
 Score = 55.5 bits (132), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 50/208 (24%), Positives = 98/208 (47%), Gaps = 16/208 (7%)
Query: 411 FSEVNLLGKGNFSSVYKGTLRDGTLVAIRSINVTS-CKSEEAEFVKGLYLLTSLRHENII 469
           + ++  +G+G +  VYK     G +VA++ I + +  +   +  ++ + LL  L H NI+
Sbjct: 23  YQKLEKVGEGTYGVVYKAKDSQGRIVALKRIRLDAEDEGIPSTAIREISLLKELHHPNIV 82
Query: 470 RLRGFCCSRGRGECF-LIYDFAPKGKLSKYLDQEEGSSNVLDWSTRVSIIIGIAKGIGYL 528
            L     S     C  L+++F  K  L K LD  E  + + D   ++  +  + +G+ + 
Sbjct: 83  SLIDVIHSE---RCLTLVFEFMEKD-LKKVLD--ENKTGLQDSQIKI-YLYQLLRGVAHC 135
Query: 529 HSSEVNKPAIVHRNLSVEKVLIDQQFNPLIADCGLHKLLADDIVFSVLKTSAAMGYLAPE 588
           H        I+HR+L  + +LI+      +AD GL +      V S       + Y AP+
Sbjct: 136 HQHR-----ILHRDLKPQNLLINSDGALKLADFGLARAFGIP-VRSYTHEVVTLWYRAPD 189
Query: 589 YVT-TGRFTERSDIFAFGVIILQILTGS 615
            +  + +++   DI++ G I  +++TG 
Sbjct: 190 VLMGSKKYSTSVDIWSIGCIFAEMITGK 217

>pdb|3RZF|A Chain A, Crystal Structure Of Inhibitor Of Kappab Kinase Beta (I4122) Length = 677

Iteration: 1
 Score = 55.5 bits (132), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 50/206 (24%), Positives = 88/206 (42%), Gaps = 16/206 (7%)
Query: 417 LGKGNFSSVYKGTLRD-GTLVAIRSINVTSCKSEEAEFVKGLYLLTSLRHENIIRLR--- 472
           LG G F  V +   +D G  VAI+             +   + ++  L H N++  R   
Sbjct: 23  LGTGGFGYVLRWIHQDTGEQVAIKQCRQELSPKNRERWCLEIQIMKKLNHPNVVSAREVP 82
Query: 473 -GFCCSRGRGECFLIYDFAPKGKLSKYLDQEEGSSNVLDWSTRVSIIIGIAKGIGYLHSS 531
            G           L  ++   G L KYL+Q E    + +   R +++  I+  + YLH +
Sbjct: 83  DGLQKLAPNDLPLLAMEYCEGGDLRKYLNQFENCCGLKEGPIR-TLLSDISSALRYLHEN 141
Query: 532 EVNKPAIVHRNLSVEKVLID---QQFNPLIADCGLHKLLADDIVFSVLKTSAAMGYLAPE 588
                 I+HR+L  E +++    Q+    I D G  K L    + +  +    + YLAPE
Sbjct: 142 R-----IIHRDLKPENIVLQPGPQRLIHKIIDLGYAKELDQGELCT--EFVGTLQYLAPE 194
Query: 589 YVTTGRFTERSDIFAFGVIILQILTG 614
            +   ++T   D ++FG +  + +TG
Sbjct: 195 LLEQKKYTVTVDYWSFGTLAFECITG 220

>pdb|4EOP|A Chain A, Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 300

Iteration: 1
 Score = 55.1 bits (131), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 50/210 (23%), Positives = 101/210 (48%), Gaps = 14/210 (6%)
Query: 407 ATQCFSEVNLLGKGNFSSVYKGTLR-DGTLVAIRSINV-TSCKSEEAEFVKGLYLLTSLR 464
           + + F +V  +G+G +  VYK   +  G +VA++ I + T  +   +  ++ + LL  L 
Sbjct: 3   SMENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELN 62
Query: 465 HENIIRLRGFCCSRGRGECFLIYDFAPKGKLSKYLDQEEGSSNVLDWSTRVSIIIGIAKG 524
           H NI++L     +  +   +L+++F  +  L K++D    +   L      S +  + +G
Sbjct: 63  HPNIVKLLDVIHTENK--LYLVFEFLHQD-LKKFMDASALTGIPLPLIK--SYLFQLLQG 117
Query: 525 IGYLHSSEVNKPAIVHRNLSVEKVLIDQQFNPLIADCGLHKLLADDIVFSVLKTSAAMGY 584
           + + HS  V     +HR+L  E +LI+ +    +AD GL +      V +       + Y
Sbjct: 118 LAFCHSHRV-----LHRDLKPENLLINTEGAIKLADFGLARAFGVP-VRTYXHEVVTLWY 171
Query: 585 LAPEYVTTGRFTERS-DIFAFGVIILQILT 613
            APE +   ++   + DI++ G I  +++T
Sbjct: 172 RAPEILLGCKYYSTAVDIWSLGCIFAEMVT 201

>pdb|1Y6A|A Chain A, Crystal Structure Of Vegfr2 In Complex With A 2-Anilino-5-Aryl-Oxazole Inhibitor Length = 366

Iteration: 1
 Score = 55.1 bits (131), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 38/158 (24%), Positives = 78/158 (49%), Gaps = 11/158 (6%)
Query: 521 IAKGIGYLHSSEVNKPAIVHRNLSVEKVLIDQQFNPLIADCGLHKLLADDIVFSVLKTSA 580
           +AKG+ +L S +      +HR+L+   +L+ ++    I D GL + +  D  + V K  A
Sbjct: 207 VAKGMEFLASRKC-----IHRDLAARNILLSEKNVVKICDFGLARDIYKDPDY-VRKGDA 260
Query: 581 --AMGYLAPEYVTTGRFTERSDIFAFGVIILQILTGSLVLTSSMRLAAESATFENFIDRN 638
              + ++APE +    +T +SD+++FGV++ +I +        +++  E   F   +   
Sbjct: 261 RLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKIDEE---FCRRLKEG 317
Query: 639 LKGKFSESEAAKLGKMALVCTHEDPENRPTMEAVIEEL 676
            + +  +    ++ +  L C H +P  RPT   ++E L
Sbjct: 318 TRMRAPDYTTPEMYQTMLDCWHGEPSQRPTFSELVEHL 355

>pdb|3VHK|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Back Pocket Binder Length = 368

Iteration: 1
 Score = 55.1 bits (131), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 38/158 (24%), Positives = 78/158 (49%), Gaps = 11/158 (6%)
Query: 521 IAKGIGYLHSSEVNKPAIVHRNLSVEKVLIDQQFNPLIADCGLHKLLADDIVFSVLKTSA 580
           +AKG+ +L S +      +HR+L+   +L+ ++    I D GL + +  D  + V K  A
Sbjct: 209 VAKGMEFLASRKC-----IHRDLAARNILLSEKNVVKICDFGLARDIYKDPDY-VRKGDA 262
Query: 581 --AMGYLAPEYVTTGRFTERSDIFAFGVIILQILTGSLVLTSSMRLAAESATFENFIDRN 638
              + ++APE +    +T +SD+++FGV++ +I +        +++  E   F   +   
Sbjct: 263 RLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKIDEE---FCRRLKEG 319
Query: 639 LKGKFSESEAAKLGKMALVCTHEDPENRPTMEAVIEEL 676
            + +  +    ++ +  L C H +P  RPT   ++E L
Sbjct: 320 TRMRAPDYTTPEMYQTMLDCWHGEPSQRPTFSELVEHL 357

>pdb|2QKR|A Chain A, Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5_2510 With Indirubin 3'-Monoxime Bound Length = 313

Iteration: 1
 Score = 55.1 bits (131), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 50/208 (24%), Positives = 98/208 (47%), Gaps = 16/208 (7%)
Query: 411 FSEVNLLGKGNFSSVYKGTLRDGTLVAIRSINVTS-CKSEEAEFVKGLYLLTSLRHENII 469
           + ++  +G+G +  VYK     G +VA++ I + +  +   +  ++ + LL  L H NI+
Sbjct: 23  YQKLEKVGEGTYGVVYKAKDSQGRIVALKRIRLDAEDEGIPSTAIREISLLKELHHPNIV 82
Query: 470 RLRGFCCSRGRGECF-LIYDFAPKGKLSKYLDQEEGSSNVLDWSTRVSIIIGIAKGIGYL 528
            L     S     C  L+++F  K  L K LD  E  + + D   ++  +  + +G+ + 
Sbjct: 83  SLIDVIHSE---RCLTLVFEFMEKD-LKKVLD--ENKTGLQDSQIKI-YLYQLLRGVAHC 135
Query: 529 HSSEVNKPAIVHRNLSVEKVLIDQQFNPLIADCGLHKLLADDIVFSVLKTSAAMGYLAPE 588
           H        I+HR+L  + +LI+      +AD GL +      V S       + Y AP+
Sbjct: 136 HQHR-----ILHRDLKPQNLLINSDGALKLADFGLARAFGIP-VRSYTHEVVTLWYRAPD 189
Query: 589 YVT-TGRFTERSDIFAFGVIILQILTGS 615
            +  + +++   DI++ G I  +++TG 
Sbjct: 190 VLMGSKKYSTSVDIWSIGCIFAEMITGK 217

>pdb|3VHE|A Chain A, Crystal Structure Of Human Vegfr2 Kinase Domain With A Novel Pyrrolopyrimidine Inhibitor Length = 359

Iteration: 1
 Score = 55.1 bits (131), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 38/158 (24%), Positives = 78/158 (49%), Gaps = 11/158 (6%)
Query: 521 IAKGIGYLHSSEVNKPAIVHRNLSVEKVLIDQQFNPLIADCGLHKLLADDIVFSVLKTSA 580
           +AKG+ +L S +      +HR+L+   +L+ ++    I D GL + +  D  + V K  A
Sbjct: 202 VAKGMEFLASRKC-----IHRDLAARNILLSEKNVVKICDFGLARDIYKDPDY-VRKGDA 255
Query: 581 --AMGYLAPEYVTTGRFTERSDIFAFGVIILQILTGSLVLTSSMRLAAESATFENFIDRN 638
              + ++APE +    +T +SD+++FGV++ +I +        +++  E   F   +   
Sbjct: 256 RLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKIDEE---FCRRLKEG 312
Query: 639 LKGKFSESEAAKLGKMALVCTHEDPENRPTMEAVIEEL 676
            + +  +    ++ +  L C H +P  RPT   ++E L
Sbjct: 313 TRMRAPDYTTPEMYQTMLDCWHGEPSQRPTFSELVEHL 350

>pdb|4EOO|A Chain A, Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3 Complex With Atp Length = 299

Iteration: 1
 Score = 55.1 bits (131), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 50/210 (23%), Positives = 101/210 (48%), Gaps = 14/210 (6%)
Query: 407 ATQCFSEVNLLGKGNFSSVYKGTLR-DGTLVAIRSINV-TSCKSEEAEFVKGLYLLTSLR 464
           + + F +V  +G+G +  VYK   +  G +VA++ I + T  +   +  ++ + LL  L 
Sbjct: 2   SMENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELN 61
Query: 465 HENIIRLRGFCCSRGRGECFLIYDFAPKGKLSKYLDQEEGSSNVLDWSTRVSIIIGIAKG 524
           H NI++L     +  +   +L+++F  +  L K++D    +   L      S +  + +G
Sbjct: 62  HPNIVKLLDVIHTENK--LYLVFEFLHQD-LKKFMDASALTGIPLPLIK--SYLFQLLQG 116
Query: 525 IGYLHSSEVNKPAIVHRNLSVEKVLIDQQFNPLIADCGLHKLLADDIVFSVLKTSAAMGY 584
           + + HS  V     +HR+L  E +LI+ +    +AD GL +      V +       + Y
Sbjct: 117 LAFCHSHRV-----LHRDLKPENLLINTEGAIKLADFGLARAFGVP-VRTYXHEVVTLWY 170
Query: 585 LAPEYVTTGRFTERS-DIFAFGVIILQILT 613
            APE +   ++   + DI++ G I  +++T
Sbjct: 171 RAPEILLGCKYYSTAVDIWSLGCIFAEMVT 200

>pdb|3VID|A Chain A, Crystal Structure Of Human Vegfr2 Kinase Domain With Compound A Length = 356

Iteration: 1
 Score = 55.1 bits (131), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 38/158 (24%), Positives = 78/158 (49%), Gaps = 11/158 (6%)
Query: 521 IAKGIGYLHSSEVNKPAIVHRNLSVEKVLIDQQFNPLIADCGLHKLLADDIVFSVLKTSA 580
           +AKG+ +L S +      +HR+L+   +L+ ++    I D GL + +  D  + V K  A
Sbjct: 200 VAKGMEFLASRKC-----IHRDLAARNILLSEKNVVKICDFGLARDIYKDPDY-VRKGDA 253
Query: 581 --AMGYLAPEYVTTGRFTERSDIFAFGVIILQILTGSLVLTSSMRLAAESATFENFIDRN 638
              + ++APE +    +T +SD+++FGV++ +I +        +++  E   F   +   
Sbjct: 254 RLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKIDEE---FCRRLKEG 310
Query: 639 LKGKFSESEAAKLGKMALVCTHEDPENRPTMEAVIEEL 676
            + +  +    ++ +  L C H +P  RPT   ++E L
Sbjct: 311 TRMRAPDYTTPEMYQTMLDCWHGEPSQRPTFSELVEHL 348

>pdb|3HNG|A Chain A, Crystal Structure Of Vegfr1 In Complex With N-(4-chlorophenyl)-2- ((pyridin-4-ylmethyl)amino)benzamide Length = 360

Iteration: 1
 Score = 54.7 bits (130), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 39/166 (23%), Positives = 82/166 (49%), Gaps = 15/166 (9%)
Query: 515 VSIIIGIAKGIGYLHSSEVNKPAIVHRNLSVEKVLIDQQFNPLIADCGLHKLLADDIVFS 574
           +S    +A+G+ +L S +      +HR+L+   +L+ +     I D GL + +  +  + 
Sbjct: 202 ISYSFQVARGMEFLSSRKC-----IHRDLAARNILLSENNVVKICDFGLARDIYKNPDY- 255
Query: 575 VLK--TSAAMGYLAPEYVTTGRFTERSDIFAFGVIILQI--LTGSLVLTSSMRLAAESAT 630
           V K  T   + ++APE +    ++ +SD++++GV++ +I  L GS      M        
Sbjct: 256 VRKGDTRLPLKWMAPESIFDKIYSTKSDVWSYGVLLWEIFSLGGSPYPGVQM-----DED 310
Query: 631 FENFIDRNLKGKFSESEAAKLGKMALVCTHEDPENRPTMEAVIEEL 676
           F + +   ++ +  E    ++ ++ L C H DP+ RP    ++E+L
Sbjct: 311 FCSRLREGMRMRAPEYSTPEIYQIMLDCWHRDPKERPRFAELVEKL 356

>pdb|4EOM|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Human Cyclin A3 Complex With Atp Length = 301

Iteration: 1
 Score = 54.7 bits (130), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 50/210 (23%), Positives = 100/210 (47%), Gaps = 14/210 (6%)
Query: 407 ATQCFSEVNLLGKGNFSSVYKGTLR-DGTLVAIRSINV-TSCKSEEAEFVKGLYLLTSLR 464
           + + F +V  +G+G +  VYK   +  G +VA++ I + T  +   +  ++ + LL  L 
Sbjct: 4   SMENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELN 63
Query: 465 HENIIRLRGFCCSRGRGECFLIYDFAPKGKLSKYLDQEEGSSNVLDWSTRVSIIIGIAKG 524
           H NI++L     +  +   +L+++F     L K++D    +   L      S +  + +G
Sbjct: 64  HPNIVKLLDVIHTENK--LYLVFEFL-SMDLKKFMDASALTGIPLPLIK--SYLFQLLQG 118
Query: 525 IGYLHSSEVNKPAIVHRNLSVEKVLIDQQFNPLIADCGLHKLLADDIVFSVLKTSAAMGY 584
           + + HS  V     +HR+L  E +LI+ +    +AD GL +      V +       + Y
Sbjct: 119 LAFCHSHRV-----LHRDLKPENLLINTEGAIKLADFGLARAFGVP-VRTYXHEVVTLWY 172
Query: 585 LAPEYVTTGRFTERS-DIFAFGVIILQILT 613
            APE +   ++   + DI++ G I  +++T
Sbjct: 173 RAPEILLGCKYYSTAVDIWSLGCIFAEMVT 202

>pdb|3MA6|A Chain A, Crystal Structure Of Kinase Domain Of Tgcdpk1 In Presence Of 3brb-Pp1 Length = 298

Iteration: 1
 Score = 54.7 bits (130), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 64/228 (28%), Positives = 104/228 (45%), Gaps = 38/228 (16%)
Query: 404 VESATQCFSE----VNLLGKGNFSSVY----KGTLRDGTLVAIRSINVTSCKSEEAEFVK 455
           V+ +T  FS+      +LGKG+F  V     K T ++  +  I    V   K+++   ++
Sbjct: 23  VQHSTAIFSDRYKGQRVLGKGSFGEVILCKDKITGQECAVKVISKRQVKQ-KTDKESLLR 81
Query: 456 GLYLLTSLRHENIIRLRGFCCSRGRGECFLIYDFAPKGKLSKYLDQEEGSSNVLDWSTRV 515
            + LL  L H NI++L  F     +G  +L+ +    G+L   +   +  S V       
Sbjct: 82  EVQLLKQLDHPNIMKLYEFF--EDKGYFYLVGEVYTGGELFDEIISRKRFSEV----DAA 135
Query: 516 SIIIGIAKGIGYLHSSEVNKPAIVHRNLSVEKVLID---QQFNPLIADCGLH------KL 566
            II  +  GI Y+H     K  IVHR+L  E +L++   +  N  I D GL       K 
Sbjct: 136 RIIRQVLSGITYMH-----KNKIVHRDLKPENLLLESKSKDANIRIIDFGLSTHFEASKK 190
Query: 567 LADDIVFSVLKTSAAMGYLAPEYVTTGRFTERSDIFAFGVIILQILTG 614
           + D I            Y+APE V  G + E+ D+++ GVI+  +L+G
Sbjct: 191 MKDKI--------GTAYYIAPE-VLHGTYDEKCDVWSTGVILYILLSG 229

>pdb|3OZ6|A Chain A, Crystal Structure Of Mapk From Cryptosporidium Parvum, Cgd2_1960 Length = 388

Iteration: 1
 Score = 54.7 bits (130), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 55/235 (23%), Positives = 110/235 (46%), Gaps = 35/235 (14%)
Query: 411 FSEVNLLGKGNFSSVYKGT-LRDGTLVAIRSINVTSCKSEEAEFV-KGLYLLTSLR-HEN 467
           +  V  LGKG +  V+K    R G +VA++ I      S +A+   + + +LT L  HEN
Sbjct: 11  YELVKKLGKGAYGIVWKSIDRRTGEVVAVKKIFDAFQNSTDAQRTFREIMILTELSGHEN 70
Query: 468 IIRLRGFCCSRGRGECFLIYDFAPKGKLSKYLDQEEGSSNVLDWSTRVSIIIGIAKGIGY 527
           I+ L     +    + +L++D+  +  L   +      +N+L+   +  ++  + K I Y
Sbjct: 71  IVNLLNVLRADNDRDVYLVFDYM-ETDLHAVI-----RANILEPVHKQYVVYQLIKVIKY 124
Query: 528 LHSSEVNKPAIVHRNLSVEKVLIDQQFNPLIADCGLH------KLLADDIVFSVLKTS-- 579
           LHS       ++HR++    +L++ + +  +AD GL       + + ++I  S+ + +  
Sbjct: 125 LHSG-----GLLHRDMKPSNILLNAECHVKVADFGLSRSFVNIRRVTNNIPLSINENTEN 179
Query: 580 ------------AAMGYLAPEYVT-TGRFTERSDIFAFGVIILQILTGSLVLTSS 621
                       A   Y APE +  + ++T+  D+++ G I+ +IL G  +   S
Sbjct: 180 FDDDQPILTDYVATRWYRAPEILLGSTKYTKGIDMWSLGCILGEILCGKPIFPGS 234

>pdb|2XB7|A Chain A, Structure Of Human Anaplastic Lymphoma Kinase In Complex With Nvp- Tae684 Length = 315

Iteration: 1
 Score = 54.7 bits (130), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 54/276 (19%), Positives = 111/276 (40%), Gaps = 30/276 (10%)
Query: 417 LGKGNFSSVYKGTLR------DGTLVAIRSINVTSCKSEEAEFVKGLYLLTSLRHENIIR 470
           LG G F  VY+G +           VA++++     + +E +F+    +++   H+NI+R
Sbjct: 30  LGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISKFNHQNIVR 89
Query: 471 LRGFCCSRGRGECFLIYDFAPKGKLSKYLDQ------EEGSSNVLDWSTRVSIIIGIAKG 524
             G   S      F++ +    G L  +L +      +  S  +LD    + +   IA G
Sbjct: 90  CIGV--SLQSLPRFILLELMAGGDLKSFLRETRPRPSQPSSLAMLDL---LHVARDIACG 144
Query: 525 IGYLHSSEVNKPAIVHRNLSVEKVLIDQQFNPLIADCGLHKLLADDIVFSVLKTSA---- 580
             YL  +       +HR+++    L+       +A  G   +  D    S  +       
Sbjct: 145 CQYLEENH-----FIHRDIAARNCLLTCPGPGRVAKIGDFGMARDIYRASYYRKGGCAML 199
Query: 581 AMGYLAPEYVTTGRFTERSDIFAFGVIILQILTGSLVLTSSMRLAAESATFENFIDRNLK 640
            + ++ PE    G FT ++D ++FGV++ +I +   +   S      +     F+    +
Sbjct: 200 PVKWMPPEAFMEGIFTSKTDTWSFGVLLWEIFSLGYMPYPS----KSNQEVLEFVTSGGR 255
Query: 641 GKFSESEAAKLGKMALVCTHEDPENRPTMEAVIEEL 676
               ++    + ++   C    PE+RP    ++E +
Sbjct: 256 MDPPKNCPGPVYRIMTQCWQHQPEDRPNFAIILERI 291

>pdb|2YHV|A Chain A, Structure Of L1196m Mutant Anaplastic Lymphoma Kinase Length = 342

Iteration: 1
 Score = 54.7 bits (130), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 54/276 (19%), Positives = 111/276 (40%), Gaps = 30/276 (10%)
Query: 417 LGKGNFSSVYKGTLR------DGTLVAIRSINVTSCKSEEAEFVKGLYLLTSLRHENIIR 470
           LG G F  VY+G +           VA++++     + +E +F+    +++   H+NI+R
Sbjct: 53  LGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISKFNHQNIVR 112
Query: 471 LRGFCCSRGRGECFLIYDFAPKGKLSKYLDQ------EEGSSNVLDWSTRVSIIIGIAKG 524
             G   S      F++ +    G L  +L +      +  S  +LD    + +   IA G
Sbjct: 113 CIGV--SLQSLPRFILMELMAGGDLKSFLRETRPRPSQPSSLAMLDL---LHVARDIACG 167
Query: 525 IGYLHSSEVNKPAIVHRNLSVEKVLIDQQFNPLIADCGLHKLLADDIVFSVLKTSA---- 580
             YL  +       +HR+++    L+       +A  G   +  D    S  +       
Sbjct: 168 CQYLEENH-----FIHRDIAARNCLLTCPGPGRVAKIGDFGMARDIYRASYYRKGGCAML 222
Query: 581 AMGYLAPEYVTTGRFTERSDIFAFGVIILQILTGSLVLTSSMRLAAESATFENFIDRNLK 640
            + ++ PE    G FT ++D ++FGV++ +I +   +   S      +     F+    +
Sbjct: 223 PVKWMPPEAFMEGIFTSKTDTWSFGVLLWEIFSLGYMPYPS----KSNQEVLEFVTSGGR 278
Query: 641 GKFSESEAAKLGKMALVCTHEDPENRPTMEAVIEEL 676
               ++    + ++   C    PE+RP    ++E +
Sbjct: 279 MDPPKNCPGPVYRIMTQCWQHQPEDRPNFAIILERI 314

>pdb|3IGO|A Chain A, Crystal Structure Of Cryptosporidium Parvum Cdpk1, Cgd3_920 Length = 486

Iteration: 1
 Score = 54.7 bits (130), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 58/210 (27%), Positives = 99/210 (47%), Gaps = 25/210 (11%)
Query: 414 VNLLGKGNFSSVYKGTLR-DGTLVAIRSINVTSCKSEE-AEFVKGLYLLTSLRHENIIRL 471
           V +LGKG+F  V K   R      A++ IN  S K+++ +  ++ + LL  L H NI++L
Sbjct: 27  VCMLGKGSFGEVLKCKDRITQQEYAVKVINKASAKNKDTSTILREVELLKKLDHPNIMKL 86
Query: 472 RGFCCSRGRGECFLIYDFAPKGKLSKYLDQEEGSSNVLDWSTRVSIIIGIAKGIGYLHSS 531
             F         +++ +    G+L   + + +  S          II  +  GI Y+H  
Sbjct: 87  --FEILEDSSSFYIVGELYTGGELFDEIIKRKRFSE----HDAARIIKQVFSGITYMH-- 138
Query: 532 EVNKPAIVHRNLSVEKVLID---QQFNPLIADCGLHKLLADDIVFSVLKTSAAMG---YL 585
              K  IVHR+L  E +L++   +  +  I D GL      +      K    +G   Y+
Sbjct: 139 ---KHNIVHRDLKPENILLESKEKDCDIKIIDFGLSTCFQQNT-----KMKDRIGTAYYI 190
Query: 586 APEYVTTGRFTERSDIFAFGVIILQILTGS 615
           APE V  G + E+ D+++ GVI+  +L+G+
Sbjct: 191 APE-VLRGTYDEKCDVWSAGVILYILLSGT 219

>pdb|4ERW|A Chain A, Cdk2 In Complex With Staurosporine Length = 306

Iteration: 1
 Score = 54.7 bits (130), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 49/206 (23%), Positives = 99/206 (48%), Gaps = 14/206 (6%)
Query: 411 FSEVNLLGKGNFSSVYKGTLR-DGTLVAIRSINV-TSCKSEEAEFVKGLYLLTSLRHENI 468
           F +V  +G+G +  VYK   +  G +VA++ I + T  +   +  ++ + LL  L H NI
Sbjct: 12  FQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNI 71
Query: 469 IRLRGFCCSRGRGECFLIYDFAPKGKLSKYLDQEEGSSNVLDWSTRVSIIIGIAKGIGYL 528
           ++L     +  +   +L+++F  +  L K++D    +   L      S +  + +G+ + 
Sbjct: 72  VKLLDVIHTENK--LYLVFEFLHQD-LKKFMDASALTGIPLPLIK--SYLFQLLQGLAFC 126
Query: 529 HSSEVNKPAIVHRNLSVEKVLIDQQFNPLIADCGLHKLLADDIVFSVLKTSAAMGYLAPE 588
           HS  V     +HR+L  + +LI+ +    +AD GL +      V +       + Y APE
Sbjct: 127 HSHRV-----LHRDLKPQNLLINTEGAIKLADFGLARAFGVP-VRTYTHEVVTLWYRAPE 180
Query: 589 YVTTGRFTERS-DIFAFGVIILQILT 613
            +   ++   + DI++ G I  +++T
Sbjct: 181 ILLGXKYYSTAVDIWSLGCIFAEMVT 206

>pdb|2YFX|A Chain A, Structure Of L1196m Mutant Anaplastic Lymphoma Kinase In Complex With Crizotinib Length = 327

Iteration: 1
 Score = 54.7 bits (130), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 54/276 (19%), Positives = 111/276 (40%), Gaps = 30/276 (10%)
Query: 417 LGKGNFSSVYKGTLR------DGTLVAIRSINVTSCKSEEAEFVKGLYLLTSLRHENIIR 470
           LG G F  VY+G +           VA++++     + +E +F+    +++   H+NI+R
Sbjct: 38  LGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISKFNHQNIVR 97
Query: 471 LRGFCCSRGRGECFLIYDFAPKGKLSKYLDQ------EEGSSNVLDWSTRVSIIIGIAKG 524
             G   S      F++ +    G L  +L +      +  S  +LD    + +   IA G
Sbjct: 98  CIGV--SLQSLPRFILMELMAGGDLKSFLRETRPRPSQPSSLAMLDL---LHVARDIACG 152
Query: 525 IGYLHSSEVNKPAIVHRNLSVEKVLIDQQFNPLIADCGLHKLLADDIVFSVLKTSA---- 580
             YL  +       +HR+++    L+       +A  G   +  D    S  +       
Sbjct: 153 CQYLEENH-----FIHRDIAARNCLLTCPGPGRVAKIGDFGMARDIYRASYYRKGGCAML 207
Query: 581 AMGYLAPEYVTTGRFTERSDIFAFGVIILQILTGSLVLTSSMRLAAESATFENFIDRNLK 640
            + ++ PE    G FT ++D ++FGV++ +I +   +   S      +     F+    +
Sbjct: 208 PVKWMPPEAFMEGIFTSKTDTWSFGVLLWEIFSLGYMPYPS----KSNQEVLEFVTSGGR 263
Query: 641 GKFSESEAAKLGKMALVCTHEDPENRPTMEAVIEEL 676
               ++    + ++   C    PE+RP    ++E +
Sbjct: 264 MDPPKNCPGPVYRIMTQCWQHQPEDRPNFAIILERI 299

>pdb|4EON|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 300

Iteration: 1
 Score = 54.3 bits (129), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 50/210 (23%), Positives = 100/210 (47%), Gaps = 14/210 (6%)
Query: 407 ATQCFSEVNLLGKGNFSSVYKGTLR-DGTLVAIRSINV-TSCKSEEAEFVKGLYLLTSLR 464
           + + F +V  +G+G +  VYK   +  G +VA++ I + T  +   +  ++ + LL  L 
Sbjct: 2   SMENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELN 61
Query: 465 HENIIRLRGFCCSRGRGECFLIYDFAPKGKLSKYLDQEEGSSNVLDWSTRVSIIIGIAKG 524
           H NI++L     +  +   +L+++F     L K++D    +   L      S +  + +G
Sbjct: 62  HPNIVKLLDVIHTENK--LYLVFEFL-SMDLKKFMDASALTGIPLPLIK--SYLFQLLQG 116
Query: 525 IGYLHSSEVNKPAIVHRNLSVEKVLIDQQFNPLIADCGLHKLLADDIVFSVLKTSAAMGY 584
           + + HS  V     +HR+L  E +LI+ +    +AD GL +      V +       + Y
Sbjct: 117 LAFCHSHRV-----LHRDLKPENLLINTEGAIKLADFGLARAFGVP-VRTYXHEVVTLWY 170
Query: 585 LAPEYVTTGRFTERS-DIFAFGVIILQILT 613
            APE +   ++   + DI++ G I  +++T
Sbjct: 171 RAPEILLGCKYYSTAVDIWSLGCIFAEMVT 200

>pdb|2XP2|A Chain A, Structure Of The Human Anaplastic Lymphoma Kinase In Complex With Crizotinib (Pf-02341066) Length = 327

Iteration: 1
 Score = 54.3 bits (129), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 54/276 (19%), Positives = 111/276 (40%), Gaps = 30/276 (10%)
Query: 417 LGKGNFSSVYKGTLR------DGTLVAIRSINVTSCKSEEAEFVKGLYLLTSLRHENIIR 470
           LG G F  VY+G +           VA++++     + +E +F+    +++   H+NI+R
Sbjct: 38  LGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISKFNHQNIVR 97
Query: 471 LRGFCCSRGRGECFLIYDFAPKGKLSKYLDQ------EEGSSNVLDWSTRVSIIIGIAKG 524
             G   S      F++ +    G L  +L +      +  S  +LD    + +   IA G
Sbjct: 98  CIGV--SLQSLPRFILLELMAGGDLKSFLRETRPRPSQPSSLAMLDL---LHVARDIACG 152
Query: 525 IGYLHSSEVNKPAIVHRNLSVEKVLIDQQFNPLIADCGLHKLLADDIVFSVLKTSA---- 580
             YL  +       +HR+++    L+       +A  G   +  D    S  +       
Sbjct: 153 CQYLEENH-----FIHRDIAARNCLLTCPGPGRVAKIGDFGMARDIYRASYYRKGGCAML 207
Query: 581 AMGYLAPEYVTTGRFTERSDIFAFGVIILQILTGSLVLTSSMRLAAESATFENFIDRNLK 640
            + ++ PE    G FT ++D ++FGV++ +I +   +   S      +     F+    +
Sbjct: 208 PVKWMPPEAFMEGIFTSKTDTWSFGVLLWEIFSLGYMPYPS----KSNQEVLEFVTSGGR 263
Query: 641 GKFSESEAAKLGKMALVCTHEDPENRPTMEAVIEEL 676
               ++    + ++   C    PE+RP    ++E +
Sbjct: 264 MDPPKNCPGPVYRIMTQCWQHQPEDRPNFAIILERI 299

>pdb|4FNX|A Chain A, Crystal Structure Of The Apo R1275q Anaplastic Lymphoma Kinase Catalytic Domain Length = 327

Iteration: 1
 Score = 54.3 bits (129), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 54/276 (19%), Positives = 111/276 (40%), Gaps = 30/276 (10%)
Query: 417 LGKGNFSSVYKGTLR------DGTLVAIRSINVTSCKSEEAEFVKGLYLLTSLRHENIIR 470
           LG G F  VY+G +           VA++++     + +E +F+    +++   H+NI+R
Sbjct: 39  LGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISKFNHQNIVR 98
Query: 471 LRGFCCSRGRGECFLIYDFAPKGKLSKYLDQ------EEGSSNVLDWSTRVSIIIGIAKG 524
             G   S      F++ +    G L  +L +      +  S  +LD    + +   IA G
Sbjct: 99  CIGV--SLQSLPRFILLELMAGGDLKSFLRETRPRPSQPSSLAMLDL---LHVARDIACG 153
Query: 525 IGYLHSSEVNKPAIVHRNLSVEKVLIDQQFNPLIADCGLHKLLADDIVFSVLKTSA---- 580
             YL  +       +HR+++    L+       +A  G   +  D    S  +       
Sbjct: 154 CQYLEENH-----FIHRDIAARNCLLTCPGPGRVAKIGDFGMAQDIYRASYYRKGGCAML 208
Query: 581 AMGYLAPEYVTTGRFTERSDIFAFGVIILQILTGSLVLTSSMRLAAESATFENFIDRNLK 640
            + ++ PE    G FT ++D ++FGV++ +I +   +   S      +     F+    +
Sbjct: 209 PVKWMPPEAFMEGIFTSKTDTWSFGVLLWEIFSLGYMPYPS----KSNQEVLEFVTSGGR 264
Query: 641 GKFSESEAAKLGKMALVCTHEDPENRPTMEAVIEEL 676
               ++    + ++   C    PE+RP    ++E +
Sbjct: 265 MDPPKNCPGPVYRIMTQCWQHQPEDRPNFAIILERI 300

>pdb|3DFA|A Chain A, Crystal Structure Of Kinase Domain Of Calcium-dependent Protein Kinase Cgd3_920 From Cryptosporidium Parvum Length = 286

Iteration: 1
 Score = 54.3 bits (129), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 61/226 (26%), Positives = 107/226 (47%), Gaps = 19/226 (8%)
Query: 395 NSFRLNLEEVESATQCFSEVNLLGKGNFSSVYKGTLR-DGTLVAIRSINVTSCKSEE-AE 452
           +S R NL    +  + ++ V +LGKG+F  V K   R      A++ IN  S K+++ + 
Sbjct: 8   SSGRENLYFQGTFAERYNIVCMLGKGSFGEVLKCKDRITQQEYAVKVINKASAKNKDTST 67
Query: 453 FVKGLYLLTSLRHENIIRLRGFCCSRGRGECFLIYDFAPKGKLSKYLDQEEGSSNVLDWS 512
            ++ + LL  L H NI++L  F         +++ +    G+L   + + +  S      
Sbjct: 68  ILREVELLKKLDHPNIMKL--FEILEDSSSFYIVGELYTGGELFDEIIKRKRFSE----H 121
Query: 513 TRVSIIIGIAKGIGYLHSSEVNKPAIVHRNLSVEKVLID---QQFNPLIADCGLHKLLAD 569
               II  +  GI Y+H     K  IVHR+L  E +L++   +  +  I D GL      
Sbjct: 122 DAARIIKQVFSGITYMH-----KHNIVHRDLKPENILLESKEKDCDIKIIDFGLSTCFQQ 176
Query: 570 DIVFSVLKTSAAMGYLAPEYVTTGRFTERSDIFAFGVIILQILTGS 615
           +        +A   Y+APE V  G + E+ D+++ GVI+  +L+G+
Sbjct: 177 NTKMKDRIGTAY--YIAPE-VLRGTYDEKCDVWSAGVILYILLSGT 219

>pdb|1GZ8|A Chain A, Human Cyclin Dependent Kinase 2 Complexed With The Inhibitor 2-Amino-6-(3'-Methyl-2'-Oxo)butoxypurine Length = 299

Iteration: 1
 Score = 54.3 bits (129), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 49/206 (23%), Positives = 99/206 (48%), Gaps = 14/206 (6%)
Query: 411 FSEVNLLGKGNFSSVYKGTLR-DGTLVAIRSINV-TSCKSEEAEFVKGLYLLTSLRHENI 468
           F +V  +G+G +  VYK   +  G +VA++ I + T  +   +  ++ + LL  L H NI
Sbjct: 5   FQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNI 64
Query: 469 IRLRGFCCSRGRGECFLIYDFAPKGKLSKYLDQEEGSSNVLDWSTRVSIIIGIAKGIGYL 528
           ++L     +  +   +L+++F  +  L K++D    +   L      S +  + +G+ + 
Sbjct: 65  VKLLDVIHTENK--LYLVFEFLHQD-LKKFMDASALTGIPLPLIK--SYLFQLLQGLAFC 119
Query: 529 HSSEVNKPAIVHRNLSVEKVLIDQQFNPLIADCGLHKLLADDIVFSVLKTSAAMGYLAPE 588
           HS  V     +HR+L  + +LI+ +    +AD GL +      V +       + Y APE
Sbjct: 120 HSHRV-----LHRDLKPQNLLINTEGAIKLADFGLARAFGVP-VRTYTHEVVTLWYRAPE 173
Query: 589 YVTTGRFTERS-DIFAFGVIILQILT 613
            +   ++   + DI++ G I  +++T
Sbjct: 174 ILLGXKYYSTAVDIWSLGCIFAEMVT 199

>pdb|2WEI|A Chain A, Crystal Structure Of The Kinase Domain Of Cryptosporidium Parvum Calcium Dependent Protein Kinase In Complex With 3- Mb-Pp1 Length = 287

Iteration: 1
 Score = 54.3 bits (129), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 61/226 (26%), Positives = 107/226 (47%), Gaps = 19/226 (8%)
Query: 395 NSFRLNLEEVESATQCFSEVNLLGKGNFSSVYKGTLR-DGTLVAIRSINVTSCKSEE-AE 452
           +S R NL    +  + ++ V +LGKG+F  V K   R      A++ IN  S K+++ + 
Sbjct: 8   SSGRENLYFQGTFAERYNIVCMLGKGSFGEVLKCKDRITQQEYAVKVINKASAKNKDTST 67
Query: 453 FVKGLYLLTSLRHENIIRLRGFCCSRGRGECFLIYDFAPKGKLSKYLDQEEGSSNVLDWS 512
            ++ + LL  L H NI++L  F         +++ +    G+L   + + +  S      
Sbjct: 68  ILREVELLKKLDHPNIMKL--FEILEDSSSFYIVGELYTGGELFDEIIKRKRFSE----H 121
Query: 513 TRVSIIIGIAKGIGYLHSSEVNKPAIVHRNLSVEKVLID---QQFNPLIADCGLHKLLAD 569
               II  +  GI Y+H     K  IVHR+L  E +L++   +  +  I D GL      
Sbjct: 122 DAARIIKQVFSGITYMH-----KHNIVHRDLKPENILLESKEKDCDIKIIDFGLSTCFQQ 176
Query: 570 DIVFSVLKTSAAMGYLAPEYVTTGRFTERSDIFAFGVIILQILTGS 615
           +        +A   Y+APE V  G + E+ D+++ GVI+  +L+G+
Sbjct: 177 NTKMKDRIGTAY--YIAPE-VLRGTYDEKCDVWSAGVILYILLSGT 219

>pdb|1OGU|A Chain A, Structure Of Human Thr160-phospho Cdk2/cyclin A Complexed With A 2-arylamino-4-cyclohexylmethyl-5-nitroso-6- aminopyrimidine Inhibitor Length = 302

Iteration: 1
 Score = 54.3 bits (129), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 49/210 (23%), Positives = 101/210 (48%), Gaps = 14/210 (6%)
Query: 407 ATQCFSEVNLLGKGNFSSVYKGTLR-DGTLVAIRSINV-TSCKSEEAEFVKGLYLLTSLR 464
           + + F +V  +G+G +  VYK   +  G +VA++ I + T  +   +  ++ + LL  L 
Sbjct: 4   SMENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELN 63
Query: 465 HENIIRLRGFCCSRGRGECFLIYDFAPKGKLSKYLDQEEGSSNVLDWSTRVSIIIGIAKG 524
           H NI++L     +  +   +L+++F  +  L K++D    +   L      S +  + +G
Sbjct: 64  HPNIVKLLDVIHTENK--LYLVFEFLHQD-LKKFMDASALTGIPLPLIK--SYLFQLLQG 118
Query: 525 IGYLHSSEVNKPAIVHRNLSVEKVLIDQQFNPLIADCGLHKLLADDIVFSVLKTSAAMGY 584
           + + HS  V     +HR+L  + +LI+ +    +AD GL +      V +       + Y
Sbjct: 119 LAFCHSHRV-----LHRDLKPQNLLINTEGAIKLADFGLARAFGVP-VRTYXHEVVTLWY 172
Query: 585 LAPEYVTTGRFTERS-DIFAFGVIILQILT 613
            APE +   ++   + DI++ G I  +++T
Sbjct: 173 RAPEILLGCKYYSTAVDIWSLGCIFAEMVT 202

>pdb|2YJS|A Chain A, Structure Of C1156y Mutant Anaplastic Lymphoma Kinase Length = 342

Iteration: 1
 Score = 53.9 bits (128), Expect = 3e-07,   Method: Compositional matrix adjust.
 Identities = 54/276 (19%), Positives = 111/276 (40%), Gaps = 30/276 (10%)
Query: 417 LGKGNFSSVYKGTLR------DGTLVAIRSINVTSCKSEEAEFVKGLYLLTSLRHENIIR 470
           LG G F  VY+G +           VA++++     + +E +F+    +++   H+NI+R
Sbjct: 53  LGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVYSEQDELDFLMEALIISKFNHQNIVR 112
Query: 471 LRGFCCSRGRGECFLIYDFAPKGKLSKYLDQ------EEGSSNVLDWSTRVSIIIGIAKG 524
             G   S      F++ +    G L  +L +      +  S  +LD    + +   IA G
Sbjct: 113 CIGV--SLQSLPRFILLELMAGGDLKSFLRETRPRPSQPSSLAMLDL---LHVARDIACG 167
Query: 525 IGYLHSSEVNKPAIVHRNLSVEKVLIDQQFNPLIADCGLHKLLADDIVFSVLKTSA---- 580
             YL  +       +HR+++    L+       +A  G   +  D    S  +       
Sbjct: 168 CQYLEENH-----FIHRDIAARNCLLTCPGPGRVAKIGDFGMARDIYRASYYRKGGCAML 222
Query: 581 AMGYLAPEYVTTGRFTERSDIFAFGVIILQILTGSLVLTSSMRLAAESATFENFIDRNLK 640
            + ++ PE    G FT ++D ++FGV++ +I +   +   S      +     F+    +
Sbjct: 223 PVKWMPPEAFMEGIFTSKTDTWSFGVLLWEIFSLGYMPYPS----KSNQEVLEFVTSGGR 278
Query: 641 GKFSESEAAKLGKMALVCTHEDPENRPTMEAVIEEL 676
               ++    + ++   C    PE+RP    ++E +
Sbjct: 279 MDPPKNCPGPVYRIMTQCWQHQPEDRPNFAIILERI 314

>pdb|1H1P|A Chain A, Structure Of Human Thr160-Phospho Cdk2CYCLIN A COMPLEXED With The Inhibitor Nu2058 Length = 303

Iteration: 1
 Score = 53.9 bits (128), Expect = 3e-07,   Method: Compositional matrix adjust.
 Identities = 49/210 (23%), Positives = 101/210 (48%), Gaps = 14/210 (6%)
Query: 407 ATQCFSEVNLLGKGNFSSVYKGTLR-DGTLVAIRSINV-TSCKSEEAEFVKGLYLLTSLR 464
           + + F +V  +G+G +  VYK   +  G +VA++ I + T  +   +  ++ + LL  L 
Sbjct: 5   SMENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELN 64
Query: 465 HENIIRLRGFCCSRGRGECFLIYDFAPKGKLSKYLDQEEGSSNVLDWSTRVSIIIGIAKG 524
           H NI++L     +  +   +L+++F  +  L K++D    +   L      S +  + +G
Sbjct: 65  HPNIVKLLDVIHTENK--LYLVFEFLHQD-LKKFMDASALTGIPLPLIK--SYLFQLLQG 119
Query: 525 IGYLHSSEVNKPAIVHRNLSVEKVLIDQQFNPLIADCGLHKLLADDIVFSVLKTSAAMGY 584
           + + HS  V     +HR+L  + +LI+ +    +AD GL +      V +       + Y
Sbjct: 120 LAFCHSHRV-----LHRDLKPQNLLINTEGAIKLADFGLARAFGVP-VRTYXHEVVTLWY 173
Query: 585 LAPEYVTTGRFTERS-DIFAFGVIILQILT 613
            APE +   ++   + DI++ G I  +++T
Sbjct: 174 RAPEILLGCKYYSTAVDIWSLGCIFAEMVT 203

>pdb|4EOQ|A Chain A, Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Complex With Atp Length = 301

Iteration: 1
 Score = 53.9 bits (128), Expect = 3e-07,   Method: Compositional matrix adjust.
 Identities = 49/210 (23%), Positives = 101/210 (48%), Gaps = 14/210 (6%)
Query: 407 ATQCFSEVNLLGKGNFSSVYKGTLR-DGTLVAIRSINV-TSCKSEEAEFVKGLYLLTSLR 464
           + + F +V  +G+G +  VYK   +  G +VA++ I + T  +   +  ++ + LL  L 
Sbjct: 4   SMENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELN 63
Query: 465 HENIIRLRGFCCSRGRGECFLIYDFAPKGKLSKYLDQEEGSSNVLDWSTRVSIIIGIAKG 524
           H NI++L     +  +   +L+++F  +  L K++D    +   L      S +  + +G
Sbjct: 64  HPNIVKLLDVIHTENK--LYLVFEFLHQD-LKKFMDASALTGIPLPLIK--SYLFQLLQG 118
Query: 525 IGYLHSSEVNKPAIVHRNLSVEKVLIDQQFNPLIADCGLHKLLADDIVFSVLKTSAAMGY 584
           + + HS  V     +HR+L  + +LI+ +    +AD GL +      V +       + Y
Sbjct: 119 LAFCHSHRV-----LHRDLKPQNLLINTEGAIKLADFGLARAFGVP-VRTYXHEVVTLWY 172
Query: 585 LAPEYVTTGRFTERS-DIFAFGVIILQILT 613
            APE +   ++   + DI++ G I  +++T
Sbjct: 173 RAPEILLGCKYYSTAVDIWSLGCIFAEMVT 202

>pdb|4BCQ|A Chain A, Structure Of Cdk2 In Complex With Cyclin A And A 2-amino-4- Heteroaryl-pyrimidine Inhibitor Length = 301

Iteration: 1
 Score = 53.9 bits (128), Expect = 3e-07,   Method: Compositional matrix adjust.
 Identities = 49/210 (23%), Positives = 101/210 (48%), Gaps = 14/210 (6%)
Query: 407 ATQCFSEVNLLGKGNFSSVYKGTLR-DGTLVAIRSINV-TSCKSEEAEFVKGLYLLTSLR 464
           + + F +V  +G+G +  VYK   +  G +VA++ I + T  +   +  ++ + LL  L 
Sbjct: 3   SMENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELN 62
Query: 465 HENIIRLRGFCCSRGRGECFLIYDFAPKGKLSKYLDQEEGSSNVLDWSTRVSIIIGIAKG 524
           H NI++L     +  +   +L+++F  +  L K++D    +   L      S +  + +G
Sbjct: 63  HPNIVKLLDVIHTENK--LYLVFEFLHQD-LKKFMDASALTGIPLPLIK--SYLFQLLQG 117
Query: 525 IGYLHSSEVNKPAIVHRNLSVEKVLIDQQFNPLIADCGLHKLLADDIVFSVLKTSAAMGY 584
           + + HS  V     +HR+L  + +LI+ +    +AD GL +      V +       + Y
Sbjct: 118 LAFCHSHRV-----LHRDLKPQNLLINTEGAIKLADFGLARAFGVP-VRTYXHEVVTLWY 171
Query: 585 LAPEYVTTGRFTERS-DIFAFGVIILQILT 613
            APE +   ++   + DI++ G I  +++T
Sbjct: 172 RAPEILLGCKYYSTAVDIWSLGCIFAEMVT 201

>pdb|3AOX|A Chain A, X-Ray Crystal Structure Of Human Anaplastic Lymphoma Kinase In Complex With Ch5424802 Length = 344

Iteration: 1
 Score = 53.9 bits (128), Expect = 3e-07,   Method: Compositional matrix adjust.
 Identities = 54/276 (19%), Positives = 111/276 (40%), Gaps = 30/276 (10%)
Query: 417 LGKGNFSSVYKGTLR------DGTLVAIRSINVTSCKSEEAEFVKGLYLLTSLRHENIIR 470
           LG G F  VY+G +           VA++++     + +E +F+    +++   H+NI+R
Sbjct: 55  LGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISKFNHQNIVR 114
Query: 471 LRGFCCSRGRGECFLIYDFAPKGKLSKYLDQ------EEGSSNVLDWSTRVSIIIGIAKG 524
             G   S      F++ +    G L  +L +      +  S  +LD    + +   IA G
Sbjct: 115 CIGV--SLQSLPRFILLELMAGGDLKSFLRETRPRPSQPSSLAMLDL---LHVARDIACG 169
Query: 525 IGYLHSSEVNKPAIVHRNLSVEKVLIDQQFNPLIADCGLHKLLADDIVFSVLKTSA---- 580
             YL  +       +HR+++    L+       +A  G   +  D    S  +       
Sbjct: 170 CQYLEENH-----FIHRDIAARNCLLTCPGPGRVAKIGDFGMARDIYRASYYRKGGCAML 224
Query: 581 AMGYLAPEYVTTGRFTERSDIFAFGVIILQILTGSLVLTSSMRLAAESATFENFIDRNLK 640
            + ++ PE    G FT ++D ++FGV++ +I +   +   S      +     F+    +
Sbjct: 225 PVKWMPPEAFMEGIFTSKTDTWSFGVLLWEIFSLGYMPYPS----KSNQEVLEFVTSGGR 280
Query: 641 GKFSESEAAKLGKMALVCTHEDPENRPTMEAVIEEL 676
               ++    + ++   C    PE+RP    ++E +
Sbjct: 281 MDPPKNCPGPVYRIMTQCWQHQPEDRPNFAIILERI 316

>pdb|4EOS|A Chain A, Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 300

Iteration: 1
 Score = 53.9 bits (128), Expect = 3e-07,   Method: Compositional matrix adjust.
 Identities = 49/210 (23%), Positives = 101/210 (48%), Gaps = 14/210 (6%)
Query: 407 ATQCFSEVNLLGKGNFSSVYKGTLR-DGTLVAIRSINV-TSCKSEEAEFVKGLYLLTSLR 464
           + + F +V  +G+G +  VYK   +  G +VA++ I + T  +   +  ++ + LL  L 
Sbjct: 3   SMENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELN 62
Query: 465 HENIIRLRGFCCSRGRGECFLIYDFAPKGKLSKYLDQEEGSSNVLDWSTRVSIIIGIAKG 524
           H NI++L     +  +   +L+++F  +  L K++D    +   L      S +  + +G
Sbjct: 63  HPNIVKLLDVIHTENK--LYLVFEFLHQD-LKKFMDASALTGIPLPLIK--SYLFQLLQG 117
Query: 525 IGYLHSSEVNKPAIVHRNLSVEKVLIDQQFNPLIADCGLHKLLADDIVFSVLKTSAAMGY 584
           + + HS  V     +HR+L  + +LI+ +    +AD GL +      V +       + Y
Sbjct: 118 LAFCHSHRV-----LHRDLKPQNLLINTEGAIKLADFGLARAFGVP-VRTYXHEVVTLWY 171
Query: 585 LAPEYVTTGRFTERS-DIFAFGVIILQILT 613
            APE +   ++   + DI++ G I  +++T
Sbjct: 172 RAPEILLGCKYYSTAVDIWSLGCIFAEMVT 201

>pdb|4FNZ|A Chain A, Crystal Structure Of Human Anaplastic Lymphoma Kinase In Complex With Piperidine-Carboxamide Inhibitor 2 Length = 327

Iteration: 1
 Score = 53.9 bits (128), Expect = 3e-07,   Method: Compositional matrix adjust.
 Identities = 54/276 (19%), Positives = 111/276 (40%), Gaps = 30/276 (10%)
Query: 417 LGKGNFSSVYKGTLR------DGTLVAIRSINVTSCKSEEAEFVKGLYLLTSLRHENIIR 470
           LG G F  VY+G +           VA++++     + +E +F+    +++   H+NI+R
Sbjct: 39  LGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISKFNHQNIVR 98
Query: 471 LRGFCCSRGRGECFLIYDFAPKGKLSKYLDQ------EEGSSNVLDWSTRVSIIIGIAKG 524
             G   S      F++ +    G L  +L +      +  S  +LD    + +   IA G
Sbjct: 99  CIGV--SLQSLPRFILLELMAGGDLKSFLRETRPRPSQPSSLAMLDL---LHVARDIACG 153
Query: 525 IGYLHSSEVNKPAIVHRNLSVEKVLIDQQFNPLIADCGLHKLLADDIVFSVLKTSA---- 580
             YL  +       +HR+++    L+       +A  G   +  D    S  +       
Sbjct: 154 CQYLEENH-----FIHRDIAARNCLLTCPGPGRVAKIGDFGMARDIYRASYYRKGGCAML 208
Query: 581 AMGYLAPEYVTTGRFTERSDIFAFGVIILQILTGSLVLTSSMRLAAESATFENFIDRNLK 640
            + ++ PE    G FT ++D ++FGV++ +I +   +   S      +     F+    +
Sbjct: 209 PVKWMPPEAFMEGIFTSKTDTWSFGVLLWEIFSLGYMPYPS----KSNQEVLEFVTSGGR 264
Query: 641 GKFSESEAAKLGKMALVCTHEDPENRPTMEAVIEEL 676
               ++    + ++   C    PE+RP    ++E +
Sbjct: 265 MDPPKNCPGPVYRIMTQCWQHQPEDRPNFAIILERI 300

>pdb|4DCE|A Chain A, Crystal Structure Of Human Anaplastic Lymphoma Kinase In Complex With A Piperidine-Carboxamide Inhibitor Length = 333

Iteration: 1
 Score = 53.9 bits (128), Expect = 3e-07,   Method: Compositional matrix adjust.
 Identities = 54/276 (19%), Positives = 111/276 (40%), Gaps = 30/276 (10%)
Query: 417 LGKGNFSSVYKGTLR------DGTLVAIRSINVTSCKSEEAEFVKGLYLLTSLRHENIIR 470
           LG G F  VY+G +           VA++++     + +E +F+    +++   H+NI+R
Sbjct: 45  LGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISKFNHQNIVR 104
Query: 471 LRGFCCSRGRGECFLIYDFAPKGKLSKYLDQ------EEGSSNVLDWSTRVSIIIGIAKG 524
             G   S      F++ +    G L  +L +      +  S  +LD    + +   IA G
Sbjct: 105 CIGV--SLQSLPRFILLELMAGGDLKSFLRETRPRPSQPSSLAMLDL---LHVARDIACG 159
Query: 525 IGYLHSSEVNKPAIVHRNLSVEKVLIDQQFNPLIADCGLHKLLADDIVFSVLKTSA---- 580
             YL  +       +HR+++    L+       +A  G   +  D    S  +       
Sbjct: 160 CQYLEENH-----FIHRDIAARNCLLTCPGPGRVAKIGDFGMARDIYRASYYRKGGCAML 214
Query: 581 AMGYLAPEYVTTGRFTERSDIFAFGVIILQILTGSLVLTSSMRLAAESATFENFIDRNLK 640
            + ++ PE    G FT ++D ++FGV++ +I +   +   S      +     F+    +
Sbjct: 215 PVKWMPPEAFMEGIFTSKTDTWSFGVLLWEIFSLGYMPYPS----KSNQEVLEFVTSGGR 270
Query: 641 GKFSESEAAKLGKMALVCTHEDPENRPTMEAVIEEL 676
               ++    + ++   C    PE+RP    ++E +
Sbjct: 271 MDPPKNCPGPVYRIMTQCWQHQPEDRPNFAIILERI 306

>pdb|1BI8|A Chain A, Mechanism Of G1 Cyclin Dependent Kinase Inhibition From The Structures Cdk6-P19ink4d Inhibitor Complex Length = 326

Iteration: 1
 Score = 53.9 bits (128), Expect = 3e-07,   Method: Compositional matrix adjust.
 Identities = 57/220 (25%), Positives = 96/220 (43%), Gaps = 29/220 (13%)
Query: 407 ATQCFSEVNLLGKGNFSSVYKGTLRD----GTLVAIRSINVTSCKS----EEAEFVKGLY 458
           A Q +  V  +G+G +  V+K   RD    G  VA++ + V + +          V  L 
Sbjct: 9   ADQQYECVAEIGEGAYGKVFKA--RDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLR 66
Query: 459 LLTSLRHENIIRLRGFC-CSRGRGECFLIYDFAPKGK-LSKYLDQ--EEGSSNVLDWSTR 514
            L +  H N++RL   C  SR   E  L   F    + L+ YLD+  E G        T 
Sbjct: 67  HLETFEHPNVVRLFDVCTVSRTDRETKLTLVFEHVDQDLTTYLDKVPEPGVPT----ETI 122
Query: 515 VSIIIGIAKGIGYLHSSEVNKPAIVHRNLSVEKVLIDQQFNPLIADCGLHKLLADDIVFS 574
             ++  + +G+ +LHS  V     VHR+L  + +L+       +AD GL ++ +    F 
Sbjct: 123 KDMMFQLLRGLDFLHSHRV-----VHRDLKPQNILVTSSGQIKLADFGLARIYS----FQ 173
Query: 575 VLKTSAA--MGYLAPEYVTTGRFTERSDIFAFGVIILQIL 612
           +  TS    + Y APE +    +    D+++ G I  ++ 
Sbjct: 174 MALTSVVVTLWYRAPEVLLQSSYATPVDLWSVGCIFAEMF 213

>pdb|3QHR|A Chain A, Structure Of A Pcdk2CYCLINA TRANSITION-State Mimic Length = 298

Iteration: 1
 Score = 53.9 bits (128), Expect = 3e-07,   Method: Compositional matrix adjust.
 Identities = 49/206 (23%), Positives = 99/206 (48%), Gaps = 14/206 (6%)
Query: 411 FSEVNLLGKGNFSSVYKGTLR-DGTLVAIRSINV-TSCKSEEAEFVKGLYLLTSLRHENI 468
           F +V  +G+G +  VYK   +  G +VA++ I + T  +   +  ++ + LL  L H NI
Sbjct: 6   FQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNI 65
Query: 469 IRLRGFCCSRGRGECFLIYDFAPKGKLSKYLDQEEGSSNVLDWSTRVSIIIGIAKGIGYL 528
           ++L     +  +   +L+++F  +  L K++D    +   L      S +  + +G+ + 
Sbjct: 66  VKLLDVIHTENK--LYLVFEFLHQD-LKKFMDASALTGIPLPLIK--SYLFQLLQGLAFC 120
Query: 529 HSSEVNKPAIVHRNLSVEKVLIDQQFNPLIADCGLHKLLADDIVFSVLKTSAAMGYLAPE 588
           HS  V     +HR+L  + +LI+ +    +AD GL +      V +       + Y APE
Sbjct: 121 HSHRV-----LHRDLKPQNLLINTEGAIKLADFGLARAFGVP-VRTYXHEVVTLWYRAPE 174
Query: 589 YVTTGRFTERS-DIFAFGVIILQILT 613
            +   ++   + DI++ G I  +++T
Sbjct: 175 ILLGCKYYSTAVDIWSLGCIFAEMVT 200

>pdb|4I3Z|A Chain A, Structure Of Pcdk2CYCLINA BOUND TO ADP AND 2 MAGNESIUM IONS Length = 296

Iteration: 1
 Score = 53.9 bits (128), Expect = 3e-07,   Method: Compositional matrix adjust.
 Identities = 49/206 (23%), Positives = 99/206 (48%), Gaps = 14/206 (6%)
Query: 411 FSEVNLLGKGNFSSVYKGTLR-DGTLVAIRSINV-TSCKSEEAEFVKGLYLLTSLRHENI 468
           F +V  +G+G +  VYK   +  G +VA++ I + T  +   +  ++ + LL  L H NI
Sbjct: 4   FQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNI 63
Query: 469 IRLRGFCCSRGRGECFLIYDFAPKGKLSKYLDQEEGSSNVLDWSTRVSIIIGIAKGIGYL 528
           ++L     +  +   +L+++F  +  L K++D    +   L      S +  + +G+ + 
Sbjct: 64  VKLLDVIHTENK--LYLVFEFLHQD-LKKFMDASALTGIPLPLIK--SYLFQLLQGLAFC 118
Query: 529 HSSEVNKPAIVHRNLSVEKVLIDQQFNPLIADCGLHKLLADDIVFSVLKTSAAMGYLAPE 588
           HS  V     +HR+L  + +LI+ +    +AD GL +      V +       + Y APE
Sbjct: 119 HSHRV-----LHRDLKPQNLLINTEGAIKLADFGLARAFGVP-VRTYXHEVVTLWYRAPE 172
Query: 589 YVTTGRFTERS-DIFAFGVIILQILT 613
            +   ++   + DI++ G I  +++T
Sbjct: 173 ILLGCKYYSTAVDIWSLGCIFAEMVT 198

>pdb|3BHT|A Chain A, Structure Of Phosphorylated Thr160 Cdk2CYCLIN A IN COMPLEX WITH THE Inhibitor Meriolin 3 Length = 300

Iteration: 1
 Score = 53.9 bits (128), Expect = 3e-07,   Method: Compositional matrix adjust.
 Identities = 49/206 (23%), Positives = 99/206 (48%), Gaps = 14/206 (6%)
Query: 411 FSEVNLLGKGNFSSVYKGTLR-DGTLVAIRSINV-TSCKSEEAEFVKGLYLLTSLRHENI 468
           F +V  +G+G +  VYK   +  G +VA++ I + T  +   +  ++ + LL  L H NI
Sbjct: 6   FQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNI 65
Query: 469 IRLRGFCCSRGRGECFLIYDFAPKGKLSKYLDQEEGSSNVLDWSTRVSIIIGIAKGIGYL 528
           ++L     +  +   +L+++F  +  L K++D    +   L      S +  + +G+ + 
Sbjct: 66  VKLLDVIHTENK--LYLVFEFLHQD-LKKFMDASALTGIPLPLIK--SYLFQLLQGLAFC 120
Query: 529 HSSEVNKPAIVHRNLSVEKVLIDQQFNPLIADCGLHKLLADDIVFSVLKTSAAMGYLAPE 588
           HS  V     +HR+L  + +LI+ +    +AD GL +      V +       + Y APE
Sbjct: 121 HSHRV-----LHRDLKPQNLLINTEGAIKLADFGLARAFGVP-VRTYXHEVVTLWYRAPE 174
Query: 589 YVTTGRFTERS-DIFAFGVIILQILT 613
            +   ++   + DI++ G I  +++T
Sbjct: 175 ILLGCKYYSTAVDIWSLGCIFAEMVT 200

>pdb|1QMZ|A Chain A, Phosphorylated Cdk2-Cyclyin A-Substrate Peptide Complex Length = 299

Iteration: 1
 Score = 53.9 bits (128), Expect = 3e-07,   Method: Compositional matrix adjust.
 Identities = 49/206 (23%), Positives = 99/206 (48%), Gaps = 14/206 (6%)
Query: 411 FSEVNLLGKGNFSSVYKGTLR-DGTLVAIRSINV-TSCKSEEAEFVKGLYLLTSLRHENI 468
           F +V  +G+G +  VYK   +  G +VA++ I + T  +   +  ++ + LL  L H NI
Sbjct: 5   FQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNI 64
Query: 469 IRLRGFCCSRGRGECFLIYDFAPKGKLSKYLDQEEGSSNVLDWSTRVSIIIGIAKGIGYL 528
           ++L     +  +   +L+++F  +  L K++D    +   L      S +  + +G+ + 
Sbjct: 65  VKLLDVIHTENK--LYLVFEFLHQD-LKKFMDASALTGIPLPLIK--SYLFQLLQGLAFC 119
Query: 529 HSSEVNKPAIVHRNLSVEKVLIDQQFNPLIADCGLHKLLADDIVFSVLKTSAAMGYLAPE 588
           HS  V     +HR+L  + +LI+ +    +AD GL +      V +       + Y APE
Sbjct: 120 HSHRV-----LHRDLKPQNLLINTEGAIKLADFGLARAFGVP-VRTYXHEVVTLWYRAPE 173
Query: 589 YVTTGRFTERS-DIFAFGVIILQILT 613
            +   ++   + DI++ G I  +++T
Sbjct: 174 ILLGCKYYSTAVDIWSLGCIFAEMVT 199

>pdb|1W98|A Chain A, The Structural Basis Of Cdk2 Activation By Cyclin E Length = 298

Iteration: 1
 Score = 53.9 bits (128), Expect = 3e-07,   Method: Compositional matrix adjust.
 Identities = 49/206 (23%), Positives = 99/206 (48%), Gaps = 14/206 (6%)
Query: 411 FSEVNLLGKGNFSSVYKGTLR-DGTLVAIRSINV-TSCKSEEAEFVKGLYLLTSLRHENI 468
           F +V  +G+G +  VYK   +  G +VA++ I + T  +   +  ++ + LL  L H NI
Sbjct: 5   FQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNI 64
Query: 469 IRLRGFCCSRGRGECFLIYDFAPKGKLSKYLDQEEGSSNVLDWSTRVSIIIGIAKGIGYL 528
           ++L     +  +   +L+++F  +  L K++D    +   L      S +  + +G+ + 
Sbjct: 65  VKLLDVIHTENK--LYLVFEFLHQD-LKKFMDASALTGIPLPLIK--SYLFQLLQGLAFC 119
Query: 529 HSSEVNKPAIVHRNLSVEKVLIDQQFNPLIADCGLHKLLADDIVFSVLKTSAAMGYLAPE 588
           HS  V     +HR+L  + +LI+ +    +AD GL +      V +       + Y APE
Sbjct: 120 HSHRV-----LHRDLKPQNLLINTEGAIKLADFGLARAFGVP-VRTYXHEVVTLWYRAPE 173
Query: 589 YVTTGRFTERS-DIFAFGVIILQILT 613
            +   ++   + DI++ G I  +++T
Sbjct: 174 ILLGCKYYSTAVDIWSLGCIFAEMVT 199

>pdb|3PXF|A Chain A, Cdk2 In Complex With Two Molecules Of 8-Anilino-1-Naphthalene Sulfonate Length = 306

Iteration: 1
 Score = 53.9 bits (128), Expect = 3e-07,   Method: Compositional matrix adjust.
 Identities = 49/206 (23%), Positives = 99/206 (48%), Gaps = 14/206 (6%)
Query: 411 FSEVNLLGKGNFSSVYKGTLR-DGTLVAIRSINV-TSCKSEEAEFVKGLYLLTSLRHENI 468
           F +V  +G+G +  VYK   +  G +VA++ I + T  +   +  ++ + LL  L H NI
Sbjct: 12  FQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNI 71
Query: 469 IRLRGFCCSRGRGECFLIYDFAPKGKLSKYLDQEEGSSNVLDWSTRVSIIIGIAKGIGYL 528
           ++L     +  +   +L+++F  +  L K++D    +   L      S +  + +G+ + 
Sbjct: 72  VKLLDVIHTENK--LYLVFEFLHQD-LKKFMDASALTGIPLPLIK--SYLFQLLQGLAFC 126
Query: 529 HSSEVNKPAIVHRNLSVEKVLIDQQFNPLIADCGLHKLLADDIVFSVLKTSAAMGYLAPE 588
           HS  V     +HR+L  + +LI+ +    +AD GL +      V +       + Y APE
Sbjct: 127 HSHRV-----LHRDLKPQNLLINTEGAIKLADFGLARAFGVP-VRTYTHEVVTLWYRAPE 180
Query: 589 YVTTGRFTERS-DIFAFGVIILQILT 613
            +   ++   + DI++ G I  +++T
Sbjct: 181 ILLGCKYYSTAVDIWSLGCIFAEMVT 206

>pdb|1E9H|A Chain A, Thr 160 Phosphorylated Cdk2-Human Cyclin A3 Complex With The Inhibitor Indirubin-5-Sulphonate Bound Length = 297

Iteration: 1
 Score = 53.9 bits (128), Expect = 3e-07,   Method: Compositional matrix adjust.
 Identities = 49/206 (23%), Positives = 99/206 (48%), Gaps = 14/206 (6%)
Query: 411 FSEVNLLGKGNFSSVYKGTLR-DGTLVAIRSINV-TSCKSEEAEFVKGLYLLTSLRHENI 468
           F +V  +G+G +  VYK   +  G +VA++ I + T  +   +  ++ + LL  L H NI
Sbjct: 5   FQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNI 64
Query: 469 IRLRGFCCSRGRGECFLIYDFAPKGKLSKYLDQEEGSSNVLDWSTRVSIIIGIAKGIGYL 528
           ++L     +  +   +L+++F  +  L K++D    +   L      S +  + +G+ + 
Sbjct: 65  VKLLDVIHTENK--LYLVFEFLHQD-LKKFMDASALTGIPLPLIK--SYLFQLLQGLAFC 119
Query: 529 HSSEVNKPAIVHRNLSVEKVLIDQQFNPLIADCGLHKLLADDIVFSVLKTSAAMGYLAPE 588
           HS  V     +HR+L  + +LI+ +    +AD GL +      V +       + Y APE
Sbjct: 120 HSHRV-----LHRDLKPQNLLINTEGAIKLADFGLARAFGVP-VRTYXHEVVTLWYRAPE 173
Query: 589 YVTTGRFTERS-DIFAFGVIILQILT 613
            +   ++   + DI++ G I  +++T
Sbjct: 174 ILLGCKYYSTAVDIWSLGCIFAEMVT 199

>pdb|1JST|A Chain A, Phosphorylated Cyclin-Dependent Kinase-2 Bound To Cyclin A Length = 298

Iteration: 1
 Score = 53.9 bits (128), Expect = 3e-07,   Method: Compositional matrix adjust.
 Identities = 49/206 (23%), Positives = 99/206 (48%), Gaps = 14/206 (6%)
Query: 411 FSEVNLLGKGNFSSVYKGTLR-DGTLVAIRSINV-TSCKSEEAEFVKGLYLLTSLRHENI 468
           F +V  +G+G +  VYK   +  G +VA++ I + T  +   +  ++ + LL  L H NI
Sbjct: 4   FQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNI 63
Query: 469 IRLRGFCCSRGRGECFLIYDFAPKGKLSKYLDQEEGSSNVLDWSTRVSIIIGIAKGIGYL 528
           ++L     +  +   +L+++F  +  L K++D    +   L      S +  + +G+ + 
Sbjct: 64  VKLLDVIHTENK--LYLVFEFLHQD-LKKFMDASALTGIPLPLIK--SYLFQLLQGLAFC 118
Query: 529 HSSEVNKPAIVHRNLSVEKVLIDQQFNPLIADCGLHKLLADDIVFSVLKTSAAMGYLAPE 588
           HS  V     +HR+L  + +LI+ +    +AD GL +      V +       + Y APE
Sbjct: 119 HSHRV-----LHRDLKPQNLLINTEGAIKLADFGLARAFGVP-VRTYXHEVVTLWYRAPE 172
Query: 589 YVTTGRFTERS-DIFAFGVIILQILT 613
            +   ++   + DI++ G I  +++T
Sbjct: 173 ILLGCKYYSTAVDIWSLGCIFAEMVT 198

>pdb|1VYW|A Chain A, Structure Of Cdk2CYCLIN A WITH PNU-292137 Length = 309

Iteration: 1
 Score = 53.9 bits (128), Expect = 3e-07,   Method: Compositional matrix adjust.
 Identities = 49/206 (23%), Positives = 99/206 (48%), Gaps = 14/206 (6%)
Query: 411 FSEVNLLGKGNFSSVYKGTLR-DGTLVAIRSINV-TSCKSEEAEFVKGLYLLTSLRHENI 468
           F +V  +G+G +  VYK   +  G +VA++ I + T  +   +  ++ + LL  L H NI
Sbjct: 9   FQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNI 68
Query: 469 IRLRGFCCSRGRGECFLIYDFAPKGKLSKYLDQEEGSSNVLDWSTRVSIIIGIAKGIGYL 528
           ++L     +  +   +L+++F  +  L K++D    +   L      S +  + +G+ + 
Sbjct: 69  VKLLDVIHTENK--LYLVFEFLHQD-LKKFMDASALTGIPLPLIK--SYLFQLLQGLAFC 123
Query: 529 HSSEVNKPAIVHRNLSVEKVLIDQQFNPLIADCGLHKLLADDIVFSVLKTSAAMGYLAPE 588
           HS  V     +HR+L  + +LI+ +    +AD GL +      V +       + Y APE
Sbjct: 124 HSHRV-----LHRDLKPQNLLINTEGAIKLADFGLARAFGVP-VRTYTHEVVTLWYRAPE 177
Query: 589 YVTTGRFTERS-DIFAFGVIILQILT 613
            +   ++   + DI++ G I  +++T
Sbjct: 178 ILLGCKYYSTAVDIWSLGCIFAEMVT 203

>pdb|3PJ8|A Chain A, Structure Of Cdk2 In Complex With A Pyrazolo[4,3-D]pyrimidine Bioisostere Of Roscovitine Length = 299

Iteration: 1
 Score = 53.5 bits (127), Expect = 3e-07,   Method: Compositional matrix adjust.
 Identities = 49/206 (23%), Positives = 99/206 (48%), Gaps = 14/206 (6%)
Query: 411 FSEVNLLGKGNFSSVYKGTLR-DGTLVAIRSINV-TSCKSEEAEFVKGLYLLTSLRHENI 468
           F +V  +G+G +  VYK   +  G +VA++ I + T  +   +  ++ + LL  L H NI
Sbjct: 5   FQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNI 64
Query: 469 IRLRGFCCSRGRGECFLIYDFAPKGKLSKYLDQEEGSSNVLDWSTRVSIIIGIAKGIGYL 528
           ++L     +  +   +L+++F  +  L K++D    +   L      S +  + +G+ + 
Sbjct: 65  VKLLDVIHTENK--LYLVFEFLHQD-LKKFMDASALTGIPLPLIK--SYLFQLLQGLAFC 119
Query: 529 HSSEVNKPAIVHRNLSVEKVLIDQQFNPLIADCGLHKLLADDIVFSVLKTSAAMGYLAPE 588
           HS  V     +HR+L  + +LI+ +    +AD GL +      V +       + Y APE
Sbjct: 120 HSHRV-----LHRDLKPQNLLINTEGAIKLADFGLARAFGVP-VRTYTHEVVTLWYRAPE 173
Query: 589 YVTTGRFTERS-DIFAFGVIILQILT 613
            +   ++   + DI++ G I  +++T
Sbjct: 174 ILLGCKYYSTAVDIWSLGCIFAEMVT 199

>pdb|3EZR|A Chain A, Cdk-2 With Indazole Inhibitor 17 Bound At Its Active Site Length = 300

Iteration: 1
 Score = 53.5 bits (127), Expect = 3e-07,   Method: Compositional matrix adjust.
 Identities = 49/206 (23%), Positives = 99/206 (48%), Gaps = 14/206 (6%)
Query: 411 FSEVNLLGKGNFSSVYKGTLR-DGTLVAIRSINV-TSCKSEEAEFVKGLYLLTSLRHENI 468
           F +V  +G+G +  VYK   +  G +VA++ I + T  +   +  ++ + LL  L H NI
Sbjct: 6   FQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNI 65
Query: 469 IRLRGFCCSRGRGECFLIYDFAPKGKLSKYLDQEEGSSNVLDWSTRVSIIIGIAKGIGYL 528
           ++L     +  +   +L+++F  +  L K++D    +   L      S +  + +G+ + 
Sbjct: 66  VKLLDVIHTENK--LYLVFEFLHQD-LKKFMDASALTGIPLPLIK--SYLFQLLQGLAFC 120
Query: 529 HSSEVNKPAIVHRNLSVEKVLIDQQFNPLIADCGLHKLLADDIVFSVLKTSAAMGYLAPE 588
           HS  V     +HR+L  + +LI+ +    +AD GL +      V +       + Y APE
Sbjct: 121 HSHRV-----LHRDLKPQNLLINTEGAIKLADFGLARAFGVP-VRTYTHEVVTLWYRAPE 174
Query: 589 YVTTGRFTERS-DIFAFGVIILQILT 613
            +   ++   + DI++ G I  +++T
Sbjct: 175 ILLGCKYYSTAVDIWSLGCIFAEMVT 200

>pdb|2W17|A Chain A, Cdk2 In Complex With The Imidazole Pyrimidine Amide, Compound (S)-8b Length = 299

Iteration: 1
 Score = 53.5 bits (127), Expect = 4e-07,   Method: Compositional matrix adjust.
 Identities = 49/206 (23%), Positives = 99/206 (48%), Gaps = 14/206 (6%)
Query: 411 FSEVNLLGKGNFSSVYKGTLR-DGTLVAIRSINV-TSCKSEEAEFVKGLYLLTSLRHENI 468
           F +V  +G+G +  VYK   +  G +VA++ I + T  +   +  ++ + LL  L H NI
Sbjct: 5   FQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNI 64
Query: 469 IRLRGFCCSRGRGECFLIYDFAPKGKLSKYLDQEEGSSNVLDWSTRVSIIIGIAKGIGYL 528
           ++L     +  +   +L+++F  +  L K++D    +   L      S +  + +G+ + 
Sbjct: 65  VKLLDVIHTENK--LYLVFEFLHQD-LKKFMDASALTGIPLPLIK--SYLFQLLQGLAFC 119
Query: 529 HSSEVNKPAIVHRNLSVEKVLIDQQFNPLIADCGLHKLLADDIVFSVLKTSAAMGYLAPE 588
           HS  V     +HR+L  + +LI+ +    +AD GL +      V +       + Y APE
Sbjct: 120 HSHRV-----LHRDLKPQNLLINTEGAIKLADFGLARAFGVP-VRTYTHEVVTLWYRAPE 173
Query: 589 YVTTGRFTERS-DIFAFGVIILQILT 613
            +   ++   + DI++ G I  +++T
Sbjct: 174 ILLGCKYYSTAVDIWSLGCIFAEMVT 199

>pdb|1FIN|A Chain A, Cyclin A-Cyclin-Dependent Kinase 2 Complex Length = 298

Iteration: 1
 Score = 53.5 bits (127), Expect = 4e-07,   Method: Compositional matrix adjust.
 Identities = 49/206 (23%), Positives = 99/206 (48%), Gaps = 14/206 (6%)
Query: 411 FSEVNLLGKGNFSSVYKGTLR-DGTLVAIRSINV-TSCKSEEAEFVKGLYLLTSLRHENI 468
           F +V  +G+G +  VYK   +  G +VA++ I + T  +   +  ++ + LL  L H NI
Sbjct: 4   FQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNI 63
Query: 469 IRLRGFCCSRGRGECFLIYDFAPKGKLSKYLDQEEGSSNVLDWSTRVSIIIGIAKGIGYL 528
           ++L     +  +   +L+++F  +  L K++D    +   L      S +  + +G+ + 
Sbjct: 64  VKLLDVIHTENK--LYLVFEFLHQD-LKKFMDASALTGIPLPLIK--SYLFQLLQGLAFC 118
Query: 529 HSSEVNKPAIVHRNLSVEKVLIDQQFNPLIADCGLHKLLADDIVFSVLKTSAAMGYLAPE 588
           HS  V     +HR+L  + +LI+ +    +AD GL +      V +       + Y APE
Sbjct: 119 HSHRV-----LHRDLKPQNLLINTEGAIKLADFGLARAFGVP-VRTYTHEVVTLWYRAPE 172
Query: 589 YVTTGRFTERS-DIFAFGVIILQILT 613
            +   ++   + DI++ G I  +++T
Sbjct: 173 ILLGCKYYSTAVDIWSLGCIFAEMVT 198

>pdb|1PF8|A Chain A, Crystal Structure Of Human Cyclin-dependent Kinase 2 Complexed With A Nucleoside Inhibitor Length = 298

Iteration: 1
 Score = 53.5 bits (127), Expect = 4e-07,   Method: Compositional matrix adjust.
 Identities = 49/206 (23%), Positives = 99/206 (48%), Gaps = 14/206 (6%)
Query: 411 FSEVNLLGKGNFSSVYKGTLR-DGTLVAIRSINV-TSCKSEEAEFVKGLYLLTSLRHENI 468
           F +V  +G+G +  VYK   +  G +VA++ I + T  +   +  ++ + LL  L H NI
Sbjct: 4   FQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNI 63
Query: 469 IRLRGFCCSRGRGECFLIYDFAPKGKLSKYLDQEEGSSNVLDWSTRVSIIIGIAKGIGYL 528
           ++L     +  +   +L+++F  +  L K++D    +   L      S +  + +G+ + 
Sbjct: 64  VKLLDVIHTENK--LYLVFEFLHQD-LKKFMDASALTGIPLPLIK--SYLFQLLQGLAFC 118
Query: 529 HSSEVNKPAIVHRNLSVEKVLIDQQFNPLIADCGLHKLLADDIVFSVLKTSAAMGYLAPE 588
           HS  V     +HR+L  + +LI+ +    +AD GL +      V +       + Y APE
Sbjct: 119 HSHRV-----LHRDLKPQNLLINTEGAIKLADFGLARAFGVP-VRTYTHEVVTLWYRAPE 172
Query: 589 YVTTGRFTERS-DIFAFGVIILQILT 613
            +   ++   + DI++ G I  +++T
Sbjct: 173 ILLGCKYYSTAVDIWSLGCIFAEMVT 198

>pdb|2JGZ|A Chain A, Crystal Structure Of Phospho-Cdk2 In Complex With Cyclin B Length = 289

Iteration: 1
 Score = 53.5 bits (127), Expect = 4e-07,   Method: Compositional matrix adjust.
 Identities = 49/210 (23%), Positives = 101/210 (48%), Gaps = 14/210 (6%)
Query: 407 ATQCFSEVNLLGKGNFSSVYKGTLR-DGTLVAIRSINV-TSCKSEEAEFVKGLYLLTSLR 464
           + + F +V  +G+G +  VYK   +  G +VA++ I + T  +   +  ++ + LL  L 
Sbjct: 1   SMENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELN 60
Query: 465 HENIIRLRGFCCSRGRGECFLIYDFAPKGKLSKYLDQEEGSSNVLDWSTRVSIIIGIAKG 524
           H NI++L     +  +   +L+++F  +  L K++D    +   L      S +  + +G
Sbjct: 61  HPNIVKLLDVIHTENK--LYLVFEFLHQD-LKKFMDASALTGIPLPLIK--SYLFQLLQG 115
Query: 525 IGYLHSSEVNKPAIVHRNLSVEKVLIDQQFNPLIADCGLHKLLADDIVFSVLKTSAAMGY 584
           + + HS  V     +HR+L  + +LI+ +    +AD GL +      V +       + Y
Sbjct: 116 LAFCHSHRV-----LHRDLKPQNLLINTEGAIKLADFGLARAFGVP-VRTYXHEVVTLWY 169
Query: 585 LAPEYVTTGRFTERS-DIFAFGVIILQILT 613
            APE +   ++   + DI++ G I  +++T
Sbjct: 170 RAPEILLGCKYYSTAVDIWSLGCIFAEMVT 199

>pdb|1H4L|A Chain A, Structure And Regulation Of The Cdk5-P25(Nck5a) Complex Length = 292

Iteration: 1
 Score = 53.5 bits (127), Expect = 4e-07,   Method: Compositional matrix adjust.
 Identities = 42/159 (26%), Positives = 81/159 (50%), Gaps = 13/159 (8%)
Query: 409 QCFSEVNLLGKGNFSSVYKGTLRD-GTLVAIRSINVTSC-KSEEAEFVKGLYLLTSLRHE 466
           Q + ++  +G+G + +V+K   R+   +VA++ + +    +   +  ++ + LL  L+H+
Sbjct: 2   QKYEKLEKIGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHK 61
Query: 467 NIIRLRGFCCSRGRGECFLIYDFAPKGKLSKYLDQEEGSSNVLDWSTRVSIIIGIAKGIG 526
           NI+RL     S  +    L+++F  +  L KY D   G    LD     S +  + KG+G
Sbjct: 62  NIVRLHDVLHSDKK--LTLVFEFCDQD-LKKYFDSCNGD---LDPEIVKSFLFQLLKGLG 115
Query: 527 YLHSSEVNKPAIVHRNLSVEKVLIDQQFNPLIADCGLHK 565
           + HS  V     +HR+L  + +LI++     +AD GL +
Sbjct: 116 FCHSRNV-----LHRDLKPQNLLINRNGELKLADFGLAR 149

>pdb|1OIT|A Chain A, Imidazopyridines: A Potent And Selective Class Of Cyclin-dependent Kinase Inhibitors Identified Through Structure-based Hybridisation Length = 299

Iteration: 1
 Score = 53.1 bits (126), Expect = 4e-07,   Method: Compositional matrix adjust.
 Identities = 49/206 (23%), Positives = 99/206 (48%), Gaps = 14/206 (6%)
Query: 411 FSEVNLLGKGNFSSVYKGTLR-DGTLVAIRSINV-TSCKSEEAEFVKGLYLLTSLRHENI 468
           F +V  +G+G +  VYK   +  G +VA++ I + T  +   +  ++ + LL  L H NI
Sbjct: 5   FQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNI 64
Query: 469 IRLRGFCCSRGRGECFLIYDFAPKGKLSKYLDQEEGSSNVLDWSTRVSIIIGIAKGIGYL 528
           ++L     +  +   +L+++F  +  L K++D    +   L      S +  + +G+ + 
Sbjct: 65  VKLLDVIHTENK--LYLVFEFLHQD-LKKFMDASALTGIPLPLIK--SYLFQLLQGLSFC 119
Query: 529 HSSEVNKPAIVHRNLSVEKVLIDQQFNPLIADCGLHKLLADDIVFSVLKTSAAMGYLAPE 588
           HS  V     +HR+L  + +LI+ +    +AD GL +      V +       + Y APE
Sbjct: 120 HSHRV-----LHRDLKPQNLLINTEGAIKLADFGLARAFGVP-VRTYTHEVVTLWYRAPE 173
Query: 589 YVTTGRFTERS-DIFAFGVIILQILT 613
            +   ++   + DI++ G I  +++T
Sbjct: 174 ILLGCKYYSTAVDIWSLGCIFAEMVT 199

>pdb|3L9P|A Chain A, Crystal Structure Of The Anaplastic Lymphoma Kinase Catalytic Domain Length = 367

Iteration: 1
 Score = 53.1 bits (126), Expect = 5e-07,   Method: Compositional matrix adjust.
 Identities = 58/277 (20%), Positives = 114/277 (41%), Gaps = 32/277 (11%)
Query: 417 LGKGNFSSVYKGTLR------DGTLVAIRSINVTSCKSEEAEFVKGLYLLTSLRHENIIR 470
           LG G F  VY+G +           VA++++     + +E +F+    +++   H+NI+R
Sbjct: 79  LGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISKFNHQNIVR 138
Query: 471 LRGFCCSRGRGECFLIYDFAPKGKLSKYLDQ------EEGSSNVLDWSTRVSIIIGIAKG 524
             G   S      F++ +    G L  +L +      +  S  +LD    + +   IA G
Sbjct: 139 CIGV--SLQSLPRFILLELMAGGDLKSFLRETRPRPSQPSSLAMLDL---LHVARDIACG 193
Query: 525 IGYLHSSEVNKPAIVHRNLSVEKVLIDQQFNPLIADCGLHKLLADDIVFS--VLKTSAAM 582
             YL  +       +HR+++    L+       +A  G   + A DI  +    K   AM
Sbjct: 194 CQYLEENH-----FIHRDIAARNCLLTCPGPGRVAKIGDFGM-ARDIYRAGYYRKGGCAM 247
Query: 583 ---GYLAPEYVTTGRFTERSDIFAFGVIILQILTGSLVLTSSMRLAAESATFENFIDRNL 639
               ++ PE    G FT ++D ++FGV++ +I +   +   S      +     F+    
Sbjct: 248 LPVKWMPPEAFMEGIFTSKTDTWSFGVLLWEIFSLGYMPYPS----KSNQEVLEFVTSGG 303
Query: 640 KGKFSESEAAKLGKMALVCTHEDPENRPTMEAVIEEL 676
           +    ++    + ++   C    PE+RP    ++E +
Sbjct: 304 RMDPPKNCPGPVYRIMTQCWQHQPEDRPNFAIILERI 340

>pdb|3LCT|A Chain A, Crystal Structure Of The Anaplastic Lymphoma Kinase Catalytic Domain Length = 344

Iteration: 1
 Score = 53.1 bits (126), Expect = 5e-07,   Method: Compositional matrix adjust.
 Identities = 58/277 (20%), Positives = 114/277 (41%), Gaps = 32/277 (11%)
Query: 417 LGKGNFSSVYKGTLR------DGTLVAIRSINVTSCKSEEAEFVKGLYLLTSLRHENIIR 470
           LG G F  VY+G +           VA++++     + +E +F+    +++   H+NI+R
Sbjct: 56  LGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISKFNHQNIVR 115
Query: 471 LRGFCCSRGRGECFLIYDFAPKGKLSKYLDQ------EEGSSNVLDWSTRVSIIIGIAKG 524
             G   S      F++ +    G L  +L +      +  S  +LD    + +   IA G
Sbjct: 116 CIGV--SLQSLPRFILLELMAGGDLKSFLRETRPRPSQPSSLAMLDL---LHVARDIACG 170
Query: 525 IGYLHSSEVNKPAIVHRNLSVEKVLIDQQFNPLIADCGLHKLLADDIVFS--VLKTSAAM 582
             YL  +       +HR+++    L+       +A  G   + A DI  +    K   AM
Sbjct: 171 CQYLEENH-----FIHRDIAARNCLLTCPGPGRVAKIGDFGM-ARDIYRAGYYRKGGCAM 224
Query: 583 ---GYLAPEYVTTGRFTERSDIFAFGVIILQILTGSLVLTSSMRLAAESATFENFIDRNL 639
               ++ PE    G FT ++D ++FGV++ +I +   +   S      +     F+    
Sbjct: 225 LPVKWMPPEAFMEGIFTSKTDTWSFGVLLWEIFSLGYMPYPS----KSNQEVLEFVTSGG 280
Query: 640 KGKFSESEAAKLGKMALVCTHEDPENRPTMEAVIEEL 676
           +    ++    + ++   C    PE+RP    ++E +
Sbjct: 281 RMDPPKNCPGPVYRIMTQCWQHQPEDRPNFAIILERI 317

>pdb|4FOB|A Chain A, Crystal Structure Of Human Anaplastic Lymphoma Kinase In Complex With Acyliminobenzimidazole Inhibitor 1 Length = 353

Iteration: 1
 Score = 53.1 bits (126), Expect = 5e-07,   Method: Compositional matrix adjust.
 Identities = 54/276 (19%), Positives = 111/276 (40%), Gaps = 30/276 (10%)
Query: 417 LGKGNFSSVYKGTLR------DGTLVAIRSINVTSCKSEEAEFVKGLYLLTSLRHENIIR 470
           LG G F  VY+G +           VA++++     + +E +F+    +++   H+NI+R
Sbjct: 65  LGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISKFNHQNIVR 124
Query: 471 LRGFCCSRGRGECFLIYDFAPKGKLSKYLDQ------EEGSSNVLDWSTRVSIIIGIAKG 524
             G   S      F++ +    G L  +L +      +  S  +LD    + +   IA G
Sbjct: 125 CIGV--SLQSLPRFILLELMAGGDLKSFLRETRPRPSQPSSLAMLDL---LHVARDIACG 179
Query: 525 IGYLHSSEVNKPAIVHRNLSVEKVLIDQQFNPLIADCGLHKLLADDIVFSVLKTSA---- 580
             YL  +       +HR+++    L+       +A  G   +  D    S  +       
Sbjct: 180 CQYLEENH-----FIHRDIAARNCLLTCPGPGRVAKIGDFGMARDIYRASYYRKGGCAML 234
Query: 581 AMGYLAPEYVTTGRFTERSDIFAFGVIILQILTGSLVLTSSMRLAAESATFENFIDRNLK 640
            + ++ PE    G FT ++D ++FGV++ +I +   +   S      +     F+    +
Sbjct: 235 PVKWMPPEAFMEGIFTSKTDTWSFGVLLWEIFSLGYMPYPS----KSNQEVLEFVTSGGR 290
Query: 641 GKFSESEAAKLGKMALVCTHEDPENRPTMEAVIEEL 676
               ++    + ++   C    PE+RP    ++E +
Sbjct: 291 MDPPKNCPGPVYRIMTQCWQHQPEDRPNFAIILERI 326

>pdb|1ZXE|A Chain A, Crystal Structure Of Eif2alpha Protein Kinase Gcn2: D835n Inactivating Mutant In Apo Form Length = 303

Iteration: 1
 Score = 53.1 bits (126), Expect = 5e-07,   Method: Compositional matrix adjust.
 Identities = 69/287 (24%), Positives = 116/287 (40%), Gaps = 48/287 (16%)
Query: 411 FSEVNLLGKGNFSSVYKG-TLRDGTLVAIRSINVTSCKSEEAEFVKGLYLLTSLRHENII 469
           F E+ +LG+G F  V K     D    AI+ I  T  K   +  +  + LL SL H+ ++
Sbjct: 8   FEEIAVLGQGAFGQVVKARNALDSRYYAIKKIRHTEEKL--STILSEVXLLASLNHQYVV 65
Query: 470 RL-------RGFC----CSRGRGECFLIYDFAPKGKLSKYLDQEEGSSNVLDWSTRVSII 518
           R        R F       + +   F+  ++     L   +  E  +    ++     + 
Sbjct: 66  RYYAAWLERRNFVKPXTAVKKKSTLFIQXEYCENRTLYDLIHSENLNQQRDEY---WRLF 122
Query: 519 IGIAKGIGYLHSSEVNKPAIVHRNLSVEKVLIDQQFNPLIADCGLH----------KLLA 568
             I + + Y+HS       I+HRNL    + ID+  N  I D GL           KL +
Sbjct: 123 RQILEALSYIHSQ-----GIIHRNLKPXNIFIDESRNVKIGDFGLAKNVHRSLDILKLDS 177
Query: 569 DDIVFSVLKTSAAMG---YLAPEYVT-TGRFTERSDIFAFGVIILQIL----TGSLVLTS 620
            ++  S    ++A+G   Y+A E +  TG + E+ D ++ G+I  + +    TG   +  
Sbjct: 178 QNLPGSSDNLTSAIGTAXYVATEVLDGTGHYNEKIDXYSLGIIFFEXIYPFSTGXERVNI 237
Query: 621 SMRLAAESATFENFIDRNLKGKFSESEAAKLGKMALVCTHEDPENRP 667
             +L + S  F    D N K K  +       K+  +    DP  RP
Sbjct: 238 LKKLRSVSIEFPPDFDDN-KXKVEK-------KIIRLLIDHDPNKRP 276

>pdb|3NUP|A Chain A, Cdk6 (Monomeric) In Complex With Inhibitor Length = 307

Iteration: 1
 Score = 53.1 bits (126), Expect = 5e-07,   Method: Compositional matrix adjust.
 Identities = 57/220 (25%), Positives = 96/220 (43%), Gaps = 29/220 (13%)
Query: 407 ATQCFSEVNLLGKGNFSSVYKGTLRD----GTLVAIRSINVTSCKS----EEAEFVKGLY 458
           A Q +  V  +G+G +  V+K   RD    G  VA++ + V + +          V  L 
Sbjct: 9   ADQQYECVAEIGEGAYGKVFKA--RDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLR 66
Query: 459 LLTSLRHENIIRLRGFC-CSRGRGECFLIYDFAPKGK-LSKYLDQ--EEGSSNVLDWSTR 514
            L +  H N++RL   C  SR   E  L   F    + L+ YLD+  E G        T 
Sbjct: 67  HLETFEHPNVVRLFDVCTVSRTDRETKLTLVFEHVDQDLTTYLDKVPEPGVPT----ETI 122
Query: 515 VSIIIGIAKGIGYLHSSEVNKPAIVHRNLSVEKVLIDQQFNPLIADCGLHKLLADDIVFS 574
             ++  + +G+ +LHS  V     VHR+L  + +L+       +AD GL ++ +    F 
Sbjct: 123 KDMMFQLLRGLDFLHSHRV-----VHRDLKPQNILVTSSGQIKLADFGLARIYS----FQ 173
Query: 575 VLKTSAA--MGYLAPEYVTTGRFTERSDIFAFGVIILQIL 612
           +  TS    + Y APE +    +    D+++ G I  ++ 
Sbjct: 174 MALTSVVVTLWYRAPEVLLQSSYATPVDLWSVGCIFAEMF 213

>pdb|1JOW|B Chain B, Crystal Structure Of A Complex Of Human Cdk6 And A Viral Cyclin Length = 308

Iteration: 1
 Score = 53.1 bits (126), Expect = 5e-07,   Method: Compositional matrix adjust.
 Identities = 57/220 (25%), Positives = 96/220 (43%), Gaps = 29/220 (13%)
Query: 407 ATQCFSEVNLLGKGNFSSVYKGTLRD----GTLVAIRSINVTSCKS----EEAEFVKGLY 458
           A Q +  V  +G+G +  V+K   RD    G  VA++ + V + +          V  L 
Sbjct: 9   ADQQYECVAEIGEGAYGKVFKA--RDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLR 66
Query: 459 LLTSLRHENIIRLRGFC-CSRGRGECFLIYDFAPKGK-LSKYLDQ--EEGSSNVLDWSTR 514
            L +  H N++RL   C  SR   E  L   F    + L+ YLD+  E G        T 
Sbjct: 67  HLETFEHPNVVRLFDVCTVSRTDRETKLTLVFEHVDQDLTTYLDKVPEPGVPT----ETI 122
Query: 515 VSIIIGIAKGIGYLHSSEVNKPAIVHRNLSVEKVLIDQQFNPLIADCGLHKLLADDIVFS 574
             ++  + +G+ +LHS  V     VHR+L  + +L+       +AD GL ++ +    F 
Sbjct: 123 KDMMFQLLRGLDFLHSHRV-----VHRDLKPQNILVTSSGQIKLADFGLARIYS----FQ 173
Query: 575 VLKTSAA--MGYLAPEYVTTGRFTERSDIFAFGVIILQIL 612
           +  TS    + Y APE +    +    D+++ G I  ++ 
Sbjct: 174 MALTSVVVTLWYRAPEVLLQSSYATPVDLWSVGCIFAEMF 213

>pdb|2JAM|A Chain A, Crystal Structure Of Human Calmodulin-Dependent Protein Kinase I G Length = 304

Iteration: 1
 Score = 52.8 bits (125), Expect = 6e-07,   Method: Compositional matrix adjust.
 Identities = 72/277 (25%), Positives = 117/277 (42%), Gaps = 37/277 (13%)
Query: 409 QCFSEVNLLGKGNFSSVYKGTLR-DGTLVAIRSINVTSCKSEEAEFVKGLYLLTSLRHEN 467
           + F  + +LG G FS V+    R  G L A++ I   S    ++     + +L  ++HEN
Sbjct: 9   KTFIFMEVLGSGAFSEVFLVKQRLTGKLFALKCIK-KSPAFRDSSLENEIAVLKKIKHEN 67
Query: 468 IIRLRGFCCSRGRGECFLIYDFAPKGKLSKYLDQ--EEGSSNVLDWSTRVSIIIGIAKGI 525
           I+ L     S      +L+      G+L    D+  E G     D S    +I  +   +
Sbjct: 68  IVTLEDIYESTTH--YYLVMQLVSGGEL---FDRILERGVYTEKDASL---VIQQVLSAV 119
Query: 526 GYLHSSEVNKPAIVHRNLSVEKVLI---DQQFNPLIADCGLHKLLADDIVFSVLKTSAAM 582
            YLH +      IVHR+L  E +L    ++    +I D GL K+  + I+ +   T    
Sbjct: 120 KYLHEN-----GIVHRDLKPENLLYLTPEENSKIMITDFGLSKMEQNGIMSTACGTP--- 171
Query: 583 GYLAPEYVTTGRFTERSDIFAFGVIILQILTGSLVLTSSMRLAAESATFENFID--RNLK 640
           GY+APE +    +++  D ++ GVI   +L G            ES  FE   +     +
Sbjct: 172 GYVAPEVLAQKPYSKAVDCWSIGVITYILLCG----YPPFYEETESKLFEKIKEGYYEFE 227
Query: 641 GKFSE--SEAAKLGKMALVCT--HEDPENRPTMEAVI 673
             F +  SE+AK      +C    +DP  R T E  +
Sbjct: 228 SPFWDDISESAK----DFICHLLEKDPNERYTCEKAL 260

>pdb|4EOI|A Chain A, Thr 160 Phosphorylated Cdk2 K89d, Q131e - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 299

Iteration: 1
 Score = 52.8 bits (125), Expect = 6e-07,   Method: Compositional matrix adjust.
 Identities = 49/210 (23%), Positives = 100/210 (47%), Gaps = 14/210 (6%)
Query: 407 ATQCFSEVNLLGKGNFSSVYKGTLR-DGTLVAIRSINV-TSCKSEEAEFVKGLYLLTSLR 464
           + + F +V  +G+G +  VYK   +  G +VA++ I + T  +   +  ++ + LL  L 
Sbjct: 1   SMENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELN 60
Query: 465 HENIIRLRGFCCSRGRGECFLIYDFAPKGKLSKYLDQEEGSSNVLDWSTRVSIIIGIAKG 524
           H NI++L     +  +   +L+++F  +  L  ++D    +   L      S +  + +G
Sbjct: 61  HPNIVKLLDVIHTENK--LYLVFEFLHQD-LKDFMDASALTGIPLPLIK--SYLFQLLQG 115
Query: 525 IGYLHSSEVNKPAIVHRNLSVEKVLIDQQFNPLIADCGLHKLLADDIVFSVLKTSAAMGY 584
           + + HS  V     +HR+L  E +LI+ +    +AD GL +      V +       + Y
Sbjct: 116 LAFCHSHRV-----LHRDLKPENLLINTEGAIKLADFGLARAFGVP-VRTYXHEVVTLWY 169
Query: 585 LAPEYVTTGRFTERS-DIFAFGVIILQILT 613
            APE +   ++   + DI++ G I  +++T
Sbjct: 170 RAPEILLGCKYYSTAVDIWSLGCIFAEMVT 199

>pdb|3I7C|A Chain A, Calcium-Dependent Protein Kinase 1 From Toxoplasma Gondii (Tgcdpk1) In Complex With Bumped Kinase Inhibitor Na-Pp2 Length = 484

Iteration: 1
 Score = 52.8 bits (125), Expect = 6e-07,   Method: Compositional matrix adjust.
 Identities = 63/225 (28%), Positives = 103/225 (45%), Gaps = 32/225 (14%)
Query: 404 VESATQCFSE----VNLLGKGNFSSVY--KGTLRDGTLVAIRSINVTSCK--SEEAEFVK 455
           V+ +T  FS+      +LGKG+F  V   K  +  G   A++ I+    K  +++   ++
Sbjct: 17  VQHSTAIFSDRYKGQRVLGKGSFGEVILCKDKIT-GQECAVKVISKRQVKQKTDKESLLR 75
Query: 456 GLYLLTSLRHENIIRLRGFCCSRGRGECFLIYDFAPKGKLSKYLDQEEGSSNVLDWSTRV 515
            + LL  L H NI +L  F     +G  +L+ +    G+L   +   +  S V       
Sbjct: 76  EVQLLKQLDHPNIXKLYEFF--EDKGYFYLVGEVYTGGELFDEIISRKRFSEV----DAA 129
Query: 516 SIIIGIAKGIGYLHSSEVNKPAIVHRNLSVEKVLID---QQFNPLIADCGLHKLLADDIV 572
            II  +  GI Y H     K  IVHR+L  E +L++   +  N  I D GL         
Sbjct: 130 RIIRQVLSGITYXH-----KNKIVHRDLKPENLLLESKSKDANIRIIDFGLSTHFE---- 180
Query: 573 FSVLKTSAAMG---YLAPEYVTTGRFTERSDIFAFGVIILQILTG 614
            +  K    +G   Y+APE V  G + E+ D+++ GVI+  +L+G
Sbjct: 181 -ASKKXKDKIGTAYYIAPE-VLHGTYDEKCDVWSTGVILYILLSG 223

>pdb|2ZOQ|A Chain A, Structural Dissection Of Human Mitogen-Activated Kinase Erk1 Length = 382

Iteration: 1
 Score = 52.8 bits (125), Expect = 7e-07,   Method: Compositional matrix adjust.
 Identities = 51/218 (23%), Positives = 106/218 (48%), Gaps = 24/218 (11%)
Query: 411 FSEVNLLGKGNF---SSVYKGTLRDGTLVAIRSINVTSCKSEEAEFVKGLYLLTSLRHEN 467
           ++++  +G+G +   SS Y    +  T VAI+ I+    ++     ++ + +L   RHEN
Sbjct: 45  YTQLQYIGEGAYGMVSSAYDHVRK--TRVAIKKISPFEHQTYCQRTLREIQILLRFRHEN 102
Query: 468 IIRLRGFCCS---RGRGECFLIYDFAPKGKLSKYLDQEEGSSNVLDWSTRVSIIIGIAKG 524
           +I +R    +       + +++ D   +  L K L  ++ S++ + +      +  I +G
Sbjct: 103 VIGIRDILRASTLEAMRDVYIVQDLM-ETDLYKLLKSQQLSNDHICY-----FLYQILRG 156
Query: 525 IGYLHSSEVNKPAIVHRNLSVEKVLIDQQFNPLIADCGLHKLLAD---DIVFSVLKTSAA 581
           + Y+HS+ V     +HR+L    +LI+   +  I D GL + +AD   D    + +  A 
Sbjct: 157 LKYIHSANV-----LHRDLKPSNLLINTTCDLKICDFGLAR-IADPEHDHTGFLTEXVAT 210
Query: 582 MGYLAPEYVTTGR-FTERSDIFAFGVIILQILTGSLVL 618
             Y APE +   + +T+  DI++ G I+ ++L+   + 
Sbjct: 211 RWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNRPIF 248

>pdb|1ZYC|A Chain A, Crystal Structure Of Eif2alpha Protein Kinase Gcn2: Wild- Type In Apo Form. Length = 303

Iteration: 1
 Score = 52.8 bits (125), Expect = 7e-07,   Method: Compositional matrix adjust.
 Identities = 67/288 (23%), Positives = 119/288 (41%), Gaps = 50/288 (17%)
Query: 411 FSEVNLLGKGNFSSVYKG-TLRDGTLVAIRSINVTSCKSEEAEFVKGLYLLTSLRHENII 469
           F E+ +LG+G F  V K     D    AI+ I  T  K   +  +  + LL SL H+ ++
Sbjct: 8   FEEIAVLGQGAFGQVVKARNALDSRYYAIKKIRHTEEKL--STILSEVMLLASLNHQYVV 65
Query: 470 RL-------RGFC----CSRGRGECFLIYDFAPKGKLSKYLDQEEGSSNVLDWSTRVSII 518
           R        R F       + +   F+  ++     L   +  E  +    ++     + 
Sbjct: 66  RYYAAWLERRNFVKPMTAVKKKSTLFIQMEYCENRTLYDLIHSENLNQQRDEYW---RLF 122
Query: 519 IGIAKGIGYLHSSEVNKPAIVHRNLSVEKVLIDQQFNPLIADCGLH----------KLLA 568
             I + + Y+HS       I+HR+L    + ID+  N  I D GL           KL +
Sbjct: 123 RQILEALSYIHSQ-----GIIHRDLKPMNIFIDESRNVKIGDFGLAKNVHRSLDILKLDS 177
Query: 569 DDIVFSVLKTSAAMG---YLAPEYVT-TGRFTERSDIFAFGVIILQIL----TGSLVLTS 620
            ++  S    ++A+G   Y+A E +  TG + E+ D+++ G+I  +++    TG   +  
Sbjct: 178 QNLPGSSDNLTSAIGTAMYVATEVLDGTGHYNEKIDMYSLGIIFFEMIYPFSTGMERVNI 237
Query: 621 SMRLAAESATF-ENFIDRNLKGKFSESEAAKLGKMALVCTHEDPENRP 667
             +L + S  F  +F D  +K +          K+  +    DP  RP
Sbjct: 238 LKKLRSVSIEFPPDFDDNKMKVE---------KKIIRLLIDHDPNKRP 276

>pdb|2HAK|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark1PAR-1 Length = 328

Iteration: 1
 Score = 52.4 bits (124), Expect = 9e-07,   Method: Compositional matrix adjust.
 Identities = 57/231 (24%), Positives = 99/231 (42%), Gaps = 26/231 (11%)
Query: 417 LGKGNFSSVYKGT-LRDGTLVAIRSINVTSCKSEE-AEFVKGLYLLTSLRHENIIRLRGF 474
           +GKGNF+ V     +  G  VA++ I+ T        +  + + ++  L H NI++L  F
Sbjct: 23  IGKGNFAKVKLARHVLTGREVAVKIIDKTQLNPTSLQKLFREVRIMKILNHPNIVKL--F 80
Query: 475 CCSRGRGECFLIYDFAPKGKLSKYLDQEEGSSNVLDWSTRVSIIIGIAKGIGYLHSSEVN 534
                    +L+ ++A  G++  YL    G     +   +   I+     + Y H     
Sbjct: 81  EVIETEKTLYLVMEYASGGEVFDYL-VAHGRMKEKEARAKFRQIVS---AVQYCHQK--- 133
Query: 535 KPAIVHRNLSVEKVLIDQQFNPLIADCGLHKLLADDIVFSVLKT-SAAMGYLAPEYVTTG 593
              IVHR+L  E +L+D   N  IAD G         V + L T   +  Y APE     
Sbjct: 134 --YIVHRDLKAENLLLDGDMNIKIADFGFSNEFT---VGNKLDTFCGSPPYAAPELFQGK 188
Query: 594 RFT-ERSDIFAFGVIILQILTGSLVLTSSMRLAAESATFENFIDRNLKGKF 643
           ++     D+++ GVI+  +++GSL          +    +   +R L+GK+
Sbjct: 189 KYDGPEVDVWSLGVILYTLVSGSLPF--------DGQNLKELRERVLRGKY 231

>pdb|1OIR|A Chain A, Imidazopyridines: A Potent And Selective Class Of Cyclin-Dependent Kinase Inhibitors Identified Through Structure-Based Hybridisation Length = 299

Iteration: 1
 Score = 52.0 bits (123), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 49/206 (23%), Positives = 98/206 (47%), Gaps = 14/206 (6%)
Query: 411 FSEVNLLGKGNFSSVYKGTLR-DGTLVAIRSINV-TSCKSEEAEFVKGLYLLTSLRHENI 468
           F +V  +G+G +  VYK   +  G +VA+  I + T  +   +  ++ + LL  L H NI
Sbjct: 5   FQKVEKIGEGTYGVVYKARNKLTGEVVALXKIRLDTETEGVPSTAIREISLLKELNHPNI 64
Query: 469 IRLRGFCCSRGRGECFLIYDFAPKGKLSKYLDQEEGSSNVLDWSTRVSIIIGIAKGIGYL 528
           ++L     +  +   +L+++F  +  L K++D    +   L      S +  + +G+ + 
Sbjct: 65  VKLLDVIHTENK--LYLVFEFLHQD-LKKFMDASALTGIPLPLIK--SYLFQLLQGLAFC 119
Query: 529 HSSEVNKPAIVHRNLSVEKVLIDQQFNPLIADCGLHKLLADDIVFSVLKTSAAMGYLAPE 588
           HS  V     +HR+L  + +LI+ +    +AD GL +      V +       + Y APE
Sbjct: 120 HSHRV-----LHRDLKPQNLLINTEGAIKLADFGLARAFGVP-VRTYTHEVVTLWYRAPE 173
Query: 589 YVTTGRFTERS-DIFAFGVIILQILT 613
            +   ++   + DI++ G I  +++T
Sbjct: 174 ILLGCKYYSTAVDIWSLGCIFAEMVT 199

>pdb|1H01|A Chain A, Cdk2 In Complex With A Disubstituted 2, 4-Bis Anilino Pyrimidine Cdk4 Inhibitor Length = 298

Iteration: 1
 Score = 52.0 bits (123), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 49/206 (23%), Positives = 98/206 (47%), Gaps = 14/206 (6%)
Query: 411 FSEVNLLGKGNFSSVYKGTLR-DGTLVAIRSINV-TSCKSEEAEFVKGLYLLTSLRHENI 468
           F +V  +G+G +  VYK   +  G +VA+  I + T  +   +  ++ + LL  L H NI
Sbjct: 4   FQKVEKIGEGTYGVVYKARNKLTGEVVALXKIRLDTETEGVPSTAIREISLLKELNHPNI 63
Query: 469 IRLRGFCCSRGRGECFLIYDFAPKGKLSKYLDQEEGSSNVLDWSTRVSIIIGIAKGIGYL 528
           ++L     +  +   +L+++F  +  L K++D    +   L      S +  + +G+ + 
Sbjct: 64  VKLLDVIHTENK--LYLVFEFLHQD-LKKFMDASALTGIPLPLIK--SYLFQLLQGLAFC 118
Query: 529 HSSEVNKPAIVHRNLSVEKVLIDQQFNPLIADCGLHKLLADDIVFSVLKTSAAMGYLAPE 588
           HS  V     +HR+L  + +LI+ +    +AD GL +      V +       + Y APE
Sbjct: 119 HSHRV-----LHRDLKPQNLLINTEGAIKLADFGLARAFGVP-VRTYTHEVVTLWYRAPE 172
Query: 589 YVTTGRFTERS-DIFAFGVIILQILT 613
            +   ++   + DI++ G I  +++T
Sbjct: 173 ILLGCKYYSTAVDIWSLGCIFAEMVT 198

>pdb|2IW8|A Chain A, Structure Of Human Thr160-Phospho Cdk2-Cyclin A F82h-L83v- H84d Mutant With An O6-Cyclohexylmethylguanine Inhibitor Length = 302

Iteration: 1
 Score = 52.0 bits (123), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 48/210 (22%), Positives = 100/210 (47%), Gaps = 14/210 (6%)
Query: 407 ATQCFSEVNLLGKGNFSSVYKGTLR-DGTLVAIRSINV-TSCKSEEAEFVKGLYLLTSLR 464
           + + F +V  +G+G +  VYK   +  G +VA++ I + T  +   +  ++ + LL  L 
Sbjct: 4   SMENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELN 63
Query: 465 HENIIRLRGFCCSRGRGECFLIYDFAPKGKLSKYLDQEEGSSNVLDWSTRVSIIIGIAKG 524
           H NI++L     +  +   +L+++   +  L K++D    +   L      S +  + +G
Sbjct: 64  HPNIVKLLDVIHTENK--LYLVFEHVDQD-LKKFMDASALTGIPLPLIK--SYLFQLLQG 118
Query: 525 IGYLHSSEVNKPAIVHRNLSVEKVLIDQQFNPLIADCGLHKLLADDIVFSVLKTSAAMGY 584
           + + HS  V     +HR+L  + +LI+ +    +AD GL +      V +       + Y
Sbjct: 119 LAFCHSHRV-----LHRDLKPQNLLINTEGAIKLADFGLARAFGVP-VRTYXHEVVTLWY 172
Query: 585 LAPEYVTTGRFTERS-DIFAFGVIILQILT 613
            APE +   ++   + DI++ G I  +++T
Sbjct: 173 RAPEILLGCKYYSTAVDIWSLGCIFAEMVT 202

>pdb|2IW6|A Chain A, Structure Of Human Thr160-Phospho Cdk2-Cyclin A Complexed With A Bisanilinopyrimidine Inhibitor Length = 302

Iteration: 1
 Score = 52.0 bits (123), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 48/210 (22%), Positives = 100/210 (47%), Gaps = 14/210 (6%)
Query: 407 ATQCFSEVNLLGKGNFSSVYKGTLR-DGTLVAIRSINV-TSCKSEEAEFVKGLYLLTSLR 464
           + + F +V  +G+G +  VYK   +  G +VA++ I + T  +   +  ++ + LL  L 
Sbjct: 4   SMENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELN 63
Query: 465 HENIIRLRGFCCSRGRGECFLIYDFAPKGKLSKYLDQEEGSSNVLDWSTRVSIIIGIAKG 524
           H NI++L     +  +   +L+++F  +  L  ++D    +   L      S +  + +G
Sbjct: 64  HPNIVKLLDVIHTENK--LYLVFEFLHQD-LKTFMDASALTGIPLPLIK--SYLFQLLQG 118
Query: 525 IGYLHSSEVNKPAIVHRNLSVEKVLIDQQFNPLIADCGLHKLLADDIVFSVLKTSAAMGY 584
           + + HS  V     +HR+L  + +LI+ +    +AD GL +      V +       + Y
Sbjct: 119 LAFCHSHRV-----LHRDLKPQNLLINTEGAIKLADFGLARAFGVP-VRTYXHEVVTLWY 172
Query: 585 LAPEYVTTGRFTERS-DIFAFGVIILQILT 613
            APE +   ++   + DI++ G I  +++T
Sbjct: 173 RAPEILLGCKYYSTAVDIWSLGCIFAEMVT 202

>pdb|2BDW|A Chain A, Crystal Structure Of The Auto-Inhibited Kinase Domain Of CalciumCALMODULIN ACTIVATED KINASE II Length = 362

Iteration: 1
 Score = 51.6 bits (122), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 55/203 (27%), Positives = 90/203 (44%), Gaps = 18/203 (8%)
Query: 417 LGKGNFSSVYKGTLRD-GTLVAIRSINVTSCKSEE-AEFVKGLYLLTSLRHENIIRLRGF 474
           LGKG FS V +   +  G   A + IN     + +  +  +   +   L+H NI+RL   
Sbjct: 37  LGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQKLEREARICRKLQHPNIVRLHDS 96
Query: 475 CCSRGRGECFLIYDFAPKGKLSKYLDQEEGSSNVLDWSTRVSIIIGIAKGIGYLHSSEVN 534
              +     +L++D    G+L + +   E  S     +     I  I + I Y HS+   
Sbjct: 97  I--QEESFHYLVFDLVTGGELFEDIVAREFYSE----ADASHCIQQILESIAYCHSN--- 147
Query: 535 KPAIVHRNLSVEKVLIDQQFNPL---IADCGLHKLLADDIVFSVLKTSAAMGYLAPEYVT 591
              IVHRNL  E +L+  +       +AD GL   + D   +     +   GYL+PE + 
Sbjct: 148 --GIVHRNLKPENLLLASKAKGAAVKLADFGLAIEVNDSEAWHGF--AGTPGYLSPEVLK 203
Query: 592 TGRFTERSDIFAFGVIILQILTG 614
              +++  DI+A GVI+  +L G
Sbjct: 204 KDPYSKPVDIWACGVILYILLVG 226

>pdb|1UNG|A Chain A, Structural Mechanism For The Inhibition Of Cdk5-P25 By Roscovitine, Aloisine And Indirubin. Length = 292

Iteration: 1
 Score = 51.6 bits (122), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 41/159 (25%), Positives = 81/159 (50%), Gaps = 13/159 (8%)
Query: 409 QCFSEVNLLGKGNFSSVYKGTLRD-GTLVAIRSINVTSC-KSEEAEFVKGLYLLTSLRHE 466
           Q + ++  +G+G + +V+K   R+   +VA++ + +    +   +  ++ + LL  L+H+
Sbjct: 2   QKYEKLEKIGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHK 61
Query: 467 NIIRLRGFCCSRGRGECFLIYDFAPKGKLSKYLDQEEGSSNVLDWSTRVSIIIGIAKGIG 526
           NI+RL     S  +    L+++F  +  L KY D   G    LD     S +  + KG+G
Sbjct: 62  NIVRLHDVLHSDKK--LTLVFEFCDQD-LKKYFDSCNGD---LDPEIVKSFLFQLLKGLG 115
Query: 527 YLHSSEVNKPAIVHRNLSVEKVLIDQQFNPLIADCGLHK 565
           + HS  V     +HR+L  + +LI++     +A+ GL +
Sbjct: 116 FCHSRNV-----LHRDLKPQNLLINRNGELKLANFGLAR 149

>pdb|4EOJ|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Human Cyclin A3 Complex With Atp Length = 302

Iteration: 1
 Score = 51.6 bits (122), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 48/210 (22%), Positives = 99/210 (47%), Gaps = 14/210 (6%)
Query: 407 ATQCFSEVNLLGKGNFSSVYKGTLR-DGTLVAIRSINV-TSCKSEEAEFVKGLYLLTSLR 464
           + + F +V  +G+G +  VYK   +  G +VA++ I + T  +   +  ++ + LL  L 
Sbjct: 4   SMENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELN 63
Query: 465 HENIIRLRGFCCSRGRGECFLIYDFAPKGKLSKYLDQEEGSSNVLDWSTRVSIIIGIAKG 524
           H NI++L     +  +   +L+++F     L  ++D    +   L      S +  + +G
Sbjct: 64  HPNIVKLLDVIHTENK--LYLVFEFL-SMDLKDFMDASALTGIPLPLIK--SYLFQLLQG 118
Query: 525 IGYLHSSEVNKPAIVHRNLSVEKVLIDQQFNPLIADCGLHKLLADDIVFSVLKTSAAMGY 584
           + + HS  V     +HR+L  + +LI+ +    +AD GL +      V +       + Y
Sbjct: 119 LAFCHSHRV-----LHRDLKPQNLLINTEGAIKLADFGLARAFGVP-VRTYXHEVVTLWY 172
Query: 585 LAPEYVTTGRFTERS-DIFAFGVIILQILT 613
            APE +   ++   + DI++ G I  +++T
Sbjct: 173 RAPEILLGCKYYSTAVDIWSLGCIFAEMVT 202

>pdb|3TXO|A Chain A, Pkc Eta Kinase In Complex With A Naphthyridine Length = 353

Iteration: 1
 Score = 51.2 bits (121), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 47/209 (22%), Positives = 94/209 (44%), Gaps = 18/209 (8%)
Query: 411 FSEVNLLGKGNFSSVYKGTLRD-GTLVAIRSINVTSC-KSEEAEFVKGLYLLTSLRHENI 468
           F  + +LGKG+F  V    +++ G L A++ +      + ++ E       + SL   + 
Sbjct: 25  FEFIRVLGKGSFGKVMLARVKETGDLYAVKVLKKDVILQDDDVECTMTEKRILSLARNHP 84
Query: 469 IRLRGFCCSRGRGECFLIYDFAPKGKLSKYLDQEEGSSNVLDWSTRVSIIIGIAKGIGYL 528
              + FCC +     F + +F   G L  ++ +    S   D +        I   + +L
Sbjct: 85  FLTQLFCCFQTPDRLFFVMEFVNGGDLMFHIQK----SRRFDEARARFYAAEIISALMFL 140
Query: 529 HSSEVNKPAIVHRNLSVEKVLIDQQFNPLIADCGLHKLLADDIVFSVLKTSAAMG---YL 585
           H        I++R+L ++ VL+D + +  +AD G+ K    + + + + T+   G   Y+
Sbjct: 141 HDK-----GIIYRDLKLDNVLLDHEGHCKLADFGMCK----EGICNGVTTATFCGTPDYI 191
Query: 586 APEYVTTGRFTERSDIFAFGVIILQILTG 614
           APE +    +    D +A GV++ ++L G
Sbjct: 192 APEILQEMLYGPAVDWWAMGVLLYEMLCG 220

>pdb|3KL8|A Chain A, Camkiintide Inhibitor Complex Length = 269

Iteration: 1
 Score = 51.2 bits (121), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 55/203 (27%), Positives = 90/203 (44%), Gaps = 18/203 (8%)
Query: 417 LGKGNFSSVYKGTLRD-GTLVAIRSINVTSCKSEE-AEFVKGLYLLTSLRHENIIRLRGF 474
           LGKG FS V +   +  G   A + IN     + +  +  +   +   L+H NI+RL   
Sbjct: 14  LGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQKLEREARICRKLQHPNIVRLHD- 72
Query: 475 CCSRGRGECFLIYDFAPKGKLSKYLDQEEGSSNVLDWSTRVSIIIGIAKGIGYLHSSEVN 534
              +     +L++D    G+L + +   E  S     +     I  I + I Y HS+   
Sbjct: 73  -SIQEESFHYLVFDLVTGGELFEDIVAREFYSE----ADASHCIQQILESIAYCHSN--- 124
Query: 535 KPAIVHRNLSVEKVLIDQQFNPL---IADCGLHKLLADDIVFSVLKTSAAMGYLAPEYVT 591
              IVHRNL  E +L+  +       +AD GL   + D   +     +   GYL+PE + 
Sbjct: 125 --GIVHRNLKPENLLLASKAKGAAVKLADFGLAIEVNDSEAWHGF--AGTPGYLSPEVLK 180
Query: 592 TGRFTERSDIFAFGVIILQILTG 614
              +++  DI+A GVI+  +L G
Sbjct: 181 KDPYSKPVDIWACGVILYILLVG 203

>pdb|4EOK|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Human Cyclin A3 Complex With The Inhibitor Nu6102 Length = 300

Iteration: 1
 Score = 51.2 bits (121), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 48/210 (22%), Positives = 99/210 (47%), Gaps = 14/210 (6%)
Query: 407 ATQCFSEVNLLGKGNFSSVYKGTLR-DGTLVAIRSINV-TSCKSEEAEFVKGLYLLTSLR 464
           + + F +V  +G+G +  VYK   +  G +VA++ I + T  +   +  ++ + LL  L 
Sbjct: 3   SMENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELN 62
Query: 465 HENIIRLRGFCCSRGRGECFLIYDFAPKGKLSKYLDQEEGSSNVLDWSTRVSIIIGIAKG 524
           H NI++L     +  +   +L+++F     L  ++D    +   L      S +  + +G
Sbjct: 63  HPNIVKLLDVIHTENK--LYLVFEFL-SMDLKDFMDASALTGIPLPLIK--SYLFQLLQG 117
Query: 525 IGYLHSSEVNKPAIVHRNLSVEKVLIDQQFNPLIADCGLHKLLADDIVFSVLKTSAAMGY 584
           + + HS  V     +HR+L  + +LI+ +    +AD GL +      V +       + Y
Sbjct: 118 LAFCHSHRV-----LHRDLKPQNLLINTEGAIKLADFGLARAFGVP-VRTYXHEVVTLWY 171
Query: 585 LAPEYVTTGRFTERS-DIFAFGVIILQILT 613
            APE +   ++   + DI++ G I  +++T
Sbjct: 172 RAPEILLGCKYYSTAVDIWSLGCIFAEMVT 201

>pdb|2Y7J|A Chain A, Structure Of Human Phosphorylase Kinase, Gamma 2 Length = 365

Iteration: 1
 Score = 50.8 bits (120), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 60/222 (27%), Positives = 101/222 (45%), Gaps = 28/222 (12%)
Query: 409 QCFSEVNLLGKGNFSSVYKGTLR-DGTLVAIRSINVTSCK--SEEAEFVKG-----LYLL 460
           Q +   +++G+G  S V +   R  G   A++ + VT+ +   E+ E V+       ++L
Sbjct: 94  QKYDPKDVIGRGVSSVVRRCVHRATGHEFAVKIMEVTAERLSPEQLEEVREATRRETHIL 153
Query: 461 TSLR-HENIIRLRGFCCSRGRGECFLIYDFAPKGKLSKYLDQEEGSSNVLDWSTRVSIII 519
             +  H +II L            FL++D   KG+L  YL ++   S      TR SI+ 
Sbjct: 154 RQVAGHPHIITL--IDSYESSSFMFLVFDLMRKGELFDYLTEKVALSEK---ETR-SIMR 207
Query: 520 GIAKGIGYLHSSEVNKPAIVHRNLSVEKVLIDQQFNPLIADCGLHKLLADDIVFSVLKTS 579
            + + + +LH++      IVHR+L  E +L+D      ++D G    L        L   
Sbjct: 208 SLLEAVSFLHANN-----IVHRDLKPENILLDDNMQIRLSDFGFSCHLEPGEKLREL--C 260
Query: 580 AAMGYLAPEYV------TTGRFTERSDIFAFGVIILQILTGS 615
              GYLAPE +      T   + +  D++A GVI+  +L GS
Sbjct: 261 GTPGYLAPEILKCSMDETHPGYGKEVDLWACGVILFTLLAGS 302

>pdb|3KK8|A Chain A, Camkii Substrate Complex A Length = 284

Iteration: 1
 Score = 50.8 bits (120), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 55/203 (27%), Positives = 90/203 (44%), Gaps = 18/203 (8%)
Query: 417 LGKGNFSSVYKGTLRD-GTLVAIRSINVTSCKSEE-AEFVKGLYLLTSLRHENIIRLRGF 474
           LGKG FS V +   +  G   A + IN     + +  +  +   +   L+H NI+RL   
Sbjct: 14  LGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQKLEREARICRKLQHPNIVRLHD- 72
Query: 475 CCSRGRGECFLIYDFAPKGKLSKYLDQEEGSSNVLDWSTRVSIIIGIAKGIGYLHSSEVN 534
              +     +L++D    G+L + +   E  S     +     I  I + I Y HS+   
Sbjct: 73  -SIQEESFHYLVFDLVTGGELFEDIVAREFYSE----ADASHCIQQILESIAYCHSN--- 124
Query: 535 KPAIVHRNLSVEKVLIDQQFNPL---IADCGLHKLLADDIVFSVLKTSAAMGYLAPEYVT 591
              IVHRNL  E +L+  +       +AD GL   + D   +     +   GYL+PE + 
Sbjct: 125 --GIVHRNLKPENLLLASKAKGAAVKLADFGLAIEVNDSEAWHGF--AGTPGYLSPEVLK 180
Query: 592 TGRFTERSDIFAFGVIILQILTG 614
              +++  DI+A GVI+  +L G
Sbjct: 181 KDPYSKPVDIWACGVILYILLVG 203

>pdb|3KK9|A Chain A, Camkii Substrate Complex B Length = 282

Iteration: 1
 Score = 50.8 bits (120), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 55/203 (27%), Positives = 90/203 (44%), Gaps = 18/203 (8%)
Query: 417 LGKGNFSSVYKGTLRD-GTLVAIRSINVTSCKSEE-AEFVKGLYLLTSLRHENIIRLRGF 474
           LGKG FS V +   +  G   A + IN     + +  +  +   +   L+H NI+RL   
Sbjct: 13  LGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQKLEREARICRKLQHPNIVRLHD- 71
Query: 475 CCSRGRGECFLIYDFAPKGKLSKYLDQEEGSSNVLDWSTRVSIIIGIAKGIGYLHSSEVN 534
              +     +L++D    G+L + +   E  S     +     I  I + I Y HS+   
Sbjct: 72  -SIQEESFHYLVFDLVTGGELFEDIVAREFYSE----ADASHCIQQILESIAYCHSN--- 123
Query: 535 KPAIVHRNLSVEKVLIDQQFNPL---IADCGLHKLLADDIVFSVLKTSAAMGYLAPEYVT 591
              IVHRNL  E +L+  +       +AD GL   + D   +     +   GYL+PE + 
Sbjct: 124 --GIVHRNLKPENLLLASKAKGAAVKLADFGLAIEVNDSEAWHGF--AGTPGYLSPEVLK 179
Query: 592 TGRFTERSDIFAFGVIILQILTG 614
              +++  DI+A GVI+  +L G
Sbjct: 180 KDPYSKPVDIWACGVILYILLVG 202

>pdb|2Y4I|C Chain C, Ksr2-Mek1 Heterodimer Length = 395

Iteration: 1
 Score = 50.4 bits (119), Expect = 3e-06,   Method: Compositional matrix adjust.
 Identities = 52/234 (22%), Positives = 105/234 (44%), Gaps = 31/234 (13%)
Query: 391 REHLNSFRLNLEEV-ESATQCFSEVNLLGKGNFSSVYKGTLRDGTLVAIRS-INVTSCKS 448
           R+ L +F    ++V E     F +++ LG GN   V+K + +   LV  R  I++    +
Sbjct: 49  RKRLEAFLTQKQKVGELKDDDFEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLEIKPA 108
Query: 449 EEAEFVKGLYLLTSLRHENIIRLRGFCCSRGRGECFLIYDFAPKGKLSKYLDQEEGSS-- 506
              + ++ L +L       I+   G               F   G++S  ++  +G S  
Sbjct: 109 IRNQIIRELQVLHECNSPYIVGFYGA--------------FYSDGEISICMEHMDGGSLD 154
Query: 507 NVLDWSTRV------SIIIGIAKGIGYLHSSEVNKPAIVHRNLSVEKVLIDQQFNPLIAD 560
            VL  + R+       + I + KG+ YL      K  I+HR++    +L++ +    + D
Sbjct: 155 QVLKKAGRIPEQILGKVSIAVIKGLTYLR----EKHKIMHRDVKPSNILVNSRGEIKLCD 210
Query: 561 CGLHKLLADDIVFSVLKTSAAMGYLAPEYVTTGRFTERSDIFAFGVIILQILTG 614
            G+   L D +  S + T +   Y++PE +    ++ +SDI++ G+ ++++  G
Sbjct: 211 FGVSGQLIDSMANSFVGTRS---YMSPERLQGTHYSVQSDIWSMGLSLVEMAVG 261

>pdb|1UA2|A Chain A, Crystal Structure Of Human Cdk7 Length = 346

Iteration: 1
 Score = 50.4 bits (119), Expect = 3e-06,   Method: Compositional matrix adjust.
 Identities = 62/243 (25%), Positives = 108/243 (44%), Gaps = 28/243 (11%)
Query: 403 EVESATQCFSEVNLLGKGNFSSVYKGTLRD-GTLVAIRSINVTSCKSEEAEFV-----KG 456
           +V+S  + + +++ LG+G F++VYK   ++   +VAI+ I +   +SE  + +     + 
Sbjct: 4   DVKSRAKRYEKLDFLGEGQFATVYKARDKNTNQIVAIKKIKLGH-RSEAKDGINRTALRE 62
Query: 457 LYLLTSLRHENIIRLRGFCCSRG-RGECFLIYDFAPKGKLSKYLDQE---EGSSNVLDWS 512
           + LL  L H NII   G   + G +    L++DF          D E   + +S VL  S
Sbjct: 63  IKLLQELSHPNII---GLLDAFGHKSNISLVFDFMET-------DLEVIIKDNSLVLTPS 112
Query: 513 TRVSIIIGIAKGIGYLHSSEVNKPAIVHRNLSVEKVLIDQQFNPLIADCGLHKLLADDIV 572
              + ++   +G+ YLH        I+HR+L    +L+D+     +AD GL K       
Sbjct: 113 HIKAYMLMTLQGLEYLHQH-----WILHRDLKPNNLLLDENGVLKLADFGLAKSFGSPNR 167
Query: 573 FSVLKTSAAMGYLAPEYVTTGR-FTERSDIFAFGVIILQILTGSLVLTSSMRLAAESATF 631
            +         Y APE +   R +    D++A G I+ ++L     L     L   +  F
Sbjct: 168 -AYXHQVVTRWYRAPELLFGARMYGVGVDMWAVGCILAELLLRVPFLPGDSDLDQLTRIF 226
Query: 632 ENF 634
           E  
Sbjct: 227 ETL 229

>pdb|1GZK|A Chain A, Molecular Mechanism For The Regulation Of Protein Kinase B Akt By Hydrophobic Motif Phosphorylation Length = 315

Iteration: 1
 Score = 50.4 bits (119), Expect = 3e-06,   Method: Compositional matrix adjust.
 Identities = 58/211 (27%), Positives = 94/211 (44%), Gaps = 19/211 (9%)
Query: 411 FSEVNLLGKGNFSSVY----KGTLRDGTLVAIRSINVTSCKSEEAEFVKGLYLLTSLRHE 466
           F  + LLGKG F  V     K T R   +  +R   V   K E A  V    +L + RH 
Sbjct: 7   FDYLKLLGKGTFGKVILVREKATGRYYAMKILRK-EVIIAKDEVAHTVTESRVLQNTRHP 65
Query: 467 NIIRLRGFCCSRGRGECFLIYDFAPKGKLSKYLDQEEGSSNVLDWSTRVSIIIGIAKGIG 526
            +  L+    +  R  CF++ ++A  G+L  +L +E     V            I   + 
Sbjct: 66  FLTALKYAFQTHDRL-CFVM-EYANGGELFFHLSRE----RVFTEERARFYGAEIVSALE 119
Query: 527 YLHSSEVNKPAIVHRNLSVEKVLIDQQFNPLIADCGLHKLLADDIVFSVLKTSAAM-GYL 585
           YLHS +V     V+R++ +E +++D+  +  I D GL K    D   + +KT      YL
Sbjct: 120 YLHSRDV-----VYRDIKLENLMLDKDGHIKITDFGLCKEGISDG--ATMKTFCGTPEYL 172
Query: 586 APEYVTTGRFTERSDIFAFGVIILQILTGSL 616
           APE +    +    D +  GV++ +++ G L
Sbjct: 173 APEVLEDNDYGRAVDWWGLGVVMYEMMCGRL 203

>pdb|1MRV|A Chain A, Crystal Structure Of An Inactive Akt2 Kinase Domain Length = 339

Iteration: 1
 Score = 50.1 bits (118), Expect = 4e-06,   Method: Compositional matrix adjust.
 Identities = 58/211 (27%), Positives = 94/211 (44%), Gaps = 19/211 (9%)
Query: 411 FSEVNLLGKGNFSSVY----KGTLRDGTLVAIRSINVTSCKSEEAEFVKGLYLLTSLRHE 466
           F  + LLGKG F  V     K T R   +  +R   V   K E A  V    +L + RH 
Sbjct: 10  FDYLKLLGKGTFGKVILVREKATGRYYAMKILRK-EVIIAKDEVAHTVTESRVLQNTRHP 68
Query: 467 NIIRLRGFCCSRGRGECFLIYDFAPKGKLSKYLDQEEGSSNVLDWSTRVSIIIGIAKGIG 526
            +  L+    +  R  CF++ ++A  G+L  +L +E     V            I   + 
Sbjct: 69  FLTALKYAFQTHDRL-CFVM-EYANGGELFFHLSRE----RVFTEERARFYGAEIVSALE 122
Query: 527 YLHSSEVNKPAIVHRNLSVEKVLIDQQFNPLIADCGLHKLLADDIVFSVLKTSAAM-GYL 585
           YLHS +V     V+R++ +E +++D+  +  I D GL K    D   + +KT      YL
Sbjct: 123 YLHSRDV-----VYRDIKLENLMLDKDGHIKITDFGLCKEGISDG--ATMKTFCGTPEYL 175
Query: 586 APEYVTTGRFTERSDIFAFGVIILQILTGSL 616
           APE +    +    D +  GV++ +++ G L
Sbjct: 176 APEVLEDNDYGRAVDWWGLGVVMYEMMCGRL 206

>pdb|3A60|A Chain A, Crystal Structure Of Unphosphorylated P70s6k1 (Form I) Length = 327

Iteration: 1
 Score = 50.1 bits (118), Expect = 4e-06,   Method: Compositional matrix adjust.
 Identities = 47/223 (21%), Positives = 95/223 (42%), Gaps = 21/223 (9%)
Query: 409 QCFSEVNLLGKGNFSSVYK-------GTLRDGTLVAIRSINVTSCKSEEAEFVKGLYLLT 461
           +CF  + +LGKG +  V++        T +   +  ++   +     + A       +L 
Sbjct: 17  ECFELLRVLGKGGYGKVFQVRKVTGANTGKIFAMKVLKKAMIVRNAKDTAHTKAERNILE 76
Query: 462 SLRHENIIRLRGFCCSRGRGECFLIYDFAPKGKLSKYLDQEEGSSNVLDWSTRVSIIIGI 521
            ++H  I+ L      +  G+ +LI ++   G+L   L++E     +    T    +  I
Sbjct: 77  EVKHPFIVDL--IYAFQTGGKLYLILEYLSGGELFMQLERE----GIFMEDTACFYLAEI 130
Query: 522 AKGIGYLHSSEVNKPAIVHRNLSVEKVLIDQQFNPLIADCGLHKL-LADDIVFSVLKTSA 580
           +  +G+LH        I++R+L  E ++++ Q +  + D GL K  + D  V        
Sbjct: 131 SMALGHLHQK-----GIIYRDLKPENIMLNHQGHVKLTDFGLCKESIHDGTVTHTF--CG 183
Query: 581 AMGYLAPEYVTTGRFTERSDIFAFGVIILQILTGSLVLTSSMR 623
            + Y+APE +         D ++ G ++  +LTG+   T   R
Sbjct: 184 TIEYMAPEILMRSGHNRAVDWWSLGALMYDMLTGAPPFTGENR 226

>pdb|1GZN|A Chain A, Structure Of Pkb Kinase Domain Length = 335

Iteration: 1
 Score = 50.1 bits (118), Expect = 4e-06,   Method: Compositional matrix adjust.
 Identities = 58/211 (27%), Positives = 94/211 (44%), Gaps = 19/211 (9%)
Query: 411 FSEVNLLGKGNFSSVY----KGTLRDGTLVAIRSINVTSCKSEEAEFVKGLYLLTSLRHE 466
           F  + LLGKG F  V     K T R   +  +R   V   K E A  V    +L + RH 
Sbjct: 7   FDYLKLLGKGTFGKVILVREKATGRYYAMKILRK-EVIIAKDEVAHTVTESRVLQNTRHP 65
Query: 467 NIIRLRGFCCSRGRGECFLIYDFAPKGKLSKYLDQEEGSSNVLDWSTRVSIIIGIAKGIG 526
            +  L+    +  R  CF++ ++A  G+L  +L +E     V            I   + 
Sbjct: 66  FLTALKYAFQTHDRL-CFVM-EYANGGELFFHLSRE----RVFTEERARFYGAEIVSALE 119
Query: 527 YLHSSEVNKPAIVHRNLSVEKVLIDQQFNPLIADCGLHKLLADDIVFSVLKTSAAM-GYL 585
           YLHS +V     V+R++ +E +++D+  +  I D GL K    D   + +KT      YL
Sbjct: 120 YLHSRDV-----VYRDIKLENLMLDKDGHIKITDFGLCKEGISDG--ATMKTFCGTPEYL 172
Query: 586 APEYVTTGRFTERSDIFAFGVIILQILTGSL 616
           APE +    +    D +  GV++ +++ G L
Sbjct: 173 APEVLEDNDYGRAVDWWGLGVVMYEMMCGRL 203

>pdb|3COM|A Chain A, Crystal Structure Of Mst1 Kinase Length = 314

Iteration: 1
 Score = 50.1 bits (118), Expect = 4e-06,   Method: Compositional matrix adjust.
 Identities = 43/211 (20%), Positives = 99/211 (46%), Gaps = 21/211 (9%)
Query: 409 QCFSEVNLLGKGNFSSVYKGTLRD-GTLVAIRSINVTSCKSEEAEFVKGLYLLTSLRHEN 467
           + F  +  LG+G++ SVYK   ++ G +VAI+ + V   +S+  E +K + ++      +
Sbjct: 29  EVFDVLEKLGEGSYGSVYKAIHKETGQIVAIKQVPV---ESDLQEIIKEISIMQQCDSPH 85
Query: 468 IIRLRGFCCSRGRGECFLIYDFAPKGKLSKYLDQEEGSSNVLDWSTRVSIIIGIAKGIGY 527
           +++  G        + +++ ++   G +S  +      +  L      +I+    KG+ Y
Sbjct: 86  VVKYYGSYFK--NTDLWIVMEYCGAGSVSDII---RLRNKTLTEDEIATILQSTLKGLEY 140
Query: 528 LHSSEVNKPAIVHRNLSVEKVLIDQQFNPLIADCGLHKLLADDIVFSVLKTSAAMG---Y 584
           LH         +HR++    +L++ + +  +AD G+   L D +     K +  +G   +
Sbjct: 141 LHFMRK-----IHRDIKAGNILLNTEGHAKLADFGVAGQLTDXMA----KRNXVIGTPFW 191
Query: 585 LAPEYVTTGRFTERSDIFAFGVIILQILTGS 615
           +APE +    +   +DI++ G+  +++  G 
Sbjct: 192 MAPEVIQEIGYNCVADIWSLGITAIEMAEGK 222

>pdb|3A62|A Chain A, Crystal Structure Of Phosphorylated P70s6k1 Length = 327

Iteration: 1
 Score = 50.1 bits (118), Expect = 4e-06,   Method: Compositional matrix adjust.
 Identities = 47/223 (21%), Positives = 95/223 (42%), Gaps = 21/223 (9%)
Query: 409 QCFSEVNLLGKGNFSSVYK-------GTLRDGTLVAIRSINVTSCKSEEAEFVKGLYLLT 461
           +CF  + +LGKG +  V++        T +   +  ++   +     + A       +L 
Sbjct: 17  ECFELLRVLGKGGYGKVFQVRKVTGANTGKIFAMKVLKKAMIVRNAKDTAHTKAERNILE 76
Query: 462 SLRHENIIRLRGFCCSRGRGECFLIYDFAPKGKLSKYLDQEEGSSNVLDWSTRVSIIIGI 521
            ++H  I+ L      +  G+ +LI ++   G+L   L++E     +    T    +  I
Sbjct: 77  EVKHPFIVDL--IYAFQTGGKLYLILEYLSGGELFMQLERE----GIFMEDTACFYLAEI 130
Query: 522 AKGIGYLHSSEVNKPAIVHRNLSVEKVLIDQQFNPLIADCGLHKL-LADDIVFSVLKTSA 580
           +  +G+LH        I++R+L  E ++++ Q +  + D GL K  + D  V        
Sbjct: 131 SMALGHLHQK-----GIIYRDLKPENIMLNHQGHVKLTDFGLCKESIHDGTVTHXF--CG 183
Query: 581 AMGYLAPEYVTTGRFTERSDIFAFGVIILQILTGSLVLTSSMR 623
            + Y+APE +         D ++ G ++  +LTG+   T   R
Sbjct: 184 TIEYMAPEILMRSGHNRAVDWWSLGALMYDMLTGAPPFTGENR 226

>pdb|1QL6|A Chain A, The Catalytic Mechanism Of Phosphorylase Kinase Probed By Mutational Studies Length = 298

Iteration: 1
 Score = 50.1 bits (118), Expect = 4e-06,   Method: Compositional matrix adjust.
 Identities = 67/219 (30%), Positives = 102/219 (46%), Gaps = 33/219 (15%)
Query: 415 NLLGKGNFSSVYKGTLRDGTL--VAIRSINVTSCKSEEAEFVKGLYLLT-----SLR--- 464
            +LG+G  SSV +  +   T    A++ I+VT   S  AE V+ L   T      LR   
Sbjct: 23  EILGRG-VSSVVRRCIHKPTCKEYAVKIIDVTGGGSFSAEEVQELREATLKEVDILRKVS 81
Query: 465 -HENIIRLRGFCCSRGRGECFLIYDFAPKGKLSKYLDQEEGSSNVLDWSTRVSIIIGIAK 523
            H NII+L+           FL++D   KG+L  YL ++   S   +  TR  I+  + +
Sbjct: 82  GHPNIIQLKD--TYETNTFFFLVFDLMKKGELFDYLTEKVTLS---EKETR-KIMRALLE 135
Query: 524 GIGYLHSSEVNKPAIVHRNLSVEKVLIDQQFNPLIADCGLH-KLLADDIVFSVLKTSAAM 582
            I  LH     K  IVHR+L  E +L+D   N  + D G   +L   + + SV  T +  
Sbjct: 136 VICALH-----KLNIVHRDLKPENILLDDDMNIKLTDFGFSCQLDPGEKLRSVCGTPS-- 188
Query: 583 GYLAPEYVTTGR------FTERSDIFAFGVIILQILTGS 615
            YLAPE +          + +  D+++ GVI+  +L GS
Sbjct: 189 -YLAPEIIECSMNDNHPGYGKEVDMWSTGVIMYTLLAGS 226

>pdb|3EQC|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In A Ternary Complex With Compound 1, Atp-Gs And Mg2p Length = 360

Iteration: 1
 Score = 49.7 bits (117), Expect = 5e-06,   Method: Compositional matrix adjust.
 Identities = 52/235 (22%), Positives = 105/235 (44%), Gaps = 31/235 (13%)
Query: 390 SREHLNSFRLNLEEV-ESATQCFSEVNLLGKGNFSSVYKGTLRDGTLVAIRS-INVTSCK 447
            R+ L +F    ++V E     F +++ LG GN   V+K + +   LV  R  I++    
Sbjct: 13  QRKRLEAFLTQKQKVGELKDDDFEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLEIKP 72
Query: 448 SEEAEFVKGLYLLTSLRHENIIRLRGFCCSRGRGECFLIYDFAPKGKLSKYLDQEEGSS- 506
           +   + ++ L +L       I+   G               F   G++S  ++  +G S 
Sbjct: 73  AIRNQIIRELQVLHECNSPYIVGFYG--------------AFYSDGEISICMEHMDGGSL 118
Query: 507 -NVLDWSTRV------SIIIGIAKGIGYLHSSEVNKPAIVHRNLSVEKVLIDQQFNPLIA 559
             VL  + R+       + I + KG+ YL      K  I+HR++    +L++ +    + 
Sbjct: 119 DQVLKKAGRIPEQILGKVSIAVIKGLTYLR----EKHKIMHRDVKPSNILVNSRGEIKLC 174
Query: 560 DCGLHKLLADDIVFSVLKTSAAMGYLAPEYVTTGRFTERSDIFAFGVIILQILTG 614
           D G+   L D +  S + T +   Y++PE +    ++ +SDI++ G+ ++++  G
Sbjct: 175 DFGVSGQLIDSMANSFVGTRS---YMSPERLQGTHYSVQSDIWSMGLSLVEMAVG 226

>pdb|2YDJ|A Chain A, Discovery Of Checkpoint Kinase Inhibitor Azd7762 By Structure Based Design And Optimization Of Thiophene Carboxamide Ureas Length = 276

Iteration: 1
 Score = 49.7 bits (117), Expect = 6e-06,   Method: Compositional matrix adjust.
 Identities = 48/207 (23%), Positives = 89/207 (42%), Gaps = 16/207 (7%)
Query: 414 VNLLGKGNFSSVYKGTLR-DGTLVAIRSINVTSCKSEEAEFVKGLYLLTSLRHENIIRLR 472
           V  LG+G +  V     R     VA++ +++           K + +   L HEN+++  
Sbjct: 12  VQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEIXINKMLNHENVVKFY 71
Query: 473 GFCCSRGRGEC-FLIYDFAPKGKLSKYLDQEEGSSNVLDWSTRVSIIIGIAKGIGYLHSS 531
           G    R  G   +L  ++   G+L   ++ + G                +  G+ YLH  
Sbjct: 72  G---HRREGNIQYLFLEYCSGGELFDRIEPDIGMPE----PDAQRFFHQLMAGVVYLHGI 124
Query: 532 EVNKPAIVHRNLSVEKVLIDQQFNPLIADCGLHKLLADDIVFSVL-KTSAAMGYLAPEYV 590
                 I HR++  E +L+D++ N  I+D GL  +   +    +L K    + Y+APE +
Sbjct: 125 -----GITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMXGTLPYVAPELL 179
Query: 591 TTGRF-TERSDIFAFGVIILQILTGSL 616
               F  E  D+++ G+++  +L G L
Sbjct: 180 KRREFHAEPVDVWSCGIVLTAMLAGEL 206

>pdb|3SLS|A Chain A, Crystal Structure Of Human Mek-1 Kinase In Complex With Ucb1353770 And Amppnp Length = 304

Iteration: 1
 Score = 49.7 bits (117), Expect = 6e-06,   Method: Compositional matrix adjust.
 Identities = 56/252 (22%), Positives = 111/252 (44%), Gaps = 34/252 (13%)
Query: 391 REHLNSFRLNLEEV-ESATQCFSEVNLLGKGNFSSVYKGTLRDGTLVAIRS-INVTSCKS 448
           R+ L +F    ++V E     F +++ LG GN   V+K + +   LV  R  I++    +
Sbjct: 6   RKRLEAFLTQKQKVGELKDDDFEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLEIKPA 65
Query: 449 EEAEFVKGLYLLTSLRHENIIRLRGFCCSRGRGECFLIYDFAPKGKLSKYLDQEEGSS-- 506
              + ++ L +L       I+   G               F   G++S  ++  +G S  
Sbjct: 66  IRNQIIRELQVLHECNSPYIVGFYG--------------AFYSDGEISICMEHMDGGSLD 111
Query: 507 NVLDWSTRV------SIIIGIAKGIGYLHSSEVNKPAIVHRNLSVEKVLIDQQFNPLIAD 560
            VL  + R+       + I + KG+ YL      K  I+HR++    +L++ +    + D
Sbjct: 112 QVLKKAGRIPEQILGKVSIAVIKGLTYLR----EKHKIMHRDVKPSNILVNSRGEIKLCD 167
Query: 561 CGLHKLLADDIVFSVLKTSAAMGYLAPEYVTTGRFTERSDIFAFGVIILQILTGSLVLTS 620
            G+   L D +  S + T +   Y++PE +    ++ +SDI++ G+ ++++  G   + S
Sbjct: 168 FGVSGQLIDSMANSFVGTRS---YMSPERLQGTHYSVQSDIWSMGLSLVEMAVGRYPIGS 224
Query: 621 SMRLAAESATFE 632
               +   A FE
Sbjct: 225 G---SGSMAIFE 233

>pdb|3ORX|A Chain A, Pdk1 Mutant Bound To Allosteric Disulfide Fragment Inhibitor 1f8 Length = 316

Iteration: 1
 Score = 49.7 bits (117), Expect = 6e-06,   Method: Compositional matrix adjust.
 Identities = 50/208 (24%), Positives = 99/208 (47%), Gaps = 23/208 (11%)
Query: 415 NLLGKGNFSSVYKG----TLRDGTLVAIRSINVTSCKSEEAEFV-KGLYLLTSLRHENII 469
            +LG+G+FS+V       T R+  +  +   ++   K  +  +V +   +++ L H   +
Sbjct: 43  KILGEGSFSTVVLARELATSREYAIKILEKRHI--IKENKVPYVTRERDVMSRLDHPFFV 100
Query: 470 RLRGFCCSRGRGECFLIYDFAPKGKLSKYLDQEEGSSNVLDWSTRVSIIIGIAKGIGYLH 529
           +L  + C +   + +    +A  G+L KY+ ++ GS    D +        I   + YLH
Sbjct: 101 KL--YFCFQDDEKLYFGLSYAKNGELLKYI-RKIGS---FDETCTRFYTAEIVSALEYLH 154
Query: 530 SSEVNKPAIVHRNLSVEKVLIDQQFNPLIADCGLHKLLADDIVFSVLKTSAAMG---YLA 586
                   I+HR+L  E +L+++  +  I D G  K+L+ +      + +  +G   Y++
Sbjct: 155 GK-----GIIHRDLKPENILLNEDMHIQITDFGTAKVLSPES--KQARANXFVGTAQYVS 207
Query: 587 PEYVTTGRFTERSDIFAFGVIILQILTG 614
           PE +T     + SD++A G II Q++ G
Sbjct: 208 PELLTEKSACKSSDLWALGCIIYQLVAG 235

>pdb|4FSZ|A Chain A, Crystal Structure Of The Chk1 Length = 279

Iteration: 1
 Score = 49.7 bits (117), Expect = 6e-06,   Method: Compositional matrix adjust.
 Identities = 48/207 (23%), Positives = 89/207 (42%), Gaps = 16/207 (7%)
Query: 414 VNLLGKGNFSSVYKGTLR-DGTLVAIRSINVTSCKSEEAEFVKGLYLLTSLRHENIIRLR 472
           V  LG+G +  V     R     VA++ +++           K + +   L HEN+++  
Sbjct: 11  VQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEIXINKMLNHENVVKFY 70
Query: 473 GFCCSRGRGEC-FLIYDFAPKGKLSKYLDQEEGSSNVLDWSTRVSIIIGIAKGIGYLHSS 531
           G    R  G   +L  ++   G+L   ++ + G                +  G+ YLH  
Sbjct: 71  G---HRREGNIQYLFLEYCSGGELFDRIEPDIGMPE----PDAQRFFHQLMAGVVYLHGI 123
Query: 532 EVNKPAIVHRNLSVEKVLIDQQFNPLIADCGLHKLLADDIVFSVL-KTSAAMGYLAPEYV 590
                 I HR++  E +L+D++ N  I+D GL  +   +    +L K    + Y+APE +
Sbjct: 124 -----GITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMXGTLPYVAPELL 178
Query: 591 TTGRF-TERSDIFAFGVIILQILTGSL 616
               F  E  D+++ G+++  +L G L
Sbjct: 179 KRREFHAEPVDVWSCGIVLTAMLAGEL 205

>pdb|1ZYS|A Chain A, Co-Crystal Structure Of Checkpoint Kinase Chk1 With A Pyrrolo-Pyridine Inhibitor Length = 273

Iteration: 1
 Score = 49.3 bits (116), Expect = 6e-06,   Method: Compositional matrix adjust.
 Identities = 48/207 (23%), Positives = 89/207 (42%), Gaps = 16/207 (7%)
Query: 414 VNLLGKGNFSSVYKGTLR-DGTLVAIRSINVTSCKSEEAEFVKGLYLLTSLRHENIIRLR 472
           V  LG+G +  V     R     VA++ +++           K + +   L HEN+++  
Sbjct: 12  VQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINAMLNHENVVKFY 71
Query: 473 GFCCSRGRGEC-FLIYDFAPKGKLSKYLDQEEGSSNVLDWSTRVSIIIGIAKGIGYLHSS 531
           G    R  G   +L  ++   G+L   ++ + G                +  G+ YLH  
Sbjct: 72  G---HRREGNIQYLFLEYCSGGELFDRIEPDIGMPE----PDAQRFFHQLMAGVVYLHGI 124
Query: 532 EVNKPAIVHRNLSVEKVLIDQQFNPLIADCGLHKLLADDIVFSVL-KTSAAMGYLAPEYV 590
                 I HR++  E +L+D++ N  I+D GL  +   +    +L K    + Y+APE +
Sbjct: 125 -----GITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELL 179
Query: 591 TTGRF-TERSDIFAFGVIILQILTGSL 616
               F  E  D+++ G+++  +L G L
Sbjct: 180 KRREFHAEPVDVWSCGIVLTAMLAGEL 206

>pdb|4FSY|A Chain A, Crystal Structure Of The Chk1 Length = 279

Iteration: 1
 Score = 49.3 bits (116), Expect = 7e-06,   Method: Compositional matrix adjust.
 Identities = 48/207 (23%), Positives = 89/207 (42%), Gaps = 16/207 (7%)
Query: 414 VNLLGKGNFSSVYKGTLR-DGTLVAIRSINVTSCKSEEAEFVKGLYLLTSLRHENIIRLR 472
           V  LG+G +  V     R     VA++ +++           K + +   L HEN+++  
Sbjct: 11  VQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEIXINKMLNHENVVKFY 70
Query: 473 GFCCSRGRGEC-FLIYDFAPKGKLSKYLDQEEGSSNVLDWSTRVSIIIGIAKGIGYLHSS 531
           G    R  G   +L  ++   G+L   ++ + G                +  G+ YLH  
Sbjct: 71  G---HRREGNIQYLFLEYCSGGELFDRIEPDIGMPE----PDAQRFFHQLMAGVVYLHGI 123
Query: 532 EVNKPAIVHRNLSVEKVLIDQQFNPLIADCGLHKLLADDIVFSVL-KTSAAMGYLAPEYV 590
                 I HR++  E +L+D++ N  I+D GL  +   +    +L K    + Y+APE +
Sbjct: 124 -----GITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELL 178
Query: 591 TTGRF-TERSDIFAFGVIILQILTGSL 616
               F  E  D+++ G+++  +L G L
Sbjct: 179 KRREFHAEPVDVWSCGIVLTAMLAGEL 205

>pdb|1Q3D|A Chain A, Gsk-3 Beta Complexed With Staurosporine Length = 424

Iteration: 1
 Score = 49.3 bits (116), Expect = 7e-06,   Method: Compositional matrix adjust.
 Identities = 52/219 (23%), Positives = 106/219 (48%), Gaps = 28/219 (12%)
Query: 411 FSEVNLLGKGNFSSVYKGTLRD-GTLVAIRSINVTSCKSEEAEFV-KGLYLLTSLRHENI 468
           +++  ++G G+F  VY+  L D G LVAI+ +       ++  F  + L ++  L H NI
Sbjct: 60  YTDTKVIGNGSFGVVYQAKLCDSGELVAIKKV------LQDKRFKNRELQIMRKLDHCNI 113
Query: 469 IRLRGFCCSRG--RGECF--LIYDFAPKG--KLSKYLDQEEGSSNVLDWSTRVSIIIGIA 522
           +RLR F  S G  + E +  L+ D+ P+   +++++  + + +  V+        +  + 
Sbjct: 114 VRLRYFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKL---YMYQLF 170
Query: 523 KGIGYLHSSEVNKPAIVHRNLSVEKVLIDQQFNPL-IADCGLHK-LLADDIVFSVLKTSA 580
           + + Y+HS       I HR++  + +L+D     L + D G  K L+  +   S +    
Sbjct: 171 RSLAYIHSF-----GICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPNVSYI---C 222
Query: 581 AMGYLAPEYVTTGR-FTERSDIFAFGVIILQILTGSLVL 618
           +  Y APE +     +T   D+++ G ++ ++L G  + 
Sbjct: 223 SRYYRAPELIFGATDYTSSIDVWSAGCVLAELLLGQPIF 261

>pdb|1PYX|A Chain A, Gsk-3 Beta Complexed With Amp-Pnp Length = 422

Iteration: 1
 Score = 49.3 bits (116), Expect = 7e-06,   Method: Compositional matrix adjust.
 Identities = 52/219 (23%), Positives = 106/219 (48%), Gaps = 28/219 (12%)
Query: 411 FSEVNLLGKGNFSSVYKGTLRD-GTLVAIRSINVTSCKSEEAEFV-KGLYLLTSLRHENI 468
           +++  ++G G+F  VY+  L D G LVAI+ +       ++  F  + L ++  L H NI
Sbjct: 58  YTDTKVIGNGSFGVVYQAKLCDSGELVAIKKV------LQDKRFKNRELQIMRKLDHCNI 111
Query: 469 IRLRGFCCSRG--RGECF--LIYDFAPKG--KLSKYLDQEEGSSNVLDWSTRVSIIIGIA 522
           +RLR F  S G  + E +  L+ D+ P+   +++++  + + +  V+        +  + 
Sbjct: 112 VRLRYFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKL---YMYQLF 168
Query: 523 KGIGYLHSSEVNKPAIVHRNLSVEKVLIDQQFNPL-IADCGLHK-LLADDIVFSVLKTSA 580
           + + Y+HS       I HR++  + +L+D     L + D G  K L+  +   S +    
Sbjct: 169 RSLAYIHSF-----GICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPNVSYI---C 220
Query: 581 AMGYLAPEYVTTGR-FTERSDIFAFGVIILQILTGSLVL 618
           +  Y APE +     +T   D+++ G ++ ++L G  + 
Sbjct: 221 SRYYRAPELIFGATDYTSSIDVWSAGCVLAELLLGQPIF 259

>pdb|1I09|A Chain A, Structure Of Glycogen Synthase Kinase-3 (Gsk3b) Length = 420

Iteration: 1
 Score = 49.3 bits (116), Expect = 7e-06,   Method: Compositional matrix adjust.
 Identities = 52/219 (23%), Positives = 106/219 (48%), Gaps = 28/219 (12%)
Query: 411 FSEVNLLGKGNFSSVYKGTLRD-GTLVAIRSINVTSCKSEEAEFV-KGLYLLTSLRHENI 468
           +++  ++G G+F  VY+  L D G LVAI+ +       ++  F  + L ++  L H NI
Sbjct: 56  YTDTKVIGNGSFGVVYQAKLCDSGELVAIKKV------LQDKRFKNRELQIMRKLDHCNI 109
Query: 469 IRLRGFCCSRG--RGECF--LIYDFAPKG--KLSKYLDQEEGSSNVLDWSTRVSIIIGIA 522
           +RLR F  S G  + E +  L+ D+ P+   +++++  + + +  V+        +  + 
Sbjct: 110 VRLRYFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKL---YMYQLF 166
Query: 523 KGIGYLHSSEVNKPAIVHRNLSVEKVLIDQQFNPL-IADCGLHK-LLADDIVFSVLKTSA 580
           + + Y+HS       I HR++  + +L+D     L + D G  K L+  +   S +    
Sbjct: 167 RSLAYIHSF-----GICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPNVSYI---C 218
Query: 581 AMGYLAPEYVTTGR-FTERSDIFAFGVIILQILTGSLVL 618
           +  Y APE +     +T   D+++ G ++ ++L G  + 
Sbjct: 219 SRYYRAPELIFGATDYTSSIDVWSAGCVLAELLLGQPIF 257

>pdb|1R0E|A Chain A, Glycogen Synthase Kinase-3 Beta In Complex With 3-Indolyl-4- Arylmaleimide Inhibitor Length = 391

Iteration: 1
 Score = 49.3 bits (116), Expect = 7e-06,   Method: Compositional matrix adjust.
 Identities = 52/219 (23%), Positives = 106/219 (48%), Gaps = 28/219 (12%)
Query: 411 FSEVNLLGKGNFSSVYKGTLRD-GTLVAIRSINVTSCKSEEAEFV-KGLYLLTSLRHENI 468
           +++  ++G G+F  VY+  L D G LVAI+ +       ++  F  + L ++  L H NI
Sbjct: 27  YTDTKVIGNGSFGVVYQAKLCDSGELVAIKKV------LQDKRFKNRELQIMRKLDHCNI 80
Query: 469 IRLRGFCCSRG--RGECF--LIYDFAPKG--KLSKYLDQEEGSSNVLDWSTRVSIIIGIA 522
           +RLR F  S G  + E +  L+ D+ P+   +++++  + + +  V+        +  + 
Sbjct: 81  VRLRYFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKL---YMYQLF 137
Query: 523 KGIGYLHSSEVNKPAIVHRNLSVEKVLIDQQFNPL-IADCGLHK-LLADDIVFSVLKTSA 580
           + + Y+HS       I HR++  + +L+D     L + D G  K L+  +   S +    
Sbjct: 138 RSLAYIHSF-----GICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPNVSYI---C 189
Query: 581 AMGYLAPEYVTTGR-FTERSDIFAFGVIILQILTGSLVL 618
           +  Y APE +     +T   D+++ G ++ ++L G  + 
Sbjct: 190 SRYYRAPELIFGATDYTSSIDVWSAGCVLAELLLGQPIF 228

>pdb|1Q5K|A Chain A, Crystal Structure Of Glycogen Synthase Kinase 3 In Complexed With Inhibitor Length = 414

Iteration: 1
 Score = 49.3 bits (116), Expect = 7e-06,   Method: Compositional matrix adjust.
 Identities = 52/219 (23%), Positives = 106/219 (48%), Gaps = 28/219 (12%)
Query: 411 FSEVNLLGKGNFSSVYKGTLRD-GTLVAIRSINVTSCKSEEAEFV-KGLYLLTSLRHENI 468
           +++  ++G G+F  VY+  L D G LVAI+ +       ++  F  + L ++  L H NI
Sbjct: 50  YTDTKVIGNGSFGVVYQAKLCDSGELVAIKKV------LQDKRFKNRELQIMRKLDHCNI 103
Query: 469 IRLRGFCCSRG--RGECF--LIYDFAPKG--KLSKYLDQEEGSSNVLDWSTRVSIIIGIA 522
           +RLR F  S G  + E +  L+ D+ P+   +++++  + + +  V+        +  + 
Sbjct: 104 VRLRYFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKL---YMYQLF 160
Query: 523 KGIGYLHSSEVNKPAIVHRNLSVEKVLIDQQFNPL-IADCGLHK-LLADDIVFSVLKTSA 580
           + + Y+HS       I HR++  + +L+D     L + D G  K L+  +   S +    
Sbjct: 161 RSLAYIHSF-----GICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPNVSYI---C 212
Query: 581 AMGYLAPEYVTTGR-FTERSDIFAFGVIILQILTGSLVL 618
           +  Y APE +     +T   D+++ G ++ ++L G  + 
Sbjct: 213 SRYYRAPELIFGATDYTSSIDVWSAGCVLAELLLGQPIF 251

>pdb|2E9V|A Chain A, Structure Of H-Chk1 Complexed With A859017 Length = 268

Iteration: 1
 Score = 49.3 bits (116), Expect = 7e-06,   Method: Compositional matrix adjust.
 Identities = 48/207 (23%), Positives = 89/207 (42%), Gaps = 16/207 (7%)
Query: 414 VNLLGKGNFSSVYKGTLR-DGTLVAIRSINVTSCKSEEAEFVKGLYLLTSLRHENIIRLR 472
           V  LG+G +  V     R     VA++ +++           K + +   L HEN+++  
Sbjct: 11  VQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFY 70
Query: 473 GFCCSRGRGEC-FLIYDFAPKGKLSKYLDQEEGSSNVLDWSTRVSIIIGIAKGIGYLHSS 531
           G    R  G   +L  ++   G+L   ++ + G                +  G+ YLH  
Sbjct: 71  G---HRREGNIQYLFLEYCSGGELFDRIEPDIGMPE----PDAQRFFHQLMAGVVYLHGI 123
Query: 532 EVNKPAIVHRNLSVEKVLIDQQFNPLIADCGLHKLLADDIVFSVL-KTSAAMGYLAPEYV 590
                 I HR++  E +L+D++ N  I+D GL  +   +    +L K    + Y+APE +
Sbjct: 124 -----GITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELL 178
Query: 591 TTGRF-TERSDIFAFGVIILQILTGSL 616
               F  E  D+++ G+++  +L G L
Sbjct: 179 KRREFHAEPVDVWSCGIVLTAMLAGEL 205

>pdb|4ACC|A Chain A, Gsk3b In Complex With Inhibitor Length = 465

Iteration: 1
 Score = 49.3 bits (116), Expect = 7e-06,   Method: Compositional matrix adjust.
 Identities = 52/219 (23%), Positives = 106/219 (48%), Gaps = 28/219 (12%)
Query: 411 FSEVNLLGKGNFSSVYKGTLRD-GTLVAIRSINVTSCKSEEAEFV-KGLYLLTSLRHENI 468
           +++  ++G G+F  VY+  L D G LVAI+ +       ++  F  + L ++  L H NI
Sbjct: 101 YTDTKVIGNGSFGVVYQAKLCDSGELVAIKKV------LQDKRFKNRELQIMRKLDHCNI 154
Query: 469 IRLRGFCCSRG--RGECF--LIYDFAPKG--KLSKYLDQEEGSSNVLDWSTRVSIIIGIA 522
           +RLR F  S G  + E +  L+ D+ P+   +++++  + + +  V+        +  + 
Sbjct: 155 VRLRYFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKL---YMYQLF 211
Query: 523 KGIGYLHSSEVNKPAIVHRNLSVEKVLIDQQFNPL-IADCGLHK-LLADDIVFSVLKTSA 580
           + + Y+HS       I HR++  + +L+D     L + D G  K L+  +   S +    
Sbjct: 212 RSLAYIHSF-----GICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPNVSYI---C 263
Query: 581 AMGYLAPEYVTTGR-FTERSDIFAFGVIILQILTGSLVL 618
           +  Y APE +     +T   D+++ G ++ ++L G  + 
Sbjct: 264 SRYYRAPELIFGATDYTSSIDVWSAGCVLAELLLGQPIF 302

>pdb|2HOG|A Chain A, Crystal Structure Of Chek1 In Complex With Inhibitor 20 Length = 322

Iteration: 1
 Score = 49.3 bits (116), Expect = 7e-06,   Method: Compositional matrix adjust.
 Identities = 48/207 (23%), Positives = 89/207 (42%), Gaps = 16/207 (7%)
Query: 414 VNLLGKGNFSSVYKGTLR-DGTLVAIRSINVTSCKSEEAEFVKGLYLLTSLRHENIIRLR 472
           V  LG+G +  V     R     VA++ +++           K + +   L HEN+++  
Sbjct: 11  VQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFY 70
Query: 473 GFCCSRGRGEC-FLIYDFAPKGKLSKYLDQEEGSSNVLDWSTRVSIIIGIAKGIGYLHSS 531
           G    R  G   +L  ++   G+L   ++ + G                +  G+ YLH  
Sbjct: 71  G---HRREGNIQYLFLEYCSGGELFDRIEPDIGMPE----PDAQRFFHQLMAGVVYLHGI 123
Query: 532 EVNKPAIVHRNLSVEKVLIDQQFNPLIADCGLHKLLADDIVFSVL-KTSAAMGYLAPEYV 590
                 I HR++  E +L+D++ N  I+D GL  +   +    +L K    + Y+APE +
Sbjct: 124 -----GITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELL 178
Query: 591 TTGRF-TERSDIFAFGVIILQILTGSL 616
               F  E  D+++ G+++  +L G L
Sbjct: 179 KRREFHAEPVDVWSCGIVLTAMLAGEL 205

>pdb|2AYP|A Chain A, Crystal Structure Of Chk1 With An Indol Inhibitor Length = 269

Iteration: 1
 Score = 49.3 bits (116), Expect = 7e-06,   Method: Compositional matrix adjust.
 Identities = 48/207 (23%), Positives = 89/207 (42%), Gaps = 16/207 (7%)
Query: 414 VNLLGKGNFSSVYKGTLR-DGTLVAIRSINVTSCKSEEAEFVKGLYLLTSLRHENIIRLR 472
           V  LG+G +  V     R     VA++ +++           K + +   L HEN+++  
Sbjct: 12  VQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFY 71
Query: 473 GFCCSRGRGEC-FLIYDFAPKGKLSKYLDQEEGSSNVLDWSTRVSIIIGIAKGIGYLHSS 531
           G    R  G   +L  ++   G+L   ++ + G                +  G+ YLH  
Sbjct: 72  G---HRREGNIQYLFLEYCSGGELFDRIEPDIGMPE----PDAQRFFHQLMAGVVYLHGI 124
Query: 532 EVNKPAIVHRNLSVEKVLIDQQFNPLIADCGLHKLLADDIVFSVL-KTSAAMGYLAPEYV 590
                 I HR++  E +L+D++ N  I+D GL  +   +    +L K    + Y+APE +
Sbjct: 125 -----GITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELL 179
Query: 591 TTGRF-TERSDIFAFGVIILQILTGSL 616
               F  E  D+++ G+++  +L G L
Sbjct: 180 KRREFHAEPVDVWSCGIVLTAMLAGEL 206

>pdb|3SAY|A Chain A, Crystal Structure Of Human Glycogen Synthase Kinase 3 Beta (Gsk3b) In Complex With Inhibitor 142 Length = 430

Iteration: 1
 Score = 49.3 bits (116), Expect = 8e-06,   Method: Compositional matrix adjust.
 Identities = 52/219 (23%), Positives = 106/219 (48%), Gaps = 28/219 (12%)
Query: 411 FSEVNLLGKGNFSSVYKGTLRD-GTLVAIRSINVTSCKSEEAEFV-KGLYLLTSLRHENI 468
           +++  ++G G+F  VY+  L D G LVAI+ +       ++  F  + L ++  L H NI
Sbjct: 56  YTDTKVIGNGSFGVVYQAKLCDSGELVAIKKV------LQDKRFKNRELQIMRKLDHCNI 109
Query: 469 IRLRGFCCSRG--RGECF--LIYDFAPKG--KLSKYLDQEEGSSNVLDWSTRVSIIIGIA 522
           +RLR F  S G  + E +  L+ D+ P+   +++++  + + +  V+        +  + 
Sbjct: 110 VRLRYFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKL---YMYQLF 166
Query: 523 KGIGYLHSSEVNKPAIVHRNLSVEKVLIDQQFNPL-IADCGLHK-LLADDIVFSVLKTSA 580
           + + Y+HS       I HR++  + +L+D     L + D G  K L+  +   S +    
Sbjct: 167 RSLAYIHSF-----GICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPNVSXI---C 218
Query: 581 AMGYLAPEYVTTGR-FTERSDIFAFGVIILQILTGSLVL 618
           +  Y APE +     +T   D+++ G ++ ++L G  + 
Sbjct: 219 SRYYRAPELIFGATDYTSSIDVWSAGCVLAELLLGQPIF 257

>pdb|2GHG|A Chain A, H-Chk1 Complexed With A431994 Length = 269

Iteration: 1
 Score = 49.3 bits (116), Expect = 8e-06,   Method: Compositional matrix adjust.
 Identities = 48/207 (23%), Positives = 89/207 (42%), Gaps = 16/207 (7%)
Query: 414 VNLLGKGNFSSVYKGTLR-DGTLVAIRSINVTSCKSEEAEFVKGLYLLTSLRHENIIRLR 472
           V  LG+G +  V     R     VA++ +++           K + +   L HEN+++  
Sbjct: 11  VQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFY 70
Query: 473 GFCCSRGRGEC-FLIYDFAPKGKLSKYLDQEEGSSNVLDWSTRVSIIIGIAKGIGYLHSS 531
           G    R  G   +L  ++   G+L   ++ + G                +  G+ YLH  
Sbjct: 71  G---HRREGNIQYLFLEYCSGGELFDRIEPDIGMPE----PDAQRFFHQLMAGVVYLHGI 123
Query: 532 EVNKPAIVHRNLSVEKVLIDQQFNPLIADCGLHKLLADDIVFSVL-KTSAAMGYLAPEYV 590
                 I HR++  E +L+D++ N  I+D GL  +   +    +L K    + Y+APE +
Sbjct: 124 -----GITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELL 178
Query: 591 TTGRF-TERSDIFAFGVIILQILTGSL 616
               F  E  D+++ G+++  +L G L
Sbjct: 179 KRREFHAEPVDVWSCGIVLTAMLAGEL 205

>pdb|1PHK|A Chain A, Two Structures Of The Catalytic Domain Of Phosphorylase, Kinase: An Active Protein Kinase Complexed With Nucleotide, Substrate-Analogue And Product Length = 298

Iteration: 1
 Score = 49.3 bits (116), Expect = 8e-06,   Method: Compositional matrix adjust.
 Identities = 65/218 (29%), Positives = 98/218 (44%), Gaps = 31/218 (14%)
Query: 415 NLLGKGNFSSVYKGTLRDGTL--VAIRSINVTSCKSEEAEFVKGLYLLT-----SLR--- 464
            +LG+G  SSV +  +   T    A++ I+VT   S  AE V+ L   T      LR   
Sbjct: 23  EILGRG-VSSVVRRCIHKPTCKEYAVKIIDVTGGGSFSAEEVQELREATLKEVDILRKVS 81
Query: 465 -HENIIRLRGFCCSRGRGECFLIYDFAPKGKLSKYLDQEEGSSNVLDWSTRVSIIIGIAK 523
            H NII+L+           FL++D   KG+L  YL ++   S   +  TR  I+  + +
Sbjct: 82  GHPNIIQLKD--TYETNTFFFLVFDLMKKGELFDYLTEKVTLS---EKETR-KIMRALLE 135
Query: 524 GIGYLHSSEVNKPAIVHRNLSVEKVLIDQQFNPLIADCGLHKLLADDIVFSVLKTSAAMG 583
            I  LH     K  IVHR+L  E +L+D   N  + D G    L  D    + +      
Sbjct: 136 VICALH-----KLNIVHRDLKPENILLDDDMNIKLTDFGFSCQL--DPGEKLREVCGTPS 188
Query: 584 YLAPEYVTTGR------FTERSDIFAFGVIILQILTGS 615
           YLAPE +          + +  D+++ GVI+  +L GS
Sbjct: 189 YLAPEIIECSMNDNHPGYGKEVDMWSTGVIMYTLLAGS 226

>pdb|3JVR|A Chain A, Characterization Of The Chk1 Allosteric Inhibitor Binding Site Length = 271

Iteration: 1
 Score = 49.3 bits (116), Expect = 8e-06,   Method: Compositional matrix adjust.
 Identities = 48/207 (23%), Positives = 89/207 (42%), Gaps = 16/207 (7%)
Query: 414 VNLLGKGNFSSVYKGTLR-DGTLVAIRSINVTSCKSEEAEFVKGLYLLTSLRHENIIRLR 472
           V  LG+G +  V     R     VA++ +++           K + +   L HEN+++  
Sbjct: 11  VQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFY 70
Query: 473 GFCCSRGRGEC-FLIYDFAPKGKLSKYLDQEEGSSNVLDWSTRVSIIIGIAKGIGYLHSS 531
           G    R  G   +L  ++   G+L   ++ + G                +  G+ YLH  
Sbjct: 71  G---HRREGNIQYLFLEYCSGGELFDRIEPDIGMPE----PDAQRFFHQLMAGVVYLHGI 123
Query: 532 EVNKPAIVHRNLSVEKVLIDQQFNPLIADCGLHKLLADDIVFSVL-KTSAAMGYLAPEYV 590
                 I HR++  E +L+D++ N  I+D GL  +   +    +L K    + Y+APE +
Sbjct: 124 -----GITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELL 178
Query: 591 TTGRF-TERSDIFAFGVIILQILTGSL 616
               F  E  D+++ G+++  +L G L
Sbjct: 179 KRREFHAEPVDVWSCGIVLTAMLAGEL 205

>pdb|2R0U|A Chain A, Crystal Structure Of Chek1 In Complex With Inhibitor 54 Length = 323

Iteration: 1
 Score = 49.3 bits (116), Expect = 8e-06,   Method: Compositional matrix adjust.
 Identities = 48/207 (23%), Positives = 89/207 (42%), Gaps = 16/207 (7%)
Query: 414 VNLLGKGNFSSVYKGTLR-DGTLVAIRSINVTSCKSEEAEFVKGLYLLTSLRHENIIRLR 472
           V  LG+G +  V     R     VA++ +++           K + +   L HEN+++  
Sbjct: 12  VQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFY 71
Query: 473 GFCCSRGRGEC-FLIYDFAPKGKLSKYLDQEEGSSNVLDWSTRVSIIIGIAKGIGYLHSS 531
           G    R  G   +L  ++   G+L   ++ + G                +  G+ YLH  
Sbjct: 72  G---HRREGNIQYLFLEYCSGGELFDRIEPDIGMPE----PDAQRFFHQLMAGVVYLHGI 124
Query: 532 EVNKPAIVHRNLSVEKVLIDQQFNPLIADCGLHKLLADDIVFSVL-KTSAAMGYLAPEYV 590
                 I HR++  E +L+D++ N  I+D GL  +   +    +L K    + Y+APE +
Sbjct: 125 -----GITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELL 179
Query: 591 TTGRF-TERSDIFAFGVIILQILTGSL 616
               F  E  D+++ G+++  +L G L
Sbjct: 180 KRREFHAEPVDVWSCGIVLTAMLAGEL 206

>pdb|2PHK|A Chain A, The Crystal Structure Of A Phosphorylase Kinase Peptide Substrate Complex: Kinase Substrate Recognition Length = 277

Iteration: 1
 Score = 49.3 bits (116), Expect = 8e-06,   Method: Compositional matrix adjust.
 Identities = 65/218 (29%), Positives = 98/218 (44%), Gaps = 31/218 (14%)
Query: 415 NLLGKGNFSSVYKGTLRDGTL--VAIRSINVTSCKSEEAEFVKGLYLLT-----SLR--- 464
            +LG+G  SSV +  +   T    A++ I+VT   S  AE V+ L   T      LR   
Sbjct: 10  EILGRG-VSSVVRRCIHKPTCKEYAVKIIDVTGGGSFSAEEVQELREATLKEVDILRKVS 68
Query: 465 -HENIIRLRGFCCSRGRGECFLIYDFAPKGKLSKYLDQEEGSSNVLDWSTRVSIIIGIAK 523
            H NII+L+           FL++D   KG+L  YL ++   S   +  TR  I+  + +
Sbjct: 69  GHPNIIQLKD--TYETNTFFFLVFDLMKKGELFDYLTEKVTLS---EKETR-KIMRALLE 122
Query: 524 GIGYLHSSEVNKPAIVHRNLSVEKVLIDQQFNPLIADCGLHKLLADDIVFSVLKTSAAMG 583
            I  LH     K  IVHR+L  E +L+D   N  + D G    L  D    + +      
Sbjct: 123 VICALH-----KLNIVHRDLKPENILLDDDMNIKLTDFGFSCQL--DPGEKLREVCGTPS 175
Query: 584 YLAPEYVTTGR------FTERSDIFAFGVIILQILTGS 615
           YLAPE +          + +  D+++ GVI+  +L GS
Sbjct: 176 YLAPEIIECSMNDNHPGYGKEVDMWSTGVIMYTLLAGS 213

>pdb|2BR1|A Chain A, Structure-Based Design Of Novel Chk1 Inhibitors: Insights Into Hydrogen Bonding And Protein-Ligand Affinity Length = 297

Iteration: 1
 Score = 49.3 bits (116), Expect = 8e-06,   Method: Compositional matrix adjust.
 Identities = 48/207 (23%), Positives = 89/207 (42%), Gaps = 16/207 (7%)
Query: 414 VNLLGKGNFSSVYKGTLR-DGTLVAIRSINVTSCKSEEAEFVKGLYLLTSLRHENIIRLR 472
           V  LG+G +  V     R     VA++ +++           K + +   L HEN+++  
Sbjct: 12  VQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFY 71
Query: 473 GFCCSRGRGEC-FLIYDFAPKGKLSKYLDQEEGSSNVLDWSTRVSIIIGIAKGIGYLHSS 531
           G    R  G   +L  ++   G+L   ++ + G                +  G+ YLH  
Sbjct: 72  G---HRREGNIQYLFLEYCSGGELFDRIEPDIGMPE----PDAQRFFHQLMAGVVYLHGI 124
Query: 532 EVNKPAIVHRNLSVEKVLIDQQFNPLIADCGLHKLLADDIVFSVL-KTSAAMGYLAPEYV 590
                 I HR++  E +L+D++ N  I+D GL  +   +    +L K    + Y+APE +
Sbjct: 125 -----GITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELL 179
Query: 591 TTGRF-TERSDIFAFGVIILQILTGSL 616
               F  E  D+++ G+++  +L G L
Sbjct: 180 KRREFHAEPVDVWSCGIVLTAMLAGEL 206

>pdb|1IA8|A Chain A, The 1.7 A Crystal Structure Of Human Cell Cycle Checkpoint Kinase Chk1 Length = 289

Iteration: 1
 Score = 49.3 bits (116), Expect = 8e-06,   Method: Compositional matrix adjust.
 Identities = 48/207 (23%), Positives = 89/207 (42%), Gaps = 16/207 (7%)
Query: 414 VNLLGKGNFSSVYKGTLR-DGTLVAIRSINVTSCKSEEAEFVKGLYLLTSLRHENIIRLR 472
           V  LG+G +  V     R     VA++ +++           K + +   L HEN+++  
Sbjct: 12  VQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFY 71
Query: 473 GFCCSRGRGEC-FLIYDFAPKGKLSKYLDQEEGSSNVLDWSTRVSIIIGIAKGIGYLHSS 531
           G    R  G   +L  ++   G+L   ++ + G                +  G+ YLH  
Sbjct: 72  G---HRREGNIQYLFLEYCSGGELFDRIEPDIGMPE----PDAQRFFHQLMAGVVYLHGI 124
Query: 532 EVNKPAIVHRNLSVEKVLIDQQFNPLIADCGLHKLLADDIVFSVL-KTSAAMGYLAPEYV 590
                 I HR++  E +L+D++ N  I+D GL  +   +    +L K    + Y+APE +
Sbjct: 125 -----GITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELL 179
Query: 591 TTGRF-TERSDIFAFGVIILQILTGSL 616
               F  E  D+++ G+++  +L G L
Sbjct: 180 KRREFHAEPVDVWSCGIVLTAMLAGEL 206

>pdb|1ZLT|A Chain A, Crystal Structure Of Chk1 Complexed With A Hymenaldisine Analog Length = 295

Iteration: 1
 Score = 49.3 bits (116), Expect = 8e-06,   Method: Compositional matrix adjust.
 Identities = 48/207 (23%), Positives = 89/207 (42%), Gaps = 16/207 (7%)
Query: 414 VNLLGKGNFSSVYKGTLR-DGTLVAIRSINVTSCKSEEAEFVKGLYLLTSLRHENIIRLR 472
           V  LG+G +  V     R     VA++ +++           K + +   L HEN+++  
Sbjct: 12  VQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFY 71
Query: 473 GFCCSRGRGEC-FLIYDFAPKGKLSKYLDQEEGSSNVLDWSTRVSIIIGIAKGIGYLHSS 531
           G    R  G   +L  ++   G+L   ++ + G                +  G+ YLH  
Sbjct: 72  G---HRREGNIQYLFLEYCSGGELFDRIEPDIGMPE----PDAQRFFHQLMAGVVYLHGI 124
Query: 532 EVNKPAIVHRNLSVEKVLIDQQFNPLIADCGLHKLLADDIVFSVL-KTSAAMGYLAPEYV 590
                 I HR++  E +L+D++ N  I+D GL  +   +    +L K    + Y+APE +
Sbjct: 125 -----GITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELL 179
Query: 591 TTGRF-TERSDIFAFGVIILQILTGSL 616
               F  E  D+++ G+++  +L G L
Sbjct: 180 KRREFHAEPVDVWSCGIVLTAMLAGEL 206

>pdb|4FSN|A Chain A, Crystal Structure Of The Chk1 Length = 278

Iteration: 1
 Score = 49.3 bits (116), Expect = 8e-06,   Method: Compositional matrix adjust.
 Identities = 48/207 (23%), Positives = 89/207 (42%), Gaps = 16/207 (7%)
Query: 414 VNLLGKGNFSSVYKGTLR-DGTLVAIRSINVTSCKSEEAEFVKGLYLLTSLRHENIIRLR 472
           V  LG+G +  V     R     VA++ +++           K + +   L HEN+++  
Sbjct: 10  VQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFY 69
Query: 473 GFCCSRGRGEC-FLIYDFAPKGKLSKYLDQEEGSSNVLDWSTRVSIIIGIAKGIGYLHSS 531
           G    R  G   +L  ++   G+L   ++ + G                +  G+ YLH  
Sbjct: 70  G---HRREGNIQYLFLEYCSGGELFDRIEPDIGMPE----PDAQRFFHQLMAGVVYLHGI 122
Query: 532 EVNKPAIVHRNLSVEKVLIDQQFNPLIADCGLHKLLADDIVFSVL-KTSAAMGYLAPEYV 590
                 I HR++  E +L+D++ N  I+D GL  +   +    +L K    + Y+APE +
Sbjct: 123 -----GITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELL 177
Query: 591 TTGRF-TERSDIFAFGVIILQILTGSL 616
               F  E  D+++ G+++  +L G L
Sbjct: 178 KRREFHAEPVDVWSCGIVLTAMLAGEL 204

>pdb|2O5K|A Chain A, Crystal Structure Of Gsk3beta In Complex With A Benzoimidazol Inhibitor Length = 372

Iteration: 1
 Score = 49.3 bits (116), Expect = 8e-06,   Method: Compositional matrix adjust.
 Identities = 52/219 (23%), Positives = 106/219 (48%), Gaps = 28/219 (12%)
Query: 411 FSEVNLLGKGNFSSVYKGTLRD-GTLVAIRSINVTSCKSEEAEFV-KGLYLLTSLRHENI 468
           +++  ++G G+F  VY+  L D G LVAI+ +       ++  F  + L ++  L H NI
Sbjct: 35  YTDTKVIGNGSFGVVYQAKLCDSGELVAIKKV------LQDKRFKNRELQIMRKLDHCNI 88
Query: 469 IRLRGFCCSRG--RGECF--LIYDFAPKG--KLSKYLDQEEGSSNVLDWSTRVSIIIGIA 522
           +RLR F  S G  + E +  L+ D+ P+   +++++  + + +  V+        +  + 
Sbjct: 89  VRLRYFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKL---YMYQLF 145
Query: 523 KGIGYLHSSEVNKPAIVHRNLSVEKVLIDQQFNPL-IADCGLHK-LLADDIVFSVLKTSA 580
           + + Y+HS       I HR++  + +L+D     L + D G  K L+  +   S +    
Sbjct: 146 RSLAYIHSF-----GICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPNVSYI---C 197
Query: 581 AMGYLAPEYVT-TGRFTERSDIFAFGVIILQILTGSLVL 618
           +  Y APE +     +T   D+++ G ++ ++L G  + 
Sbjct: 198 SRYYRAPELIFGATDYTSSIDVWSAGCVLAELLLGQPIF 236

>pdb|1GII|A Chain A, Human Cyclin Dependent Kinase 2 Complexed With The Cdk4 Inhibitor Length = 298

Iteration: 1
 Score = 48.9 bits (115), Expect = 8e-06,   Method: Compositional matrix adjust.
 Identities = 47/206 (22%), Positives = 97/206 (47%), Gaps = 14/206 (6%)
Query: 411 FSEVNLLGKGNFSSVYKGTLR-DGTLVAIRSINV-TSCKSEEAEFVKGLYLLTSLRHENI 468
           F +V  +G+G +  VYK   +  G +VA++ I + T  +   +  ++ + LL  L H NI
Sbjct: 4   FQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNI 63
Query: 469 IRLRGFCCSRGRGECFLIYDFAPKGKLSKYLDQEEGSSNVLDWSTRVSIIIGIAKGIGYL 528
           ++L     +  +   +L+++   +  L  ++D    +   L      S +  + +G+ + 
Sbjct: 64  VKLLDVIHTENK--LYLVFEHVHQD-LKTFMDASALTGIPLPLIK--SYLFQLLQGLAFC 118
Query: 529 HSSEVNKPAIVHRNLSVEKVLIDQQFNPLIADCGLHKLLADDIVFSVLKTSAAMGYLAPE 588
           HS  V     +HR+L  + +LI+ +    +AD GL +      V +       + Y APE
Sbjct: 119 HSHRV-----LHRDLKPQNLLINTEGAIKLADFGLARAFGVP-VRTYTHEVVTLWYRAPE 172
Query: 589 YVTTGRFTERS-DIFAFGVIILQILT 613
            +   ++   + DI++ G I  +++T
Sbjct: 173 ILLGCKYYSTAVDIWSLGCIFAEMVT 198

>pdb|1GNG|A Chain A, Glycogen Synthase Kinase-3 Beta (Gsk3) Complex With Frattide Peptide Length = 378

Iteration: 1
 Score = 48.9 bits (115), Expect = 8e-06,   Method: Compositional matrix adjust.
 Identities = 52/219 (23%), Positives = 106/219 (48%), Gaps = 28/219 (12%)
Query: 411 FSEVNLLGKGNFSSVYKGTLRD-GTLVAIRSINVTSCKSEEAEFV-KGLYLLTSLRHENI 468
           +++  ++G G+F  VY+  L D G LVAI+ +       ++  F  + L ++  L H NI
Sbjct: 41  YTDTKVIGNGSFGVVYQAKLCDSGELVAIKKV------LQDKRFKNRELQIMRKLDHCNI 94
Query: 469 IRLRGFCCSRG--RGECF--LIYDFAPKG--KLSKYLDQEEGSSNVLDWSTRVSIIIGIA 522
           +RLR F  S G  + E +  L+ D+ P+   +++++  + + +  V+        +  + 
Sbjct: 95  VRLRYFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKL---YMYQLF 151
Query: 523 KGIGYLHSSEVNKPAIVHRNLSVEKVLIDQQFNPL-IADCGLHK-LLADDIVFSVLKTSA 580
           + + Y+HS       I HR++  + +L+D     L + D G  K L+  +   S +    
Sbjct: 152 RSLAYIHSF-----GICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPNVSXI---C 203
Query: 581 AMGYLAPEYVT-TGRFTERSDIFAFGVIILQILTGSLVL 618
           +  Y APE +     +T   D+++ G ++ ++L G  + 
Sbjct: 204 SRYYRAPELIFGATDYTSSIDVWSAGCVLAELLLGQPIF 242

>pdb|4FST|A Chain A, Crystal Structure Of The Chk1 Length = 269

Iteration: 1
 Score = 48.9 bits (115), Expect = 8e-06,   Method: Compositional matrix adjust.
 Identities = 48/207 (23%), Positives = 89/207 (42%), Gaps = 16/207 (7%)
Query: 414 VNLLGKGNFSSVYKGTLR-DGTLVAIRSINVTSCKSEEAEFVKGLYLLTSLRHENIIRLR 472
           V  LG+G +  V     R     VA++ +++           K + +   L HEN+++  
Sbjct: 11  VQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFY 70
Query: 473 GFCCSRGRGEC-FLIYDFAPKGKLSKYLDQEEGSSNVLDWSTRVSIIIGIAKGIGYLHSS 531
           G    R  G   +L  ++   G+L   ++ + G                +  G+ YLH  
Sbjct: 71  G---HRREGNIQYLFLEYCSGGELFDRIEPDIGMPE----PDAQRFFHQLMAGVVYLHGI 123
Query: 532 EVNKPAIVHRNLSVEKVLIDQQFNPLIADCGLHKLLADDIVFSVL-KTSAAMGYLAPEYV 590
                 I HR++  E +L+D++ N  I+D GL  +   +    +L K    + Y+APE +
Sbjct: 124 -----GITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMXGTLPYVAPELL 178
Query: 591 TTGRF-TERSDIFAFGVIILQILTGSL 616
               F  E  D+++ G+++  +L G L
Sbjct: 179 KRREFHAEPVDVWSCGIVLTAMLAGEL 205

>pdb|4AFJ|A Chain A, 5-Aryl-4-Carboxamide-1,3-Oxazoles: Potent And Selective Gsk-3 Inhibitors Length = 367

Iteration: 1
 Score = 48.9 bits (115), Expect = 8e-06,   Method: Compositional matrix adjust.
 Identities = 52/219 (23%), Positives = 106/219 (48%), Gaps = 28/219 (12%)
Query: 411 FSEVNLLGKGNFSSVYKGTLRD-GTLVAIRSINVTSCKSEEAEFV-KGLYLLTSLRHENI 468
           +++  ++G G+F  VY+  L D G LVAI+ +       ++  F  + L ++  L H NI
Sbjct: 30  YTDTKVIGNGSFGVVYQAKLCDSGELVAIKKV------LQDKRFKNRELQIMRKLDHCNI 83
Query: 469 IRLRGFCCSRG--RGECF--LIYDFAPKG--KLSKYLDQEEGSSNVLDWSTRVSIIIGIA 522
           +RLR F  S G  + E +  L+ D+ P+   +++++  + + +  V+        +  + 
Sbjct: 84  VRLRYFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKL---YMYQLF 140
Query: 523 KGIGYLHSSEVNKPAIVHRNLSVEKVLIDQQFNPL-IADCGLHK-LLADDIVFSVLKTSA 580
           + + Y+HS       I HR++  + +L+D     L + D G  K L+  +   S +    
Sbjct: 141 RSLAYIHSF-----GICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPNVSXI---C 192
Query: 581 AMGYLAPEYVT-TGRFTERSDIFAFGVIILQILTGSLVL 618
           +  Y APE +     +T   D+++ G ++ ++L G  + 
Sbjct: 193 SRYYRAPELIFGATDYTSSIDVWSAGCVLAELLLGQPIF 231

>pdb|4FSM|A Chain A, Crystal Structure Of The Chk1 Length = 279

Iteration: 1
 Score = 48.9 bits (115), Expect = 8e-06,   Method: Compositional matrix adjust.
 Identities = 48/207 (23%), Positives = 89/207 (42%), Gaps = 16/207 (7%)
Query: 414 VNLLGKGNFSSVYKGTLR-DGTLVAIRSINVTSCKSEEAEFVKGLYLLTSLRHENIIRLR 472
           V  LG+G +  V     R     VA++ +++           K + +   L HEN+++  
Sbjct: 11  VQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFY 70
Query: 473 GFCCSRGRGEC-FLIYDFAPKGKLSKYLDQEEGSSNVLDWSTRVSIIIGIAKGIGYLHSS 531
           G    R  G   +L  ++   G+L   ++ + G                +  G+ YLH  
Sbjct: 71  G---HRREGNIQYLFLEYCSGGELFDRIEPDIGMPE----PDAQRFFHQLMAGVVYLHGI 123
Query: 532 EVNKPAIVHRNLSVEKVLIDQQFNPLIADCGLHKLLADDIVFSVL-KTSAAMGYLAPEYV 590
                 I HR++  E +L+D++ N  I+D GL  +   +    +L K    + Y+APE +
Sbjct: 124 -----GITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELL 178
Query: 591 TTGRF-TERSDIFAFGVIILQILTGSL 616
               F  E  D+++ G+++  +L G L
Sbjct: 179 KRREFHAEPVDVWSCGIVLTAMLAGEL 205

>pdb|3OT3|A Chain A, X-Ray Crystal Structure Of Compound 22k Bound To Human Chk1 Kinase Domain Length = 273

Iteration: 1
 Score = 48.9 bits (115), Expect = 8e-06,   Method: Compositional matrix adjust.
 Identities = 48/207 (23%), Positives = 89/207 (42%), Gaps = 16/207 (7%)
Query: 414 VNLLGKGNFSSVYKGTLR-DGTLVAIRSINVTSCKSEEAEFVKGLYLLTSLRHENIIRLR 472
           V  LG+G +  V     R     VA++ +++           K + +   L HEN+++  
Sbjct: 11  VQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFY 70
Query: 473 GFCCSRGRGEC-FLIYDFAPKGKLSKYLDQEEGSSNVLDWSTRVSIIIGIAKGIGYLHSS 531
           G    R  G   +L  ++   G+L   ++ + G                +  G+ YLH  
Sbjct: 71  G---HRREGNIQYLFLEYCSGGELFDRIEPDIGMPE----PDAQRFFHQLMAGVVYLHGI 123
Query: 532 EVNKPAIVHRNLSVEKVLIDQQFNPLIADCGLHKLLADDIVFSVL-KTSAAMGYLAPEYV 590
                 I HR++  E +L+D++ N  I+D GL  +   +    +L K    + Y+APE +
Sbjct: 124 -----GITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELL 178
Query: 591 TTGRF-TERSDIFAFGVIILQILTGSL 616
               F  E  D+++ G+++  +L G L
Sbjct: 179 KRREFHAEPVDVWSCGIVLTAMLAGEL 205

>pdb|4FSW|A Chain A, Crystal Structure Of The Chk1 Length = 279

Iteration: 1
 Score = 48.9 bits (115), Expect = 9e-06,   Method: Compositional matrix adjust.
 Identities = 48/207 (23%), Positives = 89/207 (42%), Gaps = 16/207 (7%)
Query: 414 VNLLGKGNFSSVYKGTLR-DGTLVAIRSINVTSCKSEEAEFVKGLYLLTSLRHENIIRLR 472
           V  LG+G +  V     R     VA++ +++           K + +   L HEN+++  
Sbjct: 11  VQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFY 70
Query: 473 GFCCSRGRGEC-FLIYDFAPKGKLSKYLDQEEGSSNVLDWSTRVSIIIGIAKGIGYLHSS 531
           G    R  G   +L  ++   G+L   ++ + G                +  G+ YLH  
Sbjct: 71  G---HRREGNIQYLFLEYCSGGELFDRIEPDIGMPE----PDAQRFFHQLMAGVVYLHGI 123
Query: 532 EVNKPAIVHRNLSVEKVLIDQQFNPLIADCGLHKLLADDIVFSVL-KTSAAMGYLAPEYV 590
                 I HR++  E +L+D++ N  I+D GL  +   +    +L K    + Y+APE +
Sbjct: 124 -----GITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMXGTLPYVAPELL 178
Query: 591 TTGRF-TERSDIFAFGVIILQILTGSL 616
               F  E  D+++ G+++  +L G L
Sbjct: 179 KRREFHAEPVDVWSCGIVLTAMLAGEL 205

>pdb|2JDO|A Chain A, Structure Of Pkb-Beta (Akt2) Complexed With Isoquinoline-5- Sulfonic Acid (2-(2-(4-Chlorobenzyloxy) Ethylamino)ethyl) Amide Length = 342

Iteration: 1
 Score = 48.9 bits (115), Expect = 9e-06,   Method: Compositional matrix adjust.
 Identities = 56/210 (26%), Positives = 92/210 (43%), Gaps = 17/210 (8%)
Query: 411 FSEVNLLGKGNFSSVY----KGTLRDGTLVAIRSINVTSCKSEEAEFVKGLYLLTSLRHE 466
           F  + LLGKG F  V     K T R   +  +R   V   K E A  V    +L + RH 
Sbjct: 12  FDYLKLLGKGTFGKVILVREKATGRYYAMKILRK-EVIIAKDEVAHTVTESRVLQNTRHP 70
Query: 467 NIIRLRGFCCSRGRGECFLIYDFAPKGKLSKYLDQEEGSSNVLDWSTRVSIIIGIAKGIG 526
            +  L+    +  R  CF++ ++A  G+L  +L +E     V            I   + 
Sbjct: 71  FLTALKYAFQTHDRL-CFVM-EYANGGELFFHLSRE----RVFTEERARFYGAEIVSALE 124
Query: 527 YLHSSEVNKPAIVHRNLSVEKVLIDQQFNPLIADCGLHKLLADDIVFSVLKTSAAMGYLA 586
           YLHS +V     V+R++ +E +++D+  +  I D GL K    D   ++        YLA
Sbjct: 125 YLHSRDV-----VYRDIKLENLMLDKDGHIKITDFGLCKEGISDGA-TMKXFCGTPEYLA 178
Query: 587 PEYVTTGRFTERSDIFAFGVIILQILTGSL 616
           PE +    +    D +  GV++ +++ G L
Sbjct: 179 PEVLEDNDYGRAVDWWGLGVVMYEMMCGRL 208

>pdb|2X8E|A Chain A, Discovery Of A Novel Class Of Triazolones As Checkpoint Kinase Inhibitors - Hit To Lead Exploration Length = 276

Iteration: 1
 Score = 48.9 bits (115), Expect = 9e-06,   Method: Compositional matrix adjust.
 Identities = 48/207 (23%), Positives = 89/207 (42%), Gaps = 16/207 (7%)
Query: 414 VNLLGKGNFSSVYKGTLR-DGTLVAIRSINVTSCKSEEAEFVKGLYLLTSLRHENIIRLR 472
           V  LG+G +  V     R     VA++ +++           K + +   L HEN+++  
Sbjct: 12  VQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFY 71
Query: 473 GFCCSRGRGEC-FLIYDFAPKGKLSKYLDQEEGSSNVLDWSTRVSIIIGIAKGIGYLHSS 531
           G    R  G   +L  ++   G+L   ++ + G                +  G+ YLH  
Sbjct: 72  G---HRREGNIQYLFLEYCSGGELFDRIEPDIGMPE----PDAQRFFHQLMAGVVYLHGI 124
Query: 532 EVNKPAIVHRNLSVEKVLIDQQFNPLIADCGLHKLLADDIVFSVL-KTSAAMGYLAPEYV 590
                 I HR++  E +L+D++ N  I+D GL  +   +    +L K    + Y+APE +
Sbjct: 125 -----GITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELL 179
Query: 591 TTGRF-TERSDIFAFGVIILQILTGSL 616
               F  E  D+++ G+++  +L G L
Sbjct: 180 KRREFHAEPVDVWSCGIVLTAMLAGEL 206

>pdb|3H4J|B Chain B, Crystal Structure Of Pombe Ampk Kdaid Fragment Length = 336

Iteration: 1
 Score = 48.9 bits (115), Expect = 9e-06,   Method: Compositional matrix adjust.
 Identities = 55/205 (26%), Positives = 95/205 (46%), Gaps = 20/205 (9%)
Query: 417 LGKGNFSSVYKGT-LRDGTLVAIRSINVTSCKSEEAEFV--KGLYLLTSLRHENIIRLRG 473
           LG+G+F  V   T  +    VA++ I+    K  +      + +  L  LRH +II+L  
Sbjct: 17  LGEGSFGKVKLATHYKTQQKVALKFISRQLLKKSDMHMRVEREISYLKLLRHPHIIKLYD 76
Query: 474 FCCSRGRGECFLIYDFAPKGKLSKYLDQEEGSSNVLDWSTRVSIIIGIAKGIGYLHSSEV 533
              +    +  ++ ++A  G+L  Y+ +++  +   D   R      I   I Y H  + 
Sbjct: 77  VITTPT--DIVMVIEYA-GGELFDYIVEKKRMTE--DEGRR--FFQQIICAIEYCHRHK- 128
Query: 534 NKPAIVHRNLSVEKVLIDQQFNPLIADCGLHKLLADDIVFSVLKTS-AAMGYLAPEYVTT 592
               IVHR+L  E +L+D   N  IAD GL  ++ D    + LKTS  +  Y APE +  
Sbjct: 129 ----IVHRDLKPENLLLDDNLNVKIADFGLSNIMTDG---NFLKTSCGSPNYAAPEVING 181
Query: 593 GRFT-ERSDIFAFGVIILQILTGSL 616
             +     D+++ G+++  +L G L
Sbjct: 182 KLYAGPEVDVWSCGIVLYVMLVGRL 206

>pdb|1O6K|A Chain A, Structure Of Activated Form Of Pkb Kinase Domain S474d With Gsk3 Peptide And Amp-Pnp Length = 336

Iteration: 1
 Score = 48.9 bits (115), Expect = 9e-06,   Method: Compositional matrix adjust.
 Identities = 56/210 (26%), Positives = 92/210 (43%), Gaps = 17/210 (8%)
Query: 411 FSEVNLLGKGNFSSVY----KGTLRDGTLVAIRSINVTSCKSEEAEFVKGLYLLTSLRHE 466
           F  + LLGKG F  V     K T R   +  +R   V   K E A  V    +L + RH 
Sbjct: 7   FDYLKLLGKGTFGKVILVREKATGRYYAMKILRK-EVIIAKDEVAHTVTESRVLQNTRHP 65
Query: 467 NIIRLRGFCCSRGRGECFLIYDFAPKGKLSKYLDQEEGSSNVLDWSTRVSIIIGIAKGIG 526
            +  L+    +  R  CF++ ++A  G+L  +L +E     V            I   + 
Sbjct: 66  FLTALKYAFQTHDRL-CFVM-EYANGGELFFHLSRE----RVFTEERARFYGAEIVSALE 119
Query: 527 YLHSSEVNKPAIVHRNLSVEKVLIDQQFNPLIADCGLHKLLADDIVFSVLKTSAAMGYLA 586
           YLHS +V     V+R++ +E +++D+  +  I D GL K    D   ++        YLA
Sbjct: 120 YLHSRDV-----VYRDIKLENLMLDKDGHIKITDFGLCKEGISDGA-TMKXFCGTPEYLA 173
Query: 587 PEYVTTGRFTERSDIFAFGVIILQILTGSL 616
           PE +    +    D +  GV++ +++ G L
Sbjct: 174 PEVLEDNDYGRAVDWWGLGVVMYEMMCGRL 203

>pdb|3F7Z|A Chain A, X-ray Co-crystal Structure Of Glycogen Synthase Kinase 3beta In Complex With An Inhibitor Length = 350

Iteration: 1
 Score = 48.9 bits (115), Expect = 9e-06,   Method: Compositional matrix adjust.
 Identities = 51/218 (23%), Positives = 103/218 (47%), Gaps = 26/218 (11%)
Query: 411 FSEVNLLGKGNFSSVYKGTLRD-GTLVAIRSINVTSCKSEEAEFV-KGLYLLTSLRHENI 468
           +++  ++G G+F  VY+  L D G LVAI+ +       ++  F  + L ++  L H NI
Sbjct: 23  YTDTKVIGNGSFGVVYQAKLCDSGELVAIKKV------LQDKRFKNRELQIMRKLDHCNI 76
Query: 469 IRLRGFCCSRG--RGECF--LIYDFAPKG--KLSKYLDQEEGSSNVLDWSTRVSIIIGIA 522
           +RLR F  S G  + E +  L+ D+ P+   +++++  + + +  V+        +  + 
Sbjct: 77  VRLRYFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKL---YMYQLF 133
Query: 523 KGIGYLHSSEVNKPAIVHRNLSVEKVLIDQQFNPL-IADCGLHKLLADDIVFSVLKTSAA 581
           + + Y+HS       I HR++  + +L+D     L + D G  K L        +    +
Sbjct: 134 RSLAYIHSF-----GICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGE--PNVSXICS 186
Query: 582 MGYLAPEYVTTGR-FTERSDIFAFGVIILQILTGSLVL 618
             Y APE +     +T   D+++ G ++ ++L G  + 
Sbjct: 187 RYYRAPELIFGATDYTSSIDVWSAGCVLAELLLGQPIF 224

>pdb|3E87|A Chain A, Crystal Structures Of The Kinase Domain Of Akt2 In Complex With Atp- Competitive Inhibitors Length = 335

Iteration: 1
 Score = 48.9 bits (115), Expect = 9e-06,   Method: Compositional matrix adjust.
 Identities = 56/210 (26%), Positives = 92/210 (43%), Gaps = 17/210 (8%)
Query: 411 FSEVNLLGKGNFSSVY----KGTLRDGTLVAIRSINVTSCKSEEAEFVKGLYLLTSLRHE 466
           F  + LLGKG F  V     K T R   +  +R   V   K E A  V    +L + RH 
Sbjct: 7   FDYLKLLGKGTFGKVILVREKATGRYYAMKILRK-EVIIAKDEVAHTVTESRVLQNTRHP 65
Query: 467 NIIRLRGFCCSRGRGECFLIYDFAPKGKLSKYLDQEEGSSNVLDWSTRVSIIIGIAKGIG 526
            +  L+    +  R  CF++ ++A  G+L  +L +E     V            I   + 
Sbjct: 66  FLTALKYAFQTHDRL-CFVM-EYANGGELFFHLSRE----RVFTEERARFYGAEIVSALE 119
Query: 527 YLHSSEVNKPAIVHRNLSVEKVLIDQQFNPLIADCGLHKLLADDIVFSVLKTSAAMGYLA 586
           YLHS +V     V+R++ +E +++D+  +  I D GL K    D   ++        YLA
Sbjct: 120 YLHSRDV-----VYRDIKLENLMLDKDGHIKITDFGLCKEGISDGA-TMKXFCGTPEYLA 173
Query: 587 PEYVTTGRFTERSDIFAFGVIILQILTGSL 616
           PE +    +    D +  GV++ +++ G L
Sbjct: 174 PEVLEDNDYGRAVDWWGLGVVMYEMMCGRL 203

>pdb|4DIT|A Chain A, Crystal Structure Of Gsk3beta In Complex With A Imidazopyridine Inhibitor Length = 382

Iteration: 1
 Score = 48.9 bits (115), Expect = 9e-06,   Method: Compositional matrix adjust.
 Identities = 52/219 (23%), Positives = 106/219 (48%), Gaps = 28/219 (12%)
Query: 411 FSEVNLLGKGNFSSVYKGTLRD-GTLVAIRSINVTSCKSEEAEFV-KGLYLLTSLRHENI 468
           +++  ++G G+F  VY+  L D G LVAI+ +       ++  F  + L ++  L H NI
Sbjct: 34  YTDTKVIGNGSFGVVYQAKLCDSGELVAIKKV------LQDKRFKNRELQIMRKLDHCNI 87
Query: 469 IRLRGFCCSRG--RGECF--LIYDFAPKG--KLSKYLDQEEGSSNVLDWSTRVSIIIGIA 522
           +RLR F  S G  + E +  L+ D+ P+   +++++  + + +  V+        +  + 
Sbjct: 88  VRLRYFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKL---YMYQLF 144
Query: 523 KGIGYLHSSEVNKPAIVHRNLSVEKVLIDQQFNPL-IADCGLHK-LLADDIVFSVLKTSA 580
           + + Y+HS       I HR++  + +L+D     L + D G  K L+  +   S +    
Sbjct: 145 RSLAYIHSF-----GICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPNVSXI---C 196
Query: 581 AMGYLAPEYVTTGR-FTERSDIFAFGVIILQILTGSLVL 618
           +  Y APE +     +T   D+++ G ++ ++L G  + 
Sbjct: 197 SRYYRAPELIFGATDYTSSIDVWSAGCVLAELLLGQPIF 235

>pdb|3ZRK|A Chain A, Identification Of 2-(4-Pyridyl)thienopyridinones As Gsk-3beta Inhibitors Length = 371

Iteration: 1
 Score = 48.9 bits (115), Expect = 1e-05,   Method: Compositional matrix adjust.
 Identities = 52/219 (23%), Positives = 106/219 (48%), Gaps = 28/219 (12%)
Query: 411 FSEVNLLGKGNFSSVYKGTLRD-GTLVAIRSINVTSCKSEEAEFV-KGLYLLTSLRHENI 468
           +++  ++G G+F  VY+  L D G LVAI+ +       ++  F  + L ++  L H NI
Sbjct: 34  YTDTKVIGNGSFGVVYQAKLCDSGELVAIKKV------LQDKRFKNRELQIMRKLDHCNI 87
Query: 469 IRLRGFCCSRG--RGECF--LIYDFAPKG--KLSKYLDQEEGSSNVLDWSTRVSIIIGIA 522
           +RLR F  S G  + E +  L+ D+ P+   +++++  + + +  V+        +  + 
Sbjct: 88  VRLRYFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKL---YMYQLF 144
Query: 523 KGIGYLHSSEVNKPAIVHRNLSVEKVLIDQQFNPL-IADCGLHK-LLADDIVFSVLKTSA 580
           + + Y+HS       I HR++  + +L+D     L + D G  K L+  +   S +    
Sbjct: 145 RSLAYIHSF-----GICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPNVSXI---C 196
Query: 581 AMGYLAPEYVTTGR-FTERSDIFAFGVIILQILTGSLVL 618
           +  Y APE +     +T   D+++ G ++ ++L G  + 
Sbjct: 197 SRYYRAPELIFGATDYTSSIDVWSAGCVLAELLLGQPIF 235

>pdb|3GB2|A Chain A, Gsk3beta Inhibitor Complex Length = 353

Iteration: 1
 Score = 48.9 bits (115), Expect = 1e-05,   Method: Compositional matrix adjust.
 Identities = 51/218 (23%), Positives = 103/218 (47%), Gaps = 26/218 (11%)
Query: 411 FSEVNLLGKGNFSSVYKGTLRD-GTLVAIRSINVTSCKSEEAEFV-KGLYLLTSLRHENI 468
           +++  ++G G+F  VY+  L D G LVAI+ +       ++  F  + L ++  L H NI
Sbjct: 26  YTDTKVIGNGSFGVVYQAKLCDSGELVAIKKV------LQDKRFKNRELQIMRKLDHCNI 79
Query: 469 IRLRGFCCSRG--RGECF--LIYDFAPKG--KLSKYLDQEEGSSNVLDWSTRVSIIIGIA 522
           +RLR F  S G  + E +  L+ D+ P+   +++++  + + +  V+        +  + 
Sbjct: 80  VRLRYFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKL---YMYQLF 136
Query: 523 KGIGYLHSSEVNKPAIVHRNLSVEKVLIDQQFNPL-IADCGLHKLLADDIVFSVLKTSAA 581
           + + Y+HS       I HR++  + +L+D     L + D G  K L        +    +
Sbjct: 137 RSLAYIHSF-----GICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGE--PNVSXICS 189
Query: 582 MGYLAPEYVTTGR-FTERSDIFAFGVIILQILTGSLVL 618
             Y APE +     +T   D+++ G ++ ++L G  + 
Sbjct: 190 RYYRAPELIFGATDYTSSIDVWSAGCVLAELLLGQPIF 227

>pdb|1O6L|A Chain A, Crystal Structure Of An Activated Akt/protein Kinase B (pkb-pif Chimera) Ternary Complex With Amp-pnp And Gsk3 Peptide Length = 337

Iteration: 1
 Score = 48.9 bits (115), Expect = 1e-05,   Method: Compositional matrix adjust.
 Identities = 56/211 (26%), Positives = 93/211 (44%), Gaps = 19/211 (9%)
Query: 411 FSEVNLLGKGNFSSVY----KGTLRDGTLVAIRSINVTSCKSEEAEFVKGLYLLTSLRHE 466
           F  + LLGKG F  V     K T R   +  +R   V   K E A  V    +L + RH 
Sbjct: 7   FDYLKLLGKGTFGKVILVREKATGRYYAMKILRK-EVIIAKDEVAHTVTESRVLQNTRHP 65
Query: 467 NIIRLRGFCCSRGRGECFLIYDFAPKGKLSKYLDQEEGSSNVLDWSTRVSII-IGIAKGI 525
            +  L+    +  R  CF++ ++A  G+L  +L +E   +       R       I   +
Sbjct: 66  FLTALKYAFQTHDRL-CFVM-EYANGGELFFHLSRERVFTE-----ERARFYGAEIVSAL 118
Query: 526 GYLHSSEVNKPAIVHRNLSVEKVLIDQQFNPLIADCGLHKLLADDIVFSVLKTSAAMGYL 585
            YLHS +V     V+R++ +E +++D+  +  I D GL K    D   ++        YL
Sbjct: 119 EYLHSRDV-----VYRDIKLENLMLDKDGHIKITDFGLCKEGISDGA-TMKXFCGTPEYL 172
Query: 586 APEYVTTGRFTERSDIFAFGVIILQILTGSL 616
           APE +    +    D +  GV++ +++ G L
Sbjct: 173 APEVLEDNDYGRAVDWWGLGVVMYEMMCGRL 203

>pdb|4FT3|A Chain A, Crystal Structure Of The Chk1 Length = 279

Iteration: 1
 Score = 48.9 bits (115), Expect = 1e-05,   Method: Compositional matrix adjust.
 Identities = 48/207 (23%), Positives = 89/207 (42%), Gaps = 16/207 (7%)
Query: 414 VNLLGKGNFSSVYKGTLR-DGTLVAIRSINVTSCKSEEAEFVKGLYLLTSLRHENIIRLR 472
           V  LG+G +  V     R     VA++ +++           K + +   L HEN+++  
Sbjct: 11  VQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFY 70
Query: 473 GFCCSRGRGEC-FLIYDFAPKGKLSKYLDQEEGSSNVLDWSTRVSIIIGIAKGIGYLHSS 531
           G    R  G   +L  ++   G+L   ++ + G                +  G+ YLH  
Sbjct: 71  G---HRREGNIQYLFLEYCSGGELFDRIEPDIGMPE----PDAQRFFHQLMAGVVYLHGI 123
Query: 532 EVNKPAIVHRNLSVEKVLIDQQFNPLIADCGLHKLLADDIVFSVL-KTSAAMGYLAPEYV 590
                 I HR++  E +L+D++ N  I+D GL  +   +    +L K    + Y+APE +
Sbjct: 124 -----GITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMXGTLPYVAPELL 178
Query: 591 TTGRF-TERSDIFAFGVIILQILTGSL 616
               F  E  D+++ G+++  +L G L
Sbjct: 179 KRREFHAEPVDVWSCGIVLTAMLAGEL 205

>pdb|2OW3|A Chain A, Glycogen Synthase Kinase-3 Beta In Complex With Bis- (Indole)maleimide Pyridinophane Inhibitor Length = 352

Iteration: 1
 Score = 48.9 bits (115), Expect = 1e-05,   Method: Compositional matrix adjust.
 Identities = 51/218 (23%), Positives = 103/218 (47%), Gaps = 26/218 (11%)
Query: 411 FSEVNLLGKGNFSSVYKGTLRD-GTLVAIRSINVTSCKSEEAEFV-KGLYLLTSLRHENI 468
           +++  ++G G+F  VY+  L D G LVAI+ +       ++  F  + L ++  L H NI
Sbjct: 22  YTDTKVIGNGSFGVVYQAKLCDSGELVAIKKV------LQDKRFKNRELQIMRKLDHCNI 75
Query: 469 IRLRGFCCSRG--RGECF--LIYDFAPKG--KLSKYLDQEEGSSNVLDWSTRVSIIIGIA 522
           +RLR F  S G  + E +  L+ D+ P+   +++++  + + +  V+        +  + 
Sbjct: 76  VRLRYFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKL---YMYQLF 132
Query: 523 KGIGYLHSSEVNKPAIVHRNLSVEKVLIDQQFNPL-IADCGLHKLLADDIVFSVLKTSAA 581
           + + Y+HS       I HR++  + +L+D     L + D G  K L        +    +
Sbjct: 133 RSLAYIHSF-----GICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGE--PNVSXICS 185
Query: 582 MGYLAPEYVT-TGRFTERSDIFAFGVIILQILTGSLVL 618
             Y APE +     +T   D+++ G ++ ++L G  + 
Sbjct: 186 RYYRAPELIFGATDYTSSIDVWSAGCVLAELLLGQPIF 223

>pdb|1H8F|A Chain A, Glycogen Synthase Kinase 3 Beta. Length = 352

Iteration: 1
 Score = 48.9 bits (115), Expect = 1e-05,   Method: Compositional matrix adjust.
 Identities = 53/219 (24%), Positives = 106/219 (48%), Gaps = 28/219 (12%)
Query: 411 FSEVNLLGKGNFSSVYKGTLRD-GTLVAIRSI-NVTSCKSEEAEFVKGLYLLTSLRHENI 468
           +++  ++G G+F  VY+  L D G LVAI+ +    + K+ E      L ++  L H NI
Sbjct: 22  YTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQGKAFKNRE------LQIMRKLDHCNI 75
Query: 469 IRLRGFCCSRG--RGECF--LIYDFAPKG--KLSKYLDQEEGSSNVLDWSTRVSIIIGIA 522
           +RLR F  S G  + E +  L+ D+ P+   +++++  + + +  V+        +  + 
Sbjct: 76  VRLRYFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKL---YMYQLF 132
Query: 523 KGIGYLHSSEVNKPAIVHRNLSVEKVLIDQQFNPL-IADCGLHK-LLADDIVFSVLKTSA 580
           + + Y+HS       I HR++  + +L+D     L + D G  K L+  +   S +    
Sbjct: 133 RSLAYIHSF-----GICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPNVSYI---C 184
Query: 581 AMGYLAPEYVTTGR-FTERSDIFAFGVIILQILTGSLVL 618
           +  Y APE +     +T   D+++ G ++ ++L G  + 
Sbjct: 185 SRYYRAPELIFGATDYTSSIDVWSAGCVLAELLLGQPIF 223

>pdb|3ZDI|A Chain A, Glycogen Synthase Kinase 3 Beta Complexed With Axin Peptide And Inhibitor 7d Length = 350

Iteration: 1
 Score = 48.5 bits (114), Expect = 1e-05,   Method: Compositional matrix adjust.
 Identities = 51/218 (23%), Positives = 103/218 (47%), Gaps = 26/218 (11%)
Query: 411 FSEVNLLGKGNFSSVYKGTLRD-GTLVAIRSINVTSCKSEEAEFV-KGLYLLTSLRHENI 468
           +++  ++G G+F  VY+  L D G LVAI+ +       ++  F  + L ++  L H NI
Sbjct: 22  YTDTKVIGNGSFGVVYQAKLCDSGELVAIKKV------LQDKRFKNRELQIMRKLDHCNI 75
Query: 469 IRLRGFCCSRG--RGECF--LIYDFAPKG--KLSKYLDQEEGSSNVLDWSTRVSIIIGIA 522
           +RLR F  S G  + E +  L+ D+ P+   +++++  + + +  V+        +  + 
Sbjct: 76  VRLRYFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKL---YMYQLF 132
Query: 523 KGIGYLHSSEVNKPAIVHRNLSVEKVLIDQQFNPL-IADCGLHKLLADDIVFSVLKTSAA 581
           + + Y+HS       I HR++  + +L+D     L + D G  K L        +    +
Sbjct: 133 RSLAYIHSF-----GICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGE--PNVSXICS 185
Query: 582 MGYLAPEYVTTGR-FTERSDIFAFGVIILQILTGSLVL 618
             Y APE +     +T   D+++ G ++ ++L G  + 
Sbjct: 186 RYYRAPELIFGATDYTSSIDVWSAGCVLAELLLGQPIF 223

>pdb|3SD0|A Chain A, Identification Of A Glycogen Synthase Kinase-3b Inhibitor That Attenuates Hyperactivity In Clock Mutant Mice Length = 350

Iteration: 1
 Score = 48.5 bits (114), Expect = 1e-05,   Method: Compositional matrix adjust.
 Identities = 52/219 (23%), Positives = 106/219 (48%), Gaps = 28/219 (12%)
Query: 411 FSEVNLLGKGNFSSVYKGTLRD-GTLVAIRSINVTSCKSEEAEFV-KGLYLLTSLRHENI 468
           +++  ++G G+F  VY+  L D G LVAI+ +       ++  F  + L ++  L H NI
Sbjct: 22  YTDTKVIGNGSFGVVYQAKLCDSGELVAIKKV------LQDKRFKNRELQIMRKLDHCNI 75
Query: 469 IRLRGFCCSRG--RGECF--LIYDFAPKG--KLSKYLDQEEGSSNVLDWSTRVSIIIGIA 522
           +RLR F  S G  + E +  L+ D+ P+   +++++  + + +  V+        +  + 
Sbjct: 76  VRLRYFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKL---YMYQLF 132
Query: 523 KGIGYLHSSEVNKPAIVHRNLSVEKVLIDQQFNPL-IADCGLHK-LLADDIVFSVLKTSA 580
           + + Y+HS       I HR++  + +L+D     L + D G  K L+  +   S +    
Sbjct: 133 RSLAYIHSF-----GICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPNVSYI---C 184
Query: 581 AMGYLAPEYVTTGR-FTERSDIFAFGVIILQILTGSLVL 618
           +  Y APE +     +T   D+++ G ++ ++L G  + 
Sbjct: 185 SRYYRAPELIFGATDYTSSIDVWSAGCVLAELLLGQPIF 223

>pdb|1YRP|A Chain A, Catalytic Domain Of Human Zip Kinase Phosphorylated At Thr265 Length = 278

Iteration: 1
 Score = 48.5 bits (114), Expect = 1e-05,   Method: Compositional matrix adjust.
 Identities = 63/233 (27%), Positives = 109/233 (46%), Gaps = 30/233 (12%)
Query: 394 LNSFRLNLEEVESATQCFSEVNLLGKGNFSSV----YKGTLRDGTLVAIRSINVTSCKS- 448
           +++FR   E+VE   +   E   LG G F+ V     KGT ++     I+   ++S +  
Sbjct: 2   MSTFRQ--EDVEDHYEMGEE---LGSGQFAIVRKCRQKGTGKEYAAKFIKKRRLSSSRRG 56
Query: 449 -EEAEFVKGLYLLTSLRHENIIRLRGFCCSRGRGECFLIYDFAPKGKLSKYLDQEEGSSN 507
               E  + + +L  +RH NII L        + +  LI +    G+L  +L ++E  + 
Sbjct: 57  VSREEIEREVNILREIRHPNIITLHDIF--ENKTDVVLILELVSGGELFDFLAEKESLTE 114
Query: 508 VLDWSTRVSIIIGIAKGIGYLHSSEVNKPAIVHRNLSVEKV-LIDQQF-NPLIA--DCGL 563
             D +T+   +  I  G+ YLHS       I H +L  E + L+D+   NP I   D G+
Sbjct: 115 --DEATQ--FLKQILDGVHYLHSKR-----IAHFDLKPENIMLLDKNVPNPRIKLIDFGI 165
Query: 564 -HKLLADDIVFSVLKTSAAMGYLAPEYVTTGRFTERSDIFAFGVIILQILTGS 615
            HK+ A +   ++  T     ++APE V        +D+++ GVI   +L+G+
Sbjct: 166 AHKIEAGNEFKNIFGTPE---FVAPEIVNYEPLGLEADMWSIGVITYILLSGA 215

>pdb|1UV5|A Chain A, Glycogen Synthase Kinase 3 Beta Complexed With 6-Bromoindirubin-3'-Oxime Length = 350

Iteration: 1
 Score = 48.5 bits (114), Expect = 1e-05,   Method: Compositional matrix adjust.
 Identities = 53/219 (24%), Positives = 106/219 (48%), Gaps = 28/219 (12%)
Query: 411 FSEVNLLGKGNFSSVYKGTLRD-GTLVAIRSI-NVTSCKSEEAEFVKGLYLLTSLRHENI 468
           +++  ++G G+F  VY+  L D G LVAI+ +    + K+ E      L ++  L H NI
Sbjct: 22  YTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQGKAFKNRE------LQIMRKLDHCNI 75
Query: 469 IRLRGFCCSRG--RGECF--LIYDFAPKG--KLSKYLDQEEGSSNVLDWSTRVSIIIGIA 522
           +RLR F  S G  + E +  L+ D+ P+   +++++  + + +  V+        +  + 
Sbjct: 76  VRLRYFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKL---YMYQLF 132
Query: 523 KGIGYLHSSEVNKPAIVHRNLSVEKVLIDQQFNPL-IADCGLHK-LLADDIVFSVLKTSA 580
           + + Y+HS       I HR++  + +L+D     L + D G  K L+  +   S +    
Sbjct: 133 RSLAYIHSF-----GICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPNVSYI---C 184
Query: 581 AMGYLAPEYVTTGR-FTERSDIFAFGVIILQILTGSLVL 618
           +  Y APE +     +T   D+++ G ++ ++L G  + 
Sbjct: 185 SRYYRAPELIFGATDYTSSIDVWSAGCVLAELLLGQPIF 223

>pdb|4B8C|D Chain D, Nuclease Module Of The Yeast Ccr4-Not Complex Length = 727

Iteration: 1
 Score = 48.5 bits (114), Expect = 1e-05,   Method: Compositional matrix adjust.
 Identities = 40/103 (38%), Positives = 54/103 (52%), Gaps = 4/103 (3%)
Query: 123 LDVNNLS-GNIPPEIGSMASLQVLQLCCNQLTGNIPAQIGSLKSLSVLTLQHNRLNGGIP 181
           LD++NL   NI   I     L  L L  N LT  +PA+I +L +L VL L HNRL   +P
Sbjct: 229 LDLSNLQIFNISANIFKYDFLTRLYLNGNSLT-ELPAEIKNLSNLRVLDLSHNRLT-SLP 286
Query: 182 DSLGNLGKLKRLDLSFNSLFGTIPESLANNAELLFLDVQNNTL 224
             LG+  +LK     F+++  T+P    N   L FL V+ N L
Sbjct: 287 AELGSCFQLKYFYF-FDNMVTTLPWEFGNLCNLQFLGVEGNPL 328

>pdb|3O96|A Chain A, Crystal Structure Of Human Akt1 With An Allosteric Inhibitor Length = 446

Iteration: 1
 Score = 48.5 bits (114), Expect = 1e-05,   Method: Compositional matrix adjust.
 Identities = 57/212 (26%), Positives = 95/212 (44%), Gaps = 20/212 (9%)
Query: 411 FSEVNLLGKGNFSSVY----KGTLRDGTLVAIRSINVTSCKSEEAEFVKGLYLLTSLRHE 466
           F  + LLGKG F  V     K T R   +  ++   V   K E A  +    +L + RH 
Sbjct: 153 FEYLKLLGKGTFGKVILVKEKATGRYYAMKILKK-EVIVAKDEVAHTLTENRVLQNSRHP 211
Query: 467 NIIRLRGFCCSRGRGECFLIYDFAPKGKLSKYLDQEEGSSNVLDWSTRVSII-IGIAKGI 525
            +  L+    +  R  CF++ ++A  G+L  +L +E   S       R       I   +
Sbjct: 212 FLTALKYSFQTHDRL-CFVM-EYANGGELFFHLSRERVFS-----EDRARFYGAEIVSAL 264
Query: 526 GYLHSSEVNKPAIVHRNLSVEKVLIDQQFNPLIADCGLHKLLADDIVFSVLKTSAAM-GY 584
            YLHS +     +V+R+L +E +++D+  +  I D GL K    D   + +KT      Y
Sbjct: 265 DYLHSEK----NVVYRDLKLENLMLDKDGHIKITDFGLCKEGIKDG--ATMKTFCGTPEY 318
Query: 585 LAPEYVTTGRFTERSDIFAFGVIILQILTGSL 616
           LAPE +    +    D +  GV++ +++ G L
Sbjct: 319 LAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRL 350

>pdb|4EC8|A Chain A, Structure Of Full Length Cdk9 In Complex With Cyclint And Drb Length = 373

Iteration: 1
 Score = 48.1 bits (113), Expect = 1e-05,   Method: Compositional matrix adjust.
 Identities = 56/232 (24%), Positives = 107/232 (46%), Gaps = 45/232 (19%)
Query: 411 FSEVNLLGKGNFSSVYKGTLRD-GTLVAIRSINVTSCKSEEAEF----VKGLYLLTSLRH 465
           + ++  +G+G F  V+K   R  G  VA++ + +   ++E+  F    ++ + +L  L+H
Sbjct: 20  YEKLAKIGQGTFGEVFKARHRKTGQKVALKKVLM---ENEKEGFPITALREIKILQLLKH 76
Query: 466 ENIIRLRGFC------CSRGRGECFLIYDFAPKGKLSKYLDQEEGSSNVL---DWSTRVS 516
           EN++ L   C       +R +G  +L++DF  +  L+  L      SNVL     S    
Sbjct: 77  ENVVNLIEICRTKASPYNRCKGSIYLVFDFC-EHDLAGLL------SNVLVKFTLSEIKR 129
Query: 517 IIIGIAKGIGYLHSSEVNKPAIVHRNLSVEKVLIDQQFNPLIADCGLHKLLADDIVFSVL 576
           ++  +  G+ Y+H ++     I+HR++    VLI +     +AD GL +       FS+ 
Sbjct: 130 VMQMLLNGLYYIHRNK-----ILHRDMKAANVLITRDGVLKLADFGLAR------AFSLA 178
Query: 577 KTS---------AAMGYLAPEYVTTGR-FTERSDIFAFGVIILQILTGSLVL 618
           K S           + Y  PE +   R +    D++  G I+ ++ T S ++
Sbjct: 179 KNSQPNRYXNRVVTLWYRPPELLLGERDYGPPIDLWGAGCIMAEMWTRSPIM 230

>pdb|4EJN|A Chain A, Crystal Structure Of Autoinhibited Form Of Akt1 In Complex With N-(4- (5-(3-Acetamidophenyl)-2-(2-Aminopyridin-3-Yl)-3h- Imidazo[4,5- B]pyridin-3-Yl)benzyl)-3-Fluorobenzamide Length = 446

Iteration: 1
 Score = 48.1 bits (113), Expect = 1e-05,   Method: Compositional matrix adjust.
 Identities = 57/212 (26%), Positives = 95/212 (44%), Gaps = 20/212 (9%)
Query: 411 FSEVNLLGKGNFSSVY----KGTLRDGTLVAIRSINVTSCKSEEAEFVKGLYLLTSLRHE 466
           F  + LLGKG F  V     K T R   +  ++   V   K E A  +    +L + RH 
Sbjct: 150 FEYLKLLGKGTFGKVILVKEKATGRYYAMKILKK-EVIVAKDEVAHTLTENRVLQNSRHP 208
Query: 467 NIIRLRGFCCSRGRGECFLIYDFAPKGKLSKYLDQEEGSSNVLDWSTRVSII-IGIAKGI 525
            +  L+    +  R  CF++ ++A  G+L  +L +E   S       R       I   +
Sbjct: 209 FLTALKYSFQTHDRL-CFVM-EYANGGELFFHLSRERVFSE-----DRARFYGAEIVSAL 261
Query: 526 GYLHSSEVNKPAIVHRNLSVEKVLIDQQFNPLIADCGLHKLLADDIVFSVLKTSAAM-GY 584
            YLHS +     +V+R+L +E +++D+  +  I D GL K    D   + +KT      Y
Sbjct: 262 DYLHSEK----NVVYRDLKLENLMLDKDGHIKITDFGLCKEGIKDG--ATMKTFCGTPEY 315
Query: 585 LAPEYVTTGRFTERSDIFAFGVIILQILTGSL 616
           LAPE +    +    D +  GV++ +++ G L
Sbjct: 316 LAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRL 347

>pdb|3F69|A Chain A, Crystal Structure Of The Mycobacterium Tuberculosis Pknb Mutant Kinase Domain In Complex With Kt5720 Length = 311

Iteration: 1
 Score = 48.1 bits (113), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 37/133 (27%), Positives = 65/133 (48%), Gaps = 8/133 (6%)
Query: 538 IVHRNLSVEKVLIDQQFNPLIADCGLHKLLADDIVFSVLKTSAAMG---YLAPEYVTTGR 594
           I+HR++    +LI       + D G+ + +AD    SV +T+A +G   YL+PE      
Sbjct: 137 IIHRDVKPANILISATNAVKVVDFGIARAIADS-GNSVXQTAAVIGTAQYLSPEQARGDS 195
Query: 595 FTERSDIFAFGVIILQILTGSLVLTSSMRLA-AESATFENFIDRNLKGKFSESEAAKLGK 653
              RSD+++ G ++ ++LTG    T    ++ A     E+ I  + +    E  +A L  
Sbjct: 196 VDARSDVYSLGCVLYEVLTGEPPFTGDSPVSVAYQHVREDPIPPSAR---HEGLSADLDA 252
Query: 654 MALVCTHEDPENR 666
           + L    ++PENR
Sbjct: 253 VVLKALAKNPENR 265

>pdb|3F61|A Chain A, Crystal Structure Of M. Tuberculosis Pknb Leu33aspVAL222ASP DOUBLE MUTANT IN COMPLEX WITH ADP Length = 311

Iteration: 1
 Score = 48.1 bits (113), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 34/133 (25%), Positives = 65/133 (48%), Gaps = 8/133 (6%)
Query: 538 IVHRNLSVEKVLIDQQFNPLIADCGLHKLLADDIVFSVLKTSAAMG---YLAPEYVTTGR 594
           I+HR++    ++I       + D G+ + +AD    SV +T+A +G   YL+PE      
Sbjct: 137 IIHRDVKPANIMISATNAVKVMDFGIARAIADS-GNSVTQTAAVIGTAQYLSPEQARGDS 195
Query: 595 FTERSDIFAFGVIILQILTGSLVLTSSMRLAAESATFENFIDRNL-KGKFSESEAAKLGK 653
              RSD+++ G ++ ++LTG    T     + +S  +++  +  +      E  +A L  
Sbjct: 196 VDARSDVYSLGCVLYEVLTGEPPFTGD---SPDSVAYQHVREDPIPPSARHEGLSADLDA 252
Query: 654 MALVCTHEDPENR 666
           + L    ++PENR
Sbjct: 253 VVLKALAKNPENR 265

>pdb|1O9U|A Chain A, Glycogen Synthase Kinase 3 Beta Complexed With Axin Peptide Length = 350

Iteration: 1
 Score = 48.1 bits (113), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 52/218 (23%), Positives = 102/218 (46%), Gaps = 26/218 (11%)
Query: 411 FSEVNLLGKGNFSSVYKGTLRD-GTLVAIRSI-NVTSCKSEEAEFVKGLYLLTSLRHENI 468
           +++  ++G G+F  VY+  L D G LVAI+ +    + K+ E      L ++  L H NI
Sbjct: 22  YTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQGKAFKNRE------LQIMRKLDHCNI 75
Query: 469 IRLRGFCCSRG--RGECF--LIYDFAPKG--KLSKYLDQEEGSSNVLDWSTRVSIIIGIA 522
           +RLR F  S G  + E +  L+ D+ P    +++++  + + +  V+        +  + 
Sbjct: 76  VRLRYFFYSSGEKKDEVYLNLVLDYVPATVYRVARHYSRAKQTLPVIYVKL---YMYQLF 132
Query: 523 KGIGYLHSSEVNKPAIVHRNLSVEKVLIDQQFNPL-IADCGLHKLLADDIVFSVLKTSAA 581
           + + Y+HS       I HR++  + +L+D     L + D G  K L        +    +
Sbjct: 133 RSLAYIHSF-----GICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGE--PNVSXICS 185
Query: 582 MGYLAPEYVTTGR-FTERSDIFAFGVIILQILTGSLVL 618
             Y APE +     +T   D+++ G ++ ++L G  + 
Sbjct: 186 RYYRAPELIFGATDYTSSIDVWSAGCVLAELLLGQPIF 223

>pdb|1S9J|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In A Complex With Ligand And Mgatp Length = 341

Iteration: 1
 Score = 48.1 bits (113), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 47/213 (22%), Positives = 96/213 (45%), Gaps = 30/213 (14%)
Query: 411 FSEVNLLGKGNFSSVYKGTLRDGTLVAIRS-INVTSCKSEEAEFVKGLYLLTSLRHENII 469
           F +++ LG GN   V+K + +   LV  R  I++    +   + ++ L +L       I+
Sbjct: 8   FEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLEIKPAIRNQIIRELQVLHECNSPYIV 67
Query: 470 RLRGFCCSRGRGECFLIYDFAPKGKLSKYLDQEEGSS--NVLDWSTRV------SIIIGI 521
              G               F   G++S  ++  +G S   VL  + R+       + I +
Sbjct: 68  GFYG--------------AFYSDGEISICMEHMDGGSLDQVLKKAGRIPEQILGKVSIAV 113
Query: 522 AKGIGYLHSSEVNKPAIVHRNLSVEKVLIDQQFNPLIADCGLHKLLADDIVFSVLKTSAA 581
            KG+ YL      K  I+HR++    +L++ +    + D G+   L D +  S + T + 
Sbjct: 114 IKGLTYLR----EKHKIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDSMANSFVGTRS- 168
Query: 582 MGYLAPEYVTTGRFTERSDIFAFGVIILQILTG 614
             Y++PE +    ++ +SDI++ G+ ++++  G
Sbjct: 169 --YMSPERLQGTHYSVQSDIWSMGLSLVEMAVG 199

>pdb|2FSL|X Chain X, Mitogen Activated Protein Kinase P38alpha (D176a+f327s) Activating Mutant Form-A Length = 367

Iteration: 1
 Score = 47.8 bits (112), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 62/238 (26%), Positives = 100/238 (42%), Gaps = 38/238 (15%)
Query: 389 FSREHLNSFRLNLEEVESATQCFSEVNLLGKGNFSSVYKG-TLRDGTLVAIRSINVTSCK 447
           F R+ LN     + EV    Q  S V   G G + SV      + G  VA++ ++     
Sbjct: 15  FYRQELNK---TIWEVPERYQNLSPV---GSGAYGSVCAAFDTKTGLRVAVKKLSRPFQS 68
Query: 448 SEEAEFV-KGLYLLTSLRHENIIRLRG-FCCSRGRGECFLIY--------DFAPKGKLSK 497
              A+   + L LL  ++HEN+I L   F  +R   E   +Y        D     K  K
Sbjct: 69  IIHAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQK 128
Query: 498 YLDQEEGSSNVLDWSTRVSIIIGIAKGIGYLHSSEVNKPAIVHRNLSVEKVLIDQQFNPL 557
             D                +I  I +G+ Y+HS++     I+HR+L    + +++     
Sbjct: 129 LTDDHVQF-----------LIYQILRGLKYIHSAD-----IIHRDLKPSNLAVNEDCELK 172
Query: 558 IADCGLHKLLADDIVFSVLKTSAAMGYLAPEYVTTG-RFTERSDIFAFGVIILQILTG 614
           I D GL +  AD++   V    A   Y APE +     + +  DI++ G I+ ++LTG
Sbjct: 173 ILDFGLARHTADEMTGYV----ATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTG 226

>pdb|2P55|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In A Complex With Ligand And Mgatp Length = 333

Iteration: 1
 Score = 47.8 bits (112), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 47/213 (22%), Positives = 96/213 (45%), Gaps = 30/213 (14%)
Query: 411 FSEVNLLGKGNFSSVYKGTLRDGTLVAIRS-INVTSCKSEEAEFVKGLYLLTSLRHENII 469
           F +++ LG GN   V+K + +   LV  R  I++    +   + ++ L +L       I+
Sbjct: 8   FEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLEIKPAIRNQIIRELQVLHECNSPYIV 67
Query: 470 RLRGFCCSRGRGECFLIYDFAPKGKLSKYLDQEEGSS--NVLDWSTRV------SIIIGI 521
              G               F   G++S  ++  +G S   VL  + R+       + I +
Sbjct: 68  GFYG--------------AFYSDGEISICMEHMDGGSLDQVLKKAGRIPEQILGKVSIAV 113
Query: 522 AKGIGYLHSSEVNKPAIVHRNLSVEKVLIDQQFNPLIADCGLHKLLADDIVFSVLKTSAA 581
            KG+ YL      K  I+HR++    +L++ +    + D G+   L D +  S + T + 
Sbjct: 114 IKGLTYLR----EKHKIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDSMANSFVGTRS- 168
Query: 582 MGYLAPEYVTTGRFTERSDIFAFGVIILQILTG 614
             Y++PE +    ++ +SDI++ G+ ++++  G
Sbjct: 169 --YMSPERLQGTHYSVQSDIWSMGLSLVEMAVG 199

>pdb|3RGF|A Chain A, Crystal Structure Of Human Cdk8CYCC Length = 405

Iteration: 1
 Score = 47.8 bits (112), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 60/275 (21%), Positives = 116/275 (42%), Gaps = 24/275 (8%)
Query: 394 LNSFRLNLEEVESATQCFSEVNLLGKGNFSSVYKGTLRDGTLVAIRSINVTSCKSEEAEF 453
           L+S R  +E++     C      +G+G +  VYK   +DG      ++            
Sbjct: 11  LSSERERVEDLFEYEGC-----KVGRGTYGHVYKAKRKDGKDDKDYALKQIEGTGISMSA 65
Query: 454 VKGLYLLTSLRHENIIRLRGFCCSRGRGECFLIYDFAPKG--KLSKYLDQEEGSSNVLDW 511
            + + LL  L+H N+I L+    S    + +L++D+A      + K+    + +   +  
Sbjct: 66  CREIALLRELKHPNVISLQKVFLSHADRKVWLLFDYAEHDLWHIIKFHRASKANKKPVQL 125
Query: 512 STRV--SIIIGIAKGIGYLHSSEVNKPAIVHRNLSVEKVLI----DQQFNPLIADCGLHK 565
              +  S++  I  GI YLH++ V     +HR+L    +L+     ++    IAD G  +
Sbjct: 126 PRGMVKSLLYQILDGIHYLHANWV-----LHRDLKPANILVMGEGPERGRVKIADMGFAR 180
Query: 566 LLADDI--VFSVLKTSAAMGYLAPEYVTTGR-FTERSDIFAFGVIILQILTGSLVLTSSM 622
           L    +  +  +        Y APE +   R +T+  DI+A G I  ++LT   +     
Sbjct: 181 LFNSPLKPLADLDPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTSEPIFHCRQ 240
Query: 623 R-LAAESATFENFIDR--NLKGKFSESEAAKLGKM 654
             +   +    + +DR  N+ G  ++ +   + KM
Sbjct: 241 EDIKTSNPYHHDQLDRIFNVMGFPADKDWEDIKKM 275

>pdb|3CQU|A Chain A, Crystal Structure Of Akt-1 Complexed With Substrate Peptide And Inhibitor Length = 342

Iteration: 1
 Score = 47.8 bits (112), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 57/218 (26%), Positives = 94/218 (43%), Gaps = 32/218 (14%)
Query: 411 FSEVNLLGKGNFSSVY----KGTLRDGTLVAIRSINVTSCKSEEAEFVKGLYLLTSLRHE 466
           F  + LLGKG F  V     K T R   +  ++   V   K E A  +    +L + RH 
Sbjct: 12  FEYLKLLGKGTFGKVILVKEKATGRYYAMKILKK-EVIVAKDEVAHTLTENRVLQNSRHP 70
Query: 467 NIIRLRGFCCSRGRGECFLIYDFAPKGKLSKYLDQEEGSSNVLDWSTRVSII-IGIAKGI 525
            +  L+    +  R  CF++ ++A  G+L  +L +E   S       R       I   +
Sbjct: 71  FLTALKYSFQTHDRL-CFVM-EYANGGELFFHLSRERVFSE-----DRARFYGAEIVSAL 123
Query: 526 GYLHSSEVNKPAIVHRNLSVEKVLIDQQFNPLIADCGLHKLLADDIVFSVLKTSAAMG-- 583
            YLHS +     +V+R+L +E +++D+  +  I D GL K          +K  A M   
Sbjct: 124 DYLHSEK----NVVYRDLKLENLMLDKDGHIKITDFGLCK--------EGIKDGATMKXF 171
Query: 584 -----YLAPEYVTTGRFTERSDIFAFGVIILQILTGSL 616
                YLAPE +    +    D +  GV++ +++ G L
Sbjct: 172 CGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRL 209

>pdb|2FST|X Chain X, Mitogen Activated Protein Kinase P38alpha (d176a+f327l) Activating Mutant Length = 367

Iteration: 1
 Score = 47.8 bits (112), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 62/238 (26%), Positives = 100/238 (42%), Gaps = 38/238 (15%)
Query: 389 FSREHLNSFRLNLEEVESATQCFSEVNLLGKGNFSSVYKG-TLRDGTLVAIRSINVTSCK 447
           F R+ LN     + EV    Q  S V   G G + SV      + G  VA++ ++     
Sbjct: 15  FYRQELNK---TIWEVPERYQNLSPV---GSGAYGSVCAAFDTKTGLRVAVKKLSRPFQS 68
Query: 448 SEEAEFV-KGLYLLTSLRHENIIRLRG-FCCSRGRGECFLIY--------DFAPKGKLSK 497
              A+   + L LL  ++HEN+I L   F  +R   E   +Y        D     K  K
Sbjct: 69  IIHAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQK 128
Query: 498 YLDQEEGSSNVLDWSTRVSIIIGIAKGIGYLHSSEVNKPAIVHRNLSVEKVLIDQQFNPL 557
             D                +I  I +G+ Y+HS++     I+HR+L    + +++     
Sbjct: 129 LTDDHVQF-----------LIYQILRGLKYIHSAD-----IIHRDLKPSNLAVNEDCELK 172
Query: 558 IADCGLHKLLADDIVFSVLKTSAAMGYLAPEYVTTG-RFTERSDIFAFGVIILQILTG 614
           I D GL +  AD++   V    A   Y APE +     + +  DI++ G I+ ++LTG
Sbjct: 173 ILDFGLARHTADEMTGYV----ATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTG 226

>pdb|3GBZ|A Chain A, Structure Of The Cmgc Cdk Kinase From Giardia Lamblia Length = 329

Iteration: 1
 Score = 47.8 bits (112), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 59/217 (27%), Positives = 95/217 (43%), Gaps = 35/217 (16%)
Query: 411 FSEVNLLGKGNFSSVYKG--TLRDGTLVAIRSINVTSCKSEEAEFVKG-----LYLLTSL 463
           +  +  LG+G +  VYK   T+ + T VAI+ I +      E E V G     + LL  L
Sbjct: 36  YRRITKLGEGTYGEVYKAIDTVTNET-VAIKRIRL----EHEEEGVPGTAIREVSLLKEL 90
Query: 464 RHENIIRLRGFCCSRGRGECFLIYDFAPKGKLSKYLDQEEGSSNVLDWSTRV--SIIIGI 521
           +H NII L+       R    LI+++A +  L KY+D+        D S RV  S +  +
Sbjct: 91  QHRNIIELKSVIHHNHR--LHLIFEYA-ENDLKKYMDKNP------DVSMRVIKSFLYQL 141
Query: 522 AKGIGYLHSSEVNKPAIVHRNLSVEKVLI---DQQFNPL--IADCGLHKLLADDIVFSVL 576
             G+ + HS        +HR+L  + +L+   D    P+  I D GL +     I     
Sbjct: 142 INGVNFCHSRRC-----LHRDLKPQNLLLSVSDASETPVLKIGDFGLARAFGIPIR-QFT 195
Query: 577 KTSAAMGYLAPEYVTTGR-FTERSDIFAFGVIILQIL 612
                + Y  PE +   R ++   DI++   I  ++L
Sbjct: 196 HEIITLWYRPPEILLGSRHYSTSVDIWSIACIWAEML 232

>pdb|3BLH|A Chain A, Crystal Structure Of Human Cdk9CYCLINT1 Length = 331

Iteration: 1
 Score = 47.8 bits (112), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 56/232 (24%), Positives = 107/232 (46%), Gaps = 45/232 (19%)
Query: 411 FSEVNLLGKGNFSSVYKGTLRD-GTLVAIRSINVTSCKSEEAEF----VKGLYLLTSLRH 465
           + ++  +G+G F  V+K   R  G  VA++ + +   ++E+  F    ++ + +L  L+H
Sbjct: 20  YEKLAKIGQGTFGEVFKARHRKTGQKVALKKVLM---ENEKEGFPITALREIKILQLLKH 76
Query: 466 ENIIRLRGFC------CSRGRGECFLIYDFAPKGKLSKYLDQEEGSSNVL---DWSTRVS 516
           EN++ L   C       +R +G  +L++DF  +  L+  L      SNVL     S    
Sbjct: 77  ENVVNLIEICRTKASPYNRCKGSIYLVFDFC-EHDLAGLL------SNVLVKFTLSEIKR 129
Query: 517 IIIGIAKGIGYLHSSEVNKPAIVHRNLSVEKVLIDQQFNPLIADCGLHKLLADDIVFSVL 576
           ++  +  G+ Y+H ++     I+HR++    VLI +     +AD GL +       FS+ 
Sbjct: 130 VMQMLLNGLYYIHRNK-----ILHRDMKAANVLITRDGVLKLADFGLAR------AFSLA 178
Query: 577 KTS---------AAMGYLAPEYVTTGR-FTERSDIFAFGVIILQILTGSLVL 618
           K S           + Y  PE +   R +    D++  G I+ ++ T S ++
Sbjct: 179 KNSQPNRYXNRVVTLWYRPPELLLGERDYGPPIDLWGAGCIMAEMWTRSPIM 230

>pdb|2FSO|X Chain X, Mitogen Activated Protein Kinase P38alpha (D176a) Activating Mutant Length = 367

Iteration: 1
 Score = 47.8 bits (112), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 62/238 (26%), Positives = 100/238 (42%), Gaps = 38/238 (15%)
Query: 389 FSREHLNSFRLNLEEVESATQCFSEVNLLGKGNFSSVYKG-TLRDGTLVAIRSINVTSCK 447
           F R+ LN     + EV    Q  S V   G G + SV      + G  VA++ ++     
Sbjct: 15  FYRQELNK---TIWEVPERYQNLSPV---GSGAYGSVCAAFDTKTGLRVAVKKLSRPFQS 68
Query: 448 SEEAEFV-KGLYLLTSLRHENIIRLRG-FCCSRGRGECFLIY--------DFAPKGKLSK 497
              A+   + L LL  ++HEN+I L   F  +R   E   +Y        D     K  K
Sbjct: 69  IIHAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQK 128
Query: 498 YLDQEEGSSNVLDWSTRVSIIIGIAKGIGYLHSSEVNKPAIVHRNLSVEKVLIDQQFNPL 557
             D                +I  I +G+ Y+HS++     I+HR+L    + +++     
Sbjct: 129 LTDDHVQF-----------LIYQILRGLKYIHSAD-----IIHRDLKPSNLAVNEDCELK 172
Query: 558 IADCGLHKLLADDIVFSVLKTSAAMGYLAPEYVTTG-RFTERSDIFAFGVIILQILTG 614
           I D GL +  AD++   V    A   Y APE +     + +  DI++ G I+ ++LTG
Sbjct: 173 ILDFGLARHTADEMTGYV----ATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTG 226

>pdb|3MI9|A Chain A, Crystal Structure Of Hiv-1 Tat Complexed With Human P-Tefb Length = 351

Iteration: 1
 Score = 47.8 bits (112), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 56/232 (24%), Positives = 107/232 (46%), Gaps = 45/232 (19%)
Query: 411 FSEVNLLGKGNFSSVYKGTLRD-GTLVAIRSINVTSCKSEEAEF----VKGLYLLTSLRH 465
           + ++  +G+G F  V+K   R  G  VA++ + +   ++E+  F    ++ + +L  L+H
Sbjct: 19  YEKLAKIGQGTFGEVFKARHRKTGQKVALKKVLM---ENEKEGFPITALREIKILQLLKH 75
Query: 466 ENIIRLRGFC------CSRGRGECFLIYDFAPKGKLSKYLDQEEGSSNVL---DWSTRVS 516
           EN++ L   C       +R +G  +L++DF  +  L+  L      SNVL     S    
Sbjct: 76  ENVVNLIEICRTKASPYNRCKGSIYLVFDFC-EHDLAGLL------SNVLVKFTLSEIKR 128
Query: 517 IIIGIAKGIGYLHSSEVNKPAIVHRNLSVEKVLIDQQFNPLIADCGLHKLLADDIVFSVL 576
           ++  +  G+ Y+H ++     I+HR++    VLI +     +AD GL +       FS+ 
Sbjct: 129 VMQMLLNGLYYIHRNK-----ILHRDMKAANVLITRDGVLKLADFGLAR------AFSLA 177
Query: 577 KTS---------AAMGYLAPEYVTTGR-FTERSDIFAFGVIILQILTGSLVL 618
           K S           + Y  PE +   R +    D++  G I+ ++ T S ++
Sbjct: 178 KNSQPNRYXNRVVTLWYRPPELLLGERDYGPPIDLWGAGCIMAEMWTRSPIM 229

>pdb|2BIY|A Chain A, Structure Of Pdk1-S241a Mutant Kinase Domain Length = 310

Iteration: 1
 Score = 47.8 bits (112), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 50/208 (24%), Positives = 99/208 (47%), Gaps = 23/208 (11%)
Query: 415 NLLGKGNFSSVYKG----TLRDGTLVAIRSINVTSCKSEEAEFV-KGLYLLTSLRHENII 469
            +LG+G+FS+V       T R+  +  +   ++   K  +  +V +   +++ L H   +
Sbjct: 36  KILGEGSFSTVVLARELATSREYAIKILEKRHI--IKENKVPYVTRERDVMSRLDHPFFV 93
Query: 470 RLRGFCCSRGRGECFLIYDFAPKGKLSKYLDQEEGSSNVLDWSTRVSIIIGIAKGIGYLH 529
           +L  +   +   + +    +A  G+L KY+ ++ GS    D +        I   + YLH
Sbjct: 94  KL--YFTFQDDEKLYFGLSYAKNGELLKYI-RKIGS---FDETCTRFYTAEIVSALEYLH 147
Query: 530 SSEVNKPAIVHRNLSVEKVLIDQQFNPLIADCGLHKLLADDIVFSVLKTSAAMG---YLA 586
                   I+HR+L  E +L+++  +  I D G  K+L+ +      + +A +G   Y++
Sbjct: 148 GK-----GIIHRDLKPENILLNEDMHIQITDFGTAKVLSPES--KQARANAFVGTAQYVS 200
Query: 587 PEYVTTGRFTERSDIFAFGVIILQILTG 614
           PE +T     + SD++A G II Q++ G
Sbjct: 201 PELLTEKSACKSSDLWALGCIIYQLVAG 228

>pdb|3MBL|A Chain A, Crystal Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek 1) In Complex With Ligand And Mgadp Length = 328

Iteration: 1
 Score = 47.4 bits (111), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 47/213 (22%), Positives = 96/213 (45%), Gaps = 30/213 (14%)
Query: 411 FSEVNLLGKGNFSSVYKGTLRDGTLVAIRS-INVTSCKSEEAEFVKGLYLLTSLRHENII 469
           F +++ LG GN   V+K + +   LV  R  I++    +   + ++ L +L       I+
Sbjct: 8   FEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLEIKPAIRNQIIRELQVLHECNSPYIV 67
Query: 470 RLRGFCCSRGRGECFLIYDFAPKGKLSKYLDQEEGSS--NVLDWSTRV------SIIIGI 521
              G               F   G++S  ++  +G S   VL  + R+       + I +
Sbjct: 68  GFYG--------------AFYSDGEISICMEHMDGGSLDQVLKKAGRIPEQILGKVSIAV 113
Query: 522 AKGIGYLHSSEVNKPAIVHRNLSVEKVLIDQQFNPLIADCGLHKLLADDIVFSVLKTSAA 581
            KG+ YL      K  I+HR++    +L++ +    + D G+   L D +  S + T + 
Sbjct: 114 IKGLTYLR----EKHKIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDSMANSFVGTRS- 168
Query: 582 MGYLAPEYVTTGRFTERSDIFAFGVIILQILTG 614
             Y++PE +    ++ +SDI++ G+ ++++  G
Sbjct: 169 --YMSPERLQGTHYSVQSDIWSMGLSLVEMAVG 199

>pdb|3DV3|A Chain A, Mek1 With Pf-04622664 Bound Length = 322

Iteration: 1
 Score = 47.4 bits (111), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 47/213 (22%), Positives = 96/213 (45%), Gaps = 30/213 (14%)
Query: 411 FSEVNLLGKGNFSSVYKGTLRDGTLVAIRS-INVTSCKSEEAEFVKGLYLLTSLRHENII 469
           F +++ LG GN   V+K + +   LV  R  I++    +   + ++ L +L       I+
Sbjct: 8   FEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLEIKPAIRNQIIRELQVLHECNSPYIV 67
Query: 470 RLRGFCCSRGRGECFLIYDFAPKGKLSKYLDQEEGSS--NVLDWSTRV------SIIIGI 521
              G               F   G++S  ++  +G S   VL  + R+       + I +
Sbjct: 68  GFYG--------------AFYSDGEISICMEHMDGGSLDQVLKKAGRIPEQILGKVSIAV 113
Query: 522 AKGIGYLHSSEVNKPAIVHRNLSVEKVLIDQQFNPLIADCGLHKLLADDIVFSVLKTSAA 581
            KG+ YL      K  I+HR++    +L++ +    + D G+   L D +  S + T + 
Sbjct: 114 IKGLTYLR----EKHKIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDSMANSFVGTRS- 168
Query: 582 MGYLAPEYVTTGRFTERSDIFAFGVIILQILTG 614
             Y++PE +    ++ +SDI++ G+ ++++  G
Sbjct: 169 --YMSPERLQGTHYSVQSDIWSMGLSLVEMAVG 199

>pdb|3RNY|A Chain A, Crystal Structure Of Human Rsk1 C-Terminal Kinase Domain Length = 346

Iteration: 1
 Score = 47.4 bits (111), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 65/248 (26%), Positives = 102/248 (41%), Gaps = 52/248 (20%)
Query: 448 SEEAEFVKGLYLLTSLRHENIIRLRGFCCSRGRGECFLIYDFAPKGKL------SKYLDQ 501
           SEE E      LL   +H NII L+      G+   +L+ +    G+L       K+  +
Sbjct: 68  SEEIEI-----LLRYGQHPNIITLKD-VYDDGK-HVYLVTELMRGGELLDKILRQKFFSE 120
Query: 502 EEGSSNVLDWSTRVSIIIGIAKGIGYLHSSEVNKPAIVHRNLSVEKVL-IDQQFNP---L 557
            E S           ++  I K + YLHS       +VHR+L    +L +D+  NP    
Sbjct: 121 REASF----------VLHTIGKTVEYLHSQ-----GVVHRDLKPSNILYVDESGNPECLR 165
Query: 558 IADCGLHKLLADDIVFSVLKTSAAMGYLAPEYVTTGRFTERSDIFAFGVIILQILTGSLV 617
           I D G  K L  +    ++       ++APE +    + E  DI++ G+++  +L G   
Sbjct: 166 ICDFGFAKQLRAENGL-LMTPCYTANFVAPEVLKRQGYDEGCDIWSLGILLYTMLAGYTP 224
Query: 618 LTSSMRLAAESATFENFIDRNLKGKF--------SESEAAK--LGKMALVCTHEDPENRP 667
             +       S T E  + R   GKF        + SE AK  + KM     H DP  R 
Sbjct: 225 FAN-----GPSDTPEEILTRIGSGKFTLSGGNWNTVSETAKDLVSKML----HVDPHQRL 275
Query: 668 TMEAVIEE 675
           T + V++ 
Sbjct: 276 TAKQVLQH 283

>pdb|3OCB|A Chain A, Akt1 Kinase Domain With Pyrrolopyrimidine Inhibitor Length = 341

Iteration: 1
 Score = 47.4 bits (111), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 57/218 (26%), Positives = 94/218 (43%), Gaps = 32/218 (14%)
Query: 411 FSEVNLLGKGNFSSVY----KGTLRDGTLVAIRSINVTSCKSEEAEFVKGLYLLTSLRHE 466
           F  + LLGKG F  V     K T R   +  ++   V   K E A  +    +L + RH 
Sbjct: 11  FEYLKLLGKGTFGKVILVKEKATGRYYAMKILKK-EVIVAKDEVAHTLTENRVLQNSRHP 69
Query: 467 NIIRLRGFCCSRGRGECFLIYDFAPKGKLSKYLDQEEGSSNVLDWSTRVSII-IGIAKGI 525
            +  L+    +  R  CF++ ++A  G+L  +L +E   S       R       I   +
Sbjct: 70  FLTALKYSFQTHDRL-CFVM-EYANGGELFFHLSRERVFSE-----DRARFYGAEIVSAL 122
Query: 526 GYLHSSEVNKPAIVHRNLSVEKVLIDQQFNPLIADCGLHKLLADDIVFSVLKTSAAMG-- 583
            YLHS +     +V+R+L +E +++D+  +  I D GL K          +K  A M   
Sbjct: 123 DYLHSEK----NVVYRDLKLENLMLDKDGHIKITDFGLCK--------EGIKDGATMKXF 170
Query: 584 -----YLAPEYVTTGRFTERSDIFAFGVIILQILTGSL 616
                YLAPE +    +    D +  GV++ +++ G L
Sbjct: 171 CGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRL 208

>pdb|2WNT|A Chain A, Crystal Structure Of The Human Ribosomal Protein S6 Kinase Length = 330

Iteration: 1
 Score = 47.4 bits (111), Expect = 3e-05,   Method: Compositional matrix adjust.
 Identities = 65/247 (26%), Positives = 102/247 (41%), Gaps = 52/247 (21%)
Query: 448 SEEAEFVKGLYLLTSLRHENIIRLRGFCCSRGRGECFLIYDFAPKGKL------SKYLDQ 501
           SEE E      LL   +H NII L+      G+   +L+ +    G+L       K+  +
Sbjct: 68  SEEIEI-----LLRYGQHPNIITLKD-VYDDGK-HVYLVTELMRGGELLDKILRQKFFSE 120
Query: 502 EEGSSNVLDWSTRVSIIIGIAKGIGYLHSSEVNKPAIVHRNLSVEKVL-IDQQFNP---L 557
            E S           ++  I K + YLHS       +VHR+L    +L +D+  NP    
Sbjct: 121 REASF----------VLHTIGKTVEYLHSQ-----GVVHRDLKPSNILYVDESGNPECLR 165
Query: 558 IADCGLHKLLADDIVFSVLKTSAAMGYLAPEYVTTGRFTERSDIFAFGVIILQILTGSLV 617
           I D G  K L  +    ++       ++APE +    + E  DI++ G+++  +L G   
Sbjct: 166 ICDFGFAKQLRAENGL-LMTPCYTANFVAPEVLKRQGYDEGCDIWSLGILLYTMLAGYTP 224
Query: 618 LTSSMRLAAESATFENFIDRNLKGKF--------SESEAAK--LGKMALVCTHEDPENRP 667
             +       S T E  + R   GKF        + SE AK  + KM     H DP  R 
Sbjct: 225 FAN-----GPSDTPEEILTRIGSGKFTLSGGNWNTVSETAKDLVSKML----HVDPHQRL 275
Query: 668 TMEAVIE 674
           T + V++
Sbjct: 276 TAKQVLQ 282

>pdb|3F88|A Chain A, Glycogen Synthase Kinase 3beta Inhibitor Complex Length = 349

Iteration: 1
 Score = 47.4 bits (111), Expect = 3e-05,   Method: Compositional matrix adjust.
 Identities = 50/218 (22%), Positives = 101/218 (46%), Gaps = 26/218 (11%)
Query: 411 FSEVNLLGKGNFSSVYKGTLRD-GTLVAIRSINVTSCKSEEAEFV-KGLYLLTSLRHENI 468
           +++  ++G G+F  VY+  L D G LVAI+ +       ++  F  + L ++  L H NI
Sbjct: 22  YTDTKVIGNGSFGVVYQAKLCDSGELVAIKKV------LQDKRFKNRELQIMRKLDHCNI 75
Query: 469 IRLRGFCCSRGRGECF----LIYDFAPKG--KLSKYLDQEEGSSNVLDWSTRVSIIIGIA 522
           +RLR F  S G  +      L+ D+ P+   +++++  + + +  V+        +  + 
Sbjct: 76  VRLRYFFYSSGEKKDVVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKL---YMYQLF 132
Query: 523 KGIGYLHSSEVNKPAIVHRNLSVEKVLIDQQFNPL-IADCGLHKLLADDIVFSVLKTSAA 581
           + + Y+HS       I HR++  + +L+D     L + D G  K L        +    +
Sbjct: 133 RSLAYIHSF-----GICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGE--PNVSXICS 185
Query: 582 MGYLAPEYVTTGR-FTERSDIFAFGVIILQILTGSLVL 618
             Y APE +     +T   D+++ G ++ ++L G  + 
Sbjct: 186 RYYRAPELIFGATDYTSSIDVWSAGCVLAELLLGQPIF 223

>pdb|4GV1|A Chain A, Pkb Alpha In Complex With Azd5363 Length = 340

Iteration: 1
 Score = 47.4 bits (111), Expect = 3e-05,   Method: Compositional matrix adjust.
 Identities = 57/218 (26%), Positives = 94/218 (43%), Gaps = 32/218 (14%)
Query: 411 FSEVNLLGKGNFSSVY----KGTLRDGTLVAIRSINVTSCKSEEAEFVKGLYLLTSLRHE 466
           F  + LLGKG F  V     K T R   +  ++   V   K E A  +    +L + RH 
Sbjct: 10  FEYLKLLGKGTFGKVILVKEKATGRYYAMKILKK-EVIVAKDEVAHTLTENRVLQNSRHP 68
Query: 467 NIIRLRGFCCSRGRGECFLIYDFAPKGKLSKYLDQEEGSSNVLDWSTRVSII-IGIAKGI 525
            +  L+    +  R  CF++ ++A  G+L  +L +E   S       R       I   +
Sbjct: 69  FLTALKYSFQTHDRL-CFVM-EYANGGELFFHLSRERVFSE-----DRARFYGAEIVSAL 121
Query: 526 GYLHSSEVNKPAIVHRNLSVEKVLIDQQFNPLIADCGLHKLLADDIVFSVLKTSAAMG-- 583
            YLHS +     +V+R+L +E +++D+  +  I D GL K          +K  A M   
Sbjct: 122 DYLHSEK----NVVYRDLKLENLMLDKDGHIKITDFGLCK--------EGIKDGATMKXF 169
Query: 584 -----YLAPEYVTTGRFTERSDIFAFGVIILQILTGSL 616
                YLAPE +    +    D +  GV++ +++ G L
Sbjct: 170 CGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRL 207

>pdb|3D83|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Biphenyl Amide Inhibitor Length = 360

Iteration: 1
 Score = 47.4 bits (111), Expect = 3e-05,   Method: Compositional matrix adjust.
 Identities = 58/232 (25%), Positives = 104/232 (44%), Gaps = 26/232 (11%)
Query: 389 FSREHLNSFRLNLEEVESATQCFSEVNLLGKGNFSSVYKG-TLRDGTLVAIRSINVTSCK 447
           F R+ LN     + EV    Q  S V   G G + SV      + G  VA++ ++     
Sbjct: 8   FYRQELNK---TIWEVPERYQNLSPV---GSGAYGSVCAAFDTKTGLRVAVKKLSRPFQS 61
Query: 448 SEEAEFV-KGLYLLTSLRHENIIRLRG-FCCSRGRGECFLIY--DFAPKGKLSKYLDQEE 503
              A+   + L LL  ++HEN+I L   F  +R   E   +Y         L+  +  ++
Sbjct: 62  IIHAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKXQK 121
Query: 504 GSSNVLDWSTRVSIIIGIAKGIGYLHSSEVNKPAIVHRNLSVEKVLIDQQFNPLIADCGL 563
            + + + +     +I  I +G+ Y+HS++     I+HR+L    + +++     I D GL
Sbjct: 122 LTDDHVQF-----LIYQILRGLKYIHSAD-----IIHRDLKPSNLAVNEDXELKILDFGL 171
Query: 564 HKLLADDIVFSVLKTSAAMGYLAPEYVTTG-RFTERSDIFAFGVIILQILTG 614
            +   D++   V    A   Y APE +     + +  DI++ G I+ ++LTG
Sbjct: 172 ARHTDDEMTGYV----ATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTG 219

>pdb|3ORN|A Chain A, Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In Complex With Ch4987655 And Mgamp-Pnp Length = 307

Iteration: 1
 Score = 47.4 bits (111), Expect = 3e-05,   Method: Compositional matrix adjust.
 Identities = 47/213 (22%), Positives = 96/213 (45%), Gaps = 30/213 (14%)
Query: 411 FSEVNLLGKGNFSSVYKGTLRDGTLVAIRS-INVTSCKSEEAEFVKGLYLLTSLRHENII 469
           F +++ LG GN   V+K + +   LV  R  I++    +   + ++ L +L       I+
Sbjct: 8   FEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLEIKPAIRNQIIRELQVLHECNSPYIV 67
Query: 470 RLRGFCCSRGRGECFLIYDFAPKGKLSKYLDQEEGSS--NVLDWSTRV------SIIIGI 521
              G               F   G++S  ++  +G S   VL  + R+       + I +
Sbjct: 68  GFYG--------------AFYSDGEISICMEHMDGGSLDQVLKKAGRIPEQILGKVSIAV 113
Query: 522 AKGIGYLHSSEVNKPAIVHRNLSVEKVLIDQQFNPLIADCGLHKLLADDIVFSVLKTSAA 581
            KG+ YL      K  I+HR++    +L++ +    + D G+   L D +  S + T + 
Sbjct: 114 IKGLTYLR----EKHKIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDSMANSFVGTRS- 168
Query: 582 MGYLAPEYVTTGRFTERSDIFAFGVIILQILTG 614
             Y++PE +    ++ +SDI++ G+ ++++  G
Sbjct: 169 --YMSPERLQGTHYSVQSDIWSMGLSLVEMAVG 199

>pdb|3BHY|A Chain A, Crystal Structure Of Human Death Associated Protein Kinase 3 (Dapk3) In Complex With A Beta-Carboline Ligand Length = 283

Iteration: 1
 Score = 47.4 bits (111), Expect = 3e-05,   Method: Compositional matrix adjust.
 Identities = 57/210 (27%), Positives = 98/210 (46%), Gaps = 25/210 (11%)
Query: 417 LGKGNFSSV----YKGTLRDGTLVAIRSINVTSCKS--EEAEFVKGLYLLTSLRHENIIR 470
           LG G F+ V     KGT ++     I+   ++S +      E  + + +L  +RH NII 
Sbjct: 13  LGSGQFAIVRKCRQKGTGKEYAAKFIKKRRLSSSRRGVSREEIEREVNILREIRHPNIIT 72
Query: 471 LRGFCCSRGRGECFLIYDFAPKGKLSKYLDQEEGSSNVLDWSTRVSIIIGIAKGIGYLHS 530
           L        + +  LI +    G+L  +L ++E  +   D +T+   +  I  G+ YLHS
Sbjct: 73  LHDIF--ENKTDVVLILELVSGGELFDFLAEKESLTE--DEATQ--FLKQILDGVHYLHS 126
Query: 531 SEVNKPAIVHRNLSVEKV-LIDQQF-NPLIA--DCGL-HKLLADDIVFSVLKTSAAMGYL 585
                  I H +L  E + L+D+   NP I   D G+ HK+ A +   ++  T     ++
Sbjct: 127 KR-----IAHFDLKPENIMLLDKNVPNPRIKLIDFGIAHKIEAGNEFKNIFGTPE---FV 178
Query: 586 APEYVTTGRFTERSDIFAFGVIILQILTGS 615
           APE V        +D+++ GVI   +L+G+
Sbjct: 179 APEIVNYEPLGLEADMWSIGVITYILLSGA 208

>pdb|2R5T|A Chain A, Crystal Structure Of Inactive Serum And Glucocorticoid- Regulated Kinase 1 In Complex With Amp-Pnp Length = 373

Iteration: 1
 Score = 47.4 bits (111), Expect = 3e-05,   Method: Compositional matrix adjust.
 Identities = 61/247 (24%), Positives = 114/247 (46%), Gaps = 26/247 (10%)
Query: 411 FSEVNLLGKGNFSSVYKGTLR-DGTLVAIRSINVTSC--KSEEAEFVKGL-YLLTSLRHE 466
           F  + ++GKG+F  V     + +    A++ +   +   K EE   +     LL +++H 
Sbjct: 40  FHFLKVIGKGSFGKVLLARHKAEEVFYAVKVLQKKAILKKKEEKHIMSERNVLLKNVKHP 99
Query: 467 NIIRLRGFCCSRGRGECFLIYDFAPKGKLSKYLDQEEGSSNVLDWSTRVSIIIGIAKGIG 526
            ++ L      +   + + + D+   G+L  +L +E      L+   R      IA  +G
Sbjct: 100 FLVGLH--FSFQTADKLYFVLDYINGGELFYHLQRERC---FLEPRARF-YAAEIASALG 153
Query: 527 YLHSSEVNKPAIVHRNLSVEKVLIDQQFNPLIADCGLHKLLADDIVFSVLKTSAAMG--- 583
           YLHS       IV+R+L  E +L+D Q + ++ D GL K   ++I  +   TS   G   
Sbjct: 154 YLHSLN-----IVYRDLKPENILLDSQGHIVLTDFGLCK---ENIEHNS-TTSTFCGTPE 204
Query: 584 YLAPEYVTTGRFTERSDIFAFGVIILQILTGSLVLTSSMRLAAESATFENFIDRNLKGKF 643
           YLAPE +    +    D +  G ++ ++L G     S  R  AE   ++N +++ L+ K 
Sbjct: 205 YLAPEVLHKQPYDRTVDWWCLGAVLYEMLYGLPPFYS--RNTAE--MYDNILNKPLQLKP 260
Query: 644 SESEAAK 650
           + + +A+
Sbjct: 261 NITNSAR 267

>pdb|3ORI|A Chain A, Mycobacterium Tuberculosis Pknb Kinase Domain L33d Mutant (Crystal Form 1) Length = 311

Iteration: 1
 Score = 47.0 bits (110), Expect = 3e-05,   Method: Compositional matrix adjust.
 Identities = 36/133 (27%), Positives = 65/133 (48%), Gaps = 8/133 (6%)
Query: 538 IVHRNLSVEKVLIDQQFNPLIADCGLHKLLADDIVFSVLKTSAAMG---YLAPEYVTTGR 594
           I+HR++    ++I       + D G+ + +AD    SV +T+A +G   YL+PE      
Sbjct: 137 IIHRDVKPANIMISATNAVKVMDFGIARAIADS-GNSVTQTAAVIGTAQYLSPEQARGDS 195
Query: 595 FTERSDIFAFGVIILQILTGSLVLTSSMRLA-AESATFENFIDRNLKGKFSESEAAKLGK 653
              RSD+++ G ++ ++LTG    T    ++ A     E+ I  + +    E  +A L  
Sbjct: 196 VDARSDVYSLGCVLYEVLTGEPPFTGDSPVSVAYQHVREDPIPPSAR---HEGLSADLDA 252
Query: 654 MALVCTHEDPENR 666
           + L    ++PENR
Sbjct: 253 VVLKALAKNPENR 265

>pdb|1MRU|A Chain A, Intracellular SerTHR PROTEIN KINASE DOMAIN OF Mycobacterium Tuberculosis Pknb. Length = 311

Iteration: 1
 Score = 47.0 bits (110), Expect = 3e-05,   Method: Compositional matrix adjust.
 Identities = 36/133 (27%), Positives = 65/133 (48%), Gaps = 8/133 (6%)
Query: 538 IVHRNLSVEKVLIDQQFNPLIADCGLHKLLADDIVFSVLKTSAAMG---YLAPEYVTTGR 594
           I+HR++    ++I       + D G+ + +AD    SV +T+A +G   YL+PE      
Sbjct: 137 IIHRDVKPANIMISATNAVKVMDFGIARAIADS-GNSVTQTAAVIGTAQYLSPEQARGDS 195
Query: 595 FTERSDIFAFGVIILQILTGSLVLTSSMRLA-AESATFENFIDRNLKGKFSESEAAKLGK 653
              RSD+++ G ++ ++LTG    T    ++ A     E+ I  + +    E  +A L  
Sbjct: 196 VDARSDVYSLGCVLYEVLTGEPPFTGDSPVSVAYQHVREDPIPPSAR---HEGLSADLDA 252
Query: 654 MALVCTHEDPENR 666
           + L    ++PENR
Sbjct: 253 VVLKALAKNPENR 265

>pdb|4AN2|A Chain A, Crystal Structures Of Human Mek1 With Carboxamide-Based Allosteric Inhibitor Xl518 (Gdc-0973), Or Related Analogs. Length = 301

Iteration: 1
 Score = 47.0 bits (110), Expect = 3e-05,   Method: Compositional matrix adjust.
 Identities = 46/213 (21%), Positives = 96/213 (45%), Gaps = 30/213 (14%)
Query: 411 FSEVNLLGKGNFSSVYKGTLRDGTLVAIRS-INVTSCKSEEAEFVKGLYLLTSLRHENII 469
           F +++ LG GN   V+K + +   LV  R  I++    +   + ++ L +L       I+
Sbjct: 11  FEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLEIKPAIRNQIIRELQVLHECNSPYIV 70
Query: 470 RLRGFCCSRGRGECFLIYDFAPKGKLSKYLDQEEGSS--NVLDWSTRV------SIIIGI 521
              G               F   G++S  ++  +G S   VL  + R+       + I +
Sbjct: 71  GFYG--------------AFYSDGEISICMEHMDGGSLDQVLKKAGRIPEQILGKVSIAV 116
Query: 522 AKGIGYLHSSEVNKPAIVHRNLSVEKVLIDQQFNPLIADCGLHKLLADDIVFSVLKTSAA 581
            KG+ YL      K  I+HR++    +L++ +    + D G+   L D++    + T + 
Sbjct: 117 IKGLTYLR----EKHKIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDEMANEFVGTRS- 171
Query: 582 MGYLAPEYVTTGRFTERSDIFAFGVIILQILTG 614
             Y++PE +    ++ +SDI++ G+ ++++  G
Sbjct: 172 --YMSPERLQGTHYSVQSDIWSMGLSLVEMAVG 202

>pdb|1CM8|A Chain A, Phosphorylated Map Kinase P38-Gamma Length = 367

Iteration: 1
 Score = 47.0 bits (110), Expect = 3e-05,   Method: Compositional matrix adjust.
 Identities = 56/245 (22%), Positives = 105/245 (42%), Gaps = 28/245 (11%)
Query: 387 TGFSREHLNSFRLNLEEVESATQCFSEVNLLGKGNFSSVYKGTL-RDGTLVAIRSINVTS 445
           +GF R+ +      +  V      + ++  +G G + +V      R G  VAI+ +    
Sbjct: 9   SGFYRQEVTKTAWEVRAV------YRDLQPVGSGAYGAVCSAVDGRTGAKVAIKKL-YRP 61
Query: 446 CKSE--EAEFVKGLYLLTSLRHENIIRLRG-FCCSRGRGECFLIYDFAP--KGKLSKYLD 500
            +SE       + L LL  +RHEN+I L   F       +    Y   P     L K + 
Sbjct: 62  FQSELFAKRAYRELRLLKHMRHENVIGLLDVFTPDETLDDFTDFYLVMPFMGTDLGKLMK 121
Query: 501 QEEGSSNVLDWSTRVSIIIGIAKGIGYLHSSEVNKPAIVHRNLSVEKVLIDQQFNPLIAD 560
            E+   + + +     ++  + KG+ Y+H++      I+HR+L    + +++     I D
Sbjct: 122 HEKLGEDRIQF-----LVYQMLKGLRYIHAA-----GIIHRDLKPGNLAVNEDCELKILD 171
Query: 561 CGLHKLLADDIVFSVLKTSAAMGYLAPEYVTTG-RFTERSDIFAFGVIILQILTGSLVLT 619
            GL +    ++   V+       Y APE +    R+T+  DI++ G I+ +++TG  +  
Sbjct: 172 FGLARQADSEMXGXVV----TRWYRAPEVILNWMRYTQTVDIWSVGCIMAEMITGKTLFK 227
Query: 620 SSMRL 624
            S  L
Sbjct: 228 GSDHL 232

>pdb|3ORM|A Chain A, Mycobacterium Tuberculosis Pknb Kinase Domain D76a Mutant Length = 311

Iteration: 1
 Score = 47.0 bits (110), Expect = 3e-05,   Method: Compositional matrix adjust.
 Identities = 36/133 (27%), Positives = 65/133 (48%), Gaps = 8/133 (6%)
Query: 538 IVHRNLSVEKVLIDQQFNPLIADCGLHKLLADDIVFSVLKTSAAMG---YLAPEYVTTGR 594
           I+HR++    ++I       + D G+ + +AD    SV +T+A +G   YL+PE      
Sbjct: 137 IIHRDVKPANIMISATNAVKVMDFGIARAIADS-GNSVTQTAAVIGTAQYLSPEQARGDS 195
Query: 595 FTERSDIFAFGVIILQILTGSLVLTSSMRLA-AESATFENFIDRNLKGKFSESEAAKLGK 653
              RSD+++ G ++ ++LTG    T    ++ A     E+ I  + +    E  +A L  
Sbjct: 196 VDARSDVYSLGCVLYEVLTGEPPFTGDSPVSVAYQHVREDPIPPSAR---HEGLSADLDA 252
Query: 654 MALVCTHEDPENR 666
           + L    ++PENR
Sbjct: 253 VVLKALAKNPENR 265

>pdb|1S9I|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 2 (Mek2)in A Complex With Ligand And Mgatp Length = 354

Iteration: 1
 Score = 47.0 bits (110), Expect = 4e-05,   Method: Compositional matrix adjust.
 Identities = 47/213 (22%), Positives = 95/213 (44%), Gaps = 30/213 (14%)
Query: 411 FSEVNLLGKGNFSSVYKGTLR-DGTLVAIRSINVTSCKSEEAEFVKGLYLLTSLRHENII 469
           F  ++ LG GN   V K   R  G ++A + I++    +   + ++ L +L       I+
Sbjct: 18  FERISELGAGNGGVVTKVQHRPSGLIMARKLIHLEIKPAIRNQIIRELQVLHECNSPYIV 77
Query: 470 RLRGFCCSRGRGECFLIYDFAPKGKLSKYLDQEEGSS--NVLDWSTRV------SIIIGI 521
              G               F   G++S  ++  +G S   VL  + R+       + I +
Sbjct: 78  GFYG--------------AFYSDGEISICMEHMDGGSLDQVLKEAKRIPEEILGKVSIAV 123
Query: 522 AKGIGYLHSSEVNKPAIVHRNLSVEKVLIDQQFNPLIADCGLHKLLADDIVFSVLKTSAA 581
            +G+ YL      K  I+HR++    +L++ +    + D G+   L D +  S + T + 
Sbjct: 124 LRGLAYLR----EKHQIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDSMANSFVGTRS- 178
Query: 582 MGYLAPEYVTTGRFTERSDIFAFGVIILQILTG 614
             Y+APE +    ++ +SDI++ G+ ++++  G
Sbjct: 179 --YMAPERLQGTHYSVQSDIWSMGLSLVELAVG 209

>pdb|1O6Y|A Chain A, Catalytic Domain Of Pknb Kinase From Mycobacterium Tuberculosis Length = 299

Iteration: 1
 Score = 47.0 bits (110), Expect = 4e-05,   Method: Compositional matrix adjust.
 Identities = 36/133 (27%), Positives = 65/133 (48%), Gaps = 8/133 (6%)
Query: 538 IVHRNLSVEKVLIDQQFNPLIADCGLHKLLADDIVFSVLKTSAAMG---YLAPEYVTTGR 594
           I+HR++    ++I       + D G+ + +AD    SV +T+A +G   YL+PE      
Sbjct: 154 IIHRDVKPANIMISATNAVKVMDFGIARAIADS-GNSVTQTAAVIGTAQYLSPEQARGDS 212
Query: 595 FTERSDIFAFGVIILQILTGSLVLTSSMRLA-AESATFENFIDRNLKGKFSESEAAKLGK 653
              RSD+++ G ++ ++LTG    T    ++ A     E+ I  + +    E  +A L  
Sbjct: 213 VDARSDVYSLGCVLYEVLTGEPPFTGDSPVSVAYQHVREDPIPPSAR---HEGLSADLDA 269
Query: 654 MALVCTHEDPENR 666
           + L    ++PENR
Sbjct: 270 VVLKALAKNPENR 282

>pdb|4FSU|A Chain A, Crystal Structure Of The Chk1 Length = 279

Iteration: 1
 Score = 47.0 bits (110), Expect = 4e-05,   Method: Compositional matrix adjust.
 Identities = 48/207 (23%), Positives = 88/207 (42%), Gaps = 16/207 (7%)
Query: 414 VNLLGKGNFSSVYKGTLR-DGTLVAIRSINVTSCKSEEAEFVKGLYLLTSLRHENIIRLR 472
           V  LG+G    V     R     VA++ +++           K + +   L HEN+++  
Sbjct: 11  VQTLGEGAAGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFY 70
Query: 473 GFCCSRGRGEC-FLIYDFAPKGKLSKYLDQEEGSSNVLDWSTRVSIIIGIAKGIGYLHSS 531
           G    R  G   +L  ++   G+L   ++ + G                +  G+ YLH  
Sbjct: 71  G---HRREGNIQYLFLEYCSGGELFDRIEPDIGMPE----PDAQRFFHQLMAGVVYLHGI 123
Query: 532 EVNKPAIVHRNLSVEKVLIDQQFNPLIADCGLHKLLADDIVFSVL-KTSAAMGYLAPEYV 590
                 I HR++  E +L+D++ N  I+D GL  +   +    +L K    + Y+APE +
Sbjct: 124 -----GITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELL 178
Query: 591 TTGRF-TERSDIFAFGVIILQILTGSL 616
               F  E  D+++ G+++  +L G L
Sbjct: 179 KRREFHAEPVDVWSCGIVLTAMLAGEL 205

>pdb|2J90|A Chain A, Crystal Structure Of Human Zip Kinase In Complex With A Tetracyclic Pyridone Inhibitor (pyridone 6) Length = 304

Iteration: 1
 Score = 47.0 bits (110), Expect = 4e-05,   Method: Compositional matrix adjust.
 Identities = 57/210 (27%), Positives = 97/210 (46%), Gaps = 25/210 (11%)
Query: 417 LGKGNFSSV----YKGTLRDGTLVAIRSINVTSCKS--EEAEFVKGLYLLTSLRHENIIR 470
           LG G F+ V     KGT ++     I+   + S +      E  + + +L  +RH NII 
Sbjct: 34  LGSGQFAIVRKCRQKGTGKEYAAKFIKKRRLXSSRRGVSREEIEREVNILREIRHPNIIT 93
Query: 471 LRGFCCSRGRGECFLIYDFAPKGKLSKYLDQEEGSSNVLDWSTRVSIIIGIAKGIGYLHS 530
           L        + +  LI +    G+L  +L ++E  +   D +T+   +  I  G+ YLHS
Sbjct: 94  LHDIF--ENKTDVVLILELVSGGELFDFLAEKESLTE--DEATQ--FLKQILDGVHYLHS 147
Query: 531 SEVNKPAIVHRNLSVEKV-LIDQQF-NPLIA--DCGL-HKLLADDIVFSVLKTSAAMGYL 585
                  I H +L  E + L+D+   NP I   D G+ HK+ A +   ++  T     ++
Sbjct: 148 KR-----IAHFDLKPENIMLLDKNVPNPRIKLIDFGIAHKIEAGNEFKNIFGTPE---FV 199
Query: 586 APEYVTTGRFTERSDIFAFGVIILQILTGS 615
           APE V        +D+++ GVI   +L+G+
Sbjct: 200 APEIVNYEPLGLEADMWSIGVITYILLSGA 229

>pdb|1ZWS|A Chain A, Crystal Structure Of The Catalytic Domain Of Human Drp-1 Kinase Length = 288

Iteration: 1
 Score = 46.6 bits (109), Expect = 4e-05,   Method: Compositional matrix adjust.
 Identities = 50/209 (23%), Positives = 86/209 (41%), Gaps = 23/209 (11%)
Query: 417 LGKGNFSSVYK------GTLRDGTLVAIRSINVTSCKSEEAEFVKGLYLLTSLRHENIIR 470
           LG G F+ V K      G       +  R    +       E  + + +L  + H N+I 
Sbjct: 20  LGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVSREEIEREVSILRQVLHHNVIT 79
Query: 471 LRGFCCSRGRGECFLIYDFAPKGKLSKYLDQEEGSSNVLDWSTRVSIIIGIAKGIGYLHS 530
           L        R +  LI +    G+L  +L Q+E  S         S I  I  G+ YLH+
Sbjct: 80  LHD--VYENRTDVVLILELVSGGELFDFLAQKESLSE----EEATSFIKQILDGVNYLHT 133
Query: 531 SEVNKPAIVHRNLSVEKVLIDQQFNPL----IADCGLHKLLADDIVFSVLKTSAAMGYLA 586
            +     I H +L  E +++  +  P+    + D GL   + D + F  +  +    ++A
Sbjct: 134 KK-----IAHFDLKPENIMLLDKNIPIPHIKLIDFGLAHEIEDGVEFKNIFGTPE--FVA 186
Query: 587 PEYVTTGRFTERSDIFAFGVIILQILTGS 615
           PE V        +D+++ GVI   +L+G+
Sbjct: 187 PEIVNYEPLGLEADMWSIGVITYILLSGA 215

>pdb|3D7Z|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Biphenyl Amide Inhibitor Length = 360

Iteration: 1
 Score = 46.6 bits (109), Expect = 5e-05,   Method: Compositional matrix adjust.
 Identities = 58/232 (25%), Positives = 104/232 (44%), Gaps = 26/232 (11%)
Query: 389 FSREHLNSFRLNLEEVESATQCFSEVNLLGKGNFSSVYKG-TLRDGTLVAIRSINVTSCK 447
           F R+ LN     + EV    Q  S V   G G + SV      + G  VA++ ++     
Sbjct: 8   FYRQELNK---TIWEVPERYQNLSPV---GSGAYGSVCAAFDTKTGLRVAVKKLSRPFQS 61
Query: 448 SEEAEFV-KGLYLLTSLRHENIIRLRG-FCCSRGRGECFLIY--DFAPKGKLSKYLDQEE 503
              A+   + L LL  ++HEN+I L   F  +R   E   +Y         L+  +  ++
Sbjct: 62  IIHAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKXQK 121
Query: 504 GSSNVLDWSTRVSIIIGIAKGIGYLHSSEVNKPAIVHRNLSVEKVLIDQQFNPLIADCGL 563
            + + + +     +I  I +G+ Y+HS++     I+HR+L    + +++     I D GL
Sbjct: 122 LTDDHVQF-----LIYQILRGLKYIHSAD-----IIHRDLKPSNLAVNEDCELKILDFGL 171
Query: 564 HKLLADDIVFSVLKTSAAMGYLAPEYVTTG-RFTERSDIFAFGVIILQILTG 614
            +   D++   V    A   Y APE +     + +  DI++ G I+ ++LTG
Sbjct: 172 ARHTDDEMTGYV----ATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTG 219

>pdb|4BC6|A Chain A, Crystal Structure Of Human Serine Threonine Kinase-10 Bound To Novel Bosutinib Isoform 1, Previously Thought To Be Bosutinib Length = 293

Iteration: 1
 Score = 46.2 bits (108), Expect = 6e-05,   Method: Compositional matrix adjust.
 Identities = 46/214 (21%), Positives = 102/214 (47%), Gaps = 28/214 (13%)
Query: 409 QCFSEVNLLGKGNFSSVYKGTLRD-GTLVAIRSINVTSCKSEEAEFVKGLYLLTSLRHEN 467
           + +  V  LG G F  VYK   ++ G L A + I  T  + E  +++  + +L +  H  
Sbjct: 11  EVWEIVGELGDGAFGKVYKAKNKETGALAAAKVIE-TKSEEELEDYIVEIEILATCDHPY 69
Query: 468 IIRLRGFCCSRGRGECFLIYDFAPKGKLSK-YLDQEEGSSNVLDWSTRVSIII-GIAKGI 525
           I++L G     G+   +++ +F P G +    L+ + G +       ++ ++   + + +
Sbjct: 70  IVKLLGAYYHDGK--LWIMIEFCPGGAVDAIMLELDRGLTE-----PQIQVVCRQMLEAL 122
Query: 526 GYLHSSEVNKPAIVHRNLSVEKVLIDQQFNPLIADCGLHKLLADDIVFSVLKTSAAMG-- 583
            +LHS       I+HR+L    VL+  + +  +AD G    ++   + ++ K  + +G  
Sbjct: 123 NFLHSKR-----IIHRDLKAGNVLMTLEGDIRLADFG----VSAKNLKTLQKRDSFIGTP 173
Query: 584 -YLAPEYVTTGRFTE-----RSDIFAFGVIILQI 611
            ++APE V      +     ++DI++ G+ ++++
Sbjct: 174 YWMAPEVVMCETMKDTPYDYKADIWSLGITLIEM 207

>pdb|2R7B|A Chain A, Crystal Structure Of The Phosphoinositide-Dependent Kinase- 1 (Pdk-1)catalytic Domain Bound To A Dibenzonaphthyridine Inhibitor Length = 312

Iteration: 1
 Score = 46.2 bits (108), Expect = 6e-05,   Method: Compositional matrix adjust.
 Identities = 49/208 (23%), Positives = 99/208 (47%), Gaps = 23/208 (11%)
Query: 415 NLLGKGNFSSVYKG----TLRDGTLVAIRSINVTSCKSEEAEFV-KGLYLLTSLRHENII 469
            +LG+G+FS+V       T R+  +  +   ++   K  +  +V +   +++ L H   +
Sbjct: 39  KILGEGSFSTVVLARELATSREYAIKILEKRHI--IKENKVPYVTRERDVMSRLDHPFFV 96
Query: 470 RLRGFCCSRGRGECFLIYDFAPKGKLSKYLDQEEGSSNVLDWSTRVSIIIGIAKGIGYLH 529
           +L  +   +   + +    +A  G+L KY+ ++ GS    D +        I   + YLH
Sbjct: 97  KL--YFTFQDDEKLYFGLSYAKNGELLKYI-RKIGS---FDETCTRFYTAEIVSALEYLH 150
Query: 530 SSEVNKPAIVHRNLSVEKVLIDQQFNPLIADCGLHKLLADDIVFSVLKTSAAMG---YLA 586
                   I+HR+L  E +L+++  +  I D G  K+L+ +      + ++ +G   Y++
Sbjct: 151 GK-----GIIHRDLKPENILLNEDMHIQITDFGTAKVLSPES--KQARANSFVGTAQYVS 203
Query: 587 PEYVTTGRFTERSDIFAFGVIILQILTG 614
           PE +T     + SD++A G II Q++ G
Sbjct: 204 PELLTEKSACKSSDLWALGCIIYQLVAG 231

>pdb|1Z9X|A Chain A, Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal Form With 3 Monomers In The Asymmetric Unit Length = 321

Iteration: 1
 Score = 46.2 bits (108), Expect = 6e-05,   Method: Compositional matrix adjust.
 Identities = 50/209 (23%), Positives = 86/209 (41%), Gaps = 23/209 (11%)
Query: 417 LGKGNFSSVYK------GTLRDGTLVAIRSINVTSCKSEEAEFVKGLYLLTSLRHENIIR 470
           LG G F+ V K      G       +  R    +       E  + + +L  + H N+I 
Sbjct: 20  LGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVSREEIEREVSILRQVLHHNVIT 79
Query: 471 LRGFCCSRGRGECFLIYDFAPKGKLSKYLDQEEGSSNVLDWSTRVSIIIGIAKGIGYLHS 530
           L        R +  LI +    G+L  +L Q+E  S         S I  I  G+ YLH+
Sbjct: 80  LHD--VYENRTDVVLILELVSGGELFDFLAQKESLSE----EEATSFIKQILDGVNYLHT 133
Query: 531 SEVNKPAIVHRNLSVEKVLIDQQFNPL----IADCGLHKLLADDIVFSVLKTSAAMGYLA 586
            +     I H +L  E +++  +  P+    + D GL   + D + F  +  +    ++A
Sbjct: 134 KK-----IAHFDLKPENIMLLDKNIPIPHIKLIDFGLAHEIEDGVEFKNIFGTPE--FVA 186
Query: 587 PEYVTTGRFTERSDIFAFGVIILQILTGS 615
           PE V        +D+++ GVI   +L+G+
Sbjct: 187 PEIVNYEPLGLEADMWSIGVITYILLSGA 215

>pdb|2A27|A Chain A, Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal Form With 8 Monomers In The Asymmetric Unit Length = 321

Iteration: 1
 Score = 46.2 bits (108), Expect = 6e-05,   Method: Compositional matrix adjust.
 Identities = 50/209 (23%), Positives = 86/209 (41%), Gaps = 23/209 (11%)
Query: 417 LGKGNFSSVYK------GTLRDGTLVAIRSINVTSCKSEEAEFVKGLYLLTSLRHENIIR 470
           LG G F+ V K      G       +  R    +       E  + + +L  + H N+I 
Sbjct: 20  LGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVSREEIEREVSILRQVLHHNVIT 79
Query: 471 LRGFCCSRGRGECFLIYDFAPKGKLSKYLDQEEGSSNVLDWSTRVSIIIGIAKGIGYLHS 530
           L        R +  LI +    G+L  +L Q+E  S         S I  I  G+ YLH+
Sbjct: 80  LHD--VYENRTDVVLILELVSGGELFDFLAQKESLSE----EEATSFIKQILDGVNYLHT 133
Query: 531 SEVNKPAIVHRNLSVEKVLIDQQFNPL----IADCGLHKLLADDIVFSVLKTSAAMGYLA 586
            +     I H +L  E +++  +  P+    + D GL   + D + F  +  +    ++A
Sbjct: 134 KK-----IAHFDLKPENIMLLDKNIPIPHIKLIDFGLAHEIEDGVEFKNIFGTPE--FVA 186
Query: 587 PEYVTTGRFTERSDIFAFGVIILQILTGS 615
           PE V        +D+++ GVI   +L+G+
Sbjct: 187 PEIVNYEPLGLEADMWSIGVITYILLSGA 215

>pdb|3MH0|A Chain A, Mutagenesis Of P38 Map Kinase Eshtablishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360

Iteration: 1
 Score = 46.2 bits (108), Expect = 6e-05,   Method: Compositional matrix adjust.
 Identities = 61/238 (25%), Positives = 99/238 (41%), Gaps = 38/238 (15%)
Query: 389 FSREHLNSFRLNLEEVESATQCFSEVNLLGKGNFSSVYKG-TLRDGTLVAIRSINVTSCK 447
           F R+ LN     + EV    Q  S V   G G + SV      + G  VA++ ++     
Sbjct: 8   FYRQELNK---TIWEVPERYQNLSPV---GSGAYGSVCAAFDTKTGLRVAVKKLSRPFQS 61
Query: 448 SEEAEFV-KGLYLLTSLRHENIIRLRG-FCCSRGRGECFLIY--------DFAPKGKLSK 497
              A+   + L LL  ++HEN+I L   F  +R   E   +Y        D     K  K
Sbjct: 62  IIHAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQK 121
Query: 498 YLDQEEGSSNVLDWSTRVSIIIGIAKGIGYLHSSEVNKPAIVHRNLSVEKVLIDQQFNPL 557
             D                +I  I +G+ Y+HS++     I+HR+L    + +++     
Sbjct: 122 LTDDHVQF-----------LIYQILRGLKYIHSAD-----IIHRDLKPSNLAVNEDCELK 165
Query: 558 IADCGLHKLLADDIVFSVLKTSAAMGYLAPEYVTTG-RFTERSDIFAFGVIILQILTG 614
           I D GL +   D++   V    A   Y APE +     + +  DI++ G I+ ++LTG
Sbjct: 166 ILDAGLARHTDDEMTGYV----ATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTG 219

>pdb|1WMK|A Chain A, Human Death-Associated Kinase Drp-1, Mutant S308d D40 Length = 321

Iteration: 1
 Score = 46.2 bits (108), Expect = 6e-05,   Method: Compositional matrix adjust.
 Identities = 50/209 (23%), Positives = 86/209 (41%), Gaps = 23/209 (11%)
Query: 417 LGKGNFSSVYK------GTLRDGTLVAIRSINVTSCKSEEAEFVKGLYLLTSLRHENIIR 470
           LG G F+ V K      G       +  R    +       E  + + +L  + H N+I 
Sbjct: 20  LGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVSREEIEREVSILRQVLHHNVIT 79
Query: 471 LRGFCCSRGRGECFLIYDFAPKGKLSKYLDQEEGSSNVLDWSTRVSIIIGIAKGIGYLHS 530
           L        R +  LI +    G+L  +L Q+E  S         S I  I  G+ YLH+
Sbjct: 80  LHD--VYENRTDVVLILELVSGGELFDFLAQKESLSE----EEATSFIKQILDGVNYLHT 133
Query: 531 SEVNKPAIVHRNLSVEKVLIDQQFNPL----IADCGLHKLLADDIVFSVLKTSAAMGYLA 586
            +     I H +L  E +++  +  P+    + D GL   + D + F  +  +    ++A
Sbjct: 134 KK-----IAHFDLKPENIMLLDKNIPIPHIKLIDFGLAHEIEDGVEFKNIFGTPE--FVA 186
Query: 587 PEYVTTGRFTERSDIFAFGVIILQILTGS 615
           PE V        +D+++ GVI   +L+G+
Sbjct: 187 PEIVNYEPLGLEADMWSIGVITYILLSGA 215

>pdb|3GCP|A Chain A, Human P38 Map Kinase In Complex With Sb203580 Length = 360

Iteration: 1
 Score = 46.2 bits (108), Expect = 6e-05,   Method: Compositional matrix adjust.
 Identities = 60/230 (26%), Positives = 102/230 (44%), Gaps = 22/230 (9%)
Query: 389 FSREHLNSFRLNLEEVESATQCFSEVNLLGKGNFSSVYKG-TLRDGTLVAIRSINVTSCK 447
           F R+ LN     + EV    Q  S V   G G + SV      + G  VA++ ++     
Sbjct: 8   FYRQELNK---TIWEVPERYQNLSPV---GSGAYGSVCAAFDTKTGLRVAVKKLSRPFQS 61
Query: 448 SEEAEFV-KGLYLLTSLRHENIIRLRG-FCCSRGRGECFLIYDFAPKGKLSKYLDQEEGS 505
              A+   + L LL  ++HEN+I L   F  +R   E   +Y       +   L+    S
Sbjct: 62  IIHAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVT--HLMGADLNNIVKS 119
Query: 506 SNVLDWSTRVSIIIGIAKGIGYLHSSEVNKPAIVHRNLSVEKVLIDQQFNPLIADCGLHK 565
             + D   +  +I  I +G+ Y+HS++     I+HR+L    + +++     I D GL +
Sbjct: 120 QKLTDDHVQF-LIYQILRGLKYIHSAD-----IIHRDLKPSNLAVNEDSELKILDFGLCR 173
Query: 566 LLADDIVFSVLKTSAAMGYLAPEYVTTG-RFTERSDIFAFGVIILQILTG 614
              D++   V    A   Y APE +     + +  DI++ G I+ ++LTG
Sbjct: 174 HTDDEMTGYV----ATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTG 219

>pdb|2A2A|A Chain A, High-resolution Crystallographic Analysis Of The Autoinhibited Conformation Of A Human Death-associated Protein Kinase Length = 321

Iteration: 1
 Score = 46.2 bits (108), Expect = 6e-05,   Method: Compositional matrix adjust.
 Identities = 50/209 (23%), Positives = 86/209 (41%), Gaps = 23/209 (11%)
Query: 417 LGKGNFSSVYK------GTLRDGTLVAIRSINVTSCKSEEAEFVKGLYLLTSLRHENIIR 470
           LG G F+ V K      G       +  R    +       E  + + +L  + H N+I 
Sbjct: 20  LGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVSREEIEREVSILRQVLHHNVIT 79
Query: 471 LRGFCCSRGRGECFLIYDFAPKGKLSKYLDQEEGSSNVLDWSTRVSIIIGIAKGIGYLHS 530
           L        R +  LI +    G+L  +L Q+E  S         S I  I  G+ YLH+
Sbjct: 80  LHD--VYENRTDVVLILELVSGGELFDFLAQKESLSE----EEATSFIKQILDGVNYLHT 133
Query: 531 SEVNKPAIVHRNLSVEKVLIDQQFNPL----IADCGLHKLLADDIVFSVLKTSAAMGYLA 586
            +     I H +L  E +++  +  P+    + D GL   + D + F  +  +    ++A
Sbjct: 134 KK-----IAHFDLKPENIMLLDKNIPIPHIKLIDFGLAHEIEDGVEFKNIFGTPE--FVA 186
Query: 587 PEYVTTGRFTERSDIFAFGVIILQILTGS 615
           PE V        +D+++ GVI   +L+G+
Sbjct: 187 PEIVNYEPLGLEADMWSIGVITYILLSGA 215

>pdb|1VZO|A Chain A, The Structure Of The N-Terminal Kinase Domain Of Msk1 Reveals A Novel Autoinhibitory Conformation For A Dual Kinase Protein Length = 355

Iteration: 1
 Score = 46.2 bits (108), Expect = 7e-05,   Method: Compositional matrix adjust.
 Identities = 36/134 (26%), Positives = 64/134 (47%), Gaps = 13/134 (9%)
Query: 485 LIYDFAPKGKLSKYLDQEEGSSNVLDWSTRVSIIIG-IAKGIGYLHSSEVNKPAIVHRNL 543
           LI D+   G+L  +L Q E  +        V I +G I   + +LH     K  I++R++
Sbjct: 136 LILDYINGGELFTHLSQRERFTE-----HEVQIYVGEIVLALEHLH-----KLGIIYRDI 185
Query: 544 SVEKVLIDQQFNPLIADCGLHKLLADDIVFSVLKTSAAMGYLAPEYVTTGR--FTERSDI 601
            +E +L+D   + ++ D GL K    D           + Y+AP+ V  G     +  D 
Sbjct: 186 KLENILLDSNGHVVLTDFGLSKEFVADETERAYDFCGTIEYMAPDIVRGGDSGHDKAVDW 245
Query: 602 FAFGVIILQILTGS 615
           ++ GV++ ++LTG+
Sbjct: 246 WSLGVLMYELLTGA 259

>pdb|3E92|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Biaryl Amide Inhibitor Length = 371

Iteration: 1
 Score = 46.2 bits (108), Expect = 7e-05,   Method: Compositional matrix adjust.
 Identities = 57/240 (23%), Positives = 102/240 (42%), Gaps = 33/240 (13%)
Query: 388 GFSREHLNSFRLNLEE-VESATQCFSEVNLLGKGNFSSVYKG-TLRDGTLVAIRSINVTS 445
           G S+E    +R  L + +    + +  ++ +G G + SV      + G  VA++ ++   
Sbjct: 11  GMSQERPTFYRQELNKTIWEVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPF 70
Query: 446 CKSEEAEFV-KGLYLLTSLRHENIIRLRG-FCCSRGRGECFLIY--------DFAPKGKL 495
                A+   + L LL  ++HEN+I L   F  +R   E   +Y        D     K 
Sbjct: 71  QSIIHAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKC 130
Query: 496 SKYLDQEEGSSNVLDWSTRVSIIIGIAKGIGYLHSSEVNKPAIVHRNLSVEKVLIDQQFN 555
            K  D                +I  I +G+ Y+HS++     I+HR+L    + +++   
Sbjct: 131 QKLTDDHVQF-----------LIYQILRGLKYIHSAD-----IIHRDLKPSNLAVNEDXE 174
Query: 556 PLIADCGLHKLLADDIVFSVLKTSAAMGYLAPEYVTTG-RFTERSDIFAFGVIILQILTG 614
             I D GL +   D++   V    A   Y APE +     + +  DI++ G I+ ++LTG
Sbjct: 175 LKILDFGLARHTDDEMTGYV----ATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTG 230

>pdb|2BAL|A Chain A, P38alpha Map Kinase Bound To Pyrazoloamine Length = 365

Iteration: 1
 Score = 46.2 bits (108), Expect = 7e-05,   Method: Compositional matrix adjust.
 Identities = 61/238 (25%), Positives = 99/238 (41%), Gaps = 38/238 (15%)
Query: 389 FSREHLNSFRLNLEEVESATQCFSEVNLLGKGNFSSVYKG-TLRDGTLVAIRSINVTSCK 447
           F R+ LN     + EV    Q  S V   G G + SV      + G  VA++ ++     
Sbjct: 13  FYRQELNK---TIWEVPERYQNLSPV---GSGAYGSVCAAFDTKTGLRVAVKKLSRPFQS 66
Query: 448 SEEAEFV-KGLYLLTSLRHENIIRLRG-FCCSRGRGECFLIY--------DFAPKGKLSK 497
              A+   + L LL  ++HEN+I L   F  +R   E   +Y        D     K  K
Sbjct: 67  IIHAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQK 126
Query: 498 YLDQEEGSSNVLDWSTRVSIIIGIAKGIGYLHSSEVNKPAIVHRNLSVEKVLIDQQFNPL 557
             D                +I  I +G+ Y+HS++     I+HR+L    + +++     
Sbjct: 127 LTDDHVQF-----------LIYQILRGLKYIHSAD-----IIHRDLKPSNLAVNEDXELK 170
Query: 558 IADCGLHKLLADDIVFSVLKTSAAMGYLAPEYVTTG-RFTERSDIFAFGVIILQILTG 614
           I D GL +   D++   V    A   Y APE +     + +  DI++ G I+ ++LTG
Sbjct: 171 ILDFGLARHTDDEMTGYV----ATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTG 224

>pdb|4A07|A Chain A, Human Pdk1 Kinase Domain In Complex With Allosteric Activator Ps171 Bound To The Pif-Pocket Length = 311

Iteration: 1
 Score = 46.2 bits (108), Expect = 7e-05,   Method: Compositional matrix adjust.
 Identities = 49/208 (23%), Positives = 98/208 (47%), Gaps = 23/208 (11%)
Query: 415 NLLGKGNFSSVYKG----TLRDGTLVAIRSINVTSCKSEEAEFV-KGLYLLTSLRHENII 469
            +LG+G+FS+V       T R+  +  +   ++   K  +  +V +   +++ L H   +
Sbjct: 38  KILGEGSFSTVVLARELATSREYAIKILEKRHI--IKENKVPYVTRERDVMSRLDHPFFV 95
Query: 470 RLRGFCCSRGRGECFLIYDFAPKGKLSKYLDQEEGSSNVLDWSTRVSIIIGIAKGIGYLH 529
           +L  +   +   + +    +A  G+L KY+ ++ GS    D +        I   + YLH
Sbjct: 96  KL--YFTFQDDEKLYFGLSYAKNGELLKYI-RKIGS---FDETCTRFYTAEIVSALEYLH 149
Query: 530 SSEVNKPAIVHRNLSVEKVLIDQQFNPLIADCGLHKLLADDIVFSVLKTSAAMG---YLA 586
                   I+HR+L  E +L+++  +  I D G  K+L+ +      + +  +G   Y++
Sbjct: 150 GK-----GIIHRDLKPENILLNEDMHIQITDFGTAKVLSPES--KQARANXFVGTAQYVS 202
Query: 587 PEYVTTGRFTERSDIFAFGVIILQILTG 614
           PE +T     + SD++A G II Q++ G
Sbjct: 203 PELLTEKSAXKSSDLWALGCIIYQLVAG 230

>pdb|2J7T|A Chain A, Crystal Structure Of Human Serine Threonine Kinase-10 Bound To Su11274 Length = 302

Iteration: 1
 Score = 45.8 bits (107), Expect = 7e-05,   Method: Compositional matrix adjust.
 Identities = 46/214 (21%), Positives = 102/214 (47%), Gaps = 28/214 (13%)
Query: 409 QCFSEVNLLGKGNFSSVYKGTLRD-GTLVAIRSINVTSCKSEEAEFVKGLYLLTSLRHEN 467
           + +  V  LG G F  VYK   ++ G L A + I  T  + E  +++  + +L +  H  
Sbjct: 19  EVWEIVGELGDGAFGKVYKAKNKETGALAAAKVIE-TKSEEELEDYIVEIEILATCDHPY 77
Query: 468 IIRLRGFCCSRGRGECFLIYDFAPKGKLSK-YLDQEEGSSNVLDWSTRVSIII-GIAKGI 525
           I++L G     G+   +++ +F P G +    L+ + G +       ++ ++   + + +
Sbjct: 78  IVKLLGAYYHDGK--LWIMIEFCPGGAVDAIMLELDRGLTE-----PQIQVVCRQMLEAL 130
Query: 526 GYLHSSEVNKPAIVHRNLSVEKVLIDQQFNPLIADCGLHKLLADDIVFSVLKTSAAMG-- 583
            +LHS       I+HR+L    VL+  + +  +AD G    ++   + ++ K  + +G  
Sbjct: 131 NFLHSKR-----IIHRDLKAGNVLMTLEGDIRLADFG----VSAKNLKTLQKRDSFIGTP 181
Query: 584 -YLAPEYVTTGRFTE-----RSDIFAFGVIILQI 611
            ++APE V      +     ++DI++ G+ ++++
Sbjct: 182 YWMAPEVVMCETMKDTPYDYKADIWSLGITLIEM 215

>pdb|4FR4|A Chain A, Crystal Structure Of Human SerineTHREONINE-Protein Kinase 32a (Yank1) Length = 384

Iteration: 1
 Score = 45.8 bits (107), Expect = 8e-05,   Method: Compositional matrix adjust.
 Identities = 45/211 (21%), Positives = 92/211 (43%), Gaps = 21/211 (9%)
Query: 411 FSEVNLLGKGNFSSVYKGTLRD-GTLVAIRSINVTSC--KSEEAEFVKGLYLLTSLRHEN 467
           F  +  +GKG+F  V      D   + A++ +N   C  ++E     K L ++  L H  
Sbjct: 17  FEILRAIGKGSFGKVCIVQKNDTKKMYAMKYMNKQKCVERNEVRNVFKELQIMQGLEHPF 76
Query: 468 IIRLRGFCCSRGRGECFLIYDFAPKGKLSKYLDQEEGSSNVLDWSTRVSIII-GIAKGIG 526
           ++ L  +   +   + F++ D    G L  +L Q     NV      V + I  +   + 
Sbjct: 77  LVNL--WYSFQDEEDMFMVVDLLLGGDLRYHLQQ-----NVHFKEETVKLFICELVMALD 129
Query: 527 YLHSSEVNKPAIVHRNLSVEKVLIDQQFNPLIADCGLHKLLADDIVFSVLKTSAAMGYLA 586
           YL +       I+HR++  + +L+D+  +  I D  +  +L  +   + +  +    Y+A
Sbjct: 130 YLQNQR-----IIHRDMKPDNILLDEHGHVHITDFNIAAMLPRETQITTM--AGTKPYMA 182
Query: 587 PEYVTTGR---FTERSDIFAFGVIILQILTG 614
           PE  ++ +   ++   D ++ GV   ++L G
Sbjct: 183 PEMFSSRKGAGYSFAVDWWSLGVTAYELLRG 213

>pdb|3PY3|A Chain A, Crystal Structure Of Phosphorylated P38alpha Map Kinase Length = 380

Iteration: 1
 Score = 45.8 bits (107), Expect = 8e-05,   Method: Compositional matrix adjust.
 Identities = 54/236 (22%), Positives = 108/236 (45%), Gaps = 21/236 (8%)
Query: 386 GTGFSREHLNSFRLNLEE-VESATQCFSEVNLLGKGNFSSVYKG-TLRDGTLVAIRSINV 443
           G+  S+E    +R  L + +    + +  ++ +G G + SV      + G  VA++ ++ 
Sbjct: 18  GSHMSQERPTFYRQELNKTIWEVPERYQNLSPVGSGAYGSVCAAFDTKTGHRVAVKKLSR 77
Query: 444 TSCKSEEAEFV-KGLYLLTSLRHENIIRLRG-FCCSRGRGECFLIY--DFAPKGKLSKYL 499
                  A+   + L LL  ++HEN+I L   F  +R   E   +Y         L+  +
Sbjct: 78  PFQSIIHAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIV 137
Query: 500 DQEEGSSNVLDWSTRVSIIIGIAKGIGYLHSSEVNKPAIVHRNLSVEKVLIDQQFNPLIA 559
             ++ + + + +     +I  I +G+ Y+HS++     I+HR+L    + +++     I 
Sbjct: 138 KCQKLTDDHVQF-----LIYQILRGLKYIHSAD-----IIHRDLKPSNLAVNEDCELKIL 187
Query: 560 DCGLHKLLADDIVFSVLKTSAAMGYLAPEYVTTG-RFTERSDIFAFGVIILQILTG 614
           D GL +   D++   V    A   Y APE +     + +  DI++ G I+ ++LTG
Sbjct: 188 DFGLARHTDDEMXGXV----ATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTG 239

>pdb|3NNX|A Chain A, Crystal Structure Of Phosphorylated P38 Alpha In Complex With Dp802 Length = 354

Iteration: 1
 Score = 45.8 bits (107), Expect = 8e-05,   Method: Compositional matrix adjust.
 Identities = 61/238 (25%), Positives = 99/238 (41%), Gaps = 38/238 (15%)
Query: 389 FSREHLNSFRLNLEEVESATQCFSEVNLLGKGNFSSVYKG-TLRDGTLVAIRSINVTSCK 447
           F R+ LN     + EV    Q  S V   G G + SV      + G  VA++ ++     
Sbjct: 8   FYRQELNK---TIWEVPERYQNLSPV---GSGAYGSVCAAFDTKTGLRVAVKKLSRPFQS 61
Query: 448 SEEAEFV-KGLYLLTSLRHENIIRLRG-FCCSRGRGECFLIY--------DFAPKGKLSK 497
              A+   + L LL  ++HEN+I L   F  +R   E   +Y        D     K  K
Sbjct: 62  IIHAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQK 121
Query: 498 YLDQEEGSSNVLDWSTRVSIIIGIAKGIGYLHSSEVNKPAIVHRNLSVEKVLIDQQFNPL 557
             D                +I  I +G+ Y+HS++     I+HR+L    + +++     
Sbjct: 122 LTDDHVQF-----------LIYQILRGLKYIHSAD-----IIHRDLKPSNLAVNEDCELK 165
Query: 558 IADCGLHKLLADDIVFSVLKTSAAMGYLAPEYVTTG-RFTERSDIFAFGVIILQILTG 614
           I D GL +   D++   V    A   Y APE +     + +  DI++ G I+ ++LTG
Sbjct: 166 ILDFGLARHTDDEMTGXV----ATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTG 219

>pdb|4E5A|X Chain X, The W197a Mutant Of P38a Map Kinase Length = 360

Iteration: 1
 Score = 45.8 bits (107), Expect = 8e-05,   Method: Compositional matrix adjust.
 Identities = 58/232 (25%), Positives = 104/232 (44%), Gaps = 26/232 (11%)
Query: 389 FSREHLNSFRLNLEEVESATQCFSEVNLLGKGNFSSVYKG-TLRDGTLVAIRSINVTSCK 447
           F R+ LN     + EV    Q  S V   G G + SV      + G  VA++ ++     
Sbjct: 8   FYRQELNK---TIWEVPERYQNLSPV---GSGAYGSVCAAFDTKTGLRVAVKKLSRPFQS 61
Query: 448 SEEAEFV-KGLYLLTSLRHENIIRLRG-FCCSRGRGECFLIY--DFAPKGKLSKYLDQEE 503
              A+   + L LL  ++HEN+I L   F  +R   E   +Y         L+  +  ++
Sbjct: 62  IIHAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQK 121
Query: 504 GSSNVLDWSTRVSIIIGIAKGIGYLHSSEVNKPAIVHRNLSVEKVLIDQQFNPLIADCGL 563
            + + + +     +I  I +G+ Y+HS++     I+HR+L    + +++     I D GL
Sbjct: 122 LTDDHVQF-----LIYQILRGLKYIHSAD-----IIHRDLKPSNLAVNEDCELKILDFGL 171
Query: 564 HKLLADDIVFSVLKTSAAMGYLAPEYVTTG-RFTERSDIFAFGVIILQILTG 614
            +   D++   V    A   Y APE +     + +  DI++ G I+ ++LTG
Sbjct: 172 ARHTDDEMTGYV----ATRWYRAPEIMLNAMHYNQTVDIWSVGCIMAELLTG 219

>pdb|3IOP|A Chain A, Pdk-1 In Complex With The Inhibitor Compound-8i Length = 312

Iteration: 1
 Score = 45.8 bits (107), Expect = 8e-05,   Method: Compositional matrix adjust.
 Identities = 49/208 (23%), Positives = 98/208 (47%), Gaps = 23/208 (11%)
Query: 415 NLLGKGNFSSVYKG----TLRDGTLVAIRSINVTSCKSEEAEFV-KGLYLLTSLRHENII 469
            +LG+G+FS+V       T R+  +  +   ++   K  +  +V +   +++ L H   +
Sbjct: 39  KILGEGSFSTVVLARELATSREYAIKILEKRHI--IKENKVPYVTRERDVMSRLDHPFFV 96
Query: 470 RLRGFCCSRGRGECFLIYDFAPKGKLSKYLDQEEGSSNVLDWSTRVSIIIGIAKGIGYLH 529
           +L  +   +   + +    +A  G+L KY+ ++ GS    D +        I   + YLH
Sbjct: 97  KL--YFTFQDDEKLYFGLSYAKNGELLKYI-RKIGS---FDETCTRFYTAEIVSALEYLH 150
Query: 530 SSEVNKPAIVHRNLSVEKVLIDQQFNPLIADCGLHKLLADDIVFSVLKTSAAMG---YLA 586
                   I+HR+L  E +L+++  +  I D G  K+L+ +      + +  +G   Y++
Sbjct: 151 GK-----GIIHRDLKPENILLNEDMHIQITDFGTAKVLSPES--KQARANXFVGTAQYVS 203
Query: 587 PEYVTTGRFTERSDIFAFGVIILQILTG 614
           PE +T     + SD++A G II Q++ G
Sbjct: 204 PELLTEKSACKSSDLWALGCIIYQLVAG 231

>pdb|2VZ6|A Chain A, Structure Of Human Calcium Calmodulin Dependent Protein Kinase Type Ii Alpha (Camk2a) In Complex With Indirubin E804 Length = 313

Iteration: 1
 Score = 45.8 bits (107), Expect = 8e-05,   Method: Compositional matrix adjust.
 Identities = 56/215 (26%), Positives = 94/215 (43%), Gaps = 20/215 (9%)
Query: 405 ESATQCFSEVNLLGKGNFSSVYKGT-LRDGTLVAIRSINVTSCKSEEAE-FVKGLYLLTS 462
           +S  Q F E   LGKG FS V +   +  G   A + IN     + + +   +   +   
Sbjct: 21  QSMYQLFEE---LGKGAFSVVRRCVKVLAGQEYAAKIINTKKLSARDHQKLEREARICRL 77
Query: 463 LRHENIIRLRGFCCSRGRGECFLIYDFAPKGKLSKYLDQEEGSSNVLDWSTRVSIIIGIA 522
           L+H NI+RL       G    +LI+D    G+L + +   E  S   D S  +  I+   
Sbjct: 78  LKHPNIVRLHDSISEEGHH--YLIFDLVTGGELFEDIVAREYYSEA-DASHCIQQILE-- 132
Query: 523 KGIGYLHSSEVNKPAIVHRNLSVEKVLIDQQFNPL---IADCGLHKLLADDIVFSVLKTS 579
                LH  ++    +VHR+L  E +L+  +       +AD GL  +  +    +    +
Sbjct: 133 ---AVLHCHQM---GVVHRDLKPENLLLASKLKGAAVKLADFGL-AIEVEGEQQAWFGFA 185
Query: 580 AAMGYLAPEYVTTGRFTERSDIFAFGVIILQILTG 614
              GYL+PE +    + +  D++A GVI+  +L G
Sbjct: 186 GTPGYLSPEVLRKDPYGKPVDLWACGVILYILLVG 220

>pdb|1UU3|A Chain A, Structure Of Human Pdk1 Kinase Domain In Complex With Ly333531 Length = 310

Iteration: 1
 Score = 45.8 bits (107), Expect = 8e-05,   Method: Compositional matrix adjust.
 Identities = 49/208 (23%), Positives = 98/208 (47%), Gaps = 23/208 (11%)
Query: 415 NLLGKGNFSSVYKG----TLRDGTLVAIRSINVTSCKSEEAEFV-KGLYLLTSLRHENII 469
            +LG+G+FS+V       T R+  +  +   ++   K  +  +V +   +++ L H   +
Sbjct: 36  KILGEGSFSTVVLARELATSREYAIKILEKRHI--IKENKVPYVTRERDVMSRLDHPFFV 93
Query: 470 RLRGFCCSRGRGECFLIYDFAPKGKLSKYLDQEEGSSNVLDWSTRVSIIIGIAKGIGYLH 529
           +L  +   +   + +    +A  G+L KY+ ++ GS    D +        I   + YLH
Sbjct: 94  KL--YFTFQDDEKLYFGLSYAKNGELLKYI-RKIGS---FDETCTRFYTAEIVSALEYLH 147
Query: 530 SSEVNKPAIVHRNLSVEKVLIDQQFNPLIADCGLHKLLADDIVFSVLKTSAAMG---YLA 586
                   I+HR+L  E +L+++  +  I D G  K+L+ +      + +  +G   Y++
Sbjct: 148 GK-----GIIHRDLKPENILLNEDMHIQITDFGTAKVLSPES--KQARANXFVGTAQYVS 200
Query: 587 PEYVTTGRFTERSDIFAFGVIILQILTG 614
           PE +T     + SD++A G II Q++ G
Sbjct: 201 PELLTEKSACKSSDLWALGCIIYQLVAG 228

>pdb|2XCH|A Chain A, Crystal Structure Of Pdk1 In Complex With A Pyrazoloquinazoline Inhibitor Length = 309

Iteration: 1
 Score = 45.8 bits (107), Expect = 8e-05,   Method: Compositional matrix adjust.
 Identities = 49/208 (23%), Positives = 98/208 (47%), Gaps = 23/208 (11%)
Query: 415 NLLGKGNFSSVYKG----TLRDGTLVAIRSINVTSCKSEEAEFV-KGLYLLTSLRHENII 469
            +LG+G+FS+V       T R+  +  +   ++   K  +  +V +   +++ L H   +
Sbjct: 36  KILGEGSFSTVVLARELATSREYAIKILEKRHI--IKENKVPYVTRERDVMSRLDHPFFV 93
Query: 470 RLRGFCCSRGRGECFLIYDFAPKGKLSKYLDQEEGSSNVLDWSTRVSIIIGIAKGIGYLH 529
           +L  +   +   + +    +A  G+L KY+ ++ GS    D +        I   + YLH
Sbjct: 94  KL--YFTFQDDEKLYFGLSYAKNGELLKYI-RKIGS---FDETCTRFYTAEIVSALEYLH 147
Query: 530 SSEVNKPAIVHRNLSVEKVLIDQQFNPLIADCGLHKLLADDIVFSVLKTSAAMG---YLA 586
                   I+HR+L  E +L+++  +  I D G  K+L+ +      + +  +G   Y++
Sbjct: 148 GK-----GIIHRDLKPENILLNEDMHIQITDFGTAKVLSPES--KQARANXFVGTAQYVS 200
Query: 587 PEYVTTGRFTERSDIFAFGVIILQILTG 614
           PE +T     + SD++A G II Q++ G
Sbjct: 201 PELLTEKSACKSSDLWALGCIIYQLVAG 228

>pdb|3QC4|A Chain A, Pdk1 In Complex With Dfg-Out Inhibitor Xxx Length = 314

Iteration: 1
 Score = 45.8 bits (107), Expect = 9e-05,   Method: Compositional matrix adjust.
 Identities = 49/208 (23%), Positives = 98/208 (47%), Gaps = 23/208 (11%)
Query: 415 NLLGKGNFSSVYKG----TLRDGTLVAIRSINVTSCKSEEAEFV-KGLYLLTSLRHENII 469
            +LG+G+FS+V       T R+  +  +   ++   K  +  +V +   +++ L H   +
Sbjct: 41  KILGEGSFSTVVLARELATSREYAIKILEKRHI--IKENKVPYVTRERDVMSRLDHPFFV 98
Query: 470 RLRGFCCSRGRGECFLIYDFAPKGKLSKYLDQEEGSSNVLDWSTRVSIIIGIAKGIGYLH 529
           +L  +   +   + +    +A  G+L KY+ ++ GS    D +        I   + YLH
Sbjct: 99  KL--YFTFQDDEKLYFGLSYAKNGELLKYI-RKIGS---FDETCTRFYTAEIVSALEYLH 152
Query: 530 SSEVNKPAIVHRNLSVEKVLIDQQFNPLIADCGLHKLLADDIVFSVLKTSAAMG---YLA 586
                   I+HR+L  E +L+++  +  I D G  K+L+ +      + +  +G   Y++
Sbjct: 153 GK-----GIIHRDLKPENILLNEDMHIQITDFGTAKVLSPES--KQARANXFVGTAQYVS 205
Query: 587 PEYVTTGRFTERSDIFAFGVIILQILTG 614
           PE +T     + SD++A G II Q++ G
Sbjct: 206 PELLTEKSACKSSDLWALGCIIYQLVAG 233

>pdb|1BMK|A Chain A, The Complex Structure Of The Map Kinase P38SB218655 Length = 379

Iteration: 1
 Score = 45.8 bits (107), Expect = 9e-05,   Method: Compositional matrix adjust.
 Identities = 54/236 (22%), Positives = 108/236 (45%), Gaps = 21/236 (8%)
Query: 386 GTGFSREHLNSFRLNLEE-VESATQCFSEVNLLGKGNFSSVYKG-TLRDGTLVAIRSINV 443
           G+  S+E    +R  L + +    + +  ++ +G G + SV      + G  VA++ ++ 
Sbjct: 17  GSHMSQERPTFYRQELNKTIWEVPERYQNLSPVGSGAYGSVCAAFDTKTGHRVAVKKLSR 76
Query: 444 TSCKSEEAEFV-KGLYLLTSLRHENIIRLRG-FCCSRGRGECFLIY--DFAPKGKLSKYL 499
                  A+   + L LL  ++HEN+I L   F  +R   E   +Y         L+  +
Sbjct: 77  PFQSIIHAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIV 136
Query: 500 DQEEGSSNVLDWSTRVSIIIGIAKGIGYLHSSEVNKPAIVHRNLSVEKVLIDQQFNPLIA 559
             ++ + + + +     +I  I +G+ Y+HS++     I+HR+L    + +++     I 
Sbjct: 137 KCQKLTDDHVQF-----LIYQILRGLKYIHSAD-----IIHRDLKPSNLAVNEDCELKIL 186
Query: 560 DCGLHKLLADDIVFSVLKTSAAMGYLAPEYVTTG-RFTERSDIFAFGVIILQILTG 614
           D GL +   D++   V    A   Y APE +     + +  DI++ G I+ ++LTG
Sbjct: 187 DFGLARHTDDEMTGYV----ATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTG 238

>pdb|3H9O|A Chain A, Phosphoinositide-Dependent Protein Kinase 1 (Pdk-1) In Complex With Compound 9 Length = 311

Iteration: 1
 Score = 45.8 bits (107), Expect = 9e-05,   Method: Compositional matrix adjust.
 Identities = 49/208 (23%), Positives = 98/208 (47%), Gaps = 23/208 (11%)
Query: 415 NLLGKGNFSSVYKG----TLRDGTLVAIRSINVTSCKSEEAEFV-KGLYLLTSLRHENII 469
            +LG+G+FS+V       T R+  +  +   ++   K  +  +V +   +++ L H   +
Sbjct: 38  KILGEGSFSTVVLARELATSREYAIKILEKRHI--IKENKVPYVTRERDVMSRLDHPFFV 95
Query: 470 RLRGFCCSRGRGECFLIYDFAPKGKLSKYLDQEEGSSNVLDWSTRVSIIIGIAKGIGYLH 529
           +L  +   +   + +    +A  G+L KY+ ++ GS    D +        I   + YLH
Sbjct: 96  KL--YFTFQDDEKLYFGLSYAKNGELLKYI-RKIGS---FDETCTRFYTAEIVSALEYLH 149
Query: 530 SSEVNKPAIVHRNLSVEKVLIDQQFNPLIADCGLHKLLADDIVFSVLKTSAAMG---YLA 586
                   I+HR+L  E +L+++  +  I D G  K+L+ +      + +  +G   Y++
Sbjct: 150 GK-----GIIHRDLKPENILLNEDMHIQITDFGTAKVLSPES--KQARANXFVGTAQYVS 202
Query: 587 PEYVTTGRFTERSDIFAFGVIILQILTG 614
           PE +T     + SD++A G II Q++ G
Sbjct: 203 PELLTEKSACKSSDLWALGCIIYQLVAG 230

>pdb|4GSB|A Chain A, Monoclinic Crystal Form Of The Apo-Erk2 Length = 364

Iteration: 1
 Score = 45.8 bits (107), Expect = 9e-05,   Method: Compositional matrix adjust.
 Identities = 47/217 (21%), Positives = 100/217 (46%), Gaps = 22/217 (10%)
Query: 411 FSEVNLLGKGNFS---SVYKGTLRDGTLVAIRSINVTSCKSEEAEFVKGLYLLTSLRHEN 467
           ++ ++ +G+G +    S Y     +   VAI+ I+    ++     ++ + +L   RHEN
Sbjct: 29  YTNLSYIGEGAYGMVCSAYDNL--NKVRVAIKKISPFEHQTYXQRTLREIKILLRFRHEN 86
Query: 468 IIRLRGFCCS---RGRGECFLIYDFAPKGKLSKYLDQEEGSSNVLDWSTRVSIIIGIAKG 524
           II +     +       + +++ D   +  L K L  +  S++ + +      +  I +G
Sbjct: 87  IIGINDIIRAPTIEQMKDVYIVQDLM-ETDLYKLLKTQHLSNDHICY-----FLYQILRG 140
Query: 525 IGYLHSSEVNKPAIVHRNLSVEKVLIDQQFNPLIADCGLHKLLADDIVFSVLKTS--AAM 582
           + Y+HS+ V     +HR+L    +L++   +  I D GL ++   D   +   T   A  
Sbjct: 141 LKYIHSANV-----LHRDLKPSNLLLNTTXDLKICDFGLARVADPDHDHTGFLTEYVATR 195
Query: 583 GYLAPEYVTTGR-FTERSDIFAFGVIILQILTGSLVL 618
            Y APE +   + +T+  DI++ G I+ ++L+   + 
Sbjct: 196 WYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNRPIF 232

>pdb|3RWP|A Chain A, Discovery Of A Novel, Potent And Selective Inhibitor Of 3- Phosphoinositide Dependent Kinase (Pdk1) Length = 311

Iteration: 1
 Score = 45.8 bits (107), Expect = 9e-05,   Method: Compositional matrix adjust.
 Identities = 49/208 (23%), Positives = 98/208 (47%), Gaps = 23/208 (11%)
Query: 415 NLLGKGNFSSVYKG----TLRDGTLVAIRSINVTSCKSEEAEFV-KGLYLLTSLRHENII 469
            +LG+G+FS+V       T R+  +  +   ++   K  +  +V +   +++ L H   +
Sbjct: 38  KILGEGSFSTVVLARELATSREYAIKILEKRHI--IKENKVPYVTRERDVMSRLDHPFFV 95
Query: 470 RLRGFCCSRGRGECFLIYDFAPKGKLSKYLDQEEGSSNVLDWSTRVSIIIGIAKGIGYLH 529
           +L  +   +   + +    +A  G+L KY+ ++ GS    D +        I   + YLH
Sbjct: 96  KL--YFTFQDDEKLYFGLSYAKNGELLKYI-RKIGS---FDETCTRFYTAEIVSALEYLH 149
Query: 530 SSEVNKPAIVHRNLSVEKVLIDQQFNPLIADCGLHKLLADDIVFSVLKTSAAMG---YLA 586
                   I+HR+L  E +L+++  +  I D G  K+L+ +      + +  +G   Y++
Sbjct: 150 GK-----GIIHRDLKPENILLNEDMHIQITDFGTAKVLSPES--KQARANXFVGTAQYVS 202
Query: 587 PEYVTTGRFTERSDIFAFGVIILQILTG 614
           PE +T     + SD++A G II Q++ G
Sbjct: 203 PELLTEKSACKSSDLWALGCIIYQLVAG 230

>pdb|4BCF|A Chain A, Structure Of Cdk9 In Complex With Cyclin T And A 2-amino-4- Heteroaryl-pyrimidine Inhibitor Length = 331

Iteration: 1
 Score = 45.8 bits (107), Expect = 9e-05,   Method: Compositional matrix adjust.
 Identities = 55/232 (23%), Positives = 106/232 (45%), Gaps = 45/232 (19%)
Query: 411 FSEVNLLGKGNFSSVYKGTLRD-GTLVAIRSINVTSCKSEEAEF----VKGLYLLTSLRH 465
           + ++  +G+G F  V+K   R  G  VA++ + +   ++E+  F    ++ + +L  L+H
Sbjct: 20  YEKLAKIGQGTFGEVFKARHRKTGQKVALKKVLM---ENEKEGFPITALREIKILQLLKH 76
Query: 466 ENIIRLRGFC------CSRGRGECFLIYDFAPKGKLSKYLDQEEGSSNVL---DWSTRVS 516
           EN++ L   C       +R +   +L++DF  +  L+  L      SNVL     S    
Sbjct: 77  ENVVNLIEICRTKASPYNRCKASIYLVFDFC-EHDLAGLL------SNVLVKFTLSEIKR 129
Query: 517 IIIGIAKGIGYLHSSEVNKPAIVHRNLSVEKVLIDQQFNPLIADCGLHKLLADDIVFSVL 576
           ++  +  G+ Y+H ++     I+HR++    VLI +     +AD GL +       FS+ 
Sbjct: 130 VMQMLLNGLYYIHRNK-----ILHRDMKAANVLITRDGVLKLADFGLAR------AFSLA 178
Query: 577 KTS---------AAMGYLAPEYVTTGR-FTERSDIFAFGVIILQILTGSLVL 618
           K S           + Y  PE +   R +    D++  G I+ ++ T S ++
Sbjct: 179 KNSQPNRYXNRVVTLWYRPPELLLGERDYGPPIDLWGAGCIMAEMWTRSPIM 230

>pdb|3TG1|A Chain A, Crystal Structure Of P38alpha In Complex With A Mapk Docking Partner Length = 380

Iteration: 1
 Score = 45.4 bits (106), Expect = 9e-05,   Method: Compositional matrix adjust.
 Identities = 54/236 (22%), Positives = 108/236 (45%), Gaps = 21/236 (8%)
Query: 386 GTGFSREHLNSFRLNLEE-VESATQCFSEVNLLGKGNFSSVYKG-TLRDGTLVAIRSINV 443
           G+  S+E    +R  L + +    + +  ++ +G G + SV      + G  VA++ ++ 
Sbjct: 18  GSHMSQERPTFYRQELNKTIWEVPERYQNLSPVGSGAYGSVCAAFDTKTGHRVAVKKLSR 77
Query: 444 TSCKSEEAEFV-KGLYLLTSLRHENIIRLRG-FCCSRGRGECFLIY--DFAPKGKLSKYL 499
                  A+   + L LL  ++HEN+I L   F  +R   E   +Y         L+  +
Sbjct: 78  PFQSIIHAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIV 137
Query: 500 DQEEGSSNVLDWSTRVSIIIGIAKGIGYLHSSEVNKPAIVHRNLSVEKVLIDQQFNPLIA 559
             ++ + + + +     +I  I +G+ Y+HS++     I+HR+L    + +++     I 
Sbjct: 138 KCQKLTDDHVQF-----LIYQILRGLKYIHSAD-----IIHRDLKPSNLAVNEDCELKIL 187
Query: 560 DCGLHKLLADDIVFSVLKTSAAMGYLAPEYVTTG-RFTERSDIFAFGVIILQILTG 614
           D GL +   D++   V    A   Y APE +     + +  DI++ G I+ ++LTG
Sbjct: 188 DFGLARHTDDEMTGYV----ATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTG 239

>pdb|2Y8O|A Chain A, Crystal Structure Of Human P38alpha Complexed With A Mapk Docking Peptide Length = 362

Iteration: 1
 Score = 45.4 bits (106), Expect = 9e-05,   Method: Compositional matrix adjust.
 Identities = 61/238 (25%), Positives = 99/238 (41%), Gaps = 38/238 (15%)
Query: 389 FSREHLNSFRLNLEEVESATQCFSEVNLLGKGNFSSVYKG-TLRDGTLVAIRSINVTSCK 447
           F R+ LN     + EV    Q  S V   G G + SV      + G  VA++ ++     
Sbjct: 10  FYRQELNK---TIWEVPERYQNLSPV---GSGAYGSVCAAFDTKTGLRVAVKKLSRPFQS 63
Query: 448 SEEAEFV-KGLYLLTSLRHENIIRLRG-FCCSRGRGECFLIY--------DFAPKGKLSK 497
              A+   + L LL  ++HEN+I L   F  +R   E   +Y        D     K  K
Sbjct: 64  IIHAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQK 123
Query: 498 YLDQEEGSSNVLDWSTRVSIIIGIAKGIGYLHSSEVNKPAIVHRNLSVEKVLIDQQFNPL 557
             D                +I  I +G+ Y+HS++     I+HR+L    + +++     
Sbjct: 124 LTDDHVQF-----------LIYQILRGLKYIHSAD-----IIHRDLKPSNLAVNEDSELK 167
Query: 558 IADCGLHKLLADDIVFSVLKTSAAMGYLAPEYVTTG-RFTERSDIFAFGVIILQILTG 614
           I D GL +   D++   V    A   Y APE +     + +  DI++ G I+ ++LTG
Sbjct: 168 ILDFGLARHTDDEMTGYV----ATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTG 221

>pdb|3NNU|A Chain A, Crystal Structure Of P38 Alpha In Complex With Dp1376 Length = 354

Iteration: 1
 Score = 45.4 bits (106), Expect = 9e-05,   Method: Compositional matrix adjust.
 Identities = 61/238 (25%), Positives = 99/238 (41%), Gaps = 38/238 (15%)
Query: 389 FSREHLNSFRLNLEEVESATQCFSEVNLLGKGNFSSVYKG-TLRDGTLVAIRSINVTSCK 447
           F R+ LN     + EV    Q  S V   G G + SV      + G  VA++ ++     
Sbjct: 8   FYRQELNK---TIWEVPERYQNLSPV---GSGAYGSVCAAFDTKTGLRVAVKKLSRPFQS 61
Query: 448 SEEAEFV-KGLYLLTSLRHENIIRLRG-FCCSRGRGECFLIY--------DFAPKGKLSK 497
              A+   + L LL  ++HEN+I L   F  +R   E   +Y        D     K  K
Sbjct: 62  IIHAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQK 121
Query: 498 YLDQEEGSSNVLDWSTRVSIIIGIAKGIGYLHSSEVNKPAIVHRNLSVEKVLIDQQFNPL 557
             D                +I  I +G+ Y+HS++     I+HR+L    + +++     
Sbjct: 122 LTDDHVQF-----------LIYQILRGLKYIHSAD-----IIHRDLKPSNLAVNEDCELK 165
Query: 558 IADCGLHKLLADDIVFSVLKTSAAMGYLAPEYVTTG-RFTERSDIFAFGVIILQILTG 614
           I D GL +   D++   V    A   Y APE +     + +  DI++ G I+ ++LTG
Sbjct: 166 ILDFGLARHTDDEMTGYV----ATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTG 219

>pdb|3HRC|A Chain A, Crystal Structure Of A Mutant Of Human Pdk1 Kinase Domain In Complex With Atp Length = 311

Iteration: 1
 Score = 45.4 bits (106), Expect = 9e-05,   Method: Compositional matrix adjust.
 Identities = 49/208 (23%), Positives = 98/208 (47%), Gaps = 23/208 (11%)
Query: 415 NLLGKGNFSSVYKG----TLRDGTLVAIRSINVTSCKSEEAEFV-KGLYLLTSLRHENII 469
            +LG+G+FS+V       T R+  +  +   ++   K  +  +V +   +++ L H   +
Sbjct: 38  KILGEGSFSTVVLARELATSREYAIKILEKRHI--IKENKVPYVTRERDVMSRLDHPFFV 95
Query: 470 RLRGFCCSRGRGECFLIYDFAPKGKLSKYLDQEEGSSNVLDWSTRVSIIIGIAKGIGYLH 529
           +L  +   +   + +    +A  G+L KY+ ++ GS    D +        I   + YLH
Sbjct: 96  KL--YFTFQDDEKLYFGLSYAKNGELLKYI-RKIGS---FDETCTRFYTAEIVSALEYLH 149
Query: 530 SSEVNKPAIVHRNLSVEKVLIDQQFNPLIADCGLHKLLADDIVFSVLKTSAAMG---YLA 586
                   I+HR+L  E +L+++  +  I D G  K+L+ +      + +  +G   Y++
Sbjct: 150 GK-----GIIHRDLKPENILLNEDMHIQITDFGTAKVLSPES--KQARANXFVGTAQYVS 202
Query: 587 PEYVTTGRFTERSDIFAFGVIILQILTG 614
           PE +T     + SD++A G II Q++ G
Sbjct: 203 PELLTEKSACKSSDLWALGCIIYQLVAG 230

>pdb|3KN5|A Chain A, Crystal Structure Of The C-Terminal Kinase Domain Of Msk1 In With Amp-Pnp Length = 325

Iteration: 1
 Score = 45.4 bits (106), Expect = 9e-05,   Method: Compositional matrix adjust.
 Identities = 59/240 (24%), Positives = 102/240 (42%), Gaps = 23/240 (9%)
Query: 417 LGKGNFSSVYKGTLRDGTLVAIRSINVTSCKSEEAEFVKGLYLLTSLRHENIIRLRGFCC 476
           LG+G+FS   K   +         I     ++   + +  L L     H NI++L     
Sbjct: 19  LGEGSFSICRKCVHKKSNQAFAVKIISKRMEANTQKEITALKLCEG--HPNIVKLHE--V 74
Query: 477 SRGRGECFLIYDFAPKGKLSKYLDQEEGSSNVLDWSTRVSIII-GIAKGIGYLHSSEVNK 535
              +   FL+ +    G+L + + +++  S      T  S I+  +   + ++H      
Sbjct: 75  FHDQLHTFLVMELLNGGELFERIKKKKHFS-----ETEASYIMRKLVSAVSHMHDV---- 125
Query: 536 PAIVHRNLSVEKVLIDQQFNPL---IADCGLHKLLADDIVFSVLKTSA-AMGYLAPEYVT 591
             +VHR+L  E +L   + + L   I D G  +L   D     LKT    + Y APE + 
Sbjct: 126 -GVVHRDLKPENLLFTDENDNLEIKIIDFGFARLKPPDN--QPLKTPCFTLHYAAPELLN 182
Query: 592 TGRFTERSDIFAFGVIILQILTGSLVLTSSMRLAAESATFENFIDRNLKGKFS-ESEAAK 650
              + E  D+++ GVI+  +L+G +   S  R    ++  E  + +  KG FS E EA K
Sbjct: 183 QNGYDESCDLWSLGVILYTMLSGQVPFQSHDRSLTCTSAVE-IMKKIKKGDFSFEGEAWK 241

>pdb|1H1W|A Chain A, High Resolution Crystal Structure Of The Human Pdk1 Catalytic Domain Length = 289

Iteration: 1
 Score = 45.4 bits (106), Expect = 9e-05,   Method: Compositional matrix adjust.
 Identities = 49/208 (23%), Positives = 98/208 (47%), Gaps = 23/208 (11%)
Query: 415 NLLGKGNFSSVYKG----TLRDGTLVAIRSINVTSCKSEEAEFV-KGLYLLTSLRHENII 469
            +LG+G+FS+V       T R+  +  +   ++   K  +  +V +   +++ L H   +
Sbjct: 16  KILGEGSFSTVVLARELATSREYAIKILEKRHI--IKENKVPYVTRERDVMSRLDHPFFV 73
Query: 470 RLRGFCCSRGRGECFLIYDFAPKGKLSKYLDQEEGSSNVLDWSTRVSIIIGIAKGIGYLH 529
           +L  +   +   + +    +A  G+L KY+ ++ GS    D +        I   + YLH
Sbjct: 74  KL--YFTFQDDEKLYFGLSYAKNGELLKYI-RKIGS---FDETCTRFYTAEIVSALEYLH 127
Query: 530 SSEVNKPAIVHRNLSVEKVLIDQQFNPLIADCGLHKLLADDIVFSVLKTSAAMG---YLA 586
                   I+HR+L  E +L+++  +  I D G  K+L+ +      + +  +G   Y++
Sbjct: 128 GK-----GIIHRDLKPENILLNEDMHIQITDFGTAKVLSPES--KQARANXFVGTAQYVS 180
Query: 587 PEYVTTGRFTERSDIFAFGVIILQILTG 614
           PE +T     + SD++A G II Q++ G
Sbjct: 181 PELLTEKSACKSSDLWALGCIIYQLVAG 208

>pdb|3NAX|A Chain A, Pdk1 In Complex With Inhibitor Mp7 Length = 311

Iteration: 1
 Score = 45.4 bits (106), Expect = 9e-05,   Method: Compositional matrix adjust.
 Identities = 49/208 (23%), Positives = 99/208 (47%), Gaps = 23/208 (11%)
Query: 415 NLLGKGNFSSVYKG----TLRDGTLVAIRSINVTSCKSEEAEFV-KGLYLLTSLRHENII 469
            +LG+G+FS+V       T R+  +  +   ++   K  +  +V +   +++ L H   +
Sbjct: 35  KILGEGSFSTVVLARELATSREYAIKILEKRHI--IKENKVPYVTRERDVMSRLDHPFFV 92
Query: 470 RLRGFCCSRGRGECFLIYDFAPKGKLSKYLDQEEGSSNVLDWSTRVSIIIGIAKGIGYLH 529
           +L  +   +   + +    +A  G+L KY+ ++ GS    D +        I   + YLH
Sbjct: 93  KL--YFTFQDDEKLYFGLSYAKNGELLKYI-RKIGS---FDETCTRFYTAEIVSALEYLH 146
Query: 530 SSEVNKPAIVHRNLSVEKVLIDQQFNPLIADCGLHKLLADDIVFSVLKTSAAMG---YLA 586
                   I+HR+L  E +L+++  +  I D G  K+L+ +      + ++ +G   Y++
Sbjct: 147 GK-----GIIHRDLKPENILLNEDMHIQITDFGTAKVLSPES--KQARANSFVGTAQYVS 199
Query: 587 PEYVTTGRFTERSDIFAFGVIILQILTG 614
           PE +T     + SD++A G II Q++ G
Sbjct: 200 PELLTEKSACKSSDLWALGCIIYQLVAG 227

>pdb|4G31|A Chain A, Crystal Structure Of Gsk6414 Bound To Perk (R587-R1092, Delete A660- T867) At 2.28 A Resolution Length = 299

Iteration: 1
 Score = 45.4 bits (106), Expect = 1e-04,   Method: Compositional matrix adjust.
 Identities = 49/226 (21%), Positives = 92/226 (40%), Gaps = 32/226 (14%)
Query: 411 FSEVNLLGKGNFSSVYKGTLR-DGTLVAIRSINVTSCKSEEAEFVKGLYLLTSLRHENII 469
           F  +  LG+G F  V++   + D    AI+ I + + +    + ++ +  L  L H  I+
Sbjct: 7   FEPIQCLGRGGFGVVFEAKNKVDDCNYAIKRIRLPNRELAREKVMREVKALAKLEHPGIV 66
Query: 470 RLRGFCCSRGRGECFLIYDFAPKGKLSKYLDQEEGSSNVLDW------------STRVSI 517
           R       +   E   +   +PK  L   + Q     N+ DW            S  + I
Sbjct: 67  RYFNAWLEKNTTE--KLQPSSPKVYLYIQM-QLCRKENLKDWMNGRCTIEERERSVCLHI 123
Query: 518 IIGIAKGIGYLHSSEVNKPAIVHRNLSVEKVLIDQQFNPLIADCGLHKLL-ADDIVFSVL 576
            + IA+ + +LHS       ++HR+L    +         + D GL   +  D+   +VL
Sbjct: 124 FLQIAEAVEFLHSK-----GLMHRDLKPSNIFFTMDDVVKVGDFGLVTAMDQDEEEQTVL 178
Query: 577 KTSAAMG----------YLAPEYVTTGRFTERSDIFAFGVIILQIL 612
               A            Y++PE +    ++ + DIF+ G+I+ ++L
Sbjct: 179 TPMPAYARHTGQVGTKLYMSPEQIHGNSYSHKVDIFSLGLILFELL 224

>pdb|3ODY|X Chain X, Crystal Structure Of P38alpha Y323q Active Mutant Length = 360

Iteration: 1
 Score = 45.4 bits (106), Expect = 1e-04,   Method: Compositional matrix adjust.
 Identities = 61/238 (25%), Positives = 99/238 (41%), Gaps = 38/238 (15%)
Query: 389 FSREHLNSFRLNLEEVESATQCFSEVNLLGKGNFSSVYKG-TLRDGTLVAIRSINVTSCK 447
           F R+ LN     + EV    Q  S V   G G + SV      + G  VA++ ++     
Sbjct: 8   FYRQELNK---TIWEVPERYQNLSPV---GSGAYGSVCAAFDTKTGLRVAVKKLSRPFQS 61
Query: 448 SEEAEFV-KGLYLLTSLRHENIIRLRG-FCCSRGRGECFLIY--------DFAPKGKLSK 497
              A+   + L LL  ++HEN+I L   F  +R   E   +Y        D     K  K
Sbjct: 62  IIHAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQK 121
Query: 498 YLDQEEGSSNVLDWSTRVSIIIGIAKGIGYLHSSEVNKPAIVHRNLSVEKVLIDQQFNPL 557
             D                +I  I +G+ Y+HS++     I+HR+L    + +++     
Sbjct: 122 LTDDHVQF-----------LIYQILRGLKYIHSAD-----IIHRDLKPSNLAVNEDCELK 165
Query: 558 IADCGLHKLLADDIVFSVLKTSAAMGYLAPEYVTTG-RFTERSDIFAFGVIILQILTG 614
           I D GL +   D++   V    A   Y APE +     + +  DI++ G I+ ++LTG
Sbjct: 166 ILDFGLARHTDDEMTGYV----ATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTG 219

>pdb|1OVE|A Chain A, The Structure Of P38 Alpha In Complex With A Dihydroquinolinone Length = 366

Iteration: 1
 Score = 45.4 bits (106), Expect = 1e-04,   Method: Compositional matrix adjust.
 Identities = 61/238 (25%), Positives = 99/238 (41%), Gaps = 38/238 (15%)
Query: 389 FSREHLNSFRLNLEEVESATQCFSEVNLLGKGNFSSVYKG-TLRDGTLVAIRSINVTSCK 447
           F R+ LN     + EV    Q  S V   G G + SV      + G  VA++ ++     
Sbjct: 14  FYRQELNK---TIWEVPERYQNLSPV---GSGAYGSVCAAFDTKTGLRVAVKKLSRPFQS 67
Query: 448 SEEAEFV-KGLYLLTSLRHENIIRLRG-FCCSRGRGECFLIY--------DFAPKGKLSK 497
              A+   + L LL  ++HEN+I L   F  +R   E   +Y        D     K  K
Sbjct: 68  IIHAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQK 127
Query: 498 YLDQEEGSSNVLDWSTRVSIIIGIAKGIGYLHSSEVNKPAIVHRNLSVEKVLIDQQFNPL 557
             D                +I  I +G+ Y+HS++     I+HR+L    + +++     
Sbjct: 128 LTDDHVQF-----------LIYQILRGLKYIHSAD-----IIHRDLKPSNLAVNEDSELK 171
Query: 558 IADCGLHKLLADDIVFSVLKTSAAMGYLAPEYVTTG-RFTERSDIFAFGVIILQILTG 614
           I D GL +   D++   V    A   Y APE +     + +  DI++ G I+ ++LTG
Sbjct: 172 ILDFGLARHTDDEMTGYV----ATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTG 225

>pdb|3SC1|A Chain A, Novel Isoquinolone Pdk1 Inhibitors Discovered Through Fragment-Based Lead Discovery Length = 311

Iteration: 1
 Score = 45.4 bits (106), Expect = 1e-04,   Method: Compositional matrix adjust.
 Identities = 49/208 (23%), Positives = 98/208 (47%), Gaps = 23/208 (11%)
Query: 415 NLLGKGNFSSVYKG----TLRDGTLVAIRSINVTSCKSEEAEFV-KGLYLLTSLRHENII 469
            +LG+G+FS+V       T R+  +  +   ++   K  +  +V +   +++ L H   +
Sbjct: 38  KILGEGSFSTVVLARELATSREYAIKILEKRHI--IKENKVPYVTRERDVMSRLDHPFFV 95
Query: 470 RLRGFCCSRGRGECFLIYDFAPKGKLSKYLDQEEGSSNVLDWSTRVSIIIGIAKGIGYLH 529
           +L  +   +   + +    +A  G+L KY+ ++ GS    D +        I   + YLH
Sbjct: 96  KL--YFTFQDDEKLYFGLSYAKNGELLKYI-RKIGS---FDETCTRFYTAEIVSALEYLH 149
Query: 530 SSEVNKPAIVHRNLSVEKVLIDQQFNPLIADCGLHKLLADDIVFSVLKTSAAMG---YLA 586
                   I+HR+L  E +L+++  +  I D G  K+L+ +      + +  +G   Y++
Sbjct: 150 GK-----GIIHRDLKPENILLNEDMHIQITDFGTAKVLSPES--KQARANXFVGTAQYVS 202
Query: 587 PEYVTTGRFTERSDIFAFGVIILQILTG 614
           PE +T     + SD++A G II Q++ G
Sbjct: 203 PELLTEKSACKSSDLWALGCIIYQLVAG 230

>pdb|3DT1|A Chain A, P38 Complexed With A Quinazoline Inhibitor Length = 383

Iteration: 1
 Score = 45.4 bits (106), Expect = 1e-04,   Method: Compositional matrix adjust.
 Identities = 58/232 (25%), Positives = 104/232 (44%), Gaps = 26/232 (11%)
Query: 389 FSREHLNSFRLNLEEVESATQCFSEVNLLGKGNFSSVYKG-TLRDGTLVAIRSINVTSCK 447
           F R+ LN     + EV    Q  S V   G G + SV      + G  VA++ ++     
Sbjct: 31  FYRQELNK---TIWEVPERYQNLSPV---GSGAYGSVCAAFDTKTGLRVAVKKLSRPFQS 84
Query: 448 SEEAEFV-KGLYLLTSLRHENIIRLRG-FCCSRGRGECFLIY--DFAPKGKLSKYLDQEE 503
              A+   + L LL  ++HEN+I L   F  +R   E   +Y         L+  +  ++
Sbjct: 85  IIHAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQK 144
Query: 504 GSSNVLDWSTRVSIIIGIAKGIGYLHSSEVNKPAIVHRNLSVEKVLIDQQFNPLIADCGL 563
            + + + +     +I  I +G+ Y+HS++     I+HR+L    + +++     I D GL
Sbjct: 145 LTDDHVQF-----LIYQILRGLKYIHSAD-----IIHRDLKPSNLAVNEDCELKILDFGL 194
Query: 564 HKLLADDIVFSVLKTSAAMGYLAPEYVTTG-RFTERSDIFAFGVIILQILTG 614
            +   D++   V    A   Y APE +     + +  DI++ G I+ ++LTG
Sbjct: 195 ARHTDDEMTGYV----ATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTG 242

>pdb|1LEW|A Chain A, Crystal Structure Of Map Kinase P38 Complexed To The Docking Site On Its Nuclear Substrate Mef2a Length = 360

Iteration: 1
 Score = 45.4 bits (106), Expect = 1e-04,   Method: Compositional matrix adjust.
 Identities = 61/238 (25%), Positives = 99/238 (41%), Gaps = 38/238 (15%)
Query: 389 FSREHLNSFRLNLEEVESATQCFSEVNLLGKGNFSSVYKG-TLRDGTLVAIRSINVTSCK 447
           F R+ LN     + EV    Q  S V   G G + SV      + G  VA++ ++     
Sbjct: 8   FYRQELNK---TIWEVPERYQNLSPV---GSGAYGSVCAAFDTKTGHRVAVKKLSRPFQS 61
Query: 448 SEEAEFV-KGLYLLTSLRHENIIRLRG-FCCSRGRGECFLIY--------DFAPKGKLSK 497
              A+   + L LL  ++HEN+I L   F  +R   E   +Y        D     K  K
Sbjct: 62  IIHAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQK 121
Query: 498 YLDQEEGSSNVLDWSTRVSIIIGIAKGIGYLHSSEVNKPAIVHRNLSVEKVLIDQQFNPL 557
             D                +I  I +G+ Y+HS++     I+HR+L    + +++     
Sbjct: 122 LTDDHVQF-----------LIYQILRGLKYIHSAD-----IIHRDLKPSNLAVNEDCELK 165
Query: 558 IADCGLHKLLADDIVFSVLKTSAAMGYLAPEYVTTG-RFTERSDIFAFGVIILQILTG 614
           I D GL +   D++   V    A   Y APE +     + +  DI++ G I+ ++LTG
Sbjct: 166 ILDFGLARHTDDEMTGYV----ATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTG 219

>pdb|3OD6|X Chain X, Crystal Structure Of P38alpha Y323t Active Mutant Length = 360

Iteration: 1
 Score = 45.4 bits (106), Expect = 1e-04,   Method: Compositional matrix adjust.
 Identities = 61/238 (25%), Positives = 99/238 (41%), Gaps = 38/238 (15%)
Query: 389 FSREHLNSFRLNLEEVESATQCFSEVNLLGKGNFSSVYKG-TLRDGTLVAIRSINVTSCK 447
           F R+ LN     + EV    Q  S V   G G + SV      + G  VA++ ++     
Sbjct: 8   FYRQELNK---TIWEVPERYQNLSPV---GSGAYGSVCAAFDTKTGLRVAVKKLSRPFQS 61
Query: 448 SEEAEFV-KGLYLLTSLRHENIIRLRG-FCCSRGRGECFLIY--------DFAPKGKLSK 497
              A+   + L LL  ++HEN+I L   F  +R   E   +Y        D     K  K
Sbjct: 62  IIHAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQK 121
Query: 498 YLDQEEGSSNVLDWSTRVSIIIGIAKGIGYLHSSEVNKPAIVHRNLSVEKVLIDQQFNPL 557
             D                +I  I +G+ Y+HS++     I+HR+L    + +++     
Sbjct: 122 LTDDHVQF-----------LIYQILRGLKYIHSAD-----IIHRDLKPSNLAVNEDCELK 165
Query: 558 IADCGLHKLLADDIVFSVLKTSAAMGYLAPEYVTTG-RFTERSDIFAFGVIILQILTG 614
           I D GL +   D++   V    A   Y APE +     + +  DI++ G I+ ++LTG
Sbjct: 166 ILDFGLARHTDDEMTGYV----ATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTG 219

>pdb|3KQ7|A Chain A, Structure Of Human P38alpha With N-[4-Methyl-3-(6-{[2-(1- Methylpyrrolidin-2-Yl)ethyl]amino}pyridine-3- Amido)phenyl]- 2-(Morpholin-4-Yl)pyridine-4-Carboxamide Length = 380

Iteration: 1
 Score = 45.4 bits (106), Expect = 1e-04,   Method: Compositional matrix adjust.
 Identities = 54/236 (22%), Positives = 108/236 (45%), Gaps = 21/236 (8%)
Query: 386 GTGFSREHLNSFRLNLEE-VESATQCFSEVNLLGKGNFSSVYKG-TLRDGTLVAIRSINV 443
           G+  S+E    +R  L + +    + +  ++ +G G + SV      + G  VA++ ++ 
Sbjct: 18  GSHMSQERPTFYRQELNKTIWEVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSR 77
Query: 444 TSCKSEEAEFV-KGLYLLTSLRHENIIRLRG-FCCSRGRGECFLIY--DFAPKGKLSKYL 499
                  A+   + L LL  ++HEN+I L   F  +R   E   +Y         L+  +
Sbjct: 78  PFQSIIHAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIV 137
Query: 500 DQEEGSSNVLDWSTRVSIIIGIAKGIGYLHSSEVNKPAIVHRNLSVEKVLIDQQFNPLIA 559
             ++ + + + +     +I  I +G+ Y+HS++     I+HR+L    + +++     I 
Sbjct: 138 KCQKLTDDHVQF-----LIYQILRGLKYIHSAD-----IIHRDLKPSNLAVNEDCELKIL 187
Query: 560 DCGLHKLLADDIVFSVLKTSAAMGYLAPEYVTTG-RFTERSDIFAFGVIILQILTG 614
           D GL +   D++   V    A   Y APE +     + +  DI++ G I+ ++LTG
Sbjct: 188 DFGLARHTDDEMTGYV----ATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTG 239

>pdb|1BL6|A Chain A, The Complex Structure Of The Map Kinase P38SB216995 Length = 379

Iteration: 1
 Score = 45.4 bits (106), Expect = 1e-04,   Method: Compositional matrix adjust.
 Identities = 54/236 (22%), Positives = 108/236 (45%), Gaps = 21/236 (8%)
Query: 386 GTGFSREHLNSFRLNLEE-VESATQCFSEVNLLGKGNFSSVYKG-TLRDGTLVAIRSINV 443
           G+  S+E    +R  L + +    + +  ++ +G G + SV      + G  VA++ ++ 
Sbjct: 17  GSHMSQERPTFYRQELNKTIWEVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSR 76
Query: 444 TSCKSEEAEFV-KGLYLLTSLRHENIIRLRG-FCCSRGRGECFLIY--DFAPKGKLSKYL 499
                  A+   + L LL  ++HEN+I L   F  +R   E   +Y         L+  +
Sbjct: 77  PFQSIIHAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIV 136
Query: 500 DQEEGSSNVLDWSTRVSIIIGIAKGIGYLHSSEVNKPAIVHRNLSVEKVLIDQQFNPLIA 559
             ++ + + + +     +I  I +G+ Y+HS++     I+HR+L    + +++     I 
Sbjct: 137 KCQKLTDDHVQF-----LIYQILRGLKYIHSAD-----IIHRDLKPSNLAVNEDCELKIL 186
Query: 560 DCGLHKLLADDIVFSVLKTSAAMGYLAPEYVTTG-RFTERSDIFAFGVIILQILTG 614
           D GL +   D++   V    A   Y APE +     + +  DI++ G I+ ++LTG
Sbjct: 187 DFGLARHTDDEMTGYV----ATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTG 238

>pdb|2BAQ|A Chain A, P38alpha Bound To Ro3201195 Length = 365

Iteration: 1
 Score = 45.4 bits (106), Expect = 1e-04,   Method: Compositional matrix adjust.
 Identities = 60/238 (25%), Positives = 99/238 (41%), Gaps = 38/238 (15%)
Query: 389 FSREHLNSFRLNLEEVESATQCFSEVNLLGKGNFSSVYKG-TLRDGTLVAIRSINVTSCK 447
           F R+ LN     + EV    Q  S +   G G + SV      + G  VA++ ++     
Sbjct: 13  FYRQELNK---TIWEVPERYQNLSPI---GSGAYGSVCAAFDTKTGLRVAVKKLSRPFQS 66
Query: 448 SEEAEFV-KGLYLLTSLRHENIIRLRG-FCCSRGRGECFLIY--------DFAPKGKLSK 497
              A+   + L LL  ++HEN+I L   F  +R   E   +Y        D     K  K
Sbjct: 67  IIHAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQK 126
Query: 498 YLDQEEGSSNVLDWSTRVSIIIGIAKGIGYLHSSEVNKPAIVHRNLSVEKVLIDQQFNPL 557
             D                +I  I +G+ Y+HS++     I+HR+L    + +++     
Sbjct: 127 LTDDHVQF-----------LIYQILRGLKYIHSAD-----IIHRDLKPSNLAVNEDXELK 170
Query: 558 IADCGLHKLLADDIVFSVLKTSAAMGYLAPEYVTTG-RFTERSDIFAFGVIILQILTG 614
           I D GL +   D++   V    A   Y APE +     + +  DI++ G I+ ++LTG
Sbjct: 171 ILDFGLARHTDDEMTGYV----ATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTG 224

>pdb|3PWY|A Chain A, Crystal Structure Of An Extender (Spd28345)-Modified Human Pdk1 Complex 2 Length = 311

Iteration: 1
 Score = 45.4 bits (106), Expect = 1e-04,   Method: Compositional matrix adjust.
 Identities = 49/208 (23%), Positives = 99/208 (47%), Gaps = 23/208 (11%)
Query: 415 NLLGKGNFSSVYKG----TLRDGTLVAIRSINVTSCKSEEAEFV-KGLYLLTSLRHENII 469
            +LG+G+FS+V       T R+  +  +   ++   K  +  +V +   +++ L H   +
Sbjct: 38  KILGEGSFSTVVLARELATSREYAIKILEKRHI--IKENKVPYVTRERDVMSRLDHPFFV 95
Query: 470 RLRGFCCSRGRGECFLIYDFAPKGKLSKYLDQEEGSSNVLDWSTRVSIIIGIAKGIGYLH 529
           +L  +   +   + +    +A  G L KY+ ++ GS    D +        I   + YLH
Sbjct: 96  KL--YFTFQDDEKLYFGLSYAKNGCLLKYI-RKIGS---FDETCTRFYTAEIVSALEYLH 149
Query: 530 SSEVNKPAIVHRNLSVEKVLIDQQFNPLIADCGLHKLLADDIVFSVLKTSAAMG---YLA 586
                   I+HR+L  E +L+++  +  I D G  K+L+ +      + ++ +G   Y++
Sbjct: 150 GK-----GIIHRDLKPENILLNEDMHIQITDFGTAKVLSPES--KQARANSFVGTAQYVS 202
Query: 587 PEYVTTGRFTERSDIFAFGVIILQILTG 614
           PE +T    ++ SD++A G II Q++ G
Sbjct: 203 PELLTEKSASKSSDLWALGCIIYQLVAG 230

>pdb|3HVC|A Chain A, Crystal Structure Of Human P38alpha Map Kinase Length = 362

Iteration: 1
 Score = 45.4 bits (106), Expect = 1e-04,   Method: Compositional matrix adjust.
 Identities = 61/238 (25%), Positives = 99/238 (41%), Gaps = 38/238 (15%)
Query: 389 FSREHLNSFRLNLEEVESATQCFSEVNLLGKGNFSSVYKG-TLRDGTLVAIRSINVTSCK 447
           F R+ LN     + EV    Q  S V   G G + SV      + G  VA++ ++     
Sbjct: 10  FYRQELNK---TIWEVPERYQNLSPV---GSGAYGSVCAAFDTKTGLRVAVKKLSRPFQS 63
Query: 448 SEEAEFV-KGLYLLTSLRHENIIRLRG-FCCSRGRGECFLIY--------DFAPKGKLSK 497
              A+   + L LL  ++HEN+I L   F  +R   E   +Y        D     K  K
Sbjct: 64  IIHAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQK 123
Query: 498 YLDQEEGSSNVLDWSTRVSIIIGIAKGIGYLHSSEVNKPAIVHRNLSVEKVLIDQQFNPL 557
             D                +I  I +G+ Y+HS++     I+HR+L    + +++     
Sbjct: 124 LTDDHVQF-----------LIYQILRGLKYIHSAD-----IIHRDLKPSNLAVNEDCELK 167
Query: 558 IADCGLHKLLADDIVFSVLKTSAAMGYLAPEYVTTG-RFTERSDIFAFGVIILQILTG 614
           I D GL +   D++   V    A   Y APE +     + +  DI++ G I+ ++LTG
Sbjct: 168 ILDFGLARHTDDEMTGYV----ATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTG 221

>pdb|3HEC|A Chain A, P38 In Complex With Imatinib Length = 348

Iteration: 1
 Score = 45.4 bits (106), Expect = 1e-04,   Method: Compositional matrix adjust.
 Identities = 61/238 (25%), Positives = 99/238 (41%), Gaps = 38/238 (15%)
Query: 389 FSREHLNSFRLNLEEVESATQCFSEVNLLGKGNFSSVYKG-TLRDGTLVAIRSINVTSCK 447
           F R+ LN     + EV    Q  S V   G G + SV      + G  VA++ ++     
Sbjct: 4   FYRQELNK---TIWEVPERYQNLSPV---GSGAYGSVCAAFDTKTGLRVAVKKLSRPFQS 57
Query: 448 SEEAEFV-KGLYLLTSLRHENIIRLRG-FCCSRGRGECFLIY--------DFAPKGKLSK 497
              A+   + L LL  ++HEN+I L   F  +R   E   +Y        D     K  K
Sbjct: 58  IIHAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQK 117
Query: 498 YLDQEEGSSNVLDWSTRVSIIIGIAKGIGYLHSSEVNKPAIVHRNLSVEKVLIDQQFNPL 557
             D                +I  I +G+ Y+HS++     I+HR+L    + +++     
Sbjct: 118 LTDDHVQF-----------LIYQILRGLKYIHSAD-----IIHRDLKPSNLAVNEDCELK 161
Query: 558 IADCGLHKLLADDIVFSVLKTSAAMGYLAPEYVTTG-RFTERSDIFAFGVIILQILTG 614
           I D GL +   D++   V    A   Y APE +     + +  DI++ G I+ ++LTG
Sbjct: 162 ILDFGLARHTDDEMTGYV----ATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTG 215

>pdb|1UU9|A Chain A, Structure Of Human Pdk1 Kinase Domain In Complex With Bim-3 Length = 286

Iteration: 1
 Score = 45.4 bits (106), Expect = 1e-04,   Method: Compositional matrix adjust.
 Identities = 49/208 (23%), Positives = 98/208 (47%), Gaps = 23/208 (11%)
Query: 415 NLLGKGNFSSVYKG----TLRDGTLVAIRSINVTSCKSEEAEFV-KGLYLLTSLRHENII 469
            +LG+G+FS+V       T R+  +  +   ++   K  +  +V +   +++ L H   +
Sbjct: 15  KILGEGSFSTVVLARELATSREYAIKILEKRHI--IKENKVPYVTRERDVMSRLDHPFFV 72
Query: 470 RLRGFCCSRGRGECFLIYDFAPKGKLSKYLDQEEGSSNVLDWSTRVSIIIGIAKGIGYLH 529
           +L  +   +   + +    +A  G+L KY+ ++ GS    D +        I   + YLH
Sbjct: 73  KL--YFTFQDDEKLYFGLSYAKNGELLKYI-RKIGS---FDETCTRFYTAEIVSALEYLH 126
Query: 530 SSEVNKPAIVHRNLSVEKVLIDQQFNPLIADCGLHKLLADDIVFSVLKTSAAMG---YLA 586
                   I+HR+L  E +L+++  +  I D G  K+L+ +      + +  +G   Y++
Sbjct: 127 GK-----GIIHRDLKPENILLNEDMHIQITDFGTAKVLSPES--KQARANXFVGTAQYVS 179
Query: 587 PEYVTTGRFTERSDIFAFGVIILQILTG 614
           PE +T     + SD++A G II Q++ G
Sbjct: 180 PELLTEKSACKSSDLWALGCIIYQLVAG 207

>pdb|3ODZ|X Chain X, Crystal Structure Of P38alpha Y323r Active Mutant Length = 360

Iteration: 1
 Score = 45.4 bits (106), Expect = 1e-04,   Method: Compositional matrix adjust.
 Identities = 61/238 (25%), Positives = 99/238 (41%), Gaps = 38/238 (15%)
Query: 389 FSREHLNSFRLNLEEVESATQCFSEVNLLGKGNFSSVYKG-TLRDGTLVAIRSINVTSCK 447
           F R+ LN     + EV    Q  S V   G G + SV      + G  VA++ ++     
Sbjct: 8   FYRQELNK---TIWEVPERYQNLSPV---GSGAYGSVCAAFDTKTGLRVAVKKLSRPFQS 61
Query: 448 SEEAEFV-KGLYLLTSLRHENIIRLRG-FCCSRGRGECFLIY--------DFAPKGKLSK 497
              A+   + L LL  ++HEN+I L   F  +R   E   +Y        D     K  K
Sbjct: 62  IIHAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQK 121
Query: 498 YLDQEEGSSNVLDWSTRVSIIIGIAKGIGYLHSSEVNKPAIVHRNLSVEKVLIDQQFNPL 557
             D                +I  I +G+ Y+HS++     I+HR+L    + +++     
Sbjct: 122 LTDDHVQF-----------LIYQILRGLKYIHSAD-----IIHRDLKPSNLAVNEDCELK 165
Query: 558 IADCGLHKLLADDIVFSVLKTSAAMGYLAPEYVTTG-RFTERSDIFAFGVIILQILTG 614
           I D GL +   D++   V    A   Y APE +     + +  DI++ G I+ ++LTG
Sbjct: 166 ILDFGLARHTDDEMTGYV----ATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTG 219

>pdb|3MPT|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Pyrrole-2- Carboxamide Inhibitor Length = 371

Iteration: 1
 Score = 45.4 bits (106), Expect = 1e-04,   Method: Compositional matrix adjust.
 Identities = 57/240 (23%), Positives = 102/240 (42%), Gaps = 33/240 (13%)
Query: 388 GFSREHLNSFRLNLEE-VESATQCFSEVNLLGKGNFSSVYKG-TLRDGTLVAIRSINVTS 445
           G S+E    +R  L + +    + +  ++ +G G + SV      + G  VA++ ++   
Sbjct: 11  GMSQERPTFYRQELNKTIWEVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPF 70
Query: 446 CKSEEAEFV-KGLYLLTSLRHENIIRLRG-FCCSRGRGECFLIY--------DFAPKGKL 495
                A+   + L LL  ++HEN+I L   F  +R   E   +Y        D     K 
Sbjct: 71  QSIIHAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKC 130
Query: 496 SKYLDQEEGSSNVLDWSTRVSIIIGIAKGIGYLHSSEVNKPAIVHRNLSVEKVLIDQQFN 555
            K  D                +I  I +G+ Y+HS++     I+HR+L    + +++   
Sbjct: 131 QKLTDDHVQF-----------LIYQILRGLKYIHSAD-----IIHRDLKPSNLAVNEDCE 174
Query: 556 PLIADCGLHKLLADDIVFSVLKTSAAMGYLAPEYVTTG-RFTERSDIFAFGVIILQILTG 614
             I D GL +   D++   V    A   Y APE +     + +  DI++ G I+ ++LTG
Sbjct: 175 LKILDFGLARHTDDEMTGYV----ATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTG 230

>pdb|3K3I|A Chain A, P38alpha Bound To Novel Dgf-Out Compound Pf-00215955 Length = 350

Iteration: 1
 Score = 45.4 bits (106), Expect = 1e-04,   Method: Compositional matrix adjust.
 Identities = 61/238 (25%), Positives = 99/238 (41%), Gaps = 38/238 (15%)
Query: 389 FSREHLNSFRLNLEEVESATQCFSEVNLLGKGNFSSVYKG-TLRDGTLVAIRSINVTSCK 447
           F R+ LN     + EV    Q  S V   G G + SV      + G  VA++ ++     
Sbjct: 6   FYRQELNK---TIWEVPERYQNLSPV---GSGAYGSVCAAFDTKTGLRVAVKKLSRPFQS 59
Query: 448 SEEAEFV-KGLYLLTSLRHENIIRLRG-FCCSRGRGECFLIY--------DFAPKGKLSK 497
              A+   + L LL  ++HEN+I L   F  +R   E   +Y        D     K  K
Sbjct: 60  IIHAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQK 119
Query: 498 YLDQEEGSSNVLDWSTRVSIIIGIAKGIGYLHSSEVNKPAIVHRNLSVEKVLIDQQFNPL 557
             D                +I  I +G+ Y+HS++     I+HR+L    + +++     
Sbjct: 120 LTDDHVQF-----------LIYQILRGLKYIHSAD-----IIHRDLKPSNLAVNEDCELK 163
Query: 558 IADCGLHKLLADDIVFSVLKTSAAMGYLAPEYVTTG-RFTERSDIFAFGVIILQILTG 614
           I D GL +   D++   V    A   Y APE +     + +  DI++ G I+ ++LTG
Sbjct: 164 ILDFGLARHTDDEMTGYV----ATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTG 217

>pdb|3GCU|A Chain A, Human P38 Map Kinase In Complex With Rl48 Length = 360

Iteration: 1
 Score = 45.4 bits (106), Expect = 1e-04,   Method: Compositional matrix adjust.
 Identities = 61/238 (25%), Positives = 99/238 (41%), Gaps = 38/238 (15%)
Query: 389 FSREHLNSFRLNLEEVESATQCFSEVNLLGKGNFSSVYKG-TLRDGTLVAIRSINVTSCK 447
           F R+ LN     + EV    Q  S V   G G + SV      + G  VA++ ++     
Sbjct: 8   FYRQELNK---TIWEVPERYQNLSPV---GSGAYGSVCAAFDTKTGLRVAVKKLSRPFQS 61
Query: 448 SEEAEFV-KGLYLLTSLRHENIIRLRG-FCCSRGRGECFLIY--------DFAPKGKLSK 497
              A+   + L LL  ++HEN+I L   F  +R   E   +Y        D     K  K
Sbjct: 62  IIHAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQK 121
Query: 498 YLDQEEGSSNVLDWSTRVSIIIGIAKGIGYLHSSEVNKPAIVHRNLSVEKVLIDQQFNPL 557
             D                +I  I +G+ Y+HS++     I+HR+L    + +++     
Sbjct: 122 LTDDHVQF-----------LIYQILRGLKYIHSAD-----IIHRDLKPSNLAVNEDCELK 165
Query: 558 IADCGLHKLLADDIVFSVLKTSAAMGYLAPEYVTTG-RFTERSDIFAFGVIILQILTG 614
           I D GL +   D++   V    A   Y APE +     + +  DI++ G I+ ++LTG
Sbjct: 166 ILDFGLARHTDDEMTGYV----ATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTG 219

>pdb|1Z5M|A Chain A, Crystal Structure Of N1-[3-[[5-bromo-2-[[3-[(1-pyrrolidinylcarbonyl) Amino]phenyl]amino]-4-pyrimidinyl]amino]propyl]-2,2- Dimethylpropanediamide Complexed With Human Pdk1 Length = 286

Iteration: 1
 Score = 45.4 bits (106), Expect = 1e-04,   Method: Compositional matrix adjust.
 Identities = 49/208 (23%), Positives = 98/208 (47%), Gaps = 23/208 (11%)
Query: 415 NLLGKGNFSSVYKG----TLRDGTLVAIRSINVTSCKSEEAEFV-KGLYLLTSLRHENII 469
            +LG+G+FS+V       T R+  +  +   ++   K  +  +V +   +++ L H   +
Sbjct: 13  KILGEGSFSTVVLARELATSREYAIKILEKRHI--IKENKVPYVTRERDVMSRLDHPFFV 70
Query: 470 RLRGFCCSRGRGECFLIYDFAPKGKLSKYLDQEEGSSNVLDWSTRVSIIIGIAKGIGYLH 529
           +L  +   +   + +    +A  G+L KY+ ++ GS    D +        I   + YLH
Sbjct: 71  KL--YFTFQDDEKLYFGLSYAKNGELLKYI-RKIGS---FDETCTRFYTAEIVSALEYLH 124
Query: 530 SSEVNKPAIVHRNLSVEKVLIDQQFNPLIADCGLHKLLADDIVFSVLKTSAAMG---YLA 586
                   I+HR+L  E +L+++  +  I D G  K+L+ +      + +  +G   Y++
Sbjct: 125 GK-----GIIHRDLKPENILLNEDMHIQITDFGTAKVLSPES--KQARANXFVGTAQYVS 177
Query: 587 PEYVTTGRFTERSDIFAFGVIILQILTG 614
           PE +T     + SD++A G II Q++ G
Sbjct: 178 PELLTEKSACKSSDLWALGCIIYQLVAG 205

>pdb|2LGC|A Chain A, Joint Nmr And X-Ray Refinement Reveals The Structure Of A Novel Dibenzo[a,D]cycloheptenone InhibitorP38 MAP KINASE COMPLEX IN Solution Length = 359

Iteration: 1
 Score = 45.4 bits (106), Expect = 1e-04,   Method: Compositional matrix adjust.
 Identities = 61/238 (25%), Positives = 99/238 (41%), Gaps = 38/238 (15%)
Query: 389 FSREHLNSFRLNLEEVESATQCFSEVNLLGKGNFSSVYKG-TLRDGTLVAIRSINVTSCK 447
           F R+ LN     + EV    Q  S V   G G + SV      + G  VA++ ++     
Sbjct: 13  FYRQELNK---TIWEVPERYQNLSPV---GSGAYGSVCAAFDTKTGLRVAVKKLSRPFQS 66
Query: 448 SEEAEFV-KGLYLLTSLRHENIIRLRG-FCCSRGRGECFLIY--------DFAPKGKLSK 497
              A+   + L LL  ++HEN+I L   F  +R   E   +Y        D     K  K
Sbjct: 67  IIHAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQK 126
Query: 498 YLDQEEGSSNVLDWSTRVSIIIGIAKGIGYLHSSEVNKPAIVHRNLSVEKVLIDQQFNPL 557
             D                +I  I +G+ Y+HS++     I+HR+L    + +++     
Sbjct: 127 LTDDHVQF-----------LIYQILRGLKYIHSAD-----IIHRDLKPSNLAVNEDCELK 170
Query: 558 IADCGLHKLLADDIVFSVLKTSAAMGYLAPEYVTTG-RFTERSDIFAFGVIILQILTG 614
           I D GL +   D++   V    A   Y APE +     + +  DI++ G I+ ++LTG
Sbjct: 171 ILDFGLARHTDDEMTGYV----ATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTG 224

>pdb|3MH2|A Chain A, Mutagenesis Of P38 Map Kinase Establishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360

Iteration: 1
 Score = 45.4 bits (106), Expect = 1e-04,   Method: Compositional matrix adjust.
 Identities = 61/238 (25%), Positives = 99/238 (41%), Gaps = 38/238 (15%)
Query: 389 FSREHLNSFRLNLEEVESATQCFSEVNLLGKGNFSSVYKG-TLRDGTLVAIRSINVTSCK 447
           F R+ LN     + EV    Q  S V   G G + SV      + G  VA++ ++     
Sbjct: 8   FYRQELNK---TIWEVPERYQNLSPV---GSGAYGSVCAAFDTKTGLRVAVKKLSRPFQS 61
Query: 448 SEEAEFV-KGLYLLTSLRHENIIRLRG-FCCSRGRGECFLIY--------DFAPKGKLSK 497
              A+   + L LL  ++HEN+I L   F  +R   E   +Y        D     K  K
Sbjct: 62  IIHAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQK 121
Query: 498 YLDQEEGSSNVLDWSTRVSIIIGIAKGIGYLHSSEVNKPAIVHRNLSVEKVLIDQQFNPL 557
             D                +I  I +G+ Y+HS++     I+HR+L    + +++     
Sbjct: 122 LTDDHVQF-----------LIYQILRGLKYIHSAD-----IIHRDLKPSNLAVNEDCELK 165
Query: 558 IADCGLHKLLADDIVFSVLKTSAAMGYLAPEYVTTG-RFTERSDIFAFGVIILQILTG 614
           I D GL +   D++   V    A   Y APE +     + +  DI++ G I+ ++LTG
Sbjct: 166 ILDYGLARHTDDEMTGYV----ATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTG 219

>pdb|3S3I|A Chain A, P38 Kinase Crystal Structure In Complex With Small Molecule Inhibitor Length = 349

Iteration: 1
 Score = 45.4 bits (106), Expect = 1e-04,   Method: Compositional matrix adjust.
 Identities = 61/238 (25%), Positives = 99/238 (41%), Gaps = 38/238 (15%)
Query: 389 FSREHLNSFRLNLEEVESATQCFSEVNLLGKGNFSSVYKG-TLRDGTLVAIRSINVTSCK 447
           F R+ LN     + EV    Q  S V   G G + SV      + G  VA++ ++     
Sbjct: 5   FYRQELNK---TIWEVPERYQNLSPV---GSGAYGSVCAAFDTKTGLRVAVKKLSRPFQS 58
Query: 448 SEEAEFV-KGLYLLTSLRHENIIRLRG-FCCSRGRGECFLIY--------DFAPKGKLSK 497
              A+   + L LL  ++HEN+I L   F  +R   E   +Y        D     K  K
Sbjct: 59  IIHAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQK 118
Query: 498 YLDQEEGSSNVLDWSTRVSIIIGIAKGIGYLHSSEVNKPAIVHRNLSVEKVLIDQQFNPL 557
             D                +I  I +G+ Y+HS++     I+HR+L    + +++     
Sbjct: 119 LTDDHVQF-----------LIYQILRGLKYIHSAD-----IIHRDLKPSNLAVNEDCELK 162
Query: 558 IADCGLHKLLADDIVFSVLKTSAAMGYLAPEYVTTG-RFTERSDIFAFGVIILQILTG 614
           I D GL +   D++   V    A   Y APE +     + +  DI++ G I+ ++LTG
Sbjct: 163 ILDFGLARHTDDEMTGYV----ATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTG 216

>pdb|3K3J|A Chain A, P38alpha Bound To Novel Dfg-Out Compound Pf-00416121 Length = 362

Iteration: 1
 Score = 45.4 bits (106), Expect = 1e-04,   Method: Compositional matrix adjust.
 Identities = 61/238 (25%), Positives = 99/238 (41%), Gaps = 38/238 (15%)
Query: 389 FSREHLNSFRLNLEEVESATQCFSEVNLLGKGNFSSVYKG-TLRDGTLVAIRSINVTSCK 447
           F R+ LN     + EV    Q  S V   G G + SV      + G  VA++ ++     
Sbjct: 10  FYRQELNK---TIWEVPERYQNLSPV---GSGAYGSVCAAFDTKTGLRVAVKKLSRPFQS 63
Query: 448 SEEAEFV-KGLYLLTSLRHENIIRLRG-FCCSRGRGECFLIY--------DFAPKGKLSK 497
              A+   + L LL  ++HEN+I L   F  +R   E   +Y        D     K  K
Sbjct: 64  IIHAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQK 123
Query: 498 YLDQEEGSSNVLDWSTRVSIIIGIAKGIGYLHSSEVNKPAIVHRNLSVEKVLIDQQFNPL 557
             D                +I  I +G+ Y+HS++     I+HR+L    + +++     
Sbjct: 124 LTDDHVQF-----------LIYQILRGLKYIHSAD-----IIHRDLKPSNLAVNEDCELK 167
Query: 558 IADCGLHKLLADDIVFSVLKTSAAMGYLAPEYVTTG-RFTERSDIFAFGVIILQILTG 614
           I D GL +   D++   V    A   Y APE +     + +  DI++ G I+ ++LTG
Sbjct: 168 ILDFGLARHTDDEMTGYV----ATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTG 221

>pdb|2GTM|A Chain A, Mutated Mouse P38 Map Kinase Domain In Complex With Inhibitor Pg-892579 Length = 348

Iteration: 1
 Score = 45.4 bits (106), Expect = 1e-04,   Method: Compositional matrix adjust.
 Identities = 61/238 (25%), Positives = 99/238 (41%), Gaps = 38/238 (15%)
Query: 389 FSREHLNSFRLNLEEVESATQCFSEVNLLGKGNFSSVYKG-TLRDGTLVAIRSINVTSCK 447
           F R+ LN     + EV    Q  S V   G G + SV      + G  VA++ ++     
Sbjct: 4   FYRQELNK---TIWEVPERYQNLSPV---GSGAYGSVCAAFDTKTGHRVAVKKLSRPFQS 57
Query: 448 SEEAEFV-KGLYLLTSLRHENIIRLRG-FCCSRGRGECFLIY--------DFAPKGKLSK 497
              A+   + L LL  ++HEN+I L   F  +R   E   +Y        D     K  K
Sbjct: 58  IIHAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQK 117
Query: 498 YLDQEEGSSNVLDWSTRVSIIIGIAKGIGYLHSSEVNKPAIVHRNLSVEKVLIDQQFNPL 557
             D                +I  I +G+ Y+HS++     I+HR+L    + +++     
Sbjct: 118 LTDDHVQF-----------LIYQILRGLKYIHSAD-----IIHRDLKPSNLAVNEDCELK 161
Query: 558 IADCGLHKLLADDIVFSVLKTSAAMGYLAPEYVTTG-RFTERSDIFAFGVIILQILTG 614
           I D GL +   D++   V    A   Y APE +     + +  DI++ G I+ ++LTG
Sbjct: 162 ILDFGLARHTDDEMTGYV----ATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTG 215

>pdb|2BAJ|A Chain A, P38alpha Bound To Pyrazolourea Length = 365

Iteration: 1
 Score = 45.4 bits (106), Expect = 1e-04,   Method: Compositional matrix adjust.
 Identities = 61/238 (25%), Positives = 99/238 (41%), Gaps = 38/238 (15%)
Query: 389 FSREHLNSFRLNLEEVESATQCFSEVNLLGKGNFSSVYKG-TLRDGTLVAIRSINVTSCK 447
           F R+ LN     + EV    Q  S V   G G + SV      + G  VA++ ++     
Sbjct: 13  FYRQELNK---TIWEVPERYQNLSPV---GSGAYGSVCAAFDTKTGLRVAVKKLSRPFQS 66
Query: 448 SEEAEFV-KGLYLLTSLRHENIIRLRG-FCCSRGRGECFLIY--------DFAPKGKLSK 497
              A+   + L LL  ++HEN+I L   F  +R   E   +Y        D     K  K
Sbjct: 67  IIHAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQK 126
Query: 498 YLDQEEGSSNVLDWSTRVSIIIGIAKGIGYLHSSEVNKPAIVHRNLSVEKVLIDQQFNPL 557
             D                +I  I +G+ Y+HS++     I+HR+L    + +++     
Sbjct: 127 LTDDHVQF-----------LIYQILRGLKYIHSAD-----IIHRDLKPSNLAVNEDCELK 170
Query: 558 IADCGLHKLLADDIVFSVLKTSAAMGYLAPEYVTTG-RFTERSDIFAFGVIILQILTG 614
           I D GL +   D++   V    A   Y APE +     + +  DI++ G I+ ++LTG
Sbjct: 171 ILDFGLARHTDDEMTGYV----ATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTG 224

>pdb|1ZZL|A Chain A, Crystal Structure Of P38 With Triazolopyridine Length = 351

Iteration: 1
 Score = 45.4 bits (106), Expect = 1e-04,   Method: Compositional matrix adjust.
 Identities = 61/238 (25%), Positives = 99/238 (41%), Gaps = 38/238 (15%)
Query: 389 FSREHLNSFRLNLEEVESATQCFSEVNLLGKGNFSSVYKG-TLRDGTLVAIRSINVTSCK 447
           F R+ LN     + EV    Q  S V   G G + SV      + G  VA++ ++     
Sbjct: 5   FYRQELNK---TIWEVPERYQNLSPV---GSGAYGSVCAAFDTKTGLRVAVKKLSRPFQS 58
Query: 448 SEEAEFV-KGLYLLTSLRHENIIRLRG-FCCSRGRGECFLIY--------DFAPKGKLSK 497
              A+   + L LL  ++HEN+I L   F  +R   E   +Y        D     K  K
Sbjct: 59  IIHAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQK 118
Query: 498 YLDQEEGSSNVLDWSTRVSIIIGIAKGIGYLHSSEVNKPAIVHRNLSVEKVLIDQQFNPL 557
             D                +I  I +G+ Y+HS++     I+HR+L    + +++     
Sbjct: 119 LTDDHVQF-----------LIYQILRGLKYIHSAD-----IIHRDLKPSNLAVNEDCELK 162
Query: 558 IADCGLHKLLADDIVFSVLKTSAAMGYLAPEYVTTG-RFTERSDIFAFGVIILQILTG 614
           I D GL +   D++   V    A   Y APE +     + +  DI++ G I+ ++LTG
Sbjct: 163 ILDFGLARHTDDEMTGYV----ATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTG 216

>pdb|3OEF|X Chain X, Crystal Structure Of Y323f Inactive Mutant Of P38alpha Map Kinase Length = 360

Iteration: 1
 Score = 45.4 bits (106), Expect = 1e-04,   Method: Compositional matrix adjust.
 Identities = 61/238 (25%), Positives = 99/238 (41%), Gaps = 38/238 (15%)
Query: 389 FSREHLNSFRLNLEEVESATQCFSEVNLLGKGNFSSVYKG-TLRDGTLVAIRSINVTSCK 447
           F R+ LN     + EV    Q  S V   G G + SV      + G  VA++ ++     
Sbjct: 8   FYRQELNK---TIWEVPERYQNLSPV---GSGAYGSVCAAFDTKTGLRVAVKKLSRPFQS 61
Query: 448 SEEAEFV-KGLYLLTSLRHENIIRLRG-FCCSRGRGECFLIY--------DFAPKGKLSK 497
              A+   + L LL  ++HEN+I L   F  +R   E   +Y        D     K  K
Sbjct: 62  IIHAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQK 121
Query: 498 YLDQEEGSSNVLDWSTRVSIIIGIAKGIGYLHSSEVNKPAIVHRNLSVEKVLIDQQFNPL 557
             D                +I  I +G+ Y+HS++     I+HR+L    + +++     
Sbjct: 122 LTDDHVQF-----------LIYQILRGLKYIHSAD-----IIHRDLKPSNLAVNEDCELK 165
Query: 558 IADCGLHKLLADDIVFSVLKTSAAMGYLAPEYVTTG-RFTERSDIFAFGVIILQILTG 614
           I D GL +   D++   V    A   Y APE +     + +  DI++ G I+ ++LTG
Sbjct: 166 ILDFGLARHTDDEMTGYV----ATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTG 219

>pdb|3HRB|A Chain A, P38 Kinase Crystal Structure In Complex With Small Molecule Inhibitor Length = 359

Iteration: 1
 Score = 45.4 bits (106), Expect = 1e-04,   Method: Compositional matrix adjust.
 Identities = 61/238 (25%), Positives = 99/238 (41%), Gaps = 38/238 (15%)
Query: 389 FSREHLNSFRLNLEEVESATQCFSEVNLLGKGNFSSVYKG-TLRDGTLVAIRSINVTSCK 447
           F R+ LN     + EV    Q  S V   G G + SV      + G  VA++ ++     
Sbjct: 7   FYRQELNK---TIWEVPERYQNLSPV---GSGAYGSVCAAFDTKTGLRVAVKKLSRPFQS 60
Query: 448 SEEAEFV-KGLYLLTSLRHENIIRLRG-FCCSRGRGECFLIY--------DFAPKGKLSK 497
              A+   + L LL  ++HEN+I L   F  +R   E   +Y        D     K  K
Sbjct: 61  IIHAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQK 120
Query: 498 YLDQEEGSSNVLDWSTRVSIIIGIAKGIGYLHSSEVNKPAIVHRNLSVEKVLIDQQFNPL 557
             D                +I  I +G+ Y+HS++     I+HR+L    + +++     
Sbjct: 121 LTDDHVQF-----------LIYQILRGLKYIHSAD-----IIHRDLKPSNLAVNEDCELK 164
Query: 558 IADCGLHKLLADDIVFSVLKTSAAMGYLAPEYVTTG-RFTERSDIFAFGVIILQILTG 614
           I D GL +   D++   V    A   Y APE +     + +  DI++ G I+ ++LTG
Sbjct: 165 ILDFGLARHTDDEMTGYV----ATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTG 218

>pdb|1OZ1|A Chain A, P38 Mitogen-Activated Kinase In Complex With 4-Azaindole Inhibitor Length = 372

Iteration: 1
 Score = 45.4 bits (106), Expect = 1e-04,   Method: Compositional matrix adjust.
 Identities = 61/238 (25%), Positives = 99/238 (41%), Gaps = 38/238 (15%)
Query: 389 FSREHLNSFRLNLEEVESATQCFSEVNLLGKGNFSSVYKG-TLRDGTLVAIRSINVTSCK 447
           F R+ LN     + EV    Q  S V   G G + SV      + G  VA++ ++     
Sbjct: 20  FYRQELNK---TIWEVPERYQNLSPV---GSGAYGSVCAAFDTKTGLRVAVKKLSRPFQS 73
Query: 448 SEEAEFV-KGLYLLTSLRHENIIRLRG-FCCSRGRGECFLIY--------DFAPKGKLSK 497
              A+   + L LL  ++HEN+I L   F  +R   E   +Y        D     K  K
Sbjct: 74  IIHAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQK 133
Query: 498 YLDQEEGSSNVLDWSTRVSIIIGIAKGIGYLHSSEVNKPAIVHRNLSVEKVLIDQQFNPL 557
             D                +I  I +G+ Y+HS++     I+HR+L    + +++     
Sbjct: 134 LTDDHVQF-----------LIYQILRGLKYIHSAD-----IIHRDLKPSNLAVNEDCELK 177
Query: 558 IADCGLHKLLADDIVFSVLKTSAAMGYLAPEYVTTG-RFTERSDIFAFGVIILQILTG 614
           I D GL +   D++   V    A   Y APE +     + +  DI++ G I+ ++LTG
Sbjct: 178 ILDFGLARHTDDEMTGYV----ATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTG 231

>pdb|3FI4|A Chain A, P38 Kinase Crystal Structure In Complex With Ro4499 Length = 372

Iteration: 1
 Score = 45.4 bits (106), Expect = 1e-04,   Method: Compositional matrix adjust.
 Identities = 61/238 (25%), Positives = 99/238 (41%), Gaps = 38/238 (15%)
Query: 389 FSREHLNSFRLNLEEVESATQCFSEVNLLGKGNFSSVYKG-TLRDGTLVAIRSINVTSCK 447
           F R+ LN     + EV    Q  S V   G G + SV      + G  VA++ ++     
Sbjct: 20  FYRQELNK---TIWEVPERYQNLSPV---GSGAYGSVCAAFDTKTGLRVAVKKLSKPFQS 73
Query: 448 SEEAEFV-KGLYLLTSLRHENIIRLRG-FCCSRGRGECFLIY--------DFAPKGKLSK 497
              A+   + L LL  ++HEN+I L   F  +R   E   +Y        D     K  K
Sbjct: 74  IIHAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQK 133
Query: 498 YLDQEEGSSNVLDWSTRVSIIIGIAKGIGYLHSSEVNKPAIVHRNLSVEKVLIDQQFNPL 557
             D                +I  I +G+ Y+HS++     I+HR+L    + +++     
Sbjct: 134 LTDDHVQF-----------LIYQILRGLKYIHSAD-----IIHRDLKPSNLAVNEDCELK 177
Query: 558 IADCGLHKLLADDIVFSVLKTSAAMGYLAPEYVTTG-RFTERSDIFAFGVIILQILTG 614
           I D GL +   D++   V    A   Y APE +     + +  DI++ G I+ ++LTG
Sbjct: 178 ILDFGLARHTDDEMTGYV----ATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTG 231

>pdb|2GFS|A Chain A, P38 Kinase Crystal Structure In Complex With Ro3201195 Length = 372

Iteration: 1
 Score = 45.4 bits (106), Expect = 1e-04,   Method: Compositional matrix adjust.
 Identities = 61/238 (25%), Positives = 99/238 (41%), Gaps = 38/238 (15%)
Query: 389 FSREHLNSFRLNLEEVESATQCFSEVNLLGKGNFSSVYKG-TLRDGTLVAIRSINVTSCK 447
           F R+ LN     + EV    Q  S V   G G + SV      + G  VA++ ++     
Sbjct: 20  FYRQELNK---TIWEVPERYQNLSPV---GSGAYGSVCAAFDTKTGLRVAVKKLSRPFQS 73
Query: 448 SEEAEFV-KGLYLLTSLRHENIIRLRG-FCCSRGRGECFLIY--------DFAPKGKLSK 497
              A+   + L LL  ++HEN+I L   F  +R   E   +Y        D     K  K
Sbjct: 74  IIHAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQK 133
Query: 498 YLDQEEGSSNVLDWSTRVSIIIGIAKGIGYLHSSEVNKPAIVHRNLSVEKVLIDQQFNPL 557
             D                +I  I +G+ Y+HS++     I+HR+L    + +++     
Sbjct: 134 LTDDHVQF-----------LIYQILRGLKYIHSAD-----IIHRDLKPSNLAVNEDCELK 177
Query: 558 IADCGLHKLLADDIVFSVLKTSAAMGYLAPEYVTTG-RFTERSDIFAFGVIILQILTG 614
           I D GL +   D++   V    A   Y APE +     + +  DI++ G I+ ++LTG
Sbjct: 178 ILDFGLARHTDDEMTGYV----ATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTG 231

>pdb|3ZSG|A Chain A, X-Ray Structure Of P38alpha Bound To Tak-715 Length = 362

Iteration: 1
 Score = 45.4 bits (106), Expect = 1e-04,   Method: Compositional matrix adjust.
 Identities = 61/238 (25%), Positives = 99/238 (41%), Gaps = 38/238 (15%)
Query: 389 FSREHLNSFRLNLEEVESATQCFSEVNLLGKGNFSSVYKG-TLRDGTLVAIRSINVTSCK 447
           F R+ LN     + EV    Q  S V   G G + SV      + G  VA++ ++     
Sbjct: 10  FYRQELNK---TIWEVPERYQNLSPV---GSGAYGSVCAAFDTKTGLRVAVKKLSRPFQS 63
Query: 448 SEEAEFV-KGLYLLTSLRHENIIRLRG-FCCSRGRGECFLIY--------DFAPKGKLSK 497
              A+   + L LL  ++HEN+I L   F  +R   E   +Y        D     K  K
Sbjct: 64  IIHAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQK 123
Query: 498 YLDQEEGSSNVLDWSTRVSIIIGIAKGIGYLHSSEVNKPAIVHRNLSVEKVLIDQQFNPL 557
             D                +I  I +G+ Y+HS++     I+HR+L    + +++     
Sbjct: 124 LTDDHVQF-----------LIYQILRGLKYIHSAD-----IIHRDLKPSNLAVNEDCELK 167
Query: 558 IADCGLHKLLADDIVFSVLKTSAAMGYLAPEYVTTG-RFTERSDIFAFGVIILQILTG 614
           I D GL +   D++   V    A   Y APE +     + +  DI++ G I+ ++LTG
Sbjct: 168 ILDFGLARHTDDEMTGYV----ATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTG 221

>pdb|1GOL|A Chain A, Coordinates Of Rat Map Kinase Erk2 With An Arginine Mutation At Position 52 Length = 364

Iteration: 1
 Score = 45.4 bits (106), Expect = 1e-04,   Method: Compositional matrix adjust.
 Identities = 49/223 (21%), Positives = 101/223 (45%), Gaps = 22/223 (9%)
Query: 411 FSEVNLLGKGNFS---SVYKGTLRDGTLVAIRSINVTSCKSEEAEFVKGLYLLTSLRHEN 467
           ++ ++ +G+G +    S Y     +   VAIR I+    ++     ++ + +L   RHEN
Sbjct: 29  YTNLSYIGEGAYGMVCSAYDNL--NKVRVAIRKISPFEHQTYCQRTLREIKILLRFRHEN 86
Query: 468 IIRLRGFCCS---RGRGECFLIYDFAPKGKLSKYLDQEEGSSNVLDWSTRVSIIIGIAKG 524
           II +     +       + +++ D   +  L K L  +  S++ + +      +  I +G
Sbjct: 87  IIGINDIIRAPTIEQMKDVYIVQDLM-ETDLYKLLKTQHLSNDHICY-----FLYQILRG 140
Query: 525 IGYLHSSEVNKPAIVHRNLSVEKVLIDQQFNPLIADCGLHKLLADDIVFSVLKTS--AAM 582
           + Y+HS+ V     +HR+L    +L++   +  I D GL ++   D   +   T   A  
Sbjct: 141 LKYIHSANV-----LHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEYVATR 195
Query: 583 GYLAPEYVTTGR-FTERSDIFAFGVIILQILTGSLVLTSSMRL 624
            Y APE +   + +T+  DI++ G I+ ++L+   +      L
Sbjct: 196 WYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNRPIFPGKHYL 238

>pdb|3IW4|A Chain A, Crystal Structure Of Pkc Alpha In Complex With Nvp-Aeb071 Length = 360

Iteration: 1
 Score = 45.4 bits (106), Expect = 1e-04,   Method: Compositional matrix adjust.
 Identities = 53/245 (21%), Positives = 106/245 (43%), Gaps = 24/245 (9%)
Query: 411 FSEVNLLGKGNFSSVY----KGTLRDGTLVAIRSINVTSCKSEEAEFVKGLYLLTSLRHE 466
           F+ + +LGKG+F  V     KGT     +  ++   V      E   V+   L    +  
Sbjct: 21  FNFLMVLGKGSFGKVMLADRKGTEELYAIKILKKDVVIQDDDVECTMVEKRVLALLDKPP 80
Query: 467 NIIRLRGFCCSRGRGECFLIYDFAPKGKLSKYLDQ--EEGSSNVLDWSTRVSIIIGIAKG 524
            + +L    C +     + + ++   G L  ++ Q  +      + ++  +SI      G
Sbjct: 81  FLTQLHS--CFQTVDRLYFVMEYVNGGDLMYHIQQVGKFKEPQAVFYAAEISI------G 132
Query: 525 IGYLHSSEVNKPAIVHRNLSVEKVLIDQQFNPLIADCGLHKLLADDIVFSVLKTSAAMGY 584
           + +LH     K  I++R+L ++ V++D + +  IAD G+ K    D V +  +      Y
Sbjct: 133 LFFLH-----KRGIIYRDLKLDNVMLDSEGHIKIADFGMCKEHMMDGV-TTREFCGTPDY 186
Query: 585 LAPEYVTTGRFTERSDIFAFGVIILQILTGSLVLTSSMRLAAESATFENFIDRNLKGKFS 644
           +APE +    + +  D +A+GV++ ++L G            E   F++ ++ N+    S
Sbjct: 187 IAPEIIAYQPYGKSVDWWAYGVLLYEMLAGQPPFDGE----DEDELFQSIMEHNVSYPKS 242
Query: 645 ESEAA 649
            S+ A
Sbjct: 243 LSKEA 247

>pdb|1DI9|A Chain A, The Structure Of P38 Mitogen-Activated Protein Kinase In Complex With 4-[3-Methylsulfanylanilino]-6,7- Dimethoxyquinazoline Length = 360

Iteration: 1
 Score = 45.4 bits (106), Expect = 1e-04,   Method: Compositional matrix adjust.
 Identities = 61/238 (25%), Positives = 99/238 (41%), Gaps = 38/238 (15%)
Query: 389 FSREHLNSFRLNLEEVESATQCFSEVNLLGKGNFSSVYKG-TLRDGTLVAIRSINVTSCK 447
           F R+ LN     + EV    Q  S V   G G + SV      + G  VA++ ++     
Sbjct: 8   FYRQELNK---TIWEVPERYQNLSPV---GSGAYGSVCAAFDTKTGLRVAVKKLSRPFQS 61
Query: 448 SEEAEFV-KGLYLLTSLRHENIIRLRG-FCCSRGRGECFLIY--------DFAPKGKLSK 497
              A+   + L LL  ++HEN+I L   F  +R   E   +Y        D     K  K
Sbjct: 62  IIHAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQK 121
Query: 498 YLDQEEGSSNVLDWSTRVSIIIGIAKGIGYLHSSEVNKPAIVHRNLSVEKVLIDQQFNPL 557
             D                +I  I +G+ Y+HS++     I+HR+L    + +++     
Sbjct: 122 LTDDHVQF-----------LIYQILRGLKYIHSAD-----IIHRDLKPSNLAVNEDCELK 165
Query: 558 IADCGLHKLLADDIVFSVLKTSAAMGYLAPEYVTTG-RFTERSDIFAFGVIILQILTG 614
           I D GL +   D++   V    A   Y APE +     + +  DI++ G I+ ++LTG
Sbjct: 166 ILDFGLARHTDDEMTGYV----ATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTG 219

>pdb|3TEI|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Mapk Docking Peptide Length = 362

Iteration: 1
 Score = 45.4 bits (106), Expect = 1e-04,   Method: Compositional matrix adjust.
 Identities = 48/223 (21%), Positives = 102/223 (45%), Gaps = 22/223 (9%)
Query: 411 FSEVNLLGKGNFS---SVYKGTLRDGTLVAIRSINVTSCKSEEAEFVKGLYLLTSLRHEN 467
           ++ ++ +G+G +    S Y     +   VAI+ I+    ++     ++ + +L + RHEN
Sbjct: 27  YTNLSYIGEGAYGMVCSAYDNV--NKVRVAIKKISPFEHQTYCQRTLREIKILLAFRHEN 84
Query: 468 IIRLRGFCCS---RGRGECFLIYDFAPKGKLSKYLDQEEGSSNVLDWSTRVSIIIGIAKG 524
           II +     +       + +++ D   +  L K L  +  S++ + +      +  I +G
Sbjct: 85  IIGINDIIRAPTIEQMKDVYIVQDLM-ETDLYKLLKTQHLSNDHICY-----FLYQILRG 138
Query: 525 IGYLHSSEVNKPAIVHRNLSVEKVLIDQQFNPLIADCGLHKLLADDIVFSVLKTS--AAM 582
           + Y+HS+ V     +HR+L    +L++   +  I D GL ++   D   +   T   A  
Sbjct: 139 LKYIHSANV-----LHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEYVATR 193
Query: 583 GYLAPEYVTTGR-FTERSDIFAFGVIILQILTGSLVLTSSMRL 624
            Y APE +   + +T+  DI++ G I+ ++L+   +      L
Sbjct: 194 WYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNRPIFPGKHYL 236

>pdb|2NPQ|A Chain A, A Novel Lipid Binding Site In The P38 Alpha Map Kinase Length = 367

Iteration: 1
 Score = 45.1 bits (105), Expect = 1e-04,   Method: Compositional matrix adjust.
 Identities = 61/238 (25%), Positives = 99/238 (41%), Gaps = 38/238 (15%)
Query: 389 FSREHLNSFRLNLEEVESATQCFSEVNLLGKGNFSSVYKG-TLRDGTLVAIRSINVTSCK 447
           F R+ LN     + EV    Q  S V   G G + SV      + G  VA++ ++     
Sbjct: 15  FYRQELNK---TIWEVPERYQNLSPV---GSGAYGSVCAAFDTKTGLRVAVKKLSRPFQS 68
Query: 448 SEEAEFV-KGLYLLTSLRHENIIRLRG-FCCSRGRGECFLIY--------DFAPKGKLSK 497
              A+   + L LL  ++HEN+I L   F  +R   E   +Y        D     K  K
Sbjct: 69  IIHAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQK 128
Query: 498 YLDQEEGSSNVLDWSTRVSIIIGIAKGIGYLHSSEVNKPAIVHRNLSVEKVLIDQQFNPL 557
             D                +I  I +G+ Y+HS++     I+HR+L    + +++     
Sbjct: 129 LTDDHVQF-----------LIYQILRGLKYIHSAD-----IIHRDLKPSNLAVNEDCELK 172
Query: 558 IADCGLHKLLADDIVFSVLKTSAAMGYLAPEYVTTG-RFTERSDIFAFGVIILQILTG 614
           I D GL +   D++   V    A   Y APE +     + +  DI++ G I+ ++LTG
Sbjct: 173 ILDFGLARHTDDEMTGYV----ATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTG 226

>pdb|1M7Q|A Chain A, Crystal Structure Of P38 Map Kinase In Complex With A Dihydroquinazolinone Inhibitor Length = 366

Iteration: 1
 Score = 45.1 bits (105), Expect = 1e-04,   Method: Compositional matrix adjust.
 Identities = 61/238 (25%), Positives = 99/238 (41%), Gaps = 38/238 (15%)
Query: 389 FSREHLNSFRLNLEEVESATQCFSEVNLLGKGNFSSVYKG-TLRDGTLVAIRSINVTSCK 447
           F R+ LN     + EV    Q  S V   G G + SV      + G  VA++ ++     
Sbjct: 14  FYRQELNK---TIWEVPERYQNLSPV---GSGAYGSVCAAFDTKTGLRVAVKKLSRPFQS 67
Query: 448 SEEAEFV-KGLYLLTSLRHENIIRLRG-FCCSRGRGECFLIY--------DFAPKGKLSK 497
              A+   + L LL  ++HEN+I L   F  +R   E   +Y        D     K  K
Sbjct: 68  IIHAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQK 127
Query: 498 YLDQEEGSSNVLDWSTRVSIIIGIAKGIGYLHSSEVNKPAIVHRNLSVEKVLIDQQFNPL 557
             D                +I  I +G+ Y+HS++     I+HR+L    + +++     
Sbjct: 128 LTDDHVQF-----------LIYQILRGLKYIHSAD-----IIHRDLKPSNLAVNEDCELK 171
Query: 558 IADCGLHKLLADDIVFSVLKTSAAMGYLAPEYVTTG-RFTERSDIFAFGVIILQILTG 614
           I D GL +   D++   V    A   Y APE +     + +  DI++ G I+ ++LTG
Sbjct: 172 ILDFGLARHTDDEMTGYV----ATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTG 225

>pdb|3NUS|A Chain A, Phosphoinositide-Dependent Kinase-1 (Pdk1) With Fragment8 Length = 286

Iteration: 1
 Score = 45.1 bits (105), Expect = 1e-04,   Method: Compositional matrix adjust.
 Identities = 49/208 (23%), Positives = 98/208 (47%), Gaps = 23/208 (11%)
Query: 415 NLLGKGNFSSVYKG----TLRDGTLVAIRSINVTSCKSEEAEFV-KGLYLLTSLRHENII 469
            +LG+G+FS+V       T R+  +  +   ++   K  +  +V +   +++ L H   +
Sbjct: 14  KILGEGSFSTVVLARELATSREYAIKILEKRHI--IKENKVPYVTRERDVMSRLDHPFFV 71
Query: 470 RLRGFCCSRGRGECFLIYDFAPKGKLSKYLDQEEGSSNVLDWSTRVSIIIGIAKGIGYLH 529
           +L  +   +   + +    +A  G+L KY+ ++ GS    D +        I   + YLH
Sbjct: 72  KL--YFTFQDDEKLYFGLSYAKNGELLKYI-RKIGS---FDETCTRFYTAEIVSALEYLH 125
Query: 530 SSEVNKPAIVHRNLSVEKVLIDQQFNPLIADCGLHKLLADDIVFSVLKTSAAMG---YLA 586
                   I+HR+L  E +L+++  +  I D G  K+L+ +      + +  +G   Y++
Sbjct: 126 GK-----GIIHRDLKPENILLNEDMHIQITDFGTAKVLSPES--KQARANXFVGTAQYVS 178
Query: 587 PEYVTTGRFTERSDIFAFGVIILQILTG 614
           PE +T     + SD++A G II Q++ G
Sbjct: 179 PELLTEKSACKSSDLWALGCIIYQLVAG 206

>pdb|1IAN|A Chain A, Human P38 Map Kinase Inhibitor Complex Length = 366

Iteration: 1
 Score = 45.1 bits (105), Expect = 1e-04,   Method: Compositional matrix adjust.
 Identities = 61/238 (25%), Positives = 99/238 (41%), Gaps = 38/238 (15%)
Query: 389 FSREHLNSFRLNLEEVESATQCFSEVNLLGKGNFSSVYKG-TLRDGTLVAIRSINVTSCK 447
           F R+ LN     + EV    Q  S V   G G + SV      + G  VA++ ++     
Sbjct: 14  FYRQELNK---TIWEVPERYQNLSPV---GSGAYGSVCAAFDTKTGLRVAVKKLSRPFQS 67
Query: 448 SEEAEFV-KGLYLLTSLRHENIIRLRG-FCCSRGRGECFLIY--------DFAPKGKLSK 497
              A+   + L LL  ++HEN+I L   F  +R   E   +Y        D     K  K
Sbjct: 68  IIHAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQK 127
Query: 498 YLDQEEGSSNVLDWSTRVSIIIGIAKGIGYLHSSEVNKPAIVHRNLSVEKVLIDQQFNPL 557
             D                +I  I +G+ Y+HS++     I+HR+L    + +++     
Sbjct: 128 LTDDHVQF-----------LIYQILRGLKYIHSAD-----IIHRDLKPSNLAVNEDCELK 171
Query: 558 IADCGLHKLLADDIVFSVLKTSAAMGYLAPEYVTTG-RFTERSDIFAFGVIILQILTG 614
           I D GL +   D++   V    A   Y APE +     + +  DI++ G I+ ++LTG
Sbjct: 172 ILDFGLARHTDDEMTGYV----ATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTG 225

>pdb|4EWQ|A Chain A, Human P38 Alpha Mapk In Complex With A Pyridazine Based Inhibitor Length = 383

Iteration: 1
 Score = 45.1 bits (105), Expect = 1e-04,   Method: Compositional matrix adjust.
 Identities = 61/238 (25%), Positives = 99/238 (41%), Gaps = 38/238 (15%)
Query: 389 FSREHLNSFRLNLEEVESATQCFSEVNLLGKGNFSSVYKG-TLRDGTLVAIRSINVTSCK 447
           F R+ LN     + EV    Q  S V   G G + SV      + G  VA++ ++     
Sbjct: 31  FYRQELNK---TIWEVPERYQNLSPV---GSGAYGSVCAAFDTKTGLRVAVKKLSRPFQS 84
Query: 448 SEEAEFV-KGLYLLTSLRHENIIRLRG-FCCSRGRGECFLIY--------DFAPKGKLSK 497
              A+   + L LL  ++HEN+I L   F  +R   E   +Y        D     K  K
Sbjct: 85  IIHAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQK 144
Query: 498 YLDQEEGSSNVLDWSTRVSIIIGIAKGIGYLHSSEVNKPAIVHRNLSVEKVLIDQQFNPL 557
             D                +I  I +G+ Y+HS++     I+HR+L    + +++     
Sbjct: 145 LTDDHVQF-----------LIYQILRGLKYIHSAD-----IIHRDLKPSNLAVNEDCELK 188
Query: 558 IADCGLHKLLADDIVFSVLKTSAAMGYLAPEYVTTG-RFTERSDIFAFGVIILQILTG 614
           I D GL +   D++   V    A   Y APE +     + +  DI++ G I+ ++LTG
Sbjct: 189 ILDFGLARHTDDEMXGYV----ATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTG 242

>pdb|3MH1|A Chain A, Mutagenesis Of P38 Map Kinase Establishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360

Iteration: 1
 Score = 45.1 bits (105), Expect = 1e-04,   Method: Compositional matrix adjust.
 Identities = 61/238 (25%), Positives = 99/238 (41%), Gaps = 38/238 (15%)
Query: 389 FSREHLNSFRLNLEEVESATQCFSEVNLLGKGNFSSVYKG-TLRDGTLVAIRSINVTSCK 447
           F R+ LN     + EV    Q  S V   G G + SV      + G  VA++ ++     
Sbjct: 8   FYRQELNK---TIWEVPERYQNLSPV---GSGAYGSVCAAFDTKTGLRVAVKKLSRPFQS 61
Query: 448 SEEAEFV-KGLYLLTSLRHENIIRLRG-FCCSRGRGECFLIY--------DFAPKGKLSK 497
              A+   + L LL  ++HEN+I L   F  +R   E   +Y        D     K  K
Sbjct: 62  IIHAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQK 121
Query: 498 YLDQEEGSSNVLDWSTRVSIIIGIAKGIGYLHSSEVNKPAIVHRNLSVEKVLIDQQFNPL 557
             D                +I  I +G+ Y+HS++     I+HR+L    + +++     
Sbjct: 122 LTDDHVQF-----------LIYQILRGLKYIHSAD-----IIHRDLKPSNLAVNEDCELK 165
Query: 558 IADCGLHKLLADDIVFSVLKTSAAMGYLAPEYVTTG-RFTERSDIFAFGVIILQILTG 614
           I D GL +   D++   V    A   Y APE +     + +  DI++ G I+ ++LTG
Sbjct: 166 ILDGGLARHTDDEMTGYV----ATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTG 219

>pdb|2V7O|A Chain A, Crystal Structure Of Human Calcium-Calmodulin-Dependent Protein Kinase Ii Gamma Length = 336

Iteration: 1
 Score = 45.1 bits (105), Expect = 1e-04,   Method: Compositional matrix adjust.
 Identities = 54/211 (25%), Positives = 91/211 (43%), Gaps = 20/211 (9%)
Query: 409 QCFSEVNLLGKGNFSSVYKGTLRDGTL-VAIRSINVTSCKSEEAE-FVKGLYLLTSLRHE 466
           Q F E   LGKG FS V +   +  T   A + IN     + + +   +   +   L+H 
Sbjct: 34  QLFEE---LGKGAFSVVRRCVKKTPTQEYAAKIINTKKLSARDHQKLEREARICRLLKHP 90
Query: 467 NIIRLRGFCCSRGRGECFLIYDFAPKGKLSKYLDQEEGSSNVLDWSTRVSIIIGIAKGIG 526
           NI+RL       G    +L++D    G+L + +   E  S     +     I  I + + 
Sbjct: 91  NIVRLHDSISEEGFH--YLVFDLVTGGELFEDIVAREYYSE----ADASHCIHQILESVN 144
Query: 527 YLHSSEVNKPAIVHRNLSVEKVLIDQQFNPL---IADCGLHKLLADDIVFSVLKTSAAMG 583
           ++H  +     IVHR+L  E +L+  +       +AD GL  +       +    +   G
Sbjct: 145 HIHQHD-----IVHRDLKPENLLLASKCKGAAVKLADFGL-AIEVQGEQQAWFGFAGTPG 198
Query: 584 YLAPEYVTTGRFTERSDIFAFGVIILQILTG 614
           YL+PE +    + +  DI+A GVI+  +L G
Sbjct: 199 YLSPEVLRKDPYGKPVDIWACGVILYILLVG 229

>pdb|2OZA|B Chain B, Structure Of P38alpha Complex Length = 366

Iteration: 1
 Score = 45.1 bits (105), Expect = 1e-04,   Method: Compositional matrix adjust.
 Identities = 61/238 (25%), Positives = 99/238 (41%), Gaps = 38/238 (15%)
Query: 389 FSREHLNSFRLNLEEVESATQCFSEVNLLGKGNFSSVYKG-TLRDGTLVAIRSINVTSCK 447
           F R+ LN     + EV    Q  S V   G G + SV      + G  VA++ ++     
Sbjct: 14  FYRQELNK---TIWEVPERYQNLSPV---GSGAYGSVCAAFDTKTGHRVAVKKLSRPFQS 67
Query: 448 SEEAEFV-KGLYLLTSLRHENIIRLRG-FCCSRGRGECFLIY--------DFAPKGKLSK 497
              A+   + L LL  ++HEN+I L   F  +R   E   +Y        D     K  K
Sbjct: 68  IIHAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQK 127
Query: 498 YLDQEEGSSNVLDWSTRVSIIIGIAKGIGYLHSSEVNKPAIVHRNLSVEKVLIDQQFNPL 557
             D                +I  I +G+ Y+HS++     I+HR+L    + +++     
Sbjct: 128 LTDDHVQF-----------LIYQILRGLKYIHSAD-----IIHRDLKPSNLAVNEDCELK 171
Query: 558 IADCGLHKLLADDIVFSVLKTSAAMGYLAPEYVTTG-RFTERSDIFAFGVIILQILTG 614
           I D GL +   D++   V    A   Y APE +     + +  DI++ G I+ ++LTG
Sbjct: 172 ILDFGLARHTDDEMTGYV----ATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTG 225

>pdb|4H3Q|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Mapk Docking Peptide Length = 362

Iteration: 1
 Score = 45.1 bits (105), Expect = 1e-04,   Method: Compositional matrix adjust.
 Identities = 48/223 (21%), Positives = 102/223 (45%), Gaps = 22/223 (9%)
Query: 411 FSEVNLLGKGNFS---SVYKGTLRDGTLVAIRSINVTSCKSEEAEFVKGLYLLTSLRHEN 467
           ++ ++ +G+G +    S Y     +   VAI+ I+    ++     ++ + +L + RHEN
Sbjct: 27  YTNLSYIGEGAYGMVCSAYDNV--NKVRVAIKKISPFEHQTYCQRTLREIKILLAFRHEN 84
Query: 468 IIRLRGFCCS---RGRGECFLIYDFAPKGKLSKYLDQEEGSSNVLDWSTRVSIIIGIAKG 524
           II +     +       + +++ D   +  L K L  +  S++ + +      +  I +G
Sbjct: 85  IIGINDIIRAPTIEQMKDVYIVQDLM-ETDLYKLLKTQHLSNDHICY-----FLYQILRG 138
Query: 525 IGYLHSSEVNKPAIVHRNLSVEKVLIDQQFNPLIADCGLHKLLADDIVFSVLKTS--AAM 582
           + Y+HS+ V     +HR+L    +L++   +  I D GL ++   D   +   T   A  
Sbjct: 139 LKYIHSANV-----LHRDLKPSNLLLNTTSDLKICDFGLARVADPDHDHTGFLTEYVATR 193
Query: 583 GYLAPEYVTTGR-FTERSDIFAFGVIILQILTGSLVLTSSMRL 624
            Y APE +   + +T+  DI++ G I+ ++L+   +      L
Sbjct: 194 WYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNRPIFPGKHYL 236

>pdb|3MH3|A Chain A, Mutagenesis Of P38 Map Kinase Establishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360

Iteration: 1
 Score = 45.1 bits (105), Expect = 1e-04,   Method: Compositional matrix adjust.
 Identities = 61/238 (25%), Positives = 99/238 (41%), Gaps = 38/238 (15%)
Query: 389 FSREHLNSFRLNLEEVESATQCFSEVNLLGKGNFSSVYKG-TLRDGTLVAIRSINVTSCK 447
           F R+ LN     + EV    Q  S V   G G + SV      + G  VA++ ++     
Sbjct: 8   FYRQELNK---TIWEVPERYQNLSPV---GSGAYGSVCAAFDTKTGLRVAVKKLSRPFQS 61
Query: 448 SEEAEFV-KGLYLLTSLRHENIIRLRG-FCCSRGRGECFLIY--------DFAPKGKLSK 497
              A+   + L LL  ++HEN+I L   F  +R   E   +Y        D     K  K
Sbjct: 62  IIHAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQK 121
Query: 498 YLDQEEGSSNVLDWSTRVSIIIGIAKGIGYLHSSEVNKPAIVHRNLSVEKVLIDQQFNPL 557
             D                +I  I +G+ Y+HS++     I+HR+L    + +++     
Sbjct: 122 LTDDHVQF-----------LIYQILRGLKYIHSAD-----IIHRDLKPSNLAVNEDCELK 165
Query: 558 IADCGLHKLLADDIVFSVLKTSAAMGYLAPEYVTTG-RFTERSDIFAFGVIILQILTG 614
           I D GL +   D++   V    A   Y APE +     + +  DI++ G I+ ++LTG
Sbjct: 166 ILDRGLARHTDDEMTGYV----ATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTG 219

>pdb|1YW2|A Chain A, Mutated Mus Musculus P38 Kinase (Mp38) Length = 360

Iteration: 1
 Score = 45.1 bits (105), Expect = 1e-04,   Method: Compositional matrix adjust.
 Identities = 61/238 (25%), Positives = 99/238 (41%), Gaps = 38/238 (15%)
Query: 389 FSREHLNSFRLNLEEVESATQCFSEVNLLGKGNFSSVYKG-TLRDGTLVAIRSINVTSCK 447
           F R+ LN     + EV    Q  S V   G G + SV      + G  VA++ ++     
Sbjct: 8   FYRQELNK---TIWEVPERYQNLSPV---GSGAYGSVCAAFDTKTGHRVAVKKLSRPFQS 61
Query: 448 SEEAEFV-KGLYLLTSLRHENIIRLRG-FCCSRGRGECFLIY--------DFAPKGKLSK 497
              A+   + L LL  ++HEN+I L   F  +R   E   +Y        D     K  K
Sbjct: 62  IIHAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQK 121
Query: 498 YLDQEEGSSNVLDWSTRVSIIIGIAKGIGYLHSSEVNKPAIVHRNLSVEKVLIDQQFNPL 557
             D                +I  I +G+ Y+HS++     I+HR+L    + +++     
Sbjct: 122 LTDDHVQF-----------LIYQILRGLKYIHSAD-----IIHRDLKPSNLAVNEDCELK 165
Query: 558 IADCGLHKLLADDIVFSVLKTSAAMGYLAPEYVTTG-RFTERSDIFAFGVIILQILTG 614
           I D GL +   D++   V    A   Y APE +     + +  DI++ G I+ ++LTG
Sbjct: 166 ILDFGLARHTDDEMAGFV----ATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTG 219

>pdb|2ACX|A Chain A, Crystal Structure Of G Protein Coupled Receptor Kinase 6 Bound To Amppnp Length = 576

Iteration: 1
 Score = 45.1 bits (105), Expect = 1e-04,   Method: Compositional matrix adjust.
 Identities = 23/85 (27%), Positives = 46/85 (54%), Gaps = 2/85 (2%)
Query: 531 SEVNKPAIVHRNLSVEKVLIDQQFNPLIADCGLHKLLADDIVFSVLKTSAAMGYLAPEYV 590
            ++++  IV+R+L  E +L+D   +  I+D GL   + +    ++      +GY+APE V
Sbjct: 300 EDLHRERIVYRDLKPENILLDDHGHIRISDLGLAVHVPEGQ--TIKGRVGTVGYMAPEVV 357
Query: 591 TTGRFTERSDIFAFGVIILQILTGS 615
              R+T   D +A G ++ +++ G 
Sbjct: 358 KNERYTFSPDWWALGCLLYEMIAGQ 382

>pdb|4FUX|A Chain A, Crystal Structure Of The Erk2 Complexed With E75 Length = 360

Iteration: 1
 Score = 45.1 bits (105), Expect = 1e-04,   Method: Compositional matrix adjust.
 Identities = 47/217 (21%), Positives = 100/217 (46%), Gaps = 22/217 (10%)
Query: 411 FSEVNLLGKGNFS---SVYKGTLRDGTLVAIRSINVTSCKSEEAEFVKGLYLLTSLRHEN 467
           ++ ++ +G+G +    S Y     +   VAI+ I+    ++     ++ + +L   RHEN
Sbjct: 25  YTNLSYIGEGAYGMVCSAYDNV--NKVRVAIKKISPFEHQTYCQRTLREIKILLRFRHEN 82
Query: 468 IIRLRGFCCS---RGRGECFLIYDFAPKGKLSKYLDQEEGSSNVLDWSTRVSIIIGIAKG 524
           II +     +       + +++ D   +  L K L  +  S++ + +      +  I +G
Sbjct: 83  IIGINDIIRAPTIEQMKDVYIVQDLM-ETDLYKLLKTQHLSNDHICY-----FLYQILRG 136
Query: 525 IGYLHSSEVNKPAIVHRNLSVEKVLIDQQFNPLIADCGLHKLLADDIVFSVLKTS--AAM 582
           + Y+HS+ V     +HR+L    +L++   +  I D GL ++   D   +   T   A  
Sbjct: 137 LKYIHSANV-----LHRDLKPSNLLLNTTXDLKICDFGLARVADPDHDHTGFLTEYVATR 191
Query: 583 GYLAPEYVTTGR-FTERSDIFAFGVIILQILTGSLVL 618
            Y APE +   + +T+  DI++ G I+ ++L+   + 
Sbjct: 192 WYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNRPIF 228

>pdb|1YWR|A Chain A, Crystal Structure Analysis Of Inactive P38 Kinase Domain In Complex With A Monocyclic Pyrazolone Inhibitor Length = 360

Iteration: 1
 Score = 45.1 bits (105), Expect = 1e-04,   Method: Compositional matrix adjust.
 Identities = 61/238 (25%), Positives = 99/238 (41%), Gaps = 38/238 (15%)
Query: 389 FSREHLNSFRLNLEEVESATQCFSEVNLLGKGNFSSVYKG-TLRDGTLVAIRSINVTSCK 447
           F R+ LN     + EV    Q  S V   G G + SV      + G  VA++ ++     
Sbjct: 8   FYRQELNK---TIWEVPERYQNLSPV---GSGAYGSVCAAFDTKTGHRVAVKKLSRPFQS 61
Query: 448 SEEAEFV-KGLYLLTSLRHENIIRLRG-FCCSRGRGECFLIY--------DFAPKGKLSK 497
              A+   + L LL  ++HEN+I L   F  +R   E   +Y        D     K  K
Sbjct: 62  IIHAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQK 121
Query: 498 YLDQEEGSSNVLDWSTRVSIIIGIAKGIGYLHSSEVNKPAIVHRNLSVEKVLIDQQFNPL 557
             D                +I  I +G+ Y+HS++     I+HR+L    + +++     
Sbjct: 122 LTDDHVQF-----------LIYQILRGLKYIHSAD-----IIHRDLKPSNLAVNEDCELK 165
Query: 558 IADCGLHKLLADDIVFSVLKTSAAMGYLAPEYVTTG-RFTERSDIFAFGVIILQILTG 614
           I D GL +   D++   V    A   Y APE +     + +  DI++ G I+ ++LTG
Sbjct: 166 ILDFGLARHTDDEMAGFV----ATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTG 219

>pdb|3NAY|A Chain A, Pdk1 In Complex With Inhibitor Mp6 Length = 311

Iteration: 1
 Score = 45.1 bits (105), Expect = 1e-04,   Method: Compositional matrix adjust.
 Identities = 49/208 (23%), Positives = 98/208 (47%), Gaps = 23/208 (11%)
Query: 415 NLLGKGNFSSVYKG----TLRDGTLVAIRSINVTSCKSEEAEFV-KGLYLLTSLRHENII 469
            +LG+G+FS+V       T R+  +  +   ++   K  +  +V +   +++ L H   +
Sbjct: 35  KILGEGSFSTVVLARELATSREYAIKILEKRHI--IKENKVPYVTRERDVMSRLDHPFFV 92
Query: 470 RLRGFCCSRGRGECFLIYDFAPKGKLSKYLDQEEGSSNVLDWSTRVSIIIGIAKGIGYLH 529
           +L  +   +   + +    +A  G+L KY+ ++ GS    D +        I   + YLH
Sbjct: 93  KL--YFTFQDDEKLYFGLSYAKNGELLKYI-RKIGS---FDETCTRFYTAEIVSALEYLH 146
Query: 530 SSEVNKPAIVHRNLSVEKVLIDQQFNPLIADCGLHKLLADDIVFSVLKTSAAMG---YLA 586
                   I+HR+L  E +L+++  +  I D G  K+L+ +      + +  +G   Y++
Sbjct: 147 GK-----GIIHRDLKPENILLNEDMHIQITDFGTAKVLSPES--KQARANXFVGTAQYVS 199
Query: 587 PEYVTTGRFTERSDIFAFGVIILQILTG 614
           PE +T     + SD++A G II Q++ G
Sbjct: 200 PELLTEKSACKSSDLWALGCIIYQLVAG 227

>pdb|3NUN|A Chain A, Phosphoinositide-Dependent Kinase-1 (Pdk1) With Lead Compound Length = 292

Iteration: 1
 Score = 45.1 bits (105), Expect = 1e-04,   Method: Compositional matrix adjust.
 Identities = 49/208 (23%), Positives = 98/208 (47%), Gaps = 23/208 (11%)
Query: 415 NLLGKGNFSSVYKG----TLRDGTLVAIRSINVTSCKSEEAEFV-KGLYLLTSLRHENII 469
            +LG+G+FS+V       T R+  +  +   ++   K  +  +V +   +++ L H   +
Sbjct: 20  KILGEGSFSTVVLARELATSREYAIKILEKRHI--IKENKVPYVTRERDVMSRLDHPFFV 77
Query: 470 RLRGFCCSRGRGECFLIYDFAPKGKLSKYLDQEEGSSNVLDWSTRVSIIIGIAKGIGYLH 529
           +L  +   +   + +    +A  G+L KY+ ++ GS    D +        I   + YLH
Sbjct: 78  KL--YFTFQDDEKLYFGLSYAKNGELLKYI-RKIGS---FDETCTRFYTAEIVSALEYLH 131
Query: 530 SSEVNKPAIVHRNLSVEKVLIDQQFNPLIADCGLHKLLADDIVFSVLKTSAAMG---YLA 586
                   I+HR+L  E +L+++  +  I D G  K+L+ +      + +  +G   Y++
Sbjct: 132 GK-----GIIHRDLKPENILLNEDMHIQITDFGTAKVLSPES--KQARANXFVGTAQYVS 184
Query: 587 PEYVTTGRFTERSDIFAFGVIILQILTG 614
           PE +T     + SD++A G II Q++ G
Sbjct: 185 PELLTEKSACKSSDLWALGCIIYQLVAG 212

>pdb|3NYN|A Chain A, Crystal Structure Of G Protein-Coupled Receptor Kinase 6 In Complex With Sangivamycin Length = 576

Iteration: 1
 Score = 45.1 bits (105), Expect = 1e-04,   Method: Compositional matrix adjust.
 Identities = 23/85 (27%), Positives = 46/85 (54%), Gaps = 2/85 (2%)
Query: 531 SEVNKPAIVHRNLSVEKVLIDQQFNPLIADCGLHKLLADDIVFSVLKTSAAMGYLAPEYV 590
            ++++  IV+R+L  E +L+D   +  I+D GL   + +    ++      +GY+APE V
Sbjct: 300 EDLHRERIVYRDLKPENILLDDHGHIRISDLGLAVHVPEGQ--TIKGRVGTVGYMAPEVV 357
Query: 591 TTGRFTERSDIFAFGVIILQILTGS 615
              R+T   D +A G ++ +++ G 
Sbjct: 358 KNERYTFSPDWWALGCLLYEMIAGQ 382

>pdb|3SA0|A Chain A, Complex Of Erk2 With Norathyriol Length = 360

Iteration: 1
 Score = 45.1 bits (105), Expect = 1e-04,   Method: Compositional matrix adjust.
 Identities = 47/217 (21%), Positives = 100/217 (46%), Gaps = 22/217 (10%)
Query: 411 FSEVNLLGKGNFS---SVYKGTLRDGTLVAIRSINVTSCKSEEAEFVKGLYLLTSLRHEN 467
           ++ ++ +G+G +    S Y     +   VAI+ I+    ++     ++ + +L   RHEN
Sbjct: 25  YTNLSYIGEGAYGMVCSAYDNV--NKVRVAIKKISPFEHQTYCQRTLREIKILLRFRHEN 82
Query: 468 IIRLRGFCCS---RGRGECFLIYDFAPKGKLSKYLDQEEGSSNVLDWSTRVSIIIGIAKG 524
           II +     +       + +++ D   +  L K L  +  S++ + +      +  I +G
Sbjct: 83  IIGINDIIRAPTIEQMKDVYIVQDLM-ETDLYKLLKTQHLSNDHICY-----FLYQILRG 136
Query: 525 IGYLHSSEVNKPAIVHRNLSVEKVLIDQQFNPLIADCGLHKLLADDIVFSVLKTS--AAM 582
           + Y+HS+ V     +HR+L    +L++   +  I D GL ++   D   +   T   A  
Sbjct: 137 LKYIHSANV-----LHRDLKPSNLLLNTTXDLKIXDFGLARVADPDHDHTGFLTEYVATR 191
Query: 583 GYLAPEYVTTGR-FTERSDIFAFGVIILQILTGSLVL 618
            Y APE +   + +T+  DI++ G I+ ++L+   + 
Sbjct: 192 WYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNRPIF 228

>pdb|4FV7|A Chain A, Crystal Structure Of The Erk2 Complexed With E94 Length = 360

Iteration: 1
 Score = 45.1 bits (105), Expect = 1e-04,   Method: Compositional matrix adjust.
 Identities = 47/217 (21%), Positives = 100/217 (46%), Gaps = 22/217 (10%)
Query: 411 FSEVNLLGKGNFS---SVYKGTLRDGTLVAIRSINVTSCKSEEAEFVKGLYLLTSLRHEN 467
           ++ ++ +G+G +    S Y     +   VAI+ I+    ++     ++ + +L   RHEN
Sbjct: 25  YTNLSYIGEGAYGMVCSAYDNV--NKVRVAIKKISPFEHQTYCQRTLREIKILLRFRHEN 82
Query: 468 IIRLRGFCCS---RGRGECFLIYDFAPKGKLSKYLDQEEGSSNVLDWSTRVSIIIGIAKG 524
           II +     +       + +++ D   +  L K L  +  S++ + +      +  I +G
Sbjct: 83  IIGINDIIRAPTIEQMKDVYIVQDLM-ETDLYKLLKTQHLSNDHICY-----FLYQILRG 136
Query: 525 IGYLHSSEVNKPAIVHRNLSVEKVLIDQQFNPLIADCGLHKLLADDIVFSVLKTS--AAM 582
           + Y+HS+ V     +HR+L    +L++   +  I D GL ++   D   +   T   A  
Sbjct: 137 LKYIHSANV-----LHRDLKPSNLLLNTTXDLKICDFGLARVADPDHDHTGFLTEYVATR 191
Query: 583 GYLAPEYVTTGR-FTERSDIFAFGVIILQILTGSLVL 618
            Y APE +   + +T+  DI++ G I+ ++L+   + 
Sbjct: 192 WYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNRPIF 228

>pdb|3PFQ|A Chain A, Crystal Structure And Allosteric Activation Of Protein Kinase C Beta Ii Length = 674

Iteration: 1
 Score = 45.1 bits (105), Expect = 1e-04,   Method: Compositional matrix adjust.
 Identities = 34/132 (25%), Positives = 65/132 (49%), Gaps = 16/132 (12%)
Query: 521 IAKGIGYLHSSEVNKPAIVHRNLSVEKVLIDQQFNPLIADCGLHKLLADDIVFSVLKTSA 580
           IA G+ +L S       I++R+L ++ V++D + +  IAD G+ K    + ++  + T  
Sbjct: 451 IAIGLFFLQSK-----GIIYRDLKLDNVMLDSEGHIKIADFGMCK----ENIWDGVTTKX 501
Query: 581 AMG---YLAPEYVTTGRFTERSDIFAFGVIILQILTGSLVLTSSMRLAAESATFENFIDR 637
             G   Y+APE +    + +  D +AFGV++ ++L G            E   F++ ++ 
Sbjct: 502 FCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQAPFEGE----DEDELFQSIMEH 557
Query: 638 NLKGKFSESEAA 649
           N+    S S+ A
Sbjct: 558 NVAYPKSMSKEA 569

>pdb|2GHL|A Chain A, Mutant Mus Musculus P38 Kinase Domain In Complex With Inhibitor Pg-874743 Length = 348

Iteration: 1
 Score = 45.1 bits (105), Expect = 1e-04,   Method: Compositional matrix adjust.
 Identities = 61/238 (25%), Positives = 99/238 (41%), Gaps = 38/238 (15%)
Query: 389 FSREHLNSFRLNLEEVESATQCFSEVNLLGKGNFSSVYKG-TLRDGTLVAIRSINVTSCK 447
           F R+ LN     + EV    Q  S V   G G + SV      + G  VA++ ++     
Sbjct: 4   FYRQELNK---TIWEVPERYQNLSPV---GSGAYGSVCAAFDTKTGHRVAVKKLSRPFQS 57
Query: 448 SEEAEFV-KGLYLLTSLRHENIIRLRG-FCCSRGRGECFLIY--------DFAPKGKLSK 497
              A+   + L LL  ++HEN+I L   F  +R   E   +Y        D     K  K
Sbjct: 58  IIHAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQK 117
Query: 498 YLDQEEGSSNVLDWSTRVSIIIGIAKGIGYLHSSEVNKPAIVHRNLSVEKVLIDQQFNPL 557
             D                +I  I +G+ Y+HS++     I+HR+L    + +++     
Sbjct: 118 LTDDHVQF-----------LIYQILRGLKYIHSAD-----IIHRDLKPSNLAVNEDCELK 161
Query: 558 IADCGLHKLLADDIVFSVLKTSAAMGYLAPEYVTTG-RFTERSDIFAFGVIILQILTG 614
           I D GL +   D++   V    A   Y APE +     + +  DI++ G I+ ++LTG
Sbjct: 162 ILDFGLARHTDDEMAGFV----ATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTG 215

>pdb|2XCK|A Chain A, Crystal Structure Of Pdk1 In Complex With A Pyrazoloquinazoline Inhibitor Length = 309

Iteration: 1
 Score = 45.1 bits (105), Expect = 2e-04,   Method: Compositional matrix adjust.
 Identities = 50/206 (24%), Positives = 96/206 (46%), Gaps = 19/206 (9%)
Query: 415 NLLGKGNFSS-VYKGTLRDGTLVAIRSINVTSC-KSEEAEFV-KGLYLLTSLRHENIIRL 471
            +LG+G+FS+ V    L      AI+ +      K  +  +V +   +++ L H   ++L
Sbjct: 36  KILGEGSFSTTVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHPFFVKL 95
Query: 472 RGFCCSRGRGECFLIYDFAPKGKLSKYLDQEEGSSNVLDWSTRVSIIIGIAKGIGYLHSS 531
             +   +   + +    +A  G+L KY+ ++ GS    D +        I   + YLH  
Sbjct: 96  --YFTFQDDEKLYFGLSYAKNGELLKYI-RKIGS---FDETCTRFYTAEIVSALEYLHGK 149
Query: 532 EVNKPAIVHRNLSVEKVLIDQQFNPLIADCGLHKLLADDIVFSVLKTSAAMG---YLAPE 588
                 I+HR+L  E +L+++  +  I D G  K+L+ +      + +  +G   Y++PE
Sbjct: 150 -----GIIHRDLKPENILLNEDMHIQITDFGTAKVLSPES--KQARANXFVGTAQYVSPE 202
Query: 589 YVTTGRFTERSDIFAFGVIILQILTG 614
            +T     + SD++A G II Q++ G
Sbjct: 203 LLTEKSACKSSDLWALGCIIYQLVAG 228

>pdb|3ALN|A Chain A, Crystal Structure Of Human Non-Phosphorylated Mkk4 Kinase Domain Complexed With Amp-Pnp Length = 327

Iteration: 1
 Score = 44.7 bits (104), Expect = 2e-04,   Method: Compositional matrix adjust.
 Identities = 44/208 (21%), Positives = 94/208 (45%), Gaps = 18/208 (8%)
Query: 417 LGKGNFSSVYKGTLR-DGTLVAIRSINVTSCKSEEAEFVKGLYLLTSLRHENIIRLRGFC 475
           +G+G + SV K   +  G ++A++ I  T  + E+ + +  L ++  +R  +   +  F 
Sbjct: 30  IGRGAYGSVNKMVHKPSGQIMAVKRIRSTVDEKEQKQLLMDLDVV--MRSSDCPYIVQFY 87
Query: 476 CSRGR-GECFLIYDFAPKG--KLSKYLDQEEGSSNVLDWSTRVSIIIGIAKGIGYLHSSE 532
            +  R G+C++  +       K  KY+       +V+       I +   K + +L  + 
Sbjct: 88  GALFREGDCWICMELMSTSFDKFYKYV--YSVLDDVIPEEILGKITLATVKALNHLKENL 145
Query: 533 VNKPAIVHRNLSVEKVLIDQQFNPLIADCGLHKLLADDIVFSVLKTSAAMGYLAPEYVTT 592
                I+HR++    +L+D+  N  + D G+   L D I  +  + +    Y+APE +  
Sbjct: 146 ----KIIHRDIKPSNILLDRSGNIKLCDFGISGQLVDSIAKT--RDAGCRPYMAPERIDP 199
Query: 593 GR----FTERSDIFAFGVIILQILTGSL 616
                 +  RSD+++ G+ + ++ TG  
Sbjct: 200 SASRQGYDVRSDVWSLGITLYELATGRF 227

>pdb|2YA9|A Chain A, Crystal Structure Of The Autoinhibited Form Of Mouse Dapk2 Length = 361

Iteration: 1
 Score = 44.7 bits (104), Expect = 2e-04,   Method: Compositional matrix adjust.
 Identities = 52/209 (24%), Positives = 89/209 (42%), Gaps = 23/209 (11%)
Query: 417 LGKGNFSSVYKGTLRD-GTLVAIRSINVTSCKSEE-----AEFVKGLYLLTSLRHENIIR 470
           LG G F+ V K   +  G   A + I     ++        E  + + +L  + H NII 
Sbjct: 20  LGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVCREEIEREVSILRQVLHPNIIT 79
Query: 471 LRGFCCSRGRGECFLIYDFAPKGKLSKYLDQEEGSSNVLDWSTRVSIIIGIAKGIGYLHS 530
           L        R +  LI +    G+L  +L Q+E  S         S I  I  G+ YLH+
Sbjct: 80  LHD--VYENRTDVVLILELVSGGELFDFLAQKESLSE----EEATSFIKQILDGVNYLHT 133
Query: 531 SEVNKPAIVHRNLSVEKVLIDQQFNPL----IADCGLHKLLADDIVFSVLKTSAAMGYLA 586
            +     I H +L  E +++  +  P+    + D GL   + D + F  +  +    ++A
Sbjct: 134 KK-----IAHFDLKPENIMLLDKNIPIPHIKLIDFGLAHEIEDGVEFKNIFGTPE--FVA 186
Query: 587 PEYVTTGRFTERSDIFAFGVIILQILTGS 615
           PE V        +D+++ GVI   +L+G+
Sbjct: 187 PEIVNYEPLGLEADMWSIGVITYILLSGA 215

>pdb|2Y9Q|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Mapk Docking Peptide Length = 362

Iteration: 1
 Score = 44.7 bits (104), Expect = 2e-04,   Method: Compositional matrix adjust.
 Identities = 48/223 (21%), Positives = 101/223 (45%), Gaps = 22/223 (9%)
Query: 411 FSEVNLLGKGNFS---SVYKGTLRDGTLVAIRSINVTSCKSEEAEFVKGLYLLTSLRHEN 467
           ++ ++ +G+G +    S Y     +   VAI+ I+    ++     ++ + +L   RHEN
Sbjct: 27  YTNLSYIGEGAYGMVCSAYDNV--NKVRVAIKKISPFEHQTYCQRTLREIKILLRFRHEN 84
Query: 468 IIRLRGFCCS---RGRGECFLIYDFAPKGKLSKYLDQEEGSSNVLDWSTRVSIIIGIAKG 524
           II +     +       + +++ D   +  L K L  +  S++ + +      +  I +G
Sbjct: 85  IIGINDIIRAPTIEQMKDVYIVQDLM-ETDLYKLLKTQHLSNDHICY-----FLYQILRG 138
Query: 525 IGYLHSSEVNKPAIVHRNLSVEKVLIDQQFNPLIADCGLHKLLADDIVFSVLKTS--AAM 582
           + Y+HS+ V     +HR+L    +L++   +  I D GL ++   D   +   T   A  
Sbjct: 139 LKYIHSANV-----LHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEYVATR 193
Query: 583 GYLAPEYVTTGR-FTERSDIFAFGVIILQILTGSLVLTSSMRL 624
            Y APE +   + +T+  DI++ G I+ ++L+   +      L
Sbjct: 194 WYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNRPIFPGKHYL 236

>pdb|2OJG|A Chain A, Crystal Structure Of Erk2 In Complex With N,n-dimethyl-4-(4- Phenyl-1h-pyrazol-3-yl)-1h-pyrrole-2-carboxamide Length = 380

Iteration: 1
 Score = 44.7 bits (104), Expect = 2e-04,   Method: Compositional matrix adjust.
 Identities = 48/223 (21%), Positives = 101/223 (45%), Gaps = 22/223 (9%)
Query: 411 FSEVNLLGKGNFS---SVYKGTLRDGTLVAIRSINVTSCKSEEAEFVKGLYLLTSLRHEN 467
           ++ ++ +G+G +    S Y     +   VAI+ I+    ++     ++ + +L   RHEN
Sbjct: 45  YTNLSYIGEGAYGMVCSAYDNV--NKVRVAIKKISPFEHQTYCQRTLREIKILLRFRHEN 102
Query: 468 IIRLRGFCCS---RGRGECFLIYDFAPKGKLSKYLDQEEGSSNVLDWSTRVSIIIGIAKG 524
           II +     +       + +++ D   +  L K L  +  S++ + +      +  I +G
Sbjct: 103 IIGINDIIRAPTIEQMKDVYIVQDLM-ETDLYKLLKTQHLSNDHICY-----FLYQILRG 156
Query: 525 IGYLHSSEVNKPAIVHRNLSVEKVLIDQQFNPLIADCGLHKLLADDIVFSVLKTS--AAM 582
           + Y+HS+ V     +HR+L    +L++   +  I D GL ++   D   +   T   A  
Sbjct: 157 LKYIHSANV-----LHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEYVATR 211
Query: 583 GYLAPEYVTTGR-FTERSDIFAFGVIILQILTGSLVLTSSMRL 624
            Y APE +   + +T+  DI++ G I+ ++L+   +      L
Sbjct: 212 WYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNRPIFPGKHYL 254

>pdb|4FV6|A Chain A, Crystal Structure Of The Erk2 Complexed With E57 Length = 360

Iteration: 1
 Score = 44.7 bits (104), Expect = 2e-04,   Method: Compositional matrix adjust.
 Identities = 47/217 (21%), Positives = 100/217 (46%), Gaps = 22/217 (10%)
Query: 411 FSEVNLLGKGNFS---SVYKGTLRDGTLVAIRSINVTSCKSEEAEFVKGLYLLTSLRHEN 467
           ++ ++ +G+G +    S Y     +   VAI+ I+    ++     ++ + +L   RHEN
Sbjct: 25  YTNLSYIGEGAYGMVCSAYDNV--NKVRVAIKKISPFEHQTYCQRTLREIKILLRFRHEN 82
Query: 468 IIRLRGFCCS---RGRGECFLIYDFAPKGKLSKYLDQEEGSSNVLDWSTRVSIIIGIAKG 524
           II +     +       + +++ D   +  L K L  +  S++ + +      +  I +G
Sbjct: 83  IIGINDIIRAPTIEQMKDVYIVQDLM-ETDLYKLLKTQHLSNDHICY-----FLYQILRG 136
Query: 525 IGYLHSSEVNKPAIVHRNLSVEKVLIDQQFNPLIADCGLHKLLADDIVFSVLKTS--AAM 582
           + Y+HS+ V     +HR+L    +L++   +  I D GL ++   D   +   T   A  
Sbjct: 137 LKYIHSANV-----LHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEYVATR 191
Query: 583 GYLAPEYVTTGR-FTERSDIFAFGVIILQILTGSLVL 618
            Y APE +   + +T+  DI++ G I+ ++L+   + 
Sbjct: 192 WYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNRPIF 228

>pdb|1WZY|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Pyrazolopyridazine Derivative Length = 368

Iteration: 1
 Score = 44.3 bits (103), Expect = 2e-04,   Method: Compositional matrix adjust.
 Identities = 48/223 (21%), Positives = 101/223 (45%), Gaps = 22/223 (9%)
Query: 411 FSEVNLLGKGNFS---SVYKGTLRDGTLVAIRSINVTSCKSEEAEFVKGLYLLTSLRHEN 467
           ++ ++ +G+G +    S Y     +   VAI+ I+    ++     ++ + +L   RHEN
Sbjct: 33  YTNLSYIGEGAYGMVCSAYDNV--NKVRVAIKKISPFEHQTYCQRTLREIKILLRFRHEN 90
Query: 468 IIRLRGFCCS---RGRGECFLIYDFAPKGKLSKYLDQEEGSSNVLDWSTRVSIIIGIAKG 524
           II +     +       + +++ D   +  L K L  +  S++ + +      +  I +G
Sbjct: 91  IIGINDIIRAPTIEQMKDVYIVQDLM-ETDLYKLLKTQHLSNDHICY-----FLYQILRG 144
Query: 525 IGYLHSSEVNKPAIVHRNLSVEKVLIDQQFNPLIADCGLHKLLADDIVFSVLKTS--AAM 582
           + Y+HS+ V     +HR+L    +L++   +  I D GL ++   D   +   T   A  
Sbjct: 145 LKYIHSANV-----LHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEYVATR 199
Query: 583 GYLAPEYVTTGR-FTERSDIFAFGVIILQILTGSLVLTSSMRL 624
            Y APE +   + +T+  DI++ G I+ ++L+   +      L
Sbjct: 200 WYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNRPIFPGKHYL 242

>pdb|1TVO|A Chain A, The Structure Of Erk2 In Complex With A Small Molecule Inhibitor Length = 368

Iteration: 1
 Score = 44.3 bits (103), Expect = 2e-04,   Method: Compositional matrix adjust.
 Identities = 48/223 (21%), Positives = 101/223 (45%), Gaps = 22/223 (9%)
Query: 411 FSEVNLLGKGNFS---SVYKGTLRDGTLVAIRSINVTSCKSEEAEFVKGLYLLTSLRHEN 467
           ++ ++ +G+G +    S Y     +   VAI+ I+    ++     ++ + +L   RHEN
Sbjct: 25  YTNLSYIGEGAYGMVCSAYDNV--NKVRVAIKKISPFEHQTYCQRTLREIKILLRFRHEN 82
Query: 468 IIRLRGFCCS---RGRGECFLIYDFAPKGKLSKYLDQEEGSSNVLDWSTRVSIIIGIAKG 524
           II +     +       + +++ D   +  L K L  +  S++ + +      +  I +G
Sbjct: 83  IIGINDIIRAPTIEQMKDVYIVQDLM-ETDLYKLLKTQHLSNDHICY-----FLYQILRG 136
Query: 525 IGYLHSSEVNKPAIVHRNLSVEKVLIDQQFNPLIADCGLHKLLADDIVFSVLKTS--AAM 582
           + Y+HS+ V     +HR+L    +L++   +  I D GL ++   D   +   T   A  
Sbjct: 137 LKYIHSANV-----LHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEYVATR 191
Query: 583 GYLAPEYVTTGR-FTERSDIFAFGVIILQILTGSLVLTSSMRL 624
            Y APE +   + +T+  DI++ G I+ ++L+   +      L
Sbjct: 192 WYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNRPIFPGKHYL 234

>pdb|2I0E|A Chain A, Structure Of Catalytic Domain Of Human Protein Kinase C Beta Ii Complexed With A Bisindolylmaleimide Inhibitor Length = 353

Iteration: 1
 Score = 44.3 bits (103), Expect = 2e-04,   Method: Compositional matrix adjust.
 Identities = 34/132 (25%), Positives = 65/132 (49%), Gaps = 16/132 (12%)
Query: 521 IAKGIGYLHSSEVNKPAIVHRNLSVEKVLIDQQFNPLIADCGLHKLLADDIVFSVLKTSA 580
           IA G+ +L S       I++R+L ++ V++D + +  IAD G+ K    + ++  + T  
Sbjct: 130 IAIGLFFLQSK-----GIIYRDLKLDNVMLDSEGHIKIADFGMCK----ENIWDGVTTKX 180
Query: 581 AMG---YLAPEYVTTGRFTERSDIFAFGVIILQILTGSLVLTSSMRLAAESATFENFIDR 637
             G   Y+APE +    + +  D +AFGV++ ++L G            E   F++ ++ 
Sbjct: 181 FCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQAPFEGE----DEDELFQSIMEH 236
Query: 638 NLKGKFSESEAA 649
           N+    S S+ A
Sbjct: 237 NVAYPKSMSKEA 248

>pdb|3QYW|A Chain A, Crystal Structure Of Erk2 In Complex With An Inhibitor Length = 364

Iteration: 1
 Score = 44.3 bits (103), Expect = 2e-04,   Method: Compositional matrix adjust.
 Identities = 48/223 (21%), Positives = 101/223 (45%), Gaps = 22/223 (9%)
Query: 411 FSEVNLLGKGNFS---SVYKGTLRDGTLVAIRSINVTSCKSEEAEFVKGLYLLTSLRHEN 467
           ++ ++ +G+G +    S Y     +   VAI+ I+    ++     ++ + +L   RHEN
Sbjct: 29  YTNLSYIGEGAYGMVCSAYDNL--NKVRVAIKKISPFEHQTYCQRTLREIKILLRFRHEN 86
Query: 468 IIRLRGFCCS---RGRGECFLIYDFAPKGKLSKYLDQEEGSSNVLDWSTRVSIIIGIAKG 524
           II +     +       + +++ D   +  L K L  +  S++ + +      +  I +G
Sbjct: 87  IIGINDIIRAPTIEQMKDVYIVQDLM-ETDLYKLLKTQHLSNDHICY-----FLYQILRG 140
Query: 525 IGYLHSSEVNKPAIVHRNLSVEKVLIDQQFNPLIADCGLHKLLADDIVFSVLKTS--AAM 582
           + Y+HS+ V     +HR+L    +L++   +  I D GL ++   D   +   T   A  
Sbjct: 141 LKYIHSANV-----LHRDLKPSNLLLNTTXDLKICDFGLARVADPDHDHTGFLTEYVATR 195
Query: 583 GYLAPEYVTTGR-FTERSDIFAFGVIILQILTGSLVLTSSMRL 624
            Y APE +   + +T+  DI++ G I+ ++L+   +      L
Sbjct: 196 WYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNRPIFPGKHYL 238

>pdb|3P4K|A Chain A, The Third Conformation Of P38a Map Kinase Observed In Phosphorylated P38a And In Solution Length = 370

Iteration: 1
 Score = 44.3 bits (103), Expect = 2e-04,   Method: Compositional matrix adjust.
 Identities = 60/238 (25%), Positives = 99/238 (41%), Gaps = 38/238 (15%)
Query: 389 FSREHLNSFRLNLEEVESATQCFSEVNLLGKGNFSSVYKG-TLRDGTLVAIRSINVTSCK 447
           F R+ LN     + EV    Q  + V   G G + SV      + G  VA++ ++     
Sbjct: 18  FYRQELNK---TIWEVPERYQNLAPV---GSGAYGSVCAAFDTKTGHRVAVKKLSRPFQS 71
Query: 448 SEEAEFV-KGLYLLTSLRHENIIRLRG-FCCSRGRGECFLIY--------DFAPKGKLSK 497
              A+   + L LL  ++HEN+I L   F  +R   E   +Y        D     K  K
Sbjct: 72  IIHAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQK 131
Query: 498 YLDQEEGSSNVLDWSTRVSIIIGIAKGIGYLHSSEVNKPAIVHRNLSVEKVLIDQQFNPL 557
             D                +I  I +G+ Y+HS++     I+HR+L    + +++     
Sbjct: 132 LTDDHVQF-----------LIYQILRGLKYIHSAD-----IIHRDLKPSNLAVNEDCELK 175
Query: 558 IADCGLHKLLADDIVFSVLKTSAAMGYLAPEYVTTG-RFTERSDIFAFGVIILQILTG 614
           I D GL +   D++   V    A   Y APE +     + +  DI++ G I+ ++LTG
Sbjct: 176 ILDFGLARHTDDEMTGYV----ATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTG 229

>pdb|2DYL|A Chain A, Crystal Structure Of Human Mitogen-Activated Protein Kinase Kinase 7 Activated Mutant (S287d, T291d) Length = 318

Iteration: 1
 Score = 44.3 bits (103), Expect = 2e-04,   Method: Compositional matrix adjust.
 Identities = 24/106 (22%), Positives = 52/106 (49%), Gaps = 11/106 (10%)
Query: 516 SIIIGIAKGIGYLHSSEVNKPAIVHRNLSVEKVLIDQQFNPLIADCGLHKLLADDIVFSV 575
            + + I K + YL      K  ++HR++    +L+D++    + D G+   L DD     
Sbjct: 128 KMTVAIVKALYYLK----EKHGVIHRDVKPSNILLDERGQIKLCDFGISGRLVDDKAKD- 182
Query: 576 LKTSAAMGYLAPEYV-----TTGRFTERSDIFAFGVIILQILTGSL 616
            +++    Y+APE +     T   +  R+D+++ G+ ++++ TG  
Sbjct: 183 -RSAGCAAYMAPERIDPPDPTKPDYDIRADVWSLGISLVELATGQF 227

>pdb|3SOA|A Chain A, Full-Length Human Camkii Length = 444

Iteration: 1
 Score = 44.3 bits (103), Expect = 2e-04,   Method: Compositional matrix adjust.
 Identities = 56/211 (26%), Positives = 91/211 (43%), Gaps = 20/211 (9%)
Query: 409 QCFSEVNLLGKGNFSSVYKGT-LRDGTLVAIRSINVTSCKSEEAE-FVKGLYLLTSLRHE 466
           Q F E   LGKG FS V +   +  G   A   IN     + + +   +   +   L+H 
Sbjct: 14  QLFEE---LGKGAFSVVRRCVKVLAGQEYAAMIINTKKLSARDHQKLEREARICRLLKHP 70
Query: 467 NIIRLRGFCCSRGRGECFLIYDFAPKGKLSKYLDQEEGSSNVLDWSTRVSIIIGIAKGIG 526
           NI+RL       G    +LI+D    G+L + +   E  S   D S  +  I+       
Sbjct: 71  NIVRLHDSISEEGHH--YLIFDLVTGGELFEDIVAREYYSEA-DASHCIQQILE-----A 122
Query: 527 YLHSSEVNKPAIVHRNLSVEKVLIDQQFNPL---IADCGLHKLLADDIVFSVLKTSAAMG 583
            LH  ++    +VHRNL  E +L+  +       +AD GL  +  +    +    +   G
Sbjct: 123 VLHCHQM---GVVHRNLKPENLLLASKLKGAAVKLADFGL-AIEVEGEQQAWFGFAGTPG 178
Query: 584 YLAPEYVTTGRFTERSDIFAFGVIILQILTG 614
           YL+PE +    + +  D++A GVI+  +L G
Sbjct: 179 YLSPEVLRKDPYGKPVDLWACGVILYILLVG 209

>pdb|3Q4Z|A Chain A, Structure Of Unphosphorylated Pak1 Kinase Domain Length = 306

Iteration: 1
 Score = 44.3 bits (103), Expect = 3e-04,   Method: Compositional matrix adjust.
 Identities = 41/210 (19%), Positives = 94/210 (44%), Gaps = 23/210 (10%)
Query: 411 FSEVNLLGKGNFSSVYKGT-LRDGTLVAIRSINVTSCKSEEAEFVKGLYLLTSLRHENII 469
           ++    +G+G   +VY    +  G  VAIR +N+     +E   +  + ++   ++ NI+
Sbjct: 23  YTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKEL-IINEILVMRENKNPNIV 81
Query: 470 R-LRGFCCSRGRGECFLIYDFAPKGKLSKYLDQEEGSSNVLDWSTRVSIIIGIAKGIGYL 528
             L  +       E +++ ++   G L+  +     +   +D     ++     + + +L
Sbjct: 82  NYLDSYLVG---DELWVVMEYLAGGSLTDVV-----TETCMDEGQIAAVCRECLQALEFL 133
Query: 529 HSSEVNKPAIVHRNLSVEKVLIDQQFNPLIADCGLHKLLADDIVFSVLKTSAAMG---YL 585
           HS++V     +HRN+  + +L+    +  + D G        I     K S  +G   ++
Sbjct: 134 HSNQV-----IHRNIKSDNILLGMDGSVKLTDFGF----CAQITPEQSKRSTMVGTPYWM 184
Query: 586 APEYVTTGRFTERSDIFAFGVIILQILTGS 615
           APE VT   +  + DI++ G++ ++++ G 
Sbjct: 185 APEVVTRKAYGPKVDIWSLGIMAIEMIEGE 214

>pdb|2W4O|A Chain A, Crystal Structure Of Human Camk4 In Complex With 4-Amino( Sulfamoyl-Phenylamino)-Triazole-Carbothioic Acid (2,6- Difluoro-Phenyl)-Amide) Length = 349

Iteration: 1
 Score = 43.9 bits (102), Expect = 3e-04,   Method: Compositional matrix adjust.
 Identities = 56/206 (27%), Positives = 93/206 (45%), Gaps = 28/206 (13%)
Query: 417 LGKGNFSSVY----KGTLRDGTL-VAIRSINVTSCKSEEAEFVKGLYLLTSLRHENIIRL 471
           LG+G  S VY    KGT +   L V  ++++    ++E       + +L  L H NII+L
Sbjct: 61  LGRGATSIVYRCKQKGTQKPYALKVLKKTVDKKIVRTE-------IGVLLRLSHPNIIKL 113
Query: 472 RGFCCSRGRGECFLIYDFAPKGKLSKYLDQEEGSSNVLDWSTRVSIIIGIAKGIGYLHSS 531
           +         E  L+ +    G+L   +  E+G  +  D +  V  I+   + + YLH +
Sbjct: 114 KEIF--ETPTEISLVLELVTGGELFDRI-VEKGYYSERDAADAVKQIL---EAVAYLHEN 167
Query: 532 EVNKPAIVHRNLSVEKVLIDQQF--NPL-IADCGLHKLLADDIVFSVLKTSAAMGYLAPE 588
                 IVHR+L  E +L        PL IAD GL K++   ++   +      GY APE
Sbjct: 168 -----GIVHRDLKPENLLYATPAPDAPLKIADFGLSKIVEHQVLMKTV--CGTPGYCAPE 220
Query: 589 YVTTGRFTERSDIFAFGVIILQILTG 614
            +    +    D+++ G+I   +L G
Sbjct: 221 ILRGCAYGPEVDMWSVGIITYILLCG 246

>pdb|4FIE|A Chain A, Full-Length Human Pak4 Length = 423

Iteration: 1
 Score = 43.9 bits (102), Expect = 3e-04,   Method: Compositional matrix adjust.
 Identities = 38/225 (16%), Positives = 101/225 (44%), Gaps = 21/225 (9%)
Query: 417 LGKGNFSSVYKGTLRD-GTLVAIRSINVTSCKSEEAEFVKGLYLLTSLRHENIIRLRGFC 475
           +G+G+   V   T+R  G LVA++ +++   +  E  F   + ++   +HEN++ +  + 
Sbjct: 159 IGEGSTGIVCIATVRSSGKLVAVKKMDLRKQQRRELLF-NEVVIMRDYQHENVVEM--YN 215
Query: 476 CSRGRGECFLIYDFAPKGKLSKYLDQEEGSSNVLDWSTRVSIIIGIAKGIGYLHSSEVNK 535
                 E +++ +F   G L+  +     +   +      ++ + + + +  LH+     
Sbjct: 216 SYLVGDELWVVMEFLEGGALTDIVTHTRMNEEQI-----AAVCLAVLQALSVLHAQ---- 266
Query: 536 PAIVHRNLSVEKVLIDQQFNPLIADCGLHKLLADDIVFSVLKTSAAMG---YLAPEYVTT 592
             ++HR++  + +L+       ++D G    ++ +    V +    +G   ++APE ++ 
Sbjct: 267 -GVIHRDIKSDSILLTHDGRVKLSDFGFCAQVSKE----VPRRKXLVGTPYWMAPELISR 321
Query: 593 GRFTERSDIFAFGVIILQILTGSLVLTSSMRLAAESATFENFIDR 637
             +    DI++ G+++++++ G     +   L A     +N   R
Sbjct: 322 LPYGPEVDIWSLGIMVIEMVDGEPPYFNEPPLKAMKMIRDNLPPR 366

>pdb|3R63|A Chain A, Structure Of Erk2 (Spe) Mutant (S246e) Length = 358

Iteration: 1
 Score = 43.9 bits (102), Expect = 3e-04,   Method: Compositional matrix adjust.
 Identities = 48/223 (21%), Positives = 101/223 (45%), Gaps = 22/223 (9%)
Query: 411 FSEVNLLGKGNFS---SVYKGTLRDGTLVAIRSINVTSCKSEEAEFVKGLYLLTSLRHEN 467
           ++ ++ +G+G +    S Y     +   VAI+ I+    ++     ++ + +L   RHEN
Sbjct: 23  YTNLSYIGEGAYGMVCSAYDNL--NKVRVAIKKISPFEHQTYCQRTLREIKILLRFRHEN 80
Query: 468 IIRLRGFCCS---RGRGECFLIYDFAPKGKLSKYLDQEEGSSNVLDWSTRVSIIIGIAKG 524
           II +     +       + +++ D   +  L K L  +  S++ + +      +  I +G
Sbjct: 81  IIGINDIIRAPTIEQMKDVYIVQDLM-ETDLYKLLKTQHLSNDHICY-----FLYQILRG 134
Query: 525 IGYLHSSEVNKPAIVHRNLSVEKVLIDQQFNPLIADCGLHKLLADDIVFSVLKTS--AAM 582
           + Y+HS+ V     +HR+L    +L++   +  I D GL ++   D   +   T   A  
Sbjct: 135 LKYIHSANV-----LHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEYVATR 189
Query: 583 GYLAPEYVTTGR-FTERSDIFAFGVIILQILTGSLVLTSSMRL 624
            Y APE +   + +T+  DI++ G I+ ++L+   +      L
Sbjct: 190 WYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNRPIFPGKHYL 232

>pdb|3O71|A Chain A, Crystal Structure Of Erk2DCC PEPTIDE COMPLEX Length = 358

Iteration: 1
 Score = 43.9 bits (102), Expect = 3e-04,   Method: Compositional matrix adjust.
 Identities = 48/223 (21%), Positives = 101/223 (45%), Gaps = 22/223 (9%)
Query: 411 FSEVNLLGKGNFS---SVYKGTLRDGTLVAIRSINVTSCKSEEAEFVKGLYLLTSLRHEN 467
           ++ ++ +G+G +    S Y     +   VAI+ I+    ++     ++ + +L   RHEN
Sbjct: 23  YTNLSYIGEGAYGMVCSAYDNL--NKVRVAIKKISPFEHQTYCQRTLREIKILLRFRHEN 80
Query: 468 IIRLRGFCCS---RGRGECFLIYDFAPKGKLSKYLDQEEGSSNVLDWSTRVSIIIGIAKG 524
           II +     +       + +++ D   +  L K L  +  S++ + +      +  I +G
Sbjct: 81  IIGINDIIRAPTIEQMKDVYIVQDLM-ETDLYKLLKTQHLSNDHICY-----FLYQILRG 134
Query: 525 IGYLHSSEVNKPAIVHRNLSVEKVLIDQQFNPLIADCGLHKLLADDIVFSVLKTS--AAM 582
           + Y+HS+ V     +HR+L    +L++   +  I D GL ++   D   +   T   A  
Sbjct: 135 LKYIHSANV-----LHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEYVATR 189
Query: 583 GYLAPEYVTTGR-FTERSDIFAFGVIILQILTGSLVLTSSMRL 624
            Y APE +   + +T+  DI++ G I+ ++L+   +      L
Sbjct: 190 WYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNRPIFPGKHYL 232

>pdb|3ZUV|A Chain A, Crystal Structure Of A Designed Selected Ankyrin Repeat Protein In Complex With The Phosphorylated Map Kinase Erk2 Length = 364

Iteration: 1
 Score = 43.9 bits (102), Expect = 3e-04,   Method: Compositional matrix adjust.
 Identities = 47/223 (21%), Positives = 102/223 (45%), Gaps = 22/223 (9%)
Query: 411 FSEVNLLGKGNFS---SVYKGTLRDGTLVAIRSINVTSCKSEEAEFVKGLYLLTSLRHEN 467
           ++ ++ +G+G +    S Y     +   VAI+ I+    ++     ++ + +L   RHEN
Sbjct: 29  YTNLSYIGEGAYGMVCSAYDNL--NKVRVAIKKISPFEHQTYCQRTLREIKILLRFRHEN 86
Query: 468 IIRLRGFCCS---RGRGECFLIYDFAPKGKLSKYLDQEEGSSNVLDWSTRVSIIIGIAKG 524
           II +     +       + +++ D   +  L K L  +  S++ + +      +  I +G
Sbjct: 87  IIGINDIIRAPTIEQMKDVYIVQDLM-ETDLYKLLKTQHLSNDHICY-----FLYQILRG 140
Query: 525 IGYLHSSEVNKPAIVHRNLSVEKVLIDQQFNPLIADCGLHKLLADDIVFS--VLKTSAAM 582
           + Y+HS+ V     +HR+L    +L++   +  I D GL ++   D   +  + +  A  
Sbjct: 141 LKYIHSANV-----LHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLXEXVATR 195
Query: 583 GYLAPEYVTTGR-FTERSDIFAFGVIILQILTGSLVLTSSMRL 624
            Y APE +   + +T+  DI++ G I+ ++L+   +      L
Sbjct: 196 WYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNRPIFPGKHYL 238

>pdb|2ERK|A Chain A, Phosphorylated Map Kinase Erk2 Length = 365

Iteration: 1
 Score = 43.9 bits (102), Expect = 3e-04,   Method: Compositional matrix adjust.
 Identities = 47/223 (21%), Positives = 102/223 (45%), Gaps = 22/223 (9%)
Query: 411 FSEVNLLGKGNFS---SVYKGTLRDGTLVAIRSINVTSCKSEEAEFVKGLYLLTSLRHEN 467
           ++ ++ +G+G +    S Y     +   VAI+ I+    ++     ++ + +L   RHEN
Sbjct: 30  YTNLSYIGEGAYGMVCSAYDNL--NKVRVAIKKISPFEHQTYCQRTLREIKILLRFRHEN 87
Query: 468 IIRLRGFCCS---RGRGECFLIYDFAPKGKLSKYLDQEEGSSNVLDWSTRVSIIIGIAKG 524
           II +     +       + +++ D   +  L K L  +  S++ + +      +  I +G
Sbjct: 88  IIGINDIIRAPTIEQMKDVYIVQDLM-ETDLYKLLKTQHLSNDHICY-----FLYQILRG 141
Query: 525 IGYLHSSEVNKPAIVHRNLSVEKVLIDQQFNPLIADCGLHKLLADDIVFS--VLKTSAAM 582
           + Y+HS+ V     +HR+L    +L++   +  I D GL ++   D   +  + +  A  
Sbjct: 142 LKYIHSANV-----LHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLXEXVATR 196
Query: 583 GYLAPEYVTTGR-FTERSDIFAFGVIILQILTGSLVLTSSMRL 624
            Y APE +   + +T+  DI++ G I+ ++L+   +      L
Sbjct: 197 WYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNRPIFPGKHYL 239

>pdb|3ZU7|A Chain A, Crystal Structure Of A Designed Selected Ankyrin Repeat Protein In Complex With The Map Kinase Erk2 Length = 365

Iteration: 1
 Score = 43.9 bits (102), Expect = 3e-04,   Method: Compositional matrix adjust.
 Identities = 48/223 (21%), Positives = 101/223 (45%), Gaps = 22/223 (9%)
Query: 411 FSEVNLLGKGNFS---SVYKGTLRDGTLVAIRSINVTSCKSEEAEFVKGLYLLTSLRHEN 467
           ++ ++ +G+G +    S Y     +   VAI+ I+    ++     ++ + +L   RHEN
Sbjct: 30  YTNLSYIGEGAYGMVCSAYDNL--NKVRVAIKKISPFEHQTYCQRTLREIKILLRFRHEN 87
Query: 468 IIRLRGFCCS---RGRGECFLIYDFAPKGKLSKYLDQEEGSSNVLDWSTRVSIIIGIAKG 524
           II +     +       + +++ D   +  L K L  +  S++ + +      +  I +G
Sbjct: 88  IIGINDIIRAPTIEQMKDVYIVQDLM-ETDLYKLLKTQHLSNDHICY-----FLYQILRG 141
Query: 525 IGYLHSSEVNKPAIVHRNLSVEKVLIDQQFNPLIADCGLHKLLADDIVFSVLKTS--AAM 582
           + Y+HS+ V     +HR+L    +L++   +  I D GL ++   D   +   T   A  
Sbjct: 142 LKYIHSANV-----LHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEYVATR 196
Query: 583 GYLAPEYVTTGR-FTERSDIFAFGVIILQILTGSLVLTSSMRL 624
            Y APE +   + +T+  DI++ G I+ ++L+   +      L
Sbjct: 197 WYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNRPIFPGKHYL 239

>pdb|2Z7L|A Chain A, Unphosphorylated Mitogen Activated Protein Kinase Erk2 In Complex With (4-{[5-Carbamoyl-4-(3-Methylanilino)pyrimidin 2-Yl]amino}phenyl)acetic Acid Length = 366

Iteration: 1
 Score = 43.9 bits (102), Expect = 3e-04,   Method: Compositional matrix adjust.
 Identities = 48/223 (21%), Positives = 101/223 (45%), Gaps = 22/223 (9%)
Query: 411 FSEVNLLGKGNFS---SVYKGTLRDGTLVAIRSINVTSCKSEEAEFVKGLYLLTSLRHEN 467
           ++ ++ +G+G +    S Y     +   VAI+ I+    ++     ++ + +L   RHEN
Sbjct: 31  YTNLSYIGEGAYGMVCSAYDNL--NKVRVAIKKISPFEHQTYCQRTLREIKILLRFRHEN 88
Query: 468 IIRLRGFCCS---RGRGECFLIYDFAPKGKLSKYLDQEEGSSNVLDWSTRVSIIIGIAKG 524
           II +     +       + +++ D   +  L K L  +  S++ + +      +  I +G
Sbjct: 89  IIGINDIIRAPTIEQMKDVYIVQDLM-ETDLYKLLKTQHLSNDHICY-----FLYQILRG 142
Query: 525 IGYLHSSEVNKPAIVHRNLSVEKVLIDQQFNPLIADCGLHKLLADDIVFSVLKTS--AAM 582
           + Y+HS+ V     +HR+L    +L++   +  I D GL ++   D   +   T   A  
Sbjct: 143 LKYIHSANV-----LHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEYVATR 197
Query: 583 GYLAPEYVTTGR-FTERSDIFAFGVIILQILTGSLVLTSSMRL 624
            Y APE +   + +T+  DI++ G I+ ++L+   +      L
Sbjct: 198 WYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNRPIFPGKHYL 240

>pdb|3C9W|A Chain A, Crystal Structure Of Erk-2 With Hypothemycin Covalently Bound Length = 357

Iteration: 1
 Score = 43.9 bits (102), Expect = 3e-04,   Method: Compositional matrix adjust.
 Identities = 48/223 (21%), Positives = 101/223 (45%), Gaps = 22/223 (9%)
Query: 411 FSEVNLLGKGNFS---SVYKGTLRDGTLVAIRSINVTSCKSEEAEFVKGLYLLTSLRHEN 467
           ++ ++ +G+G +    S Y     +   VAI+ I+    ++     ++ + +L   RHEN
Sbjct: 22  YTNLSYIGEGAYGMVCSAYDNL--NKVRVAIKKISPFEHQTYCQRTLREIKILLRFRHEN 79
Query: 468 IIRLRGFCCS---RGRGECFLIYDFAPKGKLSKYLDQEEGSSNVLDWSTRVSIIIGIAKG 524
           II +     +       + +++ D   +  L K L  +  S++ + +      +  I +G
Sbjct: 80  IIGINDIIRAPTIEQMKDVYIVQDLM-ETDLYKLLKTQHLSNDHICY-----FLYQILRG 133
Query: 525 IGYLHSSEVNKPAIVHRNLSVEKVLIDQQFNPLIADCGLHKLLADDIVFSVLKTS--AAM 582
           + Y+HS+ V     +HR+L    +L++   +  I D GL ++   D   +   T   A  
Sbjct: 134 LKYIHSANV-----LHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEYVATR 188
Query: 583 GYLAPEYVTTGR-FTERSDIFAFGVIILQILTGSLVLTSSMRL 624
            Y APE +   + +T+  DI++ G I+ ++L+   +      L
Sbjct: 189 WYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNRPIFPGKHYL 231

>pdb|2FYS|B Chain B, Crystal Structure Of Erk2 Complex With Kim Peptide Derived From Mkp3 Length = 364

Iteration: 1
 Score = 43.9 bits (102), Expect = 3e-04,   Method: Compositional matrix adjust.
 Identities = 48/223 (21%), Positives = 101/223 (45%), Gaps = 22/223 (9%)
Query: 411 FSEVNLLGKGNFS---SVYKGTLRDGTLVAIRSINVTSCKSEEAEFVKGLYLLTSLRHEN 467
           ++ ++ +G+G +    S Y     +   VAI+ I+    ++     ++ + +L   RHEN
Sbjct: 29  YTNLSYIGEGAYGMVCSAYDNL--NKVRVAIKKISPFEHQTYCQRTLREIKILLRFRHEN 86
Query: 468 IIRLRGFCCS---RGRGECFLIYDFAPKGKLSKYLDQEEGSSNVLDWSTRVSIIIGIAKG 524
           II +     +       + +++ D   +  L K L  +  S++ + +      +  I +G
Sbjct: 87  IIGINDIIRAPTIEQMKDVYIVQDLM-ETDLYKLLKTQHLSNDHICY-----FLYQILRG 140
Query: 525 IGYLHSSEVNKPAIVHRNLSVEKVLIDQQFNPLIADCGLHKLLADDIVFSVLKTS--AAM 582
           + Y+HS+ V     +HR+L    +L++   +  I D GL ++   D   +   T   A  
Sbjct: 141 LKYIHSANV-----LHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEYVATR 195
Query: 583 GYLAPEYVTTGR-FTERSDIFAFGVIILQILTGSLVLTSSMRL 624
            Y APE +   + +T+  DI++ G I+ ++L+   +      L
Sbjct: 196 WYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNRPIFPGKHYL 238

>pdb|4FIF|A Chain A, Catalytic Domain Of Human Pak4 With Rpkplvdp Peptide Length = 346

Iteration: 1
 Score = 43.5 bits (101), Expect = 4e-04,   Method: Compositional matrix adjust.
 Identities = 38/225 (16%), Positives = 101/225 (44%), Gaps = 21/225 (9%)
Query: 417 LGKGNFSSVYKGTLRD-GTLVAIRSINVTSCKSEEAEFVKGLYLLTSLRHENIIRLRGFC 475
           +G+G+   V   T+R  G LVA++ +++   +  E  F   + ++   +HEN++ +  + 
Sbjct: 82  IGEGSTGIVCIATVRSSGKLVAVKKMDLRKQQRRELLF-NEVVIMRDYQHENVVEM--YN 138
Query: 476 CSRGRGECFLIYDFAPKGKLSKYLDQEEGSSNVLDWSTRVSIIIGIAKGIGYLHSSEVNK 535
                 E +++ +F   G L+  +     +   +      ++ + + + +  LH+     
Sbjct: 139 SYLVGDELWVVMEFLEGGALTDIVTHTRMNEEQI-----AAVCLAVLQALSVLHAQ---- 189
Query: 536 PAIVHRNLSVEKVLIDQQFNPLIADCGLHKLLADDIVFSVLKTSAAMG---YLAPEYVTT 592
             ++HR++  + +L+       ++D G    ++ +    V +    +G   ++APE ++ 
Sbjct: 190 -GVIHRDIKSDSILLTHDGRVKLSDFGFCAQVSKE----VPRRKXLVGTPYWMAPELISR 244
Query: 593 GRFTERSDIFAFGVIILQILTGSLVLTSSMRLAAESATFENFIDR 637
             +    DI++ G+++++++ G     +   L A     +N   R
Sbjct: 245 LPYGPEVDIWSLGIMVIEMVDGEPPYFNEPPLKAMKMIRDNLPPR 289

>pdb|2WEL|A Chain A, Crystal Structure Of Su6656-Bound CalciumCALMODULIN- Dependent Protein Kinase Ii Delta In Complex With Calmodulin Length = 327

Iteration: 1
 Score = 43.5 bits (101), Expect = 4e-04,   Method: Compositional matrix adjust.
 Identities = 54/211 (25%), Positives = 91/211 (43%), Gaps = 20/211 (9%)
Query: 409 QCFSEVNLLGKGNFSSVYK-GTLRDGTLVAIRSINVTSCKSEEAE-FVKGLYLLTSLRHE 466
           Q F E   LGKG FS V +   +  G   A + IN     + + +   +   +   L+H 
Sbjct: 7   QLFEE---LGKGAFSVVRRCMKIPTGQEYAAKIINTKKLSARDHQKLEREARICRLLKHP 63
Query: 467 NIIRLRGFCCSRGRGECFLIYDFAPKGKLSKYLDQEEGSSNVLDWSTRVSIIIGIAKGIG 526
           NI+RL       G    +L++D    G+L + +   E  S     +     I  I + + 
Sbjct: 64  NIVRLHDSISEEGFH--YLVFDLVTGGELFEDIVAREYYSE----ADASHCIQQILESVN 117
Query: 527 YLHSSEVNKPAIVHRNLSVEKVLIDQQFNPL---IADCGLHKLLADDIVFSVLKTSAAMG 583
           + H +      IVHR+L  E +L+  +       +AD GL   +  D   +    +   G
Sbjct: 118 HCHLN-----GIVHRDLKPENLLLASKSKGAAVKLADFGLAIEVQGDQQ-AWFGFAGTPG 171
Query: 584 YLAPEYVTTGRFTERSDIFAFGVIILQILTG 614
           YL+PE +    + +  D++A GVI+  +L G
Sbjct: 172 YLSPEVLRKDPYGKPVDMWACGVILYILLVG 202

>pdb|2X4Z|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 4 In Complex With Pf-03758309 Length = 296

Iteration: 1
 Score = 43.5 bits (101), Expect = 4e-04,   Method: Compositional matrix adjust.
 Identities = 48/258 (18%), Positives = 114/258 (44%), Gaps = 28/258 (10%)
Query: 417 LGKGNFSSVYKGTLRD-GTLVAIRSINVTSCKSEEAEFVKGLYLLTSLRHENIIRLRGFC 475
           +G+G+   V   T+R  G LVA++ +++   +  E  F   + ++   +HEN++ +  + 
Sbjct: 32  IGEGSTGIVCIATVRSSGKLVAVKKMDLRKQQRRELLF-NEVVIMRDYQHENVVEM--YN 88
Query: 476 CSRGRGECFLIYDFAPKGKLSKYLDQEEGSSNVLDWSTRVSIIIGIAKGIGYLHSSEVNK 535
                 E +++ +F   G L+  +     +   +      ++ + + + +  LH+     
Sbjct: 89  SYLVGDELWVVMEFLEGGALTDIVTHTRMNEEQI-----AAVCLAVLQALSVLHAQ---- 139
Query: 536 PAIVHRNLSVEKVLIDQQFNPLIADCGLHKLLADDIVFSVLKTSAAMG---YLAPEYVTT 592
             ++HR++  + +L+       ++D G    ++ +    V +    +G   ++APE ++ 
Sbjct: 140 -GVIHRDIKSDSILLTHDGRVKLSDFGFCAQVSKE----VPRRKXLVGTPYWMAPELISR 194
Query: 593 GRFTERSDIFAFGVIILQILTGSLVLTSSMRLAAESATFENFIDR--NLKGKFSESEAAK 650
             +    DI++ G+++++++ G     +   L A     +N   R  NL  K S S    
Sbjct: 195 LPYGPEVDIWSLGIMVIEMVDGEPPYFNEPPLKAMKMIRDNLPPRLKNLH-KVSPSLKGF 253
Query: 651 LGKMALVCTHEDPENRPT 668
           L ++ +     DP  R T
Sbjct: 254 LDRLLV----RDPAQRAT 267

>pdb|2VN9|A Chain A, Crystal Structure Of Human Calcium Calmodulin Dependent Protein Kinase Ii Delta Isoform 1, Camkd Length = 301

Iteration: 1
 Score = 43.5 bits (101), Expect = 4e-04,   Method: Compositional matrix adjust.
 Identities = 54/211 (25%), Positives = 91/211 (43%), Gaps = 20/211 (9%)
Query: 409 QCFSEVNLLGKGNFSSVYK-GTLRDGTLVAIRSINVTSCKSEEAE-FVKGLYLLTSLRHE 466
           Q F E   LGKG FS V +   +  G   A + IN     + + +   +   +   L+H 
Sbjct: 7   QLFEE---LGKGAFSVVRRCMKIPTGQEYAAKIINTKKLSARDHQKLEREARICRLLKHP 63
Query: 467 NIIRLRGFCCSRGRGECFLIYDFAPKGKLSKYLDQEEGSSNVLDWSTRVSIIIGIAKGIG 526
           NI+RL       G    +L++D    G+L + +   E  S     +     I  I + + 
Sbjct: 64  NIVRLHDSISEEGFH--YLVFDLVTGGELFEDIVAREYYSE----ADASHCIQQILESVN 117
Query: 527 YLHSSEVNKPAIVHRNLSVEKVLIDQQFNPL---IADCGLHKLLADDIVFSVLKTSAAMG 583
           + H +      IVHR+L  E +L+  +       +AD GL   +  D   +    +   G
Sbjct: 118 HCHLN-----GIVHRDLKPENLLLASKSKGAAVKLADFGLAIEVQGDQQ-AWFGFAGTPG 171
Query: 584 YLAPEYVTTGRFTERSDIFAFGVIILQILTG 614
           YL+PE +    + +  D++A GVI+  +L G
Sbjct: 172 YLSPEVLRKDPYGKPVDMWACGVILYILLVG 202

>pdb|4EXU|A Chain A, Mapk13, Inactive Form Length = 371

Iteration: 1
 Score = 43.5 bits (101), Expect = 4e-04,   Method: Compositional matrix adjust.
 Identities = 55/242 (22%), Positives = 100/242 (41%), Gaps = 35/242 (14%)
Query: 384 LNGTGFSREHLNSFRLNLEEVESATQCFSEVNLLGKGNFSSVYKGT-LRDGTLVAIRSIN 442
           +   GF ++ +N     L       + +     +G G + SV      R G  VAI+ + 
Sbjct: 23  IRKKGFYKQDVNKTAWEL------PKTYVSPTHVGSGAYGSVCSAIDKRSGEKVAIKKL- 75
Query: 443 VTSCKSEEAEFVKGLY----LLTSLRHENIIRLRGFCCS----RGRGECFLIYDFAPKGK 494
             S   +   F K  Y    LL  ++HEN+I L          R   + +L+  F  +  
Sbjct: 76  --SRPFQSEIFAKRAYRELLLLKHMQHENVIGLLDVFTPASSLRNFYDFYLVMPFM-QTD 132
Query: 495 LSKYLDQEEGSSNVLDWSTRVSIIIGIAKGIGYLHSSEVNKPAIVHRNLSVEKVLIDQQF 554
           L K +  E     +        ++  + KG+ Y+HS+      +VHR+L    + +++  
Sbjct: 133 LQKIMGMEFSEEKI------QYLVYQMLKGLKYIHSA-----GVVHRDLKPGNLAVNEDC 181
Query: 555 NPLIADCGLHKLLADDIVFSVLKTSAAMGYLAPEYVTTG-RFTERSDIFAFGVIILQILT 613
              I D GL +    ++   V+       Y APE + +   + +  DI++ G I+ ++LT
Sbjct: 182 ELKILDFGLARHADAEMTGYVV----TRWYRAPEVILSWMHYNQTVDIWSVGCIMAEMLT 237
Query: 614 GS 615
           G 
Sbjct: 238 GK 239

>pdb|2CDZ|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 4 In Complex With Cgp74514a Length = 303

Iteration: 1
 Score = 43.5 bits (101), Expect = 4e-04,   Method: Compositional matrix adjust.
 Identities = 48/258 (18%), Positives = 114/258 (44%), Gaps = 28/258 (10%)
Query: 417 LGKGNFSSVYKGTLRD-GTLVAIRSINVTSCKSEEAEFVKGLYLLTSLRHENIIRLRGFC 475
           +G+G+   V   T+R  G LVA++ +++   +  E  F   + ++   +HEN++ +  + 
Sbjct: 39  IGEGSTGIVCIATVRSSGKLVAVKKMDLRKQQRRELLF-NEVVIMRDYQHENVVEM--YN 95
Query: 476 CSRGRGECFLIYDFAPKGKLSKYLDQEEGSSNVLDWSTRVSIIIGIAKGIGYLHSSEVNK 535
                 E +++ +F   G L+  +     +   +      ++ + + + +  LH+     
Sbjct: 96  SYLVGDELWVVMEFLEGGALTDIVTHTRMNEEQI-----AAVCLAVLQALSVLHAQ---- 146
Query: 536 PAIVHRNLSVEKVLIDQQFNPLIADCGLHKLLADDIVFSVLKTSAAMG---YLAPEYVTT 592
             ++HR++  + +L+       ++D G    ++ +    V +    +G   ++APE ++ 
Sbjct: 147 -GVIHRDIKSDSILLTHDGRVKLSDFGFCAQVSKE----VPRRKXLVGTPYWMAPELISR 201
Query: 593 GRFTERSDIFAFGVIILQILTGSLVLTSSMRLAAESATFENFIDR--NLKGKFSESEAAK 650
             +    DI++ G+++++++ G     +   L A     +N   R  NL  K S S    
Sbjct: 202 LPYGPEVDIWSLGIMVIEMVDGEPPYFNEPPLKAMKMIRDNLPPRLKNLH-KVSPSLKGF 260
Query: 651 LGKMALVCTHEDPENRPT 668
           L ++ +     DP  R T
Sbjct: 261 LDRLLV----RDPAQRAT 274

>pdb|2Q0N|A Chain A, Structure Of Human P21 Activating Kinase 4 (Pak4) In Complex With A Consensus Peptide Length = 301

Iteration: 1
 Score = 43.5 bits (101), Expect = 4e-04,   Method: Compositional matrix adjust.
 Identities = 48/258 (18%), Positives = 114/258 (44%), Gaps = 28/258 (10%)
Query: 417 LGKGNFSSVYKGTLRD-GTLVAIRSINVTSCKSEEAEFVKGLYLLTSLRHENIIRLRGFC 475
           +G+G+   V   T+R  G LVA++ +++   +  E  F   + ++   +HEN++ +  + 
Sbjct: 37  IGEGSTGIVCIATVRSSGKLVAVKKMDLRKQQRRELLF-NEVVIMRDYQHENVVEM--YN 93
Query: 476 CSRGRGECFLIYDFAPKGKLSKYLDQEEGSSNVLDWSTRVSIIIGIAKGIGYLHSSEVNK 535
                 E +++ +F   G L+  +     +   +      ++ + + + +  LH+     
Sbjct: 94  SYLVGDELWVVMEFLEGGALTDIVTHTRMNEEQI-----AAVCLAVLQALSVLHAQ---- 144
Query: 536 PAIVHRNLSVEKVLIDQQFNPLIADCGLHKLLADDIVFSVLKTSAAMG---YLAPEYVTT 592
             ++HR++  + +L+       ++D G    ++ +    V +    +G   ++APE ++ 
Sbjct: 145 -GVIHRDIKSDSILLTHDGRVKLSDFGFCAQVSKE----VPRRKXLVGTPYWMAPELISR 199
Query: 593 GRFTERSDIFAFGVIILQILTGSLVLTSSMRLAAESATFENFIDR--NLKGKFSESEAAK 650
             +    DI++ G+++++++ G     +   L A     +N   R  NL  K S S    
Sbjct: 200 LPYGPEVDIWSLGIMVIEMVDGEPPYFNEPPLKAMKMIRDNLPPRLKNLH-KVSPSLKGF 258
Query: 651 LGKMALVCTHEDPENRPT 668
           L ++ +     DP  R T
Sbjct: 259 LDRLLV----RDPAQRAT 272

>pdb|2BVA|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 4 Length = 292

Iteration: 1
 Score = 43.5 bits (101), Expect = 4e-04,   Method: Compositional matrix adjust.
 Identities = 48/258 (18%), Positives = 114/258 (44%), Gaps = 28/258 (10%)
Query: 417 LGKGNFSSVYKGTLRD-GTLVAIRSINVTSCKSEEAEFVKGLYLLTSLRHENIIRLRGFC 475
           +G+G+   V   T+R  G LVA++ +++   +  E  F   + ++   +HEN++ +  + 
Sbjct: 28  IGEGSTGIVCIATVRSSGKLVAVKKMDLRKQQRRELLF-NEVVIMRDYQHENVVEM--YN 84
Query: 476 CSRGRGECFLIYDFAPKGKLSKYLDQEEGSSNVLDWSTRVSIIIGIAKGIGYLHSSEVNK 535
                 E +++ +F   G L+  +     +   +      ++ + + + +  LH+     
Sbjct: 85  SYLVGDELWVVMEFLEGGALTDIVTHTRMNEEQI-----AAVCLAVLQALSVLHAQ---- 135
Query: 536 PAIVHRNLSVEKVLIDQQFNPLIADCGLHKLLADDIVFSVLKTSAAMG---YLAPEYVTT 592
             ++HR++  + +L+       ++D G    ++ +    V +    +G   ++APE ++ 
Sbjct: 136 -GVIHRDIKSDSILLTHDGRVKLSDFGFCAQVSKE----VPRRKXLVGTPYWMAPELISR 190
Query: 593 GRFTERSDIFAFGVIILQILTGSLVLTSSMRLAAESATFENFIDR--NLKGKFSESEAAK 650
             +    DI++ G+++++++ G     +   L A     +N   R  NL  K S S    
Sbjct: 191 LPYGPEVDIWSLGIMVIEMVDGEPPYFNEPPLKAMKMIRDNLPPRLKNLH-KVSPSLKGF 249
Query: 651 LGKMALVCTHEDPENRPT 668
           L ++ +     DP  R T
Sbjct: 250 LDRLLV----RDPAQRAT 263

>pdb|3FME|A Chain A, Crystal Structure Of Human Mitogen-Activated Protein Kinase Kinase 6 (Mek6) Activated Mutant (S207d, T211d) Length = 290

Iteration: 1
 Score = 43.1 bits (100), Expect = 5e-04,   Method: Compositional matrix adjust.
 Identities = 44/201 (21%), Positives = 89/201 (44%), Gaps = 15/201 (7%)
Query: 417 LGKGNFSSVYKGT-LRDGTLVAIRSINVTSCKSEEAEFVKGLYLLTSLRHENIIRLRGFC 475
           LG+G +  V K   +  G ++A++ I  T    E+   +  L +  S+R  +      F 
Sbjct: 15  LGRGAYGVVEKMRHVPSGQIMAVKRIRATVNSQEQKRLLMDLDI--SMRTVDCPFTVTFY 72
Query: 476 CSRGR-GECFLIYDFAPKGKLSKYLDQEEGSSNVLDWSTRVSIIIGIAKGIGYLHSSEVN 534
            +  R G+ ++  +      L K+  Q       +       I + I K + +LHS    
Sbjct: 73  GALFREGDVWICMELM-DTSLDKFYKQVIDKGQTIPEDILGKIAVSIVKALEHLHS---- 127
Query: 535 KPAIVHRNLSVEKVLIDQQFNPLIADCGLHKLLADDIVFSVLKTSAAMGYLAPEYV---- 590
           K +++HR++    VLI+      + D G+   L DD+   +   +    Y+APE +    
Sbjct: 128 KLSVIHRDVKPSNVLINALGQVKMCDFGISGYLVDDVAKDI--DAGCKPYMAPERINPEL 185
Query: 591 TTGRFTERSDIFAFGVIILQI 611
               ++ +SDI++ G+ ++++
Sbjct: 186 NQKGYSVKSDIWSLGITMIEL 206

>pdb|2GPH|A Chain A, Docking Motif Interactions In The Map Kinase Erk2 Length = 364

Iteration: 1
 Score = 43.1 bits (100), Expect = 5e-04,   Method: Compositional matrix adjust.
 Identities = 47/221 (21%), Positives = 100/221 (45%), Gaps = 18/221 (8%)
Query: 411 FSEVNLLGKGNFSSVYKGTLR-DGTLVAIRSINVTSCKSEEAEFVKGLYLLTSLRHENII 469
           ++ ++ +G+G +  V       +   VAI+ I+    ++     ++ + +L   RHENII
Sbjct: 29  YTNLSYIGEGAYGMVCSAYDNLNKVRVAIKKISPFEHQTYCQRTLREIKILLRFRHENII 88
Query: 470 RLRGFCCS---RGRGECFLIYDFAPKGKLSKYLDQEEGSSNVLDWSTRVSIIIGIAKGIG 526
            +     +       + +++ D   +  L K L  +  S++ + +      +  I +G+ 
Sbjct: 89  GINDIIRAPTIEQMKDVYIVQDLM-ETDLYKLLKCQHLSNDHICY-----FLYQILRGLK 142
Query: 527 YLHSSEVNKPAIVHRNLSVEKVLIDQQFNPLIADCGLHKLLADDIVFSVLKTS--AAMGY 584
           Y+HS+ V     +HR+L    +L++   +  I D GL ++   D   +   T   A   Y
Sbjct: 143 YIHSANV-----LHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEYVATRWY 197
Query: 585 LAPEYVTTGR-FTERSDIFAFGVIILQILTGSLVLTSSMRL 624
            APE +   + +T+  DI++ G I+ ++L+   +      L
Sbjct: 198 RAPEIMLNSKGYTKSIDIWSVGCILAEMLSNRPIFPGKHYL 238

>pdb|2PUU|A Chain A, Crystal Structure Of P38 Complex With 1-(5-Tert-Butyl-2-P- Tolyl-2h-Pyrazol-3-Yl)-3-[4-(6-Morpholin-4-Ylmethyl- Pyridin-3-Yl)naphthalen-1-Yl]urea Length = 348

Iteration: 1
 Score = 42.7 bits (99), Expect = 7e-04,   Method: Compositional matrix adjust.
 Identities = 60/238 (25%), Positives = 99/238 (41%), Gaps = 38/238 (15%)
Query: 389 FSREHLNSFRLNLEEVESATQCFSEVNLLGKGNFSSVYKG-TLRDGTLVAIRSINVTSCK 447
           F R+ L      + EV    Q  S V   G G + SV      + G  VA++ ++     
Sbjct: 4   FYRQELAK---TIWEVPERYQNLSPV---GSGAYGSVCAAFDTKTGHRVAVKKLSRPFQS 57
Query: 448 SEEAEFV-KGLYLLTSLRHENIIRLRG-FCCSRGRGECFLIY--------DFAPKGKLSK 497
              A+   + L LL  ++HEN+I L   F  +R   E   +Y        D     K +K
Sbjct: 58  IIHAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCAK 117
Query: 498 YLDQEEGSSNVLDWSTRVSIIIGIAKGIGYLHSSEVNKPAIVHRNLSVEKVLIDQQFNPL 557
             D                +I  I +G+ Y+HS++     I+HR+L    + +++     
Sbjct: 118 LTDDHVQF-----------LIYQILRGLKYIHSAD-----IIHRDLKPSNLAVNEDCELK 161
Query: 558 IADCGLHKLLADDIVFSVLKTSAAMGYLAPEYVTTG-RFTERSDIFAFGVIILQILTG 614
           I D GL +   D++   V    A   Y APE +     + +  DI++ G I+ ++LTG
Sbjct: 162 ILDFGLARHTDDEMTGYV----ATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTG 215

>pdb|1F3M|C Chain C, Crystal Structure Of Human SerineTHREONINE KINASE PAK1 Length = 297

Iteration: 1
 Score = 42.7 bits (99), Expect = 7e-04,   Method: Compositional matrix adjust.
 Identities = 40/210 (19%), Positives = 94/210 (44%), Gaps = 23/210 (10%)
Query: 411 FSEVNLLGKGNFSSVYKGT-LRDGTLVAIRSINVTSCKSEEAEFVKGLYLLTSLRHENII 469
           ++    +G+G   +VY    +  G  VAIR +N+     +E   +  + ++   ++ NI+
Sbjct: 22  YTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKEL-IINEILVMRENKNPNIV 80
Query: 470 R-LRGFCCSRGRGECFLIYDFAPKGKLSKYLDQEEGSSNVLDWSTRVSIIIGIAKGIGYL 528
             L  +       E +++ ++   G L+  +     +   +D     ++     + + +L
Sbjct: 81  NYLDSYLVG---DELWVVMEYLAGGSLTDVV-----TETCMDEGQIAAVCRECLQALEFL 132
Query: 529 HSSEVNKPAIVHRNLSVEKVLIDQQFNPLIADCGLHKLLADDIVFSVLKTSAAMG---YL 585
           HS++V     +HR++  + +L+    +  + D G        I     K S  +G   ++
Sbjct: 133 HSNQV-----IHRDIKSDNILLGMDGSVKLTDFGF----CAQITPEQSKRSTMVGTPYWM 183
Query: 586 APEYVTTGRFTERSDIFAFGVIILQILTGS 615
           APE VT   +  + DI++ G++ ++++ G 
Sbjct: 184 APEVVTRKAYGPKVDIWSLGIMAIEMIEGE 213

>pdb|3FXZ|A Chain A, Crystal Structure Of Pak1 Kinase Domain With Ruthenium Complex Lambda-Fl172 Length = 297

Iteration: 1
 Score = 42.7 bits (99), Expect = 7e-04,   Method: Compositional matrix adjust.
 Identities = 40/210 (19%), Positives = 94/210 (44%), Gaps = 23/210 (10%)
Query: 411 FSEVNLLGKGNFSSVYKGT-LRDGTLVAIRSINVTSCKSEEAEFVKGLYLLTSLRHENII 469
           ++    +G+G   +VY    +  G  VAIR +N+     +E   +  + ++   ++ NI+
Sbjct: 22  YTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKEL-IINEILVMRENKNPNIV 80
Query: 470 R-LRGFCCSRGRGECFLIYDFAPKGKLSKYLDQEEGSSNVLDWSTRVSIIIGIAKGIGYL 528
             L  +       E +++ ++   G L+  +     +   +D     ++     + + +L
Sbjct: 81  NYLDSYLVG---DELWVVMEYLAGGSLTDVV-----TETCMDEGQIAAVCRECLQALEFL 132
Query: 529 HSSEVNKPAIVHRNLSVEKVLIDQQFNPLIADCGLHKLLADDIVFSVLKTSAAMG---YL 585
           HS++V     +HR++  + +L+    +  + D G        I     K S  +G   ++
Sbjct: 133 HSNQV-----IHRDIKSDNILLGMDGSVKLTDFGF----CAQITPEQSKRSXMVGTPYWM 183
Query: 586 APEYVTTGRFTERSDIFAFGVIILQILTGS 615
           APE VT   +  + DI++ G++ ++++ G 
Sbjct: 184 APEVVTRKAYGPKVDIWSLGIMAIEMIEGE 213

>pdb|1YHV|A Chain A, Crystal Structure Of Pak1 Kinase Domain With Two Point Mutations (K299r, T423e) Length = 297

Iteration: 1
 Score = 42.4 bits (98), Expect = 8e-04,   Method: Compositional matrix adjust.
 Identities = 40/210 (19%), Positives = 94/210 (44%), Gaps = 23/210 (10%)
Query: 411 FSEVNLLGKGNFSSVYKGT-LRDGTLVAIRSINVTSCKSEEAEFVKGLYLLTSLRHENII 469
           ++    +G+G   +VY    +  G  VAIR +N+     +E   +  + ++   ++ NI+
Sbjct: 22  YTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKEL-IINEILVMRENKNPNIV 80
Query: 470 R-LRGFCCSRGRGECFLIYDFAPKGKLSKYLDQEEGSSNVLDWSTRVSIIIGIAKGIGYL 528
             L  +       E +++ ++   G L+  +     +   +D     ++     + + +L
Sbjct: 81  NYLDSYLVG---DELWVVMEYLAGGSLTDVV-----TETCMDEGQIAAVCRECLQALEFL 132
Query: 529 HSSEVNKPAIVHRNLSVEKVLIDQQFNPLIADCGLHKLLADDIVFSVLKTSAAMG---YL 585
           HS++V     +HR++  + +L+    +  + D G        I     K S  +G   ++
Sbjct: 133 HSNQV-----IHRDIKSDNILLGMDGSVKLTDFGF----CAQITPEQSKRSEMVGTPYWM 183
Query: 586 APEYVTTGRFTERSDIFAFGVIILQILTGS 615
           APE VT   +  + DI++ G++ ++++ G 
Sbjct: 184 APEVVTRKAYGPKVDIWSLGIMAIEMIEGE 213

>pdb|3OHT|A Chain A, Crystal Structure Of Salmo Salar P38alpha Length = 389

Iteration: 1
 Score = 42.4 bits (98), Expect = 8e-04,   Method: Compositional matrix adjust.
 Identities = 54/231 (23%), Positives = 100/231 (43%), Gaps = 24/231 (10%)
Query: 389 FSREHLNSFRLNLEEVESATQCFSEVNLLGKGNFSSVYKGTLRDGTLVAIRSINVTSCKS 448
           F R+ LN     + EV    Q  S V     G+  S Y   ++ G  +A++ ++      
Sbjct: 37  FYRQELNK---TIWEVPERYQTLSPVGSGAYGSVCSSYD--VKSGLKIAVKKLSRPFQSI 91
Query: 449 EEAEFV-KGLYLLTSLRHENIIRLRGFCCSRGRGECF---LIYDFAPKGKLSKYLDQEEG 504
             A+   + L LL  ++HEN+I L          E F    +        L+  +  ++ 
Sbjct: 92  IHAKRTYRELRLLKHMKHENVIGLLDVFTPATSLEEFNDVYLVTHLMGADLNNIVKCQKL 151
Query: 505 SSNVLDWSTRVSIIIGIAKGIGYLHSSEVNKPAIVHRNLSVEKVLIDQQFNPLIADCGLH 564
           + + + +     +I  I +G+ Y+HS++     I+HR+L    + +++     I D GL 
Sbjct: 152 TDDHVQF-----LIYQILRGLKYIHSAD-----IIHRDLKPSNLAVNEDCELKILDFGLA 201
Query: 565 KLLADDIVFSVLKTSAAMGYLAPEYVTTG-RFTERSDIFAFGVIILQILTG 614
           +   D++   V    A   Y APE +     +    DI++ G I+ ++LTG
Sbjct: 202 RHTDDEMTGYV----ATRWYRAPEIMLNWMHYNMTVDIWSVGCIMAELLTG 248

>pdb|3Q52|A Chain A, Structure Of Phosphorylated Pak1 Kinase Domain Length = 306

Iteration: 1
 Score = 42.4 bits (98), Expect = 8e-04,   Method: Compositional matrix adjust.
 Identities = 40/210 (19%), Positives = 94/210 (44%), Gaps = 23/210 (10%)
Query: 411 FSEVNLLGKGNFSSVYKGT-LRDGTLVAIRSINVTSCKSEEAEFVKGLYLLTSLRHENII 469
           ++    +G+G   +VY    +  G  VAIR +N+     +E   +  + ++   ++ NI+
Sbjct: 23  YTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKEL-IINEILVMRENKNPNIV 81
Query: 470 R-LRGFCCSRGRGECFLIYDFAPKGKLSKYLDQEEGSSNVLDWSTRVSIIIGIAKGIGYL 528
             L  +       E +++ ++   G L+  +     +   +D     ++     + + +L
Sbjct: 82  NYLDSYLVG---DELWVVMEYLAGGSLTDVV-----TETCMDEGQIAAVCRECLQALEFL 133
Query: 529 HSSEVNKPAIVHRNLSVEKVLIDQQFNPLIADCGLHKLLADDIVFSVLKTSAAMG---YL 585
           HS++V     +HR++  + +L+    +  + D G        I     K S  +G   ++
Sbjct: 134 HSNQV-----IHRDIKSDNILLGMDGSVKLTDFGF----CAQITPEQSKRSXMVGTPYWM 184
Query: 586 APEYVTTGRFTERSDIFAFGVIILQILTGS 615
           APE VT   +  + DI++ G++ ++++ G 
Sbjct: 185 APEVVTRKAYGPKVDIWSLGIMAIEMIEGE 214

>pdb|4AGU|A Chain A, Crystal Structure Of The Human Cdkl1 Kinase Domain Length = 311

Iteration: 1
 Score = 42.4 bits (98), Expect = 8e-04,   Method: Compositional matrix adjust.
 Identities = 50/217 (23%), Positives = 93/217 (42%), Gaps = 35/217 (16%)
Query: 411 FSEVNLLGKGNFSSVYKGTLRD-GTLVAIRSINVTSCKSEEAEFVKGLYL-----LTSLR 464
           + ++  +G+G++  V+K   RD G +VAI+       +SE+   +K + L     L  L+
Sbjct: 5   YEKIGKIGEGSYGVVFKCRNRDTGQIVAIKKF----LESEDDPVIKKIALREIRMLKQLK 60
Query: 465 HENIIRLRGFCCSRGRGECFLIYDFAPKGKLSKYLDQEEGSSNVLDWSTRVSIIIGIAKG 524
           H N++ L      R +    L++++     L +    + G    L      SI     + 
Sbjct: 61  HPNLVNL--LEVFRRKRRLHLVFEYCDHTVLHELDRYQRGVPEHL----VKSITWQTLQA 114
Query: 525 IGYLHSSEVNKPAIVHRNLSVEKVLIDQQFNPLIADCGLHKLLA------DDIVFSVLKT 578
           + + H     K   +HR++  E +LI +     + D G  +LL       DD V      
Sbjct: 115 VNFCH-----KHNCIHRDVKPENILITKHSVIKLCDFGFARLLTGPSDYYDDEV------ 163
Query: 579 SAAMGYLAPE-YVTTGRFTERSDIFAFGVIILQILTG 614
            A   Y +PE  V   ++    D++A G +  ++L+G
Sbjct: 164 -ATRWYRSPELLVGDTQYGPPVDVWAIGCVFAELLSG 199

>pdb|1PME|A Chain A, Structure Of Penta Mutant Human Erk2 Map Kinase Complexed With A Specific Inhibitor Of Human P38 Map Kinase Length = 380

Iteration: 1
 Score = 42.4 bits (98), Expect = 8e-04,   Method: Compositional matrix adjust.
 Identities = 48/223 (21%), Positives = 99/223 (44%), Gaps = 22/223 (9%)
Query: 411 FSEVNLLGKGNFS---SVYKGTLRDGTLVAIRSINVTSCKSEEAEFVKGLYLLTSLRHEN 467
           ++ ++ +G+G +    S Y     +   VAI+ I+    ++     ++ + +L   RHEN
Sbjct: 45  YTNLSYIGEGAYGMVCSAYDNV--NKVRVAIKKISPFEHQTYCQRTLREIKILLRFRHEN 102
Query: 468 IIRLRGFCCS---RGRGECFLIYDFAPKGKLSKYLDQEEGSSNVLDWSTRVSIIIGIAKG 524
           II +     +       + +L+        L K L  +  S++ + +      +  I +G
Sbjct: 103 IIGINDIIRAPTIEQMKDVYLVTHLM-GADLYKLLKTQHLSNDHICY-----FLYQILRG 156
Query: 525 IGYLHSSEVNKPAIVHRNLSVEKVLIDQQFNPLIADCGLHKLLADDIVFSVLKTS--AAM 582
           + Y+HS+ V     +HR+L    +L++   +  I D GL ++   D   +   T   A  
Sbjct: 157 LKYIHSANV-----LHRDLKPSNLLLNTTXDLKICDFGLARVADPDHDHTGFLTEYVATR 211
Query: 583 GYLAPEYVTTGR-FTERSDIFAFGVIILQILTGSLVLTSSMRL 624
            Y APE +   + +T+  DI++ G I+ ++L+   +      L
Sbjct: 212 WYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNRPIFPGKHYL 254

Structure Templates Detected by RPS-BLAST

Original result of RPS-BLAST against PDB70 database

ID	Length	Definition	E-value
Query	689
3uim_A	326	Brassinosteroid insensitive 1-associated receptor;	3e-79
2qkw_B	321	Protein kinase; three-helix bundle motif, AVRPTO-P	2e-72
2nru_A	307	Interleukin-1 receptor-associated kinase 4; inhibi	2e-64
1ogq_A	313	PGIP-2, polygalacturonase inhibiting protein; inhi	3e-62
1ogq_A	313	PGIP-2, polygalacturonase inhibiting protein; inhi	4e-41
3soc_A	322	Activin receptor type-2A; structural genomics cons	5e-58
3g2f_A	336	Bone morphogenetic protein receptor type-2; kinase	2e-48
3rgz_A	768	Protein brassinosteroid insensitive 1; phytohormon	2e-46
3rgz_A	768	Protein brassinosteroid insensitive 1; phytohormon	1e-44
3rgz_A	768	Protein brassinosteroid insensitive 1; phytohormon	2e-44
3rgz_A	768	Protein brassinosteroid insensitive 1; phytohormon	3e-44
3rgz_A	768	Protein brassinosteroid insensitive 1; phytohormon	4e-43
3rgz_A	768	Protein brassinosteroid insensitive 1; phytohormon	7e-41
3rgz_A	768	Protein brassinosteroid insensitive 1; phytohormon	9e-40
3rgz_A	768	Protein brassinosteroid insensitive 1; phytohormon	1e-37
3rgz_A	768	Protein brassinosteroid insensitive 1; phytohormon	1e-36
3rgz_A	768	Protein brassinosteroid insensitive 1; phytohormon	2e-26
3q4u_A	301	Activin receptor type-1; structural genomics conso	3e-42
3mdy_A	337	Bone morphogenetic protein receptor type-1B; compl	8e-42
3gxj_A	303	TGF-beta receptor type-1; ALK5, kinase, inhibitor,	2e-41
2eva_A	307	TAK1 kinase - TAB1 chimera fusion protein; transfe	4e-41
1b6c_B	342	TGF-B superfamily receptor type I; complex (isomer	1e-40
3kmu_A	271	ILK, integrin-linked kinase; cell adhesion, ANK re	4e-40
3p86_A	309	Serine/threonine-protein kinase CTR1; ETR1, ERS1,	9e-40
4f0f_A	287	Serine/threonine-protein kinase ROCO4; LRRK2, ATP-	6e-39
3dtc_A	271	Mitogen-activated protein kinase kinase kinase 9;	2e-38
3lb7_A	307	RAF proto-oncogene serine/threonine-protein kinas;	1e-37
3og7_A	289	AKAP9-BRAF fusion protein; proto-oncogene, V600E,	6e-37
3s95_A	310	LIMK-1, LIM domain kinase 1; structural genomics,	1e-36
3jqh_A	167	C-type lectin domain family 4 member M; DC-signr,	9e-35
3jqh_A	167	C-type lectin domain family 4 member M; DC-signr,	6e-32
3jqh_A	167	C-type lectin domain family 4 member M; DC-signr,	7e-26
3jqh_A	167	C-type lectin domain family 4 member M; DC-signr,	9e-17
2y4i_B	319	KSR2, HKSR2, kinase suppressor of RAS 2; transfera	1e-33
4eco_A	636	Uncharacterized protein; leucine-rich repeats, pro	4e-32
4eco_A	636	Uncharacterized protein; leucine-rich repeats, pro	2e-30
4eco_A	636	Uncharacterized protein; leucine-rich repeats, pro	2e-29
4eco_A	636	Uncharacterized protein; leucine-rich repeats, pro	3e-28
4eco_A	636	Uncharacterized protein; leucine-rich repeats, pro	7e-26
4eco_A	636	Uncharacterized protein; leucine-rich repeats, pro	3e-25
4eco_A	636	Uncharacterized protein; leucine-rich repeats, pro	4e-22
3fxi_A	605	TLR4, htoll, TOLL-like receptor 4; leucine rich re	2e-31
3fxi_A	605	TLR4, htoll, TOLL-like receptor 4; leucine rich re	3e-30
3fxi_A	605	TLR4, htoll, TOLL-like receptor 4; leucine rich re	4e-29
3fxi_A	605	TLR4, htoll, TOLL-like receptor 4; leucine rich re	3e-28
3fxi_A	605	TLR4, htoll, TOLL-like receptor 4; leucine rich re	1e-21
3fxi_A	605	TLR4, htoll, TOLL-like receptor 4; leucine rich re	2e-21
3fxi_A	605	TLR4, htoll, TOLL-like receptor 4; leucine rich re	5e-20
3fxi_A	605	TLR4, htoll, TOLL-like receptor 4; leucine rich re	1e-18
3fxi_A	605	TLR4, htoll, TOLL-like receptor 4; leucine rich re	1e-15
3lxp_A	318	Non-receptor tyrosine-protein kinase TYK2; JAK3, i	9e-31
4e5w_A	302	Tyrosine-protein kinase JAK1; kinase domain, trans	1e-30
3c1x_A	373	Hepatocyte growth factor receptor; receptor tyrosi	1e-30
3pls_A	298	Macrophage-stimulating protein receptor; protein k	1e-30
3ugc_A	295	Tyrosine-protein kinase JAK2; small molecule inhib	1e-30
2w1i_A	326	JAK2; chromosomal rearrangement, nucleotide-bindin	2e-30
3f66_A	298	Hepatocyte growth factor receptor; C-Met, protein	4e-30
1opk_A	495	P150, C-ABL, proto-oncogene tyrosine-protein kinas	3e-29
1ziw_A	680	TOLL-like receptor 3; innate immunity, immune syst	5e-29
1ziw_A	680	TOLL-like receptor 3; innate immunity, immune syst	1e-27
1ziw_A	680	TOLL-like receptor 3; innate immunity, immune syst	2e-27
1ziw_A	680	TOLL-like receptor 3; innate immunity, immune syst	3e-27
1ziw_A	680	TOLL-like receptor 3; innate immunity, immune syst	4e-27
1ziw_A	680	TOLL-like receptor 3; innate immunity, immune syst	8e-25
1ziw_A	680	TOLL-like receptor 3; innate immunity, immune syst	8e-25
1ziw_A	680	TOLL-like receptor 3; innate immunity, immune syst	3e-24
1ziw_A	680	TOLL-like receptor 3; innate immunity, immune syst	7e-24
1ziw_A	680	TOLL-like receptor 3; innate immunity, immune syst	2e-21
1ziw_A	680	TOLL-like receptor 3; innate immunity, immune syst	3e-15
3cbl_A	377	C-FES, proto-oncogene tyrosine-protein kinase FES/	7e-29
1fmk_A	452	C-SRC, P60-SRC, tyrosine-protein kinase SRC; tyros	8e-29
4ecn_A	876	Leucine-rich repeat protein; leucine-rich repeats,	9e-29
4ecn_A	876	Leucine-rich repeat protein; leucine-rich repeats,	8e-26
4ecn_A	876	Leucine-rich repeat protein; leucine-rich repeats,	9e-26
4ecn_A	876	Leucine-rich repeat protein; leucine-rich repeats,	9e-24
4ecn_A	876	Leucine-rich repeat protein; leucine-rich repeats,	1e-23
4ecn_A	876	Leucine-rich repeat protein; leucine-rich repeats,	2e-21
3lxl_A	327	Tyrosine-protein kinase JAK3; TYK2, inflammation,	2e-28
4fcg_A	328	Uncharacterized protein; structural genomics, PSI-	3e-28
4fcg_A	328	Uncharacterized protein; structural genomics, PSI-	9e-27
4fcg_A	328	Uncharacterized protein; structural genomics, PSI-	5e-26
4fcg_A	328	Uncharacterized protein; structural genomics, PSI-	1e-24
4fcg_A	328	Uncharacterized protein; structural genomics, PSI-	4e-24
4fcg_A	328	Uncharacterized protein; structural genomics, PSI-	2e-18
4fcg_A	328	Uncharacterized protein; structural genomics, PSI-	3e-15
4fcg_A	328	Uncharacterized protein; structural genomics, PSI-	3e-09
2h8h_A	535	Proto-oncogene tyrosine-protein kinase SRC; SRC ki	5e-28
3lzb_A	327	Epidermal growth factor receptor; epidermal growth	1e-27
1qcf_A	454	Haematopoetic cell kinase (HCK); tyrosine kinase-i	2e-27
2w5a_A	279	Serine/threonine-protein kinase NEK2; Ser/Thr prot	3e-27
3t9t_A	267	Tyrosine-protein kinase ITK/TSK; kinase domain, al	9e-27
3kfa_A	288	Tyrosine-protein kinase ABL1; CML, drug resistance	1e-26
3sxs_A	268	Cytoplasmic tyrosine-protein kinase BMX; transfera	2e-26
1qpc_A	279	LCK kinase; alpha beta fold, transferase; HET: PTR	2e-26
3poz_A	327	Epidermal growth factor receptor; kinase domain, a	3e-26
1byg_A	278	CSK, protein (C-terminal SRC kinase); protein kina	3e-26
3kul_A	325	Ephrin type-A receptor 8; ATP-binding, kinase, nuc	4e-26
1t4h_A	290	Serine/threonine-protein kinase WNK1; protein seri	6e-26
3gen_A	283	Tyrosine-protein kinase BTK; bruton'S tyrosine kin	1e-25
3kex_A	325	Receptor tyrosine-protein kinase ERBB-3; kinase do	1e-25
1u59_A	287	Tyrosine-protein kinase ZAP-70; transferase; HET:	1e-25
2j0j_A	656	Focal adhesion kinase 1; cell migration, FERM, tra	2e-25
3cc6_A	281	Protein tyrosine kinase 2 beta; focal adhesion kin	2e-25
1k9a_A	450	Carboxyl-terminal SRC kinase; COOH-terminal SRC ki	2e-25
1mp8_A	281	Focal adhesion kinase 1; tyrosine protein kinase,	2e-25
1mqb_A	333	Ephrin type-A receptor 2; tyrosine protein kinase,	4e-25
2yfx_A	327	Tyrosine-protein kinase receptor; nucleotide-bindi	6e-25
2qol_A	373	Ephrin receptor; receptor tyrosine kinase, juxtame	6e-25
2ozo_A	613	Tyrosine-protein kinase ZAP-70; inactive ZAP-70, t	6e-25
3qup_A	323	Tyrosine-protein kinase receptor TYRO3; protein ki	1e-24
3brb_A	313	Proto-oncogene tyrosine-protein kinase MER; ATP-bi	1e-24
3t6q_A	606	CD180 antigen; protein-protein complex, leucine ri	2e-24
3t6q_A	606	CD180 antigen; protein-protein complex, leucine ri	4e-24
3t6q_A	606	CD180 antigen; protein-protein complex, leucine ri	3e-23
3t6q_A	606	CD180 antigen; protein-protein complex, leucine ri	7e-20
3t6q_A	606	CD180 antigen; protein-protein complex, leucine ri	3e-18
3t6q_A	606	CD180 antigen; protein-protein complex, leucine ri	2e-15
3l9p_A	367	Anaplastic lymphoma kinase; kinase domain, ATP-bin	2e-24
1p4o_A	322	Insulin-like growth factor I receptor protein; IGF	3e-24
4euu_A	319	Serine/threonine-protein kinase TBK1; ATP binding,	6e-24
2xir_A	316	Vascular endothelial growth factor receptor 2; ang	7e-24
3vq2_A	606	TLR4, TOLL-like receptor 4; leucine rich repeat MD	7e-24
3vq2_A	606	TLR4, TOLL-like receptor 4; leucine rich repeat MD	2e-23
3vq2_A	606	TLR4, TOLL-like receptor 4; leucine rich repeat MD	2e-23
3vq2_A	606	TLR4, TOLL-like receptor 4; leucine rich repeat MD	6e-20
3vq2_A	606	TLR4, TOLL-like receptor 4; leucine rich repeat MD	2e-15
3vq2_A	606	TLR4, TOLL-like receptor 4; leucine rich repeat MD	1e-14
3vq2_A	606	TLR4, TOLL-like receptor 4; leucine rich repeat MD	2e-12
2buj_A	317	Serine/threonine-protein kinase 16; transferase, A	9e-24
3ll6_A	337	Cyclin G-associated kinase; transferase, protein k	3e-23
4eut_A	396	Serine/threonine-protein kinase TBK1; ATP binding,	3e-23
1t46_A	313	HOMO sapiens V-KIT hardy-zuckerman 4 feline sarcom	4e-23
2psq_A	370	Fibroblast growth factor receptor 2; kinase domain	5e-23
3p23_A	432	Serine/threonine-protein kinase/endoribonuclease;	6e-23
2a19_B	284	Interferon-induced, double-stranded RNA-activated	6e-23
2i1m_A	333	Macrophage colony-stimulating factor 1 receptor; k	6e-23
4g31_A	299	Eukaryotic translation initiation factor 2-alpha;	1e-22
1xbb_A	291	Tyrosine-protein kinase SYK; gleevec, STI-571, ima	1e-22
3qa8_A	676	MGC80376 protein; kinase ubiquitin-like domain, ph	2e-22
3p1a_A	311	MYT1 kinase, membrane-associated tyrosine- and thr	2e-22
1u46_A	291	ACK-1, activated CDC42 kinase 1; tyrosine kinase,	2e-22
2pvf_A	334	Fibroblast growth factor receptor 2; kinase domain	2e-22
3zzw_A	289	Tyrosine-protein kinase transmembrane receptor RO;	3e-22
1fvr_A	327	Tyrosine-protein kinase TIE-2; tyrosine kinase, tr	5e-22
2ivs_A	314	Proto-oncogene tyrosine-protein kinase receptor RE	6e-22
3v5q_A	297	NT-3 growth factor receptor; kinase domain, kinase	1e-21
4fmz_A	347	Internalin; leucine rich repeat, structural genomi	1e-21
4fmz_A	347	Internalin; leucine rich repeat, structural genomi	6e-21
4fmz_A	347	Internalin; leucine rich repeat, structural genomi	9e-21
4fmz_A	347	Internalin; leucine rich repeat, structural genomi	1e-19
4fmz_A	347	Internalin; leucine rich repeat, structural genomi	2e-17
4fmz_A	347	Internalin; leucine rich repeat, structural genomi	5e-16
4fvq_A	289	Tyrosine-protein kinase JAK2; janus protein kinase	2e-21
3tt0_A	382	Basic fibroblast growth factor receptor 1; kinase	2e-21
1luf_A	343	Muscle-specific tyrosine kinase receptor MUSK; pho	2e-21
1rjb_A	344	FL cytokine receptor; kinase, structure, autoinhib	3e-21
4aoj_A	329	High affinity nerve growth factor receptor; transf	3e-21
3o53_A	317	Protein LRIM1, AGAP006348-PA; leucine-rich repeat,	3e-21
3o53_A	317	Protein LRIM1, AGAP006348-PA; leucine-rich repeat,	8e-20
3o53_A	317	Protein LRIM1, AGAP006348-PA; leucine-rich repeat,	2e-19
3o53_A	317	Protein LRIM1, AGAP006348-PA; leucine-rich repeat,	6e-19
3o53_A	317	Protein LRIM1, AGAP006348-PA; leucine-rich repeat,	1e-17
3o53_A	317	Protein LRIM1, AGAP006348-PA; leucine-rich repeat,	6e-12
3o53_A	317	Protein LRIM1, AGAP006348-PA; leucine-rich repeat,	4e-11
3o53_A	317	Protein LRIM1, AGAP006348-PA; leucine-rich repeat,	2e-07
3o53_A	317	Protein LRIM1, AGAP006348-PA; leucine-rich repeat,	9e-05
4apc_A	350	Serine/threonine-protein kinase NEK1; transferase;	5e-21
2wqm_A	310	Serine/threonine-protein kinase NEK7; ATP-binding,	6e-21
3fdn_A	279	Serine/threonine-protein kinase 6; aurora kinase i	6e-21
1o6v_A	466	Internalin A; bacterial infection, extracellular r	1e-20
1o6v_A	466	Internalin A; bacterial infection, extracellular r	3e-19
1o6v_A	466	Internalin A; bacterial infection, extracellular r	3e-18
1o6v_A	466	Internalin A; bacterial infection, extracellular r	5e-17
1o6v_A	466	Internalin A; bacterial infection, extracellular r	1e-16
1o6v_A	466	Internalin A; bacterial infection, extracellular r	1e-14
3cek_A	313	Dual specificity protein kinase TTK; HMPS1, PYT, E	2e-20
3dbq_A	343	Dual specificity protein kinase TTK; MPS1 structur	6e-20
3e7e_A	365	HBUB1, BUB1A, mitotic checkpoint serine/threonine-	8e-20
1ozn_A	285	Reticulon 4 receptor; NOGO receptor, MAD, myelinat	9e-20
1ozn_A	285	Reticulon 4 receptor; NOGO receptor, MAD, myelinat	5e-18
1ozn_A	285	Reticulon 4 receptor; NOGO receptor, MAD, myelinat	1e-14
1ozn_A	285	Reticulon 4 receptor; NOGO receptor, MAD, myelinat	8e-08
2vgo_A	284	Serine/threonine-protein kinase 12-A; nucleotide-b	9e-20
3oja_A	487	Leucine-rich immune molecule 1; coiled-coil, helix	1e-19
3oja_A	487	Leucine-rich immune molecule 1; coiled-coil, helix	8e-19
3oja_A	487	Leucine-rich immune molecule 1; coiled-coil, helix	1e-18
3oja_A	487	Leucine-rich immune molecule 1; coiled-coil, helix	3e-18
3oja_A	487	Leucine-rich immune molecule 1; coiled-coil, helix	2e-16
3oja_A	487	Leucine-rich immune molecule 1; coiled-coil, helix	4e-14
3oja_A	487	Leucine-rich immune molecule 1; coiled-coil, helix	8e-14
3oja_A	487	Leucine-rich immune molecule 1; coiled-coil, helix	1e-11
3oja_A	487	Leucine-rich immune molecule 1; coiled-coil, helix	3e-05
3oja_A	487	Leucine-rich immune molecule 1; coiled-coil, helix	4e-05
2owb_A	335	Serine/threonine-protein kinase PLK1; catalytic do	1e-19
3cvr_A	571	Invasion plasmid antigen; leucine rich repeat and	2e-19
3cvr_A	571	Invasion plasmid antigen; leucine rich repeat and	1e-14
3cvr_A	571	Invasion plasmid antigen; leucine rich repeat and	2e-13
2rku_A	294	Serine/threonine-protein kinase PLK1; structure of	2e-19
2pml_X	348	PFPK7, Ser/Thr protein kinase; phosphorylati trans	2e-19
2rio_A	434	Serine/threonine-protein kinase/endoribonuclease I	2e-19
3cok_A	278	Serine/threonine-protein kinase PLK4; POLO-like ki	2e-19
4ezg_A	197	Putative uncharacterized protein; internalin-A, le	2e-19
4ezg_A	197	Putative uncharacterized protein; internalin-A, le	2e-19
2z63_A	570	TOLL-like receptor 4, variable lymphocyte recepto;	3e-19
2z63_A	570	TOLL-like receptor 4, variable lymphocyte recepto;	2e-18
2z63_A	570	TOLL-like receptor 4, variable lymphocyte recepto;	3e-18
2z63_A	570	TOLL-like receptor 4, variable lymphocyte recepto;	1e-17
2z63_A	570	TOLL-like receptor 4, variable lymphocyte recepto;	7e-15
2z63_A	570	TOLL-like receptor 4, variable lymphocyte recepto;	2e-11
2z63_A	570	TOLL-like receptor 4, variable lymphocyte recepto;	2e-10
2z63_A	570	TOLL-like receptor 4, variable lymphocyte recepto;	2e-10
1zy4_A	303	Serine/threonine-protein kinase GCN2; translation	3e-19
3zyi_A	452	Leucine-rich repeat-containing protein 4; cell adh	3e-19
3zyi_A	452	Leucine-rich repeat-containing protein 4; cell adh	3e-13
3zyi_A	452	Leucine-rich repeat-containing protein 4; cell adh	2e-10
3zyi_A	452	Leucine-rich repeat-containing protein 4; cell adh	1e-09
2zmd_A	390	Dual specificity protein kinase TTK; MPS1, T686A,	4e-19
2z7x_B	520	TOLL-like receptor 1, variable lymphocyte recepto;	4e-19
2z7x_B	520	TOLL-like receptor 1, variable lymphocyte recepto;	3e-15
2z7x_B	520	TOLL-like receptor 1, variable lymphocyte recepto;	5e-15
2z7x_B	520	TOLL-like receptor 1, variable lymphocyte recepto;	1e-12
2z7x_B	520	TOLL-like receptor 1, variable lymphocyte recepto;	4e-12
2z7x_B	520	TOLL-like receptor 1, variable lymphocyte recepto;	1e-11
2z7x_B	520	TOLL-like receptor 1, variable lymphocyte recepto;	7e-10
1jl5_A	454	Outer protein YOPM; leucine-rich repeat, molecular	4e-19
1jl5_A	454	Outer protein YOPM; leucine-rich repeat, molecular	1e-18
1jl5_A	454	Outer protein YOPM; leucine-rich repeat, molecular	8e-18
1jl5_A	454	Outer protein YOPM; leucine-rich repeat, molecular	1e-17
1jl5_A	454	Outer protein YOPM; leucine-rich repeat, molecular	6e-16
1jl5_A	454	Outer protein YOPM; leucine-rich repeat, molecular	9e-12
1jl5_A	454	Outer protein YOPM; leucine-rich repeat, molecular	1e-09
3q60_A	371	ROP5B; pseudokinase, transferase; HET: ATP; 1.72A	5e-19
3j0a_A	844	TOLL-like receptor 5; membrane protein, leucine-ri	1e-18
3j0a_A	844	TOLL-like receptor 5; membrane protein, leucine-ri	4e-18
3j0a_A	844	TOLL-like receptor 5; membrane protein, leucine-ri	4e-13
3j0a_A	844	TOLL-like receptor 5; membrane protein, leucine-ri	6e-13
3j0a_A	844	TOLL-like receptor 5; membrane protein, leucine-ri	6e-12
3j0a_A	844	TOLL-like receptor 5; membrane protein, leucine-ri	4e-11
3j0a_A	844	TOLL-like receptor 5; membrane protein, leucine-ri	4e-05
1x8b_A	289	WEE1HU, WEE1-like protein kinase; cell cycle, tran	2e-18
3g06_A	622	SSPH2 (leucine-rich repeat protein); E3 ubiquitin	2e-18
3g06_A	622	SSPH2 (leucine-rich repeat protein); E3 ubiquitin	1e-14
3g06_A	622	SSPH2 (leucine-rich repeat protein); E3 ubiquitin	4e-11
2z66_A	306	Variable lymphocyte receptor B, TOLL-like recepto;	3e-18
2z66_A	306	Variable lymphocyte receptor B, TOLL-like recepto;	9e-15
2z66_A	306	Variable lymphocyte receptor B, TOLL-like recepto;	5e-09
2z66_A	306	Variable lymphocyte receptor B, TOLL-like recepto;	8e-05
3byv_A	377	Rhoptry kinase; malaria, transferase, structural g	5e-18
3zyj_A	440	Leucine-rich repeat-containing protein 4C; cell ad	6e-18
3zyj_A	440	Leucine-rich repeat-containing protein 4C; cell ad	4e-14
3zyj_A	440	Leucine-rich repeat-containing protein 4C; cell ad	1e-13
3zyj_A	440	Leucine-rich repeat-containing protein 4C; cell ad	3e-12
3zyj_A	440	Leucine-rich repeat-containing protein 4C; cell ad	6e-11
3zyj_A	440	Leucine-rich repeat-containing protein 4C; cell ad	4e-09
2id5_A	477	Lingo-1, leucine rich repeat neuronal 6A; CNS-spec	6e-18
2id5_A	477	Lingo-1, leucine rich repeat neuronal 6A; CNS-spec	5e-17
2id5_A	477	Lingo-1, leucine rich repeat neuronal 6A; CNS-spec	4e-16
2id5_A	477	Lingo-1, leucine rich repeat neuronal 6A; CNS-spec	3e-13
2id5_A	477	Lingo-1, leucine rich repeat neuronal 6A; CNS-spec	4e-11
3oja_B	597	Anopheles plasmodium-responsive leucine-rich REPE	8e-18
3oja_B	597	Anopheles plasmodium-responsive leucine-rich REPE	6e-17
3oja_B	597	Anopheles plasmodium-responsive leucine-rich REPE	1e-14
3oja_B	597	Anopheles plasmodium-responsive leucine-rich REPE	1e-14
3oja_B	597	Anopheles plasmodium-responsive leucine-rich REPE	3e-14
3oja_B	597	Anopheles plasmodium-responsive leucine-rich REPE	2e-13
3oja_B	597	Anopheles plasmodium-responsive leucine-rich REPE	3e-12
3oja_B	597	Anopheles plasmodium-responsive leucine-rich REPE	5e-11
3oja_B	597	Anopheles plasmodium-responsive leucine-rich REPE	5e-06
3dzo_A	413	Rhoptry kinase domain; parasitic disease, transfer	1e-17
3o6n_A	390	APL1; leucine-rich repeat, protein binding; HET: N	1e-17
3o6n_A	390	APL1; leucine-rich repeat, protein binding; HET: N	4e-17
3o6n_A	390	APL1; leucine-rich repeat, protein binding; HET: N	5e-17
3o6n_A	390	APL1; leucine-rich repeat, protein binding; HET: N	3e-15
3o6n_A	390	APL1; leucine-rich repeat, protein binding; HET: N	4e-14
3o6n_A	390	APL1; leucine-rich repeat, protein binding; HET: N	4e-14
3o6n_A	390	APL1; leucine-rich repeat, protein binding; HET: N	4e-13
3o6n_A	390	APL1; leucine-rich repeat, protein binding; HET: N	3e-06
1p9a_G	290	Platelet glycoprotein IB alpha chain precursor; pl	2e-17
1p9a_G	290	Platelet glycoprotein IB alpha chain precursor; pl	1e-15
1p9a_G	290	Platelet glycoprotein IB alpha chain precursor; pl	1e-09
3mwu_A	486	Calmodulin-domain protein kinase 1; serine/threoni	4e-17
3lij_A	494	Calcium/calmodulin dependent protein kinase with A	4e-17
2ft3_A	332	Biglycan; proteoglycan, dimer interface, structura	7e-17
2ft3_A	332	Biglycan; proteoglycan, dimer interface, structura	9e-16
2ft3_A	332	Biglycan; proteoglycan, dimer interface, structura	2e-14
2ft3_A	332	Biglycan; proteoglycan, dimer interface, structura	1e-13
2ft3_A	332	Biglycan; proteoglycan, dimer interface, structura	3e-08
3a7i_A	303	MST3 kinase, serine/threonine kinase 24 (STE20 hom	8e-17
1h6u_A	308	Internalin H; cell adhesion, leucine rich repeat,	1e-16
1h6u_A	308	Internalin H; cell adhesion, leucine rich repeat,	9e-14
1h6u_A	308	Internalin H; cell adhesion, leucine rich repeat,	2e-13
3dls_A	335	PAS domain-containing serine/threonine-protein KI;	1e-16
3i6u_A	419	CDS1, serine/threonine-protein kinase CHK2; Ser/Th	2e-16
2z81_A	549	CD282 antigen, TOLL-like receptor 2, variable lymp	2e-16
2z81_A	549	CD282 antigen, TOLL-like receptor 2, variable lymp	4e-16
2z81_A	549	CD282 antigen, TOLL-like receptor 2, variable lymp	4e-16
2z81_A	549	CD282 antigen, TOLL-like receptor 2, variable lymp	1e-15
2z81_A	549	CD282 antigen, TOLL-like receptor 2, variable lymp	9e-15
2z81_A	549	CD282 antigen, TOLL-like receptor 2, variable lymp	2e-10
2z81_A	549	CD282 antigen, TOLL-like receptor 2, variable lymp	7e-10
2z81_A	549	CD282 antigen, TOLL-like receptor 2, variable lymp	7e-10
2z81_A	549	CD282 antigen, TOLL-like receptor 2, variable lymp	1e-08
2z81_A	549	CD282 antigen, TOLL-like receptor 2, variable lymp	2e-07
2z81_A	549	CD282 antigen, TOLL-like receptor 2, variable lymp	3e-07
2wei_A	287	Calmodulin-domain protein kinase 1, putative; nucl	4e-16
3is5_A	285	Calcium-dependent protein kinase; CDPK, structural	6e-16
2xot_A	361	Amphoterin-induced protein 1; cell adhesion, neuro	7e-16
2xot_A	361	Amphoterin-induced protein 1; cell adhesion, neuro	5e-14
2xot_A	361	Amphoterin-induced protein 1; cell adhesion, neuro	4e-07
3fe3_A	328	MAP/microtubule affinity-regulating kinase 3; seri	8e-16
3nyv_A	484	Calmodulin-domain protein kinase 1; serine/threoni	1e-15
2jam_A	304	Calcium/calmodulin-dependent protein kinase type 1	1e-15
1xku_A	330	Decorin; proteoglycan, leucine-rich repeat, struct	1e-15
1xku_A	330	Decorin; proteoglycan, leucine-rich repeat, struct	1e-13
1xku_A	330	Decorin; proteoglycan, leucine-rich repeat, struct	2e-08
1xku_A	330	Decorin; proteoglycan, leucine-rich repeat, struct	2e-08
3v47_A	455	TOLL-like receptor 5B and variable lymphocyte REC	2e-15
3v47_A	455	TOLL-like receptor 5B and variable lymphocyte REC	3e-10
3v47_A	455	TOLL-like receptor 5B and variable lymphocyte REC	3e-09
3v47_A	455	TOLL-like receptor 5B and variable lymphocyte REC	2e-08
3v47_A	455	TOLL-like receptor 5B and variable lymphocyte REC	2e-06
4g3f_A	336	NF-kappa-beta-inducing kinase; non-RD kinase, prot	2e-15
1wwl_A	312	Monocyte differentiation antigen CD14; LPS, immune	2e-15
1wwl_A	312	Monocyte differentiation antigen CD14; LPS, immune	3e-14
1wwl_A	312	Monocyte differentiation antigen CD14; LPS, immune	1e-11
1wwl_A	312	Monocyte differentiation antigen CD14; LPS, immune	2e-08
2z62_A	276	TOLL-like receptor 4, variable lymphocyte recepto;	2e-15
2z62_A	276	TOLL-like receptor 4, variable lymphocyte recepto;	9e-15
2z62_A	276	TOLL-like receptor 4, variable lymphocyte recepto;	3e-14
2z62_A	276	TOLL-like receptor 4, variable lymphocyte recepto;	3e-11
2z62_A	276	TOLL-like receptor 4, variable lymphocyte recepto;	3e-04
3a99_A	320	Proto-oncogene serine/threonine-protein kinase PI;	5e-15
2clq_A	295	Mitogen-activated protein kinase kinase kinase 5;	8e-15
2pzi_A	681	Probable serine/threonine-protein kinase PKNG; ATP	8e-15
4eqm_A	294	Protein kinase; transferase; HET: ANP; 3.00A {Stap	8e-15
2ycf_A	322	Serine/threonine-protein kinase CHK2; transferase,	1e-14
3kk8_A	284	Calcium/calmodulin dependent protein kinase II; AT	1e-14
3q5i_A	504	Protein kinase; CDPK, malaria, phosphotransferase,	1e-14
2iwi_A	312	Serine/threonine-protein kinase PIM-2; nucleotide-	1e-14
2h6d_A	276	5'-AMP-activated protein kinase catalytic subunit	2e-14
1m9s_A	605	Internalin B; cell invasion, GW domains, SH3 domai	2e-14
1m9s_A	605	Internalin B; cell invasion, GW domains, SH3 domai	6e-14
1m9s_A	605	Internalin B; cell invasion, GW domains, SH3 domai	3e-13
1m9s_A	605	Internalin B; cell invasion, GW domains, SH3 domai	1e-06
3uto_A	573	Twitchin; kinase, muscle sarcomere, transferase; H	3e-14
1dce_A	567	Protein (RAB geranylgeranyltransferase alpha subun	3e-14
1dce_A	567	Protein (RAB geranylgeranyltransferase alpha subun	1e-13
1dce_A	567	Protein (RAB geranylgeranyltransferase alpha subun	2e-10
2o6q_A	270	Variable lymphocyte receptor A; leucine-rich repea	3e-14
2o6q_A	270	Variable lymphocyte receptor A; leucine-rich repea	1e-13
2o6q_A	270	Variable lymphocyte receptor A; leucine-rich repea	3e-12
1phk_A	298	Phosphorylase kinase; glycogen metabolism, transfe	3e-14
2z80_A	353	TOLL-like receptor 2, variable lymphocyte recepto;	3e-14
2z80_A	353	TOLL-like receptor 2, variable lymphocyte recepto;	3e-13
2z80_A	353	TOLL-like receptor 2, variable lymphocyte recepto;	8e-13
2z80_A	353	TOLL-like receptor 2, variable lymphocyte recepto;	4e-11
2z80_A	353	TOLL-like receptor 2, variable lymphocyte recepto;	7e-10
2z80_A	353	TOLL-like receptor 2, variable lymphocyte recepto;	4e-06
3eqc_A	360	Dual specificity mitogen-activated protein kinase;	5e-14
3a79_B	562	TLR6, VLRB.59, TOLL-like receptor 6, variable lymp	5e-14
3a79_B	562	TLR6, VLRB.59, TOLL-like receptor 6, variable lymp	9e-14
3a79_B	562	TLR6, VLRB.59, TOLL-like receptor 6, variable lymp	7e-13
3a79_B	562	TLR6, VLRB.59, TOLL-like receptor 6, variable lymp	1e-06
3a79_B	562	TLR6, VLRB.59, TOLL-like receptor 6, variable lymp	6e-05
3a79_B	562	TLR6, VLRB.59, TOLL-like receptor 6, variable lymp	9e-05
2bdw_A	362	Hypothetical protein K11E8.1D; kinase, calmodulin	6e-14
3ork_A	311	Serine/threonine protein kinase; structural genomi	6e-14
3fhr_A	336	MAP kinase-activated protein kinase 3; kinase-inhi	9e-14
2wtk_C	305	Serine/threonine-protein kinase 11; transferase-me	9e-14
2w4o_A	349	Calcium/calmodulin-dependent protein kinase type I	9e-14
2v9t_B	220	SLIT homolog 2 protein N-product; structural prote	1e-13
2v9t_B	220	SLIT homolog 2 protein N-product; structural prote	5e-13
3c0i_A	351	Peripheral plasma membrane protein CASK; neurexin,	1e-13
3f3z_A	277	Calcium/calmodulin-dependent protein kinase with d	2e-13
2vwi_A	303	Serine/threonine-protein kinase OSR1; STE kinase,	2e-13
2yex_A	276	Serine/threonine-protein kinase CHK1; transferase,	3e-13
3vhe_A	359	Vascular endothelial growth factor receptor 2; kin	3e-13
2a2a_A	321	Death-associated protein kinase 2; autoinhibition,	3e-13
2yab_A	361	Death-associated protein kinase 2; apoptosis, tran	3e-13
2y94_A	476	5'-AMP-activated protein kinase catalytic subunit;	4e-13
3bz5_A	457	Internalin-J, INLJ; leucine rich repeat (LRR), cys	5e-13
3bz5_A	457	Internalin-J, INLJ; leucine rich repeat (LRR), cys	2e-12
3bz5_A	457	Internalin-J, INLJ; leucine rich repeat (LRR), cys	5e-12
3bz5_A	457	Internalin-J, INLJ; leucine rich repeat (LRR), cys	6e-12
3bz5_A	457	Internalin-J, INLJ; leucine rich repeat (LRR), cys	7e-12
3bz5_A	457	Internalin-J, INLJ; leucine rich repeat (LRR), cys	2e-11
3bz5_A	457	Internalin-J, INLJ; leucine rich repeat (LRR), cys	9e-11
3bz5_A	457	Internalin-J, INLJ; leucine rich repeat (LRR), cys	1e-10
3bz5_A	457	Internalin-J, INLJ; leucine rich repeat (LRR), cys	2e-08
3bz5_A	457	Internalin-J, INLJ; leucine rich repeat (LRR), cys	1e-07
1kob_A	387	Twitchin; kinase, intrasteric regulation; 2.30A {A	5e-13
3soa_A	444	Calcium/calmodulin-dependent protein kinase type a	5e-13
3tki_A	323	Serine/threonine-protein kinase CHK1; cell checkpo	6e-13
2h34_A	309	Serine/threonine-protein kinase PKNE; apoenzyme, t	7e-13
2eue_A	275	Carbon catabolite derepressing protein kinase; kin	7e-13
3h4j_B	336	AMPK kdaid, SNF1-like protein kinase SSP2; ATP-bin	1e-12
1tki_A	321	Titin; serine kinase, muscle, autoinhibition; 2.00	1e-12
2y7j_A	365	Phosphorylase B kinase gamma catalytic chain, test	1e-12
3hko_A	345	Calcium/calmodulin-dependent protein kinase with d	1e-12
2x4f_A	373	Myosin light chain kinase family member 4; LUNG, b	2e-12
3bhy_A	283	Death-associated protein kinase 3; death associate	2e-12
3qd2_B	332	Eukaryotic translation initiation factor 2-alpha;	2e-12
1h6t_A	291	Internalin B; cell adhesion, leucine rich repeat,	2e-12
1h6t_A	291	Internalin B; cell adhesion, leucine rich repeat,	4e-12
1h6t_A	291	Internalin B; cell adhesion, leucine rich repeat,	6e-12
2y0a_A	326	Death-associated protein kinase 1; transferase, ca	2e-12
2qr7_A	342	Ribosomal protein S6 kinase alpha-3; kinase domain	2e-12
2xwt_C	239	Thyrotropin receptor; signaling protein-immune sys	3e-12
2xwt_C	239	Thyrotropin receptor; signaling protein-immune sys	8e-12
2xwt_C	239	Thyrotropin receptor; signaling protein-immune sys	2e-04
2zv2_A	298	Calcium/calmodulin-dependent protein kinase kinas;	3e-12
2ac3_A	316	MAP kinase-interacting serine/threonine kinase 2;	3e-12
1xeu_A	263	Internalin C; cellular invasion, leucine-rich repe	4e-12
1xeu_A	263	Internalin C; cellular invasion, leucine-rich repe	2e-11
4ay9_X	350	Follicle-stimulating hormone receptor; hormone-rec	9e-12
4ay9_X	350	Follicle-stimulating hormone receptor; hormone-rec	7e-10
4ay9_X	350	Follicle-stimulating hormone receptor; hormone-rec	9e-10
4ay9_X	350	Follicle-stimulating hormone receptor; hormone-rec	8e-07
4ay9_X	350	Follicle-stimulating hormone receptor; hormone-rec	2e-04
3uc3_A	361	Serine/threonine-protein kinase SRK2I; SNRK2, ABA	1e-11
3lm5_A	327	Serine/threonine-protein kinase 17B; STK17B, serin	1e-11
3m19_A	251	Variable lymphocyte receptor A diversity region; a	2e-11
3m19_A	251	Variable lymphocyte receptor A diversity region; a	3e-10
3m19_A	251	Variable lymphocyte receptor A diversity region; a	2e-07
1nxk_A	400	MAP kinase-activated protein kinase 2; MK2, phosph	4e-11
1uu3_A	310	HPDK1, 3-phosphoinositide dependent protein kinase	4e-11
2dyl_A	318	Dual specificity mitogen-activated protein kinase	5e-11
3rgf_A	405	Cyclin-dependent kinase 8; protein kinase complex,	5e-11
3fme_A	290	Dual specificity mitogen-activated protein kinase;	5e-11
3e6j_A	229	Variable lymphocyte receptor diversity region; var	5e-11
3e6j_A	229	Variable lymphocyte receptor diversity region; var	3e-09
3e6j_A	229	Variable lymphocyte receptor diversity region; var	2e-07
3kn6_A	325	Ribosomal protein S6 kinase alpha-5; AMP-PNP, MSK1	6e-11
3com_A	314	Serine/threonine-protein kinase 4; MST1, STE20-lik	8e-11
2wfh_A	193	SLIT homolog 2 protein C-product; developmental pr	8e-11
2wfh_A	193	SLIT homolog 2 protein C-product; developmental pr	7e-06
3gni_B	389	Strad alpha; kinase fold, pseudokinase, alpha heli	1e-10
4e7w_A	394	Glycogen synthase kinase 3; GSK3, PTyr195, transfe	1e-10
2x7f_A	326	TRAF2 and NCK-interacting protein kinase; serine/t	2e-10
3aln_A	327	Dual specificity mitogen-activated protein kinase;	2e-10
4aaa_A	331	Cyclin-dependent kinase-like 2; transferase, phosp	3e-10
3an0_A	340	Dual specificity mitogen-activated protein kinase;	4e-10
3gbz_A	329	Kinase, CMGC CDK; ssgcid, ATP-binding, nucleotide-	6e-10
2o6s_A	208	Variable lymphocyte receptor B; leucine-rich repea	9e-10
2o6s_A	208	Variable lymphocyte receptor B; leucine-rich repea	2e-08
2o6s_A	208	Variable lymphocyte receptor B; leucine-rich repea	1e-04
1ua2_A	346	CAK, cell division protein kinase 7; cell cycle, p	9e-10
2vuw_A	336	Serine/threonine-protein kinase haspin; cell cycle	1e-09
3pvu_A	695	Beta-adrenergic receptor kinase 1; transferase, se	1e-09
1j1b_A	420	Glycogen synthase kinase-3 beta; complex, TAU, AMP	1e-09
4agu_A	311	Cyclin-dependent kinase-like 1; transferase, phosp	1e-09
2ra8_A	362	Uncharacterized protein Q64V53_bacfr; WGR domain,	2e-09
3g33_A	308	Cell division protein kinase 4; Ser/Thr protein ki	2e-09
3fxz_A	297	Serine/threonine-protein kinase PAK 1; transferase	2e-09
3m2w_A	299	MAP kinase-activated protein kinase 2; small molec	3e-09
3niz_A	311	Rhodanese family protein; structural genomics, str	3e-09
2o6r_A	177	Variable lymphocyte receptor B; leucine-rich repea	4e-09
2o6r_A	177	Variable lymphocyte receptor B; leucine-rich repea	8e-04
3mtl_A	324	Cell division protein kinase 16; pctaire1, indirub	5e-09
2v70_A	220	SLIT-2, SLIT homolog 2 protein N-product; neurogen	5e-09
2v70_A	220	SLIT-2, SLIT homolog 2 protein N-product; neurogen	5e-08
1ob3_A	288	PFPK5, cell division control protein 2 homolog; tr	5e-09
2je0_A	149	Acidic leucine-rich nuclear phosphoprotein 32 FAM	6e-09
2j7t_A	302	Serine/threonine-protein kinase 10; transferase, A	7e-09
2ifg_A	347	High affinity nerve growth factor receptor; TRK, T	8e-09
2ifg_A	347	High affinity nerve growth factor receptor; TRK, T	1e-08
2ifg_A	347	High affinity nerve growth factor receptor; TRK, T	9e-04
2c30_A	321	Serine/threonine-protein kinase PAK 6; CRIB domain	9e-09
2pmi_A	317	Negative RE, cyclin-dependent protein kinase PHO85	1e-08
3e3p_A	360	Protein kinase, putative glycogen synthase kinase;	2e-08
1u5q_A	348	Serine/threonine protein kinase TAO2; transferase;	2e-08
1vt4_I	1221	APAF-1 related killer DARK; drosophila apoptosome,	2e-08
1ds9_A	198	Outer arm dynein; leucine-rich repeat, beta-BETA-a	2e-08
1ds9_A	198	Outer arm dynein; leucine-rich repeat, beta-BETA-a	9e-08
1ds9_A	198	Outer arm dynein; leucine-rich repeat, beta-BETA-a	5e-04
2xrw_A	371	Mitogen-activated protein kinase 8; transcription,	2e-08
2ell_A	168	Acidic leucine-rich nuclear phosphoprotein 32 FAM	3e-08
2r3i_A	299	Cell division protein kinase 2; serine/threonine-p	3e-08
3o0g_A	292	Cell division protein kinase 5; kinase activator c	3e-08
3rfs_A	272	Internalin B, repeat modules, variable lymphocyte	3e-08
3rfs_A	272	Internalin B, repeat modules, variable lymphocyte	2e-06
3pfq_A	674	PKC-B, PKC-beta, protein kinase C beta type; phosp	3e-08
3c4z_A	543	Rhodopsin kinase; Ser/Thr kinase, RGS homology dom	3e-08
3ttj_A	464	Mitogen-activated protein kinase 10; JNK3, protein	4e-08
4ejn_A	446	RAC-alpha serine/threonine-protein kinase; AKT1, a	8e-08
3coi_A	353	Mitogen-activated protein kinase 13; P38D, P38delt	1e-07
2acx_A	576	G protein-coupled receptor kinase 6; GRK, G transf	2e-07
3mi9_A	351	Cell division protein kinase 9; P-TEFB, HIV-1, pro	2e-07
4fr4_A	384	YANK1, serine/threonine-protein kinase 32A; struct	2e-07
1blx_A	326	Cyclin-dependent kinase 6; inhibitor protein, cycl	4e-07
2ca6_A	386	RAN GTPase-activating protein 1; GAP, GTPase activ	7e-07
2ca6_A	386	RAN GTPase-activating protein 1; GAP, GTPase activ	4e-05
1a9n_A	176	U2A', U2A'; complex (nuclear protein/RNA), RNA, sn	7e-07
1cm8_A	367	Phosphorylated MAP kinase P38-gamma; phosphorylati	1e-06
2fst_X	367	Mitogen-activated protein kinase 14; active mutant	3e-06
1rdq_E	350	PKA C-alpha, CAMP-dependent protein kinase, alpha-	3e-06
4aw2_A	437	Serine/threonine-protein kinase MRCK alpha; transf	4e-06
3qyz_A	364	Mitogen-activated protein kinase 1; transferase, s	5e-06
1xjd_A	345	Protein kinase C, theta type; PKC-theta, ATP, AMP,	6e-06
2i6l_A	320	Mitogen-activated protein kinase 6; MAPK6, ERK3, e	9e-06
1o6l_A	337	RAC-beta serine/threonine protein kinase; protein	1e-05
4dc2_A	396	Protein kinase C IOTA type; kinase, substrate, cel	1e-05
2i0e_A	353	Protein kinase C-beta II; serine/threonine protein	2e-05
3v8s_A	410	RHO-associated protein kinase 1; dimerization, myo	2e-05
3a62_A	327	Ribosomal protein S6 kinase beta-1; kinase domain,	2e-05
3uqc_A	286	Probable conserved transmembrane protein; structur	2e-05
1w8a_A	192	SLIT protein; signaling protein, secreted protein,	2e-05
3a8x_A	345	Protein kinase C IOTA type; transferase; HET: TPO;	2e-05
3g39_A	170	Variable lymphocyte receptor VLRB.2D; antibody, X-	3e-05
3rp9_A	458	Mitogen-activated protein kinase; structural genom	3e-05
1z7x_W	461	Ribonuclease inhibitor; leucine-rich repeat, enzym	4e-05
1z7x_W	461	Ribonuclease inhibitor; leucine-rich repeat, enzym	7e-05
3txo_A	353	PKC-L, NPKC-ETA, protein kinase C ETA type; phosph	5e-05
3nsz_A	330	CK II alpha, casein kinase II subunit alpha; inhib	6e-05
2vd5_A	412	DMPK protein; serine/threonine-protein kinase, kin	6e-05
2r9u_A	174	Variable lymphocyte receptor; adaptive immunity, V	6e-05
1fot_A	318	TPK1 delta, CAMP-dependent protein kinase type 1;	1e-04
1vzo_A	355	Ribosomal protein S6 kinase alpha 5; protein kinas	1e-04
3pg1_A	362	Mitogen-activated protein kinase, putative (MAP K	2e-04
2b9h_A	353	MAP kinase FUS3, mitogen-activated protein kinase	2e-04
3g51_A	325	Ribosomal protein S6 kinase alpha-3; N-terminal ki	3e-04
2r5t_A	373	Serine/threonine-protein kinase SGK1; AGC protein	4e-04
3eb0_A	383	Putative uncharacterized protein; kinase cryptospo	7e-04

>3uim_A Brassinosteroid insensitive 1-associated receptor; kinase, protein kinase, transferase; HET: SEP TPO ANP; 2.20A {Arabidopsis thaliana} PDB: 3tl8_A* Length = 326

 Score =  254 bits (651), Expect = 3e-79
 Identities = 94/295 (31%), Positives = 165/295 (55%), Gaps = 21/295 (7%)

Query: 398 RLNLEEVESATQCFSEVNLLGKGNFSSVYKGTLRDGTLVAIRSINVTSCKSEEAEFVKGL 457
           R +L E++ A+  FS  N+LG+G F  VYKG L DGTLVA++ +     +  E +F   +
Sbjct: 19  RFSLRELQVASDNFSNKNILGRGGFGKVYKGRLADGTLVAVKRLKEERTQGGELQFQTEV 78

Query: 458 YLLTSLRHENIIRLRGFCCSRGRGECFLIYDFAPKGKLSKYLDQEEGSSNVLDWSTRVSI 517
            +++   H N++RLRGFC +    E  L+Y +   G ++  L +   S   LDW  R  I
Sbjct: 79  EMISMAVHRNLLRLRGFCMT--PTERLLVYPYMANGSVASCLRERPESQPPLDWPKRQRI 136

Query: 518 IIGIAKGIGYLHSSEVNKPAIVHRNLSVEKVLIDQQFNPLIADCGLHKLLADDIVFSVLK 577
            +G A+G+ YLH  +   P I+HR++    +L+D++F  ++ D GL KL+      + + 
Sbjct: 137 ALGSARGLAYLH--DHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLMDYKD--THVT 192

Query: 578 TSAA--MGYLAPEYVTTGRFTERSDIFAFGVIILQILTG-------------SLVLTSSM 622
           T+    +G++APEY++TG+ +E++D+F +GV++L+++TG              ++L   +
Sbjct: 193 TAVRGTIGHIAPEYLSTGKSSEKTDVFGYGVMLLELITGQRAFDLARLANDDDVMLLDWV 252

Query: 623 RLAAESATFENFIDRNLKGKFSESEAAKLGKMALVCTHEDPENRPTMEAVIEELT 677
           +   +    E  +D +L+G + + E  +L ++AL+CT   P  RP M  V+  L 
Sbjct: 253 KGLLKEKKLEALVDVDLQGNYKDEEVEQLIQVALLCTQSSPMERPKMSEVVRMLE 307

>2qkw_B Protein kinase; three-helix bundle motif, AVRPTO-PTO duplex, layered beta- sheets, transferas; HET: SEP TPO; 3.20A {Solanum pimpinellifolium} PDB: 3hgk_A* Length = 321

 Score =  236 bits (604), Expect = 2e-72
 Identities = 93/298 (31%), Positives = 145/298 (48%), Gaps = 24/298 (8%)

Query: 393 HLNSFRLNLEEVESATQCFSEVNLLGKGNFSSVYKGTLRDGTLVAIRSINVTSCKSEEAE 452
              S+R+ L ++E AT  F    L+G G F  VYKG LRDG  VA++     S +  E E
Sbjct: 23  PFESYRVPLVDLEEATNNFDHKFLIGHGVFGKVYKGVLRDGAKVALKRRTPESSQGIE-E 81

Query: 453 FVKGLYLLTSLRHENIIRLRGFCCSRGRGECFLIYDFAPKGKLSKYLDQEEGSSNVLDWS 512
           F   +  L+  RH +++ L GFC    R E  LIY +   G L ++L   +  +  + W 
Sbjct: 82  FETEIETLSFCRHPHLVSLIGFCDE--RNEMILIYKYMENGNLKRHLYGSDLPTMSMSWE 139

Query: 513 TRVSIIIGIAKGIGYLHSSEVNKPAIVHRNLSVEKVLIDQQFNPLIADCGLHKLLADDIV 572
            R+ I IG A+G+ YLH       AI+HR++    +L+D+ F P I D G+ K   +   
Sbjct: 140 QRLEICIGAARGLHYLH-----TRAIIHRDVKSINILLDENFVPKITDFGISKKGTELDQ 194

Query: 573 FSVLKTSAAM---GYLAPEYVTTGRFTERSDIFAFGVIILQILTGSLVLTSSM------- 622
             +  ++      GY+ PEY   GR TE+SD+++FGV++ ++L     +  S+       
Sbjct: 195 THL--STVVKGTLGYIDPEYFIKGRLTEKSDVYSFGVVLFEVLCARSAIVQSLPREMVNL 252

Query: 623 ----RLAAESATFENFIDRNLKGKFSESEAAKLGKMALVCTHEDPENRPTMEAVIEEL 676
                 +  +   E  +D NL  K       K G  A+ C     E+RP+M  V+ +L
Sbjct: 253 AEWAVESHNNGQLEQIVDPNLADKIRPESLRKFGDTAVKCLALSSEDRPSMGDVLWKL 310

>2nru_A Interleukin-1 receptor-associated kinase 4; inhibitor, IRAK, transferase; HET: TPO SEP T12; 2.00A {Homo sapiens} PDB: 2nry_A* 2oib_A* 2oic_A* 2oid_A* 2o8y_A* Length = 307

 Score =  214 bits (548), Expect = 2e-64
 Identities = 84/308 (27%), Positives = 146/308 (47%), Gaps = 41/308 (13%)

Query: 393 HLNSFRLNLEEVESATQCFSE------VNLLGKGNFSSVYKGTLRDGTLVAI----RSIN 442
             +SF  +  E+++ T  F E       N +G+G F  VYKG + + T VA+      ++
Sbjct: 11  RFHSF--SFYELKNVTNNFDERPISVGGNKMGEGGFGVVYKGYV-NNTTVAVKKLAAMVD 67

Query: 443 VTSCKSEEAEFVKGLYLLTSLRHENIIRLRGFCCSRGRGECFLIYDFAPKGKLSKYLDQE 502
           +T+ + ++ +F + + ++   +HEN++ L GF       +  L+Y + P G L   L   
Sbjct: 68  ITTEELKQ-QFDQEIKVMAKCQHENLVELLGFSSDGD--DLCLVYVYMPNGSLLDRLSCL 124

Query: 503 EGSSNVLDWSTRVSIIIGIAKGIGYLHSSEVNKPAIVHRNLSVEKVLIDQQFNPLIADCG 562
           +G+   L W  R  I  G A GI +LH         +HR++    +L+D+ F   I+D G
Sbjct: 125 DGTP-PLSWHMRCKIAQGAANGINFLHE-----NHHIHRDIKSANILLDEAFTAKISDFG 178

Query: 563 LHKLLADDIVFSVLKTSAAMG---YLAPEYVTTGRFTERSDIFAFGVIILQILTG----- 614
           L +         +  TS  +G   Y+APE +  G  T +SDI++FGV++L+I+TG     
Sbjct: 179 LARASEKFAQTVM--TSRIVGTTAYMAPEAL-RGEITPKSDIYSFGVVLLEIITGLPAVD 235

Query: 615 ------SLVLTSSMRLAAESATFENFIDRNLKGKFSESEAAKLGKMALVCTHEDPENRPT 668
                  L+      +  E  T E++ID+ +      +    +  +A  C HE    RP 
Sbjct: 236 EHREPQLLL-DIKEEIEDEEKTIEDYIDKKM-NDADSTSVEAMYSVASQCLHEKKNKRPD 293

Query: 669 MEAVIEEL 676
           ++ V + L
Sbjct: 294 IKKVQQLL 301

>1ogq_A PGIP-2, polygalacturonase inhibiting protein; inhibitor; HET: NAG; 1.7A {Phaseolus vulgaris} SCOP: c.10.2.8 Length = 313

 Score =  209 bits (534), Expect = 3e-62
 Identities = 76/222 (34%), Positives = 111/222 (50%), Gaps = 11/222 (4%)

Query: 22  VCGNTELRALLDLKASL-DPENKLLQSWTENGDPCSGSFEGIACNEHR---KVANISLQG 77
           +C   + +ALL +K  L +P    L SW    D C+ ++ G+ C+      +V N+ L G
Sbjct: 2   LCNPQDKQALLQIKKDLGNPTT--LSSWLPTTDCCNRTWLGVLCDTDTQTYRVNNLDLSG 59

Query: 78  KGLTG--KLSPSLSGLKCLSGLYLH-YNSLSGEIPKEIRNLTELTDLYLDVNNLSGNIPP 134
             L     +  SL+ L  L+ LY+   N+L G IP  I  LT+L  LY+   N+SG IP 
Sbjct: 60  LNLPKPYPIPSSLANLPYLNFLYIGGINNLVGPIPPAIAKLTQLHYLYITHTNVSGAIPD 119

Query: 135 EIGSMASLQVLQLCCNQLTGNIPAQIGSLKSLSVLTLQHNRLNGGIPDSLGNLGKLKR-L 193
            +  + +L  L    N L+G +P  I SL +L  +T   NR++G IPDS G+  KL   +
Sbjct: 120 FLSQIKTLVTLDFSYNALSGTLPPSISSLPNLVGITFDGNRISGAIPDSYGSFSKLFTSM 179

Query: 194 DLSFNSLFGTIPESLANNAELLFLDVQNNTLSGIVPSALKRL 235
            +S N L G IP + A N  L F+D+  N L G         
Sbjct: 180 TISRNRLTGKIPPTFA-NLNLAFVDLSRNMLEGDASVLFGSD 220

>1ogq_A PGIP-2, polygalacturonase inhibiting protein; inhibitor; HET: NAG; 1.7A {Phaseolus vulgaris} SCOP: c.10.2.8 Length = 313

 Score =  151 bits (384), Expect = 4e-41
 Identities = 54/188 (28%), Positives = 84/188 (44%), Gaps = 29/188 (15%)

Query: 73  ISLQGKGLTGKLSPSLSGLKCLS-GLYLHYNSLSGEIPKEIRNLTELTDLYLDVNNLSGN 131
           I+  G  ++G +  S      L   + +  N L+G+IP    NL  L  + L  N L G+
Sbjct: 154 ITFDGNRISGAIPDSYGSFSKLFTSMTISRNRLTGKIPPTFANLN-LAFVDLSRNMLEGD 212

Query: 132 IPPEIGSMASLQVLQLCCNQLTGNIPAQIGSLKSLSVLTLQHNRLNGGIPDSLGNLGKLK 191
                GS  + Q + L  N L  ++  ++G  K+L+ L L++NR+ G +P  L  L  L 
Sbjct: 213 ASVLFGSDKNTQKIHLAKNSLAFDLG-KVGLSKNLNGLDLRNNRIYGTLPQGLTQLKFLH 271

Query: 192 RLDLSFNSLFGTIPESLANNAELLFLDVQNNTLSGIVPSALKRLNGGFQFQNNPGLCGDG 251
            L++SFN+L G IP+                         L+R +    + NN  LCG  
Sbjct: 272 SLNVSFNNLCGEIPQG----------------------GNLQRFD-VSAYANNKCLCG-- 306

Query: 252 IASLRACT 259
            + L ACT
Sbjct: 307 -SPLPACT 313

>3soc_A Activin receptor type-2A; structural genomics consortium, SGC, transferase, protein KI; HET: GVD; 1.95A {Homo sapiens} PDB: 3q4t_A* 2qlu_A* Length = 322

 Score =  198 bits (505), Expect = 5e-58
 Identities = 70/319 (21%), Positives = 125/319 (39%), Gaps = 42/319 (13%)

Query: 390 SREHLNSFRLNLEEVESATQCFSEVNLLGKGNFSSVYKGTLRDGTLVAIRSINVTSCKSE 449
              H +   L  E +   +     + +  +G F  V+K  L     VA++   +   +S 
Sbjct: 5   HHHHSSGVDLGTENLYFQSMPLQLLEVKARGRFGCVWKAQLL-NEYVAVKIFPIQDKQSW 63

Query: 450 EAEFVKGLYLLTSLRHENIIRLRGFC--CSRGRGECFLIYDFAPKGKLSKYLDQEEGSSN 507
           + E+   +Y L  ++HENI++  G     +    + +LI  F  KG LS +L      +N
Sbjct: 64  QNEY--EVYSLPGMKHENILQFIGAEKRGTSVDVDLWLITAFHEKGSLSDFL-----KAN 116

Query: 508 VLDWSTRVSIIIGIAKGIGYLHS-----SEVNKPAIVHRNLSVEKVLIDQQFNPLIADCG 562
           V+ W+    I   +A+G+ YLH       + +KPAI HR++  + VL+       IAD G
Sbjct: 117 VVSWNELCHIAETMARGLAYLHEDIPGLKDGHKPAISHRDIKSKNVLLKNNLTACIADFG 176

Query: 563 LHKLLADDIVFSVLKTSAAMG---YLAPEYV-----TTGRFTERSDIFAFGVIILQILTG 614
           L          S   T   +G   Y+APE +            R D++A G+++ ++ + 
Sbjct: 177 LALKFEAGK--SAGDTHGQVGTRRYMAPEVLEGAINFQRDAFLRIDMYAMGLVLWELASR 234

Query: 615 SLVLTSSMR--------LAAESATFENFIDRNLKGK---------FSESEAAKLGKMALV 657
                  +            +  + E+  +  +  K            +  A L +    
Sbjct: 235 CTAADGPVDEYMLPFEEEIGQHPSLEDMQEVVVHKKKRPVLRDYWQKHAGMAMLCETIEE 294

Query: 658 CTHEDPENRPTMEAVIEEL 676
           C   D E R +   V E +
Sbjct: 295 CWDHDAEARLSAGCVGERI 313

>3g2f_A Bone morphogenetic protein receptor type-2; kinase, structural genomics, structural genomics consortium, ATP-binding, disease mutation; HET: ADP; 2.35A {Homo sapiens} Length = 336

 Score =  172 bits (438), Expect = 2e-48
 Identities = 72/316 (22%), Positives = 125/316 (39%), Gaps = 49/316 (15%)

Query: 402 EEVESATQCFSEVNLLGKGNFSSVYKGTLRDGTLVAIRSINVTSCKSEEAEFVKGLYLLT 461
            E          + L+G+G + +VYKG+L     VA++  +  + ++   E  K +Y + 
Sbjct: 6   SEPSLDLDNLKLLELIGRGRYGAVYKGSLD-ERPVAVKVFSFANRQNFINE--KNIYRVP 62

Query: 462 SLRHENIIRLRGFC---CSRGRGECFLIYDFAPKGKLSKYLDQEEGSSNVLDWSTRVSII 518
            + H+NI R         + GR E  L+ ++ P G L KYL     S +  DW +   + 
Sbjct: 63  LMEHDNIARFIVGDERVTADGRMEYLLVMEYYPNGSLXKYL-----SLHTSDWVSSCRLA 117

Query: 519 IGIAKGIGYLHSSEVN----KPAIVHRNLSVEKVLIDQQFNPLIADCGLHKLLADDIVFS 574
             + +G+ YLH+        KPAI HR+L+   VL+      +I+D GL   L  + +  
Sbjct: 118 HSVTRGLAYLHTELPRGDHYKPAISHRDLNSRNVLVKNDGTCVISDFGLSMRLTGNRLVR 177

Query: 575 VLKTSAAM-------GYLAPEY-------VTTGRFTERSDIFAFGVIILQILTGSLVLTS 620
             +   A         Y+APE               ++ D++A G+I  +I      L  
Sbjct: 178 PGEEDNAAISEVGTIRYMAPEVLEGAVNLRDXESALKQVDMYALGLIYWEIFMRCTDLFP 237

Query: 621 S-----MRLAAESA-----TFENFIDRNLKGKF----------SESEAAKLGKMALVCTH 660
                  ++A ++      TFE+      + K           +      L +    C  
Sbjct: 238 GESVPEYQMAFQTEVGNHPTFEDMQVLVSREKQRPKFPEAWKENSLAVRSLKETIEDCWD 297

Query: 661 EDPENRPTMEAVIEEL 676
           +D E R T +   E +
Sbjct: 298 QDAEARLTAQXAEERM 313

>3rgz_A Protein brassinosteroid insensitive 1; phytohormone, leucine-rich RE receptor-like kinases, leucine-rich repeat; HET: NAG BLD; 2.28A {Arabidopsis thaliana} PDB: 3rgx_A* 3riz_A* 3rj0_A* Length = 768

 Score =  175 bits (446), Expect = 2e-46
 Identities = 65/163 (39%), Positives = 97/163 (59%)

Query: 73  ISLQGKGLTGKLSPSLSGLKCLSGLYLHYNSLSGEIPKEIRNLTELTDLYLDVNNLSGNI 132
           + LQ  G TGK+ P+LS    L  L+L +N LSG IP  + +L++L DL L +N L G I
Sbjct: 399 LYLQNNGFTGKIPPTLSNCSELVSLHLSFNYLSGTIPSSLGSLSKLRDLKLWLNMLEGEI 458

Query: 133 PPEIGSMASLQVLQLCCNQLTGNIPAQIGSLKSLSVLTLQHNRLNGGIPDSLGNLGKLKR 192
           P E+  + +L+ L L  N LTG IP+ + +  +L+ ++L +NRL G IP  +G L  L  
Sbjct: 459 PQELMYVKTLETLILDFNDLTGEIPSGLSNCTNLNWISLSNNRLTGEIPKWIGRLENLAI 518

Query: 193 LDLSFNSLFGTIPESLANNAELLFLDVQNNTLSGIVPSALKRL 235
           L LS NS  G IP  L +   L++LD+  N  +G +P+A+ + 
Sbjct: 519 LKLSNNSFSGNIPAELGDCRSLIWLDLNTNLFNGTIPAAMFKQ 561

>3rgz_A Protein brassinosteroid insensitive 1; phytohormone, leucine-rich RE receptor-like kinases, leucine-rich repeat; HET: NAG BLD; 2.28A {Arabidopsis thaliana} PDB: 3rgx_A* 3riz_A* 3rj0_A* Length = 768

 Score =  170 bits (432), Expect = 1e-44
 Identities = 59/158 (37%), Positives = 84/158 (53%), Gaps = 2/158 (1%)

Query: 80  LTGKLSPSL--SGLKCLSGLYLHYNSLSGEIPKEIRNLTELTDLYLDVNNLSGNIPPEIG 137
            +G + P+L  +    L  LYL  N  +G+IP  + N +EL  L+L  N LSG IP  +G
Sbjct: 380 FSGPILPNLCQNPKNTLQELYLQNNGFTGKIPPTLSNCSELVSLHLSFNYLSGTIPSSLG 439

Query: 138 SMASLQVLQLCCNQLTGNIPAQIGSLKSLSVLTLQHNRLNGGIPDSLGNLGKLKRLDLSF 197
           S++ L+ L+L  N L G IP ++  +K+L  L L  N L G IP  L N   L  + LS 
Sbjct: 440 SLSKLRDLKLWLNMLEGEIPQELMYVKTLETLILDFNDLTGEIPSGLSNCTNLNWISLSN 499

Query: 198 NSLFGTIPESLANNAELLFLDVQNNTLSGIVPSALKRL 235
           N L G IP+ +     L  L + NN+ SG +P+ L   
Sbjct: 500 NRLTGEIPKWIGRLENLAILKLSNNSFSGNIPAELGDC 537

>3rgz_A Protein brassinosteroid insensitive 1; phytohormone, leucine-rich RE receptor-like kinases, leucine-rich repeat; HET: NAG BLD; 2.28A {Arabidopsis thaliana} PDB: 3rgx_A* 3riz_A* 3rj0_A* Length = 768

 Score =  169 bits (430), Expect = 2e-44
 Identities = 56/183 (30%), Positives = 85/183 (46%), Gaps = 13/183 (7%)

Query: 75  LQGKGLTGKLSPSLSGLKCLSGLYLHYN--SLSGEIPKEIRNLTELTDLYLDVNNLSGNI 132
           +    + GK    +         +   N     G   +++  L+      +      G+ 
Sbjct: 565 IAANFIAGKRYVYIKNDGMKKECHGAGNLLEFQGIRSEQLNRLSTRNPCNITSRVYGGHT 624

Query: 133 PPEIGSMASLQVLQLCCNQLTGNIPAQIGSLKSLSVLTLQHNRLNGGIPDSLGNLGKLKR 192
            P   +  S+  L +  N L+G IP +IGS+  L +L L HN ++G IPD +G+L  L  
Sbjct: 625 SPTFDNNGSMMFLDMSYNMLSGYIPKEIGSMPYLFILNLGHNDISGSIPDEVGDLRGLNI 684

Query: 193 LDLSFNSLFGTIPESLANNAELLFLDVQNNTLSGIVPSALKRLNGGFQ------FQNNPG 246
           LDLS N L G IP++++    L  +D+ NN LSG +P       G F+      F NNPG
Sbjct: 685 LDLSSNKLDGRIPQAMSALTMLTEIDLSNNNLSGPIPE-----MGQFETFPPAKFLNNPG 739

Query: 247 LCG 249
           LCG
Sbjct: 740 LCG 742

>3rgz_A Protein brassinosteroid insensitive 1; phytohormone, leucine-rich RE receptor-like kinases, leucine-rich repeat; HET: NAG BLD; 2.28A {Arabidopsis thaliana} PDB: 3rgx_A* 3riz_A* 3rj0_A* Length = 768

 Score =  168 bits (429), Expect = 3e-44
 Identities = 59/245 (24%), Positives = 93/245 (37%), Gaps = 39/245 (15%)

Query: 23  CGNTELRALLDLKASLDPENKLLQSWTENGDPCSGSFEGIACNEHRKVANISLQGKGLTG 82
               E+  L+  K  L  +N LL  W+ N +PC+  F+G+ C + + V +I L  K L  
Sbjct: 9   SLYREIHQLISFKDVLPDKN-LLPDWSSNKNPCT--FDGVTCRDDK-VTSIDLSSKPLNV 64

Query: 83  KLS--------------------------PSLSGLKCLSGLYLHYNSLSGEIP--KEIRN 114
             S                                  L+ L L  NSLSG +     + +
Sbjct: 65  GFSAVSSSLLSLTGLESLFLSNSHINGSVSGFKCSASLTSLDLSRNSLSGPVTTLTSLGS 124

Query: 115 LTELTDLYLDVNNLSGNIP-PEIGSMASLQVLQLCCNQLTGNIPAQI---GSLKSLSVLT 170
            + L  L +  N L           + SL+VL L  N ++G              L  L 
Sbjct: 125 CSGLKFLNVSSNTLDFPGKVSGGLKLNSLEVLDLSANSISGANVVGWVLSDGCGELKHLA 184

Query: 171 LQHNRLNGGIPDSLGNLGKLKRLDLSFNSLFGTIPESLANNAELLFLDVQNNTLSGIVPS 230
           +  N+++G +   +     L+ LD+S N+    IP  L + + L  LD+  N LSG    
Sbjct: 185 ISGNKISGDVD--VSRCVNLEFLDVSSNNFSTGIP-FLGDCSALQHLDISGNKLSGDFSR 241

Query: 231 ALKRL 235
           A+   
Sbjct: 242 AISTC 246

>3rgz_A Protein brassinosteroid insensitive 1; phytohormone, leucine-rich RE receptor-like kinases, leucine-rich repeat; HET: NAG BLD; 2.28A {Arabidopsis thaliana} PDB: 3rgx_A* 3riz_A* 3rj0_A* Length = 768

 Score =  165 bits (421), Expect = 4e-43
 Identities = 58/185 (31%), Positives = 83/185 (44%), Gaps = 4/185 (2%)

Query: 56  SGSFEGIACNEHRKVANISLQGKGLTGKLSPSLSGLKCLSGLYLHYNSLSGEIPKE-IRN 114
           +G            +  + L G    G + P       L  L L  N+ SGE+P + +  
Sbjct: 282 TGEIPDFLSGACDTLTGLDLSGNHFYGAVPPFFGSCSLLESLALSSNNFSGELPMDTLLK 341

Query: 115 LTELTDLYLDVNNLSGNIPPEIGSM-ASLQVLQLCCNQLTGNIPAQIG--SLKSLSVLTL 171
           +  L  L L  N  SG +P  + ++ ASL  L L  N  +G I   +      +L  L L
Sbjct: 342 MRGLKVLDLSFNEFSGELPESLTNLSASLLTLDLSSNNFSGPILPNLCQNPKNTLQELYL 401

Query: 172 QHNRLNGGIPDSLGNLGKLKRLDLSFNSLFGTIPESLANNAELLFLDVQNNTLSGIVPSA 231
           Q+N   G IP +L N  +L  L LSFN L GTIP SL + ++L  L +  N L G +P  
Sbjct: 402 QNNGFTGKIPPTLSNCSELVSLHLSFNYLSGTIPSSLGSLSKLRDLKLWLNMLEGEIPQE 461

Query: 232 LKRLN 236
           L  + 
Sbjct: 462 LMYVK 466

>3rgz_A Protein brassinosteroid insensitive 1; phytohormone, leucine-rich RE receptor-like kinases, leucine-rich repeat; HET: NAG BLD; 2.28A {Arabidopsis thaliana} PDB: 3rgx_A* 3riz_A* 3rj0_A* Length = 768

 Score =  158 bits (403), Expect = 7e-41
 Identities = 56/156 (35%), Positives = 82/156 (52%), Gaps = 4/156 (2%)

Query: 80  LTGKLSPSLSGLKCLSGLYLHYNSLSGEIPKEIRNLTELTDLYLDVNNLSGNIPPEIGSM 139
           L+G +  SL  L  L  L L  N L GEIP+E+  +  L  L LD N+L+G IP  + + 
Sbjct: 430 LSGTIPSSLGSLSKLRDLKLWLNMLEGEIPQELMYVKTLETLILDFNDLTGEIPSGLSNC 489

Query: 140 ASLQVLQLCCNQLTGNIPAQIGSLKSLSVLTLQHNRLNGGIPDSLGNLGKLKRLDLSFNS 199
            +L  + L  N+LTG IP  IG L++L++L L +N  +G IP  LG+   L  LDL+ N 
Sbjct: 490 TNLNWISLSNNRLTGEIPKWIGRLENLAILKLSNNSFSGNIPAELGDCRSLIWLDLNTNL 549

Query: 200 LFGTIPESLANNAELLFLDVQNNTLSGIVPSALKRL 235
             GTIP ++          +  N ++G     +K  
Sbjct: 550 FNGTIPAAMFK----QSGKIAANFIAGKRYVYIKND 581

>3rgz_A Protein brassinosteroid insensitive 1; phytohormone, leucine-rich RE receptor-like kinases, leucine-rich repeat; HET: NAG BLD; 2.28A {Arabidopsis thaliana} PDB: 3rgx_A* 3riz_A* 3rj0_A* Length = 768

 Score =  155 bits (394), Expect = 9e-40
 Identities = 59/168 (35%), Positives = 81/168 (48%), Gaps = 5/168 (2%)

Query: 72  NISLQGKGLTGKLSPSLSGLKCLSGLYLHYNSLSGEIPKEIRNLTELTDLYLDVNNLSGN 131
           ++ + G  L+G  S ++S    L  L +  N   G IP     L  L  L L  N  +G 
Sbjct: 227 HLDISGNKLSGDFSRAISTCTELKLLNISSNQFVGPIPPL--PLKSLQYLSLAENKFTGE 284

Query: 132 IPPEI-GSMASLQVLQLCCNQLTGNIPAQIGSLKSLSVLTLQHNRLNGGIP-DSLGNLGK 189
           IP  + G+  +L  L L  N   G +P   GS   L  L L  N  +G +P D+L  +  
Sbjct: 285 IPDFLSGACDTLTGLDLSGNHFYGAVPPFFGSCSLLESLALSSNNFSGELPMDTLLKMRG 344

Query: 190 LKRLDLSFNSLFGTIPESLAN-NAELLFLDVQNNTLSGIVPSALKRLN 236
           LK LDLSFN   G +PESL N +A LL LD+ +N  SG +   L +  
Sbjct: 345 LKVLDLSFNEFSGELPESLTNLSASLLTLDLSSNNFSGPILPNLCQNP 392

>3rgz_A Protein brassinosteroid insensitive 1; phytohormone, leucine-rich RE receptor-like kinases, leucine-rich repeat; HET: NAG BLD; 2.28A {Arabidopsis thaliana} PDB: 3rgx_A* 3riz_A* 3rj0_A* Length = 768

 Score =  148 bits (377), Expect = 1e-37
 Identities = 52/158 (32%), Positives = 75/158 (47%), Gaps = 6/158 (3%)

Query: 80  LTGKLSPSLSGLKCLSGLYLHYNSLSGEIPKEIRNLTELTDLYLDVNNLSGNIPPEIGSM 139
           L G++   L  +K L  L L +N L+GEIP  + N T L  + L  N L+G IP  IG +
Sbjct: 454 LEGEIPQELMYVKTLETLILDFNDLTGEIPSGLSNCTNLNWISLSNNRLTGEIPKWIGRL 513

Query: 140 ASLQVLQLCCNQLTGNIPAQIGSLKSLSVLTLQHNRLNGGIPDSLGNLGKLKRLDLSFNS 199
            +L +L+L  N  +GNIPA++G  +SL  L L  N  NG IP ++          ++ N 
Sbjct: 514 ENLAILKLSNNSFSGNIPAELGDCRSLIWLDLNTNLFNGTIPAAMFKQ----SGKIAANF 569

Query: 200 LFGTIPESLANNAELLFLDVQNNT--LSGIVPSALKRL 235
           + G     + N+          N     GI    L RL
Sbjct: 570 IAGKRYVYIKNDGMKKECHGAGNLLEFQGIRSEQLNRL 607

>3rgz_A Protein brassinosteroid insensitive 1; phytohormone, leucine-rich RE receptor-like kinases, leucine-rich repeat; HET: NAG BLD; 2.28A {Arabidopsis thaliana} PDB: 3rgx_A* 3riz_A* 3rj0_A* Length = 768

 Score =  146 bits (370), Expect = 1e-36
 Identities = 40/164 (24%), Positives = 68/164 (41%), Gaps = 9/164 (5%)

Query: 73  ISLQGKGLTGKLS-PSLSGLKCLSGLYLHYNSLSGEIPKEIR---NLTELTDLYLDVNNL 128
           +++    L           L  L  L L  NS+SG             EL  L +  N +
Sbjct: 131 LNVSSNTLDFPGKVSGGLKLNSLEVLDLSANSISGANVVGWVLSDGCGELKHLAISGNKI 190

Query: 129 SGNIPPEIGSMASLQVLQLCCNQLTGNIPAQIGSLKSLSVLTLQHNRLNGGIPDSLGNLG 188
           SG++   +    +L+ L +  N  +  IP  +G   +L  L +  N+L+G    ++    
Sbjct: 191 SGDVD--VSRCVNLEFLDVSSNNFSTGIPF-LGDCSALQHLDISGNKLSGDFSRAISTCT 247

Query: 189 KLKRLDLSFNSLFGTIPESLANNAELLFLDVQNNTLSGIVPSAL 232
           +LK L++S N   G IP     +  L +L +  N  +G +P  L
Sbjct: 248 ELKLLNISSNQFVGPIPPLPLKS--LQYLSLAENKFTGEIPDFL 289

>3rgz_A Protein brassinosteroid insensitive 1; phytohormone, leucine-rich RE receptor-like kinases, leucine-rich repeat; HET: NAG BLD; 2.28A {Arabidopsis thaliana} PDB: 3rgx_A* 3riz_A* 3rj0_A* Length = 768

 Score =  114 bits (287), Expect = 2e-26
 Identities = 40/111 (36%), Positives = 62/111 (55%)

Query: 73  ISLQGKGLTGKLSPSLSGLKCLSGLYLHYNSLSGEIPKEIRNLTELTDLYLDVNNLSGNI 132
            ++  +   G  SP+      +  L + YN LSG IPKEI ++  L  L L  N++SG+I
Sbjct: 613 CNITSRVYGGHTSPTFDNNGSMMFLDMSYNMLSGYIPKEIGSMPYLFILNLGHNDISGSI 672

Query: 133 PPEIGSMASLQVLQLCCNQLTGNIPAQIGSLKSLSVLTLQHNRLNGGIPDS 183
           P E+G +  L +L L  N+L G IP  + +L  L+ + L +N L+G IP+ 
Sbjct: 673 PDEVGDLRGLNILDLSSNKLDGRIPQAMSALTMLTEIDLSNNNLSGPIPEM 723

>3q4u_A Activin receptor type-1; structural genomics consortium, SGC, protein kinase, transfe; HET: LDN FLC; 1.82A {Homo sapiens} PDB: 3mtf_A* 3oom_A* 4dym_A* 3h9r_A* 3my0_A* Length = 301

 Score =  154 bits (391), Expect = 3e-42
 Identities = 70/294 (23%), Positives = 119/294 (40%), Gaps = 40/294 (13%)

Query: 414 VNLLGKGNFSSVYKGTLRDGTLVAIRSINVTSCKSEEAEFVKGLYLLTSLRHENIIRLRG 473
           +  +GKG +  V++G+ + G  VA++  +    KS   E    LY    LRHENI+    
Sbjct: 13  LECVGKGRYGEVWRGSWQ-GENVAVKIFSSRDEKSWFRE--TELYNTVMLRHENILGFIA 69

Query: 474 FCCSRGRG---ECFLIYDFAPKGKLSKYLDQEEGSSNVLDWSTRVSIIIGIAKGIGYLHS 530
                 R    + +LI  +   G L  YL         LD  + + I++ IA G+ +LH 
Sbjct: 70  -SDMTSRHSSTQLWLITHYHEMGSLYDYL-----QLTTLDTVSCLRIVLSIASGLAHLHI 123

Query: 531 ---SEVNKPAIVHRNLSVEKVLIDQQFNPLIADCGLHKLLADDIVFSVLKTSAAMG---Y 584
                  KPAI HR+L  + +L+ +     IAD GL  + +       +  +  +G   Y
Sbjct: 124 EIFGTQGKPAIAHRDLKSKNILVKKNGQCCIADLGLAVMHSQSTNQLDVGNNPRVGTKRY 183

Query: 585 LAPE------YVTTGRFTERSDIFAFGVIILQILTGSLVLTSSMR-------LAAESATF 631
           +APE       V      +R DI+AFG+++ ++    +              +     +F
Sbjct: 184 MAPEVLDETIQVDCFDSYKRVDIWAFGLVLWEVARRMVSNGIVEDYKPPFYDVVPNDPSF 243

Query: 632 ENFID----RNL-----KGKFSESEAAKLGKMALVCTHEDPENRPTMEAVIEEL 676
           E+                  FS+     L K+   C +++P  R T   + + L
Sbjct: 244 EDMRKVVCVDQQRPNIPNRWFSDPTLTSLAKLMKECWYQNPSARLTALRIKKTL 297

>3mdy_A Bone morphogenetic protein receptor type-1B; complex (isomerase-protein kinase), receptor serine/threonin structural genomics consortium, SGC; HET: LDN; 2.05A {Homo sapiens} Length = 337

 Score =  154 bits (390), Expect = 8e-42
 Identities = 68/294 (23%), Positives = 117/294 (39%), Gaps = 40/294 (13%)

Query: 414 VNLLGKGNFSSVYKGTLRDGTLVAIRSINVTSCKSEEAEFVKGLYLLTSLRHENIIRLRG 473
           V  +GKG +  V+ G  R G  VA++    T   S   E    +Y    +RHENI+    
Sbjct: 42  VKQIGKGRYGEVWMGKWR-GEKVAVKVFFTTEEASWFRE--TEIYQTVLMRHENILGFIA 98

Query: 474 FCCSRGRG---ECFLIYDFAPKGKLSKYLDQEEGSSNVLDWSTRVSIIIGIAKGIGYLHS 530
               +G G   + +LI D+   G L  YL      S  LD  + + +      G+ +LH+
Sbjct: 99  -ADIKGTGSWTQLYLITDYHENGSLYDYL-----KSTTLDAKSMLKLAYSSVSGLCHLHT 152

Query: 531 S---EVNKPAIVHRNLSVEKVLIDQQFNPLIADCGLHKLLADDIVFSVLKTSAAMG---Y 584
                  KPAI HR+L  + +L+ +     IAD GL      D     +  +  +G   Y
Sbjct: 153 EIFSTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAVKFISDTNEVDIPPNTRVGTKRY 212

Query: 585 LAPE------YVTTGRFTERSDIFAFGVIILQILTGSLVLTSSMR-------LAAESATF 631
           + PE           +    +D+++FG+I+ ++    +              L     ++
Sbjct: 213 MPPEVLDESLNRNHFQSYIMADMYSFGLILWEVARRCVSGGIVEEYQLPYHDLVPSDPSY 272

Query: 632 ENFID----RNL-----KGKFSESEAAKLGKMALVCTHEDPENRPTMEAVIEEL 676
           E+  +    + L         S+    ++GK+   C   +P +R T   V + L
Sbjct: 273 EDMREIVCIKKLRPSFPNRWSSDECLRQMGKLMTECWAHNPASRLTALRVKKTL 326

>2eva_A TAK1 kinase - TAB1 chimera fusion protein; transferase/transferase activator complex; HET: ADN; 2.00A {Homo sapiens} Length = 307

 Score =  151 bits (383), Expect = 4e-41
 Identities = 62/277 (22%), Positives = 120/277 (43%), Gaps = 34/277 (12%)

Query: 411 FSEVNL---LGKGNFSSVYKGTLRDGTLVAIRSINVTSCKSEEAEFVKGLYLLTSLRHEN 467
           + E+ +   +G+G F  V K   R    VAI+ I     +SE   F+  L  L+ + H N
Sbjct: 7   YKEIEVEEVVGRGAFGVVCKAKWR-AKDVAIKQIES---ESERKAFIVELRQLSRVNHPN 62

Query: 468 IIRLRGFCCSRGRGECFLIYDFAPKGKLSKYLDQEEGSSNVLDWSTRVSIIIGIAKGIGY 527
           I++L G C +       L+ ++A  G L   L   E        +  +S  +  ++G+ Y
Sbjct: 63  IVKLYGACLN----PVCLVMEYAEGGSLYNVLHGAEPLPY-YTAAHAMSWCLQCSQGVAY 117

Query: 528 LHSSEVNKPAIVHRNLSVEKVLIDQQFNPL-IADCGLHKLLADDIVFSVLKTSAA--MGY 584
           LHS +    A++HR+L    +L+      L I D G    +          T+      +
Sbjct: 118 LHSMQPK--ALIHRDLKPPNLLLVAGGTVLKICDFGTACDIQTH------MTNNKGSAAW 169

Query: 585 LAPEYVTTGRFTERSDIFAFGVIILQILTGSL----VLTSSMRLAAESATFENFIDRNLK 640
           +APE      ++E+ D+F++G+I+ +++T       +   + R+          +    +
Sbjct: 170 MAPEVFEGSNYSEKCDVFSWGIILWEVITRRKPFDEIGGPAFRIMWA-------VHNGTR 222

Query: 641 GKFSESEAAKLGKMALVCTHEDPENRPTMEAVIEELT 677
               ++    +  +   C  +DP  RP+ME +++ +T
Sbjct: 223 PPLIKNLPKPIESLMTRCWSKDPSQRPSMEEIVKIMT 259

>1b6c_B TGF-B superfamily receptor type I; complex (isomerase/protein kinase), receptor serine/threonine kinase; 2.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1ias_A 2x7o_A* 3faa_A* 3kcf_A* Length = 342

 Score =  151 bits (382), Expect = 1e-40
 Identities = 70/341 (20%), Positives = 120/341 (35%), Gaps = 43/341 (12%)

Query: 367 PLVSLEYCHGWDPLGDYLNGTGFSREHLNSFRLNLEEVESATQ-CFSEVNLLGKGNFSSV 425
           P +   +      L D +     S     S    L +   A      E   +GKG F  V
Sbjct: 3   PSLDRPFISEGTTLKDLIYDMTTS--GSGSGLPLLVQRTIARTIVLQES--IGKGRFGEV 58

Query: 426 YKGTLRDGTLVAIRSINVTSCKSEEAEFVKGLYLLTSLRHENIIRLRGFC--CSRGRGEC 483
           ++G  R G  VA++  +    +S   E    +Y    LRHENI+         +    + 
Sbjct: 59  WRGKWR-GEEVAVKIFSSREERSWFRE--AEIYQTVMLRHENILGFIAADNKDNGTWTQL 115

Query: 484 FLIYDFAPKGKLSKYLDQEEGSSNVLDWSTRVSIIIGIAKGIGYLHS---SEVNKPAIVH 540
           +L+ D+   G L  YL     +   +     + + +  A G+ +LH        KPAI H
Sbjct: 116 WLVSDYHEHGSLFDYL-----NRYTVTVEGMIKLALSTASGLAHLHMEIVGTQGKPAIAH 170

Query: 541 RNLSVEKVLIDQQFNPLIADCGLHKLLADDIVFSVLKTSAAMG---YLAPE------YVT 591
           R+L  + +L+ +     IAD GL            +  +  +G   Y+APE       + 
Sbjct: 171 RDLKSKNILVKKNGTCCIADLGLAVRHDSATDTIDIAPNHRVGTKRYMAPEVLDDSINMK 230

Query: 592 TGRFTERSDIFAFGVIILQILTGSLVLTSSMR-------LAAESATFENFID----RNL- 639
                +R+DI+A G++  +I     +             L     + E        + L 
Sbjct: 231 HFESFKRADIYAMGLVFWEIARRCSIGGIHEDYQLPYYDLVPSDPSVEEMRKVVCEQKLR 290

Query: 640 ----KGKFSESEAAKLGKMALVCTHEDPENRPTMEAVIEEL 676
                   S      + K+   C + +   R T   + + L
Sbjct: 291 PNIPNRWQSCEALRVMAKIMRECWYANGAARLTALRIKKTL 331

>3kmu_A ILK, integrin-linked kinase; cell adhesion, ANK repeat, ATP-binding, cell junction, cell membrane, integrin-binding protein, membrane, nucleotide- binding; 1.80A {Homo sapiens} PDB: 3kmw_A* 3rep_A* Length = 271

 Score =  147 bits (373), Expect = 4e-40
 Identities = 58/282 (20%), Positives = 117/282 (41%), Gaps = 41/282 (14%)

Query: 411 FSEVNL---LGKGNFSSVYKGTLRDGTLVAIRSINVTSCKSE-EAEFVKGLYLLTSLRHE 466
           F ++N    L + +   ++KG  + G  + ++ + V    +    +F +    L    H 
Sbjct: 9   FKQLNFLTKLNENHSGELWKGRWQ-GNDIVVKVLKVRDWSTRKSRDFNEECPRLRIFSHP 67

Query: 467 NIIRLRGFCCSRGRGECFLIYDFAPKGKLSKYLDQEEGSSNVLDWSTRVSIIIGIAKGIG 526
           N++ + G C S       LI  + P G L   L   EG++ V+D S  V   + +A+G+ 
Sbjct: 68  NVLPVLGACQSPPAPHPTLITHWMPYGSLYNVL--HEGTNFVVDQSQAVKFALDMARGMA 125

Query: 527 YLHSSEVNKPAIVHRNLSVEKVLIDQQFNPLIADCGLHKLLADDIVFSVLKTSAAMG--- 583
           +LH+    +P I    L+   V+ID+     I+   +             ++   M    
Sbjct: 126 FLHTL---EPLIPRHALNSRSVMIDEDMTARISMADVKF---------SFQSPGRMYAPA 173

Query: 584 YLAPEYVTTGR----FTERSDIFAFGVIILQILTGS-----LVLTSSMRLAAESATFENF 634
           ++APE     +        +D+++F V++ +++T       L   S+M +  + A     
Sbjct: 174 WVAPE-ALQKKPEDTNRRSADMWSFAVLLWELVTREVPFADL---SNMEIGMKVAL---- 225

Query: 635 IDRNLKGKFSESEAAKLGKMALVCTHEDPENRPTMEAVIEEL 676
               L+       +  + K+  +C +EDP  RP  + ++  L
Sbjct: 226 --EGLRPTIPPGISPHVSKLMKICMNEDPAKRPKFDMIVPIL 265

>3p86_A Serine/threonine-protein kinase CTR1; ETR1, ERS1, ETR2, phosphorylation, transferase; HET: STU; 2.50A {Arabidopsis thaliana} PDB: 3ppz_A* Length = 309

 Score =  147 bits (373), Expect = 9e-40
 Identities = 66/286 (23%), Positives = 129/286 (45%), Gaps = 48/286 (16%)

Query: 411 FSEVNL---LGKGNFSSVYKGTLRDGTLVAIRSINVTSCKSE-EAEFVKGLYLLTSLRHE 466
           + ++N+   +G G+F +V++     G+ VA++ +      +E   EF++ + ++  LRH 
Sbjct: 36  WCDLNIKEKIGAGSFGTVHRAEWH-GSDVAVKILMEQDFHAERVNEFLREVAIMKRLRHP 94

Query: 467 NIIRLRGFCCSRGRGECFLIYDFAPKGKLSKYLDQEEGSSNVLDWSTRVSIIIGIAKGIG 526
           NI+   G           ++ ++  +G L + L  + G+   LD   R+S+   +AKG+ 
Sbjct: 95  NIVLFMGAVTQPPN--LSIVTEYLSRGSLYRLL-HKSGAREQLDERRRLSMAYDVAKGMN 151

Query: 527 YLHSSEVNKPAIVHRNLSVEKVLIDQQFNPLIADCGLHKLLADDIVFSVLKTSAAMG--- 583
           YLH+     P IVHRNL    +L+D+++   + D GL +L A   +     + +A G   
Sbjct: 152 YLHN---RNPPIVHRNLKSPNLLVDKKYTVKVCDFGLSRLKASTFL----SSKSAAGTPE 204

Query: 584 YLAPEYVTTGRFTERSDIFAFGVIILQILTGSL-------------VLTSSMRLAAESAT 630
           ++APE +      E+SD+++FGVI+ ++ T                V     RL      
Sbjct: 205 WMAPEVLRDEPSNEKSDVYSFGVILWELATLQQPWGNLNPAQVVAAVGFKCKRL------ 258

Query: 631 FENFIDRNLKGKFSESEAAKLGKMALVCTHEDPENRPTMEAVIEEL 676
                      +   +   ++  +   C   +P  RP+   +++ L
Sbjct: 259 -----------EIPRNLNPQVAAIIEGCWTNEPWKRPSFATIMDLL 293

>4f0f_A Serine/threonine-protein kinase ROCO4; LRRK2, ATP-binding, nucleotide serine/threonine-protein kinase, transferase, signaling Pro; HET: ACP; 1.80A {Dictyostelium discoideum} PDB: 4f0g_A 4f1t_A* 4f1m_A* 4f1o_A* Length = 287

 Score =  144 bits (365), Expect = 6e-39
 Identities = 69/292 (23%), Positives = 131/292 (44%), Gaps = 49/292 (16%)

Query: 411 FSEVNL---LGKGNFSSVYKGTLR-DGTLVAIRSINVTSCKSEE------AEFVKGLYLL 460
            +E+     +GKG F  V+KG L  D ++VAI+S+ +   + E        EF + ++++
Sbjct: 18  DNEIEYEKQIGKGGFGLVHKGRLVKDKSVVAIKSLILGDSEGETEMIEKFQEFQREVFIM 77

Query: 461 TSLRHENIIRLRGFCCSRGRGECFLIYDFAPKGKLSKYLDQEEGSSNVLDWSTRVSIIIG 520
           ++L H NI++L G           ++ +F P G L   L  +   ++ + WS ++ +++ 
Sbjct: 78  SNLNHPNIVKLYGLM----HNPPRMVMEFVPCGDLYHRLLDK---AHPIKWSVKLRLMLD 130

Query: 521 IAKGIGYLHSSEVNKPAIVHR-----NLSVEKVLIDQQFNPLIADCGLHKLLADDIVFSV 575
           IA GI Y+ +     P IVHR     N+ ++ +  +      +AD GL +          
Sbjct: 131 IALGIEYMQN---QNPPIVHRDLRSPNIFLQSLDENAPVCAKVADFGLSQQSVHS----- 182

Query: 576 LKTSAAMG---YLAPEYVTTGR---FTERSDIFAFGVIILQILTGSL----VLTSSMRLA 625
              S  +G   ++APE         +TE++D ++F +I+  ILTG           ++  
Sbjct: 183 --VSGLLGNFQWMAPE-TIGAEEESYTEKADTYSFAMILYTILTGEGPFDEYSYGKIKFI 239

Query: 626 AESATFENFIDRNLKGKFSESEAAKLGKMALVCTHEDPENRPTMEAVIEELT 677
                     +  L+    E    +L  +  +C   DP+ RP    +++EL+
Sbjct: 240 NM------IREEGLRPTIPEDCPPRLRNVIELCWSGDPKKRPHFSYIVKELS 285

>3dtc_A Mitogen-activated protein kinase kinase kinase 9; mixed-lineage kinase, MLK family, MLK1 and MLK3 subtype selective inhibitors; HET: VIN; 2.60A {Homo sapiens} Length = 271

 Score =  142 bits (360), Expect = 2e-38
 Identities = 69/282 (24%), Positives = 116/282 (41%), Gaps = 35/282 (12%)

Query: 411 FSEVNL---LGKGNFSSVYKGTLRDGTLVAI---RSINVTSCKSEEAEFVKGLYLLTSLR 464
           F+E+ L   +G G F  VY+     G  VA+   R               +   L   L+
Sbjct: 6   FAELTLEEIIGIGGFGKVYRAFWI-GDEVAVKAARHDPDEDISQTIENVRQEAKLFAMLK 64

Query: 465 HENIIRLRGFCCSRGRGECFLIYDFAPKGKLSKYLDQEEGSSNVLDWSTRVSIIIGIAKG 524
           H NII LRG C         L+ +FA  G L++ L  +      +     V+  + IA+G
Sbjct: 65  HPNIIALRGVCLKEPN--LCLVMEFARGGPLNRVLSGKR-----IPPDILVNWAVQIARG 117

Query: 525 IGYLHSSEVNKPAIVHRNLSVEKVLIDQQFNPL--------IADCGLHKLLADDIVFSVL 576
           + YLH        I+HR+L    +LI Q+            I D GL +        S  
Sbjct: 118 MNYLHDE--AIVPIIHRDLKSSNILILQKVENGDLSNKILKITDFGLAREWHRTTKMSAA 175

Query: 577 KTSAAMGYLAPEYVTTGRFTERSDIFAFGVIILQILTGSLVLT--SSMRLAAESATFENF 634
              A   ++APE +    F++ SD++++GV++ ++LTG +       + +A   A     
Sbjct: 176 GAYA---WMAPEVIRASMFSKGSDVWSYGVLLWELLTGEVPFRGIDGLAVAYGVA----- 227

Query: 635 IDRNLKGKFSESEAAKLGKMALVCTHEDPENRPTMEAVIEEL 676
               L      +      K+   C + DP +RP+   ++++L
Sbjct: 228 -MNKLALPIPSTCPEPFAKLMEDCWNPDPHSRPSFTNILDQL 268

>3og7_A AKAP9-BRAF fusion protein; proto-oncogene, V600E, kinase, transferase; HET: 032; 2.45A {Homo sapiens} PDB: 3c4c_A* 3c4d_A* 3idp_A* 3ii5_A* 3d4q_A* 3ppj_A* 3ppk_A* 3prf_A* 3pri_A* 3psb_A* 3psd_A* 3q4c_A* 3skc_A* 3tv4_A* 3tv6_A* 2fb8_A* 4dbn_A* 1uwj_A* 1uwh_A* 3q96_A* Length = 289

 Score =  138 bits (351), Expect = 6e-37
 Identities = 54/276 (19%), Positives = 117/276 (42%), Gaps = 25/276 (9%)

Query: 411 FSEVNL---LGKGNFSSVYKGTLRDGTLVAIRSINVTSCKSE-EAEFVKGLYLLTSLRHE 466
             ++ +   +G G+F +VYKG    G  VA++ +NVT+   +    F   + +L   RH 
Sbjct: 23  DGQITVGQRIGSGSFGTVYKGKWH-GD-VAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHV 80

Query: 467 NIIRLRGFCCSRGRGECFLIYDFAPKGKLSKYLDQEEGSSNVLDWSTRVSIIIGIAKGIG 526
           NI+   G   +  +    ++  +     L  +L   E      +    + I    A+G+ 
Sbjct: 81  NILLFMG-YSTAPQ--LAIVTQWCEGSSLYHHLHASETK---FEMKKLIDIARQTARGMD 134

Query: 527 YLHSSEVNKPAIVHRNLSVEKVLIDQQFNPLIADCGLHKLLADDIVFSVLKTSAA-MGYL 585
           YLH+      +I+HR+L    + + +     I D GL    +        +  +  + ++
Sbjct: 135 YLHA-----KSIIHRDLKSNNIFLHEDNTVKIGDFGLATEKSRWSGSHQFEQLSGSILWM 189

Query: 586 APE---YVTTGRFTERSDIFAFGVIILQILTGSL--VLTSSMRLAAESATFENFIDRNLK 640
           APE      +  ++ +SD++AFG+++ +++TG L     ++     E     +       
Sbjct: 190 APEVIRMQDSNPYSFQSDVYAFGIVLYELMTGQLPYSNINNRDQIIEMVGRGSL--SPDL 247

Query: 641 GKFSESEAAKLGKMALVCTHEDPENRPTMEAVIEEL 676
            K   +   ++ ++   C  +  + RP+   ++ E+
Sbjct: 248 SKVRSNCPKRMKRLMAECLKKKRDERPSFPRILAEI 283

>3s95_A LIMK-1, LIM domain kinase 1; structural genomics, structural genomics consortium, SGC, PR kinase, transferase-antibiotic complex; HET: STU GOL; 1.65A {Homo sapiens} Length = 310

 Score =  139 bits (351), Expect = 1e-36
 Identities = 63/277 (22%), Positives = 113/277 (40%), Gaps = 34/277 (12%)

Query: 417 LGKGNFSSVYKGTLRD-GTLVAIRSINVTSCKSEEAEFVKGLYLLTSLRHENIIRLRGFC 475
           LGKG F    K T R+ G ++ ++ +     +  +  F+K + ++  L H N+++  G  
Sbjct: 18  LGKGCFGQAIKVTHRETGEVMVMKELIRFD-EETQRTFLKEVKVMRCLEHPNVLKFIGVL 76

Query: 476 CSRGRGECFLIYDFAPKGKLSKYLDQEEGSSNVLDWSTRVSIIIGIAKGIGYLHSSEVNK 535
               R     I ++   G L   +   +       WS RVS    IA G+ YLHS     
Sbjct: 77  YKDKR--LNFITEYIKGGTLRGIIKSMDSQ---YPWSQRVSFAKDIASGMAYLHSMN--- 128

Query: 536 PAIVHRNLSVEKVLIDQQFNPLIADCGLHKLLADDIVFS----------VLKTSAAMG-- 583
             I+HR+L+    L+ +  N ++AD GL +L+ D+                K    +G  
Sbjct: 129 --IIHRDLNSHNCLVRENKNVVVADFGLARLMVDEKTQPEGLRSLKKPDRKKRYTVVGNP 186

Query: 584 -YLAPEYVTTGRFTERSDIFAFGVIILQILTGSLV---LTSSMRLAAESATFENFIDRNL 639
            ++APE +    + E+ D+F+FG+++ +I+                  +  F   +   L
Sbjct: 187 YWMAPEMINGRSYDEKVDVFSFGIVLCEIIGRVNADPDYLPR------TMDFGLNVRGFL 240

Query: 640 KGKFSESEAAKLGKMALVCTHEDPENRPTMEAVIEEL 676
                 +       + + C   DPE RP+   +   L
Sbjct: 241 DRYCPPNCPPSFFPITVRCCDLDPEKRPSFVKLEHWL 277

>2y4i_B KSR2, HKSR2, kinase suppressor of RAS 2; transferase, KSR1; HET: ATP; 3.46A {Homo sapiens} Length = 319

 Score =  130 bits (328), Expect = 1e-33
 Identities = 67/284 (23%), Positives = 109/284 (38%), Gaps = 36/284 (12%)

Query: 411 FSEVNL---LGKGNFSSVYKGTLRDGTLVAIRSINVTSC-KSEEAEFVKGLYLLTSLRHE 466
           F ++ +   +GKG F  VY G    G  VAIR I++    + +   F + +      RHE
Sbjct: 32  FEQLEIGELIGKGRFGQVYHGRWH-GE-VAIRLIDIERDNEDQLKAFKREVMAYRQTRHE 89

Query: 467 NIIRLRGFCCSRGRGECFLIYDFAPKGKLSKYLDQEEGSSNVLDWSTRVSIIIGIAKGIG 526
           N++   G C S       +I        L   +   +    VLD +    I   I KG+G
Sbjct: 90  NVVLFMGACMSPPH--LAIITSLCKGRTLYSVVRDAK---IVLDVNKTRQIAQEIVKGMG 144

Query: 527 YLHSSEVNKPAIVHRNLSVEKVLIDQQFNPLIADCGLHKLLADDIVFS-VLKTSAAMG-- 583
           YLH+       I+H++L  + V  D     +I D GL  +           K     G  
Sbjct: 145 YLHA-----KGILHKDLKSKNVFYD-NGKVVITDFGLFSISGVLQAGRREDKLRIQNGWL 198

Query: 584 -YLAPEYVTTGR---------FTERSDIFAFGVIILQILTGSLVLTSSMRLAAESATFEN 633
            +LAPE +             F++ SD+FA G I  ++         +    A       
Sbjct: 199 CHLAPEIIRQLSPDTEEDKLPFSKHSDVFALGTIWYELHARE-WPFKTQPAEAIIWQ--- 254

Query: 634 FIDRNLKGKFSESEA-AKLGKMALVCTHEDPENRPTMEAVIEEL 676
            +   +K   S+     ++  + L C   + E RPT   +++ L
Sbjct: 255 -MGTGMKPNLSQIGMGKEISDILLFCWAFEQEERPTFTKLMDML 297

>4eco_A Uncharacterized protein; leucine-rich repeats, protein binding, structural genomics, center for structural genomics, JCSG; 2.70A {Bacteroides eggerthii dsm 20697} Length = 636

 Score =  131 bits (331), Expect = 4e-32
 Identities = 32/193 (16%), Positives = 69/193 (35%), Gaps = 30/193 (15%)

Query: 72  NISLQGKGLTGKLSPSLSGLKCLSGLYLHYNSLSGE-------------------IPKEI 112
            I      +T  +S ++  L  L   Y+  +    E                      + 
Sbjct: 187 QIGQLSNNITF-VSKAVMRLTKLRQFYMGNSPFVAENICEAWENENSEYAQQYKTEDLKW 245

Query: 113 RNLTELTDLYLDVNNLSGNIPPEIGSMASLQVLQLCCNQLT--------GNIPAQIGSLK 164
            NL +LTD+ +        +P  + ++  +Q++ + CN+              A     +
Sbjct: 246 DNLKDLTDVEVYNCPNLTKLPTFLKALPEMQLINVACNRGISGEQLKDDWQALADAPVGE 305

Query: 165 SLSVLTLQHNRLNGG-IPDSLGNLGKLKRLDLSFNSLFGTIPESLANNAELLFLDVQNNT 223
            + ++ + +N L    +  SL  + KL  L+  +N L G +P    +  +L  L++  N 
Sbjct: 306 KIQIIYIGYNNLKTFPVETSLQKMKKLGMLECLYNQLEGKLPA-FGSEIKLASLNLAYNQ 364

Query: 224 LSGIVPSALKRLN 236
           ++ I  +      
Sbjct: 365 ITEIPANFCGFTE 377

>4eco_A Uncharacterized protein; leucine-rich repeats, protein binding, structural genomics, center for structural genomics, JCSG; 2.70A {Bacteroides eggerthii dsm 20697} Length = 636

 Score =  126 bits (318), Expect = 2e-30
 Identities = 38/169 (22%), Positives = 68/169 (40%), Gaps = 13/169 (7%)

Query: 81  TGKLSPSLSGLKCLSGLYLHYNSLSGEIPKEIRNLTELTDLYLDVNNLSGNIPPEI-GSM 139
           T  +  SL  +K L  L   YN L G++P    +  +L  L L  N ++  IP    G  
Sbjct: 319 TFPVETSLQKMKKLGMLECLYNQLEGKLP-AFGSEIKLASLNLAYNQITE-IPANFCGFT 376

Query: 140 ASLQVLQLCCNQLTGNIPA--QIGSLKSLSVLTLQHNRLNG-------GIPDSLGNLGKL 190
             ++ L    N+L   IP      S+  +S +   +N +          +  +      +
Sbjct: 377 EQVENLSFAHNKLKY-IPNIFDAKSVSVMSAIDFSYNEIGSVDGKNFDPLDPTPFKGINV 435

Query: 191 KRLDLSFNSLFGTIPESLANNAELLFLDVQNNTLSGIVPSALKRLNGGF 239
             ++LS N +     E  +  + L  +++  N L+ I  ++LK  N  F
Sbjct: 436 SSINLSNNQISKFPKELFSTGSPLSSINLMGNMLTEIPKNSLKDENENF 484

>4eco_A Uncharacterized protein; leucine-rich repeats, protein binding, structural genomics, center for structural genomics, JCSG; 2.70A {Bacteroides eggerthii dsm 20697} Length = 636

 Score =  123 bits (310), Expect = 2e-29
 Identities = 31/179 (17%), Positives = 56/179 (31%), Gaps = 15/179 (8%)

Query: 72  NISLQGKGLTGKLSPSLSGLKCLSGLYLHYNSLSGEIPKEIRNLTELTDLYLDVNNLSG- 130
            I          L P+      +S + L  N +S    +     + L+ + L  N L+  
Sbjct: 413 EIGSVDGKNFDPLDPTPFKGINVSSINLSNNQISKFPKELFSTGSPLSSINLMGNMLTEI 472

Query: 131 ------NIPPEIGSMASLQVLQLCCNQLTGNIPA-QIGSLKSLSVLTLQHNRLNGGIPDS 183
                 +      +   L  + L  N+LT      +  +L  L  + L +N  +   P  
Sbjct: 473 PKNSLKDENENFKNTYLLTSIDLRFNKLTKLSDDFRATTLPYLVGIDLSYNSFS-KFPTQ 531

Query: 184 LGNLGKLKRL------DLSFNSLFGTIPESLANNAELLFLDVQNNTLSGIVPSALKRLN 236
             N   LK        D   N      PE +     L  L + +N +  +       ++
Sbjct: 532 PLNSSTLKGFGIRNQRDAQGNRTLREWPEGITLCPSLTQLQIGSNDIRKVNEKITPNIS 590

>4eco_A Uncharacterized protein; leucine-rich repeats, protein binding, structural genomics, center for structural genomics, JCSG; 2.70A {Bacteroides eggerthii dsm 20697} Length = 636

 Score =  119 bits (300), Expect = 3e-28
 Identities = 33/175 (18%), Positives = 66/175 (37%), Gaps = 20/175 (11%)

Query: 73  ISLQGKGLTGKLSPSLSGLKCLSGLYLHYNSLSG-------EIPKEIRNLTELTDLYLDV 125
           I+L    ++       S    LS + L  N L+        +  +  +N   LT + L  
Sbjct: 438 INLSNNQISKFPKELFSTGSPLSSINLMGNMLTEIPKNSLKDENENFKNTYLLTSIDLRF 497

Query: 126 NNLSGNIPPEI--GSMASLQVLQLCCNQLTGNIPAQIGSLKSLSVLTLQH------NRLN 177
           N L+  +  +    ++  L  + L  N  +   P Q  +  +L    +++      NR  
Sbjct: 498 NKLTK-LSDDFRATTLPYLVGIDLSYNSFSK-FPTQPLNSSTLKGFGIRNQRDAQGNRTL 555

Query: 178 GGIPDSLGNLGKLKRLDLSFNSLFGTIPESLANNAELLFLDVQNNTLSGIVPSAL 232
              P+ +     L +L +  N +   + E +  N  +  LD+++N    I  S +
Sbjct: 556 REWPEGITLCPSLTQLQIGSNDI-RKVNEKITPN--ISVLDIKDNPNISIDLSYV 607

>4eco_A Uncharacterized protein; leucine-rich repeats, protein binding, structural genomics, center for structural genomics, JCSG; 2.70A {Bacteroides eggerthii dsm 20697} Length = 636

 Score =  112 bits (281), Expect = 7e-26
 Identities = 28/170 (16%), Positives = 60/170 (35%), Gaps = 22/170 (12%)

Query: 80  LTGKLSPSLSG-LKCLSGLYLHYNSLSGEIPK--EIRNLTELTDLYLDVNNLSG------ 130
           +T  +  +  G  + +  L   +N L   IP   + ++++ ++ +    N +        
Sbjct: 365 ITE-IPANFCGFTEQVENLSFAHNKLK-YIPNIFDAKSVSVMSAIDFSYNEIGSVDGKNF 422

Query: 131 -NIPPEIGSMASLQVLQLCCNQLTGNIPAQIGSLKSLSVLTLQHNRLNG-------GIPD 182
             + P      ++  + L  NQ++        +   LS + L  N L            +
Sbjct: 423 DPLDPTPFKGINVSSINLSNNQISKFPKELFSTGSPLSSINLMGNMLTEIPKNSLKDENE 482

Query: 183 SLGNLGKLKRLDLSFNSLFGTIPESLA--NNAELLFLDVQNNTLSGIVPS 230
           +  N   L  +DL FN L   + +         L+ +D+  N+ S     
Sbjct: 483 NFKNTYLLTSIDLRFNKL-TKLSDDFRATTLPYLVGIDLSYNSFSKFPTQ 531

>4eco_A Uncharacterized protein; leucine-rich repeats, protein binding, structural genomics, center for structural genomics, JCSG; 2.70A {Bacteroides eggerthii dsm 20697} Length = 636

 Score =  110 bits (276), Expect = 3e-25
 Identities = 25/164 (15%), Positives = 55/164 (33%), Gaps = 13/164 (7%)

Query: 72  NISLQGKGLTGKLSPSLSGLKCLSGLYLHYNSLSGEIPKEIR--NLTELTDLYLDVNNLS 129
            ++   K      + +      L+ + L +N L+  +  + R   L  L  + L  N+ S
Sbjct: 468 MLTEIPKNSLKDENENFKNTYLLTSIDLRFNKLTK-LSDDFRATTLPYLVGIDLSYNSFS 526

Query: 130 GNIPPEIGSMASLQVLQLC------CNQLTGNIPAQIGSLKSLSVLTLQHNRLNGGIPDS 183
              P +  + ++L+   +        N+     P  I    SL+ L +  N +   + + 
Sbjct: 527 K-FPTQPLNSSTLKGFGIRNQRDAQGNRTLREWPEGITLCPSLTQLQIGSNDIR-KVNEK 584

Query: 184 LGNLGKLKRLDLSFNSLFGTIPESLANNAELLFLDVQNNTLSGI 227
           +     +  LD+  N         +    E     +  +    I
Sbjct: 585 I--TPNISVLDIKDNPNISIDLSYVCPYIEAGMYMLFYDKTQDI 626

>4eco_A Uncharacterized protein; leucine-rich repeats, protein binding, structural genomics, center for structural genomics, JCSG; 2.70A {Bacteroides eggerthii dsm 20697} Length = 636

 Score =  100 bits (250), Expect = 4e-22
 Identities = 29/218 (13%), Positives = 61/218 (27%), Gaps = 32/218 (14%)

Query: 24  GNTELRALLDLKASLDPENKLLQSWTENGDPCSGSFEGIACNEHRKVANISLQGKGLTGK 83
            +  +   L   A    +   L+   +  +  + S +G                      
Sbjct: 14  DDAIVPIKLSRTAEYIKDYLALKEIWDALNGKNWSQQGFGTQPG---------------- 57

Query: 84  LSPSLSGLKCLSGLYLHYNSLSGEIPKEIRNLTELTDLYLDVNNLSGNIPPEIGSMASLQ 143
                             +    +    + +   +T L L+    SG +P  IG +  L+
Sbjct: 58  ---------ANWNFNKELDMWGAQPGVSLNSNGRVTGLSLEGFGASGRVPDAIGQLTELE 108

Query: 144 VLQLCCNQLTGN----IPAQIGSLKSLSVLTLQHNRLNGGIPDSLGNLG--KLKRLDLSF 197
           VL L  +    N     P  I +  S                D         L +  ++ 
Sbjct: 109 VLALGSHGEKVNERLFGPKGISANMSDEQKQKMRMHYQKTFVDYDPREDFSDLIKDCINS 168

Query: 198 NSLFGTIPESLANNAELLFLDVQNNTLSGIVPSALKRL 235
           +    +I +S     +   +   +N ++ +   A+ RL
Sbjct: 169 DPQQKSIKKSSRITLKDTQIGQLSNNITFV-SKAVMRL 205

>3fxi_A TLR4, htoll, TOLL-like receptor 4; leucine rich repeat, glycoprotein, immune response, inflamma response, innate immunity, membrane, receptor; HET: PA1 KDO GMH FTT DAO MYR NAG GCS; 3.10A {Homo sapiens} Length = 605

 Score =  128 bits (325), Expect = 2e-31
 Identities = 42/162 (25%), Positives = 63/162 (38%), Gaps = 5/162 (3%)

Query: 80  LTGKLSPSLSGLKCLSGLYLHYNSLSGEIPKEIRNLTELTDLYLDVNNLSGNIPPEIGSM 139
           L    S S      L  L L    +        ++L+ L+ L L  N +          +
Sbjct: 40  LRHLGSYSFFSFPELQVLDLSRCEIQTIEDGAYQSLSHLSTLILTGNPIQSLALGAFSGL 99

Query: 140 ASLQVLQLCCNQLTGNIPAQIGSLKSLSVLTLQHNRLNGG-IPDSLGNLGKLKRLDLSFN 198
           +SLQ L      L       IG LK+L  L + HN +    +P+   NL  L+ LDLS N
Sbjct: 100 SSLQKLVAVETNLASLENFPIGHLKTLKELNVAHNLIQSFKLPEYFSNLTNLEHLDLSSN 159

Query: 199 SLFGTIPESLANNAEL----LFLDVQNNTLSGIVPSALKRLN 236
            +       L    ++    L LD+  N ++ I P A K + 
Sbjct: 160 KIQSIYCTDLRVLHQMPLLNLSLDLSLNPMNFIQPGAFKEIR 201

>3fxi_A TLR4, htoll, TOLL-like receptor 4; leucine rich repeat, glycoprotein, immune response, inflamma response, innate immunity, membrane, receptor; HET: PA1 KDO GMH FTT DAO MYR NAG GCS; 3.10A {Homo sapiens} Length = 605

 Score =  125 bits (315), Expect = 3e-30
 Identities = 35/170 (20%), Positives = 62/170 (36%), Gaps = 5/170 (2%)

Query: 84  LSPSLSGLKCLSGLYLHYNSLSGEIPKEI-RNLTELTDLYLDVNNLSGNIPPEIGSMASL 142
           +S +  GL+ L  L   +++L       +  +L  L  L +   +           ++SL
Sbjct: 388 MSSNFLGLEQLEHLDFQHSNLKQMSEFSVFLSLRNLIYLDISHTHTRVAFNGIFNGLSSL 447

Query: 143 QVLQLCCNQLTGNIPAQI-GSLKSLSVLTLQHNRLNGGIPDSLGNLGKLKRLDLSFNSLF 201
           +VL++  N    N    I   L++L+ L L   +L    P +  +L  L+ L++S N+ F
Sbjct: 448 EVLKMAGNSFQENFLPDIFTELRNLTFLDLSQCQLEQLSPTAFNSLSSLQVLNMSHNNFF 507

Query: 202 GTIPESLANNAELLFLDVQNNTLSGIVPSALKRLNGG---FQFQNNPGLC 248
                       L  LD   N +       L+             N   C
Sbjct: 508 SLDTFPYKCLNSLQVLDYSLNHIMTSKKQELQHFPSSLAFLNLTQNDFAC 557

>3fxi_A TLR4, htoll, TOLL-like receptor 4; leucine rich repeat, glycoprotein, immune response, inflamma response, innate immunity, membrane, receptor; HET: PA1 KDO GMH FTT DAO MYR NAG GCS; 3.10A {Homo sapiens} Length = 605

 Score =  121 bits (306), Expect = 4e-29
 Identities = 34/141 (24%), Positives = 54/141 (38%), Gaps = 1/141 (0%)

Query: 97  LYLHYNSLSGEIPKEIRNLTELTDLYLDVNNLSGNIPPEIGSMASLQVLQLCCNQLTGNI 156
           L L +N L         +  EL  L L    +         S++ L  L L  N +    
Sbjct: 33  LDLSFNPLRHLGSYSFFSFPELQVLDLSRCEIQTIEDGAYQSLSHLSTLILTGNPIQSLA 92

Query: 157 PAQIGSLKSLSVLTLQHNRLNGGIPDSLGNLGKLKRLDLSFNSL-FGTIPESLANNAELL 215
                 L SL  L      L       +G+L  LK L+++ N +    +PE  +N   L 
Sbjct: 93  LGAFSGLSSLQKLVAVETNLASLENFPIGHLKTLKELNVAHNLIQSFKLPEYFSNLTNLE 152

Query: 216 FLDVQNNTLSGIVPSALKRLN 236
            LD+ +N +  I  + L+ L+
Sbjct: 153 HLDLSSNKIQSIYCTDLRVLH 173

>3fxi_A TLR4, htoll, TOLL-like receptor 4; leucine rich repeat, glycoprotein, immune response, inflamma response, innate immunity, membrane, receptor; HET: PA1 KDO GMH FTT DAO MYR NAG GCS; 3.10A {Homo sapiens} Length = 605

 Score =  119 bits (300), Expect = 3e-28
 Identities = 38/157 (24%), Positives = 57/157 (36%), Gaps = 3/157 (1%)

Query: 73  ISLQGKGLTGKLSPS-LSGLKCLSGLYLHYNSLSGEIPKEIRNLTELTDLYLDVNNLSGN 131
           +  Q   L      S    L+ L  L + +             L+ L  L +  N+   N
Sbjct: 401 LDFQHSNLKQMSEFSVFLSLRNLIYLDISHTHTRVAFNGIFNGLSSLEVLKMAGNSFQEN 460

Query: 132 IPPEI-GSMASLQVLQLCCNQLTGNIPAQIGSLKSLSVLTLQHNRLNGGIPDSLGNLGKL 190
             P+I   + +L  L L   QL    P    SL SL VL + HN            L  L
Sbjct: 461 FLPDIFTELRNLTFLDLSQCQLEQLSPTAFNSLSSLQVLNMSHNNFFSLDTFPYKCLNSL 520

Query: 191 KRLDLSFNSLFGTIPESLANNAELL-FLDVQNNTLSG 226
           + LD S N +  +  + L +    L FL++  N  + 
Sbjct: 521 QVLDYSLNHIMTSKKQELQHFPSSLAFLNLTQNDFAC 557

>3fxi_A TLR4, htoll, TOLL-like receptor 4; leucine rich repeat, glycoprotein, immune response, inflamma response, innate immunity, membrane, receptor; HET: PA1 KDO GMH FTT DAO MYR NAG GCS; 3.10A {Homo sapiens} Length = 605

 Score = 98.6 bits (246), Expect = 1e-21
 Identities = 28/154 (18%), Positives = 55/154 (35%), Gaps = 7/154 (4%)

Query: 80  LTGKLSPSLSGLKCLSGLYLHYNSLSGEIPKEIRNLTELTDLYLDVNNL-SGNIPPEIGS 138
           +      + SGL  L  L     +L+      I +L  L +L +  N + S  +P    +
Sbjct: 88  IQSLALGAFSGLSSLQKLVAVETNLASLENFPIGHLKTLKELNVAHNLIQSFKLPEYFSN 147

Query: 139 MASLQVLQLCCNQLTGNIPAQIGSLKSLSV----LTLQHNRLNGGIPDSLGNLGKLKRLD 194
           + +L+ L L  N++       +  L  + +    L L  N +N   P +   + +L +L 
Sbjct: 148 LTNLEHLDLSSNKIQSIYCTDLRVLHQMPLLNLSLDLSLNPMNFIQPGAFKEI-RLHKLT 206

Query: 195 LSFNSLFGTIPESLANNAELL-FLDVQNNTLSGI 227
           L  N     + ++       L    +        
Sbjct: 207 LRNNFDSLNVMKTCIQGLAGLEVHRLVLGEFRNE 240

>3fxi_A TLR4, htoll, TOLL-like receptor 4; leucine rich repeat, glycoprotein, immune response, inflamma response, innate immunity, membrane, receptor; HET: PA1 KDO GMH FTT DAO MYR NAG GCS; 3.10A {Homo sapiens} Length = 605

 Score = 97.8 bits (244), Expect = 2e-21
 Identities = 38/165 (23%), Positives = 56/165 (33%), Gaps = 4/165 (2%)

Query: 73  ISLQGKGLTGKLSPSLSGLKCLSGLYLHYNSLSGEIPKEI-RNLTELTDLYLDVNNLSGN 131
           + +         +   +GL  L  L +  NS       +I   L  LT L L    L   
Sbjct: 426 LDISHTHTRVAFNGIFNGLSSLEVLKMAGNSFQENFLPDIFTELRNLTFLDLSQCQLEQL 485

Query: 132 IPPEIGSMASLQVLQLCCNQLTGNIPAQIGSLKSLSVLTLQHNRLNGGIPDSLGNL-GKL 190
            P    S++SLQVL +  N            L SL VL    N +       L +    L
Sbjct: 486 SPTAFNSLSSLQVLNMSHNNFFSLDTFPYKCLNSLQVLDYSLNHIMTSKKQELQHFPSSL 545

Query: 191 KRLDLSFNSLFGTIP-ESLANNA-ELLFLDVQNNTLSGIVPSALK 233
             L+L+ N    T   +S      +   L V+   +    PS  +
Sbjct: 546 AFLNLTQNDFACTCEHQSFLQWIKDQRQLLVEVERMECATPSDKQ 590

>3fxi_A TLR4, htoll, TOLL-like receptor 4; leucine rich repeat, glycoprotein, immune response, inflamma response, innate immunity, membrane, receptor; HET: PA1 KDO GMH FTT DAO MYR NAG GCS; 3.10A {Homo sapiens} Length = 605

 Score = 93.6 bits (233), Expect = 5e-20
 Identities = 28/153 (18%), Positives = 48/153 (31%), Gaps = 9/153 (5%)

Query: 86  PSLSGLKCLSGLYLHYNSLSGEIPKEIRNLTELTDLYLDVNNLSGNIPPEIGSMASLQVL 145
              S       L L           ++++L       L   +  G        + SL+ L
Sbjct: 298 KDFSYNFGWQHLELVNCKFGQFPTLKLKSLK-----RLTFTSNKGGNAFSEVDLPSLEFL 352

Query: 146 QLCCNQLT--GNIPAQIGSLKSLSVLTLQHNRLNGGIPDSLGNLGKLKRLDLSFNSLFGT 203
            L  N L+  G          SL  L L  N +   +  +   L +L+ LD   ++L   
Sbjct: 353 DLSRNGLSFKGCCSQSDFGTTSLKYLDLSFNGVIT-MSSNFLGLEQLEHLDFQHSNLKQM 411

Query: 204 IPES-LANNAELLFLDVQNNTLSGIVPSALKRL 235
              S   +   L++LD+ +             L
Sbjct: 412 SEFSVFLSLRNLIYLDISHTHTRVAFNGIFNGL 444

>3fxi_A TLR4, htoll, TOLL-like receptor 4; leucine rich repeat, glycoprotein, immune response, inflamma response, innate immunity, membrane, receptor; HET: PA1 KDO GMH FTT DAO MYR NAG GCS; 3.10A {Homo sapiens} Length = 605

 Score = 88.9 bits (221), Expect = 1e-18
 Identities = 32/174 (18%), Positives = 51/174 (29%), Gaps = 19/174 (10%)

Query: 81  TGKLSPSLSGLKCLSGLYLHYNSLSGEIPKEIRNLTELT----DLYLDVNNLSGNIPPEI 136
           + KL    S L  L  L L  N +      ++R L ++      L L +N ++  I P  
Sbjct: 138 SFKLPEYFSNLTNLEHLDLSSNKIQSIYCTDLRVLHQMPLLNLSLDLSLNPMNF-IQPGA 196

Query: 137 GSMASLQVLQLCCNQLTGNIPAQ-IGSLKSLSVLTLQHNRLNGGI---PDSLGNLGKLKR 192
                L  L L  N  + N+    I  L  L V  L                  L  L  
Sbjct: 197 FKEIRLHKLTLRNNFDSLNVMKTCIQGLAGLEVHRLVLGEFRNEGNLEKFDKSALEGLCN 256

Query: 193 LDLSFNSL------FGTIPESLANNAELLFLDVQNNTLSGIVP----SALKRLN 236
           L +    L         I +       +    + + T+  +         + L 
Sbjct: 257 LTIEEFRLAYLDYYLDDIIDLFNCLTNVSSFSLVSVTIERVKDFSYNFGWQHLE 310

>3fxi_A TLR4, htoll, TOLL-like receptor 4; leucine rich repeat, glycoprotein, immune response, inflamma response, innate immunity, membrane, receptor; HET: PA1 KDO GMH FTT DAO MYR NAG GCS; 3.10A {Homo sapiens} Length = 605

 Score = 79.3 bits (196), Expect = 1e-15
 Identities = 43/200 (21%), Positives = 72/200 (36%), Gaps = 22/200 (11%)

Query: 56  SGSFEGIACNEHRKVANISLQGKGLTGKLSPS-LSGLKCLSGLYLHYNSLS---GEIPKE 111
               +G+A  E  ++     + +G   K   S L GL  L+        L     +I   
Sbjct: 218 KTCIQGLAGLEVHRLVLGEFRNEGNLEKFDKSALEGLCNLTIEEFRLAYLDYYLDDIIDL 277

Query: 112 IRNLTELTDLYLDVNNLSGNIPPEIGSMASLQVLQLCCNQLTGNIPAQIGSLKSLSVLTL 171
              LT ++   L    +      +       Q L+L   +       ++ SLK L+    
Sbjct: 278 FNCLTNVSSFSLVSVTIER--VKDFSYNFGWQHLELVNCKFGQFPTLKLKSLKRLT---- 331

Query: 172 QHNRLNGGIPDSLGNLGKLKRLDLSFNSL--FGTIPESLANNAELLFLDVQNNTLSGIVP 229
                 GG   S  +L  L+ LDLS N L   G   +S      L +LD+  N +  +  
Sbjct: 332 -FTSNKGGNAFSEVDLPSLEFLDLSRNGLSFKGCCSQSDFGTTSLKYLDLSFNGVITMSS 390

Query: 230 S-----ALKRLNGGFQFQNN 244
           +      L+ L+    FQ++
Sbjct: 391 NFLGLEQLEHLD----FQHS 406

>3lxp_A Non-receptor tyrosine-protein kinase TYK2; JAK3, inflammation, cancer, PAN inhibitor, ATP-binding nucleotide-binding, phosphoprotein, SH2 domain; HET: PTR IZA; 1.65A {Homo sapiens} PDB: 3lxn_A* 3nz0_A* 3nyx_A* Length = 318

 Score =  122 bits (307), Expect = 9e-31
 Identities = 62/277 (22%), Positives = 113/277 (40%), Gaps = 27/277 (9%)

Query: 417 LGKGNFSSVYKGTLRD-----GTLVAIRSINVTSCKSEEAEFVKGLYLLTSLRHENIIRL 471
           LG+G+F  V            G +VA++++   +     + + + + +L +L HE+II+ 
Sbjct: 39  LGEGHFGKVSLYCYDPTNDGTGEMVAVKALKADAGPQHRSGWKQEIDILRTLYHEHIIKY 98

Query: 472 RGFCCSRGRGECFLIYDFAPKGKLSKYLDQEEGSSNVLDWSTRVSIIIGIAKGIGYLHSS 531
           +G C   G     L+ ++ P G L  YL       + +  +  +     I +G+ YLH+ 
Sbjct: 99  KGCCEDAGAASLQLVMEYVPLGSLRDYL-----PRHSIGLAQLLLFAQQICEGMAYLHAQ 153

Query: 532 EVNKPAIVHRNLSVEKVLIDQQFNPLIADCGLHKLLADDIVFSVLKTSAAM--GYLAPEY 589
                  +HR+L+   VL+D      I D GL K + +   +  ++        + APE 
Sbjct: 154 H-----YIHRDLAARNVLLDNDRLVKIGDFGLAKAVPEGHEYYRVREDGDSPVFWYAPEC 208

Query: 590 VTTGRFTERSDIFAFGVIILQILT--GSLVLTSSMRLAAESATFENFIDRNLKGKFSESE 647
           +   +F   SD+++FGV + ++LT   S     +  L              L       E
Sbjct: 209 LKEYKFYYASDVWSFGVTLYELLTHCDSSQSPPTKFLELIGIAQGQMTVLRLTELLERGE 268

Query: 648 --------AAKLGKMALVCTHEDPENRPTMEAVIEEL 676
                    A++  +   C   +   RPT E +I  L
Sbjct: 269 RLPRPDKCPAEVYHLMKNCWETEASFRPTFENLIPIL 305

>4e5w_A Tyrosine-protein kinase JAK1; kinase domain, transferase-transferase inhibit complex; HET: PTR 0NT; 1.86A {Homo sapiens} PDB: 4e4l_A* 4e4n_A* 3eyg_A* 3eyh_A* Length = 302

 Score =  121 bits (306), Expect = 1e-30
 Identities = 70/277 (25%), Positives = 121/277 (43%), Gaps = 25/277 (9%)

Query: 417 LGKGNFSSVYKGTL-----RDGTLVAIRSINVTSCKSEEAEFVKGLYLLTSLRHENIIRL 471
           LG+G+F  V            G  VA++S+   S  +  A+  K + +L +L HENI++ 
Sbjct: 29  LGEGHFGKVELCRYDPEGDNTGEQVAVKSLKPESGGNHIADLKKEIEILRNLYHENIVKY 88

Query: 472 RGFCCSRGRGECFLIYDFAPKGKLSKYLDQEEGSSNVLDWSTRVSIIIGIAKGIGYLHSS 531
           +G C   G     LI +F P G L +YL + +     ++   ++   + I KG+ YL S 
Sbjct: 89  KGICTEDGGNGIKLIMEFLPSGSLKEYLPKNKNK---INLKQQLKYAVQICKGMDYLGSR 145

Query: 532 EVNKPAIVHRNLSVEKVLIDQQFNPLIADCGLHKLLADDIVFSVLKTSAAM--GYLAPEY 589
           +      VHR+L+   VL++ +    I D GL K +  D  +  +K        + APE 
Sbjct: 146 Q-----YVHRDLAARNVLVESEHQVKIGDFGLTKAIETDKEYYTVKDDRDSPVFWYAPEC 200

Query: 590 VTTGRFTERSDIFAFGVIILQILT--GSLVLTSSMRLAAESATFENFIDRNLKGKFSESE 647
           +   +F   SD+++FGV + ++LT   S     ++ L     T        L     E +
Sbjct: 201 LMQSKFYIASDVWSFGVTLHELLTYCDSDSSPMALFLKMIGPTHGQMTVTRLVNTLKEGK 260

Query: 648 --------AAKLGKMALVCTHEDPENRPTMEAVIEEL 676
                     ++ ++   C    P NR + + +IE  
Sbjct: 261 RLPCPPNCPDEVYQLMRKCWEFQPSNRTSFQNLIEGF 297

>3c1x_A Hepatocyte growth factor receptor; receptor tyrosine kinase, signal transduction, GRB2, SHC, ATP-binding, glycoprotein, membrane; HET: CKK; 2.17A {Homo sapiens} SCOP: d.144.1.7 Length = 373

 Score =  122 bits (309), Expect = 1e-30
 Identities = 63/290 (21%), Positives = 128/290 (44%), Gaps = 18/290 (6%)

Query: 331 RYRRHKQKIGNTSESSDWQLSTDLTLAKDFNRNGASPLVSLEYCHGWDPLGDYLNGTGFS 390
            + R +  +             D   + +            E  +       +++ +  +
Sbjct: 13  HHGRRRASVAAGILVPRGSPGLDGICSIEELSTSLYKKAGSENLYFQGANTVHIDLSALN 72

Query: 391 REHLNSFRLNLEEVESATQCFSEVNLLGKGNFSSVYKGTLRDG----TLVAIRSINVTSC 446
            E + + +  +    S    F+EV  +G+G+F  VY GTL D        A++S+N  + 
Sbjct: 73  PELVQAVQHVVIGPSSLIVHFNEV--IGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITD 130

Query: 447 KSEEAEFVKGLYLLTSLRHENIIRLRGFCCSRGRGECFLIYDFAPKGKLSKYLDQEEGSS 506
             E ++F+    ++    H N++ L G  C R  G   ++  +   G L  ++  E  + 
Sbjct: 131 IGEVSQFLTEGIIMKDFSHPNVLSLLG-ICLRSEGSPLVVLPYMKHGDLRNFIRNETHNP 189

Query: 507 NVLDWSTRVSIIIGIAKGIGYLHSSEVNKPAIVHRNLSVEKVLIDQQFNPLIADCGLHKL 566
            V D    +   + +AKG+ +L  +       VHR+L+    ++D++F   +AD GL + 
Sbjct: 190 TVKD---LIGFGLQVAKGMKFL--ASKK---FVHRDLAARNCMLDEKFTVKVADFGLARD 241

Query: 567 LADDIVFSVLKTSAAM---GYLAPEYVTTGRFTERSDIFAFGVIILQILT 613
           + D    SV   + A     ++A E + T +FT +SD+++FGV++ +++T
Sbjct: 242 MYDKEFDSVHNKTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMT 291

>3pls_A Macrophage-stimulating protein receptor; protein kinase, CIS autophosphorylation conformation, recept tyrosine kinase, AMP-PNP, unphosphorylated; HET: ANP; 2.24A {Homo sapiens} Length = 298

 Score =  121 bits (305), Expect = 1e-30
 Identities = 56/206 (27%), Positives = 102/206 (49%), Gaps = 16/206 (7%)

Query: 415 NLLGKGNFSSVYKGTLRDG----TLVAIRSINVTSCKSEEAEFVKGLYLLTSLRHENIIR 470
            ++GKG+F  VY G   D        AI+S++  +   +   F++   L+  L H N++ 
Sbjct: 27  RVIGKGHFGVVYHGEYIDQAQNRIQCAIKSLSRITEMQQVEAFLREGLLMRGLNHPNVLA 86

Query: 471 LRGFCCSRGRGECFLIYDFAPKGKLSKYLDQEEGSSNVLDWSTRVSIIIGIAKGIGYLHS 530
           L G       G   ++  +   G L +++   + +  V D    +S  + +A+G+ YL  
Sbjct: 87  LIG-IMLPPEGLPHVLLPYMCHGDLLQFIRSPQRNPTVKDL---ISFGLQVARGMEYL-- 140

Query: 531 SEVNKPAIVHRNLSVEKVLIDQQFNPLIADCGLHKLLADDIVFSVLKTSAAM---GYLAP 587
               K   VHR+L+    ++D+ F   +AD GL + + D   +SV +   A     + A 
Sbjct: 141 -AEQK--FVHRDLAARNCMLDESFTVKVADFGLARDILDREYYSVQQHRHARLPVKWTAL 197

Query: 588 EYVTTGRFTERSDIFAFGVIILQILT 613
           E + T RFT +SD+++FGV++ ++LT
Sbjct: 198 ESLQTYRFTTKSDVWSFGVLLWELLT 223

>3ugc_A Tyrosine-protein kinase JAK2; small molecule inhibitor, ATP binding, transferase-transfera inhibitor complex; HET: 046; 1.34A {} PDB: 3krr_A* 3lpb_A* 4aqc_A* 3q32_A* 3rvg_A* 3tjc_A* 3tjd_A* 2b7a_A* 3fup_A* 3e64_A* 3e62_A* 3e63_A* 2xa4_A* 3iok_A* 3io7_A* 3kck_A* 3jy9_A* Length = 295

 Score =  120 bits (304), Expect = 1e-30
 Identities = 67/278 (24%), Positives = 119/278 (42%), Gaps = 27/278 (9%)

Query: 417 LGKGNFSSVYKGTLR-----DGTLVAIRSINVTSCKSEEAEFVKGLYLLTSLRHENIIRL 471
           LGKGNF SV            G +VA++ +   S +    +F + + +L SL+H+NI++ 
Sbjct: 18  LGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQ-HSTEEHLRDFEREIEILKSLQHDNIVKY 76

Query: 472 RGFCCSRGRGECFLIYDFAPKGKLSKYLDQEEGSSNVLDWSTRVSIIIGIAKGIGYLHSS 531
           +G C S GR    LI ++ P G L  YL + +     +D    +     I KG+ YL + 
Sbjct: 77  KGVCYSAGRRNLKLIMEYLPYGSLRDYLQKHKER---IDHIKLLQYTSQICKGMEYLGTK 133

Query: 532 EVNKPAIVHRNLSVEKVLIDQQFNPLIADCGLHKLLADDIVFSVLKTSAAM--GYLAPEY 589
                  +HR+L+   +L++ +    I D GL K+L  D  F  +K        + APE 
Sbjct: 134 R-----YIHRDLATRNILVENENRVKIGDFGLTKVLPQDKEFFKVKEPGESPIFWYAPES 188

Query: 590 VTTGRFTERSDIFAFGVIILQILTGSLVLTSSMRLAAESA---TFENFIDRNLKGKFSES 646
           +T  +F+  SD+++FGV++ ++ T      S                 I  +L      +
Sbjct: 189 LTESKFSVASDVWSFGVVLYELFTYIEKSKSPPAEFMRMIGNDKQGQMIVFHLIELLKNN 248

Query: 647 E--------AAKLGKMALVCTHEDPENRPTMEAVIEEL 676
                      ++  +   C + +   RP+   +   +
Sbjct: 249 GRLPRPDGCPDEIYMIMTECWNNNVNQRPSFRDLALRV 286

>2w1i_A JAK2; chromosomal rearrangement, nucleotide-binding, tyrosine-protein kinase, proto-oncogene, phosphoprotein, disease mutation, SH2 domain; HET: PTR L0I; 2.60A {Homo sapiens} Length = 326

 Score =  120 bits (304), Expect = 2e-30
 Identities = 66/278 (23%), Positives = 119/278 (42%), Gaps = 27/278 (9%)

Query: 417 LGKGNFSSVYKGTL-----RDGTLVAIRSINVTSCKSEEAEFVKGLYLLTSLRHENIIRL 471
           LGKGNF SV            G +VA++ +   S +    +F + + +L SL+H+NI++ 
Sbjct: 49  LGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQ-HSTEEHLRDFEREIEILKSLQHDNIVKY 107

Query: 472 RGFCCSRGRGECFLIYDFAPKGKLSKYLDQEEGSSNVLDWSTRVSIIIGIAKGIGYLHSS 531
           +G C S GR    LI ++ P G L  YL + +     +D    +     I KG+ YL + 
Sbjct: 108 KGVCYSAGRRNLKLIMEYLPYGSLRDYLQKHKER---IDHIKLLQYTSQICKGMEYLGTK 164

Query: 532 EVNKPAIVHRNLSVEKVLIDQQFNPLIADCGLHKLLADDIVFSVLKTSAAM--GYLAPEY 589
                  +HR+L+   +L++ +    I D GL K+L  D  +  +K        + APE 
Sbjct: 165 R-----YIHRDLATRNILVENENRVKIGDFGLTKVLPQDKEYYKVKEPGESPIFWYAPES 219

Query: 590 VTTGRFTERSDIFAFGVIILQILTGSLVLTSSMRLAAESA---TFENFIDRNLKGKFSES 646
           +T  +F+  SD+++FGV++ ++ T      S                 I  +L      +
Sbjct: 220 LTESKFSVASDVWSFGVVLYELFTYIEKSKSPPAEFMRMIGNDKQGQMIVFHLIELLKNN 279

Query: 647 E--------AAKLGKMALVCTHEDPENRPTMEAVIEEL 676
                      ++  +   C + +   RP+   +   +
Sbjct: 280 GRLPRPDGCPDEIYMIMTECWNNNVNQRPSFRDLALRV 317

>3f66_A Hepatocyte growth factor receptor; C-Met, protein kinase, quinoxaline, alternative splicing, ATP-binding, chromosomal rearrangement; HET: IHX; 1.40A {Homo sapiens} PDB: 3i5n_A* 3u6h_A* 3u6i_A* 3ccn_A* 2rfn_A* 2rfs_A* 3cd8_A* 3efj_A* 3efk_A* 3lq8_A* 3zxz_A* 2wkm_A* 2wgj_A* 3zze_A* 3q6w_A* 3r7o_A* 3q6u_A* 3cth_A* 3ce3_A* 3ctj_A* ... Length = 298

 Score =  120 bits (302), Expect = 4e-30
 Identities = 62/240 (25%), Positives = 119/240 (49%), Gaps = 22/240 (9%)

Query: 383 YLNGTGFSREHLNSFRLNLEEVESATQCFSEVNLLGKGNFSSVYKGTLRDG----TLVAI 438
           +++ +  + E + + +  +    S    F+EV  +G+G+F  VY GTL D        A+
Sbjct: 1   HIDLSALNPELVQAVQHVVIGPSSLIVHFNEV--IGRGHFGCVYHGTLLDNDGKKIHCAV 58

Query: 439 RSINVTSCKSEEAEFVKGLYLLTSLRHENIIRLRGFCCSRGRGECFLIYDFAPKGKLSKY 498
           +S+N  +   E ++F+    ++    H N++ L G  C R  G   ++  +   G L  +
Sbjct: 59  KSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSLLG-ICLRSEGSPLVVLPYMKHGDLRNF 117

Query: 499 LDQEEGSSNVLDWSTRVSIIIGIAKGIGYLHSSEVNKPAIVHRNLSVEKVLIDQQFNPLI 558
           +  E  +  V D    +   + +AKG+ YL  +       VHR+L+    ++D++F   +
Sbjct: 118 IRNETHNPTVKD---LIGFGLQVAKGMKYL--ASKK---FVHRDLAARNCMLDEKFTVKV 169

Query: 559 ADCGLHKLLADDIVFSVLKTSAAMGYL-----APEYVTTGRFTERSDIFAFGVIILQILT 613
           AD GL + + D   +SV   + A   L     A E + T +FT +SD+++FGV++ +++T
Sbjct: 170 ADFGLARDMYDKEYYSVHNKTGAK--LPVKWMALESLQTQKFTTKSDVWSFGVLLWELMT 227

>1opk_A P150, C-ABL, proto-oncogene tyrosine-protein kinase ABL1; transferase; HET: MYR P16; 1.80A {Mus musculus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1opl_A* 2fo0_A* 2abl_A Length = 495

 Score =  121 bits (304), Expect = 3e-29
 Identities = 66/360 (18%), Positives = 134/360 (37%), Gaps = 55/360 (15%)

Query: 332 YRRHKQKIGNTSESSDWQLSTDLTLAKDFNRNGASPLVSLEY-CHGWDPLGDYLNGTGFS 390
           YR +    G    SS+ + +T   L    +      + +L Y     +    Y     + 
Sbjct: 154 YRINTASDGKLYVSSESRFNTLAELVHHHSTVADGLITTLHYPAPKRNKPTIYGVSPNYD 213

Query: 391 REHLNSFRLNLEEVESATQCFSEVNLLGKGNFSSVYKGTLRD-GTLVAIRSINVTSCKSE 449
           +  +    + ++              LG G +  VY+G  +     VA++++   +   E
Sbjct: 214 KWEMERTDITMKHK------------LGGGQYGEVYEGVWKKYSLTVAVKTLKEDT--ME 259

Query: 450 EAEFVKGLYLLTSLRHENIIRLRGFCCSRGRGECFLIYDFAPKGKLSKYLDQEEGSSNVL 509
             EF+K   ++  ++H N+++L G  C+R     ++I +F   G L  YL +       +
Sbjct: 260 VEEFLKEAAVMKEIKHPNLVQLLG-VCTRE-PPFYIITEFMTYGNLLDYLRECNRQE--V 315

Query: 510 DWSTRVSIIIGIAKGIGYLHSSEVNKPAIVHRNLSVEKVLIDQQFNPLIADCGLHKLLAD 569
                + +   I+  + YL          +HRNL+    L+ +     +AD GL +L+  
Sbjct: 316 SAVVLLYMATQISSAMEYLEKKN-----FIHRNLAARNCLVGENHLVKVADFGLSRLMTG 370

Query: 570 DIVFSVLKTSAAMGYLAPEYVTTGRFTERSDIFAFGVIILQILTGSLVLTSSMRLAAESA 629
           D   +       + + APE +   +F+ +SD++AFGV++ +I T  +     +       
Sbjct: 371 DTYTAHAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGI------- 423

Query: 630 TFENFIDRNLKGKFSESEAAKLGKMA-------------LVCTHEDPENRPTMEAVIEEL 676
                 +   K            +M                C   +P +RP+   + +  
Sbjct: 424 DLSQVYELLEKD----------YRMERPEGCPEKVYELMRACWQWNPSDRPSFAEIHQAF 473

>1ziw_A TOLL-like receptor 3; innate immunity, immune system; HET: NDG NAG; 2.10A {Homo sapiens} PDB: 2a0z_A* 3cig_A* 3ciy_A* Length = 680

 Score =  122 bits (307), Expect = 5e-29
 Identities = 38/170 (22%), Positives = 64/170 (37%), Gaps = 2/170 (1%)

Query: 68  RKVANISLQGKGLTGKLSPSLSGLKCLSGLYLHYNSLSGEIPKEIRNLTELTDLYLDVNN 127
             +  ++L    L    + + +    L+ L + +N++S   P+  + L  L  L L  N 
Sbjct: 25  TNITVLNLTHNQLRRLPAANFTRYSQLTSLDVGFNTISKLEPELCQKLPMLKVLNLQHNE 84

Query: 128 LSGNIPPEIGSMASLQVLQLCCNQLTGNIPAQIGSLKSLSVLTLQHNRLNGGIPDSLGNL 187
           LS           +L  L L  N +           K+L  L L HN L+     +   L
Sbjct: 85  LSQLSDKTFAFCTNLTELHLMSNSIQKIKNNPFVKQKNLITLDLSHNGLSSTKLGTQVQL 144

Query: 188 GKLKRLDLSFNSLFGTIPESLA--NNAELLFLDVQNNTLSGIVPSALKRL 235
             L+ L LS N +     E L    N+ L  L++ +N +    P     +
Sbjct: 145 ENLQELLLSNNKIQALKSEELDIFANSSLKKLELSSNQIKEFSPGCFHAI 194

>1ziw_A TOLL-like receptor 3; innate immunity, immune system; HET: NDG NAG; 2.10A {Homo sapiens} PDB: 2a0z_A* 3cig_A* 3ciy_A* Length = 680

 Score =  117 bits (296), Expect = 1e-27
 Identities = 38/173 (21%), Positives = 61/173 (35%), Gaps = 2/173 (1%)

Query: 73  ISLQGKGLTGKLSPSLSGLKCLSGLYLHYNSLSGEIPKEIRNLTELTDLYLDVNNLSGNI 132
           + +    ++         L  L  L L +N LS    K     T LT+L+L  N++    
Sbjct: 54  LDVGFNTISKLEPELCQKLPMLKVLNLQHNELSQLSDKTFAFCTNLTELHLMSNSIQKIK 113

Query: 133 PPEIGSMASLQVLQLCCNQLTGNIPAQIGSLKSLSVLTLQHNRLNGGIPDSLGNLG--KL 190
                   +L  L L  N L+         L++L  L L +N++     + L       L
Sbjct: 114 NNPFVKQKNLITLDLSHNGLSSTKLGTQVQLENLQELLLSNNKIQALKSEELDIFANSSL 173

Query: 191 KRLDLSFNSLFGTIPESLANNAELLFLDVQNNTLSGIVPSALKRLNGGFQFQN 243
           K+L+LS N +    P        L  L + N  L   +   L         +N
Sbjct: 174 KKLELSSNQIKEFSPGCFHAIGRLFGLFLNNVQLGPSLTEKLCLELANTSIRN 226

>1ziw_A TOLL-like receptor 3; innate immunity, immune system; HET: NDG NAG; 2.10A {Homo sapiens} PDB: 2a0z_A* 3cig_A* 3ciy_A* Length = 680

 Score =  117 bits (294), Expect = 2e-27
 Identities = 33/143 (23%), Positives = 52/143 (36%)

Query: 94  LSGLYLHYNSLSGEIPKEIRNLTELTDLYLDVNNLSGNIPPEIGSMASLQVLQLCCNQLT 153
           ++ L L +N L           ++LT L +  N +S   P     +  L+VL L  N+L+
Sbjct: 27  ITVLNLTHNQLRRLPAANFTRYSQLTSLDVGFNTISKLEPELCQKLPMLKVLNLQHNELS 86

Query: 154 GNIPAQIGSLKSLSVLTLQHNRLNGGIPDSLGNLGKLKRLDLSFNSLFGTIPESLANNAE 213
                      +L+ L L  N +     +       L  LDLS N L  T   +      
Sbjct: 87  QLSDKTFAFCTNLTELHLMSNSIQKIKNNPFVKQKNLITLDLSHNGLSSTKLGTQVQLEN 146

Query: 214 LLFLDVQNNTLSGIVPSALKRLN 236
           L  L + NN +  +    L    
Sbjct: 147 LQELLLSNNKIQALKSEELDIFA 169

>1ziw_A TOLL-like receptor 3; innate immunity, immune system; HET: NDG NAG; 2.10A {Homo sapiens} PDB: 2a0z_A* 3cig_A* 3ciy_A* Length = 680

 Score =  116 bits (292), Expect = 3e-27
 Identities = 39/169 (23%), Positives = 63/169 (37%), Gaps = 5/169 (2%)

Query: 73  ISLQGKGLTGKLSPSLSGLKCLSGLYLHYNSLSGEIPKEIRNLTELTDLYLDVNNLSGNI 132
           ++LQ   L+     + +    L+ L+L  NS+             L  L L  N LS   
Sbjct: 78  LNLQHNELSQLSDKTFAFCTNLTELHLMSNSIQKIKNNPFVKQKNLITLDLSHNGLSSTK 137

Query: 133 PPEIGSMASLQVLQLCCNQLTGNIPA--QIGSLKSLSVLTLQHNRLNGGIPDSLGNLGKL 190
                 + +LQ L L  N++         I +  SL  L L  N++    P     +G+L
Sbjct: 138 LGTQVQLENLQELLLSNNKIQALKSEELDIFANSSLKKLELSSNQIKEFSPGCFHAIGRL 197

Query: 191 KRLDLSFNSLFGTIPESLA---NNAELLFLDVQNNTLSGIVPSALKRLN 236
             L L+   L  ++ E L     N  +  L + N+ LS    +    L 
Sbjct: 198 FGLFLNNVQLGPSLTEKLCLELANTSIRNLSLSNSQLSTTSNTTFLGLK 246

>1ziw_A TOLL-like receptor 3; innate immunity, immune system; HET: NDG NAG; 2.10A {Homo sapiens} PDB: 2a0z_A* 3cig_A* 3ciy_A* Length = 680

 Score =  116 bits (292), Expect = 4e-27
 Identities = 41/189 (21%), Positives = 66/189 (34%), Gaps = 13/189 (6%)

Query: 73  ISLQGKGLTGKLSPSLSGLKCLSGLYLHYNSLSG--EIPKEIRNLTELTDLYLDVNNLSG 130
           I L           S + +  L  L L   +L      P   + L  LT L L  NN++ 
Sbjct: 435 IYLSYNKYLQLTRNSFALVPSLQRLMLRRVALKNVDSSPSPFQPLRNLTILDLSNNNIAN 494

Query: 131 NIPPEIGSMASLQVLQLCCNQLT--------GNIPAQIGSLKSLSVLTLQHNRLNGGIPD 182
                +  +  L++L L  N L         G     +  L  L +L L+ N  +    +
Sbjct: 495 INDDMLEGLEKLEILDLQHNNLARLWKHANPGGPIYFLKGLSHLHILNLESNGFDEIPVE 554

Query: 183 SLGNLGKLKRLDLSFNSLFGTIPESLANNAELLFLDVQNNTLSGIVPSALKRLNGG---F 239
              +L +LK +DL  N+L         N   L  L++Q N ++ +               
Sbjct: 555 VFKDLFELKIIDLGLNNLNTLPASVFNNQVSLKSLNLQKNLITSVEKKVFGPAFRNLTEL 614

Query: 240 QFQNNPGLC 248
             + NP  C
Sbjct: 615 DMRFNPFDC 623

>1ziw_A TOLL-like receptor 3; innate immunity, immune system; HET: NDG NAG; 2.10A {Homo sapiens} PDB: 2a0z_A* 3cig_A* 3ciy_A* Length = 680

 Score =  108 bits (273), Expect = 8e-25
 Identities = 33/139 (23%), Positives = 51/139 (36%), Gaps = 3/139 (2%)

Query: 97  LYLHYNSLSGEIPKEIRNLTELTDLYLDVNNLSGNIPPEIGSMASLQVLQLCCNQLTGNI 156
               +  L+ ++P ++   T +T L L  N L           + L  L +  N ++   
Sbjct: 9   ADCSHLKLT-QVPDDL--PTNITVLNLTHNQLRRLPAANFTRYSQLTSLDVGFNTISKLE 65

Query: 157 PAQIGSLKSLSVLTLQHNRLNGGIPDSLGNLGKLKRLDLSFNSLFGTIPESLANNAELLF 216
           P     L  L VL LQHN L+     +      L  L L  NS+             L+ 
Sbjct: 66  PELCQKLPMLKVLNLQHNELSQLSDKTFAFCTNLTELHLMSNSIQKIKNNPFVKQKNLIT 125

Query: 217 LDVQNNTLSGIVPSALKRL 235
           LD+ +N LS        +L
Sbjct: 126 LDLSHNGLSSTKLGTQVQL 144

>1ziw_A TOLL-like receptor 3; innate immunity, immune system; HET: NDG NAG; 2.10A {Homo sapiens} PDB: 2a0z_A* 3cig_A* 3ciy_A* Length = 680

 Score =  108 bits (273), Expect = 8e-25
 Identities = 35/177 (19%), Positives = 62/177 (35%), Gaps = 14/177 (7%)

Query: 73  ISLQGKGLTGKLSPSLSGLKCLSGLYLHYNSLSGEIPKEIR---NLTELTDLYLDVNNLS 129
           + L    +          +  L GL+L+   L   + +++      T + +L L  + LS
Sbjct: 176 LELSSNQIKEFSPGCFHAIGRLFGLFLNNVQLGPSLTEKLCLELANTSIRNLSLSNSQLS 235

Query: 130 GNIPPEIGSMA--SLQVLQLCCNQLTGNIPAQIGSLKSLSVLTLQHNRLNGGIPDSLGNL 187
                    +   +L +L L  N L          L  L    L++N +      SL  L
Sbjct: 236 TTSNTTFLGLKWTNLTMLDLSYNNLNVVGNDSFAWLPQLEYFFLEYNNIQHLFSHSLHGL 295

Query: 188 GKLKRLDL---------SFNSLFGTIPESLANNAELLFLDVQNNTLSGIVPSALKRL 235
             ++ L+L         S  SL      S      L  L++++N + GI  +    L
Sbjct: 296 FNVRYLNLKRSFTKQSISLASLPKIDDFSFQWLKCLEHLNMEDNDIPGIKSNMFTGL 352

>1ziw_A TOLL-like receptor 3; innate immunity, immune system; HET: NDG NAG; 2.10A {Homo sapiens} PDB: 2a0z_A* 3cig_A* 3ciy_A* Length = 680

 Score =  107 bits (268), Expect = 3e-24
 Identities = 40/180 (22%), Positives = 67/180 (37%), Gaps = 15/180 (8%)

Query: 72  NISLQGKGLTGKLSPSLSGLKC--LSGLYLHYNSLSGEIPKEIRNLTELTDLYLDVNNLS 129
           N+SL    L+   + +  GLK   L+ L L YN+L+         L +L   +L+ NN+ 
Sbjct: 226 NLSLSNSQLSTTSNTTFLGLKWTNLTMLDLSYNNLNVVGNDSFAWLPQLEYFFLEYNNIQ 285

Query: 130 GNIPPEIGSMASLQVLQL---------CCNQLTGNIPAQIGSLKSLSVLTLQHNRLNGGI 180
                 +  + +++ L L             L          LK L  L ++ N + G  
Sbjct: 286 HLFSHSLHGLFNVRYLNLKRSFTKQSISLASLPKIDDFSFQWLKCLEHLNMEDNDIPGIK 345

Query: 181 PDSLGNLGKLKRLDLSFNSLFGTIPESLA----NNAELLFLDVQNNTLSGIVPSALKRLN 236
            +    L  LK L LS +        +       ++ L  L++  N +S I   A   L 
Sbjct: 346 SNMFTGLINLKYLSLSNSFTSLRTLTNETFVSLAHSPLHILNLTKNKISKIESDAFSWLG 405

>1ziw_A TOLL-like receptor 3; innate immunity, immune system; HET: NDG NAG; 2.10A {Homo sapiens} PDB: 2a0z_A* 3cig_A* 3ciy_A* Length = 680

 Score =  105 bits (265), Expect = 7e-24
 Identities = 42/193 (21%), Positives = 68/193 (35%), Gaps = 31/193 (16%)

Query: 74  SLQGKGLTGKLSPSLSGLKCLSGLYLHYNSLSGEIPKEIRNLTELTDLYLDVN------- 126
           S+    L      S   LKCL  L +  N + G        L  L  L L  +       
Sbjct: 311 SISLASLPKIDDFSFQWLKCLEHLNMEDNDIPGIKSNMFTGLINLKYLSLSNSFTSLRTL 370

Query: 127 ----------------NLSGN----IPPE-IGSMASLQVLQLCCNQLTGNIPAQ-IGSLK 164
                           NL+ N    I  +    +  L+VL L  N++   +  Q    L+
Sbjct: 371 TNETFVSLAHSPLHILNLTKNKISKIESDAFSWLGHLEVLDLGLNEIGQELTGQEWRGLE 430

Query: 165 SLSVLTLQHNRLNGGIPDSLGNLGKLKRLDLSFNSL--FGTIPESLANNAELLFLDVQNN 222
           ++  + L +N+      +S   +  L+RL L   +L    + P        L  LD+ NN
Sbjct: 431 NIFEIYLSYNKYLQLTRNSFALVPSLQRLMLRRVALKNVDSSPSPFQPLRNLTILDLSNN 490

Query: 223 TLSGIVPSALKRL 235
            ++ I    L+ L
Sbjct: 491 NIANINDDMLEGL 503

>1ziw_A TOLL-like receptor 3; innate immunity, immune system; HET: NDG NAG; 2.10A {Homo sapiens} PDB: 2a0z_A* 3cig_A* 3ciy_A* Length = 680

 Score = 98.1 bits (245), Expect = 2e-21
 Identities = 31/177 (17%), Positives = 63/177 (35%), Gaps = 14/177 (7%)

Query: 73  ISLQGKGLTGKLSPSLSGLKCLSGLYLHYN---------SLSGEIPKEIRNLTELTDLYL 123
             L+   +    S SL GL  +  L L  +         SL        + L  L  L +
Sbjct: 277 FFLEYNNIQHLFSHSLHGLFNVRYLNLKRSFTKQSISLASLPKIDDFSFQWLKCLEHLNM 336

Query: 124 DVNNLSGNIPPEIGSMASLQVLQLCCNQLT-GNIPAQIGS---LKSLSVLTLQHNRLNGG 179
           + N++ G        + +L+ L L  +  +   +  +         L +L L  N+++  
Sbjct: 337 EDNDIPGIKSNMFTGLINLKYLSLSNSFTSLRTLTNETFVSLAHSPLHILNLTKNKISKI 396

Query: 180 IPDSLGNLGKLKRLDLSFNSLFGTIP-ESLANNAELLFLDVQNNTLSGIVPSALKRL 235
             D+   LG L+ LDL  N +   +  +       +  + +  N    +  ++   +
Sbjct: 397 ESDAFSWLGHLEVLDLGLNEIGQELTGQEWRGLENIFEIYLSYNKYLQLTRNSFALV 453

>1ziw_A TOLL-like receptor 3; innate immunity, immune system; HET: NDG NAG; 2.10A {Homo sapiens} PDB: 2a0z_A* 3cig_A* 3ciy_A* Length = 680

 Score = 78.5 bits (194), Expect = 3e-15
 Identities = 28/142 (19%), Positives = 47/142 (33%), Gaps = 5/142 (3%)

Query: 74  SLQGKGLTGKLSPSLSGLKCLSGLYLHYNSLSGEIPKEIRNLTELTDLYLDVNNLSGNIP 133
            L      G     L GL  L  L L  N       +  ++L EL  + L +NNL+    
Sbjct: 518 RLWKHANPGGPIYFLKGLSHLHILNLESNGFDEIPVEVFKDLFELKIIDLGLNNLNTLPA 577

Query: 134 PEIGSMASLQVLQLCCNQLTGNIPAQIG-SLKSLSVLTLQHNRLNGGIPDSLGNLGKLKR 192
               +  SL+ L L  N +T       G + ++L+ L ++ N  +         +  +  
Sbjct: 578 SVFNNQVSLKSLNLQKNLITSVEKKVFGPAFRNLTELDMRFNPFDCTCESIAWFVNWINE 637

Query: 193 LDLSFNSLFGTI----PESLAN 210
              +   L        P     
Sbjct: 638 THTNIPELSSHYLCNTPPHYHG 659

>3cbl_A C-FES, proto-oncogene tyrosine-protein kinase FES/FPS; V-FES, fujinami, avian sarcoma, viral, feline virus, SGC; HET: STU; 1.75A {Homo sapiens} PDB: 3bkb_A* 3cd3_A* 4e93_A* Length = 377

 Score =  118 bits (297), Expect = 7e-29
 Identities = 63/277 (22%), Positives = 120/277 (43%), Gaps = 46/277 (16%)

Query: 417 LGKGNFSSVYKGTLR-DGTLVAIRSINVTSCKSEEAEFVKGLYLLTSLRHENIIRLRGFC 475
           +G+GNF  V+ G LR D TLVA++S   T     +A+F++   +L    H NI+RL G C
Sbjct: 122 IGRGNFGEVFSGRLRADNTLVAVKSCRETLPPDLKAKFLQEARILKQYSHPNIVRLIGVC 181

Query: 476 CSRGRGE-CFLIYDFAPKGKLSKYLDQEEGSSNVLDWSTRVSIIIGIAKGIGYLHSSEVN 534
               + +  +++ +    G    +L  E      L   T + ++   A G+ YL S    
Sbjct: 182 T---QKQPIYIVMELVQGGDFLTFLRTEGAR---LRVKTLLQMVGDAAAGMEYLESKCC- 234

Query: 535 KPAIVHRNLSVEKVLIDQQFNPLIADCGLHKLLADDIVFSVLKTSAAMGYL-----APEY 589
               +HR+L+    L+ ++    I+D G+ +  AD +  +    S  +  +     APE 
Sbjct: 235 ----IHRDLAARNCLVTEKNVLKISDFGMSREEADGVYAA----SGGLRQVPVKWTAPEA 286

Query: 590 VTTGRFTERSDIFAFGVIILQI----------LTGSLVLTSSMRLAAESATFENFIDRNL 639
           +  GR++  SD+++FG+++ +           L+                    F+++  
Sbjct: 287 LNYGRYSSESDVWSFGILLWETFSLGASPYPNLSNQQTR--------------EFVEKGG 332

Query: 640 KGKFSESEAAKLGKMALVCTHEDPENRPTMEAVIEEL 676
           +    E     + ++   C   +P  RP+   + +EL
Sbjct: 333 RLPCPELCPDAVFRLMEQCWAYEPGQRPSFSTIYQEL 369

>1fmk_A C-SRC, P60-SRC, tyrosine-protein kinase SRC; tyrosine kinase, phosphorylation, SH2, SH3, phosphotyrosine, proto-oncogene, phosphotransferase; HET: PTR; 1.50A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1y57_A* 2src_A* 1ksw_A* 2ptk_A* 1yol_A* 2oiq_A* 3d7t_B* 3dqx_A* 3el7_A* 3el8_A* 3en4_A* 3en5_A* 3en6_A* 3en7_A* 3f6x_A* 3g6g_A* 3uqf_A* 3uqg_A* 4agw_A* 3oez_A* ... Length = 452

 Score =  119 bits (299), Expect = 8e-29
 Identities = 64/263 (24%), Positives = 114/263 (43%), Gaps = 16/263 (6%)

Query: 414 VNLLGKGNFSSVYKGTLRDGTLVAIRSINVTSCKSEEAEFVKGLYLLTSLRHENIIRLRG 473
              LG+G F  V+ GT    T VAI+++   +       F++   ++  LRHE +++L  
Sbjct: 189 EVKLGQGCFGEVWMGTWNGTTRVAIKTLKPGT--MSPEAFLQEAQVMKKLRHEKLVQLYA 246

Query: 474 FCCSRGRGECFLIYDFAPKGKLSKYLDQEEGSSNVLDWSTRVSIIIGIAKGIGYLHSSEV 533
                     +++ ++  KG L  +L  E G    L     V +   IA G+ Y+     
Sbjct: 247 VVSEEPI---YIVTEYMSKGSLLDFLKGETGK--YLRLPQLVDMAAQIASGMAYVERMN- 300

Query: 534 NKPAIVHRNLSVEKVLIDQQFNPLIADCGLHKLLADDIVFSVLKTSAAMGYLAPEYVTTG 593
                VHR+L    +L+ +     +AD GL +L+ D+   +       + + APE    G
Sbjct: 301 ----YVHRDLRAANILVGENLVCKVADFGLARLIEDNEYTARQGAKFPIKWTAPEAALYG 356

Query: 594 RFTERSDIFAFGVIILQILTGSLVLTSSMRLAAESATFENFIDRNLKGKFSESEAAKLGK 653
           RFT +SD+++FG+++ ++ T   V    M         +  ++R  +          L  
Sbjct: 357 RFTIKSDVWSFGILLTELTTKGRVPYPGMVN---REVLD-QVERGYRMPCPPECPESLHD 412

Query: 654 MALVCTHEDPENRPTMEAVIEEL 676
           +   C  ++PE RPT E +   L
Sbjct: 413 LMCQCWRKEPEERPTFEYLQAFL 435

>4ecn_A Leucine-rich repeat protein; leucine-rich repeats, DUF4458 domain, protein binding, extra protein, structural genomics; 2.80A {Bacteroides thetaiotaomicron} Length = 876

 Score =  121 bits (306), Expect = 9e-29
 Identities = 33/171 (19%), Positives = 61/171 (35%), Gaps = 14/171 (8%)

Query: 72  NISLQGKGLTGKLSPSLSGLKCLSGLYLHYNSLSGEIPKEIRNLTELTDLYLDVNNLSG- 130
           + +            S S LK L+ + L+      ++P  + +L EL  L +  N     
Sbjct: 471 DANSDYAKQYENEELSWSNLKDLTDVELYNCPNMTQLPDFLYDLPELQSLNIACNRGISA 530

Query: 131 --------NIPPEIGSMASLQVLQLCCNQLTG-NIPAQIGSLKSLSVLTLQHNRLNGGIP 181
                    +  +  +   +Q+  +  N L      A +  +  L +L   HN++     
Sbjct: 531 AQLKADWTRLADDEDTGPKIQIFYMGYNNLEEFPASASLQKMVKLGLLDCVHNKVR--HL 588

Query: 182 DSLGNLGKLKRLDLSFNSLFGTIPESLANNA-ELLFLDVQNNTLSGIVPSA 231
           ++ G   KL  L L +N +   IPE       ++  L   +N L  I    
Sbjct: 589 EAFGTNVKLTDLKLDYNQI-EEIPEDFCAFTDQVEGLGFSHNKLKYIPNIF 638

>4ecn_A Leucine-rich repeat protein; leucine-rich repeats, DUF4458 domain, protein binding, extra protein, structural genomics; 2.80A {Bacteroides thetaiotaomicron} Length = 876

 Score =  112 bits (281), Expect = 8e-26
 Identities = 33/205 (16%), Positives = 68/205 (33%), Gaps = 24/205 (11%)

Query: 73  ISLQGKGLTGKLSPSLSGLKCLSGLYLHYNSLS-------GEIPKEIRNLTELTDLYLDV 125
           ++L    +    +   +    +S + L  N ++              +N   LT + L  
Sbjct: 678 VTLSYNEIQKFPTELFATGSPISTIILSNNLMTSIPENSLKPKDGNYKNTYLLTTIDLRF 737

Query: 126 NNLSGNIPPEI--GSMASLQVLQLCCNQLTGNIPAQIGSLKSLSVLTLQH------NRLN 177
           N L+  +  +    ++  L  + +  N  +   P Q  +   L    ++H      NR+ 
Sbjct: 738 NKLTS-LSDDFRATTLPYLSNMDVSYNCFSS-FPTQPLNSSQLKAFGIRHQRDAEGNRIL 795

Query: 178 GGIPDSLGNLGKLKRLDLSFNSLFGTIPESLANNAELLFLDVQNNTLSGIVPSALKRLNG 237
              P  +     L +L +  N +   + E L     L  LD+ +N    I  +++     
Sbjct: 796 RQWPTGITTCPSLIQLQIGSNDI-RKVDEKLTPQ--LYILDIADNPNISIDVTSV----C 848

Query: 238 GFQFQNNPGLCGDGIASLRACTVYD 262
            +       L  D    +R C    
Sbjct: 849 PYIEAGMYVLLYDKTQDIRGCDALG 873

>4ecn_A Leucine-rich repeat protein; leucine-rich repeats, DUF4458 domain, protein binding, extra protein, structural genomics; 2.80A {Bacteroides thetaiotaomicron} Length = 876

 Score =  112 bits (281), Expect = 9e-26
 Identities = 28/174 (16%), Positives = 58/174 (33%), Gaps = 19/174 (10%)

Query: 79  GLTGKLSPSLSGLKC--LSGLYLHYNSLSGEIPKEIRNLTELTDLYLDVNNLS------- 129
                +S S+   K    S + L YN +     +     + ++ + L  N ++       
Sbjct: 658 SEGRNISCSMDDYKGINASTVTLSYNEIQKFPTELFATGSPISTIILSNNLMTSIPENSL 717

Query: 130 GNIPPEIGSMASLQVLQLCCNQLTGNIPAQI--GSLKSLSVLTLQHNRLNGGIPDSLGNL 187
                   +   L  + L  N+LT  +       +L  LS + + +N  +   P    N 
Sbjct: 718 KPKDGNYKNTYLLTTIDLRFNKLTS-LSDDFRATTLPYLSNMDVSYNCFSS-FPTQPLNS 775

Query: 188 GKLKRLDLSF------NSLFGTIPESLANNAELLFLDVQNNTLSGIVPSALKRL 235
            +LK   +        N +    P  +     L+ L + +N +  +      +L
Sbjct: 776 SQLKAFGIRHQRDAEGNRILRQWPTGITTCPSLIQLQIGSNDIRKVDEKLTPQL 829

>4ecn_A Leucine-rich repeat protein; leucine-rich repeats, DUF4458 domain, protein binding, extra protein, structural genomics; 2.80A {Bacteroides thetaiotaomicron} Length = 876

 Score =  106 bits (265), Expect = 9e-24
 Identities = 27/161 (16%), Positives = 56/161 (34%), Gaps = 20/161 (12%)

Query: 86  PSLSGLKCLSGLYLHYNSLSG------EIPKEIRNLTELTDLYLDVNNLSGNIPPEIGSM 139
           P +  +K  S + L    +         I K I+ LT+L  +Y   +  + +        
Sbjct: 412 PEMKPIKKDSRISLKDTQIGNLTNRITFISKAIQRLTKLQIIYFANSPFTYDNIAV---- 467

Query: 140 ASLQVLQLCCNQLTGNIPAQIGSLKSLSVLTLQHNRLNGGIPDSLGNLGKLKRLDLSFNS 199
              +       +   N      +LK L+ + L +      +PD L +L +L+ L+++ N 
Sbjct: 468 -DWEDANSDYAKQYENEELSWSNLKDLTDVELYNCPNMTQLPDFLYDLPELQSLNIACNR 526

Query: 200 L---------FGTIPESLANNAELLFLDVQNNTLSGIVPSA 231
                     +  + +      ++    +  N L     SA
Sbjct: 527 GISAAQLKADWTRLADDEDTGPKIQIFYMGYNNLEEFPASA 567

>4ecn_A Leucine-rich repeat protein; leucine-rich repeats, DUF4458 domain, protein binding, extra protein, structural genomics; 2.80A {Bacteroides thetaiotaomicron} Length = 876

 Score =  105 bits (263), Expect = 1e-23
 Identities = 34/164 (20%), Positives = 65/164 (39%), Gaps = 12/164 (7%)

Query: 85  SPSLSGLKCLSGLYLHYNSLSGEIPKEIRNLTELTDLYLDVNNLSGNIPPEIGS-MASLQ 143
           S SL  +  L  L   +N +   +        +LTDL LD N +   IP +  +    ++
Sbjct: 566 SASLQKMVKLGLLDCVHNKVR-HLE-AFGTNVKLTDLKLDYNQIE-EIPEDFCAFTDQVE 622

Query: 144 VLQLCCNQLTGNIP--AQIGSLKSLSVLTLQHNRL-----NGGIPDSLGNLGKLKRLDLS 196
            L    N+L   IP      S+  +  +   +N++     N               + LS
Sbjct: 623 GLGFSHNKLKY-IPNIFNAKSVYVMGSVDFSYNKIGSEGRNISCSMDDYKGINASTVTLS 681

Query: 197 FNSLFGTIPESLANNAELLFLDVQNNTLSGIVPSALKRLNGGFQ 240
           +N +     E  A  + +  + + NN ++ I  ++LK  +G ++
Sbjct: 682 YNEIQKFPTELFATGSPISTIILSNNLMTSIPENSLKPKDGNYK 725

>4ecn_A Leucine-rich repeat protein; leucine-rich repeats, DUF4458 domain, protein binding, extra protein, structural genomics; 2.80A {Bacteroides thetaiotaomicron} Length = 876

 Score = 98.4 bits (245), Expect = 2e-21
 Identities = 42/284 (14%), Positives = 80/284 (28%), Gaps = 64/284 (22%)

Query: 26  TELRALLDLKASLDPEN-----------KLLQSWTENGDPCS-GSFEGIACNEHRKVANI 73
            + +AL  +  +LD +N               +W  N +    G   G+  + + +V  +
Sbjct: 269 KDYKALKAIWEALDGKNWRYYSGTINNTIHSLNWNFNKELDMWGDQPGVDLDNNGRVTGL 328

Query: 74  SLQGKGLTG----------------------KLSPSLSGLKCLSG---------LYLHYN 102
           SL G G  G                       +S  L G + L+          + +HY 
Sbjct: 329 SLAGFGAKGRVPDAIGQLTELKVLSFGTHSETVSGRLFGDEELTPDMSEERKHRIRMHYK 388

Query: 103 SLSGEIPKEIRNLTELTDLYLDVNNLSGNIPPEIGSMASLQVLQLCCNQLTGNIPAQIGS 162
            +  +  + +     L D       +   I  +         +    N++T  I   I  
Sbjct: 389 KMFLDYDQRLNLSDLLQDAINRNPEM-KPIKKDSRISLKDTQIGNLTNRITF-ISKAIQR 446

Query: 163 LKSLSVLTLQHNRLNG-------------------GIPDSLGNLGKLKRLDLSFNSLFGT 203
           L  L ++   ++                           S  NL  L  ++L        
Sbjct: 447 LTKLQIIYFANSPFTYDNIAVDWEDANSDYAKQYENEELSWSNLKDLTDVELYNCPNMTQ 506

Query: 204 IPESLANNAELLFLDVQNNTLSGIVPSALKRLNGGFQFQNNPGL 247
           +P+ L +  EL  L++  N                      P +
Sbjct: 507 LPDFLYDLPELQSLNIACNRGISAAQLKADWTRLADDEDTGPKI 550

>3lxl_A Tyrosine-protein kinase JAK3; TYK2, inflammation, cancer, PAN inhibitor, ATP-binding mutation, membrane, nucleotide-binding, phosphoprot SCID; HET: IZA; 1.74A {Homo sapiens} PDB: 3lxk_A* 3pjc_A* 1yvj_A* Length = 327

 Score =  115 bits (291), Expect = 2e-28
 Identities = 69/288 (23%), Positives = 125/288 (43%), Gaps = 40/288 (13%)

Query: 414 VNLLGKGNFSSVYKGTLR-----DGTLVAIRSINVTSCKSEEAEFVKGLYLLTSLRHENI 468
           ++ LGKGNF SV            G LVA++ +  +    +  +F + + +L +L  + I
Sbjct: 28  ISQLGKGNFGSVELCRYDPLGDNTGALVAVKQLQHSGPDQQR-DFQREIQILKALHSDFI 86

Query: 469 IRLRGFCCSRGRGECFLIYDFAPKGKLSKYLDQEEGSSNVLDWSTRVSIIIGIAKGIGYL 528
           ++ RG     GR    L+ ++ P G L  +L +       LD S  +     I KG+ YL
Sbjct: 87  VKYRGVSYGPGRQSLRLVMEYLPSGCLRDFLQRHRAR---LDASRLLLYSSQICKGMEYL 143

Query: 529 HSSEVNKPAIVHRNLSVEKVLIDQQFNPLIADCGLHKLLADDIVFSVLKTSAAM--GYLA 586
            S        VHR+L+   +L++ + +  IAD GL KLL  D  + V++        + A
Sbjct: 144 GSRR-----CVHRDLAARNILVESEAHVKIADFGLAKLLPLDKDYYVVREPGQSPIFWYA 198

Query: 587 PEYVTTGRFTERSDIFAFGVIILQILT-------GSLVLTSSMRLAAESATFENFIDRNL 639
           PE ++   F+ +SD+++FGV++ ++ T        S      M    +       ++   
Sbjct: 199 PESLSDNIFSRQSDVWSFGVVLYELFTYCDKSCSPSAEFLRMMGCERDVPALSRLLELLE 258

Query: 640 KGKFSESEAAKLGKMA----------LVCTHEDPENRPTMEAVIEELT 677
           +G+       +L               +C    P++RP+  A+  +L 
Sbjct: 259 EGQ-------RLPAPPACPAEVHELMKLCWAPSPQDRPSFSALGPQLD 299

>4fcg_A Uncharacterized protein; structural genomics, PSI-biology, midwest center for structu genomics, MCSG, LRR, N- and C-terminal helices; 2.00A {Xanthomonas campestris PV} Length = 328

 Score =  115 bits (289), Expect = 3e-28
 Identities = 35/144 (24%), Positives = 54/144 (37%), Gaps = 4/144 (2%)

Query: 83  KLSPSLSGLKCLSGLYLHYNSLSGEIPKEIRNLTELTDLYLDVNNLSGNIPPEIGSMASL 142
             S    GL  L  L L +  +   +P  I NL  L  L +  + LS  + P I  +  L
Sbjct: 174 DASGEHQGLVNLQSLRLEWTGIR-SLPASIANLQNLKSLKIRNSPLSA-LGPAIHHLPKL 231

Query: 143 QVLQLC-CNQLTGNIPAQIGSLKSLSVLTLQHNRLNGGIPDSLGNLGKLKRLDLSFNSLF 201
           + L L  C  L    P   G    L  L L+       +P  +  L +L++LDL      
Sbjct: 232 EELDLRGCTALRN-YPPIFGGRAPLKRLILKDCSNLLTLPLDIHRLTQLEKLDLRGCVNL 290

Query: 202 GTIPESLANNAELLFLDVQNNTLS 225
             +P  +A       + V  +  +
Sbjct: 291 SRLPSLIAQLPANCIILVPPHLQA 314

>4fcg_A Uncharacterized protein; structural genomics, PSI-biology, midwest center for structu genomics, MCSG, LRR, N- and C-terminal helices; 2.00A {Xanthomonas campestris PV} Length = 328

 Score =  110 bits (278), Expect = 9e-27
 Identities = 37/162 (22%), Positives = 72/162 (44%), Gaps = 12/162 (7%)

Query: 83  KLSPSLSGLKCLSGLYLHYNSLSGEIPKEIRNLTELTDLYLDVNNLSGNIPPEIGS---- 138
           +L  ++     L  L L  N L   +P  I +L  L +L +        +P  + S    
Sbjct: 118 ELPDTMQQFAGLETLTLARNPLR-ALPASIASLNRLRELSIRACPELTELPEPLASTDAS 176

Query: 139 -----MASLQVLQLCCNQLTGNIPAQIGSLKSLSVLTLQHNRLNGGIPDSLGNLGKLKRL 193
                + +LQ L+L    +  ++PA I +L++L  L ++++ L+  +  ++ +L KL+ L
Sbjct: 177 GEHQGLVNLQSLRLEWTGIR-SLPASIANLQNLKSLKIRNSPLS-ALGPAIHHLPKLEEL 234

Query: 194 DLSFNSLFGTIPESLANNAELLFLDVQNNTLSGIVPSALKRL 235
           DL   +     P      A L  L +++ +    +P  + RL
Sbjct: 235 DLRGCTALRNYPPIFGGRAPLKRLILKDCSNLLTLPLDIHRL 276

>4fcg_A Uncharacterized protein; structural genomics, PSI-biology, midwest center for structu genomics, MCSG, LRR, N- and C-terminal helices; 2.00A {Xanthomonas campestris PV} Length = 328

 Score =  108 bits (272), Expect = 5e-26
 Identities = 37/161 (22%), Positives = 66/161 (40%), Gaps = 11/161 (6%)

Query: 84  LSPSLSGLKCLSGLYLHYNSLSGEIPKEI---------RNLTELTDLYLDVNNLSGNIPP 134
           L  S++ L  L  L +       E+P+ +         + L  L  L L+   +  ++P 
Sbjct: 142 LPASIASLNRLRELSIRACPELTELPEPLASTDASGEHQGLVNLQSLRLEWTGIR-SLPA 200

Query: 135 EIGSMASLQVLQLCCNQLTGNIPAQIGSLKSLSVLTLQHNRLNGGIPDSLGNLGKLKRLD 194
            I ++ +L+ L++  + L+  +   I  L  L  L L+        P   G    LKRL 
Sbjct: 201 SIANLQNLKSLKIRNSPLSA-LGPAIHHLPKLEELDLRGCTALRNYPPIFGGRAPLKRLI 259

Query: 195 LSFNSLFGTIPESLANNAELLFLDVQNNTLSGIVPSALKRL 235
           L   S   T+P  +    +L  LD++       +PS + +L
Sbjct: 260 LKDCSNLLTLPLDIHRLTQLEKLDLRGCVNLSRLPSLIAQL 300

>4fcg_A Uncharacterized protein; structural genomics, PSI-biology, midwest center for structu genomics, MCSG, LRR, N- and C-terminal helices; 2.00A {Xanthomonas campestris PV} Length = 328

 Score =  104 bits (261), Expect = 1e-24
 Identities = 39/172 (22%), Positives = 67/172 (38%), Gaps = 16/172 (9%)

Query: 74  SLQGKGLTGKLSPSLSGLKCLSGLYLHYNSLSGEIPKEIRNLTELTDLYLDVNNLSGNIP 133
            L+   L  +       L  L  + +    L  E+P  ++    L  L L  N L   +P
Sbjct: 87  ELRSVPLP-QFPDQAFRLSHLQHMTIDAAGLM-ELPDTMQQFAGLETLTLARNPLR-ALP 143

Query: 134 PEIGSMASLQVLQL-CCNQLTGNIPAQIGS---------LKSLSVLTLQHNRLNGGIPDS 183
             I S+  L+ L +  C +LT  +P  + S         L +L  L L+   +   +P S
Sbjct: 144 ASIASLNRLRELSIRACPELT-ELPEPLASTDASGEHQGLVNLQSLRLEWTGIR-SLPAS 201

Query: 184 LGNLGKLKRLDLSFNSLFGTIPESLANNAELLFLDVQNNTLSGIVPSALKRL 235
           + NL  LK L +  + L   +  ++ +  +L  LD++  T     P      
Sbjct: 202 IANLQNLKSLKIRNSPLS-ALGPAIHHLPKLEELDLRGCTALRNYPPIFGGR 252

>4fcg_A Uncharacterized protein; structural genomics, PSI-biology, midwest center for structu genomics, MCSG, LRR, N- and C-terminal helices; 2.00A {Xanthomonas campestris PV} Length = 328

 Score =  103 bits (258), Expect = 4e-24
 Identities = 30/127 (23%), Positives = 50/127 (39%), Gaps = 4/127 (3%)

Query: 83  KLSPSLSGLKCLSGLYLHYNSLSGEIPKEIRNLTELTDLYLDVNNLSGNIPPEIGSMASL 142
            L  S++ L+ L  L +  + LS  +   I +L +L +L L       N PP  G  A L
Sbjct: 197 SLPASIANLQNLKSLKIRNSPLS-ALGPAIHHLPKLEELDLRGCTALRNYPPIFGGRAPL 255

Query: 143 QVLQLC-CNQLTGNIPAQIGSLKSLSVLTLQHNRLNGGIPDSLGNLGKLKRLDLSFNSLF 201
           + L L  C+ L   +P  I  L  L  L L+       +P  +  L     + +  +   
Sbjct: 256 KRLILKDCSNLL-TLPLDIHRLTQLEKLDLRGCVNLSRLPSLIAQLPANCIILVPPHLQ- 313

Query: 202 GTIPESL 208
             + +  
Sbjct: 314 AQLDQHR 320

>4fcg_A Uncharacterized protein; structural genomics, PSI-biology, midwest center for structu genomics, MCSG, LRR, N- and C-terminal helices; 2.00A {Xanthomonas campestris PV} Length = 328

 Score = 86.2 bits (214), Expect = 2e-18
 Identities = 28/163 (17%), Positives = 49/163 (30%), Gaps = 10/163 (6%)

Query: 83  KLSPSLSGLKCLSGLYLHYNSLSGEIPKEIRNLTELTDLYLDVNNLSGNIPPEIG--SMA 140
                LS  +       +    +        N             L       +   +  
Sbjct: 27  PYHDVLSQWQRHYNADRNRWHSAWRQA----NSNNPQIETRTGRALK-ATADLLEDATQP 81

Query: 141 SLQVLQLCCNQLTGNIPAQIGSLKSLSVLTLQHNRLNGGIPDSLGNLGKLKRLDLSFNSL 200
               L+L    L    P Q   L  L  +T+    L   +PD++     L+ L L+ N L
Sbjct: 82  GRVALELRSVPLP-QFPDQAFRLSHLQHMTIDAAGLME-LPDTMQQFAGLETLTLARNPL 139

Query: 201 FGTIPESLANNAELLFLDVQNNTLSGIVPSALKRLNGGFQFQN 243
              +P S+A+   L  L ++       +P  L   +   + Q 
Sbjct: 140 -RALPASIASLNRLRELSIRACPELTELPEPLASTDASGEHQG 181

>4fcg_A Uncharacterized protein; structural genomics, PSI-biology, midwest center for structu genomics, MCSG, LRR, N- and C-terminal helices; 2.00A {Xanthomonas campestris PV} Length = 328

 Score = 76.1 bits (188), Expect = 3e-15
 Identities = 20/147 (13%), Positives = 44/147 (29%), Gaps = 10/147 (6%)

Query: 91  LKCLSGLYLHYNSLSGEIPKEIRNLTELTDLYLDVNNLSGNIPPEIGSMASLQVLQLCCN 150
                 LY   ++        +       +   +  + +        +  + Q+      
Sbjct: 11  SSGRENLYFQGSTALRPYHDVLSQWQRHYNADRNRWHSAWRQA----NSNNPQIETRTGR 66

Query: 151 QLTGNIPAQIGSLKS--LSVLTLQHNRLNGGIPDSLGNLGKLKRLDLSFNSLFGTIPESL 208
            L       +          L L+   L    PD    L  L+ + +    L   +P+++
Sbjct: 67  ALK-ATADLLEDATQPGRVALELRSVPLPQ-FPDQAFRLSHLQHMTIDAAGL-MELPDTM 123

Query: 209 ANNAELLFLDVQNNTLSGIVPSALKRL 235
              A L  L +  N L  + P+++  L
Sbjct: 124 QQFAGLETLTLARNPLRAL-PASIASL 149

>4fcg_A Uncharacterized protein; structural genomics, PSI-biology, midwest center for structu genomics, MCSG, LRR, N- and C-terminal helices; 2.00A {Xanthomonas campestris PV} Length = 328

 Score = 58.4 bits (142), Expect = 3e-09
 Identities = 18/84 (21%), Positives = 30/84 (35%), Gaps = 3/84 (3%)

Query: 83  KLSPSLSGLKCLSGLYLHYNSLSGEIPKEIRNLTELTDLYLDVNNLSGNIPPEIGSMASL 142
              P   G   L  L L   S    +P +I  LT+L  L L        +P  I  + + 
Sbjct: 244 NYPPIFGGRAPLKRLILKDCSNLLTLPLDIHRLTQLEKLDLRGCVNLSRLPSLIAQLPAN 303

Query: 143 QVLQLCCN---QLTGNIPAQIGSL 163
            ++ +  +   QL  + P    + 
Sbjct: 304 CIILVPPHLQAQLDQHRPVARPAE 327

>2h8h_A Proto-oncogene tyrosine-protein kinase SRC; SRC kinase, transferase; HET: PTR H8H; 2.20A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 Length = 535

 Score =  118 bits (296), Expect = 5e-28
 Identities = 64/263 (24%), Positives = 114/263 (43%), Gaps = 16/263 (6%)

Query: 414 VNLLGKGNFSSVYKGTLRDGTLVAIRSINVTSCKSEEAEFVKGLYLLTSLRHENIIRLRG 473
              LG+G F  V+ GT    T VAI+++   +       F++   ++  LRHE +++L  
Sbjct: 272 EVKLGQGCFGEVWMGTWNGTTRVAIKTLKPGT--MSPEAFLQEAQVMKKLRHEKLVQLYA 329

Query: 474 FCCSRGRGECFLIYDFAPKGKLSKYLDQEEGSSNVLDWSTRVSIIIGIAKGIGYLHSSEV 533
                     +++ ++  KG L  +L  E G    L     V +   IA G+ Y+     
Sbjct: 330 VVSEEPI---YIVTEYMSKGSLLDFLKGETGKY--LRLPQLVDMAAQIASGMAYVERMN- 383

Query: 534 NKPAIVHRNLSVEKVLIDQQFNPLIADCGLHKLLADDIVFSVLKTSAAMGYLAPEYVTTG 593
                VHR+L    +L+ +     +AD GL +L+ D+   +       + + APE    G
Sbjct: 384 ----YVHRDLRAANILVGENLVCKVADFGLARLIEDNEYTARQGAKFPIKWTAPEAALYG 439

Query: 594 RFTERSDIFAFGVIILQILTGSLVLTSSMRLAAESATFENFIDRNLKGKFSESEAAKLGK 653
           RFT +SD+++FG+++ ++ T   V    M         +  ++R  +          L  
Sbjct: 440 RFTIKSDVWSFGILLTELTTKGRVPYPGMVN---REVLD-QVERGYRMPCPPECPESLHD 495

Query: 654 MALVCTHEDPENRPTMEAVIEEL 676
           +   C  ++PE RPT E +   L
Sbjct: 496 LMCQCWRKEPEERPTFEYLQAFL 518

>3lzb_A Epidermal growth factor receptor; epidermal growth factor kinase domain, multitargeted small M kinase inhibitor; HET: ITI; 2.70A {Homo sapiens} Length = 327

 Score =  113 bits (284), Expect = 1e-27
 Identities = 51/208 (24%), Positives = 94/208 (45%), Gaps = 21/208 (10%)

Query: 414 VNLLGKGNFSSVYKGTLRDG-----TLVAIRSINVTSCKSEEAEFVKGLYLLTSLRHENI 468
           + +LG G F +VYKG            VAI+ +   +      E +   Y++ S+ + ++
Sbjct: 20  IKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHV 79

Query: 469 IRLRGFCCSRGRGECFLIYDFAPKGKLSKYLDQEEGSSNVLDWSTRVSIIIGIAKGIGYL 528
            RL G C +       LI    P G L  Y+ + + +   +     ++  + IAKG+ YL
Sbjct: 80  CRLLGICLTS---TVQLITQLMPFGCLLDYVREHKDN---IGSQYLLNWCVQIAKGMNYL 133

Query: 529 HSSEVNKPAIVHRNLSVEKVLIDQQFNPLIADCGLHKLLADDIVFSVLKTSAAM---GYL 585
              +     +VHR+L+   VL+    +  I D GL KLL  +                ++
Sbjct: 134 --EDRR---LVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEE--KEYHAEGGKVPIKWM 186

Query: 586 APEYVTTGRFTERSDIFAFGVIILQILT 613
           A E +    +T +SD++++GV + +++T
Sbjct: 187 ALESILHRIYTHQSDVWSYGVTVWELMT 214

>1qcf_A Haematopoetic cell kinase (HCK); tyrosine kinase-inhibitor complex, DOWN-regulated kinase, ordered activation loop; HET: PTR PP1; 2.00A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 2c0i_A* 2c0o_A* 2c0t_A* 1ad5_A* 2hck_A* 3nhn_A 3hck_A 1bu1_A 3rea_B 3rbb_B Length = 454

 Score =  115 bits (289), Expect = 2e-27
 Identities = 48/200 (24%), Positives = 94/200 (47%), Gaps = 12/200 (6%)

Query: 414 VNLLGKGNFSSVYKGTLRDGTLVAIRSINVTSCKSEEAEFVKGLYLLTSLRHENIIRLRG 473
              LG G F  V+  T    T VA++++   S       F+    ++ +L+H+ +++L  
Sbjct: 193 EKKLGAGQFGEVWMATYNKHTKVAVKTMKPGS--MSVEAFLAEANVMKTLQHDKLVKLHA 250

Query: 474 FCCSRGRGECFLIYDFAPKGKLSKYLDQEEGSSNVLDWSTRVSIIIGIAKGIGYLHSSEV 533
                     ++I +F  KG L  +L  +EGS         +     IA+G+ ++     
Sbjct: 251 VVTKEP---IYIITEFMAKGSLLDFLKSDEGSK--QPLPKLIDFSAQIAEGMAFIEQRN- 304

Query: 534 NKPAIVHRNLSVEKVLIDQQFNPLIADCGLHKLLADDIVFSVLKTSAAMGYLAPEYVTTG 593
                +HR+L    +L+       IAD GL +++ D+   +       + + APE +  G
Sbjct: 305 ----YIHRDLRAANILVSASLVCKIADFGLARVIEDNEYTAREGAKFPIKWTAPEAINFG 360

Query: 594 RFTERSDIFAFGVIILQILT 613
            FT +SD+++FG+++++I+T
Sbjct: 361 SFTIKSDVWSFGILLMEIVT 380

>2w5a_A Serine/threonine-protein kinase NEK2; Ser/Thr protein kinase, nucleus, meiosis, mitosis, cytoplasm, metal-binding, phosphoprotein; HET: ADP; 1.55A {Homo sapiens} PDB: 2wqo_A* 2xk3_A* 2xk4_A* 2xk6_A* 2xk7_A* 2xk8_A* 2xkc_A* 2xkd_A* 2xke_A* 2xkf_A* 2xnm_A* 2xnn_A* 2xno_A* 2xnp_A* 4afe_A* 2jav_A* 2w5b_A* 2w5h_A 4a4x_A* Length = 279

 Score =  110 bits (278), Expect = 3e-27
 Identities = 50/282 (17%), Positives = 113/282 (40%), Gaps = 28/282 (9%)

Query: 405 ESATQCFSEVNLLGKGNFSSVYKGT-LRDGTLVAIRSINVTSCKSEEAEFVKG-LYLLTS 462
            S  + +  +  +G G++    K     DG ++  + ++  S    E + +   + LL  
Sbjct: 2   PSRAEDYEVLYTIGTGSYGRCQKIRRKSDGKILVWKELDYGSMTEAEKQMLVSEVNLLRE 61

Query: 463 LRHENIIRLRGFCCSRGRGECFLIYDFAPKGKLSKYLDQEEGSSNVLDWSTRVSIIIGIA 522
           L+H NI+R       R     +++ ++   G L+  + +       LD    + ++  + 
Sbjct: 62  LKHPNIVRYYDRIIDRTNTTLYIVMEYCEGGDLASVITKGTKERQYLDEEFVLRVMTQLT 121

Query: 523 KGIGYLHSSEVNKPAIVHRNLSVEKVLIDQQFNPLIADCGLHKLLADDIVFSVLKTSAAM 582
             +   H        ++HR+L    V +D + N  + D GL ++L  D  F        +
Sbjct: 122 LALKECHRRSDGGHTVLHRDLKPANVFLDGKQNVKLGDFGLARILNHDTSF----AKTFV 177

Query: 583 G---YLAPEYVTTGRFTERSDIFAFGVIILQILTGSLVLTSSMRLAAESATFENFIDRNL 639
           G   Y++PE +    + E+SDI++ G ++ ++                + + +    +  
Sbjct: 178 GTPYYMSPEQMNRMSYNEKSDIWSLGCLLYELCAL--------MPPFTAFSQKELAGKIR 229

Query: 640 KGKFSE-----SEAAKLGKMALV--CTHEDPENRPTMEAVIE 674
           +GKF       S+        ++    +    +RP++E ++E
Sbjct: 230 EGKFRRIPYRYSDELN----EIITRMLNLKDYHRPSVEEILE 267

>3t9t_A Tyrosine-protein kinase ITK/TSK; kinase domain, alpha/beta, ATP binding, phosphorylation, intracellular, transferase-transferase inhibitor complex; HET: IAQ; 1.65A {Homo sapiens} PDB: 3v5l_A* 3v5j_A* 3v8t_A* 3v8w_A* 1sm2_A* 1snu_A* 1snx_A 3qgw_A* 3qgy_A* 3miy_A* 3mj1_A* 3mj2_A* Length = 267

 Score =  109 bits (274), Expect = 9e-27
 Identities = 47/197 (23%), Positives = 96/197 (48%), Gaps = 12/197 (6%)

Query: 417 LGKGNFSSVYKGTLRDGTLVAIRSINVTSCKSEEAEFVKGLYLLTSLRHENIIRLRGFCC 476
           +G G F  V+ G   +   VAI++I   +    E +F++   ++  L H  +++L G  C
Sbjct: 16  IGSGQFGLVHLGYWLNKDKVAIKTIREGA--MSEEDFIEEAEVMMKLSHPKLVQLYG-VC 72

Query: 477 SRGRGECFLIYDFAPKGKLSKYLDQEEGSSNVLDWSTRVSIIIGIAKGIGYLHSSEVNKP 536
                   L+ +F   G LS YL  + G        T + + + + +G+ YL   E    
Sbjct: 73  LEQA-PICLVTEFMEHGCLSDYLRTQRGL---FAAETLLGMCLDVCEGMAYL--EEAC-- 124

Query: 537 AIVHRNLSVEKVLIDQQFNPLIADCGLHKLLADDIVFSVLKTSAAMGYLAPEYVTTGRFT 596
            ++HR+L+    L+ +     ++D G+ + + DD   S   T   + + +PE  +  R++
Sbjct: 125 -VIHRDLAARNCLVGENQVIKVSDFGMTRFVLDDQYTSSTGTKFPVKWASPEVFSFSRYS 183

Query: 597 ERSDIFAFGVIILQILT 613
            +SD+++FGV++ ++ +
Sbjct: 184 SKSDVWSFGVLMWEVFS 200

>3kfa_A Tyrosine-protein kinase ABL1; CML, drug resistance, inhibitor, ATP-binding, nucleotide-binding, oncogene, TRAN; HET: B91; 1.22A {Mus musculus} PDB: 2qoh_A* 3kf4_A* 3k5v_A* 1fpu_A* 1m52_A* 1iep_A* 2hzn_A* 1opj_A* 3ms9_A* 3mss_A* 3ik3_A* 2z60_A* 2e2b_A* 3pyy_A* 3oxz_A* 2g1t_A* 3ue4_A* 3oy3_A* 2hiw_A* 2v7a_A* ... Length = 288

 Score =  109 bits (274), Expect = 1e-26
 Identities = 50/198 (25%), Positives = 97/198 (48%), Gaps = 12/198 (6%)

Query: 417 LGKGNFSSVYKGTLRDGTL-VAIRSINVTSCKSEEAEFVKGLYLLTSLRHENIIRLRGFC 475
           LG G +  VY+G  +  +L VA++++   +   E  EF+K   ++  ++H N+++L G  
Sbjct: 21  LGGGQYGEVYEGVWKKYSLTVAVKTLKEDT--MEVEEFLKEAAVMKEIKHPNLVQLLG-V 77

Query: 476 CSRGRGECFLIYDFAPKGKLSKYLDQEEGSSNVLDWSTRVSIIIGIAKGIGYLHSSEVNK 535
           C+R     ++I +F   G L  YL +       +     + +   I+  + YL       
Sbjct: 78  CTRE-PPFYIITEFMTYGNLLDYLRECNRQE--VSAVVLLYMATQISSAMEYLEKKNF-- 132

Query: 536 PAIVHRNLSVEKVLIDQQFNPLIADCGLHKLLADDIVFSVLKTSAAMGYLAPEYVTTGRF 595
              +HR+L+    L+ +     +AD GL +L+  D   +       + + APE +   +F
Sbjct: 133 ---IHRDLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHAGAKFPIKWTAPESLAYNKF 189

Query: 596 TERSDIFAFGVIILQILT 613
           + +SD++AFGV++ +I T
Sbjct: 190 SIKSDVWAFGVLLWEIAT 207

>3sxs_A Cytoplasmic tyrosine-protein kinase BMX; transferase-transferase inhibitor complex; HET: PP2; 1.89A {Homo sapiens} PDB: 3sxr_A* Length = 268

 Score =  108 bits (272), Expect = 2e-26
 Identities = 47/197 (23%), Positives = 95/197 (48%), Gaps = 12/197 (6%)

Query: 417 LGKGNFSSVYKGTLRDGTLVAIRSINVTSCKSEEAEFVKGLYLLTSLRHENIIRLRGFCC 476
           LG G F  V  G  +    VA++ I   S    E EF +    +  L H  +++  G  C
Sbjct: 16  LGSGQFGVVKLGKWKGQYDVAVKMIKEGS--MSEDEFFQEAQTMMKLSHPKLVKFYG-VC 72

Query: 477 SRGRGECFLIYDFAPKGKLSKYLDQEEGSSNVLDWSTRVSIIIGIAKGIGYLHSSEVNKP 536
           S+     +++ ++   G L  YL +  G    L+ S  + +   + +G+ +L S +    
Sbjct: 73  SKEY-PIYIVTEYISNGCLLNYL-RSHGKG--LEPSQLLEMCYDVCEGMAFLESHQF--- 125

Query: 537 AIVHRNLSVEKVLIDQQFNPLIADCGLHKLLADDIVFSVLKTSAAMGYLAPEYVTTGRFT 596
             +HR+L+    L+D+     ++D G+ + + DD   S + T   + + APE     +++
Sbjct: 126 --IHRDLAARNCLVDRDLCVKVSDFGMTRYVLDDQYVSSVGTKFPVKWSAPEVFHYFKYS 183

Query: 597 ERSDIFAFGVIILQILT 613
            +SD++AFG+++ ++ +
Sbjct: 184 SKSDVWAFGILMWEVFS 200

>1qpc_A LCK kinase; alpha beta fold, transferase; HET: PTR ANP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1qpe_A* 1qpj_A* 2pl0_A* 3kxz_A* 3ac1_A* 2zm4_A* 2zyb_A* 2zm1_A* 3ac2_A* 3ac3_A* 3ac4_A* 3ac5_A* 3ac8_A* 3acj_A* 3ack_A* 3ad4_A* 3ad5_A* 3ad6_A* 3kmm_A* 1qpd_A* ... Length = 279

 Score =  108 bits (272), Expect = 2e-26
 Identities = 51/205 (24%), Positives = 92/205 (44%), Gaps = 22/205 (10%)

Query: 414 VNLLGKGNFSSVYKGTLRDGTLVAIRSINVTSCKSEEAEFVKGLYLLTSLRHENIIRLRG 473
           V  LG G F  V+ G     T VA++S+   S       F+    L+  L+H+ ++RL  
Sbjct: 18  VERLGAGQFGEVWMGYYNGHTKVAVKSLKQGS--MSPDAFLAEANLMKQLQHQRLVRLYA 75

Query: 474 FCCSRGRGECFLIYDFAPKGKLSKYLDQEEGSSNVLDWSTRVSIIIGIAKGIGYLHSSEV 533
                     ++I ++   G L  +L    G    L  +  + +   IA+G+ ++     
Sbjct: 76  VVTQEPI---YIITEYMENGSLVDFLKTPSGIK--LTINKLLDMAAQIAEGMAFIEERNY 130

Query: 534 NKPAIVHRNLSVEKVLIDQQFNPLIADCGLHKLLADDIVFSVLKTSAAMGYL-----APE 588
                +HR+L    +L+    +  IAD GL +L+ D+       T+           APE
Sbjct: 131 -----IHRDLRAANILVSDTLSCKIADFGLARLIEDNEY-----TAREGAKFPIKWTAPE 180

Query: 589 YVTTGRFTERSDIFAFGVIILQILT 613
            +  G FT +SD+++FG+++ +I+T
Sbjct: 181 AINYGTFTIKSDVWSFGILLTEIVT 205

>3poz_A Epidermal growth factor receptor; kinase domain, anti-oncogene, ATP-binding, cell cycle, disea mutation, glycoprotein, membrane, nucleotide-binding; HET: 03P; 1.50A {Homo sapiens} PDB: 2itx_A* 2ity_A* 2j5f_A* 2j6m_A* 2itw_A* 1m14_A 1m17_A* 3vjo_A* 2gs6_A* 2gs2_A* 2rf9_A 1xkk_A* 2eb2_A 3gop_A 2eb3_A* 2itn_A* 2ito_A* 2itp_A* 2itq_A* 2jiu_A* ... Length = 327

 Score =  109 bits (274), Expect = 3e-26
 Identities = 51/208 (24%), Positives = 94/208 (45%), Gaps = 21/208 (10%)

Query: 414 VNLLGKGNFSSVYKGTLRDG-----TLVAIRSINVTSCKSEEAEFVKGLYLLTSLRHENI 468
           + +LG G F +VYKG            VAI+ +   +      E +   Y++ S+ + ++
Sbjct: 20  IKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHV 79

Query: 469 IRLRGFCCSRGRGECFLIYDFAPKGKLSKYLDQEEGSSNVLDWSTRVSIIIGIAKGIGYL 528
            RL G C +       LI    P G L  Y+ + + +   +     ++  + IAKG+ YL
Sbjct: 80  CRLLGICLTS---TVQLITQLMPFGCLLDYVREHKDN---IGSQYLLNWCVQIAKGMNYL 133

Query: 529 HSSEVNKPAIVHRNLSVEKVLIDQQFNPLIADCGLHKLLADDIVFSVLKTSAAM---GYL 585
              +     +VHR+L+   VL+    +  I D GL KLL  +                ++
Sbjct: 134 --EDRR---LVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEE--KEYHAEGGKVPIKWM 186

Query: 586 APEYVTTGRFTERSDIFAFGVIILQILT 613
           A E +    +T +SD++++GV + +++T
Sbjct: 187 ALESILHRIYTHQSDVWSYGVTVWELMT 214

>1byg_A CSK, protein (C-terminal SRC kinase); protein kinase, phosphorylation, staurosporine, transferase; HET: STU; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 3d7u_A 3d7t_A* Length = 278

 Score =  108 bits (271), Expect = 3e-26
 Identities = 49/205 (23%), Positives = 93/205 (45%), Gaps = 26/205 (12%)

Query: 414 VNLLGKGNFSSVYKGTLRDGTLVAIRSINVTSCKSEEAEFVKGLYLLTSLRHENIIRLRG 473
           +  +GKG F  V  G  R G  VA++ I   +       F+    ++T LRH N+++L G
Sbjct: 26  LQTIGKGEFGDVMLGDYR-GNKVAVKCIKNDA---TAQAFLAEASVMTQLRHSNLVQLLG 81

Query: 474 FCCSRGRGECFLIYDFAPKGKLSKYLDQEEGSSNVLDWSTRVSIIIGIAKGIGYLHSSEV 533
                 +G  +++ ++  KG L  YL     S   L     +   + + + + YL  +  
Sbjct: 82  -VIVEEKGGLYIVTEYMAKGSLVDYLRSRGRSV--LGGDCLLKFSLDVCEAMEYLEGNNF 138

Query: 534 NKPAIVHRNLSVEKVLIDQQFNPLIADCGLHKLLADDIVFSVLKTSAAMGYL-----APE 588
                VHR+L+   VL+ +     ++D GL      +       ++   G L     APE
Sbjct: 139 -----VHRDLAARNVLVSEDNVAKVSDFGL----TKEAS-----STQDTGKLPVKWTAPE 184

Query: 589 YVTTGRFTERSDIFAFGVIILQILT 613
            +   +F+ +SD+++FG+++ +I +
Sbjct: 185 ALREKKFSTKSDVWSFGILLWEIYS 209

>3kul_A Ephrin type-A receptor 8; ATP-binding, kinase, nucleotide-binding, transfera phosphorylation, transmembrane, tyrosine-protein kinase; HET: PTR; 2.15A {Homo sapiens} Length = 325

 Score =  108 bits (272), Expect = 4e-26
 Identities = 54/206 (26%), Positives = 95/206 (46%), Gaps = 22/206 (10%)

Query: 417 LGKGNFSSVYKGTLRDG----TLVAIRSINVTSCKSEEAEFVKGLYLLTSLRHENIIRLR 472
           +G G+   V  G LR        VAI+++     + +  +F+    ++    H NIIRL 
Sbjct: 57  IGSGDSGEVCYGRLRVPGQRDVPVAIKALKAGYTERQRRDFLSEASIMGQFDHPNIIRLE 116

Query: 473 GFCCSRGRGECFLIYDFAPKGKLSKYLDQEEGSSNVLDWSTRVSIIIGIAKGIGYLHSSE 532
           G   +RGR    ++ ++   G L  +L   +G          V ++ G+  G+ YL  S+
Sbjct: 117 G-VVTRGR-LAMIVTEYMENGSLDTFLRTHDGQ---FTIMQLVGMLRGVGAGMRYL--SD 169

Query: 533 VNKPAIVHRNLSVEKVLIDQQFNPLIADCGLHKLLADDIVFSVLKTSAA-----MGYLAP 587
           +     VHR+L+   VL+D      ++D GL ++L DD   +   T            AP
Sbjct: 170 LG---YVHRDLAARNVLVDSNLVCKVSDFGLSRVLEDDPDAAYTTTGGKIPIRWT---AP 223

Query: 588 EYVTTGRFTERSDIFAFGVIILQILT 613
           E +    F+  SD+++FGV++ ++L 
Sbjct: 224 EAIAFRTFSSASDVWSFGVVMWEVLA 249

>1t4h_A Serine/threonine-protein kinase WNK1; protein serine/threonine kinase, transferase; 1.80A {Rattus norvegicus} SCOP: d.144.1.7 PDB: 3fpq_A Length = 290

 Score =  107 bits (269), Expect = 6e-26
 Identities = 59/258 (22%), Positives = 103/258 (39%), Gaps = 19/258 (7%)

Query: 416 LLGKGNFSSVYKGT-LRDGTLVAIRSINVTSC-KSEEAEFVKGLYLLTSLRHENIIRLRG 473
            +G+G+F +VYKG        VA   +      KSE   F +   +L  L+H NI+R   
Sbjct: 33  EIGRGSFKTVYKGLDTETTVEVAWCELQDRKLTKSERQRFKEEAEMLKGLQHPNIVRFYD 92

Query: 474 FCCSRGRGECFL--IYDFAPKGKLSKYLDQEEGSSNVLDWSTRVSIIIGIAKGIGYLHSS 531
              S  +G+  +  + +    G L  YL +      V+      S    I KG+ +LH+ 
Sbjct: 93  SWESTVKGKKCIVLVTELMTSGTLKTYLKR----FKVMKIKVLRSWCRQILKGLQFLHT- 147

Query: 532 EVNKPAIVHRNLSVEKVLIDQQFNPL-IADCGLHKLLADDIVFSVLKTSAAMGYLAPEYV 590
               P I+HR+L  + + I      + I D GL  L       +V+ T   M   APE  
Sbjct: 148 --RTPPIIHRDLKCDNIFITGPTGSVKIGDLGLATLKRASFAKAVIGTPEFM---APEMY 202

Query: 591 TTGRFTERSDIFAFGVIILQILTGSLVLTSSMRLAAESATFENFIDRNLKGKFSESEAAK 650
               + E  D++AFG+ +L++ T              +  +           F +    +
Sbjct: 203 EEK-YDESVDVYAFGMCMLEMATSE---YPYSECQNAAQIYRRVTSGVKPASFDKVAIPE 258

Query: 651 LGKMALVCTHEDPENRPT 668
           + ++   C  ++ + R +
Sbjct: 259 VKEIIEGCIRQNKDERYS 276

>3gen_A Tyrosine-protein kinase BTK; bruton'S tyrosine kinase, 4-amino-5-(4-phenoxyphenyl)-5H- pyrrolo[3, 2-D]pyrimidin-7-YL-cyclopentane, TEC-family; HET: B43; 1.60A {Homo sapiens} PDB: 3k54_A* 3pj2_A* 3piy_A* 3piz_A* 3pj1_A* 3pix_A* 3pj3_A* 3p08_A 3ocs_A* 3oct_A* 1k2p_A Length = 283

 Score =  106 bits (267), Expect = 1e-25
 Identities = 52/197 (26%), Positives = 94/197 (47%), Gaps = 12/197 (6%)

Query: 417 LGKGNFSSVYKGTLRDGTLVAIRSINVTSCKSEEAEFVKGLYLLTSLRHENIIRLRGFCC 476
           LG G F  V  G  R    VAI+ I   S    E EF++   ++ +L HE +++L G  C
Sbjct: 32  LGTGQFGVVKYGKWRGQYDVAIKMIKEGS--MSEDEFIEEAKVMMNLSHEKLVQLYG-VC 88

Query: 477 SRGRGECFLIYDFAPKGKLSKYLDQEEGSSNVLDWSTRVSIIIGIAKGIGYLHSSEVNKP 536
           ++ R   F+I ++   G L  YL +             + +   + + + YL        
Sbjct: 89  TKQR-PIFIITEYMANGCLLNYLREMRHR---FQTQQLLEMCKDVCEAMEYL--ESKQ-- 140

Query: 537 AIVHRNLSVEKVLIDQQFNPLIADCGLHKLLADDIVFSVLKTSAAMGYLAPEYVTTGRFT 596
             +HR+L+    L++ Q    ++D GL + + DD   S + +   + +  PE +   +F+
Sbjct: 141 -FLHRDLAARNCLVNDQGVVKVSDFGLSRYVLDDEYTSSVGSKFPVRWSPPEVLMYSKFS 199

Query: 597 ERSDIFAFGVIILQILT 613
            +SDI+AFGV++ +I +
Sbjct: 200 SKSDIWAFGVLMWEIYS 216

>3kex_A Receptor tyrosine-protein kinase ERBB-3; kinase domain, inactive kinase, HER3, ATP-binding, cell membrane, membrane, nucleotide-binding; HET: ANP; 2.80A {Homo sapiens} PDB: 3lmg_A* Length = 325

 Score =  107 bits (269), Expect = 1e-25
 Identities = 57/208 (27%), Positives = 95/208 (45%), Gaps = 21/208 (10%)

Query: 414 VNLLGKGNFSSVYKGTLRDG-----TLVAIRSINVTSCKSEEAEFVKGLYLLTSLRHENI 468
           + +LG G F +V+KG            V I+ I   S +         +  + SL H +I
Sbjct: 18  LKVLGSGVFGTVHKGVWIPEGESIKIPVCIKVIEDKSGRQSFQAVTDHMLAIGSLDHAHI 77

Query: 469 IRLRGFCCSRGRGECFLIYDFAPKGKLSKYLDQEEGSSNVLDWSTRVSIIIGIAKGIGYL 528
           +RL G C         L+  + P G L  ++ Q  G+   L     ++  + IAKG+ YL
Sbjct: 78  VRLLGLCPGS---SLQLVTQYLPLGSLLDHVRQHRGA---LGPQLLLNWGVQIAKGMYYL 131

Query: 529 HSSEVNKPAIVHRNLSVEKVLIDQQFNPLIADCGLHKLLADDIVFSVLKTSAAM---GYL 585
              E     +VHRNL+   VL+       +AD G+  LL  D        S A     ++
Sbjct: 132 --EEHG---MVHRNLAARNVLLKSPSQVQVADFGVADLLPPDDKQL--LYSEAKTPIKWM 184

Query: 586 APEYVTTGRFTERSDIFAFGVIILQILT 613
           A E +  G++T +SD++++GV + +++T
Sbjct: 185 ALESIHFGKYTHQSDVWSYGVTVWELMT 212

>1u59_A Tyrosine-protein kinase ZAP-70; transferase; HET: STU; 2.30A {Homo sapiens} SCOP: d.144.1.7 Length = 287

 Score =  106 bits (266), Expect = 1e-25
 Identities = 57/205 (27%), Positives = 97/205 (47%), Gaps = 22/205 (10%)

Query: 417 LGKGNFSSVYKGTLRDG---TLVAIRSINVTSCKSEEAEFVKGLYLLTSLRHENIIRLRG 473
           LG GNF SV +G  R       VAI+ +   + K++  E ++   ++  L +  I+RL G
Sbjct: 18  LGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKADTEEMMREAQIMHQLDNPYIVRLIG 77

Query: 474 FCCSRGRGECFLIYDFAPKGKLSKYLDQEEGSSNVLDWSTRVSIIIGIAKGIGYLHSSEV 533
            C +       L+ + A  G L K+L  +      +  S    ++  ++ G+ YL   E 
Sbjct: 78  VCQAEAL---MLVMEMAGGGPLHKFLVGKREE---IPVSNVAELLHQVSMGMKYL--EEK 129

Query: 534 NKPAIVHRNLSVEKVLIDQQFNPLIADCGLHKLLADDIVFSVLKTSAAMGYL-----APE 588
           N    VHR+L+   VL+  +    I+D GL K L  D       T+ + G       APE
Sbjct: 130 N---FVHRDLAARNVLLVNRHYAKISDFGLSKALGAD---DSYYTARSAGKWPLKWYAPE 183

Query: 589 YVTTGRFTERSDIFAFGVIILQILT 613
            +   +F+ RSD++++GV + + L+
Sbjct: 184 CINFRKFSSRSDVWSYGVTMWEALS 208

>2j0j_A Focal adhesion kinase 1; cell migration, FERM, transferase, integrin signaling; HET: 4ST; 2.80A {Gallus gallus} PDB: 2j0k_A* Length = 656

 Score =  111 bits (278), Expect = 2e-25
 Identities = 60/294 (20%), Positives = 113/294 (38%), Gaps = 32/294 (10%)

Query: 324 TGILIFFRYRRHKQKIGNTSESSDWQLSTDLTLAKDFNRNGASPLVSLEYCHGWDPLGDY 383
            G    F  R  K+  G  +  S  +L+ +       +    S   + +Y    D    Y
Sbjct: 322 NGATQSFIIRPQKE--GERALPSIPKLANNEKQGVRSH--TVSVSETDDYAEIIDEEDTY 377

Query: 384 LNGTGFSREHLNSFRLNLEEVESATQCFSEVNLLGKGNFSSVYKGTLRDG----TLVAIR 439
              +    E +   R+ L               +G+G F  V++G           VAI+
Sbjct: 378 TMPSTRDYE-IQRERIELGRC------------IGEGQFGDVHQGIYMSPENPAMAVAIK 424

Query: 440 SINVTSCKSEEAEFVKGLYLLTSLRHENIIRLRGFCCSRGRGECFLIYDFAPKGKLSKYL 499
           +    +  S   +F++    +    H +I++L G          ++I +    G+L  +L
Sbjct: 425 TCKNCTSDSVREKFLQEALTMRQFDHPHIVKLIGVIT---ENPVWIIMELCTLGELRSFL 481

Query: 500 DQEEGSSNVLDWSTRVSIIIGIAKGIGYLHSSEVNKPAIVHRNLSVEKVLIDQQFNPLIA 559
              + S   LD ++ +     ++  + YL          VHR+++   VL+       + 
Sbjct: 482 QVRKFS---LDLASLILYAYQLSTALAYL--ESKR---FVHRDIAARNVLVSSNDCVKLG 533

Query: 560 DCGLHKLLADDIVFSVLKTSAAMGYLAPEYVTTGRFTERSDIFAFGVIILQILT 613
           D GL + + D   +   K    + ++APE +   RFT  SD++ FGV + +IL 
Sbjct: 534 DFGLSRYMEDSTYYKASKGKLPIKWMAPESINFRRFTSASDVWMFGVCMWEILM 587

>3cc6_A Protein tyrosine kinase 2 beta; focal adhesion kinase, structural genomics, structural genom consortium, SGC, ATP-binding, membrane; 1.60A {Homo sapiens} PDB: 3fzs_A* 3et7_A 3fzo_A* 3fzr_A* 3fzp_A* 3fzt_A* 3h3c_A* Length = 281

 Score =  105 bits (265), Expect = 2e-25
 Identities = 51/201 (25%), Positives = 96/201 (47%), Gaps = 15/201 (7%)

Query: 417 LGKGNFSSVYKGTLRDG----TLVAIRSINVTSCKSEEAEFVKGLYLLTSLRHENIIRLR 472
           LG+G F  VY+G   +       VA+++         + +F+    ++ +L H +I++L 
Sbjct: 20  LGEGFFGEVYEGVYTNHKGEKINVAVKTCKKDCTLDNKEKFMSEAVIMKNLDHPHIVKLI 79

Query: 473 GFCCSRGRGECFLIYDFAPKGKLSKYLDQEEGSSNVLDWSTRVSIIIGIAKGIGYLHSSE 532
           G          ++I +  P G+L  YL++ + S   L   T V   + I K + YL    
Sbjct: 80  GIIE---EEPTWIIMELYPYGELGHYLERNKNS---LKVLTLVLYSLQICKAMAYL--ES 131

Query: 533 VNKPAIVHRNLSVEKVLIDQQFNPLIADCGLHKLLADDIVFSVLKTSAAMGYLAPEYVTT 592
           +N    VHR+++V  +L+       + D GL + + D+  +    T   + +++PE +  
Sbjct: 132 IN---CVHRDIAVRNILVASPECVKLGDFGLSRYIEDEDYYKASVTRLPIKWMSPESINF 188

Query: 593 GRFTERSDIFAFGVIILQILT 613
            RFT  SD++ F V + +IL+
Sbjct: 189 RRFTTASDVWMFAVCMWEILS 209

>1k9a_A Carboxyl-terminal SRC kinase; COOH-terminal SRC kinase, CSK, SFK, signal transduction, SH2, SH3, SRC homology, tyrosine kinase; 2.50A {Rattus norvegicus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1jeg_A Length = 450

 Score =  108 bits (273), Expect = 2e-25
 Identities = 47/197 (23%), Positives = 91/197 (46%), Gaps = 16/197 (8%)

Query: 417 LGKGNFSSVYKGTLRDGTLVAIRSINVTSCKSEEAEFVKGLYLLTSLRHENIIRLRGFCC 476
           +GKG F  V  G  R G  VA++ I   +       F+    ++T LRH N+++L G   
Sbjct: 201 IGKGEFGDVMLGDYR-GNKVAVKCIKNDA---TAQAFLAEASVMTQLRHSNLVQLLG-VI 255

Query: 477 SRGRGECFLIYDFAPKGKLSKYLDQEEGSSNVLDWSTRVSIIIGIAKGIGYLHSSEVNKP 536
              +G  +++ ++  KG L  YL     S   L     +   + + + + YL  +     
Sbjct: 256 VEEKGGLYIVTEYMAKGSLVDYLRSRGRSV--LGGDCLLKFSLDVCEAMEYLEGNN---- 309

Query: 537 AIVHRNLSVEKVLIDQQFNPLIADCGLHKLLADDIVFSVLKTSAAMGYLAPEYVTTGRFT 596
             VHR+L+   VL+ +     ++D GL      +   +       + + APE +   +F+
Sbjct: 310 -FVHRDLAARNVLVSEDNVAKVSDFGL----TKEASSTQDTGKLPVKWTAPEALREKKFS 364

Query: 597 ERSDIFAFGVIILQILT 613
            +SD+++FG+++ +I +
Sbjct: 365 TKSDVWSFGILLWEIYS 381

>1mp8_A Focal adhesion kinase 1; tyrosine protein kinase, transferase; HET: ADP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 2ijm_A* 2etm_A* 3pxk_A* 2jkq_A* 2j0m_B* 2jkm_A* 2j0l_A* 3bz3_A* 2jko_A* 2jkk_A* Length = 281

 Score =  105 bits (264), Expect = 2e-25
 Identities = 46/201 (22%), Positives = 88/201 (43%), Gaps = 15/201 (7%)

Query: 417 LGKGNFSSVYKGTLRDG----TLVAIRSINVTSCKSEEAEFVKGLYLLTSLRHENIIRLR 472
           +G+G F  V++G           VAI++    +  S   +F++    +    H +I++L 
Sbjct: 23  IGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVKLI 82

Query: 473 GFCCSRGRGECFLIYDFAPKGKLSKYLDQEEGSSNVLDWSTRVSIIIGIAKGIGYLHSSE 532
           G          ++I +    G+L  +L   + S   LD ++ +     ++  + YL    
Sbjct: 83  GVIT---ENPVWIIMELCTLGELRSFLQVRKYS---LDLASLILYAYQLSTALAYL--ES 134

Query: 533 VNKPAIVHRNLSVEKVLIDQQFNPLIADCGLHKLLADDIVFSVLKTSAAMGYLAPEYVTT 592
                 VHR+++   VL+       + D GL + + D   +   K    + ++APE +  
Sbjct: 135 KR---FVHRDIAARNVLVSSNDCVKLGDFGLSRYMEDSTYYKASKGKLPIKWMAPESINF 191

Query: 593 GRFTERSDIFAFGVIILQILT 613
            RFT  SD++ FGV + +IL 
Sbjct: 192 RRFTSASDVWMFGVCMWEILM 212

>1mqb_A Ephrin type-A receptor 2; tyrosine protein kinase, transferase; HET: ANP; 2.30A {Homo sapiens} SCOP: d.144.1.7 Length = 333

 Score =  105 bits (265), Expect = 4e-25
 Identities = 57/208 (27%), Positives = 105/208 (50%), Gaps = 25/208 (12%)

Query: 417 LGKGNFSSVYKGTLRDGT-----LVAIRSINVTSCKSEEAEFVKGLYLLTSLRHENIIRL 471
           +G G F  VYKG L+  +      VAI+++     + +  +F+    ++    H NIIRL
Sbjct: 52  IGAGEFGEVYKGMLKTSSGKKEVPVAIKTLKAGYTEKQRVDFLGEAGIMGQFSHHNIIRL 111

Query: 472 RGFCCSRGRGECFLIYDFAPKGKLSKYLDQEEGSSNVLDWSTRVSIIIGIAKGIGYLHSS 531
            G   S+ +    +I ++   G L K+L +++G          V ++ GIA G+ YL  +
Sbjct: 112 EG-VISKYK-PMMIITEYMENGALDKFLREKDGE---FSVLQLVGMLRGIAAGMKYL--A 164

Query: 532 EVNKPAIVHRNLSVEKVLIDQQFNPLIADCGLHKLLADDIVFSVLKTSAAMG------YL 585
            +N    VHR+L+   +L++      ++D GL ++L DD       T    G      + 
Sbjct: 165 NMN---YVHRDLAARNILVNSNLVCKVSDFGLSRVLEDDPEA----TYTTSGGKIPIRWT 217

Query: 586 APEYVTTGRFTERSDIFAFGVIILQILT 613
           APE ++  +FT  SD+++FG+++ +++T
Sbjct: 218 APEAISYRKFTSASDVWSFGIVMWEVMT 245

>2yfx_A Tyrosine-protein kinase receptor; nucleotide-binding, transferase; HET: VGH; 1.70A {Homo sapiens} PDB: 2xp2_A* 3aox_A* 2yhv_A 3lcs_A* 3lct_A* 4dce_A* 2xba_A* 2xb7_A* Length = 327

 Score =  105 bits (264), Expect = 6e-25
 Identities = 48/217 (22%), Positives = 87/217 (40%), Gaps = 28/217 (12%)

Query: 414 VNLLGKGNFSSVYKGTLRDG------TLVAIRSINVTSCKSEEAEFVKGLYLLTSLRHEN 467
           +  LG G F  VY+G +           VA++++     + +E +F+    +++   H+N
Sbjct: 35  IRGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISKFNHQN 94

Query: 468 IIRLRGFCCSRGRGECFLIYDFAPKGKLSKYL---DQEEGSSNVLDWSTRVSIIIGIAKG 524
           I+R  G    +     F++ +    G L  +L          + L     + +   IA G
Sbjct: 95  IVRCIG-VSLQS-LPRFILMELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACG 152

Query: 525 IGYLHSSEVNKPAIVHRNLSVEKVLIDQQFNPL---IADCGLHKLLADDIVFSVLKTSAA 581
             YL   E N    +HR+++    L+          I D G    +A DI  +       
Sbjct: 153 CQYL---EENH--FIHRDIAARNCLLTCPGPGRVAKIGDFG----MARDIYRASYYRKGG 203

Query: 582 MGYL-----APEYVTTGRFTERSDIFAFGVIILQILT 613
              L      PE    G FT ++D ++FGV++ +I +
Sbjct: 204 CAMLPVKWMPPEAFMEGIFTSKTDTWSFGVLLWEIFS 240

>2qol_A Ephrin receptor; receptor tyrosine kinase, juxtamembrane segment, structural genomics, mutant, structural genomics consortium, SGC, ATP- binding; 1.07A {Homo sapiens} PDB: 2qok_A 2qoi_A 2qoo_A 2qof_A 2qod_A 2qo9_A* 2gsf_A 2qo7_A* 2qo2_A* 2qoq_A* 2qon_A* 3fxx_A* 3fy2_A 2qoc_A* 2qob_A* 3dzq_A* 2r2p_A 2hel_A 2rei_A 3dko_A* ... Length = 373

 Score =  106 bits (266), Expect = 6e-25
 Identities = 48/203 (23%), Positives = 98/203 (48%), Gaps = 16/203 (7%)

Query: 417 LGKGNFSSVYKGTL----RDGTLVAIRSINVTSCKSEEAEFVKGLYLLTSLRHENIIRLR 472
           +G G F  V  G L    +    VAI+++ V   + +  +F+    ++    H NIIRL 
Sbjct: 53  VGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYTEKQRRDFLGEASIMGQFDHPNIIRLE 112

Query: 473 GFCCSRGRGECFLIYDFAPKGKLSKYLDQEEGSSNVLDWSTRVSIIIGIAKGIGYLHSSE 532
           G   ++ +    ++ ++   G L  +L + +           V ++ GIA G+ YL  S+
Sbjct: 113 G-VVTKSK-PVMIVTEYMENGSLDSFLRKHDAQ---FTVIQLVGMLRGIASGMKYL--SD 165

Query: 533 VNKPAIVHRNLSVEKVLIDQQFNPLIADCGLHKLLADDIVFSVLKTSAAMGYL--APEYV 590
           +     VHR+L+   +LI+      ++D GL ++L DD   +       +     +PE +
Sbjct: 166 MG---YVHRDLAARNILINSNLVCKVSDFGLGRVLEDDPEAAYTTRGGKIPIRWTSPEAI 222

Query: 591 TTGRFTERSDIFAFGVIILQILT 613
              +FT  SD++++G+++ ++++
Sbjct: 223 AYRKFTSASDVWSYGIVLWEVMS 245

>2ozo_A Tyrosine-protein kinase ZAP-70; inactive ZAP-70, tandem SH2, autoinhibition, ITAM, hydrogen bonding network, TCR signaling, transferase; HET: ANP; 2.60A {Homo sapiens} Length = 613

 Score =  108 bits (272), Expect = 6e-25
 Identities = 58/205 (28%), Positives = 97/205 (47%), Gaps = 22/205 (10%)

Query: 417 LGKGNFSSVYKGTLRDG---TLVAIRSINVTSCKSEEAEFVKGLYLLTSLRHENIIRLRG 473
           LG GNF SV +G  R       VAI+ +   + K++  E ++   ++  L +  I+RL G
Sbjct: 344 LGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKADTEEMMREAQIMHQLDNPYIVRLIG 403

Query: 474 FCCSRGRGECFLIYDFAPKGKLSKYLDQEEGSSNVLDWSTRVSIIIGIAKGIGYLHSSEV 533
            C +       L+ + A  G L K+L  +      +  S    ++  ++ G+ YL   E 
Sbjct: 404 VCQAE---ALMLVMEMAGGGPLHKFLVGKREE---IPVSNVAELLHQVSMGMKYL--EEK 455

Query: 534 NKPAIVHRNLSVEKVLIDQQFNPLIADCGLHKLLADDIVFSVLKTSAAMGYL-----APE 588
           N    VHRNL+   VL+  +    I+D GL K L  D       T+ + G       APE
Sbjct: 456 N---FVHRNLAARNVLLVNRHYAKISDFGLSKALGAD---DSYYTARSAGKWPLKWYAPE 509

Query: 589 YVTTGRFTERSDIFAFGVIILQILT 613
            +   +F+ RSD++++GV + + L+
Sbjct: 510 CINFRKFSSRSDVWSYGVTMWEALS 534

>3qup_A Tyrosine-protein kinase receptor TYRO3; protein kinase inhibitor, receptor tyrosine kinase, spirocyc kinase domain, phosphotransfer, GAS6 ligand; HET: LUN; 1.90A {Mus musculus} Length = 323

 Score =  104 bits (261), Expect = 1e-24
 Identities = 51/212 (24%), Positives = 91/212 (42%), Gaps = 23/212 (10%)

Query: 417 LGKGNFSSVYKGTLRDG----TLVAIRSINVTSC-KSEEAEFVKGLYLLTSLRHENIIRL 471
           LGKG F SV +  L+        VA++ +       S+  EF++    +    H ++ +L
Sbjct: 31  LGKGEFGSVREAQLKQEDGSFVKVAVKMLKADIIASSDIEEFLREAACMKEFDHPHVAKL 90

Query: 472 RGFCCSRGRGEC-----FLIYDFAPKGKLSKYL--DQEEGSSNVLDWSTRVSIIIGIAKG 524
            G    R R +       +I  F   G L  +L   +   +   L   T V  ++ IA G
Sbjct: 91  VG-VSLRSRAKGRLPIPMVILPFMKHGDLHAFLLASRIGENPFNLPLQTLVRFMVDIACG 149

Query: 525 IGYLHSSEVNKPAIVHRNLSVEKVLIDQQFNPLIADCGLHKLLADDIVFSVLKTSAAM-- 582
           + YL          +HR+L+    ++ +     +AD GL + +     +   +  A+   
Sbjct: 150 MEYL---SSRN--FIHRDLAARNCMLAEDMTVCVADFGLSRKIYSGDYYR--QGCASKLP 202

Query: 583 -GYLAPEYVTTGRFTERSDIFAFGVIILQILT 613
             +LA E +    +T  SD++AFGV + +I+T
Sbjct: 203 VKWLALESLADNLYTVHSDVWAFGVTMWEIMT 234

>3brb_A Proto-oncogene tyrosine-protein kinase MER; ATP-binding, disease mutation, glycoprotein, nucleot binding, phosphorylation, receptor; HET: ADP; 1.90A {Homo sapiens} PDB: 3bpr_A* 2p0c_A* Length = 313

 Score =  104 bits (261), Expect = 1e-24
 Identities = 58/215 (26%), Positives = 97/215 (45%), Gaps = 24/215 (11%)

Query: 414 VNLLGKGNFSSVYKGTLRDG----TLVAIRSINV-TSCKSEEAEFVKGLYLLTSLRHENI 468
             +LG+G F SV +G L+        VA++++ +  S + E  EF+     +    H N+
Sbjct: 39  GKILGEGEFGSVMEGNLKQEDGTSLKVAVKTMKLDNSSQREIEEFLSEAACMKDFSHPNV 98

Query: 469 IRLRGFCC---SRGRGECFLIYDFAPKGKLSKYL--DQEEGSSNVLDWSTRVSIIIGIAK 523
           IRL G C    S+G  +  +I  F   G L  YL   + E     +   T +  ++ IA 
Sbjct: 99  IRLLGVCIEMSSQGIPKPMVILPFMKYGDLHTYLLYSRLETGPKHIPLQTLLKFMVDIAL 158

Query: 524 GIGYLHSSEVNKPAIVHRNLSVEKVLIDQQFNPLIADCGLHKLLADDIVFSVLKTSAAMG 583
           G+ YL  S  N    +HR+L+    ++       +AD GL K +     +   +   A  
Sbjct: 159 GMEYL--SNRN---FLHRDLAARNCMLRDDMTVCVADFGLSKKIYSGDYYR--QGRIAK- 210

Query: 584 YL-----APEYVTTGRFTERSDIFAFGVIILQILT 613
            +     A E +    +T +SD++AFGV + +I T
Sbjct: 211 -MPVKWIAIESLADRVYTSKSDVWAFGVTMWEIAT 244

>3t6q_A CD180 antigen; protein-protein complex, leucine rich repeat, MD-2 related L recognition, receptor, innate immunity, glycosylation, IMMU; HET: NAG BMA MAN; 1.90A {Mus musculus} PDB: 3b2d_A* 3rg1_A* Length = 606

 Score =  107 bits (269), Expect = 2e-24
 Identities = 38/168 (22%), Positives = 70/168 (41%), Gaps = 5/168 (2%)

Query: 73  ISLQGKGLTGKLSPSLSGLKCLSGLYLHYNSLSGEIPKEI-RNLTELTDLYLDVNNLSGN 131
           ++L         + +      L  L L +  L  +  +   +NL  L  L L  + L  +
Sbjct: 381 LNLSYNEPLSLKTEAFKECPQLELLDLAFTRLKVKDAQSPFQNLHLLKVLNLSHSLLDIS 440

Query: 132 IPPEIGSMASLQVLQLCCNQLTGNIPAQIGS---LKSLSVLTLQHNRLNGGIPDSLGNLG 188
                  + +LQ L L  N        +  S   L  L +L L    L+     +  +L 
Sbjct: 441 SEQLFDGLPALQHLNLQGNHFPKGNIQKTNSLQTLGRLEILVLSFCDLSSIDQHAFTSLK 500

Query: 189 KLKRLDLSFNSLFGTIPESLANNAELLFLDVQNNTLSGIVPSALKRLN 236
            +  +DLS N L  +  E+L++  + ++L++ +N +S I+PS L  L+
Sbjct: 501 MMNHVDLSHNRLTSSSIEALSHL-KGIYLNLASNHISIILPSLLPILS 547

>3t6q_A CD180 antigen; protein-protein complex, leucine rich repeat, MD-2 related L recognition, receptor, innate immunity, glycosylation, IMMU; HET: NAG BMA MAN; 1.90A {Mus musculus} PDB: 3b2d_A* 3rg1_A* Length = 606

 Score =  106 bits (266), Expect = 4e-24
 Identities = 33/159 (20%), Positives = 58/159 (36%), Gaps = 2/159 (1%)

Query: 80  LTGKLSPSLSGLKCLSGLYLHYNSLSGEIPKEIRNLTELTDLYLDVNNLSGNIPPEIGSM 139
           L    + + S L  L+ L L    +        ++   L  L L  N L       +   
Sbjct: 45  LPTIQNTTFSRLINLTFLDLTRCQIYWIHEDTFQSQHRLDTLVLTANPLIFMAETALSGP 104

Query: 140 ASLQVLQLCCNQLTGNIPAQIGSLKSLSVLTLQHNRLNGGIPDSLGNLGKLKRLDLSFNS 199
            +L+ L      ++      + + K+L  L L  N ++           KLK LD   N+
Sbjct: 105 KALKHLFFIQTGISSIDFIPLHNQKTLESLYLGSNHISSIKLPKGFPTEKLKVLDFQNNA 164

Query: 200 LFGTIPESLAN--NAELLFLDVQNNTLSGIVPSALKRLN 236
           +     E +++   A  L L++  N ++GI P A     
Sbjct: 165 IHYLSKEDMSSLQQATNLSLNLNGNDIAGIEPGAFDSAV 203

>3t6q_A CD180 antigen; protein-protein complex, leucine rich repeat, MD-2 related L recognition, receptor, innate immunity, glycosylation, IMMU; HET: NAG BMA MAN; 1.90A {Mus musculus} PDB: 3b2d_A* 3rg1_A* Length = 606

 Score =  103 bits (259), Expect = 3e-23
 Identities = 36/174 (20%), Positives = 52/174 (29%), Gaps = 5/174 (2%)

Query: 64  CNEHRKVANISLQGKGLTGKLSPSLSGLKCLSGLYLHYNSLSGEIPKEIRNLTELTDLYL 123
             E  K  N   +  GL  ++  +L        L   +N L          L  LT L L
Sbjct: 10  EKEVNKTYN--CENLGLN-EIPGTLPNS--TECLEFSFNVLPTIQNTTFSRLINLTFLDL 64

Query: 124 DVNNLSGNIPPEIGSMASLQVLQLCCNQLTGNIPAQIGSLKSLSVLTLQHNRLNGGIPDS 183
               +         S   L  L L  N L       +   K+L  L      ++      
Sbjct: 65  TRCQIYWIHEDTFQSQHRLDTLVLTANPLIFMAETALSGPKALKHLFFIQTGISSIDFIP 124

Query: 184 LGNLGKLKRLDLSFNSLFGTIPESLANNAELLFLDVQNNTLSGIVPSALKRLNG 237
           L N   L+ L L  N +            +L  LD QNN +  +    +  L  
Sbjct: 125 LHNQKTLESLYLGSNHISSIKLPKGFPTEKLKVLDFQNNAIHYLSKEDMSSLQQ 178

>3t6q_A CD180 antigen; protein-protein complex, leucine rich repeat, MD-2 related L recognition, receptor, innate immunity, glycosylation, IMMU; HET: NAG BMA MAN; 1.90A {Mus musculus} PDB: 3b2d_A* 3rg1_A* Length = 606

 Score = 92.8 bits (231), Expect = 7e-20
 Identities = 34/168 (20%), Positives = 64/168 (38%), Gaps = 6/168 (3%)

Query: 73  ISLQGKGLTGKLSPSLSGLKCLSGLYLHYNSLSGEIPKEIRNLTELTDLYLDVN-NLSGN 131
           + L    ++    P     + L  L    N++     +++ +L + T+L L++N N    
Sbjct: 134 LYLGSNHISSIKLPKGFPTEKLKVLDFQNNAIHYLSKEDMSSLQQATNLSLNLNGNDIAG 193

Query: 132 IPPEIGSMASLQVLQLCCNQLTGNIPAQIG--SLKSLSVLTLQHNRLNGGIPDSLGNLGK 189
           I P     A  Q L     Q    I   +   +++SL + T +        P     L +
Sbjct: 194 IEPGAFDSAVFQSLNFGGTQNLLVIFKGLKNSTIQSLWLGTFEDMDDEDISPAVFEGLCE 253

Query: 190 --LKRLDLSFNSLFGTIPESLANNAELLFLDVQNNTLSGIVPSALKRL 235
             ++ ++L  +  F     +    + L  LD+    LS + PS L  L
Sbjct: 254 MSVESINLQKHYFFNISSNTFHCFSGLQELDLTATHLSEL-PSGLVGL 300

>3t6q_A CD180 antigen; protein-protein complex, leucine rich repeat, MD-2 related L recognition, receptor, innate immunity, glycosylation, IMMU; HET: NAG BMA MAN; 1.90A {Mus musculus} PDB: 3b2d_A* 3rg1_A* Length = 606

 Score = 87.8 bits (218), Expect = 3e-18
 Identities = 28/165 (16%), Positives = 49/165 (29%), Gaps = 6/165 (3%)

Query: 72  NISLQGKGLTGKLSPSLSGLKC--LSGLYLHYNSLSGEIPKEIRNLTE--LTDLYLDVNN 127
           +++  G      +   L       L              P     L E  +  + L  + 
Sbjct: 206 SLNFGGTQNLLVIFKGLKNSTIQSLWLGTFEDMDDEDISPAVFEGLCEMSVESINLQKHY 265

Query: 128 LSGNIPPEIGSMASLQVLQLCCNQLTGNIPAQIGSLKSLSVLTLQHNRLNGGIPDSLGNL 187
                       + LQ L L    L+  +P+ +  L +L  L L  N+       S  N 
Sbjct: 266 FFNISSNTFHCFSGLQELDLTATHLS-ELPSGLVGLSTLKKLVLSANKFENLCQISASNF 324

Query: 188 GKLKRLDLSFNSLFGTI-PESLANNAELLFLDVQNNTLSGIVPSA 231
             L  L +  N+    +    L N   L  LD+ ++ +       
Sbjct: 325 PSLTHLSIKGNTKRLELGTGCLENLENLRELDLSHDDIETSDCCN 369

>3t6q_A CD180 antigen; protein-protein complex, leucine rich repeat, MD-2 related L recognition, receptor, innate immunity, glycosylation, IMMU; HET: NAG BMA MAN; 1.90A {Mus musculus} PDB: 3b2d_A* 3rg1_A* Length = 606

 Score = 79.3 bits (196), Expect = 2e-15
 Identities = 30/131 (22%), Positives = 51/131 (38%), Gaps = 4/131 (3%)

Query: 73  ISLQGKGLTGKLSPSLSGLKCLSGLYLHYNSLSGEIPKE---IRNLTELTDLYLDVNNLS 129
           ++L    L         GL  L  L L  N       ++   ++ L  L  L L   +LS
Sbjct: 430 LNLSHSLLDISSEQLFDGLPALQHLNLQGNHFPKGNIQKTNSLQTLGRLEILVLSFCDLS 489

Query: 130 GNIPPEIGSMASLQVLQLCCNQLTGNIPAQIGSLKSLSVLTLQHNRLNGGIPDSLGNLGK 189
                   S+  +  + L  N+LT +    +  LK +  L L  N ++  +P  L  L +
Sbjct: 490 SIDQHAFTSLKMMNHVDLSHNRLTSSSIEALSHLKGI-YLNLASNHISIILPSLLPILSQ 548

Query: 190 LKRLDLSFNSL 200
            + ++L  N L
Sbjct: 549 QRTINLRQNPL 559

>3l9p_A Anaplastic lymphoma kinase; kinase domain, ATP-binding, glycoprotein, membrane, nucleotide-binding, phosphoprotein, proto-oncogene; 1.80A {Homo sapiens} Length = 367

 Score =  104 bits (262), Expect = 2e-24
 Identities = 48/217 (22%), Positives = 87/217 (40%), Gaps = 28/217 (12%)

Query: 414 VNLLGKGNFSSVYKGTLRDG------TLVAIRSINVTSCKSEEAEFVKGLYLLTSLRHEN 467
           +  LG G F  VY+G +           VA++++     + +E +F+    +++   H+N
Sbjct: 76  IRGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISKFNHQN 135

Query: 468 IIRLRGFCCSRGRGECFLIYDFAPKGKLSKYL---DQEEGSSNVLDWSTRVSIIIGIAKG 524
           I+R  G    +     F++ +    G L  +L          + L     + +   IA G
Sbjct: 136 IVRCIG-VSLQS-LPRFILLELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACG 193

Query: 525 IGYLHSSEVNKPAIVHRNLSVEKVLIDQQFNPL---IADCGLHKLLADDIVFSVLKTSAA 581
             YL   E N    +HR+++    L+          I D G    +A DI  +       
Sbjct: 194 CQYL---EENH--FIHRDIAARNCLLTCPGPGRVAKIGDFG----MARDIYRAGYYRKGG 244

Query: 582 MGYL-----APEYVTTGRFTERSDIFAFGVIILQILT 613
              L      PE    G FT ++D ++FGV++ +I +
Sbjct: 245 CAMLPVKWMPPEAFMEGIFTSKTDTWSFGVLLWEIFS 281

>1p4o_A Insulin-like growth factor I receptor protein; IGF-1R, kinase domain, hormone-growth factor complex; 1.50A {Homo sapiens} SCOP: d.144.1.7 PDB: 1m7n_A 3lvp_A* 3lw0_A* 1jqh_A* 2zm3_A* 3f5p_A* 3i81_A* 2oj9_A* 3nw5_A* 3nw6_A* 3nw7_A* 3o23_A* 3qqu_A* 3d94_A* 1k3a_A* 2z8c_A* 1ir3_A* 1gag_A* 1irk_A 3bu3_A* ... Length = 322

 Score =  103 bits (258), Expect = 3e-24
 Identities = 55/214 (25%), Positives = 97/214 (45%), Gaps = 28/214 (13%)

Query: 417 LGKGNFSSVYKGTLRDG------TLVAIRSINVTSCKSEEAEFVKGLYLLTSLRHENIIR 470
           LG+G+F  VY+G  +        T VAI+++N  +   E  EF+    ++      +++R
Sbjct: 33  LGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKEFNCHHVVR 92

Query: 471 LRGFCCSRGRGECFLIYDFAPKGKLSKYL------DQEEGSSNVLDWSTRVSIIIGIAKG 524
           L G   S+G     +I +   +G L  YL                  S  + +   IA G
Sbjct: 93  LLG-VVSQG-QPTLVIMELMTRGDLKSYLRSLRPAMANNPVLAPPSLSKMIQMAGEIADG 150

Query: 525 IGYLHSSEVNKPAIVHRNLSVEKVLIDQQFNPLIADCGLHKLLADDIVFSVLKTSAAMGY 584
           + YL++   NK   VHR+L+    ++ + F   I D G+ + + +   +   K    +  
Sbjct: 151 MAYLNA---NK--FVHRDLAARNCMVAEDFTVKIGDFGMTRDIYETDYYR--KGGKGL-- 201

Query: 585 L-----APEYVTTGRFTERSDIFAFGVIILQILT 613
           L     +PE +  G FT  SD+++FGV++ +I T
Sbjct: 202 LPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIAT 235

>4euu_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: SEP BX7; 1.80A {Homo sapiens} Length = 319

 Score =  102 bits (255), Expect = 6e-24
 Identities = 51/215 (23%), Positives = 88/215 (40%), Gaps = 23/215 (10%)

Query: 416 LLGKGNFSSVYKGTLRD-GTLVAIRSINVTSCKSEEAEFVKGLYLLTSLRHENIIRLRGF 474
           +LG+G  ++V++G  +  G L AI+  N  S        ++   +L  L H+NI++L   
Sbjct: 16  ILGQGATANVFRGRHKKTGDLFAIKVFNNISFLRPVDVQMREFEVLKKLNHKNIVKLFAI 75

Query: 475 CCSRGRGECFLIYDFAPKGKLSKYLDQEEGSSNVLDWSTRVSIIIGIAKGIGYLHSSEVN 534
                     LI +F P G L   L +E  ++  L  S  + ++  +  G+ +L  +   
Sbjct: 76  EEETTTRHKVLIMEFCPCGSLYTVL-EEPSNAYGLPESEFLIVLRDVVGGMNHLRENG-- 132

Query: 535 KPAIVHRNLSVEKVLI----DQQFNPLIADCGLHKLLADDIVFSVLKTSA-AMGYLAPEY 589
              IVHRN+    ++     D Q    + D G  + L DD       +      YL P+ 
Sbjct: 133 ---IVHRNIKPGNIMRVIGEDGQSVYKLTDFGAARELEDD---EQFVSLYGTEEYLHPDM 186

Query: 590 VTTG--------RFTERSDIFAFGVIILQILTGSL 616
                       ++    D+++ GV      TGSL
Sbjct: 187 YERAVLRKDHQKKYGATVDLWSIGVTFYHAATGSL 221

>2xir_A Vascular endothelial growth factor receptor 2; angiogenesis, nucleotide-binding, inhibitor, phosphorylation receptor, transferase, transmembrane; HET: 00J; 1.50A {Homo sapiens} PDB: 1vr2_A* 1ywn_A* 3vnt_A* 3c7q_A* 2oh4_A* 3u6j_A* 3efl_A* 2p2i_A* 3cjf_A* 3cjg_A* 3ewh_A* 2qu5_A* 2qu6_A* 2rl5_A* 3b8q_A* 3b8r_A* 2p2h_A* 3cp9_A* 3cpb_A* 3cpc_A* ... Length = 316

 Score =  101 bits (255), Expect = 7e-24
 Identities = 66/290 (22%), Positives = 116/290 (40%), Gaps = 43/290 (14%)

Query: 414 VNLLGKGNFSSVYKGTLRD------GTLVAIRSINVTSCKSEEAEFVKGLYLLTSL-RHE 466
              LG+G F  V +              VA++ +   +  SE    +  L +L  +  H 
Sbjct: 32  GKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHL 91

Query: 467 NIIRLRGFCCSRGRGECFLIYDFAPKGKLSKYL------------DQEEGSSNVLDWSTR 514
           N++ L G  C++  G   +I +F   G LS YL              E+   + L     
Sbjct: 92  NVVNLLG-ACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHL 150

Query: 515 VSIIIGIAKGIGYLHSSEVNKPAIVHRNLSVEKVLIDQQFNPLIADCGLHKLLADDIVFS 574
           +     +AKG+ +L S +      +HR+L+   +L+ ++    I D GL    A DI   
Sbjct: 151 ICYSFQVAKGMEFLASRK-----CIHRDLAARNILLSEKNVVKICDFGL----ARDIYKD 201

Query: 575 VLKTSAAMGYL-----APEYVTTGRFTERSDIFAFGVIILQILTGSLVLTSSMRLAAESA 629
                     L     APE +    +T +SD+++FGV++ +I +        +++  E  
Sbjct: 202 PDYVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKIDEE-- 259

Query: 630 TFENFIDRNLKGKFSESEA---AKLGKMALVCTHEDPENRPTMEAVIEEL 676
               F  R  +G    +      ++ +  L C H +P  RPT   ++E L
Sbjct: 260 ----FCRRLKEGTRMRAPDYTTPEMYQTMLDCWHGEPSQRPTFSELVEHL 305

>3vq2_A TLR4, TOLL-like receptor 4; leucine rich repeat MD-2 related lipid recognition, receptor immunity, lipid binding, glycosylation, secreted, immune SY; HET: NAG LP4 LP5 DAO MYR; 2.48A {Mus musculus} PDB: 3vq1_A* 2z64_A* Length = 606

 Score =  105 bits (264), Expect = 7e-24
 Identities = 29/155 (18%), Positives = 54/155 (34%), Gaps = 2/155 (1%)

Query: 84  LSPSLSGLKCLSGLYLHYNSLSGEIPKE-IRNLTELTDLYLDVNNLSGNIPPEIGSMASL 142
           +S +  GL+ L  L   +++L          +L +L  L +   N   +       + SL
Sbjct: 391 MSANFMGLEELQHLDFQHSTLKRVTEFSAFLSLEKLLYLDISYTNTKIDFDGIFLGLTSL 450

Query: 143 QVLQLCCNQLTGNIPAQI-GSLKSLSVLTLQHNRLNGGIPDSLGNLGKLKRLDLSFNSLF 201
             L++  N    N  + +  +  +L+ L L   +L          L +L+ L++S N+L 
Sbjct: 451 NTLKMAGNSFKDNTLSNVFANTTNLTFLDLSKCQLEQISWGVFDTLHRLQLLNMSHNNLL 510

Query: 202 GTIPESLANNAELLFLDVQNNTLSGIVPSALKRLN 236
                       L  LD   N +            
Sbjct: 511 FLDSSHYNQLYSLSTLDCSFNRIETSKGILQHFPK 545

>3vq2_A TLR4, TOLL-like receptor 4; leucine rich repeat MD-2 related lipid recognition, receptor immunity, lipid binding, glycosylation, secreted, immune SY; HET: NAG LP4 LP5 DAO MYR; 2.48A {Mus musculus} PDB: 3vq1_A* 2z64_A* Length = 606

 Score =  104 bits (261), Expect = 2e-23
 Identities = 35/155 (22%), Positives = 55/155 (35%), Gaps = 2/155 (1%)

Query: 73  ISLQGKGLTGKLSPS-LSGLKCLSGLYLHYNSLSGEIPKEIRNLTELTDLYLDVNNLSGN 131
           +  Q   L      S    L+ L  L + Y +   +       LT L  L +  N+   N
Sbjct: 404 LDFQHSTLKRVTEFSAFLSLEKLLYLDISYTNTKIDFDGIFLGLTSLNTLKMAGNSFKDN 463

Query: 132 IPPEI-GSMASLQVLQLCCNQLTGNIPAQIGSLKSLSVLTLQHNRLNGGIPDSLGNLGKL 190
               +  +  +L  L L   QL         +L  L +L + HN L          L  L
Sbjct: 464 TLSNVFANTTNLTFLDLSKCQLEQISWGVFDTLHRLQLLNMSHNNLLFLDSSHYNQLYSL 523

Query: 191 KRLDLSFNSLFGTIPESLANNAELLFLDVQNNTLS 225
             LD SFN +  +          L F ++ NN+++
Sbjct: 524 STLDCSFNRIETSKGILQHFPKSLAFFNLTNNSVA 558

>3vq2_A TLR4, TOLL-like receptor 4; leucine rich repeat MD-2 related lipid recognition, receptor immunity, lipid binding, glycosylation, secreted, immune SY; HET: NAG LP4 LP5 DAO MYR; 2.48A {Mus musculus} PDB: 3vq1_A* 2z64_A* Length = 606

 Score =  104 bits (261), Expect = 2e-23
 Identities = 32/142 (22%), Positives = 53/142 (37%), Gaps = 1/142 (0%)

Query: 97  LYLHYNSLSGEIPKEIRNLTELTDLYLDVNNLSGNIPPEIGSMASLQVLQLCCNQLTGNI 156
           + L +N L         N +EL  L L    +          +  L  L L  N +    
Sbjct: 37  IDLSFNPLKILKSYSFSNFSELQWLDLSRCEIETIEDKAWHGLHHLSNLILTGNPIQSFS 96

Query: 157 PAQIGSLKSLSVLTLQHNRLNGGIPDSLGNLGKLKRLDLSFNSLFG-TIPESLANNAELL 215
           P     L SL  L     +L       +G L  LK+L+++ N +    +P   +N   L+
Sbjct: 97  PGSFSGLTSLENLVAVETKLASLESFPIGQLITLKKLNVAHNFIHSCKLPAYFSNLTNLV 156

Query: 216 FLDVQNNTLSGIVPSALKRLNG 237
            +D+  N +  I  + L+ L  
Sbjct: 157 HVDLSYNYIQTITVNDLQFLRE 178

>3vq2_A TLR4, TOLL-like receptor 4; leucine rich repeat MD-2 related lipid recognition, receptor immunity, lipid binding, glycosylation, secreted, immune SY; HET: NAG LP4 LP5 DAO MYR; 2.48A {Mus musculus} PDB: 3vq1_A* 2z64_A* Length = 606

 Score = 93.2 bits (232), Expect = 6e-20
 Identities = 39/157 (24%), Positives = 65/157 (41%), Gaps = 7/157 (4%)

Query: 87  SLSGLKCLSGLYLHYNSLSGEIPKEIRNLTELTDLYLDVNNLSGNIPPEIGSMASLQVLQ 146
           +  GL  LS L L  N +    P     LT L +L      L+      IG + +L+ L 
Sbjct: 75  AWHGLHHLSNLILTGNPIQSFSPGSFSGLTSLENLVAVETKLASLESFPIGQLITLKKLN 134

Query: 147 LCCNQLTG-NIPAQIGSLKSLSVLTLQHNRLNGGIPDSLGNLGKLK----RLDLSFNSLF 201
           +  N +    +PA   +L +L  + L +N +     + L  L +       LD+S N + 
Sbjct: 135 VAHNFIHSCKLPAYFSNLTNLVHVDLSYNYIQTITVNDLQFLRENPQVNLSLDMSLNPI- 193

Query: 202 GTIPESLANNAELLFLDVQNNTLSG-IVPSALKRLNG 237
             I +      +L  L ++ N  S  I+ + L+ L G
Sbjct: 194 DFIQDQAFQGIKLHELTLRGNFNSSNIMKTCLQNLAG 230

>3vq2_A TLR4, TOLL-like receptor 4; leucine rich repeat MD-2 related lipid recognition, receptor immunity, lipid binding, glycosylation, secreted, immune SY; HET: NAG LP4 LP5 DAO MYR; 2.48A {Mus musculus} PDB: 3vq1_A* 2z64_A* Length = 606

 Score = 78.5 bits (194), Expect = 2e-15
 Identities = 38/160 (23%), Positives = 60/160 (37%), Gaps = 10/160 (6%)

Query: 72  NISLQGKGLTGKLSPSLSGLKCLSGLYLHYNSLSGEIPKEIRNLTELTDLYLDVNNLSGN 131
              L               L  +S + L   S+     +++    +   L +    L   
Sbjct: 265 EFRLTYTNDFSDDIVKFHCLANVSAMSLAGVSIKY--LEDVPKHFKWQSLSIIRCQLK-Q 321

Query: 132 IPPEIGSMASLQVLQLCCNQLTGNIPAQIGSLKSLSVLTLQHNRLNGGIPDSLGNLG--K 189
            P     +  L+ L L  N+ +  I  +  +L SLS L L  N L+     S  +LG   
Sbjct: 322 FPT--LDLPFLKSLTLTMNKGS--ISFKKVALPSLSYLDLSRNALSFSGCCSYSDLGTNS 377

Query: 190 LKRLDLSFNSLFGTIPESLANNAELLFLDVQNNTLSGIVP 229
           L+ LDLSFN     +  +     EL  LD Q++TL  +  
Sbjct: 378 LRHLDLSFNGAI-IMSANFMGLEELQHLDFQHSTLKRVTE 416

>3vq2_A TLR4, TOLL-like receptor 4; leucine rich repeat MD-2 related lipid recognition, receptor immunity, lipid binding, glycosylation, secreted, immune SY; HET: NAG LP4 LP5 DAO MYR; 2.48A {Mus musculus} PDB: 3vq1_A* 2z64_A* Length = 606

 Score = 76.2 bits (188), Expect = 1e-14
 Identities = 27/162 (16%), Positives = 49/162 (30%), Gaps = 16/162 (9%)

Query: 87  SLSGLKCLSG----LYLHYNSLSGEIPKEIRNLTELTDLYLDVNNLSGNIPPE-IGSMAS 141
            L  L+        L +  N +   I  +     +L +L L  N  S NI    + ++A 
Sbjct: 172 DLQFLRENPQVNLSLDMSLNPID-FIQDQAFQGIKLHELTLRGNFNSSNIMKTCLQNLAG 230

Query: 142 LQVLQLCCNQLTGNIPAQIGSLKSLSVLT--------LQHNRLNGGIPDSLGNLGKLKRL 193
           L V +L   +       +I     +  L         L +             L  +  +
Sbjct: 231 LHVHRLILGEFKDERNLEIFEPSIMEGLCDVTIDEFRLTYTNDFSDDIVKFHCLANVSAM 290

Query: 194 DLSFNSLFGTIPESLANNAELLFLDVQNNTLSGIVPSALKRL 235
            L+  S+     E +  + +   L +    L       L  L
Sbjct: 291 SLAGVSI--KYLEDVPKHFKWQSLSIIRCQLKQFPTLDLPFL 330

>3vq2_A TLR4, TOLL-like receptor 4; leucine rich repeat MD-2 related lipid recognition, receptor immunity, lipid binding, glycosylation, secreted, immune SY; HET: NAG LP4 LP5 DAO MYR; 2.48A {Mus musculus} PDB: 3vq1_A* 2z64_A* Length = 606

 Score = 69.3 bits (170), Expect = 2e-12
 Identities = 26/153 (16%), Positives = 51/153 (33%), Gaps = 9/153 (5%)

Query: 86  PSLSGLKCLSGLYLHYNSLSGEIPKEIRNLTELT--DLYLDVNNLSGNIPPEIGSMASLQ 143
             L   + + G +    +L    P  +  L ++T  +  L   N   +   +   +A++ 
Sbjct: 229 AGLHVHRLILGEFKDERNLEIFEPSIMEGLCDVTIDEFRLTYTNDFSDDIVKFHCLANVS 288

Query: 144 VLQLCCNQLTGNIPAQIGSLKSLSVLTLQHNRLNGGIPDSLGNLGKLKRLDLSFNSLFGT 203
            + L    +       +        L++   +L         +L  LK L L+ N    +
Sbjct: 289 AMSLAGVSIKY--LEDVPKHFKWQSLSIIRCQLKQ---FPTLDLPFLKSLTLTMNKG--S 341

Query: 204 IPESLANNAELLFLDVQNNTLSGIVPSALKRLN 236
           I         L +LD+  N LS     +   L 
Sbjct: 342 ISFKKVALPSLSYLDLSRNALSFSGCCSYSDLG 374

>2buj_A Serine/threonine-protein kinase 16; transferase, ATP-binding, lipoprotein, myristate, PA phosphorylation; HET: STU; 2.6A {Homo sapiens} Length = 317

 Score =  101 bits (254), Expect = 9e-24
 Identities = 57/288 (19%), Positives = 115/288 (39%), Gaps = 39/288 (13%)

Query: 411 FSEVNLLGKGNFSSVYKGT-LRDGTLVAIRSINVTSCKSEEAEFVKGLYLLTSLRHENII 469
           +  +  LG+G FS V     L DG   A++ I     + +  E  +   +     H NI+
Sbjct: 31  YLFIQKLGEGGFSYVDLVEGLHDGHFYALKRILCHE-QQDREEAQREADMHRLFNHPNIL 89

Query: 470 RLRGFCC--SRGRGECFLIYDFAPKGKLSKYLDQEEGSSNVLDWSTRVSIIIGIAKGIGY 527
           RL  +C      + E +L+  F  +G L   +++ +   N L     + +++GI +G+  
Sbjct: 90  RLVAYCLRERGAKHEAWLLLPFFKRGTLWNEIERLKDKGNFLTEDQILWLLLGICRGLEA 149

Query: 528 LHSSEVNKPAIVHRNLSVEKVLIDQQFNPLIADCGLHKLLADDIVFS----VLKTSAA-- 581
           +H+         HR+L    +L+  +  P++ D G        +  S     L+  AA  
Sbjct: 150 IHA-----KGYAHRDLKPTNILLGDEGQPVLMDLGSMNQACIHVEGSRQALTLQDWAAQR 204

Query: 582 --MGYLAPEYVTTGR---FTERSDIFAFGVIILQILTGSLVLTSSMRLAAESATFE-NFI 635
             + Y APE  +        ER+D+++ G ++  ++ G            +    + + +
Sbjct: 205 CTISYRAPELFSVQSHCVIDERTDVWSLGCVLYAMMFG--------EGPYDMVFQKGDSV 256

Query: 636 DRNLKGKFSE-------SEAAKLGKMALVCTHEDPENRPTMEAVIEEL 676
              ++ + S        S   +L    +     DP  RP +  ++ +L
Sbjct: 257 ALAVQNQLSIPQSPRHSSALWQLLNSMMT---VDPHQRPHIPLLLSQL 301

>3ll6_A Cyclin G-associated kinase; transferase, protein kinase, serine/threonine kinase, cyclin clathrine, membrane trafficking, structural genomics; 2.10A {Homo sapiens} Length = 337

 Score =  100 bits (251), Expect = 3e-23
 Identities = 61/310 (19%), Positives = 108/310 (34%), Gaps = 74/310 (23%)

Query: 414 VNLLGKGNFSSVYKGT-LRDGTLVAIRSINVTSCKSE-----EAEFVKGLYLLTSLRHEN 467
             +L +G F+ VY+   +  G   A++ +     +       E  F+K L       H N
Sbjct: 33  RRVLAEGGFAFVYEAQDVGSGREYALKRLLSNEEEKNRAIIQEVCFMKKL-----SGHPN 87

Query: 468 IIRLRGFCCSR------GRGECFLIYDFAPKGKLSKYLDQEEGSSNVLDWSTRVSIIIGI 521
           I++              G+ E  L+ +    G+L ++L + E S   L   T + I    
Sbjct: 88  IVQFCSAASIGKEESDTGQAEFLLLTELCK-GQLVEFLKKME-SRGPLSCDTVLKIFYQT 145

Query: 522 AKGIGYLHSSEVNKPAIVHRNLSVEKVLIDQQFNPLIADCGLHKLLADDIVFSVLKTSAA 581
            + + ++H     KP I+HR+L VE +L+  Q    + D G    ++    +S      A
Sbjct: 146 CRAVQHMHR---QKPPIIHRDLKVENLLLSNQGTIKLCDFGSATTISHYPDYSWSAQRRA 202

Query: 582 MG-----------YLAPEYVTTGR---FTERSDIFAFGVI---------------ILQIL 612
           +            Y  PE +         E+ DI+A G I                L+I+
Sbjct: 203 LVEEEITRNTTPMYRTPEIIDLYSNFPIGEKQDIWALGCILYLLCFRQHPFEDGAKLRIV 262

Query: 613 TGSLVLTSSMRLAAESATFENFIDRNLKGKFSESEAAKLGKMALVCTHEDPENRPTMEAV 672
            G   +        +   F + I   L+                     +PE R ++  V
Sbjct: 263 NGKYSIPPHDT---QYTVFHSLIRAMLQ--------------------VNPEERLSIAEV 299

Query: 673 IEELTVAAPV 682
           + +L   A  
Sbjct: 300 VHQLQEIAAA 309

>4eut_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: BX7; 2.60A {Homo sapiens} Length = 396

 Score =  101 bits (253), Expect = 3e-23
 Identities = 51/215 (23%), Positives = 88/215 (40%), Gaps = 23/215 (10%)

Query: 416 LLGKGNFSSVYKGTLRD-GTLVAIRSINVTSCKSEEAEFVKGLYLLTSLRHENIIRLRGF 474
           +LG+G  ++V++G  +  G L AI+  N  S        ++   +L  L H+NI++L   
Sbjct: 16  ILGQGATANVFRGRHKKTGDLFAIKVFNNISFLRPVDVQMREFEVLKKLNHKNIVKLFAI 75

Query: 475 CCSRGRGECFLIYDFAPKGKLSKYLDQEEGSSNVLDWSTRVSIIIGIAKGIGYLHSSEVN 534
                     LI +F P G L   L +E  ++  L  S  + ++  +  G+ +L  +   
Sbjct: 76  EEETTTRHKVLIMEFCPCGSLYTVL-EEPSNAYGLPESEFLIVLRDVVGGMNHLRENG-- 132

Query: 535 KPAIVHRNLSVEKVLI----DQQFNPLIADCGLHKLLADDIVFSVLKTSA-AMGYLAPEY 589
              IVHRN+    ++     D Q    + D G  + L DD       +      YL P+ 
Sbjct: 133 ---IVHRNIKPGNIMRVIGEDGQSVYKLTDFGAARELEDD---EQFVSLYGTEEYLHPDM 186

Query: 590 VTTG--------RFTERSDIFAFGVIILQILTGSL 616
                       ++    D+++ GV      TGSL
Sbjct: 187 YERAVLRKDHQKKYGATVDLWSIGVTFYHAATGSL 221

>1t46_A HOMO sapiens V-KIT hardy-zuckerman 4 feline sarcoma viral oncogene homolog; kinase, structure, inhibitor, STI-571, gleevec, transferase activator; HET: STI; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1pkg_A* 1t45_A 3g0e_A* 3g0f_A* Length = 313

 Score = 99.6 bits (249), Expect = 4e-23
 Identities = 62/289 (21%), Positives = 112/289 (38%), Gaps = 46/289 (15%)

Query: 417 LGKGNFSSVYKGTLRD------GTLVAIRSINVTSCKSEEAEFVKGLYLLTSL-RHENII 469
           LG G F  V + T            VA++ +  ++  +E    +  L +L+ L  H NI+
Sbjct: 31  LGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSAHLTEREALMSELKVLSYLGNHMNIV 90

Query: 470 RLRGFCCSRGRGECFLIYDFAPKGKLSKYL--------------DQEEGSSNVLDWSTRV 515
            L G  C+ G G   +I ++   G L  +L                 E     LD    +
Sbjct: 91  NLLG-ACTIG-GPTLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELALDLEDLL 148

Query: 516 SIIIGIAKGIGYLHSSEVNKPAIVHRNLSVEKVLIDQQFNPLIADCGLHKLLADDIVFSV 575
           S    +AKG+ +L S        +HR+L+   +L+       I D GL + + +D  +  
Sbjct: 149 SFSYQVAKGMAFLAS---KN--CIHRDLAARNILLTHGRITKICDFGLARDIKNDSNY-- 201

Query: 576 LKTSAAMGYL-----APEYVTTGRFTERSDIFAFGVIILQILTGSLVLTSSMRLAAESAT 630
           +    A   L     APE +    +T  SD++++G+ + ++ +        M        
Sbjct: 202 VVKGNAR--LPVKWMAPESIFNCVYTFESDVWSYGIFLWELFSLGSSPYPGM------PV 253

Query: 631 FENFIDRNLKGKFSESEA---AKLGKMALVCTHEDPENRPTMEAVIEEL 676
              F     +G    S     A++  +   C   DP  RPT + +++ +
Sbjct: 254 DSKFYKMIKEGFRMLSPEHAPAEMYDIMKTCWDADPLKRPTFKQIVQLI 302

>2psq_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xr0_A Length = 370

 Score =  100 bits (251), Expect = 5e-23
 Identities = 70/295 (23%), Positives = 123/295 (41%), Gaps = 53/295 (17%)

Query: 414 VNLLGKGNFSSVYKGTLRD--------GTLVAIRSINVTSCKSEEAEFVKGLYLLTSL-R 464
              LG+G F  V                  VA++ +   + + + ++ V  + ++  + +
Sbjct: 86  GKPLGEGCFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGK 145

Query: 465 HENIIRLRGFCCSRGRGECFLIYDFAPKGKLSKYL------------DQEEGSSNVLDWS 512
           H+NII L G  C++  G  ++I ++A KG L +YL            D        + + 
Sbjct: 146 HKNIINLLG-ACTQD-GPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFK 203

Query: 513 TRVSIIIGIAKGIGYLHSSEVNKPAIVHRNLSVEKVLIDQQFNPLIADCGLHKLLADDIV 572
             VS    +A+G+ YL S    K   +HR+L+   VL+ +     IAD GL + + +   
Sbjct: 204 DLVSCTYQLARGMEYLAS---QK--CIHRDLAARNVLVTENNVMKIADFGLARDINNIDY 258

Query: 573 FSVLKTSAAMGYL-----APEYVTTGRFTERSDIFAFGVIILQILTGSLVLTSSMRLAAE 627
           +   KT+     L     APE +    +T +SD+++FGV++ +I T          L   
Sbjct: 259 Y--KKTTNGR--LPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFT----------LGGS 304

Query: 628 ---SATFENFIDRNLKGKFSESEA---AKLGKMALVCTHEDPENRPTMEAVIEEL 676
                  E       +G   +  A    +L  M   C H  P  RPT + ++E+L
Sbjct: 305 PYPGIPVEELFKLLKEGHRMDKPANCTNELYMMMRDCWHAVPSQRPTFKQLVEDL 359

>3p23_A Serine/threonine-protein kinase/endoribonuclease; kinase domain, kinase and RNAse function, ATP binding ssRNA dephosphorylated, hydrolase; HET: ADP; 2.70A {Homo sapiens} Length = 432

 Score =  101 bits (253), Expect = 6e-23
 Identities = 62/277 (22%), Positives = 109/277 (39%), Gaps = 36/277 (12%)

Query: 411 FSEVNLLGKGNFSSVYKGTLRDGTLVAIRSINVTSCKSEEAEFVKGLYLLTSLRHENIIR 470
           F   ++LG G   ++    + D   VA++ I        + E V+   L  S  H N+IR
Sbjct: 26  FCPKDVLGHGAEGTIVYRGMFDNRDVAVKRILPECFSFADRE-VQ--LLRESDEHPNVIR 82

Query: 471 LRGFCCSRGRGECFLIYDFAPKGKLSKYLDQEEGSSNVLDWSTRVSIIIGIAKGIGYLHS 530
              FC  + R   ++  +      L +Y++Q++ +   L+    ++++     G+ +LHS
Sbjct: 83  Y--FCTEKDRQFQYIAIELCA-ATLQEYVEQKDFAHLGLE---PITLLQQTTSGLAHLHS 136

Query: 531 SEVNKPAIVHRNLSVEKVLI-----DQQFNPLIADCGLHKLLADDIV-FSVLKTSAA-MG 583
                  IVHR+L    +LI       +   +I+D GL K LA     FS         G
Sbjct: 137 LN-----IVHRDLKPHNILISMPNAHGKIKAMISDFGLCKKLAVGRHSFSRRSGVPGTEG 191

Query: 584 YLAPEYV---TTGRFTERSDIFAFGVIILQILTGSLVL---TSSMRLAAESATFENFIDR 637
           ++APE +        T   DIF+ G +   +++        +   +              
Sbjct: 192 WIAPEMLSEDCKENPTYTVDIFSAGCVFYYVISEGSHPFGKSLQRQANILLGACSLDCLH 251

Query: 638 NLKGKFSESEAAK--LGKMALVCTHEDPENRPTMEAV 672
             K    E   A+  + KM       DP+ RP+ + V
Sbjct: 252 PEK---HEDVIARELIEKM----IAMDPQKRPSAKHV 281

>2a19_B Interferon-induced, double-stranded RNA-activated kinase; transferase, protein biosynthesis, protein synthesis transferase complex; HET: TPO ANP; 2.50A {Homo sapiens} PDB: 2a1a_B* Length = 284

 Score = 98.5 bits (246), Expect = 6e-23
 Identities = 63/285 (22%), Positives = 109/285 (38%), Gaps = 51/285 (17%)

Query: 411 FSEVNLLGKGNFSSVYKGT-LRDGTLVAIRSINVTSCKSE-EAEFVKGLYLLTSLRHENI 468
           F E+ L+G G F  V+K     DG    I+ +   + K+E E +       L  L H NI
Sbjct: 13  FKEIELIGSGGFGQVFKAKHRIDGKTYVIKRVKYNNEKAEREVK------ALAKLDHVNI 66

Query: 469 IRLRGF--------------CCSRGRGECFLIYDFAPKGKLSKYLDQEEGSSNVLDWSTR 514
           +   G                        F+  +F  KG L +++++  G    LD    
Sbjct: 67  VHYNGCWDGFDYDPETSSKNSSRSKTKCLFIQMEFCDKGTLEQWIEKRRGEK--LDKVLA 124

Query: 515 VSIIIGIAKGIGYLHSSEVNKPAIVHRNLSVEKVLIDQQFNPLIADCGLHKLLADDIVFS 574
           + +   I KG+ Y+HS    K  +++R+L    + +       I D GL   L +D    
Sbjct: 125 LELFEQITKGVDYIHS---KK--LINRDLKPSNIFLVDTKQVKIGDFGLVTSLKND---G 176

Query: 575 VLKTSAAMG---YLAPEYVTTGRFTERSDIFAFGVIILQILTGSLVLTSSMRLAAESATF 631
               S   G   Y++PE +++  + +  D++A G+I+ ++L                  F
Sbjct: 177 KRTRS--KGTLRYMSPEQISSQDYGKEVDLYALGLILAELLHV------------CDTAF 222

Query: 632 E--NFIDRNLKGKFSESEAAKLGKMALVCTHEDPENRPTMEAVIE 674
           E   F      G  S+    K   +      + PE+RP    ++ 
Sbjct: 223 ETSKFFTDLRDGIISDIFDKKEKTLLQKLLSKKPEDRPNTSEILR 267

>2i1m_A Macrophage colony-stimulating factor 1 receptor; kinase domain, kinase inhibitor complex, transferase; HET: 5CN; 1.80A {Homo sapiens} PDB: 3bea_A* 3lcd_A* 2i0y_A* 2i0v_A* 3dpk_A* 3krj_A* 3krl_A* 2ogv_A 3lco_A* Length = 333

 Score = 99.6 bits (249), Expect = 6e-23
 Identities = 57/292 (19%), Positives = 110/292 (37%), Gaps = 50/292 (17%)

Query: 414 VNLLGKGNFSSVYKGTLRD------GTLVAIRSINVTSCKSEEAEFVKGLYLLTSL-RHE 466
              LG G F  V + T            VA++ +  T+   E+   +  L +++ L +HE
Sbjct: 51  GKTLGAGAFGKVVEATAFGLGKEDAVLKVAVKMLKSTAHADEKEALMSELKIMSHLGQHE 110

Query: 467 NIIRLRGFCCSRGRGECFLIYDFAPKGKLSKYL----------DQEEGSSNVLDWSTRVS 516
           NI+ L G  C+ G G   +I ++   G L  +L               +++       + 
Sbjct: 111 NIVNLLG-ACTHG-GPVLVITEYCCYGDLLNFLRRKSRVLETDPAFAIANSTASTRDLLH 168

Query: 517 IIIGIAKGIGYLHSSEVNKPAIVHRNLSVEKVLIDQQFNPLIADCGLHKLLADDIVFSVL 576
               +A+G+ +L          +HR+++   VL+       I D GL + + +D  +  +
Sbjct: 169 FSSQVAQGMAFL---ASKN--CIHRDVAARNVLLTNGHVAKIGDFGLARDIMNDSNY--I 221

Query: 577 KTSAAMGYL-----APEYVTTGRFTERSDIFAFGVIILQILTGSLVLTSSMRLAAE---- 627
               A   L     APE +    +T +SD++++G+++ +I +          L       
Sbjct: 222 VKGNAR--LPVKWMAPESIFDCVYTVQSDVWSYGILLWEIFS----------LGLNPYPG 269

Query: 628 SATFENFIDRNLKGKFSESEA---AKLGKMALVCTHEDPENRPTMEAVIEEL 676
                 F      G      A     +  +   C   +P +RPT + +   L
Sbjct: 270 ILVNSKFYKLVKDGYQMAQPAFAPKNIYSIMQACWALEPTHRPTFQQICSFL 321

>4g31_A Eukaryotic translation initiation factor 2-alpha; deletion mutant, catalytic domain, synthetic inhibitor, TRAN transferase inhibitor complex; HET: 0WH; 2.28A {Homo sapiens} PDB: 4g34_A* Length = 299

 Score = 98.2 bits (245), Expect = 1e-22
 Identities = 49/293 (16%), Positives = 99/293 (33%), Gaps = 49/293 (16%)

Query: 411 FSEVNLLGKGNFSSVYKGT-LRDGTLVAIRSINVTSCKSEEAEFVKGLYLLTSLRHENII 469
           F  +  LG+G F  V++     D    AI+ I + + +    + ++ +  L  L H  I+
Sbjct: 7   FEPIQCLGRGGFGVVFEAKNKVDDCNYAIKRIRLPNRELAREKVMREVKALAKLEHPGIV 66

Query: 470 RLRGFCC----------SRGRGECFLIYDFAPKGKLSKYLDQEEGSSNVLDWSTRVSIII 519
           R                S  +   ++      K  L  +++         + S  + I +
Sbjct: 67  RYFNAWLEKNTTEKLQPSSPKVYLYIQMQLCRKENLKDWMNGRCTIEE-RERSVCLHIFL 125

Query: 520 GIAKGIGYLHSSEVNKPAIVHRNLSVEKVLIDQQFNPLIADCGLHKLLADDIVFSVLKTS 579
            IA+ + +LHS       ++HR+L    +         + D GL   +  D     + T 
Sbjct: 126 QIAEAVEFLHS---KG--LMHRDLKPSNIFFTMDDVVKVGDFGLVTAMDQDEEEQTVLTP 180

Query: 580 AAMG-----------YLAPEYVTTGRFTERSDIFAFGVIILQILTGSLVLTSSMRLAAES 628
                          Y++PE +    ++ + DIF+ G+I+ ++L               +
Sbjct: 181 MPAYARHTGQVGTKLYMSPEQIHGNSYSHKVDIFSLGLILFELLY-----------PFST 229

Query: 629 ATFENFIDRNLK-GKFSE------SEAAKLGKMALVCTHEDPENRPTMEAVIE 674
                    +++  KF             + +         P  RP    +IE
Sbjct: 230 QMERVRTLTDVRNLKFPPLFTQKYPCEYVMVQD---MLSPSPMERPEAINIIE 279

>1xbb_A Tyrosine-protein kinase SYK; gleevec, STI-571, imatinib, spleen typrosine kinase, active conformation, structural genomics, structural genomix; HET: STI; 1.57A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xba_A* 1xbc_A* 3fqe_A* 3fqh_A* 3fqs_A* 3emg_A* 3srv_A* 4dfl_A* 4dfn_A* 3vf8_A* 3vf9_A* Length = 291

 Score = 97.7 bits (244), Expect = 1e-22
 Identities = 53/206 (25%), Positives = 94/206 (45%), Gaps = 24/206 (11%)

Query: 417 LGKGNFSSVYKGTLRDG---TLVAIRSINV-TSCKSEEAEFVKGLYLLTSLRHENIIRLR 472
           LG GNF +V KG  +       VA++ +    +  + + E +    ++  L +  I+R+ 
Sbjct: 25  LGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIVRMI 84

Query: 473 GFCCSRGRGECFLIYDFAPKGKLSKYLDQEEGSSNVLDWSTRVSIIIGIAKGIGYLHSSE 532
           G C +       L+ + A  G L+KYL Q       +     + ++  ++ G+ YL   E
Sbjct: 85  GICEAESW---MLVMEMAELGPLNKYLQQNRH----VKDKNIIELVHQVSMGMKYL--EE 135

Query: 533 VNKPAIVHRNLSVEKVLIDQQFNPLIADCGLHKLLADDIVFSVLKTSAAMGYL-----AP 587
            N    VHR+L+   VL+  Q    I+D GL K L  D        +   G       AP
Sbjct: 136 SN---FVHRDLAARNVLLVTQHYAKISDFGLSKALRAD---ENYYKAQTHGKWPVKWYAP 189

Query: 588 EYVTTGRFTERSDIFAFGVIILQILT 613
           E +   +F+ +SD+++FGV++ +  +
Sbjct: 190 ECINYYKFSSKSDVWSFGVLMWEAFS 215

>3qa8_A MGC80376 protein; kinase ubiquitin-like domain, phosphorylation, kinase domain ubiquitin-like domain, kinase, substrate binding; 3.60A {Xenopus laevis} PDB: 3qad_A* 3rzf_A* Length = 676

 Score =  101 bits (253), Expect = 2e-22
 Identities = 48/209 (22%), Positives = 82/209 (39%), Gaps = 18/209 (8%)

Query: 417 LGKGNFSSVYKGTLRD-GTLVAIRSINVTSCKSEEAEFVKGLYLLTSLRHENIIRLR--- 472
           LG G F  V +   +D G  VAI+             +   + ++  L H N++  R   
Sbjct: 22  LGTGGFGYVLRWIHQDTGEQVAIKQCRQELSPKNRERWCLEIQIMKKLNHPNVVSAREVP 81

Query: 473 -GFCCSRGRGECFLIYDFAPKGKLSKYLDQEEGSSNVLDWSTRVSIIIGIAKGIGYLHSS 531
            G           L  ++   G L KYL  +  +   L      +++  I+  + YLH +
Sbjct: 82  DGLQKLAPNDLPLLAMEYCEGGDLRKYL-NQFENCCGLKEGPIRTLLSDISSALRYLHEN 140

Query: 532 EVNKPAIVHRNLSVEKVLIDQQFNPL---IADCGLHKLLADDIVFSVLKTSA-AMGYLAP 587
                 I+HR+L  E +++      L   I D G  K L       +       + YLAP
Sbjct: 141 R-----IIHRDLKPENIVLQPGPQRLIHKIIDLGYAKELDQG---ELCTEFVGTLQYLAP 192

Query: 588 EYVTTGRFTERSDIFAFGVIILQILTGSL 616
           E +   ++T   D ++FG +  + +TG  
Sbjct: 193 ELLEQKKYTVTVDYWSFGTLAFECITGFR 221

>3p1a_A MYT1 kinase, membrane-associated tyrosine- and threonine-speci inhibitory kinase; structural genomics, structural genomics consortium, SGC; 1.70A {Homo sapiens} Length = 311

 Score = 97.8 bits (244), Expect = 2e-22
 Identities = 52/274 (18%), Positives = 103/274 (37%), Gaps = 34/274 (12%)

Query: 409 QCFSEVNLLGKGNFSSVYKGT-LRDGTLVAIRSINVTSCKS-EEAEFVKGLYLLTSL-RH 465
           Q F  ++ LG G++  V+K     DG L A++          + A  +  +     + +H
Sbjct: 57  QSFQRLSRLGHGSYGEVFKVRSKEDGRLYAVKRSMSPFRGPKDRARKLAEVGSHEKVGQH 116

Query: 466 ENIIRLRGFCCSRGRGECFLIYDFAPKGKLSKYLDQEEGSSNVLDWSTRVSIIIGIAKGI 525
              +RL         G  +L  +      L ++  +  G+S  L  +     +      +
Sbjct: 117 PCCVRLEQ--AWEEGGILYLQTELC-GPSLQQHC-EAWGAS--LPEAQVWGYLRDTLLAL 170

Query: 526 GYLHSSEVNKPAIVHRNLSVEKVLIDQQFNPLIADCGLHKLLADDIVFSVLK-TSAAMGY 584
            +LHS       +VH ++    + +  +    + D GL   L       V +       Y
Sbjct: 171 AHLHSQG-----LVHLDVKPANIFLGPRGRCKLGDFGLLVELGTAGAGEVQEGDP---RY 222

Query: 585 LAPEYVTTGRFTERSDIFAFGVIILQILTGSLVLTSSMRLAAESATFENFIDRNLKGKFS 644
           +APE +  G +   +D+F+ G+ IL++          M L      ++      L  +F+
Sbjct: 223 MAPE-LLQGSYGTAADVFSLGLTILEVACN-------MELPHGGEGWQQLRQGYLPPEFT 274

Query: 645 E--SEAAKLGKMALV--CTHEDPENRPTMEAVIE 674
              S   +    +++      DP+ R T EA++ 
Sbjct: 275 AGLSSELR----SVLVMMLEPDPKLRATAEALLA 304

>1u46_A ACK-1, activated CDC42 kinase 1; tyrosine kinase, transferase; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 1u4d_A* 1u54_A* 3eqr_A* 3eqp_B* Length = 291

 Score = 96.9 bits (242), Expect = 2e-22
 Identities = 65/288 (22%), Positives = 112/288 (38%), Gaps = 52/288 (18%)

Query: 417 LGKGNFSSVYKGTLR----DGTLVAIRSI--NVTSCKSEEAEFVKGLYLLTSLRHENIIR 470
           LG G+F  V +G           VA++ +  +V S      +F++ +  + SL H N+IR
Sbjct: 26  LGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLDHRNLIR 85

Query: 471 LRGFCCSRGRGECFLIYDFAPKGKLSKYLDQEEGSSNVLDWSTRVSIIIGIAKGIGYLHS 530
           L G   +       ++ + AP G L   L + +G        T     + +A+G+GYL  
Sbjct: 86  LYGVVLTPPM---KMVTELAPLGSLLDRLRKHQGH---FLLGTLSRYAVQVAEGMGYL-- 137

Query: 531 SEVNKPAIVHRNLSVEKVLIDQQFNPLIADCGLHKLLADDIVFSVLKTSAAMGY--LAPE 588
                   +HR+L+   +L+  +    I D GL + L  +    V++    + +   APE
Sbjct: 138 ESKR---FIHRDLAARNLLLATRDLVKIGDFGLMRALPQNDDHYVMQEHRKVPFAWCAPE 194

Query: 589 YVTTGRFTERSDIFAFGVIILQILTG--------------SLVLTSSMRLAA-ESATFEN 633
            + T  F+  SD + FGV + ++ T                 +     RL   E      
Sbjct: 195 SLKTRTFSHASDTWMFGVTLWEMFTYGQEPWIGLNGSQILHKIDKEGERLPRPEDCP--- 251

Query: 634 FIDRNLKGKFSESEAAKLGKMALVCTHEDPENRPTMEAVIEELTVAAP 681
                            +  + + C    PE+RPT  A+ + L  A P
Sbjct: 252 ---------------QDIYNVMVQCWAHKPEDRPTFVALRDFLLEAQP 284

>2pvf_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; HET: PTR ACP; 1.80A {Homo sapiens} PDB: 3cly_A* 2pzr_A* 2pzp_A* 2pvy_A* 2pz5_A* 2q0b_A* 2pwl_A* 2py3_A* 3ri1_A* 1gjo_A 1oec_A* 3b2t_A* 3gql_A* 3gqi_A* 1fgk_A 1fgi_A* 1agw_A 2fgi_A* 3js2_A* 3ky2_A ... Length = 334

 Score = 98.1 bits (245), Expect = 2e-22
 Identities = 69/295 (23%), Positives = 123/295 (41%), Gaps = 53/295 (17%)

Query: 414 VNLLGKGNFSSVYKGTLRD--------GTLVAIRSINVTSCKSEEAEFVKGLYLLTSL-R 464
              LG+G F  V                  VA++ +   + + + ++ V  + ++  + +
Sbjct: 40  GKPLGEGAFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGK 99

Query: 465 HENIIRLRGFCCSRGRGECFLIYDFAPKGKLSKYL------------DQEEGSSNVLDWS 512
           H+NII L G  C++  G  ++I ++A KG L +YL            D        + + 
Sbjct: 100 HKNIINLLG-ACTQD-GPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFK 157

Query: 513 TRVSIIIGIAKGIGYLHSSEVNKPAIVHRNLSVEKVLIDQQFNPLIADCGLHKLLADDIV 572
             VS    +A+G+ YL S +      +HR+L+   VL+ +     IAD GL + + +   
Sbjct: 158 DLVSCTYQLARGMEYLASQK-----CIHRDLAARNVLVTENNVMKIADFGLARDINNIDY 212

Query: 573 FSVLKTSAAMGYL-----APEYVTTGRFTERSDIFAFGVIILQILTGSLVLTSSMRLAAE 627
           +   KT+     L     APE +    +T +SD+++FGV++ +I T          L   
Sbjct: 213 YK--KTTNGR--LPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFT----------LGGS 258

Query: 628 ---SATFENFIDRNLKGKFSESEA---AKLGKMALVCTHEDPENRPTMEAVIEEL 676
                  E       +G   +  A    +L  M   C H  P  RPT + ++E+L
Sbjct: 259 PYPGIPVEELFKLLKEGHRMDKPANCTNELYMMMRDCWHAVPSQRPTFKQLVEDL 313

>3zzw_A Tyrosine-protein kinase transmembrane receptor RO; transferase, neurotrophic tyrosine kinase, receptor-related NTRKR2; 2.90A {Homo sapiens} Length = 289

 Score = 96.5 bits (241), Expect = 3e-22
 Identities = 53/223 (23%), Positives = 98/223 (43%), Gaps = 34/223 (15%)

Query: 414 VNLLGKGNFSSVYKGTLRDG------TLVAIRSINVTSCKSEEAEFVKGLYLLTSLRHEN 467
           +  LG+  F  VYKG L           VAI+++   +      EF     L   L+H N
Sbjct: 14  MEELGEDRFGKVYKGHLFGPAPGEQTQAVAIKTLKDKAEGPLREEFRHEAMLRARLQHPN 73

Query: 468 IIRLRGFCCSRGRGECFLIYDFAPKGKLSKYL------------DQEEGSSNVLDWSTRV 515
           ++ L G   ++ +    +I+ +   G L ++L            D +    + L+    V
Sbjct: 74  VVCLLG-VVTKDQPLS-MIFSYCSHGDLHEFLVMRSPHSDVGSTDDDRTVKSALEPPDFV 131

Query: 516 SIIIGIAKGIGYLHSSEVNKPAIVHRNLSVEKVLIDQQFNPLIADCGLHKLLADDIVFSV 575
            ++  IA G+ YL  S  +   +VH++L+   VL+  + N  I+D G    L  ++  + 
Sbjct: 132 HLVAQIAAGMEYL--SSHH---VVHKDLATRNVLVYDKLNVKISDLG----LFREVYAAD 182

Query: 576 LKTSAAMGYL-----APEYVTTGRFTERSDIFAFGVIILQILT 613
                    L     APE +  G+F+  SDI+++GV++ ++ +
Sbjct: 183 YYKLLGNSLLPIRWMAPEAIMYGKFSIDSDIWSYGVVLWEVFS 225

>1fvr_A Tyrosine-protein kinase TIE-2; tyrosine kinase, transferase; 2.20A {Homo sapiens} SCOP: d.144.1.7 PDB: 2oo8_X* 2osc_A* 2p4i_A* 3l8p_A* 2wqb_A* Length = 327

 Score = 97.0 bits (242), Expect = 5e-22
 Identities = 53/221 (23%), Positives = 98/221 (44%), Gaps = 35/221 (15%)

Query: 414 VNLLGKGNFSSVYKGTLRDG---TLVAIRSINVTSCKSEEAEFVKGLYLLTSL-RHENII 469
            +++G+GNF  V K  ++        AI+ +   + K +  +F   L +L  L  H NII
Sbjct: 30  QDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNII 89

Query: 470 RLRGFCCSRGRGECFLIYDFAPKGKLSKYL------------DQEEGSSNVLDWSTRVSI 517
            L G  C    G  +L  ++AP G L  +L                 +++ L     +  
Sbjct: 90  NLLG-ACEHR-GYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHF 147

Query: 518 IIGIAKGIGYLHSSEVNKPAIVHRNLSVEKVLIDQQFNPLIADCGLHKLLADDIVFSVLK 577
              +A+G+ YL  S+      +HR+L+   +L+ + +   IAD GL +    ++      
Sbjct: 148 AADVARGMDYL--SQKQ---FIHRDLAARNILVGENYVAKIADFGLSR--GQEV-----Y 195

Query: 578 TSAAMGYL-----APEYVTTGRFTERSDIFAFGVIILQILT 613
               MG L     A E +    +T  SD++++GV++ +I++
Sbjct: 196 VKKTMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVS 236

>2ivs_A Proto-oncogene tyrosine-protein kinase receptor RET; nucleotide-binding, hirschsprung disease, phosphorylation, disease mutation; HET: ACK; 2.00A {Homo sapiens} PDB: 2ivt_A* 2ivu_A* 2x2k_A* 2x2l_A* 2x2m_A* 2ivv_A* Length = 314

 Score = 96.2 bits (240), Expect = 6e-22
 Identities = 64/297 (21%), Positives = 121/297 (40%), Gaps = 58/297 (19%)

Query: 417 LGKGNFSSVYKGTLRDG------TLVAIRSINVTSCKSEEAEFVKGLYLLTSLRHENIIR 470
           LG+G F  V K T          T VA++ +   +  SE  + +    +L  + H ++I+
Sbjct: 31  LGEGEFGKVVKATAFHLKGRAGYTTVAVKMLKENASPSELRDLLSEFNVLKQVNHPHVIK 90

Query: 471 LRGFCCSRGRGECFLIYDFAPKGKLSKYL--------------------DQEEGSSNVLD 510
           L G  CS+  G   LI ++A  G L  +L                      +      L 
Sbjct: 91  LYG-ACSQD-GPLLLIVEYAKYGSLRGFLRESRKVGPGYLGSGGSRNSSSLDHPDERALT 148

Query: 511 WSTRVSIIIGIAKGIGYLHSSEVNKPAIVHRNLSVEKVLIDQQFNPLIADCGLHKLLADD 570
               +S    I++G+ YL  +E+    +VHR+L+   +L+ +     I+D GL + + ++
Sbjct: 149 MGDLISFAWQISQGMQYL--AEMK---LVHRDLAARNILVAEGRKMKISDFGLSRDVYEE 203

Query: 571 IVFSVLKTSAAMGYL-----APEYVTTGRFTERSDIFAFGVIILQILTGSLVLTSSMRLA 625
             +   K S     +     A E +    +T +SD+++FGV++ +I+T          L 
Sbjct: 204 DSYV--KRSQGR--IPVKWMAIESLFDHIYTTQSDVWSFGVLLWEIVT----------LG 249

Query: 626 A---ESATFENFIDRNLKGKFSESEA---AKLGKMALVCTHEDPENRPTMEAVIEEL 676
                    E   +    G   E       ++ ++ L C  ++P+ RP    + ++L
Sbjct: 250 GNPYPGIPPERLFNLLKTGHRMERPDNCSEEMYRLMLQCWKQEPDKRPVFADISKDL 306

>3v5q_A NT-3 growth factor receptor; kinase domain, kinase, phosphorylation, transferase-transfer inhibitor complex; HET: 0F4; 2.20A {Homo sapiens} Length = 297

 Score = 95.0 bits (237), Expect = 1e-21
 Identities = 54/220 (24%), Positives = 96/220 (43%), Gaps = 35/220 (15%)

Query: 417 LGKGNFSSVYKGTLRDG------TLVAIRSINVTSCKSEEAEFVKGLYLLTSLRHENIIR 470
           LG+G F  V+     +        LVA++++   +  +   +F +   LLT+L+HE+I++
Sbjct: 23  LGEGAFGKVFLAECYNLSPTKDKMLVAVKALKDPT-LAARKDFQREAELLTNLQHEHIVK 81

Query: 471 LRGFCCSRGRGECFLIYDFAPKGKLSKYL------------DQEEGSSNVLDWSTRVSII 518
             G  C  G     +++++   G L+K+L             Q   +   L  S  + I 
Sbjct: 82  FYG-VCGDGDPLI-MVFEYMKHGDLNKFLRAHGPDAMILVDGQPRQAKGELGLSQMLHIA 139

Query: 519 IGIAKGIGYLHSSEVNKPAIVHRNLSVEKVLIDQQFNPLIADCGLHKLLADDIVFSVLKT 578
             IA G+ YL  +  +    VHR+L+    L+       I D G+ + +     +     
Sbjct: 140 SQIASGMVYL--ASQH---FVHRDLATRNCLVGANLLVKIGDFGMSRDVYSTDYYR--VG 192

Query: 579 SAAMGYL-----APEYVTTGRFTERSDIFAFGVIILQILT 613
              M  L      PE +   +FT  SD+++FGVI+ +I T
Sbjct: 193 GHTM--LPIRWMPPESIMYRKFTTESDVWSFGVILWEIFT 230

>4fmz_A Internalin; leucine rich repeat, structural genomic center for structural genomics, JCSG, protein structure INI PSI-biology; HET: MSE; 1.91A {Listeria monocytogenes serotype 4B} Length = 347

 Score = 95.7 bits (239), Expect = 1e-21
 Identities = 36/155 (23%), Positives = 70/155 (45%), Gaps = 12/155 (7%)

Query: 86  PSLSGLKCLSGLYLHYNSLSGEIPKEIRNLTELTDLYLDVNNLSGNIPPEIGSMASLQVL 145
             L+ L  L     + N ++   P  + N+T L  L +  N ++ ++ P + +++ L  L
Sbjct: 193 SPLASLTSLHYFTAYVNQITDITP--VANMTRLNSLKIGNNKIT-DLSP-LANLSQLTWL 248

Query: 146 QLCCNQLTGNIPAQIGSLKSLSVLTLQHNRLNGGIPDSLGNLGKLKRLDLSFNSLFGTIP 205
           ++  NQ++ +I A +  L  L +L +  N+++      L NL +L  L L+ N L     
Sbjct: 249 EIGTNQIS-DINA-VKDLTKLKMLNVGSNQISD--ISVLNNLSQLNSLFLNNNQLGNEDM 304

Query: 206 ESLANNAELLFLDVQNNTLSGIVP----SALKRLN 236
           E +     L  L +  N ++ I P    S +   +
Sbjct: 305 EVIGGLTNLTTLFLSQNHITDIRPLASLSKMDSAD 339

>4fmz_A Internalin; leucine rich repeat, structural genomic center for structural genomics, JCSG, protein structure INI PSI-biology; HET: MSE; 1.91A {Listeria monocytogenes serotype 4B} Length = 347

 Score = 93.8 bits (234), Expect = 6e-21
 Identities = 34/140 (24%), Positives = 67/140 (47%), Gaps = 8/140 (5%)

Query: 86  PSLSGLKCLSGLYLHYNSLSGEIPKEIRNLTELTDLYLDVNNLSGNIPPEIGSMASLQVL 145
             ++ +  L+ L +  N ++   P  + NL++LT L +  N +S      +  +  L++L
Sbjct: 215 TPVANMTRLNSLKIGNNKITDLSP--LANLSQLTWLEIGTNQISD--INAVKDLTKLKML 270

Query: 146 QLCCNQLTGNIPAQIGSLKSLSVLTLQHNRLNGGIPDSLGNLGKLKRLDLSFNSLFGTIP 205
            +  NQ++ +I   + +L  L+ L L +N+L     + +G L  L  L LS N +  T  
Sbjct: 271 NVGSNQIS-DISV-LNNLSQLNSLFLNNNQLGNEDMEVIGGLTNLTTLFLSQNHI--TDI 326

Query: 206 ESLANNAELLFLDVQNNTLS 225
             LA+ +++   D  N  + 
Sbjct: 327 RPLASLSKMDSADFANQVIK 346

>4fmz_A Internalin; leucine rich repeat, structural genomic center for structural genomics, JCSG, protein structure INI PSI-biology; HET: MSE; 1.91A {Listeria monocytogenes serotype 4B} Length = 347

 Score = 93.4 bits (233), Expect = 9e-21
 Identities = 38/152 (25%), Positives = 72/152 (47%), Gaps = 10/152 (6%)

Query: 86  PSLSGLKCLSGLYLHYNSLSGEIPKEIRNLTELTDLYLDVNNLSGNIPPEIGSMASLQVL 145
             LS L  L+ LY+  N ++      ++NLT L +LYL+ +N+S      + ++  +  L
Sbjct: 82  SPLSNLVKLTNLYIGTNKIT--DISALQNLTNLRELYLNEDNISD--ISPLANLTKMYSL 137

Query: 146 QLCCNQLTGNIPAQIGSLKSLSVLTLQHNRLNGGIPDSLGNLGKLKRLDLSFNSLFGTIP 205
            L  N    ++   + ++  L+ LT+  +++    P  + NL  L  L L++N +     
Sbjct: 138 NLGANHNLSDLSP-LSNMTGLNYLTVTESKVKDVTP--IANLTDLYSLSLNYNQI--EDI 192

Query: 206 ESLANNAELLFLDVQNNTLSGIVP-SALKRLN 236
             LA+   L +     N ++ I P + + RLN
Sbjct: 193 SPLASLTSLHYFTAYVNQITDITPVANMTRLN 224

>4fmz_A Internalin; leucine rich repeat, structural genomic center for structural genomics, JCSG, protein structure INI PSI-biology; HET: MSE; 1.91A {Listeria monocytogenes serotype 4B} Length = 347

 Score = 89.9 bits (224), Expect = 1e-19
 Identities = 34/155 (21%), Positives = 68/155 (43%), Gaps = 13/155 (8%)

Query: 86  PSLSGLKCLSGLYLHYNSLSGEIPKEIRNLTELTDLYLDVNNLSGNIPPEIGSMASLQVL 145
            +   L+ ++ L +    ++    + I  LT L  L L+ N ++      + ++  L  L
Sbjct: 38  VTQEELESITKLVVAGEKVAS--IQGIEYLTNLEYLNLNGNQITD--ISPLSNLVKLTNL 93

Query: 146 QLCCNQLTGNIPAQIGSLKSLSVLTLQHNRLNGGIPDSLGNLGKLKRLDLSFNSLFGTIP 205
            +  N++T +I A + +L +L  L L  + ++      L NL K+  L+L  N    +  
Sbjct: 94  YIGTNKIT-DISA-LQNLTNLRELYLNEDNISD--ISPLANLTKMYSLNLGANHN-LSDL 148

Query: 206 ESLANNAELLFLDVQNNTLSGIVP----SALKRLN 236
             L+N   L +L V  + +  + P    + L  L+
Sbjct: 149 SPLSNMTGLNYLTVTESKVKDVTPIANLTDLYSLS 183

>4fmz_A Internalin; leucine rich repeat, structural genomic center for structural genomics, JCSG, protein structure INI PSI-biology; HET: MSE; 1.91A {Listeria monocytogenes serotype 4B} Length = 347

 Score = 83.4 bits (207), Expect = 2e-17
 Identities = 32/149 (21%), Positives = 63/149 (42%), Gaps = 11/149 (7%)

Query: 87  SLSGLKCLSGLYLHYNSLSGEIPKEIRNLTELTDLYLDVNNLSGNIPPEIGSMASLQVLQ 146
             + L       L   S++  + +E   L  +T L +    ++      I  + +L+ L 
Sbjct: 17  PDADLAEGIRAVLQKASVTDVVTQE--ELESITKLVVAGEKVAS--IQGIEYLTNLEYLN 72

Query: 147 LCCNQLTGNIPAQIGSLKSLSVLTLQHNRLNGGIPDSLGNLGKLKRLDLSFNSLFGTIPE 206
           L  NQ+T   P  + +L  L+ L +  N++      +L NL  L+ L L+ +++  +   
Sbjct: 73  LNGNQITDISP--LSNLVKLTNLYIGTNKIT--DISALQNLTNLRELYLNEDNI--SDIS 126

Query: 207 SLANNAELLFLDVQNNTLSGIVPSALKRL 235
            LAN  ++  L++  N       S L  +
Sbjct: 127 PLANLTKMYSLNLGANHNLSD-LSPLSNM 154

>4fmz_A Internalin; leucine rich repeat, structural genomic center for structural genomics, JCSG, protein structure INI PSI-biology; HET: MSE; 1.91A {Listeria monocytogenes serotype 4B} Length = 347

 Score = 79.1 bits (196), Expect = 5e-16
 Identities = 31/147 (21%), Positives = 55/147 (37%), Gaps = 14/147 (9%)

Query: 94  LSGLYLHYNSLSGEIPKEIRNLTELTDLYLDVNNLSGNIPPEIGSMASLQVLQLCCNQLT 153
            + L      ++   P    +L E     L   +++         + S+  L +   ++ 
Sbjct: 2   AATLATLPAPINQIFP--DADLAEGIRAVLQKASVTD--VVTQEELESITKLVVAGEKVA 57

Query: 154 GNIPAQIGSLKSLSVLTLQHNRLNGGIPDSLGNLGKLKRLDLSFNSLFGTIPESLANNAE 213
            +I   I  L +L  L L  N++       L NL KL  L +  N +  T   +L N   
Sbjct: 58  -SIQG-IEYLTNLEYLNLNGNQITD--ISPLSNLVKLTNLYIGTNKI--TDISALQNLTN 111

Query: 214 LLFLDVQNNTLSGIVP----SALKRLN 236
           L  L +  + +S I P    + +  LN
Sbjct: 112 LRELYLNEDNISDISPLANLTKMYSLN 138

>4fvq_A Tyrosine-protein kinase JAK2; janus protein kinase, pseudokinase, ATP binding, phosphoryla transferase; HET: ATP; 1.75A {Homo sapiens} PDB: 4fvp_A* 4fvr_A* Length = 289

 Score = 94.3 bits (235), Expect = 2e-21
 Identities = 53/288 (18%), Positives = 115/288 (39%), Gaps = 61/288 (21%)

Query: 417 LGKGNFSSVYKGTLRD--------GTLVAIRSINVTSCKSEEAEFVKGLYLLTSLRHENI 468
           LG+G F+ ++KG  R+         T V ++ ++       E  F +   +++ L H+++
Sbjct: 16  LGQGTFTKIFKGVRREVGDYGQLHETEVLLKVLDKAHRNYSE-SFFEAASMMSKLSHKHL 74

Query: 469 IRLRGFCCSRGRGECFLIYDFAPKGKLSKYLDQEEGSSNVLDWSTRVSIIIGIAKGIGYL 528
           +   G  C  G  E  L+ +F   G L  YL + +     ++   ++ +   +A  + +L
Sbjct: 75  VLNYG-VCVCGD-ENILVQEFVKFGSLDTYLKKNKNC---INILWKLEVAKQLAAAMHFL 129

Query: 529 HSSEVNKPAIVHRNLSVEKVLIDQQFNPL--------IADCGLHKLLADDIVFSVLKTSA 580
              E     ++H N+  + +L+ ++ +          ++D G+   +             
Sbjct: 130 --EENT---LIHGNVCAKNILLIREEDRKTGNPPFIKLSDPGISITVLPK---------- 174

Query: 581 AMGYL-------APEYVTTGR-FTERSDIFAFGVIILQILTGSLV----LTSSMRLAAES 628
               L        PE +   +     +D ++FG  + +I +G       L S  +L    
Sbjct: 175 --DILQERIPWVPPECIENPKNLNLATDKWSFGTTLWEICSGGDKPLSALDSQRKL---- 228

Query: 629 ATFENFIDRNLKGKFSESEAAKLGKMALVCTHEDPENRPTMEAVIEEL 676
                F +     +    +AA+L  +   C   +P++RP+  A+I +L
Sbjct: 229 ----QFYEDR--HQLPAPKAAELANLINNCMDYEPDHRPSFRAIIRDL 270

>3tt0_A Basic fibroblast growth factor receptor 1; kinase domain, transferase, transferase-transferase inhibito; HET: 07J; 2.80A {Homo sapiens} Length = 382

 Score = 96.3 bits (240), Expect = 2e-21
 Identities = 68/292 (23%), Positives = 121/292 (41%), Gaps = 53/292 (18%)

Query: 417 LGKGNFSSVYKGTLRD--------GTLVAIRSINVTSCKSEEAEFVKGLYLLTSL-RHEN 467
           LG+G F  V                T VA++ +   + + + ++ +  + ++  + +H+N
Sbjct: 77  LGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGKHKN 136

Query: 468 IIRLRGFCCSRGRGECFLIYDFAPKGKLSKYL------------DQEEGSSNVLDWSTRV 515
           II L G  C++  G  ++I ++A KG L +YL            +        L     V
Sbjct: 137 IINLLG-ACTQD-GPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLSSKDLV 194

Query: 516 SIIIGIAKGIGYLHSSEVNKPAIVHRNLSVEKVLIDQQFNPLIADCGLHKLLADDIVFSV 575
           S    +A+G+ YL      K   +HR+L+   VL+ +     IAD GL + +     +  
Sbjct: 195 SCAYQVARGMEYL---ASKK--CIHRDLAARNVLVTEDNVMKIADFGLARDIHHIDYYK- 248

Query: 576 LKTSAAMGYL-----APEYVTTGRFTERSDIFAFGVIILQILTGSLVLTSSMRLAAE--- 627
            KT+     L     APE +    +T +SD+++FGV++ +I T          L      
Sbjct: 249 -KTTNGR--LPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFT----------LGGSPYP 295

Query: 628 SATFENFIDRNLKGKFSESEA---AKLGKMALVCTHEDPENRPTMEAVIEEL 676
               E       +G   +  +    +L  M   C H  P  RPT + ++E+L
Sbjct: 296 GVPVEELFKLLKEGHRMDKPSNCTNELYMMMRDCWHAVPSQRPTFKQLVEDL 347

>1luf_A Muscle-specific tyrosine kinase receptor MUSK; phosphorylation, signal transduction, MASS spectrometry, transferase; 2.05A {Rattus norvegicus} SCOP: d.144.1.7 Length = 343

 Score = 95.1 bits (237), Expect = 2e-21
 Identities = 58/300 (19%), Positives = 113/300 (37%), Gaps = 58/300 (19%)

Query: 414 VNLLGKGNFSSVYKGTLRDG------TLVAIRSINVTSCKSEEAEFVKGLYLLTSLRHEN 467
           V  +G+G F  V++            T+VA++ +   +    +A+F +   L+    + N
Sbjct: 52  VRDIGEGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASADMQADFQREAALMAEFDNPN 111

Query: 468 IIRLRGFCCSRGRGECFLIYDFAPKGKLSKYL--------------------DQEEGSSN 507
           I++L G  C+ G     L++++   G L+++L                            
Sbjct: 112 IVKLLG-VCAVG-KPMCLLFEYMAYGDLNEFLRSMSPHTVCSLSHSDLSTRARVSSPGPP 169

Query: 508 VLDWSTRVSIIIGIAKGIGYLHSSEVNKPAIVHRNLSVEKVLIDQQFNPLIADCGLHKLL 567
            L  + ++ I   +A G+ YL      K   VHR+L+    L+ +     IAD G    L
Sbjct: 170 PLSCAEQLCIARQVAAGMAYLSE---RK--FVHRDLATRNCLVGENMVVKIADFG----L 220

Query: 568 ADDIVFSVLKTSAAMGYL-----APEYVTTGRFTERSDIFAFGVIILQILTGSLVLTSSM 622
           + +I  +    +     +      PE +   R+T  SD++A+GV++ +I +         
Sbjct: 221 SRNIYSADYYKADGNDAIPIRWMPPESIFYNRYTTESDVWAYGVVLWEIFS--------- 271

Query: 623 RLAA---ESATFENFIDRNLKGKFSESEA---AKLGKMALVCTHEDPENRPTMEAVIEEL 676
                       E  I     G           +L  +  +C  + P +RP+  ++   L
Sbjct: 272 -YGLQPYYGMAHEEVIYYVRDGNILACPENCPLELYNLMRLCWSKLPADRPSFCSIHRIL 330

>1rjb_A FL cytokine receptor; kinase, structure, autoinhibition, juxtamembrane domain, transferase; 2.10A {Homo sapiens} SCOP: d.144.1.7 Length = 344

 Score = 95.1 bits (237), Expect = 3e-21
 Identities = 67/298 (22%), Positives = 111/298 (37%), Gaps = 59/298 (19%)

Query: 417 LGKGNFSSVYKGTLRDG------TLVAIRSINVTSCKSEEAEFVKGLYLLTSL-RHENII 469
           LG G F  V   T            VA++ +   +  SE    +  L ++T L  HENI+
Sbjct: 53  LGSGAFGKVMNATAYGISKTGVSIQVAVKMLKEKADSSEREALMSELKMMTQLGSHENIV 112

Query: 470 RLRGFCCSRGRGECFLIYDFAPKGKLSKYL-------------------DQEEGSSNVLD 510
            L G  C+   G  +LI+++   G L  YL                    +EE   NVL 
Sbjct: 113 NLLG-ACTLS-GPIYLIFEYCCYGDLLNYLRSKREKFSEDEIEYENQKRLEEEEDLNVLT 170

Query: 511 WSTRVSIIIGIAKGIGYLHSSEVNKPAIVHRNLSVEKVLIDQQFNPLIADCGLHKLLADD 570
           +   +     +AKG+ +L          VHR+L+   VL+       I D GL + +  D
Sbjct: 171 FEDLLCFAYQVAKGMEFLEFKS-----CVHRDLAARNVLVTHGKVVKICDFGLARDIMSD 225

Query: 571 IVFSVLKTSAAMGYL-----APEYVTTGRFTERSDIFAFGVIILQILTGSLVLTSSMRLA 625
             +  +    A   L     APE +  G +T +SD++++G+++ +I +          L 
Sbjct: 226 SNY--VVRGNAR--LPVKWMAPESLFEGIYTIKSDVWSYGILLWEIFS----------LG 271

Query: 626 A----ESATFENFIDRNLKGKFSESEA---AKLGKMALVCTHEDPENRPTMEAVIEEL 676
                      NF      G   +       ++  +   C   D   RP+   +   L
Sbjct: 272 VNPYPGIPVDANFYKLIQNGFKMDQPFYATEEIYIIMQSCWAFDSRKRPSFPNLTSFL 329

>4aoj_A High affinity nerve growth factor receptor; transferase, inhibitor; HET: V4Z; 2.75A {Homo sapiens} Length = 329

 Score = 94.7 bits (236), Expect = 3e-21
 Identities = 54/222 (24%), Positives = 101/222 (45%), Gaps = 34/222 (15%)

Query: 414 VNLLGKGNFSSVYKGTLRDG------TLVAIRSINVTSCKSEEAEFVKGLYLLTSLRHEN 467
              LG+G F  V+     +        LVA++++   S +S   +F +   LLT L+H++
Sbjct: 46  KWELGEGAFGKVFLAECHNLLPEQDKMLVAVKALKEAS-ESARQDFQREAELLTMLQHQH 104

Query: 468 IIRLRGFCCSRGRGECFLIYDFAPKGKLSKYL-----------DQEEGSSNVLDWSTRVS 516
           I+R  G  C+ GR    +++++   G L+++L             E+ +   L     ++
Sbjct: 105 IVRFFG-VCTEGRPLL-MVFEYMRHGDLNRFLRSHGPDAKLLAGGEDVAPGPLGLGQLLA 162

Query: 517 IIIGIAKGIGYLHSSEVNKPAIVHRNLSVEKVLIDQQFNPLIADCGLHKLLADDIVFSVL 576
           +   +A G+ YL  + ++    VHR+L+    L+ Q     I D G+    + DI  +  
Sbjct: 163 VASQVAAGMVYL--AGLH---FVHRDLATRNCLVGQGLVVKIGDFGM----SRDIYSTDY 213

Query: 577 KTSAAMGYL-----APEYVTTGRFTERSDIFAFGVIILQILT 613
                   L      PE +   +FT  SD+++FGV++ +I T
Sbjct: 214 YRVGGRTMLPIRWMPPESILYRKFTTESDVWSFGVVLWEIFT 255

>3o53_A Protein LRIM1, AGAP006348-PA; leucine-rich repeat, protein binding; HET: NAG; 2.00A {Anopheles gambiae} Length = 317

 Score = 93.9 bits (234), Expect = 3e-21
 Identities = 29/151 (19%), Positives = 54/151 (35%), Gaps = 5/151 (3%)

Query: 87  SLSGLKCLSGLYLHYNSLSGEIPKEIRNLTELTDLYLDVNNLSG-NIPPEIGSMASLQVL 145
           S S  +    +YL  N ++     +    + +  L L +N +   N      S  +L+ L
Sbjct: 115 SCSRGQGKKNIYLANNKITMLRDLDEGCRSRVQYLDLKLNEIDTVNFAELAASSDTLEHL 174

Query: 146 QLCCNQLTGNIPAQIGSLKSLSVLTLQHNRLNGGIPDSLGNLGKLKRLDLSFNSLFGTIP 205
            L  N +  ++  Q+     L  L L  N+L   +     +   +  + L  N L   I 
Sbjct: 175 NLQYNFIY-DVKGQV-VFAKLKTLDLSSNKLAF-MGPEFQSAAGVTWISLRNNKL-VLIE 230

Query: 206 ESLANNAELLFLDVQNNTLSGIVPSALKRLN 236
           ++L  +  L   D++ N             N
Sbjct: 231 KALRFSQNLEHFDLRGNGFHCGTLRDFFSKN 261

>3o53_A Protein LRIM1, AGAP006348-PA; leucine-rich repeat, protein binding; HET: NAG; 2.00A {Anopheles gambiae} Length = 317

 Score = 90.0 bits (224), Expect = 8e-20
 Identities = 27/165 (16%), Positives = 55/165 (33%), Gaps = 6/165 (3%)

Query: 87  SLSGLKCLSGLYLHYNSLSG-EIPKEIRNLTELTDLYLDVNNLSGNIPPEIGSMASLQVL 145
                  +  L L  N +      +   +   L  L L  N +  ++  ++   A L+ L
Sbjct: 139 DEGCRSRVQYLDLKLNEIDTVNFAELAASSDTLEHLNLQYNFIY-DVKGQV-VFAKLKTL 196

Query: 146 QLCCNQLTGNIPAQIGSLKSLSVLTLQHNRLNGGIPDSLGNLGKLKRLDLSFNSLFGTIP 205
            L  N+L   +  +  S   ++ ++L++N+L   I  +L     L+  DL  N       
Sbjct: 197 DLSSNKLA-FMGPEFQSAAGVTWISLRNNKLVL-IEKALRFSQNLEHFDLRGNGFHCGTL 254

Query: 206 ESLANNAELLFLDVQNNTLSGIVPSALKRLNGGFQFQNNPGLCGD 250
               +  + +   V   T+  +     +              C D
Sbjct: 255 RDFFSKNQRV-QTVAKQTVKKLTGQNEEECTVPTLGHYGAYCCED 298

>3o53_A Protein LRIM1, AGAP006348-PA; leucine-rich repeat, protein binding; HET: NAG; 2.00A {Anopheles gambiae} Length = 317

 Score = 88.9 bits (221), Expect = 2e-19
 Identities = 24/145 (16%), Positives = 50/145 (34%), Gaps = 10/145 (6%)

Query: 91  LKCLSGLYLHYNSLSGEIPKEIRNLTELTDLYLDVNNLSGNIPPEIGSMASLQVLQLCCN 150
                   +  +SL   +    ++   + +L L  N LS     ++     L++L L  N
Sbjct: 9   GNRYKIEKVTDSSLKQALASLRQSAWNVKELDLSGNPLSQISAADLAPFTKLELLNLSSN 68

Query: 151 QLTGNIPAQIGSLKSLSVLTLQHNRLNGGIPDSLGNLGKLKRLDLSFNSLFGTIPESLAN 210
            L       + SL +L  L L +N +       L     ++ L  + N++   +  S   
Sbjct: 69  VLY-ETLD-LESLSTLRTLDLNNNYVQ-----ELLVGPSIETLHAANNNI-SRVSCSRGQ 120

Query: 211 NAELLFLDVQNNTLSGIVPSALKRL 235
                 + + NN ++ +        
Sbjct: 121 G--KKNIYLANNKITMLRDLDEGCR 143

>3o53_A Protein LRIM1, AGAP006348-PA; leucine-rich repeat, protein binding; HET: NAG; 2.00A {Anopheles gambiae} Length = 317

 Score = 87.4 bits (217), Expect = 6e-19
 Identities = 30/159 (18%), Positives = 61/159 (38%), Gaps = 10/159 (6%)

Query: 74  SLQGKGLTGKLSPSLSGLKCLSGLYLHYNSLSGEIPKEIRNLTELTDLYLDVNNLSGNIP 133
            +    L   L+        +  L L  N LS     ++   T+L  L L  N L     
Sbjct: 16  KVTDSSLKQALASLRQSAWNVKELDLSGNPLSQISAADLAPFTKLELLNLSSNVLYE--T 73

Query: 134 PEIGSMASLQVLQLCCNQLTGNIPAQIGSLKSLSVLTLQHNRLNGGIPDSLGNLGKLKRL 193
            ++ S+++L+ L L  N +      ++    S+  L   +N ++  +  S G     K +
Sbjct: 74  LDLESLSTLRTLDLNNNYVQ-----ELLVGPSIETLHAANNNIS-RVSCSRGQ--GKKNI 125

Query: 194 DLSFNSLFGTIPESLANNAELLFLDVQNNTLSGIVPSAL 232
            L+ N +           + + +LD++ N +  +  + L
Sbjct: 126 YLANNKITMLRDLDEGCRSRVQYLDLKLNEIDTVNFAEL 164

>3o53_A Protein LRIM1, AGAP006348-PA; leucine-rich repeat, protein binding; HET: NAG; 2.00A {Anopheles gambiae} Length = 317

 Score = 83.5 bits (207), Expect = 1e-17
 Identities = 27/129 (20%), Positives = 48/129 (37%), Gaps = 9/129 (6%)

Query: 108 IPKEIRNLTELTDLYLDVNNLSGNIPPEIGS-MASLQVLQLCCNQLTGNIPAQIGSLKSL 166
           I +  +N        +  ++L       +     +++ L L  N L+    A +     L
Sbjct: 2   IHEIKQNGNRYKIEKVTDSSLK-QALASLRQSAWNVKELDLSGNPLSQISAADLAPFTKL 60

Query: 167 SVLTLQHNRLNGGIPDSLGNLGKLKRLDLSFNSLFGTIPESLANNAELLFLDVQNNTLSG 226
            +L L  N L     D L +L  L+ LDL+ N +     + L     +  L   NN +S 
Sbjct: 61  ELLNLSSNVLY-ETLD-LESLSTLRTLDLNNNYV-----QELLVGPSIETLHAANNNISR 113

Query: 227 IVPSALKRL 235
           +  S  +  
Sbjct: 114 VSCSRGQGK 122

>3o53_A Protein LRIM1, AGAP006348-PA; leucine-rich repeat, protein binding; HET: NAG; 2.00A {Anopheles gambiae} Length = 317

 Score = 66.6 bits (163), Expect = 6e-12
 Identities = 22/106 (20%), Positives = 45/106 (42%), Gaps = 3/106 (2%)

Query: 132 IPPEIGSMASLQVLQLCCNQLTGNIPAQIGSLKSLSVLTLQHNRLNGGIPDSLGNLGKLK 191
           I     +    ++ ++  + L   + +   S  ++  L L  N L+      L    KL+
Sbjct: 2   IHEIKQNGNRYKIEKVTDSSLKQALASLRQSAWNVKELDLSGNPLSQISAADLAPFTKLE 61

Query: 192 RLDLSFNSLFGTIPESLANNAELLFLDVQNNTLSGIVP-SALKRLN 236
            L+LS N L       L + + L  LD+ NN +  ++   +++ L+
Sbjct: 62  LLNLSSNVL--YETLDLESLSTLRTLDLNNNYVQELLVGPSIETLH 105

>3o53_A Protein LRIM1, AGAP006348-PA; leucine-rich repeat, protein binding; HET: NAG; 2.00A {Anopheles gambiae} Length = 317

 Score = 63.9 bits (156), Expect = 4e-11
 Identities = 19/123 (15%), Positives = 35/123 (28%), Gaps = 4/123 (3%)

Query: 86  PSLSGLKCLSGLYLHYNSLSGEIPKEIRNLTELTDLYLDVNNLSGNIPPEIGSMASLQVL 145
                   L  L L  N L+  +  E ++   +T + L  N L   I   +    +L+  
Sbjct: 185 KGQVVFAKLKTLDLSSNKLA-FMGPEFQSAAGVTWISLRNNKLV-LIEKALRFSQNLEHF 242

Query: 146 QLCCNQLTGNIPAQIGSLKSLSVLTLQHNRLNGGIPDSLGNLGKLKRLDLSFNSLFGTIP 205
            L  N        +    K+  V T+    +   +         +  L          +P
Sbjct: 243 DLRGNGFH-CGTLRDFFSKNQRVQTVAKQTVK-KLTGQNEEECTVPTLGHYGAYCCEDLP 300

Query: 206 ESL 208
              
Sbjct: 301 APF 303

>3o53_A Protein LRIM1, AGAP006348-PA; leucine-rich repeat, protein binding; HET: NAG; 2.00A {Anopheles gambiae} Length = 317

 Score = 52.3 bits (126), Expect = 2e-07
 Identities = 16/115 (13%), Positives = 29/115 (25%), Gaps = 4/115 (3%)

Query: 83  KLSPSLSGLKCLSGLYLHYNSLSGEIPKEIRNLTELTDLYLDVNNLSGNIPPEIGSMASL 142
            + P       ++ + L  N L   I K +R    L    L  N              + 
Sbjct: 205 FMGPEFQSAAGVTWISLRNNKLV-LIEKALRFSQNLEHFDLRGNGFH-CGTLRDFFSKNQ 262

Query: 143 QVLQLCCNQLTGNIPAQIGSLKSLSVLTLQHNRLNGGIPDSLG-NLGKLKRLDLS 196
           +V  +    +   +  Q     ++  L          +P      L  L      
Sbjct: 263 RVQTVAKQTVK-KLTGQNEEECTVPTLGHYGAYCCEDLPAPFADRLIALGHHHHH 316

>3o53_A Protein LRIM1, AGAP006348-PA; leucine-rich repeat, protein binding; HET: NAG; 2.00A {Anopheles gambiae} Length = 317

 Score = 44.2 bits (105), Expect = 9e-05
 Identities = 12/57 (21%), Positives = 22/57 (38%)

Query: 179 GIPDSLGNLGKLKRLDLSFNSLFGTIPESLANNAELLFLDVQNNTLSGIVPSALKRL 235
            I +   N  + K   ++ +SL   +     +   +  LD+  N LS I  + L   
Sbjct: 1   AIHEIKQNGNRYKIEKVTDSSLKQALASLRQSAWNVKELDLSGNPLSQISAADLAPF 57

>4apc_A Serine/threonine-protein kinase NEK1; transferase; 2.10A {Homo sapiens} Length = 350

 Score = 94.4 bits (235), Expect = 5e-21
 Identities = 55/278 (19%), Positives = 123/278 (44%), Gaps = 41/278 (14%)

Query: 411 FSEVNLLGKGNFSSVYKGT-LRDGTLVAIRSINVTSCKSEEAEFVKG-LYLLTSLRHENI 468
           +  +  +G+G+F          DG    I+ IN++   S+E E  +  + +L +++H NI
Sbjct: 26  YVRLQKIGEGSFGKAILVKSTEDGRQYVIKEINISRMSSKEREESRREVAVLANMKHPNI 85

Query: 469 IRLRGFCCSRGRGECFLIYDFAPKGKLSKYLDQEEGS----SNVLDWSTRVSIIIGIAKG 524
           ++ R      G    +++ D+   G L K ++ ++G       +LDW       + I   
Sbjct: 86  VQYRESFEENG--SLYIVMDYCEGGDLFKRINAQKGVLFQEDQILDW------FVQICLA 137

Query: 525 IGYLHSSEVNKPAIVHRNLSVEKVLIDQQFNPLIADCGLHKLLADDIVFSVLKTSAAMG- 583
           + ++H  +     I+HR++  + + + +     + D G+ ++L   +        A +G 
Sbjct: 138 LKHVHDRK-----ILHRDIKSQNIFLTKDGTVQLGDFGIARVLNSTVEL----ARACIGT 188

Query: 584 --YLAPEYVTTGRFTERSDIFAFGVIILQILTGSLVLTSSMRLAAESATFENFIDRNLKG 641
             YL+PE      +  +SDI+A G ++ ++ T         + A E+ + +N + + + G
Sbjct: 189 PYYLSPEICENKPYNNKSDIWALGCVLYELCTL--------KHAFEAGSMKNLVLKIISG 240

Query: 642 KFSE-----SEAAKLGKMALVCTHEDPENRPTMEAVIE 674
            F       S   +   +       +P +RP++ +++E
Sbjct: 241 SFPPVSLHYSYDLR--SLVSQLFKRNPRDRPSVNSILE 276

>2wqm_A Serine/threonine-protein kinase NEK7; ATP-binding, polymorphism, metal-binding, cell cycle kinase, mitosis, cytoplasm, magnesium, transferase; 2.10A {Homo sapiens} PDB: 2wqn_A* Length = 310

 Score = 93.1 bits (232), Expect = 6e-21
 Identities = 52/279 (18%), Positives = 110/279 (39%), Gaps = 37/279 (13%)

Query: 411 FSEVNLLGKGNFSSVYKGT-LRDGTLVAIRSINVTSCKSEEA--EFVKGLYLLTSLRHEN 467
           F     +G+G FS VY+   L DG  VA++ + +      +A  + +K + LL  L H N
Sbjct: 34  FRIEKKIGRGQFSEVYRAACLLDGVPVALKKVQIFDLMDAKARADCIKEIDLLKQLNHPN 93

Query: 468 IIRLRGFCCSRGRGECFLIY-DFAPKGKLSKYLDQEEGSSNVLDWSTRVSIIIGIAKGIG 526
           +I+               I  + A  G LS+ +   +    ++   T     + +   + 
Sbjct: 94  VIKYYASFIEDN---ELNIVLELADAGDLSRMIKHFKKQKRLIPERTVWKYFVQLCSALE 150

Query: 527 YLHSSEVNKPAIVHRNLSVEKVLIDQQFNPLIADCGLHKLLADDIVFSVLKTSAAMG--- 583
           ++HS    +  ++HR++    V I       + D GL +  +     +   +    G   
Sbjct: 151 HMHS---RR--VMHRDIKPANVFITATGVVKLGDLGLGRFFSSK--TTAAHSLV--GTPY 201

Query: 584 YLAPEYVTTGRFTERSDIFAFGVIILQILTGSLVLTSSMRLA--AESATFENFIDRNLKG 641
           Y++PE +    +  +SDI++ G ++ ++           +     +     +   +  + 
Sbjct: 202 YMSPERIHENGYNFKSDIWSLGCLLYEMAAL--------QSPFYGDKMNLYSLCKKIEQC 253

Query: 642 KFSE------SEAAKLGKMALVCTHEDPENRPTMEAVIE 674
            +        SE  +  ++  +C + DPE RP +  V +
Sbjct: 254 DYPPLPSDHYSEELR--QLVNMCINPDPEKRPDVTYVYD 290

>3fdn_A Serine/threonine-protein kinase 6; aurora kinase inhibitors, virtual screening, X-RAY CO- crystal analysis, structure-based drug design (SBDD); HET: MMH; 1.90A {Homo sapiens} PDB: 3k5u_A* 3m11_A* 2c6e_A* 1muo_A* 2bmc_A* 2j4z_A* 1ol6_A* 3up2_A* 3unz_A* 3uo5_A* 3uo6_A* 3uod_A* 3uoh_A* 3uoj_A* 3uok_A* 3uo4_A* 3uol_A* 3up7_A* 3lau_A* 2wtv_A* ... Length = 279

 Score = 92.3 bits (230), Expect = 6e-21
 Identities = 65/273 (23%), Positives = 111/273 (40%), Gaps = 43/273 (15%)

Query: 415 NLLGKGNFSSVYKGT-LRDGTLVAIRSINVTSCKSE--EAEFVKGLY----LLTSLRHEN 467
             LGKG F +VY     +   ++A++ +     K++  +A     L     + + LRH N
Sbjct: 15  RPLGKGKFGNVYLAREKQSKFILALKVLF----KAQLEKAGVEHQLRREVEIQSHLRHPN 70

Query: 468 IIRLRGFCCSRGRGECFLIYDFAPKGKLSKYLDQEEGSSNVLDWSTRVSIIIGIAKGIGY 527
           I+RL G+     R   +LI ++AP G + + L Q+       D     + I  +A  + Y
Sbjct: 71  ILRLYGYFHDATR--VYLILEYAPLGTVYREL-QKLSK---FDEQRTATYITELANALSY 124

Query: 528 LHSSEVNKPAIVHRNLSVEKVLIDQQFNPLIADCGLHKLLADDIVFSVLKTS-AAMGYLA 586
            HS  V     +HR++  E +L+       IAD G           S        + YL 
Sbjct: 125 CHSKRV-----IHRDIKPENLLLGSAGELKIADFGWSVHAPS----SRRTDLCGTLDYLP 175

Query: 587 PEYVTTGRFTERSDIFAFGVIILQILTGSLVLTSSMRLAAESATFENFIDRNLKGKFS-- 644
           PE +      E+ D+++ GV+  + L G        +   E+ T++    R  + +F+  
Sbjct: 176 PEMIEGRMHDEKVDLWSLGVLCYEFLVG--------KPPFEANTYQETYKRISRVEFTFP 227

Query: 645 ---ESEAAKLGKMALVCTHEDPENRPTMEAVIE 674
                 A  L    L     +P  RP +  V+E
Sbjct: 228 DFVTEGARDLISRLLK---HNPSQRPMLREVLE 257

>1o6v_A Internalin A; bacterial infection, extracellular recognition, cell WALL attached, leucine rich repeat; 1.5A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 PDB: 1o6s_A* 1o6t_A 2omz_A 2omy_A 2omw_A 2omv_A 2omt_A 2omx_A 2omu_A Length = 466

 Score = 94.6 bits (236), Expect = 1e-20
 Identities = 41/162 (25%), Positives = 67/162 (41%), Gaps = 10/162 (6%)

Query: 86  PSLSGLKCLSGLYLHYNSLSGEIPKEIRNLTELTDLYLDVNNLSGNIPPEIGSMASLQVL 145
             LSGL  L+ L L  N +S   P  +  LT LT+L L+ N L       I ++ +L  L
Sbjct: 259 APLSGLTKLTELKLGANQISNISP--LAGLTALTNLELNENQLED--ISPISNLKNLTYL 314

Query: 146 QLCCNQLTGNIPAQIGSLKSLSVLTLQHNRLNGGIPDSLGNLGKLKRLDLSFNSLFGTIP 205
            L  N ++   P  + SL  L  L   +N+++     SL NL  +  L    N +  +  
Sbjct: 315 TLYFNNISDISP--VSSLTKLQRLFFYNNKVSD--VSSLANLTNINWLSAGHNQI--SDL 368

Query: 206 ESLANNAELLFLDVQNNTLSGIVPSALKRLNGGFQFQNNPGL 247
             LAN   +  L + +   +    +    ++     +N  G 
Sbjct: 369 TPLANLTRITQLGLNDQAWTNAPVNYKANVSIPNTVKNVTGA 410

>1o6v_A Internalin A; bacterial infection, extracellular recognition, cell WALL attached, leucine rich repeat; 1.5A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 PDB: 1o6s_A* 1o6t_A 2omz_A 2omy_A 2omw_A 2omv_A 2omt_A 2omx_A 2omu_A Length = 466

 Score = 90.4 bits (225), Expect = 3e-19
 Identities = 50/197 (25%), Positives = 79/197 (40%), Gaps = 19/197 (9%)

Query: 86  PSLSGLKCLSGLYLHYNSLSGEIPKEIRNLTELTDLYLDVNNLSGNIPPEIGSMASLQVL 145
             L+ L  L+GL L  N ++   P  ++NLT L  L L  N +S      +  + SLQ L
Sbjct: 106 TPLANLTNLTGLTLFNNQITDIDP--LKNLTNLNRLELSSNTISD--ISALSGLTSLQQL 161

Query: 146 QLCCNQLTGNIPAQIGSLKSLSVLTLQHNRLNGGIPDSLGNLGKLKRLDLSFNSLFGTIP 205
               NQ+T   P  + +L +L  L +  N+++      L  L  L+ L  + N +  +  
Sbjct: 162 SFG-NQVTDLKP--LANLTTLERLDISSNKVSD--ISVLAKLTNLESLIATNNQI--SDI 214

Query: 206 ESLANNAELLFLDVQNNTLSGIVP----SALKRLNGGF-QFQNNPGLCGDGIASLRACTV 260
             L     L  L +  N L  I      + L  L+    Q  N   L   G+  L    +
Sbjct: 215 TPLGILTNLDELSLNGNQLKDIGTLASLTNLTDLDLANNQISNLAPLS--GLTKLTELKL 272

Query: 261 YDNTQINPVKPFGSHSN 277
             N QI+ + P    + 
Sbjct: 273 GAN-QISNISPLAGLTA 288

>1o6v_A Internalin A; bacterial infection, extracellular recognition, cell WALL attached, leucine rich repeat; 1.5A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 PDB: 1o6s_A* 1o6t_A 2omz_A 2omy_A 2omw_A 2omv_A 2omt_A 2omx_A 2omu_A Length = 466

 Score = 86.9 bits (216), Expect = 3e-18
 Identities = 39/196 (19%), Positives = 81/196 (41%), Gaps = 17/196 (8%)

Query: 86  PSLSGLKCLSGLYLHYNSLSGEIPKEIRNLTELTDLYLDVNNLSGNIPPEIGSMASLQVL 145
            + + L       L   +++  + +   +L ++T L  D   +       +  + +L  +
Sbjct: 18  FTDTALAEKMKTVLGKTNVTDTVSQT--DLDQVTTLQADRLGIK--SIDGVEYLNNLTQI 73

Query: 146 QLCCNQLTGNIPAQIGSLKSLSVLTLQHNRLNGGIPDSLGNLGKLKRLDLSFNSLFGTIP 205
               NQLT   P  + +L  L  + + +N++       L NL  L  L L  N +  T  
Sbjct: 74  NFSNNQLTDITP--LKNLTKLVDILMNNNQIAD--ITPLANLTNLTGLTLFNNQI--TDI 127

Query: 206 ESLANNAELLFLDVQNNTLSGIVP----SALKRLNGGFQFQNNPGLCGDGIASLRACTVY 261
           + L N   L  L++ +NT+S I      ++L++L+ G Q  +   L    + +L    + 
Sbjct: 128 DPLKNLTNLNRLELSSNTISDISALSGLTSLQQLSFGNQVTDLKPL--ANLTTLERLDIS 185

Query: 262 DNTQINPVKPFGSHSN 277
            N +++ +      +N
Sbjct: 186 SN-KVSDISVLAKLTN 200

>1o6v_A Internalin A; bacterial infection, extracellular recognition, cell WALL attached, leucine rich repeat; 1.5A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 PDB: 1o6s_A* 1o6t_A 2omz_A 2omy_A 2omw_A 2omv_A 2omt_A 2omx_A 2omu_A Length = 466

 Score = 83.5 bits (207), Expect = 5e-17
 Identities = 46/155 (29%), Positives = 67/155 (43%), Gaps = 14/155 (9%)

Query: 86  PSLSGLKCLSGLYLHYNSLSGEIPKEIRNLTELTDLYLDVNNLSGNIPPEIGSMASLQVL 145
             L+ L  L  L +  N +S      +  LT L  L    N +S +I P +G + +L  L
Sbjct: 171 KPLANLTTLERLDISSNKVSD--ISVLAKLTNLESLIATNNQIS-DITP-LGILTNLDEL 226

Query: 146 QLCCNQLTGNIPAQIGSLKSLSVLTLQHNRLNGGIPDSLGNLGKLKRLDLSFNSLFGTIP 205
            L  NQL  +I   + SL +L+ L L +N+++   P  L  L KL  L L  N +  +  
Sbjct: 227 SLNGNQLK-DIGT-LASLTNLTDLDLANNQISNLAP--LSGLTKLTELKLGANQI--SNI 280

Query: 206 ESLANNAELLFLDVQNNTLSGIVP----SALKRLN 236
             LA    L  L++  N L  I P      L  L 
Sbjct: 281 SPLAGLTALTNLELNENQLEDISPISNLKNLTYLT 315

>1o6v_A Internalin A; bacterial infection, extracellular recognition, cell WALL attached, leucine rich repeat; 1.5A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 PDB: 1o6s_A* 1o6t_A 2omz_A 2omy_A 2omw_A 2omv_A 2omt_A 2omx_A 2omu_A Length = 466

 Score = 82.3 bits (204), Expect = 1e-16
 Identities = 37/140 (26%), Positives = 63/140 (45%), Gaps = 8/140 (5%)

Query: 86  PSLSGLKCLSGLYLHYNSLSGEIPKEIRNLTELTDLYLDVNNLSGNIPPEIGSMASLQVL 145
             L+GL  L+ L L+ N L       I NL  LT L L  NN+S   P  + S+  LQ L
Sbjct: 281 SPLAGLTALTNLELNENQLED--ISPISNLKNLTYLTLYFNNISDISP--VSSLTKLQRL 336

Query: 146 QLCCNQLTGNIPAQIGSLKSLSVLTLQHNRLNGGIPDSLGNLGKLKRLDLSFNSLFGTIP 205
               N+++    + + +L +++ L+  HN+++   P  L NL ++ +L L+  +      
Sbjct: 337 FFYNNKVSD--VSSLANLTNINWLSAGHNQISDLTP--LANLTRITQLGLNDQAWTNAPV 392

Query: 206 ESLANNAELLFLDVQNNTLS 225
              AN +    +      L 
Sbjct: 393 NYKANVSIPNTVKNVTGALI 412

>1o6v_A Internalin A; bacterial infection, extracellular recognition, cell WALL attached, leucine rich repeat; 1.5A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 PDB: 1o6s_A* 1o6t_A 2omz_A 2omy_A 2omw_A 2omv_A 2omt_A 2omx_A 2omu_A Length = 466

 Score = 75.8 bits (187), Expect = 1e-14
 Identities = 33/170 (19%), Positives = 65/170 (38%), Gaps = 29/170 (17%)

Query: 86  PSLSGLKCLSGLYLHYNSLSGEIPKEIRNLTELTDLYLDVNNLSGNIPPEIGSMASLQVL 145
             +S LK L+ L L++N++S   P  + +LT+L  L+   N +S      + ++ ++  L
Sbjct: 303 SPISNLKNLTYLTLYFNNISDISP--VSSLTKLQRLFFYNNKVSD--VSSLANLTNINWL 358

Query: 146 QLCCNQLTGNIPAQIGSLKSLSVLTLQHNRLNGGI----------------------PDS 183
               NQ++   P  + +L  ++ L L                               P +
Sbjct: 359 SAGHNQISDLTP--LANLTRITQLGLNDQAWTNAPVNYKANVSIPNTVKNVTGALIAPAT 416

Query: 184 LGNLGKLKRLDLSFNSLFGTIPESLANNAELLFLDVQNNTLSGIVPSALK 233
           + + G     D+++N       E     ++ + +     T SG V   LK
Sbjct: 417 ISDGGSYTEPDITWNLP-SYTNEVSYTFSQPVTIGKGTTTFSGTVTQPLK 465

>3cek_A Dual specificity protein kinase TTK; HMPS1, PYT, ESK, phosphotyros picked threonine kinase, SGC, structural genomics consortiu binding; HET: 7PE; 2.30A {Homo sapiens} PDB: 3gfw_A* 3h9f_A* 2x9e_A* 3hmp_A* 3hmn_A* 3hmo_A* Length = 313

 Score = 91.6 bits (228), Expect = 2e-20
 Identities = 48/284 (16%), Positives = 107/284 (37%), Gaps = 49/284 (17%)

Query: 415 NLLGKGNFSSVYKGTLRDGTLVAIRSINVTSCKSEEAEFVKG-LYLLTSLRH--ENIIRL 471
             +G G  S V++       + AI+ +N+    ++  +  +  +  L  L+   + IIRL
Sbjct: 34  KQIGSGGSSKVFQVLNEKKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSDKIIRL 93

Query: 472 RGFCCSRGRGECFLIYDFAPKGKLSKYLDQEEGSSNVLDWSTRVSIIIGIAKGIGYLHSS 531
             +         +++ +      L+ +L +++ S   +D   R S    + + +  +H  
Sbjct: 94  YDYE--ITDQYIYMVMECG-NIDLNSWL-KKKKS---IDPWERKSYWKNMLEAVHTIHQH 146

Query: 532 EVNKPAIVHRNLSVEKVLIDQQFNPLIADCGLHKLLADDIVFSVLKTSAAMG---YLAPE 588
                 IVH +L     LI       + D G+   +  D    V  +   +G   Y+ PE
Sbjct: 147 G-----IVHSDLKPANFLIVDG-MLKLIDFGIANQMQPDTTSVVKDSQ--VGTVNYMPPE 198

Query: 589 -----------YVTTGRFTERSDIFAFGVIILQILTGSL---VLTSSMRLAAESATFENF 634
                        +  + + +SD+++ G I+  +  G      + + +      +     
Sbjct: 199 AIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQIINQI------SKLHAI 252

Query: 635 IDRNLKGKFSE--SEAAK--LGKMALVCTHEDPENRPTMEAVIE 674
           ID N + +F +   +  +  L      C   DP+ R ++  ++ 
Sbjct: 253 IDPNHEIEFPDIPEKDLQDVLKC----CLKRDPKQRISIPELLA 292

>3dbq_A Dual specificity protein kinase TTK; MPS1 structure, kinase activation, phosphorylation, ATP- binding, nucleotide-binding, phosphoprotein; 2.70A {Homo sapiens} Length = 343

 Score = 90.5 bits (225), Expect = 6e-20
 Identities = 48/284 (16%), Positives = 106/284 (37%), Gaps = 49/284 (17%)

Query: 415 NLLGKGNFSSVYKGTLRDGTLVAIRSINVTSCKSEEAEFVKG-LYLLTSLRH--ENIIRL 471
             +G G  S V++       + AI+ +N+    ++  +  +  +  L  L+   + IIRL
Sbjct: 15  KQIGSGGSSKVFQVLNEKKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSDKIIRL 74

Query: 472 RGFCCSRGRGECFLIYDFAPKGKLSKYLDQEEGSSNVLDWSTRVSIIIGIAKGIGYLHSS 531
             +         +++ +      L+ +L +++ S   +D   R S    + + +  +H  
Sbjct: 75  YDY--EITDQYIYMVMECG-NIDLNSWL-KKKKS---IDPWERKSYWKNMLEAVHTIHQH 127

Query: 532 EVNKPAIVHRNLSVEKVLIDQQFNPLIADCGLHKLLADDIVFSVLKTSAAMG---YLAPE 588
                 IVH +L     LI       + D G+   +  D    V  +    G   Y+ PE
Sbjct: 128 -----GIVHSDLKPANFLIVDG-MLKLIDFGIANQMQPDTTSVVKDSQV--GTVNYMPPE 179

Query: 589 -----------YVTTGRFTERSDIFAFGVIILQILTGSL---VLTSSMRLAAESATFENF 634
                        +  + + +SD+++ G I+  +  G      + + +      +     
Sbjct: 180 AIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQIINQI------SKLHAI 233

Query: 635 IDRNLKGKFSE--SEAAK--LGKMALVCTHEDPENRPTMEAVIE 674
           ID N + +F +   +  +  L      C   DP+ R ++  ++ 
Sbjct: 234 IDPNHEIEFPDIPEKDLQDVLKC----CLKRDPKQRISIPELLA 273

>3e7e_A HBUB1, BUB1A, mitotic checkpoint serine/threonine-protein kinas; spindle assembly checkpoint, mitosis, kinase, activation, KE CDC20, ATP-binding; HET: ATP; 2.31A {Homo sapiens} Length = 365

 Score = 90.8 bits (225), Expect = 8e-20
 Identities = 41/297 (13%), Positives = 98/297 (32%), Gaps = 42/297 (14%)

Query: 402 EEVESATQCFSEVNLLGKGNFSSVYKGTLRD------GTLVAIRSINVTSCKSEEAEFVK 455
            E +  ++     +LLG+G F+ VY+ T  D           ++     +   E     +
Sbjct: 58  TEFQLGSKLVYVHHLLGEGAFAQVYEATQGDLNDAKNKQKFVLKVQK-PANPWEFYIGTQ 116

Query: 456 GLYLLTSLRHENIIRLRGFCCSRGRGECFLIYDFAPKGKLSKYLDQ-EEGSSNVLDWSTR 514
            +  L        ++         +    L+ +    G L   ++  +     V+     
Sbjct: 117 LMERLKPSMQHMFMKFYSAHLF--QNGSVLVGELYSYGTLLNAINLYKNTPEKVMPQGLV 174

Query: 515 VSIIIGIAKGIGYLHSSEVNKPAIVHRNLSVEKVLIDQQFNPL-----------IADCGL 563
           +S  + +   I  +H  E     I+H ++  +  ++   F              + D G 
Sbjct: 175 ISFAMRMLYMIEQVHDCE-----IIHGDIKPDNFILGNGFLEQDDEDDLSAGLALIDLGQ 229

Query: 564 ---HKLLADDIVF-SVLKTSAAMGYLAPEYVTTGRFTERSDIFAFGVIILQILTGSLVLT 619
               KL     +F +  +TS   G+   E ++   +  + D F     +  +L G+    
Sbjct: 230 SIDMKLFPKGTIFTAKCETS---GFQCVEMLSNKPWNYQIDYFGVAATVYCMLFGTY--- 283

Query: 620 SSMRLAAESATFENFIDRNLKGKFSESEAAKLGKMALVCTHEDPENRPTMEAVIEEL 676
               +  ++   E   +   +         +   + L     D  + P+++ + ++L
Sbjct: 284 ----MKVKNEGGECKPEGLFRRLPHLDMWNEFFHVML--NIPDCHHLPSLDLLRQKL 334

>1ozn_A Reticulon 4 receptor; NOGO receptor, MAD, myelination inhibition, OMGP, MAG, NOGO- signal transduction, neuronal regeneration, ligand binding; HET: NDG MAN NAG BMA; 1.52A {Homo sapiens} SCOP: c.10.2.7 PDB: 1p8t_A* 3kj4_A* Length = 285

 Score = 89.3 bits (222), Expect = 9e-20
 Identities = 46/175 (26%), Positives = 70/175 (40%), Gaps = 7/175 (4%)

Query: 87  SLSGLKCLSGLYLHYNSLSGEIPKEI-RNLTELTDLYLDVNNLSGNIPPEI-GSMASLQV 144
           + +GL  L  L L  N+    +       L  L  L+LD   L   + P +   +A+LQ 
Sbjct: 75  AFTGLALLEQLDLSDNAQLRSVDPATFHGLGRLHTLHLDRCGLQ-ELGPGLFRGLAALQY 133

Query: 145 LQLCCNQLTGNIPAQI-GSLKSLSVLTLQHNRLNGGIPDSLGNLGKLKRLDLSFNSLFGT 203
           L L  N L   +P      L +L+ L L  NR++     +   L  L RL L  N +   
Sbjct: 134 LYLQDNALQ-ALPDDTFRDLGNLTHLFLHGNRISSVPERAFRGLHSLDRLLLHQNRVAHV 192

Query: 204 IPESLANNAELLFLDVQNNTLSGIVPSALKRLNG--GFQFQNNPGLCGDGIASLR 256
            P +  +   L+ L +  N LS +   AL  L      +  +NP +C      L 
Sbjct: 193 HPHAFRDLGRLMTLYLFANNLSALPTEALAPLRALQYLRLNDNPWVCDCRARPLW 247

>1ozn_A Reticulon 4 receptor; NOGO receptor, MAD, myelination inhibition, OMGP, MAG, NOGO- signal transduction, neuronal regeneration, ligand binding; HET: NDG MAN NAG BMA; 1.52A {Homo sapiens} SCOP: c.10.2.7 PDB: 1p8t_A* 3kj4_A* Length = 285

 Score = 84.3 bits (209), Expect = 5e-18
 Identities = 42/168 (25%), Positives = 65/168 (38%), Gaps = 7/168 (4%)

Query: 72  NISLQGKGLTGKLSPSLSGLKCLSGLYLHYNSLSGEIPKEI-RNLTELTDLYLDVNNLSG 130
            I L G  ++   + S    + L+ L+LH N L+  I       L  L  L L  N    
Sbjct: 36  RIFLHGNRISHVPAASFRACRNLTILWLHSNVLA-RIDAAAFTGLALLEQLDLSDNAQLR 94

Query: 131 NIPPEI-GSMASLQVLQLCCNQLTGNIPAQI-GSLKSLSVLTLQHNRLNGGIPD-SLGNL 187
           ++ P     +  L  L L    L   +   +   L +L  L LQ N L   +PD +  +L
Sbjct: 95  SVDPATFHGLGRLHTLHLDRCGLQ-ELGPGLFRGLAALQYLYLQDNALQ-ALPDDTFRDL 152

Query: 188 GKLKRLDLSFNSLFGTIPESLANNAELLFLDVQNNTLSGIVPSALKRL 235
           G L  L L  N +      +      L  L +  N ++ + P A + L
Sbjct: 153 GNLTHLFLHGNRISSVPERAFRGLHSLDRLLLHQNRVAHVHPHAFRDL 200

>1ozn_A Reticulon 4 receptor; NOGO receptor, MAD, myelination inhibition, OMGP, MAG, NOGO- signal transduction, neuronal regeneration, ligand binding; HET: NDG MAN NAG BMA; 1.52A {Homo sapiens} SCOP: c.10.2.7 PDB: 1p8t_A* 3kj4_A* Length = 285

 Score = 73.9 bits (182), Expect = 1e-14
 Identities = 36/145 (24%), Positives = 55/145 (37%), Gaps = 5/145 (3%)

Query: 94  LSGLYLHYNSLSGEIPKEIRNLTELTDLYLDVNNLSGNIPPEI-GSMASLQVLQLCCNQL 152
              ++LH N +S       R    LT L+L  N L+  I       +A L+ L L  N  
Sbjct: 34  SQRIFLHGNRISHVPAASFRACRNLTILWLHSNVLA-RIDAAAFTGLALLEQLDLSDNAQ 92

Query: 153 TGNIPAQI-GSLKSLSVLTLQHNRLNGGIPDSLGNLGKLKRLDLSFNSLFGTIPE-SLAN 210
             ++       L  L  L L    L    P     L  L+ L L  N+L   +P+ +  +
Sbjct: 93  LRSVDPATFHGLGRLHTLHLDRCGLQELGPGLFRGLAALQYLYLQDNAL-QALPDDTFRD 151

Query: 211 NAELLFLDVQNNTLSGIVPSALKRL 235
              L  L +  N +S +   A + L
Sbjct: 152 LGNLTHLFLHGNRISSVPERAFRGL 176

>1ozn_A Reticulon 4 receptor; NOGO receptor, MAD, myelination inhibition, OMGP, MAG, NOGO- signal transduction, neuronal regeneration, ligand binding; HET: NDG MAN NAG BMA; 1.52A {Homo sapiens} SCOP: c.10.2.7 PDB: 1p8t_A* 3kj4_A* Length = 285

 Score = 53.1 bits (128), Expect = 8e-08
 Identities = 25/111 (22%), Positives = 46/111 (41%), Gaps = 4/111 (3%)

Query: 126 NNLSGNIPPEIGSMASLQVLQLCCNQLTGNIPAQIGSLKSLSVLTLQHNRLNGGIPDSLG 185
             L   +P  I   A+ Q + L  N+++    A   + ++L++L L  N L      +  
Sbjct: 21  QGLQ-AVPVGI--PAASQRIFLHGNRISHVPAASFRACRNLTILWLHSNVLARIDAAAFT 77

Query: 186 NLGKLKRLDLSFNSLFGTIP-ESLANNAELLFLDVQNNTLSGIVPSALKRL 235
            L  L++LDLS N+   ++   +      L  L +    L  + P   + L
Sbjct: 78  GLALLEQLDLSDNAQLRSVDPATFHGLGRLHTLHLDRCGLQELGPGLFRGL 128

>2vgo_A Serine/threonine-protein kinase 12-A; nucleotide-binding, serine/threonine-protein kinase, ATP-binding, transferase, coiled coil, cell division, kinase; HET: TPO AD5; 1.7A {Xenopus laevis} PDB: 2bfx_A* 2vgp_A* 3ztx_A* 2vrx_A* 2bfy_A* 4af3_A* 3dj6_A* 3d15_A* 3d2i_A* 3d2k_A* 3d14_A* 3dj5_A* 3dj7_A* 3daj_A* 1ol5_A* 1ol7_A* 2x6d_A* 2x6e_A* 2xng_A* 2dwb_A* ... Length = 284

 Score = 89.2 bits (222), Expect = 9e-20
 Identities = 60/272 (22%), Positives = 109/272 (40%), Gaps = 43/272 (15%)

Query: 416 LLGKGNFSSVYKGTLRD-GTLVAIRSINVTSCKSE--EAEFVKGLY----LLTSLRHENI 468
            LGKG F +VY    +    ++A++ +     KS+  +      L     + + LRH NI
Sbjct: 21  PLGKGKFGNVYLAREKQNKFIMALKVLF----KSQLEKEGVEHQLRREIEIQSHLRHPNI 76

Query: 469 IRLRGFCCSRGRGECFLIYDFAPKGKLSKYLDQEEGSSNVLDWSTRVSIIIGIAKGIGYL 528
           +R+  +   R R   +L+ +FAP+G+L K L Q+ G  +  +  +  + +  +A  + Y 
Sbjct: 77  LRMYNYFHDRKR--IYLMLEFAPRGELYKEL-QKHGRFD--EQRSA-TFMEELADALHYC 130

Query: 529 HSSEVNKPAIVHRNLSVEKVLIDQQFNPLIADCGLHKLLADDIVFSVLKTS-AAMGYLAP 587
           H  +V     +HR++  E +L+  +    IAD G              +T    + YL P
Sbjct: 131 HERKV-----IHRDIKPENLLMGYKGELKIADFGWSVHAPS----LRRRTMCGTLDYLPP 181

Query: 588 EYVTTGRFTERSDIFAFGVIILQILTGSLVLTSSMRLAAESATFENFIDRNLKGKFS--- 644
           E +      E+ D++  GV+  + L G            +S +      R +        
Sbjct: 182 EMIEGKTHDEKVDLWCAGVLCYEFLVG--------MPPFDSPSHTETHRRIVNVDLKFPP 233

Query: 645 --ESEAAKLGKMALVCTHEDPENRPTMEAVIE 674
                +  L    L      P  R  ++ V+E
Sbjct: 234 FLSDGSKDLISKLLR---YHPPQRLPLKGVME 262

>3oja_A Leucine-rich immune molecule 1; coiled-coil, helix-loop-helix, leucine-rich repeat, protein; HET: NAG MAN; 2.70A {Anopheles gambiae} Length = 487

 Score = 91.8 bits (228), Expect = 1e-19
 Identities = 29/151 (19%), Positives = 54/151 (35%), Gaps = 5/151 (3%)

Query: 87  SLSGLKCLSGLYLHYNSLSGEIPKEIRNLTELTDLYLDVNNLSG-NIPPEIGSMASLQVL 145
           S S  +    +YL  N ++     +    + +  L L +N +   N      S  +L+ L
Sbjct: 115 SCSRGQGKKNIYLANNKITMLRDLDEGCRSRVQYLDLKLNEIDTVNFAELAASSDTLEHL 174

Query: 146 QLCCNQLTGNIPAQIGSLKSLSVLTLQHNRLNGGIPDSLGNLGKLKRLDLSFNSLFGTIP 205
            L  N +  ++  Q+     L  L L  N+L   +     +   +  + L  N L   I 
Sbjct: 175 NLQYNFIY-DVKGQV-VFAKLKTLDLSSNKLAF-MGPEFQSAAGVTWISLRNNKL-VLIE 230

Query: 206 ESLANNAELLFLDVQNNTLSGIVPSALKRLN 236
           ++L  +  L   D++ N             N
Sbjct: 231 KALRFSQNLEHFDLRGNGFHCGTLRDFFSKN 261

>3oja_A Leucine-rich immune molecule 1; coiled-coil, helix-loop-helix, leucine-rich repeat, protein; HET: NAG MAN; 2.70A {Anopheles gambiae} Length = 487

 Score = 89.1 bits (221), Expect = 8e-19
 Identities = 30/159 (18%), Positives = 61/159 (38%), Gaps = 10/159 (6%)

Query: 74  SLQGKGLTGKLSPSLSGLKCLSGLYLHYNSLSGEIPKEIRNLTELTDLYLDVNNLSGNIP 133
            +    L   L+        +  L L  N LS     ++   T+L  L L  N L     
Sbjct: 16  KVTDSSLKQALASLRQSAWNVKELDLSGNPLSQISAADLAPFTKLELLNLSSNVLYE--T 73

Query: 134 PEIGSMASLQVLQLCCNQLTGNIPAQIGSLKSLSVLTLQHNRLNGGIPDSLGNLGKLKRL 193
            ++ S+++L+ L L  N +      ++    S+  L   +N ++  +  S G     K +
Sbjct: 74  LDLESLSTLRTLDLNNNYVQ-----ELLVGPSIETLHAANNNIS-RVSCSRGQ--GKKNI 125

Query: 194 DLSFNSLFGTIPESLANNAELLFLDVQNNTLSGIVPSAL 232
            L+ N +           + + +LD++ N +  +  + L
Sbjct: 126 YLANNKITMLRDLDEGCRSRVQYLDLKLNEIDTVNFAEL 164

>3oja_A Leucine-rich immune molecule 1; coiled-coil, helix-loop-helix, leucine-rich repeat, protein; HET: NAG MAN; 2.70A {Anopheles gambiae} Length = 487

 Score = 88.8 bits (220), Expect = 1e-18
 Identities = 33/181 (18%), Positives = 64/181 (35%), Gaps = 8/181 (4%)

Query: 72  NISLQGKGLTGKLSPSLSGLKCLSGLYLHYNSLSG-EIPKEIRNLTELTDLYLDVNNLSG 130
           NI L    +T            +  L L  N +      +   +   L  L L  N +  
Sbjct: 124 NIYLANNKITMLRDLDEGCRSRVQYLDLKLNEIDTVNFAELAASSDTLEHLNLQYNFIY- 182

Query: 131 NIPPEIGSMASLQVLQLCCNQLTGNIPAQIGSLKSLSVLTLQHNRLNGGIPDSLGNLGKL 190
           ++  ++   A L+ L L  N+L   +  +  S   ++ ++L++N+L   I  +L     L
Sbjct: 183 DVKGQV-VFAKLKTLDLSSNKLA-FMGPEFQSAAGVTWISLRNNKLV-LIEKALRFSQNL 239

Query: 191 KRLDLSFNSL-FGTIPESLANNAELLFLDVQNNTLSGIVPSALKRLNGGFQFQNNPGLCG 249
           +  DL  N    GT+ +  + N  +  +     T+  +     +              C 
Sbjct: 240 EHFDLRGNGFHCGTLRDFFSKNQRVQTVA--KQTVKKLTGQNEEECTVPTLGHYGAYCCE 297

Query: 250 D 250
           D
Sbjct: 298 D 298

>3oja_A Leucine-rich immune molecule 1; coiled-coil, helix-loop-helix, leucine-rich repeat, protein; HET: NAG MAN; 2.70A {Anopheles gambiae} Length = 487

 Score = 87.2 bits (216), Expect = 3e-18
 Identities = 24/142 (16%), Positives = 50/142 (35%), Gaps = 10/142 (7%)

Query: 94  LSGLYLHYNSLSGEIPKEIRNLTELTDLYLDVNNLSGNIPPEIGSMASLQVLQLCCNQLT 153
                +  +SL   +    ++   + +L L  N LS     ++     L++L L  N L 
Sbjct: 12  YKIEKVTDSSLKQALASLRQSAWNVKELDLSGNPLSQISAADLAPFTKLELLNLSSNVLY 71

Query: 154 GNIPAQIGSLKSLSVLTLQHNRLNGGIPDSLGNLGKLKRLDLSFNSLFGTIPESLANNAE 213
                 + SL +L  L L +N +       L     ++ L  + N++   +  S      
Sbjct: 72  -ETLD-LESLSTLRTLDLNNNYVQ-----ELLVGPSIETLHAANNNI-SRVSCSRGQG-- 121

Query: 214 LLFLDVQNNTLSGIVPSALKRL 235
              + + NN ++ +        
Sbjct: 122 KKNIYLANNKITMLRDLDEGCR 143

>3oja_A Leucine-rich immune molecule 1; coiled-coil, helix-loop-helix, leucine-rich repeat, protein; HET: NAG MAN; 2.70A {Anopheles gambiae} Length = 487

 Score = 81.8 bits (202), Expect = 2e-16
 Identities = 28/128 (21%), Positives = 49/128 (38%), Gaps = 7/128 (5%)

Query: 108 IPKEIRNLTELTDLYLDVNNLSGNIPPEIGSMASLQVLQLCCNQLTGNIPAQIGSLKSLS 167
           I +  +N        +  ++L   +     S  +++ L L  N L+    A +     L 
Sbjct: 2   IHEIKQNGNRYKIEKVTDSSLKQALASLRQSAWNVKELDLSGNPLSQISAADLAPFTKLE 61

Query: 168 VLTLQHNRLNGGIPDSLGNLGKLKRLDLSFNSLFGTIPESLANNAELLFLDVQNNTLSGI 227
           +L L  N L     D L +L  L+ LDL+ N +     + L     +  L   NN +S +
Sbjct: 62  LLNLSSNVLY-ETLD-LESLSTLRTLDLNNNYV-----QELLVGPSIETLHAANNNISRV 114

Query: 228 VPSALKRL 235
             S  +  
Sbjct: 115 SCSRGQGK 122

>3oja_A Leucine-rich immune molecule 1; coiled-coil, helix-loop-helix, leucine-rich repeat, protein; HET: NAG MAN; 2.70A {Anopheles gambiae} Length = 487

 Score = 74.5 bits (183), Expect = 4e-14
 Identities = 26/159 (16%), Positives = 47/159 (29%), Gaps = 6/159 (3%)

Query: 86  PSLSGLKCLSGLYLHYNSLSGEIPKEIRNLTELTDLYLDVNNLSGNIPPEIGSMASLQVL 145
                   L  L L  N L+  +  E ++   +T + L  N L   I   +    +L+  
Sbjct: 185 KGQVVFAKLKTLDLSSNKLA-FMGPEFQSAAGVTWISLRNNKLV-LIEKALRFSQNLEHF 242

Query: 146 QLCCNQLTGNIPAQIGSLKSLSVLTLQHNRLNGGIPDSLGNLGKLKRLDLSFNSLFGTIP 205
            L  N        +    K+  V T+    +      +                    +P
Sbjct: 243 DLRGNGFHCGTL-RDFFSKNQRVQTVAKQTVKKLTGQNEEECTVPTLGHYGAYCC-EDLP 300

Query: 206 ESLANNAELLFLDVQNNTLSGIVPSALKRLNGGFQFQNN 244
              A+   L+ L  + + L     S  +RL    + Q  
Sbjct: 301 APFADR--LIALKRKEHALLSGQGSETERLECERENQAR 337

>3oja_A Leucine-rich immune molecule 1; coiled-coil, helix-loop-helix, leucine-rich repeat, protein; HET: NAG MAN; 2.70A {Anopheles gambiae} Length = 487

 Score = 73.3 bits (180), Expect = 8e-14
 Identities = 21/158 (13%), Positives = 39/158 (24%), Gaps = 6/158 (3%)

Query: 83  KLSPSLSGLKCLSGLYLHYNSLSGEIPKEIRNLTELTDLYLDVNNLSGNIPPEIGSMASL 142
            + P       ++ + L  N L   I K +R    L    L  N        +  S  + 
Sbjct: 205 FMGPEFQSAAGVTWISLRNNKLV-LIEKALRFSQNLEHFDLRGNGFHCGTLRDFFS-KNQ 262

Query: 143 QVLQLCCNQLTGNIPAQIGSLKSLSVLTLQHNRLNGGIPDSLGNLGKLKRLDLSFNSL-- 200
           +V  +    +              ++                  L  LKR + +  S   
Sbjct: 263 RVQTVAKQTVKKLTGQNEEECTVPTLGHYGAYCCEDLPAPFADRLIALKRKEHALLSGQG 322

Query: 201 --FGTIPESLANNAELLFLDVQNNTLSGIVPSALKRLN 236
                +     N A    +D        ++     R  
Sbjct: 323 SETERLECERENQARQREIDALKEQYRTVIDQVTLRKQ 360

>3oja_A Leucine-rich immune molecule 1; coiled-coil, helix-loop-helix, leucine-rich repeat, protein; HET: NAG MAN; 2.70A {Anopheles gambiae} Length = 487

 Score = 66.4 bits (162), Expect = 1e-11
 Identities = 21/102 (20%), Positives = 44/102 (43%), Gaps = 3/102 (2%)

Query: 136 IGSMASLQVLQLCCNQLTGNIPAQIGSLKSLSVLTLQHNRLNGGIPDSLGNLGKLKRLDL 195
             +    ++ ++  + L   + +   S  ++  L L  N L+      L    KL+ L+L
Sbjct: 6   KQNGNRYKIEKVTDSSLKQALASLRQSAWNVKELDLSGNPLSQISAADLAPFTKLELLNL 65

Query: 196 SFNSLFGTIPESLANNAELLFLDVQNNTLSGIVP-SALKRLN 236
           S N L       L + + L  LD+ NN +  ++   +++ L+
Sbjct: 66  SSNVL--YETLDLESLSTLRTLDLNNNYVQELLVGPSIETLH 105

>3oja_A Leucine-rich immune molecule 1; coiled-coil, helix-loop-helix, leucine-rich repeat, protein; HET: NAG MAN; 2.70A {Anopheles gambiae} Length = 487

 Score = 46.4 bits (110), Expect = 3e-05
 Identities = 12/57 (21%), Positives = 22/57 (38%)

Query: 179 GIPDSLGNLGKLKRLDLSFNSLFGTIPESLANNAELLFLDVQNNTLSGIVPSALKRL 235
            I +   N  + K   ++ +SL   +     +   +  LD+  N LS I  + L   
Sbjct: 1   AIHEIKQNGNRYKIEKVTDSSLKQALASLRQSAWNVKELDLSGNPLSQISAADLAPF 57

>3oja_A Leucine-rich immune molecule 1; coiled-coil, helix-loop-helix, leucine-rich repeat, protein; HET: NAG MAN; 2.70A {Anopheles gambiae} Length = 487

 Score = 45.6 bits (108), Expect = 4e-05
 Identities = 16/146 (10%), Positives = 35/146 (23%), Gaps = 2/146 (1%)

Query: 78  KGLTGKLSPSLSGLKCLSGLYLHYNSLSGEIPKEIRNLTELTDLYLDV-NNLSGNIPPEI 136
           K LTG+     +              L       +  L       L    + +  +  E 
Sbjct: 273 KKLTGQNEEECTVPTLGHYGAYCCEDLPAPFADRLIALKRKEHALLSGQGSETERLECER 332

Query: 137 GSMASLQVLQLCCNQLTGNIPAQIGSLKSLSVLTLQHNRLNGGIPDSLGNLGKLKRLDLS 196
            + A  + +     Q    I       ++   L  +   L+  + +      +L      
Sbjct: 333 ENQARQREIDALKEQYRTVIDQVTLRKQAKITLEQKKKALDEQVSNGRRAHAELDGTLQQ 392

Query: 197 FNSLFGTIPESLANNAELLFLDVQNN 222
                  +  +    + L  L     
Sbjct: 393 AVGQ-IELQHATEEQSPLQLLRAIVK 417

>2owb_A Serine/threonine-protein kinase PLK1; catalytic domain, POLO-like kinase1, transfera; HET: 626; 2.10A {Homo sapiens} PDB: 2ou7_A* 3fc2_A* 3thb_A* Length = 335

 Score = 89.7 bits (223), Expect = 1e-19
 Identities = 52/271 (19%), Positives = 105/271 (38%), Gaps = 39/271 (14%)

Query: 416 LLGKGNFSSVYKGT-LRDGTLVAIRSINVTSCKSEEAE--FVKGLYLLTSLRHENIIRLR 472
            LGKG F+  ++ +      + A + +  +              + +  SL H++++   
Sbjct: 48  FLGKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQREKMSMEISIHRSLAHQHVVGFH 107

Query: 473 GFCCSRGRGECFLIYDFAPKGKLSKYLDQEEGSSNVLDWSTRVSIIIGIAKGIGYLHSSE 532
           GF         F++ +   +  L +   +   +  + +   R   +  I  G  YLH + 
Sbjct: 108 GFFEDNDF--VFVVLELCRRRSLLELH-KRRKA--LTEPEAR-YYLRQIVLGCQYLHRNR 161

Query: 533 VNKPAIVHRNLSVEKVLIDQQFNPLIADCGLHKLLADDIVFSVLKTSAAMG---YLAPEY 589
           V     +HR+L +  + +++     I D GL   +  D      K     G   Y+APE 
Sbjct: 162 V-----IHRDLKLGNLFLNEDLEVKIGDFGLATKVEYDGER--KKVLC--GTPNYIAPEV 212

Query: 590 VTTGRFTERSDIFAFGVIILQILTGSLVLTSSMRLAAESATFENFIDRNLKGKFSE---- 645
           ++    +   D+++ G I+  +L G        +   E++  +    R  K ++S     
Sbjct: 213 LSKKGHSFEVDVWSIGCIMYTLLVG--------KPPFETSCLKETYLRIKKNEYSIPKHI 264

Query: 646 SEAAK--LGKMALVCTHEDPENRPTMEAVIE 674
           +  A   + KM L     DP  RPT+  ++ 
Sbjct: 265 NPVAASLIQKM-LQ---TDPTARPTINELLN 291

>3cvr_A Invasion plasmid antigen; leucine rich repeat and alpha fold, ligase; 2.80A {Shigella flexneri 2A} Length = 571

 Score = 91.6 bits (227), Expect = 2e-19
 Identities = 39/153 (25%), Positives = 70/153 (45%), Gaps = 21/153 (13%)

Query: 86  PSLSGLKCLSGLYLHYNSLSGEIPKEIRNLTELTDLYLDVNNLSGNIPPEIGSMASLQVL 145
                +   S L L+  +LS  +P  +    ++T L +  N L  ++P       SL+ L
Sbjct: 53  LKECLINQFSELQLNRLNLS-SLPDNL--PPQITVLEITQNALI-SLPELPA---SLEYL 105

Query: 146 QLCCNQLTGNIPAQIGSLKSLSVLTLQHNRLNGGIPDSLGNLGKLKRLDLSFNSLFGTIP 205
             C N+L+  +P    SLK L    + +N+L   +P+       L+ ++   N L   +P
Sbjct: 106 DACDNRLS-TLPELPASLKHLD---VDNNQLT-MLPELPAL---LEYINADNNQL-TMLP 156

Query: 206 ESLANNAELLFLDVQNNTLSGI--VPSALKRLN 236
           E   +   L  L V+NN L+ +  +P +L+ L+
Sbjct: 157 ELPTS---LEVLSVRNNQLTFLPELPESLEALD 186

>3cvr_A Invasion plasmid antigen; leucine rich repeat and alpha fold, ligase; 2.80A {Shigella flexneri 2A} Length = 571

 Score = 76.2 bits (187), Expect = 1e-14
 Identities = 24/135 (17%), Positives = 45/135 (33%), Gaps = 15/135 (11%)

Query: 94  LSGLYLHYNSLSGEIPKEIRNLTELTDLYLDVNNLSGNIPPEIGSMASLQVLQLCCNQLT 153
           L  +    N L+  +P+   +L  L    +  N L+  +P    S   L+ L +  N L 
Sbjct: 142 LEYINADNNQLT-MLPELPTSLEVL---SVRNNQLTF-LPELPES---LEALDVSTNLLE 193

Query: 154 GNIPAQIGSLKSLS----VLTLQHNRLNGGIPDSLGNLGKLKRLDLSFNSLFGTIPESLA 209
            ++PA                 + NR+   IP+++ +L     + L  N L  +      
Sbjct: 194 -SLPAVPVRNHHSEETEIFFRCRENRIT-HIPENILSLDPTCTIILEDNPL-SSRIRESL 250

Query: 210 NNAELLFLDVQNNTL 224
           +              
Sbjct: 251 SQQTAQPDYHGPRIY 265

>3cvr_A Invasion plasmid antigen; leucine rich repeat and alpha fold, ligase; 2.80A {Shigella flexneri 2A} Length = 571

 Score = 72.7 bits (178), Expect = 2e-13
 Identities = 35/143 (24%), Positives = 62/143 (43%), Gaps = 18/143 (12%)

Query: 99  LHYNSLSG---EIPKEIRNLTELTDLYLDVNNLSGNIPPEIGSMASLQVLQLCCNQLTGN 155
             YN++SG   +         +      + N    ++  E   +     LQL    L+ +
Sbjct: 17  SFYNTISGTYADYFSAWDKWEKQALPGENRNEAV-SLLKEC-LINQFSELQLNRLNLS-S 73

Query: 156 IPAQIGSLKSLSVLTLQHNRLNGGIPDSLGNLGKLKRLDLSFNSLFGTIPESLANNAELL 215
           +P  +     ++VL +  N L   +P+   +L   + LD   N L  T+PE  A+   L 
Sbjct: 74  LPDNLP--PQITVLEITQNAL-ISLPELPASL---EYLDACDNRL-STLPELPAS---LK 123

Query: 216 FLDVQNNTLSGI--VPSALKRLN 236
            LDV NN L+ +  +P+ L+ +N
Sbjct: 124 HLDVDNNQLTMLPELPALLEYIN 146

>2rku_A Serine/threonine-protein kinase PLK1; structure of PLK1, selectivity residues, POLO-like K structure based drug design, ATP-binding; HET: R78 TLA SRT TAR; 1.95A {Homo sapiens} PDB: 2v5q_A 2yac_A* 4a4l_A* 4a4o_A* 3kb7_A* 3d5w_A* 3d5u_A* 3d5v_A 3db8_A* 3dbc_A* 3dbd_A* 3d5x_A* 3db6_A* 3dbe_A* 3dbf_A* Length = 294

 Score = 88.4 bits (220), Expect = 2e-19
 Identities = 52/271 (19%), Positives = 105/271 (38%), Gaps = 39/271 (14%)

Query: 416 LLGKGNFSSVYKGT-LRDGTLVAIRSINVTSCKSEEAE--FVKGLYLLTSLRHENIIRLR 472
            LGKG F+  ++ +      + A + +  +              + +  SL H++++   
Sbjct: 22  FLGKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQREKMSMEISIHRSLAHQHVVGFH 81

Query: 473 GFCCSRGRGECFLIYDFAPKGKLSKYLDQEEGSSNVLDWSTRVSIIIGIAKGIGYLHSSE 532
           GF         F++ +   +  L +   +   +  + +   R   +  I  G  YLH + 
Sbjct: 82  GFFEDNDF--VFVVLELCRRRSLLELH-KRRKA--LTEPEAR-YYLRQIVLGCQYLHRNR 135

Query: 533 VNKPAIVHRNLSVEKVLIDQQFNPLIADCGLHKLLADDIVFSVLKTSAAMG---YLAPEY 589
           V     +HR+L +  + +++     I D GL   +  D      K     G   Y+APE 
Sbjct: 136 V-----IHRDLKLGNLFLNEDLEVKIGDFGLATKVEYDGER--KKVLC--GTPNYIAPEV 186

Query: 590 VTTGRFTERSDIFAFGVIILQILTGSLVLTSSMRLAAESATFENFIDRNLKGKFSE---- 645
           ++    +   D+++ G I+  +L G        +   E++  +    R  K ++S     
Sbjct: 187 LSKKGHSFEVDVWSIGCIMYTLLVG--------KPPFETSCLKETYLRIKKNEYSIPKHI 238

Query: 646 SEAAK--LGKMALVCTHEDPENRPTMEAVIE 674
           +  A   + KM L     DP  RPT+  ++ 
Sbjct: 239 NPVAASLIQKM-LQ---TDPTARPTINELLN 265

>2pml_X PFPK7, Ser/Thr protein kinase; phosphorylati transferase, transferase; HET: ANP; 2.60A {Plasmodium falciparum} PDB: 2pmn_X* 2pmo_X* Length = 348

 Score = 89.4 bits (222), Expect = 2e-19
 Identities = 40/301 (13%), Positives = 99/301 (32%), Gaps = 60/301 (19%)

Query: 417 LGKGNFSSVYKGTLRDGTLVAIRSIN------------VTSCKSEEAEFVKGLY----LL 460
           L +G F+ +     +D    A++                 + K               ++
Sbjct: 39  LNQGKFNKIILCE-KDNKFYALKKYEKSLLEKKRDFTKSNNDKISIKSKYDDFKNELQII 97

Query: 461 TSLRHENIIRLRGFCCSRGRGECFLIYDFAPKGKLSKYLDQ----EEGSSNVLDWSTRVS 516
           T +++E  +   G   +      ++IY++     + K+ +     ++  +  +       
Sbjct: 98  TDIKNEYCLTCEGIITNYDE--VYIIYEYMENDSILKFDEYFFVLDKNYTCFIPIQVIKC 155

Query: 517 IIIGIAKGIGYLHSSEVNKPAIVHRNLSVEKVLIDQQFNPLIADCGLHKLLADDIVFSVL 576
           II  +     Y+H+    +  I HR++    +L+D+     ++D G  + + D      +
Sbjct: 156 IIKSVLNSFSYIHN----EKNICHRDVKPSNILMDKNGRVKLSDFGESEYMVD----KKI 207

Query: 577 KTSAAMG---YLAPEYVTTGRFT--ERSDIFAFGVIILQILTGSL--------------V 617
           K S   G   ++ PE+ +        + DI++ G+ +  +    +              +
Sbjct: 208 KGS--RGTYEFMPPEFFSNESSYNGAKVDIWSLGICLYVMFYNVVPFSLKISLVELFNNI 265

Query: 618 LTSSMRLAAESATFENFIDRNLKGKFSE--SEAAK--LGKMALVCTHEDPENRPTMEAVI 673
            T ++    +   F   +        +   S      L          +P  R T E  +
Sbjct: 266 RTKNIEYPLDRNHFLYPLTNKKSTCSNNFLSNEDIDFLKLFLRK----NPAERITSEDAL 321

Query: 674 E 674
           +
Sbjct: 322 K 322

>2rio_A Serine/threonine-protein kinase/endoribonuclease IRE1; protein-nucleotide complex, ATP-binding, endoplasmic reticulum, glycoprotein; HET: ADP; 2.40A {Saccharomyces cerevisiae} PDB: 3lj0_A* 3lj1_A* 3lj2_A* 3fbv_A* 3sdm_A* 3sdj_A* Length = 434

 Score = 90.2 bits (224), Expect = 2e-19
 Identities = 64/291 (21%), Positives = 103/291 (35%), Gaps = 47/291 (16%)

Query: 415 NLLGKGNFSSVYKGTLRDGTLVAIRSINVTSCKSEEAEFVKGLYLLTSLRHENIIRLRGF 474
            +LG G+  +V       G  VA++ + +  C     E +K   L  S  H N+IR   +
Sbjct: 21  KILGYGSSGTVVFQGSFQGRPVAVKRMLIDFCDIALME-IK--LLTESDDHPNVIRY--Y 75

Query: 475 CCSRGRGECFLIYDFAPKGKLSKYLDQEEGSSNVLDWSTR---VSIIIGIAKGIGYLHSS 531
           C        ++  +      L   ++ +  S   L        +S++  IA G+ +LHS 
Sbjct: 76  CSETTDRFLYIALELCN-LNLQDLVESKNVSDENLKLQKEYNPISLLRQIASGVAHLHS- 133

Query: 532 EVNKPAIVHRNLSVEKVLID-------------QQFNPLIADCGLHKLLADDIVFSVLKT 578
              K  I+HR+L  + +L+              +    LI+D GL K L           
Sbjct: 134 --LK--IIHRDLKPQNILVSTSSRFTADQQTGAENLRILISDFGLCKKLDSGQSSFRTNL 189

Query: 579 SAAMG---YLAPE-------YVTTGRFTERSDIFAFGVIILQILTGSLVLTSSMRLAAES 628
           +   G   + APE         T  R T   DIF+ G +   IL+         + + ES
Sbjct: 190 NNPSGTSGWRAPELLEESNNLQTKRRLTRSIDIFSMGCVFYYILSKGKHPFGD-KYSRES 248

Query: 629 ATFE---NFIDRNLKGKFSESEAAKLGKMALV--CTHEDPENRPTMEAVIE 674
                  +  +       S    A      L+      DP  RPT   V+ 
Sbjct: 249 NIIRGIFSLDEMKCLHDRSLIAEAT----DLISQMIDHDPLKRPTAMKVLR 295

>3cok_A Serine/threonine-protein kinase PLK4; POLO-like kinase 4, SAK, STK18, PSI, structural genomics, protein structure initiative; HET: ANP; 2.25A {Homo sapiens} Length = 278

 Score = 88.0 bits (219), Expect = 2e-19
 Identities = 62/274 (22%), Positives = 120/274 (43%), Gaps = 44/274 (16%)

Query: 416 LLGKGNFSSVYKGT-LRDGTLVAIRSINVTSCKSE--EAEFVKGLY----LLTSLRHENI 468
           LLGKG+F+ VY+   +  G  VAI+ I+    K    +A  V+ +     +   L+H +I
Sbjct: 18  LLGKGSFAGVYRAESIHTGLEVAIKMID----KKAMYKAGMVQRVQNEVKIHCQLKHPSI 73

Query: 469 IRLRGFCCSRGRGECFLIYDFAPKGKLSKYLDQEEGSSNVLDWSTRVSIIIGIAKGIGYL 528
           + L  +         +L+ +    G++++YL          +   R   +  I  G+ YL
Sbjct: 74  LELYNYFEDSNY--VYLVLEMCHNGEMNRYLKNRVKP--FSENEAR-HFMHQIITGMLYL 128

Query: 529 HSSEVNKPAIVHRNLSVEKVLIDQQFNPLIADCGL-HKLLADDIVFSVLKTS-AAMGYLA 586
           HS  +     +HR+L++  +L+ +  N  IAD GL  +L           T      Y++
Sbjct: 129 HSHGI-----LHRDLTLSNLLLTRNMNIKIADFGLATQLKMPH---EKHYTLCGTPNYIS 180

Query: 587 PEYVTTGRFTERSDIFAFGVIILQILTGSLVLTSSMRLAAESATFENFIDRNLKGKFSE- 645
           PE  T       SD+++ G +   +L G        R   ++ T +N +++ +   +   
Sbjct: 181 PEIATRSAHGLESDVWSLGCMFYTLLIG--------RPPFDTDTVKNTLNKVVLADYEMP 232

Query: 646 ---SEAAK--LGKMALVCTHEDPENRPTMEAVIE 674
              S  AK  + ++ L     +P +R ++ +V++
Sbjct: 233 SFLSIEAKDLIHQL-LR---RNPADRLSLSSVLD 262

>4ezg_A Putative uncharacterized protein; internalin-A, leucine-rich repeat protein, structural genomi center for structural genomics, JCSG; HET: MSE; 1.50A {Listeria monocytogenes} Length = 197

 Score = 85.8 bits (213), Expect = 2e-19
 Identities = 31/151 (20%), Positives = 69/151 (45%), Gaps = 6/151 (3%)

Query: 87  SLSGLKCLSGLYLHYNSLSGEIPKEIRNLTELTDLYLDVNNLSGNIPPEIGSMASLQVLQ 146
           + + +  L+ + L   +++ ++   I     + DL ++  + + N  P I  +++L+ L+
Sbjct: 39  TEAQMNSLTYITLANINVT-DL-TGIEYAHNIKDLTINNIHAT-NYNP-ISGLSNLERLR 94

Query: 147 LCCNQLTGNIPAQIGSLKSLSVLTLQHNRLNGGIPDSLGNLGKLKRLDLSFNSLFGTIPE 206
           +    +T +    +  L SL++L + H+  +  I   +  L K+  +DLS+N     I  
Sbjct: 95  IMGKDVTSDKIPNLSGLTSLTLLDISHSAHDDSILTKINTLPKVNSIDLSYNGAITDI-M 153

Query: 207 SLANNAELLFLDVQNNTLSGIVP-SALKRLN 236
            L    EL  L++Q + +          +LN
Sbjct: 154 PLKTLPELKSLNIQFDGVHDYRGIEDFPKLN 184

>4ezg_A Putative uncharacterized protein; internalin-A, leucine-rich repeat protein, structural genomi center for structural genomics, JCSG; HET: MSE; 1.50A {Listeria monocytogenes} Length = 197

 Score = 85.8 bits (213), Expect = 2e-19
 Identities = 29/156 (18%), Positives = 65/156 (41%), Gaps = 7/156 (4%)

Query: 72  NISLQGKGLTGKLSPSLSGLKCLSGLYLHYNSLSGEIPKEIRNLTELTDLYLDVNNLSGN 131
            I+L    +T  L+  +     +  L ++    +      I  L+ L  L +   +++ +
Sbjct: 48  YITLANINVT-DLTG-IEYAHNIKDLTINNIHATN--YNPISGLSNLERLRIMGKDVTSD 103

Query: 132 IPPEIGSMASLQVLQLCCNQLTGNIPAQIGSLKSLSVLTLQHNRLNGGIPDSLGNLGKLK 191
             P +  + SL +L +  +    +I  +I +L  ++ + L +N     I   L  L +LK
Sbjct: 104 KIPNLSGLTSLTLLDISHSAHDDSILTKINTLPKVNSIDLSYNGAITDI-MPLKTLPELK 162

Query: 192 RLDLSFNSLFGTIPESLANNAELLFLDVQNNTLSGI 227
            L++ F+ +       + +  +L  L   + T+ G 
Sbjct: 163 SLNIQFDGV--HDYRGIEDFPKLNQLYAFSQTIGGK 196

>2z63_A TOLL-like receptor 4, variable lymphocyte recepto; TLR4, MD-2, LPS, immune system; HET: NAG FUL; 2.00A {Homo sapiens} Length = 570

 Score = 90.9 bits (226), Expect = 3e-19
 Identities = 37/155 (23%), Positives = 54/155 (34%), Gaps = 5/155 (3%)

Query: 85  SPSLSGLKCLSGLYLHYNSLSGEIPKEIRNLTELTDLYLDVNNLSGNIPPEI--GSMASL 142
           S S  G   L  L L +N +   +      L +L  L    +NL   +       S+ +L
Sbjct: 366 SQSDFGTTSLKYLDLSFNGVI-TMSSNFLGLEQLEHLDFQHSNLK-QMSEFSVFLSLRNL 423

Query: 143 QVLQLCCNQLTGNIPAQIGSLKSLSVLTLQHNRLNGGI-PDSLGNLGKLKRLDLSFNSLF 201
             L +               L SL VL +  N       PD    L  L  LDLS   L 
Sbjct: 424 IYLDISHTHTRVAFNGIFNGLSSLEVLKMAGNSFQENFLPDIFTELRNLTFLDLSQCQLE 483

Query: 202 GTIPESLANNAELLFLDVQNNTLSGIVPSALKRLN 236
              P +  + + L  L++ +N L  +      RL 
Sbjct: 484 QLSPTAFNSLSSLQVLNMASNQLKSVPDGIFDRLT 518

>2z63_A TOLL-like receptor 4, variable lymphocyte recepto; TLR4, MD-2, LPS, immune system; HET: NAG FUL; 2.00A {Homo sapiens} Length = 570

 Score = 88.2 bits (219), Expect = 2e-18
 Identities = 39/178 (21%), Positives = 59/178 (33%), Gaps = 12/178 (6%)

Query: 64  CNEHRKVANISLQGKGLT---GKLSPSLSGLKCLSGLYLHYNSLSGEIPKEIRNLTELTD 120
           C E                    L  S   L       L +N L         +  EL  
Sbjct: 3   CVEVVPNITYQCMELNFYKIPDNLPFSTKNL------DLSFNPLRHLGSYSFFSFPELQV 56

Query: 121 LYLDVNNLSGNIPPE-IGSMASLQVLQLCCNQLTGNIPAQIGSLKSLSVLTLQHNRLNGG 179
           L L    +   I      S++ L  L L  N +          L SL  L      L   
Sbjct: 57  LDLSRCEIQ-TIEDGAYQSLSHLSTLILTGNPIQSLALGAFSGLSSLQKLVAVETNLASL 115

Query: 180 IPDSLGNLGKLKRLDLSFNSL-FGTIPESLANNAELLFLDVQNNTLSGIVPSALKRLN 236
               +G+L  LK L+++ N +    +PE  +N   L  LD+ +N +  I  + L+ L+
Sbjct: 116 ENFPIGHLKTLKELNVAHNLIQSFKLPEYFSNLTNLEHLDLSSNKIQSIYCTDLRVLH 173

>2z63_A TOLL-like receptor 4, variable lymphocyte recepto; TLR4, MD-2, LPS, immune system; HET: NAG FUL; 2.00A {Homo sapiens} Length = 570

 Score = 87.8 bits (218), Expect = 3e-18
 Identities = 32/153 (20%), Positives = 61/153 (39%), Gaps = 5/153 (3%)

Query: 73  ISLQGKGLTGKLSPSLSGLKCLSGLYLHYNSLSGEIPKEI-RNLTELTDLYLDVNNLSGN 131
           + L   G+   +S +  GL+ L  L   +++L       +  +L  L  L +   +    
Sbjct: 378 LDLSFNGVI-TMSSNFLGLEQLEHLDFQHSNLKQMSEFSVFLSLRNLIYLDISHTHTR-V 435

Query: 132 IPPEI-GSMASLQVLQLCCNQLTGNIPAQI-GSLKSLSVLTLQHNRLNGGIPDSLGNLGK 189
               I   ++SL+VL++  N    N    I   L++L+ L L   +L    P +  +L  
Sbjct: 436 AFNGIFNGLSSLEVLKMAGNSFQENFLPDIFTELRNLTFLDLSQCQLEQLSPTAFNSLSS 495

Query: 190 LKRLDLSFNSLFGTIPESLANNAELLFLDVQNN 222
           L+ L+++ N L             L  + +  N
Sbjct: 496 LQVLNMASNQLKSVPDGIFDRLTSLQKIWLHTN 528

>2z63_A TOLL-like receptor 4, variable lymphocyte recepto; TLR4, MD-2, LPS, immune system; HET: NAG FUL; 2.00A {Homo sapiens} Length = 570

 Score = 85.5 bits (212), Expect = 1e-17
 Identities = 36/149 (24%), Positives = 55/149 (36%), Gaps = 6/149 (4%)

Query: 87  SLSGLKCLSGLYLHYNSLSGEIPKEIRNLTELTDLYLDVNNLSGNIPPEIGSMASLQVLQ 146
           +   L  LS L L  N +          L+ L  L     NL+      IG + +L+ L 
Sbjct: 71  AYQSLSHLSTLILTGNPIQSLALGAFSGLSSLQKLVAVETNLASLENFPIGHLKTLKELN 130

Query: 147 LCCNQLT-GNIPAQIGSLKSLSVLTLQHNRLNGGIPDSLGNLGKLK----RLDLSFNSLF 201
           +  N +    +P    +L +L  L L  N++       L  L ++      LDLS N + 
Sbjct: 131 VAHNLIQSFKLPEYFSNLTNLEHLDLSSNKIQSIYCTDLRVLHQMPLLNLSLDLSLNPM- 189

Query: 202 GTIPESLANNAELLFLDVQNNTLSGIVPS 230
             I         L  L ++NN  S  V  
Sbjct: 190 NFIQPGAFKEIRLHKLTLRNNFDSLNVMK 218

>2z63_A TOLL-like receptor 4, variable lymphocyte recepto; TLR4, MD-2, LPS, immune system; HET: NAG FUL; 2.00A {Homo sapiens} Length = 570

 Score = 77.1 bits (190), Expect = 7e-15
 Identities = 29/119 (24%), Positives = 44/119 (36%), Gaps = 1/119 (0%)

Query: 88  LSGLKCLSGLYLHYNSLSGEIPKEIRNLTELTDLYLDVNNLSGNIPPEI-GSMASLQVLQ 146
              L+ L  L + +             L+ L  L +  N+   N  P+I   + +L  L 
Sbjct: 417 FLSLRNLIYLDISHTHTRVAFNGIFNGLSSLEVLKMAGNSFQENFLPDIFTELRNLTFLD 476

Query: 147 LCCNQLTGNIPAQIGSLKSLSVLTLQHNRLNGGIPDSLGNLGKLKRLDLSFNSLFGTIP 205
           L   QL    P    SL SL VL +  N+L          L  L+++ L  N    + P
Sbjct: 477 LSQCQLEQLSPTAFNSLSSLQVLNMASNQLKSVPDGIFDRLTSLQKIWLHTNPWDCSCP 535

>2z63_A TOLL-like receptor 4, variable lymphocyte recepto; TLR4, MD-2, LPS, immune system; HET: NAG FUL; 2.00A {Homo sapiens} Length = 570

 Score = 65.9 bits (161), Expect = 2e-11
 Identities = 37/213 (17%), Positives = 65/213 (30%), Gaps = 18/213 (8%)

Query: 81  TGKLSPSLSGLKCLSGLYLHYNSLSGEIPKEIRNLTELT----DLYLDVNNLSGNIPPEI 136
           + KL    S L  L  L L  N +      ++R L ++      L L +N ++  I P  
Sbjct: 138 SFKLPEYFSNLTNLEHLDLSSNKIQSIYCTDLRVLHQMPLLNLSLDLSLNPMNF-IQPGA 196

Query: 137 GSMASLQVLQLCCNQLTGNIPAQ-IGSLKSLSVLTLQ------HNRLNGGIPDSLGNLGK 189
                L  L L  N  + N+    I  L  L V  L          L      +L  L  
Sbjct: 197 FKEIRLHKLTLRNNFDSLNVMKTCIQGLAGLEVHRLVLGEFRNEGNLEKFDKSALEGLCN 256

Query: 190 L--KRLDLSFNSLFGT-IPESLANNAELLFLDVQNNTLSGIVPSALKRLNGGFQFQNNP- 245
           L  +   L++   +   I +       +    + + T+  +   +        +  N   
Sbjct: 257 LTIEEFRLAYLDYYLDDIIDLFNCLTNVSSFSLVSVTIERVKDFSYNFGWQHLELVNCKF 316

Query: 246 -GLCGDGIASLRACTVYDNTQINPVKPFGSHSN 277
                  + SL+  T   N +           +
Sbjct: 317 GQFPTLKLKSLKRLTFTSN-KGGNAFSEVDLPS 348

>2z63_A TOLL-like receptor 4, variable lymphocyte recepto; TLR4, MD-2, LPS, immune system; HET: NAG FUL; 2.00A {Homo sapiens} Length = 570

 Score = 62.8 bits (153), Expect = 2e-10
 Identities = 38/177 (21%), Positives = 60/177 (33%), Gaps = 25/177 (14%)

Query: 80  LTGKLSPSLSGLKCLSGLYLHYNSLSG---EIPKEIRNLTELTDLYLDVNNLSGNIPPEI 136
           L      +L GL  L+        L     +I      LT ++   L    +   +    
Sbjct: 243 LEKFDKSALEGLCNLTIEEFRLAYLDYYLDDIIDLFNCLTNVSSFSLVSVTIE-RVKDFS 301

Query: 137 G--SMASLQVLQLCCNQLTGNIPAQIGSLKSLSVLTLQHNRLNGGIPDSLGNLGKLKRLD 194
                  L+++     Q           LKSL  LT   N+       S  +L  L+ LD
Sbjct: 302 YNFGWQHLELVNCKFGQFPTL------KLKSLKRLTFTSNKGGNAF--SEVDLPSLEFLD 353

Query: 195 LSFNSL--FGTIPESLANNAELLFLDVQNNTLSGIVP-----SALKRLNGGFQFQNN 244
           LS N L   G   +S      L +LD+  N +  +         L+ L+    FQ++
Sbjct: 354 LSRNGLSFKGCCSQSDFGTTSLKYLDLSFNGVITMSSNFLGLEQLEHLD----FQHS 406

>2z63_A TOLL-like receptor 4, variable lymphocyte recepto; TLR4, MD-2, LPS, immune system; HET: NAG FUL; 2.00A {Homo sapiens} Length = 570

 Score = 62.4 bits (152), Expect = 2e-10
 Identities = 29/98 (29%), Positives = 38/98 (38%), Gaps = 3/98 (3%)

Query: 87  SLSGLKCLSGLYLHYNSLSGEIPKEI-RNLTELTDLYLDVNNLSGNIPPEI-GSMASLQV 144
             +GL  L  L +  NS       +I   L  LT L L    L   + P    S++SLQV
Sbjct: 440 IFNGLSSLEVLKMAGNSFQENFLPDIFTELRNLTFLDLSQCQLEQ-LSPTAFNSLSSLQV 498

Query: 145 LQLCCNQLTGNIPAQIGSLKSLSVLTLQHNRLNGGIPD 182
           L +  NQL          L SL  + L  N  +   P 
Sbjct: 499 LNMASNQLKSVPDGIFDRLTSLQKIWLHTNPWDCSCPR 536

>1zy4_A Serine/threonine-protein kinase GCN2; translation regulator, signal transduction, acid starvation, starvation stress response; 1.95A {Saccharomyces cerevisiae} PDB: 1zy5_A* 1zyd_A* 1zyc_A* 1zxe_A Length = 303

 Score = 87.8 bits (218), Expect = 3e-19
 Identities = 51/230 (22%), Positives = 90/230 (39%), Gaps = 36/230 (15%)

Query: 411 FSEVNLLGKGNFSSVYKGT-LRDGTLVAIRSINVTSCKSEEAEFVKGLYLLTSLRHENII 469
           F E+ +LG+G F  V K     D    AI+ I  T  + + +  +  + LL SL H+ ++
Sbjct: 8   FEEIAVLGQGAFGQVVKARNALDSRYYAIKKIRHT--EEKLSTILSEVMLLASLNHQYVV 65

Query: 470 RLRGFCCSRGRGEC-----------FLIYDFAPKGKLSKYLDQEEGSSNVLDWSTRVSII 518
           R       R                F+  ++   G L   +  E  +           + 
Sbjct: 66  RYYAAWLERRNFVKPMTAVKKKSTLFIQMEYCENGTLYDLIHSENLNQQR---DEYWRLF 122

Query: 519 IGIAKGIGYLHSSEVNKPAIVHRNLSVEKVLIDQQFNPLIADCGLHKLLADDIVFSVLKT 578
             I + + Y+HS       I+HR+L    + ID+  N  I D GL K +   +    L +
Sbjct: 123 RQILEALSYIHS---QG--IIHRDLKPMNIFIDESRNVKIGDFGLAKNVHRSLDILKLDS 177

Query: 579 SAAMG-------------YLAPEYVT-TGRFTERSDIFAFGVIILQILTG 614
               G             Y+A E +  TG + E+ D+++ G+I  +++  
Sbjct: 178 QNLPGSSDNLTSAIGTAMYVATEVLDGTGHYNEKIDMYSLGIIFFEMIYP 227

>3zyi_A Leucine-rich repeat-containing protein 4; cell adhesion, LRRC4 complex, synapse; HET: NAG; 2.60A {Homo sapiens} PDB: 3zyo_A* 3zyn_A* 2dl9_A Length = 452

 Score = 89.8 bits (223), Expect = 3e-19
 Identities = 37/175 (21%), Positives = 60/175 (34%), Gaps = 7/175 (4%)

Query: 87  SLSGLKCLSGLYLHYNSLSGEIPKEI-RNLTELTDLYLDVNNLSGNIPPEI-GSMASLQV 144
           +   L  L  L+L  N +   IP      +  L  L L        I       + +L+ 
Sbjct: 142 AFEYLSKLRELWLRNNPIE-SIPSYAFNRVPSLMRLDLGELKKLEYISEGAFEGLFNLKY 200

Query: 145 LQLCCNQLTGNIPAQIGSLKSLSVLTLQHNRLNGGIPDSLGNLGKLKRLDLSFNSLFGTI 204
           L L    +  ++P  +  L  L  L +  N      P S   L  LK+L +  + +    
Sbjct: 201 LNLGMCNIK-DMPN-LTPLVGLEELEMSGNHFPEIRPGSFHGLSSLKKLWVMNSQVSLIE 258

Query: 205 PESLANNAELLFLDVQNNTLSGIVPSALKRLNG--GFQFQNNPGLCGDGIASLRA 257
             +    A L+ L++ +N LS +       L         +NP  C   I  L  
Sbjct: 259 RNAFDGLASLVELNLAHNNLSSLPHDLFTPLRYLVELHLHHNPWNCDCDILWLAW 313

>3zyi_A Leucine-rich repeat-containing protein 4; cell adhesion, LRRC4 complex, synapse; HET: NAG; 2.60A {Homo sapiens} PDB: 3zyo_A* 3zyn_A* 2dl9_A Length = 452

 Score = 71.7 bits (176), Expect = 3e-13
 Identities = 38/190 (20%), Positives = 68/190 (35%), Gaps = 19/190 (10%)

Query: 44  LLQSWTENGDPCSGSFEGIACNEHRKVANISLQGKGLT---GKLSPSLSGLKCLSGLYLH 100
           +  + +     C        C+   + + +    +GL+     +  +   L       L 
Sbjct: 35  IAAAASAGPQNCPS-----VCSCSNQFSKVVCTRRGLSEVPQGIPSNTRYL------NLM 83

Query: 101 YNSLSGEIPKEIRNLTELTDLYLDVNNLSGNIPPEI-GSMASLQVLQLCCNQLTGNIPAQ 159
            N++        R+L  L  L L  N++   I       +ASL  L+L  N LT  IP+ 
Sbjct: 84  ENNIQMIQADTFRHLHHLEVLQLGRNSIR-QIEVGAFNGLASLNTLELFDNWLT-VIPSG 141

Query: 160 I-GSLKSLSVLTLQHNRLNGGIPDSLGNLGKLKRLDLSFNSLFGTIPE-SLANNAELLFL 217
               L  L  L L++N +      +   +  L RLDL        I E +      L +L
Sbjct: 142 AFEYLSKLRELWLRNNPIESIPSYAFNRVPSLMRLDLGELKKLEYISEGAFEGLFNLKYL 201

Query: 218 DVQNNTLSGI 227
           ++    +  +
Sbjct: 202 NLGMCNIKDM 211

>3zyi_A Leucine-rich repeat-containing protein 4; cell adhesion, LRRC4 complex, synapse; HET: NAG; 2.60A {Homo sapiens} PDB: 3zyo_A* 3zyn_A* 2dl9_A Length = 452

 Score = 62.8 bits (153), Expect = 2e-10
 Identities = 26/119 (21%), Positives = 44/119 (36%), Gaps = 3/119 (2%)

Query: 117 ELTDLYLDVNNLSGNIPPEIGSMASLQVLQLCCNQLTGNIPAQIGSLKSLSVLTLQHNRL 176
           + + +      LS  +P  I   ++ + L L  N +          L  L VL L  N +
Sbjct: 55  QFSKVVCTRRGLS-EVPQGI--PSNTRYLNLMENNIQMIQADTFRHLHHLEVLQLGRNSI 111

Query: 177 NGGIPDSLGNLGKLKRLDLSFNSLFGTIPESLANNAELLFLDVQNNTLSGIVPSALKRL 235
                 +   L  L  L+L  N L      +    ++L  L ++NN +  I   A  R+
Sbjct: 112 RQIEVGAFNGLASLNTLELFDNWLTVIPSGAFEYLSKLRELWLRNNPIESIPSYAFNRV 170

>3zyi_A Leucine-rich repeat-containing protein 4; cell adhesion, LRRC4 complex, synapse; HET: NAG; 2.60A {Homo sapiens} PDB: 3zyo_A* 3zyn_A* 2dl9_A Length = 452

 Score = 60.1 bits (146), Expect = 1e-09
 Identities = 27/92 (29%), Positives = 41/92 (44%), Gaps = 6/92 (6%)

Query: 86  PSLSGLKCLSGLYLHYNSLSGEIPKE-IRNLTELTDLYLDVNNLSGNIPPE-IGSMASLQ 143
           P+L+ L  L  L +  N    EI       L+ L  L++  + +S  I       +ASL 
Sbjct: 212 PNLTPLVGLEELEMSGNHFP-EIRPGSFHGLSSLKKLWVMNSQVS-LIERNAFDGLASLV 269

Query: 144 VLQLCCNQLTGNIPAQI-GSLKSLSVLTLQHN 174
            L L  N L+ ++P  +   L+ L  L L HN
Sbjct: 270 ELNLAHNNLS-SLPHDLFTPLRYLVELHLHHN 300

>2zmd_A Dual specificity protein kinase TTK; MPS1, T686A, ATP-binding, nucleotide-bindi phosphoprotein, serine/threonine-protein kinase; HET: 537 7PE; 2.88A {Homo sapiens} PDB: 2zmc_A* Length = 390

 Score = 89.1 bits (221), Expect = 4e-19
 Identities = 49/288 (17%), Positives = 109/288 (37%), Gaps = 49/288 (17%)

Query: 411 FSEVNLLGKGNFSSVYKGTLRDGTLVAIRSINVTSCKSEEAEFVKG-LYLLTSLRH--EN 467
           +S +  +G G  S V++       + AI+ +N+    ++  +  +  +  L  L+   + 
Sbjct: 58  YSILKQIGSGGSSKVFQVLNEKKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSDK 117

Query: 468 IIRLRGFCCSRGRGECFLIYDFAPKGKLSKYLDQEEGSSNVLDWSTRVSIIIGIAKGIGY 527
           IIRL  +         +++ +      L+ +L +++ S   +D   R S    + + +  
Sbjct: 118 IIRLYDYE--ITDQYIYMVMECG-NIDLNSWL-KKKKS---IDPWERKSYWKNMLEAVHT 170

Query: 528 LHSSEVNKPAIVHRNLSVEKVLIDQQFNPLIADCGLHKLLADDIVFSVLKTSAAMG---Y 584
           +H        IVH +L     LI       + D G+   +  D    V  +    G   Y
Sbjct: 171 IHQHG-----IVHSDLKPANFLIVDG-MLKLIDFGIANQMQPDTTSVVKDSQV--GAVNY 222

Query: 585 LAPE-----------YVTTGRFTERSDIFAFGVIILQILTGSL---VLTSSMRLAAESAT 630
           + PE             +  + + +SD+++ G I+  +  G      + + +      + 
Sbjct: 223 MPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQIINQI------SK 276

Query: 631 FENFIDRNLKGKFSE--SEAAK--LGKMALVCTHEDPENRPTMEAVIE 674
               ID N + +F +   +  +  L    L     DP+ R ++  ++ 
Sbjct: 277 LHAIIDPNHEIEFPDIPEKDLQDVLKCC-LK---RDPKQRISIPELLA 320

>2z7x_B TOLL-like receptor 1, variable lymphocyte recepto; TLR2, TLR1, lipopeptide, innate immunity, glycoPro immune response, inflammatory response, leucine-rich repeat membrane, receptor; HET: NAG NDG MAN BMA PCJ; 2.10A {Homo sapiens} Length = 520

 Score = 90.3 bits (224), Expect = 4e-19
 Identities = 41/166 (24%), Positives = 63/166 (37%), Gaps = 8/166 (4%)

Query: 74  SLQGKGLTGKLSPSLSGLKCLSGLYLHYNSLSGEIPKEIRNLTELTDLYLDVNNLSGNIP 133
           +    G         S +     L    N L+  + +   +LTEL  L L +N L   + 
Sbjct: 306 NFTVSGTRMVHMLCPSKISPFLHLDFSNNLLTDTVFENCGHLTELETLILQMNQLK-ELS 364

Query: 134 PEIG---SMASLQVLQLCCNQLTGNIPAQI-GSLKSLSVLTLQHNRLNGGIPDSLGNLGK 189
                   M SLQ L +  N ++ +         KSL  L +  N L   I   L    +
Sbjct: 365 KIAEMTTQMKSLQQLDISQNSVSYDEKKGDCSWTKSLLSLNMSSNILTDTIFRCL--PPR 422

Query: 190 LKRLDLSFNSLFGTIPESLANNAELLFLDVQNNTLSGIVPSALKRL 235
           +K LDL  N +  +IP+ +     L  L+V +N L  +      RL
Sbjct: 423 IKVLDLHSNKIK-SIPKQVVKLEALQELNVASNQLKSVPDGIFDRL 467

>2z7x_B TOLL-like receptor 1, variable lymphocyte recepto; TLR2, TLR1, lipopeptide, innate immunity, glycoPro immune response, inflammatory response, leucine-rich repeat membrane, receptor; HET: NAG NDG MAN BMA PCJ; 2.10A {Homo sapiens} Length = 520

 Score = 78.0 bits (192), Expect = 3e-15
 Identities = 33/143 (23%), Positives = 55/143 (38%), Gaps = 7/143 (4%)

Query: 97  LYLHYNSLSGEIPKEIRNLTELTDLYLDVNNLSGNIPPEI-GSMASLQVLQLCCNQLTGN 155
           L +  N +S     +I +L++L  L +  N +   +   +      L+ L L  N+L   
Sbjct: 26  LNISQNYISELWTSDILSLSKLRILIISHNRIQ-YLDISVFKFNQELEYLDLSHNKLV-K 83

Query: 156 IPAQIGSLKSLSVLTLQHNRLNG-GIPDSLGNLGKLKRLDLSFNSLFGTIPESLAN-NAE 213
           I        +L  L L  N  +   I    GN+ +LK L LS   L  +    +A+ N  
Sbjct: 84  ISCH--PTVNLKHLDLSFNAFDALPICKEFGNMSQLKFLGLSTTHLEKSSVLPIAHLNIS 141

Query: 214 LLFLDVQNNTLSGIVPSALKRLN 236
            + L +         P  L+  N
Sbjct: 142 KVLLVLGETYGEKEDPEGLQDFN 164

>2z7x_B TOLL-like receptor 1, variable lymphocyte recepto; TLR2, TLR1, lipopeptide, innate immunity, glycoPro immune response, inflammatory response, leucine-rich repeat membrane, receptor; HET: NAG NDG MAN BMA PCJ; 2.10A {Homo sapiens} Length = 520

 Score = 77.2 bits (190), Expect = 5e-15
 Identities = 35/171 (20%), Positives = 63/171 (36%), Gaps = 3/171 (1%)

Query: 65  NEHRKVANISLQGKGLTGKLSPSLSGLKCLSGLYLHYNSLSGEIPKEIRNLTELTDLYLD 124
             +  ++N+ LQG+        S + LK LS   +  +             + +      
Sbjct: 249 VWYFSISNVKLQGQLDFRDFDYSGTSLKALSIHQVVSDVFGFPQSYIYEIFSNMNIKNFT 308

Query: 125 VNNLSGNIPPEIGSMASLQVLQLCCNQLTGNIPAQIGSLKSLSVLTLQHNRLN--GGIPD 182
           V+            ++    L    N LT  +    G L  L  L LQ N+L     I +
Sbjct: 309 VSGTRMVHMLCPSKISPFLHLDFSNNLLTDTVFENCGHLTELETLILQMNQLKELSKIAE 368

Query: 183 SLGNLGKLKRLDLSFNSL-FGTIPESLANNAELLFLDVQNNTLSGIVPSAL 232
               +  L++LD+S NS+ +       +    LL L++ +N L+  +   L
Sbjct: 369 MTTQMKSLQQLDISQNSVSYDEKKGDCSWTKSLLSLNMSSNILTDTIFRCL 419

>2z7x_B TOLL-like receptor 1, variable lymphocyte recepto; TLR2, TLR1, lipopeptide, innate immunity, glycoPro immune response, inflammatory response, leucine-rich repeat membrane, receptor; HET: NAG NDG MAN BMA PCJ; 2.10A {Homo sapiens} Length = 520

 Score = 69.9 bits (171), Expect = 1e-12
 Identities = 34/221 (15%), Positives = 66/221 (29%), Gaps = 8/221 (3%)

Query: 17  SLTGLVCGNTELRALLDLKASLDPENKLLQSWTENGDPCSGSFEGIACNEHRKVANISLQ 76
           +L  +         +L L          + +    G      F+  +    + ++   + 
Sbjct: 226 TLNNIETTWNSFIRILQLVWHTTVWYFSISNVKLQGQLDFRDFD-YSGTSLKALSIHQVV 284

Query: 77  GKGLTGKLSPSLSGLKCLSGLYLHYNSLSGEIPKEIRNLTELTDLYLDVNNLSGNIPPEI 136
                   S        ++      +            ++    L    N L+  +    
Sbjct: 285 SDVFGFPQSYIYEIFSNMNIKNFTVSGTRMVHMLCPSKISPFLHLDFSNNLLTDTVFENC 344

Query: 137 GSMASLQVLQLCCNQLTGNIPAQIG---SLKSLSVLTLQHNRLNGGIPDSL-GNLGKLKR 192
           G +  L+ L L  NQL   +         +KSL  L +  N ++             L  
Sbjct: 345 GHLTELETLILQMNQLK-ELSKIAEMTTQMKSLQQLDISQNSVSYDEKKGDCSWTKSLLS 403

Query: 193 LDLSFNSLFGTIPESLANNAELLFLDVQNNTLSGIVPSALK 233
           L++S N L  TI   L     +  LD+ +N +  I    +K
Sbjct: 404 LNMSSNILTDTIFRCLPPR--IKVLDLHSNKIKSIPKQVVK 442

>2z7x_B TOLL-like receptor 1, variable lymphocyte recepto; TLR2, TLR1, lipopeptide, innate immunity, glycoPro immune response, inflammatory response, leucine-rich repeat membrane, receptor; HET: NAG NDG MAN BMA PCJ; 2.10A {Homo sapiens} Length = 520

 Score = 68.4 bits (167), Expect = 4e-12
 Identities = 36/148 (24%), Positives = 59/148 (39%), Gaps = 9/148 (6%)

Query: 99  LHYNSLSGEIPKEIRNLTELTDLYLDVNNLSGNIPPEIGSMASLQVLQLCCNQLTGNIPA 158
              N L   +PK++    + T L +  N +S     +I S++ L++L +  N++     +
Sbjct: 7   RSKNGLI-HVPKDL--SQKTTILNISQNYISELWTSDILSLSKLRILIISHNRIQYLDIS 63

Query: 159 QIGSLKSLSVLTLQHNRLNGGIPDSLGNLGKLKRLDLSFNSLFGTIPES--LANNAELLF 216
                + L  L L HN+L   I         LK LDLSFN+    +P      N ++L F
Sbjct: 64  VFKFNQELEYLDLSHNKLV-KIS--CHPTVNLKHLDLSFNAF-DALPICKEFGNMSQLKF 119

Query: 217 LDVQNNTLSGIVPSALKRLNGGFQFQNN 244
           L +    L       +  LN        
Sbjct: 120 LGLSTTHLEKSSVLPIAHLNISKVLLVL 147

>2z7x_B TOLL-like receptor 1, variable lymphocyte recepto; TLR2, TLR1, lipopeptide, innate immunity, glycoPro immune response, inflammatory response, leucine-rich repeat membrane, receptor; HET: NAG NDG MAN BMA PCJ; 2.10A {Homo sapiens} Length = 520

 Score = 66.4 bits (162), Expect = 1e-11
 Identities = 34/131 (25%), Positives = 58/131 (44%), Gaps = 8/131 (6%)

Query: 74  SLQGKGLT--GKLSPSLSGLKCLSGLYLHYNSLSGEIPKEI-RNLTELTDLYLDVNNLSG 130
            LQ   L    K++   + +K L  L +  NS+S +  K        L  L +  N L+ 
Sbjct: 354 ILQMNQLKELSKIAEMTTQMKSLQQLDISQNSVSYDEKKGDCSWTKSLLSLNMSSNILTD 413

Query: 131 NIPPEIGSMASLQVLQLCCNQLTGNIPAQIGSLKSLSVLTLQHNRLNGGIPD-SLGNLGK 189
            I   +     ++VL L  N++  +IP Q+  L++L  L +  N+L   +PD     L  
Sbjct: 414 TIFRCLPP--RIKVLDLHSNKIK-SIPKQVVKLEALQELNVASNQLKS-VPDGIFDRLTS 469

Query: 190 LKRLDLSFNSL 200
           L+++ L  N  
Sbjct: 470 LQKIWLHTNPW 480

>2z7x_B TOLL-like receptor 1, variable lymphocyte recepto; TLR2, TLR1, lipopeptide, innate immunity, glycoPro immune response, inflammatory response, leucine-rich repeat membrane, receptor; HET: NAG NDG MAN BMA PCJ; 2.10A {Homo sapiens} Length = 520

 Score = 61.0 bits (148), Expect = 7e-10
 Identities = 39/218 (17%), Positives = 67/218 (30%), Gaps = 9/218 (4%)

Query: 83  KLSPS-LSGLKCLSGLYLHYNSLSGEIPKEIRNLTELTDLYLDVNNLSGNIPPEIGSMAS 141
           +L  S +  L  L  L + +N +        +   EL  L L  N L   I        +
Sbjct: 35  ELWTSDILSLSKLRILIISHNRIQYLDISVFKFNQELEYLDLSHNKLV-KIS--CHPTVN 91

Query: 142 LQVLQLCCNQLTG-NIPAQIGSLKSLSVLTLQHNRLNGGIPDSLGNLGKLKRLDLSFNSL 200
           L+ L L  N      I  + G++  L  L L    L       + +L   K L +   + 
Sbjct: 92  LKHLDLSFNAFDALPICKEFGNMSQLKFLGLSTTHLEKSSVLPIAHLNISKVLLVLGETY 151

Query: 201 FGTI-PESLAN--NAELLFLDVQNNTLSGIVPSALKRLNGGFQFQNNPGLCGDGIASLRA 257
                PE L +     L  +   N     I+  ++K +    +  N   +  D   S   
Sbjct: 152 GEKEDPEGLQDFNTESLHIVFPTNKEFHFILDVSVKTVA-NLELSNIKCVLEDNKCSYFL 210

Query: 258 CTVYDNTQINPVKPFGSHSNDTTPIDISEPSGFKEHCN 295
             +        +     ++ +TT            H  
Sbjct: 211 SILAKLQTNPKLSNLTLNNIETTWNSFIRILQLVWHTT 248

>1jl5_A Outer protein YOPM; leucine-rich repeat, molecular pathogenesis, effector protein, virulence factor, toxin; 2.10A {Yersinia pestis} SCOP: c.10.2.6 PDB: 1g9u_A Length = 454

 Score = 89.7 bits (223), Expect = 4e-19
 Identities = 37/153 (24%), Positives = 63/153 (41%), Gaps = 18/153 (11%)

Query: 86  PSLSGLKCLSGLYLHYNSLSGEIPKEIRNLTELTDLYLDVNNLSGNIPPEIGSMASLQVL 145
           P L     L  + +  NSL  ++P    +L  +       N L     PE+ ++  L  +
Sbjct: 147 PELQNSSFLKIIDVDNNSLK-KLPDLPPSLEFI---AAGNNQLE--ELPELQNLPFLTAI 200

Query: 146 QLCCNQLTGNIPAQIGSLKSLSVLTLQHNRLNGGIPDSLGNLGKLKRLDLSFNSLFGTIP 205
               N L   +P    SL+S   +   +N L       L NL  L  +    N L  T+P
Sbjct: 201 YADNNSLK-KLPDLPLSLES---IVAGNNILE--ELPELQNLPFLTTIYADNNLL-KTLP 253

Query: 206 ESLANNAELLFLDVQNNTLSGI--VPSALKRLN 236
           +   +   L  L+V++N L+ +  +P +L  L+
Sbjct: 254 DLPPS---LEALNVRDNYLTDLPELPQSLTFLD 283

>1jl5_A Outer protein YOPM; leucine-rich repeat, molecular pathogenesis, effector protein, virulence factor, toxin; 2.10A {Yersinia pestis} SCOP: c.10.2.6 PDB: 1g9u_A Length = 454

 Score = 88.1 bits (219), Expect = 1e-18
 Identities = 37/153 (24%), Positives = 65/153 (42%), Gaps = 20/153 (13%)

Query: 86  PSLSGLKCLSGLYLHYNSLSGEIPKEIRNLTELTDLYLDVNNLSGNIPPEIGSMASLQVL 145
           P L  L  L+ +Y   NSL  ++P    +L  +       N L     PE+ ++  L  +
Sbjct: 189 PELQNLPFLTAIYADNNSLK-KLPDLPLSLESI---VAGNNILE--ELPELQNLPFLTTI 242

Query: 146 QLCCNQLTGNIPAQIGSLKSLSVLTLQHNRLNGGIPDSLGNLGKLKRLDLSFNSLFGTIP 205
               N L   +P    SL++   L ++ N L   +P+   +L  L   +  F+ L     
Sbjct: 243 YADNNLLK-TLPDLPPSLEA---LNVRDNYLT-DLPELPQSLTFLDVSENIFSGL----S 293

Query: 206 ESLANNAELLFLDVQNNTLSGI--VPSALKRLN 236
           E   N   L +L+  +N +  +  +P +L+ LN
Sbjct: 294 ELPPN---LYYLNASSNEIRSLCDLPPSLEELN 323

>1jl5_A Outer protein YOPM; leucine-rich repeat, molecular pathogenesis, effector protein, virulence factor, toxin; 2.10A {Yersinia pestis} SCOP: c.10.2.6 PDB: 1g9u_A Length = 454

 Score = 85.8 bits (213), Expect = 8e-18
 Identities = 34/157 (21%), Positives = 56/157 (35%), Gaps = 26/157 (16%)

Query: 84  LSPSLSGLKCLSGLYLHYNSLSGEIPKEIRNLTELTDLYLDVNNLSGNIPPEIGSMA--- 140
           ++P       L     H ++L+ E+P E  N+   T+ Y   +    N PP  G      
Sbjct: 3   INPRNVSNTFLQEPLRHSSNLT-EMPVEAENVKSKTEYYNAWSEWERNAPPGNGEQREMA 61

Query: 141 ----------SLQVLQLCCNQLTGNIPAQIGSLKSLSVLTLQHNRLNGGIPDSLGNLGKL 190
                         L+L    L+ ++P     L+SL       N L   +P+   +L  L
Sbjct: 62  VSRLRDCLDRQAHELELNNLGLS-SLPELPPHLESLV---ASCNSLT-ELPELPQSLKSL 116

Query: 191 KRLDLSFNSLFGTIPESLANNAELLFLDVQNNTLSGI 227
              + +  +L   +P  L        L V NN L  +
Sbjct: 117 LVDNNNLKAL-SDLPPLLEY------LGVSNNQLEKL 146

>1jl5_A Outer protein YOPM; leucine-rich repeat, molecular pathogenesis, effector protein, virulence factor, toxin; 2.10A {Yersinia pestis} SCOP: c.10.2.6 PDB: 1g9u_A Length = 454

 Score = 85.4 bits (212), Expect = 1e-17
 Identities = 36/172 (20%), Positives = 55/172 (31%), Gaps = 35/172 (20%)

Query: 83  KLSPSLSGLKCLSGLYLHYNSLSGEIPKEIRNLTELTDLYLDVN--------NLSGN--- 131
           ++      +K  +  Y  ++      P       E+    L            L+     
Sbjct: 25  EMPVEAENVKSKTEYYNAWSEWERNAPPGNGEQREMAVSRLRDCLDRQAHELELNNLGLS 84

Query: 132 -IPPEIGSMASLQVLQLCCNQLTGNIPAQIGSLKSLSVLTLQHNRLNGGIP--------- 181
            +P        L+ L   CN LT  +P    SLKSL V       L+   P         
Sbjct: 85  SLPELPP---HLESLVASCNSLT-ELPELPQSLKSLLVDNNNLKALSDLPPLLEYLGVSN 140

Query: 182 ------DSLGNLGKLKRLDLSFNSLFGTIPESLANNAELLFLDVQNNTLSGI 227
                   L N   LK +D+  NSL   +P+   +   L F+   NN L  +
Sbjct: 141 NQLEKLPELQNSSFLKIIDVDNNSL-KKLPDLPPS---LEFIAAGNNQLEEL 188

>1jl5_A Outer protein YOPM; leucine-rich repeat, molecular pathogenesis, effector protein, virulence factor, toxin; 2.10A {Yersinia pestis} SCOP: c.10.2.6 PDB: 1g9u_A Length = 454

 Score = 80.0 bits (198), Expect = 6e-16
 Identities = 35/153 (22%), Positives = 58/153 (37%), Gaps = 22/153 (14%)

Query: 86  PSLSGLKCLSGLYLHYNSLSGEIPKEIRNLTELTDLYLDVNNLSGNIPPEIGSMASLQVL 145
           P L  L  L+ +Y   N L   +P    +L  L      + +L    P    S+  L V 
Sbjct: 231 PELQNLPFLTTIYADNNLLK-TLPDLPPSLEALNVRDNYLTDL----PELPQSLTFLDVS 285

Query: 146 QLCCNQLTGNIPAQIGSLKSLSVLTLQHNRLNGGIPDSLGNLGKLKRLDLSFNSLFGTIP 205
           +   + L+   P       +L  L    N +   + D   +L   + L++S N L   +P
Sbjct: 286 ENIFSGLSELPP-------NLYYLNASSNEIRS-LCDLPPSL---EELNVSNNKL-IELP 333

Query: 206 ESLANNAELLFLDVQNNTLSGI--VPSALKRLN 236
                   L  L    N L+ +  +P  LK+L+
Sbjct: 334 ALPPR---LERLIASFNHLAEVPELPQNLKQLH 363

>1jl5_A Outer protein YOPM; leucine-rich repeat, molecular pathogenesis, effector protein, virulence factor, toxin; 2.10A {Yersinia pestis} SCOP: c.10.2.6 PDB: 1g9u_A Length = 454

 Score = 66.9 bits (164), Expect = 9e-12
 Identities = 28/152 (18%), Positives = 51/152 (33%), Gaps = 31/152 (20%)

Query: 91  LKCLSGLYLHYNSLSGEIPKEIRNLTELTDLYLDVNNLSGNIPPEIGSMASLQVLQLCCN 150
              L  L +  N L  E+P     L  L       N+L+  +P    +   L+ L +  N
Sbjct: 316 PPSLEELNVSNNKLI-ELPALPPRLERL---IASFNHLA-EVPELPQN---LKQLHVEYN 367

Query: 151 QLTGNIPAQIGSLKSLSV----------------LTLQHNRLNGGIPDSLGNLGKLKRLD 194
            L    P    S++ L +                L ++ N L    PD   ++   + L 
Sbjct: 368 PLR-EFPDIPESVEDLRMNSHLAEVPELPQNLKQLHVETNPLRE-FPDIPESV---EDLR 422

Query: 195 LSFNSLFGTIPESLANNAELLFLDV-QNNTLS 225
           ++   +     E      + L  DV +++   
Sbjct: 423 MNSERV-VDPYEFAHETTDKLEDDVFEHHHHH 453

>1jl5_A Outer protein YOPM; leucine-rich repeat, molecular pathogenesis, effector protein, virulence factor, toxin; 2.10A {Yersinia pestis} SCOP: c.10.2.6 PDB: 1g9u_A Length = 454

 Score = 60.0 bits (146), Expect = 1e-09
 Identities = 21/116 (18%), Positives = 41/116 (35%), Gaps = 16/116 (13%)

Query: 83  KLSPSLSGLKCLSGLYLHYNSLSGEIPKEIRNLTELTDLYLDVNNLSGNIPPEIGSMASL 142
           ++      LK L   ++ YN L  E P    ++ +L      +N+    +P    +   L
Sbjct: 351 EVPELPQNLKQL---HVEYNPLR-EFPDIPESVEDL-----RMNSHLAEVPELPQN---L 398

Query: 143 QVLQLCCNQLTGNIPAQIGSLKSLSVLTLQHNRLNGGIPDSLGNLGKLKRLDLSFN 198
           + L +  N L    P    S++ L    +   R+      +     KL+      +
Sbjct: 399 KQLHVETNPLR-EFPDIPESVEDL---RMNSERVVDPYEFAHETTDKLEDDVFEHH 450

>3q60_A ROP5B; pseudokinase, transferase; HET: ATP; 1.72A {Toxoplasma gondii} PDB: 3q5z_A* Length = 371

 Score = 88.6 bits (219), Expect = 5e-19
 Identities = 36/297 (12%), Positives = 69/297 (23%), Gaps = 51/297 (17%)

Query: 416 LLGKGNFSSVYKGTLRD-GTLVAIRSINVTSCKSEEAE--FVKGLYLLTSLRHEN----- 467
            L  G+ S V+     +     A++   + +  S        +  +    L  E+     
Sbjct: 69  PLRVGDRSVVFLVRDVERLEDFALKVFTMGAENSRSELERLHEATFAAARLLGESPEEAR 128

Query: 468 -------------------IIRLRGFCCSRGRGECFLIYDFAP--KGKLSKYLDQEEGSS 506
                                +L             L+   A      L   LD      
Sbjct: 129 DRRRLLLPSDAVAVQSQPPFAQLSPGQDDYAVANYLLLMPAASVDLELLFSTLDFVYVFR 188

Query: 507 NVLDWSTRVSIIIGIAKGIGYLHSSEVNKPAIVHRNLSVEKVLIDQQFNPLIADCGLHKL 566
                     +   + +    L S       +VH + + + + I      ++ D     L
Sbjct: 189 GDEGILALHILTAQLIRLAANLQSKG-----LVHGHFTPDNLFIMPDGRLMLGDVSA--L 241

Query: 567 LADDIVFSVLKTSAAMGYLAPEYVT--TGRFTERSDIFAFGVIILQILTGSL-----VLT 619
                            Y   E++   T  FT   + +  G+ I ++    L        
Sbjct: 242 WKVGTRGPASSVPVT--YAPREFLNASTATFTHALNAWQLGLSIYRVWCLFLPFGLVTPG 299

Query: 620 SSMRLAAESATFENFIDRNLKGKFSESEAAK--LGKMALVCTHEDPENRPTMEAVIE 674
                   S                  +  K  +G+  L     D   R      +E
Sbjct: 300 IKGSWKRPSLRVPGTDSLAFGSCTPLPDFVKTLIGRF-LNF---DRRRRLLPLEAME 352

>3j0a_A TOLL-like receptor 5; membrane protein, leucine-rich repeat, asymmetric homodimer, glycoprotein, immune system; HET: NAG FUC; 26.00A {Homo sapiens} Length = 844

 Score = 89.5 bits (222), Expect = 1e-18
 Identities = 59/252 (23%), Positives = 95/252 (37%), Gaps = 20/252 (7%)

Query: 93  CLSGLYLHYNSLSG-EIPKEIRNLTELTDLYLDVNNLSGNIPPE--IGSMASLQVLQLCC 149
             + ++L  N L   +I   +  +  L  L L+ N  S +   +       SL+ L L  
Sbjct: 402 TANLIHLSENRLENLDILYFLLRVPHLQILILNQNRFS-SCSGDQTPSENPSLEQLFLGE 460

Query: 150 NQLTGNIPAQI-----GSLKSLSVLTLQHNRLNGGIPDSLGNLGKLKRLDLSFNSLFGTI 204
           N L      ++       L  L VL L HN LN   P    +L  L+ L L+ N L    
Sbjct: 461 NMLQLAWETELCWDVFEGLSHLQVLYLNHNYLNSLPPGVFSHLTALRGLSLNSNRLTVLS 520

Query: 205 PESLANNAELLFLDVQNNTLSGIVPSALKRLNGGFQFQNNPGLCGDGIASLRACTVYDNT 264
              L  N  L  LD+  N L    P     L+      +N  +C   +++      + N 
Sbjct: 521 HNDLPAN--LEILDISRNQLLAPNPDVFVSLS-VLDITHNKFICECELSTFINWLNHTNV 577

Query: 265 QI--NPVKPFGSHSNDTTPIDISEPSGFKEHCNQSQCSNSSKFPQIAVLAAVTSVTVILA 322
            I   P   +  + +  + + +   S   E C++ +   S KF     L  V +VT+ L 
Sbjct: 578 TIAGPPADIYCVYPDSFSGVSLFSLS--TEGCDEEEVLKSLKFS----LFIVCTVTLTLF 631

Query: 323 GTGILIFFRYRR 334
              IL   ++R 
Sbjct: 632 LMTILTVTKFRG 643

>3j0a_A TOLL-like receptor 5; membrane protein, leucine-rich repeat, asymmetric homodimer, glycoprotein, immune system; HET: NAG FUC; 26.00A {Homo sapiens} Length = 844

 Score = 87.9 bits (218), Expect = 4e-18
 Identities = 37/180 (20%), Positives = 63/180 (35%), Gaps = 12/180 (6%)

Query: 63  ACNEHRKVANISLQGKGLTGKLSPSLSGLKCLSGLYLHYNSLSGEIPKEIRNLTELTDLY 122
           +C+   ++A            L+     L     L L +N +          L +L  L 
Sbjct: 1   SCSFDGRIAFYRFCN------LTQVPQVLNTTERLLLSFNYIRTVTASSFPFLEQLQLLE 54

Query: 123 LDVNNLSGNIPPEI-GSMASLQVLQLCCNQLTGNIPAQI-GSLKSLSVLTLQHNRLNGGI 180
           L        I  E   ++ +L++L L  +++   +       L  L  L L    L+  +
Sbjct: 55  LGSQYTPLTIDKEAFRNLPNLRILDLGSSKIY-FLHPDAFQGLFHLFELRLYFCGLSDAV 113

Query: 181 --PDSLGNLGKLKRLDLSFNSLFG-TIPESLANNAELLFLDVQNNTLSGIVPSALKRLNG 237
                  NL  L RLDLS N +    +  S      L  +D  +N +  +    L+ L G
Sbjct: 114 LKDGYFRNLKALTRLDLSKNQIRSLYLHPSFGKLNSLKSIDFSSNQIFLVCEHELEPLQG 173

>3j0a_A TOLL-like receptor 5; membrane protein, leucine-rich repeat, asymmetric homodimer, glycoprotein, immune system; HET: NAG FUC; 26.00A {Homo sapiens} Length = 844

 Score = 71.8 bits (176), Expect = 4e-13
 Identities = 31/170 (18%), Positives = 65/170 (38%), Gaps = 6/170 (3%)

Query: 78  KGLTGKLSPSLSGLKCLSGLYLHYNSLSGEIPKEIRNL--TELTDLYLDVNNLSGNIPPE 135
             ++   + SL     + G    ++++          L  + +  L L    +  ++   
Sbjct: 226 NAISKSQAFSLILAHHIMGAGFGFHNIKDPDQNTFAGLARSSVRHLDLSHGFVF-SLNSR 284

Query: 136 I-GSMASLQVLQLCCNQLTGNIPAQIGSLKSLSVLTLQHNRLNGGIPDSLGNLGKLKRLD 194
           +  ++  L+VL L  N++          L +L VL L +N L      +   L K+  +D
Sbjct: 285 VFETLKDLKVLNLAYNKINKIADEAFYGLDNLQVLNLSYNLLGELYSSNFYGLPKVAYID 344

Query: 195 LSFNSLFGTIPESLANNAELLFLDVQNNTLSGIVPSALKRLNGGFQFQNN 244
           L  N +     ++     +L  LD+++N L+ I    +  +   F   N 
Sbjct: 345 LQKNHIAIIQDQTFKFLEKLQTLDLRDNALTTI--HFIPSIPDIFLSGNK 392

>3j0a_A TOLL-like receptor 5; membrane protein, leucine-rich repeat, asymmetric homodimer, glycoprotein, immune system; HET: NAG FUC; 26.00A {Homo sapiens} Length = 844

 Score = 71.4 bits (175), Expect = 6e-13
 Identities = 36/203 (17%), Positives = 72/203 (35%), Gaps = 25/203 (12%)

Query: 55  CSGSFEGIACNEHRKVANISLQGKGLTGKLSPSLSGL------KCLSGLYLHYNSLSGEI 108
           C    E +   + + ++  SL    L  ++S              L  L +  N  + +I
Sbjct: 164 CEHELEPL---QGKTLSFFSLAANSLYSRVSVDWGKCMNPFRNMVLEILDVSGNGWTVDI 220

Query: 109 PKEIRN------------LTELTDLYLDVNNLSGNIPPEI---GSMASLQVLQLCCNQLT 153
                N               +       +N+  +         + +S++ L L    + 
Sbjct: 221 TGNFSNAISKSQAFSLILAHHIMGAGFGFHNIK-DPDQNTFAGLARSSVRHLDLSHGFVF 279

Query: 154 GNIPAQIGSLKSLSVLTLQHNRLNGGIPDSLGNLGKLKRLDLSFNSLFGTIPESLANNAE 213
                   +LK L VL L +N++N    ++   L  L+ L+LS+N L      +     +
Sbjct: 280 SLNSRVFETLKDLKVLNLAYNKINKIADEAFYGLDNLQVLNLSYNLLGELYSSNFYGLPK 339

Query: 214 LLFLDVQNNTLSGIVPSALKRLN 236
           + ++D+Q N ++ I     K L 
Sbjct: 340 VAYIDLQKNHIAIIQDQTFKFLE 362

>3j0a_A TOLL-like receptor 5; membrane protein, leucine-rich repeat, asymmetric homodimer, glycoprotein, immune system; HET: NAG FUC; 26.00A {Homo sapiens} Length = 844

 Score = 67.9 bits (166), Expect = 6e-12
 Identities = 34/176 (19%), Positives = 60/176 (34%), Gaps = 32/176 (18%)

Query: 87  SLSGLKCLSGLYLHYNSLSGEIPKEIRNLTELTDLYLDVNNLSGNIPPEIGSMASLQVLQ 146
           +  GL  ++ + L  N ++    +  + L +L  L L  N L+      I  + S+  + 
Sbjct: 333 NFYGLPKVAYIDLQKNHIAIIQDQTFKFLEKLQTLDLRDNALT-----TIHFIPSIPDIF 387

Query: 147 LCCNQLTG---------------------NIPAQIGSLKSLSVLTLQHNRLNGGIPDSL- 184
           L  N+L                       +I   +  +  L +L L  NR +    D   
Sbjct: 388 LSGNKLVTLPKINLTANLIHLSENRLENLDILYFLLRVPHLQILILNQNRFSSCSGDQTP 447

Query: 185 GNLGKLKRLDLSFNSLFGTIPESLANNA-----ELLFLDVQNNTLSGIVPSALKRL 235
                L++L L  N L       L  +       L  L + +N L+ + P     L
Sbjct: 448 SENPSLEQLFLGENMLQLAWETELCWDVFEGLSHLQVLYLNHNYLNSLPPGVFSHL 503

>3j0a_A TOLL-like receptor 5; membrane protein, leucine-rich repeat, asymmetric homodimer, glycoprotein, immune system; HET: NAG FUC; 26.00A {Homo sapiens} Length = 844

 Score = 65.2 bits (159), Expect = 4e-11
 Identities = 28/176 (15%), Positives = 57/176 (32%), Gaps = 22/176 (12%)

Query: 83  KLSPSLSGLKCLSGLYLHYNSLSGEIPKEIRNLT--ELTDLYLDVNNLSGNIPPEIGSMA 140
            L PS   L  L  +    N +      E+  L    L+   L  N+L   +  + G   
Sbjct: 139 YLHPSFGKLNSLKSIDFSSNQIFLVCEHELEPLQGKTLSFFSLAANSLYSRVSVDWGKCM 198

Query: 141 ------SLQVLQL------------CCNQLTGNIPAQIGSLKSLSVLTLQHNRLNGGIPD 182
                  L++L +              N ++ +    +     +       + +     +
Sbjct: 199 NPFRNMVLEILDVSGNGWTVDITGNFSNAISKSQAFSLILAHHIMGAGFGFHNIKDPDQN 258

Query: 183 SLGNLGK--LKRLDLSFNSLFGTIPESLANNAELLFLDVQNNTLSGIVPSALKRLN 236
           +   L +  ++ LDLS   +F           +L  L++  N ++ I   A   L+
Sbjct: 259 TFAGLARSSVRHLDLSHGFVFSLNSRVFETLKDLKVLNLAYNKINKIADEAFYGLD 314

>3j0a_A TOLL-like receptor 5; membrane protein, leucine-rich repeat, asymmetric homodimer, glycoprotein, immune system; HET: NAG FUC; 26.00A {Homo sapiens} Length = 844

 Score = 46.0 bits (109), Expect = 4e-05
 Identities = 33/105 (31%), Positives = 48/105 (45%), Gaps = 7/105 (6%)

Query: 74  SLQGKGLTGKLSPSLSGLKCLSGLYLHYNSLSGEIPKEI-RNLTELTDLYLDVNNLSGNI 132
            LQ    T        GL  L  LYL++N L+  +P  +  +LT L  L L+ N L+  +
Sbjct: 462 MLQLAWETELCWDVFEGLSHLQVLYLNHNYLN-SLPPGVFSHLTALRGLSLNSNRLT-VL 519

Query: 133 PPEIGSMASLQVLQLCCNQLTGNIPAQIGSLKSLSVLTLQHNRLN 177
                  A+L++L +  NQL    P       SLSVL + HN+  
Sbjct: 520 SHNDLP-ANLEILDISRNQLLAPNP---DVFVSLSVLDITHNKFI 560

>1x8b_A WEE1HU, WEE1-like protein kinase; cell cycle, transferase; HET: 824; 1.81A {Homo sapiens} PDB: 3bi6_A* 3biz_A* 3cqe_A* 3cr0_A* 2in6_A* 2io6_A* 2z2w_A* Length = 289

 Score = 85.5 bits (212), Expect = 2e-18
 Identities = 51/284 (17%), Positives = 100/284 (35%), Gaps = 43/284 (15%)

Query: 408 TQCFSEVNLLGKGNFSSVYKGT-LRDGTLVAIRSINVTSCKS-EEAEFVKGLYLLTSL-R 464
           T  F E+  +G G F SV+K     DG + AI+        S +E   ++ +Y    L +
Sbjct: 10  TTEFHELEKIGSGEFGSVFKCVKRLDGCIYAIKRSKKPLAGSVDEQNALREVYAHAVLGQ 69

Query: 465 HENIIRLRGFCCSRGRGECFLIYDFAPKGKLSKYLDQEEGSSNVLDWSTRVSIIIGIAKG 524
           H +++R              +  ++   G L+  + +     +    +    +++ + +G
Sbjct: 70  HSHVVRYFS--AWAEDDHMLIQNEYCNGGSLADAISENYRIMSYFKEAELKDLLLQVGRG 127

Query: 525 IGYLHSSEVNKPAIVHR-----N--LSVEKVLIDQQFNPLIADCGLHKL---LAD-DIVF 573
           + Y+HS       +VH      N  +S   +           D   +K+   + D   V 
Sbjct: 128 LRYIHSMS-----LVHMDIKPSNIFISRTSIPNAASEEGDEDDWASNKVMFKIGDLGHVT 182

Query: 574 SVLKTSAAMG---YLAPEYVT-TGRFTERSDIFAFGVIILQILTGSLVLTSSMRLAAESA 629
            +       G   +LA E +        ++DIFA  + ++              L     
Sbjct: 183 RISSPQVEEGDSRFLANEVLQENYTHLPKADIFALALTVVCAAGA-------EPLPRNGD 235

Query: 630 TFENFIDRNLKGKFSE-----SEAAKLGKMALVCTHEDPENRPT 668
            +        +G+        S+     ++  V  H DPE RP+
Sbjct: 236 QWHEIR----QGRLPRIPQVLSQEFT--ELLKVMIHPDPERRPS 273

>3g06_A SSPH2 (leucine-rich repeat protein); E3 ubiquitin ligase, leucine rich repeat domain, type three effector, salmonella virulence factor; 1.90A {Salmonella typhimurium} Length = 622

 Score = 88.8 bits (220), Expect = 2e-18
 Identities = 40/156 (25%), Positives = 60/156 (38%), Gaps = 25/156 (16%)

Query: 83  KLSPSLSGLKCLSGLYLHYNSLSGEIPKEIRNLTELTDLYLDVNNLSGNIPPEIGSMASL 142
            L     GL  LS        L           + L  L++  N L+ ++P        L
Sbjct: 95  SLPVLPPGLLELSIFSNPLTHLPAL-------PSGLCKLWIFGNQLT-SLPVLPP---GL 143

Query: 143 QVLQLCCNQLTGNIPAQIGSLKSLSVLTLQHNRLNGGIPDSLGNLGKLKRLDLSFNSLFG 202
           Q L +  NQL  ++PA    L     L   +N+L   +P        L+ L +S N L  
Sbjct: 144 QELSVSDNQLA-SLPALPSELCK---LWAYNNQLT-SLPMLPSG---LQELSVSDNQL-A 194

Query: 203 TIPESLANNAELLFLDVQNNTLSGI--VPSALKRLN 236
           ++P   +    L  L   NN L+ +  +PS LK L 
Sbjct: 195 SLPTLPSE---LYKLWAYNNRLTSLPALPSGLKELI 227

>3g06_A SSPH2 (leucine-rich repeat protein); E3 ubiquitin ligase, leucine rich repeat domain, type three effector, salmonella virulence factor; 1.90A {Salmonella typhimurium} Length = 622

 Score = 76.1 bits (187), Expect = 1e-14
 Identities = 28/151 (18%), Positives = 55/151 (36%), Gaps = 31/151 (20%)

Query: 106 GEIPKEIRN--LTELTDLYLDVNNLSGNIPPEIGSMASLQVLQLCCNQLTGNIPAQIGSL 163
             + +++R         L +  + L+  +P  + +   +  L +  N LT ++PA    L
Sbjct: 28  AAVVQKMRACLNNGNAVLNVGESGLT-TLPDCLPA--HITTLVIPDNNLT-SLPALPPEL 83

Query: 164 KSLSVLTLQHNRLNGGIPDSLGNLGKLKRLDLSFNSL----------------FGTIPES 207
           ++L    +  N+L   +P     L +L         L                  ++P  
Sbjct: 84  RTL---EVSGNQLTS-LPVLPPGLLELSIFSNPLTHLPALPSGLCKLWIFGNQLTSLPVL 139

Query: 208 LANNAELLFLDVQNNTLSGI--VPSALKRLN 236
                 L  L V +N L+ +  +PS L +L 
Sbjct: 140 PPG---LQELSVSDNQLASLPALPSELCKLW 167

>3g06_A SSPH2 (leucine-rich repeat protein); E3 ubiquitin ligase, leucine rich repeat domain, type three effector, salmonella virulence factor; 1.90A {Salmonella typhimurium} Length = 622

 Score = 65.3 bits (159), Expect = 4e-11
 Identities = 28/164 (17%), Positives = 51/164 (31%), Gaps = 12/164 (7%)

Query: 84  LSPSLSGLKCLSGLYLHYNSLSGEIPKEIRNLTELTDLYLDVNNLSGNIPPEIGSMASLQ 143
           L    S LK L    +  N L+  +P     L  L    +  N L+  +P  +  ++S  
Sbjct: 236 LPVLPSELKEL---MVSGNRLT-SLPMLPSGLLSL---SVYRNQLT-RLPESLIHLSSET 287

Query: 144 VLQLCCNQLTGNIPAQIGSLKSLSVLTLQHNRLNGGIPDSLGNLGKLKRLDLSFNSLFGT 203
            + L  N L+      +  + S    +    R +     +      L     + + L   
Sbjct: 288 TVNLEGNPLSERTLQALREITSAPGYSGPIIRFDMAGASAPRETRAL--HLAAADWLVPA 345

Query: 204 IPESLANNAELLFLDVQNNTLSGIVPSALKRLNGGFQFQNNPGL 247
                A          ++N  +      L RL+    F  + G 
Sbjct: 346 REGEPAPADRWHMFGQEDN--ADAFSLFLDRLSETENFIKDAGF 387

>2z66_A Variable lymphocyte receptor B, TOLL-like recepto; TLR4, TOLL-like receptor, MD-2, LPS, leucine-rich repeat, glycoprotein, immune response; HET: NAG BMA FUL; 1.90A {Eptatretus burgeri} Length = 306

 Score = 85.1 bits (211), Expect = 3e-18
 Identities = 38/179 (21%), Positives = 65/179 (36%), Gaps = 7/179 (3%)

Query: 84  LSPSLSGLKCLSGLYLHYNSLSGEIPKEI-RNLTELTDLYLDVNNLSGNIPPEI-GSMAS 141
           +S +  GL+ L  L   +++L       +  +L  L  L +   +        I   ++S
Sbjct: 93  MSSNFLGLEQLEHLDFQHSNLKQMSEFSVFLSLRNLIYLDISHTHTR-VAFNGIFNGLSS 151

Query: 142 LQVLQLCCNQLTGNIPAQI-GSLKSLSVLTLQHNRLNGGIPDSLGNLGKLKRLDLSFNSL 200
           L+VL++  N    N    I   L++L+ L L   +L    P +  +L  L+ L++S N+ 
Sbjct: 152 LEVLKMAGNSFQENFLPDIFTELRNLTFLDLSQCQLEQLSPTAFNSLSSLQVLNMSHNNF 211

Query: 201 FGTIPESLANNAELLFLDVQNNTLSGIVPSALKRLNGGFQF---QNNPGLCGDGIASLR 256
           F            L  LD   N +       L+       F     N   C     S  
Sbjct: 212 FSLDTFPYKCLNSLQVLDYSLNHIMTSKKQELQHFPSSLAFLNLTQNDFACTCEHQSFL 270

>2z66_A Variable lymphocyte receptor B, TOLL-like recepto; TLR4, TOLL-like receptor, MD-2, LPS, leucine-rich repeat, glycoprotein, immune response; HET: NAG BMA FUL; 1.90A {Eptatretus burgeri} Length = 306

 Score = 74.7 bits (184), Expect = 9e-15
 Identities = 35/143 (24%), Positives = 50/143 (34%), Gaps = 5/143 (3%)

Query: 97  LYLHYNSLSGEIPKEIRNLTELTDLYLDVNNLS-GNIPPEIGS-MASLQVLQLCCNQLTG 154
           L L  N L          LT+LT L L  N LS      +      SL+ L L  N +  
Sbjct: 33  LELESNKLQSLPHGVFDKLTQLTKLSLSSNGLSFKGCCSQSDFGTTSLKYLDLSFNGVI- 91

Query: 155 NIPAQIGSLKSLSVLTLQHNRLNGGIPDSL-GNLGKLKRLDLSFNSLFGTIPESLANNAE 213
            + +    L+ L  L  QH+ L      S+  +L  L  LD+S               + 
Sbjct: 92  TMSSNFLGLEQLEHLDFQHSNLKQMSEFSVFLSLRNLIYLDISHTHTRVAFNGIFNGLSS 151

Query: 214 LLFLDVQ-NNTLSGIVPSALKRL 235
           L  L +  N+     +P     L
Sbjct: 152 LEVLKMAGNSFQENFLPDIFTEL 174

>2z66_A Variable lymphocyte receptor B, TOLL-like recepto; TLR4, TOLL-like receptor, MD-2, LPS, leucine-rich repeat, glycoprotein, immune response; HET: NAG BMA FUL; 1.90A {Eptatretus burgeri} Length = 306

 Score = 57.3 bits (139), Expect = 5e-09
 Identities = 23/104 (22%), Positives = 36/104 (34%), Gaps = 7/104 (6%)

Query: 78  KGLTGKLSPSLSGLKCLSGLYLHYNSLSGEIPKEI-RNLTELTDLYLDVNNLSGNIPPEI 136
                 L    + L+ L+ L L    L  ++      +L+ L  L +  NN   ++    
Sbjct: 161 SFQENFLPDIFTELRNLTFLDLSQCQLE-QLSPTAFNSLSSLQVLNMSHNNFF-SLDTFP 218

Query: 137 -GSMASLQVLQLCCNQLTGNIPAQI--GSLKSLSVLTLQHNRLN 177
              + SLQVL    N +      Q       SL+ L L  N   
Sbjct: 219 YKCLNSLQVLDYSLNHIM-TSKKQELQHFPSSLAFLNLTQNDFA 261

>2z66_A Variable lymphocyte receptor B, TOLL-like recepto; TLR4, TOLL-like receptor, MD-2, LPS, leucine-rich repeat, glycoprotein, immune response; HET: NAG BMA FUL; 1.90A {Eptatretus burgeri} Length = 306

 Score = 44.2 bits (105), Expect = 8e-05
 Identities = 24/88 (27%), Positives = 36/88 (40%), Gaps = 6/88 (6%)

Query: 150 NQLTGNIPAQIGSLKSLSVLTLQHNRLNGGIPDSLGNLGKLKRLDLSFNSL--FGTIPES 207
             LT ++P  I    S + L L+ N+L          L +L +L LS N L   G   +S
Sbjct: 17  KGLT-SVPTGI--PSSATRLELESNKLQSLPHGVFDKLTQLTKLSLSSNGLSFKGCCSQS 73

Query: 208 LANNAELLFLDVQNNTLSGIVPSALKRL 235
                 L +LD+  N +  +  S    L
Sbjct: 74  DFGTTSLKYLDLSFNGVITM-SSNFLGL 100

>3byv_A Rhoptry kinase; malaria, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} PDB: 2w1z_A Length = 377

 Score = 85.4 bits (211), Expect = 5e-18
 Identities = 44/302 (14%), Positives = 85/302 (28%), Gaps = 65/302 (21%)

Query: 416 LLGKGNFSSVYKGT-LRDGTLVAIRSINVTSCKSEEAE---------------------- 452
           +LG+ +  +  + T    G    +     T      A                       
Sbjct: 80  VLGQEDPYAYLEATDQETGESFEVHVPYFTERPPSNAIKQMKEEVLRLRLLRGIKNQKQA 139

Query: 453 -----FVKGLYLLTSLRHENIIRLRGFCCSRGRGECFLIYDFA--PKGKLSKYLDQEEGS 505
                F+    L+   + + +IR+R           F +Y           + L     +
Sbjct: 140 KVHLRFIFPFDLVKDPQKKKMIRVRLDERDMWVLSRFFLYPRMQSNLQTFGEVLLSHSST 199

Query: 506 SNVLDWSTRVSIIIGIAKGIGYLHSSEVNKPAIVHRNLSVEKVLIDQQFNPLIADCGLHK 565
              L    R+ + + + + +  LH        +VH  L    +++DQ+    +       
Sbjct: 200 HKSLVHHARLQLTLQVIRLLASLHHYG-----LVHTYLRPVDIVLDQRGGVFLTGFEHLV 254

Query: 566 LLADDIVFSVLKTSAAMGYLAPEYVTT-----------GRFTERSDIFAFGVIILQILTG 614
                +V SV     + G+  PE                  T   D +A G++I  I   
Sbjct: 255 RDGARVVSSV-----SRGFEPPELEARRATISYHRDRRTLMTFSFDAWALGLVIYWIWCA 309

Query: 615 SLVLTSSMRLAAESATFENFIDRNLKGKFSESEAAKLGKMALV--CTHEDPENRPTMEAV 672
            L +T      A     E       +   +  +  +    AL+        E+R      
Sbjct: 310 DLPITKD----AALGGSE----WIFRSCKNIPQPVR----ALLEGFLRYPKEDRLLPLQA 357

Query: 673 IE 674
           +E
Sbjct: 358 ME 359

>3zyj_A Leucine-rich repeat-containing protein 4C; cell adhesion, synapse; HET: NAG BMA MAN; 3.25A {Homo sapiens} Length = 440

 Score = 86.0 bits (213), Expect = 6e-18
 Identities = 46/154 (29%), Positives = 66/154 (42%), Gaps = 9/154 (5%)

Query: 87  SLSGLKCLSGLYLHYNSLSGEIPKEI-RNLTELTDLYLDVNNLSGNIPPEI-GSMASLQV 144
           + +GL  L+ L L  N L+  IP      L++L +L+L  N +  +IP      + SL+ 
Sbjct: 107 AFNGLANLNTLELFDNRLT-TIPNGAFVYLSKLKELWLRNNPIE-SIPSYAFNRIPSLRR 164

Query: 145 LQLC-CNQLTGNIPAQI-GSLKSLSVLTLQHNRLNGGIPDSLGNLGKLKRLDLSFNSLFG 202
           L L    +L+  I       L +L  L L    L   IP+ L  L KL  LDLS N L  
Sbjct: 165 LDLGELKRLS-YISEGAFEGLSNLRYLNLAMCNLRE-IPN-LTPLIKLDELDLSGNHLSA 221

Query: 203 TIPESLANNAELLFLDVQNNTLSGIVPSALKRLN 236
             P S      L  L +  + +  I  +A   L 
Sbjct: 222 IRPGSFQGLMHLQKLWMIQSQIQVIERNAFDNLQ 255

>3zyj_A Leucine-rich repeat-containing protein 4C; cell adhesion, synapse; HET: NAG BMA MAN; 3.25A {Homo sapiens} Length = 440

 Score = 74.0 bits (182), Expect = 4e-14
 Identities = 31/140 (22%), Positives = 54/140 (38%), Gaps = 9/140 (6%)

Query: 87  SLSGLKCLSGLYL-HYNSLSGEIPKEI-RNLTELTDLYLDVNNLSGNIPPEIGSMASLQV 144
           + + +  L  L L     LS  I +     L+ L  L L + NL     P +  +  L  
Sbjct: 155 AFNRIPSLRRLDLGELKRLS-YISEGAFEGLSNLRYLNLAMCNLRE--IPNLTPLIKLDE 211

Query: 145 LQLCCNQLTGNIPAQI-GSLKSLSVLTLQHNRLNGGIPDSLGNLGKLKRLDLSFNSLFGT 203
           L L  N L+  I       L  L  L +  +++     ++  NL  L  ++L+ N+L   
Sbjct: 212 LDLSGNHLS-AIRPGSFQGLMHLQKLWMIQSQIQVIERNAFDNLQSLVEINLAHNNL-TL 269

Query: 204 IPES-LANNAELLFLDVQNN 222
           +P         L  + + +N
Sbjct: 270 LPHDLFTPLHHLERIHLHHN 289

>3zyj_A Leucine-rich repeat-containing protein 4C; cell adhesion, synapse; HET: NAG BMA MAN; 3.25A {Homo sapiens} Length = 440

 Score = 72.5 bits (178), Expect = 1e-13
 Identities = 41/190 (21%), Positives = 69/190 (36%), Gaps = 19/190 (10%)

Query: 44  LLQSWTENGDPCSGSFEGIACNEHRKVANISLQGKGLT---GKLSPSLSGLKCLSGLYLH 100
              + T +   C        C+   + + +    K L      +S +   L       LH
Sbjct: 24  GCVAETGSAQTCPS-----VCSCSNQFSKVICVRKNLREVPDGISTNTRLL------NLH 72

Query: 101 YNSLSGEIPKEIRNLTELTDLYLDVNNLSGNIPPEI-GSMASLQVLQLCCNQLTGNIPAQ 159
            N +        ++L  L  L L  N++   I       +A+L  L+L  N+LT  IP  
Sbjct: 73  ENQIQIIKVNSFKHLRHLEILQLSRNHIR-TIEIGAFNGLANLNTLELFDNRLT-TIPNG 130

Query: 160 I-GSLKSLSVLTLQHNRLNGGIPDSLGNLGKLKRLDLSFNSLFGTIPE-SLANNAELLFL 217
               L  L  L L++N +      +   +  L+RLDL        I E +    + L +L
Sbjct: 131 AFVYLSKLKELWLRNNPIESIPSYAFNRIPSLRRLDLGELKRLSYISEGAFEGLSNLRYL 190

Query: 218 DVQNNTLSGI 227
           ++    L  I
Sbjct: 191 NLAMCNLREI 200

>3zyj_A Leucine-rich repeat-containing protein 4C; cell adhesion, synapse; HET: NAG BMA MAN; 3.25A {Homo sapiens} Length = 440

 Score = 68.2 bits (167), Expect = 3e-12
 Identities = 36/116 (31%), Positives = 51/116 (43%), Gaps = 6/116 (5%)

Query: 87  SLSGLKCLSGLYLHYNSLSGEIPKEIRNLTELTDLYLDVNNLSGNIPPEI-GSMASLQVL 145
           +  GL  L  L L   +L  EIP  +  L +L +L L  N+LS  I P     +  LQ L
Sbjct: 180 AFEGLSNLRYLNLAMCNLR-EIP-NLTPLIKLDELDLSGNHLS-AIRPGSFQGLMHLQKL 236

Query: 146 QLCCNQLTGNIPAQ-IGSLKSLSVLTLQHNRLNGGIPDSLGNLGKLKRLDLSFNSL 200
            +  +Q+   I      +L+SL  + L HN L     D    L  L+R+ L  N  
Sbjct: 237 WMIQSQIQ-VIERNAFDNLQSLVEINLAHNNLTLLPHDLFTPLHHLERIHLHHNPW 291

>3zyj_A Leucine-rich repeat-containing protein 4C; cell adhesion, synapse; HET: NAG BMA MAN; 3.25A {Homo sapiens} Length = 440

 Score = 64.0 bits (156), Expect = 6e-11
 Identities = 27/127 (21%), Positives = 47/127 (37%), Gaps = 3/127 (2%)

Query: 109 PKEIRNLTELTDLYLDVNNLSGNIPPEIGSMASLQVLQLCCNQLTGNIPAQIGSLKSLSV 168
           P       + + +     NL   +P  I    + ++L L  NQ+          L+ L +
Sbjct: 36  PSVCSCSNQFSKVICVRKNLR-EVPDGIS--TNTRLLNLHENQIQIIKVNSFKHLRHLEI 92

Query: 169 LTLQHNRLNGGIPDSLGNLGKLKRLDLSFNSLFGTIPESLANNAELLFLDVQNNTLSGIV 228
           L L  N +      +   L  L  L+L  N L      +    ++L  L ++NN +  I 
Sbjct: 93  LQLSRNHIRTIEIGAFNGLANLNTLELFDNRLTTIPNGAFVYLSKLKELWLRNNPIESIP 152

Query: 229 PSALKRL 235
             A  R+
Sbjct: 153 SYAFNRI 159

>3zyj_A Leucine-rich repeat-containing protein 4C; cell adhesion, synapse; HET: NAG BMA MAN; 3.25A {Homo sapiens} Length = 440

 Score = 58.2 bits (141), Expect = 4e-09
 Identities = 26/92 (28%), Positives = 39/92 (42%), Gaps = 6/92 (6%)

Query: 86  PSLSGLKCLSGLYLHYNSLSGEIPKEI-RNLTELTDLYLDVNNLSGNIPPE-IGSMASLQ 143
           P+L+ L  L  L L  N LS  I     + L  L  L++  + +   I      ++ SL 
Sbjct: 201 PNLTPLIKLDELDLSGNHLS-AIRPGSFQGLMHLQKLWMIQSQIQ-VIERNAFDNLQSLV 258

Query: 144 VLQLCCNQLTGNIPAQI-GSLKSLSVLTLQHN 174
            + L  N LT  +P  +   L  L  + L HN
Sbjct: 259 EINLAHNNLT-LLPHDLFTPLHHLERIHLHHN 289

>2id5_A Lingo-1, leucine rich repeat neuronal 6A; CNS-specific LRR-IG containing, ligand binding protein,membr protein; HET: NAG MAN; 2.70A {Homo sapiens} Length = 477

 Score = 86.3 bits (214), Expect = 6e-18
 Identities = 38/151 (25%), Positives = 65/151 (43%), Gaps = 6/151 (3%)

Query: 88  LSGLKCLSGLYLHYNSLSGEIPKEI-RNLTELTDLYLDVNNLSGNIPPEI-GSMASLQVL 145
            +GL  L+ L +  N +   +   + ++L  L  L +  N+L   I       + SL+ L
Sbjct: 100 FTGLSNLTKLDISENKIV-ILLDYMFQDLYNLKSLEVGDNDLV-YISHRAFSGLNSLEQL 157

Query: 146 QLCCNQLTGNIPAQI-GSLKSLSVLTLQHNRLNGGIPDSLGNLGKLKRLDLSFNSLFGTI 204
            L    LT +IP +    L  L VL L+H  +N     S   L +LK L++S      T+
Sbjct: 158 TLEKCNLT-SIPTEALSHLHGLIVLRLRHLNINAIRDYSFKRLYRLKVLEISHWPYLDTM 216

Query: 205 PESLANNAELLFLDVQNNTLSGIVPSALKRL 235
             +      L  L + +  L+ +   A++ L
Sbjct: 217 TPNCLYGLNLTSLSITHCNLTAVPYLAVRHL 247

>2id5_A Lingo-1, leucine rich repeat neuronal 6A; CNS-specific LRR-IG containing, ligand binding protein,membr protein; HET: NAG MAN; 2.70A {Homo sapiens} Length = 477

 Score = 83.2 bits (206), Expect = 5e-17
 Identities = 36/166 (21%), Positives = 60/166 (36%), Gaps = 6/166 (3%)

Query: 87  SLSGLKCLSGLYLHYNSLSGEIPKEI-RNLTELTDLYLDVNNLSGNIPPEIGSMASLQVL 145
           +LS L  L  L L + +++  I     + L  L  L +        + P      +L  L
Sbjct: 171 ALSHLHGLIVLRLRHLNIN-AIRDYSFKRLYRLKVLEISHWPYLDTMTPNCLYGLNLTSL 229

Query: 146 QLCCNQLTGNIPAQ-IGSLKSLSVLTLQHNRLNGGIPDSLGNLGKLKRLDLSFNSLFGTI 204
            +    LT  +P   +  L  L  L L +N ++      L  L +L+ + L    L    
Sbjct: 230 SITHCNLT-AVPYLAVRHLVYLRFLNLSYNPISTIEGSMLHELLRLQEIQLVGGQLAVVE 288

Query: 205 PESLANNAELLFLDVQNNTLSGIVPSALKRLN--GGFQFQNNPGLC 248
           P +      L  L+V  N L+ +  S    +         +NP  C
Sbjct: 289 PYAFRGLNYLRVLNVSGNQLTTLEESVFHSVGNLETLILDSNPLAC 334

>2id5_A Lingo-1, leucine rich repeat neuronal 6A; CNS-specific LRR-IG containing, ligand binding protein,membr protein; HET: NAG MAN; 2.70A {Homo sapiens} Length = 477

 Score = 80.5 bits (199), Expect = 4e-16
 Identities = 38/167 (22%), Positives = 70/167 (41%), Gaps = 8/167 (4%)

Query: 73  ISLQGKGLTGKLSPSLSGLKCLSGLYLHYNSLSGEIPKEI-RNLTELTDLYLDVNNLSGN 131
           + L    +        +    L  L L+ N +S  +      NL  L  L L  N L   
Sbjct: 37  LDLGKNRIKTLNQDEFASFPHLEELELNENIVS-AVEPGAFNNLFNLRTLGLRSNRLK-L 94

Query: 132 IPPEI-GSMASLQVLQLCCNQLTGNIPAQI-GSLKSLSVLTLQHNRLNGGIPDSLGNLGK 189
           IP  +   +++L  L +  N++   +   +   L +L  L +  N L      +   L  
Sbjct: 95  IPLGVFTGLSNLTKLDISENKIV-ILLDYMFQDLYNLKSLEVGDNDLVYISHRAFSGLNS 153

Query: 190 LKRLDLSFNSLFGTIP-ESLANNAELLFLDVQNNTLSGIVPSALKRL 235
           L++L L   +L  +IP E+L++   L+ L +++  ++ I   + KRL
Sbjct: 154 LEQLTLEKCNL-TSIPTEALSHLHGLIVLRLRHLNINAIRDYSFKRL 199

>2id5_A Lingo-1, leucine rich repeat neuronal 6A; CNS-specific LRR-IG containing, ligand binding protein,membr protein; HET: NAG MAN; 2.70A {Homo sapiens} Length = 477

 Score = 71.3 bits (175), Expect = 3e-13
 Identities = 35/142 (24%), Positives = 56/142 (39%), Gaps = 7/142 (4%)

Query: 97  LYLHYNSLSGEIPKEIRNLTELTDLYLDVNNLSGNIPPEI-GSMASLQVLQLCCNQLTGN 155
           +  H       +P+ I   TE   L L  N +   +  +   S   L+ L+L  N ++  
Sbjct: 16  VLCHRKRFV-AVPEGI--PTETRLLDLGKNRIK-TLNQDEFASFPHLEELELNENIVS-A 70

Query: 156 IPAQI-GSLKSLSVLTLQHNRLNGGIPDSLGNLGKLKRLDLSFNSLFGTIPESLANNAEL 214
           +      +L +L  L L+ NRL          L  L +LD+S N +   +     +   L
Sbjct: 71  VEPGAFNNLFNLRTLGLRSNRLKLIPLGVFTGLSNLTKLDISENKIVILLDYMFQDLYNL 130

Query: 215 LFLDVQNNTLSGIVPSALKRLN 236
             L+V +N L  I   A   LN
Sbjct: 131 KSLEVGDNDLVYISHRAFSGLN 152

>2id5_A Lingo-1, leucine rich repeat neuronal 6A; CNS-specific LRR-IG containing, ligand binding protein,membr protein; HET: NAG MAN; 2.70A {Homo sapiens} Length = 477

 Score = 64.7 bits (158), Expect = 4e-11
 Identities = 31/130 (23%), Positives = 53/130 (40%), Gaps = 6/130 (4%)

Query: 74  SLQGKGLTGKLSPSLSGLKCLSGLYLHYNSLSGEIPKE-IRNLTELTDLYLDVNNLSGNI 132
            +        ++P+      L+ L + + +L+  +P   +R+L  L  L L  N +S  I
Sbjct: 206 EISHWPYLDTMTPNCLYGLNLTSLSITHCNLT-AVPYLAVRHLVYLRFLNLSYNPIS-TI 263

Query: 133 PPEI-GSMASLQVLQLCCNQLTGNIPAQI-GSLKSLSVLTLQHNRLNGGIPDSLGNLGKL 190
              +   +  LQ +QL   QL   +       L  L VL +  N+L         ++G L
Sbjct: 264 EGSMLHELLRLQEIQLVGGQLA-VVEPYAFRGLNYLRVLNVSGNQLTTLEESVFHSVGNL 322

Query: 191 KRLDLSFNSL 200
           + L L  N L
Sbjct: 323 ETLILDSNPL 332

>3oja_B Anopheles plasmodium-responsive leucine-rich REPE 1; coiled-coil, helix-loop-helix, leucine-rich repeat, protein; HET: NAG MAN; 2.70A {Anopheles gambiae} Length = 597

 Score = 86.5 bits (214), Expect = 8e-18
 Identities = 35/150 (23%), Positives = 61/150 (40%), Gaps = 9/150 (6%)

Query: 87  SLSGLKCLSGLYLHYNSLSGEIPKEIRNLTELTDLYLDVNNLSGNIPPEIGSMASLQVLQ 146
           +L+    +  L   +NS++  +   +    ELT L L  NNL+      + +   L  + 
Sbjct: 206 TLAIPIAVEELDASHNSIN-VVRGPV--NVELTILKLQHNNLTD--TAWLLNYPGLVEVD 260

Query: 147 LCCNQLTGNIPAQI-GSLKSLSVLTLQHNRLNGGIPDSLGNLGKLKRLDLSFNSLFGTIP 205
           L  N+L   I       ++ L  L + +NRL   +      +  LK LDLS N L   + 
Sbjct: 261 LSYNELE-KIMYHPFVKMQRLERLYISNNRLV-ALNLYGQPIPTLKVLDLSHNHL-LHVE 317

Query: 206 ESLANNAELLFLDVQNNTLSGIVPSALKRL 235
            +      L  L + +N++  +  S    L
Sbjct: 318 RNQPQFDRLENLYLDHNSIVTLKLSTHHTL 347

>3oja_B Anopheles plasmodium-responsive leucine-rich REPE 1; coiled-coil, helix-loop-helix, leucine-rich repeat, protein; HET: NAG MAN; 2.70A {Anopheles gambiae} Length = 597

 Score = 83.8 bits (207), Expect = 6e-17
 Identities = 30/167 (17%), Positives = 66/167 (39%), Gaps = 8/167 (4%)

Query: 72  NISLQGKGLTGKLSPSLSGLKCLSGLYLHYNSLSGEIPKEI-RNLTELTDLYLDVNNLSG 130
           +I +Q + +          L     +    +++  ++P  +  +  ++  L L+   +  
Sbjct: 33  HIDMQTQDVY--FGFEDITLNNQKIVTFKNSTMR-KLPAALLDSFRQVELLNLNDLQIE- 88

Query: 131 NIPPEI-GSMASLQVLQLCCNQLTGNIPAQI-GSLKSLSVLTLQHNRLNGGIPDSLGNLG 188
            I         ++Q L +  N +   +P  +  ++  L+VL L+ N L+        N  
Sbjct: 89  EIDTYAFAYAHTIQKLYMGFNAIR-YLPPHVFQNVPLLTVLVLERNDLSSLPRGIFHNTP 147

Query: 189 KLKRLDLSFNSLFGTIPESLANNAELLFLDVQNNTLSGIVPSALKRL 235
           KL  L +S N+L     ++      L  L + +N L+ +  S +  L
Sbjct: 148 KLTTLSMSNNNLERIEDDTFQATTSLQNLQLSSNRLTHVDLSLIPSL 194

>3oja_B Anopheles plasmodium-responsive leucine-rich REPE 1; coiled-coil, helix-loop-helix, leucine-rich repeat, protein; HET: NAG MAN; 2.70A {Anopheles gambiae} Length = 597

 Score = 76.5 bits (188), Expect = 1e-14
 Identities = 30/116 (25%), Positives = 42/116 (36%), Gaps = 7/116 (6%)

Query: 86  PSLSGLKCLSGLYLHYNSLSGEIPKEI-RNLTELTDLYLDVNNLSGNIPPEIGSMASLQV 144
             L     L  + L YN L  +I       +  L  LY+  N L   +      + +L+V
Sbjct: 248 AWLLNYPGLVEVDLSYNELE-KIMYHPFVKMQRLERLYISNNRLV-ALNLYGQPIPTLKV 305

Query: 145 LQLCCNQLTGNIPAQIGSLKSLSVLTLQHNRLNGGIPDSLGNLGKLKRLDLSFNSL 200
           L L  N L  ++         L  L L HN +   +   L     LK L LS N  
Sbjct: 306 LDLSHNHLL-HVERNQPQFDRLENLYLDHNSIV-TLK--LSTHHTLKNLTLSHNDW 357

>3oja_B Anopheles plasmodium-responsive leucine-rich REPE 1; coiled-coil, helix-loop-helix, leucine-rich repeat, protein; HET: NAG MAN; 2.70A {Anopheles gambiae} Length = 597

 Score = 76.5 bits (188), Expect = 1e-14
 Identities = 30/147 (20%), Positives = 57/147 (38%), Gaps = 11/147 (7%)

Query: 87  SLSGLKCLSGLYLHYNSLSGEIPKEIRNLTELTDLYLDVNNLSGNIPPEIGSMASLQVLQ 146
            LS +  L    + YN LS      +     + +L    N+++  +         L +L+
Sbjct: 187 DLSLIPSLFHANVSYNLLS-----TLAIPIAVEELDASHNSIN-VVRG--PVNVELTILK 238

Query: 147 LCCNQLTGNIPAQIGSLKSLSVLTLQHNRLNGGIPDSLGNLGKLKRLDLSFNSLFGTIPE 206
           L  N LT +    + +   L  + L +N L   +      + +L+RL +S N L   +  
Sbjct: 239 LQHNNLT-DTAW-LLNYPGLVEVDLSYNELEKIMYHPFVKMQRLERLYISNNRL-VALNL 295

Query: 207 SLANNAELLFLDVQNNTLSGIVPSALK 233
                  L  LD+ +N L  +  +  +
Sbjct: 296 YGQPIPTLKVLDLSHNHLLHVERNQPQ 322

>3oja_B Anopheles plasmodium-responsive leucine-rich REPE 1; coiled-coil, helix-loop-helix, leucine-rich repeat, protein; HET: NAG MAN; 2.70A {Anopheles gambiae} Length = 597

 Score = 75.0 bits (184), Expect = 3e-14
 Identities = 43/168 (25%), Positives = 68/168 (40%), Gaps = 25/168 (14%)

Query: 87  SLSGLKCLSGLYLHYNSLSGEIPKEI-RNLTELTDLYLDVNNLSGNIPPEI-GSMASLQV 144
               +  L+ L L  N LS  +P+ I  N  +LT L +  NNL   I  +   +  SLQ 
Sbjct: 118 VFQNVPLLTVLVLERNDLS-SLPRGIFHNTPKLTTLSMSNNNLE-RIEDDTFQATTSLQN 175

Query: 145 LQLCCNQLT----------------GNIPAQIGSLKSLSVLTLQHNRLNGGIPDSLGNLG 188
           LQL  N+LT                 N+ + +    ++  L   HN +N  +   +    
Sbjct: 176 LQLSSNRLTHVDLSLIPSLFHANVSYNLLSTLAIPIAVEELDASHNSIN-VVRGPV--NV 232

Query: 189 KLKRLDLSFNSLFGTIPESLANNAELLFLDVQNNTLSGIVPSALKRLN 236
           +L  L L  N+L  T    L N   L+ +D+  N L  I+     ++ 
Sbjct: 233 ELTILKLQHNNL--TDTAWLLNYPGLVEVDLSYNELEKIMYHPFVKMQ 278

>3oja_B Anopheles plasmodium-responsive leucine-rich REPE 1; coiled-coil, helix-loop-helix, leucine-rich repeat, protein; HET: NAG MAN; 2.70A {Anopheles gambiae} Length = 597

 Score = 72.7 bits (178), Expect = 2e-13
 Identities = 25/141 (17%), Positives = 47/141 (33%), Gaps = 6/141 (4%)

Query: 99  LHYNSLSGEIPK--EIRNLTELTDLYLDVNNLSGNIPPEI-GSMASLQVLQLCCNQLTGN 155
           +H +  + ++    E   L     +    + +   +P  +  S   +++L L   Q+   
Sbjct: 32  VHIDMQTQDVYFGFEDITLNNQKIVTFKNSTMR-KLPAALLDSFRQVELLNLNDLQIE-E 89

Query: 156 IPAQI-GSLKSLSVLTLQHNRLNGGIPDSLGNLGKLKRLDLSFNSLFGTIPESLANNAEL 214
           I         ++  L +  N +    P    N+  L  L L  N L         N  +L
Sbjct: 90  IDTYAFAYAHTIQKLYMGFNAIRYLPPHVFQNVPLLTVLVLERNDLSSLPRGIFHNTPKL 149

Query: 215 LFLDVQNNTLSGIVPSALKRL 235
             L + NN L  I     +  
Sbjct: 150 TTLSMSNNNLERIEDDTFQAT 170

>3oja_B Anopheles plasmodium-responsive leucine-rich REPE 1; coiled-coil, helix-loop-helix, leucine-rich repeat, protein; HET: NAG MAN; 2.70A {Anopheles gambiae} Length = 597

 Score = 68.8 bits (168), Expect = 3e-12
 Identities = 21/144 (14%), Positives = 53/144 (36%), Gaps = 9/144 (6%)

Query: 99  LHYNSLS-----GEIPKEIRNLTELTDLYLDVNNLSGNIPPEIGSMASLQVLQLCCNQLT 153
             YN          I   ++      D+++D+         E  ++ + +++    + + 
Sbjct: 5   QRYNVKPRQPEYKCIDSNLQYDCVFYDVHIDMQTQDVYFGFEDITLNNQKIVTFKNSTMR 64

Query: 154 GNIPAQI-GSLKSLSVLTLQHNRLNGGIPDSLGNLGKLKRLDLSFNSLFGTIPES-LANN 211
             +PA +  S + + +L L   ++      +      +++L + FN++   +P     N 
Sbjct: 65  -KLPAALLDSFRQVELLNLNDLQIEEIDTYAFAYAHTIQKLYMGFNAI-RYLPPHVFQNV 122

Query: 212 AELLFLDVQNNTLSGIVPSALKRL 235
             L  L ++ N LS +        
Sbjct: 123 PLLTVLVLERNDLSSLPRGIFHNT 146

>3oja_B Anopheles plasmodium-responsive leucine-rich REPE 1; coiled-coil, helix-loop-helix, leucine-rich repeat, protein; HET: NAG MAN; 2.70A {Anopheles gambiae} Length = 597

 Score = 64.9 bits (158), Expect = 5e-11
 Identities = 24/124 (19%), Positives = 44/124 (35%), Gaps = 7/124 (5%)

Query: 87  SLSGLKCLSGLYLHYNSLSGEIPKEIRNLTELTDLYLDVNNLSGNIPPEIGSMASLQVLQ 146
               ++ L  LY+  N L   +    + +  L  L L  N+L  ++         L+ L 
Sbjct: 273 PFVKMQRLERLYISNNRLV-ALNLYGQPIPTLKVLDLSHNHLL-HVERNQPQFDRLENLY 330

Query: 147 LCCNQLTGNIPAQIGSLKSLSVLTLQHNRLNGGIPDSLGNLGKLKRLDLSFNSLFGTIPE 206
           L  N +   +   + +  +L  LTL HN  +     +L     + R  +        I  
Sbjct: 331 LDHNSIV-TLK--LSTHHTLKNLTLSHNDWDCNSLRAL--FRNVARPAVDDADQHCKIDY 385

Query: 207 SLAN 210
            L +
Sbjct: 386 QLEH 389

>3oja_B Anopheles plasmodium-responsive leucine-rich REPE 1; coiled-coil, helix-loop-helix, leucine-rich repeat, protein; HET: NAG MAN; 2.70A {Anopheles gambiae} Length = 597

 Score = 48.8 bits (116), Expect = 5e-06
 Identities = 19/103 (18%), Positives = 39/103 (37%), Gaps = 6/103 (5%)

Query: 84  LSPSLSGLKCLSGLYLHYNSLSGEIPKEIRNLTELTDLYLDVNNLSGNIPPEIGSMASLQ 143
           L+     +  L  L L +N L   + +       L +LYLD N++   +     +  +L+
Sbjct: 293 LNLYGQPIPTLKVLDLSHNHLL-HVERNQPQFDRLENLYLDHNSIV-TLKL--STHHTLK 348

Query: 144 VLQLCCNQLTGNIPAQIGSLKSLSVLTLQHNRLNGGIPDSLGN 186
            L L  N    N    +   ++++   +     +  I   L +
Sbjct: 349 NLTLSHNDWDCNSLRAL--FRNVARPAVDDADQHCKIDYQLEH 389

>3dzo_A Rhoptry kinase domain; parasitic disease, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} Length = 413

 Score = 85.1 bits (210), Expect = 1e-17
 Identities = 38/301 (12%), Positives = 77/301 (25%), Gaps = 64/301 (21%)

Query: 416 LLGKGNFSSVYKGT-LRDGTLVAIRSINVTSCKSEEA----------------------- 451
           +LG+ +  +  + T    G    +     T      A                       
Sbjct: 85  VLGQEDPYAYLEATDQETGESFEVHVPYFTERPPSNAIKQMKEEVLRLRLLRGIKNQKQA 144

Query: 452 ----EFVKGLYLLTSLRHENIIRLRGFCCSRGRGECFLIYDFAPK--GKLSKYLDQEEGS 505
                F+    L+   + + +IR+R           F +Y           + L     +
Sbjct: 145 KVHLRFIFPFDLVKDPQKKKMIRVRLDERDMWVLSRFFLYPRMQSNLQTFGEVLLSHSST 204

Query: 506 SNVLDWSTRVSIIIGIAKGIGYLHSSEVNKPAIVHRNLSVEKVLIDQQFNPLIADCGLHK 565
              L    R+ + + + + +  LH        +VH  L    +++DQ+    +       
Sbjct: 205 HKSLVHHARLQLTLQVIRLLASLHHYG-----LVHTYLRPVDIVLDQRGGVFLTGFEHLV 259

Query: 566 LLADDIVFSVLKTSAAMGYLAPEYVT----------TGRFTERSDIFAFGVIILQILTGS 615
                 V     +    G+  PE                 T   D +  G+ I  I    
Sbjct: 260 RDGASAV-----SPIGRGFAPPETTAERMLPFGQHHPTLMTFAFDTWTLGLAIYWIWCA- 313

Query: 616 LVLTSSMRLAAESATFENFIDRNLKGKFSESEAAKLGKMALV--CTHEDPENRPTMEAVI 673
                   L           +   +   +  +  +    AL+        E+R      +
Sbjct: 314 -------DLPNTDDAALGGSEWIFRSCKNIPQPVR----ALLEGFLRYPKEDRLLPLQAM 362

Query: 674 E 674
           E
Sbjct: 363 E 363

>3o6n_A APL1; leucine-rich repeat, protein binding; HET: NAG; 1.85A {Anopheles gambiae} Length = 390

 Score = 84.7 bits (210), Expect = 1e-17
 Identities = 28/167 (16%), Positives = 64/167 (38%), Gaps = 6/167 (3%)

Query: 72  NISLQGKGLTGKLSPSLSGLKCLSGLYLHYNSLSGEIPKEI-RNLTELTDLYLDVNNLSG 130
           ++ +  +            L     +    +++  ++P  +  +  ++  L L+   +  
Sbjct: 25  DVHIDMQTQDVYFGFEDITLNNQKIVTFKNSTMR-KLPAALLDSFRQVELLNLNDLQIE- 82

Query: 131 NIPPEI-GSMASLQVLQLCCNQLTGNIPAQI-GSLKSLSVLTLQHNRLNGGIPDSLGNLG 188
            I         ++Q L +  N +   +P  +  ++  L+VL L+ N L+        N  
Sbjct: 83  EIDTYAFAYAHTIQKLYMGFNAIR-YLPPHVFQNVPLLTVLVLERNDLSSLPRGIFHNTP 141

Query: 189 KLKRLDLSFNSLFGTIPESLANNAELLFLDVQNNTLSGIVPSALKRL 235
           KL  L +S N+L     ++      L  L + +N L+ +  S +  L
Sbjct: 142 KLTTLSMSNNNLERIEDDTFQATTSLQNLQLSSNRLTHVDLSLIPSL 188

>3o6n_A APL1; leucine-rich repeat, protein binding; HET: NAG; 1.85A {Anopheles gambiae} Length = 390

 Score = 83.2 bits (206), Expect = 4e-17
 Identities = 37/152 (24%), Positives = 67/152 (44%), Gaps = 14/152 (9%)

Query: 87  SLSGLKCLSGLYLHYNSLSGEIPKEI-RNLTELTDLYLDVNNLSGNIPPEI-GSMASLQV 144
           + +    +  LY+ +N++   +P  + +N+  LT L L+ N+LS ++P  I  +   L  
Sbjct: 88  AFAYAHTIQKLYMGFNAIR-YLPPHVFQNVPLLTVLVLERNDLS-SLPRGIFHNTPKLTT 145

Query: 145 LQLCCNQLTGNIPAQI-GSLKSLSVLTLQHNRLNGGIPDSLGNLGKLKRLDLSFNSLFGT 203
           L +  N L   I      +  SL  L L  NRL   +   L  +  L   ++S+N L   
Sbjct: 146 LSMSNNNLE-RIEDDTFQATTSLQNLQLSSNRLT-HVD--LSLIPSLFHANVSYNLL--- 198

Query: 204 IPESLANNAELLFLDVQNNTLSGIVPSALKRL 235
              +LA    +  LD  +N+++ +       L
Sbjct: 199 --STLAIPIAVEELDASHNSINVVRGPVNVEL 228

>3o6n_A APL1; leucine-rich repeat, protein binding; HET: NAG; 1.85A {Anopheles gambiae} Length = 390

 Score = 82.8 bits (205), Expect = 5e-17
 Identities = 37/156 (23%), Positives = 61/156 (39%), Gaps = 9/156 (5%)

Query: 94  LSGLYLHYNSLSGEIPKEIRNLTELTDLYLDVNNLSGNIPPEI-GSMASLQVLQLCCNQL 152
           L+ L L +N+L+ +    + N   L ++ L  N L   I       M  L+ L +  N+L
Sbjct: 228 LTILKLQHNNLT-DTA-WLLNYPGLVEVDLSYNELE-KIMYHPFVKMQRLERLYISNNRL 284

Query: 153 TGNIPAQIGSLKSLSVLTLQHNRLNGGIPDSLGNLGKLKRLDLSFNSLFGTIPESLANNA 212
              +      + +L VL L HN L   +  +     +L+ L L  NS+  T+  S  +  
Sbjct: 285 V-ALNLYGQPIPTLKVLDLSHNHLLH-VERNQPQFDRLENLYLDHNSI-VTLKLSTHHT- 340

Query: 213 ELLFLDVQNNTLSGIVPSALKRLNGGFQFQNNPGLC 248
            L  L + +N        AL R        +    C
Sbjct: 341 -LKNLTLSHNDWDCNSLRALFRNVARPAVDDADQHC 375

>3o6n_A APL1; leucine-rich repeat, protein binding; HET: NAG; 1.85A {Anopheles gambiae} Length = 390

 Score = 77.4 bits (191), Expect = 3e-15
 Identities = 30/116 (25%), Positives = 42/116 (36%), Gaps = 7/116 (6%)

Query: 86  PSLSGLKCLSGLYLHYNSLSGEIPKEI-RNLTELTDLYLDVNNLSGNIPPEIGSMASLQV 144
             L     L  + L YN L  +I       +  L  LY+  N L   +      + +L+V
Sbjct: 242 AWLLNYPGLVEVDLSYNELE-KIMYHPFVKMQRLERLYISNNRLV-ALNLYGQPIPTLKV 299

Query: 145 LQLCCNQLTGNIPAQIGSLKSLSVLTLQHNRLNGGIPDSLGNLGKLKRLDLSFNSL 200
           L L  N L  ++         L  L L HN +   +   L     LK L LS N  
Sbjct: 300 LDLSHNHLL-HVERNQPQFDRLENLYLDHNSIV-TLK--LSTHHTLKNLTLSHNDW 351

>3o6n_A APL1; leucine-rich repeat, protein binding; HET: NAG; 1.85A {Anopheles gambiae} Length = 390

 Score = 73.9 bits (182), Expect = 4e-14
 Identities = 25/151 (16%), Positives = 47/151 (31%), Gaps = 4/151 (2%)

Query: 87  SLSGLKCLSGLYLHYNSLSGEIPKEIRNLTELTDLYLDVNNLSGNIPPEI-GSMASLQVL 145
           +L        +++   +       E   L     +    + +   +P  +  S   +++L
Sbjct: 16  NLQYDCVFYDVHIDMQTQDVYFGFEDITLNNQKIVTFKNSTMR-KLPAALLDSFRQVELL 74

Query: 146 QLCCNQLTGNIPAQI-GSLKSLSVLTLQHNRLNGGIPDSLGNLGKLKRLDLSFNSLFGTI 204
            L   Q+   I         ++  L +  N +    P    N+  L  L L  N L    
Sbjct: 75  NLNDLQIE-EIDTYAFAYAHTIQKLYMGFNAIRYLPPHVFQNVPLLTVLVLERNDLSSLP 133

Query: 205 PESLANNAELLFLDVQNNTLSGIVPSALKRL 235
                N  +L  L + NN L  I     +  
Sbjct: 134 RGIFHNTPKLTTLSMSNNNLERIEDDTFQAT 164

>3o6n_A APL1; leucine-rich repeat, protein binding; HET: NAG; 1.85A {Anopheles gambiae} Length = 390

 Score = 73.9 bits (182), Expect = 4e-14
 Identities = 35/158 (22%), Positives = 56/158 (35%), Gaps = 23/158 (14%)

Query: 87  SLSGLKCLSGLYLHYNSLSGEIPKEI-RNLTELTDLYLDVN----------------NLS 129
                  L+ L +  N+L   I  +  +  T L +L L  N                N+S
Sbjct: 136 IFHNTPKLTTLSMSNNNLE-RIEDDTFQATTSLQNLQLSSNRLTHVDLSLIPSLFHANVS 194

Query: 130 GNIPPEIGSMASLQVLQLCCNQLTGNIPAQIGSLKSLSVLTLQHNRLNGGIPDSLGNLGK 189
            N+   +    +++ L    N +   +         L++L LQHN L       L N   
Sbjct: 195 YNLLSTLAIPIAVEELDASHNSIN-VVRG--PVNVELTILKLQHNNLTD--TAWLLNYPG 249

Query: 190 LKRLDLSFNSLFGTIPESLANNAELLFLDVQNNTLSGI 227
           L  +DLS+N L   +         L  L + NN L  +
Sbjct: 250 LVEVDLSYNELEKIMYHPFVKMQRLERLYISNNRLVAL 287

>3o6n_A APL1; leucine-rich repeat, protein binding; HET: NAG; 1.85A {Anopheles gambiae} Length = 390

 Score = 70.5 bits (173), Expect = 4e-13
 Identities = 19/129 (14%), Positives = 50/129 (38%), Gaps = 2/129 (1%)

Query: 108 IPKEIRNLTELTDLYLDVNNLSGNIPPEIGSMASLQVLQLCCNQLTGNIPAQI-GSLKSL 166
           I   ++      D+++D+         E  ++ + +++    + +   +PA +  S + +
Sbjct: 13  IDSNLQYDCVFYDVHIDMQTQDVYFGFEDITLNNQKIVTFKNSTMR-KLPAALLDSFRQV 71

Query: 167 SVLTLQHNRLNGGIPDSLGNLGKLKRLDLSFNSLFGTIPESLANNAELLFLDVQNNTLSG 226
            +L L   ++      +      +++L + FN++    P    N   L  L ++ N LS 
Sbjct: 72  ELLNLNDLQIEEIDTYAFAYAHTIQKLYMGFNAIRYLPPHVFQNVPLLTVLVLERNDLSS 131

Query: 227 IVPSALKRL 235
           +        
Sbjct: 132 LPRGIFHNT 140

>3o6n_A APL1; leucine-rich repeat, protein binding; HET: NAG; 1.85A {Anopheles gambiae} Length = 390

 Score = 48.9 bits (117), Expect = 3e-06
 Identities = 19/103 (18%), Positives = 39/103 (37%), Gaps = 6/103 (5%)

Query: 84  LSPSLSGLKCLSGLYLHYNSLSGEIPKEIRNLTELTDLYLDVNNLSGNIPPEIGSMASLQ 143
           L+     +  L  L L +N L   + +       L +LYLD N++   +     +  +L+
Sbjct: 287 LNLYGQPIPTLKVLDLSHNHLL-HVERNQPQFDRLENLYLDHNSIV-TLKL--STHHTLK 342

Query: 144 VLQLCCNQLTGNIPAQIGSLKSLSVLTLQHNRLNGGIPDSLGN 186
            L L  N    N    +   ++++   +     +  I   L +
Sbjct: 343 NLTLSHNDWDCNSLRAL--FRNVARPAVDDADQHCKIDYQLEH 383

>1p9a_G Platelet glycoprotein IB alpha chain precursor; platelet receptors, glycocalicin, leucine rich repeats, BLOO clotting; HET: NAG BMA; 1.70A {Homo sapiens} SCOP: c.10.2.7 PDB: 1ook_G* 1qyy_A* 3pmh_G* 1m0z_A 1m10_B 1sq0_B 1gwb_A* 1p8v_A* 1u0n_D 3p72_A Length = 290

 Score = 82.1 bits (203), Expect = 2e-17
 Identities = 41/140 (29%), Positives = 58/140 (41%), Gaps = 8/140 (5%)

Query: 86  PSLSGLKCLSGLYLHYNSLSGEIPKEIRNLTELTDLYLDVNNLSGNIPPEI-GSMASLQV 144
                L  L  L L +N L   +P   + L  LT L +  N L+ ++P      +  LQ 
Sbjct: 71  QVDGTLPVLGTLDLSHNQLQ-SLPLLGQTLPALTVLDVSFNRLT-SLPLGALRGLGELQE 128

Query: 145 LQLCCNQLTGNIPAQI-GSLKSLSVLTLQHNRLNGGIPDSL-GNLGKLKRLDLSFNSLFG 202
           L L  N+L   +P  +      L  L+L +N L   +P  L   L  L  L L  NSL  
Sbjct: 129 LYLKGNELK-TLPPGLLTPTPKLEKLSLANNNLTE-LPAGLLNGLENLDTLLLQENSL-Y 185

Query: 203 TIPESLANNAELLFLDVQNN 222
           TIP+    +  L F  +  N
Sbjct: 186 TIPKGFFGSHLLPFAFLHGN 205

>1p9a_G Platelet glycoprotein IB alpha chain precursor; platelet receptors, glycocalicin, leucine rich repeats, BLOO clotting; HET: NAG BMA; 1.70A {Homo sapiens} SCOP: c.10.2.7 PDB: 1ook_G* 1qyy_A* 3pmh_G* 1m0z_A 1m10_B 1sq0_B 1gwb_A* 1p8v_A* 1u0n_D 3p72_A Length = 290

 Score = 77.1 bits (190), Expect = 1e-15
 Identities = 52/189 (27%), Positives = 75/189 (39%), Gaps = 10/189 (5%)

Query: 72  NISLQGKGLTGKLSPS-LSGLKCLSGLYLHYNSLSGEIPKEIRNLTELTDLYLDVNNLSG 130
            + L    L    S + L     L+ L L    L+ ++      L  L  L L  N L  
Sbjct: 35  ILHLSENLLY-TFSLATLMPYTRLTQLNLDRAELT-KLQ-VDGTLPVLGTLDLSHNQLQ- 90

Query: 131 NIPPEIGSMASLQVLQLCCNQLTGNIPAQI-GSLKSLSVLTLQHNRLNGGIPDSLGNLGK 189
           ++P    ++ +L VL +  N+LT ++P      L  L  L L+ N L    P  L    K
Sbjct: 91  SLPLLGQTLPALTVLDVSFNRLT-SLPLGALRGLGELQELYLKGNELKTLPPGLLTPTPK 149

Query: 190 LKRLDLSFNSLFGTIPESLANN-AELLFLDVQNNTLSGIVPSALKRLNGGF-QFQNNPGL 247
           L++L L+ N+L   +P  L N    L  L +Q N+L  I           F     NP L
Sbjct: 150 LEKLSLANNNL-TELPAGLLNGLENLDTLLLQENSLYTIPKGFFGSHLLPFAFLHGNPWL 208

Query: 248 CGDGIASLR 256
           C   I   R
Sbjct: 209 CNCEILYFR 217

>1p9a_G Platelet glycoprotein IB alpha chain precursor; platelet receptors, glycocalicin, leucine rich repeats, BLOO clotting; HET: NAG BMA; 1.70A {Homo sapiens} SCOP: c.10.2.7 PDB: 1ook_G* 1qyy_A* 3pmh_G* 1m0z_A 1m10_B 1sq0_B 1gwb_A* 1p8v_A* 1u0n_D 3p72_A Length = 290

 Score = 59.0 bits (143), Expect = 1e-09
 Identities = 33/123 (26%), Positives = 49/123 (39%), Gaps = 6/123 (4%)

Query: 113 RNLTELTDLYLDVNNLSGNIPPEIGSMASLQVLQLCCNQLTGNIPAQIGSLKSLSVLTLQ 172
             +    ++  D  NL+  +PP++       +L L  N L     A +     L+ L L 
Sbjct: 7   SKVASHLEVNCDKRNLT-ALPPDLP--KDTTILHLSENLLYTFSLATLMPYTRLTQLNLD 63

Query: 173 HNRLNGGIPDSLGNLGKLKRLDLSFNSLFGTIPESLANNAELLFLDVQNNTLSGIVPSAL 232
              L   +    G L  L  LDLS N L  ++P        L  LDV  N L+ +   AL
Sbjct: 64  RAELT-KLQ-VDGTLPVLGTLDLSHNQL-QSLPLLGQTLPALTVLDVSFNRLTSLPLGAL 120

Query: 233 KRL 235
           + L
Sbjct: 121 RGL 123

>3mwu_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, bumped kinase inhibitor, BKI; HET: BK3; 1.98A {Cryptosporidium parvum} PDB: 3igo_A* 3ncg_A* Length = 486

 Score = 83.6 bits (207), Expect = 4e-17
 Identities = 75/318 (23%), Positives = 121/318 (38%), Gaps = 81/318 (25%)

Query: 392 EHLNSFRLNLEEVESATQCFSEVNLLGKGNFSSVYKGTLR-DGTLVAIRSINVTSCKSEE 450
            H +S R NL    +  + ++ V +LGKG+F  V K   R      A++ IN  S K+++
Sbjct: 5   HHHSSGRENLYFQGTFAERYNIVCMLGKGSFGEVLKCKDRITQQEYAVKVINKASAKNKD 64

Query: 451 AEFVKG-LYLLTSLRHENIIRLRGFC------------CSRGRGECFLIYDFAPKGKLSK 497
              +   + LL  L H NI++L                 + G GE  L  +   + + S 
Sbjct: 65  TSTILREVELLKKLDHPNIMKLFEILEDSSSFYIVGELYT-G-GE--LFDEIIKRKRFS- 119

Query: 498 YLDQEEGSSNVLDWSTRVSIIIGIAKGIGYLHSSEVNKPAIVHRNLSVEKVLI---DQQF 554
               E  ++          II  +  GI Y+H        IVHR+L  E +L+   ++  
Sbjct: 120 ----EHDAAR---------IIKQVFSGITYMHKH-----NIVHRDLKPENILLESKEKDC 161

Query: 555 NPLIADCGLHKLLADDIVFSVLKTSAAMGYLAPEYVTTGRFTERSDIFAFGVIILQILTG 614
           +  I D GL      +        +A   Y+APE V  G + E+ D+++ GVI+  +L+G
Sbjct: 162 DIKIIDFGLSTCFQQNTKMKDRIGTA--YYIAPE-VLRGTYDEKCDVWSAGVILYILLSG 218

Query: 615 SLVLTSSMRLAAESATFENFIDRNLKGKFSE----------------SEAAK--LGKMAL 656
           +                  F  +N                       S+ AK  + KM L
Sbjct: 219 TP----------------PFYGKNEYDILKRVETGKYAFDLPQWRTISDDAKDLIRKM-L 261

Query: 657 VCTHEDPENRPTMEAVIE 674
                 P  R T    +E
Sbjct: 262 TF---HPSLRITATQCLE 276

>3lij_A Calcium/calmodulin dependent protein kinase with A kinase domain and 4 calmodulin...; transferase, calcium dependent protein kinase; HET: ANP; 1.90A {Cryptosporidium parvum} PDB: 3hzt_A* 3dxn_A 3l19_A* Length = 494

 Score = 83.6 bits (207), Expect = 4e-17
 Identities = 64/285 (22%), Positives = 107/285 (37%), Gaps = 65/285 (22%)

Query: 417 LGKGNFSSVYKGTLR-DGTLVAIRSINVTSCKSEEAEFVKG-LYLLTSLRHENIIRLRGF 474
           LG G +  V     +      AI+ I  TS  +     +   + +L  L H NI++L  F
Sbjct: 45  LGSGAYGEVLLCRDKVTHVERAIKIIRKTSVSTSSNSKLLEEVAVLKLLDHPNIMKLYDF 104

Query: 475 C------------CSRGRGECFLIYDFAPKGKLSKYLDQEEGSSNVLDWSTRVSIIIGIA 522
                           G GE  L  +   + K +     E  ++          II  + 
Sbjct: 105 FEDKRNYYLVMECYK-G-GE--LFDEIIHRMKFN-----EVDAAV---------IIKQVL 146

Query: 523 KGIGYLHSSEVNKPAIVHRNLSVEKVLI---DQQFNPLIADCGLHKLLADDIVFSVLKTS 579
            G+ YLH        IVHR+L  E +L+   ++     I D GL  +  +         +
Sbjct: 147 SGVTYLHKH-----NIVHRDLKPENLLLESKEKDALIKIVDFGLSAVFENQKKMKERLGT 201

Query: 580 AAMGYLAPEYVTTGRFTERSDIFAFGVIILQILTGSLVLTSSMRLAAESATFENFIDRNL 639
           A   Y+APE V   ++ E+ D+++ GVI+  +L G            +       +    
Sbjct: 202 A--YYIAPE-VLRKKYDEKCDVWSIGVILFILLAGYPPFGGQT----DQEILRK-V---E 250

Query: 640 KGKF--------SESEAAK--LGKMALVCTHEDPENRPTMEAVIE 674
           KGK+        + SE AK  + +M L     D + R + +  +E
Sbjct: 251 KGKYTFDSPEWKNVSEGAKDLIKQM-LQ---FDSQRRISAQQALE 291

>2ft3_A Biglycan; proteoglycan, dimer interface, structural protein, signaling; HET: NAG FLC; 3.40A {Bos taurus} Length = 332

 Score = 81.6 bits (202), Expect = 7e-17
 Identities = 34/163 (20%), Positives = 62/163 (38%), Gaps = 7/163 (4%)

Query: 87  SLSGLKCLSGLYLHYNSL-SGEIPKEIRNLTELTDLYLDVNNLSGNIPPEIGSMASLQVL 145
             SGL+ ++ + +  N L +        +  +L  L +    L+  IP       +L  L
Sbjct: 142 VFSGLRNMNCIEMGGNPLENSGFEPGAFDGLKLNYLRISEAKLT-GIPK--DLPETLNEL 198

Query: 146 QLCCNQLTGNIPAQI-GSLKSLSVLTLQHNRLNGGIPDSLGNLGKLKRLDLSFNSLFGTI 204
            L  N++   I  +       L  L L HN++      SL  L  L+ L L  N L   +
Sbjct: 199 HLDHNKIQ-AIELEDLLRYSKLYRLGLGHNQIRMIENGSLSFLPTLRELHLDNNKL-SRV 256

Query: 205 PESLANNAELLFLDVQNNTLSGIVPSALKRLNGGFQFQNNPGL 247
           P  L +   L  + +  N ++ +  +    +  G +     G+
Sbjct: 257 PAGLPDLKLLQVVYLHTNNITKVGVNDFCPVGFGVKRAYYNGI 299

>2ft3_A Biglycan; proteoglycan, dimer interface, structural protein, signaling; HET: NAG FLC; 3.40A {Bos taurus} Length = 332

 Score = 78.1 bits (193), Expect = 9e-16
 Identities = 34/142 (23%), Positives = 54/142 (38%), Gaps = 8/142 (5%)

Query: 97  LYLHYNSLSGEIPKE-IRNLTELTDLYLDVNNLSGNIPPEI-GSMASLQVLQLCCNQLTG 154
           L L  N +S E+ K+  + L  L  L L  N +S  I  +    +  LQ L +  N L  
Sbjct: 59  LDLQNNDIS-ELRKDDFKGLQHLYALVLVNNKIS-KIHEKAFSPLRKLQKLYISKNHLV- 115

Query: 155 NIPAQIGSLKSLSVLTLQHNRLNGGIPDSLGNLGKLKRLDLSFNSL-FGTIPESLANNAE 213
            IP       SL  L +  NR+          L  +  +++  N L          +  +
Sbjct: 116 EIPP--NLPSSLVELRIHDNRIRKVPKGVFSGLRNMNCIEMGGNPLENSGFEPGAFDGLK 173

Query: 214 LLFLDVQNNTLSGIVPSALKRL 235
           L +L +    L+GI     + L
Sbjct: 174 LNYLRISEAKLTGIPKDLPETL 195

>2ft3_A Biglycan; proteoglycan, dimer interface, structural protein, signaling; HET: NAG FLC; 3.40A {Bos taurus} Length = 332

 Score = 74.3 bits (183), Expect = 2e-14
 Identities = 41/151 (27%), Positives = 65/151 (43%), Gaps = 9/151 (5%)

Query: 87  SLSGLKCLSGLYLHYNSLSGEIPKEIRNLTELTDLYLDVNNLSGNIPPEIGSMASLQVLQ 146
              GL+ L  L L  N +S    K    L +L  LY+  N+L   IPP     +SL  L+
Sbjct: 73  DFKGLQHLYALVLVNNKISKIHEKAFSPLRKLQKLYISKNHLV-EIPP--NLPSSLVELR 129

Query: 147 LCCNQLTGNIPAQI-GSLKSLSVLTLQHNRL-NGGIPDSLGNLGKLKRLDLSFNSLFGTI 204
           +  N++   +P  +   L++++ + +  N L N G      +  KL  L +S   L   I
Sbjct: 130 IHDNRIR-KVPKGVFSGLRNMNCIEMGGNPLENSGFEPGAFDGLKLNYLRISEAKL-TGI 187

Query: 205 PESLANNAELLFLDVQNNTLSGIVPSALKRL 235
           P+ L     L  L + +N +  I    L R 
Sbjct: 188 PKDLPET--LNELHLDHNKIQAIELEDLLRY 216

>2ft3_A Biglycan; proteoglycan, dimer interface, structural protein, signaling; HET: NAG FLC; 3.40A {Bos taurus} Length = 332

 Score = 72.0 bits (177), Expect = 1e-13
 Identities = 38/160 (23%), Positives = 67/160 (41%), Gaps = 19/160 (11%)

Query: 87  SLSGLKCLSGLYLHYNSLSGEIPKEIRNLTELTDLYLDVNNLSGNIPPEI-GSMASLQVL 145
           +  GLK L+ L +    L+  IPK++     L +L+LD N +   I  E     + L  L
Sbjct: 168 AFDGLK-LNYLRISEAKLT-GIPKDL--PETLNELHLDHNKIQ-AIELEDLLRYSKLYRL 222

Query: 146 QLCCNQLTGNIPAQI-GSLKSLSVLTLQHNRLNGGIPDSLGNLGKLKRLDLSFNSLFGTI 204
            L  NQ+   I       L +L  L L +N+L+  +P  L +L  L+ + L  N++   +
Sbjct: 223 GLGHNQIR-MIENGSLSFLPTLRELHLDNNKLSR-VPAGLPDLKLLQVVYLHTNNI-TKV 279

Query: 205 PES-------LANNAELLFLDVQNN--TLSGIVPSALKRL 235
             +           A    + + NN      + P+  + +
Sbjct: 280 GVNDFCPVGFGVKRAYYNGISLFNNPVPYWEVQPATFRCV 319

>2ft3_A Biglycan; proteoglycan, dimer interface, structural protein, signaling; HET: NAG FLC; 3.40A {Bos taurus} Length = 332

 Score = 55.0 bits (133), Expect = 3e-08
 Identities = 27/120 (22%), Positives = 49/120 (40%), Gaps = 6/120 (5%)

Query: 117 ELTDLYLDVNNLSGNIPPEIGSMASLQVLQLCCNQLTGNIPAQIGSLKSLSVLTLQHNRL 176
            L  +      L   +P EI       +L L  N ++         L+ L  L L +N++
Sbjct: 34  HLRVVQCSDLGLK-AVPKEISP--DTTLLDLQNNDISELRKDDFKGLQHLYALVLVNNKI 90

Query: 177 NGGIPDSLGNLGKLKRLDLSFNSLFGTIPESLANNAELLFLDVQNNTLSGIVPSALKRLN 236
           +     +   L KL++L +S N L   IP +L ++  L+ L + +N +  +       L 
Sbjct: 91  SKIHEKAFSPLRKLQKLYISKNHL-VEIPPNLPSS--LVELRIHDNRIRKVPKGVFSGLR 147

>3a7i_A MST3 kinase, serine/threonine kinase 24 (STE20 homolog, yeast); two-LOBE protein kinase fold, ATP-binding, nucleotid binding, transferase; HET: TPO ADE; 1.45A {Homo sapiens} PDB: 3a7g_A* 3a7h_A* 3a7f_A* 3a7j_A* 3ckw_A 3ckx_A* 3ggf_A* 2xik_A* Length = 303

 Score = 80.8 bits (200), Expect = 8e-17
 Identities = 59/268 (22%), Positives = 120/268 (44%), Gaps = 37/268 (13%)

Query: 411 FSEVNLLGKGNFSSVYKGT-LRDGTLVAIRSINVTSCKSEEAEFVKGLYLLTSLRHENII 469
           F+++  +GKG+F  V+KG   R   +VAI+ I++   + E  +  + + +L+      + 
Sbjct: 24  FTKLEKIGKGSFGEVFKGIDNRTQKVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYVT 83

Query: 470 RLRGFCCSRGRGECFLIYDFAPKGKLSKYLDQEEGSSNVLDWSTRVSIIIGIAKGIGYLH 529
           +   +       + ++I ++   G     L+        LD +   +I+  I KG+ YLH
Sbjct: 84  KY--YGSYLKDTKLWIIMEYLGGGSALDLLE-----PGPLDETQIATILREILKGLDYLH 136

Query: 530 SSEVNKPAIVHRNLSVEKVLIDQQFNPLIADCGLHKLLADDIVFSVLKTSAAMG---YLA 586
           S        +HR++    VL+ +     +AD G+   L D    + +K +  +G   ++A
Sbjct: 137 SE-----KKIHRDIKAANVLLSEHGEVKLADFGVAGQLTD----TQIKRNTFVGTPFWMA 187

Query: 587 PEYVTTGRFTERSDIFAFGVIILQILTGS--LVLTSSMRLAAESATFENFIDRN----LK 640
           PE +    +  ++DI++ G+  +++  G         M+       F   I +N    L+
Sbjct: 188 PEVIKQSAYDSKADIWSLGITAIELARGEPPHSELHPMK-----VLF--LIPKNNPPTLE 240

Query: 641 GKFSESEAAKLGKMALVCTHEDPENRPT 668
           G +S+     L +    C +++P  RPT
Sbjct: 241 GNYSKP----LKEFVEACLNKEPSFRPT 264

>1h6u_A Internalin H; cell adhesion, leucine rich repeat, IG-like domain, EF-hand domain; 1.8A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 Length = 308

 Score = 80.1 bits (198), Expect = 1e-16
 Identities = 36/150 (24%), Positives = 71/150 (47%), Gaps = 10/150 (6%)

Query: 86  PSLSGLKCLSGLYLHYNSLSGEIPKEIRNLTELTDLYLDVNNLSGNIPPEIGSMASLQVL 145
            +++GL+ +  L L    ++   P  +  L+ L  LYLD+N ++ NI P +  + +LQ L
Sbjct: 101 SAIAGLQSIKTLDLTSTQITDVTP--LAGLSNLQVLYLDLNQIT-NISP-LAGLTNLQYL 156

Query: 146 QLCCNQLTGNIPAQIGSLKSLSVLTLQHNRLNGGIPDSLGNLGKLKRLDLSFNSLFGTIP 205
            +   Q++ ++   + +L  L+ L    N+++  I   L +L  L  + L  N +  +  
Sbjct: 157 SIGNAQVS-DLTP-LANLSKLTTLKADDNKISD-IS-PLASLPNLIEVHLKNNQI--SDV 210

Query: 206 ESLANNAELLFLDVQNNTLSGIVPSALKRL 235
             LAN + L  + + N T++         L
Sbjct: 211 SPLANTSNLFIVTLTNQTITNQPVFYNNNL 240

>1h6u_A Internalin H; cell adhesion, leucine rich repeat, IG-like domain, EF-hand domain; 1.8A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 Length = 308

 Score = 71.6 bits (176), Expect = 9e-14
 Identities = 34/147 (23%), Positives = 70/147 (47%), Gaps = 10/147 (6%)

Query: 86  PSLSGLKCLSGLYLHYNSLSGEIPKEIRNLTELTDLYLDVNNLSGNIPPEIGSMASLQVL 145
             L+GL  L  LYL  N ++  I   +  LT L  L +    +S ++ P + +++ L  L
Sbjct: 123 TPLAGLSNLQVLYLDLNQIT-NIS-PLAGLTNLQYLSIGNAQVS-DLTP-LANLSKLTTL 178

Query: 146 QLCCNQLTGNIPAQIGSLKSLSVLTLQHNRLNGGIPDSLGNLGKLKRLDLSFNSLFGTIP 205
           +   N+++ +I   + SL +L  + L++N+++      L N   L  + L+  ++  T  
Sbjct: 179 KADDNKIS-DISP-LASLPNLIEVHLKNNQISD--VSPLANTSNLFIVTLTNQTI--TNQ 232

Query: 206 ESLANNAELLFLDVQNNTLSGIVPSAL 232
               NN  ++   V+  + + I P+ +
Sbjct: 233 PVFYNNNLVVPNVVKGPSGAPIAPATI 259

>1h6u_A Internalin H; cell adhesion, leucine rich repeat, IG-like domain, EF-hand domain; 1.8A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 Length = 308

 Score = 70.5 bits (173), Expect = 2e-13
 Identities = 31/150 (20%), Positives = 62/150 (41%), Gaps = 11/150 (7%)

Query: 88  LSGLKCLSGLYLHYNSLSGEIPKEIRNLTELTDLYLDVNNLSGNIPPEIGSMASLQVLQL 147
              L     +    ++++  +     +L  +T L      ++  I   +  + +L  L+L
Sbjct: 15  DPALANAIKIAAGKSNVTDTVT--QADLDGITTLSAFGTGVT-TIEG-VQYLNNLIGLEL 70

Query: 148 CCNQLTGNIPAQIGSLKSLSVLTLQHNRLNGGIPDSLGNLGKLKRLDLSFNSLFGTIPES 207
             NQ+T ++   + +L  ++ L L  N L      ++  L  +K LDL+   +  T    
Sbjct: 71  KDNQIT-DLAP-LKNLTKITELELSGNPLK--NVSAIAGLQSIKTLDLTSTQI--TDVTP 124

Query: 208 LANNAELLFLDVQNNTLSGIVP-SALKRLN 236
           LA  + L  L +  N ++ I P + L  L 
Sbjct: 125 LAGLSNLQVLYLDLNQITNISPLAGLTNLQ 154

>3dls_A PAS domain-containing serine/threonine-protein KI; PAS kinase, PASK, protein kinase, drug discovery, ATP-bindin kinase, nucleotide-binding; HET: ADP; 2.30A {Homo sapiens} Length = 335

 Score = 80.5 bits (199), Expect = 1e-16
 Identities = 51/276 (18%), Positives = 94/276 (34%), Gaps = 51/276 (18%)

Query: 417 LGKGNFSSVYKGT-LRDGTLVAIRSIN---VTSCKSEEAEFVKGLYL----LTSLRHENI 468
           LG G F  V+          V ++ I    V      E   +  + L    L+ + H NI
Sbjct: 32  LGSGAFGFVWTAVDKEKNKEVVVKFIKKEKVLEDCWIEDPKLGKVTLEIAILSRVEHANI 91

Query: 469 IRLRGFCCSRGRGECFLIYDFAPKGK-LSKYLDQEEGSSNVLDWSTRVSIIIGIAKGIGY 527
           I++     ++G     L+ +    G  L  ++D+       LD      I   +   +GY
Sbjct: 92  IKVLDIFENQG--FFQLVMEKHGSGLDLFAFIDRHPR----LDEPLASYIFRQLVSAVGY 145

Query: 528 LHSSEVNKPAIVHRNLSVEKVLIDQQFNPLIADCGLHKLLADDIVFSVLKTSAA-MGYLA 586
           L         I+HR++  E ++I + F   + D G    L       +  T    + Y A
Sbjct: 146 LRLK-----DIIHRDIKDENIVIAEDFTIKLIDFGSAAYLERG---KLFYTFCGTIEYCA 197

Query: 587 PEYVTTGRFTE--RSDIFAFGVIILQILTGSLVLTSSMRLAAESATFENFIDRNLKGKFS 644
           PE V  G        ++++ GV +  ++                  F    +  ++    
Sbjct: 198 PE-VLMGNPYRGPELEMWSLGVTLYTLVFEEN-------------PFCEL-EETVEAAIH 242

Query: 645 E----SEAAK--LGKMALVCTHEDPENRPTMEAVIE 674
                S+     +  +        PE R T+E ++ 
Sbjct: 243 PPYLVSKELMSLVSGLLQP----VPERRTTLEKLVT 274

>3i6u_A CDS1, serine/threonine-protein kinase CHK2; Ser/Thr protein kinase, FHA domain, ATP-binding, cell cycle, mutation, LI-fraumeni syndrome, magnesium; 3.00A {Homo sapiens} PDB: 3i6w_A Length = 419

 Score = 81.3 bits (201), Expect = 2e-16
 Identities = 66/289 (22%), Positives = 108/289 (37%), Gaps = 63/289 (21%)

Query: 417 LGKGNFSSVYKGTLRD-GTLVAIRSIN---VTSCKSEEAEFVKGLY----LLTSLRHENI 468
           LG G    V     R     VAIR I+        + EA+    +     +L  L H  I
Sbjct: 143 LGSGACGEVKLAFERKTCKKVAIRIISKRKFAIGSAREADPALNVETEIEILKKLNHPCI 202

Query: 469 IRLRGFCCSRGRGECFLIYDFAPKGKL------SKYLDQEEGSSNVLDWSTRVSIIIGIA 522
           I+++ F  +    + +++ +    G+L      +K L +                   + 
Sbjct: 203 IKIKNFFDAE---DYYIVLELMEGGELFDKVVGNKRLKEATCK----------LYFYQML 249

Query: 523 KGIGYLHSSEVNKPAIVHRNLSVEKVLIDQQFNPL---IADCGLHKLLADDIVFSVLKTS 579
             + YLH +      I+HR+L  E VL+  Q       I D G  K+L +    S+++T 
Sbjct: 250 LAVQYLHENG-----IIHRDLKPENVLLSSQEEDCLIKITDFGHSKILGET---SLMRTL 301

Query: 580 A-AMGYLAPE---YVTTGRFTERSDIFAFGVIILQILTGSLVLTSSMRLAAESATFENFI 635
                YLAPE    V T  +    D ++ GVI+   L+G    +                
Sbjct: 302 CGTPTYLAPEVLVSVGTAGYNRAVDCWSLGVILFICLSGYPPFS------EHRTQVSLK- 354

Query: 636 DRNLKGKFSE--------SEAAK--LGKMALVCTHEDPENRPTMEAVIE 674
           D+   GK++         SE A   + K+ +V    DP+ R T E  + 
Sbjct: 355 DQITSGKYNFIPEVWAEVSEKALDLVKKLLVV----DPKARFTTEEALR 399

>2z81_A CD282 antigen, TOLL-like receptor 2, variable lymphocyte recepto; TLR2, PAM3CSK4, lipopeptide, innate immunity, cytoplasmic VE glycoprotein; HET: NAG BMA MAN PCJ; 1.80A {Mus musculus} PDB: 2z82_A* 3a7c_A* 3a79_A* 3a7b_A* 2z7x_A* Length = 549

 Score = 82.1 bits (203), Expect = 2e-16
 Identities = 29/152 (19%), Positives = 54/152 (35%), Gaps = 2/152 (1%)

Query: 87  SLSGLKCLSGLYLHYNSLSGEIPKEIRNLTELTDLYLDVNNLSG-NIPPEIGSMASLQVL 145
           +   L  L  L L  N LS         L+ L  L L  N      +     ++ +LQ L
Sbjct: 69  AFYSLGSLEHLDLSDNHLSSLSSSWFGPLSSLKYLNLMGNPYQTLGVTSLFPNLTNLQTL 128

Query: 146 QLCCNQLTGNIPAQ-IGSLKSLSVLTLQHNRLNGGIPDSLGNLGKLKRLDLSFNSLFGTI 204
           ++   +    I       L SL+ L ++   L      SL ++  +  L L  +     +
Sbjct: 129 RIGNVETFSEIRRIDFAGLTSLNELEIKALSLRNYQSQSLKSIRDIHHLTLHLSESAFLL 188

Query: 205 PESLANNAELLFLDVQNNTLSGIVPSALKRLN 236
                  + + +L++++  L+    S L    
Sbjct: 189 EIFADILSSVRYLELRDTNLARFQFSPLPVDE 220

>2z81_A CD282 antigen, TOLL-like receptor 2, variable lymphocyte recepto; TLR2, PAM3CSK4, lipopeptide, innate immunity, cytoplasmic VE glycoprotein; HET: NAG BMA MAN PCJ; 1.80A {Mus musculus} PDB: 2z82_A* 3a7c_A* 3a79_A* 3a7b_A* 2z7x_A* Length = 549

 Score = 80.9 bits (200), Expect = 4e-16
 Identities = 35/146 (23%), Positives = 60/146 (41%), Gaps = 6/146 (4%)

Query: 94  LSGLYLHYNSLSGEIPKEIRNLTELTDLYLDVNNLSGNIPPEI-GSMASLQVLQLCCNQL 152
           +  L L +N ++     ++R    L  L L  + ++  I  +   S+ SL+ L L  N L
Sbjct: 28  MKSLDLSFNKITYIGHGDLRACANLQVLILKSSRIN-TIEGDAFYSLGSLEHLDLSDNHL 86

Query: 153 TGNIPAQ-IGSLKSLSVLTLQHNRLNG-GIPDSLGNLGKLKRLDLSFNSLFGTIPE-SLA 209
           + ++ +   G L SL  L L  N     G+     NL  L+ L +     F  I     A
Sbjct: 87  S-SLSSSWFGPLSSLKYLNLMGNPYQTLGVTSLFPNLTNLQTLRIGNVETFSEIRRIDFA 145

Query: 210 NNAELLFLDVQNNTLSGIVPSALKRL 235
               L  L+++  +L      +LK +
Sbjct: 146 GLTSLNELEIKALSLRNYQSQSLKSI 171

>2z81_A CD282 antigen, TOLL-like receptor 2, variable lymphocyte recepto; TLR2, PAM3CSK4, lipopeptide, innate immunity, cytoplasmic VE glycoprotein; HET: NAG BMA MAN PCJ; 1.80A {Mus musculus} PDB: 2z82_A* 3a7c_A* 3a79_A* 3a7b_A* 2z7x_A* Length = 549

 Score = 80.9 bits (200), Expect = 4e-16
 Identities = 31/154 (20%), Positives = 60/154 (38%), Gaps = 6/154 (3%)

Query: 87  SLSGLKCLSGLYLHYNSLSGEIPKEI-RNLTELTDLYLDVNNLSGNIPPE-IGSMASLQV 144
            L     L  L L  + ++  I  +   +L  L  L L  N+LS ++     G ++SL+ 
Sbjct: 45  DLRACANLQVLILKSSRIN-TIEGDAFYSLGSLEHLDLSDNHLS-SLSSSWFGPLSSLKY 102

Query: 145 LQLCCNQLTG-NIPAQIGSLKSLSVLTLQHNRLNGGIP-DSLGNLGKLKRLDLSFNSLFG 202
           L L  N      + +   +L +L  L + +      I       L  L  L++   SL  
Sbjct: 103 LNLMGNPYQTLGVTSLFPNLTNLQTLRIGNVETFSEIRRIDFAGLTSLNELEIKALSLRN 162

Query: 203 TIPESLANNAELLFLDVQNNTLSGIVPSALKRLN 236
              +SL +  ++  L +  +  + ++      L+
Sbjct: 163 YQSQSLKSIRDIHHLTLHLSESAFLLEIFADILS 196

>2z81_A CD282 antigen, TOLL-like receptor 2, variable lymphocyte recepto; TLR2, PAM3CSK4, lipopeptide, innate immunity, cytoplasmic VE glycoprotein; HET: NAG BMA MAN PCJ; 1.80A {Mus musculus} PDB: 2z82_A* 3a7c_A* 3a79_A* 3a7b_A* 2z7x_A* Length = 549

 Score = 79.4 bits (196), Expect = 1e-15
 Identities = 43/186 (23%), Positives = 71/186 (38%), Gaps = 12/186 (6%)

Query: 56  SGSFEGIACNEHRKVANISLQGKGLTGKLSPSLSGLKCLSGLYLHYNSLSGEIPKEI-RN 114
           S     +   E   +  + +    L   LS   S L+ +  + +  + +   +P    ++
Sbjct: 274 SDVVSELGKVETVTIRRLHIPQFYLFYDLSTVYSLLEKVKRITVENSKVF-LVPCSFSQH 332

Query: 115 LTELTDLYLDVNNLSGNIPPE---IGSMASLQVLQLCCNQLT--GNIPAQIGSLKSLSVL 169
           L  L  L L  N +           G+  SLQ L L  N L         + +LK+L+ L
Sbjct: 333 LKSLEFLDLSENLMVEEYLKNSACKGAWPSLQTLVLSQNHLRSMQKTGEILLTLKNLTSL 392

Query: 170 TLQHNRLNGGIPDSLGNLGKLKRLDLSFNSLFGTIPESLANNAELLFLDVQNNTLSGIVP 229
            +  N  +  +PDS     K++ L+LS   +   +   +     L  LDV NN L     
Sbjct: 393 DISRNTFHP-MPDSCQWPEKMRFLNLSSTGI-RVVKTCIPQT--LEVLDVSNNNLDSF-S 447

Query: 230 SALKRL 235
             L RL
Sbjct: 448 LFLPRL 453

>2z81_A CD282 antigen, TOLL-like receptor 2, variable lymphocyte recepto; TLR2, PAM3CSK4, lipopeptide, innate immunity, cytoplasmic VE glycoprotein; HET: NAG BMA MAN PCJ; 1.80A {Mus musculus} PDB: 2z82_A* 3a7c_A* 3a79_A* 3a7b_A* 2z7x_A* Length = 549

 Score = 76.7 bits (189), Expect = 9e-15
 Identities = 34/159 (21%), Positives = 57/159 (35%), Gaps = 12/159 (7%)

Query: 80  LTGKLSPSLSGLKCLSGLYLHYNSLS--GEIPKEIRNLTELTDLYLDVNNLSGNIPPEIG 137
              K S        L  L L  N L    +  + +  L  LT L +  N     +P    
Sbjct: 349 EYLKNSACKGAWPSLQTLVLSQNHLRSMQKTGEILLTLKNLTSLDISRNTFH-PMPDSCQ 407

Query: 138 SMASLQVLQLCCNQLTGNIPAQIGSLKSLSVLTLQHNRLNGGIPDSLGNLGKLKRLDLSF 197
               ++ L L    +   +       ++L VL + +N L+      L  L   + L +S 
Sbjct: 408 WPEKMRFLNLSSTGIR-VVKT--CIPQTLEVLDVSNNNLDS-FSLFLPRL---QELYISR 460

Query: 198 NSLFGTIPESLANNAELLFLDVQNNTLSGIVPSALKRLN 236
           N L  T+P++ +    LL + +  N L  +      RL 
Sbjct: 461 NKL-KTLPDA-SLFPVLLVMKISRNQLKSVPDGIFDRLT 497

>2z81_A CD282 antigen, TOLL-like receptor 2, variable lymphocyte recepto; TLR2, PAM3CSK4, lipopeptide, innate immunity, cytoplasmic VE glycoprotein; HET: NAG BMA MAN PCJ; 1.80A {Mus musculus} PDB: 2z82_A* 3a7c_A* 3a79_A* 3a7b_A* 2z7x_A* Length = 549

 Score = 62.8 bits (153), Expect = 2e-10
 Identities = 23/118 (19%), Positives = 40/118 (33%), Gaps = 9/118 (7%)

Query: 83  KLSPSLSGLKCLSGLYLHYNSLSGEIPKEIRNLTELTDLYLDVNNLSGNIPPEIGSMASL 142
            +  S    + +  L L    +   +   I     L  L +  NNL  +       +  L
Sbjct: 401 PMPDSCQWPEKMRFLNLSSTGIR-VVKTCI--PQTLEVLDVSNNNLD-SFSL---FLPRL 453

Query: 143 QVLQLCCNQLTGNIPAQIGSLKSLSVLTLQHNRLNGGIPDSLGNLGKLKRLDLSFNSL 200
           Q L +  N+L   +P        L V+ +  N+L          L  L+++ L  N  
Sbjct: 454 QELYISRNKLK-TLPD-ASLFPVLLVMKISRNQLKSVPDGIFDRLTSLQKIWLHTNPW 509

>2z81_A CD282 antigen, TOLL-like receptor 2, variable lymphocyte recepto; TLR2, PAM3CSK4, lipopeptide, innate immunity, cytoplasmic VE glycoprotein; HET: NAG BMA MAN PCJ; 1.80A {Mus musculus} PDB: 2z82_A* 3a7c_A* 3a79_A* 3a7b_A* 2z7x_A* Length = 549

 Score = 60.9 bits (148), Expect = 7e-10
 Identities = 26/198 (13%), Positives = 64/198 (32%), Gaps = 42/198 (21%)

Query: 80  LTGKLSPSLSGLKCLSGLYLHYNSLSGEIPKEIRNLTELTDLYLDVNNLSGNIPPEIGSM 139
            +       +GL  L+ L +   SL     + ++++ ++  L L ++  +  +      +
Sbjct: 136 FSEIRRIDFAGLTSLNELEIKALSLRNYQSQSLKSIRDIHHLTLHLSESAFLLEIFADIL 195

Query: 140 ASLQVLQLCCNQLTGNIPAQIGSLKSLSVLTLQHNRLNGGIPDSLGNLGKL--------- 190
           +S++ L+L    L     + +   +  S +     R +    +S   L KL         
Sbjct: 196 SSVRYLELRDTNLARFQFSPLPVDEVSSPMKKLAFRGSVLTDESFNELLKLLRYILELSE 255

Query: 191 ---------------------------------KRLDLSFNSLFGTIPESLANNAELLFL 217
                                            +RL +    LF  +    +   ++  +
Sbjct: 256 VEFDDCTLNGLGDFNPSESDVVSELGKVETVTIRRLHIPQFYLFYDLSTVYSLLEKVKRI 315

Query: 218 DVQNNTLSGIVPSALKRL 235
            V+N+ +  +  S  + L
Sbjct: 316 TVENSKVFLVPCSFSQHL 333

>2z81_A CD282 antigen, TOLL-like receptor 2, variable lymphocyte recepto; TLR2, PAM3CSK4, lipopeptide, innate immunity, cytoplasmic VE glycoprotein; HET: NAG BMA MAN PCJ; 1.80A {Mus musculus} PDB: 2z82_A* 3a7c_A* 3a79_A* 3a7b_A* 2z7x_A* Length = 549

 Score = 60.9 bits (148), Expect = 7e-10
 Identities = 28/152 (18%), Positives = 53/152 (34%), Gaps = 8/152 (5%)

Query: 84  LSPSLSGLKCLSGLYLHYNSLSGEIPKE-IRNLTELTDLYLDVNNLSGNIPPEIGSMASL 142
           ++     L  L  L +       EI +     LT L +L +   +L       + S+  +
Sbjct: 115 VTSLFPNLTNLQTLRIGNVETFSEIRRIDFAGLTSLNELEIKALSLRNYQSQSLKSIRDI 174

Query: 143 QVLQLCCNQLTGNIPAQIGSLKSLSVLTLQHNRLNG---GIPDSLGNLGKLKRLDLSFNS 199
             L L  ++    +      L S+  L L+   L                +K+L    + 
Sbjct: 175 HHLTLHLSESAFLLEIFADILSSVRYLELRDTNLARFQFSPLPVDEVSSPMKKLAFRGSV 234

Query: 200 L----FGTIPESLANNAELLFLDVQNNTLSGI 227
           L    F  + + L    EL  ++  + TL+G+
Sbjct: 235 LTDESFNELLKLLRYILELSEVEFDDCTLNGL 266

>2z81_A CD282 antigen, TOLL-like receptor 2, variable lymphocyte recepto; TLR2, PAM3CSK4, lipopeptide, innate immunity, cytoplasmic VE glycoprotein; HET: NAG BMA MAN PCJ; 1.80A {Mus musculus} PDB: 2z82_A* 3a7c_A* 3a79_A* 3a7b_A* 2z7x_A* Length = 549

 Score = 57.4 bits (139), Expect = 1e-08
 Identities = 27/107 (25%), Positives = 52/107 (48%), Gaps = 3/107 (2%)

Query: 126 NNLSGNIPPEIGSMASLQVLQLCCNQLTGNIPAQIGSLKSLSVLTLQHNRLNGGIPDSLG 185
            + + +IP  +   A+++ L L  N++T      + +  +L VL L+ +R+N    D+  
Sbjct: 15  RSFT-SIPSGL--TAAMKSLDLSFNKITYIGHGDLRACANLQVLILKSSRINTIEGDAFY 71

Query: 186 NLGKLKRLDLSFNSLFGTIPESLANNAELLFLDVQNNTLSGIVPSAL 232
           +LG L+ LDLS N L           + L +L++  N    +  ++L
Sbjct: 72  SLGSLEHLDLSDNHLSSLSSSWFGPLSSLKYLNLMGNPYQTLGVTSL 118

>2z81_A CD282 antigen, TOLL-like receptor 2, variable lymphocyte recepto; TLR2, PAM3CSK4, lipopeptide, innate immunity, cytoplasmic VE glycoprotein; HET: NAG BMA MAN PCJ; 1.80A {Mus musculus} PDB: 2z82_A* 3a7c_A* 3a79_A* 3a7b_A* 2z7x_A* Length = 549

 Score = 53.2 bits (128), Expect = 2e-07
 Identities = 23/177 (12%), Positives = 52/177 (29%), Gaps = 18/177 (10%)

Query: 72  NISLQGKGLTGKLSPSLSGLKCLSGLYLHYNSLSGEIPKEIRNLTELTDLYLDVNNLSG- 130
           +++L        L      L  +  L L   +L+      +      + +       S  
Sbjct: 176 HLTLHLSESAFLLEIFADILSSVRYLELRDTNLARFQFSPLPVDEVSSPMKKLAFRGSVL 235

Query: 131 ---------NIPPEIGSMASLQVLQLCCNQLTGNIPAQIGSLK--------SLSVLTLQH 173
                     +   I  ++ ++      N L    P++   +         ++  L +  
Sbjct: 236 TDESFNELLKLLRYILELSEVEFDDCTLNGLGDFNPSESDVVSELGKVETVTIRRLHIPQ 295

Query: 174 NRLNGGIPDSLGNLGKLKRLDLSFNSLFGTIPESLANNAELLFLDVQNNTLSGIVPS 230
             L   +      L K+KR+ +  + +F        +   L FLD+  N +      
Sbjct: 296 FYLFYDLSTVYSLLEKVKRITVENSKVFLVPCSFSQHLKSLEFLDLSENLMVEEYLK 352

>2z81_A CD282 antigen, TOLL-like receptor 2, variable lymphocyte recepto; TLR2, PAM3CSK4, lipopeptide, innate immunity, cytoplasmic VE glycoprotein; HET: NAG BMA MAN PCJ; 1.80A {Mus musculus} PDB: 2z82_A* 3a7c_A* 3a79_A* 3a7b_A* 2z7x_A* Length = 549

 Score = 52.8 bits (127), Expect = 3e-07
 Identities = 22/171 (12%), Positives = 57/171 (33%), Gaps = 18/171 (10%)

Query: 75  LQGKGLTGKLSPSLSGLKCLSGLYLHYNSLS----GEIPKEIRNLTELTDLYLD------ 124
                      P       +  L    + L+     E+ K +R + EL+++  D      
Sbjct: 206 TNLARFQFSPLPVDEVSSPMKKLAFRGSVLTDESFNELLKLLRYILELSEVEFDDCTLNG 265

Query: 125 VNNLSGNIPPEIGSMASLQVLQLCCNQLTGN-----IPAQIGSLKSLSVLTLQHNRLNGG 179
           + + + +    +  +  ++ + +    +        +      L+ +  +T++++++   
Sbjct: 266 LGDFNPSESDVVSELGKVETVTIRRLHIPQFYLFYDLSTVYSLLEKVKRITVENSKVFLV 325

Query: 180 IPDSLGNLGKLKRLDLSFN---SLFGTIPESLANNAELLFLDVQNNTLSGI 227
                 +L  L+ LDLS N     +            L  L +  N L  +
Sbjct: 326 PCSFSQHLKSLEFLDLSENLMVEEYLKNSACKGAWPSLQTLVLSQNHLRSM 376

>2wei_A Calmodulin-domain protein kinase 1, putative; nucleotide-binding, serine/threonine-protein kinase, CGD3_920, transferase; HET: VGG; 1.65A {Cryptosporidium parvum iowa II} PDB: 3dfa_A 3ma6_A* Length = 287

 Score = 78.4 bits (194), Expect = 4e-16
 Identities = 69/283 (24%), Positives = 112/283 (39%), Gaps = 61/283 (21%)

Query: 417 LGKGNFSSVYKGTLRD-GTLVAIRSINVTSCKSEEAEFVKG-LYLLTSLRHENIIRLRGF 474
           LGKG+F  V K   R      A++ IN  S K+++   +   + LL  L H NI++L   
Sbjct: 30  LGKGSFGEVLKCKDRITQQEYAVKVINKASAKNKDTSTILREVELLKKLDHPNIMKLFEI 89

Query: 475 CCSRGRGECFLIYDFAPKGKLSKYLDQ--EEGSSNVLDWSTRVSIIIGIAKGIGYLHSSE 532
                    +++ +    G+L    D+  +    +  D +    II  +  GI Y+H   
Sbjct: 90  LED--SSSFYIVGELYTGGEL---FDEIIKRKRFSEHDAAR---IIKQVFSGITYMHKHN 141

Query: 533 VNKPAIVHRNLSVEKVLI---DQQFNPLIADCGLHKLLADDIVFSVLKTSAAMGYLAPEY 589
                IVHR+L  E +L+   ++  +  I D GL      +        +A   Y+APE 
Sbjct: 142 -----IVHRDLKPENILLESKEKDCDIKIIDFGLSTCFQQNTKMKDRIGTA--YYIAPE- 193

Query: 590 VTTGRFTERSDIFAFGVIILQILTGSLVLTSSMRLAAESATFENFIDRN--------LKG 641
           V  G + E+ D+++ GVI+  +L+G                   F  +N          G
Sbjct: 194 VLRGTYDEKCDVWSAGVILYILLSG----------------TPPFYGKNEYDILKRVETG 237

Query: 642 KF---SE-----SEAAK--LGKMALVCTHEDPENRPTMEAVIE 674
           K+          S+ AK  + KM L      P  R T    +E
Sbjct: 238 KYAFDLPQWRTISDDAKDLIRKM-LTF---HPSLRITATQCLE 276

>3is5_A Calcium-dependent protein kinase; CDPK, structural genomics, parasitology, structural genomics consortium, SGC, ATP-binding, nucleotide-binding; HET: ANP; 2.55A {Toxoplasma gondii} Length = 285

 Score = 77.7 bits (192), Expect = 6e-16
 Identities = 67/295 (22%), Positives = 112/295 (37%), Gaps = 35/295 (11%)

Query: 393 HLNSFRLNLEEVESATQCFSEVNLLGKGNFSSVYKGTLRD-GTLVAIRSINVTSCKSEEA 451
           H +S R NL    +    F     LG G F  V+    R  G    I++IN    +    
Sbjct: 6   HHSSGRENLYFQGTIDDLFIFKRKLGSGAFGDVHLVEERSSGLERVIKTINKDRSQVPME 65

Query: 452 EFVKGLYLLTSLRHENIIRLRGFCCSRGRGECFLIYDFAPKGKLSKYLDQEEGSSNVLDW 511
           +    + +L SL H NII++            +++ +    G+L + +   +     L  
Sbjct: 66  QIEAEIEVLKSLDHPNIIKIFEVFED--YHNMYIVMETCEGGELLERIVSAQARGKALSE 123

Query: 512 STRVSIIIGIAKGIGYLHSSEVNKPAIVHRNLSVEKVLI---DQQFNPLIADCGLHKLLA 568
                ++  +   + Y HS       +VH++L  E +L           I D GL +L  
Sbjct: 124 GYVAELMKQMMNALAYFHSQH-----VVHKDLKPENILFQDTSPHSPIKIIDFGLAELFK 178

Query: 569 DDIVFSVLKTSAAMGYLAPEYVTTGRFTERSDIFAFGVIILQILTGSLVLTSSMRLAAES 628
            D   +    +A   Y+APE V     T + DI++ GV++  +LTG L  T +    +  
Sbjct: 179 SDEHSTNAAGTA--LYMAPE-VFKRDVTFKCDIWSAGVVMYFLLTGCLPFTGT----SLE 231

Query: 629 ATFENFIDRNLKGKF---SE----SEAAK--LGKMALVCTHEDPENRPTMEAVIE 674
              +         +     E    +  A   L +M L     DPE RP+   V+ 
Sbjct: 232 EVQQK-A---TYKEPNYAVECRPLTPQAVDLLKQM-LTK---DPERRPSAAQVLH 278

>2xot_A Amphoterin-induced protein 1; cell adhesion, neuronal protein, neurite growth regulation; HET: NAG BMA; 2.00A {Mus musculus} Length = 361

 Score = 78.7 bits (194), Expect = 7e-16
 Identities = 44/164 (26%), Positives = 74/164 (45%), Gaps = 16/164 (9%)

Query: 97  LYLHYNSLSGEIPKEI--RNLTELTDLYLDVNNLSGNIPPEI-GSMASLQVLQLCCNQLT 153
           L L +N+LS  +  E     LT L  L L  N+L+  I  E    + +L+ L L  N L 
Sbjct: 44  LDLSHNNLS-RLRAEWTPTRLTNLHSLLLSHNHLN-FISSEAFVPVPNLRYLDLSSNHLH 101

Query: 154 GNIPAQI-GSLKSLSVLTLQHNRLNGGIPDSLGNLGKLKRLDLSFNSLFGTIPE----SL 208
             +   +   L++L VL L +N +     ++  ++ +L++L LS N +    P       
Sbjct: 102 -TLDEFLFSDLQALEVLLLYNNHIVVVDRNAFEDMAQLQKLYLSQNQIS-RFPVELIKDG 159

Query: 209 ANNAELLFLDVQNNTLSGIVPSALKRL----NGGFQFQNNPGLC 248
               +L+ LD+ +N L  +  + L++L      G    NNP  C
Sbjct: 160 NKLPKLMLLDLSSNKLKKLPLTDLQKLPAWVKNGLYLHNNPLEC 203

>2xot_A Amphoterin-induced protein 1; cell adhesion, neuronal protein, neurite growth regulation; HET: NAG BMA; 2.00A {Mus musculus} Length = 361

 Score = 73.0 bits (179), Expect = 5e-14
 Identities = 35/145 (24%), Positives = 56/145 (38%), Gaps = 13/145 (8%)

Query: 87  SLSGLKCLSGLYLHYNSLSGEIPKEI-RNLTELTDLYLDVNNLSGNIPPEI-GSMASLQV 144
           + + L  L  L L +N L+  I  E    +  L  L L  N+L   +   +   + +L+V
Sbjct: 59  TPTRLTNLHSLLLSHNHLN-FISSEAFVPVPNLRYLDLSSNHLH-TLDEFLFSDLQALEV 116

Query: 145 LQLCCNQLTGNIPAQI-GSLKSLSVLTLQHNRLN---GGIPDSLGNLGKLKRLDLSFNSL 200
           L L  N +   +       +  L  L L  N+++     +      L KL  LDLS N L
Sbjct: 117 LLLYNNHIV-VVDRNAFEDMAQLQKLYLSQNQISRFPVELIKDGNKLPKLMLLDLSSNKL 175

Query: 201 FGTIPESLANNAELL---FLDVQNN 222
              +P +            L + NN
Sbjct: 176 -KKLPLTDLQKLPAWVKNGLYLHNN 199

>2xot_A Amphoterin-induced protein 1; cell adhesion, neuronal protein, neurite growth regulation; HET: NAG BMA; 2.00A {Mus musculus} Length = 361

 Score = 51.4 bits (123), Expect = 4e-07
 Identities = 27/108 (25%), Positives = 47/108 (43%), Gaps = 11/108 (10%)

Query: 131 NIPPEIGSMASLQVLQLCCNQLTGNIPAQI--GSLKSLSVLTLQHNRLNGGIPDSLGNLG 188
           ++P          +L L  N L+  + A+     L +L  L L HN LN    ++   + 
Sbjct: 36  SLPSYT------ALLDLSHNNLS-RLRAEWTPTRLTNLHSLLLSHNHLNFISSEAFVPVP 88

Query: 189 KLKRLDLSFNSLFGTIP-ESLANNAELLFLDVQNNTLSGIVPSALKRL 235
            L+ LDLS N L  T+     ++   L  L + NN +  +  +A + +
Sbjct: 89  NLRYLDLSSNHL-HTLDEFLFSDLQALEVLLLYNNHIVVVDRNAFEDM 135

>3fe3_A MAP/microtubule affinity-regulating kinase 3; serine/threonine protein kinase, MARK;PAR-1, UBA domai TAK1;P78;MARK3, ATP-binding; 1.90A {Homo sapiens} PDB: 2qnj_A 1y8g_A* 1zmw_A 1zmu_A 1zmv_A 2wzj_A 2r0i_A 2hak_A 3iec_A Length = 328

 Score = 78.1 bits (193), Expect = 8e-16
 Identities = 65/271 (23%), Positives = 111/271 (40%), Gaps = 42/271 (15%)

Query: 417 LGKGNFSSVYKGT-LRDGTLVAIRSINVTSCKSEEAEFVKG-LYLLTSLRHENIIRLRGF 474
           +GKGNF+ V     +  G  VAI+ I+ T       + +   + ++  L H NI++L  F
Sbjct: 23  IGKGNFAKVKLARHILTGREVAIKIIDKTQLNPTSLQKLFREVRIMKILNHPNIVKL--F 80

Query: 475 CCSRGRGECFLIYDFAPKGKLSKYLDQEEGSSNVLDWSTRVSIIIGIAKGIGYLHSSEVN 534
                    +LI ++A  G++  YL         +      S    I   + Y H     
Sbjct: 81  EVIETEKTLYLIMEYASGGEVFDYLVAHGR----MKEKEARSKFRQIVSAVQYCHQK--- 133

Query: 535 KPAIVHRNLSVEKVLIDQQFNPLIADCGLHKLLADDIVFSVLKTSAAMG---YLAPEYVT 591
              IVHR+L  E +L+D   N  IAD G             L      G   Y APE + 
Sbjct: 134 --RIVHRDLKAENLLLDADMNIKIADFGFSNEFTVG---GKLDAFC--GAPPYAAPE-LF 185

Query: 592 TGRFTE--RSDIFAFGVIILQILTGSLVLTSSMRLAAESATFENFIDRNLKGKFSE---- 645
            G+  +    D+++ GVI+  +++GSL          +    +   +R L+GK+      
Sbjct: 186 QGKKYDGPEVDVWSLGVILYTLVSGSLPF--------DGQNLKELRERVLRGKYRIPFYM 237

Query: 646 SEAAK--LGKMALVCTHEDPENRPTMEAVIE 674
           S   +  L +  ++    +P  R T+E +++
Sbjct: 238 STDCENLLKRFLVL----NPIKRGTLEQIMK 264

>3nyv_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, EF hand, bumped kinase inhibitor; HET: MSE DTQ; 1.88A {Toxoplasma gondii} PDB: 3i79_A* 3i7b_A* 3n51_A* 3i7c_A* 3sx9_A* 3sxf_A* 3t3u_A* 3t3v_A* 3upx_A* 3upz_A* 3v51_A* 3v5p_A* 3v5t_A* 3ku2_A* 3hx4_A* Length = 484

 Score = 79.4 bits (196), Expect = 1e-15
 Identities = 69/279 (24%), Positives = 113/279 (40%), Gaps = 52/279 (18%)

Query: 417 LGKGNFSSVYKGTLR-DGTLVAIRSINVTSCKSEEA-EFVKG-LYLLTSLRHENIIRLRG 473
           LGKG+F  V     +  G   A++ I+    K +   E +   + LL  L H NI++L  
Sbjct: 34  LGKGSFGEVILCKDKITGQECAVKVISKRQVKQKTDKESLLREVQLLKQLDHPNIMKLYE 93

Query: 474 FCCSRGRGECFLIYDFAPKGKLSKYLDQ-----EEGSSNVLDWSTRVSIIIGIAKGIGYL 528
           F   +G    +L+ +    G+L   +       E  ++          II  +  GI Y+
Sbjct: 94  FFEDKG--YFYLVGEVYTGGELFDEIISRKRFSEVDAAR---------IIRQVLSGITYM 142

Query: 529 HSSEVNKPAIVHRNLSVEKVLI---DQQFNPLIADCGLHKLLADDIVFSVLKTSAAMGYL 585
           H +      IVHR+L  E +L+    +  N  I D GL               +A   Y+
Sbjct: 143 HKN-----KIVHRDLKPENLLLESKSKDANIRIIDFGLSTHFEASKKMKDKIGTA--YYI 195

Query: 586 APEYVTTGRFTERSDIFAFGVIILQILTGSLVLTSSMRLAAESATFENFIDRNLKGKF-- 643
           APE V  G + E+ D+++ GVI+  +L+G      +     E    +  +    KGK+  
Sbjct: 196 APE-VLHGTYDEKCDVWSTGVILYILLSGCPPFNGAN----EYDILKK-V---EKGKYTF 246

Query: 644 ------SESEAAK--LGKMALVCTHEDPENRPTMEAVIE 674
                   SE+AK  + KM L      P  R +    ++
Sbjct: 247 ELPQWKKVSESAKDLIRKM-LT---YVPSMRISARDALD 281

>2jam_A Calcium/calmodulin-dependent protein kinase type 1G; transferase, kinase, membrane, ATP-binding, prenylation, serine/threonine-protein kinase, alternative splicing; HET: J60; 1.7A {Homo sapiens} PDB: 2jc6_A* 1a06_A Length = 304

 Score = 77.2 bits (191), Expect = 1e-15
 Identities = 68/295 (23%), Positives = 112/295 (37%), Gaps = 85/295 (28%)

Query: 416 LLGKGNFSSVYKGTLRD-GTLVAIRSINVTSCKSEEA---EFVKGLYLLTSLRHENIIRL 471
           +LG G FS V+    R  G L A++ I  +    + +   E    + +L  ++HENI+ L
Sbjct: 16  VLGSGAFSEVFLVKQRLTGKLFALKCIKKSPAFRDSSLENE----IAVLKKIKHENIVTL 71

Query: 472 RGFCCSRGR----------GECF-LIYDFAPKGKLSKYLDQEEGSSNVLDWSTRVSIIIG 520
                S             GE F  I +   +G  +     E+ +S          +I  
Sbjct: 72  EDIYESTTHYYLVMQLVSGGELFDRILE---RGVYT-----EKDASL---------VIQQ 114

Query: 521 IAKGIGYLHSSEVNKPAIVHRNLSVEKVLIDQQFN--PL-IADCGLHKLLADDIVFSVLK 577
           +   + YLH +      IVHR+L  E +L         + I D GL K+  + I+ +   
Sbjct: 115 VLSAVKYLHENG-----IVHRDLKPENLLYLTPEENSKIMITDFGLSKMEQNGIMSTACG 169

Query: 578 TSAAMGYLAPEYVTTGRFTERSDIFAFGVIILQILTGSLVLTSSMRLAAESATFENFIDR 637
           T    GY+APE +    +++  D ++ GVI   +L G                +  F + 
Sbjct: 170 T---PGYVAPEVLAQKPYSKAVDCWSIGVITYILLCG----------------YPPFYEE 210

Query: 638 N--------LKGKF---SE-----SEAAK--LGKMALVCTHEDPENRPTMEAVIE 674
                     +G +   S      SE+AK  +  + L     DP  R T E  + 
Sbjct: 211 TESKLFEKIKEGYYEFESPFWDDISESAKDFICHL-LEK---DPNERYTCEKALS 261

>1xku_A Decorin; proteoglycan, leucine-rich repeat, structural protein; HET: NAG; 2.15A {Bos taurus} SCOP: c.10.2.7 PDB: 1xec_A* 1xcd_A* Length = 330

 Score = 77.3 bits (191), Expect = 1e-15
 Identities = 42/154 (27%), Positives = 71/154 (46%), Gaps = 12/154 (7%)

Query: 87  SLSGLKCLSGLYLHYNSLSGEIPKEI-RNLTELTDLYLDVNNLSGNIPPEIGSMASLQVL 145
               LK L  L L  N +S +I       L +L  LYL  N L   +P       +LQ L
Sbjct: 71  DFKNLKNLHTLILINNKIS-KISPGAFAPLVKLERLYLSKNQLK-ELPE--KMPKTLQEL 126

Query: 146 QLCCNQLTGNIPAQI-GSLKSLSVLTLQHNRL-NGGIPD-SLGNLGKLKRLDLSFNSLFG 202
           ++  N++T  +   +   L  + V+ L  N L + GI + +   + KL  + ++  ++  
Sbjct: 127 RVHENEIT-KVRKSVFNGLNQMIVVELGTNPLKSSGIENGAFQGMKKLSYIRIADTNI-T 184

Query: 203 TIPESLANNAELLFLDVQNNTLSGIVPSALKRLN 236
           TIP+ L  +   L LD   N ++ +  ++LK LN
Sbjct: 185 TIPQGLPPSLTELHLD--GNKITKVDAASLKGLN 216

>1xku_A Decorin; proteoglycan, leucine-rich repeat, structural protein; HET: NAG; 2.15A {Bos taurus} SCOP: c.10.2.7 PDB: 1xec_A* 1xcd_A* Length = 330

 Score = 72.0 bits (177), Expect = 1e-13
 Identities = 31/160 (19%), Positives = 66/160 (41%), Gaps = 18/160 (11%)

Query: 87  SLSGLKCLSGLYLHYNSLSGEIPKEIRNLTELTDLYLDVNNLSGNIPPEI-GSMASLQVL 145
           +  G+K LS + +   +++  IP+ +     LT+L+LD N ++  +       + +L  L
Sbjct: 166 AFQGMKKLSYIRIADTNIT-TIPQGL--PPSLTELHLDGNKIT-KVDAASLKGLNNLAKL 221

Query: 146 QLCCNQLTGNIPAQI-GSLKSLSVLTLQHNRLNGGIPDSLGNLGKLKRLDLSFNSLFGTI 204
            L  N ++  +      +   L  L L +N+L   +P  L +   ++ + L  N++   I
Sbjct: 222 GLSFNSIS-AVDNGSLANTPHLRELHLNNNKLVK-VPGGLADHKYIQVVYLHNNNI-SAI 278

Query: 205 PES-------LANNAELLFLDVQNN--TLSGIVPSALKRL 235
             +           A    + + +N      I PS  + +
Sbjct: 279 GSNDFCPPGYNTKKASYSGVSLFSNPVQYWEIQPSTFRCV 318

>1xku_A Decorin; proteoglycan, leucine-rich repeat, structural protein; HET: NAG; 2.15A {Bos taurus} SCOP: c.10.2.7 PDB: 1xec_A* 1xcd_A* Length = 330

 Score = 55.8 bits (135), Expect = 2e-08
 Identities = 32/120 (26%), Positives = 52/120 (43%), Gaps = 6/120 (5%)

Query: 117 ELTDLYLDVNNLSGNIPPEIGSMASLQVLQLCCNQLTGNIPAQIGSLKSLSVLTLQHNRL 176
            L  +      L   +P ++       +L L  N++T        +LK+L  L L +N++
Sbjct: 32  HLRVVQCSDLGLE-KVPKDLPP--DTALLDLQNNKITEIKDGDFKNLKNLHTLILINNKI 88

Query: 177 NGGIPDSLGNLGKLKRLDLSFNSLFGTIPESLANNAELLFLDVQNNTLSGIVPSALKRLN 236
           +   P +   L KL+RL LS N L   +PE +     L  L V  N ++ +  S    LN
Sbjct: 89  SKISPGAFAPLVKLERLYLSKNQL-KELPEKMPKT--LQELRVHENEITKVRKSVFNGLN 145

>1xku_A Decorin; proteoglycan, leucine-rich repeat, structural protein; HET: NAG; 2.15A {Bos taurus} SCOP: c.10.2.7 PDB: 1xec_A* 1xcd_A* Length = 330

 Score = 55.4 bits (134), Expect = 2e-08
 Identities = 20/98 (20%), Positives = 37/98 (37%), Gaps = 11/98 (11%)

Query: 87  SLSGLKCLSGLYLHYNSLSGEIPKEIRNLTELTDLYLDVNNLSGNIPPE-------IGSM 139
           SL+    L  L+L+ N L  ++P  + +   +  +YL  NN+S  I              
Sbjct: 235 SLANTPHLRELHLNNNKLV-KVPGGLADHKYIQVVYLHNNNIS-AIGSNDFCPPGYNTKK 292

Query: 140 ASLQVLQLCCNQLT-GNIPAQI-GSLKSLSVLTLQHNR 175
           AS   + L  N +    I       +   + + L + +
Sbjct: 293 ASYSGVSLFSNPVQYWEIQPSTFRCVYVRAAVQLGNYK 330

>3v47_A TOLL-like receptor 5B and variable lymphocyte REC chimeric protein; innate immunity, leucine-rich repeat, innate immune receptor system; HET: NAG; 2.47A {Danio rerio} PDB: 3v44_A* Length = 455

 Score = 78.6 bits (194), Expect = 2e-15
 Identities = 35/146 (23%), Positives = 55/146 (37%), Gaps = 6/146 (4%)

Query: 97  LYLHYNSLSGEIPKEIRNLTELTDLYLDVNNLSGNIPPEI-GSMASLQVLQLCCNQLTGN 155
           + L  NS++         L +L  L ++       I       ++SL +L+L  NQ    
Sbjct: 35  VDLSLNSIAELNETSFSRLQDLQFLKVEQQTPGLVIRNNTFRGLSSLIILKLDYNQFL-Q 93

Query: 156 IPAQI-GSLKSLSVLTLQHNRLNGGI--PDSLGNLGKLKRLDLSFNSLFGTIPESL-ANN 211
           +       L +L VLTL    L+G +   +    L  L+ L L  N++    P S   N 
Sbjct: 94  LETGAFNGLANLEVLTLTQCNLDGAVLSGNFFKPLTSLEMLVLRDNNIKKIQPASFFLNM 153

Query: 212 AELLFLDVQNNTLSGIVPSALKRLNG 237
                LD+  N +  I    L    G
Sbjct: 154 RRFHVLDLTFNKVKSICEEDLLNFQG 179

>3v47_A TOLL-like receptor 5B and variable lymphocyte REC chimeric protein; innate immunity, leucine-rich repeat, innate immune receptor system; HET: NAG; 2.47A {Danio rerio} PDB: 3v44_A* Length = 455

 Score = 62.1 bits (151), Expect = 3e-10
 Identities = 38/213 (17%), Positives = 62/213 (29%), Gaps = 27/213 (12%)

Query: 42  NKLLQ-SWTENGDPCSGSFEGIACNEHRKVANISLQGKGLTGKLSPSLSGLKCLS----- 95
             L   +    G    G+              + L G G    ++         +     
Sbjct: 190 ITLQDMNEYWLGWEKCGNPFKNTSITT-----LDLSGNGFKESMAKRFFDAIAGTKIQSL 244

Query: 96  GLYLHYNSLSGEIPKEIRNL----------TELTDLYLDVNNLSGNIPPEI-GSMASLQV 144
            L   YN  S       ++           + +    L  + +   +   +      L+ 
Sbjct: 245 ILSNSYNMGSSFGHTNFKDPDNFTFKGLEASGVKTCDLSKSKIF-ALLKSVFSHFTDLEQ 303

Query: 145 LQLCCNQLTGNIPAQI-GSLKSLSVLTLQHNRLNGGIPDSLGNLGKLKRLDLSFNSLFGT 203
           L L  N++   I       L  L  L L  N L         NL KL+ LDLS+N +   
Sbjct: 304 LTLAQNEIN-KIDDNAFWGLTHLLKLNLSQNFLGSIDSRMFENLDKLEVLDLSYNHI-RA 361

Query: 204 IPE-SLANNAELLFLDVQNNTLSGIVPSALKRL 235
           + + S      L  L +  N L  +      RL
Sbjct: 362 LGDQSFLGLPNLKELALDTNQLKSVPDGIFDRL 394

>3v47_A TOLL-like receptor 5B and variable lymphocyte REC chimeric protein; innate immunity, leucine-rich repeat, innate immune receptor system; HET: NAG; 2.47A {Danio rerio} PDB: 3v44_A* Length = 455

 Score = 58.6 bits (142), Expect = 3e-09
 Identities = 34/171 (19%), Positives = 56/171 (32%), Gaps = 22/171 (12%)

Query: 88  LSGLKCLSGLYLHYNSL-SGEIPKEI-RNLTELTDLYLDVNNLSGNIPPEI--GSMASLQ 143
            +GL  L  L L   +L    +     + LT L  L L  NN+   I P     +M    
Sbjct: 99  FNGLANLEVLTLTQCNLDGAVLSGNFFKPLTSLEMLVLRDNNIK-KIQPASFFLNMRRFH 157

Query: 144 VLQLCCNQLTGNIPAQI-----------GSLKSLSVLTLQHNRLNGGIPDSLGNLGKLKR 192
           VL L  N++  +I  +              L S+++  +    L      +      +  
Sbjct: 158 VLDLTFNKVK-SICEEDLLNFQGKHFTLLRLSSITLQDMNEYWLGWEKCGNPFKNTSITT 216

Query: 193 LDLSFNSLFGTIPESLANNAEL-----LFLDVQNNTLSGIVPSALKRLNGG 238
           LDLS N    ++ +   +         L L    N  S    +  K  +  
Sbjct: 217 LDLSGNGFKESMAKRFFDAIAGTKIQSLILSNSYNMGSSFGHTNFKDPDNF 267

>3v47_A TOLL-like receptor 5B and variable lymphocyte REC chimeric protein; innate immunity, leucine-rich repeat, innate immune receptor system; HET: NAG; 2.47A {Danio rerio} PDB: 3v44_A* Length = 455

 Score = 55.9 bits (135), Expect = 2e-08
 Identities = 37/188 (19%), Positives = 61/188 (32%), Gaps = 33/188 (17%)

Query: 14  ITSSLTGLVCGNTELRALLDLKASLDPENKLLQSWTENGDPCSGSFEGIACNEHRKVANI 73
              S+            +  L  S           T   DP + +F+G+  +  +     
Sbjct: 224 FKESMAKRFFDAIAGTKIQSLILSNSYNMGSSFGHTNFKDPDNFTFKGLEASGVKTC--- 280

Query: 74  SLQGKGLTGKLSPSL-SGLKCLSGLYLHYNSLS-----------------------GEIP 109
            L    +   L  S+ S    L  L L  N ++                       G I 
Sbjct: 281 DLSKSKIF-ALLKSVFSHFTDLEQLTLAQNEINKIDDNAFWGLTHLLKLNLSQNFLGSID 339

Query: 110 KEI-RNLTELTDLYLDVNNLSGNIPPEI-GSMASLQVLQLCCNQLTGNIPAQI-GSLKSL 166
             +  NL +L  L L  N++   +  +    + +L+ L L  NQL  ++P  I   L SL
Sbjct: 340 SRMFENLDKLEVLDLSYNHIR-ALGDQSFLGLPNLKELALDTNQLK-SVPDGIFDRLTSL 397

Query: 167 SVLTLQHN 174
             + L  N
Sbjct: 398 QKIWLHTN 405

>3v47_A TOLL-like receptor 5B and variable lymphocyte REC chimeric protein; innate immunity, leucine-rich repeat, innate immune receptor system; HET: NAG; 2.47A {Danio rerio} PDB: 3v44_A* Length = 455

 Score = 49.7 bits (119), Expect = 2e-06
 Identities = 26/172 (15%), Positives = 55/172 (31%), Gaps = 25/172 (14%)

Query: 89  SGLKCLSGLYLHYNSLSGEIPKEIRNLT--ELTDLYLDVNNLSGNIPPEIGS-------- 138
             ++    L L +N +     +++ N      T L L    L       +G         
Sbjct: 151 LNMRRFHVLDLTFNKVKSICEEDLLNFQGKHFTLLRLSSITLQDMNEYWLGWEKCGNPFK 210

Query: 139 MASLQVLQLCCNQLTGNIPAQIGSLKSLSVLTLQHNRLNGGIPDSLGN------------ 186
             S+  L L  N    ++  +     + + +       +  +  S G+            
Sbjct: 211 NTSITTLDLSGNGFKESMAKRFFDAIAGTKIQSLILSNSYNMGSSFGHTNFKDPDNFTFK 270

Query: 187 ---LGKLKRLDLSFNSLFGTIPESLANNAELLFLDVQNNTLSGIVPSALKRL 235
                 +K  DLS + +F  +    ++  +L  L +  N ++ I  +A   L
Sbjct: 271 GLEASGVKTCDLSKSKIFALLKSVFSHFTDLEQLTLAQNEINKIDDNAFWGL 322

>4g3f_A NF-kappa-beta-inducing kinase; non-RD kinase, protein serine/threonine kinase, S based drug design, MAP3K14, transferase; HET: 0WB; 1.64A {Mus musculus} PDB: 4g3g_A* 4g3c_A 4dn5_A* Length = 336

 Score = 77.5 bits (191), Expect = 2e-15
 Identities = 43/207 (20%), Positives = 83/207 (40%), Gaps = 25/207 (12%)

Query: 415 NLLGKGNFSSVYKGT-LRDGTLVAIRSINVTSCKSEEAEFVKGLYLLTSLRHENIIRLRG 473
             +G+G+F  V++    + G   A++ + +   + EE      L     L    I+ L G
Sbjct: 64  PRVGRGSFGEVHRMKDKQTGFQCAVKKVRLEVFRVEE------LVACAGLSSPRIVPLYG 117

Query: 474 FCCSRGRGECFLIY-DFAPKGKLSKYLDQEEGSSNVLDWSTRVSIIIGIAKGIGYLHSSE 532
                  G    I+ +    G L + + ++ G    L     +  +    +G+ YLH+  
Sbjct: 118 AVRE---GPWVNIFMELLEGGSLGQLI-KQMGC---LPEDRALYYLGQALEGLEYLHTRR 170

Query: 533 VNKPAIVHRNLSVEKVLIDQQFNPL-IADCGLHKLLADDIVFSVLKTSAAM-G---YLAP 587
                I+H ++  + VL+    +   + D G    L  D +   L T   + G   ++AP
Sbjct: 171 -----ILHGDVKADNVLLSSDGSRAALCDFGHALCLQPDGLGKSLLTGDYIPGTETHMAP 225

Query: 588 EYVTTGRFTERSDIFAFGVIILQILTG 614
           E V       + DI++   ++L +L G
Sbjct: 226 EVVMGKPCDAKVDIWSSCCMMLHMLNG 252

>1wwl_A Monocyte differentiation antigen CD14; LPS, immune system; HET: NAG; 2.50A {Mus musculus} Length = 312

 Score = 76.5 bits (188), Expect = 2e-15
 Identities = 37/177 (20%), Positives = 54/177 (30%), Gaps = 16/177 (9%)

Query: 72  NISLQGKGLTGKLSPSLSGLKCLSGLYLHYNSLSGEIPKEIRNLTELTDLYLDVNNLSGN 131
           N+S   +               L  L +          +++R    L+ L L  N   G 
Sbjct: 130 NVSWATRDAWLAELQQWLKPG-LKVLSIAQAHSLNFSCEQVRVFPALSTLDLSDNPELGE 188

Query: 132 IPPEI----GSMASLQVLQLCCNQLT---GNIPAQIGSLKSLSVLTLQHNRLNGGIPDSL 184
                        +LQVL L    +    G   A   +   L  L L HN L        
Sbjct: 189 RGLISALCPLKFPTLQVLALRNAGMETPSGVCSALAAARVQLQGLDLSHNSLRDAAGAPS 248

Query: 185 -GNLGKLKRLDLSFNSLFGTIPESLANNAELLFLDVQNNTLSGIVPSA----LKRLN 236
                +L  L+LSF  L   +P+ L     L  LD+  N L           +  L+
Sbjct: 249 CDWPSQLNSLNLSFTGL-KQVPKGLPAK--LSVLDLSYNRLDRNPSPDELPQVGNLS 302

>1wwl_A Monocyte differentiation antigen CD14; LPS, immune system; HET: NAG; 2.50A {Mus musculus} Length = 312

 Score = 73.4 bits (180), Expect = 3e-14
 Identities = 32/177 (18%), Positives = 61/177 (34%), Gaps = 12/177 (6%)

Query: 72  NISLQGKGLTGKLSPSLSGLKCLSGLYLHYNSLSGEIPKEIRNLTE-LTDLYLDVNNLSG 130
           N+ + G      L  +   L  L+   + + +    + +  + L   L  L +   +   
Sbjct: 104 NLEVTGTAPPPLLEATGPDLNILNLRNVSWATRDAWLAELQQWLKPGLKVLSIAQAHSLN 163

Query: 131 NIPPEIGSMASLQVLQLCCNQLTGNIP----AQIGSLKSLSVLTLQHNRLN---GGIPDS 183
               ++    +L  L L  N   G              +L VL L++  +    G     
Sbjct: 164 FSCEQVRVFPALSTLDLSDNPELGERGLISALCPLKFPTLQVLALRNAGMETPSGVCSAL 223

Query: 184 LGNLGKLKRLDLSFNSLFGTIPESL-ANNAELLFLDVQNNTLSGI---VPSALKRLN 236
                +L+ LDLS NSL            ++L  L++    L  +   +P+ L  L+
Sbjct: 224 AAARVQLQGLDLSHNSLRDAAGAPSCDWPSQLNSLNLSFTGLKQVPKGLPAKLSVLD 280

>1wwl_A Monocyte differentiation antigen CD14; LPS, immune system; HET: NAG; 2.50A {Mus musculus} Length = 312

 Score = 64.9 bits (158), Expect = 1e-11
 Identities = 34/137 (24%), Positives = 48/137 (35%), Gaps = 9/137 (6%)

Query: 72  NISLQGKGLTGKLSP-SLSGLKCLSGLYLHYNSLSGEIPKEIRNLTELTDLYLDVNNLSG 130
           N  L  +GL   L P     L+ L+       + SG          +L  L L  N+L  
Sbjct: 183 NPELGERGLISALCPLKFPTLQVLALRNAGMETPSGVCSALAAARVQLQGLDLSHNSLRD 242

Query: 131 NIPPEIGS-MASLQVLQLCCNQLTGNIPAQIGSLKSLSVLTLQHNRLNGGIPDSLGNLGK 189
                     + L  L L    L   +P  + +   LSVL L +NRL+   P     L +
Sbjct: 243 AAGAPSCDWPSQLNSLNLSFTGLKQ-VPKGLPA--KLSVLDLSYNRLDR-NPSPDE-LPQ 297

Query: 190 LKRLDLSFNSLFGTIPE 206
           +  L L  N       E
Sbjct: 298 VGNLSLKGNPF--LDSE 312

>1wwl_A Monocyte differentiation antigen CD14; LPS, immune system; HET: NAG; 2.50A {Mus musculus} Length = 312

 Score = 55.3 bits (133), Expect = 2e-08
 Identities = 33/187 (17%), Positives = 55/187 (29%), Gaps = 10/187 (5%)

Query: 53  DPCSGSFEGIACNEHRKVANISLQGKGLTGKLSPSLSGLKCLSGLYLHYN-SLSGEIPKE 111
           +PC    E  +CN      + S     L         G + L  L    +         +
Sbjct: 4   EPCELDEESCSCNFSDPKPDWSSAFNCLGAADVELYGGGRSLEYLLKRVDTEADLGQFTD 63

Query: 112 IRNLTELTDLYLDVNNLSGNIPP---EIGSMASLQVLQLCCNQLTGNIPAQIGSLKSLSV 168
           I     L  L +    +   I      +  ++ LQ L L   ++TG  P  +       +
Sbjct: 64  IIKSLSLKRLTVRAARIPSRILFGALRVLGISGLQELTLENLEVTGTAPPPLLEATGPDL 123

Query: 169 LTLQHNRLN-GGIPDSLGNLG-----KLKRLDLSFNSLFGTIPESLANNAELLFLDVQNN 222
             L    ++       L  L       LK L ++         E +     L  LD+ +N
Sbjct: 124 NILNLRNVSWATRDAWLAELQQWLKPGLKVLSIAQAHSLNFSCEQVRVFPALSTLDLSDN 183

Query: 223 TLSGIVP 229
              G   
Sbjct: 184 PELGERG 190

>2z62_A TOLL-like receptor 4, variable lymphocyte recepto; TLR, VLR hybrid, MD-2, LPS, glycoprotein response, inflammatory response, innate immunity; HET: NAG FUL BMA; 1.70A {Homo sapiens} PDB: 2z65_A* 3ul8_A* 3ula_A* 3ul7_A* Length = 276

 Score = 75.8 bits (187), Expect = 2e-15
 Identities = 34/154 (22%), Positives = 54/154 (35%), Gaps = 10/154 (6%)

Query: 89  SGLKCLSGLYLHYNSLSGEIPKEI-RNLTELTDLYLDVNNLSGNIPPEI-GSMASLQVLQ 146
             L  LS L L  N +   +       L+ L  L     NL+ ++     G + +L+ L 
Sbjct: 73  QSLSHLSTLILTGNPIQ-SLALGAFSGLSSLQKLVAVETNLA-SLENFPIGHLKTLKELN 130

Query: 147 LCCNQLTGNIPAQI-GSLKSLSVLTLQHNRL---NGGIPDSLGNLGKLK-RLDLSFNSLF 201
           +  N +      +   +L +L  L L  N++          L  +  L   LDLS N + 
Sbjct: 131 VAHNLIQSFKLPEYFSNLTNLEHLDLSSNKIQSIYCTDLRVLHQMPLLNLSLDLSLNPM- 189

Query: 202 GTIPESLANNAELLFLDVQNNTLSGIVPSALKRL 235
             I         L  L +  N L  +      RL
Sbjct: 190 NFIQPGAFKEIRLKELALDTNQLKSVPDGIFDRL 223

>2z62_A TOLL-like receptor 4, variable lymphocyte recepto; TLR, VLR hybrid, MD-2, LPS, glycoprotein response, inflammatory response, innate immunity; HET: NAG FUL BMA; 1.70A {Homo sapiens} PDB: 2z65_A* 3ul8_A* 3ula_A* 3ul7_A* Length = 276

 Score = 74.2 bits (183), Expect = 9e-15
 Identities = 35/142 (24%), Positives = 56/142 (39%), Gaps = 5/142 (3%)

Query: 97  LYLHYNSLSGEIPKEIRNLTELTDLYLDVNNLSGNIPPEI-GSMASLQVLQLCCNQLTGN 155
           L L +N L         +  EL  L L    +   I      S++ L  L L  N +  +
Sbjct: 33  LDLSFNPLRHLGSYSFFSFPELQVLDLSRCEIQ-TIEDGAYQSLSHLSTLILTGNPIQ-S 90

Query: 156 IPAQI-GSLKSLSVLTLQHNRLNGGIPDSLGNLGKLKRLDLSFNSL-FGTIPESLANNAE 213
           +       L SL  L      L       +G+L  LK L+++ N +    +PE  +N   
Sbjct: 91  LALGAFSGLSSLQKLVAVETNLASLENFPIGHLKTLKELNVAHNLIQSFKLPEYFSNLTN 150

Query: 214 LLFLDVQNNTLSGIVPSALKRL 235
           L  LD+ +N +  I  + L+ L
Sbjct: 151 LEHLDLSSNKIQSIYCTDLRVL 172

>2z62_A TOLL-like receptor 4, variable lymphocyte recepto; TLR, VLR hybrid, MD-2, LPS, glycoprotein response, inflammatory response, innate immunity; HET: NAG FUL BMA; 1.70A {Homo sapiens} PDB: 2z65_A* 3ul8_A* 3ula_A* 3ul7_A* Length = 276

 Score = 72.7 bits (179), Expect = 3e-14
 Identities = 42/164 (25%), Positives = 67/164 (40%), Gaps = 14/164 (8%)

Query: 83  KLSP-SLSGLKCLSGLYLHYNSLSGEIPKEI-RNLTELTDLYLDVNNLSGNIPPEI-GSM 139
            L   S      L  L L    +   I     ++L+ L+ L L  N +  ++       +
Sbjct: 42  HLGSYSFFSFPELQVLDLSRCEIQ-TIEDGAYQSLSHLSTLILTGNPIQ-SLALGAFSGL 99

Query: 140 ASLQVLQLCCNQLTGNIPAQI-GSLKSLSVLTLQHNRL-NGGIPDSLGNLGKLKRLDLSF 197
           +SLQ L      L  ++     G LK+L  L + HN + +  +P+   NL  L+ LDLS 
Sbjct: 100 SSLQKLVAVETNLA-SLENFPIGHLKTLKELNVAHNLIQSFKLPEYFSNLTNLEHLDLSS 158

Query: 198 NSLFGTIPE----SLAN-NAELLFLDVQNNTLSGIVPSALKRLN 236
           N +  +I       L       L LD+  N ++ I P A K + 
Sbjct: 159 NKI-QSIYCTDLRVLHQMPLLNLSLDLSLNPMNFIQPGAFKEIR 201

>2z62_A TOLL-like receptor 4, variable lymphocyte recepto; TLR, VLR hybrid, MD-2, LPS, glycoprotein response, inflammatory response, innate immunity; HET: NAG FUL BMA; 1.70A {Homo sapiens} PDB: 2z65_A* 3ul8_A* 3ula_A* 3ul7_A* Length = 276

 Score = 63.8 bits (156), Expect = 3e-11
 Identities = 32/144 (22%), Positives = 55/144 (38%), Gaps = 16/144 (11%)

Query: 89  SGLKCLSGLYLHYNSLSGEIPKEI-RNLTELTDLYLDVNNLSGNIPPEI-GSMASLQVLQ 146
           SGL  L  L     +L+  +      +L  L +L +  N +     PE   ++ +L+ L 
Sbjct: 97  SGLSSLQKLVAVETNLA-SLENFPIGHLKTLKELNVAHNLIQSFKLPEYFSNLTNLEHLD 155

Query: 147 LCCNQLTGNIPAQIGSLKSLSVLT-------LQHNRLNGGIPDSLGNLGKLKRLDLSFNS 199
           L  N++  +I      L+ L  +        L  N +N  I        +LK L L  N 
Sbjct: 156 LSSNKIQ-SIYC--TDLRVLHQMPLLNLSLDLSLNPMN-FIQPGAFKEIRLKELALDTNQ 211

Query: 200 LFGTIPE-SLANNAELLFLDVQNN 222
           L  ++P+        L  + +  N
Sbjct: 212 L-KSVPDGIFDRLTSLQKIWLHTN 234

>2z62_A TOLL-like receptor 4, variable lymphocyte recepto; TLR, VLR hybrid, MD-2, LPS, glycoprotein response, inflammatory response, innate immunity; HET: NAG FUL BMA; 1.70A {Homo sapiens} PDB: 2z65_A* 3ul8_A* 3ula_A* 3ul7_A* Length = 276

 Score = 42.3 bits (100), Expect = 3e-04
 Identities = 24/108 (22%), Positives = 35/108 (32%), Gaps = 12/108 (11%)

Query: 131 NIPPEIGSMASLQVLQLCCNQLTGNIPAQIGSLKSLSVLTLQHNRLNGGIPDSLGNLGKL 190
           N+P       S + L L  N L         S   L VL L    +      +  +L  L
Sbjct: 25  NLP------FSTKNLDLSFNPLRHLGSYSFFSFPELQVLDLSRCEIQTIEDGAYQSLSHL 78

Query: 191 KRLDLSFN---SLFGTIPESLANNAELLFLDVQNNTLSGIVPSALKRL 235
             L L+ N   SL       L++   L  L      L+ +    +  L
Sbjct: 79  STLILTGNPIQSLALGAFSGLSS---LQKLVAVETNLASLENFPIGHL 123

>3a99_A Proto-oncogene serine/threonine-protein kinase PI; PIM-1, P27KIP1, peptide drug, prostate cancer, transferase; HET: ANP; 1.60A {Homo sapiens} PDB: 3bgq_A* 3bgp_A* 2obj_A* 3bgz_A* 3t9i_A* 3dcv_A* 1xws_A* 2xj1_A* 2xix_A* 2xiz_A* 2xj0_A* 2xiy_A* 2xj2_A* 3f2a_A* 1xr1_A* 1xqz_A* 3cy2_A* 3cxw_A* 3cy3_A* 2bik_B* ... Length = 320

 Score = 75.5 bits (186), Expect = 5e-15
 Identities = 57/294 (19%), Positives = 100/294 (34%), Gaps = 85/294 (28%)

Query: 416 LLGKGNFSSVYKGT-LRDGTLVAIRSINVTSCKSEEAEFVKG-----LYLLTSLRHE--N 467
           LLG G F SVY G  + D   VAI+ +                    + LL  +      
Sbjct: 50  LLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSG 109

Query: 468 IIRLRGFCCSR-----------GRGECFLIYDF-APKGKLS-----KYLDQEEGSSNVLD 510
           +IRL  +                  + F   DF   +G L       +  Q         
Sbjct: 110 VIRLLDWFERPDSFVLILERPEPVQDLF---DFITERGALQEELARSFFWQ--------- 157

Query: 511 WSTRVSIIIGIAKGIGYLHSSEVNKPAIVHRNLSVEKVLIDQQFNPL-IADCGLHKLLAD 569
                     + + + + H+       ++HR++  E +LID     L + D G   LL D
Sbjct: 158 ----------VLEAVRHCHNC-----GVLHRDIKDENILIDLNRGELKLIDFGSGALLKD 202

Query: 570 DIVFSVLKTSAAMG---YLAPEYVTTGRFT-ERSDIFAFGVIILQILTGSLVLTSSMRLA 625
               +V       G   Y  PE++   R+    + +++ G+++  ++ G +         
Sbjct: 203 ----TVYTDFD--GTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDI--------- 247

Query: 626 AESATFENFIDRNLKGKFSE-----SEAAKLGKMALVCTHEDPENRPTMEAVIE 674
                FE+  +  ++G+        SE   L +  L      P +RPT E +  
Sbjct: 248 ----PFEH-DEEIIRGQVFFRQRVSSECQHLIRWCLA---LRPSDRPTFEEIQN 293

>2clq_A Mitogen-activated protein kinase kinase kinase 5; transferase, metal-binding, apoptosis; HET: STU; 2.3A {Homo sapiens} Length = 295

 Score = 74.6 bits (184), Expect = 8e-15
 Identities = 55/206 (26%), Positives = 90/206 (43%), Gaps = 20/206 (9%)

Query: 416 LLGKGNFSSVYKGT-LRDGTLVAIRSINVTSCKSEEAEFVKGLYLLTSLRHENIIRLRGF 474
           +LGKG +  VY G  L +   +AI+ I             + + L   L+H+NI++  G 
Sbjct: 29  VLGKGTYGIVYAGRDLSNQVRIAIKEIPERD-SRYSQPLHEEIALHKHLKHKNIVQYLGS 87

Query: 475 CCSRGRGECFLIY-DFAPKGKLSKYLDQEEGSSNVLDWSTRVSIIIGIAKGIGYLHSSEV 533
                      I+ +  P G LS  L  + G     + +        I +G+ YLH ++ 
Sbjct: 88  FSEN---GFIKIFMEQVPGGSLSALLRSKWGPLKDNEQTIGF-YTKQILEGLKYLHDNQ- 142

Query: 534 NKPAIVHRNLSVEKVLIDQQFNPL-IADCGLHKLLAD--DIVFSVLKTSAAMGYLAPEYV 590
               IVHR++  + VLI+     L I+D G  K LA       +   T   M   APE +
Sbjct: 143 ----IVHRDIKGDNVLINTYSGVLKISDFGTSKRLAGINPCTETFTGTLQYM---APEII 195

Query: 591 TTGR--FTERSDIFAFGVIILQILTG 614
             G   + + +DI++ G  I+++ TG
Sbjct: 196 DKGPRGYGKAADIWSLGCTIIEMATG 221

>2pzi_A Probable serine/threonine-protein kinase PKNG; ATP-recognition, kinase-INH complex, rubredoxin fold, TPR domain, transferase; HET: AXX; 2.40A {Mycobacterium tuberculosis} Length = 681

 Score = 77.2 bits (190), Expect = 8e-15
 Identities = 47/302 (15%), Positives = 91/302 (30%), Gaps = 89/302 (29%)

Query: 416 LLGKGNFSSVYKG--TLRDGTLVAIRSINVTSCKS------EEAEFVKGLYLLTSLRHEN 467
            +  G    +Y       +G  V ++ +  +           E +F      L  + H +
Sbjct: 87  CIAHGGLGWIYLALDRNVNGRPVVLKGLVHSGDAEAQAMAMAERQF------LAEVVHPS 140

Query: 468 IIRLRGFCCSRGRGECFLIYDF----APKGKLSKYLDQE--EGSS------NVLDWSTRV 515
           I++               I++F       G    Y+  E   G S        L  +  +
Sbjct: 141 IVQ---------------IFNFVEHTDRHGDPVGYIVMEYVGGQSLKRSKGQKLPVAEAI 185

Query: 516 SIIIGIAKGIGYLHSSEVNKPAIVHRNLSVEKVLIDQQFNPLIADCGLHKLLADDIVFSV 575
           + ++ I   + YLHS       +V+ +L  E +++ ++    + D G         V  +
Sbjct: 186 AYLLEILPALSYLHSI-----GLVYNDLKPENIMLTEE-QLKLIDLG--------AVSRI 231

Query: 576 LKTSAAMG---YLAPEYVTTGRFTERSDIFAFGVIILQILTGSL--------VLTSSMRL 624
                  G   + APE +     T  +DI+  G  +  +              L     +
Sbjct: 232 NSFGYLYGTPGFQAPE-IVRTGPTVATDIYTVGRTLAALTLDLPTRNGRYVDGLPEDDPV 290

Query: 625 AAESATFENFIDRNLKGKFSESEAAKLGKMALVCTHEDPENRP-TMEAVIEEL-TVAAPV 682
                ++   + R                        DP  R  T E +  +L  V   V
Sbjct: 291 LKTYDSYGRLLRR--------------------AIDPDPRQRFTTAEEMSAQLTGVLREV 330

Query: 683 MA 684
           +A
Sbjct: 331 VA 332

>4eqm_A Protein kinase; transferase; HET: ANP; 3.00A {Staphylococcus aureus subsp} Length = 294

 Score = 74.6 bits (184), Expect = 8e-15
 Identities = 52/228 (22%), Positives = 86/228 (37%), Gaps = 62/228 (27%)

Query: 416 LLGKGNFSSVYKGT-LRDGTLVAIRSINVTSCK------SEEAEFVKGLYL----LTSLR 464
            LG G  S+VY          VAI        K       E+ E +K         + L 
Sbjct: 18  KLGGGGMSTVYLAEDTILNIKVAI--------KAIFIPPREKEETLKRFEREVHNSSQLS 69

Query: 465 HENIIRLRGFCCSRGRGECFLIYDFAPKGK-------------LSKYLDQEEGSSNVLDW 511
           H+NI+                + D   +               LS+Y+ +  G    L  
Sbjct: 70  HQNIVS---------------MIDVDEEDDCYYLVMEYIEGPTLSEYI-ESHGP---LSV 110

Query: 512 STRVSIIIGIAKGIGYLHSSEVNKPAIVHRNLSVEKVLIDQQFNPLIADCGLHKLLADDI 571
            T ++    I  GI + H        IVHR++  + +LID      I D G+ K L++  
Sbjct: 111 DTAINFTNQILDGIKHAHDMR-----IVHRDIKPQNILIDSNKTLKIFDFGIAKALSET- 164

Query: 572 VFSVLKTSAAMG---YLAPEYVTTGRFTERSDIFAFGVIILQILTGSL 616
             S+ +T+  +G   Y +PE        E +DI++ G+++ ++L G  
Sbjct: 165 --SLTQTNHVLGTVQYFSPEQAKGEATDECTDIYSIGIVLYEMLVGEP 210

>2ycf_A Serine/threonine-protein kinase CHK2; transferase, anticancer, anticancer drug design; HET: YCF; 1.77A {Homo sapiens} PDB: 2yiq_A* 2w7x_A* 2ycq_A* 2ycs_A* 2w0j_A* 2yir_A* 2yit_A* 2wtj_A* 2cn8_A* 2wtc_A* 2wtd_A* 2wti_A* 2cn5_A* 2xbj_A* 2xm8_A* 2xm9_A* 2xk9_A* 2ycr_A* Length = 322

 Score = 74.6 bits (184), Expect = 1e-14
 Identities = 65/289 (22%), Positives = 108/289 (37%), Gaps = 63/289 (21%)

Query: 417 LGKGNFSSVYKGTLRD-GTLVAIRSIN---VTSCKSEEAEFVKGLY----LLTSLRHENI 468
           LG G    V     R     VAI+ I+        + EA+    +     +L  L H  I
Sbjct: 18  LGSGACGEVKLAFERKTCKKVAIKIISKRKFAIGSAREADPALNVETEIEILKKLNHPCI 77

Query: 469 IRLRGFCCSRGRGECFLIYDFAPKGKL------SKYLDQEEGSSNVLDWSTRVSIIIGIA 522
           I+++ F  +    + +++ +    G+L      +K L +                   + 
Sbjct: 78  IKIKNFFDAE---DYYIVLELMEGGELFDKVVGNKRLKEATCK----------LYFYQML 124

Query: 523 KGIGYLHSSEVNKPAIVHRNLSVEKVLIDQQFNPL---IADCGLHKLLADDIVFSVLKTS 579
             + YLH +      I+HR+L  E VL+  Q       I D G  K+L +    S+++T 
Sbjct: 125 LAVQYLHENG-----IIHRDLKPENVLLSSQEEDCLIKITDFGHSKILGET---SLMRTL 176

Query: 580 AAM-GYLAPE---YVTTGRFTERSDIFAFGVIILQILTGSLVLTSSMRLAAESATFENFI 635
                YLAPE    V T  +    D ++ GVI+   L+G    +                
Sbjct: 177 CGTPTYLAPEVLVSVGTAGYNRAVDCWSLGVILFICLSGYPPFS------EHRTQVSLK- 229

Query: 636 DRNLKGKFSE--------SEAAK--LGKMALVCTHEDPENRPTMEAVIE 674
           D+   GK++         SE A   + K+ +V    DP+ R T E  + 
Sbjct: 230 DQITSGKYNFIPEVWAEVSEKALDLVKKLLVV----DPKARFTTEEALR 274

>3kk8_A Calcium/calmodulin dependent protein kinase II; ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; HET: TPO; 1.72A {Caenorhabditis elegans} PDB: 3kk9_A* 3kl8_A 2vn9_A* 3bhh_A* Length = 284

 Score = 74.1 bits (183), Expect = 1e-14
 Identities = 54/206 (26%), Positives = 90/206 (43%), Gaps = 32/206 (15%)

Query: 417 LGKGNFSSVYKGTLRD-GTLVAIRSINVTSCKSEEAEFVKG-LYLLTSLRHENIIRLRGF 474
           LGKG FS V +   +  G   A + IN     + + + ++    +   L+H NI+RL   
Sbjct: 14  LGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQKLEREARICRKLQHPNIVRLHDS 73

Query: 475 CCSRGRGECFLIYDFAPKGKL------SKYLDQEEGSSNVLDWSTRVSIIIGIAKGIGYL 528
              +     +L++D    G+L       ++  + + S            I  I + I Y 
Sbjct: 74  I--QEESFHYLVFDLVTGGELFEDIVAREFYSEADAS----------HCIQQILESIAYC 121

Query: 529 HSSEVNKPAIVHRNLSVEKVLIDQQFN--PL-IADCGLHKLLADDIVFSVLKTSAAMGYL 585
           HS+      IVHRNL  E +L+  +     + +AD GL   + D   +     +   GYL
Sbjct: 122 HSNG-----IVHRNLKPENLLLASKAKGAAVKLADFGLAIEVNDSEAWHGFAGTP--GYL 174

Query: 586 APEYVTTGRFTERSDIFAFGVI--IL 609
           +PE +    +++  DI+A GVI  IL
Sbjct: 175 SPEVLKKDPYSKPVDIWACGVILYIL 200

>3q5i_A Protein kinase; CDPK, malaria, phosphotransferase, structural genomics, structural genomic consortium, SGC, transferase; HET: ANP; 2.10A {Plasmodium berghei} Length = 504

 Score = 75.9 bits (187), Expect = 1e-14
 Identities = 67/301 (22%), Positives = 106/301 (35%), Gaps = 82/301 (27%)

Query: 415 NLLGKGNFSSVYKGTLR-DGTLVAIRSIN------------VTSCKSEEAEFVKGLYLLT 461
             LG G +  V     +   +  AI+ I               + +    E    + LL 
Sbjct: 42  RKLGSGAYGEVLLCKEKNGHSEKAIKVIKKSQFDKGRYSDDNKNIEKFHEEIYNEISLLK 101

Query: 462 SLRHENIIRLRGFCCSRGRGECFLIYDFAPKGKL-------SKYLDQEEGSSNVLDWSTR 514
           SL H NII+L      +     +L+ +F   G+L        K+   E  ++N       
Sbjct: 102 SLDHPNIIKLFDVFEDKKY--FYLVTEFYEGGELFEQIINRHKF--DECDAAN------- 150

Query: 515 VSIIIGIAKGIGYLHSSEVNKPAIVHRNLSVEKVLI---DQQFNPLIADCGLHKLLADDI 571
             I+  I  GI YLH        IVHR++  E +L+   +   N  I D GL    + D 
Sbjct: 151 --IMKQILSGICYLHKH-----NIVHRDIKPENILLENKNSLLNIKIVDFGLSSFFSKDY 203

Query: 572 VFSVLKTSAAMGYLAPEYVTTGRFTERSDIFAFGVIILQILTGSLVLTSSMRLAAESATF 631
                  +A   Y+APE V   ++ E+ D+++ GVI+  +L G                 
Sbjct: 204 KLRDRLGTA--YYIAPE-VLKKKYNEKCDVWSCGVIMYILLCGYP--------------- 245

Query: 632 ENFIDRNLKGKFSE----------------SEAAK--LGKMALVCTHEDPENRPTMEAVI 673
             F  +N +    +                S+ AK  +  M L     D   R T E  +
Sbjct: 246 -PFGGQNDQDIIKKVEKGKYYFDFNDWKNISDEAKELIKLM-LT---YDYNKRCTAEEAL 300

Query: 674 E 674
            
Sbjct: 301 N 301

>2iwi_A Serine/threonine-protein kinase PIM-2; nucleotide-binding, cancer, leukemia, transferase, ATP-binding, proto- oncogene, phosphorylation; HET: HB1; 2.80A {Homo sapiens} Length = 312

 Score = 74.3 bits (183), Expect = 1e-14
 Identities = 53/294 (18%), Positives = 96/294 (32%), Gaps = 83/294 (28%)

Query: 416 LLGKGNFSSVYKGT-LRDGTLVAIRSINVTSCKSEEAEFVKG---------LYLLTSLRH 465
           LLGKG F +V+ G  L D   VAI+ I                          +     H
Sbjct: 38  LLGKGGFGTVFAGHRLTDRLQVAIKVIPRNRVLGWSPLSDSVTCPLEVALLWKVGAGGGH 97

Query: 466 ENIIRLRGFCCSRGR-----------GECFLIYDF-APKGKLS-----KYLDQEEGSSNV 508
             +IRL  +  ++              + F   D+   KG L       +  Q       
Sbjct: 98  PGVIRLLDWFETQEGFMLVLERPLPAQDLF---DYITEKGPLGEGPSRCFFGQ------- 147

Query: 509 LDWSTRVSIIIGIAKGIGYLHSSEVNKPAIVHRNLSVEKVLIDQQFNPL-IADCGLHKLL 567
                       +   I + HS       +VHR++  E +LID +     + D G   LL
Sbjct: 148 ------------VVAAIQHCHSR-----GVVHRDIKDENILIDLRRGCAKLIDFGSGALL 190

Query: 568 ADDIVFSVLKTSA-AMGYLAPEYVTTGRFT-ERSDIFAFGVIILQILTGSLVLTSSMRLA 625
            D               Y  PE+++  ++    + +++ G+++  ++ G +         
Sbjct: 191 HD----EPYTDFDGTRVYSPPEWISRHQYHALPATVWSLGILLYDMVCGDI--------- 237

Query: 626 AESATFENFIDRNLKGKFSE-----SEAAKLGKMALVCTHEDPENRPTMEAVIE 674
                FE      L+ +         +   L +  L      P +RP++E ++ 
Sbjct: 238 ----PFER-DQEILEAELHFPAHVSPDCCALIRRCLA---PKPSSRPSLEEILL 283

>2h6d_A 5'-AMP-activated protein kinase catalytic subunit alpha-2; ATP-binding, cholesterol biosynthesis, fatty acid biosynthesis;kinase, lipid synthesis; 1.85A {Homo sapiens} PDB: 3aqv_A* 2yza_A* Length = 276

 Score = 73.0 bits (180), Expect = 2e-14
 Identities = 71/283 (25%), Positives = 111/283 (39%), Gaps = 63/283 (22%)

Query: 416 LLGKGNFSSVYKGT-LRDGTLVAIRSINVTSCKSEEAEFVKGLY----LLTSLRHENIIR 470
            LG G F  V  G     G  VA++ +N    K    + V  +      L   RH +II+
Sbjct: 18  TLGVGTFGKVKIGEHQLTGHKVAVKILNRQ--KIRSLDVVGKIKREIQNLKLFRHPHIIK 75

Query: 471 LRGFCCSRGRGECFLIYDFAPKGKLSKYLDQEEGSSNVLDWSTRVSIIIGIAKGIGYLHS 530
           L  +       + F++ ++   G+L  Y+ +       ++      +   I   + Y H 
Sbjct: 76  L--YQVISTPTDFFMVMEYVSGGELFDYICKHGR----VEEMEARRLFQQILSAVDYCHR 129

Query: 531 SEVNKPAIVHRNLSVEKVLIDQQFNPLIADCGLHKLLADDIVFSVLKTSAAMG---YLAP 587
                  +VHR+L  E VL+D   N  IAD GL  +++D      L+TS   G   Y AP
Sbjct: 130 H-----MVVHRDLKPENVLLDAHMNAKIADFGLSNMMSDG---EFLRTSC--GSPNYAAP 179

Query: 588 EYVTTGRFTE--RSDIFAFGVIILQILTGSLVLTSSMRLAAESATFENFIDRNL------ 639
           E V +GR       DI++ GVI+  +L G+L                 F D ++      
Sbjct: 180 E-VISGRLYAGPEVDIWSCGVILYALLCGTL----------------PFDDEHVPTLFKK 222

Query: 640 --KGKFSE----SEAAK--LGKMALVCTHEDPENRPTMEAVIE 674
              G F      + +    L  M  V    DP  R T++ + E
Sbjct: 223 IRGGVFYIPEYLNRSVATLLMHMLQV----DPLKRATIKDIRE 261

>1m9s_A Internalin B; cell invasion, GW domains, SH3 domains, signaling protein; 2.65A {Listeria monocytogenes} SCOP: b.1.18.15 b.34.11.1 b.34.11.1 b.34.11.1 c.10.2.1 PDB: 2y5q_A Length = 605

 Score = 75.5 bits (185), Expect = 2e-14
 Identities = 43/176 (24%), Positives = 77/176 (43%), Gaps = 13/176 (7%)

Query: 62  IACNEHRKVANISLQGKGLTGKLSPSLSGLKCLSGLYLHYNSLSGEIPKEIRNLTELTDL 121
           +  NE   +  I      +   +   +  L  ++ L+L+ N L+ +I K + NL  L  L
Sbjct: 37  VTQNELNSIDQIIANNSDIK-SVQG-IQYLPNVTKLFLNGNKLT-DI-KPLTNLKNLGWL 92

Query: 122 YLDVNNLSGNIPPEIGSMASLQVLQLCCNQLTGNIPAQIGSLKSLSVLTLQHNRLNGGIP 181
           +LD N +  ++   +  +  L+ L L  N ++ +I   +  L  L  L L +N++     
Sbjct: 93  FLDENKIK-DLSS-LKDLKKLKSLSLEHNGIS-DING-LVHLPQLESLYLGNNKIT--DI 146

Query: 182 DSLGNLGKLKRLDLSFNSLFGTIPESLANNAELLFLDVQNNTLSGIVP-SALKRLN 236
             L  L KL  L L  N +  +    LA   +L  L +  N +S +   + LK L+
Sbjct: 147 TVLSRLTKLDTLSLEDNQI--SDIVPLAGLTKLQNLYLSKNHISDLRALAGLKNLD 200

>1m9s_A Internalin B; cell invasion, GW domains, SH3 domains, signaling protein; 2.65A {Listeria monocytogenes} SCOP: b.1.18.15 b.34.11.1 b.34.11.1 b.34.11.1 c.10.2.1 PDB: 2y5q_A Length = 605

 Score = 74.0 bits (181), Expect = 6e-14
 Identities = 41/204 (20%), Positives = 83/204 (40%), Gaps = 27/204 (13%)

Query: 83  KLSPSLSGLKCLSGLYLHYNSLSGEIPKEIRNLTELTDLYLDVNNLSGNIPPEIGSMASL 142
           ++ P            L   S++  +      L  +  +  + +++  ++   I  + ++
Sbjct: 13  QIFP-DDAFAETIKDNLKKKSVTDAVT--QNELNSIDQIIANNSDIK-SVQG-IQYLPNV 67

Query: 143 QVLQLCCNQLTGNIPAQIGSLKSLSVLTLQHNRLNGGIPDSLGNLGKLKRLDLSFNSLFG 202
             L L  N+LT +I   + +LK+L  L L  N++   +  SL +L KLK L L  N +  
Sbjct: 68  TKLFLNGNKLT-DIKP-LTNLKNLGWLFLDENKIK-DL-SSLKDLKKLKSLSLEHNGI-- 121

Query: 203 TIPESLANNAELLFLDVQNNTLSGIVP----SALKRLNGGFQFQNN-----PGLCGDGIA 253
           +    L +  +L  L + NN ++ I      + L  L+     ++N       L   G+ 
Sbjct: 122 SDINGLVHLPQLESLYLGNNKITDITVLSRLTKLDTLS----LEDNQISDIVPL--AGLT 175

Query: 254 SLRACTVYDNTQINPVKPFGSHSN 277
            L+   +  N  I+ ++      N
Sbjct: 176 KLQNLYLSKN-HISDLRALAGLKN 198

>1m9s_A Internalin B; cell invasion, GW domains, SH3 domains, signaling protein; 2.65A {Listeria monocytogenes} SCOP: b.1.18.15 b.34.11.1 b.34.11.1 b.34.11.1 c.10.2.1 PDB: 2y5q_A Length = 605

 Score = 72.1 bits (176), Expect = 3e-13
 Identities = 42/261 (16%), Positives = 76/261 (29%), Gaps = 14/261 (5%)

Query: 86  PSLSGLKCLSGLYLHYNSLSGEIPKEIRNLTELTDLYLDVNNLSGNIPPEIGSMASLQVL 145
            SL  LK L  L L +N +S +I   + +L +L  LYL  N ++ +I   +  +  L  L
Sbjct: 103 SSLKDLKKLKSLSLEHNGIS-DIN-GLVHLPQLESLYLGNNKIT-DITV-LSRLTKLDTL 158

Query: 146 QLCCNQLTGNIPAQIGSLKSLSVLTLQHNRLNGGIPDSLGNLGKLKRLDLSFNSLFGTIP 205
            L  NQ++ +I   +  L  L  L L  N ++     +L  L  L  L+L          
Sbjct: 159 SLEDNQIS-DIVP-LAGLTKLQNLYLSKNHIS--DLRALAGLKNLDVLELFSQECLNKPI 214

Query: 206 ESLANNAELLFLDVQNNTLSGIVP-SALKRLNGGFQFQNNPGLCGDGIASLRACTVYDNT 264
              +N      +   + +L      S            + P    +      +   Y   
Sbjct: 215 NHQSNLVVPNTVKNTDGSLVTPEIISDDGDYEKPNVKWHLPEFTNE-----VSFIFYQPV 269

Query: 265 QINPVKPFGSHSNDTTPIDISEPSGFKEHCNQSQCSNSSKFPQIAVLAAVTSVTVILAGT 324
            I   K            ++   S   +         +                     T
Sbjct: 270 TIGKAKARFHGRVTQPLKEVYTVSYDVDGTVIKTKVEAGTRITAPKPPTKQGYVFKGWYT 329

Query: 325 GILIFFRYRRHKQKIGNTSES 345
                  +  +   +     +
Sbjct: 330 EKNGGHEWNFNTDYMSGNDFT 350

>1m9s_A Internalin B; cell invasion, GW domains, SH3 domains, signaling protein; 2.65A {Listeria monocytogenes} SCOP: b.1.18.15 b.34.11.1 b.34.11.1 b.34.11.1 c.10.2.1 PDB: 2y5q_A Length = 605

 Score = 50.5 bits (120), Expect = 1e-06
 Identities = 21/119 (17%), Positives = 42/119 (35%), Gaps = 9/119 (7%)

Query: 118 LTDLYLDVNNLSGNIPPEIGSMASLQVLQLCCNQLTGNIPAQIGSLKSLSVLTLQHNRLN 177
           + +       +   I P   + A      L    +T  +      L S+  +   ++ + 
Sbjct: 1   MGETITVSTPIK-QIFP-DDAFAETIKDNLKKKSVTDAVT--QNELNSIDQIIANNSDIK 56

Query: 178 GGIPDSLGNLGKLKRLDLSFNSLFGTIPESLANNAELLFLDVQNNTLSGIVP-SALKRL 235
                 +  L  + +L L+ N L  T  + L N   L +L +  N +  +     LK+L
Sbjct: 57  --SVQGIQYLPNVTKLFLNGNKL--TDIKPLTNLKNLGWLFLDENKIKDLSSLKDLKKL 111

>3uto_A Twitchin; kinase, muscle sarcomere, transferase; HET: FLC P33; 2.40A {Caenorhabditis elegans} PDB: 1koa_A Length = 573

 Score = 75.3 bits (185), Expect = 3e-14
 Identities = 59/272 (21%), Positives = 105/272 (38%), Gaps = 40/272 (14%)

Query: 417 LGKGNFSSVYKGTLRD-GTLVAIRSINVTSCKSEEAEFVKG-LYLLTSLRHENIIRLRGF 474
           LG G F  V++ T R  G   A + +        + E V+  +  ++ LRH  ++ L   
Sbjct: 165 LGTGAFGVVHRVTERATGNNFAAKFVMTP--HESDKETVRKEIQTMSVLRHPTLVNLHDA 222

Query: 475 CCSRGRGECFLIYDFAPKGKLSKYLDQEEGSSNVLDWSTRVSIIIGIAKGIGYLHSSEVN 534
                  E  +IY+F   G+L + +  E    +  +    V  +  + KG+ ++H +   
Sbjct: 223 FEDDN--EMVMIYEFMSGGELFEKVADEHNKMSEDE---AVEYMRQVCKGLCHMHENN-- 275

Query: 535 KPAIVHRNLSVEKVLI-DQQFNPL-IADCGLHKLLADDIVFSVLKTSAAMGYLAPEYVTT 592
               VH +L  E ++   ++ N L + D GL   L       V   +A   + APE    
Sbjct: 276 ---YVHLDLKPENIMFTTKRSNELKLIDFGLTAHLDPKQSVKVTTGTA--EFAAPEVAEG 330

Query: 593 GRFTERSDIFAFGVIILQILTGSLVLTSSMRLAAESATFENFIDRNLKGKF---SE---- 645
                 +D+++ GV+   +L+G     S      +  T  N         +         
Sbjct: 331 KPVGYYTDMWSVGVLSYILLSG----LSPFGGENDDETLRNV----KSCDWNMDDSAFSG 382

Query: 646 -SEAAK--LGKMALVCTHEDPENRPTMEAVIE 674
            SE  K  + K+ L+    DP  R T+   +E
Sbjct: 383 ISEDGKDFIRKL-LL---ADPNTRMTIHQALE 410

>1dce_A Protein (RAB geranylgeranyltransferase alpha subunit); 2.0 A resolution, N-formylmethionine, alpha subunit; HET: FME; 2.00A {Rattus norvegicus} SCOP: a.118.6.1 b.7.4.1 c.10.2.2 PDB: 1ltx_A* Length = 567

 Score = 74.8 bits (183), Expect = 3e-14
 Identities = 46/176 (26%), Positives = 67/176 (38%), Gaps = 14/176 (7%)

Query: 5   HVLIPLLVLITS--SLTGLVCGNTELRALLDLKASLDPENKLLQSWTENGDPCSGSFEGI 62
                LL +I    +L  L+     L+    LKA +DP          +          +
Sbjct: 380 ENKWCLLTIILLMRALDPLLYEKETLQYFSTLKA-VDPMRAAYLDDLRS---KFLLENSV 435

Query: 63  ACNEHRKVANISLQGKGLTGKLSPSLSGLKCLSGLYLHYNSLSGEIPKEIRNLTELTDLY 122
              E+  V  + L  K LT  L   L  L  ++ L L +N L   +P  +  L  L  L 
Sbjct: 436 LKMEYADVRVLHLAHKDLT-VL-CHLEQLLLVTHLDLSHNRLR-ALPPALAALRCLEVLQ 492

Query: 123 LDVNNLSGNIPPEIGSMASLQVLQLCCNQLTGNIPA--QIGSLKSLSVLTLQHNRL 176
              N L  N+   + ++  LQ L LC N+L     A   + S   L +L LQ N L
Sbjct: 493 ASDNALE-NVDG-VANLPRLQELLLCNNRLQ-QSAAIQPLVSCPRLVLLNLQGNSL 545

>1dce_A Protein (RAB geranylgeranyltransferase alpha subunit); 2.0 A resolution, N-formylmethionine, alpha subunit; HET: FME; 2.00A {Rattus norvegicus} SCOP: a.118.6.1 b.7.4.1 c.10.2.2 PDB: 1ltx_A* Length = 567

 Score = 72.9 bits (178), Expect = 1e-13
 Identities = 32/106 (30%), Positives = 50/106 (47%), Gaps = 8/106 (7%)

Query: 97  LYLHYNSLSGEIPKEIRNLTELTDLYLDVNNLSGNIPPEIGSMASLQVLQLCCNQLTGNI 156
           L+L +  L+  +   +  L  +T L L  N L   +PP + ++  L+VLQ   N L  N+
Sbjct: 446 LHLAHKDLT-VLC-HLEQLLLVTHLDLSHNRLR-ALPPALAALRCLEVLQASDNALE-NV 501

Query: 157 PAQIGSLKSLSVLTLQHNRLNGGIPD--SLGNLGKLKRLDLSFNSL 200
              + +L  L  L L +NRL         L +  +L  L+L  NSL
Sbjct: 502 DG-VANLPRLQELLLCNNRLQQ-SAAIQPLVSCPRLVLLNLQGNSL 545

>1dce_A Protein (RAB geranylgeranyltransferase alpha subunit); 2.0 A resolution, N-formylmethionine, alpha subunit; HET: FME; 2.00A {Rattus norvegicus} SCOP: a.118.6.1 b.7.4.1 c.10.2.2 PDB: 1ltx_A* Length = 567

 Score = 62.9 bits (152), Expect = 2e-10
 Identities = 41/166 (24%), Positives = 62/166 (37%), Gaps = 22/166 (13%)

Query: 87  SLSGLKCLSGLYLHYNSLSGEIPKEIRNLTELTDLYLDVNNLSGNIPPEIGSMASLQVLQ 146
           +L  L        ++++L    P     L +L   +L                A ++VL 
Sbjct: 394 ALDPLLYEKETLQYFSTLKAVDPMRAAYLDDLRSKFLL------ENSVLKMEYADVRVLH 447

Query: 147 LCCNQLTGNIPAQIGSLKSLSVLTLQHNRLNGGIPDSLGNLGKLKRLDLSFNSLFGTIPE 206
           L    LT  +   +  L  ++ L L HNRL   +P +L  L  L+ L  S N+L   +  
Sbjct: 448 LAHKDLT-VLCH-LEQLLLVTHLDLSHNRLRA-LPPALAALRCLEVLQASDNALE-NVDG 503

Query: 207 SLANNAELLFLDVQNN---TLSGIVP----SALKRLNGGFQFQNNP 245
            +AN   L  L + NN     + I P      L  LN     Q N 
Sbjct: 504 -VANLPRLQELLLCNNRLQQSAAIQPLVSCPRLVLLN----LQGNS 544

>2o6q_A Variable lymphocyte receptor A; leucine-rich repeat protein, LRR, immune system; 2.50A {Eptatretus burgeri} Length = 270

 Score = 72.3 bits (178), Expect = 3e-14
 Identities = 51/184 (27%), Positives = 74/184 (40%), Gaps = 27/184 (14%)

Query: 97  LYLHYNSLSGEIPKEIRNLTELTDLYLDVNNLSGNIPPEI-GSMASLQVLQLCCNQLTGN 155
           L L  N LS    K    LT+L  LYL+ N L   +P  I   + +L+ L +  N+L   
Sbjct: 42  LDLQSNKLSSLPSKAFHRLTKLRLLYLNDNKLQ-TLPAGIFKELKNLETLWVTDNKLQ-A 99

Query: 156 IPAQI-GSLKSLSVLTLQHNRLN---GGIPDSLGNLGKLKRLDLSFNSLFGTIPESLANN 211
           +P  +   L +L+ L L  N+L      + DSL     L  L L +N L     +SL   
Sbjct: 100 LPIGVFDQLVNLAELRLDRNQLKSLPPRVFDSLTK---LTYLSLGYNEL-----QSLPKG 151

Query: 212 A-----ELLFLDVQNNTLSGIVPSA------LKRLN-GGFQFQNNPGLCGDGIASLRACT 259
                  L  L + NN L  +   A      LK L     Q +  P    D +  L+   
Sbjct: 152 VFDKLTSLKELRLYNNQLKRVPEGAFDKLTELKTLKLDNNQLKRVPEGAFDSLEKLKMLQ 211

Query: 260 VYDN 263
           + +N
Sbjct: 212 LQEN 215

>2o6q_A Variable lymphocyte receptor A; leucine-rich repeat protein, LRR, immune system; 2.50A {Eptatretus burgeri} Length = 270

 Score = 70.8 bits (174), Expect = 1e-13
 Identities = 55/179 (30%), Positives = 79/179 (44%), Gaps = 14/179 (7%)

Query: 75  LQGKGLTGKLSPS-LSGLKCLSGLYLHYNSLSGEIPKEI-RNLTELTDLYLDVNNLSGNI 132
           LQ   L+  L       L  L  LYL+ N L   +P  I + L  L  L++  N L   +
Sbjct: 44  LQSNKLS-SLPSKAFHRLTKLRLLYLNDNKLQ-TLPAGIFKELKNLETLWVTDNKLQ-AL 100

Query: 133 PPEI-GSMASLQVLQLCCNQLTGNIPAQI-GSLKSLSVLTLQHNRLNGGIPDSL-GNLGK 189
           P  +   + +L  L+L  NQL  ++P ++  SL  L+ L+L +N L   +P  +   L  
Sbjct: 101 PIGVFDQLVNLAELRLDRNQLK-SLPPRVFDSLTKLTYLSLGYNELQ-SLPKGVFDKLTS 158

Query: 190 LKRLDLSFNSLFGTIPESLANN-AELLFLDVQNNTLSGIVPSALKRLNG--GFQFQNNP 245
           LK L L  N L   +PE   +   EL  L + NN L  +   A   L      Q Q NP
Sbjct: 159 LKELRLYNNQL-KRVPEGAFDKLTELKTLKLDNNQLKRVPEGAFDSLEKLKMLQLQENP 216

>2o6q_A Variable lymphocyte receptor A; leucine-rich repeat protein, LRR, immune system; 2.50A {Eptatretus burgeri} Length = 270

 Score = 66.2 bits (162), Expect = 3e-12
 Identities = 39/129 (30%), Positives = 57/129 (44%), Gaps = 8/129 (6%)

Query: 74  SLQGKGLTGKLSPSL-SGLKCLSGLYLHYNSLSGEIPKEI-RNLTELTDLYLDVNNLSGN 131
            +    L   L   +   L  L+ L L  N L   +P  +  +LT+LT L L  N L  +
Sbjct: 91  WVTDNKLQ-ALPIGVFDQLVNLAELRLDRNQLK-SLPPRVFDSLTKLTYLSLGYNELQ-S 147

Query: 132 IPPEI-GSMASLQVLQLCCNQLTGNIPAQI-GSLKSLSVLTLQHNRLNGGIPDSLGNLGK 189
           +P  +   + SL+ L+L  NQL   +P      L  L  L L +N+L      +  +L K
Sbjct: 148 LPKGVFDKLTSLKELRLYNNQLK-RVPEGAFDKLTELKTLKLDNNQLKRVPEGAFDSLEK 206

Query: 190 LKRLDLSFN 198
           LK L L  N
Sbjct: 207 LKMLQLQEN 215

>1phk_A Phosphorylase kinase; glycogen metabolism, transferase, serine/threonine-protein, ATP-binding, calmodulin-binding; HET: ATP; 2.20A {Oryctolagus cuniculus} SCOP: d.144.1.7 PDB: 1ql6_A* 2phk_A* Length = 298

 Score = 72.7 bits (179), Expect = 3e-14
 Identities = 69/300 (23%), Positives = 106/300 (35%), Gaps = 83/300 (27%)

Query: 417 LGKGNFSSVYKGTLRD-GTLVAIRSINVTSCKSEEAEFVKGLYLLTS-----LR----HE 466
           LG+G  S V +   +      A++ I+VT   S  AE V+ L   T      LR    H 
Sbjct: 25  LGRGVSSVVRRCIHKPTCKEYAVKIIDVTGGGSFSAEEVQELREATLKEVDILRKVSGHP 84

Query: 467 NIIRLRGFCCSRGRGECFLIYDFAPKGKL------SKYLDQEEGSSNVLDWSTRVSIIIG 520
           NII+L+    +      FL++D   KG+L         L ++E             I+  
Sbjct: 85  NIIQLKDTYETNT--FFFLVFDLMKKGELFDYLTEKVTLSEKETRK----------IMRA 132

Query: 521 IAKGIGYLHSSEVNKPAIVHRNLSVEKVLIDQQFNPLIADCGLHKLLADDIVFSVLKTSA 580
           + + I  LH        IVHR+L  E +L+D   N  + D G    L        +  + 
Sbjct: 133 LLEVICALHKL-----NIVHRDLKPENILLDDDMNIKLTDFGFSCQLDPGEKLREVCGTP 187

Query: 581 AMGYLAPE------YVTTGRFTERSDIFAFGVI--ILQILTGSLVLTSSMRLAAESATFE 632
              YLAPE            + +  D+++ GVI   L  L G                  
Sbjct: 188 --SYLAPEIIECSMNDNHPGYGKEVDMWSTGVIMYTL--LAG----------------SP 227

Query: 633 NFIDRN--------LKGKF---SE-----SEAAK--LGKMALVCTHEDPENRPTMEAVIE 674
            F  R         + G +   S      S+  K  + +  +V     P+ R T E  + 
Sbjct: 228 PFWHRKQMLMLRMIMSGNYQFGSPEWDDYSDTVKDLVSRFLVV----QPQKRYTAEEALA 283

>2z80_A TOLL-like receptor 2, variable lymphocyte recepto; TLR2, lipopeptide, innate immunity, glycoprotein, immune RES inflammatory response; HET: NAG; 1.80A {Homo sapiens} Length = 353

 Score = 73.6 bits (181), Expect = 3e-14
 Identities = 35/147 (23%), Positives = 61/147 (41%), Gaps = 8/147 (5%)

Query: 94  LSGLYLHYNSLSGEIPKEIRNLTELTDLYLDVNNLSGNIPPEI-GSMASLQVLQLCCNQL 152
           +  L L  N ++     +++    L  L L  N ++  I  +   S+ SL+ L L  N L
Sbjct: 54  VKSLDLSNNRITYISNSDLQRCVNLQALVLTSNGIN-TIEEDSFSSLGSLEHLDLSYNYL 112

Query: 153 TGNIPAQI-GSLKSLSVLTLQHNRLNGGIPDS--LGNLGKLKRLDLSFNSLFGTIPE-SL 208
           + N+ +     L SL+ L L  N     + ++    +L KL+ L +     F  I     
Sbjct: 113 S-NLSSSWFKPLSSLTFLNLLGNPYK-TLGETSLFSHLTKLQILRVGNMDTFTKIQRKDF 170

Query: 209 ANNAELLFLDVQNNTLSGIVPSALKRL 235
           A    L  L++  + L    P +LK +
Sbjct: 171 AGLTFLEELEIDASDLQSYEPKSLKSI 197

>2z80_A TOLL-like receptor 2, variable lymphocyte recepto; TLR2, lipopeptide, innate immunity, glycoprotein, immune RES inflammatory response; HET: NAG; 1.80A {Homo sapiens} Length = 353

 Score = 70.5 bits (173), Expect = 3e-13
 Identities = 33/159 (20%), Positives = 58/159 (36%), Gaps = 7/159 (4%)

Query: 83  KLSPS-LSGLKCLSGLYLHYNSLSGEIPKEI-RNLTELTDLYLDVNNLSGNIPPEI-GSM 139
            +S S L     L  L L  N ++  I ++   +L  L  L L  N LS N+       +
Sbjct: 66  YISNSDLQRCVNLQALVLTSNGIN-TIEEDSFSSLGSLEHLDLSYNYLS-NLSSSWFKPL 123

Query: 140 ASLQVLQLCCNQLTGNIPAQI-GSLKSLSVLTLQHNRLNGGIPD-SLGNLGKLKRLDLSF 197
           +SL  L L  N         +   L  L +L + +      I       L  L+ L++  
Sbjct: 124 SSLTFLNLLGNPYKTLGETSLFSHLTKLQILRVGNMDTFTKIQRKDFAGLTFLEELEIDA 183

Query: 198 NSLFGTIPESLANNAELLFLDVQNNTLSGIVPSALKRLN 236
           + L    P+SL +   +  L +       ++   +   +
Sbjct: 184 SDLQSYEPKSLKSIQNVSHLILHMKQHILLLEIFVDVTS 222

>2z80_A TOLL-like receptor 2, variable lymphocyte recepto; TLR2, lipopeptide, innate immunity, glycoprotein, immune RES inflammatory response; HET: NAG; 1.80A {Homo sapiens} Length = 353

 Score = 69.4 bits (170), Expect = 8e-13
 Identities = 34/151 (22%), Positives = 56/151 (37%), Gaps = 8/151 (5%)

Query: 87  SLSGLKCLSGLYLHYNSLSGEIPKEI-RNLTELTDLYLDVNNLSGNIPPEI--GSMASLQ 143
           S S L  L  L L YN LS  +     + L+ LT L L  N     +        +  LQ
Sbjct: 95  SFSSLGSLEHLDLSYNYLS-NLSSSWFKPLSSLTFLNLLGNPYK-TLGETSLFSHLTKLQ 152

Query: 144 VLQLCCNQLTGNIPAQI-GSLKSLSVLTLQHNRLNGGIPDSLGNLGKLKRLDLSFNSLFG 202
           +L++        I  +    L  L  L +  + L    P SL ++  +  L L       
Sbjct: 153 ILRVGNMDTFTKIQRKDFAGLTFLEELEIDASDLQSYEPKSLKSIQNVSHLILHMKQH-I 211

Query: 203 TIPE-SLANNAELLFLDVQNNTLSGIVPSAL 232
            + E  +   + +  L++++  L     S L
Sbjct: 212 LLLEIFVDVTSSVECLELRDTDLDTFHFSEL 242

>2z80_A TOLL-like receptor 2, variable lymphocyte recepto; TLR2, lipopeptide, innate immunity, glycoprotein, immune RES inflammatory response; HET: NAG; 1.80A {Homo sapiens} Length = 353

 Score = 64.0 bits (156), Expect = 4e-11
 Identities = 30/172 (17%), Positives = 60/172 (34%), Gaps = 19/172 (11%)

Query: 88  LSGLKCLSGLYLHYNSLSGEIPKEI-RNLTELTDLYLDVNNLSGNIPPEI-GSMASLQVL 145
              L  L+ L L  N         +  +LT+L  L +   +    I  +    +  L+ L
Sbjct: 120 FKPLSSLTFLNLLGNPYKTLGETSLFSHLTKLQILRVGNMDTFTKIQRKDFAGLTFLEEL 179

Query: 146 QLCCNQLTGNIPAQIGSLKSLSVLTLQHNRLNGGIPDSLGNLGKLKRLDLS--------F 197
           ++  + L    P  + S++++S L L   +    +   +     ++ L+L         F
Sbjct: 180 EIDASDLQSYEPKSLKSIQNVSHLILHMKQHILLLEIFVDVTSSVECLELRDTDLDTFHF 239

Query: 198 NSLFGTIPESLANNAELLFLDVQNNTLSGIVP-----SALKRLNGGFQFQNN 244
           + L      SL        + + + +L  ++      S L  L     F  N
Sbjct: 240 SELSTGETNSLIKKFTFRNVKITDESLFQVMKLLNQISGLLELE----FSRN 287

>2z80_A TOLL-like receptor 2, variable lymphocyte recepto; TLR2, lipopeptide, innate immunity, glycoprotein, immune RES inflammatory response; HET: NAG; 1.80A {Homo sapiens} Length = 353

 Score = 60.1 bits (146), Expect = 7e-10
 Identities = 39/163 (23%), Positives = 59/163 (36%), Gaps = 13/163 (7%)

Query: 80  LTGKLSPSLSGLKCLSG--LYLHYNSLSGEIPKEIRNLTELTDLYLDVNNLSGNIPPEI- 136
           L+ + S + + L C           SL+  IP  +     +  L L  N ++  I     
Sbjct: 17  LSKEESSNQASLSCDRNGICKGSSGSLN-SIPSGL--TEAVKSLDLSNNRIT-YISNSDL 72

Query: 137 GSMASLQVLQLCCNQLTGNIPAQI-GSLKSLSVLTLQHNRLNGGIPDSLGNLGKLKRLDL 195
               +LQ L L  N +   I      SL SL  L L +N L+         L  L  L+L
Sbjct: 73  QRCVNLQALVLTSNGIN-TIEEDSFSSLGSLEHLDLSYNYLSNLSSSWFKPLSSLTFLNL 131

Query: 196 SFNSLFGTIPES--LANNAELLFLDVQNNT-LSGIVPSALKRL 235
             N    T+ E+   ++  +L  L V N    + I       L
Sbjct: 132 LGNPY-KTLGETSLFSHLTKLQILRVGNMDTFTKIQRKDFAGL 173

>2z80_A TOLL-like receptor 2, variable lymphocyte recepto; TLR2, lipopeptide, innate immunity, glycoprotein, immune RES inflammatory response; HET: NAG; 1.80A {Homo sapiens} Length = 353

 Score = 48.6 bits (116), Expect = 4e-06
 Identities = 20/113 (17%), Positives = 36/113 (31%), Gaps = 11/113 (9%)

Query: 74  SLQGKGLTGKLSPSLSGLKCLSGLYLHYNSLSGEIPKEI--------RNLTELTDLYLDV 125
            L  K     L   +     +  L L    L      E+               ++ +  
Sbjct: 204 ILHMKQHILLLEIFVDVTSSVECLELRDTDLDTFHFSELSTGETNSLIKKFTFRNVKITD 263

Query: 126 NNLSGNIPPEIGSMASLQVLQLCCNQLTGNIPAQI-GSLKSLSVLTLQHNRLN 177
            +L   +   +  ++ L  L+   NQL  ++P  I   L SL  + L  N  +
Sbjct: 264 ESLF-QVMKLLNQISGLLELEFSRNQLK-SVPDGIFDRLTSLQKIWLHTNPWD 314

>3eqc_A Dual specificity mitogen-activated protein kinase; MEK1 kinase, ATP-binding, disease mutation, nucleoti binding, phosphoprotein; HET: 3BM AGS; 1.80A {Homo sapiens} PDB: 3eqd_A* 3eqf_A* 3eqg_A* 3eqh_A* 3eqi_A* 2y4i_C* 3eqb_A* 2p55_A* 1s9j_A* 3dy7_A* 3e8n_A* 3dv3_A* 3mbl_A* 3pp1_A* 3orn_A* 3os3_A* 3sls_A* 1s9i_A* Length = 360

 Score = 73.3 bits (180), Expect = 5e-14
 Identities = 51/305 (16%), Positives = 116/305 (38%), Gaps = 26/305 (8%)

Query: 387 TGFSREHLNSFRLNLEEVESATQCFSEVNLLGKGNFSSVYKGTLR-DGTLVAIRSINVTS 445
             F  +      L  ++ E       +++ LG GN   V+K + +  G ++A + I++  
Sbjct: 18  EAFLTQKQKVGELKDDDFE-------KISELGAGNGGVVFKVSHKPSGLVMARKLIHLEI 70

Query: 446 CKSEEAEFVKGLYLLTSLRHENIIRLRGFCCSRGRGECFLIYDFAPKGKLSKYLDQEEG- 504
             +   + ++ L +L       I+   G       GE  +  +    G L + L +    
Sbjct: 71  KPAIRNQIIRELQVLHECNSPYIVGFYG--AFYSDGEISICMEHMDGGSLDQVLKKAGRI 128

Query: 505 SSNVLDWSTRVSIIIGIAKGIGYLHSSEVNKPAIVHRNLSVEKVLIDQQFNPLIADCGLH 564
              +L       + I + KG+ YL      K  I+HR++    +L++ +    + D G+ 
Sbjct: 129 PEQIL-----GKVSIAVIKGLTYLRE----KHKIMHRDVKPSNILVNSRGEIKLCDFGVS 179

Query: 565 KLLADDIVFSVLKTSAAMGYLAPEYVTTGRFTERSDIFAFGVIILQILTGSLVLTSSMRL 624
             L D +  S + T +   Y++PE +    ++ +SDI++ G+ ++++  G   +      
Sbjct: 180 GQLIDSMANSFVGTRS---YMSPERLQGTHYSVQSDIWSMGLSLVEMAVGRYPIPPPDAK 236

Query: 625 AAESATFENFIDRNLKGKFSESEAAKLGKMALVCTHEDPENRPTMEAVIEELTVAAPVMA 684
             E            +         +      + +         ++ ++ E     P + 
Sbjct: 237 ELELMFGCQVEGDAAETPPRPRTPGRPLNKFGMDSRPPMAIFELLDYIVNE---PPPKLP 293

Query: 685 TFLFS 689
           + +FS
Sbjct: 294 SGVFS 298

>3a79_B TLR6, VLRB.59, TOLL-like receptor 6, variable lymphocyte recepto; diacyl lipopeptide, innate immunity, Leu repeat, cell membrane, cytoplasmic vesicle; HET: PXS NAG BMA NDG; 2.90A {Mus musculus} Length = 562

 Score = 74.1 bits (182), Expect = 5e-14
 Identities = 40/178 (22%), Positives = 71/178 (39%), Gaps = 7/178 (3%)

Query: 66  EHRKVANISLQGKGLTGKLSPSLSGLKCLSGLYLHYNSLSGEIPKEIRNLTELTDLYLDV 125
           E+  + N+++  +    + + S + LK L   ++                 E+    L +
Sbjct: 279 EYLNIYNLTITERIDREEFTYSETALKSLMIEHVKNQVFLFSKEALYSVFAEMNIKMLSI 338

Query: 126 NNLSGNIPPEIGSMASLQVLQLCCNQLTGNIPAQIGSLKSLSVLTLQHNRLN--GGIPDS 183
           ++          S +S   L    N  T ++     +LK L  L LQ N L     +   
Sbjct: 339 SDTPFIHMVCPPSPSSFTFLNFTQNVFTDSVFQGCSTLKRLQTLILQRNGLKNFFKVALM 398

Query: 184 LGNLGKLKRLDLSFNSLFGTIPESLANNAE-LLFLDVQNNTLSGIV----PSALKRLN 236
             N+  L+ LD+S NSL     +     AE +L L++ +N L+G V    P  +K L+
Sbjct: 399 TKNMSSLETLDVSLNSLNSHAYDRTCAWAESILVLNLSSNMLTGSVFRCLPPKVKVLD 456

>3a79_B TLR6, VLRB.59, TOLL-like receptor 6, variable lymphocyte recepto; diacyl lipopeptide, innate immunity, Leu repeat, cell membrane, cytoplasmic vesicle; HET: PXS NAG BMA NDG; 2.90A {Mus musculus} Length = 562

 Score = 73.4 bits (180), Expect = 9e-14
 Identities = 35/165 (21%), Positives = 54/165 (32%), Gaps = 8/165 (4%)

Query: 75  LQGKGLTGKLSPSLSGLKCLSGLYLHYNSLSGEIPKEIRNLTELTDLYLDVNNLSGNIPP 134
           L                   + L    N  +  + +    L  L  L L  N L  N   
Sbjct: 336 LSISDTPFIHMVCPPSPSSFTFLNFTQNVFTDSVFQGCSTLKRLQTLILQRNGLK-NFFK 394

Query: 135 EIGSMASLQVLQLCCNQLT----GNIPAQIGSLKSLSVLTLQHNRLNGGIPDSLGNLGKL 190
                 ++  L+     L               +S+ VL L  N L G +   L    K+
Sbjct: 395 VALMTKNMSSLETLDVSLNSLNSHAYDRTCAWAESILVLNLSSNMLTGSVFRCL--PPKV 452

Query: 191 KRLDLSFNSLFGTIPESLANNAELLFLDVQNNTLSGIVPSALKRL 235
           K LDL  N +  +IP+ + +   L  L+V +N L  +      RL
Sbjct: 453 KVLDLHNNRI-MSIPKDVTHLQALQELNVASNQLKSVPDGVFDRL 496

>3a79_B TLR6, VLRB.59, TOLL-like receptor 6, variable lymphocyte recepto; diacyl lipopeptide, innate immunity, Leu repeat, cell membrane, cytoplasmic vesicle; HET: PXS NAG BMA NDG; 2.90A {Mus musculus} Length = 562

 Score = 70.7 bits (173), Expect = 7e-13
 Identities = 37/143 (25%), Positives = 59/143 (41%), Gaps = 7/143 (4%)

Query: 97  LYLHYNSLSGEIPKEIRNLTELTDLYLDVNNLSGNIPPEI-GSMASLQVLQLCCNQLTGN 155
           L L  NS+S     +I  L+EL  L L  N +  ++   +      L+ L +  N+L  N
Sbjct: 57  LSLSQNSISELRMPDISFLSELRVLRLSHNRIR-SLDFHVFLFNQDLEYLDVSHNRLQ-N 114

Query: 156 IPAQIGSLKSLSVLTLQHNRLNG-GIPDSLGNLGKLKRLDLSFNSLFGTIPESLAN-NAE 213
           I      + SL  L L  N  +   +    GNL KL  L LS           +A+ +  
Sbjct: 115 ISC--CPMASLRHLDLSFNDFDVLPVCKEFGNLTKLTFLGLSAAKFRQLDLLPVAHLHLS 172

Query: 214 LLFLDVQNNTLSGIVPSALKRLN 236
            + LD+ +  + G    +L+  N
Sbjct: 173 CILLDLVSYHIKGGETESLQIPN 195

>3a79_B TLR6, VLRB.59, TOLL-like receptor 6, variable lymphocyte recepto; diacyl lipopeptide, innate immunity, Leu repeat, cell membrane, cytoplasmic vesicle; HET: PXS NAG BMA NDG; 2.90A {Mus musculus} Length = 562

 Score = 50.3 bits (120), Expect = 1e-06
 Identities = 29/137 (21%), Positives = 47/137 (34%), Gaps = 6/137 (4%)

Query: 91  LKCLSGLYLHYNSLSGEIPKEIRNLTELTDLYLDVNNL-SGNIPPEIGSMASLQVLQLCC 149
            + L  L + +N L   I      +  L  L L  N+     +  E G++  L  L L  
Sbjct: 99  NQDLEYLDVSHNRLQ-NIS--CCPMASLRHLDLSFNDFDVLPVCKEFGNLTKLTFLGLSA 155

Query: 150 NQLTGNIPAQIGSLK-SLSVLTLQHNRLNGGIPDSLGNLGKLKRLDLSFNSLFGTIPESL 208
            +        +  L  S  +L L    + GG  +SL        L L F+       +  
Sbjct: 156 AKFRQLDLLPVAHLHLSCILLDLVSYHIKGGETESLQIP-NTTVLHLVFHPNSLFSVQVN 214

Query: 209 ANNAELLFLDVQNNTLS 225
            +   L  L + N  L+
Sbjct: 215 MSVNALGHLQLSNIKLN 231

>3a79_B TLR6, VLRB.59, TOLL-like receptor 6, variable lymphocyte recepto; diacyl lipopeptide, innate immunity, Leu repeat, cell membrane, cytoplasmic vesicle; HET: PXS NAG BMA NDG; 2.90A {Mus musculus} Length = 562

 Score = 45.2 bits (107), Expect = 6e-05
 Identities = 28/132 (21%), Positives = 51/132 (38%), Gaps = 6/132 (4%)

Query: 17  SLTGLVCGNTELRALLDLKASLDPENKLLQSWTENGDPCSGSFEGIACNEHRKVANISLQ 76
            L  L+     L+    +       + L           S +++   C     +  ++L 
Sbjct: 378 RLQTLILQRNGLKNFFKVALMTKNMSSLETLDVSLNSLNSHAYDRT-CAWAESILVLNLS 436

Query: 77  GKGLTGKLSPSLSGLKCLSGLYLHYNSLSGEIPKEIRNLTELTDLYLDVNNLSGNIPPEI 136
              LTG +   L     +  L LH N +   IPK++ +L  L +L +  N L  ++P  +
Sbjct: 437 SNMLTGSVFRCLPPK--VKVLDLHNNRIM-SIPKDVTHLQALQELNVASNQLK-SVPDGV 492

Query: 137 -GSMASLQVLQL 147
              + SLQ + L
Sbjct: 493 FDRLTSLQYIWL 504

>3a79_B TLR6, VLRB.59, TOLL-like receptor 6, variable lymphocyte recepto; diacyl lipopeptide, innate immunity, Leu repeat, cell membrane, cytoplasmic vesicle; HET: PXS NAG BMA NDG; 2.90A {Mus musculus} Length = 562

 Score = 44.9 bits (106), Expect = 9e-05
 Identities = 30/148 (20%), Positives = 48/148 (32%), Gaps = 16/148 (10%)

Query: 132 IPPEIGSMASLQVLQLCCNQLTGNIPAQIGSLKSLSVLTLQHNRLNGGIPDSLGNLGKLK 191
           +P ++      + L L  N ++      I  L  L VL L HNR+             L+
Sbjct: 46  VPKDL--PPRTKALSLSQNSISELRMPDISFLSELRVLRLSHNRIRSLDFHVFLFNQDLE 103

Query: 192 RLDLSFNSLFGTIPESLANNAELLFLDVQNNTLSGIVPSA-------LKRLN-GGFQFQN 243
            LD+S N L   I      +  L  LD+  N    +           L  L     +F+ 
Sbjct: 104 YLDVSHNRL-QNISCCPMAS--LRHLDLSFNDFDVLPVCKEFGNLTKLTFLGLSAAKFRQ 160

Query: 244 NPGLCGDGIASLRACTVYDNTQINPVKP 271
                   +A L    +  +     +K 
Sbjct: 161 LD---LLPVAHLHLSCILLDLVSYHIKG 185

>2bdw_A Hypothetical protein K11E8.1D; kinase, calmodulin activated, transferase; 1.80A {Caenorhabditis elegans} PDB: 2wel_A* 2v7o_A* 2vz6_A* 1cdm_B 1cm1_B 1cm4_B Length = 362

 Score = 73.1 bits (180), Expect = 6e-14
 Identities = 54/206 (26%), Positives = 89/206 (43%), Gaps = 32/206 (15%)

Query: 417 LGKGNFSSVYKGTLRD-GTLVAIRSINVTSCKSEEAEFVKG-LYLLTSLRHENIIRLRGF 474
           LGKG FS V +   +  G   A + IN     + + + ++    +   L+H NI+RL   
Sbjct: 37  LGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQKLEREARICRKLQHPNIVRLHDS 96

Query: 475 CCSRGRGECFLIYDFAPKGKL------SKYLDQEEGSSNVLDWSTRVSIIIGIAKGIGYL 528
                    +L++D    G+L       ++  + + S            I  I + I Y 
Sbjct: 97  IQE--ESFHYLVFDLVTGGELFEDIVAREFYSEADAS----------HCIQQILESIAYC 144

Query: 529 HSSEVNKPAIVHRNLSVEKVLIDQQFN--PL-IADCGLHKLLADDIVFSVLKTSAAMGYL 585
           HS+      IVHRNL  E +L+  +     + +AD GL   + D   +     +   GYL
Sbjct: 145 HSNG-----IVHRNLKPENLLLASKAKGAAVKLADFGLAIEVNDSEAWHGFAGTP--GYL 197

Query: 586 APEYVTTGRFTERSDIFAFGVI--IL 609
           +PE +    +++  DI+A GVI  IL
Sbjct: 198 SPEVLKKDPYSKPVDIWACGVILYIL 223

>3ork_A Serine/threonine protein kinase; structural genomics, TB structural genomics consortium, TBSG domain, signal transduction; HET: AGS; 1.60A {Mycobacterium tuberculosis} PDB: 3ori_A* 3orl_A* 3oro_A* 3orp_A* 3ort_A* 3f61_A* 1mru_A* 3f69_A* 3orm_A* 1o6y_A* 2fum_A* Length = 311

 Score = 72.3 bits (178), Expect = 6e-14
 Identities = 45/217 (20%), Positives = 87/217 (40%), Gaps = 34/217 (15%)

Query: 416 LLGKGNFSSVYKGT-LRDGTLVAIRSINVTSCK------SEEAEFVKGLYL----LTSLR 464
           +LG G  S V+    LRD   VA+        K      + +  F            +L 
Sbjct: 19  ILGFGGMSEVHLARDLRDHRDVAV--------KVLRADLARDPSFYLRFRREAQNAAALN 70

Query: 465 HENIIRL--RGFCCSRGRGECFLIYDFAPKGKLSKYLDQEEGSSNVLDWSTRVSIIIGIA 522
           H  I+ +   G   +      +++ ++     L   +   EG    +     + +I    
Sbjct: 71  HPAIVAVYDTGEAETPAGPLPYIVMEYVDGVTLRDIV-HTEGP---MTPKRAIEVIADAC 126

Query: 523 KGIGYLHSSEVNKPAIVHRNLSVEKVLIDQQFNPLIADCGLHKLLADDIVFSVLKTSAAM 582
           + + + H +      I+HR++    ++I       + D G+ + +AD    SV +T+A +
Sbjct: 127 QALNFSHQNG-----IIHRDVKPANIMISATNAVKVMDFGIARAIADSGN-SVTQTAAVI 180

Query: 583 G---YLAPEYVTTGRFTERSDIFAFGVIILQILTGSL 616
           G   YL+PE         RSD+++ G ++ ++LTG  
Sbjct: 181 GTAQYLSPEQARGDSVDARSDVYSLGCVLYEVLTGEP 217

>3fhr_A MAP kinase-activated protein kinase 3; kinase-inhibitor complex, ATP-binding, cytoplasm, nucleotide-binding, nucleus, phosphoprotein, polymorphism; HET: P4O; 1.90A {Homo sapiens} PDB: 3fxw_A* 3r1n_A* 3she_A* 2oza_A 3fyk_X* 3fyj_X* 2p3g_X* 3ka0_A* 3fpm_A* 2pzy_A* 3a2c_A* 3kc3_A* 3gok_A* 2jbo_A* 2jbp_A* 3r2y_A* 3r30_A* 3r2b_A* Length = 336

 Score = 72.0 bits (177), Expect = 9e-14
 Identities = 55/279 (19%), Positives = 104/279 (37%), Gaps = 47/279 (16%)

Query: 416 LLGKGNFSSVYKGTLRD-GTLVAIRSINVTSCKSEEAEFVKGLYLLTSLRHENIIRLRGF 474
           +LG G    V +   R  G   A++ +  +    +E +     +   +    +I+ +   
Sbjct: 36  VLGLGVNGKVLECFHRRTGQKCALKLLYDSPKARQEVD-----HHWQASGGPHIVCILDV 90

Query: 475 CCSRGRGEC--FLIYDFAPKGKLSKYLD--QEEGSSNVLDWSTR--VSIIIGIAKGIGYL 528
             +   G+    +I +    G+L       QE G      ++ R    I+  I   I +L
Sbjct: 91  YENMHHGKRCLLIIMECMEGGEL---FSRIQERGDQA---FTEREAAEIMRDIGTAIQFL 144

Query: 529 HSSEVNKPAIVHRNLSVEKVLI---DQQFNPLIADCGLHKLLADDIVFSVLKTSAAMGYL 585
           HS       I HR++  E +L    ++     + D G  K    + + +   T     Y+
Sbjct: 145 HSHN-----IAHRDVKPENLLYTSKEKDAVLKLTDFGFAKETTQNALQTPCYTP---YYV 196

Query: 586 APEYVTTGRFTERSDIFAFGVIILQILTGSLVLTSSMRLAAESATFENFIDRNLKGKF-- 643
           APE +   ++ +  D+++ GVI+  +L G     S+       A       R   G++  
Sbjct: 197 APEVLGPEKYDKSCDMWSLGVIMYILLCGFPPFYSN----TGQAISPGMKRRIRLGQYGF 252

Query: 644 -SE-----SEAAK--LGKMALVCTHEDPENRPTMEAVIE 674
            +      SE AK  +  + L     DP  R T+   + 
Sbjct: 253 PNPEWSEVSEDAKQLIRLL-LKT---DPTERLTITQFMN 287

>2wtk_C Serine/threonine-protein kinase 11; transferase-metal-binding protein complex, transferase metal protein complex, nucleus; HET: ANP; 2.65A {Homo sapiens} Length = 305

 Score = 71.5 bits (176), Expect = 9e-14
 Identities = 57/301 (18%), Positives = 96/301 (31%), Gaps = 91/301 (30%)

Query: 416 LLGKGNFSSVYKGT-LRDGTLVAIRSIN---VTSCKSEEAEFVKGLYLLTSLRHENIIRL 471
           LLG+G++  V +          A++ +    +    + EA   K + LL  LRH+N+I+L
Sbjct: 12  LLGEGSYGKVKEVLDSETLCRRAVKILKKKKLRRIPNGEANVKKEIQLLRRLRHKNVIQL 71

Query: 472 RGFC--------------CSRGRGECFLIYDFAPKGKLS-----KYLDQEEGSSNVLDWS 512
                             C  G  E     D  P+ +        Y  Q           
Sbjct: 72  VDVLYNEEKQKMYMVMEYCVCGMQEML---DSVPEKRFPVCQAHGYFCQ----------- 117

Query: 513 TRVSIIIGIAKGIGYLHSSEVNKPAIVHRNLSVEKVLIDQQFNPLIADCGLHKLLADDIV 572
               +I G+     YLHS       IVH+++    +L+       I+  G+ + L     
Sbjct: 118 ----LIDGLE----YLHSQ-----GIVHKDIKPGNLLLTTGGTLKISALGVAEALHPFAA 164

Query: 573 FSVLKTSAAMG---YLAPEYVTTGRFTE--RSDIFAFGVIILQILTGSLVLTSSMRLAAE 627
               +TS   G   +  PE           + DI++ GV +  I TG             
Sbjct: 165 DDTCRTSQ--GSPAFQPPEIANGLDTFSGFKVDIWSAGVTLYNITTGLY----------- 211

Query: 628 SATFENFIDRNL--------KGKFSE----SEAAK--LGKMALVCTHEDPENRPTMEAVI 673
                 F   N+        KG ++            L  M       +P  R ++  + 
Sbjct: 212 -----PFEGDNIYKLFENIGKGSYAIPGDCGPPLSDLLKGMLEY----EPAKRFSIRQIR 262

Query: 674 E 674
           +
Sbjct: 263 Q 263

>2w4o_A Calcium/calmodulin-dependent protein kinase type IV; calmodulin-binding, nucleotide-binding, serine/threonine-protein kinase, ATP-binding; HET: DKI; 2.17A {Homo sapiens} Length = 349

 Score = 72.0 bits (177), Expect = 9e-14
 Identities = 70/293 (23%), Positives = 115/293 (39%), Gaps = 81/293 (27%)

Query: 416 LLGKGNFSSVYKGTLRD-GTLVAIRSINVTSCKSEEAEFVKG-LYLLTSLRHENIIRLRG 473
            LG+G  S VY+   +      A++ +     K+ + + V+  + +L  L H NII+L+ 
Sbjct: 60  ELGRGATSIVYRCKQKGTQKPYALKVLK----KTVDKKIVRTEIGVLLRLSHPNIIKLKE 115

Query: 474 FCCSRGRGECFLIYDFAPKGKL-------SKYLDQEEGSSNVLDWSTRVSIIIGIAKGIG 526
              +    E  L+ +    G+L         Y   E  +++          +  I + + 
Sbjct: 116 IFETPT--EISLVLELVTGGELFDRIVEKGYY--SERDAAD---------AVKQILEAVA 162

Query: 527 YLHSSEVNKPAIVHRNLSVEKVLIDQQFN--PL-IADCGLHKLLADDIVFSVLKTSA-AM 582
           YLH +      IVHR+L  E +L        PL IAD GL K++       ++KT     
Sbjct: 163 YLHENG-----IVHRDLKPENLLYATPAPDAPLKIADFGLSKIVEHQ---VLMKTVCGTP 214

Query: 583 GYLAPEYVTTGRFTERSDIFAFGVI--ILQILTGSLVLTSSMRLAAESATFENFIDRN-- 638
           GY APE +    +    D+++ G+I  IL  L G                FE F D    
Sbjct: 215 GYCAPEILRGCAYGPEVDMWSVGIITYIL--LCG----------------FEPFYDERGD 256

Query: 639 -------LKGKF---SE-----SEAAK--LGKMALVCTHEDPENRPTMEAVIE 674
                  L  ++   S      S  AK  + K+ +V    DP+ R T    ++
Sbjct: 257 QFMFRRILNCEYYFISPWWDEVSLNAKDLVRKL-IVL---DPKKRLTTFQALQ 305

>2v9t_B SLIT homolog 2 protein N-product; structural protein-receptor complex, developmental protein, domain, roundabout, chemotaxis, LRR domain; 1.70A {Homo sapiens} PDB: 2v9s_A Length = 220

 Score = 69.7 bits (171), Expect = 1e-13
 Identities = 31/131 (23%), Positives = 59/131 (45%), Gaps = 8/131 (6%)

Query: 72  NISLQGKGLTGKLSP-SLSGLKCLSGLYLHYNSLSGEIPKEI-RNLTELTDLYLDVNNLS 129
            I L+   +   + P + S  K L  + L  N +S E+  +  + L  L  L L  N ++
Sbjct: 36  EIRLEQNTIK-VIPPGAFSPYKKLRRIDLSNNQIS-ELAPDAFQGLRSLNSLVLYGNKIT 93

Query: 130 GNIPPEI-GSMASLQVLQLCCNQLTGNIPAQI-GSLKSLSVLTLQHNRLNGGIPDSLGNL 187
             +P  +   + SLQ+L L  N++   +       L +L++L+L  N+L      +   L
Sbjct: 94  -ELPKSLFEGLFSLQLLLLNANKIN-CLRVDAFQDLHNLNLLSLYDNKLQTIAKGTFSPL 151

Query: 188 GKLKRLDLSFN 198
             ++ + L+ N
Sbjct: 152 RAIQTMHLAQN 162

>2v9t_B SLIT homolog 2 protein N-product; structural protein-receptor complex, developmental protein, domain, roundabout, chemotaxis, LRR domain; 1.70A {Homo sapiens} PDB: 2v9s_A Length = 220

 Score = 67.8 bits (166), Expect = 5e-13
 Identities = 30/128 (23%), Positives = 53/128 (41%), Gaps = 4/128 (3%)

Query: 97  LYLHYNSLSGEIPKEIRNLTELTDLYLDVNNLSGNIPPEI-GSMASLQVLQLCCNQLTGN 155
           + L  N++    P       +L  + L  N +S  + P+    + SL  L L  N++T  
Sbjct: 37  IRLEQNTIKVIPPGAFSPYKKLRRIDLSNNQIS-ELAPDAFQGLRSLNSLVLYGNKIT-E 94

Query: 156 IPAQI-GSLKSLSVLTLQHNRLNGGIPDSLGNLGKLKRLDLSFNSLFGTIPESLANNAEL 214
           +P  +   L SL +L L  N++N    D+  +L  L  L L  N L      + +    +
Sbjct: 95  LPKSLFEGLFSLQLLLLNANKINCLRVDAFQDLHNLNLLSLYDNKLQTIAKGTFSPLRAI 154

Query: 215 LFLDVQNN 222
             + +  N
Sbjct: 155 QTMHLAQN 162

>3c0i_A Peripheral plasma membrane protein CASK; neurexin, Ca2+/calmodulin dependent protein kinase, Mg synaptic plasticity, pseudokinase, maguk; HET: 3AM; 1.85A {Homo sapiens} PDB: 3c0h_A* 3c0g_A* 3mfr_A* 3mfs_A* 3mft_A 3mfu_A* 3tac_A Length = 351

 Score = 71.6 bits (176), Expect = 1e-13
 Identities = 61/277 (22%), Positives = 116/277 (41%), Gaps = 41/277 (14%)

Query: 417 LGKGNFSSVYKGTLRD-GTLVAIRSINVTSCKSEEAEFVKGLY----LLTSLRHENIIRL 471
           +GKG FS V +   R+ G   A++ ++V    S      + L     +   L+H +I+ L
Sbjct: 32  IGKGPFSVVRRCINRETGQQFAVKIVDVAKFTSSPGLSTEDLKREASICHMLKHPHIVEL 91

Query: 472 RGFCCSRGRGECFLIYDFAPKGKLSKYLDQEEGSSNVLDWSTRVSIIIGIAKGIGYLHSS 531
                S   G  +++++F     L   + +   +  V   +     +  I + + Y H +
Sbjct: 92  LETYSS--DGMLYMVFEFMDGADLCFEIVKRADAGFVYSEAVASHYMRQILEALRYCHDN 149

Query: 532 EVNKPAIVHRNLSVEKVLIDQQFN--PL-IADCGL-HKLLADDIVFSVLKTSAAMGYLAP 587
                 I+HR++    VL+  + N  P+ +   G+  +L    +V      +    ++AP
Sbjct: 150 N-----IIHRDVKPHCVLLASKENSAPVKLGGFGVAIQLGESGLVAGGRVGTP--HFMAP 202

Query: 588 EYVTTGRFTERSDIFAFGVIILQILTGSLVLTSSMRLAAESATFENFIDRNLKGKF---S 644
           E V    + +  D++  GVI+  +L+G L    +     +   FE  I   +KGK+    
Sbjct: 203 EVVKREPYGKPVDVWGCGVILFILLSGCLPFYGT-----KERLFEG-I---IKGKYKMNP 253

Query: 645 E-----SEAAK--LGKMALVCTHEDPENRPTMEAVIE 674
                 SE+AK  + +M L+    DP  R T+   + 
Sbjct: 254 RQWSHISESAKDLVRRM-LML---DPAERITVYEALN 286

>3f3z_A Calcium/calmodulin-dependent protein kinase with domain and 4 calmodulin like EF...; calcium dependent protein kinase; HET: SEP DRK; 1.84A {Cryptosporidium parvum iowa II} PDB: 2qg5_A* Length = 277

 Score = 70.7 bits (174), Expect = 2e-13
 Identities = 52/284 (18%), Positives = 95/284 (33%), Gaps = 65/284 (22%)

Query: 417 LGKGNFSSVYKGTLRD-GTLVAIRSINVTSCKSEEAEFVKGLYLLTSLRHENIIRLRGFC 475
           +G+G++  V     +      A + I     +  +  F + + ++ SL H NIIRL    
Sbjct: 17  IGRGSWGEVKIAVQKGTRIRRAAKKIPKYFVEDVDR-FKQEIEIMKSLDHPNIIRLYETF 75

Query: 476 ------------CSRGRGECFLIYDFAPKGKLSKYLDQEEGSSNVLDWSTRVSIIIGIAK 523
                       C+ G GE F       K         E  ++          I+  +  
Sbjct: 76  EDNTDIYLVMELCT-G-GELF--ERVVHKRVFR-----ESDAAR---------IMKDVLS 117

Query: 524 GIGYLHSSEVNKPAIVHRNLSVEKVLI---DQQFNPLIADCGLHKLLADDIVFSVLKTSA 580
            + Y H        + HR+L  E  L           + D GL        +      + 
Sbjct: 118 AVAYCHKLN-----VAHRDLKPENFLFLTDSPDSPLKLIDFGLAARFKPGKMMRTKVGTP 172

Query: 581 AMGYLAPEYVTTGRFTERSDIFAFGVIILQILTGSLVLTSSMRLAAESATFENFIDRNLK 640
              Y++P+ V  G +    D ++ GV++  +L G    ++      +S      I    +
Sbjct: 173 --YYVSPQ-VLEGLYGPECDEWSAGVMMYVLLCGYPPFSAP----TDSEVMLK-I---RE 221

Query: 641 GKF---SE-----SEAAK--LGKMALVCTHEDPENRPTMEAVIE 674
           G F    +     S  A+  + ++ L      P+ R T    +E
Sbjct: 222 GTFTFPEKDWLNVSPQAESLIRRL-LTK---SPKQRITSLQALE 261

>2vwi_A Serine/threonine-protein kinase OSR1; STE kinase, hypertension, transferase; HET: ANP; 2.15A {Homo sapiens} PDB: 3dak_A* Length = 303

 Score = 70.4 bits (173), Expect = 2e-13
 Identities = 64/276 (23%), Positives = 121/276 (43%), Gaps = 29/276 (10%)

Query: 411 FSEVNLLGKGNFSSVYKGT-LRDGTLVAIRSINVTSCKSEEAEFVKGLYLLTSLRHENII 469
           +    ++G G  + V           VAI+ IN+  C++   E +K +  ++   H NI+
Sbjct: 17  YELQEVIGSGATAVVQAAYCAPKKEKVAIKRINLEKCQTSMDELLKEIQAMSQCHHPNIV 76

Query: 470 RLRGFCCSRGRGECFLIYDFAPKGKLS----KYLDQEEGSSNVLDWSTRVSIIIGIAKGI 525
               +     + E +L+      G +       + + E  S VLD ST  +I+  + +G+
Sbjct: 77  SY--YTSFVVKDELWLVMKLLSGGSVLDIIKHIVAKGEHKSGVLDESTIATILREVLEGL 134

Query: 526 GYLHSSEVNKPAIVHRNLSVEKVLIDQQFNPLIADCGLHKLLADDIVFSVLKTSAAM-G- 583
            YLH +       +HR++    +L+ +  +  IAD G+   LA     +  K      G 
Sbjct: 135 EYLHKN-----GQIHRDVKAGNILLGEDGSVQIADFGVSAFLATGGDITRNKVRKTFVGT 189

Query: 584 --YLAPEYVTTGR-FTERSDIFAFGVIILQILTGS--LVLTSSMR---LAAESAT---FE 632
             ++APE +   R +  ++DI++FG+  +++ TG+        M+   L  ++       
Sbjct: 190 PCWMAPEVMEQVRGYDFKADIWSFGITAIELATGAAPYHKYPPMKVLMLTLQNDPPSLET 249

Query: 633 NFIDRNLKGKFSESEAAKLGKMALVCTHEDPENRPT 668
              D+ +  K+ +S      KM  +C  +DPE RPT
Sbjct: 250 GVQDKEMLKKYGKS----FRKMISLCLQKDPEKRPT 281

>2yex_A Serine/threonine-protein kinase CHK1; transferase, cell cycle; HET: YEX; 1.30A {Homo sapiens} PDB: 2x8e_A* 2ydk_A* 2ydj_A* 2yer_A* 2ydi_A* 1nvq_A* 1nvr_A* 1nvs_A* 2wmq_A* 2wmr_A* 2wms_A* 2wmt_A* 2wmu_A* 2wmv_A* 2wmw_A* 2wmx_A* 2x8d_A* 2x8i_A* 2xey_A* 2xez_A* ... Length = 276

 Score = 69.9 bits (172), Expect = 3e-13
 Identities = 45/227 (19%), Positives = 83/227 (36%), Gaps = 60/227 (26%)

Query: 416 LLGKGNFSSVYKGT-LRDGTLVAIRSINVTSCKSEEAEFVKGLY----LLTSLRHENIIR 470
            LG+G +  V           VA++ ++         +  + +     +   L HEN+++
Sbjct: 14  TLGEGAYGEVQLAVNRVTEEAVAVKIVD----MKRAVDCPENIKKEICINKMLNHENVVK 69

Query: 471 LRGFCCSRGR----------GECFLIYDF-APKGKLS-----KYLDQEEGSSNVLDWSTR 514
             G                 GE F   D   P   +      ++  Q             
Sbjct: 70  FYGHRREGNIQYLFLEYCSGGELF---DRIEPDIGMPEPDAQRFFHQ------------- 113

Query: 515 VSIIIGIAKGIGYLHSSEVNKPAIVHRNLSVEKVLIDQQFNPLIADCGLHKLLADDIVFS 574
              ++    G+ YLH        I HR++  E +L+D++ N  I+D GL  +   +    
Sbjct: 114 ---LMA---GVVYLHGIG-----ITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRER 162

Query: 575 VLKTSAAMG---YLAPEYVTTGR--FTERSDIFAFGVIILQILTGSL 616
           +L      G   Y+APE +   R    E  D+++ G+++  +L G L
Sbjct: 163 LLNKMC--GTLPYVAPE-LLKRREFHAEPVDVWSCGIVLTAMLAGEL 206

>3vhe_A Vascular endothelial growth factor receptor 2; kinase domain, kinase, transferase-transferase inhibitor COM; HET: 42Q; 1.55A {Homo sapiens} PDB: 1y6a_A* 1y6b_A* 3vid_A* 3hng_A* Length = 359

 Score = 70.7 bits (173), Expect = 3e-13
 Identities = 63/330 (19%), Positives = 118/330 (35%), Gaps = 79/330 (23%)

Query: 417 LGKGNFSSVYKGTL------RDGTLVAIRSINVTSCKSEEAEFVKGLYLLTSL-RHENII 469
           LG+G F  V +              VA++ +   +  SE    +  L +L  +  H N++
Sbjct: 30  LGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVV 89

Query: 470 RLRGFCCSRGRGECFLIYDFAPKGKLSKYL---------------DQEEGSSNV------ 508
            L G  C++  G   +I +F   G LS YL                  +G   V      
Sbjct: 90  NLLG-ACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKTKGARFRQGKDYVGAIPVD 148

Query: 509 ------LDWSTRVSIIIGIAKGIGYLHSSEVNKPAIVHRN-------------------- 542
                    S++ S   G  +        E   P  ++++                    
Sbjct: 149 LKRRLDSITSSQSSASSGFVEEKSLSDVEEEEAPEDLYKDFLTLEHLICYSFQVAKGMEF 208

Query: 543 ----------LSVEKVLIDQQFNPLIADCGLHKLLADDIVFSVLKTSAAM---GYLAPEY 589
                     L+   +L+ ++    I D GL + +  D  +  ++   A     ++APE 
Sbjct: 209 LASRKCIHRDLAARNILLSEKNVVKICDFGLARDIYKDPDY--VRKGDARLPLKWMAPET 266

Query: 590 VTTGRFTERSDIFAFGVIILQILTGSLVLTSSMRLAAESATFENFID---RNLKGKFSES 646
           +    +T +SD+++FGV++ +I +        +++  E   F   +    R     ++  
Sbjct: 267 IFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKIDEE---FCRRLKEGTRMRAPDYTTP 323

Query: 647 EAAKLGKMALVCTHEDPENRPTMEAVIEEL 676
           E  +   M L C H +P  RPT   ++E L
Sbjct: 324 EMYQT--M-LDCWHGEPSQRPTFSELVEHL 350

>2a2a_A Death-associated protein kinase 2; autoinhibition, transferase; 1.47A {Homo sapiens} PDB: 2cke_A* 1wmk_A 1z9x_A 2a27_A 2x0g_A 2xuu_A* 2w4k_A* 2xzs_A Length = 321

 Score = 70.0 bits (172), Expect = 3e-13
 Identities = 65/281 (23%), Positives = 110/281 (39%), Gaps = 51/281 (18%)

Query: 417 LGKGNFSSVYKGTLRD-GTLVAIRSINVTSCKSEEAEFVKGLYL-----LTSLRHENIIR 470
           LG G F+ V K   +  G   A + I     ++      +         L  + H N+I 
Sbjct: 20  LGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVSREEIEREVSILRQVLHHNVIT 79

Query: 471 LRGFCCSRGRGECFLIYDFAPKGKLSKYLDQEEGSSNVLDWSTRVSIIIG-IAKGIGYLH 529
           L     +R   +  LI +    G+L  +L Q+E  S         +  I  I  G+ YLH
Sbjct: 80  LHDVYENRT--DVVLILELVSGGELFDFLAQKESLS-----EEEATSFIKQILDGVNYLH 132

Query: 530 SSEVNKPAIVHRNLSVEKVLIDQQFNPL----IADCGLHKLLADDIVFSVLKTSAAMGYL 585
           + +     I H +L  E +++  +  P+    + D GL   + D + F  +  +    ++
Sbjct: 133 TKK-----IAHFDLKPENIMLLDKNIPIPHIKLIDFGLAHEIEDGVEFKNIFGTP--EFV 185

Query: 586 APEYVTTGRFTERSDIFAFGVI--ILQILTGSLVLTSSMRLAAESATFENFIDRNLKGKF 643
           APE V        +D+++ GVI  IL  L+G     S      +  T  N I       +
Sbjct: 186 APEIVNYEPLGLEADMWSIGVITYIL--LSG----ASPFLGDTKQETLAN-I---TSVSY 235

Query: 644 ---SE-----SEAAK--LGKMALVCTHEDPENRPTMEAVIE 674
               E     SE AK  + K+ LV   ++   R T++  + 
Sbjct: 236 DFDEEFFSHTSELAKDFIRKL-LV---KETRKRLTIQEALR 272

>2yab_A Death-associated protein kinase 2; apoptosis, transferase; HET: AMP; 1.90A {Mus musculus} PDB: 2yaa_A* 2ya9_A* Length = 361

 Score = 70.5 bits (173), Expect = 3e-13
 Identities = 66/286 (23%), Positives = 109/286 (38%), Gaps = 61/286 (21%)

Query: 417 LGKGNFSSVYKGTLRD-GTLVAIRSINVTSCKSEEAEFVKGLYL-----LTSLRHENIIR 470
           LG G F+ V K   +  G   A + I     ++      +         L  + H NII 
Sbjct: 20  LGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVCREEIEREVSILRQVLHPNIIT 79

Query: 471 LRGFCCSRGRGECFLIYDFAPKGKL------SKYLDQEEGSSNVLDWSTRVSIIIGIAKG 524
           L     +R   +  LI +    G+L       + L +EE +S           I  I  G
Sbjct: 80  LHDVYENRT--DVVLILELVSGGELFDFLAQKESLSEEEATS----------FIKQILDG 127

Query: 525 IGYLHSSEVNKPAIVHRNLSVEKVLIDQQFNPL----IADCGLHKLLADDIVFSVLKTSA 580
           + YLH+ +     I H +L  E +++  +  P+    + D GL   + D + F  +  + 
Sbjct: 128 VNYLHTKK-----IAHFDLKPENIMLLDKNIPIPHIKLIDFGLAHEIEDGVEFKNIFGTP 182

Query: 581 AMGYLAPEYVTTGRFTERSDIFAFGVI--ILQILTGSLVLTSSMRLAAESATFENFIDRN 638
              ++APE V        +D+++ GVI  IL  L+G     S      +  T  N I   
Sbjct: 183 --EFVAPEIVNYEPLGLEADMWSIGVITYIL--LSG----ASPFLGDTKQETLAN-I--- 230

Query: 639 LKGKF---SE-----SEAAK--LGKMALVCTHEDPENRPTMEAVIE 674
               +    E     SE AK  + K+ LV    +   R T++  + 
Sbjct: 231 TAVSYDFDEEFFSQTSELAKDFIRKL-LVK---ETRKRLTIQEALR 272

>2y94_A 5'-AMP-activated protein kinase catalytic subunit; transferase, nucleotide-binding, staurosporine-binding, serine/threonine-protein kinase; HET: TPO STU AMP; 3.24A {Rattus norvegicus} Length = 476

 Score = 71.4 bits (175), Expect = 4e-13
 Identities = 74/283 (26%), Positives = 110/283 (38%), Gaps = 63/283 (22%)

Query: 416 LLGKGNFSSVYKGT-LRDGTLVAIRSINVTSCKSEEAEFVKGLY----LLTSLRHENIIR 470
            LG G F  V  G     G  VA++ +N    K    + V  +      L   RH +II+
Sbjct: 23  TLGVGTFGKVKVGKHELTGHKVAVKILNRQ--KIRSLDVVGKIRREIQNLKLFRHPHIIK 80

Query: 471 LRGFCCSRGRGECFLIYDFAPKGKLSKYLDQEEGSSNVLDWSTRVSIIIGIAKGIGYLHS 530
           L  +       + F++ ++   G+L  Y+ +       LD      +   I  G+ Y H 
Sbjct: 81  L--YQVISTPSDIFMVMEYVSGGELFDYICKNGR----LDEKESRRLFQQILSGVDYCHR 134

Query: 531 SEVNKPAIVHRNLSVEKVLIDQQFNPLIADCGLHKLLADDIVFSVLKTSAAMG---YLAP 587
                  +VHR+L  E VL+D   N  IAD GL  +++D      L+TS   G   Y AP
Sbjct: 135 H-----MVVHRDLKPENVLLDAHMNAKIADFGLSNMMSDG---EFLRTSC--GSPNYAAP 184

Query: 588 EYVTTGRFTE--RSDIFAFGVIILQILTGSLVLTSSMRLAAESATFENFIDRNL------ 639
           E V +GR       DI++ GVI+  +L G+L                 F D ++      
Sbjct: 185 E-VISGRLYAGPEVDIWSSGVILYALLCGTL----------------PFDDDHVPTLFKK 227

Query: 640 --KGKFS-----ESEAAKL-GKMALVCTHEDPENRPTMEAVIE 674
              G F            L   M  V    DP  R T++ + E
Sbjct: 228 ICDGIFYTPQYLNPSVISLLKHMLQV----DPMKRATIKDIRE 266

>3bz5_A Internalin-J, INLJ; leucine rich repeat (LRR), cysteine ladder, asparagine ladder, virulence factor, solenoid, cell WALL; 2.70A {Listeria monocytogenes} Length = 457

 Score = 70.9 bits (174), Expect = 5e-13
 Identities = 34/168 (20%), Positives = 61/168 (36%), Gaps = 16/168 (9%)

Query: 69  KVANISLQGKGLTGKLSPSLSGLKCLSGLYLHYNSLSGEIPKEIRNLTELTDLYLDVNNL 128
            + ++      +T      +  L  L+ L    N+++  +   +   T LT L  D N L
Sbjct: 43  TLTSLDCHNSSITD--MTGIEKLTGLTKLICTSNNIT-TLD--LSQNTNLTYLACDSNKL 97

Query: 129 SGNIPPEIGSMASLQVLQLCCNQLTGNIPAQIGSLKSLSVLTLQHNRLNGGIPDSLGNLG 188
           + N+   +  +  L  L    N+LT  +   +     L+ L    N L       + +  
Sbjct: 98  T-NLD--VTPLTKLTYLNCDTNKLT-KLD--VSQNPLLTYLNCARNTLT---EIDVSHNT 148

Query: 189 KLKRLDLSFNSLFGTIPESLANNAELLFLDVQNNTLSGIVPSALKRLN 236
           +L  LD   N         +    +L  LD   N ++ +  S  K LN
Sbjct: 149 QLTELDCHLNKK--ITKLDVTPQTQLTTLDCSFNKITELDVSQNKLLN 194

>3bz5_A Internalin-J, INLJ; leucine rich repeat (LRR), cysteine ladder, asparagine ladder, virulence factor, solenoid, cell WALL; 2.70A {Listeria monocytogenes} Length = 457

 Score = 68.6 bits (168), Expect = 2e-12
 Identities = 35/150 (23%), Positives = 60/150 (40%), Gaps = 14/150 (9%)

Query: 87  SLSGLKCLSGLYLHYNSLSGEIPKEIRNLTELTDLYLDVNNLSGNIPPEIGSMASLQVLQ 146
            +S    L+ L    N+L+ EI   + + T+LT+L   +N        ++     L  L 
Sbjct: 122 DVSQNPLLTYLNCARNTLT-EID--VSHNTQLTELDCHLNKKIT--KLDVTPQTQLTTLD 176

Query: 147 LCCNQLTGNIPAQIGSLKSLSVLTLQHNRLNGGIPDSLGNLGKLKRLDLSFNSLFGTIPE 206
              N++T  +   +   K L+ L    N +   +   L    +L  LD S N L   I  
Sbjct: 177 CSFNKIT-ELD--VSQNKLLNRLNCDTNNIT-KLD--LNQNIQLTFLDCSSNKL-TEID- 228

Query: 207 SLANNAELLFLDVQNNTLSGIVPSALKRLN 236
            +    +L + D   N L+ +  S L +L 
Sbjct: 229 -VTPLTQLTYFDCSVNPLTELDVSTLSKLT 257

>3bz5_A Internalin-J, INLJ; leucine rich repeat (LRR), cysteine ladder, asparagine ladder, virulence factor, solenoid, cell WALL; 2.70A {Listeria monocytogenes} Length = 457

 Score = 67.4 bits (165), Expect = 5e-12
 Identities = 38/170 (22%), Positives = 68/170 (40%), Gaps = 18/170 (10%)

Query: 71  ANISLQGKGLTGKLSPSLSGLKCLSGLYLHYNSLSGEIPKEIRNLTELTDLYLDVNNLSG 130
           A+       +    + S   L  L+ L  H +S++ ++   I  LT LT L    NN++ 
Sbjct: 21  ASEVAAAFEMQATDTISEEQLATLTSLDCHNSSIT-DMT-GIEKLTGLTKLICTSNNIT- 77

Query: 131 NIPPEIGSMASLQVLQLCCNQLTGNIPAQIGSLKSLSVLTLQHNRLNGGIPDSLGNLGKL 190
            +   +    +L  L    N+LT N+   +  L  L+ L    N+L       +     L
Sbjct: 78  TLD--LSQNTNLTYLACDSNKLT-NLD--VTPLTKLTYLNCDTNKLT---KLDVSQNPLL 129

Query: 191 KRLDLSFNSLFGTIPESLANNAELLFLDVQNNTLSGIVP----SALKRLN 236
             L+ + N+L   I   +++N +L  LD   N     +     + L  L+
Sbjct: 130 TYLNCARNTL-TEID--VSHNTQLTELDCHLNKKITKLDVTPQTQLTTLD 176

>3bz5_A Internalin-J, INLJ; leucine rich repeat (LRR), cysteine ladder, asparagine ladder, virulence factor, solenoid, cell WALL; 2.70A {Listeria monocytogenes} Length = 457

 Score = 67.4 bits (165), Expect = 6e-12
 Identities = 29/149 (19%), Positives = 55/149 (36%), Gaps = 14/149 (9%)

Query: 87  SLSGLKCLSGLYLHYNSLSGEIPKEIRNLTELTDLYLDVNNLSGNIPPEIGSMASLQVLQ 146
            +S  K L+ L    N+++ ++   +    +LT L    N L+  I   +  +  L    
Sbjct: 186 DVSQNKLLNRLNCDTNNIT-KLD--LNQNIQLTFLDCSSNKLT-EID--VTPLTQLTYFD 239

Query: 147 LCCNQLTGNIPAQIGSLKSLSVLTLQHNRLNGGIPDSLGNLGKLKRLDLSFNSLFGTIPE 206
              N LT  +   + +L  L+ L      L   I   L +  +L             +  
Sbjct: 240 CSVNPLT-ELD--VSTLSKLTTLHCIQTDLL-EID--LTHNTQLIYFQAEGCRKIKELD- 292

Query: 207 SLANNAELLFLDVQNNTLSGIVPSALKRL 235
            + +N +L  LD Q   ++ +  S   +L
Sbjct: 293 -VTHNTQLYLLDCQAAGITELDLSQNPKL 320

>3bz5_A Internalin-J, INLJ; leucine rich repeat (LRR), cysteine ladder, asparagine ladder, virulence factor, solenoid, cell WALL; 2.70A {Listeria monocytogenes} Length = 457

 Score = 67.0 bits (164), Expect = 7e-12
 Identities = 31/156 (19%), Positives = 55/156 (35%), Gaps = 19/156 (12%)

Query: 85  SPSLSGLKCLSGLYLHYNSLSGEIPKEIRNLTELTDLYLDVNNLSGNIPPEIGSMASLQV 144
              ++    L+ L   +N ++ E+   +     L  L  D NN++  +   +     L  
Sbjct: 163 KLDVTPQTQLTTLDCSFNKIT-ELD--VSQNKLLNRLNCDTNNIT-KLD--LNQNIQLTF 216

Query: 145 LQLCCNQLTGNIPAQIGSLKSLSVLTLQHNRLNGGIPDSLGNLGKLKRLDLSFNSLFGTI 204
           L    N+LT  I   +  L  L+      N L   +  S   L KL  L      L   I
Sbjct: 217 LDCSSNKLT-EID--VTPLTQLTYFDCSVNPLT-ELDVS--TLSKLTTLHCIQTDL-LEI 269

Query: 205 PESLANNAELLFLDVQNNTLSGIVP----SALKRLN 236
              L +N +L++   +       +     + L  L+
Sbjct: 270 D--LTHNTQLIYFQAEGCRKIKELDVTHNTQLYLLD 303

>3bz5_A Internalin-J, INLJ; leucine rich repeat (LRR), cysteine ladder, asparagine ladder, virulence factor, solenoid, cell WALL; 2.70A {Listeria monocytogenes} Length = 457

 Score = 65.5 bits (160), Expect = 2e-11
 Identities = 32/149 (21%), Positives = 57/149 (38%), Gaps = 14/149 (9%)

Query: 87  SLSGLKCLSGLYLHYNSLSGEIPKEIRNLTELTDLYLDVNNLSGNIPPEIGSMASLQVLQ 146
            ++ L  L+ L    N L+ ++   +     LT L    N L+  I   +     L  L 
Sbjct: 101 DVTPLTKLTYLNCDTNKLT-KLD--VSQNPLLTYLNCARNTLT-EID--VSHNTQLTELD 154

Query: 147 LCCNQLTGNIPAQIGSLKSLSVLTLQHNRLNGGIPDSLGNLGKLKRLDLSFNSLFGTIPE 206
              N+    +   +     L+ L    N++       +     L RL+   N++   +  
Sbjct: 155 CHLNKKITKLD--VTPQTQLTTLDCSFNKITE---LDVSQNKLLNRLNCDTNNIT-KLD- 207

Query: 207 SLANNAELLFLDVQNNTLSGIVPSALKRL 235
            L  N +L FLD  +N L+ I  + L +L
Sbjct: 208 -LNQNIQLTFLDCSSNKLTEIDVTPLTQL 235

>3bz5_A Internalin-J, INLJ; leucine rich repeat (LRR), cysteine ladder, asparagine ladder, virulence factor, solenoid, cell WALL; 2.70A {Listeria monocytogenes} Length = 457

 Score = 63.6 bits (155), Expect = 9e-11
 Identities = 29/143 (20%), Positives = 50/143 (34%), Gaps = 11/143 (7%)

Query: 94  LSGLYLHYNSLSGEIPKEIRNLTELTDLYLDVNNLSGNIPPEIGSMASLQVLQLCCNQLT 153
            +        +          L  LT L    ++++      I  +  L  L    N +T
Sbjct: 20  FASEVAAAFEMQATDTISEEQLATLTSLDCHNSSITD--MTGIEKLTGLTKLICTSNNIT 77

Query: 154 GNIPAQIGSLKSLSVLTLQHNRLNGGIPDSLGNLGKLKRLDLSFNSLFGTIPESLANNAE 213
             +   +    +L+ L    N+L   +   +  L KL  L+   N L   +  S   N  
Sbjct: 78  -TLD--LSQNTNLTYLACDSNKLT-NLD--VTPLTKLTYLNCDTNKL-TKLDVS--QNPL 128

Query: 214 LLFLDVQNNTLSGIVPSALKRLN 236
           L +L+   NTL+ I  S   +L 
Sbjct: 129 LTYLNCARNTLTEIDVSHNTQLT 151

>3bz5_A Internalin-J, INLJ; leucine rich repeat (LRR), cysteine ladder, asparagine ladder, virulence factor, solenoid, cell WALL; 2.70A {Listeria monocytogenes} Length = 457

 Score = 63.2 bits (154), Expect = 1e-10
 Identities = 23/158 (14%), Positives = 48/158 (30%), Gaps = 10/158 (6%)

Query: 87  SLSGLKCLSGLYLHYNSLSGEIPKEIRNLTELTDLYLDVNNLSGNIPPEIGSMASLQVLQ 146
            L+    L            E+  ++ + T+L  L      ++  +   +     L  L 
Sbjct: 270 DLTHNTQLIYFQAEGCRKIKEL--DVTHNTQLYLLDCQAAGIT-ELD--LSQNPKLVYLY 324

Query: 147 LCCNQLTGNIPAQIGSLKSLSVLTLQHNRLNGGIPDSLGNLGKLKRLDLSFNSLFGTIPE 206
           L   +LT  +   +     L  L+  +  +      S+G +  L     +         E
Sbjct: 325 LNNTELT-ELD--VSHNTKLKSLSCVNAHIQD-FS-SVGKIPALNNNFEAEGQTITMPKE 379

Query: 207 SLANNAELLFLDVQNNTLSGIVPSALKRLNGGFQFQNN 244
           +L NN+  + +        G   +      G +    N
Sbjct: 380 TLTNNSLTIAVSPDLLDQFGNPMNIEPGDGGVYDQATN 417

>3bz5_A Internalin-J, INLJ; leucine rich repeat (LRR), cysteine ladder, asparagine ladder, virulence factor, solenoid, cell WALL; 2.70A {Listeria monocytogenes} Length = 457

 Score = 56.2 bits (136), Expect = 2e-08
 Identities = 21/122 (17%), Positives = 39/122 (31%), Gaps = 11/122 (9%)

Query: 114 NLTELTDLYLDVNNLSGNIPPEIGSMASLQVLQLCCNQLTGNIPAQIGSLKSLSVLTLQH 173
           N         ++             +A+L  L    + +T ++   I  L  L+ L    
Sbjct: 19  NFASEVAAAFEMQATD---TISEEQLATLTSLDCHNSSIT-DMTG-IEKLTGLTKLICTS 73

Query: 174 NRLNGGIPDSLGNLGKLKRLDLSFNSLFGTIPESLANNAELLFLDVQNNTLSGIVPSALK 233
           N +   +   L     L  L    N L   +   +    +L +L+   N L+ +  S   
Sbjct: 74  NNITT-LD--LSQNTNLTYLACDSNKL-TNLD--VTPLTKLTYLNCDTNKLTKLDVSQNP 127

Query: 234 RL 235
            L
Sbjct: 128 LL 129

>3bz5_A Internalin-J, INLJ; leucine rich repeat (LRR), cysteine ladder, asparagine ladder, virulence factor, solenoid, cell WALL; 2.70A {Listeria monocytogenes} Length = 457

 Score = 53.5 bits (129), Expect = 1e-07
 Identities = 21/152 (13%), Positives = 46/152 (30%), Gaps = 17/152 (11%)

Query: 85  SPSLSGLKCLSGLYLHYNSLSGEIPKEIRNLTELTDLYLDVNNLSGNIPPEIGSMASLQV 144
              ++    L  L      ++ E+   +    +L  LYL+   L+  +   +     L+ 
Sbjct: 290 ELDVTHNTQLYLLDCQAAGIT-ELD--LSQNPKLVYLYLNNTELT-ELD--VSHNTKLKS 343

Query: 145 LQLCCNQLTGNIPAQIGSLKSLSVLTLQHNRLNGGIPDSLGNLGKL------KRLDLSFN 198
           L      +  +  + +G + +L+       +    +P        L        LD   N
Sbjct: 344 LSCVNAHIQ-DFSS-VGKIPALNNNFEAEGQTI-TMPKETLTNNSLTIAVSPDLLDQFGN 400

Query: 199 SLFGTIPESLANNAELLFLDVQNNTLSGIVPS 230
            +   I        +     +    LS   P+
Sbjct: 401 PM--NIEPGDGGVYDQATNTITWENLSTDNPA 430

>1kob_A Twitchin; kinase, intrasteric regulation; 2.30A {Aplysia californica} SCOP: d.144.1.7 Length = 387

 Score = 70.1 bits (172), Expect = 5e-13
 Identities = 57/273 (20%), Positives = 108/273 (39%), Gaps = 42/273 (15%)

Query: 417 LGKGNFSSVYKGTLRD-GTLVAIRSINVTSCKSEEAEFVKGLYLLTSLRHENIIRLRGFC 475
           LG G F  V++   +  G +   + IN      +       + ++  L H  +I L    
Sbjct: 59  LGSGAFGVVHRCVEKATGRVFVAKFINTPYPLDKY-TVKNEISIMNQLHHPKLINLHDAF 117

Query: 476 CSRGRGECFLIYDFAPKGKLSKYLDQEEGSSNVLDWSTRVSIIIGIAKGIGYLHSSEVNK 535
             +   E  LI +F   G+L   +  E+   +  +    ++ +    +G+ ++H      
Sbjct: 118 EDKY--EMVLILEFLSGGELFDRIAAEDYKMSEAE---VINYMRQACEGLKHMHEHS--- 169

Query: 536 PAIVHRNLSVEKVLI-DQQFNPL-IADCGLHKLLADDIVFSVLKTSAAMGYLAPEYVTTG 593
             IVH ++  E ++   ++ + + I D GL   L  D +  V   +A   + APE V   
Sbjct: 170 --IVHLDIKPENIMCETKKASSVKIIDFGLATKLNPDEIVKVTTATA--EFAAPEIVDRE 225

Query: 594 RFTERSDIFAFGVI--ILQILTGSLVLTSSMRLAAESATFENFIDRNLKGK--FSE---- 645
                +D++A GV+  +L  L+G     S      +  T +N +    +    F E    
Sbjct: 226 PVGFYTDMWAIGVLGYVL--LSG----LSPFAGEDDLETLQN-V---KRCDWEFDEDAFS 275

Query: 646 --SEAAK--LGKMALVCTHEDPENRPTMEAVIE 674
             S  AK  +  + L    ++P  R T+   +E
Sbjct: 276 SVSPEAKDFIKNL-LQ---KEPRKRLTVHDALE 304

>3soa_A Calcium/calmodulin-dependent protein kinase type alpha with A beta 7 linker; phosphorylation, cytosolic, transferase-transferase inhibitor complex; HET: DB8; 3.55A {Homo sapiens} Length = 444

 Score = 70.4 bits (173), Expect = 5e-13
 Identities = 67/291 (23%), Positives = 106/291 (36%), Gaps = 75/291 (25%)

Query: 417 LGKGNFSSVYKGTLRD-GTLVAIRSINVTSCKSEEAEFVKG-LYLLTSLRHENIIRLRGF 474
           LGKG FS V +      G   A   IN     + + + ++    +   L+H NI+RL   
Sbjct: 19  LGKGAFSVVRRCVKVLAGQEYAAMIINTKKLSARDHQKLEREARICRLLKHPNIVRLHDS 78

Query: 475 CCSRGRGECFLIYDFAPKGKL-------SKYLDQEEGSSNVLDWSTRVSIIIGIAKGIGY 527
                 G  +LI+D    G+L         Y   E  +S+          I  I + + +
Sbjct: 79  ISE--EGHHYLIFDLVTGGELFEDIVAREYY--SEADASH---------CIQQILEAVLH 125

Query: 528 LHSSEVNKPAIVHRNLSVEKVLIDQQFN--PL-IADCGLHKLLADDIVFSVLKTSA-AMG 583
            H        +VHRNL  E +L+  +     + +AD GL   +  +         A   G
Sbjct: 126 CHQMG-----VVHRNLKPENLLLASKLKGAAVKLADFGLAIEVEGE--QQAWFGFAGTPG 178

Query: 584 YLAPEYVTTGRFTERSDIFAFGVI--ILQILTGSLVLTSSMRLAAESATFENFIDRN--- 638
           YL+PE +    + +  D++A GVI  IL  L G                +  F D +   
Sbjct: 179 YLSPEVLRKDPYGKPVDLWACGVILYIL--LVG----------------YPPFWDEDQHR 220

Query: 639 -----LKGKF---SE-----SEAAK--LGKMALVCTHEDPENRPTMEAVIE 674
                  G +   S      +  AK  + KM L     +P  R T    ++
Sbjct: 221 LYQQIKAGAYDFPSPEWDTVTPEAKDLINKM-LTI---NPSKRITAAEALK 267

>3tki_A Serine/threonine-protein kinase CHK1; cell checkpoint, transferase-transferase inhib complex; HET: S25; 1.60A {Homo sapiens} PDB: 2qhm_A* 2r0u_A* 3tkh_A* 2qhn_A* 2hy0_A* 2hog_A* 2hxq_A* 2hxl_A* 3f9n_A* Length = 323

 Score = 69.3 bits (170), Expect = 6e-13
 Identities = 45/227 (19%), Positives = 83/227 (36%), Gaps = 60/227 (26%)

Query: 416 LLGKGNFSSVYKGT-LRDGTLVAIRSINVTSCKSEEAEFVKGLY----LLTSLRHENIIR 470
            LG+G +  V           VA++ ++         +  + +     +   L HEN+++
Sbjct: 14  TLGEGAYGEVQLAVNRVTEEAVAVKIVD----MKRAVDCPENIKKEICINKMLNHENVVK 69

Query: 471 LRGFCCSRGR----------GECFLIYDF-APKGKLS-----KYLDQEEGSSNVLDWSTR 514
             G                 GE F   D   P   +      ++  Q             
Sbjct: 70  FYGHRREGNIQYLFLEYCSGGELF---DRIEPDIGMPEPDAQRFFHQ------------- 113

Query: 515 VSIIIGIAKGIGYLHSSEVNKPAIVHRNLSVEKVLIDQQFNPLIADCGLHKLLADDIVFS 574
             ++ G+     YLH        I HR++  E +L+D++ N  I+D GL  +   +    
Sbjct: 114 --LMAGVV----YLHGIG-----ITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRER 162

Query: 575 VLKTSAAMG---YLAPEYVTTGRF--TERSDIFAFGVIILQILTGSL 616
           +L      G   Y+APE +   R    E  D+++ G+++  +L G L
Sbjct: 163 LLNKMC--GTLPYVAPE-LLKRREFHAEPVDVWSCGIVLTAMLAGEL 206

>2h34_A Serine/threonine-protein kinase PKNE; apoenzyme, transferase; 2.80A {Mycobacterium tuberculosis} Length = 309

 Score = 68.8 bits (169), Expect = 7e-13
 Identities = 44/227 (19%), Positives = 78/227 (34%), Gaps = 60/227 (26%)

Query: 416 LLGKGNFSSVYKGTLRDGTL---VAIRSINVTSCK------SEEAEFVKGL----YLLTS 462
           L+G+G    VY+    D      VA+        K      S +  F   +         
Sbjct: 41  LVGRGGMGDVYEA--EDTVRERIVAL--------KLMSETLSSDPVFRTRMQREARTAGR 90

Query: 463 LRHENIIRLRGFCCSRGRGECFLIYDFAPKGKLSKYLDQE--EGSS--------NVLDWS 512
           L+  +++                I+DF        Y+D     G            L   
Sbjct: 91  LQEPHVVP---------------IHDFGEIDGQL-YVDMRLINGVDLAAMLRRQGPLAPP 134

Query: 513 TRVSIIIGIAKGIGYLHSSEVNKPAIVHRNLSVEKVLIDQQFNPLIADCGLHKLLADDIV 572
             V+I+  I   +   H++        HR++  E +L+       + D G+     D+  
Sbjct: 135 RAVAIVRQIGSALDAAHAAG-----ATHRDVKPENILVSADDFAYLVDFGIASATTDE-- 187

Query: 573 FSVLKTSAAMG---YLAPEYVTTGRFTERSDIFAFGVIILQILTGSL 616
             + +    +G   Y+APE  +    T R+DI+A   ++ + LTGS 
Sbjct: 188 -KLTQLGNTVGTLYYMAPERFSESHATYRADIYALTCVLYECLTGSP 233

>3h4j_B AMPK kdaid, SNF1-like protein kinase SSP2; ATP-binding, nucleotide-binding, phosphoprotei serine/threonine-protein kinase, transferase; 2.80A {Schizosaccharomyces pombe} Length = 336

 Score = 68.8 bits (169), Expect = 1e-12
 Identities = 66/298 (22%), Positives = 107/298 (35%), Gaps = 94/298 (31%)

Query: 416 LLGKGNFSSVYKGT-LRDGTLVAIRSINVTSCKSEEAEFVKGLY----LLTSLRHENIIR 470
            LG+G+F  V   T  +    VA++ I+      ++++    +      L  LRH +II+
Sbjct: 16  TLGEGSFGKVKLATHYKTQQKVALKFISRQ--LLKKSDMHMRVEREISYLKLLRHPHIIK 73

Query: 471 LRGFCCSRGR---------GECFLIYDF-APKGKLS-----KYLDQEEGSSNVLDWSTRV 515
           L     +            GE F   D+   K +++     ++  Q              
Sbjct: 74  LYDVITTPTDIVMVIEYAGGELF---DYIVEKKRMTEDEGRRFFQQ-------------- 116

Query: 516 SIIIGIAKGIGYLHSSEVNKPAIVHRNLSVEKVLIDQQFNPLIADCGLHKLLADDIVFSV 575
                I   I Y H        IVHR+L  E +L+D   N  IAD GL  ++ D    + 
Sbjct: 117 -----IICAIEYCHRH-----KIVHRDLKPENLLLDDNLNVKIADFGLSNIMTDG---NF 163

Query: 576 LKTSAAMG---YLAPEYVTTGRFTE--RSDIFAFGVIILQILTGSLVLTSSMRLAAESAT 630
           LKTS   G   Y APE V  G+       D+++ G+++  +L G L              
Sbjct: 164 LKTSC--GSPNYAAPE-VINGKLYAGPEVDVWSCGIVLYVMLVGRL-------------- 206

Query: 631 FENFIDRNL--------KGKFS-----ESEAAKL-GKMALVCTHEDPENRPTMEAVIE 674
              F D  +           +         A  L  +M +     DP  R T++ +  
Sbjct: 207 --PFDDEFIPNLFKKVNSCVYVMPDFLSPGAQSLIRRMIVA----DPMQRITIQEIRR 258

>1tki_A Titin; serine kinase, muscle, autoinhibition; 2.00A {Homo sapiens} SCOP: d.144.1.7 Length = 321

 Score = 68.4 bits (168), Expect = 1e-12
 Identities = 42/208 (20%), Positives = 83/208 (39%), Gaps = 31/208 (14%)

Query: 417 LGKGNFSSVYKGTLRD-GTLVAIRSINVTSCKSEEAEFVKG-LYLLTSLRHENIIRLRGF 474
           LG+G F  V++            + +     K  +   VK  + +L   RH NI+ L   
Sbjct: 13  LGRGEFGIVHRCVETSSKKTYMAKFVK---VKGTDQVLVKKEISILNIARHRNILHLHES 69

Query: 475 CCSRGRGECFLIYDFAPKGKLSKYLDQ--EEGSSNVLDWSTR--VSIIIGIAKGIGYLHS 530
             S    E  +I++F     +    ++            + R  VS +  + + + +LHS
Sbjct: 70  FESME--ELVMIFEFISGLDI---FERINTSAFE----LNEREIVSYVHQVCEALQFLHS 120

Query: 531 SEVNKPAIVHRNLSVEKVL-IDQQFNPL-IADCGLHKLLADDIVFSVLKTSAAMGYLAPE 588
                  I H ++  E ++   ++ + + I + G  + L     F +L T+    Y APE
Sbjct: 121 HN-----IGHFDIRPENIIYQTRRSSTIKIIEFGQARQLKPGDNFRLLFTAP--EYYAPE 173

Query: 589 YVTTGRFTERSDIFAFGVI--ILQILTG 614
                  +  +D+++ G +  +L  L+G
Sbjct: 174 VHQHDVVSTATDMWSLGTLVYVL--LSG 199

>2y7j_A Phosphorylase B kinase gamma catalytic chain, testis/liver isoform; transferase; HET: B49; 2.50A {Homo sapiens} PDB: 1h0t_A 1lp1_B 1q2n_A 2spz_A 3mzw_B* 1ss1_A 2jwd_A 1bdc_A 1bdd_A 1fc2_C* 2b87_A 2b88_A 1h0t_B 1lp1_A 2b87_B 2b89_A 3s1k_A Length = 365

 Score = 69.0 bits (169), Expect = 1e-12
 Identities = 68/302 (22%), Positives = 111/302 (36%), Gaps = 88/302 (29%)

Query: 417 LGKGNFSSVYKGTLRD-GTLVAIRSINVTSCKSEEAEFVKGLYLLTS----LR----HEN 467
           +G+G  S V +   R  G   A++ + VT+ +    +  +           LR    H +
Sbjct: 102 IGRGVSSVVRRCVHRATGHEFAVKIMEVTAERLSPEQLEEVREATRRETHILRQVAGHPH 161

Query: 468 IIRLRGFCCSRGRGECFLIYDFAPKGKL------SKYLDQEEGSSNVLDWSTRVSIIIGI 521
           II L     S      FL++D   KG+L         L ++E            SI+  +
Sbjct: 162 IITLIDSYES--SSFMFLVFDLMRKGELFDYLTEKVALSEKETR----------SIMRSL 209

Query: 522 AKGIGYLHSSEVNKPAIVHRNLSVEKVLIDQQFNPLIADCGLHKLLADDIVFSVLKT--- 578
            + + +LH++      IVHR+L  E +L+D      ++D G    L        L+    
Sbjct: 210 LEAVSFLHAN-----NIVHRDLKPENILLDDNMQIRLSDFGFSCHLEPG---EKLRELCG 261

Query: 579 SAAMGYLAPE------YVTTGRFTERSDIFAFGVI--ILQILTGSLVLTSSMRLAAESAT 630
           +   GYLAPE        T   + +  D++A GVI   L  L G                
Sbjct: 262 TP--GYLAPEILKCSMDETHPGYGKEVDLWACGVILFTL--LAG---------------- 301

Query: 631 FENFIDRN--------LKGKF---SE-----SEAAK--LGKMALVCTHEDPENRPTMEAV 672
              F  R         ++G++   S      S   K  + ++ L     DPE R T E  
Sbjct: 302 SPPFWHRRQILMLRMIMEGQYQFSSPEWDDRSSTVKDLISRL-LQV---DPEARLTAEQA 357

Query: 673 IE 674
           ++
Sbjct: 358 LQ 359

>3hko_A Calcium/calmodulin-dependent protein kinase with domain and 2 calmodulin-like EF...; structural genomics, protist parasite; HET: ANP; 1.80A {Cryptosporidium parvum iowa II} Length = 345

 Score = 68.3 bits (167), Expect = 1e-12
 Identities = 52/314 (16%), Positives = 98/314 (31%), Gaps = 73/314 (23%)

Query: 417 LGKGNFSSVYKGTLRD-GTLVAIRSINVTSCKSEEAEFVKGLY----LLTSLRHENIIRL 471
           +G+G++  V          + AI+ +N    +    + V+ +     L+  L H NI RL
Sbjct: 34  IGQGSYGVVRVAIENQTRAIRAIKIMNKNKIRQINPKDVERIKTEVRLMKKLHHPNIARL 93

Query: 472 RGF------------CCS----------RGRGECFLIYDFAPKGKLSKYLDQEEGSSNVL 509
                           C                         K ++    +  E + N  
Sbjct: 94  YEVYEDEQYICLVMELCHGGHLLDKLNVFIDDSTGKCAMDVVKTQICPCPECNEEAINGS 153

Query: 510 DWSTRV------------SIIIGIAKGIGYLHSSEVNKPAIVHRNLSVEKVLI--DQQFN 555
               R             +I+  I   + YLH+       I HR++  E  L   ++ F 
Sbjct: 154 IHGFRESLDFVQREKLISNIMRQIFSALHYLHNQG-----ICHRDIKPENFLFSTNKSFE 208

Query: 556 PLIADCGLHKLLADDIVFSVLKTSAAMG---YLAPEYVTTG--RFTERSDIFAFGVIILQ 610
             + D GL K             +   G   ++APE + T    +  + D ++ GV++  
Sbjct: 209 IKLVDFGLSKEFYKLNNGEYYGMTTKAGTPYFVAPEVLNTTNESYGPKCDAWSAGVLLHL 268

Query: 611 ILTGSLVLTSSMRLAAESATFENFIDRNLKGKF--------SESEAAK--LGKMALVCTH 660
           +L G++          ++ T        L  K           S  A+  L  + L    
Sbjct: 269 LLMGAVPFPGV----NDADTISQ----VLNKKLCFENPNYNVLSPLARDLLSNL-LNR-- 317

Query: 661 EDPENRPTMEAVIE 674
            + + R      ++
Sbjct: 318 -NVDERFDAMRALQ 330

>2x4f_A Myosin light chain kinase family member 4; LUNG, breast cancer, transferase, serine/threonine-protein kinase, nucleotide-binding; HET: 16X 1PE; 2.67A {Homo sapiens} Length = 373

 Score = 68.6 bits (168), Expect = 2e-12
 Identities = 50/213 (23%), Positives = 93/213 (43%), Gaps = 28/213 (13%)

Query: 411 FSEVNLLGKGNFSSVYKGTLRD-GTLVAIRSINVTSCKSEEAEFVKGLYLLTSLRHENII 469
            S+  +LG G F  V+K      G  +A + I     K +E E    + ++  L H N+I
Sbjct: 91  VSKTEILGGGRFGQVHKCEETATGLKLAAKIIKTRGMKDKE-EVKNEISVMNQLDHANLI 149

Query: 470 RLRGFCCSRGRGECFLIYDFAPKGKLSKYLDQ--EEGSSNVLDWSTR--VSIIIGIAKGI 525
           +L     S  + +  L+ ++   G+L    D+  +E  +     +    +  +  I +GI
Sbjct: 150 QLYDAFES--KNDIVLVMEYVDGGEL---FDRIIDESYN----LTELDTILFMKQICEGI 200

Query: 526 GYLHSSEVNKPAIVHRNLSVEKVL-IDQQFNPL-IADCGLHKLLADDIVFSVLKTSAAMG 583
            ++H        I+H +L  E +L +++    + I D GL +         V   +    
Sbjct: 201 RHMHQMY-----ILHLDLKPENILCVNRDAKQIKIIDFGLARRYKPREKLKVNFGTP--E 253

Query: 584 YLAPEYVTTGRFTERSDIFAFGVI--ILQILTG 614
           +LAPE V     +  +D+++ GVI  +L  L+G
Sbjct: 254 FLAPEVVNYDFVSFPTDMWSVGVIAYML--LSG 284

>3bhy_A Death-associated protein kinase 3; death associated kinase, DAPK3, ZIP kinase, ZIPK, DAP kinase like kinase, DLK, structural genomics consortium; HET: 7CP; 1.24A {Homo sapiens} PDB: 3bqr_A* 2j90_A* 1yrp_A* 2yak_A* 2y4p_A* 3f5u_A* 1jks_A 1jkk_A* 1ig1_A* 1jkl_A 1jkt_A 3eh9_A* 3eha_A* 3f5g_A* 1p4f_A* 1wvw_A 1wvx_A* 1wvy_A* 2w4j_A* 3dgk_A ... Length = 283

 Score = 67.6 bits (166), Expect = 2e-12
 Identities = 66/282 (23%), Positives = 107/282 (37%), Gaps = 53/282 (18%)

Query: 417 LGKGNFSSVYKGTLRD-GTLVAIRSINVTSCKSEEAEFVKGLYL-----LTSLRHENIIR 470
           LG G F+ V K   +  G   A + I      S      +         L  +RH NII 
Sbjct: 13  LGSGQFAIVRKCRQKGTGKEYAAKFIKKRRLSSSRRGVSREEIEREVNILREIRHPNIIT 72

Query: 471 LRGFCCSRGRGECFLIYDFAPKGKLSKYLDQ--EEGSSNVLDWSTRVSIIIGIAKGIGYL 528
           L     +  + +  LI +    G+L    D   E+ S    + +     +  I  G+ YL
Sbjct: 73  LHDIFEN--KTDVVLILELVSGGEL---FDFLAEKESLTEDEAT---QFLKQILDGVHYL 124

Query: 529 HSSEVNKPAIVHRNLSVEKVLIDQQFNPL----IADCGLHKLLADDIVFSVLKTSAAMGY 584
           HS       I H +L  E +++  +  P     + D G+   +     F  +  +    +
Sbjct: 125 HSKR-----IAHFDLKPENIMLLDKNVPNPRIKLIDFGIAHKIEAGNEFKNIFGTP--EF 177

Query: 585 LAPEYVTTGRFTERSDIFAFGVI--ILQILTGSLVLTSSMRLAAESATFENFIDRNLKGK 642
           +APE V        +D+++ GVI  IL  L+G     S      +  T  N I       
Sbjct: 178 VAPEIVNYEPLGLEADMWSIGVITYIL--LSG----ASPFLGETKQETLTN-I---SAVN 227

Query: 643 F---SE-----SEAAK--LGKMALVCTHEDPENRPTMEAVIE 674
           +    E     SE AK  + ++ LV   +DP+ R T+   +E
Sbjct: 228 YDFDEEYFSNTSELAKDFIRRL-LV---KDPKRRMTIAQSLE 265

>3qd2_B Eukaryotic translation initiation factor 2-alpha; EIF2A kinase, phosphoryalation, gene regulation; HET: TPO; 2.81A {Mus musculus} Length = 332

 Score = 68.0 bits (166), Expect = 2e-12
 Identities = 43/327 (13%), Positives = 92/327 (28%), Gaps = 72/327 (22%)

Query: 411 FSEVNLLGKGNFSSVYKGT-LRDGTLVAIRSINVTSCKSEEAEFVKGLYLLTSLRHENII 469
           F  +  +G+G F  V++     D    AI+ I + + +    + ++ +  L  L H  I+
Sbjct: 8   FEPIQCMGRGGFGVVFEAKNKVDDCNYAIKRIRLPNRELAREKVMREVKALAKLEHPGIV 67

Query: 470 RLRG-FCCSRGRGECFLIYDFAPKGKLSKYLDQEEGSSNVLDWSTRVSIIIGIAKGIGYL 528
           R    +  +        + +   K + + +        +      R          +G L
Sbjct: 68  RYFNAWLETPPEKWQEEMDEIWLKDESTDWPLSSPSPMDAPSVKIRRMDPFSTKNTVGQL 127

Query: 529 HSSEVN---------------KPAIVHRNLSVEK-------------------------- 547
             S                  K  +  R    ++                          
Sbjct: 128 QPSSPKVYLYIQMQLCRKENLKDWMNRRCSLEDREHGVCLHIFIQIAEAVEFLHSKGLMH 187

Query: 548 -------VLIDQQFNPLIADCGLHKLLADDIVFSVLKTSAAMG-----------YLAPEY 589
                  +         + D GL   +  D     + T                Y++PE 
Sbjct: 188 RDLKPSNIFFTMDDVVKVGDFGLVTAMDQDEEEQTVLTPMPAYATHTGQVGTKLYMSPEQ 247

Query: 590 VTTGRFTERSDIFAFGVIILQILTGSLVLTSSMRLAAESATFENFIDRNLKGKFSE--SE 647
           +    ++ + DIF+ G+I+ ++L      T   R         +  +      F++   +
Sbjct: 248 IHGNNYSHKVDIFSLGLILFELLYS--FSTQMER----VRIITDVRNLKFPLLFTQKYPQ 301

Query: 648 AAKLGKMALVCTHEDPENRPTMEAVIE 674
              + +         P  RP    +IE
Sbjct: 302 EHMMVQD---MLSPSPTERPEATDIIE 325

>1h6t_A Internalin B; cell adhesion, leucine rich repeat, IG-like domain, EF-hand domain; 1.6A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 PDB: 2wqu_A 2uzy_A 2uzx_A 2wqv_A* 2wqw_A 2wqx_A 1d0b_A 1otn_A 1oto_A 1otm_A Length = 291

 Score = 67.4 bits (165), Expect = 2e-12
 Identities = 43/172 (25%), Positives = 75/172 (43%), Gaps = 13/172 (7%)

Query: 65  NEHRKVANISLQGKGLTGKLSPSLSGLKCLSGLYLHYNSLSGEIPKEIRNLTELTDLYLD 124
           NE   +  I      +   +   +  L  ++ L+L+ N L+ +I K + NL  L  L+LD
Sbjct: 43  NELNSIDQIIANNSDIK-SVQG-IQYLPNVTKLFLNGNKLT-DI-KPLANLKNLGWLFLD 98

Query: 125 VNNLSGNIPPEIGSMASLQVLQLCCNQLTGNIPAQIGSLKSLSVLTLQHNRLNGGIPDSL 184
            N +  ++   +  +  L+ L L  N ++ +I   +  L  L  L L +N++       L
Sbjct: 99  ENKVK-DLSS-LKDLKKLKSLSLEHNGIS-DING-LVHLPQLESLYLGNNKIT--DITVL 152

Query: 185 GNLGKLKRLDLSFNSLFGTIPESLANNAELLFLDVQNNTLSGIVP-SALKRL 235
             L KL  L L  N +  +    LA   +L  L +  N +S +   + LK L
Sbjct: 153 SRLTKLDTLSLEDNQI--SDIVPLAGLTKLQNLYLSKNHISDLRALAGLKNL 202

>1h6t_A Internalin B; cell adhesion, leucine rich repeat, IG-like domain, EF-hand domain; 1.6A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 PDB: 2wqu_A 2uzy_A 2uzx_A 2wqv_A* 2wqw_A 2wqx_A 1d0b_A 1otn_A 1oto_A 1otm_A Length = 291

 Score = 66.6 bits (163), Expect = 4e-12
 Identities = 33/153 (21%), Positives = 64/153 (41%), Gaps = 14/153 (9%)

Query: 88  LSGLKCLSGLYLHYNSLSGEIPKEIRNLTELTDLYLDVNNLSGNIPPEIGSMASLQVLQL 147
                      L   S++  +      L  +  +  + +++  ++   I  + ++  L L
Sbjct: 20  DDAFAETIKDNLKKKSVTDAVT--QNELNSIDQIIANNSDIK-SVQG-IQYLPNVTKLFL 75

Query: 148 CCNQLTGNIPAQIGSLKSLSVLTLQHNRLNGGIPDSLGNLGKLKRLDLSFNSLFGTIPES 207
             N+LT +I   + +LK+L  L L  N++      SL +L KLK L L  N +  +    
Sbjct: 76  NGNKLT-DIKP-LANLKNLGWLFLDENKVK--DLSSLKDLKKLKSLSLEHNGI--SDING 129

Query: 208 LANNAELLFLDVQNNTLSGIVP----SALKRLN 236
           L +  +L  L + NN ++ I      + L  L+
Sbjct: 130 LVHLPQLESLYLGNNKITDITVLSRLTKLDTLS 162

>1h6t_A Internalin B; cell adhesion, leucine rich repeat, IG-like domain, EF-hand domain; 1.6A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 PDB: 2wqu_A 2uzy_A 2uzx_A 2wqv_A* 2wqw_A 2wqx_A 1d0b_A 1otn_A 1oto_A 1otm_A Length = 291

 Score = 65.8 bits (161), Expect = 6e-12
 Identities = 35/141 (24%), Positives = 58/141 (41%), Gaps = 8/141 (5%)

Query: 87  SLSGLKCLSGLYLHYNSLSGEIPKEIRNLTELTDLYLDVNNLSGNIPPEIGSMASLQVLQ 146
           SL  LK L  L L +N +S +I   + +L +L  LYL  N ++ +I   +  +  L  L 
Sbjct: 107 SLKDLKKLKSLSLEHNGIS-DIN-GLVHLPQLESLYLGNNKIT-DITV-LSRLTKLDTLS 162

Query: 147 LCCNQLTGNIPAQIGSLKSLSVLTLQHNRLNGGIPDSLGNLGKLKRLDLSFNSLFGTIPE 206
           L  NQ++ +I   +  L  L  L L  N ++     +L  L  L  L+L           
Sbjct: 163 LEDNQIS-DIVP-LAGLTKLQNLYLSKNHISD--LRALAGLKNLDVLELFSQECLNKPIN 218

Query: 207 SLANNAELLFLDVQNNTLSGI 227
             +N      +   + +L   
Sbjct: 219 HQSNLVVPNTVKNTDGSLVTP 239

>2y0a_A Death-associated protein kinase 1; transferase, calmodulin, esprit; HET: MES; 2.60A {Homo sapiens} Length = 326

 Score = 67.7 bits (166), Expect = 2e-12
 Identities = 64/284 (22%), Positives = 108/284 (38%), Gaps = 57/284 (20%)

Query: 417 LGKGNFSSVYKGTLRD-GTLVAIRSINVTSCKSEEAEFVKGLYL-----LTSLRHENIIR 470
           LG G F+ V K   +  G   A + I     KS      +         L  ++H N+I 
Sbjct: 19  LGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQHPNVIT 78

Query: 471 LRGFCCSRGRGECFLIYDFAPKGKLSKYLDQ--EEGSSNVLDWSTR--VSIIIGIAKGIG 526
           L     ++   +  LI +    G+L    D   E+ S      +       +  I  G+ 
Sbjct: 79  LHEVYENKT--DVILILELVAGGEL---FDFLAEKES-----LTEEEATEFLKQILNGVY 128

Query: 527 YLHSSEVNKPAIVHRNLSVEKVLIDQQFNPL----IADCGLHKLLADDIVFSVLKTSAAM 582
           YLHS +     I H +L  E +++  +  P     I D GL   +     F  +  +   
Sbjct: 129 YLHSLQ-----IAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFGNEFKNIFGTP-- 181

Query: 583 GYLAPEYVTTGRFTERSDIFAFGVI--ILQILTGSLVLTSSMRLAAESATFENFIDRNLK 640
            ++APE V        +D+++ GVI  IL  L+G     S      +  T  N +     
Sbjct: 182 EFVAPEIVNYEPLGLEADMWSIGVITYIL--LSG----ASPFLGDTKQETLAN-V---SA 231

Query: 641 GK--FSE------SEAAK--LGKMALVCTHEDPENRPTMEAVIE 674
               F +      S  AK  + ++ LV   +DP+ R T++  ++
Sbjct: 232 VNYEFEDEYFSNTSALAKDFIRRL-LV---KDPKKRMTIQDSLQ 271

>2qr7_A Ribosomal protein S6 kinase alpha-3; kinase domain, RSK2, autoinhibitory, ATP-binding, nucleotide phosphorylation, serine/threonine-protein kinase; 2.00A {Mus musculus} PDB: 2qr8_A 4d9t_A* 4d9u_A* 3rny_A 2wnt_A Length = 342

 Score = 67.7 bits (166), Expect = 2e-12
 Identities = 67/290 (23%), Positives = 111/290 (38%), Gaps = 74/290 (25%)

Query: 417 LGKGNFSSVYKGTLRD-GTLVAIRSINVTSCK-SEEAEFVKGLYLLTSLRHENIIRLRGF 474
           +G G++S   +   +      A++ I+ +    +EE E      LL   +H NII L+  
Sbjct: 30  IGVGSYSVCKRCIHKATNMEFAVKIIDKSKRDPTEEIEI-----LLRYGQHPNIITLKDV 84

Query: 475 CCSRGRGECFLIYDFAPKGKL------SKYLDQEEGSSNVLDWSTRVSIIIGIAKGIGYL 528
                    +++ +    G+L       K+  + E S+          ++  I K + YL
Sbjct: 85  YDDGKY--VYVVTELMKGGELLDKILRQKFFSEREASA----------VLFTITKTVEYL 132

Query: 529 HSSEVNKPAIVHRNLSVEKVL-IDQQFNPL---IADCGLHKLLADDIVFSVLKT---SAA 581
           H+       +VHR+L    +L +D+  NP    I D G  K L  +    +L T   +A 
Sbjct: 133 HAQG-----VVHRDLKPSNILYVDESGNPESIRICDFGFAKQLRAEN--GLLMTPCYTA- 184

Query: 582 MGYLAPEYVTTGRFTERSDIFAFGVIILQILTGSLVLTSSMRL-------AAESATFENF 634
             ++APE +    +    DI++ GV +L  +           L            T E  
Sbjct: 185 -NFVAPEVLERQGYDAACDIWSLGV-LLYTM-----------LTGYTPFANGPDDTPEEI 231

Query: 635 IDRNLKGKF---SE-----SEAAK--LGKMALVCTHEDPENRPTMEAVIE 674
           + R   GKF          S+ AK  + KM L     DP  R T   V+ 
Sbjct: 232 LARIGSGKFSLSGGYWNSVSDTAKDLVSKM-LHV---DPHQRLTAALVLR 277

>2xwt_C Thyrotropin receptor; signaling protein-immune system complex, GPCR, graves' disea autoimmunity, receptor-autoantibody complex; HET: NAG BMA MAN; 1.90A {Homo sapiens} PDB: 3g04_C* Length = 239

 Score = 66.2 bits (162), Expect = 3e-12
 Identities = 25/150 (16%), Positives = 52/150 (34%), Gaps = 9/150 (6%)

Query: 94  LSGLYLHYNSLSGEIPKEI-RNLTELTDLYLDVNNLSGNIPPEI-GSMASLQVLQLCCNQ 151
              L L    L   IP     NL  ++ +Y+ ++     +      +++ +  +++   +
Sbjct: 33  TQTLKLIETHLR-TIPSHAFSNLPNISRIYVSIDVTLQQLESHSFYNLSKVTHIEIRNTR 91

Query: 152 LTGNIPAQI-GSLKSLSVLTLQHNRLNGGIPD--SLGNLGKLKRLDLSFNSLFGTIPESL 208
               I       L  L  L + +  L    PD   + +      L+++ N    +IP + 
Sbjct: 92  NLTYIDPDALKELPLLKFLGIFNTGLK-MFPDLTKVYSTDIFFILEITDNPYMTSIPVNA 150

Query: 209 ANN--AELLFLDVQNNTLSGIVPSALKRLN 236
                 E L L + NN  + +   A     
Sbjct: 151 FQGLCNETLTLKLYNNGFTSVQGYAFNGTK 180

>2xwt_C Thyrotropin receptor; signaling protein-immune system complex, GPCR, graves' disea autoimmunity, receptor-autoantibody complex; HET: NAG BMA MAN; 1.90A {Homo sapiens} PDB: 3g04_C* Length = 239

 Score = 64.6 bits (158), Expect = 8e-12
 Identities = 29/166 (17%), Positives = 53/166 (31%), Gaps = 10/166 (6%)

Query: 89  SGLKCLSGLYLHYNSLSGEIPKEI-RNLTELTDLYLDVNNLSGNIPPE--IGSMASLQVL 145
             L  ++ + +        I  +  + L  L  L +    L    P    + S     +L
Sbjct: 77  YNLSKVTHIEIRNTRNLTYIDPDALKELPLLKFLGIFNTGLK-MFPDLTKVYSTDIFFIL 135

Query: 146 QLCCNQLTGNIPAQI--GSLKSLSVLTLQHNRLNGGIPDSLGNLGKLKRLDLSFNSLFGT 203
           ++  N    +IP     G       L L +N     +     N  KL  + L+ N     
Sbjct: 136 EITDNPYMTSIPVNAFQGLCNETLTLKLYNNGFTS-VQGYAFNGTKLDAVYLNKNKYLTV 194

Query: 204 IPE-SLANNAELL-FLDVQNNTLSGIVPSALKRLNGGFQFQNNPGL 247
           I + +          LDV   +++ +    L+ L      +N   L
Sbjct: 195 IDKDAFGGVYSGPSLLDVSQTSVTALPSKGLEHLK-ELIARNTWTL 239

>2xwt_C Thyrotropin receptor; signaling protein-immune system complex, GPCR, graves' disea autoimmunity, receptor-autoantibody complex; HET: NAG BMA MAN; 1.90A {Homo sapiens} PDB: 3g04_C* Length = 239

 Score = 42.3 bits (100), Expect = 2e-04
 Identities = 21/97 (21%), Positives = 39/97 (40%), Gaps = 6/97 (6%)

Query: 141 SLQVLQLCCNQLTGNIPAQIGSLKSLSVLTLQHNRLNGGIPDSLGNLGKLKRLDLSFNSL 200
             +  ++ C  +   IP       S   L L    L      +  NL  + R+ +S +  
Sbjct: 12  QEEDFRVTCKDIQ-RIP---SLPPSTQTLKLIETHLRTIPSHAFSNLPNISRIYVSIDVT 67

Query: 201 FGTIPE-SLANNAELLFLDVQNN-TLSGIVPSALKRL 235
              +   S  N +++  ++++N   L+ I P ALK L
Sbjct: 68  LQQLESHSFYNLSKVTHIEIRNTRNLTYIDPDALKEL 104

>2zv2_A Calcium/calmodulin-dependent protein kinase kinas; beta, camkk2, E.C.2.7.11.17, phosphorylation, AMPKK, metabolism, binding, calmodulin-binding; HET: 609; 2.40A {Homo sapiens} Length = 298

 Score = 66.9 bits (164), Expect = 3e-12
 Identities = 49/307 (15%), Positives = 101/307 (32%), Gaps = 82/307 (26%)

Query: 416 LLGKGNFSSVYKGT-LRDGTLVAIRSIN---------------------VTSCKSEEAEF 453
            +GKG++  V       D T  A++ ++                           +    
Sbjct: 20  EIGKGSYGVVKLAYNENDNTYYAMKVLSKKKLIRQAGFPRRPPPRGTRPAPGGCIQPRGP 79

Query: 454 VKGLY----LLTSLRHENIIRLRGFCCSRGRGECFLIYDFAPKGKLSKYLDQEEGSSNVL 509
           ++ +Y    +L  L H N+++L            +++++   +G + +       +   L
Sbjct: 80  IEQVYQEIAILKKLDHPNVVKLVEVLDDPNEDHLYMVFELVNQGPVMEVP-----TLKPL 134

Query: 510 DWSTRVSIIIGIAKGIGYLHSSEVNKPAIVHRNLSVEKVLIDQQFNPLIADCGLHKLLAD 569
                      + KGI YLH     K  I+HR++    +L+ +  +  IAD G+      
Sbjct: 135 SEDQARFYFQDLIKGIEYLHY---QK--IIHRDIKPSNLLVGEDGHIKIADFGVSNEFKG 189

Query: 570 DIVFSVLKTSAAMG---YLAPEYVTTGRFT---ERSDIFAFGVIILQILTGSLVLTSSMR 623
                 L  +   G   ++APE ++  R     +  D++A GV +   + G         
Sbjct: 190 SDAL--LSNTV--GTPAFMAPESLSETRKIFSGKALDVWAMGVTLYCFVFGQC------- 238

Query: 624 LAAESATFENFIDRNL--------KGKFS------ESEAAK--LGKMALVCTHEDPENRP 667
                     F+D  +                    +E  K  + +M       +PE+R 
Sbjct: 239 ---------PFMDERIMCLHSKIKSQALEFPDQPDIAEDLKDLITRMLDK----NPESRI 285

Query: 668 TMEAVIE 674
            +  +  
Sbjct: 286 VVPEIKL 292

>2ac3_A MAP kinase-interacting serine/threonine kinase 2; DFD motif, transferase; 2.10A {Homo sapiens} PDB: 2hw7_A* 2ac5_A* 2hw6_A Length = 316

 Score = 66.9 bits (164), Expect = 3e-12
 Identities = 67/313 (21%), Positives = 117/313 (37%), Gaps = 64/313 (20%)

Query: 405 ESATQCFSEV-----NLLGKGNFSSVYKGTLRD-GTLVAIRSINVTSCKSEEAEF--VKG 456
           +S +  F +V     ++LG+G  + V            A++ I           F  V+ 
Sbjct: 4   DSFSGRFEDVYQLQEDVLGEGAHARVQTCINLITSQEYAVKIIEKQPGHIRSRVFREVEM 63

Query: 457 LYLLTSLRHENIIRLRGFCCSRGRGECFLIYDFAPKGKLSKYLD--QEEGSSNVLDWSTR 514
           LY      H N++ L  F     R   +L+++    G +   L    +    N L+ S  
Sbjct: 64  LYQCQG--HRNVLELIEFFEEEDR--FYLVFEKMRGGSI---LSHIHKRRHFNELEAS-- 114

Query: 515 VSIIIGIAKGIGYLHSSEVNKPAIVHRNLSVEKVLIDQQFN--PL-IADCGLHKLLADDI 571
             ++  +A  + +LH+       I HR+L  E +L +      P+ I D  L   +  + 
Sbjct: 115 -VVVQDVASALDFLHN-----KGIAHRDLKPENILCEHPNQVSPVKICDFDLGSGIKLNG 168

Query: 572 VFSVLKTSAAM------GYLAPE-----YVTTGRFTERSDIFAFGVI--ILQILTG---- 614
             S + T   +       Y+APE           + +R D+++ GVI  IL  L+G    
Sbjct: 169 DCSPISTPELLTPCGSAEYMAPEVVEAFSEEASIYDKRCDLWSLGVILYIL--LSGYPPF 226

Query: 615 ---SLVLTSSMRLAAESATFENFIDRNLKGKF---SE-----SEAAK--LGKMALVCTHE 661
                      R  A  A      +   +GK+    +     S AAK  + K+ LV    
Sbjct: 227 VGRCGSDCGWDRGEACPACQNMLFESIQEGKYEFPDKDWAHISCAAKDLISKL-LVR--- 282

Query: 662 DPENRPTMEAVIE 674
           D + R +   V++
Sbjct: 283 DAKQRLSAAQVLQ 295

>1xeu_A Internalin C; cellular invasion, leucine-rich repeat, cell invasion; 2.05A {Listeria monocytogenes} Length = 263

 Score = 65.8 bits (161), Expect = 4e-12
 Identities = 36/155 (23%), Positives = 67/155 (43%), Gaps = 13/155 (8%)

Query: 83  KLSPSLSGLKCLSGLYLHYNSLSGEIPKEIRNLTELTDLYLDVNNLSGNIPPEIGSMASL 142
           ++ P   GL       L   S++  +    + L+ + +   D +N+  ++   +    +L
Sbjct: 11  QVFP-DPGLANAVKQNLGKQSVTDLVS--QKELSGVQNFNGDNSNIQ-SLAG-MQFFTNL 65

Query: 143 QVLQLCCNQLTGNIPAQIGSLKSLSVLTLQHNRLNGGIPDSLGNLGKLKRLDLSFNSLFG 202
           + L L  NQ++ ++   +  L  L  L++  NRL     + + +   L RL L  N L  
Sbjct: 66  KELHLSHNQIS-DLSP-LKDLTKLEELSVNRNRLK--NLNGIPSA-CLSRLFLDNNEL-- 118

Query: 203 TIPESLANNAELLFLDVQNNTLSGIVP-SALKRLN 236
              +SL +   L  L ++NN L  IV    L +L 
Sbjct: 119 RDTDSLIHLKNLEILSIRNNKLKSIVMLGFLSKLE 153

>1xeu_A Internalin C; cellular invasion, leucine-rich repeat, cell invasion; 2.05A {Listeria monocytogenes} Length = 263

 Score = 64.3 bits (157), Expect = 2e-11
 Identities = 42/202 (20%), Positives = 75/202 (37%), Gaps = 21/202 (10%)

Query: 86  PSLSGLKCLSGLYLHYNSLSGEIPKEIRNLTELTDLYLDVNNLSGNIPPEIGSMASLQVL 145
            S   L  +       +++   +   ++  T L +L+L  N +S ++ P +  +  L+ L
Sbjct: 35  VSQKELSGVQNFNGDNSNIQ-SL-AGMQFFTNLKELHLSHNQIS-DLSP-LKDLTKLEEL 90

Query: 146 QLCCNQLTGNIPAQIGSLKSLSVLTLQHNRLNGGIPDSLGNLGKLKRLDLSFNSLFGTIP 205
            +  N+L  N+         LS L L +N L     DSL +L  L+ L +  N L     
Sbjct: 91  SVNRNRLK-NLNG--IPSACLSRLFLDNNELRD--TDSLIHLKNLEILSIRNNKL--KSI 143

Query: 206 ESLANNAELLFLDVQNNTLSGIVP-SALKRLNGGFQFQNNPGLCGDGIASLRACTVYDNT 264
             L   ++L  LD+  N ++     + LK++N                 +       +  
Sbjct: 144 VMLGFLSKLEVLDLHGNEITNTGGLTRLKKVN-WIDLTGQK------CVNEPVKYQPELY 196

Query: 265 QINPVKPFGSHSNDTTPIDISE 286
             N VK         +P  IS 
Sbjct: 197 ITNTVK--DPDGRWISPYYISN 216

>4ay9_X Follicle-stimulating hormone receptor; hormone-receptor complex, leucine-rich repeats, LRR, GPCR; HET: TYS NAG; 2.50A {Homo sapiens} PDB: 1xwd_C* Length = 350

 Score = 66.0 bits (161), Expect = 9e-12
 Identities = 28/147 (19%), Positives = 54/147 (36%), Gaps = 10/147 (6%)

Query: 97  LYLHYNSLSGEIPKEI-RNLTELTDLYLDVNNLSGNIPPEI-GSMASLQVLQLC-CNQLT 153
           L      L   I K       +L  + +  N++   I  ++  ++  L  +++   N L 
Sbjct: 35  LRFVLTKLR-VIQKGAFSGFGDLEKIEISQNDVLEVIEADVFSNLPKLHEIRIEKANNLL 93

Query: 154 GNIPAQI-GSLKSLSVLTLQHNRLNGGIPD-SLGNLGKLKRLDLSFNSLFGTIPE-SLAN 210
             I  +   +L +L  L + +  +   +PD    +  +   LD+  N    TI   S   
Sbjct: 94  -YINPEAFQNLPNLQYLLISNTGIK-HLPDVHKIHSLQKVLLDIQDNINIHTIERNSFVG 151

Query: 211 -NAELLFLDVQNNTLSGIVPSALKRLN 236
            + E + L +  N +  I  SA     
Sbjct: 152 LSFESVILWLNKNGIQEIHNSAFNGTQ 178

>4ay9_X Follicle-stimulating hormone receptor; hormone-receptor complex, leucine-rich repeats, LRR, GPCR; HET: TYS NAG; 2.50A {Homo sapiens} PDB: 1xwd_C* Length = 350

 Score = 60.2 bits (146), Expect = 7e-10
 Identities = 34/156 (21%), Positives = 56/156 (35%), Gaps = 13/156 (8%)

Query: 89  SGLKCLSGLYL-HYNSLSGEIPKEI-RNLTELTDLYLDVNNLSGNIPPEI-GSMASLQVL 145
           S L  L  + +   N+L   I  E  +NL  L  L +    +  ++P           +L
Sbjct: 76  SNLPKLHEIRIEKANNLL-YINPEAFQNLPNLQYLLISNTGIK-HLPDVHKIHSLQKVLL 133

Query: 146 QLCCNQLTGNIPAQIGSLKSLSV----LTLQHNRLNGGIPDSLGNLGKLKRLDLSFNSLF 201
            +  N     I     S   LS     L L  N +   I +S  N  +L  L+LS N+  
Sbjct: 134 DIQDNINIHTIER--NSFVGLSFESVILWLNKNGIQE-IHNSAFNGTQLDELNLSDNNNL 190

Query: 202 GTIPE-SLANNAELLFLDVQNNTLSGIVPSALKRLN 236
             +P       +  + LD+    +  +    L+ L 
Sbjct: 191 EELPNDVFHGASGPVILDISRTRIHSLPSYGLENLK 226

>4ay9_X Follicle-stimulating hormone receptor; hormone-receptor complex, leucine-rich repeats, LRR, GPCR; HET: TYS NAG; 2.50A {Homo sapiens} PDB: 1xwd_C* Length = 350

 Score = 59.8 bits (145), Expect = 9e-10
 Identities = 22/140 (15%), Positives = 36/140 (25%), Gaps = 6/140 (4%)

Query: 88  LSGLKCLSGLYLHYNSLSGEIPKEI-RNLTELTDLYLDVNNLSGNIPPEI--GSMASLQV 144
              L  L  L +    +   +P     +  +   L +  N     I      G      +
Sbjct: 100 FQNLPNLQYLLISNTGIK-HLPDVHKIHSLQKVLLDIQDNINIHTIERNSFVGLSFESVI 158

Query: 145 LQLCCNQLTGNIPAQI-GSLKSLSVLTLQHNRLNGGIPDSLGNLGKLKRLDLSFNSLFGT 203
           L L  N +   I        +   +    +N L     D          LD+S   +   
Sbjct: 159 LWLNKNGIQ-EIHNSAFNGTQLDELNLSDNNNLEELPNDVFHGASGPVILDISRTRIHSL 217

Query: 204 IPESLANNAELLFLDVQNNT 223
               L N  +L      N  
Sbjct: 218 PSYGLENLKKLRARSTYNLK 237

>4ay9_X Follicle-stimulating hormone receptor; hormone-receptor complex, leucine-rich repeats, LRR, GPCR; HET: TYS NAG; 2.50A {Homo sapiens} PDB: 1xwd_C* Length = 350

 Score = 50.6 bits (121), Expect = 8e-07
 Identities = 23/153 (15%), Positives = 44/153 (28%), Gaps = 10/153 (6%)

Query: 74  SLQGKGLTGKLSPSLSGLKCLSGLYLHYNSLSGEIPKE-IRNLT-ELTDLYLDVNNLSGN 131
            +   G+                L +  N     I +     L+ E   L+L+ N +   
Sbjct: 110 LISNTGIKHLPDVHKIHSLQKVLLDIQDNINIHTIERNSFVGLSFESVILWLNKNGIQ-E 168

Query: 132 IPPEI-GSMASLQVLQLCCNQLTGNIPAQI-GSLKSLSVLTLQHNRLNGGIPDSLGNLGK 189
           I           ++     N L   +P  +        +L +   R++      L NL K
Sbjct: 169 IHNSAFNGTQLDELNLSDNNNLE-ELPNDVFHGASGPVILDISRTRIHSLPSYGLENLKK 227

Query: 190 LKRLDLSFNSLFGTIPESLANNAELLFLDVQNN 222
           L+            +P +L     L+   +   
Sbjct: 228 LRARSTYNLK---KLP-TLEKLVALMEASLTYP 256

>4ay9_X Follicle-stimulating hormone receptor; hormone-receptor complex, leucine-rich repeats, LRR, GPCR; HET: TYS NAG; 2.50A {Homo sapiens} PDB: 1xwd_C* Length = 350

 Score = 42.9 bits (101), Expect = 2e-04
 Identities = 20/97 (20%), Positives = 42/97 (43%), Gaps = 5/97 (5%)

Query: 141 SLQVLQLCCNQLTGNIPAQIGSLKSLSVLTLQHNRLNGGIPDSLGNLGKLKRLDLSFNSL 200
           S +V     +++T  IP+ +   ++   L     +L      +    G L+++++S N +
Sbjct: 10  SNRVFLCQESKVT-EIPSDL--PRNAIELRFVLTKLRVIQKGAFSGFGDLEKIEISQNDV 66

Query: 201 FGTIPES-LANNAELLFLDVQN-NTLSGIVPSALKRL 235
              I     +N  +L  + ++  N L  I P A + L
Sbjct: 67  LEVIEADVFSNLPKLHEIRIEKANNLLYINPEAFQNL 103

>3uc3_A Serine/threonine-protein kinase SRK2I; SNRK2, ABA signaling, transferase; 1.90A {Arabidopsis thaliana} PDB: 3zut_A 3zuu_A 3uc4_A 3ujg_A 3udb_A Length = 361

 Score = 65.8 bits (161), Expect = 1e-11
 Identities = 61/287 (21%), Positives = 108/287 (37%), Gaps = 63/287 (21%)

Query: 414 VNLLGKGNFSSVYKGT-LRDGTLVAIRSINVTSCKSEEAEFVKGLYLLTSLRHENIIRLR 472
           V  +G GNF             LVA++ I   +   E  +  + +    SLRH NI+R +
Sbjct: 25  VKDIGSGNFGVARLMRDKLTKELVAVKYIERGAAIDENVQ--REIINHRSLRHPNIVRFK 82

Query: 473 GFCCSRGRGECFLIYDFAPKGKLSKYLDQEEGSSNVLDWSTRVS----------IIIGIA 522
               +       +I ++A  G+L + +            + R S          ++ G++
Sbjct: 83  EVILTPT--HLAIIMEYASGGELYERICN----------AGRFSEDEARFFFQQLLSGVS 130

Query: 523 KGIGYLHSSEVNKPAIVHRNLSVEKVLIDQQFNPL--IADCGLHKLLADDIVFSVLKTSA 580
               Y HS ++      HR+L +E  L+D    P   I D G  K        S  K++ 
Sbjct: 131 ----YCHSMQI-----CHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLH---SQPKSTV 178

Query: 581 AMG---YLAPEYVTTGRFTE--RSDIFAFGVIILQILTGSLVLTSSMRLAAESATFENFI 635
             G   Y+APE V   +  +   +D+++ GV +  +L G+           E   +   I
Sbjct: 179 --GTPAYIAPE-VLLRQEYDGKIADVWSCGVTLYVMLVGAYPFEDP----EEPRDYRKTI 231

Query: 636 DRNLKGKFSE------SEAAK--LGKMALVCTHEDPENRPTMEAVIE 674
            R L  K+S       S      + ++ +     DP  R ++  +  
Sbjct: 232 QRILSVKYSIPDDIRISPECCHLISRIFVA----DPATRISIPEIKT 274

>3lm5_A Serine/threonine-protein kinase 17B; STK17B, serine/threonine kinase 17B, DRAK2, DAP kinase relat apoptosis-inducing protein kinase 2; HET: QUE; 2.29A {Homo sapiens} PDB: 3lm0_A* Length = 327

 Score = 65.4 bits (160), Expect = 1e-11
 Identities = 60/278 (21%), Positives = 108/278 (38%), Gaps = 47/278 (16%)

Query: 417 LGKGNFSSVYKGTLRD-GTLVAIRSINVTSCKSEEAEFVKG-LYLLTSLRH-ENIIRLRG 473
           LG+G F+ V +   +  G   A + +       +    +   + +L   +    +I L  
Sbjct: 37  LGRGKFAVVRQCISKSTGQEYAAKFLKKRRRGQDCRAEILHEIAVLELAKSCPRVINLHE 96

Query: 474 FCCSRGRGECFLIYDFAPKGKLSKYLDQEEGSSNVLDWSTR--VSIIIGIAKGIGYLHSS 531
              +    E  LI ++A  G++      E         S    + +I  I +G+ YLH +
Sbjct: 97  VYENTS--EIILILEYAAGGEIFSLCLPELAEM----VSENDVIRLIKQILEGVYYLHQN 150

Query: 532 EVNKPAIVHRNLSVEKVLIDQQF--NPL-IADCGLHKLLADDIVFSVLKTSAAMGYLAPE 588
                 IVH +L  + +L+   +    + I D G+ + +        +  +    YLAPE
Sbjct: 151 N-----IVHLDLKPQNILLSSIYPLGDIKIVDFGMSRKIGHACELREIMGTP--EYLAPE 203

Query: 589 YVTTGRFTERSDIFAFGVI--ILQILTGSLVLTSSMRLAAESATFENFIDRNLKGK--FS 644
            +     T  +D++  G+I  +L  LT     TS         T+ N I    +    +S
Sbjct: 204 ILNYDPITTATDMWNIGIIAYML--LTH----TSPFVGEDNQETYLN-I---SQVNVDYS 253

Query: 645 E------SEAAK--LGKMALVCTHEDPENRPTMEAVIE 674
           E      S+ A   +  + LV   ++PE RPT E  + 
Sbjct: 254 EETFSSVSQLATDFIQSL-LV---KNPEKRPTAEICLS 287

>3m19_A Variable lymphocyte receptor A diversity region; adaptive immunity, antibody, T cell, leucine-rich repeat, immune system; 1.70A {Petromyzon marinus} PDB: 3m18_A Length = 251

 Score = 63.6 bits (155), Expect = 2e-11
 Identities = 47/160 (29%), Positives = 61/160 (38%), Gaps = 20/160 (12%)

Query: 97  LYLHYNSLSGEIPKEIRNLTELTDLYLDVNNLSGNIPPEI-GSMASLQVLQLCCNQLTGN 155
           L L    L+       R LT+LT L LD N L   +   +   +  L  L L  NQL  +
Sbjct: 40  LDLQSTGLATLSDATFRGLTKLTWLNLDYNQLQ-TLSAGVFDDLTELGTLGLANNQLA-S 97

Query: 156 IPAQI-GSLKSLSVLTLQHNRLNG---GIPDSLGNLGKLKRLDLSFNSLFGTIPE----S 207
           +P  +   L  L  L L  N+L     G+ D L     LK L L+ N L  +IP      
Sbjct: 98  LPLGVFDHLTQLDKLYLGGNQLKSLPSGVFDRLTK---LKELRLNTNQL-QSIPAGAFDK 153

Query: 208 LANNAELLFLDVQNNTLSGIVPSALKRLNG--GFQFQNNP 245
           L N   L  L +  N L  +   A  RL          N 
Sbjct: 154 LTN---LQTLSLSTNQLQSVPHGAFDRLGKLQTITLFGNQ 190

>3m19_A Variable lymphocyte receptor A diversity region; adaptive immunity, antibody, T cell, leucine-rich repeat, immune system; 1.70A {Petromyzon marinus} PDB: 3m18_A Length = 251

 Score = 60.1 bits (146), Expect = 3e-10
 Identities = 44/143 (30%), Positives = 61/143 (42%), Gaps = 7/143 (4%)

Query: 72  NISLQGKGLTGKLSPSLSGLKCLSGLYLHYNSLSGEIPKEIRNLTELTDLYLDVNNLSGN 131
            + LQ  GL      +  GL  L+ L L YN L         +LTEL  L L  N L+ +
Sbjct: 39  KLDLQSTGLATLSDATFRGLTKLTWLNLDYNQLQTLSAGVFDDLTELGTLGLANNQLA-S 97

Query: 132 IPPEI-GSMASLQVLQLCCNQLTGNIPAQI-GSLKSLSVLTLQHNRLNGGIPDSL-GNLG 188
           +P  +   +  L  L L  NQL   +P+ +   L  L  L L  N+L   IP      L 
Sbjct: 98  LPLGVFDHLTQLDKLYLGGNQLKS-LPSGVFDRLTKLKELRLNTNQLQ-SIPAGAFDKLT 155

Query: 189 KLKRLDLSFNSLFGTIPESLANN 211
            L+ L LS N L  ++P    + 
Sbjct: 156 NLQTLSLSTNQL-QSVPHGAFDR 177

>3m19_A Variable lymphocyte receptor A diversity region; adaptive immunity, antibody, T cell, leucine-rich repeat, immune system; 1.70A {Petromyzon marinus} PDB: 3m18_A Length = 251

 Score = 51.6 bits (124), Expect = 2e-07
 Identities = 43/171 (25%), Positives = 64/171 (37%), Gaps = 25/171 (14%)

Query: 108 IPKEIRNLTELTDLYLDVNNLSGNIPPEIGSMASLQVLQLCCNQLTGNIPAQI-GSLKSL 166
           +P  I    +   L L    L+         +  L  L L  NQL   + A +   L  L
Sbjct: 29  VPSGIP--ADTEKLDLQSTGLATLSDATFRGLTKLTWLNLDYNQLQ-TLSAGVFDDLTEL 85

Query: 167 SVLTLQHNRLN---GGIPDSLGNLGKLKRLDLSFNSLFGTIPE----SLANNAELLFLDV 219
             L L +N+L     G+ D    L +L +L L  N L  ++P      L     L  L +
Sbjct: 86  GTLGLANNQLASLPLGVFDH---LTQLDKLYLGGNQL-KSLPSGVFDRLTK---LKELRL 138

Query: 220 QNNTLSGIVPSA------LKRLN-GGFQFQNNPGLCGDGIASLRACTVYDN 263
             N L  I   A      L+ L+    Q Q+ P    D +  L+  T++ N
Sbjct: 139 NTNQLQSIPAGAFDKLTNLQTLSLSTNQLQSVPHGAFDRLGKLQTITLFGN 189

>1nxk_A MAP kinase-activated protein kinase 2; MK2, phosphorylation, staurosporine, transfe; HET: STU; 2.70A {Homo sapiens} SCOP: d.144.1.7 PDB: 1kwp_A* 1ny3_A* 2onl_C Length = 400

 Score = 64.8 bits (158), Expect = 4e-11
 Identities = 58/283 (20%), Positives = 103/283 (36%), Gaps = 56/283 (19%)

Query: 417 LGKGNFSSVYKGTLRD-GTLVAIRSINVTSCKSEEAEFVKGLYLLTSLRHENIIRLRGFC 475
           LG G    V +   +      A++ +        E E         + +  +I+R+    
Sbjct: 70  LGLGINGKVLQIFNKRTQEKFALKMLQDCPKARREVEL-----HWRASQCPHIVRIVDVY 124

Query: 476 --CSRGRGECFLIYDFAPKGKLSKYLD--QEEGSSNVLDWSTR--VSIIIGIAKGIGYLH 529
                GR    ++ +    G+L       Q+ G      ++ R    I+  I + I YLH
Sbjct: 125 ENLYAGRKCLLIVMECLDGGEL---FSRIQDRGDQA---FTEREASEIMKSIGEAIQYLH 178

Query: 530 SSEVNKPAIVHRNLSVEKVL-IDQQFNPL--IADCGLHKLLADDIVFSVLKT---SAAMG 583
           S       I HR++  E +L   ++ N +  + D G  K        + L T   +    
Sbjct: 179 SIN-----IAHRDVKPENLLYTSKRPNAILKLTDFGFAKETTSH---NSLTTPCYTP--Y 228

Query: 584 YLAPEYVTTGRFTERSDIFAFGVI--ILQILTGSLVLTSSMRLAAESATFENFIDRNLKG 641
           Y+APE +   ++ +  D+++ GVI  IL  L G     S+  LA           R   G
Sbjct: 229 YVAPEVLGPEKYDKSCDMWSLGVIMYIL--LCGYPPFYSNHGLAISPGMKT----RIRMG 282

Query: 642 KF---SE-----SEAAK--LGKMALVCTHEDPENRPTMEAVIE 674
           ++   +      SE  K  +  + L     +P  R T+   + 
Sbjct: 283 QYEFPNPEWSEVSEEVKMLIRNL-LKT---EPTQRMTITEFMN 321

>1uu3_A HPDK1, 3-phosphoinositide dependent protein kinase-1; PKB, inhibitor, LY333531, diabetes, cancer, transferase, serine/threonine-protein kinase; HET: SEP LY4; 1.7A {Homo sapiens} SCOP: d.144.1.7 PDB: 1okz_A* 1oky_A* 1uu7_A* 1uu8_A* 2biy_A* 3rwp_A* 2xch_A* 3rwq_A* 3sc1_A* 3qd0_A* 2r7b_A* 3ion_A* 3qcq_A* 3qcs_A* 3qcx_A* 3qcy_A* 3iop_A* 3qd3_A* 3qd4_A* 3h9o_A* ... Length = 310

 Score = 63.8 bits (156), Expect = 4e-11
 Identities = 49/218 (22%), Positives = 96/218 (44%), Gaps = 31/218 (14%)

Query: 409 QCFSEVNLLGKGNFSSVYKGTLRD-GTLVAIRSINVTSCKSE-----EAEFVKG-LYLLT 461
           + F    +LG+G+FS+V            AI+ +     K       +  +V     +++
Sbjct: 30  EDFKFGKILGEGSFSTVVLARELATSREYAIKILE----KRHIIKENKVPYVTRERDVMS 85

Query: 462 SLRHENIIRLRGFCCSRGRGECFLIYDFAPKGKLSKYLDQEEGSSNVLDWSTRVSIIIG- 520
            L H   ++L        +   +    +A  G+L KY+ ++ GS     +    +     
Sbjct: 86  RLDHPFFVKLYFTFQDDEK--LYFGLSYAKNGELLKYI-RKIGS-----FDETCTRFYTA 137

Query: 521 -IAKGIGYLHSSEVNKPAIVHRNLSVEKVLIDQQFNPLIADCGLHKLLADDIVFSVLKTS 579
            I   + YLH        I+HR+L  E +L+++  +  I D G  K+L+ +   +  + +
Sbjct: 138 EIVSALEYLHGKG-----IIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQA--RAN 190

Query: 580 AAMG---YLAPEYVTTGRFTERSDIFAFGVIILQILTG 614
           + +G   Y++PE +T     + SD++A G II Q++ G
Sbjct: 191 SFVGTAQYVSPELLTEKSACKSSDLWALGCIIYQLVAG 228

>2dyl_A Dual specificity mitogen-activated protein kinase kinase 7; MKK7, activated mutant, ATP-binding, structural genomics, NPPSFA; 2.45A {Homo sapiens} Length = 318

 Score = 63.5 bits (155), Expect = 5e-11
 Identities = 57/329 (17%), Positives = 112/329 (34%), Gaps = 92/329 (27%)

Query: 379 PLGDYLNGTGFSREHLNSFRLNLEEVESATQCFSEVNLLGKGNFSSVYKGT-LRDGTLVA 437
             G     TG+       ++  + ++E        +  +G G    V+K    + G ++A
Sbjct: 2   SSGSSGKQTGYLTIGGQRYQAEINDLE-------NLGEMGSGTCGQVWKMRFRKTGHVIA 54

Query: 438 IRSINVTSCKSEEAEFVKGL-YLLTSLRHENIIRLRGFCCSRGRGECFLIYDFAPKGKLS 496
           ++ +  +  K E    +  L  +L S     I++      +           F     + 
Sbjct: 55  VKQMRRSGNKEENKRILMDLDVVLKSHDCPYIVQ---CFGT-----------FITNTDVF 100

Query: 497 ---KYLDQEEGSSNVLDWSTRVSI---IIG-----IAKGIGYLHSSEVNKPAIVHRNLSV 545
              + +      +  L    +  I   I+G     I K + YL      K  ++HR++  
Sbjct: 101 IAMELMG---TCAEKLKKRMQGPIPERILGKMTVAIVKALYYLKE----KHGVIHRDVKP 153

Query: 546 EKVLIDQQFNPLIADCGLHKLLADDIVFSVLKTSAAMG---YLAPE-----YVTTGRFTE 597
             +L+D++    + D G+   L D       K  +A G   Y+APE       T   +  
Sbjct: 154 SNILLDERGQIKLCDFGISGRLVD----DKAKDRSA-GCAAYMAPERIDPPDPTKPDYDI 208

Query: 598 RSDIFAFGVIILQILTG--------------SLVLTSSM-RLAAE---SATFENFIDRNL 639
           R+D+++ G+ ++++ TG              + VL      L      S  F++F+    
Sbjct: 209 RADVWSLGISLVELATGQFPYKNCKTDFEVLTKVLQEEPPLLPGHMGFSGDFQSFVKD-- 266

Query: 640 KGKFSESEAAKLGKMALVCTHEDPENRPT 668
                             C  +D   RP 
Sbjct: 267 ------------------CLTKDHRKRPK 277

>3rgf_A Cyclin-dependent kinase 8; protein kinase complex, transferase,transcription; HET: BAX; 2.20A {Homo sapiens} Length = 405

 Score = 64.0 bits (156), Expect = 5e-11
 Identities = 39/159 (24%), Positives = 65/159 (40%), Gaps = 21/159 (13%)

Query: 417 LGKGNFSSVYKGTLRD---GTLVAIRSINVTSCKSEEAEFVKGLYLLTSLRHENIIRLRG 473
           +G+G +  VYK   +D       A++ I  T          + + LL  L+H N+I L+ 
Sbjct: 29  VGRGTYGHVYKAKRKDGKDDKDYALKQIEGTGISMSA---CREIALLRELKHPNVISLQK 85

Query: 474 FCCSRGRGECFLIYDFAPKGKLSKYLDQEEGSSN-----VLDWSTRVSIIIGIAKGIGYL 528
              S    + +L++D+A    L   +     S        L      S++  I  GI YL
Sbjct: 86  VFLSHADRKVWLLFDYAEH-DLWHIIKFHRASKANKKPVQLPRGMVKSLLYQILDGIHYL 144

Query: 529 HSSEVNKPAIVHRNLSVEKVLIDQQFNPL----IADCGL 563
           H+   N   ++HR+L    +L+  +        IAD G 
Sbjct: 145 HA---NW--VLHRDLKPANILVMGEGPERGRVKIADMGF 178

>3fme_A Dual specificity mitogen-activated protein kinase; active mutant, structural genomics consortium, SCG, binding, nucleotide-binding, phosphoprotein; HET: STU; 2.26A {Homo sapiens} PDB: 3enm_A Length = 290

 Score = 63.0 bits (154), Expect = 5e-11
 Identities = 58/299 (19%), Positives = 112/299 (37%), Gaps = 65/299 (21%)

Query: 396 SFRLNLEEVESATQCFSEVNLLGKGNFSSVYKGTLR-DGTLVAIRSINVTSCKSEEAEFV 454
           S  +  +++E        +  LG+G +  V K      G ++A++ I  T    E+   +
Sbjct: 1   SMEVKADDLE-------PIMELGRGAYGVVEKMRHVPSGQIMAVKRIRATVNSQEQKRLL 53

Query: 455 KGL-YLLTSLRHENIIRLRGFCCSRGRGECFLIYDFAPKGKLSKYLDQEEGSSNVLDWST 513
             L   + ++     +   G       G+ ++  +      L K+  Q       +    
Sbjct: 54  MDLDISMRTVDCPFTVTFYG--ALFREGDVWICMELMD-TSLDKFYKQVIDKGQTIPEDI 110

Query: 514 RVSIIIGIAKGIGYLHSSEVNKPAIVHRNLSVEKVLIDQQFNPLIADCGLHKLLADDIVF 573
              I + I K + +LHS    K +++HR++    VLI+      + D G+   L D    
Sbjct: 111 LGKIAVSIVKALEHLHS----KLSVIHRDVKPSNVLINALGQVKMCDFGISGYLVD---- 162

Query: 574 SVLKTSAAMG---YLAPE----YVTTGRFTERSDIFAFGVIILQILTGS----------- 615
            V K   A G   Y+APE     +    ++ +SDI++ G+ ++++               
Sbjct: 163 DVAKDIDA-GCKPYMAPERINPELNQKGYSVKSDIWSLGITMIELAILRFPYDSWGTPFQ 221

Query: 616 ----LVLTSSMRLAAE--SATFENFIDRNLKGKFSESEAAKLGKMALVCTHEDPENRPT 668
               +V   S +L A+  SA F +F  +                    C  ++ + RPT
Sbjct: 222 QLKQVVEEPSPQLPADKFSAEFVDFTSQ--------------------CLKKNSKERPT 260

>3e6j_A Variable lymphocyte receptor diversity region; variable lymphocyte receptors, VLR, leucine-rich repeat, LRR adaptive immunity, immune system; HET: DR2; 1.67A {Petromyzon marinus} Length = 229

 Score = 62.0 bits (151), Expect = 5e-11
 Identities = 36/106 (33%), Positives = 50/106 (47%), Gaps = 5/106 (4%)

Query: 97  LYLHYNSLSGEIPKEIRNLTELTDLYLDVNNLSGNIPPEI-GSMASLQVLQLCCNQLTGN 155
           LYLH N ++   P    +L  L +LYL  N L   +P  +  S+  L VL L  NQLT  
Sbjct: 45  LYLHDNQITKLEPGVFDSLINLKELYLGSNQLG-ALPVGVFDSLTQLTVLDLGTNQLT-V 102

Query: 156 IPAQI-GSLKSLSVLTLQHNRLNGGIPDSLGNLGKLKRLDLSFNSL 200
           +P+ +   L  L  L +  N+L   +P  +  L  L  L L  N L
Sbjct: 103 LPSAVFDRLVHLKELFMCCNKLT-ELPRGIERLTHLTHLALDQNQL 147

>3e6j_A Variable lymphocyte receptor diversity region; variable lymphocyte receptors, VLR, leucine-rich repeat, LRR adaptive immunity, immune system; HET: DR2; 1.67A {Petromyzon marinus} Length = 229

 Score = 56.6 bits (137), Expect = 3e-09
 Identities = 38/129 (29%), Positives = 55/129 (42%), Gaps = 5/129 (3%)

Query: 72  NISLQGKGLTGKLSPSLSGLKCLSGLYLHYNSLSGEIPKEI-RNLTELTDLYLDVNNLSG 130
            + L    +T         L  L  LYL  N L   +P  +  +LT+LT L L  N L+ 
Sbjct: 44  ILYLHDNQITKLEPGVFDSLINLKELYLGSNQLG-ALPVGVFDSLTQLTVLDLGTNQLT- 101

Query: 131 NIPPEI-GSMASLQVLQLCCNQLTGNIPAQIGSLKSLSVLTLQHNRLNGGIPDSLGNLGK 189
            +P  +   +  L+ L +CCN+LT  +P  I  L  L+ L L  N+L      +   L  
Sbjct: 102 VLPSAVFDRLVHLKELFMCCNKLT-ELPRGIERLTHLTHLALDQNQLKSIPHGAFDRLSS 160

Query: 190 LKRLDLSFN 198
           L    L  N
Sbjct: 161 LTHAYLFGN 169

>3e6j_A Variable lymphocyte receptor diversity region; variable lymphocyte receptors, VLR, leucine-rich repeat, LRR adaptive immunity, immune system; HET: DR2; 1.67A {Petromyzon marinus} Length = 229

 Score = 51.6 bits (124), Expect = 2e-07
 Identities = 38/124 (30%), Positives = 52/124 (41%), Gaps = 9/124 (7%)

Query: 116 TELTDLYLDVNNLSGNIPPEIGSMASLQVLQLCCNQLTGNIPAQI-GSLKSLSVLTLQHN 174
           T    LYL  N ++   P    S+ +L+ L L  NQL   +P  +  SL  L+VL L  N
Sbjct: 40  TNAQILYLHDNQITKLEPGVFDSLINLKELYLGSNQLG-ALPVGVFDSLTQLTVLDLGTN 98

Query: 175 RLNG---GIPDSLGNLGKLKRLDLSFNSLFGTIPESLANNAELLFLDVQNNTLSGIVPSA 231
           +L      + D    L  LK L +  N L   +P  +     L  L +  N L  I   A
Sbjct: 99  QLTVLPSAVFDR---LVHLKELFMCCNKL-TELPRGIERLTHLTHLALDQNQLKSIPHGA 154

Query: 232 LKRL 235
             RL
Sbjct: 155 FDRL 158

>3kn6_A Ribosomal protein S6 kinase alpha-5; AMP-PNP, MSK1, MSK, ATP-binding, metal-binding, NUCL binding, serine/threonine-protein kinase, transferase; 2.00A {Homo sapiens} PDB: 3kn5_A Length = 325

 Score = 63.5 bits (155), Expect = 6e-11
 Identities = 66/278 (23%), Positives = 112/278 (40%), Gaps = 46/278 (16%)

Query: 417 LGKGNFSSVYKGTLRD-GTLVAIRSINVTSCKSEEAEFVKGLYLLTSLR-HENIIRLRGF 474
           LG+G+FS   K   +      A++ I+    K  EA   K +  L     H NI++L   
Sbjct: 19  LGEGSFSICRKCVHKKSNQAFAVKIIS----KRMEANTQKEITALKLCEGHPNIVKLHEV 74

Query: 475 CCSRGRGECFLIYDFAPKGKLSKYLD--QEEGSSNVLDWSTRVSIIIGIAKGIGYLHSSE 532
              +     FL+ +    G+L    +  +++   +  + S    I+  +   + ++H   
Sbjct: 75  FHDQLH--TFLVMELLNGGEL---FERIKKKKHFSETEAS---YIMRKLVSAVSHMHDVG 126

Query: 533 VNKPAIVHRNLSVEKVL-IDQQFNPL--IADCGLHKLLADDIVFSVLKT---SAAMGYLA 586
                +VHR+L  E +L  D+  N    I D G  +L   D     LKT   +    Y A
Sbjct: 127 -----VVHRDLKPENLLFTDENDNLEIKIIDFGFARLKPPDN--QPLKTPCFTL--HYAA 177

Query: 587 PEYVTTGRFTERSDIFAFGVIILQILTGSLVLTSSMRLAAESATFENFIDRNLKGKF--- 643
           PE +    + E  D+++ GVI+  +L+G +   S  R    ++  E    +  KG F   
Sbjct: 178 PELLNQNGYDESCDLWSLGVILYTMLSGQVPFQSHDRSLTCTSAVEIM-KKIKKGDFSFE 236

Query: 644 SE-----SEAAK--LGKMALVCTHEDPENRPTMEAVIE 674
            E     S+ AK  +  + L     DP  R  M  +  
Sbjct: 237 GEAWKNVSQEAKDLIQGL-LTV---DPNKRLKMSGLRY 270

>3com_A Serine/threonine-protein kinase 4; MST1, STE20-like kinase, PSI, structural genomics, protein structure initiative; HET: TPO; 2.20A {Homo sapiens} Length = 314

 Score = 62.8 bits (153), Expect = 8e-11
 Identities = 52/282 (18%), Positives = 114/282 (40%), Gaps = 58/282 (20%)

Query: 408 TQCFSEVNLLGKGNFSSVYKGT-LRDGTLVAIRSINVTSCKSEEAEFVKGLYLLTSLRHE 466
            + F  +  LG+G++ SVYK      G +VAI+ + V   +S+  E +K + ++      
Sbjct: 28  EEVFDVLEKLGEGSYGSVYKAIHKETGQIVAIKQVPV---ESDLQEIIKEISIMQQCDSP 84

Query: 467 NIIRLRGFCCSRGRGECFLIYDFAPKGKLSKYLDQEEGSSNVLDWSTRVSIIIGIAKGIG 526
           ++++  G    +   + +++ ++   G +S   D     +  L      +I+    KG+ 
Sbjct: 85  HVVKYYG-SYFKN-TDLWIVMEYCGAGSVS---DIIRLRNKTLTEDEIATILQSTLKGLE 139

Query: 527 YLHSSEVNKPAIVHRNLSVEKVLIDQQFNPLIADCGLHKLLADDIVFSVLKTSAAMG--- 583
           YLH         +HR++    +L++ + +  +AD G+   L D    ++ K +  +G   
Sbjct: 140 YLHFMR-----KIHRDIKAGNILLNTEGHAKLADFGVAGQLTD----TMAKRNTVIGTPF 190

Query: 584 YLAPEYVTTGRFTERSDIFAFGVIILQILTGS-----------LVLTSSM---RLAAE-- 627
           ++APE +    +   +DI++ G+  +++  G            + +  +           
Sbjct: 191 WMAPEVIQEIGYNCVADIWSLGITAIEMAEGKPPYADIHPMRAIFMIPTNPPPTFRKPEL 250

Query: 628 -SATFENFIDRNLKGKFSESEAAKLGKMALVCTHEDPENRPT 668
            S  F +F+ +                    C  + PE R T
Sbjct: 251 WSDNFTDFVKQ--------------------CLVKSPEQRAT 272

>2wfh_A SLIT homolog 2 protein C-product; developmental protein, neurogenesis, splicing, glycoprotein, leucine-rich repeat, disulfide bond, differentiation; 1.80A {Homo sapiens} Length = 193

 Score = 60.8 bits (148), Expect = 8e-11
 Identities = 33/105 (31%), Positives = 52/105 (49%), Gaps = 7/105 (6%)

Query: 97  LYLHYNSLSGEIPKEIRNLTELTDLYLDVNNLSGNIPPEI-GSMASLQVLQLCCNQLTGN 155
           LYL  N  +  +PKE+ N   LT + L  N +S  +  +   +M  L  L L  N+L   
Sbjct: 36  LYLDGNQFT-LVPKELSNYKHLTLIDLSNNRIS-TLSNQSFSNMTQLLTLILSYNRLR-C 92

Query: 156 IPAQI-GSLKSLSVLTLQHNRLNGGIPD-SLGNLGKLKRLDLSFN 198
           IP +    LKSL +L+L  N ++  +P+ +  +L  L  L +  N
Sbjct: 93  IPPRTFDGLKSLRLLSLHGNDIS-VVPEGAFNDLSALSHLAIGAN 136

>2wfh_A SLIT homolog 2 protein C-product; developmental protein, neurogenesis, splicing, glycoprotein, leucine-rich repeat, disulfide bond, differentiation; 1.80A {Homo sapiens} Length = 193

 Score = 46.5 bits (111), Expect = 7e-06
 Identities = 31/102 (30%), Positives = 46/102 (45%), Gaps = 5/102 (4%)

Query: 75  LQGKGLTGKLSPSLSGLKCLSGLYLHYNSLSGEIPKEIRNLTELTDLYLDVNNLSGNIPP 134
           L G   T  +   LS  K L+ + L  N +S    +   N+T+L  L L  N L   IPP
Sbjct: 38  LDGNQFT-LVPKELSNYKHLTLIDLSNNRISTLSNQSFSNMTQLLTLILSYNRLR-CIPP 95

Query: 135 EI-GSMASLQVLQLCCNQLTGNIPAQI-GSLKSLSVLTLQHN 174
                + SL++L L  N ++  +P      L +LS L +  N
Sbjct: 96  RTFDGLKSLRLLSLHGNDIS-VVPEGAFNDLSALSHLAIGAN 136

>3gni_B Strad alpha; kinase fold, pseudokinase, alpha helical repeat protein, ADA protein, ATP-binding, cell cycle, kinase, nucleotide-bindin nucleus; HET: ATP CIT; 2.35A {Homo sapiens} PDB: 2wtk_B* Length = 389

 Score = 63.0 bits (153), Expect = 1e-10
 Identities = 43/237 (18%), Positives = 88/237 (37%), Gaps = 21/237 (8%)

Query: 390 SREHLNSFRLNLEEVESATQCFSEVNLLGKG--NFSSVYKGT-LRDGTLVAIRSINVTSC 446
                N +   +        C+  + ++GKG  +  +V        G  V +R IN+ +C
Sbjct: 6   HHHMENLYFQGMSSFLPEGGCYELLTVIGKGFEDLMTVNLARYKPTGEYVTVRRINLEAC 65

Query: 447 KSEEAEFVKG-LYLLTSLRHENIIRLRGFCCSRGRGECFLIYDFAPKGKLSKYLDQEEGS 505
            +E   F++G L++     H NI+            E +++  F   G     +      
Sbjct: 66  SNEMVTFLQGELHVSKLFNHPNIVPY--RATFIADNELWVVTSFMAYGSAKDLI--CTHF 121

Query: 506 SNVLDWSTRVSIIIGIAKGIGYLHSSEVNKPAIVHRNLSVEKVLIDQQFNPLIADCGLHK 565
            + ++      I+ G+ K + Y+H         VHR++    +LI       ++    + 
Sbjct: 122 MDGMNELAIAYILQGVLKALDYIHHMGY-----VHRSVKASHILISVDGKVYLSGLRSNL 176

Query: 566 LLADDI-----VFSVLKTSAAMGY-LAPEYVTTGR--FTERSDIFAFGVIILQILTG 614
            +         V    K S  +   L+PE +      +  +SDI++ G+   ++  G
Sbjct: 177 SMISHGQRQRVVHDFPKYSVKVLPWLSPEVLQQNLQGYDAKSDIYSVGITACELANG 233

>4e7w_A Glycogen synthase kinase 3; GSK3, PTyr195, transferase; HET: PTR; 3.30A {Ustilago maydis} Length = 394

 Score = 62.7 bits (153), Expect = 1e-10
 Identities = 32/164 (19%), Positives = 71/164 (43%), Gaps = 20/164 (12%)

Query: 411 FSEVNLLGKGNFSSVYKGTLRDGTLVAIRSINVTSCKSEEAEFVKG--LYLLTSLRHENI 468
           ++   ++G G+F  V++  L +   VAI+ +       ++  F K   L ++  ++H N+
Sbjct: 42  YTNCKVIGNGSFGVVFQAKLVESDEVAIKKV------LQDKRF-KNRELQIMRIVKHPNV 94

Query: 469 IRLRGFCCSRGRGECF----LIYDFAPKGKLSKYLDQEEGSSNVLDWSTRVSIIIGIAKG 524
           + L+ F  S G  +      L+ ++ P+  + +           +        +  + + 
Sbjct: 95  VDLKAFFYSNGDKKDEVFLNLVLEYVPE-TVYRASRHYAKLKQTMPMLLIKLYMYQLLRS 153

Query: 525 IGYLHSSEVNKPAIVHRNLSVEKVLIDQQFNPL-IADCGLHKLL 567
           + Y+HS       I HR++  + +L+D     L + D G  K+L
Sbjct: 154 LAYIHSI-----GICHRDIKPQNLLLDPPSGVLKLIDFGSAKIL 192

>2x7f_A TRAF2 and NCK-interacting protein kinase; serine/threonine-protein kinase, phosphoprotein; HET: 824; 2.80A {Homo sapiens} Length = 326

 Score = 62.0 bits (151), Expect = 2e-10
 Identities = 64/303 (21%), Positives = 121/303 (39%), Gaps = 63/303 (20%)

Query: 398 RLNLEEVESATQCFSEVNLLGKGNFSSVYKGT-LRDGTLVAIRSINVTSCKSEEAEFVKG 456
            ++L  +      F  V L+G G +  VYKG  ++ G L AI+ ++VT    EE E  + 
Sbjct: 13  EIDLSALRDPAGIFELVELVGNGTYGQVYKGRHVKTGQLAAIKVMDVTG--DEEEEIKQE 70

Query: 457 LYLLTSL-RHENIIRLRG----FCCSRGRGECFLIYDFAPKGKLSKYLDQEEGSSNVLDW 511
           + +L     H NI    G            + +L+ +F   G ++  +   +G  N L  
Sbjct: 71  INMLKKYSHHRNIATYYGAFIKKNPPGMDDQLWLVMEFCGAGSVTDLIKNTKG--NTLKE 128

Query: 512 STRVSIIIGIAKGIGYLHSSEVNKPAIVHRNLSVEKVLIDQQFNPLIADCGLHKLLADDI 571
                I   I +G+ +LH  +V     +HR++  + VL+ +     + D G+   L    
Sbjct: 129 EWIAYICREILRGLSHLHQHKV-----IHRDIKGQNVLLTENAEVKLVDFGVSAQLDR-- 181

Query: 572 VFSVLKTSAAMG---YLAPEYVTTGRFTE-----RSDIFAFGVIILQILTGS--LVLTSS 621
             +V + +  +G   ++APE +      +     +SD+++ G+  +++  G+  L     
Sbjct: 182 --TVGRRNTFIGTPYWMAPEVIACDENPDATYDFKSDLWSLGITAIEMAEGAPPLCDMHP 239

Query: 622 MR------------LAAE--SATFENFIDRNLKGKFSESEAAKLGKMALVCTHEDPENRP 667
           MR            L ++  S  F++FI+                     C  ++   RP
Sbjct: 240 MRALFLIPRNPAPRLKSKKWSKKFQSFIES--------------------CLVKNHSQRP 279

Query: 668 TME 670
             E
Sbjct: 280 ATE 282

>3aln_A Dual specificity mitogen-activated protein kinase; protein AMP-PNP complex, transferase; HET: ANP; 2.30A {Homo sapiens} PDB: 3alo_A* Length = 327

 Score = 61.6 bits (150), Expect = 2e-10
 Identities = 58/302 (19%), Positives = 115/302 (38%), Gaps = 67/302 (22%)

Query: 396 SFRLNLEEVESATQCFSEVNLLGKGNFSSVYKGT-LRDGTLVAIRSINVTSCKSEEAEFV 454
            +    E+++       ++  +G+G + SV K      G ++A++ I  T  + E+ + +
Sbjct: 16  HWDFTAEDLK-------DLGEIGRGAYGSVNKMVHKPSGQIMAVKRIRSTVDEKEQKQLL 68

Query: 455 KGLY-LLTSLRHENIIRLRGFCCSRGRGECFLIYDFAPKGKLSKYLDQEEGSSNVLDWST 513
             L  ++ S     I++  G    R  G+C++  +         Y        +V+    
Sbjct: 69  MDLDVVMRSSDCPYIVQFYG-ALFRE-GDCWICMELMSTSFDKFYKYVYSVLDDVIPEEI 126

Query: 514 RVSIIIGIAKGIGYLHSSEVNKPAIVHRNLSVEKVLIDQQFNPLIADCGLHKLLADDIVF 573
              I +   K + +L         I+HR++    +L+D+  N  + D G+   L D    
Sbjct: 127 LGKITLATVKALNHLKE----NLKIIHRDIKPSNILLDRSGNIKLCDFGISGQLVD---- 178

Query: 574 SVLKTSAAMG---YLAPE----YVTTGRFTERSDIFAFGVIILQILTG------------ 614
           S+ KT  A G   Y+APE      +   +  RSD+++ G+ + ++ TG            
Sbjct: 179 SIAKTRDA-GCRPYMAPERIDPSASRQGYDVRSDVWSLGITLYELATGRFPYPKWNSVFD 237

Query: 615 --SLVLTSSM-RLAAE-----SATFENFIDRNLKGKFSESEAAKLGKMALVCTHEDPENR 666
             + V+     +L+       S +F NF++                     C  +D   R
Sbjct: 238 QLTQVVKGDPPQLSNSEEREFSPSFINFVNL--------------------CLTKDESKR 277

Query: 667 PT 668
           P 
Sbjct: 278 PK 279

>4aaa_A Cyclin-dependent kinase-like 2; transferase, phospho-mimetic; HET: DKI; 1.53A {Homo sapiens} Length = 331

 Score = 61.1 bits (149), Expect = 3e-10
 Identities = 42/161 (26%), Positives = 76/161 (47%), Gaps = 21/161 (13%)

Query: 409 QCFSEVNLLGKGNFSSVYKGTLRD-GTLVAIRSINVTSCKSEEAEFVKG-----LYLLTS 462
           + +  + L+G+G++  V K   +D G +VAI+        S++ + VK      + LL  
Sbjct: 25  EKYENLGLVGEGSYGMVMKCRNKDTGRIVAIKKFLE----SDDDKMVKKIAMREIKLLKQ 80

Query: 463 LRHENIIRLRGFCCSRGRGECFLIYDFAPKGKLSKYLDQEEGSSNVLDWSTRVSIIIGIA 522
           LRHEN++ L   C  + +   +L+++F     +   L+      N LD+      +  I 
Sbjct: 81  LRHENLVNLLEVC--KKKKRWYLVFEFVDH-TILDDLEL---FPNGLDYQVVQKYLFQII 134

Query: 523 KGIGYLHSSEVNKPAIVHRNLSVEKVLIDQQFNPLIADCGL 563
            GIG+ HS   +   I+HR++  E +L+ Q     + D G 
Sbjct: 135 NGIGFCHS---HN--IIHRDIKPENILVSQSGVVKLCDFGF 170

>3gbz_A Kinase, CMGC CDK; ssgcid, ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; 1.85A {Giardia lamblia} PDB: 3gc0_A* Length = 329

 Score = 60.3 bits (147), Expect = 6e-10
 Identities = 42/188 (22%), Positives = 72/188 (38%), Gaps = 33/188 (17%)

Query: 390 SREHLNSFRLNLEEVESATQCFSEVNLLGKGNFSSVYKGT-LRDGTLVAIRSINVTSCKS 448
             +   S  ++     ++   +  +  LG+G +  VYK         VAI+ I +     
Sbjct: 15  QTQGPGSMSVSAAPSATSIDRYRRITKLGEGTYGEVYKAIDTVTNETVAIKRIRL----E 70

Query: 449 EEAEFVKGL--------YLLTSLRHENIIRLRGFCCSRGRGECFLIYDFAPKGKLSKYLD 500
            E E   G+         LL  L+H NII L+       R    LI+++A    L KY+D
Sbjct: 71  HEEE---GVPGTAIREVSLLKELQHRNIIELKSVIHHNHR--LHLIFEYAEN-DLKKYMD 124

Query: 501 QEEGSSNVLDWSTRVSIIIGIAKGIGYLHSSEVNKPAIVHRNLSVEKVLIDQQFNPL--- 557
                +  +      S +  +  G+ + HS    +   +HR+L  + +L+          
Sbjct: 125 ----KNPDVSMRVIKSFLYQLINGVNFCHS---RR--CLHRDLKPQNLLLSVSDASETPV 175

Query: 558 --IADCGL 563
             I D GL
Sbjct: 176 LKIGDFGL 183

>2o6s_A Variable lymphocyte receptor B; leucine-rich repeat protein, LRR, immune system; 1.50A {Eptatretus burgeri} Length = 208

 Score = 58.1 bits (141), Expect = 9e-10
 Identities = 38/109 (34%), Positives = 47/109 (43%), Gaps = 10/109 (9%)

Query: 97  LYLHYNSLSGEIPKEIRNLTELTDLYLDVNNLSGNIPPEI-GSMASLQVLQLCCNQLTGN 155
           L L  NSL          LT LT LYL  N L  ++P  +   + SL  L L  NQL  +
Sbjct: 33  LDLETNSLKSLPNGVFDELTSLTQLYLGGNKLQ-SLPNGVFNKLTSLTYLNLSTNQLQ-S 90

Query: 156 IPAQI-GSLKSLSVLTLQHNRLN---GGIPDSLGNLGKLKRLDLSFNSL 200
           +P  +   L  L  L L  N+L     G+ D L     LK L L  N L
Sbjct: 91  LPNGVFDKLTQLKELALNTNQLQSLPDGVFDKLTQ---LKDLRLYQNQL 136

>2o6s_A Variable lymphocyte receptor B; leucine-rich repeat protein, LRR, immune system; 1.50A {Eptatretus burgeri} Length = 208

 Score = 54.3 bits (131), Expect = 2e-08
 Identities = 37/130 (28%), Positives = 53/130 (40%), Gaps = 6/130 (4%)

Query: 72  NISLQGKGLTGKLSPSLSGLKCLSGLYLHYNSLSGEIPKEIRNLTELTDLYLDVNNLSGN 131
            + L+   L    +     L  L+ LYL  N L          LT LT L L  N L  +
Sbjct: 32  YLDLETNSLKSLPNGVFDELTSLTQLYLGGNKLQSLPNGVFNKLTSLTYLNLSTNQLQ-S 90

Query: 132 IPPEI-GSMASLQVLQLCCNQLTGNIPAQI-GSLKSLSVLTLQHNRLNGGIPD-SLGNLG 188
           +P  +   +  L+ L L  NQL  ++P  +   L  L  L L  N+L   +PD     L 
Sbjct: 91  LPNGVFDKLTQLKELALNTNQLQ-SLPDGVFDKLTQLKDLRLYQNQLK-SVPDGVFDRLT 148

Query: 189 KLKRLDLSFN 198
            L+ + L  N
Sbjct: 149 SLQYIWLHDN 158

>2o6s_A Variable lymphocyte receptor B; leucine-rich repeat protein, LRR, immune system; 1.50A {Eptatretus burgeri} Length = 208

 Score = 43.1 bits (102), Expect = 1e-04
 Identities = 37/133 (27%), Positives = 59/133 (44%), Gaps = 12/133 (9%)

Query: 108 IPKEIRNLTELTDLYLDVNNLSGNIPPEIGSMASLQVLQLCCNQLTGNIPAQI-GSLKSL 166
           +P  I    + T L L+ N+L          + SL  L L  N+L  ++P  +   L SL
Sbjct: 22  VPTGIP--AQTTYLDLETNSLKSLPNGVFDELTSLTQLYLGGNKLQ-SLPNGVFNKLTSL 78

Query: 167 SVLTLQHNRLNG---GIPDSLGNLGKLKRLDLSFNSLFGTIPESLANN-AELLFLDVQNN 222
           + L L  N+L     G+ D    L +LK L L+ N L  ++P+ + +   +L  L +  N
Sbjct: 79  TYLNLSTNQLQSLPNGVFDK---LTQLKELALNTNQL-QSLPDGVFDKLTQLKDLRLYQN 134

Query: 223 TLSGIVPSALKRL 235
            L  +      RL
Sbjct: 135 QLKSVPDGVFDRL 147

>1ua2_A CAK, cell division protein kinase 7; cell cycle, phosphorylation, protein-protein interaction, PR kinase, cell cycle, transferase; HET: TPO ATP; 3.02A {Homo sapiens} SCOP: d.144.1.7 Length = 346

 Score = 59.9 bits (146), Expect = 9e-10
 Identities = 45/170 (26%), Positives = 77/170 (45%), Gaps = 24/170 (14%)

Query: 403 EVESATQCFSEVNLLGKGNFSSVYKGT-LRDGTLVAIRSINVTSCKSEEAEFVKGL---- 457
           +V+S  + + +++ LG+G F++VYK        +VAI+ I +       +E   G+    
Sbjct: 4   DVKSRAKRYEKLDFLGEGQFATVYKARDKNTNQIVAIKKIKLGH----RSEAKDGINRTA 59

Query: 458 ----YLLTSLRHENIIRLRGFCCSRGRGECFLIYDFAPKGKLSKYLDQEEGSSNVLDWST 513
                LL  L H NII L      +      L++DF     L   +     +S VL  S 
Sbjct: 60  LREIKLLQELSHPNIIGLLDAFGHKSN--ISLVFDFMETD-LEVIIKD---NSLVLTPSH 113

Query: 514 RVSIIIGIAKGIGYLHSSEVNKPAIVHRNLSVEKVLIDQQFNPLIADCGL 563
             + ++   +G+ YLH    +   I+HR+L    +L+D+     +AD GL
Sbjct: 114 IKAYMLMTLQGLEYLHQ---HW--ILHRDLKPNNLLLDENGVLKLADFGL 158

>2vuw_A Serine/threonine-protein kinase haspin; cell cycle, transferase, CAsp8, nucleotide binding; HET: MSE 5ID MPD; 1.80A {Homo sapiens} PDB: 3f2n_A* 3e7v_A* 3dlz_A* 3fmd_A* 3iq7_A* 2wb8_A Length = 336

 Score = 59.5 bits (143), Expect = 1e-09
 Identities = 33/198 (16%), Positives = 56/198 (28%), Gaps = 44/198 (22%)

Query: 407 ATQCFSEVNLLGKGNFSSVYKGTLRDGTLVAIRSINVTSCKSEEAEF------------- 453
            T+       +G+G F  V++    D T VAI+ I +                       
Sbjct: 18  PTEKLQRCEKIGEGVFGEVFQTIA-DHTPVAIKIIAIEGPDLVNGSHQKTFEEILPEIII 76

Query: 454 ---VKGLYLLTSLRHENIIRLRGFCCSRGRGECFLI--YDFAPKGKLSKY---------- 498
              +  L      R E  I L    C +G     L+  +D     K S            
Sbjct: 77  SKELSLLSGEVCNRTEGFIGLNSVHCVQGSYPPLLLKAWDHYNSTKGSANDRPDFFKDDQ 136

Query: 499 -----------LDQEEGSSNVLDWSTRVSIIIGIAKGIGYLHSSEVNKPAIVHRNLSVEK 547
                      +D E+  + +   +T  SI+  +   +              HR+L    
Sbjct: 137 LFIVLEFEFGGIDLEQMRTKLSSLATAKSILHQLTASLAVAE----ASLRFEHRDLHWGN 192

Query: 548 VLIDQQFNPLIADCGLHK 565
           VL+ +     +      K
Sbjct: 193 VLLKKTSLKKLHYTLNGK 210

>3pvu_A Beta-adrenergic receptor kinase 1; transferase, serine/threonine-protein kinase, ATP-binding, I membrane; HET: QRW; 2.48A {Bos taurus} PDB: 3psc_A* 3pvw_A* 1omw_A 1ym7_A 2bcj_A* 3cik_A 3krw_A* 3krx_A* 1bak_A Length = 695

 Score = 60.7 bits (147), Expect = 1e-09
 Identities = 51/246 (20%), Positives = 96/246 (39%), Gaps = 27/246 (10%)

Query: 378 DPLGDYLNGTGFSREHLNSFRLNLEEVESAT-QCFSEVNLLGKGNFSSVYKGTLRD-GTL 435
           D    ++    F+R        N+E     T   FS   ++G+G F  VY     D G +
Sbjct: 160 DVFQKFIESDKFTRFC---QWKNVELNIHLTMNDFSVHRIIGRGGFGEVYGCRKADTGKM 216

Query: 436 VAIRSINVTSCKS-EEAEFVKG----LYLLTSLRHENIIRLRGFCCSRGRGECFLIYDFA 490
            A++ ++    K  +           L L+++     I+ +          +   I D  
Sbjct: 217 YAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMS--YAFHTPDKLSFILDLM 274

Query: 491 PKGKLSKYLDQEEGSSNVLDWSTRVSIIIG-IAKGIGYLHSSEVNKPAIVHRNLSVEKVL 549
             G L  +L Q    S        +      I  G+ ++H+       +V+R+L    +L
Sbjct: 275 NGGDLHYHLSQHGVFSE-----ADMRFYAAEIILGLEHMHNRF-----VVYRDLKPANIL 324

Query: 550 IDQQFNPLIADCGLHKLLADDIVFSVLKTSAAMGYLAPEYVTTG-RFTERSDIFAFGVII 608
           +D+  +  I+D GL    +     + + T    GY+APE +  G  +   +D F+ G ++
Sbjct: 325 LDEHGHVRISDLGLACDFSKKKPHASVGT---HGYMAPEVLQKGVAYDSSADWFSLGCML 381

Query: 609 LQILTG 614
            ++L G
Sbjct: 382 FKLLRG 387

>1j1b_A Glycogen synthase kinase-3 beta; complex, TAU, AMPPNP, transferase; HET: ANP; 1.80A {Homo sapiens} SCOP: d.144.1.7 PDB: 1i09_A* 1j1c_A* 2jld_A* 3m1s_A* 3pup_A* 3du8_A* 1pyx_A* 1q41_A* 1q3w_A* 1q3d_A* 1q4l_A* 3q3b_A* 1q5k_A* 3i4b_A* 3l1s_A* 1r0e_A* 3zrk_A* 3zrl_A* 3zrm_A* 4dit_A* ... Length = 420

 Score = 60.1 bits (146), Expect = 1e-09
 Identities = 43/168 (25%), Positives = 76/168 (45%), Gaps = 21/168 (12%)

Query: 411 FSEVNLLGKGNFSSVYKGTLRD-GTLVAIRSINVTSCKSEEAEFVKG--LYLLTSLRHEN 467
           +++  ++G G+F  VY+  L D G LVAI+ +       ++  F K   L ++  L H N
Sbjct: 56  YTDTKVIGNGSFGVVYQAKLCDSGELVAIKKV------LQDKRF-KNRELQIMRKLDHCN 108

Query: 468 IIRLRGFCCSRG--RGECFL--IYDFAPKGKLSKYLDQEEGSSNVLDWSTRVSIIIGIAK 523
           I+RLR F  S G  + E +L  + D+ P+  + +       +   L        +  + +
Sbjct: 109 IVRLRYFFYSSGEKKDEVYLNLVLDYVPE-TVYRVARHYSRAKQTLPVIYVKLYMYQLFR 167

Query: 524 GIGYLHSSEVNKPAIVHRNLSVEKVLIDQQFNPL-IADCGLHKLLADD 570
            + Y+HS       I HR++  + +L+D     L + D G  K L   
Sbjct: 168 SLAYIHSFG-----ICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRG 210

>4agu_A Cyclin-dependent kinase-like 1; transferase, phospho-mimetic; HET: D15; 2.40A {Homo sapiens} Length = 311

 Score = 59.1 bits (144), Expect = 1e-09
 Identities = 32/161 (19%), Positives = 68/161 (42%), Gaps = 21/161 (13%)

Query: 409 QCFSEVNLLGKGNFSSVYKGTLRD-GTLVAIRSINVTSCKSEEAEFVKG-----LYLLTS 462
           + + ++  +G+G++  V+K   RD G +VAI+        SE+   +K      + +L  
Sbjct: 3   EKYEKIGKIGEGSYGVVFKCRNRDTGQIVAIKKFLE----SEDDPVIKKIALREIRMLKQ 58

Query: 463 LRHENIIRLRGFCCSRGRGECFLIYDFAPKGKLSKYLDQEEGSSNVLDWSTRVSIIIGIA 522
           L+H N++ L      R +    L++++     +   LD+       +      SI     
Sbjct: 59  LKHPNLVNLLEVF--RRKRRLHLVFEYCDH-TVLHELDR---YQRGVPEHLVKSITWQTL 112

Query: 523 KGIGYLHSSEVNKPAIVHRNLSVEKVLIDQQFNPLIADCGL 563
           + + + H    +    +HR++  E +LI +     + D G 
Sbjct: 113 QAVNFCHK---HN--CIHRDVKPENILITKHSVIKLCDFGF 148

>2ra8_A Uncharacterized protein Q64V53_bacfr; WGR domain, LRR domain, leucine rich repeats, BFR43, structural genomics, PSI-2; 1.95A {Bacteroides fragilis} Length = 362

 Score = 59.2 bits (142), Expect = 2e-09
 Identities = 28/173 (16%), Positives = 59/173 (34%), Gaps = 23/173 (13%)

Query: 71  ANISLQGKGL--TGKLSPSLSGLKCLSGLYLHYNSLSGEIPKEIR-----NLTELTDLYL 123
           A   L    +  T  LS        L  L +    L   + ++I      NL +L  LY+
Sbjct: 170 AMPLLNNLKIKGTNNLSIGKKPRPNLKSLEIISGGLPDSVVEDILGSDLPNLEKL-VLYV 228

Query: 124 DVNNLSGNIPPEI-------GSMASLQVLQLCCNQLTGNIPAQIGS---LKSLSVLTLQH 173
            V +   +    +           +L+ L +   +    +         L  L  + +  
Sbjct: 229 GVEDYGFDGDMNVFRPLFSKDRFPNLKWLGIVDAEEQNVVVEMFLESDILPQLETMDISA 288

Query: 174 NRLNGG----IPDSLGNLGKLKRLDLSFNSLFGTIPESLANNAELLFLDVQNN 222
             L       + D +  +  LK +++ +N L   + + L  +  +  +DV ++
Sbjct: 289 GVLTDEGARLLLDHVDKIKHLKFINMKYNYLSDEMKKELQKSLPMK-IDVSDS 340

>3g33_A Cell division protein kinase 4; Ser/Thr protein kinase, cell cycle, phosphorylation, ATP-BIN cell division, disease mutation, kinase; 3.00A {Homo sapiens} Length = 308

 Score = 58.4 bits (142), Expect = 2e-09
 Identities = 43/169 (25%), Positives = 70/169 (41%), Gaps = 19/169 (11%)

Query: 406 SATQCFSEVNLLGKGNFSSVYKGT-LRDGTLVAIRSINVTSCKSEEAEF-------VKGL 457
            AT  +  V  +G G + +VYK      G  VA++S+ V +               V  L
Sbjct: 6   MATSRYEPVAEIGVGAYGTVYKARDPHSGHFVALKSVRVPNGGGGGGGLPISTVREVALL 65

Query: 458 YLLTSLRHENIIRLRGFCCSRGRGEC---FLIYDFAPKGKLSKYLDQEEGSSNVLDWSTR 514
             L +  H N++RL   C +          L+++   +  L  YLD+       L   T 
Sbjct: 66  RRLEAFEHPNVVRLMDVCATSRTDREIKVTLVFEHVDQ-DLRTYLDKAPPPG--LPAETI 122

Query: 515 VSIIIGIAKGIGYLHSSEVNKPAIVHRNLSVEKVLIDQQFNPLIADCGL 563
             ++    +G+ +LH+   N   IVHR+L  E +L+       +AD GL
Sbjct: 123 KDLMRQFLRGLDFLHA---NC--IVHRDLKPENILVTSGGTVKLADFGL 166

>3fxz_A Serine/threonine-protein kinase PAK 1; transferase, ATP-binding, phosphorylation, allosteric enzyme, alternative splicing, apoptosis, cell junction; HET: TPO FLL; 1.64A {Homo sapiens} PDB: 3fy0_A* 4daw_A* 3q52_A* 3q53_A* 1yhw_A 1f3m_C 1yhv_A 2hy8_1* 3q4z_A* Length = 297

 Score = 58.1 bits (141), Expect = 2e-09
 Identities = 48/282 (17%), Positives = 112/282 (39%), Gaps = 58/282 (20%)

Query: 408 TQCFSEVNLLGKGNFSSVYKGT-LRDGTLVAIRSINVTSCKSEEAEFVKGLYLLTSLRHE 466
            + ++    +G+G   +VY    +  G  VAIR +N+   + ++   +  + ++   ++ 
Sbjct: 19  KKKYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQ-QPKKELIINEILVMRENKNP 77

Query: 467 NIIRLRGFCCSRGRGECFLIYDFAPKGKLSKYLDQEEGSSNVLDWSTRVSIIIGIAKGIG 526
           NI+            E +++ ++   G L+  + +       +D     ++     + + 
Sbjct: 78  NIVNYLD--SYLVGDELWVVMEYLAGGSLTDVVTE-----TCMDEGQIAAVCRECLQALE 130

Query: 527 YLHSSEVNKPAIVHRNLSVEKVLIDQQFNPLIADCGLHKLLADDIVFSVLKTSAAMG--- 583
           +LHS++     ++HR++  + +L+    +  + D G    +         K S  +G   
Sbjct: 131 FLHSNQ-----VIHRDIKSDNILLGMDGSVKLTDFGFCAQITP----EQSKRSTMVGTPY 181

Query: 584 YLAPEYVTTGRFTERSDIFAFGVIILQILTGS-----------LVLTSSM---RLAAE-- 627
           ++APE VT   +  + DI++ G++ ++++ G            L L ++     L     
Sbjct: 182 WMAPEVVTRKAYGPKVDIWSLGIMAIEMIEGEPPYLNENPLRALYLIATNGTPELQNPEK 241

Query: 628 -SATFENFIDRNLKGKFSESEAAKLGKMALVCTHEDPENRPT 668
            SA F +F++R                    C   D E R +
Sbjct: 242 LSAIFRDFLNR--------------------CLEMDVEKRGS 263

>3m2w_A MAP kinase-activated protein kinase 2; small molecule inhibitor, spiroazetidine-tetracycle, ATP-SIT inhibitor, novartis compound NVP-BXS169; HET: L8I; 2.41A {Homo sapiens} PDB: 3kga_A* 3m42_A* Length = 299

 Score = 57.7 bits (140), Expect = 3e-09
 Identities = 51/278 (18%), Positives = 94/278 (33%), Gaps = 67/278 (24%)

Query: 417 LGKGNFSSVYKGTLRD-GTLVAIRSINVTSCKSEEAEFVKGLYLLTSLRHENIIRLRGFC 475
           LG G    V +   +      A++ +        E E         + +  +I+R+    
Sbjct: 26  LGLGINGKVLQIFNKRTQEKFALKMLQDCPKARREVEL-----HWRASQCPHIVRIVDVY 80

Query: 476 --CSRGRGECFLIYDFAPKGKLSKYLD--QEEGSSNVLDWSTR--VSIIIGIAKGIGYLH 529
                GR    ++ +    G+L       Q+ G      ++ R    I+  I + I YLH
Sbjct: 81  ENLYAGRKCLLIVMECLDGGEL---FSRIQDRGDQA---FTEREASEIMKSIGEAIQYLH 134

Query: 530 SSEVNKPAIVHRNLSVEKVL-IDQQFNPL--IADCGLHKLLADDIVFSVLKTSAAMGYLA 586
           S       I HR++  E +L   ++ N +  + D G                       A
Sbjct: 135 SIN-----IAHRDVKPENLLYTSKRPNAILKLTDFG----------------------FA 167

Query: 587 PEYVTTGRFTERSDIFAFGVIILQILTGSLVLTSSMRLAAESATFENFIDRNLKGKF--- 643
            E  T  ++ +  D+++ GVI+  +L G     S+  LA           R   G++   
Sbjct: 168 KE-TTGEKYDKSCDMWSLGVIMYILLCGYPPFYSNHGLAISPGMKT----RIRMGQYEFP 222

Query: 644 SE-----SEAAK--LGKMALVCTHEDPENRPTMEAVIE 674
           +      SE  K  +  +       +P  R T+   + 
Sbjct: 223 NPEWSEVSEEVKMLIRNLLKT----EPTQRMTITEFMN 256

>3niz_A Rhodanese family protein; structural genomics, structural genomics consortium, SGC, phosphotransferase, cyclin dependent kinase; HET: ADP; 2.40A {Cryptosporidium parvum} PDB: 2qkr_A* Length = 311

 Score = 58.0 bits (141), Expect = 3e-09
 Identities = 41/167 (24%), Positives = 74/167 (44%), Gaps = 26/167 (15%)

Query: 405 ESATQCFSEVNLLGKGNFSSVYKGTLRDGTLVAIRSINVTSCKSEEAEFVKGL------- 457
           +   + + ++  +G+G +  VYK     G +VA++ I + +    E E   G+       
Sbjct: 17  QGLMEKYQKLEKVGEGTYGVVYKAKDSQGRIVALKRIRLDA----EDE---GIPSTAIRE 69

Query: 458 -YLLTSLRHENIIRLRGFCCSRGRGECFLIYDFAPKGKLSKYLDQEEGSSNVLDWSTRVS 516
             LL  L H NI+ L     S       L+++F  K  L K LD+   +   L  S    
Sbjct: 70  ISLLKELHHPNIVSLIDVIHSERC--LTLVFEFMEKD-LKKVLDE---NKTGLQDSQIKI 123

Query: 517 IIIGIAKGIGYLHSSEVNKPAIVHRNLSVEKVLIDQQFNPLIADCGL 563
            +  + +G+ + H    ++  I+HR+L  + +LI+      +AD GL
Sbjct: 124 YLYQLLRGVAHCHQ---HR--ILHRDLKPQNLLINSDGALKLADFGL 165

>2o6r_A Variable lymphocyte receptor B; leucine-rich repeat protein, LRR, immune system; 2.30A {Eptatretus burgeri} Length = 177

 Score = 55.3 bits (134), Expect = 4e-09
 Identities = 30/105 (28%), Positives = 46/105 (43%), Gaps = 6/105 (5%)

Query: 97  LYLHYNSLSGEIPKEIRNLTELTDLYLDVNNLSGNIPPEI-GSMASLQVLQLCCNQLTGN 155
           L L  N L          LT+LT L L  N +  ++P  +   +  L +L L  N+L  +
Sbjct: 33  LELESNKLQSLPHGVFDKLTQLTKLSLSQNQIQ-SLPDGVFDKLTKLTILYLHENKLQ-S 90

Query: 156 IPAQI-GSLKSLSVLTLQHNRLNGGIPD-SLGNLGKLKRLDLSFN 198
           +P  +   L  L  L L  N+L   +PD     L  L+++ L  N
Sbjct: 91  LPNGVFDKLTQLKELALDTNQLK-SVPDGIFDRLTSLQKIWLHTN 134

>2o6r_A Variable lymphocyte receptor B; leucine-rich repeat protein, LRR, immune system; 2.30A {Eptatretus burgeri} Length = 177

 Score = 39.9 bits (94), Expect = 8e-04
 Identities = 28/109 (25%), Positives = 43/109 (39%), Gaps = 14/109 (12%)

Query: 131 NIPPEIGSMASLQVLQLCCNQLTGNIPAQIGSLKSLSVLTLQHNRLNG---GIPDSLGNL 187
            IP      +S   L+L  N+L          L  L+ L+L  N++     G+ D    L
Sbjct: 25  GIP------SSATRLELESNKLQSLPHGVFDKLTQLTKLSLSQNQIQSLPDGVFDK---L 75

Query: 188 GKLKRLDLSFNSLFGTIPESLANN-AELLFLDVQNNTLSGIVPSALKRL 235
            KL  L L  N L  ++P  + +   +L  L +  N L  +      RL
Sbjct: 76  TKLTILYLHENKL-QSLPNGVFDKLTQLKELALDTNQLKSVPDGIFDRL 123

>3mtl_A Cell division protein kinase 16; pctaire1, indirubin, structural genomics, structural consortium, SGC, transferase; HET: FEF; 2.40A {Homo sapiens} Length = 324

 Score = 57.6 bits (140), Expect = 5e-09
 Identities = 41/164 (25%), Positives = 79/164 (48%), Gaps = 28/164 (17%)

Query: 409 QCFSEVNLLGKGNFSSVYKGTLRD-GTLVAIRSINVTSCKSEEAEFVKGL--------YL 459
           + + +++ LG+G +++VYKG  +    LVA++ I +   + EE     G          L
Sbjct: 2   ETYIKLDKLGEGTYATVYKGKSKLTDNLVALKEIRL---EHEE-----GAPCTAIREVSL 53

Query: 460 LTSLRHENIIRLRGFCCSRGRGECFLIYDFAPKGKLSKYLDQEEGSSNVLDWSTRVSIII 519
           L  L+H NI+ L     +       L++++  K  L +YLD      N+++       + 
Sbjct: 54  LKDLKHANIVTLHDIIHTEKS--LTLVFEYLDK-DLKQYLDD---CGNIINMHNVKLFLF 107

Query: 520 GIAKGIGYLHSSEVNKPAIVHRNLSVEKVLIDQQFNPLIADCGL 563
            + +G+ Y H     K  ++HR+L  + +LI+++    +AD GL
Sbjct: 108 QLLRGLAYCHR---QK--VLHRDLKPQNLLINERGELKLADFGL 146

>2v70_A SLIT-2, SLIT homolog 2 protein N-product; neurogenesis, glycoprotein, secreted, chemotaxis, LRR structural protein, differentiation; HET: NAG; 3.01A {Homo sapiens} Length = 220

 Score = 56.2 bits (136), Expect = 5e-09
 Identities = 26/125 (20%), Positives = 54/125 (43%), Gaps = 13/125 (10%)

Query: 54  PCSGSFEGIACNEHRKVANISLQGKGLTGKLSP-SLSGLKCLSGLYLHYNSLSGEIPKEI 112
             +G F+ +      ++  I+     +T  +   +  G   ++ + L  N L   +  ++
Sbjct: 48  EATGIFKKL-----PQLRKINFSNNKIT-DIEEGAFEGASGVNEILLTSNRLE-NVQHKM 100

Query: 113 -RNLTELTDLYLDVNNLSGNIPPEI-GSMASLQVLQLCCNQLTGNIPAQI-GSLKSLSVL 169
            + L  L  L L  N ++  +  +    ++S+++L L  NQ+T  +      +L SLS L
Sbjct: 101 FKGLESLKTLMLRSNRIT-CVGNDSFIGLSSVRLLSLYDNQIT-TVAPGAFDTLHSLSTL 158

Query: 170 TLQHN 174
            L  N
Sbjct: 159 NLLAN 163

>2v70_A SLIT-2, SLIT homolog 2 protein N-product; neurogenesis, glycoprotein, secreted, chemotaxis, LRR structural protein, differentiation; HET: NAG; 3.01A {Homo sapiens} Length = 220

 Score = 53.1 bits (128), Expect = 5e-08
 Identities = 28/165 (16%), Positives = 54/165 (32%), Gaps = 31/165 (18%)

Query: 97  LYLHYNSLSGEIPKEI-RNLTELTDLYLDVNNLSGNIPPEI-GSMASLQVLQLCCNQLTG 154
           L L+ N  +      I + L +L  +    N ++ +I        + +  + L  N+L  
Sbjct: 37  LRLNNNEFTVLEATGIFKKLPQLRKINFSNNKIT-DIEEGAFEGASGVNEILLTSNRLE- 94

Query: 155 NIPAQIGSLKSLSVLTLQHNRLNGGIPDSLGNLGKLKRLDLSFNSLFGTIPESLANN-AE 213
           N+  ++                          L  LK L L  N +   +        + 
Sbjct: 95  NVQHKM-----------------------FKGLESLKTLMLRSNRI-TCVGNDSFIGLSS 130

Query: 214 LLFLDVQNNTLSGIVPSALKRLN--GGFQFQNNPGLCGDGIASLR 256
           +  L + +N ++ + P A   L+         NP  C   +A L 
Sbjct: 131 VRLLSLYDNQITTVAPGAFDTLHSLSTLNLLANPFNCNCYLAWLG 175

>1ob3_A PFPK5, cell division control protein 2 homolog; transferase, serine/threonine-protein kinase, ATP-binding, phosphorylation, CDK; 1.9A {Plasmodium falciparum} SCOP: d.144.1.7 PDB: 1v0p_A* 1v0o_A* 1v0b_A Length = 288

 Score = 57.1 bits (139), Expect = 5e-09
 Identities = 40/163 (24%), Positives = 74/163 (45%), Gaps = 26/163 (15%)

Query: 409 QCFSEVNLLGKGNFSSVYKGTLRDGTLVAIRSINVTSCKSEEAEFVKGL--------YLL 460
           + +  +  +G+G +  VYK     G   A++ I +     +E E   G+         +L
Sbjct: 2   EKYHGLEKIGEGTYGVVYKAQNNYGETFALKKIRL----EKEDE---GIPSTTIREISIL 54

Query: 461 TSLRHENIIRLRGFCCSRGRGECFLIYDFAPKGKLSKYLDQEEGSSNVLDWSTRVSIIIG 520
             L+H NI++L     ++ R    L+++   +  L K LD        L+  T  S ++ 
Sbjct: 55  KELKHSNIVKLYDVIHTKKR--LVLVFEHLDQD-LKKLLDV---CEGGLESVTAKSFLLQ 108

Query: 521 IAKGIGYLHSSEVNKPAIVHRNLSVEKVLIDQQFNPLIADCGL 563
           +  GI Y H     +  ++HR+L  + +LI+++    IAD GL
Sbjct: 109 LLNGIAYCHD---RR--VLHRDLKPQNLLINREGELKIADFGL 146

>2je0_A Acidic leucine-rich nuclear phosphoprotein 32 FAM member A; nuclear protein; 2.40A {Homo sapiens} PDB: 2je1_A Length = 149

 Score = 54.3 bits (131), Expect = 6e-09
 Identities = 32/115 (27%), Positives = 47/115 (40%), Gaps = 10/115 (8%)

Query: 113 RNLTELTDLYLDVN-NLSGNIPPEIGSMASLQVLQLCCNQLT--GNIPAQIGSLKSLSVL 169
           R  +++ +L LD + +  G +         L+ L      LT   N+P     L  L  L
Sbjct: 14  RTPSDVKELVLDNSRSNEGKLEGLTDEFEELEFLSTINVGLTSIANLP----KLNKLKKL 69

Query: 170 TLQHNRLNGGIPDSLGNLGKLKRLDLSFNSL--FGTIPESLANNAELLFLDVQNN 222
            L  NR++GG+         L  L+LS N +    TI E L     L  LD+ N 
Sbjct: 70  ELSDNRVSGGLEVLAEKCPNLTHLNLSGNKIKDLSTI-EPLKKLENLKSLDLFNC 123

>2j7t_A Serine/threonine-protein kinase 10; transferase, ATP-binding, cell cycle progression, phosphorylation, disease mutation, nucleotide- binding; HET: 274; 2.0A {Homo sapiens} PDB: 4aot_A* 3zz2_A* 2j51_A* 2jfl_A* 2jfm_A* 2uv2_A* Length = 302

 Score = 56.6 bits (137), Expect = 7e-09
 Identities = 54/284 (19%), Positives = 106/284 (37%), Gaps = 61/284 (21%)

Query: 411 FSEVNLLGKGNFSSVYKGT-LRDGTLVAIRSINVTSCKSEEAEFVKGLYLLTSLRHENII 469
           +  V  LG G F  VYK      G L A + I   S + E  +++  + +L +  H  I+
Sbjct: 21  WEIVGELGDGAFGKVYKAKNKETGALAAAKVIETKS-EEELEDYIVEIEILATCDHPYIV 79

Query: 470 RLRGFCCSRGRGECFLIYDFAPKGKLSKYLDQEEGSSNVLDWSTRVSIIIGIAKGIGYLH 529
           +L G       G+ +++ +F P G +             L       +   + + + +LH
Sbjct: 80  KLLG--AYYHDGKLWIMIEFCPGGAVD---AIMLELDRGLTEPQIQVVCRQMLEALNFLH 134

Query: 530 SSEVNKPAIVHRNLSVEKVLIDQQFNPLIADCGLHKLLADDIVFSVLKTSAAMG---YLA 586
           S  +     +HR+L    VL+  + +  +AD G+          ++ K  + +G   ++A
Sbjct: 135 SKRI-----IHRDLKAGNVLMTLEGDIRLADFGVSAKNLK----TLQKRDSFIGTPYWMA 185

Query: 587 PEYVTTGRFTE-----RSDIFAFGVIILQILTGS--LVLTSSMR------------LAAE 627
           PE V      +     ++DI++ G+ ++++          + MR            L   
Sbjct: 186 PEVVMCETMKDTPYDYKADIWSLGITLIEMAQIEPPHHELNPMRVLLKIAKSDPPTLLTP 245

Query: 628 ---SATFENFIDRNLKGKFSESEAAKLGKMALVCTHEDPENRPT 668
              S  F +F+                         ++PE RP+
Sbjct: 246 SKWSVEFRDFLKI--------------------ALDKNPETRPS 269

>2ifg_A High affinity nerve growth factor receptor; TRK, TRKA, receptor-ligand complex transferase; HET: NAG NDG MAN BMA; 3.40A {Homo sapiens} SCOP: b.1.1.4 b.1.1.4 c.10.2.7 Length = 347

 Score = 57.1 bits (137), Expect = 8e-09
 Identities = 20/101 (19%), Positives = 37/101 (36%), Gaps = 4/101 (3%)

Query: 102 NSLSGEIPKEIRNLTELTDLYLDVNNLSGNIPPE-IGSMASLQVLQLCCNQLTGNIPAQI 160
              + +    +     LT+LY++      ++    +  +  L+ L +  + L   +    
Sbjct: 17  RDGALDSLHHLPGAENLTELYIENQQHLQHLELRDLRGLGELRNLTIVKSGLR-FVAPDA 75

Query: 161 GS-LKSLSVLTLQHNRLNGGIPDSLGNLGKLKRLDLSFNSL 200
                 LS L L  N L      ++  L  L+ L LS N L
Sbjct: 76  FHFTPRLSRLNLSFNALESLSWKTVQGL-SLQELVLSGNPL 115

>2ifg_A High affinity nerve growth factor receptor; TRK, TRKA, receptor-ligand complex transferase; HET: NAG NDG MAN BMA; 3.40A {Homo sapiens} SCOP: b.1.1.4 b.1.1.4 c.10.2.7 Length = 347

 Score = 56.7 bits (136), Expect = 1e-08
 Identities = 18/103 (17%), Positives = 40/103 (38%), Gaps = 2/103 (1%)

Query: 148 CCNQLTGNIPAQIGSLKSLSVLTLQHNRLNGGIPD-SLGNLGKLKRLDLSFNSLFGTIPE 206
           C      +    +   ++L+ L +++ +    +    L  LG+L+ L +  + L    P+
Sbjct: 15  CTRDGALDSLHHLPGAENLTELYIENQQHLQHLELRDLRGLGELRNLTIVKSGLRFVAPD 74

Query: 207 SLANNAELLFLDVQNNTLSGIVPSALKRLN-GGFQFQNNPGLC 248
           +      L  L++  N L  +    ++ L+        NP  C
Sbjct: 75  AFHFTPRLSRLNLSFNALESLSWKTVQGLSLQELVLSGNPLHC 117

>2ifg_A High affinity nerve growth factor receptor; TRK, TRKA, receptor-ligand complex transferase; HET: NAG NDG MAN BMA; 3.40A {Homo sapiens} SCOP: b.1.1.4 b.1.1.4 c.10.2.7 Length = 347

 Score = 40.9 bits (95), Expect = 9e-04
 Identities = 18/68 (26%), Positives = 26/68 (38%), Gaps = 3/68 (4%)

Query: 87  SLSGLKCLSGLYLHYNSLSGEIPKEI-RNLTELTDLYLDVNNLSGNIPPEIGSMASLQVL 145
            L GL  L  L +  + L   +  +       L+ L L  N L  ++  +     SLQ L
Sbjct: 51  DLRGLGELRNLTIVKSGLR-FVAPDAFHFTPRLSRLNLSFNALE-SLSWKTVQGLSLQEL 108

Query: 146 QLCCNQLT 153
            L  N L 
Sbjct: 109 VLSGNPLH 116

>2c30_A Serine/threonine-protein kinase PAK 6; CRIB domain, ATP-binding, transferase, nucleotide-binding; HET: SEP; 1.6A {Homo sapiens} PDB: 2f57_A* 2j0i_A* 2cdz_A* 2q0n_A* 2x4z_A* 2bva_A* Length = 321

 Score = 56.6 bits (137), Expect = 9e-09
 Identities = 41/282 (14%), Positives = 103/282 (36%), Gaps = 58/282 (20%)

Query: 408 TQCFSEVNLLGKGNFSSVYKGT-LRDGTLVAIRSINVTSCKSEEAEFVKGLYLLTSLRHE 466
                    +G+G+   V        G  VA++ +++   +         + ++   +H 
Sbjct: 44  RLLLDSYVKIGEGSTGIVCLAREKHSGRQVAVKMMDLRK-QQRRELLFNEVVIMRDYQHF 102

Query: 467 NIIRLRGFCCSRGRGECFLIYDFAPKGKLSKYLDQEEGSSNVLDWSTRVSIIIGIAKGIG 526
           N++ +          E +++ +F   G L+  + Q       L+     ++   + + + 
Sbjct: 103 NVVEMYK--SYLVGEELWVLMEFLQGGALTDIVSQ-----VRLNEEQIATVCEAVLQALA 155

Query: 527 YLHSSEVNKPAIVHRNLSVEKVLIDQQFNPLIADCGLHKLLADDIVFSVLKTSAAMG--- 583
           YLH+       ++HR++  + +L+       ++D G    ++ D    V K  + +G   
Sbjct: 156 YLHAQG-----VIHRDIKSDSILLTLDGRVKLSDFGFCAQISKD----VPKRKSLVGTPY 206

Query: 584 YLAPEYVTTGRFTERSDIFAFGVIILQILTGS-----------LVLTSSM---RLAAE-- 627
           ++APE ++   +    DI++ G+++++++ G            +         +L     
Sbjct: 207 WMAPEVISRSLYATEVDIWSLGIMVIEMVDGEPPYFSDSPVQAMKRLRDSPPPKLKNSHK 266

Query: 628 -SATFENFIDRNLKGKFSESEAAKLGKMALVCTHEDPENRPT 668
            S    +F++R                        DP+ R T
Sbjct: 267 VSPVLRDFLER--------------------MLVRDPQERAT 288

>2pmi_A Negative RE, cyclin-dependent protein kinase PHO85; cyclin-dependent kinase, signaling protein,transfera cycle complex; HET: MES AGS; 2.90A {Saccharomyces cerevisiae} PDB: 2pk9_A* Length = 317

 Score = 56.1 bits (136), Expect = 1e-08
 Identities = 43/169 (25%), Positives = 77/169 (45%), Gaps = 27/169 (15%)

Query: 406 SATQCFSEVNLLGKGNFSSVYKGT-LRDGTLVAIRSINVTSCKSEEAEFVKGL------- 457
           S++  F ++  LG G +++VYKG     G  VA++ + +    SEE     G        
Sbjct: 2   SSSSQFKQLEKLGNGTYATVYKGLNKTTGVYVALKEVKL---DSEE-----GTPSTAIRE 53

Query: 458 -YLLTSLRHENIIRLRGFCCSRGRGECFLIYDFAPKGKLSKYLDQEEGSSNVLDWSTRV- 515
             L+  L+HENI+RL     +  +    L+++F     L KY+D     +        + 
Sbjct: 54  ISLMKELKHENIVRLYDVIHTENK--LTLVFEFMDN-DLKKYMDSRTVGNTPRGLELNLV 110

Query: 516 -SIIIGIAKGIGYLHSSEVNKPAIVHRNLSVEKVLIDQQFNPLIADCGL 563
                 + +G+ + H    NK  I+HR+L  + +LI+++    + D GL
Sbjct: 111 KYFQWQLLQGLAFCHE---NK--ILHRDLKPQNLLINKRGQLKLGDFGL 154

>3e3p_A Protein kinase, putative glycogen synthase kinase; leishmaniasis, transferase; 2.00A {Leishmania major} Length = 360

 Score = 56.1 bits (136), Expect = 2e-08
 Identities = 39/190 (20%), Positives = 70/190 (36%), Gaps = 17/190 (8%)

Query: 390 SREHLNSFRLNLEEVESATQCFSEVNLLGKGNFSSVYKGTLRD-GTLVAIRSI--NVTSC 446
           S   LN+     E        F    + G+G F +V  G  +  G  VAI+ +  +    
Sbjct: 4   SMMSLNAAAAADERSRKEMDRFQVERMAGQGTFGTVQLGKEKSTGMSVAIKKVIQDPRFR 63

Query: 447 KSEEAEFVKGLYLLTSLRHENIIRLRGFCCSRGRGE-----CFLIYDFAPKGKLSKYLDQ 501
             E       +  L  L H NI++L+ +  + G  +       ++ ++ P   L +    
Sbjct: 64  NRELQI----MQDLAVLHHPNIVQLQSYFYTLGERDRRDIYLNVVMEYVPD-TLHRCCRN 118

Query: 502 EEGSSNVLDWSTRVSIIIGIAKGIGYLHSSEVNKPAIVHRNLSVEKVLIDQQFNPL-IAD 560
                           +  + + IG LH   VN   + HR++    VL+++    L + D
Sbjct: 119 YYRRQVAPPPILIKVFLFQLIRSIGCLHLPSVN---VCHRDIKPHNVLVNEADGTLKLCD 175

Query: 561 CGLHKLLADD 570
            G  K L+  
Sbjct: 176 FGSAKKLSPS 185

>1u5q_A Serine/threonine protein kinase TAO2; transferase; HET: SEP; 2.10A {Rattus norvegicus} SCOP: d.144.1.7 PDB: 1u5r_A* 2gcd_A* Length = 348

 Score = 55.9 bits (135), Expect = 2e-08
 Identities = 62/290 (21%), Positives = 116/290 (40%), Gaps = 78/290 (26%)

Query: 411 FSEVNLLGKGNFSSVYKGT-LRDGTLVAIRSINVTSCKSEE--AEFVKGLYLLTSLRHEN 467
           FS++  +G G+F +VY    +R+  +VAI+ ++ +  +S E   + +K +  L  LRH N
Sbjct: 56  FSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPN 115

Query: 468 IIRLRGFCCSRGRGECFLIYDFAPKGKLSKYLDQEEGSSNVLDWSTRVSIIIGIAKGIGY 527
            I+ RG  C       +L+ ++          D  E     L      ++  G  +G+ Y
Sbjct: 116 TIQYRG--CYLREHTAWLVMEYCLGS----ASDLLEVHKKPLQEVEIAAVTHGALQGLAY 169

Query: 528 LHSSEVNKPAIVHRNLSVEKVLIDQQFNPLIADCGLHKLLADDIVFSVLKTSAAMG---- 583
           LHS       ++HR++    +L+ +         GL K L D   F     ++ M     
Sbjct: 170 LHSHN-----MIHRDVKAGNILLSEP--------GLVK-LGD---FGS---ASIMAPANS 209

Query: 584 ------YLAPEYVTT---GRFTERSDIFAFGVIILQILTGS--LVLTSSMR--------- 623
                 ++APE +     G++  + D+++ G+  +++      L   ++M          
Sbjct: 210 FVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSALYHIAQNE 269

Query: 624 ---LAAE--SATFENFIDRNLKGKFSESEAAKLGKMALVCTHEDPENRPT 668
              L +   S  F NF+D                     C  + P++RPT
Sbjct: 270 SPALQSGHWSEYFRNFVDS--------------------CLQKIPQDRPT 299

>1vt4_I APAF-1 related killer DARK; drosophila apoptosome, apoptosis, programmed cell death; HET: DTP; 6.90A {Drosophila melanogaster} PDB: 3iz8_A* Length = 1221

 Score = 56.8 bits (136), Expect = 2e-08
 Identities = 85/612 (13%), Positives = 168/612 (27%), Gaps = 211/612 (34%)

Query: 95  SGLYLHYNSLSGEIPKEIRNLTELTDLYLD-VNNLSGNIPPEIGSMASLQV--------L 145
             L ++Y  L   I  E R  + +T +Y++  + L  +        A   V        L
Sbjct: 85  EVLRINYKFLMSPIKTEQRQPSMMTRMYIEQRDRLYNDNQV----FAKYNVSRLQPYLKL 140

Query: 146 QLCCNQLTGNIPAQI-------GSLKSLSVLTLQ-------HNRLNGGI----------P 181
           +    +L    PA+        GS K  + + L          +++  I          P
Sbjct: 141 RQALLELR---PAKNVLIDGVLGSGK--TWVALDVCLSYKVQCKMDFKIFWLNLKNCNSP 195

Query: 182 DSLGNLGKLKRLDLSFNSLFGTIPESLANNAELLFLDVQNNTLSGIVPSALKRLNGGFQF 241
           +++  L  L++L    +  + +  +  + N +L    +Q           L+RL    + 
Sbjct: 196 ETV--LEMLQKLLYQIDPNWTSRSDHSS-NIKLRIHSIQA---------ELRRL---LKS 240

Query: 242 QNNPGLCGDGIASLRACTVYDNTQINP--VKPFGSHSNDTTPIDISEPSGFKEHCNQSQC 299
           +                 V  N Q N      F          ++              C
Sbjct: 241 KPYE----------NCLLVLLNVQ-NAKAWNAF----------NL-------------SC 266

Query: 300 SNSSKFPQIAVLAAVTSVTVILAGTGILIFFRYRRHKQKIGNTSESSDWQLSTDLT---L 356
                  +I +      VT  L+            H      + +     L+ D     L
Sbjct: 267 -------KILLTTRFKQVTDFLSAA-------TTTHI-----SLDHHSMTLTPDEVKSLL 307

Query: 357 AKDFN-RNGASPLVSLEYCHGWDPLGDYLNGTG-FSREHLNSF----RLNLEEVESATQC 410
            K  + R    P    E     +P    L+      R+ L ++     +N +++ +  + 
Sbjct: 308 LKYLDCRPQDLP---REVLTT-NPR--RLSIIAESIRDGLATWDNWKHVNCDKLTTIIES 361

Query: 411 FSEVNLLGKGNFSSVYK--GTLRDGTLVAIRSINVTSCKSEE-------AEFVK------ 455
              +N+L    +  ++           +    +++      +        +  K      
Sbjct: 362 S--LNVLEPAEYRKMFDRLSVFPPSAHIPTILLSLIWFDVIKSDVMVVVNKLHKYSLVEK 419

Query: 456 ----------GLYLLTSLRHENIIRLRGFCCSRGRGECFLIYDFAPKGKLSKYLDQEEGS 505
                      +YL   ++ EN   L               Y       + K  D ++  
Sbjct: 420 QPKESTISIPSIYLELKVKLENEYALHRSIVDH--------Y------NIPKTFDSDDLI 465

Query: 506 SNVLDWSTRVSIIIG-IAKGIGYLHSSEVNKPAIVHRNLSVEKVLIDQQF--NPLIADC- 561
              LD               IG+ H   +  P    R      V +D +F    +  D  
Sbjct: 466 PPYLD---------QYFYSHIGH-HLKNIEHP---ERMTLFRMVFLDFRFLEQKIRHDST 512

Query: 562 ------GLHKLLADDIVFSVLKTSAAMGYLAPEYVT--TGRFTER-SDIFAFGVIILQIL 612
                  +   L        LK      Y    Y+     ++    + I  F    L  +
Sbjct: 513 AWNASGSILNTLQQ------LKF-----YK--PYICDNDPKYERLVNAILDF----LPKI 555

Query: 613 TGSLVLTSSMRL 624
             +L+ +    L
Sbjct: 556 EENLICSKYTDL 567

>1ds9_A Outer arm dynein; leucine-rich repeat, beta-BETA-alpha cylinder, flagella, contractIle protein; NMR {Chlamydomonas reinhardtii} SCOP: c.10.3.1 PDB: 1m9l_A Length = 198

 Score = 53.5 bits (129), Expect = 2e-08
 Identities = 34/118 (28%), Positives = 55/118 (46%), Gaps = 8/118 (6%)

Query: 83  KLSPSLSGLKCLSGLYLHYNSLSGEIPKEIRNLTELTDLYLDVNNLSGNIPPEIGSMASL 142
           K+  +LS LK    L L  N++  +I   +  +  L  L L  N +   I        +L
Sbjct: 39  KMDATLSTLKACKHLALSTNNIE-KI-SSLSGMENLRILSLGRNLIK-KIENLDAVADTL 95

Query: 143 QVLQLCCNQLTGNIPAQIGSLKSLSVLTLQHNRLN--GGIPDSLGNLGKLKRLDLSFN 198
           + L +  NQ+  ++   I  L +L VL + +N++   G I D L  L KL+ L L+ N
Sbjct: 96  EELWISYNQIA-SLSG-IEKLVNLRVLYMSNNKITNWGEI-DKLAALDKLEDLLLAGN 150

>1ds9_A Outer arm dynein; leucine-rich repeat, beta-BETA-alpha cylinder, flagella, contractIle protein; NMR {Chlamydomonas reinhardtii} SCOP: c.10.3.1 PDB: 1m9l_A Length = 198

 Score = 52.0 bits (125), Expect = 9e-08
 Identities = 28/138 (20%), Positives = 55/138 (39%), Gaps = 10/138 (7%)

Query: 87  SLSGLKCLSGLYLHYNSLSGEIPKEIRNLTELTDLYLDVNNLSGNIPPEIGSMASLQVLQ 146
             +  + +  L+     +  ++   +  L     L L  NN+   I   +  M +L++L 
Sbjct: 21  VATEAEKVE-LHGMIPPIE-KMDATLSTLKACKHLALSTNNIE-KISS-LSGMENLRILS 76

Query: 147 LCCNQLTGNIPAQIGSLKSLSVLTLQHNRLNGGIPDSLGNLGKLKRLDLSFNSL--FGTI 204
           L  N +   I        +L  L + +N++       +  L  L+ L +S N +  +G I
Sbjct: 77  LGRNLIK-KIENLDAVADTLEELWISYNQIA--SLSGIEKLVNLRVLYMSNNKITNWGEI 133

Query: 205 PESLANNAELLFLDVQNN 222
            + LA   +L  L +  N
Sbjct: 134 -DKLAALDKLEDLLLAGN 150

>1ds9_A Outer arm dynein; leucine-rich repeat, beta-BETA-alpha cylinder, flagella, contractIle protein; NMR {Chlamydomonas reinhardtii} SCOP: c.10.3.1 PDB: 1m9l_A Length = 198

 Score = 40.8 bits (96), Expect = 5e-04
 Identities = 26/98 (26%), Positives = 38/98 (38%), Gaps = 15/98 (15%)

Query: 145 LQLCCNQLTGNIPAQIGSLKSLSVLTLQHNRLNGGIP--DSLGNLGKLKRLDLSFNSLFG 202
           L      +   + A + +LK+   L L  N     I    SL  +  L+ L L  N +  
Sbjct: 30  LHGMIPPIE-KMDATLSTLKACKHLALSTNN----IEKISSLSGMENLRILSLGRNLI-- 82

Query: 203 TIPESLANNAELL-FLDVQNN---TLSGIVPSALKRLN 236
              E+L   A+ L  L +  N   +LSGI    L  L 
Sbjct: 83  KKIENLDAVADTLEELWISYNQIASLSGI--EKLVNLR 118

>2xrw_A Mitogen-activated protein kinase 8; transcription, MAPK signaling pathways, linear binding motif; HET: ANP; 1.33A {Homo sapiens} PDB: 1ukh_A 1uki_A* 2xs0_A* 3elj_A* 2h96_A* 2gmx_A* 2g01_A* 2no3_A* 3o2m_A* 3o17_A* 3pze_A* 3g9l_X* 2p33_A* 3cgf_A* 3cgo_A* 3g90_X* 2ok1_A* 3g9n_A* 1pmn_A* 1pmq_A* ... Length = 371

 Score = 55.5 bits (134), Expect = 2e-08
 Identities = 48/216 (22%), Positives = 82/216 (37%), Gaps = 32/216 (14%)

Query: 411 FSEVNLLGKGNFSSVYKGT-LRDGTLVAIRSI-----NVTSCKSEEAEFVKGLYLLTSLR 464
           +  +  +G G    V           VAI+ +     N T  K    E V    L+  + 
Sbjct: 27  YQNLKPIGSGAQGIVCAAYDAILERNVAIKKLSRPFQNQTHAKRAYRELV----LMKCVN 82

Query: 465 HENIIRLRGFCCSRGRGECF----LIYDFAPKGKLSKYLDQEEGSSNVLDWSTRVSIIIG 520
           H+NII L      +   E F    ++ +      L + +  E      LD      ++  
Sbjct: 83  HKNIIGLLNVFTPQKSLEEFQDVYIVMELMDA-NLCQVIQME------LDHERMSYLLYQ 135

Query: 521 IAKGIGYLHSSEVNKPAIVHRNLSVEKVLIDQQFNPLIADCGLHKLLADDIVFSVLKTS- 579
           +  GI +LHS+ +     +HR+L    +++       I D G    LA     S + T  
Sbjct: 136 MLCGIKHLHSAGI-----IHRDLKPSNIVVKSDCTLKILDFG----LARTAGTSFMMTPY 186

Query: 580 -AAMGYLAPEYVTTGRFTERSDIFAFGVIILQILTG 614
                Y APE +    + E  DI++ G I+ +++ G
Sbjct: 187 VVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMIKG 222

>2ell_A Acidic leucine-rich nuclear phosphoprotein 32 FAM B; phapi2 protein, silver-stainable protein SSP29, acidic prote in leucines, structural genomics; NMR {Homo sapiens} PDB: 2rr6_A 2jqd_A Length = 168

 Score = 52.8 bits (127), Expect = 3e-08
 Identities = 34/115 (29%), Positives = 45/115 (39%), Gaps = 10/115 (8%)

Query: 113 RNLTELTDLYLDVNNLS-GNIPPEIGSMASLQVLQLCCNQLT--GNIPAQIGSLKSLSVL 169
           R    + +L LD    + G I        +L+ L L    L    N+P     L  L  L
Sbjct: 21  RTPAAVRELVLDNCKSNDGKIEGLTAEFVNLEFLSLINVGLISVSNLP----KLPKLKKL 76

Query: 170 TLQHNRLNGGIPDSLGNLGKLKRLDLSFNSL--FGTIPESLANNAELLFLDVQNN 222
            L  NR+ GG+      L  L  L+LS N L    T+ E L     L  LD+ N 
Sbjct: 77  ELSENRIFGGLDMLAEKLPNLTHLNLSGNKLKDISTL-EPLKKLECLKSLDLFNC 130

>2r3i_A Cell division protein kinase 2; serine/threonine-protein kinase, cell cycle, inhibition, cyclin-dependent kinase, cancer, ATP-binding; HET: SCF; 1.28A {Homo sapiens} PDB: 2r3j_A* 2r3k_A* 2r3l_A* 2r3m_A* 2r3n_A* 2r3o_A* 2r3p_A* 2r3q_A* 1jvp_P* 1buh_A 1ckp_A* 1di8_A* 1dm2_A* 1f5q_A 1fin_A* 1fq1_B* 1fvt_A* 1fvv_A* 1g5s_A* 1gih_A* ... Length = 299

 Score = 54.8 bits (133), Expect = 3e-08
 Identities = 39/164 (23%), Positives = 77/164 (46%), Gaps = 26/164 (15%)

Query: 409 QCFSEVNLLGKGNFSSVYKGT-LRDGTLVAIRSINVTSCKSEEAEFVKGL--------YL 459
           + F +V  +G+G +  VYK      G +VA++ I +      E E   G+         L
Sbjct: 3   ENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRL----DTETE---GVPSTAIREISL 55

Query: 460 LTSLRHENIIRLRGFCCSRGRGECFLIYDFAPKGKLSKYLDQEEGSSNVLDWSTRVSIII 519
           L  L H NI++L     +  +   +L+++F  +  L K++D    +   +      S + 
Sbjct: 56  LKELNHPNIVKLLDVIHTENK--LYLVFEFLHQ-DLKKFMDAS--ALTGIPLPLIKSYLF 110

Query: 520 GIAKGIGYLHSSEVNKPAIVHRNLSVEKVLIDQQFNPLIADCGL 563
            + +G+ + HS   ++  ++HR+L  + +LI+ +    +AD GL
Sbjct: 111 QLLQGLAFCHS---HR--VLHRDLKPQNLLINTEGAIKLADFGL 149

>3o0g_A Cell division protein kinase 5; kinase activator complex, kinase inhibitor complex, transferase-transferase activator complex; HET: 3O0; 1.95A {Homo sapiens} PDB: 1unh_A* 1ung_A* 1unl_A* 1h4l_A Length = 292

 Score = 54.8 bits (133), Expect = 3e-08
 Identities = 40/164 (24%), Positives = 78/164 (47%), Gaps = 27/164 (16%)

Query: 409 QCFSEVNLLGKGNFSSVYKGT-LRDGTLVAIRSINVTSCKSEEAEFVKGL--------YL 459
           Q + ++  +G+G + +V+K        +VA++ + +     ++ E   G+         L
Sbjct: 2   QKYEKLEKIGEGTYGTVFKAKNRETHEIVALKRVRL----DDDDE---GVPSSALREICL 54

Query: 460 LTSLRHENIIRLRGFCCSRGRGECFLIYDFAPKGKLSKYLDQEEGSSNVLDWSTRVSIII 519
           L  L+H+NI+RL     S  +    L+++F  +  L KY D     +  LD     S + 
Sbjct: 55  LKELKHKNIVRLHDVLHSDKK--LTLVFEFCDQ-DLKKYFDS---CNGDLDPEIVKSFLF 108

Query: 520 GIAKGIGYLHSSEVNKPAIVHRNLSVEKVLIDQQFNPLIADCGL 563
            + KG+G+ HS       ++HR+L  + +LI++     +A+ GL
Sbjct: 109 QLLKGLGFCHS---RN--VLHRDLKPQNLLINRNGELKLANFGL 147

>3rfs_A Internalin B, repeat modules, variable lymphocyte B; LRR, protein binding, plasma; 1.70A {Listeria monocytogenes} PDB: 3rfj_A Length = 272

 Score = 54.6 bits (132), Expect = 3e-08
 Identities = 49/171 (28%), Positives = 77/171 (45%), Gaps = 16/171 (9%)

Query: 63  ACNEHRKVANISLQGKGLTGKLSPSLSGLKCLSGLYLHYNSLSGEIPKEIRNLTELTDLY 122
             NE   +  I      +       +  L  +  L L  N L  +I   ++ LT LT L 
Sbjct: 36  TQNELNSIDQIIANNSDIK--SVQGIQYLPNVRYLALGGNKLH-DISA-LKELTNLTYLI 91

Query: 123 LDVNNLSGNIPPEI-GSMASLQVLQLCCNQLTGNIPAQI-GSLKSLSVLTLQHNRLNG-- 178
           L  N L  ++P  +   + +L+ L L  NQL  ++P  +   L +L+ L L HN+L    
Sbjct: 92  LTGNQLQ-SLPNGVFDKLTNLKELVLVENQLQ-SLPDGVFDKLTNLTYLNLAHNQLQSLP 149

Query: 179 -GIPDSLGNLGKLKRLDLSFNSLFGTIPESLANN-AELLFLDVQNNTLSGI 227
            G+ D L NL     LDLS+N L  ++PE + +   +L  L +  N L  +
Sbjct: 150 KGVFDKLTNL---TELDLSYNQL-QSLPEGVFDKLTQLKDLRLYQNQLKSV 196

>3rfs_A Internalin B, repeat modules, variable lymphocyte B; LRR, protein binding, plasma; 1.70A {Listeria monocytogenes} PDB: 3rfj_A Length = 272

 Score = 49.2 bits (118), Expect = 2e-06
 Identities = 29/135 (21%), Positives = 57/135 (42%), Gaps = 20/135 (14%)

Query: 97  LYLHYNSLSGEIPKEIRNLTELTDLYLDVNNLSGNIPPEIGSMASLQVLQLCCNQLTGNI 156
             L   S++  + +    L  +  +  + +++       I  + +++ L L  N+L    
Sbjct: 24  ANLKKKSVTDAVTQ--NELNSIDQIIANNSDIKS--VQGIQYLPNVRYLALGGNKLH--- 76

Query: 157 PAQIG---SLKSLSVLTLQHNRLN---GGIPDSLGNLGKLKRLDLSFNSLFGTIPESLAN 210
              I     L +L+ L L  N+L     G+ D    L  LK L L  N L  ++P+ + +
Sbjct: 77  --DISALKELTNLTYLILTGNQLQSLPNGVFDK---LTNLKELVLVENQL-QSLPDGVFD 130

Query: 211 N-AELLFLDVQNNTL 224
               L +L++ +N L
Sbjct: 131 KLTNLTYLNLAHNQL 145

>3pfq_A PKC-B, PKC-beta, protein kinase C beta type; phosphorylation, transferase; HET: TPO SEP ANP; 4.00A {Rattus norvegicus} PDB: 1tbn_A 1tbo_A 2e73_A Length = 674

 Score = 55.8 bits (134), Expect = 3e-08
 Identities = 50/223 (22%), Positives = 92/223 (41%), Gaps = 42/223 (18%)

Query: 409 QCFSEVNLLGKGNFSSV----YKGTLRDGTLVAIRSI---------NVTSCKSEEAEFVK 455
             F+ + +LGKG+F  V     KGT     L A++ +         +V     E+     
Sbjct: 341 TDFNFLMVLGKGSFGKVMLSERKGT---DELYAVKILKKDVVIQDDDVECTMVEKR---- 393

Query: 456 GLYLLTSLRHENIIRLRGFCCSRGRGECFLIYDFAPKGKLSKYLDQEEGSSNVLDWSTRV 515
              L    +   + +L    C +     + + ++   G L  ++ Q              
Sbjct: 394 --VLALPGKPPFLTQL--HSCFQTMDRLYFVMEYVNGGDLMYHIQQVGRFK-----EPHA 444

Query: 516 SIIIG-IAKGIGYLHSSEVNKPAIVHRNLSVEKVLIDQQFNPLIADCGLHKLLADDIVFS 574
                 IA G+ +L S       I++R+L ++ V++D + +  IAD G+ K   ++I   
Sbjct: 445 VFYAAEIAIGLFFLQSK-----GIIYRDLKLDNVMLDSEGHIKIADFGMCK---ENIWDG 496

Query: 575 VLKTSAAMG---YLAPEYVTTGRFTERSDIFAFGVIILQILTG 614
           V  T    G   Y+APE +    + +  D +AFGV++ ++L G
Sbjct: 497 V-TTKTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAG 538

>3c4z_A Rhodopsin kinase; Ser/Thr kinase, RGS homology domain, G protein coupled recep kinase, GRK, GRK1, P-loop, autophosphoryl ADP, ATP-binding; HET: ADP; 1.84A {Bos taurus} PDB: 3c4x_A* 3c4y_A 3c4w_A* 3c50_A* 3c51_A* 3qc9_A* 2i94_B Length = 543

 Score = 55.6 bits (134), Expect = 3e-08
 Identities = 57/308 (18%), Positives = 109/308 (35%), Gaps = 48/308 (15%)

Query: 378 DPLGDYLNGTGFSR----EHLNSFRLNLEEVESATQCFSEVNLLGKGNFSSVYKGTLRD- 432
            P  ++L+   F R    + L +  +  +        F +  +LG+G F  V+   ++  
Sbjct: 157 APFQEFLDSLYFLRFLQWKWLEAQPMGEDW-------FLDFRVLGRGGFGEVFACQMKAT 209

Query: 433 GTLVAIRSIN---------VTSCKSEEAEFVKGLYLLTSLRHENIIRLRGFCCSRGRGEC 483
           G L A + +N               E+        +L  +    I+ L        + + 
Sbjct: 210 GKLYACKKLNKKRLKKRKGYQGAMVEKK-------ILAKVHSRFIVSL--AYAFETKTDL 260

Query: 484 FLIYDFAPKGKLSKYLDQEEGSSNVLDWSTRVSIIIGIAKGIGYLHSSEVNKPAIVHRNL 543
            L+      G +  ++   +  +        +     I  G+ +LH        I++R+L
Sbjct: 261 CLVMTIMNGGDIRYHIYNVDEDNPGFQEPRAIFYTAQIVSGLEHLHQRN-----IIYRDL 315

Query: 544 SVEKVLIDQQFNPLIADCGLHKLLADDIVFSVLKTSAAMG---YLAPEYVTTGRFTERSD 600
             E VL+D   N  I+D GL   L         KT    G   ++APE +    +    D
Sbjct: 316 KPENVLLDDDGNVRISDLGLAVELKAGQT----KTKGYAGTPGFMAPELLLGEEYDFSVD 371

Query: 601 IFAFGVIILQILTGSLVLTSSMRLAAESATFENFIDRNLK--GKFSESEAAKLGKMALVC 658
            FA GV + +++       +           +  +++ +    KFS   +    +  L  
Sbjct: 372 YFALGVTLYEMIAARGPFRARGEKVENKELKQRVLEQAVTYPDKFSP-ASKDFCEALL-- 428

Query: 659 THEDPENR 666
             +DPE R
Sbjct: 429 -QKDPEKR 435

>3ttj_A Mitogen-activated protein kinase 10; JNK3, protein kinase in transferase-transferase inhibitor complex; HET: JBI; 2.10A {Homo sapiens} PDB: 3tti_A* 1jnk_A* Length = 464

 Score = 55.2 bits (133), Expect = 4e-08
 Identities = 46/219 (21%), Positives = 82/219 (37%), Gaps = 32/219 (14%)

Query: 408 TQCFSEVNLLGKGNFSSVYKGT-LRDGTLVAIRSI-----NVTSCKSEEAEFVKGLYLLT 461
            + +  +  +G G    V           VAI+ +     N T  K    E V    L+ 
Sbjct: 61  LKRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYRELV----LMK 116

Query: 462 SLRHENIIRLRGFCCSRGRGECF----LIYDFAPKGKLSKYLDQEEGSSNVLDWSTRVSI 517
            + H+NII L      +   E F    L+ +      L + +  E      LD      +
Sbjct: 117 CVNHKNIISLLNVFTPQKTLEEFQDVYLVMELMDA-NLCQVIQME------LDHERMSYL 169

Query: 518 IIGIAKGIGYLHSSEVNKPAIVHRNLSVEKVLIDQQFNPLIADCGLHKLLADDIVFS--V 575
           +  +  GI +LHS+ +     +HR+L    +++       I D GL +      + +  V
Sbjct: 170 LYQMLCGIKHLHSAGI-----IHRDLKPSNIVVKSDCTLKILDFGLARTAGTSFMMTPYV 224

Query: 576 LKTSAAMGYLAPEYVTTGRFTERSDIFAFGVIILQILTG 614
                   Y APE +    + E  DI++ G I+ +++  
Sbjct: 225 ----VTRYYRAPEVILGMGYKENVDIWSVGCIMGEMVRH 259

>4ejn_A RAC-alpha serine/threonine-protein kinase; AKT1, autoinhibition, allosteric inhibitor, kinase inhibitor hydrophobic collapase, ATPase; HET: 0R4; 2.19A {Homo sapiens} PDB: 3o96_A* Length = 446

 Score = 54.4 bits (131), Expect = 8e-08
 Identities = 52/225 (23%), Positives = 87/225 (38%), Gaps = 42/225 (18%)

Query: 409 QCFSEVNLLGKGNFSSVY----KGTLRDGTLVAIRSIN---------VTSCKSEEAEFVK 455
             F  + LLGKG F  V     K T   G   A++ +          V    +E      
Sbjct: 148 NEFEYLKLLGKGTFGKVILVKEKAT---GRYYAMKILKKEVIVAKDEVAHTLTENR---- 200

Query: 456 GLYLLTSLRHENIIRLRGFCCSRGRGECFLIYDFAPKGKLSKYLDQEEGSSNVLDWSTRV 515
              +L + RH  +  L      +       + ++A  G+L  +L +E   S       R 
Sbjct: 201 ---VLQNSRHPFLTAL--KYSFQTHDRLCFVMEYANGGELFFHLSRERVFSE-----DRA 250

Query: 516 SIIIG-IAKGIGYLHSSEVNKPAIVHRNLSVEKVLIDQQFNPLIADCGLHKLLADDIVFS 574
                 I   + YLHS    +  +V+R+L +E +++D+  +  I D GL K   + I   
Sbjct: 251 RFYGAEIVSALDYLHS----EKNVVYRDLKLENLMLDKDGHIKITDFGLCK---EGIKDG 303

Query: 575 VLKTSAAMG---YLAPEYVTTGRFTERSDIFAFGVIILQILTGSL 616
                   G   YLAPE +    +    D +  GV++ +++ G L
Sbjct: 304 A-TMKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRL 347

>3coi_A Mitogen-activated protein kinase 13; P38D, P38delta, ERK, MAP kinase, PMK, STK26, stress-activated protein kinase, structural genomics, PSI; 2.09A {Homo sapiens} Length = 353

 Score = 53.5 bits (129), Expect = 1e-07
 Identities = 50/218 (22%), Positives = 86/218 (39%), Gaps = 31/218 (14%)

Query: 408 TQCFSEVNLLGKGNFSSVYKGT-LRDGTLVAIRSI-----NVTSCKSEEAEFVKGLYLLT 461
            + +     +G G + SV      R G  VAI+ +     +    K    E    L LL 
Sbjct: 23  PKTYVSPTHVGSGAYGSVCSAIDKRSGEKVAIKKLSRPFQSEIFAKRAYRE----LLLLK 78

Query: 462 SLRHENIIRLRGFCCSRGRGECF----LIYDFAPKGKLSKYLDQEEGSSNVLDWSTRVSI 517
            ++HEN+I L            F    L+  F     L K +  +              +
Sbjct: 79  HMQHENVIGLLDVFTPASSLRNFYDFYLVMPFMQT-DLQKIMGLK------FSEEKIQYL 131

Query: 518 IIGIAKGIGYLHSSEVNKPAIVHRNLSVEKVLIDQQFNPLIADCGLHKLLADDIVFSVLK 577
           +  + KG+ Y+HS+ V     VHR+L    + +++     I D GL +    ++   V  
Sbjct: 132 VYQMLKGLKYIHSAGV-----VHRDLKPGNLAVNEDCELKILDFGLARHADAEMTGYV-- 184

Query: 578 TSAAMGYLAPEYVTT-GRFTERSDIFAFGVIILQILTG 614
                 Y APE + +   + +  DI++ G I+ ++LTG
Sbjct: 185 --VTRWYRAPEVILSWMHYNQTVDIWSVGCIMAEMLTG 220

>2acx_A G protein-coupled receptor kinase 6; GRK, G transferase; HET: ANP; 2.60A {Homo sapiens} PDB: 3nyn_A* 3nyo_A* Length = 576

 Score = 53.3 bits (128), Expect = 2e-07
 Identities = 60/303 (19%), Positives = 104/303 (34%), Gaps = 42/303 (13%)

Query: 328 IFFRYRRHKQKIGNTSESSDWQLSTDLTLAKDFNRNGASPLVSL--EYCHGWDPLGDYLN 385
           +   +  H               +    L +   ++    L  L  EY     P  DYL+
Sbjct: 105 LTQNFLSHTGPDLIPEVPRQLVTNCTQRLEQGPCKDLFQELTRLTHEYLSV-APFADYLD 163

Query: 386 GTGFSREHLNSFRLNLEEVESATQCFSEVNLLGKGNFSSVYKGTLRD-GTLVAIRSIN-- 442
              F+R  L    L  + V      F +  +LGKG F  V    +R  G + A + +   
Sbjct: 164 SIYFNR-FLQWKWLERQPV--TKNTFRQYRVLGKGGFGEVCACQVRATGKMYACKKLEKK 220

Query: 443 -------VTSCKSEEAEFVKGLYLLTSLRHENIIRLRGFCCSRGRGECFLIYDFAPKGKL 495
                       +E+        +L  +    ++ L        +    L+      G L
Sbjct: 221 RIKKRKGEAMALNEKQ-------ILEKVNSRFVVSL--AYAYETKDALCLVLTLMNGGDL 271

Query: 496 SKYLDQEEGSSNVLDWSTRVSIIIGIAKGIGYLHSSEVNKPAIVHRNLSVEKVLIDQQFN 555
             ++            +  V     I  G+  LH        IV+R+L  E +L+D   +
Sbjct: 272 KFHIYHM--GQAGFPEARAVFYAAEICCGLEDLHRER-----IVYRDLKPENILLDDHGH 324

Query: 556 PLIADCGLHKLLADDIVFSVLKTSAAM----GYLAPEYVTTGRFTERSDIFAFGVIILQI 611
             I+D GL   + +       +T        GY+APE V   R+T   D +A G ++ ++
Sbjct: 325 IRISDLGLAVHVPEG------QTIKGRVGTVGYMAPEVVKNERYTFSPDWWALGCLLYEM 378

Query: 612 LTG 614
           + G
Sbjct: 379 IAG 381

>3mi9_A Cell division protein kinase 9; P-TEFB, HIV-1, protein binding; HET: TPO; 2.10A {Homo sapiens} PDB: 3mia_A* 3blh_A* 3blq_A* 3blr_A* 3lq5_A* 3my1_A* 3tn8_A* 3tnh_A* 3tni_A* Length = 351

 Score = 52.6 bits (127), Expect = 2e-07
 Identities = 38/170 (22%), Positives = 72/170 (42%), Gaps = 33/170 (19%)

Query: 410 CFSEVNLLGKGNFSSVYKGT-LRDGTLVA---IR------SINVTSCKSEEAEFVKGLYL 459
            + ++  +G+G F  V+K    + G  VA   +          +T+        ++ + +
Sbjct: 18  KYEKLAKIGQGTFGEVFKARHRKTGQKVALKKVLMENEKEGFPITA--------LREIKI 69

Query: 460 LTSLRHENIIRLRGFCCSRG------RGECFLIYDFAPKGKLSKYLDQEEGSSNVLDWST 513
           L  L+HEN++ L   C ++       +G  +L++DF     L+  L            S 
Sbjct: 70  LQLLKHENVVNLIEICRTKASPYNRCKGSIYLVFDFCEH-DLAGLLSN---VLVKFTLSE 125

Query: 514 RVSIIIGIAKGIGYLHSSEVNKPAIVHRNLSVEKVLIDQQFNPLIADCGL 563
              ++  +  G+ Y+H    NK  I+HR++    VLI +     +AD GL
Sbjct: 126 IKRVMQMLLNGLYYIHR---NK--ILHRDMKAANVLITRDGVLKLADFGL 170

>4fr4_A YANK1, serine/threonine-protein kinase 32A; structural genomics, structural genomics consortium, SGC, TR; HET: STU; 2.29A {Homo sapiens} Length = 384

 Score = 52.7 bits (127), Expect = 2e-07
 Identities = 46/213 (21%), Positives = 89/213 (41%), Gaps = 25/213 (11%)

Query: 411 FSEVNLLGKGNFSSVYKGTLRD-GTLVAIRSINVTSC-KSEEAEFVKG-LYLLTSLRHEN 467
           F  +  +GKG+F  V      D   + A++ +N   C +  E   V   L ++  L H  
Sbjct: 17  FEILRAIGKGSFGKVCIVQKNDTKKMYAMKYMNKQKCVERNEVRNVFKELQIMQGLEHPF 76

Query: 468 IIRLRG-FCCSRGRGECFLIYDFAPKGKLSKYLDQEEGSSNVLDWSTRVSIIIG-IAKGI 525
           ++ L   F   +   + F++ D    G L  +L Q             V + I  +   +
Sbjct: 77  LVNLWYSF---QDEEDMFMVVDLLLGGDLRYHLQQNVHFKE-----ETVKLFICELVMAL 128

Query: 526 GYLHSSEVNKPAIVHRNLSVEKVLIDQQFNPLIADCGLHKLLADDIVFSVLKT-SAAMGY 584
            YL +       I+HR++  + +L+D+  +  I D  +  +L  +   + + T +    Y
Sbjct: 129 DYLQNQR-----IIHRDMKPDNILLDEHGHVHITDFNIAAMLPRE---TQITTMAGTKPY 180

Query: 585 LAPEYVTTGRFTERS---DIFAFGVIILQILTG 614
           +APE  ++ +    S   D ++ GV   ++L G
Sbjct: 181 MAPEMFSSRKGAGYSFAVDWWSLGVTAYELLRG 213

>1blx_A Cyclin-dependent kinase 6; inhibitor protein, cyclin-dependent kinase, cell cycle control, alpha/beta, complex (inhibitor protein/kinase); 1.90A {Homo sapiens} SCOP: d.144.1.7 PDB: 1bi7_A 1bi8_A 1g3n_A 2f2c_B* 1jow_B* 2euf_B* 1xo2_B* 3nup_A* 3nux_A* 2w9z_B 2w99_B 2w96_B 2w9f_B Length = 326

 Score = 51.4 bits (124), Expect = 4e-07
 Identities = 39/170 (22%), Positives = 73/170 (42%), Gaps = 23/170 (13%)

Query: 406 SATQCFSEVNLLGKGNFSSVYKG--TLRDGTLVAIRSINVTSCKSEEAEF-------VKG 456
            A Q +  V  +G+G +  V+K       G  VA++ + V   ++ E          V  
Sbjct: 8   RADQQYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRV---QTGEEGMPLSTIREVAV 64

Query: 457 LYLLTSLRHENIIRLRGFCCSRGRGEC---FLIYDFAPKGKLSKYLDQEEGSSNVLDWST 513
           L  L +  H N++RL   C            L+++   +  L+ YLD+       +   T
Sbjct: 65  LRHLETFEHPNVVRLFDVCTVSRTDRETKLTLVFEHVDQ-DLTTYLDKVPEPG--VPTET 121

Query: 514 RVSIIIGIAKGIGYLHSSEVNKPAIVHRNLSVEKVLIDQQFNPLIADCGL 563
              ++  + +G+ +LHS   ++  +VHR+L  + +L+       +AD GL
Sbjct: 122 IKDMMFQLLRGLDFLHS---HR--VVHRDLKPQNILVTSSGQIKLADFGL 166

>2ca6_A RAN GTPase-activating protein 1; GAP, GTPase activation, hemihedral twinning, leucine-rich repeat protein, LRR, merohedral twinning; 2.2A {Schizosaccharomyces pombe} SCOP: c.10.1.2 PDB: 1k5g_C* 1k5d_C 1yrg_A Length = 386

 Score = 51.3 bits (123), Expect = 7e-07
 Identities = 35/178 (19%), Positives = 59/178 (33%), Gaps = 36/178 (20%)

Query: 84  LSPSLSGLKCLSGLYLHYNS---LSGEIPKEIRNLTE-------LTDLYLDVNNLSGN-- 131
           LS +++  K L            +  EIP+ +R L +       L  + L  N       
Sbjct: 52  LSENIASKKDLEIAEFSDIFTGRVKDEIPEALRLLLQALLKCPKLHTVRLSDNAFGPTAQ 111

Query: 132 --IPPEIGSMASLQVLQLCCNQLT-------------GNIPAQIGSLKSLSVLTLQHNRL 176
             +   +     L+ L L  N L                +  +  +   L  +    NRL
Sbjct: 112 EPLIDFLSKHTPLEHLYLHNNGLGPQAGAKIARALQELAVNKKAKNAPPLRSIICGRNRL 171

Query: 177 -NGG---IPDSLGNLGKLKRLDLSFNSLF-----GTIPESLANNAELLFLDVQNNTLS 225
            NG       +  +   L  + +  N +        + E LA   EL  LD+Q+NT +
Sbjct: 172 ENGSMKEWAKTFQSHRLLHTVKMVQNGIRPEGIEHLLLEGLAYCQELKVLDLQDNTFT 229

>2ca6_A RAN GTPase-activating protein 1; GAP, GTPase activation, hemihedral twinning, leucine-rich repeat protein, LRR, merohedral twinning; 2.2A {Schizosaccharomyces pombe} SCOP: c.10.1.2 PDB: 1k5g_C* 1k5d_C 1yrg_A Length = 386

 Score = 45.5 bits (108), Expect = 4e-05
 Identities = 34/174 (19%), Positives = 57/174 (32%), Gaps = 32/174 (18%)

Query: 84  LSPSLSGLKCLSGLYLHYNSLSGE-------------IPKEIRNLTELTDLYLDVNNLSG 130
           L   LS    L  LYLH N L  +             + K+ +N   L  +    N L  
Sbjct: 114 LIDFLSKHTPLEHLYLHNNGLGPQAGAKIARALQELAVNKKAKNAPPLRSIICGRNRLEN 173

Query: 131 NIPPEIGSM----ASLQVLQLCCNQLT-----GNIPAQIGSLKSLSVLTLQHNRLNG--- 178
               E          L  +++  N +        +   +   + L VL LQ N       
Sbjct: 174 GSMKEWAKTFQSHRLLHTVKMVQNGIRPEGIEHLLLEGLAYCQELKVLDLQDNTFTHLGS 233

Query: 179 -GIPDSLGNLGKLKRLDLSFNSL----FGTIPESLAN--NAELLFLDVQNNTLS 225
             +  +L +   L+ L L+   L       + ++ +   N  L  L +Q N + 
Sbjct: 234 SALAIALKSWPNLRELGLNDCLLSARGAAAVVDAFSKLENIGLQTLRLQYNEIE 287

>1a9n_A U2A', U2A'; complex (nuclear protein/RNA), RNA, snRNP, ribonucleoprotein, RNA binding protein/RNA complex; 2.38A {Homo sapiens} SCOP: c.10.2.4 Length = 176

 Score = 48.9 bits (117), Expect = 7e-07
 Identities = 24/116 (20%), Positives = 41/116 (35%), Gaps = 10/116 (8%)

Query: 111 EIRNLTELTDLYLDVNNLSGNIPPEIGSMASLQVLQLCCNQLT--GNIPAQIGSLKSLSV 168
           +  N     +L L        I     ++     +    N++      P     L+ L  
Sbjct: 14  QYTNAVRDRELDLR-GYKIPVIENLGATLDQFDAIDFSDNEIRKLDGFP----LLRRLKT 68

Query: 169 LTLQHNRLNGGIPDSLGNLGKLKRLDLSFNSL--FGTIPESLANNAELLFLDVQNN 222
           L + +NR+          L  L  L L+ NSL   G + + LA+   L +L +  N
Sbjct: 69  LLVNNNRICRIGEGLDQALPDLTELILTNNSLVELGDL-DPLASLKSLTYLCILRN 123

>1cm8_A Phosphorylated MAP kinase P38-gamma; phosphorylation, transferase; HET: TPO PTR ANP; 2.40A {Homo sapiens} SCOP: d.144.1.7 Length = 367

 Score = 50.4 bits (121), Expect = 1e-06
 Identities = 49/215 (22%), Positives = 89/215 (41%), Gaps = 30/215 (13%)

Query: 411 FSEVNLLGKGNFSSVYKGT-LRDGTLVAIRSI-----NVTSCKSEEAEFVKGLYLLTSLR 464
           + ++  +G G + +V      R G  VAI+ +     +    K    E    L LL  +R
Sbjct: 27  YRDLQPVGSGAYGAVCSAVDGRTGAKVAIKKLYRPFQSELFAKRAYRE----LRLLKHMR 82

Query: 465 HENIIRLRGFCCSRGRGECF----LIYDFAPKGKLSKYLDQEEGSSNVLDWSTRVSIIIG 520
           HEN+I L          + F    L+  F     L K +         L       ++  
Sbjct: 83  HENVIGLLDVFTPDETLDDFTDFYLVMPFMGT-DLGKLM-----KHEKLGEDRIQFLVYQ 136

Query: 521 IAKGIGYLHSSEVNKPAIVHRNLSVEKVLIDQQFNPLIADCGLHKLLADDIVFSVLKTSA 580
           + KG+ Y+H++ +     +HR+L    + +++     I D GL +    ++   V     
Sbjct: 137 MLKGLRYIHAAGI-----IHRDLKPGNLAVNEDCELKILDFGLARQADSEMTGYV----V 187

Query: 581 AMGYLAPEYV-TTGRFTERSDIFAFGVIILQILTG 614
              Y APE +    R+T+  DI++ G I+ +++TG
Sbjct: 188 TRWYRAPEVILNWMRYTQTVDIWSVGCIMAEMITG 222

>2fst_X Mitogen-activated protein kinase 14; active mutants, lipids, MAP kinase insertion, autophosphorylation, transferase; HET: BOG; 1.45A {Homo sapiens} PDB: 2fso_X* 2fsl_X* 2fsm_X* 2npq_A* 2bal_A* 2baj_A* 2bak_A* 2baq_A* 2qd9_A* 1ian_A* 2rg5_A* 2rg6_A* 3bv2_A* 3bv3_A* 3bx5_A* 3c5u_A* 3cg2_A* 3l8x_A* 3mvl_A* 3mvm_A* ... Length = 367

 Score = 49.3 bits (118), Expect = 3e-06
 Identities = 50/218 (22%), Positives = 92/218 (42%), Gaps = 30/218 (13%)

Query: 408 TQCFSEVNLLGKGNFSSVYKGT-LRDGTLVAIRSI-----NVTSCKSEEAEFVKGLYLLT 461
            + +  ++ +G G + SV      + G  VA++ +     ++   K    E    L LL 
Sbjct: 28  PERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRE----LRLLK 83

Query: 462 SLRHENIIRLRGFCCSRGRGECF----LIYDFAPKGKLSKYLDQEEGSSNVLDWSTRVSI 517
            ++HEN+I L          E F    L+        L+  +         L       +
Sbjct: 84  HMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGA-DLNNIV-----KCQKLTDDHVQFL 137

Query: 518 IIGIAKGIGYLHSSEVNKPAIVHRNLSVEKVLIDQQFNPLIADCGLHKLLADDIVFSVLK 577
           I  I +G+ Y+HS+++     +HR+L    + +++     I D GL +  AD++   V  
Sbjct: 138 IYQILRGLKYIHSADI-----IHRDLKPSNLAVNEDCELKILDFGLARHTADEMTGYV-- 190

Query: 578 TSAAMGYLAPEYVTT-GRFTERSDIFAFGVIILQILTG 614
             A   Y APE +     + +  DI++ G I+ ++LTG
Sbjct: 191 --ATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTG 226

>1rdq_E PKA C-alpha, CAMP-dependent protein kinase, alpha-catalytic SU; CAMP-dependent protein kinase,catalytic mechanism, ATP hydro two nucleotide states; HET: TPO SEP ADP ATP; 1.26A {Mus musculus} SCOP: d.144.1.7 PDB: 2erz_E* 3fjq_E* 1bkx_A* 1atp_E* 1fmo_E* 1j3h_A* 1jlu_E* 1bx6_A* 1re8_A* 1rej_A* 1rek_A* 2cpk_E* 2qcs_A* 2qvs_E* 1l3r_E* 3idb_A* 3idc_A* 3o7l_D* 3ow3_A* 3tnp_C* ... Length = 350

 Score = 48.8 bits (117), Expect = 3e-06
 Identities = 43/211 (20%), Positives = 85/211 (40%), Gaps = 26/211 (12%)

Query: 411 FSEVNLLGKGNFSSVYKGTLRD-GTLVAIRSINVTSC-KSEEAEFVKG-LYLLTSLRHEN 467
           F  +  LG G+F  V     ++ G   A++ ++     K ++ E       +L ++    
Sbjct: 43  FDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPF 102

Query: 468 IIRLRGFCCSRGRGECFLIYDFAPKGKLSKYLDQEEGSSNVLDWSTRVSIIIG-IAKGIG 526
           +++L            +++ ++   G++  +L +    S               I     
Sbjct: 103 LVKLEFSFKDNSN--LYMVMEYVAGGEMFSHLRRIGRFSE-----PHARFYAAQIVLTFE 155

Query: 527 YLHSSEVNKPAIVHRNLSVEKVLIDQQFNPLIADCGLHKLLADDIVFSVLKTSAAMG--- 583
           YLHS +     +++R+L  E +LIDQQ    + D G  K +         +T    G   
Sbjct: 156 YLHSLD-----LIYRDLKPENLLIDQQGYIQVTDFGFAKRVKG-------RTWTLCGTPE 203

Query: 584 YLAPEYVTTGRFTERSDIFAFGVIILQILTG 614
            LAPE + +  + +  D +A GV+I ++  G
Sbjct: 204 ALAPEIILSKGYNKAVDWWALGVLIYEMAAG 234

>4aw2_A Serine/threonine-protein kinase MRCK alpha; transferase, CDC42BPA; HET: 22E; 1.70A {Rattus norvegicus} PDB: 3tku_A* 3qfv_A* Length = 437

 Score = 49.0 bits (117), Expect = 4e-06
 Identities = 56/298 (18%), Positives = 111/298 (37%), Gaps = 47/298 (15%)

Query: 392 EHLNSFRLNLEEVESAT---QCFSEVNLLGKGNFSSVY----KGTLRDGTLVAIRSIN-V 443
           E+L   +    +V+      + F  + ++G+G F  V     K       + A++ +N  
Sbjct: 54  EYLEWAKPFTSKVKQMRLHREDFEILKVIGRGAFGEVAVVKLKNA---DKVFAMKILNKW 110

Query: 444 TSCKSEEAEFVKG-LYLLTSLRHENIIRLRGFCCSRGRGECFLIYDFAPKGKLSKYLDQE 502
              K  E    +    +L +   + I  L      +     +L+ D+   G L   L + 
Sbjct: 111 EMLKRAETACFREERDVLVNGDSKWITTL--HYAFQDDNNLYLVMDYYVGGDLLTLLSKF 168

Query: 503 EGSSNVLDWSTRVSIIIG-IAKGIGYLHSSEVNKPAIVHRNLSVEKVLIDQQFNPLIADC 561
           E     L         +  +   I  +H         VHR++  + +L+D   +  +AD 
Sbjct: 169 ED---RLP-EEMARFYLAEMVIAIDSVHQLH-----YVHRDIKPDNILMDMNGHIRLADF 219

Query: 562 GLHKLLADDIVFSVLKTSAAMG---YLAPEYVTTGRFTERS-----DIFAFGVIILQILT 613
           G    L +D     +++S A+G   Y++PE +      +       D ++ GV + ++L 
Sbjct: 220 GSCLKLMED---GTVQSSVAVGTPDYISPEILQAMEGGKGRYGPECDWWSLGVCMYEMLY 276

Query: 614 GSLVLTSSMRLAAESATFENFIDRNLKGKFSE-----SEAAKLGKMALVCTHEDPENR 666
           G     +     +   T+   ++   + +F       SE AK     L+C     E+R
Sbjct: 277 GETPFYAE----SLVETYGKIMNHKERFQFPTQVTDVSENAKDLIRRLIC---SREHR 327

>3qyz_A Mitogen-activated protein kinase 1; transferase, serine/threonine-protein kinase, ATP-binding CE phosphorylation; HET: CME Z8B SO4; 1.46A {Rattus norvegicus} PDB: 2fys_B 1erk_A* 3qyi_A* 3erk_A* 3qyw_A* 4erk_A* 2z7l_A* 2erk_A* 1gol_A* 2gph_A 3o71_A 3r63_A 3c9w_A* 2y9q_A* 3sa0_A* 1wzy_A* 2e14_A* 1tvo_A* 2ojg_A* 2oji_A* ... Length = 364

 Score = 48.0 bits (115), Expect = 5e-06
 Identities = 49/215 (22%), Positives = 93/215 (43%), Gaps = 26/215 (12%)

Query: 411 FSEVNLLGKGNFSSVYKGT-LRDGTLVAIRSI----NVTSCKSEEAEFVKGLYLLTSLRH 465
           ++ ++ +G+G +  V       +   VAI+ I    + T C+    E    + +L   RH
Sbjct: 29  YTNLSYIGEGAYGMVCSAYDNLNKVRVAIKKISPFEHQTYCQRTLRE----IKILLRFRH 84

Query: 466 ENIIRLRGFCCSRGR---GECFLIYDFAPKGKLSKYLDQEEGSSNVLDWSTRVSIIIGIA 522
           ENII +     +       + +++ D      L K L      +  L        +  I 
Sbjct: 85  ENIIGINDIIRAPTIEQMKDVYIVQDLMET-DLYKLL-----KTQHLSNDHICYFLYQIL 138

Query: 523 KGIGYLHSSEVNKPAIVHRNLSVEKVLIDQQFNPLIADCGLHKLLADDIVFSVLKTS--A 580
           +G+ Y+HS+ V     +HR+L    +L++   +  I D GL ++   D   +   T   A
Sbjct: 139 RGLKYIHSANV-----LHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEYVA 193

Query: 581 AMGYLAPEYV-TTGRFTERSDIFAFGVIILQILTG 614
              Y APE +  +  +T+  DI++ G I+ ++L+ 
Sbjct: 194 TRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSN 228

>1xjd_A Protein kinase C, theta type; PKC-theta, ATP, AMP,, transferase; HET: TPO SEP STU; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jed_A* Length = 345

 Score = 48.0 bits (115), Expect = 6e-06
 Identities = 51/222 (22%), Positives = 95/222 (42%), Gaps = 40/222 (18%)

Query: 409 QCFSEVNLLGKGNFSSV----YKGTLRDGTLVAIRSIN---------VTSCKSEEAEFVK 455
           + F    +LGKG+F  V    +K T       AI+++          V     E+     
Sbjct: 17  EDFILHKMLGKGSFGKVFLAEFKKT---NQFFAIKALKKDVVLMDDDVECTMVEKR---- 69

Query: 456 GLYLLTSLRHENIIRLRGFCCSRGRGECFLIYDFAPKGKLSKYLDQEEGSSNVLDWSTRV 515
              L  +  H  +  +  FC  + +   F + ++   G L  ++          D S   
Sbjct: 70  --VLSLAWEHPFLTHM--FCTFQTKENLFFVMEYLNGGDLMYHIQSCH----KFDLSRAT 121

Query: 516 SIIIGIAKGIGYLHSSEVNKPAIVHRNLSVEKVLIDQQFNPLIADCGLHKLLADDIVFSV 575
                I  G+ +LHS       IV+R+L ++ +L+D+  +  IAD G+ K   ++++   
Sbjct: 122 FYAAEIILGLQFLHSK-----GIVYRDLKLDNILLDKDGHIKIADFGMCK---ENMLGDA 173

Query: 576 LKTSAAMG---YLAPEYVTTGRFTERSDIFAFGVIILQILTG 614
            KT+   G   Y+APE +   ++    D ++FGV++ ++L G
Sbjct: 174 -KTNTFCGTPDYIAPEILLGQKYNHSVDWWSFGVLLYEMLIG 214

>2i6l_A Mitogen-activated protein kinase 6; MAPK6, ERK3, extracellular signal regulated kinase 3, serine phosphorylation, threonine phosphorylation; 2.25A {Homo sapiens} Length = 320

 Score = 47.3 bits (113), Expect = 9e-06
 Identities = 45/220 (20%), Positives = 85/220 (38%), Gaps = 27/220 (12%)

Query: 411 FSEVNLLGKGNFSSVYKGT-LRDGTLVAIRSI---NVTSCKSEEAEFVKGLYLLTSLRHE 466
           + ++  LG G    V+          VAI+ I   +  S K    E    + ++  L H+
Sbjct: 13  YMDLKPLGCGGNGLVFSAVDNDCDKRVAIKKIVLTDPQSVKHALRE----IKIIRRLDHD 68

Query: 467 NIIRLRGFCCSRGRGECFLIYDFAPKGKLSKYLDQE--EG------SSNVLDWSTRVSII 518
           NI+++       G      +        +  Y+ QE  E           L        +
Sbjct: 69  NIVKVFEILGPSGSQLTDDVGSLTELNSV--YIVQEYMETDLANVLEQGPLLEEHARLFM 126

Query: 519 IGIAKGIGYLHSSEVNKPAIVHRNLSVEKVLIDQQFNPL-IADCGLHKLLADDIVFSVLK 577
             + +G+ Y+HS+ V     +HR+L    + I+ +   L I D GL +++          
Sbjct: 127 YQLLRGLKYIHSANV-----LHRDLKPANLFINTEDLVLKIGDFGLARIMDPHYSHKGHL 181

Query: 578 TS--AAMGYLAPE-YVTTGRFTERSDIFAFGVIILQILTG 614
           +       Y +P   ++   +T+  D++A G I  ++LTG
Sbjct: 182 SEGLVTKWYRSPRLLLSPNNYTKAIDMWAAGCIFAEMLTG 221

>1o6l_A RAC-beta serine/threonine protein kinase; protein kinase, transferase, serine/threonine-protein kinase; HET: TPO ANP; 1.6A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jdo_A* 2jdr_A* 2uw9_A* 2x37_A* 2x39_A* 2xh5_A* 3d0e_A* 3e87_A* 3e88_A* 3e8d_A* 1o6k_A* 1mrv_A 1mry_A 1gzn_A 1gzk_A 1gzo_A 3qkl_A* 3ocb_A* 3ow4_A* 3qkk_A* ... Length = 337

 Score = 46.8 bits (112), Expect = 1e-05
 Identities = 47/220 (21%), Positives = 85/220 (38%), Gaps = 37/220 (16%)

Query: 409 QCFSEVNLLGKGNFSSVYKGTLRD-GTLVAIRSIN---------VTSCKSEEAEFVKGLY 458
             F  + LLGKG F  V     +  G   A++ +          V    +E         
Sbjct: 5   NDFDYLKLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESR------- 57

Query: 459 LLTSLRHENIIRLRGFCCSRGRGECFLIYDFAPKGKLSKYLDQEEGSSNVLDWSTRVSII 518
           +L + RH  +  L      +       + ++A  G+L  +L +E   +       R    
Sbjct: 58  VLQNTRHPFLTAL--KYAFQTHDRLCFVMEYANGGELFFHLSRERVFT-----EERARFY 110

Query: 519 IG-IAKGIGYLHSSEVNKPAIVHRNLSVEKVLIDQQFNPLIADCGLHKLLADDIVFSVLK 577
              I   + YLHS +     +V+R++ +E +++D+  +  I D GL K   + I      
Sbjct: 111 GAEIVSALEYLHSRD-----VVYRDIKLENLMLDKDGHIKITDFGLCK---EGISDGA-T 161

Query: 578 TSAAMG---YLAPEYVTTGRFTERSDIFAFGVIILQILTG 614
                G   YLAPE +    +    D +  GV++ +++ G
Sbjct: 162 MKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCG 201

>4dc2_A Protein kinase C IOTA type; kinase, substrate, cell polarity, atypical PKC, trans transferase substrate complex; HET: TPO ADE; 2.40A {Mus musculus} Length = 396

 Score = 47.0 bits (112), Expect = 1e-05
 Identities = 40/220 (18%), Positives = 90/220 (40%), Gaps = 36/220 (16%)

Query: 409 QCFSEVNLLGKGNFSSVYKGTLRD-GTLVAIRSI---------NVTSCKSEEAEFVKGLY 458
           Q F  + ++G+G+++ V    L+    + A+R +         ++   ++E+        
Sbjct: 52  QDFDLLRVIGRGSYAKVLLVRLKKTDRIYAMRVVKKELVNDDEDIDWVQTEKH------V 105

Query: 459 LLTSLRHENIIRLRGFCCSRGRGECFLIYDFAPKGKLSKYLDQEEGSSNVLDWSTRVSII 518
              +  H  ++ L    C +     F + ++   G L  ++ ++                
Sbjct: 106 FEQASNHPFLVGL--HSCFQTESRLFFVIEYVNGGDLMFHMQRQRKLP-----EEHARFY 158

Query: 519 IG-IAKGIGYLHSSEVNKPAIVHRNLSVEKVLIDQQFNPLIADCGLHKLLADDIVFSVLK 577
              I+  + YLH        I++R+L ++ VL+D + +  + D G+ K   + +      
Sbjct: 159 SAEISLALNYLHERG-----IIYRDLKLDNVLLDSEGHIKLTDYGMCK---EGLRPGD-T 209

Query: 578 TSAAMG---YLAPEYVTTGRFTERSDIFAFGVIILQILTG 614
           TS   G   Y+APE +    +    D +A GV++ +++ G
Sbjct: 210 TSTFCGTPNYIAPEILRGEDYGFSVDWWALGVLMFEMMAG 249

>2i0e_A Protein kinase C-beta II; serine/threonine protein kinase, transferase; HET: TPO SEP PDS; 2.60A {Homo sapiens} PDB: 3iw4_A* Length = 353

 Score = 46.5 bits (111), Expect = 2e-05
 Identities = 47/220 (21%), Positives = 90/220 (40%), Gaps = 36/220 (16%)

Query: 409 QCFSEVNLLGKGNFSSVYKGTLRD-GTLVAIRSI---------NVTSCKSEEAEFVKGLY 458
             F+ + +LGKG+F  V     +    L A++ +         +V     E+        
Sbjct: 20  TDFNFLMVLGKGSFGKVMLSERKGTDELYAVKILKKDVVIQDDDVECTMVEKR------V 73

Query: 459 LLTSLRHENIIRLRGFCCSRGRGECFLIYDFAPKGKLSKYLDQEEGSSNVLDWSTRVSII 518
           L    +   + +L    C +     + + ++   G L  ++ Q                 
Sbjct: 74  LALPGKPPFLTQL--HSCFQTMDRLYFVMEYVNGGDLMYHIQQVGRFK-----EPHAVFY 126

Query: 519 IG-IAKGIGYLHSSEVNKPAIVHRNLSVEKVLIDQQFNPLIADCGLHKLLADDIVFSVLK 577
              IA G+ +L S       I++R+L ++ V++D + +  IAD G+ K   ++I   V  
Sbjct: 127 AAEIAIGLFFLQSK-----GIIYRDLKLDNVMLDSEGHIKIADFGMCK---ENIWDGV-T 177

Query: 578 TSAAMG---YLAPEYVTTGRFTERSDIFAFGVIILQILTG 614
           T    G   Y+APE +    + +  D +AFGV++ ++L G
Sbjct: 178 TKTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAG 217

>3v8s_A RHO-associated protein kinase 1; dimerization, myosin, transferase, inhibitor, transf transferase inhibitor complex; HET: 0HD; 2.29A {Homo sapiens} PDB: 3tv7_A* 2etr_A* 2esm_A* 2eto_A* 2etk_A* 3d9v_A* 3ncz_A* 3ndm_A* 2v55_A* 2f2u_A* 2h9v_A* Length = 410

 Score = 46.6 bits (111), Expect = 2e-05
 Identities = 43/272 (15%), Positives = 102/272 (37%), Gaps = 56/272 (20%)

Query: 368 LVSLEYCHGWDPLGDYLNGTGFSREHLNSFRLNLEEVESATQCFSEVNLLGKGNFSSVY- 426
           L +L Y   +  L    N   F   +       + ++    + +  V ++G+G F  V  
Sbjct: 29  LDALVYDLDFPALRKNKNIDNFLSRY-KDTINKIRDLRMKAEDYEVVKVIGRGAFGEVQL 87

Query: 427 ---KGTLRDGTLVAIRSINVTSCKSE-----EAEFVKG-LYLLTSLRHENIIRLRGFCCS 477
              K T     + A++ ++    K E     ++ F      ++       +++L  F   
Sbjct: 88  VRHKST---RKVYAMKLLS----KFEMIKRSDSAFFWEERDIMAFANSPWVVQL--FYAF 138

Query: 478 RGRGECFLIYDFAPKGKLSKYLDQEEGSSNVLDWSTRVSIIIGIAK--------GIGYLH 529
           +     +++ ++ P G L   +   +                  A+         +  +H
Sbjct: 139 QDDRYLYMVMEYMPGGDLVNLMSNYDVPEKW-------------ARFYTAEVVLALDAIH 185

Query: 530 SSEVNKPAIVHRNLSVEKVLIDQQFNPLIADCGLHKLLADDIVFSVLKTSAAMG---YLA 586
           S        +HR++  + +L+D+  +  +AD G    +  +    +++   A+G   Y++
Sbjct: 186 SMG-----FIHRDVKPDNMLLDKSGHLKLADFGTCMKMNKE---GMVRCDTAVGTPDYIS 237

Query: 587 PEYVTT----GRFTERSDIFAFGVIILQILTG 614
           PE + +    G +    D ++ GV + ++L G
Sbjct: 238 PEVLKSQGGDGYYGRECDWWSVGVFLYEMLVG 269

>3a62_A Ribosomal protein S6 kinase beta-1; kinase domain, inactive, active, ribosomal S6 kinase, activation, alternative initiation, ATP-binding; HET: TPO STU; 2.35A {Homo sapiens} PDB: 3a61_A* 3a60_A* Length = 327

 Score = 46.4 bits (111), Expect = 2e-05
 Identities = 48/220 (21%), Positives = 96/220 (43%), Gaps = 29/220 (13%)

Query: 409 QCFSEVNLLGKGNFSSVY---KGTLRD-GTLVAIRSIN--VTSCKSEEAEFVKG-LYLLT 461
           +CF  + +LGKG +  V+   K T  + G + A++ +   +    +++    K    +L 
Sbjct: 17  ECFELLRVLGKGGYGKVFQVRKVTGANTGKIFAMKVLKKAMIVRNAKDTAHTKAERNILE 76

Query: 462 SLRHENIIRLRGFCCSRGRGECFLIYDFAPKGKLSKYLDQEEGSSNVLDWSTRVSIIIG- 520
            ++H  I+ L      +  G+ +LI ++   G+L   L++E                +  
Sbjct: 77  EVKHPFIVDL--IYAFQTGGKLYLILEYLSGGELFMQLEREGIFM-----EDTACFYLAE 129

Query: 521 IAKGIGYLHSSEVNKPAIVHRNLSVEKVLIDQQFNPLIADCGLHKL-LADDIVFSVLKTS 579
           I+  +G+LH        I++R+L  E ++++ Q +  + D GL K  + D        T 
Sbjct: 130 ISMALGHLHQK-----GIIYRDLKPENIMLNHQGHVKLTDFGLCKESIHDGT-----VTH 179

Query: 580 AAMG---YLAPEYVTTGRFTERSDIFAFGVIILQILTGSL 616
              G   Y+APE +         D ++ G ++  +LTG+ 
Sbjct: 180 TFCGTIEYMAPEILMRSGHNRAVDWWSLGALMYDMLTGAP 219

>3uqc_A Probable conserved transmembrane protein; structural genomics, TB structural genomics consortium, TBSG fold, FHAA, transferase; 2.26A {Mycobacterium tuberculosis} PDB: 3oun_B* 3otv_A 3ouk_A Length = 286

 Score = 45.9 bits (109), Expect = 2e-05
 Identities = 31/277 (11%), Positives = 74/277 (26%), Gaps = 51/277 (18%)

Query: 416 LLGKGNFSSVYKGTLRDGTL---VAIRSINVTSCKSEE--AEFVKGLYLLTSLRHENIIR 470
             G       ++    D  L   VA+  ++      ++   E +     L+ +    + R
Sbjct: 38  FHGGVPPLQFWQA--LDTALDRQVALTFVDPQGVLPDDVLQETLSRTLRLSRIDKPGVAR 95

Query: 471 LRGFCCSRGRGECFLIYDFAPKGKLSKYLDQEEGSSNVLDWSTRVSIIIGIAKGIGYLHS 530
           +        R    ++ ++   G L +  D              +  +  +A      H 
Sbjct: 96  V--LDVVHTRAGGLVVAEWIRGGSLQEVADTS------PSPVGAIRAMQSLAAAADAAHR 147

Query: 531 SEVNKPAIVHRNLSVEKVLIDQQFNPLIADCGLHKLLADDIVFSVLKTSAAMGYLAPEYV 590
           +      +        +V +                  D  V  VL   A    +     
Sbjct: 148 A-----GVALSIDHPSRVRVS----------------IDGDV--VL---AYPATMPDA-- 179

Query: 591 TTGRFTERSDIFAFGVIILQILTGSLVLTSSMRLAAESATFENFIDRNLK-GKFSESEAA 649
                  + DI   G  +  +L     L  +   +  +    +   + ++          
Sbjct: 180 -----NPQDDIRGIGASLYALLVNRWPLPEAGVRSGLAPAERDTAGQPIEPADIDRDIPF 234

Query: 650 KLGKMALVCTHEDPENRP--TMEAVIEELTVAAPVMA 684
           ++  +A      D   R   T+  ++++ T  A    
Sbjct: 235 QISAVAARSVQGDGGIRSASTLLNLMQQATAVADRTE 271

>1w8a_A SLIT protein; signaling protein, secreted protein, AXON guidance, leucine-rich repeat glycoprotein, EGF-like domain, signal protein; 2.8A {Drosophila melanogaster} SCOP: c.10.2.7 Length = 192

 Score = 44.6 bits (106), Expect = 2e-05
 Identities = 26/107 (24%), Positives = 42/107 (39%), Gaps = 7/107 (6%)

Query: 72  NISLQGKGLTGKLSPS--LSGLKCLSGLYLHYNSLSGEIPKEIRNLTELTDLYLDVNNLS 129
            + L    L  ++S       L  L  L L  N L+G  P      + + +L L  N + 
Sbjct: 33  ELLLNDNELG-RISSDGLFGRLPHLVKLELKRNQLTGIEPNAFEGASHIQELQLGENKIK 91

Query: 130 GNIPPEI-GSMASLQVLQLCCNQLTGNIPAQI-GSLKSLSVLTLQHN 174
             I  ++   +  L+ L L  NQ++  +       L SL+ L L  N
Sbjct: 92  -EISNKMFLGLHQLKTLNLYDNQIS-CVMPGSFEHLNSLTSLNLASN 136

>3a8x_A Protein kinase C IOTA type; transferase; HET: TPO; 2.00A {Homo sapiens} PDB: 3a8w_A* 1zrz_A* Length = 345

 Score = 46.1 bits (110), Expect = 2e-05
 Identities = 39/220 (17%), Positives = 90/220 (40%), Gaps = 36/220 (16%)

Query: 409 QCFSEVNLLGKGNFSSVYKGTLRD-GTLVAIRSI---------NVTSCKSEEAEFVKGLY 458
           Q F  + ++G+G+++ V    L+    + A++ +         ++   ++E+        
Sbjct: 9   QDFDLLRVIGRGSYAKVLLVRLKKTDRIYAMKVVKKELVNDDEDIDWVQTEKH------V 62

Query: 459 LLTSLRHENIIRLRGFCCSRGRGECFLIYDFAPKGKLSKYLDQEEGSSNVLDWSTRVSII 518
              +  H  ++ L    C +     F + ++   G L  ++ ++                
Sbjct: 63  FEQASNHPFLVGL--HSCFQTESRLFFVIEYVNGGDLMFHMQRQRKLP-----EEHARFY 115

Query: 519 IG-IAKGIGYLHSSEVNKPAIVHRNLSVEKVLIDQQFNPLIADCGLHKLLADDIVFSVLK 577
              I+  + YLH        I++R+L ++ VL+D + +  + D G+ K   + +      
Sbjct: 116 SAEISLALNYLHERG-----IIYRDLKLDNVLLDSEGHIKLTDYGMCK---EGLRPGD-T 166

Query: 578 TSAAMG---YLAPEYVTTGRFTERSDIFAFGVIILQILTG 614
           TS   G   Y+APE +    +    D +A GV++ +++ G
Sbjct: 167 TSTFCGTPNYIAPEILRGEDYGFSVDWWALGVLMFEMMAG 206

>3g39_A Variable lymphocyte receptor VLRB.2D; antibody, X-RAY, crystallography, immune system; 1.55A {Petromyzon marinus} PDB: 3g3a_A 3g3b_A 3twi_D Length = 170

 Score = 44.1 bits (105), Expect = 3e-05
 Identities = 29/80 (36%), Positives = 42/80 (52%), Gaps = 4/80 (5%)

Query: 97  LYLHYNSLSGEIPKEIRNLTELTDLYLDVNNLSGNIPPEI-GSMASLQVLQLCCNQLTGN 155
           LYL+ N ++   P     LT+LT L LD N L+  +P  +   +  L  L L  NQL  +
Sbjct: 35  LYLYDNQITKLEPGVFDRLTQLTRLDLDNNQLT-VLPAGVFDKLTQLTQLSLNDNQLK-S 92

Query: 156 IPAQI-GSLKSLSVLTLQHN 174
           IP     +LKSL+ + L +N
Sbjct: 93  IPRGAFDNLKSLTHIWLLNN 112

>3rp9_A Mitogen-activated protein kinase; structural genomics, structural genomics consortium, SGC, TR; 2.40A {Toxoplasma gondii} Length = 458

 Score = 46.0 bits (109), Expect = 3e-05
 Identities = 30/162 (18%), Positives = 69/162 (42%), Gaps = 23/162 (14%)

Query: 411 FSEVNLLGKGNFSSVYKGT-LRDGTLVAIRSI-----NVTSCKSEEAEFVKGLYLLTSLR 464
           +   +L+G G++  V +     +  +VAI+ I     ++  CK    E    + +L  L 
Sbjct: 55  YEIRHLIGTGSYGHVCEAYDKLEKRVVAIKKILRVFEDLIDCKRILRE----IAILNRLN 110

Query: 465 HENIIRLRGFCCSRGR---GECFLIYDFAPKGKLSKYLDQEEGSSNVLDWSTRVSIIIGI 521
           H++++++      +      E +++ + A      K       +   L      +++  +
Sbjct: 111 HDHVVKVLDIVIPKDVEKFDELYVVLEIADS-DFKKLFR----TPVYLTELHIKTLLYNL 165

Query: 522 AKGIGYLHSSEVNKPAIVHRNLSVEKVLIDQQFNPLIADCGL 563
             G+ Y+HS+ +     +HR+L     L++Q  +  + D GL
Sbjct: 166 LVGVKYVHSAGI-----LHRDLKPANCLVNQDCSVKVCDFGL 202

>1z7x_W Ribonuclease inhibitor; leucine-rich repeat, enzyme- inhibitor complex, structural genomics, protein structure initiative, PSI, CESG; HET: CIT; 1.95A {Homo sapiens} SCOP: c.10.1.1 PDB: 2q4g_W* 2bex_A 1a4y_A 2bnh_A 1dfj_I Length = 461

 Score = 45.7 bits (109), Expect = 4e-05
 Identities = 32/160 (20%), Positives = 59/160 (36%), Gaps = 22/160 (13%)

Query: 88  LSGLKCLSGLYLHYNSLSGE----IPKEIRNLTELTDLYLDVNNLSGNIPPEIGSM---- 139
           L     L  L++    ++ +    + + +R    L +L L  N L       +       
Sbjct: 252 LHPSSRLRTLWIWECGITAKGCGDLCRVLRAKESLKELSLAGNELGDEGARLLCETLLEP 311

Query: 140 -ASLQVLQLCCNQLTG----NIPAQIGSLKSLSVLTLQHNRL-NGGIP---DSLGNLG-K 189
              L+ L +     T     +  + +   + L  L + +NRL + G+      LG  G  
Sbjct: 312 GCQLESLWVKSCSFTAACCSHFSSVLAQNRFLLELQISNNRLEDAGVRELCQGLGQPGSV 371

Query: 190 LKRLDLSFNSL----FGTIPESLANNAELLFLDVQNNTLS 225
           L+ L L+   +      ++  +L  N  L  LD+ NN L 
Sbjct: 372 LRVLWLADCDVSDSSCSSLAATLLANHSLRELDLSNNCLG 411

>1z7x_W Ribonuclease inhibitor; leucine-rich repeat, enzyme- inhibitor complex, structural genomics, protein structure initiative, PSI, CESG; HET: CIT; 1.95A {Homo sapiens} SCOP: c.10.1.1 PDB: 2q4g_W* 2bex_A 1a4y_A 2bnh_A 1dfj_I Length = 461

 Score = 44.6 bits (106), Expect = 7e-05
 Identities = 30/165 (18%), Positives = 59/165 (35%), Gaps = 23/165 (13%)

Query: 84  LSPSLSGLKCLSGLYLHYNSLSGEIPKEI-----RNLTELTDLYLDVNNLSGNIPPEIGS 138
           L+  L        L +  N ++    + +      +  +L  L L+   ++ +   ++  
Sbjct: 162 LASVLRAKPDFKELTVSNNDINEAGVRVLCQGLKDSPCQLEALKLESCGVTSDNCRDLCG 221

Query: 139 M----ASLQVLQLCCNQLTGN-----IPAQIGSLKSLSVLTLQHNRLN----GGIPDSLG 185
           +    ASL+ L L  N+L         P  +     L  L +    +     G +   L 
Sbjct: 222 IVASKASLRELALGSNKLGDVGMAELCPGLLHPSSRLRTLWIWECGITAKGCGDLCRVLR 281

Query: 186 NLGKLKRLDLSFNSLFGT----IPESLAN-NAELLFLDVQNNTLS 225
               LK L L+ N L       + E+L     +L  L V++ + +
Sbjct: 282 AKESLKELSLAGNELGDEGARLLCETLLEPGCQLESLWVKSCSFT 326

>3txo_A PKC-L, NPKC-ETA, protein kinase C ETA type; phosphotransferase, transferase-transferase inhibito; HET: TPO 07U; 2.05A {Homo sapiens} Length = 353

 Score = 44.9 bits (107), Expect = 5e-05
 Identities = 52/223 (23%), Positives = 92/223 (41%), Gaps = 42/223 (18%)

Query: 409 QCFSEVNLLGKGNFSSVY----KGTLRDGTLVAIRSI---------NVTSCKSEEAEFVK 455
             F  + +LGKG+F  V     K T   G L A++ +         +V    +E+     
Sbjct: 23  DNFEFIRVLGKGSFGKVMLARVKET---GDLYAVKVLKKDVILQDDDVECTMTEKR---- 75

Query: 456 GLYLLTSLRHENIIRLRGFCCSRGRGECFLIYDFAPKGKLSKYLDQEEGSSNVLDWSTRV 515
              L  +  H  + +L  FCC +     F + +F   G L  ++ +            R 
Sbjct: 76  --ILSLARNHPFLTQL--FCCFQTPDRLFFVMEFVNGGDLMFHIQKSRRFD-----EARA 126

Query: 516 SIIIG-IAKGIGYLHSSEVNKPAIVHRNLSVEKVLIDQQFNPLIADCGLHKLLADDIVFS 574
                 I   + +LH        I++R+L ++ VL+D + +  +AD G+ K   + I   
Sbjct: 127 RFYAAEIISALMFLHDK-----GIIYRDLKLDNVLLDHEGHCKLADFGMCK---EGICNG 178

Query: 575 VLKTSAAMG---YLAPEYVTTGRFTERSDIFAFGVIILQILTG 614
           V  T+   G   Y+APE +    +    D +A GV++ ++L G
Sbjct: 179 V-TTATFCGTPDYIAPEILQEMLYGPAVDWWAMGVLLYEMLCG 220

>3nsz_A CK II alpha, casein kinase II subunit alpha; inhibitor, transferase-transferase inhibitor CO; HET: ANP; 1.30A {Homo sapiens} PDB: 2r7i_A 3pe1_A* 1jwh_A* 3pe2_A* 3r0t_A* 3h30_A* 3q9w_A* 3q9x_A* 3q9y_A* 3q9z_A* 3qa0_A 3bqc_A* 2rkp_A* 3c13_A* 3fwq_A 3rps_A* 3mb7_A* 3mb6_A* 3owj_A* 3owk_A* ... Length = 330

 Score = 45.0 bits (107), Expect = 6e-05
 Identities = 34/156 (21%), Positives = 60/156 (38%), Gaps = 19/156 (12%)

Query: 411 FSEVNLLGKGNFSSVYKGT-LRDGTLVAIRSINVTSCKSEEAEFVKGLYLLTSLR-HENI 468
           +  V  LG+G +S V++   + +   V ++ +     K  + E +K   +L +LR   NI
Sbjct: 38  YQLVRKLGRGKYSEVFEAINITNNEKVVVKILKPVKKKKIKRE-IK---ILENLRGGPNI 93

Query: 469 IRLRGFCCSRGRGECFLIYDFAPKGKLSKYLDQEEGSSNVLDWSTRVSIIIGIAKGIGYL 528
           I L             L+++        +           L        +  I K + Y 
Sbjct: 94  ITLADIVKDPVSRTPALVFEHVNNTDFKQLYQT-------LTDYDIRFYMYEILKALDYC 146

Query: 529 HSSEVNKPAIVHRNLSVEKVLIDQQFNPL-IADCGL 563
           HS       I+HR++    V+ID +   L + D GL
Sbjct: 147 HSMG-----IMHRDVKPHNVMIDHEHRKLRLIDWGL 177

>2vd5_A DMPK protein; serine/threonine-protein kinase, kinase, transferase, ATP-BI nucleotide-binding, cardiac contractility, muscle different; HET: BI8; 2.80A {Homo sapiens} Length = 412

 Score = 45.1 bits (107), Expect = 6e-05
 Identities = 54/282 (19%), Positives = 99/282 (35%), Gaps = 54/282 (19%)

Query: 411 FSEVNLLGKGNFSSVY----KGTLRDGTLVAIRSINVTSCKSE-----EAEFVKG-LYLL 460
           F  + ++G+G FS V     K T   G + A++ +N    K +     E    +    +L
Sbjct: 63  FEILKVIGRGAFSEVAVVKMKQT---GQVYAMKIMN----KWDMLKRGEVSCFREERDVL 115

Query: 461 TSLRHENIIRLRGFCCSRGRGECFLIYDFAPKGKLSKYLDQEEGSSNVLDWSTRVSIIIG 520
            +     I +L      +     +L+ ++   G L   L +                 + 
Sbjct: 116 VNGDRRWITQL--HFAFQDENYLYLVMEYYVGGDLLTLLSKFGERIPA----EMARFYLA 169

Query: 521 -IAKGIGYLHSSEVNKPAIVHRNLSVEKVLIDQQFNPLIADCGLHKLLADDIVFSVLKTS 579
            I   I  +H         VHR++  + +L+D+  +  +AD G    L  D     +++ 
Sbjct: 170 EIVMAIDSVHRL-----GYVHRDIKPDNILLDRCGHIRLADFGSCLKLRAD---GTVRSL 221

Query: 580 AAMG---YLAPE-------YVTTGRFTERSDIFAFGVIILQILTGSLVLTSSMRLAAESA 629
            A+G   YL+PE          TG +    D +A GV   ++  G     +     + + 
Sbjct: 222 VAVGTPDYLSPEILQAVGGGPGTGSYGPECDWWALGVFAYEMFYGQTPFYAD----STAE 277

Query: 630 TFENFIDRNLKGKFSE-----SEAAKLGKMALVCTHEDPENR 666
           T+   +                E A+     L+C    PE R
Sbjct: 278 TYGKIVHYKEHLSLPLVDEGVPEEARDFIQRLLC---PPETR 316

>2r9u_A Variable lymphocyte receptor; adaptive immunity, VLR, leucine-rich repeat, LRR, system; 2.10A {Petromyzon marinus} Length = 174

 Score = 43.0 bits (102), Expect = 6e-05
 Identities = 25/80 (31%), Positives = 39/80 (48%), Gaps = 4/80 (5%)

Query: 97  LYLHYNSLSGEIPKEIRNLTELTDLYLDVNNLSGNIPPEI-GSMASLQVLQLCCNQLTGN 155
           L+L+ N ++   P    +L  L  LY + N L+  IP  +   +  L  L L  N L  +
Sbjct: 38  LWLNNNQITKLEPGVFDHLVNLQQLYFNSNKLT-AIPTGVFDKLTQLTQLDLNDNHLK-S 95

Query: 156 IPAQI-GSLKSLSVLTLQHN 174
           IP     +LKSL+ + L +N
Sbjct: 96  IPRGAFDNLKSLTHIYLYNN 115

>1fot_A TPK1 delta, CAMP-dependent protein kinase type 1; open conformation, transferase; HET: TPO; 2.80A {Saccharomyces cerevisiae} SCOP: d.144.1.7 Length = 318

 Score = 43.7 bits (104), Expect = 1e-04
 Identities = 52/211 (24%), Positives = 92/211 (43%), Gaps = 26/211 (12%)

Query: 411 FSEVNLLGKGNFSSVYKGTLRD-GTLVAIRSINVTSC-KSEEAEFVKG-LYLLTSLRHEN 467
           F  +  LG G+F  V+    R  G   A++ +      + ++ E       +L+ + H  
Sbjct: 8   FQILRTLGTGSFGRVHLIRSRHNGRYYAMKVLKKEIVVRLKQVEHTNDERLMLSIVTHPF 67

Query: 468 IIRLRGFCCSRGRGECFLIYDFAPKGKLSKYLDQEEGSSNVLDWSTRVSIIIG-IAKGIG 526
           IIR+ G      +   F+I D+   G+L   L + +   N              +   + 
Sbjct: 68  IIRMWGTFQDAQQ--IFMIMDYIEGGELFSLLRKSQRFPN-----PVAKFYAAEVCLALE 120

Query: 527 YLHSSEVNKPAIVHRNLSVEKVLIDQQFNPLIADCGLHKLLADDIVFSVLKTSAAMG--- 583
           YLHS +     I++R+L  E +L+D+  +  I D G  K + D        T    G   
Sbjct: 121 YLHSKD-----IIYRDLKPENILLDKNGHIKITDFGFAKYVPD-------VTYTLCGTPD 168

Query: 584 YLAPEYVTTGRFTERSDIFAFGVIILQILTG 614
           Y+APE V+T  + +  D ++FG++I ++L G
Sbjct: 169 YIAPEVVSTKPYNKSIDWWSFGILIYEMLAG 199

>1vzo_A Ribosomal protein S6 kinase alpha 5; protein kinase, transferase, phosphorylation, serine/threonine protein kinase; 1.8A {Homo sapiens} SCOP: d.144.1.7 Length = 355

 Score = 43.8 bits (104), Expect = 1e-04
 Identities = 53/256 (20%), Positives = 104/256 (40%), Gaps = 29/256 (11%)

Query: 409 QCFSEVNLLGKGNFSSVY---KGTLRD-GTLVAIRSIN--VTSCKSEEAEFVKG--LYLL 460
           + F  + +LG G +  V+   K +  D G L A++ +       K++  E  +     L 
Sbjct: 54  ENFELLKVLGTGAYGKVFLVRKISGHDTGKLYAMKVLKKATIVQKAKTTEHTRTERQVLE 113

Query: 461 TSLRHENIIRLRGFCCSRGRGECFLIYDFAPKGKLSKYLDQEEGSSNVLDWSTRVSIIIG 520
              +   ++ L      +   +  LI D+   G+L  +L Q E  +        V I +G
Sbjct: 114 HIRQSPFLVTLH--YAFQTETKLHLILDYINGGELFTHLSQRERFTE-----HEVQIYVG 166

Query: 521 -IAKGIGYLHSSEVNKPAIVHRNLSVEKVLIDQQFNPLIADCGLHKLLADDIVFSVLKTS 579
            I   + +LH        I++R++ +E +L+D   + ++ D GL K   + +     +  
Sbjct: 167 EIVLALEHLHKL-----GIIYRDIKLENILLDSNGHVVLTDFGLSK---EFVADETERAY 218

Query: 580 AAMG---YLAPEYVTTGR--FTERSDIFAFGVIILQILTGSLVLTSSMRLAAESATFENF 634
              G   Y+AP+ V  G     +  D ++ GV++ ++LTG+   T      +++      
Sbjct: 219 DFCGTIEYMAPDIVRGGDSGHDKAVDWWSLGVLMYELLTGASPFTVDGEKNSQAEISRRI 278

Query: 635 IDRNLKGKFSESEAAK 650
           +          S  AK
Sbjct: 279 LKSEPPYPQEMSALAK 294

>3pg1_A Mitogen-activated protein kinase, putative (MAP K protein); EPK Ser/Thr protein kinase fold, Ser/Thr protein kinase, TRA; 1.95A {Leishmania major} Length = 362

 Score = 43.1 bits (102), Expect = 2e-04
 Identities = 40/239 (16%), Positives = 72/239 (30%), Gaps = 67/239 (28%)

Query: 411 FSEVNLLGKGNFSSVYKGTLRDGTLVAIRSINVTSCKSEEAE-FVKGLY---------LL 460
           ++    +  G++ +V  G   +G  VAI+ +  T                        LL
Sbjct: 24  YTVQRFISSGSYGAVCAGVDSEGIPVAIKRVFNTVSDGRTVNILSDSFLCKRVLREIRLL 83

Query: 461 TSLRHENIIRLRGFCCSRGRG---ECFLIYDF----------APKGKLSKYLDQEEGSSN 507
               H NI+ LR            + +L+ +             +  +S    Q      
Sbjct: 84  NHFHHPNILGLRDIFVHFEEPAMHKLYLVTELMRTDLAQVIHDQRIVISPQHIQ------ 137

Query: 508 VLDWSTRVSIIIGIAKGIGYLHSSEVNKPAIVHRNLSVEKVLIDQQFNPLIADCGLHKLL 567
                     +  I  G+  LH + V     VHR+L    +L+    +  I D  L +  
Sbjct: 138 --------YFMYHILLGLHVLHEAGV-----VHRDLHPGNILLADNNDITICDFNLARED 184

Query: 568 ADDIVFSVLKTSAAMGYLAPEYVTT------------GRFTERSDIFAFGVIILQILTG 614
             D         A        YVT               FT+  D+++ G ++ ++   
Sbjct: 185 TAD---------ANK----THYVTHRWYRAPELVMQFKGFTKLVDMWSAGCVMAEMFNR 230

>2b9h_A MAP kinase FUS3, mitogen-activated protein kinase FUS3; transferase; HET: ADP; 1.55A {Saccharomyces cerevisiae} PDB: 2b9i_A* 2b9j_A* 2f49_A 2fa2_A 2b9f_A* 2f9g_A* Length = 353

 Score = 43.0 bits (102), Expect = 2e-04
 Identities = 44/231 (19%), Positives = 83/231 (35%), Gaps = 51/231 (22%)

Query: 411 FSEVNLLGKGNFSSVYKGT-LRDGTLVAIRSINV----TSCKSEEAEFVKGLYLLTSLRH 465
           F   +LLG+G +  V   T    G +VAI+ I              E    + +L   +H
Sbjct: 13  FQLKSLLGEGAYGVVCSATHKPTGEIVAIKKIEPFDKPLFALRTLRE----IKILKHFKH 68

Query: 466 ENIIRLRGFCCSRGR---GECFLIYDFAPKGKLSKYLDQEEGSSNVLDWSTRVSIIIGIA 522
           ENII +             E ++I +      L + +     S+ +L        I    
Sbjct: 69  ENIITIFNIQRPDSFENFNEVYIIQELMQT-DLHRVI-----STQMLSDDHIQYFIYQTL 122

Query: 523 KGIGYLHSSEVNKPAIVHRNLSVEKVLIDQQFNPLIADCGLHKLL-------ADDIVFSV 575
           + +  LH S V     +HR+L    +LI+       ++C L K+         D+     
Sbjct: 123 RAVKVLHGSNV-----IHRDLKPSNLLIN-------SNCDL-KVCDFGLARIIDESAADN 169

Query: 576 LKTSAAMGYLAPEYVTT------------GRFTERSDIFAFGVIILQILTG 614
            + +     +  E+V T             +++   D+++ G I+ ++   
Sbjct: 170 SEPTGQQSGM-VEFVATRWYRAPEVMLTSAKYSRAMDVWSCGCILAELFLR 219

>3g51_A Ribosomal protein S6 kinase alpha-3; N-terminal kinase domain of P90 ribosomal S6 kinase 2, ATP- binding, nucleotide-binding, phosphoprotein; HET: ANP; 1.80A {Mus musculus} PDB: 2z7q_A* 2z7r_A* 2z7s_A* Length = 325

 Score = 42.5 bits (101), Expect = 3e-04
 Identities = 57/224 (25%), Positives = 100/224 (44%), Gaps = 39/224 (17%)

Query: 409 QCFSEVNLLGKGNFSSVY---KGTLRD-GTLVAIRSI--------NVTSCKSEEAEFVKG 456
             F  + +LG+G+F  V+   K +  D   L A++ +        +    K E       
Sbjct: 24  SQFELLKVLGQGSFGKVFLVKKISGSDARQLYAMKVLKKATLKVRDRVRTKMER------ 77

Query: 457 LYLLTSLRHENIIRLRGFCCSRGRGECFLIYDFAPKGKLSKYLDQEEGSSNVLDWSTRVS 516
             +L  + H  I++L      +  G+ +LI DF   G L   L +E   +        V 
Sbjct: 78  -DILVEVNHPFIVKL--HYAFQTEGKLYLILDFLRGGDLFTRLSKEVMFT-----EEDVK 129

Query: 517 IIIG-IAKGIGYLHSSEVNKPAIVHRNLSVEKVLIDQQFNPLIADCGLHKLLADDIVFSV 575
             +  +A  + +LHS       I++R+L  E +L+D++ +  + D GL K   D      
Sbjct: 130 FYLAELALALDHLHSL-----GIIYRDLKPENILLDEEGHIKLTDFGLSKESIDHEK--- 181

Query: 576 LKTSAAMG---YLAPEYVTTGRFTERSDIFAFGVIILQILTGSL 616
            K  +  G   Y+APE V     T+ +D ++FGV++ ++LTG+L
Sbjct: 182 -KAYSFCGTVEYMAPEVVNRRGHTQSADWWSFGVLMFEMLTGTL 224

>2r5t_A Serine/threonine-protein kinase SGK1; AGC protein kinase, apoptosis, ATP-binding, cytoplasm, endoplasmic reticulum, nucleotide-binding, nucleus; HET: ANP; 1.90A {Homo sapiens} PDB: 3hdm_A* 3hdn_A* Length = 373

 Score = 42.2 bits (100), Expect = 4e-04
 Identities = 52/220 (23%), Positives = 90/220 (40%), Gaps = 36/220 (16%)

Query: 409 QCFSEVNLLGKGNFSSVYKGTLRD-GTLVAIRSIN---------VTSCKSEEAEFVKGLY 458
             F  + ++GKG+F  V     +      A++ +               SE         
Sbjct: 38  SDFHFLKVIGKGSFGKVLLARHKAEEVFYAVKVLQKKAILKKKEEKHIMSERN------V 91

Query: 459 LLTSLRHENIIRLRGFCCSRGRGECFLIYDFAPKGKLSKYLDQEEGSSNVLDWSTRVSII 518
           LL +++H  ++ L      +   + + + D+   G+L  +L Q E          R    
Sbjct: 92  LLKNVKHPFLVGL--HFSFQTADKLYFVLDYINGGELFYHL-QRERCFLE----PRARFY 144

Query: 519 IG-IAKGIGYLHSSEVNKPAIVHRNLSVEKVLIDQQFNPLIADCGLHKLLADDIVFSVLK 577
              IA  +GYLHS       IV+R+L  E +L+D Q + ++ D GL K   ++I  +   
Sbjct: 145 AAEIASALGYLHSLN-----IVYRDLKPENILLDSQGHIVLTDFGLCK---ENIEHNS-T 195

Query: 578 TSAAMG---YLAPEYVTTGRFTERSDIFAFGVIILQILTG 614
           TS   G   YLAPE +    +    D +  G ++ ++L G
Sbjct: 196 TSTFCGTPEYLAPEVLHKQPYDRTVDWWCLGAVLYEMLYG 235

>3eb0_A Putative uncharacterized protein; kinase cryptosporidium parvum, ATP-binding, kinase, nucleoti binding; HET: PTR DRK; 2.65A {Cryptosporidium parvum iowa II} Length = 383

 Score = 41.6 bits (98), Expect = 7e-04
 Identities = 34/204 (16%), Positives = 71/204 (34%), Gaps = 49/204 (24%)

Query: 405 ESATQCFSEVNLLGKGNFSSVYKGTLRD-GTLVAIRSI-NVTSCKSEEAEFVKGLYLLTS 462
           E++++ +S    LG G+F  V +    + G   A++ +      K+ E      L ++  
Sbjct: 3   ETSSKKYSLGKTLGTGSFGIVCEVFDIESGKRFALKKVLQDPRYKNRE------LDIMKV 56

Query: 463 LRHENIIRLRGFCCSRGRGECFLIYDFAPKGKLSKYLDQEEGSSNVLDWSTR-------- 514
           L H NII+L  +  + G  E           KL    +        +  +          
Sbjct: 57  LDHVNIIKLVDYFYTTGDEEPKPPQPPDDHNKLGGKNNGVNNHHKSVIVNPSQNKYLNVI 116

Query: 515 -------VSIIIG--------------------IAKGIGYLHSSEVNKPAIVHRNLSVEK 547
                  +  ++                     + + +G++HS  +      HR++  + 
Sbjct: 117 MEYVPDTLHKVLKSFIRSGRSIPMNLISIYIYQLFRAVGFIHSLGI-----CHRDIKPQN 171

Query: 548 VLIDQQFNPL-IADCGLHKLLADD 570
           +L++ + N L + D G  K L   
Sbjct: 172 LLVNSKDNTLKLCDFGSAKKLIPS 195

Structure Templates Detected by HHsearch

Original result of HHsearch against PDB70 database

No hit with probability above 80.00

---

Homologous Structure Domains

Structure Domains Detected by RPS-BLAST

Original result of RPS-BLAST against SCOP70(version1.75) database

ID	Length	Definition	E-value
Query	689
d1qpca_	272	d.144.1.7 (A:) Lymphocyte kinase (lck) {Human (Hom	3e-53
d1uwha_	276	d.144.1.7 (A:) B-Raf kinase {Human (Homo sapiens)	4e-51
d1sm2a_	263	d.144.1.7 (A:) Tyrosine-protein kinase Itk/Tsk {Hu	9e-51
d1fmka3	285	d.144.1.7 (A:249-533) c-src tyrosine kinase {Human	3e-50
d1opja_	287	d.144.1.7 (A:) Abelsone tyrosine kinase (abl) {Mou	1e-49
d1k2pa_	258	d.144.1.7 (A:) Bruton's tyrosine kinase (Btk) {Hum	1e-49
d1mqba_	283	d.144.1.7 (A:) epha2 receptor tyrosine kinase {Hum	2e-49
d2java1	269	d.144.1.7 (A:3-271) Serine/threonine-protein kinas	1e-48
d1u59a_	285	d.144.1.7 (A:) Tyrosine-protein kinase ZAP-70 {Hum	2e-48
d1jpaa_	299	d.144.1.7 (A:) ephb2 receptor tyrosine kinase {Mou	4e-48
d1r0pa_	311	d.144.1.7 (A:) Hepatocyte growth factor receptor,	7e-47
d1xbba_	277	d.144.1.7 (A:) Tyrosine-protein kinase SYK {Human	1e-46
d1byga_	262	d.144.1.7 (A:) Carboxyl-terminal src kinase (csk)	2e-46
d1rjba_	325	d.144.1.7 (A:) Fl cytokine receptor {Human (Homo s	4e-46
d1vjya_	303	d.144.1.7 (A:) Type I TGF-beta receptor R4 {Human	2e-45
d1lufa_	301	d.144.1.7 (A:) Musk tyrosine kinase {Rat (Rattus n	3e-45
d1t46a_	311	d.144.1.7 (A:) c-KIT receptor {Human (Homo sapiens	6e-45
d1t4ha_	270	d.144.1.7 (A:) Protein kinase wnk1 {Human (Homo sa	4e-44
d1s9ja_	322	d.144.1.7 (A:) Dual specificity mitogen-activated	5e-44
d1u46a_	273	d.144.1.7 (A:) Activated CDC42 kinase 1, ACK1 {Hum	8e-44
d1fvra_	309	d.144.1.7 (A:) Tie2 kinase {Human (Homo sapiens) [	1e-43
d1xkka_	317	d.144.1.7 (A:) EGF receptor tyrosine kinase, Erbb-	3e-43
d2j4za1	263	d.144.1.7 (A:126-388) Aurora-related kinase 1 (aur	3e-42
d1u5ra_	309	d.144.1.7 (A:) Serine/threonine protein kinase TAO	3e-42
d1mp8a_	273	d.144.1.7 (A:) Focal adhesion kinase 1 (fak) {Huma	3e-41
d1nvra_	271	d.144.1.7 (A:) Cell cycle checkpoint kinase chk1 {	7e-41
d1ywna1	299	d.144.1.7 (A:818-1166) Vascular endothelial growth	2e-40
d1p4oa_	308	d.144.1.7 (A:) Insulin-like growth factor 1 recept	4e-40
d2jfla1	288	d.144.1.7 (A:21-308) STE20-like serine/threonine-p	1e-38
d1fgka_	299	d.144.1.7 (A:) Fibroblast growth factor receptor 1	3e-38
d1yhwa1	293	d.144.1.7 (A:249-541) pak1 {Human (Homo sapiens) [	2e-37
d1koaa2	350	d.144.1.7 (A:5915-6264) Twitchin, kinase domain {C	4e-37
d1uu3a_	288	d.144.1.7 (A:) 3-phosphoinositide dependent protei	1e-36
d1koba_	352	d.144.1.7 (A:) Twitchin, kinase domain {California	5e-36
d1o6ya_	277	d.144.1.7 (A:) Mycobacterial protein kinase PknB,	1e-35
d1a06a_	307	d.144.1.7 (A:) Calmodulin-dependent protein kinase	3e-35
d1tkia_	321	d.144.1.7 (A:) Titin, kinase domain {Human (Homo s	1e-33
d2ozaa1	335	d.144.1.7 (A:51-385) MAP kinase activated protein	2e-32
d1omwa3	364	d.144.1.7 (A:186-549) G-protein coupled receptor k	5e-32
d1phka_	277	d.144.1.7 (A:) gamma-subunit of glycogen phosphory	5e-32
d1ckia_	299	d.144.1.7 (A:) Casein kinase-1, CK1 {Rat (Rattus n	1e-30
d1q5ka_	350	d.144.1.7 (A:) Glycogen synthase kinase-3 beta (Gs	1e-30
d1ob3a_	286	d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {(Plasmod	5e-30
d1xjda_	320	d.144.1.7 (A:) Protein kinase C, theta type {Human	7e-30
d1blxa_	305	d.144.1.7 (A:) Cyclin-dependent PK, CDK6 {Human (H	7e-30
d1xwsa_	273	d.144.1.7 (A:) Proto-oncogene serine/threonine-pro	1e-29
d1gz8a_	298	d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {Human (H	2e-29
d1jksa_	293	d.144.1.7 (A:) Death-associated protein kinase, Da	2e-29
d1fota_	316	d.144.1.7 (A:) cAMP-dependent PK, catalytic subuni	1e-28
d1pmea_	345	d.144.1.7 (A:) MAP kinase Erk2 {Human (Homo sapien	5e-28
d1cm8a_	346	d.144.1.7 (A:) MAP kinase p38-gamma {Human (Homo s	4e-27
d1csna_	293	d.144.1.7 (A:) Casein kinase-1, CK1 {Fission yeast	6e-27
d1ua2a_	299	d.144.1.7 (A:) Cell division protein kinase 7, CDK	1e-26
d1o6la_	337	d.144.1.7 (A:) Pkb kinase (Akt-2) {Human (Homo sap	4e-25
d3blha1	318	d.144.1.7 (A:8-325) Cell division protein kinase 9	1e-24
d1unla_	292	d.144.1.7 (A:) Cyclin-dependent PK, CDK5 {Human (H	5e-24
d1rdqe_	350	d.144.1.7 (E:) cAMP-dependent PK, catalytic subuni	7e-24
d1vzoa_	322	d.144.1.7 (A:) Ribosomal protein S6 kinase alpha 5	6e-22
d3bqca1	328	d.144.1.7 (A:3-330) Protein kinase CK2, alpha subu	9e-20
d2b1pa1	355	d.144.1.7 (A:46-400) c-jun N-terminal kinase (jnk3	2e-19
d2gfsa1	348	d.144.1.7 (A:5-352) MAP kinase p38 {Human (Homo sa	2e-19
d1ogqa_	313	c.10.2.8 (A:) Polygalacturonase inhibiting protein	3e-18
d1ogqa_	313	c.10.2.8 (A:) Polygalacturonase inhibiting protein	1e-10
d1ogqa_	313	c.10.2.8 (A:) Polygalacturonase inhibiting protein	1e-10
d1ogqa_	313	c.10.2.8 (A:) Polygalacturonase inhibiting protein	1e-09
d1ogqa_	313	c.10.2.8 (A:) Polygalacturonase inhibiting protein	1e-07
d1q8ya_	362	d.144.1.7 (A:) Sky1p {Baker's yeast (Saccharomyces	4e-18
d2omza2	384	c.10.2.1 (A:33-416) Internalin A {Listeria monocyt	2e-17
d2omza2	384	c.10.2.1 (A:33-416) Internalin A {Listeria monocyt	3e-16
d2omza2	384	c.10.2.1 (A:33-416) Internalin A {Listeria monocyt	3e-04
d1zara2	191	d.144.1.9 (A:91-281) Rio2 serine protein kinase C-	5e-14
d1ozna_	284	c.10.2.7 (A:) Reticulon 4 receptor (Nogo-66 recept	4e-13
d1ozna_	284	c.10.2.7 (A:) Reticulon 4 receptor (Nogo-66 recept	6e-10
d1ozna_	284	c.10.2.7 (A:) Reticulon 4 receptor (Nogo-66 recept	2e-09
d1ozna_	284	c.10.2.7 (A:) Reticulon 4 receptor (Nogo-66 recept	3e-09
d1ozna_	284	c.10.2.7 (A:) Reticulon 4 receptor (Nogo-66 recept	4e-09
d1xkua_	305	c.10.2.7 (A:) Decorin {Cow (Bos taurus) [TaxId: 99	6e-13
d1xkua_	305	c.10.2.7 (A:) Decorin {Cow (Bos taurus) [TaxId: 99	2e-09
d1jl5a_	353	c.10.2.6 (A:) Leucine rich effector protein YopM {	1e-10
d1jl5a_	353	c.10.2.6 (A:) Leucine rich effector protein YopM {	2e-09
d1jl5a_	353	c.10.2.6 (A:) Leucine rich effector protein YopM {	3e-09
d1jl5a_	353	c.10.2.6 (A:) Leucine rich effector protein YopM {	9e-05
d1jl5a_	353	c.10.2.6 (A:) Leucine rich effector protein YopM {	0.001
d1dcea3	124	c.10.2.2 (A:444-567) Rab geranylgeranyltransferase	1e-08
d1dcea3	124	c.10.2.2 (A:444-567) Rab geranylgeranyltransferase	9e-07
d1dcea3	124	c.10.2.2 (A:444-567) Rab geranylgeranyltransferase	5e-06
d1dcea3	124	c.10.2.2 (A:444-567) Rab geranylgeranyltransferase	0.004
d1z7xw1	460	c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human (	3e-08
d1z7xw1	460	c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human (	2e-07
d1z7xw1	460	c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human (	1e-06
d1z7xw1	460	c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human (	6e-06
d1z7xw1	460	c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human (	2e-05
d1z7xw1	460	c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human (	3e-04
d1z7xw1	460	c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human (	0.001
d1p9ag_	266	c.10.2.7 (G:) von Willebrand factor binding domain	2e-07
d1p9ag_	266	c.10.2.7 (G:) von Willebrand factor binding domain	4e-05
d1p9ag_	266	c.10.2.7 (G:) von Willebrand factor binding domain	1e-04
d1p9ag_	266	c.10.2.7 (G:) von Willebrand factor binding domain	2e-04
d1p9ag_	266	c.10.2.7 (G:) von Willebrand factor binding domain	7e-04
d1koha1	162	c.10.2.3 (A:201-362) mRNA export factor tap {Human	6e-06
d1w8aa_	192	c.10.2.7 (A:) Slit {Fruit fly (Drosophila melanoga	6e-06
d2astb2	284	c.10.1.3 (B:2136-2419) Cyclin A/CDK2-associated p1	3e-05
d1h6ua2	227	c.10.2.1 (A:36-262) Internalin H {Listeria monocyt	1e-04
d1h6ua2	227	c.10.2.1 (A:36-262) Internalin H {Listeria monocyt	5e-04
d1h6ua2	227	c.10.2.1 (A:36-262) Internalin H {Listeria monocyt	0.003
d2ifga3	156	c.10.2.7 (A:36-191) High affinity nerve growth fac	2e-04
d2ca6a1	344	c.10.1.2 (A:2-345) Rna1p (RanGAP1), N-terminal dom	9e-04
d2ca6a1	344	c.10.1.2 (A:2-345) Rna1p (RanGAP1), N-terminal dom	0.002
d2ca6a1	344	c.10.1.2 (A:2-345) Rna1p (RanGAP1), N-terminal dom	0.003
d2ca6a1	344	c.10.1.2 (A:2-345) Rna1p (RanGAP1), N-terminal dom	0.004
d1xwdc1	242	c.10.2.7 (C:18-259) Follicle-stimulating hormone r	0.001
d1a9na_	162	c.10.2.4 (A:) Splicesomal U2A' protein {Human (Hom	0.001
d1a9na_	162	c.10.2.4 (A:) Splicesomal U2A' protein {Human (Hom	0.004

>d1qpca_ d.144.1.7 (A:) Lymphocyte kinase (lck) {Human (Homo sapiens) [TaxId: 9606]} Length = 272

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Lymphocyte kinase (lck)
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  182 bits (463), Expect = 3e-53
 Identities = 62/266 (23%), Positives = 120/266 (45%), Gaps = 16/266 (6%)

Query: 411 FSEVNLLGKGNFSSVYKGTLRDGTLVAIRSINVTSCKSEEAEFVKGLYLLTSLRHENIIR 470
              V  LG G F  V+ G     T VA++S+   S   +   F+    L+  L+H+ ++R
Sbjct: 15  LKLVERLGAGQFGEVWMGYYNGHTKVAVKSLKQGSMSPDA--FLAEANLMKQLQHQRLVR 72

Query: 471 LRGFCCSRGRGECFLIYDFAPKGKLSKYLDQEEGSSNVLDWSTRVSIIIGIAKGIGYLHS 530
           L            ++I ++   G L  +L    G    L  +  + +   IA+G+ ++  
Sbjct: 73  LYAVVTQ---EPIYIITEYMENGSLVDFLKTPSGIK--LTINKLLDMAAQIAEGMAFIEE 127

Query: 531 SEVNKPAIVHRNLSVEKVLIDQQFNPLIADCGLHKLLADDIVFSVLKTSAAMGYLAPEYV 590
                   +HR+L    +L+    +  IAD GL +L+ D+   +       + + APE +
Sbjct: 128 -----RNYIHRDLRAANILVSDTLSCKIADFGLARLIEDNEYTAREGAKFPIKWTAPEAI 182

Query: 591 TTGRFTERSDIFAFGVIILQILTGSLVLTSSMRLAAESATFENFIDRNLKGKFSESEAAK 650
             G FT +SD+++FG+++ +I+T   +    M         +N ++R  +    ++   +
Sbjct: 183 NYGTFTIKSDVWSFGILLTEIVTHGRIPYPGM---TNPEVIQN-LERGYRMVRPDNCPEE 238

Query: 651 LGKMALVCTHEDPENRPTMEAVIEEL 676
           L ++  +C  E PE+RPT + +   L
Sbjct: 239 LYQLMRLCWKERPEDRPTFDYLRSVL 264

>d1uwha_ d.144.1.7 (A:) B-Raf kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 276

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: B-Raf kinase
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  176 bits (448), Expect = 4e-51
 Identities = 51/271 (18%), Positives = 112/271 (41%), Gaps = 18/271 (6%)

Query: 411 FSEVNLLGKGNFSSVYKGTLRDGTLVAIRSINVTSCKSEE-AEFVKGLYLLTSLRHENII 469
            +    +G G+F +VYKG       VA++ +NVT+   ++   F   + +L   RH NI+
Sbjct: 10  ITVGQRIGSGSFGTVYKGKWHGD--VAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNIL 67

Query: 470 RLRGFCCSRGRGECFLIYDFAPKGKLSKYLDQEEGSSNVLDWSTRVSIIIGIAKGIGYLH 529
              G+  +    +  ++  +     L  +L   E      +    + I    A+G+ YLH
Sbjct: 68  LFMGYSTA---PQLAIVTQWCEGSSLYHHLHIIETK---FEMIKLIDIARQTAQGMDYLH 121

Query: 530 SSEVNKPAIVHRNLSVEKVLIDQQFNPLIADCGLHKLLADDIVFSVLKTSA-AMGYLAPE 588
                  +I+HR+L    + + +     I D GL  + +        +  + ++ ++APE
Sbjct: 122 -----AKSIIHRDLKSNNIFLHEDLTVKIGDFGLATVKSRWSGSHQFEQLSGSILWMAPE 176

Query: 589 YVTT---GRFTERSDIFAFGVIILQILTGSLVLTSSMRLAAESATFENFIDRNLKGKFSE 645
            +       ++ +SD++AFG+++ +++TG L  ++                     K   
Sbjct: 177 VIRMQDKNPYSFQSDVYAFGIVLYELMTGQLPYSNINNRDQIIFMVGRGYLSPDLSKVRS 236

Query: 646 SEAAKLGKMALVCTHEDPENRPTMEAVIEEL 676
           +    + ++   C  +  + RP    ++  +
Sbjct: 237 NCPKAMKRLMAECLKKKRDERPLFPQILASI 267

>d1sm2a_ d.144.1.7 (A:) Tyrosine-protein kinase Itk/Tsk {Human (Homo sapiens) [TaxId: 9606]} Length = 263

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Tyrosine-protein kinase Itk/Tsk
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  175 bits (444), Expect = 9e-51
 Identities = 56/266 (21%), Positives = 121/266 (45%), Gaps = 16/266 (6%)

Query: 411 FSEVNLLGKGNFSSVYKGTLRDGTLVAIRSINVTSCKSEEAEFVKGLYLLTSLRHENIIR 470
            + V  +G G F  V+ G   +   VAI++I        E +F++   ++  L H  +++
Sbjct: 7   LTFVQEIGSGQFGLVHLGYWLNKDKVAIKTIREG--AMSEEDFIEEAEVMMKLSHPKLVQ 64

Query: 471 LRGFCCSRGRGECFLIYDFAPKGKLSKYLDQEEGSSNVLDWSTRVSIIIGIAKGIGYLHS 530
           L G C  +      L+++F   G LS YL  +     +    T + + + + +G+ YL  
Sbjct: 65  LYGVCLEQA--PICLVFEFMEHGCLSDYLRTQR---GLFAAETLLGMCLDVCEGMAYLE- 118

Query: 531 SEVNKPAIVHRNLSVEKVLIDQQFNPLIADCGLHKLLADDIVFSVLKTSAAMGYLAPEYV 590
               +  ++HR+L+    L+ +     ++D G+ + + DD   S   T   + + +PE  
Sbjct: 119 ----EACVIHRDLAARNCLVGENQVIKVSDFGMTRFVLDDQYTSSTGTKFPVKWASPEVF 174

Query: 591 TTGRFTERSDIFAFGVIILQILTGSLVLTSSMRLAAESATFENFIDRNLKGKFSESEAAK 650
           +  R++ +SD+++FGV++ ++ +   +   +      S   E+ I    +       +  
Sbjct: 175 SFSRYSSKSDVWSFGVLMWEVFSEGKIPYENRS---NSEVVED-ISTGFRLYKPRLASTH 230

Query: 651 LGKMALVCTHEDPENRPTMEAVIEEL 676
           + ++   C  E PE+RP    ++ +L
Sbjct: 231 VYQIMNHCWKERPEDRPAFSRLLRQL 256

>d1fmka3 d.144.1.7 (A:249-533) c-src tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 285

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: c-src tyrosine kinase
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  174 bits (443), Expect = 3e-50
 Identities = 66/278 (23%), Positives = 120/278 (43%), Gaps = 16/278 (5%)

Query: 399 LNLEEVESATQCFSEVNLLGKGNFSSVYKGTLRDGTLVAIRSINVTSCKSEEAEFVKGLY 458
           L  +  E   +       LG+G F  V+ GT    T VAI+++   +   E   F++   
Sbjct: 7   LAKDAWEIPRESLRLEVKLGQGCFGEVWMGTWNGTTRVAIKTLKPGTMSPEA--FLQEAQ 64

Query: 459 LLTSLRHENIIRLRGFCCSRGRGECFLIYDFAPKGKLSKYLDQEEGSSNVLDWSTRVSII 518
           ++  LRHE +++L            +++ ++  KG L  +L  E G          V + 
Sbjct: 65  VMKKLRHEKLVQLYAVVS---EEPIYIVTEYMSKGSLLDFLKGETGKYL--RLPQLVDMA 119

Query: 519 IGIAKGIGYLHSSEVNKPAIVHRNLSVEKVLIDQQFNPLIADCGLHKLLADDIVFSVLKT 578
             IA G+ Y+      +   VHR+L    +L+ +     +AD GL +L+ D+   +    
Sbjct: 120 AQIASGMAYVE-----RMNYVHRDLRAANILVGENLVCKVADFGLARLIEDNEYTARQGA 174

Query: 579 SAAMGYLAPEYVTTGRFTERSDIFAFGVIILQILTGSLVLTSSMRLAAESATFENFIDRN 638
              + + APE    GRFT +SD+++FG+++ ++ T   V    M     +    + ++R 
Sbjct: 175 KFPIKWTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPYPGM----VNREVLDQVERG 230

Query: 639 LKGKFSESEAAKLGKMALVCTHEDPENRPTMEAVIEEL 676
            +          L  +   C  ++PE RPT E +   L
Sbjct: 231 YRMPCPPECPESLHDLMCQCWRKEPEERPTFEYLQAFL 268

>d1opja_ d.144.1.7 (A:) Abelsone tyrosine kinase (abl) {Mouse (Mus musculus) [TaxId: 10090]} Length = 287

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Abelsone tyrosine kinase (abl)
species: Mouse (Mus musculus) [TaxId: 10090]

 Score =  173 bits (439), Expect = 1e-49
 Identities = 58/280 (20%), Positives = 125/280 (44%), Gaps = 16/280 (5%)

Query: 398 RLNLEEVESATQCFSEVNLLGKGNFSSVYKGTLRD-GTLVAIRSINVTSCKSEEAEFVKG 456
             N ++ E      +  + LG G +  VY+G  +     VA++++   + + EE  F+K 
Sbjct: 6   SPNYDKWEMERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVEE--FLKE 63

Query: 457 LYLLTSLRHENIIRLRGFCCSRGRGECFLIYDFAPKGKLSKYLDQEEGSSNVLDWSTRVS 516
             ++  ++H N+++L G C        ++I +F   G L  YL   E +   +     + 
Sbjct: 64  AAVMKEIKHPNLVQLLGVCTREP--PFYIITEFMTYGNLLDYLR--ECNRQEVSAVVLLY 119

Query: 517 IIIGIAKGIGYLHSSEVNKPAIVHRNLSVEKVLIDQQFNPLIADCGLHKLLADDIVFSVL 576
           +   I+  + YL          +HR+L+    L+ +     +AD GL +L+  D   +  
Sbjct: 120 MATQISSAMEYLEK-----KNFIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHA 174

Query: 577 KTSAAMGYLAPEYVTTGRFTERSDIFAFGVIILQILTGSLVLTSSMRLAAESATFENFID 636
                + + APE +   +F+ +SD++AFGV++ +I T  +     + L    +     ++
Sbjct: 175 GAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGIDL----SQVYELLE 230

Query: 637 RNLKGKFSESEAAKLGKMALVCTHEDPENRPTMEAVIEEL 676
           ++ + +  E    K+ ++   C   +P +RP+   + +  
Sbjct: 231 KDYRMERPEGCPEKVYELMRACWQWNPSDRPSFAEIHQAF 270

>d1k2pa_ d.144.1.7 (A:) Bruton's tyrosine kinase (Btk) {Human (Homo sapiens) [TaxId: 9606]} Length = 258

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Bruton's tyrosine kinase (Btk)
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  172 bits (436), Expect = 1e-49
 Identities = 60/266 (22%), Positives = 116/266 (43%), Gaps = 16/266 (6%)

Query: 411 FSEVNLLGKGNFSSVYKGTLRDGTLVAIRSINVTSCKSEEAEFVKGLYLLTSLRHENIIR 470
            + +  LG G F  V  G  R    VAI+ I   S    E EF++   ++ +L HE +++
Sbjct: 6   LTFLKELGTGQFGVVKYGKWRGQYDVAIKMIKEGS--MSEDEFIEEAKVMMNLSHEKLVQ 63

Query: 471 LRGFCCSRGRGECFLIYDFAPKGKLSKYLDQEEGSSNVLDWSTRVSIIIGIAKGIGYLHS 530
           L G C  +     F+I ++   G L  YL +             + +   + + + YL  
Sbjct: 64  LYGVCTKQR--PIFIITEYMANGCLLNYLREMRHR---FQTQQLLEMCKDVCEAMEYLE- 117

Query: 531 SEVNKPAIVHRNLSVEKVLIDQQFNPLIADCGLHKLLADDIVFSVLKTSAAMGYLAPEYV 590
                   +HR+L+    L++ Q    ++D GL + + DD   S + +   + +  PE +
Sbjct: 118 ----SKQFLHRDLAARNCLVNDQGVVKVSDFGLSRYVLDDEYTSSVGSKFPVRWSPPEVL 173

Query: 591 TTGRFTERSDIFAFGVIILQILTGSLVLTSSMRLAAESATFENFIDRNLKGKFSESEAAK 650
              +F+ +SDI+AFGV++ +I +   +          ++     I + L+       + K
Sbjct: 174 MYSKFSSKSDIWAFGVLMWEIYSLGKMPYERF----TNSETAEHIAQGLRLYRPHLASEK 229

Query: 651 LGKMALVCTHEDPENRPTMEAVIEEL 676
           +  +   C HE  + RPT + ++  +
Sbjct: 230 VYTIMYSCWHEKADERPTFKILLSNI 255

>d1mqba_ d.144.1.7 (A:) epha2 receptor tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 283

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: epha2 receptor tyrosine kinase
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  172 bits (436), Expect = 2e-49
 Identities = 60/279 (21%), Positives = 122/279 (43%), Gaps = 21/279 (7%)

Query: 405 ESATQCFSEVNLLGKGNFSSVYKGTLRDGT-----LVAIRSINVTSCKSEEAEFVKGLYL 459
           E    C +   ++G G F  VYKG L+  +      VAI+++     + +  +F+    +
Sbjct: 3   EIHPSCVTRQKVIGAGEFGEVYKGMLKTSSGKKEVPVAIKTLKAGYTEKQRVDFLGEAGI 62

Query: 460 LTSLRHENIIRLRGFCCSRGRGECFLIYDFAPKGKLSKYLDQEEGSSNVLDWSTRVSIII 519
           +    H NIIRL G           +I ++   G L K+L +++G          V ++ 
Sbjct: 63  MGQFSHHNIIRLEGVISKYK--PMMIITEYMENGALDKFLREKDG---EFSVLQLVGMLR 117

Query: 520 GIAKGIGYLHSSEVNKPAIVHRNLSVEKVLIDQQFNPLIADCGLHKLLADDIVFSVLKTS 579
           GIA G+ YL +        VHR+L+   +L++      ++D GL ++L DD   +   + 
Sbjct: 118 GIAAGMKYLAN-----MNYVHRDLAARNILVNSNLVCKVSDFGLSRVLEDDPEATYTTSG 172

Query: 580 AA--MGYLAPEYVTTGRFTERSDIFAFGVIILQILTGSLVLTSSMRLAAESATFENFIDR 637
               + + APE ++  +FT  SD+++FG+++ +++T              +      I+ 
Sbjct: 173 GKIPIRWTAPEAISYRKFTSASDVWSFGIVMWEVMTYG----ERPYWELSNHEVMKAIND 228

Query: 638 NLKGKFSESEAAKLGKMALVCTHEDPENRPTMEAVIEEL 676
             +        + + ++ + C  ++   RP    ++  L
Sbjct: 229 GFRLPTPMDCPSAIYQLMMQCWQQERARRPKFADIVSIL 267

>d2java1 d.144.1.7 (A:3-271) Serine/threonine-protein kinase Nek2 {Human (Homo sapiens) [TaxId: 9606]} Length = 269

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Serine/threonine-protein kinase Nek2
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  169 bits (430), Expect = 1e-48
 Identities = 50/273 (18%), Positives = 115/273 (42%), Gaps = 22/273 (8%)

Query: 411 FSEVNLLGKGNFSSVYKGTLR-DGTLVAIRSINVTSC-KSEEAEFVKGLYLLTSLRHENI 468
           +  +  +G G++    K   + DG ++  + ++  S  ++E+   V  + LL  L+H NI
Sbjct: 6   YEVLYTIGTGSYGRCQKIRRKSDGKILVWKELDYGSMTEAEKQMLVSEVNLLRELKHPNI 65

Query: 469 IRLRGFCCSRGRGECFLIYDFAPKGKLSKYLDQEEGSSNVLDWSTRVSIIIGIAKGIGYL 528
           +R       R     +++ ++   G L+  + +       LD    + ++  +   +   
Sbjct: 66  VRYYDRIIDRTNTTLYIVMEYCEGGDLASVITKGTKERQYLDEEFVLRVMTQLTLALKEC 125

Query: 529 HSSEVNKPAIVHRNLSVEKVLIDQQFNPLIADCGLHKLLADDIVF--SVLKTSAAMGYLA 586
           H        ++HR+L    V +D + N  + D GL ++L  D  F  + + T     Y++
Sbjct: 126 HRRSDGGHTVLHRDLKPANVFLDGKQNVKLGDFGLARILNHDTSFAKAFVGT---PYYMS 182

Query: 587 PEYVTTGRFTERSDIFAFGVIILQILTGSLVLTSSMRLAAESATFENFIDRNLKGKFSE- 645
           PE +    + E+SDI++ G ++ ++                + + +    +  +GKF   
Sbjct: 183 PEQMNRMSYNEKSDIWSLGCLLYELCAL--------MPPFTAFSQKELAGKIREGKFRRI 234

Query: 646 ----SEAAKLGKMALVCTHEDPENRPTMEAVIE 674
               S+     ++     +    +RP++E ++E
Sbjct: 235 PYRYSDELN--EIITRMLNLKDYHRPSVEEILE 265

>d1u59a_ d.144.1.7 (A:) Tyrosine-protein kinase ZAP-70 {Human (Homo sapiens) [TaxId: 9606]} Length = 285

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Tyrosine-protein kinase ZAP-70
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  169 bits (430), Expect = 2e-48
 Identities = 62/265 (23%), Positives = 117/265 (44%), Gaps = 20/265 (7%)

Query: 417 LGKGNFSSVYKGTLR---DGTLVAIRSINVTSCKSEEAEFVKGLYLLTSLRHENIIRLRG 473
           LG GNF SV +G  R       VAI+ +   + K++  E ++   ++  L +  I+RL G
Sbjct: 17  LGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKADTEEMMREAQIMHQLDNPYIVRLIG 76

Query: 474 FCCSRGRGECFLIYDFAPKGKLSKYLDQEEGSSNVLDWSTRVSIIIGIAKGIGYLHSSEV 533
            C +       L+ + A  G L K+L  +      +  S    ++  ++ G+ YL     
Sbjct: 77  VCQAEAL---MLVMEMAGGGPLHKFLVGKREE---IPVSNVAELLHQVSMGMKYLE---- 126

Query: 534 NKPAIVHRNLSVEKVLIDQQFNPLIADCGLHKLLADDIVFSVLKTSAA--MGYLAPEYVT 591
            +   VHR+L+   VL+  +    I+D GL K L  D  +   +++    + + APE + 
Sbjct: 127 -EKNFVHRDLAARNVLLVNRHYAKISDFGLSKALGADDSYYTARSAGKWPLKWYAPECIN 185

Query: 592 TGRFTERSDIFAFGVIILQILTGSLVLTSSMRLAAESATFENFIDRNLKGKFSESEAAKL 651
             +F+ RSD++++GV + + L+        M    +      FI++  + +       +L
Sbjct: 186 FRKFSSRSDVWSYGVTMWEALSYGQKPYKKM----KGPEVMAFIEQGKRMECPPECPPEL 241

Query: 652 GKMALVCTHEDPENRPTMEAVIEEL 676
             +   C     E+RP    V + +
Sbjct: 242 YALMSDCWIYKWEDRPDFLTVEQRM 266

>d1jpaa_ d.144.1.7 (A:) ephb2 receptor tyrosine kinase {Mouse (Mus musculus) [TaxId: 10090]} Length = 299

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: ephb2 receptor tyrosine kinase
species: Mouse (Mus musculus) [TaxId: 10090]

 Score =  169 bits (429), Expect = 4e-48
 Identities = 61/293 (20%), Positives = 121/293 (41%), Gaps = 31/293 (10%)

Query: 401 LEEVESATQCFSE---------VNLLGKGNFSSVYKGTLR----DGTLVAIRSINVTSCK 447
            E+   A + F++           ++G G F  V  G L+        VAI+++     +
Sbjct: 9   FEDPNEAVREFAKEIDISCVKIEQVIGAGEFGEVCSGHLKLPGKREIFVAIKTLKSGYTE 68

Query: 448 SEEAEFVKGLYLLTSLRHENIIRLRGFCCSRGRGECFLIYDFAPKGKLSKYLDQEEGSSN 507
            +  +F+    ++    H N+I L G           +I +F   G L  +L Q +G   
Sbjct: 69  KQRRDFLSEASIMGQFDHPNVIHLEGVVTK--STPVMIITEFMENGSLDSFLRQNDGQF- 125

Query: 508 VLDWSTRVSIIIGIAKGIGYLHSSEVNKPAIVHRNLSVEKVLIDQQFNPLIADCGLHKLL 567
                  V ++ GIA G+ YL          VHR+L+   +L++      ++D GL + L
Sbjct: 126 --TVIQLVGMLRGIAAGMKYLA-----DMNYVHRDLAARNILVNSNLVCKVSDFGLSRFL 178

Query: 568 ADDIVFSVLKTSAAM----GYLAPEYVTTGRFTERSDIFAFGVIILQILTGSLVLTSSMR 623
            DD       ++        + APE +   +FT  SD++++G+++ ++++        M 
Sbjct: 179 EDDTSDPTYTSALGGKIPIRWTAPEAIQYRKFTSASDVWSYGIVMWEVMSYGERPYWDM- 237

Query: 624 LAAESATFENFIDRNLKGKFSESEAAKLGKMALVCTHEDPENRPTMEAVIEEL 676
               +    N I+++ +        + L ++ L C  +D  +RP    ++  L
Sbjct: 238 ---TNQDVINAIEQDYRLPPPMDCPSALHQLMLDCWQKDRNHRPKFGQIVNTL 287

>d1r0pa_ d.144.1.7 (A:) Hepatocyte growth factor receptor, c-MET {Human (Homo sapiens) [TaxId: 9606]} Length = 311

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Hepatocyte growth factor receptor, c-MET
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  166 bits (420), Expect = 7e-47
 Identities = 66/302 (21%), Positives = 136/302 (45%), Gaps = 22/302 (7%)

Query: 383 YLNGTGFSREHLNSFRLNLEEVESATQCFSEVNLLGKGNFSSVYKGTLRD----GTLVAI 438
           +++ +  + E + + +  +    S    F+EV  +G+G+F  VY GTL D        A+
Sbjct: 3   HIDLSALNPELVQAVQHVVIGPSSLIVHFNEV--IGRGHFGCVYHGTLLDNDGKKIHCAV 60

Query: 439 RSINVTSCKSEEAEFVKGLYLLTSLRHENIIRLRGFCCSRGRGECFLIYDFAPKGKLSKY 498
           +S+N  +   E ++F+    ++    H N++ L G  C R  G   ++  +   G L  +
Sbjct: 61  KSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSLLG-ICLRSEGSPLVVLPYMKHGDLRNF 119

Query: 499 LDQEEGSSNVLDWSTRVSIIIGIAKGIGYLHSSEVNKPAIVHRNLSVEKVLIDQQFNPLI 558
           +  E  +         +   + +AKG+ +L          VHR+L+    ++D++F   +
Sbjct: 120 IRNETHN---PTVKDLIGFGLQVAKGMKFLA-----SKKFVHRDLAARNCMLDEKFTVKV 171

Query: 559 ADCGLHKLLADDIVFSVLKTSAAMG---YLAPEYVTTGRFTERSDIFAFGVIILQILTGS 615
           AD GL + + D    SV   + A     ++A E + T +FT +SD+++FGV++ +++T  
Sbjct: 172 ADFGLARDMYDKEFDSVHNKTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRG 231

Query: 616 LVLTSSMRLAAESATFENFIDRNLKGKFSESEAAKLGKMALVCTHEDPENRPTMEAVIEE 675
                 +           ++ +  +    E     L ++ L C H   E RP+   ++  
Sbjct: 232 APPYPDVNTFD----ITVYLLQGRRLLQPEYCPDPLYEVMLKCWHPKAEMRPSFSELVSR 287

Query: 676 LT 677
           ++
Sbjct: 288 IS 289

>d1xbba_ d.144.1.7 (A:) Tyrosine-protein kinase SYK {Human (Homo sapiens) [TaxId: 9606]} Length = 277

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Tyrosine-protein kinase SYK
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  164 bits (417), Expect = 1e-46
 Identities = 66/290 (22%), Positives = 121/290 (41%), Gaps = 33/290 (11%)

Query: 393 HLNSFRLNLEEVESATQCFSEVNLLGKGNFSSVYKGTLRD---GTLVAIRSINVTSCKSE 449
           +L+   L LE+             LG GNF +V KG  +       VA++ +   +    
Sbjct: 2   YLDRKLLTLED-----------KELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPA 50

Query: 450 -EAEFVKGLYLLTSLRHENIIRLRGFCCSRGRGECFLIYDFAPKGKLSKYLDQEEGSSNV 508
            + E +    ++  L +  I+R+ G C         L+ + A  G L+KYL Q       
Sbjct: 51  LKDELLAEANVMQQLDNPYIVRMIGICE---AESWMLVMEMAELGPLNKYLQQNRH---- 103

Query: 509 LDWSTRVSIIIGIAKGIGYLHSSEVNKPAIVHRNLSVEKVLIDQQFNPLIADCGLHKLLA 568
           +     + ++  ++ G+ YL  S       VHR+L+   VL+  Q    I+D GL K L 
Sbjct: 104 VKDKNIIELVHQVSMGMKYLEESN-----FVHRDLAARNVLLVTQHYAKISDFGLSKALR 158

Query: 569 DDIVFSVLKTSAA--MGYLAPEYVTTGRFTERSDIFAFGVIILQILTGSLVLTSSMRLAA 626
            D  +   +T     + + APE +   +F+ +SD+++FGV++ +  +        M    
Sbjct: 159 ADENYYKAQTHGKWPVKWYAPECINYYKFSSKSDVWSFGVLMWEAFSYGQKPYRGM---- 214

Query: 627 ESATFENFIDRNLKGKFSESEAAKLGKMALVCTHEDPENRPTMEAVIEEL 676
           + +     +++  +         ++  +  +C   D ENRP   AV   L
Sbjct: 215 KGSEVTAMLEKGERMGCPAGCPREMYDLMNLCWTYDVENRPGFAAVELRL 264

>d1byga_ d.144.1.7 (A:) Carboxyl-terminal src kinase (csk) {Human (Homo sapiens) [TaxId: 9606]} Length = 262

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Carboxyl-terminal src kinase (csk)
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  163 bits (413), Expect = 2e-46
 Identities = 59/266 (22%), Positives = 113/266 (42%), Gaps = 20/266 (7%)

Query: 411 FSEVNLLGKGNFSSVYKGTLRDGTLVAIRSINVTSCKSEEAEFVKGLYLLTSLRHENIIR 470
              +  +GKG F  V  G  R G  VA++ I      +    F+    ++T LRH N+++
Sbjct: 9   LKLLQTIGKGEFGDVMLGDYR-GNKVAVKCIK---NDATAQAFLAEASVMTQLRHSNLVQ 64

Query: 471 LRGFCCSRGRGECFLIYDFAPKGKLSKYLDQEEGSSNVLDWSTRVSIIIGIAKGIGYLHS 530
           L G      +G  +++ ++  KG L  YL     S  VL     +   + + + + YL  
Sbjct: 65  LLGVIV-EEKGGLYIVTEYMAKGSLVDYLRSRGRS--VLGGDCLLKFSLDVCEAMEYLEG 121

Query: 531 SEVNKPAIVHRNLSVEKVLIDQQFNPLIADCGLHKLLADDIVFSVLKTSAAMGYLAPEYV 590
                   VHR+L+   VL+ +     ++D GL K  +             + + APE +
Sbjct: 122 -----NNFVHRDLAARNVLVSEDNVAKVSDFGLTKEASSTQD----TGKLPVKWTAPEAL 172

Query: 591 TTGRFTERSDIFAFGVIILQILTGSLVLTSSMRLAAESATFENFIDRNLKGKFSESEAAK 650
              +F+ +SD+++FG+++ +I +   V    + L          +++  K    +     
Sbjct: 173 REKKFSTKSDVWSFGILLWEIYSFGRVPYPRIPLKD----VVPRVEKGYKMDAPDGCPPA 228

Query: 651 LGKMALVCTHEDPENRPTMEAVIEEL 676
           + ++   C H D   RP+   + E+L
Sbjct: 229 VYEVMKNCWHLDAAMRPSFLQLREQL 254

>d1rjba_ d.144.1.7 (A:) Fl cytokine receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 325

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Fl cytokine receptor
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  164 bits (416), Expect = 4e-46
 Identities = 66/293 (22%), Positives = 115/293 (39%), Gaps = 37/293 (12%)

Query: 411 FSEVNLLGKGNFSSVYKGTLRD------GTLVAIRSINVTSCKSEEAEFVKGLYLLTSL- 463
                +LG G F  V   T            VA++ +   +  SE    +  L ++T L 
Sbjct: 39  LEFGKVLGSGAFGKVMNATAYGISKTGVSIQVAVKMLKEKADSSEREALMSELKMMTQLG 98

Query: 464 RHENIIRLRGFCCSRGRGECFLIYDFAPKGKLSKYL-------------------DQEEG 504
            HENI+ L G C   G    +LI+++   G L  YL                    +EE 
Sbjct: 99  SHENIVNLLGACTLSG--PIYLIFEYCCYGDLLNYLRSKREKFSEDEIEYENQKRLEEEE 156

Query: 505 SSNVLDWSTRVSIIIGIAKGIGYLHSSEVNKPAIVHRNLSVEKVLIDQQFNPLIADCGLH 564
             NVL +   +     +AKG+ +L        + VHR+L+   VL+       I D GL 
Sbjct: 157 DLNVLTFEDLLCFAYQVAKGMEFLEF-----KSCVHRDLAARNVLVTHGKVVKICDFGLA 211

Query: 565 KLLADDIVFSVLKTSA-AMGYLAPEYVTTGRFTERSDIFAFGVIILQILTGSLVLTSSMR 623
           + +  D  + V   +   + ++APE +  G +T +SD++++G+++ +I +  +     + 
Sbjct: 212 RDIMSDSNYVVRGNARLPVKWMAPESLFEGIYTIKSDVWSYGILLWEIFSLGVNPYPGIP 271

Query: 624 LAAESATFENFIDRNLKGKFSESEAAKLGKMALVCTHEDPENRPTMEAVIEEL 676
                A F   I    K         ++  +   C   D   RP+   +   L
Sbjct: 272 ---VDANFYKLIQNGFKMDQPFYATEEIYIIMQSCWAFDSRKRPSFPNLTSFL 321

>d1vjya_ d.144.1.7 (A:) Type I TGF-beta receptor R4 {Human (Homo sapiens) [TaxId: 9606]} Length = 303

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Type I TGF-beta receptor R4
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  161 bits (409), Expect = 2e-45
 Identities = 65/291 (22%), Positives = 115/291 (39%), Gaps = 38/291 (13%)

Query: 417 LGKGNFSSVYKGTLRDGTLVAIRSINVTSCKSEEAEFVKGLYLLTSLRHENIIRLRGFCC 476
           +GKG F  V++G  R G  VA++  +    +S   E    +Y    LRHENI+       
Sbjct: 11  IGKGRFGEVWRGKWR-GEEVAVKIFSSREERSWFRE--AEIYQTVMLRHENILGFIAADN 67

Query: 477 SRGRG--ECFLIYDFAPKGKLSKYLDQEEGSSNVLDWSTRVSIIIGIAKGIGYLHSSEVN 534
                  + +L+ D+   G L  YL++       +     + + +  A G+ +LH   V 
Sbjct: 68  KDNGTWTQLWLVSDYHEHGSLFDYLNRYT-----VTVEGMIKLALSTASGLAHLHMEIVG 122

Query: 535 ---KPAIVHRNLSVEKVLIDQQFNPLIADCGLHKLLADDIVFSVLKTSAAMG---YLAPE 588
              KPAI HR+L  + +L+ +     IAD GL            +  +  +G   Y+APE
Sbjct: 123 TQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAVRHDSATDTIDIAPNHRVGTKRYMAPE 182

Query: 589 YVTT------GRFTERSDIFAFGVIILQILTGS---------------LVLTSSMRLAAE 627
            +            +R+DI+A G++  +I                   LV +        
Sbjct: 183 VLDDSINMKHFESFKRADIYAMGLVFWEIARRCSIGGIHEDYQLPYYDLVPSDPSVEEMR 242

Query: 628 SATFENFIDRNLKGKFSESEAAK-LGKMALVCTHEDPENRPTMEAVIEELT 677
               E  +  N+  ++   EA + + K+   C + +   R T   + + L+
Sbjct: 243 KVVCEQKLRPNIPNRWQSCEALRVMAKIMRECWYANGAARLTALRIKKTLS 293

>d1lufa_ d.144.1.7 (A:) Musk tyrosine kinase {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 301

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Musk tyrosine kinase
species: Rat (Rattus norvegicus) [TaxId: 10116]

 Score =  161 bits (408), Expect = 3e-45
 Identities = 61/303 (20%), Positives = 120/303 (39%), Gaps = 38/303 (12%)

Query: 401 LEEVESATQCFSEVNLLGKGNFSSVYKGTLR------DGTLVAIRSINVTSCKSEEAEFV 454
           L  +E        V  +G+G F  V++            T+VA++ +   +    +A+F 
Sbjct: 5   LLSLEYPRNNIEYVRDIGEGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASADMQADFQ 64

Query: 455 KGLYLLTSLRHENIIRLRGFCCSRGRGECFLIYDFAPKGKLSKYLDQEEGSSN------- 507
           +   L+    + NI++L G C         L++++   G L+++L      +        
Sbjct: 65  REAALMAEFDNPNIVKLLGVCAVGK--PMCLLFEYMAYGDLNEFLRSMSPHTVCSLSHSD 122

Query: 508 -------------VLDWSTRVSIIIGIAKGIGYLHSSEVNKPAIVHRNLSVEKVLIDQQF 554
                         L  + ++ I   +A G+ YL          VHR+L+    L+ +  
Sbjct: 123 LSTRARVSSPGPPPLSCAEQLCIARQVAAGMAYLSE-----RKFVHRDLATRNCLVGENM 177

Query: 555 NPLIADCGLHKLLADDIVFSVLKTSA-AMGYLAPEYVTTGRFTERSDIFAFGVIILQILT 613
              IAD GL + +     +      A  + ++ PE +   R+T  SD++A+GV++ +I +
Sbjct: 178 VVKIADFGLSRNIYSADYYKADGNDAIPIRWMPPESIFYNRYTTESDVWAYGVVLWEIFS 237

Query: 614 GSLVLTSSMRLAAESATFENFIDRNLKGKFSESEAAKLGKMALVCTHEDPENRPTMEAVI 673
             L     M   A         D N+     E+   +L  +  +C  + P +RP+  ++ 
Sbjct: 238 YGLQPYYGM---AHEEVIYYVRDGNIL-ACPENCPLELYNLMRLCWSKLPADRPSFCSIH 293

Query: 674 EEL 676
             L
Sbjct: 294 RIL 296

>d1t46a_ d.144.1.7 (A:) c-KIT receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 311

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: c-KIT receptor
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  160 bits (406), Expect = 6e-45
 Identities = 61/288 (21%), Positives = 116/288 (40%), Gaps = 32/288 (11%)

Query: 411 FSEVNLLGKGNFSSVYKGTLR------DGTLVAIRSINVTSCKSEEAEFVKGLYLLTSL- 463
            S    LG G F  V + T            VA++ +  ++  +E    +  L +L+ L 
Sbjct: 25  LSFGKTLGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSAHLTEREALMSELKVLSYLG 84

Query: 464 RHENIIRLRGFCCSRGRGECFLIYDFAPKGKLSKYLDQE--------------EGSSNVL 509
            H NI+ L G C   G     +I ++   G L  +L ++              E     L
Sbjct: 85  NHMNIVNLLGACTIGG--PTLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELAL 142

Query: 510 DWSTRVSIIIGIAKGIGYLHSSEVNKPAIVHRNLSVEKVLIDQQFNPLIADCGLHKLLAD 569
           D    +S    +AKG+ +L S        +HR+L+   +L+       I D GL + + +
Sbjct: 143 DLEDLLSFSYQVAKGMAFLAS-----KNCIHRDLAARNILLTHGRITKICDFGLARDIKN 197

Query: 570 DIVFSVLKTSA-AMGYLAPEYVTTGRFTERSDIFAFGVIILQILTGSLVLTSSMRLAAES 628
           D  + V   +   + ++APE +    +T  SD++++G+ + ++ +        M      
Sbjct: 198 DSNYVVKGNARLPVKWMAPESIFNCVYTFESDVWSYGIFLWELFSLGSSPYPGMP---VD 254

Query: 629 ATFENFIDRNLKGKFSESEAAKLGKMALVCTHEDPENRPTMEAVIEEL 676
           + F   I    +    E   A++  +   C   DP  RPT + +++ +
Sbjct: 255 SKFYKMIKEGFRMLSPEHAPAEMYDIMKTCWDADPLKRPTFKQIVQLI 302

>d1t4ha_ d.144.1.7 (A:) Protein kinase wnk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 270

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Protein kinase wnk1
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  157 bits (398), Expect = 4e-44
 Identities = 58/263 (22%), Positives = 110/263 (41%), Gaps = 19/263 (7%)

Query: 417 LGKGNFSSVYKGTLRD-GTLVAIRSINVTSC-KSEEAEFVKGLYLLTSLRHENIIRLRGF 474
           +G+G+F +VYKG   +    VA   +      KSE   F +   +L  L+H NI+R    
Sbjct: 17  IGRGSFKTVYKGLDTETTVEVAWCELQDRKLTKSERQRFKEEAEMLKGLQHPNIVRFYDS 76

Query: 475 C--CSRGRGECFLIYDFAPKGKLSKYLDQEEGSSNVLDWSTRVSIIIGIAKGIGYLHSSE 532
                +G+    L+ +    G L  YL +      V+      S    I KG+ +LH+  
Sbjct: 77  WESTVKGKKCIVLVTELMTSGTLKTYLKRF----KVMKIKVLRSWCRQILKGLQFLHT-- 130

Query: 533 VNKPAIVHRNLSVEKVLIDQQFNPL-IADCGLHKLLADDIVFSVLKTSAAMGYLAPEYVT 591
              P I+HR+L  + + I      + I D GL  L       +V+ T     ++APE   
Sbjct: 131 -RTPPIIHRDLKCDNIFITGPTGSVKIGDLGLATLKRASFAKAVIGT---PEFMAPEMYE 186

Query: 592 TGRFTERSDIFAFGVIILQILTGSLVLTSSMRLAAESATFENFIDRNLKGKFSESEAAKL 651
             ++ E  D++AFG+ +L++ T     +        +  +           F +    ++
Sbjct: 187 -EKYDESVDVYAFGMCMLEMATSEYPYSECQN---AAQIYRRVTSGVKPASFDKVAIPEV 242

Query: 652 GKMALVCTHEDPENRPTMEAVIE 674
            ++   C  ++ + R +++ ++ 
Sbjct: 243 KEIIEGCIRQNKDERYSIKDLLN 265

>d1s9ja_ d.144.1.7 (A:) Dual specificity mitogen-activated protein kinase kinase 1, Mek1 {Human (Homo sapiens) [TaxId: 9606]} Length = 322

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Dual specificity mitogen-activated protein kinase kinase 1, Mek1
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  158 bits (401), Expect = 5e-44
 Identities = 44/207 (21%), Positives = 93/207 (44%), Gaps = 14/207 (6%)

Query: 411 FSEVNLLGKGNFSSVYKGTLR-DGTLVAIRSINVTSCKSEEAEFVKGLYLLTSLRHENII 469
           F +++ LG GN   V+K + +  G ++A + I++    +   + ++ L +L       I+
Sbjct: 8   FEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLEIKPAIRNQIIRELQVLHECNSPYIV 67

Query: 470 RLRGFCCSRGRGECFLIYDFAPKGKLSKYLDQEEGSSNVLDWSTRVSIIIGIAKGIGYLH 529
              G   S G  E  +  +    G L + L +       +       + I + KG+ YL 
Sbjct: 68  GFYGAFYSDG--EISICMEHMDGGSLDQVLKKA----GRIPEQILGKVSIAVIKGLTYLR 121

Query: 530 SSEVNKPAIVHRNLSVEKVLIDQQFNPLIADCGLHKLLADDIVFSVLKTSAAMGYLAPEY 589
                K  I+HR++    +L++ +    + D G+   L D +  S + T     Y++PE 
Sbjct: 122 E----KHKIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDSMANSFVGT---RSYMSPER 174

Query: 590 VTTGRFTERSDIFAFGVIILQILTGSL 616
           +    ++ +SDI++ G+ ++++  G  
Sbjct: 175 LQGTHYSVQSDIWSMGLSLVEMAVGRY 201

>d1u46a_ d.144.1.7 (A:) Activated CDC42 kinase 1, ACK1 {Human (Homo sapiens) [TaxId: 9606]} Length = 273

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Activated CDC42 kinase 1, ACK1
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  156 bits (396), Expect = 8e-44
 Identities = 63/275 (22%), Positives = 110/275 (40%), Gaps = 22/275 (8%)

Query: 411 FSEVNLLGKGNFSSVYKGTLR----DGTLVAIRSINVTSCKSEEA--EFVKGLYLLTSLR 464
              +  LG G+F  V +G           VA++ +        EA  +F++ +  + SL 
Sbjct: 10  LRLLEKLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLD 69

Query: 465 HENIIRLRGFCCSRGRGECFLIYDFAPKGKLSKYLDQEEGSSNVLDWSTRVSIIIGIAKG 524
           H N+IRL G   +       ++ + AP G L   L + +G        T     + +A+G
Sbjct: 70  HRNLIRLYGVVLT---PPMKMVTELAPLGSLLDRLRKHQGH---FLLGTLSRYAVQVAEG 123

Query: 525 IGYLHSSEVNKPAIVHRNLSVEKVLIDQQFNPLIADCGLHKLLADDIVFSVLKTSAA--M 582
           +GYL S        +HR+L+   +L+  +    I D GL + L  +    V++       
Sbjct: 124 MGYLES-----KRFIHRDLAARNLLLATRDLVKIGDFGLMRALPQNDDHYVMQEHRKVPF 178

Query: 583 GYLAPEYVTTGRFTERSDIFAFGVIILQILTGSLVLTSSMRLAAESATFENFIDRNLKGK 642
            + APE + T  F+  SD + FGV + ++ T        +     S           +  
Sbjct: 179 AWCAPESLKTRTFSHASDTWMFGVTLWEMFTYGQEPWIGLN---GSQILHKIDKEGERLP 235

Query: 643 FSESEAAKLGKMALVCTHEDPENRPTMEAVIEELT 677
             E     +  + + C    PE+RPT  A+ + L 
Sbjct: 236 RPEDCPQDIYNVMVQCWAHKPEDRPTFVALRDFLL 270

>d1fvra_ d.144.1.7 (A:) Tie2 kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 309

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Tie2 kinase
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  157 bits (398), Expect = 1e-43
 Identities = 60/282 (21%), Positives = 122/282 (43%), Gaps = 29/282 (10%)

Query: 411 FSEVNLLGKGNFSSVYKGTLRDGTL---VAIRSINVTSCKSEEAEFVKGLYLLTSL-RHE 466
               +++G+GNF  V K  ++   L    AI+ +   + K +  +F   L +L  L  H 
Sbjct: 12  IKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHP 71

Query: 467 NIIRLRGFCCSRGRGECFLIYDFAPKGKLSKYLDQE------------EGSSNVLDWSTR 514
           NII L G C    RG  +L  ++AP G L  +L +               +++ L     
Sbjct: 72  NIINLLGAC--EHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQL 129

Query: 515 VSIIIGIAKGIGYLHSSEVNKPAIVHRNLSVEKVLIDQQFNPLIADCGLHKLLADDIVFS 574
           +     +A+G+ YL          +HR+L+   +L+ + +   IAD GL +     +  +
Sbjct: 130 LHFAADVARGMDYLSQ-----KQFIHRDLAARNILVGENYVAKIADFGLSRGQEVYVKKT 184

Query: 575 VLKTSAAMGYLAPEYVTTGRFTERSDIFAFGVIILQILTGSLVLTSSMRLAAESATFENF 634
           + +    + ++A E +    +T  SD++++GV++ +I++        M  A     +E  
Sbjct: 185 MGRLP--VRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPYCGMTCA---ELYEK- 238

Query: 635 IDRNLKGKFSESEAAKLGKMALVCTHEDPENRPTMEAVIEEL 676
           + +  + +   +   ++  +   C  E P  RP+   ++  L
Sbjct: 239 LPQGYRLEKPLNCDDEVYDLMRQCWREKPYERPSFAQILVSL 280

>d1xkka_ d.144.1.7 (A:) EGF receptor tyrosine kinase, Erbb-1 {Human (Homo sapiens) [TaxId: 9606]} Length = 317

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: EGF receptor tyrosine kinase, Erbb-1
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  156 bits (395), Expect = 3e-43
 Identities = 59/272 (21%), Positives = 114/272 (41%), Gaps = 21/272 (7%)

Query: 411 FSEVNLLGKGNFSSVYKGTLRD-----GTLVAIRSINVTSCKSEEAEFVKGLYLLTSLRH 465
           F ++ +LG G F +VYKG            VAI+ +   +      E +   Y++ S+ +
Sbjct: 11  FKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDN 70

Query: 466 ENIIRLRGFCCSRGRGECFLIYDFAPKGKLSKYLDQEEGSSNVLDWSTRVSIIIGIAKGI 525
            ++ RL G C +       LI    P G L   LD      + +     ++  + IAKG+
Sbjct: 71  PHVCRLLGICLT---STVQLITQLMPFGCL---LDYVREHKDNIGSQYLLNWCVQIAKGM 124

Query: 526 GYLHSSEVNKPAIVHRNLSVEKVLIDQQFNPLIADCGLHKLLADDIVFSVLKTSAA-MGY 584
            YL         +VHR+L+   VL+    +  I D GL KLL  +      +     + +
Sbjct: 125 NYLE-----DRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKW 179

Query: 585 LAPEYVTTGRFTERSDIFAFGVIILQILTGSLVLTSSMRLAAESATFENFIDRNLKGKFS 644
           +A E +    +T +SD++++GV + +++T        +  +       + +++  +    
Sbjct: 180 MALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASE----ISSILEKGERLPQP 235

Query: 645 ESEAAKLGKMALVCTHEDPENRPTMEAVIEEL 676
                 +  + + C   D ++RP    +I E 
Sbjct: 236 PICTIDVYMIMVKCWMIDADSRPKFRELIIEF 267

>d2j4za1 d.144.1.7 (A:126-388) Aurora-related kinase 1 (aurora-2) {Human (Homo sapiens) [TaxId: 9606]} Length = 263

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Aurora-related kinase 1 (aurora-2)
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  152 bits (384), Expect = 3e-42
 Identities = 61/271 (22%), Positives = 114/271 (42%), Gaps = 31/271 (11%)

Query: 411 FSEVNLLGKGNFSSVYKGTLR-DGTLVAIRSINVTSCKSEEAE--FVKGLYLLTSLRHEN 467
           F     LGKG F +VY    +    ++A++ +     +    E    + + + + LRH N
Sbjct: 8   FEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPN 67

Query: 468 IIRLRGFCCSRGRGECFLIYDFAPKGKLSKYLDQEEGSSNVLDWSTRVSIIIGIAKGIGY 527
           I+RL G+     R   +LI ++AP G + + L +     +  D     + I  +A  + Y
Sbjct: 68  ILRLYGYFHDATR--VYLILEYAPLGTVYRELQKL----SKFDEQRTATYITELANALSY 121

Query: 528 LHSSEVNKPAIVHRNLSVEKVLIDQQFNPLIADCGLHKLLADDIVFSVLKTSAAMGYLAP 587
            HS       ++HR++  E +L+       IAD G           ++  T   + YL P
Sbjct: 122 CHSKR-----VIHRDIKPENLLLGSAGELKIADFGWSVHAPSSRRTTLCGT---LDYLPP 173

Query: 588 EYVTTGRFTERSDIFAFGVIILQILTGSLVLTSSMRLAAESATFENFIDRNLKGKFSE-- 645
           E +      E+ D+++ GV+  + L G        +   E+ T++    R  + +F+   
Sbjct: 174 EMIEGRMHDEKVDLWSLGVLCYEFLVG--------KPPFEANTYQETYKRISRVEFTFPD 225

Query: 646 --SEAAKLGKMALVCTHEDPENRPTMEAVIE 674
             +E A+   +       +P  RP +  V+E
Sbjct: 226 FVTEGAR--DLISRLLKHNPSQRPMLREVLE 254

>d1u5ra_ d.144.1.7 (A:) Serine/threonine protein kinase TAO2 {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 309

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Serine/threonine protein kinase TAO2
species: Rat (Rattus norvegicus) [TaxId: 10116]

 Score =  153 bits (387), Expect = 3e-42
 Identities = 55/273 (20%), Positives = 117/273 (42%), Gaps = 26/273 (9%)

Query: 408 TQCFSEVNLLGKGNFSSVYKGT-LRDGTLVAIRSINVTSCKSEEA--EFVKGLYLLTSLR 464
            + FS++  +G G+F +VY    +R+  +VAI+ ++ +  +S E   + +K +  L  LR
Sbjct: 14  EKLFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLR 73

Query: 465 HENIIRLRGFCCSRGRGECFLIYDFAPKGKLSKYLDQEEGSSNVLDWSTRVSIIIGIAKG 524
           H N I+ RG          +L+ ++            ++     L      ++  G  +G
Sbjct: 74  HPNTIQYRGCYLREHT--AWLVMEYCLGSASDLLEVHKKP----LQEVEIAAVTHGALQG 127

Query: 525 IGYLHSSEVNKPAIVHRNLSVEKVLIDQQFNPLIADCGLHKLLADDIVFSVLKTSAAMGY 584
           + YLHS       ++HR++    +L+ +     + D G   ++A    F          +
Sbjct: 128 LAYLHSH-----NMIHRDVKAGNILLSEPGLVKLGDFGSASIMAPANSF-----VGTPYW 177

Query: 585 LAPEYVTT---GRFTERSDIFAFGVIILQILTGSLVLTSSMRLAAESATFENFIDRNLKG 641
           +APE +     G++  + D+++ G+  +++      L +   ++A     +N       G
Sbjct: 178 MAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSALYHIAQNESPALQSG 237

Query: 642 KFSESEAAKLGKMALVCTHEDPENRPTMEAVIE 674
            +SE            C  + P++RPT E +++
Sbjct: 238 HWSE-YFRNFVDS---CLQKIPQDRPTSEVLLK 266

>d1mp8a_ d.144.1.7 (A:) Focal adhesion kinase 1 (fak) {Human (Homo sapiens) [TaxId: 9606]} Length = 273

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Focal adhesion kinase 1 (fak)
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  149 bits (377), Expect = 3e-41
 Identities = 55/268 (20%), Positives = 107/268 (39%), Gaps = 19/268 (7%)

Query: 414 VNLLGKGNFSSVYKGTLRD----GTLVAIRSINVTSCKSEEAEFVKGLYLLTSLRHENII 469
              +G+G F  V++G           VAI++    +  S   +F++    +    H +I+
Sbjct: 12  GRCIGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIV 71

Query: 470 RLRGFCCSRGRGECFLIYDFAPKGKLSKYLDQEEGSSNVLDWSTRVSIIIGIAKGIGYLH 529
           +L G          ++I +    G+L  +L   + S   LD ++ +     ++  + YL 
Sbjct: 72  KLIGVIT---ENPVWIIMELCTLGELRSFLQVRKYS---LDLASLILYAYQLSTALAYLE 125

Query: 530 SSEVNKPAIVHRNLSVEKVLIDQQFNPLIADCGLHKLLADDIVFSVLKTSAAMGYLAPEY 589
           S        VHR+++   VL+       + D GL + + D   +   K    + ++APE 
Sbjct: 126 S-----KRFVHRDIAARNVLVSSNDCVKLGDFGLSRYMEDSTYYKASKGKLPIKWMAPES 180

Query: 590 VTTGRFTERSDIFAFGVIILQILTGSLVLTSSMRLAAESATFENFIDRNLKGKFSESEAA 649
           +   RFT  SD++ FGV + +IL   +     ++           I+   +     +   
Sbjct: 181 INFRRFTSASDVWMFGVCMWEILMHGVKPFQGVKNND----VIGRIENGERLPMPPNCPP 236

Query: 650 KLGKMALVCTHEDPENRPTMEAVIEELT 677
            L  +   C   DP  RP    +  +L+
Sbjct: 237 TLYSLMTKCWAYDPSRRPRFTELKAQLS 264

>d1nvra_ d.144.1.7 (A:) Cell cycle checkpoint kinase chk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 271

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cell cycle checkpoint kinase chk1
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  148 bits (374), Expect = 7e-41
 Identities = 54/267 (20%), Positives = 105/267 (39%), Gaps = 17/267 (6%)

Query: 411 FSEVNLLGKGNFSSVYKGTLR-DGTLVAIRSINVTSCKSEEAEFVKGLYLLTSLRHENII 469
           +  V  LG+G +  V     R     VA++ +++           K + +   L HEN++
Sbjct: 7   WDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVV 66

Query: 470 RLRGFCCSRGRGECFLIYDFAPKGKLSKYLDQEEGSSNVLDWSTRVSIIIGIAKGIGYLH 529
           +  G    R     +L  ++   G+L   ++ + G    +           +  G+ YLH
Sbjct: 67  KFYGHR--REGNIQYLFLEYCSGGELFDRIEPDIG----MPEPDAQRFFHQLMAGVVYLH 120

Query: 530 SSEVNKPAIVHRNLSVEKVLIDQQFNPLIADCGLHKLLADDIVFSVLKTSAA-MGYLAPE 588
                   I HR++  E +L+D++ N  I+D GL  +   +    +L      + Y+APE
Sbjct: 121 G-----IGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPE 175

Query: 589 YVTTGRF-TERSDIFAFGVIILQILTGSLVLTSSMRLAAESATFENFIDRNLKGKFSESE 647
            +    F  E  D+++ G+++  +L G L          E + ++         K  +S 
Sbjct: 176 LLKRREFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQEYSDWKEKKTYLNPWKKIDSA 235

Query: 648 AAKLGKMALVCTHEDPENRPTMEAVIE 674
              L         E+P  R T+  + +
Sbjct: 236 PLALLHK---ILVENPSARITIPDIKK 259

>d1ywna1 d.144.1.7 (A:818-1166) Vascular endothelial growth factor receptor 2 (kdr) {Human (Homo sapiens) [TaxId: 9606]} Length = 299

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Vascular endothelial growth factor receptor 2 (kdr)
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  148 bits (373), Expect = 2e-40
 Identities = 58/285 (20%), Positives = 116/285 (40%), Gaps = 27/285 (9%)

Query: 411 FSEVNLLGKGNFSSVYKGTLR------DGTLVAIRSINVTSCKSEEAEFVKGLYLLTSLR 464
                 LG+G F  V +              VA++ +   +  SE    +  L +L  + 
Sbjct: 15  LKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIG 74

Query: 465 HENIIRLRGFCCSRGRGECFLIYDFAPKGKLSKYLDQ------------EEGSSNVLDWS 512
           H   +      C++  G   +I +F   G LS YL              E+   + L   
Sbjct: 75  HHLNVVNLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLE 134

Query: 513 TRVSIIIGIAKGIGYLHSSEVNKPAIVHRNLSVEKVLIDQQFNPLIADCGLHKLLADDIV 572
             +     +AKG+ +L S +      +HR+L+   +L+ ++    I D GL + +  D  
Sbjct: 135 HLICYSFQVAKGMEFLASRK-----CIHRDLAARNILLSEKNVVKICDFGLARDIYKDPD 189

Query: 573 FSVLKTSA-AMGYLAPEYVTTGRFTERSDIFAFGVIILQILTGSLVLTSSMRLAAESATF 631
           +     +   + ++APE +    +T +SD+++FGV++ +I +        +++  E   F
Sbjct: 190 YVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKIDEE---F 246

Query: 632 ENFIDRNLKGKFSESEAAKLGKMALVCTHEDPENRPTMEAVIEEL 676
              +    + +  +    ++ +  L C H +P  RPT   ++E L
Sbjct: 247 CRRLKEGTRMRAPDYTTPEMYQTMLDCWHGEPSQRPTFSELVEHL 291

>d1p4oa_ d.144.1.7 (A:) Insulin-like growth factor 1 receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 308

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Insulin-like growth factor 1 receptor
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  147 bits (371), Expect = 4e-40
 Identities = 60/291 (20%), Positives = 123/291 (42%), Gaps = 30/291 (10%)

Query: 402 EEVESATQCFSEVNLLGKGNFSSVYKGTLR------DGTLVAIRSINVTSCKSEEAEFVK 455
           +E E A +  +    LG+G+F  VY+G  +        T VAI+++N  +   E  EF+ 
Sbjct: 13  DEWEVAREKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEFLN 72

Query: 456 GLYLLTSLRHENIIRLRGFCCSRGRGECFLIYDFAPKGKLSKYLDQ------EEGSSNVL 509
              ++      +++RL G           +I +   +G L  YL                
Sbjct: 73  EASVMKEFNCHHVVRLLGVVSQ--GQPTLVIMELMTRGDLKSYLRSLRPAMANNPVLAPP 130

Query: 510 DWSTRVSIIIGIAKGIGYLHSSEVNKPAIVHRNLSVEKVLIDQQFNPLIADCGLHKLLAD 569
             S  + +   IA G+ YL++++      VHR+L+    ++ + F   I D G+ + + +
Sbjct: 131 SLSKMIQMAGEIADGMAYLNANK-----FVHRDLAARNCMVAEDFTVKIGDFGMTRDIYE 185

Query: 570 DIVFSVLKTSA-AMGYLAPEYVTTGRFTERSDIFAFGVIILQILTGSLVLTSSMRLAAES 628
              +         + +++PE +  G FT  SD+++FGV++ +I T             + 
Sbjct: 186 TDYYRKGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIATL-------AEQPYQG 238

Query: 629 ATFENFIDRNLKGK---FSESEAAKLGKMALVCTHEDPENRPTMEAVIEEL 676
            + E  +   ++G      ++    L ++  +C   +P+ RP+   +I  +
Sbjct: 239 LSNEQVLRFVMEGGLLDKPDNCPDMLFELMRMCWQYNPKMRPSFLEIISSI 289

>d2jfla1 d.144.1.7 (A:21-308) STE20-like serine/threonine-protein kinase, SLK {Human (Homo sapiens) [TaxId: 9606]} Length = 288

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: STE20-like serine/threonine-protein kinase, SLK
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  142 bits (359), Expect = 1e-38
 Identities = 47/270 (17%), Positives = 102/270 (37%), Gaps = 27/270 (10%)

Query: 414 VNLLGKGNFSSVYKGTLRD-GTLVAIRSINVTSCKSEEAEFVKGLYLLTSLRHENIIRLR 472
           +  LG G F  VYK   ++   L A + I+  S + E  +++  + +L S  H NI++L 
Sbjct: 17  IGELGDGAFGKVYKAQNKETSVLAAAKVIDTKS-EEELEDYMVEIDILASCDHPNIVKLL 75

Query: 473 GFCCSRGRGECFLIYDFAPKGKLSKYLDQEEGSSNVLDWSTRVSIIIGIAKGIGYLHSSE 532
                      +++ +F   G +   + + E     L  S    +       + YLH + 
Sbjct: 76  DAFYYENN--LWILIEFCAGGAVDAVMLELERP---LTESQIQVVCKQTLDALNYLHDN- 129

Query: 533 VNKPAIVHRNLSVEKVLIDQQFNPLIADCGLHKLLADDIVFSVLKTSAAMG---YLAPEY 589
                I+HR+L    +L     +  +AD G+       I     +  + +G   ++APE 
Sbjct: 130 ----KIIHRDLKAGNILFTLDGDIKLADFGVSAKNTRTIQ----RRDSFIGTPYWMAPEV 181

Query: 590 V-----TTGRFTERSDIFAFGVIILQILTGSLVLTSSMRLAAESATFENFIDRNLKGKFS 644
           V         +  ++D+++ G+ ++++            +       ++      +    
Sbjct: 182 VMCETSKDRPYDYKADVWSLGITLIEMAEIEPPHHELNPMRVLLKIAKSEPPTLAQPSRW 241

Query: 645 ESEAAKLGKMALVCTHEDPENRPTMEAVIE 674
            S      K    C  ++ + R T   +++
Sbjct: 242 SSNFKDFLKK---CLEKNVDARWTTSQLLQ 268

>d1fgka_ d.144.1.7 (A:) Fibroblast growth factor receptor 1 {Human (Homo sapiens) [TaxId: 9606]} Length = 299

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Fibroblast growth factor receptor 1
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  141 bits (356), Expect = 3e-38
 Identities = 62/288 (21%), Positives = 117/288 (40%), Gaps = 33/288 (11%)

Query: 411 FSEVNLLGKGNFSSVYKGTLR--------DGTLVAIRSINVTSCKSEEAEFVKGLYLLTS 462
                 LG+G F  V                T VA++ +   + + + ++ +  + ++  
Sbjct: 15  LVLGKPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKM 74

Query: 463 L-RHENIIRLRGFCCSRGRGECFLIYDFAPKGKLSKYL------------DQEEGSSNVL 509
           + +H+NII L G C   G    ++I ++A KG L +YL            +        L
Sbjct: 75  IGKHKNIINLLGACTQDGP--LYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQL 132

Query: 510 DWSTRVSIIIGIAKGIGYLHSSEVNKPAIVHRNLSVEKVLIDQQFNPLIADCGLHKLLAD 569
                VS    +A+G+ YL S        +HR+L+   VL+ +     IAD GL + +  
Sbjct: 133 SSKDLVSCAYQVARGMEYLAS-----KKCIHRDLAARNVLVTEDNVMKIADFGLARDIHH 187

Query: 570 DIVFSVLKTSA-AMGYLAPEYVTTGRFTERSDIFAFGVIILQILTGSLVLTSSMRLAAES 628
              +         + ++APE +    +T +SD+++FGV++ +I T        + +    
Sbjct: 188 IDYYKKTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGSPYPGVPVEE-- 245

Query: 629 ATFENFIDRNLKGKFSESEAAKLGKMALVCTHEDPENRPTMEAVIEEL 676
                 +    +     +   +L  M   C H  P  RPT + ++E+L
Sbjct: 246 --LFKLLKEGHRMDKPSNCTNELYMMMRDCWHAVPSQRPTFKQLVEDL 291

>d1yhwa1 d.144.1.7 (A:249-541) pak1 {Human (Homo sapiens) [TaxId: 9606]} Length = 293

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: pak1
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  139 bits (352), Expect = 2e-37
 Identities = 41/265 (15%), Positives = 103/265 (38%), Gaps = 18/265 (6%)

Query: 411 FSEVNLLGKGNFSSVYKGT-LRDGTLVAIRSINVTSCKSEEAEFVKGLYLLTSLRHENII 469
           ++    +G+G   +VY    +  G  VAIR +N+     +E   +  + ++   ++ NI+
Sbjct: 22  YTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKE-LIINEILVMRENKNPNIV 80

Query: 470 RLRGFCCSRGRGECFLIYDFAPKGKLSKYLDQEEGSSNVLDWSTRVSIIIGIAKGIGYLH 529
                       E +++ ++   G L+  + +       +D     ++     + + +LH
Sbjct: 81  NYLDSYLVGD--ELWVVMEYLAGGSLTDVVTE-----TCMDEGQIAAVCRECLQALEFLH 133

Query: 530 SSEVNKPAIVHRNLSVEKVLIDQQFNPLIADCGLHKLLADDIVFSVLKTSAAMGYLAPEY 589
           S+      ++HR++  + +L+    +  + D G    +  +             ++APE 
Sbjct: 134 SN-----QVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQSKRS-TMVGTPYWMAPEV 187

Query: 590 VTTGRFTERSDIFAFGVIILQILTGSLVLTSSMRLAAESATFENFIDRNLKGKFSESEAA 649
           VT   +  + DI++ G++ ++++ G     +   L A      N        +   +   
Sbjct: 188 VTRKAYGPKVDIWSLGIMAIEMIEGEPPYLNENPLRALYLIATNGTPELQNPEKLSAIFR 247

Query: 650 KLGKMALVCTHEDPENRPTMEAVIE 674
                   C   D E R + + +++
Sbjct: 248 DFLNR---CLDMDVEKRGSAKELLQ 269

>d1koaa2 d.144.1.7 (A:5915-6264) Twitchin, kinase domain {Caenorhabditis elegans, pjk4 [TaxId: 6239]} Length = 350

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Twitchin, kinase domain
species: Caenorhabditis elegans, pjk4 [TaxId: 6239]

 Score =  140 bits (353), Expect = 4e-37
 Identities = 52/268 (19%), Positives = 99/268 (36%), Gaps = 26/268 (9%)

Query: 414 VNLLGKGNFSSVYKGT-LRDGTLVAIRSINVTSCKSEEAEFVKGLYLLTSLRHENIIRLR 472
              LG G F  V++ T    G   A + +       +E    K +  ++ LRH  ++ L 
Sbjct: 31  HEELGTGAFGVVHRVTERATGNNFAAKFVMTPHESDKE-TVRKEIQTMSVLRHPTLVNLH 89

Query: 473 GFCCSRGRGECFLIYDFAPKGKLSKYLDQEEGSSNVLDWSTRVSIIIGIAKGIGYLHSSE 532
                    E  +IY+F   G+L + +  E      +     V  +  + KG+ ++H + 
Sbjct: 90  DAFEDDN--EMVMIYEFMSGGELFEKVADEHNK---MSEDEAVEYMRQVCKGLCHMHENN 144

Query: 533 VNKPAIVHRNLSVEKVLIDQQFNPLI--ADCGLHKLLADDIVFSVLKTSAAMGYLAPEYV 590
                 VH +L  E ++   + +  +   D GL   L      SV  T+    + APE  
Sbjct: 145 -----YVHLDLKPENIMFTTKRSNELKLIDFGLTAHLDPK--QSVKVTTGTAEFAAPEVA 197

Query: 591 TTGRFTERSDIFAFGVIILQILTGSLVLTSSMRLAAESATFENFIDRNLKGKFSESEAAK 650
                   +D+++ GV+   +L+G            +  T  N   ++      +S  + 
Sbjct: 198 EGKPVGYYTDMWSVGVLSYILLSGLSPFGGEN----DDETLRNV--KSCDWNMDDSAFSG 251

Query: 651 LGKMA--LV--CTHEDPENRPTMEAVIE 674
           + +     +      DP  R T+   +E
Sbjct: 252 ISEDGKDFIRKLLLADPNTRMTIHQALE 279

>d1uu3a_ d.144.1.7 (A:) 3-phosphoinositide dependent protein kinase-1 Pdk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 288

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: 3-phosphoinositide dependent protein kinase-1 Pdk1
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  136 bits (344), Expect = 1e-36
 Identities = 57/264 (21%), Positives = 102/264 (38%), Gaps = 21/264 (7%)

Query: 411 FSEVNLLGKGNFSSVYKGT-LRDGTLVAIRSINVTSCKSEEA--EFVKGLYLLTSLRHEN 467
           F    +LG+G+FS+V     L      AI+ +       E       +   +++ L H  
Sbjct: 10  FKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHPF 69

Query: 468 IIRLRGFCCSRGRGECFLIYDFAPKGKLSKYLDQEEGSSNVLDWSTRVSIIIGIAKGIGY 527
            ++L      +   + +    +A  G+L KY+ +        D +        I   + Y
Sbjct: 70  FVKLYFTF--QDDEKLYFGLSYAKNGELLKYIRKI----GSFDETCTRFYTAEIVSALEY 123

Query: 528 LHSSEVNKPAIVHRNLSVEKVLIDQQFNPLIADCGLHKLLADDIVFSVLKTSAAM-GYLA 586
           LH        I+HR+L  E +L+++  +  I D G  K+L+ +   +   +      Y++
Sbjct: 124 LHG-----KGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANSFVGTAQYVS 178

Query: 587 PEYVTTGRFTERSDIFAFGVIILQILTGSLVLTSSMRLAAESATFENFIDRNLKGKFSES 646
           PE +T     + SD++A G II Q++ G     +      E   F+  I   L+  F E 
Sbjct: 179 PELLTEKSACKSSDLWALGCIIYQLVAGLPPFRAGN----EYLIFQKII--KLEYDFPEK 232

Query: 647 EAAKLGKMALVCTHEDPENRPTME 670
              K   +       D   R   E
Sbjct: 233 FFPKARDLVEKLLVLDATKRLGCE 256

>d1koba_ d.144.1.7 (A:) Twitchin, kinase domain {California sea hare (Aplysia californica), twk43 [TaxId: 6500]} Length = 352

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Twitchin, kinase domain
species: California sea hare (Aplysia californica), twk43 [TaxId: 6500]

 Score =  136 bits (344), Expect = 5e-36
 Identities = 50/269 (18%), Positives = 100/269 (37%), Gaps = 22/269 (8%)

Query: 411 FSEVNLLGKGNFSSVYKGT-LRDGTLVAIRSINVTSCKSEEAEFVKGLYLLTSLRHENII 469
           +  +  LG G F  V++      G +   + IN      ++      + ++  L H  +I
Sbjct: 31  YDILEELGSGAFGVVHRCVEKATGRVFVAKFINTPY-PLDKYTVKNEISIMNQLHHPKLI 89

Query: 470 RLRGFCCSRGRGECFLIYDFAPKGKLSKYLDQEEGSSNVLDWSTRVSIIIGIAKGIGYLH 529
            L      +      LI +F   G+L   +  E+     +  +  ++ +    +G+ ++H
Sbjct: 90  NLHDAFEDKYE--MVLILEFLSGGELFDRIAAEDYK---MSEAEVINYMRQACEGLKHMH 144

Query: 530 SSEVNKPAIVHRNLSVEKVLIDQQFNPLI--ADCGLHKLLADDIVFSVLKTSAAMGYLAP 587
                  +IVH ++  E ++ + +    +   D GL   L  D +  V   +A   + AP
Sbjct: 145 EH-----SIVHLDIKPENIMCETKKASSVKIIDFGLATKLNPDEIVKVTTATA--EFAAP 197

Query: 588 EYVTTGRFTERSDIFAFGVIILQILTGSLVLTSSMRLAAESATFENFIDRNLKGKFSESE 647
           E V        +D++A GV+   +L+G         L           + +     S S 
Sbjct: 198 EIVDREPVGFYTDMWAIGVLGYVLLSGLSPFAGEDDLETLQNVKRCDWEFDEDAFSSVSP 257

Query: 648 AAKLGKMALV--CTHEDPENRPTMEAVIE 674
            AK      +     ++P  R T+   +E
Sbjct: 258 EAK----DFIKNLLQKEPRKRLTVHDALE 282

>d1o6ya_ d.144.1.7 (A:) Mycobacterial protein kinase PknB, catalytic domain {Mycobacterium tuberculosis [TaxId: 1773]} Length = 277

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Mycobacterial protein kinase PknB, catalytic domain
species: Mycobacterium tuberculosis [TaxId: 1773]

 Score =  134 bits (337), Expect = 1e-35
 Identities = 48/276 (17%), Positives = 100/276 (36%), Gaps = 23/276 (8%)

Query: 411 FSEVNLLGKGNFSSVYKGT-LRDGTLVAIRSINVTSCKSEEA--EFVKGLYLLTSLRHEN 467
           +    +LG G  S V+    LR    VA++ +     +       F +      +L H  
Sbjct: 9   YELGEILGFGGMSEVHLARDLRLHRDVAVKVLRADLARDPSFYLRFRREAQNAAALNHPA 68

Query: 468 IIRLRGFCCSRGR--GECFLIYDFAPKGKLSKYLDQEEGSSNVLDWSTRVSIIIGIAKGI 525
           I+ +     +        +++ ++     L   +  E      +     + +I    + +
Sbjct: 69  IVAVYDTGEAETPAGPLPYIVMEYVDGVTLRDIVHTE----GPMTPKRAIEVIADACQAL 124

Query: 526 GYLHSSEVNKPAIVHRNLSVEKVLIDQQFNPLIADCGLHKLLADDIVFSVLKTSAA--MG 583
            + H +      I+HR++    ++I       + D G+ + +AD         +      
Sbjct: 125 NFSHQNG-----IIHRDVKPANIMISATNAVKVMDFGIARAIADSGNSVTQTAAVIGTAQ 179

Query: 584 YLAPEYVTTGRFTERSDIFAFGVIILQILTGSLVLT--SSMRLAAESATFENFIDRNLKG 641
           YL+PE         RSD+++ G ++ ++LTG    T  S + +A +    +         
Sbjct: 180 YLSPEQARGDSVDARSDVYSLGCVLYEVLTGEPPFTGDSPVSVAYQHVREDPIPPSARHE 239

Query: 642 KFSESEAAKLGKMALVCTHEDPENRP-TMEAVIEEL 676
             S      L  + L    ++PENR  T   +  +L
Sbjct: 240 GLSAD----LDAVVLKALAKNPENRYQTAAEMRADL 271

>d1a06a_ d.144.1.7 (A:) Calmodulin-dependent protein kinase {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 307

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Calmodulin-dependent protein kinase
species: Rat (Rattus norvegicus) [TaxId: 10116]

 Score =  133 bits (336), Expect = 3e-35
 Identities = 64/277 (23%), Positives = 109/277 (39%), Gaps = 19/277 (6%)

Query: 402 EEVESATQCFSEVNLLGKGNFSSVYKGT-LRDGTLVAIRSINVTSCKSEEAEFVKGLYLL 460
           ++ E     +   ++LG G FS V      R   LVAI+ I   + + +E      + +L
Sbjct: 2   KQAEDIRDIYDFRDVLGTGAFSEVILAEDKRTQKLVAIKCIAKKALEGKEGSMENEIAVL 61

Query: 461 TSLRHENIIRLRGFCCSRGRGECFLIYDFAPKGKLSKYLDQEEGSSNVLDWSTRVSIIIG 520
             ++H NI+ L     S G    +LI      G+L   + ++              +I  
Sbjct: 62  HKIKHPNIVALDDIYESGGH--LYLIMQLVSGGELFDRIVEK----GFYTERDASRLIFQ 115

Query: 521 IAKGIGYLHSSEVNKPAIVHRNLSVEKVLI---DQQFNPLIADCGLHKLLADDIVFSVLK 577
           +   + YLH        IVHR+L  E +L    D+    +I+D GL K+     V S   
Sbjct: 116 VLDAVKYLH-----DLGIVHRDLKPENLLYYSLDEDSKIMISDFGLSKMEDPGSVLSTAC 170

Query: 578 TSAAMGYLAPEYVTTGRFTERSDIFAFGVIILQILTGSLVLTSSMRLAAESATFENFIDR 637
            +   GY+APE +    +++  D ++ GVI   +L G                 +   + 
Sbjct: 171 GTP--GYVAPEVLAQKPYSKAVDCWSIGVIAYILLCGYPPFYDENDAKLFEQILKAEYEF 228

Query: 638 NLKGKFSESEAAKLGKMALVCTHEDPENRPTMEAVIE 674
           +       S++AK          +DPE R T E  ++
Sbjct: 229 DSPYWDDISDSAK--DFIRHLMEKDPEKRFTCEQALQ 263

>d1tkia_ d.144.1.7 (A:) Titin, kinase domain {Human (Homo sapiens) [TaxId: 9606]} Length = 321

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Titin, kinase domain
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  129 bits (324), Expect = 1e-33
 Identities = 49/268 (18%), Positives = 103/268 (38%), Gaps = 27/268 (10%)

Query: 414 VNLLGKGNFSSVYKGT-LRDGTLVAIRSINVTSCKSEEAEFVKGLYLLTSLRHENIIRLR 472
              LG+G F  V++            + + V    +++    K + +L   RH NI+ L 
Sbjct: 10  AEDLGRGEFGIVHRCVETSSKKTYMAKFVKVK--GTDQVLVKKEISILNIARHRNILHLH 67

Query: 473 GFCCSRGRGECFLIYDFAPKGKLSKYLDQEEGSSNVLDWSTRVSIIIGIAKGIGYLHSSE 532
               S    E  +I++F     + + ++        L+    VS +  + + + +LHS  
Sbjct: 68  ESFESME--ELVMIFEFISGLDIFERINTSAFE---LNEREIVSYVHQVCEALQFLHSHN 122

Query: 533 VNKPAIVHRNLSVEKVLIDQQFNPL--IADCGLHKLLADDIVFSVLKTSAAMGYLAPEYV 590
                I H ++  E ++   + +    I + G  + L     F +L T+    Y APE  
Sbjct: 123 -----IGHFDIRPENIIYQTRRSSTIKIIEFGQARQLKPGDNFRLLFTA--PEYYAPEVH 175

Query: 591 TTGRFTERSDIFAFGVIILQILTGSLVLTSSMRLAAESATFENFIDRNLKGKFSESEAAK 650
                +  +D+++ G ++  +L+G     +           EN +  N +  F E    +
Sbjct: 176 QHDVVSTATDMWSLGTLVYVLLSGINPFLAET----NQQIIENIM--NAEYTFDEEAFKE 229

Query: 651 LGKMA--LV--CTHEDPENRPTMEAVIE 674
           +   A   V     ++ ++R T    ++
Sbjct: 230 ISIEAMDFVDRLLVKERKSRMTASEALQ 257

>d2ozaa1 d.144.1.7 (A:51-385) MAP kinase activated protein kinase 2, mapkap2 {Human (Homo sapiens) [TaxId: 9606]} Length = 335

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: MAP kinase activated protein kinase 2, mapkap2
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  125 bits (316), Expect = 2e-32
 Identities = 49/269 (18%), Positives = 96/269 (35%), Gaps = 26/269 (9%)

Query: 416 LLGKGNFSSVYKGT-LRDGTLVAIRSINVTSCKSEEAEFVKGLYLLTSLRHENIIRLRGF 474
           +LG G    V +    R     A++ +        E E         + +  +I+R+   
Sbjct: 19  VLGLGINGKVLQIFNKRTQEKFALKMLQDCPKARREVEL-----HWRASQCPHIVRIVDV 73

Query: 475 C--CSRGRGECFLIYDFAPKGKLSKYLDQEEGSSNVLDWSTRVSIIIGIAKGIGYLHSSE 532
                 GR    ++ +    G+L   +  ++             I+  I + I YLHS  
Sbjct: 74  YENLYAGRKCLLIVMECLDGGELFSRI--QDRGDQAFTEREASEIMKSIGEAIQYLHSIN 131

Query: 533 VNKPAIVHRNLSVEKVLIDQQFNPL---IADCGLHKLLADDIVFSVLKTSAAMGYLAPEY 589
                I HR++  E +L   +       + D G  K        +    +    Y+APE 
Sbjct: 132 -----IAHRDVKPENLLYTSKRPNAILKLTDFGFAKETTSHNSLTTPCYT--PYYVAPEV 184

Query: 590 VTTGRFTERSDIFAFGVIILQILTGSLVLTSSMRLAAESATFENFIDRNLKGKFSESEAA 649
           +   ++ +  D+++ GVI+  +L G     S+  LA           R  + +F   E +
Sbjct: 185 LGPEKYDKSCDMWSLGVIMYILLCGYPPFYSNHGLAISPGMKTRI--RMGQYEFPNPEWS 242

Query: 650 KLGKMA--LV--CTHEDPENRPTMEAVIE 674
           ++ +    L+      +P  R T+   + 
Sbjct: 243 EVSEEVKMLIRNLLKTEPTQRMTITEFMN 271

>d1omwa3 d.144.1.7 (A:186-549) G-protein coupled receptor kinase 2 {Cow (Bos taurus) [TaxId: 9913]} Length = 364

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: G-protein coupled receptor kinase 2
species: Cow (Bos taurus) [TaxId: 9913]

 Score =  125 bits (315), Expect = 5e-32
 Identities = 50/274 (18%), Positives = 103/274 (37%), Gaps = 25/274 (9%)

Query: 411 FSEVNLLGKGNFSSVYKGTLRD-GTLVAIRSINVTSCKSEEAE-----FVKGLYLLTSLR 464
           FS   ++G+G F  VY     D G + A++ ++    K ++ E         L L+++  
Sbjct: 6   FSVHRIIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGD 65

Query: 465 HENIIRLRGFCCSRGRGECFLIYDFAPKGKLSKYLDQEEGSSNVLDWSTRVSIIIGIAKG 524
              I+ +     +  +     I D    G L  +L Q          +        I  G
Sbjct: 66  CPFIVCMSYAFHTPDK--LSFILDLMNGGDLHYHLSQHGVF----SEADMRFYAAEIILG 119

Query: 525 IGYLHSSEVNKPAIVHRNLSVEKVLIDQQFNPLIADCGLHKLLADDIVFSVLKTSAAMGY 584
           + ++H+       +V+R+L    +L+D+  +  I+D GL    +     + + T    GY
Sbjct: 120 LEHMHN-----RFVVYRDLKPANILLDEHGHVRISDLGLACDFSKKKPHASVGT---HGY 171

Query: 585 LAPEYVTTGR-FTERSDIFAFGVIILQILTGSLVLTSSMRLAAESATFENFIDRNLKGKF 643
           +APE +  G  +   +D F+ G ++ ++L G        +   +       +   ++   
Sbjct: 172 MAPEVLQKGVAYDSSADWFSLGCMLFKLLRGHSPF-RQHKTKDKHEIDRMTLTMAVELPD 230

Query: 644 SESEAAKLGKMALVCTHEDPENRPT-MEAVIEEL 676
           S S   +   +       D   R   +    +E+
Sbjct: 231 SFSPELR--SLLEGLLQRDVNRRLGCLGRGAQEV 262

>d1phka_ d.144.1.7 (A:) gamma-subunit of glycogen phosphorylase kinase (Phk) {Rabbit (Oryctolagus cuniculus) [TaxId: 9986]} Length = 277

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: gamma-subunit of glycogen phosphorylase kinase (Phk)
species: Rabbit (Oryctolagus cuniculus) [TaxId: 9986]

 Score =  123 bits (310), Expect = 5e-32
 Identities = 65/284 (22%), Positives = 107/284 (37%), Gaps = 39/284 (13%)

Query: 411 FSEVNLLGKGNFSSVYKGT-LRDGTLVAIRSINVTSCKSEEAEFVKGLY--------LLT 461
           +    +LG+G  S V +          A++ I+VT   S  AE V+ L         +L 
Sbjct: 5   YEPKEILGRGVSSVVRRCIHKPTCKEYAVKIIDVTGGGSFSAEEVQELREATLKEVDILR 64

Query: 462 SLR-HENIIRLRGFCCSRGRGECFLIYDFAPKGKLSKYLDQEEGSSNVLDWSTRVSIIIG 520
            +  H NII+L+    +      FL++D   KG+L  YL ++      L       I+  
Sbjct: 65  KVSGHPNIIQLKDTYETNTF--FFLVFDLMKKGELFDYLTEKVT----LSEKETRKIMRA 118

Query: 521 IAKGIGYLHSSEVNKPAIVHRNLSVEKVLIDQQFNPLIADCGLHKLLADDIVFSVLKTSA 580
           + + I  LH        IVHR+L  E +L+D   N  + D G    L        +  + 
Sbjct: 119 LLEVICALHKLN-----IVHRDLKPENILLDDDMNIKLTDFGFSCQLDPGEKLREVCGT- 172

Query: 581 AMGYLAPEYVTTGR------FTERSDIFAFGVIILQILTGSLVLTSSMRLAAESATFENF 634
              YLAPE +          + +  D+++ GVI+  +L GS           +       
Sbjct: 173 -PSYLAPEIIECSMNDNHPGYGKEVDMWSTGVIMYTLLAGSPPFWHR----KQMLMLRMI 227

Query: 635 IDRNLKGKFSE----SEAAKLGKMALVCTHEDPENRPTMEAVIE 674
           +  N +    E    S+  K   +        P+ R T E  + 
Sbjct: 228 MSGNYQFGSPEWDDYSDTVK--DLVSRFLVVQPQKRYTAEEALA 269

>d1ckia_ d.144.1.7 (A:) Casein kinase-1, CK1 {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 299

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Casein kinase-1, CK1
species: Rat (Rattus norvegicus) [TaxId: 10116]

 Score =  119 bits (300), Expect = 1e-30
 Identities = 44/279 (15%), Positives = 87/279 (31%), Gaps = 33/279 (11%)

Query: 414 VNLLGKGNFSSVYKGT-LRDGTLVAIRSINVTSCKSEEAEFVKGLYLLTSLRHENIIRLR 472
              +G G+F  +Y GT +  G  VAI+   V   K++  +      +   ++    I   
Sbjct: 12  GRKIGSGSFGDIYLGTDIAAGEEVAIKLECV---KTKHPQLHIESKIYKMMQGGVGIPTI 68

Query: 473 GFCCSRGRGECFLIYDFAPKGKLSKYLDQEEGSSNVLDWSTRVSIIIGIAKGIGYLHSSE 532
            +C + G     ++ +           D     S      T + +   +   I Y+HS  
Sbjct: 69  RWCGAEG-DYNVMVMELLGPS----LEDLFNFCSRKFSLKTVLLLADQMISRIEYIHSK- 122

Query: 533 VNKPAIVHRNLSVEKVLI---DQQFNPLIADCGLHKLLADDIVFSVL---KTSAAMG--- 583
                 +HR++  +  L+    +     I D GL K   D      +   +     G   
Sbjct: 123 ----NFIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKKYRDARTHQHIPYRENKNLTGTAR 178

Query: 584 YLAPEYVTTGRFTERSDIFAFGVIILQILTGSLVL------TSSMRLAAESATFENFIDR 637
           Y +         + R D+ + G +++    GSL        T   +    S    +    
Sbjct: 179 YASINTHLGIEQSRRDDLESLGYVLMYFNLGSLPWQGLKAATKRQKYERISEKKMSTPIE 238

Query: 638 NLKGKFSESEAAKLGKMALVCTHEDPENRPTMEAVIEEL 676
            L   +              C     +++P    + +  
Sbjct: 239 VLCKGYPSE----FATYLNFCRSLRFDDKPDYSYLRQLF 273

>d1q5ka_ d.144.1.7 (A:) Glycogen synthase kinase-3 beta (Gsk3b) {Human (Homo sapiens) [TaxId: 9606]} Length = 350

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Glycogen synthase kinase-3 beta (Gsk3b)
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  121 bits (303), Expect = 1e-30
 Identities = 54/294 (18%), Positives = 104/294 (35%), Gaps = 43/294 (14%)

Query: 411 FSEVNLLGKGNFSSVYKGTLRD-GTLVAIRSINVTSCKSEEAEFVKGLYLLTSLRHENII 469
           +++  ++G G+F  VY+  L D G LVAI+ +       ++    + L ++  L H NI+
Sbjct: 22  YTDTKVIGNGSFGVVYQAKLCDSGELVAIKKV-----LQDKRFKNRELQIMRKLDHCNIV 76

Query: 470 RLRGFCCSRGRGE----CFLIYDFAPKGKLSKYLDQEEGSSNVLDWSTRVSIIIGIAKGI 525
           RLR F  S G  +      L+ D+ P+    +       +   L        +  + + +
Sbjct: 77  RLRYFFYSSGEKKDEVYLNLVLDYVPETVY-RVARHYSRAKQTLPVIYVKLYMYQLFRSL 135

Query: 526 GYLHSSEVNKPAIVHRNLSVEKVLIDQQFNPL-IADCGLHKLLADDIVFSVLKTSAAMGY 584
            Y+HS       I HR++  + +L+D     L + D G  K L             +  Y
Sbjct: 136 AYIHS-----FGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPNV--SYICSRYY 188

Query: 585 LAP-EYVTTGRFTERSDIFAFGVIILQILTGSLVLTSS------MRLAAESATFENFIDR 637
            AP        +T   D+++ G ++ ++L G  +          + +     T      R
Sbjct: 189 RAPELIFGATDYTSSIDVWSAGCVLAELLLGQPIFPGDSGVDQLVEIIKVLGTPTREQIR 248

Query: 638 NLKGKFSESEAAKLGKMALV-----------------CTHEDPENRPTMEAVIE 674
            +   ++E +  ++                            P  R T      
Sbjct: 249 EMNPNYTEFKFPQIKAHPWTKVFRPRTPPEAIALCSRLLEYTPTARLTPLEACA 302

>d1ob3a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {(Plasmodium falciparum) [TaxId: 5833]} Length = 286

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cyclin-dependent PK, CDK2
species: (Plasmodium falciparum) [TaxId: 5833]

 Score =  117 bits (294), Expect = 5e-30
 Identities = 54/288 (18%), Positives = 105/288 (36%), Gaps = 35/288 (12%)

Query: 411 FSEVNLLGKGNFSSVYKGTLRDGTLVAIRSINVTSCKSE-EAEFVKGLYLLTSLRHENII 469
           +  +  +G+G +  VYK     G   A++ I +        +  ++ + +L  L+H NI+
Sbjct: 4   YHGLEKIGEGTYGVVYKAQNNYGETFALKKIRLEKEDEGIPSTTIREISILKELKHSNIV 63

Query: 470 RLRGFCCSRGRGECFLIYDFAPKGKLSKYLDQEEGSSNVLDWSTRVSIIIGIAKGIGYLH 529
           +L     ++ R    ++        L K LD  EG    L+  T  S ++ +  GI Y H
Sbjct: 64  KLYDVIHTKKR---LVLVFEHLDQDLKKLLDVCEGG---LESVTAKSFLLQLLNGIAYCH 117

Query: 530 SSEVNKPAIVHRNLSVEKVLIDQQFNPLIADCGLHKLLADDIVFSVLKTSAAMGYLAPEY 589
                   ++HR+L  + +LI+++    IAD GL +     +     +            
Sbjct: 118 D-----RRVLHRDLKPQNLLINREGELKIADFGLARAFGIPVRKYTHEIVTLWYRAPDVL 172

Query: 590 VTTGRFTERSDIFAFGVIILQILTGSLVLTSSMRLAAESATFENFIDRNLKGKFSESEAA 649
           + + +++   DI++ G I  +++ G+ +             F      N K   + +E  
Sbjct: 173 MGSKKYSTTIDIWSVGCIFAEMVNGTPLFPGVSEADQLMRIFRILGTPNSKNWPNVTELP 232

Query: 650 KLGKMALV-----------------------CTHEDPENRPTMEAVIE 674
           K      V                           DP  R T +  +E
Sbjct: 233 KYDPNFTVYEPLPWESFLKGLDESGIDLLSKMLKLDPNQRITAKQALE 280

>d1xjda_ d.144.1.7 (A:) Protein kinase C, theta type {Human (Homo sapiens) [TaxId: 9606]} Length = 320

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Protein kinase C, theta type
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  118 bits (296), Expect = 7e-30
 Identities = 54/269 (20%), Positives = 101/269 (37%), Gaps = 26/269 (9%)

Query: 411 FSEVNLLGKGNFSSVYKGTLR-DGTLVAIRSINVTSCKSE---EAEFVKGLYLLTSLRHE 466
           F    +LGKG+F  V+    +      AI+++       +   E   V+   L  +  H 
Sbjct: 4   FILHKMLGKGSFGKVFLAEFKKTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEHP 63

Query: 467 NIIRLRGFCCSRGRGECFLIYDFAPKGKLSKYLDQEEGSSNVLDWSTRVSIIIGIAKGIG 526
            +  +     ++     F + ++   G L  ++          D S        I  G+ 
Sbjct: 64  FLTHMFCTFQTKEN--LFFVMEYLNGGDLMYHIQSCHK----FDLSRATFYAAEIILGLQ 117

Query: 527 YLHSSEVNKPAIVHRNLSVEKVLIDQQFNPLIADCGLHKLL--ADDIVFSVLKTSAAMGY 584
           +LH        IV+R+L ++ +L+D+  +  IAD G+ K     D    +   T     Y
Sbjct: 118 FLH-----SKGIVYRDLKLDNILLDKDGHIKIADFGMCKENMLGDAKTNTFCGT---PDY 169

Query: 585 LAPEYVTTGRFTERSDIFAFGVIILQILTGSLVLTSSMRLAAESATFENFIDRNLKGKFS 644
           +APE +   ++    D ++FGV++ ++L G            E   F +    N      
Sbjct: 170 IAPEILLGQKYNHSVDWWSFGVLLYEMLIGQSPFHGQD----EEELFHSIRMDNPFYPRW 225

Query: 645 ESEAAKLGKMALVCTHEDPENRPTMEAVI 673
             + AK   + +     +PE R  +   I
Sbjct: 226 LEKEAK--DLLVKLFVREPEKRLGVRGDI 252

>d1blxa_ d.144.1.7 (A:) Cyclin-dependent PK, CDK6 {Human (Homo sapiens) [TaxId: 9606]} Length = 305

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cyclin-dependent PK, CDK6
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  118 bits (295), Expect = 7e-30
 Identities = 45/295 (15%), Positives = 101/295 (34%), Gaps = 34/295 (11%)

Query: 407 ATQCFSEVNLLGKGNFSSVYKGTLR--DGTLVAIRSINVTSCKSEEAE----FVKGLYLL 460
           A Q +  V  +G+G +  V+K       G  VA++ + V + +          V  L  L
Sbjct: 5   ADQQYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHL 64

Query: 461 TSLRHENIIRLRGFCCSRGRGECFLIYDFAPKGKLSKYLDQEEGSSNVLDWSTRVSIIIG 520
            +  H N++RL   C          +               ++     +   T   ++  
Sbjct: 65  ETFEHPNVVRLFDVCTVSRTDRETKLTLVFEHVDQDLTTYLDKVPEPGVPTETIKDMMFQ 124

Query: 521 IAKGIGYLHSSEVNKPAIVHRNLSVEKVLIDQQFNPLIADCGLHKLLADDIVFSVLKTSA 580
           + +G+ +LHS       +VHR+L  + +L+       +AD GL ++ +  +  + +  + 
Sbjct: 125 LLRGLDFLHSHR-----VVHRDLKPQNILVTSSGQIKLADFGLARIYSFQMALTSVVVT- 178

Query: 581 AMGYLAPEYVTTGRFTERSDIFAFGVIILQILTG-----------------SLVLTSSMR 623
            + Y APE +    +    D+++ G I  ++                     ++      
Sbjct: 179 -LWYRAPEVLLQSSYATPVDLWSVGCIFAEMFRRKPLFRGSSDVDQLGKILDVIGLPGEE 237

Query: 624 LAAESATFENFIDRNLKGKFSESEAAKLGKMA--LV--CTHEDPENRPTMEAVIE 674
                         +   +  E     + ++   L+  C   +P  R +  + + 
Sbjct: 238 DWPRDVALPRQAFHSKSAQPIEKFVTDIDELGKDLLLKCLTFNPAKRISAYSALS 292

>d1xwsa_ d.144.1.7 (A:) Proto-oncogene serine/threonine-protein kinase Pim-1 {Human (Homo sapiens) [TaxId: 9606]} Length = 273

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Proto-oncogene serine/threonine-protein kinase Pim-1
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  116 bits (291), Expect = 1e-29
 Identities = 51/269 (18%), Positives = 92/269 (34%), Gaps = 35/269 (13%)

Query: 416 LLGKGNFSSVYKGT-LRDGTLVAIRSINVTSCKSEE-----AEFVKGLYLLTSLR--HEN 467
           LLG G F SVY G  + D   VAI+ +                    + LL  +      
Sbjct: 11  LLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSG 70

Query: 468 IIRLRGFCCSRGRGECFLIYDFAPKGKLSKYLDQEEGSSNVLDWSTRVSIIIGIAKGIGY 527
           +IRL  +          LI +     +       E G+   L      S    + + + +
Sbjct: 71  VIRLLDWFERPDS--FVLILERPEPVQDLFDFITERGA---LQEELARSFFWQVLEAVRH 125

Query: 528 LHSSEVNKPAIVHRNLSVEKVLIDQQFNPL-IADCGLHKLLADDIVFSVLKTSAAMGYLA 586
            H+       ++HR++  E +LID     L + D G   LL D +      T     Y  
Sbjct: 126 CHNCG-----VLHRDIKDENILIDLNRGELKLIDFGSGALLKDTVYTDFDGT---RVYSP 177

Query: 587 PEYVTTGRF-TERSDIFAFGVIILQILTGSLVLTSSMRLAAESATFENFIDRNLKGKFSE 645
           PE++   R+    + +++ G+++  ++ G +       +      F   +    +     
Sbjct: 178 PEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPFEHDEEIIRGQVFFRQRVSSECQ----- 232

Query: 646 SEAAKLGKMALVCTHEDPENRPTMEAVIE 674
                   +   C    P +RPT E +  
Sbjct: 233 -------HLIRWCLALRPSDRPTFEEIQN 254

>d1gz8a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {Human (Homo sapiens) [TaxId: 9606]} Length = 298

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cyclin-dependent PK, CDK2
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  116 bits (291), Expect = 2e-29
 Identities = 46/289 (15%), Positives = 103/289 (35%), Gaps = 35/289 (12%)

Query: 411 FSEVNLLGKGNFSSVYKGTLR-DGTLVAIRSINVTSCKSEEAE-FVKGLYLLTSLRHENI 468
           F +V  +G+G +  VYK   +  G +VA++ I + +         ++ + LL  L H NI
Sbjct: 4   FQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNI 63

Query: 469 IRLRGFCCSRGRGECFLIYDFAPKGKLSKYLDQEEGSSNVLDWSTRVSIIIGIAKGIGYL 528
           ++L     +  +   +L+++F  +                +      S +  + +G+ + 
Sbjct: 64  VKLLDVIHTENK--LYLVFEFLHQDLKKFMDASALTG---IPLPLIKSYLFQLLQGLAFC 118

Query: 529 HSSEVNKPAIVHRNLSVEKVLIDQQFNPLIADCGLHKLLADDIVFSVLKTSAAMGYLAPE 588
           HS       ++HR+L  + +LI+ +    +AD GL +     +     +           
Sbjct: 119 HS-----HRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYTHEVVTLWYRAPEI 173

Query: 589 YVTTGRFTERSDIFAFGVIILQILTGSL------------VLTSSMRLAAESATFENFID 636
            +    ++   DI++ G I  +++T                +  ++    E         
Sbjct: 174 LLGCKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTSM 233

Query: 637 RNLKGKFSESEAAKLGKMALVCTHE-----------DPENRPTMEAVIE 674
            + K  F +       K+      +           DP  R + +A + 
Sbjct: 234 PDYKPSFPKWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALA 282

>d1jksa_ d.144.1.7 (A:) Death-associated protein kinase, Dap {Human (Homo sapiens) [TaxId: 9606]} Length = 293

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Death-associated protein kinase, Dap
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  116 bits (290), Expect = 2e-29
 Identities = 59/298 (19%), Positives = 111/298 (37%), Gaps = 38/298 (12%)

Query: 387 TGFSREHLNSFRLNLEEVESATQCFSEVNLLGKGNFSSVYKGT-LRDGTLVAIRSINVTS 445
           T F +E+++ +             +     LG G F+ V K      G   A + I    
Sbjct: 1   TVFRQENVDDY-------------YDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRR 47

Query: 446 CKSEE-----AEFVKGLYLLTSLRHENIIRLRGFCCSRGRGECFLIYDFAPKGKLSKYLD 500
            KS        +  + + +L  ++H N+I L        + +  LI +    G+L  +L 
Sbjct: 48  TKSSRRGVSREDIEREVSILKEIQHPNVITLHEVY--ENKTDVILILELVAGGELFDFLA 105

Query: 501 QEEGSSNVLDWSTRVSIIIGIAKGIGYLHSSEVNKPAIVHRNLSVEKVLIDQQFNPL--- 557
           ++E     L        +  I  G+ YLHS       I H +L  E +++  +  P    
Sbjct: 106 EKES----LTEEEATEFLKQILNGVYYLHS-----LQIAHFDLKPENIMLLDRNVPKPRI 156

Query: 558 -IADCGLHKLLADDIVFSVLKTSAAMGYLAPEYVTTGRFTERSDIFAFGVIILQILTGSL 616
            I D GL   +     F  +  +    ++APE V        +D+++ GVI   +L+G+ 
Sbjct: 157 KIIDFGLAHKIDFGNEFKNIFGT--PEFVAPEIVNYEPLGLEADMWSIGVITYILLSGAS 214

Query: 617 VLTSSMRLAAESATFENFIDRNLKGKFSESEAAKLGKMALVCTHEDPENRPTMEAVIE 674
                 +    +       +   +   + S  AK          +DP+ R T++  ++
Sbjct: 215 PFLGDTKQETLANVSAVNYEFEDEYFSNTSALAK--DFIRRLLVKDPKKRMTIQDSLQ 270

>d1fota_ d.144.1.7 (A:) cAMP-dependent PK, catalytic subunit {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} Length = 316

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: cAMP-dependent PK, catalytic subunit
species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]

 Score =  114 bits (286), Expect = 1e-28
 Identities = 59/272 (21%), Positives = 106/272 (38%), Gaps = 29/272 (10%)

Query: 411 FSEVNLLGKGNFSSVYKGTLR-DGTLVAIRSINVTSCKSEEA--EFVKGLYLLTSLRHEN 467
           F  +  LG G+F  V+    R +G   A++ +        +          +L+ + H  
Sbjct: 6   FQILRTLGTGSFGRVHLIRSRHNGRYYAMKVLKKEIVVRLKQVEHTNDERLMLSIVTHPF 65

Query: 468 IIRLRGFCCSRGRGECFLIYDFAPKGKLSKYLDQEEGSSNVLDWSTRVSIIIGIAKGIGY 527
           IIR+ G      +   F+I D+   G+L   L +    S              +   + Y
Sbjct: 66  IIRMWGTFQDAQQ--IFMIMDYIEGGELFSLLRK----SQRFPNPVAKFYAAEVCLALEY 119

Query: 528 LHSSEVNKPAIVHRNLSVEKVLIDQQFNPLIADCGLHKLLADDIVFSVLKTSAAMGYLAP 587
           LHS       I++R+L  E +L+D+  +  I D G  K + D              Y+AP
Sbjct: 120 LHS-----KDIIYRDLKPENILLDKNGHIKITDFGFAKYVPDVTYTLC----GTPDYIAP 170

Query: 588 EYVTTGRFTERSDIFAFGVIILQILTGSLVLTSSMRLAAESATFENFIDRNLKGKFSESE 647
           E V+T  + +  D ++FG++I ++L G      S        T+E  ++  L+     +E
Sbjct: 171 EVVSTKPYNKSIDWWSFGILIYEMLAGYTPFYDS----NTMKTYEKILNAELRFPPFFNE 226

Query: 648 AAKLGKMALV--CTHEDPENRPT-MEAVIEEL 676
             K     L+      D   R   ++   E++
Sbjct: 227 DVK----DLLSRLITRDLSQRLGNLQNGTEDV 254

>d1pmea_ d.144.1.7 (A:) MAP kinase Erk2 {Human (Homo sapiens) [TaxId: 9606]} Length = 345

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: MAP kinase Erk2
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  113 bits (283), Expect = 5e-28
 Identities = 44/210 (20%), Positives = 90/210 (42%), Gaps = 16/210 (7%)

Query: 411 FSEVNLLGKGNFSSVYKGT-LRDGTLVAIRSINVTSCKSEEAEFVKGLYLLTSLRHENII 469
           ++ ++ +G+G +  V       +   VAI+ I+    ++     ++ + +L   RHENII
Sbjct: 10  YTNLSYIGEGAYGMVCSAYDNVNKVRVAIKKISPFEHQTYCQRTLREIKILLRFRHENII 69

Query: 470 RLRGFCCSRG--RGECFLIYDFAPKGKLSKYLDQEEGSSNVLDWSTRVSIIIGIAKGIGY 527
            +     +    + +   +        L K L  +      L        +  I +G+ Y
Sbjct: 70  GINDIIRAPTIEQMKDVYLVTHLMGADLYKLLKTQH-----LSNDHICYFLYQILRGLKY 124

Query: 528 LHSSEVNKPAIVHRNLSVEKVLIDQQFNPLIADCGLHKLLADDIVFSVLKTS--AAMGYL 585
           +HS+      ++HR+L    +L++   +  I D GL ++   D   +   T   A   Y 
Sbjct: 125 IHSAN-----VLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEYVATRWYR 179

Query: 586 APEYVTTGRFTERS-DIFAFGVIILQILTG 614
           APE +   +   +S DI++ G I+ ++L+ 
Sbjct: 180 APEIMLNSKGYTKSIDIWSVGCILAEMLSN 209

>d1cm8a_ d.144.1.7 (A:) MAP kinase p38-gamma {Human (Homo sapiens) [TaxId: 9606]} Length = 346

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: MAP kinase p38-gamma
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  111 bits (277), Expect = 4e-27
 Identities = 53/235 (22%), Positives = 98/235 (41%), Gaps = 28/235 (11%)

Query: 387 TGFSREHLNSFRLNLEEVESATQCFSEVNLLGKGNFSSVYKGT-LRDGTLVAIRSINVTS 445
           +GF R+ +      +  V      + ++  +G G + +V      R G  VAI+ +    
Sbjct: 2   SGFYRQEVTKTAWEVRAV------YRDLQPVGSGAYGAVCSAVDGRTGAKVAIKKLYRPF 55

Query: 446 CKSEEAE-FVKGLYLLTSLRHENIIRLRGFCCSRGR----GECFLIYDFAPKGKLSKYLD 500
                A+   + L LL  +RHEN+I L              + +L+  F   G     L 
Sbjct: 56  QSELFAKRAYRELRLLKHMRHENVIGLLDVFTPDETLDDFTDFYLVMPFM--GTDLGKLM 113

Query: 501 QEEGSSNVLDWSTRVSIIIGIAKGIGYLHSSEVNKPAIVHRNLSVEKVLIDQQFNPLIAD 560
           + E     L       ++  + KG+ Y+H+       I+HR+L    + +++     I D
Sbjct: 114 KHEK----LGEDRIQFLVYQMLKGLRYIHA-----AGIIHRDLKPGNLAVNEDCELKILD 164

Query: 561 CGLHKLLADDIVFSVLKTSAAMGYLAPE-YVTTGRFTERSDIFAFGVIILQILTG 614
            GL +    ++   V+       Y APE  +   R+T+  DI++ G I+ +++TG
Sbjct: 165 FGLARQADSEMTGYVVTR----WYRAPEVILNWMRYTQTVDIWSVGCIMAEMITG 215

>d1csna_ d.144.1.7 (A:) Casein kinase-1, CK1 {Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]} Length = 293

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Casein kinase-1, CK1
species: Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]

 Score =  109 bits (272), Expect = 6e-27
 Identities = 41/278 (14%), Positives = 85/278 (30%), Gaps = 29/278 (10%)

Query: 414 VNLLGKGNFSSVYKGT-LRDGTLVAIRSINVTSCKSEEAEFVKGLYLLTSLRHENIIRLR 472
              +G+G+F  +++GT L +   VAI+       +S+  +          L     I   
Sbjct: 10  GRRIGEGSFGVIFEGTNLLNNQQVAIKFEPR---RSDAPQLRDEYRTYKLLAGCTGIPNV 66

Query: 473 GFCCSRGRGECFLIYDFAPKGKLSKYLDQEEGSSNVLDWSTRVSIIIGIAKGIGYLHSSE 532
            +    G     L+ D           D  +         T       +   +  +H   
Sbjct: 67  YYFGQEG-LHNVLVIDLLGPS----LEDLLDLCGRKFSVKTVAMAAKQMLARVQSIHEKS 121

Query: 533 VNKPAIVHRNLSVEKVLIDQQFNPL-----IADCGLHKLLADDIVFSVLKTSAA------ 581
                +V+R++  +  LI +  +       + D G+ K   D +    +           
Sbjct: 122 -----LVYRDIKPDNFLIGRPNSKNANMIYVVDFGMVKFYRDPVTKQHIPYREKKNLSGT 176

Query: 582 MGYLAPEYVTTGRFTERSDIFAFGVIILQILTGSLVLTSSMRLAAESATFENFIDRNLKG 641
             Y++         + R D+ A G + +  L GSL     ++ A     +E   ++    
Sbjct: 177 ARYMSINTHLGREQSRRDDLEALGHVFMYFLRGSLPW-QGLKAATNKQKYERIGEKKQST 235

Query: 642 KFSESEA---AKLGKMALVCTHEDPENRPTMEAVIEEL 676
              E  A    +  K      +   +  P  + +    
Sbjct: 236 PLRELCAGFPEEFYKYMHYARNLAFDATPDYDYLQGLF 273

>d1ua2a_ d.144.1.7 (A:) Cell division protein kinase 7, CDK7 {Human (Homo sapiens) [TaxId: 9606]} Length = 299

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cell division protein kinase 7, CDK7
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  108 bits (270), Expect = 1e-26
 Identities = 64/291 (21%), Positives = 105/291 (36%), Gaps = 46/291 (15%)

Query: 415 NLLGKGNFSSVYKGTLR-DGTLVAIRSINVTSCKSEEAEFVKGLY----LLTSLRHENII 469
           + LG+G F++VYK   +    +VAI+ I +      +    +       LL  L H NII
Sbjct: 4   DFLGEGQFATVYKARDKNTNQIVAIKKIKLGHRSEAKDGINRTALREIKLLQELSHPNII 63

Query: 470 RLRGFCCSRGRGECFLIYDFAPKGKLSKYLDQEEGSSNVLDWSTRVSIIIGIAKGIGYLH 529
            L      +      L++DF          D     S VL  S   + ++   +G+ YLH
Sbjct: 64  GLLDAFGHKS--NISLVFDFMETDLEVIIKDN----SLVLTPSHIKAYMLMTLQGLEYLH 117

Query: 530 SSEVNKPAIVHRNLSVEKVLIDQQFNPLIADCGLHKLLADDIVFSVLKTSAAMGYLAPEY 589
                   I+HR+L    +L+D+     +AD GL K        +         Y APE 
Sbjct: 118 Q-----HWILHRDLKPNNLLLDENGVLKLADFGLAKSFGSPN-RAYTHQVVTRWYRAPEL 171

Query: 590 VTTGR-FTERSDIFAFGVIILQILTGSLVLTSS-----------------------MRLA 625
           +   R +    D++A G I+ ++L     L                          M   
Sbjct: 172 LFGARMYGVGVDMWAVGCILAELLLRVPFLPGDSDLDQLTRIFETLGTPTEEQWPDMCSL 231

Query: 626 AESATFENFIDRNLKGKFSE--SEAAKLGKMALVCTHEDPENRPTMEAVIE 674
            +  TF++F    L   FS    +   L +   +    +P  R T    ++
Sbjct: 232 PDYVTFKSFPGIPLHHIFSAAGDDLLDLIQGLFLF---NPCARITATQALK 279

>d1o6la_ d.144.1.7 (A:) Pkb kinase (Akt-2) {Human (Homo sapiens) [TaxId: 9606]} Length = 337

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Pkb kinase (Akt-2)
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  104 bits (261), Expect = 4e-25
 Identities = 57/272 (20%), Positives = 105/272 (38%), Gaps = 26/272 (9%)

Query: 411 FSEVNLLGKGNFSSVYKGT-LRDGTLVAIRSINVTSCKSEE--AEFVKGLYLLTSLRHEN 467
           F  + LLGKG F  V        G   A++ +      +++  A  V    +L + RH  
Sbjct: 7   FDYLKLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHPF 66

Query: 468 IIRLRGFCCSRGRGECFLIYDFAPKGKLSKYLDQEEGSSNVLDWSTRVSIIIGIAKGIGY 527
           +  L      +       + ++A  G+L  +L +E     V            I   + Y
Sbjct: 67  LTAL--KYAFQTHDRLCFVMEYANGGELFFHLSRE----RVFTEERARFYGAEIVSALEY 120

Query: 528 LHSSEVNKPAIVHRNLSVEKVLIDQQFNPLIADCGLHKLLADDIVFSVLKTSAAMGYLAP 587
           LHS       +V+R++ +E +++D+  +  I D GL K    D             YLAP
Sbjct: 121 LHS-----RDVVYRDIKLENLMLDKDGHIKITDFGLCKEGISDGATMKTFCGT-PEYLAP 174

Query: 588 EYVTTGRFTERSDIFAFGVIILQILTGSLVLTSSMRLAAESATFENFIDRNLKGKFSESE 647
           E +    +    D +  GV++ +++ G L   +          FE  +   ++   + S 
Sbjct: 175 EVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQ----DHERLFELILMEEIRFPRTLSP 230

Query: 648 AAKLGKMALV--CTHEDPENRPTM-EAVIEEL 676
            AK    +L+     +DP+ R     +  +E+
Sbjct: 231 EAK----SLLAGLLKKDPKQRLGGGPSDAKEV 258

>d3blha1 d.144.1.7 (A:8-325) Cell division protein kinase 9, CDK9 {Human (Homo sapiens) [TaxId: 9606]} Length = 318

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cell division protein kinase 9, CDK9
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  103 bits (256), Expect = 1e-24
 Identities = 51/302 (16%), Positives = 106/302 (35%), Gaps = 47/302 (15%)

Query: 411 FSEVNLLGKGNFSSVYKGTLR-DGTLVAIRSINVTSCK-SEEAEFVKGLYLLTSLRHENI 468
           + ++  +G+G F  V+K   R  G  VA++ + + + K       ++ + +L  L+HEN+
Sbjct: 12  YEKLAKIGQGTFGEVFKARHRKTGQKVALKKVLMENEKEGFPITALREIKILQLLKHENV 71

Query: 469 IRLRGFCCS------RGRGECFLIYDFAPKGKLSKYLDQEEGSSNVLDWSTRVSIIIGIA 522
           + L   C +      R +G  +L++DF          +           S    ++  + 
Sbjct: 72  VNLIEICRTKASPYNRCKGSIYLVFDFCEHDLAGLLSNVLVK----FTLSEIKRVMQMLL 127

Query: 523 KGIGYLHSSEVNKPAIVHRNLSVEKVLIDQQFNPLIADCGLHKLLADDIVFSVLKTSAAM 582
            G+ Y+H ++     I+HR++    VLI +     +AD GL +  +        + +  +
Sbjct: 128 NGLYYIHRNK-----ILHRDMKAANVLITRDGVLKLADFGLARAFSLAKNSQPNRYTNRV 182

Query: 583 G---YLAPEYVTTGR-FTERSDIFAFGVIILQILTGSLVLTS------------------ 620
               Y  PE +   R +    D++  G I+ ++ T S ++                    
Sbjct: 183 VTLWYRPPELLLGERDYGPPIDLWGAGCIMAEMWTRSPIMQGNTEQHQLALISQLCGSIT 242

Query: 621 -------SMRLAAESATFENFIDRNLKGKFSESEAAKLGKMALV-CTHEDPENRPTMEAV 672
                        E         R +K +             +      DP  R   +  
Sbjct: 243 PEVWPNVDNYELYEKLELVKGQKRKVKDRLKAYVRDPYALDLIDKLLVLDPAQRIDSDDA 302

Query: 673 IE 674
           + 
Sbjct: 303 LN 304

>d1unla_ d.144.1.7 (A:) Cyclin-dependent PK, CDK5 {Human (Homo sapiens) [TaxId: 9606]} Length = 292

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cyclin-dependent PK, CDK5
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  100 bits (249), Expect = 5e-24
 Identities = 43/290 (14%), Positives = 100/290 (34%), Gaps = 37/290 (12%)

Query: 411 FSEVNLLGKGNFSSVYKGTLR-DGTLVAIRSINVTSCKSEEAE-FVKGLYLLTSLRHENI 468
           + ++  +G+G + +V+K   R    +VA++ + +           ++ + LL  L+H+NI
Sbjct: 4   YEKLEKIGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNI 63

Query: 469 IRLRGFCCSRGRGECFLIYDFAPKGKLSKYLDQEEGSSNVLDWSTRVSIIIGIAKGIGYL 528
           +RL     S    +  L+++F  +          +  +  LD     S +  + KG+G+ 
Sbjct: 64  VRLHDVLHSDK--KLTLVFEFCDQ----DLKKYFDSCNGDLDPEIVKSFLFQLLKGLGFC 117

Query: 529 HSSEVNKPAIVHRNLSVEKVLIDQQFNPLIADCGLHKLLADDIVFSVLKTSAAMGYLAPE 588
           H        ++HR+L  + +LI++     +A+ GL +     +     +           
Sbjct: 118 H-----SRNVLHRDLKPQNLLINRNGELKLANFGLARAFGIPVRCYSAEVVTLWYRPPDV 172

Query: 589 YVTTGRFTERSDIFAFGVIILQILTGSLVL------------------------TSSMRL 624
                 ++   D+++ G I  ++      L                          SM  
Sbjct: 173 LFGAKLYSTSIDMWSAGCIFAELANAGRPLFPGNDVDDQLKRIFRLLGTPTEEQWPSMTK 232

Query: 625 AAESATFENFIDRNLKGKFSESEAAKLGKMALVCTHEDPENRPTMEAVIE 674
             +   +  +              A    +       +P  R + E  ++
Sbjct: 233 LPDYKPYPMYPATTSLVNVVPKLNATGRDLLQNLLKCNPVQRISAEEALQ 282

>d1rdqe_ d.144.1.7 (E:) cAMP-dependent PK, catalytic subunit {Mouse (Mus musculus) [TaxId: 10090]} Length = 350

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: cAMP-dependent PK, catalytic subunit
species: Mouse (Mus musculus) [TaxId: 10090]

 Score =  101 bits (252), Expect = 7e-24
 Identities = 43/270 (15%), Positives = 93/270 (34%), Gaps = 25/270 (9%)

Query: 411 FSEVNLLGKGNFSSVYKGT-LRDGTLVAIRSINVTSCKSEE--AEFVKGLYLLTSLRHEN 467
           F  +  LG G+F  V        G   A++ ++       +     +    +L ++    
Sbjct: 43  FDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPF 102

Query: 468 IIRLRGFCCSRGRGECFLIYDFAPKGKLSKYLDQEEGSSNVLDWSTRVSIIIGIAKGIGY 527
           +++L            +++ ++   G++  +L +                   I     Y
Sbjct: 103 LVKLEFSFKDNSN--LYMVMEYVAGGEMFSHLRRIGR----FSEPHARFYAAQIVLTFEY 156

Query: 528 LHSSEVNKPAIVHRNLSVEKVLIDQQFNPLIADCGLHKLLADDIVFSVLKTSAAMGYLAP 587
           LHS +     +++R+L  E +LIDQQ    + D G     A  +             LAP
Sbjct: 157 LHSLD-----LIYRDLKPENLLIDQQGYIQVTDFGF----AKRVKGRTWTLCGTPEALAP 207

Query: 588 EYVTTGRFTERSDIFAFGVIILQILTGSLVLTSSMRLAAESATFENFIDRNLKGKFSESE 647
           E + +  + +  D +A GV+I ++  G     +          +E  +   ++     S 
Sbjct: 208 EIILSKGYNKAVDWWALGVLIYEMAAGYPPFFADQ----PIQIYEKIVSGKVRFPSHFSS 263

Query: 648 AAKLGKMALVCTHEDPENR-PTMEAVIEEL 676
             K   +       D   R   ++  + ++
Sbjct: 264 DLK--DLLRNLLQVDLTKRFGNLKNGVNDI 291

>d1vzoa_ d.144.1.7 (A:) Ribosomal protein S6 kinase alpha 5, Msk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 322

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Ribosomal protein S6 kinase alpha 5, Msk1
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 94.9 bits (235), Expect = 6e-22
 Identities = 53/294 (18%), Positives = 109/294 (37%), Gaps = 33/294 (11%)

Query: 395 NSFRLNLEEVESATQCFSEVNLLGKGNFSSVYKGTL----RDGTLVAIRSINVTSCKSEE 450
           ++ ++ +E        F  + +LG G +  V+          G L A++ +   +   + 
Sbjct: 17  HAEKVGIEN-------FELLKVLGTGAYGKVFLVRKISGHDTGKLYAMKVLKKATIVQKA 69

Query: 451 ---AEFVKGLYLLTSLRHENIIRLRGFCCSRGRGECFLIYDFAPKGKLSKYLDQEEGSSN 507
                      +L  +R    +    +   +   +  LI D+   G+L  +L Q E    
Sbjct: 70  KTTEHTRTERQVLEHIRQSPFLVTLHYAF-QTETKLHLILDYINGGELFTHLSQRER--- 125

Query: 508 VLDWSTRVSIIIGIAKGIGYLHSSEVNKPAIVHRNLSVEKVLIDQQFNPLIADCGLHKLL 567
                     +  I   + +LH     K  I++R++ +E +L+D   + ++ D GL K  
Sbjct: 126 -FTEHEVQIYVGEIVLALEHLH-----KLGIIYRDIKLENILLDSNGHVVLTDFGLSKEF 179

Query: 568 ADDIVFSVLKTSAAMGYLAPEYVTTGR--FTERSDIFAFGVIILQILTGSLVLTSSMRLA 625
             D           + Y+AP+ V  G     +  D ++ GV++ ++LTG+   T      
Sbjct: 180 VADETERAYDFCGTIEYMAPDIVRGGDSGHDKAVDWWSLGVLMYELLTGASPFTVDGEKN 239

Query: 626 AESATFENFIDRNLKGKFSESEAAKLGKMALV--CTHEDPENRPTM-EAVIEEL 676
           +++      +          S  AK     L+     +DP+ R        +E+
Sbjct: 240 SQAEISRRILKSEPPYPQEMSALAK----DLIQRLLMKDPKKRLGCGPRDADEI 289

>d3bqca1 d.144.1.7 (A:3-330) Protein kinase CK2, alpha subunit {Rattus norvegicus [TaxId: 10116]} Length = 328

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Protein kinase CK2, alpha subunit
species: Rattus norvegicus [TaxId: 10116]

 Score = 88.7 bits (219), Expect = 9e-20
 Identities = 36/207 (17%), Positives = 76/207 (36%), Gaps = 20/207 (9%)

Query: 411 FSEVNLLGKGNFSSVYKGT-LRDGTLVAIRSINVTSCKSEEAEFVKGLYLLTSLR-HENI 468
           +  V  LG+G +S V++   + +   V ++ +       ++ +  + + +L +LR   NI
Sbjct: 37  YQLVRKLGRGKYSEVFEAINITNNEKVVVKILK----PVKKKKIKREIKILENLRGGPNI 92

Query: 469 IRLRGFCCSRGRGECFLIYDFAPKGKLSKYLDQEEGSSNVLDWSTRVSIIIGIAKGIGYL 528
           I L             L+++        +           L        +  I K + Y 
Sbjct: 93  ITLADIVKDPVSRTPALVFEHVNNTDFKQLYQT-------LTDYDIRFYMYEILKALDYC 145

Query: 529 HSSEVNKPAIVHRNLSVEKVLIDQQFNPL-IADCGLHKLLADDIVFSVLKTSAAMGYLAP 587
           HS       I+HR++    V+ID +   L + D GL +       ++V   S        
Sbjct: 146 HSMG-----IMHRDVKPHNVMIDHEHRKLRLIDWGLAEFYHPGQEYNVRVAS-RYFKGPE 199

Query: 588 EYVTTGRFTERSDIFAFGVIILQILTG 614
             V    +    D+++ G ++  ++  
Sbjct: 200 LLVDYQMYDYSLDMWSLGCMLASMIFR 226

>d2b1pa1 d.144.1.7 (A:46-400) c-jun N-terminal kinase (jnk3s) {Human (Homo sapiens) [TaxId: 9606]} Length = 355

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: c-jun N-terminal kinase (jnk3s)
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 88.5 bits (218), Expect = 2e-19
 Identities = 39/210 (18%), Positives = 76/210 (36%), Gaps = 20/210 (9%)

Query: 411 FSEVNLLGKGNFSSVYKGT-LRDGTLVAIRSINVTSCKSEEAE-FVKGLYLLTSLRHENI 468
           +  +  +G G    V           VAI+ ++        A+   + L L+  + H+NI
Sbjct: 19  YQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNI 78

Query: 469 IRLRGFCCSRGRGE----CFLIYDFAPKGKLSKYLDQEEGSSNVLDWSTRVSIIIGIAKG 524
           I L      +   E     +L+ +            +        D      ++  +  G
Sbjct: 79  ISLLNVFTPQKTLEEFQDVYLVMELMDANLCQVIQMEL-------DHERMSYLLYQMLCG 131

Query: 525 IGYLHSSEVNKPAIVHRNLSVEKVLIDQQFNPLIADCGLHKLLADDIVFSVLKTSAAMGY 584
           I +LHS       I+HR+L    +++       I D GL +      + +    +    Y
Sbjct: 132 IKHLHS-----AGIIHRDLKPSNIVVKSDCTLKILDFGLARTAGTSFMMTPYVVT--RYY 184

Query: 585 LAPEYVTTGRFTERSDIFAFGVIILQILTG 614
            APE +    + E  DI++ G I+ +++  
Sbjct: 185 RAPEVILGMGYKENVDIWSVGCIMGEMVRH 214

>d2gfsa1 d.144.1.7 (A:5-352) MAP kinase p38 {Human (Homo sapiens) [TaxId: 9606]} Length = 348

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: MAP kinase p38
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 88.0 bits (217), Expect = 2e-19
 Identities = 45/209 (21%), Positives = 83/209 (39%), Gaps = 18/209 (8%)

Query: 411 FSEVNLLGKGNFSSVYKGT-LRDGTLVAIRSINVTSCKSEEAE-FVKGLYLLTSLRHENI 468
           +  ++ +G G + SV      + G  VA++ ++        A+   + L LL  ++HEN+
Sbjct: 20  YQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENV 79

Query: 469 IRLRGFCCSRG--RGECFLIYDFAPKGKLSKYLDQEEGSSNVLDWSTRVSIIIGIAKGIG 526
           I L               +       G     + + +     L       +I  I +G+ 
Sbjct: 80  IGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQK----LTDDHVQFLIYQILRGLK 135

Query: 527 YLHSSEVNKPAIVHRNLSVEKVLIDQQFNPLIADCGLHKLLADDIVFSVLKTSAAMGYLA 586
           Y+HS       I+HR+L    + +++     I D GL    A      +    A   Y A
Sbjct: 136 YIHS-----ADIIHRDLKPSNLAVNEDCELKILDFGL----ARHTDDEMTGYVATRWYRA 186

Query: 587 PE-YVTTGRFTERSDIFAFGVIILQILTG 614
           PE  +    + +  DI++ G I+ ++LTG
Sbjct: 187 PEIMLNWMHYNQTVDIWSVGCIMAELLTG 215

>d1ogqa_ c.10.2.8 (A:) Polygalacturonase inhibiting protein PGIP {Kidney bean (Phaseolus vulgaris) [TaxId: 3885]} Length = 313

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Polygalacturonase inhibiting protein PGIP
domain: Polygalacturonase inhibiting protein PGIP
species: Kidney bean (Phaseolus vulgaris) [TaxId: 3885]

 Score = 84.0 bits (206), Expect = 3e-18
 Identities = 60/174 (34%), Positives = 89/174 (51%), Gaps = 7/174 (4%)

Query: 23  CGNTELRALLDLKASLDPENKLLQSWTENGDPCSGSFEGIACN---EHRKVANISLQGKG 79
           C   + +ALL +K  L      L SW    D C+ ++ G+ C+   +  +V N+ L G  
Sbjct: 3   CNPQDKQALLQIKKDLGNPT-TLSSWLPTTDCCNRTWLGVLCDTDTQTYRVNNLDLSGLN 61

Query: 80  LTGK--LSPSLSGLKCLSGLYLHYN-SLSGEIPKEIRNLTELTDLYLDVNNLSGNIPPEI 136
           L     +  SL+ L  L+ LY+    +L G IP  I  LT+L  LY+   N+SG IP  +
Sbjct: 62  LPKPYPIPSSLANLPYLNFLYIGGINNLVGPIPPAIAKLTQLHYLYITHTNVSGAIPDFL 121

Query: 137 GSMASLQVLQLCCNQLTGNIPAQIGSLKSLSVLTLQHNRLNGGIPDSLGNLGKL 190
             + +L  L    N L+G +P  I SL +L  +T   NR++G IPDS G+  KL
Sbjct: 122 SQIKTLVTLDFSYNALSGTLPPSISSLPNLVGITFDGNRISGAIPDSYGSFSKL 175

>d1ogqa_ c.10.2.8 (A:) Polygalacturonase inhibiting protein PGIP {Kidney bean (Phaseolus vulgaris) [TaxId: 3885]} Length = 313

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Polygalacturonase inhibiting protein PGIP
domain: Polygalacturonase inhibiting protein PGIP
species: Kidney bean (Phaseolus vulgaris) [TaxId: 3885]

 Score = 61.3 bits (147), Expect = 1e-10
 Identities = 30/96 (31%), Positives = 44/96 (45%), Gaps = 26/96 (27%)

Query: 164 KSLSVLTLQHNRLNGGIPDSLGNLGKLKRLDLSFNSLFGTIPESLANNAELLFLDVQNNT 223
           K+L+ L L++NR+ G +P  L  L  L  L++SFN+L G IP+                 
Sbjct: 244 KNLNGLDLRNNRIYGTLPQGLTQLKFLHSLNVSFNNLCGEIPQG---------------- 287

Query: 224 LSGIVPSALKRLNGGFQFQNNPGLCGDGIASLRACT 259
                   L+R +    + NN  LCG   + L ACT
Sbjct: 288 ------GNLQRFD-VSAYANNKCLCG---SPLPACT 313

>d1ogqa_ c.10.2.8 (A:) Polygalacturonase inhibiting protein PGIP {Kidney bean (Phaseolus vulgaris) [TaxId: 3885]} Length = 313

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Polygalacturonase inhibiting protein PGIP
domain: Polygalacturonase inhibiting protein PGIP
species: Kidney bean (Phaseolus vulgaris) [TaxId: 3885]

 Score = 60.5 bits (145), Expect = 1e-10
 Identities = 18/60 (30%), Positives = 25/60 (41%), Gaps = 1/60 (1%)

Query: 146 QLCCNQLTGNIPAQIGSLKSLSVLTLQHNRLNGGIPDSLGNLGKLKRLDLSFNSLFGTIP 205
            L  N++ G +P  +  LK L  L +  N L G IP   GNL +      + N      P
Sbjct: 250 DLRNNRIYGTLPQGLTQLKFLHSLNVSFNNLCGEIP-QGGNLQRFDVSAYANNKCLCGSP 308

>d1ogqa_ c.10.2.8 (A:) Polygalacturonase inhibiting protein PGIP {Kidney bean (Phaseolus vulgaris) [TaxId: 3885]} Length = 313

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Polygalacturonase inhibiting protein PGIP
domain: Polygalacturonase inhibiting protein PGIP
species: Kidney bean (Phaseolus vulgaris) [TaxId: 3885]

 Score = 57.5 bits (137), Expect = 1e-09
 Identities = 17/60 (28%), Positives = 26/60 (43%), Gaps = 1/60 (1%)

Query: 98  YLHYNSLSGEIPKEIRNLTELTDLYLDVNNLSGNIPPEIGSMASLQVLQLCCNQLTGNIP 157
            L  N + G +P+ +  L  L  L +  NNL G I P+ G++    V     N+     P
Sbjct: 250 DLRNNRIYGTLPQGLTQLKFLHSLNVSFNNLCGEI-PQGGNLQRFDVSAYANNKCLCGSP 308

>d1ogqa_ c.10.2.8 (A:) Polygalacturonase inhibiting protein PGIP {Kidney bean (Phaseolus vulgaris) [TaxId: 3885]} Length = 313

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Polygalacturonase inhibiting protein PGIP
domain: Polygalacturonase inhibiting protein PGIP
species: Kidney bean (Phaseolus vulgaris) [TaxId: 3885]

 Score = 52.1 bits (123), Expect = 1e-07
 Identities = 18/70 (25%), Positives = 28/70 (40%), Gaps = 1/70 (1%)

Query: 64  CNEHRKVANISLQGKGLTGKLSPSLSGLKCLSGLYLHYNSLSGEIPKEIRNLTELTDLYL 123
               + +  + L+   + G L   L+ LK L  L + +N+L GEIP +  NL        
Sbjct: 240 VGLSKNLNGLDLRNNRIYGTLPQGLTQLKFLHSLNVSFNNLCGEIP-QGGNLQRFDVSAY 298

Query: 124 DVNNLSGNIP 133
             N      P
Sbjct: 299 ANNKCLCGSP 308

>d1q8ya_ d.144.1.7 (A:) Sky1p {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} Length = 362

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Sky1p
species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]

 Score = 84.3 bits (207), Expect = 4e-18
 Identities = 37/216 (17%), Positives = 77/216 (35%), Gaps = 19/216 (8%)

Query: 414 VNLLGKGNFSSVYKGT-LRDGTLVAIRSINVTSCKSEEAEFVKGLYLLTSLRHENIIRLR 472
           V  LG G+FS+V+    + + T VA++ +      +E AE    + LL  +   +  +  
Sbjct: 18  VRKLGWGHFSTVWLAKDMVNNTHVAMKIVRGDKVYTEAAE--DEIKLLQRVNDADNTKED 75

Query: 473 GFCCSRGRGECFLIYDFAPKGKLSKYLDQEEGSSNVL----------DWSTRVSIIIGIA 522
               +             P G     + +  G + +                  I   + 
Sbjct: 76  SMGANHILKLLDHFNHKGPNGVHVVMVFEVLGENLLALIKKYEHRGIPLIYVKQISKQLL 135

Query: 523 KGIGYLHSSEVNKPAIVHRNLSVEKVLIDQQ-FNPLIADCGLHKL-LADDIVFSVLKTSA 580
            G+ Y+H     +  I+H ++  E VL++       +    +  L  A         +  
Sbjct: 136 LGLDYMH----RRCGIIHTDIKPENVLMEIVDSPENLIQIKIADLGNACWYDEHYTNSIQ 191

Query: 581 AMGYLAPEYVTTGRFTERSDIFAFGVIILQILTGSL 616
              Y +PE +    +   +DI++   +I +++TG  
Sbjct: 192 TREYRSPEVLLGAPWGCGADIWSTACLIFELITGDF 227

>d2omza2 c.10.2.1 (A:33-416) Internalin A {Listeria monocytogenes [TaxId: 1639]} Length = 384

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Internalin LRR domain
domain: Internalin A
species: Listeria monocytogenes [TaxId: 1639]

 Score = 82.7 bits (203), Expect = 2e-17
 Identities = 43/181 (23%), Positives = 68/181 (37%), Gaps = 30/181 (16%)

Query: 62  IACNEHRKVANISLQGKGLTGKLSPSLSGLKCLSGLYLHYNSLSGEIPKEIRNLTELTDL 121
                   +  +SL G  L      +L+ L  L+ L L  N +S   P  +  LT+LT+L
Sbjct: 213 TPLGILTNLDELSLNGNQLKD--IGTLASLTNLTDLDLANNQISNLAP--LSGLTKLTEL 268

Query: 122 YLDVNNLSGNIP--------------------PEIGSMASLQVLQLCCNQLTGNIPAQIG 161
            L  N +S   P                      I ++ +L  L L  N ++   P  + 
Sbjct: 269 KLGANQISNISPLAGLTALTNLELNENQLEDISPISNLKNLTYLTLYFNNISDISP--VS 326

Query: 162 SLKSLSVLTLQHNRLNGGIPDSLGNLGKLKRLDLSFNSLFGTIPESLANNAELLFLDVQN 221
           SL  L  L   +N+++     SL NL  +  L    N +    P  LAN   +  L + +
Sbjct: 327 SLTKLQRLFFANNKVSD--VSSLANLTNINWLSAGHNQISDLTP--LANLTRITQLGLND 382

Query: 222 N 222
            
Sbjct: 383 Q 383

>d2omza2 c.10.2.1 (A:33-416) Internalin A {Listeria monocytogenes [TaxId: 1639]} Length = 384

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Internalin LRR domain
domain: Internalin A
species: Listeria monocytogenes [TaxId: 1639]

 Score = 78.9 bits (193), Expect = 3e-16
 Identities = 45/169 (26%), Positives = 74/169 (43%), Gaps = 32/169 (18%)

Query: 92  KCLSGLYLHYNSLSGEIPKEIRNLTELTDLYLDVNNLSGNIPPEIGSMASLQVLQLCCNQ 151
             L  L L+ N L       + +LT LTDL L  N +S   P  +  +  L  L+L  NQ
Sbjct: 219 TNLDELSLNGNQLKD--IGTLASLTNLTDLDLANNQISNLAP--LSGLTKLTELKLGANQ 274

Query: 152 LTGNIP--------------------AQIGSLKSLSVLTLQHNRLNGGIPDSLGNLGKLK 191
           ++   P                    + I +LK+L+ LTL  N ++   P  + +L KL+
Sbjct: 275 ISNISPLAGLTALTNLELNENQLEDISPISNLKNLTYLTLYFNNISDISP--VSSLTKLQ 332

Query: 192 RLDLSFNSLFGTIPESLANNAELLFLDVQNNTLSGIVP----SALKRLN 236
           RL  + N +  +   SLAN   + +L   +N +S + P    + + +L 
Sbjct: 333 RLFFANNKV--SDVSSLANLTNINWLSAGHNQISDLTPLANLTRITQLG 379

>d2omza2 c.10.2.1 (A:33-416) Internalin A {Listeria monocytogenes [TaxId: 1639]} Length = 384

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Internalin LRR domain
domain: Internalin A
species: Listeria monocytogenes [TaxId: 1639]

 Score = 41.5 bits (96), Expect = 3e-04
 Identities = 14/79 (17%), Positives = 34/79 (43%), Gaps = 8/79 (10%)

Query: 97  LYLHYNSLSGEIPK-EIRNLTELTDLYLDVNNLSGNIPPEIGSMASLQVLQLCCNQLTGN 155
             L   +++  + + ++  +T L    L + ++ G     +  + +L  +    NQLT  
Sbjct: 27  TVLGKTNVTDTVSQTDLDQVTTLQADRLGIKSIDG-----VEYLNNLTQINFSNNQLTDI 81

Query: 156 IPAQIGSLKSLSVLTLQHN 174
            P  + +L  L  + + +N
Sbjct: 82  TP--LKNLTKLVDILMNNN 98

>d1zara2 d.144.1.9 (A:91-281) Rio2 serine protein kinase C-terminal domain {Archaeoglobus fulgidus [TaxId: 2234]} Length = 191

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: RIO1-like kinases
domain: Rio2 serine protein kinase C-terminal domain
species: Archaeoglobus fulgidus [TaxId: 2234]

 Score = 68.7 bits (167), Expect = 5e-14
 Identities = 23/158 (14%), Positives = 50/158 (31%), Gaps = 24/158 (15%)

Query: 415 NLLGKGNFSSVYKGTLRDGTLVAIRSINVTSCKSE---------EAEFVKGLYLLTSLRH 465
            L+G+G  S+V+           ++   V     +         +  F            
Sbjct: 6   KLMGEGKESAVFNCYSEKFGECVVKFHKVGHTSFKKVKEKRDYGDLHFSVLAIRSARNEF 65

Query: 466 ENIIRLRGFCCSRGRGECFLIYDFAPKGKLSKYLDQEEGSSNVLDWSTRVSIIIGIAKGI 525
             + +L+G    +       +Y +     L + +D +E     ++      ++  I + +
Sbjct: 66  RALQKLQGLAVPK-------VYAWEGNAVLMELIDAKELYRVRVENPDE--VLDMILEEV 116

Query: 526 GYLHSSEVNKPAIVHRNLSVEKVLIDQQFNPLIADCGL 563
              +        IVH +LS   VL+  +    I D   
Sbjct: 117 AKFYH-----RGIVHGDLSQYNVLVS-EEGIWIIDFPQ 148

>d1ozna_ c.10.2.7 (A:) Reticulon 4 receptor (Nogo-66 receptor, Ngr) {Human (Homo sapiens) [TaxId: 9606]} Length = 284

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Ngr ectodomain-like
domain: Reticulon 4 receptor (Nogo-66 receptor, Ngr)
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 68.3 bits (165), Expect = 4e-13
 Identities = 35/163 (21%), Positives = 58/163 (35%), Gaps = 4/163 (2%)

Query: 64  CNEHRKVANISLQGKGLTGKLSPSLSGLKCLSGLYLHYNSLSGEIPKEIRNLTELTDLYL 123
                 +  + LQ   L      +   L  L+ L+LH N +S    +  R L  L  L L
Sbjct: 125 FRGLAALQYLYLQDNALQALPDDTFRDLGNLTHLFLHGNRISSVPERAFRGLHSLDRLLL 184

Query: 124 DVNNLSGNIPPEIGSMASLQVLQLCCNQLTGNIPAQIGSLKSLSVLTLQHNRLNGGIPDS 183
             N ++   P     +  L  L L  N L+      +  L++L  L L  N        +
Sbjct: 185 HQNRVAHVHPHAFRDLGRLMTLYLFANNLSALPTEALAPLRALQYLRLNDNPWVCDC-RA 243

Query: 184 LGNLGKLKRLDLSFNSLFGTIPESLANNAELLFLDVQNNTLSG 226
                 L++   S + +  ++P+ LA         +  N L G
Sbjct: 244 RPLWAWLQKFRGSSSEVPCSLPQRLAG---RDLKRLAANDLQG 283

>d1ozna_ c.10.2.7 (A:) Reticulon 4 receptor (Nogo-66 receptor, Ngr) {Human (Homo sapiens) [TaxId: 9606]} Length = 284

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Ngr ectodomain-like
domain: Reticulon 4 receptor (Nogo-66 receptor, Ngr)
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 58.3 bits (139), Expect = 6e-10
 Identities = 40/139 (28%), Positives = 55/139 (39%)

Query: 88  LSGLKCLSGLYLHYNSLSGEIPKEIRNLTELTDLYLDVNNLSGNIPPEIGSMASLQVLQL 147
             GL  L  L+L    L    P   R L  L  LYL  N L          + +L  L L
Sbjct: 101 FHGLGRLHTLHLDRCGLQELGPGLFRGLAALQYLYLQDNALQALPDDTFRDLGNLTHLFL 160

Query: 148 CCNQLTGNIPAQIGSLKSLSVLTLQHNRLNGGIPDSLGNLGKLKRLDLSFNSLFGTIPES 207
             N+++         L SL  L L  NR+    P +  +LG+L  L L  N+L     E+
Sbjct: 161 HGNRISSVPERAFRGLHSLDRLLLHQNRVAHVHPHAFRDLGRLMTLYLFANNLSALPTEA 220

Query: 208 LANNAELLFLDVQNNTLSG 226
           LA    L +L + +N    
Sbjct: 221 LAPLRALQYLRLNDNPWVC 239

>d1ozna_ c.10.2.7 (A:) Reticulon 4 receptor (Nogo-66 receptor, Ngr) {Human (Homo sapiens) [TaxId: 9606]} Length = 284

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Ngr ectodomain-like
domain: Reticulon 4 receptor (Nogo-66 receptor, Ngr)
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 56.7 bits (135), Expect = 2e-09
 Identities = 36/144 (25%), Positives = 54/144 (37%), Gaps = 1/144 (0%)

Query: 93  CLSGLYLHYNSLSGEIPKEIRNLTELTDLYLDVNNLSGNIPPEIGSMASLQVLQLCCNQL 152
            L  LYL  N+L        R+L  LT L+L  N +S         + SL  L L  N++
Sbjct: 130 ALQYLYLQDNALQALPDDTFRDLGNLTHLFLHGNRISSVPERAFRGLHSLDRLLLHQNRV 189

Query: 153 TGNIPAQIGSLKSLSVLTLQHNRLNGGIPDSLGNLGKLKRLDLSFNSLFGTIPESLANNA 212
               P     L  L  L L  N L+    ++L  L  L+ L L+ N        +    A
Sbjct: 190 AHVHPHAFRDLGRLMTLYLFANNLSALPTEALAPLRALQYLRLNDNPWVCDCR-ARPLWA 248

Query: 213 ELLFLDVQNNTLSGIVPSALKRLN 236
            L      ++ +   +P  L   +
Sbjct: 249 WLQKFRGSSSEVPCSLPQRLAGRD 272

>d1ozna_ c.10.2.7 (A:) Reticulon 4 receptor (Nogo-66 receptor, Ngr) {Human (Homo sapiens) [TaxId: 9606]} Length = 284

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Ngr ectodomain-like
domain: Reticulon 4 receptor (Nogo-66 receptor, Ngr)
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 56.4 bits (134), Expect = 3e-09
 Identities = 43/207 (20%), Positives = 61/207 (29%), Gaps = 29/207 (14%)

Query: 64  CNEHRKVANISLQGKGLTGKLSPSLSGLKCLSGLYLHYNSLSGEIPKEIRNLTELTDLYL 123
           C    KV   S   +GL   +   +        ++LH N +S       R    LT L+L
Sbjct: 8   CYNEPKV-TTSCPQQGLQ-AVPVGIP--AASQRIFLHGNRISHVPAASFRACRNLTILWL 63

Query: 124 DVNN-------------------------LSGNIPPEIGSMASLQVLQLCCNQLTGNIPA 158
             N                          L    P     +  L  L L    L    P 
Sbjct: 64  HSNVLARIDAAAFTGLALLEQLDLSDNAQLRSVDPATFHGLGRLHTLHLDRCGLQELGPG 123

Query: 159 QIGSLKSLSVLTLQHNRLNGGIPDSLGNLGKLKRLDLSFNSLFGTIPESLANNAELLFLD 218
               L +L  L LQ N L     D+  +LG L  L L  N +      +      L  L 
Sbjct: 124 LFRGLAALQYLYLQDNALQALPDDTFRDLGNLTHLFLHGNRISSVPERAFRGLHSLDRLL 183

Query: 219 VQNNTLSGIVPSALKRLNGGFQFQNNP 245
           +  N ++ + P A + L          
Sbjct: 184 LHQNRVAHVHPHAFRDLGRLMTLYLFA 210

>d1ozna_ c.10.2.7 (A:) Reticulon 4 receptor (Nogo-66 receptor, Ngr) {Human (Homo sapiens) [TaxId: 9606]} Length = 284

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Ngr ectodomain-like
domain: Reticulon 4 receptor (Nogo-66 receptor, Ngr)
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 56.0 bits (133), Expect = 4e-09
 Identities = 42/164 (25%), Positives = 59/164 (35%), Gaps = 10/164 (6%)

Query: 100 HYNSLSGEIPKEIRNLTELTDLYLDVNNLSGNIPPEIGSMASLQVLQLCCNQLTGNIPAQ 159
               L    P     L  L  L+LD   L    P     +A+LQ L L  N L       
Sbjct: 89  DNAQLRSVDPATFHGLGRLHTLHLDRCGLQELGPGLFRGLAALQYLYLQDNALQALPDDT 148

Query: 160 IGSLKSLSVLTLQHNRLNGGIPDSLGNLGKLKRLDLSFNSLFGTIPESLANNAELLFLDV 219
              L +L+ L L  NR++     +   L  L RL L  N +    P +  +   L+ L +
Sbjct: 149 FRDLGNLTHLFLHGNRISSVPERAFRGLHSLDRLLLHQNRVAHVHPHAFRDLGRLMTLYL 208

Query: 220 QNNTLSGIVPS------ALKRLNGGFQFQNNPGLCGDGIASLRA 257
             N LS +         AL+ L       +NP +C      L A
Sbjct: 209 FANNLSALPTEALAPLRALQYLR----LNDNPWVCDCRARPLWA 248

>d1xkua_ c.10.2.7 (A:) Decorin {Cow (Bos taurus) [TaxId: 9913]} Length = 305

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Ngr ectodomain-like
domain: Decorin
species: Cow (Bos taurus) [TaxId: 9913]

 Score = 68.1 bits (165), Expect = 6e-13
 Identities = 27/139 (19%), Positives = 51/139 (36%), Gaps = 1/139 (0%)

Query: 97  LYLHYNSLSGEIPKEIRNLTELTDLYLDVNNLSGNIPPEIGSMASLQVLQLCCNQLTGNI 156
           L L  N ++     + +NL  L  L L  N +S   P     +  L+ L L  NQL    
Sbjct: 36  LDLQNNKITEIKDGDFKNLKNLHTLILINNKISKISPGAFAPLVKLERLYLSKNQLKELP 95

Query: 157 PAQIGSLKSLSVLTLQHNRLNGGIPDSLGNLGKLKRLDLSFNSLFGTIPESLANNAELLF 216
                +L+ L V   +  ++   + + L N   +  L  +     G    +     +L +
Sbjct: 96  EKMPKTLQELRVHENEITKVRKSVFNGL-NQMIVVELGTNPLKSSGIENGAFQGMKKLSY 154

Query: 217 LDVQNNTLSGIVPSALKRL 235
           + + +  ++ I       L
Sbjct: 155 IRIADTNITTIPQGLPPSL 173

>d1xkua_ c.10.2.7 (A:) Decorin {Cow (Bos taurus) [TaxId: 9913]} Length = 305

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Ngr ectodomain-like
domain: Decorin
species: Cow (Bos taurus) [TaxId: 9913]

 Score = 57.4 bits (137), Expect = 2e-09
 Identities = 41/228 (17%), Positives = 85/228 (37%), Gaps = 17/228 (7%)

Query: 16  SSLTGLVCGNTELRALLDLKASLDPENKLLQSWTENGDPCSGSFEGIACNEHRKVANISL 75
             L  L     +L+ L +         +L     E        F G+      ++    L
Sbjct: 79  VKLERLYLSKNQLKELPE--KMPKTLQELRVHENEITKVRKSVFNGLNQMIVVELGTNPL 136

Query: 76  QGKGLTGKLSPSLSGLKCLSGLYLHYNSLSGEIPKEIRNLTELTDLYLDVNNLSGNIPPE 135
           +    +G  + +  G+K LS + +   +++  IP+ +     LT+L+LD N ++      
Sbjct: 137 K---SSGIENGAFQGMKKLSYIRIADTNIT-TIPQGL--PPSLTELHLDGNKITKVDAAS 190

Query: 136 IGSMASLQVLQLCCNQLTGNIPAQIGSLKSLSVLTLQHNRLNGGIPDSLGNLGKLKRLDL 195
           +  + +L  L L  N ++      + +   L  L L +N+L   +P  L +   ++ + L
Sbjct: 191 LKGLNNLAKLGLSFNSISAVDNGSLANTPHLRELHLNNNKLVK-VPGGLADHKYIQVVYL 249

Query: 196 SFNSLFG------TIPESLANNAELLFLDVQNN--TLSGIVPSALKRL 235
             N++          P      A    + + +N      I PS  + +
Sbjct: 250 HNNNISAIGSNDFCPPGYNTKKASYSGVSLFSNPVQYWEIQPSTFRCV 297

>d1jl5a_ c.10.2.6 (A:) Leucine rich effector protein YopM {Yersinia pestis [TaxId: 632]} Length = 353

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Leucine rich effector protein YopM
domain: Leucine rich effector protein YopM
species: Yersinia pestis [TaxId: 632]

 Score = 61.4 bits (147), Expect = 1e-10
 Identities = 22/94 (23%), Positives = 36/94 (38%), Gaps = 9/94 (9%)

Query: 98  YLHYNSLSGEIPKEIRNLTELTDLYLDVNNLSGNIPPEIGSMASLQVLQLCCNQLTGNIP 157
             + N+ S EI         L +L +  N L   +P        L+ L    N L   +P
Sbjct: 266 LYYLNASSNEIRSLCDLPPSLEELNVSNNKLI-ELPALPP---RLERLIASFNHLA-EVP 320

Query: 158 AQIGSLKSLSVLTLQHNRLNGGIPDSLGNLGKLK 191
               +LK L    +++N L    PD   ++  L+
Sbjct: 321 ELPQNLKQLH---VEYNPLR-EFPDIPESVEDLR 350

>d1jl5a_ c.10.2.6 (A:) Leucine rich effector protein YopM {Yersinia pestis [TaxId: 632]} Length = 353

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Leucine rich effector protein YopM
domain: Leucine rich effector protein YopM
species: Yersinia pestis [TaxId: 632]

 Score = 57.5 bits (137), Expect = 2e-09
 Identities = 25/93 (26%), Positives = 38/93 (40%), Gaps = 10/93 (10%)

Query: 146 QLCCNQLTGNIPAQIGSLKSLSVLTLQHNRLNGGIPDSLGNLGKLKRLDLSFNSLFGTIP 205
               N  +  I +      SL  L + +N+L   +P     L   +RL  SFN L   +P
Sbjct: 266 LYYLNASSNEIRSLCDLPPSLEELNVSNNKLIE-LPALPPRL---ERLIASFNHL-AEVP 320

Query: 206 ESLANNAELLFLDVQNNTLSGI--VPSALKRLN 236
           E   N   L  L V+ N L     +P +++ L 
Sbjct: 321 ELPQN---LKQLHVEYNPLREFPDIPESVEDLR 350

>d1jl5a_ c.10.2.6 (A:) Leucine rich effector protein YopM {Yersinia pestis [TaxId: 632]} Length = 353

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Leucine rich effector protein YopM
domain: Leucine rich effector protein YopM
species: Yersinia pestis [TaxId: 632]

 Score = 57.1 bits (136), Expect = 3e-09
 Identities = 26/91 (28%), Positives = 39/91 (42%), Gaps = 10/91 (10%)

Query: 122 YLDVNNLSGNIPPEIGSMASLQVLQLCCNQLTGNIPAQIGSLKSLSVLTLQHNRLNGGIP 181
              +N  S  I        SL+ L +  N+L   +PA    L+ L       N L   +P
Sbjct: 266 LYYLNASSNEIRSLCDLPPSLEELNVSNNKLI-ELPALPPRLERLI---ASFNHLA-EVP 320

Query: 182 DSLGNLGKLKRLDLSFNSL--FGTIPESLAN 210
           +   N   LK+L + +N L  F  IPES+ +
Sbjct: 321 ELPQN---LKQLHVEYNPLREFPDIPESVED 348

>d1jl5a_ c.10.2.6 (A:) Leucine rich effector protein YopM {Yersinia pestis [TaxId: 632]} Length = 353

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Leucine rich effector protein YopM
domain: Leucine rich effector protein YopM
species: Yersinia pestis [TaxId: 632]

 Score = 42.9 bits (99), Expect = 9e-05
 Identities = 14/56 (25%), Positives = 27/56 (48%), Gaps = 5/56 (8%)

Query: 89  SGLKCLSGLYLHYNSLSGEIPKEIRNLTELTDLYLDVNNLSGNIPPEIGSMASLQV 144
           +    L  L   +N L+ E+P+  +NL +   L+++ N L    P    S+  L++
Sbjct: 301 ALPPRLERLIASFNHLA-EVPELPQNLKQ---LHVEYNPLRE-FPDIPESVEDLRM 351

>d1jl5a_ c.10.2.6 (A:) Leucine rich effector protein YopM {Yersinia pestis [TaxId: 632]} Length = 353

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Leucine rich effector protein YopM
domain: Leucine rich effector protein YopM
species: Yersinia pestis [TaxId: 632]

 Score = 39.0 bits (89), Expect = 0.001
 Identities = 18/64 (28%), Positives = 28/64 (43%), Gaps = 8/64 (12%)

Query: 164 KSLSVLTLQHNRLNGGIPDSLGNLGKLKRLDLSFNSLFGTIPESLANNAELLFLDVQNNT 223
           +    L L +  L+  +P+   +L   + L  S NSL   +PE   +   L  L V NN 
Sbjct: 38  RQAHELELNNLGLSS-LPELPPHL---ESLVASCNSL-TELPELPQS---LKSLLVDNNN 89

Query: 224 LSGI 227
           L  +
Sbjct: 90  LKAL 93

>d1dcea3 c.10.2.2 (A:444-567) Rab geranylgeranyltransferase alpha-subunit, C-terminal domain {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 124

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Rab geranylgeranyltransferase alpha-subunit, C-terminal domain
domain: Rab geranylgeranyltransferase alpha-subunit, C-terminal domain
species: Rat (Rattus norvegicus) [TaxId: 10116]

 Score = 51.6 bits (123), Expect = 1e-08
 Identities = 30/105 (28%), Positives = 44/105 (41%), Gaps = 6/105 (5%)

Query: 97  LYLHYNSLSGEIPKEIRNLTELTDLYLDVNNLSGNIPPEIGSMASLQVLQLCCNQLTGNI 156
           L+L +  L+  +   +  L  +T L L  N L    PP + ++  L+VLQ   N L    
Sbjct: 3   LHLAHKDLT--VLCHLEQLLLVTHLDLSHNRLRAL-PPALAALRCLEVLQASDNALENVD 59

Query: 157 PAQIGSLKSLSVLTLQHNRLNGG-IPDSLGNLGKLKRLDLSFNSL 200
                    L  L L +NRL        L +  +L  L+L  NSL
Sbjct: 60  GVANL--PRLQELLLCNNRLQQSAAIQPLVSCPRLVLLNLQGNSL 102

>d1dcea3 c.10.2.2 (A:444-567) Rab geranylgeranyltransferase alpha-subunit, C-terminal domain {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 124

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Rab geranylgeranyltransferase alpha-subunit, C-terminal domain
domain: Rab geranylgeranyltransferase alpha-subunit, C-terminal domain
species: Rat (Rattus norvegicus) [TaxId: 10116]

 Score = 46.2 bits (109), Expect = 9e-07
 Identities = 29/108 (26%), Positives = 50/108 (46%), Gaps = 6/108 (5%)

Query: 121 LYLDVNNLSGNIPPEIGSMASLQVLQLCCNQLTGNIPAQIGSLKSLSVLTLQHNRLNGGI 180
           L+L   +L+  +   +  +  +  L L  N+L    PA + +L+ L VL    N L    
Sbjct: 3   LHLAHKDLT--VLCHLEQLLLVTHLDLSHNRLRALPPA-LAALRCLEVLQASDNALE--N 57

Query: 181 PDSLGNLGKLKRLDLSFNSLFGT-IPESLANNAELLFLDVQNNTLSGI 227
            D + NL +L+ L L  N L  +   + L +   L+ L++Q N+L   
Sbjct: 58  VDGVANLPRLQELLLCNNRLQQSAAIQPLVSCPRLVLLNLQGNSLCQE 105

>d1dcea3 c.10.2.2 (A:444-567) Rab geranylgeranyltransferase alpha-subunit, C-terminal domain {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 124

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Rab geranylgeranyltransferase alpha-subunit, C-terminal domain
domain: Rab geranylgeranyltransferase alpha-subunit, C-terminal domain
species: Rat (Rattus norvegicus) [TaxId: 10116]

 Score = 43.9 bits (103), Expect = 5e-06
 Identities = 29/119 (24%), Positives = 45/119 (37%), Gaps = 7/119 (5%)

Query: 73  ISLQGKGLTGKLSPSLSGLKCLSGLYLHYNSLSGEIPKEIRNLTELTDLYLDVNNLSGNI 132
           + L  K LT      L  L  ++ L L +N L    P  +  L  L    L  ++ +   
Sbjct: 3   LHLAHKDLTV--LCHLEQLLLVTHLDLSHNRLRALPP-ALAALRCLE--VLQASDNALEN 57

Query: 133 PPEIGSMASLQVLQLCCNQLTG-NIPAQIGSLKSLSVLTLQHNRLNGGIPDSLGNLGKL 190
              + ++  LQ L LC N+L        + S   L +L LQ N L          L ++
Sbjct: 58  VDGVANLPRLQELLLCNNRLQQSAAIQPLVSCPRLVLLNLQGNSLC-QEEGIQERLAEM 115

>d1dcea3 c.10.2.2 (A:444-567) Rab geranylgeranyltransferase alpha-subunit, C-terminal domain {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 124

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Rab geranylgeranyltransferase alpha-subunit, C-terminal domain
domain: Rab geranylgeranyltransferase alpha-subunit, C-terminal domain
species: Rat (Rattus norvegicus) [TaxId: 10116]

 Score = 35.8 bits (82), Expect = 0.004
 Identities = 26/92 (28%), Positives = 32/92 (34%), Gaps = 3/92 (3%)

Query: 168 VLTLQHNRLNGGIPDSLGNLGKLKRLDLSFNSLFGTIPESLANNAELLFLDVQNNTLSGI 227
           VL L H  L   +   L  L  +  LDLS N L    P +LA    L  L   +N L  +
Sbjct: 2   VLHLAHKDLT--VLCHLEQLLLVTHLDLSHNRLRALPP-ALAALRCLEVLQASDNALENV 58

Query: 228 VPSALKRLNGGFQFQNNPGLCGDGIASLRACT 259
              A           NN       I  L +C 
Sbjct: 59  DGVANLPRLQELLLCNNRLQQSAAIQPLVSCP 90

>d1z7xw1 c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human (Homo sapiens) [TaxId: 9606]} Length = 460

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: RNI-like
family: 28-residue LRR
domain: Ribonuclease inhibitor
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 54.2 bits (128), Expect = 3e-08
 Identities = 18/91 (19%), Positives = 32/91 (35%), Gaps = 5/91 (5%)

Query: 141 SLQVLQLCCNQLTGNIPAQI-GSLKSLSVLTLQHNRLNG----GIPDSLGNLGKLKRLDL 195
            +Q L + C +L+    A++   L+   V+ L    L       I  +L     L  L+L
Sbjct: 3   DIQSLDIQCEELSDARWAELLPLLQQCQVVRLDDCGLTEARCKDISSALRVNPALAELNL 62

Query: 196 SFNSLFGTIPESLANNAELLFLDVQNNTLSG 226
             N L       +    +     +Q  +L  
Sbjct: 63  RSNELGDVGVHCVLQGLQTPSCKIQKLSLQN 93

>d1z7xw1 c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human (Homo sapiens) [TaxId: 9606]} Length = 460

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: RNI-like
family: 28-residue LRR
domain: Ribonuclease inhibitor
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 51.5 bits (121), Expect = 2e-07
 Identities = 20/102 (19%), Positives = 31/102 (30%), Gaps = 14/102 (13%)

Query: 155 NIPAQIGSLKSLSVLTLQHNRLNG----GIPDSLGNLGKLKRLDLSFNSLFGTIPESLA- 209
                      L VL L    ++      +  +L     L+ LDLS N L       L  
Sbjct: 360 LCQGLGQPGSVLRVLWLADCDVSDSSCSSLAATLLANHSLRELDLSNNCLGDAGILQLVE 419

Query: 210 ----NNAELLFLDVQNNTLSGIVPSALKRLNGGFQFQNNPGL 247
                   L  L + +   S  +   L+ L      ++ P L
Sbjct: 420 SVRQPGCLLEQLVLYDIYWSEEMEDRLQAL-----EKDKPSL 456

>d1z7xw1 c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human (Homo sapiens) [TaxId: 9606]} Length = 460

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: RNI-like
family: 28-residue LRR
domain: Ribonuclease inhibitor
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 49.2 bits (115), Expect = 1e-06
 Identities = 14/73 (19%), Positives = 28/73 (38%), Gaps = 5/73 (6%)

Query: 165 SLSVLTLQHNRLN-GGIPDSLGNLGKLKRLDLSFNSL----FGTIPESLANNAELLFLDV 219
            +  L +Q   L+     + L  L + + + L    L       I  +L  N  L  L++
Sbjct: 3   DIQSLDIQCEELSDARWAELLPLLQQCQVVRLDDCGLTEARCKDISSALRVNPALAELNL 62

Query: 220 QNNTLSGIVPSAL 232
           ++N L  +    +
Sbjct: 63  RSNELGDVGVHCV 75

>d1z7xw1 c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human (Homo sapiens) [TaxId: 9606]} Length = 460

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: RNI-like
family: 28-residue LRR
domain: Ribonuclease inhibitor
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 46.9 bits (109), Expect = 6e-06
 Identities = 17/90 (18%), Positives = 28/90 (31%), Gaps = 5/90 (5%)

Query: 94  LSGLYLHYNSLSGEIPKEI-RNLTELTDLYLDVNNLSGNIPPEIGSM----ASLQVLQLC 148
           +  L +    LS     E+   L +   + LD   L+     +I S      +L  L L 
Sbjct: 4   IQSLDIQCEELSDARWAELLPLLQQCQVVRLDDCGLTEARCKDISSALRVNPALAELNLR 63

Query: 149 CNQLTGNIPAQIGSLKSLSVLTLQHNRLNG 178
            N+L       +          +Q   L  
Sbjct: 64  SNELGDVGVHCVLQGLQTPSCKIQKLSLQN 93

>d1z7xw1 c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human (Homo sapiens) [TaxId: 9606]} Length = 460

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: RNI-like
family: 28-residue LRR
domain: Ribonuclease inhibitor
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 45.0 bits (104), Expect = 2e-05
 Identities = 19/88 (21%), Positives = 31/88 (35%), Gaps = 9/88 (10%)

Query: 113 RNLTELTDLYLDVNNLSGNIPPEIGSM----ASLQVLQLCCNQLTGNIPAQIGS-----L 163
           +  + L  L+L   ++S +    + +      SL+ L L  N L      Q+        
Sbjct: 366 QPGSVLRVLWLADCDVSDSSCSSLAATLLANHSLRELDLSNNCLGDAGILQLVESVRQPG 425

Query: 164 KSLSVLTLQHNRLNGGIPDSLGNLGKLK 191
             L  L L     +  + D L  L K K
Sbjct: 426 CLLEQLVLYDIYWSEEMEDRLQALEKDK 453

>d1z7xw1 c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human (Homo sapiens) [TaxId: 9606]} Length = 460

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: RNI-like
family: 28-residue LRR
domain: Ribonuclease inhibitor
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 41.5 bits (95), Expect = 3e-04
 Identities = 16/89 (17%), Positives = 28/89 (31%), Gaps = 10/89 (11%)

Query: 73  ISLQGKGLTGK-LSPSLSGLKCLSGLYLHYNSLSGE----IPKEIRNLTELTDLYLDVNN 127
           + +Q + L+    +  L  L+    + L    L+      I   +R    L +L L  N 
Sbjct: 7   LDIQCEELSDARWAELLPLLQQCQVVRLDDCGLTEARCKDISSALRVNPALAELNLRSNE 66

Query: 128 LSGNIPPEIGSM-----ASLQVLQLCCNQ 151
           L       +          +Q L L    
Sbjct: 67  LGDVGVHCVLQGLQTPSCKIQKLSLQNCC 95

>d1z7xw1 c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human (Homo sapiens) [TaxId: 9606]} Length = 460

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: RNI-like
family: 28-residue LRR
domain: Ribonuclease inhibitor
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 39.6 bits (90), Expect = 0.001
 Identities = 17/113 (15%), Positives = 32/113 (28%), Gaps = 13/113 (11%)

Query: 46  QSWTENGDPCSGSFEGIACNEHRKVANISLQGKGLTGK----LSPSLSGLKCLSGLYLHY 101
            S     D                +  + L    ++      L+ +L     L  L L  
Sbjct: 347 ISNNRLEDAGVRELCQGLGQPGSVLRVLWLADCDVSDSSCSSLAATLLANHSLRELDLSN 406

Query: 102 NSLSGEIPKEI-----RNLTELTDLYLDVNNLSGNIPPEIGSMA----SLQVL 145
           N L      ++     +    L  L L     S  +   + ++     SL+V+
Sbjct: 407 NCLGDAGILQLVESVRQPGCLLEQLVLYDIYWSEEMEDRLQALEKDKPSLRVI 459

>d1p9ag_ c.10.2.7 (G:) von Willebrand factor binding domain of glycoprotein Ib alpha {Human (Homo sapiens) [TaxId: 9606]} Length = 266

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Ngr ectodomain-like
domain: von Willebrand factor binding domain of glycoprotein Ib alpha
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 50.5 bits (119), Expect = 2e-07
 Identities = 44/204 (21%), Positives = 63/204 (30%), Gaps = 49/204 (24%)

Query: 64  CNEHRKVANISLQGKGLTGKLSPSLSGLKCLSGLYLHYNSLSGEIPKEIRNLTELTDLYL 123
            ++      ++   + LT  L P L   K  + L+L  N L       +   T LT L L
Sbjct: 6   VSKVASHLEVNCDKRNLT-ALPPDLP--KDTTILHLSENLLYTFSLATLMPYTRLTQLNL 62

Query: 124 D---------------------------------------------VNNLSGNIPPEIGS 138
           D                                              N L+      +  
Sbjct: 63  DRAELTKLQVDGTLPVLGTLDLSHNQLQSLPLLGQTLPALTVLDVSFNRLTSLPLGALRG 122

Query: 139 MASLQVLQLCCNQLTGNIPAQIGSLKSLSVLTLQHNRLNGGIPDSLGNLGKLKRLDLSFN 198
           +  LQ L L  N+L    P  +     L  L+L +N L       L  L  L  L L  N
Sbjct: 123 LGELQELYLKGNELKTLPPGLLTPTPKLEKLSLANNNLTELPAGLLNGLENLDTLLLQEN 182

Query: 199 SLFGTIPESLANNAELLFLDVQNN 222
           SL+ TIP+    +  L F  +  N
Sbjct: 183 SLY-TIPKGFFGSHLLPFAFLHGN 205

>d1p9ag_ c.10.2.7 (G:) von Willebrand factor binding domain of glycoprotein Ib alpha {Human (Homo sapiens) [TaxId: 9606]} Length = 266

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Ngr ectodomain-like
domain: von Willebrand factor binding domain of glycoprotein Ib alpha
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 43.6 bits (101), Expect = 4e-05
 Identities = 14/65 (21%), Positives = 25/65 (38%), Gaps = 3/65 (4%)

Query: 111 EIRNLTELTDLYLDVNNLSGNIPPEIGSMASLQVLQLCCNQLTGNIPAQIGSLKSLSVLT 170
           E+  +    ++  D  NL+  +PP++       +L L  N L     A +     L+ L 
Sbjct: 5   EVSKVASHLEVNCDKRNLT-ALPPDLPK--DTTILHLSENLLYTFSLATLMPYTRLTQLN 61

Query: 171 LQHNR 175
           L    
Sbjct: 62  LDRAE 66

>d1p9ag_ c.10.2.7 (G:) von Willebrand factor binding domain of glycoprotein Ib alpha {Human (Homo sapiens) [TaxId: 9606]} Length = 266

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Ngr ectodomain-like
domain: von Willebrand factor binding domain of glycoprotein Ib alpha
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 42.0 bits (97), Expect = 1e-04
 Identities = 15/62 (24%), Positives = 26/62 (41%), Gaps = 3/62 (4%)

Query: 135 EIGSMASLQVLQLCCNQLTGNIPAQIGSLKSLSVLTLQHNRLNGGIPDSLGNLGKLKRLD 194
           E+  +AS   +      LT  +P  +   K  ++L L  N L      +L    +L +L+
Sbjct: 5   EVSKVASHLEVNCDKRNLT-ALPPDLP--KDTTILHLSENLLYTFSLATLMPYTRLTQLN 61

Query: 195 LS 196
           L 
Sbjct: 62  LD 63

>d1p9ag_ c.10.2.7 (G:) von Willebrand factor binding domain of glycoprotein Ib alpha {Human (Homo sapiens) [TaxId: 9606]} Length = 266

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Ngr ectodomain-like
domain: von Willebrand factor binding domain of glycoprotein Ib alpha
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 41.6 bits (96), Expect = 2e-04
 Identities = 30/101 (29%), Positives = 39/101 (38%), Gaps = 1/101 (0%)

Query: 100 HYNSLSGEIPKEIRNLTELTDLYLDVNNLSGNIPPEIGSMASLQVLQLCCNQLTGNIPAQ 159
            +N L+      +R L EL +LYL  N L    P  +     L+ L L  N LT      
Sbjct: 108 SFNRLTSLPLGALRGLGELQELYLKGNELKTLPPGLLTPTPKLEKLSLANNNLTELPAGL 167

Query: 160 IGSLKSLSVLTLQHNRLNGGIPDSLGNLGKLKRLDLSFNSL 200
           +  L++L  L LQ N L   IP        L    L  N  
Sbjct: 168 LNGLENLDTLLLQENSLY-TIPKGFFGSHLLPFAFLHGNPW 207

>d1p9ag_ c.10.2.7 (G:) von Willebrand factor binding domain of glycoprotein Ib alpha {Human (Homo sapiens) [TaxId: 9606]} Length = 266

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Ngr ectodomain-like
domain: von Willebrand factor binding domain of glycoprotein Ib alpha
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 39.7 bits (91), Expect = 7e-04
 Identities = 19/78 (24%), Positives = 25/78 (32%), Gaps = 1/78 (1%)

Query: 100 HYNSLSGEIPKEIRNLTELTDLYLDVNNLSGNIPPEIGSMASLQVLQLCCNQLTGNIPAQ 159
             N L    P  +    +L  L L  NNL+      +  + +L  L L  N L   IP  
Sbjct: 132 KGNELKTLPPGLLTPTPKLEKLSLANNNLTELPAGLLNGLENLDTLLLQENSLY-TIPKG 190

Query: 160 IGSLKSLSVLTLQHNRLN 177
                 L    L  N   
Sbjct: 191 FFGSHLLPFAFLHGNPWL 208

>d1koha1 c.10.2.3 (A:201-362) mRNA export factor tap {Human (Homo sapiens) [TaxId: 9606]} Length = 162

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: mRNA export factor tap
domain: mRNA export factor tap
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 44.8 bits (105), Expect = 6e-06
 Identities = 24/126 (19%), Positives = 44/126 (34%), Gaps = 5/126 (3%)

Query: 107 EIPKEIRNLTELTDLYLDVNNLSGNIPPEIGSMASLQVLQLCCNQLTGNIPAQIGSLKSL 166
           ++   +    + +   LD+  L     P++ +     VL    +     +     ++  L
Sbjct: 11  QLKLIMSKRYDGSQQALDLKGL--RSDPDLVAQNIDVVLNRRSSMAA-TLRIIEENIPEL 67

Query: 167 SVLTLQHNRLNG--GIPDSLGNLGKLKRLDLSFNSLFGTIPESLANNAELLFLDVQNNTL 224
             L L +NRL     +   +     LK L+LS N L            +L  L +  N+L
Sbjct: 68  LSLNLSNNRLYRLDDMSSIVQKAPNLKILNLSGNELKSERELDKIKGLKLEELWLDGNSL 127

Query: 225 SGIVPS 230
           S     
Sbjct: 128 SDTFRD 133

>d1w8aa_ c.10.2.7 (A:) Slit {Fruit fly (Drosophila melanogaster) [TaxId: 7227]} Length = 192

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Ngr ectodomain-like
domain: Slit
species: Fruit fly (Drosophila melanogaster) [TaxId: 7227]

 Score = 45.2 bits (105), Expect = 6e-06
 Identities = 38/169 (22%), Positives = 63/169 (37%), Gaps = 4/169 (2%)

Query: 95  SGLYLHYNSLSGEIPKEIRNLTELTDLYLDVNNLSGNIPPEI-GSMASLQVLQLCCNQLT 153
           + +      L  EIP++I      T+L L+ N L       + G +  L  L+L  NQLT
Sbjct: 11  TTVDCTGRGLK-EIPRDI--PLHTTELLLNDNELGRISSDGLFGRLPHLVKLELKRNQLT 67

Query: 154 GNIPAQIGSLKSLSVLTLQHNRLNGGIPDSLGNLGKLKRLDLSFNSLFGTIPESLANNAE 213
           G  P        +  L L  N++          L +LK L+L  N +   +P S  +   
Sbjct: 68  GIEPNAFEGASHIQELQLGENKIKEISNKMFLGLHQLKTLNLYDNQISCVMPGSFEHLNS 127

Query: 214 LLFLDVQNNTLSGIVPSALKRLNGGFQFQNNPGLCGDGIASLRACTVYD 262
           L  L++ +N  +     A        +  N         + +R   + D
Sbjct: 128 LTSLNLASNPFNCNCHLAWFAEWLRKKSLNGGAARCGAPSKVRDVQIKD 176

>d2astb2 c.10.1.3 (B:2136-2419) Cyclin A/CDK2-associated p19, Skp2 {Human (Homo sapiens) [TaxId: 9606]} Length = 284

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: RNI-like
family: Cyclin A/CDK2-associated p19, Skp2
domain: Cyclin A/CDK2-associated p19, Skp2
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 43.9 bits (102), Expect = 3e-05
 Identities = 15/94 (15%), Positives = 40/94 (42%), Gaps = 3/94 (3%)

Query: 143 QVLQLCCNQLTGNIPAQIGSLKSLSVLTLQHNRLNGGIPDSLGNLGKLKRLDLSFNSL-F 201
           Q L L    L  ++  ++ S   +       + ++  + +      +++ +DLS + +  
Sbjct: 3   QTLDLTGKNLHPDVTGRLLSQ-GVIAFRCPRSFMDQPLAEHFSPF-RVQHMDLSNSVIEV 60

Query: 202 GTIPESLANNAELLFLDVQNNTLSGIVPSALKRL 235
            T+   L+  ++L  L ++   LS  + + L + 
Sbjct: 61  STLHGILSQCSKLQNLSLEGLRLSDPIVNTLAKN 94

>d1h6ua2 c.10.2.1 (A:36-262) Internalin H {Listeria monocytogenes [TaxId: 1639]} Length = 227

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Internalin LRR domain
domain: Internalin H
species: Listeria monocytogenes [TaxId: 1639]

 Score = 41.6 bits (96), Expect = 1e-04
 Identities = 18/62 (29%), Positives = 34/62 (54%), Gaps = 4/62 (6%)

Query: 112 IRNLTELTDLYLDVNNLSGNIPPEIGSMASLQVLQLCCNQLTGNIPAQIGSLKSLSVLTL 171
           + NL++LT L  D N +S   P  + S+ +L  + L  NQ++   P  + +  +L ++TL
Sbjct: 169 LANLSKLTTLKADDNKISDISP--LASLPNLIEVHLKNNQISDVSP--LANTSNLFIVTL 224

Query: 172 QH 173
            +
Sbjct: 225 TN 226

>d1h6ua2 c.10.2.1 (A:36-262) Internalin H {Listeria monocytogenes [TaxId: 1639]} Length = 227

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Internalin LRR domain
domain: Internalin H
species: Listeria monocytogenes [TaxId: 1639]

 Score = 39.6 bits (91), Expect = 5e-04
 Identities = 16/63 (25%), Positives = 28/63 (44%), Gaps = 4/63 (6%)

Query: 159 QIGSLKSLSVLTLQHNRLNGGIPDSLGNLGKLKRLDLSFNSLFGTIPESLANNAELLFLD 218
            + +L  L+ L    N+++   P  L +L  L  + L  N +    P  LAN + L  + 
Sbjct: 168 PLANLSKLTTLKADDNKISDISP--LASLPNLIEVHLKNNQISDVSP--LANTSNLFIVT 223

Query: 219 VQN 221
           + N
Sbjct: 224 LTN 226

>d1h6ua2 c.10.2.1 (A:36-262) Internalin H {Listeria monocytogenes [TaxId: 1639]} Length = 227

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Internalin LRR domain
domain: Internalin H
species: Listeria monocytogenes [TaxId: 1639]

 Score = 37.7 bits (86), Expect = 0.003
 Identities = 17/66 (25%), Positives = 32/66 (48%), Gaps = 5/66 (7%)

Query: 86  PSLSGLKCLSGLYLHYNSLSGEIPKEIRNLTELTDLYLDVNNLSGNIPPEIGSMASLQVL 145
             L+ L  L+ L    N +S   P  + +L  L +++L  N +S   P  + + ++L ++
Sbjct: 167 TPLANLSKLTTLKADDNKISDISP--LASLPNLIEVHLKNNQISDVSP--LANTSNLFIV 222

Query: 146 QLCCNQ 151
            L  NQ
Sbjct: 223 TL-TNQ 227

>d2ifga3 c.10.2.7 (A:36-191) High affinity nerve growth factor receptor, N-terminal domain {Human (Homo sapiens) [TaxId: 9606]} Length = 156

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Ngr ectodomain-like
domain: High affinity nerve growth factor receptor, N-terminal domain
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 40.5 bits (93), Expect = 2e-04
 Identities = 27/145 (18%), Positives = 43/145 (29%), Gaps = 4/145 (2%)

Query: 94  LSGLYLHYNSLSGEIPKEIRNLTELTDLYLDVNNLSGNIPPEI-GSMASLQVLQLCCNQL 152
            SGL    +    +    +     LT+LY++      ++       +  L+ L +  + L
Sbjct: 10  SSGLRCTRDGAL-DSLHHLPGAENLTELYIENQQHLQHLELRDLRGLGELRNLTIVKSGL 68

Query: 153 TGNIPAQIGSLKSLSVLTLQHNRLNGGIPDSLGNLGKLKRLDLSFNSLFGTI-PESLANN 211
               P        LS L L  N     +         L+ L LS N L  +     L   
Sbjct: 69  RFVAPDAFHFTPRLSRLNLSFNA-LESLSWKTVQGLSLQELVLSGNPLHCSCALRWLQRW 127

Query: 212 AELLFLDVQNNTLSGIVPSALKRLN 236
            E     V    L       L  + 
Sbjct: 128 EEEGLGGVPEQKLQCHGQGPLAHMP 152

>d2ca6a1 c.10.1.2 (A:2-345) Rna1p (RanGAP1), N-terminal domain {Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]} Length = 344

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: RNI-like
family: Rna1p (RanGAP1), N-terminal domain
domain: Rna1p (RanGAP1), N-terminal domain
species: Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]

 Score = 39.9 bits (91), Expect = 9e-04
 Identities = 14/83 (16%), Positives = 27/83 (32%), Gaps = 12/83 (14%)

Query: 122 YLDVNNLSGNIPPEIGSM------ASLQVLQLCCNQLTGNIPAQIGS-----LKSLSVLT 170
            L+   LS      +           LQ L+L  N++  +    + +     +  L  L 
Sbjct: 249 GLNDCLLSARGAAAVVDAFSKLENIGLQTLRLQYNEIELDAVRTLKTVIDEKMPDLLFLE 308

Query: 171 LQHNRLNGGIPDSLGNLGKLKRL 193
           L  NR      D +  + ++   
Sbjct: 309 LNGNRF-SEEDDVVDEIREVFST 330

>d2ca6a1 c.10.1.2 (A:2-345) Rna1p (RanGAP1), N-terminal domain {Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]} Length = 344

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: RNI-like
family: Rna1p (RanGAP1), N-terminal domain
domain: Rna1p (RanGAP1), N-terminal domain
species: Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]

 Score = 38.7 bits (88), Expect = 0.002
 Identities = 8/67 (11%), Positives = 23/67 (34%), Gaps = 8/67 (11%)

Query: 94  LSGLYLHYNSLSGE----IPKEIRNLTELTDLYLDVNNLSGN----IPPEIGSMASLQVL 145
           + G  L  ++++ E    +   +     + ++ L  N +       +   I S   L++ 
Sbjct: 5   IEGKSLKLDAITTEDEKSVFAVLLEDDSVKEIVLSGNTIGTEAARWLSENIASKKDLEIA 64

Query: 146 QLCCNQL 152
           +      
Sbjct: 65  EFSDIFT 71

>d2ca6a1 c.10.1.2 (A:2-345) Rna1p (RanGAP1), N-terminal domain {Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]} Length = 344

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: RNI-like
family: Rna1p (RanGAP1), N-terminal domain
domain: Rna1p (RanGAP1), N-terminal domain
species: Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]

 Score = 37.9 bits (86), Expect = 0.003
 Identities = 11/68 (16%), Positives = 26/68 (38%), Gaps = 5/68 (7%)

Query: 164 KSLSVLTLQHNRLNGGIPDSLGNLGKLKRLDLSFNSL----FGTIPESLANNAELLFLDV 219
           KSL +  +        +   L     +K + LS N++       + E++A+  +L   + 
Sbjct: 8   KSLKLDAITTEDEKS-VFAVLLEDDSVKEIVLSGNTIGTEAARWLSENIASKKDLEIAEF 66

Query: 220 QNNTLSGI 227
            +     +
Sbjct: 67  SDIFTGRV 74

>d2ca6a1 c.10.1.2 (A:2-345) Rna1p (RanGAP1), N-terminal domain {Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]} Length = 344

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: RNI-like
family: Rna1p (RanGAP1), N-terminal domain
domain: Rna1p (RanGAP1), N-terminal domain
species: Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]

 Score = 37.9 bits (86), Expect = 0.004
 Identities = 14/91 (15%), Positives = 28/91 (30%), Gaps = 13/91 (14%)

Query: 98  YLHYNSLSGEIPKEIRN------LTELTDLYLDVNNLSGNIPPEIGS-----MASLQVLQ 146
            L+   LS      + +         L  L L  N +  +    + +     M  L  L+
Sbjct: 249 GLNDCLLSARGAAAVVDAFSKLENIGLQTLRLQYNEIELDAVRTLKTVIDEKMPDLLFLE 308

Query: 147 LCCNQLTGNIPAQIGSLKSLSVLTLQHNRLN 177
           L  N+        +  ++ +   T     L+
Sbjct: 309 LNGNRF-SEEDDVVDEIREV-FSTRGRGELD 337

>d1xwdc1 c.10.2.7 (C:18-259) Follicle-stimulating hormone receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 242

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Ngr ectodomain-like
domain: Follicle-stimulating hormone receptor
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 39.1 bits (89), Expect = 0.001
 Identities = 12/76 (15%), Positives = 22/76 (28%)

Query: 121 LYLDVNNLSGNIPPEIGSMASLQVLQLCCNQLTGNIPAQIGSLKSLSVLTLQHNRLNGGI 180
           L+L+ N +              ++     N L               +L +   R++   
Sbjct: 158 LWLNKNGIQEIHNCAFNGTQLDELNLSDNNNLEELPNDVFHGASGPVILDISRTRIHSLP 217

Query: 181 PDSLGNLGKLKRLDLS 196
              L NL KL+     
Sbjct: 218 SYGLENLKKLRARSTY 233

>d1a9na_ c.10.2.4 (A:) Splicesomal U2A' protein {Human (Homo sapiens) [TaxId: 9606]} Length = 162

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: U2A'-like
domain: Splicesomal U2A' protein
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 37.6 bits (86), Expect = 0.001
 Identities = 14/93 (15%), Positives = 28/93 (30%), Gaps = 3/93 (3%)

Query: 85  SPSLSGLKCLSGLYLHYNSLSGEIPKEIRNLTELTDLYLDVNNLSGNIPPEIGSMASLQV 144
           +   +       L L    +   I      L +   +    N +          +  L+ 
Sbjct: 11  AAQYTNAVRDRELDLRGYKIP-VIENLGATLDQFDAIDFSDNEI--RKLDGFPLLRRLKT 67

Query: 145 LQLCCNQLTGNIPAQIGSLKSLSVLTLQHNRLN 177
           L +  N++         +L  L+ L L +N L 
Sbjct: 68  LLVNNNRICRIGEGLDQALPDLTELILTNNSLV 100

>d1a9na_ c.10.2.4 (A:) Splicesomal U2A' protein {Human (Homo sapiens) [TaxId: 9606]} Length = 162

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: U2A'-like
domain: Splicesomal U2A' protein
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 36.5 bits (83), Expect = 0.004
 Identities = 17/90 (18%), Positives = 31/90 (34%), Gaps = 3/90 (3%)

Query: 111 EIRNLTELTDLYLDVNNLSGNIPPEIGSMASLQVLQLCCNQLTGNIPAQIGSLKSLSVLT 170
           +  N     +L L    +   I     ++     +    N++   +      L+ L  L 
Sbjct: 13  QYTNAVRDRELDLRGYKIP-VIENLGATLDQFDAIDFSDNEIR-KLDGF-PLLRRLKTLL 69

Query: 171 LQHNRLNGGIPDSLGNLGKLKRLDLSFNSL 200
           + +NR+          L  L  L L+ NSL
Sbjct: 70  VNNNRICRIGEGLDQALPDLTELILTNNSL 99

Homologous Domains Detected by HHsearch

Original result of HHsearch against SCOP70(version1.75) database

ID	Length	Definition	Probability
Query	689
d1jpaa_	299	ephb2 receptor tyrosine kinase {Mouse (Mus musculu	100.0
d1uwha_	276	B-Raf kinase {Human (Homo sapiens) [TaxId: 9606]}	100.0
d1opja_	287	Abelsone tyrosine kinase (abl) {Mouse (Mus musculu	100.0
d1sm2a_	263	Tyrosine-protein kinase Itk/Tsk {Human (Homo sapie	100.0
d2java1	269	Serine/threonine-protein kinase Nek2 {Human (Homo	100.0
d1qpca_	272	Lymphocyte kinase (lck) {Human (Homo sapiens) [Tax	100.0
d1yhwa1	293	pak1 {Human (Homo sapiens) [TaxId: 9606]}	100.0
d1s9ja_	322	Dual specificity mitogen-activated protein kinase	100.0
d1nvra_	271	Cell cycle checkpoint kinase chk1 {Human (Homo sap	100.0
d1rjba_	325	Fl cytokine receptor {Human (Homo sapiens) [TaxId:	100.0
d1u59a_	285	Tyrosine-protein kinase ZAP-70 {Human (Homo sapien	100.0
d1k2pa_	258	Bruton's tyrosine kinase (Btk) {Human (Homo sapien	100.0
d2j4za1	263	Aurora-related kinase 1 (aurora-2) {Human (Homo sa	100.0
d1mqba_	283	epha2 receptor tyrosine kinase {Human (Homo sapien	100.0
d1a06a_	307	Calmodulin-dependent protein kinase {Rat (Rattus n	100.0
d1koaa2	350	Twitchin, kinase domain {Caenorhabditis elegans, p	100.0
d2jfla1	288	STE20-like serine/threonine-protein kinase, SLK {H	100.0
d1u5ra_	309	Serine/threonine protein kinase TAO2 {Rat (Rattus	100.0
d1koba_	352	Twitchin, kinase domain {California sea hare (Aply	100.0
d1xkka_	317	EGF receptor tyrosine kinase, Erbb-1 {Human (Homo	100.0
d1fmka3	285	c-src tyrosine kinase {Human (Homo sapiens) [TaxId	100.0
d1t4ha_	270	Protein kinase wnk1 {Human (Homo sapiens) [TaxId:	100.0
d1xbba_	277	Tyrosine-protein kinase SYK {Human (Homo sapiens)	100.0
d1lufa_	301	Musk tyrosine kinase {Rat (Rattus norvegicus) [Tax	100.0
d1o6la_	337	Pkb kinase (Akt-2) {Human (Homo sapiens) [TaxId: 9	100.0
d1uu3a_	288	3-phosphoinositide dependent protein kinase-1 Pdk1	100.0
d1mp8a_	273	Focal adhesion kinase 1 (fak) {Human (Homo sapiens	100.0
d1jksa_	293	Death-associated protein kinase, Dap {Human (Homo	100.0
d1fota_	316	cAMP-dependent PK, catalytic subunit {Baker's yeas	100.0
d1ywna1	299	Vascular endothelial growth factor receptor 2 (kdr	100.0
d1rdqe_	350	cAMP-dependent PK, catalytic subunit {Mouse (Mus m	100.0
d1r0pa_	311	Hepatocyte growth factor receptor, c-MET {Human (H	100.0
d1omwa3	364	G-protein coupled receptor kinase 2 {Cow (Bos taur	100.0
d1fvra_	309	Tie2 kinase {Human (Homo sapiens) [TaxId: 9606]}	100.0
d1byga_	262	Carboxyl-terminal src kinase (csk) {Human (Homo sa	100.0
d1p4oa_	308	Insulin-like growth factor 1 receptor {Human (Homo	100.0
d1tkia_	321	Titin, kinase domain {Human (Homo sapiens) [TaxId:	100.0
d2ozaa1	335	MAP kinase activated protein kinase 2, mapkap2 {Hu	100.0
d1fgka_	299	Fibroblast growth factor receptor 1 {Human (Homo s	100.0
d1t46a_	311	c-KIT receptor {Human (Homo sapiens) [TaxId: 9606]	100.0
d1xjda_	320	Protein kinase C, theta type {Human (Homo sapiens)	100.0
d1phka_	277	gamma-subunit of glycogen phosphorylase kinase (Ph	100.0
d1u46a_	273	Activated CDC42 kinase 1, ACK1 {Human (Homo sapien	100.0
d1o6ya_	277	Mycobacterial protein kinase PknB, catalytic domai	100.0
d1vjya_	303	Type I TGF-beta receptor R4 {Human (Homo sapiens)	100.0
d1ua2a_	299	Cell division protein kinase 7, CDK7 {Human (Homo	100.0
d1gz8a_	298	Cyclin-dependent PK, CDK2 {Human (Homo sapiens) [T	100.0
d1ob3a_	286	Cyclin-dependent PK, CDK2 {(Plasmodium falciparum)	100.0
d1blxa_	305	Cyclin-dependent PK, CDK6 {Human (Homo sapiens) [T	100.0
d1pmea_	345	MAP kinase Erk2 {Human (Homo sapiens) [TaxId: 9606	100.0
d1xwsa_	273	Proto-oncogene serine/threonine-protein kinase Pim	100.0
d3blha1	318	Cell division protein kinase 9, CDK9 {Human (Homo	100.0
d1q5ka_	350	Glycogen synthase kinase-3 beta (Gsk3b) {Human (Ho	100.0
d1cm8a_	346	MAP kinase p38-gamma {Human (Homo sapiens) [TaxId:	100.0
d3bqca1	328	Protein kinase CK2, alpha subunit {Rattus norvegic	100.0
d2b1pa1	355	c-jun N-terminal kinase (jnk3s) {Human (Homo sapie	100.0
d1vzoa_	322	Ribosomal protein S6 kinase alpha 5, Msk1 {Human (	100.0
d1unla_	292	Cyclin-dependent PK, CDK5 {Human (Homo sapiens) [T	100.0
d1ckia_	299	Casein kinase-1, CK1 {Rat (Rattus norvegicus) [Tax	100.0
d2gfsa1	348	MAP kinase p38 {Human (Homo sapiens) [TaxId: 9606]	100.0
d1csna_	293	Casein kinase-1, CK1 {Fission yeast (Schizosacchar	100.0
d1q8ya_	362	Sky1p {Baker's yeast (Saccharomyces cerevisiae) [T	100.0
d1ogqa_	313	Polygalacturonase inhibiting protein PGIP {Kidney	100.0
d1p9ag_	266	von Willebrand factor binding domain of glycoprote	99.97
d1ozna_	284	Reticulon 4 receptor (Nogo-66 receptor, Ngr) {Huma	99.96
d1zara2	191	Rio2 serine protein kinase C-terminal domain {Arch	99.95
d1xkua_	305	Decorin {Cow (Bos taurus) [TaxId: 9913]}	99.94
d1ogqa_	313	Polygalacturonase inhibiting protein PGIP {Kidney	99.94
d1p9ag_	266	von Willebrand factor binding domain of glycoprote	99.93
d1w8aa_	192	Slit {Fruit fly (Drosophila melanogaster) [TaxId:	99.92
d1ozna_	284	Reticulon 4 receptor (Nogo-66 receptor, Ngr) {Huma	99.91
d1w8aa_	192	Slit {Fruit fly (Drosophila melanogaster) [TaxId:	99.89
d1xkua_	305	Decorin {Cow (Bos taurus) [TaxId: 9913]}	99.87
d2omxa2	199	Internalin B {Listeria monocytogenes [TaxId: 1639]	99.85
d2omza2	384	Internalin A {Listeria monocytogenes [TaxId: 1639]	99.84
d2omza2	384	Internalin A {Listeria monocytogenes [TaxId: 1639]	99.83
d1xwdc1	242	Follicle-stimulating hormone receptor {Human (Homo	99.82
d1h6ta2	210	Internalin B {Listeria monocytogenes [TaxId: 1639]	99.82
d1h6ta2	210	Internalin B {Listeria monocytogenes [TaxId: 1639]	99.8
d1h6ua2	227	Internalin H {Listeria monocytogenes [TaxId: 1639]	99.8
d1a9na_	162	Splicesomal U2A' protein {Human (Homo sapiens) [Ta	99.79
d2omxa2	199	Internalin B {Listeria monocytogenes [TaxId: 1639]	99.77
d1dcea3	124	Rab geranylgeranyltransferase alpha-subunit, C-ter	99.75
d1h6ua2	227	Internalin H {Listeria monocytogenes [TaxId: 1639]	99.73
d1a9na_	162	Splicesomal U2A' protein {Human (Homo sapiens) [Ta	99.7
d1xwdc1	242	Follicle-stimulating hormone receptor {Human (Homo	99.7
d1dcea3	124	Rab geranylgeranyltransferase alpha-subunit, C-ter	99.69
d1m9la_	198	Outer arm dynein light chain 1 {Green algae (Chlam	99.68
d1jl5a_	353	Leucine rich effector protein YopM {Yersinia pesti	99.64
d2ifga3	156	High affinity nerve growth factor receptor, N-term	99.63
d2ifga3	156	High affinity nerve growth factor receptor, N-term	99.61
d1m9la_	198	Outer arm dynein light chain 1 {Green algae (Chlam	99.6
d2astb2	284	Cyclin A/CDK2-associated p19, Skp2 {Human (Homo sa	99.49
d1jl5a_	353	Leucine rich effector protein YopM {Yersinia pesti	99.4
d2astb2	284	Cyclin A/CDK2-associated p19, Skp2 {Human (Homo sa	99.36
d2ca6a1	344	Rna1p (RanGAP1), N-terminal domain {Fission yeast	99.32
d2ca6a1	344	Rna1p (RanGAP1), N-terminal domain {Fission yeast	99.28
d1z7xw1	460	Ribonuclease inhibitor {Human (Homo sapiens) [TaxI	99.25
d1j7la_	263	Type IIIa 3',5"-aminoglycoside phosphotransferase	99.11
d1z7xw1	460	Ribonuclease inhibitor {Human (Homo sapiens) [TaxI	99.06
d1koha1	162	mRNA export factor tap {Human (Homo sapiens) [TaxI	98.94
d1koha1	162	mRNA export factor tap {Human (Homo sapiens) [TaxI	98.86
d1nd4a_	255	Aminoglycoside 3'-phosphotransferase IIa (Kanamyci	98.72
d2pula1	392	Methylthioribose kinase MtnK {Bacillus subtilis [T	98.54
d1pgva_	167	Tropomodulin C-terminal domain {nematode (Caenorha	98.35
d1pgva_	167	Tropomodulin C-terminal domain {nematode (Caenorha	98.19
d1nw1a_	395	Choline kinase {Caenorhabditis elegans [TaxId: 623	98.04
d1zyla1	325	RdoA {Escherichia coli [TaxId: 562]}	97.98
d2ppqa1	316	Homoserine kinase ThrB {Agrobacterium tumefaciens	97.77
d1io0a_	166	Tropomodulin C-terminal domain {Chicken (Gallus ga	97.71
d1io0a_	166	Tropomodulin C-terminal domain {Chicken (Gallus ga	97.52

>d1jpaa_ d.144.1.7 (A:) ephb2 receptor tyrosine kinase {Mouse (Mus musculus) [TaxId: 10090]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: ephb2 receptor tyrosine kinase
species: Mouse (Mus musculus) [TaxId: 10090]

Probab=100.00  E-value=0  Score=378.15  Aligned_cols=258  Identities=24%  Similarity=0.476  Sum_probs=212.4

Q ss_pred             CCCCCCCCCCCCCCCEEEEEEEC-CC---CEEEEEEECCCCCCHHHHHHHHHHHHHHCCCCCCCEEEEEEEECCCCCEEE
Q ss_conf             05884542154885209999955-99---399999902468762799999999998514899511486689718998189
Q 005586          409 QCFSEVNLLGKGNFSSVYKGTLR-DG---TLVAIRSINVTSCKSEEAEFVKGLYLLTSLRHENIIRLRGFCCSRGRGECF  484 (689)
Q Consensus       409 ~~f~~~~~lg~G~~g~Vy~~~~~-~g---~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~~~  484 (689)
                      ++|...+.||+|+||.||+|+++ ++   ..||+|.+.........+.|.+|+.++++++|||||+++|++.  ..+..+
T Consensus        26 ~~~~~~~~lG~G~fg~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~g~~~--~~~~~~  103 (299)
T d1jpaa_          26 SCVKIEQVIGAGEFGEVCSGHLKLPGKREIFVAIKTLKSGYTEKQRRDFLSEASIMGQFDHPNVIHLEGVVT--KSTPVM  103 (299)
T ss_dssp             GGEEEEEEEEECSSSEEEEEEECC---CCEEEEEEECCSSCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEEC--SSSSCE
T ss_pred             HHCEEEEEEEECCCEEEEEEEEECCCCEEEEEEEEEECCCCCHHHHHHHHHHHHHHHHCCCCCCCCEEEEEE--ECCEEE
T ss_conf             042785698027882999999957997889999999784459899999999999998579988861899996--288779


Q ss_pred             EEEECCCCCCHHHHHHHCCCCCCCCCHHHHHHHHHHHHHHHHHHHCCCCCCCCEEECCCCCCCEEECCCCCEEEECCCCC
Q ss_conf             99972899998888600179998789999999999999997553079999996362587998665459998078035653
Q 005586          485 LIYDFAPKGKLSKYLDQEEGSSNVLDWSTRVSIIIGIAKGIGYLHSSEVNKPAIVHRNLSVEKVLIDQQFNPLIADCGLH  564 (689)
Q Consensus       485 lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~ia~~ia~gL~~LH~~~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgla  564 (689)
                      +||||+++|+|.+++....+   .++|.+++.|+.|++.||+|||+.+     |+||||||+|||+++++.+||+|||++
T Consensus       104 iv~Ey~~~g~L~~~~~~~~~---~l~~~~~~~i~~qia~gl~yLH~~~-----iiHrDlKp~NILl~~~~~~Kl~DFGla  175 (299)
T d1jpaa_         104 IITEFMENGSLDSFLRQNDG---QFTVIQLVGMLRGIAAGMKYLADMN-----YVHRDLAARNILVNSNLVCKVSDFGLS  175 (299)
T ss_dssp             EEEECCTTEEHHHHHHTTTT---CSCHHHHHHHHHHHHHHHHHHHHTT-----CCCSCCCGGGEEECTTCCEEECCC---
T ss_pred             EEEEECCCCCCEEEECCCCC---CCCHHHHHHHHHHHHHHHHHHHHCC-----CCCCCCCCCEEEECCCCCEEECCCCCC
T ss_conf             99972279853002104567---9999999999999999889885279-----835761504489889991998884431


Q ss_pred             CCCCCCCEE----EEECCCCCCCCCCCCCCCCCCCCCCCCCHHHHHHHHHHHH-CCCCCCHHHHHHHHHHHHHHHHCCCC
Q ss_conf             345687113----4514788878888102235888986640208899999991-99885214778874222567640014
Q 005586          565 KLLADDIVF----SVLKTSAAMGYLAPEYVTTGRFTERSDIFAFGVIILQILT-GSLVLTSSMRLAAESATFENFIDRNL  639 (689)
Q Consensus       565 ~~~~~~~~~----~~~~~~~t~~y~aPE~~~~~~~~~~sDv~S~Gvil~ellt-G~~p~~~~~~~~~~~~~~~~~~~~~~  639 (689)
                      +.+......    ......+++.|+|||++.++.++.++|||||||++|||+| |+.||.+.....     ....+....
T Consensus       176 ~~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~sDvwS~Gvvl~el~t~g~~Pf~~~~~~~-----~~~~i~~~~  250 (299)
T d1jpaa_         176 RFLEDDTSDPTYTSALGGKIPIRWTAPEAIQYRKFTSASDVWSYGIVMWEVMSYGERPYWDMTNQD-----VINAIEQDY  250 (299)
T ss_dssp             --------------------CGGGSCHHHHHSCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCHHH-----HHHHHHTTC
T ss_pred             EECCCCCCCCEEEECCCCCCCCCCCCHHHHHCCCCCCCCCCCCCHHHHHHHHHCCCCCCCCCCHHH-----HHHHHHCCC
T ss_conf             575677776536502566688300387888369978612144535789999867999999999999-----999997378


Q ss_pred             CCCCCHHHHHHHHHHHHHHCCCCCCCCCCHHHHHHHHHHHCC
Q ss_conf             899998999999999998111799999999999999986087
Q 005586          640 KGKFSESEAAKLGKMALVCTHEDPENRPTMEAVIEELTVAAP  681 (689)
Q Consensus       640 ~~~~~~~~~~~~~~l~~~Cl~~dP~~RPs~~evl~~L~~~~~  681 (689)
                      ....+...+..+.+++.+||+.||.+||+|.++++.|+.+..
T Consensus       251 ~~~~~~~~~~~l~~li~~cl~~~P~~RPs~~ei~~~L~~~l~  292 (299)
T d1jpaa_         251 RLPPPMDCPSALHQLMLDCWQKDRNHRPKFGQIVNTLDKMIR  292 (299)
T ss_dssp             CCCCCTTCCHHHHHHHHHHTCSSTTTSCCHHHHHHHHHHHHH
T ss_pred             CCCCCCCCHHHHHHHHHHHCCCCHHHCCCHHHHHHHHHHHHC
T ss_conf             899974226999999999758797689299999999999841

>d1uwha_ d.144.1.7 (A:) B-Raf kinase {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: B-Raf kinase
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=0  Score=382.69  Aligned_cols=263  Identities=20%  Similarity=0.347  Sum_probs=209.6

Q ss_pred             HCCCCCCCCCCCCCCCEEEEEEECCCCEEEEEEECCCCC-CHHHHHHHHHHHHHHCCCCCCCEEEEEEEECCCCCEEEEE
Q ss_conf             305884542154885209999955993999999024687-6279999999999851489951148668971899818999
Q 005586          408 TQCFSEVNLLGKGNFSSVYKGTLRDGTLVAIRSINVTSC-KSEEAEFVKGLYLLTSLRHENIIRLRGFCCSRGRGECFLI  486 (689)
Q Consensus       408 ~~~f~~~~~lg~G~~g~Vy~~~~~~g~~vaiK~~~~~~~-~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~~~lv  486 (689)
                      .++|...+.||+|+||.||+|+++  ..||||+++.... ......|.+|+.++.+++|||||+++|++.+   ...++|
T Consensus         7 ~~~~~~~~~lG~G~fg~Vy~~~~~--~~vAvK~~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~~~~~~~~---~~~~lv   81 (276)
T d1uwha_           7 DGQITVGQRIGSGSFGTVYKGKWH--GDVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFMGYSTA---PQLAIV   81 (276)
T ss_dssp             TTCCCCCSEEEECSSCEEEEEESS--SEEEEEECCCSSCCTTHHHHHHHHHHHHTTCCCTTBCCEEEEECS---SSCEEE
T ss_pred             CCCEEEEEEEEECCCCEEEEEEEC--CEEEEEEEECCCCCHHHHHHHHHHHHHHHHCCCCCEEEEEEEEEC---CEEEEE
T ss_conf             451899889830788589999999--989999997346998999999999999984799878645679715---589999


Q ss_pred             EECCCCCCHHHHHHHCCCCCCCCCHHHHHHHHHHHHHHHHHHHCCCCCCCCEEECCCCCCCEEECCCCCEEEECCCCCCC
Q ss_conf             97289999888860017999878999999999999999755307999999636258799866545999807803565334
Q 005586          487 YDFAPKGKLSKYLDQEEGSSNVLDWSTRVSIIIGIAKGIGYLHSSEVNKPAIVHRNLSVEKVLIDQQFNPLIADCGLHKL  566 (689)
Q Consensus       487 ~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~ia~~ia~gL~~LH~~~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgla~~  566 (689)
                      |||+++|+|.+++.....   .+++..+..|+.|++.||+|||+.+     |+||||||+|||+++++.+||+|||+|+.
T Consensus        82 ~Ey~~~g~L~~~l~~~~~---~~~~~~~~~i~~qi~~gl~yLH~~~-----ivHrDlKp~NiLl~~~~~~Kl~DFGla~~  153 (276)
T d1uwha_          82 TQWCEGSSLYHHLHIIET---KFEMIKLIDIARQTAQGMDYLHAKS-----IIHRDLKSNNIFLHEDLTVKIGDFGLATV  153 (276)
T ss_dssp             EECCCEEEHHHHHHTSCC---CCCHHHHHHHHHHHHHHHHHHHHTT-----CCCSCCCGGGEEEETTSSEEECCCCCSCC
T ss_pred             EECCCCCCHHHHHHHCCC---CCCHHHHHHHHHHHHHHHHHHHCCC-----EECCCCCHHHEEECCCCCEEECCCCCEEE
T ss_conf             965899888999852357---8999999999999999988875099-----95161478997981899788750022133


Q ss_pred             CCCCCE-EEEECCCCCCCCCCCCCCCC---CCCCCCCCCHHHHHHHHHHHHCCCCCCHHHHHHHHHHHHHHHHCCCCCCC
Q ss_conf             568711-34514788878888102235---88898664020889999999199885214778874222567640014899
Q 005586          567 LADDIV-FSVLKTSAAMGYLAPEYVTT---GRFTERSDIFAFGVIILQILTGSLVLTSSMRLAAESATFENFIDRNLKGK  642 (689)
Q Consensus       567 ~~~~~~-~~~~~~~~t~~y~aPE~~~~---~~~~~~sDv~S~Gvil~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~  642 (689)
                      ...... .......||+.|+|||++.+   ..++.++|||||||++|||+||+.||.+................+.....
T Consensus       154 ~~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~~~~sDiwS~Gv~l~el~tg~~Pf~~~~~~~~~~~~~~~~~~~p~~~~  233 (276)
T d1uwha_         154 KSRWSGSHQFEQLSGSILWMAPEVIRMQDKNPYSFQSDVYAFGIVLYELMTGQLPYSNINNRDQIIFMVGRGYLSPDLSK  233 (276)
T ss_dssp             ------------CCCCGGGCCHHHHTTCSSCCCCHHHHHHHHHHHHHHHHHSSCTTTTCCCHHHHHHHHHHTSCCCCGGG
T ss_pred             CCCCCCCCCCCCCCCCCCCCCHHHHHCCCCCCCCCHHHHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHHCCCCCCCCHH
T ss_conf             35567763125665574317999995056899995315163599999999788998998969999999965888986000


Q ss_pred             CCHHHHHHHHHHHHHHCCCCCCCCCCHHHHHHHHHHHCCCC
Q ss_conf             99899999999999811179999999999999998608754
Q 005586          643 FSESEAAKLGKMALVCTHEDPENRPTMEAVIEELTVAAPVM  683 (689)
Q Consensus       643 ~~~~~~~~~~~l~~~Cl~~dP~~RPs~~evl~~L~~~~~~~  683 (689)
                      .+...++.+.+++.+||+.||.+||||.+++++|+.++...
T Consensus       234 ~~~~~~~~l~~li~~cl~~dp~~RPt~~~il~~Le~l~~~~  274 (276)
T d1uwha_         234 VRSNCPKAMKRLMAECLKKKRDERPLFPQILASIELLARSL  274 (276)
T ss_dssp             SCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHTC
T ss_pred             CCCCCHHHHHHHHHHHCCCCHHHCCCHHHHHHHHHHHHHCC
T ss_conf             36555499999999975889768929999999999999709

>d1opja_ d.144.1.7 (A:) Abelsone tyrosine kinase (abl) {Mouse (Mus musculus) [TaxId: 10090]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Abelsone tyrosine kinase (abl)
species: Mouse (Mus musculus) [TaxId: 10090]

Probab=100.00  E-value=0  Score=380.70  Aligned_cols=259  Identities=21%  Similarity=0.424  Sum_probs=217.7

Q ss_pred             HCCCCCCCCCCCCCCCEEEEEEEC-CCCEEEEEEECCCCCCHHHHHHHHHHHHHHCCCCCCCEEEEEEEECCCCCEEEEE
Q ss_conf             305884542154885209999955-9939999990246876279999999999851489951148668971899818999
Q 005586          408 TQCFSEVNLLGKGNFSSVYKGTLR-DGTLVAIRSINVTSCKSEEAEFVKGLYLLTSLRHENIIRLRGFCCSRGRGECFLI  486 (689)
Q Consensus       408 ~~~f~~~~~lg~G~~g~Vy~~~~~-~g~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~~~lv  486 (689)
                      .++|...+.||+|+||.||+|+++ +++.||+|+++...  ...++|.+|+.++++++|||||+++|++.  +.+..++|
T Consensus        16 ~~~~~~~~~iG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~--~~~~~~~~E~~il~~l~HpnIv~~~~~~~--~~~~~~iv   91 (287)
T d1opja_          16 RTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDT--MEVEEFLKEAAVMKEIKHPNLVQLLGVCT--REPPFYII   91 (287)
T ss_dssp             GGGEEEEEETTTTTTSSEEEEEEGGGTEEEEEEECCTTC--SCHHHHHHHHHHHHHCCCTTBCCEEEEEC--SSSSCEEE
T ss_pred             HHHEEEEEEEEECCCEEEEEEEECCCCEEEEEEEECCCC--CHHHHHHHHHHHHHHCCCCCEECCCCCEE--ECCEEEEE
T ss_conf             799398659820888089999999999699999977761--03999999999998679998826775274--57854787


Q ss_pred             EECCCCCCHHHHHHHCCCCCCCCCHHHHHHHHHHHHHHHHHHHCCCCCCCCEEECCCCCCCEEECCCCCEEEECCCCCCC
Q ss_conf             97289999888860017999878999999999999999755307999999636258799866545999807803565334
Q 005586          487 YDFAPKGKLSKYLDQEEGSSNVLDWSTRVSIIIGIAKGIGYLHSSEVNKPAIVHRNLSVEKVLIDQQFNPLIADCGLHKL  566 (689)
Q Consensus       487 ~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~ia~~ia~gL~~LH~~~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgla~~  566 (689)
                      |||+++|+|.+++.....  ..+++..+..|+.|++.||+|||+.+     |+||||||+|||+++++.+||+|||+++.
T Consensus        92 ~E~~~~g~l~~~l~~~~~--~~~~~~~~~~i~~qi~~gL~yLH~~~-----iiHrDlKp~NILl~~~~~~Kl~DFG~a~~  164 (287)
T d1opja_          92 TEFMTYGNLLDYLRECNR--QEVSAVVLLYMATQISSAMEYLEKKN-----FIHRDLAARNCLVGENHLVKVADFGLSRL  164 (287)
T ss_dssp             EECCTTCBHHHHHHHSCT--TTSCHHHHHHHHHHHHHHHHHHHHTT-----CCCSCCSGGGEEECGGGCEEECCCCCTTT
T ss_pred             EECCCCCCHHHHHHHCCC--CCHHHHHHHHHHHHHHHHHHHHHHCC-----CCCCCCCCCEEEECCCCCEEECCCCCEEE
T ss_conf             631467606777530355--41579999999999999788898789-----30576045768998999289832445465


Q ss_pred             CCCCCEEEEECCCCCCCCCCCCCCCCCCCCCCCCCHHHHHHHHHHHHCCCCCCHHHHHHHHHHHHHHHHCCCCCCCCCHH
Q ss_conf             56871134514788878888102235888986640208899999991998852147788742225676400148999989
Q 005586          567 LADDIVFSVLKTSAAMGYLAPEYVTTGRFTERSDIFAFGVIILQILTGSLVLTSSMRLAAESATFENFIDRNLKGKFSES  646 (689)
Q Consensus       567 ~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~sDv~S~Gvil~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  646 (689)
                      ...+.........++..|+|||++.+..++.++|||||||++|||++|+.|+.......    ...+.+........+..
T Consensus       165 ~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~k~DiwS~Gv~l~ell~~~~p~~~~~~~~----~~~~~i~~~~~~~~~~~  240 (287)
T d1opja_         165 MTGDTYTAHAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGIDLS----QVYELLEKDYRMERPEG  240 (287)
T ss_dssp             CCSSSSEEETTEEECGGGCCHHHHHHCCCSHHHHHHHHHHHHHHHHTTSCCSSTTCCHH----HHHHHHHTTCCCCCCTT
T ss_pred             CCCCCCEEECCCCCCCCCCCHHHHCCCCCCCHHHHHHHHHHHHHHHHCCCCCCCCCHHH----HHHHHHHCCCCCCCCCC
T ss_conf             37887221035566546669278727999810430217899999986799887742599----99999855888888743


Q ss_pred             HHHHHHHHHHHHCCCCCCCCCCHHHHHHHHHHHCC
Q ss_conf             99999999998111799999999999999986087
Q 005586          647 EAAKLGKMALVCTHEDPENRPTMEAVIEELTVAAP  681 (689)
Q Consensus       647 ~~~~~~~l~~~Cl~~dP~~RPs~~evl~~L~~~~~  681 (689)
                      .+..+.+++..||+.||++|||+.++++.|+....
T Consensus       241 ~~~~l~~li~~cl~~dP~~Rps~~ei~~~L~~~~~  275 (287)
T d1opja_         241 CPEKVYELMRACWQWNPSDRPSFAEIHQAFETMFQ  275 (287)
T ss_dssp             CCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHTTS
T ss_pred             CHHHHHHHHHHHCCCCHHHCCCHHHHHHHHHHHHH
T ss_conf             30999999999757797689399999999999987

>d1sm2a_ d.144.1.7 (A:) Tyrosine-protein kinase Itk/Tsk {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Tyrosine-protein kinase Itk/Tsk
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=0  Score=377.59  Aligned_cols=255  Identities=22%  Similarity=0.433  Sum_probs=212.0

Q ss_pred             CCCCCCCCCCCCCCCEEEEEEECCCCEEEEEEECCCCCCHHHHHHHHHHHHHHCCCCCCCEEEEEEEECCCCCEEEEEEE
Q ss_conf             05884542154885209999955993999999024687627999999999985148995114866897189981899997
Q 005586          409 QCFSEVNLLGKGNFSSVYKGTLRDGTLVAIRSINVTSCKSEEAEFVKGLYLLTSLRHENIIRLRGFCCSRGRGECFLIYD  488 (689)
Q Consensus       409 ~~f~~~~~lg~G~~g~Vy~~~~~~g~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~~~lv~e  488 (689)
                      ++|+..+.||+|+||.||+|++++++.||||+++...  ....+|.+|++.+.+++||||++++|+|..  .+..++|||
T Consensus         5 ~~~~~~~~iG~G~fg~Vy~~~~~~~~~vAvK~i~~~~--~~~~~~~~E~~~l~~l~HpnIv~~~g~~~~--~~~~~lv~E   80 (263)
T d1sm2a_           5 SELTFVQEIGSGQFGLVHLGYWLNKDKVAIKTIREGA--MSEEDFIEEAEVMMKLSHPKLVQLYGVCLE--QAPICLVFE   80 (263)
T ss_dssp             SCEEEEEEEECCSSCCEEEEEETTTEEEEEEECCSSS--SCHHHHHHHHHHHHHCCCTTBCCEEEEECS--SSSCEEEEE
T ss_pred             HHCEEEEEEEECCCEEEEEEEECCCCEEEEEEECCCC--CCHHHHHHHHHHHHHCCCCCCCCCCCEECC--CCCEEEEEE
T ss_conf             9958888982088829999998899999999987886--768999999999996689975653524315--993379998


Q ss_pred             CCCCCCHHHHHHHCCCCCCCCCHHHHHHHHHHHHHHHHHHHCCCCCCCCEEECCCCCCCEEECCCCCEEEECCCCCCCCC
Q ss_conf             28999988886001799987899999999999999975530799999963625879986654599980780356533456
Q 005586          489 FAPKGKLSKYLDQEEGSSNVLDWSTRVSIIIGIAKGIGYLHSSEVNKPAIVHRNLSVEKVLIDQQFNPLIADCGLHKLLA  568 (689)
Q Consensus       489 ~~~~gsL~~~l~~~~~~~~~l~~~~~~~ia~~ia~gL~~LH~~~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgla~~~~  568 (689)
                      |+++|+|.+++....   ..+++..+..|+.|++.||+|||+.+     |+||||||+|||+++++.+||+|||+++...
T Consensus        81 ~~~~g~L~~~l~~~~---~~~~~~~~~~i~~qia~gl~~lH~~~-----iiHrDlKp~Nill~~~~~~Kl~DFGla~~~~  152 (263)
T d1sm2a_          81 FMEHGCLSDYLRTQR---GLFAAETLLGMCLDVCEGMAYLEEAC-----VIHRDLAARNCLVGENQVIKVSDFGMTRFVL  152 (263)
T ss_dssp             CCTTCBHHHHHHTTT---TCCCHHHHHHHHHHHHHHHHHHHHTT-----CCCTTCSGGGEEECGGGCEEECSCC------
T ss_pred             ECCCCCHHHHHHCCC---CCCCHHHHHHHHHHHHHHHHHHHCCC-----EEECCCCHHHEEECCCCCEEECCCCHHEECC
T ss_conf             369991899752013---47889999999999999877653164-----3104431532666688776865532100236


Q ss_pred             CCCEEEEECCCCCCCCCCCCCCCCCCCCCCCCCHHHHHHHHHHHHCC-CCCCHHHHHHHHHHHHHHHHCCCCCCCCCHHH
Q ss_conf             87113451478887888810223588898664020889999999199-88521477887422256764001489999899
Q 005586          569 DDIVFSVLKTSAAMGYLAPEYVTTGRFTERSDIFAFGVIILQILTGS-LVLTSSMRLAAESATFENFIDRNLKGKFSESE  647 (689)
Q Consensus       569 ~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~sDv~S~Gvil~elltG~-~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  647 (689)
                      ...........++..|+|||++.+..++.++|||||||++|||+|+. +|+.......     +.+.+........+..+
T Consensus       153 ~~~~~~~~~~~gt~~y~aPE~l~~~~~~~k~DVwS~Gvil~el~t~~~~~~~~~~~~~-----~~~~i~~~~~~~~p~~~  227 (263)
T d1sm2a_         153 DDQYTSSTGTKFPVKWASPEVFSFSRYSSKSDVWSFGVLMWEVFSEGKIPYENRSNSE-----VVEDISTGFRLYKPRLA  227 (263)
T ss_dssp             ------------CTTSCCHHHHTTCCCCHHHHHHHHHHHHHHHHTTSCCTTCSCCHHH-----HHHHHHHTCCCCCCTTS
T ss_pred             CCCCEEECCEECCCCCCCHHHHCCCCCCCHHHHCCHHHHHHHHHHCCCCCCCCCCHHH-----HHHHHHHCCCCCCCCCC
T ss_conf             8873350430017666785786079998403321059999999878988877899999-----99999806888995436


Q ss_pred             HHHHHHHHHHHCCCCCCCCCCHHHHHHHHHHHC
Q ss_conf             999999999811179999999999999998608
Q 005586          648 AAKLGKMALVCTHEDPENRPTMEAVIEELTVAA  680 (689)
Q Consensus       648 ~~~~~~l~~~Cl~~dP~~RPs~~evl~~L~~~~  680 (689)
                      +.++.+++..||+.||++||+|++++++|+.++
T Consensus       228 ~~~l~~li~~cl~~~p~~Rps~~~il~~L~~i~  260 (263)
T d1sm2a_         228 STHVYQIMNHCWKERPEDRPAFSRLLRQLAEIA  260 (263)
T ss_dssp             CHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHH
T ss_pred             CHHHHHHHHHHCCCCHHHCCCHHHHHHHHHHHH
T ss_conf             799999999976579768919999999999998

>d2java1 d.144.1.7 (A:3-271) Serine/threonine-protein kinase Nek2 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Serine/threonine-protein kinase Nek2
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=0  Score=381.76  Aligned_cols=263  Identities=17%  Similarity=0.310  Sum_probs=216.9

Q ss_pred             CCCCCCCCCCCCCCCEEEEEEEC-CCCEEEEEEECCCCC-CHHHHHHHHHHHHHHCCCCCCCEEEEEEEECCCCCEEEEE
Q ss_conf             05884542154885209999955-993999999024687-6279999999999851489951148668971899818999
Q 005586          409 QCFSEVNLLGKGNFSSVYKGTLR-DGTLVAIRSINVTSC-KSEEAEFVKGLYLLTSLRHENIIRLRGFCCSRGRGECFLI  486 (689)
Q Consensus       409 ~~f~~~~~lg~G~~g~Vy~~~~~-~g~~vaiK~~~~~~~-~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~~~lv  486 (689)
                      ++|+..+.||+|+||.||+|+.+ +|+.||+|++..... +...+.+.+|++++.+++||||+++++++.++.....++|
T Consensus         4 edy~~~~~iG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~~~iv   83 (269)
T d2java1           4 EDYEVLYTIGTGSYGRCQKIRRKSDGKILVWKELDYGSMTEAEKQMLVSEVNLLRELKHPNIVRYYDRIIDRTNTTLYIV   83 (269)
T ss_dssp             GGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECCTTSCHHHHHHHHHHHHHTTSCCCTTBCCEEEEEEC----CEEEE
T ss_pred             HHCEEEEEEECCCCEEEEEEEECCCCCEEEEEEECHHHCCHHHHHHHHHHHHHHHHCCCCCEEEEEEEEEECCCCEEEEE
T ss_conf             33799679830889199999999999799999987465797999999999999997789998248999991789989999


Q ss_pred             EECCCCCCHHHHHHHCCCCCCCCCHHHHHHHHHHHHHHHHHHHCCCCCCCCEEECCCCCCCEEECCCCCEEEECCCCCCC
Q ss_conf             97289999888860017999878999999999999999755307999999636258799866545999807803565334
Q 005586          487 YDFAPKGKLSKYLDQEEGSSNVLDWSTRVSIIIGIAKGIGYLHSSEVNKPAIVHRNLSVEKVLIDQQFNPLIADCGLHKL  566 (689)
Q Consensus       487 ~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~ia~~ia~gL~~LH~~~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgla~~  566 (689)
                      |||+++|+|.+++.........+++..++.++.|++.||+|||+.+....+|+||||||+|||+++++.+||+|||+++.
T Consensus        84 mEy~~~g~L~~~i~~~~~~~~~l~e~~~~~i~~qi~~al~ylH~~~~~~~~IiHrDiKp~NIll~~~~~vkl~DFG~a~~  163 (269)
T d2java1          84 MEYCEGGDLASVITKGTKERQYLDEEFVLRVMTQLTLALKECHRRSDGGHTVLHRDLKPANVFLDGKQNVKLGDFGLARI  163 (269)
T ss_dssp             EECCTTEEHHHHHHHHHHHTCCCCHHHHHHHHHHHHHHHHHHHHHCC---------CCGGGEEECTTSCEEECCHHHHHH
T ss_pred             EECCCCCCHHHHHHHCCCCCCCCCHHHHHHHHHHHHHHHHHHHHHCCCCCCEEECCCCHHHCCCCCCCCEEEEECCCEEE
T ss_conf             95689993899998515457899999999999999999999997167788788586765425747888579800100032


Q ss_pred             CCCCCEEEEECCCCCCCCCCCCCCCCCCCCCCCCCHHHHHHHHHHHHCCCCCCHHHHHHHHHHHHHHHHCCCCCCCCCHH
Q ss_conf             56871134514788878888102235888986640208899999991998852147788742225676400148999989
Q 005586          567 LADDIVFSVLKTSAAMGYLAPEYVTTGRFTERSDIFAFGVIILQILTGSLVLTSSMRLAAESATFENFIDRNLKGKFSES  646 (689)
Q Consensus       567 ~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~sDv~S~Gvil~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  646 (689)
                      +..+.. ......||+.|+|||++.+..++.++|||||||++|||+||+.||.........    ..+.... ....+..
T Consensus       164 ~~~~~~-~~~~~~gt~~Y~APE~l~~~~~~~~~DIwSlGvilyel~tg~~Pf~~~~~~~~~----~~i~~~~-~~~~~~~  237 (269)
T d2java1         164 LNHDTS-FAKAFVGTPYYMSPEQMNRMSYNEKSDIWSLGCLLYELCALMPPFTAFSQKELA----GKIREGK-FRRIPYR  237 (269)
T ss_dssp             C------------CCCSCCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCSCCCSSHHHHH----HHHHHTC-CCCCCTT
T ss_pred             CCCCCC-CCCCCCCCCCCCCHHHHCCCCCCHHHHHHHHCHHHHHHHHCCCCCCCCCHHHHH----HHHHCCC-CCCCCCC
T ss_conf             245777-556677882327999983999993898875278999980188998998999999----9997189-9889743


Q ss_pred             HHHHHHHHHHHHCCCCCCCCCCHHHHHHHHH
Q ss_conf             9999999999811179999999999999998
Q 005586          647 EAAKLGKMALVCTHEDPENRPTMEAVIEELT  677 (689)
Q Consensus       647 ~~~~~~~l~~~Cl~~dP~~RPs~~evl~~L~  677 (689)
                      .++++.+++.+||+.||.+||++.|+++|.|
T Consensus       238 ~s~~l~~li~~~L~~dp~~Rps~~ell~hp~  268 (269)
T d2java1         238 YSDELNEIITRMLNLKDYHRPSVEEILENPL  268 (269)
T ss_dssp             SCHHHHHHHHHHTCSSGGGSCCHHHHHTSTT
T ss_pred             CCHHHHHHHHHHCCCCHHHCCCHHHHHHCCC
T ss_conf             5999999999976799557918999972981

>d1qpca_ d.144.1.7 (A:) Lymphocyte kinase (lck) {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Lymphocyte kinase (lck)
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=0  Score=379.54  Aligned_cols=255  Identities=24%  Similarity=0.438  Sum_probs=211.5

Q ss_pred             HCCCCCCCCCCCCCCCEEEEEEECCCCEEEEEEECCCCCCHHHHHHHHHHHHHHCCCCCCCEEEEEEEECCCCCEEEEEE
Q ss_conf             30588454215488520999995599399999902468762799999999998514899511486689718998189999
Q 005586          408 TQCFSEVNLLGKGNFSSVYKGTLRDGTLVAIRSINVTSCKSEEAEFVKGLYLLTSLRHENIIRLRGFCCSRGRGECFLIY  487 (689)
Q Consensus       408 ~~~f~~~~~lg~G~~g~Vy~~~~~~g~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~~~lv~  487 (689)
                      .++|+..+.||+|+||.||+|++++++.||||+++...  ...+.|.+|+.++.+++|||||+++|++.+   +..++||
T Consensus        12 ~~~~~~~~~iG~G~fg~Vy~~~~~~~~~vAvK~~~~~~--~~~~~~~~E~~~l~~l~HpnIv~~~g~~~~---~~~~iv~   86 (272)
T d1qpca_          12 RETLKLVERLGAGQFGEVWMGYYNGHTKVAVKSLKQGS--MSPDAFLAEANLMKQLQHQRLVRLYAVVTQ---EPIYIIT   86 (272)
T ss_dssp             GGGEEEEEEEEEETTEEEEEEEETTTEEEEEEEECTTS--SCHHHHHHHHHHHHHCCCTTBCCEEEEECS---SSCEEEE
T ss_pred             HHHEEEEEEEECCCCCEEEEEEECCCCEEEEEEECCCC--CCHHHHHHHHHHHHHCCCCCEEEEEEEECC---CCEEEEE
T ss_conf             89938867981079828999999999999999986476--888999999999986799988578731045---9769999


Q ss_pred             ECCCCCCHHHHHHHCCCCCCCCCHHHHHHHHHHHHHHHHHHHCCCCCCCCEEECCCCCCCEEECCCCCEEEECCCCCCCC
Q ss_conf             72899998888600179998789999999999999997553079999996362587998665459998078035653345
Q 005586          488 DFAPKGKLSKYLDQEEGSSNVLDWSTRVSIIIGIAKGIGYLHSSEVNKPAIVHRNLSVEKVLIDQQFNPLIADCGLHKLL  567 (689)
Q Consensus       488 e~~~~gsL~~~l~~~~~~~~~l~~~~~~~ia~~ia~gL~~LH~~~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgla~~~  567 (689)
                      ||+++|+|.+++.....  ..+++..++.|+.|++.||+|||+.+     |+||||||+|||+++++.+||+|||+|+.+
T Consensus        87 Ey~~~g~L~~~~~~~~~--~~l~~~~~~~i~~qi~~gl~~lH~~~-----ivHrDiKp~NIll~~~~~~Kl~DFGla~~~  159 (272)
T d1qpca_          87 EYMENGSLVDFLKTPSG--IKLTINKLLDMAAQIAEGMAFIEERN-----YIHRDLRAANILVSDTLSCKIADFGLARLI  159 (272)
T ss_dssp             ECCTTCBHHHHTTSHHH--HTCCHHHHHHHHHHHHHHHHHHHHTT-----EECSCCSGGGEEECTTSCEEECCCTTCEEC
T ss_pred             EECCCCCHHHHHHHCCC--CCCCHHHHHHHHHHHHHHHHHHHHCC-----CCCCCCCHHHEEEECCCCEEECCCCCEEEC
T ss_conf             95789828888751478--98878899999999999999997489-----546756422515620244042341014773


Q ss_pred             CCCCEEEEECCCCCCCCCCCCCCCCCCCCCCCCCHHHHHHHHHHHHCCCCCCHHHHHHHHHHHHHHHHCCCCCCCCCHHH
Q ss_conf             68711345147888788881022358889866402088999999919988521477887422256764001489999899
Q 005586          568 ADDIVFSVLKTSAAMGYLAPEYVTTGRFTERSDIFAFGVIILQILTGSLVLTSSMRLAAESATFENFIDRNLKGKFSESE  647 (689)
Q Consensus       568 ~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~sDv~S~Gvil~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  647 (689)
                      ............+++.|+|||++.++.++.++|||||||++|||+||..|+........    ....+........+...
T Consensus       160 ~~~~~~~~~~~~gt~~y~APE~~~~~~~~~~sDvwS~Gvvl~ellt~~~~~~~~~~~~~----~~~~i~~~~~~~~p~~~  235 (272)
T d1qpca_         160 EDNEYTAREGAKFPIKWTAPEAINYGTFTIKSDVWSFGILLTEIVTHGRIPYPGMTNPE----VIQNLERGYRMVRPDNC  235 (272)
T ss_dssp             SSSCEECCTTCCCCTTTSCHHHHHHCEECHHHHHHHHHHHHHHHHTTTCCSSTTCCHHH----HHHHHHTTCCCCCCTTC
T ss_pred             CCCCCCCCCCCCCCCCCCCHHHHHCCCCCCHHHHHHHHHHHHHHHHCCCCCCCCCCHHH----HHHHHHHCCCCCCCCCC
T ss_conf             58864420356774444582898379998245645257999999968988888889999----99999706888896557


Q ss_pred             HHHHHHHHHHHCCCCCCCCCCHHHHHHHHHH
Q ss_conf             9999999998111799999999999999986
Q 005586          648 AAKLGKMALVCTHEDPENRPTMEAVIEELTV  678 (689)
Q Consensus       648 ~~~~~~l~~~Cl~~dP~~RPs~~evl~~L~~  678 (689)
                      +.++.+++.+||+.||++||||.+|++.|+.
T Consensus       236 ~~~l~~li~~cl~~~P~~Rpt~~ei~~~L~~  266 (272)
T d1qpca_         236 PEELYQLMRLCWKERPEDRPTFDYLRSVLED  266 (272)
T ss_dssp             CHHHHHHHHHHTCSSGGGSCCHHHHHHHHHH
T ss_pred             HHHHHHHHHHHCCCCHHHCCCHHHHHHHHHH
T ss_conf             1999999999758897689399999998611

>d1yhwa1 d.144.1.7 (A:249-541) pak1 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: pak1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=0  Score=370.98  Aligned_cols=254  Identities=16%  Similarity=0.304  Sum_probs=212.1

Q ss_pred             CCCCCCCCCCCCCCCEEEEEEEC-CCCEEEEEEECCCCCCHHHHHHHHHHHHHHCCCCCCCEEEEEEEECCCCCEEEEEE
Q ss_conf             05884542154885209999955-99399999902468762799999999998514899511486689718998189999
Q 005586          409 QCFSEVNLLGKGNFSSVYKGTLR-DGTLVAIRSINVTSCKSEEAEFVKGLYLLTSLRHENIIRLRGFCCSRGRGECFLIY  487 (689)
Q Consensus       409 ~~f~~~~~lg~G~~g~Vy~~~~~-~g~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~~~lv~  487 (689)
                      ++|+..+.||+|+||.||+|+.+ +|+.||+|++..... ...+.+.+|+.++++++||||+++++++.+  .+..++||
T Consensus        20 ~~Y~~~~~iG~G~fg~Vy~a~~~~~~~~vAvK~~~~~~~-~~~~~~~~E~~il~~l~HpnIv~~~~~~~~--~~~~~ivm   96 (293)
T d1yhwa1          20 KKYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQ-PKKELIINEILVMRENKNPNIVNYLDSYLV--GDELWVVM   96 (293)
T ss_dssp             TTBCSCEECCCSSSCEEEEEEBTTTCCEEEEEEEEGGGC-SCHHHHHHHHHHHHHCCCTTBCCEEEEEEE--TTEEEEEE
T ss_pred             CCCEEEEEEECCCCCEEEEEEECCCCCEEEEEEEECCCC-HHHHHHHHHHHHHHHCCCCCEEEEEEEEEE--CCEEEEEE
T ss_conf             053887898128582999999989998999999843017-279999999999986799988058577988--99989999


Q ss_pred             ECCCCCCHHHHHHHCCCCCCCCCHHHHHHHHHHHHHHHHHHHCCCCCCCCEEECCCCCCCEEECCCCCEEEECCCCCCCC
Q ss_conf             72899998888600179998789999999999999997553079999996362587998665459998078035653345
Q 005586          488 DFAPKGKLSKYLDQEEGSSNVLDWSTRVSIIIGIAKGIGYLHSSEVNKPAIVHRNLSVEKVLIDQQFNPLIADCGLHKLL  567 (689)
Q Consensus       488 e~~~~gsL~~~l~~~~~~~~~l~~~~~~~ia~~ia~gL~~LH~~~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgla~~~  567 (689)
                      ||+++|+|.+++...     .+++..+..++.|++.||+|||+.+     |+||||||+|||++.++.+||+|||+++.+
T Consensus        97 Ey~~gg~L~~~~~~~-----~l~~~~~~~i~~qi~~aL~yLH~~~-----iiHrDiKp~NILl~~~~~vkl~DFG~a~~~  166 (293)
T d1yhwa1          97 EYLAGGSLTDVVTET-----CMDEGQIAAVCRECLQALEFLHSNQ-----VIHRDIKSDNILLGMDGSVKLTDFGFCAQI  166 (293)
T ss_dssp             ECCTTCBHHHHHHHS-----CCCHHHHHHHHHHHHHHHHHHHHTT-----EECCCCSGGGEEECTTCCEEECCCTTCEEC
T ss_pred             EECCCCCHHHHHHCC-----CCCHHHHHHHHHHHHHHHHHHHHCC-----CCCCCCCHHHEEECCCCCEEECCCHHHEEE
T ss_conf             703798089886415-----9999999999999999999999879-----722677688868878996864251564132


Q ss_pred             CCCCEEEEECCCCCCCCCCCCCCCCCCCCCCCCCHHHHHHHHHHHHCCCCCCHHHHHHHHHHHHHHHHCCCCCCCCCHHH
Q ss_conf             68711345147888788881022358889866402088999999919988521477887422256764001489999899
Q 005586          568 ADDIVFSVLKTSAAMGYLAPEYVTTGRFTERSDIFAFGVIILQILTGSLVLTSSMRLAAESATFENFIDRNLKGKFSESE  647 (689)
Q Consensus       568 ~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~sDv~S~Gvil~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  647 (689)
                      ..... ......||+.|+|||++.+..++.++||||+||++|||+||+.||..............   ........+...
T Consensus       167 ~~~~~-~~~~~~gt~~Y~aPE~~~~~~~~~~~DiwSlGvilyemltG~~Pf~~~~~~~~~~~~~~---~~~~~~~~~~~~  242 (293)
T d1yhwa1         167 TPEQS-KRSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMIEGEPPYLNENPLRALYLIAT---NGTPELQNPEKL  242 (293)
T ss_dssp             CSTTC-CBCCCCSCGGGCCHHHHSSSCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHHHH---HCSCCCSSGGGS
T ss_pred             CCCCC-CCCCCCCCCCCCCHHHHCCCCCCCHHCEEHHHHHHHHHHHCCCCCCCCCHHHHHHHHHH---CCCCCCCCCCCC
T ss_conf             13666-44444447773682664479988012031372999998048899899799999999985---799988885537


Q ss_pred             HHHHHHHHHHHCCCCCCCCCCHHHHHHHHHHH
Q ss_conf             99999999981117999999999999999860
Q 005586          648 AAKLGKMALVCTHEDPENRPTMEAVIEELTVA  679 (689)
Q Consensus       648 ~~~~~~l~~~Cl~~dP~~RPs~~evl~~L~~~  679 (689)
                      +..+.+++.+||+.||.+||++.|+++|.|.-
T Consensus       243 s~~~~~li~~~L~~dP~~R~s~~eil~Hp~~~  274 (293)
T d1yhwa1         243 SAIFRDFLNRCLDMDVEKRGSAKELLQHQFLK  274 (293)
T ss_dssp             CHHHHHHHHHHTCSSTTTSCCHHHHTTCGGGG
T ss_pred             CHHHHHHHHHHCCCCHHHCCCHHHHHCCHHHC
T ss_conf             99999999998669966890999996499657

>d1s9ja_ d.144.1.7 (A:) Dual specificity mitogen-activated protein kinase kinase 1, Mek1 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Dual specificity mitogen-activated protein kinase kinase 1, Mek1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=0  Score=374.32  Aligned_cols=259  Identities=19%  Similarity=0.326  Sum_probs=209.7

Q ss_pred             HCCCCCCCCCCCCCCCEEEEEEEC-CCCEEEEEEECCCCCCHHHHHHHHHHHHHHCCCCCCCEEEEEEEECCCCCEEEEE
Q ss_conf             305884542154885209999955-9939999990246876279999999999851489951148668971899818999
Q 005586          408 TQCFSEVNLLGKGNFSSVYKGTLR-DGTLVAIRSINVTSCKSEEAEFVKGLYLLTSLRHENIIRLRGFCCSRGRGECFLI  486 (689)
Q Consensus       408 ~~~f~~~~~lg~G~~g~Vy~~~~~-~g~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~~~lv  486 (689)
                      .++|+..+.||+|+||.||+|+.+ +|+.||+|+++..........+.+|+.++++++|||||++++++.+  ....++|
T Consensus         5 ~d~y~~~~~iG~G~fg~V~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~--~~~~~iV   82 (322)
T d1s9ja_           5 DDDFEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLEIKPAIRNQIIRELQVLHECNSPYIVGFYGAFYS--DGEISIC   82 (322)
T ss_dssp             GGGEEEEEEEECCSSCCEEEEEETTTTEEEEEEEEECCCCTTHHHHHHHHGGGGGGCCCTTBCCEEEEEEC--SSEEEEE
T ss_pred             CCCCEEEEEEECCCCEEEEEEEECCCCCEEEEEEECHHHCHHHHHHHHHHHHHHHHCCCCCCCCEEEEEEE--CCEEEEE
T ss_conf             56888978971277809999999899969999998754097899999999999986799999949999998--9999999


Q ss_pred             EECCCCCCHHHHHHHCCCCCCCCCHHHHHHHHHHHHHHHHHHHCC-CCCCCCEEECCCCCCCEEECCCCCEEEECCCCCC
Q ss_conf             972899998888600179998789999999999999997553079-9999963625879986654599980780356533
Q 005586          487 YDFAPKGKLSKYLDQEEGSSNVLDWSTRVSIIIGIAKGIGYLHSS-EVNKPAIVHRNLSVEKVLIDQQFNPLIADCGLHK  565 (689)
Q Consensus       487 ~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~ia~~ia~gL~~LH~~-~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgla~  565 (689)
                      |||+++|+|.+++.....    +++..+..++.|++.||.|||+. +     |+||||||+|||+++++.+||+|||+|+
T Consensus        83 mEy~~gg~L~~~l~~~~~----l~~~~~~~~~~qil~aL~yLH~~~~-----IiHRDiKP~NILl~~~~~vkl~DFGla~  153 (322)
T d1s9ja_          83 MEHMDGGSLDQVLKKAGR----IPEQILGKVSIAVIKGLTYLREKHK-----IMHRDVKPSNILVNSRGEIKLCDFGVSG  153 (322)
T ss_dssp             EECCTTEEHHHHHHHHSS----CCHHHHHHHHHHHHHHHHHHHHHHC-----CCCSCCSGGGEEECTTCCEEECCCCCCH
T ss_pred             EECCCCCCHHHHHHHCCC----CCHHHHHHHHHHHHHHHHHHHHHCC-----EECCCCCHHHEEECCCCCEEEEECCCCC
T ss_conf             976799868998742499----9999999999999999999998599-----9714457799468789989995487762


Q ss_pred             CCCCCCEEEEECCCCCCCCCCCCCCCCCCCCCCCCCHHHHHHHHHHHHCCCCCCHHHHHHHHHH---H------------
Q ss_conf             4568711345147888788881022358889866402088999999919988521477887422---2------------
Q 005586          566 LLADDIVFSVLKTSAAMGYLAPEYVTTGRFTERSDIFAFGVIILQILTGSLVLTSSMRLAAESA---T------------  630 (689)
Q Consensus       566 ~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~sDv~S~Gvil~elltG~~p~~~~~~~~~~~~---~------------  630 (689)
                      ...+...   ....||..|+|||++.+..|+.++||||+||++|||++|+.||...........   .            
T Consensus       154 ~~~~~~~---~~~~GT~~Y~APEvl~~~~y~~~~DiWSlGvil~ell~G~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~  230 (322)
T d1s9ja_         154 QLIDSMA---NSFVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVEMAVGRYPIPPPDAKELELMFGCQVEGDAAETPPRP  230 (322)
T ss_dssp             HHHHHTC------CCSSCCCCHHHHHCSCCCTTHHHHHHHHHHHHHHHSSCCSSCCCTTHHHHHC---------------
T ss_pred             CCCCCCC---CCCCCCCCCCCCHHHCCCCCCCHHHHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHHHHCCCCCCCCCCC
T ss_conf             5678862---1113771411946875899894888998999999999888998998878999999887517754577421


Q ss_pred             -------------------HHHHHCC---CCCCCC-CHHHHHHHHHHHHHHCCCCCCCCCCHHHHHHHHHHHC
Q ss_conf             -------------------5676400---148999-9899999999999811179999999999999998608
Q 005586          631 -------------------FENFIDR---NLKGKF-SESEAAKLGKMALVCTHEDPENRPTMEAVIEELTVAA  680 (689)
Q Consensus       631 -------------------~~~~~~~---~~~~~~-~~~~~~~~~~l~~~Cl~~dP~~RPs~~evl~~L~~~~  680 (689)
                                         ..+..+.   ...... ....+.++.+++.+||+.||.+|||+.|+++|.+...
T Consensus       231 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~~L~~dP~~R~ta~e~L~Hpf~~~  303 (322)
T d1s9ja_         231 RTPGRPLSSYGMDSRPPMAIFELLDYIVNEPPPKLPSGVFSLEFQDFVNKCLIKNPAERADLKQLMVHAFIKR  303 (322)
T ss_dssp             ---------------CCCCHHHHHHHHHTSCCCCCCBTTBCHHHHHHHHHHTCSSTTTSCCHHHHHTSHHHHH
T ss_pred             CCCCCCCCCCCCCCCCCHHHHHHHHHHHCCCCCCCCCCCCCHHHHHHHHHHCCCCHHHCCCHHHHHHCHHHCC
T ss_conf             2333221111222354134778876650268766764448999999999986899467908999960986476

>d1nvra_ d.144.1.7 (A:) Cell cycle checkpoint kinase chk1 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cell cycle checkpoint kinase chk1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=0  Score=375.50  Aligned_cols=260  Identities=19%  Similarity=0.320  Sum_probs=213.2

Q ss_pred             CCCCCCCCCCCCCCCEEEEEEEC-CCCEEEEEEECCCCCCHHHHHHHHHHHHHHCCCCCCCEEEEEEEECCCCCEEEEEE
Q ss_conf             05884542154885209999955-99399999902468762799999999998514899511486689718998189999
Q 005586          409 QCFSEVNLLGKGNFSSVYKGTLR-DGTLVAIRSINVTSCKSEEAEFVKGLYLLTSLRHENIIRLRGFCCSRGRGECFLIY  487 (689)
Q Consensus       409 ~~f~~~~~lg~G~~g~Vy~~~~~-~g~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~~~lv~  487 (689)
                      ++|+..+.||+|+||.||+|+.+ +|+.||+|++.........+.+.+|+.++++++||||+++++++.+  .+..++||
T Consensus         5 ~dy~~~~~lG~G~fg~V~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~Ei~~l~~l~HpnIv~~~~~~~~--~~~~~ivm   82 (271)
T d1nvra_           5 EDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYGHRRE--GNIQYLFL   82 (271)
T ss_dssp             TEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECC-------CHHHHHHHHHTCCCTTBCCEEEEEEE--TTEEEEEE
T ss_pred             CCEEEEEEEECCCCEEEEEEEECCCCCEEEEEEEEHHHCCHHHHHHHHHHHHHHHCCCCCEEEEEEEECC--CCEEEEEE
T ss_conf             4608998972174809999999999979999998456641279999999999985799888469654046--74367988


Q ss_pred             ECCCCCCHHHHHHHCCCCCCCCCHHHHHHHHHHHHHHHHHHHCCCCCCCCEEECCCCCCCEEECCCCCEEEECCCCCCCC
Q ss_conf             72899998888600179998789999999999999997553079999996362587998665459998078035653345
Q 005586          488 DFAPKGKLSKYLDQEEGSSNVLDWSTRVSIIIGIAKGIGYLHSSEVNKPAIVHRNLSVEKVLIDQQFNPLIADCGLHKLL  567 (689)
Q Consensus       488 e~~~~gsL~~~l~~~~~~~~~l~~~~~~~ia~~ia~gL~~LH~~~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgla~~~  567 (689)
                      ||+++|+|.+++....    .+++.++..++.|++.||+|||+.+     |+||||||+|||+++++.+||+|||+|+..
T Consensus        83 Ey~~gg~L~~~l~~~~----~l~e~~~~~i~~qi~~al~ylH~~~-----IiHrDiKp~NILl~~~~~~KL~DFG~a~~~  153 (271)
T d1nvra_          83 EYCSGGELFDRIEPDI----GMPEPDAQRFFHQLMAGVVYLHGIG-----ITHRDIKPENLLLDERDNLKISDFGLATVF  153 (271)
T ss_dssp             ECCTTEEGGGGSBTTT----BCCHHHHHHHHHHHHHHHHHHHHTT-----EECSCCCGGGEEECTTCCEEECCCTTCEEC
T ss_pred             ECCCCCCHHHHHHCCC----CCCHHHHHHHHHHHHHHHHHHHHCC-----CCCCCCCHHHEEECCCCCEEECCCHHHEEE
T ss_conf             6458980899975379----9999999999999999999999759-----835754689978878998798323142240


Q ss_pred             CCCCE-EEEECCCCCCCCCCCCCCCCCCC-CCCCCCHHHHHHHHHHHHCCCCCCHHHHHHHHHHHHHHHHCCCCCCCCCH
Q ss_conf             68711-34514788878888102235888-98664020889999999199885214778874222567640014899998
Q 005586          568 ADDIV-FSVLKTSAAMGYLAPEYVTTGRF-TERSDIFAFGVIILQILTGSLVLTSSMRLAAESATFENFIDRNLKGKFSE  645 (689)
Q Consensus       568 ~~~~~-~~~~~~~~t~~y~aPE~~~~~~~-~~~sDv~S~Gvil~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~  645 (689)
                      ..... .......||+.|+|||++.+..+ +.++||||+||++|||+||+.||.........   ...............
T Consensus       154 ~~~~~~~~~~~~~GT~~Y~APE~~~~~~~~~~~~DiwSlGvilyeml~G~~pf~~~~~~~~~---~~~~~~~~~~~~~~~  230 (271)
T d1nvra_         154 RYNNRERLLNKMCGTLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQE---YSDWKEKKTYLNPWK  230 (271)
T ss_dssp             EETTEECCBCCCCSCGGGSCTHHHHCSSBCHHHHHHHHHHHHHHHHHHSSCSCSSSSTTSHH---HHHHHTTCTTSTTGG
T ss_pred             CCCCCCCCCCCEEECCCCCCHHHHCCCCCCCCCEEEEHHHHHHHHHHHCCCCCCCCCHHHHH---HHHHHCCCCCCCCCC
T ss_conf             46886531113255747428728618999997101617379999998299788889859999---999863888788644


Q ss_pred             HHHHHHHHHHHHHCCCCCCCCCCHHHHHHHHHHHCCC
Q ss_conf             9999999999981117999999999999999860875
Q 005586          646 SEAAKLGKMALVCTHEDPENRPTMEAVIEELTVAAPV  682 (689)
Q Consensus       646 ~~~~~~~~l~~~Cl~~dP~~RPs~~evl~~L~~~~~~  682 (689)
                      ..+.++.+++.+||+.||++|||+.|+++|.|.-.+.
T Consensus       231 ~~s~~~~~li~~~L~~dP~~R~t~~eil~hpwf~~~l  267 (271)
T d1nvra_         231 KIDSAPLALLHKILVENPSARITIPDIKKDRWYNKPL  267 (271)
T ss_dssp             GSCHHHHHHHHHHSCSSTTTSCCHHHHTTCTTTTCCC
T ss_pred             CCCHHHHHHHHHHCCCCHHHCCCHHHHHCCHHHCCCC
T ss_conf             6999999999997679966890999996198458598

>d1rjba_ d.144.1.7 (A:) Fl cytokine receptor {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Fl cytokine receptor
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=0  Score=371.57  Aligned_cols=260  Identities=25%  Similarity=0.402  Sum_probs=213.7

Q ss_pred             HCCCCCCCCCCCCCCCEEEEEEECC------CCEEEEEEECCCCCCHHHHHHHHHHHHHHCC-CCCCCEEEEEEEECCCC
Q ss_conf             3058845421548852099999559------9399999902468762799999999998514-89951148668971899
Q 005586          408 TQCFSEVNLLGKGNFSSVYKGTLRD------GTLVAIRSINVTSCKSEEAEFVKGLYLLTSL-RHENIIRLRGFCCSRGR  480 (689)
Q Consensus       408 ~~~f~~~~~lg~G~~g~Vy~~~~~~------g~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l-~h~niv~l~~~~~~~~~  480 (689)
                      .++|...+.||+|+||.||+|+++.      ...||+|.+...........+.+|+.++.++ +|||||++++++  .+.
T Consensus        36 ~~~~~l~~~lG~G~fG~Vy~a~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~HpnIv~l~~~~--~~~  113 (325)
T d1rjba_          36 RENLEFGKVLGSGAFGKVMNATAYGISKTGVSIQVAVKMLKEKADSSEREALMSELKMMTQLGSHENIVNLLGAC--TLS  113 (325)
T ss_dssp             GGGEEEEEEEEECSSEEEEEEEEESCSSSSCEEEEEEEEECC------CHHHHHHHHHHHHHCCCTTBCCEEEEE--CSS
T ss_pred             HHHEEEEEEEEECCCEEEEEEEECCCCCCCCEEEEEEEEECCCCCHHHHHHHHHHHHHHHHHCCCCCEEEEEEEE--EEC
T ss_conf             899397019830788199999985788554204999999663358789999999999999715899686877888--629


Q ss_pred             CEEEEEEECCCCCCHHHHHHHCCCC-------------------CCCCCHHHHHHHHHHHHHHHHHHHCCCCCCCCEEEC
Q ss_conf             8189999728999988886001799-------------------987899999999999999975530799999963625
Q 005586          481 GECFLIYDFAPKGKLSKYLDQEEGS-------------------SNVLDWSTRVSIIIGIAKGIGYLHSSEVNKPAIVHR  541 (689)
Q Consensus       481 ~~~~lv~e~~~~gsL~~~l~~~~~~-------------------~~~l~~~~~~~ia~~ia~gL~~LH~~~~~~~~ivH~  541 (689)
                      +..++||||+++|+|.++++.....                   ...+++..++.|+.|++.||+|||+.+     |+||
T Consensus       114 ~~~~lv~Ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~gl~yLH~~~-----IiHR  188 (325)
T d1rjba_         114 GPIYLIFEYCCYGDLLNYLRSKREKFSEDEIEYENQKRLEEEEDLNVLTFEDLLCFAYQVAKGMEFLEFKS-----CVHR  188 (325)
T ss_dssp             SSCEEEEECCTTCBHHHHHHTTTTCC---------------------CCHHHHHHHHHHHHHHHHHHHHTT-----EEET
T ss_pred             CEEEEEEECCCCCCHHHHHHHCCCCCCCHHHHHCCCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHHCC-----EEEC
T ss_conf             95899997279995999998625777510221000012220012577899999999999999999997399-----0505


Q ss_pred             CCCCCCEEECCCCCEEEECCCCCCCCCCCCEE-EEECCCCCCCCCCCCCCCCCCCCCCCCCHHHHHHHHHHHH-CCCCCC
Q ss_conf             87998665459998078035653345687113-4514788878888102235888986640208899999991-998852
Q 005586          542 NLSVEKVLIDQQFNPLIADCGLHKLLADDIVF-SVLKTSAAMGYLAPEYVTTGRFTERSDIFAFGVIILQILT-GSLVLT  619 (689)
Q Consensus       542 dlk~~Nill~~~~~~kl~Dfgla~~~~~~~~~-~~~~~~~t~~y~aPE~~~~~~~~~~sDv~S~Gvil~ellt-G~~p~~  619 (689)
                      ||||+|||++.++.+||+|||+|+........ ......+|+.|+|||++.++.++.++|||||||++|||+| |+.||.
T Consensus       189 DlKp~Nill~~~~~~Kl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~DiwS~Gvil~emlt~g~~Pf~  268 (325)
T d1rjba_         189 DLAARNVLVTHGKVVKICDFGLARDIMSDSNYVVRGNARLPVKWMAPESLFEGIYTIKSDVWSYGILLWEIFSLGVNPYP  268 (325)
T ss_dssp             TCSGGGEEEETTTEEEECCCGGGSCGGGCTTSEEETTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHTTTSCCSST
T ss_pred             CCCHHCCCCCCCCEEEEEECCCCCCCCCCCCEEEECCCCCCCCCCCHHHHCCCCCCCCEECCCHHHHHHHHHHCCCCCCC
T ss_conf             27032144345982898514222204577861562343578765783887279999633030003999999838999999


Q ss_pred             HHHHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHHHHHHCCCCCCCCCCHHHHHHHHHH
Q ss_conf             14778874222567640014899998999999999998111799999999999999986
Q 005586          620 SSMRLAAESATFENFIDRNLKGKFSESEAAKLGKMALVCTHEDPENRPTMEAVIEELTV  678 (689)
Q Consensus       620 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~Cl~~dP~~RPs~~evl~~L~~  678 (689)
                      +....    ..+.+++........+...++++.+++.+||+.||++|||+.||+++|..
T Consensus       269 ~~~~~----~~~~~~~~~~~~~~~p~~~~~~l~~li~~cl~~dP~~RPt~~ei~~~L~~  323 (325)
T d1rjba_         269 GIPVD----ANFYKLIQNGFKMDQPFYATEEIYIIMQSCWAFDSRKRPSFPNLTSFLGC  323 (325)
T ss_dssp             TCCCS----HHHHHHHHTTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHH
T ss_pred             CCCHH----HHHHHHHHCCCCCCCCCCCCHHHHHHHHHHCCCCHHHCCCHHHHHHHHHC
T ss_conf             98989----99999985699899887678999999999758896689399999999748

>d1u59a_ d.144.1.7 (A:) Tyrosine-protein kinase ZAP-70 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Tyrosine-protein kinase ZAP-70
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=0  Score=369.31  Aligned_cols=255  Identities=24%  Similarity=0.393  Sum_probs=209.5

Q ss_pred             CCCCCCC-CCCCCCCCEEEEEEEC---CCCEEEEEEECCCCCCHHHHHHHHHHHHHHCCCCCCCEEEEEEEECCCCCEEE
Q ss_conf             0588454-2154885209999955---99399999902468762799999999998514899511486689718998189
Q 005586          409 QCFSEVN-LLGKGNFSSVYKGTLR---DGTLVAIRSINVTSCKSEEAEFVKGLYLLTSLRHENIIRLRGFCCSRGRGECF  484 (689)
Q Consensus       409 ~~f~~~~-~lg~G~~g~Vy~~~~~---~g~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~~~  484 (689)
                      ++|...+ .||+|+||.||+|.++   ++..||||+++.........+|.+|++++.+++|||||+++|++..   +..+
T Consensus         8 ~~~~~~~~~iG~G~fg~Vy~~~~~~~~~~~~vAvK~l~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~g~~~~---~~~~   84 (285)
T d1u59a_           8 DNLLIADIELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKADTEEMMREAQIMHQLDNPYIVRLIGVCQA---EALM   84 (285)
T ss_dssp             GGEEEEEEEEECCTTEEEEEEEEC---CCEEEEEEEECSSCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEES---SSEE
T ss_pred             CCEEECCCEEECCCCEEEEEEEEECCCCCEEEEEEEECHHCCHHHHHHHHHHHHHHHHCCCCCEEEEEEEECC---CEEE
T ss_conf             4718878487306080999999960897689999998820397899999999999986799888068656036---8079


Q ss_pred             EEEECCCCCCHHHHHHHCCCCCCCCCHHHHHHHHHHHHHHHHHHHCCCCCCCCEEECCCCCCCEEECCCCCEEEECCCCC
Q ss_conf             99972899998888600179998789999999999999997553079999996362587998665459998078035653
Q 005586          485 LIYDFAPKGKLSKYLDQEEGSSNVLDWSTRVSIIIGIAKGIGYLHSSEVNKPAIVHRNLSVEKVLIDQQFNPLIADCGLH  564 (689)
Q Consensus       485 lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~ia~~ia~gL~~LH~~~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgla  564 (689)
                      +||||+++|+|.+++....   ..+++..+..|+.|++.||+|||+.+     |+||||||+|||++.++.+||+|||++
T Consensus        85 lvmE~~~~g~L~~~l~~~~---~~l~~~~~~~i~~qi~~gL~ylH~~~-----iiHrDlKp~Nill~~~~~~Kl~DFGla  156 (285)
T d1u59a_          85 LVMEMAGGGPLHKFLVGKR---EEIPVSNVAELLHQVSMGMKYLEEKN-----FVHRDLAARNVLLVNRHYAKISDFGLS  156 (285)
T ss_dssp             EEEECCTTEEHHHHHTTCT---TTSCHHHHHHHHHHHHHHHHHHHHTT-----EECCCCSGGGEEEEETTEEEECCCTTC
T ss_pred             EEEEECCCCCHHHHHHCCC---CCCCHHHHHHHHHHHHHHHHHHHHCC-----EECCCCCHHHEEECCCCCEEECCCHHH
T ss_conf             9998078996899752125---69999999999999999878998688-----105767646604546885420331342


Q ss_pred             CCCCCCCEEE--EECCCCCCCCCCCCCCCCCCCCCCCCCHHHHHHHHHHHH-CCCCCCHHHHHHHHHHHHHHHHCCCCCC
Q ss_conf             3456871134--514788878888102235888986640208899999991-9988521477887422256764001489
Q 005586          565 KLLADDIVFS--VLKTSAAMGYLAPEYVTTGRFTERSDIFAFGVIILQILT-GSLVLTSSMRLAAESATFENFIDRNLKG  641 (689)
Q Consensus       565 ~~~~~~~~~~--~~~~~~t~~y~aPE~~~~~~~~~~sDv~S~Gvil~ellt-G~~p~~~~~~~~~~~~~~~~~~~~~~~~  641 (689)
                      +.+.......  .....+++.|+|||++.++.++.++|||||||++|||+| |+.||.......     +...+......
T Consensus       157 ~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDVwS~Gv~l~E~lt~G~~Pf~~~~~~~-----~~~~i~~~~~~  231 (285)
T d1u59a_         157 KALGADDSYYTARSAGKWPLKWYAPECINFRKFSSRSDVWSYGVTMWEALSYGQKPYKKMKGPE-----VMAFIEQGKRM  231 (285)
T ss_dssp             EECTTCSCEECCCCSSCCCGGGCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCTTTTCCTHH-----HHHHHHTTCCC
T ss_pred             HCCCCCCCCCCCCCCCCCCCCCCCHHHHHCCCCCCCCHHHCCHHHHHHHHHCCCCCCCCCCHHH-----HHHHHHCCCCC
T ss_conf             1155434321135621137433586887279999541232201789999938999999979999-----99999818999


Q ss_pred             CCCHHHHHHHHHHHHHHCCCCCCCCCCHHHHHHHHHHH
Q ss_conf             99989999999999981117999999999999999860
Q 005586          642 KFSESEAAKLGKMALVCTHEDPENRPTMEAVIEELTVA  679 (689)
Q Consensus       642 ~~~~~~~~~~~~l~~~Cl~~dP~~RPs~~evl~~L~~~  679 (689)
                      ..+...+.++.+++..||+.+|++||+|.++++.|+..
T Consensus       232 ~~p~~~~~~l~~li~~cl~~~p~~RPs~~~i~~~L~~~  269 (285)
T d1u59a_         232 ECPPECPPELYALMSDCWIYKWEDRPDFLTVEQRMRAC  269 (285)
T ss_dssp             CCCTTCCHHHHHHHHHTTCSSGGGSCCHHHHHHHHHHH
T ss_pred             CCCCCCCHHHHHHHHHHCCCCHHHCCCHHHHHHHHHHH
T ss_conf             99976789999999997577976890999999999999

>d1k2pa_ d.144.1.7 (A:) Bruton's tyrosine kinase (Btk) {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Bruton's tyrosine kinase (Btk)
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=0  Score=367.69  Aligned_cols=254  Identities=24%  Similarity=0.432  Sum_probs=215.5

Q ss_pred             CCCCCCCCCCCCCCCEEEEEEECCCCEEEEEEECCCCCCHHHHHHHHHHHHHHCCCCCCCEEEEEEEECCCCCEEEEEEE
Q ss_conf             05884542154885209999955993999999024687627999999999985148995114866897189981899997
Q 005586          409 QCFSEVNLLGKGNFSSVYKGTLRDGTLVAIRSINVTSCKSEEAEFVKGLYLLTSLRHENIIRLRGFCCSRGRGECFLIYD  488 (689)
Q Consensus       409 ~~f~~~~~lg~G~~g~Vy~~~~~~g~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~~~lv~e  488 (689)
                      ++|+..+.||+|+||.||+|++++++.||||+++....  ...+|.+|+..+.+++||||++++|+|.  +.+..++|||
T Consensus         4 ~~~~~~~~iG~G~fg~Vy~~~~~~~~~vAvK~l~~~~~--~~~~~~~Ev~~~~~l~HpnIv~~~g~~~--~~~~~~iv~E   79 (258)
T d1k2pa_           4 KDLTFLKELGTGQFGVVKYGKWRGQYDVAIKMIKEGSM--SEDEFIEEAKVMMNLSHEKLVQLYGVCT--KQRPIFIITE   79 (258)
T ss_dssp             CCCCCCCCCCEETTEEEEEEEETTTEEEEEEEEESSSS--CHHHHHHHHHHHHTCCCTTBCCEEEEEC--CSSSEEEEEE
T ss_pred             HHCEEEEEEECCCCEEEEEEEECCCCEEEEEEECCCCC--CHHHHHHHHHHHHHCCCCCEEEEEEEEE--ECCCEEEEEE
T ss_conf             99799689820788399999988998999999874757--7899999999999668986015889985--0781699997


Q ss_pred             CCCCCCHHHHHHHCCCCCCCCCHHHHHHHHHHHHHHHHHHHCCCCCCCCEEECCCCCCCEEECCCCCEEEECCCCCCCCC
Q ss_conf             28999988886001799987899999999999999975530799999963625879986654599980780356533456
Q 005586          489 FAPKGKLSKYLDQEEGSSNVLDWSTRVSIIIGIAKGIGYLHSSEVNKPAIVHRNLSVEKVLIDQQFNPLIADCGLHKLLA  568 (689)
Q Consensus       489 ~~~~gsL~~~l~~~~~~~~~l~~~~~~~ia~~ia~gL~~LH~~~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgla~~~~  568 (689)
                      |+++|+|.+++.....   .+++..+.+++.|+++||+|||+.+     |+||||||+|||+++++.+||+|||+++...
T Consensus        80 y~~~g~l~~~~~~~~~---~~~~~~~~~i~~qi~~gl~~LH~~~-----iiH~dlk~~Nill~~~~~~kl~DfG~a~~~~  151 (258)
T d1k2pa_          80 YMANGCLLNYLREMRH---RFQTQQLLEMCKDVCEAMEYLESKQ-----FLHRDLAARNCLVNDQGVVKVSDFGLSRYVL  151 (258)
T ss_dssp             CCTTEEHHHHHHSGGG---CCCHHHHHHHHHHHHHHHHHHHHTT-----BCCSCCSGGGEEECTTCCEEECCCSSCCBCS
T ss_pred             CCCCCCHHHHHHCCCC---CCCHHHHHHHHHHHHHHHHHHHHCC-----CCCCCCCCEEEEECCCCCEEECCCHHHEECC
T ss_conf             0489938886410246---7768999999999999999875468-----4346654135887699847988614420235


Q ss_pred             CCCEEEEECCCCCCCCCCCCCCCCCCCCCCCCCHHHHHHHHHHHH-CCCCCCHHHHHHHHHHHHHHHHCCCCCCCCCHHH
Q ss_conf             871134514788878888102235888986640208899999991-9988521477887422256764001489999899
Q 005586          569 DDIVFSVLKTSAAMGYLAPEYVTTGRFTERSDIFAFGVIILQILT-GSLVLTSSMRLAAESATFENFIDRNLKGKFSESE  647 (689)
Q Consensus       569 ~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~sDv~S~Gvil~ellt-G~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  647 (689)
                      ...........++..|+|||.+.+..++.++||||||+++|||+| |+.||.........     ..+........+...
T Consensus       152 ~~~~~~~~~~~~t~~y~aPE~~~~~~~~~ksDiwS~G~~l~el~t~g~~Pf~~~~~~~~~-----~~i~~~~~~~~p~~~  226 (258)
T d1k2pa_         152 DDEYTSSVGSKFPVRWSPPEVLMYSKFSSKSDIWAFGVLMWEIYSLGKMPYERFTNSETA-----EHIAQGLRLYRPHLA  226 (258)
T ss_dssp             SSSCCCCCCSCCCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTSCHHHHH-----HHHHTTCCCCCCTTC
T ss_pred             CCCCEEECCCCCCCCCCCCHHHCCCCCCCCEEECCCCHHHHHHHHCCCCCCCCCCHHHHH-----HHHHHCCCCCCCCCC
T ss_conf             787225246578877578078637998852103364324673975599998899999999-----999807978996546


Q ss_pred             HHHHHHHHHHHCCCCCCCCCCHHHHHHHHHHH
Q ss_conf             99999999981117999999999999999860
Q 005586          648 AAKLGKMALVCTHEDPENRPTMEAVIEELTVA  679 (689)
Q Consensus       648 ~~~~~~l~~~Cl~~dP~~RPs~~evl~~L~~~  679 (689)
                      +.++.+++.+||+.||.+|||+.+++++|..+
T Consensus       227 ~~~l~~li~~cl~~dP~~RPt~~eil~~L~di  258 (258)
T d1k2pa_         227 SEKVYTIMYSCWHEKADERPTFKILLSNILDV  258 (258)
T ss_dssp             CHHHHHHHHHTTCSSGGGSCCHHHHHHHHHCC
T ss_pred             CHHHHHHHHHHCCCCHHHCCCHHHHHHHHHCC
T ss_conf             59999999997668976893999999874188

>d2j4za1 d.144.1.7 (A:126-388) Aurora-related kinase 1 (aurora-2) {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Aurora-related kinase 1 (aurora-2)
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=0  Score=368.58  Aligned_cols=251  Identities=22%  Similarity=0.372  Sum_probs=211.9

Q ss_pred             CCCCCCCCCCCCCCCEEEEEEEC-CCCEEEEEEECCCCC--CHHHHHHHHHHHHHHCCCCCCCEEEEEEEECCCCCEEEE
Q ss_conf             05884542154885209999955-993999999024687--627999999999985148995114866897189981899
Q 005586          409 QCFSEVNLLGKGNFSSVYKGTLR-DGTLVAIRSINVTSC--KSEEAEFVKGLYLLTSLRHENIIRLRGFCCSRGRGECFL  485 (689)
Q Consensus       409 ~~f~~~~~lg~G~~g~Vy~~~~~-~g~~vaiK~~~~~~~--~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~~~l  485 (689)
                      ++|+..+.||+|+||.||+|+.+ +++.||+|++.+...  ......+.+|+.++++++||||+++++++.  +.+..++
T Consensus         6 ~dy~i~~~iG~G~fg~Vy~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~--~~~~~~i   83 (263)
T d2j4za1           6 EDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRLYGYFH--DATRVYL   83 (263)
T ss_dssp             GGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHTCCCTTBCCEEEEEE--CSSEEEE
T ss_pred             HHEEEEEEEECCCCCEEEEEEECCCCCEEEEEEECHHHCCCHHHHHHHHHHHHHHHHCCCCCCCEEEEEEE--ECCEEEE
T ss_conf             37699889851778589999998999499999981688567689999999999998568888885999999--8999899


Q ss_pred             EEECCCCCCHHHHHHHCCCCCCCCCHHHHHHHHHHHHHHHHHHHCCCCCCCCEEECCCCCCCEEECCCCCEEEECCCCCC
Q ss_conf             99728999988886001799987899999999999999975530799999963625879986654599980780356533
Q 005586          486 IYDFAPKGKLSKYLDQEEGSSNVLDWSTRVSIIIGIAKGIGYLHSSEVNKPAIVHRNLSVEKVLIDQQFNPLIADCGLHK  565 (689)
Q Consensus       486 v~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~ia~~ia~gL~~LH~~~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgla~  565 (689)
                      ||||+++|+|.+++.....    +++..+..++.|++.||+|||+.+     |+||||||+|||+++++.+||+|||+++
T Consensus        84 vmEy~~~g~L~~~l~~~~~----l~e~~~~~i~~qi~~al~~lH~~~-----ivHrDiKp~Nill~~~~~~kl~DFG~a~  154 (263)
T d2j4za1          84 ILEYAPLGTVYRELQKLSK----FDEQRTATYITELANALSYCHSKR-----VIHRDIKPENLLLGSAGELKIADFGWSV  154 (263)
T ss_dssp             EEECCTTCBHHHHHHHHSS----CCHHHHHHHHHHHHHHHHHHHHTT-----CCCCCCCGGGEEECTTSCEEECCCCSCS
T ss_pred             EEEECCCCCHHHHHHHCCC----CCHHHHHHHHHHHHHHHHHHHHCC-----EEEEEECCCCCEECCCCCEEECCCCEEE
T ss_conf             9850479858988750489----999999999999999999999889-----4652202344146689987115556335


Q ss_pred             CCCCCCEEEEECCCCCCCCCCCCCCCCCCCCCCCCCHHHHHHHHHHHHCCCCCCHHHHHHHHHHHHHHHHCCCCCCCCCH
Q ss_conf             45687113451478887888810223588898664020889999999199885214778874222567640014899998
Q 005586          566 LLADDIVFSVLKTSAAMGYLAPEYVTTGRFTERSDIFAFGVIILQILTGSLVLTSSMRLAAESATFENFIDRNLKGKFSE  645 (689)
Q Consensus       566 ~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~sDv~S~Gvil~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~  645 (689)
                      .......   ....||+.|+|||++.+..++.++||||+||++|||++|+.||.........    ..+...  ...++.
T Consensus       155 ~~~~~~~---~~~~Gt~~Y~APE~~~~~~~~~~~DiwSlGvilyell~G~~Pf~~~~~~~~~----~~i~~~--~~~~p~  225 (263)
T d2j4za1         155 HAPSSRR---TTLCGTLDYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPPFEANTYQETY----KRISRV--EFTFPD  225 (263)
T ss_dssp             CCCCCCC---EETTEEGGGCCHHHHTTCCCCTTHHHHHHHHHHHHHHHSSCTTCCSSHHHHH----HHHHTT--CCCCCT
T ss_pred             ECCCCCC---CCCCCCCCCCCHHHHCCCCCCCHHHHHHHHHHHHHHHCCCCCCCCCCHHHHH----HHHHCC--CCCCCC
T ss_conf             4488852---3557887634999975899893144046759999983299998889999999----999718--999986


Q ss_pred             HHHHHHHHHHHHHCCCCCCCCCCHHHHHHHHHHH
Q ss_conf             9999999999981117999999999999999860
Q 005586          646 SEAAKLGKMALVCTHEDPENRPTMEAVIEELTVA  679 (689)
Q Consensus       646 ~~~~~~~~l~~~Cl~~dP~~RPs~~evl~~L~~~  679 (689)
                      ..++++.+++.+||+.||++|||+.|+++|.|..
T Consensus       226 ~~s~~~~~li~~~L~~dp~~R~t~~eil~hp~~~  259 (263)
T d2j4za1         226 FVTEGARDLISRLLKHNPSQRPMLREVLEHPWIT  259 (263)
T ss_dssp             TSCHHHHHHHHHHTCSSGGGSCCHHHHHTCHHHH
T ss_pred             CCCHHHHHHHHHHCCCCHHHCCCHHHHHCCCCCC
T ss_conf             6899999999997647976890999997190707

>d1mqba_ d.144.1.7 (A:) epha2 receptor tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: epha2 receptor tyrosine kinase
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=0  Score=366.90  Aligned_cols=260  Identities=23%  Similarity=0.456  Sum_probs=213.0

Q ss_pred             CCCCCCCCCCCCCCCEEEEEEECCC-----CEEEEEEECCCCCCHHHHHHHHHHHHHHCCCCCCCEEEEEEEECCCCCEE
Q ss_conf             0588454215488520999995599-----39999990246876279999999999851489951148668971899818
Q 005586          409 QCFSEVNLLGKGNFSSVYKGTLRDG-----TLVAIRSINVTSCKSEEAEFVKGLYLLTSLRHENIIRLRGFCCSRGRGEC  483 (689)
Q Consensus       409 ~~f~~~~~lg~G~~g~Vy~~~~~~g-----~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~~  483 (689)
                      ++|+..++||+|+||.||+|.++..     ..||||++..........+|.+|+.++.+++|||||+++|++.  +....
T Consensus         7 ~~~~~~~~iG~G~fG~Vy~~~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~E~~il~~l~H~nIv~~~g~~~--~~~~~   84 (283)
T d1mqba_           7 SCVTRQKVIGAGEFGEVYKGMLKTSSGKKEVPVAIKTLKAGYTEKQRVDFLGEAGIMGQFSHHNIIRLEGVIS--KYKPM   84 (283)
T ss_dssp             TTEEEEEEEEECSSSEEEEEEEEC---CCEEEEEEEEECTTCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEC--SSSSE
T ss_pred             HHEEEEEEEEECCCEEEEEEEEECCCCEEEEEEEEEEECCCCCHHHHHHHHHHHHHHHHCCCCCEEEEEEEEE--CCCCE
T ss_conf             9968615981177909999999689987879999999884459689999999999998568987832367783--38803


Q ss_pred             EEEEECCCCCCHHHHHHHCCCCCCCCCHHHHHHHHHHHHHHHHHHHCCCCCCCCEEECCCCCCCEEECCCCCEEEECCCC
Q ss_conf             99997289999888860017999878999999999999999755307999999636258799866545999807803565
Q 005586          484 FLIYDFAPKGKLSKYLDQEEGSSNVLDWSTRVSIIIGIAKGIGYLHSSEVNKPAIVHRNLSVEKVLIDQQFNPLIADCGL  563 (689)
Q Consensus       484 ~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~ia~~ia~gL~~LH~~~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgl  563 (689)
                      ++||||+.++++.+.+.....   .+++..+..++.|++.||+|||+.+     |+||||||+|||++.++.+||+|||+
T Consensus        85 ~~v~e~~~~~~l~~~~~~~~~---~~~~~~~~~i~~~i~~gl~~lH~~~-----iiHrDlKp~NILl~~~~~~Kl~DFGl  156 (283)
T d1mqba_          85 MIITEYMENGALDKFLREKDG---EFSVLQLVGMLRGIAAGMKYLANMN-----YVHRDLAARNILVNSNLVCKVSDFGL  156 (283)
T ss_dssp             EEEEECCTTEEHHHHHHHTTT---CSCHHHHHHHHHHHHHHHHHHHHTT-----CCCSCCCGGGEEECTTCCEEECCCCC
T ss_pred             EEEEEECCCCCCHHHHHCCCC---CCCHHHHHHHHHHHHHHHHHCCCCC-----CCCCCCCCCEEEECCCCEEEECCCCH
T ss_conf             899972135740222102345---4208999999999998541212123-----42576564427888998499845510


Q ss_pred             CCCCCCCCE--EEEECCCCCCCCCCCCCCCCCCCCCCCCCHHHHHHHHHHHHCCCCCCHHHHHHHHHHHHHHHHCCCCCC
Q ss_conf             334568711--345147888788881022358889866402088999999919988521477887422256764001489
Q 005586          564 HKLLADDIV--FSVLKTSAAMGYLAPEYVTTGRFTERSDIFAFGVIILQILTGSLVLTSSMRLAAESATFENFIDRNLKG  641 (689)
Q Consensus       564 a~~~~~~~~--~~~~~~~~t~~y~aPE~~~~~~~~~~sDv~S~Gvil~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~  641 (689)
                      ++.+.....  .......||+.|+|||++.++.++.++|||||||++|||++|..|+.......    ...+.+....+.
T Consensus       157 a~~~~~~~~~~~~~~~~~gt~~Y~APE~l~~~~~~~~sDI~S~Gvil~el~t~~~~~~~~~~~~----~~~~~i~~~~~~  232 (283)
T d1mqba_         157 SRVLEDDPEATYTTSGGKIPIRWTAPEAISYRKFTSASDVWSFGIVMWEVMTYGERPYWELSNH----EVMKAINDGFRL  232 (283)
T ss_dssp             -----------------CCCGGGSCHHHHHSCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCHH----HHHHHHHTTCCC
T ss_pred             HHCCCCCCCCCEEECCCCCCCCCCCHHHHCCCCCCCCCCCCCCHHHHHHHHHCCCCCCCCCCHH----HHHHHHHCCCCC
T ss_conf             3003578765267426777734348888704999973556344898999996798865568999----999998635789


Q ss_pred             CCCHHHHHHHHHHHHHHCCCCCCCCCCHHHHHHHHHHHCCC
Q ss_conf             99989999999999981117999999999999999860875
Q 005586          642 KFSESEAAKLGKMALVCTHEDPENRPTMEAVIEELTVAAPV  682 (689)
Q Consensus       642 ~~~~~~~~~~~~l~~~Cl~~dP~~RPs~~evl~~L~~~~~~  682 (689)
                      ..+...+..+.+++.+||+.||++||+|.+|++.|+.+...
T Consensus       233 ~~~~~~~~~l~~li~~cl~~~p~~RPt~~eil~~L~~l~~~  273 (283)
T d1mqba_         233 PTPMDCPSAIYQLMMQCWQQERARRPKFADIVSILDKLIRA  273 (283)
T ss_dssp             CCCTTCBHHHHHHHHHHTCSSTTTSCCHHHHHHHHHHHHHS
T ss_pred             CCCHHHHHHHHHHHHHHCCCCHHHCCCHHHHHHHHHHHHHC
T ss_conf             98504579999999997767976893999999999998669

>d1a06a_ d.144.1.7 (A:) Calmodulin-dependent protein kinase {Rat (Rattus norvegicus) [TaxId: 10116]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Calmodulin-dependent protein kinase
species: Rat (Rattus norvegicus) [TaxId: 10116]

Probab=100.00  E-value=0  Score=368.29  Aligned_cols=256  Identities=23%  Similarity=0.361  Sum_probs=213.1

Q ss_pred             HCCCCCCCCCCCCCCCEEEEEEEC-CCCEEEEEEECCCCCCHHHHHHHHHHHHHHCCCCCCCEEEEEEEECCCCCEEEEE
Q ss_conf             305884542154885209999955-9939999990246876279999999999851489951148668971899818999
Q 005586          408 TQCFSEVNLLGKGNFSSVYKGTLR-DGTLVAIRSINVTSCKSEEAEFVKGLYLLTSLRHENIIRLRGFCCSRGRGECFLI  486 (689)
Q Consensus       408 ~~~f~~~~~lg~G~~g~Vy~~~~~-~g~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~~~lv  486 (689)
                      .+.|+..+.||+|+||.||+|+.+ +++.||+|++...........+.+|+.++.+++||||+++++++.  +.+..++|
T Consensus         8 ~d~Y~~~~~lG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~--~~~~~~lv   85 (307)
T d1a06a_           8 RDIYDFRDVLGTGAFSEVILAEDKRTQKLVAIKCIAKKALEGKEGSMENEIAVLHKIKHPNIVALDDIYE--SGGHLYLI   85 (307)
T ss_dssp             GGTEEEEEESBSGGGGGEEEEEETTTCCEEEEEEEEC----------CHHHHHHHTCCCTTBCCEEEEEE--CSSEEEEE
T ss_pred             CCCEEEEEEEEECCCEEEEEEEECCCCCEEEEEEECHHHHHHHHHHHHHHHHHHHHCCCCCCCCEEEEEE--ECCEEEEE
T ss_conf             6666998899406583999999999998999999815773128999999999998679989991989999--89988898


Q ss_pred             EECCCCCCHHHHHHHCCCCCCCCCHHHHHHHHHHHHHHHHHHHCCCCCCCCEEECCCCCCCEEEC---CCCCEEEECCCC
Q ss_conf             97289999888860017999878999999999999999755307999999636258799866545---999807803565
Q 005586          487 YDFAPKGKLSKYLDQEEGSSNVLDWSTRVSIIIGIAKGIGYLHSSEVNKPAIVHRNLSVEKVLID---QQFNPLIADCGL  563 (689)
Q Consensus       487 ~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~ia~~ia~gL~~LH~~~~~~~~ivH~dlk~~Nill~---~~~~~kl~Dfgl  563 (689)
                      |||+++|+|.+++....    .+++..+..++.|++.||+|||+.+     |+||||||+|||+.   +++.+||+|||+
T Consensus        86 mE~~~gg~L~~~l~~~~----~l~e~~~~~~~~qi~~al~ylH~~~-----iiHrDiKp~Nil~~~~~~~~~vkl~DFG~  156 (307)
T d1a06a_          86 MQLVSGGELFDRIVEKG----FYTERDASRLIFQVLDAVKYLHDLG-----IVHRDLKPENLLYYSLDEDSKIMISDFGL  156 (307)
T ss_dssp             ECCCCSCBHHHHHHTCS----CCCHHHHHHHHHHHHHHHHHHHHTT-----CCCSCCCGGGEEESSSSTTCCEEECCC--
T ss_pred             EECCCCCCHHHHHHCCC----CCCHHHHHHHHHHHHHHHHHHHHCE-----EEEEEECCCCEEECCCCCCCEEEEECCCE
T ss_conf             85268984888653036----7887899999999999987524130-----55687046300110468882499831543


Q ss_pred             CCCCCCCCEEEEECCCCCCCCCCCCCCCCCCCCCCCCCHHHHHHHHHHHHCCCCCCHHHHHHHHHHHHHHHHCCC--CCC
Q ss_conf             334568711345147888788881022358889866402088999999919988521477887422256764001--489
Q 005586          564 HKLLADDIVFSVLKTSAAMGYLAPEYVTTGRFTERSDIFAFGVIILQILTGSLVLTSSMRLAAESATFENFIDRN--LKG  641 (689)
Q Consensus       564 a~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~sDv~S~Gvil~elltG~~p~~~~~~~~~~~~~~~~~~~~~--~~~  641 (689)
                      ++.......  .....||+.|+|||++.+..++.++||||+||++|||++|+.||.+.......    ..+....  ...
T Consensus       157 a~~~~~~~~--~~~~~GT~~y~APE~~~~~~~~~~~DiwSlGvilyell~g~~Pf~~~~~~~~~----~~i~~~~~~~~~  230 (307)
T d1a06a_         157 SKMEDPGSV--LSTACGTPGYVAPEVLAQKPYSKAVDCWSIGVIAYILLCGYPPFYDENDAKLF----EQILKAEYEFDS  230 (307)
T ss_dssp             ------------------CTTSCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHH----HHHHTTCCCCCT
T ss_pred             EEECCCCCE--EEEEEECCCCCCCHHHCCCCCCCHHHHHHHHHHHHHHHHCCCCCCCCCHHHHH----HHHHCCCCCCCC
T ss_conf             587258970--44003284225918873799980787345159999998597999998999999----998616877787


Q ss_pred             CCCHHHHHHHHHHHHHHCCCCCCCCCCHHHHHHHHHHHC
Q ss_conf             999899999999999811179999999999999998608
Q 005586          642 KFSESEAAKLGKMALVCTHEDPENRPTMEAVIEELTVAA  680 (689)
Q Consensus       642 ~~~~~~~~~~~~l~~~Cl~~dP~~RPs~~evl~~L~~~~  680 (689)
                      ......+.++.+++.+||+.||.+|||+.|+++|.|...
T Consensus       231 ~~~~~~s~~~~~li~~~L~~dP~~R~s~~eil~hp~~~~  269 (307)
T d1a06a_         231 PYWDDISDSAKDFIRHLMEKDPEKRFTCEQALQHPWIAG  269 (307)
T ss_dssp             TTTTTSCHHHHHHHHHHSCSSGGGSCCHHHHHHSTTTTS
T ss_pred             CCCCCCCHHHHHHHHHHCCCCHHHCCCHHHHHCCHHHCC
T ss_conf             666678999999999976089757918999862984479

>d1koaa2 d.144.1.7 (A:5915-6264) Twitchin, kinase domain {Caenorhabditis elegans, pjk4 [TaxId: 6239]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Twitchin, kinase domain
species: Caenorhabditis elegans, pjk4 [TaxId: 6239]

Probab=100.00  E-value=0  Score=365.71  Aligned_cols=255  Identities=20%  Similarity=0.264  Sum_probs=210.9

Q ss_pred             HCCCCCCCCCCCCCCCEEEEEEEC-CCCEEEEEEECCCCCCHHHHHHHHHHHHHHCCCCCCCEEEEEEEECCCCCEEEEE
Q ss_conf             305884542154885209999955-9939999990246876279999999999851489951148668971899818999
Q 005586          408 TQCFSEVNLLGKGNFSSVYKGTLR-DGTLVAIRSINVTSCKSEEAEFVKGLYLLTSLRHENIIRLRGFCCSRGRGECFLI  486 (689)
Q Consensus       408 ~~~f~~~~~lg~G~~g~Vy~~~~~-~g~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~~~lv  486 (689)
                      .++|++.+.||+|+||.||+|+.+ +|+.||+|++.... ....+.+.+|+.++.+++|||||++++++.+  .+..++|
T Consensus        25 l~~Y~i~~~lG~G~fg~Vy~~~~~~~g~~vAvK~i~~~~-~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~--~~~~~iv  101 (350)
T d1koaa2          25 LDHYDIHEELGTGAFGVVHRVTERATGNNFAAKFVMTPH-ESDKETVRKEIQTMSVLRHPTLVNLHDAFED--DNEMVMI  101 (350)
T ss_dssp             GGTEEEEEEEEEETTEEEEEEEETTTTEEEEEEEECCCS-HHHHHHHHHHHHHHHHTCCTTBCCEEEEEEE--TTEEEEE
T ss_pred             CCCEEEEEEEECCCCEEEEEEEECCCCCEEEEEEECCCC-HHHHHHHHHHHHHHHHCCCCCCCCEEEEEEE--CCEEEEE
T ss_conf             657589889840768199999988999899999984524-3169999999999986799799929999998--9999999


Q ss_pred             EECCCCCCHHHHHHHCCCCCCCCCHHHHHHHHHHHHHHHHHHHCCCCCCCCEEECCCCCCCEEECC--CCCEEEECCCCC
Q ss_conf             972899998888600179998789999999999999997553079999996362587998665459--998078035653
Q 005586          487 YDFAPKGKLSKYLDQEEGSSNVLDWSTRVSIIIGIAKGIGYLHSSEVNKPAIVHRNLSVEKVLIDQ--QFNPLIADCGLH  564 (689)
Q Consensus       487 ~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~ia~~ia~gL~~LH~~~~~~~~ivH~dlk~~Nill~~--~~~~kl~Dfgla  564 (689)
                      |||+++|+|.+++....+   .+++..+..|+.|++.||.|||+.+     |+||||||+|||++.  ++.+||+|||++
T Consensus       102 mE~~~gg~L~~~l~~~~~---~l~e~~~~~i~~qi~~aL~ylH~~~-----iiHrDiKp~NIll~~~~~~~vkL~DFG~a  173 (350)
T d1koaa2         102 YEFMSGGELFEKVADEHN---KMSEDEAVEYMRQVCKGLCHMHENN-----YVHLDLKPENIMFTTKRSNELKLIDFGLT  173 (350)
T ss_dssp             ECCCCSCBHHHHHTCTTS---CBCHHHHHHHHHHHHHHHHHHHHTT-----EECCCCCGGGEEESSTTSCCEEECCCTTC
T ss_pred             EECCCCCCHHHHHHHHCC---CCCHHHHHHHHHHHHHHHHHHHHCC-----CEEEEECHHHEEECCCCCCEEEEEECCHH
T ss_conf             985799889999976237---8999999999999999999997569-----76000154673641688986999545210


Q ss_pred             CCCCCCCEEEEECCCCCCCCCCCCCCCCCCCCCCCCCHHHHHHHHHHHHCCCCCCHHHHHHHHHHHHHHHHCCCC--CCC
Q ss_conf             345687113451478887888810223588898664020889999999199885214778874222567640014--899
Q 005586          565 KLLADDIVFSVLKTSAAMGYLAPEYVTTGRFTERSDIFAFGVIILQILTGSLVLTSSMRLAAESATFENFIDRNL--KGK  642 (689)
Q Consensus       565 ~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~sDv~S~Gvil~elltG~~p~~~~~~~~~~~~~~~~~~~~~~--~~~  642 (689)
                      +.+.....  .....||+.|+|||++.+..++.++||||+||++|||++|+.||.+.......    ..+.....  ...
T Consensus       174 ~~~~~~~~--~~~~~gT~~Y~aPEv~~~~~~~~~~DiwSlGvilyell~G~~Pf~~~~~~~~~----~~i~~~~~~~~~~  247 (350)
T d1koaa2         174 AHLDPKQS--VKVTTGTAEFAAPEVAEGKPVGYYTDMWSVGVLSYILLSGLSPFGGENDDETL----RNVKSCDWNMDDS  247 (350)
T ss_dssp             EECCTTSC--EEEECSCTTTCCHHHHHTCCBCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHH----HHHHHTCCCSCCG
T ss_pred             EECCCCCC--CCEECCCCCCCCHHHHCCCCCCHHHHHHHHHHHHHHHHHCCCCCCCCCHHHHH----HHHHHCCCCCCCC
T ss_conf             44256543--20006862421889975899872676554659999998598998997999999----9998478898942


Q ss_pred             CCHHHHHHHHHHHHHHCCCCCCCCCCHHHHHHHHHHH
Q ss_conf             9989999999999981117999999999999999860
Q 005586          643 FSESEAAKLGKMALVCTHEDPENRPTMEAVIEELTVA  679 (689)
Q Consensus       643 ~~~~~~~~~~~l~~~Cl~~dP~~RPs~~evl~~L~~~  679 (689)
                      .....+..+.+++.+||+.||++|||+.|+++|.|..
T Consensus       248 ~~~~~s~~~~~li~~~L~~dP~~R~t~~eil~hp~~~  284 (350)
T d1koaa2         248 AFSGISEDGKDFIRKLLLADPNTRMTIHQALEHPWLT  284 (350)
T ss_dssp             GGGGCCHHHHHHHHHHCCSSGGGSCCHHHHHHSTTTS
T ss_pred             CCCCCCHHHHHHHHHHCCCCHHHCCCHHHHHCCCCCC
T ss_conf             2358999999999997568966790899986291328

>d2jfla1 d.144.1.7 (A:21-308) STE20-like serine/threonine-protein kinase, SLK {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: STE20-like serine/threonine-protein kinase, SLK
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=0  Score=367.99  Aligned_cols=256  Identities=18%  Similarity=0.278  Sum_probs=209.7

Q ss_pred             CCCCCCCCCCCCCCCEEEEEEEC-CCCEEEEEEECCCCCCHHHHHHHHHHHHHHCCCCCCCEEEEEEEECCCCCEEEEEE
Q ss_conf             05884542154885209999955-99399999902468762799999999998514899511486689718998189999
Q 005586          409 QCFSEVNLLGKGNFSSVYKGTLR-DGTLVAIRSINVTSCKSEEAEFVKGLYLLTSLRHENIIRLRGFCCSRGRGECFLIY  487 (689)
Q Consensus       409 ~~f~~~~~lg~G~~g~Vy~~~~~-~g~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~~~lv~  487 (689)
                      +.|+..+.||+|+||.||+|+.+ ++..||+|++.... ....+.+.+|++++++++|||||++++++..  .+..++||
T Consensus        12 d~Y~i~~~iG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~-~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~--~~~~~lvm   88 (288)
T d2jfla1          12 DFWEIIGELGDGAFGKVYKAQNKETSVLAAAKVIDTKS-EEELEDYMVEIDILASCDHPNIVKLLDAFYY--ENNLWILI   88 (288)
T ss_dssp             GTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECSS-SGGGGGTHHHHHHHHHCCCTTBCCEEEEEEE--TTEEEEEE
T ss_pred             CCEEEEEEEEECCCCEEEEEEECCCCEEEEEEEECCCC-HHHHHHHHHHHHHHHHCCCCCCCEEEEEEEE--CCEEEEEE
T ss_conf             37598479930778199999999999399999987289-9999999999999986799998849889800--99589999


Q ss_pred             ECCCCCCHHHHHHHCCCCCCCCCHHHHHHHHHHHHHHHHHHHCCCCCCCCEEECCCCCCCEEECCCCCEEEECCCCCCCC
Q ss_conf             72899998888600179998789999999999999997553079999996362587998665459998078035653345
Q 005586          488 DFAPKGKLSKYLDQEEGSSNVLDWSTRVSIIIGIAKGIGYLHSSEVNKPAIVHRNLSVEKVLIDQQFNPLIADCGLHKLL  567 (689)
Q Consensus       488 e~~~~gsL~~~l~~~~~~~~~l~~~~~~~ia~~ia~gL~~LH~~~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgla~~~  567 (689)
                      ||+++|+|.+++.....   .+++..+..++.|++.||.|||+.+     |+||||||+|||++.++.+||+|||+|+..
T Consensus        89 Ey~~~g~L~~~~~~~~~---~l~e~~~~~i~~qi~~gL~ylH~~~-----ivHrDiKp~NIll~~~~~~Kl~DFG~a~~~  160 (288)
T d2jfla1          89 EFCAGGAVDAVMLELER---PLTESQIQVVCKQTLDALNYLHDNK-----IIHRDLKAGNILFTLDGDIKLADFGVSAKN  160 (288)
T ss_dssp             ECCTTEEHHHHHHHHTS---CCCHHHHHHHHHHHHHHHHHHHHTT-----EECCCCSGGGEEECTTSCEEECCCTTCEEC
T ss_pred             ECCCCCCHHHHHHHCCC---CCCHHHHHHHHHHHHHHHHHHHHCC-----EEEEECCHHHEEECCCCCEEEEECHHHHCC
T ss_conf             62799818899986289---9999999999999999999999889-----887140700314878999899716123035


Q ss_pred             CCCCEEEEECCCCCCCCCCCCCCC-----CCCCCCCCCCHHHHHHHHHHHHCCCCCCHHHHHHHHHHHHHHHHCCC-CCC
Q ss_conf             687113451478887888810223-----58889866402088999999919988521477887422256764001-489
Q 005586          568 ADDIVFSVLKTSAAMGYLAPEYVT-----TGRFTERSDIFAFGVIILQILTGSLVLTSSMRLAAESATFENFIDRN-LKG  641 (689)
Q Consensus       568 ~~~~~~~~~~~~~t~~y~aPE~~~-----~~~~~~~sDv~S~Gvil~elltG~~p~~~~~~~~~~~~~~~~~~~~~-~~~  641 (689)
                      ..... ......||+.|+|||++.     +..|+.++||||+||++|||+||+.||........    +..+.... ...
T Consensus       161 ~~~~~-~~~~~~Gt~~y~APE~l~~~~~~~~~y~~k~DiwSlGvilyemltg~~Pf~~~~~~~~----~~~i~~~~~~~~  235 (288)
T d2jfla1         161 TRTIQ-RRDSFIGTPYWMAPEVVMCETSKDRPYDYKADVWSLGITLIEMAEIEPPHHELNPMRV----LLKIAKSEPPTL  235 (288)
T ss_dssp             HHHHH-HHTCCCSCCTTCCHHHHTTCSTTTSSTTTHHHHHHHHHHHHHHHHSSCTTTTSCGGGH----HHHHHHSCCCCC
T ss_pred             CCCCC-CCCCCCCCCCCCCHHHHHHCCCCCCCCCHHHHHHHHHHHHHHHHHCCCCCCCCCHHHH----HHHHHCCCCCCC
T ss_conf             77864-1001025626479999832025788888066578789999998208899999899999----999970799877


Q ss_pred             CCCHHHHHHHHHHHHHHCCCCCCCCCCHHHHHHHHHHHC
Q ss_conf             999899999999999811179999999999999998608
Q 005586          642 KFSESEAAKLGKMALVCTHEDPENRPTMEAVIEELTVAA  680 (689)
Q Consensus       642 ~~~~~~~~~~~~l~~~Cl~~dP~~RPs~~evl~~L~~~~  680 (689)
                      ..+...+.++.+++.+||+.||.+|||+.|+++|.|...
T Consensus       236 ~~~~~~s~~~~~li~~~L~~dp~~R~t~~ell~hp~~~~  274 (288)
T d2jfla1         236 AQPSRWSSNFKDFLKKCLEKNVDARWTTSQLLQHPFVTV  274 (288)
T ss_dssp             SSGGGSCHHHHHHHHHHSCSSTTTSCCHHHHTTSGGGCC
T ss_pred             CCCCCCCHHHHHHHHHHCCCCHHHCCCHHHHHCCCCCCC
T ss_conf             765669999999999976699668919999962923188

>d1u5ra_ d.144.1.7 (A:) Serine/threonine protein kinase TAO2 {Rat (Rattus norvegicus) [TaxId: 10116]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Serine/threonine protein kinase TAO2
species: Rat (Rattus norvegicus) [TaxId: 10116]

Probab=100.00  E-value=0  Score=364.38  Aligned_cols=254  Identities=20%  Similarity=0.352  Sum_probs=208.7

Q ss_pred             CCCCCCCCCCCCCCCEEEEEEEC-CCCEEEEEEECCCCCCH--HHHHHHHHHHHHHCCCCCCCEEEEEEEECCCCCEEEE
Q ss_conf             05884542154885209999955-99399999902468762--7999999999985148995114866897189981899
Q 005586          409 QCFSEVNLLGKGNFSSVYKGTLR-DGTLVAIRSINVTSCKS--EEAEFVKGLYLLTSLRHENIIRLRGFCCSRGRGECFL  485 (689)
Q Consensus       409 ~~f~~~~~lg~G~~g~Vy~~~~~-~g~~vaiK~~~~~~~~~--~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~~~l  485 (689)
                      +.|+..+.||+|+||.||+|+.+ +++.||+|++.......  ..+.+.+|+.++.+++|||||++++++.+  ....++
T Consensus        15 ~~y~~l~~lG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~~~~~~~~--~~~~~i   92 (309)
T d1u5ra_          15 KLFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPNTIQYRGCYLR--EHTAWL   92 (309)
T ss_dssp             HHEEEEEEEEECSSSEEEEEEETTTTEEEEEEEEECCSSCHHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEE--TTEEEE
T ss_pred             HHCEEEEEEECCCCEEEEEEEECCCCCEEEEEEECHHHCCCHHHHHHHHHHHHHHHHCCCCCEEEEEEEEEE--CCEEEE
T ss_conf             856762797018880999999989993999999844443588999999999999997789998238999998--998899


Q ss_pred             EEECCCCCCHHHHHHHCCCCCCCCCHHHHHHHHHHHHHHHHHHHCCCCCCCCEEECCCCCCCEEECCCCCEEEECCCCCC
Q ss_conf             99728999988886001799987899999999999999975530799999963625879986654599980780356533
Q 005586          486 IYDFAPKGKLSKYLDQEEGSSNVLDWSTRVSIIIGIAKGIGYLHSSEVNKPAIVHRNLSVEKVLIDQQFNPLIADCGLHK  565 (689)
Q Consensus       486 v~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~ia~~ia~gL~~LH~~~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgla~  565 (689)
                      ||||+++|+|..++....    .+++..+..++.|++.||.|||+.+     |+||||||+|||+++++.+||+|||+++
T Consensus        93 v~E~~~~g~l~~~~~~~~----~l~e~~~~~i~~qi~~aL~yLH~~~-----iiHrDiKp~NILl~~~~~~Kl~DFG~a~  163 (309)
T d1u5ra_          93 VMEYCLGSASDLLEVHKK----PLQEVEIAAVTHGALQGLAYLHSHN-----MIHRDVKAGNILLSEPGLVKLGDFGSAS  163 (309)
T ss_dssp             EEECCSEEHHHHHHHHTS----CCCHHHHHHHHHHHHHHHHHHHHTT-----CBCCCCSGGGEEEETTTEEEECCCTTCB
T ss_pred             EEEECCCCCHHHHHHHCC----CCCHHHHHHHHHHHHHHHHHHHHCC-----EECCCCCCCEEEECCCCCEEEEECCCCC
T ss_conf             998069994578997379----9999999999999999999998689-----7666788421798799978984436533


Q ss_pred             CCCCCCEEEEECCCCCCCCCCCCCCCC---CCCCCCCCCHHHHHHHHHHHHCCCCCCHHHHHHHHHHHHHHHHCCCCCCC
Q ss_conf             456871134514788878888102235---88898664020889999999199885214778874222567640014899
Q 005586          566 LLADDIVFSVLKTSAAMGYLAPEYVTT---GRFTERSDIFAFGVIILQILTGSLVLTSSMRLAAESATFENFIDRNLKGK  642 (689)
Q Consensus       566 ~~~~~~~~~~~~~~~t~~y~aPE~~~~---~~~~~~sDv~S~Gvil~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~  642 (689)
                      .....     ....||+.|+|||++.+   ..|+.++|||||||++|||++|+.||........    +..+........
T Consensus       164 ~~~~~-----~~~~GT~~Y~APE~~~~~~~~~y~~~~DiwSlGvilyel~~g~~Pf~~~~~~~~----~~~i~~~~~~~~  234 (309)
T d1u5ra_         164 IMAPA-----NSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSA----LYHIAQNESPAL  234 (309)
T ss_dssp             SSSSB-----CCCCSCGGGCCHHHHTTTTSCCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHHH----HHHHHHSCCCCC
T ss_pred             CCCCC-----CCCCCCCCCCCHHHHHCCCCCCCCCHHHHHHHHHHHHHHHHCCCCCCCCCHHHH----HHHHHHCCCCCC
T ss_conf             46778-----731347663688998346788867214545589999999878899999799999----999982899988


Q ss_pred             CCHHHHHHHHHHHHHHCCCCCCCCCCHHHHHHHHHHHCCC
Q ss_conf             9989999999999981117999999999999999860875
Q 005586          643 FSESEAAKLGKMALVCTHEDPENRPTMEAVIEELTVAAPV  682 (689)
Q Consensus       643 ~~~~~~~~~~~l~~~Cl~~dP~~RPs~~evl~~L~~~~~~  682 (689)
                      .+...++.+.+++.+||+.||.+|||+.|+++|.|.....
T Consensus       235 ~~~~~s~~~~~li~~~L~~dP~~Rpt~~ell~Hp~~~~~~  274 (309)
T d1u5ra_         235 QSGHWSEYFRNFVDSCLQKIPQDRPTSEVLLKHRFVLRER  274 (309)
T ss_dssp             SCTTSCHHHHHHHHHHTCSSGGGSCCHHHHTTCHHHHSCC
T ss_pred             CCCCCCHHHHHHHHHHCCCCHHHCCCHHHHHHCHHHCCCC
T ss_conf             8788899999999997737965791899997199753789

>d1koba_ d.144.1.7 (A:) Twitchin, kinase domain {California sea hare (Aplysia californica), twk43 [TaxId: 6500]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Twitchin, kinase domain
species: California sea hare (Aplysia californica), twk43 [TaxId: 6500]

Probab=100.00  E-value=0  Score=363.68  Aligned_cols=254  Identities=20%  Similarity=0.294  Sum_probs=211.2

Q ss_pred             CCCCCCCCCCCCCCCEEEEEEEC-CCCEEEEEEECCCCCCHHHHHHHHHHHHHHCCCCCCCEEEEEEEECCCCCEEEEEE
Q ss_conf             05884542154885209999955-99399999902468762799999999998514899511486689718998189999
Q 005586          409 QCFSEVNLLGKGNFSSVYKGTLR-DGTLVAIRSINVTSCKSEEAEFVKGLYLLTSLRHENIIRLRGFCCSRGRGECFLIY  487 (689)
Q Consensus       409 ~~f~~~~~lg~G~~g~Vy~~~~~-~g~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~~~lv~  487 (689)
                      ++|++.+.||+|+||.||+|+.+ +|+.||+|++.... ......+.+|+.++.+++||||+++++++.  +....++||
T Consensus        29 d~Y~i~~~lG~G~fg~V~~a~~~~~~~~vAiK~i~~~~-~~~~~~~~~Ei~il~~l~HpnIv~~~~~~~--~~~~~~ivm  105 (352)
T d1koba_          29 DYYDILEELGSGAFGVVHRCVEKATGRVFVAKFINTPY-PLDKYTVKNEISIMNQLHHPKLINLHDAFE--DKYEMVLIL  105 (352)
T ss_dssp             GTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCS-HHHHHHHHHHHHHHTTCCSTTBCCEEEEEE--CSSEEEEEE
T ss_pred             CCEEEEEEEECCCCEEEEEEEECCCCCEEEEEEECCCC-HHHHHHHHHHHHHHHHCCCCCCCCEEEEEE--ECCEEEEEE
T ss_conf             03599899931778299999998999799999988726-467999999999998679979891999999--899999999


Q ss_pred             ECCCCCCHHHHHHHCCCCCCCCCHHHHHHHHHHHHHHHHHHHCCCCCCCCEEECCCCCCCEEEC--CCCCEEEECCCCCC
Q ss_conf             7289999888860017999878999999999999999755307999999636258799866545--99980780356533
Q 005586          488 DFAPKGKLSKYLDQEEGSSNVLDWSTRVSIIIGIAKGIGYLHSSEVNKPAIVHRNLSVEKVLID--QQFNPLIADCGLHK  565 (689)
Q Consensus       488 e~~~~gsL~~~l~~~~~~~~~l~~~~~~~ia~~ia~gL~~LH~~~~~~~~ivH~dlk~~Nill~--~~~~~kl~Dfgla~  565 (689)
                      ||+++|+|.+++....   ..+++..+..|+.|++.||+|||+.+     |+||||||+|||++  +++.+||+|||+|+
T Consensus       106 E~~~gg~L~~~~~~~~---~~l~e~~~~~i~~qi~~aL~ylH~~~-----iiHRDiKp~NILl~~~~~~~vkL~DFGla~  177 (352)
T d1koba_         106 EFLSGGELFDRIAAED---YKMSEAEVINYMRQACEGLKHMHEHS-----IVHLDIKPENIMCETKKASSVKIIDFGLAT  177 (352)
T ss_dssp             ECCCCCBHHHHTTCTT---CCBCHHHHHHHHHHHHHHHHHHHHTT-----EECCCCCGGGEEESSTTCCCEEECCCTTCE
T ss_pred             ECCCCCHHHHHHHHCC---CCCCHHHHHHHHHHHHHHHHHHHHCC-----EEECCCCCCCCCCCCCCCCEEEEEECCCCE
T ss_conf             8289980888898638---99899999999999999999999779-----265131445531134678848995256303


Q ss_pred             CCCCCCEEEEECCCCCCCCCCCCCCCCCCCCCCCCCHHHHHHHHHHHHCCCCCCHHHHHHHHHHHHHHHHCCC--CCCCC
Q ss_conf             4568711345147888788881022358889866402088999999919988521477887422256764001--48999
Q 005586          566 LLADDIVFSVLKTSAAMGYLAPEYVTTGRFTERSDIFAFGVIILQILTGSLVLTSSMRLAAESATFENFIDRN--LKGKF  643 (689)
Q Consensus       566 ~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~sDv~S~Gvil~elltG~~p~~~~~~~~~~~~~~~~~~~~~--~~~~~  643 (689)
                      .+.....  .....+++.|+|||++.+..++.++||||+||++|||+||+.||.+.......    ..+....  .....
T Consensus       178 ~~~~~~~--~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvilyelltG~~Pf~~~~~~~~~----~~i~~~~~~~~~~~  251 (352)
T d1koba_         178 KLNPDEI--VKVTTATAEFAAPEIVDREPVGFYTDMWAIGVLGYVLLSGLSPFAGEDDLETL----QNVKRCDWEFDEDA  251 (352)
T ss_dssp             ECCTTSC--EEEECSSGGGCCHHHHTTCCBCHHHHHHHHHHHHHHHHHSCCSSCCSSHHHHH----HHHHHCCCCCCSST
T ss_pred             ECCCCCC--EEECCCCCCCCCHHHHCCCCCCCCCCHHHHHHHHHHHHHCCCCCCCCCHHHHH----HHHHHCCCCCCCCC
T ss_conf             4378872--01004764534899974799897633389899999999688998997999999----99984788989300


Q ss_pred             CHHHHHHHHHHHHHHCCCCCCCCCCHHHHHHHHHHH
Q ss_conf             989999999999981117999999999999999860
Q 005586          644 SESEAAKLGKMALVCTHEDPENRPTMEAVIEELTVA  679 (689)
Q Consensus       644 ~~~~~~~~~~l~~~Cl~~dP~~RPs~~evl~~L~~~  679 (689)
                      ....+.++.+++.+||+.||.+|||+.|+++|.|.-
T Consensus       252 ~~~~s~~~~~li~~~L~~dp~~R~s~~eil~Hp~~~  287 (352)
T d1koba_         252 FSSVSPEAKDFIKNLLQKEPRKRLTVHDALEHPWLK  287 (352)
T ss_dssp             TTTSCHHHHHHHHTTSCSSGGGSCCHHHHHTSTTTS
T ss_pred             CCCCCHHHHHHHHHHCCCCHHHCCCHHHHHCCHHHC
T ss_conf             247999999999997569966891899996097348

>d1xkka_ d.144.1.7 (A:) EGF receptor tyrosine kinase, Erbb-1 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: EGF receptor tyrosine kinase, Erbb-1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=0  Score=364.08  Aligned_cols=256  Identities=24%  Similarity=0.444  Sum_probs=212.1

Q ss_pred             CCCCCCCCCCCCCCEEEEEEEC-CCC----EEEEEEECCCCCCHHHHHHHHHHHHHHCCCCCCCEEEEEEEECCCCCEEE
Q ss_conf             5884542154885209999955-993----99999902468762799999999998514899511486689718998189
Q 005586          410 CFSEVNLLGKGNFSSVYKGTLR-DGT----LVAIRSINVTSCKSEEAEFVKGLYLLTSLRHENIIRLRGFCCSRGRGECF  484 (689)
Q Consensus       410 ~f~~~~~lg~G~~g~Vy~~~~~-~g~----~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~~~  484 (689)
                      +|+..+.||+|+||.||+|.+. +|+    .||+|++.........++|.+|+.++.+++|||||+++|+|.+   ...+
T Consensus        10 dy~~~~~lG~G~fG~Vy~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~g~~~~---~~~~   86 (317)
T d1xkka_          10 EFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRLLGICLT---STVQ   86 (317)
T ss_dssp             TEEEEEEEEECSSEEEEEEEECC----CCEEEEEEEECC----CTHHHHHHHHHHHHHCCCTTBCCEEEEEES---SSEE
T ss_pred             HCEEEEEEECCCCEEEEEEEECCCCCEEEEEEEEEEECCCCCHHHHHHHHHHHHHHHHCCCCCEEEEEEEEEC---CCEE
T ss_conf             9978319820899299999995899889899999996513497999999999999986799888158999961---9836


Q ss_pred             EEEECCCCCCHHHHHHHCCCCCCCCCHHHHHHHHHHHHHHHHHHHCCCCCCCCEEECCCCCCCEEECCCCCEEEECCCCC
Q ss_conf             99972899998888600179998789999999999999997553079999996362587998665459998078035653
Q 005586          485 LIYDFAPKGKLSKYLDQEEGSSNVLDWSTRVSIIIGIAKGIGYLHSSEVNKPAIVHRNLSVEKVLIDQQFNPLIADCGLH  564 (689)
Q Consensus       485 lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~ia~~ia~gL~~LH~~~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgla  564 (689)
                      +++|++.+|+|.+++....   ..+++..++.|+.|++.||+|||+.+     |+||||||+|||++.++.+||+|||++
T Consensus        87 ~v~e~~~~~~l~~~~~~~~---~~~~~~~~~~i~~qi~~gl~yLH~~~-----iiHrDlKp~NIll~~~~~~kl~DFGla  158 (317)
T d1xkka_          87 LITQLMPFGCLLDYVREHK---DNIGSQYLLNWCVQIAKGMNYLEDRR-----LVHRDLAARNVLVKTPQHVKITDFGLA  158 (317)
T ss_dssp             EEEECCTTCBHHHHHHHTS---SSCCHHHHHHHHHHHHHHHHHHHHTT-----CCCSCCCGGGEEEEETTEEEECCCSHH
T ss_pred             EEEEECCCCCCCCCCCCCC---CCCCHHHHHHHHHHHHHHHHHHHHCC-----CCCCCCHHHCCEECCCCCEEEECCCCC
T ss_conf             9998426874010111334---57999999999999999999998769-----504762120311679987586025522


Q ss_pred             CCCCCCCE-EEEECCCCCCCCCCCCCCCCCCCCCCCCCHHHHHHHHHHHH-CCCCCCHHHHHHHHHHHHHHHHCCCCCCC
Q ss_conf             34568711-34514788878888102235888986640208899999991-99885214778874222567640014899
Q 005586          565 KLLADDIV-FSVLKTSAAMGYLAPEYVTTGRFTERSDIFAFGVIILQILT-GSLVLTSSMRLAAESATFENFIDRNLKGK  642 (689)
Q Consensus       565 ~~~~~~~~-~~~~~~~~t~~y~aPE~~~~~~~~~~sDv~S~Gvil~ellt-G~~p~~~~~~~~~~~~~~~~~~~~~~~~~  642 (689)
                      +....... .......+|..|+|||++.++.++.++|||||||++|||+| |+.||.....     ..+...+.......
T Consensus       159 ~~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~sDvwS~Gvil~el~t~g~~p~~~~~~-----~~~~~~i~~~~~~~  233 (317)
T d1xkka_         159 KLLGAEEKEYHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPA-----SEISSILEKGERLP  233 (317)
T ss_dssp             HHTTTTCC--------CCTTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTSCG-----GGHHHHHHHTCCCC
T ss_pred             EECCCCCCCCCCCCCCCCCCCCCHHHHHCCCCCHHHHHHHHHHHHHHHHHCCCCCCCCCCH-----HHHHHHHHCCCCCC
T ss_conf             2335444532236510586446708874699983565440799999999779999999998-----99999997599899


Q ss_pred             CCHHHHHHHHHHHHHHCCCCCCCCCCHHHHHHHHHHHCC
Q ss_conf             998999999999998111799999999999999986087
Q 005586          643 FSESEAAKLGKMALVCTHEDPENRPTMEAVIEELTVAAP  681 (689)
Q Consensus       643 ~~~~~~~~~~~l~~~Cl~~dP~~RPs~~evl~~L~~~~~  681 (689)
                      .+...+..+.+++.+||+.||.+||++.+++++|.....
T Consensus       234 ~p~~~~~~~~~li~~cl~~dP~~RPs~~eil~~l~~~~~  272 (317)
T d1xkka_         234 QPPICTIDVYMIMVKCWMIDADSRPKFRELIIEFSKMAR  272 (317)
T ss_dssp             CCTTBCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred             CCCCCCHHHHHHHHHHCCCCHHHCCCHHHHHHHHHHHHH
T ss_conf             985568999999998478993469199999999999875

>d1fmka3 d.144.1.7 (A:249-533) c-src tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: c-src tyrosine kinase
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=0  Score=363.48  Aligned_cols=256  Identities=25%  Similarity=0.428  Sum_probs=213.5

Q ss_pred             CCCCCCCCCCCCCCCEEEEEEECCCCEEEEEEECCCCCCHHHHHHHHHHHHHHCCCCCCCEEEEEEEECCCCCEEEEEEE
Q ss_conf             05884542154885209999955993999999024687627999999999985148995114866897189981899997
Q 005586          409 QCFSEVNLLGKGNFSSVYKGTLRDGTLVAIRSINVTSCKSEEAEFVKGLYLLTSLRHENIIRLRGFCCSRGRGECFLIYD  488 (689)
Q Consensus       409 ~~f~~~~~lg~G~~g~Vy~~~~~~g~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~~~lv~e  488 (689)
                      ++|++.+.||+|+||.||+|+++++..||+|+++....  ..+.|.+|+.++.+++|+|||+++|++.+   +..++|||
T Consensus        17 ~~~~i~~~iG~G~fg~Vy~~~~~~~~~vAiK~l~~~~~--~~~~~~~E~~~l~~l~h~nIv~~~g~~~~---~~~~lv~E   91 (285)
T d1fmka3          17 ESLRLEVKLGQGCFGEVWMGTWNGTTRVAIKTLKPGTM--SPEAFLQEAQVMKKLRHEKLVQLYAVVSE---EPIYIVTE   91 (285)
T ss_dssp             GGEEEEEEEEECSSCEEEEEEETTTEEEEEEECCTTSS--CHHHHHHHHHHHHHCCCTTBCCEEEEECS---SSCEEEEC
T ss_pred             HHEEEEEEEEECCCEEEEEEEECCCCEEEEEEECCCCC--CHHHHHHHHHHHHHCCCCCEEEEEEEEEC---CCEEEEEE
T ss_conf             99798469930798099999999999999999880448--88999999999986666788689999823---97599999


Q ss_pred             CCCCCCHHHHHHHCCCCCCCCCHHHHHHHHHHHHHHHHHHHCCCCCCCCEEECCCCCCCEEECCCCCEEEECCCCCCCCC
Q ss_conf             28999988886001799987899999999999999975530799999963625879986654599980780356533456
Q 005586          489 FAPKGKLSKYLDQEEGSSNVLDWSTRVSIIIGIAKGIGYLHSSEVNKPAIVHRNLSVEKVLIDQQFNPLIADCGLHKLLA  568 (689)
Q Consensus       489 ~~~~gsL~~~l~~~~~~~~~l~~~~~~~ia~~ia~gL~~LH~~~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgla~~~~  568 (689)
                      |+++|+|..++.....  ..++|.+++.|+.|++.||+|||+.+     |+||||||+|||+++++.+||+|||+++...
T Consensus        92 y~~~g~l~~~~~~~~~--~~l~~~~~~~i~~~i~~gl~~LH~~~-----ivH~DlKp~NIll~~~~~~kl~DfGla~~~~  164 (285)
T d1fmka3          92 YMSKGSLLDFLKGETG--KYLRLPQLVDMAAQIASGMAYVERMN-----YVHRDLRAANILVGENLVCKVADFGLARLIE  164 (285)
T ss_dssp             CCTTCBHHHHHSHHHH--TTCCHHHHHHHHHHHHHHHHHHHHTT-----CCCSCCSGGGEEECGGGCEEECCCCTTC---
T ss_pred             ECCCCCHHHHHHHCCC--CCCHHHHHHHHHHHHHHHHHHHHHHH-----EECCCCCCEEEEECCCCCEEECCCCHHHHCC
T ss_conf             4479943542000035--53059999999999999999875411-----4335312307999899929984425554256


Q ss_pred             CCCEEEEECCCCCCCCCCCCCCCCCCCCCCCCCHHHHHHHHHHHHCCCCCCHHHHHHHHHHHHHHHHCCCCCCCCCHHHH
Q ss_conf             87113451478887888810223588898664020889999999199885214778874222567640014899998999
Q 005586          569 DDIVFSVLKTSAAMGYLAPEYVTTGRFTERSDIFAFGVIILQILTGSLVLTSSMRLAAESATFENFIDRNLKGKFSESEA  648 (689)
Q Consensus       569 ~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~sDv~S~Gvil~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  648 (689)
                      ...........++..|+|||++..+.++.++||||||+++|||+||+.|+........    ....+........+...+
T Consensus       165 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDI~S~Giil~el~t~~~p~~~~~~~~~----~~~~i~~~~~~~~~~~~~  240 (285)
T d1fmka3         165 DNEYTARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPYPGMVNRE----VLDQVERGYRMPCPPECP  240 (285)
T ss_dssp             -----------CCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCSSTTCCHHH----HHHHHHTTCCCCCCTTSC
T ss_pred             CCCCEEECCCCCCCCCCCHHHHHCCCCCCHHHHHCCHHHHHHHHHCCCCCCCCCCHHH----HHHHHHHCCCCCCCCCCC
T ss_conf             8873352454556654580898379989177413235899999868999998888999----999998268999983237


Q ss_pred             HHHHHHHHHHCCCCCCCCCCHHHHHHHHHHHC
Q ss_conf             99999999811179999999999999998608
Q 005586          649 AKLGKMALVCTHEDPENRPTMEAVIEELTVAA  680 (689)
Q Consensus       649 ~~~~~l~~~Cl~~dP~~RPs~~evl~~L~~~~  680 (689)
                      .++.+++.+||+.||++||+|++|++.|+..-
T Consensus       241 ~~l~~li~~cl~~dP~~Rps~~~i~~~L~~~~  272 (285)
T d1fmka3         241 ESLHDLMCQCWRKEPEERPTFEYLQAFLEDYF  272 (285)
T ss_dssp             HHHHHHHHHHTCSSGGGSCCHHHHHHHHHTTT
T ss_pred             HHHHHHHHHHCCCCHHHCCCHHHHHHHHHHHH
T ss_conf             99999999975669758919999999876662

>d1t4ha_ d.144.1.7 (A:) Protein kinase wnk1 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Protein kinase wnk1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=0  Score=360.19  Aligned_cols=253  Identities=23%  Similarity=0.378  Sum_probs=202.2

Q ss_pred             CCCCCCCCCCCCEEEEEEEC-CCCEEEEEEECCCCC-CHHHHHHHHHHHHHHCCCCCCCEEEEEEEECC--CCCEEEEEE
Q ss_conf             84542154885209999955-993999999024687-62799999999998514899511486689718--998189999
Q 005586          412 SEVNLLGKGNFSSVYKGTLR-DGTLVAIRSINVTSC-KSEEAEFVKGLYLLTSLRHENIIRLRGFCCSR--GRGECFLIY  487 (689)
Q Consensus       412 ~~~~~lg~G~~g~Vy~~~~~-~g~~vaiK~~~~~~~-~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~--~~~~~~lv~  487 (689)
                      ...+.||+|+||+||+|+++ ++..||+|++..... ....+.+.+|++++++++||||+++++++...  .....++||
T Consensus        12 ~~~~~iG~G~fg~Vy~~~~~~~~~~va~K~i~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~~~~~ivm   91 (270)
T d1t4ha_          12 KFDIEIGRGSFKTVYKGLDTETTVEVAWCELQDRKLTKSERQRFKEEAEMLKGLQHPNIVRFYDSWESTVKGKKCIVLVT   91 (270)
T ss_dssp             EEEEEEEECSSEEEEEEEETTTCCEEEEEEEEGGGSCHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEEESSSCEEEEEEE
T ss_pred             EEEEEEECCCCCEEEEEEECCCCEEEEEEEECHHHCCHHHHHHHHHHHHHHHHCCCCCEEEEEEEEEECCCCCCEEEEEE
T ss_conf             85169700828499999999999599999985122798999999999999985799985069999840334588899999


Q ss_pred             ECCCCCCHHHHHHHCCCCCCCCCHHHHHHHHHHHHHHHHHHHCCCCCCCCEEECCCCCCCEEEC-CCCCEEEECCCCCCC
Q ss_conf             7289999888860017999878999999999999999755307999999636258799866545-999807803565334
Q 005586          488 DFAPKGKLSKYLDQEEGSSNVLDWSTRVSIIIGIAKGIGYLHSSEVNKPAIVHRNLSVEKVLID-QQFNPLIADCGLHKL  566 (689)
Q Consensus       488 e~~~~gsL~~~l~~~~~~~~~l~~~~~~~ia~~ia~gL~~LH~~~~~~~~ivH~dlk~~Nill~-~~~~~kl~Dfgla~~  566 (689)
                      ||+++|+|.+++....    .+++..+..++.|++.||+|||+.+   ++|+||||||+|||++ +++.+||+|||+++.
T Consensus        92 E~~~~g~L~~~l~~~~----~~~~~~~~~~~~qi~~gl~yLH~~~---~~IiHrDiKp~NILl~~~~~~~Kl~DFGla~~  164 (270)
T d1t4ha_          92 ELMTSGTLKTYLKRFK----VMKIKVLRSWCRQILKGLQFLHTRT---PPIIHRDLKCDNIFITGPTGSVKIGDLGLATL  164 (270)
T ss_dssp             ECCCSCBHHHHHHHHS----SCCHHHHHHHHHHHHHHHHHHHTSS---SCCCCSCCCGGGEEESSTTSCEEECCTTGGGG
T ss_pred             ECCCCCCHHHHHHCCC----CCCHHHHHHHHHHHHHHHHHHHHCC---CCEEECCCCHHHCEEECCCCCEEEEECCCCEE
T ss_conf             5789894899975135----5469999999999999999999789---97996876743511667999889800576542


Q ss_pred             CCCCCEEEEECCCCCCCCCCCCCCCCCCCCCCCCCHHHHHHHHHHHHCCCCCCHHHHHHHHHHHHHHHHCCCCCCCCCHH
Q ss_conf             56871134514788878888102235888986640208899999991998852147788742225676400148999989
Q 005586          567 LADDIVFSVLKTSAAMGYLAPEYVTTGRFTERSDIFAFGVIILQILTGSLVLTSSMRLAAESATFENFIDRNLKGKFSES  646 (689)
Q Consensus       567 ~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~sDv~S~Gvil~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  646 (689)
                      ......   ....||+.|+|||++.+ .++.++||||+||++|||++|+.||.........   ...+.........+..
T Consensus       165 ~~~~~~---~~~~GT~~Y~aPE~~~~-~~~~~~DIwSlGvilyel~~g~~Pf~~~~~~~~~---~~~i~~~~~~~~~~~~  237 (270)
T d1t4ha_         165 KRASFA---KAVIGTPEFMAPEMYEE-KYDESVDVYAFGMCMLEMATSEYPYSECQNAAQI---YRRVTSGVKPASFDKV  237 (270)
T ss_dssp             CCTTSB---EESCSSCCCCCGGGGGT-CCCTHHHHHHHHHHHHHHHHSSCTTTTCSSHHHH---HHHHTTTCCCGGGGGC
T ss_pred             CCCCCC---CCCCCCCCCCCHHHHCC-CCCCCCCHHHHHHHHHHHHHCCCCCCCCCCHHHH---HHHHHCCCCCCCCCCC
T ss_conf             368766---77553813008988478-9998671100799999998788999876559999---9999738998656755


Q ss_pred             HHHHHHHHHHHHCCCCCCCCCCHHHHHHHHHH
Q ss_conf             99999999998111799999999999999986
Q 005586          647 EAAKLGKMALVCTHEDPENRPTMEAVIEELTV  678 (689)
Q Consensus       647 ~~~~~~~l~~~Cl~~dP~~RPs~~evl~~L~~  678 (689)
                      .++++.+++.+||+.||++|||+.|+++|.|.
T Consensus       238 ~~~~~~~li~~~l~~dp~~R~s~~ell~Hp~f  269 (270)
T d1t4ha_         238 AIPEVKEIIEGCIRQNKDERYSIKDLLNHAFF  269 (270)
T ss_dssp             CCHHHHHHHHHHSCSSGGGSCCHHHHHTSGGG
T ss_pred             CCHHHHHHHHHHCCCCHHHCCCHHHHHCCCCC
T ss_conf             78999999999763797589299999677540

>d1xbba_ d.144.1.7 (A:) Tyrosine-protein kinase SYK {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Tyrosine-protein kinase SYK
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=0  Score=360.66  Aligned_cols=247  Identities=25%  Similarity=0.411  Sum_probs=204.7

Q ss_pred             CCCCCCCCCEEEEEEEC---CCCEEEEEEECCCCC-CHHHHHHHHHHHHHHCCCCCCCEEEEEEEECCCCCEEEEEEECC
Q ss_conf             42154885209999955---993999999024687-62799999999998514899511486689718998189999728
Q 005586          415 NLLGKGNFSSVYKGTLR---DGTLVAIRSINVTSC-KSEEAEFVKGLYLLTSLRHENIIRLRGFCCSRGRGECFLIYDFA  490 (689)
Q Consensus       415 ~~lg~G~~g~Vy~~~~~---~g~~vaiK~~~~~~~-~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~~~lv~e~~  490 (689)
                      +.||+|+||.||+|.++   .++.||+|+++.... ....++|.+|+.++.+++|||||+++|+|..   +..++||||+
T Consensus        13 k~iG~G~fG~Vy~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~g~~~~---~~~~lvmE~~   89 (277)
T d1xbba_          13 KELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIVRMIGICEA---ESWMLVMEMA   89 (277)
T ss_dssp             EEEEECSSEEEEEEEEECSSSEEEEEEEEEC-----CHHHHHHHHHHHHHHTCCCTTBCCEEEEEES---SSEEEEEECC
T ss_pred             CCCCCCCCEEEEEEEECCCCCCEEEEEEEECHHHCCHHHHHHHHHHHHHHHHCCCCCCCEEEEEECC---CCEEEEEECC
T ss_conf             7834587829999998169738599999988010898999999999999986799898527777505---9779999747


Q ss_pred             CCCCHHHHHHHCCCCCCCCCHHHHHHHHHHHHHHHHHHHCCCCCCCCEEECCCCCCCEEECCCCCEEEECCCCCCCCCCC
Q ss_conf             99998888600179998789999999999999997553079999996362587998665459998078035653345687
Q 005586          491 PKGKLSKYLDQEEGSSNVLDWSTRVSIIIGIAKGIGYLHSSEVNKPAIVHRNLSVEKVLIDQQFNPLIADCGLHKLLADD  570 (689)
Q Consensus       491 ~~gsL~~~l~~~~~~~~~l~~~~~~~ia~~ia~gL~~LH~~~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgla~~~~~~  570 (689)
                      ++|+|.+++....    .+++..++.|+.|++.||+|||+.+     |+||||||+|||++.++.+|++|||+++.+...
T Consensus        90 ~~g~L~~~l~~~~----~l~~~~~~~i~~qi~~gl~ylH~~~-----iiHrDlKp~Nill~~~~~~kl~DFGla~~~~~~  160 (277)
T d1xbba_          90 ELGPLNKYLQQNR----HVKDKNIIELVHQVSMGMKYLEESN-----FVHRDLAARNVLLVTQHYAKISDFGLSKALRAD  160 (277)
T ss_dssp             TTEEHHHHHHHCT----TCCHHHHHHHHHHHHHHHHHHHHTT-----EECSCCSGGGEEEEETTEEEECCCTTCEECCTT
T ss_pred             CCCCHHHHHHHCC----CCCHHHHHHHHHHHHHHHHHHHHCC-----CCCCCCCCHHHCCCCCCCCCCCCHHHHHHCCCC
T ss_conf             8896899975225----7899999999999999976687479-----556777611310235675123413453313432


Q ss_pred             CEE--EEECCCCCCCCCCCCCCCCCCCCCCCCCHHHHHHHHHHHH-CCCCCCHHHHHHHHHHHHHHHHCCCCCCCCCHHH
Q ss_conf             113--4514788878888102235888986640208899999991-9988521477887422256764001489999899
Q 005586          571 IVF--SVLKTSAAMGYLAPEYVTTGRFTERSDIFAFGVIILQILT-GSLVLTSSMRLAAESATFENFIDRNLKGKFSESE  647 (689)
Q Consensus       571 ~~~--~~~~~~~t~~y~aPE~~~~~~~~~~sDv~S~Gvil~ellt-G~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  647 (689)
                      ...  ......+|+.|+|||.+.+..++.++|||||||++|||+| |+.||.+.....     ....+........+...
T Consensus       161 ~~~~~~~~~~~gt~~y~APE~l~~~~~~~~sDiwS~Gv~l~ellt~g~~Pf~~~~~~~-----~~~~i~~~~~~~~p~~~  235 (277)
T d1xbba_         161 ENYYKAQTHGKWPVKWYAPECINYYKFSSKSDVWSFGVLMWEAFSYGQKPYRGMKGSE-----VTAMLEKGERMGCPAGC  235 (277)
T ss_dssp             CSEEEC----CCCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTTCCSSTTCCHHH-----HHHHHHTTCCCCCCTTC
T ss_pred             CCCCCCCCCCCCCCEECCCHHHCCCCCCCHHHHCCCHHHHHHHHHCCCCCCCCCCHHH-----HHHHHHCCCCCCCCCCC
T ss_conf             3443224456778420391665379998434430340313289658999999989999-----99999828999998656


Q ss_pred             HHHHHHHHHHHCCCCCCCCCCHHHHHHHHHH
Q ss_conf             9999999998111799999999999999986
Q 005586          648 AAKLGKMALVCTHEDPENRPTMEAVIEELTV  678 (689)
Q Consensus       648 ~~~~~~l~~~Cl~~dP~~RPs~~evl~~L~~  678 (689)
                      +.++.+++.+||+.||++||++.+|++.|+.
T Consensus       236 ~~~~~~li~~cl~~dp~~RPs~~~i~~~L~~  266 (277)
T d1xbba_         236 PREMYDLMNLCWTYDVENRPGFAAVELRLRN  266 (277)
T ss_dssp             CHHHHHHHHHHTCSSTTTSCCHHHHHHHHHH
T ss_pred             CHHHHHHHHHHCCCCHHHCCCHHHHHHHHHC
T ss_conf             7999999999758897689098999998528

>d1lufa_ d.144.1.7 (A:) Musk tyrosine kinase {Rat (Rattus norvegicus) [TaxId: 10116]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Musk tyrosine kinase
species: Rat (Rattus norvegicus) [TaxId: 10116]

Probab=100.00  E-value=0  Score=362.70  Aligned_cols=266  Identities=20%  Similarity=0.359  Sum_probs=216.5

Q ss_pred             HHHHHHCCCCCCCCCCCCCCCEEEEEEEC------CCCEEEEEEECCCCCCHHHHHHHHHHHHHHCCCCCCCEEEEEEEE
Q ss_conf             99998305884542154885209999955------993999999024687627999999999985148995114866897
Q 005586          403 EVESATQCFSEVNLLGKGNFSSVYKGTLR------DGTLVAIRSINVTSCKSEEAEFVKGLYLLTSLRHENIIRLRGFCC  476 (689)
Q Consensus       403 ~~~~~~~~f~~~~~lg~G~~g~Vy~~~~~------~g~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~  476 (689)
                      +++...++|+..+.||+|+||.||+|+++      +++.||||+++.........+|.+|+.++++++||||+++++++.
T Consensus         7 ~~e~p~~~~~~~~~lG~G~fG~Vy~a~~~~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~E~~il~~l~h~niv~~~~~~~   86 (301)
T d1lufa_           7 SLEYPRNNIEYVRDIGEGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASADMQADFQREAALMAEFDNPNIVKLLGVCA   86 (301)
T ss_dssp             HTBCCGGGCEEEEEEEECSSCEEEEEEEETSSTTSSEEEEEEEECCTTCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEC
T ss_pred             HCCCCHHHCEEEEEEEECCCEEEEEEEECCCCCCCCCEEEEEEEECHHCCHHHHHHHHHHHHHHHHCCCCCCCCCEEEEC
T ss_conf             11389889388679820788399999988876577882999999882108579999999999999668997655246660


Q ss_pred             CCCCCEEEEEEECCCCCCHHHHHHHCCC--------------------CCCCCCHHHHHHHHHHHHHHHHHHHCCCCCCC
Q ss_conf             1899818999972899998888600179--------------------99878999999999999999755307999999
Q 005586          477 SRGRGECFLIYDFAPKGKLSKYLDQEEG--------------------SSNVLDWSTRVSIIIGIAKGIGYLHSSEVNKP  536 (689)
Q Consensus       477 ~~~~~~~~lv~e~~~~gsL~~~l~~~~~--------------------~~~~l~~~~~~~ia~~ia~gL~~LH~~~~~~~  536 (689)
                        +....+++|||+++|+|.+++.....                    ....+++..++.|+.|++.||+|||+.+    
T Consensus        87 --~~~~~~~v~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~gl~ylH~~~----  160 (301)
T d1lufa_          87 --VGKPMCLLFEYMAYGDLNEFLRSMSPHTVCSLSHSDLSTRARVSSPGPPPLSCAEQLCIARQVAAGMAYLSERK----  160 (301)
T ss_dssp             --SSSSCEEEEECCTTCBHHHHHHHTCC----------------------CCCCHHHHHHHHHHHHHHHHHHHHTT----
T ss_pred             --CCCCEEEEEEECCCCCHHHHHHHCCCCCCCCCCCCCCCHHHHCCCCCCCCCCHHHHHHHHHHHHHHHHHCCCCC----
T ss_conf             --59803899981589929999985275542100001110012103467889899999999999999855413578----


Q ss_pred             CEEECCCCCCCEEECCCCCEEEECCCCCCCCCCCCEE-EEECCCCCCCCCCCCCCCCCCCCCCCCCHHHHHHHHHHHHCC
Q ss_conf             6362587998665459998078035653345687113-451478887888810223588898664020889999999199
Q 005586          537 AIVHRNLSVEKVLIDQQFNPLIADCGLHKLLADDIVF-SVLKTSAAMGYLAPEYVTTGRFTERSDIFAFGVIILQILTGS  615 (689)
Q Consensus       537 ~ivH~dlk~~Nill~~~~~~kl~Dfgla~~~~~~~~~-~~~~~~~t~~y~aPE~~~~~~~~~~sDv~S~Gvil~elltG~  615 (689)
                       |+||||||+|||++.++.+||+|||+++.+...... ......+++.|+|||++.+..++.++|||||||++|||++|.
T Consensus       161 -ivHrDlKp~NILld~~~~~Kl~DFGls~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~t~ksDVwS~Gvvl~ell~~~  239 (301)
T d1lufa_         161 -FVHRDLATRNCLVGENMVVKIADFGLSRNIYSADYYKADGNDAIPIRWMPPESIFYNRYTTESDVWAYGVVLWEIFSYG  239 (301)
T ss_dssp             -CCCSCCSGGGEEECGGGCEEECCCSCHHHHTGGGCBC----CCBCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTT
T ss_pred             -EEEEEECCCCEEECCCCCEEECCCHHHEECCCCCCCCCCCCCCCCCCCCCHHHHCCCCCCHHHHHCCCHHHHHHHHCCC
T ss_conf             -6854884011689899928983314421136776411157777676767989972688980563025236299998068


Q ss_pred             -CCCCHHHHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHHHHHHCCCCCCCCCCHHHHHHHHHHHC
Q ss_conf             -88521477887422256764001489999899999999999811179999999999999998608
Q 005586          616 -LVLTSSMRLAAESATFENFIDRNLKGKFSESEAAKLGKMALVCTHEDPENRPTMEAVIEELTVAA  680 (689)
Q Consensus       616 -~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~Cl~~dP~~RPs~~evl~~L~~~~  680 (689)
                       +||........    ...+. .......+...+.++.+++.+||+.+|++||||.||++.|+.+.
T Consensus       240 ~~p~~~~~~~e~----~~~v~-~~~~~~~p~~~~~~~~~li~~cl~~~P~~RPt~~ev~~~L~~i~  300 (301)
T d1lufa_         240 LQPYYGMAHEEV----IYYVR-DGNILACPENCPLELYNLMRLCWSKLPADRPSFCSIHRILQRMC  300 (301)
T ss_dssp             CCTTTTSCHHHH----HHHHH-TTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHTT
T ss_pred             CCCCCCCCHHHH----HHHHH-CCCCCCCCCCCHHHHHHHHHHHCCCCHHHCCCHHHHHHHHHHHC
T ss_conf             999999899999----99997-39978887325299999999974889657939999999999842

>d1o6la_ d.144.1.7 (A:) Pkb kinase (Akt-2) {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Pkb kinase (Akt-2)
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=0  Score=357.28  Aligned_cols=253  Identities=22%  Similarity=0.287  Sum_probs=212.1

Q ss_pred             CCCCCCCCCCCCCCCEEEEEEEC-CCCEEEEEEECCCCC--CHHHHHHHHHHHHHHCCCCCCCEEEEEEEECCCCCEEEE
Q ss_conf             05884542154885209999955-993999999024687--627999999999985148995114866897189981899
Q 005586          409 QCFSEVNLLGKGNFSSVYKGTLR-DGTLVAIRSINVTSC--KSEEAEFVKGLYLLTSLRHENIIRLRGFCCSRGRGECFL  485 (689)
Q Consensus       409 ~~f~~~~~lg~G~~g~Vy~~~~~-~g~~vaiK~~~~~~~--~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~~~l  485 (689)
                      ++|.+.+.||+|+||.||+|+.+ +|+.||+|++.+...  ......+.+|+.++++++||||+++++++.  +....++
T Consensus         5 ~dy~~~~~lG~G~fg~V~~~~~~~~~~~~AiK~i~k~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~--~~~~~~i   82 (337)
T d1o6la_           5 NDFDYLKLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHPFLTALKYAFQ--THDRLCF   82 (337)
T ss_dssp             GGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHSCCCTTBCCEEEEEE--CSSEEEE
T ss_pred             HHCEEEEEEECCCCEEEEEEEECCCCCEEEEEEECHHHCCCHHHHHHHHHHHHHHHHCCCCCEEEEEEEEC--CCCCCCC
T ss_conf             74289889831768499999998999899999981565449799999999999998679998877876403--5642111


Q ss_pred             EEECCCCCCHHHHHHHCCCCCCCCCHHHHHHHHHHHHHHHHHHHCCCCCCCCEEECCCCCCCEEECCCCCEEEECCCCCC
Q ss_conf             99728999988886001799987899999999999999975530799999963625879986654599980780356533
Q 005586          486 IYDFAPKGKLSKYLDQEEGSSNVLDWSTRVSIIIGIAKGIGYLHSSEVNKPAIVHRNLSVEKVLIDQQFNPLIADCGLHK  565 (689)
Q Consensus       486 v~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~ia~~ia~gL~~LH~~~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgla~  565 (689)
                      ||||+++|+|.+++.....    +++..+..++.|++.||+|||+.+     |+||||||+|||+++++.+||+|||+|+
T Consensus        83 v~ey~~gg~L~~~~~~~~~----~~e~~~~~~~~qil~al~ylH~~~-----iiHRDlKP~NILl~~~g~vkl~DFG~a~  153 (337)
T d1o6la_          83 VMEYANGGELFFHLSRERV----FTEERARFYGAEIVSALEYLHSRD-----VVYRDIKLENLMLDKDGHIKITDFGLCK  153 (337)
T ss_dssp             EEECCTTCBHHHHHHHHSC----CCHHHHHHHHHHHHHHHHHHHHTT-----CBCCCCCGGGEEECTTSCEEECCCTTCB
T ss_pred             CEECCCCCCHHHHHHCCCC----CCHHHHHHHHHHHHHHHHHHHHCC-----CCCCCCCHHHEEECCCCCEEEEECCCCC
T ss_conf             0003579860555532567----759999999999965211343159-----6224647778476589988882056520


Q ss_pred             CCCCCCEEEEECCCCCCCCCCCCCCCCCCCCCCCCCHHHHHHHHHHHHCCCCCCHHHHHHHHHHHHHHHHCCCCCCCCCH
Q ss_conf             45687113451478887888810223588898664020889999999199885214778874222567640014899998
Q 005586          566 LLADDIVFSVLKTSAAMGYLAPEYVTTGRFTERSDIFAFGVIILQILTGSLVLTSSMRLAAESATFENFIDRNLKGKFSE  645 (689)
Q Consensus       566 ~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~sDv~S~Gvil~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~  645 (689)
                      ....... ......||+.|+|||++.+..|+.++||||+||++|||++|+.||.........    ..+...  ...++.
T Consensus       154 ~~~~~~~-~~~~~~GT~~Y~aPE~~~~~~y~~~~DiwSlGvilyeml~G~~pf~~~~~~~~~----~~i~~~--~~~~p~  226 (337)
T d1o6la_         154 EGISDGA-TMKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHERLF----ELILME--EIRFPR  226 (337)
T ss_dssp             CSCCTTC-CBCCCEECGGGCCGGGGSSSCBCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHH----HHHHHC--CCCCCT
T ss_pred             CCCCCCC-CCCCCEECHHHHHHHHCCCCCCCHHHCCCCHHHHHHHHHHCCCCCCCCCHHHHH----HHHHCC--CCCCCC
T ss_conf             0356786-205510088996666504898883331022306788998789999996999999----998528--998986


Q ss_pred             HHHHHHHHHHHHHCCCCCCCCCC-----HHHHHHHHHHH
Q ss_conf             99999999999811179999999-----99999999860
Q 005586          646 SEAAKLGKMALVCTHEDPENRPT-----MEAVIEELTVA  679 (689)
Q Consensus       646 ~~~~~~~~l~~~Cl~~dP~~RPs-----~~evl~~L~~~  679 (689)
                      ..+.++.+++..||++||.+|++     +.++++|.|..
T Consensus       227 ~~s~~~~dli~~~L~~dP~~R~~~~~~~~~eil~Hp~f~  265 (337)
T d1o6la_         227 TLSPEAKSLLAGLLKKDPKQRLGGGPSDAKEVMEHRFFL  265 (337)
T ss_dssp             TSCHHHHHHHHHHTCSSTTTSTTCSTTTHHHHHTSGGGT
T ss_pred             CCCHHHHHHHHHHCCCCCHHHCCCCCCCHHHHHCCCCCC
T ss_conf             689999999986663893442256523499997291503

>d1uu3a_ d.144.1.7 (A:) 3-phosphoinositide dependent protein kinase-1 Pdk1 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: 3-phosphoinositide dependent protein kinase-1 Pdk1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=0  Score=362.14  Aligned_cols=252  Identities=21%  Similarity=0.269  Sum_probs=209.2

Q ss_pred             CCCCCCCCCCCCCCCEEEEEEEC-CCCEEEEEEECCCCC--CHHHHHHHHHHHHHHCCCCCCCEEEEEEEECCCCCEEEE
Q ss_conf             05884542154885209999955-993999999024687--627999999999985148995114866897189981899
Q 005586          409 QCFSEVNLLGKGNFSSVYKGTLR-DGTLVAIRSINVTSC--KSEEAEFVKGLYLLTSLRHENIIRLRGFCCSRGRGECFL  485 (689)
Q Consensus       409 ~~f~~~~~lg~G~~g~Vy~~~~~-~g~~vaiK~~~~~~~--~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~~~l  485 (689)
                      ++|+..+.||+|+||.||+|+.+ +++.||+|++.....  ......+.+|++++++++||||+++++++.  +.+..++
T Consensus         8 ~dy~i~~~lG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~--~~~~~~i   85 (288)
T d1uu3a_           8 EDFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHPFFVKLYFTFQ--DDEKLYF   85 (288)
T ss_dssp             GGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHCCSTTBCCEEEEEE--CSSEEEE
T ss_pred             CCCEEEEEEEECCCEEEEEEEECCCCCEEEEEEEEHHHCCCHHHHHHHHHHHHHHHHCCCCCEEEEEEEEE--ECCEEEE
T ss_conf             87789889850879099999998999799999986577557778999999999998768888617999999--8998899


Q ss_pred             EEECCCCCCHHHHHHHCCCCCCCCCHHHHHHHHHHHHHHHHHHHCCCCCCCCEEECCCCCCCEEECCCCCEEEECCCCCC
Q ss_conf             99728999988886001799987899999999999999975530799999963625879986654599980780356533
Q 005586          486 IYDFAPKGKLSKYLDQEEGSSNVLDWSTRVSIIIGIAKGIGYLHSSEVNKPAIVHRNLSVEKVLIDQQFNPLIADCGLHK  565 (689)
Q Consensus       486 v~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~ia~~ia~gL~~LH~~~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgla~  565 (689)
                      ||||+++|+|.+++.....    +++..+..++.|++.||+|||+.+     |+||||||+|||+++++.+||+|||+++
T Consensus        86 vmEy~~gg~L~~~~~~~~~----l~e~~~~~~~~qi~~al~ylH~~~-----iiHrDiKp~NIll~~~~~vkl~DFG~a~  156 (288)
T d1uu3a_          86 GLSYAKNGELLKYIRKIGS----FDETCTRFYTAEIVSALEYLHGKG-----IIHRDLKPENILLNEDMHIQITDFGTAK  156 (288)
T ss_dssp             EECCCTTEEHHHHHHHHSS----CCHHHHHHHHHHHHHHHHHHHHTT-----EECSCCSGGGEEECTTSCEEECCCTTCE
T ss_pred             EEECCCCCCHHHHHHCCCC----CCHHHHHHHHHHHHHHHHHHCCCC-----EECCCCCCCCCCCCCCCEEEECCCCCCE
T ss_conf             9970489877776531599----999999999999999997621650-----8847677412366888538860321024


Q ss_pred             CCCCCCE-EEEECCCCCCCCCCCCCCCCCCCCCCCCCHHHHHHHHHHHHCCCCCCHHHHHHHHHHHHHHHHCCCCCCCCC
Q ss_conf             4568711-345147888788881022358889866402088999999919988521477887422256764001489999
Q 005586          566 LLADDIV-FSVLKTSAAMGYLAPEYVTTGRFTERSDIFAFGVIILQILTGSLVLTSSMRLAAESATFENFIDRNLKGKFS  644 (689)
Q Consensus       566 ~~~~~~~-~~~~~~~~t~~y~aPE~~~~~~~~~~sDv~S~Gvil~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~  644 (689)
                      .+..... .......||+.|+|||++.+..++.++||||+||++|||++|+.||.........    ..+....  ..++
T Consensus       157 ~~~~~~~~~~~~~~~GT~~Y~APE~~~~~~~~~~~DiwSlGvilyell~g~~Pf~~~~~~~~~----~~i~~~~--~~~p  230 (288)
T d1uu3a_         157 VLSPESKQARANSFVGTAQYVSPELLTEKSACKSSDLWALGCIIYQLVAGLPPFRAGNEYLIF----QKIIKLE--YDFP  230 (288)
T ss_dssp             ECC----------CCCCGGGCCHHHHHTCCCCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHH----HHHHTTC--CCCC
T ss_pred             ECCCCCCCCCCCCCCCCCCCCCCEEECCCCCCCCCCEEHHHHHHHHHHHCCCCCCCCCHHHHH----HHHHCCC--CCCC
T ss_conf             225677643335556775525844002689896662304569999980388998995999999----9997189--9998


Q ss_pred             HHHHHHHHHHHHHHCCCCCCCCCCHHHHHHHHH
Q ss_conf             899999999999811179999999999999998
Q 005586          645 ESEAAKLGKMALVCTHEDPENRPTMEAVIEELT  677 (689)
Q Consensus       645 ~~~~~~~~~l~~~Cl~~dP~~RPs~~evl~~L~  677 (689)
                      ...+.++.+++.+||+.||.+|||+.|++++.+
T Consensus       231 ~~~s~~~~~li~~~L~~dP~~R~t~~e~~~~~~  263 (288)
T d1uu3a_         231 EKFFPKARDLVEKLLVLDATKRLGCEEMEGYGP  263 (288)
T ss_dssp             TTCCHHHHHHHHTTSCSSGGGSTTSGGGTCHHH
T ss_pred             CCCCHHHHHHHHHHCCCCHHHCCCHHHHCCCHH
T ss_conf             547999999999985579768919789737789

>d1mp8a_ d.144.1.7 (A:) Focal adhesion kinase 1 (fak) {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Focal adhesion kinase 1 (fak)
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=0  Score=358.03  Aligned_cols=257  Identities=21%  Similarity=0.382  Sum_probs=213.7

Q ss_pred             HCCCCCCCCCCCCCCCEEEEEEECC----CCEEEEEEECCCCCCHHHHHHHHHHHHHHCCCCCCCEEEEEEEECCCCCEE
Q ss_conf             3058845421548852099999559----939999990246876279999999999851489951148668971899818
Q 005586          408 TQCFSEVNLLGKGNFSSVYKGTLRD----GTLVAIRSINVTSCKSEEAEFVKGLYLLTSLRHENIIRLRGFCCSRGRGEC  483 (689)
Q Consensus       408 ~~~f~~~~~lg~G~~g~Vy~~~~~~----g~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~~  483 (689)
                      .++|...+.||+|+||.||+|++..    +..||+|.++..........+.+|+.++++++||||++++|++.+   +..
T Consensus         6 ~~~~~l~~~iG~G~fg~Vy~a~~~~~~~~~~~vaik~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~---~~~   82 (273)
T d1mp8a_           6 RERIELGRCIGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVKLIGVITE---NPV   82 (273)
T ss_dssp             GGGEEEEEEEEECSSSEEEEEEECCC--CCEEEEEEECTTTTSHHHHHHHHHHHHHHHTCCCTTBCCEEEEECS---SSC
T ss_pred             HHHEEEEEEEEECCCCEEEEEEEECCCCEEEEEEEEEECCCCCHHHHHHHHHHHHHHHHCCCCCEEEEEEEEEC---CEE
T ss_conf             89969877993078829999999369964499999993656687999999999999986899998569889953---747


Q ss_pred             EEEEECCCCCCHHHHHHHCCCCCCCCCHHHHHHHHHHHHHHHHHHHCCCCCCCCEEECCCCCCCEEECCCCCEEEECCCC
Q ss_conf             99997289999888860017999878999999999999999755307999999636258799866545999807803565
Q 005586          484 FLIYDFAPKGKLSKYLDQEEGSSNVLDWSTRVSIIIGIAKGIGYLHSSEVNKPAIVHRNLSVEKVLIDQQFNPLIADCGL  563 (689)
Q Consensus       484 ~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~ia~~ia~gL~~LH~~~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgl  563 (689)
                      ++||||+++|+|.+++.....   .+++..++.++.|++.||.|||+.+     |+||||||+||++++++.+||+|||+
T Consensus        83 ~iv~E~~~~g~l~~~~~~~~~---~l~~~~~~~~~~qi~~gl~ylH~~~-----iiHrDlKp~NIll~~~~~~Kl~DfG~  154 (273)
T d1mp8a_          83 WIIMELCTLGELRSFLQVRKY---SLDLASLILYAYQLSTALAYLESKR-----FVHRDIAARNVLVSSNDCVKLGDFGL  154 (273)
T ss_dssp             EEEEECCTTEEHHHHHHHTTT---TSCHHHHHHHHHHHHHHHHHHHHTT-----CCCSCCSGGGEEEEETTEEEECC---
T ss_pred             EEEEEECCCCCHHHHHHCCCC---CCCHHHHHHHHHHHHHHHHHHCCCC-----EECCCCCHHHEEECCCCCEEECCCHH
T ss_conf             999984069807765422478---9999999999999987752302267-----44141026553206789678765034


Q ss_pred             CCCCCCCCEEEEECCCCCCCCCCCCCCCCCCCCCCCCCHHHHHHHHHHHH-CCCCCCHHHHHHHHHHHHHHHHCCCCCCC
Q ss_conf             33456871134514788878888102235888986640208899999991-99885214778874222567640014899
Q 005586          564 HKLLADDIVFSVLKTSAAMGYLAPEYVTTGRFTERSDIFAFGVIILQILT-GSLVLTSSMRLAAESATFENFIDRNLKGK  642 (689)
Q Consensus       564 a~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~sDv~S~Gvil~ellt-G~~p~~~~~~~~~~~~~~~~~~~~~~~~~  642 (689)
                      ++.+............+|+.|+|||++.+..++.++|||||||++|||+| |.+||........     ...+.......
T Consensus       155 a~~~~~~~~~~~~~~~gt~~y~apE~l~~~~~~~~~DiwSlGvil~e~lt~g~~P~~~~~~~~~-----~~~i~~~~~~~  229 (273)
T d1mp8a_         155 SRYMEDSTYYKASKGKLPIKWMAPESINFRRFTSASDVWMFGVCMWEILMHGVKPFQGVKNNDV-----IGRIENGERLP  229 (273)
T ss_dssp             ----------------CCGGGCCHHHHHHCCCSHHHHHHHHHHHHHHHHTTSCCTTTTCCGGGH-----HHHHHTTCCCC
T ss_pred             HEECCCCCCEECCCEECCCCCCHHHHHCCCCCCCCCCCCCCHHHHHHHHHCCCCCCCCCCHHHH-----HHHHHCCCCCC
T ss_conf             2133677623305400583103266751699887452444247899998269999888999999-----99998189998


Q ss_pred             CCHHHHHHHHHHHHHHCCCCCCCCCCHHHHHHHHHHHC
Q ss_conf             99899999999999811179999999999999998608
Q 005586          643 FSESEAAKLGKMALVCTHEDPENRPTMEAVIEELTVAA  680 (689)
Q Consensus       643 ~~~~~~~~~~~l~~~Cl~~dP~~RPs~~evl~~L~~~~  680 (689)
                      .+...+..+.+++..||+.||.+|||+.+++++|+.+.
T Consensus       230 ~~~~~~~~~~~li~~cl~~dp~~Rps~~ei~~~L~~i~  267 (273)
T d1mp8a_         230 MPPNCPPTLYSLMTKCWAYDPSRRPRFTELKAQLSTIL  267 (273)
T ss_dssp             CCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHH
T ss_pred             CCCCCCHHHHHHHHHHCCCCHHHCCCHHHHHHHHHHHH
T ss_conf             98777999999999976879768929999999999997

>d1jksa_ d.144.1.7 (A:) Death-associated protein kinase, Dap {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Death-associated protein kinase, Dap
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=0  Score=357.94  Aligned_cols=252  Identities=21%  Similarity=0.314  Sum_probs=209.1

Q ss_pred             CCCCCCCCCCCCCCCEEEEEEEC-CCCEEEEEEECCCCC-----CHHHHHHHHHHHHHHCCCCCCCEEEEEEEECCCCCE
Q ss_conf             05884542154885209999955-993999999024687-----627999999999985148995114866897189981
Q 005586          409 QCFSEVNLLGKGNFSSVYKGTLR-DGTLVAIRSINVTSC-----KSEEAEFVKGLYLLTSLRHENIIRLRGFCCSRGRGE  482 (689)
Q Consensus       409 ~~f~~~~~lg~G~~g~Vy~~~~~-~g~~vaiK~~~~~~~-----~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~  482 (689)
                      ++|...+.||+|+||.||+|+.+ +|+.||+|++.+...     ....+.+.+|+.++++++|||||++++++.  +...
T Consensus        10 d~Y~~~~~lG~G~fg~Vy~~~~~~~~~~~AvK~i~~~~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~--~~~~   87 (293)
T d1jksa_          10 DYYDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQHPNVITLHEVYE--NKTD   87 (293)
T ss_dssp             GTEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEBCSSTTCSSSBCHHHHHHHHHHHHHCCCTTBCCEEEEEE--CSSE
T ss_pred             CCEEEEEEEECCCCEEEEEEEECCCCCEEEEEEEEHHHCCHHHHHHHHHHHHHHHHHHHHCCCCCCCCEEEEEE--ECCE
T ss_conf             67798279811789599999999999899999987566321340689999999999998679989993889999--7998


Q ss_pred             EEEEEECCCCCCHHHHHHHCCCCCCCCCHHHHHHHHHHHHHHHHHHHCCCCCCCCEEECCCCCCCEEECCCC----CEEE
Q ss_conf             899997289999888860017999878999999999999999755307999999636258799866545999----8078
Q 005586          483 CFLIYDFAPKGKLSKYLDQEEGSSNVLDWSTRVSIIIGIAKGIGYLHSSEVNKPAIVHRNLSVEKVLIDQQF----NPLI  558 (689)
Q Consensus       483 ~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~ia~~ia~gL~~LH~~~~~~~~ivH~dlk~~Nill~~~~----~~kl  558 (689)
                      .++||||+++|+|.+++....    .+++..+..++.|++.||+|||+.+     |+||||||+|||++.++    .+|+
T Consensus        88 ~~iv~E~~~gg~L~~~i~~~~----~l~~~~~~~~~~qi~~al~yLH~~~-----ivHrDiKp~Nill~~~~~~~~~vkl  158 (293)
T d1jksa_          88 VILILELVAGGELFDFLAEKE----SLTEEEATEFLKQILNGVYYLHSLQ-----IAHFDLKPENIMLLDRNVPKPRIKI  158 (293)
T ss_dssp             EEEEEECCCSCBHHHHHHHHS----SCCHHHHHHHHHHHHHHHHHHHHTT-----EECCCCSGGGEEESCSSSSSCCEEE
T ss_pred             EEEEEECCCCCCCCCHHCCCC----CCCHHHHHHHHHHHHHHHHHHHHCC-----EEECCCCCCEEEEECCCCCCCCEEE
T ss_conf             999998677864310010356----4215578999999999987666254-----2211333012798258986664696


Q ss_pred             ECCCCCCCCCCCCEEEEECCCCCCCCCCCCCCCCCCCCCCCCCHHHHHHHHHHHHCCCCCCHHHHHHHHHHHHHHHHCCC
Q ss_conf             03565334568711345147888788881022358889866402088999999919988521477887422256764001
Q 005586          559 ADCGLHKLLADDIVFSVLKTSAAMGYLAPEYVTTGRFTERSDIFAFGVIILQILTGSLVLTSSMRLAAESATFENFIDRN  638 (689)
Q Consensus       559 ~Dfgla~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~sDv~S~Gvil~elltG~~p~~~~~~~~~~~~~~~~~~~~~  638 (689)
                      +|||+++......  ......+++.|+|||++.+..++.++||||+||++|||++|+.||.+.......    ..+....
T Consensus       159 ~DfG~a~~~~~~~--~~~~~~~t~~y~APE~~~~~~~~~~~DiwSlGvilyell~g~~Pf~~~~~~~~~----~~i~~~~  232 (293)
T d1jksa_         159 IDFGLAHKIDFGN--EFKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGDTKQETL----ANVSAVN  232 (293)
T ss_dssp             CCCTTCEECTTSC--BCSCCCCCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHH----HHHHTTC
T ss_pred             CCHHHHHHCCCCC--CCCCCCCCCCCCCHHHHCCCCCCCCCCCHHHHHHHHHHHCCCCCCCCCCHHHHH----HHHHHCC
T ss_conf             4334421057776--312247777430999981899997665221409999997088998899999999----9998168


Q ss_pred             CCCCCC----HHHHHHHHHHHHHHCCCCCCCCCCHHHHHHHHHHH
Q ss_conf             489999----89999999999981117999999999999999860
Q 005586          639 LKGKFS----ESEAAKLGKMALVCTHEDPENRPTMEAVIEELTVA  679 (689)
Q Consensus       639 ~~~~~~----~~~~~~~~~l~~~Cl~~dP~~RPs~~evl~~L~~~  679 (689)
                        ...+    ...+..+.+++.+||+.||.+|||+.|+++|.|.-
T Consensus       233 --~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~s~~eil~hp~~~  275 (293)
T d1jksa_         233 --YEFEDEYFSNTSALAKDFIRRLLVKDPKKRMTIQDSLQHPWIK  275 (293)
T ss_dssp             --CCCCHHHHTTSCHHHHHHHHTTSCSSGGGSCCHHHHHHSTTTC
T ss_pred             --CCCCCHHCCCCCHHHHHHHHHHCCCCHHHCCCHHHHHCCCCCC
T ss_conf             --8887010478899999999998638966891999996190418

>d1fota_ d.144.1.7 (A:) cAMP-dependent PK, catalytic subunit {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: cAMP-dependent PK, catalytic subunit
species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]

Probab=100.00  E-value=0  Score=354.30  Aligned_cols=249  Identities=22%  Similarity=0.327  Sum_probs=210.1

Q ss_pred             CCCCCCCCCCCCCCCEEEEEEEC-CCCEEEEEEECCCCC--CHHHHHHHHHHHHHHCCCCCCCEEEEEEEECCCCCEEEE
Q ss_conf             05884542154885209999955-993999999024687--627999999999985148995114866897189981899
Q 005586          409 QCFSEVNLLGKGNFSSVYKGTLR-DGTLVAIRSINVTSC--KSEEAEFVKGLYLLTSLRHENIIRLRGFCCSRGRGECFL  485 (689)
Q Consensus       409 ~~f~~~~~lg~G~~g~Vy~~~~~-~g~~vaiK~~~~~~~--~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~~~l  485 (689)
                      ++|+..+.||+|+||.||+|+.+ +|+.||+|++++...  ......+.+|+.++++++||||+++++++.  +....++
T Consensus         4 ~dy~i~~~lG~G~fg~Vy~a~~~~~g~~vAvK~i~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~--~~~~~~i   81 (316)
T d1fota_           4 QDFQILRTLGTGSFGRVHLIRSRHNGRYYAMKVLKKEIVVRLKQVEHTNDERLMLSIVTHPFIIRMWGTFQ--DAQQIFM   81 (316)
T ss_dssp             GGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHSCCBTTBCCEEEEEE--CSSEEEE
T ss_pred             HHEEEEEEEECCCCCEEEEEEECCCCCEEEEEEECHHHCCCHHHHHHHHHHHHHHHHCCCCCHHHEEEEEE--ECCEEEE
T ss_conf             47088889720768089999998999799999984577548899999999999998636967533035685--2880056


Q ss_pred             EEECCCCCCHHHHHHHCCCCCCCCCHHHHHHHHHHHHHHHHHHHCCCCCCCCEEECCCCCCCEEECCCCCEEEECCCCCC
Q ss_conf             99728999988886001799987899999999999999975530799999963625879986654599980780356533
Q 005586          486 IYDFAPKGKLSKYLDQEEGSSNVLDWSTRVSIIIGIAKGIGYLHSSEVNKPAIVHRNLSVEKVLIDQQFNPLIADCGLHK  565 (689)
Q Consensus       486 v~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~ia~~ia~gL~~LH~~~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgla~  565 (689)
                      ||||+++|+|..++.....    +++..+..++.|++.||+|||+.+     |+||||||+|||++.++.+||+|||+|+
T Consensus        82 vmE~~~gg~l~~~~~~~~~----~~~~~~~~~~~qi~~al~~lH~~~-----iiHrDiKp~NILl~~~g~vkL~DFG~a~  152 (316)
T d1fota_          82 IMDYIEGGELFSLLRKSQR----FPNPVAKFYAAEVCLALEYLHSKD-----IIYRDLKPENILLDKNGHIKITDFGFAK  152 (316)
T ss_dssp             EECCCCSCBHHHHHHHTSS----CCHHHHHHHHHHHHHHHHHHHTTT-----EECCCCCGGGEEECTTSCEEECCCSSCE
T ss_pred             EEEECCCCCCCCCCCCCCC----CCCCHHHHHHHHHHHHHHHHCCCC-----EECCCCCCHHEEECCCCCEEEECCCCCE
T ss_conf             7650378632234322221----110079999999987655412476-----7705568105038689988983175216


Q ss_pred             CCCCCCEEEEECCCCCCCCCCCCCCCCCCCCCCCCCHHHHHHHHHHHHCCCCCCHHHHHHHHHHHHHHHHCCCCCCCCCH
Q ss_conf             45687113451478887888810223588898664020889999999199885214778874222567640014899998
Q 005586          566 LLADDIVFSVLKTSAAMGYLAPEYVTTGRFTERSDIFAFGVIILQILTGSLVLTSSMRLAAESATFENFIDRNLKGKFSE  645 (689)
Q Consensus       566 ~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~sDv~S~Gvil~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~  645 (689)
                      ......    ....||+.|+|||++.+..++.++||||+||++|||+||+.||.+.......    ..+....  ..++.
T Consensus       153 ~~~~~~----~~~~Gt~~Y~APE~l~~~~y~~~~DiwSlGvilyemltG~~Pf~~~~~~~~~----~~i~~~~--~~~p~  222 (316)
T d1fota_         153 YVPDVT----YTLCGTPDYIAPEVVSTKPYNKSIDWWSFGILIYEMLAGYTPFYDSNTMKTY----EKILNAE--LRFPP  222 (316)
T ss_dssp             ECSSCB----CCCCSCTTTCCHHHHTTCCBCTTHHHHHHHHHHHHHHHSSCTTCCSSHHHHH----HHHHHCC--CCCCT
T ss_pred             EECCCC----CCCCCCCCCCCHHHHCCCCCCCHHHCCCCCHHHHHHHHCCCCCCCCCHHHHH----HHHHCCC--CCCCC
T ss_conf             712456----4345763435999983899980430465333689997598999996999999----9997089--88997


Q ss_pred             HHHHHHHHHHHHHCCCCCCCCC-----CHHHHHHHHHH
Q ss_conf             9999999999981117999999-----99999999986
Q 005586          646 SEAAKLGKMALVCTHEDPENRP-----TMEAVIEELTV  678 (689)
Q Consensus       646 ~~~~~~~~l~~~Cl~~dP~~RP-----s~~evl~~L~~  678 (689)
                      ..+.++.+++.+|++.||.+|+     ++.++++|.|.
T Consensus       223 ~~s~~~~~li~~~L~~dp~~R~~~~r~t~~~il~Hp~f  260 (316)
T d1fota_         223 FFNEDVKDLLSRLITRDLSQRLGNLQNGTEDVKNHPWF  260 (316)
T ss_dssp             TSCHHHHHHHHHHTCSCTTTCTTSSTTTTHHHHTSGGG
T ss_pred             CCCHHHHHHHHHHHHHCHHHCCCCCHHHHHHHHCCCCC
T ss_conf             78999999999995449976664310219999819351

>d1ywna1 d.144.1.7 (A:818-1166) Vascular endothelial growth factor receptor 2 (kdr) {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Vascular endothelial growth factor receptor 2 (kdr)
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=0  Score=358.29  Aligned_cols=266  Identities=23%  Similarity=0.375  Sum_probs=212.5

Q ss_pred             HHHHHCCCCCCCCCCCCCCCEEEEEEEC------CCCEEEEEEECCCCCCHHHHHHHHHHHHHHCC-CCCCCEEEEEEEE
Q ss_conf             9998305884542154885209999955------99399999902468762799999999998514-8995114866897
Q 005586          404 VESATQCFSEVNLLGKGNFSSVYKGTLR------DGTLVAIRSINVTSCKSEEAEFVKGLYLLTSL-RHENIIRLRGFCC  476 (689)
Q Consensus       404 ~~~~~~~f~~~~~lg~G~~g~Vy~~~~~------~g~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l-~h~niv~l~~~~~  476 (689)
                      ++...++|...+.||+|+||.||+|.+.      +++.||+|+++..........+.+|...+.++ +|+||+.+++++.
T Consensus         8 wei~~~~y~~~~~iG~G~fG~Vy~a~~~~~~~~~~~~~vAvK~l~~~~~~~~~~~~~~e~~~l~~~~~h~~iv~~~~~~~   87 (299)
T d1ywna1           8 WEFPRDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVVNLLGACT   87 (299)
T ss_dssp             HBCCGGGEEEEEEEEECSSCEEEEEEEESTTSSSCEEEEEEEEC----CHHHHHHHHHHHHHHHHHCCCTTBCCEEEEEC
T ss_pred             CCCCHHHEEEEEEEEECCCEEEEEEEECCCCCCCCCEEEEEEEECCCCCCHHHHHHHHHHHHHHHHCCCCEEEEEEEEEC
T ss_conf             26167997984498416783999999867775557839999998600171789999999999886149984997411540


Q ss_pred             CCCCCEEEEEEECCCCCCHHHHHHHCCC------------CCCCCCHHHHHHHHHHHHHHHHHHHCCCCCCCCEEECCCC
Q ss_conf             1899818999972899998888600179------------9987899999999999999975530799999963625879
Q 005586          477 SRGRGECFLIYDFAPKGKLSKYLDQEEG------------SSNVLDWSTRVSIIIGIAKGIGYLHSSEVNKPAIVHRNLS  544 (689)
Q Consensus       477 ~~~~~~~~lv~e~~~~gsL~~~l~~~~~------------~~~~l~~~~~~~ia~~ia~gL~~LH~~~~~~~~ivH~dlk  544 (689)
                      +. ....++||||+++|+|.++++....            ....+++..++.++.|++.||+|||+.+     |+|||||
T Consensus        88 ~~-~~~~~iv~E~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~gl~ylH~~~-----ivHrDlK  161 (299)
T d1ywna1          88 KP-GGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYSFQVAKGMEFLASRK-----CIHRDLA  161 (299)
T ss_dssp             ST-TSCCEEEEECCTTCBHHHHHHHTGGGBCC-----------CBCHHHHHHHHHHHHHHHHHHHHTT-----CCCSCCC
T ss_pred             CC-CCEEEEEEEECCCCCHHHHHHHCCCCCCCCCCCHHHHHCCCCCHHHHHHHHHHHHHHHHHHHHCC-----CCCCCCC
T ss_conf             47-97579999845899299999853666665322202332146899999999999999999887379-----7178677


Q ss_pred             CCCEEECCCCCEEEECCCCCCCCCCCCE-EEEECCCCCCCCCCCCCCCCCCCCCCCCCHHHHHHHHHHHHCC-CCCCHHH
Q ss_conf             9866545999807803565334568711-3451478887888810223588898664020889999999199-8852147
Q 005586          545 VEKVLIDQQFNPLIADCGLHKLLADDIV-FSVLKTSAAMGYLAPEYVTTGRFTERSDIFAFGVIILQILTGS-LVLTSSM  622 (689)
Q Consensus       545 ~~Nill~~~~~~kl~Dfgla~~~~~~~~-~~~~~~~~t~~y~aPE~~~~~~~~~~sDv~S~Gvil~elltG~-~p~~~~~  622 (689)
                      |+|||+++++.+||+|||+|+....... .......||+.|+|||++.++.++.++|||||||++|||+||. .||....
T Consensus       162 p~NILl~~~~~~Kl~DFGla~~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~sDiwS~Gvil~ellt~~~~p~~~~~  241 (299)
T d1ywna1         162 ARNILLSEKNVVKICDFGLARDIYKDPDYVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVK  241 (299)
T ss_dssp             GGGEEECGGGCEEECC------CCSCTTSCCTTSCCCGGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCC
T ss_pred             CCCEEECCCCCEEECCCCCHHHCCCCCCCCCCCCEEECCCCCCHHHHHCCCCCCCCCEEEHHHHHHHHHHCCCCCCCCCC
T ss_conf             31065779982898457520011356652224751667210203686468899663221367899999868899998999


Q ss_pred             HHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHHHHHHCCCCCCCCCCHHHHHHHHHHH
Q ss_conf             788742225676400148999989999999999981117999999999999999860
Q 005586          623 RLAAESATFENFIDRNLKGKFSESEAAKLGKMALVCTHEDPENRPTMEAVIEELTVA  679 (689)
Q Consensus       623 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~Cl~~dP~~RPs~~evl~~L~~~  679 (689)
                      ..    ..+...+........+...+.++.+++.+||+.||++|||+.|++++|+.+
T Consensus       242 ~~----~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rpt~~eil~~L~~i  294 (299)
T d1ywna1         242 ID----EEFCRRLKEGTRMRAPDYTTPEMYQTMLDCWHGEPSQRPTFSELVEHLGNL  294 (299)
T ss_dssp             CS----HHHHHHHHHTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred             HH----HHHHHHHHCCCCCCCCCCCCHHHHHHHHHHCCCCHHHCCCHHHHHHHHHHH
T ss_conf             89----999999963898888865789999999997677966791999999999799

>d1rdqe_ d.144.1.7 (E:) cAMP-dependent PK, catalytic subunit {Mouse (Mus musculus) [TaxId: 10090]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: cAMP-dependent PK, catalytic subunit
species: Mouse (Mus musculus) [TaxId: 10090]

Probab=100.00  E-value=0  Score=353.95  Aligned_cols=251  Identities=18%  Similarity=0.255  Sum_probs=210.3

Q ss_pred             CCCCCCCCCCCCCCCEEEEEEEC-CCCEEEEEEECCCCC--CHHHHHHHHHHHHHHCCCCCCCEEEEEEEECCCCCEEEE
Q ss_conf             05884542154885209999955-993999999024687--627999999999985148995114866897189981899
Q 005586          409 QCFSEVNLLGKGNFSSVYKGTLR-DGTLVAIRSINVTSC--KSEEAEFVKGLYLLTSLRHENIIRLRGFCCSRGRGECFL  485 (689)
Q Consensus       409 ~~f~~~~~lg~G~~g~Vy~~~~~-~g~~vaiK~~~~~~~--~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~~~l  485 (689)
                      ++|+..+.||+|+||.||+|+.+ +|+.||+|++.+...  ......+.+|+.++..++||||+++++++.  +....++
T Consensus        41 d~y~i~~~lG~G~fg~Vy~a~~~~~g~~~AvK~i~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~--~~~~~~~  118 (350)
T d1rdqe_          41 DQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEFSFK--DNSNLYM  118 (350)
T ss_dssp             GGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHTTCCCTTBCCEEEEEE--CSSEEEE
T ss_pred             CCEEEEEEEECCCCCEEEEEEECCCCCEEEEEEECHHHCCCHHHHHHHHHHHHHHHHCCCCCEEECCCCCC--CCCCCCC
T ss_conf             37089889611768089999998999899999982677458899999999999999748772740344443--2222232


Q ss_pred             EEECCCCCCHHHHHHHCCCCCCCCCHHHHHHHHHHHHHHHHHHHCCCCCCCCEEECCCCCCCEEECCCCCEEEECCCCCC
Q ss_conf             99728999988886001799987899999999999999975530799999963625879986654599980780356533
Q 005586          486 IYDFAPKGKLSKYLDQEEGSSNVLDWSTRVSIIIGIAKGIGYLHSSEVNKPAIVHRNLSVEKVLIDQQFNPLIADCGLHK  565 (689)
Q Consensus       486 v~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~ia~~ia~gL~~LH~~~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgla~  565 (689)
                      |+||+.+|+|.+++.....    +++..+..++.|++.||.|||+.+     |+||||||+|||++.++.+||+|||+++
T Consensus       119 v~e~~~~g~l~~~l~~~~~----l~e~~~~~i~~qi~~aL~yLH~~~-----iiHRDIKP~NILl~~~g~ikL~DFG~a~  189 (350)
T d1rdqe_         119 VMEYVAGGEMFSHLRRIGR----FSEPHARFYAAQIVLTFEYLHSLD-----LIYRDLKPENLLIDQQGYIQVTDFGFAK  189 (350)
T ss_dssp             EEECCTTCBHHHHHHHHCC----CCHHHHHHHHHHHHHHHHHHHHTT-----EECCCCSGGGEEECTTSCEEECCCTTCE
T ss_pred             CCCCCCCCCHHHHHHHCCC----CCHHHHHHHHHHHHHHHHHHHHCC-----EECCCCCHHHCCCCCCCCEEEEECEEEE
T ss_conf             2223346622666751589----899999999999999899998599-----8617679999360778978861010333


Q ss_pred             CCCCCCEEEEECCCCCCCCCCCCCCCCCCCCCCCCCHHHHHHHHHHHHCCCCCCHHHHHHHHHHHHHHHHCCCCCCCCCH
Q ss_conf             45687113451478887888810223588898664020889999999199885214778874222567640014899998
Q 005586          566 LLADDIVFSVLKTSAAMGYLAPEYVTTGRFTERSDIFAFGVIILQILTGSLVLTSSMRLAAESATFENFIDRNLKGKFSE  645 (689)
Q Consensus       566 ~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~sDv~S~Gvil~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~  645 (689)
                      .+....    ....||+.|+|||++.+..++.++||||+||++|||+||+.||.........    ..+....  ...+.
T Consensus       190 ~~~~~~----~~~~Gt~~Y~APE~~~~~~~~~~~DiwSlGvilyemltG~~Pf~~~~~~~~~----~~i~~~~--~~~p~  259 (350)
T d1rdqe_         190 RVKGRT----WTLCGTPEALAPEIILSKGYNKAVDWWALGVLIYEMAAGYPPFFADQPIQIY----EKIVSGK--VRFPS  259 (350)
T ss_dssp             ECSSCB----CCCEECGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHH----HHHHHCC--CCCCT
T ss_pred             ECCCCC----CCCCCCCCCCCHHHHCCCCCCCCCCCCCHHHHHHHHHHCCCCCCCCCHHHHH----HHHHCCC--CCCCC
T ss_conf             225666----4336763567889971799885331145007899997588998995999999----9986179--88976


Q ss_pred             HHHHHHHHHHHHHCCCCCCCCC-----CHHHHHHHHHHHC
Q ss_conf             9999999999981117999999-----9999999998608
Q 005586          646 SEAAKLGKMALVCTHEDPENRP-----TMEAVIEELTVAA  680 (689)
Q Consensus       646 ~~~~~~~~l~~~Cl~~dP~~RP-----s~~evl~~L~~~~  680 (689)
                      ..+.++.+++..||+.||.+|+     ++.++++|.|...
T Consensus       260 ~~s~~~~~li~~~L~~dP~kR~~~~r~t~~ell~Hp~f~~  299 (350)
T d1rdqe_         260 HFSSDLKDLLRNLLQVDLTKRFGNLKNGVNDIKNHKWFAT  299 (350)
T ss_dssp             TCCHHHHHHHHHHSCSCTTTCTTSSTTTTHHHHTSGGGTT
T ss_pred             CCCHHHHHHHHHHHHHCHHHCCCCCCCCHHHHHCCCCCCC
T ss_conf             6899999999998340998606553454999971905158

>d1r0pa_ d.144.1.7 (A:) Hepatocyte growth factor receptor, c-MET {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Hepatocyte growth factor receptor, c-MET
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=0  Score=351.96  Aligned_cols=254  Identities=23%  Similarity=0.429  Sum_probs=206.8

Q ss_pred             CCCCCCCCCCEEEEEEECC----CCEEEEEEECCCCCCHHHHHHHHHHHHHHCCCCCCCEEEEEEEECCCCCEEEEEEEC
Q ss_conf             5421548852099999559----939999990246876279999999999851489951148668971899818999972
Q 005586          414 VNLLGKGNFSSVYKGTLRD----GTLVAIRSINVTSCKSEEAEFVKGLYLLTSLRHENIIRLRGFCCSRGRGECFLIYDF  489 (689)
Q Consensus       414 ~~~lg~G~~g~Vy~~~~~~----g~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~~~lv~e~  489 (689)
                      .++||+|+||+||+|++.+    ...||||+++.........+|.+|++++++++||||++++|++.+. .+..++||||
T Consensus        32 ~~~iG~G~fg~Vyk~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~~~g~~~~~-~~~~~lv~E~  110 (311)
T d1r0pa_          32 NEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSLLGICLRS-EGSPLVVLPY  110 (311)
T ss_dssp             EEEEEEETTEEEEEEEECC----CEEEEEEEECCCCCHHHHHHHHHHHHHHHTCCCTTBCCCCEEEEET-TTEEEEEEEC
T ss_pred             CEEEEECCCEEEEEEEEECCCCEEEEEEEEEECCCCCHHHHHHHHHHHHHHHHCCCCCEEEEEEEEEEC-CCCEEEEEEE
T ss_conf             669813688099999997799879999999988436978999999999999867899986786789806-9943899987


Q ss_pred             CCCCCHHHHHHHCCCCCCCCCHHHHHHHHHHHHHHHHHHHCCCCCCCCEEECCCCCCCEEECCCCCEEEECCCCCCCCCC
Q ss_conf             89999888860017999878999999999999999755307999999636258799866545999807803565334568
Q 005586          490 APKGKLSKYLDQEEGSSNVLDWSTRVSIIIGIAKGIGYLHSSEVNKPAIVHRNLSVEKVLIDQQFNPLIADCGLHKLLAD  569 (689)
Q Consensus       490 ~~~gsL~~~l~~~~~~~~~l~~~~~~~ia~~ia~gL~~LH~~~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgla~~~~~  569 (689)
                      +++|+|.+++.....   .+++..++.++.|++.||.|+|+.+     |+||||||+|||+++++.+||+|||+++.+..
T Consensus       111 ~~~g~l~~~~~~~~~---~~~~~~~~~i~~qia~gL~~lH~~~-----iiHrDLK~~NILl~~~~~~kL~DFG~~~~~~~  182 (311)
T d1r0pa_         111 MKHGDLRNFIRNETH---NPTVKDLIGFGLQVAKGMKFLASKK-----FVHRDLAARNCMLDEKFTVKVADFGLARDMYD  182 (311)
T ss_dssp             CTTCBHHHHHHCTTC---CCBHHHHHHHHHHHHHHHHHHHHTT-----CCCSCCSGGGEEECTTCCEEECSSGGGCCTTT
T ss_pred             EECCCHHHHHCCCCC---CCHHHHHHHHHHHHHHHHHHHCCCC-----CCCCCCCHHHEEECCCCCEEEECCCCHHHCCC
T ss_conf             406741442101345---4048999999999887652003367-----62577668757677999889910652322556


Q ss_pred             CCEE---EEECCCCCCCCCCCCCCCCCCCCCCCCCHHHHHHHHHHHHCCCCCCHHHHHHHHHHHHHHHHCCCCCCCCCHH
Q ss_conf             7113---4514788878888102235888986640208899999991998852147788742225676400148999989
Q 005586          570 DIVF---SVLKTSAAMGYLAPEYVTTGRFTERSDIFAFGVIILQILTGSLVLTSSMRLAAESATFENFIDRNLKGKFSES  646 (689)
Q Consensus       570 ~~~~---~~~~~~~t~~y~aPE~~~~~~~~~~sDv~S~Gvil~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  646 (689)
                      ....   ......++..|+|||.+.++.++.++||||||+++|||+||+.||........    ....+........+..
T Consensus       183 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDI~SfGivl~El~t~~~p~~~~~~~~~----~~~~i~~g~~~~~p~~  258 (311)
T d1r0pa_         183 KEFDSVHNKTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVNTFD----ITVYLLQGRRLLQPEY  258 (311)
T ss_dssp             TTCCCTTCTTCSSCCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSCC----------CHHHHHTTCCCCCCTT
T ss_pred             CCCCCCEECCCCCCCCCCCCHHHHHCCCCCCHHHHHHHHHHHHHHHHCCCCCCCCCCHHH----HHHHHHCCCCCCCCCC
T ss_conf             655531002565556455676887437999745746619999999978999988899999----9999980898899644


Q ss_pred             HHHHHHHHHHHHCCCCCCCCCCHHHHHHHHHHHC
Q ss_conf             9999999999811179999999999999998608
Q 005586          647 EAAKLGKMALVCTHEDPENRPTMEAVIEELTVAA  680 (689)
Q Consensus       647 ~~~~~~~l~~~Cl~~dP~~RPs~~evl~~L~~~~  680 (689)
                      .+.++.+++.+||+.||++||+|.||+++|+.+.
T Consensus       259 ~~~~l~~li~~cl~~dP~~RPs~~ei~~~L~~i~  292 (311)
T d1r0pa_         259 CPDPLYEVMLKCWHPKAEMRPSFSELVSRISAIF  292 (311)
T ss_dssp             CCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHH
T ss_pred             CCHHHHHHHHHHCCCCHHHCCCHHHHHHHHHHHH
T ss_conf             7599999999976889768939999999999999

>d1omwa3 d.144.1.7 (A:186-549) G-protein coupled receptor kinase 2 {Cow (Bos taurus) [TaxId: 9913]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: G-protein coupled receptor kinase 2
species: Cow (Bos taurus) [TaxId: 9913]

Probab=100.00  E-value=0  Score=352.14  Aligned_cols=254  Identities=19%  Similarity=0.246  Sum_probs=203.0

Q ss_pred             CCCCCCCCCCCCCCCEEEEEEEC-CCCEEEEEEECCCCC--CHHHH---HHHHHHHHHHCCCCCCCEEEEEEEECCCCCE
Q ss_conf             05884542154885209999955-993999999024687--62799---9999999985148995114866897189981
Q 005586          409 QCFSEVNLLGKGNFSSVYKGTLR-DGTLVAIRSINVTSC--KSEEA---EFVKGLYLLTSLRHENIIRLRGFCCSRGRGE  482 (689)
Q Consensus       409 ~~f~~~~~lg~G~~g~Vy~~~~~-~g~~vaiK~~~~~~~--~~~~~---~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~  482 (689)
                      ++|.+.+.||+|+||.||+|+.+ +|+.||+|++.+...  .....   ....++.+++.++||||+++++++.  +.+.
T Consensus         4 ddy~i~~~lG~G~fg~Vy~~~~~~t~~~vAiK~i~~~~~~~~~~~~~~~~e~~~~~~l~~~~hpnIv~l~~~~~--~~~~   81 (364)
T d1omwa3           4 NDFSVHRIIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMSYAFH--TPDK   81 (364)
T ss_dssp             TTEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHHTCHHHHHHHHHHHHHHSSSCCTTBCCEEEEEE--CSSE
T ss_pred             HHCEEEEEEECCCCEEEEEEEECCCCCEEEEEEECHHHCCHHHHHHHHHHHHHHHHHHHCCCCCCEEEEEEEEE--ECCE
T ss_conf             76851018842889099999999999799999984587542667999999999999985089985889999999--8998


Q ss_pred             EEEEEECCCCCCHHHHHHHCCCCCCCCCHHHHHHHHHHHHHHHHHHHCCCCCCCCEEECCCCCCCEEECCCCCEEEECCC
Q ss_conf             89999728999988886001799987899999999999999975530799999963625879986654599980780356
Q 005586          483 CFLIYDFAPKGKLSKYLDQEEGSSNVLDWSTRVSIIIGIAKGIGYLHSSEVNKPAIVHRNLSVEKVLIDQQFNPLIADCG  562 (689)
Q Consensus       483 ~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~ia~~ia~gL~~LH~~~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg  562 (689)
                      .++||||+++|+|.+++.....    +++..+..++.|++.||.|||+.+     |+||||||+|||+++++.+||+|||
T Consensus        82 ~~ivmE~~~gg~L~~~l~~~~~----~~e~~~~~~~~qi~~aL~ylH~~~-----iiHrDlKP~NILl~~~g~iKl~DFG  152 (364)
T d1omwa3          82 LSFILDLMNGGDLHYHLSQHGV----FSEADMRFYAAEIILGLEHMHNRF-----VVYRDLKPANILLDEHGHVRISDLG  152 (364)
T ss_dssp             EEEEECCCCSCBHHHHHHHHCS----CCHHHHHHHHHHHHHHHHHHHHTT-----EECCCCSGGGEEECSSSCEEECCCT
T ss_pred             EEEEEEECCCCCHHHHHHHCCC----CCHHHHHHHHHHHHHHHHHHHHCC-----CCCEEECCCEEEECCCCCEEEEEEC
T ss_conf             8999991489838999873255----327899999999999999999779-----6220444221678588967982201


Q ss_pred             CCCCCCCCCEEEEECCCCCCCCCCCCCCCC-CCCCCCCCCHHHHHHHHHHHHCCCCCCHHHHHHHHHHHHHHHHCCCCCC
Q ss_conf             533456871134514788878888102235-8889866402088999999919988521477887422256764001489
Q 005586          563 LHKLLADDIVFSVLKTSAAMGYLAPEYVTT-GRFTERSDIFAFGVIILQILTGSLVLTSSMRLAAESATFENFIDRNLKG  641 (689)
Q Consensus       563 la~~~~~~~~~~~~~~~~t~~y~aPE~~~~-~~~~~~sDv~S~Gvil~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~  641 (689)
                      +|+......   .....||+.|+|||++.. ..++.++||||+||++|||+||+.||.........  ...... .....
T Consensus       153 la~~~~~~~---~~~~~GT~~y~APE~~~~~~~~~~~~DiwSlGvilyemltG~~Pf~~~~~~~~~--~~~~~~-~~~~~  226 (364)
T d1omwa3         153 LACDFSKKK---PHASVGTHGYMAPEVLQKGVAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKH--EIDRMT-LTMAV  226 (364)
T ss_dssp             TCEECSSSC---CCSCCSCGGGCCHHHHSTTCCCCTHHHHHHHHHHHHHHHHSSCSSCSSCSSCHH--HHHHHS-SSCCC
T ss_pred             EEEECCCCC---CCCCCCCCCCCHHHHHHCCCCCCCCCCHHHHHHHHHHHHHCCCCCCCCCHHHHH--HHHHHC-CCCCC
T ss_conf             023337886---433113455421687603899984410467789999998599988889989999--999860-46888


Q ss_pred             CCCHHHHHHHHHHHHHHCCCCCCCCCC-----HHHHHHHHHHH
Q ss_conf             999899999999999811179999999-----99999999860
Q 005586          642 KFSESEAAKLGKMALVCTHEDPENRPT-----MEAVIEELTVA  679 (689)
Q Consensus       642 ~~~~~~~~~~~~l~~~Cl~~dP~~RPs-----~~evl~~L~~~  679 (689)
                      ..+...+.++.+++.+||+.||.+||+     +.|+++|.|.-
T Consensus       227 ~~~~~~s~~~~~li~~~L~~dP~~R~t~~~~~a~eil~Hp~f~  269 (364)
T d1omwa3         227 ELPDSFSPELRSLLEGLLQRDVNRRLGCLGRGAQEVKESPFFR  269 (364)
T ss_dssp             CCCSSSCHHHHHHHHHHTCSSTTTSTTTSSSTHHHHHTSGGGT
T ss_pred             CCCCCCCHHHHHHHHHHCCCCHHHHCCCCCCCHHHHHCCCCCC
T ss_conf             7887789999999999856698880887435799997491023

>d1fvra_ d.144.1.7 (A:) Tie2 kinase {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Tie2 kinase
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=0  Score=354.34  Aligned_cols=262  Identities=22%  Similarity=0.400  Sum_probs=210.9

Q ss_pred             CCCCCCCCCCCCCCCEEEEEEEC-CCC--EEEEEEECCCCCCHHHHHHHHHHHHHHCC-CCCCCEEEEEEEECCCCCEEE
Q ss_conf             05884542154885209999955-993--99999902468762799999999998514-899511486689718998189
Q 005586          409 QCFSEVNLLGKGNFSSVYKGTLR-DGT--LVAIRSINVTSCKSEEAEFVKGLYLLTSL-RHENIIRLRGFCCSRGRGECF  484 (689)
Q Consensus       409 ~~f~~~~~lg~G~~g~Vy~~~~~-~g~--~vaiK~~~~~~~~~~~~~~~~e~~~l~~l-~h~niv~l~~~~~~~~~~~~~  484 (689)
                      ++|+..+.||+|+||.||+|+++ ++.  .||||++.........+.+.+|++++.++ +||||++++|++.+  .+..+
T Consensus        10 ~~~~~~~~iG~G~fg~Vy~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~~HpnIv~~~~~~~~--~~~~~   87 (309)
T d1fvra_          10 NDIKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIINLLGACEH--RGYLY   87 (309)
T ss_dssp             GGCEEEEEEECGGGCEEEEEEEEETTEEEEEEEEEEECC------CHHHHHHHHHTTCCCCTTBCCEEEEEEE--TTEEE
T ss_pred             HHCEEEEEEEECCCCEEEEEEECCCCEEEEEEEEEECCCCCHHHHHHHHHHHHHHHHCCCCCCEEEEEEEEEC--CCEEE
T ss_conf             9968877982078828999999899969999999978233857999999999999862289988367888841--87369


Q ss_pred             EEEECCCCCCHHHHHHHCC------------CCCCCCCHHHHHHHHHHHHHHHHHHHCCCCCCCCEEECCCCCCCEEECC
Q ss_conf             9997289999888860017------------9998789999999999999997553079999996362587998665459
Q 005586          485 LIYDFAPKGKLSKYLDQEE------------GSSNVLDWSTRVSIIIGIAKGIGYLHSSEVNKPAIVHRNLSVEKVLIDQ  552 (689)
Q Consensus       485 lv~e~~~~gsL~~~l~~~~------------~~~~~l~~~~~~~ia~~ia~gL~~LH~~~~~~~~ivH~dlk~~Nill~~  552 (689)
                      +||||+++|+|.++++...            .....+++..+.+++.|++.||.|+|+.+     |+||||||+|||++.
T Consensus        88 iV~ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qia~gl~~lH~~~-----iiHrDlkp~NIL~~~  162 (309)
T d1fvra_          88 LAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQKQ-----FIHRDLAARNILVGE  162 (309)
T ss_dssp             EEECCCTTCBHHHHHHTTCHHHHCHHHHHHTTBSCSSCHHHHHHHHHHHHHHHHHHHHTT-----EECSCCSGGGEEECG
T ss_pred             EEEEECCCCCHHHHHHHCCCCCCCHHHHCCCCCCCCCCHHHHHHHHHHHHHHHHHHHCCC-----CCCCCCCCCEEEECC
T ss_conf             999802898699998640355555123101234578999999999999999987663089-----545550520489868


Q ss_pred             CCCEEEECCCCCCCCCCCCEEEEECCCCCCCCCCCCCCCCCCCCCCCCCHHHHHHHHHHHHCCC-CCCHHHHHHHHHHHH
Q ss_conf             9980780356533456871134514788878888102235888986640208899999991998-852147788742225
Q 005586          553 QFNPLIADCGLHKLLADDIVFSVLKTSAAMGYLAPEYVTTGRFTERSDIFAFGVIILQILTGSL-VLTSSMRLAAESATF  631 (689)
Q Consensus       553 ~~~~kl~Dfgla~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~sDv~S~Gvil~elltG~~-p~~~~~~~~~~~~~~  631 (689)
                      ++.+||+|||+++......  ......++..|+|||.+.+..++.++||||||+++|||++|.. ||.......     +
T Consensus       163 ~~~~kl~DfG~a~~~~~~~--~~~~~~gt~~y~aPE~l~~~~~~~~sDvwSfGvil~ell~~~~~p~~~~~~~~-----~  235 (309)
T d1fvra_         163 NYVAKIADFGLSRGQEVYV--KKTMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPYCGMTCAE-----L  235 (309)
T ss_dssp             GGCEEECCTTCEESSCEEC--CC----CCTTTCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCTTTTCCHHH-----H
T ss_pred             CCCEEECCCCCCCCCCCCC--CCCCEECCCCCCCHHHHCCCCCCCCCEEEHHHHHHHHHHHCCCCCCCCCCHHH-----H
T ss_conf             8763874344322444223--45530137755553875269999622153138899999836899999999999-----9


Q ss_pred             HHHHCCCCCCCCCHHHHHHHHHHHHHHCCCCCCCCCCHHHHHHHHHHHCCCCC
Q ss_conf             67640014899998999999999998111799999999999999986087542
Q 005586          632 ENFIDRNLKGKFSESEAAKLGKMALVCTHEDPENRPTMEAVIEELTVAAPVMA  684 (689)
Q Consensus       632 ~~~~~~~~~~~~~~~~~~~~~~l~~~Cl~~dP~~RPs~~evl~~L~~~~~~~~  684 (689)
                      .+.+........+...++++.+++.+||+.||++||+|.+++++|..+.....
T Consensus       236 ~~~i~~~~~~~~~~~~~~~~~~li~~cl~~dP~~RPs~~eil~~L~~i~~~~~  288 (309)
T d1fvra_         236 YEKLPQGYRLEKPLNCDDEVYDLMRQCWREKPYERPSFAQILVSLNRMLEERK  288 (309)
T ss_dssp             HHHGGGTCCCCCCTTBCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHSSS
T ss_pred             HHHHHHCCCCCCCCCCCHHHHHHHHHHCCCCHHHCCCHHHHHHHHHHHHHCCC
T ss_conf             99998268888876678999999999767896689499999999999986186

>d1byga_ d.144.1.7 (A:) Carboxyl-terminal src kinase (csk) {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Carboxyl-terminal src kinase (csk)
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=0  Score=353.47  Aligned_cols=251  Identities=23%  Similarity=0.428  Sum_probs=208.4

Q ss_pred             CCCCCCCCCCCCCCCEEEEEEECCCCEEEEEEECCCCCCHHHHHHHHHHHHHHCCCCCCCEEEEEEEECCCCCEEEEEEE
Q ss_conf             05884542154885209999955993999999024687627999999999985148995114866897189981899997
Q 005586          409 QCFSEVNLLGKGNFSSVYKGTLRDGTLVAIRSINVTSCKSEEAEFVKGLYLLTSLRHENIIRLRGFCCSRGRGECFLIYD  488 (689)
Q Consensus       409 ~~f~~~~~lg~G~~g~Vy~~~~~~g~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~~~lv~e  488 (689)
                      ++|+..+.||+|+||.||+|+++ |+.||+|+++...   ..+.+.+|++++++++||||++++|+|.+. .+..++|||
T Consensus         7 ~~~~~~~~lG~G~fg~Vy~~~~~-~~~vAvK~i~~~~---~~~~~~~E~~~l~~l~HpnIv~~~g~~~~~-~~~~~lv~e   81 (262)
T d1byga_           7 KELKLLQTIGKGEFGDVMLGDYR-GNKVAVKCIKNDA---TAQAFLAEASVMTQLRHSNLVQLLGVIVEE-KGGLYIVTE   81 (262)
T ss_dssp             GGEEEEEEEEECSSCEEEEEEET-TEEEEEEECCCCC-----HHHHHTHHHHTTCCCTTBCCEEEEECCC---CCEEEEC
T ss_pred             HHEEEEEEEECCCCEEEEEEEEC-CEEEEEEEECCHH---HHHHHHHHHHHHHHCCCCCEEEEEEEEEEC-CCCEEEEEE
T ss_conf             99488579820798089999999-9099999988577---799999999999867898985498788723-892899996


Q ss_pred             CCCCCCHHHHHHHCCCCCCCCCHHHHHHHHHHHHHHHHHHHCCCCCCCCEEECCCCCCCEEECCCCCEEEECCCCCCCCC
Q ss_conf             28999988886001799987899999999999999975530799999963625879986654599980780356533456
Q 005586          489 FAPKGKLSKYLDQEEGSSNVLDWSTRVSIIIGIAKGIGYLHSSEVNKPAIVHRNLSVEKVLIDQQFNPLIADCGLHKLLA  568 (689)
Q Consensus       489 ~~~~gsL~~~l~~~~~~~~~l~~~~~~~ia~~ia~gL~~LH~~~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgla~~~~  568 (689)
                      |+++|+|.+++.....  ..++|..+++|+.|++.||+|||+.+     |+||||||+|||++.++.+|++|||+++...
T Consensus        82 y~~~g~L~~~l~~~~~--~~l~~~~~~~i~~~i~~al~ylH~~~-----ivH~dlkp~Nil~~~~~~~kl~dfg~s~~~~  154 (262)
T d1byga_          82 YMAKGSLVDYLRSRGR--SVLGGDCLLKFSLDVCEAMEYLEGNN-----FVHRDLAARNVLVSEDNVAKVSDFGLTKEAS  154 (262)
T ss_dssp             CCTTEEHHHHHHHHHH--HHCCHHHHHHHHHHHHHHHHHHHHTT-----CCCSCCSGGGEEECTTSCEEECCCCC-----
T ss_pred             CCCCCCHHHHHHHCCC--CCCCHHHHHHHHHHHHHHCCCCCCCC-----EECCCCCHHHHEECCCCCEEECCCCCCEECC
T ss_conf             3699989999874578--88899999999999985232113376-----5536665676014689977632456003447


Q ss_pred             CCCEEEEECCCCCCCCCCCCCCCCCCCCCCCCCHHHHHHHHHHHH-CCCCCCHHHHHHHHHHHHHHHHCCCCCCCCCHHH
Q ss_conf             871134514788878888102235888986640208899999991-9988521477887422256764001489999899
Q 005586          569 DDIVFSVLKTSAAMGYLAPEYVTTGRFTERSDIFAFGVIILQILT-GSLVLTSSMRLAAESATFENFIDRNLKGKFSESE  647 (689)
Q Consensus       569 ~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~sDv~S~Gvil~ellt-G~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  647 (689)
                      ...    ....++..|+|||++.+..++.++||||||+++|||+| |++|+......     .+...+....+...+...
T Consensus       155 ~~~----~~~~~~~~y~aPE~l~~~~~t~~sDIwSfG~il~el~t~~~~p~~~~~~~-----~~~~~i~~~~~~~~~~~~  225 (262)
T d1byga_         155 STQ----DTGKLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRIPLK-----DVVPRVEKGYKMDAPDGC  225 (262)
T ss_dssp             -----------CCTTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSCTTSCGG-----GHHHHHTTTCCCCCCTTC
T ss_pred             CCC----CCCCCCCCCCCHHHHHCCCCCHHHHHHHHHHHHHHHHHCCCCCCCCCCHH-----HHHHHHHCCCCCCCCCCC
T ss_conf             877----65566646778178727988858877757999999997899999999999-----999999808999997657


Q ss_pred             HHHHHHHHHHHCCCCCCCCCCHHHHHHHHHHHC
Q ss_conf             999999999811179999999999999998608
Q 005586          648 AAKLGKMALVCTHEDPENRPTMEAVIEELTVAA  680 (689)
Q Consensus       648 ~~~~~~l~~~Cl~~dP~~RPs~~evl~~L~~~~  680 (689)
                      +.++.+++.+||+.||.+||+|.+++++|+.+.
T Consensus       226 ~~~~~~li~~cl~~dP~~Rps~~~l~~~L~~i~  258 (262)
T d1byga_         226 PPAVYEVMKNCWHLDAAMRPSFLQLREQLEHIK  258 (262)
T ss_dssp             CHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHH
T ss_pred             CHHHHHHHHHHCCCCHHHCCCHHHHHHHHHHHH
T ss_conf             999999999975669768939999999999998

>d1p4oa_ d.144.1.7 (A:) Insulin-like growth factor 1 receptor {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Insulin-like growth factor 1 receptor
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=0  Score=350.52  Aligned_cols=262  Identities=21%  Similarity=0.372  Sum_probs=212.6

Q ss_pred             HCCCCCCCCCCCCCCCEEEEEEEC------CCCEEEEEEECCCCCCHHHHHHHHHHHHHHCCCCCCCEEEEEEEECCCCC
Q ss_conf             305884542154885209999955------99399999902468762799999999998514899511486689718998
Q 005586          408 TQCFSEVNLLGKGNFSSVYKGTLR------DGTLVAIRSINVTSCKSEEAEFVKGLYLLTSLRHENIIRLRGFCCSRGRG  481 (689)
Q Consensus       408 ~~~f~~~~~lg~G~~g~Vy~~~~~------~g~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~  481 (689)
                      .++|...+.||+|+||.||+|.++      +++.||||+++..........|.+|+.++.+++||||++++|++.  ...
T Consensus        19 ~~~~~l~~~lG~G~fG~Vy~a~~~~~~~~~~~~~VAvK~~~~~~~~~~~~~~~~E~~il~~l~h~nIv~~~~~~~--~~~   96 (308)
T d1p4oa_          19 REKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKEFNCHHVVRLLGVVS--QGQ   96 (308)
T ss_dssp             GGGEEEEEEEEECSSSEEEEEEEEEEETTEEEEEEEEEECCTTSCHHHHHHHHHHHHHGGGCCCTTBCCEEEEEC--SSS
T ss_pred             HHHEEEEEEEEECCCEEEEEEEECCCCCCCCCCEEEEEEECCCCCHHHHHHHHHHHHHHHHCCCCCEEEEEEEEE--CCC
T ss_conf             899188359820788189999987864477896899999870128689999999999999769998841254784--288


Q ss_pred             EEEEEEECCCCCCHHHHHHHCC------CCCCCCCHHHHHHHHHHHHHHHHHHHCCCCCCCCEEECCCCCCCEEECCCCC
Q ss_conf             1899997289999888860017------9998789999999999999997553079999996362587998665459998
Q 005586          482 ECFLIYDFAPKGKLSKYLDQEE------GSSNVLDWSTRVSIIIGIAKGIGYLHSSEVNKPAIVHRNLSVEKVLIDQQFN  555 (689)
Q Consensus       482 ~~~lv~e~~~~gsL~~~l~~~~------~~~~~l~~~~~~~ia~~ia~gL~~LH~~~~~~~~ivH~dlk~~Nill~~~~~  555 (689)
                      ..++||||+++|+|.+++....      .....+++..+.+++.|++.||.|||+.+     |+||||||+|||+++++.
T Consensus        97 ~~~lv~e~~~~g~l~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~ia~gl~~LH~~~-----ivHrDlk~~NiLld~~~~  171 (308)
T d1p4oa_          97 PTLVIMELMTRGDLKSYLRSLRPAMANNPVLAPPSLSKMIQMAGEIADGMAYLNANK-----FVHRDLAARNCMVAEDFT  171 (308)
T ss_dssp             SCEEEEECCTTCBHHHHHHHHHHHHHHCTTCCCCCHHHHHHHHHHHHHHHHHHHHTT-----CBCSCCSGGGEEECTTCC
T ss_pred             CEEEEEEECCCCCHHHHHHHCCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHHCC-----EEECEECCCCEEECCCCE
T ss_conf             106777604899889998750332113444688799999999999999999876479-----654328677540359964


Q ss_pred             EEEECCCCCCCCCCCCEEE-EECCCCCCCCCCCCCCCCCCCCCCCCCHHHHHHHHHHHHCC-CCCCHHHHHHHHHHHHHH
Q ss_conf             0780356533456871134-51478887888810223588898664020889999999199-885214778874222567
Q 005586          556 PLIADCGLHKLLADDIVFS-VLKTSAAMGYLAPEYVTTGRFTERSDIFAFGVIILQILTGS-LVLTSSMRLAAESATFEN  633 (689)
Q Consensus       556 ~kl~Dfgla~~~~~~~~~~-~~~~~~t~~y~aPE~~~~~~~~~~sDv~S~Gvil~elltG~-~p~~~~~~~~~~~~~~~~  633 (689)
                      +||+|||+++.+....... .....+++.|+|||.+.+..++.++||||||+++|||+||. .||.......    .+..
T Consensus       172 ~Kl~DFGla~~~~~~~~~~~~~~~~~t~~y~aPe~l~~~~~~~~~Dv~S~G~il~El~t~~~~p~~~~~~~~----~~~~  247 (308)
T d1p4oa_         172 VKIGDFGMTRDIYETDYYRKGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIATLAEQPYQGLSNEQ----VLRF  247 (308)
T ss_dssp             EEECCTTCCCGGGGGGCEEGGGSSEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHHTSCCTTTTSCHHH----HHHH
T ss_pred             EEEEECCCCEECCCCCCEEECCCEECCCCCCCHHHHCCCCCCCCCCCCCHHHHHHHHHHCCCCCCCCCCHHH----HHHH
T ss_conf             999424542023577630313402316323788887369988333444378999999968999999989999----9999


Q ss_pred             HHCCCCCCCCCHHHHHHHHHHHHHHCCCCCCCCCCHHHHHHHHHHHCC
Q ss_conf             640014899998999999999998111799999999999999986087
Q 005586          634 FIDRNLKGKFSESEAAKLGKMALVCTHEDPENRPTMEAVIEELTVAAP  681 (689)
Q Consensus       634 ~~~~~~~~~~~~~~~~~~~~l~~~Cl~~dP~~RPs~~evl~~L~~~~~  681 (689)
                      +.+ ......+...+..+.+++.+||+.+|.+||+|.+|+++|+....
T Consensus       248 i~~-~~~~~~p~~~~~~l~~li~~cl~~~P~~RPs~~~il~~L~~~~~  294 (308)
T d1p4oa_         248 VME-GGLLDKPDNCPDMLFELMRMCWQYNPKMRPSFLEIISSIKEEME  294 (308)
T ss_dssp             HHT-TCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHGGGSC
T ss_pred             HHH-CCCCCCCCCCHHHHHHHHHHHCCCCHHHCCCHHHHHHHHHHHCC
T ss_conf             980-88888863353999999999757796589399999999787617

>d1tkia_ d.144.1.7 (A:) Titin, kinase domain {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Titin, kinase domain
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=0  Score=350.10  Aligned_cols=253  Identities=17%  Similarity=0.231  Sum_probs=209.4

Q ss_pred             HCCCCCCCCCCCCCCCEEEEEEEC-CCCEEEEEEECCCCCCHHHHHHHHHHHHHHCCCCCCCEEEEEEEECCCCCEEEEE
Q ss_conf             305884542154885209999955-9939999990246876279999999999851489951148668971899818999
Q 005586          408 TQCFSEVNLLGKGNFSSVYKGTLR-DGTLVAIRSINVTSCKSEEAEFVKGLYLLTSLRHENIIRLRGFCCSRGRGECFLI  486 (689)
Q Consensus       408 ~~~f~~~~~lg~G~~g~Vy~~~~~-~g~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~~~lv  486 (689)
                      .++|.+.+.||+|+||.||+|+.+ +++.||+|+++...  .....+.+|++++.+++||||+++++++.+  .+..|+|
T Consensus         4 ~~rY~i~~~lG~G~fg~Vy~~~~~~~~~~~AiK~i~~~~--~~~~~~~~Ei~il~~l~HpnIv~~~~~~~~--~~~~~lv   79 (321)
T d1tkia_           4 YEKYMIAEDLGRGEFGIVHRCVETSSKKTYMAKFVKVKG--TDQVLVKKEISILNIARHRNILHLHESFES--MEELVMI   79 (321)
T ss_dssp             TTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECCCT--HHHHHHHHHHHHHHHSCCTTBCCEEEEEEE--TTEEEEE
T ss_pred             CCCEEEEEEEECCCCEEEEEEEECCCCCEEEEEEECCCC--CCHHHHHHHHHHHHHCCCCCCCEEEEEEEE--CCEEEEE
T ss_conf             010588789831778399999998999699999975786--659999999999985799798909899988--9988999


Q ss_pred             EECCCCCCHHHHHHHCCCCCCCCCHHHHHHHHHHHHHHHHHHHCCCCCCCCEEECCCCCCCEEECC--CCCEEEECCCCC
Q ss_conf             972899998888600179998789999999999999997553079999996362587998665459--998078035653
Q 005586          487 YDFAPKGKLSKYLDQEEGSSNVLDWSTRVSIIIGIAKGIGYLHSSEVNKPAIVHRNLSVEKVLIDQ--QFNPLIADCGLH  564 (689)
Q Consensus       487 ~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~ia~~ia~gL~~LH~~~~~~~~ivH~dlk~~Nill~~--~~~~kl~Dfgla  564 (689)
                      |||+++|+|.+++.....   .+++.++..|+.|++.||.|||+.+     |+||||||+|||++.  ...+||+|||++
T Consensus        80 mE~~~gg~L~~~i~~~~~---~l~e~~~~~i~~qi~~al~yLH~~~-----iiHrDlKp~NIll~~~~~~~ikl~DFG~~  151 (321)
T d1tkia_          80 FEFISGLDIFERINTSAF---ELNEREIVSYVHQVCEALQFLHSHN-----IGHFDIRPENIIYQTRRSSTIKIIEFGQA  151 (321)
T ss_dssp             ECCCCCCBHHHHHTSSSC---CCCHHHHHHHHHHHHHHHHHHHHTT-----EECCCCCGGGEEESSSSCCCEEECCCTTC
T ss_pred             EECCCCCCHHHHHHHCCC---CCCHHHHHHHHHHHHHHHHHHHHCC-----CCCCCCCCCCEEECCCCCEEEEECCCCHH
T ss_conf             953899808899875389---9999999999999999999998769-----97513554443443788518997644111


Q ss_pred             CCCCCCCEEEEECCCCCCCCCCCCCCCCCCCCCCCCCHHHHHHHHHHHHCCCCCCHHHHHHHHHHHHHHHHCCCCCCCCC
Q ss_conf             34568711345147888788881022358889866402088999999919988521477887422256764001489999
Q 005586          565 KLLADDIVFSVLKTSAAMGYLAPEYVTTGRFTERSDIFAFGVIILQILTGSLVLTSSMRLAAESATFENFIDRNLKGKFS  644 (689)
Q Consensus       565 ~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~sDv~S~Gvil~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~  644 (689)
                      +.......  .....+++.|+|||...+..++.++||||+||++|||++|+.||.........    ..+.....  .++
T Consensus       152 ~~~~~~~~--~~~~~~t~~y~ape~~~~~~~~~~~DiWSlGvily~ll~G~~Pf~~~~~~~~~----~~i~~~~~--~~~  223 (321)
T d1tkia_         152 RQLKPGDN--FRLLFTAPEYYAPEVHQHDVVSTATDMWSLGTLVYVLLSGINPFLAETNQQII----ENIMNAEY--TFD  223 (321)
T ss_dssp             EECCTTCE--EEEEESCGGGSCHHHHTTCEECHHHHHHHHHHHHHHHHHSSCTTCCSSHHHHH----HHHHHTCC--CCC
T ss_pred             HCCCCCCC--CCCCCCCCCCCCCHHCCCCCCCCHHHCCCHHHHHHHHHHCCCCCCCCCHHHHH----HHHHHCCC--CCC
T ss_conf             00346775--32122332223402104877784011302799999998289999998999999----99983899--988


Q ss_pred             H----HHHHHHHHHHHHHCCCCCCCCCCHHHHHHHHHHHC
Q ss_conf             8----99999999999811179999999999999998608
Q 005586          645 E----SEAAKLGKMALVCTHEDPENRPTMEAVIEELTVAA  680 (689)
Q Consensus       645 ~----~~~~~~~~l~~~Cl~~dP~~RPs~~evl~~L~~~~  680 (689)
                      .    ..+.++.+++.+|+..||.+||++.|+++|.|...
T Consensus       224 ~~~~~~~s~~~~~li~~~L~~dp~~R~s~~eil~hp~~~~  263 (321)
T d1tkia_         224 EEAFKEISIEAMDFVDRLLVKERKSRMTASEALQHPWLKQ  263 (321)
T ss_dssp             HHHHTTSCHHHHHHHHTTSCSSGGGSCCHHHHHHSHHHHS
T ss_pred             HHHCCCCCHHHHHHHHHHCCCCHHHCCCHHHHHCCHHHCC
T ss_conf             0223678999999999986699668909999963996566

>d2ozaa1 d.144.1.7 (A:51-385) MAP kinase activated protein kinase 2, mapkap2 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: MAP kinase activated protein kinase 2, mapkap2
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=0  Score=348.44  Aligned_cols=256  Identities=17%  Similarity=0.221  Sum_probs=202.4

Q ss_pred             CCCCCC-CCCCCCCCCEEEEEEEC-CCCEEEEEEECCCCCCHHHHHHHHHHHHHHCC-CCCCCEEEEEEEEC--CCCCEE
Q ss_conf             058845-42154885209999955-99399999902468762799999999998514-89951148668971--899818
Q 005586          409 QCFSEV-NLLGKGNFSSVYKGTLR-DGTLVAIRSINVTSCKSEEAEFVKGLYLLTSL-RHENIIRLRGFCCS--RGRGEC  483 (689)
Q Consensus       409 ~~f~~~-~~lg~G~~g~Vy~~~~~-~g~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l-~h~niv~l~~~~~~--~~~~~~  483 (689)
                      ++|.+. +.||+|+||.||+|+.. +++.||+|++...      ..+.+|+.++.++ +||||+++++++..  ......
T Consensus        11 ~~y~i~~~~lG~G~fg~Vy~a~~~~~~~~vAiK~i~~~------~~~~~E~~~~~~~~~hpnIv~l~~~~~~~~~~~~~~   84 (335)
T d2ozaa1          11 DDYKVTSQVLGLGINGKVLQIFNKRTQEKFALKMLQDC------PKARREVELHWRASQCPHIVRIVDVYENLYAGRKCL   84 (335)
T ss_dssp             GTEEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEECS------HHHHHHHHHHHHHTTSTTBCCEEEEEEEEETTEEEE
T ss_pred             CCEEEEEEEEEECCCEEEEEEEECCCCCEEEEEEECCC------HHHHHHHHHHHHHCCCCCCCEEEEEEEECCCCCCEE
T ss_conf             48798107965454869999998899989999998974------779999999998669999782989995034689789


Q ss_pred             EEEEECCCCCCHHHHHHHCCCCCCCCCHHHHHHHHHHHHHHHHHHHCCCCCCCCEEECCCCCCCEEECC---CCCEEEEC
Q ss_conf             999972899998888600179998789999999999999997553079999996362587998665459---99807803
Q 005586          484 FLIYDFAPKGKLSKYLDQEEGSSNVLDWSTRVSIIIGIAKGIGYLHSSEVNKPAIVHRNLSVEKVLIDQ---QFNPLIAD  560 (689)
Q Consensus       484 ~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~ia~~ia~gL~~LH~~~~~~~~ivH~dlk~~Nill~~---~~~~kl~D  560 (689)
                      |+||||+++|+|.+++.....  ..+++.++..|+.|++.||+|||+.+     |+||||||+|||+++   ++.+||+|
T Consensus        85 ~ivmEy~~gg~L~~~i~~~~~--~~l~e~~~~~i~~qi~~al~ylH~~~-----iiHRDiKp~NIll~~~~~~~~~Kl~D  157 (335)
T d2ozaa1          85 LIVMECLDGGELFSRIQDRGD--QAFTEREASEIMKSIGEAIQYLHSIN-----IAHRDVKPENLLYTSKRPNAILKLTD  157 (335)
T ss_dssp             EEEEECCCSEEHHHHHHSCSC--CCEEHHHHHHHHHHHHHHHHHHHHTT-----EECCCCSGGGEEESCSSTTCCEEECC
T ss_pred             EEEEECCCCCCHHHHHHHCCC--CCCCHHHHHHHHHHHHHHHHHHHHCC-----CCCCCCCCCCCCCCCCCCCCCCCCCC
T ss_conf             999977899849999986278--77579999999999999999999769-----86444100220113555566311354


Q ss_pred             CCCCCCCCCCCEEEEECCCCCCCCCCCCCCCCCCCCCCCCCHHHHHHHHHHHHCCCCCCHHHHHHHHHHHHHHHHCCCCC
Q ss_conf             56533456871134514788878888102235888986640208899999991998852147788742225676400148
Q 005586          561 CGLHKLLADDIVFSVLKTSAAMGYLAPEYVTTGRFTERSDIFAFGVIILQILTGSLVLTSSMRLAAESATFENFIDRNLK  640 (689)
Q Consensus       561 fgla~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~sDv~S~Gvil~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~  640 (689)
                      ||+++......  ......||+.|+|||++.+..|+.++||||+||++|||+||+.||.+.............+......
T Consensus       158 FG~a~~~~~~~--~~~~~~gt~~y~aPE~~~~~~y~~~~DiwSlGvily~lltg~~Pf~~~~~~~~~~~~~~~i~~~~~~  235 (335)
T d2ozaa1         158 FGFAKETTSHN--SLTTPCYTPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGYPPFYSNHGLAISPGMKTRIRMGQYE  235 (335)
T ss_dssp             CTTCEECCCCC--CCCCCSCCCSSCCCCCCCGGGGSHHHHHHHHHHHHHHHTTSSCSCEETTCC--------CCCSCSSS
T ss_pred             CCEEEECCCCC--CCCCCCCCCCCCCCHHHCCCCCCHHHHHHHHCHHHHHHHHCCCCCCCCCHHHHHHHHHHHHHCCCCC
T ss_conf             55123336888--6432267756379277748988888888764516778865889988988778899999998538888


Q ss_pred             CC--CCHHHHHHHHHHHHHHCCCCCCCCCCHHHHHHHHHHH
Q ss_conf             99--9989999999999981117999999999999999860
Q 005586          641 GK--FSESEAAKLGKMALVCTHEDPENRPTMEAVIEELTVA  679 (689)
Q Consensus       641 ~~--~~~~~~~~~~~l~~~Cl~~dP~~RPs~~evl~~L~~~  679 (689)
                      ..  .....+.++.+++.+||+.||++||++.|+++|.|..
T Consensus       236 ~~~~~~~~~s~~~~~li~~~L~~dP~~R~s~~eil~hp~~~  276 (335)
T d2ozaa1         236 FPNPEWSEVSEEVKMLIRNLLKTEPTQRMTITEFMNHPWIM  276 (335)
T ss_dssp             CCTTHHHHSCHHHHHHHHHHSCSSTTTSCCHHHHHHSHHHH
T ss_pred             CCCCCCCCCCHHHHHHHHHHCCCCHHHCCCHHHHHCCHHHH
T ss_conf             89854346999999999997569965790999997098761

>d1fgka_ d.144.1.7 (A:) Fibroblast growth factor receptor 1 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Fibroblast growth factor receptor 1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=0  Score=348.49  Aligned_cols=260  Identities=24%  Similarity=0.409  Sum_probs=213.6

Q ss_pred             CCCCCCCCCCCCCCCEEEEEEECC--------CCEEEEEEECCCCCCHHHHHHHHHHHHHHCC-CCCCCEEEEEEEECCC
Q ss_conf             058845421548852099999559--------9399999902468762799999999998514-8995114866897189
Q 005586          409 QCFSEVNLLGKGNFSSVYKGTLRD--------GTLVAIRSINVTSCKSEEAEFVKGLYLLTSL-RHENIIRLRGFCCSRG  479 (689)
Q Consensus       409 ~~f~~~~~lg~G~~g~Vy~~~~~~--------g~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l-~h~niv~l~~~~~~~~  479 (689)
                      ++|...+.||+|+||.||+|+...        +..||+|+++.........++.+|...+.++ +|||||+++++|.+  
T Consensus        13 ~~~~l~~~iG~G~fg~Vy~~~~~~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~e~~~l~~~~~HpnIv~~~~~~~~--   90 (299)
T d1fgka_          13 DRLVLGKPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGKHKNIINLLGACTQ--   90 (299)
T ss_dssp             GGEEEEEECC-----CEEEEEEECC----CCCEEEEEEECCCTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECS--
T ss_pred             HHEEEEEEEEECCCCEEEEEEECCCCCCCCCCCEEEEEEEECCCCCHHHHHHHHHHHHHHHHHCCCCEEEECCCCCCC--
T ss_conf             996970098516782899999857875556675499999988112868899999999999981399969734652201--


Q ss_pred             CCEEEEEEECCCCCCHHHHHHHCCC------------CCCCCCHHHHHHHHHHHHHHHHHHHCCCCCCCCEEECCCCCCC
Q ss_conf             9818999972899998888600179------------9987899999999999999975530799999963625879986
Q 005586          480 RGECFLIYDFAPKGKLSKYLDQEEG------------SSNVLDWSTRVSIIIGIAKGIGYLHSSEVNKPAIVHRNLSVEK  547 (689)
Q Consensus       480 ~~~~~lv~e~~~~gsL~~~l~~~~~------------~~~~l~~~~~~~ia~~ia~gL~~LH~~~~~~~~ivH~dlk~~N  547 (689)
                      ....++||||+++|+|.+++.....            ....+++.+++.++.|++.||+|||+.+     |+||||||+|
T Consensus        91 ~~~~~~v~e~~~~g~l~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~ylH~~~-----ivHrDiKp~N  165 (299)
T d1fgka_          91 DGPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLSSKDLVSCAYQVARGMEYLASKK-----CIHRDLAARN  165 (299)
T ss_dssp             SSSCEEEECCCTTCBHHHHHHTTSCC------------CCCCCHHHHHHHHHHHHHHHHHHHHTT-----CCCSCCSGGG
T ss_pred             CCEEEEEEECCCCCCHHHHHHHHCCCCCCCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHHCC-----EEEEEECCCC
T ss_conf             88689999736999099999860677643222334574346799999999999999998766379-----7863022102


Q ss_pred             EEECCCCCEEEECCCCCCCCCCCCEE-EEECCCCCCCCCCCCCCCCCCCCCCCCCHHHHHHHHHHHH-CCCCCCHHHHHH
Q ss_conf             65459998078035653345687113-4514788878888102235888986640208899999991-998852147788
Q 005586          548 VLIDQQFNPLIADCGLHKLLADDIVF-SVLKTSAAMGYLAPEYVTTGRFTERSDIFAFGVIILQILT-GSLVLTSSMRLA  625 (689)
Q Consensus       548 ill~~~~~~kl~Dfgla~~~~~~~~~-~~~~~~~t~~y~aPE~~~~~~~~~~sDv~S~Gvil~ellt-G~~p~~~~~~~~  625 (689)
                      ||++.++.+||+|||+++........ ......+++.|+|||.+.++.++.++||||||+++|||++ |..||.......
T Consensus       166 iLl~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~l~~~~y~~k~DiwS~Gvvl~ell~~g~~p~~~~~~~~  245 (299)
T d1fgka_         166 VLVTEDNVMKIADFGLARDIHHIDYYKKTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGSPYPGVPVEE  245 (299)
T ss_dssp             EEECTTCCEEECSTTCCCCGGGCCTTCCCTTSCCGGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCHHH
T ss_pred             EEECCCCCEEECCCHHHCCCCCCCCCCCCCCCCCCHHHHHHHHHCCCCCCCHHHHHHHHHHHHHHCCCCCCCCCCCCHHH
T ss_conf             24547897676221110113555554314667888466326675179888255547758888874017989899999999


Q ss_pred             HHHHHHHHHHCCCCCCCCCHHHHHHHHHHHHHHCCCCCCCCCCHHHHHHHHHHHC
Q ss_conf             7422256764001489999899999999999811179999999999999998608
Q 005586          626 AESATFENFIDRNLKGKFSESEAAKLGKMALVCTHEDPENRPTMEAVIEELTVAA  680 (689)
Q Consensus       626 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~Cl~~dP~~RPs~~evl~~L~~~~  680 (689)
                           ..+.+........+...+..+.+++.+||+.||.+|||+.||++.|+.+.
T Consensus       246 -----~~~~i~~~~~~~~p~~~~~~l~~li~~cl~~dP~~Rps~~eil~~L~~i~  295 (299)
T d1fgka_         246 -----LFKLLKEGHRMDKPSNCTNELYMMMRDCWHAVPSQRPTFKQLVEDLDRIV  295 (299)
T ss_dssp             -----HHHHHHTTCCCCCCSSCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHH
T ss_pred             -----HHHHHHCCCCCCCCCCCHHHHHHHHHHHCCCCHHHCCCHHHHHHHHHHHH
T ss_conf             -----99999728888987435299999999976679767939999999998886

>d1t46a_ d.144.1.7 (A:) c-KIT receptor {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: c-KIT receptor
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=0  Score=348.04  Aligned_cols=261  Identities=22%  Similarity=0.380  Sum_probs=214.6

Q ss_pred             HCCCCCCCCCCCCCCCEEEEEEEC------CCCEEEEEEECCCCCCHHHHHHHHHHHHHHCC-CCCCCEEEEEEEECCCC
Q ss_conf             305884542154885209999955------99399999902468762799999999998514-89951148668971899
Q 005586          408 TQCFSEVNLLGKGNFSSVYKGTLR------DGTLVAIRSINVTSCKSEEAEFVKGLYLLTSL-RHENIIRLRGFCCSRGR  480 (689)
Q Consensus       408 ~~~f~~~~~lg~G~~g~Vy~~~~~------~g~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l-~h~niv~l~~~~~~~~~  480 (689)
                      .++|+..+.||+|+||.||+|+++      +++.||||+++.........++.+|+.++..+ +|||||+++|++.  +.
T Consensus        22 ~~~~~l~~~iG~G~fg~Vy~a~~~~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~E~~~~~~l~~HpnIv~~~g~~~--~~   99 (311)
T d1t46a_          22 RNRLSFGKTLGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSAHLTEREALMSELKVLSYLGNHMNIVNLLGACT--IG   99 (311)
T ss_dssp             GGGEEEEEEEEECSSEEEEEEEEESSSSTTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEEC--SS
T ss_pred             HHHEEEEEEEEECCCEEEEEEEEECCCCCCCCEEEEEEEECCCCCHHHHHHHHHHHHHHHHCCCCCCEEEEEEEEE--EC
T ss_conf             8996985498206882999999806644778869999998742487799999999999876269998878998983--19


Q ss_pred             CEEEEEEECCCCCCHHHHHHHCCC--------------CCCCCCHHHHHHHHHHHHHHHHHHHCCCCCCCCEEECCCCCC
Q ss_conf             818999972899998888600179--------------998789999999999999997553079999996362587998
Q 005586          481 GECFLIYDFAPKGKLSKYLDQEEG--------------SSNVLDWSTRVSIIIGIAKGIGYLHSSEVNKPAIVHRNLSVE  546 (689)
Q Consensus       481 ~~~~lv~e~~~~gsL~~~l~~~~~--------------~~~~l~~~~~~~ia~~ia~gL~~LH~~~~~~~~ivH~dlk~~  546 (689)
                      ...++||||+++|+|.++++....              ....+++..+..++.|++.||+|||+++     ++||||||+
T Consensus       100 ~~~~lvmE~~~~g~l~~~l~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~gl~~LH~~~-----ivHrDLKp~  174 (311)
T d1t46a_         100 GPTLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELALDLEDLLSFSYQVAKGMAFLASKN-----CIHRDLAAR  174 (311)
T ss_dssp             SSCEEEEECCTTEEHHHHHHHTTTTC--------------CCCCHHHHHHHHHHHHHHHHHHHHTT-----CCCSCCSGG
T ss_pred             CEEEEEEECCCCCCHHHHHHHCCCCCCCCCCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHHCC-----EEECCCCCC
T ss_conf             978999973799879999985356654444453322233458899999999999999999887579-----266624102


Q ss_pred             CEEECCCCCEEEECCCCCCCCCCCCE-EEEECCCCCCCCCCCCCCCCCCCCCCCCCHHHHHHHHHHHHCCCC-CCHHHHH
Q ss_conf             66545999807803565334568711-345147888788881022358889866402088999999919988-5214778
Q 005586          547 KVLIDQQFNPLIADCGLHKLLADDIV-FSVLKTSAAMGYLAPEYVTTGRFTERSDIFAFGVIILQILTGSLV-LTSSMRL  624 (689)
Q Consensus       547 Nill~~~~~~kl~Dfgla~~~~~~~~-~~~~~~~~t~~y~aPE~~~~~~~~~~sDv~S~Gvil~elltG~~p-~~~~~~~  624 (689)
                      ||+++.++.+|++|||.++....... .......+++.|+|||++.++.++.++||||||+++|||+|++.| +..... 
T Consensus       175 NIl~~~~~~~ki~DfG~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DIwS~G~~l~ellt~g~p~~~~~~~-  253 (311)
T d1t46a_         175 NILLTHGRITKICDFGLARDIKNDSNYVVKGNARLPVKWMAPESIFNCVYTFESDVWSYGIFLWELFSLGSSPYPGMPV-  253 (311)
T ss_dssp             GEEEETTTEEEECCCGGGSCTTSCTTSEECSSSEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCSSTTCCS-
T ss_pred             CCCCCCCCCCCCCCCCHHEECCCCCCCEEEEECCCCHHHCCHHHHCCCCCCCCCCCCCHHHHHHHHHHCCCCCCCCCCH-
T ss_conf             1000025752102340102336788615862013596876778861799997400102589999998589988778998-


Q ss_pred             HHHHHHHHHHHCCCCCCCCCHHHHHHHHHHHHHHCCCCCCCCCCHHHHHHHHHHH
Q ss_conf             8742225676400148999989999999999981117999999999999999860
Q 005586          625 AAESATFENFIDRNLKGKFSESEAAKLGKMALVCTHEDPENRPTMEAVIEELTVA  679 (689)
Q Consensus       625 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~Cl~~dP~~RPs~~evl~~L~~~  679 (689)
                         ...+.+++........+...+..+.+++.+||+.||.+||+|.++++.|+..
T Consensus       254 ---~~~~~~~i~~~~~~~~~~~~~~~l~~Li~~cl~~dP~~RPs~~~il~~L~~~  305 (311)
T d1t46a_         254 ---DSKFYKMIKEGFRMLSPEHAPAEMYDIMKTCWDADPLKRPTFKQIVQLIEKQ  305 (311)
T ss_dssp             ---SHHHHHHHHHTCCCCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred             ---HHHHHHHHHCCCCCCCCCCCCHHHHHHHHHHCCCCHHHCCCHHHHHHHHHHH
T ss_conf             ---9999999866898898543659999999997577965792999999999876

>d1xjda_ d.144.1.7 (A:) Protein kinase C, theta type {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Protein kinase C, theta type
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=0  Score=350.15  Aligned_cols=252  Identities=18%  Similarity=0.267  Sum_probs=206.3

Q ss_pred             CCCCCCCCCCCCCCCEEEEEEEC-CCCEEEEEEECCCCC--CHHHHHHHHHHHHHH-CCCCCCCEEEEEEEECCCCCEEE
Q ss_conf             05884542154885209999955-993999999024687--627999999999985-14899511486689718998189
Q 005586          409 QCFSEVNLLGKGNFSSVYKGTLR-DGTLVAIRSINVTSC--KSEEAEFVKGLYLLT-SLRHENIIRLRGFCCSRGRGECF  484 (689)
Q Consensus       409 ~~f~~~~~lg~G~~g~Vy~~~~~-~g~~vaiK~~~~~~~--~~~~~~~~~e~~~l~-~l~h~niv~l~~~~~~~~~~~~~  484 (689)
                      ++|...+.||+|+||+||+|+.+ +++.||+|++.+...  ......+..|..++. .++||||+++++++.  +.+..|
T Consensus         2 ddy~i~~~iG~G~fg~Vy~~~~~~t~~~vAvK~i~k~~~~~~~~~~~~~~e~~~l~~~~~hp~Iv~~~~~~~--~~~~~y   79 (320)
T d1xjda_           2 EDFILHKMLGKGSFGKVFLAEFKKTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEHPFLTHMFCTFQ--TKENLF   79 (320)
T ss_dssp             TTEEEEEEEEECSSSEEEEEEETTTTEEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHHTTCTTBCCEEEEEE--CSSEEE
T ss_pred             CCEEEEEEEECCCCCEEEEEEECCCCCEEEEEEECHHHCCCHHHHHHHHHHHHHHHHHCCCCCEEEEEEEEC--CCCCEE
T ss_conf             971886589408782899999999998999999805553384899999999999998479996878988970--498316


Q ss_pred             EEEECCCCCCHHHHHHHCCCCCCCCCHHHHHHHHHHHHHHHHHHHCCCCCCCCEEECCCCCCCEEECCCCCEEEECCCCC
Q ss_conf             99972899998888600179998789999999999999997553079999996362587998665459998078035653
Q 005586          485 LIYDFAPKGKLSKYLDQEEGSSNVLDWSTRVSIIIGIAKGIGYLHSSEVNKPAIVHRNLSVEKVLIDQQFNPLIADCGLH  564 (689)
Q Consensus       485 lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~ia~~ia~gL~~LH~~~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgla  564 (689)
                      +||||+++|+|.+++.....    +++..+..++.|++.||+|||+.+     |+||||||+|||+++++.+||+|||++
T Consensus        80 ivmEy~~~g~L~~~i~~~~~----~~e~~~~~~~~qi~~al~ylH~~~-----iiHrDikp~NiL~~~~~~~kl~DFG~a  150 (320)
T d1xjda_          80 FVMEYLNGGDLMYHIQSCHK----FDLSRATFYAAEIILGLQFLHSKG-----IVYRDLKLDNILLDKDGHIKIADFGMC  150 (320)
T ss_dssp             EEEECCTTCBHHHHHHHHSS----CCHHHHHHHHHHHHHHHHHHHHTT-----CBCCCCCGGGEEECTTSCEEECCCTTC
T ss_pred             EEEEECCCCCHHHHHHCCCC----CCHHHHHHHHHHHHHHHHHHHHCC-----EEECCCCCCCEEECCCCCEECCCCCHH
T ss_conf             77750379808998640478----999999999999999999998689-----340347654044448996301555302


Q ss_pred             CCCCCCCEEEEECCCCCCCCCCCCCCCCCCCCCCCCCHHHHHHHHHHHHCCCCCCHHHHHHHHHHHHHHHHCCCCCCCCC
Q ss_conf             34568711345147888788881022358889866402088999999919988521477887422256764001489999
Q 005586          565 KLLADDIVFSVLKTSAAMGYLAPEYVTTGRFTERSDIFAFGVIILQILTGSLVLTSSMRLAAESATFENFIDRNLKGKFS  644 (689)
Q Consensus       565 ~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~sDv~S~Gvil~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~  644 (689)
                      +....... ......||+.|+|||++.+..++.++||||+||++|||+||+.||.+.........    +...  ...++
T Consensus       151 ~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvilyemltG~~PF~~~~~~~~~~~----i~~~--~~~~p  223 (320)
T d1xjda_         151 KENMLGDA-KTNTFCGTPDYIAPEILLGQKYNHSVDWWSFGVLLYEMLIGQSPFHGQDEEELFHS----IRMD--NPFYP  223 (320)
T ss_dssp             BCCCCTTC-CBCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHH----HHHC--CCCCC
T ss_pred             HHCCCCCC-CCCCCCCCCCCCCHHHHCCCCCCCHHHHHHHHHHHHHHHHCCCCCCCCCHHHHHHH----HHCC--CCCCC
T ss_conf             32356653-34545787776899998279988323201122789898738899999899999999----9718--99897


Q ss_pred             HHHHHHHHHHHHHHCCCCCCCCCCHH-HHHHHHHH
Q ss_conf             89999999999981117999999999-99999986
Q 005586          645 ESEAAKLGKMALVCTHEDPENRPTME-AVIEELTV  678 (689)
Q Consensus       645 ~~~~~~~~~l~~~Cl~~dP~~RPs~~-evl~~L~~  678 (689)
                      ...+.++.+++.+||+.||.+||++. ++++|.|.
T Consensus       224 ~~~s~~~~dli~~~L~~dP~~R~s~~~~l~~hpff  258 (320)
T d1xjda_         224 RWLEKEAKDLLVKLFVREPEKRLGVRGDIRQHPLF  258 (320)
T ss_dssp             TTSCHHHHHHHHHHSCSSGGGSBTTBSCGGGSGGG
T ss_pred             CCCCHHHHHHHHHHCCCCCCCCCCHHHHHHHCCHH
T ss_conf             56799999999996544898783889999809013

>d1phka_ d.144.1.7 (A:) gamma-subunit of glycogen phosphorylase kinase (Phk) {Rabbit (Oryctolagus cuniculus) [TaxId: 9986]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: gamma-subunit of glycogen phosphorylase kinase (Phk)
species: Rabbit (Oryctolagus cuniculus) [TaxId: 9986]

Probab=100.00  E-value=0  Score=344.32  Aligned_cols=255  Identities=22%  Similarity=0.314  Sum_probs=209.4

Q ss_pred             CCCCCCCCCCCCCCCEEEEEEEC-CCCEEEEEEECCCCCC--------HHHHHHHHHHHHHHCCC-CCCCEEEEEEEECC
Q ss_conf             05884542154885209999955-9939999990246876--------27999999999985148-99511486689718
Q 005586          409 QCFSEVNLLGKGNFSSVYKGTLR-DGTLVAIRSINVTSCK--------SEEAEFVKGLYLLTSLR-HENIIRLRGFCCSR  478 (689)
Q Consensus       409 ~~f~~~~~lg~G~~g~Vy~~~~~-~g~~vaiK~~~~~~~~--------~~~~~~~~e~~~l~~l~-h~niv~l~~~~~~~  478 (689)
                      ++|+..+.||+|+||+||+|+.+ +|+.||+|++.+....        .....+.+|+.++++++ ||||+++++++.  
T Consensus         3 ~~y~~~~~iG~G~~g~V~~~~~~~~~~~~AvK~i~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~hpnIv~~~~~~~--   80 (277)
T d1phka_           3 ENYEPKEILGRGVSSVVRRCIHKPTCKEYAVKIIDVTGGGSFSAEEVQELREATLKEVDILRKVSGHPNIIQLKDTYE--   80 (277)
T ss_dssp             TTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEETTCSTTCCHHHHHHHHHHHHHHHHHHHHHTTCTTBCCEEEEEE--
T ss_pred             CCCEECEEEECCCCEEEEEEEECCCCCEEEEEEEECCCCCCHHHHHHHHHHHHHHHHHHHHHHHCCCCCEEEEEEECC--
T ss_conf             638885288417684999999999998999999962446411478889999999999999998507997479976214--


Q ss_pred             CCCEEEEEEECCCCCCHHHHHHHCCCCCCCCCHHHHHHHHHHHHHHHHHHHCCCCCCCCEEECCCCCCCEEECCCCCEEE
Q ss_conf             99818999972899998888600179998789999999999999997553079999996362587998665459998078
Q 005586          479 GRGECFLIYDFAPKGKLSKYLDQEEGSSNVLDWSTRVSIIIGIAKGIGYLHSSEVNKPAIVHRNLSVEKVLIDQQFNPLI  558 (689)
Q Consensus       479 ~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~ia~~ia~gL~~LH~~~~~~~~ivH~dlk~~Nill~~~~~~kl  558 (689)
                      +.+..++||||+++|+|.+++....    .+++..+..++.|++.||+|||+.+     |+||||||+|||+++++.+||
T Consensus        81 ~~~~~~ivmE~~~~g~L~~~l~~~~----~l~e~~~~~~~~qi~~al~~lH~~~-----ivHrDlkp~Nill~~~~~~kl  151 (277)
T d1phka_          81 TNTFFFLVFDLMKKGELFDYLTEKV----TLSEKETRKIMRALLEVICALHKLN-----IVHRDLKPENILLDDDMNIKL  151 (277)
T ss_dssp             CSSEEEEEEECCTTCBHHHHHHHHS----SCCHHHHHHHHHHHHHHHHHHHHTT-----EECSCCSGGGEEECTTCCEEE
T ss_pred             CCCCEEEEEECCCCCHHHHHHHHCC----CCCHHHHHHHHHHHHHHHHHHHHCC-----CCCCCCCCCEEEECCCCCEEE
T ss_conf             6760599997689866899998659----9999999999999999999998759-----943234625489868998387


Q ss_pred             ECCCCCCCCCCCCEEEEECCCCCCCCCCCCCCCC------CCCCCCCCCHHHHHHHHHHHHCCCCCCHHHHHHHHHHHHH
Q ss_conf             0356533456871134514788878888102235------8889866402088999999919988521477887422256
Q 005586          559 ADCGLHKLLADDIVFSVLKTSAAMGYLAPEYVTT------GRFTERSDIFAFGVIILQILTGSLVLTSSMRLAAESATFE  632 (689)
Q Consensus       559 ~Dfgla~~~~~~~~~~~~~~~~t~~y~aPE~~~~------~~~~~~sDv~S~Gvil~elltG~~p~~~~~~~~~~~~~~~  632 (689)
                      +|||+++......  ......||..|+|||++.+      ..++.++||||+||++|||++|+.||..............
T Consensus       152 ~DFG~a~~~~~~~--~~~~~~gt~~y~~PE~~~~~~~~~~~~~~~~~DiwslGvilyeml~g~~Pf~~~~~~~~~~~i~~  229 (277)
T d1phka_         152 TDFGFSCQLDPGE--KLREVCGTPSYLAPEIIECSMNDNHPGYGKEVDMWSTGVIMYTLLAGSPPFWHRKQMLMLRMIMS  229 (277)
T ss_dssp             CCCTTCEECCTTC--CBCCCCSCGGGCCHHHHHHHHCTTSCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHH
T ss_pred             CCCHHEEECCCCC--CEEEEECCCCCCCHHHHHCCCCCCCCCCCCHHEECCCCHHHHHHCCCCCCCCCCCHHHHHHHHHH
T ss_conf             1240316726887--21345246788898886053445678899233185656023103228889889999999999981


Q ss_pred             HHHCCCCCCCCCHHHHHHHHHHHHHHCCCCCCCCCCHHHHHHHHHH
Q ss_conf             7640014899998999999999998111799999999999999986
Q 005586          633 NFIDRNLKGKFSESEAAKLGKMALVCTHEDPENRPTMEAVIEELTV  678 (689)
Q Consensus       633 ~~~~~~~~~~~~~~~~~~~~~l~~~Cl~~dP~~RPs~~evl~~L~~  678 (689)
                      .-  ...........++++.+++.+||+.||++||++.|+++|.|.
T Consensus       230 ~~--~~~~~~~~~~~s~~~~~li~~~L~~~p~~R~s~~eil~h~~~  273 (277)
T d1phka_         230 GN--YQFGSPEWDDYSDTVKDLVSRFLVVQPQKRYTAEEALAHPFF  273 (277)
T ss_dssp             TC--CCCCTTTGGGSCHHHHHHHHHHCCSSGGGSCCHHHHTTSGGG
T ss_pred             CC--CCCCCCCCCCCCHHHHHHHHHHCCCCHHHCCCHHHHHCCHHH
T ss_conf             89--888985434689999999999765896689199999739787

>d1u46a_ d.144.1.7 (A:) Activated CDC42 kinase 1, ACK1 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Activated CDC42 kinase 1, ACK1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=0  Score=347.49  Aligned_cols=256  Identities=24%  Similarity=0.373  Sum_probs=209.4

Q ss_pred             CCCCCCCCCCCCCCCEEEEEEEC--C--CCEEEEEEECCCCC--CHHHHHHHHHHHHHHCCCCCCCEEEEEEEECCCCCE
Q ss_conf             05884542154885209999955--9--93999999024687--627999999999985148995114866897189981
Q 005586          409 QCFSEVNLLGKGNFSSVYKGTLR--D--GTLVAIRSINVTSC--KSEEAEFVKGLYLLTSLRHENIIRLRGFCCSRGRGE  482 (689)
Q Consensus       409 ~~f~~~~~lg~G~~g~Vy~~~~~--~--g~~vaiK~~~~~~~--~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~  482 (689)
                      ++|+..+.||+|+||.||+|++.  +  ...||+|+++....  ....++|.+|+.++.+++||||++++|++.+   ..
T Consensus         8 ~d~~~~~~iG~G~fg~Vy~~~~~~~~~~~~~vAiK~l~~~~~~~~~~~~~~~~Ei~~l~~l~H~nIv~~~g~~~~---~~   84 (273)
T d1u46a_           8 KDLRLLEKLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLDHRNLIRLYGVVLT---PP   84 (273)
T ss_dssp             GGEEEEEECC----CCCEEEEEECTTSCEEEEEEEC--------CHHHHHHHHHHHHHHHCCCTTBCCEEEEECS---SS
T ss_pred             HHEEEEEEEECCCCEEEEEEEEECCCCCEEEEEEEEECHHHCCCHHHHHHHHHHHHHHHHCCCCCEEEEEEEEEE---CC
T ss_conf             891997898038883999999988999079999999983555798999999999999986899998789877740---10


Q ss_pred             EEEEEECCCCCCHHHHHHHCCCCCCCCCHHHHHHHHHHHHHHHHHHHCCCCCCCCEEECCCCCCCEEECCCCCEEEECCC
Q ss_conf             89999728999988886001799987899999999999999975530799999963625879986654599980780356
Q 005586          483 CFLIYDFAPKGKLSKYLDQEEGSSNVLDWSTRVSIIIGIAKGIGYLHSSEVNKPAIVHRNLSVEKVLIDQQFNPLIADCG  562 (689)
Q Consensus       483 ~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~ia~~ia~gL~~LH~~~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg  562 (689)
                      .++||||+++|++.+++.....   .+++..++.++.|++.||.|||+.+     |+||||||+||+++.++.+||+|||
T Consensus        85 ~~lv~e~~~~~~l~~~~~~~~~---~l~~~~~~~~~~qi~~gl~ylH~~~-----iiHrDikp~NIll~~~~~vkl~DfG  156 (273)
T d1u46a_          85 MKMVTELAPLGSLLDRLRKHQG---HFLLGTLSRYAVQVAEGMGYLESKR-----FIHRDLAARNLLLATRDLVKIGDFG  156 (273)
T ss_dssp             CEEEEECCTTCBHHHHHHHHGG---GSCHHHHHHHHHHHHHHHHHHHHTT-----EECSCCCGGGEEEEETTEEEECCCT
T ss_pred             HHEEEEEECCCCHHHHHHCCCC---CCCHHHHHHHHHHHHHHHHHHHHCC-----EEEEEECHHHHCCCCCCCEEECCCH
T ss_conf             0114654238612544421268---9999999999999999998752178-----7520566888156556543325611


Q ss_pred             CCCCCCCCCEE--EEECCCCCCCCCCCCCCCCCCCCCCCCCHHHHHHHHHHHH-CCCCCCHHHHHHHHHHHHHHHHCCCC
Q ss_conf             53345687113--4514788878888102235888986640208899999991-99885214778874222567640014
Q 005586          563 LHKLLADDIVF--SVLKTSAAMGYLAPEYVTTGRFTERSDIFAFGVIILQILT-GSLVLTSSMRLAAESATFENFIDRNL  639 (689)
Q Consensus       563 la~~~~~~~~~--~~~~~~~t~~y~aPE~~~~~~~~~~sDv~S~Gvil~ellt-G~~p~~~~~~~~~~~~~~~~~~~~~~  639 (689)
                      +++........  ......++..|+|||.+.+..++.++||||||+++|||+| |+.||........    ...+.....
T Consensus       157 l~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~Di~S~Gvil~emlt~G~~Pf~~~~~~~~----~~~i~~~~~  232 (273)
T d1u46a_         157 LMRALPQNDDHYVMQEHRKVPFAWCAPESLKTRTFSHASDTWMFGVTLWEMFTYGQEPWIGLNGSQI----LHKIDKEGE  232 (273)
T ss_dssp             TCEECCC-CCEEEC-----CCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTSCCTTTTCCHHHH----HHHHHTSCC
T ss_pred             HHHHCCCCCCCCEECCCCCCCCCCCCHHHHHCCCCCCCHHHHHHHHHHHHHHHCCCCCCCCCCHHHH----HHHHHHCCC
T ss_conf             5553035887526547632573107999983799994215661489999999689999999699999----999984799


Q ss_pred             CCCCCHHHHHHHHHHHHHHCCCCCCCCCCHHHHHHHHHHH
Q ss_conf             8999989999999999981117999999999999999860
Q 005586          640 KGKFSESEAAKLGKMALVCTHEDPENRPTMEAVIEELTVA  679 (689)
Q Consensus       640 ~~~~~~~~~~~~~~l~~~Cl~~dP~~RPs~~evl~~L~~~  679 (689)
                      ....+...+..+.+++..||+.||.+||||.+|++.|+.+
T Consensus       233 ~~~~~~~~~~~l~~li~~cl~~dp~~RPt~~ei~~~L~~~  272 (273)
T d1u46a_         233 RLPRPEDCPQDIYNVMVQCWAHKPEDRPTFVALRDFLLEA  272 (273)
T ss_dssp             CCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred             CCCCCCCCCHHHHHHHHHHCCCCHHHCCCHHHHHHHHHHC
T ss_conf             9998544539999999997688966792999999999964

>d1o6ya_ d.144.1.7 (A:) Mycobacterial protein kinase PknB, catalytic domain {Mycobacterium tuberculosis [TaxId: 1773]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Mycobacterial protein kinase PknB, catalytic domain
species: Mycobacterium tuberculosis [TaxId: 1773]

Probab=100.00  E-value=0  Score=343.15  Aligned_cols=261  Identities=18%  Similarity=0.253  Sum_probs=210.7

Q ss_pred             HCCCCCCCCCCCCCCCEEEEEEEC-CCCEEEEEEECCCCC--CHHHHHHHHHHHHHHCCCCCCCEEEEEEEECCCC--CE
Q ss_conf             305884542154885209999955-993999999024687--6279999999999851489951148668971899--81
Q 005586          408 TQCFSEVNLLGKGNFSSVYKGTLR-DGTLVAIRSINVTSC--KSEEAEFVKGLYLLTSLRHENIIRLRGFCCSRGR--GE  482 (689)
Q Consensus       408 ~~~f~~~~~lg~G~~g~Vy~~~~~-~g~~vaiK~~~~~~~--~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~--~~  482 (689)
                      .++|++.+.||+|+||.||+|+.. +|+.||+|+++....  ......+.+|+.+++.++||||+++++++...+.  ..
T Consensus         6 ~drY~i~~~lG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~E~~~l~~~~hpniv~~~~~~~~~~~~~~~   85 (277)
T d1o6ya_           6 SDRYELGEILGFGGMSEVHLARDLRLHRDVAVKVLRADLARDPSFYLRFRREAQNAAALNHPAIVAVYDTGEAETPAGPL   85 (277)
T ss_dssp             TTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSTTTTCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEEEECSSSEE
T ss_pred             CCEEEEEEEEEECCCEEEEEEEECCCCCEEEEEEECHHHCCCHHHHHHHHHHHHHHHHCCCCCCCCCCCEEEECCCCCCE
T ss_conf             62069868996089929999999999989999998556646989999999999999856999887311435432688766


Q ss_pred             EEEEEECCCCCCHHHHHHHCCCCCCCCCHHHHHHHHHHHHHHHHHHHCCCCCCCCEEECCCCCCCEEECCCCCEEEECCC
Q ss_conf             89999728999988886001799987899999999999999975530799999963625879986654599980780356
Q 005586          483 CFLIYDFAPKGKLSKYLDQEEGSSNVLDWSTRVSIIIGIAKGIGYLHSSEVNKPAIVHRNLSVEKVLIDQQFNPLIADCG  562 (689)
Q Consensus       483 ~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~ia~~ia~gL~~LH~~~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg  562 (689)
                      .|+||||+++++|.+++....    .+++.++..|+.|++.||+|||+.+     |+||||||+|||++.++..+++|||
T Consensus        86 ~~lvmE~~~g~~L~~~~~~~~----~l~~~~~~~i~~qi~~al~~lH~~~-----iiHrDiKP~NIll~~~~~~~l~d~~  156 (277)
T d1o6ya_          86 PYIVMEYVDGVTLRDIVHTEG----PMTPKRAIEVIADACQALNFSHQNG-----IIHRDVKPANIMISATNAVKVMDFG  156 (277)
T ss_dssp             EEEEEECCCEEEHHHHHHHHC----SCCHHHHHHHHHHHHHHHHHHHHTT-----EECCCCSGGGEEEETTSCEEECCCT
T ss_pred             EEEEEECCCCCEEHHHHCCCC----CCCHHHHHHHHHHHHHHHHHHHHCC-----CCCCCCCCCCCCCCCCCCCEEEHHH
T ss_conf             999997788987101120358----9999999999999999999998579-----5276346755665754320100344


Q ss_pred             CCCCCCCCC--EEEEECCCCCCCCCCCCCCCCCCCCCCCCCHHHHHHHHHHHHCCCCCCHHHHHHHHHHHHHHHHCCCCC
Q ss_conf             533456871--134514788878888102235888986640208899999991998852147788742225676400148
Q 005586          563 LHKLLADDI--VFSVLKTSAAMGYLAPEYVTTGRFTERSDIFAFGVIILQILTGSLVLTSSMRLAAESATFENFIDRNLK  640 (689)
Q Consensus       563 la~~~~~~~--~~~~~~~~~t~~y~aPE~~~~~~~~~~sDv~S~Gvil~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~  640 (689)
                      .+.......  ........||+.|+|||++.+..++.++||||+||++|||+||+.||................  +...
T Consensus       157 ~~~~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~~~~~~~DiwSlGvilyelltG~~Pf~~~~~~~~~~~~~~~~--~~~~  234 (277)
T d1o6ya_         157 IARAIADSGNSVTQTAAVIGTAQYLSPEQARGDSVDARSDVYSLGCVLYEVLTGEPPFTGDSPVSVAYQHVRED--PIPP  234 (277)
T ss_dssp             TCEECC----------------TTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHCC--CCCG
T ss_pred             HHHHHCCCCCCCCCCCCCCCCCCCCCHHHHCCCCCCCCEECCCCHHHHHHHHHCCCCCCCCCHHHHHHHHHHCC--CCCC
T ss_conf             43221235443333464257624369999839999966320265289999976979989969999999998469--9997


Q ss_pred             CCCCHHHHHHHHHHHHHHCCCCCCCCC-CHHHHHHHHHHH
Q ss_conf             999989999999999981117999999-999999999860
Q 005586          641 GKFSESEAAKLGKMALVCTHEDPENRP-TMEAVIEELTVA  679 (689)
Q Consensus       641 ~~~~~~~~~~~~~l~~~Cl~~dP~~RP-s~~evl~~L~~~  679 (689)
                      .......+.++.+++.+|+++||.+|| +++++++.|..+
T Consensus       235 ~~~~~~~s~~l~~li~~~L~~dp~~R~~sa~~l~~~l~r~  274 (277)
T d1o6ya_         235 SARHEGLSADLDAVVLKALAKNPENRYQTAAEMRADLVRV  274 (277)
T ss_dssp             GGTSSSCCHHHHHHHHHHTCSSGGGSCSSHHHHHHHHHHH
T ss_pred             CHHCCCCCHHHHHHHHHHCCCCHHHCHHHHHHHHHHHHHH
T ss_conf             1003478999999999986679767773999999999997

>d1vjya_ d.144.1.7 (A:) Type I TGF-beta receptor R4 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Type I TGF-beta receptor R4
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=0  Score=341.94  Aligned_cols=264  Identities=22%  Similarity=0.309  Sum_probs=199.9

Q ss_pred             CCCCCCCCCCCCCCCEEEEEEECCCCEEEEEEECCCCCCHHHHHHHHHHHHHHCCCCCCCEEEEEEEECCCC--CEEEEE
Q ss_conf             058845421548852099999559939999990246876279999999999851489951148668971899--818999
Q 005586          409 QCFSEVNLLGKGNFSSVYKGTLRDGTLVAIRSINVTSCKSEEAEFVKGLYLLTSLRHENIIRLRGFCCSRGR--GECFLI  486 (689)
Q Consensus       409 ~~f~~~~~lg~G~~g~Vy~~~~~~g~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~--~~~~lv  486 (689)
                      ++|...+.||+|+||.||+|+++ |+.||||++....  ........|+..+.+++||||+++++++.++..  ...++|
T Consensus         3 ~~~~l~~~iG~G~fg~Vy~~~~~-g~~vAvK~~~~~~--~~~~~~e~ei~~~~~~~HpnIv~~~~~~~~~~~~~~~~~lv   79 (303)
T d1vjya_           3 RTIVLQESIGKGRFGEVWRGKWR-GEEVAVKIFSSRE--ERSWFREAEIYQTVMLRHENILGFIAADNKDNGTWTQLWLV   79 (303)
T ss_dssp             GGEEEEEEEECCSSSEEEEEEET-TEEEEEEEECGGG--HHHHHHHHHHHTSTTCCCTTBCCEEEEEEEECSSSEEEEEE
T ss_pred             CEEEEEEEEEECCCEEEEEEEEC-CEEEEEEEECCCC--HHHHHHHHHHHHHHHCCCCCCCCEEEEEEECCCCCEEEEEE
T ss_conf             68999889820788199999999-9899999987200--46799999999996279986832688998379860489999


Q ss_pred             EECCCCCCHHHHHHHCCCCCCCCCHHHHHHHHHHHHHHHHHHHCCCC---CCCCEEECCCCCCCEEECCCCCEEEECCCC
Q ss_conf             97289999888860017999878999999999999999755307999---999636258799866545999807803565
Q 005586          487 YDFAPKGKLSKYLDQEEGSSNVLDWSTRVSIIIGIAKGIGYLHSSEV---NKPAIVHRNLSVEKVLIDQQFNPLIADCGL  563 (689)
Q Consensus       487 ~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~ia~~ia~gL~~LH~~~~---~~~~ivH~dlk~~Nill~~~~~~kl~Dfgl  563 (689)
                      |||+++|+|.++++..     .++|..++.++.|++.||+|+|+...   ..++|+||||||+|||+++++.+||+|||+
T Consensus        80 ~Ey~~~g~L~~~l~~~-----~l~~~~~~~~~~~ia~gl~~lH~~~~~~~~~~~IvHrDlKp~NILl~~~~~~Kl~DFGl  154 (303)
T d1vjya_          80 SDYHEHGSLFDYLNRY-----TVTVEGMIKLALSTASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVKKNGTCCIADLGL  154 (303)
T ss_dssp             EECCTTCBHHHHHHHC-----CBCHHHHHHHHHHHHHHHHHHHCCBCSTTCBCEEECSCCCGGGEEECTTSCEEECCCTT
T ss_pred             EECCCCCCHHHHHHCC-----CCCHHHHHHHHHHHHHHHHHHHHHHHHHCCCCCEECCCCCCCCEEECCCCCEEEEECCC
T ss_conf             9646698989998658-----99989999999999999999887665204689866153173135786887768876386


Q ss_pred             CCCCCCCCEE---EEECCCCCCCCCCCCCCCCCC------CCCCCCCHHHHHHHHHHHHCCCCCCHHHHH----------
Q ss_conf             3345687113---451478887888810223588------898664020889999999199885214778----------
Q 005586          564 HKLLADDIVF---SVLKTSAAMGYLAPEYVTTGR------FTERSDIFAFGVIILQILTGSLVLTSSMRL----------  624 (689)
Q Consensus       564 a~~~~~~~~~---~~~~~~~t~~y~aPE~~~~~~------~~~~sDv~S~Gvil~elltG~~p~~~~~~~----------  624 (689)
                      ++........   ......||+.|+|||++.+..      ++.++|||||||++|||+||..|+......          
T Consensus       155 ~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~k~Di~S~Gvvl~el~tg~~~~~~~~~~~~~~~~~~~~  234 (303)
T d1vjya_         155 AVRHDSATDTIDIAPNHRVGTKRYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEIARRCSIGGIHEDYQLPYYDLVPS  234 (303)
T ss_dssp             CEEEETTTTEECC----CCSCGGGCCHHHHTTCSCTTCHHHHHHHHHHHHHHHHHHHHHTBCBTTBCCCCCCTTTTTSCS
T ss_pred             CCCCCCCCCCEECCCCCEECCCCCCCHHHCCCCCCCCCCCCCCCHHHHHHHHHHHHHHHCCCCCCCCCCCCCCHHHCCCC
T ss_conf             62346777620013552503547678221056545467776750122015999999962899887663112410122556


Q ss_pred             HHH-HHHHHHHHCCCCCCCC-----CHHHHHHHHHHHHHHCCCCCCCCCCHHHHHHHHHHHC
Q ss_conf             874-2225676400148999-----9899999999999811179999999999999998608
Q 005586          625 AAE-SATFENFIDRNLKGKF-----SESEAAKLGKMALVCTHEDPENRPTMEAVIEELTVAA  680 (689)
Q Consensus       625 ~~~-~~~~~~~~~~~~~~~~-----~~~~~~~~~~l~~~Cl~~dP~~RPs~~evl~~L~~~~  680 (689)
                      ... ............+...     ..+....+.+++.+||+.||++||||.||+++|..+.
T Consensus       235 ~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~ei~~~L~~i~  296 (303)
T d1vjya_         235 DPSVEEMRKVVCEQKLRPNIPNRWQSCEALRVMAKIMRECWYANGAARLTALRIKKTLSQLS  296 (303)
T ss_dssp             SCCHHHHHHHHTTSCCCCCCCGGGGGCHHHHHHHHHHHTTCCSSGGGSCCHHHHHHHHHHHH
T ss_pred             CCHHHHHHHHHHCCCCCCCCCCCCCCHHHHHHHHHHHHHHCCCCHHHCCCHHHHHHHHHHHH
T ss_conf             43099999987502468887765577689999999999976069858959999999999888

>d1ua2a_ d.144.1.7 (A:) Cell division protein kinase 7, CDK7 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cell division protein kinase 7, CDK7
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=0  Score=339.61  Aligned_cols=255  Identities=23%  Similarity=0.297  Sum_probs=199.7

Q ss_pred             CCCCCCCCCCCEEEEEEEC-CCCEEEEEEECCCCCCHH----HHHHHHHHHHHHCCCCCCCEEEEEEEECCCCCEEEEEE
Q ss_conf             4542154885209999955-993999999024687627----99999999998514899511486689718998189999
Q 005586          413 EVNLLGKGNFSSVYKGTLR-DGTLVAIRSINVTSCKSE----EAEFVKGLYLLTSLRHENIIRLRGFCCSRGRGECFLIY  487 (689)
Q Consensus       413 ~~~~lg~G~~g~Vy~~~~~-~g~~vaiK~~~~~~~~~~----~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~~~lv~  487 (689)
                      .+++||+|+||+||+|+.+ +|+.||+|+++.......    ...+.+|+.++++++||||+++++++  .+.+..++||
T Consensus         2 ~l~~lG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~~~~~~--~~~~~~~ivm   79 (299)
T d1ua2a_           2 KLDFLGEGQFATVYKARDKNTNQIVAIKKIKLGHRSEAKDGINRTALREIKLLQELSHPNIIGLLDAF--GHKSNISLVF   79 (299)
T ss_dssp             EEEEEEEETTEEEEEEECSSCCSEEEEEEC------------CTHHHHHHHHHHHCCCTTBCCEEEEE--CCTTCCEEEE
T ss_pred             CCEEECCCCCEEEEEEEECCCCCEEEEEEEEHHHHHHHHHHHHHHHHHHHHHHHHCCCCCEEEEEEEE--CCCCCEEEHH
T ss_conf             56385127282999999999996999999842021245679999999999999867999986898542--2587402204


Q ss_pred             ECCCCCCHHHHHHHCCCCCCCCCHHHHHHHHHHHHHHHHHHHCCCCCCCCEEECCCCCCCEEECCCCCEEEECCCCCCCC
Q ss_conf             72899998888600179998789999999999999997553079999996362587998665459998078035653345
Q 005586          488 DFAPKGKLSKYLDQEEGSSNVLDWSTRVSIIIGIAKGIGYLHSSEVNKPAIVHRNLSVEKVLIDQQFNPLIADCGLHKLL  567 (689)
Q Consensus       488 e~~~~gsL~~~l~~~~~~~~~l~~~~~~~ia~~ia~gL~~LH~~~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgla~~~  567 (689)
                      ||++++++.......    ..+++..+..++.|++.||+|||+.+     |+||||||+|||+++++.+||+|||+++..
T Consensus        80 E~~~~~~~~~~~~~~----~~l~~~~~~~~~~qil~aL~~lH~~~-----iiHrDiKp~NIli~~~~~~KL~DFG~a~~~  150 (299)
T d1ua2a_          80 DFMETDLEVIIKDNS----LVLTPSHIKAYMLMTLQGLEYLHQHW-----ILHRDLKPNNLLLDENGVLKLADFGLAKSF  150 (299)
T ss_dssp             ECCSEEHHHHHTTCC----SSCCSSHHHHHHHHHHHHHHHHHHTT-----CCCCCCCGGGEEECTTCCEEECCCGGGSTT
T ss_pred             HHHCCHHHHHHHHCC----CCCCHHHHHHHHHHHHHHHHHHHCCC-----EECCCCCCCEEEECCCCCCCCCCCCCCCCC
T ss_conf             553450776554126----67789999999999999998863163-----550357762588537784114657610005


Q ss_pred             CCCCEEEEECCCCCCCCCCCCCCCCC-CCCCCCCCHHHHHHHHHHHHCCCCCCHHHHHHHHHHHHHHHHCCC--------
Q ss_conf             68711345147888788881022358-889866402088999999919988521477887422256764001--------
Q 005586          568 ADDIVFSVLKTSAAMGYLAPEYVTTG-RFTERSDIFAFGVIILQILTGSLVLTSSMRLAAESATFENFIDRN--------  638 (689)
Q Consensus       568 ~~~~~~~~~~~~~t~~y~aPE~~~~~-~~~~~sDv~S~Gvil~elltG~~p~~~~~~~~~~~~~~~~~~~~~--------  638 (689)
                      ..... ......+|..|+|||++... .++.++||||+||++|||+||+.||..................+.        
T Consensus       151 ~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlGvil~el~~g~~pf~~~~~~~~l~~i~~~~~~~~~~~~~~~~  229 (299)
T d1ua2a_         151 GSPNR-AYTHQVVTRWYRAPELLFGARMYGVGVDMWAVGCILAELLLRVPFLPGDSDLDQLTRIFETLGTPTEEQWPDMC  229 (299)
T ss_dssp             TSCCC-CCCCSCCCCTTCCHHHHTTCSCCCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCCCTTTSSSTT
T ss_pred             CCCCC-CCCCEECCHHHCCHHHHCCCCCCCHHHHHHHCCHHHHHHHHCCCCCCCCCHHHHHHHHHHHCCCCCHHHCCCHH
T ss_conf             78755-43302047333639997267788805643630428999985969999999999999999851899725452100


Q ss_pred             -------C--CCCCC-----HHHHHHHHHHHHHHCCCCCCCCCCHHHHHHHHHHH
Q ss_conf             -------4--89999-----89999999999981117999999999999999860
Q 005586          639 -------L--KGKFS-----ESEAAKLGKMALVCTHEDPENRPTMEAVIEELTVA  679 (689)
Q Consensus       639 -------~--~~~~~-----~~~~~~~~~l~~~Cl~~dP~~RPs~~evl~~L~~~  679 (689)
                             .  ....+     ...+..+.+++.+||+.||++|||+.|+++|.|.-
T Consensus       230 ~~~~~~~~~~~~~~~~~~~~~~~s~~~~dll~~~L~~dP~~R~sa~e~L~Hp~f~  284 (299)
T d1ua2a_         230 SLPDYVTFKSFPGIPLHHIFSAAGDDLLDLIQGLFLFNPCARITATQALKMKYFS  284 (299)
T ss_dssp             SSTTCCCCCCCCCCCHHHHCTTCCHHHHHHHHHHHCSSTTTSCCHHHHHTSGGGT
T ss_pred             CCCHHHHHCCCCCCCHHHHCCCCCHHHHHHHHHHCCCCHHHCCCHHHHHCCHHHC
T ss_conf             0213443034789886785656899999999997638945690899996799657

>d1gz8a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cyclin-dependent PK, CDK2
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=0  Score=336.60  Aligned_cols=259  Identities=20%  Similarity=0.383  Sum_probs=201.7

Q ss_pred             CCCCCCCCCCCCCCCEEEEEEEC-CCCEEEEEEECCCCCC-HHHHHHHHHHHHHHCCCCCCCEEEEEEEECCCCCEEEEE
Q ss_conf             05884542154885209999955-9939999990246876-279999999999851489951148668971899818999
Q 005586          409 QCFSEVNLLGKGNFSSVYKGTLR-DGTLVAIRSINVTSCK-SEEAEFVKGLYLLTSLRHENIIRLRGFCCSRGRGECFLI  486 (689)
Q Consensus       409 ~~f~~~~~lg~G~~g~Vy~~~~~-~g~~vaiK~~~~~~~~-~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~~~lv  486 (689)
                      ++|...+.||+|+||.||+|+.. +|+.||+|+++..... .....+.+|+.++++++||||+++++++.+  ....++|
T Consensus         2 d~Y~~~~~lG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~Ei~il~~l~Hp~Iv~~~~~~~~--~~~~~iv   79 (298)
T d1gz8a_           2 ENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLLDVIHT--ENKLYLV   79 (298)
T ss_dssp             TTEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEC-------CCHHHHHHHHHHTTCCCTTBCCEEEEEEE--TTEEEEE
T ss_pred             CCCEECCEEECCCCEEEEEEEECCCCCEEEEEEEEHHHCCHHHHHHHHHHHHHHHHCCCCCEEEECCCCCC--CCCEEEE
T ss_conf             99776517723768099999999999799999980222575899999999999986799838874453322--4320378


Q ss_pred             EECCCCCCHHHHHHHCCCCCCCCCHHHHHHHHHHHHHHHHHHHCCCCCCCCEEECCCCCCCEEECCCCCEEEECCCCCCC
Q ss_conf             97289999888860017999878999999999999999755307999999636258799866545999807803565334
Q 005586          487 YDFAPKGKLSKYLDQEEGSSNVLDWSTRVSIIIGIAKGIGYLHSSEVNKPAIVHRNLSVEKVLIDQQFNPLIADCGLHKL  566 (689)
Q Consensus       487 ~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~ia~~ia~gL~~LH~~~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgla~~  566 (689)
                      |||+.+ ++.+++.....  ..+++..+..++.|++.||+|||+.+     |+||||||+|||++.++.+||+|||+++.
T Consensus        80 ~e~~~~-~~~~~~~~~~~--~~l~e~~~~~~~~qil~~L~yLH~~~-----IiHrDiKpeNIl~~~~~~~kl~DFG~a~~  151 (298)
T d1gz8a_          80 FEFLHQ-DLKKFMDASAL--TGIPLPLIKSYLFQLLQGLAFCHSHR-----VLHRDLKPQNLLINTEGAIKLADFGLARA  151 (298)
T ss_dssp             EECCSE-EHHHHHHHTTT--TCCCHHHHHHHHHHHHHHHHHHHHTT-----CCCSCCCGGGEEECTTSCEEECSTTHHHH
T ss_pred             EEECCC-CHHHHHHHHCC--CCCCHHHHHHHHHHHHHHHHHHHCCC-----EECCCCCCHHEEECCCCCCEECCCCCCEE
T ss_conf             862377-44555442025--68888999999999999999865288-----99213571140113467621035786134


Q ss_pred             CCCCCEEEEECCCCCCCCCCCCCCCCCC-CCCCCCCHHHHHHHHHHHHCCCCCCHHHHHHHHHHHHHHHHC---------
Q ss_conf             5687113451478887888810223588-898664020889999999199885214778874222567640---------
Q 005586          567 LADDIVFSVLKTSAAMGYLAPEYVTTGR-FTERSDIFAFGVIILQILTGSLVLTSSMRLAAESATFENFID---------  636 (689)
Q Consensus       567 ~~~~~~~~~~~~~~t~~y~aPE~~~~~~-~~~~sDv~S~Gvil~elltG~~p~~~~~~~~~~~~~~~~~~~---------  636 (689)
                      ...... ......+++.|+|||.+.... ++.++||||+||++|||++|+.||..................         
T Consensus       152 ~~~~~~-~~~~~~gt~~y~apE~~~~~~~~~~~~DiwSlGvily~m~~G~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~  230 (298)
T d1gz8a_         152 FGVPVR-TYTHEVVTLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGV  230 (298)
T ss_dssp             HCCCSB-CTTCCBCCCTTCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCTTTSTTG
T ss_pred             CCCCCC-CCEEECCCCEEEEHHHHCCCCCCCCCCCCCCCCHHHHHHHHCCCCCCCCCHHHHHHHHHHHCCCCCHHHCCCC
T ss_conf             368864-1001036521541122136657774221033331342796687998988999999999983289833314442


Q ss_pred             ---CCCCCCC-----------CHHHHHHHHHHHHHHCCCCCCCCCCHHHHHHHHHH
Q ss_conf             ---0148999-----------98999999999998111799999999999999986
Q 005586          637 ---RNLKGKF-----------SESEAAKLGKMALVCTHEDPENRPTMEAVIEELTV  678 (689)
Q Consensus       637 ---~~~~~~~-----------~~~~~~~~~~l~~~Cl~~dP~~RPs~~evl~~L~~  678 (689)
                         .......           ....+.++.+++.+|++.||.+|||+.|+++|.|.
T Consensus       231 ~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dll~~mL~~dP~~R~t~~ell~H~ff  286 (298)
T d1gz8a_         231 TSMPDYKPSFPKWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALAHPFF  286 (298)
T ss_dssp             GGSTTCCTTSCCCCCCCHHHHSTTCCHHHHHHHHHHTCSSTTTSCCHHHHHTSGGG
T ss_pred             CCCCCCCCCCCCCCCCCHHHHCCCCCHHHHHHHHHHCCCCHHHCCCHHHHHCCHHH
T ss_conf             22421243454322220444166789999999999763995579189999678701

>d1ob3a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {(Plasmodium falciparum) [TaxId: 5833]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cyclin-dependent PK, CDK2
species: (Plasmodium falciparum) [TaxId: 5833]

Probab=100.00  E-value=0  Score=332.99  Aligned_cols=258  Identities=19%  Similarity=0.320  Sum_probs=203.7

Q ss_pred             CCCCCCCCCCCCCCCEEEEEEECCCCEEEEEEECCCCC-CHHHHHHHHHHHHHHCCCCCCCEEEEEEEECCCCCEEEEEE
Q ss_conf             05884542154885209999955993999999024687-62799999999998514899511486689718998189999
Q 005586          409 QCFSEVNLLGKGNFSSVYKGTLRDGTLVAIRSINVTSC-KSEEAEFVKGLYLLTSLRHENIIRLRGFCCSRGRGECFLIY  487 (689)
Q Consensus       409 ~~f~~~~~lg~G~~g~Vy~~~~~~g~~vaiK~~~~~~~-~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~~~lv~  487 (689)
                      ++|...+.||+|+||+||+|+.++|+.||+|+++.... ......+.+|+.++++++||||+++++++..  .+..++++
T Consensus         2 ~~Y~~~~~iG~G~fg~Vy~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~--~~~~~i~~   79 (286)
T d1ob3a_           2 EKYHGLEKIGEGTYGVVYKAQNNYGETFALKKIRLEKEDEGIPSTTIREISILKELKHSNIVKLYDVIHT--KKRLVLVF   79 (286)
T ss_dssp             CSEEEEEEEEEETTEEEEEEEETTSCEEEEEEECCSSGGGCCCHHHHHHHHGGGGCCCTTBCCEEEEEEC--SSCEEEEE
T ss_pred             CCCEECCEEECCCCCEEEEEEECCCCEEEEEEEEHHHCCHHHHHHHHHHHHHHHHCCCCCEEEEEEECCC--CCCEEEEE
T ss_conf             9963431872277818999996899999999981232685899999999999986799868766012046--77315899


Q ss_pred             ECCCCCCHHHHHHHCCCCCCCCCHHHHHHHHHHHHHHHHHHHCCCCCCCCEEECCCCCCCEEECCCCCEEEECCCCCCCC
Q ss_conf             72899998888600179998789999999999999997553079999996362587998665459998078035653345
Q 005586          488 DFAPKGKLSKYLDQEEGSSNVLDWSTRVSIIIGIAKGIGYLHSSEVNKPAIVHRNLSVEKVLIDQQFNPLIADCGLHKLL  567 (689)
Q Consensus       488 e~~~~gsL~~~l~~~~~~~~~l~~~~~~~ia~~ia~gL~~LH~~~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgla~~~  567 (689)
                      |++.++.+..+....    ..+++..+..++.|++.||+|||+.+     |+||||||+|||++.++.+|++|||.+...
T Consensus        80 e~~~~~~~~~~~~~~----~~l~~~~~~~i~~qi~~~L~~LH~~~-----IvHrDiKp~NIll~~~~~~kl~DfG~a~~~  150 (286)
T d1ob3a_          80 EHLDQDLKKLLDVCE----GGLESVTAKSFLLQLLNGIAYCHDRR-----VLHRDLKPQNLLINREGELKIADFGLARAF  150 (286)
T ss_dssp             ECCSEEHHHHHHTST----TCCCHHHHHHHHHHHHHHHHHHHHTT-----CCCSCCCGGGEEECTTSCEEECCTTHHHHH
T ss_pred             EEEHHHHHHHHHHHC----CCCCHHHHHHHHHHHHHHHHHHCCCC-----EEECCCCCCEEEECCCCCEEECCCCCCEEC
T ss_conf             740045678998604----77514456899999999999860574-----882678775056868997873236643011


Q ss_pred             CCCCEEEEECCCCCCCCCCCCCCCCC-CCCCCCCCHHHHHHHHHHHHCCCCCCHHHHHHHHHHHHHHHHCC---------
Q ss_conf             68711345147888788881022358-88986640208899999991998852147788742225676400---------
Q 005586          568 ADDIVFSVLKTSAAMGYLAPEYVTTG-RFTERSDIFAFGVIILQILTGSLVLTSSMRLAAESATFENFIDR---------  637 (689)
Q Consensus       568 ~~~~~~~~~~~~~t~~y~aPE~~~~~-~~~~~sDv~S~Gvil~elltG~~p~~~~~~~~~~~~~~~~~~~~---------  637 (689)
                      ..... ......+++.|+|||.+.+. .++.++||||+||++|||++|+.||.+................+         
T Consensus       151 ~~~~~-~~~~~~~~~~y~~pE~~~~~~~~~~~~DiwslGv~l~el~~G~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~  229 (286)
T d1ob3a_         151 GIPVR-KYTHEIVTLWYRAPDVLMGSKKYSTTIDIWSVGCIFAEMVNGTPLFPGVSEADQLMRIFRILGTPNSKNWPNVT  229 (286)
T ss_dssp             CC----------CCCTTCCHHHHTTCCSCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCTTTSTTGG
T ss_pred             CCCCC-CCCEECCCCHHHHHHHHHCCCCCCCCEEEHHCCCHHHHHHHCCCCCCCCCHHHHHHHHHHHHCCCCHHHCCCHH
T ss_conf             46765-41010243110137887178888841002111758999977979989889899999999863899711042123


Q ss_pred             -------CCC-------CCCCHHHHHHHHHHHHHHCCCCCCCCCCHHHHHHHHHH
Q ss_conf             -------148-------99998999999999998111799999999999999986
Q 005586          638 -------NLK-------GKFSESEAAKLGKMALVCTHEDPENRPTMEAVIEELTV  678 (689)
Q Consensus       638 -------~~~-------~~~~~~~~~~~~~l~~~Cl~~dP~~RPs~~evl~~L~~  678 (689)
                             ...       .......+..+.+++.+|++.||++|||+.|+++|.|.
T Consensus       230 ~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~~L~~dP~~R~s~~ell~Hp~f  284 (286)
T d1ob3a_         230 ELPKYDPNFTVYEPLPWESFLKGLDESGIDLLSKMLKLDPNQRITAKQALEHAYF  284 (286)
T ss_dssp             GSTTCCTTCCCCCCCCGGGTCCSCCHHHHHHHHHHTCSSTTTSCCHHHHHTSGGG
T ss_pred             HHHHCCCCCCCCCCCCHHHHCCCCCHHHHHHHHHHCCCCHHHCCCHHHHHCCCCC
T ss_conf             3322143333356764666512589999999999866896689099998569220

>d1blxa_ d.144.1.7 (A:) Cyclin-dependent PK, CDK6 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cyclin-dependent PK, CDK6
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=0  Score=333.75  Aligned_cols=261  Identities=18%  Similarity=0.317  Sum_probs=198.7

Q ss_pred             HCCCCCCCCCCCCCCCEEEEEEEC-C-CCEEEEEEECCCCCC-HHHHHHHHHHHHHHC---CCCCCCEEEEEEEECC---
Q ss_conf             305884542154885209999955-9-939999990246876-279999999999851---4899511486689718---
Q 005586          408 TQCFSEVNLLGKGNFSSVYKGTLR-D-GTLVAIRSINVTSCK-SEEAEFVKGLYLLTS---LRHENIIRLRGFCCSR---  478 (689)
Q Consensus       408 ~~~f~~~~~lg~G~~g~Vy~~~~~-~-g~~vaiK~~~~~~~~-~~~~~~~~e~~~l~~---l~h~niv~l~~~~~~~---  478 (689)
                      .++|++.+.||+|+||.||+|++. + ++.||+|+++..... .....+.+|+.+++.   .+||||+++++++...   
T Consensus         6 ~~~Y~i~~~LG~G~fg~V~~a~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~E~~~l~~l~~~~HpnIv~~~~~~~~~~~~   85 (305)
T d1blxa_           6 DQQYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHLETFEHPNVVRLFDVCTVSRTD   85 (305)
T ss_dssp             GGTEEEEEEEEEETTEEEEEEEETTTTTEEEEEEEEEEEBCTTSCBCTHHHHHHHHHHHHHTCCTTBCCEEEEEEEEECS
T ss_pred             CCCEEEEEEEECCCCEEEEEEEEECCCCEEEEEEEEEHHHCCCHHHHHHHHHHHHHHHHHHCCCCCCCEEEEEECCCCCC
T ss_conf             58979888992155869999999888998999999802324516799999999999987425898802366322146666


Q ss_pred             CCCEEEEEEECCCCCCHHHHHHHCCCCCCCCCHHHHHHHHHHHHHHHHHHHCCCCCCCCEEECCCCCCCEEECCCCCEEE
Q ss_conf             99818999972899998888600179998789999999999999997553079999996362587998665459998078
Q 005586          479 GRGECFLIYDFAPKGKLSKYLDQEEGSSNVLDWSTRVSIIIGIAKGIGYLHSSEVNKPAIVHRNLSVEKVLIDQQFNPLI  558 (689)
Q Consensus       479 ~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~ia~~ia~gL~~LH~~~~~~~~ivH~dlk~~Nill~~~~~~kl  558 (689)
                      .....++++|+++++++........   ..+++..+..++.|++.||+|||+.+     |+||||||+|||+++++.+||
T Consensus        86 ~~~~~~~~~e~~~~~~~~~~~~~~~---~~~~~~~~~~~~~qi~~aL~yLH~~~-----ivHrDiKp~NILi~~~~~~kl  157 (305)
T d1blxa_          86 RETKLTLVFEHVDQDLTTYLDKVPE---PGVPTETIKDMMFQLLRGLDFLHSHR-----VVHRDLKPQNILVTSSGQIKL  157 (305)
T ss_dssp             SEEEEEEEEECCSCBHHHHHHHSCT---TCSCHHHHHHHHHHHHHHHHHHHHTT-----CCCCCCCGGGEEECTTCCEEE
T ss_pred             CCCEEEEEEEECCCCCHHHHHHCCC---CCCCHHHHHHHHHHHHHHHHHHHHCC-----EEECCCCCCEEEECCCCCEEE
T ss_conf             6746999997405871444443037---89998999999999999999997588-----983579862789858997542


Q ss_pred             ECCCCCCCCCCCCEEEEECCCCCCCCCCCCCCCCCCCCCCCCCHHHHHHHHHHHHCCCCCCHHHHHHHHHHHHHHHHCC-
Q ss_conf             0356533456871134514788878888102235888986640208899999991998852147788742225676400-
Q 005586          559 ADCGLHKLLADDIVFSVLKTSAAMGYLAPEYVTTGRFTERSDIFAFGVIILQILTGSLVLTSSMRLAAESATFENFIDR-  637 (689)
Q Consensus       559 ~Dfgla~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~sDv~S~Gvil~elltG~~p~~~~~~~~~~~~~~~~~~~~-  637 (689)
                      +|||+++......  ......||+.|+|||++.+..++.++||||+||++|||++|+.||..................+ 
T Consensus       158 ~dfg~~~~~~~~~--~~~~~~gT~~Y~APE~~~~~~y~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~  235 (305)
T d1blxa_         158 ADFGLARIYSFQM--ALTSVVVTLWYRAPEVLLQSSYATPVDLWSVGCIFAEMFRRKPLFRGSSDVDQLGKILDVIGLPG  235 (305)
T ss_dssp             CSCCSCCCCCGGG--GGCCCCCCCTTCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCC
T ss_pred             CCHHHHHHHCCCC--CCCCCCCCHHHCCCCHHCCCCCCHHEHHHCHHHHHHHHHHCCCCCCCCCHHHHHHHHHHHHCCCC
T ss_conf             1000101100234--57776548511483100179888111000328999999878799899898999999998407996


Q ss_pred             -------------CC-------CCCCCHHHHHHHHHHHHHHCCCCCCCCCCHHHHHHHHHH
Q ss_conf             -------------14-------899998999999999998111799999999999999986
Q 005586          638 -------------NL-------KGKFSESEAAKLGKMALVCTHEDPENRPTMEAVIEELTV  678 (689)
Q Consensus       638 -------------~~-------~~~~~~~~~~~~~~l~~~Cl~~dP~~RPs~~evl~~L~~  678 (689)
                                   ..       ........++.+.+++.+||+.||++|||+.|+++|.|.
T Consensus       236 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~mL~~dP~~R~sa~e~L~Hpff  296 (305)
T d1blxa_         236 EEDWPRDVALPRQAFHSKSAQPIEKFVTDIDELGKDLLLKCLTFNPAKRISAYSALSHPYF  296 (305)
T ss_dssp             GGGSCTTCSSCGGGSCCCCCCCGGGTCCSCCHHHHHHHHHHSCSSTTTSCCHHHHHTSGGG
T ss_pred             HHCCCCCCCCHHHHHCCCCCCCHHHCCCCCCHHHHHHHHHHCCCCHHHCCCHHHHHCCHHH
T ss_conf             1105321111033302234564544044589999999999874896679189999669634

>d1pmea_ d.144.1.7 (A:) MAP kinase Erk2 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: MAP kinase Erk2
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=0  Score=330.88  Aligned_cols=262  Identities=19%  Similarity=0.288  Sum_probs=201.4

Q ss_pred             HCCCCCCCCCCCCCCCEEEEEEEC-CCCEEEEEEECCCCCCHHHHHHHHHHHHHHCCCCCCCEEEEEEEECCCC--CEEE
Q ss_conf             305884542154885209999955-9939999990246876279999999999851489951148668971899--8189
Q 005586          408 TQCFSEVNLLGKGNFSSVYKGTLR-DGTLVAIRSINVTSCKSEEAEFVKGLYLLTSLRHENIIRLRGFCCSRGR--GECF  484 (689)
Q Consensus       408 ~~~f~~~~~lg~G~~g~Vy~~~~~-~g~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~--~~~~  484 (689)
                      +.+|+..+.||+|+||+||+|+.+ +|+.||||++...........+.+|+.++.+++||||+++++++.....  ...+
T Consensus         7 ~~rY~~~~~LG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~Ei~il~~l~hp~iv~~~~~~~~~~~~~~~~~   86 (345)
T d1pmea_           7 GPRYTNLSYIGEGAYGMVCSAYDNVNKVRVAIKKISPFEHQTYCQRTLREIKILLRFRHENIIGINDIIRAPTIEQMKDV   86 (345)
T ss_dssp             CTTEEEEEECC---CCCEEEEEETTTCSEEEEEEECCTTCHHHHHHHHHHHHHHHHCCCTTBCCCCEEECCSSTTTCCCE
T ss_pred             CCCEEEEEEEEECCCEEEEEEEECCCCCEEEEEEEEHHCCHHHHHHHHHHHHHHHHCCCCCCCCEEEEEEECCCCCCCEE
T ss_conf             89859978994064809999999999949999998031095899999999999997689898858889950564554149


Q ss_pred             EEEECCCCCCHHHHHHHCCCCCCCCCHHHHHHHHHHHHHHHHHHHCCCCCCCCEEECCCCCCCEEECCCCCEEEECCCCC
Q ss_conf             99972899998888600179998789999999999999997553079999996362587998665459998078035653
Q 005586          485 LIYDFAPKGKLSKYLDQEEGSSNVLDWSTRVSIIIGIAKGIGYLHSSEVNKPAIVHRNLSVEKVLIDQQFNPLIADCGLH  564 (689)
Q Consensus       485 lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~ia~~ia~gL~~LH~~~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgla  564 (689)
                      ++++++.+|+|.+++...     .+++..+..++.|++.||+|||+.+     |+||||||+|||+++++.+||+|||++
T Consensus        87 ~l~~~~~~g~L~~~l~~~-----~l~~~~i~~i~~qil~al~yLH~~~-----iiHRDIKp~NILl~~~~~~kl~DfG~a  156 (345)
T d1pmea_          87 YLVTHLMGADLYKLLKTQ-----HLSNDHICYFLYQILRGLKYIHSAN-----VLHRDLKPSNLLLNTTCDLKICDFGLA  156 (345)
T ss_dssp             EEEEECCCEEHHHHHHHC-----CCCHHHHHHHHHHHHHHHHHHHHTT-----EECCCCCGGGEEECTTCCEEECCCTTC
T ss_pred             EEEEEECCCCHHHHHHCC-----CCCHHHHHHHHHHHHHHHHHHHHCC-----CCCCCCCCCEEEECCCCCEEECCCCCE
T ss_conf             999962598656644058-----9999999999999999999999789-----867778764378879997787545705


Q ss_pred             CCCCCCCEE--EEECCCCCCCCCCCCCCCC-CCCCCCCCCHHHHHHHHHHHHCCCCCCHHHHHHHHHHHHH---------
Q ss_conf             345687113--4514788878888102235-8889866402088999999919988521477887422256---------
Q 005586          565 KLLADDIVF--SVLKTSAAMGYLAPEYVTT-GRFTERSDIFAFGVIILQILTGSLVLTSSMRLAAESATFE---------  632 (689)
Q Consensus       565 ~~~~~~~~~--~~~~~~~t~~y~aPE~~~~-~~~~~~sDv~S~Gvil~elltG~~p~~~~~~~~~~~~~~~---------  632 (689)
                      .........  ......++..|+|||++.. ..++.++||||+||++|||++|+.||..............         
T Consensus       157 ~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~DiwSlG~il~eml~g~~pf~~~~~~~~~~~~~~~~~~~~~~~  236 (345)
T d1pmea_         157 RVADPDHDHTGFLTEYVATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQLNHILGILGSPSQED  236 (345)
T ss_dssp             EECCGGGCBCCTTCCCCSCGGGCCGGGTTTBCSCSTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCSCCHHH
T ss_pred             EECCCCCCCCEEECCCCCCCEECHHHHHHCCCCCCCHHHHHCCCCEEHHHHHCCCCCCCCCHHHHHHHHHHHCCCCCHHH
T ss_conf             65047776410101102652000387860478887410100467013377669799788888999998765206997566


Q ss_pred             ----------HHHCC-CCCCCCC-----HHHHHHHHHHHHHHCCCCCCCCCCHHHHHHHHHHH
Q ss_conf             ----------76400-1489999-----89999999999981117999999999999999860
Q 005586          633 ----------NFIDR-NLKGKFS-----ESEAAKLGKMALVCTHEDPENRPTMEAVIEELTVA  679 (689)
Q Consensus       633 ----------~~~~~-~~~~~~~-----~~~~~~~~~l~~~Cl~~dP~~RPs~~evl~~L~~~  679 (689)
                                ..... ......+     ...+.++.+++.+|++.||.+||++.|+++|.+.-
T Consensus       237 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~ta~e~L~hpf~~  299 (345)
T d1pmea_         237 LNCIINLKARNYLLSLPHKNKVPWNRLFPNADSKALDLLDKMLTFNPHKRIEVEQALAHPYLE  299 (345)
T ss_dssp             HHTCCCHHHHHHHHTSCCCCCCCHHHHCTTSCHHHHHHHHHHSCSSTTTSCCHHHHHTSGGGT
T ss_pred             HHHHHHHHHHCCCCCCCCCCCCCHHHHCCCCCHHHHHHHHHHCCCCHHHCCCHHHHHCCHHHC
T ss_conf             423433222202446775577877783789999999999997648956790899986198655

>d1xwsa_ d.144.1.7 (A:) Proto-oncogene serine/threonine-protein kinase Pim-1 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Proto-oncogene serine/threonine-protein kinase Pim-1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=0  Score=335.98  Aligned_cols=245  Identities=20%  Similarity=0.340  Sum_probs=200.0

Q ss_pred             CCCCCCCCCCCCCCCEEEEEEEC-CCCEEEEEEECCCCCC-----HHHHHHHHHHHHHHCCC--CCCCEEEEEEEECCCC
Q ss_conf             05884542154885209999955-9939999990246876-----27999999999985148--9951148668971899
Q 005586          409 QCFSEVNLLGKGNFSSVYKGTLR-DGTLVAIRSINVTSCK-----SEEAEFVKGLYLLTSLR--HENIIRLRGFCCSRGR  480 (689)
Q Consensus       409 ~~f~~~~~lg~G~~g~Vy~~~~~-~g~~vaiK~~~~~~~~-----~~~~~~~~e~~~l~~l~--h~niv~l~~~~~~~~~  480 (689)
                      ++|++.+.||+|+||.||+|+.. +|+.||+|++......     .....+.+|+.++++++  ||||+++++++.  +.
T Consensus         4 ~~Y~i~~~lG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~~~~E~~il~~l~~~h~nIv~~~~~~~--~~   81 (273)
T d1xwsa_           4 SQYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSGVIRLLDWFE--RP   81 (273)
T ss_dssp             TTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCCCEEECTTCCEEEHHHHHHHHHCSSSCSBCCEEEEEE--CS
T ss_pred             CEEEEEEEEEECCCEEEEEEEECCCCCEEEEEEEEHHHCCCHHHHHHHHHHHHHHHHHHHHCCCCCCCCEEEEEEE--EC
T ss_conf             8379967984087839999999999979999998568844334556799999999999974358988127999983--09


Q ss_pred             CEEEEEEECCCC-CCHHHHHHHCCCCCCCCCHHHHHHHHHHHHHHHHHHHCCCCCCCCEEECCCCCCCEEECC-CCCEEE
Q ss_conf             818999972899-998888600179998789999999999999997553079999996362587998665459-998078
Q 005586          481 GECFLIYDFAPK-GKLSKYLDQEEGSSNVLDWSTRVSIIIGIAKGIGYLHSSEVNKPAIVHRNLSVEKVLIDQ-QFNPLI  558 (689)
Q Consensus       481 ~~~~lv~e~~~~-gsL~~~l~~~~~~~~~l~~~~~~~ia~~ia~gL~~LH~~~~~~~~ivH~dlk~~Nill~~-~~~~kl  558 (689)
                      +..++||||+.+ +++.+++....    .+++.++..++.|++.||+|||+.+     |+||||||+|||++. ++.+||
T Consensus        82 ~~~~lv~e~~~~~~~l~~~~~~~~----~l~e~~~~~~~~qi~~al~~lH~~~-----iiHrDiKp~NIll~~~~~~vkl  152 (273)
T d1xwsa_          82 DSFVLILERPEPVQDLFDFITERG----ALQEELARSFFWQVLEAVRHCHNCG-----VLHRDIKDENILIDLNRGELKL  152 (273)
T ss_dssp             SEEEEEEECCSSEEEHHHHHHHHC----SCCHHHHHHHHHHHHHHHHHHHHTT-----EECSCCSGGGEEEETTTTEEEE
T ss_pred             CEEEEEEEECCCCCHHHHHHHCCC----CCCHHHHHHHHHHHHHHHHHHHHCC-----CCCCCCCCCCEEEECCCCEEEE
T ss_conf             968999983368622899986158----9999999999999999999998779-----7556676111477447884897


Q ss_pred             ECCCCCCCCCCCCEEEEECCCCCCCCCCCCCCCCCCC-CCCCCCHHHHHHHHHHHHCCCCCCHHHHHHHHHHHHHHHHCC
Q ss_conf             0356533456871134514788878888102235888-986640208899999991998852147788742225676400
Q 005586          559 ADCGLHKLLADDIVFSVLKTSAAMGYLAPEYVTTGRF-TERSDIFAFGVIILQILTGSLVLTSSMRLAAESATFENFIDR  637 (689)
Q Consensus       559 ~Dfgla~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~-~~~sDv~S~Gvil~elltG~~p~~~~~~~~~~~~~~~~~~~~  637 (689)
                      +|||+++......   .....||..|+|||++.+..+ +.++||||+||++|||+||+.||.......          ..
T Consensus       153 ~DFG~a~~~~~~~---~~~~~GT~~y~aPE~~~~~~~~~~~~DiwSlGvilyell~g~~Pf~~~~~i~----------~~  219 (273)
T d1xwsa_         153 IDFGSGALLKDTV---YTDFDGTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPFEHDEEII----------RG  219 (273)
T ss_dssp             CCCTTCEECCSSC---BCCCCSCGGGSCHHHHHHSCBCHHHHHHHHHHHHHHHHHHSSCSCCSHHHHH----------HC
T ss_pred             CCCCCCEECCCCC---CCCCCCCCCCCCHHHHCCCCCCCCCCCCCCCEEEEHHHHHCCCCCCCCHHHH----------HC
T ss_conf             7546535324445---5665658774799998489978865332554034536756889988736776----------15


Q ss_pred             CCCCCCCHHHHHHHHHHHHHHCCCCCCCCCCHHHHHHHHHHH
Q ss_conf             148999989999999999981117999999999999999860
Q 005586          638 NLKGKFSESEAAKLGKMALVCTHEDPENRPTMEAVIEELTVA  679 (689)
Q Consensus       638 ~~~~~~~~~~~~~~~~l~~~Cl~~dP~~RPs~~evl~~L~~~  679 (689)
                      .  ..++...+.++.+++.+||+.||++|||+.|+++|.|.-
T Consensus       220 ~--~~~~~~~s~~~~~li~~~L~~dp~~R~s~~eil~hp~~~  259 (273)
T d1xwsa_         220 Q--VFFRQRVSSECQHLIRWCLALRPSDRPTFEEIQNHPWMQ  259 (273)
T ss_dssp             C--CCCSSCCCHHHHHHHHHHTCSSGGGSCCHHHHHTSGGGS
T ss_pred             C--CCCCCCCCHHHHHHHHHHCCCCHHHCCCHHHHHCCHHHC
T ss_conf             4--477877999999999997608975893999985398667

>d3blha1 d.144.1.7 (A:8-325) Cell division protein kinase 9, CDK9 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cell division protein kinase 9, CDK9
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=0  Score=325.73  Aligned_cols=267  Identities=18%  Similarity=0.265  Sum_probs=204.2

Q ss_pred             CCCCCCCCCCCCCCCEEEEEEEC-CCCEEEEEEECCCCC-CHHHHHHHHHHHHHHCCCCCCCEEEEEEEECCC------C
Q ss_conf             05884542154885209999955-993999999024687-627999999999985148995114866897189------9
Q 005586          409 QCFSEVNLLGKGNFSSVYKGTLR-DGTLVAIRSINVTSC-KSEEAEFVKGLYLLTSLRHENIIRLRGFCCSRG------R  480 (689)
Q Consensus       409 ~~f~~~~~lg~G~~g~Vy~~~~~-~g~~vaiK~~~~~~~-~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~------~  480 (689)
                      ++|.+.+.||+|+||+||+|+++ +|+.||||++..... ......+.+|+.++++++|+|++++++++....      .
T Consensus        10 ~rY~i~~~LG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~E~~il~~l~h~nii~~~~~~~~~~~~~~~~~   89 (318)
T d3blha1          10 SKYEKLAKIGQGTFGEVFKARHRKTGQKVALKKVLMENEKEGFPITALREIKILQLLKHENVVNLIEICRTKASPYNRCK   89 (318)
T ss_dssp             GGEEEEEEEEECSSSEEEEEEETTTCCEEEEEEC----CTTSSCHHHHHHHHHHHHCCCTTBCCEEEEEEC---------
T ss_pred             CCEEEEEEEECCCCEEEEEEEECCCCCEEEEEEEEHHHCCHHHHHHHHHHHHHHHHHCCCCCCCEEEEEECCCCCCCCCC
T ss_conf             79889999722748299999998999799999984222463789999999999998359996606765402465444457


Q ss_pred             CEEEEEEECCCCCCHHHHHHHCCCCCCCCCHHHHHHHHHHHHHHHHHHHCCCCCCCCEEECCCCCCCEEECCCCCEEEEC
Q ss_conf             81899997289999888860017999878999999999999999755307999999636258799866545999807803
Q 005586          481 GECFLIYDFAPKGKLSKYLDQEEGSSNVLDWSTRVSIIIGIAKGIGYLHSSEVNKPAIVHRNLSVEKVLIDQQFNPLIAD  560 (689)
Q Consensus       481 ~~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~ia~~ia~gL~~LH~~~~~~~~ivH~dlk~~Nill~~~~~~kl~D  560 (689)
                      ...++||||+.++.+.......    ..+++..+..++.|++.||.|||+.+     |+||||||+|||+++++.+|++|
T Consensus        90 ~~~~iv~e~~~~~~~~~~~~~~----~~~~~~~~~~i~~qil~~l~~lH~~~-----ivHrDlKp~NILl~~~~~~kl~d  160 (318)
T d3blha1          90 GSIYLVFDFCEHDLAGLLSNVL----VKFTLSEIKRVMQMLLNGLYYIHRNK-----ILHRDMKAANVLITRDGVLKLAD  160 (318)
T ss_dssp             -CEEEEEECCCEEHHHHHTCTT----CCCCHHHHHHHHHHHHHHHHHHHHTT-----EECCCCCGGGEEECTTSCEEECC
T ss_pred             CEEEEEEECCCCCCCCHHHHCC----CCCCCHHHHHHHHHHHHHHHHHCCCC-----EEECCCCCHHEEECCCCCEEEEE
T ss_conf             6389998535787410122203----44330899999999999998852299-----88567672220366899687631


Q ss_pred             CCCCCCCCCCCEE---EEECCCCCCCCCCCCCCCCC-CCCCCCCCHHHHHHHHHHHHCCCCCCHHHHHHHHHHHHHHHHC
Q ss_conf             5653345687113---45147888788881022358-8898664020889999999199885214778874222567640
Q 005586          561 CGLHKLLADDIVF---SVLKTSAAMGYLAPEYVTTG-RFTERSDIFAFGVIILQILTGSLVLTSSMRLAAESATFENFID  636 (689)
Q Consensus       561 fgla~~~~~~~~~---~~~~~~~t~~y~aPE~~~~~-~~~~~sDv~S~Gvil~elltG~~p~~~~~~~~~~~~~~~~~~~  636 (689)
                      ||+++........   ......+|..|+|||++.+. .++.++||||+||++|||++|+.||..................
T Consensus       161 fg~~~~~~~~~~~~~~~~~~~~gT~~Y~aPE~~~~~~~~~~k~DiwSlGvil~el~~g~~pf~~~~~~~~~~~i~~~~~~  240 (318)
T d3blha1         161 FGLARAFSLAKNSQPNRYTNRVVTLWYRPPELLLGERDYGPPIDLWGAGCIMAEMWTRSPIMQGNTEQHQLALISQLCGS  240 (318)
T ss_dssp             CTTCEECCC-----CCCCCSCCSCGGGCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCC
T ss_pred             CCEEEECCCCCCCCCCCCCCEECCHHHHHHHHHCCCCCCCCHHHCCCCCCEEEEHHHCCCCCCCCCHHHHHHHHHHHCCC
T ss_conf             35002235544432113566024978742899707999891787006786466174487998998999999999984189


Q ss_pred             --CC-----------------CCCCCCH-------HHHHHHHHHHHHHCCCCCCCCCCHHHHHHHHHHHCCCCC
Q ss_conf             --01-----------------4899998-------999999999998111799999999999999986087542
Q 005586          637 --RN-----------------LKGKFSE-------SEAAKLGKMALVCTHEDPENRPTMEAVIEELTVAAPVMA  684 (689)
Q Consensus       637 --~~-----------------~~~~~~~-------~~~~~~~~l~~~Cl~~dP~~RPs~~evl~~L~~~~~~~~  684 (689)
                        +.                 .......       .....+.+++.+||+.||++|||+.|+++|.|.-..+++
T Consensus       241 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dLl~~mL~~dP~~R~sa~elL~Hpff~~~p~p  314 (318)
T d3blha1         241 ITPEVWPNVDNYELYEKLELVKGQKRKVKDRLKAYVRDPYALDLIDKLLVLDPAQRIDSDDALNHDFFWSDPMP  314 (318)
T ss_dssp             CCTTTSTTCCCC-------CCSSCCBCHHHHHHHHHCCHHHHHHHHHHSCSSTTTSCCHHHHHHSGGGSSSSCC
T ss_pred             CCHHHCCCCCHHHHHHHHCCCCCCCCCCHHHHCCCCCCHHHHHHHHHHCCCCHHHCCCHHHHHCCHHHCCCCCC
T ss_conf             98255344320344433201334455503340444599899999999873896589099999749501569999

>d1q5ka_ d.144.1.7 (A:) Glycogen synthase kinase-3 beta (Gsk3b) {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Glycogen synthase kinase-3 beta (Gsk3b)
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=0  Score=328.58  Aligned_cols=257  Identities=19%  Similarity=0.286  Sum_probs=195.5

Q ss_pred             CCCCCCCCCCCCCCEEEEEEEC-CCCEEEEEEECCCCCCHHHHHHHHHHHHHHCCCCCCCEEEEEEEECC----CCCEEE
Q ss_conf             5884542154885209999955-99399999902468762799999999998514899511486689718----998189
Q 005586          410 CFSEVNLLGKGNFSSVYKGTLR-DGTLVAIRSINVTSCKSEEAEFVKGLYLLTSLRHENIIRLRGFCCSR----GRGECF  484 (689)
Q Consensus       410 ~f~~~~~lg~G~~g~Vy~~~~~-~g~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~----~~~~~~  484 (689)
                      +|...++||+|+||+||+|+++ +|+.||+|++.....     ...+|+.++++++|+||+++++++...    +....+
T Consensus        21 ~Y~~~k~LG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~-----~~~~Ei~il~~l~h~niv~~~~~~~~~~~~~~~~~~~   95 (350)
T d1q5ka_          21 SYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDKR-----FKNRELQIMRKLDHCNIVRLRYFFYSSGEKKDEVYLN   95 (350)
T ss_dssp             EEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCSS-----SCCHHHHHHHHCCCTTBCCEEEEEEEC--CCSCCEEE
T ss_pred             CCEEEEEEEECCCEEEEEEEECCCCCEEEEEEECCCCH-----HHHHHHHHHHHCCCCCCCCEEEEEEECCCCCCCEEEE
T ss_conf             76751698217683999999999997999999881606-----8999999998668989873878997447657731899


Q ss_pred             EEEECCCCCCHHHHHHHCCCCCCCCCHHHHHHHHHHHHHHHHHHHCCCCCCCCEEECCCCCCCEEECCCC-CEEEECCCC
Q ss_conf             9997289999888860017999878999999999999999755307999999636258799866545999-807803565
Q 005586          485 LIYDFAPKGKLSKYLDQEEGSSNVLDWSTRVSIIIGIAKGIGYLHSSEVNKPAIVHRNLSVEKVLIDQQF-NPLIADCGL  563 (689)
Q Consensus       485 lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~ia~~ia~gL~~LH~~~~~~~~ivH~dlk~~Nill~~~~-~~kl~Dfgl  563 (689)
                      +||||++++ +.+.+.........+++..+..++.|++.||+|||+.+     |+||||||+|||++.++ .+||+|||+
T Consensus        96 lv~Ey~~~~-~~~~l~~~~~~~~~l~~~~~~~i~~qil~aL~yLH~~~-----IiHrDiKp~NILl~~~~~~~kl~DFG~  169 (350)
T d1q5ka_          96 LVLDYVPET-VYRVARHYSRAKQTLPVIYVKLYMYQLFRSLAYIHSFG-----ICHRDIKPQNLLLDPDTAVLKLCDFGS  169 (350)
T ss_dssp             EEEECCSEE-HHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHTTT-----EECCCCCGGGEEECTTTCCEEECCCTT
T ss_pred             EEEECCCCC-CHHHHHHHHHCCCCCCHHHHHHHHHHHHHHHHHHHHCC-----CCCCCCCCCEEEEECCCCCEEEECCCC
T ss_conf             998416886-07888863103689999999999999999999998668-----764578860378735897116733660


Q ss_pred             CCCCCCCCEEEEECCCCCCCCCCCCCCCC-CCCCCCCCCHHHHHHHHHHHHCCCCCCHHHHHHHHHHHHH----------
Q ss_conf             33456871134514788878888102235-8889866402088999999919988521477887422256----------
Q 005586          564 HKLLADDIVFSVLKTSAAMGYLAPEYVTT-GRFTERSDIFAFGVIILQILTGSLVLTSSMRLAAESATFE----------  632 (689)
Q Consensus       564 a~~~~~~~~~~~~~~~~t~~y~aPE~~~~-~~~~~~sDv~S~Gvil~elltG~~p~~~~~~~~~~~~~~~----------  632 (689)
                      ++.......  .....++..|+|||.+.+ ..++.++||||+||++|||++|+.||..............          
T Consensus       170 a~~~~~~~~--~~~~~gt~~y~aPE~~~~~~~~~~~~DIwSlG~il~el~~g~~pf~~~~~~~~l~~i~~~~g~~~~~~~  247 (350)
T d1q5ka_         170 AKQLVRGEP--NVSYICSRYYRAPELIFGATDYTSSIDVWSAGCVLAELLLGQPIFPGDSGVDQLVEIIKVLGTPTREQI  247 (350)
T ss_dssp             CEECCTTSC--CCSCCSCTTSCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHTSCSSCCSSHHHHHHHHHHHHCCCCHHHH
T ss_pred             HHHCCCCCC--CCCCCCCCCCCCHHHHHCCCCCCCCEEECCCCEEEEEHHHCCCCCCCCCHHHHHHHHHHHHCCCHHHHH
T ss_conf             544047765--320025555568277640468882100024652778550287998987999999999997489817765


Q ss_pred             -HHH----CCCCC--------CCCCHHHHHHHHHHHHHHCCCCCCCCCCHHHHHHHHHHH
Q ss_conf             -764----00148--------999989999999999981117999999999999999860
Q 005586          633 -NFI----DRNLK--------GKFSESEAAKLGKMALVCTHEDPENRPTMEAVIEELTVA  679 (689)
Q Consensus       633 -~~~----~~~~~--------~~~~~~~~~~~~~l~~~Cl~~dP~~RPs~~evl~~L~~~  679 (689)
                       ...    .....        .......+.++.+++.+||+.||++|||+.|+++|.|.-
T Consensus       248 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dLl~~mL~~dP~~R~ta~e~L~Hp~f~  307 (350)
T d1q5ka_         248 REMNPNYTEFKFPQIKAHPWTKVFRPRTPPEAIALCSRLLEYTPTARLTPLEACAHSFFD  307 (350)
T ss_dssp             HHHCC---CCCCCCCCCCCGGGTSCTTSCHHHHHHHHHHSCSSGGGSCCHHHHHTSGGGG
T ss_pred             HHHCCCHHHCCCCCCCCCCHHHHCCCCCCHHHHHHHHHHCCCCHHHCCCHHHHHCCHHHC
T ss_conf             430621011035544567444431568999999999997658955792999996698452

>d1cm8a_ d.144.1.7 (A:) MAP kinase p38-gamma {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: MAP kinase p38-gamma
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=0  Score=325.94  Aligned_cols=257  Identities=21%  Similarity=0.302  Sum_probs=202.9

Q ss_pred             HCCCCCCCCCCCCCCCEEEEEEEC-CCCEEEEEEECCCCC-CHHHHHHHHHHHHHHCCCCCCCEEEEEEEECCC----CC
Q ss_conf             305884542154885209999955-993999999024687-627999999999985148995114866897189----98
Q 005586          408 TQCFSEVNLLGKGNFSSVYKGTLR-DGTLVAIRSINVTSC-KSEEAEFVKGLYLLTSLRHENIIRLRGFCCSRG----RG  481 (689)
Q Consensus       408 ~~~f~~~~~lg~G~~g~Vy~~~~~-~g~~vaiK~~~~~~~-~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~----~~  481 (689)
                      .++|...+.||+|+||+||+|..+ +|+.||+|++..... ....+.+.+|+.++++++|||||++++++...+    ..
T Consensus        17 ~~~Y~~i~~lG~G~fg~V~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~Ei~il~~l~hpniv~l~~~~~~~~~~~~~~   96 (346)
T d1cm8a_          17 RAVYRDLQPVGSGAYGAVCSAVDGRTGAKVAIKKLYRPFQSELFAKRAYRELRLLKHMRHENVIGLLDVFTPDETLDDFT   96 (346)
T ss_dssp             BSSEEEEEEC------CEEEEEETTTCCEEEEEECSSTTSSHHHHHHHHHHHHHHHHCCBTTBCCCSEEECSCSSTTTCC
T ss_pred             CCCEEEEEEEECCCCEEEEEEEECCCCCEEEEEEECHHHCCHHHHHHHHHHHHHHHHCCCCCEEEEEEEECCCCCCCCCC
T ss_conf             77189988980177819999999999989999998522259699999999999998668987547999863576555541


Q ss_pred             EEEEEEECCCCCCHHHHHHHCCCCCCCCCHHHHHHHHHHHHHHHHHHHCCCCCCCCEEECCCCCCCEEECCCCCEEEECC
Q ss_conf             18999972899998888600179998789999999999999997553079999996362587998665459998078035
Q 005586          482 ECFLIYDFAPKGKLSKYLDQEEGSSNVLDWSTRVSIIIGIAKGIGYLHSSEVNKPAIVHRNLSVEKVLIDQQFNPLIADC  561 (689)
Q Consensus       482 ~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~ia~~ia~gL~~LH~~~~~~~~ivH~dlk~~Nill~~~~~~kl~Df  561 (689)
                      ..++||||+ +.+|..+....     .+++..+..++.|++.||.|||+.+     |+||||||+|||++.++.+|++||
T Consensus        97 ~~~lv~e~~-~~~l~~~~~~~-----~l~~~~~~~~~~qi~~aL~~LH~~~-----IiHrDiKp~NIL~~~~~~~kl~Df  165 (346)
T d1cm8a_          97 DFYLVMPFM-GTDLGKLMKHE-----KLGEDRIQFLVYQMLKGLRYIHAAG-----IIHRDLKPGNLAVNEDCELKILDF  165 (346)
T ss_dssp             CCEEEEECC-SEEHHHHHHHC-----CCCHHHHHHHHHHHHHHHHHHHHTT-----EECCCCCGGGEEECTTCCEEECCC
T ss_pred             EEEEEEECC-CCCHHHHHHHC-----CCCHHHHHHHHHHHHHHHHHHHHCC-----CCCCCCCCCHHHCCCCCCCCCCCC
T ss_conf             599998405-52189998740-----2269999999999999999987378-----764566851111210012211343


Q ss_pred             CCCCCCCCCCEEEEECCCCCCCCCCCCCCCCC-CCCCCCCCHHHHHHHHHHHHCCCCCCHHHHHHHHHHHH---------
Q ss_conf             65334568711345147888788881022358-88986640208899999991998852147788742225---------
Q 005586          562 GLHKLLADDIVFSVLKTSAAMGYLAPEYVTTG-RFTERSDIFAFGVIILQILTGSLVLTSSMRLAAESATF---------  631 (689)
Q Consensus       562 gla~~~~~~~~~~~~~~~~t~~y~aPE~~~~~-~~~~~sDv~S~Gvil~elltG~~p~~~~~~~~~~~~~~---------  631 (689)
                      |+++......    ....++..|+|||++.+. .++.++||||+||++|||++|+.||.............         
T Consensus       166 g~a~~~~~~~----~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlGvil~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~  241 (346)
T d1cm8a_         166 GLARQADSEM----TGYVVTRWYRAPEVILNWMRYTQTVDIWSVGCIMAEMITGKTLFKGSDHLDQLKEIMKVTGTPPAE  241 (346)
T ss_dssp             TTCEECCSSC----CSSCSCGGGCCTHHHHTTTCCCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCCCHH
T ss_pred             CCEECCCCCC----CCCCCCCCCCCHHHHCCCCCCCCCCHHHCCHHHHHHHHHCCCCCCCCCHHHHHHHHHHCCCCCCHH
T ss_conf             1022068763----102455333588998178789965010300389999997869988897689999998503788488


Q ss_pred             -------------HHHHCCCCC---CCCCHHHHHHHHHHHHHHCCCCCCCCCCHHHHHHHHHHH
Q ss_conf             -------------676400148---999989999999999981117999999999999999860
Q 005586          632 -------------ENFIDRNLK---GKFSESEAAKLGKMALVCTHEDPENRPTMEAVIEELTVA  679 (689)
Q Consensus       632 -------------~~~~~~~~~---~~~~~~~~~~~~~l~~~Cl~~dP~~RPs~~evl~~L~~~  679 (689)
                                   .........   .......+..+.+++.+||..||.+|||+.|+++|.|.-
T Consensus       242 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~mL~~dP~~R~ta~eiL~Hp~f~  305 (346)
T d1cm8a_         242 FVQRLQSDEAKNYMKGLPELEKKDFASILTNASPLAVNLLEKMLVLDAEQRVTAGEALAHPYFE  305 (346)
T ss_dssp             HHHTCSCHHHHHHHHHSCCCCCCCGGGTCTTCCHHHHHHHHHHSCSSTTTSCCHHHHHHSGGGT
T ss_pred             HHHHHCCHHHHHHHCCCCCCCCCCHHHHCCCCCHHHHHHHHHHCCCCHHHCCCHHHHHCCHHHC
T ss_conf             8865300034433115786665566775568999999999997729955792999996396237

>d3bqca1 d.144.1.7 (A:3-330) Protein kinase CK2, alpha subunit {Rattus norvegicus [TaxId: 10116]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Protein kinase CK2, alpha subunit
species: Rattus norvegicus [TaxId: 10116]

Probab=100.00  E-value=0  Score=323.89  Aligned_cols=254  Identities=16%  Similarity=0.231  Sum_probs=200.5

Q ss_pred             CCCCCCCCCCCCCCCEEEEEEEC-CCCEEEEEEECCCCCCHHHHHHHHHHHHHHCCC-CCCCEEEEEEEECCCCCEEEEE
Q ss_conf             05884542154885209999955-993999999024687627999999999985148-9951148668971899818999
Q 005586          409 QCFSEVNLLGKGNFSSVYKGTLR-DGTLVAIRSINVTSCKSEEAEFVKGLYLLTSLR-HENIIRLRGFCCSRGRGECFLI  486 (689)
Q Consensus       409 ~~f~~~~~lg~G~~g~Vy~~~~~-~g~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~-h~niv~l~~~~~~~~~~~~~lv  486 (689)
                      ++|++.+.||+|+||+||+|+.+ +|+.||+|+++..    ....+.+|+.++..++ ||||+++++++........++|
T Consensus        35 d~y~i~~~LG~G~fg~V~~a~~~~~~~~vAiK~i~~~----~~~~~~~Ei~il~~l~~hpnIv~~~~~~~~~~~~~~~~v  110 (328)
T d3bqca1          35 DDYQLVRKLGRGKYSEVFEAINITNNEKVVVKILKPV----KKKKIKREIKILENLRGGPNIITLADIVKDPVSRTPALV  110 (328)
T ss_dssp             GGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSS----CHHHHHHHHHHHHHHTTSTTBCCEEEEEECTTTCSEEEE
T ss_pred             CCEEEEEEEECCCCEEEEEEEECCCCCEEEEEEECHH----HHHHHHHHHHHHHHCCCCCCCCEEEEEEEECCCCCEEEE
T ss_conf             6718978983174819999998899979999998889----999999999999851579987679999981687712688


Q ss_pred             EECCCCCCHHHHHHHCCCCCCCCCHHHHHHHHHHHHHHHHHHHCCCCCCCCEEECCCCCCCEEECCCC-CEEEECCCCCC
Q ss_conf             97289999888860017999878999999999999999755307999999636258799866545999-80780356533
Q 005586          487 YDFAPKGKLSKYLDQEEGSSNVLDWSTRVSIIIGIAKGIGYLHSSEVNKPAIVHRNLSVEKVLIDQQF-NPLIADCGLHK  565 (689)
Q Consensus       487 ~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~ia~~ia~gL~~LH~~~~~~~~ivH~dlk~~Nill~~~~-~~kl~Dfgla~  565 (689)
                      |||+++++|....+       .+++..+..++.|++.||+|||+.+     |+||||||+|||++.++ .+||+|||+++
T Consensus       111 ~e~~~~~~L~~~~~-------~l~e~~i~~i~~qil~aL~~LH~~g-----IvHrDiKp~NILi~~~~~~vkl~DFG~a~  178 (328)
T d3bqca1         111 FEHVNNTDFKQLYQ-------TLTDYDIRFYMYEILKALDYCHSMG-----IMHRDVKPHNVMIDHEHRKLRLIDWGLAE  178 (328)
T ss_dssp             EECCCSCBGGGTTT-------SCCHHHHHHHHHHHHHHHHHHHHTT-----EECCCCSGGGEEEETTTTEEEECCGGGCE
T ss_pred             EEECCCCCHHHHHC-------CCCHHHHHHHHHHHHHHHHHHHHCC-----CCCCCCCCCCEEECCCCCEEEECCCCCCE
T ss_conf             86317985899746-------8999999999999999998876433-----44345644123774899836641565426


Q ss_pred             CCCCCCEEEEECCCCCCCCCCCCCCCCC-CCCCCCCCHHHHHHHHHHHHCCCCCCHHHHHHHHHHH--------------
Q ss_conf             4568711345147888788881022358-8898664020889999999199885214778874222--------------
Q 005586          566 LLADDIVFSVLKTSAAMGYLAPEYVTTG-RFTERSDIFAFGVIILQILTGSLVLTSSMRLAAESAT--------------  630 (689)
Q Consensus       566 ~~~~~~~~~~~~~~~t~~y~aPE~~~~~-~~~~~sDv~S~Gvil~elltG~~p~~~~~~~~~~~~~--------------  630 (689)
                      ......  ......+|..|+|||.+.+. .++.++||||+|+++|||++|+.||............              
T Consensus       179 ~~~~~~--~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~~l~e~~~g~~pf~~~~~~~~~~~~i~~~~g~~~~~~~~  256 (328)
T d3bqca1         179 FYHPGQ--EYNVRVASRYFKGPELLVDYQMYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQLVRIAKVLGTEDLYDYI  256 (328)
T ss_dssp             ECCTTC--CCCSCCSCGGGCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHTCSSSSCCSSHHHHHHHHHHHHCHHHHHHHH
T ss_pred             ECCCCC--CCCCCCCCCCCCCCCCCCCCCCCCCCCCHHHHHHHHHHHCCCCCCCCCCCHHHHHHHHHHHHHCCCHHHHHH
T ss_conf             646887--444322486424761026888888452323354555876048899988760189999999987884155555


Q ss_pred             ----------HHHHHCC--------CCCCCCCHHHHHHHHHHHHHHCCCCCCCCCCHHHHHHHHHHHC
Q ss_conf             ----------5676400--------1489999899999999999811179999999999999998608
Q 005586          631 ----------FENFIDR--------NLKGKFSESEAAKLGKMALVCTHEDPENRPTMEAVIEELTVAA  680 (689)
Q Consensus       631 ----------~~~~~~~--------~~~~~~~~~~~~~~~~l~~~Cl~~dP~~RPs~~evl~~L~~~~  680 (689)
                                .......        ..........+.++.+++.+|++.||++|||+.|+++|.|.-.
T Consensus       257 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~mL~~dP~~R~ta~e~L~Hp~F~~  324 (328)
T d3bqca1         257 DKYNIELDPRFNDILGRHSRKRWERFVHSENQHLVSPEALDFLDKLLRYDHQSRLTAREAMEHPYFYT  324 (328)
T ss_dssp             HHTTCCCCGGGGGTCCCCCCCCGGGGCCTTTGGGCCHHHHHHHHHHSCSSGGGSCCHHHHHTSGGGTT
T ss_pred             HHCCCCCCCCCCHHCCCCCCCCHHHCCCCCCCCCCCHHHHHHHHHHCCCCHHHCCCHHHHHCCCCCCC
T ss_conf             42254447430000033343311211552112448999999999986699568908999964935588

>d2b1pa1 d.144.1.7 (A:46-400) c-jun N-terminal kinase (jnk3s) {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: c-jun N-terminal kinase (jnk3s)
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=0  Score=321.28  Aligned_cols=258  Identities=17%  Similarity=0.283  Sum_probs=204.0

Q ss_pred             CCCCCCCCCCCCCCCEEEEEEEC-CCCEEEEEEECCCCCC-HHHHHHHHHHHHHHCCCCCCCEEEEEEEECC----CCCE
Q ss_conf             05884542154885209999955-9939999990246876-2799999999998514899511486689718----9981
Q 005586          409 QCFSEVNLLGKGNFSSVYKGTLR-DGTLVAIRSINVTSCK-SEEAEFVKGLYLLTSLRHENIIRLRGFCCSR----GRGE  482 (689)
Q Consensus       409 ~~f~~~~~lg~G~~g~Vy~~~~~-~g~~vaiK~~~~~~~~-~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~----~~~~  482 (689)
                      ++|.+.+.||+|+||+||+|+++ +|+.||||++...... .....+.+|+.++++++||||+++++++...    ....
T Consensus        17 ~~Y~i~~~LG~G~fg~V~~~~d~~t~~~vAvK~i~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~~~~~f~~~~~~~~~~~   96 (355)
T d2b1pa1          17 KRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIISLLNVFTPQKTLEEFQD   96 (355)
T ss_dssp             TTEEEEEECSCC--CEEEEEEETTTTEEEEEEEEESTTSSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCCSTTTCCE
T ss_pred             CCEEEEEEEECCCCEEEEEEEECCCCCEEEEEEECHHHCCHHHHHHHHHHHHHHHHCCCCCEEEEEEEEECCCCCCCCCE
T ss_conf             77599889621758599999999999899999988233697999999999999986489876489989702564345762


Q ss_pred             EEEEEECCCCCCHHHHHHHCCCCCCCCCHHHHHHHHHHHHHHHHHHHCCCCCCCCEEECCCCCCCEEECCCCCEEEECCC
Q ss_conf             89999728999988886001799987899999999999999975530799999963625879986654599980780356
Q 005586          483 CFLIYDFAPKGKLSKYLDQEEGSSNVLDWSTRVSIIIGIAKGIGYLHSSEVNKPAIVHRNLSVEKVLIDQQFNPLIADCG  562 (689)
Q Consensus       483 ~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~ia~~ia~gL~~LH~~~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg  562 (689)
                      .|+||||+.++ +.+.+..      .+++..+..++.|++.||.|||+.+     |+||||||+|||++.++.+|++|||
T Consensus        97 ~~iv~Ey~~~~-l~~~~~~------~~~~~~i~~~~~qil~gl~~LH~~g-----iiHrDlKP~Nil~~~~~~~kl~df~  164 (355)
T d2b1pa1          97 VYLVMELMDAN-LCQVIQM------ELDHERMSYLLYQMLCGIKHLHSAG-----IIHRDLKPSNIVVKSDCTLKILDFG  164 (355)
T ss_dssp             EEEEEECCSEE-HHHHHTS------CCCHHHHHHHHHHHHHHHHHHHHTT-----CCCSCCCGGGEEECTTCCEEECCCC
T ss_pred             EEEEEECCCHH-HHHHHHC------CCCHHHHHHHHHHHHHHHHHHHHCC-----CCCCCCCCCCCCCCCCCCEEEECHH
T ss_conf             69998414467-7876503------8999999999999999998865221-----1245677632113654431320102


Q ss_pred             CCCCCCCCCEEEEECCCCCCCCCCCCCCCCCCCCCCCCCHHHHHHHHHHHHCCCCCCHHHHHHHHHHHH-----------
Q ss_conf             533456871134514788878888102235888986640208899999991998852147788742225-----------
Q 005586          563 LHKLLADDIVFSVLKTSAAMGYLAPEYVTTGRFTERSDIFAFGVIILQILTGSLVLTSSMRLAAESATF-----------  631 (689)
Q Consensus       563 la~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~sDv~S~Gvil~elltG~~p~~~~~~~~~~~~~~-----------  631 (689)
                      +++......  ......+|..|+|||++.+..++.++||||+||++|||++|+.||.............           
T Consensus       165 ~~~~~~~~~--~~~~~~~t~~y~aPE~l~~~~~~~~~DiwSlG~~l~ell~g~~pF~~~~~~~~~~~i~~~~~~~~~~~~  242 (355)
T d2b1pa1         165 LARTAGTSF--MMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMVRHKILFPGRDYIDQWNKVIEQLGTPCPEFM  242 (355)
T ss_dssp             C-----------------CCTTCCHHHHTTCCCCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCCCHHHH
T ss_pred             HHHCCCCCC--CCCCCCCCCCCCCHHHHCCCCCCCCCCCCCCCCHHHHHHHCCCCCCCCCHHHHHHHHHHHCCCCCHHHH
T ss_conf             321146665--533221465555813314777787743335662578986598998889778899999972058987999


Q ss_pred             -------HHHHCC---------------CCCCC---CCHHHHHHHHHHHHHHCCCCCCCCCCHHHHHHHHHHHC
Q ss_conf             -------676400---------------14899---99899999999999811179999999999999998608
Q 005586          632 -------ENFIDR---------------NLKGK---FSESEAAKLGKMALVCTHEDPENRPTMEAVIEELTVAA  680 (689)
Q Consensus       632 -------~~~~~~---------------~~~~~---~~~~~~~~~~~l~~~Cl~~dP~~RPs~~evl~~L~~~~  680 (689)
                             ......               .....   .....+..+.+++.+|++.||++|||++|+++|.|.-.
T Consensus       243 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dll~~mL~~dP~~R~ta~elL~Hpw~~~  316 (355)
T d2b1pa1         243 KKLQPTVRNYVENRPKYAGLTFPKLFPDSLFPADSEHNKLKASQARDLLSKMLVIDPAKRISVDDALQHPYINV  316 (355)
T ss_dssp             TTSCHHHHHHHHTSCCCCCCCHHHHSCGGGSCCSSHHHHHHHHHHHHHHHHHSCSSTTTSCCHHHHHTSTTTGG
T ss_pred             HHHHHHHHHHHHCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCHHHHHHHHHHCCCCHHHCCCHHHHHCCCCCCC
T ss_conf             87656677776417543566642126433354321013337999999999987699457908999966942087

>d1vzoa_ d.144.1.7 (A:) Ribosomal protein S6 kinase alpha 5, Msk1 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Ribosomal protein S6 kinase alpha 5, Msk1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=0  Score=327.43  Aligned_cols=257  Identities=19%  Similarity=0.300  Sum_probs=207.1

Q ss_pred             CCCCCCCCCCCCCCCEEEEEEEC----CCCEEEEEEECCCCC---CHHHHHHHHHHHHHHCCCC-CCCEEEEEEEECCCC
Q ss_conf             05884542154885209999955----993999999024687---6279999999999851489-951148668971899
Q 005586          409 QCFSEVNLLGKGNFSSVYKGTLR----DGTLVAIRSINVTSC---KSEEAEFVKGLYLLTSLRH-ENIIRLRGFCCSRGR  480 (689)
Q Consensus       409 ~~f~~~~~lg~G~~g~Vy~~~~~----~g~~vaiK~~~~~~~---~~~~~~~~~e~~~l~~l~h-~niv~l~~~~~~~~~  480 (689)
                      ++|+..+.||+|+||+||+|+..    +|+.||+|+++....   ....+.+.+|+.++.+++| |||+++++++..  .
T Consensus        24 ~~y~~~~~IG~G~fg~Vy~~~~~~~~~~g~~vAvK~i~~~~~~~~~~~~~~~~~E~~il~~l~h~pnIv~~~~~~~~--~  101 (322)
T d1vzoa_          24 ENFELLKVLGTGAYGKVFLVRKISGHDTGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHIRQSPFLVTLHYAFQT--E  101 (322)
T ss_dssp             GGEEEEEEEEETTTEEEEEEEECSSTTTTCEEEEEEESEEEEEEEESSGGGCCCHHHHHHHHHTCTTBCCEEEEEEE--T
T ss_pred             HCEEEEEEEECCCCEEEEEEEECCCCCCCCEEEEEEEEHHHHCCCHHHHHHHHHHHHHHHHCCCCCEEEEEEEEECC--C
T ss_conf             02599989832878399999987658879489999983677210168999999999999864679839996200024--8


Q ss_pred             CEEEEEEECCCCCCHHHHHHHCCCCCCCCCHHHHHHHHHHHHHHHHHHHCCCCCCCCEEECCCCCCCEEECCCCCEEEEC
Q ss_conf             81899997289999888860017999878999999999999999755307999999636258799866545999807803
Q 005586          481 GECFLIYDFAPKGKLSKYLDQEEGSSNVLDWSTRVSIIIGIAKGIGYLHSSEVNKPAIVHRNLSVEKVLIDQQFNPLIAD  560 (689)
Q Consensus       481 ~~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~ia~~ia~gL~~LH~~~~~~~~ivH~dlk~~Nill~~~~~~kl~D  560 (689)
                      ...++++||+.+|+|.+++.....    +.+.....++.|++.||.|+|+.+     |+||||||+|||++.++.+||+|
T Consensus       102 ~~~~~v~e~~~~~~L~~~i~~~~~----~~e~~~~~~~~Qi~~al~~lH~~~-----ivHrDiKp~Nill~~~~~vkL~D  172 (322)
T d1vzoa_         102 TKLHLILDYINGGELFTHLSQRER----FTEHEVQIYVGEIVLALEHLHKLG-----IIYRDIKLENILLDSNGHVVLTD  172 (322)
T ss_dssp             TEEEEEECCCCSCBHHHHHHHHSC----CCHHHHHHHHHHHHHHHHHHHHTT-----CCCCCCCGGGEEECTTSCEEESC
T ss_pred             CCEEEEEECCCCCHHHHHHHHCCC----CCHHHHHHHHHHHHHHHHHHHCCC-----EEECCCCCCCEEECCCCCEEEEE
T ss_conf             730012312341179999873045----437888888999999998851499-----89654773201246999888741


Q ss_pred             CCCCCCCCCCCEEEEECCCCCCCCCCCCCCCCC--CCCCCCCCHHHHHHHHHHHHCCCCCCHHHHHHHHHHHHHHHHCCC
Q ss_conf             565334568711345147888788881022358--889866402088999999919988521477887422256764001
Q 005586          561 CGLHKLLADDIVFSVLKTSAAMGYLAPEYVTTG--RFTERSDIFAFGVIILQILTGSLVLTSSMRLAAESATFENFIDRN  638 (689)
Q Consensus       561 fgla~~~~~~~~~~~~~~~~t~~y~aPE~~~~~--~~~~~sDv~S~Gvil~elltG~~p~~~~~~~~~~~~~~~~~~~~~  638 (689)
                      ||+++.+............++..|++||.+.+.  .++.++||||+||++|||++|+.||..................  
T Consensus       173 FG~a~~~~~~~~~~~~~~~g~~~~~~pe~~~~~~~~~~~ksDIWSlG~iLyelltG~~PF~~~~~~~~~~~i~~~~~~--  250 (322)
T d1vzoa_         173 FGLSKEFVADETERAYDFCGTIEYMAPDIVRGGDSGHDKAVDWWSLGVLMYELLTGASPFTVDGEKNSQAEISRRILK--  250 (322)
T ss_dssp             SSEEEECCGGGGGGGCGGGSCCTTCCHHHHTTCC---CTHHHHHHHHHHHHHHHHSSCTTSCTTSCCCHHHHHHHHHH--
T ss_pred             CCCHHHHCCCCCCCCCCCCCCCCCCHHHHHHCCCCCCCCHHHHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHHHCCC--
T ss_conf             320222034444322122233333106876057768871325177779999997689998888777799999983356--


Q ss_pred             CCCCCCHHHHHHHHHHHHHHCCCCCCCCC-----CHHHHHHHHHH
Q ss_conf             48999989999999999981117999999-----99999999986
Q 005586          639 LKGKFSESEAAKLGKMALVCTHEDPENRP-----TMEAVIEELTV  678 (689)
Q Consensus       639 ~~~~~~~~~~~~~~~l~~~Cl~~dP~~RP-----s~~evl~~L~~  678 (689)
                      ....++...+.++.+++.+|+++||.+||     +++|+++|.|.
T Consensus       251 ~~~~~~~~~s~~~~~li~~~l~~dP~~R~s~~~~t~~eil~Hpff  295 (322)
T d1vzoa_         251 SEPPYPQEMSALAKDLIQRLLMKDPKKRLGCGPRDADEIKEHLFF  295 (322)
T ss_dssp             CCCCCCTTSCHHHHHHHHHHTCSSGGGSTTSSTTTHHHHHTSGGG
T ss_pred             CCCCCCCCCCHHHHHHHHHHCCCCHHHCCCCCCCCHHHHHCCHHH
T ss_conf             899886547999999999974458988199974509999749723

>d1unla_ d.144.1.7 (A:) Cyclin-dependent PK, CDK5 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cyclin-dependent PK, CDK5
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=0  Score=318.62  Aligned_cols=259  Identities=17%  Similarity=0.304  Sum_probs=204.8

Q ss_pred             CCCCCCCCCCCCCCCEEEEEEEC-CCCEEEEEEECCCCC-CHHHHHHHHHHHHHHCCCCCCCEEEEEEEECCCCCEEEEE
Q ss_conf             05884542154885209999955-993999999024687-6279999999999851489951148668971899818999
Q 005586          409 QCFSEVNLLGKGNFSSVYKGTLR-DGTLVAIRSINVTSC-KSEEAEFVKGLYLLTSLRHENIIRLRGFCCSRGRGECFLI  486 (689)
Q Consensus       409 ~~f~~~~~lg~G~~g~Vy~~~~~-~g~~vaiK~~~~~~~-~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~~~lv  486 (689)
                      ++|+..+.||+|+||+||+|+++ +++.||+|+++.... ......+.+|+.+++.++||||+++++++..  ....++|
T Consensus         2 ~ry~~i~~LG~G~fg~V~~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~E~~il~~l~h~niv~~~~~~~~--~~~~~iv   79 (292)
T d1unla_           2 QKYEKLEKIGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRLHDVLHS--DKKLTLV   79 (292)
T ss_dssp             CSEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEESSCSSTTHHHHHHHHHHHHTTCCCTTBCCEEEEEEC--SSEEEEE
T ss_pred             CCCEEEEEEECCCCEEEEEEEECCCCCEEEEEEEEHHHCCHHHHHHHHHHHHHHHHCCCCCEEEECCCCCC--CCCEEEE
T ss_conf             99786269712868199999999999699999980321786899999999999985675788821354444--4311588


Q ss_pred             EECCCCCCHHHHHHHCCCCCCCCCHHHHHHHHHHHHHHHHHHHCCCCCCCCEEECCCCCCCEEECCCCCEEEECCCCCCC
Q ss_conf             97289999888860017999878999999999999999755307999999636258799866545999807803565334
Q 005586          487 YDFAPKGKLSKYLDQEEGSSNVLDWSTRVSIIIGIAKGIGYLHSSEVNKPAIVHRNLSVEKVLIDQQFNPLIADCGLHKL  566 (689)
Q Consensus       487 ~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~ia~~ia~gL~~LH~~~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgla~~  566 (689)
                      +|++.++++..++....    .+++..+..++.|++.||+|||+.+     |+||||||+|||++.++.+|++|||.++.
T Consensus        80 ~~~~~~~~l~~~~~~~~----~~~~~~~~~~~~q~~~aL~~lH~~~-----IvHrDiKP~NIli~~~~~~kl~DFG~a~~  150 (292)
T d1unla_          80 FEFCDQDLKKYFDSCNG----DLDPEIVKSFLFQLLKGLGFCHSRN-----VLHRDLKPQNLLINRNGELKLANFGLARA  150 (292)
T ss_dssp             EECCSEEHHHHHHHTTT----CCCHHHHHHHHHHHHHHHHHHHHTT-----EECCCCSGGGEEECTTCCEEECCCTTCEE
T ss_pred             EEECCCCCCCCCCCCCC----CCCHHHHHHHHHHHHHHHHHHHCCC-----EEEECCCCCCCCCCCCCCEEEEECCHHHC
T ss_conf             63023322211212356----5403678999999999987743399-----86001467612113378266520460110


Q ss_pred             CCCCCEEEEECCCCCCCCCCCCCCCCCC-CCCCCCCHHHHHHHHHHHHCCCCCCHHHHHHHHHHHHHHHHC---------
Q ss_conf             5687113451478887888810223588-898664020889999999199885214778874222567640---------
Q 005586          567 LADDIVFSVLKTSAAMGYLAPEYVTTGR-FTERSDIFAFGVIILQILTGSLVLTSSMRLAAESATFENFID---------  636 (689)
Q Consensus       567 ~~~~~~~~~~~~~~t~~y~aPE~~~~~~-~~~~sDv~S~Gvil~elltG~~p~~~~~~~~~~~~~~~~~~~---------  636 (689)
                      ...... ......++..|+|||.+.+.. ++.++||||+||++|||++|+.||............+.....         
T Consensus       151 ~~~~~~-~~~~~~~~~~~~~pe~~~~~~~~~~~~DiwSlG~il~ell~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~  229 (292)
T d1unla_         151 FGIPVR-CYSAEVVTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPLFPGNDVDDQLKRIFRLLGTPTEEQWPS  229 (292)
T ss_dssp             CCSCCS-CCCSCCSCGGGCCHHHHTTCSCCCTHHHHHHHHHHHHHHTTTSCCSCCCSSHHHHHHHHHHHHCCCCTTTCTT
T ss_pred             CCCCCC-CCEEECCCCCHHHHHHHCCCCCCCCHHHCCCCCHHHHHHHHCCCCCCCCCCHHHHHHHHHHHCCCCCHHHHHH
T ss_conf             468875-1001034431014667506988880444026541889985189999889999999999986118997355134


Q ss_pred             ------C---------CCCCCCCHHHHHHHHHHHHHHCCCCCCCCCCHHHHHHHHHHH
Q ss_conf             ------0---------148999989999999999981117999999999999999860
Q 005586          637 ------R---------NLKGKFSESEAAKLGKMALVCTHEDPENRPTMEAVIEELTVA  679 (689)
Q Consensus       637 ------~---------~~~~~~~~~~~~~~~~l~~~Cl~~dP~~RPs~~evl~~L~~~  679 (689)
                            .         ..........+..+.+++.+|++.||.+|||++|+++|.|..
T Consensus       230 ~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dll~~mL~~dP~~R~sa~e~L~Hp~f~  287 (292)
T d1unla_         230 MTKLPDYKPYPMYPATTSLVNVVPKLNATGRDLLQNLLKCNPVQRISAEEALQHPYFS  287 (292)
T ss_dssp             GGGSTTCCCCCCCCTTCCCTTTSTTCCHHHHHHHHHHSCSSGGGSCCHHHHTTSGGGS
T ss_pred             HHHCCCCCCCCCCCCCCHHHHCCCCCCHHHHHHHHHHCCCCHHHCCCHHHHHCCHHHC
T ss_conf             4322211334445443104330656899999999998649966890999996495340

>d1ckia_ d.144.1.7 (A:) Casein kinase-1, CK1 {Rat (Rattus norvegicus) [TaxId: 10116]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Casein kinase-1, CK1
species: Rat (Rattus norvegicus) [TaxId: 10116]

Probab=100.00  E-value=0  Score=316.08  Aligned_cols=258  Identities=14%  Similarity=0.170  Sum_probs=195.0

Q ss_pred             CCCCCCCCCCCCCCCEEEEEEEC-CCCEEEEEEECCCCCCHHHHHHHHHHHHHHCCCCCCCEEEEEEEECCCCCEEEEEE
Q ss_conf             05884542154885209999955-99399999902468762799999999998514899511486689718998189999
Q 005586          409 QCFSEVNLLGKGNFSSVYKGTLR-DGTLVAIRSINVTSCKSEEAEFVKGLYLLTSLRHENIIRLRGFCCSRGRGECFLIY  487 (689)
Q Consensus       409 ~~f~~~~~lg~G~~g~Vy~~~~~-~g~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~~~lv~  487 (689)
                      ++|+..+.||+|+||.||+|++. +|+.||+|++......   .++..|++++..++|+|++..++.+.. +....++||
T Consensus         7 ~rY~l~~~iG~G~fG~Vy~a~~~~~~~~vAvK~~~~~~~~---~~~~~E~~i~~~l~~~~~i~~~~~~~~-~~~~~~ivm   82 (299)
T d1ckia_           7 NRYRLGRKIGSGSFGDIYLGTDIAAGEEVAIKLECVKTKH---PQLHIESKIYKMMQGGVGIPTIRWCGA-EGDYNVMVM   82 (299)
T ss_dssp             TTEEEEEEEEECSSSEEEEEEETTTTEEEEEEEEESCTTS---CCHHHHHHHHHHSTTSTTCCCEEEEEE-ETTEEEEEE
T ss_pred             CEEEEEEEEEECCCCEEEEEEECCCCCEEEEEEECHHCCC---HHHHHHHHHHHHCCCCCCCCEEEEEEE-CCCEEEEEE
T ss_conf             8899968985078809999999889989999997210058---889999999997038996017999995-198778999


Q ss_pred             ECCCCCCHHHHHHHCCCCCCCCCHHHHHHHHHHHHHHHHHHHCCCCCCCCEEECCCCCCCEEEC---CCCCEEEECCCCC
Q ss_conf             7289999888860017999878999999999999999755307999999636258799866545---9998078035653
Q 005586          488 DFAPKGKLSKYLDQEEGSSNVLDWSTRVSIIIGIAKGIGYLHSSEVNKPAIVHRNLSVEKVLID---QQFNPLIADCGLH  564 (689)
Q Consensus       488 e~~~~gsL~~~l~~~~~~~~~l~~~~~~~ia~~ia~gL~~LH~~~~~~~~ivH~dlk~~Nill~---~~~~~kl~Dfgla  564 (689)
                      ||+ ++++...+.....   .+++..+..++.|++.||+|||+.+     |+||||||+|||++   .+..+|++|||+|
T Consensus        83 e~~-~~~l~~~~~~~~~---~~~~~~~~~~~~qi~~~l~~lH~~~-----iiHrDiKp~NIl~~~~~~~~~vkl~DFG~a  153 (299)
T d1ckia_          83 ELL-GPSLEDLFNFCSR---KFSLKTVLLLADQMISRIEYIHSKN-----FIHRDVKPDNFLMGLGKKGNLVYIIDFGLA  153 (299)
T ss_dssp             ECC-CCBHHHHHHHTTT---CCCHHHHHHHHHHHHHHHHHHHHTT-----EECSCCCGGGEEECCGGGTTCEEECCCSSC
T ss_pred             EEC-CCCHHHHHHHCCC---CCCHHHHHHHHHHHHHHHHHHHHCC-----EEECCCCHHHCCCCCCCCCCEEEEECCCCC
T ss_conf             873-8713332443068---8768999999999999999999799-----442667876606433577761565046751


Q ss_pred             CCCCCCCE------EEEECCCCCCCCCCCCCCCCCCCCCCCCCHHHHHHHHHHHHCCCCCCHHHHHHHHHH--HHHHHHC
Q ss_conf             34568711------345147888788881022358889866402088999999919988521477887422--2567640
Q 005586          565 KLLADDIV------FSVLKTSAAMGYLAPEYVTTGRFTERSDIFAFGVIILQILTGSLVLTSSMRLAAESA--TFENFID  636 (689)
Q Consensus       565 ~~~~~~~~------~~~~~~~~t~~y~aPE~~~~~~~~~~sDv~S~Gvil~elltG~~p~~~~~~~~~~~~--~~~~~~~  636 (689)
                      +.+.....      .......||+.|+|||.+.+..++.++|||||||++|||+||+.||...........  .......
T Consensus       154 ~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~~l~el~tg~~P~~~~~~~~~~~~~~~~~~~~~  233 (299)
T d1ckia_         154 KKYRDARTHQHIPYRENKNLTGTARYASINTHLGIEQSRRDDLESLGYVLMYFNLGSLPWQGLKAATKRQKYERISEKKM  233 (299)
T ss_dssp             EECBCTTTCCBCCCCBCCSCCCCSSSCCHHHHTTBCCCHHHHHHHHHHHHHHHHHSSCTTCCCC-------HHHHHHHHH
T ss_pred             EECCCCCCCCCEECCCCCCCCCCCCCCCHHHHHCCCCCCHHHEEECCHHHHHHHHCCCCCCCCCHHHHHHHHHHHHCCCC
T ss_conf             34255445541000135776787353299999189989832188617789999849876655305779999998523567


Q ss_pred             CCCCCCCCHHHHHHHHHHHHHHCCCCCCCCCCHHHHHHHHHHH
Q ss_conf             0148999989999999999981117999999999999999860
Q 005586          637 RNLKGKFSESEAAKLGKMALVCTHEDPENRPTMEAVIEELTVA  679 (689)
Q Consensus       637 ~~~~~~~~~~~~~~~~~l~~~Cl~~dP~~RPs~~evl~~L~~~  679 (689)
                      ...........+.++.+++..|++.+|.+||++.++.+.|+..
T Consensus       234 ~~~~~~~~~~~p~~~~~li~~cl~~~p~~RP~~~~i~~~l~~~  276 (299)
T d1ckia_         234 STPIEVLCKGYPSEFATYLNFCRSLRFDDKPDYSYLRQLFRNL  276 (299)
T ss_dssp             HSCHHHHTTTSCHHHHHHHHHHHHSCTTCCCCHHHHHHHHHHH
T ss_pred             CCCHHHHCCCCCHHHHHHHHHHCCCCHHHCCCHHHHHHHHHHH
T ss_conf             8983575347889999999998439955791999999999999

>d2gfsa1 d.144.1.7 (A:5-352) MAP kinase p38 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: MAP kinase p38
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=0  Score=319.57  Aligned_cols=258  Identities=19%  Similarity=0.273  Sum_probs=201.2

Q ss_pred             HCCCCCCCCCCCCCCCEEEEEEEC-CCCEEEEEEECCCCCC-HHHHHHHHHHHHHHCCCCCCCEEEEEEEECC---CCCE
Q ss_conf             305884542154885209999955-9939999990246876-2799999999998514899511486689718---9981
Q 005586          408 TQCFSEVNLLGKGNFSSVYKGTLR-DGTLVAIRSINVTSCK-SEEAEFVKGLYLLTSLRHENIIRLRGFCCSR---GRGE  482 (689)
Q Consensus       408 ~~~f~~~~~lg~G~~g~Vy~~~~~-~g~~vaiK~~~~~~~~-~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~---~~~~  482 (689)
                      .++|+..+.||+|+||+||+|+.. +|+.||+|++...... .....+.+|+.++++++|+|++++++++...   +...
T Consensus        17 ~~rY~i~~~LG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~Ei~il~~l~h~~iv~~~~~~~~~~~~~~~~   96 (348)
T d2gfsa1          17 PERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEFN   96 (348)
T ss_dssp             ETTEEEEEECGGGTTSSEEEEEETTTTEEEEEEECSCTTSSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCSSTTTCC
T ss_pred             CCCEEEEEEEECCCCEEEEEEEECCCCCEEEEEEECCHHCCHHHHHHHHHHHHHHHHCCCCCEEEEEEEEEECCCCCCCC
T ss_conf             98718888983178839999999999979999998820028689999999999998668987425999996346456686


Q ss_pred             EEEEEECCCCCCHHHHHHHCCCCCCCCCHHHHHHHHHHHHHHHHHHHCCCCCCCCEEECCCCCCCEEECCCCCEEEECCC
Q ss_conf             89999728999988886001799987899999999999999975530799999963625879986654599980780356
Q 005586          483 CFLIYDFAPKGKLSKYLDQEEGSSNVLDWSTRVSIIIGIAKGIGYLHSSEVNKPAIVHRNLSVEKVLIDQQFNPLIADCG  562 (689)
Q Consensus       483 ~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~ia~~ia~gL~~LH~~~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg  562 (689)
                      .+++++++.+|+|.+++...     .+++..+..++.|++.||+|||+.+     |+||||||+|||++.++.+|++|||
T Consensus        97 ~~~i~~~~~gg~L~~~~~~~-----~l~e~~~~~i~~qil~aL~~LH~~g-----iiHrDiKp~NILi~~~~~~kl~dfg  166 (348)
T d2gfsa1          97 DVYLVTHLMGADLNNIVKCQ-----KLTDDHVQFLIYQILRGLKYIHSAD-----IIHRDLKPSNLAVNEDCELKILDFG  166 (348)
T ss_dssp             CCEEEEECCSEEHHHHHTTC-----CCCHHHHHHHHHHHHHHHHHHHHTT-----CCCCCCCGGGEEECTTCCEEECCC-
T ss_pred             EEEEEEEECCCCHHHHCCCC-----CCCHHHHHHHHHHHHHHHHHHHHCC-----CCCCCCCCCCCCCCCCCCCCCCCCC
T ss_conf             49999962588623200224-----5309999999999999999997388-----7651667763345543220013210


Q ss_pred             CCCCCCCCCEEEEECCCCCCCCCCCCCCCCCC-CCCCCCCHHHHHHHHHHHHCCCCCCHHHHHHHHHHHHHH--------
Q ss_conf             53345687113451478887888810223588-898664020889999999199885214778874222567--------
Q 005586          563 LHKLLADDIVFSVLKTSAAMGYLAPEYVTTGR-FTERSDIFAFGVIILQILTGSLVLTSSMRLAAESATFEN--------  633 (689)
Q Consensus       563 la~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~-~~~~sDv~S~Gvil~elltG~~p~~~~~~~~~~~~~~~~--------  633 (689)
                      ++.......    ....++..|+|||...+.. ++.++||||+||++|||++|+.||.+.............        
T Consensus       167 ~a~~~~~~~----~~~~g~~~y~apE~~~~~~~~~~~~DiwSlGv~l~~ll~g~~pF~~~~~~~~~~~i~~~~~~~~~~~  242 (348)
T d2gfsa1         167 LARHTDDEM----TGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAEL  242 (348)
T ss_dssp             ---CCTGGG----SSSCHHHHTSCHHHHTTCSCCCTTHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCHHH
T ss_pred             HHCCCCCCC----CCCCCCCCCCCCHHHCCCCCCCCCCCHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHHHCCCCCHHH
T ss_conf             001257544----4434543555835533775678551243205899999768899788988999999997307997577


Q ss_pred             -----------HHCCCCC-CCC-----CHHHHHHHHHHHHHHCCCCCCCCCCHHHHHHHHHHH
Q ss_conf             -----------6400148-999-----989999999999981117999999999999999860
Q 005586          634 -----------FIDRNLK-GKF-----SESEAAKLGKMALVCTHEDPENRPTMEAVIEELTVA  679 (689)
Q Consensus       634 -----------~~~~~~~-~~~-----~~~~~~~~~~l~~~Cl~~dP~~RPs~~evl~~L~~~  679 (689)
                                 ....... ...     ....+..+.+++.+|++.||.+|||+.|+++|.|..
T Consensus       243 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~mL~~dP~~R~ta~elL~Hp~f~  305 (348)
T d2gfsa1         243 LKKISSESARNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAHAYFA  305 (348)
T ss_dssp             HTTCCCHHHHHHHTTSCCCCCCCHHHHSTTCCHHHHHHHHHHSCSSGGGSCCHHHHHTSGGGT
T ss_pred             HHHCCCHHHHHHHHHCCCCCCCCHHHHCCCCCHHHHHHHHHHCCCCHHHCCCHHHHHCCHHHC
T ss_conf             320010244544430355787555662678999999999997758834593899985599548

>d1csna_ d.144.1.7 (A:) Casein kinase-1, CK1 {Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Casein kinase-1, CK1
species: Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]

Probab=100.00  E-value=0  Score=308.85  Aligned_cols=257  Identities=15%  Similarity=0.149  Sum_probs=197.8

Q ss_pred             CCCCCCCCCCCCCCCEEEEEEEC-CCCEEEEEEECCCCCCHHHHHHHHHHHHHHCCCC-CCCEEEEEEEECCCCCEEEEE
Q ss_conf             05884542154885209999955-9939999990246876279999999999851489-951148668971899818999
Q 005586          409 QCFSEVNLLGKGNFSSVYKGTLR-DGTLVAIRSINVTSCKSEEAEFVKGLYLLTSLRH-ENIIRLRGFCCSRGRGECFLI  486 (689)
Q Consensus       409 ~~f~~~~~lg~G~~g~Vy~~~~~-~g~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h-~niv~l~~~~~~~~~~~~~lv  486 (689)
                      ++|.+.+.||+|+||.||+|++. +|+.||+|++......   ..+.+|++.+..++| +|++.+++++..  ....++|
T Consensus         5 ~~Y~i~~~iG~G~fG~Vy~a~~~~~~~~vAvK~~~~~~~~---~~~~~e~~~~~~l~~~~~i~~~~~~~~~--~~~~~~v   79 (293)
T d1csna_           5 VHYKVGRRIGEGSFGVIFEGTNLLNNQQVAIKFEPRRSDA---PQLRDEYRTYKLLAGCTGIPNVYYFGQE--GLHNVLV   79 (293)
T ss_dssp             TTEEEEEEEEECSSCEEEEEEETTTTEEEEEEEEECCTTS---CCHHHHHHHHHHTTTCTTCCCEEEEEEE--TTEEEEE
T ss_pred             CCEEEEEEEECCCCEEEEEEEECCCCCEEEEEEECCCCCC---HHHHHHHHHHHHHCCCCCCCEEEEEEEC--CCCCEEE
T ss_conf             8069979984178829999999889979999997502582---9999999999996489998779999601--8811799


Q ss_pred             EECCCCCCHHHHHHHCCCCCCCCCHHHHHHHHHHHHHHHHHHHCCCCCCCCEEECCCCCCCEEECC-----CCCEEEECC
Q ss_conf             972899998888600179998789999999999999997553079999996362587998665459-----998078035
Q 005586          487 YDFAPKGKLSKYLDQEEGSSNVLDWSTRVSIIIGIAKGIGYLHSSEVNKPAIVHRNLSVEKVLIDQ-----QFNPLIADC  561 (689)
Q Consensus       487 ~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~ia~~ia~gL~~LH~~~~~~~~ivH~dlk~~Nill~~-----~~~~kl~Df  561 (689)
                      |||+ +++|.+++.....   .+++.++..++.|++.||+|||+.+     |+||||||+|||++.     ++.+||+||
T Consensus        80 me~~-~~~l~~~~~~~~~---~~~~~~~~~i~~q~~~~l~~lH~~g-----iiHrDiKp~Nili~~~~~~~~~~vkl~DF  150 (293)
T d1csna_          80 IDLL-GPSLEDLLDLCGR---KFSVKTVAMAAKQMLARVQSIHEKS-----LVYRDIKPDNFLIGRPNSKNANMIYVVDF  150 (293)
T ss_dssp             EECC-CCBHHHHHHHTTT---CCCHHHHHHHHHHHHHHHHHHHTTT-----EECCCCCGGGEEECCSSSTTTTCEEECCC
T ss_pred             EEEC-CCCHHHHHHHHCC---CHHHHHHHHHHHHHHHHHHHHHHCC-----CEECCCCCCCEEECCCCCCCCCCEEECCC
T ss_conf             9964-8887999975203---1106899999999999999999779-----66266771315234754344795687236


Q ss_pred             CCCCCCCCCCE------EEEECCCCCCCCCCCCCCCCCCCCCCCCCHHHHHHHHHHHHCCCCCCHHHHHH--HHHHHHHH
Q ss_conf             65334568711------34514788878888102235888986640208899999991998852147788--74222567
Q 005586          562 GLHKLLADDIV------FSVLKTSAAMGYLAPEYVTTGRFTERSDIFAFGVIILQILTGSLVLTSSMRLA--AESATFEN  633 (689)
Q Consensus       562 gla~~~~~~~~------~~~~~~~~t~~y~aPE~~~~~~~~~~sDv~S~Gvil~elltG~~p~~~~~~~~--~~~~~~~~  633 (689)
                      |+|+.......      .......||+.|+|||.+.+..++.++||||||+++|||+||+.||.......  .....+..
T Consensus       151 G~a~~~~~~~~~~~~~~~~~~~~~GT~~y~aPE~~~~~~~~~~~DiwSlG~~l~elltg~~Pf~~~~~~~~~~~~~~i~~  230 (293)
T d1csna_         151 GMVKFYRDPVTKQHIPYREKKNLSGTARYMSINTHLGREQSRRDDLEALGHVFMYFLRGSLPWQGLKAATNKQKYERIGE  230 (293)
T ss_dssp             TTCEESBCTTTCCBCCCCCCCCCCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTSSCCSCCHHHHHHHHHH
T ss_pred             CEEEECCCCCCCCCEEECCCCCEEECHHHCCHHHHCCCCCCHHHHHHHHHHHHHHHHHCCCCCCCCCCHHHHHHHHHHHH
T ss_conf             60577146766541110246762775102679896488888699989831999999869876788530219999999970


Q ss_pred             HHCCCCCCCCCHHHHHHHHHHHHHHCCCCCCCCCCHHHHHHHHHHH
Q ss_conf             6400148999989999999999981117999999999999999860
Q 005586          634 FIDRNLKGKFSESEAAKLGKMALVCTHEDPENRPTMEAVIEELTVA  679 (689)
Q Consensus       634 ~~~~~~~~~~~~~~~~~~~~l~~~Cl~~dP~~RPs~~evl~~L~~~  679 (689)
                      ..............++++.+++..|++.+|.+||+++.+.+.++.+
T Consensus       231 ~~~~~~~~~l~~~~p~~l~~ii~~~~~~~~~~rP~y~~l~~~l~~~  276 (293)
T d1csna_         231 KKQSTPLRELCAGFPEEFYKYMHYARNLAFDATPDYDYLQGLFSKV  276 (293)
T ss_dssp             HHHHSCHHHHTTTSCHHHHHHHHHHHHCCTTCCCCHHHHHHHHHHH
T ss_pred             CCCCCCHHHHCCCCCHHHHHHHHHHHCCCCCCCCCHHHHHHHHHHH
T ss_conf             5679995896579989999999998439930085999999999999

>d1q8ya_ d.144.1.7 (A:) Sky1p {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Sky1p
species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]

Probab=100.00  E-value=0  Score=288.27  Aligned_cols=259  Identities=19%  Similarity=0.258  Sum_probs=194.2

Q ss_pred             CCCCCCCCCCCCCCCEEEEEEEC-CCCEEEEEEECCCCCCHHHHHHHHHHHHHHCCC-----------CCCCEEEEEEEE
Q ss_conf             05884542154885209999955-993999999024687627999999999985148-----------995114866897
Q 005586          409 QCFSEVNLLGKGNFSSVYKGTLR-DGTLVAIRSINVTSCKSEEAEFVKGLYLLTSLR-----------HENIIRLRGFCC  476 (689)
Q Consensus       409 ~~f~~~~~lg~G~~g~Vy~~~~~-~g~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~-----------h~niv~l~~~~~  476 (689)
                      ++|++.+.||+|+||+||+|+.+ +|+.||||+++...  .....+.+|+.++..++           |+||+++++++.
T Consensus        13 ~rY~i~~~LG~G~fg~Vy~~~~~~~g~~vAvKvi~~~~--~~~~~~~~Ei~~l~~l~~~~~~~~~~~~~~~iv~~~~~~~   90 (362)
T d1q8ya_          13 ARYILVRKLGWGHFSTVWLAKDMVNNTHVAMKIVRGDK--VYTEAAEDEIKLLQRVNDADNTKEDSMGANHILKLLDHFN   90 (362)
T ss_dssp             TTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSCH--HHHHHHHHHHHHHHHHHHTCCSHHHHHHHTTBCCCCEEEE
T ss_pred             CCEEEEEEEEECCCEEEEEEEECCCCCEEEEEEEECCC--CCHHHHHHHHHHHHHHCCHHHHHHHHCCCCCEEEEEEEEE
T ss_conf             85799899750778189999999999799999983431--3368999999999984014555554227676478998763


Q ss_pred             CCCCCEEEEEEECCCCCCHHHHHHHCCCCCCCCCHHHHHHHHHHHHHHHHHHHC-CCCCCCCEEECCCCCCCEEECCCCC
Q ss_conf             189981899997289999888860017999878999999999999999755307-9999996362587998665459998
Q 005586          477 SRGRGECFLIYDFAPKGKLSKYLDQEEGSSNVLDWSTRVSIIIGIAKGIGYLHS-SEVNKPAIVHRNLSVEKVLIDQQFN  555 (689)
Q Consensus       477 ~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~ia~~ia~gL~~LH~-~~~~~~~ivH~dlk~~Nill~~~~~  555 (689)
                      .......+++++++..+.......... ....+++..+..++.|++.||+|||+ .+     |+||||||+|||++.++.
T Consensus        91 ~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~i~~i~~qil~al~~lh~~~~-----IvHrDlKp~NIll~~~~~  164 (362)
T d1q8ya_          91 HKGPNGVHVVMVFEVLGENLLALIKKY-EHRGIPLIYVKQISKQLLLGLDYMHRRCG-----IIHTDIKPENVLMEIVDS  164 (362)
T ss_dssp             EEETTEEEEEEEECCCCEEHHHHHHHT-TTSCCCHHHHHHHHHHHHHHHHHHHHTTC-----EECSCCSGGGEEEEEEET
T ss_pred             ECCCCCEEEEEEECCCCCCCCCCCCCC-CCCCCCHHHHHHHHHHHHHHHHHHHHHCC-----CCCCCCCHHHEEEECCCC
T ss_conf             125652023432000354200000122-34678689999999999999888764058-----646567705705630576


Q ss_pred             ------EEEECCCCCCCCCCCCEEEEECCCCCCCCCCCCCCCCCCCCCCCCCHHHHHHHHHHHHCCCCCCHHHHHHH---
Q ss_conf             ------07803565334568711345147888788881022358889866402088999999919988521477887---
Q 005586          556 ------PLIADCGLHKLLADDIVFSVLKTSAAMGYLAPEYVTTGRFTERSDIFAFGVIILQILTGSLVLTSSMRLAA---  626 (689)
Q Consensus       556 ------~kl~Dfgla~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~sDv~S~Gvil~elltG~~p~~~~~~~~~---  626 (689)
                            ++++|||.+......    .....++..|+|||++....++.++|+||+||+++||++|+.||........   
T Consensus       165 ~~~~~~~kl~dfg~s~~~~~~----~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~el~~g~~pF~~~~~~~~~~~  240 (362)
T d1q8ya_         165 PENLIQIKIADLGNACWYDEH----YTNSIQTREYRSPEVLLGAPWGCGADIWSTACLIFELITGDFLFEPDEGHSYTKD  240 (362)
T ss_dssp             TTTEEEEEECCCTTCEETTBC----CCSCCSCGGGCCHHHHHTCCCCTHHHHHHHHHHHHHHHHSSCCC---------CH
T ss_pred             CCCCCEEEEEECCCCCCCCCC----CCCCCCCCCCCCHHHCCCCCCCCCCCCCCHHHHHHHHHHCCCCCCCCCCCCCCCH
T ss_conf             564430567531442123445----4223665210571321466777643201237899999878899898755432102


Q ss_pred             ---HHHH-----------------HHHHHCC-------------------CCCCCCCHHHHHHHHHHHHHHCCCCCCCCC
Q ss_conf             ---4222-----------------5676400-------------------148999989999999999981117999999
Q 005586          627 ---ESAT-----------------FENFIDR-------------------NLKGKFSESEAAKLGKMALVCTHEDPENRP  667 (689)
Q Consensus       627 ---~~~~-----------------~~~~~~~-------------------~~~~~~~~~~~~~~~~l~~~Cl~~dP~~RP  667 (689)
                         ....                 .....+.                   ..........+..+.+++.+|+..||.+||
T Consensus       241 ~~~~~~~~~~lg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dll~~mL~~dP~~Rp  320 (362)
T d1q8ya_         241 DDHIAQIIELLGELPSYLLRNGKYTRTFFNSRGLLRNISKLKFWPLEDVLTEKYKFSKDEAKEISDFLSPMLQLDPRKRA  320 (362)
T ss_dssp             HHHHHHHHHHHCSCCHHHHHHCTTHHHHBCC--CBSSCCCCCBCCHHHHHHHTTCCCHHHHHHHHHHHGGGGCSSTTTCB
T ss_pred             HHHHHHHHHHHCCCCHHHHHCCCCCCCCCCCCHHHHCCCCCCCCCHHHHCCCCCCCCCCCCHHHHHHHHHHCCCCHHHCC
T ss_conf             68999999983799878862453220001320122024323577644421000156743589999999998779945790


Q ss_pred             CHHHHHHHHHHH
Q ss_conf             999999999860
Q 005586          668 TMEAVIEELTVA  679 (689)
Q Consensus       668 s~~evl~~L~~~  679 (689)
                      |++|+++|.|..
T Consensus       321 ta~e~L~Hp~f~  332 (362)
T d1q8ya_         321 DAGGLVNHPWLK  332 (362)
T ss_dssp             CHHHHHTCGGGT
T ss_pred             CHHHHHCCCCCC
T ss_conf             899996693407

>d1ogqa_ c.10.2.8 (A:) Polygalacturonase inhibiting protein PGIP {Kidney bean (Phaseolus vulgaris) [TaxId: 3885]}

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Polygalacturonase inhibiting protein PGIP
domain: Polygalacturonase inhibiting protein PGIP
species: Kidney bean (Phaseolus vulgaris) [TaxId: 3885]

Probab=100.00  E-value=0  Score=267.95  Aligned_cols=213  Identities=35%  Similarity=0.599  Sum_probs=181.6

Q ss_pred             CCCHHHHHHHHHHHHCCCCCCCCCCCCCCCCCCCCCCCCEEECCCC---CCEEEEECCCCCCCC--CCCCCCCCCCCCCE
Q ss_conf             5795789999999880699987547878899999997351881999---977999917998633--24957678998888
Q 005586           22 VCGNTELRALLDLKASLDPENKLLQSWTENGDPCSGSFEGIACNEH---RKVANISLQGKGLTG--KLSPSLSGLKCLSG   96 (689)
Q Consensus        22 ~~~~~~~~~l~~~k~~~~~~~~~~~~w~~~~~~C~~~w~gv~c~~~---~~v~~l~L~~~~l~g--~~~~~~~~l~~L~~   96 (689)
                      .|.++|+.||++||+++.+++ .+.+|+.++|||.++|.||+|+..   .+|+.|+|++++++|  .+|+++.+|+.|++
T Consensus         2 ~c~~~e~~aLl~~k~~~~~~~-~l~sW~~~~d~C~~~w~gv~C~~~~~~~~v~~L~L~~~~l~g~~~lp~~l~~L~~L~~   80 (313)
T d1ogqa_           2 LCNPQDKQALLQIKKDLGNPT-TLSSWLPTTDCCNRTWLGVLCDTDTQTYRVNNLDLSGLNLPKPYPIPSSLANLPYLNF   80 (313)
T ss_dssp             CSCHHHHHHHHHHHHHTTCCG-GGTTCCTTSCTTTTCSTTEEECCSSSCCCEEEEEEECCCCSSCEECCGGGGGCTTCSE
T ss_pred             CCCHHHHHHHHHHHHHCCCCC-CCCCCCCCCCCCCCCCCCEEEECCCCCEEEEEEECCCCCCCCCCCCCHHHHCCCCCCC
T ss_conf             989899999999999779998-6778899999988948896974899947988998989988888879847846753352


Q ss_pred             EECCC-CCCCCCCCCCCCCCCCCCEEEECCCCCCCCCCCCCCCCCCCCEEEEECCCCCCCCCHHCCCCCCCCEEECCCCC
Q ss_conf             98318-83444478000188888689922568889999533688554389610665888880120899888889656885
Q 005586           97 LYLHY-NSLSGEIPKEIRNLTELTDLYLDVNNLSGNIPPEIGSMASLQVLQLCCNQLTGNIPAQIGSLKSLSVLTLQHNR  175 (689)
Q Consensus        97 L~L~~-N~l~~~~p~~~~~l~~L~~L~Ls~N~l~g~~p~~~~~l~~L~~L~ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~  175 (689)
                      |+|++ |.++|.+|..|.+|++|++|+|++|++.+..+..+..+..|+.+++++|.+.+.+|..+.+++.|+.+++++|.
T Consensus        81 L~Ls~~N~l~g~iP~~i~~L~~L~~L~Ls~N~l~~~~~~~~~~~~~L~~l~l~~N~~~~~~p~~l~~l~~L~~l~l~~n~  160 (313)
T d1ogqa_          81 LYIGGINNLVGPIPPAIAKLTQLHYLYITHTNVSGAIPDFLSQIKTLVTLDFSYNALSGTLPPSISSLPNLVGITFDGNR  160 (313)
T ss_dssp             EEEEEETTEESCCCGGGGGCTTCSEEEEEEECCEEECCGGGGGCTTCCEEECCSSEEESCCCGGGGGCTTCCEEECCSSC
T ss_pred             CCCCCCCCCCCCCCCCCCCCCCCCHHHHCCCCCCCCCCCCCCCHHHHCCCCCCCCCCCCCCCHHHCCCCCCCEEECCCCC
T ss_conf             02026543330024311454200110203564344332222201110011112245555685122067400000023553


Q ss_pred             CCCCCCCCCCCCCCC-CEEECCCCCCCCCCHHHHHCCCCCCEEECCCCCCCCCCCHHHHHCC
Q ss_conf             898799234799878-8342337738887414320897885773426748766523677134
Q 005586          176 LNGGIPDSLGNLGKL-KRLDLSFNSLFGTIPESLANNAELLFLDVQNNTLSGIVPSALKRLN  236 (689)
Q Consensus       176 l~~~~p~~~~~l~~L-~~L~ls~N~l~~~~p~~l~~~~~L~~l~l~~N~l~~~~p~~~~~l~  236 (689)
                      +.+.+|..+..+..+ +.++++.|++++..|..+..+. ...+++.+|.+.+.+|..+..+.
T Consensus       161 l~~~ip~~~~~l~~l~~~l~~~~n~l~~~~~~~~~~l~-~~~l~l~~~~~~~~~~~~~~~~~  221 (313)
T d1ogqa_         161 ISGAIPDSYGSFSKLFTSMTISRNRLTGKIPPTFANLN-LAFVDLSRNMLEGDASVLFGSDK  221 (313)
T ss_dssp             CEEECCGGGGCCCTTCCEEECCSSEEEEECCGGGGGCC-CSEEECCSSEEEECCGGGCCTTS
T ss_pred             CCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCC-CCCCCCCCCCCCCCCCCCCCCCC
T ss_conf             35620312144311232310224643533243322222-22333333433222222222222

>d1p9ag_ c.10.2.7 (G:) von Willebrand factor binding domain of glycoprotein Ib alpha {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Ngr ectodomain-like
domain: von Willebrand factor binding domain of glycoprotein Ib alpha
species: Human (Homo sapiens) [TaxId: 9606]

Probab=99.97  E-value=5.4e-30  Score=170.33  Aligned_cols=182  Identities=25%  Similarity=0.221  Sum_probs=160.5

Q ss_pred             CCEEEEECCCCCCCCCCCCCCCCCCCCCEEECCCCCCCCCCCCCCCCCCCCCEEEECCCCCCCCCCCCCCCCCCCCEEEE
Q ss_conf             97799991799863324957678998888983188344447800018888868992256888999953368855438961
Q 005586           68 RKVANISLQGKGLTGKLSPSLSGLKCLSGLYLHYNSLSGEIPKEIRNLTELTDLYLDVNNLSGNIPPEIGSMASLQVLQL  147 (689)
Q Consensus        68 ~~v~~l~L~~~~l~g~~~~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~g~~p~~~~~l~~L~~L~l  147 (689)
                      .+++.|+|++|.|++..+..|.++++|++|+|++|.|+. +| .+..+++|+.|+|++|+++ ..+..+..+++|+.|++
T Consensus        31 ~~l~~L~Ls~N~i~~l~~~~f~~l~~L~~L~L~~N~l~~-l~-~~~~l~~L~~L~Ls~N~l~-~~~~~~~~l~~L~~L~l  107 (266)
T d1p9ag_          31 KDTTILHLSENLLYTFSLATLMPYTRLTQLNLDRAELTK-LQ-VDGTLPVLGTLDLSHNQLQ-SLPLLGQTLPALTVLDV  107 (266)
T ss_dssp             TTCCEEECTTSCCSEEEGGGGTTCTTCCEEECTTSCCCE-EE-CCSCCTTCCEEECCSSCCS-SCCCCTTTCTTCCEEEC
T ss_pred             CCCCEEECCCCCCCCCCHHHHHCCCCCCCCCCCCCCCCC-CC-CCCCCCCCCCCCCCCCCCC-CCCCCCCCCCCCCCCCC
T ss_conf             688989884992898597786345655221356654444-31-1111223211111222221-11112122222222222


Q ss_pred             ECCCCCCCCCHHCCCCCCCCEEECCCCCCCCCCCCCCCCCCCCCEEECCCCCCCCCCHHHHHCCCCCCEEECCCCCCCCC
Q ss_conf             06658888801208998888896568858987992347998788342337738887414320897885773426748766
Q 005586          148 CCNQLTGNIPAQIGSLKSLSVLTLQHNRLNGGIPDSLGNLGKLKRLDLSFNSLFGTIPESLANNAELLFLDVQNNTLSGI  227 (689)
Q Consensus       148 s~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~ls~N~l~~~~p~~l~~~~~L~~l~l~~N~l~~~  227 (689)
                      ++|.+.+..+..+..+.+++.|++++|.+....+..+..++.++.+++++|++++..+..+..+++|+.|+|++|+++. 
T Consensus       108 ~~~~~~~~~~~~~~~l~~l~~L~l~~n~l~~l~~~~~~~l~~l~~l~l~~N~l~~~~~~~~~~l~~L~~L~Ls~N~L~~-  186 (266)
T d1p9ag_         108 SFNRLTSLPLGALRGLGELQELYLKGNELKTLPPGLLTPTPKLEKLSLANNNLTELPAGLLNGLENLDTLLLQENSLYT-  186 (266)
T ss_dssp             CSSCCCCCCSSTTTTCTTCCEEECTTSCCCCCCTTTTTTCTTCCEEECTTSCCSCCCTTTTTTCTTCCEEECCSSCCCC-
T ss_pred             CCCCCCEEECCCCCCCCCCCCCCCCCCCCCEECCCCCCCCCCCHHCCCCCCCCCCCCCCCCCCCCCCCEEECCCCCCCC-
T ss_conf             2231101100112222111122124342102212333221110000000156522372001342124234301397855-


Q ss_pred             CCHHHHHCC--CCCCCCCCCCCCCCCCC
Q ss_conf             523677134--76200369999899987
Q 005586          228 VPSALKRLN--GGFQFQNNPGLCGDGIA  253 (689)
Q Consensus       228 ~p~~~~~l~--~~~~~~~n~~~c~~~~~  253 (689)
                      +|..+..+.  ..+.+.+|||.|.|.+.
T Consensus       187 lp~~~~~~~~L~~L~L~~Np~~CdC~~~  214 (266)
T d1p9ag_         187 IPKGFFGSHLLPFAFLHGNPWLCNCEIL  214 (266)
T ss_dssp             CCTTTTTTCCCSEEECCSCCBCCSGGGH
T ss_pred             CCHHHCCCCCCCEEEECCCCCCCCCCHH
T ss_conf             6866777888999983699987886437

>d1ozna_ c.10.2.7 (A:) Reticulon 4 receptor (Nogo-66 receptor, Ngr) {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Ngr ectodomain-like
domain: Reticulon 4 receptor (Nogo-66 receptor, Ngr)
species: Human (Homo sapiens) [TaxId: 9606]

Probab=99.96  E-value=1.2e-28  Score=163.28  Aligned_cols=184  Identities=27%  Similarity=0.296  Sum_probs=142.8

Q ss_pred             CCEEEEECCCCCCCCCCCCCCCCCCCCCEEECCCCCCCCCC-------------------------CCCCCCCCCCCEEE
Q ss_conf             97799991799863324957678998888983188344447-------------------------80001888886899
Q 005586           68 RKVANISLQGKGLTGKLSPSLSGLKCLSGLYLHYNSLSGEI-------------------------PKEIRNLTELTDLY  122 (689)
Q Consensus        68 ~~v~~l~L~~~~l~g~~~~~~~~l~~L~~L~L~~N~l~~~~-------------------------p~~~~~l~~L~~L~  122 (689)
                      ..++.|+|++|.|+...+..|.+++.|++|++++|.+....                         +..|.++++|+.|+
T Consensus        32 ~~~~~L~Ls~N~i~~i~~~~f~~l~~L~~L~ls~n~l~~i~~~~~~~~~~~~~l~~~~~~~~~~l~~~~~~~l~~L~~L~  111 (284)
T d1ozna_          32 AASQRIFLHGNRISHVPAASFRACRNLTILWLHSNVLARIDAAAFTGLALLEQLDLSDNAQLRSVDPATFHGLGRLHTLH  111 (284)
T ss_dssp             TTCSEEECTTSCCCEECTTTTTTCTTCCEEECCSSCCCEECTTTTTTCTTCCEEECCSCTTCCCCCTTTTTTCTTCCEEE
T ss_pred             CCCCEEECCCCCCCCCCHHHHHCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCHHHCCCCCCCEEE
T ss_conf             99888977488179879778641421300001344543321112122222222222210223544620101010277875


Q ss_pred             ECCCCCCCCCCCCCCCCCCCCEEEEECCCCCCCCCHHCCCCCCCCEEECCCCCCCCCCCCCCCCCCCCCEEECCCCCCCC
Q ss_conf             22568889999533688554389610665888880120899888889656885898799234799878834233773888
Q 005586          123 LDVNNLSGNIPPEIGSMASLQVLQLCCNQLTGNIPAQIGSLKSLSVLTLQHNRLNGGIPDSLGNLGKLKRLDLSFNSLFG  202 (689)
Q Consensus       123 Ls~N~l~g~~p~~~~~l~~L~~L~ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~ls~N~l~~  202 (689)
                      +++|.+....+..+...++|+.+++++|++++..+..|..+++|+.|++++|.+++..+..|..+++|+.+++++|++++
T Consensus       112 l~~n~~~~~~~~~~~~~~~L~~l~l~~N~l~~i~~~~f~~~~~L~~L~l~~N~l~~l~~~~f~~l~~L~~l~l~~N~l~~  191 (284)
T d1ozna_         112 LDRCGLQELGPGLFRGLAALQYLYLQDNALQALPDDTFRDLGNLTHLFLHGNRISSVPERAFRGLHSLDRLLLHQNRVAH  191 (284)
T ss_dssp             CTTSCCCCCCTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCCEECTTTTTTCTTCCEEECCSSCCCE
T ss_pred             CCCCCCCCCCCCCCCHHCCCCHHHHCCCCCCCCCHHHHCCCCCHHHCCCCCCCCCCCCHHHHCCCCCCCHHHHHHCCCCC
T ss_conf             68854432013533200012110200143144580574043405022314176566256665465634131421143466


Q ss_pred             CCHHHHHCCCCCCEEECCCCCCCCCCCHHHHHCCC--CCCCCCCCCCCCCC
Q ss_conf             74143208978857734267487665236771347--62003699998999
Q 005586          203 TIPESLANNAELLFLDVQNNTLSGIVPSALKRLNG--GFQFQNNPGLCGDG  251 (689)
Q Consensus       203 ~~p~~l~~~~~L~~l~l~~N~l~~~~p~~~~~l~~--~~~~~~n~~~c~~~  251 (689)
                      ..|..|..+++|+.|++++|.+.+..+..|..+..  .+.+.+||+.|.|.
T Consensus       192 i~~~~f~~l~~L~~L~l~~N~i~~~~~~~~~~~~~L~~L~l~~N~l~C~C~  242 (284)
T d1ozna_         192 VHPHAFRDLGRLMTLYLFANNLSALPTEALAPLRALQYLRLNDNPWVCDCR  242 (284)
T ss_dssp             ECTTTTTTCTTCCEEECCSSCCSCCCHHHHTTCTTCCEEECCSSCEECSGG
T ss_pred             CCHHHHHHHHHCCCCCCCCCCCCCCCCCCCCCCCCCCEEEECCCCCCCCCC
T ss_conf             281676653200023333352210000023554656889811998878756

>d1zara2 d.144.1.9 (A:91-281) Rio2 serine protein kinase C-terminal domain {Archaeoglobus fulgidus [TaxId: 2234]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: RIO1-like kinases
domain: Rio2 serine protein kinase C-terminal domain
species: Archaeoglobus fulgidus [TaxId: 2234]

Probab=99.95  E-value=1.3e-28  Score=163.09  Aligned_cols=170  Identities=14%  Similarity=0.122  Sum_probs=119.5

Q ss_pred             CCCCCCCCCCCCEEEEEEECCCCEEEEEEECCCCCC-----------------HHHHHHHHHHHHHHCCCCCCCEEEEEE
Q ss_conf             845421548852099999559939999990246876-----------------279999999999851489951148668
Q 005586          412 SEVNLLGKGNFSSVYKGTLRDGTLVAIRSINVTSCK-----------------SEEAEFVKGLYLLTSLRHENIIRLRGF  474 (689)
Q Consensus       412 ~~~~~lg~G~~g~Vy~~~~~~g~~vaiK~~~~~~~~-----------------~~~~~~~~e~~~l~~l~h~niv~l~~~  474 (689)
                      .+.+.||+|+||.||+|+..+|+.||+|+++.....                 .......+|...+.++.|.+++..+++
T Consensus         3 ~vg~~IG~G~~g~Vy~a~~~~g~~vAvKi~r~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~v~~~~~~   82 (191)
T d1zara2           3 AIGKLMGEGKESAVFNCYSEKFGECVVKFHKVGHTSFKKVKEKRDYGDLHFSVLAIRSARNEFRALQKLQGLAVPKVYAW   82 (191)
T ss_dssp             EEEEEEEECSSEEEEEEEETTTEEEEEEEECC------CCCC-------CHHHHHHHHHHHHHHHHHHTTTSSSCCEEEE
T ss_pred             HHCCEEEECCCEEEEEEECCCCCEEEEEEEECCCCHHHHHHHHHHHCCHHHHHHHHHHHHHHHHHHHHCCCCCCCEEEEE
T ss_conf             22778024856599999979999999999860443466655656300088899999977899999998169991449986


Q ss_pred             EECCCCCEEEEEEECCCCCCHHHHHHHCCCCCCCCCHHHHHHHHHHHHHHHHHHHCCCCCCCCEEECCCCCCCEEECCCC
Q ss_conf             97189981899997289999888860017999878999999999999999755307999999636258799866545999
Q 005586          475 CCSRGRGECFLIYDFAPKGKLSKYLDQEEGSSNVLDWSTRVSIIIGIAKGIGYLHSSEVNKPAIVHRNLSVEKVLIDQQF  554 (689)
Q Consensus       475 ~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~ia~~ia~gL~~LH~~~~~~~~ivH~dlk~~Nill~~~~  554 (689)
                      .  .    .+++|||+++..+.+           ++......++.|++.+++|||+.+     |+||||||+|||++++ 
T Consensus        83 ~--~----~~lvme~~~~~~~~~-----------l~~~~~~~i~~ql~~~l~~lH~~g-----iiHrDiKP~NILv~~~-  139 (191)
T d1zara2          83 E--G----NAVLMELIDAKELYR-----------VRVENPDEVLDMILEEVAKFYHRG-----IVHGDLSQYNVLVSEE-  139 (191)
T ss_dssp             E--T----TEEEEECCCCEEGGG-----------CCCSCHHHHHHHHHHHHHHHHHTT-----EECSCCSTTSEEEETT-
T ss_pred             C--C----CEEEEEEECCCCCCC-----------HHHHHHHHHHHHHHHHHHHHHHCC-----EEECCCCHHHEEEECC-
T ss_conf             2--8----889999504565420-----------015789999999999999982688-----8983689036114289-


Q ss_pred             CEEEECCCCCCCCCCCCEEEEECCCCCCCCCCCCCCCCCCCCCCCCCHHHHHHH
Q ss_conf             807803565334568711345147888788881022358889866402088999
Q 005586          555 NPLIADCGLHKLLADDIVFSVLKTSAAMGYLAPEYVTTGRFTERSDIFAFGVII  608 (689)
Q Consensus       555 ~~kl~Dfgla~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~sDv~S~Gvil  608 (689)
                      .++++|||+|..............  .... -.+.+ ...|+.++|+||..--+
T Consensus       140 ~~~liDFG~a~~~~~~~~~~~l~r--d~~~-~~~~f-~r~y~~~~d~~s~~~~~  189 (191)
T d1zara2         140 GIWIIDFPQSVEVGEEGWREILER--DVRN-IITYF-SRTYRTEKDINSAIDRI  189 (191)
T ss_dssp             EEEECCCTTCEETTSTTHHHHHHH--HHHH-HHHHH-HHHHCCCCCHHHHHHHH
T ss_pred             CEEEEECCCCCCCCCCCCHHHHHH--HHHH-HHHHH-CCCCCCCCCHHHHHHHH
T ss_conf             899987788430899870999987--7999-99997-57899844689999987

>d1xkua_ c.10.2.7 (A:) Decorin {Cow (Bos taurus) [TaxId: 9913]}

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Ngr ectodomain-like
domain: Decorin
species: Cow (Bos taurus) [TaxId: 9913]

Probab=99.94  E-value=2.6e-26  Score=151.16  Aligned_cols=176  Identities=25%  Similarity=0.336  Sum_probs=118.5

Q ss_pred             CCCCCCEEECCC----------CCCEEEEECCCCCCCCCCCCCCCCCCCCCEEECCCCCCCCCCCCCCCCCCCCCEEEEC
Q ss_conf             999735188199----------9977999917998633249576789988889831883444478000188888689922
Q 005586           55 CSGSFEGIACNE----------HRKVANISLQGKGLTGKLSPSLSGLKCLSGLYLHYNSLSGEIPKEIRNLTELTDLYLD  124 (689)
Q Consensus        55 C~~~w~gv~c~~----------~~~v~~l~L~~~~l~g~~~~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls  124 (689)
                      |.+.|.+|.|+.          ...++.|+|++|.|+...+..|.++++|++|++++|.+....|..|.++++|+.|+++
T Consensus         8 c~c~~~~~~C~~~~L~~lP~~l~~~l~~L~Ls~N~i~~l~~~~f~~l~~L~~L~l~~n~~~~i~~~~f~~l~~L~~L~l~   87 (305)
T d1xkua_           8 CQCHLRVVQCSDLGLEKVPKDLPPDTALLDLQNNKITEIKDGDFKNLKNLHTLILINNKISKISPGAFAPLVKLERLYLS   87 (305)
T ss_dssp             CEEETTEEECTTSCCCSCCCSCCTTCCEEECCSSCCCCBCTTTTTTCTTCCEEECCSSCCCCBCTTTTTTCTTCCEEECC
T ss_pred             CEECCCEEEECCCCCCCCCCCCCCCCCEEECCCCCCCCCCHHHHHCCCCCCCCCCCCCCCCCCCHHHHHCCCCCCEECCC
T ss_conf             89559999855999885198889997989784991898696576046565231123443445235665279855783156


Q ss_pred             CCCCCCCCCCCCCCCCCCCEEEEECCCCCCCCCHH--------------------------CCCCCCCCEEECCCCCCCC
Q ss_conf             56888999953368855438961066588888012--------------------------0899888889656885898
Q 005586          125 VNNLSGNIPPEIGSMASLQVLQLCCNQLTGNIPAQ--------------------------IGSLKSLSVLTLQHNRLNG  178 (689)
Q Consensus       125 ~N~l~g~~p~~~~~l~~L~~L~ls~N~l~~~~p~~--------------------------~~~l~~L~~L~Ls~N~l~~  178 (689)
                      +|+++ .+|..+.  ..+..|+++.|.+.+..+..                          +..+++|+.+++++|.++ 
T Consensus        88 ~n~l~-~l~~~~~--~~l~~L~~~~n~l~~l~~~~~~~~~~~~~l~~~~n~~~~~~~~~~~~~~l~~L~~l~l~~n~l~-  163 (305)
T d1xkua_          88 KNQLK-ELPEKMP--KTLQELRVHENEITKVRKSVFNGLNQMIVVELGTNPLKSSGIENGAFQGMKKLSYIRIADTNIT-  163 (305)
T ss_dssp             SSCCS-BCCSSCC--TTCCEEECCSSCCCBBCHHHHTTCTTCCEEECCSSCCCGGGBCTTGGGGCTTCCEEECCSSCCC-
T ss_pred             CCCCC-CCCCCHH--HHHHHHHCCCCCHHHHHHHHHHCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCC-
T ss_conf             87567-6764001--1132321024610234444540133110000123333346777642234565671203467745-


Q ss_pred             CCCCCCCCCCCCCEEECCCCCCCCCCHHHHHCCCCCCEEECCCCCCCCCCCHHHHHCC
Q ss_conf             7992347998788342337738887414320897885773426748766523677134
Q 005586          179 GIPDSLGNLGKLKRLDLSFNSLFGTIPESLANNAELLFLDVQNNTLSGIVPSALKRLN  236 (689)
Q Consensus       179 ~~p~~~~~l~~L~~L~ls~N~l~~~~p~~l~~~~~L~~l~l~~N~l~~~~p~~~~~l~  236 (689)
                      .+|..+  +++|+.|++++|...+..+..+..++.+..|++++|.+.+..+..+..+.
T Consensus       164 ~l~~~~--~~~L~~L~l~~n~~~~~~~~~~~~~~~l~~L~~s~n~l~~~~~~~~~~l~  219 (305)
T d1xkua_         164 TIPQGL--PPSLTELHLDGNKITKVDAASLKGLNNLAKLGLSFNSISAVDNGSLANTP  219 (305)
T ss_dssp             SCCSSC--CTTCSEEECTTSCCCEECTGGGTTCTTCCEEECCSSCCCEECTTTGGGST
T ss_pred             CCCCCC--CCCCCEEECCCCCCCCCCHHHHHCCCCCCCCCCCCCCCCCCCCCCCCCCC
T ss_conf             167101--77667898978867788826764134133015445533222345433443

>d1ogqa_ c.10.2.8 (A:) Polygalacturonase inhibiting protein PGIP {Kidney bean (Phaseolus vulgaris) [TaxId: 3885]}

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Polygalacturonase inhibiting protein PGIP
domain: Polygalacturonase inhibiting protein PGIP
species: Kidney bean (Phaseolus vulgaris) [TaxId: 3885]

Probab=99.94  E-value=4.1e-28  Score=160.56  Aligned_cols=183  Identities=31%  Similarity=0.522  Sum_probs=143.1

Q ss_pred             CCEEEEECCC-CCCCCCCCCCCCCCCCCCEEECCCCCCCCCCCCCCCCCCCCCEEEECCCCCCCCCCCCCCCCCCCCEEE
Q ss_conf             9779999179-986332495767899888898318834444780001888886899225688899995336885543896
Q 005586           68 RKVANISLQG-KGLTGKLSPSLSGLKCLSGLYLHYNSLSGEIPKEIRNLTELTDLYLDVNNLSGNIPPEIGSMASLQVLQ  146 (689)
Q Consensus        68 ~~v~~l~L~~-~~l~g~~~~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~g~~p~~~~~l~~L~~L~  146 (689)
                      .+++.|+|++ |++.|.+|.+|.+|++|++|+|++|++.+..+..+..+.+|+.+++++|.+.+.+|..+..++.|+.++
T Consensus        76 ~~L~~L~Ls~~N~l~g~iP~~i~~L~~L~~L~Ls~N~l~~~~~~~~~~~~~L~~l~l~~N~~~~~~p~~l~~l~~L~~l~  155 (313)
T d1ogqa_          76 PYLNFLYIGGINNLVGPIPPAIAKLTQLHYLYITHTNVSGAIPDFLSQIKTLVTLDFSYNALSGTLPPSISSLPNLVGIT  155 (313)
T ss_dssp             TTCSEEEEEEETTEESCCCGGGGGCTTCSEEEEEEECCEEECCGGGGGCTTCCEEECCSSEEESCCCGGGGGCTTCCEEE
T ss_pred             CCCCCCCCCCCCCCCCCCCCCCCCCCCCCHHHHCCCCCCCCCCCCCCCHHHHCCCCCCCCCCCCCCCHHHCCCCCCCEEE
T ss_conf             53352020265433300243114542001102035643443322222011100111122455556851220674000000


Q ss_pred             EECCCCCCCCCHHCCCCC------------------------------------------------CCCEEECCCCCCCC
Q ss_conf             106658888801208998------------------------------------------------88889656885898
Q 005586          147 LCCNQLTGNIPAQIGSLK------------------------------------------------SLSVLTLQHNRLNG  178 (689)
Q Consensus       147 ls~N~l~~~~p~~~~~l~------------------------------------------------~L~~L~Ls~N~l~~  178 (689)
                      +++|.+.+.+|..+..+.                                                +++.+++++|.+.+
T Consensus       156 l~~n~l~~~ip~~~~~l~~l~~~l~~~~n~l~~~~~~~~~~l~~~~l~l~~~~~~~~~~~~~~~~~~l~~l~~~~~~l~~  235 (313)
T d1ogqa_         156 FDGNRISGAIPDSYGSFSKLFTSMTISRNRLTGKIPPTFANLNLAFVDLSRNMLEGDASVLFGSDKNTQKIHLAKNSLAF  235 (313)
T ss_dssp             CCSSCCEEECCGGGGCCCTTCCEEECCSSEEEEECCGGGGGCCCSEEECCSSEEEECCGGGCCTTSCCSEEECCSSEECC
T ss_pred             CCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCC
T ss_conf             23553356203121443112323102246435332433222222233333343322222222222221112222222222


Q ss_pred             CCCCCCCCCCCCCEEECCCCCCCCCCHHHHHCCCCCCEEECCCCCCCCCCCHH--HHHCCCCCCCCCCCCCCCCCC
Q ss_conf             79923479987883423377388874143208978857734267487665236--771347620036999989998
Q 005586          179 GIPDSLGNLGKLKRLDLSFNSLFGTIPESLANNAELLFLDVQNNTLSGIVPSA--LKRLNGGFQFQNNPGLCGDGI  252 (689)
Q Consensus       179 ~~p~~~~~l~~L~~L~ls~N~l~~~~p~~l~~~~~L~~l~l~~N~l~~~~p~~--~~~l~~~~~~~~n~~~c~~~~  252 (689)
                      .+ ..++.+++|+.|+|++|+++|.+|..+..+++|+.|+|++|+|+|.+|..  +..+ ..+.+.+|+.+||.++
T Consensus       236 ~~-~~~~~~~~L~~L~Ls~N~l~g~iP~~l~~L~~L~~L~Ls~N~l~g~iP~~~~L~~L-~~l~l~~N~~l~g~pl  309 (313)
T d1ogqa_         236 DL-GKVGLSKNLNGLDLRNNRIYGTLPQGLTQLKFLHSLNVSFNNLCGEIPQGGNLQRF-DVSAYANNKCLCGSPL  309 (313)
T ss_dssp             BG-GGCCCCTTCCEEECCSSCCEECCCGGGGGCTTCCEEECCSSEEEEECCCSTTGGGS-CGGGTCSSSEEESTTS
T ss_pred             CC-CCCCCCCCCCCCCCCCCEECCCCCHHHHCCCCCCEEECCCCCCCCCCCCCCCCCCC-CHHHHCCCCCCCCCCC
T ss_conf             22-22224554444447657066608768847999998979588351668986667998-9788688950019898

>d1p9ag_ c.10.2.7 (G:) von Willebrand factor binding domain of glycoprotein Ib alpha {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Ngr ectodomain-like
domain: von Willebrand factor binding domain of glycoprotein Ib alpha
species: Human (Homo sapiens) [TaxId: 9606]

Probab=99.93  E-value=3.8e-25  Score=145.09  Aligned_cols=176  Identities=29%  Similarity=0.321  Sum_probs=147.5

Q ss_pred             CCCCCCEEEEECCCCCCCCCCCCCCCCCCCCCEEECCCCCCCCCCCCCCCCCCCCCEEEECCCCCCCCCCCCCCCCCCCC
Q ss_conf             19999779999179986332495767899888898318834444780001888886899225688899995336885543
Q 005586           64 CNEHRKVANISLQGKGLTGKLSPSLSGLKCLSGLYLHYNSLSGEIPKEIRNLTELTDLYLDVNNLSGNIPPEIGSMASLQ  143 (689)
Q Consensus        64 c~~~~~v~~l~L~~~~l~g~~~~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~g~~p~~~~~l~~L~  143 (689)
                      |........++.++++|+ .+|+.+.  +.|++|+|++|.|++..+..|.++++|++|+|++|+++ .+| .++.+++|+
T Consensus         6 ~~~~~~~~~v~C~~~~L~-~iP~~lp--~~l~~L~Ls~N~i~~l~~~~f~~l~~L~~L~L~~N~l~-~l~-~~~~l~~L~   80 (266)
T d1p9ag_           6 VSKVASHLEVNCDKRNLT-ALPPDLP--KDTTILHLSENLLYTFSLATLMPYTRLTQLNLDRAELT-KLQ-VDGTLPVLG   80 (266)
T ss_dssp             EECSTTCCEEECTTSCCS-SCCSCCC--TTCCEEECTTSCCSEEEGGGGTTCTTCCEEECTTSCCC-EEE-CCSCCTTCC
T ss_pred             ECCCCCCEEEECCCCCCC-EECCCCC--CCCCEEECCCCCCCCCCHHHHHCCCCCCCCCCCCCCCC-CCC-CCCCCCCCC
T ss_conf             742689869980699988-6196757--68898988499289859778634565522135665444-431-111122321


Q ss_pred             EEEEECCCCCCCCCHHCCCCCCCCEEECCCCCCCCCCCCCCCCCCCCCEEECCCCCCCCCCHHHHHCCCCCCEEECCCCC
Q ss_conf             89610665888880120899888889656885898799234799878834233773888741432089788577342674
Q 005586          144 VLQLCCNQLTGNIPAQIGSLKSLSVLTLQHNRLNGGIPDSLGNLGKLKRLDLSFNSLFGTIPESLANNAELLFLDVQNNT  223 (689)
Q Consensus       144 ~L~ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~ls~N~l~~~~p~~l~~~~~L~~l~l~~N~  223 (689)
                      .|+|++|++++ .+..+.++++|+.|++++|.+....+..+..+.+++.|++++|.+....+..+..++.+..+++++|+
T Consensus        81 ~L~Ls~N~l~~-~~~~~~~l~~L~~L~l~~~~~~~~~~~~~~~l~~l~~L~l~~n~l~~l~~~~~~~l~~l~~l~l~~N~  159 (266)
T d1p9ag_          81 TLDLSHNQLQS-LPLLGQTLPALTVLDVSFNRLTSLPLGALRGLGELQELYLKGNELKTLPPGLLTPTPKLEKLSLANNN  159 (266)
T ss_dssp             EEECCSSCCSS-CCCCTTTCTTCCEEECCSSCCCCCCSSTTTTCTTCCEEECTTSCCCCCCTTTTTTCTTCCEEECTTSC
T ss_pred             CCCCCCCCCCC-CCCCCCCCCCCCCCCCCCCCCCEEECCCCCCCCCCCCCCCCCCCCCEECCCCCCCCCCCHHCCCCCCC
T ss_conf             11112222211-11121222222222222231101100112222111122124342102212333221110000000156


Q ss_pred             CCCCCCHHHHHCCC--CCCCCCCC
Q ss_conf             87665236771347--62003699
Q 005586          224 LSGIVPSALKRLNG--GFQFQNNP  245 (689)
Q Consensus       224 l~~~~p~~~~~l~~--~~~~~~n~  245 (689)
                      +++..+..|..+..  .+.+++|.
T Consensus       160 l~~~~~~~~~~l~~L~~L~Ls~N~  183 (266)
T d1p9ag_         160 LTELPAGLLNGLENLDTLLLQENS  183 (266)
T ss_dssp             CSCCCTTTTTTCTTCCEEECCSSC
T ss_pred             CCCCCCCCCCCCCCCCEEECCCCC
T ss_conf             522372001342124234301397

>d1w8aa_ c.10.2.7 (A:) Slit {Fruit fly (Drosophila melanogaster) [TaxId: 7227]}

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Ngr ectodomain-like
domain: Slit
species: Fruit fly (Drosophila melanogaster) [TaxId: 7227]

Probab=99.92  E-value=7.2e-25  Score=143.65  Aligned_cols=172  Identities=21%  Similarity=0.235  Sum_probs=130.8

Q ss_pred             EEECCCCCCCCCCCCCCCCCCCCCEEECCCCCCCCC-CCCCCCCCCCCCEEEECCCCCCCCCCCCCCCCCCCCEEEEECC
Q ss_conf             999179986332495767899888898318834444-7800018888868992256888999953368855438961066
Q 005586           72 NISLQGKGLTGKLSPSLSGLKCLSGLYLHYNSLSGE-IPKEIRNLTELTDLYLDVNNLSGNIPPEIGSMASLQVLQLCCN  150 (689)
Q Consensus        72 ~l~L~~~~l~g~~~~~~~~l~~L~~L~L~~N~l~~~-~p~~~~~l~~L~~L~Ls~N~l~g~~p~~~~~l~~L~~L~ls~N  150 (689)
                      .++.++++++ .+|..+.  +.+++|+|++|.|++. .+..|.++++|+.|+|++|.+....+..|..+++|+.|+|++|
T Consensus        12 ~v~Cs~~~L~-~iP~~lp--~~l~~L~Ls~N~i~~~~~~~~f~~l~~L~~L~L~~N~i~~~~~~~~~~~~~L~~L~Ls~N   88 (192)
T d1w8aa_          12 TVDCTGRGLK-EIPRDIP--LHTTELLLNDNELGRISSDGLFGRLPHLVKLELKRNQLTGIEPNAFEGASHIQELQLGEN   88 (192)
T ss_dssp             EEECTTSCCS-SCCSCCC--TTCSEEECCSCCCCSBCCSCSGGGCTTCCEEECCSSCCCCBCTTTTTTCTTCCEEECCSC
T ss_pred             EEEEECCCCC-CCCCCCC--CCCCEEEECCCCCCCCCCCCCCCCCCEEEEEECCCCCCCCCCCCCCCCCCCCCEEEECCC
T ss_conf             9997089967-0298989--787889848987755302002578762721301363221212122211222210100355


Q ss_pred             CCCCCCCHHCCCCCCCCEEECCCCCCCCCCCCCCCCCCCCCEEECCCCCCCCCCHHHHHCCCCCCEEECCCCCCCCCCCH
Q ss_conf             58888801208998888896568858987992347998788342337738887414320897885773426748766523
Q 005586          151 QLTGNIPAQIGSLKSLSVLTLQHNRLNGGIPDSLGNLGKLKRLDLSFNSLFGTIPESLANNAELLFLDVQNNTLSGIVPS  230 (689)
Q Consensus       151 ~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~ls~N~l~~~~p~~l~~~~~L~~l~l~~N~l~~~~p~  230 (689)
                      ++++..+..|.++++|+.|+|++|++++..+..|..+++|++|+|++|.+......... ...+..+.+..|.+....|.
T Consensus        89 ~l~~l~~~~F~~l~~L~~L~L~~N~l~~i~~~~f~~l~~L~~l~L~~N~~~~~~~~~~~-~~~l~~~~l~~~~~~c~~p~  167 (192)
T d1w8aa_          89 KIKEISNKMFLGLHQLKTLNLYDNQISCVMPGSFEHLNSLTSLNLASNPFNCNCHLAWF-AEWLRKKSLNGGAARCGAPS  167 (192)
T ss_dssp             CCCEECSSSSTTCTTCCEEECCSSCCCEECTTSSTTCTTCCEEECTTCCBCCSGGGHHH-HHHHHHHCCSGGGCBBCSST
T ss_pred             CCCCCCHHHHHCCCCCCCCCCCCCCCCCCCHHHHCCCCCCCCCCCCCCCCCCCCCHHHH-HHHHHHHCCCCCCEEECCCH
T ss_conf             34434979980797465524577453535977856875334200036443435302777-64235403568982768984


Q ss_pred             HHHHCCCCCCCCCCCCCC
Q ss_conf             677134762003699998
Q 005586          231 ALKRLNGGFQFQNNPGLC  248 (689)
Q Consensus       231 ~~~~l~~~~~~~~n~~~c  248 (689)
                      .+..+. ..++..|...|
T Consensus       168 ~l~~~~-l~~L~~n~l~C  184 (192)
T d1w8aa_         168 KVRDVQ-IKDLPHSEFKC  184 (192)
T ss_dssp             TTTTSB-GGGSCTTTCCC
T ss_pred             HHCCCE-EEECCHHHCCC
T ss_conf             336988-61448755758

>d1ozna_ c.10.2.7 (A:) Reticulon 4 receptor (Nogo-66 receptor, Ngr) {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Ngr ectodomain-like
domain: Reticulon 4 receptor (Nogo-66 receptor, Ngr)
species: Human (Homo sapiens) [TaxId: 9606]

Probab=99.91  E-value=6.7e-24  Score=138.59  Aligned_cols=173  Identities=24%  Similarity=0.279  Sum_probs=103.9

Q ss_pred             CEEECCCCCCEEEEECCCCCCCCCCCCCCCCCCCCCEEECCCCCCCCCCCCCCCCCCCCCEEEECCCCCCCCCCCCCCCC
Q ss_conf             51881999977999917998633249576789988889831883444478000188888689922568889999533688
Q 005586           60 EGIACNEHRKVANISLQGKGLTGKLSPSLSGLKCLSGLYLHYNSLSGEIPKEIRNLTELTDLYLDVNNLSGNIPPEIGSM  139 (689)
Q Consensus        60 ~gv~c~~~~~v~~l~L~~~~l~g~~~~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~g~~p~~~~~l  139 (689)
                      .+..|..... ..++.++++++ .+|..+.  +.+++|+|++|.|+...+..|.++++|++|++++|.+....+..+..+
T Consensus         4 ~~C~C~~~~~-~~v~c~~~~L~-~iP~~ip--~~~~~L~Ls~N~i~~i~~~~f~~l~~L~~L~ls~n~l~~i~~~~~~~~   79 (284)
T d1ozna_           4 GACVCYNEPK-VTTSCPQQGLQ-AVPVGIP--AASQRIFLHGNRISHVPAASFRACRNLTILWLHSNVLARIDAAAFTGL   79 (284)
T ss_dssp             TTCEEECSSS-CEEECCSSCCS-SCCTTCC--TTCSEEECTTSCCCEECTTTTTTCTTCCEEECCSSCCCEECTTTTTTC
T ss_pred             CCCEECCCCC-EEEECCCCCCC-CCCCCCC--CCCCEEECCCCCCCCCCHHHHHCCCCCCCCCCCCCCCCCCCCCCCCCC
T ss_conf             9889869999-69984799989-4497889--998889774881798797786414213000013445433211121222


Q ss_pred             CCCCEEEEE-CCCCCCCCCHHCCCCCCCCEEECCCCCCCCCCCCCCCCCCCCCEEECCCCCCCCCCHHHHHCCCCCCEEE
Q ss_conf             554389610-6658888801208998888896568858987992347998788342337738887414320897885773
Q 005586          140 ASLQVLQLC-CNQLTGNIPAQIGSLKSLSVLTLQHNRLNGGIPDSLGNLGKLKRLDLSFNSLFGTIPESLANNAELLFLD  218 (689)
Q Consensus       140 ~~L~~L~ls-~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~ls~N~l~~~~p~~l~~~~~L~~l~  218 (689)
                      +.+..+... .|.++...+..+.++++|+.|++++|.+....+..+..+.+|+.+++++|++++..+..|...++|+.|+
T Consensus        80 ~~~~~l~~~~~~~~~~l~~~~~~~l~~L~~L~l~~n~~~~~~~~~~~~~~~L~~l~l~~N~l~~i~~~~f~~~~~L~~L~  159 (284)
T d1ozna_          80 ALLEQLDLSDNAQLRSVDPATFHGLGRLHTLHLDRCGLQELGPGLFRGLAALQYLYLQDNALQALPDDTFRDLGNLTHLF  159 (284)
T ss_dssp             TTCCEEECCSCTTCCCCCTTTTTTCTTCCEEECTTSCCCCCCTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEE
T ss_pred             CCCCCCCCCCCCCCCCCCCHHHCCCCCCCEEECCCCCCCCCCCCCCCHHCCCCHHHHCCCCCCCCCHHHHCCCCCHHHCC
T ss_conf             22222222210223544620101010277875688544320135332000121102001431445805740434050223


Q ss_pred             CCCCCCCCCCCHHHHHCC
Q ss_conf             426748766523677134
Q 005586          219 VQNNTLSGIVPSALKRLN  236 (689)
Q Consensus       219 l~~N~l~~~~p~~~~~l~  236 (689)
                      +++|.+.+..+..|..+.
T Consensus       160 l~~N~l~~l~~~~f~~l~  177 (284)
T d1ozna_         160 LHGNRISSVPERAFRGLH  177 (284)
T ss_dssp             CCSSCCCEECTTTTTTCT
T ss_pred             CCCCCCCCCCHHHHCCCC
T ss_conf             141765662566654656

>d1w8aa_ c.10.2.7 (A:) Slit {Fruit fly (Drosophila melanogaster) [TaxId: 7227]}

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Ngr ectodomain-like
domain: Slit
species: Fruit fly (Drosophila melanogaster) [TaxId: 7227]

Probab=99.89  E-value=4e-24  Score=139.75  Aligned_cols=134  Identities=25%  Similarity=0.266  Sum_probs=112.9

Q ss_pred             CCEEECCCCCCCCCCCCCCCCCCCCCEEEECCCCCCCCC-CCCCCCCCCCCEEEEECCCCCCCCCHHCCCCCCCCEEECC
Q ss_conf             888983188344447800018888868992256888999-9533688554389610665888880120899888889656
Q 005586           94 LSGLYLHYNSLSGEIPKEIRNLTELTDLYLDVNNLSGNI-PPEIGSMASLQVLQLCCNQLTGNIPAQIGSLKSLSVLTLQ  172 (689)
Q Consensus        94 L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~g~~-p~~~~~l~~L~~L~ls~N~l~~~~p~~~~~l~~L~~L~Ls  172 (689)
                      .++++.++|+|+ .+|..+.  +++++|+|++|++++.+ +..|..+++|+.|++++|.+....+..+..+++|+.|+|+
T Consensus        10 ~~~v~Cs~~~L~-~iP~~lp--~~l~~L~Ls~N~i~~~~~~~~f~~l~~L~~L~L~~N~i~~~~~~~~~~~~~L~~L~Ls   86 (192)
T d1w8aa_          10 GTTVDCTGRGLK-EIPRDIP--LHTTELLLNDNELGRISSDGLFGRLPHLVKLELKRNQLTGIEPNAFEGASHIQELQLG   86 (192)
T ss_dssp             TTEEECTTSCCS-SCCSCCC--TTCSEEECCSCCCCSBCCSCSGGGCTTCCEEECCSSCCCCBCTTTTTTCTTCCEEECC
T ss_pred             CCEEEEECCCCC-CCCCCCC--CCCCEEEECCCCCCCCCCCCCCCCCCEEEEEECCCCCCCCCCCCCCCCCCCCCEEEEC
T ss_conf             999997089967-0298989--7878898489877553020025787627213013632212121222112222101003


Q ss_pred             CCCCCCCCCCCCCCCCCCCEEECCCCCCCCCCHHHHHCCCCCCEEECCCCCCCCCCCH
Q ss_conf             8858987992347998788342337738887414320897885773426748766523
Q 005586          173 HNRLNGGIPDSLGNLGKLKRLDLSFNSLFGTIPESLANNAELLFLDVQNNTLSGIVPS  230 (689)
Q Consensus       173 ~N~l~~~~p~~~~~l~~L~~L~ls~N~l~~~~p~~l~~~~~L~~l~l~~N~l~~~~p~  230 (689)
                      +|+++...|..|.++++|+.|+|++|+|++..+..|..+++|+.++|++|.+....+.
T Consensus        87 ~N~l~~l~~~~F~~l~~L~~L~L~~N~l~~i~~~~f~~l~~L~~l~L~~N~~~~~~~~  144 (192)
T d1w8aa_          87 ENKIKEISNKMFLGLHQLKTLNLYDNQISCVMPGSFEHLNSLTSLNLASNPFNCNCHL  144 (192)
T ss_dssp             SCCCCEECSSSSTTCTTCCEEECCSSCCCEECTTSSTTCTTCCEEECTTCCBCCSGGG
T ss_pred             CCCCCCCCHHHHHCCCCCCCCCCCCCCCCCCCHHHHCCCCCCCCCCCCCCCCCCCCCH
T ss_conf             5534434979980797465524577453535977856875334200036443435302

>d1xkua_ c.10.2.7 (A:) Decorin {Cow (Bos taurus) [TaxId: 9913]}

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Ngr ectodomain-like
domain: Decorin
species: Cow (Bos taurus) [TaxId: 9913]

Probab=99.87  E-value=2.5e-21  Score=125.23  Aligned_cols=159  Identities=21%  Similarity=0.300  Sum_probs=94.9

Q ss_pred             CCEEECCCCCCEEEEECCCCCCCCCCCCCCCCCCCCCEEECCCCCCCCCCCCCCCCCCCCCEEEECCCCCCCCCCCCCCC
Q ss_conf             35188199997799991799863324957678998888983188344447800018888868992256888999953368
Q 005586           59 FEGIACNEHRKVANISLQGKGLTGKLSPSLSGLKCLSGLYLHYNSLSGEIPKEIRNLTELTDLYLDVNNLSGNIPPEIGS  138 (689)
Q Consensus        59 w~gv~c~~~~~v~~l~L~~~~l~g~~~~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~g~~p~~~~~  138 (689)
                      ..+..|.    ...++-++++++ .+|..+.  +.|++|+|++|+|+...+..|.++++|+.|++++|.+....|..|..
T Consensus         5 p~~c~c~----~~~~~C~~~~L~-~lP~~l~--~~l~~L~Ls~N~i~~l~~~~f~~l~~L~~L~l~~n~~~~i~~~~f~~   77 (305)
T d1xkua_           5 PFRCQCH----LRVVQCSDLGLE-KVPKDLP--PDTALLDLQNNKITEIKDGDFKNLKNLHTLILINNKISKISPGAFAP   77 (305)
T ss_dssp             CTTCEEE----TTEEECTTSCCC-SCCCSCC--TTCCEEECCSSCCCCBCTTTTTTCTTCCEEECCSSCCCCBCTTTTTT
T ss_pred             CCCCEEC----CCEEEECCCCCC-CCCCCCC--CCCCEEECCCCCCCCCCHHHHHCCCCCCCCCCCCCCCCCCCHHHHHC
T ss_conf             9988955----999985599988-5198889--99798978499189869657604656523112344344523566527


Q ss_pred             CCCCCEEEEECCCCCCCCCHHCCCCCCCCEEECCCCCCCCCCCCCCCCCCCCCEEECCCCCCC--CCCHHHHHCCCCCCE
Q ss_conf             855438961066588888012089988888965688589879923479987883423377388--874143208978857
Q 005586          139 MASLQVLQLCCNQLTGNIPAQIGSLKSLSVLTLQHNRLNGGIPDSLGNLGKLKRLDLSFNSLF--GTIPESLANNAELLF  216 (689)
Q Consensus       139 l~~L~~L~ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~ls~N~l~--~~~p~~l~~~~~L~~  216 (689)
                      ++.|+.|++++|+++. +|..+  ...+..|++.+|.+.+..+..+.....+..++...|...  ...+..+..+++|..
T Consensus        78 l~~L~~L~l~~n~l~~-l~~~~--~~~l~~L~~~~n~l~~l~~~~~~~~~~~~~l~~~~n~~~~~~~~~~~~~~l~~L~~  154 (305)
T d1xkua_          78 LVKLERLYLSKNQLKE-LPEKM--PKTLQELRVHENEITKVRKSVFNGLNQMIVVELGTNPLKSSGIENGAFQGMKKLSY  154 (305)
T ss_dssp             CTTCCEEECCSSCCSB-CCSSC--CTTCCEEECCSSCCCBBCHHHHTTCTTCCEEECCSSCCCGGGBCTTGGGGCTTCCE
T ss_pred             CCCCCEECCCCCCCCC-CCCCH--HHHHHHHHCCCCCHHHHHHHHHHCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCC
T ss_conf             9855783156875676-76400--11132321024610234444540133110000123333346777642234565671


Q ss_pred             EECCCCCCCCC
Q ss_conf             73426748766
Q 005586          217 LDVQNNTLSGI  227 (689)
Q Consensus       217 l~l~~N~l~~~  227 (689)
                      +++++|.+...
T Consensus       155 l~l~~n~l~~l  165 (305)
T d1xkua_         155 IRIADTNITTI  165 (305)
T ss_dssp             EECCSSCCCSC
T ss_pred             CCCCCCCCCCC
T ss_conf             20346774516

>d2omxa2 c.10.2.1 (A:37-235) Internalin B {Listeria monocytogenes [TaxId: 1639]}

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Internalin LRR domain
domain: Internalin B
species: Listeria monocytogenes [TaxId: 1639]

Probab=99.85  E-value=3.5e-20  Score=119.24  Aligned_cols=148  Identities=28%  Similarity=0.427  Sum_probs=127.2

Q ss_pred             CCEEEEECCCCCCCCCCCCCCCCCCCCCEEECCCCCCCCCCCCCCCCCCCCCEEEECCCCCCCCCCCCCCCCCCCCEEEE
Q ss_conf             97799991799863324957678998888983188344447800018888868992256888999953368855438961
Q 005586           68 RKVANISLQGKGLTGKLSPSLSGLKCLSGLYLHYNSLSGEIPKEIRNLTELTDLYLDVNNLSGNIPPEIGSMASLQVLQL  147 (689)
Q Consensus        68 ~~v~~l~L~~~~l~g~~~~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~g~~p~~~~~l~~L~~L~l  147 (689)
                      .+++.|++.+++++..  ..+..+++|++|+|++|.+++..|  +.++++|+.|++++|.+. .++ .+..++.|+.|++
T Consensus        40 ~~l~~L~l~~~~i~~l--~~l~~l~nL~~L~Ls~N~l~~~~~--l~~l~~L~~L~l~~n~~~-~~~-~l~~l~~L~~L~l  113 (199)
T d2omxa2          40 DQVTTLQADRLGIKSI--DGVEYLNNLTQINFSNNQLTDITP--LKNLTKLVDILMNNNQIA-DIT-PLANLTNLTGLTL  113 (199)
T ss_dssp             TTCCEEECTTSCCCCC--TTGGGCTTCCEEECCSSCCCCCGG--GTTCTTCCEEECCSSCCC-CCG-GGTTCTTCSEEEC
T ss_pred             CCCCEEECCCCCCCCC--CCCCCCCCCCCCCCCCCCCCCCCC--CCCCCCCCCCCCCCCCCC-CCC-CCCCCCCCCCCCC
T ss_conf             6878998999999775--202137886757545655667640--167752231111222222-221-1111223222111


Q ss_pred             ECCCCCCCCCHHCCCCCCCCEEECCCCCCCCCCCCCCCCCCCCCEEECCCCCCCCCCHHHHHCCCCCCEEECCCCCCCCC
Q ss_conf             06658888801208998888896568858987992347998788342337738887414320897885773426748766
Q 005586          148 CCNQLTGNIPAQIGSLKSLSVLTLQHNRLNGGIPDSLGNLGKLKRLDLSFNSLFGTIPESLANNAELLFLDVQNNTLSGI  227 (689)
Q Consensus       148 s~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~ls~N~l~~~~p~~l~~~~~L~~l~l~~N~l~~~  227 (689)
                      ++|.....  ..+..+++|+.|++++|.+. .++ .+..+++|+.|++++|++++. + .+..+++|+.|++++|++++.
T Consensus       114 ~~~~~~~~--~~~~~l~~L~~L~l~~n~l~-~~~-~l~~~~~L~~L~l~~n~l~~l-~-~l~~l~~L~~L~ls~N~i~~i  187 (199)
T d2omxa2         114 FNNQITDI--DPLKNLTNLNRLELSSNTIS-DIS-ALSGLTSLQQLNFSSNQVTDL-K-PLANLTTLERLDISSNKVSDI  187 (199)
T ss_dssp             CSSCCCCC--GGGTTCTTCSEEECCSSCCC-CCG-GGTTCTTCSEEECCSSCCCCC-G-GGTTCTTCCEEECCSSCCCCC
T ss_pred             CCCCCCCC--CCCCHHHHHHHHHHHHHHHC-CCC-CCCCCCCCCCCCCCCCCCCCC-C-CCCCCCCCCEEECCCCCCCCC
T ss_conf             22222232--10001223677643111100-234-333211111122345555677-0-116799899997879979988

>d2omza2 c.10.2.1 (A:33-416) Internalin A {Listeria monocytogenes [TaxId: 1639]}

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Internalin LRR domain
domain: Internalin A
species: Listeria monocytogenes [TaxId: 1639]

Probab=99.84  E-value=2.4e-20  Score=120.05  Aligned_cols=154  Identities=29%  Similarity=0.427  Sum_probs=96.1

Q ss_pred             CCCCEEEEECCCCCCCCCCCCCCCCCCCCCEEECCCCCCCCCCCCCCCCCCCCCEEEECCCCCCCCCCCCCCCCCCCCEE
Q ss_conf             99977999917998633249576789988889831883444478000188888689922568889999533688554389
Q 005586           66 EHRKVANISLQGKGLTGKLSPSLSGLKCLSGLYLHYNSLSGEIPKEIRNLTELTDLYLDVNNLSGNIPPEIGSMASLQVL  145 (689)
Q Consensus        66 ~~~~v~~l~L~~~~l~g~~~~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~g~~p~~~~~l~~L~~L  145 (689)
                      +...++.|++++++++..  ..+..+++|++|+|++|+|++..|  +.++++|++|++++|.+++ ++ .+..+++|+.|
T Consensus        42 ~l~~l~~L~l~~~~I~~l--~gl~~L~nL~~L~Ls~N~l~~l~~--l~~L~~L~~L~L~~n~i~~-i~-~l~~l~~L~~L  115 (384)
T d2omza2          42 DLDQVTTLQADRLGIKSI--DGVEYLNNLTQINFSNNQLTDITP--LKNLTKLVDILMNNNQIAD-IT-PLANLTNLTGL  115 (384)
T ss_dssp             HHTTCCEEECCSSCCCCC--TTGGGCTTCCEEECCSSCCCCCGG--GTTCTTCCEEECCSSCCCC-CG-GGTTCTTCCEE
T ss_pred             HHCCCCEEECCCCCCCCC--CCCCCCCCCCEEECCCCCCCCCCC--CCCCCCCCCCCCCCCCCCC-CC-CCCCCCCCCCC
T ss_conf             957878998999898776--242458999989681881798863--3477110103013433322-22-11123343334


Q ss_pred             EEECCCCCCCCCH---------------------------------------------------------------HCCC
Q ss_conf             6106658888801---------------------------------------------------------------2089
Q 005586          146 QLCCNQLTGNIPA---------------------------------------------------------------QIGS  162 (689)
Q Consensus       146 ~ls~N~l~~~~p~---------------------------------------------------------------~~~~  162 (689)
                      ++++|.+++..+.                                                               .+..
T Consensus       116 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  195 (384)
T d2omza2         116 TLFNNQITDIDPLKNLTNLNRLELSSNTISDISALSGLTSLQQLSFGNQVTDLKPLANLTTLERLDISSNKVSDISVLAK  195 (384)
T ss_dssp             ECCSSCCCCCGGGTTCTTCSEEEEEEEEECCCGGGTTCTTCSEEEEEESCCCCGGGTTCTTCCEEECCSSCCCCCGGGGG
T ss_pred             CCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCHHHHHCCCCCCCCCCCCCCCCCCCCCCCC
T ss_conf             43322222222222222221121346631310023222211222221232201111245421101122243332110022


Q ss_pred             CCCCCEEECCCCCCCCCCCCCCCCCCCCCEEECCCCCCCCCCHHHHHCCCCCCEEECCCCCCCCCCC
Q ss_conf             9888889656885898799234799878834233773888741432089788577342674876652
Q 005586          163 LKSLSVLTLQHNRLNGGIPDSLGNLGKLKRLDLSFNSLFGTIPESLANNAELLFLDVQNNTLSGIVP  229 (689)
Q Consensus       163 l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~ls~N~l~~~~p~~l~~~~~L~~l~l~~N~l~~~~p  229 (689)
                      ++++..+++++|.+++..|  +..+++|+.|++++|+++. ++ .+..+++|..+++.+|.+++..+
T Consensus       196 l~~~~~l~l~~n~i~~~~~--~~~~~~L~~L~l~~n~l~~-~~-~l~~l~~L~~L~l~~n~l~~~~~  258 (384)
T d2omza2         196 LTNLESLIATNNQISDITP--LGILTNLDELSLNGNQLKD-IG-TLASLTNLTDLDLANNQISNLAP  258 (384)
T ss_dssp             CTTCSEEECCSSCCCCCGG--GGGCTTCCEEECCSSCCCC-CG-GGGGCTTCSEEECCSSCCCCCGG
T ss_pred             CCCCCEEECCCCCCCCCCC--CCCCCCCCEEECCCCCCCC-CC-HHHCCCCCCHHCCCCCCCCCCCC
T ss_conf             3532333035774478786--4445778788887777789-61-34325653410044674478775

>d2omza2 c.10.2.1 (A:33-416) Internalin A {Listeria monocytogenes [TaxId: 1639]}

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Internalin LRR domain
domain: Internalin A
species: Listeria monocytogenes [TaxId: 1639]

Probab=99.83  E-value=7.2e-20  Score=117.61  Aligned_cols=159  Identities=29%  Similarity=0.433  Sum_probs=107.7

Q ss_pred             CCEEECCCCCCEEEEECCCCCCCCCCCCCCCCCCCCCEEECCCCCCCCCCCCCCCCCCCCCEEEECCCCCCCCCC-----
Q ss_conf             351881999977999917998633249576789988889831883444478000188888689922568889999-----
Q 005586           59 FEGIACNEHRKVANISLQGKGLTGKLSPSLSGLKCLSGLYLHYNSLSGEIPKEIRNLTELTDLYLDVNNLSGNIP-----  133 (689)
Q Consensus        59 w~gv~c~~~~~v~~l~L~~~~l~g~~~~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~g~~p-----  133 (689)
                      -+|+..  ..+++.|+|++|.|++..  .|.++++|++|++++|.+.+..+  +..+++|+.|++++|.+++..+     
T Consensus        59 l~gl~~--L~nL~~L~Ls~N~l~~l~--~l~~L~~L~~L~L~~n~i~~i~~--l~~l~~L~~L~~~~~~~~~~~~~~~~~  132 (384)
T d2omza2          59 IDGVEY--LNNLTQINFSNNQLTDIT--PLKNLTKLVDILMNNNQIADITP--LANLTNLTGLTLFNNQITDIDPLKNLT  132 (384)
T ss_dssp             CTTGGG--CTTCCEEECCSSCCCCCG--GGTTCTTCCEEECCSSCCCCCGG--GTTCTTCCEEECCSSCCCCCGGGTTCT
T ss_pred             CCCCCC--CCCCCEEECCCCCCCCCC--CCCCCCCCCCCCCCCCCCCCCCC--CCCCCCCCCCCCCCCCCCCCCCCCCCC
T ss_conf             624245--899998968188179886--33477110103013433322221--112334333443322222222222222


Q ss_pred             ----------------------------------------------------------CCCCCCCCCCEEEEECCCCCCC
Q ss_conf             ----------------------------------------------------------5336885543896106658888
Q 005586          134 ----------------------------------------------------------PEIGSMASLQVLQLCCNQLTGN  155 (689)
Q Consensus       134 ----------------------------------------------------------~~~~~l~~L~~L~ls~N~l~~~  155 (689)
                                                                                ..+..++++..+++++|.+++.
T Consensus       133 ~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~l~l~~n~i~~~  212 (384)
T d2omza2         133 NLNRLELSSNTISDISALSGLTSLQQLSFGNQVTDLKPLANLTTLERLDISSNKVSDISVLAKLTNLESLIATNNQISDI  212 (384)
T ss_dssp             TCSEEEEEEEEECCCGGGTTCTTCSEEEEEESCCCCGGGTTCTTCCEEECCSSCCCCCGGGGGCTTCSEEECCSSCCCCC
T ss_pred             CCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCHHHHHCCCCCCCCCCCCCCCCCCCCCCCCCCCCCEEECCCCCCCCC
T ss_conf             22112134663131002322221122222123220111124542110112224333211002235323330357744787


Q ss_pred             CCHHCCCCCCCCEEECCCCCCCCCCCCCCCCCCCCCEEECCCCCCCCCCHHHHHCCCCCCEEECCCCCCCCCCC
Q ss_conf             80120899888889656885898799234799878834233773888741432089788577342674876652
Q 005586          156 IPAQIGSLKSLSVLTLQHNRLNGGIPDSLGNLGKLKRLDLSFNSLFGTIPESLANNAELLFLDVQNNTLSGIVP  229 (689)
Q Consensus       156 ~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~ls~N~l~~~~p~~l~~~~~L~~l~l~~N~l~~~~p  229 (689)
                      .|  +...++|+.|++++|.++. ++ .+..+++|+.|++++|.+++..+  +..+++|+.+++++|.+++..+
T Consensus       213 ~~--~~~~~~L~~L~l~~n~l~~-~~-~l~~l~~L~~L~l~~n~l~~~~~--~~~~~~L~~L~l~~~~l~~~~~  280 (384)
T d2omza2         213 TP--LGILTNLDELSLNGNQLKD-IG-TLASLTNLTDLDLANNQISNLAP--LSGLTKLTELKLGANQISNISP  280 (384)
T ss_dssp             GG--GGGCTTCCEEECCSSCCCC-CG-GGGGCTTCSEEECCSSCCCCCGG--GTTCTTCSEEECCSSCCCCCGG
T ss_pred             CC--CCCCCCCCEEECCCCCCCC-CC-HHHCCCCCCHHCCCCCCCCCCCC--CCCCCCCCEEECCCCCCCCCCC
T ss_conf             86--4445778788887777789-61-34325653410044674478775--3554668775456744578773

>d1xwdc1 c.10.2.7 (C:18-259) Follicle-stimulating hormone receptor {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Ngr ectodomain-like
domain: Follicle-stimulating hormone receptor
species: Human (Homo sapiens) [TaxId: 9606]

Probab=99.82  E-value=8.4e-20  Score=117.26  Aligned_cols=181  Identities=20%  Similarity=0.177  Sum_probs=97.7

Q ss_pred             CCCCCCCEEECCC----------CCCEEEEECCCCCCCCCCCCCCCCCCCCCEEECCCCCCCCCC-CCCCCCCCCCCEEE
Q ss_conf             9999735188199----------997799991799863324957678998888983188344447-80001888886899
Q 005586           54 PCSGSFEGIACNE----------HRKVANISLQGKGLTGKLSPSLSGLKCLSGLYLHYNSLSGEI-PKEIRNLTELTDLY  122 (689)
Q Consensus        54 ~C~~~w~gv~c~~----------~~~v~~l~L~~~~l~g~~~~~~~~l~~L~~L~L~~N~l~~~~-p~~~~~l~~L~~L~  122 (689)
                      .|.|+...|.|..          ..+++.|+|++|.++...+..|.++++|++|+|++|.+...+ +..|.+++.++.++
T Consensus         5 ~C~C~~~~i~c~~~~l~~iP~~l~~~l~~L~Ls~n~i~~l~~~~f~~l~~L~~L~ls~n~~~~~i~~~~f~~l~~l~~l~   84 (242)
T d1xwdc1           5 ICHCSNRVFLCQESKVTEIPSDLPRNAIELRFVLTKLRVIQKGAFSGFGDLEKIEISQNDVLEVIEADVFSNLPKLHEIR   84 (242)
T ss_dssp             SEEECSSEEEEESCSCSSCCSCSCSCCSEEEEESCCCCEECTTTTTTCTTCCEEEEESCTTCCEECSSSEESCTTCCEEE
T ss_pred             CCCCCCCEEEEECCCCCCCCCCCCCCCCEEECCCCCCCCCCHHHHHCCCHHHHHHHCCCCCCCEEECCCCCCCCCCCCCC
T ss_conf             28873999998189988768888998899987699189649668614643232110221124201001122222222211


Q ss_pred             ECC-CCCCCCCCCCCCCCCCCCEEEEECCCCCCCCCH-HCCCCCCCCEEECCCCCCCCCCCCCCCCCC-CCCEEECCCCC
Q ss_conf             225-688899995336885543896106658888801-208998888896568858987992347998-78834233773
Q 005586          123 LDV-NNLSGNIPPEIGSMASLQVLQLCCNQLTGNIPA-QIGSLKSLSVLTLQHNRLNGGIPDSLGNLG-KLKRLDLSFNS  199 (689)
Q Consensus       123 Ls~-N~l~g~~p~~~~~l~~L~~L~ls~N~l~~~~p~-~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~-~L~~L~ls~N~  199 (689)
                      +.. |.+....+..|..+++|+.|++++|.+....+. .+..+..+..+..+++.+....+..|..++ .+..|++++|+
T Consensus        85 ~~~~n~l~~~~~~~~~~l~~L~~l~l~~~~l~~~~~~~~~~~l~~l~~~~~~n~~l~~i~~~~~~~~~~~l~~L~l~~n~  164 (242)
T d1xwdc1          85 IEKANNLLYINPEAFQNLPNLQYLLISNTGIKHLPDVHKIHSLQKVLLDIQDNINIHTIERNSFVGLSFESVILWLNKNG  164 (242)
T ss_dssp             EECCTTCCEECTTSEECCTTCCEEEEESCCCCSCCCCTTTCBSSCEEEEEESCTTCCEECTTSSTTSBSSCEEEECCSSC
T ss_pred             CCCCCCCCCCCCCCCCCCCCCCCCCCCHHHHCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCEEEECCCCC
T ss_conf             11123432222221222222222234211112554333222111122222221211122222222223310012200123


Q ss_pred             CCCCCHHHHHCCCCCCEE-ECCCCCCCCCCCHHHHHC
Q ss_conf             888741432089788577-342674876652367713
Q 005586          200 LFGTIPESLANNAELLFL-DVQNNTLSGIVPSALKRL  235 (689)
Q Consensus       200 l~~~~p~~l~~~~~L~~l-~l~~N~l~~~~p~~~~~l  235 (689)
                      ++. ++......+++..+ ++.+|.++...+..|..+
T Consensus       165 l~~-i~~~~~~~~~l~~~~~l~~n~l~~l~~~~f~~l  200 (242)
T d1xwdc1         165 IQE-IHNCAFNGTQLDELNLSDNNNLEELPNDVFHGA  200 (242)
T ss_dssp             CCE-ECTTTTTTCCEEEEECTTCTTCCCCCTTTTTTS
T ss_pred             CCC-CCCCCCCCHHHHCCCCCCCCCCCCCCHHHHCCC
T ss_conf             333-222222201110121235432464247886689

>d1h6ta2 c.10.2.1 (A:31-240) Internalin B {Listeria monocytogenes [TaxId: 1639]}

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Internalin LRR domain
domain: Internalin B
species: Listeria monocytogenes [TaxId: 1639]

Probab=99.82  E-value=3e-19  Score=114.34  Aligned_cols=148  Identities=25%  Similarity=0.331  Sum_probs=121.2

Q ss_pred             CCEEEEECCCCCCCCCCCCCCCCCCCCCEEECCCCCCCCCCCCCCCCCCCCCEEEECCCCCCCCCCCCCCCCCCCCEEEE
Q ss_conf             97799991799863324957678998888983188344447800018888868992256888999953368855438961
Q 005586           68 RKVANISLQGKGLTGKLSPSLSGLKCLSGLYLHYNSLSGEIPKEIRNLTELTDLYLDVNNLSGNIPPEIGSMASLQVLQL  147 (689)
Q Consensus        68 ~~v~~l~L~~~~l~g~~~~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~g~~p~~~~~l~~L~~L~l  147 (689)
                      ..++.|+++++.++...  .+..+++|++|+|++|.+++..  .+..+++|+.|++++|++++ +| .+..+++|+.|++
T Consensus        46 ~~L~~L~l~~~~i~~l~--~l~~l~~L~~L~L~~n~i~~l~--~~~~l~~L~~L~l~~n~i~~-l~-~l~~l~~L~~L~l  119 (210)
T d1h6ta2          46 NSIDQIIANNSDIKSVQ--GIQYLPNVTKLFLNGNKLTDIK--PLANLKNLGWLFLDENKVKD-LS-SLKDLKKLKSLSL  119 (210)
T ss_dssp             HTCCEEECTTSCCCCCT--TGGGCTTCCEEECCSSCCCCCG--GGTTCTTCCEEECCSSCCCC-GG-GGTTCTTCCEEEC
T ss_pred             CCCCEEECCCCCCCCCH--HHHHCCCCCEEECCCCCCCCCC--CCCCCCCCCCCCCCCCCCCC-CC-CCCCCCCCCCCCC
T ss_conf             48458978279888744--4764899898769896025860--11358621201433333212-22-1212221112234


Q ss_pred             ECCCCCCCCCHHCCCCCCCCEEECCCCCCCCCCCCCCCCCCCCCEEECCCCCCCCCCHHHHHCCCCCCEEECCCCCCCCC
Q ss_conf             06658888801208998888896568858987992347998788342337738887414320897885773426748766
Q 005586          148 CCNQLTGNIPAQIGSLKSLSVLTLQHNRLNGGIPDSLGNLGKLKRLDLSFNSLFGTIPESLANNAELLFLDVQNNTLSGI  227 (689)
Q Consensus       148 s~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~ls~N~l~~~~p~~l~~~~~L~~l~l~~N~l~~~  227 (689)
                      ++|.+.. + ..+..++.++.++++.|.++.  +..+..+++|+.+++++|++++ ++ .+..+++|+.|++++|.++..
T Consensus       120 ~~~~~~~-~-~~l~~l~~l~~l~~~~n~l~~--~~~~~~l~~L~~l~l~~n~l~~-i~-~l~~l~~L~~L~Ls~N~i~~l  193 (210)
T d1h6ta2         120 EHNGISD-I-NGLVHLPQLESLYLGNNKITD--ITVLSRLTKLDTLSLEDNQISD-IV-PLAGLTKLQNLYLSKNHISDL  193 (210)
T ss_dssp             TTSCCCC-C-GGGGGCTTCCEEECCSSCCCC--CGGGGGCTTCSEEECCSSCCCC-CG-GGTTCTTCCEEECCSSCCCBC
T ss_pred             CCCCCCC-C-CCCCCCCCCCCCCCCCCCCCC--CCCCCCCCCCCCCCCCCCCCCC-CC-CCCCCCCCCEEECCCCCCCCC
T ss_conf             5653221-1-220111112221122233345--4310001332100134643025-64-536789899998979989987

>d1h6ta2 c.10.2.1 (A:31-240) Internalin B {Listeria monocytogenes [TaxId: 1639]}

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Internalin LRR domain
domain: Internalin B
species: Listeria monocytogenes [TaxId: 1639]

Probab=99.80  E-value=6.9e-19  Score=112.50  Aligned_cols=143  Identities=29%  Similarity=0.410  Sum_probs=115.6

Q ss_pred             CCCEEEEECCCCCCCCCCCCCCCCCCCCCEEECCCCCCCCCCCCCCCCCCCCCEEEECCCCCCCCCCCCCCCCCCCCEEE
Q ss_conf             99779999179986332495767899888898318834444780001888886899225688899995336885543896
Q 005586           67 HRKVANISLQGKGLTGKLSPSLSGLKCLSGLYLHYNSLSGEIPKEIRNLTELTDLYLDVNNLSGNIPPEIGSMASLQVLQ  146 (689)
Q Consensus        67 ~~~v~~l~L~~~~l~g~~~~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~g~~p~~~~~l~~L~~L~  146 (689)
                      ..+++.|+|++|.+++..  .+..+++|+.|++++|++++ +| .+..+++|+.|++++|.+. .+ +.+..++.++.++
T Consensus        67 l~~L~~L~L~~n~i~~l~--~~~~l~~L~~L~l~~n~i~~-l~-~l~~l~~L~~L~l~~~~~~-~~-~~l~~l~~l~~l~  140 (210)
T d1h6ta2          67 LPNVTKLFLNGNKLTDIK--PLANLKNLGWLFLDENKVKD-LS-SLKDLKKLKSLSLEHNGIS-DI-NGLVHLPQLESLY  140 (210)
T ss_dssp             CTTCCEEECCSSCCCCCG--GGTTCTTCCEEECCSSCCCC-GG-GGTTCTTCCEEECTTSCCC-CC-GGGGGCTTCCEEE
T ss_pred             CCCCCEEECCCCCCCCCC--CCCCCCCCCCCCCCCCCCCC-CC-CCCCCCCCCCCCCCCCCCC-CC-CCCCCCCCCCCCC
T ss_conf             899898769896025860--11358621201433333212-22-1212221112234565322-11-2201111122211


Q ss_pred             EECCCCCCCCCHHCCCCCCCCEEECCCCCCCCCCCCCCCCCCCCCEEECCCCCCCCCCHHHHHCCCCCCEEECCC
Q ss_conf             106658888801208998888896568858987992347998788342337738887414320897885773426
Q 005586          147 LCCNQLTGNIPAQIGSLKSLSVLTLQHNRLNGGIPDSLGNLGKLKRLDLSFNSLFGTIPESLANNAELLFLDVQN  221 (689)
Q Consensus       147 ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~ls~N~l~~~~p~~l~~~~~L~~l~l~~  221 (689)
                      ++.|.+++.  ..+..+++|+.+++++|++++ +++ +..+++|+.|++++|+++ .++ .+..+++|+.|++++
T Consensus       141 ~~~n~l~~~--~~~~~l~~L~~l~l~~n~l~~-i~~-l~~l~~L~~L~Ls~N~i~-~l~-~l~~l~~L~~L~Ls~  209 (210)
T d1h6ta2         141 LGNNKITDI--TVLSRLTKLDTLSLEDNQISD-IVP-LAGLTKLQNLYLSKNHIS-DLR-ALAGLKNLDVLELFS  209 (210)
T ss_dssp             CCSSCCCCC--GGGGGCTTCSEEECCSSCCCC-CGG-GTTCTTCCEEECCSSCCC-BCG-GGTTCTTCSEEEEEE
T ss_pred             CCCCCCCCC--CCCCCCCCCCCCCCCCCCCCC-CCC-CCCCCCCCEEECCCCCCC-CCH-HHCCCCCCCEEECCC
T ss_conf             222333454--310001332100134643025-645-367898999989799899-872-116999989997118

>d1h6ua2 c.10.2.1 (A:36-262) Internalin H {Listeria monocytogenes [TaxId: 1639]}

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Internalin LRR domain
domain: Internalin H
species: Listeria monocytogenes [TaxId: 1639]

Probab=99.80  E-value=1.5e-18  Score=110.70  Aligned_cols=148  Identities=30%  Similarity=0.420  Sum_probs=84.2

Q ss_pred             CCEEEEECCCCCCCCCCCCCCCCCCCCCEEECCCCCCCCCCCCCCCCCCCCCEEEECCCCCCCCCCCCCCCCCCCCEEEE
Q ss_conf             97799991799863324957678998888983188344447800018888868992256888999953368855438961
Q 005586           68 RKVANISLQGKGLTGKLSPSLSGLKCLSGLYLHYNSLSGEIPKEIRNLTELTDLYLDVNNLSGNIPPEIGSMASLQVLQL  147 (689)
Q Consensus        68 ~~v~~l~L~~~~l~g~~~~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~g~~p~~~~~l~~L~~L~l  147 (689)
                      .+++.|++.+++++.. + .+..+++|++|+|++|.+++..|  +..+++|+.+++++|.++ .++ .+..+++|+.+++
T Consensus        41 ~~L~~L~l~~~~i~~l-~-~l~~l~~L~~L~ls~n~i~~~~~--l~~l~~l~~l~~~~n~~~-~i~-~l~~l~~L~~l~l  114 (227)
T d1h6ua2          41 DGITTLSAFGTGVTTI-E-GVQYLNNLIGLELKDNQITDLAP--LKNLTKITELELSGNPLK-NVS-AIAGLQSIKTLDL  114 (227)
T ss_dssp             HTCCEEECTTSCCCCC-T-TGGGCTTCCEEECCSSCCCCCGG--GTTCCSCCEEECCSCCCS-CCG-GGTTCTTCCEEEC
T ss_pred             CCCCEEECCCCCCCCC-H-HHHCCCCCCEEECCCCEEECCCC--CCCCCCCCCCCCCCCCCC-CCC-CCCCCCCCCCCCC
T ss_conf             8868997779999766-4-57448888376357853202543--112334320121112222-222-2222222212212


Q ss_pred             ECCCCCCCCCHHCCCCCCCCEEECCCCCCCCCCCCCCCCCCCCCEEECCCCCCCCCCHHHHHCCCCCCEEECCCCCCCCC
Q ss_conf             06658888801208998888896568858987992347998788342337738887414320897885773426748766
Q 005586          148 CCNQLTGNIPAQIGSLKSLSVLTLQHNRLNGGIPDSLGNLGKLKRLDLSFNSLFGTIPESLANNAELLFLDVQNNTLSGI  227 (689)
Q Consensus       148 s~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~ls~N~l~~~~p~~l~~~~~L~~l~l~~N~l~~~  227 (689)
                      +.+...+..  .+...+.+..+.++.+.+...  ..+..+++|+.|++++|.+....  .+..+++|+.|++++|++++.
T Consensus       115 ~~~~~~~~~--~~~~~~~~~~l~~~~~~~~~~--~~~~~~~~L~~L~l~~n~~~~~~--~l~~l~~L~~L~Ls~n~l~~l  188 (227)
T d1h6ua2         115 TSTQITDVT--PLAGLSNLQVLYLDLNQITNI--SPLAGLTNLQYLSIGNAQVSDLT--PLANLSKLTTLKADDNKISDI  188 (227)
T ss_dssp             TTSCCCCCG--GGTTCTTCCEEECCSSCCCCC--GGGGGCTTCCEEECCSSCCCCCG--GGTTCTTCCEEECCSSCCCCC
T ss_pred             CCCCCCCCC--HHCCCCCHHHHHCHHHHHCHH--HHHCCCCCCCCCCCCCCCCCCCH--HHCCCCCCEECCCCCCCCCCC
T ss_conf             224433110--000023012220000000000--00010211100233333333100--105646335644588841778

>d1a9na_ c.10.2.4 (A:) Splicesomal U2A' protein {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: U2A'-like
domain: Splicesomal U2A' protein
species: Human (Homo sapiens) [TaxId: 9606]

Probab=99.79  E-value=1.4e-19  Score=116.17  Aligned_cols=129  Identities=17%  Similarity=0.124  Sum_probs=92.1

Q ss_pred             CCCCCCCCCCEEECCCCCCCCCCCCCCCCCCCCCEEEECCCCCCCCCCCCCCCCCCCCEEEEECCCCCCCCCHHCCCCCC
Q ss_conf             57678998888983188344447800018888868992256888999953368855438961066588888012089988
Q 005586           86 PSLSGLKCLSGLYLHYNSLSGEIPKEIRNLTELTDLYLDVNNLSGNIPPEIGSMASLQVLQLCCNQLTGNIPAQIGSLKS  165 (689)
Q Consensus        86 ~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~g~~p~~~~~l~~L~~L~ls~N~l~~~~p~~~~~l~~  165 (689)
                      +.|.+...|++|+|++|+|+. ++..+..+++|+.|+|++|.++ .++ .+..+++|+.|++++|+++...+..+..+++
T Consensus        12 ~~~~n~~~lr~L~L~~n~I~~-i~~~~~~l~~L~~L~Ls~N~i~-~l~-~~~~l~~L~~L~ls~N~i~~l~~~~~~~l~~   88 (162)
T d1a9na_          12 AQYTNAVRDRELDLRGYKIPV-IENLGATLDQFDAIDFSDNEIR-KLD-GFPLLRRLKTLLVNNNRICRIGEGLDQALPD   88 (162)
T ss_dssp             CEEECTTSCEEEECTTSCCCS-CCCGGGGTTCCSEEECCSSCCC-EEC-CCCCCSSCCEEECCSSCCCEECSCHHHHCTT
T ss_pred             HHCCCCCCCCEEECCCCCCCC-CCCCCCCCCCCCEEECCCCCCC-CCC-CCCCCCCHHHHHCCCCCCCCCCCCCCCCCCC
T ss_conf             751685748489788997886-5762004145998989799787-647-7445761306431021345777632233453


Q ss_pred             CCEEECCCCCCCCCCC--CCCCCCCCCCEEECCCCCCCCCC---HHHHHCCCCCCEEE
Q ss_conf             8889656885898799--23479987883423377388874---14320897885773
Q 005586          166 LSVLTLQHNRLNGGIP--DSLGNLGKLKRLDLSFNSLFGTI---PESLANNAELLFLD  218 (689)
Q Consensus       166 L~~L~Ls~N~l~~~~p--~~~~~l~~L~~L~ls~N~l~~~~---p~~l~~~~~L~~l~  218 (689)
                      |+.|++++|+++. ++  ..+..+++|+.|++++|+++...   +..+..+++|+.||
T Consensus        89 L~~L~L~~N~i~~-~~~l~~l~~l~~L~~L~l~~N~i~~~~~~r~~~i~~lp~L~~LD  145 (162)
T d1a9na_          89 LTELILTNNSLVE-LGDLDPLASLKSLTYLCILRNPVTNKKHYRLYVIYKVPQVRVLD  145 (162)
T ss_dssp             CCEEECCSCCCCC-GGGGGGGGGCTTCCEEECCSSGGGGSTTHHHHHHHHCTTCSEET
T ss_pred             CCCCEECCCCCCC-CCCCCCCCCCCCCCHHHCCCCCCCCCCCHHHHHHHHCCCCCEEC
T ss_conf             4434203000166-54211001365320664079963456106999998789958337

>d2omxa2 c.10.2.1 (A:37-235) Internalin B {Listeria monocytogenes [TaxId: 1639]}

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Internalin LRR domain
domain: Internalin B
species: Listeria monocytogenes [TaxId: 1639]

Probab=99.77  E-value=8e-18  Score=106.94  Aligned_cols=130  Identities=28%  Similarity=0.428  Sum_probs=77.7

Q ss_pred             CCCCCCCEEECCCCCCCCCCCCCCCCCCCCCEEEECCCCCCCCCCCCCCCCCCCCEEEEECCCCCCCCCHHCCCCCCCCE
Q ss_conf             78998888983188344447800018888868992256888999953368855438961066588888012089988888
Q 005586           89 SGLKCLSGLYLHYNSLSGEIPKEIRNLTELTDLYLDVNNLSGNIPPEIGSMASLQVLQLCCNQLTGNIPAQIGSLKSLSV  168 (689)
Q Consensus        89 ~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~g~~p~~~~~l~~L~~L~ls~N~l~~~~p~~~~~l~~L~~  168 (689)
                      ..+..|++|++++|.++. + ..+..+++|++|+|++|++++ +++ ++.+++|+.|++++|.+.. ++ .+.+++.|+.
T Consensus        37 ~~l~~l~~L~l~~~~i~~-l-~~l~~l~nL~~L~Ls~N~l~~-~~~-l~~l~~L~~L~l~~n~~~~-~~-~l~~l~~L~~  110 (199)
T d2omxa2          37 TDLDQVTTLQADRLGIKS-I-DGVEYLNNLTQINFSNNQLTD-ITP-LKNLTKLVDILMNNNQIAD-IT-PLANLTNLTG  110 (199)
T ss_dssp             HHHTTCCEEECTTSCCCC-C-TTGGGCTTCCEEECCSSCCCC-CGG-GTTCTTCCEEECCSSCCCC-CG-GGTTCTTCSE
T ss_pred             HHHCCCCEEECCCCCCCC-C-CCCCCCCCCCCCCCCCCCCCC-CCC-CCCCCCCCCCCCCCCCCCC-CC-CCCCCCCCCC
T ss_conf             794687899899999977-5-202137886757545655667-640-1677522311112222222-21-1111223222


Q ss_pred             EECCCCCCCCCCCCCCCCCCCCCEEECCCCCCCCCCHHHHHCCCCCCEEECCCCCCCCCC
Q ss_conf             965688589879923479987883423377388874143208978857734267487665
Q 005586          169 LTLQHNRLNGGIPDSLGNLGKLKRLDLSFNSLFGTIPESLANNAELLFLDVQNNTLSGIV  228 (689)
Q Consensus       169 L~Ls~N~l~~~~p~~~~~l~~L~~L~ls~N~l~~~~p~~l~~~~~L~~l~l~~N~l~~~~  228 (689)
                      +++++|.... + ..+..+++|+.|++++|++. .++ .+..+++++.|++.+|++++..
T Consensus       111 L~l~~~~~~~-~-~~~~~l~~L~~L~l~~n~l~-~~~-~l~~~~~L~~L~l~~n~l~~l~  166 (199)
T d2omxa2         111 LTLFNNQITD-I-DPLKNLTNLNRLELSSNTIS-DIS-ALSGLTSLQQLNFSSNQVTDLK  166 (199)
T ss_dssp             EECCSSCCCC-C-GGGTTCTTCSEEECCSSCCC-CCG-GGTTCTTCSEEECCSSCCCCCG
T ss_pred             CCCCCCCCCC-C-CCCCHHHHHHHHHHHHHHHC-CCC-CCCCCCCCCCCCCCCCCCCCCC
T ss_conf             1112222223-2-10001223677643111100-234-3332111111223455556770

>d1dcea3 c.10.2.2 (A:444-567) Rab geranylgeranyltransferase alpha-subunit, C-terminal domain {Rat (Rattus norvegicus) [TaxId: 10116]}

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Rab geranylgeranyltransferase alpha-subunit, C-terminal domain
domain: Rab geranylgeranyltransferase alpha-subunit, C-terminal domain
species: Rat (Rattus norvegicus) [TaxId: 10116]

Probab=99.75  E-value=1e-17  Score=106.34  Aligned_cols=118  Identities=26%  Similarity=0.284  Sum_probs=78.3

Q ss_pred             CEEECCCCCCCCCCCCCCCCCCCCCEEEECCCCCCCCCCCCCCCCCCCCEEEEECCCCCCCCCHHCCCCCCCCEEECCCC
Q ss_conf             88983188344447800018888868992256888999953368855438961066588888012089988888965688
Q 005586           95 SGLYLHYNSLSGEIPKEIRNLTELTDLYLDVNNLSGNIPPEIGSMASLQVLQLCCNQLTGNIPAQIGSLKSLSVLTLQHN  174 (689)
Q Consensus        95 ~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~g~~p~~~~~l~~L~~L~ls~N~l~~~~p~~~~~l~~L~~L~Ls~N  174 (689)
                      ++|+|++|.++ .++ .+..+++|++|++++|+++ .+|+.++.+++|+.|++++|+++. ++ .+..+++|+.+++++|
T Consensus         1 R~L~Ls~n~l~-~l~-~l~~l~~L~~L~ls~N~l~-~lp~~~~~l~~L~~L~l~~N~i~~-l~-~~~~l~~L~~L~l~~N   75 (124)
T d1dcea3           1 RVLHLAHKDLT-VLC-HLEQLLLVTHLDLSHNRLR-ALPPALAALRCLEVLQASDNALEN-VD-GVANLPRLQELLLCNN   75 (124)
T ss_dssp             SEEECTTSCCS-SCC-CGGGGTTCCEEECCSSCCC-CCCGGGGGCTTCCEEECCSSCCCC-CG-GGTTCSSCCEEECCSS
T ss_pred             CEEECCCCCCC-CCC-CCCCCCCCCEEECCCCCCC-CCHHHHHHHHCCCCCCCCCCCCCC-CC-CCCCCCCCCEEECCCC
T ss_conf             98986899898-871-0105898898979787168-652156554313545324321123-57-4123355576888898


Q ss_pred             CCCCCC-CCCCCCCCCCCEEECCCCCCCCC---CHHHHHCCCCCCEE
Q ss_conf             589879-92347998788342337738887---41432089788577
Q 005586          175 RLNGGI-PDSLGNLGKLKRLDLSFNSLFGT---IPESLANNAELLFL  217 (689)
Q Consensus       175 ~l~~~~-p~~~~~l~~L~~L~ls~N~l~~~---~p~~l~~~~~L~~l  217 (689)
                      +++... ...+..+++|+.|++++|+++..   .......+|++..+
T Consensus        76 ~i~~~~~~~~l~~~~~L~~L~l~~N~i~~~~~~~~~l~~~lp~L~~L  122 (124)
T d1dcea3          76 RLQQSAAIQPLVSCPRLVLLNLQGNSLCQEEGIQERLAEMLPSVSSI  122 (124)
T ss_dssp             CCCSSSTTGGGGGCTTCCEEECTTSGGGGSSSCTTHHHHHCTTCSEE
T ss_pred             CCCCCCCCHHHCCCCCCCEEECCCCCCCCCCCHHHHHHHHCCCCCEE
T ss_conf             65888882565379999999897996886826799999989673138

>d1h6ua2 c.10.2.1 (A:36-262) Internalin H {Listeria monocytogenes [TaxId: 1639]}

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Internalin LRR domain
domain: Internalin H
species: Listeria monocytogenes [TaxId: 1639]

Probab=99.73  E-value=5.1e-17  Score=102.76  Aligned_cols=158  Identities=25%  Similarity=0.395  Sum_probs=129.2

Q ss_pred             CCCEEECCCCCCEEEEECCCCCCCCCCCCCCCCCCCCCEEECCCCCCCCCCCCCCCCCCCCCEEEECCCCCCCCCCCCCC
Q ss_conf             73518819999779999179986332495767899888898318834444780001888886899225688899995336
Q 005586           58 SFEGIACNEHRKVANISLQGKGLTGKLSPSLSGLKCLSGLYLHYNSLSGEIPKEIRNLTELTDLYLDVNNLSGNIPPEIG  137 (689)
Q Consensus        58 ~w~gv~c~~~~~v~~l~L~~~~l~g~~~~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~g~~p~~~~  137 (689)
                      +..|+..  -.+++.|++++|.+++..+  +..++.|+.+++++|.++. ++ .+.++++|+.++++.+...+.  ..+.
T Consensus        55 ~l~~l~~--l~~L~~L~ls~n~i~~~~~--l~~l~~l~~l~~~~n~~~~-i~-~l~~l~~L~~l~l~~~~~~~~--~~~~  126 (227)
T d1h6ua2          55 TIEGVQY--LNNLIGLELKDNQITDLAP--LKNLTKITELELSGNPLKN-VS-AIAGLQSIKTLDLTSTQITDV--TPLA  126 (227)
T ss_dssp             CCTTGGG--CTTCCEEECCSSCCCCCGG--GTTCCSCCEEECCSCCCSC-CG-GGTTCTTCCEEECTTSCCCCC--GGGT
T ss_pred             CCHHHHC--CCCCCEEECCCCEEECCCC--CCCCCCCCCCCCCCCCCCC-CC-CCCCCCCCCCCCCCCCCCCCC--CHHC
T ss_conf             6645744--8888376357853202543--1123343201211122222-22-222222221221222443311--0000


Q ss_pred             CCCCCCEEEEECCCCCCCCCHHCCCCCCCCEEECCCCCCCCCCCCCCCCCCCCCEEECCCCCCCCCCHHHHHCCCCCCEE
Q ss_conf             88554389610665888880120899888889656885898799234799878834233773888741432089788577
Q 005586          138 SMASLQVLQLCCNQLTGNIPAQIGSLKSLSVLTLQHNRLNGGIPDSLGNLGKLKRLDLSFNSLFGTIPESLANNAELLFL  217 (689)
Q Consensus       138 ~l~~L~~L~ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~ls~N~l~~~~p~~l~~~~~L~~l  217 (689)
                      ..+.+..+.++++.+....  .+.+.++|+.|++++|.+.. .+ .+..+++|+.|++++|++++ ++ .+..+++|+.|
T Consensus       127 ~~~~~~~l~~~~~~~~~~~--~~~~~~~L~~L~l~~n~~~~-~~-~l~~l~~L~~L~Ls~n~l~~-l~-~l~~l~~L~~L  200 (227)
T d1h6ua2         127 GLSNLQVLYLDLNQITNIS--PLAGLTNLQYLSIGNAQVSD-LT-PLANLSKLTTLKADDNKISD-IS-PLASLPNLIEV  200 (227)
T ss_dssp             TCTTCCEEECCSSCCCCCG--GGGGCTTCCEEECCSSCCCC-CG-GGTTCTTCCEEECCSSCCCC-CG-GGGGCTTCCEE
T ss_pred             CCCCHHHHHCHHHHHCHHH--HHCCCCCCCCCCCCCCCCCC-CH-HHCCCCCCEECCCCCCCCCC-CH-HHCCCCCCCEE
T ss_conf             0230122200000000000--00102111002333333331-00-10564633564458884177-85-34479999989


Q ss_pred             ECCCCCCCCCCC
Q ss_conf             342674876652
Q 005586          218 DVQNNTLSGIVP  229 (689)
Q Consensus       218 ~l~~N~l~~~~p  229 (689)
                      ++++|++++..|
T Consensus       201 ~Ls~N~lt~i~~  212 (227)
T d1h6ua2         201 HLKNNQISDVSP  212 (227)
T ss_dssp             ECTTSCCCBCGG
T ss_pred             ECCCCCCCCCCC
T ss_conf             795996899802

>d1a9na_ c.10.2.4 (A:) Splicesomal U2A' protein {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: U2A'-like
domain: Splicesomal U2A' protein
species: Human (Homo sapiens) [TaxId: 9606]

Probab=99.70  E-value=3.5e-17  Score=103.62  Aligned_cols=115  Identities=19%  Similarity=0.172  Sum_probs=78.5

Q ss_pred             CCCCCCCCCEEEECCCCCCCCCCCCCCCCCCCCEEEEECCCCCCCCCHHCCCCCCCCEEECCCCCCCCCCCCCCCCCCCC
Q ss_conf             00188888689922568889999533688554389610665888880120899888889656885898799234799878
Q 005586          111 EIRNLTELTDLYLDVNNLSGNIPPEIGSMASLQVLQLCCNQLTGNIPAQIGSLKSLSVLTLQHNRLNGGIPDSLGNLGKL  190 (689)
Q Consensus       111 ~~~~l~~L~~L~Ls~N~l~g~~p~~~~~l~~L~~L~ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L  190 (689)
                      .|.+..+|++|+|++|+++ .++..+..+++|+.|++++|+++. + ..+..+++|+.|++++|+++...+..+..+++|
T Consensus        13 ~~~n~~~lr~L~L~~n~I~-~i~~~~~~l~~L~~L~Ls~N~i~~-l-~~~~~l~~L~~L~ls~N~i~~l~~~~~~~l~~L   89 (162)
T d1a9na_          13 QYTNAVRDRELDLRGYKIP-VIENLGATLDQFDAIDFSDNEIRK-L-DGFPLLRRLKTLLVNNNRICRIGEGLDQALPDL   89 (162)
T ss_dssp             EEECTTSCEEEECTTSCCC-SCCCGGGGTTCCSEEECCSSCCCE-E-CCCCCCSSCCEEECCSSCCCEECSCHHHHCTTC
T ss_pred             HCCCCCCCCEEECCCCCCC-CCCCCCCCCCCCCEEECCCCCCCC-C-CCCCCCCCHHHHHCCCCCCCCCCCCCCCCCCCC
T ss_conf             5168574848978899788-657620041459989897997876-4-774457613064310213457776322334534


Q ss_pred             CEEECCCCCCCCCCH-HHHHCCCCCCEEECCCCCCCCCC
Q ss_conf             834233773888741-43208978857734267487665
Q 005586          191 KRLDLSFNSLFGTIP-ESLANNAELLFLDVQNNTLSGIV  228 (689)
Q Consensus       191 ~~L~ls~N~l~~~~p-~~l~~~~~L~~l~l~~N~l~~~~  228 (689)
                      +.|++++|+++.... ..+..+++|+.+++++|.++...
T Consensus        90 ~~L~L~~N~i~~~~~l~~l~~l~~L~~L~l~~N~i~~~~  128 (162)
T d1a9na_          90 TELILTNNSLVELGDLDPLASLKSLTYLCILRNPVTNKK  128 (162)
T ss_dssp             CEEECCSCCCCCGGGGGGGGGCTTCCEEECCSSGGGGST
T ss_pred             CCCEECCCCCCCCCCCCCCCCCCCCCHHHCCCCCCCCCC
T ss_conf             434203000166542110013653206640799634561

>d1xwdc1 c.10.2.7 (C:18-259) Follicle-stimulating hormone receptor {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Ngr ectodomain-like
domain: Follicle-stimulating hormone receptor
species: Human (Homo sapiens) [TaxId: 9606]

Probab=99.70  E-value=1.6e-16  Score=100.14  Aligned_cols=168  Identities=14%  Similarity=0.116  Sum_probs=122.4

Q ss_pred             CEEECCCCCCEEEEECCCCCCCCCCCCCCCCCCCCCEEECCCCCCCCCCCCCCCCCCCCCEEEECCCCCCCCC-CCCCCC
Q ss_conf             5188199997799991799863324957678998888983188344447800018888868992256888999-953368
Q 005586           60 EGIACNEHRKVANISLQGKGLTGKLSPSLSGLKCLSGLYLHYNSLSGEIPKEIRNLTELTDLYLDVNNLSGNI-PPEIGS  138 (689)
Q Consensus        60 ~gv~c~~~~~v~~l~L~~~~l~g~~~~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~g~~-p~~~~~  138 (689)
                      .-..|.  +  ..++.++.+++ .+|+.+.  +.+++|+|++|.|+...+..|.++++|++|+|++|.+...+ +..|..
T Consensus         4 ~~C~C~--~--~~i~c~~~~l~-~iP~~l~--~~l~~L~Ls~n~i~~l~~~~f~~l~~L~~L~ls~n~~~~~i~~~~f~~   76 (242)
T d1xwdc1           4 RICHCS--N--RVFLCQESKVT-EIPSDLP--RNAIELRFVLTKLRVIQKGAFSGFGDLEKIEISQNDVLEVIEADVFSN   76 (242)
T ss_dssp             SSEEEC--S--SEEEEESCSCS-SCCSCSC--SCCSEEEEESCCCCEECTTTTTTCTTCCEEEEESCTTCCEECSSSEES
T ss_pred             CCCCCC--C--CEEEEECCCCC-CCCCCCC--CCCCEEECCCCCCCCCCHHHHHCCCHHHHHHHCCCCCCCEEECCCCCC
T ss_conf             828873--9--99998189988-7688889--988999876991896496686146432321102211242010011222


Q ss_pred             CCCCCEEEEEC-CCCCCCCCHHCCCCCCCCEEECCCCCCCCCCCC-CCCCCCCCCEEECCCCCCCCCCHHHHHCCC-CCC
Q ss_conf             85543896106-658888801208998888896568858987992-347998788342337738887414320897-885
Q 005586          139 MASLQVLQLCC-NQLTGNIPAQIGSLKSLSVLTLQHNRLNGGIPD-SLGNLGKLKRLDLSFNSLFGTIPESLANNA-ELL  215 (689)
Q Consensus       139 l~~L~~L~ls~-N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~-~~~~l~~L~~L~ls~N~l~~~~p~~l~~~~-~L~  215 (689)
                      ++.++.+.+.. |.+....+..|.++++|+.+++++|.+....+. .+..+..+..+...++.+....+..+..++ .+.
T Consensus        77 l~~l~~l~~~~~n~l~~~~~~~~~~l~~L~~l~l~~~~l~~~~~~~~~~~l~~l~~~~~~n~~l~~i~~~~~~~~~~~l~  156 (242)
T d1xwdc1          77 LPKLHEIRIEKANNLLYINPEAFQNLPNLQYLLISNTGIKHLPDVHKIHSLQKVLLDIQDNINIHTIERNSFVGLSFESV  156 (242)
T ss_dssp             CTTCCEEEEECCTTCCEECTTSEECCTTCCEEEEESCCCCSCCCCTTTCBSSCEEEEEESCTTCCEECTTSSTTSBSSCE
T ss_pred             CCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCHHHHCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCE
T ss_conf             22222211111234322222212222222222342111125543332221111222222212111222222222233100


Q ss_pred             EEECCCCCCCCCCCHHHHH
Q ss_conf             7734267487665236771
Q 005586          216 FLDVQNNTLSGIVPSALKR  234 (689)
Q Consensus       216 ~l~l~~N~l~~~~p~~~~~  234 (689)
                      .+++++|.++...+..+..
T Consensus       157 ~L~l~~n~l~~i~~~~~~~  175 (242)
T d1xwdc1         157 ILWLNKNGIQEIHNCAFNG  175 (242)
T ss_dssp             EEECCSSCCCEECTTTTTT
T ss_pred             EEECCCCCCCCCCCCCCCC
T ss_conf             1220012333322222220

>d1dcea3 c.10.2.2 (A:444-567) Rab geranylgeranyltransferase alpha-subunit, C-terminal domain {Rat (Rattus norvegicus) [TaxId: 10116]}

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Rab geranylgeranyltransferase alpha-subunit, C-terminal domain
domain: Rab geranylgeranyltransferase alpha-subunit, C-terminal domain
species: Rat (Rattus norvegicus) [TaxId: 10116]

Probab=99.69  E-value=1.2e-16  Score=100.75  Aligned_cols=103  Identities=26%  Similarity=0.397  Sum_probs=54.8

Q ss_pred             CEEEECCCCCCCCCCCCCCCCCCCCEEEEECCCCCCCCCHHCCCCCCCCEEECCCCCCCCCCCCCCCCCCCCCEEECCCC
Q ss_conf             68992256888999953368855438961066588888012089988888965688589879923479987883423377
Q 005586          119 TDLYLDVNNLSGNIPPEIGSMASLQVLQLCCNQLTGNIPAQIGSLKSLSVLTLQHNRLNGGIPDSLGNLGKLKRLDLSFN  198 (689)
Q Consensus       119 ~~L~Ls~N~l~g~~p~~~~~l~~L~~L~ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~ls~N  198 (689)
                      |.|+|++|+++ .++ .+..+++|++|++++|+++ .+|..+..+++|+.|++++|.++ .+| .+..+++|+.|++++|
T Consensus         1 R~L~Ls~n~l~-~l~-~l~~l~~L~~L~ls~N~l~-~lp~~~~~l~~L~~L~l~~N~i~-~l~-~~~~l~~L~~L~l~~N   75 (124)
T d1dcea3           1 RVLHLAHKDLT-VLC-HLEQLLLVTHLDLSHNRLR-ALPPALAALRCLEVLQASDNALE-NVD-GVANLPRLQELLLCNN   75 (124)
T ss_dssp             SEEECTTSCCS-SCC-CGGGGTTCCEEECCSSCCC-CCCGGGGGCTTCCEEECCSSCCC-CCG-GGTTCSSCCEEECCSS
T ss_pred             CEEECCCCCCC-CCC-CCCCCCCCCEEECCCCCCC-CCHHHHHHHHCCCCCCCCCCCCC-CCC-CCCCCCCCCEEECCCC
T ss_conf             98986899898-871-0105898898979787168-65215655431354532432112-357-4123355576888898


Q ss_pred             CCCCCC-HHHHHCCCCCCEEECCCCCCCC
Q ss_conf             388874-1432089788577342674876
Q 005586          199 SLFGTI-PESLANNAELLFLDVQNNTLSG  226 (689)
Q Consensus       199 ~l~~~~-p~~l~~~~~L~~l~l~~N~l~~  226 (689)
                      +++... ...+..+++|+.+++++|+++.
T Consensus        76 ~i~~~~~~~~l~~~~~L~~L~l~~N~i~~  104 (124)
T d1dcea3          76 RLQQSAAIQPLVSCPRLVLLNLQGNSLCQ  104 (124)
T ss_dssp             CCCSSSTTGGGGGCTTCCEEECTTSGGGG
T ss_pred             CCCCCCCCHHHCCCCCCCEEECCCCCCCC
T ss_conf             65888882565379999999897996886

>d1m9la_ c.10.3.1 (A:) Outer arm dynein light chain 1 {Green algae (Chlamydomonas reinhardtii) [TaxId: 3055]}

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: Outer arm dynein light chain 1
family: Outer arm dynein light chain 1
domain: Outer arm dynein light chain 1
species: Green algae (Chlamydomonas reinhardtii) [TaxId: 3055]

Probab=99.68  E-value=4.7e-20  Score=118.55  Aligned_cols=129  Identities=28%  Similarity=0.343  Sum_probs=86.9

Q ss_pred             CCCCCCCCCCCCEEECCCCCCCCCCCCCCCCCCCCCEEEECCCCCCCCCCCCCCCCCCCCEEEEECCCCCCCCCHHCCCC
Q ss_conf             49576789988889831883444478000188888689922568889999533688554389610665888880120899
Q 005586           84 LSPSLSGLKCLSGLYLHYNSLSGEIPKEIRNLTELTDLYLDVNNLSGNIPPEIGSMASLQVLQLCCNQLTGNIPAQIGSL  163 (689)
Q Consensus        84 ~~~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~g~~p~~~~~l~~L~~L~ls~N~l~~~~p~~~~~l  163 (689)
                      ++.++..|++|+.|+|++|.|+. ++ .+..+++|+.|+|++|.++ .+|..+..+++|+.|++++|+++. + ..+..+
T Consensus        40 l~~sl~~L~~L~~L~Ls~n~I~~-i~-~l~~l~~L~~L~Ls~N~i~-~i~~~~~~~~~L~~L~l~~N~i~~-l-~~~~~l  114 (198)
T d1m9la_          40 MDATLSTLKACKHLALSTNNIEK-IS-SLSGMENLRILSLGRNLIK-KIENLDAVADTLEELWISYNQIAS-L-SGIEKL  114 (198)
T ss_dssp             CHHHHHHTTTCCEEECSEEEESC-CC-CHHHHTTCCEEECCEEEEC-SCSSHHHHHHHCCEEECSEEECCC-H-HHHHHH
T ss_pred             HHHHHHCCCCCCEEECCCCCCCC-CC-CCCCCCCCCCHHHCCCCCC-CCCCCCCCCCCCCCCCCCCCCCCC-C-CCCCCC
T ss_conf             24677626046151994468998-64-4247825357341353432-100003322123333333322222-2-222222


Q ss_pred             CCCCEEECCCCCCCCCCC--CCCCCCCCCCEEECCCCCCCCCCHH----------HHHCCCCCCEEE
Q ss_conf             888889656885898799--2347998788342337738887414----------320897885773
Q 005586          164 KSLSVLTLQHNRLNGGIP--DSLGNLGKLKRLDLSFNSLFGTIPE----------SLANNAELLFLD  218 (689)
Q Consensus       164 ~~L~~L~Ls~N~l~~~~p--~~~~~l~~L~~L~ls~N~l~~~~p~----------~l~~~~~L~~l~  218 (689)
                      ++|+.|++++|+++. ++  ..+..+++|+.|++++|++....+.          .+..+++|+.||
T Consensus       115 ~~L~~L~L~~N~i~~-~~~~~~l~~l~~L~~L~L~~N~l~~~~~~~~~~~~~r~~vi~~lp~L~~LD  180 (198)
T d1m9la_         115 VNLRVLYMSNNKITN-WGEIDKLAALDKLEDLLLAGNPLYNDYKENNATSEYRIEVVKRLPNLKKLD  180 (198)
T ss_dssp             HHSSEEEESEEECCC-HHHHHHHTTTTTCSEEEECSSHHHHHHCTTTTHHHHHHHHHHHCSSCCEES
T ss_pred             CCCCCCCCCCCHHCC-CCCCCCCCCCCCCCEEECCCCCCCCCCCCCCCHHHHHHHHHHHCCCCCEEC
T ss_conf             234111234102125-542212367776302342798434676322220558999998788958769

>d1jl5a_ c.10.2.6 (A:) Leucine rich effector protein YopM {Yersinia pestis [TaxId: 632]}

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Leucine rich effector protein YopM
domain: Leucine rich effector protein YopM
species: Yersinia pestis [TaxId: 632]

Probab=99.64  E-value=7.1e-15  Score=91.60  Aligned_cols=141  Identities=27%  Similarity=0.341  Sum_probs=105.7

Q ss_pred             CCEEEEECCCCCCCCCCCCCCCCCCCCCEEECCCCCCCCCCCCCCCCCCCCCEEEECCCCCCCCCCCCCCCCCCCCEEEE
Q ss_conf             97799991799863324957678998888983188344447800018888868992256888999953368855438961
Q 005586           68 RKVANISLQGKGLTGKLSPSLSGLKCLSGLYLHYNSLSGEIPKEIRNLTELTDLYLDVNNLSGNIPPEIGSMASLQVLQL  147 (689)
Q Consensus        68 ~~v~~l~L~~~~l~g~~~~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~g~~p~~~~~l~~L~~L~l  147 (689)
                      .+++.|+|++++++ .+|+.   +++|++|+|++|+|+ .+|..   +.+|+.|++++|+++ .++..   .+.|++|++
T Consensus        38 ~~l~~LdLs~~~L~-~lp~~---~~~L~~L~Ls~N~l~-~lp~~---~~~L~~L~l~~n~l~-~l~~l---p~~L~~L~L  105 (353)
T d1jl5a_          38 RQAHELELNNLGLS-SLPEL---PPHLESLVASCNSLT-ELPEL---PQSLKSLLVDNNNLK-ALSDL---PPLLEYLGV  105 (353)
T ss_dssp             HTCSEEECTTSCCS-CCCSC---CTTCSEEECCSSCCS-SCCCC---CTTCCEEECCSSCCS-CCCSC---CTTCCEEEC
T ss_pred             CCCCEEEECCCCCC-CCCCC---CCCCCEEECCCCCCC-CCCCC---HHHHHHHHHHHCCCC-HHHHH---CCCCCCCCC
T ss_conf             69989993799988-78898---789888989999796-33620---332033266551432-03210---221111133


Q ss_pred             ECCCCCCCCCHHCCCCCCCCEEECCCCCCCCCCCCCCCCCCCCCEEECCCCCCCCCCHHHHHCCCCCCEEECCCCCCCCC
Q ss_conf             06658888801208998888896568858987992347998788342337738887414320897885773426748766
Q 005586          148 CCNQLTGNIPAQIGSLKSLSVLTLQHNRLNGGIPDSLGNLGKLKRLDLSFNSLFGTIPESLANNAELLFLDVQNNTLSGI  227 (689)
Q Consensus       148 s~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~ls~N~l~~~~p~~l~~~~~L~~l~l~~N~l~~~  227 (689)
                      ++|.+. .+|. ++.+++|+.|++++|.+.. .+..   ...+..+.+..+....  ...+..++.+..+++.+|.+...
T Consensus       106 ~~n~l~-~lp~-~~~l~~L~~L~l~~~~~~~-~~~~---~~~l~~l~~~~~~~~~--~~~l~~l~~l~~L~l~~n~~~~~  177 (353)
T d1jl5a_         106 SNNQLE-KLPE-LQNSSFLKIIDVDNNSLKK-LPDL---PPSLEFIAAGNNQLEE--LPELQNLPFLTAIYADNNSLKKL  177 (353)
T ss_dssp             CSSCCS-SCCC-CTTCTTCCEEECCSSCCSC-CCCC---CTTCCEEECCSSCCSS--CCCCTTCTTCCEEECCSSCCSSC
T ss_pred             CCCCCC-CCCC-HHHHCCCEEECCCCCCCCC-CCCC---CCCCCCHHHCCCCCCC--CCCCCCCCCCEECCCCCCCCCCC
T ss_conf             455432-2210-0110131231135651001-3223---3332100001222223--33200012220011123344322


Q ss_pred             C
Q ss_conf             5
Q 005586          228 V  228 (689)
Q Consensus       228 ~  228 (689)
                      .
T Consensus       178 ~  178 (353)
T d1jl5a_         178 P  178 (353)
T ss_dssp             C
T ss_pred             C
T ss_conf             2

>d2ifga3 c.10.2.7 (A:36-191) High affinity nerve growth factor receptor, N-terminal domain {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Ngr ectodomain-like
domain: High affinity nerve growth factor receptor, N-terminal domain
species: Human (Homo sapiens) [TaxId: 9606]

Probab=99.63  E-value=5.8e-16  Score=97.25  Aligned_cols=69  Identities=26%  Similarity=0.308  Sum_probs=27.9

Q ss_pred             CCCCCCCCCCCEEECCCC-CCCCCCCCCCCCCCCCCEEEECCCCCCCCCCCCCCCCCCCCEEEEECCCCC
Q ss_conf             957678998888983188-344447800018888868992256888999953368855438961066588
Q 005586           85 SPSLSGLKCLSGLYLHYN-SLSGEIPKEIRNLTELTDLYLDVNNLSGNIPPEIGSMASLQVLQLCCNQLT  153 (689)
Q Consensus        85 ~~~~~~l~~L~~L~L~~N-~l~~~~p~~~~~l~~L~~L~Ls~N~l~g~~p~~~~~l~~L~~L~ls~N~l~  153 (689)
                      |..+.++++|++|+|++| .|+...+..|.++++|+.|+|++|+++...|..|..+++|+.|+|++|+++
T Consensus        24 p~~l~~l~~l~~L~l~~n~~l~~i~~~~f~~l~~L~~L~Ls~N~l~~i~~~~f~~l~~L~~L~Ls~N~l~   93 (156)
T d2ifga3          24 LHHLPGAENLTELYIENQQHLQHLELRDLRGLGELRNLTIVKSGLRFVAPDAFHFTPRLSRLNLSFNALE   93 (156)
T ss_dssp             TTTSCSCSCCSEEECCSCSSCCEECGGGSCSCCCCSEEECCSSCCCEECTTGGGSCSCCCEEECCSSCCS
T ss_pred             CCCCCCCCCCCEEECCCCCCCCCCCCHHHCCCCCCCCCEEECCCCCCCCCCCCCCCCCCCCEECCCCCCC
T ss_conf             6002576565743168986644369212256666672162021247742011124554333322678785

>d2ifga3 c.10.2.7 (A:36-191) High affinity nerve growth factor receptor, N-terminal domain {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Ngr ectodomain-like
domain: High affinity nerve growth factor receptor, N-terminal domain
species: Human (Homo sapiens) [TaxId: 9606]

Probab=99.61  E-value=3.1e-15  Score=93.46  Aligned_cols=102  Identities=22%  Similarity=0.189  Sum_probs=44.2

Q ss_pred             EECCCCCCCCCCCCCCCCCCCCCEEEECCCC-CCCCCCCCCCCCCCCCEEEEECCCCCCCCCHHCCCCCCCCEEECCCCC
Q ss_conf             9831883444478000188888689922568-889999533688554389610665888880120899888889656885
Q 005586           97 LYLHYNSLSGEIPKEIRNLTELTDLYLDVNN-LSGNIPPEIGSMASLQVLQLCCNQLTGNIPAQIGSLKSLSVLTLQHNR  175 (689)
Q Consensus        97 L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~-l~g~~p~~~~~l~~L~~L~ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~  175 (689)
                      ++.+++.+. ..|..+..+++|+.|++++|+ ++...++.|.++++|+.|++++|+++...+..|.++++|+.|+|++|+
T Consensus        13 l~c~~~~~~-~~p~~l~~l~~l~~L~l~~n~~l~~i~~~~f~~l~~L~~L~Ls~N~l~~i~~~~f~~l~~L~~L~Ls~N~   91 (156)
T d2ifga3          13 LRCTRDGAL-DSLHHLPGAENLTELYIENQQHLQHLELRDLRGLGELRNLTIVKSGLRFVAPDAFHFTPRLSRLNLSFNA   91 (156)
T ss_dssp             EECCSSCCC-TTTTTSCSCSCCSEEECCSCSSCCEECGGGSCSCCCCSEEECCSSCCCEECTTGGGSCSCCCEEECCSSC
T ss_pred             EEECCCCCC-CCCCCCCCCCCCCEEECCCCCCCCCCCCHHHCCCCCCCCCEEECCCCCCCCCCCCCCCCCCCCEECCCCC
T ss_conf             985289976-5860025765657431689866443692122566666721620212477420111245543333226787


Q ss_pred             CCCCCCCCCCCCCCCCEEECCCCCC
Q ss_conf             8987992347998788342337738
Q 005586          176 LNGGIPDSLGNLGKLKRLDLSFNSL  200 (689)
Q Consensus       176 l~~~~p~~~~~l~~L~~L~ls~N~l  200 (689)
                      ++...+..|.. .+|+.|+|++|.+
T Consensus        92 l~~l~~~~~~~-~~l~~L~L~~Np~  115 (156)
T d2ifga3          92 LESLSWKTVQG-LSLQELVLSGNPL  115 (156)
T ss_dssp             CSCCCSTTTCS-CCCCEEECCSSCC
T ss_pred             CCCCCHHHHCC-CCCCCCCCCCCCC
T ss_conf             85157456335-3212433579863

>d1m9la_ c.10.3.1 (A:) Outer arm dynein light chain 1 {Green algae (Chlamydomonas reinhardtii) [TaxId: 3055]}

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: Outer arm dynein light chain 1
family: Outer arm dynein light chain 1
domain: Outer arm dynein light chain 1
species: Green algae (Chlamydomonas reinhardtii) [TaxId: 3055]

Probab=99.60  E-value=8.1e-18  Score=106.92  Aligned_cols=130  Identities=22%  Similarity=0.235  Sum_probs=102.5

Q ss_pred             CCEEECCCC--CCCCCCCCCCCCCCCCCEEEECCCCCCCCCCCCCCCCCCCCEEEEECCCCCCCCCHHCCCCCCCCEEEC
Q ss_conf             888983188--344447800018888868992256888999953368855438961066588888012089988888965
Q 005586           94 LSGLYLHYN--SLSGEIPKEIRNLTELTDLYLDVNNLSGNIPPEIGSMASLQVLQLCCNQLTGNIPAQIGSLKSLSVLTL  171 (689)
Q Consensus        94 L~~L~L~~N--~l~~~~p~~~~~l~~L~~L~Ls~N~l~g~~p~~~~~l~~L~~L~ls~N~l~~~~p~~~~~l~~L~~L~L  171 (689)
                      ++.++++.+  .+. .++..+..|++|+.|+|++|+++ .++ .+..+++|+.|++++|+++ .++.....+++|+.|++
T Consensus        25 ~~~~~l~~~~~~i~-~l~~sl~~L~~L~~L~Ls~n~I~-~i~-~l~~l~~L~~L~Ls~N~i~-~i~~~~~~~~~L~~L~l  100 (198)
T d1m9la_          25 AEKVELHGMIPPIE-KMDATLSTLKACKHLALSTNNIE-KIS-SLSGMENLRILSLGRNLIK-KIENLDAVADTLEELWI  100 (198)
T ss_dssp             CSCEECCBCCTTCC-CCHHHHHHTTTCCEEECSEEEES-CCC-CHHHHTTCCEEECCEEEEC-SCSSHHHHHHHCCEEEC
T ss_pred             CCEEEEECCCCCHH-HHHHHHHCCCCCCEEECCCCCCC-CCC-CCCCCCCCCCHHHCCCCCC-CCCCCCCCCCCCCCCCC
T ss_conf             31002555568520-02467762604615199446899-864-4247825357341353432-10000332212333333


Q ss_pred             CCCCCCCCCCCCCCCCCCCCEEECCCCCCCCCCH-HHHHCCCCCCEEECCCCCCCCCCC
Q ss_conf             6885898799234799878834233773888741-432089788577342674876652
Q 005586          172 QHNRLNGGIPDSLGNLGKLKRLDLSFNSLFGTIP-ESLANNAELLFLDVQNNTLSGIVP  229 (689)
Q Consensus       172 s~N~l~~~~p~~~~~l~~L~~L~ls~N~l~~~~p-~~l~~~~~L~~l~l~~N~l~~~~p  229 (689)
                      ++|.++. ++ .+..+++|+.|++++|+++.... ..+..+++|+.|++++|++....+
T Consensus       101 ~~N~i~~-l~-~~~~l~~L~~L~L~~N~i~~~~~~~~l~~l~~L~~L~L~~N~l~~~~~  157 (198)
T d1m9la_         101 SYNQIAS-LS-GIEKLVNLRVLYMSNNKITNWGEIDKLAALDKLEDLLLAGNPLYNDYK  157 (198)
T ss_dssp             SEEECCC-HH-HHHHHHHSSEEEESEEECCCHHHHHHHTTTTTCSEEEECSSHHHHHHC
T ss_pred             CCCCCCC-CC-CCCCCCCCCCCCCCCCHHCCCCCCCCCCCCCCCCEEECCCCCCCCCCC
T ss_conf             3322222-22-222222341112341021255422123677763023427984346763

>d2astb2 c.10.1.3 (B:2136-2419) Cyclin A/CDK2-associated p19, Skp2 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: RNI-like
family: Cyclin A/CDK2-associated p19, Skp2
domain: Cyclin A/CDK2-associated p19, Skp2
species: Human (Homo sapiens) [TaxId: 9606]

Probab=99.49  E-value=5.9e-15  Score=91.99  Aligned_cols=161  Identities=20%  Similarity=0.167  Sum_probs=107.7

Q ss_pred             CCEEEEECCCCCCCCC-CCCCCCCCCCCCEEECCCCCCCCCCCCCCCCCCCCCEEEECCC-CCCCC-CCCCCCCCCCCCE
Q ss_conf             9779999179986332-4957678998888983188344447800018888868992256-88899-9953368855438
Q 005586           68 RKVANISLQGKGLTGK-LSPSLSGLKCLSGLYLHYNSLSGEIPKEIRNLTELTDLYLDVN-NLSGN-IPPEIGSMASLQV  144 (689)
Q Consensus        68 ~~v~~l~L~~~~l~g~-~~~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N-~l~g~-~p~~~~~l~~L~~  144 (689)
                      .+++.|+|+++.+... +...+.++++|++|+|+++.+++..+..+..+++|++|+|+++ .++.. +...+..+++|+.
T Consensus        46 ~~L~~LdLs~~~i~~~~l~~l~~~c~~L~~L~L~~~~l~~~~~~~l~~~~~L~~L~Ls~c~~itd~~l~~l~~~~~~L~~  125 (284)
T d2astb2          46 FRVQHMDLSNSVIEVSTLHGILSQCSKLQNLSLEGLRLSDPIVNTLAKNSNLVRLNLSGCSGFSEFALQTLLSSCSRLDE  125 (284)
T ss_dssp             BCCCEEECTTCEECHHHHHHHHTTBCCCSEEECTTCBCCHHHHHHHTTCTTCSEEECTTCBSCCHHHHHHHHHHCTTCCE
T ss_pred             CCCCEEECCCCCCCHHHHHHHHHHCCCCCCCCCCCCCCCCHHHHHHHCCCCCCCCCCCCCCCCCCCCCCHHHHHHHHCCC
T ss_conf             87887889898457779999997487765145234679867899985189975715100134123554036578874356


Q ss_pred             EEEECCC-CCCC-CCHHCC-CCCCCCEEECCCCC--CCC-CCCCCCCCCCCCCEEECCCCC-CCCCCHHHHHCCCCCCEE
Q ss_conf             9610665-8888-801208-99888889656885--898-799234799878834233773-888741432089788577
Q 005586          145 LQLCCNQ-LTGN-IPAQIG-SLKSLSVLTLQHNR--LNG-GIPDSLGNLGKLKRLDLSFNS-LFGTIPESLANNAELLFL  217 (689)
Q Consensus       145 L~ls~N~-l~~~-~p~~~~-~l~~L~~L~Ls~N~--l~~-~~p~~~~~l~~L~~L~ls~N~-l~~~~p~~l~~~~~L~~l  217 (689)
                      |+++++. ++.. +...+. ..++|+.|+++++.  ++. .+...+..+++|+.|++++|. ++......+..+++|+.|
T Consensus       126 L~ls~c~~~~~~~~~~~~~~~~~~L~~L~l~~~~~~i~~~~l~~l~~~~~~L~~L~L~~~~~itd~~~~~l~~~~~L~~L  205 (284)
T d2astb2         126 LNLSWCFDFTEKHVQVAVAHVSETITQLNLSGYRKNLQKSDLSTLVRRCPNLVHLDLSDSVMLKNDCFQEFFQLNYLQHL  205 (284)
T ss_dssp             EECCCCTTCCHHHHHHHHHHSCTTCCEEECCSCGGGSCHHHHHHHHHHCTTCSEEECTTCTTCCGGGGGGGGGCTTCCEE
T ss_pred             CCCCCCCCCCCCCCHHHHCCCCCCCCHHHHCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCHHHHHHCCCCCCCEE
T ss_conf             52245332333220001000111110122135542444443434232322212355322347783033332135768779


Q ss_pred             ECCCC-CCCCCC
Q ss_conf             34267-487665
Q 005586          218 DVQNN-TLSGIV  228 (689)
Q Consensus       218 ~l~~N-~l~~~~  228 (689)
                      +++++ .+++..
T Consensus       206 ~L~~C~~i~~~~  217 (284)
T d2astb2         206 SLSRCYDIIPET  217 (284)
T ss_dssp             ECTTCTTCCGGG
T ss_pred             ECCCCCCCCHHH
T ss_conf             899999787378

>d1jl5a_ c.10.2.6 (A:) Leucine rich effector protein YopM {Yersinia pestis [TaxId: 632]}

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Leucine rich effector protein YopM
domain: Leucine rich effector protein YopM
species: Yersinia pestis [TaxId: 632]

Probab=99.40  E-value=1.7e-11  Score=74.02  Aligned_cols=117  Identities=29%  Similarity=0.370  Sum_probs=77.4

Q ss_pred             CCCCEEECCCCCCCCCCCCCCCCCCCCCEEEECCCCCCCCCCCCCCCCCCCCEEEEECCCCCCCCCHHCCCCCCCCEEEC
Q ss_conf             98888983188344447800018888868992256888999953368855438961066588888012089988888965
Q 005586           92 KCLSGLYLHYNSLSGEIPKEIRNLTELTDLYLDVNNLSGNIPPEIGSMASLQVLQLCCNQLTGNIPAQIGSLKSLSVLTL  171 (689)
Q Consensus        92 ~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~g~~p~~~~~l~~L~~L~ls~N~l~~~~p~~~~~l~~L~~L~L  171 (689)
                      .+++.|||++|.|+ .+|+.   +++|++|+|++|+++ .+|..+   .+|+.|++++|+++. ++. +  .+.|++|++
T Consensus        38 ~~l~~LdLs~~~L~-~lp~~---~~~L~~L~Ls~N~l~-~lp~~~---~~L~~L~l~~n~l~~-l~~-l--p~~L~~L~L  105 (353)
T d1jl5a_          38 RQAHELELNNLGLS-SLPEL---PPHLESLVASCNSLT-ELPELP---QSLKSLLVDNNNLKA-LSD-L--PPLLEYLGV  105 (353)
T ss_dssp             HTCSEEECTTSCCS-CCCSC---CTTCSEEECCSSCCS-SCCCCC---TTCCEEECCSSCCSC-CCS-C--CTTCCEEEC
T ss_pred             CCCCEEEECCCCCC-CCCCC---CCCCCEEECCCCCCC-CCCCCH---HHHHHHHHHHCCCCH-HHH-H--CCCCCCCCC
T ss_conf             69989993799988-78898---789888989999796-336203---320332665514320-321-0--221111133


Q ss_pred             CCCCCCCCCCCCCCCCCCCCEEECCCCCCCCCCHHHHHCCCCCCEEECCCCCCCC
Q ss_conf             6885898799234799878834233773888741432089788577342674876
Q 005586          172 QHNRLNGGIPDSLGNLGKLKRLDLSFNSLFGTIPESLANNAELLFLDVQNNTLSG  226 (689)
Q Consensus       172 s~N~l~~~~p~~~~~l~~L~~L~ls~N~l~~~~p~~l~~~~~L~~l~l~~N~l~~  226 (689)
                      ++|.+. .+|. ++.++.|+.|++++|.+... +..   ...+..+.+..+....
T Consensus       106 ~~n~l~-~lp~-~~~l~~L~~L~l~~~~~~~~-~~~---~~~l~~l~~~~~~~~~  154 (353)
T d1jl5a_         106 SNNQLE-KLPE-LQNSSFLKIIDVDNNSLKKL-PDL---PPSLEFIAAGNNQLEE  154 (353)
T ss_dssp             CSSCCS-SCCC-CTTCTTCCEEECCSSCCSCC-CCC---CTTCCEEECCSSCCSS
T ss_pred             CCCCCC-CCCC-HHHHCCCEEECCCCCCCCCC-CCC---CCCCCCHHHCCCCCCC
T ss_conf             455432-2210-01101312311356510013-223---3332100001222223

>d2astb2 c.10.1.3 (B:2136-2419) Cyclin A/CDK2-associated p19, Skp2 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: RNI-like
family: Cyclin A/CDK2-associated p19, Skp2
domain: Cyclin A/CDK2-associated p19, Skp2
species: Human (Homo sapiens) [TaxId: 9606]

Probab=99.36  E-value=1.6e-13  Score=84.52  Aligned_cols=154  Identities=19%  Similarity=0.204  Sum_probs=62.5

Q ss_pred             CEEEEECCCCCCCCCCCCCCCCCCCCCEEECCC-CCCCCC-CCCCCCCCCCCCEEEECCCC-CCC-CCCCCCCC-CCCCC
Q ss_conf             779999179986332495767899888898318-834444-78000188888689922568-889-99953368-85543
Q 005586           69 KVANISLQGKGLTGKLSPSLSGLKCLSGLYLHY-NSLSGE-IPKEIRNLTELTDLYLDVNN-LSG-NIPPEIGS-MASLQ  143 (689)
Q Consensus        69 ~v~~l~L~~~~l~g~~~~~~~~l~~L~~L~L~~-N~l~~~-~p~~~~~l~~L~~L~Ls~N~-l~g-~~p~~~~~-l~~L~  143 (689)
                      +++.|+|.++.+.+.....+..+++|+.|+|++ +.++.. +..-..++++|++|+++++. ++. .+...+.. .++|+
T Consensus        72 ~L~~L~L~~~~l~~~~~~~l~~~~~L~~L~Ls~c~~itd~~l~~l~~~~~~L~~L~ls~c~~~~~~~~~~~~~~~~~~L~  151 (284)
T d2astb2          72 KLQNLSLEGLRLSDPIVNTLAKNSNLVRLNLSGCSGFSEFALQTLLSSCSRLDELNLSWCFDFTEKHVQVAVAHVSETIT  151 (284)
T ss_dssp             CCSEEECTTCBCCHHHHHHHTTCTTCSEEECTTCBSCCHHHHHHHHHHCTTCCEEECCCCTTCCHHHHHHHHHHSCTTCC
T ss_pred             CCCCCCCCCCCCCCHHHHHHHCCCCCCCCCCCCCCCCCCCCCCHHHHHHHHCCCCCCCCCCCCCCCCCHHHHCCCCCCCC
T ss_conf             76514523467986789998518997571510013412355403657887435652245332333220001000111110


Q ss_pred             EEEEECC--CCCC-CCCHHCCCCCCCCEEECCCCC-CCCCCCCCCCCCCCCCEEECCC-CCCCCCCHHHHHCCCCCCEEE
Q ss_conf             8961066--5888-880120899888889656885-8987992347998788342337-738887414320897885773
Q 005586          144 VLQLCCN--QLTG-NIPAQIGSLKSLSVLTLQHNR-LNGGIPDSLGNLGKLKRLDLSF-NSLFGTIPESLANNAELLFLD  218 (689)
Q Consensus       144 ~L~ls~N--~l~~-~~p~~~~~l~~L~~L~Ls~N~-l~~~~p~~~~~l~~L~~L~ls~-N~l~~~~p~~l~~~~~L~~l~  218 (689)
                      .|+++++  .++. .+...+.++++|+.|++++|. ++......+..+++|++|++++ +.++......+..+++|+.|+
T Consensus       152 ~L~l~~~~~~i~~~~l~~l~~~~~~L~~L~L~~~~~itd~~~~~l~~~~~L~~L~L~~C~~i~~~~l~~L~~~~~L~~L~  231 (284)
T d2astb2         152 QLNLSGYRKNLQKSDLSTLVRRCPNLVHLDLSDSVMLKNDCFQEFFQLNYLQHLSLSRCYDIIPETLLELGEIPTLKTLQ  231 (284)
T ss_dssp             EEECCSCGGGSCHHHHHHHHHHCTTCSEEECTTCTTCCGGGGGGGGGCTTCCEEECTTCTTCCGGGGGGGGGCTTCCEEE
T ss_pred             HHHHCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCHHHHHHCCCCCCCEEECCCCCCCCHHHHHHHHCCCCCCEEE
T ss_conf             12213554244444343423232221235532234778303333213576877989999978737899972699989896


Q ss_pred             CCCC
Q ss_conf             4267
Q 005586          219 VQNN  222 (689)
Q Consensus       219 l~~N  222 (689)
                      +.++
T Consensus       232 l~~~  235 (284)
T d2astb2         232 VFGI  235 (284)
T ss_dssp             CTTS
T ss_pred             EECC
T ss_conf             4488

>d2ca6a1 c.10.1.2 (A:2-345) Rna1p (RanGAP1), N-terminal domain {Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]}

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: RNI-like
family: Rna1p (RanGAP1), N-terminal domain
domain: Rna1p (RanGAP1), N-terminal domain
species: Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]

Probab=99.32  E-value=5.5e-14  Score=86.95  Aligned_cols=157  Identities=22%  Similarity=0.214  Sum_probs=62.6

Q ss_pred             CEEEEECCCCCCCCC----CCCCCCCCCCCCEEECCCCCCCCC----------CCCCCCCCCCCCEEEECCCCCCCCC--
Q ss_conf             779999179986332----495767899888898318834444----------7800018888868992256888999--
Q 005586           69 KVANISLQGKGLTGK----LSPSLSGLKCLSGLYLHYNSLSGE----------IPKEIRNLTELTDLYLDVNNLSGNI--  132 (689)
Q Consensus        69 ~v~~l~L~~~~l~g~----~~~~~~~l~~L~~L~L~~N~l~~~----------~p~~~~~l~~L~~L~Ls~N~l~g~~--  132 (689)
                      .++.|+|++|.+...    +...+...+.|+.|+++++.+...          +...+...++|+.|+|++|.+....  
T Consensus        32 ~l~~L~Ls~n~i~~~~~~~l~~~l~~~~~L~~l~l~~~~~~~~~~~~~~~~~~l~~~l~~~~~L~~L~L~~n~i~~~~~~  111 (344)
T d2ca6a1          32 SVKEIVLSGNTIGTEAARWLSENIASKKDLEIAEFSDIFTGRVKDEIPEALRLLLQALLKCPKLHTVRLSDNAFGPTAQE  111 (344)
T ss_dssp             CCCEEECTTSEECHHHHHHHHHTTTTCTTCCEEECCSCCTTSCGGGSHHHHHHHHHHHTTCTTCCEEECCSCCCCTTTHH
T ss_pred             CCCEEECCCCCCCHHHHHHHHHHHHHCCCCCEEECCCCCCCCCCCCCCHHHHHHHHHHHHCCCCCCCCCCCCCCCCCCCC
T ss_conf             97889784983778999999999985899888888777543345421067879998875477756330000134554333


Q ss_pred             --CCCCCCCCCCCEEEEECCCCCCCCCH-------------HCCCCCCCCEEECCCCCCCCC----CCCCCCCCCCCCEE
Q ss_conf             --95336885543896106658888801-------------208998888896568858987----99234799878834
Q 005586          133 --PPEIGSMASLQVLQLCCNQLTGNIPA-------------QIGSLKSLSVLTLQHNRLNGG----IPDSLGNLGKLKRL  193 (689)
Q Consensus       133 --p~~~~~l~~L~~L~ls~N~l~~~~p~-------------~~~~l~~L~~L~Ls~N~l~~~----~p~~~~~l~~L~~L  193 (689)
                        ...+...++|+.|++++|.+...-..             .....+.|+.+.++.|.+...    +...+...+.|+.|
T Consensus       112 ~l~~~l~~~~~L~~L~l~~n~l~~~~~~~l~~~l~~~~~~~~~~~~~~L~~l~l~~n~i~~~~~~~l~~~l~~~~~L~~L  191 (344)
T d2ca6a1         112 PLIDFLSKHTPLEHLYLHNNGLGPQAGAKIARALQELAVNKKAKNAPPLRSIICGRNRLENGSMKEWAKTFQSHRLLHTV  191 (344)
T ss_dssp             HHHHHHHHCTTCCEEECCSSCCHHHHHHHHHHHHHHHHHHHHHHTCCCCCEEECCSSCCTGGGHHHHHHHHHHCTTCCEE
T ss_pred             CHHHHHCCCCCCHHEECCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCEEECCCCCCCCCCCCCCCCHHHHHHHHCCC
T ss_conf             10111002343210000024666654311112122221100014676421110136501355433221111233321335


Q ss_pred             ECCCCCCCCC-----CHHHHHCCCCCCEEECCCCCCC
Q ss_conf             2337738887-----4143208978857734267487
Q 005586          194 DLSFNSLFGT-----IPESLANNAELLFLDVQNNTLS  225 (689)
Q Consensus       194 ~ls~N~l~~~-----~p~~l~~~~~L~~l~l~~N~l~  225 (689)
                      ++++|.+...     +...+...+.|+.|++++|.++
T Consensus       192 ~L~~n~i~~~g~~~~l~~~l~~~~~L~~L~Ls~N~i~  228 (344)
T d2ca6a1         192 KMVQNGIRPEGIEHLLLEGLAYCQELKVLDLQDNTFT  228 (344)
T ss_dssp             ECCSSCCCHHHHHHHHHTTGGGCTTCCEEECCSSCCH
T ss_pred             CCCCCCCCCCCCCCCHHHHHCCHHHHCCCCCCCCCCC
T ss_conf             4333222222232002433211012112223333222

>d2ca6a1 c.10.1.2 (A:2-345) Rna1p (RanGAP1), N-terminal domain {Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]}

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: RNI-like
family: Rna1p (RanGAP1), N-terminal domain
domain: Rna1p (RanGAP1), N-terminal domain
species: Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]

Probab=99.28  E-value=1.8e-13  Score=84.33  Aligned_cols=165  Identities=18%  Similarity=0.156  Sum_probs=105.0

Q ss_pred             CCCCEEEEECCCCCCCCC----------CCCCCCCCCCCCEEECCCCCCCCC----CCCCCCCCCCCCEEEECCCCCCCC
Q ss_conf             999779999179986332----------495767899888898318834444----780001888886899225688899
Q 005586           66 EHRKVANISLQGKGLTGK----------LSPSLSGLKCLSGLYLHYNSLSGE----IPKEIRNLTELTDLYLDVNNLSGN  131 (689)
Q Consensus        66 ~~~~v~~l~L~~~~l~g~----------~~~~~~~l~~L~~L~L~~N~l~~~----~p~~~~~l~~L~~L~Ls~N~l~g~  131 (689)
                      ...++..+++.++.....          +...+...++|+.|+|++|.++..    +...+...++|++|++++|.+...
T Consensus        57 ~~~~L~~l~l~~~~~~~~~~~~~~~~~~l~~~l~~~~~L~~L~L~~n~i~~~~~~~l~~~l~~~~~L~~L~l~~n~l~~~  136 (344)
T d2ca6a1          57 SKKDLEIAEFSDIFTGRVKDEIPEALRLLLQALLKCPKLHTVRLSDNAFGPTAQEPLIDFLSKHTPLEHLYLHNNGLGPQ  136 (344)
T ss_dssp             TCTTCCEEECCSCCTTSCGGGSHHHHHHHHHHHTTCTTCCEEECCSCCCCTTTHHHHHHHHHHCTTCCEEECCSSCCHHH
T ss_pred             HCCCCCEEECCCCCCCCCCCCCCHHHHHHHHHHHHCCCCCCCCCCCCCCCCCCCCCHHHHHCCCCCCHHEECCCCCCCCC
T ss_conf             58998888887775433454210678799988754777563300001345543331011100234321000002466665


Q ss_pred             CCCC-------------CCCCCCCCEEEEECCCCCCCC----CHHCCCCCCCCEEECCCCCCCCC-----CCCCCCCCCC
Q ss_conf             9953-------------368855438961066588888----01208998888896568858987-----9923479987
Q 005586          132 IPPE-------------IGSMASLQVLQLCCNQLTGNI----PAQIGSLKSLSVLTLQHNRLNGG-----IPDSLGNLGK  189 (689)
Q Consensus       132 ~p~~-------------~~~l~~L~~L~ls~N~l~~~~----p~~~~~l~~L~~L~Ls~N~l~~~-----~p~~~~~l~~  189 (689)
                      ....             ....+.|+.|++++|.+....    ...+.....|+.|+|++|.+...     +...+..+++
T Consensus       137 ~~~~l~~~l~~~~~~~~~~~~~~L~~l~l~~n~i~~~~~~~l~~~l~~~~~L~~L~L~~n~i~~~g~~~~l~~~l~~~~~  216 (344)
T d2ca6a1         137 AGAKIARALQELAVNKKAKNAPPLRSIICGRNRLENGSMKEWAKTFQSHRLLHTVKMVQNGIRPEGIEHLLLEGLAYCQE  216 (344)
T ss_dssp             HHHHHHHHHHHHHHHHHHHTCCCCCEEECCSSCCTGGGHHHHHHHHHHCTTCCEEECCSSCCCHHHHHHHHHTTGGGCTT
T ss_pred             CCCCCCCCCCCCCCCCCCCCCCCCCEEECCCCCCCCCCCCCCCCHHHHHHHHCCCCCCCCCCCCCCCCCCHHHHHCCHHH
T ss_conf             43111121222211000146764211101365013554332211112333213354333222222232002433211012


Q ss_pred             CCEEECCCCCCCCC----CHHHHHCCCCCCEEECCCCCCCCCCCH
Q ss_conf             88342337738887----414320897885773426748766523
Q 005586          190 LKRLDLSFNSLFGT----IPESLANNAELLFLDVQNNTLSGIVPS  230 (689)
Q Consensus       190 L~~L~ls~N~l~~~----~p~~l~~~~~L~~l~l~~N~l~~~~p~  230 (689)
                      |+.|++++|.++..    +...+...+.|+.|++++|.+++....
T Consensus       217 L~~L~Ls~N~i~~~g~~~L~~~l~~~~~L~~L~Ls~n~i~~~g~~  261 (344)
T d2ca6a1         217 LKVLDLQDNTFTHLGSSALAIALKSWPNLRELGLNDCLLSARGAA  261 (344)
T ss_dssp             CCEEECCSSCCHHHHHHHHHHHGGGCTTCCEEECTTCCCCHHHHH
T ss_pred             HCCCCCCCCCCCCCCCCCCCCCCCCCCCCHHHHHHCCCCCCHHHH
T ss_conf             112223333222222223444332322111103004756715667

>d1z7xw1 c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: RNI-like
family: 28-residue LRR
domain: Ribonuclease inhibitor
species: Human (Homo sapiens) [TaxId: 9606]

Probab=99.25  E-value=1.4e-13  Score=84.87  Aligned_cols=109  Identities=23%  Similarity=0.284  Sum_probs=54.7

Q ss_pred             CEEEEECCCCCCCCCC-CCCCCCCCCCCEEECCCCCCCC----CCCCCCCCCCCCCEEEECCCCCCCC----CCCCCC-C
Q ss_conf             7799991799863324-9576789988889831883444----4780001888886899225688899----995336-8
Q 005586           69 KVANISLQGKGLTGKL-SPSLSGLKCLSGLYLHYNSLSG----EIPKEIRNLTELTDLYLDVNNLSGN----IPPEIG-S  138 (689)
Q Consensus        69 ~v~~l~L~~~~l~g~~-~~~~~~l~~L~~L~L~~N~l~~----~~p~~~~~l~~L~~L~Ls~N~l~g~----~p~~~~-~  138 (689)
                      +++.|+++++++++.. ..-+..+++++.|+|++|.++.    .+...+..+++|+.|||++|.++..    +...+. .
T Consensus         3 ~l~~ld~~~~~i~~~~~~~l~~~l~~l~~L~L~~~~i~~~~~~~l~~~L~~~~~L~~LdLs~N~i~~~~~~~l~~~l~~~   82 (460)
T d1z7xw1           3 DIQSLDIQCEELSDARWAELLPLLQQCQVVRLDDCGLTEARCKDISSALRVNPALAELNLRSNELGDVGVHCVLQGLQTP   82 (460)
T ss_dssp             EEEEEEEESCCCCHHHHHHHHHHHTTCSEEEEESSCCCHHHHHHHHHHHHTCTTCCEEECTTCCCHHHHHHHHHHTTCST
T ss_pred             CCCEEEEECCCCCHHHHHHHHHHCCCCCEEEECCCCCCHHHHHHHHHHHHCCCCCCEEECCCCCCCHHHHHHHHHHHHCC
T ss_conf             87779820895886899999976779999982899998899999999985399988897959859728999999998437


Q ss_pred             CCCCCEEEEECCCCCCC----CCHHCCCCCCCCEEECCCCCCC
Q ss_conf             85543896106658888----8012089988888965688589
Q 005586          139 MASLQVLQLCCNQLTGN----IPAQIGSLKSLSVLTLQHNRLN  177 (689)
Q Consensus       139 l~~L~~L~ls~N~l~~~----~p~~~~~l~~L~~L~Ls~N~l~  177 (689)
                      ..+|+.|+|++|+++..    ++..+..+++|+.|++++|.++
T Consensus        83 ~~~L~~L~L~~n~it~~~~~~l~~~l~~~~~L~~L~L~~N~i~  125 (460)
T d1z7xw1          83 SCKIQKLSLQNCCLTGAGCGVLSSTLRTLPTLQELHLSDNLLG  125 (460)
T ss_dssp             TCCCCEEECTTSCCBGGGHHHHHHHTTSCTTCCEEECCSSBCH
T ss_pred             CCCCCEEECCCCCCCCCCCCCCCCHHHCCCCCCCCCCCCCCCH
T ss_conf             8877887788877543221012110000343200244433202

>d1j7la_ d.144.1.6 (A:) Type IIIa 3',5"-aminoglycoside phosphotransferase {Enterococcus faecalis [TaxId: 1351]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: APH phosphotransferases
domain: Type IIIa 3',5"-aminoglycoside phosphotransferase
species: Enterococcus faecalis [TaxId: 1351]

Probab=99.11  E-value=4.4e-10  Score=66.61  Aligned_cols=151  Identities=15%  Similarity=0.091  Sum_probs=94.5

Q ss_pred             HHHHHHHCCCCCCCCCCCCCCCEEEEEEECCCCEEEEEEECCCCCCHHHHHHHHHHHHHHCCC-CCCCEEEEEEEECCCC
Q ss_conf             899998305884542154885209999955993999999024687627999999999985148-9951148668971899
Q 005586          402 EEVESATQCFSEVNLLGKGNFSSVYKGTLRDGTLVAIRSINVTSCKSEEAEFVKGLYLLTSLR-HENIIRLRGFCCSRGR  480 (689)
Q Consensus       402 ~~~~~~~~~f~~~~~lg~G~~g~Vy~~~~~~g~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~-h~niv~l~~~~~~~~~  480 (689)
                      .++...-+.|...+..+.+....||+.... +..+++|+....... ....+.+|...+..+. +--+.+++.+.  .+.
T Consensus         7 ~~l~~~~~~~~~~~~~~G~s~~~v~rv~~~-~~~~vlk~~~~~~~~-~~~~~~~E~~~l~~l~~~vpvP~vl~~~--~~~   82 (263)
T d1j7la_           7 PELKKLIEKYRCVKDTEGMSPAKVYKLVGE-NENLYLKMTDSRYKG-TTYDVEREKDMMLWLEGKLPVPKVLHFE--RHD   82 (263)
T ss_dssp             HHHHHHHTTSEEEECSCCCSSSEEEEEECS-SCEEEEEEECGGGTT-STTCHHHHHHHHHHHTTTSCCCCEEEEE--EET
T ss_pred             HHHHHHHHCEEEEECCCCCCCCCEEEEEEC-CCEEEEEECCCCCCC-CHHHHHHHHHHHHHHHCCCCCCCEEEEE--ECC
T ss_conf             999975135279976789987718999908-986999984887653-2556999999999876069987289997--508


Q ss_pred             CEEEEEEECCCCCCHHHHHHHCCCCCCCCCHHHHHHHHHHHHHHHHHHHCCCC---------------------------
Q ss_conf             81899997289999888860017999878999999999999999755307999---------------------------
Q 005586          481 GECFLIYDFAPKGKLSKYLDQEEGSSNVLDWSTRVSIIIGIAKGIGYLHSSEV---------------------------  533 (689)
Q Consensus       481 ~~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~ia~~ia~gL~~LH~~~~---------------------------  533 (689)
                      +..++||+++++.++.+.....      .   ....++.++++.++.||+...                           
T Consensus        83 ~~~~lv~~~l~G~~~~~~~~~~------~---~~~~~~~~l~~~l~~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  153 (263)
T d1j7la_          83 GWSNLLMSEADGVLCSEEYEDE------Q---SPEKIIELYAECIRLFHSIDISDCPYTNSLDSRLAELDYLLNNDLADV  153 (263)
T ss_dssp             TEEEEEEECCSSEEHHHHTTTC------S---CHHHHHHHHHHHHHHHHTSCCTTCSCBCCHHHHHHHHHHHHHTTCSCC
T ss_pred             CCEEEEEEECCCCCCCCCCCCC------C---CHHHHHHHHHHHHHHHHCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHH
T ss_conf             9649999860433435433440------2---699999989999999855684214357644656555778998776555


Q ss_pred             ---------------------------CCCCEEECCCCCCCEEECCCCCEEEECCCCCC
Q ss_conf             ---------------------------99963625879986654599980780356533
Q 005586          534 ---------------------------NKPAIVHRNLSVEKVLIDQQFNPLIADCGLHK  565 (689)
Q Consensus       534 ---------------------------~~~~ivH~dlk~~Nill~~~~~~kl~Dfgla~  565 (689)
                                                 ..+.++|+|+.+.||+++++...-++||+.+.
T Consensus       154 ~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~l~HgD~~~~Nil~~~~~~~~lIDwe~a~  212 (263)
T d1j7la_         154 DCENWEEDTPFKDPRELYDFLKTEKPEEELVFSHGDLGDSNIFVKDGKVSGFIDLGRSG  212 (263)
T ss_dssp             CGGGGSTTCSCSSHHHHHHHHHHSCCCCCEEEECSCCCTTSEEEETTEEEEECCCTTCE
T ss_pred             HHHCCCCCCCCHHHHHHHHHHHHCCCCCCCEEEEEECCCCCEEECCCCEEEEEECHHCC
T ss_conf             54303323200579999999984498678178986004764236499659996023144

>d1z7xw1 c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: RNI-like
family: 28-residue LRR
domain: Ribonuclease inhibitor
species: Human (Homo sapiens) [TaxId: 9606]

Probab=99.06  E-value=3.6e-12  Score=77.53  Aligned_cols=109  Identities=24%  Similarity=0.256  Sum_probs=58.0

Q ss_pred             CCCEEECCCCCCCCC-CCCCCCCCCCCCEEEECCCCCCC----CCCCCCCCCCCCCEEEEECCCCCCC----CCHHCC-C
Q ss_conf             888898318834444-78000188888689922568889----9995336885543896106658888----801208-9
Q 005586           93 CLSGLYLHYNSLSGE-IPKEIRNLTELTDLYLDVNNLSG----NIPPEIGSMASLQVLQLCCNQLTGN----IPAQIG-S  162 (689)
Q Consensus        93 ~L~~L~L~~N~l~~~-~p~~~~~l~~L~~L~Ls~N~l~g----~~p~~~~~l~~L~~L~ls~N~l~~~----~p~~~~-~  162 (689)
                      .|+.||++.|++++. +..-+..+++++.|+|++|.++.    .++..+..+++|+.|+|++|.++..    +...+. .
T Consensus         3 ~l~~ld~~~~~i~~~~~~~l~~~l~~l~~L~L~~~~i~~~~~~~l~~~L~~~~~L~~LdLs~N~i~~~~~~~l~~~l~~~   82 (460)
T d1z7xw1           3 DIQSLDIQCEELSDARWAELLPLLQQCQVVRLDDCGLTEARCKDISSALRVNPALAELNLRSNELGDVGVHCVLQGLQTP   82 (460)
T ss_dssp             EEEEEEEESCCCCHHHHHHHHHHHTTCSEEEEESSCCCHHHHHHHHHHHHTCTTCCEEECTTCCCHHHHHHHHHHTTCST
T ss_pred             CCCEEEEECCCCCHHHHHHHHHHCCCCCEEEECCCCCCHHHHHHHHHHHHCCCCCCEEECCCCCCCHHHHHHHHHHHHCC
T ss_conf             87779820895886899999976779999982899998899999999985399988897959859728999999998437


Q ss_pred             CCCCCEEECCCCCCCCC----CCCCCCCCCCCCEEECCCCCCC
Q ss_conf             98888896568858987----9923479987883423377388
Q 005586          163 LKSLSVLTLQHNRLNGG----IPDSLGNLGKLKRLDLSFNSLF  201 (689)
Q Consensus       163 l~~L~~L~Ls~N~l~~~----~p~~~~~l~~L~~L~ls~N~l~  201 (689)
                      ..+|+.|+|++|.++..    ++..+..+++|+.|++++|.+.
T Consensus        83 ~~~L~~L~L~~n~it~~~~~~l~~~l~~~~~L~~L~L~~N~i~  125 (460)
T d1z7xw1          83 SCKIQKLSLQNCCLTGAGCGVLSSTLRTLPTLQELHLSDNLLG  125 (460)
T ss_dssp             TCCCCEEECTTSCCBGGGHHHHHHHTTSCTTCCEEECCSSBCH
T ss_pred             CCCCCEEECCCCCCCCCCCCCCCCHHHCCCCCCCCCCCCCCCH
T ss_conf             8877887788877543221012110000343200244433202

>d1koha1 c.10.2.3 (A:201-362) mRNA export factor tap {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: mRNA export factor tap
domain: mRNA export factor tap
species: Human (Homo sapiens) [TaxId: 9606]

Probab=98.94  E-value=7.8e-12  Score=75.76  Aligned_cols=15  Identities=47%  Similarity=0.328  Sum_probs=5.6

Q ss_pred             CCCCCEEECCCCCCC
Q ss_conf             987883423377388
Q 005586          187 LGKLKRLDLSFNSLF  201 (689)
Q Consensus       187 l~~L~~L~ls~N~l~  201 (689)
                      +++|+.|+|++|.++
T Consensus        90 l~~L~~L~Ls~N~i~  104 (162)
T d1koha1          90 APNLKILNLSGNELK  104 (162)
T ss_dssp             STTCCCCCCTTSCCC
T ss_pred             CCCCCCCCCCCCCCC
T ss_conf             885610004357213

>d1koha1 c.10.2.3 (A:201-362) mRNA export factor tap {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: mRNA export factor tap
domain: mRNA export factor tap
species: Human (Homo sapiens) [TaxId: 9606]

Probab=98.86  E-value=3.9e-11  Score=72.13  Aligned_cols=80  Identities=28%  Similarity=0.191  Sum_probs=31.3

Q ss_pred             CCCCCEEEEECCCCCCC--CCHHCCCCCCCCEEECCCCCCCCCCCCCCCCCCCCCEEECCCCCCCCCCH-------HHHH
Q ss_conf             85543896106658888--80120899888889656885898799234799878834233773888741-------4320
Q 005586          139 MASLQVLQLCCNQLTGN--IPAQIGSLKSLSVLTLQHNRLNGGIPDSLGNLGKLKRLDLSFNSLFGTIP-------ESLA  209 (689)
Q Consensus       139 l~~L~~L~ls~N~l~~~--~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~ls~N~l~~~~p-------~~l~  209 (689)
                      +++|+.|+|++|+++..  ++..+..+++|+.|+|++|.++...+..+.....|+.|++++|++.....       ..+.
T Consensus        64 ~~~L~~L~Ls~N~i~~l~~~~~~~~~l~~L~~L~Ls~N~i~~l~~l~~l~~~~L~~L~L~~Npl~~~~~~~~~y~~~i~~  143 (162)
T d1koha1          64 IPELLSLNLSNNRLYRLDDMSSIVQKAPNLKILNLSGNELKSERELDKIKGLKLEELWLDGNSLSDTFRDQSTYISAIRE  143 (162)
T ss_dssp             CTTCCCCCCCSSCCCCCSGGGTHHHHSTTCCCCCCTTSCCCCGGGHHHHTTCCCSSCCCTTSTTSSSSSSHHHHHHHHHT
T ss_pred             CCCCCEEECCCCCCCCCCHHHHHHHHCCCCCCCCCCCCCCCCCHHHHHHHCCCCCEEECCCCCCCCCCCCCHHHHHHHHH
T ss_conf             87878863777666677315889865885610004357213423442220331042664899767676661569999999


Q ss_pred             CCCCCCEEE
Q ss_conf             897885773
Q 005586          210 NNAELLFLD  218 (689)
Q Consensus       210 ~~~~L~~l~  218 (689)
                      .+|+|+.||
T Consensus       144 ~~P~L~~LD  152 (162)
T d1koha1         144 RFPKLLRLD  152 (162)
T ss_dssp             TSTTCCEET
T ss_pred             HCCCCCEEC
T ss_conf             889978799

>d1nd4a_ d.144.1.6 (A:) Aminoglycoside 3'-phosphotransferase IIa (Kanamycin kinase) {Bacteria (Klebsiella pneumoniae) [TaxId: 573]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: APH phosphotransferases
domain: Aminoglycoside 3'-phosphotransferase IIa (Kanamycin kinase)
species: Bacteria (Klebsiella pneumoniae) [TaxId: 573]

Probab=98.72  E-value=1.1e-08  Score=59.34  Aligned_cols=132  Identities=13%  Similarity=0.132  Sum_probs=79.6

Q ss_pred             CCCCCC-CCEEEEEEECCCCEEEEEEECCCCCCHHHHHHHHHHHHHHCCC--CCCCEEEEEEEECCCCCEEEEEEECCCC
Q ss_conf             215488-5209999955993999999024687627999999999985148--9951148668971899818999972899
Q 005586          416 LLGKGN-FSSVYKGTLRDGTLVAIRSINVTSCKSEEAEFVKGLYLLTSLR--HENIIRLRGFCCSRGRGECFLIYDFAPK  492 (689)
Q Consensus       416 ~lg~G~-~g~Vy~~~~~~g~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~--h~niv~l~~~~~~~~~~~~~lv~e~~~~  492 (689)
                      .+..|. ...||+....++..+++|.......    ..+..|...+..+.  .-.+.+++++.  .+.+..++||++++|
T Consensus        17 ~~~~G~s~~~v~r~~~~~~~~~vlK~~~~~~~----~~l~~E~~~l~~L~~~gvpvP~v~~~~--~~~~~~~~v~~~i~G   90 (255)
T d1nd4a_          17 QQTIGCSDAAVFRLSAQGRPVLFVKTDLSGAL----NELQDEAARLSWLATTGVPCAAVLDVV--TEAGRDWLLLGEVPG   90 (255)
T ss_dssp             ECSCTTSSCEEEEEECTTSCCEEEEEECSCTT----SCHHHHHHHHHHHHTTTCCBCCEEEEE--ECSSCEEEEEECCSS
T ss_pred             ECCCCCCCCEEEEEEECCCCEEEEEECCCCCH----HHHHHHHHHHHHHHHCCCCCCCEEEEC--CCCCCEEEEEEEEEC
T ss_conf             76786547758999938987899995896677----689999999999986599988613222--456615999874413


Q ss_pred             CCHHHHHHHCCCCCCCCCHHHHHHHHHHHHHHHHHHHCCC----------------------------------------
Q ss_conf             9988886001799987899999999999999975530799----------------------------------------
Q 005586          493 GKLSKYLDQEEGSSNVLDWSTRVSIIIGIAKGIGYLHSSE----------------------------------------  532 (689)
Q Consensus       493 gsL~~~l~~~~~~~~~l~~~~~~~ia~~ia~gL~~LH~~~----------------------------------------  532 (689)
                      .++.+..         ....   .++.+++..|+.||+..                                        
T Consensus        91 ~~~~~~~---------~~~~---~~~~~l~~~la~LH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  158 (255)
T d1nd4a_          91 QDLLSSH---------LAPA---EKVSIMADAMRRLHTLDPATCPFDHQAKHRIERARTRMEAGLVDQDDLDEEHQGLAP  158 (255)
T ss_dssp             EETTTSC---------CCHH---HHHHHHHHHHHHHTTSCGGGCCCBCCHHHHHHHHHHHHHTTCCCTTSCCGGGTTCCH
T ss_pred             CCCCCCC---------CCHH---HHHHHHHHHHHHHCCCCHHHCCCCCCCHHHHHHHHHHHHHHHHCCCCCCCHHHHHHH
T ss_conf             5543221---------2689---999999999998736885448875541246889999998754110113401121379


Q ss_pred             -------------CCCCCEEECCCCCCCEEECCCCCEEEECCCCCC
Q ss_conf             -------------999963625879986654599980780356533
Q 005586          533 -------------VNKPAIVHRNLSVEKVLIDQQFNPLIADCGLHK  565 (689)
Q Consensus       533 -------------~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgla~  565 (689)
                                   ...+.++|+|+.+.||+++++..+-|+||+.+.
T Consensus       159 ~~~~~~l~~~~~~~~~~~liHgD~~~~Nvl~~~~~~~~iID~~~~~  204 (255)
T d1nd4a_         159 AELFARLKARMPDGEDLVVTHGDACLPNIMVENGRFSGFIDCGRLG  204 (255)
T ss_dssp             HHHHHHHHHTCCSSCCEEEECSSCCGGGEEEETTEEEEECCCTTCE
T ss_pred             HHHHHHHHHHCCCCCCCEEEECCCCCCCEEEECCCEEEEEECHHCC
T ss_conf             9999999871876579567867888763577379658999853326

>d2pula1 d.144.1.6 (A:5-396) Methylthioribose kinase MtnK {Bacillus subtilis [TaxId: 1423]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: APH phosphotransferases
domain: Methylthioribose kinase MtnK
species: Bacillus subtilis [TaxId: 1423]

Probab=98.54  E-value=4.7e-07  Score=50.85  Aligned_cols=78  Identities=13%  Similarity=0.017  Sum_probs=46.7

Q ss_pred             CCCCCCCCCCEEEEEEECC-CCEEEEEEECCC------CCCHHHHHHHHHHHHHHCC-CC--CCCEEEEEEEECCCCCEE
Q ss_conf             5421548852099999559-939999990246------8762799999999998514-89--951148668971899818
Q 005586          414 VNLLGKGNFSSVYKGTLRD-GTLVAIRSINVT------SCKSEEAEFVKGLYLLTSL-RH--ENIIRLRGFCCSRGRGEC  483 (689)
Q Consensus       414 ~~~lg~G~~g~Vy~~~~~~-g~~vaiK~~~~~------~~~~~~~~~~~e~~~l~~l-~h--~niv~l~~~~~~~~~~~~  483 (689)
                      .+.||.|....||+....+ ++.+++|.-...      .......+...|.+.+..+ .+  ..+.+++.+.  .  ...
T Consensus        31 ~~eig~G~~N~vfrV~~~~~~~svivKqa~p~~r~~g~~~~~~~~R~~~E~~~L~~~~~~~p~~vP~v~~~d--~--~~~  106 (392)
T d2pula1          31 CQEIGDGNLNYVFHIYDQEHDRALIIKQAVPYAKVVGESWPLTIDRARIESSALIRQGEHVPHLVPRVFYSD--T--EMA  106 (392)
T ss_dssp             EEECCSSSSEEEEEEEC----CEEEEEEECCGGGC--CCCCCCTTHHHHHHHHHHHHHTTCGGGSCCEEEEE--T--TTT
T ss_pred             EEEECCCCEEEEEEEEECCCCEEEEEECCCCHHCCCCCCCCCCHHHHHHHHHHHHHHHHHCCCCCCEEEEEC--C--CCC
T ss_conf             998079852768999957998489996177130346777888778999999999986505798855289985--9--887


Q ss_pred             EEEEECCCCCCH
Q ss_conf             999972899998
Q 005586          484 FLIYDFAPKGKL  495 (689)
Q Consensus       484 ~lv~e~~~~gsL  495 (689)
                      ++|||++++..+
T Consensus       107 ~lvmE~L~~~~~  118 (392)
T d2pula1         107 VTVMEDLSHLKI  118 (392)
T ss_dssp             EEEECCCTTSEE
T ss_pred             EEEEECCCCCCC
T ss_conf             798713577653

>d1pgva_ c.10.1.1 (A:) Tropomodulin C-terminal domain {nematode (Caenorhabditis elegans) [TaxId: 6239]}

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: RNI-like
family: 28-residue LRR
domain: Tropomodulin C-terminal domain
species: nematode (Caenorhabditis elegans) [TaxId: 6239]

Probab=98.35  E-value=7.3e-08  Score=55.08  Aligned_cols=39  Identities=15%  Similarity=0.121  Sum_probs=15.7

Q ss_pred             CCCCCEEECCCC-CCCCC----CCCCCCCCCCCCEEEECCCCCC
Q ss_conf             998888983188-34444----7800018888868992256888
Q 005586           91 LKCLSGLYLHYN-SLSGE----IPKEIRNLTELTDLYLDVNNLS  129 (689)
Q Consensus        91 l~~L~~L~L~~N-~l~~~----~p~~~~~l~~L~~L~Ls~N~l~  129 (689)
                      .+.|++|+|+++ .++..    +-..+...+.|+.|+|++|.+.
T Consensus        14 ~~~L~~L~L~~~~~i~~~~~~~l~~~L~~n~~L~~L~Ls~n~l~   57 (167)
T d1pgva_          14 DTDLKEVNINNMKRVSKERIRSLIEAACNSKHIEKFSLANTAIS   57 (167)
T ss_dssp             CSSCCEEECTTCCSSCHHHHHHHHHHHTTCSCCCEEECTTSCCB
T ss_pred             CCCCCEEEECCCCCCCHHHHHHHHHHHHHCCCCCEEECCCCCCC
T ss_conf             99981978279999898999999999763776454012015621

>d1pgva_ c.10.1.1 (A:) Tropomodulin C-terminal domain {nematode (Caenorhabditis elegans) [TaxId: 6239]}

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: RNI-like
family: 28-residue LRR
domain: Tropomodulin C-terminal domain
species: nematode (Caenorhabditis elegans) [TaxId: 6239]

Probab=98.19  E-value=3.8e-07  Score=51.34  Aligned_cols=68  Identities=13%  Similarity=0.155  Sum_probs=29.9

Q ss_pred             CCCCCCCCEEECCCCCCCCC----CCCCCCCCCCCCEEECCCCCCCCC----CHHHHHCCCCCCEEECCCCCCCCC
Q ss_conf             08998888896568858987----992347998788342337738887----414320897885773426748766
Q 005586          160 IGSLKSLSVLTLQHNRLNGG----IPDSLGNLGKLKRLDLSFNSLFGT----IPESLANNAELLFLDVQNNTLSGI  227 (689)
Q Consensus       160 ~~~l~~L~~L~Ls~N~l~~~----~p~~~~~l~~L~~L~ls~N~l~~~----~p~~l~~~~~L~~l~l~~N~l~~~  227 (689)
                      +...+.|+.|+|++|.+...    +...+...+.|+.|++++|.+...    +-..+...+.|+.|++++|.+...
T Consensus        40 L~~n~~L~~L~Ls~n~l~~~~~~~la~~L~~n~~L~~L~L~~n~i~~~g~~~l~~aL~~n~sL~~L~l~~n~~~~~  115 (167)
T d1pgva_          40 ACNSKHIEKFSLANTAISDSEARGLIELIETSPSLRVLNVESNFLTPELLARLLRSTLVTQSIVEFKADNQRQSVL  115 (167)
T ss_dssp             HTTCSCCCEEECTTSCCBHHHHTTHHHHHHHCSSCCEEECCSSBCCHHHHHHHHHHTTTTCCCSEEECCCCSSCCC
T ss_pred             HHHCCCCCEEECCCCCCCHHHHHHHHHHHHHCCCCCCEEEEHHHCCHHHHHHHHHHHHHCCCCCEEECCCCCCCCC
T ss_conf             7637764540120156215679887531000234330033010214599999999998489389877887768886

>d1nw1a_ d.144.1.8 (A:) Choline kinase {Caenorhabditis elegans [TaxId: 6239]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Choline kinase
domain: Choline kinase
species: Caenorhabditis elegans [TaxId: 6239]

Probab=98.04  E-value=2.3e-05  Score=42.02  Aligned_cols=73  Identities=18%  Similarity=0.213  Sum_probs=46.0

Q ss_pred             CCCCCCCCCCEEEEEEECC--------CCEEEEEEECCCCCCHHHHHHHHHHHHHHCCC-CCCCEEEEEEEECCCCCEEE
Q ss_conf             5421548852099999559--------93999999024687627999999999985148-99511486689718998189
Q 005586          414 VNLLGKGNFSSVYKGTLRD--------GTLVAIRSINVTSCKSEEAEFVKGLYLLTSLR-HENIIRLRGFCCSRGRGECF  484 (689)
Q Consensus       414 ~~~lg~G~~g~Vy~~~~~~--------g~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~-h~niv~l~~~~~~~~~~~~~  484 (689)
                      .+.|+.|-.-.+|++..++        ...|.+++.....   ......+|..+++.+. +.-..++++++  .  +  .
T Consensus        47 v~~l~GGltN~~y~v~~~~~~~~~~~~~~~vllRi~g~~~---~~idr~~E~~i~~~ls~~gl~Pkll~~~--~--~--g  117 (395)
T d1nw1a_          47 ISRIKGGMSNMLFLCRLSEVYPPIRNEPNKVLLRVYFNPE---TESHLVAESVIFTLLSERHLGPKLYGIF--S--G--G  117 (395)
T ss_dssp             EEEECCCTTEEEEEEEECTTSCCSSSCCSEEEEEEECSCC---CHHHHHHHHHHHHHHHHTTSSSCEEEEE--T--T--E
T ss_pred             EEECCCCCCCCEEEEEECCCCCCCCCCCCCEEEEECCCCC---HHHHHHHHHHHHHHHHHCCCCCEEEEEC--C--C--C
T ss_conf             9991785334348999688775445789817999659961---1658999999999997579998089981--8--9--5


Q ss_pred             EEEECCCCCCH
Q ss_conf             99972899998
Q 005586          485 LIYDFAPKGKL  495 (689)
Q Consensus       485 lv~e~~~~gsL  495 (689)
                      .|+||+++.++
T Consensus       118 ~I~efi~g~~l  128 (395)
T d1nw1a_         118 RLEEYIPSRPL  128 (395)
T ss_dssp             EEECCCCEEEC
T ss_pred             EEEEEECCCCC
T ss_conf             69997345548

>d1zyla1 d.144.1.6 (A:4-328) RdoA {Escherichia coli [TaxId: 562]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: APH phosphotransferases
domain: RdoA
species: Escherichia coli [TaxId: 562]

Probab=97.98  E-value=5.8e-05  Score=39.95  Aligned_cols=139  Identities=9%  Similarity=0.110  Sum_probs=72.3

Q ss_pred             CEEEEEEECCCCEEEEEEECCCCCCHHHHHHHHHHHHHHCCCCCCC-----EEEEEEEECCCCCEEEEEEECCCCCCH--
Q ss_conf             2099999559939999990246876279999999999851489951-----148668971899818999972899998--
Q 005586          423 SSVYKGTLRDGTLVAIRSINVTSCKSEEAEFVKGLYLLTSLRHENI-----IRLRGFCCSRGRGECFLIYDFAPKGKL--  495 (689)
Q Consensus       423 g~Vy~~~~~~g~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~ni-----v~l~~~~~~~~~~~~~lv~e~~~~gsL--  495 (689)
                      -.||++..++|..+++|+......  ...++..|...+..+....+     +..-+-......+..+.++++++|..+  
T Consensus        36 N~vy~v~~~dg~~~VlK~~rp~~~--s~~~i~~E~~~l~~L~~~gipv~~p~~~~g~~~~~~~~~~~~l~~~~~G~~~~~  113 (325)
T d1zyla1          36 NRVYQFQDEDRRRFVVKFYRPERW--TADQILEEHQFALQLVNDEVPVAAPVAFNGQTLLNHQGFYFAVFPSVGGRQFEA  113 (325)
T ss_dssp             SEEEEECCTTCCCEEEEEECTTTS--CHHHHHHHHHHHHHHHHTTCSBCCCCCBTTBSCEEETTEEEEEEECCCCEECCS
T ss_pred             CEEEEEECCCCCEEEEEEECCCCC--CHHHHHHHHHHHHHHHHCCCCCCCCEECCCCEEEEEEEEEEEEEEECCCCCCCC
T ss_conf             026999838999799998478778--899999999999999855998787520689805665347999986527768899


Q ss_pred             ---HHH---------HHH----CCC-CCCCCCHHH----------------------HHHHHHHHHHHHHHHHCCCCCCC
Q ss_conf             ---888---------600----179-998789999----------------------99999999999755307999999
Q 005586          496 ---SKY---------LDQ----EEG-SSNVLDWST----------------------RVSIIIGIAKGIGYLHSSEVNKP  536 (689)
Q Consensus       496 ---~~~---------l~~----~~~-~~~~l~~~~----------------------~~~ia~~ia~gL~~LH~~~~~~~  536 (689)
                         ..+         ++.    ... ....+++..                      ....+..+...+.-.-... ...
T Consensus       114 ~~~~~~~~lG~~LA~lH~~~~~~~~~~r~~~d~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~~~~~~-~p~  192 (325)
T d1zyla1         114 DNIDQMEAVGRYLGRMHQTGRKQLFIHRPTIGLNEYLIEPRKLFEDATLIPSGLKAAFLKATDELIAAVTAHWRED-FTV  192 (325)
T ss_dssp             SCHHHHHHHHHHHHHHHHHHTSSCCSSSCBCSHHHHTHHHHHHHHTCSSSCTTTHHHHHHHHHHHHHHHHHHCCSC-SCC
T ss_pred             CCHHHHHHHHHHHHHHHHHCCCCCCCCCCCCCHHHHHHHHHHHHHHCCCCCHHHHHHHHHHHHHHHHHHHHHCCCC-CCC
T ss_conf             9999999989999998863035786556778978876656899987476998898999999999999999845456-871


Q ss_pred             CEEECCCCCCCEEECCCCCEEEECCCCCCC
Q ss_conf             636258799866545999807803565334
Q 005586          537 AIVHRNLSVEKVLIDQQFNPLIADCGLHKL  566 (689)
Q Consensus       537 ~ivH~dlk~~Nill~~~~~~kl~Dfgla~~  566 (689)
                      .++|+|+.+.|||++++  ..++||+-+..
T Consensus       193 ~liHgDlh~~NvL~~~~--~~~IDFdd~~~  220 (325)
T d1zyla1         193 LRLHGDCHAGNILWRDG--PMFVDLDDARN  220 (325)
T ss_dssp             EECCSSCSGGGEEESSS--EEECCCTTCCE
T ss_pred             EEECCCCCCCCEEEECC--CEEEECHHCCC
T ss_conf             20247888042878389--35886520146

>d2ppqa1 d.144.1.6 (A:5-320) Homoserine kinase ThrB {Agrobacterium tumefaciens [TaxId: 358]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: APH phosphotransferases
domain: Homoserine kinase ThrB
species: Agrobacterium tumefaciens [TaxId: 358]

Probab=97.77  E-value=0.00032  Score=36.12  Aligned_cols=162  Identities=12%  Similarity=0.012  Sum_probs=80.2

Q ss_pred             CCHHHHHHHHCCCCCCCCC-----CCCCCCEEEEEEECCCCEEEEEEECCCCCCHHHHHHHHHHHHHHCCC-----CCCC
Q ss_conf             2778999983058845421-----54885209999955993999999024687627999999999985148-----9951
Q 005586          399 LNLEEVESATQCFSEVNLL-----GKGNFSSVYKGTLRDGTLVAIRSINVTSCKSEEAEFVKGLYLLTSLR-----HENI  468 (689)
Q Consensus       399 ~~~~~~~~~~~~f~~~~~l-----g~G~~g~Vy~~~~~~g~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~-----h~ni  468 (689)
                      ++.+|++....+|...+..     ..|.--+.|+....+|+ +++|++.......   ++..|+..+..+.     -|..
T Consensus         3 ls~~el~~~l~~Y~lg~~~~~~~i~~G~~N~ny~v~t~~g~-yVLri~~~~~~~~---~l~~~~~~l~~L~~~g~pvp~p   78 (316)
T d2ppqa1           3 ITEDELRNFLTQYDVGSLTSYKGIAEGVENSNFLLHTTKDP-LILTLYEKRVEKN---DLPFFLGLMQHLAAKGLSCPLP   78 (316)
T ss_dssp             CCHHHHHHHHTTBCCCCEEEEEEECC---EEEEEEEESSCC-EEEEEECC---CC---HHHHHHHHHHHHHHTTCCCCCB
T ss_pred             CCHHHHHHHHHHCCCCCCEEEECCCCCCCCCEEEEEECCCC-EEEEECCCCCCHH---HHHHHHHHHHHHHHCCCCCCCC
T ss_conf             89999999998679998568523788852673899978972-8999807899988---9999999987543025554556


Q ss_pred             EEEE-EEEECCCCCEEEEEEECCCCCCHH--------------HHHHHCCC----CC-CCCCH-----------------
Q ss_conf             1486-689718998189999728999988--------------88600179----99-87899-----------------
Q 005586          469 IRLR-GFCCSRGRGECFLIYDFAPKGKLS--------------KYLDQEEG----SS-NVLDW-----------------  511 (689)
Q Consensus       469 v~l~-~~~~~~~~~~~~lv~e~~~~gsL~--------------~~l~~~~~----~~-~~l~~-----------------  511 (689)
                      +... |.....-......++.+..+....              ..++....    .. .....                 
T Consensus        79 i~~~~g~~~~~~~~~~~~~~~~~~g~~~~~~~~~~~~~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  158 (316)
T d2ppqa1          79 LPRKDGELLGELSGRPAALISFLEGMWLRKPEAKHCREVGKALAAMHLASEGFEIKRPNALSVDGWKVLWDKSEERADEV  158 (316)
T ss_dssp             CCBTTCCSCEEETTEEEEEEECCCCBCCSSCCHHHHHHHHHHHHHHHHHTTTCCCCCBCTTSHHHHHHHHHHHGGGGGGT
T ss_pred             CEECCCCCCEEEECCCCEEEEECCCCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCCCCCCCCHHHCCHHHHHHHHHHHHC
T ss_conf             41048976213412550245311465533320467888889987645444320245310111012002456777765311


Q ss_pred             -HHHHHHHHHHHHHHHHHHCCCCCCCCEEECCCCCCCEEECCCCCEEEECCCCCC
Q ss_conf             -999999999999975530799999963625879986654599980780356533
Q 005586          512 -STRVSIIIGIAKGIGYLHSSEVNKPAIVHRNLSVEKVLIDQQFNPLIADCGLHK  565 (689)
Q Consensus       512 -~~~~~ia~~ia~gL~~LH~~~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgla~  565 (689)
                       ......+......+...+... ....++|+|+.+.||+++++...-+.||+.+.
T Consensus       159 ~~~~~~~l~~~~~~~~~~~~~~-L~~giIHgDl~~dNvl~~~~~v~gvIDF~~~~  212 (316)
T d2ppqa1         159 EKGLREEIRPEIDYLAAHWPKD-LPAGVIHADLFQDNVFFLGDELSGLIDFYFAC  212 (316)
T ss_dssp             STTHHHHHHHHHHHHHHHCCCS-SCEEEECSCCCGGGEEEETTEEEEECCCTTCE
T ss_pred             CHHHHHHHHHHHHHHHCCCCCC-CCCCCCCCCCCHHHHHCCCCCCEEEECCCCCC
T ss_conf             4127999999987642048554-54503337863656402045412674222123

>d1io0a_ c.10.1.1 (A:) Tropomodulin C-terminal domain {Chicken (Gallus gallus) [TaxId: 9031]}

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: RNI-like
family: 28-residue LRR
domain: Tropomodulin C-terminal domain
species: Chicken (Gallus gallus) [TaxId: 9031]

Probab=97.71  E-value=1.4e-06  Score=48.37  Aligned_cols=40  Identities=8%  Similarity=0.004  Sum_probs=17.9

Q ss_pred             CCCCCCEEECCC-CCCCCC----CCCCCCCCCCCCEEEECCCCCC
Q ss_conf             899888898318-834444----7800018888868992256888
Q 005586           90 GLKCLSGLYLHY-NSLSGE----IPKEIRNLTELTDLYLDVNNLS  129 (689)
Q Consensus        90 ~l~~L~~L~L~~-N~l~~~----~p~~~~~l~~L~~L~Ls~N~l~  129 (689)
                      +.+.|++|+|++ +.++..    +-..+...++|++|+|++|.++
T Consensus        15 ~~~~L~~L~L~~~~~i~~~~~~~l~~al~~n~~L~~L~Ls~n~l~   59 (166)
T d1io0a_          15 NDPDLEEVNLNNIMNIPVPTLKACAEALKTNTYVKKFSIVGTRSN   59 (166)
T ss_dssp             TCTTCCEEECTTCTTCCHHHHHHHHHHHTTCCSCCEEECTTSCCC
T ss_pred             CCCCCCEEECCCCCCCCHHHHHHHHHHHHCCCCCCEEECCCCCCC
T ss_conf             599986887689999898999999988841982574301589611

>d1io0a_ c.10.1.1 (A:) Tropomodulin C-terminal domain {Chicken (Gallus gallus) [TaxId: 9031]}

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: RNI-like
family: 28-residue LRR
domain: Tropomodulin C-terminal domain
species: Chicken (Gallus gallus) [TaxId: 9031]

Probab=97.52  E-value=7.5e-06  Score=44.58  Aligned_cols=111  Identities=15%  Similarity=0.206  Sum_probs=49.0

Q ss_pred             CCCCCCCCEEEECC-CCCCCC----CCCCCCCCCCCCEEEEECCCCCCCCC----HHCCCCCCCCEEECCCCCCCCC---
Q ss_conf             01888886899225-688899----99533688554389610665888880----1208998888896568858987---
Q 005586          112 IRNLTELTDLYLDV-NNLSGN----IPPEIGSMASLQVLQLCCNQLTGNIP----AQIGSLKSLSVLTLQHNRLNGG---  179 (689)
Q Consensus       112 ~~~l~~L~~L~Ls~-N~l~g~----~p~~~~~l~~L~~L~ls~N~l~~~~p----~~~~~l~~L~~L~Ls~N~l~~~---  179 (689)
                      ..+.+.|++|+|++ +.++..    +-..+...+.|+.|++++|.+.....    ..+....+++.+++++|.+...   
T Consensus        13 ~~~~~~L~~L~L~~~~~i~~~~~~~l~~al~~n~~L~~L~Ls~n~l~~~~~~~L~~~l~~~~~l~~l~l~~~~~~~~g~~   92 (166)
T d1io0a_          13 QNNDPDLEEVNLNNIMNIPVPTLKACAEALKTNTYVKKFSIVGTRSNDPVAFALAEMLKVNNTLKSLNVESNFISGSGIL   92 (166)
T ss_dssp             HTTCTTCCEEECTTCTTCCHHHHHHHHHHHTTCCSCCEEECTTSCCCHHHHHHHHHHHHHCSSCCEEECCSSCCCHHHHH
T ss_pred             HHCCCCCCEEECCCCCCCCHHHHHHHHHHHHCCCCCCEEECCCCCCCHHHHHHHHHHHHHCCCCHHHHHCCCCCCCHHHH
T ss_conf             95599986887689999898999999988841982574301589611778999998775212210121025432201478


Q ss_pred             -CCCCCCCCCCCCEEEC--CCCCCCC----CCHHHHHCCCCCCEEECCCC
Q ss_conf             -9923479987883423--3773888----74143208978857734267
Q 005586          180 -IPDSLGNLGKLKRLDL--SFNSLFG----TIPESLANNAELLFLDVQNN  222 (689)
Q Consensus       180 -~p~~~~~l~~L~~L~l--s~N~l~~----~~p~~l~~~~~L~~l~l~~N  222 (689)
                       +-..+...++|+.++|  +.|.+..    .+...+...+.|+.|+++.+
T Consensus        93 ~l~~~l~~~~~L~~l~L~l~~n~i~~~~~~~La~~L~~n~~L~~L~l~~~  142 (166)
T d1io0a_          93 ALVEALQSNTSLIELRIDNQSQPLGNNVEMEIANMLEKNTTLLKFGYHFT  142 (166)
T ss_dssp             HHHHGGGGCSSCCEEECCCCSSCCCHHHHHHHHHHHHHCSSCCEEECCCS
T ss_pred             HHHHHHHHCCCCCEEEECCCCCCCCHHHHHHHHHHHHHCCCCCEEECCCC
T ss_conf             89999984865247732167786767999999999984998478858189